id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
161893225|NCT00398216|584658424|FG000|Overall Study|Adverse Event|4|||
161893226|NCT00398216|584658425|FG001|Overall Study|Adverse Event|2|||
161893227|NCT00398216|584658426|FG002|Overall Study|Adverse Event|5|||
161893228|NCT00398216|584658427|FG003|Overall Study|Adverse Event|7|||
161893229|NCT00398216|584658428|FG004|Overall Study|Adverse Event|2|||
161893230|NCT00398216|584658424|FG000|Overall Study|Protocol Violation|2|||
161893231|NCT00398216|584658425|FG001|Overall Study|Protocol Violation|4|||
161893232|NCT00398216|584658426|FG002|Overall Study|Protocol Violation|5|||
161893233|NCT00398216|584658427|FG003|Overall Study|Protocol Violation|7|||
161893234|NCT00398216|584658428|FG004|Overall Study|Protocol Violation|5|||
161893235|NCT00398216|584658424|FG000|Overall Study|Lost to Follow-up|1|||
161893236|NCT00398216|584658425|FG001|Overall Study|Lost to Follow-up|6|||
161893237|NCT00398216|584658426|FG002|Overall Study|Lost to Follow-up|4|||
161893238|NCT00398216|584658427|FG003|Overall Study|Lost to Follow-up|4|||
161893239|NCT00398216|584658428|FG004|Overall Study|Lost to Follow-up|1|||
161893240|NCT00398216|584658424|FG000|Overall Study|Death|0|||
161893241|NCT00398216|584658425|FG001|Overall Study|Death|3|||
161893242|NCT00398216|584658426|FG002|Overall Study|Death|0|||
161893243|NCT00398216|584658427|FG003|Overall Study|Death|0|||
161893244|NCT00398216|584658428|FG004|Overall Study|Death|0|||
161893245|NCT00398216|584658424|FG000|Overall Study|Withdrawal by Subject|1|||
161893246|NCT00398216|584658425|FG001|Overall Study|Withdrawal by Subject|0|||
161893247|NCT00398216|584658426|FG002|Overall Study|Withdrawal by Subject|3|||
161779061|NCT01964898|584233825|FG000|Overall Study|ineligible post-randomization|1|||
161893248|NCT00398216|584658427|FG003|Overall Study|Withdrawal by Subject|1|||
161893249|NCT00398216|584658428|FG004|Overall Study|Withdrawal by Subject|2|||
161893250|NCT00398216|584658424|FG000|Overall Study|administrative reasons|3|||
161893251|NCT00398216|584658425|FG001|Overall Study|administrative reasons|4|||
161893252|NCT00398216|584658426|FG002|Overall Study|administrative reasons|4|||
161893253|NCT00398216|584658427|FG003|Overall Study|administrative reasons|3|||
161893254|NCT00398216|584658428|FG004|Overall Study|administrative reasons|3|||
161893255|NCT00398216|584658424|FG000|Overall Study|entrance criteria|0|||
161893256|NCT00398216|584658425|FG001|Overall Study|entrance criteria|0|||
161893257|NCT00398216|584658426|FG002|Overall Study|entrance criteria|0|||
161893258|NCT00398216|584658427|FG003|Overall Study|entrance criteria|0|||
161893259|NCT00398216|584658428|FG004|Overall Study|entrance criteria|2|||
161893260|NCT01048944|584658429|FG000|Overall Study|Protocol Violation|8|||
161893261|NCT01048944|584658430|FG001|Overall Study|Protocol Violation|10|||
161893262|NCT01048944|584658431|FG002|Overall Study|Protocol Violation|10|||
161893263|NCT01048944|584658432|FG003|Overall Study|Protocol Violation|2|||
161893264|NCT01962948|584658433|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
161893265|NCT01962948|584658434|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
161893266|NCT01962948|584658435|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
161893267|NCT01962948|584658436|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
161893268|NCT00376532|584658437|FG000|Overall Study|Lack sufficient blood sample|6|||
161893269|NCT00376532|584658438|FG001|Overall Study|Lack sufficient blood sample|6|||
161893270|NCT01133704|584658439|FG000|Overall Study|Death|44|||
161893271|NCT01133704|584658440|FG001|Overall Study|Death|26|||
161893272|NCT01133704|584658439|FG000|Overall Study|Patient refused to continue|4|||
161893273|NCT01133704|584658440|FG001|Overall Study|Patient refused to continue|0|||
161893274|NCT01133704|584658439|FG000|Overall Study|Study Closure|1|||
161893275|NCT01133704|584658440|FG001|Overall Study|Study Closure|0|||
161893276|NCT02207400|584658441|FG000|Overall Study|Adverse Event|1|||
161893277|NCT02207400|584658442|FG001|Overall Study|Adverse Event|1|||
161893278|NCT02207400|584658441|FG000|Overall Study|Lost to Follow-up|6|||
161893279|NCT02207400|584658442|FG001|Overall Study|Lost to Follow-up|7|||
161893280|NCT02207400|584658441|FG000|Overall Study|Protocol Violation|1|||
161893281|NCT02207400|584658442|FG001|Overall Study|Protocol Violation|1|||
161893282|NCT02207400|584658441|FG000|Overall Study|Withdrawal by Subject|8|||
161893283|NCT02207400|584658442|FG001|Overall Study|Withdrawal by Subject|4|||
161893284|NCT02207400|584658441|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
161893285|NCT02207400|584658442|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
161893286|NCT02849704|584658443|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
161893287|NCT02849704|584658444|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
161893288|NCT02849704|584658443|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
161893289|NCT02849704|584658444|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
161893290|NCT02849704|584658443|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
161893291|NCT02849704|584658444|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
161893292|NCT00314808|584658452|FG000|Overall Study|Disease Progression without AE|4|||
161893293|NCT00314808|584658452|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
161893294|NCT04304508|584658453|FG000|Overall Study|Subject Decision|29|||
161893295|NCT04304508|584658454|FG001|Overall Study|Subject Decision|39|||
161893296|NCT04304508|584658455|FG002|Overall Study|Subject Decision|37|||
161893297|NCT04304508|584658456|FG003|Overall Study|Subject Decision|48|||
161893298|NCT04304508|584658453|FG000|Overall Study|Death|6|||
161893299|NCT04304508|584658454|FG001|Overall Study|Death|1|||
161893300|NCT04304508|584658455|FG002|Overall Study|Death|8|||
161893301|NCT04304508|584658456|FG003|Overall Study|Death|5|||
161893302|NCT04304508|584658453|FG000|Overall Study|Non-compliance With Study Drug|3|||
161893303|NCT04304508|584658454|FG001|Overall Study|Non-compliance With Study Drug|1|||
161893304|NCT04304508|584658455|FG002|Overall Study|Non-compliance With Study Drug|2|||
161893305|NCT04304508|584658456|FG003|Overall Study|Non-compliance With Study Drug|0|||
161893306|NCT04304508|584658453|FG000|Overall Study|Switching To Other Therapy|1|||
161893307|NCT04304508|584658454|FG001|Overall Study|Switching To Other Therapy|1|||
161893308|NCT04304508|584658455|FG002|Overall Study|Switching To Other Therapy|1|||
161893309|NCT04304508|584658456|FG003|Overall Study|Switching To Other Therapy|2|||
161893310|NCT04304508|584658453|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
161893311|NCT04304508|584658454|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
161893312|NCT04304508|584658455|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
161893313|NCT04304508|584658456|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
161893314|NCT04304508|584658453|FG000|Overall Study|Withdrawal by Subject|7|||
161893315|NCT04304508|584658454|FG001|Overall Study|Withdrawal by Subject|5|||
161893316|NCT04304508|584658455|FG002|Overall Study|Withdrawal by Subject|11|||
161893317|NCT04304508|584658456|FG003|Overall Study|Withdrawal by Subject|6|||
161893318|NCT04304508|584658453|FG000|Overall Study|Logistical Difficulties|2|||
161893319|NCT04304508|584658454|FG001|Overall Study|Logistical Difficulties|2|||
161893320|NCT04304508|584658455|FG002|Overall Study|Logistical Difficulties|3|||
161893321|NCT04304508|584658456|FG003|Overall Study|Logistical Difficulties|2|||
161893322|NCT04304508|584658453|FG000|Overall Study|Missing Information|1|||
161893323|NCT04304508|584658454|FG001|Overall Study|Missing Information|2|||
161893324|NCT04304508|584658455|FG002|Overall Study|Missing Information|1|||
161893325|NCT04304508|584658456|FG003|Overall Study|Missing Information|3|||
161893326|NCT04304508|584658453|FG000|Overall Study|Other|7|||
161893327|NCT04304508|584658454|FG001|Overall Study|Other|6|||
161893328|NCT04304508|584658455|FG002|Overall Study|Other|5|||
161893329|NCT04304508|584658456|FG003|Overall Study|Other|4|||
161893330|NCT04304508|584658453|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
161893331|NCT04304508|584658454|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161893332|NCT04304508|584658455|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161893333|NCT04304508|584658456|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161893334|NCT04304508|584658453|FG000|Overall Study|Physician Decision|3|||
161893335|NCT04304508|584658454|FG001|Overall Study|Physician Decision|4|||
161893336|NCT04304508|584658455|FG002|Overall Study|Physician Decision|9|||
161893337|NCT04304508|584658456|FG003|Overall Study|Physician Decision|7|||
161893338|NCT04304508|584658453|FG000|Overall Study|Study drug never administered|10|||
161893339|NCT04304508|584658454|FG001|Overall Study|Study drug never administered|4|||
161893340|NCT04304508|584658455|FG002|Overall Study|Study drug never administered|4|||
161893341|NCT04304508|584658456|FG003|Overall Study|Study drug never administered|4|||
161893342|NCT04304508|584658453|FG000|Overall Study|Adverse Event|49|||
161893343|NCT04304508|584658454|FG001|Overall Study|Adverse Event|50|||
161893344|NCT04304508|584658455|FG002|Overall Study|Adverse Event|51|||
161893345|NCT04304508|584658456|FG003|Overall Study|Adverse Event|56|||
161893346|NCT04304508|584658453|FG000|Overall Study|Lost to Follow-up|1|||
161893347|NCT04304508|584658454|FG001|Overall Study|Lost to Follow-up|5|||
161893348|NCT04304508|584658455|FG002|Overall Study|Lost to Follow-up|2|||
161893349|NCT04304508|584658456|FG003|Overall Study|Lost to Follow-up|3|||
161893350|NCT02113007|584658457|FG000|Overall Study|Progressive disease|2|||
161893351|NCT00885378|584658458|FG000|Overall Study|Lack of Efficacy|2|||
161893352|NCT00885378|584658459|FG001|Overall Study|Lack of Efficacy|2|||
161893353|NCT00885378|584658458|FG000|Overall Study|Withdrawal by Subject|1|||
161893354|NCT00885378|584658459|FG001|Overall Study|Withdrawal by Subject|2|||
161893355|NCT00885378|584658458|FG000|Overall Study|Lost to Follow-up|1|||
161550193|NCT01282476|583405065|FG000|Overall Study|Death|11|||
161550194|NCT00592319|583405068|FG000|Overall Study|Lost to Follow-up|0|||
161550195|NCT00592319|583405069|FG001|Overall Study|Lost to Follow-up|3|||
161550196|NCT01087723|583405071|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
161550197|NCT01087723|583405072|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
161779062|NCT01964898|584233826|FG001|Overall Study|ineligible post-randomization|1|||
161779063|NCT01964898|584233825|FG000|Overall Study|did not receive the allocated interventi|2|||
161779064|NCT01964898|584233826|FG001|Overall Study|did not receive the allocated interventi|1|||
161779065|NCT01964898|584233825|FG000|Overall Study|Lost to Follow-up|3|||
161779066|NCT01964898|584233826|FG001|Overall Study|Lost to Follow-up|5|||
161779067|NCT01964898|584233825|FG000|Overall Study|Withdrawal by Subject|1|||
161779068|NCT01964898|584233826|FG001|Overall Study|Withdrawal by Subject|0|||
161779069|NCT02428231|584233829|FG000|Overall Study|Other|10|||
161779070|NCT02428231|584233830|FG001|Overall Study|Other|16|||
161779071|NCT02428231|584233829|FG000|Overall Study|Required Symptomatic Therapy|0|||
161779072|NCT02428231|584233830|FG001|Overall Study|Required Symptomatic Therapy|1|||
161893356|NCT00885378|584658459|FG001|Overall Study|Lost to Follow-up|2|||
161893357|NCT00885378|584658458|FG000|Overall Study|Poor/Noncompliance|2|||
161893358|NCT00885378|584658459|FG001|Overall Study|Poor/Noncompliance|2|||
161893359|NCT00885378|584658458|FG000|Overall Study|Protocol Violation|2|||
161893360|NCT00885378|584658459|FG001|Overall Study|Protocol Violation|0|||
161893361|NCT01775787|584658460|FG000|First 7-10 Days|Adverse Event|0|||
161893362|NCT01775787|584658461|FG001|First 7-10 Days|Adverse Event|1|||
161893363|NCT01775787|584658460|FG000|First 7-10 Days|family emergency|0|||
161893364|NCT01775787|584658461|FG001|First 7-10 Days|family emergency|1|||
161779073|NCT02428231|584233829|FG000|Overall Study|Adverse Event|3|||
161779074|NCT02428231|584233830|FG001|Overall Study|Adverse Event|0|||
161779075|NCT02957682|584233833|FG000|Overall Study|Adverse Event|64|||
161779076|NCT02957682|584233834|FG001|Overall Study|Adverse Event|67|||
161779077|NCT02957682|584233833|FG000|Overall Study|Poor Compliance to Protocol|30|||
161779078|NCT02957682|584233834|FG001|Overall Study|Poor Compliance to Protocol|26|||
161893365|NCT01775787|584658460|FG000|First 7-10 Days|time commitment|0|||
161893366|NCT01775787|584658461|FG001|First 7-10 Days|time commitment|2|||
161893367|NCT01775787|584658460|FG000|First 7-10 Days|concerns with using IV|1|||
161779079|NCT02957682|584233833|FG000|Overall Study|Physician Decision|4|||
161779080|NCT02957682|584233834|FG001|Overall Study|Physician Decision|4|||
161779081|NCT02957682|584233833|FG000|Overall Study|Study Terminated by Sponsor|4|||
161779082|NCT02957682|584233834|FG001|Overall Study|Study Terminated by Sponsor|3|||
161779083|NCT02957682|584233833|FG000|Overall Study|Subject Moved|10|||
161779084|NCT02957682|584233834|FG001|Overall Study|Subject Moved|16|||
161779085|NCT02957682|584233833|FG000|Overall Study|Withdrawal by Subject|64|||
161779086|NCT02957682|584233834|FG001|Overall Study|Withdrawal by Subject|33|||
161779087|NCT02957682|584233833|FG000|Overall Study|Related to IMP Administration|3|||
161779088|NCT02957682|584233834|FG001|Overall Study|Related to IMP Administration|6|||
161779089|NCT02957682|584233833|FG000|Overall Study|Non-disclosed|16|||
161779090|NCT02957682|584233834|FG001|Overall Study|Non-disclosed|12|||
161779091|NCT02957682|584233833|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
161779092|NCT02957682|584233834|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
161779093|NCT02953262|584233835|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
161779094|NCT02953262|584233836|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
161779095|NCT02953262|584233837|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
161779096|NCT02953262|584233838|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
161779097|NCT03284424|584233839|FG000|Overall Study|Death|70|||
161779098|NCT03284424|584233840|FG001|Overall Study|Death|24|||
161779099|NCT03284424|584233839|FG000|Overall Study|Lost to Follow-up|3|||
161779100|NCT03284424|584233840|FG001|Overall Study|Lost to Follow-up|1|||
161779101|NCT03284424|584233839|FG000|Overall Study|Physician Decision|1|||
161779102|NCT03284424|584233840|FG001|Overall Study|Physician Decision|2|||
161893368|NCT01775787|584658461|FG001|First 7-10 Days|concerns with using IV|2|||
161893369|NCT01775787|584658460|FG000|Second 7-10 Days|time commitment|0|||
161893370|NCT01775787|584658461|FG001|Second 7-10 Days|time commitment|1|||
161779103|NCT03284424|584233839|FG000|Overall Study|Withdrawal by Subject|4|||
161779104|NCT03284424|584233840|FG001|Overall Study|Withdrawal by Subject|5|||
161779105|NCT03284424|584233839|FG000|Overall Study|Sponsor's decision|27|||
161779106|NCT03284424|584233840|FG001|Overall Study|Sponsor's decision|22|||
161779107|NCT02406742|584233841|FG000|Overall Study|Progression of Disease|5|||
161779108|NCT02406742|584233842|FG001|Overall Study|Progression of Disease|1|||
161779109|NCT02406742|584233843|FG002|Overall Study|Progression of Disease|6|||
161779110|NCT02406742|584233841|FG000|Overall Study|Adverse Event|3|||
161779111|NCT02406742|584233842|FG001|Overall Study|Adverse Event|0|||
161779112|NCT02406742|584233843|FG002|Overall Study|Adverse Event|2|||
161779113|NCT02406742|584233841|FG000|Overall Study|Death|1|||
161779114|NCT02406742|584233842|FG001|Overall Study|Death|0|||
161779115|NCT02406742|584233843|FG002|Overall Study|Death|0|||
161779116|NCT02406742|584233841|FG000|Overall Study|Lack of Efficacy|0|||
161779117|NCT02406742|584233842|FG001|Overall Study|Lack of Efficacy|0|||
161779118|NCT02406742|584233843|FG002|Overall Study|Lack of Efficacy|1|||
161779119|NCT02406742|584233841|FG000|Overall Study|Withdrawal by Participant|1|||
161779120|NCT02406742|584233842|FG001|Overall Study|Withdrawal by Participant|2|||
161893371|NCT01775787|584658460|FG000|Second 7-10 Days|concerns with using IV|0|||
161893372|NCT01775787|584658461|FG001|Second 7-10 Days|concerns with using IV|1|||
161893373|NCT03091738|584658462|FG000|Overall Study|Adverse Event|1|||
161779121|NCT02406742|584233843|FG002|Overall Study|Withdrawal by Participant|0|||
161779122|NCT02406742|584233841|FG000|Overall Study|Physician Decision|1|||
161779123|NCT02406742|584233842|FG001|Overall Study|Physician Decision|2|||
161893374|NCT03091738|584658462|FG000|Overall Study|Lost to Follow-up|1|||
161893375|NCT04446429|584658469|FG000|Overall Study|Lost to Follow-up|6|||
161893376|NCT04446429|584658470|FG001|Overall Study|Lost to Follow-up|0|||
161603526|NCT04055012|583602412|FG000|Overall Study|Metformin Recall|1|||
161893377|NCT05205005|584658471|FG000|Overall Study|Withdrawal by Subject|1|||
161893378|NCT05205005|584658472|FG001|Overall Study|Withdrawal by Subject|0|||
161893379|NCT05205005|584658471|FG000|Overall Study|Adverse Event|1|||
161893380|NCT05205005|584658472|FG001|Overall Study|Adverse Event|0|||
161893381|NCT03042910|584658473|FG000|Overall Study|Adverse Event|1|||
161893382|NCT03042910|584658473|FG000|Overall Study|Disease Progression|2|||
161893383|NCT03042910|584658473|FG000|Overall Study|Withdrawal by Subject|3|||
161893384|NCT03042910|584658473|FG000|Overall Study|Enrolled but not treated|1|||
161893385|NCT02187861|584658474|FG000|Overall Study|Adverse Event|2|||
161893386|NCT02187861|584658475|FG001|Overall Study|Adverse Event|1|||
161893387|NCT02187861|584658476|FG002|Overall Study|Adverse Event|2|||
161893388|NCT02187861|584658477|FG003|Overall Study|Adverse Event|1|||
161893389|NCT02187861|584658474|FG000|Overall Study|Death|0|||
161893390|NCT02187861|584658475|FG001|Overall Study|Death|3|||
161893391|NCT02187861|584658476|FG002|Overall Study|Death|1|||
161893392|NCT02187861|584658477|FG003|Overall Study|Death|2|||
161893393|NCT02187861|584658474|FG000|Overall Study|Physician Decision|0|||
161893394|NCT02187861|584658475|FG001|Overall Study|Physician Decision|1|||
161893395|NCT02187861|584658476|FG002|Overall Study|Physician Decision|0|||
161893396|NCT02187861|584658477|FG003|Overall Study|Physician Decision|3|||
161893397|NCT02187861|584658474|FG000|Overall Study|Progressive Disease|4|||
161893398|NCT02187861|584658475|FG001|Overall Study|Progressive Disease|42|||
161893399|NCT02187861|584658476|FG002|Overall Study|Progressive Disease|19|||
161893400|NCT02187861|584658477|FG003|Overall Study|Progressive Disease|22|||
161893401|NCT02187861|584658474|FG000|Overall Study|Withdrawal by Subject|0|||
161893402|NCT02187861|584658475|FG001|Overall Study|Withdrawal by Subject|0|||
161893403|NCT02187861|584658476|FG002|Overall Study|Withdrawal by Subject|3|||
161893404|NCT02187861|584658477|FG003|Overall Study|Withdrawal by Subject|3|||
161893405|NCT02187861|584658474|FG000|Overall Study|Other|0|||
161893406|NCT02187861|584658475|FG001|Overall Study|Other|1|||
161893407|NCT02187861|584658476|FG002|Overall Study|Other|7|||
161893408|NCT02187861|584658477|FG003|Overall Study|Other|1|||
161893409|NCT01491841|584658479|FG000|Overall Study|Screen Failure|10|||
161893410|NCT01491841|584658479|FG000|Overall Study|Withdrawal by Subject|1|||
161893411|NCT00264290|584658480|FG000|Intervention (8 Weeks)|Adverse Event|1|||
161893412|NCT00264290|584658481|FG001|Intervention (8 Weeks)|Adverse Event|0|||
161893413|NCT04472494|584658482|FG000|Pre-treatment|Other reasons|2|||
161893414|NCT04472494|584658483|FG001|Pre-treatment|Other reasons|0|||
161893415|NCT04472494|584658482|FG000|Treatment|Death|5|||
161893416|NCT04472494|584658483|FG001|Treatment|Death|2|||
161893417|NCT04472494|584658482|FG000|Treatment|Hospital discharge|1|||
161893418|NCT04472494|584658483|FG001|Treatment|Hospital discharge|1|||
161893419|NCT00587795|584658489|FG000|Overall Study|Withdrawal by Subject|1|||
161893420|NCT00587795|584658490|FG001|Overall Study|Withdrawal by Subject|0|||
161893421|NCT01869777|584658491|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
161893422|NCT01951573|584658492|FG000|Washout Period|Adverse Event|0|||
161893423|NCT01951573|584658493|FG001|Washout Period|Adverse Event|1|||
161893424|NCT04399889|584658494|FG000|Overall Study|Death|5|||
161893425|NCT04399889|584658495|FG001|Overall Study|Death|1|||
161893426|NCT04399889|584658496|FG002|Overall Study|Death|1|||
161893427|NCT00707980|584658497|FG000|Overall Study|Adverse Event|49|||
161893428|NCT00707980|584658497|FG000|Overall Study|Lack of Efficacy|35|||
161893429|NCT00707980|584658497|FG000|Overall Study|Non-Compliance with Study Drug|28|||
161893430|NCT00707980|584658497|FG000|Overall Study|Protocol Deviations|19|||
161893431|NCT00707980|584658497|FG000|Overall Study|Withdrawal of Consent|81|||
161893432|NCT00707980|584658497|FG000|Overall Study|Lost to Follow-up|59|||
161893433|NCT00707980|584658497|FG000|Overall Study|Other|39|||
161893434|NCT01152996|584658498|FG000|Overall Study|Withdrawal by Subject|142|||
161893435|NCT01152996|584658498|FG000|Overall Study|Adverse Event|115|||
161893436|NCT01152996|584658498|FG000|Overall Study|Lost to Follow-up|112|||
161893437|NCT01152996|584658498|FG000|Overall Study|Lack of Efficacy|68|||
161893438|NCT01152996|584658498|FG000|Overall Study|Noncompliance|41|||
161893439|NCT01152996|584658498|FG000|Overall Study|Other|36|||
161893440|NCT01152996|584658498|FG000|Overall Study|Protocol Violation|22|||
161893441|NCT01152996|584658498|FG000|Overall Study|Elevated liver enzymes|1|||
161893442|NCT00460239|584658499|FG000|Overall Study|Physician Decision|0|||
161893443|NCT00460239|584658500|FG001|Overall Study|Physician Decision|1|||
161893444|NCT00460239|584658501|FG002|Overall Study|Physician Decision|0|||
161893445|NCT00460239|584658502|FG003|Overall Study|Physician Decision|0|||
161893446|NCT00460239|584658503|FG004|Overall Study|Physician Decision|0|||
161893447|NCT00460239|584658504|FG005|Overall Study|Physician Decision|2|||
161893448|NCT00460239|584658505|FG006|Overall Study|Physician Decision|0|||
161893449|NCT00460239|584658506|FG007|Overall Study|Physician Decision|0|||
161893450|NCT00460239|584658507|FG008|Overall Study|Physician Decision|0|||
161893451|NCT00460239|584658499|FG000|Overall Study|Withdrawal by Subject|0|||
161893452|NCT00460239|584658500|FG001|Overall Study|Withdrawal by Subject|0|||
161893453|NCT00460239|584658501|FG002|Overall Study|Withdrawal by Subject|0|||
161893454|NCT00460239|584658502|FG003|Overall Study|Withdrawal by Subject|0|||
161893455|NCT00460239|584658503|FG004|Overall Study|Withdrawal by Subject|0|||
161893456|NCT00460239|584658504|FG005|Overall Study|Withdrawal by Subject|1|||
161893457|NCT00460239|584658505|FG006|Overall Study|Withdrawal by Subject|0|||
161893458|NCT00460239|584658506|FG007|Overall Study|Withdrawal by Subject|0|||
161893459|NCT00460239|584658507|FG008|Overall Study|Withdrawal by Subject|0|||
161893460|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
161893461|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
161893462|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
161893463|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
161893464|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
161893465|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
161893466|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
161893467|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
161893468|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
161893469|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
161893470|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
161893471|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
161893472|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
161893473|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
161893474|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
161893475|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
161893476|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161893477|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
161893478|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161893479|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161893480|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893481|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
161893482|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893483|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893484|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893485|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
161893486|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
161893487|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
161893488|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
161893489|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
161893490|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
161893491|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
161893492|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
161893493|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
161893494|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
161893495|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893496|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893497|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
161893498|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893499|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893500|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893501|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893502|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893503|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893504|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
161893505|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161893506|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161893507|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
161893508|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
161893509|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161893510|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
161893511|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
161893512|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
161893513|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161893514|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161893515|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161893516|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
161893517|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893518|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893519|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893520|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893521|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893522|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
161893523|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
161893524|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161893525|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161893526|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161550198|NCT01087723|583405071|FG000|Overall Study|Withdrawal by Subject|10|||
161664344|NCT05195489|583824189|FG000|Overall Study|Lost to Follow-up|1|||
161893527|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161893528|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
161893529|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
161893530|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
161893531|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161893532|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161893533|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161893534|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161893535|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161893536|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161893537|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
161893538|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
161893539|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
161893540|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161893541|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161893542|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161893543|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
161893544|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
161893545|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
161893546|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893547|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893548|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893549|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893550|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
161893551|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
161893552|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161893553|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161893554|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161893555|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
161893556|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
161893557|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
161893558|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161893559|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161893560|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161893561|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
161893562|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
161893563|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
161893564|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893565|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893566|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893567|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893568|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893569|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
161893570|NCT01882803|584658524|FG000|Overall Study|Disease Progression|1|||
161893571|NCT01882803|584658524|FG000|Overall Study|Withdrawal by Subject|9|||
161893572|NCT01882803|584658524|FG000|Overall Study|Death|68|||
161893573|NCT01882803|584658524|FG000|Overall Study|Physician Decision|3|||
161893574|NCT01882803|584658524|FG000|Overall Study|Lost to Follow-up|3|||
161893575|NCT01882803|584658524|FG000|Overall Study|Follow-up Completed|39|||
161893576|NCT01882803|584658524|FG000|Overall Study|Study Terminated by the Sponsor|6|||
161893577|NCT02869893|584658525|FG000|Overall Study|participant aversion to IV|5|||
161779124|NCT02406742|584233843|FG002|Overall Study|Physician Decision|1|||
161779125|NCT02406742|584233841|FG000|Overall Study|Transition to other treatment|2|||
161779126|NCT02406742|584233842|FG001|Overall Study|Transition to other treatment|0|||
161779127|NCT02406742|584233843|FG002|Overall Study|Transition to other treatment|1|||
161779128|NCT02406742|584233841|FG000|Overall Study|Other Reasons|1|||
161779129|NCT02406742|584233842|FG001|Overall Study|Other Reasons|11|||
161779130|NCT02406742|584233843|FG002|Overall Study|Other Reasons|5|||
161779131|NCT00765999|584233844|FG000|Overall Study|Adverse Event|203|||
161779132|NCT00765999|584233844|FG000|Overall Study|Insufficient Therapeutic Response|100|||
161779133|NCT00765999|584233844|FG000|Overall Study|Protocol Violation|95|||
161779134|NCT00765999|584233844|FG000|Overall Study|Consent Withdrawn|202|||
161779135|NCT00765999|584233844|FG000|Overall Study|Lost to Follow-up|131|||
161779136|NCT00765999|584233844|FG000|Overall Study|Study Terminated by Sponsor|2|||
161779137|NCT00765999|584233844|FG000|Overall Study|Other Miscellaneous Reasons|51|||
161779138|NCT02367729|584233847|FG000|Overall Study|Organic disorder diagnosed|2|||
161779139|NCT02367729|584233848|FG001|Overall Study|Organic disorder diagnosed|1|||
161893578|NCT02869893|584658525|FG000|Overall Study|participant fear of MRI scanner|2|||
161893579|NCT01563913|584658526|FG000|Overall Study|Physician Decision|1|||
161893580|NCT01563913|584658527|FG001|Overall Study|Physician Decision|0|||
161893581|NCT01563913|584658526|FG000|Overall Study|Spouse Passed Away|1|||
161893582|NCT01563913|584658527|FG001|Overall Study|Spouse Passed Away|0|||
161893583|NCT03066778|584658528|FG000|Overall Study|Death|195|||
161893584|NCT03066778|584658529|FG001|Overall Study|Death|205|||
161893585|NCT03066778|584658528|FG000|Overall Study|Withdrawal by Subject|5|||
161893586|NCT03066778|584658529|FG001|Overall Study|Withdrawal by Subject|7|||
161893587|NCT00551525|584658530|FG000|Overall Study|Protocol Violation|5|||
161893588|NCT05259917|584658536|FG000|Overall Study|Protocol Violation|0|||
161893589|NCT05259917|584658537|FG001|Overall Study|Protocol Violation|0|||
161893590|NCT05259917|584658538|FG002|Overall Study|Protocol Violation|1|||
161893591|NCT05259917|584658539|FG003|Overall Study|Protocol Violation|0|||
161893592|NCT05259917|584658540|FG004|Overall Study|Protocol Violation|0|||
161893593|NCT05259917|584658541|FG005|Overall Study|Protocol Violation|0|||
161893594|NCT05259917|584658536|FG000|Overall Study|Lost to Follow-up|0|||
161893595|NCT05259917|584658537|FG001|Overall Study|Lost to Follow-up|0|||
161893596|NCT05259917|584658538|FG002|Overall Study|Lost to Follow-up|1|||
161893597|NCT05259917|584658539|FG003|Overall Study|Lost to Follow-up|0|||
161893598|NCT05259917|584658540|FG004|Overall Study|Lost to Follow-up|0|||
161893599|NCT05259917|584658541|FG005|Overall Study|Lost to Follow-up|1|||
161893600|NCT05259917|584658536|FG000|Overall Study|Physician Decision|0|||
161893601|NCT05259917|584658537|FG001|Overall Study|Physician Decision|1|||
161779140|NCT02367729|584233847|FG000|Overall Study|Adverse Event|1|||
161779141|NCT02367729|584233848|FG001|Overall Study|Adverse Event|2|||
161893602|NCT05259917|584658538|FG002|Overall Study|Physician Decision|0|||
161893603|NCT05259917|584658539|FG003|Overall Study|Physician Decision|0|||
161893604|NCT05259917|584658540|FG004|Overall Study|Physician Decision|0|||
161893605|NCT05259917|584658541|FG005|Overall Study|Physician Decision|0|||
161893606|NCT05259917|584658536|FG000|Overall Study|Withdrawal by Subject|0|||
161893607|NCT05259917|584658537|FG001|Overall Study|Withdrawal by Subject|1|||
161893608|NCT05259917|584658538|FG002|Overall Study|Withdrawal by Subject|0|||
161893609|NCT05259917|584658539|FG003|Overall Study|Withdrawal by Subject|0|||
161893610|NCT05259917|584658540|FG004|Overall Study|Withdrawal by Subject|1|||
161893611|NCT05259917|584658541|FG005|Overall Study|Withdrawal by Subject|1|||
161893612|NCT05259917|584658536|FG000|Overall Study|Trial Termination by Sponsor|7|||
161779142|NCT02367729|584233847|FG000|Overall Study|Withdrawal by Subject|0|||
161779143|NCT02367729|584233848|FG001|Overall Study|Withdrawal by Subject|5|||
161779144|NCT00759174|584233849|FG000|Overall Study|Other|0|||
161779145|NCT00759174|584233850|FG001|Overall Study|Other|2|||
161779146|NCT01890109|584233851|FG000|Overall Study|Withdrawal by Subject|0|||
161779147|NCT01890109|584233852|FG001|Overall Study|Withdrawal by Subject|3|||
161893613|NCT05259917|584658537|FG001|Overall Study|Trial Termination by Sponsor|2|||
161893614|NCT05259917|584658538|FG002|Overall Study|Trial Termination by Sponsor|3|||
161893615|NCT05259917|584658539|FG003|Overall Study|Trial Termination by Sponsor|5|||
161893616|NCT05259917|584658540|FG004|Overall Study|Trial Termination by Sponsor|11|||
161893617|NCT05259917|584658541|FG005|Overall Study|Trial Termination by Sponsor|4|||
161893618|NCT05259917|584658536|FG000|Overall Study|Other|1|||
161893619|NCT05259917|584658537|FG001|Overall Study|Other|0|||
161893620|NCT05259917|584658538|FG002|Overall Study|Other|2|||
161893621|NCT05259917|584658539|FG003|Overall Study|Other|0|||
161893622|NCT05259917|584658540|FG004|Overall Study|Other|0|||
161893623|NCT05259917|584658541|FG005|Overall Study|Other|0|||
161893624|NCT00303472|584658546|FG000|Treatment Period|Adverse Event|0|||
161893625|NCT00303472|584658547|FG001|Treatment Period|Adverse Event|0|||
161893626|NCT00303472|584658548|FG002|Treatment Period|Adverse Event|0|||
161893627|NCT00303472|584658549|FG003|Treatment Period|Adverse Event|0|||
161893628|NCT00303472|584658550|FG004|Treatment Period|Adverse Event|1|||
161893629|NCT00303472|584658551|FG005|Treatment Period|Adverse Event|0|||
161893630|NCT00303472|584658552|FG006|Treatment Period|Adverse Event|0|||
161893631|NCT00303472|584658546|FG000|Treatment Period|Death|0|||
161893632|NCT00303472|584658547|FG001|Treatment Period|Death|0|||
161893633|NCT00303472|584658548|FG002|Treatment Period|Death|0|||
161893634|NCT00303472|584658549|FG003|Treatment Period|Death|1|||
161893635|NCT00303472|584658550|FG004|Treatment Period|Death|0|||
161893636|NCT00303472|584658551|FG005|Treatment Period|Death|0|||
161893637|NCT00303472|584658552|FG006|Treatment Period|Death|1|||
161893638|NCT00303472|584658546|FG000|Treatment Period|Withdrawal by Subject|0|||
161893639|NCT00303472|584658547|FG001|Treatment Period|Withdrawal by Subject|0|||
161893640|NCT00303472|584658548|FG002|Treatment Period|Withdrawal by Subject|0|||
161893641|NCT00303472|584658549|FG003|Treatment Period|Withdrawal by Subject|1|||
161893642|NCT00303472|584658550|FG004|Treatment Period|Withdrawal by Subject|0|||
161893643|NCT00303472|584658551|FG005|Treatment Period|Withdrawal by Subject|1|||
161893644|NCT00303472|584658552|FG006|Treatment Period|Withdrawal by Subject|0|||
161893645|NCT00303472|584658546|FG000|Treatment Period|Other|0|||
161779148|NCT01890109|584233851|FG000|Overall Study|Lost to Follow-up|1|||
161893646|NCT00303472|584658547|FG001|Treatment Period|Other|0|||
161893647|NCT00303472|584658548|FG002|Treatment Period|Other|0|||
161893648|NCT00303472|584658549|FG003|Treatment Period|Other|0|||
161893649|NCT00303472|584658550|FG004|Treatment Period|Other|1|||
161893650|NCT00303472|584658551|FG005|Treatment Period|Other|0|||
161893651|NCT00303472|584658552|FG006|Treatment Period|Other|1|||
161893652|NCT00303472|584658546|FG000|Treatment Period|Disease Progression (to AML)|0|||
161893653|NCT00303472|584658547|FG001|Treatment Period|Disease Progression (to AML)|0|||
161893654|NCT00303472|584658548|FG002|Treatment Period|Disease Progression (to AML)|0|||
161893655|NCT00303472|584658549|FG003|Treatment Period|Disease Progression (to AML)|0|||
161893656|NCT00303472|584658550|FG004|Treatment Period|Disease Progression (to AML)|1|||
161893657|NCT00303472|584658551|FG005|Treatment Period|Disease Progression (to AML)|0|||
161893658|NCT00303472|584658552|FG006|Treatment Period|Disease Progression (to AML)|0|||
161893659|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Adverse Event|1|||
161893660|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Adverse Event|0|||
161893661|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Adverse Event|1|||
161893662|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Adverse Event|0|||
161893663|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Adverse Event|0|||
161893664|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Adverse Event|0|||
161893665|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Adverse Event|0|||
161893666|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Death|2|||
161893667|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Death|0|||
161893668|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Death|1|||
161893669|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Death|0|||
161893670|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Death|0|||
161893671|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Death|0|||
161893672|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Death|0|||
161893673|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893674|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893675|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893676|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
161893677|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893678|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893679|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893680|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Physician Decision|0|||
161893681|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Physician Decision|4|||
161893682|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Physician Decision|2|||
161893683|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Physician Decision|3|||
161893684|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Physician Decision|2|||
161893685|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Physician Decision|0|||
161893686|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Physician Decision|0|||
161893687|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161893688|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161893689|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161893690|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
161893691|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161893692|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161893693|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161550199|NCT01087723|583405072|FG001|Overall Study|Withdrawal by Subject|13|||
161550200|NCT01087723|583405071|FG000|Overall Study|Physician Decision|2|||
161550201|NCT01087723|583405072|FG001|Overall Study|Physician Decision|0|||
161550202|NCT01087723|583405071|FG000|Overall Study|Lost to Follow-up|1|||
161550203|NCT01087723|583405072|FG001|Overall Study|Lost to Follow-up|4|||
161550204|NCT01087723|583405071|FG000|Overall Study|Reason Not Specified|1|||
161550205|NCT01087723|583405072|FG001|Overall Study|Reason Not Specified|2|||
161550206|NCT01868035|583405073|FG000|Overall Study|Lost to Follow-up|3|||
161550207|NCT01868035|583405073|FG000|Overall Study|Withdrawal by Subject|1|||
161550208|NCT01868035|583405073|FG000|Overall Study|Progressive Disease|2|||
161550209|NCT01868035|583405073|FG000|Overall Study|Non-compliance|1|||
161550210|NCT01757665|583405078|FG000|Overall Study|Still on Study - Visit Completed|240|||
161550211|NCT01757665|583405079|FG001|Overall Study|Still on Study - Visit Completed|30|||
161550212|NCT01757665|583405078|FG000|Overall Study|Still on Study - Visit Pending|398|||
161550213|NCT01757665|583405079|FG001|Overall Study|Still on Study - Visit Pending|40|||
161550214|NCT01757665|583405078|FG000|Overall Study|Still on Study - Missed Visit|14|||
161550215|NCT01757665|583405079|FG001|Overall Study|Still on Study - Missed Visit|1|||
161550216|NCT01757665|583405078|FG000|Overall Study|Death|25|||
161550217|NCT01757665|583405079|FG001|Overall Study|Death|8|||
161436012|NCT01148979|582991250|FG000|Overall Study|Lost to Follow-up|0|||
161436013|NCT01148979|582991251|FG001|Overall Study|Lost to Follow-up|1|||
161893694|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Other|0|||
161893695|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Other|2|||
161893696|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Other|4|||
161893697|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Other|2|||
161550218|NCT01757665|583405078|FG000|Overall Study|Explant|1|||
161893698|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Other|1|||
161893699|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Other|0|||
161436014|NCT00777153|582991252|FG000|Overall Study|Lost to Follow-up|1|||
161436015|NCT00777153|582991253|FG001|Overall Study|Lost to Follow-up|1|||
161436016|NCT00777153|582991254|FG002|Overall Study|Lost to Follow-up|0|||
161436017|NCT00777153|582991252|FG000|Overall Study|Death|85|||
161436018|NCT00777153|582991253|FG001|Overall Study|Death|73|||
161436019|NCT00777153|582991254|FG002|Overall Study|Death|33|||
161436020|NCT00777153|582991252|FG000|Overall Study|Withdrawal by Subject|3|||
161436021|NCT00777153|582991253|FG001|Overall Study|Withdrawal by Subject|4|||
161436022|NCT00777153|582991254|FG002|Overall Study|Withdrawal by Subject|3|||
161436023|NCT00777153|582991252|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
161436024|NCT00777153|582991253|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
161436025|NCT00777153|582991254|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
161550219|NCT01757665|583405079|FG001|Overall Study|Explant|2|||
161550220|NCT01757665|583405078|FG000|Overall Study|Withdrawal by Subject|10|||
161550221|NCT01757665|583405079|FG001|Overall Study|Withdrawal by Subject|0|||
161550222|NCT01757665|583405078|FG000|Overall Study|Lost to Follow-up|1|||
161550223|NCT01757665|583405079|FG001|Overall Study|Lost to Follow-up|1|||
161550224|NCT01757665|583405078|FG000|Overall Study|Not Implanted with Device|5|||
161550225|NCT01757665|583405079|FG001|Overall Study|Not Implanted with Device|1|||
161550226|NCT01912222|583405082|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
161550227|NCT01912222|583405083|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
161550228|NCT01912222|583405084|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
161550229|NCT01912222|583405082|FG000|Part B: Treatment Period|Progressive disease|10|||
161550230|NCT01912222|583405083|FG001|Part B: Treatment Period|Progressive disease|12|||
161550231|NCT01912222|583405084|FG002|Part B: Treatment Period|Progressive disease|15|||
161550232|NCT01912222|583405082|FG000|Part B: Treatment Period|Adverse Event|1|||
161550233|NCT01912222|583405083|FG001|Part B: Treatment Period|Adverse Event|2|||
161550234|NCT01912222|583405084|FG002|Part B: Treatment Period|Adverse Event|3|||
161550235|NCT01912222|583405082|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
161893700|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Other|0|||
161893701|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
161893702|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893703|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893704|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893705|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893706|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
161893707|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893708|NCT01808222|584658553|FG000|Overall Study|mpMR scan was not performed|1|||
161893709|NCT00621517|584658554|FG000|Overall Study|Lost to Follow-up|3|||
161893710|NCT00621517|584658555|FG001|Overall Study|Lost to Follow-up|3|||
161893711|NCT00621517|584658554|FG000|Overall Study|Withdrawal by Subject|3|||
161893712|NCT00621517|584658555|FG001|Overall Study|Withdrawal by Subject|4|||
161893713|NCT00621517|584658554|FG000|Overall Study|Adverse Event|1|||
161893714|NCT00621517|584658555|FG001|Overall Study|Adverse Event|0|||
161893715|NCT00856843|584658556|FG000|Overall Study|Withdrawal by Subject|1|||
161893716|NCT00856843|584658557|FG001|Overall Study|Withdrawal by Subject|5|||
161550236|NCT01912222|583405083|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
161550237|NCT01912222|583405084|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
161550238|NCT00154063|583405085|FG000|Overall Study|Adverse Event|4|||
161550239|NCT00154063|583405086|FG001|Overall Study|Adverse Event|8|||
161550240|NCT00154063|583405085|FG000|Overall Study|Protocol Violation|1|||
161550241|NCT00154063|583405086|FG001|Overall Study|Protocol Violation|1|||
161550242|NCT00154063|583405085|FG000|Overall Study|Investigator or Sponsor Request|0|||
161550243|NCT00154063|583405086|FG001|Overall Study|Investigator or Sponsor Request|1|||
161550244|NCT00154063|583405085|FG000|Overall Study|Withdrawal by Subject|4|||
161550245|NCT00154063|583405086|FG001|Overall Study|Withdrawal by Subject|9|||
161550246|NCT00154063|583405085|FG000|Overall Study|Other|3|||
161550247|NCT00154063|583405086|FG001|Overall Study|Other|3|||
161550248|NCT01804673|583405087|FG000|Overall Study|Adverse Event|4|||
161550249|NCT01804673|583405087|FG000|Overall Study|Withdrawal by Subject|1|||
161550250|NCT01804673|583405087|FG000|Overall Study|Lack of Efficacy|9|||
161550251|NCT01804673|583405087|FG000|Overall Study|Change to Oral Therapy|37|||
161550252|NCT01804673|583405087|FG000|Overall Study|No Further Therapy Required|84|||
161550253|NCT01804673|583405087|FG000|Overall Study|Use of Prohibited Medication|1|||
161550254|NCT01804673|583405087|FG000|Overall Study|Other|4|||
161550255|NCT01857934|583405095|FG000|Overall Study|Relapse or progression|2|||
161550256|NCT01857934|583405095|FG000|Overall Study|Unacceptable toxicity|3|||
161550257|NCT01857934|583405095|FG000|Overall Study|Unwillingness or inability to comply|2|||
161550258|NCT01857934|583405095|FG000|Overall Study|Physician Decision|3|||
161550259|NCT04012814|583405102|FG000|Overall Study|Lost to Follow-up|4|||
161550260|NCT04012814|583405102|FG000|Overall Study|Withdrawal by Subject|2|||
161550261|NCT04012814|583405102|FG000|Overall Study|Protocol Violation|1|||
161550262|NCT04012814|583405102|FG000|Overall Study|Adverse Event|1|||
161550263|NCT04789577|583405103|FG000|Overall Study|Withdrawal by Subject|1|||
161550264|NCT04789577|583405104|FG001|Overall Study|Withdrawal by Subject|1|||
161550265|NCT04789577|583405105|FG002|Overall Study|Withdrawal by Subject|1|||
161550266|NCT04789577|583405106|FG003|Overall Study|Withdrawal by Subject|3|||
161550267|NCT04789577|583405107|FG004|Overall Study|Withdrawal by Subject|1|||
161550268|NCT04789577|583405108|FG005|Overall Study|Withdrawal by Subject|7|||
161550269|NCT04789577|583405109|FG006|Overall Study|Withdrawal by Subject|1|||
161550270|NCT04789577|583405103|FG000|Overall Study|Lost to Follow-up|7|||
161550271|NCT04789577|583405104|FG001|Overall Study|Lost to Follow-up|12|||
161550272|NCT04789577|583405105|FG002|Overall Study|Lost to Follow-up|7|||
161550273|NCT04789577|583405106|FG003|Overall Study|Lost to Follow-up|10|||
161550274|NCT04789577|583405107|FG004|Overall Study|Lost to Follow-up|8|||
161550275|NCT04789577|583405108|FG005|Overall Study|Lost to Follow-up|6|||
161550276|NCT04789577|583405109|FG006|Overall Study|Lost to Follow-up|10|||
161550277|NCT04789577|583405103|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
161550278|NCT04789577|583405104|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
161550279|NCT04789577|583405105|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
161550280|NCT04789577|583405106|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
161550281|NCT04789577|583405107|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
161550282|NCT04789577|583405108|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
161550283|NCT04789577|583405109|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
161550284|NCT04789577|583405103|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
161550285|NCT04789577|583405104|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
161550286|NCT04789577|583405105|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
161550287|NCT04789577|583405106|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
161550288|NCT04789577|583405107|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
161550289|NCT04789577|583405108|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
161550290|NCT04789577|583405109|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
161550291|NCT02441946|583405110|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
161550292|NCT02441946|583405111|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
161550293|NCT02441946|583405112|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
161550294|NCT02441946|583405110|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
161550295|NCT02441946|583405111|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
161550296|NCT02441946|583405112|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
161550297|NCT02441946|583405110|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161550298|NCT02441946|583405111|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
161550299|NCT02441946|583405112|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161664345|NCT05195489|583824190|FG001|Overall Study|Lost to Follow-up|0|||
161550300|NCT02441946|583405110|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
161550301|NCT02441946|583405111|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
161550302|NCT02441946|583405112|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
161550303|NCT02441946|583405110|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
161550304|NCT02441946|583405111|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
161550305|NCT02441946|583405112|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
161550306|NCT02441946|583405110|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
161550307|NCT02441946|583405111|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
161550308|NCT02441946|583405112|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
161550309|NCT02441946|583405110|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
161550310|NCT02441946|583405111|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
161550311|NCT02441946|583405112|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
161550312|NCT02441946|583405110|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
161550313|NCT02441946|583405111|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
161550314|NCT02441946|583405112|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
161550315|NCT02441946|583405110|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
161550316|NCT02441946|583405111|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
161550317|NCT02441946|583405112|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
161550318|NCT02441946|583405110|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
161550319|NCT02441946|583405111|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
161550320|NCT02441946|583405112|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
161550321|NCT02441946|583405110|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
161550322|NCT02441946|583405111|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161550323|NCT02441946|583405112|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161550324|NCT00579982|583405117|FG000|Overall Study|Adverse Event|4|||
161550325|NCT00579982|583405117|FG000|Overall Study|Protocol Violation|4|||
161550326|NCT00988351|583405119|FG000|Overall Study|Withdrawal by Subject|8|||
161550327|NCT00988351|583405120|FG001|Overall Study|Withdrawal by Subject|0|||
161550328|NCT00988351|583405119|FG000|Overall Study|Lost to Follow-up|6|||
161550329|NCT00988351|583405120|FG001|Overall Study|Lost to Follow-up|9|||
161550330|NCT00988351|583405119|FG000|Overall Study|not using CPAP|5|||
161550331|NCT00988351|583405120|FG001|Overall Study|not using CPAP|3|||
161550332|NCT02038764|583405121|FG000|Overall Study|Adverse Event|0|||
161550333|NCT02038764|583405122|FG001|Overall Study|Adverse Event|0|||
161550334|NCT02038764|583405123|FG002|Overall Study|Adverse Event|1|||
161550335|NCT02038764|583405124|FG003|Overall Study|Adverse Event|0|||
161550336|NCT02038764|583405125|FG004|Overall Study|Adverse Event|0|||
161550337|NCT02038764|583405121|FG000|Overall Study|Lost to Follow-up|0|||
161550338|NCT02038764|583405122|FG001|Overall Study|Lost to Follow-up|1|||
161550339|NCT02038764|583405123|FG002|Overall Study|Lost to Follow-up|0|||
161550340|NCT02038764|583405124|FG003|Overall Study|Lost to Follow-up|0|||
161550341|NCT02038764|583405125|FG004|Overall Study|Lost to Follow-up|0|||
161550342|NCT02038764|583405121|FG000|Overall Study|Withdrawal by Subject|0|||
161550343|NCT02038764|583405122|FG001|Overall Study|Withdrawal by Subject|0|||
161550344|NCT02038764|583405123|FG002|Overall Study|Withdrawal by Subject|0|||
161550345|NCT02038764|583405124|FG003|Overall Study|Withdrawal by Subject|0|||
161550346|NCT02038764|583405125|FG004|Overall Study|Withdrawal by Subject|1|||
161550347|NCT02038764|583405121|FG000|Overall Study|Other|1|||
161550348|NCT02038764|583405122|FG001|Overall Study|Other|0|||
161550349|NCT02038764|583405123|FG002|Overall Study|Other|1|||
161550350|NCT02038764|583405124|FG003|Overall Study|Other|0|||
161550351|NCT02038764|583405125|FG004|Overall Study|Other|0|||
161550352|NCT04297241|583405130|FG000|Overall Study|Withdrawal by Subject|1|||
161550353|NCT04297241|583405130|FG000|Overall Study|Adverse Event|1|||
161550354|NCT04297241|583405130|FG000|Overall Study|Physician Decision|3|||
161550355|NCT02836613|583405133|FG000|Overall Study|Accidental drowning|1|||
161550356|NCT02836613|583405134|FG001|Overall Study|Accidental drowning|0|||
161550357|NCT02836613|583405133|FG000|Overall Study|Lost to Follow-up|0|||
161550358|NCT02836613|583405134|FG001|Overall Study|Lost to Follow-up|1|||
161550359|NCT02836613|583405133|FG000|Overall Study|Withdrawal by Subject|0|||
161550360|NCT02836613|583405134|FG001|Overall Study|Withdrawal by Subject|2|||
161550361|NCT01464255|583405135|FG000|Overall Study|unresolve corneal staining|0|||
161550362|NCT01464255|583405136|FG001|Overall Study|unresolve corneal staining|1|||
161550363|NCT01799720|583405137|FG000|Overall Study|Withdrawal by Subject|3|||
161550364|NCT01799720|583405138|FG001|Overall Study|Withdrawal by Subject|0|||
161550365|NCT01799720|583405139|FG002|Overall Study|Withdrawal by Subject|0|||
161550366|NCT01799720|583405137|FG000|Overall Study|Protocol Violation|0|||
161550367|NCT01799720|583405138|FG001|Overall Study|Protocol Violation|1|||
161550368|NCT01799720|583405139|FG002|Overall Study|Protocol Violation|0|||
161550369|NCT01799720|583405137|FG000|Overall Study|Pregnancy|0|||
161893717|NCT00856843|584658556|FG000|Overall Study|Lack of Efficacy|1|||
161893718|NCT00856843|584658557|FG001|Overall Study|Lack of Efficacy|0|||
161893719|NCT00583102|584658558|FG000|Overall Study|Adverse Event|3|||
161893720|NCT00628927|584658559|FG000|Overall Study|Problems performing blood draw|6|||
161893721|NCT00628927|584658560|FG001|Overall Study|Problems performing blood draw|0|||
161893722|NCT00628927|584658559|FG000|Overall Study|Lost to Follow-up|1|||
161893723|NCT00628927|584658560|FG001|Overall Study|Lost to Follow-up|0|||
161893724|NCT00628927|584658559|FG000|Overall Study|Equipment failure|1|||
161893725|NCT00628927|584658560|FG001|Overall Study|Equipment failure|0|||
161893726|NCT01738191|584658561|FG000|Overall Study|Withdrawal by Subject|4|||
161893727|NCT01738191|584658562|FG001|Overall Study|Withdrawal by Subject|1|||
161893728|NCT02483572|584658563|FG000|Overall Study|Withdrawal by Subject|1|||
161550370|NCT01799720|583405138|FG001|Overall Study|Pregnancy|0|||
161550371|NCT01799720|583405139|FG002|Overall Study|Pregnancy|1|||
161550372|NCT04654468|583405147|FG000|Overall Study|Death|1|||
161550373|NCT04654468|583405147|FG000|Overall Study|Ongoing in the Study|50|||
161550374|NCT01155661|583405148|FG000|Overall Study|Adverse Event|101|||
161550375|NCT01155661|583405148|FG000|Overall Study|Death|1|||
161550376|NCT01155661|583405148|FG000|Overall Study|Lack of Efficacy|32|||
161550377|NCT01155661|583405148|FG000|Overall Study|Lost to Follow-up|22|||
161550378|NCT01155661|583405148|FG000|Overall Study|Physician Decision|3|||
161550379|NCT01155661|583405148|FG000|Overall Study|Protocol Violation|35|||
161550380|NCT01155661|583405148|FG000|Overall Study|Withdrawal by Subject|73|||
161550381|NCT01155661|583405148|FG000|Overall Study|Sponsor Decision|13|||
161550382|NCT05064735|583405158|FG000|Overall Study|Withdrawal by Subject|7|||
161550383|NCT05064735|583405159|FG001|Overall Study|Withdrawal by Subject|8|||
161550384|NCT05064735|583405158|FG000|Overall Study|Lost to Follow-up|7|||
161550385|NCT05064735|583405159|FG001|Overall Study|Lost to Follow-up|2|||
161550386|NCT05064735|583405158|FG000|Overall Study|Physician Decision|2|||
161550387|NCT05064735|583405159|FG001|Overall Study|Physician Decision|1|||
161550388|NCT05064735|583405158|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
161550389|NCT05064735|583405159|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
161550390|NCT05064735|583405158|FG000|Overall Study|Site Closure|7|||
161550391|NCT05064735|583405159|FG001|Overall Study|Site Closure|2|||
161550392|NCT04844970|583405165|FG000|Overall Study|Adverse Event|0|||
161550393|NCT04844970|583405166|FG001|Overall Study|Adverse Event|1|||
161550394|NCT04844970|583405165|FG000|Overall Study|Withdrawal by Subject|2|||
161550395|NCT04844970|583405166|FG001|Overall Study|Withdrawal by Subject|0|||
161550396|NCT03169881|583405167|FG000|Overall Study|Incomplete Follow-up|10|||
161550397|NCT03169881|583405168|FG001|Overall Study|Incomplete Follow-up|15|||
161550398|NCT03169881|583405167|FG000|Overall Study|Lost to Follow-up|18|||
161550399|NCT03169881|583405168|FG001|Overall Study|Lost to Follow-up|20|||
161550400|NCT03169881|583405167|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
161550401|NCT03169881|583405168|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
161550402|NCT00447954|583405169|FG000|Overall Study|Adverse Event|0|||
161550403|NCT00447954|583405170|FG001|Overall Study|Adverse Event|2|||
161550404|NCT00447954|583405171|FG002|Overall Study|Adverse Event|0|||
161550405|NCT00447954|583405169|FG000|Overall Study|Withdrawal by Subject|0|||
161550406|NCT00447954|583405170|FG001|Overall Study|Withdrawal by Subject|1|||
161550407|NCT00447954|583405171|FG002|Overall Study|Withdrawal by Subject|1|||
161550408|NCT00447954|583405169|FG000|Overall Study|Lost to Follow-up|0|||
161550409|NCT00447954|583405170|FG001|Overall Study|Lost to Follow-up|1|||
161550410|NCT00447954|583405171|FG002|Overall Study|Lost to Follow-up|0|||
161550411|NCT00447954|583405169|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
161550412|NCT00447954|583405170|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
161550413|NCT00447954|583405171|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
161550414|NCT02090634|583405172|FG000|Overall Study|Lost to Follow-up|0|||
161550415|NCT02090634|583405173|FG001|Overall Study|Lost to Follow-up|1|||
161550416|NCT02090634|583405172|FG000|Overall Study|Death|0|||
161550417|NCT02090634|583405173|FG001|Overall Study|Death|1|||
161550418|NCT02090634|583405172|FG000|Overall Study|Protocol Violation|3|||
161550419|NCT02090634|583405173|FG001|Overall Study|Protocol Violation|1|||
161550420|NCT02090634|583405172|FG000|Overall Study|Adverse Event|2|||
161550421|NCT02090634|583405173|FG001|Overall Study|Adverse Event|0|||
161550422|NCT03757234|583405174|FG000|Overall Study|Adverse Event|0|||
161550423|NCT03757234|583405175|FG001|Overall Study|Adverse Event|0|||
161550424|NCT03757234|583405176|FG002|Overall Study|Adverse Event|0|||
161550425|NCT03757234|583405177|FG003|Overall Study|Adverse Event|0|||
161550426|NCT03757234|583405178|FG004|Overall Study|Adverse Event|1|||
161550427|NCT03757234|583405174|FG000|Overall Study|Lost to Follow-up|1|||
161550428|NCT03757234|583405175|FG001|Overall Study|Lost to Follow-up|0|||
161550429|NCT03757234|583405176|FG002|Overall Study|Lost to Follow-up|0|||
161550430|NCT03757234|583405177|FG003|Overall Study|Lost to Follow-up|0|||
161550431|NCT03757234|583405178|FG004|Overall Study|Lost to Follow-up|1|||
161550432|NCT03757234|583405174|FG000|Overall Study|Withdrawal by Subject|1|||
161550433|NCT03757234|583405175|FG001|Overall Study|Withdrawal by Subject|1|||
161550434|NCT03757234|583405176|FG002|Overall Study|Withdrawal by Subject|0|||
161550435|NCT03757234|583405177|FG003|Overall Study|Withdrawal by Subject|1|||
161550436|NCT03757234|583405178|FG004|Overall Study|Withdrawal by Subject|2|||
161550437|NCT03757234|583405174|FG000|Overall Study|Other|1|||
161550438|NCT03757234|583405175|FG001|Overall Study|Other|1|||
161550439|NCT03757234|583405176|FG002|Overall Study|Other|0|||
161550440|NCT03757234|583405177|FG003|Overall Study|Other|0|||
161550441|NCT03757234|583405178|FG004|Overall Study|Other|0|||
161550442|NCT02023879|583405183|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
161550443|NCT02023879|583405184|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
161550444|NCT02023879|583405185|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
161550445|NCT02023879|583405183|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
161550446|NCT02023879|583405184|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
161550447|NCT02023879|583405185|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
161550448|NCT02023879|583405183|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
161550449|NCT02023879|583405184|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
161550450|NCT02023879|583405185|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
161550451|NCT02023879|583405183|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
161550452|NCT02023879|583405184|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
161550453|NCT02023879|583405185|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
161550454|NCT02023879|583405183|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
161550455|NCT02023879|583405184|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
161550456|NCT02023879|583405185|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
161550457|NCT02023879|583405183|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
161550458|NCT02023879|583405184|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
161550459|NCT02023879|583405185|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
161550460|NCT02023879|583405183|FG000|Extension Open Label Treatment|Adverse Event|1|||
161550461|NCT02023879|583405184|FG001|Extension Open Label Treatment|Adverse Event|7|||
161550462|NCT02023879|583405185|FG002|Extension Open Label Treatment|Adverse Event|3|||
161550463|NCT02023879|583405183|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
161550464|NCT02023879|583405184|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
161550465|NCT02023879|583405185|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
161550466|NCT02023879|583405183|FG000|Extension Open Label Treatment|Participant moved|1|||
161550467|NCT02023879|583405184|FG001|Extension Open Label Treatment|Participant moved|2|||
161550468|NCT02023879|583405185|FG002|Extension Open Label Treatment|Participant moved|0|||
161550469|NCT02023879|583405183|FG000|Extension Open Label Treatment|Other than specified above|2|||
161550470|NCT02023879|583405184|FG001|Extension Open Label Treatment|Other than specified above|7|||
161550471|NCT02023879|583405185|FG002|Extension Open Label Treatment|Other than specified above|2|||
161550472|NCT00874432|583405186|FG000|Overall Study|Withdrawal by Subject|1|||
161550473|NCT00874432|583405187|FG001|Overall Study|Withdrawal by Subject|0|||
161550474|NCT00874432|583405188|FG002|Overall Study|Withdrawal by Subject|0|||
161550475|NCT00874432|583405189|FG003|Overall Study|Withdrawal by Subject|0|||
161550476|NCT00874432|583405186|FG000|Overall Study|Physician Decision|1|||
161550477|NCT00874432|583405187|FG001|Overall Study|Physician Decision|0|||
161550478|NCT00874432|583405188|FG002|Overall Study|Physician Decision|0|||
161550479|NCT00874432|583405189|FG003|Overall Study|Physician Decision|0|||
161550480|NCT00874432|583405186|FG000|Overall Study|Other|1|||
161550481|NCT00874432|583405187|FG001|Overall Study|Other|2|||
161550482|NCT00874432|583405188|FG002|Overall Study|Other|8|||
161550483|NCT00874432|583405189|FG003|Overall Study|Other|3|||
161550484|NCT05256381|583405190|FG000|Overall Study|Withdrawal by Subject|4|||
161550485|NCT05256381|583405191|FG001|Overall Study|Withdrawal by Subject|0|||
161550486|NCT05256381|583405192|FG002|Overall Study|Withdrawal by Subject|2|||
161550487|NCT05256381|583405193|FG003|Overall Study|Withdrawal by Subject|2|||
161550488|NCT05256381|583405194|FG004|Overall Study|Withdrawal by Subject|8|||
161550489|NCT05256381|583405195|FG005|Overall Study|Withdrawal by Subject|6|||
161550490|NCT05256381|583405190|FG000|Overall Study|Physician Decision|0|||
161550491|NCT05256381|583405191|FG001|Overall Study|Physician Decision|0|||
161550492|NCT05256381|583405192|FG002|Overall Study|Physician Decision|1|||
161550493|NCT05256381|583405193|FG003|Overall Study|Physician Decision|0|||
161550494|NCT05256381|583405194|FG004|Overall Study|Physician Decision|2|||
161550495|NCT05256381|583405195|FG005|Overall Study|Physician Decision|0|||
161550496|NCT05256381|583405190|FG000|Overall Study|Death|17|||
161550497|NCT05256381|583405191|FG001|Overall Study|Death|3|||
161550498|NCT05256381|583405192|FG002|Overall Study|Death|4|||
161550499|NCT05256381|583405193|FG003|Overall Study|Death|5|||
161550500|NCT05256381|583405194|FG004|Overall Study|Death|24|||
161550501|NCT05256381|583405195|FG005|Overall Study|Death|21|||
161550502|NCT05256381|583405190|FG000|Overall Study|Other, not specified|0|||
161550503|NCT05256381|583405191|FG001|Overall Study|Other, not specified|0|||
161550504|NCT05256381|583405192|FG002|Overall Study|Other, not specified|0|||
161550505|NCT05256381|583405193|FG003|Overall Study|Other, not specified|0|||
161550506|NCT05256381|583405194|FG004|Overall Study|Other, not specified|2|||
161550507|NCT05256381|583405195|FG005|Overall Study|Other, not specified|1|||
161550508|NCT05256381|583405190|FG000|Overall Study|Study terminated by sponsor|18|||
161550509|NCT05256381|583405191|FG001|Overall Study|Study terminated by sponsor|5|||
161550510|NCT05256381|583405192|FG002|Overall Study|Study terminated by sponsor|5|||
161550511|NCT05256381|583405193|FG003|Overall Study|Study terminated by sponsor|5|||
161550512|NCT05256381|583405194|FG004|Overall Study|Study terminated by sponsor|18|||
161550513|NCT05256381|583405195|FG005|Overall Study|Study terminated by sponsor|11|||
161550514|NCT05256381|583405190|FG000|Overall Study|Lost to Follow-up|1|||
161550515|NCT05256381|583405191|FG001|Overall Study|Lost to Follow-up|0|||
161893729|NCT02483572|584658564|FG001|Overall Study|Withdrawal by Subject|0|||
161893730|NCT02483572|584658563|FG000|Overall Study|Lost to Follow-up|1|||
161550516|NCT05256381|583405192|FG002|Overall Study|Lost to Follow-up|0|||
161550517|NCT05256381|583405193|FG003|Overall Study|Lost to Follow-up|0|||
161550518|NCT05256381|583405194|FG004|Overall Study|Lost to Follow-up|1|||
161550519|NCT05256381|583405195|FG005|Overall Study|Lost to Follow-up|0|||
161550520|NCT01518946|583405198|FG000|Open-label Phase|Other|4|||
161550521|NCT01518946|583405199|FG001|Open-label Phase|Other|0|||
161550522|NCT01518946|583405200|FG002|Open-label Phase|Other|0|||
161550523|NCT01518946|583405198|FG000|Randomized Phase (First Intervention)|Other|0|||
161550524|NCT01518946|583405199|FG001|Randomized Phase (First Intervention)|Other|1|||
161550525|NCT01518946|583405200|FG002|Randomized Phase (First Intervention)|Other|0|||
161603527|NCT04055012|583602413|FG001|Overall Study|Metformin Recall|1|||
161603528|NCT04055012|583602414|FG002|Overall Study|Metformin Recall|1|||
161603529|NCT04055012|583602415|FG003|Overall Study|Metformin Recall|0|||
161603530|NCT02492711|583602418|FG000|Overall Study|Adverse Event|9|||
161603531|NCT02492711|583602419|FG001|Overall Study|Adverse Event|9|||
161603532|NCT02492711|583602420|FG002|Overall Study|Adverse Event|2|||
161603533|NCT02492711|583602418|FG000|Overall Study|Death|3|||
161603534|NCT02492711|583602419|FG001|Overall Study|Death|3|||
161603535|NCT02492711|583602420|FG002|Overall Study|Death|0|||
161603536|NCT02492711|583602418|FG000|Overall Study|Withdrawal by Subject|10|||
161603537|NCT02492711|583602419|FG001|Overall Study|Withdrawal by Subject|16|||
161603538|NCT02492711|583602420|FG002|Overall Study|Withdrawal by Subject|5|||
161603539|NCT02492711|583602418|FG000|Overall Study|Physician Decision|10|||
161603540|NCT02492711|583602419|FG001|Overall Study|Physician Decision|6|||
161603541|NCT02492711|583602420|FG002|Overall Study|Physician Decision|4|||
161603542|NCT02492711|583602418|FG000|Overall Study|Lost to Follow-up|0|||
161603543|NCT02492711|583602419|FG001|Overall Study|Lost to Follow-up|0|||
161603544|NCT02492711|583602420|FG002|Overall Study|Lost to Follow-up|1|||
161603545|NCT02492711|583602418|FG000|Overall Study|study treatment delay|2|||
161603546|NCT02492711|583602419|FG001|Overall Study|study treatment delay|1|||
161603547|NCT02492711|583602420|FG002|Overall Study|study treatment delay|0|||
161603548|NCT02492711|583602418|FG000|Overall Study|change in chemotherapy|0|||
161603549|NCT02492711|583602419|FG001|Overall Study|change in chemotherapy|1|||
161603550|NCT02492711|583602420|FG002|Overall Study|change in chemotherapy|0|||
161603551|NCT02492711|583602418|FG000|Overall Study|never treated|2|||
161603552|NCT02492711|583602419|FG001|Overall Study|never treated|4|||
161603553|NCT02492711|583602420|FG002|Overall Study|never treated|0|||
161603554|NCT02492711|583602418|FG000|Overall Study|Other|0|||
161603555|NCT02492711|583602419|FG001|Overall Study|Other|0|||
161603556|NCT02492711|583602420|FG002|Overall Study|Other|1|||
161603557|NCT05830799|583602424|FG000|Overall Study|Withdrawal by Subject|1|||
161603558|NCT03652272|583602425|FG000|3 Month|Withdrawal by Subject|1|||
161603559|NCT03652272|583602426|FG001|3 Month|Withdrawal by Subject|1|||
161603560|NCT03652272|583602425|FG000|3 Month|Lost to Follow-up|16|||
161603561|NCT03652272|583602426|FG001|3 Month|Lost to Follow-up|14|||
161603562|NCT04631016|583602431|FG000|Overall Study|Adverse Event|3|||
161603563|NCT04631016|583602432|FG001|Overall Study|Adverse Event|0|||
161603564|NCT04631016|583602431|FG000|Overall Study|Withdrawal by Subject|5|||
161603565|NCT04631016|583602432|FG001|Overall Study|Withdrawal by Subject|4|||
161603566|NCT04631016|583602431|FG000|Overall Study|Reason unspecified|1|||
161603567|NCT04631016|583602432|FG001|Overall Study|Reason unspecified|0|||
161603568|NCT04631016|583602431|FG000|Overall Study|Failure to meet randomization criteria|2|||
161603569|NCT04631016|583602432|FG001|Overall Study|Failure to meet randomization criteria|1|||
161603570|NCT04967599|583602435|FG000|Overall Study|Lost to Follow-up|35|||
161603571|NCT04967599|583602436|FG001|Overall Study|Lost to Follow-up|19|||
161603572|NCT04967599|583602437|FG002|Overall Study|Lost to Follow-up|23|||
161603573|NCT05541484|583602440|FG000|Overall Study|Withdrawal by Subject|1|||
161603574|NCT05541484|583602441|FG001|Overall Study|Withdrawal by Subject|0|||
161603575|NCT02919917|583602446|FG000|Overall Study|Withdrawal by Subject|4|||
161603576|NCT02919917|583602447|FG001|Overall Study|Withdrawal by Subject|8|||
161603577|NCT03418740|583602448|FG000|Overall Study|Lost to Follow-up|13|||
161603578|NCT03418740|583602448|FG000|Overall Study|Scheduling Issues|7|||
161603579|NCT03418740|583602448|FG000|Overall Study|Withdrawal by Subject|2|||
161603580|NCT03418740|583602448|FG000|Overall Study|Unable to Continue Consent|1|||
161603581|NCT04743973|583602449|FG000|Overall Study|Withdrawal by Subject|5|||
161603582|NCT02461134|583602454|FG000|Overall Study|Adverse Event|1|||
161603583|NCT00626795|583602455|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
161603584|NCT00626795|583602456|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
161603585|NCT00626795|583602457|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
161893731|NCT02483572|584658564|FG001|Overall Study|Lost to Follow-up|0|||
161893732|NCT02483572|584658563|FG000|Overall Study|Physician Decision|0|||
161893733|NCT02483572|584658564|FG001|Overall Study|Physician Decision|1|||
161893734|NCT01298141|584658568|FG000|Overall Study|Adverse Event|3|||
161603586|NCT00626795|583602455|FG000|Blinded Treatment|Lack of Efficacy|2|||
161603587|NCT00626795|583602456|FG001|Blinded Treatment|Lack of Efficacy|0|||
161603588|NCT00626795|583602457|FG002|Blinded Treatment|Lack of Efficacy|0|||
161603589|NCT00626795|583602455|FG000|Blinded Treatment|Unacceptable adverse event|0|||
161603590|NCT00626795|583602456|FG001|Blinded Treatment|Unacceptable adverse event|0|||
161603591|NCT00626795|583602457|FG002|Blinded Treatment|Unacceptable adverse event|1|||
161603592|NCT00626795|583602455|FG000|Blinded Treatment|Protocol Violation|0|||
161550526|NCT03918239|583406862|FG000|Overall Study|Lost to Follow-up|3|||
161550527|NCT03918239|583406863|FG001|Overall Study|Lost to Follow-up|1|||
161550528|NCT03918239|583406862|FG000|Overall Study|Pregnancy|0|||
161550529|NCT03918239|583406863|FG001|Overall Study|Pregnancy|2|||
161550530|NCT03918239|583406862|FG000|Overall Study|Withdrawal by Subject|3|||
161550531|NCT03918239|583406863|FG001|Overall Study|Withdrawal by Subject|3|||
161550532|NCT03918239|583406862|FG000|Overall Study|positive urine drug screening results|4|||
161550533|NCT03918239|583406863|FG001|Overall Study|positive urine drug screening results|1|||
161550534|NCT01984424|583406868|FG000|Overall Study|Withdrawal by Subject|3|||
161550535|NCT01984424|583406869|FG001|Overall Study|Withdrawal by Subject|5|||
161550536|NCT01984424|583406868|FG000|Overall Study|Sponsor Decision|0|||
161550537|NCT01984424|583406869|FG001|Overall Study|Sponsor Decision|1|||
161550538|NCT01984424|583406868|FG000|Overall Study|Lost to Follow-up|0|||
161550539|NCT01984424|583406869|FG001|Overall Study|Lost to Follow-up|1|||
161550540|NCT01807221|583406872|FG000|Overall Study|Progressive disease|1|||
161550541|NCT01807221|583406873|FG001|Overall Study|Progressive disease|0|||
161550542|NCT01807221|583406874|FG002|Overall Study|Progressive disease|1|||
161550543|NCT01807221|583406875|FG003|Overall Study|Progressive disease|0|||
161550544|NCT01807221|583406876|FG004|Overall Study|Progressive disease|0|||
161550545|NCT01807221|583406877|FG005|Overall Study|Progressive disease|0|||
161550546|NCT01807221|583406872|FG000|Overall Study|Death|7|||
161550547|NCT01807221|583406873|FG001|Overall Study|Death|9|||
161550548|NCT01807221|583406874|FG002|Overall Study|Death|4|||
161550549|NCT01807221|583406875|FG003|Overall Study|Death|2|||
161550550|NCT01807221|583406876|FG004|Overall Study|Death|1|||
161550551|NCT01807221|583406877|FG005|Overall Study|Death|6|||
161550552|NCT01807221|583406872|FG000|Overall Study|Physician Decision|2|||
161550553|NCT01807221|583406873|FG001|Overall Study|Physician Decision|1|||
161550554|NCT01807221|583406874|FG002|Overall Study|Physician Decision|0|||
161550555|NCT01807221|583406875|FG003|Overall Study|Physician Decision|0|||
161550556|NCT01807221|583406876|FG004|Overall Study|Physician Decision|0|||
161550557|NCT01807221|583406877|FG005|Overall Study|Physician Decision|0|||
161550558|NCT01807221|583406872|FG000|Overall Study|Adverse Event|33|||
161550559|NCT01807221|583406873|FG001|Overall Study|Adverse Event|22|||
161550560|NCT01807221|583406874|FG002|Overall Study|Adverse Event|26|||
161550561|NCT01807221|583406875|FG003|Overall Study|Adverse Event|25|||
161550562|NCT01807221|583406876|FG004|Overall Study|Adverse Event|18|||
161550563|NCT01807221|583406877|FG005|Overall Study|Adverse Event|21|||
161550564|NCT01807221|583406872|FG000|Overall Study|Protocol Violation|0|||
161550565|NCT01807221|583406873|FG001|Overall Study|Protocol Violation|2|||
161550566|NCT01807221|583406874|FG002|Overall Study|Protocol Violation|1|||
161550567|NCT01807221|583406875|FG003|Overall Study|Protocol Violation|2|||
161550568|NCT01807221|583406876|FG004|Overall Study|Protocol Violation|0|||
161550569|NCT01807221|583406877|FG005|Overall Study|Protocol Violation|1|||
161550570|NCT01807221|583406872|FG000|Overall Study|Non-compliance|1|||
161550571|NCT01807221|583406873|FG001|Overall Study|Non-compliance|2|||
161550572|NCT01807221|583406874|FG002|Overall Study|Non-compliance|0|||
161550573|NCT01807221|583406875|FG003|Overall Study|Non-compliance|1|||
161550574|NCT01807221|583406876|FG004|Overall Study|Non-compliance|0|||
161550575|NCT01807221|583406877|FG005|Overall Study|Non-compliance|0|||
161550576|NCT01807221|583406872|FG000|Overall Study|Logistical difficulties|0|||
161550577|NCT01807221|583406873|FG001|Overall Study|Logistical difficulties|1|||
161550578|NCT01807221|583406874|FG002|Overall Study|Logistical difficulties|0|||
161550579|NCT01807221|583406875|FG003|Overall Study|Logistical difficulties|0|||
161550580|NCT01807221|583406876|FG004|Overall Study|Logistical difficulties|1|||
161550581|NCT01807221|583406877|FG005|Overall Study|Logistical difficulties|0|||
161550582|NCT01807221|583406872|FG000|Overall Study|Withdrawal by Subject|33|||
161550583|NCT01807221|583406873|FG001|Overall Study|Withdrawal by Subject|15|||
161550584|NCT01807221|583406874|FG002|Overall Study|Withdrawal by Subject|8|||
161550585|NCT01807221|583406875|FG003|Overall Study|Withdrawal by Subject|14|||
161550586|NCT01807221|583406876|FG004|Overall Study|Withdrawal by Subject|16|||
161893735|NCT01298141|584658568|FG000|Overall Study|Refusal of Required Study Procedures|1|||
161550587|NCT01807221|583406877|FG005|Overall Study|Withdrawal by Subject|13|||
161550588|NCT01807221|583406872|FG000|Overall Study|Sponsor decision|2|||
161550589|NCT01807221|583406873|FG001|Overall Study|Sponsor decision|0|||
161550590|NCT01807221|583406874|FG002|Overall Study|Sponsor decision|1|||
161550591|NCT01807221|583406875|FG003|Overall Study|Sponsor decision|1|||
161550592|NCT01807221|583406876|FG004|Overall Study|Sponsor decision|0|||
161550593|NCT01807221|583406877|FG005|Overall Study|Sponsor decision|0|||
161893736|NCT01298141|584658568|FG000|Overall Study|Withdrawal by Subject|6|||
161550594|NCT01807221|583406872|FG000|Overall Study|Lost to Follow-up|1|||
161550595|NCT01807221|583406873|FG001|Overall Study|Lost to Follow-up|0|||
161550596|NCT01807221|583406874|FG002|Overall Study|Lost to Follow-up|2|||
161550597|NCT01807221|583406875|FG003|Overall Study|Lost to Follow-up|1|||
161550598|NCT01807221|583406876|FG004|Overall Study|Lost to Follow-up|0|||
161550599|NCT01807221|583406877|FG005|Overall Study|Lost to Follow-up|0|||
161550600|NCT00594906|583406880|FG000|Overall Study|Physician Decision|1|||
161550601|NCT00594906|583406881|FG001|Overall Study|Physician Decision|0|||
161550602|NCT00594906|583406880|FG000|Overall Study|Physician Decision|0|||
161550603|NCT00594906|583406881|FG001|Overall Study|Physician Decision|1|||
161550604|NCT00594906|583406880|FG000|Overall Study|Death|0|||
161550605|NCT00594906|583406881|FG001|Overall Study|Death|1|||
161550606|NCT01027364|583406887|FG000|Overall Study|Adverse Event|1|||
161550607|NCT01027364|583406888|FG001|Overall Study|Adverse Event|0|||
161550608|NCT01027364|583406889|FG002|Overall Study|Adverse Event|1|||
161550609|NCT01027364|583406890|FG003|Overall Study|Adverse Event|0|||
161550610|NCT01027364|583406887|FG000|Overall Study|Lost to Follow-up|1|||
161550611|NCT01027364|583406888|FG001|Overall Study|Lost to Follow-up|0|||
161550612|NCT01027364|583406889|FG002|Overall Study|Lost to Follow-up|0|||
161550613|NCT01027364|583406890|FG003|Overall Study|Lost to Follow-up|0|||
161550614|NCT01027364|583406887|FG000|Overall Study|Protocol Violation|1|||
161550615|NCT01027364|583406888|FG001|Overall Study|Protocol Violation|0|||
161550616|NCT01027364|583406889|FG002|Overall Study|Protocol Violation|0|||
161550617|NCT01027364|583406890|FG003|Overall Study|Protocol Violation|1|||
161550618|NCT01027364|583406887|FG000|Overall Study|Withdrawal by Subject|1|||
161550619|NCT01027364|583406888|FG001|Overall Study|Withdrawal by Subject|2|||
161550620|NCT01027364|583406889|FG002|Overall Study|Withdrawal by Subject|0|||
161550621|NCT01027364|583406890|FG003|Overall Study|Withdrawal by Subject|0|||
161550622|NCT01394250|583406891|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
161550623|NCT01394250|583406892|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
161550624|NCT01394250|583406891|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
161550625|NCT01394250|583406892|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
161550626|NCT03772314|583406895|FG000|Overall Study|Adverse Event|7|||
161550627|NCT03772314|583406896|FG001|Overall Study|Adverse Event|2|||
161550628|NCT01613027|583406897|FG000|Overall Study|Lost to Follow-up|5|||
161550629|NCT01613027|583406897|FG000|Overall Study|Switched Physician|1|||
161550630|NCT01613027|583406897|FG000|Overall Study|Lack of Efficacy|1|||
161550631|NCT01613027|583406897|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
161550632|NCT04267614|583406900|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
161550633|NCT04267614|583406900|FG000|Overall Study|Lost to Follow-up|115|||
161550634|NCT03632434|583406908|FG000|Overall Study|Withdrawal by Subject|2|||
161550635|NCT02141659|583406910|FG000|Overall Study|Major Protocol Deviation|0|||
161550636|NCT02141659|583406911|FG001|Overall Study|Major Protocol Deviation|1|||
161550637|NCT02141659|583406912|FG002|Overall Study|Major Protocol Deviation|0|||
161550638|NCT02141659|583406913|FG003|Overall Study|Major Protocol Deviation|0|||
161550639|NCT02141659|583406914|FG004|Overall Study|Major Protocol Deviation|0|||
161550640|NCT02141659|583406915|FG005|Overall Study|Major Protocol Deviation|0|||
161550641|NCT02141659|583406910|FG000|Overall Study|Lack of Efficacy|0|||
161550642|NCT02141659|583406911|FG001|Overall Study|Lack of Efficacy|0|||
161550643|NCT02141659|583406912|FG002|Overall Study|Lack of Efficacy|0|||
161664346|NCT05195489|583824189|FG000|Overall Study|Protocol Violation|0|||
161664347|NCT05195489|583824190|FG001|Overall Study|Protocol Violation|2|||
161664348|NCT05195489|583824189|FG000|Overall Study|Withdrawal by Subject|1|||
161664349|NCT05195489|583824190|FG001|Overall Study|Withdrawal by Subject|1|||
161664350|NCT05195489|583824189|FG000|Overall Study|Removed|0|||
161664351|NCT05195489|583824190|FG001|Overall Study|Removed|1|||
161664352|NCT00409773|583824192|FG000|Overall Study|Adverse Event|3|||
161664353|NCT00409773|583824193|FG001|Overall Study|Adverse Event|4|||
161664354|NCT00409773|583824194|FG002|Overall Study|Adverse Event|4|||
161664355|NCT00409773|583824195|FG003|Overall Study|Adverse Event|2|||
161664356|NCT00409773|583824196|FG004|Overall Study|Adverse Event|6|||
161664357|NCT00409773|583824192|FG000|Overall Study|Lost to Follow-up|6|||
161664358|NCT00409773|583824193|FG001|Overall Study|Lost to Follow-up|1|||
161664359|NCT00409773|583824194|FG002|Overall Study|Lost to Follow-up|2|||
161893737|NCT01298141|584658568|FG000|Overall Study|Termination of Study by the Investigator|5|||
161893738|NCT01298141|584658568|FG000|Overall Study|Other|5|||
161550644|NCT02141659|583406913|FG003|Overall Study|Lack of Efficacy|0|||
161550645|NCT02141659|583406914|FG004|Overall Study|Lack of Efficacy|0|||
161550646|NCT02141659|583406915|FG005|Overall Study|Lack of Efficacy|1|||
161550647|NCT02141659|583406910|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
161664360|NCT00409773|583824195|FG003|Overall Study|Lost to Follow-up|3|||
161664361|NCT00409773|583824196|FG004|Overall Study|Lost to Follow-up|1|||
161664362|NCT00409773|583824192|FG000|Overall Study|Physician Decision|0|||
161664363|NCT00409773|583824193|FG001|Overall Study|Physician Decision|0|||
161664364|NCT00409773|583824194|FG002|Overall Study|Physician Decision|0|||
161664365|NCT00409773|583824195|FG003|Overall Study|Physician Decision|2|||
161664366|NCT00409773|583824196|FG004|Overall Study|Physician Decision|0|||
161664367|NCT00409773|583824192|FG000|Overall Study|Protocol Violation|0|||
161893739|NCT01298141|584658568|FG000|Overall Study|Lost to Follow-up|1|||
161550648|NCT02141659|583406911|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
161550649|NCT02141659|583406912|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
161664368|NCT00409773|583824193|FG001|Overall Study|Protocol Violation|2|||
161664369|NCT00409773|583824194|FG002|Overall Study|Protocol Violation|3|||
161550650|NCT02141659|583406913|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
161550651|NCT02141659|583406914|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
161664370|NCT00409773|583824195|FG003|Overall Study|Protocol Violation|3|||
161664371|NCT00409773|583824196|FG004|Overall Study|Protocol Violation|1|||
161893740|NCT01298141|584658568|FG000|Overall Study|Death|6|||
161893741|NCT01298141|584658568|FG000|Overall Study|Not treated|4|||
161893742|NCT00350779|584658569|FG000|Overall Study|Adverse Event|4|||
161893743|NCT00350779|584658570|FG001|Overall Study|Adverse Event|2|||
161893744|NCT00350779|584658569|FG000|Overall Study|Lack of Efficacy|0|||
161893745|NCT00350779|584658570|FG001|Overall Study|Lack of Efficacy|4|||
161893746|NCT00350779|584658569|FG000|Overall Study|Lost to Follow-up|2|||
161893747|NCT00350779|584658570|FG001|Overall Study|Lost to Follow-up|0|||
161893748|NCT00350779|584658569|FG000|Overall Study|Physician Decision|2|||
161893749|NCT00350779|584658570|FG001|Overall Study|Physician Decision|4|||
161893750|NCT00350779|584658569|FG000|Overall Study|Protocol Violation|3|||
161893751|NCT00350779|584658570|FG001|Overall Study|Protocol Violation|1|||
161893752|NCT00350779|584658569|FG000|Overall Study|Withdrawal by Subject|9|||
161893753|NCT00350779|584658570|FG001|Overall Study|Withdrawal by Subject|8|||
161893754|NCT00350779|584658569|FG000|Overall Study|Patient Moved|2|||
161893755|NCT00350779|584658570|FG001|Overall Study|Patient Moved|1|||
161893756|NCT00350779|584658569|FG000|Overall Study|Non-compliance with study procedures|0|||
161893757|NCT00350779|584658570|FG001|Overall Study|Non-compliance with study procedures|1|||
161893758|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
161893759|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893760|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893761|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893762|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893763|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893764|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893765|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893766|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893767|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161664372|NCT00409773|583824192|FG000|Overall Study|Withdrawal by Subject|0|||
161664373|NCT00409773|583824193|FG001|Overall Study|Withdrawal by Subject|0|||
161664374|NCT00409773|583824194|FG002|Overall Study|Withdrawal by Subject|0|||
161664375|NCT00409773|583824195|FG003|Overall Study|Withdrawal by Subject|2|||
161664376|NCT00409773|583824196|FG004|Overall Study|Withdrawal by Subject|1|||
161664377|NCT00409773|583824192|FG000|Overall Study|Lack of Eligibility|0|||
161664378|NCT00409773|583824193|FG001|Overall Study|Lack of Eligibility|0|||
161664379|NCT00409773|583824194|FG002|Overall Study|Lack of Eligibility|0|||
161664380|NCT00409773|583824195|FG003|Overall Study|Lack of Eligibility|0|||
161664381|NCT00409773|583824196|FG004|Overall Study|Lack of Eligibility|1|||
161664382|NCT01201343|583824197|FG000|Overall Study|Adverse Event|6|||
161664383|NCT01201343|583824197|FG000|Overall Study|Withdrawal by Subject|5|||
161664384|NCT01201343|583824197|FG000|Overall Study|Lost to Follow-up|2|||
161664385|NCT01201343|583824197|FG000|Overall Study|Lack of Efficacy|2|||
161664386|NCT01201343|583824197|FG000|Overall Study|Participant wrongly included in trial|1|||
161664387|NCT01201343|583824197|FG000|Overall Study|Randomized, not treated|3|||
161664388|NCT01440374|583824198|FG000|Part 1: Open-label Phase|Adverse Event|5|||
161664389|NCT01440374|583824199|FG001|Part 1: Open-label Phase|Adverse Event|0|||
161664390|NCT01440374|583824200|FG002|Part 1: Open-label Phase|Adverse Event|0|||
161664391|NCT01440374|583824201|FG003|Part 1: Open-label Phase|Adverse Event|0|||
161664392|NCT01440374|583824198|FG000|Part 1: Open-label Phase|Physician Decision|1|||
161664393|NCT01440374|583824199|FG001|Part 1: Open-label Phase|Physician Decision|0|||
161664394|NCT01440374|583824200|FG002|Part 1: Open-label Phase|Physician Decision|0|||
161664395|NCT01440374|583824201|FG003|Part 1: Open-label Phase|Physician Decision|0|||
161664396|NCT01440374|583824198|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
161664397|NCT01440374|583824199|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
161664398|NCT01440374|583824200|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
161664399|NCT01440374|583824201|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
161664400|NCT01440374|583824198|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
161664401|NCT01440374|583824199|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
161664402|NCT01440374|583824200|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
161664403|NCT01440374|583824201|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
161550652|NCT02141659|583406915|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
161550653|NCT00305864|583406926|FG000|Overall Study|Ineligible / No protocol treatment|0|||
161550654|NCT00305864|583406927|FG001|Overall Study|Ineligible / No protocol treatment|1|||
161550655|NCT00305864|583406928|FG002|Overall Study|Ineligible / No protocol treatment|1|||
161550656|NCT00305864|583406929|FG003|Overall Study|Ineligible / No protocol treatment|13|||
161664404|NCT01440374|583824198|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
161664405|NCT01440374|583824199|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
161779149|NCT01890109|584233852|FG001|Overall Study|Lost to Follow-up|2|||
161893768|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
161893769|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
161893770|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
161893771|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161893772|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
161893773|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
161664406|NCT01440374|583824200|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
161664407|NCT01440374|583824201|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
161664408|NCT01440374|583824198|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
161664409|NCT01440374|583824199|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
161664410|NCT01440374|583824200|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
161664411|NCT01440374|583824201|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
161664412|NCT01440374|583824198|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
161664413|NCT01440374|583824199|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
161664414|NCT01440374|583824200|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
161664415|NCT01440374|583824201|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
161664416|NCT01440374|583824198|FG000|Part 2; Double-blind Phase|Not treated|0|||
161664417|NCT01440374|583824199|FG001|Part 2; Double-blind Phase|Not treated|0|||
161664418|NCT01440374|583824200|FG002|Part 2; Double-blind Phase|Not treated|1|||
161664419|NCT01440374|583824201|FG003|Part 2; Double-blind Phase|Not treated|0|||
161664420|NCT01440374|583824198|FG000|Part 3: Extension|Withdrawal by Subject|0|||
161664421|NCT01440374|583824199|FG001|Part 3: Extension|Withdrawal by Subject|0|||
161664422|NCT01440374|583824200|FG002|Part 3: Extension|Withdrawal by Subject|0|||
161550657|NCT04276090|583406930|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
161550658|NCT04276090|583406931|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
161550659|NCT02303626|583406935|FG000|Overall Study|Lack of Efficacy|1|||
161550660|NCT02303626|583406936|FG001|Overall Study|Lack of Efficacy|0|||
161550661|NCT02303626|583406937|FG002|Overall Study|Lack of Efficacy|1|||
161550662|NCT02303626|583406935|FG000|Overall Study|Adverse Event|0|||
161664423|NCT01440374|583824201|FG003|Part 3: Extension|Withdrawal by Subject|5|||
161664424|NCT01440374|583824198|FG000|Part 3: Extension|Adverse Event|0|||
161664425|NCT01440374|583824199|FG001|Part 3: Extension|Adverse Event|0|||
161664426|NCT01440374|583824200|FG002|Part 3: Extension|Adverse Event|0|||
161664427|NCT01440374|583824201|FG003|Part 3: Extension|Adverse Event|13|||
161664428|NCT01440374|583824198|FG000|Part 3: Extension|Physician Decision|0|||
161664429|NCT01440374|583824199|FG001|Part 3: Extension|Physician Decision|0|||
161664430|NCT01440374|583824200|FG002|Part 3: Extension|Physician Decision|0|||
161664431|NCT01440374|583824201|FG003|Part 3: Extension|Physician Decision|14|||
161664432|NCT04812548|583824203|FG000|Overall Study|Adverse Event|2|||
161664433|NCT04812548|583824204|FG001|Overall Study|Adverse Event|7|||
161664434|NCT04812548|583824203|FG000|Overall Study|HSCT Planned|2|||
161664435|NCT04812548|583824204|FG001|Overall Study|HSCT Planned|3|||
161664436|NCT04812548|583824203|FG000|Overall Study|Progressive Disease|0|||
161664437|NCT04812548|583824204|FG001|Overall Study|Progressive Disease|2|||
161664438|NCT04812548|583824203|FG000|Overall Study|Death|0|||
161550663|NCT02303626|583406936|FG001|Overall Study|Adverse Event|2|||
161550664|NCT02303626|583406937|FG002|Overall Study|Adverse Event|0|||
161550665|NCT02303626|583406935|FG000|Overall Study|Protocol Violation|0|||
161550666|NCT02303626|583406936|FG001|Overall Study|Protocol Violation|1|||
161550667|NCT02303626|583406937|FG002|Overall Study|Protocol Violation|0|||
161550668|NCT02303626|583406935|FG000|Overall Study|Pregnancy|0|||
161550669|NCT02303626|583406936|FG001|Overall Study|Pregnancy|0|||
161550670|NCT02303626|583406937|FG002|Overall Study|Pregnancy|1|||
161550671|NCT02303626|583406935|FG000|Overall Study|Subject Non-Compliance|0|||
161550672|NCT02303626|583406936|FG001|Overall Study|Subject Non-Compliance|0|||
161779150|NCT01643928|584233853|FG000|Overall Study|Lost to Follow-up|1|||
161779151|NCT01643928|584233854|FG001|Overall Study|Lost to Follow-up|0|||
161550673|NCT02303626|583406937|FG002|Overall Study|Subject Non-Compliance|1|||
161550674|NCT01265823|583406938|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
161550675|NCT01265823|583406938|FG000|Overall Study|Failure to Return|4|||
161550676|NCT01265823|583406938|FG000|Overall Study|Protocol Violation|1|||
161779152|NCT01643928|584233855|FG002|Overall Study|Lost to Follow-up|2|||
161779153|NCT01643928|584233856|FG003|Overall Study|Lost to Follow-up|0|||
161550677|NCT01265823|583406938|FG000|Overall Study|Participant Request|1|||
161550678|NCT01263106|583406939|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
161550679|NCT01263106|583406940|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
161550680|NCT05027074|583406948|FG000|Overall Study|Death|47|||
161550681|NCT05027074|583406949|FG001|Overall Study|Death|42|||
161550682|NCT05027074|583406950|FG002|Overall Study|Death|39|||
161550683|NCT05027074|583406948|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161550684|NCT05027074|583406949|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161550685|NCT05027074|583406950|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161550686|NCT05027074|583406948|FG000|Overall Study|Site Terminated By Sponsor|3|||
161550687|NCT05027074|583406949|FG001|Overall Study|Site Terminated By Sponsor|0|||
161550688|NCT05027074|583406950|FG002|Overall Study|Site Terminated By Sponsor|2|||
161779154|NCT01643928|584233857|FG004|Overall Study|Lost to Follow-up|0|||
161779155|NCT01643928|584233853|FG000|Overall Study|Withdrawal by Subject|2|||
161779156|NCT01643928|584233854|FG001|Overall Study|Withdrawal by Subject|0|||
161550689|NCT05027074|583406948|FG000|Overall Study|Withdrawal by Subject|13|||
161664439|NCT04812548|583824204|FG001|Overall Study|Death|1|||
161664440|NCT04812548|583824203|FG000|Overall Study|Post Study Access to Treatment|0|||
161550690|NCT05027074|583406949|FG001|Overall Study|Withdrawal by Subject|8|||
161550691|NCT05027074|583406950|FG002|Overall Study|Withdrawal by Subject|10|||
161550692|NCT05027074|583406948|FG000|Overall Study|Lost to Follow-up|2|||
161550693|NCT05027074|583406949|FG001|Overall Study|Lost to Follow-up|4|||
161550694|NCT05027074|583406950|FG002|Overall Study|Lost to Follow-up|3|||
161550695|NCT05027074|583406948|FG000|Overall Study|Status Not Recorded|0|||
161550696|NCT05027074|583406949|FG001|Overall Study|Status Not Recorded|0|||
161550697|NCT05027074|583406950|FG002|Overall Study|Status Not Recorded|1|||
161550698|NCT02180438|583406956|FG000|Overall Study|Lost to Follow-up|1|||
161550699|NCT00785707|583406957|FG000|Overall Study|Lost to Follow-up|7|||
161550700|NCT04908449|583406958|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
161550701|NCT04908449|583406959|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
161550702|NCT04908449|583406958|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
161550703|NCT04908449|583406959|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
161550704|NCT02401308|583406960|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
161550705|NCT02401308|583406961|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
161550706|NCT02736968|583406965|FG000|Overall Study|Lost to Follow-up|0|||
161664441|NCT04812548|583824204|FG001|Overall Study|Post Study Access to Treatment|1|||
161664442|NCT04812548|583824203|FG000|Overall Study|Withdrawal by Subject|0|||
161664443|NCT04812548|583824204|FG001|Overall Study|Withdrawal by Subject|1|||
161550707|NCT02736968|583406966|FG001|Overall Study|Lost to Follow-up|0|||
161664444|NCT04812548|583824203|FG000|Overall Study|Physician Decision|1|||
161664445|NCT04812548|583824204|FG001|Overall Study|Physician Decision|0|||
161664446|NCT02141984|583824205|FG000|Overall Study|Lack of Efficacy|2|||
161664447|NCT03057977|583824206|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
161664448|NCT03057977|583824207|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
161664449|NCT03057977|583824206|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
161664450|NCT03057977|583824207|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
161664451|NCT03057977|583824206|FG000|Discontinuation From Treatment|Protocol Violation|6|||
161664452|NCT03057977|583824207|FG001|Discontinuation From Treatment|Protocol Violation|5|||
161664453|NCT03057977|583824206|FG000|Discontinuation From Treatment|Not treated|4|||
161664454|NCT03057977|583824207|FG001|Discontinuation From Treatment|Not treated|0|||
161664455|NCT03057977|583824206|FG000|Discontinuation From Treatment|Adverse Event|343|||
161664456|NCT03057977|583824207|FG001|Discontinuation From Treatment|Adverse Event|337|||
161664457|NCT03057977|583824206|FG000|Discontinuation From Treatment|Reason Unknown|0|||
161664458|NCT03057977|583824207|FG001|Discontinuation From Treatment|Reason Unknown|1|||
161664459|NCT03057977|583824206|FG000|Discontinuation From Treatment|Personal Reasons|1|||
161664460|NCT03057977|583824207|FG001|Discontinuation From Treatment|Personal Reasons|1|||
161664461|NCT03057977|583824206|FG000|Discontinuation From Treatment|Unblinded medication|1|||
161664462|NCT03057977|583824207|FG001|Discontinuation From Treatment|Unblinded medication|0|||
161664463|NCT03057977|583824206|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
161664464|NCT03057977|583824207|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
161664465|NCT03057977|583824206|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
161664466|NCT03057977|583824207|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
161664467|NCT03057977|583824206|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
161664468|NCT03057977|583824207|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
161664469|NCT03057977|583824206|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
161664470|NCT03057977|583824207|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
161664471|NCT03057977|583824206|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
161664472|NCT03057977|583824207|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
161664473|NCT03057977|583824206|FG000|Discontinuation From Treatment|Not attending study visit|3|||
161664474|NCT03057977|583824207|FG001|Discontinuation From Treatment|Not attending study visit|10|||
161664475|NCT03057977|583824206|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
161664476|NCT03057977|583824207|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
161664477|NCT03057977|583824206|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
161664478|NCT03057977|583824207|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
161664479|NCT03057977|583824206|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
161664480|NCT03057977|583824207|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
161664481|NCT03057977|583824206|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
161664482|NCT03057977|583824207|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
161664483|NCT03057977|583824206|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
161664484|NCT03057977|583824207|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
161664485|NCT01350336|583824208|FG000|Overall Study|Lost to Follow-up|31|||
161664486|NCT01350336|583824208|FG000|Overall Study|Withdrawal by Subject|14|||
161893774|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161664487|NCT01350336|583824208|FG000|Overall Study|Physician Decision|8|||
161664488|NCT01350336|583824208|FG000|Overall Study|Death|4|||
161550708|NCT02736968|583406967|FG002|Overall Study|Lost to Follow-up|0|||
161550709|NCT02736968|583406968|FG003|Overall Study|Lost to Follow-up|0|||
161664489|NCT02079610|583824209|FG000|Overall Study|Withdrawal by Subject|1|||
161664490|NCT02079610|583824210|FG001|Overall Study|Withdrawal by Subject|1|||
161664491|NCT01716117|583824211|FG000|Overall Study|Death|5|||
161664492|NCT01716117|583824212|FG001|Overall Study|Death|2|||
161664493|NCT01716117|583824211|FG000|Overall Study|Withdrawal by Subject|2|||
161664494|NCT01716117|583824212|FG001|Overall Study|Withdrawal by Subject|0|||
161664495|NCT03645057|583824214|FG000|Randomization to Baseline|Lost to Follow-up|1|||
161664496|NCT03645057|583824215|FG001|Randomization to Baseline|Lost to Follow-up|0|||
161664497|NCT03645057|583824216|FG002|Randomization to Baseline|Lost to Follow-up|1|||
161664498|NCT03645057|583824217|FG003|Randomization to Baseline|Lost to Follow-up|0|||
161664499|NCT03645057|583824214|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
161664500|NCT03645057|583824215|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
161664501|NCT03645057|583824216|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
161664502|NCT03645057|583824217|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
161664503|NCT03645057|583824214|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
161664504|NCT03645057|583824215|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
161664505|NCT03645057|583824216|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
161664506|NCT03645057|583824217|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
161664507|NCT03645057|583824214|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
161664508|NCT03645057|583824215|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
161664509|NCT03645057|583824216|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
161664510|NCT03645057|583824217|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
161664511|NCT01171807|583824221|FG000|Overall Study|Treatment failure|2|||
161664512|NCT01171807|583824222|FG001|Overall Study|Treatment failure|4|||
161664513|NCT01171807|583824221|FG000|Overall Study|Non compliance|1|||
161664514|NCT01171807|583824222|FG001|Overall Study|Non compliance|0|||
161664515|NCT01171807|583824221|FG000|Overall Study|Lost to Follow-up|3|||
161664516|NCT01171807|583824222|FG001|Overall Study|Lost to Follow-up|0|||
161664517|NCT01901341|583824223|FG000|Overall Study|Adverse Event|4|||
161664518|NCT01901341|583824224|FG001|Overall Study|Adverse Event|2|||
161664519|NCT01901341|583824223|FG000|Overall Study|Lack of Efficacy|0|||
161664520|NCT01901341|583824224|FG001|Overall Study|Lack of Efficacy|2|||
161664521|NCT01901341|583824223|FG000|Overall Study|Lost to Follow-up|0|||
161664522|NCT01901341|583824224|FG001|Overall Study|Lost to Follow-up|1|||
161664523|NCT01901341|583824223|FG000|Overall Study|Protocol Violation|2|||
161664524|NCT01901341|583824224|FG001|Overall Study|Protocol Violation|0|||
161664525|NCT01901341|583824223|FG000|Overall Study|Study Terminated by Sponsor|13|||
161664526|NCT01901341|583824224|FG001|Overall Study|Study Terminated by Sponsor|15|||
161664527|NCT01901341|583824223|FG000|Overall Study|Withdrawal by Subject|1|||
161664528|NCT01901341|583824224|FG001|Overall Study|Withdrawal by Subject|1|||
161664529|NCT04964388|583824225|FG000|Overall Study|Lost to Follow-up|3|||
161664530|NCT04964388|583824226|FG001|Overall Study|Lost to Follow-up|2|||
161664531|NCT00250679|583824227|FG000|Overall Study|Adverse Event|12|||
161664532|NCT00250679|583824228|FG001|Overall Study|Adverse Event|15|||
161664533|NCT00250679|583824229|FG002|Overall Study|Adverse Event|16|||
161664534|NCT00250679|583824227|FG000|Overall Study|Protocol Violation|2|||
161664535|NCT00250679|583824228|FG001|Overall Study|Protocol Violation|4|||
161664536|NCT00250679|583824229|FG002|Overall Study|Protocol Violation|3|||
161664537|NCT00250679|583824227|FG000|Overall Study|Withdrawal by Subject|15|||
161664538|NCT00250679|583824228|FG001|Overall Study|Withdrawal by Subject|18|||
161664539|NCT00250679|583824229|FG002|Overall Study|Withdrawal by Subject|15|||
161664540|NCT00250679|583824227|FG000|Overall Study|Lost to Follow-up|3|||
161664541|NCT00250679|583824228|FG001|Overall Study|Lost to Follow-up|4|||
161664542|NCT00250679|583824229|FG002|Overall Study|Lost to Follow-up|2|||
161664543|NCT00250679|583824227|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
161664544|NCT00250679|583824228|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
161664545|NCT00250679|583824229|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
161664546|NCT00250679|583824227|FG000|Overall Study|Lack of Efficacy|0|||
161664547|NCT00250679|583824228|FG001|Overall Study|Lack of Efficacy|1|||
161664548|NCT00250679|583824229|FG002|Overall Study|Lack of Efficacy|3|||
161664549|NCT00250679|583824227|FG000|Overall Study|Technical Holter issues|1|||
161664550|NCT00250679|583824228|FG001|Overall Study|Technical Holter issues|0|||
161664551|NCT00250679|583824229|FG002|Overall Study|Technical Holter issues|2|||
161664552|NCT00250679|583824227|FG000|Overall Study|Moved|1|||
161664553|NCT00250679|583824228|FG001|Overall Study|Moved|1|||
161664554|NCT00250679|583824229|FG002|Overall Study|Moved|0|||
161664555|NCT00250679|583824227|FG000|Overall Study|Non-compliance|1|||
161664556|NCT00250679|583824228|FG001|Overall Study|Non-compliance|1|||
161664557|NCT00250679|583824229|FG002|Overall Study|Non-compliance|0|||
161664558|NCT00250679|583824227|FG000|Overall Study|various single events: hip surgery,diary|3|||
161664559|NCT00250679|583824228|FG001|Overall Study|various single events: hip surgery,diary|1|||
161664560|NCT00250679|583824229|FG002|Overall Study|various single events: hip surgery,diary|1|||
161664561|NCT00448279|583824231|FG000|Overall Study|Lost to Follow-up|2|||
161664562|NCT00448279|583824232|FG001|Overall Study|Lost to Follow-up|2|||
161664563|NCT00448279|583824231|FG000|Overall Study|Adverse Event|1|||
161664564|NCT00448279|583824232|FG001|Overall Study|Adverse Event|1|||
161779157|NCT01643928|584233855|FG002|Overall Study|Withdrawal by Subject|0|||
161664565|NCT00448279|583824231|FG000|Overall Study|Disease progression|16|||
161664566|NCT00448279|583824232|FG001|Overall Study|Disease progression|18|||
161664567|NCT00448279|583824231|FG000|Overall Study|Withdrawal by Subject|4|||
161664568|NCT00448279|583824232|FG001|Overall Study|Withdrawal by Subject|3|||
161664569|NCT00448279|583824231|FG000|Overall Study|Other|6|||
161664570|NCT00448279|583824232|FG001|Overall Study|Other|4|||
161664571|NCT00448279|583824231|FG000|Overall Study|Protocol Violation|0|||
161664572|NCT00448279|583824232|FG001|Overall Study|Protocol Violation|1|||
161664573|NCT03907410|583824233|FG000|Overall Study|Lost to Follow-up|4|||
161664574|NCT03907410|583824234|FG001|Overall Study|Lost to Follow-up|1|||
161664575|NCT03907410|583824235|FG002|Overall Study|Lost to Follow-up|1|||
161664576|NCT03907410|583824233|FG000|Overall Study|Lost to follow-up and research burden|0|||
161664577|NCT03907410|583824234|FG001|Overall Study|Lost to follow-up and research burden|0|||
161664578|NCT03907410|583824235|FG002|Overall Study|Lost to follow-up and research burden|1|||
161664579|NCT04776148|583824236|FG000|Overall Study|Death|249|||
161664580|NCT04776148|583824237|FG001|Overall Study|Death|260|||
161664581|NCT04776148|583824236|FG000|Overall Study|Lost to Follow-up|0|||
161664582|NCT04776148|583824237|FG001|Overall Study|Lost to Follow-up|1|||
161779158|NCT01643928|584233856|FG003|Overall Study|Withdrawal by Subject|1|||
161779159|NCT01643928|584233857|FG004|Overall Study|Withdrawal by Subject|0|||
161779160|NCT01643928|584233853|FG000|Overall Study|Pregnancy|0|||
161779161|NCT01643928|584233854|FG001|Overall Study|Pregnancy|0|||
161779162|NCT01643928|584233855|FG002|Overall Study|Pregnancy|0|||
161779163|NCT01643928|584233856|FG003|Overall Study|Pregnancy|1|||
161779164|NCT01643928|584233857|FG004|Overall Study|Pregnancy|0|||
161664583|NCT04776148|583824236|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161664584|NCT04776148|583824237|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161664585|NCT04776148|583824236|FG000|Overall Study|Withdrawal by Subject|3|||
161664586|NCT04776148|583824237|FG001|Overall Study|Withdrawal by Subject|4|||
161664587|NCT04776148|583824236|FG000|Overall Study|Sponsor Decision|30|||
161664588|NCT04776148|583824237|FG001|Overall Study|Sponsor Decision|15|||
161664589|NCT01155375|583824238|FG000|Overall Study|Adverse Event|1|||
161664590|NCT01155375|583824239|FG001|Overall Study|Adverse Event|0|||
161664591|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
161664592|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
161664593|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
161664594|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
161664595|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
161664596|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
161664597|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
161664598|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
161664599|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
161664600|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
161664601|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
161664602|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
161664603|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
161664604|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
161664605|NCT00757588|583824240|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
161893775|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161893776|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
161893777|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
161893778|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
161893779|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
161893780|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
161893781|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
161893782|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
161664606|NCT00757588|583824241|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
161664607|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
161893783|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
161893784|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
161893785|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
161664608|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
161664609|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
161664610|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
161664611|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
161664612|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
161664613|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
161664614|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
161779165|NCT01643928|584233853|FG000|Overall Study|Other|5|||
161893786|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
161893787|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161664615|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
161664616|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
161893788|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161893789|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161893790|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161893791|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161893792|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161893793|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
161893794|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893795|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893796|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893797|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
161893798|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893799|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
161893800|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893801|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893802|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893803|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161893804|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893805|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161893806|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893807|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893808|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161893809|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893810|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893811|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893812|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
161893813|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893814|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893815|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
161893816|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893817|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893818|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893819|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
161893820|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893821|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
161893822|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
161893823|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
161893824|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161893825|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161893826|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161893827|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
161893828|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
161893829|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
161893830|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
161893831|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
161893832|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
161893833|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161893834|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
161893835|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
161893836|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
161893837|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161664617|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
161779166|NCT01643928|584233854|FG001|Overall Study|Other|1|||
161779167|NCT01643928|584233855|FG002|Overall Study|Other|1|||
161779168|NCT01643928|584233856|FG003|Overall Study|Other|0|||
161779169|NCT01643928|584233857|FG004|Overall Study|Other|0|||
161779170|NCT01643928|584233853|FG000|Overall Study|Adverse Event|2|||
161779171|NCT01643928|584233854|FG001|Overall Study|Adverse Event|1|||
161779172|NCT01643928|584233855|FG002|Overall Study|Adverse Event|0|||
161779173|NCT01643928|584233856|FG003|Overall Study|Adverse Event|1|||
161779174|NCT01643928|584233857|FG004|Overall Study|Adverse Event|2|||
161779175|NCT00203892|584233860|FG000|Overall Study|Physician Decision|1|||
161779176|NCT00203892|584233861|FG001|Overall Study|Physician Decision|2|||
161779177|NCT00203892|584233862|FG002|Overall Study|Physician Decision|0|||
161779178|NCT00203892|584233860|FG000|Overall Study|Death|1|||
161779179|NCT00203892|584233861|FG001|Overall Study|Death|0|||
161779180|NCT00203892|584233862|FG002|Overall Study|Death|0|||
161779181|NCT00556166|584233864|FG000|Overall Study|Withdrawal by Subject|1|||
161779182|NCT03359473|584233865|FG000|Overall Study|Adverse Event|0|||
161779183|NCT03359473|584233866|FG001|Overall Study|Adverse Event|2|||
161779184|NCT03359473|584233867|FG002|Overall Study|Adverse Event|5|||
161779185|NCT03359473|584233868|FG003|Overall Study|Adverse Event|3|||
161779186|NCT03359473|584233865|FG000|Overall Study|Lost to Follow-up|0|||
161779187|NCT03359473|584233866|FG001|Overall Study|Lost to Follow-up|1|||
161779188|NCT03359473|584233867|FG002|Overall Study|Lost to Follow-up|0|||
161779189|NCT03359473|584233868|FG003|Overall Study|Lost to Follow-up|0|||
161779190|NCT03359473|584233865|FG000|Overall Study|Physician Decision|0|||
161779191|NCT03359473|584233866|FG001|Overall Study|Physician Decision|1|||
161779192|NCT03359473|584233867|FG002|Overall Study|Physician Decision|0|||
161779193|NCT03359473|584233868|FG003|Overall Study|Physician Decision|1|||
161779194|NCT03359473|584233865|FG000|Overall Study|Withdrawal by Subject|1|||
161779195|NCT03359473|584233866|FG001|Overall Study|Withdrawal by Subject|2|||
161779196|NCT03359473|584233867|FG002|Overall Study|Withdrawal by Subject|1|||
161779197|NCT03359473|584233868|FG003|Overall Study|Withdrawal by Subject|0|||
161779198|NCT03359473|584233865|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161779199|NCT03359473|584233866|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161779200|NCT03359473|584233867|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161893838|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161893839|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
161893840|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
161893841|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
161893842|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
161893843|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
161893844|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
161893845|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
161893846|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
161893847|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
161893848|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
161893849|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
161893850|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161893851|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161893852|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
161893853|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
161893854|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
161893855|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
161893856|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161779201|NCT03359473|584233868|FG003|Overall Study|Protocol-defined stopping criteria|1|||
161779202|NCT03829462|584233874|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
161779203|NCT03829462|584233875|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
161779204|NCT03829462|584233874|FG000|Overall Study|No treatment due to progression disease|0|||
161779205|NCT03829462|584233875|FG001|Overall Study|No treatment due to progression disease|1|||
161779206|NCT03000075|584233885|FG000|Part A|Adverse Event|4|||
161779207|NCT03000075|584233886|FG001|Part A|Adverse Event|0|||
161779208|NCT03000075|584233887|FG002|Part A|Adverse Event|0|||
161779209|NCT03000075|584233888|FG003|Part A|Adverse Event|0|||
161779210|NCT03000075|584233889|FG004|Part A|Adverse Event|0|||
161779211|NCT03000075|584233890|FG005|Part A|Adverse Event|0|||
161779212|NCT03000075|584233891|FG006|Part A|Adverse Event|0|||
161779213|NCT03000075|584233885|FG000|Part B|Not dosed due to AE|0|||
161779214|NCT03000075|584233886|FG001|Part B|Not dosed due to AE|0|||
161779215|NCT03000075|584233887|FG002|Part B|Not dosed due to AE|0|||
161779216|NCT03000075|584233888|FG003|Part B|Not dosed due to AE|0|||
161779217|NCT03000075|584233889|FG004|Part B|Not dosed due to AE|0|||
161779218|NCT03000075|584233890|FG005|Part B|Not dosed due to AE|2|||
161550710|NCT02736968|583406969|FG004|Overall Study|Lost to Follow-up|0|||
161779219|NCT03000075|584233891|FG006|Part B|Not dosed due to AE|1|||
161779220|NCT03000075|584233885|FG000|Part B|Adverse Event|0|||
161779221|NCT03000075|584233886|FG001|Part B|Adverse Event|0|||
161779222|NCT03000075|584233887|FG002|Part B|Adverse Event|0|||
161550711|NCT02736968|583406970|FG005|Overall Study|Lost to Follow-up|0|||
161779223|NCT03000075|584233888|FG003|Part B|Adverse Event|0|||
161779224|NCT03000075|584233889|FG004|Part B|Adverse Event|1|||
161550712|NCT02736968|583406971|FG006|Overall Study|Lost to Follow-up|5|||
161779225|NCT03000075|584233890|FG005|Part B|Adverse Event|0|||
161550713|NCT02736968|583406972|FG007|Overall Study|Lost to Follow-up|2|||
161779226|NCT03000075|584233891|FG006|Part B|Adverse Event|0|||
161779227|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
161779228|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
161779229|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Death|5|||
161893857|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893858|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161893859|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161664618|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
161664619|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
161893860|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161893861|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893862|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893863|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161893864|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893865|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893866|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893867|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893868|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893869|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893870|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
161893871|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
161893872|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893873|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893874|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893875|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893876|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161893877|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893878|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893879|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893880|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893881|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161893882|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893883|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161893884|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161893885|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161893886|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
161893887|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161893888|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
161893889|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
161893890|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
161893891|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
161893892|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
161893893|NCT01289574|584658580|FG000|Overall Study|Lack of Efficacy|4|||
161893894|NCT01289574|584658581|FG001|Overall Study|Lack of Efficacy|0|||
161893895|NCT01289574|584658582|FG002|Overall Study|Lack of Efficacy|1|||
161893896|NCT01289574|584658580|FG000|Overall Study|Lost to Follow-up|2|||
161893897|NCT01289574|584658581|FG001|Overall Study|Lost to Follow-up|0|||
161893898|NCT01289574|584658582|FG002|Overall Study|Lost to Follow-up|1|||
161893899|NCT01289574|584658580|FG000|Overall Study|Withdrawal by Subject|1|||
161893900|NCT01289574|584658581|FG001|Overall Study|Withdrawal by Subject|1|||
161893901|NCT01289574|584658582|FG002|Overall Study|Withdrawal by Subject|1|||
161893902|NCT01289574|584658580|FG000|Overall Study|Adverse Event|0|||
161893903|NCT01289574|584658581|FG001|Overall Study|Adverse Event|1|||
161893904|NCT01289574|584658582|FG002|Overall Study|Adverse Event|0|||
161893905|NCT01289574|584658580|FG000|Overall Study|Subject wanted alternate treatment|0|||
161893906|NCT01289574|584658581|FG001|Overall Study|Subject wanted alternate treatment|1|||
161893907|NCT01289574|584658582|FG002|Overall Study|Subject wanted alternate treatment|0|||
161893908|NCT02432144|584658583|FG000|Overall Study|Participant Non-Compliance|1|||
161893909|NCT00262002|584658584|FG000|Overall Study|Adverse Event|2|||
161893910|NCT00262002|584658585|FG001|Overall Study|Adverse Event|1|||
161893911|NCT00262002|584658586|FG002|Overall Study|Adverse Event|0|||
161893912|NCT00262002|584658587|FG003|Overall Study|Adverse Event|0|||
161893913|NCT00262002|584658588|FG004|Overall Study|Adverse Event|0|||
161893914|NCT00262002|584658589|FG005|Overall Study|Adverse Event|1|||
161893915|NCT00262002|584658590|FG006|Overall Study|Adverse Event|0|||
161893916|NCT00262002|584658584|FG000|Overall Study|Withdrawal by Subject|4|||
161893917|NCT00262002|584658585|FG001|Overall Study|Withdrawal by Subject|2|||
161893918|NCT00262002|584658586|FG002|Overall Study|Withdrawal by Subject|0|||
161893919|NCT00262002|584658587|FG003|Overall Study|Withdrawal by Subject|1|||
161893920|NCT00262002|584658588|FG004|Overall Study|Withdrawal by Subject|2|||
161664620|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
161893921|NCT00262002|584658589|FG005|Overall Study|Withdrawal by Subject|2|||
161893922|NCT00262002|584658590|FG006|Overall Study|Withdrawal by Subject|2|||
161893923|NCT00262002|584658584|FG000|Overall Study|Lost to Follow-up|2|||
161893924|NCT00262002|584658585|FG001|Overall Study|Lost to Follow-up|0|||
161893925|NCT00262002|584658586|FG002|Overall Study|Lost to Follow-up|0|||
161893926|NCT00262002|584658587|FG003|Overall Study|Lost to Follow-up|2|||
161893927|NCT00262002|584658588|FG004|Overall Study|Lost to Follow-up|0|||
161893928|NCT00262002|584658589|FG005|Overall Study|Lost to Follow-up|1|||
161893929|NCT00262002|584658590|FG006|Overall Study|Lost to Follow-up|0|||
161893930|NCT00262002|584658584|FG000|Overall Study|Inapropriate enrollment|0|||
161893931|NCT00262002|584658585|FG001|Overall Study|Inapropriate enrollment|1|||
161893932|NCT00262002|584658586|FG002|Overall Study|Inapropriate enrollment|0|||
161893933|NCT00262002|584658587|FG003|Overall Study|Inapropriate enrollment|0|||
161893934|NCT00262002|584658588|FG004|Overall Study|Inapropriate enrollment|0|||
161893935|NCT00262002|584658589|FG005|Overall Study|Inapropriate enrollment|0|||
161893936|NCT00262002|584658590|FG006|Overall Study|Inapropriate enrollment|0|||
161893937|NCT00262002|584658584|FG000|Overall Study|Protocol Violation|3|||
161893938|NCT00262002|584658585|FG001|Overall Study|Protocol Violation|2|||
161893939|NCT00262002|584658586|FG002|Overall Study|Protocol Violation|0|||
161893940|NCT00262002|584658587|FG003|Overall Study|Protocol Violation|2|||
161893941|NCT00262002|584658588|FG004|Overall Study|Protocol Violation|5|||
161893942|NCT00262002|584658589|FG005|Overall Study|Protocol Violation|3|||
161893943|NCT00262002|584658590|FG006|Overall Study|Protocol Violation|2|||
161893944|NCT00262002|584658584|FG000|Overall Study|Unable to classify|0|||
161893945|NCT00262002|584658585|FG001|Overall Study|Unable to classify|0|||
161893946|NCT00262002|584658586|FG002|Overall Study|Unable to classify|0|||
161893947|NCT00262002|584658587|FG003|Overall Study|Unable to classify|0|||
161893948|NCT00262002|584658588|FG004|Overall Study|Unable to classify|0|||
161893949|NCT00262002|584658589|FG005|Overall Study|Unable to classify|0|||
161893950|NCT00262002|584658590|FG006|Overall Study|Unable to classify|2|||
161893951|NCT01451554|584658591|FG000|Overall Study|Withdrawal by Subject|14|||
161893952|NCT01451554|584658592|FG001|Overall Study|Withdrawal by Subject|9|||
161893953|NCT00958412|584658593|FG000|Overall Study|Study prematurely terminated|18|||
161893954|NCT02552888|584658596|FG000|Overall Study|Lost to Follow-up|1|||
161893955|NCT02552888|584658597|FG001|Overall Study|Lost to Follow-up|1|||
161893956|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
161893957|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161893958|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161893959|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161893960|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
161893961|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161893962|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161893963|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161893964|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
161893965|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
161893966|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
161893967|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
161893968|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
161893969|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161893970|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161893971|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161893972|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
161893973|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
161893974|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
161893975|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
161893976|NCT02362425|584660865|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161893977|NCT02362425|584660866|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161893978|NCT02362425|584660867|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161893979|NCT02362425|584660868|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
161893980|NCT02362425|584660865|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161893981|NCT02362425|584660866|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161893982|NCT02362425|584660867|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161893983|NCT02362425|584660868|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
161893984|NCT02362425|584660865|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161893985|NCT02362425|584660866|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161893986|NCT02362425|584660867|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
161893987|NCT02362425|584660868|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161893988|NCT02688764|584660878|FG000|Overall Study|Adverse Event|3|||
161893989|NCT02688764|584660879|FG001|Overall Study|Adverse Event|3|||
161893990|NCT02688764|584660878|FG000|Overall Study|AE/Kidney transplant|1|||
161893991|NCT02688764|584660879|FG001|Overall Study|AE/Kidney transplant|0|||
161893992|NCT02688764|584660878|FG000|Overall Study|AE/Lack of efficacy|1|||
161893993|NCT02688764|584660879|FG001|Overall Study|AE/Lack of efficacy|0|||
161893994|NCT02688764|584660878|FG000|Overall Study|AE/Non-compl.|1|||
161893995|NCT02688764|584660879|FG001|Overall Study|AE/Non-compl.|0|||
161893996|NCT02688764|584660878|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
161550714|NCT02736968|583406965|FG000|Overall Study|COVID-19 Pandemic|0|||
161893997|NCT02688764|584660879|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
161893998|NCT02688764|584660878|FG000|Overall Study|AE/Other|0|||
161893999|NCT02688764|584660879|FG001|Overall Study|AE/Other|1|||
161894000|NCT02688764|584660878|FG000|Overall Study|AE/Physician decision|1|||
161894001|NCT02688764|584660879|FG001|Overall Study|AE/Physician decision|0|||
161894002|NCT02688764|584660878|FG000|Overall Study|AE/Withd. parent|3|||
161894003|NCT02688764|584660879|FG001|Overall Study|AE/Withd. parent|0|||
161894004|NCT02688764|584660878|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
161894005|NCT02688764|584660879|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
161894006|NCT02688764|584660878|FG000|Overall Study|AE/Withd. subject|1|||
161894007|NCT02688764|584660879|FG001|Overall Study|AE/Withd. subject|0|||
161894008|NCT02688764|584660878|FG000|Overall Study|Kidney transplant|10|||
161894009|NCT02688764|584660879|FG001|Overall Study|Kidney transplant|4|||
161894010|NCT02688764|584660878|FG000|Overall Study|Lack of Efficacy|3|||
161894011|NCT02688764|584660879|FG001|Overall Study|Lack of Efficacy|2|||
161894012|NCT02688764|584660878|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
161894013|NCT02688764|584660879|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
161894014|NCT02688764|584660878|FG000|Overall Study|Non-compliance with study drug|4|||
161894015|NCT02688764|584660879|FG001|Overall Study|Non-compliance with study drug|0|||
161894016|NCT02688764|584660878|FG000|Overall Study|Non-compl./Physician decision|2|||
161894017|NCT02688764|584660879|FG001|Overall Study|Non-compl./Physician decision|0|||
161894018|NCT02688764|584660878|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
161894019|NCT02688764|584660879|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
161894020|NCT02688764|584660878|FG000|Overall Study|Non-compl./Withd. subject|0|||
161894021|NCT02688764|584660879|FG001|Overall Study|Non-compl./Withd. subject|2|||
161550715|NCT02736968|583406966|FG001|Overall Study|COVID-19 Pandemic|0|||
161894022|NCT02688764|584660878|FG000|Overall Study|Phosphorus level outside safe range|0|||
161894023|NCT02688764|584660879|FG001|Overall Study|Phosphorus level outside safe range|1|||
161894024|NCT02688764|584660878|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
161894025|NCT02688764|584660879|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
161894026|NCT02688764|584660878|FG000|Overall Study|Study drug taste/Withd. parent|1|||
161894027|NCT02688764|584660879|FG001|Overall Study|Study drug taste/Withd. parent|0|||
161894028|NCT02688764|584660878|FG000|Overall Study|Subject moving out|2|||
161894029|NCT02688764|584660879|FG001|Overall Study|Subject moving out|0|||
161894030|NCT02688764|584660878|FG000|Overall Study|Subject taken off dialysis|1|||
161894031|NCT02688764|584660879|FG001|Overall Study|Subject taken off dialysis|0|||
161894032|NCT02688764|584660878|FG000|Overall Study|Withdrawal by parent|3|||
161894033|NCT02688764|584660879|FG001|Overall Study|Withdrawal by parent|0|||
161894034|NCT02579382|584660880|FG000|Main Study Phase|Lost to Follow-up|0|||
161894035|NCT02579382|584660881|FG001|Main Study Phase|Lost to Follow-up|0|||
161894036|NCT02579382|584660882|FG002|Main Study Phase|Lost to Follow-up|2|||
161894037|NCT02579382|584660883|FG003|Main Study Phase|Lost to Follow-up|0|||
161894038|NCT02579382|584660880|FG000|Main Study Phase|Withdrew Consent|0|||
161894039|NCT02579382|584660881|FG001|Main Study Phase|Withdrew Consent|0|||
161894040|NCT02579382|584660882|FG002|Main Study Phase|Withdrew Consent|0|||
161894041|NCT02579382|584660883|FG003|Main Study Phase|Withdrew Consent|2|||
161894042|NCT02579382|584660880|FG000|Main Study Phase|Lack of Efficacy|0|||
161894043|NCT02579382|584660881|FG001|Main Study Phase|Lack of Efficacy|0|||
161894044|NCT02579382|584660882|FG002|Main Study Phase|Lack of Efficacy|0|||
161894045|NCT02579382|584660883|FG003|Main Study Phase|Lack of Efficacy|1|||
161894046|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
161894047|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
161894048|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
161894049|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
161894050|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
161894051|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
161894052|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
161894053|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
161894054|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
161894055|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161894056|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161894057|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161894058|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161894059|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
161894060|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161894061|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161894062|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161894063|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
161894064|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161894065|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161894066|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161894067|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
161894068|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161894069|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161894070|NCT03026283|584660884|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
161894071|NCT03026283|584660885|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
161894072|NCT03026283|584660886|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
161894073|NCT03026283|584660887|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
161894074|NCT03026283|584660888|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
161894075|NCT03026283|584660889|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
161894076|NCT03026283|584660890|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
161894077|NCT03026283|584660891|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
161894078|NCT03026283|584660884|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
161894079|NCT03026283|584660885|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
161894080|NCT03026283|584660886|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
161894081|NCT03026283|584660887|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
161894082|NCT03026283|584660888|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
161894083|NCT03026283|584660889|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
161894084|NCT03026283|584660890|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
161894085|NCT03026283|584660891|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
161894086|NCT03026283|584660884|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894087|NCT03026283|584660885|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
161894088|NCT03026283|584660886|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894089|NCT03026283|584660887|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894090|NCT03026283|584660888|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894091|NCT03026283|584660889|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894092|NCT03026283|584660890|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894093|NCT03026283|584660891|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894094|NCT03026283|584660884|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894095|NCT03026283|584660885|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894096|NCT03026283|584660886|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
161894097|NCT03026283|584660887|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894098|NCT03026283|584660888|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894099|NCT03026283|584660889|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894100|NCT03026283|584660890|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894101|NCT03026283|584660891|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894102|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894103|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894104|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894105|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
161894106|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
161894107|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894108|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894109|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894110|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894111|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894112|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894113|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
161894114|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
161894115|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
161894116|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894117|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894118|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894119|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894120|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894121|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
161894122|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894123|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
161894124|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894125|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894126|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894127|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894128|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894129|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
161894130|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894131|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894132|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894133|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894134|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894135|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894136|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894137|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894138|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
161894139|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
161894140|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894141|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894142|NCT00824655|584660892|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
161894143|NCT00824655|584660893|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
161894144|NCT00824655|584660892|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
161894145|NCT00824655|584660893|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
161894146|NCT01826981|584660896|FG000|Overall Study|Lack of Efficacy|0|||
161894147|NCT01826981|584660897|FG001|Overall Study|Lack of Efficacy|1|||
161894148|NCT01826981|584660898|FG002|Overall Study|Lack of Efficacy|0|||
161894149|NCT01826981|584660899|FG003|Overall Study|Lack of Efficacy|0|||
161894150|NCT01826981|584660900|FG004|Overall Study|Lack of Efficacy|5|||
161894151|NCT01826981|584660901|FG005|Overall Study|Lack of Efficacy|0|||
161894152|NCT01826981|584660902|FG006|Overall Study|Lack of Efficacy|0|||
161894153|NCT01826981|584660903|FG007|Overall Study|Lack of Efficacy|8|||
161894154|NCT01826981|584660904|FG008|Overall Study|Lack of Efficacy|7|||
161894155|NCT01826981|584660905|FG009|Overall Study|Lack of Efficacy|0|||
161894156|NCT01826981|584660906|FG010|Overall Study|Lack of Efficacy|1|||
161894157|NCT01826981|584660907|FG011|Overall Study|Lack of Efficacy|0|||
161894158|NCT01826981|584660908|FG012|Overall Study|Lack of Efficacy|0|||
161894159|NCT01826981|584660909|FG013|Overall Study|Lack of Efficacy|3|||
161894160|NCT01826981|584660910|FG014|Overall Study|Lack of Efficacy|0|||
161894161|NCT01826981|584660896|FG000|Overall Study|Lost to Follow-up|0|||
161894162|NCT01826981|584660897|FG001|Overall Study|Lost to Follow-up|0|||
161894163|NCT01826981|584660898|FG002|Overall Study|Lost to Follow-up|0|||
161894164|NCT01826981|584660899|FG003|Overall Study|Lost to Follow-up|0|||
161894165|NCT01826981|584660900|FG004|Overall Study|Lost to Follow-up|1|||
161894166|NCT01826981|584660901|FG005|Overall Study|Lost to Follow-up|1|||
161894167|NCT01826981|584660902|FG006|Overall Study|Lost to Follow-up|0|||
161894168|NCT01826981|584660903|FG007|Overall Study|Lost to Follow-up|1|||
161894169|NCT01826981|584660904|FG008|Overall Study|Lost to Follow-up|0|||
161894170|NCT01826981|584660905|FG009|Overall Study|Lost to Follow-up|1|||
161894171|NCT01826981|584660906|FG010|Overall Study|Lost to Follow-up|1|||
161894172|NCT01826981|584660907|FG011|Overall Study|Lost to Follow-up|1|||
161894173|NCT01826981|584660908|FG012|Overall Study|Lost to Follow-up|1|||
161894174|NCT01826981|584660909|FG013|Overall Study|Lost to Follow-up|0|||
161894175|NCT01826981|584660910|FG014|Overall Study|Lost to Follow-up|0|||
161894176|NCT01826981|584660896|FG000|Overall Study|Withdrew Consent|0|||
161894177|NCT01826981|584660897|FG001|Overall Study|Withdrew Consent|0|||
161894178|NCT01826981|584660898|FG002|Overall Study|Withdrew Consent|0|||
161894179|NCT01826981|584660899|FG003|Overall Study|Withdrew Consent|0|||
161894180|NCT01826981|584660900|FG004|Overall Study|Withdrew Consent|0|||
161894181|NCT01826981|584660901|FG005|Overall Study|Withdrew Consent|0|||
161894182|NCT01826981|584660902|FG006|Overall Study|Withdrew Consent|1|||
161894183|NCT01826981|584660903|FG007|Overall Study|Withdrew Consent|1|||
161894184|NCT01826981|584660904|FG008|Overall Study|Withdrew Consent|0|||
161894185|NCT01826981|584660905|FG009|Overall Study|Withdrew Consent|0|||
161894186|NCT01826981|584660906|FG010|Overall Study|Withdrew Consent|0|||
161894187|NCT01826981|584660907|FG011|Overall Study|Withdrew Consent|1|||
161894188|NCT01826981|584660908|FG012|Overall Study|Withdrew Consent|0|||
161894189|NCT01826981|584660909|FG013|Overall Study|Withdrew Consent|1|||
161894190|NCT01826981|584660910|FG014|Overall Study|Withdrew Consent|0|||
161894191|NCT01826981|584660896|FG000|Overall Study|Adverse Event|0|||
161894192|NCT01826981|584660897|FG001|Overall Study|Adverse Event|0|||
161894193|NCT01826981|584660898|FG002|Overall Study|Adverse Event|0|||
161894194|NCT01826981|584660899|FG003|Overall Study|Adverse Event|0|||
161894195|NCT01826981|584660900|FG004|Overall Study|Adverse Event|1|||
161894196|NCT01826981|584660901|FG005|Overall Study|Adverse Event|0|||
161894197|NCT01826981|584660902|FG006|Overall Study|Adverse Event|0|||
161894198|NCT01826981|584660903|FG007|Overall Study|Adverse Event|0|||
161894199|NCT01826981|584660904|FG008|Overall Study|Adverse Event|0|||
161894200|NCT01826981|584660905|FG009|Overall Study|Adverse Event|0|||
161894201|NCT01826981|584660906|FG010|Overall Study|Adverse Event|0|||
161894202|NCT01826981|584660907|FG011|Overall Study|Adverse Event|0|||
161894203|NCT01826981|584660908|FG012|Overall Study|Adverse Event|0|||
161894204|NCT01826981|584660909|FG013|Overall Study|Adverse Event|0|||
161894205|NCT01826981|584660910|FG014|Overall Study|Adverse Event|0|||
161894206|NCT01826981|584660896|FG000|Overall Study|Upper G-I Haemorrhage|0|||
161894207|NCT01826981|584660897|FG001|Overall Study|Upper G-I Haemorrhage|0|||
161894208|NCT01826981|584660898|FG002|Overall Study|Upper G-I Haemorrhage|0|||
161894209|NCT01826981|584660899|FG003|Overall Study|Upper G-I Haemorrhage|0|||
161894210|NCT01826981|584660900|FG004|Overall Study|Upper G-I Haemorrhage|0|||
161894211|NCT01826981|584660901|FG005|Overall Study|Upper G-I Haemorrhage|0|||
161894212|NCT01826981|584660902|FG006|Overall Study|Upper G-I Haemorrhage|0|||
161894213|NCT01826981|584660903|FG007|Overall Study|Upper G-I Haemorrhage|0|||
161894214|NCT01826981|584660904|FG008|Overall Study|Upper G-I Haemorrhage|0|||
161894215|NCT01826981|584660905|FG009|Overall Study|Upper G-I Haemorrhage|0|||
161894216|NCT01826981|584660906|FG010|Overall Study|Upper G-I Haemorrhage|0|||
161894217|NCT01826981|584660907|FG011|Overall Study|Upper G-I Haemorrhage|0|||
161894218|NCT01826981|584660908|FG012|Overall Study|Upper G-I Haemorrhage|0|||
161894219|NCT01826981|584660909|FG013|Overall Study|Upper G-I Haemorrhage|1|||
161894220|NCT01826981|584660910|FG014|Overall Study|Upper G-I Haemorrhage|0|||
161894221|NCT01826981|584660896|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894222|NCT01826981|584660897|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894223|NCT01826981|584660898|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894224|NCT01826981|584660899|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894225|NCT01826981|584660900|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894226|NCT01826981|584660901|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894227|NCT01826981|584660902|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894228|NCT01826981|584660903|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
161894229|NCT01826981|584660904|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894230|NCT01826981|584660905|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894231|NCT01826981|584660906|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894232|NCT01826981|584660907|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894233|NCT01826981|584660908|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894234|NCT01826981|584660909|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894235|NCT01826981|584660910|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894236|NCT03746405|584660913|FG000|Overall Study|Withdrawal by Subject|3|||
161894237|NCT03746405|584660914|FG001|Overall Study|Withdrawal by Subject|0|||
161894238|NCT03746405|584660913|FG000|Overall Study|technical difficulties|0|||
161894239|NCT03746405|584660914|FG001|Overall Study|technical difficulties|2|||
161894240|NCT03479008|584660915|FG000|Overall Study|Withdrawal by Subject|3|||
161894241|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
161894242|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
161894243|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
161894244|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
161894245|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Other|1|||
161894246|NCT00412932|584660916|FG000|Olmesartan 40 mg|Adverse Event|4|||
161894247|NCT00412932|584660916|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
161894248|NCT00412932|584660916|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
161894249|NCT00412932|584660916|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
161894250|NCT00412932|584660916|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
161894251|NCT00412932|584660916|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
161894252|NCT00412932|584660916|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
161894253|NCT02630563|584660917|FG000|Overall Study|Administrative|1|||
161894254|NCT00929994|584660918|FG000|Overall Study|Withdrawal by Subject|1|||
161894255|NCT00929994|584660918|FG000|Overall Study|medical issue unrelated to intervention|4|||
161894256|NCT00929994|584660918|FG000|Overall Study|employment|1|||
161894257|NCT02061813|584660920|FG000|Overall Study|Withdrawal by Subject|1|||
161894258|NCT02061813|584660920|FG000|Overall Study|Protocol Violation|2|||
161894259|NCT01705080|584660921|FG000|Overall Study|Missed visit|10|||
161894260|NCT01705080|584660922|FG001|Overall Study|Missed visit|4|||
161894261|NCT01705080|584660923|FG002|Overall Study|Missed visit|1|||
161894262|NCT01705080|584660921|FG000|Overall Study|Death|4|||
161894263|NCT01705080|584660922|FG001|Overall Study|Death|4|||
161894264|NCT01705080|584660923|FG002|Overall Study|Death|6|||
161894265|NCT01705080|584660921|FG000|Overall Study|Withdrawal by Subject|61|||
161894266|NCT01705080|584660922|FG001|Overall Study|Withdrawal by Subject|44|||
161894267|NCT01705080|584660923|FG002|Overall Study|Withdrawal by Subject|9|||
161894268|NCT00667563|584660925|FG000|Overall Study|Protocol Violation|24|||
161894269|NCT03130959|584660928|FG000|Overall Study|Disease progression|19|||
161894270|NCT03130959|584660929|FG001|Overall Study|Disease progression|7|||
161894271|NCT03130959|584660930|FG002|Overall Study|Disease progression|12|||
161894272|NCT03130959|584660931|FG003|Overall Study|Disease progression|7|||
161894273|NCT03130959|584660932|FG004|Overall Study|Disease progression|12|||
161894274|NCT03130959|584660933|FG005|Overall Study|Disease progression|3|||
161894275|NCT03130959|584660934|FG006|Overall Study|Disease progression|6|||
161894276|NCT03130959|584660935|FG007|Overall Study|Disease progression|3|||
161894277|NCT03130959|584660936|FG008|Overall Study|Disease progression|15|||
161894278|NCT03130959|584660937|FG009|Overall Study|Disease progression|8|||
161894279|NCT03130959|584660928|FG000|Overall Study|Study drug toxicity|2|||
161894280|NCT03130959|584660929|FG001|Overall Study|Study drug toxicity|2|||
161894281|NCT03130959|584660930|FG002|Overall Study|Study drug toxicity|1|||
161894282|NCT03130959|584660931|FG003|Overall Study|Study drug toxicity|2|||
161894283|NCT03130959|584660932|FG004|Overall Study|Study drug toxicity|1|||
161894284|NCT03130959|584660933|FG005|Overall Study|Study drug toxicity|1|||
161894285|NCT03130959|584660934|FG006|Overall Study|Study drug toxicity|3|||
161894286|NCT03130959|584660935|FG007|Overall Study|Study drug toxicity|0|||
161894287|NCT03130959|584660936|FG008|Overall Study|Study drug toxicity|3|||
161894288|NCT03130959|584660937|FG009|Overall Study|Study drug toxicity|3|||
161894289|NCT03130959|584660928|FG000|Overall Study|Other reasons|0|||
161894290|NCT03130959|584660929|FG001|Overall Study|Other reasons|0|||
161894291|NCT03130959|584660930|FG002|Overall Study|Other reasons|0|||
161894292|NCT03130959|584660931|FG003|Overall Study|Other reasons|0|||
161894293|NCT03130959|584660932|FG004|Overall Study|Other reasons|0|||
161894294|NCT03130959|584660933|FG005|Overall Study|Other reasons|1|||
161894295|NCT03130959|584660934|FG006|Overall Study|Other reasons|1|||
161894296|NCT03130959|584660935|FG007|Overall Study|Other reasons|0|||
161894297|NCT03130959|584660936|FG008|Overall Study|Other reasons|0|||
161894298|NCT03130959|584660937|FG009|Overall Study|Other reasons|0|||
161894299|NCT03130959|584660928|FG000|Overall Study|Subject request to discontinue therapy|0|||
161894300|NCT03130959|584660929|FG001|Overall Study|Subject request to discontinue therapy|0|||
161894301|NCT03130959|584660930|FG002|Overall Study|Subject request to discontinue therapy|1|||
161894302|NCT03130959|584660931|FG003|Overall Study|Subject request to discontinue therapy|1|||
161894303|NCT03130959|584660932|FG004|Overall Study|Subject request to discontinue therapy|0|||
161894304|NCT03130959|584660933|FG005|Overall Study|Subject request to discontinue therapy|0|||
161894305|NCT03130959|584660934|FG006|Overall Study|Subject request to discontinue therapy|1|||
161894306|NCT03130959|584660935|FG007|Overall Study|Subject request to discontinue therapy|1|||
161894307|NCT03130959|584660936|FG008|Overall Study|Subject request to discontinue therapy|0|||
161894308|NCT03130959|584660937|FG009|Overall Study|Subject request to discontinue therapy|0|||
161894309|NCT03130959|584660928|FG000|Overall Study|Not reported|0|||
161894310|NCT03130959|584660929|FG001|Overall Study|Not reported|0|||
161894311|NCT03130959|584660930|FG002|Overall Study|Not reported|0|||
161894312|NCT03130959|584660931|FG003|Overall Study|Not reported|1|||
161894313|NCT03130959|584660932|FG004|Overall Study|Not reported|0|||
161550716|NCT02736968|583406967|FG002|Overall Study|COVID-19 Pandemic|0|||
161550717|NCT02736968|583406968|FG003|Overall Study|COVID-19 Pandemic|0|||
161550718|NCT02736968|583406969|FG004|Overall Study|COVID-19 Pandemic|0|||
161550719|NCT02736968|583406970|FG005|Overall Study|COVID-19 Pandemic|0|||
161550720|NCT02736968|583406971|FG006|Overall Study|COVID-19 Pandemic|2|||
161550721|NCT02736968|583406972|FG007|Overall Study|COVID-19 Pandemic|0|||
161550722|NCT02736968|583406965|FG000|Overall Study|Withdrawal by Subject|0|||
161550723|NCT02736968|583406966|FG001|Overall Study|Withdrawal by Subject|0|||
161550724|NCT02736968|583406967|FG002|Overall Study|Withdrawal by Subject|0|||
161550725|NCT02736968|583406968|FG003|Overall Study|Withdrawal by Subject|0|||
161550726|NCT02736968|583406969|FG004|Overall Study|Withdrawal by Subject|0|||
161550727|NCT02736968|583406970|FG005|Overall Study|Withdrawal by Subject|0|||
161664621|NCT00757588|583824240|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
161436026|NCT02266888|582991265|FG000|Overall Study|Death|2|||
161550728|NCT02736968|583406971|FG006|Overall Study|Withdrawal by Subject|1|||
161550729|NCT02736968|583406972|FG007|Overall Study|Withdrawal by Subject|0|||
161550730|NCT00147225|583406975|FG000|Overall Study|Withdrawal by Subject|1|||
161550731|NCT00147225|583406976|FG001|Overall Study|Withdrawal by Subject|0|||
161550732|NCT00147225|583406977|FG002|Overall Study|Withdrawal by Subject|1|||
161664622|NCT00757588|583824241|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
161664623|NCT02563522|583824242|FG000|Overall Study|Adverse Event|2|||
161664624|NCT02563522|583824243|FG001|Overall Study|Adverse Event|3|||
161664625|NCT02563522|583824242|FG000|Overall Study|Lost to Follow-up|1|||
161436027|NCT02266888|582991266|FG001|Overall Study|Death|2|||
161894314|NCT03130959|584660933|FG005|Overall Study|Not reported|1|||
161894315|NCT03130959|584660934|FG006|Overall Study|Not reported|0|||
161894316|NCT03130959|584660935|FG007|Overall Study|Not reported|0|||
161894317|NCT03130959|584660936|FG008|Overall Study|Not reported|0|||
161894318|NCT03130959|584660937|FG009|Overall Study|Not reported|1|||
161894319|NCT03130959|584660928|FG000|Overall Study|Adverse Event unrelated to drug|0|||
161894320|NCT03130959|584660929|FG001|Overall Study|Adverse Event unrelated to drug|0|||
161894321|NCT03130959|584660930|FG002|Overall Study|Adverse Event unrelated to drug|1|||
161894322|NCT03130959|584660931|FG003|Overall Study|Adverse Event unrelated to drug|1|||
161894323|NCT03130959|584660932|FG004|Overall Study|Adverse Event unrelated to drug|1|||
161894324|NCT03130959|584660933|FG005|Overall Study|Adverse Event unrelated to drug|0|||
161894325|NCT03130959|584660934|FG006|Overall Study|Adverse Event unrelated to drug|1|||
161894326|NCT03130959|584660935|FG007|Overall Study|Adverse Event unrelated to drug|0|||
161894327|NCT03130959|584660936|FG008|Overall Study|Adverse Event unrelated to drug|1|||
161894328|NCT03130959|584660937|FG009|Overall Study|Adverse Event unrelated to drug|1|||
161894329|NCT03130959|584660928|FG000|Overall Study|Participant withdrew consent|0|||
161894330|NCT03130959|584660929|FG001|Overall Study|Participant withdrew consent|1|||
161894331|NCT03130959|584660930|FG002|Overall Study|Participant withdrew consent|0|||
161894332|NCT03130959|584660931|FG003|Overall Study|Participant withdrew consent|2|||
161894333|NCT03130959|584660932|FG004|Overall Study|Participant withdrew consent|1|||
161894334|NCT03130959|584660933|FG005|Overall Study|Participant withdrew consent|0|||
161894335|NCT03130959|584660934|FG006|Overall Study|Participant withdrew consent|0|||
161894336|NCT03130959|584660935|FG007|Overall Study|Participant withdrew consent|0|||
161894337|NCT03130959|584660936|FG008|Overall Study|Participant withdrew consent|0|||
161894338|NCT03130959|584660937|FG009|Overall Study|Participant withdrew consent|2|||
161894339|NCT03130959|584660928|FG000|Overall Study|Administrative reason by sponsor|1|||
161894340|NCT03130959|584660929|FG001|Overall Study|Administrative reason by sponsor|0|||
161894341|NCT03130959|584660930|FG002|Overall Study|Administrative reason by sponsor|1|||
161894342|NCT03130959|584660931|FG003|Overall Study|Administrative reason by sponsor|0|||
161894343|NCT03130959|584660932|FG004|Overall Study|Administrative reason by sponsor|0|||
161894344|NCT03130959|584660933|FG005|Overall Study|Administrative reason by sponsor|0|||
161894345|NCT03130959|584660934|FG006|Overall Study|Administrative reason by sponsor|0|||
161894346|NCT03130959|584660935|FG007|Overall Study|Administrative reason by sponsor|0|||
161894347|NCT03130959|584660936|FG008|Overall Study|Administrative reason by sponsor|0|||
161894348|NCT03130959|584660937|FG009|Overall Study|Administrative reason by sponsor|0|||
161894349|NCT03130959|584660928|FG000|Overall Study|Lost to Follow-up|1|||
161894350|NCT03130959|584660929|FG001|Overall Study|Lost to Follow-up|0|||
161894351|NCT03130959|584660930|FG002|Overall Study|Lost to Follow-up|0|||
161894352|NCT03130959|584660931|FG003|Overall Study|Lost to Follow-up|0|||
161894353|NCT03130959|584660932|FG004|Overall Study|Lost to Follow-up|0|||
161894354|NCT03130959|584660933|FG005|Overall Study|Lost to Follow-up|0|||
161894355|NCT03130959|584660934|FG006|Overall Study|Lost to Follow-up|0|||
161894356|NCT03130959|584660935|FG007|Overall Study|Lost to Follow-up|0|||
161894357|NCT03130959|584660936|FG008|Overall Study|Lost to Follow-up|0|||
161894358|NCT03130959|584660937|FG009|Overall Study|Lost to Follow-up|0|||
161894359|NCT02384538|584660950|FG000|Overall Study|Adverse Event|1|||
161894360|NCT02384538|584660951|FG001|Overall Study|Adverse Event|4|||
161894361|NCT02384538|584660950|FG000|Overall Study|Lack of Efficacy|4|||
161894362|NCT02384538|584660951|FG001|Overall Study|Lack of Efficacy|4|||
161894363|NCT02384538|584660950|FG000|Overall Study|Withdrew Consent|0|||
161894364|NCT02384538|584660951|FG001|Overall Study|Withdrew Consent|4|||
161894365|NCT02384538|584660950|FG000|Overall Study|Other|1|||
161894366|NCT02384538|584660951|FG001|Overall Study|Other|3|||
161894367|NCT01301079|584660952|FG000|Overall Study|Lost to Follow-up|2|||
161894368|NCT01301079|584660953|FG001|Overall Study|Lost to Follow-up|2|||
161894369|NCT00313586|584660954|FG000|Overall Study|Disease progression|14|||
161894370|NCT00313586|584660955|FG001|Overall Study|Disease progression|19|||
161894371|NCT00313586|584660956|FG002|Overall Study|Disease progression|10|||
161894372|NCT00313586|584660957|FG003|Overall Study|Disease progression|3|||
161894373|NCT00313586|584660954|FG000|Overall Study|Adverse Event|12|||
161894374|NCT00313586|584660955|FG001|Overall Study|Adverse Event|18|||
161894375|NCT00313586|584660956|FG002|Overall Study|Adverse Event|3|||
161894376|NCT00313586|584660957|FG003|Overall Study|Adverse Event|10|||
161894377|NCT00313586|584660954|FG000|Overall Study|Death|11|||
161894378|NCT00313586|584660955|FG001|Overall Study|Death|8|||
161894379|NCT00313586|584660956|FG002|Overall Study|Death|1|||
161894380|NCT00313586|584660957|FG003|Overall Study|Death|7|||
161894381|NCT00313586|584660954|FG000|Overall Study|Withdrawal by Subject|13|||
161894382|NCT00313586|584660955|FG001|Overall Study|Withdrawal by Subject|6|||
161894383|NCT00313586|584660956|FG002|Overall Study|Withdrawal by Subject|6|||
161894384|NCT00313586|584660957|FG003|Overall Study|Withdrawal by Subject|2|||
161894385|NCT00313586|584660954|FG000|Overall Study|Alternative therapy|3|||
161894386|NCT00313586|584660955|FG001|Overall Study|Alternative therapy|6|||
161894387|NCT00313586|584660956|FG002|Overall Study|Alternative therapy|2|||
161894388|NCT00313586|584660957|FG003|Overall Study|Alternative therapy|0|||
161894389|NCT00313586|584660954|FG000|Overall Study|Other complicating disease|2|||
161550733|NCT00147225|583406978|FG003|Overall Study|Withdrawal by Subject|0|||
161550734|NCT00147225|583406979|FG004|Overall Study|Withdrawal by Subject|0|||
161550735|NCT00147225|583406980|FG005|Overall Study|Withdrawal by Subject|1|||
161550736|NCT00147225|583406975|FG000|Overall Study|Adverse Event|0|||
161550737|NCT00147225|583406976|FG001|Overall Study|Adverse Event|0|||
161550738|NCT00147225|583406977|FG002|Overall Study|Adverse Event|1|||
161550739|NCT00147225|583406978|FG003|Overall Study|Adverse Event|1|||
161550740|NCT00147225|583406979|FG004|Overall Study|Adverse Event|0|||
161550741|NCT00147225|583406980|FG005|Overall Study|Adverse Event|0|||
161550742|NCT00147225|583406975|FG000|Overall Study|Screen Failure|0|||
161550743|NCT00147225|583406976|FG001|Overall Study|Screen Failure|0|||
161550744|NCT00147225|583406977|FG002|Overall Study|Screen Failure|0|||
161550745|NCT00147225|583406978|FG003|Overall Study|Screen Failure|0|||
161550746|NCT00147225|583406979|FG004|Overall Study|Screen Failure|1|||
161550747|NCT00147225|583406980|FG005|Overall Study|Screen Failure|0|||
161550748|NCT00147225|583406975|FG000|Overall Study|Chemotherapy Changed|0|||
161550749|NCT00147225|583406976|FG001|Overall Study|Chemotherapy Changed|0|||
161550750|NCT00147225|583406977|FG002|Overall Study|Chemotherapy Changed|0|||
161550751|NCT00147225|583406978|FG003|Overall Study|Chemotherapy Changed|0|||
161550752|NCT00147225|583406979|FG004|Overall Study|Chemotherapy Changed|0|||
161550753|NCT00147225|583406980|FG005|Overall Study|Chemotherapy Changed|1|||
161550754|NCT01032044|583406981|FG000|Overall Study|Protocol Violation|14|||
161550755|NCT01032044|583406982|FG001|Overall Study|Protocol Violation|8|||
161550756|NCT01032044|583406981|FG000|Overall Study|Adverse Event|0|||
161550757|NCT01032044|583406982|FG001|Overall Study|Adverse Event|1|||
161550758|NCT01032044|583406981|FG000|Overall Study|Lost to Follow-up|11|||
161550759|NCT01032044|583406982|FG001|Overall Study|Lost to Follow-up|11|||
161550760|NCT01567865|583406993|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
161550761|NCT01567865|583406994|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
161550762|NCT01567865|583406995|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
161550763|NCT01567865|583406996|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
161550764|NCT01567865|583406993|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
161550765|NCT01567865|583406994|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
161550766|NCT01567865|583406995|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
161550767|NCT01567865|583406996|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
161550768|NCT01051063|583407005|FG000|Overall Study|Death|2|||
161550769|NCT01051063|583407006|FG001|Overall Study|Death|2|||
161550770|NCT01051063|583407005|FG000|Overall Study|Withdrawal by Subject|1|||
161550771|NCT01051063|583407006|FG001|Overall Study|Withdrawal by Subject|1|||
161550772|NCT01051063|583407005|FG000|Overall Study|Termination of the study|5|||
161550773|NCT01051063|583407006|FG001|Overall Study|Termination of the study|0|||
161550774|NCT01051063|583407005|FG000|Overall Study|Moved from the study site area|1|||
161550775|NCT01051063|583407006|FG001|Overall Study|Moved from the study site area|0|||
161550776|NCT01051063|583407005|FG000|Overall Study|Other|1|||
161550777|NCT01051063|583407006|FG001|Overall Study|Other|0|||
161550778|NCT01051063|583407005|FG000|Overall Study|Lost to Follow-up|0|||
161550779|NCT01051063|583407006|FG001|Overall Study|Lost to Follow-up|1|||
161550780|NCT05569954|583407009|FG000|Overall Study|Lost to Follow-up|3|||
161550781|NCT05569954|583407010|FG001|Overall Study|Lost to Follow-up|4|||
161550782|NCT05569954|583407009|FG000|Overall Study|Protocol Violation|1|||
161550783|NCT05569954|583407010|FG001|Overall Study|Protocol Violation|2|||
161550784|NCT05569954|583407009|FG000|Overall Study|Withdrawal by Subject|4|||
161550785|NCT05569954|583407010|FG001|Overall Study|Withdrawal by Subject|2|||
161550786|NCT03857841|583407020|FG000|Overall Study|Death|1|||
161550787|NCT03857841|583407021|FG001|Overall Study|Death|0|||
161550788|NCT03857841|583407022|FG002|Overall Study|Death|0|||
161550789|NCT03857841|583407023|FG003|Overall Study|Death|0|||
161550790|NCT03857841|583407020|FG000|Overall Study|Study Terminated by Sponsor|1|||
161550791|NCT03857841|583407021|FG001|Overall Study|Study Terminated by Sponsor|0|||
161550792|NCT03857841|583407022|FG002|Overall Study|Study Terminated by Sponsor|0|||
161550793|NCT03857841|583407023|FG003|Overall Study|Study Terminated by Sponsor|0|||
161550794|NCT00384059|583407024|FG000|Infant Series|Not consented|2|||
161550795|NCT00384059|583407025|FG001|Infant Series|Not consented|6|||
161550796|NCT00384059|583407024|FG000|Infant Series|Withdrawal by Subject|2|||
161550797|NCT00384059|583407025|FG001|Infant Series|Withdrawal by Subject|2|||
161550798|NCT00384059|583407024|FG000|Infant Series|Adverse Event|1|||
161550799|NCT00384059|583407025|FG001|Infant Series|Adverse Event|2|||
161550800|NCT00384059|583407024|FG000|Infant Series|Protocol Violation|1|||
161550801|NCT00384059|583407025|FG001|Infant Series|Protocol Violation|2|||
161550802|NCT00384059|583407024|FG000|Infant Series|Lost to Follow-up|0|||
161550803|NCT00384059|583407025|FG001|Infant Series|Lost to Follow-up|1|||
161550804|NCT00384059|583407024|FG000|After Infant Series|Protocol Violation|2|||
161550805|NCT00384059|583407025|FG001|After Infant Series|Protocol Violation|3|||
161550806|NCT00384059|583407024|FG000|After Infant Series|Withdrawal by Subject|2|||
161550807|NCT00384059|583407025|FG001|After Infant Series|Withdrawal by Subject|2|||
161550808|NCT00384059|583407024|FG000|After Infant Series|Failed to Return|0|||
161550809|NCT00384059|583407025|FG001|After Infant Series|Failed to Return|2|||
161550810|NCT00384059|583407024|FG000|After Infant Series|Adverse Event|0|||
161550811|NCT00384059|583407025|FG001|After Infant Series|Adverse Event|1|||
161550812|NCT00384059|583407024|FG000|After Infant Series|Physician Decision|0|||
161550813|NCT00384059|583407025|FG001|After Infant Series|Physician Decision|1|||
161550814|NCT00384059|583407024|FG000|After Infant Series|Lost to Follow-up|0|||
161550815|NCT00384059|583407025|FG001|After Infant Series|Lost to Follow-up|1|||
161550816|NCT00384059|583407024|FG000|Toddler Dose|Lost to Follow-up|1|||
161550817|NCT00384059|583407025|FG001|Toddler Dose|Lost to Follow-up|1|||
161550818|NCT00384059|583407024|FG000|Toddler Dose|Failed to return|0|||
161550819|NCT00384059|583407025|FG001|Toddler Dose|Failed to return|1|||
161550820|NCT00381641|583407028|FG000|Overall Study|Withdrawal by Subject|0|||
161550821|NCT00381641|583407029|FG001|Overall Study|Withdrawal by Subject|2|||
161550822|NCT00802737|583408731|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
161550823|NCT00802737|583408732|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
161550824|NCT00802737|583408733|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
161550825|NCT00802737|583408731|FG000|Overall Study|Death|6|||
161550826|NCT00802737|583408732|FG001|Overall Study|Death|5|||
161550827|NCT00802737|583408733|FG002|Overall Study|Death|1|||
161550828|NCT00802737|583408731|FG000|Overall Study|Adverse Event|1|||
161550829|NCT00802737|583408732|FG001|Overall Study|Adverse Event|0|||
161550830|NCT00802737|583408733|FG002|Overall Study|Adverse Event|0|||
161550831|NCT00802737|583408731|FG000|Overall Study|Received Prohibited Therapy|1|||
161436028|NCT02266888|582991267|FG002|Overall Study|Death|4|||
161894390|NCT00313586|584660955|FG001|Overall Study|Other complicating disease|2|||
161894391|NCT00313586|584660956|FG002|Overall Study|Other complicating disease|0|||
161894392|NCT00313586|584660957|FG003|Overall Study|Other complicating disease|0|||
161894393|NCT00313586|584660954|FG000|Overall Study|Did not achieve HI-major/better response|10|||
161550832|NCT00802737|583408732|FG001|Overall Study|Received Prohibited Therapy|0|||
161550833|NCT00802737|583408733|FG002|Overall Study|Received Prohibited Therapy|0|||
161550834|NCT00802737|583408731|FG000|Overall Study|Ongoing CLL-Treatment|0|||
161550835|NCT00802737|583408732|FG001|Overall Study|Ongoing CLL-Treatment|1|||
161550836|NCT00802737|583408733|FG002|Overall Study|Ongoing CLL-Treatment|0|||
161550837|NCT00802737|583408731|FG000|Overall Study|Participant too Unwell|0|||
161550838|NCT00802737|583408732|FG001|Overall Study|Participant too Unwell|2|||
161550839|NCT00802737|583408733|FG002|Overall Study|Participant too Unwell|0|||
161550840|NCT03864926|583408736|FG000|Overall Study|Death|0|||
161550841|NCT03864926|583408737|FG001|Overall Study|Death|2|||
161550842|NCT00445601|583408738|FG000|Overall Study|Withdrawal by Subject|11|||
161550843|NCT00445601|583408739|FG001|Overall Study|Withdrawal by Subject|11|||
161550844|NCT00445601|583408738|FG000|Overall Study|TURBT Complication|12|||
161550845|NCT00445601|583408739|FG001|Overall Study|TURBT Complication|8|||
161550846|NCT00445601|583408738|FG000|Overall Study|Incorrect Disease Status|6|||
161550847|NCT00445601|583408739|FG001|Overall Study|Incorrect Disease Status|6|||
161550848|NCT00445601|583408738|FG000|Overall Study|Drug Delivery Issue|2|||
161550849|NCT00445601|583408739|FG001|Overall Study|Drug Delivery Issue|2|||
161550850|NCT00445601|583408738|FG000|Overall Study|Adverse Event|2|||
161550851|NCT00445601|583408739|FG001|Overall Study|Adverse Event|0|||
161550852|NCT00445601|583408738|FG000|Overall Study|Death prior to TURBT|0|||
161550853|NCT00445601|583408739|FG001|Overall Study|Death prior to TURBT|1|||
161550854|NCT00619476|583408740|FG000|Overall Study|Adverse Event|12|||
161550855|NCT00619476|583408741|FG001|Overall Study|Adverse Event|6|||
161550856|NCT00619476|583408742|FG002|Overall Study|Adverse Event|12|||
161550857|NCT00619476|583408743|FG003|Overall Study|Adverse Event|16|||
161550858|NCT00619476|583408740|FG000|Overall Study|Lack of Efficacy|6|||
161550859|NCT00619476|583408741|FG001|Overall Study|Lack of Efficacy|1|||
161550860|NCT00619476|583408742|FG002|Overall Study|Lack of Efficacy|1|||
161550861|NCT00619476|583408743|FG003|Overall Study|Lack of Efficacy|4|||
161550862|NCT00619476|583408740|FG000|Overall Study|Protocol Violation|5|||
161550863|NCT00619476|583408741|FG001|Overall Study|Protocol Violation|4|||
161550864|NCT00619476|583408742|FG002|Overall Study|Protocol Violation|4|||
161550865|NCT00619476|583408743|FG003|Overall Study|Protocol Violation|9|||
161550866|NCT00619476|583408740|FG000|Overall Study|Lost to Follow-up|1|||
161550867|NCT00619476|583408741|FG001|Overall Study|Lost to Follow-up|2|||
161550868|NCT00619476|583408742|FG002|Overall Study|Lost to Follow-up|0|||
161550869|NCT00619476|583408743|FG003|Overall Study|Lost to Follow-up|1|||
161550870|NCT00619476|583408740|FG000|Overall Study|Investigator Discretion|2|||
161550871|NCT00619476|583408741|FG001|Overall Study|Investigator Discretion|2|||
161550872|NCT00619476|583408742|FG002|Overall Study|Investigator Discretion|2|||
161550873|NCT00619476|583408743|FG003|Overall Study|Investigator Discretion|0|||
161550874|NCT00619476|583408740|FG000|Overall Study|Withdrawal by Subject|5|||
161550875|NCT00619476|583408741|FG001|Overall Study|Withdrawal by Subject|7|||
161550876|NCT00619476|583408742|FG002|Overall Study|Withdrawal by Subject|5|||
161550877|NCT00619476|583408743|FG003|Overall Study|Withdrawal by Subject|4|||
161550878|NCT01091428|583408744|FG000|Phase 1|Progressive Disease|24|||
161550879|NCT01091428|583408745|FG001|Phase 1|Progressive Disease|8|||
161550880|NCT01091428|583408746|FG002|Phase 1|Progressive Disease|0|||
161550881|NCT01091428|583408747|FG003|Phase 1|Progressive Disease|0|||
161550882|NCT01091428|583408744|FG000|Phase 1|Symptomatic Deterioration|3|||
161550883|NCT01091428|583408745|FG001|Phase 1|Symptomatic Deterioration|2|||
161550884|NCT01091428|583408746|FG002|Phase 1|Symptomatic Deterioration|0|||
161550885|NCT01091428|583408747|FG003|Phase 1|Symptomatic Deterioration|0|||
161550886|NCT01091428|583408744|FG000|Phase 1|Adverse Event|2|||
161550887|NCT01091428|583408745|FG001|Phase 1|Adverse Event|0|||
161550888|NCT01091428|583408746|FG002|Phase 1|Adverse Event|0|||
161550889|NCT01091428|583408747|FG003|Phase 1|Adverse Event|0|||
161550890|NCT01091428|583408744|FG000|Phase 1|Withdrawal by Subject|7|||
161550891|NCT01091428|583408745|FG001|Phase 1|Withdrawal by Subject|0|||
161550892|NCT01091428|583408746|FG002|Phase 1|Withdrawal by Subject|0|||
161550893|NCT01091428|583408747|FG003|Phase 1|Withdrawal by Subject|0|||
161550894|NCT01091428|583408744|FG000|Phase 1|Reason not specified|0|||
161550895|NCT01091428|583408745|FG001|Phase 1|Reason not specified|1|||
161550896|NCT01091428|583408746|FG002|Phase 1|Reason not specified|0|||
161550897|NCT01091428|583408747|FG003|Phase 1|Reason not specified|0|||
161550898|NCT01091428|583408744|FG000|Phase 1|Single-Patient IND|2|||
161550899|NCT01091428|583408745|FG001|Phase 1|Single-Patient IND|0|||
161550900|NCT01091428|583408746|FG002|Phase 1|Single-Patient IND|0|||
161550901|NCT01091428|583408747|FG003|Phase 1|Single-Patient IND|0|||
161550902|NCT01091428|583408744|FG000|Phase 2|Progressive Disease|0|||
161550903|NCT01091428|583408745|FG001|Phase 2|Progressive Disease|0|||
161550904|NCT01091428|583408746|FG002|Phase 2|Progressive Disease|44|||
161550905|NCT01091428|583408747|FG003|Phase 2|Progressive Disease|46|||
161550906|NCT01091428|583408744|FG000|Phase 2|Symptomatic Deterioration|0|||
161550907|NCT01091428|583408745|FG001|Phase 2|Symptomatic Deterioration|0|||
161550908|NCT01091428|583408746|FG002|Phase 2|Symptomatic Deterioration|1|||
161550909|NCT01091428|583408747|FG003|Phase 2|Symptomatic Deterioration|6|||
161550910|NCT01091428|583408744|FG000|Phase 2|Adverse Event|0|||
161550911|NCT01091428|583408745|FG001|Phase 2|Adverse Event|0|||
161550912|NCT01091428|583408746|FG002|Phase 2|Adverse Event|12|||
161550913|NCT01091428|583408747|FG003|Phase 2|Adverse Event|5|||
161550914|NCT01091428|583408744|FG000|Phase 2|Withdrawal by Subject|0|||
161550915|NCT01091428|583408745|FG001|Phase 2|Withdrawal by Subject|0|||
161550916|NCT01091428|583408746|FG002|Phase 2|Withdrawal by Subject|9|||
161550917|NCT01091428|583408747|FG003|Phase 2|Withdrawal by Subject|8|||
161550918|NCT01091428|583408744|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
161550919|NCT01091428|583408745|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
161550920|NCT01091428|583408746|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
161550921|NCT01091428|583408747|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
161550922|NCT01091428|583408744|FG000|Phase 2|Reason not specified|0|||
161550923|NCT01091428|583408745|FG001|Phase 2|Reason not specified|0|||
161550924|NCT01091428|583408746|FG002|Phase 2|Reason not specified|4|||
161550925|NCT01091428|583408747|FG003|Phase 2|Reason not specified|3|||
161550926|NCT01091428|583408744|FG000|Phase 2|Physician Decision|0|||
161550927|NCT01091428|583408745|FG001|Phase 2|Physician Decision|0|||
161550928|NCT01091428|583408746|FG002|Phase 2|Physician Decision|2|||
161550929|NCT01091428|583408747|FG003|Phase 2|Physician Decision|0|||
161550930|NCT01625910|583408752|FG000|Overall Study|Lost to Follow-up|3|||
161550931|NCT01625910|583408753|FG001|Overall Study|Lost to Follow-up|4|||
161550932|NCT02959138|583408754|FG000|Overall Study|Enrolled but Never Treated|0|||
161550933|NCT02959138|583408755|FG001|Overall Study|Enrolled but Never Treated|1|||
161550934|NCT02959138|583408756|FG002|Overall Study|Enrolled but Never Treated|0|||
161550935|NCT02391038|583408757|FG000|Overall Study|Progressive disease|3|||
161550936|NCT02391038|583408758|FG001|Overall Study|Progressive disease|3|||
161550937|NCT02391038|583408759|FG002|Overall Study|Progressive disease|6|||
161550938|NCT04213989|583408760|FG000|Overall Study|Withdrawal by Subject|3|||
161550939|NCT04213989|583408761|FG001|Overall Study|Withdrawal by Subject|2|||
161550940|NCT04213989|583408760|FG000|Overall Study|Physician Decision|1|||
161550941|NCT04213989|583408761|FG001|Overall Study|Physician Decision|0|||
161550942|NCT04213989|583408760|FG000|Overall Study|Lost to Follow-up|0|||
161550943|NCT04213989|583408761|FG001|Overall Study|Lost to Follow-up|4|||
161550944|NCT01327547|583408762|FG000|Overall Study|Adverse Event|4|||
161550945|NCT01327547|583408763|FG001|Overall Study|Adverse Event|1|||
161550946|NCT01327547|583408762|FG000|Overall Study|Death|1|||
161550947|NCT01327547|583408763|FG001|Overall Study|Death|2|||
161550948|NCT01327547|583408762|FG000|Overall Study|Lost to Follow-up|6|||
161550949|NCT01327547|583408763|FG001|Overall Study|Lost to Follow-up|6|||
161550950|NCT01327547|583408762|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
161550951|NCT01327547|583408763|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
161550952|NCT01327547|583408762|FG000|Overall Study|Withdrawal by Subject|3|||
161550953|NCT01327547|583408763|FG001|Overall Study|Withdrawal by Subject|7|||
161550954|NCT01327547|583408762|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
161550955|NCT01327547|583408763|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
161550956|NCT01327547|583408762|FG000|Overall Study|Protocol Violation|1|||
161550957|NCT01327547|583408763|FG001|Overall Study|Protocol Violation|0|||
161550958|NCT01327547|583408762|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
161550959|NCT01327547|583408763|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
161550960|NCT01327547|583408762|FG000|Overall Study|Required prohibited medication|2|||
161550961|NCT01327547|583408763|FG001|Overall Study|Required prohibited medication|0|||
161550962|NCT01327547|583408762|FG000|Overall Study|Non-compliance with study procedures|1|||
161550963|NCT01327547|583408763|FG001|Overall Study|Non-compliance with study procedures|0|||
161550964|NCT01327547|583408762|FG000|Overall Study|By investigator in subject's interest|0|||
161550965|NCT01327547|583408763|FG001|Overall Study|By investigator in subject's interest|1|||
161550966|NCT03390036|583408766|FG000|Overall Study|Lost to Follow-up|1|||
161550967|NCT03390036|583408767|FG001|Overall Study|Lost to Follow-up|0|||
161550968|NCT03390036|583408768|FG002|Overall Study|Lost to Follow-up|0|||
161550969|NCT03390036|583408766|FG000|Overall Study|Lack of Efficacy|1|||
161550970|NCT03390036|583408767|FG001|Overall Study|Lack of Efficacy|0|||
161550971|NCT03390036|583408768|FG002|Overall Study|Lack of Efficacy|0|||
161550972|NCT01681368|583408771|FG000|Overall Study|Refused further treatment|1|||
161550973|NCT01681368|583408771|FG000|Overall Study|Refused further follow up|1|||
161550974|NCT06017999|583408774|FG000|Overall Study|Withdrawal by Subject|0|||
161550975|NCT06017999|583408775|FG001|Overall Study|Withdrawal by Subject|4|||
161550976|NCT06017999|583408776|FG002|Overall Study|Withdrawal by Subject|3|||
161550977|NCT06017999|583408774|FG000|Overall Study|Adverse Event|2|||
161550978|NCT06017999|583408775|FG001|Overall Study|Adverse Event|1|||
161550979|NCT06017999|583408776|FG002|Overall Study|Adverse Event|1|||
161550980|NCT06017999|583408774|FG000|Overall Study|Lost to Follow-up|0|||
161550981|NCT06017999|583408775|FG001|Overall Study|Lost to Follow-up|0|||
161550982|NCT06017999|583408776|FG002|Overall Study|Lost to Follow-up|1|||
161550983|NCT06017999|583408774|FG000|Overall Study|Physician Decision|1|||
161550984|NCT06017999|583408775|FG001|Overall Study|Physician Decision|1|||
161550985|NCT06017999|583408776|FG002|Overall Study|Physician Decision|0|||
161550986|NCT06017999|583408774|FG000|Overall Study|Non-Compliance|0|||
161550987|NCT06017999|583408775|FG001|Overall Study|Non-Compliance|0|||
161550988|NCT06017999|583408776|FG002|Overall Study|Non-Compliance|1|||
161550989|NCT06017999|583408774|FG000|Overall Study|Lack of Efficacy|1|||
161550990|NCT06017999|583408775|FG001|Overall Study|Lack of Efficacy|0|||
161550991|NCT06017999|583408776|FG002|Overall Study|Lack of Efficacy|7|||
161550992|NCT06017999|583408774|FG000|Overall Study|COVID Positive|0|||
161550993|NCT06017999|583408775|FG001|Overall Study|COVID Positive|1|||
161550994|NCT06017999|583408776|FG002|Overall Study|COVID Positive|0|||
161550995|NCT06017999|583408774|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
161550996|NCT06017999|583408775|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
161550997|NCT06017999|583408776|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
161550998|NCT01155388|583408777|FG000|Overall Study|Adverse Event|1|||
161550999|NCT01155388|583408778|FG001|Overall Study|Adverse Event|0|||
161551000|NCT03943589|583408779|FG000|Overall Study|Death|1|||
161551001|NCT03943589|583408779|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
161551002|NCT04329104|583408780|FG000|Efficacy Study|Withdrawal by Subject|0|||
161551003|NCT04329104|583408781|FG001|Efficacy Study|Withdrawal by Subject|0|||
161551004|NCT04329104|583408782|FG002|Efficacy Study|Withdrawal by Subject|0|||
161551005|NCT04329104|583408783|FG003|Efficacy Study|Withdrawal by Subject|5|||
161551006|NCT04329104|583408784|FG004|Efficacy Study|Withdrawal by Subject|6|||
161551007|NCT04329104|583408785|FG005|Efficacy Study|Withdrawal by Subject|8|||
161551008|NCT03884231|583408786|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
161551009|NCT03884231|583408786|FG000|Overall Study|Subject Withdrew Consent|1|||
161551010|NCT03884231|583408786|FG000|Overall Study|MRI Scan Not Performed|1|||
161551011|NCT00900627|583408787|FG000|Overall Study|Condition under investigation worsened|4|||
161551012|NCT00900627|583408788|FG001|Overall Study|Condition under investigation worsened|0|||
161551013|NCT00900627|583408789|FG002|Overall Study|Condition under investigation worsened|5|||
161551014|NCT00900627|583408790|FG003|Overall Study|Condition under investigation worsened|3|||
161551015|NCT00900627|583408791|FG004|Overall Study|Condition under investigation worsened|0|||
161551016|NCT00900627|583408792|FG005|Overall Study|Condition under investigation worsened|0|||
161551017|NCT00900627|583408787|FG000|Overall Study|Withdrawal by Subject|1|||
161551018|NCT00900627|583408788|FG001|Overall Study|Withdrawal by Subject|0|||
161551019|NCT00900627|583408789|FG002|Overall Study|Withdrawal by Subject|1|||
161551020|NCT00900627|583408790|FG003|Overall Study|Withdrawal by Subject|0|||
161551021|NCT00900627|583408791|FG004|Overall Study|Withdrawal by Subject|1|||
161551022|NCT00900627|583408792|FG005|Overall Study|Withdrawal by Subject|2|||
161551023|NCT00900627|583408787|FG000|Overall Study|Adverse Event|1|||
161551024|NCT00900627|583408788|FG001|Overall Study|Adverse Event|2|||
161551025|NCT00900627|583408789|FG002|Overall Study|Adverse Event|0|||
161551026|NCT00900627|583408790|FG003|Overall Study|Adverse Event|3|||
161551027|NCT00900627|583408791|FG004|Overall Study|Adverse Event|0|||
161551028|NCT00900627|583408792|FG005|Overall Study|Adverse Event|0|||
161551029|NCT00900627|583408787|FG000|Overall Study|Death|0|||
161551030|NCT00900627|583408788|FG001|Overall Study|Death|0|||
161551031|NCT00900627|583408789|FG002|Overall Study|Death|0|||
161551032|NCT00900627|583408790|FG003|Overall Study|Death|0|||
161551033|NCT00900627|583408791|FG004|Overall Study|Death|28|||
161551034|NCT00900627|583408792|FG005|Overall Study|Death|24|||
161551035|NCT00373295|583408793|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161551036|NCT00373295|583408794|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
161551037|NCT00373295|583408795|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161551038|NCT00373295|583408796|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161551039|NCT00373295|583408797|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161551040|NCT00373295|583408798|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161551041|NCT00830947|583408799|FG000|Overall Study|Lost to Follow-up|4|||
161551042|NCT00830947|583408800|FG001|Overall Study|Lost to Follow-up|4|||
161551043|NCT01474512|583408812|FG000|Induction Period|Adverse Event|6|||
161551044|NCT01474512|583408813|FG001|Induction Period|Adverse Event|10|||
161551045|NCT01474512|583408814|FG002|Induction Period|Adverse Event|10|||
161551046|NCT01474512|583408815|FG003|Induction Period|Adverse Event|0|||
161551047|NCT01474512|583408816|FG004|Induction Period|Adverse Event|0|||
161551048|NCT01474512|583408817|FG005|Induction Period|Adverse Event|0|||
161551049|NCT01474512|583408818|FG006|Induction Period|Adverse Event|0|||
161551050|NCT01474512|583408819|FG007|Induction Period|Adverse Event|0|||
161551051|NCT01474512|583408820|FG008|Induction Period|Adverse Event|0|||
161551052|NCT01474512|583408821|FG009|Induction Period|Adverse Event|0|||
161551053|NCT01474512|583408822|FG010|Induction Period|Adverse Event|0|||
161551054|NCT01474512|583408823|FG011|Induction Period|Adverse Event|0|||
161551055|NCT01474512|583408824|FG012|Induction Period|Adverse Event|0|||
161551056|NCT01474512|583408825|FG013|Induction Period|Adverse Event|0|||
161551057|NCT01474512|583408826|FG014|Induction Period|Adverse Event|0|||
161551058|NCT01474512|583408827|FG015|Induction Period|Adverse Event|0|||
161551059|NCT01474512|583408828|FG016|Induction Period|Adverse Event|0|||
161551060|NCT01474512|583408829|FG017|Induction Period|Adverse Event|0|||
161551061|NCT01474512|583408812|FG000|Induction Period|Lack of Efficacy|7|||
161551062|NCT01474512|583408813|FG001|Induction Period|Lack of Efficacy|1|||
161551063|NCT01474512|583408814|FG002|Induction Period|Lack of Efficacy|0|||
161551064|NCT01474512|583408815|FG003|Induction Period|Lack of Efficacy|0|||
161551065|NCT01474512|583408816|FG004|Induction Period|Lack of Efficacy|0|||
161551066|NCT01474512|583408817|FG005|Induction Period|Lack of Efficacy|0|||
161551067|NCT01474512|583408818|FG006|Induction Period|Lack of Efficacy|0|||
161551068|NCT01474512|583408819|FG007|Induction Period|Lack of Efficacy|0|||
161551069|NCT01474512|583408820|FG008|Induction Period|Lack of Efficacy|0|||
161551070|NCT01474512|583408821|FG009|Induction Period|Lack of Efficacy|0|||
161551071|NCT01474512|583408822|FG010|Induction Period|Lack of Efficacy|0|||
161551072|NCT01474512|583408823|FG011|Induction Period|Lack of Efficacy|0|||
161551073|NCT01474512|583408824|FG012|Induction Period|Lack of Efficacy|0|||
161551074|NCT01474512|583408825|FG013|Induction Period|Lack of Efficacy|0|||
161551075|NCT01474512|583408826|FG014|Induction Period|Lack of Efficacy|0|||
161551076|NCT01474512|583408827|FG015|Induction Period|Lack of Efficacy|0|||
161551077|NCT01474512|583408828|FG016|Induction Period|Lack of Efficacy|0|||
161551078|NCT01474512|583408829|FG017|Induction Period|Lack of Efficacy|0|||
161551079|NCT01474512|583408812|FG000|Induction Period|Withdrawal by Subject|6|||
161551080|NCT01474512|583408813|FG001|Induction Period|Withdrawal by Subject|6|||
161551081|NCT01474512|583408814|FG002|Induction Period|Withdrawal by Subject|5|||
161551082|NCT01474512|583408815|FG003|Induction Period|Withdrawal by Subject|0|||
161551083|NCT01474512|583408816|FG004|Induction Period|Withdrawal by Subject|0|||
161551084|NCT01474512|583408817|FG005|Induction Period|Withdrawal by Subject|0|||
161551085|NCT01474512|583408818|FG006|Induction Period|Withdrawal by Subject|0|||
161551086|NCT01474512|583408819|FG007|Induction Period|Withdrawal by Subject|0|||
161551087|NCT01474512|583408820|FG008|Induction Period|Withdrawal by Subject|0|||
161551088|NCT01474512|583408821|FG009|Induction Period|Withdrawal by Subject|0|||
161551089|NCT01474512|583408822|FG010|Induction Period|Withdrawal by Subject|0|||
161551090|NCT01474512|583408823|FG011|Induction Period|Withdrawal by Subject|0|||
161551091|NCT01474512|583408824|FG012|Induction Period|Withdrawal by Subject|0|||
161551092|NCT01474512|583408825|FG013|Induction Period|Withdrawal by Subject|0|||
161551093|NCT01474512|583408826|FG014|Induction Period|Withdrawal by Subject|0|||
161551094|NCT01474512|583408827|FG015|Induction Period|Withdrawal by Subject|0|||
161551095|NCT01474512|583408828|FG016|Induction Period|Withdrawal by Subject|0|||
161551096|NCT01474512|583408829|FG017|Induction Period|Withdrawal by Subject|0|||
161551097|NCT01474512|583408812|FG000|Induction Period|Protocol Violation|3|||
161551098|NCT01474512|583408813|FG001|Induction Period|Protocol Violation|6|||
161551099|NCT01474512|583408814|FG002|Induction Period|Protocol Violation|0|||
161551100|NCT01474512|583408815|FG003|Induction Period|Protocol Violation|0|||
161551101|NCT01474512|583408816|FG004|Induction Period|Protocol Violation|0|||
161551102|NCT01474512|583408817|FG005|Induction Period|Protocol Violation|0|||
161551103|NCT01474512|583408818|FG006|Induction Period|Protocol Violation|0|||
161551104|NCT01474512|583408819|FG007|Induction Period|Protocol Violation|0|||
161551105|NCT01474512|583408820|FG008|Induction Period|Protocol Violation|0|||
161551106|NCT01474512|583408821|FG009|Induction Period|Protocol Violation|0|||
161551107|NCT01474512|583408822|FG010|Induction Period|Protocol Violation|0|||
161551108|NCT01474512|583408823|FG011|Induction Period|Protocol Violation|0|||
161551109|NCT01474512|583408824|FG012|Induction Period|Protocol Violation|0|||
161551110|NCT01474512|583408825|FG013|Induction Period|Protocol Violation|0|||
161551111|NCT01474512|583408826|FG014|Induction Period|Protocol Violation|0|||
161551112|NCT01474512|583408827|FG015|Induction Period|Protocol Violation|0|||
161551113|NCT01474512|583408828|FG016|Induction Period|Protocol Violation|0|||
161551114|NCT01474512|583408829|FG017|Induction Period|Protocol Violation|0|||
161551115|NCT01474512|583408812|FG000|Induction Period|Sponsor Decision|1|||
161551116|NCT01474512|583408813|FG001|Induction Period|Sponsor Decision|1|||
161551117|NCT01474512|583408814|FG002|Induction Period|Sponsor Decision|1|||
161551118|NCT01474512|583408815|FG003|Induction Period|Sponsor Decision|0|||
161551119|NCT01474512|583408816|FG004|Induction Period|Sponsor Decision|0|||
161551120|NCT01474512|583408817|FG005|Induction Period|Sponsor Decision|0|||
161551121|NCT01474512|583408818|FG006|Induction Period|Sponsor Decision|0|||
161551122|NCT01474512|583408819|FG007|Induction Period|Sponsor Decision|0|||
161551123|NCT01474512|583408820|FG008|Induction Period|Sponsor Decision|0|||
161551124|NCT01474512|583408821|FG009|Induction Period|Sponsor Decision|0|||
161551125|NCT01474512|583408822|FG010|Induction Period|Sponsor Decision|0|||
161551126|NCT01474512|583408823|FG011|Induction Period|Sponsor Decision|0|||
161551127|NCT01474512|583408824|FG012|Induction Period|Sponsor Decision|0|||
161551128|NCT01474512|583408825|FG013|Induction Period|Sponsor Decision|0|||
161551129|NCT01474512|583408826|FG014|Induction Period|Sponsor Decision|0|||
161551130|NCT01474512|583408827|FG015|Induction Period|Sponsor Decision|0|||
161551131|NCT01474512|583408828|FG016|Induction Period|Sponsor Decision|0|||
161551132|NCT01474512|583408829|FG017|Induction Period|Sponsor Decision|0|||
161551133|NCT01474512|583408812|FG000|Induction Period|Lost to Follow-up|1|||
161551134|NCT01474512|583408813|FG001|Induction Period|Lost to Follow-up|0|||
161551135|NCT01474512|583408814|FG002|Induction Period|Lost to Follow-up|2|||
161551136|NCT01474512|583408815|FG003|Induction Period|Lost to Follow-up|0|||
161551137|NCT01474512|583408816|FG004|Induction Period|Lost to Follow-up|0|||
161551138|NCT01474512|583408817|FG005|Induction Period|Lost to Follow-up|0|||
161551139|NCT01474512|583408818|FG006|Induction Period|Lost to Follow-up|0|||
161551140|NCT01474512|583408819|FG007|Induction Period|Lost to Follow-up|0|||
161551141|NCT01474512|583408820|FG008|Induction Period|Lost to Follow-up|0|||
161551142|NCT01474512|583408821|FG009|Induction Period|Lost to Follow-up|0|||
161551143|NCT01474512|583408822|FG010|Induction Period|Lost to Follow-up|0|||
161551144|NCT01474512|583408823|FG011|Induction Period|Lost to Follow-up|0|||
161551145|NCT01474512|583408824|FG012|Induction Period|Lost to Follow-up|0|||
161551146|NCT01474512|583408825|FG013|Induction Period|Lost to Follow-up|0|||
161551147|NCT01474512|583408826|FG014|Induction Period|Lost to Follow-up|0|||
161551148|NCT01474512|583408827|FG015|Induction Period|Lost to Follow-up|0|||
161551149|NCT01474512|583408828|FG016|Induction Period|Lost to Follow-up|0|||
161551150|NCT01474512|583408829|FG017|Induction Period|Lost to Follow-up|0|||
161551151|NCT01474512|583408812|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551152|NCT01474512|583408813|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551153|NCT01474512|583408814|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551154|NCT01474512|583408815|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
161551155|NCT01474512|583408816|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
161551156|NCT01474512|583408817|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
161551157|NCT01474512|583408818|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
161551158|NCT01474512|583408819|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551159|NCT01474512|583408820|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551160|NCT01474512|583408821|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551161|NCT01474512|583408822|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551162|NCT01474512|583408823|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551163|NCT01474512|583408824|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551164|NCT01474512|583408825|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551165|NCT01474512|583408826|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551166|NCT01474512|583408827|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551167|NCT01474512|583408828|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161664626|NCT02563522|583824243|FG001|Overall Study|Lost to Follow-up|0|||
161664627|NCT02563522|583824242|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
161664628|NCT02563522|583824243|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
161664629|NCT01052103|583824244|FG000|Overall Study|Adverse Event|10|||
161664630|NCT01052103|583824245|FG001|Overall Study|Adverse Event|6|||
161664631|NCT01052103|583824244|FG000|Overall Study|Entry Criteria Not Met|3|||
161664632|NCT01052103|583824245|FG001|Overall Study|Entry Criteria Not Met|1|||
161664633|NCT01052103|583824244|FG000|Overall Study|Lost to Follow-up|3|||
161664634|NCT01052103|583824245|FG001|Overall Study|Lost to Follow-up|5|||
161664635|NCT01052103|583824244|FG000|Overall Study|Protocol Violation|10|||
161664636|NCT01052103|583824245|FG001|Overall Study|Protocol Violation|4|||
161664637|NCT01052103|583824244|FG000|Overall Study|Scheduling conflict|2|||
161664638|NCT01052103|583824245|FG001|Overall Study|Scheduling conflict|1|||
161664639|NCT01052103|583824244|FG000|Overall Study|Sponsor Decision|2|||
161664640|NCT01052103|583824245|FG001|Overall Study|Sponsor Decision|0|||
161664641|NCT01052103|583824244|FG000|Overall Study|Withdrawal by Subject|3|||
161664642|NCT01052103|583824245|FG001|Overall Study|Withdrawal by Subject|6|||
161664643|NCT01052103|583824244|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161664644|NCT01052103|583824245|FG001|Overall Study|Perceived Lack of Efficacy|0|||
161664645|NCT00666679|583824249|FG000|First Intervention|Lost to Follow-up|1|||
161551168|NCT01474512|583408829|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
161551169|NCT01474512|583408812|FG000|Maintenance Period|Adverse Event|0|||
161551170|NCT01474512|583408813|FG001|Maintenance Period|Adverse Event|0|||
161551171|NCT01474512|583408814|FG002|Maintenance Period|Adverse Event|0|||
161551172|NCT01474512|583408815|FG003|Maintenance Period|Adverse Event|4|||
161551173|NCT01474512|583408816|FG004|Maintenance Period|Adverse Event|2|||
161551174|NCT01474512|583408817|FG005|Maintenance Period|Adverse Event|7|||
161551175|NCT01474512|583408818|FG006|Maintenance Period|Adverse Event|0|||
161551176|NCT01474512|583408819|FG007|Maintenance Period|Adverse Event|19|||
161664646|NCT00666679|583824250|FG001|First Intervention|Lost to Follow-up|0|||
161551177|NCT01474512|583408820|FG008|Maintenance Period|Adverse Event|1|||
161551178|NCT01474512|583408821|FG009|Maintenance Period|Adverse Event|3|||
161551179|NCT01474512|583408822|FG010|Maintenance Period|Adverse Event|0|||
161551180|NCT01474512|583408823|FG011|Maintenance Period|Adverse Event|0|||
161551181|NCT01474512|583408824|FG012|Maintenance Period|Adverse Event|0|||
161551182|NCT01474512|583408825|FG013|Maintenance Period|Adverse Event|0|||
161551183|NCT01474512|583408826|FG014|Maintenance Period|Adverse Event|0|||
161551184|NCT01474512|583408827|FG015|Maintenance Period|Adverse Event|0|||
161551185|NCT01474512|583408828|FG016|Maintenance Period|Adverse Event|0|||
161551186|NCT01474512|583408829|FG017|Maintenance Period|Adverse Event|0|||
161551187|NCT01474512|583408812|FG000|Maintenance Period|Withdrawal by Subject|0|||
161551188|NCT01474512|583408813|FG001|Maintenance Period|Withdrawal by Subject|0|||
161551189|NCT01474512|583408814|FG002|Maintenance Period|Withdrawal by Subject|0|||
161551190|NCT01474512|583408815|FG003|Maintenance Period|Withdrawal by Subject|6|||
161551191|NCT01474512|583408816|FG004|Maintenance Period|Withdrawal by Subject|2|||
161551192|NCT01474512|583408817|FG005|Maintenance Period|Withdrawal by Subject|3|||
161551193|NCT01474512|583408818|FG006|Maintenance Period|Withdrawal by Subject|1|||
161551194|NCT01474512|583408819|FG007|Maintenance Period|Withdrawal by Subject|6|||
161551195|NCT01474512|583408820|FG008|Maintenance Period|Withdrawal by Subject|3|||
161551196|NCT01474512|583408821|FG009|Maintenance Period|Withdrawal by Subject|1|||
161551197|NCT01474512|583408822|FG010|Maintenance Period|Withdrawal by Subject|0|||
161551198|NCT01474512|583408823|FG011|Maintenance Period|Withdrawal by Subject|0|||
161551199|NCT01474512|583408824|FG012|Maintenance Period|Withdrawal by Subject|0|||
161551200|NCT01474512|583408825|FG013|Maintenance Period|Withdrawal by Subject|0|||
161551201|NCT01474512|583408826|FG014|Maintenance Period|Withdrawal by Subject|0|||
161551202|NCT01474512|583408827|FG015|Maintenance Period|Withdrawal by Subject|0|||
161551203|NCT01474512|583408828|FG016|Maintenance Period|Withdrawal by Subject|0|||
161551204|NCT01474512|583408829|FG017|Maintenance Period|Withdrawal by Subject|0|||
161551205|NCT01474512|583408812|FG000|Maintenance Period|Lost to Follow-up|0|||
161551206|NCT01474512|583408813|FG001|Maintenance Period|Lost to Follow-up|0|||
161551207|NCT01474512|583408814|FG002|Maintenance Period|Lost to Follow-up|0|||
161551208|NCT01474512|583408815|FG003|Maintenance Period|Lost to Follow-up|3|||
161551209|NCT01474512|583408816|FG004|Maintenance Period|Lost to Follow-up|3|||
161551210|NCT01474512|583408817|FG005|Maintenance Period|Lost to Follow-up|0|||
161664647|NCT00666679|583824249|FG000|First Intervention|Protocol Violation|1|||
161664648|NCT00666679|583824250|FG001|First Intervention|Protocol Violation|0|||
161664649|NCT00666679|583824249|FG000|First Intervention|Withdrawal by Subject|1|||
161664650|NCT00666679|583824250|FG001|First Intervention|Withdrawal by Subject|0|||
161664651|NCT00666679|583824249|FG000|First Intervention|Randomized did not start treatment|1|||
161664652|NCT00666679|583824250|FG001|First Intervention|Randomized did not start treatment|1|||
161664653|NCT00666679|583824249|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
161664654|NCT00666679|583824250|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
161664655|NCT00666679|583824249|FG000|Washout Period of 1 Week|Protocol Violation|0|||
161664656|NCT00666679|583824250|FG001|Washout Period of 1 Week|Protocol Violation|1|||
161664657|NCT00666679|583824249|FG000|Second Intervention|Adverse Event|1|||
161664658|NCT00666679|583824250|FG001|Second Intervention|Adverse Event|0|||
161664659|NCT00666679|583824249|FG000|Second Intervention|Death|0|||
161664660|NCT00666679|583824250|FG001|Second Intervention|Death|1|||
161664661|NCT04874415|583824251|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664662|NCT04874415|583824252|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664663|NCT04874415|583824253|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664664|NCT04874415|583824254|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664665|NCT04874415|583824255|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664666|NCT04874415|583824256|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664667|NCT04874415|583824257|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161664668|NCT04874415|583824258|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664669|NCT04874415|583824259|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
161664670|NCT04874415|583824260|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161664671|NCT04874415|583824261|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664672|NCT04874415|583824262|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161664673|NCT04874415|583824263|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161664674|NCT04874415|583824264|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161664675|NCT04874415|583824265|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
161551211|NCT01474512|583408818|FG006|Maintenance Period|Lost to Follow-up|0|||
161551212|NCT01474512|583408819|FG007|Maintenance Period|Lost to Follow-up|2|||
161551213|NCT01474512|583408820|FG008|Maintenance Period|Lost to Follow-up|1|||
161551214|NCT01474512|583408821|FG009|Maintenance Period|Lost to Follow-up|1|||
161551215|NCT01474512|583408822|FG010|Maintenance Period|Lost to Follow-up|0|||
161551216|NCT01474512|583408823|FG011|Maintenance Period|Lost to Follow-up|0|||
161551217|NCT01474512|583408824|FG012|Maintenance Period|Lost to Follow-up|0|||
161551218|NCT01474512|583408825|FG013|Maintenance Period|Lost to Follow-up|0|||
161551219|NCT01474512|583408826|FG014|Maintenance Period|Lost to Follow-up|0|||
161551220|NCT01474512|583408827|FG015|Maintenance Period|Lost to Follow-up|0|||
161551221|NCT01474512|583408828|FG016|Maintenance Period|Lost to Follow-up|0|||
161551222|NCT01474512|583408829|FG017|Maintenance Period|Lost to Follow-up|0|||
161551223|NCT01474512|583408812|FG000|Maintenance Period|Death|0|||
161551224|NCT01474512|583408813|FG001|Maintenance Period|Death|0|||
161551225|NCT01474512|583408814|FG002|Maintenance Period|Death|0|||
161551226|NCT01474512|583408815|FG003|Maintenance Period|Death|0|||
161551227|NCT01474512|583408816|FG004|Maintenance Period|Death|0|||
161551228|NCT01474512|583408817|FG005|Maintenance Period|Death|2|||
161551229|NCT01474512|583408818|FG006|Maintenance Period|Death|0|||
161551230|NCT01474512|583408819|FG007|Maintenance Period|Death|0|||
161551231|NCT01474512|583408820|FG008|Maintenance Period|Death|0|||
161551232|NCT01474512|583408821|FG009|Maintenance Period|Death|0|||
161551233|NCT01474512|583408822|FG010|Maintenance Period|Death|0|||
161551234|NCT01474512|583408823|FG011|Maintenance Period|Death|0|||
161551235|NCT01474512|583408824|FG012|Maintenance Period|Death|0|||
161551236|NCT01474512|583408825|FG013|Maintenance Period|Death|0|||
161551237|NCT01474512|583408826|FG014|Maintenance Period|Death|0|||
161551238|NCT01474512|583408827|FG015|Maintenance Period|Death|0|||
161551239|NCT01474512|583408828|FG016|Maintenance Period|Death|0|||
161551240|NCT01474512|583408829|FG017|Maintenance Period|Death|0|||
161551241|NCT01474512|583408812|FG000|Maintenance Period|Physician Decision|0|||
161551242|NCT01474512|583408813|FG001|Maintenance Period|Physician Decision|0|||
161551243|NCT01474512|583408814|FG002|Maintenance Period|Physician Decision|0|||
161551244|NCT01474512|583408815|FG003|Maintenance Period|Physician Decision|0|||
161551245|NCT01474512|583408816|FG004|Maintenance Period|Physician Decision|0|||
161551246|NCT01474512|583408817|FG005|Maintenance Period|Physician Decision|1|||
161551247|NCT01474512|583408818|FG006|Maintenance Period|Physician Decision|0|||
161551248|NCT01474512|583408819|FG007|Maintenance Period|Physician Decision|2|||
161551249|NCT01474512|583408820|FG008|Maintenance Period|Physician Decision|0|||
161551250|NCT01474512|583408821|FG009|Maintenance Period|Physician Decision|0|||
161551251|NCT01474512|583408822|FG010|Maintenance Period|Physician Decision|0|||
161551252|NCT01474512|583408823|FG011|Maintenance Period|Physician Decision|0|||
161551253|NCT01474512|583408824|FG012|Maintenance Period|Physician Decision|0|||
161551254|NCT01474512|583408825|FG013|Maintenance Period|Physician Decision|0|||
161551255|NCT01474512|583408826|FG014|Maintenance Period|Physician Decision|0|||
161551256|NCT01474512|583408827|FG015|Maintenance Period|Physician Decision|0|||
161551257|NCT01474512|583408828|FG016|Maintenance Period|Physician Decision|0|||
161551258|NCT01474512|583408829|FG017|Maintenance Period|Physician Decision|0|||
161551259|NCT01474512|583408812|FG000|Maintenance Period|Clinical Relapse|0|||
161551260|NCT01474512|583408813|FG001|Maintenance Period|Clinical Relapse|0|||
161551261|NCT01474512|583408814|FG002|Maintenance Period|Clinical Relapse|0|||
161551262|NCT01474512|583408815|FG003|Maintenance Period|Clinical Relapse|1|||
161551263|NCT01474512|583408816|FG004|Maintenance Period|Clinical Relapse|0|||
161551264|NCT01474512|583408817|FG005|Maintenance Period|Clinical Relapse|0|||
161551265|NCT01474512|583408818|FG006|Maintenance Period|Clinical Relapse|0|||
161551266|NCT01474512|583408819|FG007|Maintenance Period|Clinical Relapse|0|||
161551267|NCT01474512|583408820|FG008|Maintenance Period|Clinical Relapse|0|||
161551268|NCT01474512|583408821|FG009|Maintenance Period|Clinical Relapse|0|||
161551269|NCT01474512|583408822|FG010|Maintenance Period|Clinical Relapse|0|||
161551270|NCT01474512|583408823|FG011|Maintenance Period|Clinical Relapse|0|||
161551271|NCT01474512|583408824|FG012|Maintenance Period|Clinical Relapse|0|||
161551272|NCT01474512|583408825|FG013|Maintenance Period|Clinical Relapse|0|||
161551273|NCT01474512|583408826|FG014|Maintenance Period|Clinical Relapse|0|||
161551274|NCT01474512|583408827|FG015|Maintenance Period|Clinical Relapse|0|||
161551275|NCT01474512|583408828|FG016|Maintenance Period|Clinical Relapse|0|||
161551276|NCT01474512|583408829|FG017|Maintenance Period|Clinical Relapse|0|||
161551277|NCT01474512|583408812|FG000|Maintenance Period|Lack of Efficacy|0|||
161551278|NCT01474512|583408813|FG001|Maintenance Period|Lack of Efficacy|0|||
161551279|NCT01474512|583408814|FG002|Maintenance Period|Lack of Efficacy|0|||
161551280|NCT01474512|583408815|FG003|Maintenance Period|Lack of Efficacy|1|||
161551281|NCT01474512|583408816|FG004|Maintenance Period|Lack of Efficacy|0|||
161551282|NCT01474512|583408817|FG005|Maintenance Period|Lack of Efficacy|0|||
161551283|NCT01474512|583408818|FG006|Maintenance Period|Lack of Efficacy|0|||
161551284|NCT01474512|583408819|FG007|Maintenance Period|Lack of Efficacy|11|||
161551285|NCT01474512|583408820|FG008|Maintenance Period|Lack of Efficacy|11|||
161551286|NCT01474512|583408821|FG009|Maintenance Period|Lack of Efficacy|12|||
161551287|NCT01474512|583408822|FG010|Maintenance Period|Lack of Efficacy|0|||
161551288|NCT01474512|583408823|FG011|Maintenance Period|Lack of Efficacy|0|||
161551289|NCT01474512|583408824|FG012|Maintenance Period|Lack of Efficacy|0|||
161664676|NCT04874415|583824266|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161551290|NCT01474512|583408825|FG013|Maintenance Period|Lack of Efficacy|0|||
161551291|NCT01474512|583408826|FG014|Maintenance Period|Lack of Efficacy|0|||
161551292|NCT01474512|583408827|FG015|Maintenance Period|Lack of Efficacy|0|||
161551293|NCT01474512|583408828|FG016|Maintenance Period|Lack of Efficacy|0|||
161551294|NCT01474512|583408829|FG017|Maintenance Period|Lack of Efficacy|0|||
161551295|NCT01474512|583408812|FG000|Maintenance Period|Protocol Violation|0|||
161551296|NCT01474512|583408813|FG001|Maintenance Period|Protocol Violation|0|||
161551297|NCT01474512|583408814|FG002|Maintenance Period|Protocol Violation|0|||
161551298|NCT01474512|583408815|FG003|Maintenance Period|Protocol Violation|1|||
161551299|NCT01474512|583408816|FG004|Maintenance Period|Protocol Violation|0|||
161551300|NCT01474512|583408817|FG005|Maintenance Period|Protocol Violation|0|||
161551301|NCT01474512|583408818|FG006|Maintenance Period|Protocol Violation|0|||
161551302|NCT01474512|583408819|FG007|Maintenance Period|Protocol Violation|1|||
161551303|NCT01474512|583408820|FG008|Maintenance Period|Protocol Violation|0|||
161551304|NCT01474512|583408821|FG009|Maintenance Period|Protocol Violation|1|||
161551305|NCT01474512|583408822|FG010|Maintenance Period|Protocol Violation|0|||
161551306|NCT01474512|583408823|FG011|Maintenance Period|Protocol Violation|0|||
161551307|NCT01474512|583408824|FG012|Maintenance Period|Protocol Violation|0|||
161551308|NCT01474512|583408825|FG013|Maintenance Period|Protocol Violation|0|||
161551309|NCT01474512|583408826|FG014|Maintenance Period|Protocol Violation|0|||
161551310|NCT01474512|583408827|FG015|Maintenance Period|Protocol Violation|0|||
161551311|NCT01474512|583408828|FG016|Maintenance Period|Protocol Violation|0|||
161551312|NCT01474512|583408829|FG017|Maintenance Period|Protocol Violation|0|||
161551313|NCT01474512|583408812|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
161551314|NCT01474512|583408813|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
161551315|NCT01474512|583408814|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
161551316|NCT01474512|583408815|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
161551317|NCT01474512|583408816|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
161551318|NCT01474512|583408817|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
161551319|NCT01474512|583408818|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
161551320|NCT01474512|583408819|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
161551321|NCT01474512|583408820|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
161551322|NCT01474512|583408821|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
161551323|NCT01474512|583408822|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
161551324|NCT01474512|583408823|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
161551325|NCT01474512|583408824|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
161551326|NCT01474512|583408825|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
161551327|NCT01474512|583408826|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
161551328|NCT01474512|583408827|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
161551329|NCT01474512|583408828|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
161551330|NCT01474512|583408829|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
161551331|NCT01474512|583408812|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
161551332|NCT01474512|583408813|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
161551333|NCT01474512|583408814|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
161551334|NCT01474512|583408815|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
161551335|NCT01474512|583408816|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
161551336|NCT01474512|583408817|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
161551337|NCT01474512|583408818|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
161551338|NCT01474512|583408819|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
161551339|NCT01474512|583408820|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
161551340|NCT01474512|583408821|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
161551341|NCT01474512|583408822|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
161551342|NCT01474512|583408823|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
161551343|NCT01474512|583408824|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
161551344|NCT01474512|583408825|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
161551345|NCT01474512|583408826|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
161551346|NCT01474512|583408827|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
161551347|NCT01474512|583408828|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
161551348|NCT01474512|583408829|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
161551349|NCT01474512|583408812|FG000|Long-Term Extension Period|Adverse Event|0|||
161551350|NCT01474512|583408813|FG001|Long-Term Extension Period|Adverse Event|0|||
161551351|NCT01474512|583408814|FG002|Long-Term Extension Period|Adverse Event|0|||
161551352|NCT01474512|583408815|FG003|Long-Term Extension Period|Adverse Event|0|||
161551353|NCT01474512|583408816|FG004|Long-Term Extension Period|Adverse Event|0|||
161551354|NCT01474512|583408817|FG005|Long-Term Extension Period|Adverse Event|0|||
161551355|NCT01474512|583408818|FG006|Long-Term Extension Period|Adverse Event|0|||
161551356|NCT01474512|583408819|FG007|Long-Term Extension Period|Adverse Event|0|||
161551357|NCT01474512|583408820|FG008|Long-Term Extension Period|Adverse Event|0|||
161551358|NCT01474512|583408821|FG009|Long-Term Extension Period|Adverse Event|0|||
161551359|NCT01474512|583408822|FG010|Long-Term Extension Period|Adverse Event|0|||
161551360|NCT01474512|583408823|FG011|Long-Term Extension Period|Adverse Event|1|||
161664677|NCT04874415|583824251|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
161551361|NCT01474512|583408824|FG012|Long-Term Extension Period|Adverse Event|57|||
161551362|NCT01474512|583408825|FG013|Long-Term Extension Period|Adverse Event|58|||
161551363|NCT01474512|583408826|FG014|Long-Term Extension Period|Adverse Event|0|||
161551364|NCT01474512|583408827|FG015|Long-Term Extension Period|Adverse Event|0|||
161551365|NCT01474512|583408828|FG016|Long-Term Extension Period|Adverse Event|0|||
161551366|NCT01474512|583408829|FG017|Long-Term Extension Period|Adverse Event|0|||
161551367|NCT01474512|583408812|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
161551368|NCT01474512|583408813|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
161551369|NCT01474512|583408814|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
161551370|NCT01474512|583408815|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
161551371|NCT01474512|583408816|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
161551372|NCT01474512|583408817|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
161551373|NCT01474512|583408818|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
161551374|NCT01474512|583408819|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
161551375|NCT01474512|583408820|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
161551376|NCT01474512|583408821|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
161551377|NCT01474512|583408822|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
161551378|NCT01474512|583408823|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
161551379|NCT01474512|583408824|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
161551380|NCT01474512|583408825|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
161551381|NCT01474512|583408826|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
161551382|NCT01474512|583408827|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
161551383|NCT01474512|583408828|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
161551384|NCT01474512|583408829|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
161551385|NCT01474512|583408812|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
161551386|NCT01474512|583408813|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
161551387|NCT01474512|583408814|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
161551388|NCT01474512|583408815|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
161551389|NCT01474512|583408816|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
161551390|NCT01474512|583408817|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
161551391|NCT01474512|583408818|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
161551392|NCT01474512|583408819|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
161551393|NCT01474512|583408820|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
161551394|NCT01474512|583408821|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
161551395|NCT01474512|583408822|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
161551396|NCT01474512|583408823|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
161551397|NCT01474512|583408824|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
161551398|NCT01474512|583408825|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
161551399|NCT01474512|583408826|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
161551400|NCT01474512|583408827|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
161551401|NCT01474512|583408828|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
161551402|NCT01474512|583408829|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
161551403|NCT01474512|583408812|FG000|Long-Term Extension Period|Physician Decision|0|||
161551404|NCT01474512|583408813|FG001|Long-Term Extension Period|Physician Decision|0|||
161551405|NCT01474512|583408814|FG002|Long-Term Extension Period|Physician Decision|0|||
161551406|NCT01474512|583408815|FG003|Long-Term Extension Period|Physician Decision|0|||
161551407|NCT01474512|583408816|FG004|Long-Term Extension Period|Physician Decision|0|||
161551408|NCT01474512|583408817|FG005|Long-Term Extension Period|Physician Decision|0|||
161551409|NCT01474512|583408818|FG006|Long-Term Extension Period|Physician Decision|0|||
161551410|NCT01474512|583408819|FG007|Long-Term Extension Period|Physician Decision|0|||
161551411|NCT01474512|583408820|FG008|Long-Term Extension Period|Physician Decision|0|||
161551412|NCT01474512|583408821|FG009|Long-Term Extension Period|Physician Decision|0|||
161551413|NCT01474512|583408822|FG010|Long-Term Extension Period|Physician Decision|0|||
161551414|NCT01474512|583408823|FG011|Long-Term Extension Period|Physician Decision|0|||
161551415|NCT01474512|583408824|FG012|Long-Term Extension Period|Physician Decision|21|||
161551416|NCT01474512|583408825|FG013|Long-Term Extension Period|Physician Decision|21|||
161551417|NCT01474512|583408826|FG014|Long-Term Extension Period|Physician Decision|0|||
161551418|NCT01474512|583408827|FG015|Long-Term Extension Period|Physician Decision|0|||
161551419|NCT01474512|583408828|FG016|Long-Term Extension Period|Physician Decision|0|||
161551420|NCT01474512|583408829|FG017|Long-Term Extension Period|Physician Decision|0|||
161551421|NCT01474512|583408812|FG000|Long-Term Extension Period|Clinical Relapse|0|||
161551422|NCT01474512|583408813|FG001|Long-Term Extension Period|Clinical Relapse|0|||
161551423|NCT01474512|583408814|FG002|Long-Term Extension Period|Clinical Relapse|0|||
161664678|NCT04874415|583824252|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
161664679|NCT04874415|583824253|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
161664680|NCT04874415|583824254|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
161664681|NCT04874415|583824255|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
161664682|NCT04874415|583824256|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
161664683|NCT04874415|583824257|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
161664684|NCT04874415|583824258|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
161664685|NCT04874415|583824259|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
161664686|NCT04874415|583824260|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
161664687|NCT04874415|583824261|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
161664688|NCT04874415|583824262|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
161551424|NCT01474512|583408815|FG003|Long-Term Extension Period|Clinical Relapse|0|||
161551425|NCT01474512|583408816|FG004|Long-Term Extension Period|Clinical Relapse|0|||
161551426|NCT01474512|583408817|FG005|Long-Term Extension Period|Clinical Relapse|0|||
161551427|NCT01474512|583408818|FG006|Long-Term Extension Period|Clinical Relapse|0|||
161551428|NCT01474512|583408819|FG007|Long-Term Extension Period|Clinical Relapse|0|||
161551429|NCT01474512|583408820|FG008|Long-Term Extension Period|Clinical Relapse|0|||
161551430|NCT01474512|583408821|FG009|Long-Term Extension Period|Clinical Relapse|0|||
161551431|NCT01474512|583408822|FG010|Long-Term Extension Period|Clinical Relapse|0|||
161551432|NCT01474512|583408823|FG011|Long-Term Extension Period|Clinical Relapse|0|||
161551433|NCT01474512|583408824|FG012|Long-Term Extension Period|Clinical Relapse|9|||
161551434|NCT01474512|583408825|FG013|Long-Term Extension Period|Clinical Relapse|9|||
161551435|NCT01474512|583408826|FG014|Long-Term Extension Period|Clinical Relapse|0|||
161551436|NCT01474512|583408827|FG015|Long-Term Extension Period|Clinical Relapse|0|||
161551437|NCT01474512|583408828|FG016|Long-Term Extension Period|Clinical Relapse|0|||
161551438|NCT01474512|583408829|FG017|Long-Term Extension Period|Clinical Relapse|0|||
161551439|NCT01474512|583408812|FG000|Long-Term Extension Period|Death|0|||
161551440|NCT01474512|583408813|FG001|Long-Term Extension Period|Death|0|||
161551441|NCT01474512|583408814|FG002|Long-Term Extension Period|Death|0|||
161551442|NCT01474512|583408815|FG003|Long-Term Extension Period|Death|0|||
161551443|NCT01474512|583408816|FG004|Long-Term Extension Period|Death|0|||
161551444|NCT01474512|583408817|FG005|Long-Term Extension Period|Death|0|||
161551445|NCT01474512|583408818|FG006|Long-Term Extension Period|Death|0|||
161551446|NCT01474512|583408819|FG007|Long-Term Extension Period|Death|0|||
161551447|NCT01474512|583408820|FG008|Long-Term Extension Period|Death|0|||
161551448|NCT01474512|583408821|FG009|Long-Term Extension Period|Death|0|||
161551449|NCT01474512|583408822|FG010|Long-Term Extension Period|Death|0|||
161551450|NCT01474512|583408823|FG011|Long-Term Extension Period|Death|0|||
161551451|NCT01474512|583408824|FG012|Long-Term Extension Period|Death|9|||
161551452|NCT01474512|583408825|FG013|Long-Term Extension Period|Death|9|||
161551453|NCT01474512|583408826|FG014|Long-Term Extension Period|Death|0|||
161551454|NCT01474512|583408827|FG015|Long-Term Extension Period|Death|0|||
161551455|NCT01474512|583408828|FG016|Long-Term Extension Period|Death|0|||
161551456|NCT01474512|583408829|FG017|Long-Term Extension Period|Death|0|||
161551457|NCT01474512|583408812|FG000|Long-Term Extension Period|Sponsor Decision|0|||
161551458|NCT01474512|583408813|FG001|Long-Term Extension Period|Sponsor Decision|0|||
161551459|NCT01474512|583408814|FG002|Long-Term Extension Period|Sponsor Decision|0|||
161551460|NCT01474512|583408815|FG003|Long-Term Extension Period|Sponsor Decision|0|||
161551461|NCT01474512|583408816|FG004|Long-Term Extension Period|Sponsor Decision|0|||
161551462|NCT01474512|583408817|FG005|Long-Term Extension Period|Sponsor Decision|0|||
161551463|NCT01474512|583408818|FG006|Long-Term Extension Period|Sponsor Decision|0|||
161551464|NCT01474512|583408819|FG007|Long-Term Extension Period|Sponsor Decision|0|||
161551465|NCT01474512|583408820|FG008|Long-Term Extension Period|Sponsor Decision|0|||
161551466|NCT01474512|583408821|FG009|Long-Term Extension Period|Sponsor Decision|0|||
161551467|NCT01474512|583408822|FG010|Long-Term Extension Period|Sponsor Decision|0|||
161551468|NCT01474512|583408823|FG011|Long-Term Extension Period|Sponsor Decision|0|||
161551469|NCT01474512|583408824|FG012|Long-Term Extension Period|Sponsor Decision|6|||
161551470|NCT01474512|583408825|FG013|Long-Term Extension Period|Sponsor Decision|6|||
161551471|NCT01474512|583408826|FG014|Long-Term Extension Period|Sponsor Decision|0|||
161551472|NCT01474512|583408827|FG015|Long-Term Extension Period|Sponsor Decision|0|||
161551473|NCT01474512|583408828|FG016|Long-Term Extension Period|Sponsor Decision|0|||
161551474|NCT01474512|583408829|FG017|Long-Term Extension Period|Sponsor Decision|0|||
161551475|NCT01474512|583408812|FG000|Long-Term Extension Period|Protocol Violation|0|||
161551476|NCT01474512|583408813|FG001|Long-Term Extension Period|Protocol Violation|0|||
161551477|NCT01474512|583408814|FG002|Long-Term Extension Period|Protocol Violation|0|||
161551478|NCT01474512|583408815|FG003|Long-Term Extension Period|Protocol Violation|0|||
161551479|NCT01474512|583408816|FG004|Long-Term Extension Period|Protocol Violation|0|||
161551480|NCT01474512|583408817|FG005|Long-Term Extension Period|Protocol Violation|0|||
161551481|NCT01474512|583408818|FG006|Long-Term Extension Period|Protocol Violation|0|||
161551482|NCT01474512|583408819|FG007|Long-Term Extension Period|Protocol Violation|0|||
161551483|NCT01474512|583408820|FG008|Long-Term Extension Period|Protocol Violation|0|||
161551484|NCT01474512|583408821|FG009|Long-Term Extension Period|Protocol Violation|0|||
161551485|NCT01474512|583408822|FG010|Long-Term Extension Period|Protocol Violation|0|||
161551486|NCT01474512|583408823|FG011|Long-Term Extension Period|Protocol Violation|0|||
161551487|NCT01474512|583408824|FG012|Long-Term Extension Period|Protocol Violation|5|||
161551488|NCT01474512|583408825|FG013|Long-Term Extension Period|Protocol Violation|5|||
161551489|NCT01474512|583408826|FG014|Long-Term Extension Period|Protocol Violation|0|||
161551490|NCT01474512|583408827|FG015|Long-Term Extension Period|Protocol Violation|0|||
161551491|NCT01474512|583408828|FG016|Long-Term Extension Period|Protocol Violation|0|||
161551492|NCT01474512|583408829|FG017|Long-Term Extension Period|Protocol Violation|0|||
161551493|NCT01474512|583408812|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551494|NCT01474512|583408813|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551495|NCT01474512|583408814|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551496|NCT01474512|583408815|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551497|NCT01474512|583408816|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551498|NCT01474512|583408817|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551499|NCT01474512|583408818|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551500|NCT01474512|583408819|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551501|NCT01474512|583408820|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551502|NCT01474512|583408821|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551503|NCT01474512|583408822|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551504|NCT01474512|583408823|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551505|NCT01474512|583408824|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
161551506|NCT01474512|583408825|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
161551507|NCT01474512|583408826|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551508|NCT01474512|583408827|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551509|NCT01474512|583408828|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551510|NCT01474512|583408829|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161551511|NCT01474512|583408812|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551512|NCT01474512|583408813|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551513|NCT01474512|583408814|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551514|NCT01474512|583408815|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551515|NCT01474512|583408816|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551516|NCT01474512|583408817|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551517|NCT01474512|583408818|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551518|NCT01474512|583408819|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551519|NCT01474512|583408820|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551520|NCT01474512|583408821|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551521|NCT01474512|583408822|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551522|NCT01474512|583408823|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
161551523|NCT01474512|583408824|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551524|NCT01474512|583408825|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551525|NCT01474512|583408826|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551526|NCT01474512|583408827|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551527|NCT01474512|583408828|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551528|NCT01474512|583408829|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161551529|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
161551530|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
161551531|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
161551532|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
161551533|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
161551534|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
161551535|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
161551536|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
161551537|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
161551538|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
161551539|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
161551540|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
161551541|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
161551542|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
161551543|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
161551544|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
161551545|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
161551546|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
161551547|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551548|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551549|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551550|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551551|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551552|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551553|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551554|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551555|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551556|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551557|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551558|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551559|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161551560|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161664689|NCT04874415|583824263|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
161664690|NCT04874415|583824264|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
161551561|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
161664691|NCT04874415|583824265|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
161664692|NCT04874415|583824266|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
161664693|NCT04874415|583824251|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664694|NCT04874415|583824252|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664695|NCT04874415|583824253|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664696|NCT04874415|583824254|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664697|NCT04874415|583824255|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
161664698|NCT04874415|583824256|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664699|NCT04874415|583824257|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664700|NCT04874415|583824258|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664701|NCT04874415|583824259|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664702|NCT04874415|583824260|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664703|NCT04874415|583824261|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664704|NCT04874415|583824262|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664705|NCT04874415|583824263|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664706|NCT04874415|583824264|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664707|NCT04874415|583824265|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664708|NCT04874415|583824266|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161664709|NCT00918580|583824267|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
161664710|NCT00918580|583824267|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
161664711|NCT00918580|583824267|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
161664712|NCT00918580|583824267|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
161664713|NCT00918580|583824267|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
161664714|NCT00918580|583824267|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
161664715|NCT00918580|583824267|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
161664716|NCT00881608|583824268|FG000|Overall Study|Study prematurely terminated|11|||
161664717|NCT00701220|583824269|FG000|Overall Study|Withdrawal by Subject|0|||
161664718|NCT00701220|583824270|FG001|Overall Study|Withdrawal by Subject|2|||
161664719|NCT00701220|583824269|FG000|Overall Study|Protocol Violation|2|||
161664720|NCT00701220|583824270|FG001|Overall Study|Protocol Violation|0|||
161664721|NCT00211185|583824271|FG000|Overall Study|Death|2|||
161664722|NCT00211185|583824271|FG000|Overall Study|Disease progression|7|||
161664723|NCT00211185|583824271|FG000|Overall Study|Withdrawal by Subject|6|||
161664724|NCT00211185|583824271|FG000|Overall Study|Physician Decision|5|||
161664725|NCT00069108|583824272|FG000|Overall Study|Withdrawal by Subject|5|||
161664726|NCT00069108|583824273|FG001|Overall Study|Withdrawal by Subject|9|||
161664727|NCT00069108|583824272|FG000|Overall Study|Adverse Event|64|||
161664728|NCT00069108|583824273|FG001|Overall Study|Adverse Event|42|||
161664729|NCT00069108|583824272|FG000|Overall Study|Death|6|||
161664730|NCT00069108|583824273|FG001|Overall Study|Death|6|||
161664731|NCT00069108|583824272|FG000|Overall Study|Administration|15|||
161664732|NCT00069108|583824273|FG001|Overall Study|Administration|4|||
161664733|NCT00069108|583824272|FG000|Overall Study|Insufficient therapy|117|||
161664734|NCT00069108|583824273|FG001|Overall Study|Insufficient therapy|144|||
161664735|NCT00069108|583824272|FG000|Overall Study|Violation criteria|1|||
161664736|NCT00069108|583824273|FG001|Overall Study|Violation criteria|4|||
161664737|NCT00069108|583824272|FG000|Overall Study|Refused treatment|5|||
161664738|NCT00069108|583824273|FG001|Overall Study|Refused treatment|10|||
161664739|NCT00903630|583824274|FG000|Phase 2|Adverse Event|0|||
161664740|NCT00903630|583824275|FG001|Phase 2|Adverse Event|0|||
161664741|NCT00903630|583824276|FG002|Phase 2|Adverse Event|1|||
161779230|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Death|2|||
161779231|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
161779232|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
161779233|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
161779234|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
161779235|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
161779236|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
161779237|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Relapse|1|||
161779238|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Relapse|0|||
161779239|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
161779240|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
161779241|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
161779242|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
161779243|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
161664742|NCT03658668|583824279|FG000|Overall Study|Time Commitment|1|||
161664743|NCT03658668|583824280|FG001|Overall Study|Time Commitment|1|||
161664744|NCT03305731|583824281|FG000|Overall Study|Protocol Violation|1|||
161664745|NCT04634825|583824282|FG000|Overall Study|Death|10|||
161664746|NCT04634825|583824283|FG001|Overall Study|Death|3|||
161664747|NCT04634825|583824282|FG000|Overall Study|Lost to Follow-up|1|||
161664748|NCT04634825|583824283|FG001|Overall Study|Lost to Follow-up|0|||
161664749|NCT04634825|583824282|FG000|Overall Study|Study terminated by sponsor|35|||
161664750|NCT04634825|583824283|FG001|Overall Study|Study terminated by sponsor|11|||
161664751|NCT04634825|583824282|FG000|Overall Study|Withdrawal by Subject|2|||
161664752|NCT04634825|583824283|FG001|Overall Study|Withdrawal by Subject|0|||
161664753|NCT01127139|583824286|FG000|Overall Study|Adverse Event|40|||
161664754|NCT01127139|583824286|FG000|Overall Study|Incompliance|12|||
161664755|NCT01127139|583824286|FG000|Overall Study|Lack of Efficacy|4|||
161664756|NCT01127139|583824286|FG000|Overall Study|Reason not specified|1|||
161664757|NCT01136772|583824287|FG000|Overall Study|Adverse Event|15|||
161664758|NCT01136772|583824288|FG001|Overall Study|Adverse Event|14|||
161664759|NCT01136772|583824287|FG000|Overall Study|Lack of Efficacy|42|||
161664760|NCT01136772|583824288|FG001|Overall Study|Lack of Efficacy|39|||
161664761|NCT01136772|583824287|FG000|Overall Study|Administrative|14|||
161664762|NCT01136772|583824288|FG001|Overall Study|Administrative|12|||
161664763|NCT01136772|583824287|FG000|Overall Study|Withdrawal by Subject|33|||
161664764|NCT01136772|583824288|FG001|Overall Study|Withdrawal by Subject|36|||
161664765|NCT01136772|583824287|FG000|Overall Study|Did not receive injection|10|||
161664766|NCT01136772|583824288|FG001|Overall Study|Did not receive injection|7|||
161664767|NCT01136772|583824287|FG000|Overall Study|Did not follow up after first injection|2|||
161664768|NCT01136772|583824288|FG001|Overall Study|Did not follow up after first injection|2|||
161664769|NCT01718353|583824294|FG000|Overall Study|Lost to Follow-up|0|||
161664770|NCT01718353|583824295|FG001|Overall Study|Lost to Follow-up|1|||
161664771|NCT01718353|583824294|FG000|Overall Study|Principal Investigator's Decision|10|||
161664772|NCT01718353|583824295|FG001|Overall Study|Principal Investigator's Decision|4|||
161664773|NCT01718353|583824294|FG000|Overall Study|Randomized but not treated|2|||
161664774|NCT01718353|583824295|FG001|Overall Study|Randomized but not treated|0|||
161664775|NCT01959516|583824296|FG000|Epoch 1|Adverse Event|4|||
161664776|NCT01959516|583824297|FG001|Epoch 1|Adverse Event|1|||
161664777|NCT01959516|583824296|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
161664778|NCT01959516|583824297|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
161664779|NCT01959516|583824296|FG000|Epoch 1|Subject withdrew consent|3|||
161664780|NCT01959516|583824297|FG001|Epoch 1|Subject withdrew consent|2|||
161664781|NCT01959516|583824296|FG000|Epoch 1|Administrative problems|1|||
161664782|NCT01959516|583824297|FG001|Epoch 1|Administrative problems|0|||
161664783|NCT01959516|583824296|FG000|Epoch 1|Use of prohibited treatment|1|||
161664784|NCT01959516|583824297|FG001|Epoch 1|Use of prohibited treatment|0|||
161664785|NCT01959516|583824296|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
161664786|NCT01959516|583824297|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
161664787|NCT01959516|583824296|FG000|Epoch 1|Protocol deviation|0|||
161664788|NCT01959516|583824297|FG001|Epoch 1|Protocol deviation|1|||
161664789|NCT01959516|583824296|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
161664790|NCT01959516|583824297|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
161664791|NCT01959516|583824296|FG000|Epoch 2|Subject withdrew consent|1|||
161664792|NCT01959516|583824297|FG001|Epoch 2|Subject withdrew consent|0|||
161664793|NCT01959516|583824296|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
161664794|NCT01959516|583824297|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
161664795|NCT02581631|583824302|FG000|Overall Study|Disease progression|29|||
161664796|NCT02581631|583824303|FG001|Overall Study|Disease progression|19|||
161664797|NCT02581631|583824304|FG002|Overall Study|Disease progression|13|||
161664798|NCT02581631|583824305|FG003|Overall Study|Disease progression|5|||
161664799|NCT02581631|583824306|FG004|Overall Study|Disease progression|8|||
161664800|NCT02581631|583824302|FG000|Overall Study|Study drug toxicity|4|||
161664801|NCT02581631|583824303|FG001|Overall Study|Study drug toxicity|6|||
161664802|NCT02581631|583824304|FG002|Overall Study|Study drug toxicity|7|||
161664803|NCT02581631|583824305|FG003|Overall Study|Study drug toxicity|0|||
161664804|NCT02581631|583824306|FG004|Overall Study|Study drug toxicity|3|||
161664805|NCT02581631|583824302|FG000|Overall Study|AE unrelated to study drug|3|||
161664806|NCT02581631|583824303|FG001|Overall Study|AE unrelated to study drug|1|||
161664807|NCT02581631|583824304|FG002|Overall Study|AE unrelated to study drug|1|||
161664808|NCT02581631|583824305|FG003|Overall Study|AE unrelated to study drug|0|||
161664809|NCT02581631|583824306|FG004|Overall Study|AE unrelated to study drug|2|||
161664810|NCT02581631|583824302|FG000|Overall Study|Request to discontinue|1|||
161664811|NCT02581631|583824303|FG001|Overall Study|Request to discontinue|0|||
161664812|NCT02581631|583824304|FG002|Overall Study|Request to discontinue|3|||
161664813|NCT02581631|583824305|FG003|Overall Study|Request to discontinue|0|||
161664814|NCT02581631|583824306|FG004|Overall Study|Request to discontinue|1|||
161664815|NCT02581631|583824302|FG000|Overall Study|participant withdrew consent|3|||
161664816|NCT02581631|583824303|FG001|Overall Study|participant withdrew consent|0|||
161664817|NCT02581631|583824304|FG002|Overall Study|participant withdrew consent|1|||
161664818|NCT02581631|583824305|FG003|Overall Study|participant withdrew consent|0|||
161664819|NCT02581631|583824306|FG004|Overall Study|participant withdrew consent|0|||
161664820|NCT02581631|583824302|FG000|Overall Study|Maximum clinical benefit|1|||
161664821|NCT02581631|583824303|FG001|Overall Study|Maximum clinical benefit|7|||
161664822|NCT02581631|583824304|FG002|Overall Study|Maximum clinical benefit|1|||
161664823|NCT02581631|583824305|FG003|Overall Study|Maximum clinical benefit|3|||
161664824|NCT02581631|583824306|FG004|Overall Study|Maximum clinical benefit|13|||
161664825|NCT02581631|583824302|FG000|Overall Study|Other Reasons|1|||
161664826|NCT02581631|583824303|FG001|Overall Study|Other Reasons|0|||
161664827|NCT02581631|583824304|FG002|Overall Study|Other Reasons|2|||
161664828|NCT02581631|583824305|FG003|Overall Study|Other Reasons|2|||
161664829|NCT02581631|583824306|FG004|Overall Study|Other Reasons|3|||
161664830|NCT02581631|583824302|FG000|Overall Study|Poor/Non-Compliance|0|||
161664831|NCT02581631|583824303|FG001|Overall Study|Poor/Non-Compliance|0|||
161664832|NCT02581631|583824304|FG002|Overall Study|Poor/Non-Compliance|1|||
161664833|NCT02581631|583824305|FG003|Overall Study|Poor/Non-Compliance|0|||
161664834|NCT02581631|583824306|FG004|Overall Study|Poor/Non-Compliance|0|||
161664835|NCT01759368|583824307|FG000|Overall Study|Lost to Follow-up|1|||
161664836|NCT01759368|583824308|FG001|Overall Study|Lost to Follow-up|0|||
161664837|NCT01191268|583824309|FG000|Overall Study|Withdrawal by Subject|19|||
161664838|NCT01191268|583824310|FG001|Overall Study|Withdrawal by Subject|25|||
161664839|NCT01191268|583824311|FG002|Overall Study|Withdrawal by Subject|21|||
161664840|NCT01191268|583824309|FG000|Overall Study|Adverse Event|21|||
161664841|NCT01191268|583824310|FG001|Overall Study|Adverse Event|13|||
161664842|NCT01191268|583824311|FG002|Overall Study|Adverse Event|8|||
161664843|NCT01191268|583824309|FG000|Overall Study|Physician Decision|6|||
161664844|NCT01191268|583824310|FG001|Overall Study|Physician Decision|8|||
161664845|NCT01191268|583824311|FG002|Overall Study|Physician Decision|9|||
161664846|NCT01191268|583824309|FG000|Overall Study|Lost to Follow-up|8|||
161664847|NCT01191268|583824310|FG001|Overall Study|Lost to Follow-up|5|||
161664848|NCT01191268|583824311|FG002|Overall Study|Lost to Follow-up|9|||
161664849|NCT01191268|583824309|FG000|Overall Study|Entry Criteria Not Met|3|||
161664850|NCT01191268|583824310|FG001|Overall Study|Entry Criteria Not Met|1|||
161664851|NCT01191268|583824311|FG002|Overall Study|Entry Criteria Not Met|1|||
161664852|NCT01191268|583824309|FG000|Overall Study|Death|0|||
161664853|NCT01191268|583824310|FG001|Overall Study|Death|1|||
161664854|NCT01191268|583824311|FG002|Overall Study|Death|3|||
161664855|NCT01191268|583824309|FG000|Overall Study|Protocol Violation|1|||
161664856|NCT01191268|583824310|FG001|Overall Study|Protocol Violation|0|||
161664857|NCT01191268|583824311|FG002|Overall Study|Protocol Violation|1|||
161664858|NCT01191268|583824309|FG000|Overall Study|Sponsor Decision|0|||
161664859|NCT01191268|583824310|FG001|Overall Study|Sponsor Decision|2|||
161664860|NCT01191268|583824311|FG002|Overall Study|Sponsor Decision|0|||
161664861|NCT02027623|583824312|FG000|Overall Study|Lost to Follow-up|3|||
161664862|NCT02027623|583824313|FG001|Overall Study|Lost to Follow-up|3|||
161664863|NCT02027623|583824312|FG000|Overall Study|Withdrawal by Subject|6|||
161664864|NCT02027623|583824313|FG001|Overall Study|Withdrawal by Subject|9|||
161664865|NCT01211288|583824314|FG000|Overall Study|Lost to Follow-up|1|||
161664866|NCT01211288|583824315|FG001|Overall Study|Lost to Follow-up|1|||
161664867|NCT01270971|583824316|FG000|Overall Study|Withdrawal by Subject|24|||
161664868|NCT01270971|583824317|FG001|Overall Study|Withdrawal by Subject|11|||
161664869|NCT01270971|583824316|FG000|Overall Study|Lost to Follow-up|18|||
161664870|NCT01270971|583824317|FG001|Overall Study|Lost to Follow-up|5|||
161664871|NCT01270971|583824316|FG000|Overall Study|Adverse Event|1|||
161664872|NCT01270971|583824317|FG001|Overall Study|Adverse Event|2|||
161664873|NCT01270971|583824316|FG000|Overall Study|Non compliance|2|||
161664874|NCT01270971|583824317|FG001|Overall Study|Non compliance|2|||
161664875|NCT01270971|583824316|FG000|Overall Study|Non-specific|7|||
161664876|NCT01270971|583824317|FG001|Overall Study|Non-specific|3|||
161664877|NCT01551212|583824318|FG000|Overall Study|Graft loss/Retransplantation|0|||
161664878|NCT01551212|583824319|FG001|Overall Study|Graft loss/Retransplantation|1|||
161664879|NCT01551212|583824318|FG000|Overall Study|Administrative problems|1|||
161664880|NCT01551212|583824319|FG001|Overall Study|Administrative problems|2|||
161664881|NCT01551212|583824318|FG000|Overall Study|Lost to Follow-up|0|||
161664882|NCT01551212|583824319|FG001|Overall Study|Lost to Follow-up|1|||
161664883|NCT01551212|583824318|FG000|Overall Study|Protocol Violation|0|||
161664884|NCT01551212|583824319|FG001|Overall Study|Protocol Violation|1|||
161664885|NCT01551212|583824318|FG000|Overall Study|Withdrawal by Subject|0|||
161664886|NCT01551212|583824319|FG001|Overall Study|Withdrawal by Subject|7|||
161664887|NCT01551212|583824318|FG000|Overall Study|Death|2|||
161664888|NCT01551212|583824319|FG001|Overall Study|Death|4|||
161664889|NCT01551212|583824318|FG000|Overall Study|Never Received Study Treatment|2|||
161664890|NCT01551212|583824319|FG001|Overall Study|Never Received Study Treatment|4|||
161664891|NCT04217590|583824320|FG000|Overall Study|Other|1|||
161664892|NCT04217590|583824321|FG001|Overall Study|Other|1|||
161664893|NCT04217590|583824320|FG000|Overall Study|Withdrawal by Subject|3|||
161664894|NCT04217590|583824321|FG001|Overall Study|Withdrawal by Subject|1|||
161664895|NCT04217590|583824320|FG000|Overall Study|Death|0|||
161664896|NCT04217590|583824321|FG001|Overall Study|Death|1|||
161664897|NCT01013285|583824322|FG000|Overall Study|Death|48|||
161664898|NCT01013285|583824323|FG001|Overall Study|Death|89|||
161664899|NCT01395888|583824324|FG000|2-week Run-in Period|Adverse Event|2|||
161664900|NCT01395888|583824325|FG001|2-week Run-in Period|Adverse Event|0|||
161664901|NCT01395888|583824326|FG002|2-week Run-in Period|Adverse Event|0|||
161664902|NCT01395888|583824324|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
161682985|NCT02969915|583890219|FG000|Overall Study|Death|104|||
161664903|NCT01395888|583824325|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
161664904|NCT01395888|583824326|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
161664905|NCT01395888|583824324|FG000|2-week Run-in Period|Lost to Follow-up|1|||
161664906|NCT01395888|583824325|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161664907|NCT01395888|583824326|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161664908|NCT01395888|583824324|FG000|2-week Run-in Period|Protocol Violation|2|||
161664909|NCT01395888|583824325|FG001|2-week Run-in Period|Protocol Violation|0|||
161664910|NCT01395888|583824326|FG002|2-week Run-in Period|Protocol Violation|0|||
161664911|NCT01395888|583824324|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
161664912|NCT01395888|583824325|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161664913|NCT01395888|583824326|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161664914|NCT01395888|583824324|FG000|Treatment Period (TP)|Adverse Event|0|||
161664915|NCT01395888|583824325|FG001|Treatment Period (TP)|Adverse Event|7|||
161664916|NCT01395888|583824326|FG002|Treatment Period (TP)|Adverse Event|6|||
161664917|NCT01395888|583824324|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
161664918|NCT01395888|583824325|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
161664919|NCT01395888|583824326|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
161664920|NCT01395888|583824324|FG000|Treatment Period (TP)|Protocol Violation|0|||
161664921|NCT01395888|583824325|FG001|Treatment Period (TP)|Protocol Violation|1|||
161664922|NCT01395888|583824326|FG002|Treatment Period (TP)|Protocol Violation|5|||
161664923|NCT01395888|583824324|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
161664924|NCT01395888|583824325|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
161664925|NCT01395888|583824326|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
161664926|NCT01395888|583824324|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
161664927|NCT01395888|583824325|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
161664928|NCT01395888|583824326|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
161664929|NCT02457559|583824327|FG000|Overall Study|Progressive Disease|1|||
161664930|NCT02457559|583824328|FG001|Overall Study|Progressive Disease|2|||
161664931|NCT02457559|583824329|FG002|Overall Study|Progressive Disease|3|||
161664932|NCT02457559|583824330|FG003|Overall Study|Progressive Disease|0|||
161664933|NCT02457559|583824331|FG004|Overall Study|Progressive Disease|0|||
161664934|NCT02457559|583824332|FG005|Overall Study|Progressive Disease|2|||
161664935|NCT02457559|583824333|FG006|Overall Study|Progressive Disease|1|||
161664936|NCT02457559|583824334|FG007|Overall Study|Progressive Disease|0|||
161664937|NCT02457559|583824335|FG008|Overall Study|Progressive Disease|1|||
161664938|NCT02457559|583824336|FG009|Overall Study|Progressive Disease|1|||
161894394|NCT00313586|584660955|FG001|Overall Study|Did not achieve HI-major/better response|7|||
161894395|NCT00313586|584660956|FG002|Overall Study|Did not achieve HI-major/better response|2|||
161894396|NCT00313586|584660957|FG003|Overall Study|Did not achieve HI-major/better response|1|||
161894397|NCT00313586|584660954|FG000|Overall Study|Physician Decision|2|||
161894398|NCT00313586|584660955|FG001|Overall Study|Physician Decision|1|||
161894399|NCT00313586|584660956|FG002|Overall Study|Physician Decision|0|||
161894400|NCT00313586|584660957|FG003|Overall Study|Physician Decision|0|||
161894401|NCT00313586|584660954|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
161894402|NCT00313586|584660955|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
161894403|NCT00313586|584660956|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
161894404|NCT00313586|584660957|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
161894405|NCT00313586|584660954|FG000|Overall Study|Lost insurance|0|||
161894406|NCT00313586|584660955|FG001|Overall Study|Lost insurance|1|||
161894407|NCT00313586|584660956|FG002|Overall Study|Lost insurance|0|||
161894408|NCT00313586|584660957|FG003|Overall Study|Lost insurance|0|||
161894409|NCT00313586|584660954|FG000|Overall Study|Moved|0|||
161664939|NCT02457559|583824337|FG010|Overall Study|Progressive Disease|1|||
161664940|NCT02457559|583824327|FG000|Overall Study|Investigator's Discretion|0|||
161664941|NCT02457559|583824328|FG001|Overall Study|Investigator's Discretion|0|||
161664942|NCT02457559|583824329|FG002|Overall Study|Investigator's Discretion|2|||
161664943|NCT02457559|583824330|FG003|Overall Study|Investigator's Discretion|0|||
161664944|NCT02457559|583824331|FG004|Overall Study|Investigator's Discretion|1|||
161664945|NCT02457559|583824332|FG005|Overall Study|Investigator's Discretion|0|||
161664946|NCT02457559|583824333|FG006|Overall Study|Investigator's Discretion|1|||
161664947|NCT02457559|583824334|FG007|Overall Study|Investigator's Discretion|0|||
161664948|NCT02457559|583824335|FG008|Overall Study|Investigator's Discretion|1|||
161664949|NCT02457559|583824336|FG009|Overall Study|Investigator's Discretion|0|||
161664950|NCT02457559|583824337|FG010|Overall Study|Investigator's Discretion|1|||
161894410|NCT00313586|584660955|FG001|Overall Study|Moved|1|||
161894411|NCT00313586|584660956|FG002|Overall Study|Moved|0|||
161664951|NCT02457559|583824327|FG000|Overall Study|Adverse Event|0|||
161664952|NCT02457559|583824328|FG001|Overall Study|Adverse Event|1|||
161664953|NCT02457559|583824329|FG002|Overall Study|Adverse Event|2|||
161664954|NCT02457559|583824330|FG003|Overall Study|Adverse Event|0|||
161664955|NCT02457559|583824331|FG004|Overall Study|Adverse Event|0|||
161894412|NCT00313586|584660957|FG003|Overall Study|Moved|0|||
161894413|NCT00313586|584660954|FG000|Overall Study|Death before starting treatment|1|||
161894414|NCT00313586|584660955|FG001|Overall Study|Death before starting treatment|0|||
161894415|NCT00313586|584660956|FG002|Overall Study|Death before starting treatment|0|||
161664956|NCT02457559|583824332|FG005|Overall Study|Adverse Event|0|||
161664957|NCT02457559|583824333|FG006|Overall Study|Adverse Event|0|||
161664958|NCT02457559|583824334|FG007|Overall Study|Adverse Event|0|||
161664959|NCT02457559|583824335|FG008|Overall Study|Adverse Event|0|||
161664960|NCT02457559|583824336|FG009|Overall Study|Adverse Event|0|||
161664961|NCT02457559|583824337|FG010|Overall Study|Adverse Event|0|||
161664962|NCT02457559|583824327|FG000|Overall Study|Reason not Specified|1|||
161664963|NCT02457559|583824328|FG001|Overall Study|Reason not Specified|0|||
161664964|NCT02457559|583824329|FG002|Overall Study|Reason not Specified|0|||
161664965|NCT02457559|583824330|FG003|Overall Study|Reason not Specified|0|||
161664966|NCT02457559|583824331|FG004|Overall Study|Reason not Specified|0|||
161664967|NCT02457559|583824332|FG005|Overall Study|Reason not Specified|0|||
161664968|NCT02457559|583824333|FG006|Overall Study|Reason not Specified|0|||
161664969|NCT02457559|583824334|FG007|Overall Study|Reason not Specified|0|||
161664970|NCT02457559|583824335|FG008|Overall Study|Reason not Specified|0|||
161664971|NCT02457559|583824336|FG009|Overall Study|Reason not Specified|2|||
161664972|NCT02457559|583824337|FG010|Overall Study|Reason not Specified|0|||
161664973|NCT02457559|583824327|FG000|Overall Study|Death|0|||
161664974|NCT02457559|583824328|FG001|Overall Study|Death|0|||
161664975|NCT02457559|583824329|FG002|Overall Study|Death|0|||
161664976|NCT02457559|583824330|FG003|Overall Study|Death|0|||
161664977|NCT02457559|583824331|FG004|Overall Study|Death|0|||
161664978|NCT02457559|583824332|FG005|Overall Study|Death|0|||
161664979|NCT02457559|583824333|FG006|Overall Study|Death|0|||
161664980|NCT02457559|583824334|FG007|Overall Study|Death|0|||
161664981|NCT02457559|583824335|FG008|Overall Study|Death|1|||
161664982|NCT02457559|583824336|FG009|Overall Study|Death|1|||
161664983|NCT02457559|583824337|FG010|Overall Study|Death|0|||
161664984|NCT05590884|583824338|FG000|Overall Study|Withdrawal by Subject|1|||
161664985|NCT05590884|583824339|FG001|Overall Study|Withdrawal by Subject|0|||
161664986|NCT05590884|583824340|FG002|Overall Study|Withdrawal by Subject|0|||
161664987|NCT04134845|583824350|FG000|Overall Study|withdrawl by PI|12|||
161664988|NCT04134845|583824351|FG001|Overall Study|withdrawl by PI|5|||
161664989|NCT01620255|583826371|FG000|Overall Study|Withdrawal by Subject|4|||
161894416|NCT00313586|584660957|FG003|Overall Study|Death before starting treatment|0|||
161894417|NCT03519919|584660958|FG000|Overall Study|Withdrawal by Subject|1|||
161664990|NCT01620255|583826372|FG001|Overall Study|Withdrawal by Subject|1|||
161664991|NCT01620255|583826373|FG002|Overall Study|Withdrawal by Subject|1|||
161664992|NCT01620255|583826374|FG003|Overall Study|Withdrawal by Subject|2|||
161664993|NCT01620255|583826375|FG004|Overall Study|Withdrawal by Subject|4|||
161664994|NCT01620255|583826371|FG000|Overall Study|Participant underwent fecal transplant|0|||
161664995|NCT01620255|583826372|FG001|Overall Study|Participant underwent fecal transplant|0|||
161664996|NCT01620255|583826373|FG002|Overall Study|Participant underwent fecal transplant|1|||
161664997|NCT01620255|583826374|FG003|Overall Study|Participant underwent fecal transplant|0|||
161664998|NCT01620255|583826375|FG004|Overall Study|Participant underwent fecal transplant|0|||
161664999|NCT01620255|583826371|FG000|Overall Study|Non-compliance|0|||
161665000|NCT01620255|583826372|FG001|Overall Study|Non-compliance|1|||
161665001|NCT01620255|583826373|FG002|Overall Study|Non-compliance|0|||
161665002|NCT01620255|583826374|FG003|Overall Study|Non-compliance|0|||
161665003|NCT01620255|583826375|FG004|Overall Study|Non-compliance|0|||
161665004|NCT01620255|583826371|FG000|Overall Study|Adverse Event|0|||
161665005|NCT01620255|583826372|FG001|Overall Study|Adverse Event|4|||
161665006|NCT01620255|583826373|FG002|Overall Study|Adverse Event|0|||
161665007|NCT01620255|583826374|FG003|Overall Study|Adverse Event|1|||
161665008|NCT01620255|583826375|FG004|Overall Study|Adverse Event|1|||
161665009|NCT01620255|583826371|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
161665010|NCT01620255|583826372|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
161665011|NCT01620255|583826373|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
161665012|NCT01620255|583826374|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
161665013|NCT01620255|583826375|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
161665014|NCT01873495|583826382|FG000|Overall Study|Withdrawal by Subject|1|||
161665015|NCT01873495|583826382|FG000|Overall Study|Physician Decision|3|||
161665016|NCT01873495|583826382|FG000|Overall Study|Adverse Event|1|||
161665017|NCT01873495|583826382|FG000|Overall Study|Removed for Transplantation|1|||
161665018|NCT01873495|583826382|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
161665019|NCT04335812|583826383|FG000|Overall Study|Withdrawal by Subject|1|||
161665020|NCT04335812|583826384|FG001|Overall Study|Withdrawal by Subject|3|||
161665021|NCT04335812|583826383|FG000|Overall Study|Lost to Follow-up|12|||
161665022|NCT04335812|583826384|FG001|Overall Study|Lost to Follow-up|12|||
161665023|NCT04335812|583826383|FG000|Overall Study|Did not engage in the intervention|22|||
161665024|NCT04335812|583826384|FG001|Overall Study|Did not engage in the intervention|18|||
161665025|NCT03864146|583826388|FG000|Overall Study|Lost to Follow-up|14|||
161665026|NCT03864146|583826389|FG001|Overall Study|Lost to Follow-up|23|||
161665027|NCT03864146|583826388|FG000|Overall Study|Withdrawal by Subject|3|||
161665028|NCT03864146|583826389|FG001|Overall Study|Withdrawal by Subject|2|||
161665029|NCT00799513|583826390|FG000|Overall Study|Physician Decision|1|||
161894418|NCT03519919|584660958|FG000|Overall Study|Lack of Efficacy|1|||
161665030|NCT00799513|583826390|FG000|Overall Study|Adverse Event|1|||
161894419|NCT03519919|584660958|FG000|Overall Study|Screen Failure|1|||
161894420|NCT03076996|584660959|FG000|Overall Study|Withdrawal by Subject|2|||
161894421|NCT03076996|584660959|FG000|Overall Study|Lost to Follow-up|3|||
161894422|NCT03076996|584660959|FG000|Overall Study|Literacy precluded participation|1|||
161894423|NCT02144077|584660960|FG000|Overall Study|Withdrawal by Subject|3|||
161894424|NCT02144077|584660961|FG001|Overall Study|Withdrawal by Subject|3|||
161894425|NCT02144077|584660960|FG000|Overall Study|Adverse Event|2|||
161894426|NCT02144077|584660961|FG001|Overall Study|Adverse Event|3|||
161665031|NCT05062759|583826393|FG000|Overall Study|Death|0|||
161665032|NCT05062759|583826394|FG001|Overall Study|Death|1|||
161665033|NCT05062759|583826393|FG000|Overall Study|Lost to Follow-up|1|||
161665034|NCT05062759|583826394|FG001|Overall Study|Lost to Follow-up|0|||
161665035|NCT04981366|583826395|FG000|Overall Study|Withdrawal by Subject|5|||
161665036|NCT04981366|583826396|FG001|Overall Study|Withdrawal by Subject|4|||
161665037|NCT04981366|583826397|FG002|Overall Study|Withdrawal by Subject|8|||
161665038|NCT04981366|583826395|FG000|Overall Study|Health issues unrelated to the trial|1|||
161665039|NCT04981366|583826396|FG001|Overall Study|Health issues unrelated to the trial|2|||
161665040|NCT04981366|583826397|FG002|Overall Study|Health issues unrelated to the trial|0|||
161665041|NCT04371198|583826398|FG000|Overall Study|inadequate sample|4|||
161665042|NCT01112306|583826399|FG000|Overall Study|Death|175|||
161665043|NCT01112306|583826399|FG000|Overall Study|Lost to Follow-up|9|||
161665044|NCT01112306|583826399|FG000|Overall Study|Withdrawal by Subject|31|||
161665045|NCT01112306|583826399|FG000|Overall Study|Other|70|||
161665046|NCT03214094|583826400|FG000|Overall Study|Case Report Forms Uncollected|14|||
161665047|NCT03214094|583826400|FG000|Overall Study|Protocol Deviation|46|||
161665048|NCT05559099|583826418|FG000|Overall Study|Death|5|||
161894427|NCT02144077|584660960|FG000|Overall Study|Lost to Follow-up|2|||
161894428|NCT02144077|584660961|FG001|Overall Study|Lost to Follow-up|2|||
161894429|NCT02144077|584660960|FG000|Overall Study|Protocol Violation|1|||
161894430|NCT02144077|584660961|FG001|Overall Study|Protocol Violation|2|||
161894431|NCT02144077|584660960|FG000|Overall Study|Death|0|||
161894432|NCT02144077|584660961|FG001|Overall Study|Death|1|||
161894433|NCT02144077|584660960|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
161894434|NCT02144077|584660961|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
161894435|NCT00943592|584660962|FG000|Overall Study|Death|3|||
161894436|NCT01909973|584660963|FG000|Overall Study|Lost to Follow-up|1|||
161894437|NCT01909973|584660964|FG001|Overall Study|Lost to Follow-up|0|||
161894438|NCT02438280|584660969|FG000|Overall Study|Physician Decision|1|||
161894439|NCT02438280|584660970|FG001|Overall Study|Physician Decision|0|||
161894440|NCT02982863|584660971|FG000|Overall Study|Not eligible patients|809|||
161894441|NCT02982863|584660972|FG001|Overall Study|Not eligible patients|4261|||
161894442|NCT02982863|584660973|FG002|Overall Study|Not eligible patients|1852|||
161894443|NCT02982863|584660974|FG003|Overall Study|Not eligible patients|1400|||
161665049|NCT05559099|583826419|FG001|Overall Study|Death|4|||
161894444|NCT02982863|584660975|FG004|Overall Study|Not eligible patients|492|||
161894445|NCT03739710|584660976|FG000|Overall Study|Screen Failed|81|||
161894446|NCT04313400|584660980|FG000|Overall Study|Withdrawal by Subject|0|||
161894447|NCT04313400|584660981|FG001|Overall Study|Withdrawal by Subject|0|||
161894448|NCT04313400|584660982|FG002|Overall Study|Withdrawal by Subject|0|||
161894449|NCT04313400|584660983|FG003|Overall Study|Withdrawal by Subject|0|||
161894450|NCT04313400|584660984|FG004|Overall Study|Withdrawal by Subject|0|||
161894451|NCT04313400|584660985|FG005|Overall Study|Withdrawal by Subject|4|||
161894452|NCT04313400|584660986|FG006|Overall Study|Withdrawal by Subject|1|||
161665050|NCT05559099|583826418|FG000|Overall Study|Lost to Follow-up|0|||
161665051|NCT05559099|583826419|FG001|Overall Study|Lost to Follow-up|2|||
161665052|NCT05559099|583826418|FG000|Overall Study|Adverse Event|1|||
161665053|NCT05559099|583826419|FG001|Overall Study|Adverse Event|1|||
161665054|NCT04018092|583826420|FG000|Overall Study|Withdrawal by Subject|1|||
161665055|NCT04018092|583826421|FG001|Overall Study|Withdrawal by Subject|1|||
161665056|NCT04018092|583826420|FG000|Overall Study|Withdrawal by Subject|1|||
161665057|NCT04018092|583826421|FG001|Overall Study|Withdrawal by Subject|1|||
161665058|NCT04218084|583826422|FG000|Overall Study|Adverse Event|7|||
161665059|NCT04218084|583826423|FG001|Overall Study|Adverse Event|2|||
161894453|NCT04313400|584660980|FG000|Overall Study|Adverse Event|0|||
161894454|NCT04313400|584660981|FG001|Overall Study|Adverse Event|0|||
161894455|NCT04313400|584660982|FG002|Overall Study|Adverse Event|0|||
161894456|NCT04313400|584660983|FG003|Overall Study|Adverse Event|0|||
161894457|NCT04313400|584660984|FG004|Overall Study|Adverse Event|0|||
161665060|NCT04218084|583826422|FG000|Overall Study|Withdrawal of Consent|4|||
161665061|NCT04218084|583826423|FG001|Overall Study|Withdrawal of Consent|5|||
161665062|NCT04218084|583826422|FG000|Overall Study|Physician Decision|1|||
161665063|NCT04218084|583826423|FG001|Overall Study|Physician Decision|1|||
161665064|NCT04218084|583826422|FG000|Overall Study|Lost to Follow-up|1|||
161665065|NCT04218084|583826423|FG001|Overall Study|Lost to Follow-up|1|||
161665066|NCT04218084|583826422|FG000|Overall Study|Non-compliance with study drug|1|||
161894458|NCT04313400|584660985|FG005|Overall Study|Adverse Event|1|||
161894459|NCT04313400|584660986|FG006|Overall Study|Adverse Event|0|||
161665067|NCT04218084|583826423|FG001|Overall Study|Non-compliance with study drug|1|||
161665068|NCT04218084|583826422|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
161665069|NCT04218084|583826423|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
161665070|NCT04218084|583826422|FG000|Overall Study|Other|0|||
161665071|NCT04218084|583826423|FG001|Overall Study|Other|1|||
161665072|NCT04218084|583826422|FG000|Overall Study|Ongoing at data cut-off date|62|||
161665073|NCT04218084|583826423|FG001|Overall Study|Ongoing at data cut-off date|58|||
161665074|NCT06469242|583826424|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
161665075|NCT06469242|583826425|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
161665076|NCT06469242|583826424|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
161665077|NCT06469242|583826425|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
161665078|NCT05041101|583826426|FG000|Overall Study|Adverse Event|1|||
161665079|NCT05041101|583826427|FG001|Overall Study|Adverse Event|0|||
161665080|NCT05041101|583826428|FG002|Overall Study|Adverse Event|0|||
161665081|NCT05041101|583826426|FG000|Overall Study|Diease Progression|5|||
161665082|NCT05041101|583826427|FG001|Overall Study|Diease Progression|0|||
161665083|NCT05041101|583826428|FG002|Overall Study|Diease Progression|0|||
161665084|NCT01205152|583826429|FG000|Overall Study|Death|1|||
161665085|NCT02783768|583826430|FG000|Overall Study|Lost to Follow-up|1|||
161665086|NCT02783768|583826431|FG001|Overall Study|Lost to Follow-up|0|||
161665087|NCT02208999|583826432|FG000|Overall Study|Lost to Follow-up|1|||
161665088|NCT00319839|583826433|FG000|Overall Study|Adverse Event|5|||
161665089|NCT00319839|583826433|FG000|Overall Study|Withdrawal by Subject|1|||
161665090|NCT00986674|583826434|FG000|Overall Study|Lack of Efficacy|28|||
161665091|NCT00986674|583826435|FG001|Overall Study|Lack of Efficacy|25|||
161665092|NCT00986674|583826436|FG002|Overall Study|Lack of Efficacy|23|||
161665093|NCT00986674|583826434|FG000|Overall Study|Adverse Event|4|||
161665094|NCT00986674|583826435|FG001|Overall Study|Adverse Event|8|||
161665095|NCT00986674|583826436|FG002|Overall Study|Adverse Event|9|||
161665096|NCT00986674|583826434|FG000|Overall Study|Death|5|||
161665097|NCT00986674|583826435|FG001|Overall Study|Death|0|||
161665098|NCT00986674|583826436|FG002|Overall Study|Death|4|||
161665099|NCT00986674|583826434|FG000|Overall Study|Withdrawal by Subject|6|||
161665100|NCT00986674|583826435|FG001|Overall Study|Withdrawal by Subject|2|||
161665101|NCT00986674|583826436|FG002|Overall Study|Withdrawal by Subject|1|||
161665102|NCT00986674|583826434|FG000|Overall Study|alternative therapy|0|||
161665103|NCT00986674|583826435|FG001|Overall Study|alternative therapy|0|||
161665104|NCT00986674|583826436|FG002|Overall Study|alternative therapy|1|||
161665105|NCT00986674|583826434|FG000|Overall Study|not start protocol therapy|4|||
161665106|NCT00986674|583826435|FG001|Overall Study|not start protocol therapy|3|||
161665107|NCT00986674|583826436|FG002|Overall Study|not start protocol therapy|1|||
161665108|NCT00986674|583826434|FG000|Overall Study|unknown/not specify|0|||
161665109|NCT00986674|583826435|FG001|Overall Study|unknown/not specify|7|||
161665110|NCT00986674|583826436|FG002|Overall Study|unknown/not specify|9|||
161665111|NCT01853137|583826437|FG000|Overall Study|Lost to Follow-up|4|||
161665112|NCT01853137|583826438|FG001|Overall Study|Lost to Follow-up|1|||
161665113|NCT00842985|583826439|FG000|Screening|Did not meet entrance requirements|27|||
161665114|NCT00842985|583826439|FG000|First Intervention|Withdrawal by Subject|3|||
161665115|NCT00842985|583826439|FG000|First Intervention|Protocol Violation|3|||
161665116|NCT00842985|583826439|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
161665117|NCT00842985|583826439|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
161665118|NCT01037244|583826440|FG000|Overall Study|Adverse Event|3|||
161665119|NCT01037244|583826441|FG001|Overall Study|Adverse Event|2|||
161665120|NCT01037244|583826442|FG002|Overall Study|Adverse Event|6|||
161665121|NCT01037244|583826443|FG003|Overall Study|Adverse Event|3|||
161665122|NCT01037244|583826440|FG000|Overall Study|Lack of Efficacy|1|||
161665123|NCT01037244|583826441|FG001|Overall Study|Lack of Efficacy|1|||
161665124|NCT01037244|583826442|FG002|Overall Study|Lack of Efficacy|0|||
161665125|NCT01037244|583826443|FG003|Overall Study|Lack of Efficacy|1|||
161665126|NCT01037244|583826440|FG000|Overall Study|Lost to Follow-up|3|||
161665127|NCT01037244|583826441|FG001|Overall Study|Lost to Follow-up|3|||
161894460|NCT04313400|584660980|FG000|Overall Study|Lost to Follow-up|0|||
161894461|NCT04313400|584660981|FG001|Overall Study|Lost to Follow-up|0|||
161665128|NCT01037244|583826442|FG002|Overall Study|Lost to Follow-up|4|||
161665129|NCT01037244|583826443|FG003|Overall Study|Lost to Follow-up|4|||
161665130|NCT01037244|583826440|FG000|Overall Study|Withdrawal by Subject|1|||
161665131|NCT01037244|583826441|FG001|Overall Study|Withdrawal by Subject|5|||
161665132|NCT01037244|583826442|FG002|Overall Study|Withdrawal by Subject|3|||
161665133|NCT01037244|583826443|FG003|Overall Study|Withdrawal by Subject|5|||
161665134|NCT01037244|583826440|FG000|Overall Study|Partner Withdrew Consent|2|||
161665135|NCT01037244|583826441|FG001|Overall Study|Partner Withdrew Consent|1|||
161665136|NCT01037244|583826442|FG002|Overall Study|Partner Withdrew Consent|0|||
161665137|NCT01037244|583826443|FG003|Overall Study|Partner Withdrew Consent|0|||
161665138|NCT01037244|583826440|FG000|Overall Study|Various|3|||
161665139|NCT01037244|583826441|FG001|Overall Study|Various|2|||
161665140|NCT01037244|583826442|FG002|Overall Study|Various|1|||
161665141|NCT01037244|583826443|FG003|Overall Study|Various|1|||
161665142|NCT00690820|583826444|FG000|Period 1|Withdrawal by Subject|0|||
161665143|NCT00690820|583826445|FG001|Period 1|Withdrawal by Subject|1|||
161665144|NCT00848926|583826446|FG000|Treatment Period|Progressive disease|45|||
161665145|NCT00848926|583826446|FG000|Treatment Period|Adverse Event|20|||
161665146|NCT00848926|583826446|FG000|Treatment Period|Physician Decision|12|||
161665147|NCT00848926|583826446|FG000|Treatment Period|Withdrawal by Subject|7|||
161665148|NCT00848926|583826446|FG000|Follow-up Period|Lost to Follow-up|7|||
161665149|NCT00848926|583826446|FG000|Follow-up Period|Withdrawal by Subject|3|||
161665150|NCT00848926|583826446|FG000|Follow-up Period|Other|2|||
161665151|NCT04025580|583826447|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
161665152|NCT04025580|583826448|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
161665153|NCT04025580|583826449|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
161665154|NCT00966277|583826450|FG000|Overall Study|Withdrawal by Subject|3|||
161665155|NCT00966277|583826451|FG001|Overall Study|Withdrawal by Subject|0|||
161665156|NCT00966277|583826450|FG000|Overall Study|Ineligible|1|||
161665157|NCT00966277|583826451|FG001|Overall Study|Ineligible|3|||
161665158|NCT00966277|583826450|FG000|Overall Study|Treatment Plan Changed|0|||
161665159|NCT00966277|583826451|FG001|Overall Study|Treatment Plan Changed|1|||
161894462|NCT04313400|584660982|FG002|Overall Study|Lost to Follow-up|0|||
161894463|NCT04313400|584660983|FG003|Overall Study|Lost to Follow-up|0|||
161894464|NCT04313400|584660984|FG004|Overall Study|Lost to Follow-up|0|||
161894465|NCT04313400|584660985|FG005|Overall Study|Lost to Follow-up|1|||
161894466|NCT04313400|584660986|FG006|Overall Study|Lost to Follow-up|0|||
161894467|NCT02091414|584660987|FG000|Overall Study|Withdrawal by Subject|2|||
161894468|NCT02091414|584660987|FG000|Overall Study|Death|2|||
161894469|NCT02521792|584660990|FG000|Overall Study|Study Terminated|6|||
161894470|NCT00902746|584660991|FG000|Overall Study|Protocol Violation|7|||
161894471|NCT00902746|584660991|FG000|Overall Study|Withdrawal by Subject|16|||
161894472|NCT00902746|584660991|FG000|Overall Study|Adverse Event|8|||
161894473|NCT00902746|584660991|FG000|Overall Study|Lost to Follow-up|3|||
161894474|NCT00902746|584660991|FG000|Overall Study|Physician Decision|2|||
161894475|NCT02081001|584660992|FG000|Overall Study|Adverse Event|0|||
161894476|NCT02081001|584660993|FG001|Overall Study|Adverse Event|0|||
161894477|NCT02081001|584660994|FG002|Overall Study|Adverse Event|0|||
161894478|NCT02081001|584660995|FG003|Overall Study|Adverse Event|0|||
161894479|NCT02081001|584660996|FG004|Overall Study|Adverse Event|1|||
161894480|NCT02081001|584660997|FG005|Overall Study|Adverse Event|0|||
161894481|NCT02081001|584660998|FG006|Overall Study|Adverse Event|0|||
161894482|NCT02081001|584660999|FG007|Overall Study|Adverse Event|0|||
161894483|NCT02081001|584661000|FG008|Overall Study|Adverse Event|0|||
161894484|NCT02081001|584661001|FG009|Overall Study|Adverse Event|0|||
161894485|NCT02081001|584661002|FG010|Overall Study|Adverse Event|0|||
161894486|NCT02081001|584661003|FG011|Overall Study|Adverse Event|0|||
161894487|NCT02937636|584661004|FG000|Overall Study|Other (Not specified)|3|||
161894488|NCT02937636|584661005|FG001|Overall Study|Other (Not specified)|2|||
161894489|NCT00359294|584661006|FG000|Overall Study|Progressive disease|1|||
161894490|NCT00359294|584661007|FG001|Overall Study|Progressive disease|1|||
161894491|NCT00359294|584661008|FG002|Overall Study|Progressive disease|2|||
161894492|NCT00359294|584661009|FG003|Overall Study|Progressive disease|3|||
161894493|NCT00359294|584661010|FG004|Overall Study|Progressive disease|2|||
161894494|NCT00359294|584661006|FG000|Overall Study|Withdrawal by Subject|0|||
161894495|NCT00359294|584661007|FG001|Overall Study|Withdrawal by Subject|0|||
161894496|NCT00359294|584661008|FG002|Overall Study|Withdrawal by Subject|0|||
161894497|NCT00359294|584661009|FG003|Overall Study|Withdrawal by Subject|0|||
161894498|NCT00359294|584661010|FG004|Overall Study|Withdrawal by Subject|1|||
161894499|NCT00359294|584661006|FG000|Overall Study|Not treated|0|||
161894500|NCT00359294|584661007|FG001|Overall Study|Not treated|0|||
161894501|NCT00359294|584661008|FG002|Overall Study|Not treated|0|||
161894502|NCT00359294|584661009|FG003|Overall Study|Not treated|1|||
161894503|NCT00359294|584661010|FG004|Overall Study|Not treated|0|||
161894504|NCT00359294|584661006|FG000|Overall Study|Physician Decision|0|||
161894505|NCT00359294|584661007|FG001|Overall Study|Physician Decision|0|||
161894506|NCT00359294|584661008|FG002|Overall Study|Physician Decision|1|||
161894507|NCT00359294|584661009|FG003|Overall Study|Physician Decision|0|||
161894508|NCT00359294|584661010|FG004|Overall Study|Physician Decision|0|||
161894509|NCT04208412|584661011|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
161665160|NCT01249274|583826452|FG000|Overall Study|Lost to Follow-up|3|||
161665161|NCT01249274|583826453|FG001|Overall Study|Lost to Follow-up|4|||
161665162|NCT01249274|583826452|FG000|Overall Study|Received inpatient substance treatment|1|||
161665163|NCT01249274|583826453|FG001|Overall Study|Received inpatient substance treatment|2|||
161665164|NCT01498653|583826454|FG000|Overall Study|Adverse Event|2|||
161665165|NCT01498653|583826455|FG001|Overall Study|Adverse Event|2|||
161894510|NCT04208412|584661012|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
161665166|NCT01498653|583826454|FG000|Overall Study|Lack of Efficacy|12|||
161894511|NCT04208412|584661011|FG000|Overall Study|Withdrawal by Subject|1|||
161894512|NCT04208412|584661012|FG001|Overall Study|Withdrawal by Subject|0|||
161894513|NCT04208412|584661011|FG000|Overall Study|Lost to Follow-up|0|||
161665167|NCT01498653|583826455|FG001|Overall Study|Lack of Efficacy|26|||
161665168|NCT01498653|583826454|FG000|Overall Study|Protocol Violation|0|||
161665169|NCT01498653|583826455|FG001|Overall Study|Protocol Violation|4|||
161665170|NCT01498653|583826454|FG000|Overall Study|Lost to Follow-up|1|||
161665171|NCT01498653|583826455|FG001|Overall Study|Lost to Follow-up|0|||
161665172|NCT01498653|583826454|FG000|Overall Study|Physician Decision|2|||
161665173|NCT01498653|583826455|FG001|Overall Study|Physician Decision|0|||
161665174|NCT01498653|583826454|FG000|Overall Study|Withdrawal by Subject|2|||
161665175|NCT01498653|583826455|FG001|Overall Study|Withdrawal by Subject|3|||
161665176|NCT02070588|583826461|FG000|Overall Study|Withdrawal by Subject|29|||
161894514|NCT04208412|584661012|FG001|Overall Study|Lost to Follow-up|1|||
161894515|NCT03148067|584661014|FG000|Overall Study|Lost to Follow-up|3|||
161894516|NCT03148067|584661014|FG000|Overall Study|Death|1|||
161894517|NCT00435188|584661016|FG000|Overall Study|Death|1|||
161894518|NCT00435188|584661017|FG001|Overall Study|Death|6|||
161894519|NCT00435188|584661016|FG000|Overall Study|Withdrawal by Subject|16|||
161894520|NCT00435188|584661017|FG001|Overall Study|Withdrawal by Subject|11|||
161894521|NCT00435188|584661016|FG000|Overall Study|Lost to Follow-up|5|||
161894522|NCT00435188|584661017|FG001|Overall Study|Lost to Follow-up|6|||
161894523|NCT02912455|584661018|FG000|Overall Study|Withdrawal by Subject|0|||
161894524|NCT02912455|584661019|FG001|Overall Study|Withdrawal by Subject|1|||
161894525|NCT02912455|584661018|FG000|Overall Study|Lack of Efficacy|0|||
161894526|NCT02912455|584661019|FG001|Overall Study|Lack of Efficacy|1|||
161894527|NCT02912455|584661018|FG000|Overall Study|Lost to Follow-up|2|||
161894528|NCT02912455|584661019|FG001|Overall Study|Lost to Follow-up|1|||
161894529|NCT00073008|584661020|FG000|Overall Study|Missing|6|||
161894530|NCT00073008|584661021|FG001|Overall Study|Missing|6|||
161894531|NCT00073008|584661020|FG000|Overall Study|Withdrawal by Subject|2|||
161894532|NCT00073008|584661021|FG001|Overall Study|Withdrawal by Subject|2|||
161894533|NCT00073008|584661020|FG000|Overall Study|Lost to Follow-up|1|||
161894534|NCT00073008|584661021|FG001|Overall Study|Lost to Follow-up|3|||
161894535|NCT00073008|584661020|FG000|Overall Study|Death|46|||
161894536|NCT00073008|584661021|FG001|Overall Study|Death|47|||
161894537|NCT00073008|584661020|FG000|Overall Study|"Other selected on Case Report Form"|7|||
161894538|NCT00073008|584661021|FG001|Overall Study|"Other selected on Case Report Form"|5|||
161894539|NCT01778751|584661031|FG000|Overall Study|Lost to Follow-up|1|||
161894540|NCT01778751|584661032|FG001|Overall Study|Lost to Follow-up|0|||
161894541|NCT01778751|584661031|FG000|Overall Study|Withdrawal by Subject|0|||
161894542|NCT01778751|584661032|FG001|Overall Study|Withdrawal by Subject|2|||
161894543|NCT01778751|584661031|FG000|Overall Study|Transfered care|1|||
161894544|NCT01778751|584661032|FG001|Overall Study|Transfered care|0|||
161894545|NCT03337048|584661033|FG000|Overall Study|Withdrawal by Subject|2|||
161894546|NCT03337048|584661034|FG001|Overall Study|Withdrawal by Subject|0|||
161894547|NCT03337048|584661035|FG002|Overall Study|Withdrawal by Subject|0|||
161894548|NCT02669667|584661036|FG000|Overall Study|Lost to Follow-up|0|||
161894549|NCT02669667|584661037|FG001|Overall Study|Lost to Follow-up|0|||
161894550|NCT02669667|584661038|FG002|Overall Study|Lost to Follow-up|0|||
161894551|NCT02669667|584661039|FG003|Overall Study|Lost to Follow-up|0|||
161894552|NCT02669667|584661040|FG004|Overall Study|Lost to Follow-up|0|||
161894553|NCT02669667|584661041|FG005|Overall Study|Lost to Follow-up|1|||
161894554|NCT02669667|584661042|FG006|Overall Study|Lost to Follow-up|0|||
161894555|NCT00636961|584661056|FG000|Period 1|Administrative problems|1|||
161894556|NCT00636961|584661057|FG001|Period 1|Administrative problems|1|||
161894557|NCT00636961|584661056|FG000|Period 2|Adverse Event|1|||
161665177|NCT02070588|583826462|FG001|Overall Study|Withdrawal by Subject|1|||
161665178|NCT02070588|583826463|FG002|Overall Study|Withdrawal by Subject|0|||
161894558|NCT00636961|584661057|FG001|Period 2|Adverse Event|0|||
161894559|NCT01428115|584661061|FG000|Overall Study|Lack of Efficacy|3|||
161894560|NCT01428115|584661061|FG000|Overall Study|Lost to Follow-up|10|||
161894561|NCT01428115|584661061|FG000|Overall Study|Pregnancy|1|||
161894562|NCT01428115|584661061|FG000|Overall Study|Protocol Violation|3|||
161894563|NCT01428115|584661061|FG000|Overall Study|Withdrawal by Subject|4|||
161894564|NCT03755518|584661062|FG000|Overall Study|Lack of Efficacy|10|||
161894565|NCT03755518|584661062|FG000|Overall Study|Adverse Event|7|||
161894566|NCT03755518|584661062|FG000|Overall Study|Study Terminated by Sponsor|5|||
161894567|NCT03755518|584661062|FG000|Overall Study|Death|1|||
161894568|NCT03755518|584661062|FG000|Overall Study|Withdrawal by Subject|3|||
161894569|NCT03755518|584661062|FG000|Overall Study|Progressive Disease|4|||
161894570|NCT03755518|584661062|FG000|Overall Study|Bone Marrow Transplant|4|||
161894571|NCT03755518|584661062|FG000|Overall Study|Physicians Decision|1|||
161894572|NCT03755518|584661062|FG000|Overall Study|Relapse|1|||
161894573|NCT03755518|584661062|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
161894574|NCT03755518|584661062|FG000|Overall Study|Withdrawal by PI|1|||
161894575|NCT01714609|584661063|FG000|Overall Study|Protocol Violation|1|||
161894576|NCT01714609|584661064|FG001|Overall Study|Protocol Violation|0|||
161894577|NCT03403621|584661065|FG000|Overall Study|Withdrawal by Subject|2|||
161894578|NCT03403621|584661066|FG001|Overall Study|Withdrawal by Subject|2|||
161894579|NCT00395642|584661068|FG000|Overall Study|Death|4|||
161894580|NCT00395642|584661068|FG000|Overall Study|Lost to Follow-up|1|||
161894581|NCT00395642|584661068|FG000|Overall Study|Physician Decision|7|||
161894582|NCT00395642|584661068|FG000|Overall Study|Withdrawal by Subject|1|||
161894583|NCT02749799|584661072|FG000|Overall Study|Adverse Event|2|||
161894584|NCT02749799|584661072|FG000|Overall Study|Lost to Follow-up|4|||
161894585|NCT02749799|584661072|FG000|Overall Study|Protocol Violation|1|||
161894586|NCT02749799|584661072|FG000|Overall Study|Withdrawal by Subject|1|||
161894587|NCT02070978|584661073|FG000|Overall Study|Adverse Event|6|||
161894588|NCT02070978|584661074|FG001|Overall Study|Adverse Event|2|||
161894589|NCT02070978|584661075|FG002|Overall Study|Adverse Event|0|||
161894590|NCT02070978|584661073|FG000|Overall Study|Lost to Follow-up|1|||
161894591|NCT02070978|584661074|FG001|Overall Study|Lost to Follow-up|3|||
161894592|NCT02070978|584661075|FG002|Overall Study|Lost to Follow-up|4|||
161894593|NCT02070978|584661073|FG000|Overall Study|Withdrawal by Subject|3|||
161894594|NCT02070978|584661074|FG001|Overall Study|Withdrawal by Subject|5|||
161894595|NCT02070978|584661075|FG002|Overall Study|Withdrawal by Subject|3|||
161894596|NCT02070978|584661073|FG000|Overall Study|Protocol Violation|1|||
161894597|NCT02070978|584661074|FG001|Overall Study|Protocol Violation|0|||
161894598|NCT02070978|584661075|FG002|Overall Study|Protocol Violation|3|||
161894599|NCT02070978|584661073|FG000|Overall Study|Lack of Efficacy|0|||
161894600|NCT02070978|584661074|FG001|Overall Study|Lack of Efficacy|1|||
161894601|NCT02070978|584661075|FG002|Overall Study|Lack of Efficacy|0|||
161894602|NCT02070978|584661073|FG000|Overall Study|Death|0|||
161894603|NCT02070978|584661074|FG001|Overall Study|Death|0|||
161894604|NCT02070978|584661075|FG002|Overall Study|Death|2|||
161894605|NCT02070978|584661073|FG000|Overall Study|Un-specified|3|||
161894606|NCT02070978|584661074|FG001|Overall Study|Un-specified|2|||
161894607|NCT02070978|584661075|FG002|Overall Study|Un-specified|2|||
161894608|NCT02070978|584661073|FG000|Overall Study|Terminated by Sponsor|33|||
161894609|NCT02070978|584661074|FG001|Overall Study|Terminated by Sponsor|40|||
161894610|NCT02070978|584661075|FG002|Overall Study|Terminated by Sponsor|39|||
161894611|NCT03951753|584661076|FG000|Overall Study|Adverse Event|1|||
161894612|NCT03951753|584661077|FG001|Overall Study|Adverse Event|0|||
161894613|NCT03951753|584661078|FG002|Overall Study|Adverse Event|3|||
161665179|NCT02070588|583826461|FG000|Overall Study|Writhdrawal due to early termination|9|||
161665180|NCT02070588|583826462|FG001|Overall Study|Writhdrawal due to early termination|0|||
161665181|NCT02070588|583826463|FG002|Overall Study|Writhdrawal due to early termination|0|||
161665182|NCT02070588|583826461|FG000|Overall Study|Adverse Event|1|||
161665183|NCT02070588|583826462|FG001|Overall Study|Adverse Event|0|||
161665184|NCT02070588|583826463|FG002|Overall Study|Adverse Event|0|||
161665185|NCT03421431|583826464|FG000|Overall Study|Adverse Event|2|||
161665186|NCT03421431|583826465|FG001|Overall Study|Adverse Event|1|||
161665187|NCT03421431|583826466|FG002|Overall Study|Adverse Event|12|||
161665188|NCT03421431|583826464|FG000|Overall Study|Lost to Follow-up|1|||
161665189|NCT03421431|583826465|FG001|Overall Study|Lost to Follow-up|1|||
161665190|NCT03421431|583826466|FG002|Overall Study|Lost to Follow-up|1|||
161894614|NCT03951753|584661076|FG000|Overall Study|Withdrawal by Subject|3|||
161894615|NCT03951753|584661077|FG001|Overall Study|Withdrawal by Subject|1|||
161894616|NCT03951753|584661078|FG002|Overall Study|Withdrawal by Subject|0|||
161894617|NCT03951753|584661076|FG000|Overall Study|Lost to Follow-up|0|||
161894618|NCT03951753|584661077|FG001|Overall Study|Lost to Follow-up|0|||
161894619|NCT03951753|584661078|FG002|Overall Study|Lost to Follow-up|1|||
161894620|NCT01905592|584661081|FG000|Overall Study|Disease Progression|51|||
161894621|NCT01905592|584661082|FG001|Overall Study|Disease Progression|110|||
161894622|NCT01905592|584661081|FG000|Overall Study|Toxicity|1|||
161894623|NCT01905592|584661082|FG001|Overall Study|Toxicity|16|||
161894624|NCT01905592|584661081|FG000|Overall Study|Physician Decision|0|||
161894625|NCT01905592|584661082|FG001|Overall Study|Physician Decision|2|||
161894626|NCT01905592|584661081|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
161665191|NCT03421431|583826464|FG000|Overall Study|Withdrawal by Subject|3|||
161665192|NCT03421431|583826465|FG001|Overall Study|Withdrawal by Subject|2|||
161665193|NCT03421431|583826466|FG002|Overall Study|Withdrawal by Subject|1|||
161665194|NCT03421431|583826464|FG000|Overall Study|Protocol Violation|0|||
161894627|NCT01905592|584661082|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
161894628|NCT01905592|584661081|FG000|Overall Study|Protocol Violation|0|||
161894629|NCT01905592|584661082|FG001|Overall Study|Protocol Violation|1|||
161894630|NCT01905592|584661081|FG000|Overall Study|Sponsor's decision|1|||
161894631|NCT01905592|584661082|FG001|Overall Study|Sponsor's decision|1|||
161894632|NCT01905592|584661081|FG000|Overall Study|Not treated|7|||
161894633|NCT01905592|584661082|FG001|Overall Study|Not treated|3|||
161894634|NCT01905592|584661081|FG000|Overall Study|Withdrawal by Subject|10|||
161894635|NCT01905592|584661082|FG001|Overall Study|Withdrawal by Subject|2|||
161894636|NCT02669043|584661083|FG000|Overall Study|Didn't meet I/E criteria|4|||
161894637|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
161894638|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894639|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894640|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
161894641|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
161894642|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
161894643|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
161894644|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894645|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894646|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894647|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894648|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894649|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894650|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894651|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894652|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161894653|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894654|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161894655|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894656|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894657|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161894658|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894659|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894660|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894661|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894662|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894663|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894664|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894665|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
161894666|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894667|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894668|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894669|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161665195|NCT03421431|583826465|FG001|Overall Study|Protocol Violation|1|||
161665196|NCT03421431|583826466|FG002|Overall Study|Protocol Violation|0|||
161665197|NCT03421431|583826464|FG000|Overall Study|Participant met Stopping Rules|0|||
161665198|NCT03421431|583826465|FG001|Overall Study|Participant met Stopping Rules|1|||
161665199|NCT03421431|583826466|FG002|Overall Study|Participant met Stopping Rules|0|||
161665200|NCT02216357|583826470|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
161665201|NCT02216357|583826471|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
161665202|NCT00141726|583826473|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
161665203|NCT00235326|583826478|FG000|Overall Study|Lost to Follow-up|746|||
161665204|NCT00235326|583826479|FG001|Overall Study|Lost to Follow-up|1400|||
161665205|NCT01790126|583826482|FG000|Overall Study|PSA Progression|12|||
161665206|NCT01790126|583826483|FG001|Overall Study|PSA Progression|16|||
161665207|NCT01790126|583826484|FG002|Overall Study|PSA Progression|16|||
161665208|NCT01790126|583826482|FG000|Overall Study|Other|5|||
161665209|NCT01790126|583826483|FG001|Overall Study|Other|4|||
161665210|NCT01790126|583826484|FG002|Overall Study|Other|8|||
161665211|NCT01790126|583826482|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
161665212|NCT01790126|583826483|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
161665213|NCT01790126|583826484|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
161894670|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894671|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894672|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161665214|NCT01790126|583826482|FG000|Overall Study|Withdrawal by Physician|1|||
161665215|NCT01790126|583826483|FG001|Overall Study|Withdrawal by Physician|1|||
161665216|NCT01790126|583826484|FG002|Overall Study|Withdrawal by Physician|2|||
161665217|NCT01790126|583826482|FG000|Overall Study|Withdrawal by Subject|3|||
161665218|NCT01790126|583826483|FG001|Overall Study|Withdrawal by Subject|1|||
161665219|NCT01790126|583826484|FG002|Overall Study|Withdrawal by Subject|2|||
161665220|NCT01790126|583826482|FG000|Overall Study|Lost to Follow-up|1|||
161665221|NCT01790126|583826483|FG001|Overall Study|Lost to Follow-up|0|||
161665222|NCT01790126|583826484|FG002|Overall Study|Lost to Follow-up|1|||
161665223|NCT01790126|583826482|FG000|Overall Study|Adverse Event|0|||
161665224|NCT01790126|583826483|FG001|Overall Study|Adverse Event|2|||
161665225|NCT01790126|583826484|FG002|Overall Study|Adverse Event|0|||
161665226|NCT01790126|583826482|FG000|Overall Study|Death|2|||
161665227|NCT01790126|583826483|FG001|Overall Study|Death|0|||
161665228|NCT01790126|583826484|FG002|Overall Study|Death|0|||
161665229|NCT01790126|583826482|FG000|Overall Study|Radiographic Progression|3|||
161894673|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894674|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894675|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894676|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894677|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894678|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894679|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
161894680|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
161894681|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
161894682|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
161894683|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
161894684|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
161894685|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
161894686|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
161894687|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
161894688|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
161894689|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
161894690|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
161894691|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
161894692|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
161894693|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
161894694|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
161894695|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
161894696|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
161894697|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
161894698|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
161894699|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
161894700|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
161894701|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
161894702|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
161894703|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
161894704|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
161894705|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
161894706|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
161894707|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894708|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894709|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894710|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894711|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894712|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894713|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894714|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161894715|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161894716|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894717|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894718|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161665230|NCT01790126|583826483|FG001|Overall Study|Radiographic Progression|1|||
161665231|NCT01790126|583826484|FG002|Overall Study|Radiographic Progression|0|||
161894719|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161894720|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161665232|NCT00455325|583826485|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
161665233|NCT00455325|583826486|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
161665234|NCT00455325|583826487|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
161665235|NCT00455325|583826488|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
161665236|NCT00455325|583826485|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
161665237|NCT00455325|583826486|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
161665238|NCT00455325|583826487|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
161665239|NCT00455325|583826488|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
161665240|NCT00455325|583826485|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
161665241|NCT00455325|583826486|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
161665242|NCT00455325|583826487|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
161665243|NCT00455325|583826488|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
161665244|NCT00455325|583826485|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
161665245|NCT00455325|583826486|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
161665246|NCT00455325|583826487|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
161665247|NCT00455325|583826488|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
161665248|NCT00455325|583826485|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
161665249|NCT00455325|583826486|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
161665250|NCT00455325|583826487|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
161665251|NCT00455325|583826488|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
161665252|NCT00455325|583826485|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
161665253|NCT00455325|583826486|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
161665254|NCT00455325|583826487|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
161665255|NCT00455325|583826488|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
161665256|NCT00455325|583826485|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
161665257|NCT00455325|583826486|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
161665258|NCT00455325|583826487|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
161665259|NCT00455325|583826488|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
161665260|NCT02435966|583826489|FG000|Overall Study|Withdrawal by Subject|0|||
161665261|NCT02435966|583826490|FG001|Overall Study|Withdrawal by Subject|1|||
161665262|NCT02435966|583826491|FG002|Overall Study|Withdrawal by Subject|0|||
161665263|NCT00928746|583826495|FG000|Overall Study|Adverse Event|2|||
161665264|NCT00928746|583826495|FG000|Overall Study|Protocol Violation|1|||
161665265|NCT00928746|583826495|FG000|Overall Study|Withdrawal by Subject|1|||
161665266|NCT00928746|583826495|FG000|Overall Study|Other|2|||
161665267|NCT02745392|583826500|FG000|Overall Study|Lost to Follow-up|0|||
161665268|NCT02745392|583826501|FG001|Overall Study|Lost to Follow-up|1|||
161665269|NCT02745392|583826502|FG002|Overall Study|Lost to Follow-up|0|||
161665270|NCT02745392|583826503|FG003|Overall Study|Lost to Follow-up|0|||
161665271|NCT02004353|583826508|FG000|Overall Study|Voluntary participation|1334|||
161665272|NCT01691768|583826509|FG000|Overall Study|Death|0|||
161665273|NCT01691768|583826510|FG001|Overall Study|Death|2|||
161665274|NCT01691768|583826509|FG000|Overall Study|Lost to Follow-up|4|||
161665275|NCT01691768|583826510|FG001|Overall Study|Lost to Follow-up|3|||
161665276|NCT01691768|583826509|FG000|Overall Study|Withdrawal by Subject|10|||
161665277|NCT01691768|583826510|FG001|Overall Study|Withdrawal by Subject|9|||
161665278|NCT01691768|583826509|FG000|Overall Study|Relocated|0|||
161665279|NCT01691768|583826510|FG001|Overall Study|Relocated|1|||
161665280|NCT01691768|583826509|FG000|Overall Study|Investigator decision|1|||
161665281|NCT01691768|583826510|FG001|Overall Study|Investigator decision|1|||
161665282|NCT02481947|583826521|FG000|Overall Study|Withdrawal by Subject|24|||
161665283|NCT02481947|583826522|FG001|Overall Study|Withdrawal by Subject|10|||
161665284|NCT02481947|583826521|FG000|Overall Study|Lost to Follow-up|11|||
161665285|NCT02481947|583826522|FG001|Overall Study|Lost to Follow-up|5|||
161665286|NCT02481947|583826521|FG000|Overall Study|Adverse Event|6|||
161665287|NCT02481947|583826522|FG001|Overall Study|Adverse Event|11|||
161665288|NCT02481947|583826521|FG000|Overall Study|Physician Decision|4|||
161665289|NCT02481947|583826522|FG001|Overall Study|Physician Decision|5|||
161665290|NCT02481947|583826521|FG000|Overall Study|Protocol Violation|1|||
161665291|NCT02481947|583826522|FG001|Overall Study|Protocol Violation|5|||
161665292|NCT01007448|583826523|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
161665293|NCT01007448|583826524|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
161665294|NCT01007448|583826523|FG000|Overall Study|Staph Skin Infection Flare|1|||
161665295|NCT01007448|583826524|FG001|Overall Study|Staph Skin Infection Flare|0|||
161665296|NCT01007448|583826523|FG000|Overall Study|Participant Leaving the Country|1|||
161665297|NCT01007448|583826524|FG001|Overall Study|Participant Leaving the Country|0|||
161665298|NCT01007448|583826523|FG000|Overall Study|Participant Given Prohibited Medication|1|||
161665299|NCT01007448|583826524|FG001|Overall Study|Participant Given Prohibited Medication|0|||
161665300|NCT01007448|583826523|FG000|Overall Study|Progressive Disease|1|||
161665301|NCT01007448|583826524|FG001|Overall Study|Progressive Disease|2|||
161665302|NCT01007448|583826523|FG000|Overall Study|Lack of Efficacy|2|||
161665303|NCT01007448|583826524|FG001|Overall Study|Lack of Efficacy|0|||
161665304|NCT01007448|583826523|FG000|Overall Study|Withdrawal by Subject|2|||
161665305|NCT01007448|583826524|FG001|Overall Study|Withdrawal by Subject|3|||
161665306|NCT01007448|583826523|FG000|Overall Study|Adverse Event|1|||
161665307|NCT01007448|583826524|FG001|Overall Study|Adverse Event|4|||
161665308|NCT02751320|583826525|FG000|Overall Study|Adverse Event|2|||
161665309|NCT02751320|583826525|FG000|Overall Study|Withdrawal by Subject|1|||
161665310|NCT03426605|583826526|FG000|Overall Study|AML relapse or progression|2|||
161665311|NCT03426605|583826527|FG001|Overall Study|AML relapse or progression|1|||
161665312|NCT03426605|583826528|FG002|Overall Study|AML relapse or progression|2|||
161665313|NCT03426605|583826529|FG003|Overall Study|AML relapse or progression|2|||
161665314|NCT03426605|583826526|FG000|Overall Study|Treatment failure|3|||
161665315|NCT03426605|583826527|FG001|Overall Study|Treatment failure|2|||
161665316|NCT03426605|583826528|FG002|Overall Study|Treatment failure|0|||
161665317|NCT03426605|583826529|FG003|Overall Study|Treatment failure|0|||
161665318|NCT03426605|583826526|FG000|Overall Study|Adverse Event|1|||
161665319|NCT03426605|583826527|FG001|Overall Study|Adverse Event|0|||
161665320|NCT03426605|583826528|FG002|Overall Study|Adverse Event|1|||
161665321|NCT03426605|583826529|FG003|Overall Study|Adverse Event|1|||
161665322|NCT03426605|583826526|FG000|Overall Study|Withdrawal by Subject|0|||
161665323|NCT03426605|583826527|FG001|Overall Study|Withdrawal by Subject|0|||
161665324|NCT03426605|583826528|FG002|Overall Study|Withdrawal by Subject|1|||
161665325|NCT03426605|583826529|FG003|Overall Study|Withdrawal by Subject|1|||
161665326|NCT01920854|583826532|FG000|Overall Study|Withdrawal by Subject|1|||
161665327|NCT01920854|583826533|FG001|Overall Study|Withdrawal by Subject|0|||
161665328|NCT01920854|583826534|FG002|Overall Study|Withdrawal by Subject|0|||
161665329|NCT01920854|583826535|FG003|Overall Study|Withdrawal by Subject|0|||
161665330|NCT01920854|583826536|FG004|Overall Study|Withdrawal by Subject|1|||
161665331|NCT01920854|583826537|FG005|Overall Study|Withdrawal by Subject|0|||
161665332|NCT01920854|583826538|FG006|Overall Study|Withdrawal by Subject|1|||
161665333|NCT01886378|583826539|FG000|Overall Study|Adverse Event|1|||
161665334|NCT01886378|583826539|FG000|Overall Study|Withdrawal by Subject|4|||
161665335|NCT03333837|583826549|FG000|Overall Study|Adverse Event|2|||
161665336|NCT03333837|583826550|FG001|Overall Study|Adverse Event|1|||
161665337|NCT03333837|583826551|FG002|Overall Study|Adverse Event|1|||
161665338|NCT03333837|583826552|FG003|Overall Study|Adverse Event|1|||
161665339|NCT03333837|583826553|FG004|Overall Study|Adverse Event|0|||
161665340|NCT03333837|583826549|FG000|Overall Study|Caregiver withdrew|0|||
161665341|NCT03333837|583826550|FG001|Overall Study|Caregiver withdrew|2|||
161665342|NCT03333837|583826551|FG002|Overall Study|Caregiver withdrew|1|||
161665343|NCT03333837|583826552|FG003|Overall Study|Caregiver withdrew|0|||
161665344|NCT03333837|583826553|FG004|Overall Study|Caregiver withdrew|0|||
161665345|NCT03333837|583826549|FG000|Overall Study|Withdrawal by Subject|0|||
161665346|NCT03333837|583826550|FG001|Overall Study|Withdrawal by Subject|0|||
161665347|NCT03333837|583826551|FG002|Overall Study|Withdrawal by Subject|1|||
161665348|NCT03333837|583826552|FG003|Overall Study|Withdrawal by Subject|1|||
161665349|NCT03333837|583826553|FG004|Overall Study|Withdrawal by Subject|3|||
161665350|NCT03333837|583826549|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161665351|NCT03333837|583826550|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161665352|NCT03333837|583826551|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
161665353|NCT03333837|583826552|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161665354|NCT03333837|583826553|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161665355|NCT02232243|583826557|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
161665356|NCT02232243|583826558|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
161665357|NCT02232243|583826559|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
161665358|NCT00704405|583826560|FG000|Overall Study (NC Population)|Adverse Event|1|||
161665359|NCT00704405|583826561|FG001|Overall Study (NC Population)|Adverse Event|0|||
161665360|NCT00704405|583826562|FG002|Overall Study (NC Population)|Adverse Event|0|||
161665361|NCT00704405|583826563|FG003|Overall Study (NC Population)|Adverse Event|0|||
161665362|NCT00704405|583826564|FG004|Overall Study (NC Population)|Adverse Event|0|||
161665363|NCT00704405|583826560|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
161665364|NCT00704405|583826561|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
161665365|NCT00704405|583826562|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
161665366|NCT00704405|583826563|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
161665367|NCT00704405|583826564|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
161665368|NCT00704405|583826560|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
161665369|NCT00704405|583826561|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
161665370|NCT00704405|583826562|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
161665371|NCT00704405|583826563|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
161665372|NCT00704405|583826564|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
161665373|NCT00704405|583826560|FG000|Overall Study (NC Population)|Other|0|||
161665374|NCT00704405|583826561|FG001|Overall Study (NC Population)|Other|0|||
161665375|NCT00704405|583826562|FG002|Overall Study (NC Population)|Other|0|||
161665376|NCT00704405|583826563|FG003|Overall Study (NC Population)|Other|0|||
161665377|NCT00704405|583826564|FG004|Overall Study (NC Population)|Other|1|||
161665378|NCT00704405|583826560|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
161665379|NCT00704405|583826561|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
161665380|NCT00704405|583826562|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
161665381|NCT00704405|583826563|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
161665382|NCT00704405|583826564|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
161665383|NCT00704405|583826560|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
161665384|NCT00704405|583826561|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
161665385|NCT00704405|583826562|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
161665386|NCT00704405|583826563|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
161665387|NCT00704405|583826564|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
161665388|NCT02374671|583826565|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
161665389|NCT02374671|583826566|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
161665390|NCT02374671|583826567|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
161665391|NCT02374671|583826565|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
161665392|NCT02374671|583826566|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
161665393|NCT02374671|583826567|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
161665394|NCT02374671|583826565|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
161665395|NCT02374671|583826566|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
161665396|NCT02374671|583826567|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
161665397|NCT02374671|583826565|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
161665398|NCT02374671|583826566|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
161665399|NCT02374671|583826567|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
161665400|NCT02374671|583826565|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
161665401|NCT02374671|583826566|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161665402|NCT02374671|583826567|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161665403|NCT03169101|583826571|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
161665404|NCT03169101|583826572|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
161665405|NCT03169101|583826573|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
161665406|NCT03169101|583826574|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
161665407|NCT02641496|583826577|FG000|Overall Study|Lost to Follow-up|13|||
161665408|NCT02641496|583826578|FG001|Overall Study|Lost to Follow-up|12|||
161665409|NCT02641496|583826577|FG000|Overall Study|Withdrawal by Subject|1|||
161665410|NCT02641496|583826578|FG001|Overall Study|Withdrawal by Subject|0|||
161665411|NCT01912456|583828342|FG000|Period 1|Physician Decision|0|||
161665412|NCT01912456|583828343|FG001|Period 1|Physician Decision|0|||
161665413|NCT01912456|583828344|FG002|Period 1|Physician Decision|1|||
161665414|NCT01912456|583828345|FG003|Period 1|Physician Decision|0|||
161665415|NCT01912456|583828342|FG000|Period 1|non-compliance|1|||
161665416|NCT01912456|583828343|FG001|Period 1|non-compliance|0|||
161665417|NCT01912456|583828344|FG002|Period 1|non-compliance|0|||
161665418|NCT01912456|583828345|FG003|Period 1|non-compliance|1|||
161665419|NCT01912456|583828342|FG000|Period 1|Adverse Event|1|||
161665420|NCT01912456|583828343|FG001|Period 1|Adverse Event|0|||
161665421|NCT01912456|583828344|FG002|Period 1|Adverse Event|0|||
161665422|NCT01912456|583828345|FG003|Period 1|Adverse Event|1|||
161665423|NCT01912456|583828342|FG000|Period 1|Withdrawal by Subject|0|||
161665424|NCT01912456|583828343|FG001|Period 1|Withdrawal by Subject|1|||
161665425|NCT01912456|583828344|FG002|Period 1|Withdrawal by Subject|1|||
161665426|NCT01912456|583828345|FG003|Period 1|Withdrawal by Subject|1|||
161665427|NCT01912456|583828342|FG000|Period 2|Lack of Efficacy|0|||
161665428|NCT01912456|583828343|FG001|Period 2|Lack of Efficacy|2|||
161665429|NCT01912456|583828344|FG002|Period 2|Lack of Efficacy|0|||
161665430|NCT01912456|583828345|FG003|Period 2|Lack of Efficacy|0|||
161665431|NCT01912456|583828342|FG000|Period 2|Adverse Event|0|||
161665432|NCT01912456|583828343|FG001|Period 2|Adverse Event|0|||
161665433|NCT01912456|583828344|FG002|Period 2|Adverse Event|0|||
161665434|NCT01912456|583828345|FG003|Period 2|Adverse Event|1|||
161665435|NCT01340196|583828346|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
161665436|NCT00171704|583828352|FG000|Overall Study|Adverse Event|24|||
161665437|NCT00171704|583828353|FG001|Overall Study|Adverse Event|33|||
161665438|NCT00171704|583828352|FG000|Overall Study|Disease Progression|14|||
161665439|NCT00171704|583828353|FG001|Overall Study|Disease Progression|9|||
161665440|NCT00171704|583828352|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
161665441|NCT00171704|583828353|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
161665442|NCT00171704|583828352|FG000|Overall Study|Administrative Problems|2|||
161665443|NCT00171704|583828353|FG001|Overall Study|Administrative Problems|1|||
161665444|NCT00171704|583828352|FG000|Overall Study|Death|2|||
161665445|NCT00171704|583828353|FG001|Overall Study|Death|2|||
161665446|NCT00171704|583828352|FG000|Overall Study|Withdrawal by Subject|1|||
161665447|NCT00171704|583828353|FG001|Overall Study|Withdrawal by Subject|3|||
161665448|NCT00171704|583828352|FG000|Overall Study|Protocol Violation|0|||
161665449|NCT00171704|583828353|FG001|Overall Study|Protocol Violation|1|||
161665450|NCT00320541|583828357|FG000|Overall Study|Adverse Event|21|||
161665451|NCT00320541|583828358|FG001|Overall Study|Adverse Event|19|||
161665452|NCT00320541|583828357|FG000|Overall Study|Protocol Violation|0|||
161665453|NCT00320541|583828358|FG001|Overall Study|Protocol Violation|1|||
161665454|NCT00320541|583828357|FG000|Overall Study|Withdrawal by Subject|12|||
161665455|NCT00320541|583828358|FG001|Overall Study|Withdrawal by Subject|16|||
161665456|NCT00320541|583828357|FG000|Overall Study|Physician Decision|9|||
161665457|NCT00320541|583828358|FG001|Overall Study|Physician Decision|13|||
161894721|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894722|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894723|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894724|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894725|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894726|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894727|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894728|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894729|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161894730|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894731|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894732|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161894733|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894734|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161894735|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894736|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894737|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894738|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894739|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894740|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894741|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894742|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894743|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
161894744|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894745|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
161894746|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894747|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894748|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
161894749|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894750|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894751|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894752|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894753|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894754|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894755|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894756|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894757|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
161894758|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894759|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894760|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894761|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
161894762|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
161894763|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
161894764|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
161894765|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
161894766|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
161894767|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
161894768|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
161894769|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
161894770|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
161894771|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
161894772|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
161894773|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
161894774|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
161894775|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
161894776|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
161894777|NCT02109445|584661099|FG000|Overall Study|Symptomatic deterioration|2|||
161894778|NCT02109445|584661099|FG000|Overall Study|Adverse Event|1|||
161894779|NCT00966355|584661104|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
161894780|NCT00966355|584661105|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
161894781|NCT00966355|584661106|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
161894782|NCT00966355|584661104|FG000|Overall Study|newly diagnosed advanced HCC|11|||
161894783|NCT00966355|584661105|FG001|Overall Study|newly diagnosed advanced HCC|12|||
161894784|NCT00966355|584661106|FG002|Overall Study|newly diagnosed advanced HCC|10|||
161436029|NCT02266888|582991268|FG003|Overall Study|Death|2|||
161894785|NCT00966355|584661104|FG000|Overall Study|Lost to Follow-up|5|||
161894786|NCT00966355|584661105|FG001|Overall Study|Lost to Follow-up|4|||
161894787|NCT00966355|584661106|FG002|Overall Study|Lost to Follow-up|3|||
161894788|NCT00401193|584663456|FG000|Overall Study|Adverse Event|1|||
161894789|NCT00401193|584663457|FG001|Overall Study|Adverse Event|3|||
161894790|NCT00401193|584663458|FG002|Overall Study|Adverse Event|1|||
161894791|NCT00401193|584663456|FG000|Overall Study|Protocol Violation|3|||
161894792|NCT00401193|584663457|FG001|Overall Study|Protocol Violation|1|||
161894793|NCT00401193|584663458|FG002|Overall Study|Protocol Violation|1|||
161894794|NCT00401193|584663456|FG000|Overall Study|Lost to Follow-up|6|||
161894795|NCT00401193|584663457|FG001|Overall Study|Lost to Follow-up|5|||
161894796|NCT00401193|584663458|FG002|Overall Study|Lost to Follow-up|1|||
161894797|NCT00401193|584663456|FG000|Overall Study|Withdrawal by Subject|2|||
161894798|NCT00401193|584663457|FG001|Overall Study|Withdrawal by Subject|0|||
161894799|NCT00401193|584663458|FG002|Overall Study|Withdrawal by Subject|1|||
161894800|NCT00401193|584663456|FG000|Overall Study|Other Event|3|||
161894801|NCT00401193|584663457|FG001|Overall Study|Other Event|2|||
161894802|NCT00401193|584663458|FG002|Overall Study|Other Event|2|||
161894803|NCT04378569|584663462|FG000|Overall Study|Adverse Event|0|||
161894804|NCT04378569|584663463|FG001|Overall Study|Adverse Event|0|||
161894805|NCT04378569|584663464|FG002|Overall Study|Adverse Event|2|||
161894806|NCT04378569|584663465|FG003|Overall Study|Adverse Event|0|||
161894807|NCT04378569|584663466|FG004|Overall Study|Adverse Event|3|||
161779244|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
161779245|NCT00111007|584233892|FG000|Active Follow-up|Adverse Event|1|||
161779246|NCT00111007|584233893|FG001|Active Follow-up|Adverse Event|0|||
161779247|NCT00111007|584233892|FG000|Active Follow-up|Death|2|||
161779248|NCT00111007|584233893|FG001|Active Follow-up|Death|0|||
161779249|NCT00111007|584233892|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
161779250|NCT00111007|584233893|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
161779251|NCT00111007|584233892|FG000|Long Term Follow-up|Death|34|||
161779252|NCT00111007|584233893|FG001|Long Term Follow-up|Death|39|||
161779253|NCT00111007|584233892|FG000|Long Term Follow-up|Lost to Follow-up|1|||
161779254|NCT00111007|584233893|FG001|Long Term Follow-up|Lost to Follow-up|1|||
161779255|NCT00111007|584233892|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
161779256|NCT00111007|584233893|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
161779257|NCT00111007|584233892|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
161779258|NCT00111007|584233893|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
161779259|NCT00111007|584233892|FG000|Long Term Follow-up|Missing|10|||
161779260|NCT00111007|584233893|FG001|Long Term Follow-up|Missing|3|||
161779261|NCT01495793|584233894|FG000|Overall Study|Lost to Follow-up|1|||
161665458|NCT00320541|583828357|FG000|Overall Study|Other|3|||
161665459|NCT00320541|583828358|FG001|Overall Study|Other|4|||
161665460|NCT00320541|583828357|FG000|Overall Study|Sponsor Decision|2|||
161665461|NCT00320541|583828358|FG001|Overall Study|Sponsor Decision|1|||
161665462|NCT00320541|583828357|FG000|Overall Study|Death due to Study Disease|1|||
161665463|NCT00320541|583828358|FG001|Overall Study|Death due to Study Disease|3|||
161665464|NCT00320541|583828357|FG000|Overall Study|Death due to Adverse Event(s)|1|||
161665465|NCT00320541|583828358|FG001|Overall Study|Death due to Adverse Event(s)|0|||
161665466|NCT00320541|583828357|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
161665467|NCT00320541|583828358|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
161665468|NCT00655486|583828361|FG000|Overall Study|Adverse Event|10|||
161665469|NCT00655486|583828361|FG000|Overall Study|Lack of Efficacy|8|||
161665470|NCT00655486|583828361|FG000|Overall Study|Withdrawal by Subject|4|||
161665471|NCT00655486|583828361|FG000|Overall Study|Protocol Violation|1|||
161665472|NCT00655486|583828361|FG000|Overall Study|Unsatisfactory compliance|2|||
161894808|NCT04378569|584663467|FG005|Overall Study|Adverse Event|3|||
161894809|NCT04378569|584663462|FG000|Overall Study|Lost to Follow-up|0|||
161894810|NCT04378569|584663463|FG001|Overall Study|Lost to Follow-up|3|||
161894811|NCT04378569|584663464|FG002|Overall Study|Lost to Follow-up|1|||
161894812|NCT04378569|584663465|FG003|Overall Study|Lost to Follow-up|0|||
161894813|NCT04378569|584663466|FG004|Overall Study|Lost to Follow-up|1|||
161894814|NCT04378569|584663467|FG005|Overall Study|Lost to Follow-up|1|||
161894815|NCT04378569|584663462|FG000|Overall Study|Protocol Violation|0|||
161894816|NCT04378569|584663463|FG001|Overall Study|Protocol Violation|0|||
161894817|NCT04378569|584663464|FG002|Overall Study|Protocol Violation|0|||
161665473|NCT00655486|583828361|FG000|Overall Study|Other: Pregnancy|1|||
161665474|NCT00655486|583828361|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
161665475|NCT00655486|583828361|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
161665476|NCT00310037|583828362|FG000|Overall Study|Adverse Event|7|||
161665477|NCT00310037|583828363|FG001|Overall Study|Adverse Event|14|||
161665478|NCT00310037|583828362|FG000|Overall Study|Withdrawal by Subject|4|||
161894818|NCT04378569|584663465|FG003|Overall Study|Protocol Violation|0|||
161894819|NCT04378569|584663466|FG004|Overall Study|Protocol Violation|0|||
161894820|NCT04378569|584663467|FG005|Overall Study|Protocol Violation|1|||
161894821|NCT04378569|584663462|FG000|Overall Study|Withdrawal by Subject|0|||
161894822|NCT04378569|584663463|FG001|Overall Study|Withdrawal by Subject|6|||
161894823|NCT04378569|584663464|FG002|Overall Study|Withdrawal by Subject|7|||
161894824|NCT04378569|584663465|FG003|Overall Study|Withdrawal by Subject|4|||
161894825|NCT04378569|584663466|FG004|Overall Study|Withdrawal by Subject|5|||
161894826|NCT04378569|584663467|FG005|Overall Study|Withdrawal by Subject|4|||
161894827|NCT04378569|584663462|FG000|Overall Study|Lack of response|0|||
161894828|NCT04378569|584663463|FG001|Overall Study|Lack of response|0|||
161894829|NCT04378569|584663464|FG002|Overall Study|Lack of response|1|||
161894830|NCT04378569|584663465|FG003|Overall Study|Lack of response|0|||
161894831|NCT04378569|584663466|FG004|Overall Study|Lack of response|1|||
161894832|NCT04378569|584663467|FG005|Overall Study|Lack of response|1|||
161894833|NCT01844817|584663468|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
161894834|NCT01844817|584663469|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
161894835|NCT01844817|584663468|FG000|Treatment|Progressive Disease|27|||
161894836|NCT01844817|584663469|FG001|Treatment|Progressive Disease|36|||
161894837|NCT01844817|584663468|FG000|Treatment|Adverse Event|17|||
161894838|NCT01844817|584663469|FG001|Treatment|Adverse Event|9|||
161894839|NCT01844817|584663468|FG000|Treatment|Withdrawal by Subject|10|||
161894840|NCT01844817|584663469|FG001|Treatment|Withdrawal by Subject|6|||
161894841|NCT01844817|584663468|FG000|Treatment|Death|10|||
161894842|NCT01844817|584663469|FG001|Treatment|Death|8|||
161894843|NCT01844817|584663468|FG000|Treatment|Lost to Follow-up|0|||
161894844|NCT01844817|584663469|FG001|Treatment|Lost to Follow-up|1|||
161894845|NCT01844817|584663468|FG000|Treatment|Other|0|||
161894846|NCT01844817|584663469|FG001|Treatment|Other|3|||
161894847|NCT03638466|584663471|FG000|Overall Study|Early Termination|0|||
161894848|NCT03638466|584663472|FG001|Overall Study|Early Termination|1|||
161894849|NCT02576977|584663473|FG000|Overall Study|Adverse Event|13|||
161894850|NCT02576977|584663474|FG001|Overall Study|Adverse Event|2|||
161894851|NCT02576977|584663473|FG000|Overall Study|Death|73|||
161894852|NCT02576977|584663474|FG001|Overall Study|Death|60|||
161894853|NCT02576977|584663473|FG000|Overall Study|Screen failure|1|||
161894854|NCT02576977|584663474|FG001|Overall Study|Screen failure|0|||
161894855|NCT02576977|584663473|FG000|Overall Study|Study Terminated at Selected Sites|27|||
161894856|NCT02576977|584663474|FG001|Overall Study|Study Terminated at Selected Sites|50|||
161894857|NCT02576977|584663473|FG000|Overall Study|Withdrawal by Subject|11|||
161894858|NCT02576977|584663474|FG001|Overall Study|Withdrawal by Subject|11|||
161894859|NCT02576977|584663473|FG000|Overall Study|Final Disposition Unknown|0|||
161894860|NCT02576977|584663474|FG001|Overall Study|Final Disposition Unknown|1|||
161894861|NCT02576977|584663473|FG000|Overall Study|Lost to Follow-up|1|||
161894862|NCT02576977|584663474|FG001|Overall Study|Lost to Follow-up|0|||
161894863|NCT02576977|584663473|FG000|Overall Study|Progressive Disease|0|||
161894864|NCT02576977|584663474|FG001|Overall Study|Progressive Disease|1|||
161894865|NCT02447328|584663479|FG000|Overall Study|Withdrawal by Subject|1|||
161894866|NCT02906579|584663490|FG000|Overall Study|Adverse Event|1|||
161894867|NCT02906579|584663490|FG000|Overall Study|Physician Decision|1|||
161894868|NCT00759655|584663491|FG000|Overall Study|Termination of the study by sponsor|1|||
161894869|NCT02753816|584663492|FG000|Overall Study|Protocol Violation|0|||
161894870|NCT02753816|584663493|FG001|Overall Study|Protocol Violation|1|||
161894871|NCT02753816|584663494|FG002|Overall Study|Protocol Violation|0|||
161894872|NCT01473940|584663495|FG000|Induction Therapy|Death|0|||
161894873|NCT01473940|584663496|FG001|Induction Therapy|Death|0|||
161894874|NCT01473940|584663497|FG002|Induction Therapy|Death|1|||
161894875|NCT01473940|584663498|FG003|Induction Therapy|Death|1|||
161894876|NCT01473940|584663495|FG000|Induction Therapy|Progressive Disease|0|||
161894877|NCT01473940|584663496|FG001|Induction Therapy|Progressive Disease|1|||
161894878|NCT01473940|584663497|FG002|Induction Therapy|Progressive Disease|1|||
161894879|NCT01473940|584663498|FG003|Induction Therapy|Progressive Disease|0|||
161894880|NCT01473940|584663495|FG000|Maintenance Therapy|Progressive Disease|1|||
161894881|NCT01473940|584663496|FG001|Maintenance Therapy|Progressive Disease|2|||
161894882|NCT01473940|584663497|FG002|Maintenance Therapy|Progressive Disease|1|||
161894883|NCT01473940|584663498|FG003|Maintenance Therapy|Progressive Disease|4|||
161894884|NCT00534248|584663499|FG000|Overall Study|Adverse Event|19|||
161894885|NCT00534248|584663500|FG001|Overall Study|Adverse Event|29|||
161894886|NCT00534248|584663499|FG000|Overall Study|Lost to Follow-up|353|||
161894887|NCT00534248|584663500|FG001|Overall Study|Lost to Follow-up|375|||
161894888|NCT00534248|584663499|FG000|Overall Study|Other protocol specified criteria|13|||
161894889|NCT00534248|584663500|FG001|Overall Study|Other protocol specified criteria|3|||
161894890|NCT00534248|584663499|FG000|Overall Study|Physician Decision|10|||
161894891|NCT00534248|584663500|FG001|Overall Study|Physician Decision|7|||
161894892|NCT00534248|584663499|FG000|Overall Study|Protocol Violation|3|||
161894893|NCT00534248|584663500|FG001|Overall Study|Protocol Violation|4|||
161894894|NCT00534248|584663499|FG000|Overall Study|Withdrawal by Subject|263|||
161894895|NCT00534248|584663500|FG001|Overall Study|Withdrawal by Subject|255|||
161894896|NCT02849171|584663501|FG000|Overall Study|Withdrawal by Subject|1|||
161894897|NCT02849171|584663501|FG000|Overall Study|Not treated|1|||
161894898|NCT03084302|584663508|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
161894899|NCT03084302|584663508|FG000|Overall Study|No valid objective monitor data|6|||
161894900|NCT01704755|584663512|FG000|Overall Study|Adverse Event|4|||
161894901|NCT01704755|584663513|FG001|Overall Study|Adverse Event|1|||
161894902|NCT01704755|584663512|FG000|Overall Study|Lost to Follow-up|3|||
161894903|NCT01704755|584663513|FG001|Overall Study|Lost to Follow-up|4|||
161894904|NCT01704755|584663512|FG000|Overall Study|Withdrew consent|1|||
161894905|NCT01704755|584663513|FG001|Overall Study|Withdrew consent|1|||
161894906|NCT01704755|584663512|FG000|Overall Study|Other (not specified)|3|||
161894907|NCT01704755|584663513|FG001|Overall Study|Other (not specified)|1|||
161894908|NCT01704755|584663512|FG000|Overall Study|Withdrew consent and personal issues|1|||
161894909|NCT01704755|584663513|FG001|Overall Study|Withdrew consent and personal issues|0|||
161894910|NCT02075008|584663520|FG000|Overall Study|Technical problems|1|||
161894911|NCT02075008|584663520|FG000|Overall Study|Pregnancy|1|||
161894912|NCT02075008|584663520|FG000|Overall Study|Physician Decision|1|||
161894913|NCT02075008|584663520|FG000|Overall Study|Lost to Follow-up|1|||
161894914|NCT02075008|584663520|FG000|Overall Study|Lack of Efficacy|1|||
161894915|NCT02075008|584663520|FG000|Overall Study|Death|1|||
161894916|NCT02075008|584663520|FG000|Overall Study|Adverse Event|5|||
161894917|NCT02075008|584663520|FG000|Overall Study|Withdrawal by Subject|6|||
161894918|NCT02075008|584663520|FG000|Overall Study|Study terminated by Sponsor|159|||
161894919|NCT02821416|584663521|FG000|Overall Study|Adverse Event|0|||
161894920|NCT02821416|584663522|FG001|Overall Study|Adverse Event|1|||
161894921|NCT02821416|584663521|FG000|Overall Study|Withdrawal by Subject|2|||
161894922|NCT02821416|584663522|FG001|Overall Study|Withdrawal by Subject|0|||
161894923|NCT02821416|584663521|FG000|Overall Study|Lost to Follow-up|1|||
161894924|NCT02821416|584663522|FG001|Overall Study|Lost to Follow-up|0|||
161894925|NCT01763203|584663529|FG000|Overall Study|Death|4|||
161894926|NCT01763203|584663530|FG001|Overall Study|Death|7|||
161894927|NCT01763203|584663529|FG000|Overall Study|Lost to Follow-up|12|||
161894928|NCT01763203|584663530|FG001|Overall Study|Lost to Follow-up|12|||
161894929|NCT01763203|584663529|FG000|Overall Study|Withdrawal by Subject|8|||
161894930|NCT01763203|584663530|FG001|Overall Study|Withdrawal by Subject|12|||
161894931|NCT01763203|584663529|FG000|Overall Study|Moved out of study region|7|||
161894932|NCT01763203|584663530|FG001|Overall Study|Moved out of study region|10|||
161894933|NCT01763203|584663529|FG000|Overall Study|Physician Decision|2|||
161894934|NCT01763203|584663530|FG001|Overall Study|Physician Decision|1|||
161894935|NCT02256917|584663531|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
161894936|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
161894937|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
161894938|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
161894939|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
161894940|NCT02933528|584663532|FG000|Overall Study|Lost to Follow-up|2|||
161894941|NCT01639703|584663533|FG000|Overall Study|Withdrawal by Subject|5|||
161894942|NCT01639703|584663533|FG000|Overall Study|Other reason|7|||
161894943|NCT01753115|584663535|FG000|Overall Study|Lost to Follow-up|3|||
161894944|NCT01753115|584663536|FG001|Overall Study|Lost to Follow-up|6|||
161894945|NCT01753115|584663537|FG002|Overall Study|Lost to Follow-up|8|||
161894946|NCT01753115|584663535|FG000|Overall Study|Withdrawal by Subject|6|||
161894947|NCT01753115|584663536|FG001|Overall Study|Withdrawal by Subject|5|||
161894948|NCT01753115|584663537|FG002|Overall Study|Withdrawal by Subject|6|||
161894949|NCT01753115|584663535|FG000|Overall Study|Subject non-compliant|3|||
161894950|NCT01753115|584663536|FG001|Overall Study|Subject non-compliant|3|||
161894951|NCT01753115|584663537|FG002|Overall Study|Subject non-compliant|0|||
161894952|NCT01753115|584663535|FG000|Overall Study|Used excluded drug|0|||
161894953|NCT01753115|584663536|FG001|Overall Study|Used excluded drug|1|||
161894954|NCT01753115|584663537|FG002|Overall Study|Used excluded drug|0|||
161894955|NCT02782377|584663540|FG000|Overall Study|Physician Decision|5|||
161894956|NCT01188668|584663541|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
161894957|NCT01188668|584663541|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
161894958|NCT01188668|584663541|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
161894959|NCT03882957|584663549|FG000|Overall Study|Did not complete all three arms|1|||
161894960|NCT03762681|584663552|FG000|Part 1|Withdrawal by Subject|0|||
161894961|NCT03762681|584663553|FG001|Part 1|Withdrawal by Subject|0|||
161894962|NCT03762681|584663554|FG002|Part 1|Withdrawal by Subject|0|||
161894963|NCT03762681|584663555|FG003|Part 1|Withdrawal by Subject|1|||
161894964|NCT03762681|584663556|FG004|Part 1|Withdrawal by Subject|0|||
161894965|NCT03762681|584663557|FG005|Part 1|Withdrawal by Subject|0|||
161894966|NCT03762681|584663558|FG006|Part 1|Withdrawal by Subject|0|||
161894967|NCT03762681|584663559|FG007|Part 1|Withdrawal by Subject|0|||
161894968|NCT03762681|584663552|FG000|Part 2a|Pandemic Travel Restrictions|0|||
161894969|NCT03762681|584663553|FG001|Part 2a|Pandemic Travel Restrictions|0|||
161894970|NCT03762681|584663554|FG002|Part 2a|Pandemic Travel Restrictions|0|||
161894971|NCT03762681|584663555|FG003|Part 2a|Pandemic Travel Restrictions|0|||
161894972|NCT03762681|584663556|FG004|Part 2a|Pandemic Travel Restrictions|0|||
161894973|NCT03762681|584663557|FG005|Part 2a|Pandemic Travel Restrictions|0|||
161894974|NCT03762681|584663558|FG006|Part 2a|Pandemic Travel Restrictions|0|||
161894975|NCT03762681|584663559|FG007|Part 2a|Pandemic Travel Restrictions|1|||
161894976|NCT01915771|584663563|FG000|Day 1|Withdrawal by Subject|1|||
161894977|NCT01915771|584663563|FG000|Day 15|Withdrawal by Subject|1|||
161894978|NCT04811664|584663564|FG000|Overall Study|Lost to Follow-up|78|||
161894979|NCT04811664|584663565|FG001|Overall Study|Lost to Follow-up|125|||
161894980|NCT04811664|584663566|FG002|Overall Study|Lost to Follow-up|46|||
161894981|NCT04811664|584663564|FG000|Overall Study|Withdrawal by Subject|39|||
161894982|NCT04811664|584663565|FG001|Overall Study|Withdrawal by Subject|76|||
161894983|NCT04811664|584663566|FG002|Overall Study|Withdrawal by Subject|12|||
161894984|NCT04811664|584663564|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161894985|NCT04811664|584663565|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
161894986|NCT04811664|584663566|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
161894987|NCT04811664|584663564|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
161894988|NCT04811664|584663565|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
161894989|NCT04811664|584663566|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
161894990|NCT04811664|584663564|FG000|Overall Study|Protocol Violation|0|||
161894991|NCT04811664|584663565|FG001|Overall Study|Protocol Violation|5|||
161894992|NCT04811664|584663566|FG002|Overall Study|Protocol Violation|11|||
161894993|NCT04811664|584663564|FG000|Overall Study|Study Terminated by Sponsor|4|||
161894994|NCT04811664|584663565|FG001|Overall Study|Study Terminated by Sponsor|3|||
161894995|NCT04811664|584663566|FG002|Overall Study|Study Terminated by Sponsor|34|||
161894996|NCT04811664|584663564|FG000|Overall Study|Early Study Closure|3|||
161894997|NCT04811664|584663565|FG001|Overall Study|Early Study Closure|7|||
161894998|NCT04811664|584663566|FG002|Overall Study|Early Study Closure|79|||
161665479|NCT00310037|583828363|FG001|Overall Study|Withdrawal by Subject|3|||
161665480|NCT00310037|583828362|FG000|Overall Study|Progression|6|||
161665481|NCT00310037|583828363|FG001|Overall Study|Progression|0|||
161665482|NCT00310037|583828362|FG000|Overall Study|Non-protocol treatment|1|||
161665483|NCT00310037|583828363|FG001|Overall Study|Non-protocol treatment|0|||
161665484|NCT00440999|583828364|FG000|Overall Study|Adverse Event|0|||
161665485|NCT00440999|583828365|FG001|Overall Study|Adverse Event|2|||
161665486|NCT00440999|583828364|FG000|Overall Study|Lack of Efficacy|6|||
161665487|NCT00440999|583828365|FG001|Overall Study|Lack of Efficacy|7|||
161665488|NCT00440999|583828364|FG000|Overall Study|Lost to Follow-up|19|||
161665489|NCT00440999|583828365|FG001|Overall Study|Lost to Follow-up|12|||
161665490|NCT00440999|583828364|FG000|Overall Study|Protocol Violation|1|||
161665491|NCT00440999|583828365|FG001|Overall Study|Protocol Violation|0|||
161665492|NCT00440999|583828364|FG000|Overall Study|Withdrawal by Subject|2|||
161665493|NCT00440999|583828365|FG001|Overall Study|Withdrawal by Subject|5|||
161894999|NCT04811664|584663564|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
161665494|NCT00440999|583828364|FG000|Overall Study|Subjets missed the visit|1|||
161665495|NCT00440999|583828365|FG001|Overall Study|Subjets missed the visit|0|||
161665496|NCT00440999|583828364|FG000|Overall Study|Mixed infection at entry|1|||
161665497|NCT00440999|583828365|FG001|Overall Study|Mixed infection at entry|0|||
161665498|NCT00440999|583828364|FG000|Overall Study|P. falciparum malaria|5|||
161665499|NCT00440999|583828365|FG001|Overall Study|P. falciparum malaria|14|||
161665500|NCT00440999|583828364|FG000|Overall Study|Subj left hosp without inform staff|0|||
161665501|NCT00440999|583828365|FG001|Overall Study|Subj left hosp without inform staff|1|||
161665502|NCT01122862|583828366|FG000|Period 1|Protocol Violation|0|||
161665503|NCT01122862|583828367|FG001|Period 1|Protocol Violation|1|||
161665504|NCT01122862|583828368|FG002|Period 1|Protocol Violation|0|||
161665505|NCT01122862|583828366|FG000|Period 2|Adverse Event|0|||
161665506|NCT01122862|583828367|FG001|Period 2|Adverse Event|0|||
161665507|NCT01122862|583828368|FG002|Period 2|Adverse Event|1|||
161665508|NCT01477333|583828371|FG000|Overall Study|Adverse Event|1|||
161665509|NCT01477333|583828371|FG000|Overall Study|Withdrawal by Subject|1|||
161665510|NCT01477333|583828371|FG000|Overall Study|Clinical Deterioration|1|||
161665511|NCT01178671|583828372|FG000|Overall Study|Adverse Event|4|||
161665512|NCT01178671|583828373|FG001|Overall Study|Adverse Event|6|||
161665513|NCT01178671|583828372|FG000|Overall Study|Protocol Violation|1|||
161665514|NCT01178671|583828373|FG001|Overall Study|Protocol Violation|1|||
161665515|NCT01178671|583828372|FG000|Overall Study|Lack of Efficacy|0|||
161665516|NCT01178671|583828373|FG001|Overall Study|Lack of Efficacy|1|||
161665517|NCT01178671|583828372|FG000|Overall Study|Lost to Follow-up|3|||
161665518|NCT01178671|583828373|FG001|Overall Study|Lost to Follow-up|1|||
161895000|NCT04811664|584663565|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
161895001|NCT04811664|584663566|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
161895002|NCT02717442|584663567|FG000|Overall Study|Study Terminated by Sponsor|31|||
161895003|NCT02717442|584663568|FG001|Overall Study|Study Terminated by Sponsor|29|||
161895004|NCT02717442|584663567|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
161665519|NCT01178671|583828372|FG000|Overall Study|Physician Decision|4|||
161665520|NCT01178671|583828373|FG001|Overall Study|Physician Decision|6|||
161665521|NCT04620811|583828374|FG000|Overall Study|Withdrawal by Subject|18|||
161665522|NCT04620811|583828375|FG001|Overall Study|Withdrawal by Subject|15|||
161665523|NCT04620811|583828374|FG000|Overall Study|Adverse Event|6|||
161665524|NCT04620811|583828375|FG001|Overall Study|Adverse Event|11|||
161665525|NCT04620811|583828374|FG000|Overall Study|Lost to Follow-up|4|||
161665526|NCT04620811|583828375|FG001|Overall Study|Lost to Follow-up|8|||
161895005|NCT02717442|584663568|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
161895006|NCT02717442|584663567|FG000|Overall Study|Other - Not Specified|2|||
161895007|NCT02717442|584663568|FG001|Overall Study|Other - Not Specified|0|||
161895008|NCT02774005|584663570|FG000|Overall Study|Adverse Event|8|||
161895009|NCT02774005|584663570|FG000|Overall Study|Withdrawal by Subject|23|||
161895010|NCT02774005|584663570|FG000|Overall Study|Lost to Follow-up|7|||
161895011|NCT02774005|584663570|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
161895012|NCT02774005|584663570|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
161895013|NCT02774005|584663570|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
161895014|NCT02774005|584663570|FG000|Overall Study|Death|1|||
161895015|NCT02774005|584663570|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
161895016|NCT02774005|584663570|FG000|Overall Study|Lack of compliance with study medication|4|||
161895017|NCT02774005|584663570|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
161895018|NCT02774005|584663570|FG000|Overall Study|another study|1|||
161895019|NCT02774005|584663570|FG000|Overall Study|cardiologist imposed travel restriction|1|||
161665527|NCT04620811|583828374|FG000|Overall Study|Physician Decision|1|||
161665528|NCT04620811|583828375|FG001|Overall Study|Physician Decision|4|||
161665529|NCT04620811|583828374|FG000|Overall Study|Sponsor Decision|0|||
161665530|NCT04620811|583828375|FG001|Overall Study|Sponsor Decision|1|||
161665531|NCT04620811|583828374|FG000|Overall Study|Elevation of ALT or AST|1|||
161665532|NCT04620811|583828375|FG001|Overall Study|Elevation of ALT or AST|0|||
161665533|NCT04620811|583828374|FG000|Overall Study|Other|3|||
161665534|NCT04620811|583828375|FG001|Overall Study|Other|5|||
161665535|NCT01078675|583828376|FG000|Overall Study|Withdrawal by Subject|7|||
161665536|NCT01078675|583828377|FG001|Overall Study|Withdrawal by Subject|3|||
161665537|NCT01078675|583828376|FG000|Overall Study|Protocol Violation|56|||
161665538|NCT01078675|583828377|FG001|Overall Study|Protocol Violation|0|||
161665539|NCT01078675|583828376|FG000|Overall Study|Provided in CRF for specific reasons|2|||
161665540|NCT01078675|583828377|FG001|Overall Study|Provided in CRF for specific reasons|3|||
161665541|NCT01078675|583828376|FG000|Overall Study|Adverse Event|3|||
161665542|NCT01078675|583828377|FG001|Overall Study|Adverse Event|0|||
161665543|NCT02513303|583828378|FG000|Overall Study|Withdrawal by Subject|9|||
161665544|NCT02513303|583828379|FG001|Overall Study|Withdrawal by Subject|7|||
161665545|NCT02513303|583828380|FG002|Overall Study|Withdrawal by Subject|2|||
161665546|NCT02513303|583828378|FG000|Overall Study|Lost to Follow-up|2|||
161665547|NCT02513303|583828379|FG001|Overall Study|Lost to Follow-up|4|||
161665548|NCT02513303|583828380|FG002|Overall Study|Lost to Follow-up|0|||
161665549|NCT02513303|583828378|FG000|Overall Study|Adverse Event|0|||
161665550|NCT02513303|583828379|FG001|Overall Study|Adverse Event|1|||
161665551|NCT02513303|583828380|FG002|Overall Study|Adverse Event|0|||
161665552|NCT02513303|583828378|FG000|Overall Study|Physician Decision|1|||
161665553|NCT02513303|583828379|FG001|Overall Study|Physician Decision|1|||
161665554|NCT02513303|583828380|FG002|Overall Study|Physician Decision|0|||
161665555|NCT02513303|583828378|FG000|Overall Study|Death|8|||
161665556|NCT02513303|583828379|FG001|Overall Study|Death|4|||
161665557|NCT02513303|583828380|FG002|Overall Study|Death|2|||
161665558|NCT00679627|583828381|FG000|Overall Study|Death|41|||
161665559|NCT00679627|583828382|FG001|Overall Study|Death|29|||
161665560|NCT00679627|583828381|FG000|Overall Study|Adverse Event|43|||
161665561|NCT00679627|583828382|FG001|Overall Study|Adverse Event|53|||
161665562|NCT00679627|583828381|FG000|Overall Study|Withdrawal by Subject|168|||
161665563|NCT00679627|583828382|FG001|Overall Study|Withdrawal by Subject|172|||
161665564|NCT00679627|583828381|FG000|Overall Study|Lost to Follow-up|22|||
161665565|NCT00679627|583828382|FG001|Overall Study|Lost to Follow-up|26|||
161665566|NCT00679627|583828381|FG000|Overall Study|Early Study Closure|425|||
161665567|NCT00679627|583828382|FG001|Overall Study|Early Study Closure|405|||
161665568|NCT03513588|583828384|FG000|Overall Study|Lost to Follow-up|0|||
161665569|NCT03513588|583828385|FG001|Overall Study|Lost to Follow-up|1|||
161665570|NCT03513588|583828386|FG002|Overall Study|Lost to Follow-up|1|||
161665571|NCT03513588|583828384|FG000|Overall Study|Study dosing paused by sponsor|1|||
161665572|NCT03513588|583828385|FG001|Overall Study|Study dosing paused by sponsor|1|||
161665573|NCT03513588|583828386|FG002|Overall Study|Study dosing paused by sponsor|0|||
161665574|NCT03513588|583828384|FG000|Overall Study|Death|0|||
161665575|NCT03513588|583828385|FG001|Overall Study|Death|0|||
161665576|NCT03513588|583828386|FG002|Overall Study|Death|1|||
161665577|NCT01275131|583828387|FG000|Period 1|Withdrawal by Subject|1|||
161665578|NCT01275131|583828388|FG001|Period 1|Withdrawal by Subject|0|||
161665579|NCT01275131|583828389|FG002|Period 1|Withdrawal by Subject|3|||
161665580|NCT01275131|583828390|FG003|Period 1|Withdrawal by Subject|2|||
161665581|NCT01275131|583828387|FG000|Period 1|Physician Decision|1|||
161665582|NCT01275131|583828388|FG001|Period 1|Physician Decision|0|||
161665583|NCT01275131|583828389|FG002|Period 1|Physician Decision|0|||
161665584|NCT01275131|583828390|FG003|Period 1|Physician Decision|0|||
161665585|NCT01275131|583828387|FG000|Period 2 (Crossover)|Adverse Event|0|||
161665586|NCT01275131|583828388|FG001|Period 2 (Crossover)|Adverse Event|1|||
161665587|NCT01275131|583828389|FG002|Period 2 (Crossover)|Adverse Event|0|||
161665588|NCT01275131|583828390|FG003|Period 2 (Crossover)|Adverse Event|0|||
161665589|NCT01275131|583828387|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
161665590|NCT01275131|583828388|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
161665591|NCT01275131|583828389|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
161665592|NCT01275131|583828390|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
161779262|NCT01495793|584233894|FG000|Overall Study|Violation of inclusion criteria|1|||
161779263|NCT03014570|584233895|FG000|Overall Study|COVID-19 Restrictions|38|||
161779264|NCT03014570|584233896|FG001|Overall Study|COVID-19 Restrictions|24|||
161779265|NCT03014570|584233895|FG000|Overall Study|Death|70|||
161779266|NCT03014570|584233896|FG001|Overall Study|Death|79|||
161779267|NCT03014570|584233895|FG000|Overall Study|Transfer from facility|11|||
161779268|NCT03014570|584233896|FG001|Overall Study|Transfer from facility|14|||
161779269|NCT03014570|584233895|FG000|Overall Study|Hospitalized|5|||
161779270|NCT03014570|584233896|FG001|Overall Study|Hospitalized|3|||
161779271|NCT03014570|584233895|FG000|Overall Study|Transfer within facility|1|||
161779272|NCT03014570|584233896|FG001|Overall Study|Transfer within facility|0|||
161779273|NCT03014570|584233895|FG000|Overall Study|Site refusal|0|||
161779274|NCT03014570|584233896|FG001|Overall Study|Site refusal|11|||
161779275|NCT02362646|584233897|FG000|Overall Study|Death|15|||
161779276|NCT02362646|584233898|FG001|Overall Study|Death|8|||
161779277|NCT02362646|584233897|FG000|Overall Study|Withdrawal by Subject|2|||
161779278|NCT02362646|584233898|FG001|Overall Study|Withdrawal by Subject|2|||
161779279|NCT02362646|584233897|FG000|Overall Study|received transplant|21|||
161779280|NCT02362646|584233898|FG001|Overall Study|received transplant|14|||
161779281|NCT00929864|584233902|FG000|Overall Study|Death|1|||
161779282|NCT00929864|584233903|FG001|Overall Study|Death|1|||
161779283|NCT00929864|584233902|FG000|Overall Study|Adverse Event|11|||
161895020|NCT00723697|584663571|FG000|Overall Study|Physician questionnaires not received|2|||
161895021|NCT00723697|584663571|FG000|Overall Study|Missing Informed Consent Form|10|||
161895022|NCT00723697|584663571|FG000|Overall Study|Other exclusion criteria applied|6|||
161895023|NCT03275389|584663574|FG000|Overall Study|Lost to Follow-up|10|||
161895024|NCT03275389|584663575|FG001|Overall Study|Lost to Follow-up|10|||
161895025|NCT03275389|584663576|FG002|Overall Study|Lost to Follow-up|19|||
161895026|NCT03275389|584663577|FG003|Overall Study|Lost to Follow-up|12|||
161895027|NCT03275389|584663578|FG004|Overall Study|Lost to Follow-up|11|||
161895028|NCT03275389|584663579|FG005|Overall Study|Lost to Follow-up|12|||
161895029|NCT03275389|584663580|FG006|Overall Study|Lost to Follow-up|21|||
161895030|NCT03275389|584663581|FG007|Overall Study|Lost to Follow-up|15|||
161895031|NCT03275389|584663582|FG008|Overall Study|Lost to Follow-up|12|||
161895032|NCT03275389|584663583|FG009|Overall Study|Lost to Follow-up|14|||
161895033|NCT03275389|584663574|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895034|NCT03275389|584663575|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895035|NCT03275389|584663576|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895036|NCT03275389|584663577|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895037|NCT03275389|584663578|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895038|NCT03275389|584663579|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
161895039|NCT03275389|584663580|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895040|NCT03275389|584663581|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895041|NCT03275389|584663582|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895042|NCT03275389|584663583|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
161895043|NCT03275389|584663574|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161895044|NCT03275389|584663575|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161895045|NCT03275389|584663576|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161895046|NCT03275389|584663577|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
161895047|NCT03275389|584663578|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161895048|NCT03275389|584663579|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161665593|NCT00490724|583828392|FG000|Period I|Physician Decision|0|||
161779284|NCT00929864|584233903|FG001|Overall Study|Adverse Event|30|||
161779285|NCT00929864|584233902|FG000|Overall Study|Lack of Efficacy|19|||
161665594|NCT00490724|583828393|FG001|Period I|Physician Decision|0|||
161779286|NCT00929864|584233903|FG001|Overall Study|Lack of Efficacy|16|||
161895049|NCT03275389|584663580|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161895050|NCT03275389|584663581|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161895051|NCT03275389|584663582|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161895052|NCT03275389|584663583|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161895053|NCT03275389|584663574|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895054|NCT03275389|584663575|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161895055|NCT03275389|584663576|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895056|NCT03275389|584663577|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
161895057|NCT03275389|584663578|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895058|NCT03275389|584663579|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895059|NCT03275389|584663580|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161895060|NCT03275389|584663581|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895061|NCT03275389|584663582|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895062|NCT03275389|584663583|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895063|NCT03275389|584663574|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895064|NCT03275389|584663575|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895065|NCT03275389|584663576|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161779287|NCT00929864|584233902|FG000|Overall Study|Lost to Follow-up|7|||
161779288|NCT00929864|584233903|FG001|Overall Study|Lost to Follow-up|12|||
161779289|NCT00929864|584233902|FG000|Overall Study|Withdrawal by Subject|20|||
161779290|NCT00929864|584233903|FG001|Overall Study|Withdrawal by Subject|9|||
161779291|NCT00929864|584233902|FG000|Overall Study|No longer met criteria|2|||
161779292|NCT00929864|584233903|FG001|Overall Study|No longer met criteria|1|||
161779293|NCT00929864|584233902|FG000|Overall Study|Poor or non-compliance|3|||
161779294|NCT00929864|584233903|FG001|Overall Study|Poor or non-compliance|3|||
161779295|NCT00929864|584233902|FG000|Overall Study|Pregnancy|0|||
161779296|NCT00929864|584233903|FG001|Overall Study|Pregnancy|3|||
161779297|NCT00929864|584233902|FG000|Overall Study|Administrative reason by Sponsor|1|||
161779298|NCT00929864|584233903|FG001|Overall Study|Administrative reason by Sponsor|1|||
161779299|NCT00929864|584233902|FG000|Overall Study|Non-specified|2|||
161779300|NCT00929864|584233903|FG001|Overall Study|Non-specified|7|||
161779301|NCT03428217|584233905|FG000|Overall Study|Death|89|||
161779302|NCT03428217|584233906|FG001|Overall Study|Death|93|||
161779303|NCT03428217|584233905|FG000|Overall Study|Withdrawal by Subject|8|||
161779304|NCT03428217|584233906|FG001|Overall Study|Withdrawal by Subject|7|||
161779305|NCT03428217|584233905|FG000|Overall Study|Lost to Follow-up|1|||
161779306|NCT03428217|584233906|FG001|Overall Study|Lost to Follow-up|3|||
161779307|NCT03428217|584233905|FG000|Overall Study|Study terminated by sponsor|124|||
161779308|NCT03428217|584233906|FG001|Overall Study|Study terminated by sponsor|118|||
161779309|NCT03428217|584233905|FG000|Overall Study|Other, Not Specified|1|||
161779310|NCT03428217|584233906|FG001|Overall Study|Other, Not Specified|0|||
161779311|NCT00621309|584233907|FG000|Overall Study|Withdrawal by Subject|2|||
161779312|NCT00621309|584233908|FG001|Overall Study|Withdrawal by Subject|0|||
161779313|NCT00621309|584233909|FG002|Overall Study|Withdrawal by Subject|1|||
161779314|NCT00621309|584233910|FG003|Overall Study|Withdrawal by Subject|1|||
161779315|NCT00621309|584233911|FG004|Overall Study|Withdrawal by Subject|1|||
161779316|NCT00621309|584233912|FG005|Overall Study|Withdrawal by Subject|1|||
161779317|NCT00905437|584233913|FG000|Overall Study|Adverse Event|3|||
161779318|NCT00905437|584233914|FG001|Overall Study|Adverse Event|2|||
161779319|NCT00905437|584233913|FG000|Overall Study|Lost to Follow-up|0|||
161779320|NCT00905437|584233914|FG001|Overall Study|Lost to Follow-up|1|||
161779321|NCT00905437|584233913|FG000|Overall Study|Withdrawal by Subject|0|||
161779322|NCT00905437|584233914|FG001|Overall Study|Withdrawal by Subject|1|||
161779323|NCT00905437|584233913|FG000|Overall Study|Other|5|||
161779324|NCT00905437|584233914|FG001|Overall Study|Other|6|||
161779325|NCT05246111|584233915|FG000|Period 01|NOT ELIGIBLE IC5|1|||
161779326|NCT05246111|584233916|FG001|Period 01|NOT ELIGIBLE IC5|0|||
161779327|NCT01306968|584233917|FG000|Overall Study|Lost to Follow-up|1|||
161779328|NCT01306968|584233918|FG001|Overall Study|Lost to Follow-up|1|||
161779329|NCT01306968|584233919|FG002|Overall Study|Lost to Follow-up|0|||
161779330|NCT01306968|584233920|FG003|Overall Study|Lost to Follow-up|0|||
161779331|NCT01306968|584233917|FG000|Overall Study|Physician Decision|0|||
161779332|NCT01306968|584233918|FG001|Overall Study|Physician Decision|1|||
161779333|NCT01306968|584233919|FG002|Overall Study|Physician Decision|0|||
161779334|NCT01306968|584233920|FG003|Overall Study|Physician Decision|0|||
161779335|NCT01306968|584233917|FG000|Overall Study|Relocated and left active duty|0|||
161779336|NCT01306968|584233918|FG001|Overall Study|Relocated and left active duty|1|||
161779337|NCT01306968|584233919|FG002|Overall Study|Relocated and left active duty|1|||
161779338|NCT01306968|584233920|FG003|Overall Study|Relocated and left active duty|1|||
161779339|NCT01306968|584233917|FG000|Overall Study|Withdrew - time commitment|0|||
161779340|NCT01306968|584233918|FG001|Overall Study|Withdrew - time commitment|0|||
161779341|NCT01306968|584233919|FG002|Overall Study|Withdrew - time commitment|0|||
161779342|NCT01306968|584233920|FG003|Overall Study|Withdrew - time commitment|2|||
161779343|NCT01306968|584233917|FG000|Overall Study|Withdrew over privacy concerns|0|||
161779344|NCT01306968|584233918|FG001|Overall Study|Withdrew over privacy concerns|0|||
161779345|NCT01306968|584233919|FG002|Overall Study|Withdrew over privacy concerns|0|||
161779346|NCT01306968|584233920|FG003|Overall Study|Withdrew over privacy concerns|1|||
161779347|NCT02736695|584233921|FG000|Overall Study|Ineligible|6|||
161779348|NCT02736695|584233922|FG001|Overall Study|Ineligible|0|||
161779349|NCT01329562|584233925|FG000|Overall Study|Protocol Violation|5|||
161779350|NCT01329562|584233926|FG001|Overall Study|Protocol Violation|3|||
161779351|NCT01329562|584233925|FG000|Overall Study|Lost to Follow-up|1|||
161779352|NCT01329562|584233926|FG001|Overall Study|Lost to Follow-up|1|||
161779353|NCT01329562|584233925|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
161779354|NCT01329562|584233926|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
161779355|NCT01329562|584233925|FG000|Overall Study|Physician Decision|0|||
161779356|NCT01329562|584233926|FG001|Overall Study|Physician Decision|1|||
161779357|NCT03252015|584233927|FG000|Overall Study|Withdrawal by Subject|0|||
161779358|NCT03252015|584233928|FG001|Overall Study|Withdrawal by Subject|1|||
161779359|NCT03252015|584233929|FG002|Overall Study|Withdrawal by Subject|1|||
161779360|NCT03252015|584233930|FG003|Overall Study|Withdrawal by Subject|0|||
161779361|NCT03252015|584233927|FG000|Overall Study|Adverse Event|1|||
161779362|NCT03252015|584233928|FG001|Overall Study|Adverse Event|0|||
161779363|NCT03252015|584233929|FG002|Overall Study|Adverse Event|0|||
161779364|NCT03252015|584233930|FG003|Overall Study|Adverse Event|1|||
161779365|NCT00061568|584233931|FG000|Overall Study|Lost to Follow-up|12|||
161779366|NCT00061568|584233932|FG001|Overall Study|Lost to Follow-up|0|||
161779367|NCT00061568|584233931|FG000|Overall Study|Death|6|||
161779368|NCT00061568|584233932|FG001|Overall Study|Death|0|||
161779369|NCT00061568|584233931|FG000|Overall Study|Withdrawal by Subject|1|||
161779370|NCT00061568|584233932|FG001|Overall Study|Withdrawal by Subject|0|||
161779371|NCT01381068|584233933|FG000|Overall Study|Death|1|||
161779372|NCT01381068|584233934|FG001|Overall Study|Death|0|||
161779373|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
161779374|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
161779375|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
161779376|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
161779377|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
161779378|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
161779379|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
161779380|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
161779381|NCT01843660|584233944|FG000|Overall Study|Other|30|||
161779382|NCT00526227|584233945|FG000|Overall Study|Device not implanted|1|||
161779383|NCT00526227|584233945|FG000|Overall Study|Death|1|||
161779384|NCT01721369|584233946|FG000|Overall Study|Not initial etiological diagnosis|12|||
161831440|NCT01467479|584424744|FG002|Overall Study|Withdrawal of Consent|7|||
161831441|NCT01467479|584424742|FG000|Overall Study|Study Terminated by Sponsor|1|||
161831442|NCT01467479|584424743|FG001|Overall Study|Study Terminated by Sponsor|3|||
161831443|NCT01467479|584424744|FG002|Overall Study|Study Terminated by Sponsor|3|||
161831444|NCT01467479|584424742|FG000|Overall Study|Other|1|||
161831445|NCT01467479|584424743|FG001|Overall Study|Other|0|||
161831446|NCT01467479|584424744|FG002|Overall Study|Other|0|||
161831447|NCT02284347|584424755|FG000|Overall Study|Lost to Follow-up|2|||
161831448|NCT02284347|584424755|FG000|Overall Study|Withdrawn prior to treatment|1|||
161831449|NCT01730040|584424757|FG000|Overall Study|Randomized but not treated|0|||
161831450|NCT01730040|584424758|FG001|Overall Study|Randomized but not treated|0|||
161831451|NCT01730040|584424759|FG002|Overall Study|Randomized but not treated|0|||
161831452|NCT01730040|584424760|FG003|Overall Study|Randomized but not treated|0|||
161831453|NCT01730040|584424761|FG004|Overall Study|Randomized but not treated|0|||
161831454|NCT01730040|584424762|FG005|Overall Study|Randomized but not treated|1|||
161831455|NCT01730040|584424763|FG006|Overall Study|Randomized but not treated|0|||
161831456|NCT01730040|584424757|FG000|Overall Study|Subject moved|0|||
161831457|NCT01730040|584424758|FG001|Overall Study|Subject moved|0|||
161831458|NCT01730040|584424759|FG002|Overall Study|Subject moved|1|||
161831459|NCT01730040|584424760|FG003|Overall Study|Subject moved|0|||
161831460|NCT01730040|584424761|FG004|Overall Study|Subject moved|0|||
161895066|NCT03275389|584663577|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161831461|NCT01730040|584424762|FG005|Overall Study|Subject moved|0|||
161895067|NCT03275389|584663578|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895068|NCT03275389|584663579|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895069|NCT03275389|584663580|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895070|NCT03275389|584663581|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895071|NCT03275389|584663582|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895072|NCT03275389|584663583|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161895073|NCT03275389|584663574|FG000|Overall Study|Other|0|||
161895074|NCT03275389|584663575|FG001|Overall Study|Other|4|||
161895075|NCT03275389|584663576|FG002|Overall Study|Other|3|||
161895076|NCT03275389|584663577|FG003|Overall Study|Other|2|||
161895077|NCT03275389|584663578|FG004|Overall Study|Other|2|||
161895078|NCT03275389|584663579|FG005|Overall Study|Other|2|||
161895079|NCT03275389|584663580|FG006|Overall Study|Other|0|||
161895080|NCT03275389|584663581|FG007|Overall Study|Other|0|||
161895081|NCT03275389|584663582|FG008|Overall Study|Other|1|||
161895082|NCT03275389|584663583|FG009|Overall Study|Other|0|||
161895083|NCT00978341|584663586|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
161895084|NCT00978341|584663587|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
161895085|NCT03035916|584663588|FG000|Overall Study|Puncture failed|0|||
161895086|NCT03035916|584663589|FG001|Overall Study|Puncture failed|2|||
161895087|NCT03035916|584663590|FG002|Overall Study|Puncture failed|0|||
161895088|NCT03885999|584663591|FG000|Overall Study|Adverse Event|1|||
161895089|NCT02452554|584663592|FG000|Overall Study|Death|2|||
161895090|NCT02452554|584663593|FG001|Overall Study|Death|1|||
161895091|NCT02452554|584663594|FG002|Overall Study|Death|0|||
161895092|NCT02452554|584663595|FG003|Overall Study|Death|0|||
161895093|NCT02452554|584663596|FG004|Overall Study|Death|0|||
161895094|NCT02452554|584663597|FG005|Overall Study|Death|0|||
161895095|NCT02452554|584663592|FG000|Overall Study|Lack of Efficacy|13|||
161895096|NCT02452554|584663593|FG001|Overall Study|Lack of Efficacy|14|||
161895097|NCT02452554|584663594|FG002|Overall Study|Lack of Efficacy|9|||
161895098|NCT02452554|584663595|FG003|Overall Study|Lack of Efficacy|1|||
161895099|NCT02452554|584663596|FG004|Overall Study|Lack of Efficacy|5|||
161895100|NCT02452554|584663597|FG005|Overall Study|Lack of Efficacy|8|||
161895101|NCT02452554|584663592|FG000|Overall Study|Physician Decision|0|||
161895102|NCT02452554|584663593|FG001|Overall Study|Physician Decision|1|||
161895103|NCT02452554|584663594|FG002|Overall Study|Physician Decision|0|||
161895104|NCT02452554|584663595|FG003|Overall Study|Physician Decision|0|||
161895105|NCT02452554|584663596|FG004|Overall Study|Physician Decision|0|||
161895106|NCT02452554|584663597|FG005|Overall Study|Physician Decision|0|||
161895107|NCT02452554|584663592|FG000|Overall Study|Withdrawal by Subject|1|||
161895108|NCT02452554|584663593|FG001|Overall Study|Withdrawal by Subject|0|||
161895109|NCT02452554|584663594|FG002|Overall Study|Withdrawal by Subject|2|||
161895110|NCT02452554|584663595|FG003|Overall Study|Withdrawal by Subject|0|||
161895111|NCT02452554|584663596|FG004|Overall Study|Withdrawal by Subject|0|||
161895112|NCT02452554|584663597|FG005|Overall Study|Withdrawal by Subject|1|||
161895113|NCT02452554|584663592|FG000|Overall Study|Ineligible|0|||
161895114|NCT02452554|584663593|FG001|Overall Study|Ineligible|1|||
161895115|NCT02452554|584663594|FG002|Overall Study|Ineligible|0|||
161895116|NCT02452554|584663595|FG003|Overall Study|Ineligible|0|||
161895117|NCT02452554|584663596|FG004|Overall Study|Ineligible|0|||
161895118|NCT02452554|584663597|FG005|Overall Study|Ineligible|0|||
161895119|NCT02452554|584663592|FG000|Overall Study|Never Received Treatment|1|||
161895120|NCT02452554|584663593|FG001|Overall Study|Never Received Treatment|0|||
161895121|NCT02452554|584663594|FG002|Overall Study|Never Received Treatment|0|||
161895122|NCT02452554|584663595|FG003|Overall Study|Never Received Treatment|0|||
161895123|NCT02452554|584663596|FG004|Overall Study|Never Received Treatment|0|||
161895124|NCT02452554|584663597|FG005|Overall Study|Never Received Treatment|0|||
161895125|NCT01790516|584663598|FG000|Overall Study|Physician Decision|1|||
161895126|NCT01790516|584663599|FG001|Overall Study|Physician Decision|0|||
161895127|NCT01402986|584663600|FG000|Overall Study|Withdrawal by Subject|7|||
161895128|NCT01402986|584663601|FG001|Overall Study|Withdrawal by Subject|10|||
161895129|NCT01402986|584663602|FG002|Overall Study|Withdrawal by Subject|7|||
161895130|NCT01402986|584663603|FG003|Overall Study|Withdrawal by Subject|13|||
161895131|NCT01402986|584663600|FG000|Overall Study|Death|0|||
161895132|NCT01402986|584663601|FG001|Overall Study|Death|0|||
161895133|NCT01402986|584663602|FG002|Overall Study|Death|0|||
161895134|NCT01402986|584663603|FG003|Overall Study|Death|2|||
161895135|NCT01402986|584663600|FG000|Overall Study|Lost to Follow-up|0|||
161895136|NCT01402986|584663601|FG001|Overall Study|Lost to Follow-up|0|||
161895137|NCT01402986|584663602|FG002|Overall Study|Lost to Follow-up|0|||
161895138|NCT01402986|584663603|FG003|Overall Study|Lost to Follow-up|1|||
161895139|NCT01402986|584663600|FG000|Overall Study|Other|2|||
161895140|NCT01402986|584663601|FG001|Overall Study|Other|5|||
161895141|NCT01402986|584663602|FG002|Overall Study|Other|1|||
161895142|NCT01402986|584663603|FG003|Overall Study|Other|6|||
161895143|NCT01085084|584663604|FG000|Overall Study|Withdrawal by Subject|1|||
161895144|NCT01085084|584663605|FG001|Overall Study|Withdrawal by Subject|0|||
161895145|NCT01085084|584663606|FG002|Overall Study|Withdrawal by Subject|0|||
161895146|NCT01085084|584663604|FG000|Overall Study|Lost to Follow-up|2|||
161895147|NCT01085084|584663605|FG001|Overall Study|Lost to Follow-up|1|||
161895148|NCT01085084|584663606|FG002|Overall Study|Lost to Follow-up|1|||
161895149|NCT01085084|584663604|FG000|Overall Study|Adverse Event|4|||
161895150|NCT01085084|584663605|FG001|Overall Study|Adverse Event|3|||
161895151|NCT01085084|584663606|FG002|Overall Study|Adverse Event|6|||
161895152|NCT01085084|584663604|FG000|Overall Study|Treatment Failure|0|||
161895153|NCT01085084|584663605|FG001|Overall Study|Treatment Failure|1|||
161895154|NCT01085084|584663606|FG002|Overall Study|Treatment Failure|2|||
161895155|NCT03749109|584663607|FG000|Overall Study|Adverse Event|2|||
161895156|NCT03749109|584663608|FG001|Overall Study|Adverse Event|0|||
161895157|NCT03178851|584663609|FG000|Overall Study|Death|48|||
161895158|NCT03178851|584663610|FG001|Overall Study|Death|2|||
161895159|NCT03178851|584663611|FG002|Overall Study|Death|25|||
161895160|NCT03178851|584663609|FG000|Overall Study|Withdrawal by Subject|8|||
161895161|NCT03178851|584663610|FG001|Overall Study|Withdrawal by Subject|0|||
161895162|NCT03178851|584663611|FG002|Overall Study|Withdrawal by Subject|0|||
161895163|NCT03178851|584663609|FG000|Overall Study|Lost to Follow-up|5|||
161895164|NCT03178851|584663610|FG001|Overall Study|Lost to Follow-up|2|||
161895165|NCT03178851|584663611|FG002|Overall Study|Lost to Follow-up|0|||
161551562|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
161895166|NCT03178851|584663609|FG000|Overall Study|Adverse Event|0|||
161895167|NCT03178851|584663610|FG001|Overall Study|Adverse Event|0|||
161895168|NCT03178851|584663611|FG002|Overall Study|Adverse Event|1|||
161895169|NCT03178851|584663609|FG000|Overall Study|Study Termination by Sponsor|31|||
161779385|NCT00858234|584235524|FG000|Overall Study|Adverse Event|6|||
161779386|NCT00858234|584235524|FG000|Overall Study|Progressive disease|2|||
161779387|NCT00858234|584235524|FG000|Overall Study|Status unknown|1|||
161779388|NCT01678924|584235525|FG000|Overall Study|Adverse Event|1|||
161779389|NCT01678924|584235526|FG001|Overall Study|Adverse Event|1|||
161779390|NCT01678924|584235527|FG002|Overall Study|Adverse Event|0|||
161779391|NCT01678924|584235528|FG003|Overall Study|Adverse Event|1|||
161779392|NCT01678924|584235525|FG000|Overall Study|Lack of Efficacy|7|||
161779393|NCT01678924|584235526|FG001|Overall Study|Lack of Efficacy|2|||
161779394|NCT01678924|584235527|FG002|Overall Study|Lack of Efficacy|0|||
161779395|NCT01678924|584235528|FG003|Overall Study|Lack of Efficacy|5|||
161779396|NCT01678924|584235525|FG000|Overall Study|Lost to Follow-up|0|||
161779397|NCT01678924|584235526|FG001|Overall Study|Lost to Follow-up|4|||
161779398|NCT01678924|584235527|FG002|Overall Study|Lost to Follow-up|0|||
161779399|NCT01678924|584235528|FG003|Overall Study|Lost to Follow-up|2|||
161779400|NCT01678924|584235525|FG000|Overall Study|Personal Reasons|2|||
161779401|NCT01678924|584235526|FG001|Overall Study|Personal Reasons|2|||
161779402|NCT01678924|584235527|FG002|Overall Study|Personal Reasons|2|||
161779403|NCT01678924|584235528|FG003|Overall Study|Personal Reasons|7|||
161779404|NCT01678924|584235525|FG000|Overall Study|Withdrawal by Subject|0|||
161779405|NCT01678924|584235526|FG001|Overall Study|Withdrawal by Subject|3|||
161779406|NCT01678924|584235527|FG002|Overall Study|Withdrawal by Subject|0|||
161779407|NCT01678924|584235528|FG003|Overall Study|Withdrawal by Subject|2|||
161895170|NCT03178851|584663610|FG001|Overall Study|Study Termination by Sponsor|7|||
161895171|NCT03178851|584663611|FG002|Overall Study|Study Termination by Sponsor|26|||
161895172|NCT00520767|584663617|FG000|Overall Study|Death|2|||
161895173|NCT04530838|584666216|FG000|Overall Study|Other|2|||
161895174|NCT04530838|584666217|FG001|Overall Study|Other|1|||
161895175|NCT04530838|584666218|FG002|Overall Study|Other|0|||
161895176|NCT04530838|584666216|FG000|Overall Study|Physician Decision|0|||
161895177|NCT04530838|584666217|FG001|Overall Study|Physician Decision|0|||
161895178|NCT04530838|584666218|FG002|Overall Study|Physician Decision|1|||
161895179|NCT04530838|584666216|FG000|Overall Study|Death|0|||
161895180|NCT04530838|584666217|FG001|Overall Study|Death|0|||
161895181|NCT04530838|584666218|FG002|Overall Study|Death|1|||
161895182|NCT04530838|584666216|FG000|Overall Study|Adverse Event|0|||
161895183|NCT04530838|584666217|FG001|Overall Study|Adverse Event|1|||
161895184|NCT04530838|584666218|FG002|Overall Study|Adverse Event|0|||
161895185|NCT04530838|584666216|FG000|Overall Study|No longer meets eligibility criteria|1|||
161895186|NCT04530838|584666217|FG001|Overall Study|No longer meets eligibility criteria|0|||
161895187|NCT04530838|584666218|FG002|Overall Study|No longer meets eligibility criteria|2|||
161895188|NCT04530838|584666216|FG000|Overall Study|Withdrawal by parent/guardian|5|||
161895189|NCT04530838|584666217|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161895190|NCT04530838|584666218|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161895191|NCT02155309|584666223|FG000|Overall Study|Protocol Violation|0|||
161895192|NCT02155309|584666224|FG001|Overall Study|Protocol Violation|0|||
161895193|NCT02155309|584666225|FG002|Overall Study|Protocol Violation|1|||
161895194|NCT02501161|584666227|FG000|Overall Study|Adverse Event|2|||
161895195|NCT02501161|584666228|FG001|Overall Study|Adverse Event|6|||
161895196|NCT02501161|584666227|FG000|Overall Study|Lost to Follow-up|7|||
161895197|NCT02501161|584666228|FG001|Overall Study|Lost to Follow-up|4|||
161895198|NCT02501161|584666227|FG000|Overall Study|Withdrawal by Subject|10|||
161895199|NCT02501161|584666228|FG001|Overall Study|Withdrawal by Subject|15|||
161895200|NCT02501161|584666227|FG000|Overall Study|Other|3|||
161895201|NCT02501161|584666228|FG001|Overall Study|Other|0|||
161895202|NCT04336475|584666229|FG000|Overall Study|pain|1|||
161895203|NCT04336475|584666230|FG001|Overall Study|pain|0|||
161895204|NCT04336475|584666229|FG000|Overall Study|upper respiratory infection|1|||
161895205|NCT04336475|584666230|FG001|Overall Study|upper respiratory infection|0|||
161779408|NCT01678924|584235525|FG000|Overall Study|Unable to attend scheduled visits|0|||
161831462|NCT01730040|584424763|FG006|Overall Study|Subject moved|1|||
161831463|NCT01730040|584424757|FG000|Overall Study|Physician Decision|0|||
161831464|NCT01730040|584424758|FG001|Overall Study|Physician Decision|0|||
161831465|NCT01730040|584424759|FG002|Overall Study|Physician Decision|0|||
161831466|NCT01730040|584424760|FG003|Overall Study|Physician Decision|0|||
161831467|NCT01730040|584424761|FG004|Overall Study|Physician Decision|0|||
161831468|NCT01730040|584424762|FG005|Overall Study|Physician Decision|1|||
161831469|NCT01730040|584424763|FG006|Overall Study|Physician Decision|1|||
161831470|NCT01730040|584424757|FG000|Overall Study|Other than specified|7|||
161831471|NCT01730040|584424758|FG001|Overall Study|Other than specified|8|||
161831472|NCT01730040|584424759|FG002|Overall Study|Other than specified|5|||
161831473|NCT01730040|584424760|FG003|Overall Study|Other than specified|5|||
161831474|NCT01730040|584424761|FG004|Overall Study|Other than specified|5|||
161831475|NCT01730040|584424762|FG005|Overall Study|Other than specified|4|||
161831476|NCT01730040|584424763|FG006|Overall Study|Other than specified|4|||
161895206|NCT04336475|584666229|FG000|Overall Study|Lost to Follow-up|0|||
161895207|NCT04336475|584666230|FG001|Overall Study|Lost to Follow-up|2|||
161895208|NCT02030119|584666233|FG000|Overall Study|Withdrawal by Subject|3|||
161895209|NCT02030119|584666234|FG001|Overall Study|Withdrawal by Subject|1|||
161895210|NCT02030119|584666235|FG002|Overall Study|Withdrawal by Subject|5|||
161895211|NCT02030119|584666236|FG003|Overall Study|Withdrawal by Subject|3|||
161895212|NCT02030119|584666233|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
161895213|NCT02030119|584666234|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
161895214|NCT02030119|584666235|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
161895215|NCT02030119|584666236|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
161895216|NCT02213380|584666241|FG000|Underwent Randomization|Withdrawal by Subject|2|||
161895217|NCT02213380|584666242|FG001|Underwent Randomization|Withdrawal by Subject|0|||
161895218|NCT02213380|584666241|FG000|Underwent Randomization|Not treated|3|||
161895219|NCT02213380|584666242|FG001|Underwent Randomization|Not treated|3|||
161895220|NCT02213380|584666241|FG000|Per-protocol Analysis|Protocol Violation|32|||
161895221|NCT02213380|584666242|FG001|Per-protocol Analysis|Protocol Violation|36|||
161895222|NCT01465230|584666251|FG000|Overall Study|Withdrawal by Subject|2|||
161895223|NCT00905567|584666252|FG000|Washout|Withdrawal by Subject|0|||
161895224|NCT00905567|584666253|FG001|Washout|Withdrawal by Subject|1|||
161895225|NCT01738919|584666259|FG000|Overall Study|Lost to Follow-up|1|||
161895226|NCT01738919|584666260|FG001|Overall Study|Lost to Follow-up|0|||
161895227|NCT01738919|584666259|FG000|Overall Study|Immigrated|0|||
161895228|NCT01738919|584666260|FG001|Overall Study|Immigrated|1|||
161895229|NCT01738919|584666259|FG000|Overall Study|Withdrawal by Subject|0|||
161779409|NCT01678924|584235526|FG001|Overall Study|Unable to attend scheduled visits|0|||
161779410|NCT01678924|584235527|FG002|Overall Study|Unable to attend scheduled visits|0|||
161779411|NCT01678924|584235528|FG003|Overall Study|Unable to attend scheduled visits|1|||
161779412|NCT02253654|584235529|FG000|Overall Study|Withdrawal by Subject|12|||
161895230|NCT01738919|584666260|FG001|Overall Study|Withdrawal by Subject|1|||
161436030|NCT02266888|582991265|FG000|Overall Study|Physician Decision|0|||
161436031|NCT02266888|582991266|FG001|Overall Study|Physician Decision|1|||
161665595|NCT00490724|583828394|FG002|Period I|Physician Decision|1|||
161436032|NCT02266888|582991267|FG002|Overall Study|Physician Decision|2|||
161436033|NCT02266888|582991268|FG003|Overall Study|Physician Decision|2|||
161436034|NCT02266888|582991265|FG000|Overall Study|Study Terminated|5|||
161436035|NCT02266888|582991266|FG001|Overall Study|Study Terminated|1|||
161551563|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
161551564|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
161551565|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551566|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551567|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551568|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551569|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551570|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551571|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551572|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551573|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551574|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551575|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551576|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551577|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551578|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
161551579|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
161551580|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
161551581|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
161895231|NCT01738919|584666259|FG000|Overall Study|Not treated in accordance to guidelines|0|||
161436036|NCT02266888|582991267|FG002|Overall Study|Study Terminated|0|||
161436037|NCT02266888|582991268|FG003|Overall Study|Study Terminated|0|||
161436038|NCT02266888|582991265|FG000|Overall Study|No Longer Eligible|0|||
161436039|NCT02266888|582991266|FG001|Overall Study|No Longer Eligible|0|||
161436040|NCT02266888|582991267|FG002|Overall Study|No Longer Eligible|0|||
161551582|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
161551583|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551584|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161895232|NCT01738919|584666260|FG001|Overall Study|Not treated in accordance to guidelines|1|||
161895233|NCT02532257|584666261|FG000|Overall Study|Adverse Event|2|||
161436041|NCT02266888|582991268|FG003|Overall Study|No Longer Eligible|2|||
161436042|NCT02266888|582991265|FG000|Overall Study|Randomization Closed|0|||
161436043|NCT02266888|582991266|FG001|Overall Study|Randomization Closed|0|||
161436044|NCT02266888|582991267|FG002|Overall Study|Randomization Closed|4|||
161436045|NCT02266888|582991268|FG003|Overall Study|Randomization Closed|0|||
161436046|NCT02266888|582991265|FG000|Overall Study|Personnel unavailable at transplant|0|||
161436047|NCT02266888|582991266|FG001|Overall Study|Personnel unavailable at transplant|0|||
161895234|NCT02532257|584666261|FG000|Overall Study|Physician Decision|4|||
161895235|NCT02532257|584666261|FG000|Overall Study|Withdrawal by Subject|3|||
161895236|NCT02532257|584666261|FG000|Overall Study|Progressive Disease|10|||
161895237|NCT02259400|584666262|FG000|Overall Study|Death|0|||
161895238|NCT02259400|584666263|FG001|Overall Study|Death|2|||
161895239|NCT03498313|584666267|FG000|Experimental Period 1|Adverse Event|1|||
161895240|NCT03498313|584666268|FG001|Experimental Period 1|Adverse Event|0|||
161895241|NCT03498313|584666269|FG002|Experimental Period 1|Adverse Event|0|||
161895242|NCT03498313|584666270|FG003|Experimental Period 1|Adverse Event|1|||
161895243|NCT03498313|584666271|FG004|Experimental Period 1|Adverse Event|0|||
161895244|NCT03498313|584666272|FG005|Experimental Period 1|Adverse Event|0|||
161895245|NCT03498313|584666267|FG000|Experimental Period 1|Withdrawal by Subject|0|||
161895246|NCT03498313|584666268|FG001|Experimental Period 1|Withdrawal by Subject|1|||
161895247|NCT03498313|584666269|FG002|Experimental Period 1|Withdrawal by Subject|0|||
161895248|NCT03498313|584666270|FG003|Experimental Period 1|Withdrawal by Subject|0|||
161895249|NCT03498313|584666271|FG004|Experimental Period 1|Withdrawal by Subject|0|||
161895250|NCT03498313|584666272|FG005|Experimental Period 1|Withdrawal by Subject|0|||
161895251|NCT03498313|584666267|FG000|Washout Period 1|Anovulation|1|||
161895252|NCT03498313|584666268|FG001|Washout Period 1|Anovulation|0|||
161895253|NCT03498313|584666269|FG002|Washout Period 1|Anovulation|0|||
161895254|NCT03498313|584666270|FG003|Washout Period 1|Anovulation|0|||
161895255|NCT03498313|584666271|FG004|Washout Period 1|Anovulation|0|||
161895256|NCT03498313|584666272|FG005|Washout Period 1|Anovulation|0|||
161895257|NCT03498313|584666267|FG000|Washout Period 1|Withdrawal by Subject|0|||
161895258|NCT03498313|584666268|FG001|Washout Period 1|Withdrawal by Subject|3|||
161895259|NCT03498313|584666269|FG002|Washout Period 1|Withdrawal by Subject|0|||
161895260|NCT03498313|584666270|FG003|Washout Period 1|Withdrawal by Subject|1|||
161895261|NCT03498313|584666271|FG004|Washout Period 1|Withdrawal by Subject|0|||
161895262|NCT03498313|584666272|FG005|Washout Period 1|Withdrawal by Subject|1|||
161895263|NCT03498313|584666267|FG000|Experimental Period 2|Adverse Event|0|||
161895264|NCT03498313|584666268|FG001|Experimental Period 2|Adverse Event|0|||
161895265|NCT03498313|584666269|FG002|Experimental Period 2|Adverse Event|0|||
161779413|NCT02253654|584235530|FG001|Overall Study|Withdrawal by Subject|4|||
161779414|NCT02253654|584235529|FG000|Overall Study|Decision by Sponsor|1|||
161779415|NCT02253654|584235530|FG001|Overall Study|Decision by Sponsor|1|||
161779416|NCT02253654|584235529|FG000|Overall Study|Lost to Follow-up|2|||
161779417|NCT02253654|584235530|FG001|Overall Study|Lost to Follow-up|5|||
161779418|NCT02253654|584235529|FG000|Overall Study|Death|4|||
161779419|NCT02253654|584235530|FG001|Overall Study|Death|7|||
161779420|NCT02253654|584235529|FG000|Overall Study|Did Not Receive Study Treatment|4|||
161895266|NCT03498313|584666270|FG003|Experimental Period 2|Adverse Event|0|||
161779421|NCT02253654|584235530|FG001|Overall Study|Did Not Receive Study Treatment|1|||
161779422|NCT01614925|584235531|FG000|Overall Study|Withdrawal by Subject|1|||
161779423|NCT01614925|584235532|FG001|Overall Study|Withdrawal by Subject|0|||
161779424|NCT01614925|584235531|FG000|Overall Study|Protocol Violation|3|||
161779425|NCT01614925|584235532|FG001|Overall Study|Protocol Violation|2|||
161779426|NCT01652573|584235543|FG000|Overall Study|Adverse Event|0|||
161779427|NCT01652573|584235544|FG001|Overall Study|Adverse Event|1|||
161895267|NCT03498313|584666271|FG004|Experimental Period 2|Adverse Event|1|||
161895268|NCT03498313|584666272|FG005|Experimental Period 2|Adverse Event|2|||
161895269|NCT03498313|584666267|FG000|Washout Period 2|Physician Decision|1|||
161895270|NCT03498313|584666268|FG001|Washout Period 2|Physician Decision|0|||
161895271|NCT03498313|584666269|FG002|Washout Period 2|Physician Decision|0|||
161895272|NCT03498313|584666270|FG003|Washout Period 2|Physician Decision|1|||
161895273|NCT03498313|584666271|FG004|Washout Period 2|Physician Decision|0|||
161895274|NCT03498313|584666272|FG005|Washout Period 2|Physician Decision|1|||
161895275|NCT03498313|584666267|FG000|Washout Period 2|Withdrawal by Subject|3|||
161895276|NCT03498313|584666268|FG001|Washout Period 2|Withdrawal by Subject|2|||
161895277|NCT03498313|584666269|FG002|Washout Period 2|Withdrawal by Subject|0|||
161895278|NCT03498313|584666270|FG003|Washout Period 2|Withdrawal by Subject|0|||
161895279|NCT03498313|584666271|FG004|Washout Period 2|Withdrawal by Subject|2|||
161895280|NCT03498313|584666272|FG005|Washout Period 2|Withdrawal by Subject|0|||
161895281|NCT03498313|584666267|FG000|Washout Period 2|Anovulation|0|||
161895282|NCT03498313|584666268|FG001|Washout Period 2|Anovulation|0|||
161895283|NCT03498313|584666269|FG002|Washout Period 2|Anovulation|0|||
161895284|NCT03498313|584666270|FG003|Washout Period 2|Anovulation|0|||
161895285|NCT03498313|584666271|FG004|Washout Period 2|Anovulation|0|||
161895286|NCT03498313|584666272|FG005|Washout Period 2|Anovulation|1|||
161895287|NCT02372383|584666276|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
161895288|NCT02372383|584666277|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
161895289|NCT02372383|584666278|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
161895290|NCT00621257|584666279|FG000|Overall Study|Lost to Follow-up|4|||
161895291|NCT00621257|584666280|FG001|Overall Study|Lost to Follow-up|0|||
161895292|NCT00621257|584666281|FG002|Overall Study|Lost to Follow-up|2|||
161895293|NCT00621257|584666282|FG003|Overall Study|Lost to Follow-up|4|||
161895294|NCT00621257|584666283|FG004|Overall Study|Lost to Follow-up|7|||
161895295|NCT00621257|584666279|FG000|Overall Study|Adverse Event|0|||
161895296|NCT00621257|584666280|FG001|Overall Study|Adverse Event|1|||
161895297|NCT00621257|584666281|FG002|Overall Study|Adverse Event|1|||
161895298|NCT00621257|584666282|FG003|Overall Study|Adverse Event|0|||
161895299|NCT00621257|584666283|FG004|Overall Study|Adverse Event|0|||
161895300|NCT00621257|584666279|FG000|Overall Study|Physician Decision|0|||
161895301|NCT00621257|584666280|FG001|Overall Study|Physician Decision|2|||
161895302|NCT00621257|584666281|FG002|Overall Study|Physician Decision|0|||
161895303|NCT00621257|584666282|FG003|Overall Study|Physician Decision|1|||
161895304|NCT00621257|584666283|FG004|Overall Study|Physician Decision|1|||
161895305|NCT00621257|584666279|FG000|Overall Study|Withdrawal by Subject|0|||
161895306|NCT00621257|584666280|FG001|Overall Study|Withdrawal by Subject|0|||
161895307|NCT00621257|584666281|FG002|Overall Study|Withdrawal by Subject|0|||
161895308|NCT00621257|584666282|FG003|Overall Study|Withdrawal by Subject|1|||
161895309|NCT00621257|584666283|FG004|Overall Study|Withdrawal by Subject|1|||
161895310|NCT01255904|584666284|FG000|Overall Study|Physician Decision|1|||
161895311|NCT01255904|584666285|FG001|Overall Study|Physician Decision|4|||
161895312|NCT00694356|584666292|FG000|Overall Study|Adverse Event|1|||
161895313|NCT00694356|584666293|FG001|Overall Study|Adverse Event|0|||
161895314|NCT00694356|584666294|FG002|Overall Study|Adverse Event|0|||
161895315|NCT00694356|584666292|FG000|Overall Study|Progressive Disease|2|||
161895316|NCT00694356|584666293|FG001|Overall Study|Progressive Disease|6|||
161895317|NCT00694356|584666294|FG002|Overall Study|Progressive Disease|6|||
161895318|NCT02756819|584666295|FG000|Overall Study|Lost for observation|23|||
161895319|NCT02756819|584666295|FG000|Overall Study|Patient's unwillingness|16|||
161895320|NCT02756819|584666295|FG000|Overall Study|Insufficient efficacy|2|||
161895321|NCT02756819|584666295|FG000|Overall Study|Adverse Event|2|||
161895322|NCT02756819|584666295|FG000|Overall Study|Reason not Specified|9|||
161895323|NCT00741598|584666296|FG000|Overall Study|Lost to Follow-up|3|||
161895324|NCT00741598|584666297|FG001|Overall Study|Lost to Follow-up|4|||
161895325|NCT00741598|584666296|FG000|Overall Study|Lack of Efficacy|1|||
161779428|NCT00934622|584235545|FG000|Overall Study|Lost to Follow-up|7|||
161779429|NCT00934622|584235545|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
161551585|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551586|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551587|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551588|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551589|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551590|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551591|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551592|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551593|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551594|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551595|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551596|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551597|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551598|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161551599|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
161551600|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
161551601|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
161551602|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
161551603|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
161551604|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
161551605|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
161551606|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
161551607|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
161551608|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
161551609|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
161551610|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
161551611|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
161551612|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
161551613|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
161551614|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
161551615|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
161551616|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
161551617|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
161551618|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
161551619|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551620|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551621|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551622|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551623|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551624|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551625|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551626|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551627|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551628|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551629|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551630|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551631|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551632|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551633|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551634|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
161551635|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
161551636|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
161895326|NCT00741598|584666297|FG001|Overall Study|Lack of Efficacy|2|||
161551637|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
161551638|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
161551639|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
161551640|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
161551641|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
161551642|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
161551643|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
161551644|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
161551645|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
161551646|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
161551647|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
161551648|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
161551649|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
161551650|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
161551651|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
161551652|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
161551653|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
161551654|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
161551655|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551656|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551657|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551658|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551659|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551660|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551661|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551662|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551663|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551664|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551665|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551666|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551667|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551668|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551669|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
161551670|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551671|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
161895327|NCT00741598|584666296|FG000|Overall Study|Physician Decision|1|||
161551672|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
161551673|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551674|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551675|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551676|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551677|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551678|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551679|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551680|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551681|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551682|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551683|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551684|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551685|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551686|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551687|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
161551688|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551689|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
161551690|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
161551691|NCT01474512|583408812|FG000|Post-Treatment Follow-Up|Death|0|||
161551692|NCT01474512|583408813|FG001|Post-Treatment Follow-Up|Death|0|||
161551693|NCT01474512|583408814|FG002|Post-Treatment Follow-Up|Death|0|||
161551694|NCT01474512|583408815|FG003|Post-Treatment Follow-Up|Death|0|||
161551695|NCT01474512|583408816|FG004|Post-Treatment Follow-Up|Death|0|||
161551696|NCT01474512|583408817|FG005|Post-Treatment Follow-Up|Death|0|||
161551697|NCT01474512|583408818|FG006|Post-Treatment Follow-Up|Death|0|||
161551698|NCT01474512|583408819|FG007|Post-Treatment Follow-Up|Death|0|||
161551699|NCT01474512|583408820|FG008|Post-Treatment Follow-Up|Death|0|||
161551700|NCT01474512|583408821|FG009|Post-Treatment Follow-Up|Death|0|||
161551701|NCT01474512|583408822|FG010|Post-Treatment Follow-Up|Death|0|||
161551702|NCT01474512|583408823|FG011|Post-Treatment Follow-Up|Death|0|||
161551703|NCT01474512|583408824|FG012|Post-Treatment Follow-Up|Death|0|||
161551704|NCT01474512|583408825|FG013|Post-Treatment Follow-Up|Death|0|||
161551705|NCT01474512|583408826|FG014|Post-Treatment Follow-Up|Death|0|||
161551706|NCT01474512|583408827|FG015|Post-Treatment Follow-Up|Death|0|||
161551707|NCT01474512|583408828|FG016|Post-Treatment Follow-Up|Death|1|||
161551708|NCT01474512|583408829|FG017|Post-Treatment Follow-Up|Death|0|||
161551709|NCT01118962|583408834|FG000|Overall Study|Adverse Event|2|||
161551710|NCT01118962|583408834|FG000|Overall Study|Lack of Efficacy|1|||
161551711|NCT01118962|583408834|FG000|Overall Study|Protocol Violation|1|||
161551712|NCT01118962|583408834|FG000|Overall Study|Withdrawal by Subject|4|||
161551713|NCT01118962|583408834|FG000|Overall Study|Pregnancy|1|||
161551714|NCT01118962|583408834|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
161551715|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
161551716|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
161551717|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
161551718|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
161551719|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
161551720|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
161551721|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
161551722|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
161551723|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
161551724|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
161551725|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
161551726|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
161551727|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
161551728|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
161551729|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
161551730|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
161551731|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
161551732|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
161551733|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
161551734|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
161551735|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
161551736|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
161551737|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
161551738|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
161551739|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
161551740|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
161551741|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
161779430|NCT00468312|584235548|FG000|Overall Study|Adverse Event|2|||
161551742|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
161551743|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
161779431|NCT00468312|584235549|FG001|Overall Study|Adverse Event|1|||
161551744|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
161551745|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
161551746|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
161551747|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
161551748|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
161551749|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
161551750|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
161551751|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
161551752|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
161551753|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
161551754|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
161551755|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
161551756|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
161551757|NCT01089556|583408835|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
161551758|NCT01089556|583408836|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
161551759|NCT01089556|583408837|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
161551760|NCT01089556|583408838|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
161551761|NCT01089556|583408839|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
161551762|NCT01089556|583408840|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
161551763|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
161551764|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
161551765|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
161551766|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
161551767|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
161551768|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
161551769|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
161551770|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
161551771|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
161551772|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
161551773|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
161551774|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
161551775|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
161551776|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
161551777|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
161551778|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
161551779|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
161551780|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
161551781|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
161551782|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
161551783|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
161551784|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
161551785|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
161551786|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
161551787|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
161551788|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
161551789|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
161551790|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
161551791|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
161551792|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
161551793|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
161551794|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
161551795|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
161551796|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
161551797|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
161551798|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
161551799|NCT01089556|583408835|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
161551800|NCT01089556|583408836|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
161551801|NCT01089556|583408837|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
161551802|NCT01089556|583408838|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
161551803|NCT01089556|583408839|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
161551804|NCT01089556|583408840|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
161551805|NCT02222896|583408841|FG000|Abdomen|Did not qualify|34|||
161551806|NCT02222896|583408842|FG001|Abdomen|Did not qualify|10|||
161551807|NCT02222896|583408843|FG002|Abdomen|Did not qualify|32|||
161551808|NCT02222896|583408841|FG000|Groin|Did not qualify|43|||
161551809|NCT02222896|583408842|FG001|Groin|Did not qualify|9|||
161551810|NCT02222896|583408843|FG002|Groin|Did not qualify|40|||
161551811|NCT01865617|583408845|FG000|Overall Study|Death|27|||
161551812|NCT01865617|583408846|FG001|Overall Study|Death|3|||
161551813|NCT01865617|583408847|FG002|Overall Study|Death|1|||
161551814|NCT01865617|583408848|FG003|Overall Study|Death|1|||
161551815|NCT01865617|583408849|FG004|Overall Study|Death|5|||
161551816|NCT01865617|583408850|FG005|Overall Study|Death|1|||
161551817|NCT01865617|583408851|FG006|Overall Study|Death|11|||
161551818|NCT01865617|583408852|FG007|Overall Study|Death|1|||
161551819|NCT01865617|583408853|FG008|Overall Study|Death|11|||
161551820|NCT01865617|583408854|FG009|Overall Study|Death|3|||
161551821|NCT01865617|583408855|FG010|Overall Study|Death|32|||
161551822|NCT01865617|583408856|FG011|Overall Study|Death|6|||
161551823|NCT01865617|583408857|FG012|Overall Study|Death|13|||
161551824|NCT01865617|583408845|FG000|Overall Study|Lost to Follow-up|2|||
161551825|NCT01865617|583408846|FG001|Overall Study|Lost to Follow-up|0|||
161551826|NCT01865617|583408847|FG002|Overall Study|Lost to Follow-up|0|||
161551827|NCT01865617|583408848|FG003|Overall Study|Lost to Follow-up|0|||
161551828|NCT01865617|583408849|FG004|Overall Study|Lost to Follow-up|0|||
161551829|NCT01865617|583408850|FG005|Overall Study|Lost to Follow-up|0|||
161551830|NCT01865617|583408851|FG006|Overall Study|Lost to Follow-up|0|||
161551831|NCT01865617|583408852|FG007|Overall Study|Lost to Follow-up|0|||
161551832|NCT01865617|583408853|FG008|Overall Study|Lost to Follow-up|0|||
161551833|NCT01865617|583408854|FG009|Overall Study|Lost to Follow-up|0|||
161551834|NCT01865617|583408855|FG010|Overall Study|Lost to Follow-up|0|||
161551835|NCT01865617|583408856|FG011|Overall Study|Lost to Follow-up|0|||
161551836|NCT01865617|583408857|FG012|Overall Study|Lost to Follow-up|0|||
161551837|NCT01865617|583408845|FG000|Overall Study|Withdrawal by Subject|1|||
161551838|NCT01865617|583408846|FG001|Overall Study|Withdrawal by Subject|0|||
161551839|NCT01865617|583408847|FG002|Overall Study|Withdrawal by Subject|0|||
161551840|NCT01865617|583408848|FG003|Overall Study|Withdrawal by Subject|0|||
161551841|NCT01865617|583408849|FG004|Overall Study|Withdrawal by Subject|0|||
161551842|NCT01865617|583408850|FG005|Overall Study|Withdrawal by Subject|0|||
161551843|NCT01865617|583408851|FG006|Overall Study|Withdrawal by Subject|0|||
161551844|NCT01865617|583408852|FG007|Overall Study|Withdrawal by Subject|0|||
161551845|NCT01865617|583408853|FG008|Overall Study|Withdrawal by Subject|0|||
161551846|NCT01865617|583408854|FG009|Overall Study|Withdrawal by Subject|0|||
161551847|NCT01865617|583408855|FG010|Overall Study|Withdrawal by Subject|0|||
161551848|NCT01865617|583408856|FG011|Overall Study|Withdrawal by Subject|0|||
161551849|NCT01865617|583408857|FG012|Overall Study|Withdrawal by Subject|0|||
161551850|NCT01865617|583408845|FG000|Overall Study|Patient proceeded to new therapy|0|||
161551851|NCT01865617|583408846|FG001|Overall Study|Patient proceeded to new therapy|0|||
161551852|NCT01865617|583408847|FG002|Overall Study|Patient proceeded to new therapy|0|||
161551853|NCT01865617|583408848|FG003|Overall Study|Patient proceeded to new therapy|0|||
161551854|NCT01865617|583408849|FG004|Overall Study|Patient proceeded to new therapy|2|||
161551855|NCT01865617|583408850|FG005|Overall Study|Patient proceeded to new therapy|0|||
161551856|NCT01865617|583408851|FG006|Overall Study|Patient proceeded to new therapy|0|||
161551857|NCT01865617|583408852|FG007|Overall Study|Patient proceeded to new therapy|0|||
161551858|NCT01865617|583408853|FG008|Overall Study|Patient proceeded to new therapy|0|||
161551859|NCT01865617|583408854|FG009|Overall Study|Patient proceeded to new therapy|0|||
161551860|NCT01865617|583408855|FG010|Overall Study|Patient proceeded to new therapy|0|||
161551861|NCT01865617|583408856|FG011|Overall Study|Patient proceeded to new therapy|0|||
161551862|NCT01865617|583408857|FG012|Overall Study|Patient proceeded to new therapy|0|||
161551863|NCT01865617|583408845|FG000|Overall Study|Other|0|||
161551864|NCT01865617|583408846|FG001|Overall Study|Other|0|||
161551865|NCT01865617|583408847|FG002|Overall Study|Other|0|||
161551866|NCT01865617|583408848|FG003|Overall Study|Other|0|||
161551867|NCT01865617|583408849|FG004|Overall Study|Other|0|||
161551868|NCT01865617|583408850|FG005|Overall Study|Other|0|||
161551869|NCT01865617|583408851|FG006|Overall Study|Other|1|||
161551870|NCT01865617|583408852|FG007|Overall Study|Other|0|||
161551871|NCT01865617|583408853|FG008|Overall Study|Other|0|||
161551872|NCT01865617|583408854|FG009|Overall Study|Other|0|||
161551873|NCT01865617|583408855|FG010|Overall Study|Other|0|||
161551874|NCT01865617|583408856|FG011|Overall Study|Other|0|||
161551875|NCT01865617|583408857|FG012|Overall Study|Other|0|||
161551876|NCT02500979|583408858|FG000|Period 1|Hyperglycemia|1|||
161551877|NCT02500979|583408859|FG001|Period 1|Hyperglycemia|0|||
161551878|NCT02500979|583408858|FG000|Period 1|Severe non-compliance to protocol|0|||
161551879|NCT02500979|583408859|FG001|Period 1|Severe non-compliance to protocol|1|||
161551880|NCT02500979|583408858|FG000|Period 1|Adverse Event|1|||
161551881|NCT02500979|583408859|FG001|Period 1|Adverse Event|0|||
161551882|NCT02500979|583408858|FG000|Period 1|Subject decision|2|||
161551883|NCT02500979|583408859|FG001|Period 1|Subject decision|0|||
161551884|NCT02500979|583408858|FG000|Period 2|Change in risk|1|||
161551885|NCT02500979|583408859|FG001|Period 2|Change in risk|0|||
161551886|NCT00119262|583408860|FG000|Overall Study|Lack of Efficacy|0|||
161551887|NCT00119262|583408861|FG001|Overall Study|Lack of Efficacy|3|||
161551888|NCT00119262|583408860|FG000|Overall Study|Withdrawal by Subject|12|||
161551889|NCT00119262|583408861|FG001|Overall Study|Withdrawal by Subject|11|||
161551890|NCT00119262|583408860|FG000|Overall Study|Adverse Event|33|||
161551891|NCT00119262|583408861|FG001|Overall Study|Adverse Event|35|||
161551892|NCT00119262|583408860|FG000|Overall Study|other disease|0|||
161551893|NCT00119262|583408861|FG001|Overall Study|other disease|2|||
161551894|NCT00119262|583408860|FG000|Overall Study|ineligble|1|||
161551895|NCT00119262|583408861|FG001|Overall Study|ineligble|2|||
161551896|NCT00119262|583408860|FG000|Overall Study|others|0|||
161551897|NCT00119262|583408861|FG001|Overall Study|others|5|||
161551898|NCT03853317|583408862|FG000|Overall Study|Progressive Disease|5|||
161551899|NCT03853317|583408862|FG000|Overall Study|Adverse Event|1|||
161551900|NCT03853317|583408862|FG000|Overall Study|Death|1|||
161551901|NCT03853317|583408862|FG000|Overall Study|other event|2|||
161551902|NCT03881059|583408864|FG000|Treatment Period - Part A|Adverse Event|1|||
161551903|NCT03881059|583408865|FG001|Treatment Period - Part A|Adverse Event|3|||
161551904|NCT03881059|583408866|FG002|Treatment Period - Part A|Adverse Event|4|||
161551905|NCT03881059|583408864|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
161551906|NCT03881059|583408865|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
161779432|NCT00468312|584235548|FG000|Overall Study|Lack of Efficacy|0|||
161779433|NCT00468312|584235549|FG001|Overall Study|Lack of Efficacy|1|||
161779434|NCT00468312|584235548|FG000|Overall Study|Withdrawal by Subject|0|||
161551907|NCT03881059|583408866|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
161551908|NCT03881059|583408864|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
161551909|NCT03881059|583408865|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
161551910|NCT03881059|583408866|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
161551911|NCT03881059|583408864|FG000|Treatment Period - Part A|Other reasons|2|||
161551912|NCT03881059|583408865|FG001|Treatment Period - Part A|Other reasons|1|||
161436048|NCT02266888|582991267|FG002|Overall Study|Personnel unavailable at transplant|0|||
161779435|NCT00468312|584235549|FG001|Overall Study|Withdrawal by Subject|1|||
161779436|NCT00468312|584235548|FG000|Overall Study|Protocol Violation|2|||
161551913|NCT03881059|583408866|FG002|Treatment Period - Part A|Other reasons|0|||
161551914|NCT03881059|583408864|FG000|Treatment Period - Part B|Adverse Event|0|||
161551915|NCT03881059|583408865|FG001|Treatment Period - Part B|Adverse Event|0|||
161551916|NCT03881059|583408866|FG002|Treatment Period - Part B|Adverse Event|3|||
161551917|NCT03881059|583408864|FG000|Treatment Period - Part B|Death|0|||
161551918|NCT03881059|583408865|FG001|Treatment Period - Part B|Death|1|||
161665596|NCT00490724|583828392|FG000|Period II|Treatment Discontinuation|3|||
161665597|NCT00490724|583828393|FG001|Period II|Treatment Discontinuation|1|||
161665598|NCT00490724|583828394|FG002|Period II|Treatment Discontinuation|3|||
161665599|NCT00903682|583828396|FG000|Overall Study|Adverse Event|6|||
161665600|NCT00903682|583828397|FG001|Overall Study|Adverse Event|13|||
161665601|NCT00903682|583828396|FG000|Overall Study|Lost to Follow-up|1|||
161665602|NCT00903682|583828397|FG001|Overall Study|Lost to Follow-up|0|||
161665603|NCT00903682|583828396|FG000|Overall Study|Withdrawal by Subject|5|||
161665604|NCT00903682|583828397|FG001|Overall Study|Withdrawal by Subject|0|||
161665605|NCT00903682|583828396|FG000|Overall Study|Pregnancy|0|||
161665606|NCT00903682|583828397|FG001|Overall Study|Pregnancy|1|||
161665607|NCT00903682|583828396|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
161665608|NCT00903682|583828397|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
161665609|NCT00903682|583828396|FG000|Overall Study|Subject Non-Compliant|1|||
161665610|NCT00903682|583828397|FG001|Overall Study|Subject Non-Compliant|0|||
161665611|NCT00903682|583828396|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
161665612|NCT00903682|583828397|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
161665613|NCT00903682|583828396|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
161665614|NCT00903682|583828397|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
161665615|NCT03866473|583828398|FG000|Phase 1|Death|1|||
161665616|NCT03866473|583828399|FG001|Phase 1|Death|0|||
161665617|NCT03866473|583828398|FG000|Phase 2|Death|0|||
161665618|NCT03866473|583828399|FG001|Phase 2|Death|2|||
161665619|NCT03866473|583828398|FG000|Phase 2|Dropped|1|||
161665620|NCT03866473|583828399|FG001|Phase 2|Dropped|1|||
161665621|NCT03866473|583828398|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
161665622|NCT03866473|583828399|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
161665623|NCT03110185|583828400|FG000|Overall Study|Death|0|||
161665624|NCT03110185|583828401|FG001|Overall Study|Death|1|||
161665625|NCT03110185|583828400|FG000|Overall Study|Withdrawal by Subject|2|||
161665626|NCT03110185|583828401|FG001|Overall Study|Withdrawal by Subject|7|||
161665627|NCT03110185|583828400|FG000|Overall Study|Time Constraints|0|||
161665628|NCT03110185|583828401|FG001|Overall Study|Time Constraints|6|||
161665629|NCT03110185|583828400|FG000|Overall Study|Conflict with care|5|||
161665630|NCT03110185|583828401|FG001|Overall Study|Conflict with care|12|||
161665631|NCT03110185|583828400|FG000|Overall Study|Protocol Violation|1|||
161665632|NCT03110185|583828401|FG001|Overall Study|Protocol Violation|4|||
161665633|NCT03110185|583828400|FG000|Overall Study|MRI Incompatible|2|||
161665634|NCT03110185|583828401|FG001|Overall Study|MRI Incompatible|0|||
161665635|NCT03110185|583828400|FG000|Overall Study|Patient Refusal|0|||
161665636|NCT03110185|583828401|FG001|Overall Study|Patient Refusal|1|||
161665637|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
161665638|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
161665639|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
161665640|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
161665641|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
161665642|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
161665643|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
161665644|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
161665645|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
161665646|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
161665647|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
161551919|NCT03881059|583408866|FG002|Treatment Period - Part B|Death|1|||
161551920|NCT03881059|583408864|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
161551921|NCT03881059|583408865|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
161551922|NCT03881059|583408866|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
161551923|NCT03881059|583408864|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
161551924|NCT03881059|583408865|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
161551925|NCT03881059|583408866|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
161551926|NCT03881059|583408864|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
161551927|NCT03881059|583408865|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
161551928|NCT03881059|583408866|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
161551929|NCT03881059|583408864|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
161551930|NCT03881059|583408865|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
161551931|NCT03881059|583408866|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
161551932|NCT03881059|583408864|FG000|Treatment Period - Part B|Other reasons|4|||
161551933|NCT03881059|583408865|FG001|Treatment Period - Part B|Other reasons|3|||
161551934|NCT03881059|583408866|FG002|Treatment Period - Part B|Other reasons|3|||
161551935|NCT02743793|583408867|FG000|Overall Study|Death|1|||
161682986|NCT02969915|583890220|FG001|Overall Study|Death|125|||
161682987|NCT02969915|583890219|FG000|Overall Study|Lost to Follow-up|108|||
161551936|NCT02743793|583408868|FG001|Overall Study|Death|1|||
161551937|NCT02743793|583408867|FG000|Overall Study|Withdrawal by Subject|0|||
161551938|NCT02743793|583408868|FG001|Overall Study|Withdrawal by Subject|1|||
161551939|NCT02743793|583408867|FG000|Overall Study|Screen Failure|4|||
161551940|NCT02743793|583408868|FG001|Overall Study|Screen Failure|0|||
161551941|NCT02743793|583408867|FG000|Overall Study|No Primary Care Physician|0|||
161551942|NCT02743793|583408868|FG001|Overall Study|No Primary Care Physician|1|||
161551943|NCT02743793|583408867|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
161551944|NCT02743793|583408868|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
161551945|NCT02743793|583408867|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
161551946|NCT02743793|583408868|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
161551947|NCT02065570|583408869|FG000|Induction Study|Adverse Event|5|||
161551948|NCT02065570|583408870|FG001|Induction Study|Adverse Event|12|||
161551949|NCT02065570|583408871|FG002|Induction Study|Adverse Event|0|||
161551950|NCT02065570|583408872|FG003|Induction Study|Adverse Event|0|||
161551951|NCT02065570|583408869|FG000|Induction Study|Withdrawal by Subject|2|||
161551952|NCT02065570|583408870|FG001|Induction Study|Withdrawal by Subject|3|||
161551953|NCT02065570|583408871|FG002|Induction Study|Withdrawal by Subject|0|||
161551954|NCT02065570|583408872|FG003|Induction Study|Withdrawal by Subject|0|||
161551955|NCT02065570|583408869|FG000|Induction Study|Lost to Follow-up|1|||
161551956|NCT02065570|583408870|FG001|Induction Study|Lost to Follow-up|1|||
161551957|NCT02065570|583408871|FG002|Induction Study|Lost to Follow-up|0|||
161551958|NCT02065570|583408872|FG003|Induction Study|Lost to Follow-up|0|||
161551959|NCT02065570|583408869|FG000|Induction Study|Other, Not Specified|6|||
161551960|NCT02065570|583408870|FG001|Induction Study|Other, Not Specified|5|||
161551961|NCT02065570|583408871|FG002|Induction Study|Other, Not Specified|0|||
161551962|NCT02065570|583408872|FG003|Induction Study|Other, Not Specified|0|||
161551963|NCT02065570|583408869|FG000|Maintenance Study|Adverse Event|0|||
161551964|NCT02065570|583408870|FG001|Maintenance Study|Adverse Event|0|||
161551965|NCT02065570|583408871|FG002|Maintenance Study|Adverse Event|8|||
161551966|NCT02065570|583408872|FG003|Maintenance Study|Adverse Event|8|||
161551967|NCT02065570|583408869|FG000|Maintenance Study|Withdrawal by Subject|0|||
161551968|NCT02065570|583408870|FG001|Maintenance Study|Withdrawal by Subject|0|||
161551969|NCT02065570|583408871|FG002|Maintenance Study|Withdrawal by Subject|1|||
161551970|NCT02065570|583408872|FG003|Maintenance Study|Withdrawal by Subject|4|||
161551971|NCT02065570|583408869|FG000|Maintenance Study|Lost to Follow-up|0|||
161551972|NCT02065570|583408870|FG001|Maintenance Study|Lost to Follow-up|0|||
161551973|NCT02065570|583408871|FG002|Maintenance Study|Lost to Follow-up|2|||
161551974|NCT02065570|583408872|FG003|Maintenance Study|Lost to Follow-up|2|||
161551975|NCT02065570|583408869|FG000|Maintenance Study|Other, Not Specified|0|||
161551976|NCT02065570|583408870|FG001|Maintenance Study|Other, Not Specified|0|||
161551977|NCT02065570|583408871|FG002|Maintenance Study|Other, Not Specified|11|||
161551978|NCT02065570|583408872|FG003|Maintenance Study|Other, Not Specified|5|||
161551979|NCT00786474|583408875|FG000|Overall Study|Death|5|||
161551980|NCT00786474|583408876|FG001|Overall Study|Death|4|||
161551981|NCT00786474|583408875|FG000|Overall Study|Withdrawal by Subject|23|||
161551982|NCT00786474|583408876|FG001|Overall Study|Withdrawal by Subject|31|||
161551983|NCT00786474|583408875|FG000|Overall Study|Lost to Follow-up|3|||
161551984|NCT00786474|583408876|FG001|Overall Study|Lost to Follow-up|3|||
161551985|NCT00786474|583408875|FG000|Overall Study|Physician Decision|2|||
161551986|NCT00786474|583408876|FG001|Overall Study|Physician Decision|1|||
161551987|NCT00786474|583408875|FG000|Overall Study|Other|4|||
161551988|NCT00786474|583408876|FG001|Overall Study|Other|4|||
161551989|NCT04642469|583408877|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
161551990|NCT04642469|583408878|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
161551991|NCT04642469|583408877|FG000|Overall Study|Death|1|||
161551992|NCT04642469|583408878|FG001|Overall Study|Death|2|||
161551993|NCT04642469|583408877|FG000|Overall Study|Study/site closed following amendment 1|11|||
161551994|NCT04642469|583408878|FG001|Overall Study|Study/site closed following amendment 1|11|||
161551995|NCT04642469|583408877|FG000|Overall Study|Other|1|||
161551996|NCT04642469|583408878|FG001|Overall Study|Other|1|||
161551997|NCT04642469|583408877|FG000|Overall Study|Withdrawal by Subject|1|||
161551998|NCT04642469|583408878|FG001|Overall Study|Withdrawal by Subject|0|||
161551999|NCT01088529|583408880|FG000|Overall Study|Did not receive study treatment|0|||
161552000|NCT01088529|583408881|FG001|Overall Study|Did not receive study treatment|1|||
161552001|NCT02838628|583408883|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
161552002|NCT02838628|583408884|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
161552003|NCT02838628|583408883|FG000|Recurrence Follow-up Period|Adverse Event|1|||
161552004|NCT02838628|583408884|FG001|Recurrence Follow-up Period|Adverse Event|0|||
161552005|NCT02838628|583408883|FG000|Recurrence Follow-up Period|Non-compliance|0|||
161552006|NCT02838628|583408884|FG001|Recurrence Follow-up Period|Non-compliance|1|||
161552007|NCT02838628|583408883|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
161552008|NCT02838628|583408884|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
161552009|NCT02838628|583408883|FG000|Recurrence Follow-up Period|Other un-specified|1|||
161552010|NCT02838628|583408884|FG001|Recurrence Follow-up Period|Other un-specified|1|||
161552011|NCT05832437|583408885|FG000|Overall Study|time off work|1|||
161552012|NCT05832437|583408886|FG001|Overall Study|time off work|0|||
161552013|NCT05832437|583408887|FG002|Overall Study|time off work|0|||
161552014|NCT05832437|583408888|FG003|Overall Study|time off work|0|||
161552015|NCT04159415|583408889|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552016|NCT04159415|583408890|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552017|NCT04159415|583408891|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552018|NCT04159415|583408892|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552019|NCT04159415|583408893|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552020|NCT04159415|583408894|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552021|NCT04159415|583408895|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
161552022|NCT04159415|583408896|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
161552023|NCT04159415|583408897|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552024|NCT04159415|583408898|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161552025|NCT04159415|583408889|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552026|NCT04159415|583408890|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552027|NCT04159415|583408891|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552028|NCT04159415|583408892|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552029|NCT04159415|583408893|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552030|NCT04159415|583408894|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552031|NCT04159415|583408895|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552032|NCT04159415|583408896|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
161552033|NCT04159415|583408897|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552034|NCT04159415|583408898|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161552035|NCT04159415|583408889|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552036|NCT04159415|583408890|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552037|NCT04159415|583408891|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552038|NCT04159415|583408892|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552039|NCT04159415|583408893|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552040|NCT04159415|583408894|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552041|NCT04159415|583408895|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552042|NCT04159415|583408896|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
161552043|NCT04159415|583408897|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552044|NCT04159415|583408898|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
161552045|NCT04159415|583408889|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552046|NCT04159415|583408890|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552047|NCT04159415|583408891|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552048|NCT04159415|583408892|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552049|NCT04159415|583408893|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552050|NCT04159415|583408894|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552051|NCT04159415|583408895|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552052|NCT04159415|583408896|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552053|NCT04159415|583408897|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
161552054|NCT04159415|583408898|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
161552055|NCT05407311|583408899|FG000|Overall Study|Withdrawal by Subject|5|||
161552056|NCT05407311|583408899|FG000|Overall Study|Protocol Violation|3|||
161552057|NCT05407311|583408899|FG000|Overall Study|Physician Decision|1|||
161552058|NCT05407311|583408899|FG000|Overall Study|Non-compliance|1|||
161552059|NCT00337662|583408900|FG000|Study Period II|Lost to Follow-up|0|||
161552060|NCT00337662|583408901|FG001|Study Period II|Lost to Follow-up|0|||
161552061|NCT00337662|583408902|FG002|Study Period II|Lost to Follow-up|0|||
161552062|NCT00337662|583408903|FG003|Study Period II|Lost to Follow-up|35|||
161552063|NCT00337662|583408900|FG000|Study Period II|Withdrawal by Subject|0|||
161552064|NCT00337662|583408901|FG001|Study Period II|Withdrawal by Subject|0|||
161552065|NCT00337662|583408902|FG002|Study Period II|Withdrawal by Subject|0|||
161552066|NCT00337662|583408903|FG003|Study Period II|Withdrawal by Subject|20|||
161552067|NCT00337662|583408900|FG000|Study Period II|Adverse Event|0|||
161552068|NCT00337662|583408901|FG001|Study Period II|Adverse Event|0|||
161552069|NCT00337662|583408902|FG002|Study Period II|Adverse Event|0|||
161552070|NCT00337662|583408903|FG003|Study Period II|Adverse Event|16|||
161552071|NCT00337662|583408900|FG000|Study Period II|Physician Decision|0|||
161552072|NCT00337662|583408901|FG001|Study Period II|Physician Decision|0|||
161552073|NCT00337662|583408902|FG002|Study Period II|Physician Decision|0|||
161552074|NCT00337662|583408903|FG003|Study Period II|Physician Decision|13|||
161552075|NCT00337662|583408900|FG000|Study Period II|Entry Criteria Not Met|0|||
161552076|NCT00337662|583408901|FG001|Study Period II|Entry Criteria Not Met|0|||
161552077|NCT00337662|583408902|FG002|Study Period II|Entry Criteria Not Met|0|||
161552078|NCT00337662|583408903|FG003|Study Period II|Entry Criteria Not Met|6|||
161552079|NCT00337662|583408900|FG000|Study Period II|Protocol Violation|0|||
161552080|NCT00337662|583408901|FG001|Study Period II|Protocol Violation|0|||
161552081|NCT00337662|583408902|FG002|Study Period II|Protocol Violation|0|||
161552082|NCT00337662|583408903|FG003|Study Period II|Protocol Violation|6|||
161552083|NCT00337662|583408900|FG000|Study Period II|Lack of Efficacy|0|||
161552084|NCT00337662|583408901|FG001|Study Period II|Lack of Efficacy|0|||
161552085|NCT00337662|583408902|FG002|Study Period II|Lack of Efficacy|0|||
161552086|NCT00337662|583408903|FG003|Study Period II|Lack of Efficacy|7|||
161552087|NCT00337662|583408900|FG000|Study Period II|Sponsor Decision|0|||
161552088|NCT00337662|583408901|FG001|Study Period II|Sponsor Decision|0|||
161552089|NCT00337662|583408902|FG002|Study Period II|Sponsor Decision|0|||
161552090|NCT00337662|583408903|FG003|Study Period II|Sponsor Decision|2|||
161552091|NCT00337662|583408900|FG000|Study Period II|Parent/Caregiver Decision|0|||
161552092|NCT00337662|583408901|FG001|Study Period II|Parent/Caregiver Decision|0|||
161552093|NCT00337662|583408902|FG002|Study Period II|Parent/Caregiver Decision|0|||
161552094|NCT00337662|583408903|FG003|Study Period II|Parent/Caregiver Decision|1|||
161552095|NCT00337662|583408900|FG000|Study Period III|Lost to Follow-up|14|||
161552096|NCT00337662|583408901|FG001|Study Period III|Lost to Follow-up|16|||
161552097|NCT00337662|583408902|FG002|Study Period III|Lost to Follow-up|14|||
161552098|NCT00337662|583408903|FG003|Study Period III|Lost to Follow-up|0|||
161552099|NCT00337662|583408900|FG000|Study Period III|Withdrawal by Subject|18|||
161552100|NCT00337662|583408901|FG001|Study Period III|Withdrawal by Subject|14|||
161552101|NCT00337662|583408902|FG002|Study Period III|Withdrawal by Subject|12|||
161552102|NCT00337662|583408903|FG003|Study Period III|Withdrawal by Subject|0|||
161552103|NCT00337662|583408900|FG000|Study Period III|Adverse Event|9|||
161552104|NCT00337662|583408901|FG001|Study Period III|Adverse Event|10|||
161552105|NCT00337662|583408902|FG002|Study Period III|Adverse Event|8|||
161552106|NCT00337662|583408903|FG003|Study Period III|Adverse Event|0|||
161552107|NCT00337662|583408900|FG000|Study Period III|Protocol Violation|3|||
161552108|NCT00337662|583408901|FG001|Study Period III|Protocol Violation|8|||
161552109|NCT00337662|583408902|FG002|Study Period III|Protocol Violation|2|||
161552110|NCT00337662|583408903|FG003|Study Period III|Protocol Violation|0|||
161552111|NCT00337662|583408900|FG000|Study Period III|Physician Decision|6|||
161552112|NCT00337662|583408901|FG001|Study Period III|Physician Decision|5|||
161552113|NCT00337662|583408902|FG002|Study Period III|Physician Decision|0|||
161552114|NCT00337662|583408903|FG003|Study Period III|Physician Decision|0|||
161552115|NCT00337662|583408900|FG000|Study Period III|Entry Criteria Not Met|4|||
161552116|NCT00337662|583408901|FG001|Study Period III|Entry Criteria Not Met|1|||
161552117|NCT00337662|583408902|FG002|Study Period III|Entry Criteria Not Met|3|||
161552118|NCT00337662|583408903|FG003|Study Period III|Entry Criteria Not Met|0|||
161552119|NCT00337662|583408900|FG000|Study Period III|Lack of Efficacy|4|||
161552120|NCT00337662|583408901|FG001|Study Period III|Lack of Efficacy|4|||
161552121|NCT00337662|583408902|FG002|Study Period III|Lack of Efficacy|2|||
161552122|NCT00337662|583408903|FG003|Study Period III|Lack of Efficacy|0|||
161552123|NCT00337662|583408900|FG000|Study Period III|Parent/Caregiver Decision|0|||
161552124|NCT00337662|583408901|FG001|Study Period III|Parent/Caregiver Decision|0|||
161552125|NCT00337662|583408902|FG002|Study Period III|Parent/Caregiver Decision|2|||
161552126|NCT00337662|583408903|FG003|Study Period III|Parent/Caregiver Decision|0|||
161552127|NCT00337662|583408900|FG000|Study Period III|Sponsor Decision|1|||
161552128|NCT00337662|583408901|FG001|Study Period III|Sponsor Decision|0|||
161552129|NCT00337662|583408902|FG002|Study Period III|Sponsor Decision|1|||
161552130|NCT00337662|583408903|FG003|Study Period III|Sponsor Decision|0|||
161552131|NCT00337662|583408900|FG000|Study Period III|Clinical Relapse|1|||
161552132|NCT00337662|583408901|FG001|Study Period III|Clinical Relapse|0|||
161552133|NCT00337662|583408902|FG002|Study Period III|Clinical Relapse|0|||
161552134|NCT00337662|583408903|FG003|Study Period III|Clinical Relapse|0|||
161552135|NCT00882921|583408904|FG000|Overall Study|Death|2|||
161552136|NCT00882921|583408904|FG000|Overall Study|Other|3|||
161552137|NCT00882921|583408904|FG000|Overall Study|Lost to Follow-up|2|||
161552138|NCT00882921|583408904|FG000|Overall Study|Termination By Investigator|3|||
161552139|NCT00882921|583408904|FG000|Overall Study|Withdrawal Of Consent|1|||
161552140|NCT03391960|583408915|FG000|Overall Study|Protocol Violation|0|||
161552141|NCT03391960|583408916|FG001|Overall Study|Protocol Violation|0|||
161552142|NCT01702428|583410356|FG000|Overall Study|Adverse Event|2|||
161552143|NCT01702428|583410357|FG001|Overall Study|Adverse Event|0|||
161552144|NCT01702428|583410358|FG002|Overall Study|Adverse Event|0|||
161552145|NCT01702428|583410359|FG003|Overall Study|Adverse Event|0|||
161552146|NCT01702428|583410356|FG000|Overall Study|Lost to Follow-up|33|||
161552147|NCT01702428|583410357|FG001|Overall Study|Lost to Follow-up|41|||
161552148|NCT01702428|583410358|FG002|Overall Study|Lost to Follow-up|37|||
161552149|NCT01702428|583410359|FG003|Overall Study|Lost to Follow-up|44|||
161552150|NCT01702428|583410356|FG000|Overall Study|Parents cannot assist to site|1|||
161552151|NCT01702428|583410357|FG001|Overall Study|Parents cannot assist to site|0|||
161552152|NCT01702428|583410358|FG002|Overall Study|Parents cannot assist to site|1|||
161552153|NCT01702428|583410359|FG003|Overall Study|Parents cannot assist to site|0|||
161552154|NCT01702428|583410356|FG000|Overall Study|Lost Coverage|0|||
161552155|NCT01702428|583410357|FG001|Overall Study|Lost Coverage|0|||
161552156|NCT01702428|583410358|FG002|Overall Study|Lost Coverage|0|||
161552157|NCT01702428|583410359|FG003|Overall Study|Lost Coverage|1|||
161552158|NCT01702428|583410356|FG000|Overall Study|Lost Health Plan|3|||
161552159|NCT01702428|583410357|FG001|Overall Study|Lost Health Plan|5|||
161552160|NCT01702428|583410358|FG002|Overall Study|Lost Health Plan|0|||
161552161|NCT01702428|583410359|FG003|Overall Study|Lost Health Plan|2|||
161552162|NCT01702428|583410356|FG000|Overall Study|Mother transferred care|0|||
161552163|NCT01702428|583410357|FG001|Overall Study|Mother transferred care|1|||
161552164|NCT01702428|583410358|FG002|Overall Study|Mother transferred care|0|||
161552165|NCT01702428|583410359|FG003|Overall Study|Mother transferred care|0|||
161552166|NCT01702428|583410356|FG000|Overall Study|Parents too busy|1|||
161552167|NCT01702428|583410357|FG001|Overall Study|Parents too busy|0|||
161552168|NCT01702428|583410358|FG002|Overall Study|Parents too busy|0|||
161552169|NCT01702428|583410359|FG003|Overall Study|Parents too busy|0|||
161552170|NCT01702428|583410356|FG000|Overall Study|Protocol Violation|3|||
161552171|NCT01702428|583410357|FG001|Overall Study|Protocol Violation|0|||
161552172|NCT01702428|583410358|FG002|Overall Study|Protocol Violation|1|||
161552173|NCT01702428|583410359|FG003|Overall Study|Protocol Violation|0|||
161552174|NCT01702428|583410356|FG000|Overall Study|Withdrawal by Subject|21|||
161552175|NCT01702428|583410357|FG001|Overall Study|Withdrawal by Subject|23|||
161552176|NCT01702428|583410358|FG002|Overall Study|Withdrawal by Subject|14|||
161552177|NCT01702428|583410359|FG003|Overall Study|Withdrawal by Subject|10|||
161552178|NCT02091869|583410360|FG000|Overall Study|Withdrawal by Subject|0|||
161552179|NCT02091869|583410361|FG001|Overall Study|Withdrawal by Subject|3|||
161552180|NCT03685708|583410365|FG000|Overall Study|Withdrawal by Subject|0|||
161552181|NCT03685708|583410366|FG001|Overall Study|Withdrawal by Subject|0|||
161552182|NCT03685708|583410367|FG002|Overall Study|Withdrawal by Subject|1|||
161552183|NCT03685708|583410365|FG000|Overall Study|Screen Fail|0|||
161552184|NCT03685708|583410366|FG001|Overall Study|Screen Fail|1|||
161552185|NCT03685708|583410367|FG002|Overall Study|Screen Fail|1|||
161552186|NCT03685708|583410365|FG000|Overall Study|COVID 19 Pandemic|1|||
161552187|NCT03685708|583410366|FG001|Overall Study|COVID 19 Pandemic|1|||
161552188|NCT03685708|583410367|FG002|Overall Study|COVID 19 Pandemic|6|||
161552189|NCT03685708|583410365|FG000|Overall Study|Disease Progression|0|||
161552190|NCT03685708|583410366|FG001|Overall Study|Disease Progression|0|||
161552191|NCT03685708|583410367|FG002|Overall Study|Disease Progression|1|||
161552192|NCT02771210|583410369|FG000|Period 1|Adverse Event|5|||
161552193|NCT02771210|583410370|FG001|Period 1|Adverse Event|3|||
161552194|NCT02771210|583410369|FG000|Period 1|Lack of Efficacy|3|||
161552195|NCT02771210|583410370|FG001|Period 1|Lack of Efficacy|6|||
161552196|NCT02771210|583410369|FG000|Period 1|Lost to Follow-up|2|||
161552197|NCT02771210|583410370|FG001|Period 1|Lost to Follow-up|0|||
161552198|NCT02771210|583410369|FG000|Period 1|Physician Decision|0|||
161552199|NCT02771210|583410370|FG001|Period 1|Physician Decision|1|||
161552200|NCT02771210|583410369|FG000|Period 1|Withdrawal by Subject|0|||
161552201|NCT02771210|583410370|FG001|Period 1|Withdrawal by Subject|3|||
161552202|NCT02771210|583410369|FG000|Period 1|Withdrawal of informed consent|1|||
161552203|NCT02771210|583410370|FG001|Period 1|Withdrawal of informed consent|5|||
161552204|NCT02771210|583410369|FG000|Period 2|Adverse Event|1|||
161552205|NCT02771210|583410370|FG001|Period 2|Adverse Event|0|||
161552206|NCT02771210|583410369|FG000|Period 2|Lack of Efficacy|0|||
161552207|NCT02771210|583410370|FG001|Period 2|Lack of Efficacy|1|||
161552208|NCT02771210|583410369|FG000|Period 2|Withdrawal by Subject|1|||
161552209|NCT02771210|583410370|FG001|Period 2|Withdrawal by Subject|0|||
161552210|NCT02771210|583410369|FG000|Period 2|Withdrawal of informed consent|0|||
161552211|NCT02771210|583410370|FG001|Period 2|Withdrawal of informed consent|2|||
161552212|NCT04397523|583410371|FG000|Overall Study|Lost to Follow-up|3|||
161552213|NCT04397523|583410371|FG000|Overall Study|Transfer from/to other hospital|8|||
161552214|NCT01275196|583410372|FG000|Overall Study|Adverse Event|3|||
161552215|NCT01275196|583410373|FG001|Overall Study|Adverse Event|5|||
161552216|NCT01275196|583410372|FG000|Overall Study|Withdrawal by Subject|4|||
161552217|NCT01275196|583410373|FG001|Overall Study|Withdrawal by Subject|5|||
161552218|NCT01275196|583410372|FG000|Overall Study|Lost to Follow-up|1|||
161552219|NCT01275196|583410373|FG001|Overall Study|Lost to Follow-up|0|||
161552220|NCT01275196|583410372|FG000|Overall Study|Disease Progression|6|||
161552221|NCT01275196|583410373|FG001|Overall Study|Disease Progression|5|||
161552222|NCT01275196|583410372|FG000|Overall Study|Protocol Violation|1|||
161552223|NCT01275196|583410373|FG001|Overall Study|Protocol Violation|0|||
161552224|NCT01275196|583410372|FG000|Overall Study|Suboptimal response/treatment failure|5|||
161682988|NCT02969915|583890220|FG001|Overall Study|Lost to Follow-up|112|||
161682989|NCT02969915|583890219|FG000|Overall Study|Censored due to COVID-19|481|||
161682990|NCT02969915|583890220|FG001|Overall Study|Censored due to COVID-19|471|||
161552225|NCT01275196|583410373|FG001|Overall Study|Suboptimal response/treatment failure|6|||
161552226|NCT01744496|583410376|FG000|Titration Period|Adverse Event|2|||
161552227|NCT01744496|583410377|FG001|Titration Period|Adverse Event|1|||
161552228|NCT01744496|583410376|FG000|Titration Period|Personal reasons|0|||
161552229|NCT01744496|583410377|FG001|Titration Period|Personal reasons|1|||
161552230|NCT01744496|583410376|FG000|Maintenance Period|Adverse Event|1|||
161552231|NCT01744496|583410377|FG001|Maintenance Period|Adverse Event|3|||
161552232|NCT01744496|583410376|FG000|Maintenance Period|Protocol Violation|1|||
161552233|NCT01744496|583410377|FG001|Maintenance Period|Protocol Violation|0|||
161552234|NCT01744496|583410376|FG000|Maintenance Period|Withdrawal by Subject|1|||
161552235|NCT01744496|583410377|FG001|Maintenance Period|Withdrawal by Subject|1|||
161552236|NCT01744496|583410376|FG000|Maintenance Period|Subject left town|1|||
161552237|NCT01744496|583410377|FG001|Maintenance Period|Subject left town|0|||
161552238|NCT01380990|583410380|FG000|Overall Study|Treatment Failure|1|||
161552239|NCT01380990|583410381|FG001|Overall Study|Treatment Failure|0|||
161552240|NCT01380990|583410380|FG000|Overall Study|Death|0|||
161552241|NCT01380990|583410381|FG001|Overall Study|Death|1|||
161552242|NCT01964521|583410382|FG000|Overall Study|Lost to Follow-up|4|||
161552243|NCT01284140|583410383|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
161552244|NCT01284140|583410384|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
161552245|NCT01284140|583410383|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
161552246|NCT01284140|583410384|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
161552247|NCT01463293|583410385|FG000|Overall Study|Lost to Follow-up|1|||
161552248|NCT01463293|583410386|FG001|Overall Study|Lost to Follow-up|4|||
161552249|NCT01463293|583410387|FG002|Overall Study|Lost to Follow-up|5|||
161552250|NCT01463293|583410385|FG000|Overall Study|Adverse Event|1|||
161552251|NCT01463293|583410386|FG001|Overall Study|Adverse Event|2|||
161552252|NCT01463293|583410387|FG002|Overall Study|Adverse Event|0|||
161552253|NCT01463293|583410385|FG000|Overall Study|Withdrawal by Subject|4|||
161552254|NCT01463293|583410386|FG001|Overall Study|Withdrawal by Subject|10|||
161552255|NCT01463293|583410387|FG002|Overall Study|Withdrawal by Subject|5|||
161552256|NCT01463293|583410385|FG000|Overall Study|Other|0|||
161552257|NCT01463293|583410386|FG001|Overall Study|Other|0|||
161552258|NCT01463293|583410387|FG002|Overall Study|Other|2|||
161552259|NCT02796963|583410388|FG000|Overall Study|Lost to Follow-up|89|||
161552260|NCT02796963|583410389|FG001|Overall Study|Lost to Follow-up|76|||
161552261|NCT02796963|583410390|FG002|Overall Study|Lost to Follow-up|69|||
161552262|NCT02796963|583410391|FG003|Overall Study|Lost to Follow-up|72|||
161552263|NCT03192215|583410392|FG000|Overall Study|Death|28|||
161552264|NCT03192215|583410393|FG001|Overall Study|Death|23|||
161552265|NCT03192215|583410392|FG000|Overall Study|Lost to Follow-up|10|||
161552266|NCT03192215|583410393|FG001|Overall Study|Lost to Follow-up|15|||
161552267|NCT03192215|583410392|FG000|Overall Study|Withdrawal by Subject|49|||
161552268|NCT03192215|583410393|FG001|Overall Study|Withdrawal by Subject|48|||
161552269|NCT03192215|583410392|FG000|Overall Study|Other as reported in analysis|4|||
161552270|NCT03192215|583410393|FG001|Overall Study|Other as reported in analysis|1|||
161552271|NCT01551303|583410403|FG000|Overall Study|failed awareness check on vision test|4|||
161552272|NCT01551303|583410404|FG001|Overall Study|failed awareness check on vision test|7|||
161552273|NCT01927731|583410410|FG000|Overall Study|Graft Failure|1|||
161552274|NCT01927731|583410411|FG001|Overall Study|Graft Failure|2|||
161552275|NCT01927731|583410410|FG000|Overall Study|Physician Decision|2|||
161552276|NCT01927731|583410411|FG001|Overall Study|Physician Decision|3|||
161552277|NCT01927731|583410410|FG000|Overall Study|Withdrawal by Subject|0|||
161552278|NCT01927731|583410411|FG001|Overall Study|Withdrawal by Subject|2|||
161552279|NCT01927731|583410410|FG000|Overall Study|Death|0|||
161552280|NCT01927731|583410411|FG001|Overall Study|Death|3|||
161552281|NCT02589392|583410416|FG000|Overall Study|Adverse Event|1|||
161552282|NCT02589392|583410417|FG001|Overall Study|Adverse Event|1|||
161552283|NCT02589392|583410416|FG000|Overall Study|Withdrawal by Subject|1|||
161552284|NCT02589392|583410417|FG001|Overall Study|Withdrawal by Subject|2|||
161552285|NCT02589392|583410416|FG000|Overall Study|Protocol Violation|1|||
161552286|NCT02589392|583410417|FG001|Overall Study|Protocol Violation|1|||
161552287|NCT02589392|583410416|FG000|Overall Study|Lost to Follow-up|2|||
161552288|NCT02589392|583410417|FG001|Overall Study|Lost to Follow-up|2|||
161552289|NCT02589392|583410416|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
161552290|NCT02589392|583410417|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
161552291|NCT00322374|583410419|FG000|Starting Dose|Physician Decision|2|||
161552292|NCT00322374|583410420|FG001|Starting Dose|Physician Decision|0|||
161552293|NCT00322374|583410421|FG002|Starting Dose|Physician Decision|0|||
161552294|NCT00322374|583410422|FG003|Starting Dose|Physician Decision|0|||
161552295|NCT00322374|583410419|FG000|Starting Dose|Study Drug Toxicity|4|||
161552296|NCT00322374|583410420|FG001|Starting Dose|Study Drug Toxicity|0|||
161552297|NCT00322374|583410421|FG002|Starting Dose|Study Drug Toxicity|0|||
161779437|NCT00468312|584235549|FG001|Overall Study|Protocol Violation|1|||
161779438|NCT00468312|584235548|FG000|Overall Study|Did not meet protocol eligibility|0|||
161552298|NCT00322374|583410422|FG003|Starting Dose|Study Drug Toxicity|0|||
161552299|NCT00322374|583410419|FG000|First Escalation|Documented Disease Progression|0|||
161552300|NCT00322374|583410420|FG001|First Escalation|Documented Disease Progression|6|||
161552301|NCT00322374|583410421|FG002|First Escalation|Documented Disease Progression|0|||
161552302|NCT00322374|583410422|FG003|First Escalation|Documented Disease Progression|0|||
161552303|NCT00322374|583410419|FG000|First Escalation|Physician Decision|0|||
161552304|NCT00322374|583410420|FG001|First Escalation|Physician Decision|12|||
161552305|NCT00322374|583410421|FG002|First Escalation|Physician Decision|0|||
161552306|NCT00322374|583410422|FG003|First Escalation|Physician Decision|0|||
161552307|NCT00322374|583410419|FG000|First Escalation|Study Drug Toxicity|0|||
161552308|NCT00322374|583410420|FG001|First Escalation|Study Drug Toxicity|11|||
161552309|NCT00322374|583410421|FG002|First Escalation|Study Drug Toxicity|0|||
161552310|NCT00322374|583410422|FG003|First Escalation|Study Drug Toxicity|0|||
161552311|NCT00322374|583410419|FG000|First Escalation|Participant Request|0|||
161552312|NCT00322374|583410420|FG001|First Escalation|Participant Request|1|||
161552313|NCT00322374|583410421|FG002|First Escalation|Participant Request|0|||
161552314|NCT00322374|583410422|FG003|First Escalation|Participant Request|0|||
161552315|NCT00322374|583410419|FG000|Second Escalation|Physician Decision|0|||
161552316|NCT00322374|583410420|FG001|Second Escalation|Physician Decision|0|||
161552317|NCT00322374|583410421|FG002|Second Escalation|Physician Decision|5|||
161552318|NCT00322374|583410422|FG003|Second Escalation|Physician Decision|0|||
161552319|NCT00322374|583410419|FG000|Second Escalation|Study Drug Toxicity|0|||
161552320|NCT00322374|583410420|FG001|Second Escalation|Study Drug Toxicity|0|||
161552321|NCT00322374|583410421|FG002|Second Escalation|Study Drug Toxicity|1|||
161552322|NCT00322374|583410422|FG003|Second Escalation|Study Drug Toxicity|0|||
161552323|NCT03382600|583410423|FG000|Overall Study|Adverse Event|3|||
161552324|NCT03382600|583410424|FG001|Overall Study|Adverse Event|3|||
161552325|NCT03382600|583410423|FG000|Overall Study|Clinical Disease Progression|2|||
161552326|NCT03382600|583410424|FG001|Overall Study|Clinical Disease Progression|4|||
161552327|NCT03382600|583410423|FG000|Overall Study|Radiological Progression|40|||
161552328|NCT03382600|583410424|FG001|Overall Study|Radiological Progression|31|||
161552329|NCT03382600|583410423|FG000|Overall Study|Withdrawal by Subject|0|||
161552330|NCT03382600|583410424|FG001|Overall Study|Withdrawal by Subject|1|||
161552331|NCT03382600|583410423|FG000|Overall Study|Other|9|||
161552332|NCT03382600|583410424|FG001|Overall Study|Other|7|||
161552333|NCT02269943|583410425|FG000|Treatment Period|Death|0|||
161552334|NCT02269943|583410426|FG001|Treatment Period|Death|1|||
161552335|NCT02269943|583410425|FG000|Treatment Period|Adverse Event|1|||
161552336|NCT02269943|583410426|FG001|Treatment Period|Adverse Event|10|||
161552337|NCT02269943|583410425|FG000|Treatment Period|Progressive Disease|5|||
161552338|NCT02269943|583410426|FG001|Treatment Period|Progressive Disease|17|||
161552339|NCT02269943|583410425|FG000|Treatment Period|Symptomatic Deterioration|0|||
161552340|NCT02269943|583410426|FG001|Treatment Period|Symptomatic Deterioration|2|||
161552341|NCT02269943|583410425|FG000|Follow-Up Survival Period|Death|3|||
161552342|NCT02269943|583410426|FG001|Follow-Up Survival Period|Death|16|||
161665648|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
161665649|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
161665650|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
161665651|NCT00600886|583828402|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
161665652|NCT00600886|583828403|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
161665653|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
161665654|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
161665655|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
161665656|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
161665657|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
161552343|NCT02269943|583410425|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
161552344|NCT02269943|583410426|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
161552345|NCT02269943|583410425|FG000|Follow-Up Survival Period|Alive|2|||
161552346|NCT02269943|583410426|FG001|Follow-Up Survival Period|Alive|8|||
161665658|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
161665659|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
161665660|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
161665661|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
161665662|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
161552347|NCT02733042|583410427|FG000|Overall Study|Adverse Event|1|||
161552348|NCT02733042|583410428|FG001|Overall Study|Adverse Event|0|||
161552349|NCT02733042|583410429|FG002|Overall Study|Adverse Event|1|||
161552350|NCT02733042|583410430|FG003|Overall Study|Adverse Event|1|||
161552351|NCT02733042|583410431|FG004|Overall Study|Adverse Event|0|||
161665663|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
161552352|NCT02733042|583410432|FG005|Overall Study|Adverse Event|0|||
161552353|NCT02733042|583410433|FG006|Overall Study|Adverse Event|0|||
161552354|NCT02733042|583410434|FG007|Overall Study|Adverse Event|0|||
161552355|NCT02733042|583410435|FG008|Overall Study|Adverse Event|0|||
161552356|NCT02733042|583410436|FG009|Overall Study|Adverse Event|0|||
161552357|NCT02733042|583410437|FG010|Overall Study|Adverse Event|2|||
161682991|NCT03625687|583890221|FG000|Overall Study|Death|1|||
161665664|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
161665665|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Death|1|||
161665666|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Death|1|||
161665667|NCT00600886|583828402|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
161665668|NCT00600886|583828403|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
161665669|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
161552358|NCT02733042|583410438|FG011|Overall Study|Adverse Event|2|||
161552359|NCT02733042|583410439|FG012|Overall Study|Adverse Event|0|||
161552360|NCT02733042|583410440|FG013|Overall Study|Adverse Event|2|||
161552361|NCT02733042|583410441|FG014|Overall Study|Adverse Event|0|||
161552362|NCT02733042|583410442|FG015|Overall Study|Adverse Event|0|||
161552363|NCT02733042|583410443|FG016|Overall Study|Adverse Event|0|||
161552364|NCT02733042|583410444|FG017|Overall Study|Adverse Event|1|||
161552365|NCT02733042|583410445|FG018|Overall Study|Adverse Event|0|||
161552366|NCT02733042|583410427|FG000|Overall Study|Progressive Disease|2|||
161552367|NCT02733042|583410428|FG001|Overall Study|Progressive Disease|1|||
161552368|NCT02733042|583410429|FG002|Overall Study|Progressive Disease|3|||
161552369|NCT02733042|583410430|FG003|Overall Study|Progressive Disease|1|||
161552370|NCT02733042|583410431|FG004|Overall Study|Progressive Disease|2|||
161552371|NCT02733042|583410432|FG005|Overall Study|Progressive Disease|3|||
161552372|NCT02733042|583410433|FG006|Overall Study|Progressive Disease|0|||
161552373|NCT02733042|583410434|FG007|Overall Study|Progressive Disease|3|||
161552374|NCT02733042|583410435|FG008|Overall Study|Progressive Disease|3|||
161552375|NCT02733042|583410436|FG009|Overall Study|Progressive Disease|2|||
161552376|NCT02733042|583410437|FG010|Overall Study|Progressive Disease|2|||
161552377|NCT02733042|583410438|FG011|Overall Study|Progressive Disease|2|||
161552378|NCT02733042|583410439|FG012|Overall Study|Progressive Disease|8|||
161552379|NCT02733042|583410440|FG013|Overall Study|Progressive Disease|1|||
161552380|NCT02733042|583410441|FG014|Overall Study|Progressive Disease|4|||
161552381|NCT02733042|583410442|FG015|Overall Study|Progressive Disease|7|||
161665670|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
161665671|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
161665672|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
161665673|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
161665674|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
161665675|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
161665676|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
161665677|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
161665678|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
161665679|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
161665680|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
161665681|NCT00600886|583828402|FG000|Extension - After Crossover (CAS)|Death|1|||
161665682|NCT00600886|583828403|FG001|Extension - After Crossover (CAS)|Death|0|||
161665683|NCT02053792|583828404|FG000|Overall Study|Physician Decision|0|||
161665684|NCT02053792|583828405|FG001|Overall Study|Physician Decision|1|||
161665685|NCT02053792|583828404|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
161665686|NCT02053792|583828405|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
161665687|NCT02053792|583828404|FG000|Overall Study|Lack of Efficacy|1|||
161665688|NCT02053792|583828405|FG001|Overall Study|Lack of Efficacy|0|||
161665689|NCT02053792|583828404|FG000|Overall Study|Adverse Event|1|||
161665690|NCT02053792|583828405|FG001|Overall Study|Adverse Event|0|||
161665691|NCT02053792|583828404|FG000|Overall Study|Withdrawal by Subject|2|||
161665692|NCT02053792|583828405|FG001|Overall Study|Withdrawal by Subject|2|||
161665693|NCT02053792|583828404|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
161665694|NCT02053792|583828405|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
161665695|NCT02053792|583828404|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
161665696|NCT02053792|583828405|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
161665697|NCT03075410|583828406|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
161665698|NCT03075410|583828407|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665699|NCT03075410|583828408|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
161665700|NCT03075410|583828409|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665701|NCT03075410|583828410|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665702|NCT03075410|583828411|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665703|NCT03075410|583828412|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665704|NCT03075410|583828413|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665705|NCT03075410|583828414|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
161665706|NCT03075410|583828406|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
161552382|NCT02733042|583410443|FG016|Overall Study|Progressive Disease|2|||
161552383|NCT02733042|583410444|FG017|Overall Study|Progressive Disease|3|||
161552384|NCT02733042|583410445|FG018|Overall Study|Progressive Disease|4|||
161552385|NCT02733042|583410427|FG000|Overall Study|Withdrawal by Subject|0|||
161552386|NCT02733042|583410428|FG001|Overall Study|Withdrawal by Subject|1|||
161665707|NCT03075410|583828407|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665708|NCT03075410|583828408|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665709|NCT03075410|583828409|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665710|NCT03075410|583828410|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665711|NCT03075410|583828411|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665712|NCT03075410|583828412|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665713|NCT03075410|583828413|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665714|NCT03075410|583828414|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161665715|NCT01427751|583828415|FG000|Overall Study|Adverse Event|18|||
161665716|NCT01427751|583828416|FG001|Overall Study|Adverse Event|2|||
161665717|NCT01427751|583828415|FG000|Overall Study|No further treatment benefit expected|5|||
161665718|NCT01427751|583828416|FG001|Overall Study|No further treatment benefit expected|1|||
161665719|NCT01427751|583828415|FG000|Overall Study|Lost to Follow-up|3|||
161665720|NCT01427751|583828416|FG001|Overall Study|Lost to Follow-up|1|||
161665721|NCT01427751|583828415|FG000|Overall Study|Withdrawal of consent|2|||
161665722|NCT01427751|583828416|FG001|Overall Study|Withdrawal of consent|2|||
161665723|NCT01427751|583828415|FG000|Overall Study|Protocol Violation|6|||
161665724|NCT01427751|583828416|FG001|Overall Study|Protocol Violation|4|||
161665725|NCT01427751|583828415|FG000|Overall Study|Death|2|||
161665726|NCT01427751|583828416|FG001|Overall Study|Death|0|||
161665727|NCT01427751|583828415|FG000|Overall Study|Other miscellaneous reasons|6|||
161665728|NCT01427751|583828416|FG001|Overall Study|Other miscellaneous reasons|4|||
161665729|NCT01028027|583828417|FG000|Overall Study|Lost to Follow-up|4|||
161665730|NCT01028027|583828418|FG001|Overall Study|Lost to Follow-up|1|||
161665731|NCT01028027|583828417|FG000|Overall Study|Withdrawal by Subject|5|||
161665732|NCT01028027|583828418|FG001|Overall Study|Withdrawal by Subject|3|||
161665733|NCT01028027|583828417|FG000|Overall Study|Adverse Event|4|||
161665734|NCT01028027|583828418|FG001|Overall Study|Adverse Event|7|||
161665735|NCT01028027|583828417|FG000|Overall Study|Protocol Violation|3|||
161665736|NCT01028027|583828418|FG001|Overall Study|Protocol Violation|1|||
161665737|NCT01028027|583828417|FG000|Overall Study|Lack of Efficacy|0|||
161665738|NCT01028027|583828418|FG001|Overall Study|Lack of Efficacy|1|||
161665739|NCT00368992|583828429|FG000|Overall Study|Ineligible|5|||
161665740|NCT00368992|583828429|FG000|Overall Study|Refused treatment|3|||
161665741|NCT00368992|583828429|FG000|Overall Study|Lack of Efficacy|63|||
161665742|NCT00368992|583828429|FG000|Overall Study|Adverse Event|26|||
161665743|NCT00368992|583828429|FG000|Overall Study|Death|4|||
161665744|NCT00368992|583828429|FG000|Overall Study|Other|9|||
161665745|NCT00790751|583828436|FG000|Overall Study|Protocol non-compliance|16|||
161665746|NCT00790751|583828437|FG001|Overall Study|Protocol non-compliance|16|||
161665747|NCT00790751|583828438|FG002|Overall Study|Protocol non-compliance|10|||
161665748|NCT00790751|583828439|FG003|Overall Study|Protocol non-compliance|11|||
161665749|NCT00790751|583828436|FG000|Overall Study|Lost to Follow-up|4|||
161665750|NCT00790751|583828437|FG001|Overall Study|Lost to Follow-up|9|||
161665751|NCT00790751|583828438|FG002|Overall Study|Lost to Follow-up|4|||
161665752|NCT00790751|583828439|FG003|Overall Study|Lost to Follow-up|5|||
161665753|NCT00790751|583828436|FG000|Overall Study|Adverse Event|5|||
161665754|NCT00790751|583828437|FG001|Overall Study|Adverse Event|3|||
161665755|NCT00790751|583828438|FG002|Overall Study|Adverse Event|5|||
161665756|NCT00790751|583828439|FG003|Overall Study|Adverse Event|4|||
161665757|NCT00790751|583828436|FG000|Overall Study|Requirement for restricted medication|0|||
161665758|NCT00790751|583828437|FG001|Overall Study|Requirement for restricted medication|2|||
161665759|NCT00790751|583828438|FG002|Overall Study|Requirement for restricted medication|0|||
161665760|NCT00790751|583828439|FG003|Overall Study|Requirement for restricted medication|0|||
161665761|NCT00790751|583828436|FG000|Overall Study|Death|0|||
161665762|NCT00790751|583828437|FG001|Overall Study|Death|0|||
161665763|NCT00790751|583828438|FG002|Overall Study|Death|1|||
161665764|NCT00790751|583828439|FG003|Overall Study|Death|0|||
161665765|NCT00790751|583828436|FG000|Overall Study|Physician Decision|0|||
161665766|NCT00790751|583828437|FG001|Overall Study|Physician Decision|0|||
161665767|NCT00790751|583828438|FG002|Overall Study|Physician Decision|0|||
161665768|NCT00790751|583828439|FG003|Overall Study|Physician Decision|1|||
161665769|NCT02427464|583828442|FG000|Overall Study|Adverse Event|6|||
161665770|NCT02427464|583828443|FG001|Overall Study|Adverse Event|1|||
161665771|NCT02427464|583828442|FG000|Overall Study|Lost to Follow-up|16|||
161665772|NCT02427464|583828443|FG001|Overall Study|Lost to Follow-up|5|||
161779439|NCT00468312|584235549|FG001|Overall Study|Did not meet protocol eligibility|1|||
161665773|NCT02427464|583828442|FG000|Overall Study|Physician Decision|2|||
161779440|NCT01052038|584235550|FG000|Overall Study|Lost to Follow-up|2|||
161665774|NCT02427464|583828443|FG001|Overall Study|Physician Decision|0|||
161665775|NCT02427464|583828442|FG000|Overall Study|Withdrawal by Subject|10|||
161665776|NCT02427464|583828443|FG001|Overall Study|Withdrawal by Subject|8|||
161665777|NCT02427464|583828442|FG000|Overall Study|Noncompliance|16|||
161665778|NCT02427464|583828443|FG001|Overall Study|Noncompliance|10|||
161665779|NCT04443153|583828447|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
161665780|NCT04443153|583828448|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
161665781|NCT04443153|583828447|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
161665782|NCT04443153|583828448|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
161665783|NCT04443153|583828447|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
161665784|NCT04443153|583828448|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
161665785|NCT04443153|583828447|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
161665786|NCT04443153|583828448|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
161665787|NCT02572843|583828449|FG000|Accrual|Brain metastasis retrospectively detected|1|||
161665788|NCT02572843|583828449|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
161665789|NCT02572843|583828449|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
161665790|NCT02572843|583828449|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
161665791|NCT02572843|583828449|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
161665792|NCT02572843|583828449|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
161665793|NCT02572843|583828449|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
161665794|NCT02572843|583828449|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
161665795|NCT02572843|583828449|FG000|Surgery|lost to follow up|7|||
161665796|NCT02572843|583828449|FG000|Surgery|Death|1|||
161665797|NCT01078454|583828453|FG000|Overall Study|Adverse Event|1|||
161665798|NCT01078454|583828454|FG001|Overall Study|Adverse Event|1|||
161665799|NCT01078454|583828453|FG000|Overall Study|Death|0|||
161665800|NCT01078454|583828454|FG001|Overall Study|Death|1|||
161665801|NCT04737187|583828455|FG000|Overall Study|Switched to marketed drug|32|||
161665802|NCT04737187|583828456|FG001|Overall Study|Switched to marketed drug|4|||
161665803|NCT04737187|583828455|FG000|Overall Study|Radiological Progressive Disease|145|||
161665804|NCT04737187|583828456|FG001|Overall Study|Radiological Progressive Disease|146|||
161665805|NCT04737187|583828455|FG000|Overall Study|Clinical Progressive Disease|20|||
161665806|NCT04737187|583828456|FG001|Overall Study|Clinical Progressive Disease|20|||
161665807|NCT04737187|583828455|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
161665808|NCT04737187|583828456|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
161665809|NCT04737187|583828455|FG000|Overall Study|Adverse Event|16|||
161665810|NCT04737187|583828456|FG001|Overall Study|Adverse Event|16|||
161665811|NCT04737187|583828455|FG000|Overall Study|Physician Decision|2|||
161665812|NCT04737187|583828456|FG001|Overall Study|Physician Decision|0|||
161665813|NCT04737187|583828455|FG000|Overall Study|Withdrawal by Subject|5|||
161665814|NCT04737187|583828456|FG001|Overall Study|Withdrawal by Subject|8|||
161665815|NCT05227703|583828457|FG000|Overall Study|Adverse Event|2|||
161665816|NCT05227703|583828458|FG001|Overall Study|Adverse Event|6|||
161665817|NCT05227703|583828459|FG002|Overall Study|Adverse Event|4|||
161665818|NCT05227703|583828457|FG000|Overall Study|Lack of Efficacy|4|||
161665819|NCT05227703|583828458|FG001|Overall Study|Lack of Efficacy|0|||
161665820|NCT05227703|583828459|FG002|Overall Study|Lack of Efficacy|1|||
161665821|NCT05227703|583828457|FG000|Overall Study|Physician Decision|2|||
161665822|NCT05227703|583828458|FG001|Overall Study|Physician Decision|2|||
161665823|NCT05227703|583828459|FG002|Overall Study|Physician Decision|1|||
161665824|NCT05227703|583828457|FG000|Overall Study|Protocol Violation|2|||
161665825|NCT05227703|583828458|FG001|Overall Study|Protocol Violation|1|||
161665826|NCT05227703|583828459|FG002|Overall Study|Protocol Violation|0|||
161665827|NCT05227703|583828457|FG000|Overall Study|Withdrawal by Subject|17|||
161665828|NCT05227703|583828458|FG001|Overall Study|Withdrawal by Subject|26|||
161665829|NCT05227703|583828459|FG002|Overall Study|Withdrawal by Subject|32|||
161665830|NCT05227703|583828457|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
161665831|NCT05227703|583828458|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
161665832|NCT05227703|583828459|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
161665833|NCT05227703|583828457|FG000|Overall Study|Other|1|||
161665834|NCT05227703|583828458|FG001|Overall Study|Other|1|||
161665835|NCT05227703|583828459|FG002|Overall Study|Other|0|||
161665836|NCT03464097|583828466|FG000|Overall Study|Withdrawal by Subject|15|||
161665837|NCT03464097|583828467|FG001|Overall Study|Withdrawal by Subject|13|||
161665838|NCT03464097|583828468|FG002|Overall Study|Withdrawal by Subject|11|||
161665839|NCT03464097|583828466|FG000|Overall Study|Study terminated by sponsor|47|||
161665840|NCT03464097|583828467|FG001|Overall Study|Study terminated by sponsor|44|||
161665841|NCT03464097|583828468|FG002|Overall Study|Study terminated by sponsor|40|||
161665842|NCT03464097|583828466|FG000|Overall Study|Pregnancy|0|||
161665843|NCT03464097|583828467|FG001|Overall Study|Pregnancy|1|||
161665844|NCT03464097|583828468|FG002|Overall Study|Pregnancy|0|||
161665845|NCT03464097|583828466|FG000|Overall Study|Other reasons|5|||
161665846|NCT03464097|583828467|FG001|Overall Study|Other reasons|12|||
161665847|NCT03464097|583828468|FG002|Overall Study|Other reasons|14|||
161665848|NCT03464097|583828466|FG000|Overall Study|Lost to Follow-up|0|||
161665849|NCT03464097|583828467|FG001|Overall Study|Lost to Follow-up|1|||
161665850|NCT03464097|583828468|FG002|Overall Study|Lost to Follow-up|1|||
161665851|NCT03464097|583828466|FG000|Overall Study|Lack of Efficacy|11|||
161665852|NCT03464097|583828467|FG001|Overall Study|Lack of Efficacy|18|||
161665853|NCT03464097|583828468|FG002|Overall Study|Lack of Efficacy|30|||
161665854|NCT03464097|583828466|FG000|Overall Study|Death|1|||
161665855|NCT03464097|583828467|FG001|Overall Study|Death|0|||
161665856|NCT03464097|583828468|FG002|Overall Study|Death|0|||
161665857|NCT03464097|583828466|FG000|Overall Study|Adverse Event|13|||
161665858|NCT03464097|583828467|FG001|Overall Study|Adverse Event|6|||
161665859|NCT03464097|583828468|FG002|Overall Study|Adverse Event|8|||
161665860|NCT03035201|583828469|FG000|Overall Study|Death|9|||
161665861|NCT03035201|583828470|FG001|Overall Study|Death|12|||
161665862|NCT03035201|583828471|FG002|Overall Study|Death|9|||
161665863|NCT03035201|583828472|FG003|Overall Study|Death|10|||
161665864|NCT03035201|583828469|FG000|Overall Study|Withdrawal by Subject|51|||
161665865|NCT03035201|583828470|FG001|Overall Study|Withdrawal by Subject|49|||
161665866|NCT03035201|583828471|FG002|Overall Study|Withdrawal by Subject|37|||
161665867|NCT03035201|583828472|FG003|Overall Study|Withdrawal by Subject|46|||
161665868|NCT03035201|583828469|FG000|Overall Study|Lost to Follow-up|67|||
161665869|NCT03035201|583828470|FG001|Overall Study|Lost to Follow-up|51|||
161665870|NCT03035201|583828471|FG002|Overall Study|Lost to Follow-up|64|||
161665871|NCT03035201|583828472|FG003|Overall Study|Lost to Follow-up|69|||
161665872|NCT05328167|583828480|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
161665873|NCT05328167|583828480|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
161665874|NCT03727438|583828481|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
161665875|NCT03727438|583828482|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
161665876|NCT03727438|583828481|FG000|Intervention Period|Excluded (health)|1|||
161665877|NCT03727438|583828482|FG001|Intervention Period|Excluded (health)|0|||
161665878|NCT03727438|583828481|FG000|Intervention Period|Withdrawal by Subject|3|||
161665879|NCT03727438|583828482|FG001|Intervention Period|Withdrawal by Subject|1|||
161665880|NCT03727438|583828481|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
161665881|NCT03727438|583828482|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
161665882|NCT03727438|583828481|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
161665883|NCT03727438|583828482|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
161665884|NCT03727438|583828481|FG000|8 Week Assessment|Withdrawal by Subject|6|||
161665885|NCT03727438|583828482|FG001|8 Week Assessment|Withdrawal by Subject|1|||
161665886|NCT03727438|583828481|FG000|6 mo Assessment|did not complete assessment|10|||
161665887|NCT03727438|583828482|FG001|6 mo Assessment|did not complete assessment|11|||
161665888|NCT06729606|583828483|FG000|Overall Study|Adverse Event|0|||
161665889|NCT06729606|583828484|FG001|Overall Study|Adverse Event|2|||
161665890|NCT06729606|583828483|FG000|Overall Study|Death|1|||
161665891|NCT06729606|583828484|FG001|Overall Study|Death|0|||
161665892|NCT06729606|583828483|FG000|Overall Study|Physician Decision|0|||
161665893|NCT06729606|583828484|FG001|Overall Study|Physician Decision|1|||
161665894|NCT06729606|583828483|FG000|Overall Study|Withdrawal by Subject|2|||
161665895|NCT06729606|583828484|FG001|Overall Study|Withdrawal by Subject|4|||
161665896|NCT03170349|583828491|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
161665897|NCT03170349|583828491|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
161665898|NCT03170349|583828491|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
161665899|NCT03170349|583828491|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
161665900|NCT03170349|583828491|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
161665901|NCT03170349|583828491|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
161665902|NCT03170349|583828491|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
161665903|NCT03170349|583828491|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
161665904|NCT03170349|583828491|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
161665905|NCT03170349|583828491|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
161665906|NCT03170349|583828491|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
161665907|NCT03170349|583828491|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
161665908|NCT03170349|583828491|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
161665909|NCT03170349|583828491|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
161665910|NCT03170349|583828491|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
161665911|NCT03170349|583828491|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
161665912|NCT03440320|583830092|FG000|Overall Study|Withdrawal by Subject|0|||
161665913|NCT03440320|583830093|FG001|Overall Study|Withdrawal by Subject|1|||
161665914|NCT00001962|583830094|FG000|Overall Study|Lack of Efficacy|18|||
161665915|NCT00001962|583830094|FG000|Overall Study|Lack of Accrual|6|||
161665916|NCT00001962|583830094|FG000|Overall Study|Death|1|||
161665917|NCT00001962|583830094|FG000|Overall Study|Lost to Follow-up|2|||
161665918|NCT00001962|583830094|FG000|Overall Study|Adverse Event|1|||
161665919|NCT00604279|583830098|FG000|Overall Study|Lack of Efficacy|22|||
161665920|NCT00604279|583830099|FG001|Overall Study|Lack of Efficacy|9|||
161665921|NCT00604279|583830098|FG000|Overall Study|Lost to Follow-up|9|||
161665922|NCT00604279|583830099|FG001|Overall Study|Lost to Follow-up|14|||
161665923|NCT00604279|583830098|FG000|Overall Study|Pregnancy|2|||
161665924|NCT00604279|583830099|FG001|Overall Study|Pregnancy|0|||
161665925|NCT00604279|583830098|FG000|Overall Study|Protocol Violation|3|||
161665926|NCT00604279|583830099|FG001|Overall Study|Protocol Violation|1|||
161665927|NCT00604279|583830098|FG000|Overall Study|Withdrawal by Subject|16|||
161665928|NCT00604279|583830099|FG001|Overall Study|Withdrawal by Subject|5|||
161665929|NCT00604279|583830098|FG000|Overall Study|Adverse Event|4|||
161665930|NCT00604279|583830099|FG001|Overall Study|Adverse Event|5|||
161665931|NCT00604279|583830098|FG000|Overall Study|Other|8|||
161665932|NCT00604279|583830099|FG001|Overall Study|Other|4|||
161665933|NCT03938545|583830100|FG000|Overall Study|Lost to Follow-up|0|||
161665934|NCT03938545|583830101|FG001|Overall Study|Lost to Follow-up|0|||
161665935|NCT03938545|583830102|FG002|Overall Study|Lost to Follow-up|0|||
161665936|NCT03938545|583830103|FG003|Overall Study|Lost to Follow-up|1|||
161665937|NCT03938545|583830100|FG000|Overall Study|Non-compliance with study drug|0|||
161665938|NCT03938545|583830101|FG001|Overall Study|Non-compliance with study drug|0|||
161665939|NCT03938545|583830102|FG002|Overall Study|Non-compliance with study drug|1|||
161665940|NCT03938545|583830103|FG003|Overall Study|Non-compliance with study drug|0|||
161665941|NCT03938545|583830100|FG000|Overall Study|Pregnancy|1|||
161665942|NCT03938545|583830101|FG001|Overall Study|Pregnancy|0|||
161665943|NCT03938545|583830102|FG002|Overall Study|Pregnancy|0|||
161665944|NCT03938545|583830103|FG003|Overall Study|Pregnancy|0|||
161665945|NCT03938545|583830100|FG000|Overall Study|Study terminated by sponsor|6|||
161665946|NCT03938545|583830101|FG001|Overall Study|Study terminated by sponsor|4|||
161665947|NCT03938545|583830102|FG002|Overall Study|Study terminated by sponsor|2|||
161665948|NCT03938545|583830103|FG003|Overall Study|Study terminated by sponsor|4|||
161665949|NCT03938545|583830100|FG000|Overall Study|Withdrawal by Subject|0|||
161665950|NCT03938545|583830101|FG001|Overall Study|Withdrawal by Subject|1|||
161665951|NCT03938545|583830102|FG002|Overall Study|Withdrawal by Subject|0|||
161665952|NCT03938545|583830103|FG003|Overall Study|Withdrawal by Subject|0|||
161665953|NCT03938545|583830100|FG000|Overall Study|Adverse Event|1|||
161665954|NCT03938545|583830101|FG001|Overall Study|Adverse Event|0|||
161665955|NCT03938545|583830102|FG002|Overall Study|Adverse Event|0|||
161665956|NCT03938545|583830103|FG003|Overall Study|Adverse Event|0|||
161665957|NCT00355056|583830104|FG000|Randomization Period|Early Termination|4|||
161665958|NCT00355056|583830105|FG001|Randomization Period|Early Termination|6|||
161665959|NCT01060540|583830106|FG000|Overall Study|Withdrawal by Subject|10|||
161665960|NCT01060540|583830107|FG001|Overall Study|Withdrawal by Subject|20|||
161665961|NCT01060540|583830106|FG000|Overall Study|Lost to Follow-up|52|||
161665962|NCT01060540|583830107|FG001|Overall Study|Lost to Follow-up|43|||
161665963|NCT01060540|583830106|FG000|Overall Study|Death|2|||
161552387|NCT02733042|583410429|FG002|Overall Study|Withdrawal by Subject|2|||
161552388|NCT02733042|583410430|FG003|Overall Study|Withdrawal by Subject|1|||
161552389|NCT02733042|583410431|FG004|Overall Study|Withdrawal by Subject|1|||
161552390|NCT02733042|583410432|FG005|Overall Study|Withdrawal by Subject|0|||
161552391|NCT02733042|583410433|FG006|Overall Study|Withdrawal by Subject|0|||
161552392|NCT02733042|583410434|FG007|Overall Study|Withdrawal by Subject|0|||
161552393|NCT02733042|583410435|FG008|Overall Study|Withdrawal by Subject|1|||
161552394|NCT02733042|583410436|FG009|Overall Study|Withdrawal by Subject|1|||
161552395|NCT02733042|583410437|FG010|Overall Study|Withdrawal by Subject|0|||
161552396|NCT02733042|583410438|FG011|Overall Study|Withdrawal by Subject|2|||
161552397|NCT02733042|583410439|FG012|Overall Study|Withdrawal by Subject|1|||
161552398|NCT02733042|583410440|FG013|Overall Study|Withdrawal by Subject|1|||
161552399|NCT02733042|583410441|FG014|Overall Study|Withdrawal by Subject|0|||
161552400|NCT02733042|583410442|FG015|Overall Study|Withdrawal by Subject|0|||
161552401|NCT02733042|583410443|FG016|Overall Study|Withdrawal by Subject|0|||
161552402|NCT02733042|583410444|FG017|Overall Study|Withdrawal by Subject|0|||
161552403|NCT02733042|583410445|FG018|Overall Study|Withdrawal by Subject|0|||
161552404|NCT02733042|583410427|FG000|Overall Study|Other Reasons|0|||
161552405|NCT02733042|583410428|FG001|Overall Study|Other Reasons|0|||
161552406|NCT02733042|583410429|FG002|Overall Study|Other Reasons|1|||
161552407|NCT02733042|583410430|FG003|Overall Study|Other Reasons|0|||
161552408|NCT02733042|583410431|FG004|Overall Study|Other Reasons|0|||
161552409|NCT02733042|583410432|FG005|Overall Study|Other Reasons|0|||
161552410|NCT02733042|583410433|FG006|Overall Study|Other Reasons|0|||
161552411|NCT02733042|583410434|FG007|Overall Study|Other Reasons|0|||
161552412|NCT02733042|583410435|FG008|Overall Study|Other Reasons|0|||
161552413|NCT02733042|583410436|FG009|Overall Study|Other Reasons|1|||
161552414|NCT02733042|583410437|FG010|Overall Study|Other Reasons|1|||
161552415|NCT02733042|583410438|FG011|Overall Study|Other Reasons|0|||
161552416|NCT02733042|583410439|FG012|Overall Study|Other Reasons|0|||
161552417|NCT02733042|583410440|FG013|Overall Study|Other Reasons|0|||
161552418|NCT02733042|583410441|FG014|Overall Study|Other Reasons|0|||
161552419|NCT02733042|583410442|FG015|Overall Study|Other Reasons|1|||
161552420|NCT02733042|583410443|FG016|Overall Study|Other Reasons|0|||
161552421|NCT02733042|583410444|FG017|Overall Study|Other Reasons|1|||
161552422|NCT02733042|583410445|FG018|Overall Study|Other Reasons|0|||
161552423|NCT02733042|583410427|FG000|Overall Study|Death|0|||
161552424|NCT02733042|583410428|FG001|Overall Study|Death|0|||
161552425|NCT02733042|583410429|FG002|Overall Study|Death|0|||
161552426|NCT02733042|583410430|FG003|Overall Study|Death|0|||
161552427|NCT02733042|583410431|FG004|Overall Study|Death|0|||
161665964|NCT01060540|583830107|FG001|Overall Study|Death|1|||
161895328|NCT00741598|584666297|FG001|Overall Study|Physician Decision|1|||
161665965|NCT01060540|583830106|FG000|Overall Study|Physician Decision|0|||
161895329|NCT00741598|584666296|FG000|Overall Study|Pregnancy|1|||
161665966|NCT01060540|583830107|FG001|Overall Study|Physician Decision|1|||
161665967|NCT00816400|583830111|FG000|Overall Study|Death|2|||
161665968|NCT00816400|583830112|FG001|Overall Study|Death|3|||
161665969|NCT00816400|583830113|FG002|Overall Study|Death|3|||
161665970|NCT00816400|583830114|FG003|Overall Study|Death|3|||
161665971|NCT00816400|583830115|FG004|Overall Study|Death|2|||
161665972|NCT00816400|583830116|FG005|Overall Study|Death|3|||
161665973|NCT00816400|583830117|FG006|Overall Study|Death|2|||
161665974|NCT00816400|583830118|FG007|Overall Study|Death|5|||
161665975|NCT00816400|583830119|FG008|Overall Study|Death|6|||
161665976|NCT00816400|583830111|FG000|Overall Study|In hospice care at the end of the study|0|||
161665977|NCT00816400|583830112|FG001|Overall Study|In hospice care at the end of the study|0|||
161665978|NCT00816400|583830113|FG002|Overall Study|In hospice care at the end of the study|2|||
161665979|NCT00816400|583830114|FG003|Overall Study|In hospice care at the end of the study|0|||
161665980|NCT00816400|583830115|FG004|Overall Study|In hospice care at the end of the study|0|||
161665981|NCT00816400|583830116|FG005|Overall Study|In hospice care at the end of the study|0|||
161665982|NCT00816400|583830117|FG006|Overall Study|In hospice care at the end of the study|0|||
161665983|NCT00816400|583830118|FG007|Overall Study|In hospice care at the end of the study|0|||
161665984|NCT00816400|583830119|FG008|Overall Study|In hospice care at the end of the study|0|||
161665985|NCT00596427|583830120|FG000|Overall Study|Withdrawal by Subject|2|||
161665986|NCT00596427|583830121|FG001|Overall Study|Withdrawal by Subject|2|||
161665987|NCT00596427|583830120|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
161665988|NCT00596427|583830121|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
161665989|NCT00596427|583830120|FG000|Overall Study|Protocol Violation|1|||
161665990|NCT00596427|583830121|FG001|Overall Study|Protocol Violation|0|||
161665991|NCT02401867|583830122|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
161665992|NCT02401867|583830122|FG000|Analysis|Cervical assay could not be conducted|9|||
161665993|NCT01650246|583830123|FG000|Overall Study|Adverse Event|23|||
161665994|NCT01650246|583830123|FG000|Overall Study|Protocol Violation|5|||
161665995|NCT01650246|583830123|FG000|Overall Study|Sponsor terminated study|53|||
161665996|NCT01650246|583830123|FG000|Overall Study|Lost to Follow-up|5|||
161665997|NCT01650246|583830123|FG000|Overall Study|Withdrawal by Subject|26|||
161665998|NCT01650246|583830123|FG000|Overall Study|Death|1|||
161665999|NCT01650246|583830123|FG000|Overall Study|Lack of Efficacy|30|||
161666000|NCT03435497|583830125|FG000|Overall Study|Lost to Follow-up|1|||
161666001|NCT03435497|583830126|FG001|Overall Study|Lost to Follow-up|0|||
161666002|NCT03435497|583830125|FG000|Overall Study|Death|1|||
161666003|NCT03435497|583830126|FG001|Overall Study|Death|0|||
161666004|NCT03435497|583830125|FG000|Overall Study|Withdrawal by Subject|0|||
161666005|NCT03435497|583830126|FG001|Overall Study|Withdrawal by Subject|4|||
161666006|NCT03435497|583830125|FG000|Overall Study|Wrong survey administered|0|||
161666007|NCT03435497|583830126|FG001|Overall Study|Wrong survey administered|2|||
161666008|NCT04281004|583830129|FG000|Overall Study|Physician Decision|1|||
161666009|NCT04281004|583830130|FG001|Overall Study|Physician Decision|0|||
161666010|NCT00701779|583830131|FG000|Overall Study|Adverse Event|6|||
161666011|NCT00701779|583830131|FG000|Overall Study|Lost to Follow-up|1|||
161666012|NCT00701779|583830131|FG000|Overall Study|Withdrawal by Subject|2|||
161666013|NCT02245672|583830132|FG000|Overall Study|Adverse Event|4|||
161666014|NCT02245672|583830133|FG001|Overall Study|Adverse Event|4|||
161666015|NCT02245672|583830134|FG002|Overall Study|Adverse Event|4|||
161666016|NCT02245672|583830132|FG000|Overall Study|Lost to Follow-up|3|||
161666017|NCT02245672|583830133|FG001|Overall Study|Lost to Follow-up|5|||
161666018|NCT02245672|583830134|FG002|Overall Study|Lost to Follow-up|1|||
161666019|NCT02245672|583830132|FG000|Overall Study|Withdrawal by Subject|6|||
161666020|NCT02245672|583830133|FG001|Overall Study|Withdrawal by Subject|3|||
161666021|NCT02245672|583830134|FG002|Overall Study|Withdrawal by Subject|0|||
161666022|NCT02245672|583830132|FG000|Overall Study|Randomized in error (not treated)|0|||
161666023|NCT02245672|583830133|FG001|Overall Study|Randomized in error (not treated)|1|||
161666024|NCT02245672|583830134|FG002|Overall Study|Randomized in error (not treated)|0|||
161666025|NCT04363801|583830140|FG000|Overall Study|Death|18|||
161666026|NCT04363801|583830141|FG001|Overall Study|Death|14|||
161666027|NCT04363801|583830142|FG002|Overall Study|Death|16|||
161666028|NCT04363801|583830143|FG003|Overall Study|Death|48|||
161666029|NCT04363801|583830144|FG004|Overall Study|Death|38|||
161666030|NCT04363801|583830140|FG000|Overall Study|Withdrawal by Subject|1|||
161666031|NCT04363801|583830141|FG001|Overall Study|Withdrawal by Subject|6|||
161666032|NCT04363801|583830142|FG002|Overall Study|Withdrawal by Subject|1|||
161666033|NCT04363801|583830143|FG003|Overall Study|Withdrawal by Subject|4|||
161666034|NCT04363801|583830144|FG004|Overall Study|Withdrawal by Subject|14|||
161666035|NCT04363801|583830140|FG000|Overall Study|Sponsor Decision|6|||
161666036|NCT04363801|583830141|FG001|Overall Study|Sponsor Decision|4|||
161666037|NCT04363801|583830142|FG002|Overall Study|Sponsor Decision|10|||
161666038|NCT04363801|583830143|FG003|Overall Study|Sponsor Decision|33|||
161666039|NCT04363801|583830144|FG004|Overall Study|Sponsor Decision|32|||
161666040|NCT04363801|583830140|FG000|Overall Study|Lost to Follow-up|0|||
161666041|NCT04363801|583830141|FG001|Overall Study|Lost to Follow-up|0|||
161666042|NCT04363801|583830142|FG002|Overall Study|Lost to Follow-up|1|||
161666043|NCT04363801|583830143|FG003|Overall Study|Lost to Follow-up|0|||
161666044|NCT04363801|583830144|FG004|Overall Study|Lost to Follow-up|1|||
161666045|NCT01146054|583830145|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
161666046|NCT01146054|583830145|FG000|Overall Study|Rapid tumor progression|2|||
161666047|NCT01146054|583830145|FG000|Overall Study|Other illness precluded treatment|2|||
161666048|NCT01146054|583830145|FG000|Overall Study|Lost to Follow-up|1|||
161666049|NCT00762970|583830146|FG000|Overall Study|Withdrawal by Subject|7|||
161666050|NCT00762970|583830147|FG001|Overall Study|Withdrawal by Subject|4|||
161666051|NCT00762970|583830148|FG002|Overall Study|Withdrawal by Subject|0|||
161666052|NCT00762970|583830146|FG000|Overall Study|Protocol Violation|3|||
161666053|NCT00762970|583830147|FG001|Overall Study|Protocol Violation|1|||
161666054|NCT00762970|583830148|FG002|Overall Study|Protocol Violation|1|||
161666055|NCT00762970|583830146|FG000|Overall Study|Lost to Follow-up|1|||
161666056|NCT00762970|583830147|FG001|Overall Study|Lost to Follow-up|2|||
161666057|NCT00762970|583830148|FG002|Overall Study|Lost to Follow-up|0|||
161666058|NCT00762970|583830146|FG000|Overall Study|Difficulty of handling lens|1|||
161666059|NCT00762970|583830147|FG001|Overall Study|Difficulty of handling lens|2|||
161666060|NCT00762970|583830148|FG002|Overall Study|Difficulty of handling lens|0|||
161666061|NCT02901041|583830149|FG000|Overall Study|Withdrawal by PI|4|||
161666062|NCT02901041|583830150|FG001|Overall Study|Withdrawal by PI|8|||
161666063|NCT02901041|583830149|FG000|Overall Study|Withdrawal by Subject|7|||
161666064|NCT02901041|583830150|FG001|Overall Study|Withdrawal by Subject|3|||
161666065|NCT01480674|583830151|FG000|Overall Study|Death|23|||
161666066|NCT01480674|583830151|FG000|Overall Study|Lost to Follow-up|2|||
161666067|NCT01480674|583830151|FG000|Overall Study|visit not done|10|||
161666068|NCT03818204|583830152|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666069|NCT03818204|583830153|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666070|NCT03818204|583830154|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666071|NCT03818204|583830155|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666072|NCT03818204|583830156|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
161666073|NCT03818204|583830157|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666074|NCT03818204|583830158|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666075|NCT03818204|583830159|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666076|NCT03818204|583830160|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666077|NCT03818204|583830161|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666078|NCT03818204|583830162|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666079|NCT03818204|583830163|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666080|NCT03818204|583830164|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666081|NCT03818204|583830165|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
161666082|NCT03818204|583830166|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666083|NCT03818204|583830167|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666084|NCT03818204|583830168|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666085|NCT03818204|583830169|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666086|NCT03818204|583830170|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161666087|NCT03818204|583830152|FG000|Overall Study|Physician Decision|0|||
161666088|NCT03818204|583830153|FG001|Overall Study|Physician Decision|0|||
161666089|NCT03818204|583830154|FG002|Overall Study|Physician Decision|0|||
161666090|NCT03818204|583830155|FG003|Overall Study|Physician Decision|0|||
161666091|NCT03818204|583830156|FG004|Overall Study|Physician Decision|0|||
161666092|NCT03818204|583830157|FG005|Overall Study|Physician Decision|0|||
161666093|NCT03818204|583830158|FG006|Overall Study|Physician Decision|0|||
161666094|NCT03818204|583830159|FG007|Overall Study|Physician Decision|0|||
161666095|NCT03818204|583830160|FG008|Overall Study|Physician Decision|0|||
161666096|NCT03818204|583830161|FG009|Overall Study|Physician Decision|0|||
161666097|NCT03818204|583830162|FG010|Overall Study|Physician Decision|0|||
161666098|NCT03818204|583830163|FG011|Overall Study|Physician Decision|0|||
161666099|NCT03818204|583830164|FG012|Overall Study|Physician Decision|0|||
161666100|NCT03818204|583830165|FG013|Overall Study|Physician Decision|0|||
161666101|NCT03818204|583830166|FG014|Overall Study|Physician Decision|1|||
161666102|NCT03818204|583830167|FG015|Overall Study|Physician Decision|0|||
161666103|NCT03818204|583830168|FG016|Overall Study|Physician Decision|0|||
161666104|NCT03818204|583830169|FG017|Overall Study|Physician Decision|0|||
161666105|NCT03818204|583830170|FG018|Overall Study|Physician Decision|0|||
161666106|NCT00887250|583830171|FG000|Overall Study|Adverse Event|3|||
161666107|NCT00887250|583830172|FG001|Overall Study|Adverse Event|0|||
161666108|NCT00887250|583830173|FG002|Overall Study|Adverse Event|7|||
161666109|NCT00887250|583830171|FG000|Overall Study|Lack of Efficacy|9|||
161666110|NCT00887250|583830172|FG001|Overall Study|Lack of Efficacy|6|||
161666111|NCT00887250|583830173|FG002|Overall Study|Lack of Efficacy|1|||
161666112|NCT00887250|583830171|FG000|Overall Study|Lost to Follow-up|2|||
161666113|NCT00887250|583830172|FG001|Overall Study|Lost to Follow-up|3|||
161666114|NCT00887250|583830173|FG002|Overall Study|Lost to Follow-up|1|||
161666115|NCT00887250|583830171|FG000|Overall Study|Protocol Violation|2|||
161666116|NCT00887250|583830172|FG001|Overall Study|Protocol Violation|2|||
161666117|NCT00887250|583830173|FG002|Overall Study|Protocol Violation|1|||
161666118|NCT00887250|583830171|FG000|Overall Study|Withdrawal by Subject|2|||
161666119|NCT00887250|583830172|FG001|Overall Study|Withdrawal by Subject|1|||
161895330|NCT00741598|584666297|FG001|Overall Study|Pregnancy|0|||
161666120|NCT00887250|583830173|FG002|Overall Study|Withdrawal by Subject|2|||
161666121|NCT00887250|583830171|FG000|Overall Study|Patient uncooperative|0|||
161666122|NCT00887250|583830172|FG001|Overall Study|Patient uncooperative|0|||
161666123|NCT00887250|583830173|FG002|Overall Study|Patient uncooperative|1|||
161666124|NCT05754333|583830174|FG000|Overall Study|Miscellaneous|3|||
161666125|NCT05754333|583830175|FG001|Overall Study|Miscellaneous|0|||
161666126|NCT05754333|583830176|FG002|Overall Study|Miscellaneous|0|||
161666127|NCT05754333|583830177|FG003|Overall Study|Miscellaneous|0|||
161666128|NCT05754333|583830174|FG000|Overall Study|Lost to Follow-up|2|||
161666129|NCT05754333|583830175|FG001|Overall Study|Lost to Follow-up|1|||
161666130|NCT05754333|583830176|FG002|Overall Study|Lost to Follow-up|0|||
161666131|NCT05754333|583830177|FG003|Overall Study|Lost to Follow-up|1|||
161666132|NCT03401229|583830183|FG000|Overall Study|Lost to Follow-up|2|||
161666133|NCT03401229|583830184|FG001|Overall Study|Lost to Follow-up|1|||
161666134|NCT03401229|583830183|FG000|Overall Study|Other|1|||
161666135|NCT03401229|583830184|FG001|Overall Study|Other|3|||
161666136|NCT03401229|583830183|FG000|Overall Study|Adverse Event|8|||
161666137|NCT03401229|583830184|FG001|Overall Study|Adverse Event|6|||
161666138|NCT03401229|583830183|FG000|Overall Study|Withdrawal by Subject|29|||
161666139|NCT03401229|583830184|FG001|Overall Study|Withdrawal by Subject|26|||
161666140|NCT03401229|583830183|FG000|Overall Study|COVID-19|0|||
161666141|NCT03401229|583830184|FG001|Overall Study|COVID-19|1|||
161666142|NCT05333224|583830185|FG000|Overall Study - Infants|Lost to Follow-up|1|||
161666143|NCT05333224|583830186|FG001|Overall Study - Infants|Lost to Follow-up|1|||
161666144|NCT01776424|583830190|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
161666145|NCT01776424|583830191|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
161666146|NCT01776424|583830192|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
161666147|NCT01776424|583830190|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
161666148|NCT01776424|583830191|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
161666149|NCT01776424|583830192|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
161666150|NCT01776424|583830190|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
161666151|NCT01776424|583830191|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
161666152|NCT01776424|583830192|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
161666153|NCT01776424|583830190|FG000|LTOLE Part (Open Label)|Refused|5|||
161666154|NCT01776424|583830191|FG001|LTOLE Part (Open Label)|Refused|2|||
161666155|NCT01776424|583830192|FG002|LTOLE Part (Open Label)|Refused|11|||
161666156|NCT01776424|583830190|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
161666157|NCT01776424|583830191|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
161666158|NCT01776424|583830192|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
161666159|NCT00819390|583830194|FG000|Overall Study|Lost to Follow-up|1|||
161666160|NCT00819390|583830195|FG001|Overall Study|Lost to Follow-up|1|||
161666161|NCT00819390|583830196|FG002|Overall Study|Lost to Follow-up|0|||
161666162|NCT00819390|583830197|FG003|Overall Study|Lost to Follow-up|0|||
161666163|NCT00819390|583830194|FG000|Overall Study|Withdrawal by Subject|2|||
161666164|NCT00819390|583830195|FG001|Overall Study|Withdrawal by Subject|0|||
161666165|NCT00819390|583830196|FG002|Overall Study|Withdrawal by Subject|0|||
161666166|NCT00819390|583830197|FG003|Overall Study|Withdrawal by Subject|0|||
161666167|NCT00819390|583830194|FG000|Overall Study|Adverse Event|0|||
161666168|NCT00819390|583830195|FG001|Overall Study|Adverse Event|0|||
161666169|NCT00819390|583830196|FG002|Overall Study|Adverse Event|1|||
161666170|NCT00819390|583830197|FG003|Overall Study|Adverse Event|0|||
161666171|NCT02294227|583830198|FG000|Overall Study|Death|0|||
161666172|NCT02294227|583830199|FG001|Overall Study|Death|0|||
161666173|NCT02294227|583830200|FG002|Overall Study|Death|1|||
161666174|NCT02294227|583830198|FG000|Overall Study|Subject/Guardian Decision|6|||
161666175|NCT02294227|583830199|FG001|Overall Study|Subject/Guardian Decision|3|||
161666176|NCT02294227|583830200|FG002|Overall Study|Subject/Guardian Decision|7|||
161666177|NCT02294227|583830198|FG000|Overall Study|Physician Decision|1|||
161666178|NCT02294227|583830199|FG001|Overall Study|Physician Decision|2|||
161666179|NCT02294227|583830200|FG002|Overall Study|Physician Decision|1|||
161666180|NCT02294227|583830198|FG000|Overall Study|Lost to Follow-up|1|||
161666181|NCT02294227|583830199|FG001|Overall Study|Lost to Follow-up|0|||
161666182|NCT02294227|583830200|FG002|Overall Study|Lost to Follow-up|0|||
161666183|NCT02294227|583830198|FG000|Overall Study|Lack of Efficacy|11|||
161666184|NCT02294227|583830199|FG001|Overall Study|Lack of Efficacy|12|||
161666185|NCT02294227|583830200|FG002|Overall Study|Lack of Efficacy|8|||
161666186|NCT02294227|583830198|FG000|Overall Study|Adverse Event|6|||
161666187|NCT02294227|583830199|FG001|Overall Study|Adverse Event|8|||
161666188|NCT02294227|583830200|FG002|Overall Study|Adverse Event|2|||
161666189|NCT00887432|583830201|FG000|Overall Study|Start Excluded Therapy|3|||
161666190|NCT00887432|583830202|FG001|Overall Study|Start Excluded Therapy|0|||
161666191|NCT00887432|583830201|FG000|Overall Study|Did not complete treatment|6|||
161666192|NCT00887432|583830202|FG001|Overall Study|Did not complete treatment|8|||
161666193|NCT00887432|583830201|FG000|Overall Study|Protocol Violation|2|||
161666194|NCT00887432|583830202|FG001|Overall Study|Protocol Violation|3|||
161666195|NCT00887432|583830201|FG000|Overall Study|Withdrawal by Subject|3|||
161666196|NCT00887432|583830202|FG001|Overall Study|Withdrawal by Subject|2|||
161666197|NCT00887432|583830201|FG000|Overall Study|Lost to Follow-up|1|||
161666198|NCT00887432|583830202|FG001|Overall Study|Lost to Follow-up|0|||
161666199|NCT00887432|583830201|FG000|Overall Study|No reason provided|0|||
161666200|NCT00887432|583830202|FG001|Overall Study|No reason provided|1|||
161666201|NCT00899548|583830203|FG000|Overall Study|Physician Decision|3|||
161666202|NCT00551460|583830204|FG000|Overall Study|Adverse Event|1|||
161666203|NCT00551460|583830204|FG000|Overall Study|Withdrawal by Subject|1|||
161666204|NCT00551460|583830204|FG000|Overall Study|Physician Decision|1|||
161666205|NCT00551460|583830204|FG000|Overall Study|Death|7|||
161666206|NCT00551460|583830204|FG000|Overall Study|Ineligible|4|||
161666207|NCT00551460|583830204|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
161666208|NCT01636960|583830205|FG000|Induction Phase|Adverse Event|2|||
161666209|NCT01636960|583830205|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
161666210|NCT01636960|583830205|FG000|Maintenance Phase|Adverse Event|3|||
161666211|NCT01636960|583830205|FG000|Maintenance Phase|Progressive disease|1|||
161666212|NCT01209780|583830206|FG000|Overall Study|Adverse Event|0|||
161666213|NCT01209780|583830207|FG001|Overall Study|Adverse Event|1|||
161666214|NCT01209780|583830208|FG002|Overall Study|Adverse Event|0|||
161666215|NCT01209780|583830209|FG003|Overall Study|Adverse Event|0|||
161666216|NCT01209780|583830210|FG004|Overall Study|Adverse Event|0|||
161666217|NCT01209780|583830206|FG000|Overall Study|Withdrawal by Subject|9|||
161666218|NCT01209780|583830207|FG001|Overall Study|Withdrawal by Subject|2|||
161666219|NCT01209780|583830208|FG002|Overall Study|Withdrawal by Subject|1|||
161666220|NCT01209780|583830209|FG003|Overall Study|Withdrawal by Subject|1|||
161666221|NCT01209780|583830210|FG004|Overall Study|Withdrawal by Subject|0|||
161666222|NCT01209780|583830206|FG000|Overall Study|Lost to Follow-up|17|||
161666223|NCT01209780|583830207|FG001|Overall Study|Lost to Follow-up|12|||
161666224|NCT01209780|583830208|FG002|Overall Study|Lost to Follow-up|3|||
161666225|NCT01209780|583830209|FG003|Overall Study|Lost to Follow-up|9|||
161666226|NCT01209780|583830210|FG004|Overall Study|Lost to Follow-up|4|||
161666227|NCT01209780|583830206|FG000|Overall Study|Protocol Violation|0|||
161666228|NCT01209780|583830207|FG001|Overall Study|Protocol Violation|1|||
161666229|NCT01209780|583830208|FG002|Overall Study|Protocol Violation|0|||
161666230|NCT01209780|583830209|FG003|Overall Study|Protocol Violation|0|||
161666231|NCT01209780|583830210|FG004|Overall Study|Protocol Violation|0|||
161666232|NCT01209780|583830206|FG000|Overall Study|Inappropriate enrollment|0|||
161666233|NCT01209780|583830207|FG001|Overall Study|Inappropriate enrollment|2|||
161666234|NCT01209780|583830208|FG002|Overall Study|Inappropriate enrollment|0|||
161666235|NCT01209780|583830209|FG003|Overall Study|Inappropriate enrollment|0|||
161666236|NCT01209780|583830210|FG004|Overall Study|Inappropriate enrollment|1|||
161666237|NCT00448123|583830212|FG000|Overall Study|Lost to Follow-up|9|||
161666238|NCT00448123|583830213|FG001|Overall Study|Lost to Follow-up|6|||
161666239|NCT00448123|583830212|FG000|Overall Study|Physician Decision|6|||
161666240|NCT00448123|583830213|FG001|Overall Study|Physician Decision|6|||
161666241|NCT02318797|583830216|FG000|Overall Study|Death|3|||
161666242|NCT02318797|583830217|FG001|Overall Study|Death|6|||
161666243|NCT02318797|583830216|FG000|Overall Study|Lost to Follow-up|85|||
161666244|NCT02318797|583830217|FG001|Overall Study|Lost to Follow-up|96|||
161666245|NCT02709096|583830222|FG000|Overall Study|non-compliance|1|||
161666246|NCT02709096|583830223|FG001|Overall Study|non-compliance|1|||
161666247|NCT00818649|583830224|FG000|Overall Study|Declining performance status|2|||
161666248|NCT00818649|583830224|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
161666249|NCT00818649|583830224|FG000|Overall Study|Adverse Event|1|||
161666250|NCT00505284|583830225|FG000|Overall Study|Adverse Event|3|||
161666251|NCT00505284|583830226|FG001|Overall Study|Adverse Event|7|||
161666252|NCT00505284|583830227|FG002|Overall Study|Adverse Event|9|||
161666253|NCT00505284|583830228|FG003|Overall Study|Adverse Event|14|||
161666254|NCT00505284|583830229|FG004|Overall Study|Adverse Event|22|||
161666255|NCT00505284|583830225|FG000|Overall Study|Protocol Violation|0|||
161666256|NCT00505284|583830226|FG001|Overall Study|Protocol Violation|1|||
161666257|NCT00505284|583830227|FG002|Overall Study|Protocol Violation|1|||
161666258|NCT00505284|583830228|FG003|Overall Study|Protocol Violation|0|||
161666259|NCT00505284|583830229|FG004|Overall Study|Protocol Violation|0|||
161666260|NCT00505284|583830225|FG000|Overall Study|Withdrawal by Subject|2|||
161666261|NCT00505284|583830226|FG001|Overall Study|Withdrawal by Subject|6|||
161666262|NCT00505284|583830227|FG002|Overall Study|Withdrawal by Subject|1|||
161666263|NCT00505284|583830228|FG003|Overall Study|Withdrawal by Subject|0|||
161666264|NCT00505284|583830229|FG004|Overall Study|Withdrawal by Subject|6|||
161666265|NCT00505284|583830225|FG000|Overall Study|Lack of Efficacy|0|||
161666266|NCT00505284|583830226|FG001|Overall Study|Lack of Efficacy|1|||
161666267|NCT00505284|583830227|FG002|Overall Study|Lack of Efficacy|1|||
161666268|NCT00505284|583830228|FG003|Overall Study|Lack of Efficacy|1|||
161666269|NCT00505284|583830229|FG004|Overall Study|Lack of Efficacy|1|||
161666270|NCT00505284|583830225|FG000|Overall Study|Physician Decision|0|||
161666271|NCT00505284|583830226|FG001|Overall Study|Physician Decision|1|||
161666272|NCT00505284|583830227|FG002|Overall Study|Physician Decision|0|||
161666273|NCT00505284|583830228|FG003|Overall Study|Physician Decision|0|||
161666274|NCT00505284|583830229|FG004|Overall Study|Physician Decision|0|||
161666275|NCT00505284|583830225|FG000|Overall Study|Other|5|||
161666276|NCT00505284|583830226|FG001|Overall Study|Other|0|||
161666277|NCT00505284|583830227|FG002|Overall Study|Other|0|||
161666278|NCT00505284|583830228|FG003|Overall Study|Other|4|||
161666279|NCT00505284|583830229|FG004|Overall Study|Other|4|||
161666280|NCT00940108|583830230|FG000|Overall Study|Adverse Event|2|||
161666281|NCT00940108|583830231|FG001|Overall Study|Adverse Event|4|||
161666282|NCT00940108|583830232|FG002|Overall Study|Adverse Event|0|||
161666283|NCT00940108|583830233|FG003|Overall Study|Adverse Event|2|||
161666284|NCT00940108|583830230|FG000|Overall Study|Withdrew Consent|2|||
161666285|NCT00940108|583830231|FG001|Overall Study|Withdrew Consent|1|||
161666286|NCT00940108|583830232|FG002|Overall Study|Withdrew Consent|0|||
161666287|NCT00940108|583830233|FG003|Overall Study|Withdrew Consent|1|||
161666288|NCT00940108|583830230|FG000|Overall Study|Dose 2 contraindicated|1|||
161666289|NCT00940108|583830231|FG001|Overall Study|Dose 2 contraindicated|1|||
161666290|NCT00940108|583830232|FG002|Overall Study|Dose 2 contraindicated|0|||
161666291|NCT00940108|583830233|FG003|Overall Study|Dose 2 contraindicated|1|||
161666292|NCT00940108|583830230|FG000|Overall Study|Declined further vaccination|0|||
161666293|NCT00940108|583830231|FG001|Overall Study|Declined further vaccination|1|||
161666294|NCT00940108|583830232|FG002|Overall Study|Declined further vaccination|3|||
161666295|NCT00940108|583830233|FG003|Overall Study|Declined further vaccination|0|||
161666296|NCT00940108|583830230|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
161666297|NCT00940108|583830231|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
161666298|NCT00940108|583830232|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
161666299|NCT00940108|583830233|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
161666300|NCT00940108|583830230|FG000|Overall Study|Viral illness after Dose 1|0|||
161666301|NCT00940108|583830231|FG001|Overall Study|Viral illness after Dose 1|1|||
161666302|NCT00940108|583830232|FG002|Overall Study|Viral illness after Dose 1|0|||
161666303|NCT00940108|583830233|FG003|Overall Study|Viral illness after Dose 1|0|||
161666304|NCT00940108|583830230|FG000|Overall Study|Diagnosed with H1N1|0|||
161666305|NCT00940108|583830231|FG001|Overall Study|Diagnosed with H1N1|0|||
161666306|NCT00940108|583830232|FG002|Overall Study|Diagnosed with H1N1|0|||
161666307|NCT00940108|583830233|FG003|Overall Study|Diagnosed with H1N1|1|||
161666308|NCT01740323|583830234|FG000|Overall Study|Adverse Event|1|||
161666309|NCT01740323|583830235|FG001|Overall Study|Adverse Event|0|||
161666310|NCT01740323|583830234|FG000|Overall Study|Randomized but did not take study drug|1|||
161666311|NCT01740323|583830235|FG001|Overall Study|Randomized but did not take study drug|0|||
161666312|NCT06338462|583830236|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
161666313|NCT00928447|583830237|FG000|Overall Study|Withdrawal by Subject|1|||
161666314|NCT00928447|583830237|FG000|Overall Study|Investigator's decision|1|||
161666315|NCT02112708|583830244|FG000|Baseline|Physician Decision|16|||
161666316|NCT02112708|583830245|FG001|Baseline|Physician Decision|11|||
161666317|NCT02112708|583830244|FG000|Baseline|Lost to Follow-up|12|||
161666318|NCT02112708|583830245|FG001|Baseline|Lost to Follow-up|0|||
161666319|NCT02112708|583830244|FG000|4 Month|Death|0|||
161666320|NCT02112708|583830245|FG001|4 Month|Death|1|||
161666321|NCT02112708|583830244|FG000|4 Month|Withdrawal by Subject|12|||
161666322|NCT02112708|583830245|FG001|4 Month|Withdrawal by Subject|0|||
161666323|NCT00953745|583830246|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
161666324|NCT00953745|583830247|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
161666325|NCT00953745|583830246|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
161666326|NCT00953745|583830247|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
161666327|NCT00953745|583830246|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
161666328|NCT00953745|583830247|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
161666329|NCT00953745|583830246|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
161666330|NCT00953745|583830247|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
161666331|NCT00953745|583830246|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
161666332|NCT00953745|583830247|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
161666333|NCT00953745|583830246|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
161666334|NCT00953745|583830247|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
161666335|NCT03756129|583830249|FG000|Overall Study|Adverse Event|1|||
161666336|NCT03756129|583830250|FG001|Overall Study|Adverse Event|1|||
161666337|NCT03756129|583830251|FG002|Overall Study|Adverse Event|0|||
161666338|NCT03756129|583830252|FG003|Overall Study|Adverse Event|2|||
161666339|NCT03756129|583830253|FG004|Overall Study|Adverse Event|0|||
161666340|NCT03756129|583830254|FG005|Overall Study|Adverse Event|0|||
161666341|NCT03756129|583830249|FG000|Overall Study|Withdrawal by Subject|2|||
161666342|NCT03756129|583830250|FG001|Overall Study|Withdrawal by Subject|1|||
161666343|NCT03756129|583830251|FG002|Overall Study|Withdrawal by Subject|3|||
161666344|NCT03756129|583830252|FG003|Overall Study|Withdrawal by Subject|1|||
161666345|NCT03756129|583830253|FG004|Overall Study|Withdrawal by Subject|1|||
161666346|NCT03756129|583830254|FG005|Overall Study|Withdrawal by Subject|3|||
161666347|NCT03756129|583830249|FG000|Overall Study|Lost to Follow-up|0|||
161666348|NCT03756129|583830250|FG001|Overall Study|Lost to Follow-up|0|||
161666349|NCT03756129|583830251|FG002|Overall Study|Lost to Follow-up|0|||
161666350|NCT03756129|583830252|FG003|Overall Study|Lost to Follow-up|0|||
161666351|NCT03756129|583830253|FG004|Overall Study|Lost to Follow-up|0|||
161666352|NCT03756129|583830254|FG005|Overall Study|Lost to Follow-up|1|||
161666353|NCT03756129|583830249|FG000|Overall Study|Physician Decision|0|||
161666354|NCT03756129|583830250|FG001|Overall Study|Physician Decision|0|||
161666355|NCT03756129|583830251|FG002|Overall Study|Physician Decision|0|||
161779441|NCT01052038|584235551|FG001|Overall Study|Lost to Follow-up|3|||
161779442|NCT01052038|584235552|FG002|Overall Study|Lost to Follow-up|1|||
161779443|NCT01052038|584235550|FG000|Overall Study|Protocol Violation|2|||
161779444|NCT01052038|584235551|FG001|Overall Study|Protocol Violation|3|||
161779445|NCT01052038|584235552|FG002|Overall Study|Protocol Violation|3|||
161779446|NCT03349437|584235553|FG000|Screening|Screen Fail|4|||
161779447|NCT03349437|584235554|FG001|Screening|Screen Fail|0|||
161779448|NCT03349437|584235555|FG002|Screening|Screen Fail|0|||
161779449|NCT03349437|584235553|FG000|Screening|Withdrawn|1|||
161779450|NCT03349437|584235554|FG001|Screening|Withdrawn|0|||
161779451|NCT03349437|584235555|FG002|Screening|Withdrawn|0|||
161779452|NCT03343054|584235558|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
161779453|NCT03343054|584235559|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
161779454|NCT03343054|584235560|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
161779455|NCT03343054|584235558|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
161831477|NCT01730040|584424757|FG000|Overall Study|Adverse Event|4|||
161666356|NCT03756129|583830252|FG003|Overall Study|Physician Decision|0|||
161666357|NCT03756129|583830253|FG004|Overall Study|Physician Decision|0|||
161666358|NCT03756129|583830254|FG005|Overall Study|Physician Decision|1|||
161666359|NCT02647320|583831795|FG000|Overall Study|Adverse Event|0|||
161666360|NCT02647320|583831796|FG001|Overall Study|Adverse Event|1|||
161666361|NCT02647320|583831797|FG002|Overall Study|Adverse Event|3|||
161666362|NCT02647320|583831798|FG003|Overall Study|Adverse Event|2|||
161666363|NCT02647320|583831799|FG004|Overall Study|Adverse Event|1|||
161666364|NCT02647320|583831795|FG000|Overall Study|Protocol Violation|0|||
161666365|NCT02647320|583831796|FG001|Overall Study|Protocol Violation|0|||
161666366|NCT02647320|583831797|FG002|Overall Study|Protocol Violation|3|||
161666367|NCT02647320|583831798|FG003|Overall Study|Protocol Violation|0|||
161666368|NCT02647320|583831799|FG004|Overall Study|Protocol Violation|0|||
161666369|NCT02647320|583831795|FG000|Overall Study|Withdrawal by Subject|7|||
161666370|NCT02647320|583831796|FG001|Overall Study|Withdrawal by Subject|4|||
161666371|NCT02647320|583831797|FG002|Overall Study|Withdrawal by Subject|2|||
161666372|NCT02647320|583831798|FG003|Overall Study|Withdrawal by Subject|2|||
161666373|NCT02647320|583831799|FG004|Overall Study|Withdrawal by Subject|7|||
161666374|NCT02647320|583831795|FG000|Overall Study|Persistent hyperglycemia|0|||
161666375|NCT02647320|583831796|FG001|Overall Study|Persistent hyperglycemia|1|||
161666376|NCT02647320|583831797|FG002|Overall Study|Persistent hyperglycemia|1|||
161666377|NCT02647320|583831798|FG003|Overall Study|Persistent hyperglycemia|1|||
161666378|NCT02647320|583831799|FG004|Overall Study|Persistent hyperglycemia|1|||
161666379|NCT02647320|583831795|FG000|Overall Study|Study terminated by sponsor|1|||
161666380|NCT02647320|583831796|FG001|Overall Study|Study terminated by sponsor|1|||
161666381|NCT02647320|583831797|FG002|Overall Study|Study terminated by sponsor|1|||
161666382|NCT02647320|583831798|FG003|Overall Study|Study terminated by sponsor|1|||
161666383|NCT02647320|583831799|FG004|Overall Study|Study terminated by sponsor|2|||
161666384|NCT02647320|583831795|FG000|Overall Study|Reason not provided|0|||
161666385|NCT02647320|583831796|FG001|Overall Study|Reason not provided|0|||
161666386|NCT02647320|583831797|FG002|Overall Study|Reason not provided|1|||
161666387|NCT02647320|583831798|FG003|Overall Study|Reason not provided|0|||
161666388|NCT02647320|583831799|FG004|Overall Study|Reason not provided|2|||
161666389|NCT02647320|583831795|FG000|Overall Study|Lost to Follow-up|1|||
161666390|NCT02647320|583831796|FG001|Overall Study|Lost to Follow-up|1|||
161666391|NCT02647320|583831797|FG002|Overall Study|Lost to Follow-up|0|||
161666392|NCT02647320|583831798|FG003|Overall Study|Lost to Follow-up|0|||
161666393|NCT02647320|583831799|FG004|Overall Study|Lost to Follow-up|0|||
161666394|NCT02647320|583831795|FG000|Overall Study|Develop anemia|1|||
161666395|NCT02647320|583831796|FG001|Overall Study|Develop anemia|0|||
161666396|NCT02647320|583831797|FG002|Overall Study|Develop anemia|0|||
161666397|NCT02647320|583831798|FG003|Overall Study|Develop anemia|0|||
161666398|NCT02647320|583831799|FG004|Overall Study|Develop anemia|0|||
161666399|NCT02647320|583831795|FG000|Overall Study|Lack of Efficacy|0|||
161666400|NCT02647320|583831796|FG001|Overall Study|Lack of Efficacy|0|||
161666401|NCT02647320|583831797|FG002|Overall Study|Lack of Efficacy|0|||
161666402|NCT02647320|583831798|FG003|Overall Study|Lack of Efficacy|1|||
161666403|NCT02647320|583831799|FG004|Overall Study|Lack of Efficacy|0|||
161666404|NCT02647320|583831795|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
161666405|NCT02647320|583831796|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
161666406|NCT02647320|583831797|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
161666407|NCT02647320|583831798|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
161666408|NCT02647320|583831799|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
161666409|NCT00081770|583831800|FG000|Overall Study|Adverse Event|130|||
161666410|NCT00081770|583831801|FG001|Overall Study|Adverse Event|98|||
161666411|NCT00081770|583831802|FG002|Overall Study|Adverse Event|136|||
161666412|NCT00081770|583831800|FG000|Overall Study|Lack of Efficacy|262|||
161666413|NCT00081770|583831801|FG001|Overall Study|Lack of Efficacy|357|||
161666414|NCT00081770|583831802|FG002|Overall Study|Lack of Efficacy|211|||
161666415|NCT00081770|583831800|FG000|Overall Study|Lost to Follow-up|45|||
161666416|NCT00081770|583831801|FG001|Overall Study|Lost to Follow-up|34|||
161666417|NCT00081770|583831802|FG002|Overall Study|Lost to Follow-up|45|||
161666418|NCT00081770|583831800|FG000|Overall Study|Protocol Violation|15|||
161666419|NCT00081770|583831801|FG001|Overall Study|Protocol Violation|10|||
161666420|NCT00081770|583831802|FG002|Overall Study|Protocol Violation|10|||
161666421|NCT00081770|583831800|FG000|Overall Study|Withdrawal by Subject|45|||
161666422|NCT00081770|583831801|FG001|Overall Study|Withdrawal by Subject|40|||
161666423|NCT00081770|583831802|FG002|Overall Study|Withdrawal by Subject|42|||
161666424|NCT00081770|583831800|FG000|Overall Study|Did not meet protocol eligibility|2|||
161666425|NCT00081770|583831801|FG001|Overall Study|Did not meet protocol eligibility|0|||
161666426|NCT00081770|583831802|FG002|Overall Study|Did not meet protocol eligibility|3|||
161666427|NCT00081770|583831800|FG000|Overall Study|Administrative|1|||
161666428|NCT00081770|583831801|FG001|Overall Study|Administrative|0|||
161666429|NCT00081770|583831802|FG002|Overall Study|Administrative|1|||
161666430|NCT00081770|583831800|FG000|Overall Study|Other|2|||
161666431|NCT00081770|583831801|FG001|Overall Study|Other|7|||
161666432|NCT00081770|583831802|FG002|Overall Study|Other|8|||
161666433|NCT01072877|583831803|FG000|Overall Study|Lost to Follow-up|1|||
161666434|NCT01072877|583831804|FG001|Overall Study|Lost to Follow-up|1|||
161666435|NCT01072877|583831805|FG002|Overall Study|Lost to Follow-up|0|||
161666436|NCT01072877|583831806|FG003|Overall Study|Lost to Follow-up|2|||
161666437|NCT01072877|583831807|FG004|Overall Study|Lost to Follow-up|0|||
161666438|NCT00601419|583831808|FG000|Overall Study|Lost to Follow-up|3|||
161666439|NCT00601419|583831808|FG000|Overall Study|Missed Visits|1|||
161666440|NCT00971932|583831819|FG000|Overall Study|Withdrawal by Subject|1|||
161666441|NCT00971932|583831819|FG000|Overall Study|Investigator's decision|2|||
161666442|NCT00971932|583831819|FG000|Overall Study|Ongoing|4|||
161666443|NCT01217957|583831820|FG000|Phase 1|Withdrawal by Patient|1|||
161666444|NCT01217957|583831821|FG001|Phase 1|Withdrawal by Patient|0|||
161666445|NCT01217957|583831822|FG002|Phase 1|Withdrawal by Patient|1|||
161666446|NCT01217957|583831823|FG003|Phase 1|Withdrawal by Patient|1|||
161666447|NCT01217957|583831824|FG004|Phase 1|Withdrawal by Patient|0|||
161666448|NCT01217957|583831820|FG000|Phase 2|Withdrawal by Patient|0|||
161666449|NCT01217957|583831821|FG001|Phase 2|Withdrawal by Patient|0|||
161666450|NCT01217957|583831822|FG002|Phase 2|Withdrawal by Patient|0|||
161666451|NCT01217957|583831823|FG003|Phase 2|Withdrawal by Patient|0|||
161666452|NCT01217957|583831824|FG004|Phase 2|Withdrawal by Patient|1|||
161666453|NCT01640054|583831826|FG000|Overall Study|Study-specific disc criteria|1|||
161666454|NCT01640054|583831826|FG000|Overall Study|Lack of Efficacy|3|||
161666455|NCT01640054|583831826|FG000|Overall Study|Adverse Event|2|||
161666456|NCT01206777|583831827|FG000|Overall Study|Death|1|||
161666457|NCT01206777|583831827|FG000|Overall Study|Adverse Event|1|||
161666458|NCT02382016|583831828|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
161666459|NCT02382016|583831829|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
161666460|NCT02382016|583831828|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
161666461|NCT02382016|583831829|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
161666462|NCT02382016|583831828|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
161666463|NCT02382016|583831829|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
161666464|NCT02382016|583831828|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
161666465|NCT02382016|583831829|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
161666466|NCT02382016|583831828|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
161666467|NCT02382016|583831829|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
161666468|NCT02382016|583831828|FG000|Open-label (OL) Treatment Period|Death|4|||
161666469|NCT02382016|583831829|FG001|Open-label (OL) Treatment Period|Death|0|||
161666470|NCT02382016|583831828|FG000|OL Extension Period|Physician Decision|3|||
161666471|NCT02382016|583831829|FG001|OL Extension Period|Physician Decision|0|||
161666472|NCT02382016|583831828|FG000|OL Extension Period|Death|2|||
161666473|NCT02382016|583831829|FG001|OL Extension Period|Death|0|||
161666474|NCT02382016|583831828|FG000|OL Extension Period|Withdrawal by Subject|1|||
161666475|NCT02382016|583831829|FG001|OL Extension Period|Withdrawal by Subject|0|||
161666476|NCT00730171|583831834|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
161666477|NCT00730171|583831834|FG000|Overall Study|Adverse Event|193|||
161666478|NCT00730171|583831834|FG000|Overall Study|Protocol Violation|48|||
161666479|NCT00730171|583831834|FG000|Overall Study|Withdrawal by Subject|202|||
161666480|NCT00730171|583831834|FG000|Overall Study|Lost to Follow-up|121|||
161666481|NCT00730171|583831834|FG000|Overall Study|Insufficient Therapeutic Response|141|||
161666482|NCT00730171|583831834|FG000|Overall Study|Other|61|||
161666483|NCT01729156|583831835|FG000|Overall Study|Withdrawal by Subject|1|||
161666484|NCT01729156|583831836|FG001|Overall Study|Withdrawal by Subject|0|||
161666485|NCT01729156|583831837|FG002|Overall Study|Withdrawal by Subject|0|||
161666486|NCT01256658|583831840|FG000|Period 1|Lost to Follow-up|837|||
161666487|NCT01256658|583831841|FG001|Period 1|Lost to Follow-up|661|||
161666488|NCT01256658|583831840|FG000|Period 1|Withdrawal by Subject|35|||
161666489|NCT01256658|583831841|FG001|Period 1|Withdrawal by Subject|43|||
161666490|NCT01256658|583831840|FG000|Period 1|Death|48|||
161666491|NCT01256658|583831841|FG001|Period 1|Death|44|||
161666492|NCT00719563|583831842|FG000|Overall Study|Adverse Event|16|||
161666493|NCT00719563|583831843|FG001|Overall Study|Adverse Event|13|||
161666494|NCT00719563|583831842|FG000|Overall Study|Medical condition changed|3|||
161666495|NCT00719563|583831843|FG001|Overall Study|Medical condition changed|5|||
161666496|NCT00719563|583831842|FG000|Overall Study|Lack of Efficacy|3|||
161666497|NCT00719563|583831843|FG001|Overall Study|Lack of Efficacy|7|||
161666498|NCT00719563|583831842|FG000|Overall Study|Personal reasons|6|||
161666499|NCT00719563|583831843|FG001|Overall Study|Personal reasons|7|||
161666500|NCT00719563|583831842|FG000|Overall Study|Unknown reasons|4|||
161666501|NCT00719563|583831843|FG001|Overall Study|Unknown reasons|6|||
161666502|NCT00719563|583831842|FG000|Overall Study|Noncompliant|1|||
161666503|NCT00719563|583831843|FG001|Overall Study|Noncompliant|1|||
161666504|NCT00719563|583831842|FG000|Overall Study|Lost to Follow-up|5|||
161666505|NCT00719563|583831843|FG001|Overall Study|Lost to Follow-up|3|||
161666506|NCT01386788|583831848|FG000|Overall Study|Lost to Follow-up|2|||
161666507|NCT00462865|583831849|FG000|Overall Study|Adverse Event|1|||
161666508|NCT02120625|583831850|FG000|Overall Study|Physician Decision|2|||
161666509|NCT04142450|583831851|FG000|Overall Study|Screen Failure|1|||
161666510|NCT04142450|583831851|FG000|Overall Study|Lost to Follow-up|1|||
161666511|NCT00120406|583831852|FG000|Overall Study|Death|9|||
161666512|NCT00120406|583831853|FG001|Overall Study|Death|4|||
161666513|NCT00120406|583831852|FG000|Overall Study|Withdrawal by Subject|5|||
161666514|NCT00120406|583831853|FG001|Overall Study|Withdrawal by Subject|7|||
161666515|NCT00120406|583831852|FG000|Overall Study|Lost to Follow-up|5|||
161666516|NCT00120406|583831853|FG001|Overall Study|Lost to Follow-up|2|||
161666517|NCT00120406|583831852|FG000|Overall Study|received non-study stent|0|||
161666518|NCT00120406|583831853|FG001|Overall Study|received non-study stent|2|||
161666519|NCT00120406|583831852|FG000|Overall Study|patient moved but has not withdrawn|0|||
161666520|NCT00120406|583831853|FG001|Overall Study|patient moved but has not withdrawn|1|||
161666521|NCT06336603|583831854|FG000|Overall Study|Withdrawal by Subject|1|||
161666522|NCT06336603|583831854|FG000|Overall Study|Lost to Follow-up|2|||
161666523|NCT00975507|583831862|FG000|Overall Study|Adverse Event|1|||
161666524|NCT00975507|583831863|FG001|Overall Study|Adverse Event|0|||
161666525|NCT00975507|583831862|FG000|Overall Study|Lost to Follow-up|7|||
161666526|NCT00975507|583831863|FG001|Overall Study|Lost to Follow-up|1|||
161666527|NCT00975507|583831862|FG000|Overall Study|Protocol Violation|2|||
161666528|NCT00975507|583831863|FG001|Overall Study|Protocol Violation|0|||
161666529|NCT00975507|583831862|FG000|Overall Study|Withdrawal by Subject|10|||
161666530|NCT00975507|583831863|FG001|Overall Study|Withdrawal by Subject|3|||
161666531|NCT01295034|583831864|FG000|Overall Study|Lost to Follow-up|5|||
161666532|NCT01295034|583831865|FG001|Overall Study|Lost to Follow-up|5|||
161666533|NCT03249714|583831866|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
161666534|NCT03249714|583831867|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
161666535|NCT03249714|583831866|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
161666536|NCT03249714|583831867|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
161666537|NCT03249714|583831866|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
161666538|NCT03249714|583831867|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
161666539|NCT03249714|583831866|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
161666540|NCT03249714|583831867|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
161666541|NCT00824161|583831870|FG000|Overall Study|Withdrawal by Subject|1|||
161666542|NCT00824161|583831870|FG000|Overall Study|Screen Failure|1|||
161666543|NCT00879762|583831871|FG000|Overall Study|Lost to Follow-up|3|||
161666544|NCT00879762|583831872|FG001|Overall Study|Lost to Follow-up|1|||
161666545|NCT04754477|583831875|FG000|Overall Study|Withdrawal by Subject|1|||
161666546|NCT02699983|583831877|FG000|Overall Study|Withdrawal by Subject|1|||
161666547|NCT02699983|583831878|FG001|Overall Study|Withdrawal by Subject|0|||
161666548|NCT03575143|583831879|FG000|Overall Study|Lost to Follow-up|0|||
161666549|NCT03575143|583831880|FG001|Overall Study|Lost to Follow-up|0|||
161666550|NCT03575143|583831881|FG002|Overall Study|Lost to Follow-up|4|||
161666551|NCT03575143|583831879|FG000|Overall Study|Withdrawal by Subject|0|||
161666552|NCT03575143|583831880|FG001|Overall Study|Withdrawal by Subject|0|||
161666553|NCT03575143|583831881|FG002|Overall Study|Withdrawal by Subject|5|||
161666554|NCT03575143|583831879|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
161666555|NCT03575143|583831880|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
161666556|NCT03575143|583831881|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
161666557|NCT01211197|583831885|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161666558|NCT01211197|583831886|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161666559|NCT01211197|583831887|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161666560|NCT01211197|583831888|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161666561|NCT01211197|583831889|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161666562|NCT01211197|583831890|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161779456|NCT03343054|584235559|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
161779457|NCT03343054|584235560|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
161779458|NCT03343054|584235558|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
161895331|NCT00741598|584666296|FG000|Overall Study|Withdrawal by Subject|3|||
161666563|NCT01211197|583831885|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
161666564|NCT01211197|583831886|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
161666565|NCT01211197|583831887|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
161666566|NCT01211197|583831888|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
161666567|NCT01211197|583831889|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
161666568|NCT01211197|583831890|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
161666569|NCT04781387|583831891|FG000|Overall Study|Withdrawal by Subject|1|||
161666570|NCT04781387|583831892|FG001|Overall Study|Withdrawal by Subject|0|||
161666571|NCT04781387|583831893|FG002|Overall Study|Withdrawal by Subject|1|||
161666572|NCT04781387|583831891|FG000|Overall Study|Lost to Follow-up|1|||
161666573|NCT04781387|583831892|FG001|Overall Study|Lost to Follow-up|0|||
161666574|NCT04781387|583831893|FG002|Overall Study|Lost to Follow-up|0|||
161666575|NCT03581825|583831894|FG000|Period 1|Lens Discomfort|1|||
161666576|NCT03581825|583831895|FG001|Period 1|Lens Discomfort|0|||
161666577|NCT03581825|583831894|FG000|Period 2|Unsatisfactory Vision to Test|0|||
161666578|NCT03581825|583831895|FG001|Period 2|Unsatisfactory Vision to Test|1|||
161666579|NCT02533570|583831897|FG000|Overall Study|Adverse Event|0|||
161666580|NCT02533570|583831898|FG001|Overall Study|Adverse Event|1|||
161666581|NCT02533570|583831899|FG002|Overall Study|Adverse Event|1|||
161666582|NCT01163916|583831900|FG000|Overall Study|Withdrawal by Subject|2|||
161666583|NCT01163916|583831901|FG001|Overall Study|Withdrawal by Subject|0|||
161666584|NCT01163916|583831902|FG002|Overall Study|Withdrawal by Subject|2|||
161666585|NCT01163916|583831900|FG000|Overall Study|Adverse Event|2|||
161666586|NCT01163916|583831901|FG001|Overall Study|Adverse Event|0|||
161666587|NCT01163916|583831902|FG002|Overall Study|Adverse Event|1|||
161666588|NCT01163916|583831900|FG000|Overall Study|Lack of Efficacy|2|||
161666589|NCT01163916|583831901|FG001|Overall Study|Lack of Efficacy|0|||
161666590|NCT01163916|583831902|FG002|Overall Study|Lack of Efficacy|1|||
161666591|NCT01163916|583831900|FG000|Overall Study|Other|24|||
161666592|NCT01163916|583831901|FG001|Overall Study|Other|4|||
161666593|NCT01163916|583831902|FG002|Overall Study|Other|16|||
161666594|NCT00529958|583831903|FG000|2-Year Follow-up|Lost to Follow-up|1|||
161666595|NCT00529958|583831904|FG001|2-Year Follow-up|Lost to Follow-up|2|||
161666596|NCT00529958|583831905|FG002|2-Year Follow-up|Lost to Follow-up|2|||
161666597|NCT00529958|583831903|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
161666598|NCT00529958|583831904|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
161666599|NCT00529958|583831905|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
161666600|NCT00529958|583831903|FG000|5-Year Follow-up|Lost to Follow-up|2|||
161666601|NCT00529958|583831904|FG001|5-Year Follow-up|Lost to Follow-up|3|||
161666602|NCT00529958|583831905|FG002|5-Year Follow-up|Lost to Follow-up|1|||
161666603|NCT00529958|583831903|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
161666604|NCT00529958|583831904|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
161666605|NCT00529958|583831905|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
161666606|NCT02337751|583831906|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
161666607|NCT02337751|583831907|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161666608|NCT02337751|583831906|FG000|Overall Study|Voluntary Withdrawal|6|||
161666609|NCT02337751|583831907|FG001|Overall Study|Voluntary Withdrawal|8|||
161666610|NCT02337751|583831906|FG000|Overall Study|Lack of Efficacy|2|||
161666611|NCT02337751|583831907|FG001|Overall Study|Lack of Efficacy|5|||
161666612|NCT02337751|583831906|FG000|Overall Study|Investigator's Judgement|1|||
161666613|NCT02337751|583831907|FG001|Overall Study|Investigator's Judgement|0|||
161666614|NCT01340651|583831908|FG000|Overall Study|Adverse Event|3|||
161666615|NCT01340651|583831908|FG000|Overall Study|Consent Withdrawn|2|||
161666616|NCT01340651|583831908|FG000|Overall Study|Commercial Supply per Sponsor|12|||
161666617|NCT01315353|583831909|FG000|Overall Study|Death|2|||
161666618|NCT01315353|583831910|FG001|Overall Study|Death|1|||
161666619|NCT01315353|583831911|FG002|Overall Study|Death|0|||
161666620|NCT01315353|583831909|FG000|Overall Study|Withdrawal by Subject|2|||
161666621|NCT01315353|583831910|FG001|Overall Study|Withdrawal by Subject|6|||
161666622|NCT01315353|583831911|FG002|Overall Study|Withdrawal by Subject|1|||
161666623|NCT01315353|583831909|FG000|Overall Study|Lost to Follow-up|13|||
161666624|NCT01315353|583831910|FG001|Overall Study|Lost to Follow-up|6|||
161666625|NCT01315353|583831911|FG002|Overall Study|Lost to Follow-up|6|||
161666626|NCT01315353|583831909|FG000|Overall Study|Unwilling to adhere to requirements|5|||
161666627|NCT01315353|583831910|FG001|Overall Study|Unwilling to adhere to requirements|5|||
161666628|NCT01315353|583831911|FG002|Overall Study|Unwilling to adhere to requirements|4|||
161666629|NCT01315353|583831909|FG000|Overall Study|Site closing|7|||
161666630|NCT01315353|583831910|FG001|Overall Study|Site closing|4|||
161666631|NCT01315353|583831911|FG002|Overall Study|Site closing|0|||
161666632|NCT01315353|583831909|FG000|Overall Study|Taken off study by site in error|0|||
161666633|NCT01315353|583831910|FG001|Overall Study|Taken off study by site in error|1|||
161666634|NCT01315353|583831911|FG002|Overall Study|Taken off study by site in error|0|||
161666635|NCT01315353|583831909|FG000|Overall Study|Inadvertent randomization/assignment|0|||
161666636|NCT01315353|583831910|FG001|Overall Study|Inadvertent randomization/assignment|0|||
161666637|NCT01315353|583831911|FG002|Overall Study|Inadvertent randomization/assignment|2|||
161666638|NCT01009580|583831912|FG000|Overall Study|Adverse Event|4|||
161666639|NCT01009580|583831913|FG001|Overall Study|Adverse Event|4|||
161666640|NCT01009580|583831912|FG000|Overall Study|Lack of Efficacy|0|||
161666641|NCT01009580|583831913|FG001|Overall Study|Lack of Efficacy|1|||
161666642|NCT01009580|583831912|FG000|Overall Study|Protocol Violation|2|||
161666643|NCT01009580|583831913|FG001|Overall Study|Protocol Violation|3|||
161666644|NCT01009580|583831912|FG000|Overall Study|Withdrawal Criteria|4|||
161666645|NCT01009580|583831913|FG001|Overall Study|Withdrawal Criteria|6|||
161666646|NCT01009580|583831912|FG000|Overall Study|Unclassified|17|||
161666647|NCT01009580|583831913|FG001|Overall Study|Unclassified|21|||
161666648|NCT04469270|583831914|FG000|Overall Study|Adverse Event|2|||
161666649|NCT04469270|583831915|FG001|Overall Study|Adverse Event|0|||
161666650|NCT04469270|583831914|FG000|Overall Study|Lost to Follow-up|4|||
161666651|NCT04469270|583831915|FG001|Overall Study|Lost to Follow-up|3|||
161666652|NCT04469270|583831914|FG000|Overall Study|Withdrawal by Subject|7|||
161666653|NCT04469270|583831915|FG001|Overall Study|Withdrawal by Subject|3|||
161666654|NCT04469270|583831914|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
161666655|NCT04469270|583831915|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
161666656|NCT04469270|583831914|FG000|Overall Study|missing|1|||
161666657|NCT04469270|583831915|FG001|Overall Study|missing|0|||
161666658|NCT05572021|583831918|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
161666659|NCT05572021|583831919|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
161666660|NCT03432260|583831920|FG000|Overall Study|Lost to Follow-up|1|||
161666661|NCT03432260|583831921|FG001|Overall Study|Lost to Follow-up|1|||
161666662|NCT03432260|583831922|FG002|Overall Study|Lost to Follow-up|0|||
161666663|NCT03432260|583831923|FG003|Overall Study|Lost to Follow-up|0|||
161666664|NCT03432260|583831924|FG004|Overall Study|Lost to Follow-up|1|||
161666665|NCT02186847|583831925|FG000|Overall Study|Protocol Violation|3|||
161666666|NCT02186847|583831926|FG001|Overall Study|Protocol Violation|0|||
161666667|NCT00345293|583831927|FG000|Overall Study|Unable to access line for sample|1|||
161666668|NCT00345293|583831928|FG001|Overall Study|Unable to access line for sample|0|||
161666669|NCT00345293|583831927|FG000|Overall Study|Withdrawal by Subject|1|||
161666670|NCT00345293|583831928|FG001|Overall Study|Withdrawal by Subject|0|||
161666671|NCT03319849|583831929|FG000|Overall Study|Adverse Event|1|||
161666672|NCT03319849|583831930|FG001|Overall Study|Adverse Event|0|||
161666673|NCT03319849|583831929|FG000|Overall Study|Physician Decision|0|||
161666674|NCT03319849|583831930|FG001|Overall Study|Physician Decision|1|||
161666675|NCT03319849|583831929|FG000|Overall Study|Withdrawal by Subject|0|||
161666676|NCT03319849|583831930|FG001|Overall Study|Withdrawal by Subject|1|||
161666677|NCT03319849|583831929|FG000|Overall Study|COVID-19|0|||
161666678|NCT03319849|583831930|FG001|Overall Study|COVID-19|1|||
161666679|NCT03319849|583831929|FG000|Overall Study|Other|1|||
161666680|NCT03319849|583831930|FG001|Overall Study|Other|2|||
161666681|NCT03319849|583831929|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
161666682|NCT03319849|583831930|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
161666683|NCT03319849|583831929|FG000|Overall Study|Lost to Follow-up|0|||
161666684|NCT03319849|583831930|FG001|Overall Study|Lost to Follow-up|2|||
161666685|NCT00112047|583831933|FG000|Randomized Phase|Lost to Follow-up|26|||
161666686|NCT00112047|583831934|FG001|Randomized Phase|Lost to Follow-up|33|||
161666687|NCT00112047|583831933|FG000|Randomized Phase|Adverse Event|10|||
161666688|NCT00112047|583831934|FG001|Randomized Phase|Adverse Event|10|||
161666689|NCT00112047|583831933|FG000|Randomized Phase|Withrawal of consent|10|||
161666690|NCT00112047|583831934|FG001|Randomized Phase|Withrawal of consent|18|||
161666691|NCT00112047|583831933|FG000|Randomized Phase|Sub-optimal virological response|3|||
161666692|NCT00112047|583831934|FG001|Randomized Phase|Sub-optimal virological response|13|||
161666693|NCT00112047|583831933|FG000|Randomized Phase|Noncompliance|8|||
161666694|NCT00112047|583831934|FG001|Randomized Phase|Noncompliance|4|||
161666695|NCT00112047|583831933|FG000|Randomized Phase|Protocol Violation|2|||
161666696|NCT00112047|583831934|FG001|Randomized Phase|Protocol Violation|0|||
161666697|NCT00112047|583831933|FG000|Randomized Phase|Pregnancy|3|||
161666698|NCT00112047|583831934|FG001|Randomized Phase|Pregnancy|1|||
161666699|NCT00112047|583831933|FG000|Randomized Phase|Death|1|||
161666700|NCT00112047|583831934|FG001|Randomized Phase|Death|3|||
161666701|NCT00112047|583831933|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
161666702|NCT00112047|583831934|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
161666703|NCT00112047|583831933|FG000|Randomized Phase|Inability to swallow pills|0|||
161666704|NCT00112047|583831934|FG001|Randomized Phase|Inability to swallow pills|1|||
161666705|NCT00112047|583831933|FG000|Randomized Phase|Incarceration|3|||
161666706|NCT00112047|583831934|FG001|Randomized Phase|Incarceration|2|||
161666707|NCT00112047|583831933|FG000|Randomized Phase|Moved out of State|0|||
161666708|NCT00112047|583831934|FG001|Randomized Phase|Moved out of State|1|||
161666709|NCT00112047|583831933|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
161666710|NCT00112047|583831934|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
161666711|NCT00112047|583831933|FG000|Randomized Phase|High Hepatitis B DNA|0|||
161666712|NCT00112047|583831934|FG001|Randomized Phase|High Hepatitis B DNA|1|||
161666713|NCT00112047|583831933|FG000|Atripla Phase|Adverse Event|2|||
161666714|NCT00112047|583831934|FG001|Atripla Phase|Adverse Event|1|||
161666715|NCT00112047|583831933|FG000|Atripla Phase|Lost to Follow-up|5|||
161666716|NCT00112047|583831934|FG001|Atripla Phase|Lost to Follow-up|7|||
161666717|NCT00112047|583831933|FG000|Atripla Phase|Pregnancy|0|||
161666718|NCT00112047|583831934|FG001|Atripla Phase|Pregnancy|1|||
161666719|NCT00112047|583831933|FG000|Atripla Phase|Death|0|||
161666720|NCT00112047|583831934|FG001|Atripla Phase|Death|2|||
161666721|NCT00112047|583831933|FG000|Atripla Phase|Withdrew consent|7|||
161666722|NCT00112047|583831934|FG001|Atripla Phase|Withdrew consent|7|||
161666723|NCT00112047|583831933|FG000|Atripla Phase|Sub-optimal virological response|0|||
161666724|NCT00112047|583831934|FG001|Atripla Phase|Sub-optimal virological response|1|||
161666725|NCT00112047|583831933|FG000|Atripla Phase|Non-compliance|1|||
161666726|NCT00112047|583831934|FG001|Atripla Phase|Non-compliance|0|||
161666727|NCT00112047|583831933|FG000|Atripla Phase|Other|3|||
161666728|NCT00112047|583831934|FG001|Atripla Phase|Other|1|||
161666729|NCT01307579|583831935|FG000|Overall Study|Death|3|||
161666730|NCT01307579|583831936|FG001|Overall Study|Death|6|||
161666731|NCT01307579|583831935|FG000|Overall Study|Physician Decision|26|||
161666732|NCT01307579|583831936|FG001|Overall Study|Physician Decision|29|||
161666733|NCT01307579|583831935|FG000|Overall Study|Withdrawal by Subject|7|||
161666734|NCT01307579|583831936|FG001|Overall Study|Withdrawal by Subject|3|||
161666735|NCT01307579|583831935|FG000|Overall Study|Institutional diagnosis of IFD|21|||
161666736|NCT01307579|583831936|FG001|Overall Study|Institutional diagnosis of IFD|36|||
161666737|NCT01307579|583831935|FG000|Overall Study|Begin conditioning for HSCT|42|||
161666738|NCT01307579|583831936|FG001|Overall Study|Begin conditioning for HSCT|44|||
161666739|NCT01307579|583831935|FG000|Overall Study|Refractory or relapsed AML|38|||
161666740|NCT01307579|583831936|FG001|Overall Study|Refractory or relapsed AML|23|||
161666741|NCT01307579|583831935|FG000|Overall Study|Ineligible|3|||
161666742|NCT01307579|583831936|FG001|Overall Study|Ineligible|4|||
161666743|NCT05677893|583833678|FG000|Overall Study|Withdrawal by Subject|0|||
161666744|NCT05677893|583833679|FG001|Overall Study|Withdrawal by Subject|0|||
161666745|NCT05677893|583833680|FG002|Overall Study|Withdrawal by Subject|0|||
161666746|NCT05677893|583833681|FG003|Overall Study|Withdrawal by Subject|0|||
161666747|NCT05677893|583833682|FG004|Overall Study|Withdrawal by Subject|1|||
161666748|NCT05677893|583833683|FG005|Overall Study|Withdrawal by Subject|1|||
161666749|NCT05677893|583833684|FG006|Overall Study|Withdrawal by Subject|0|||
161666750|NCT05677893|583833678|FG000|Overall Study|Others|1|||
161666751|NCT05677893|583833679|FG001|Overall Study|Others|0|||
161666752|NCT05677893|583833680|FG002|Overall Study|Others|0|||
161666753|NCT05677893|583833681|FG003|Overall Study|Others|0|||
161666754|NCT05677893|583833682|FG004|Overall Study|Others|0|||
161666755|NCT05677893|583833683|FG005|Overall Study|Others|0|||
161666756|NCT05677893|583833684|FG006|Overall Study|Others|0|||
161666757|NCT03217266|583833685|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
161682992|NCT04206605|583890226|FG000|Overall Study|Adverse Event|0|||
161682993|NCT04206605|583890227|FG001|Overall Study|Adverse Event|1|||
161682994|NCT04206605|583890226|FG000|Overall Study|Withdrawal by Subject|1|||
161682995|NCT04206605|583890227|FG001|Overall Study|Withdrawal by Subject|0|||
161682996|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
161682997|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
161682998|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Death|0|||
161682999|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Death|1|||
161683000|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
161683001|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
161683002|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
161683003|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
161683004|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
161683005|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
161683006|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
161683007|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
161683008|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
161683009|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
161683010|NCT01131520|583890233|FG000|Overall Study|Computer problem|1|||
161683011|NCT01131520|583890234|FG001|Overall Study|Computer problem|0|||
161683012|NCT01131520|583890233|FG000|Overall Study|Counselor not available|0|||
161683013|NCT01131520|583890234|FG001|Overall Study|Counselor not available|3|||
161683014|NCT01131520|583890233|FG000|Overall Study|Subject changed history after enrollment|0|||
161683015|NCT01131520|583890234|FG001|Overall Study|Subject changed history after enrollment|1|||
161683016|NCT04066491|583890241|FG000|Overall Study|Randomized, not treated|0|||
161683017|NCT04066491|583890242|FG001|Overall Study|Randomized, not treated|0|||
161683018|NCT04066491|583890243|FG002|Overall Study|Randomized, not treated|2|||
161779459|NCT03343054|584235559|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
161779460|NCT03343054|584235560|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
161779461|NCT03343054|584235558|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
161779462|NCT03343054|584235559|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
161779463|NCT03343054|584235560|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
161779464|NCT05723835|584235566|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
161779465|NCT05723835|584235567|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
161779466|NCT05723835|584235568|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
161779467|NCT05723835|584235569|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
161779468|NCT05723835|584235570|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
161779469|NCT05723835|584235571|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
161779470|NCT05723835|584235572|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
161779471|NCT05723835|584235573|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
161779472|NCT05226286|584235574|FG000|Overall Study|Screen failures prior to implant|62|||
161779473|NCT05226286|584235574|FG000|Overall Study|Withdrawal by Subject|13|||
161779474|NCT05226286|584235574|FG000|Overall Study|Lost to Follow-up|3|||
161779475|NCT05226286|584235574|FG000|Overall Study|Physician Decision|1|||
161779476|NCT05226286|584235574|FG000|Overall Study|Adverse Event|1|||
161779477|NCT05226286|584235574|FG000|Overall Study|Death|1|||
161779478|NCT05226286|584235574|FG000|Overall Study|Device explant with no planned replacement|1|||
161779479|NCT05226286|584235574|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
161779480|NCT05226286|584235574|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
161779481|NCT00602641|584235575|FG000|Overall Study|Never started protocol therapy|6|||
161779482|NCT00602641|584235576|FG001|Overall Study|Never started protocol therapy|2|||
161779483|NCT00602641|584235575|FG000|Overall Study|Still on treatment at time of analysis|8|||
161779484|NCT00602641|584235576|FG001|Overall Study|Still on treatment at time of analysis|15|||
161779485|NCT00602641|584235575|FG000|Overall Study|Adverse Event|62|||
161779486|NCT00602641|584235576|FG001|Overall Study|Adverse Event|53|||
161779487|NCT00602641|584235575|FG000|Overall Study|Disease progression|38|||
161779488|NCT00602641|584235576|FG001|Overall Study|Disease progression|55|||
161779489|NCT00602641|584235575|FG000|Overall Study|Death|6|||
161779490|NCT00602641|584235576|FG001|Overall Study|Death|5|||
161779491|NCT00602641|584235575|FG000|Overall Study|Withdrawal by Subject|15|||
161779492|NCT00602641|584235576|FG001|Overall Study|Withdrawal by Subject|12|||
161779493|NCT00602641|584235575|FG000|Overall Study|Alternative therapy|5|||
161779494|NCT00602641|584235576|FG001|Overall Study|Alternative therapy|2|||
161779495|NCT00602641|584235575|FG000|Overall Study|Other Complicating Disease|5|||
161779496|NCT00602641|584235576|FG001|Overall Study|Other Complicating Disease|2|||
161779497|NCT00602641|584235575|FG000|Overall Study|Physician Decision|5|||
161779498|NCT00602641|584235576|FG001|Overall Study|Physician Decision|4|||
161779499|NCT00602641|584235575|FG000|Overall Study|Administrative Closure|1|||
161666758|NCT03217266|583833686|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161666759|NCT03217266|583833687|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161666760|NCT03217266|583833688|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161666761|NCT03217266|583833685|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
161666762|NCT03217266|583833686|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
161666763|NCT03217266|583833687|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
161666764|NCT03217266|583833688|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
161666765|NCT03217266|583833685|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
161666766|NCT03217266|583833686|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
161666767|NCT03217266|583833687|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
161666768|NCT03217266|583833688|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
161666769|NCT02101034|583833689|FG000|Overall Study|Enrolled but did not start treatment|0|||
161666770|NCT02101034|583833690|FG001|Overall Study|Enrolled but did not start treatment|0|||
161666771|NCT02101034|583833691|FG002|Overall Study|Enrolled but did not start treatment|1|||
161666772|NCT02101034|583833692|FG003|Overall Study|Enrolled but did not start treatment|0|||
161666773|NCT02101034|583833693|FG004|Overall Study|Enrolled but did not start treatment|0|||
161666774|NCT01101477|583833695|FG000|Overall Study|Protocol Violation|5|||
161666775|NCT01101477|583833696|FG001|Overall Study|Protocol Violation|3|||
161666776|NCT01101477|583833697|FG002|Overall Study|Protocol Violation|1|||
161666777|NCT01222507|583833698|FG000|Overall Study|Physician Decision|1|||
161666778|NCT01222507|583833698|FG000|Overall Study|Withdrawal by Subject|1|||
161666779|NCT01786174|583833703|FG000|Overall Study|Discontinued Study Drug|2|||
161666780|NCT01786174|583833704|FG001|Overall Study|Discontinued Study Drug|0|||
161666781|NCT00995020|583833705|FG000|Overall Study|margin analysis not performed|2|||
161666782|NCT00995020|583833706|FG001|Overall Study|margin analysis not performed|5|||
161666783|NCT00995020|583833705|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
161666784|NCT00995020|583833706|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
161666785|NCT01614197|583833707|FG000|Overall Study|Withdrawal by Subject|0|||
161666786|NCT01614197|583833708|FG001|Overall Study|Withdrawal by Subject|1|||
161666787|NCT01614197|583833709|FG002|Overall Study|Withdrawal by Subject|0|||
161666788|NCT01614197|583833710|FG003|Overall Study|Withdrawal by Subject|0|||
161666789|NCT03442985|583833711|FG000|Overall Study|Sponsor Request|55|||
161666790|NCT03442985|583833712|FG001|Overall Study|Sponsor Request|60|||
161666791|NCT03442985|583833713|FG002|Overall Study|Sponsor Request|54|||
161666792|NCT03442985|583833711|FG000|Overall Study|Lost to Follow-up|5|||
161666793|NCT03442985|583833712|FG001|Overall Study|Lost to Follow-up|2|||
161666794|NCT03442985|583833713|FG002|Overall Study|Lost to Follow-up|7|||
161666795|NCT03442985|583833711|FG000|Overall Study|Withdrawal by Subject|2|||
161666796|NCT03442985|583833712|FG001|Overall Study|Withdrawal by Subject|3|||
161666797|NCT03442985|583833713|FG002|Overall Study|Withdrawal by Subject|4|||
161666798|NCT03442985|583833711|FG000|Overall Study|Adverse Event|0|||
161666799|NCT03442985|583833712|FG001|Overall Study|Adverse Event|1|||
161666800|NCT03442985|583833713|FG002|Overall Study|Adverse Event|0|||
161666801|NCT00876694|583833715|FG000|Overall Study|Adverse Event|10|||
161666802|NCT00876694|583833716|FG001|Overall Study|Adverse Event|7|||
161666803|NCT00876694|583833715|FG000|Overall Study|Subject withdrew consent|6|||
161666804|NCT00876694|583833716|FG001|Overall Study|Subject withdrew consent|4|||
161666805|NCT00876694|583833715|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161666806|NCT00876694|583833716|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161666807|NCT00876694|583833715|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161666808|NCT00876694|583833716|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161666809|NCT00876694|583833715|FG000|Overall Study|Administrative problems|1|||
161666810|NCT00876694|583833716|FG001|Overall Study|Administrative problems|1|||
161666811|NCT00876694|583833715|FG000|Overall Study|Death|1|||
161666812|NCT00876694|583833716|FG001|Overall Study|Death|0|||
161666813|NCT00288509|583833717|FG000|Treatment Cycle 1|Adverse Event|1|||
161666814|NCT00288509|583833717|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
161666815|NCT00288509|583833717|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
161666816|NCT00288509|583833717|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
161666817|NCT00288509|583833717|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
161666818|NCT00288509|583833717|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
161666819|NCT00288509|583833717|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
161666820|NCT00288509|583833717|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
161666821|NCT00288509|583833717|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
161666822|NCT00288509|583833717|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
161666823|NCT00288509|583833717|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
161666824|NCT00288509|583833717|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
161666825|NCT00288509|583833717|FG000|Treatment Cycle 4|Physician Decision|4|||
161666826|NCT00288509|583833717|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
161666827|NCT00084266|583833718|FG000|Overall Study|Death|42|||
161666828|NCT00084266|583833719|FG001|Overall Study|Death|39|||
161666829|NCT00084266|583833718|FG000|Overall Study|Adverse Event|8|||
161666830|NCT00084266|583833719|FG001|Overall Study|Adverse Event|5|||
161666831|NCT00084266|583833718|FG000|Overall Study|Lack of Efficacy|2|||
161666832|NCT00084266|583833719|FG001|Overall Study|Lack of Efficacy|4|||
161666833|NCT00084266|583833718|FG000|Overall Study|Lost to Follow-up|5|||
161666834|NCT00084266|583833719|FG001|Overall Study|Lost to Follow-up|3|||
161666835|NCT00084266|583833718|FG000|Overall Study|Participant not willing to participate|3|||
161666836|NCT00084266|583833719|FG001|Overall Study|Participant not willing to participate|8|||
161666837|NCT00084266|583833718|FG000|Overall Study|Other|360|||
161666838|NCT00084266|583833719|FG001|Overall Study|Other|344|||
161666839|NCT00084266|583833718|FG000|Overall Study|Randomized not treated|21|||
161666840|NCT00084266|583833719|FG001|Overall Study|Randomized not treated|20|||
161666841|NCT01215422|583833720|FG000|Overall Study|Relocation|1|||
161666842|NCT01215422|583833721|FG001|Overall Study|Relocation|0|||
161666843|NCT01215422|583833722|FG002|Overall Study|Relocation|0|||
161666844|NCT01215422|583833723|FG003|Overall Study|Relocation|0|||
161666845|NCT01215422|583833720|FG000|Overall Study|Failed intubations|0|||
161666846|NCT01215422|583833721|FG001|Overall Study|Failed intubations|0|||
161666847|NCT01215422|583833722|FG002|Overall Study|Failed intubations|3|||
161666848|NCT01215422|583833723|FG003|Overall Study|Failed intubations|8|||
161666849|NCT01215422|583833720|FG000|Overall Study|Did not complete all intubations|7|||
161666850|NCT01215422|583833721|FG001|Overall Study|Did not complete all intubations|0|||
161666851|NCT01215422|583833722|FG002|Overall Study|Did not complete all intubations|0|||
161666852|NCT01215422|583833723|FG003|Overall Study|Did not complete all intubations|0|||
161666853|NCT02864381|583833730|FG000|Overall Study|Death|58|||
161666854|NCT02864381|583833731|FG001|Overall Study|Death|61|||
161666855|NCT02864381|583833730|FG000|Overall Study|Withdrew Consent|5|||
161666856|NCT02864381|583833731|FG001|Overall Study|Withdrew Consent|6|||
161666857|NCT02864381|583833730|FG000|Overall Study|Reason Unknown|7|||
161666858|NCT02864381|583833731|FG001|Overall Study|Reason Unknown|3|||
161666859|NCT02864381|583833730|FG000|Overall Study|Lost to Follow-up|1|||
161666860|NCT02864381|583833731|FG001|Overall Study|Lost to Follow-up|1|||
161666861|NCT02864381|583833730|FG000|Overall Study|Investigator's Discretion|1|||
161779500|NCT00602641|584235576|FG001|Overall Study|Administrative Closure|1|||
161779501|NCT00602641|584235575|FG000|Overall Study|Other|3|||
161779502|NCT00602641|584235576|FG001|Overall Study|Other|1|||
161779503|NCT03901339|584235577|FG000|Overall Study|Death|220|||
161779504|NCT03901339|584235578|FG001|Overall Study|Death|192|||
161779505|NCT03901339|584235577|FG000|Overall Study|Informed consent withdrawn|13|||
161779506|NCT03901339|584235578|FG001|Overall Study|Informed consent withdrawn|40|||
161779507|NCT03901339|584235577|FG000|Overall Study|Sponsor request|30|||
161779508|NCT03901339|584235578|FG001|Overall Study|Sponsor request|23|||
161779509|NCT03901339|584235577|FG000|Overall Study|Reason not specified|5|||
161779510|NCT03901339|584235578|FG001|Overall Study|Reason not specified|7|||
161779511|NCT03901339|584235577|FG000|Overall Study|Lost to Follow-up|4|||
161779512|NCT03901339|584235578|FG001|Overall Study|Lost to Follow-up|7|||
161779513|NCT03901339|584235577|FG000|Overall Study|Covid19|0|||
161779514|NCT03901339|584235578|FG001|Overall Study|Covid19|2|||
161779515|NCT00457418|584235579|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
161779516|NCT00457418|584235579|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
161779517|NCT00457418|584235579|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
161779518|NCT00457418|584235579|FG000|Post PK Maintenance|Adverse Event|10|||
161779519|NCT00457418|584235579|FG000|Post PK Maintenance|Progression of Disease|6|||
161779520|NCT00457418|584235579|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
161779521|NCT00457418|584235579|FG000|Post PK Maintenance|Lost to Follow-up|1|||
161779522|NCT03387735|584235582|FG000|Overall Study|Lost to Follow-up|4|||
161779523|NCT03387735|584235583|FG001|Overall Study|Lost to Follow-up|8|||
161666862|NCT02864381|583833731|FG001|Overall Study|Investigator's Discretion|0|||
161666863|NCT02864381|583833730|FG000|Overall Study|Protocol Violation|0|||
161666864|NCT02864381|583833731|FG001|Overall Study|Protocol Violation|1|||
161666865|NCT02986334|583833733|FG000|Overall Study|Withdrawal by Subject|0|||
161666866|NCT02986334|583833734|FG001|Overall Study|Withdrawal by Subject|1|||
161666867|NCT02986334|583833735|FG002|Overall Study|Withdrawal by Subject|2|||
161666868|NCT02986334|583833733|FG000|Overall Study|Lost to Follow-up|1|||
161666869|NCT02986334|583833734|FG001|Overall Study|Lost to Follow-up|2|||
161666870|NCT02986334|583833735|FG002|Overall Study|Lost to Follow-up|1|||
161666871|NCT02986334|583833733|FG000|Overall Study|Adverse Event|0|||
161666872|NCT02986334|583833734|FG001|Overall Study|Adverse Event|2|||
161666873|NCT02986334|583833735|FG002|Overall Study|Adverse Event|1|||
161666874|NCT02986334|583833733|FG000|Overall Study|non compliance in phone ratings|2|||
161666875|NCT02986334|583833734|FG001|Overall Study|non compliance in phone ratings|1|||
161666876|NCT02986334|583833735|FG002|Overall Study|non compliance in phone ratings|2|||
161666877|NCT02986334|583833733|FG000|Overall Study|undisclosed comorbidities|0|||
161666878|NCT02986334|583833734|FG001|Overall Study|undisclosed comorbidities|1|||
161666879|NCT02986334|583833735|FG002|Overall Study|undisclosed comorbidities|1|||
161666880|NCT00667355|583833737|FG000|Overall Study|Adverse Event|5|||
161666881|NCT00667355|583833737|FG000|Overall Study|Lost to Follow-up|1|||
161666882|NCT00667355|583833737|FG000|Overall Study|Other reason was not specified|5|||
161666883|NCT01313637|583833740|FG000|Overall Study|Adverse Event|17|||
161666884|NCT01313637|583833741|FG001|Overall Study|Adverse Event|24|||
161666885|NCT01313637|583833742|FG002|Overall Study|Adverse Event|25|||
161666886|NCT01313637|583833743|FG003|Overall Study|Adverse Event|18|||
161666887|NCT01313637|583833740|FG000|Overall Study|Lack of Efficacy|44|||
161666888|NCT01313637|583833741|FG001|Overall Study|Lack of Efficacy|38|||
161666889|NCT01313637|583833742|FG002|Overall Study|Lack of Efficacy|37|||
161666890|NCT01313637|583833743|FG003|Overall Study|Lack of Efficacy|24|||
161666891|NCT01313637|583833740|FG000|Overall Study|Protocol Violation|4|||
161666892|NCT01313637|583833741|FG001|Overall Study|Protocol Violation|3|||
161666893|NCT01313637|583833742|FG002|Overall Study|Protocol Violation|11|||
161666894|NCT01313637|583833743|FG003|Overall Study|Protocol Violation|5|||
161666895|NCT01313637|583833740|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
161666896|NCT01313637|583833741|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
161666897|NCT01313637|583833742|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
161666898|NCT01313637|583833743|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
161666899|NCT01313637|583833740|FG000|Overall Study|Lost to Follow-up|0|||
161666900|NCT01313637|583833741|FG001|Overall Study|Lost to Follow-up|2|||
161666901|NCT01313637|583833742|FG002|Overall Study|Lost to Follow-up|1|||
161666902|NCT01313637|583833743|FG003|Overall Study|Lost to Follow-up|3|||
161666903|NCT01313637|583833740|FG000|Overall Study|Withdrawal by Subject|11|||
161666904|NCT01313637|583833741|FG001|Overall Study|Withdrawal by Subject|13|||
161666905|NCT01313637|583833742|FG002|Overall Study|Withdrawal by Subject|18|||
161666906|NCT01313637|583833743|FG003|Overall Study|Withdrawal by Subject|15|||
161666907|NCT00795951|583833746|FG000|Overall Study|Lost to Follow-up|1|||
161666908|NCT00795951|583833746|FG000|Overall Study|Withdrawal by Subject|1|||
161666909|NCT00655863|583833748|FG000|Overall Study|Lost to Follow-up|0|||
161666910|NCT00655863|583833749|FG001|Overall Study|Lost to Follow-up|0|||
161666911|NCT00655863|583833750|FG002|Overall Study|Lost to Follow-up|1|||
161666912|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
161666913|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
161666914|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
161666915|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
161666916|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
161666917|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
161666918|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
161666919|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
161666920|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
161666921|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
161666922|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
161666923|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
161666924|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
161666925|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
161666926|NCT03548987|583833751|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
161666927|NCT03548987|583833752|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
161666928|NCT03548987|583833751|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
161666929|NCT03548987|583833752|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
161666930|NCT03548987|583833751|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
161666931|NCT03548987|583833752|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
161666932|NCT03548987|583833751|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
161666933|NCT03548987|583833752|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
161666934|NCT03548987|583833751|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
161666935|NCT03548987|583833752|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
161666936|NCT03548987|583833751|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
161666937|NCT03548987|583833752|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
161666938|NCT03548987|583833751|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
161666939|NCT03548987|583833752|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
161666940|NCT04572841|583833753|FG000|Overall Study|Adverse Event|1|||
161666941|NCT04572841|583833754|FG001|Overall Study|Adverse Event|1|||
161666942|NCT04572841|583833753|FG000|Overall Study|Withdrawal by Subject|2|||
161666943|NCT04572841|583833754|FG001|Overall Study|Withdrawal by Subject|1|||
161666944|NCT01323647|583833759|FG000|Overall Study|Migrated/moved from study area|2|||
161666945|NCT01323647|583833760|FG001|Overall Study|Migrated/moved from study area|0|||
161666946|NCT01323647|583833759|FG000|Overall Study|Withdrawal by Subject|5|||
161666947|NCT01323647|583833760|FG001|Overall Study|Withdrawal by Subject|0|||
161666948|NCT01323647|583833759|FG000|Overall Study|Lost to Follow-up|2|||
161666949|NCT01323647|583833760|FG001|Overall Study|Lost to Follow-up|0|||
161666950|NCT00712673|583833761|FG000|Overall Study|Adverse Event|3|||
161666951|NCT00712673|583833762|FG001|Overall Study|Adverse Event|3|||
161666952|NCT00712673|583833763|FG002|Overall Study|Adverse Event|21|||
161666953|NCT00712673|583833764|FG003|Overall Study|Adverse Event|26|||
161666954|NCT00712673|583833761|FG000|Overall Study|Lack of Efficacy|2|||
161666955|NCT00712673|583833762|FG001|Overall Study|Lack of Efficacy|8|||
161666956|NCT00712673|583833763|FG002|Overall Study|Lack of Efficacy|8|||
161666957|NCT00712673|583833764|FG003|Overall Study|Lack of Efficacy|6|||
161666958|NCT00712673|583833761|FG000|Overall Study|Poor Compliance to Protocol|3|||
161666959|NCT00712673|583833762|FG001|Overall Study|Poor Compliance to Protocol|3|||
161666960|NCT00712673|583833763|FG002|Overall Study|Poor Compliance to Protocol|4|||
161666961|NCT00712673|583833764|FG003|Overall Study|Poor Compliance to Protocol|16|||
161666962|NCT00712673|583833761|FG000|Overall Study|Lost to Follow-up|1|||
161895332|NCT00741598|584666297|FG001|Overall Study|Withdrawal by Subject|2|||
161666963|NCT00712673|583833762|FG001|Overall Study|Lost to Follow-up|0|||
161666964|NCT00712673|583833763|FG002|Overall Study|Lost to Follow-up|2|||
161666965|NCT00712673|583833764|FG003|Overall Study|Lost to Follow-up|0|||
161666966|NCT00712673|583833761|FG000|Overall Study|Withdrawal by Subject|6|||
161666967|NCT00712673|583833762|FG001|Overall Study|Withdrawal by Subject|7|||
161666968|NCT00712673|583833763|FG002|Overall Study|Withdrawal by Subject|15|||
161666969|NCT00712673|583833764|FG003|Overall Study|Withdrawal by Subject|20|||
161666970|NCT00712673|583833761|FG000|Overall Study|Familial and Personal Reasons|5|||
161666971|NCT00712673|583833762|FG001|Overall Study|Familial and Personal Reasons|0|||
161683019|NCT00853749|583890247|FG000|Overall Study|Lost to Follow-up|0|||
161683020|NCT00853749|583890248|FG001|Overall Study|Lost to Follow-up|1|||
161683021|NCT01392677|583890251|FG000|Overall Study|Adverse Event|3|||
161683022|NCT01392677|583890252|FG001|Overall Study|Adverse Event|1|||
161683023|NCT01392677|583890251|FG000|Overall Study|Withdrawal by Subject|0|||
161683024|NCT01392677|583890252|FG001|Overall Study|Withdrawal by Subject|2|||
161683025|NCT01392677|583890251|FG000|Overall Study|Incorrect enrollment|2|||
161683026|NCT01392677|583890252|FG001|Overall Study|Incorrect enrollment|3|||
161683027|NCT01392677|583890251|FG000|Overall Study|Other reason|3|||
161683028|NCT01392677|583890252|FG001|Overall Study|Other reason|2|||
161683029|NCT01357577|583890255|FG000|Overall Study|Lost to Follow-up|20|||
161683030|NCT01357577|583890256|FG001|Overall Study|Lost to Follow-up|16|||
161683031|NCT01357577|583890255|FG000|Overall Study|Withdrawal by Subject|16|||
161683032|NCT01357577|583890256|FG001|Overall Study|Withdrawal by Subject|8|||
161683033|NCT01357577|583890255|FG000|Overall Study|look at data in database?|1|||
161683034|NCT01357577|583890256|FG001|Overall Study|look at data in database?|2|||
161683035|NCT05493280|583890257|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
161683036|NCT05493280|583890258|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
161683037|NCT00075400|583891212|FG000|Overall Study|Ineligible: wrong primary|1|||
161683038|NCT00075400|583891212|FG000|Overall Study|Never treated|2|||
161683039|NCT00666458|583891219|FG000|Overall Study|Adverse Event|8|||
161683040|NCT00666458|583891220|FG001|Overall Study|Adverse Event|7|||
161683041|NCT00666458|583891219|FG000|Overall Study|Withdrawal by Subject|5|||
161683042|NCT00666458|583891220|FG001|Overall Study|Withdrawal by Subject|4|||
161683043|NCT00666458|583891219|FG000|Overall Study|Lost to Follow-up|0|||
161683044|NCT00666458|583891220|FG001|Overall Study|Lost to Follow-up|3|||
161683045|NCT00666458|583891219|FG000|Overall Study|Administrative reason by sponsor|1|||
161683046|NCT00666458|583891220|FG001|Overall Study|Administrative reason by sponsor|1|||
161683047|NCT00666458|583891219|FG000|Overall Study|Incorrect enrollment|7|||
161683048|NCT00666458|583891220|FG001|Overall Study|Incorrect enrollment|1|||
161683049|NCT00666458|583891219|FG000|Overall Study|Study specific discontinuation criteria|14|||
161683050|NCT00666458|583891220|FG001|Overall Study|Study specific discontinuation criteria|7|||
161683051|NCT00666458|583891219|FG000|Overall Study|Severe non-compliance to the protocol|1|||
161683052|NCT00666458|583891220|FG001|Overall Study|Severe non-compliance to the protocol|1|||
161683053|NCT00666458|583891219|FG000|Overall Study|Safety reasons|1|||
161779524|NCT03387735|584235582|FG000|Overall Study|Death|4|||
161779525|NCT03387735|584235583|FG001|Overall Study|Death|8|||
161779526|NCT03099161|584235584|FG000|Overall Study|Adverse Event|0|||
161779527|NCT03099161|584235585|FG001|Overall Study|Adverse Event|0|||
161779528|NCT03099161|584235586|FG002|Overall Study|Adverse Event|2|||
161779529|NCT03099161|584235584|FG000|Overall Study|Physician Decision|2|||
161779530|NCT03099161|584235585|FG001|Overall Study|Physician Decision|0|||
161779531|NCT03099161|584235586|FG002|Overall Study|Physician Decision|0|||
161779532|NCT03099161|584235584|FG000|Overall Study|Progressive Disease|1|||
161779533|NCT03099161|584235585|FG001|Overall Study|Progressive Disease|4|||
161779534|NCT03099161|584235586|FG002|Overall Study|Progressive Disease|1|||
161779535|NCT00110084|584235589|FG000|Overall Study|Adverse Event|9|||
161779536|NCT00110084|584235589|FG000|Overall Study|Death|1|||
161779537|NCT00110084|584235589|FG000|Overall Study|Patient Refusal|10|||
161779538|NCT00110084|584235589|FG000|Overall Study|Alternate Therapy|5|||
161779539|NCT00110084|584235589|FG000|Overall Study|Intercurrent Illness|1|||
161779540|NCT00110084|584235589|FG000|Overall Study|Other|2|||
161779541|NCT04854707|584235591|FG000|Overall Study|Lack of Efficacy|78|||
161779542|NCT04854707|584235592|FG001|Overall Study|Lack of Efficacy|59|||
161779543|NCT04854707|584235593|FG002|Overall Study|Lack of Efficacy|30|||
161779544|NCT05302414|584235595|FG000|Pretest to Posttest|Lost to Follow-up|12|||
161779545|NCT05302414|584235596|FG001|Pretest to Posttest|Lost to Follow-up|8|||
161779546|NCT05302414|584235597|FG002|Pretest to Posttest|Lost to Follow-up|8|||
161779547|NCT05302414|584235595|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161779548|NCT05302414|584235596|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161779549|NCT05302414|584235597|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161779550|NCT00742859|584235598|FG000|Overall Study|Adverse Event|5|||
161779551|NCT00742859|584235599|FG001|Overall Study|Adverse Event|6|||
161779552|NCT00742859|584235600|FG002|Overall Study|Adverse Event|3|||
161779553|NCT00742859|584235601|FG003|Overall Study|Adverse Event|1|||
161779554|NCT00742859|584235598|FG000|Overall Study|Death|1|||
161779555|NCT00742859|584235599|FG001|Overall Study|Death|0|||
161779556|NCT00742859|584235600|FG002|Overall Study|Death|0|||
161779557|NCT00742859|584235601|FG003|Overall Study|Death|1|||
161779558|NCT00742859|584235598|FG000|Overall Study|Physician Decision|1|||
161779559|NCT00742859|584235599|FG001|Overall Study|Physician Decision|2|||
161779560|NCT00742859|584235600|FG002|Overall Study|Physician Decision|0|||
161779561|NCT00742859|584235601|FG003|Overall Study|Physician Decision|0|||
161779562|NCT00742859|584235598|FG000|Overall Study|Withdrawal by Subject|4|||
161779563|NCT00742859|584235599|FG001|Overall Study|Withdrawal by Subject|2|||
161779564|NCT00742859|584235600|FG002|Overall Study|Withdrawal by Subject|4|||
161779565|NCT00742859|584235601|FG003|Overall Study|Withdrawal by Subject|1|||
161779566|NCT00742859|584235598|FG000|Overall Study|Endpoint|0|||
161779567|NCT00742859|584235599|FG001|Overall Study|Endpoint|1|||
161779568|NCT00742859|584235600|FG002|Overall Study|Endpoint|1|||
161779569|NCT00742859|584235601|FG003|Overall Study|Endpoint|2|||
161779570|NCT00742859|584235598|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
161779571|NCT00742859|584235599|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
161779572|NCT00742859|584235600|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
161779573|NCT00742859|584235601|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
161779574|NCT00742859|584235598|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
161779575|NCT00742859|584235599|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
161779576|NCT00742859|584235600|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
161779577|NCT00742859|584235601|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
161779578|NCT00742859|584235598|FG000|Overall Study|Sponsor request patient out of town|0|||
161779579|NCT00742859|584235599|FG001|Overall Study|Sponsor request patient out of town|0|||
161779580|NCT00742859|584235600|FG002|Overall Study|Sponsor request patient out of town|1|||
161779581|NCT00742859|584235601|FG003|Overall Study|Sponsor request patient out of town|1|||
161779582|NCT00742859|584235598|FG000|Overall Study|Site error|0|||
161779583|NCT00742859|584235599|FG001|Overall Study|Site error|0|||
161779584|NCT00742859|584235600|FG002|Overall Study|Site error|1|||
161779585|NCT00742859|584235601|FG003|Overall Study|Site error|1|||
161779586|NCT01346501|584235605|FG000|Overall Study|Initiated Other Biological Agents|3|||
161779587|NCT01346501|584235606|FG001|Overall Study|Initiated Other Biological Agents|1|||
161779588|NCT01346501|584235605|FG000|Overall Study|Other|8|||
161779589|NCT01346501|584235606|FG001|Overall Study|Other|12|||
161779590|NCT02564952|584235609|FG000|Overall Study|Adverse Event|6|||
161779591|NCT02564952|584235609|FG000|Overall Study|Lost to Follow-up|1|||
161779592|NCT02564952|584235609|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
161779593|NCT02564952|584235609|FG000|Overall Study|Withdrawal by Subject|1|||
161779594|NCT02564952|584235609|FG000|Overall Study|Low Efficacy|1|||
161779595|NCT02564952|584235609|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161779596|NCT01071083|584235614|FG000|Overall Study|Adverse Event|1|||
161779597|NCT01071083|584235615|FG001|Overall Study|Adverse Event|0|||
161779598|NCT01071083|584235616|FG002|Overall Study|Adverse Event|1|||
161779599|NCT01071083|584235617|FG003|Overall Study|Adverse Event|0|||
161779600|NCT01071083|584235618|FG004|Overall Study|Adverse Event|1|||
161779601|NCT01071083|584235614|FG000|Overall Study|Withdrawal by Subject|3|||
161779602|NCT01071083|584235615|FG001|Overall Study|Withdrawal by Subject|0|||
161779603|NCT01071083|584235616|FG002|Overall Study|Withdrawal by Subject|2|||
161779604|NCT01071083|584235617|FG003|Overall Study|Withdrawal by Subject|0|||
161779605|NCT01071083|584235618|FG004|Overall Study|Withdrawal by Subject|3|||
161779606|NCT01071083|584235614|FG000|Overall Study|Physician Decision|1|||
161779607|NCT01071083|584235615|FG001|Overall Study|Physician Decision|0|||
161779608|NCT01071083|584235616|FG002|Overall Study|Physician Decision|0|||
161779609|NCT01071083|584235617|FG003|Overall Study|Physician Decision|1|||
161779610|NCT01071083|584235618|FG004|Overall Study|Physician Decision|1|||
161779611|NCT01071083|584235614|FG000|Overall Study|Early Rescue|1|||
161779612|NCT01071083|584235615|FG001|Overall Study|Early Rescue|0|||
161779613|NCT01071083|584235616|FG002|Overall Study|Early Rescue|0|||
161779614|NCT01071083|584235617|FG003|Overall Study|Early Rescue|0|||
161779615|NCT01071083|584235618|FG004|Overall Study|Early Rescue|1|||
161779616|NCT01071083|584235614|FG000|Overall Study|Subject Moved|0|||
161779617|NCT01071083|584235615|FG001|Overall Study|Subject Moved|1|||
161779618|NCT01071083|584235616|FG002|Overall Study|Subject Moved|0|||
161779619|NCT01071083|584235617|FG003|Overall Study|Subject Moved|0|||
161779620|NCT01071083|584235618|FG004|Overall Study|Subject Moved|0|||
161779621|NCT01071083|584235614|FG000|Overall Study|Images Not Usable (Motion)|0|||
161779622|NCT01071083|584235615|FG001|Overall Study|Images Not Usable (Motion)|1|||
161779623|NCT01071083|584235616|FG002|Overall Study|Images Not Usable (Motion)|0|||
161779624|NCT01071083|584235617|FG003|Overall Study|Images Not Usable (Motion)|0|||
161779625|NCT01071083|584235618|FG004|Overall Study|Images Not Usable (Motion)|0|||
161779626|NCT01071083|584235614|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161779627|NCT01071083|584235615|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161779628|NCT01071083|584235616|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
161779629|NCT01071083|584235617|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
161779630|NCT01071083|584235618|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
161779631|NCT01071083|584235614|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
161779632|NCT01071083|584235615|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
161779633|NCT01071083|584235616|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
161779634|NCT01071083|584235617|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
161779635|NCT01071083|584235618|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
161779636|NCT01071083|584235614|FG000|Overall Study|Subject Refused to Continue|1|||
161779637|NCT01071083|584235615|FG001|Overall Study|Subject Refused to Continue|0|||
161779638|NCT01071083|584235616|FG002|Overall Study|Subject Refused to Continue|0|||
161779639|NCT01071083|584235617|FG003|Overall Study|Subject Refused to Continue|0|||
161779640|NCT01071083|584235618|FG004|Overall Study|Subject Refused to Continue|0|||
161779641|NCT03972709|584235619|FG000|Overall Study|Withdrawal by Subject|18|||
161779642|NCT03972709|584235620|FG001|Overall Study|Withdrawal by Subject|7|||
161779643|NCT03972709|584235621|FG002|Overall Study|Withdrawal by Subject|14|||
161779644|NCT03972709|584235619|FG000|Overall Study|Study Terminated by Sponsor|48|||
161779645|NCT03972709|584235620|FG001|Overall Study|Study Terminated by Sponsor|25|||
161779646|NCT03972709|584235621|FG002|Overall Study|Study Terminated by Sponsor|50|||
161779647|NCT03972709|584235619|FG000|Overall Study|Physician Decision|1|||
161779648|NCT03972709|584235620|FG001|Overall Study|Physician Decision|0|||
161779649|NCT03972709|584235621|FG002|Overall Study|Physician Decision|0|||
161779650|NCT03972709|584235619|FG000|Overall Study|COVID-19|0|||
161779651|NCT03972709|584235620|FG001|Overall Study|COVID-19|1|||
161779652|NCT03972709|584235621|FG002|Overall Study|COVID-19|1|||
161779653|NCT03972709|584235619|FG000|Overall Study|Lost to Follow-up|6|||
161779654|NCT03972709|584235620|FG001|Overall Study|Lost to Follow-up|1|||
161779655|NCT03972709|584235621|FG002|Overall Study|Lost to Follow-up|2|||
161779656|NCT03972709|584235619|FG000|Overall Study|Death|5|||
161779657|NCT03972709|584235620|FG001|Overall Study|Death|1|||
161779658|NCT03972709|584235621|FG002|Overall Study|Death|4|||
161779659|NCT03972709|584235619|FG000|Overall Study|Adverse Event|3|||
161779660|NCT03972709|584235620|FG001|Overall Study|Adverse Event|1|||
161779661|NCT03972709|584235621|FG002|Overall Study|Adverse Event|4|||
161779662|NCT03972709|584235619|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
161779663|NCT03972709|584235620|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
161779664|NCT03972709|584235621|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
161779665|NCT03972709|584235619|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
161779666|NCT03972709|584235620|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
161779667|NCT03972709|584235621|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
161779668|NCT03972709|584235619|FG000|Overall Study|Subject Unable to be Contacted|0|||
161779669|NCT03972709|584235620|FG001|Overall Study|Subject Unable to be Contacted|1|||
161779670|NCT03972709|584235621|FG002|Overall Study|Subject Unable to be Contacted|0|||
161779671|NCT03972709|584235619|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
161779672|NCT03972709|584235620|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
161779673|NCT03972709|584235621|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
161779674|NCT03972709|584235619|FG000|Overall Study|Subject Moved|0|||
161779675|NCT03972709|584235620|FG001|Overall Study|Subject Moved|1|||
161779676|NCT03972709|584235621|FG002|Overall Study|Subject Moved|0|||
161779677|NCT03972709|584235619|FG000|Overall Study|Missed Study Visits|1|||
161779678|NCT03972709|584235620|FG001|Overall Study|Missed Study Visits|0|||
161779679|NCT03972709|584235621|FG002|Overall Study|Missed Study Visits|0|||
161779680|NCT01339000|584235622|FG000|Overall Study|study closed due to lack of drug supply|1|||
161779681|NCT01339000|584235623|FG001|Overall Study|study closed due to lack of drug supply|0|||
161779682|NCT00728988|584235624|FG000|Overall Study|Not Treated|2|||
161779683|NCT00728988|584235625|FG001|Overall Study|Not Treated|2|||
161779684|NCT00728988|584235624|FG000|Overall Study|Death|1|||
161779685|NCT00728988|584235625|FG001|Overall Study|Death|1|||
161779686|NCT00728988|584235624|FG000|Overall Study|Adverse Event|3|||
161779687|NCT00728988|584235625|FG001|Overall Study|Adverse Event|2|||
161779688|NCT00728988|584235624|FG000|Overall Study|Other|85|||
161779689|NCT00728988|584235625|FG001|Overall Study|Other|77|||
161779690|NCT00728988|584235624|FG000|Overall Study|Withdrawal by Subject|2|||
161779691|NCT00728988|584235625|FG001|Overall Study|Withdrawal by Subject|6|||
161779692|NCT02017535|584235628|FG000|Overall Study|Withdrawal by Subject|1|||
161779693|NCT02017535|584235629|FG001|Overall Study|Withdrawal by Subject|0|||
161779694|NCT02017535|584235630|FG002|Overall Study|Withdrawal by Subject|0|||
161779695|NCT02017535|584235631|FG003|Overall Study|Withdrawal by Subject|0|||
161779696|NCT05511428|584235632|FG000|Overall Study|Withdrawal by Subject|1|||
161779697|NCT05511428|584235632|FG000|Overall Study|Adverse Event|1|||
161779698|NCT04088734|584235633|FG000|Overall Study|Other, Not Specified|5|||
161779699|NCT00664066|584235638|FG000|Overall Study|Study terminated|3|||
161779700|NCT03332212|584235642|FG000|Overall Study|Not treated|0|||
161779701|NCT03332212|584235643|FG001|Overall Study|Not treated|1|||
161779702|NCT03332212|584235644|FG002|Overall Study|Not treated|0|||
161779703|NCT03332212|584235645|FG003|Overall Study|Not treated|0|||
161779704|NCT03332212|584235642|FG000|Overall Study|Adverse Event|0|||
161779705|NCT03332212|584235643|FG001|Overall Study|Adverse Event|0|||
161779706|NCT03332212|584235644|FG002|Overall Study|Adverse Event|0|||
161779707|NCT03332212|584235645|FG003|Overall Study|Adverse Event|1|||
161779708|NCT03332212|584235642|FG000|Overall Study|worsening of disease under study|1|||
161779709|NCT03332212|584235643|FG001|Overall Study|worsening of disease under study|1|||
161779710|NCT03332212|584235644|FG002|Overall Study|worsening of disease under study|0|||
161779711|NCT03332212|584235645|FG003|Overall Study|worsening of disease under study|0|||
161779712|NCT00975000|584235648|FG000|Overall Study|Other|1|||
161779713|NCT00975000|584235649|FG001|Overall Study|Other|0|||
161779714|NCT00975000|584235648|FG000|Overall Study|Adverse Event|1|||
161779715|NCT00975000|584235649|FG001|Overall Study|Adverse Event|1|||
161779716|NCT00975000|584235648|FG000|Overall Study|Withdrawal by Subject|2|||
161779717|NCT00975000|584235649|FG001|Overall Study|Withdrawal by Subject|2|||
161779718|NCT00975000|584235648|FG000|Overall Study|Lost to Follow-up|0|||
161779719|NCT00975000|584235649|FG001|Overall Study|Lost to Follow-up|1|||
161779720|NCT00975000|584235648|FG000|Overall Study|Protocol-specified Criteria|1|||
161779721|NCT00975000|584235649|FG001|Overall Study|Protocol-specified Criteria|0|||
161779722|NCT00975000|584235648|FG000|Overall Study|Non-compliance|0|||
161779723|NCT00975000|584235649|FG001|Overall Study|Non-compliance|1|||
161779724|NCT02392377|584235650|FG000|Overall Study|Withdrawal by Subject|0|||
161779725|NCT02392377|584235651|FG001|Overall Study|Withdrawal by Subject|1|||
161779726|NCT01126359|584235654|FG000|First Intervention (20-minutes)|Physician Decision|0|||
161779727|NCT01126359|584235655|FG001|First Intervention (20-minutes)|Physician Decision|1|||
161779728|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161779729|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
161779730|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
161779731|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161779732|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161779733|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
161779734|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
161779735|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779736|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779737|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779738|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779739|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
161779740|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779741|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779742|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779743|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779744|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
161779745|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
161779746|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779747|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779748|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779749|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
161779750|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779751|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779752|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779753|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779754|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779755|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
161779756|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779757|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779758|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779759|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779760|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779761|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779762|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
161779763|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
161779764|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779765|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779766|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
161779767|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
161779768|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779769|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779770|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779771|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779772|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779773|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779774|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779775|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
161779776|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779777|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779778|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779779|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
161779780|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779781|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779782|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779783|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779784|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
161779785|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779786|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779787|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779788|NCT00902486|584235656|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779789|NCT00902486|584235657|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779790|NCT00902486|584235658|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779791|NCT00902486|584235659|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
161779792|NCT00902486|584235660|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779793|NCT00902486|584235661|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779794|NCT00209560|584235662|FG000|Overall Study|Lack of Efficacy|1|||
161779795|NCT00209560|584235663|FG001|Overall Study|Lack of Efficacy|0|||
161779796|NCT04439110|584235664|FG000|Overall Study|Ineligible|2|||
161779797|NCT04439110|584235664|FG000|Overall Study|Adverse Event|4|||
161779798|NCT04439110|584235664|FG000|Overall Study|Death|2|||
161779799|NCT04439110|584235664|FG000|Overall Study|Disease proression|25|||
161779800|NCT04439110|584235664|FG000|Overall Study|Withdrawal by Subject|1|||
161779801|NCT04439110|584235664|FG000|Overall Study|Alternative therapy|1|||
161779802|NCT04439110|584235664|FG000|Overall Study|Other complicating disease|1|||
161779803|NCT04439110|584235664|FG000|Overall Study|Personal reasons|1|||
161779804|NCT04439110|584235664|FG000|Overall Study|Still on treatment|1|||
161779805|NCT01298661|584235665|FG000|Overall Study|Withdrawal by Subject|2|||
161779806|NCT01298661|584235666|FG001|Overall Study|Withdrawal by Subject|0|||
161779807|NCT01298661|584235667|FG002|Overall Study|Withdrawal by Subject|2|||
161779808|NCT05257109|584235670|FG000|Overall Study|Withdrawal by Subject|1|||
161779809|NCT05257109|584235671|FG001|Overall Study|Withdrawal by Subject|0|||
161779810|NCT05257109|584235672|FG002|Overall Study|Withdrawal by Subject|0|||
161779811|NCT05257109|584235673|FG003|Overall Study|Withdrawal by Subject|0|||
161779812|NCT01607398|584236984|FG000|Overall Study|Adverse Event|0|||
161779813|NCT01607398|584236985|FG001|Overall Study|Adverse Event|2|||
161779814|NCT01607398|584236984|FG000|Overall Study|Severe COPD|2|||
161779815|NCT01607398|584236985|FG001|Overall Study|Severe COPD|0|||
161779816|NCT03044431|584236988|FG000|Overall Study|Lost to Follow-up|59|||
161779817|NCT02576054|584236989|FG000|Overall Study|Withdrawal by Subject|1|||
161895333|NCT03117361|584666298|FG000|Overall Study|Progressive disease|5|||
161779818|NCT01396161|584236990|FG000|Overall Study|Withdrawal by Subject|0|||
161779819|NCT01396161|584236991|FG001|Overall Study|Withdrawal by Subject|0|||
161779820|NCT01396161|584236992|FG002|Overall Study|Withdrawal by Subject|0|||
161779821|NCT01396161|584236993|FG003|Overall Study|Withdrawal by Subject|0|||
161779822|NCT01396161|584236994|FG004|Overall Study|Withdrawal by Subject|1|||
161779823|NCT01396161|584236995|FG005|Overall Study|Withdrawal by Subject|0|||
161779824|NCT01396161|584236996|FG006|Overall Study|Withdrawal by Subject|0|||
161779825|NCT01396161|584236990|FG000|Overall Study|Other|0|||
161779826|NCT01396161|584236991|FG001|Overall Study|Other|0|||
161779827|NCT01396161|584236992|FG002|Overall Study|Other|0|||
161779828|NCT01396161|584236993|FG003|Overall Study|Other|0|||
161779829|NCT01396161|584236994|FG004|Overall Study|Other|0|||
161779830|NCT01396161|584236995|FG005|Overall Study|Other|0|||
161779831|NCT01396161|584236996|FG006|Overall Study|Other|1|||
161779832|NCT03976076|584236997|FG000|Overall Study|Withdrawal by Subject|2|||
161779833|NCT02962739|584236998|FG000|Overall Study|Withdrawal by Subject|0|||
161779834|NCT02962739|584236999|FG001|Overall Study|Withdrawal by Subject|1|||
161779835|NCT02962739|584237000|FG002|Overall Study|Withdrawal by Subject|0|||
161779836|NCT02962739|584237001|FG003|Overall Study|Withdrawal by Subject|0|||
161779837|NCT02962739|584237002|FG004|Overall Study|Withdrawal by Subject|0|||
161779838|NCT02962739|584237003|FG005|Overall Study|Withdrawal by Subject|0|||
161779839|NCT02962739|584236998|FG000|Overall Study|Protocol Violation|0|||
161779840|NCT02962739|584236999|FG001|Overall Study|Protocol Violation|0|||
161779841|NCT02962739|584237000|FG002|Overall Study|Protocol Violation|1|||
161779842|NCT02962739|584237001|FG003|Overall Study|Protocol Violation|0|||
161779843|NCT02962739|584237002|FG004|Overall Study|Protocol Violation|1|||
161779844|NCT02962739|584237003|FG005|Overall Study|Protocol Violation|0|||
161779845|NCT00414011|584237004|FG000|Overall Study|Physician Decision|3|||
161779846|NCT00414011|584237004|FG000|Overall Study|Withdrawal by Subject|2|||
161779847|NCT00981409|584237009|FG000|Overall Study|Adverse Event|4|||
161779848|NCT00981409|584237010|FG001|Overall Study|Adverse Event|0|||
161779849|NCT00981409|584237009|FG000|Overall Study|Protocol Violation|0|||
161779850|NCT00981409|584237010|FG001|Overall Study|Protocol Violation|1|||
161779851|NCT00981409|584237009|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
161779852|NCT00981409|584237010|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
161779853|NCT00450177|584237011|FG000|Overall Study|Adverse Event|7|||
161779854|NCT00450177|584237012|FG001|Overall Study|Adverse Event|4|||
161779855|NCT00450177|584237011|FG000|Overall Study|Withdrawal by Subject|1|||
161779856|NCT00450177|584237012|FG001|Overall Study|Withdrawal by Subject|6|||
161779857|NCT00450177|584237011|FG000|Overall Study|Withdrawal by Primary Team|1|||
161779858|NCT00450177|584237012|FG001|Overall Study|Withdrawal by Primary Team|1|||
161779859|NCT03869684|584237015|FG000|Overall Study|Adverse Event|0|||
161779860|NCT03869684|584237016|FG001|Overall Study|Adverse Event|3|||
161779861|NCT03869684|584237017|FG002|Overall Study|Adverse Event|1|||
161779862|NCT03869684|584237015|FG000|Overall Study|Withdrawal by Subject|1|||
161779863|NCT03869684|584237016|FG001|Overall Study|Withdrawal by Subject|0|||
161779864|NCT03869684|584237017|FG002|Overall Study|Withdrawal by Subject|0|||
161779865|NCT03869684|584237015|FG000|Overall Study|Lost to Follow-up|1|||
161779866|NCT03869684|584237016|FG001|Overall Study|Lost to Follow-up|0|||
161779867|NCT03869684|584237017|FG002|Overall Study|Lost to Follow-up|0|||
161779868|NCT03869684|584237015|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
161779869|NCT03869684|584237016|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
161779870|NCT03869684|584237017|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
161779871|NCT04056299|584237018|FG000|Overall Study|Sponsor discontinued study|3|||
161779872|NCT04056299|584237019|FG001|Overall Study|Sponsor discontinued study|3|||
161779873|NCT01227954|584237024|FG000|Overall Study|Protocol Violation|6|||
161779874|NCT01227954|584237024|FG000|Overall Study|No protocol treatment|7|||
161779875|NCT00078312|584237027|FG000|Overall Study|Adverse Event|43|||
161779876|NCT00078312|584237027|FG000|Overall Study|Lack of Efficacy|15|||
161779877|NCT00078312|584237027|FG000|Overall Study|Lost to Follow-up|41|||
161779878|NCT00078312|584237027|FG000|Overall Study|Physician Decision|9|||
161779879|NCT00078312|584237027|FG000|Overall Study|Protocol Violation|3|||
161779880|NCT00078312|584237027|FG000|Overall Study|Withdrawal by Subject|33|||
161779881|NCT00078312|584237027|FG000|Overall Study|Miscellaneous|33|||
161779882|NCT03901352|584237028|FG000|Double-blind Phase|Adverse Event|6|||
161779883|NCT03901352|584237029|FG001|Double-blind Phase|Adverse Event|4|||
161779884|NCT03901352|584237028|FG000|Double-blind Phase|Death|1|||
161779885|NCT03901352|584237029|FG001|Double-blind Phase|Death|0|||
161779886|NCT03901352|584237028|FG000|Double-blind Phase|Lack of Efficacy|0|||
161779887|NCT03901352|584237029|FG001|Double-blind Phase|Lack of Efficacy|1|||
161779888|NCT03901352|584237028|FG000|Double-blind Phase|Protocol Violation|0|||
161779889|NCT03901352|584237029|FG001|Double-blind Phase|Protocol Violation|1|||
161779890|NCT03901352|584237028|FG000|Double-blind Phase|Withdrawal by Subject|10|||
161779891|NCT03901352|584237029|FG001|Double-blind Phase|Withdrawal by Subject|8|||
161779892|NCT03901352|584237028|FG000|Open-label Extension Phase|Adverse Event|24|||
161779893|NCT03901352|584237029|FG001|Open-label Extension Phase|Adverse Event|0|||
161779894|NCT03901352|584237028|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
161779895|NCT03901352|584237029|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
161779896|NCT03901352|584237028|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
161779897|NCT03901352|584237029|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
161779898|NCT03901352|584237028|FG000|Open-label Extension Phase|Other|1|||
161779899|NCT03901352|584237029|FG001|Open-label Extension Phase|Other|0|||
161779900|NCT01826201|584237032|FG000|Overall Study|Non compliance with protocol|4|||
161779901|NCT01988337|584237035|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
161779902|NCT02742818|584237036|FG000|Overall Study|Adverse Event|0|||
161779903|NCT02742818|584237037|FG001|Overall Study|Adverse Event|1|||
161779904|NCT02742818|584237036|FG000|Overall Study|Protocol Violation|0|||
161779905|NCT02742818|584237037|FG001|Overall Study|Protocol Violation|1|||
161779906|NCT04701658|584237038|FG000|Overall Study|Lost to Follow-up|6|||
161779907|NCT00756652|584237041|FG000|Original Phase|Withdrawal by Subject|864|||
161779908|NCT00756652|584237042|FG001|Original Phase|Withdrawal by Subject|23|||
161779909|NCT00756652|584237041|FG000|Original Phase|Lost to Follow-up|601|||
161779910|NCT00756652|584237042|FG001|Original Phase|Lost to Follow-up|0|||
161779911|NCT00756652|584237041|FG000|Original Phase|Other Discontinuation|797|||
161779912|NCT00756652|584237042|FG001|Original Phase|Other Discontinuation|5|||
161779913|NCT00756652|584237041|FG000|Original Phase|Participant Noncompliance|18622|||
161779914|NCT00756652|584237042|FG001|Original Phase|Participant Noncompliance|424|||
161779915|NCT00756652|584237041|FG000|Original Phase|Unknown Discontinuation Reason|2|||
161779916|NCT00756652|584237042|FG001|Original Phase|Unknown Discontinuation Reason|0|||
161779917|NCT00756652|584237041|FG000|Original Phase|Participants without data|3259|||
161779918|NCT00756652|584237042|FG001|Original Phase|Participants without data|466|||
161779919|NCT00756652|584237041|FG000|Original Phase|Death|168|||
161779920|NCT00756652|584237042|FG001|Original Phase|Death|1|||
161779921|NCT00756652|584237041|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
161779922|NCT00756652|584237042|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
161779923|NCT00756652|584237041|FG000|Re-Op Phase|Withdrawal by Subject|62|||
161779924|NCT00756652|584237042|FG001|Re-Op Phase|Withdrawal by Subject|0|||
161779925|NCT00756652|584237041|FG000|Re-Op Phase|Death|6|||
161779926|NCT00756652|584237042|FG001|Re-Op Phase|Death|0|||
161779927|NCT00756652|584237041|FG000|Re-Op Phase|Lost to Follow-up|340|||
161779928|NCT00756652|584237042|FG001|Re-Op Phase|Lost to Follow-up|0|||
161779929|NCT00756652|584237041|FG000|Re-Op Phase|Site Closed|2454|||
161779930|NCT00756652|584237042|FG001|Re-Op Phase|Site Closed|0|||
161779931|NCT00756652|584237041|FG000|Re-Op Phase|Withdrawn after explant|14|||
161779932|NCT00756652|584237042|FG001|Re-Op Phase|Withdrawn after explant|0|||
161779933|NCT00038467|584237049|FG000|Overall Study|Adverse Event|170|||
161779934|NCT00038467|584237050|FG001|Overall Study|Adverse Event|145|||
161779935|NCT00038467|584237049|FG000|Overall Study|Withdrawal by Subject|150|||
161779936|NCT00038467|584237050|FG001|Overall Study|Withdrawal by Subject|107|||
161779937|NCT00038467|584237049|FG000|Overall Study|Protocol Violation|19|||
161779938|NCT00038467|584237050|FG001|Overall Study|Protocol Violation|22|||
161779939|NCT00038467|584237049|FG000|Overall Study|Death|22|||
161779940|NCT00038467|584237050|FG001|Overall Study|Death|16|||
161779941|NCT00038467|584237049|FG000|Overall Study|Lost to Follow-up|15|||
161779942|NCT00038467|584237050|FG001|Overall Study|Lost to Follow-up|10|||
161779943|NCT00038467|584237049|FG000|Overall Study|Recurrence|109|||
161779944|NCT00038467|584237050|FG001|Overall Study|Recurrence|179|||
161779945|NCT00038467|584237049|FG000|Overall Study|Randomized, but not treated|31|||
161779946|NCT00038467|584237050|FG001|Overall Study|Randomized, but not treated|35|||
161779947|NCT00038467|584237049|FG000|Overall Study|Other|26|||
161779948|NCT00038467|584237050|FG001|Overall Study|Other|28|||
161779949|NCT01523301|584237051|FG000|Overall Study|Adverse Event|25|||
161779950|NCT01523301|584237052|FG001|Overall Study|Adverse Event|16|||
161779951|NCT01523301|584237051|FG000|Overall Study|Lack of Efficacy|0|||
161779952|NCT01523301|584237052|FG001|Overall Study|Lack of Efficacy|2|||
161779953|NCT01523301|584237051|FG000|Overall Study|Protocol Violation|3|||
161779954|NCT01523301|584237052|FG001|Overall Study|Protocol Violation|4|||
161779955|NCT01523301|584237051|FG000|Overall Study|Lost to Follow-up|1|||
161779956|NCT01523301|584237052|FG001|Overall Study|Lost to Follow-up|0|||
161779957|NCT01523301|584237051|FG000|Overall Study|Withdrawal by Subject|6|||
161779958|NCT01523301|584237052|FG001|Overall Study|Withdrawal by Subject|8|||
161779959|NCT01523301|584237051|FG000|Overall Study|Other Reason|0|||
161779960|NCT01523301|584237052|FG001|Overall Study|Other Reason|2|||
161779961|NCT00481871|584237053|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
161779962|NCT00481871|584237054|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
161779963|NCT00481871|584237055|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
161779964|NCT00481871|584237056|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
161779965|NCT00481871|584237057|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
161779966|NCT03889197|584237061|FG000|Overall Study|Withdrawal by Subject|1|||
161779967|NCT03889197|584237062|FG001|Overall Study|Withdrawal by Subject|0|||
161779968|NCT03889197|584237061|FG000|Overall Study|Physician Decision|0|||
161779969|NCT03889197|584237062|FG001|Overall Study|Physician Decision|1|||
161779970|NCT03889197|584237061|FG000|Overall Study|met exclusion criteria|0|||
161779971|NCT03889197|584237062|FG001|Overall Study|met exclusion criteria|1|||
161779972|NCT03889197|584237061|FG000|Overall Study|Protocol Violation|1|||
161779973|NCT03889197|584237062|FG001|Overall Study|Protocol Violation|0|||
161779974|NCT03193190|584237068|FG000|Stage 1|Arm Terminated by Sponsor|0|||
161779975|NCT03193190|584237069|FG001|Stage 1|Arm Terminated by Sponsor|0|||
161779976|NCT03193190|584237070|FG002|Stage 1|Arm Terminated by Sponsor|0|||
161779977|NCT03193190|584237071|FG003|Stage 1|Arm Terminated by Sponsor|1|||
161779978|NCT03193190|584237072|FG004|Stage 1|Arm Terminated by Sponsor|0|||
161779979|NCT03193190|584237073|FG005|Stage 1|Arm Terminated by Sponsor|2|||
161779980|NCT03193190|584237074|FG006|Stage 1|Arm Terminated by Sponsor|0|||
161779981|NCT03193190|584237075|FG007|Stage 1|Arm Terminated by Sponsor|0|||
161779982|NCT03193190|584237076|FG008|Stage 1|Arm Terminated by Sponsor|0|||
161779983|NCT03193190|584237077|FG009|Stage 1|Arm Terminated by Sponsor|0|||
161779984|NCT03193190|584237078|FG010|Stage 1|Arm Terminated by Sponsor|0|||
161779985|NCT03193190|584237079|FG011|Stage 1|Arm Terminated by Sponsor|0|||
161779986|NCT03193190|584237080|FG012|Stage 1|Arm Terminated by Sponsor|0|||
161779987|NCT03193190|584237081|FG013|Stage 1|Arm Terminated by Sponsor|0|||
161779988|NCT03193190|584237082|FG014|Stage 1|Arm Terminated by Sponsor|0|||
161779989|NCT03193190|584237083|FG015|Stage 1|Arm Terminated by Sponsor|0|||
161779990|NCT03193190|584237068|FG000|Stage 1|Death|22|||
161779991|NCT03193190|584237069|FG001|Stage 1|Death|8|||
161779992|NCT03193190|584237070|FG002|Stage 1|Death|23|||
161779993|NCT03193190|584237071|FG003|Stage 1|Death|14|||
161779994|NCT03193190|584237072|FG004|Stage 1|Death|34|||
161779995|NCT03193190|584237073|FG005|Stage 1|Death|28|||
161779996|NCT03193190|584237074|FG006|Stage 1|Death|19|||
161779997|NCT03193190|584237075|FG007|Stage 1|Death|21|||
161779998|NCT03193190|584237076|FG008|Stage 1|Death|14|||
161779999|NCT03193190|584237077|FG009|Stage 1|Death|10|||
161780000|NCT03193190|584237078|FG010|Stage 1|Death|59|||
161780001|NCT03193190|584237079|FG011|Stage 1|Death|14|||
161780002|NCT03193190|584237080|FG012|Stage 1|Death|14|||
161780003|NCT03193190|584237081|FG013|Stage 1|Death|0|||
161780004|NCT03193190|584237082|FG014|Stage 1|Death|0|||
161780005|NCT03193190|584237083|FG015|Stage 1|Death|0|||
161780006|NCT03193190|584237068|FG000|Stage 1|Lost to Follow-up|2|||
161780007|NCT03193190|584237069|FG001|Stage 1|Lost to Follow-up|1|||
161780008|NCT03193190|584237070|FG002|Stage 1|Lost to Follow-up|1|||
161780009|NCT03193190|584237071|FG003|Stage 1|Lost to Follow-up|0|||
161780010|NCT03193190|584237072|FG004|Stage 1|Lost to Follow-up|0|||
161780011|NCT03193190|584237073|FG005|Stage 1|Lost to Follow-up|0|||
161780012|NCT03193190|584237074|FG006|Stage 1|Lost to Follow-up|1|||
161780013|NCT03193190|584237075|FG007|Stage 1|Lost to Follow-up|0|||
161780014|NCT03193190|584237076|FG008|Stage 1|Lost to Follow-up|0|||
161780015|NCT03193190|584237077|FG009|Stage 1|Lost to Follow-up|0|||
161780016|NCT03193190|584237078|FG010|Stage 1|Lost to Follow-up|0|||
161780017|NCT03193190|584237079|FG011|Stage 1|Lost to Follow-up|0|||
161780018|NCT03193190|584237080|FG012|Stage 1|Lost to Follow-up|0|||
161780019|NCT03193190|584237081|FG013|Stage 1|Lost to Follow-up|0|||
161780020|NCT03193190|584237082|FG014|Stage 1|Lost to Follow-up|0|||
161780021|NCT03193190|584237083|FG015|Stage 1|Lost to Follow-up|0|||
161780022|NCT03193190|584237068|FG000|Stage 1|Reason not Specified|1|||
161780023|NCT03193190|584237069|FG001|Stage 1|Reason not Specified|0|||
161780024|NCT03193190|584237070|FG002|Stage 1|Reason not Specified|0|||
161780025|NCT03193190|584237071|FG003|Stage 1|Reason not Specified|1|||
161780026|NCT03193190|584237072|FG004|Stage 1|Reason not Specified|0|||
161780027|NCT03193190|584237073|FG005|Stage 1|Reason not Specified|1|||
161780028|NCT03193190|584237074|FG006|Stage 1|Reason not Specified|2|||
161780029|NCT03193190|584237075|FG007|Stage 1|Reason not Specified|2|||
161780030|NCT03193190|584237076|FG008|Stage 1|Reason not Specified|0|||
161780031|NCT03193190|584237077|FG009|Stage 1|Reason not Specified|1|||
161780032|NCT03193190|584237078|FG010|Stage 1|Reason not Specified|3|||
161780033|NCT03193190|584237079|FG011|Stage 1|Reason not Specified|0|||
161780034|NCT03193190|584237080|FG012|Stage 1|Reason not Specified|1|||
161780035|NCT03193190|584237081|FG013|Stage 1|Reason not Specified|0|||
161780036|NCT03193190|584237082|FG014|Stage 1|Reason not Specified|0|||
161780037|NCT03193190|584237083|FG015|Stage 1|Reason not Specified|0|||
161780038|NCT03193190|584237068|FG000|Stage 1|Physician Decision|0|||
161780039|NCT03193190|584237069|FG001|Stage 1|Physician Decision|0|||
161780040|NCT03193190|584237070|FG002|Stage 1|Physician Decision|0|||
161780041|NCT03193190|584237071|FG003|Stage 1|Physician Decision|0|||
161780042|NCT03193190|584237072|FG004|Stage 1|Physician Decision|0|||
161780043|NCT03193190|584237073|FG005|Stage 1|Physician Decision|0|||
161780044|NCT03193190|584237074|FG006|Stage 1|Physician Decision|0|||
161780045|NCT03193190|584237075|FG007|Stage 1|Physician Decision|0|||
161780046|NCT03193190|584237076|FG008|Stage 1|Physician Decision|0|||
161780047|NCT03193190|584237077|FG009|Stage 1|Physician Decision|0|||
161780048|NCT03193190|584237078|FG010|Stage 1|Physician Decision|0|||
161780049|NCT03193190|584237079|FG011|Stage 1|Physician Decision|1|||
161780050|NCT03193190|584237080|FG012|Stage 1|Physician Decision|0|||
161780051|NCT03193190|584237081|FG013|Stage 1|Physician Decision|0|||
161780052|NCT03193190|584237082|FG014|Stage 1|Physician Decision|0|||
161780053|NCT03193190|584237083|FG015|Stage 1|Physician Decision|0|||
161780054|NCT03193190|584237068|FG000|Stage 1|Progressive Disease|1|||
161780055|NCT03193190|584237069|FG001|Stage 1|Progressive Disease|0|||
161780056|NCT03193190|584237070|FG002|Stage 1|Progressive Disease|0|||
161666972|NCT00712673|583833763|FG002|Overall Study|Familial and Personal Reasons|5|||
161666973|NCT00712673|583833764|FG003|Overall Study|Familial and Personal Reasons|2|||
161666974|NCT00712673|583833761|FG000|Overall Study|Investigator's Decision|1|||
161666975|NCT00712673|583833762|FG001|Overall Study|Investigator's Decision|0|||
161666976|NCT00712673|583833763|FG002|Overall Study|Investigator's Decision|0|||
161666977|NCT00712673|583833764|FG003|Overall Study|Investigator's Decision|0|||
161666978|NCT00712673|583833761|FG000|Overall Study|Protocol Violation|0|||
161666979|NCT00712673|583833762|FG001|Overall Study|Protocol Violation|0|||
161666980|NCT00712673|583833763|FG002|Overall Study|Protocol Violation|2|||
161666981|NCT00712673|583833764|FG003|Overall Study|Protocol Violation|0|||
161666982|NCT02768870|583833767|FG000|Overall Study|Death|1|||
161666983|NCT02768870|583833767|FG000|Overall Study|Reoperation|6|||
161666984|NCT02768870|583833767|FG000|Overall Study|Lost to Follow-up|1|||
161666985|NCT02768870|583833767|FG000|Overall Study|Exit|4|||
161780057|NCT03193190|584237071|FG003|Stage 1|Progressive Disease|0|||
161780058|NCT03193190|584237072|FG004|Stage 1|Progressive Disease|0|||
161780059|NCT03193190|584237073|FG005|Stage 1|Progressive Disease|0|||
161780060|NCT03193190|584237074|FG006|Stage 1|Progressive Disease|0|||
161780061|NCT03193190|584237075|FG007|Stage 1|Progressive Disease|0|||
161780062|NCT03193190|584237076|FG008|Stage 1|Progressive Disease|0|||
161780063|NCT03193190|584237077|FG009|Stage 1|Progressive Disease|0|||
161780064|NCT03193190|584237078|FG010|Stage 1|Progressive Disease|0|||
161780065|NCT03193190|584237079|FG011|Stage 1|Progressive Disease|0|||
161780066|NCT03193190|584237080|FG012|Stage 1|Progressive Disease|0|||
161780067|NCT03193190|584237081|FG013|Stage 1|Progressive Disease|0|||
161780068|NCT03193190|584237082|FG014|Stage 1|Progressive Disease|0|||
161780069|NCT03193190|584237083|FG015|Stage 1|Progressive Disease|0|||
161780070|NCT03193190|584237068|FG000|Stage 1|Study Terminated By Sponsor|3|||
161780071|NCT03193190|584237069|FG001|Stage 1|Study Terminated By Sponsor|0|||
161780072|NCT03193190|584237070|FG002|Stage 1|Study Terminated By Sponsor|0|||
161780073|NCT03193190|584237071|FG003|Stage 1|Study Terminated By Sponsor|0|||
161780074|NCT03193190|584237072|FG004|Stage 1|Study Terminated By Sponsor|6|||
161780075|NCT03193190|584237073|FG005|Stage 1|Study Terminated By Sponsor|0|||
161780076|NCT03193190|584237074|FG006|Stage 1|Study Terminated By Sponsor|0|||
161780077|NCT03193190|584237075|FG007|Stage 1|Study Terminated By Sponsor|0|||
161780078|NCT03193190|584237076|FG008|Stage 1|Study Terminated By Sponsor|0|||
161780079|NCT03193190|584237077|FG009|Stage 1|Study Terminated By Sponsor|0|||
161780080|NCT03193190|584237078|FG010|Stage 1|Study Terminated By Sponsor|0|||
161780081|NCT03193190|584237079|FG011|Stage 1|Study Terminated By Sponsor|0|||
161780082|NCT03193190|584237080|FG012|Stage 1|Study Terminated By Sponsor|0|||
161780083|NCT03193190|584237081|FG013|Stage 1|Study Terminated By Sponsor|0|||
161780084|NCT03193190|584237082|FG014|Stage 1|Study Terminated By Sponsor|0|||
161780085|NCT03193190|584237083|FG015|Stage 1|Study Terminated By Sponsor|0|||
161780086|NCT03193190|584237068|FG000|Stage 1|Withdrawal by Subject|6|||
161780087|NCT03193190|584237069|FG001|Stage 1|Withdrawal by Subject|0|||
161780088|NCT03193190|584237070|FG002|Stage 1|Withdrawal by Subject|1|||
161780089|NCT03193190|584237071|FG003|Stage 1|Withdrawal by Subject|0|||
161780090|NCT03193190|584237072|FG004|Stage 1|Withdrawal by Subject|2|||
161780091|NCT03193190|584237073|FG005|Stage 1|Withdrawal by Subject|0|||
161780092|NCT03193190|584237074|FG006|Stage 1|Withdrawal by Subject|3|||
161780093|NCT03193190|584237075|FG007|Stage 1|Withdrawal by Subject|2|||
161780094|NCT03193190|584237076|FG008|Stage 1|Withdrawal by Subject|2|||
161780095|NCT03193190|584237077|FG009|Stage 1|Withdrawal by Subject|4|||
161780096|NCT03193190|584237078|FG010|Stage 1|Withdrawal by Subject|9|||
161780097|NCT03193190|584237079|FG011|Stage 1|Withdrawal by Subject|1|||
161780098|NCT03193190|584237080|FG012|Stage 1|Withdrawal by Subject|0|||
161780099|NCT03193190|584237081|FG013|Stage 1|Withdrawal by Subject|0|||
161780100|NCT03193190|584237082|FG014|Stage 1|Withdrawal by Subject|0|||
161780101|NCT03193190|584237083|FG015|Stage 1|Withdrawal by Subject|0|||
161780102|NCT03193190|584237068|FG000|Stage 2|Death|0|||
161780103|NCT03193190|584237069|FG001|Stage 2|Death|0|||
161780104|NCT03193190|584237070|FG002|Stage 2|Death|0|||
161780105|NCT03193190|584237071|FG003|Stage 2|Death|0|||
161780106|NCT03193190|584237072|FG004|Stage 2|Death|0|||
161780107|NCT03193190|584237073|FG005|Stage 2|Death|0|||
161666986|NCT02963610|583833768|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
161666987|NCT01774110|583833769|FG000|Overall Study|Lost to Follow-up|7|||
161780108|NCT03193190|584237074|FG006|Stage 2|Death|0|||
161780109|NCT03193190|584237075|FG007|Stage 2|Death|0|||
161780110|NCT03193190|584237076|FG008|Stage 2|Death|0|||
161666988|NCT00063154|583833770|FG000|Overall Study|Disease progression|27|||
161666989|NCT00063154|583833770|FG000|Overall Study|Adverse Event|2|||
161780111|NCT03193190|584237077|FG009|Stage 2|Death|0|||
161780112|NCT03193190|584237078|FG010|Stage 2|Death|0|||
161780113|NCT03193190|584237079|FG011|Stage 2|Death|0|||
161780114|NCT03193190|584237080|FG012|Stage 2|Death|0|||
161780115|NCT03193190|584237081|FG013|Stage 2|Death|14|||
161780116|NCT03193190|584237082|FG014|Stage 2|Death|4|||
161780117|NCT03193190|584237083|FG015|Stage 2|Death|1|||
161780118|NCT03193190|584237068|FG000|Stage 2|Lost to Follow-up|0|||
161666990|NCT00063154|583833770|FG000|Overall Study|Physician Decision|10|||
161666991|NCT00063154|583833770|FG000|Overall Study|Death|3|||
161666992|NCT00063154|583833770|FG000|Overall Study|Reason unspecified|1|||
161666993|NCT00063154|583833770|FG000|Overall Study|Did not receive treatment|8|||
161666994|NCT02203695|583833771|FG000|Overall Study|Patient withdrew consent|1|||
161666995|NCT02203695|583833772|FG001|Overall Study|Patient withdrew consent|1|||
161666996|NCT02203695|583833771|FG000|Overall Study|Started non-study treatment|1|||
161666997|NCT02203695|583833772|FG001|Overall Study|Started non-study treatment|0|||
161666998|NCT01259726|583833773|FG000|Overall Study|Death|1|||
161666999|NCT01259726|583833774|FG001|Overall Study|Death|0|||
161667000|NCT01259726|583833775|FG002|Overall Study|Death|0|||
161667001|NCT01259726|583833776|FG003|Overall Study|Death|0|||
161667002|NCT01259726|583833773|FG000|Overall Study|Physician Decision|2|||
161667003|NCT01259726|583833774|FG001|Overall Study|Physician Decision|0|||
161667004|NCT01259726|583833775|FG002|Overall Study|Physician Decision|1|||
161667005|NCT01259726|583833776|FG003|Overall Study|Physician Decision|1|||
161667006|NCT01259726|583833773|FG000|Overall Study|Withdrawal by Subject|1|||
161667007|NCT01259726|583833774|FG001|Overall Study|Withdrawal by Subject|3|||
161667008|NCT01259726|583833775|FG002|Overall Study|Withdrawal by Subject|2|||
161667009|NCT01259726|583833776|FG003|Overall Study|Withdrawal by Subject|1|||
161667010|NCT01259726|583833773|FG000|Overall Study|Lost to Follow-up|1|||
161667011|NCT01259726|583833774|FG001|Overall Study|Lost to Follow-up|1|||
161667012|NCT01259726|583833775|FG002|Overall Study|Lost to Follow-up|1|||
161667013|NCT01259726|583833776|FG003|Overall Study|Lost to Follow-up|3|||
161667014|NCT00261846|583833777|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
161667015|NCT00261846|583833778|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
161667016|NCT00261846|583833779|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
161667017|NCT00261846|583833780|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667018|NCT00261846|583833781|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667019|NCT00261846|583833782|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667020|NCT00261846|583833783|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667021|NCT00261846|583833784|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667022|NCT00261846|583833785|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667023|NCT00261846|583833786|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667024|NCT00261846|583833787|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667025|NCT00261846|583833788|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161667026|NCT00261846|583833777|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667027|NCT00261846|583833778|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667028|NCT00261846|583833779|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667029|NCT00261846|583833780|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
161667030|NCT00261846|583833781|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667031|NCT00261846|583833782|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667032|NCT00261846|583833783|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667033|NCT00261846|583833784|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667034|NCT00261846|583833785|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
161667035|NCT00261846|583833786|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667036|NCT00261846|583833787|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667037|NCT00261846|583833788|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161667038|NCT00261846|583833777|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161667039|NCT00261846|583833778|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161667040|NCT00261846|583833779|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161667041|NCT00261846|583833780|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
161667042|NCT00261846|583833781|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
161667043|NCT00261846|583833782|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
161667044|NCT00261846|583833783|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
161667045|NCT00261846|583833784|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
161667046|NCT00261846|583833785|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161667047|NCT00261846|583833786|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
161667048|NCT00261846|583833787|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161667049|NCT00261846|583833788|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161667050|NCT00261846|583833777|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161667051|NCT00261846|583833778|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161667052|NCT00261846|583833779|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161667053|NCT00261846|583833780|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
161667054|NCT00261846|583833781|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161667055|NCT00261846|583833782|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161667056|NCT00261846|583833783|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161667057|NCT00261846|583833784|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161667058|NCT00261846|583833785|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
161667059|NCT00261846|583833786|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161683054|NCT00666458|583891220|FG001|Overall Study|Safety reasons|0|||
161780119|NCT03193190|584237069|FG001|Stage 2|Lost to Follow-up|0|||
161780120|NCT03193190|584237070|FG002|Stage 2|Lost to Follow-up|0|||
161780121|NCT03193190|584237071|FG003|Stage 2|Lost to Follow-up|0|||
161780122|NCT03193190|584237072|FG004|Stage 2|Lost to Follow-up|0|||
161780123|NCT03193190|584237073|FG005|Stage 2|Lost to Follow-up|0|||
161780124|NCT03193190|584237074|FG006|Stage 2|Lost to Follow-up|0|||
161780125|NCT03193190|584237075|FG007|Stage 2|Lost to Follow-up|0|||
161780126|NCT03193190|584237076|FG008|Stage 2|Lost to Follow-up|0|||
161780127|NCT03193190|584237077|FG009|Stage 2|Lost to Follow-up|0|||
161780128|NCT03193190|584237078|FG010|Stage 2|Lost to Follow-up|0|||
161780129|NCT03193190|584237079|FG011|Stage 2|Lost to Follow-up|0|||
161780130|NCT03193190|584237080|FG012|Stage 2|Lost to Follow-up|0|||
161780131|NCT03193190|584237081|FG013|Stage 2|Lost to Follow-up|0|||
161780132|NCT03193190|584237082|FG014|Stage 2|Lost to Follow-up|1|||
161780133|NCT03193190|584237083|FG015|Stage 2|Lost to Follow-up|0|||
161780134|NCT03193190|584237068|FG000|Stage 2|Withdrawal by Subject|0|||
161780135|NCT03193190|584237069|FG001|Stage 2|Withdrawal by Subject|0|||
161780136|NCT03193190|584237070|FG002|Stage 2|Withdrawal by Subject|0|||
161780137|NCT03193190|584237071|FG003|Stage 2|Withdrawal by Subject|0|||
161780138|NCT03193190|584237072|FG004|Stage 2|Withdrawal by Subject|0|||
161780139|NCT03193190|584237073|FG005|Stage 2|Withdrawal by Subject|0|||
161780140|NCT03193190|584237074|FG006|Stage 2|Withdrawal by Subject|0|||
161780141|NCT03193190|584237075|FG007|Stage 2|Withdrawal by Subject|0|||
161780142|NCT03193190|584237076|FG008|Stage 2|Withdrawal by Subject|0|||
161780143|NCT03193190|584237077|FG009|Stage 2|Withdrawal by Subject|0|||
161780144|NCT03193190|584237078|FG010|Stage 2|Withdrawal by Subject|0|||
161780145|NCT03193190|584237079|FG011|Stage 2|Withdrawal by Subject|0|||
161780146|NCT03193190|584237080|FG012|Stage 2|Withdrawal by Subject|0|||
161780147|NCT03193190|584237081|FG013|Stage 2|Withdrawal by Subject|1|||
161780148|NCT03193190|584237082|FG014|Stage 2|Withdrawal by Subject|1|||
161780149|NCT03193190|584237083|FG015|Stage 2|Withdrawal by Subject|0|||
161780150|NCT03532295|584237084|FG000|Overall Study|Did not start treatment|0|||
161780151|NCT03532295|584237085|FG001|Overall Study|Did not start treatment|2|||
161780152|NCT05004181|584237089|FG000|Overall Study|Withdrawal of consent|0|||
161780153|NCT05004181|584237090|FG001|Overall Study|Withdrawal of consent|0|||
161780154|NCT05004181|584237091|FG002|Overall Study|Withdrawal of consent|1|||
161780155|NCT05004181|584237092|FG003|Overall Study|Withdrawal of consent|3|||
161780156|NCT05004181|584237093|FG004|Overall Study|Withdrawal of consent|3|||
161780157|NCT05004181|584237094|FG005|Overall Study|Withdrawal of consent|0|||
161780158|NCT05004181|584237095|FG006|Overall Study|Withdrawal of consent|30|||
161780159|NCT05004181|584237096|FG007|Overall Study|Withdrawal of consent|9|||
161780160|NCT05004181|584237097|FG008|Overall Study|Withdrawal of consent|3|||
161780161|NCT05004181|584237098|FG009|Overall Study|Withdrawal of consent|2|||
161780162|NCT05004181|584237099|FG010|Overall Study|Withdrawal of consent|5|||
161780163|NCT05004181|584237100|FG011|Overall Study|Withdrawal of consent|1|||
161780164|NCT05004181|584237089|FG000|Overall Study|Lost to Follow-up|2|||
161780165|NCT05004181|584237090|FG001|Overall Study|Lost to Follow-up|4|||
161780166|NCT05004181|584237091|FG002|Overall Study|Lost to Follow-up|2|||
161780167|NCT05004181|584237092|FG003|Overall Study|Lost to Follow-up|3|||
161780168|NCT05004181|584237093|FG004|Overall Study|Lost to Follow-up|5|||
161780169|NCT05004181|584237094|FG005|Overall Study|Lost to Follow-up|2|||
161780170|NCT05004181|584237095|FG006|Overall Study|Lost to Follow-up|15|||
161780171|NCT05004181|584237096|FG007|Overall Study|Lost to Follow-up|12|||
161780172|NCT05004181|584237097|FG008|Overall Study|Lost to Follow-up|38|||
161780173|NCT05004181|584237098|FG009|Overall Study|Lost to Follow-up|6|||
161780174|NCT05004181|584237099|FG010|Overall Study|Lost to Follow-up|6|||
161780175|NCT05004181|584237100|FG011|Overall Study|Lost to Follow-up|0|||
161780176|NCT05004181|584237089|FG000|Overall Study|Death|0|||
161780177|NCT05004181|584237090|FG001|Overall Study|Death|0|||
161780178|NCT05004181|584237091|FG002|Overall Study|Death|0|||
161895334|NCT03117361|584666298|FG000|Overall Study|Death|1|||
161780179|NCT05004181|584237092|FG003|Overall Study|Death|0|||
161780180|NCT05004181|584237093|FG004|Overall Study|Death|0|||
161780181|NCT05004181|584237094|FG005|Overall Study|Death|0|||
161780182|NCT05004181|584237095|FG006|Overall Study|Death|1|||
161780183|NCT05004181|584237096|FG007|Overall Study|Death|0|||
161780184|NCT05004181|584237097|FG008|Overall Study|Death|2|||
161780185|NCT05004181|584237098|FG009|Overall Study|Death|0|||
161780186|NCT05004181|584237099|FG010|Overall Study|Death|0|||
161780187|NCT05004181|584237100|FG011|Overall Study|Death|0|||
161895335|NCT03117361|584666298|FG000|Overall Study|Physician Decision|2|||
161780188|NCT05004181|584237089|FG000|Overall Study|Physician Decision|0|||
161780189|NCT05004181|584237090|FG001|Overall Study|Physician Decision|0|||
161780190|NCT05004181|584237091|FG002|Overall Study|Physician Decision|0|||
161780191|NCT05004181|584237092|FG003|Overall Study|Physician Decision|0|||
161780192|NCT05004181|584237093|FG004|Overall Study|Physician Decision|0|||
161780193|NCT05004181|584237094|FG005|Overall Study|Physician Decision|0|||
161780194|NCT05004181|584237095|FG006|Overall Study|Physician Decision|2|||
161780195|NCT05004181|584237096|FG007|Overall Study|Physician Decision|0|||
161780196|NCT05004181|584237097|FG008|Overall Study|Physician Decision|7|||
161780197|NCT05004181|584237098|FG009|Overall Study|Physician Decision|0|||
161780198|NCT05004181|584237099|FG010|Overall Study|Physician Decision|0|||
161667060|NCT00261846|583833787|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161667061|NCT00261846|583833788|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161667062|NCT00261846|583833777|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
161667063|NCT00261846|583833778|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
161667064|NCT00261846|583833779|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
161667065|NCT00261846|583833780|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
161667066|NCT00261846|583833781|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
161667067|NCT00261846|583833782|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
161667068|NCT00261846|583833783|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
161667069|NCT00261846|583833784|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
161667070|NCT00261846|583833785|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
161667071|NCT00261846|583833786|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
161667072|NCT00261846|583833787|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
161667073|NCT00261846|583833788|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
161667074|NCT00261846|583833777|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
161667075|NCT00261846|583833778|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
161667076|NCT00261846|583833779|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
161667077|NCT00261846|583833780|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
161667078|NCT00261846|583833781|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
161667079|NCT00261846|583833782|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
161667080|NCT00261846|583833783|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
161667081|NCT00261846|583833784|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
161667082|NCT00261846|583833785|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
161667083|NCT00261846|583833786|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
161667084|NCT00261846|583833787|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
161667085|NCT00261846|583833788|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
161667086|NCT00261846|583833777|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
161667087|NCT00261846|583833778|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
161667088|NCT00261846|583833779|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
161667089|NCT00261846|583833780|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
161667090|NCT00261846|583833781|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
161667091|NCT00261846|583833782|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
161667092|NCT00261846|583833783|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
161667093|NCT00261846|583833784|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
161667094|NCT00261846|583833785|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
161667095|NCT00261846|583833786|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
161667096|NCT00261846|583833787|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
161667097|NCT00261846|583833788|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
161667098|NCT01745848|583833793|FG000|Overall Study|Adverse Event|6|||
161667099|NCT00926211|583833801|FG000|Overall Study|Lost to Follow-up|1|||
161667100|NCT00585195|583833804|FG000|Overall Study|Adverse Event|0|||
161667101|NCT00585195|583833805|FG001|Overall Study|Adverse Event|0|||
161667102|NCT00585195|583833806|FG002|Overall Study|Adverse Event|0|||
161667103|NCT00585195|583833807|FG003|Overall Study|Adverse Event|0|||
161667104|NCT00585195|583833808|FG004|Overall Study|Adverse Event|2|||
161667105|NCT00585195|583833809|FG005|Overall Study|Adverse Event|1|||
161667106|NCT00585195|583833810|FG006|Overall Study|Adverse Event|0|||
161667107|NCT00585195|583833811|FG007|Overall Study|Adverse Event|1|||
161667108|NCT00585195|583833812|FG008|Overall Study|Adverse Event|0|||
161667109|NCT00585195|583833813|FG009|Overall Study|Adverse Event|0|||
161667110|NCT00585195|583833814|FG010|Overall Study|Adverse Event|3|||
161667111|NCT00585195|583833815|FG011|Overall Study|Adverse Event|0|||
161667112|NCT00585195|583833816|FG012|Overall Study|Adverse Event|8|||
161667113|NCT00585195|583833817|FG013|Overall Study|Adverse Event|6|||
161667114|NCT00585195|583833818|FG014|Overall Study|Adverse Event|4|||
161667115|NCT00585195|583833819|FG015|Overall Study|Adverse Event|1|||
161667116|NCT00585195|583833820|FG016|Overall Study|Adverse Event|14|||
161667117|NCT00585195|583833821|FG017|Overall Study|Adverse Event|9|||
161667118|NCT00585195|583833822|FG018|Overall Study|Adverse Event|2|||
161667119|NCT00585195|583833823|FG019|Overall Study|Adverse Event|3|||
161667120|NCT00585195|583833824|FG020|Overall Study|Adverse Event|1|||
161780199|NCT05004181|584237100|FG011|Overall Study|Physician Decision|0|||
161667121|NCT00585195|583833804|FG000|Overall Study|Progressive Disease|2|||
161667122|NCT00585195|583833805|FG001|Overall Study|Progressive Disease|2|||
161780200|NCT05004181|584237089|FG000|Overall Study|Withdrawal by Subject|2|||
161667123|NCT00585195|583833806|FG002|Overall Study|Progressive Disease|5|||
161667124|NCT00585195|583833807|FG003|Overall Study|Progressive Disease|4|||
161667125|NCT00585195|583833808|FG004|Overall Study|Progressive Disease|6|||
161667126|NCT00585195|583833809|FG005|Overall Study|Progressive Disease|4|||
161667127|NCT00585195|583833810|FG006|Overall Study|Progressive Disease|6|||
161667128|NCT00585195|583833811|FG007|Overall Study|Progressive Disease|3|||
161667129|NCT00585195|583833812|FG008|Overall Study|Progressive Disease|0|||
161667130|NCT00585195|583833813|FG009|Overall Study|Progressive Disease|5|||
161667131|NCT00585195|583833814|FG010|Overall Study|Progressive Disease|2|||
161667132|NCT00585195|583833815|FG011|Overall Study|Progressive Disease|25|||
161667133|NCT00585195|583833816|FG012|Overall Study|Progressive Disease|29|||
161667134|NCT00585195|583833817|FG013|Overall Study|Progressive Disease|26|||
161667135|NCT00585195|583833818|FG014|Overall Study|Progressive Disease|21|||
161667136|NCT00585195|583833819|FG015|Overall Study|Progressive Disease|12|||
161780201|NCT05004181|584237090|FG001|Overall Study|Withdrawal by Subject|3|||
161780202|NCT05004181|584237091|FG002|Overall Study|Withdrawal by Subject|2|||
161780203|NCT05004181|584237092|FG003|Overall Study|Withdrawal by Subject|2|||
161780204|NCT05004181|584237093|FG004|Overall Study|Withdrawal by Subject|4|||
161780205|NCT05004181|584237094|FG005|Overall Study|Withdrawal by Subject|2|||
161780206|NCT05004181|584237095|FG006|Overall Study|Withdrawal by Subject|4|||
161780207|NCT05004181|584237096|FG007|Overall Study|Withdrawal by Subject|22|||
161780208|NCT05004181|584237097|FG008|Overall Study|Withdrawal by Subject|8|||
161780209|NCT05004181|584237098|FG009|Overall Study|Withdrawal by Subject|1|||
161780210|NCT05004181|584237099|FG010|Overall Study|Withdrawal by Subject|3|||
161780211|NCT05004181|584237100|FG011|Overall Study|Withdrawal by Subject|2|||
161780212|NCT05004181|584237089|FG000|Overall Study|Protocol Violation|2|||
161780213|NCT05004181|584237090|FG001|Overall Study|Protocol Violation|3|||
161780214|NCT05004181|584237091|FG002|Overall Study|Protocol Violation|0|||
161780215|NCT05004181|584237092|FG003|Overall Study|Protocol Violation|0|||
161780216|NCT05004181|584237093|FG004|Overall Study|Protocol Violation|1|||
161780217|NCT05004181|584237094|FG005|Overall Study|Protocol Violation|0|||
161780218|NCT05004181|584237095|FG006|Overall Study|Protocol Violation|16|||
161780219|NCT05004181|584237096|FG007|Overall Study|Protocol Violation|18|||
161780220|NCT05004181|584237097|FG008|Overall Study|Protocol Violation|2|||
161780221|NCT05004181|584237098|FG009|Overall Study|Protocol Violation|2|||
161780222|NCT05004181|584237099|FG010|Overall Study|Protocol Violation|2|||
161780223|NCT05004181|584237100|FG011|Overall Study|Protocol Violation|1|||
161895336|NCT03117361|584666298|FG000|Overall Study|On study treatment at the end of study|1|||
161895337|NCT03117361|584666298|FG000|Overall Study|Treatment-related adverse event|1|||
161895338|NCT02072941|584666299|FG000|Overall Study|Withdrawal by Subject|29|||
161895339|NCT02072941|584666300|FG001|Overall Study|Withdrawal by Subject|21|||
161895340|NCT02072941|584666299|FG000|Overall Study|Lost to Follow-up|4|||
161895341|NCT02072941|584666300|FG001|Overall Study|Lost to Follow-up|4|||
161895342|NCT02072941|584666299|FG000|Overall Study|Death|3|||
161895343|NCT02072941|584666300|FG001|Overall Study|Death|2|||
161895344|NCT02072941|584666299|FG000|Overall Study|Removed by Study Staff|2|||
161895345|NCT02072941|584666300|FG001|Overall Study|Removed by Study Staff|2|||
161895346|NCT01247350|584666303|FG000|Overall Study|Adverse Event|0|||
161895347|NCT01247350|584666304|FG001|Overall Study|Adverse Event|0|||
161895348|NCT01247350|584666305|FG002|Overall Study|Adverse Event|1|||
161895349|NCT01247350|584666306|FG003|Overall Study|Adverse Event|0|||
161895350|NCT01247350|584666307|FG004|Overall Study|Adverse Event|0|||
161895351|NCT01247350|584666303|FG000|Overall Study|Withdrawal by Subject|0|||
161895352|NCT01247350|584666304|FG001|Overall Study|Withdrawal by Subject|0|||
161895353|NCT01247350|584666305|FG002|Overall Study|Withdrawal by Subject|0|||
161895354|NCT01247350|584666306|FG003|Overall Study|Withdrawal by Subject|1|||
161895355|NCT01247350|584666307|FG004|Overall Study|Withdrawal by Subject|0|||
161895356|NCT01247350|584666303|FG000|Overall Study|Entry criteria not met|0|||
161895357|NCT01247350|584666304|FG001|Overall Study|Entry criteria not met|0|||
161895358|NCT01247350|584666305|FG002|Overall Study|Entry criteria not met|0|||
161895359|NCT01247350|584666306|FG003|Overall Study|Entry criteria not met|0|||
161895360|NCT01247350|584666307|FG004|Overall Study|Entry criteria not met|1|||
161895361|NCT00169104|584666308|FG000|Overall Study|Withdrawal by Subject|2|||
161895362|NCT00169104|584666309|FG001|Overall Study|Withdrawal by Subject|0|||
161895363|NCT00169104|584666308|FG000|Overall Study|Protocol Violation|0|||
161895364|NCT00169104|584666309|FG001|Overall Study|Protocol Violation|1|||
161895365|NCT00169104|584666308|FG000|Overall Study|Physician Decision|0|||
161895366|NCT00169104|584666309|FG001|Overall Study|Physician Decision|1|||
161895367|NCT00715299|584666315|FG000|Overall Study|Withdrawal by Subject|1|||
161895368|NCT00715299|584666315|FG000|Overall Study|Adverse Event|3|||
161895369|NCT00715299|584666315|FG000|Overall Study|failed the pre-screen exercise test|2|||
161895370|NCT02020889|584666316|FG000|Overall Study|Adverse Event|0|||
161895371|NCT02020889|584666317|FG001|Overall Study|Adverse Event|1|||
161895372|NCT02020889|584666316|FG000|Overall Study|Lack of Efficacy|1|||
161895373|NCT02020889|584666317|FG001|Overall Study|Lack of Efficacy|0|||
161895374|NCT02020889|584666316|FG000|Overall Study|Lost to Follow-up|1|||
161895375|NCT02020889|584666317|FG001|Overall Study|Lost to Follow-up|0|||
161895376|NCT02020889|584666316|FG000|Overall Study|Physician Decision|2|||
161895377|NCT02020889|584666317|FG001|Overall Study|Physician Decision|0|||
161895378|NCT02020889|584666316|FG000|Overall Study|Withdrawal by Subject|3|||
161895379|NCT02020889|584666317|FG001|Overall Study|Withdrawal by Subject|2|||
161895380|NCT01540981|584666318|FG000|Overall Study|Withdrawal by Subject|1|||
161895381|NCT01540981|584666319|FG001|Overall Study|Withdrawal by Subject|0|||
161895382|NCT00809094|584666320|FG000|Overall Study|Lost to Follow-up|0|||
161895383|NCT00809094|584666321|FG001|Overall Study|Lost to Follow-up|1|||
161895384|NCT00232557|584666322|FG000|Overall Study|Lost to Follow-up|3|||
161780224|NCT05004181|584237089|FG000|Overall Study|Not further specified|1|||
161895385|NCT00232557|584666323|FG001|Overall Study|Lost to Follow-up|5|||
161895386|NCT02457195|584666328|FG000|Overall Study|Adverse Event|3|||
161780225|NCT05004181|584237090|FG001|Overall Study|Not further specified|0|||
161780226|NCT05004181|584237091|FG002|Overall Study|Not further specified|0|||
161780227|NCT05004181|584237092|FG003|Overall Study|Not further specified|0|||
161667137|NCT00585195|583833820|FG016|Overall Study|Progressive Disease|94|||
161667138|NCT00585195|583833821|FG017|Overall Study|Progressive Disease|42|||
161667139|NCT00585195|583833822|FG018|Overall Study|Progressive Disease|4|||
161667140|NCT00585195|583833823|FG019|Overall Study|Progressive Disease|9|||
161667141|NCT00585195|583833824|FG020|Overall Study|Progressive Disease|8|||
161667142|NCT00585195|583833804|FG000|Overall Study|Withdrawal by Subject|1|||
161667143|NCT00585195|583833805|FG001|Overall Study|Withdrawal by Subject|1|||
161667144|NCT00585195|583833806|FG002|Overall Study|Withdrawal by Subject|2|||
161667145|NCT00585195|583833807|FG003|Overall Study|Withdrawal by Subject|2|||
161667146|NCT00585195|583833808|FG004|Overall Study|Withdrawal by Subject|0|||
161667147|NCT00585195|583833809|FG005|Overall Study|Withdrawal by Subject|0|||
161667148|NCT00585195|583833810|FG006|Overall Study|Withdrawal by Subject|0|||
161667149|NCT00585195|583833811|FG007|Overall Study|Withdrawal by Subject|1|||
161667150|NCT00585195|583833812|FG008|Overall Study|Withdrawal by Subject|0|||
161667151|NCT00585195|583833813|FG009|Overall Study|Withdrawal by Subject|0|||
161667152|NCT00585195|583833814|FG010|Overall Study|Withdrawal by Subject|3|||
161667153|NCT00585195|583833815|FG011|Overall Study|Withdrawal by Subject|8|||
161667154|NCT00585195|583833816|FG012|Overall Study|Withdrawal by Subject|15|||
161667155|NCT00585195|583833817|FG013|Overall Study|Withdrawal by Subject|0|||
161667156|NCT00585195|583833818|FG014|Overall Study|Withdrawal by Subject|3|||
161667157|NCT00585195|583833819|FG015|Overall Study|Withdrawal by Subject|0|||
161667158|NCT00585195|583833820|FG016|Overall Study|Withdrawal by Subject|7|||
161667159|NCT00585195|583833821|FG017|Overall Study|Withdrawal by Subject|1|||
161667160|NCT00585195|583833822|FG018|Overall Study|Withdrawal by Subject|2|||
161667161|NCT00585195|583833823|FG019|Overall Study|Withdrawal by Subject|2|||
161667162|NCT00585195|583833824|FG020|Overall Study|Withdrawal by Subject|0|||
161667163|NCT00585195|583833804|FG000|Overall Study|Other|0|||
161667164|NCT00585195|583833805|FG001|Overall Study|Other|1|||
161667165|NCT00585195|583833806|FG002|Overall Study|Other|1|||
161667166|NCT00585195|583833807|FG003|Overall Study|Other|1|||
161667167|NCT00585195|583833808|FG004|Overall Study|Other|0|||
161667168|NCT00585195|583833809|FG005|Overall Study|Other|1|||
161667169|NCT00585195|583833810|FG006|Overall Study|Other|0|||
161667170|NCT00585195|583833811|FG007|Overall Study|Other|0|||
161667171|NCT00585195|583833812|FG008|Overall Study|Other|2|||
161667172|NCT00585195|583833813|FG009|Overall Study|Other|1|||
161667173|NCT00585195|583833814|FG010|Overall Study|Other|0|||
161667174|NCT00585195|583833815|FG011|Overall Study|Other|19|||
161667175|NCT00585195|583833816|FG012|Overall Study|Other|24|||
161667176|NCT00585195|583833817|FG013|Overall Study|Other|7|||
161667177|NCT00585195|583833818|FG014|Overall Study|Other|11|||
161667178|NCT00585195|583833819|FG015|Overall Study|Other|3|||
161667179|NCT00585195|583833820|FG016|Overall Study|Other|28|||
161667180|NCT00585195|583833821|FG017|Overall Study|Other|12|||
161667181|NCT00585195|583833822|FG018|Overall Study|Other|10|||
161667182|NCT00585195|583833823|FG019|Overall Study|Other|4|||
161780228|NCT05004181|584237093|FG004|Overall Study|Not further specified|0|||
161667183|NCT00585195|583833824|FG020|Overall Study|Other|2|||
161667184|NCT00585195|583833804|FG000|Overall Study|Randomized not treated|0|||
161667185|NCT00585195|583833805|FG001|Overall Study|Randomized not treated|0|||
161667186|NCT00585195|583833806|FG002|Overall Study|Randomized not treated|1|||
161667187|NCT00585195|583833807|FG003|Overall Study|Randomized not treated|0|||
161667188|NCT00585195|583833808|FG004|Overall Study|Randomized not treated|1|||
161667189|NCT00585195|583833809|FG005|Overall Study|Randomized not treated|0|||
161667190|NCT00585195|583833810|FG006|Overall Study|Randomized not treated|1|||
161667191|NCT00585195|583833811|FG007|Overall Study|Randomized not treated|0|||
161667192|NCT00585195|583833812|FG008|Overall Study|Randomized not treated|0|||
161667193|NCT00585195|583833813|FG009|Overall Study|Randomized not treated|0|||
161667194|NCT00585195|583833814|FG010|Overall Study|Randomized not treated|2|||
161667195|NCT00585195|583833815|FG011|Overall Study|Randomized not treated|0|||
161667196|NCT00585195|583833816|FG012|Overall Study|Randomized not treated|0|||
161667197|NCT00585195|583833817|FG013|Overall Study|Randomized not treated|0|||
161667198|NCT00585195|583833818|FG014|Overall Study|Randomized not treated|0|||
161667199|NCT00585195|583833819|FG015|Overall Study|Randomized not treated|1|||
161667200|NCT00585195|583833820|FG016|Overall Study|Randomized not treated|0|||
161667201|NCT00585195|583833821|FG017|Overall Study|Randomized not treated|1|||
161667202|NCT00585195|583833822|FG018|Overall Study|Randomized not treated|3|||
161667203|NCT00585195|583833823|FG019|Overall Study|Randomized not treated|0|||
161667204|NCT00585195|583833824|FG020|Overall Study|Randomized not treated|2|||
161667205|NCT00585195|583833804|FG000|Overall Study|Death|0|||
161667206|NCT00585195|583833805|FG001|Overall Study|Death|0|||
161667207|NCT00585195|583833806|FG002|Overall Study|Death|0|||
161667208|NCT00585195|583833807|FG003|Overall Study|Death|0|||
161667209|NCT00585195|583833808|FG004|Overall Study|Death|0|||
161667210|NCT00585195|583833809|FG005|Overall Study|Death|0|||
161667211|NCT00585195|583833810|FG006|Overall Study|Death|0|||
161667212|NCT00585195|583833811|FG007|Overall Study|Death|0|||
161667213|NCT00585195|583833812|FG008|Overall Study|Death|1|||
161667214|NCT00585195|583833813|FG009|Overall Study|Death|0|||
161667215|NCT00585195|583833814|FG010|Overall Study|Death|1|||
161780229|NCT05004181|584237094|FG005|Overall Study|Not further specified|0|||
161780230|NCT05004181|584237095|FG006|Overall Study|Not further specified|1|||
161780231|NCT05004181|584237096|FG007|Overall Study|Not further specified|0|||
161780232|NCT05004181|584237097|FG008|Overall Study|Not further specified|2|||
161780233|NCT05004181|584237098|FG009|Overall Study|Not further specified|1|||
161780234|NCT05004181|584237099|FG010|Overall Study|Not further specified|0|||
161780235|NCT05004181|584237100|FG011|Overall Study|Not further specified|1|||
161780236|NCT03868059|584237102|FG000|Overall Study|Adverse Event|3|||
161780237|NCT03868059|584237102|FG000|Overall Study|Lost to Follow-up|3|||
161780238|NCT03868059|584237102|FG000|Overall Study|Withdrawal by Subject|6|||
161780239|NCT04278872|584237103|FG000|Overall Study|Adverse Event|1|||
161780240|NCT04278872|584237104|FG001|Overall Study|Adverse Event|0|||
161780241|NCT04278872|584237103|FG000|Overall Study|Protocol Violation|0|||
161780242|NCT04278872|584237104|FG001|Overall Study|Protocol Violation|1|||
161780243|NCT04278872|584237103|FG000|Overall Study|Study Termination|2|||
161780244|NCT04278872|584237104|FG001|Overall Study|Study Termination|0|||
161780245|NCT01211613|584238454|FG000|Overall Study|Lost to Follow-up|2|||
161780246|NCT01211613|584238455|FG001|Overall Study|Lost to Follow-up|2|||
161780247|NCT01211613|584238456|FG002|Overall Study|Lost to Follow-up|2|||
161780248|NCT01211613|584238454|FG000|Overall Study|Withdrawal by Subject|1|||
161780249|NCT01211613|584238455|FG001|Overall Study|Withdrawal by Subject|0|||
161780250|NCT01211613|584238456|FG002|Overall Study|Withdrawal by Subject|0|||
161780251|NCT03853213|584238457|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
161780252|NCT03853213|584238458|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
161780253|NCT03853213|584238457|FG000|Overall Study|Other (e.g., too busy)|0|||
161780254|NCT03853213|584238458|FG001|Overall Study|Other (e.g., too busy)|2|||
161780255|NCT02239692|584238459|FG000|Overall Study|Incomplete colonoscopy|1|||
161780256|NCT02239692|584238460|FG001|Overall Study|Incomplete colonoscopy|2|||
161780257|NCT02239692|584238459|FG000|Overall Study|Adverse Event|0|||
161780258|NCT02239692|584238460|FG001|Overall Study|Adverse Event|1|||
161780259|NCT02239692|584238459|FG000|Overall Study|Physician Decision|0|||
161780260|NCT02239692|584238460|FG001|Overall Study|Physician Decision|1|||
161780261|NCT02239692|584238459|FG000|Overall Study|Lost to Follow-up|1|||
161780262|NCT02239692|584238460|FG001|Overall Study|Lost to Follow-up|4|||
161780263|NCT02239692|584238459|FG000|Overall Study|Withdrawal by Subject|3|||
161780264|NCT02239692|584238460|FG001|Overall Study|Withdrawal by Subject|5|||
161780265|NCT02239692|584238459|FG000|Overall Study|Other reason|1|||
161780266|NCT02239692|584238460|FG001|Overall Study|Other reason|0|||
161780267|NCT01901146|584238461|FG000|Neoadjuvant Phase|Death|1|||
161780268|NCT01901146|584238462|FG001|Neoadjuvant Phase|Death|2|||
161780269|NCT01901146|584238463|FG002|Neoadjuvant Phase|Death|0|||
161780270|NCT01901146|584238464|FG003|Neoadjuvant Phase|Death|0|||
161780271|NCT01901146|584238465|FG004|Neoadjuvant Phase|Death|0|||
161780272|NCT01901146|584238461|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
161780273|NCT01901146|584238462|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
161780274|NCT01901146|584238463|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161780275|NCT01901146|584238464|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161780276|NCT01901146|584238465|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161780277|NCT01901146|584238461|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
161780278|NCT01901146|584238462|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161780279|NCT01901146|584238463|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
161780280|NCT01901146|584238464|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161780281|NCT01901146|584238465|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161780282|NCT01901146|584238461|FG000|Neoadjuvant Phase|Physician Decision|1|||
161780283|NCT01901146|584238462|FG001|Neoadjuvant Phase|Physician Decision|2|||
161780284|NCT01901146|584238463|FG002|Neoadjuvant Phase|Physician Decision|0|||
161780285|NCT01901146|584238464|FG003|Neoadjuvant Phase|Physician Decision|0|||
161780286|NCT01901146|584238465|FG004|Neoadjuvant Phase|Physician Decision|0|||
161780287|NCT01901146|584238461|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
161780288|NCT01901146|584238462|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
161780289|NCT01901146|584238463|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161780290|NCT01901146|584238464|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161780291|NCT01901146|584238465|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161780292|NCT01901146|584238461|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780293|NCT01901146|584238462|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
161780294|NCT01901146|584238463|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780295|NCT01901146|584238464|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780296|NCT01901146|584238465|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780297|NCT01901146|584238461|FG000|Adjuvant Phase|Other|0|||
161895387|NCT02457195|584666328|FG000|Overall Study|Protocol Violation|2|||
161780298|NCT01901146|584238462|FG001|Adjuvant Phase|Other|0|||
161780299|NCT01901146|584238463|FG002|Adjuvant Phase|Other|1|||
161780300|NCT01901146|584238464|FG003|Adjuvant Phase|Other|0|||
161780301|NCT01901146|584238465|FG004|Adjuvant Phase|Other|0|||
161780302|NCT01901146|584238461|FG000|Adjuvant Phase|Death|0|||
161780303|NCT01901146|584238462|FG001|Adjuvant Phase|Death|0|||
161780304|NCT01901146|584238463|FG002|Adjuvant Phase|Death|0|||
161780305|NCT01901146|584238464|FG003|Adjuvant Phase|Death|0|||
161780306|NCT01901146|584238465|FG004|Adjuvant Phase|Death|3|||
161780307|NCT01901146|584238461|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
161780308|NCT01901146|584238462|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
161780309|NCT01901146|584238463|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
161780310|NCT01901146|584238464|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
161780311|NCT01901146|584238465|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
161780312|NCT01901146|584238461|FG000|Adjuvant Phase|Physician Decision|0|||
161780313|NCT01901146|584238462|FG001|Adjuvant Phase|Physician Decision|0|||
161780314|NCT01901146|584238463|FG002|Adjuvant Phase|Physician Decision|9|||
161780315|NCT01901146|584238464|FG003|Adjuvant Phase|Physician Decision|2|||
161780316|NCT01901146|584238465|FG004|Adjuvant Phase|Physician Decision|4|||
161780317|NCT01901146|584238461|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
161780318|NCT01901146|584238462|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
161780319|NCT01901146|584238463|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
161780320|NCT01901146|584238464|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
161780321|NCT01901146|584238465|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
161780322|NCT00297492|584238466|FG000|Set Quit Date|Lost to Follow-up|7|||
161780323|NCT00297492|584238467|FG001|Set Quit Date|Lost to Follow-up|13|||
161780324|NCT00297492|584238468|FG002|Set Quit Date|Lost to Follow-up|5|||
161780325|NCT00297492|584238466|FG000|6 Month Follow-up|Lost to Follow-up|63|||
161780326|NCT00297492|584238467|FG001|6 Month Follow-up|Lost to Follow-up|49|||
161780327|NCT00297492|584238468|FG002|6 Month Follow-up|Lost to Follow-up|27|||
161780328|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
161780329|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
161780330|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
161780331|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
161780332|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
161780333|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
161780334|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
161780335|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
161780336|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
161780337|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
161780338|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
161780339|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
161780340|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Other|2|||
161780341|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Other|1|||
161780342|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Other|0|||
161780343|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Other|2|||
161780344|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
161780345|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
161780346|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
161780347|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
161780348|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
161780349|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
161780350|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
161780351|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
161780352|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
161780353|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
161780354|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
161780355|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
161780356|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
161780357|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
161780358|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
161780359|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
161780360|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
161780361|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
161780362|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
161780363|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
161780364|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Other|8|||
161780365|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Other|12|||
161780366|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Other|23|||
161780367|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Other|15|||
161780368|NCT01784419|584238475|FG000|Overall Study|Adverse Event|3|||
161780369|NCT02237118|584238476|FG000|Overall Study|Protocol Violation|0|||
161780370|NCT02237118|584238477|FG001|Overall Study|Protocol Violation|1|||
161780371|NCT02237118|584238476|FG000|Overall Study|consent withdrawn|1|||
161780372|NCT02237118|584238477|FG001|Overall Study|consent withdrawn|0|||
161780373|NCT00080288|584238478|FG000|Overall Study|Adverse Event|7|||
161780374|NCT00080288|584238479|FG001|Overall Study|Adverse Event|4|||
161780375|NCT00080288|584238478|FG000|Overall Study|Lost to Follow-up|3|||
161780376|NCT00080288|584238479|FG001|Overall Study|Lost to Follow-up|5|||
161780377|NCT00080288|584238478|FG000|Overall Study|Physician Decision|6|||
161780378|NCT00080288|584238479|FG001|Overall Study|Physician Decision|2|||
161780379|NCT00080288|584238478|FG000|Overall Study|Withdrawal by Subject|3|||
161780380|NCT00080288|584238479|FG001|Overall Study|Withdrawal by Subject|16|||
161780381|NCT00080288|584238478|FG000|Overall Study|Miscellaneous|11|||
161780382|NCT00080288|584238479|FG001|Overall Study|Miscellaneous|11|||
161780383|NCT00569231|584238480|FG000|Overall Study|Study unrelated surgery|1|||
161780384|NCT00569231|584238480|FG000|Overall Study|Airfare expense|2|||
161780385|NCT00569231|584238480|FG000|Overall Study|Withdrawal by Subject|1|||
161780386|NCT00569231|584238480|FG000|Overall Study|Car accident injury|1|||
161667216|NCT00585195|583833815|FG011|Overall Study|Death|1|||
161667217|NCT00585195|583833816|FG012|Overall Study|Death|7|||
161667218|NCT00585195|583833817|FG013|Overall Study|Death|2|||
161667219|NCT00585195|583833818|FG014|Overall Study|Death|8|||
161667220|NCT00585195|583833819|FG015|Overall Study|Death|2|||
161667221|NCT00585195|583833820|FG016|Overall Study|Death|11|||
161667222|NCT00585195|583833821|FG017|Overall Study|Death|0|||
161780387|NCT00569231|584238480|FG000|Overall Study|Non-compliance|2|||
161780388|NCT03456726|584238481|FG000|Overall Study|Disease Progression|6|||
161780389|NCT03456726|584238482|FG001|Overall Study|Disease Progression|1|||
161780390|NCT03456726|584238481|FG000|Overall Study|Adverse Event|4|||
161780391|NCT03456726|584238482|FG001|Overall Study|Adverse Event|2|||
161780392|NCT03456726|584238481|FG000|Overall Study|Withdrawal by Subject|1|||
161780393|NCT03456726|584238482|FG001|Overall Study|Withdrawal by Subject|0|||
161780394|NCT03456726|584238481|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
161780395|NCT03456726|584238482|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
161780396|NCT04470622|584238483|FG000|Overall Study|Withdrawal by Subject|0|||
161780397|NCT04470622|584238484|FG001|Overall Study|Withdrawal by Subject|1|||
161780398|NCT04470622|584238483|FG000|Overall Study|Screen Failure|0|||
161780399|NCT04470622|584238484|FG001|Overall Study|Screen Failure|1|||
161780400|NCT04470622|584238483|FG000|Overall Study|Death|0|||
161780401|NCT04470622|584238484|FG001|Overall Study|Death|1|||
161780402|NCT03978117|584238487|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
161780403|NCT03978117|584238488|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
161780404|NCT03978117|584238487|FG000|Overall Study|Lost to Follow-up|4|||
161780405|NCT03978117|584238488|FG001|Overall Study|Lost to Follow-up|4|||
161780406|NCT00791154|584238489|FG000|Overall Study|Noncompliance|0|||
161780407|NCT00791154|584238490|FG001|Overall Study|Noncompliance|1|||
161780408|NCT00791154|584238491|FG002|Overall Study|Noncompliance|0|||
161780409|NCT00791154|584238492|FG003|Overall Study|Noncompliance|0|||
161780410|NCT00791154|584238493|FG004|Overall Study|Noncompliance|1|||
161780411|NCT00791154|584238494|FG005|Overall Study|Noncompliance|1|||
161780412|NCT00791154|584238495|FG006|Overall Study|Noncompliance|1|||
161780413|NCT00791154|584238489|FG000|Overall Study|Adverse Event|0|||
161780414|NCT00791154|584238490|FG001|Overall Study|Adverse Event|0|||
161780415|NCT00791154|584238491|FG002|Overall Study|Adverse Event|0|||
161780416|NCT00791154|584238492|FG003|Overall Study|Adverse Event|0|||
161780417|NCT00791154|584238493|FG004|Overall Study|Adverse Event|2|||
161780418|NCT00791154|584238494|FG005|Overall Study|Adverse Event|0|||
161780419|NCT00791154|584238495|FG006|Overall Study|Adverse Event|1|||
161780420|NCT00791154|584238489|FG000|Overall Study|Full Consent withdrawn|1|||
161780421|NCT00791154|584238490|FG001|Overall Study|Full Consent withdrawn|3|||
161780422|NCT00791154|584238491|FG002|Overall Study|Full Consent withdrawn|0|||
161780423|NCT00791154|584238492|FG003|Overall Study|Full Consent withdrawn|0|||
161780424|NCT00791154|584238493|FG004|Overall Study|Full Consent withdrawn|1|||
161780425|NCT00791154|584238494|FG005|Overall Study|Full Consent withdrawn|3|||
161780426|NCT00791154|584238495|FG006|Overall Study|Full Consent withdrawn|1|||
161780427|NCT00791154|584238489|FG000|Overall Study|Lost to Follow-up|0|||
161780428|NCT00791154|584238490|FG001|Overall Study|Lost to Follow-up|0|||
161780429|NCT00791154|584238491|FG002|Overall Study|Lost to Follow-up|0|||
161780430|NCT00791154|584238492|FG003|Overall Study|Lost to Follow-up|1|||
161780431|NCT00791154|584238493|FG004|Overall Study|Lost to Follow-up|2|||
161780432|NCT00791154|584238494|FG005|Overall Study|Lost to Follow-up|0|||
161780433|NCT00791154|584238495|FG006|Overall Study|Lost to Follow-up|4|||
161780434|NCT00791154|584238489|FG000|Overall Study|Death|5|||
161780435|NCT00791154|584238490|FG001|Overall Study|Death|4|||
161780436|NCT00791154|584238491|FG002|Overall Study|Death|4|||
161780437|NCT00791154|584238492|FG003|Overall Study|Death|7|||
161780438|NCT00791154|584238493|FG004|Overall Study|Death|54|||
161780439|NCT00791154|584238494|FG005|Overall Study|Death|54|||
161780440|NCT00791154|584238495|FG006|Overall Study|Death|52|||
161780441|NCT00791154|584238489|FG000|Overall Study|Other event|0|||
161780442|NCT00791154|584238490|FG001|Overall Study|Other event|0|||
161780443|NCT00791154|584238491|FG002|Overall Study|Other event|2|||
161780444|NCT00791154|584238492|FG003|Overall Study|Other event|0|||
161780445|NCT00791154|584238493|FG004|Overall Study|Other event|2|||
161667223|NCT00585195|583833822|FG018|Overall Study|Death|0|||
161667224|NCT00585195|583833823|FG019|Overall Study|Death|0|||
161780446|NCT00791154|584238494|FG005|Overall Study|Other event|4|||
161780447|NCT00791154|584238495|FG006|Overall Study|Other event|2|||
161780448|NCT00953927|584238496|FG000|Overall Study|Lost to Follow-up|61|||
161780449|NCT00953927|584238497|FG001|Overall Study|Lost to Follow-up|65|||
161780450|NCT00953927|584238496|FG000|Overall Study|Withdrawal by Subject|36|||
161780451|NCT00953927|584238497|FG001|Overall Study|Withdrawal by Subject|25|||
161780452|NCT00953927|584238496|FG000|Overall Study|Death|7|||
161780453|NCT00953927|584238497|FG001|Overall Study|Death|4|||
161780454|NCT00953927|584238496|FG000|Overall Study|Other study discontinuation|1|||
161780455|NCT00953927|584238497|FG001|Overall Study|Other study discontinuation|1|||
161780456|NCT01296152|584238500|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161780457|NCT01268683|584238501|FG000|Overall Study|Lost to Follow-up|1|||
161780458|NCT01268683|584238501|FG000|Overall Study|Death|1|||
161780459|NCT04256759|584238502|FG000|Overall Study|Physician Decision|1|||
161780460|NCT04256759|584238502|FG000|Overall Study|Lack of Efficacy|1|||
161780461|NCT03981614|584238507|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
161780462|NCT03981614|584238508|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
161780463|NCT03981614|584238509|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
161780464|NCT04732728|584238510|FG000|Overall Study|Death|12|||
161780465|NCT04732728|584238510|FG000|Overall Study|Withdrawn|136|||
161780466|NCT05349188|584238511|FG000|Overall Study|Withdrawal by Subject|1|||
161780467|NCT05349188|584238512|FG001|Overall Study|Withdrawal by Subject|0|||
161780468|NCT04971226|584238513|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161780469|NCT04971226|584238514|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161780470|NCT04971226|584238515|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
161780471|NCT04971226|584238516|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
161780472|NCT04971226|584238513|FG000|Overall Study|Adverse Event|6|||
161780473|NCT04971226|584238514|FG001|Overall Study|Adverse Event|5|||
161780474|NCT04971226|584238515|FG002|Overall Study|Adverse Event|11|||
161780475|NCT04971226|584238516|FG003|Overall Study|Adverse Event|10|||
161780476|NCT04971226|584238513|FG000|Overall Study|Progressive disease|2|||
161780477|NCT04971226|584238514|FG001|Overall Study|Progressive disease|0|||
161780478|NCT04971226|584238515|FG002|Overall Study|Progressive disease|3|||
161780479|NCT04971226|584238516|FG003|Overall Study|Progressive disease|1|||
161780480|NCT04971226|584238513|FG000|Overall Study|Protocol Deviation|1|||
161780481|NCT04971226|584238514|FG001|Overall Study|Protocol Deviation|0|||
161780482|NCT04971226|584238515|FG002|Overall Study|Protocol Deviation|1|||
161780483|NCT04971226|584238516|FG003|Overall Study|Protocol Deviation|1|||
161780484|NCT04971226|584238513|FG000|Overall Study|Subject Decision|0|||
161780485|NCT04971226|584238514|FG001|Overall Study|Subject Decision|1|||
161780486|NCT04971226|584238515|FG002|Overall Study|Subject Decision|1|||
161780487|NCT04971226|584238516|FG003|Overall Study|Subject Decision|1|||
161780488|NCT04971226|584238513|FG000|Overall Study|Pregnancy|0|||
161780489|NCT04971226|584238514|FG001|Overall Study|Pregnancy|0|||
161667225|NCT00585195|583833824|FG020|Overall Study|Death|1|||
161667226|NCT00585195|583833804|FG000|Overall Study|Lost to Follow-up|0|||
161667227|NCT00585195|583833805|FG001|Overall Study|Lost to Follow-up|0|||
161667228|NCT00585195|583833806|FG002|Overall Study|Lost to Follow-up|0|||
161667229|NCT00585195|583833807|FG003|Overall Study|Lost to Follow-up|0|||
161667230|NCT00585195|583833808|FG004|Overall Study|Lost to Follow-up|0|||
161667231|NCT00585195|583833809|FG005|Overall Study|Lost to Follow-up|0|||
161667232|NCT00585195|583833810|FG006|Overall Study|Lost to Follow-up|0|||
161667233|NCT00585195|583833811|FG007|Overall Study|Lost to Follow-up|0|||
161667234|NCT00585195|583833812|FG008|Overall Study|Lost to Follow-up|0|||
161667235|NCT00585195|583833813|FG009|Overall Study|Lost to Follow-up|0|||
161667236|NCT00585195|583833814|FG010|Overall Study|Lost to Follow-up|0|||
161667237|NCT00585195|583833815|FG011|Overall Study|Lost to Follow-up|0|||
161667238|NCT00585195|583833816|FG012|Overall Study|Lost to Follow-up|1|||
161667239|NCT00585195|583833817|FG013|Overall Study|Lost to Follow-up|0|||
161667240|NCT00585195|583833818|FG014|Overall Study|Lost to Follow-up|0|||
161667241|NCT00585195|583833819|FG015|Overall Study|Lost to Follow-up|0|||
161667242|NCT00585195|583833820|FG016|Overall Study|Lost to Follow-up|0|||
161667243|NCT00585195|583833821|FG017|Overall Study|Lost to Follow-up|2|||
161667244|NCT00585195|583833822|FG018|Overall Study|Lost to Follow-up|0|||
161667245|NCT00585195|583833823|FG019|Overall Study|Lost to Follow-up|0|||
161780490|NCT04971226|584238515|FG002|Overall Study|Pregnancy|0|||
161780491|NCT04971226|584238516|FG003|Overall Study|Pregnancy|1|||
161667246|NCT00585195|583833824|FG020|Overall Study|Lost to Follow-up|0|||
161780492|NCT04971226|584238513|FG000|Overall Study|Participants not treated|1|||
161667247|NCT00585195|583833804|FG000|Overall Study|Site Terminated by Sponsor|0|||
161667248|NCT00585195|583833805|FG001|Overall Study|Site Terminated by Sponsor|0|||
161667249|NCT00585195|583833806|FG002|Overall Study|Site Terminated by Sponsor|0|||
161780493|NCT04971226|584238514|FG001|Overall Study|Participants not treated|0|||
161780494|NCT04971226|584238515|FG002|Overall Study|Participants not treated|2|||
161780495|NCT04971226|584238516|FG003|Overall Study|Participants not treated|1|||
161667250|NCT00585195|583833807|FG003|Overall Study|Site Terminated by Sponsor|0|||
161667251|NCT00585195|583833808|FG004|Overall Study|Site Terminated by Sponsor|0|||
161667252|NCT00585195|583833809|FG005|Overall Study|Site Terminated by Sponsor|0|||
161667253|NCT00585195|583833810|FG006|Overall Study|Site Terminated by Sponsor|0|||
161667254|NCT00585195|583833811|FG007|Overall Study|Site Terminated by Sponsor|0|||
161667255|NCT00585195|583833812|FG008|Overall Study|Site Terminated by Sponsor|0|||
161667256|NCT00585195|583833813|FG009|Overall Study|Site Terminated by Sponsor|0|||
161667257|NCT00585195|583833814|FG010|Overall Study|Site Terminated by Sponsor|0|||
161667258|NCT00585195|583833815|FG011|Overall Study|Site Terminated by Sponsor|0|||
161667259|NCT00585195|583833816|FG012|Overall Study|Site Terminated by Sponsor|1|||
161667260|NCT00585195|583833817|FG013|Overall Study|Site Terminated by Sponsor|0|||
161667261|NCT00585195|583833818|FG014|Overall Study|Site Terminated by Sponsor|0|||
161667262|NCT00585195|583833819|FG015|Overall Study|Site Terminated by Sponsor|0|||
161667263|NCT00585195|583833820|FG016|Overall Study|Site Terminated by Sponsor|0|||
161667264|NCT00585195|583833821|FG017|Overall Study|Site Terminated by Sponsor|0|||
161667265|NCT00585195|583833822|FG018|Overall Study|Site Terminated by Sponsor|0|||
161667266|NCT00585195|583833823|FG019|Overall Study|Site Terminated by Sponsor|0|||
161667267|NCT00585195|583833824|FG020|Overall Study|Site Terminated by Sponsor|0|||
161667268|NCT00585195|583833804|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
161667269|NCT00585195|583833805|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
161667270|NCT00585195|583833806|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
161667271|NCT00585195|583833807|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
161667272|NCT00585195|583833808|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
161667273|NCT00585195|583833809|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
161667274|NCT00585195|583833810|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
161667275|NCT00585195|583833811|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
161667276|NCT00585195|583833812|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
161667277|NCT00585195|583833813|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
161667278|NCT00585195|583833814|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
161667279|NCT00585195|583833815|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
161667280|NCT00585195|583833816|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
161667281|NCT00585195|583833817|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
161667282|NCT00585195|583833818|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
161667283|NCT00585195|583833819|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
161667284|NCT00585195|583833820|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
161667285|NCT00585195|583833821|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
161667286|NCT00585195|583833822|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
161667287|NCT00585195|583833823|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
161667288|NCT00585195|583833824|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
161667289|NCT00770341|583833825|FG000|Overall Study|Did not meet eligibility criteria|1|||
161667290|NCT00770341|583833826|FG001|Overall Study|Did not meet eligibility criteria|0|||
161667291|NCT00770341|583833827|FG002|Overall Study|Did not meet eligibility criteria|0|||
161667292|NCT00770341|583833825|FG000|Overall Study|Withdrawal by Subject|0|||
161667293|NCT00770341|583833826|FG001|Overall Study|Withdrawal by Subject|1|||
161667294|NCT00770341|583833827|FG002|Overall Study|Withdrawal by Subject|0|||
161667295|NCT00770341|583833825|FG000|Overall Study|Clinical Adverse Event|3|||
161667296|NCT00770341|583833826|FG001|Overall Study|Clinical Adverse Event|1|||
161667297|NCT00770341|583833827|FG002|Overall Study|Clinical Adverse Event|2|||
161667298|NCT00770341|583833825|FG000|Overall Study|Laboratory adverse event|3|||
161667299|NCT00770341|583833826|FG001|Overall Study|Laboratory adverse event|3|||
161667300|NCT00770341|583833827|FG002|Overall Study|Laboratory adverse event|0|||
161667301|NCT00770341|583833825|FG000|Overall Study|Lack of Efficacy|3|||
161667302|NCT00770341|583833826|FG001|Overall Study|Lack of Efficacy|0|||
161667303|NCT00770341|583833827|FG002|Overall Study|Lack of Efficacy|1|||
161667304|NCT00770341|583833825|FG000|Overall Study|Other|1|||
161667305|NCT00770341|583833826|FG001|Overall Study|Other|0|||
161667306|NCT00770341|583833827|FG002|Overall Study|Other|0|||
161667307|NCT00770341|583833825|FG000|Overall Study|Not treated|1|||
161667308|NCT00770341|583833826|FG001|Overall Study|Not treated|0|||
161667309|NCT00770341|583833827|FG002|Overall Study|Not treated|0|||
161667310|NCT02739360|583833828|FG000|Overall Study|Adverse Event|1|||
161667311|NCT02739360|583833828|FG000|Overall Study|Study terminated by Sponsor|2|||
161667320|NCT04873232|583833837|FG000|Overall Study|Lost to Follow-up|1|||
161667321|NCT04873232|583833838|FG001|Overall Study|Lost to Follow-up|4|||
161667322|NCT04873232|583833837|FG000|Overall Study|Withdrawal by Subject|1|||
161667323|NCT04873232|583833838|FG001|Overall Study|Withdrawal by Subject|0|||
161667324|NCT01390181|583835663|FG000|Overall Study|Lost to Follow-up|1|||
161667325|NCT01390181|583835663|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
161667326|NCT00720941|583835668|FG000|Overall Study|Protocol Violation|1|||
161667327|NCT00720941|583835669|FG001|Overall Study|Protocol Violation|2|||
161683055|NCT00666458|583891219|FG000|Overall Study|Medical history of anemia|1|||
161667328|NCT00720941|583835668|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
161667329|NCT00720941|583835669|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
161667330|NCT00720941|583835668|FG000|Overall Study|Lost to Follow-up|20|||
161667331|NCT00720941|583835669|FG001|Overall Study|Lost to Follow-up|15|||
161667332|NCT00720941|583835668|FG000|Overall Study|Physician Decision|14|||
161667333|NCT00720941|583835669|FG001|Overall Study|Physician Decision|12|||
161667334|NCT00720941|583835668|FG000|Overall Study|Withdrawal by Subject|29|||
161667335|NCT00720941|583835669|FG001|Overall Study|Withdrawal by Subject|36|||
161667336|NCT03511053|583835670|FG000|Overall Study|Withdrawal by Subject|1|||
161667337|NCT03628898|583835672|FG000|Overall Study|Device deficiency|1|||
161667338|NCT00294554|583835675|FG000|Overall Study|Lack of Efficacy|0|||
161667339|NCT00294554|583835676|FG001|Overall Study|Lack of Efficacy|1|||
161667340|NCT00294554|583835675|FG000|Overall Study|Physician Decision|0|||
161667341|NCT00294554|583835676|FG001|Overall Study|Physician Decision|1|||
161667342|NCT02598557|583835677|FG000|Overall Study|Withdrawal by Subject|1|||
161667343|NCT02598557|583835678|FG001|Overall Study|Withdrawal by Subject|0|||
161667344|NCT02598557|583835679|FG002|Overall Study|Withdrawal by Subject|1|||
161667345|NCT02598557|583835677|FG000|Overall Study|Participant did not start treatment|2|||
161667346|NCT02598557|583835678|FG001|Overall Study|Participant did not start treatment|1|||
161667347|NCT02598557|583835679|FG002|Overall Study|Participant did not start treatment|1|||
161667348|NCT02598557|583835677|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
161667349|NCT02598557|583835678|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
161667350|NCT02598557|583835679|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
161667351|NCT02598557|583835677|FG000|Overall Study|Adverse Event|1|||
161667352|NCT02598557|583835678|FG001|Overall Study|Adverse Event|1|||
161667353|NCT02598557|583835679|FG002|Overall Study|Adverse Event|0|||
161667354|NCT01138007|583835680|FG000|Overall Study|Adverse Event|4|||
161667355|NCT01138007|583835681|FG001|Overall Study|Adverse Event|12|||
161667356|NCT01138007|583835682|FG002|Overall Study|Adverse Event|9|||
161667357|NCT01138007|583835680|FG000|Overall Study|Lack of Efficacy|2|||
161667358|NCT01138007|583835681|FG001|Overall Study|Lack of Efficacy|0|||
161667359|NCT01138007|583835682|FG002|Overall Study|Lack of Efficacy|6|||
161667360|NCT01138007|583835680|FG000|Overall Study|Protocol Violation|2|||
161667361|NCT01138007|583835681|FG001|Overall Study|Protocol Violation|3|||
161667362|NCT01138007|583835682|FG002|Overall Study|Protocol Violation|2|||
161667363|NCT01138007|583835680|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
161667364|NCT01138007|583835681|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
161667365|NCT01138007|583835682|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
161667366|NCT01138007|583835680|FG000|Overall Study|Lost to Follow-up|3|||
161667367|NCT01138007|583835681|FG001|Overall Study|Lost to Follow-up|3|||
161667368|NCT01138007|583835682|FG002|Overall Study|Lost to Follow-up|5|||
161667369|NCT01138007|583835680|FG000|Overall Study|Physician Decision|0|||
161667370|NCT01138007|583835681|FG001|Overall Study|Physician Decision|5|||
161667371|NCT01138007|583835682|FG002|Overall Study|Physician Decision|3|||
161667372|NCT01138007|583835680|FG000|Overall Study|Withdrawal by Subject|5|||
161667373|NCT01138007|583835681|FG001|Overall Study|Withdrawal by Subject|6|||
161667374|NCT01138007|583835682|FG002|Overall Study|Withdrawal by Subject|15|||
161667375|NCT04661878|583835683|FG000|Overall Study|Lost to Follow-up|6|||
161667376|NCT04661878|583835684|FG001|Overall Study|Lost to Follow-up|5|||
161667377|NCT03603028|583835685|FG000|Overall Study|Withdrawal by Subject|1|||
161667378|NCT00640016|583835688|FG000|Overall Study|Withdrawal by Subject|0|||
161667379|NCT00640016|583835689|FG001|Overall Study|Withdrawal by Subject|1|||
161667380|NCT00640016|583835690|FG002|Overall Study|Withdrawal by Subject|0|||
161667381|NCT00640016|583835691|FG003|Overall Study|Withdrawal by Subject|0|||
161667382|NCT00640016|583835688|FG000|Overall Study|Study termination|2|||
161667383|NCT00640016|583835689|FG001|Overall Study|Study termination|1|||
161667384|NCT00640016|583835690|FG002|Overall Study|Study termination|3|||
161667385|NCT00640016|583835691|FG003|Overall Study|Study termination|2|||
161667386|NCT00640016|583835688|FG000|Overall Study|Adverse Event|0|||
161667387|NCT00640016|583835689|FG001|Overall Study|Adverse Event|0|||
161667388|NCT00640016|583835690|FG002|Overall Study|Adverse Event|0|||
161667389|NCT00640016|583835691|FG003|Overall Study|Adverse Event|1|||
161667390|NCT00846391|583835692|FG000|Overall Study|Physician Decision|0|||
161667391|NCT00846391|583835693|FG001|Overall Study|Physician Decision|0|||
161667392|NCT00846391|583835694|FG002|Overall Study|Physician Decision|1|||
161667393|NCT00846391|583835692|FG000|Overall Study|Study Terminated by Sponsor|1|||
161667394|NCT00846391|583835693|FG001|Overall Study|Study Terminated by Sponsor|2|||
161667395|NCT00846391|583835694|FG002|Overall Study|Study Terminated by Sponsor|2|||
161667396|NCT01287065|583835695|FG000|Treatment Period 1|Adverse Event|0|||
161667397|NCT01287065|583835696|FG001|Treatment Period 1|Adverse Event|0|||
161667398|NCT01287065|583835697|FG002|Treatment Period 1|Adverse Event|0|||
161667399|NCT01287065|583835698|FG003|Treatment Period 1|Adverse Event|0|||
161667400|NCT01287065|583835699|FG004|Treatment Period 1|Adverse Event|1|||
161667401|NCT01287065|583835700|FG005|Treatment Period 1|Adverse Event|0|||
161667402|NCT01287065|583835695|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161780506|NCT06065176|584238527|FG000|Overall Study|Lost to Follow-up|11|||
161780507|NCT06065176|584238528|FG001|Overall Study|Lost to Follow-up|11|||
161780508|NCT06065176|584238529|FG002|Overall Study|Lost to Follow-up|10|||
161780509|NCT06065176|584238527|FG000|Overall Study|Withdrawal by Subject|1|||
161780510|NCT06065176|584238528|FG001|Overall Study|Withdrawal by Subject|1|||
161780511|NCT06065176|584238529|FG002|Overall Study|Withdrawal by Subject|2|||
161780512|NCT06065176|584238527|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
161780513|NCT06065176|584238528|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
161780514|NCT06065176|584238529|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
161780515|NCT04521608|584238530|FG000|Overall Study|Death|8|||
161780516|NCT04521608|584238531|FG001|Overall Study|Death|9|||
161780517|NCT04521608|584238530|FG000|Overall Study|Withdrawal by Subject|25|||
161780518|NCT04521608|584238531|FG001|Overall Study|Withdrawal by Subject|18|||
161780519|NCT04521608|584238530|FG000|Overall Study|Disease Progression|3|||
161780520|NCT04521608|584238531|FG001|Overall Study|Disease Progression|10|||
161780521|NCT04521608|584238530|FG000|Overall Study|Complicating Disease|6|||
161780522|NCT04521608|584238531|FG001|Overall Study|Complicating Disease|3|||
161780523|NCT04521608|584238530|FG000|Overall Study|Lost Contact|25|||
161780524|NCT04521608|584238531|FG001|Overall Study|Lost Contact|27|||
161780525|NCT04521608|584238530|FG000|Overall Study|Ineligible|1|||
161780526|NCT04521608|584238531|FG001|Overall Study|Ineligible|0|||
161780527|NCT04521608|584238530|FG000|Overall Study|Refused Further Study Participation|13|||
161780528|NCT04521608|584238531|FG001|Overall Study|Refused Further Study Participation|7|||
161667403|NCT01287065|583835696|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161667404|NCT01287065|583835697|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161667405|NCT01287065|583835698|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161667406|NCT01287065|583835699|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161667407|NCT01287065|583835700|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161667408|NCT01580969|583835705|FG000|Overall Study|Physician Decision|3|||
161667409|NCT01580969|583835706|FG001|Overall Study|Physician Decision|0|||
161667410|NCT01580969|583835707|FG002|Overall Study|Physician Decision|0|||
161667411|NCT00511472|583835709|FG000|Overall Study|Clinical Adverse Event|1|||
161667412|NCT00511472|583835710|FG001|Overall Study|Clinical Adverse Event|2|||
161667413|NCT00511472|583835709|FG000|Overall Study|Laboratory Adverse Event|0|||
161667414|NCT00511472|583835710|FG001|Overall Study|Laboratory Adverse Event|2|||
161667415|NCT00511472|583835709|FG000|Overall Study|Not reported|2|||
161667416|NCT00511472|583835710|FG001|Overall Study|Not reported|2|||
161667417|NCT02019927|583835711|FG000|Overall Study|Lost to Follow-up|2|||
161667418|NCT02019927|583835712|FG001|Overall Study|Lost to Follow-up|4|||
161667419|NCT02019927|583835713|FG002|Overall Study|Lost to Follow-up|1|||
161667420|NCT02019927|583835714|FG003|Overall Study|Lost to Follow-up|2|||
161667421|NCT02019927|583835715|FG004|Overall Study|Lost to Follow-up|3|||
161667422|NCT02019927|583835716|FG005|Overall Study|Lost to Follow-up|1|||
161667423|NCT03181451|583835729|FG000|Overall Study|Adverse Event|0|||
161667424|NCT03181451|583835730|FG001|Overall Study|Adverse Event|1|||
161667425|NCT03181451|583835731|FG002|Overall Study|Adverse Event|0|||
161667426|NCT03181451|583835729|FG000|Overall Study|Withdrawal by Subject|0|||
161667427|NCT03181451|583835730|FG001|Overall Study|Withdrawal by Subject|1|||
161667428|NCT03181451|583835731|FG002|Overall Study|Withdrawal by Subject|0|||
161667429|NCT01259284|583835732|FG000|Overall Study|Study Termination|2|||
161667430|NCT01259284|583835733|FG001|Overall Study|Study Termination|0|||
161667431|NCT01259284|583835734|FG002|Overall Study|Study Termination|0|||
161667432|NCT00069238|583835735|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
161667433|NCT00069238|583835736|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
161780529|NCT04083378|584238534|FG000|Overall Study|Death|18|||
161780530|NCT04083378|584238535|FG001|Overall Study|Death|4|||
161780531|NCT04083378|584238534|FG000|Overall Study|Lost to Follow-up|4|||
161780532|NCT04083378|584238535|FG001|Overall Study|Lost to Follow-up|0|||
161780533|NCT00644228|584238536|FG000|Randomization & Eligibility|Ineligible|31|||
161780534|NCT00644228|584238537|FG001|Randomization & Eligibility|Ineligible|21|||
161667434|NCT00069238|583835737|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
161667435|NCT00069238|583835735|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
161780535|NCT00644228|584238536|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
161780536|NCT00644228|584238537|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
161667436|NCT00069238|583835736|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
161667437|NCT00069238|583835737|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
161667438|NCT00069238|583835735|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
161667439|NCT00069238|583835736|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
161667440|NCT00069238|583835737|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
161667441|NCT01001832|583835739|FG000|Short-term Period|Adverse Event|2|||
161780537|NCT00644228|584238536|FG000|Randomization & Eligibility|Invalid Consent|0|||
161780538|NCT00644228|584238537|FG001|Randomization & Eligibility|Invalid Consent|1|||
161780539|NCT00644228|584238536|FG000|Induction Therapy|Adverse Event|22|||
161780540|NCT00644228|584238537|FG001|Induction Therapy|Adverse Event|55|||
161780541|NCT00644228|584238536|FG000|Induction Therapy|Withdrawal by Subject|10|||
161780542|NCT00644228|584238537|FG001|Induction Therapy|Withdrawal by Subject|3|||
161780543|NCT00644228|584238536|FG000|Induction Therapy|Progression/Relapse|24|||
161780544|NCT00644228|584238537|FG001|Induction Therapy|Progression/Relapse|12|||
161780545|NCT00644228|584238536|FG000|Induction Therapy|Death|3|||
161780546|NCT00644228|584238537|FG001|Induction Therapy|Death|7|||
161780547|NCT00644228|584238536|FG000|Induction Therapy|Not Protocol-Specified|24|||
161780548|NCT00644228|584238537|FG001|Induction Therapy|Not Protocol-Specified|28|||
161780549|NCT00644228|584238536|FG000|Maintenance|Adverse Event|27|||
161780550|NCT00644228|584238537|FG001|Maintenance|Adverse Event|31|||
161780551|NCT00644228|584238536|FG000|Maintenance|Withdrawal by Subject|6|||
161780552|NCT00644228|584238537|FG001|Maintenance|Withdrawal by Subject|4|||
161780553|NCT00644228|584238536|FG000|Maintenance|Progression/Relapse|67|||
161780554|NCT00644228|584238537|FG001|Maintenance|Progression/Relapse|42|||
161780555|NCT00644228|584238536|FG000|Maintenance|Death|3|||
161780556|NCT00644228|584238537|FG001|Maintenance|Death|3|||
161780557|NCT00644228|584238536|FG000|Maintenance|Not Protocol-Specified|14|||
161780558|NCT00644228|584238537|FG001|Maintenance|Not Protocol-Specified|15|||
161780559|NCT00644228|584238536|FG000|Maintenance|On Treatment|26|||
161780560|NCT00644228|584238537|FG001|Maintenance|On Treatment|40|||
161780561|NCT06078124|584238538|FG000|Overall Study|Lost to Follow-up|14|||
161780562|NCT06078124|584238539|FG001|Overall Study|Lost to Follow-up|14|||
161780563|NCT05824273|584238540|FG000|Overall Study|Lost to Follow-up|16|||
161780564|NCT05824273|584238541|FG001|Overall Study|Lost to Follow-up|13|||
161780565|NCT04050293|584238544|FG000|Overall Study|Lost to Follow-up|1|||
161780566|NCT04050293|584238545|FG001|Overall Study|Lost to Follow-up|2|||
161780567|NCT04050293|584238544|FG000|Overall Study|Withdrawal by Subject|2|||
161780568|NCT04050293|584238545|FG001|Overall Study|Withdrawal by Subject|0|||
161780569|NCT02949219|584238558|FG000|Overall Study|Withdrawal by Subject|1|||
161780570|NCT03494816|584238559|FG000|Overall Study|Protocol Violation|2|||
161780571|NCT03494816|584238559|FG000|Overall Study|Physician Decision|2|||
161780572|NCT03494816|584238559|FG000|Overall Study|Did not start trial treatment|1|||
161780573|NCT03494816|584238559|FG000|Overall Study|Adverse Event|1|||
161780574|NCT00633217|584238573|FG000|Overall Study|Adverse Event|5|||
161780575|NCT00633217|584238574|FG001|Overall Study|Adverse Event|9|||
161780576|NCT00633217|584238573|FG000|Overall Study|Lack of Efficacy|0|||
161780577|NCT00633217|584238574|FG001|Overall Study|Lack of Efficacy|2|||
161780578|NCT00633217|584238573|FG000|Overall Study|Protocol Violation|3|||
161780579|NCT00633217|584238574|FG001|Overall Study|Protocol Violation|7|||
161780580|NCT00633217|584238573|FG000|Overall Study|Lost to Follow-up|2|||
161780581|NCT00633217|584238574|FG001|Overall Study|Lost to Follow-up|2|||
161780582|NCT00633217|584238573|FG000|Overall Study|Investigator Discretion|2|||
161780583|NCT00633217|584238574|FG001|Overall Study|Investigator Discretion|0|||
161780584|NCT00633217|584238573|FG000|Overall Study|Withdrew Consent|3|||
161780585|NCT00633217|584238574|FG001|Overall Study|Withdrew Consent|3|||
161780586|NCT05838755|584238575|FG000|Overall Study|Adverse Event|1|||
161780587|NCT05838755|584238576|FG001|Overall Study|Adverse Event|0|||
161780588|NCT05838755|584238577|FG002|Overall Study|Adverse Event|0|||
161780589|NCT05838755|584238575|FG000|Overall Study|Lack of Efficacy|1|||
161780590|NCT05838755|584238576|FG001|Overall Study|Lack of Efficacy|0|||
161780591|NCT05838755|584238577|FG002|Overall Study|Lack of Efficacy|1|||
161780592|NCT05838755|584238575|FG000|Overall Study|Lost to Follow-up|0|||
161780593|NCT05838755|584238576|FG001|Overall Study|Lost to Follow-up|1|||
161780594|NCT05838755|584238577|FG002|Overall Study|Lost to Follow-up|4|||
161780595|NCT05838755|584238575|FG000|Overall Study|Withdrawal by Subject|0|||
161780596|NCT05838755|584238576|FG001|Overall Study|Withdrawal by Subject|2|||
161780597|NCT05838755|584238577|FG002|Overall Study|Withdrawal by Subject|0|||
161780598|NCT05838755|584238575|FG000|Overall Study|Study terminated by sponsor|26|||
161780599|NCT05838755|584238576|FG001|Overall Study|Study terminated by sponsor|27|||
161780600|NCT05838755|584238577|FG002|Overall Study|Study terminated by sponsor|26|||
161780601|NCT05838755|584238575|FG000|Overall Study|Randomized, not treated|2|||
161780602|NCT05838755|584238576|FG001|Overall Study|Randomized, not treated|0|||
161780603|NCT05838755|584238577|FG002|Overall Study|Randomized, not treated|1|||
161780604|NCT05838755|584238575|FG000|Overall Study|Pregnancy|0|||
161780605|NCT05838755|584238576|FG001|Overall Study|Pregnancy|1|||
161780606|NCT05838755|584238577|FG002|Overall Study|Pregnancy|0|||
161780607|NCT01283282|584238578|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
161780608|NCT01283282|584238579|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
161780609|NCT01283282|584238578|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
161780610|NCT01283282|584238579|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
161780611|NCT01283282|584238578|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
161780612|NCT01283282|584238579|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
161780613|NCT01682681|584238586|FG000|Overall Study|Lack of Efficacy|62|||
161780614|NCT01682681|584238586|FG000|Overall Study|Withdrawal by Subject|1|||
161780615|NCT01682681|584238586|FG000|Overall Study|Moved to other hospital|10|||
161780616|NCT01682681|584238586|FG000|Overall Study|Lost to Follow-up|174|||
161780617|NCT01682681|584238586|FG000|Overall Study|Adverse Event|46|||
161780618|NCT01682681|584238586|FG000|Overall Study|tapering of topiramate|5|||
161780619|NCT01682681|584238586|FG000|Overall Study|Other|21|||
161780620|NCT01682681|584238586|FG000|Overall Study|Low compliance|13|||
161780621|NCT02044094|584238587|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
161780622|NCT02044094|584238587|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
161780623|NCT02044094|584238587|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
161780624|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
161780625|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
161780626|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
161780627|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
161780628|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
161780629|NCT03205163|584238590|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
161780630|NCT03205163|584238591|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
161780631|NCT00005879|584238592|FG000|Overall Study|Withdrawal by Subject|8|||
161780632|NCT00005879|584238593|FG001|Overall Study|Withdrawal by Subject|10|||
161780633|NCT01238172|584238594|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
161780634|NCT01238172|584238595|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
161780635|NCT01238172|584238594|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
161780636|NCT01238172|584238595|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
161780637|NCT05022121|584238596|FG000|Overall Study|Lack of Efficacy|1|||
161780638|NCT05022121|584238597|FG001|Overall Study|Lack of Efficacy|0|||
161780639|NCT05022121|584238596|FG000|Overall Study|Lost to Follow-up|0|||
161780640|NCT05022121|584238597|FG001|Overall Study|Lost to Follow-up|2|||
161780641|NCT01020773|584240355|FG000|Overall Study|Withdrawal by Subject|4|||
161780642|NCT01020773|584240356|FG001|Overall Study|Withdrawal by Subject|3|||
161780643|NCT03302299|584240357|FG000|Overall Study|Protocol Violation|1|||
161780644|NCT01458132|584240358|FG000|Overall Study|Other|15|||
161780645|NCT01458132|584240359|FG001|Overall Study|Other|3|||
161780646|NCT01788163|584240365|FG000|Overall Study|Other|53|||
161780647|NCT01788163|584240366|FG001|Overall Study|Other|0|||
161780648|NCT01788163|584240367|FG002|Overall Study|Other|0|||
161780649|NCT01788163|584240368|FG003|Overall Study|Other|0|||
161780650|NCT01788163|584240369|FG004|Overall Study|Other|0|||
161780651|NCT01788163|584240370|FG005|Overall Study|Other|7|||
161780652|NCT01788163|584240371|FG006|Overall Study|Other|1|||
161780653|NCT01788163|584240372|FG007|Overall Study|Other|48|||
161780654|NCT01788163|584240373|FG008|Overall Study|Other|15|||
161780655|NCT01788163|584240365|FG000|Overall Study|Withdrawal by Subject|2|||
161780656|NCT01788163|584240366|FG001|Overall Study|Withdrawal by Subject|0|||
161780657|NCT01788163|584240367|FG002|Overall Study|Withdrawal by Subject|0|||
161780658|NCT01788163|584240368|FG003|Overall Study|Withdrawal by Subject|0|||
161780659|NCT01788163|584240369|FG004|Overall Study|Withdrawal by Subject|0|||
161780660|NCT01788163|584240370|FG005|Overall Study|Withdrawal by Subject|0|||
161780661|NCT01788163|584240371|FG006|Overall Study|Withdrawal by Subject|0|||
161780662|NCT01788163|584240372|FG007|Overall Study|Withdrawal by Subject|0|||
161780663|NCT01788163|584240373|FG008|Overall Study|Withdrawal by Subject|1|||
161780664|NCT02803138|584240376|FG000|Overall Study|Failure to return|38|||
161780665|NCT02803138|584240376|FG000|Overall Study|Insufficient virological response|2|||
161780666|NCT02803138|584240376|FG000|Overall Study|Withdrawn consent|1|||
161780667|NCT02803138|584240376|FG000|Overall Study|Death|1|||
161780668|NCT02803138|584240376|FG000|Overall Study|Other, not specified|28|||
161780669|NCT04318535|584240377|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
161780670|NCT04318535|584240378|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
161780671|NCT04318535|584240379|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
161780672|NCT00021229|584240384|FG000|Overall Study|Adverse Event|10|||
161780673|NCT00021229|584240385|FG001|Overall Study|Adverse Event|5|||
161780674|NCT00021229|584240386|FG002|Overall Study|Adverse Event|2|||
161780675|NCT00021229|584240384|FG000|Overall Study|Death|0|||
161780676|NCT00021229|584240385|FG001|Overall Study|Death|1|||
161780677|NCT00021229|584240386|FG002|Overall Study|Death|0|||
161780678|NCT00021229|584240384|FG000|Overall Study|Withdrawal by Subject|7|||
161780679|NCT00021229|584240385|FG001|Overall Study|Withdrawal by Subject|7|||
161780680|NCT00021229|584240386|FG002|Overall Study|Withdrawal by Subject|1|||
161780681|NCT00021229|584240384|FG000|Overall Study|Progressive Disease|15|||
161780682|NCT00021229|584240385|FG001|Overall Study|Progressive Disease|19|||
161780683|NCT00021229|584240386|FG002|Overall Study|Progressive Disease|12|||
161780684|NCT00021229|584240384|FG000|Overall Study|Protocol Violation|1|||
161780685|NCT00021229|584240385|FG001|Overall Study|Protocol Violation|1|||
161780686|NCT00021229|584240386|FG002|Overall Study|Protocol Violation|0|||
161780687|NCT00021229|584240384|FG000|Overall Study|Physician Decision|0|||
161780688|NCT00021229|584240385|FG001|Overall Study|Physician Decision|0|||
161780689|NCT00021229|584240386|FG002|Overall Study|Physician Decision|1|||
161780690|NCT00021229|584240384|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
161780691|NCT00021229|584240385|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
161780692|NCT00021229|584240386|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
161780693|NCT02156466|584240390|FG000|Overall Study|Adverse Event|0|||
161780694|NCT02156466|584240391|FG001|Overall Study|Adverse Event|0|||
161780695|NCT02156466|584240392|FG002|Overall Study|Adverse Event|1|||
161780696|NCT02156466|584240393|FG003|Overall Study|Adverse Event|1|||
161780697|NCT02156466|584240394|FG004|Overall Study|Adverse Event|0|||
161780698|NCT02156466|584240390|FG000|Overall Study|Quantiferon Positivity|0|||
161780699|NCT02156466|584240391|FG001|Overall Study|Quantiferon Positivity|0|||
161780700|NCT02156466|584240392|FG002|Overall Study|Quantiferon Positivity|0|||
161780701|NCT02156466|584240393|FG003|Overall Study|Quantiferon Positivity|1|||
161780702|NCT02156466|584240394|FG004|Overall Study|Quantiferon Positivity|0|||
161780703|NCT03724968|584240395|FG000|Overall Study|Insurance issues|0|||
161780704|NCT03724968|584240396|FG001|Overall Study|Insurance issues|1|||
161780705|NCT03724968|584240395|FG000|Overall Study|Study closed|0|||
161780706|NCT03724968|584240396|FG001|Overall Study|Study closed|1|||
161780707|NCT00306852|584240399|FG000|Overall Study|Death|14|||
161780708|NCT00306852|584240400|FG001|Overall Study|Death|14|||
161780709|NCT00306852|584240399|FG000|Overall Study|Lost to Follow-up|15|||
161780710|NCT00306852|584240400|FG001|Overall Study|Lost to Follow-up|24|||
161780711|NCT00817778|584240401|FG000|Overall Study|Adverse Event|1|||
161780712|NCT00817778|584240402|FG001|Overall Study|Adverse Event|0|||
161780713|NCT00817778|584240401|FG000|Overall Study|Withdrawal by Subject|1|||
161780714|NCT00817778|584240402|FG001|Overall Study|Withdrawal by Subject|1|||
161780715|NCT00817778|584240401|FG000|Overall Study|Protocol Violation|0|||
161780716|NCT00817778|584240402|FG001|Overall Study|Protocol Violation|1|||
161780717|NCT00817778|584240401|FG000|Overall Study|Study-specific discontinuation criteria|0|||
161780718|NCT00817778|584240402|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161780719|NCT00817778|584240401|FG000|Overall Study|Poor venous access|1|||
161780720|NCT00817778|584240402|FG001|Overall Study|Poor venous access|0|||
161780721|NCT01286207|584240403|FG000|Overall Study|Adverse Event|27|||
161780722|NCT01286207|584240404|FG001|Overall Study|Adverse Event|41|||
161780723|NCT01286207|584240405|FG002|Overall Study|Adverse Event|8|||
161780724|NCT01286207|584240403|FG000|Overall Study|Lost to Follow-up|49|||
161780725|NCT01286207|584240404|FG001|Overall Study|Lost to Follow-up|43|||
161780726|NCT01286207|584240405|FG002|Overall Study|Lost to Follow-up|20|||
161780727|NCT01286207|584240403|FG000|Overall Study|Withdrawal by Subject|93|||
161780728|NCT01286207|584240404|FG001|Overall Study|Withdrawal by Subject|79|||
161780729|NCT01286207|584240405|FG002|Overall Study|Withdrawal by Subject|41|||
161780730|NCT01286207|584240403|FG000|Overall Study|Lack of Response|92|||
161780731|NCT01286207|584240404|FG001|Overall Study|Lack of Response|38|||
161780732|NCT01286207|584240405|FG002|Overall Study|Lack of Response|8|||
161780733|NCT01286207|584240403|FG000|Overall Study|Other|37|||
161780734|NCT01286207|584240404|FG001|Overall Study|Other|47|||
161780735|NCT01286207|584240405|FG002|Overall Study|Other|13|||
161780736|NCT02923115|584240406|FG000|Overall Study|Lost to Follow-up|0|||
161780737|NCT02923115|584240407|FG001|Overall Study|Lost to Follow-up|0|||
161780738|NCT02923115|584240408|FG002|Overall Study|Lost to Follow-up|0|||
161780739|NCT02923115|584240409|FG003|Overall Study|Lost to Follow-up|1|||
161780740|NCT02923115|584240410|FG004|Overall Study|Lost to Follow-up|0|||
161780741|NCT02923115|584240411|FG005|Overall Study|Lost to Follow-up|0|||
161780742|NCT02923115|584240406|FG000|Overall Study|Withdrawal by Subject|0|||
161780743|NCT02923115|584240407|FG001|Overall Study|Withdrawal by Subject|1|||
161780744|NCT02923115|584240408|FG002|Overall Study|Withdrawal by Subject|0|||
161780745|NCT02923115|584240409|FG003|Overall Study|Withdrawal by Subject|0|||
161780746|NCT02923115|584240410|FG004|Overall Study|Withdrawal by Subject|0|||
161780747|NCT02923115|584240411|FG005|Overall Study|Withdrawal by Subject|0|||
161780748|NCT02923115|584240406|FG000|Overall Study|Randomized, but not dosed|0|||
161780749|NCT02923115|584240407|FG001|Overall Study|Randomized, but not dosed|0|||
161780750|NCT02923115|584240408|FG002|Overall Study|Randomized, but not dosed|3|||
161780751|NCT02923115|584240409|FG003|Overall Study|Randomized, but not dosed|1|||
161780752|NCT02923115|584240410|FG004|Overall Study|Randomized, but not dosed|5|||
161780753|NCT02923115|584240411|FG005|Overall Study|Randomized, but not dosed|0|||
161780754|NCT01875991|584240414|FG000|Overall Study|Withdrawal by Subject|6|||
161780755|NCT01875991|584240415|FG001|Overall Study|Withdrawal by Subject|6|||
161780756|NCT01875991|584240414|FG000|Overall Study|Sponsor Decision|1|||
161780757|NCT01875991|584240415|FG001|Overall Study|Sponsor Decision|0|||
161780758|NCT03151707|584240416|FG000|Overall Study|Lost to Follow-up|6|||
161780759|NCT04439149|584240418|FG000|Overall Study|Ineligible|1|||
161780760|NCT04439149|584240418|FG000|Overall Study|Never start protocol therapy|1|||
161780761|NCT04439149|584240418|FG000|Overall Study|Adverse Event|4|||
161780762|NCT04439149|584240418|FG000|Overall Study|Disease Progression|14|||
161780763|NCT04439149|584240418|FG000|Overall Study|Complicating disease|1|||
161780764|NCT04439149|584240418|FG000|Overall Study|Withdrawal by Subject|3|||
161780765|NCT02617446|584240419|FG000|Overall Study|Withdrawal by Subject|0|||
161780766|NCT02617446|584240420|FG001|Overall Study|Withdrawal by Subject|2|||
161780767|NCT02617446|584240421|FG002|Overall Study|Withdrawal by Subject|0|||
161780768|NCT02617446|584240419|FG000|Overall Study|Adverse Event|1|||
161780769|NCT02617446|584240420|FG001|Overall Study|Adverse Event|0|||
161780770|NCT02617446|584240421|FG002|Overall Study|Adverse Event|5|||
161780771|NCT02617446|584240419|FG000|Overall Study|Lost to Follow-up|3|||
161780772|NCT02617446|584240420|FG001|Overall Study|Lost to Follow-up|0|||
161780773|NCT02617446|584240421|FG002|Overall Study|Lost to Follow-up|0|||
161780774|NCT02617446|584240419|FG000|Overall Study|Death|0|||
161780775|NCT02617446|584240420|FG001|Overall Study|Death|0|||
161780776|NCT02617446|584240421|FG002|Overall Study|Death|2|||
161780777|NCT05264506|584240432|FG000|Overall Study|Adverse Event|59|||
161780778|NCT05264506|584240432|FG000|Overall Study|Lost to Follow-up|204|||
161780779|NCT05264506|584240432|FG000|Overall Study|Protocol Violation|185|||
161780780|NCT05264506|584240432|FG000|Overall Study|Pregnancy|60|||
161780781|NCT05264506|584240432|FG000|Overall Study|Physician Decision|6|||
161780782|NCT05264506|584240432|FG000|Overall Study|Non-compliance with Study Drug|29|||
161780783|NCT05264506|584240432|FG000|Overall Study|Study termination|677|||
161780784|NCT05264506|584240432|FG000|Overall Study|Withdrawal by Subject|208|||
161780785|NCT05264506|584240432|FG000|Overall Study|Discontinued prior treatment|89|||
161780786|NCT03252756|584240436|FG000|Overall Study|Protocol Violation|2|||
161780787|NCT03252756|584240437|FG001|Overall Study|Protocol Violation|4|||
161780788|NCT03252756|584240436|FG000|Overall Study|COVID-19 Pandemic|1|||
161780789|NCT03252756|584240437|FG001|Overall Study|COVID-19 Pandemic|1|||
161780790|NCT03252756|584240436|FG000|Overall Study|Study Drug Expiration|0|||
161780791|NCT03252756|584240437|FG001|Overall Study|Study Drug Expiration|1|||
161780792|NCT04223193|584240438|FG000|Overall Study|Adverse Event|6|||
161780793|NCT04223193|584240439|FG001|Overall Study|Adverse Event|36|||
161780794|NCT04223193|584240438|FG000|Overall Study|Lack of Efficacy|2|||
161780795|NCT04223193|584240439|FG001|Overall Study|Lack of Efficacy|2|||
161780796|NCT04223193|584240438|FG000|Overall Study|Lost to Follow-up|1|||
161780797|NCT04223193|584240439|FG001|Overall Study|Lost to Follow-up|1|||
161780798|NCT04223193|584240438|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
161780799|NCT04223193|584240439|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161780800|NCT04223193|584240438|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
161780801|NCT04223193|584240439|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161780802|NCT04223193|584240438|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161780803|NCT04223193|584240439|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161780804|NCT04223193|584240438|FG000|Overall Study|Physician Decision|0|||
161780805|NCT04223193|584240439|FG001|Overall Study|Physician Decision|1|||
161780806|NCT04223193|584240438|FG000|Overall Study|Protocol Violation|1|||
161780807|NCT04223193|584240439|FG001|Overall Study|Protocol Violation|1|||
161780808|NCT04223193|584240438|FG000|Overall Study|Site Terminated by Sponsor|1|||
161780809|NCT04223193|584240439|FG001|Overall Study|Site Terminated by Sponsor|3|||
161780810|NCT04223193|584240438|FG000|Overall Study|Withdrawal by Subject|5|||
161780811|NCT04223193|584240439|FG001|Overall Study|Withdrawal by Subject|6|||
161780812|NCT04223193|584240438|FG000|Overall Study|Other|3|||
161780813|NCT04223193|584240439|FG001|Overall Study|Other|6|||
161780814|NCT03594175|584240440|FG000|Overall Study|Not treated|8|||
161780815|NCT03594175|584240441|FG001|Overall Study|Not treated|1|||
161780816|NCT03594175|584240442|FG002|Overall Study|Not treated|5|||
161780817|NCT03594175|584240440|FG000|Overall Study|Adverse Event|3|||
161780818|NCT03594175|584240441|FG001|Overall Study|Adverse Event|0|||
161780819|NCT03594175|584240442|FG002|Overall Study|Adverse Event|0|||
161780820|NCT03594175|584240440|FG000|Overall Study|Withdrawal by Subject|3|||
161780821|NCT03594175|584240441|FG001|Overall Study|Withdrawal by Subject|0|||
161780822|NCT03594175|584240442|FG002|Overall Study|Withdrawal by Subject|0|||
161780823|NCT03594175|584240440|FG000|Overall Study|Protocol Violation|2|||
161780824|NCT03594175|584240441|FG001|Overall Study|Protocol Violation|2|||
161780825|NCT03594175|584240442|FG002|Overall Study|Protocol Violation|2|||
161780826|NCT03732677|584240443|FG000|Overall Study|Terminated the study|154|||
161780827|NCT03732677|584240444|FG001|Overall Study|Terminated the study|197|||
161780828|NCT03732677|584240443|FG000|Overall Study|Continuing study off treatment|379|||
161780829|NCT03732677|584240444|FG001|Overall Study|Continuing study off treatment|333|||
161780830|NCT04644237|584240445|FG000|Overall Study|Death|4|||
161780831|NCT04644237|584240446|FG001|Overall Study|Death|2|||
161780832|NCT04644237|584240445|FG000|Overall Study|Adverse Event|18|||
161780833|NCT04644237|584240446|FG001|Overall Study|Adverse Event|19|||
161780834|NCT04644237|584240445|FG000|Overall Study|Progressive Disease|61|||
161780835|NCT04644237|584240446|FG001|Overall Study|Progressive Disease|23|||
161780836|NCT04644237|584240445|FG000|Overall Study|Clinical Progression|4|||
161780837|NCT04644237|584240446|FG001|Overall Study|Clinical Progression|1|||
161780838|NCT04644237|584240445|FG000|Overall Study|Withdrawal by Subject|4|||
161780839|NCT04644237|584240446|FG001|Overall Study|Withdrawal by Subject|2|||
161780840|NCT04644237|584240445|FG000|Overall Study|Physician Decision|4|||
161780841|NCT04644237|584240446|FG001|Overall Study|Physician Decision|0|||
161780842|NCT04644237|584240445|FG000|Overall Study|Other|6|||
161780843|NCT04644237|584240446|FG001|Overall Study|Other|3|||
161780844|NCT04644237|584240445|FG000|Overall Study|Randomized but not Treated|1|||
161780845|NCT04644237|584240446|FG001|Overall Study|Randomized but not Treated|0|||
161780846|NCT03131817|584240447|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
161780847|NCT02061293|584240449|FG000|Overall Study|Elevated Blood Pressure|1|||
161780848|NCT02061293|584240450|FG001|Overall Study|Elevated Blood Pressure|1|||
161780849|NCT04066894|584240452|FG000|Overall Study|Lack of Efficacy|1|||
161780850|NCT04066894|584240452|FG000|Overall Study|Screen Failure|1|||
161780851|NCT01500434|584240453|FG000|Overall Study|Death|1|||
161780852|NCT01500434|584240453|FG000|Overall Study|Withdrawal by Subject|1|||
161780853|NCT01500434|584240453|FG000|Overall Study|Missed 12-month follow-up|5|||
161780854|NCT00096031|584240454|FG000|Overall Study|Adverse Event|3|||
161780855|NCT00096031|584240454|FG000|Overall Study|Lack of Efficacy|42|||
161780856|NCT00096031|584240454|FG000|Overall Study|Death|4|||
161780857|NCT00096031|584240454|FG000|Overall Study|Withdrawal by Subject|1|||
161780858|NCT00096031|584240454|FG000|Overall Study|Ineligible|8|||
161780859|NCT00096031|584240454|FG000|Overall Study|Not protocol specified|5|||
161780860|NCT00483717|584240455|FG000|Overall Study|Protocol Violation|5|||
161780861|NCT00483717|584240456|FG001|Overall Study|Protocol Violation|7|||
161780862|NCT00483717|584240455|FG000|Overall Study|Time of dosing missing|1|||
161780863|NCT00483717|584240456|FG001|Overall Study|Time of dosing missing|1|||
161780864|NCT00483717|584240455|FG000|Overall Study|No treatment for migraine|16|||
161780865|NCT00483717|584240456|FG001|Overall Study|No treatment for migraine|13|||
161780866|NCT00483717|584240455|FG000|Overall Study|Lost to Follow-up|1|||
161780867|NCT00483717|584240456|FG001|Overall Study|Lost to Follow-up|0|||
161780868|NCT00483717|584240455|FG000|Overall Study|Withdrawal by Subject|1|||
161780869|NCT00483717|584240456|FG001|Overall Study|Withdrawal by Subject|0|||
161780870|NCT00083226|584240457|FG000|Overall Study|Lack of Efficacy|19|||
161780871|NCT00083226|584240457|FG000|Overall Study|Adverse Event|9|||
161780872|NCT00083226|584240457|FG000|Overall Study|Death|4|||
161780873|NCT00083226|584240457|FG000|Overall Study|Withdrawal by Subject|4|||
161780874|NCT00083226|584240457|FG000|Overall Study|Other|2|||
161780875|NCT00083226|584240457|FG000|Overall Study|ineligible or not receiving treatment|4|||
161780876|NCT00909857|584240458|FG000|Overall Study|Withdrawal by Subject|6|||
161780877|NCT00909857|584240459|FG001|Overall Study|Withdrawal by Subject|10|||
161780878|NCT00909857|584240458|FG000|Overall Study|Adverse Event|5|||
161780879|NCT00909857|584240459|FG001|Overall Study|Adverse Event|5|||
161780880|NCT00909857|584240458|FG000|Overall Study|Lost to Follow-up|2|||
161780881|NCT00909857|584240459|FG001|Overall Study|Lost to Follow-up|5|||
161780882|NCT00909857|584240458|FG000|Overall Study|Protocol Violation|2|||
161780883|NCT00909857|584240459|FG001|Overall Study|Protocol Violation|1|||
161780884|NCT00909857|584240458|FG000|Overall Study|Pregnancy|1|||
161780885|NCT00909857|584240459|FG001|Overall Study|Pregnancy|0|||
161780886|NCT00909857|584240458|FG000|Overall Study|Other|1|||
161780887|NCT00909857|584240459|FG001|Overall Study|Other|0|||
161780888|NCT00909857|584240458|FG000|Overall Study|Did not receive study medication|19|||
161780889|NCT00909857|584240459|FG001|Overall Study|Did not receive study medication|24|||
161780890|NCT03878108|584240460|FG000|Overall Study|Adverse Event|1|||
161780891|NCT03878108|584240461|FG001|Overall Study|Adverse Event|0|||
161780892|NCT00604175|584240462|FG000|Entry Through Week 28|Death|2|||
161780893|NCT00604175|584240463|FG001|Entry Through Week 28|Death|0|||
161780894|NCT00604175|584240464|FG002|Entry Through Week 28|Death|0|||
161780895|NCT00604175|584240462|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
161780896|NCT00604175|584240463|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
161780897|NCT00604175|584240464|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
161780898|NCT00604175|584240462|FG000|Entry Through Week 28|Lost to Follow-up|4|||
161780899|NCT00604175|584240463|FG001|Entry Through Week 28|Lost to Follow-up|3|||
161780900|NCT00604175|584240464|FG002|Entry Through Week 28|Lost to Follow-up|0|||
161780901|NCT00604175|584240462|FG000|Entry Through Week 28|Ineligible|1|||
161780902|NCT00604175|584240463|FG001|Entry Through Week 28|Ineligible|0|||
161780903|NCT00604175|584240464|FG002|Entry Through Week 28|Ineligible|0|||
161780904|NCT00604175|584240462|FG000|Entry Through Week 28|Did not start intervention|2|||
161780905|NCT00604175|584240463|FG001|Entry Through Week 28|Did not start intervention|0|||
161780906|NCT00604175|584240464|FG002|Entry Through Week 28|Did not start intervention|1|||
161780907|NCT00604175|584240462|FG000|Week 29 Through Week 72|Death|0|||
161780908|NCT00604175|584240463|FG001|Week 29 Through Week 72|Death|0|||
161780909|NCT00604175|584240464|FG002|Week 29 Through Week 72|Death|1|||
161780910|NCT00604175|584240462|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
161780911|NCT00604175|584240463|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
161780912|NCT00604175|584240464|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
161780913|NCT00604175|584240462|FG000|Week 29 Through Week 72|Site closure|0|||
161780914|NCT00604175|584240463|FG001|Week 29 Through Week 72|Site closure|1|||
161780915|NCT00604175|584240464|FG002|Week 29 Through Week 72|Site closure|0|||
161780916|NCT00604175|584240462|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
161780917|NCT00604175|584240463|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
161780918|NCT00604175|584240464|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
161780919|NCT03353415|584240465|FG000|Masked CGM Wear|Lost to Follow-up|2|||
161831478|NCT01730040|584424758|FG001|Overall Study|Adverse Event|3|||
161667442|NCT01001832|583835740|FG001|Short-term Period|Adverse Event|3|||
161667443|NCT01001832|583835739|FG000|Long-term Period|Adverse Event|2|||
161667444|NCT01001832|583835740|FG001|Long-term Period|Adverse Event|1|||
161667445|NCT01001832|583835739|FG000|Long-term Period|Withdrawal by Subject|1|||
161667446|NCT01001832|583835740|FG001|Long-term Period|Withdrawal by Subject|0|||
161667447|NCT01001832|583835739|FG000|Long-term Period|Lack of Efficacy|0|||
161667448|NCT01001832|583835740|FG001|Long-term Period|Lack of Efficacy|2|||
161667449|NCT01001832|583835739|FG000|Long-term Period|Other|1|||
161667450|NCT01001832|583835740|FG001|Long-term Period|Other|2|||
161667451|NCT01001832|583835739|FG000|Follow-up Period|Withdrawal by Subject|1|||
161667452|NCT01001832|583835740|FG001|Follow-up Period|Withdrawal by Subject|0|||
161667453|NCT01001832|583835739|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
161667454|NCT01001832|583835740|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
161667455|NCT01001832|583835739|FG000|Follow-up Period|Other|2|||
161667456|NCT01001832|583835740|FG001|Follow-up Period|Other|1|||
161667457|NCT01032382|583835742|FG000|Overall Study|Disease dissemination|1|||
161667458|NCT01032382|583835743|FG001|Overall Study|Disease dissemination|1|||
161667459|NCT01032382|583835742|FG000|Overall Study|Treatment failure|3|||
161667460|NCT01032382|583835743|FG001|Overall Study|Treatment failure|1|||
161667461|NCT01032382|583835742|FG000|Overall Study|Index lesion relapse|1|||
161667462|NCT01032382|583835743|FG001|Overall Study|Index lesion relapse|3|||
161667463|NCT01012713|583835744|FG000|Overall Study|Lack of Efficacy|3|||
161667464|NCT01242800|583835745|FG000|Overall Study|Patient refusal|0|||
161667465|NCT01242800|583835746|FG001|Overall Study|Patient refusal|10|||
161667466|NCT01242800|583835745|FG000|Overall Study|Physician Decision|0|||
161667467|NCT01242800|583835746|FG001|Overall Study|Physician Decision|1|||
161667468|NCT01242800|583835745|FG000|Overall Study|Disease progression|0|||
161667469|NCT01242800|583835746|FG001|Overall Study|Disease progression|3|||
161667470|NCT01242800|583835745|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
161667471|NCT01242800|583835746|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
161667472|NCT01242800|583835745|FG000|Overall Study|Reasons not reported|0|||
161667473|NCT01242800|583835746|FG001|Overall Study|Reasons not reported|4|||
161667474|NCT04508023|583835748|FG000|Overall Study|Withdrawal by Subject|1|||
161667475|NCT04508023|583835749|FG001|Overall Study|Withdrawal by Subject|2|||
161667476|NCT00511901|583835757|FG000|Overall Study|Withdrawal by Subject|1|||
161667477|NCT00511901|583835758|FG001|Overall Study|Withdrawal by Subject|3|||
161667478|NCT02447172|583835759|FG000|Overall Study|Adverse Event|11|||
161667479|NCT02447172|583835760|FG001|Overall Study|Adverse Event|8|||
161667480|NCT02447172|583835761|FG002|Overall Study|Adverse Event|7|||
161667481|NCT02447172|583835759|FG000|Overall Study|Death|3|||
161667482|NCT02447172|583835760|FG001|Overall Study|Death|1|||
161667483|NCT02447172|583835761|FG002|Overall Study|Death|0|||
161667484|NCT02447172|583835759|FG000|Overall Study|Protocol Violation|2|||
161667485|NCT02447172|583835760|FG001|Overall Study|Protocol Violation|1|||
161667486|NCT02447172|583835761|FG002|Overall Study|Protocol Violation|2|||
161667487|NCT02447172|583835759|FG000|Overall Study|Lost to Follow-up|7|||
161667488|NCT02447172|583835760|FG001|Overall Study|Lost to Follow-up|4|||
161667489|NCT02447172|583835761|FG002|Overall Study|Lost to Follow-up|4|||
161667490|NCT02447172|583835759|FG000|Overall Study|Withdrawal by Subject|5|||
161667491|NCT02447172|583835760|FG001|Overall Study|Withdrawal by Subject|1|||
161667492|NCT02447172|583835761|FG002|Overall Study|Withdrawal by Subject|3|||
161667493|NCT02447172|583835759|FG000|Overall Study|protocol specific treatment unrelated|3|||
161667494|NCT02447172|583835760|FG001|Overall Study|protocol specific treatment unrelated|0|||
161667495|NCT02447172|583835761|FG002|Overall Study|protocol specific treatment unrelated|2|||
161667496|NCT03562247|583835765|FG000|Overall Study|Lost to Follow-up|3|||
161667497|NCT03562247|583835766|FG001|Overall Study|Lost to Follow-up|1|||
161667498|NCT03562247|583835767|FG002|Overall Study|Lost to Follow-up|1|||
161667499|NCT00983931|583835768|FG000|14 Day Washout Period|Physician Decision|1|||
161667500|NCT01281969|583835769|FG000|Overall Study|not randomized didn't meet criteria|0|||
161667501|NCT01281969|583835770|FG001|Overall Study|not randomized didn't meet criteria|0|||
161667502|NCT01281969|583835771|FG002|Overall Study|not randomized didn't meet criteria|7|||
161667503|NCT01281969|583835769|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
161667504|NCT01281969|583835770|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
161667505|NCT01281969|583835771|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
161667506|NCT01281969|583835769|FG000|Overall Study|not randomized, child consent not given|0|||
161667507|NCT01281969|583835770|FG001|Overall Study|not randomized, child consent not given|0|||
161667508|NCT01281969|583835771|FG002|Overall Study|not randomized, child consent not given|2|||
161667509|NCT02409368|583835776|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
161667510|NCT02409368|583835777|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
161667511|NCT02409368|583835778|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
161667512|NCT02409368|583835779|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
161667513|NCT02409368|583835776|FG000|ECOG Reclassification|Death|1|||
161667514|NCT02409368|583835777|FG001|ECOG Reclassification|Death|5|||
161667515|NCT02409368|583835778|FG002|ECOG Reclassification|Death|0|||
161667516|NCT02409368|583835779|FG003|ECOG Reclassification|Death|0|||
161667517|NCT02409368|583835776|FG000|ECOG Reclassification|Disease Progression|113|||
161780920|NCT03353415|584240465|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
161780921|NCT00131937|584240466|FG000|Overall Study|Adverse Event|3|||
161780922|NCT00131937|584240466|FG000|Overall Study|Withdrawal by Subject|2|||
161780923|NCT00131937|584240466|FG000|Overall Study|Physician Decision|1|||
161780924|NCT00131937|584240466|FG000|Overall Study|Disease Progression|7|||
161780925|NCT00131937|584240466|FG000|Overall Study|Alternative therapy|1|||
161780926|NCT04647253|584240473|FG000|Overall Study|Death ≤ 365 Days|16|||
161780927|NCT04647253|584240474|FG001|Overall Study|Death ≤ 365 Days|7|||
161780928|NCT04647253|584240473|FG000|Overall Study|Physician Decision|0|||
161780929|NCT04647253|584240474|FG001|Overall Study|Physician Decision|1|||
161780930|NCT04647253|584240473|FG000|Overall Study|Withdrawal by Subject|7|||
161780931|NCT04647253|584240474|FG001|Overall Study|Withdrawal by Subject|2|||
161780932|NCT04647253|584240473|FG000|Overall Study|Missed 12-Month Visit|9|||
161780933|NCT04647253|584240474|FG001|Overall Study|Missed 12-Month Visit|7|||
161780934|NCT04647253|584240473|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
161780935|NCT04647253|584240474|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
161780936|NCT04502862|584240477|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
161780937|NCT04502862|584240478|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
161780938|NCT04502862|584240477|FG000|Overall Study|Withdrawal by Subject|1|||
161780939|NCT04502862|584240478|FG001|Overall Study|Withdrawal by Subject|0|||
161780940|NCT04502862|584240477|FG000|Overall Study|Adverse Event|1|||
161780941|NCT04502862|584240478|FG001|Overall Study|Adverse Event|1|||
161780942|NCT02038959|584241929|FG000|Overall Study|Withdrawal by Subject|6|||
161780943|NCT02038959|584241930|FG001|Overall Study|Withdrawal by Subject|8|||
161780944|NCT00819091|584241936|FG000|Overall Study|Adverse Event|3|||
161780945|NCT00819091|584241937|FG001|Overall Study|Adverse Event|5|||
161780946|NCT00819091|584241936|FG000|Overall Study|Protocol Violation|0|||
161780947|NCT00819091|584241937|FG001|Overall Study|Protocol Violation|1|||
161780948|NCT00819091|584241936|FG000|Overall Study|Lost to Follow-up|2|||
161780949|NCT00819091|584241937|FG001|Overall Study|Lost to Follow-up|0|||
161780950|NCT00819091|584241936|FG000|Overall Study|Withdrawal by Subject|1|||
161780951|NCT00819091|584241937|FG001|Overall Study|Withdrawal by Subject|2|||
161780952|NCT00819091|584241936|FG000|Overall Study|Other|1|||
161780953|NCT00819091|584241937|FG001|Overall Study|Other|2|||
161780954|NCT00545441|584241938|FG000|Overall Study|Fistula draining at 6 months|2|||
161780955|NCT00545441|584241939|FG001|Overall Study|Fistula draining at 6 months|4|||
161780956|NCT00545441|584241938|FG000|Overall Study|Lost to Follow-up|9|||
161780957|NCT00545441|584241939|FG001|Overall Study|Lost to Follow-up|5|||
161780958|NCT00545441|584241938|FG000|Overall Study|Technical failure|0|||
161780959|NCT00545441|584241939|FG001|Overall Study|Technical failure|1|||
161780960|NCT00545441|584241938|FG000|Overall Study|Withdrawal by Subject|1|||
161780961|NCT00545441|584241939|FG001|Overall Study|Withdrawal by Subject|1|||
161780962|NCT00545441|584241938|FG000|Overall Study|Persistence or recurrence of fistula|5|||
161780963|NCT00545441|584241939|FG001|Overall Study|Persistence or recurrence of fistula|2|||
161780964|NCT00545441|584241938|FG000|Overall Study|Patients were not treated|1|||
161780965|NCT00545441|584241939|FG001|Overall Study|Patients were not treated|3|||
161780966|NCT03911960|584241940|FG000|Overall Study|Lost to Follow-up|5|||
161780967|NCT03911960|584241941|FG001|Overall Study|Lost to Follow-up|3|||
161780968|NCT00265239|584241942|FG000|Overall Study|Adverse Event|2|||
161780969|NCT00265239|584241943|FG001|Overall Study|Adverse Event|1|||
161780970|NCT00424515|584241944|FG000|Overall Study|Progressive Disease|10|||
161780971|NCT00424515|584241945|FG001|Overall Study|Progressive Disease|11|||
161780972|NCT00424515|584241944|FG000|Overall Study|Adverse Event|0|||
161780973|NCT00424515|584241945|FG001|Overall Study|Adverse Event|1|||
161780974|NCT00424515|584241944|FG000|Overall Study|Intercurrent Illness|0|||
161780975|NCT00424515|584241945|FG001|Overall Study|Intercurrent Illness|1|||
161780976|NCT00424515|584241944|FG000|Overall Study|Withdrawal by Subject|1|||
161780977|NCT00424515|584241945|FG001|Overall Study|Withdrawal by Subject|0|||
161780978|NCT04071366|584241946|FG000|Part 1: Open-label (29 Days)|Death|4|||
161780979|NCT04071366|584241947|FG001|Part 1: Open-label (29 Days)|Death|2|||
161780980|NCT04071366|584241948|FG002|Part 1: Open-label (29 Days)|Death|8|||
161780981|NCT04071366|584241949|FG003|Part 1: Open-label (29 Days)|Death|0|||
161780982|NCT04071366|584241950|FG004|Part 1: Open-label (29 Days)|Death|0|||
161780983|NCT04071366|584241946|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780984|NCT04071366|584241947|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780985|NCT04071366|584241948|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
161780986|NCT04071366|584241949|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780987|NCT04071366|584241950|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780988|NCT04071366|584241946|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
161780989|NCT04071366|584241947|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161780990|NCT04071366|584241948|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
161780991|NCT04071366|584241949|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161780992|NCT04071366|584241950|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161780993|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Death|0|||
161780994|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Death|0|||
161780995|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Death|0|||
161780996|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Death|2|||
161780997|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Death|2|||
161780998|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161780999|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161781000|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161781001|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161781002|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
161781003|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781004|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781005|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781006|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781007|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
161781008|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161781009|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161781010|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161781011|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
161781012|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
161781013|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781014|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781015|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781016|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781017|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
161781018|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781019|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781020|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781021|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
161781022|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781023|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781024|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781025|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781026|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
161781027|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781028|NCT01858558|584241951|FG000|Overall Study|Death|1|||
161781029|NCT01858558|584241952|FG001|Overall Study|Death|1|||
161781030|NCT01858558|584241951|FG000|Overall Study|Lost to Follow-up|1|||
161781031|NCT01858558|584241952|FG001|Overall Study|Lost to Follow-up|0|||
161781032|NCT01858558|584241951|FG000|Overall Study|Disease progression|3|||
161781033|NCT01858558|584241952|FG001|Overall Study|Disease progression|1|||
161781034|NCT01858558|584241951|FG000|Overall Study|Product contamination|2|||
161781035|NCT01858558|584241952|FG001|Overall Study|Product contamination|0|||
161781036|NCT01858558|584241951|FG000|Overall Study|Failed expansion of cell product|2|||
161781037|NCT01858558|584241952|FG001|Overall Study|Failed expansion of cell product|0|||
161781038|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
161781039|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161781040|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161781041|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161781042|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
161781043|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161781044|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161781045|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161781046|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
161781047|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
161781048|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
161781049|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161781050|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
161781051|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
161781052|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
161781053|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
161781054|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
161781055|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161781056|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161781057|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161781058|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161781059|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
161781060|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
161781061|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
161667518|NCT02409368|583835777|FG001|ECOG Reclassification|Disease Progression|382|||
161667519|NCT02409368|583835778|FG002|ECOG Reclassification|Disease Progression|70|||
161667520|NCT02409368|583835779|FG003|ECOG Reclassification|Disease Progression|1|||
161667521|NCT02409368|583835776|FG000|ECOG Reclassification|Lost to Follow-up|1|||
161667522|NCT02409368|583835777|FG001|ECOG Reclassification|Lost to Follow-up|5|||
161667523|NCT02409368|583835778|FG002|ECOG Reclassification|Lost to Follow-up|0|||
161667524|NCT02409368|583835779|FG003|ECOG Reclassification|Lost to Follow-up|0|||
161667525|NCT02409368|583835776|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
161667526|NCT02409368|583835777|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
161781062|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161667527|NCT02409368|583835778|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
161667528|NCT02409368|583835779|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
161667529|NCT02409368|583835776|FG000|ECOG Reclassification|Poor/non-compliance|0|||
161667530|NCT02409368|583835777|FG001|ECOG Reclassification|Poor/non-compliance|3|||
161667531|NCT02409368|583835778|FG002|ECOG Reclassification|Poor/non-compliance|2|||
161667532|NCT02409368|583835779|FG003|ECOG Reclassification|Poor/non-compliance|0|||
161667533|NCT02409368|583835776|FG000|ECOG Reclassification|Study drug toxicity|17|||
161667534|NCT02409368|583835777|FG001|ECOG Reclassification|Study drug toxicity|42|||
161667535|NCT02409368|583835778|FG002|ECOG Reclassification|Study drug toxicity|7|||
161667536|NCT02409368|583835779|FG003|ECOG Reclassification|Study drug toxicity|0|||
161667537|NCT02409368|583835776|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
161667538|NCT02409368|583835777|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
161667539|NCT02409368|583835778|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
161667540|NCT02409368|583835779|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
161667541|NCT02409368|583835776|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
161781063|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161781064|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161781065|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161781066|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
161781067|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161781068|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161781069|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
161781070|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161781071|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161781072|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161781073|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161781074|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
161781075|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
161667542|NCT02409368|583835777|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
161667543|NCT02409368|583835778|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
161667544|NCT02409368|583835779|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
161781076|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
161781077|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
161781078|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161781079|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
161781080|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161781081|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161781082|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161781083|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
161781084|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161781085|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
161781086|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161781087|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
161781088|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
161781089|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
161781090|NCT00399490|584241961|FG000|Overall Study|Adverse Event|19|||
161781091|NCT00399490|584241961|FG000|Overall Study|Lack of Efficacy|31|||
161781092|NCT00399490|584241961|FG000|Overall Study|Lost to Follow-up|5|||
161781093|NCT00399490|584241961|FG000|Overall Study|Withdrawal by Subject|18|||
161781094|NCT00399490|584241961|FG000|Overall Study|Other|25|||
161781095|NCT02437890|584241962|FG000|Overall Study|Non-compliance to study drug|0|||
161781096|NCT02437890|584241963|FG001|Overall Study|Non-compliance to study drug|1|||
161667545|NCT02409368|583835776|FG000|ECOG Reclassification|Participant withdrew consent|2|||
161667546|NCT02409368|583835777|FG001|ECOG Reclassification|Participant withdrew consent|3|||
161667547|NCT02409368|583835778|FG002|ECOG Reclassification|Participant withdrew consent|4|||
161667548|NCT02409368|583835779|FG003|ECOG Reclassification|Participant withdrew consent|0|||
161781097|NCT02437890|584241964|FG002|Overall Study|Non-compliance to study drug|0|||
161781098|NCT02437890|584241965|FG003|Overall Study|Non-compliance to study drug|0|||
161781099|NCT02437890|584241966|FG004|Overall Study|Non-compliance to study drug|1|||
161781100|NCT02437890|584241962|FG000|Overall Study|Sponsor's decision|1|||
161781101|NCT02437890|584241963|FG001|Overall Study|Sponsor's decision|1|||
161781102|NCT02437890|584241964|FG002|Overall Study|Sponsor's decision|4|||
161781103|NCT02437890|584241965|FG003|Overall Study|Sponsor's decision|0|||
161781104|NCT02437890|584241966|FG004|Overall Study|Sponsor's decision|2|||
161781105|NCT02437890|584241962|FG000|Overall Study|Physician Decision|0|||
161781106|NCT02437890|584241963|FG001|Overall Study|Physician Decision|0|||
161781107|NCT02437890|584241964|FG002|Overall Study|Physician Decision|0|||
161781108|NCT02437890|584241965|FG003|Overall Study|Physician Decision|1|||
161781109|NCT02437890|584241966|FG004|Overall Study|Physician Decision|0|||
161781110|NCT02437890|584241962|FG000|Overall Study|Unable to attend visit(s)|1|||
161781111|NCT02437890|584241963|FG001|Overall Study|Unable to attend visit(s)|0|||
161781112|NCT02437890|584241964|FG002|Overall Study|Unable to attend visit(s)|0|||
161781113|NCT02437890|584241965|FG003|Overall Study|Unable to attend visit(s)|0|||
161781114|NCT02437890|584241966|FG004|Overall Study|Unable to attend visit(s)|0|||
161781115|NCT02437890|584241962|FG000|Overall Study|Lack of Efficacy|1|||
161781116|NCT02437890|584241963|FG001|Overall Study|Lack of Efficacy|3|||
161781117|NCT02437890|584241964|FG002|Overall Study|Lack of Efficacy|0|||
161781118|NCT02437890|584241965|FG003|Overall Study|Lack of Efficacy|3|||
161781119|NCT02437890|584241966|FG004|Overall Study|Lack of Efficacy|1|||
161781120|NCT02437890|584241962|FG000|Overall Study|Adverse Event|4|||
161781121|NCT02437890|584241963|FG001|Overall Study|Adverse Event|9|||
161781122|NCT02437890|584241964|FG002|Overall Study|Adverse Event|5|||
161781123|NCT02437890|584241965|FG003|Overall Study|Adverse Event|11|||
161781124|NCT02437890|584241966|FG004|Overall Study|Adverse Event|7|||
161781125|NCT02437890|584241962|FG000|Overall Study|Withdrawal by Subject|1|||
161781126|NCT02437890|584241963|FG001|Overall Study|Withdrawal by Subject|2|||
161781127|NCT02437890|584241964|FG002|Overall Study|Withdrawal by Subject|6|||
161781128|NCT02437890|584241965|FG003|Overall Study|Withdrawal by Subject|5|||
161781129|NCT02437890|584241966|FG004|Overall Study|Withdrawal by Subject|5|||
161781130|NCT02437890|584241962|FG000|Overall Study|Death|0|||
161781131|NCT02437890|584241963|FG001|Overall Study|Death|0|||
161781132|NCT02437890|584241964|FG002|Overall Study|Death|0|||
161781133|NCT02437890|584241965|FG003|Overall Study|Death|2|||
161781134|NCT02437890|584241966|FG004|Overall Study|Death|0|||
161781135|NCT02328547|584241967|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
161781136|NCT02328547|584241968|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
161781137|NCT02328547|584241967|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161781138|NCT02328547|584241968|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161781139|NCT00344305|584241969|FG000|Overall Study|Lost to Follow-up|2|||
161781140|NCT00344305|584241970|FG001|Overall Study|Lost to Follow-up|0|||
161781141|NCT00344305|584241969|FG000|Overall Study|Participant was not contacted in window|0|||
161781142|NCT00344305|584241970|FG001|Overall Study|Participant was not contacted in window|1|||
161781143|NCT01422720|584241972|FG000|Overall Study|Adverse Event|16|||
161781144|NCT01422720|584241972|FG000|Overall Study|Lack of Efficacy|1|||
161781145|NCT01422720|584241972|FG000|Overall Study|Withdrawal by Subject|4|||
161781146|NCT01422720|584241972|FG000|Overall Study|Ineligibility|1|||
161781147|NCT01537549|584241981|FG000|Overall Study|Lost to Follow-up|1|||
161781148|NCT01537549|584241981|FG000|Overall Study|Withdrawal by Subject|2|||
161781149|NCT00883740|584241982|FG000|First Intervention|Lost to Follow-up|1|||
161781150|NCT00883740|584241983|FG001|First Intervention|Lost to Follow-up|0|||
161781151|NCT00883740|584241982|FG000|First Intervention|No longer willing to participate|2|||
161781152|NCT00883740|584241983|FG001|First Intervention|No longer willing to participate|0|||
161781153|NCT00883740|584241982|FG000|First Intervention|Protocol Violation|3|||
161781154|NCT00883740|584241983|FG001|First Intervention|Protocol Violation|6|||
161781155|NCT00883740|584241982|FG000|First Intervention|Adverse Event|1|||
161781156|NCT00883740|584241983|FG001|First Intervention|Adverse Event|2|||
161781157|NCT00883740|584241982|FG000|Second Intervention|Protocol Violation|1|||
161781158|NCT00883740|584241983|FG001|Second Intervention|Protocol Violation|0|||
161781159|NCT00883740|584241982|FG000|Second Intervention|No longer willing to participate|0|||
161781160|NCT00883740|584241983|FG001|Second Intervention|No longer willing to participate|1|||
161781161|NCT04840901|584241986|FG000|Overall Study|Lost to Follow-up|3|||
161781162|NCT04840901|584241987|FG001|Overall Study|Lost to Follow-up|1|||
161781163|NCT04840901|584241986|FG000|Overall Study|Moved|1|||
161781164|NCT04840901|584241987|FG001|Overall Study|Moved|0|||
161781165|NCT04840901|584241986|FG000|Overall Study|Unable to comply with study schedule|0|||
161781166|NCT04840901|584241987|FG001|Overall Study|Unable to comply with study schedule|1|||
161781167|NCT04840901|584241986|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
161781168|NCT04840901|584241987|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
161781169|NCT00103259|584241988|FG000|Overall Study|Death|3|||
161781170|NCT00103259|584241989|FG001|Overall Study|Death|2|||
161781171|NCT00103259|584241988|FG000|Overall Study|Withdrawal by Subject|2|||
161781172|NCT00103259|584241989|FG001|Overall Study|Withdrawal by Subject|3|||
161667549|NCT02409368|583835776|FG000|ECOG Reclassification|Other Reasons|5|||
161667550|NCT02409368|583835777|FG001|ECOG Reclassification|Other Reasons|26|||
161667551|NCT02409368|583835778|FG002|ECOG Reclassification|Other Reasons|2|||
161667552|NCT02409368|583835779|FG003|ECOG Reclassification|Other Reasons|0|||
161667553|NCT02409368|583835776|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
161667554|NCT02409368|583835777|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
161667555|NCT02409368|583835778|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
161667556|NCT02409368|583835779|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
161667557|NCT01296347|583835780|FG000|Allocation|Withdrawal by Subject|1|||
161667558|NCT01296347|583835781|FG001|Allocation|Withdrawal by Subject|2|||
161667559|NCT01296347|583835780|FG000|Allocation|Lack of Efficacy|1|||
161667560|NCT01296347|583835781|FG001|Allocation|Lack of Efficacy|2|||
161667561|NCT01296347|583835780|FG000|Allocation|not received infusion|1|||
161667562|NCT01296347|583835781|FG001|Allocation|not received infusion|0|||
161667563|NCT01296347|583835780|FG000|6 Week Follow up|Death|0|||
161667564|NCT01296347|583835781|FG001|6 Week Follow up|Death|1|||
161667565|NCT01296347|583835780|FG000|3 Month Follow up|Death|1|||
161667566|NCT01296347|583835781|FG001|3 Month Follow up|Death|0|||
161667567|NCT01296347|583835780|FG000|3 Month Follow up|Lost to Follow-up|0|||
161667568|NCT01296347|583835781|FG001|3 Month Follow up|Lost to Follow-up|1|||
161667569|NCT01296347|583835780|FG000|6 Month Follow up|Death|2|||
161667570|NCT01296347|583835781|FG001|6 Month Follow up|Death|1|||
161667571|NCT01296347|583835780|FG000|6 Month Follow up|Lost to Follow-up|0|||
161667572|NCT01296347|583835781|FG001|6 Month Follow up|Lost to Follow-up|1|||
161667573|NCT01296347|583835780|FG000|12 Month Follow up|Lost to Follow-up|3|||
161667574|NCT01296347|583835781|FG001|12 Month Follow up|Lost to Follow-up|1|||
161667575|NCT01296347|583835780|FG000|12 Month Follow up|Death|1|||
161667576|NCT01296347|583835781|FG001|12 Month Follow up|Death|1|||
161667577|NCT01296347|583835780|FG000|12 Month Follow up|Withdrawal by Subject|0|||
161667578|NCT01296347|583835781|FG001|12 Month Follow up|Withdrawal by Subject|1|||
161667579|NCT02240693|583835782|FG000|Overall Study|Adverse Event|0|||
161667580|NCT02240693|583835783|FG001|Overall Study|Adverse Event|0|||
161667581|NCT02240693|583835784|FG002|Overall Study|Adverse Event|0|||
161667582|NCT02240693|583835785|FG003|Overall Study|Adverse Event|0|||
161667583|NCT02240693|583835786|FG004|Overall Study|Adverse Event|1|||
161667584|NCT02240693|583835782|FG000|Overall Study|Withdrawal by Subject|0|||
161667585|NCT02240693|583835783|FG001|Overall Study|Withdrawal by Subject|0|||
161667586|NCT02240693|583835784|FG002|Overall Study|Withdrawal by Subject|2|||
161667587|NCT02240693|583835785|FG003|Overall Study|Withdrawal by Subject|1|||
161667588|NCT02240693|583835786|FG004|Overall Study|Withdrawal by Subject|0|||
161667589|NCT02240693|583835782|FG000|Overall Study|Other than specified|0|||
161667590|NCT02240693|583835783|FG001|Overall Study|Other than specified|0|||
161667591|NCT02240693|583835784|FG002|Overall Study|Other than specified|2|||
161667592|NCT02240693|583835785|FG003|Overall Study|Other than specified|0|||
161667593|NCT02240693|583835786|FG004|Overall Study|Other than specified|0|||
161667594|NCT03343301|583835787|FG000|Overall Study|Withdrawal by Subject|1|||
161667595|NCT03343301|583835788|FG001|Overall Study|Withdrawal by Subject|1|||
161667596|NCT03343301|583835787|FG000|Overall Study|Death|0|||
161667597|NCT03343301|583835788|FG001|Overall Study|Death|2|||
161667598|NCT03343301|583835787|FG000|Overall Study|Other|0|||
161667599|NCT03343301|583835788|FG001|Overall Study|Other|6|||
161667600|NCT03343301|583835787|FG000|Overall Study|Missing|2|||
161667601|NCT03343301|583835788|FG001|Overall Study|Missing|0|||
161781173|NCT00103259|584241988|FG000|Overall Study|alternative therapy|1|||
161667602|NCT02668185|583835791|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
161667603|NCT02668185|583835792|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
161781174|NCT00103259|584241989|FG001|Overall Study|alternative therapy|0|||
161781175|NCT00103259|584241988|FG000|Overall Study|other (reasons were not specified)|2|||
161781176|NCT00103259|584241989|FG001|Overall Study|other (reasons were not specified)|1|||
161781177|NCT00103259|584241988|FG000|Overall Study|ineligible/no protocol therapy|4|||
161781178|NCT00103259|584241989|FG001|Overall Study|ineligible/no protocol therapy|6|||
161781179|NCT03224234|584241990|FG000|Main Study|Lost to Follow-up|5|||
161781180|NCT03224234|584241991|FG001|Main Study|Lost to Follow-up|5|||
161781181|NCT02610842|584241992|FG000|Overall Study|Lost to Follow-up|5|||
161781182|NCT02494583|584241995|FG000|Overall Study|Death|224|||
161781183|NCT02494583|584241996|FG001|Overall Study|Death|214|||
161781184|NCT02494583|584241997|FG002|Overall Study|Death|225|||
161781185|NCT02494583|584241995|FG000|Overall Study|Lost to Follow-up|1|||
161781186|NCT02494583|584241996|FG001|Overall Study|Lost to Follow-up|0|||
161781187|NCT02494583|584241997|FG002|Overall Study|Lost to Follow-up|0|||
161781188|NCT02494583|584241995|FG000|Overall Study|Protocol Violation|1|||
161781189|NCT02494583|584241996|FG001|Overall Study|Protocol Violation|2|||
161781190|NCT02494583|584241997|FG002|Overall Study|Protocol Violation|0|||
161667604|NCT02668185|583835791|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
161667605|NCT02668185|583835792|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
161667606|NCT02668185|583835791|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
161781191|NCT02494583|584241995|FG000|Overall Study|Screen Failure|0|||
161781192|NCT02494583|584241996|FG001|Overall Study|Screen Failure|1|||
161895388|NCT02457195|584666328|FG000|Overall Study|Withdrawal by Subject|4|||
161895389|NCT02328937|584666331|FG000|Period 1|Lost to Follow-up|0|||
161895390|NCT02328937|584666332|FG001|Period 1|Lost to Follow-up|0|||
161895391|NCT02328937|584666333|FG002|Period 1|Lost to Follow-up|0|||
161895392|NCT02328937|584666334|FG003|Period 1|Lost to Follow-up|1|||
161895393|NCT02328937|584666335|FG004|Period 1|Lost to Follow-up|0|||
161895394|NCT02328937|584666336|FG005|Period 1|Lost to Follow-up|0|||
161895395|NCT02328937|584666331|FG000|Period 2|Adverse Event|0|||
161895396|NCT02328937|584666332|FG001|Period 2|Adverse Event|0|||
161895397|NCT02328937|584666333|FG002|Period 2|Adverse Event|1|||
161895398|NCT02328937|584666334|FG003|Period 2|Adverse Event|0|||
161895399|NCT02328937|584666335|FG004|Period 2|Adverse Event|0|||
161895400|NCT02328937|584666336|FG005|Period 2|Adverse Event|0|||
161895401|NCT00435461|584666341|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
161895402|NCT00435461|584666342|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
161895403|NCT00435461|584666343|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
161895404|NCT00435461|584666341|FG000|Overall Study|Protocol Violation|6|||
161895405|NCT00435461|584666342|FG001|Overall Study|Protocol Violation|9|||
161895406|NCT00435461|584666343|FG002|Overall Study|Protocol Violation|10|||
161895407|NCT00435461|584666341|FG000|Overall Study|Participant randomized(inadequate score)|1|||
161895408|NCT00435461|584666342|FG001|Overall Study|Participant randomized(inadequate score)|0|||
161895409|NCT00435461|584666343|FG002|Overall Study|Participant randomized(inadequate score)|0|||
161895410|NCT00435461|584666341|FG000|Overall Study|Compliance less than 80 percent|1|||
161895411|NCT00435461|584666342|FG001|Overall Study|Compliance less than 80 percent|0|||
161895412|NCT00435461|584666343|FG002|Overall Study|Compliance less than 80 percent|0|||
161895413|NCT00435461|584666341|FG000|Overall Study|In error, two study medications switched|1|||
161895414|NCT00435461|584666342|FG001|Overall Study|In error, two study medications switched|0|||
161895415|NCT00435461|584666343|FG002|Overall Study|In error, two study medications switched|0|||
161895416|NCT00435461|584666341|FG000|Overall Study|Lack of Efficacy|2|||
161895417|NCT00435461|584666342|FG001|Overall Study|Lack of Efficacy|1|||
161895418|NCT00435461|584666343|FG002|Overall Study|Lack of Efficacy|0|||
161895419|NCT00435461|584666341|FG000|Overall Study|Withdrawal by Subject|1|||
161895420|NCT00435461|584666342|FG001|Overall Study|Withdrawal by Subject|0|||
161895421|NCT00435461|584666343|FG002|Overall Study|Withdrawal by Subject|2|||
161895422|NCT00435461|584666341|FG000|Overall Study|Randomized in error|1|||
161895423|NCT00435461|584666342|FG001|Overall Study|Randomized in error|0|||
161895424|NCT00435461|584666343|FG002|Overall Study|Randomized in error|0|||
161895425|NCT00435461|584666341|FG000|Overall Study|Participant could not tolerate symptoms|0|||
161895426|NCT00435461|584666342|FG001|Overall Study|Participant could not tolerate symptoms|0|||
161895427|NCT00435461|584666343|FG002|Overall Study|Participant could not tolerate symptoms|1|||
161895428|NCT00435461|584666341|FG000|Overall Study|Participant could not swallow capsule|0|||
161895429|NCT00435461|584666342|FG001|Overall Study|Participant could not swallow capsule|0|||
161895430|NCT00435461|584666343|FG002|Overall Study|Participant could not swallow capsule|1|||
161895431|NCT00435461|584666341|FG000|Overall Study|Pregnancy|2|||
161895432|NCT00435461|584666342|FG001|Overall Study|Pregnancy|0|||
161895433|NCT00435461|584666343|FG002|Overall Study|Pregnancy|0|||
161895434|NCT00435461|584666341|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
161895435|NCT00435461|584666342|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
161895436|NCT00435461|584666343|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
161895437|NCT00435461|584666341|FG000|Overall Study|Participant ended study one day early|1|||
161895438|NCT00435461|584666342|FG001|Overall Study|Participant ended study one day early|0|||
161895439|NCT00435461|584666343|FG002|Overall Study|Participant ended study one day early|0|||
161895440|NCT00435461|584666341|FG000|Overall Study|Noncompliance with study requirements|1|||
161895441|NCT00435461|584666342|FG001|Overall Study|Noncompliance with study requirements|1|||
161895442|NCT00435461|584666343|FG002|Overall Study|Noncompliance with study requirements|1|||
161895443|NCT00435461|584666341|FG000|Overall Study|Adverse Event|1|||
161895444|NCT00435461|584666342|FG001|Overall Study|Adverse Event|2|||
161895445|NCT00435461|584666343|FG002|Overall Study|Adverse Event|6|||
161895446|NCT00435461|584666341|FG000|Overall Study|Non-Compliance of diary|2|||
161895447|NCT00435461|584666342|FG001|Overall Study|Non-Compliance of diary|0|||
161895448|NCT00435461|584666343|FG002|Overall Study|Non-Compliance of diary|1|||
161895449|NCT00435461|584666341|FG000|Overall Study|Lost to Follow-up|1|||
161895450|NCT00435461|584666342|FG001|Overall Study|Lost to Follow-up|1|||
161895451|NCT00435461|584666343|FG002|Overall Study|Lost to Follow-up|2|||
161895452|NCT04676724|584666344|FG000|Overall Study|Adverse Event|2|||
161895453|NCT04676724|584666345|FG001|Overall Study|Adverse Event|0|||
161895454|NCT04676724|584666344|FG000|Overall Study|Lost to Follow-up|1|||
161895455|NCT04676724|584666345|FG001|Overall Study|Lost to Follow-up|0|||
161895456|NCT04676724|584666344|FG000|Overall Study|Physician Decision|0|||
161895457|NCT04676724|584666345|FG001|Overall Study|Physician Decision|1|||
161895458|NCT04676724|584666344|FG000|Overall Study|Withdrawal by Subject|3|||
161895459|NCT04676724|584666345|FG001|Overall Study|Withdrawal by Subject|2|||
161895460|NCT00398047|584666351|FG000|Overall Study|all patient progressed before completion|3|||
161895461|NCT02588092|584666358|FG000|Overall Study|Death|4|||
161895462|NCT02588092|584666359|FG001|Overall Study|Death|3|||
161895463|NCT02588092|584666360|FG002|Overall Study|Death|3|||
161895464|NCT02588092|584666361|FG003|Overall Study|Death|3|||
161895465|NCT02588092|584666362|FG004|Overall Study|Death|2|||
161895466|NCT02588092|584666363|FG005|Overall Study|Death|2|||
161895467|NCT02588092|584666364|FG006|Overall Study|Death|2|||
161895468|NCT02588092|584666365|FG007|Overall Study|Death|1|||
161895469|NCT02588092|584666366|FG008|Overall Study|Death|5|||
161895470|NCT02588092|584666367|FG009|Overall Study|Death|2|||
161895471|NCT02588092|584666358|FG000|Overall Study|Withdrawal by Subject|0|||
161895472|NCT02588092|584666359|FG001|Overall Study|Withdrawal by Subject|0|||
161895473|NCT02588092|584666360|FG002|Overall Study|Withdrawal by Subject|0|||
161895474|NCT02588092|584666361|FG003|Overall Study|Withdrawal by Subject|0|||
161895475|NCT02588092|584666362|FG004|Overall Study|Withdrawal by Subject|0|||
161895476|NCT02588092|584666363|FG005|Overall Study|Withdrawal by Subject|1|||
161895477|NCT02588092|584666364|FG006|Overall Study|Withdrawal by Subject|1|||
161895478|NCT02588092|584666365|FG007|Overall Study|Withdrawal by Subject|2|||
161895479|NCT02588092|584666366|FG008|Overall Study|Withdrawal by Subject|0|||
161895480|NCT02588092|584666367|FG009|Overall Study|Withdrawal by Subject|0|||
161895481|NCT02588092|584666358|FG000|Overall Study|Started Another Treatment|0|||
161895482|NCT02588092|584666359|FG001|Overall Study|Started Another Treatment|0|||
161895483|NCT02588092|584666360|FG002|Overall Study|Started Another Treatment|0|||
161895484|NCT02588092|584666361|FG003|Overall Study|Started Another Treatment|0|||
161895485|NCT02588092|584666362|FG004|Overall Study|Started Another Treatment|1|||
161895486|NCT02588092|584666363|FG005|Overall Study|Started Another Treatment|0|||
161895487|NCT02588092|584666364|FG006|Overall Study|Started Another Treatment|0|||
161895488|NCT02588092|584666365|FG007|Overall Study|Started Another Treatment|1|||
161895489|NCT02588092|584666366|FG008|Overall Study|Started Another Treatment|0|||
161895490|NCT02588092|584666367|FG009|Overall Study|Started Another Treatment|0|||
161895491|NCT02588092|584666358|FG000|Overall Study|Sponsor Decision|0|||
161895492|NCT02588092|584666359|FG001|Overall Study|Sponsor Decision|0|||
161895493|NCT02588092|584666360|FG002|Overall Study|Sponsor Decision|0|||
161895494|NCT02588092|584666361|FG003|Overall Study|Sponsor Decision|0|||
161895495|NCT02588092|584666362|FG004|Overall Study|Sponsor Decision|0|||
161895496|NCT02588092|584666363|FG005|Overall Study|Sponsor Decision|0|||
161895497|NCT02588092|584666364|FG006|Overall Study|Sponsor Decision|0|||
161895498|NCT02588092|584666365|FG007|Overall Study|Sponsor Decision|0|||
161667607|NCT02668185|583835792|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
161667608|NCT02668185|583835791|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
161667609|NCT02668185|583835792|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
161667610|NCT01013597|583835793|FG000|Overall Study|Withdrawal by Subject|1|||
161667611|NCT00427895|583835794|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667612|NCT00427895|583835795|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667613|NCT00427895|583835796|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667614|NCT00427895|583835797|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
161667615|NCT00427895|583835798|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667616|NCT00427895|583835799|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667617|NCT00427895|583835800|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667618|NCT00427895|583835801|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161667619|NCT00427895|583835794|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161667620|NCT00427895|583835795|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161667621|NCT00427895|583835796|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161667622|NCT00427895|583835797|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161667623|NCT00427895|583835798|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161895499|NCT02588092|584666366|FG008|Overall Study|Sponsor Decision|1|||
161895500|NCT02588092|584666367|FG009|Overall Study|Sponsor Decision|1|||
161895501|NCT01348100|584666368|FG000|Overall Study|Subject Withdrew Consent|0|||
161895502|NCT01348100|584666369|FG001|Overall Study|Subject Withdrew Consent|0|||
161895503|NCT01348100|584666370|FG002|Overall Study|Subject Withdrew Consent|2|||
161895504|NCT01348100|584666371|FG003|Overall Study|Subject Withdrew Consent|0|||
161895505|NCT01348100|584666372|FG004|Overall Study|Subject Withdrew Consent|1|||
161895506|NCT01348100|584666373|FG005|Overall Study|Subject Withdrew Consent|0|||
161895507|NCT01348100|584666374|FG006|Overall Study|Subject Withdrew Consent|1|||
161667624|NCT00427895|583835799|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161667625|NCT00427895|583835800|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161667626|NCT00427895|583835801|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
161667627|NCT00427895|583835794|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
161667628|NCT00427895|583835795|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
161895508|NCT01348100|584666368|FG000|Overall Study|Protocol Deviation|0|||
161895509|NCT01348100|584666369|FG001|Overall Study|Protocol Deviation|0|||
161895510|NCT01348100|584666370|FG002|Overall Study|Protocol Deviation|0|||
161895511|NCT01348100|584666371|FG003|Overall Study|Protocol Deviation|1|||
161895512|NCT01348100|584666372|FG004|Overall Study|Protocol Deviation|0|||
161895513|NCT01348100|584666373|FG005|Overall Study|Protocol Deviation|0|||
161552428|NCT02733042|583410432|FG005|Overall Study|Death|0|||
161895514|NCT01348100|584666374|FG006|Overall Study|Protocol Deviation|0|||
161895515|NCT01348100|584666368|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895516|NCT01348100|584666369|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895517|NCT01348100|584666370|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895518|NCT01348100|584666371|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895519|NCT01348100|584666372|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895520|NCT01348100|584666373|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161895521|NCT01348100|584666374|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895522|NCT01348100|584666368|FG000|Overall Study|Lost to Follow-up|0|||
161895523|NCT01348100|584666369|FG001|Overall Study|Lost to Follow-up|0|||
161895524|NCT01348100|584666370|FG002|Overall Study|Lost to Follow-up|0|||
161895525|NCT01348100|584666371|FG003|Overall Study|Lost to Follow-up|0|||
161895526|NCT01348100|584666372|FG004|Overall Study|Lost to Follow-up|0|||
161895527|NCT01348100|584666373|FG005|Overall Study|Lost to Follow-up|0|||
161895528|NCT01348100|584666374|FG006|Overall Study|Lost to Follow-up|1|||
161895529|NCT01348100|584666368|FG000|Overall Study|Administrative Problems|0|||
161895530|NCT01348100|584666369|FG001|Overall Study|Administrative Problems|0|||
161895531|NCT01348100|584666370|FG002|Overall Study|Administrative Problems|0|||
161895532|NCT01348100|584666371|FG003|Overall Study|Administrative Problems|0|||
161895533|NCT01348100|584666372|FG004|Overall Study|Administrative Problems|0|||
161895534|NCT01348100|584666373|FG005|Overall Study|Administrative Problems|1|||
161895535|NCT01348100|584666374|FG006|Overall Study|Administrative Problems|1|||
161895536|NCT00531947|584666377|FG000|Overall Study|Adverse Event|5|||
161895537|NCT00531947|584666378|FG001|Overall Study|Adverse Event|10|||
161895538|NCT00531947|584666377|FG000|Overall Study|Lost to Follow-up|12|||
161895539|NCT00531947|584666378|FG001|Overall Study|Lost to Follow-up|9|||
161895540|NCT00531947|584666377|FG000|Overall Study|Withdrawal by Subject|14|||
161895541|NCT00531947|584666378|FG001|Overall Study|Withdrawal by Subject|19|||
161895542|NCT00531947|584666377|FG000|Overall Study|Protocol Violation|2|||
161895543|NCT00531947|584666378|FG001|Overall Study|Protocol Violation|1|||
161667629|NCT00427895|583835796|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
161667630|NCT00427895|583835797|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
161895544|NCT00531947|584666377|FG000|Overall Study|Non-Compliance|4|||
161895545|NCT00531947|584666378|FG001|Overall Study|Non-Compliance|7|||
161895546|NCT00531947|584666377|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
161667631|NCT00427895|583835798|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
161667632|NCT00427895|583835799|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
161667633|NCT00427895|583835800|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
161667634|NCT00427895|583835801|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
161667635|NCT00427895|583835794|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
161667636|NCT00427895|583835795|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
161667637|NCT00427895|583835796|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
161667638|NCT00427895|583835797|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
161667639|NCT00427895|583835798|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
161667640|NCT00427895|583835799|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
161667641|NCT00427895|583835800|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
161667642|NCT00427895|583835801|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
161667643|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161667644|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
161667645|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
161667646|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
161667647|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161667648|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161667649|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161667650|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161667651|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
161667652|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161667653|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
161667654|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
161667655|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161667656|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161667657|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161667658|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161667659|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
161667660|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
161667661|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161895547|NCT00531947|584666378|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
161895548|NCT02383355|584666381|FG000|Overall Study|Adverse Event|2|||
161895549|NCT02383355|584666382|FG001|Overall Study|Adverse Event|0|||
161895550|NCT00524680|584666383|FG000|Overall Study|progression|0|||
161667662|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161895551|NCT00524680|584666384|FG001|Overall Study|progression|0|||
161895552|NCT00524680|584666385|FG002|Overall Study|progression|0|||
161667663|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161667664|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161667665|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161667666|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161667667|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
161667668|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
161667669|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
161667670|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
161667671|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161667672|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161667673|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161667674|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161667675|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667676|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667677|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667678|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
161667679|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667680|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667681|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667682|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161667683|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
161667684|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
161667685|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
161667686|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
161667687|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161667688|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161667689|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161667690|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161667691|NCT00427895|583835794|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161667692|NCT00427895|583835795|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161667693|NCT00427895|583835796|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
161667694|NCT00427895|583835797|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
161667695|NCT00427895|583835798|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161667696|NCT00427895|583835799|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161667697|NCT00427895|583835800|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161667698|NCT00427895|583835801|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161667699|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161667700|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
161667701|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
161667702|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
161667703|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161667704|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161781193|NCT02494583|584241997|FG002|Overall Study|Screen Failure|0|||
161781194|NCT02494583|584241995|FG000|Overall Study|Transferred to Extension Study|15|||
161781195|NCT02494583|584241996|FG001|Overall Study|Transferred to Extension Study|15|||
161781196|NCT02494583|584241997|FG002|Overall Study|Transferred to Extension Study|6|||
161781197|NCT02494583|584241995|FG000|Overall Study|Did Not Continue on Extension Study|8|||
161781198|NCT02494583|584241996|FG001|Overall Study|Did Not Continue on Extension Study|10|||
161781199|NCT02494583|584241997|FG002|Overall Study|Did Not Continue on Extension Study|4|||
161781200|NCT02494583|584241995|FG000|Overall Study|Withdrawal by Subject|7|||
161781201|NCT02494583|584241996|FG001|Overall Study|Withdrawal by Subject|15|||
161781202|NCT02494583|584241997|FG002|Overall Study|Withdrawal by Subject|15|||
161781203|NCT00627458|584242000|FG000|Overall Study|Migrated from study area|1|||
161781204|NCT00627458|584242001|FG001|Overall Study|Migrated from study area|0|||
161781205|NCT00627458|584242002|FG002|Overall Study|Migrated from study area|1|||
161781206|NCT00627458|584242000|FG000|Overall Study|Withdrawal by Subject|2|||
161781207|NCT00627458|584242001|FG001|Overall Study|Withdrawal by Subject|6|||
161781208|NCT00627458|584242002|FG002|Overall Study|Withdrawal by Subject|5|||
161781209|NCT00627458|584242000|FG000|Overall Study|Lost to Follow-up|1|||
161781210|NCT00627458|584242001|FG001|Overall Study|Lost to Follow-up|1|||
161781211|NCT00627458|584242002|FG002|Overall Study|Lost to Follow-up|0|||
161781212|NCT03891875|584242003|FG000|Overall Study|Withdrawal by Subject|20|||
161781213|NCT03891875|584242004|FG001|Overall Study|Withdrawal by Subject|3|||
161781214|NCT03891875|584242003|FG000|Overall Study|Adverse Event|10|||
161781215|NCT03891875|584242004|FG001|Overall Study|Adverse Event|4|||
161781216|NCT03891875|584242003|FG000|Overall Study|Physician Decision|1|||
161781217|NCT03891875|584242004|FG001|Overall Study|Physician Decision|1|||
161781218|NCT03891875|584242003|FG000|Overall Study|Protocol Violation|1|||
161781219|NCT03891875|584242004|FG001|Overall Study|Protocol Violation|0|||
161781220|NCT03891875|584242003|FG000|Overall Study|Lost to Follow-up|1|||
161781221|NCT03891875|584242004|FG001|Overall Study|Lost to Follow-up|0|||
161895553|NCT00524680|584666386|FG003|Overall Study|progression|1|||
161895554|NCT00524680|584666383|FG000|Overall Study|Adverse Event|2|||
161895555|NCT00524680|584666384|FG001|Overall Study|Adverse Event|0|||
161895556|NCT00524680|584666385|FG002|Overall Study|Adverse Event|0|||
161895557|NCT00524680|584666386|FG003|Overall Study|Adverse Event|1|||
161895558|NCT00524680|584666383|FG000|Overall Study|Other|0|||
161895559|NCT00524680|584666384|FG001|Overall Study|Other|1|||
161895560|NCT00524680|584666385|FG002|Overall Study|Other|2|||
161895561|NCT00524680|584666386|FG003|Overall Study|Other|3|||
161895562|NCT00524680|584666383|FG000|Overall Study|Withdrawal by Subject|1|||
161895563|NCT00524680|584666384|FG001|Overall Study|Withdrawal by Subject|0|||
161895564|NCT00524680|584666385|FG002|Overall Study|Withdrawal by Subject|1|||
161895565|NCT00524680|584666386|FG003|Overall Study|Withdrawal by Subject|1|||
161895566|NCT01146561|584666387|FG000|Overall Study|Withdrawal by Subject|1|||
161781222|NCT03891875|584242003|FG000|Overall Study|COVID-19 infection|1|||
161781223|NCT03891875|584242004|FG001|Overall Study|COVID-19 infection|0|||
161781224|NCT00530088|584242009|FG000|Overall Study|Disease Progression|4|||
161781225|NCT00530088|584242009|FG000|Overall Study|Physician Decision|4|||
161895567|NCT01146561|584666387|FG000|Overall Study|Lost to Follow-up|1|||
161895568|NCT00334295|584666396|FG000|Overall Study|Patients received fewer than 3 injection|5|||
161895569|NCT00893971|584666397|FG000|Overall Study|Physician Decision|3|||
161895570|NCT01416155|584666398|FG000|Overall Study|Adverse Event|8|||
161895571|NCT01416155|584666398|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
161895572|NCT01416155|584666398|FG000|Overall Study|Withdrawal by Subject|33|||
161895573|NCT01416155|584666398|FG000|Overall Study|Investigator decision|8|||
161895574|NCT01416155|584666398|FG000|Overall Study|Other|7|||
161895575|NCT00829829|584666402|FG000|Overall Study|Protocol Violation|0|||
161895576|NCT00829829|584666403|FG001|Overall Study|Protocol Violation|3|||
161895577|NCT00829829|584666404|FG002|Overall Study|Protocol Violation|0|||
161895578|NCT00829829|584666402|FG000|Overall Study|Adverse Event|4|||
161895579|NCT00829829|584666403|FG001|Overall Study|Adverse Event|4|||
161895580|NCT00829829|584666404|FG002|Overall Study|Adverse Event|3|||
161895581|NCT00829829|584666402|FG000|Overall Study|Withdrawal by Subject|8|||
161895582|NCT00829829|584666403|FG001|Overall Study|Withdrawal by Subject|4|||
161895583|NCT00829829|584666404|FG002|Overall Study|Withdrawal by Subject|2|||
161895584|NCT00829829|584666402|FG000|Overall Study|Decision by the Sponsor|1|||
161895585|NCT00829829|584666403|FG001|Overall Study|Decision by the Sponsor|0|||
161895586|NCT00829829|584666404|FG002|Overall Study|Decision by the Sponsor|2|||
161895587|NCT00829829|584666402|FG000|Overall Study|Lost to Follow-up|7|||
161895588|NCT00829829|584666403|FG001|Overall Study|Lost to Follow-up|3|||
161667705|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161667706|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161667707|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
161667708|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
161667709|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161667710|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
161667711|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161667712|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161667713|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161667714|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161667715|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
161667716|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
161667717|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
161667718|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
161667719|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161667720|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161667721|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161667722|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161667723|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161667724|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
161667725|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161781226|NCT00530088|584242009|FG000|Overall Study|Other Not Specified|2|||
161781227|NCT00285012|584242024|FG000|Assigned to Study Treatment (Tx)|Other|2|||
161781228|NCT00285012|584242025|FG001|Assigned to Study Treatment (Tx)|Other|3|||
161781229|NCT00285012|584242024|FG000|Received Study Tx|Death|2|||
161781230|NCT00285012|584242025|FG001|Received Study Tx|Death|1|||
161781231|NCT00285012|584242024|FG000|Received Study Tx|Adverse Event|5|||
161781232|NCT00285012|584242025|FG001|Received Study Tx|Adverse Event|11|||
161781233|NCT00285012|584242024|FG000|Received Study Tx|Lack of Efficacy|0|||
161781234|NCT00285012|584242025|FG001|Received Study Tx|Lack of Efficacy|3|||
161781235|NCT00285012|584242024|FG000|Received Study Tx|Lost to Follow-up|29|||
161781236|NCT00285012|584242025|FG001|Received Study Tx|Lost to Follow-up|31|||
161895589|NCT00829829|584666404|FG002|Overall Study|Lost to Follow-up|3|||
161895590|NCT00829829|584666402|FG000|Overall Study|Other than specified above|2|||
161895591|NCT00829829|584666403|FG001|Overall Study|Other than specified above|2|||
161895592|NCT00829829|584666404|FG002|Overall Study|Other than specified above|1|||
161895593|NCT00382109|584666405|FG000|Overall Study|Adverse Event|3|||
161667726|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161667727|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161667728|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161667729|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161667730|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161667731|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Death|1|||
161667732|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Death|0|||
161667733|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Death|0|||
161667734|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Death|0|||
161667735|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Death|0|||
161667736|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Death|0|||
161667737|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Death|0|||
161667738|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Death|0|||
161667739|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161667740|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161781237|NCT00285012|584242024|FG000|Received Study Tx|Withdrawal by Subject|31|||
161895594|NCT00382109|584666406|FG001|Overall Study|Adverse Event|0|||
161895595|NCT00382109|584666405|FG000|Overall Study|Physician Decision|6|||
161895596|NCT00382109|584666406|FG001|Overall Study|Physician Decision|1|||
161895597|NCT00382109|584666405|FG000|Overall Study|Withdrawal by Subject|1|||
161895598|NCT00382109|584666406|FG001|Overall Study|Withdrawal by Subject|0|||
161895599|NCT00382109|584666405|FG000|Overall Study|ineligible|2|||
161895600|NCT00382109|584666406|FG001|Overall Study|ineligible|0|||
161895601|NCT00382109|584666405|FG000|Overall Study|Other|0|||
161895602|NCT00382109|584666406|FG001|Overall Study|Other|2|||
161895603|NCT00382109|584666405|FG000|Overall Study|consent withdrawal|0|||
161895604|NCT00382109|584666406|FG001|Overall Study|consent withdrawal|1|||
161895605|NCT05052697|584666407|FG000|Substudy A|Lost to Follow-up|0|||
161895606|NCT05052697|584666408|FG001|Substudy A|Lost to Follow-up|0|||
161895607|NCT05052697|584666409|FG002|Substudy A|Lost to Follow-up|0|||
161895608|NCT05052697|584666410|FG003|Substudy A|Lost to Follow-up|0|||
161895609|NCT05052697|584666411|FG004|Substudy A|Lost to Follow-up|0|||
161895610|NCT05052697|584666412|FG005|Substudy A|Lost to Follow-up|1|||
161781238|NCT00285012|584242025|FG001|Received Study Tx|Withdrawal by Subject|43|||
161781239|NCT00285012|584242024|FG000|Received Study Tx|Other|5|||
161781240|NCT00285012|584242025|FG001|Received Study Tx|Other|5|||
161781241|NCT05631093|584242028|FG000|Overall Study|Death|0|||
161895611|NCT05052697|584666413|FG006|Substudy A|Lost to Follow-up|0|||
161895612|NCT05052697|584666414|FG007|Substudy A|Lost to Follow-up|0|||
161895613|NCT05052697|584666415|FG008|Substudy A|Lost to Follow-up|0|||
161895614|NCT05052697|584666416|FG009|Substudy A|Lost to Follow-up|0|||
161895615|NCT05052697|584666417|FG010|Substudy A|Lost to Follow-up|0|||
161895616|NCT05052697|584666418|FG011|Substudy A|Lost to Follow-up|0|||
161895617|NCT05052697|584666419|FG012|Substudy A|Lost to Follow-up|0|||
161895618|NCT05052697|584666420|FG013|Substudy A|Lost to Follow-up|0|||
161895619|NCT05052697|584666421|FG014|Substudy A|Lost to Follow-up|0|||
161895620|NCT05052697|584666422|FG015|Substudy A|Lost to Follow-up|2|||
161895621|NCT05052697|584666423|FG016|Substudy A|Lost to Follow-up|0|||
161895622|NCT05052697|584666424|FG017|Substudy A|Lost to Follow-up|0|||
161895623|NCT05052697|584666425|FG018|Substudy A|Lost to Follow-up|0|||
161895624|NCT05052697|584666426|FG019|Substudy A|Lost to Follow-up|0|||
161895625|NCT05052697|584666427|FG020|Substudy A|Lost to Follow-up|0|||
161895626|NCT05052697|584666428|FG021|Substudy A|Lost to Follow-up|0|||
161895627|NCT05052697|584666429|FG022|Substudy A|Lost to Follow-up|0|||
161895628|NCT05052697|584666430|FG023|Substudy A|Lost to Follow-up|0|||
161895629|NCT05052697|584666431|FG024|Substudy A|Lost to Follow-up|0|||
161895630|NCT05052697|584666432|FG025|Substudy A|Lost to Follow-up|0|||
161895631|NCT05052697|584666433|FG026|Substudy A|Lost to Follow-up|0|||
161895632|NCT05052697|584666434|FG027|Substudy A|Lost to Follow-up|0|||
161895633|NCT05052697|584666435|FG028|Substudy A|Lost to Follow-up|0|||
161895634|NCT05052697|584666436|FG029|Substudy A|Lost to Follow-up|0|||
161552429|NCT02733042|583410433|FG006|Overall Study|Death|1|||
161667741|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
161667742|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
161667743|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161781242|NCT05631093|584242029|FG001|Overall Study|Death|1|||
161781243|NCT05631093|584242028|FG000|Overall Study|Lost to Follow-up|1|||
161781244|NCT05631093|584242029|FG001|Overall Study|Lost to Follow-up|2|||
161781245|NCT05631093|584242028|FG000|Overall Study|Physician Decision|1|||
161781246|NCT05631093|584242029|FG001|Overall Study|Physician Decision|0|||
161895635|NCT05052697|584666437|FG030|Substudy A|Lost to Follow-up|0|||
161895636|NCT05052697|584666438|FG031|Substudy A|Lost to Follow-up|0|||
161895637|NCT05052697|584666439|FG032|Substudy A|Lost to Follow-up|0|||
161895638|NCT05052697|584666440|FG033|Substudy A|Lost to Follow-up|0|||
161895639|NCT05052697|584666407|FG000|Substudy A|No longer met eligibility criteria|0|||
161895640|NCT05052697|584666408|FG001|Substudy A|No longer met eligibility criteria|0|||
161895641|NCT05052697|584666409|FG002|Substudy A|No longer met eligibility criteria|0|||
161895642|NCT05052697|584666410|FG003|Substudy A|No longer met eligibility criteria|0|||
161895643|NCT05052697|584666411|FG004|Substudy A|No longer met eligibility criteria|0|||
161895644|NCT05052697|584666412|FG005|Substudy A|No longer met eligibility criteria|0|||
161781247|NCT05631093|584242028|FG000|Overall Study|Withdrawal by Subject|4|||
161781248|NCT05631093|584242029|FG001|Overall Study|Withdrawal by Subject|1|||
161781249|NCT05631093|584242028|FG000|Overall Study|Ongoing|353|||
161781250|NCT05631093|584242029|FG001|Overall Study|Ongoing|177|||
161781251|NCT05631093|584242028|FG000|Overall Study|Adverse Event|0|||
161781252|NCT05631093|584242029|FG001|Overall Study|Adverse Event|1|||
161781253|NCT02873195|584242030|FG000|Overall Study|Ineligible|5|||
161781254|NCT02873195|584242031|FG001|Overall Study|Ineligible|0|||
161781255|NCT03107715|584242032|FG000|Overall Study|did not deliver at the home hospital|4|||
161781256|NCT03107715|584242033|FG001|Overall Study|did not deliver at the home hospital|6|||
161781257|NCT03107715|584242032|FG000|Overall Study|infant stillborn|0|||
161781258|NCT03107715|584242033|FG001|Overall Study|infant stillborn|1|||
161781259|NCT04822701|584242036|FG000|Overall Study|Not treated|2|||
161781260|NCT04822701|584242037|FG001|Overall Study|Not treated|0|||
161781261|NCT04822701|584242036|FG000|Overall Study|Lost to Follow-up|1|||
161895645|NCT05052697|584666413|FG006|Substudy A|No longer met eligibility criteria|0|||
161895646|NCT05052697|584666414|FG007|Substudy A|No longer met eligibility criteria|0|||
161895647|NCT05052697|584666415|FG008|Substudy A|No longer met eligibility criteria|0|||
161895648|NCT05052697|584666416|FG009|Substudy A|No longer met eligibility criteria|0|||
161895649|NCT05052697|584666417|FG010|Substudy A|No longer met eligibility criteria|0|||
161895650|NCT05052697|584666418|FG011|Substudy A|No longer met eligibility criteria|0|||
161895651|NCT05052697|584666419|FG012|Substudy A|No longer met eligibility criteria|0|||
161895652|NCT05052697|584666420|FG013|Substudy A|No longer met eligibility criteria|1|||
161895653|NCT05052697|584666421|FG014|Substudy A|No longer met eligibility criteria|0|||
161895654|NCT05052697|584666422|FG015|Substudy A|No longer met eligibility criteria|0|||
161895655|NCT05052697|584666423|FG016|Substudy A|No longer met eligibility criteria|0|||
161895656|NCT05052697|584666424|FG017|Substudy A|No longer met eligibility criteria|0|||
161895657|NCT05052697|584666425|FG018|Substudy A|No longer met eligibility criteria|0|||
161895658|NCT05052697|584666426|FG019|Substudy A|No longer met eligibility criteria|0|||
161895659|NCT05052697|584666427|FG020|Substudy A|No longer met eligibility criteria|0|||
161895660|NCT05052697|584666428|FG021|Substudy A|No longer met eligibility criteria|0|||
161895661|NCT05052697|584666429|FG022|Substudy A|No longer met eligibility criteria|0|||
161895662|NCT05052697|584666430|FG023|Substudy A|No longer met eligibility criteria|0|||
161895663|NCT05052697|584666431|FG024|Substudy A|No longer met eligibility criteria|0|||
161895664|NCT05052697|584666432|FG025|Substudy A|No longer met eligibility criteria|0|||
161895665|NCT05052697|584666433|FG026|Substudy A|No longer met eligibility criteria|0|||
161895666|NCT05052697|584666434|FG027|Substudy A|No longer met eligibility criteria|0|||
161895667|NCT05052697|584666435|FG028|Substudy A|No longer met eligibility criteria|0|||
161895668|NCT05052697|584666436|FG029|Substudy A|No longer met eligibility criteria|0|||
161895669|NCT05052697|584666437|FG030|Substudy A|No longer met eligibility criteria|0|||
161895670|NCT05052697|584666438|FG031|Substudy A|No longer met eligibility criteria|0|||
161895671|NCT05052697|584666439|FG032|Substudy A|No longer met eligibility criteria|0|||
161895672|NCT05052697|584666440|FG033|Substudy A|No longer met eligibility criteria|0|||
161895673|NCT05052697|584666407|FG000|Substudy A|Not vaccinated|0|||
161895674|NCT05052697|584666408|FG001|Substudy A|Not vaccinated|0|||
161895675|NCT05052697|584666409|FG002|Substudy A|Not vaccinated|0|||
161895676|NCT05052697|584666410|FG003|Substudy A|Not vaccinated|1|||
161895677|NCT05052697|584666411|FG004|Substudy A|Not vaccinated|0|||
161895678|NCT05052697|584666412|FG005|Substudy A|Not vaccinated|0|||
161895679|NCT05052697|584666413|FG006|Substudy A|Not vaccinated|0|||
161895680|NCT05052697|584666414|FG007|Substudy A|Not vaccinated|0|||
161895681|NCT05052697|584666415|FG008|Substudy A|Not vaccinated|1|||
161895682|NCT05052697|584666416|FG009|Substudy A|Not vaccinated|0|||
161895683|NCT05052697|584666417|FG010|Substudy A|Not vaccinated|0|||
161895684|NCT05052697|584666418|FG011|Substudy A|Not vaccinated|0|||
161895685|NCT05052697|584666419|FG012|Substudy A|Not vaccinated|0|||
161895686|NCT05052697|584666420|FG013|Substudy A|Not vaccinated|0|||
161895687|NCT05052697|584666421|FG014|Substudy A|Not vaccinated|0|||
161895688|NCT05052697|584666422|FG015|Substudy A|Not vaccinated|0|||
161895689|NCT05052697|584666423|FG016|Substudy A|Not vaccinated|0|||
161781262|NCT04822701|584242037|FG001|Overall Study|Lost to Follow-up|0|||
161781263|NCT04822701|584242036|FG000|Overall Study|Withdrawal by Subject|1|||
161781264|NCT04822701|584242037|FG001|Overall Study|Withdrawal by Subject|0|||
161895690|NCT05052697|584666424|FG017|Substudy A|Not vaccinated|0|||
161895691|NCT05052697|584666425|FG018|Substudy A|Not vaccinated|0|||
161895692|NCT05052697|584666426|FG019|Substudy A|Not vaccinated|0|||
161895693|NCT05052697|584666427|FG020|Substudy A|Not vaccinated|0|||
161895694|NCT05052697|584666428|FG021|Substudy A|Not vaccinated|0|||
161895695|NCT05052697|584666429|FG022|Substudy A|Not vaccinated|0|||
161895696|NCT05052697|584666430|FG023|Substudy A|Not vaccinated|0|||
161895697|NCT05052697|584666431|FG024|Substudy A|Not vaccinated|0|||
161895698|NCT05052697|584666432|FG025|Substudy A|Not vaccinated|0|||
161895699|NCT05052697|584666433|FG026|Substudy A|Not vaccinated|0|||
161895700|NCT05052697|584666434|FG027|Substudy A|Not vaccinated|0|||
161895701|NCT05052697|584666435|FG028|Substudy A|Not vaccinated|0|||
161895702|NCT05052697|584666436|FG029|Substudy A|Not vaccinated|0|||
161895703|NCT05052697|584666437|FG030|Substudy A|Not vaccinated|0|||
161895704|NCT05052697|584666438|FG031|Substudy A|Not vaccinated|0|||
161895705|NCT05052697|584666439|FG032|Substudy A|Not vaccinated|0|||
161667744|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161667745|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161667746|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161667747|NCT00427895|583835794|FG000|Vax 1/Year 1 Follow-up|Other|0|||
161667748|NCT00427895|583835795|FG001|Vax 1/Year 1 Follow-up|Other|0|||
161667749|NCT00427895|583835796|FG002|Vax 1/Year 1 Follow-up|Other|0|||
161667750|NCT00427895|583835797|FG003|Vax 1/Year 1 Follow-up|Other|2|||
161667751|NCT00427895|583835798|FG004|Vax 1/Year 1 Follow-up|Other|0|||
161667752|NCT00427895|583835799|FG005|Vax 1/Year 1 Follow-up|Other|0|||
161667753|NCT00427895|583835800|FG006|Vax 1/Year 1 Follow-up|Other|0|||
161667754|NCT00427895|583835801|FG007|Vax 1/Year 1 Follow-up|Other|0|||
161667755|NCT00427895|583835794|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
161667756|NCT00427895|583835795|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
161667757|NCT00427895|583835796|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
161667758|NCT00427895|583835797|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
161667759|NCT00427895|583835798|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161667760|NCT00427895|583835799|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161667761|NCT00427895|583835800|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161667762|NCT00427895|583835801|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161667763|NCT02678247|583835802|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
161667764|NCT02678247|583835803|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
161667765|NCT02678247|583835802|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
161667766|NCT02678247|583835803|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
161667767|NCT02678247|583835802|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
161667768|NCT02678247|583835803|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
161667769|NCT02678247|583835802|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
161667770|NCT02678247|583835803|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
161667771|NCT02678247|583835802|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
161667772|NCT02678247|583835803|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
161667773|NCT02678247|583835802|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
161667774|NCT02678247|583835803|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
161667775|NCT02796560|583835809|FG000|Overall Study|Adverse Event|2|||
161667776|NCT02796560|583835810|FG001|Overall Study|Adverse Event|0|||
161667777|NCT02796560|583835809|FG000|Overall Study|Withdrawal by Subject|2|||
161667778|NCT02796560|583835810|FG001|Overall Study|Withdrawal by Subject|2|||
161667779|NCT03816332|583835812|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
161667780|NCT03816332|583835812|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
161667781|NCT05330312|583835813|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
161667782|NCT05330312|583835814|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
161667783|NCT05330312|583835815|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
161667784|NCT05330312|583835813|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
161667785|NCT05330312|583835814|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
161667786|NCT05330312|583835815|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
161667787|NCT05330312|583835813|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
161667788|NCT05330312|583835814|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
161667789|NCT05330312|583835815|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
161667790|NCT05330312|583835813|FG000|Pivotal Investigation - Part 2|Death|1|||
161667791|NCT05330312|583835814|FG001|Pivotal Investigation - Part 2|Death|4|||
161667792|NCT05330312|583835815|FG002|Pivotal Investigation - Part 2|Death|0|||
161667793|NCT03534284|583835816|FG000|Overall Study|Death|2|||
161667794|NCT03534284|583835817|FG001|Overall Study|Death|3|||
161667795|NCT03534284|583835818|FG002|Overall Study|Death|3|||
161667796|NCT03534284|583835816|FG000|Overall Study|Withdrawal by Subject|5|||
161667797|NCT03534284|583835817|FG001|Overall Study|Withdrawal by Subject|0|||
161667798|NCT03534284|583835818|FG002|Overall Study|Withdrawal by Subject|0|||
161667799|NCT03316300|583835819|FG000|Overall Study|Withdrawal by Subject|3|||
161667800|NCT03316300|583835820|FG001|Overall Study|Withdrawal by Subject|2|||
161667801|NCT03316300|583835819|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
161667802|NCT03316300|583835820|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
161667803|NCT03316300|583835819|FG000|Overall Study|Adverse Event|1|||
161667804|NCT03316300|583835820|FG001|Overall Study|Adverse Event|0|||
161667805|NCT03316300|583835819|FG000|Overall Study|COVID-19|0|||
161667806|NCT03316300|583835820|FG001|Overall Study|COVID-19|1|||
161667807|NCT00423930|583835821|FG000|Overall Study|Withdrawal by Subject|2|||
161667808|NCT04002401|583835822|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
161667809|NCT04002401|583835822|FG000|Overall Study|Death|10|||
161667810|NCT04002401|583835822|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
161667811|NCT04002401|583835822|FG000|Overall Study|Enrolled but Never Treated|1|||
161895706|NCT05052697|584666440|FG033|Substudy A|Not vaccinated|0|||
161667812|NCT04002401|583835822|FG000|Overall Study|Lost to Follow-up|1|||
161667813|NCT02881957|583835827|FG000|Overall Study|Comfort care|0|||
161667814|NCT02881957|583835828|FG001|Overall Study|Comfort care|1|||
161667815|NCT02881957|583835827|FG000|Overall Study|Concurrent trial enrollment|0|||
161667816|NCT02881957|583835828|FG001|Overall Study|Concurrent trial enrollment|1|||
161667817|NCT02881957|583835827|FG000|Overall Study|Discharged within 48 hours|0|||
161667818|NCT02881957|583835828|FG001|Overall Study|Discharged within 48 hours|1|||
161667819|NCT02881957|583835827|FG000|Overall Study|Withdrawal by Subject|2|||
161667820|NCT02881957|583835828|FG001|Overall Study|Withdrawal by Subject|1|||
161667821|NCT02881957|583835827|FG000|Overall Study|Protocol Violation|1|||
161667822|NCT02881957|583835828|FG001|Overall Study|Protocol Violation|0|||
161667823|NCT02390245|583835834|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
161667824|NCT02390245|583835835|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
161667825|NCT02390245|583835836|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
161667826|NCT02390245|583835834|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
161667827|NCT02390245|583835835|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
161667828|NCT02390245|583835836|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
161667829|NCT02425644|583837418|FG000|Overall Study|Lost to Follow-up|2|||
161667830|NCT02425644|583837419|FG001|Overall Study|Lost to Follow-up|3|||
161667831|NCT02425644|583837418|FG000|Overall Study|Withdrawal by Subject|41|||
161667832|NCT02425644|583837419|FG001|Overall Study|Withdrawal by Subject|36|||
161667833|NCT02425644|583837418|FG000|Overall Study|Lack of Efficacy|3|||
161667834|NCT02425644|583837419|FG001|Overall Study|Lack of Efficacy|10|||
161667835|NCT02425644|583837418|FG000|Overall Study|Adverse Event|13|||
161667836|NCT02425644|583837419|FG001|Overall Study|Adverse Event|3|||
161667837|NCT02425644|583837418|FG000|Overall Study|Death|0|||
161667838|NCT02425644|583837419|FG001|Overall Study|Death|2|||
161667839|NCT02425644|583837418|FG000|Overall Study|Other|18|||
161667840|NCT02425644|583837419|FG001|Overall Study|Other|17|||
161667841|NCT02720536|583837420|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
161667842|NCT02720536|583837420|FG000|Overall Study|PR - pregnancy|2|||
161667843|NCT02720536|583837420|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
161667844|NCT02720536|583837420|FG000|Overall Study|PR - death|1|||
161667845|NCT02720536|583837420|FG000|Overall Study|PR - adverse event|1|||
161667846|NCT02720536|583837420|FG000|Overall Study|PR - abnormal lab value(s)|1|||
161667847|NCT02720536|583837420|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
161667848|NCT00985166|583837421|FG000|Overall Study|Lost to Follow-up|3|||
161667849|NCT00985166|583837422|FG001|Overall Study|Lost to Follow-up|2|||
161667850|NCT00985166|583837423|FG002|Overall Study|Lost to Follow-up|2|||
161667851|NCT00985166|583837421|FG000|Overall Study|Withdrawal by Subject|3|||
161667852|NCT00985166|583837422|FG001|Overall Study|Withdrawal by Subject|2|||
161667853|NCT00985166|583837423|FG002|Overall Study|Withdrawal by Subject|0|||
161667854|NCT00985166|583837421|FG000|Overall Study|Test not done|2|||
161667855|NCT00985166|583837422|FG001|Overall Study|Test not done|0|||
161667856|NCT00985166|583837423|FG002|Overall Study|Test not done|4|||
161667857|NCT00985166|583837421|FG000|Overall Study|Other|1|||
161667858|NCT00985166|583837422|FG001|Overall Study|Other|0|||
161667859|NCT00985166|583837423|FG002|Overall Study|Other|1|||
161667860|NCT01028222|583837424|FG000|Overall Study|Protocol deviation|1|||
161667861|NCT01028222|583837425|FG001|Overall Study|Protocol deviation|0|||
161667862|NCT01028222|583837424|FG000|Overall Study|Disease progression|33|||
161667863|NCT01028222|583837425|FG001|Overall Study|Disease progression|9|||
161667864|NCT01028222|583837424|FG000|Overall Study|Administrative problems|1|||
161667865|NCT01028222|583837425|FG001|Overall Study|Administrative problems|1|||
161667866|NCT01028222|583837424|FG000|Overall Study|Lost to Follow-up|0|||
161667867|NCT01028222|583837425|FG001|Overall Study|Lost to Follow-up|1|||
161667868|NCT01028222|583837424|FG000|Overall Study|Withdrawal by Subject|1|||
161667869|NCT01028222|583837425|FG001|Overall Study|Withdrawal by Subject|0|||
161667870|NCT01028222|583837424|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
161667871|NCT01028222|583837425|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
161667872|NCT01028222|583837424|FG000|Overall Study|Adverse Event|2|||
161667873|NCT01028222|583837425|FG001|Overall Study|Adverse Event|0|||
161667874|NCT00146328|583837426|FG000|Overall Study|Adverse Event|39|||
161667875|NCT00146328|583837427|FG001|Overall Study|Adverse Event|48|||
161667876|NCT00146328|583837428|FG002|Overall Study|Adverse Event|79|||
161667877|NCT00146328|583837426|FG000|Overall Study|Protocol Violation|11|||
161667878|NCT00146328|583837427|FG001|Overall Study|Protocol Violation|6|||
161667879|NCT00146328|583837428|FG002|Overall Study|Protocol Violation|12|||
161667880|NCT00146328|583837426|FG000|Overall Study|Lost to Follow-up|7|||
161667881|NCT00146328|583837427|FG001|Overall Study|Lost to Follow-up|4|||
161667882|NCT00146328|583837428|FG002|Overall Study|Lost to Follow-up|7|||
161667883|NCT00146328|583837426|FG000|Overall Study|Withdrawal by Subject|16|||
161667884|NCT00146328|583837427|FG001|Overall Study|Withdrawal by Subject|16|||
161667885|NCT00146328|583837428|FG002|Overall Study|Withdrawal by Subject|22|||
161667886|NCT00146328|583837426|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
161667887|NCT00146328|583837427|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
161667888|NCT00146328|583837428|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
161667889|NCT00146328|583837426|FG000|Overall Study|Trial ended/site closed|8|||
161667890|NCT00146328|583837427|FG001|Overall Study|Trial ended/site closed|2|||
161895707|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895708|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895709|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895710|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895711|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895712|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895713|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895714|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895715|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895716|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895717|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895718|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895719|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895720|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895721|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895722|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895723|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895724|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895725|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161895726|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161895727|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895728|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161895729|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
161895730|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895731|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895732|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895733|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895734|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895735|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895736|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895737|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895738|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895739|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895740|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895741|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895742|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895743|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895744|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
161667891|NCT00146328|583837428|FG002|Overall Study|Trial ended/site closed|19|||
161667892|NCT00146328|583837426|FG000|Overall Study|Patient decision to end|0|||
161667893|NCT00146328|583837427|FG001|Overall Study|Patient decision to end|1|||
161667894|NCT00146328|583837428|FG002|Overall Study|Patient decision to end|6|||
161667895|NCT00146328|583837426|FG000|Overall Study|Enroll into other trial|2|||
161667896|NCT00146328|583837427|FG001|Overall Study|Enroll into other trial|4|||
161667897|NCT00146328|583837428|FG002|Overall Study|Enroll into other trial|2|||
161667898|NCT00146328|583837426|FG000|Overall Study|Death|0|||
161667899|NCT00146328|583837427|FG001|Overall Study|Death|1|||
161667900|NCT00146328|583837428|FG002|Overall Study|Death|1|||
161667901|NCT00146328|583837426|FG000|Overall Study|Moved|2|||
161667902|NCT00146328|583837427|FG001|Overall Study|Moved|0|||
161667903|NCT00146328|583837428|FG002|Overall Study|Moved|0|||
161667904|NCT00146328|583837426|FG000|Overall Study|Interaction with other medication|2|||
161667905|NCT00146328|583837427|FG001|Overall Study|Interaction with other medication|0|||
161667906|NCT00146328|583837428|FG002|Overall Study|Interaction with other medication|1|||
161667907|NCT00300781|583837429|FG000|Overall Study|Disease Progression|55|||
161781265|NCT02706353|584242038|FG000|Dose Level 1|Disease Progression|1|||
161781266|NCT02706353|584242039|FG001|Dose Level 1|Disease Progression|0|||
161781267|NCT02706353|584242040|FG002|Dose Level 1|Disease Progression|0|||
161781268|NCT02706353|584242041|FG003|Dose Level 1|Disease Progression|0|||
161781269|NCT02706353|584242042|FG004|Dose Level 1|Disease Progression|0|||
161781270|NCT02706353|584242043|FG005|Dose Level 1|Disease Progression|0|||
161781271|NCT02706353|584242038|FG000|Dose Level 3|Disease Progression|0|||
161781272|NCT02706353|584242039|FG001|Dose Level 3|Disease Progression|0|||
161781273|NCT02706353|584242040|FG002|Dose Level 3|Disease Progression|2|||
161781274|NCT02706353|584242041|FG003|Dose Level 3|Disease Progression|0|||
161781275|NCT02706353|584242042|FG004|Dose Level 3|Disease Progression|0|||
161895745|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
161667908|NCT00300781|583837430|FG001|Overall Study|Disease Progression|52|||
161781276|NCT02706353|584242043|FG005|Dose Level 3|Disease Progression|0|||
161781277|NCT02706353|584242038|FG000|Dose Level 4|Disease Progression|0|||
161781278|NCT02706353|584242039|FG001|Dose Level 4|Disease Progression|0|||
161667909|NCT00300781|583837429|FG000|Overall Study|Adverse Event|5|||
161667910|NCT00300781|583837430|FG001|Overall Study|Adverse Event|6|||
161667911|NCT00300781|583837429|FG000|Overall Study|Withdrawal by Subject|1|||
161667912|NCT00300781|583837430|FG001|Overall Study|Withdrawal by Subject|2|||
161667913|NCT00300781|583837429|FG000|Overall Study|Physician Decision|1|||
161667914|NCT00300781|583837430|FG001|Overall Study|Physician Decision|0|||
161667915|NCT00300781|583837429|FG000|Overall Study|Not Recorded|0|||
161667916|NCT00300781|583837430|FG001|Overall Study|Not Recorded|1|||
161667917|NCT00300781|583837429|FG000|Overall Study|Symptomatic Deterioration|1|||
161667918|NCT00300781|583837430|FG001|Overall Study|Symptomatic Deterioration|0|||
161667919|NCT00300781|583837429|FG000|Overall Study|Lost to Follow-up|0|||
161667920|NCT00300781|583837430|FG001|Overall Study|Lost to Follow-up|1|||
161667921|NCT00567268|583837431|FG000|Overall Study|Protocol Violation|7|||
161667922|NCT00567268|583837431|FG000|Overall Study|Lost to Follow-up|36|||
161667923|NCT00567268|583837431|FG000|Overall Study|No Visit After First Day of Treatment|2|||
161667924|NCT00567268|583837431|FG000|Overall Study|No Drug Administration|4|||
161667925|NCT00567268|583837431|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
161667926|NCT01717989|583837432|FG000|Overall Study|Ineligibility determined|6|||
161667927|NCT01717989|583837432|FG000|Overall Study|Protocol deviation|6|||
161667928|NCT01717989|583837432|FG000|Overall Study|Withdrawal by Subject|11|||
161667929|NCT01717989|583837432|FG000|Overall Study|Physician Decision|2|||
161667930|NCT01717989|583837432|FG000|Overall Study|Lost to Follow-up|11|||
161667931|NCT01717989|583837432|FG000|Overall Study|Death|439|||
161667932|NCT01717989|583837432|FG000|Overall Study|Protocol-specified criteria|551|||
161667933|NCT01717989|583837432|FG000|Overall Study|Other|40|||
161667934|NCT03224325|583837433|FG000|Overall Study|Adverse Event|1|||
161667935|NCT03224325|583837434|FG001|Overall Study|Adverse Event|0|||
161667936|NCT03224325|583837435|FG002|Overall Study|Adverse Event|0|||
161667937|NCT03224325|583837436|FG003|Overall Study|Adverse Event|0|||
161667938|NCT03224325|583837437|FG004|Overall Study|Adverse Event|0|||
161667939|NCT03224325|583837438|FG005|Overall Study|Adverse Event|0|||
161667940|NCT03224325|583837439|FG006|Overall Study|Adverse Event|1|||
161667941|NCT03224325|583837433|FG000|Overall Study|Withdrawal by Subject|0|||
161667942|NCT03224325|583837434|FG001|Overall Study|Withdrawal by Subject|0|||
161667943|NCT03224325|583837435|FG002|Overall Study|Withdrawal by Subject|0|||
161667944|NCT03224325|583837436|FG003|Overall Study|Withdrawal by Subject|1|||
161667945|NCT03224325|583837437|FG004|Overall Study|Withdrawal by Subject|0|||
161667946|NCT03224325|583837438|FG005|Overall Study|Withdrawal by Subject|0|||
161667947|NCT03224325|583837439|FG006|Overall Study|Withdrawal by Subject|0|||
161667948|NCT02525861|583837445|FG000|Overall Study|Adverse Event|1|||
161667949|NCT02525861|583837446|FG001|Overall Study|Adverse Event|0|||
161667950|NCT02525861|583837445|FG000|Overall Study|Withdrawal by Subject|0|||
161667951|NCT02525861|583837446|FG001|Overall Study|Withdrawal by Subject|1|||
161667952|NCT02525861|583837445|FG000|Overall Study|Physician Decision|0|||
161667953|NCT02525861|583837446|FG001|Overall Study|Physician Decision|1|||
161667954|NCT01117454|583837447|FG000|Overall Study|Pregnancy|0|||
161667955|NCT01117454|583837448|FG001|Overall Study|Pregnancy|1|||
161667956|NCT00888433|583837451|FG000|Overall Study|Withdrawal by Subject|1|||
161667957|NCT00888433|583837452|FG001|Overall Study|Withdrawal by Subject|2|||
161667958|NCT00888433|583837451|FG000|Overall Study|Missed Visit|2|||
161667959|NCT00888433|583837452|FG001|Overall Study|Missed Visit|1|||
161667960|NCT01607554|583837456|FG000|Overall Study|Disease progression|2|||
161667961|NCT03952806|583837460|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
161667962|NCT03952806|583837461|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
161667963|NCT03952806|583837460|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
161667964|NCT03952806|583837461|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
161667965|NCT03952806|583837460|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
161667966|NCT03952806|583837461|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
161667967|NCT03952806|583837460|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
161667968|NCT03952806|583837461|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
161667969|NCT03952806|583837460|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
161895746|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895747|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895748|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895749|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895750|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895751|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895752|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895753|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895754|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895755|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895756|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895757|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895758|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
161895759|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
161667970|NCT03952806|583837461|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
161895760|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895761|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895762|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895763|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895764|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895765|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895766|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895767|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895768|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895769|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895770|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895771|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895772|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895773|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895774|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895775|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895776|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895777|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895778|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895779|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895780|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161667971|NCT03952806|583837460|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
161667972|NCT03952806|583837461|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
161667973|NCT03952806|583837460|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
161667974|NCT03952806|583837461|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
161667975|NCT03952806|583837460|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
161667976|NCT03952806|583837461|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
161667977|NCT03952806|583837460|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
161667978|NCT03952806|583837461|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
161667979|NCT03952806|583837460|FG000|OLE Phase (48 Weeks)|Other|16|||
161667980|NCT03952806|583837461|FG001|OLE Phase (48 Weeks)|Other|13|||
161667981|NCT05580588|583837462|FG000|Overall Study|Lack of Efficacy|12|||
161667982|NCT00756470|583837467|FG000|Overall Study|Withdrawal by Subject|1|||
161667983|NCT00756470|583837467|FG000|Overall Study|Adverse Event|4|||
161667984|NCT02875977|583837468|FG000|Overall Study|Lost to Follow-up|42|||
161667985|NCT02875977|583837469|FG001|Overall Study|Lost to Follow-up|29|||
161667986|NCT01079741|583837470|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161667987|NCT01079741|583837471|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
161667988|NCT01079741|583837472|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161667989|NCT01079741|583837473|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161667990|NCT01079741|583837474|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161667991|NCT01079741|583837470|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161667992|NCT01079741|583837471|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161667993|NCT01079741|583837472|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161667994|NCT01079741|583837473|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161667995|NCT01079741|583837474|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
161667996|NCT00446992|583837475|FG000|Overall Study|Adverse Event|11|||
161667997|NCT00446992|583837475|FG000|Overall Study|Lost to Follow-up|5|||
161667998|NCT00406653|583837476|FG000|Induction Period|Adverse Event|1|||
161667999|NCT00406653|583837477|FG001|Induction Period|Adverse Event|10|||
161668000|NCT00406653|583837478|FG002|Induction Period|Adverse Event|4|||
161668001|NCT00406653|583837479|FG003|Induction Period|Adverse Event|11|||
161668002|NCT00406653|583837480|FG004|Induction Period|Adverse Event|0|||
161668003|NCT00406653|583837481|FG005|Induction Period|Adverse Event|0|||
161668004|NCT00406653|583837482|FG006|Induction Period|Adverse Event|0|||
161895781|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895782|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895783|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895784|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895785|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895786|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895787|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895788|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895789|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895790|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895791|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895792|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895793|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895794|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
161781279|NCT02706353|584242040|FG002|Dose Level 4|Disease Progression|0|||
161781280|NCT02706353|584242041|FG003|Dose Level 4|Disease Progression|1|||
161781281|NCT02706353|584242042|FG004|Dose Level 4|Disease Progression|0|||
161781282|NCT02706353|584242043|FG005|Dose Level 4|Disease Progression|0|||
161781283|NCT02706353|584242038|FG000|Dose Level 4|Toxicity|0|||
161781284|NCT02706353|584242039|FG001|Dose Level 4|Toxicity|0|||
161781285|NCT02706353|584242040|FG002|Dose Level 4|Toxicity|0|||
161781286|NCT02706353|584242041|FG003|Dose Level 4|Toxicity|1|||
161781287|NCT02706353|584242042|FG004|Dose Level 4|Toxicity|0|||
161781288|NCT02706353|584242043|FG005|Dose Level 4|Toxicity|0|||
161781289|NCT02706353|584242038|FG000|Dose Level 4|Death|0|||
161781290|NCT02706353|584242039|FG001|Dose Level 4|Death|0|||
161781291|NCT02706353|584242040|FG002|Dose Level 4|Death|0|||
161781292|NCT02706353|584242041|FG003|Dose Level 4|Death|1|||
161781293|NCT02706353|584242042|FG004|Dose Level 4|Death|0|||
161781294|NCT02706353|584242043|FG005|Dose Level 4|Death|0|||
161781295|NCT02706353|584242038|FG000|Dose Level 5|Toxicity|0|||
161781296|NCT02706353|584242039|FG001|Dose Level 5|Toxicity|0|||
161781297|NCT02706353|584242040|FG002|Dose Level 5|Toxicity|0|||
161781298|NCT02706353|584242041|FG003|Dose Level 5|Toxicity|0|||
161781299|NCT02706353|584242042|FG004|Dose Level 5|Toxicity|1|||
161781300|NCT02706353|584242043|FG005|Dose Level 5|Toxicity|0|||
161781301|NCT02706353|584242038|FG000|Dose Level 5|Disease Progression|0|||
161781302|NCT02706353|584242039|FG001|Dose Level 5|Disease Progression|0|||
161781303|NCT02706353|584242040|FG002|Dose Level 5|Disease Progression|0|||
161781304|NCT02706353|584242041|FG003|Dose Level 5|Disease Progression|0|||
161781305|NCT02706353|584242042|FG004|Dose Level 5|Disease Progression|3|||
161781306|NCT02706353|584242043|FG005|Dose Level 5|Disease Progression|2|||
161781307|NCT02706353|584242038|FG000|Dose Level 5|Death|0|||
161781308|NCT02706353|584242039|FG001|Dose Level 5|Death|0|||
161781309|NCT02706353|584242040|FG002|Dose Level 5|Death|0|||
161781310|NCT02706353|584242041|FG003|Dose Level 5|Death|0|||
161781311|NCT02706353|584242042|FG004|Dose Level 5|Death|1|||
161781312|NCT02706353|584242043|FG005|Dose Level 5|Death|6|||
161781313|NCT02706353|584242038|FG000|Dose Level 5|Withdrawal by Subject|0|||
161781314|NCT02706353|584242039|FG001|Dose Level 5|Withdrawal by Subject|0|||
161781315|NCT02706353|584242040|FG002|Dose Level 5|Withdrawal by Subject|0|||
161781316|NCT02706353|584242041|FG003|Dose Level 5|Withdrawal by Subject|0|||
161781317|NCT02706353|584242042|FG004|Dose Level 5|Withdrawal by Subject|0|||
161781318|NCT02706353|584242043|FG005|Dose Level 5|Withdrawal by Subject|2|||
161781319|NCT03560466|584242044|FG000|Overall Study|Adverse Event|1|||
161781320|NCT03560466|584242045|FG001|Overall Study|Adverse Event|2|||
161895795|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161552430|NCT02733042|583410434|FG007|Overall Study|Death|0|||
161668005|NCT00406653|583837476|FG000|Induction Period|Lack of Efficacy|11|||
161668006|NCT00406653|583837477|FG001|Induction Period|Lack of Efficacy|14|||
161668007|NCT00406653|583837478|FG002|Induction Period|Lack of Efficacy|8|||
161668008|NCT00406653|583837479|FG003|Induction Period|Lack of Efficacy|10|||
161668009|NCT00406653|583837480|FG004|Induction Period|Lack of Efficacy|0|||
161668010|NCT00406653|583837481|FG005|Induction Period|Lack of Efficacy|0|||
161668011|NCT00406653|583837482|FG006|Induction Period|Lack of Efficacy|0|||
161668012|NCT00406653|583837476|FG000|Induction Period|Lost to Follow-up|0|||
161668013|NCT00406653|583837477|FG001|Induction Period|Lost to Follow-up|2|||
161668014|NCT00406653|583837478|FG002|Induction Period|Lost to Follow-up|0|||
161668015|NCT00406653|583837479|FG003|Induction Period|Lost to Follow-up|0|||
161781321|NCT03560466|584242046|FG002|Overall Study|Adverse Event|0|||
161781322|NCT03560466|584242044|FG000|Overall Study|Poor Compliance to Protocol|0|||
161781323|NCT03560466|584242045|FG001|Overall Study|Poor Compliance to Protocol|2|||
161781324|NCT03560466|584242046|FG002|Overall Study|Poor Compliance to Protocol|0|||
161781325|NCT03560466|584242044|FG000|Overall Study|Other|6|||
161781326|NCT03560466|584242045|FG001|Overall Study|Other|8|||
161781327|NCT03560466|584242046|FG002|Overall Study|Other|1|||
161781328|NCT01190098|584243623|FG000|Overall Study|Adverse Event|2|||
161781329|NCT01190098|584243624|FG001|Overall Study|Adverse Event|0|||
161781330|NCT01190098|584243623|FG000|Overall Study|Patient coomorbidity|0|||
161781331|NCT01190098|584243624|FG001|Overall Study|Patient coomorbidity|1|||
161781332|NCT01190098|584243623|FG000|Overall Study|Lack of transportation|1|||
161895796|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895797|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895798|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895799|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895800|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895801|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895802|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895803|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895804|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161668016|NCT00406653|583837480|FG004|Induction Period|Lost to Follow-up|0|||
161668017|NCT00406653|583837481|FG005|Induction Period|Lost to Follow-up|0|||
161668018|NCT00406653|583837482|FG006|Induction Period|Lost to Follow-up|0|||
161668019|NCT00406653|583837476|FG000|Induction Period|Withdrawal of Consent|2|||
161895805|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895806|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895807|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895808|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895809|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895810|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895811|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895812|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895813|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895814|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895815|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895816|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895817|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895818|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895819|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895820|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895821|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895822|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895823|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895824|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895825|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161668020|NCT00406653|583837477|FG001|Induction Period|Withdrawal of Consent|5|||
161668021|NCT00406653|583837478|FG002|Induction Period|Withdrawal of Consent|1|||
161895826|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161895827|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895828|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895829|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895830|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895831|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895832|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895833|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895834|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161895835|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895836|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161895837|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895838|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895839|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895840|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895841|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895842|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895843|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895844|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895845|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895846|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895847|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895848|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895849|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895850|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895851|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895852|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161668022|NCT00406653|583837479|FG003|Induction Period|Withdrawal of Consent|2|||
161668023|NCT00406653|583837480|FG004|Induction Period|Withdrawal of Consent|0|||
161668024|NCT00406653|583837481|FG005|Induction Period|Withdrawal of Consent|0|||
161895853|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895854|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895855|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895856|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895857|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161668025|NCT00406653|583837482|FG006|Induction Period|Withdrawal of Consent|0|||
161668026|NCT00406653|583837476|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
161668027|NCT00406653|583837477|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
161668028|NCT00406653|583837478|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
161668029|NCT00406653|583837479|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
161668030|NCT00406653|583837480|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
161668031|NCT00406653|583837481|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
161668032|NCT00406653|583837482|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
161668033|NCT00406653|583837476|FG000|Induction Period|Pregnancy|1|||
161668034|NCT00406653|583837477|FG001|Induction Period|Pregnancy|0|||
161668035|NCT00406653|583837478|FG002|Induction Period|Pregnancy|0|||
161668036|NCT00406653|583837479|FG003|Induction Period|Pregnancy|0|||
161781333|NCT01190098|584243624|FG001|Overall Study|Lack of transportation|0|||
161781334|NCT01190098|584243623|FG000|Overall Study|Other|0|||
161781335|NCT01190098|584243624|FG001|Overall Study|Other|1|||
161781336|NCT04723173|584243629|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
161781337|NCT02996448|584243630|FG000|Overall Study|Study terminated due to adverse effects|3|||
161781338|NCT00606801|584243631|FG000|Intervention|Protocol Violation|3|||
161781339|NCT00606801|584243632|FG001|Intervention|Protocol Violation|3|||
161781340|NCT02082262|584243633|FG000|Overall Study|Withdrawal by Subject|3|||
161781341|NCT02082262|584243633|FG000|Overall Study|Adverse Event|48|||
161781342|NCT01726335|584243638|FG000|Overall Study|Lost to Follow-up|2|||
161781343|NCT01726335|584243638|FG000|Overall Study|Withdrawal by Subject|15|||
161781344|NCT01726335|584243638|FG000|Overall Study|Adverse Event|4|||
161781345|NCT01726335|584243638|FG000|Overall Study|Lost to Follow-up|2|||
161781346|NCT01726335|584243638|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
161781347|NCT01586624|584243639|FG000|Overall Study|Adverse Event|3|||
161781348|NCT01586624|584243640|FG001|Overall Study|Adverse Event|0|||
161781349|NCT01586624|584243641|FG002|Overall Study|Adverse Event|2|||
161781350|NCT01586624|584243642|FG003|Overall Study|Adverse Event|1|||
161781351|NCT01586624|584243643|FG004|Overall Study|Adverse Event|3|||
161781352|NCT01586624|584243644|FG005|Overall Study|Adverse Event|3|||
161781353|NCT01586624|584243645|FG006|Overall Study|Adverse Event|2|||
161781354|NCT01586624|584243646|FG007|Overall Study|Adverse Event|3|||
161781355|NCT01586624|584243639|FG000|Overall Study|Physician Decision|0|||
161781356|NCT01586624|584243640|FG001|Overall Study|Physician Decision|1|||
161781357|NCT01586624|584243641|FG002|Overall Study|Physician Decision|1|||
161781358|NCT01586624|584243642|FG003|Overall Study|Physician Decision|0|||
161781359|NCT01586624|584243643|FG004|Overall Study|Physician Decision|2|||
161781360|NCT01586624|584243644|FG005|Overall Study|Physician Decision|0|||
161781361|NCT01586624|584243645|FG006|Overall Study|Physician Decision|1|||
161781362|NCT01586624|584243646|FG007|Overall Study|Physician Decision|1|||
161781363|NCT01586624|584243639|FG000|Overall Study|Withdrawal by Subject|0|||
161781364|NCT01586624|584243640|FG001|Overall Study|Withdrawal by Subject|0|||
161781365|NCT01586624|584243641|FG002|Overall Study|Withdrawal by Subject|0|||
161781366|NCT01586624|584243642|FG003|Overall Study|Withdrawal by Subject|1|||
161781367|NCT01586624|584243643|FG004|Overall Study|Withdrawal by Subject|0|||
161781368|NCT01586624|584243644|FG005|Overall Study|Withdrawal by Subject|0|||
161781369|NCT01586624|584243645|FG006|Overall Study|Withdrawal by Subject|0|||
161895858|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895859|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895860|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895861|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895862|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895863|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895864|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895865|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895866|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161781370|NCT01586624|584243646|FG007|Overall Study|Withdrawal by Subject|0|||
161781371|NCT01586624|584243639|FG000|Overall Study|Evidence of disease progression|1|||
161781372|NCT01586624|584243640|FG001|Overall Study|Evidence of disease progression|3|||
161781373|NCT01586624|584243641|FG002|Overall Study|Evidence of disease progression|2|||
161781374|NCT01586624|584243642|FG003|Overall Study|Evidence of disease progression|5|||
161781375|NCT01586624|584243643|FG004|Overall Study|Evidence of disease progression|3|||
161781376|NCT01586624|584243644|FG005|Overall Study|Evidence of disease progression|5|||
161895867|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895868|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161781377|NCT01586624|584243645|FG006|Overall Study|Evidence of disease progression|4|||
161781378|NCT01586624|584243646|FG007|Overall Study|Evidence of disease progression|6|||
161781379|NCT01586624|584243639|FG000|Overall Study|Screen failure (no treatment received)|0|||
161781380|NCT01586624|584243640|FG001|Overall Study|Screen failure (no treatment received)|0|||
161781381|NCT01586624|584243641|FG002|Overall Study|Screen failure (no treatment received)|0|||
161895869|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895870|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895871|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
161895872|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895873|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161895874|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161895875|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161895876|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895877|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895878|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895879|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895880|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895881|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895882|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895883|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895884|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895885|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895886|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895887|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895888|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895889|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895890|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895891|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895892|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895893|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895894|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895895|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895896|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895897|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895898|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895899|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895900|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895901|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895902|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895903|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895904|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895905|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
161895906|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
161895907|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
161895908|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
161895909|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
161895910|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895911|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161781382|NCT01586624|584243642|FG003|Overall Study|Screen failure (no treatment received)|0|||
161781383|NCT01586624|584243643|FG004|Overall Study|Screen failure (no treatment received)|0|||
161781384|NCT01586624|584243644|FG005|Overall Study|Screen failure (no treatment received)|0|||
161781385|NCT01586624|584243645|FG006|Overall Study|Screen failure (no treatment received)|1|||
161781386|NCT01586624|584243646|FG007|Overall Study|Screen failure (no treatment received)|0|||
161781387|NCT01796860|584243651|FG000|Overall Study|Withdrawal by Subject|3|||
161781388|NCT00647426|584243654|FG000|Overall Study|Withdrawal by Subject|2|||
161781389|NCT02748616|584243662|FG000|Overall Study|Lost to Follow-up|1|||
161781390|NCT02748616|584243662|FG000|Overall Study|Withdrawal by Subject|2|||
161781391|NCT02748616|584243662|FG000|Overall Study|Physician Decision|2|||
161781392|NCT02748616|584243662|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
161781393|NCT00068406|584243663|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
161781394|NCT00068406|584243663|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
161781395|NCT02018042|584243664|FG000|Overall Study|Withdrawal by Subject|1|||
161781396|NCT03231709|584243665|FG000|Treatment Period 1|Reason not Specified|0|||
161781397|NCT03231709|584243666|FG001|Treatment Period 1|Reason not Specified|1|||
161781398|NCT03231709|584243665|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
161781399|NCT03231709|584243666|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
161781400|NCT02609178|584243667|FG000|First Crown|Withdrawal by Subject|0|||
161781401|NCT02609178|584243668|FG001|First Crown|Withdrawal by Subject|0|||
161781402|NCT02609178|584243669|FG002|First Crown|Withdrawal by Subject|1|||
161781403|NCT02609178|584243670|FG003|First Crown|Withdrawal by Subject|1|||
161781404|NCT02609178|584243671|FG004|First Crown|Withdrawal by Subject|0|||
161895912|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895913|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895914|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895915|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161781405|NCT02609178|584243672|FG005|First Crown|Withdrawal by Subject|0|||
161781406|NCT02419469|584243673|FG000|Overall Study|Withdrawal by Subject|1|||
161781407|NCT01785875|584243674|FG000|Overall Study|Withdrawal by Subject|41|||
161781408|NCT01785875|584243675|FG001|Overall Study|Withdrawal by Subject|34|||
161781409|NCT01785875|584243676|FG002|Overall Study|Withdrawal by Subject|36|||
161781410|NCT01785875|584243674|FG000|Overall Study|Lost to Follow-up|19|||
161781411|NCT01785875|584243675|FG001|Overall Study|Lost to Follow-up|22|||
161781412|NCT01785875|584243676|FG002|Overall Study|Lost to Follow-up|6|||
161781413|NCT01785875|584243674|FG000|Overall Study|Death|27|||
161781414|NCT01785875|584243675|FG001|Overall Study|Death|16|||
161781415|NCT01785875|584243676|FG002|Overall Study|Death|7|||
161781416|NCT01785875|584243674|FG000|Overall Study|Sponsor Decision|0|||
161781417|NCT01785875|584243675|FG001|Overall Study|Sponsor Decision|2|||
161781418|NCT01785875|584243676|FG002|Overall Study|Sponsor Decision|0|||
161781419|NCT01785875|584243674|FG000|Overall Study|Protocol Specified Criteria|207|||
161781420|NCT01785875|584243675|FG001|Overall Study|Protocol Specified Criteria|214|||
161781421|NCT01785875|584243676|FG002|Overall Study|Protocol Specified Criteria|55|||
161781422|NCT01785875|584243674|FG000|Overall Study|Missing|0|||
161781423|NCT01785875|584243675|FG001|Overall Study|Missing|1|||
161781424|NCT01785875|584243676|FG002|Overall Study|Missing|3|||
161781425|NCT01414062|584243679|FG000|Overall Study|Lost to Follow-up|3|||
161781426|NCT01414062|584243680|FG001|Overall Study|Lost to Follow-up|2|||
161781427|NCT01414062|584243679|FG000|Overall Study|Left Country|1|||
161781428|NCT01414062|584243680|FG001|Overall Study|Left Country|1|||
161781429|NCT01414062|584243679|FG000|Overall Study|Family Disapproval|1|||
161781430|NCT01414062|584243680|FG001|Overall Study|Family Disapproval|0|||
161781431|NCT01414062|584243679|FG000|Overall Study|Withdrawal by Subject|0|||
161781432|NCT01414062|584243680|FG001|Overall Study|Withdrawal by Subject|1|||
161781433|NCT04075292|584243681|FG000|Overall Study|Withdrawal by Subject|1|||
161781434|NCT04075292|584243682|FG001|Overall Study|Withdrawal by Subject|9|||
161781435|NCT04075292|584243681|FG000|Overall Study|Death|2|||
161781436|NCT04075292|584243682|FG001|Overall Study|Death|5|||
161781437|NCT04075292|584243681|FG000|Overall Study|Remained on study at time of DCO|74|||
161781438|NCT04075292|584243682|FG001|Overall Study|Remained on study at time of DCO|64|||
161781439|NCT00902265|584243685|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
161781440|NCT00902265|584243685|FG000|Overall Study|Adverse Event|2|||
161781441|NCT00902265|584243685|FG000|Overall Study|Lack of Efficacy|2|||
161781442|NCT00902265|584243685|FG000|Overall Study|Protocol Violation|1|||
161781443|NCT02866695|584243687|FG000|Overall Study|Adverse Event|1|||
161781444|NCT02866695|584243687|FG000|Overall Study|Lost to Follow-up|1|||
161781445|NCT05016765|584243688|FG000|Overall Study|Lost to Follow-up|4|||
161781446|NCT01988493|584243691|FG000|Overall Study|Randomized but not treated|0|||
161781447|NCT01988493|584243692|FG001|Overall Study|Randomized but not treated|0|||
161781448|NCT01988493|584243693|FG002|Overall Study|Randomized but not treated|0|||
161781449|NCT01988493|584243694|FG003|Overall Study|Randomized but not treated|0|||
161781450|NCT01988493|584243695|FG004|Overall Study|Randomized but not treated|1|||
161781451|NCT00185731|584243700|FG000|Overall Study|Withdrawal by Subject|1|||
161781452|NCT00185731|584243700|FG000|Overall Study|Not Eligible|1|||
161781453|NCT03087773|584243701|FG000|Overall Study|Withdrawal by Subject|8|||
161781454|NCT03087773|584243702|FG001|Overall Study|Withdrawal by Subject|4|||
161781455|NCT03087773|584243701|FG000|Overall Study|Lost to Follow-up|12|||
161781456|NCT03087773|584243702|FG001|Overall Study|Lost to Follow-up|8|||
161781457|NCT05144477|584243705|FG000|Overall Study|Withdrawal by Subject|1|||
161781458|NCT05144477|584243706|FG001|Overall Study|Withdrawal by Subject|1|||
161781459|NCT01787188|584243709|FG000|Overall Study|Adverse Event|2|||
161781460|NCT01787188|584243710|FG001|Overall Study|Adverse Event|4|||
161781461|NCT01787188|584243711|FG002|Overall Study|Adverse Event|6|||
161781462|NCT01787188|584243709|FG000|Overall Study|Lack of Efficacy|7|||
161781463|NCT01787188|584243710|FG001|Overall Study|Lack of Efficacy|3|||
161781464|NCT01787188|584243711|FG002|Overall Study|Lack of Efficacy|5|||
161781465|NCT01787188|584243709|FG000|Overall Study|Non-compliance with Study Drug|0|||
161781466|NCT01787188|584243710|FG001|Overall Study|Non-compliance with Study Drug|1|||
161781467|NCT01787188|584243711|FG002|Overall Study|Non-compliance with Study Drug|0|||
161781468|NCT01787188|584243709|FG000|Overall Study|Withdrawal by Subject|4|||
161781469|NCT01787188|584243710|FG001|Overall Study|Withdrawal by Subject|3|||
161781470|NCT01787188|584243711|FG002|Overall Study|Withdrawal by Subject|2|||
161781471|NCT01787188|584243709|FG000|Overall Study|Protocol Violation|3|||
161781472|NCT01787188|584243710|FG001|Overall Study|Protocol Violation|2|||
161781473|NCT01787188|584243711|FG002|Overall Study|Protocol Violation|3|||
161895916|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161781474|NCT01787188|584243709|FG000|Overall Study|Lost to Follow-up|1|||
161781475|NCT01787188|584243710|FG001|Overall Study|Lost to Follow-up|2|||
161781476|NCT01787188|584243711|FG002|Overall Study|Lost to Follow-up|2|||
161781477|NCT01787188|584243709|FG000|Overall Study|Other, including patient moved|0|||
161781478|NCT01787188|584243710|FG001|Overall Study|Other, including patient moved|3|||
161781479|NCT01787188|584243711|FG002|Overall Study|Other, including patient moved|0|||
161781480|NCT00854607|584243712|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
161781481|NCT01783483|584243718|FG000|Overall Study|Death|3|||
161895917|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895918|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895919|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895920|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895921|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895922|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895923|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895924|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895925|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895926|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895927|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895928|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895929|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895930|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895931|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895932|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895933|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895934|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895935|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895936|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895937|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895938|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895939|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895940|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895941|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895942|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895943|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
161895944|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895945|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895946|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895947|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895948|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895949|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895950|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895951|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895952|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895953|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895954|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895955|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895956|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895957|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895958|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895959|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895960|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895961|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895962|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895963|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895964|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895965|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895966|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895967|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895968|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895969|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895970|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895971|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895972|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895973|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
161895974|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
161895975|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
161895976|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895977|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895978|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895979|NCT01249833|584666441|FG000|Overall Study|Lost to Follow-up|0|||
161895980|NCT01249833|584666442|FG001|Overall Study|Lost to Follow-up|1|||
161895981|NCT03796676|584666443|FG000|Overall Study|Adverse Event|2|||
161895982|NCT03796676|584666444|FG001|Overall Study|Adverse Event|1|||
161895983|NCT03796676|584666445|FG002|Overall Study|Adverse Event|2|||
161895984|NCT03796676|584666443|FG000|Overall Study|Lost to Follow-up|2|||
161895985|NCT03796676|584666444|FG001|Overall Study|Lost to Follow-up|1|||
161781482|NCT01783483|584243719|FG001|Overall Study|Death|3|||
161781483|NCT01783483|584243718|FG000|Overall Study|Lost to Follow-up|14|||
161781484|NCT01783483|584243719|FG001|Overall Study|Lost to Follow-up|10|||
161781485|NCT01783483|584243718|FG000|Overall Study|Withdrawal by Subject|2|||
161781486|NCT01783483|584243719|FG001|Overall Study|Withdrawal by Subject|1|||
161781487|NCT01783483|584243718|FG000|Overall Study|Physician Decision|1|||
161781488|NCT01783483|584243719|FG001|Overall Study|Physician Decision|1|||
161781489|NCT02268045|584243720|FG000|Overall Study|Death|4|||
161781490|NCT02268045|584243721|FG001|Overall Study|Death|4|||
161781491|NCT02268045|584243720|FG000|Overall Study|Disease Progression|2|||
161781492|NCT02268045|584243721|FG001|Overall Study|Disease Progression|1|||
161781493|NCT02268045|584243720|FG000|Overall Study|Adverse Event|7|||
161781494|NCT02268045|584243721|FG001|Overall Study|Adverse Event|7|||
161781495|NCT02268045|584243720|FG000|Overall Study|Withdrawal by Subject|2|||
161781496|NCT02268045|584243721|FG001|Overall Study|Withdrawal by Subject|6|||
161781497|NCT02268045|584243720|FG000|Overall Study|Physician Decision|0|||
161781498|NCT02268045|584243721|FG001|Overall Study|Physician Decision|1|||
161781499|NCT02268045|584243720|FG000|Overall Study|Protocol Violation|1|||
161781500|NCT02268045|584243721|FG001|Overall Study|Protocol Violation|1|||
161781501|NCT00835068|584243722|FG000|Overall Study|Death|1|||
161781502|NCT00835068|584243723|FG001|Overall Study|Death|0|||
161781503|NCT00835068|584243722|FG000|Overall Study|Adverse Event|0|||
161781504|NCT00835068|584243723|FG001|Overall Study|Adverse Event|1|||
161781505|NCT00835068|584243722|FG000|Overall Study|Other|8|||
161781506|NCT00835068|584243723|FG001|Overall Study|Other|0|||
161781507|NCT00835068|584243722|FG000|Overall Study|Withdrawal by Subject|1|||
161781508|NCT00835068|584243723|FG001|Overall Study|Withdrawal by Subject|0|||
161781509|NCT01308762|584243724|FG000|Overall Study|Protocol Violation|0|||
161781510|NCT01308762|584243725|FG001|Overall Study|Protocol Violation|1|||
161781511|NCT01308762|584243726|FG002|Overall Study|Protocol Violation|0|||
161781512|NCT00646282|584243727|FG000|Overall Study|Protocol terminated|4|||
161781513|NCT00646282|584243728|FG001|Overall Study|Protocol terminated|4|||
161436049|NCT02266888|582991268|FG003|Overall Study|Personnel unavailable at transplant|1|||
161436050|NCT02266888|582991265|FG000|Overall Study|Transfer of care|0|||
161436051|NCT02266888|582991266|FG001|Overall Study|Transfer of care|0|||
161436052|NCT02266888|582991267|FG002|Overall Study|Transfer of care|1|||
161436053|NCT02266888|582991268|FG003|Overall Study|Transfer of care|0|||
161436054|NCT03877510|582991271|FG000|Overall Study|Death|6|||
161436055|NCT03877510|582991271|FG000|Overall Study|Lost to Follow-up|2|||
161436056|NCT03877510|582991271|FG000|Overall Study|Non-compliance with study drug|2|||
161436057|NCT03877510|582991271|FG000|Overall Study|Lack of Efficacy|14|||
161436058|NCT03877510|582991271|FG000|Overall Study|Adverse Event|20|||
161436059|NCT03877510|582991271|FG000|Overall Study|Withdrawal by Subject|22|||
161436060|NCT03877510|582991271|FG000|Overall Study|Miscellaneous|1|||
161436061|NCT03040336|582991272|FG000|Overall Study|Death|1|||
161436062|NCT03040336|582991273|FG001|Overall Study|Death|0|||
161436063|NCT03040336|582991272|FG000|Overall Study|Withdrawal by Subject|2|||
161781514|NCT01556490|584243729|FG000|Randomized Patients Summary|Protocol Violation|22|||
161781515|NCT01556490|584243730|FG001|Randomized Patients Summary|Protocol Violation|23|||
161781516|NCT01556490|584243729|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
161781517|NCT01556490|584243730|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
161781518|NCT02058368|584243732|FG000|Overall Study|Adverse Event|15|||
161781519|NCT02058368|584243733|FG001|Overall Study|Adverse Event|20|||
161781520|NCT02058368|584243732|FG000|Overall Study|Lack of Efficacy|0|||
161781521|NCT02058368|584243733|FG001|Overall Study|Lack of Efficacy|1|||
161781522|NCT02058368|584243732|FG000|Overall Study|Protocol Violation|0|||
161781523|NCT02058368|584243733|FG001|Overall Study|Protocol Violation|4|||
161781524|NCT02058368|584243732|FG000|Overall Study|Lost to Follow-up|2|||
161781525|NCT02058368|584243733|FG001|Overall Study|Lost to Follow-up|0|||
161781526|NCT02058368|584243732|FG000|Overall Study|Physician Decision|2|||
161781527|NCT02058368|584243733|FG001|Overall Study|Physician Decision|3|||
161781528|NCT02058368|584243732|FG000|Overall Study|Withdrawal by Subject|22|||
161781529|NCT02058368|584243733|FG001|Overall Study|Withdrawal by Subject|26|||
161781530|NCT02181842|584243735|FG000|Overall Study|Case Report Forms Uncollected|2|||
161781531|NCT01652872|584243736|FG000|Overall Study|Death|36|||
161781532|NCT01652872|584243737|FG001|Overall Study|Death|39|||
161781533|NCT01652872|584243736|FG000|Overall Study|Lost to Follow-up|28|||
161781534|NCT01652872|584243737|FG001|Overall Study|Lost to Follow-up|23|||
161781535|NCT01652872|584243736|FG000|Overall Study|Decision by sponsor|5|||
161781536|NCT01652872|584243737|FG001|Overall Study|Decision by sponsor|7|||
161781537|NCT01652872|584243736|FG000|Overall Study|Withdrawal by Subject|76|||
161781538|NCT01652872|584243737|FG001|Overall Study|Withdrawal by Subject|84|||
161781539|NCT00758706|584243738|FG000|Overall Study|Adverse Event|4|||
161781540|NCT00758706|584243739|FG001|Overall Study|Adverse Event|4|||
161781541|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
161781542|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
161781543|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
161436064|NCT03040336|582991273|FG001|Overall Study|Withdrawal by Subject|3|||
161436065|NCT01524796|582991275|FG000|Overall Study|Adverse Event|13|||
161781544|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
161781545|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
161781546|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
161781547|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
161781548|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161781549|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
161781550|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161781551|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161781552|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
161781553|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161781554|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161781555|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161781556|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161781557|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161781558|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161781559|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
161781560|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
161781561|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
161781562|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
161781563|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
161781564|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
161781565|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
161781566|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
161781567|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161781568|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161781569|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161781570|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
161781571|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
161781572|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
161781573|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
161781574|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
161781575|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
161781576|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
161781577|NCT03985293|584243743|FG000|FOLLOW-UP|Lost to Follow-up|0|||
161781578|NCT03985293|584243744|FG001|FOLLOW-UP|Lost to Follow-up|0|||
161781579|NCT03985293|584243745|FG002|FOLLOW-UP|Lost to Follow-up|1|||
161781580|NCT03985293|584243746|FG003|FOLLOW-UP|Lost to Follow-up|0|||
161781581|NCT03985293|584243747|FG004|FOLLOW-UP|Lost to Follow-up|0|||
161781582|NCT03985293|584243748|FG005|FOLLOW-UP|Lost to Follow-up|0|||
161781583|NCT02588651|584243749|FG000|Overall Study|Adverse Event|1|||
161781584|NCT02588651|584243749|FG000|Overall Study|Withdrawal by Subject|2|||
161781585|NCT02588651|584243749|FG000|Overall Study|Death|1|||
161781586|NCT02588651|584243749|FG000|Overall Study|Lack of Efficacy|13|||
161781587|NCT02588651|584243749|FG000|Overall Study|Lost to Follow-up|1|||
161781588|NCT02588651|584243749|FG000|Overall Study|Physician Decision|1|||
161781589|NCT02588651|584243749|FG000|Overall Study|Disease progression|2|||
161781590|NCT05899218|584243750|FG000|Overall Study|Lost to Follow-up|2|||
161781591|NCT05899218|584243751|FG001|Overall Study|Lost to Follow-up|2|||
161781592|NCT05899218|584243750|FG000|Overall Study|deemed ineligible out of country|1|||
161781593|NCT05899218|584243751|FG001|Overall Study|deemed ineligible out of country|0|||
161781594|NCT02587325|584243756|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
161781595|NCT02587325|584243757|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781596|NCT02587325|584243758|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781597|NCT02587325|584243759|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781598|NCT02587325|584243760|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781599|NCT02587325|584243756|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781600|NCT02587325|584243757|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781601|NCT02587325|584243758|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781602|NCT02587325|584243759|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
161781603|NCT02587325|584243760|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781604|NCT02587325|584243756|FG000|32-Week Optional Extension Part|Adverse Event|0|||
161895986|NCT03796676|584666445|FG002|Overall Study|Lost to Follow-up|0|||
161895987|NCT03796676|584666443|FG000|Overall Study|Protocol Violation|0|||
161895988|NCT03796676|584666444|FG001|Overall Study|Protocol Violation|0|||
161781605|NCT02587325|584243757|FG001|32-Week Optional Extension Part|Adverse Event|0|||
161781606|NCT02587325|584243758|FG002|32-Week Optional Extension Part|Adverse Event|1|||
161781607|NCT02587325|584243759|FG003|32-Week Optional Extension Part|Adverse Event|0|||
161781608|NCT02587325|584243760|FG004|32-Week Optional Extension Part|Adverse Event|0|||
161781609|NCT02587325|584243756|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
161781610|NCT02587325|584243757|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
161781611|NCT02587325|584243758|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
161895989|NCT03796676|584666445|FG002|Overall Study|Protocol Violation|1|||
161895990|NCT03796676|584666443|FG000|Overall Study|Withdrawal by Subject|1|||
161895991|NCT03796676|584666444|FG001|Overall Study|Withdrawal by Subject|1|||
161781612|NCT02587325|584243759|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
161781613|NCT02587325|584243760|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
161781614|NCT00390572|584243761|FG000|Overall Study|Lost to Follow-up|8|||
161781615|NCT00390572|584243762|FG001|Overall Study|Lost to Follow-up|4|||
161781616|NCT00390572|584243761|FG000|Overall Study|health condition|0|||
161781617|NCT00390572|584243762|FG001|Overall Study|health condition|1|||
161781618|NCT03078192|584243793|FG000|Overall Study|Withdrawal by Subject|2|||
161781619|NCT03078192|584243794|FG001|Overall Study|Withdrawal by Subject|1|||
161781620|NCT03078192|584243793|FG000|Overall Study|screen failure|0|||
161781621|NCT03078192|584243794|FG001|Overall Study|screen failure|3|||
161781622|NCT01142466|584245748|FG000|Overall Study|Adverse Event|2|||
161781623|NCT01142466|584245749|FG001|Overall Study|Adverse Event|1|||
161781624|NCT01142466|584245748|FG000|Overall Study|Withdrawal by Subject|1|||
161781625|NCT01142466|584245749|FG001|Overall Study|Withdrawal by Subject|1|||
161781626|NCT02414854|584245750|FG000|Overall Study|Adverse Event|9|||
161781627|NCT02414854|584245751|FG001|Overall Study|Adverse Event|7|||
161781628|NCT02414854|584245752|FG002|Overall Study|Adverse Event|1|||
161781629|NCT02414854|584245753|FG003|Overall Study|Adverse Event|12|||
161781630|NCT02414854|584245750|FG000|Overall Study|Poor compliance to protocol|1|||
161781631|NCT02414854|584245751|FG001|Overall Study|Poor compliance to protocol|1|||
161781632|NCT02414854|584245752|FG002|Overall Study|Poor compliance to protocol|2|||
161781633|NCT02414854|584245753|FG003|Overall Study|Poor compliance to protocol|2|||
161781634|NCT02414854|584245750|FG000|Overall Study|Other than specified above|12|||
161781635|NCT02414854|584245751|FG001|Overall Study|Other than specified above|37|||
161781636|NCT02414854|584245752|FG002|Overall Study|Other than specified above|17|||
161781637|NCT02414854|584245753|FG003|Overall Study|Other than specified above|37|||
161781638|NCT01355523|584245754|FG000|Overall Study|Withdrawal by Subject|1|||
161781639|NCT01355523|584245755|FG001|Overall Study|Withdrawal by Subject|4|||
161781640|NCT01355523|584245754|FG000|Overall Study|Lost to Follow-up|0|||
161781641|NCT01355523|584245755|FG001|Overall Study|Lost to Follow-up|2|||
161781642|NCT01355523|584245754|FG000|Overall Study|Protocol Violation|0|||
161781643|NCT01355523|584245755|FG001|Overall Study|Protocol Violation|2|||
161781644|NCT01355523|584245754|FG000|Overall Study|Adverse Event|0|||
161781645|NCT01355523|584245755|FG001|Overall Study|Adverse Event|2|||
161781646|NCT00303316|584245756|FG000|Overall Study|Protocol Violation|1|||
161781647|NCT00303316|584245757|FG001|Overall Study|Protocol Violation|0|||
161781648|NCT00303316|584245756|FG000|Overall Study|Lost to Follow-up|0|||
161781649|NCT00303316|584245757|FG001|Overall Study|Lost to Follow-up|1|||
161781650|NCT00303316|584245756|FG000|Overall Study|Withdrawal by Subject|1|||
161781651|NCT00303316|584245757|FG001|Overall Study|Withdrawal by Subject|2|||
161781652|NCT01074307|584245759|FG000|Overall Study|No primary endpoint evaluation|14|||
161781653|NCT01074307|584245760|FG001|Overall Study|No primary endpoint evaluation|6|||
161781654|NCT01074307|584245759|FG000|Overall Study|Exclusion criterion|0|||
161781655|NCT01074307|584245760|FG001|Overall Study|Exclusion criterion|1|||
161781656|NCT01074307|584245759|FG000|Overall Study|Protocol Violation|8|||
161781657|NCT01074307|584245760|FG001|Overall Study|Protocol Violation|5|||
161781658|NCT01408576|584245765|FG000|Overall Study|Lack of Efficacy|17|||
161781659|NCT01408576|584245766|FG001|Overall Study|Lack of Efficacy|30|||
161781660|NCT01408576|584245767|FG002|Overall Study|Lack of Efficacy|48|||
161781661|NCT01408576|584245765|FG000|Overall Study|Protocol Violation|1|||
161781662|NCT01408576|584245766|FG001|Overall Study|Protocol Violation|2|||
161781663|NCT01408576|584245767|FG002|Overall Study|Protocol Violation|2|||
161781664|NCT01408576|584245765|FG000|Overall Study|Lost to Follow-up|10|||
161781665|NCT01408576|584245766|FG001|Overall Study|Lost to Follow-up|9|||
161781666|NCT01408576|584245767|FG002|Overall Study|Lost to Follow-up|17|||
161781667|NCT01408576|584245765|FG000|Overall Study|Withdrawal by Subject|34|||
161781668|NCT01408576|584245766|FG001|Overall Study|Withdrawal by Subject|60|||
161781669|NCT01408576|584245767|FG002|Overall Study|Withdrawal by Subject|66|||
161781670|NCT01408576|584245765|FG000|Overall Study|Sponsor terminated study|89|||
161781671|NCT01408576|584245766|FG001|Overall Study|Sponsor terminated study|333|||
161781672|NCT01408576|584245767|FG002|Overall Study|Sponsor terminated study|330|||
161781673|NCT01408576|584245765|FG000|Overall Study|AE, serious fatal|4|||
161781674|NCT01408576|584245766|FG001|Overall Study|AE, serious fatal|4|||
161781675|NCT01408576|584245767|FG002|Overall Study|AE, serious fatal|1|||
161781676|NCT01408576|584245765|FG000|Overall Study|SAE, non-fatal|11|||
161781677|NCT01408576|584245766|FG001|Overall Study|SAE, non-fatal|23|||
161781678|NCT01408576|584245767|FG002|Overall Study|SAE, non-fatal|14|||
161781679|NCT01408576|584245765|FG000|Overall Study|AE, non-serious non-fatal|12|||
161781680|NCT01408576|584245766|FG001|Overall Study|AE, non-serious non-fatal|19|||
161781681|NCT01408576|584245767|FG002|Overall Study|AE, non-serious non-fatal|11|||
161781682|NCT01408576|584245765|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161781683|NCT01408576|584245766|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161781684|NCT01408576|584245767|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161781685|NCT01408576|584245765|FG000|Overall Study|AE, unknown type|0|||
161781686|NCT01408576|584245766|FG001|Overall Study|AE, unknown type|1|||
161781687|NCT01408576|584245767|FG002|Overall Study|AE, unknown type|0|||
161781688|NCT01408576|584245765|FG000|Overall Study|Other|10|||
161781689|NCT01408576|584245766|FG001|Overall Study|Other|16|||
161781690|NCT01408576|584245767|FG002|Overall Study|Other|18|||
161781691|NCT02703454|584245771|FG000|Overall Study|Not treated|1|||
161781692|NCT02703454|584245772|FG001|Overall Study|Not treated|3|||
161781693|NCT02703454|584245771|FG000|Overall Study|Withdrawal by Subject|4|||
161781694|NCT02703454|584245772|FG001|Overall Study|Withdrawal by Subject|3|||
161781695|NCT02703454|584245771|FG000|Overall Study|Lost to Follow-up|1|||
161781696|NCT02703454|584245772|FG001|Overall Study|Lost to Follow-up|2|||
161781697|NCT02703454|584245771|FG000|Overall Study|Study discontinuation|5|||
161781698|NCT02703454|584245772|FG001|Overall Study|Study discontinuation|8|||
161781699|NCT02284373|584245773|FG000|Overall Study|Withdrawal by Subject|0|||
161781700|NCT02284373|584245774|FG001|Overall Study|Withdrawal by Subject|1|||
161781701|NCT02284373|584245775|FG002|Overall Study|Withdrawal by Subject|0|||
161781702|NCT02284373|584245773|FG000|Overall Study|Other|0|||
161781703|NCT02284373|584245774|FG001|Overall Study|Other|1|||
161781704|NCT02284373|584245775|FG002|Overall Study|Other|0|||
161781705|NCT02284373|584245773|FG000|Overall Study|Lost to Follow-up|0|||
161781706|NCT02284373|584245774|FG001|Overall Study|Lost to Follow-up|1|||
161781707|NCT02284373|584245775|FG002|Overall Study|Lost to Follow-up|0|||
161781708|NCT02016755|584245776|FG000|Overall Study|Major amputation of index limb|2|||
161781709|NCT02016755|584245776|FG000|Overall Study|Adverse Event|2|||
161781710|NCT02016755|584245776|FG000|Overall Study|Physician Decision|1|||
161781711|NCT02016755|584245776|FG000|Overall Study|Death|2|||
161781712|NCT02476851|584245777|FG000|Overall Study|Protocol Violation|1|||
161781713|NCT02476851|584245778|FG001|Overall Study|Protocol Violation|1|||
161781714|NCT02360397|584245791|FG000|Overall Study|Incomplete screening|3|||
161781715|NCT02360397|584245791|FG000|Overall Study|Adverse Event|1|||
161781716|NCT03543046|584245798|FG000|Overall Study|Adverse Event|1|||
161781717|NCT03543046|584245799|FG001|Overall Study|Adverse Event|1|||
161781718|NCT03543046|584245798|FG000|Overall Study|Physician Decision|1|||
161781719|NCT03543046|584245799|FG001|Overall Study|Physician Decision|1|||
161781720|NCT03543046|584245798|FG000|Overall Study|Protocol Violation|1|||
161781721|NCT03543046|584245799|FG001|Overall Study|Protocol Violation|0|||
161781722|NCT03174925|584245800|FG000|Overall Study|Elastographic images not retrievable|2|||
161781723|NCT03174925|584245800|FG000|Overall Study|Elastography image not interpretable|1|||
161781724|NCT04247594|584245803|FG000|Overall Study|Withdrawal by Subject|4|||
161781725|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
161781726|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
161781727|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
161781728|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
161781729|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
161781730|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
161781731|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
161781732|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
161781733|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781734|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781735|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781736|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
161781737|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
161781738|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781739|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781740|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781741|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
161781742|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
161781743|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
161781744|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
161781745|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
161781746|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
161781747|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
161781748|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
161781749|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
161781750|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781751|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
161781752|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781753|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
161781754|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781755|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161831479|NCT01730040|584424759|FG002|Overall Study|Adverse Event|5|||
161781756|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781757|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
161781758|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781759|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
161781760|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
161781761|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781762|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781763|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
161781764|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781765|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781766|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781767|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
161781768|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
161781769|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781770|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
161781771|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781772|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
161781773|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
161781774|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
161781775|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781776|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
161781777|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781778|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781779|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781780|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781781|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
161781782|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
161781783|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
161781784|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
161781785|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
161781786|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
161781787|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
161781788|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
161781789|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
161781790|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
161781791|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
161781792|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
161781793|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
161781794|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
161781795|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
161781796|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
161781797|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
161781798|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
161781799|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
161781800|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
161781801|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
161781802|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
161781803|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
161781804|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
161781805|NCT04440163|584245805|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
161781806|NCT04440163|584245806|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
161781807|NCT04440163|584245807|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161781808|NCT04440163|584245808|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161781809|NCT04440163|584245809|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
161781810|NCT04440163|584245810|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161781811|NCT04440163|584245811|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
161781812|NCT04440163|584245812|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
161781813|NCT04440163|584245805|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781814|NCT04440163|584245806|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781815|NCT04440163|584245807|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781816|NCT04440163|584245808|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
161781817|NCT04440163|584245809|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781818|NCT04440163|584245810|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161895992|NCT03796676|584666445|FG002|Overall Study|Withdrawal by Subject|0|||
161781819|NCT04440163|584245811|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781820|NCT04440163|584245812|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781821|NCT00589693|584245818|FG000|Overall Study|randomized in error|12|||
161781822|NCT00589693|584245819|FG001|Overall Study|randomized in error|6|||
161781823|NCT00589693|584245818|FG000|Overall Study|Adverse Event|4|||
161781824|NCT00589693|584245819|FG001|Overall Study|Adverse Event|4|||
161781825|NCT00589693|584245818|FG000|Overall Study|Death|26|||
161781826|NCT00589693|584245819|FG001|Overall Study|Death|16|||
161781827|NCT00589693|584245818|FG000|Overall Study|Lack of Efficacy|0|||
161781828|NCT00589693|584245819|FG001|Overall Study|Lack of Efficacy|1|||
161781829|NCT00589693|584245818|FG000|Overall Study|Lost to Follow-up|1|||
161781830|NCT00589693|584245819|FG001|Overall Study|Lost to Follow-up|0|||
161781831|NCT00589693|584245818|FG000|Overall Study|Physician Decision|0|||
161781832|NCT00589693|584245819|FG001|Overall Study|Physician Decision|1|||
161781833|NCT00589693|584245818|FG000|Overall Study|Protocol Violation|1|||
161781834|NCT00589693|584245819|FG001|Overall Study|Protocol Violation|1|||
161781835|NCT01128153|584245820|FG000|Overall Study|Adverse Event|1|||
161781836|NCT01128153|584245821|FG001|Overall Study|Adverse Event|3|||
161781837|NCT01128153|584245820|FG000|Overall Study|Condition under investigation worsened|8|||
161781838|NCT01128153|584245821|FG001|Overall Study|Condition under investigation worsened|7|||
161781839|NCT01128153|584245820|FG000|Overall Study|Withdrawal by Subject|2|||
161781840|NCT01128153|584245821|FG001|Overall Study|Withdrawal by Subject|3|||
161781841|NCT01128153|584245820|FG000|Overall Study|Incorrect enrolment to study|2|||
161781842|NCT01128153|584245821|FG001|Overall Study|Incorrect enrolment to study|1|||
161781843|NCT01128153|584245820|FG000|Overall Study|Protocol Violation|2|||
161781844|NCT01128153|584245821|FG001|Overall Study|Protocol Violation|0|||
161781845|NCT01128153|584245820|FG000|Overall Study|Developed discontinuation criteria|1|||
161781846|NCT01128153|584245821|FG001|Overall Study|Developed discontinuation criteria|1|||
161781847|NCT01954082|584245822|FG000|Overall Study|Study Suspension|42|||
161781848|NCT01954082|584245823|FG001|Overall Study|Study Suspension|36|||
161781849|NCT01954082|584245822|FG000|Overall Study|Adverse Event|10|||
161781850|NCT01954082|584245823|FG001|Overall Study|Adverse Event|4|||
161781851|NCT01954082|584245822|FG000|Overall Study|Intolerance|0|||
161781852|NCT01954082|584245823|FG001|Overall Study|Intolerance|1|||
161781853|NCT01954082|584245822|FG000|Overall Study|Non-compliance|6|||
161781854|NCT01954082|584245823|FG001|Overall Study|Non-compliance|4|||
161781855|NCT01954082|584245822|FG000|Overall Study|Physician Decision|2|||
161781856|NCT01954082|584245823|FG001|Overall Study|Physician Decision|0|||
161781857|NCT01954082|584245822|FG000|Overall Study|Parent Decision|1|||
161781858|NCT01954082|584245823|FG001|Overall Study|Parent Decision|0|||
161781859|NCT01954082|584245822|FG000|Overall Study|Withdrawal by Subject|0|||
161781860|NCT01954082|584245823|FG001|Overall Study|Withdrawal by Subject|1|||
161781861|NCT01954082|584245822|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
161781862|NCT01954082|584245823|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
161781863|NCT01954082|584245822|FG000|Overall Study|Redirection of Care|0|||
161781864|NCT01954082|584245823|FG001|Overall Study|Redirection of Care|2|||
161781865|NCT01954082|584245822|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
161781866|NCT01954082|584245823|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
161895993|NCT03796676|584666443|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
161895994|NCT03796676|584666444|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
161895995|NCT03796676|584666445|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
161895996|NCT01900899|584666448|FG000|Overall Study|Withdrawal by Subject|7|||
161895997|NCT01900899|584666449|FG001|Overall Study|Withdrawal by Subject|1|||
161895998|NCT01900899|584666448|FG000|Overall Study|Migrated from study area|2|||
161895999|NCT01900899|584666449|FG001|Overall Study|Migrated from study area|0|||
161896000|NCT02772809|584666450|FG000|Overall Study|not completed some tasks|6|||
161896001|NCT00534105|584666453|FG000|Overall Study|Lost to Follow-up|23|||
161896002|NCT00534105|584666454|FG001|Overall Study|Lost to Follow-up|39|||
161896003|NCT03034135|584666455|FG000|Overall Study|Withdrawal by Subject|2|||
161896004|NCT03251482|584668296|FG000|Overall Study|Withdrawal by Subject|0|||
161896005|NCT03251482|584668297|FG001|Overall Study|Withdrawal by Subject|1|||
161896006|NCT03251482|584668298|FG002|Overall Study|Withdrawal by Subject|0|||
161896007|NCT03251482|584668299|FG003|Overall Study|Withdrawal by Subject|0|||
161896008|NCT03251482|584668300|FG004|Overall Study|Withdrawal by Subject|0|||
161896009|NCT00803712|584668301|FG000|Overall Study|Noncompliance|3|||
161781867|NCT01954082|584245822|FG000|Overall Study|Comfort Care|0|||
161781868|NCT01954082|584245823|FG001|Overall Study|Comfort Care|1|||
161781869|NCT01954082|584245822|FG000|Overall Study|Infant Moved|0|||
161781870|NCT01954082|584245823|FG001|Overall Study|Infant Moved|1|||
161781871|NCT01954082|584245822|FG000|Overall Study|Randomized not Treated|4|||
161781872|NCT01954082|584245823|FG001|Overall Study|Randomized not Treated|2|||
161781873|NCT01682512|584245824|FG000|Overall Study|Adverse Event|6|||
161781874|NCT01682512|584245825|FG001|Overall Study|Adverse Event|5|||
161781875|NCT01682512|584245826|FG002|Overall Study|Adverse Event|2|||
161781876|NCT01682512|584245824|FG000|Overall Study|Withdrawal by Subject|2|||
161781877|NCT01682512|584245825|FG001|Overall Study|Withdrawal by Subject|6|||
161781878|NCT01682512|584245826|FG002|Overall Study|Withdrawal by Subject|3|||
161781879|NCT01682512|584245824|FG000|Overall Study|Physician Decision|0|||
161781880|NCT01682512|584245825|FG001|Overall Study|Physician Decision|2|||
161781881|NCT01682512|584245826|FG002|Overall Study|Physician Decision|0|||
161781882|NCT01682512|584245824|FG000|Overall Study|Study terminated by sponsor|46|||
161896010|NCT00803712|584668302|FG001|Overall Study|Noncompliance|0|||
161896011|NCT00803712|584668301|FG000|Overall Study|Adverse Event|5|||
161896012|NCT00803712|584668302|FG001|Overall Study|Adverse Event|0|||
161896013|NCT00803712|584668301|FG000|Overall Study|Death|8|||
161896014|NCT00803712|584668302|FG001|Overall Study|Death|7|||
161896015|NCT00803712|584668301|FG000|Overall Study|Lost to Follow-up|3|||
161896016|NCT00803712|584668302|FG001|Overall Study|Lost to Follow-up|1|||
161896017|NCT00803712|584668301|FG000|Overall Study|Withdrawal by Subject|2|||
161896018|NCT00803712|584668302|FG001|Overall Study|Withdrawal by Subject|4|||
161896019|NCT00803712|584668301|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
161896020|NCT00803712|584668302|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
161896021|NCT00803712|584668301|FG000|Overall Study|Protocol criteria (other)|0|||
161896022|NCT00803712|584668302|FG001|Overall Study|Protocol criteria (other)|2|||
161896023|NCT00803712|584668301|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
161896024|NCT00803712|584668302|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
161896025|NCT00803712|584668301|FG000|Overall Study|Administrative decision|2|||
161896026|NCT00803712|584668302|FG001|Overall Study|Administrative decision|3|||
161896027|NCT00803712|584668301|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
161896028|NCT00803712|584668302|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
161896029|NCT02823470|584668303|FG000|Overall Study|Adverse Event|1|||
161896030|NCT02823470|584668304|FG001|Overall Study|Adverse Event|0|||
161896031|NCT02823470|584668303|FG000|Overall Study|Study terminated by sponsor|8|||
161896032|NCT02823470|584668304|FG001|Overall Study|Study terminated by sponsor|15|||
161896033|NCT01310127|584668305|FG000|Overall Study|Protocol Violation|1|||
161896034|NCT01310127|584668306|FG001|Overall Study|Protocol Violation|1|||
161896035|NCT01310127|584668305|FG000|Overall Study|advanced psc cataract outlier|1|||
161896036|NCT01310127|584668306|FG001|Overall Study|advanced psc cataract outlier|0|||
161896037|NCT01490840|584668307|FG000|Phase 1|Lost to Follow-up|1|||
161896038|NCT01490840|584668308|FG001|Phase 1|Lost to Follow-up|0|||
161781883|NCT01682512|584245825|FG001|Overall Study|Study terminated by sponsor|43|||
161781884|NCT01682512|584245826|FG002|Overall Study|Study terminated by sponsor|0|||
161781885|NCT01682512|584245824|FG000|Overall Study|Lost to Follow-up|3|||
161781886|NCT01682512|584245825|FG001|Overall Study|Lost to Follow-up|0|||
161781887|NCT01682512|584245826|FG002|Overall Study|Lost to Follow-up|2|||
161781888|NCT01682512|584245824|FG000|Overall Study|Protocol Violation|2|||
161781889|NCT01682512|584245825|FG001|Overall Study|Protocol Violation|3|||
161781890|NCT01682512|584245826|FG002|Overall Study|Protocol Violation|2|||
161781891|NCT01682512|584245824|FG000|Overall Study|Primary lack of efficacy|10|||
161781892|NCT01682512|584245825|FG001|Overall Study|Primary lack of efficacy|7|||
161781893|NCT01682512|584245826|FG002|Overall Study|Primary lack of efficacy|7|||
161781894|NCT01682512|584245824|FG000|Overall Study|Secondary lack of efficacy|1|||
161781895|NCT01682512|584245825|FG001|Overall Study|Secondary lack of efficacy|1|||
161781896|NCT01682512|584245826|FG002|Overall Study|Secondary lack of efficacy|0|||
161781897|NCT01682512|584245824|FG000|Overall Study|Other than stated above|2|||
161781898|NCT01682512|584245825|FG001|Overall Study|Other than stated above|4|||
161781899|NCT01682512|584245826|FG002|Overall Study|Other than stated above|2|||
161781900|NCT01377233|584245827|FG000|Open-label|Adverse Event|1|||
161781901|NCT01377233|584245828|FG001|Open-label|Adverse Event|0|||
161781902|NCT01377233|584245829|FG002|Open-label|Adverse Event|0|||
161781903|NCT01377233|584245830|FG003|Open-label|Adverse Event|0|||
161781904|NCT01377233|584245831|FG004|Open-label|Adverse Event|0|||
161781905|NCT01377233|584245827|FG000|Open-label|Withdrawal by Subject|3|||
161781906|NCT01377233|584245828|FG001|Open-label|Withdrawal by Subject|0|||
161781907|NCT01377233|584245829|FG002|Open-label|Withdrawal by Subject|0|||
161781908|NCT01377233|584245830|FG003|Open-label|Withdrawal by Subject|0|||
161781909|NCT01377233|584245831|FG004|Open-label|Withdrawal by Subject|0|||
161781910|NCT01377233|584245827|FG000|Double-blind|Adverse Event|0|||
161781911|NCT01377233|584245828|FG001|Double-blind|Adverse Event|1|||
161781912|NCT01377233|584245829|FG002|Double-blind|Adverse Event|2|||
161781913|NCT01377233|584245830|FG003|Double-blind|Adverse Event|2|||
161896039|NCT01490840|584668307|FG000|Phase 1|Adverse Event|2|||
161896040|NCT01490840|584668308|FG001|Phase 1|Adverse Event|1|||
161896041|NCT01490840|584668307|FG000|Phase 1|Withdrawal by Subject|6|||
161896042|NCT01490840|584668308|FG001|Phase 1|Withdrawal by Subject|5|||
161896043|NCT01490840|584668307|FG000|Phase 1|Visit 6a omitted|1|||
161781914|NCT01377233|584245831|FG004|Double-blind|Adverse Event|0|||
161896044|NCT01490840|584668308|FG001|Phase 1|Visit 6a omitted|0|||
161781915|NCT01377233|584245827|FG000|Double-blind|Protocol Violation|0|||
161781916|NCT01377233|584245828|FG001|Double-blind|Protocol Violation|0|||
161781917|NCT01377233|584245829|FG002|Double-blind|Protocol Violation|0|||
161781918|NCT01377233|584245830|FG003|Double-blind|Protocol Violation|0|||
161781919|NCT01377233|584245831|FG004|Double-blind|Protocol Violation|1|||
161896045|NCT01490840|584668307|FG000|Phase 2|Withdrawal by Subject|4|||
161896046|NCT01490840|584668308|FG001|Phase 2|Withdrawal by Subject|3|||
161896047|NCT01490840|584668307|FG000|Phase 2|Permanent interruption of fingolimod|0|||
161896048|NCT01490840|584668308|FG001|Phase 2|Permanent interruption of fingolimod|1|||
161896049|NCT01490840|584668307|FG000|Phase 2|Lost to Follow-up|1|||
161896050|NCT01490840|584668308|FG001|Phase 2|Lost to Follow-up|1|||
161896051|NCT01490840|584668307|FG000|Phase 2|Adverse Event|1|||
161896052|NCT01490840|584668308|FG001|Phase 2|Adverse Event|1|||
161896053|NCT00184002|584668309|FG000|Overall Study|Adverse Event|9|||
161896054|NCT00184002|584668309|FG000|Overall Study|Death|3|||
161896055|NCT00184002|584668309|FG000|Overall Study|Physician Decision|1|||
161896056|NCT00184002|584668309|FG000|Overall Study|Withdrawal by Subject|4|||
161896057|NCT02087670|584668312|FG000|Overall Study|Withdrawal by Subject|3|||
161896058|NCT02087670|584668313|FG001|Overall Study|Withdrawal by Subject|2|||
161896059|NCT00878800|584668315|FG000|Overall Study|Adverse Event|0|||
161896060|NCT00878800|584668316|FG001|Overall Study|Adverse Event|0|||
161896061|NCT00878800|584668317|FG002|Overall Study|Adverse Event|2|||
161896062|NCT00878800|584668318|FG003|Overall Study|Adverse Event|0|||
161896063|NCT00878800|584668319|FG004|Overall Study|Adverse Event|1|||
161896064|NCT00878800|584668315|FG000|Overall Study|Progressive disease|1|||
161896065|NCT00878800|584668316|FG001|Overall Study|Progressive disease|5|||
161896066|NCT00878800|584668317|FG002|Overall Study|Progressive disease|6|||
161896067|NCT00878800|584668318|FG003|Overall Study|Progressive disease|5|||
161896068|NCT00878800|584668319|FG004|Overall Study|Progressive disease|13|||
161896069|NCT00878800|584668315|FG000|Overall Study|Withdrew consent|1|||
161896070|NCT00878800|584668316|FG001|Overall Study|Withdrew consent|1|||
161896071|NCT00878800|584668317|FG002|Overall Study|Withdrew consent|0|||
161896072|NCT00878800|584668318|FG003|Overall Study|Withdrew consent|1|||
161896073|NCT00878800|584668319|FG004|Overall Study|Withdrew consent|1|||
161896074|NCT00878800|584668315|FG000|Overall Study|Death|0|||
161896075|NCT00878800|584668316|FG001|Overall Study|Death|0|||
161896076|NCT00878800|584668317|FG002|Overall Study|Death|1|||
161896077|NCT00878800|584668318|FG003|Overall Study|Death|0|||
161896078|NCT00878800|584668319|FG004|Overall Study|Death|0|||
161896079|NCT00878800|584668315|FG000|Overall Study|Other|1|||
161781920|NCT01377233|584245827|FG000|Double-blind|Withdrawal by Subject|0|||
161896080|NCT00878800|584668316|FG001|Overall Study|Other|1|||
161896081|NCT00878800|584668317|FG002|Overall Study|Other|0|||
161896082|NCT00878800|584668318|FG003|Overall Study|Other|0|||
161896083|NCT00878800|584668319|FG004|Overall Study|Other|1|||
161896084|NCT04819438|584668321|FG000|Overall Study|Withdrawal by Subject|1|||
161896085|NCT04819438|584668322|FG001|Overall Study|Withdrawal by Subject|0|||
161896086|NCT04819438|584668321|FG000|Overall Study|Adverse Event|0|||
161896087|NCT04819438|584668322|FG001|Overall Study|Adverse Event|1|||
161896088|NCT04819438|584668321|FG000|Overall Study|Protocol Violation|0|||
161896089|NCT04819438|584668322|FG001|Overall Study|Protocol Violation|1|||
161896090|NCT03836209|584668323|FG000|Overall Study|Adverse Event|5|||
161896091|NCT03836209|584668324|FG001|Overall Study|Adverse Event|2|||
161781921|NCT01377233|584245828|FG001|Double-blind|Withdrawal by Subject|0|||
161781922|NCT01377233|584245829|FG002|Double-blind|Withdrawal by Subject|0|||
161781923|NCT01377233|584245830|FG003|Double-blind|Withdrawal by Subject|1|||
161781924|NCT01377233|584245831|FG004|Double-blind|Withdrawal by Subject|0|||
161781925|NCT01377233|584245827|FG000|Double-blind|Administrative or other|0|||
161781926|NCT01377233|584245828|FG001|Double-blind|Administrative or other|0|||
161781927|NCT01377233|584245829|FG002|Double-blind|Administrative or other|0|||
161781928|NCT01377233|584245830|FG003|Double-blind|Administrative or other|1|||
161781929|NCT01377233|584245831|FG004|Double-blind|Administrative or other|1|||
161781930|NCT00417027|584245832|FG000|Overall Study|Protocol Violation|0|||
161781931|NCT00417027|584245833|FG001|Overall Study|Protocol Violation|5|||
161781932|NCT00417027|584245834|FG002|Overall Study|Protocol Violation|5|||
161781933|NCT03137082|584245835|FG000|Overall Study|Withdrawal by Subject|1|||
161781934|NCT03137082|584245836|FG001|Overall Study|Withdrawal by Subject|1|||
161781935|NCT03137082|584245835|FG000|Overall Study|Lost to Follow-up|1|||
161781936|NCT03137082|584245836|FG001|Overall Study|Lost to Follow-up|0|||
161781937|NCT00965263|584245841|FG000|Overall Study|Physician Decision|2|||
161781938|NCT00965263|584245842|FG001|Overall Study|Physician Decision|0|||
161781939|NCT00965263|584245841|FG000|Overall Study|Family emergency|0|||
161781940|NCT00965263|584245842|FG001|Overall Study|Family emergency|1|||
161781941|NCT00965263|584245841|FG000|Overall Study|Protocol Violation|0|||
161781942|NCT00965263|584245842|FG001|Overall Study|Protocol Violation|2|||
161896092|NCT03836209|584668323|FG000|Overall Study|Death|4|||
161896093|NCT03836209|584668324|FG001|Overall Study|Death|1|||
161896094|NCT03836209|584668323|FG000|Overall Study|Lack of Efficacy|7|||
161896095|NCT03836209|584668324|FG001|Overall Study|Lack of Efficacy|10|||
161896096|NCT03836209|584668323|FG000|Overall Study|Physician Decision|7|||
161781943|NCT03959137|584245843|FG000|Overall Study|Protocol Violation|6|||
161781944|NCT02756078|584245844|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
161781945|NCT02756078|584245845|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
161781946|NCT02756078|584245844|FG000|Period 1|Lost to Follow-up|0|||
161896097|NCT03836209|584668324|FG001|Overall Study|Physician Decision|11|||
161896098|NCT03836209|584668323|FG000|Overall Study|Protocol Violation|0|||
161896099|NCT03836209|584668324|FG001|Overall Study|Protocol Violation|3|||
161896100|NCT03836209|584668323|FG000|Overall Study|Withdrawal by Subject|2|||
161781947|NCT02756078|584245845|FG001|Period 1|Lost to Follow-up|2|||
161781948|NCT02756078|584245844|FG000|Period 1|Protocol Violation|0|||
161781949|NCT02756078|584245845|FG001|Period 1|Protocol Violation|1|||
161781950|NCT02756078|584245844|FG000|Period 1|Adverse Event|1|||
161781951|NCT02756078|584245845|FG001|Period 1|Adverse Event|10|||
161781952|NCT02756078|584245844|FG000|Period 1|Withdrawal by Subject|6|||
161781953|NCT02756078|584245845|FG001|Period 1|Withdrawal by Subject|6|||
161781954|NCT02756078|584245844|FG000|Period 1|Lens Discomfort|2|||
161781955|NCT02756078|584245845|FG001|Period 1|Lens Discomfort|2|||
161781956|NCT02756078|584245844|FG000|Period 2|Adverse Event|3|||
161781957|NCT02756078|584245845|FG001|Period 2|Adverse Event|5|||
161781958|NCT02756078|584245844|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
161781959|NCT02756078|584245845|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
161781960|NCT02756078|584245844|FG000|Period 2|Withdrawal by Subject|3|||
161781961|NCT02756078|584245845|FG001|Period 2|Withdrawal by Subject|1|||
161781962|NCT00810615|584245846|FG000|Overall Study|Withdrawal by Subject|1|||
161781963|NCT00810615|584245847|FG001|Overall Study|Withdrawal by Subject|1|||
161781964|NCT01766310|584245849|FG000|Overall Study|Lost to Follow-up|1|||
161781965|NCT01766310|584245850|FG001|Overall Study|Lost to Follow-up|3|||
161781966|NCT01591499|584245851|FG000|Baseline Visit|Withdrawal by Subject|0|||
161781967|NCT01591499|584245852|FG001|Baseline Visit|Withdrawal by Subject|2|||
161781968|NCT01591499|584245853|FG002|Baseline Visit|Withdrawal by Subject|0|||
161781969|NCT01591499|584245854|FG003|Baseline Visit|Withdrawal by Subject|2|||
161781970|NCT01591499|584245851|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
161781971|NCT01591499|584245852|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
161781972|NCT01591499|584245853|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
161781973|NCT01591499|584245854|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
161781974|NCT01591499|584245851|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
161781975|NCT01591499|584245852|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
161781976|NCT01591499|584245853|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
161781977|NCT01591499|584245854|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
161781978|NCT02125734|584245855|FG000|Period 2|Adverse Event|0|||
161781979|NCT02125734|584245856|FG001|Period 2|Adverse Event|1|||
161781980|NCT00902278|584245857|FG000|Overall Study|Physician Decision|1|||
161781981|NCT00902278|584245858|FG001|Overall Study|Physician Decision|0|||
161781982|NCT00902278|584245859|FG002|Overall Study|Physician Decision|2|||
161781983|NCT00902278|584245860|FG003|Overall Study|Physician Decision|0|||
161781984|NCT00902278|584245861|FG004|Overall Study|Physician Decision|1|||
161781985|NCT00902278|584245857|FG000|Overall Study|Lost to Follow-up|3|||
161781986|NCT00902278|584245858|FG001|Overall Study|Lost to Follow-up|2|||
161781987|NCT00902278|584245859|FG002|Overall Study|Lost to Follow-up|3|||
161781988|NCT00902278|584245860|FG003|Overall Study|Lost to Follow-up|0|||
161781989|NCT00902278|584245861|FG004|Overall Study|Lost to Follow-up|1|||
161781990|NCT01488071|584245864|FG000|Overall Study|Adverse Event|15|||
161781991|NCT01488071|584245865|FG001|Overall Study|Adverse Event|23|||
161781992|NCT01488071|584245864|FG000|Overall Study|Lack of Efficacy|11|||
161781993|NCT01488071|584245865|FG001|Overall Study|Lack of Efficacy|17|||
161781994|NCT01488071|584245864|FG000|Overall Study|Non-compliance with study drug|2|||
161781995|NCT01488071|584245865|FG001|Overall Study|Non-compliance with study drug|0|||
161781996|NCT01488071|584245864|FG000|Overall Study|Protocol Violation|5|||
161781997|NCT01488071|584245865|FG001|Overall Study|Protocol Violation|7|||
161781998|NCT01488071|584245864|FG000|Overall Study|Withdrawal of Consent|14|||
161781999|NCT01488071|584245865|FG001|Overall Study|Withdrawal of Consent|12|||
161782000|NCT01488071|584245864|FG000|Overall Study|Lost to Follow-up|1|||
161782001|NCT01488071|584245865|FG001|Overall Study|Lost to Follow-up|0|||
161782002|NCT01488071|584245864|FG000|Overall Study|Administrative or Other Reason(s)|5|||
161782003|NCT01488071|584245865|FG001|Overall Study|Administrative or Other Reason(s)|4|||
161782004|NCT02139306|584245866|FG000|Overall Study|Withdrawal by Subject|4|||
161782005|NCT02139306|584245867|FG001|Overall Study|Withdrawal by Subject|6|||
161782006|NCT02139306|584245866|FG000|Overall Study|Adverse Event|3|||
161782007|NCT02139306|584245867|FG001|Overall Study|Adverse Event|4|||
161782008|NCT02139306|584245866|FG000|Overall Study|Physician Decision|0|||
161782009|NCT02139306|584245867|FG001|Overall Study|Physician Decision|1|||
161782010|NCT02139306|584245866|FG000|Overall Study|Other Unspecified|2|||
161782011|NCT02139306|584245867|FG001|Overall Study|Other Unspecified|3|||
161782012|NCT02139306|584245866|FG000|Overall Study|Protocol Violation|4|||
161782013|NCT02139306|584245867|FG001|Overall Study|Protocol Violation|0|||
161782014|NCT04449354|584245868|FG000|Overall Study|Withdrawal by Subject|1|||
161782015|NCT05789420|584245869|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
161782016|NCT05789420|584245869|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
161782017|NCT02278952|584245870|FG000|Overall Study|Insufficient Sample|6|||
161782018|NCT01220128|584245871|FG000|Overall Study|Progressive disease|0|||
161782019|NCT01220128|584245872|FG001|Overall Study|Progressive disease|0|||
161782020|NCT01220128|584245873|FG002|Overall Study|Progressive disease|2|||
161782021|NCT01220128|584245874|FG003|Overall Study|Progressive disease|0|||
161782022|NCT01220128|584245875|FG004|Overall Study|Progressive disease|0|||
161782023|NCT01220128|584245876|FG005|Overall Study|Progressive disease|0|||
161782024|NCT01220128|584245877|FG006|Overall Study|Progressive disease|0|||
161782025|NCT01220128|584245871|FG000|Overall Study|Sponsor study termination|0|||
161782026|NCT01220128|584245872|FG001|Overall Study|Sponsor study termination|1|||
161782027|NCT01220128|584245873|FG002|Overall Study|Sponsor study termination|0|||
161782028|NCT01220128|584245874|FG003|Overall Study|Sponsor study termination|0|||
161782029|NCT01220128|584245875|FG004|Overall Study|Sponsor study termination|0|||
161782030|NCT01220128|584245876|FG005|Overall Study|Sponsor study termination|0|||
161782031|NCT01220128|584245877|FG006|Overall Study|Sponsor study termination|1|||
161782032|NCT01220128|584245871|FG000|Overall Study|Adverse event, serious fatal|2|||
161782033|NCT01220128|584245872|FG001|Overall Study|Adverse event, serious fatal|0|||
161782034|NCT01220128|584245873|FG002|Overall Study|Adverse event, serious fatal|0|||
161782035|NCT01220128|584245874|FG003|Overall Study|Adverse event, serious fatal|0|||
161782036|NCT01220128|584245875|FG004|Overall Study|Adverse event, serious fatal|0|||
161782037|NCT01220128|584245876|FG005|Overall Study|Adverse event, serious fatal|0|||
161782038|NCT01220128|584245877|FG006|Overall Study|Adverse event, serious fatal|1|||
161782039|NCT01220128|584245871|FG000|Overall Study|Adverse event, non-fatal|1|||
161782040|NCT01220128|584245872|FG001|Overall Study|Adverse event, non-fatal|0|||
161782041|NCT01220128|584245873|FG002|Overall Study|Adverse event, non-fatal|0|||
161782042|NCT01220128|584245874|FG003|Overall Study|Adverse event, non-fatal|0|||
161782043|NCT01220128|584245875|FG004|Overall Study|Adverse event, non-fatal|0|||
161782044|NCT01220128|584245876|FG005|Overall Study|Adverse event, non-fatal|0|||
161782045|NCT01220128|584245877|FG006|Overall Study|Adverse event, non-fatal|3|||
161782046|NCT01220128|584245871|FG000|Overall Study|Other|0|||
161782047|NCT01220128|584245872|FG001|Overall Study|Other|0|||
161782048|NCT01220128|584245873|FG002|Overall Study|Other|1|||
161782049|NCT01220128|584245874|FG003|Overall Study|Other|0|||
161782050|NCT01220128|584245875|FG004|Overall Study|Other|0|||
161782051|NCT01220128|584245876|FG005|Overall Study|Other|0|||
161782052|NCT01220128|584245877|FG006|Overall Study|Other|0|||
161782053|NCT01220128|584245871|FG000|Overall Study|Consent withdrawn by subject|1|||
161782054|NCT01220128|584245872|FG001|Overall Study|Consent withdrawn by subject|0|||
161782055|NCT01220128|584245873|FG002|Overall Study|Consent withdrawn by subject|0|||
161782056|NCT01220128|584245874|FG003|Overall Study|Consent withdrawn by subject|0|||
161782057|NCT01220128|584245875|FG004|Overall Study|Consent withdrawn by subject|0|||
161782058|NCT01220128|584245876|FG005|Overall Study|Consent withdrawn by subject|0|||
161782059|NCT01220128|584245877|FG006|Overall Study|Consent withdrawn by subject|0|||
161782060|NCT02913261|584245878|FG000|Overall Study|Technical problems|0|||
161782061|NCT02913261|584245879|FG001|Overall Study|Technical problems|1|||
161782062|NCT02913261|584245878|FG000|Overall Study|Lack of Efficacy|32|||
161782063|NCT02913261|584245879|FG001|Overall Study|Lack of Efficacy|69|||
161782064|NCT02913261|584245878|FG000|Overall Study|Adverse Event|27|||
161782065|NCT02913261|584245879|FG001|Overall Study|Adverse Event|5|||
161782066|NCT02913261|584245878|FG000|Overall Study|Death|25|||
161782067|NCT02913261|584245879|FG001|Overall Study|Death|22|||
161782068|NCT02913261|584245878|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
161782069|NCT02913261|584245879|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
161782070|NCT02913261|584245878|FG000|Overall Study|Disease relapse|8|||
161782071|NCT02913261|584245879|FG001|Overall Study|Disease relapse|13|||
161782072|NCT02913261|584245878|FG000|Overall Study|Physician Decision|8|||
161782073|NCT02913261|584245879|FG001|Overall Study|Physician Decision|9|||
161782074|NCT02913261|584245878|FG000|Overall Study|Subject/guardian decision|4|||
161782075|NCT02913261|584245879|FG001|Overall Study|Subject/guardian decision|6|||
161782076|NCT02913261|584245878|FG000|Overall Study|Graft loss|2|||
161782077|NCT02913261|584245879|FG001|Overall Study|Graft loss|0|||
161782078|NCT02304302|584245882|FG000|Overall Study|Adverse Event|2|||
161782079|NCT02304302|584245883|FG001|Overall Study|Adverse Event|3|||
161782080|NCT02304302|584245882|FG000|Overall Study|Lost to Follow-up|1|||
161782081|NCT02304302|584245883|FG001|Overall Study|Lost to Follow-up|4|||
161782082|NCT02304302|584245882|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
161782083|NCT02304302|584245883|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
161782084|NCT00391118|584245884|FG000|Overall Study|Adverse Event|3|||
161782085|NCT00391118|584245885|FG001|Overall Study|Adverse Event|10|||
161782086|NCT00391118|584245886|FG002|Overall Study|Adverse Event|7|||
161782087|NCT00391118|584245884|FG000|Overall Study|Lost to Follow-up|0|||
161782088|NCT00391118|584245885|FG001|Overall Study|Lost to Follow-up|2|||
161782089|NCT00391118|584245886|FG002|Overall Study|Lost to Follow-up|3|||
161782090|NCT00391118|584245884|FG000|Overall Study|Withdrawal by Subject|0|||
161782091|NCT00391118|584245885|FG001|Overall Study|Withdrawal by Subject|9|||
161782092|NCT00391118|584245886|FG002|Overall Study|Withdrawal by Subject|1|||
161782093|NCT00391118|584245884|FG000|Overall Study|Death|0|||
161782094|NCT00391118|584245885|FG001|Overall Study|Death|1|||
161782095|NCT00391118|584245886|FG002|Overall Study|Death|0|||
161782096|NCT00391118|584245884|FG000|Overall Study|Physician Decision|0|||
161782097|NCT00391118|584245885|FG001|Overall Study|Physician Decision|3|||
161782098|NCT00391118|584245886|FG002|Overall Study|Physician Decision|0|||
161782099|NCT00391118|584245884|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
161782100|NCT00391118|584245885|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
161782101|NCT00391118|584245886|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
161782102|NCT00391118|584245884|FG000|Overall Study|Progressive Disease|7|||
161782103|NCT00391118|584245885|FG001|Overall Study|Progressive Disease|26|||
161782104|NCT00391118|584245886|FG002|Overall Study|Progressive Disease|43|||
161782105|NCT00391118|584245884|FG000|Overall Study|Sponsor Decision|0|||
161782106|NCT00391118|584245885|FG001|Overall Study|Sponsor Decision|1|||
161782107|NCT00391118|584245886|FG002|Overall Study|Sponsor Decision|3|||
161782108|NCT00391118|584245884|FG000|Overall Study|Protocol Violation|1|||
161782109|NCT00391118|584245885|FG001|Overall Study|Protocol Violation|0|||
161782110|NCT00391118|584245886|FG002|Overall Study|Protocol Violation|0|||
161782111|NCT01311505|584245887|FG000|First Intervention Period|Protocol Violation|0|||
161782112|NCT01311505|584245888|FG001|First Intervention Period|Protocol Violation|1|||
161782113|NCT00532779|584245889|FG000|Overall Study|Adverse Event|122|||
161782114|NCT00532779|584245890|FG001|Overall Study|Adverse Event|112|||
161782115|NCT00532779|584245891|FG002|Overall Study|Adverse Event|56|||
161782116|NCT00532779|584245889|FG000|Overall Study|Lost to Follow-up|76|||
161782117|NCT00532779|584245890|FG001|Overall Study|Lost to Follow-up|65|||
161782118|NCT00532779|584245891|FG002|Overall Study|Lost to Follow-up|66|||
161782119|NCT00532779|584245889|FG000|Overall Study|Withdrawal by Subject|63|||
161782120|NCT00532779|584245890|FG001|Overall Study|Withdrawal by Subject|60|||
161782121|NCT00532779|584245891|FG002|Overall Study|Withdrawal by Subject|90|||
161782122|NCT00532779|584245889|FG000|Overall Study|Lack of Efficacy|12|||
161782123|NCT00532779|584245890|FG001|Overall Study|Lack of Efficacy|12|||
161782124|NCT00532779|584245891|FG002|Overall Study|Lack of Efficacy|40|||
161782125|NCT00532779|584245889|FG000|Overall Study|Protocol Violation|5|||
161782126|NCT00532779|584245890|FG001|Overall Study|Protocol Violation|9|||
161782127|NCT00532779|584245891|FG002|Overall Study|Protocol Violation|7|||
161782128|NCT00532779|584245889|FG000|Overall Study|Pregnancy|2|||
161782129|NCT00532779|584245890|FG001|Overall Study|Pregnancy|5|||
161896101|NCT03836209|584668324|FG001|Overall Study|Withdrawal by Subject|10|||
161896102|NCT03836209|584668323|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
161896103|NCT03836209|584668324|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
161896104|NCT05980013|584668325|FG000|Overall Study|Withdrawal by Subject|0|||
161896105|NCT05980013|584668326|FG001|Overall Study|Withdrawal by Subject|1|||
161896106|NCT05980013|584668325|FG000|Overall Study|Device Error|0|||
161896107|NCT05980013|584668326|FG001|Overall Study|Device Error|1|||
161896108|NCT04892446|584668327|FG000|Overall Study|Death|4|||
161896109|NCT04892446|584668328|FG001|Overall Study|Death|4|||
161896110|NCT04892446|584668329|FG002|Overall Study|Death|0|||
161896111|NCT04892446|584668327|FG000|Overall Study|Withdrew consent|3|||
161896112|NCT04892446|584668328|FG001|Overall Study|Withdrew consent|0|||
161896113|NCT04892446|584668329|FG002|Overall Study|Withdrew consent|1|||
161896114|NCT04892446|584668327|FG000|Overall Study|Investigator's discretion|1|||
161896115|NCT04892446|584668328|FG001|Overall Study|Investigator's discretion|1|||
161896116|NCT04892446|584668329|FG002|Overall Study|Investigator's discretion|0|||
161896117|NCT04892446|584668327|FG000|Overall Study|Study terminated by sponsor|0|||
161896118|NCT04892446|584668328|FG001|Overall Study|Study terminated by sponsor|0|||
161896119|NCT04892446|584668329|FG002|Overall Study|Study terminated by sponsor|2|||
161896120|NCT01768559|584668331|FG000|Overall Study|Randomized but not treated|0|||
161896121|NCT01768559|584668332|FG001|Overall Study|Randomized but not treated|0|||
161896122|NCT01768559|584668333|FG002|Overall Study|Randomized but not treated|1|||
161896123|NCT01768559|584668331|FG000|Overall Study|Adverse Event|15|||
161896124|NCT01768559|584668332|FG001|Overall Study|Adverse Event|2|||
161896125|NCT01768559|584668333|FG002|Overall Study|Adverse Event|5|||
161896126|NCT01768559|584668331|FG000|Overall Study|Lack of Efficacy|6|||
161896127|NCT01768559|584668332|FG001|Overall Study|Lack of Efficacy|4|||
161896128|NCT01768559|584668333|FG002|Overall Study|Lack of Efficacy|0|||
161896129|NCT01768559|584668331|FG000|Overall Study|Poor compliance to protocol|0|||
161896130|NCT01768559|584668332|FG001|Overall Study|Poor compliance to protocol|3|||
161896131|NCT01768559|584668333|FG002|Overall Study|Poor compliance to protocol|2|||
161896132|NCT01768559|584668331|FG000|Overall Study|Other than specified|9|||
161896133|NCT01768559|584668332|FG001|Overall Study|Other than specified|8|||
161896134|NCT01768559|584668333|FG002|Overall Study|Other than specified|5|||
161896135|NCT00237692|584668336|FG000|Overall Study|Lost to Follow-up|9|||
161896136|NCT00237692|584668337|FG001|Overall Study|Lost to Follow-up|3|||
161782130|NCT00532779|584245891|FG002|Overall Study|Pregnancy|3|||
161782131|NCT00532779|584245889|FG000|Overall Study|Death|0|||
161782132|NCT00532779|584245890|FG001|Overall Study|Death|1|||
161782133|NCT00532779|584245891|FG002|Overall Study|Death|0|||
161782134|NCT00532779|584245889|FG000|Overall Study|Drug noncompliance, moved, other|14|||
161782135|NCT00532779|584245890|FG001|Overall Study|Drug noncompliance, moved, other|23|||
161782136|NCT00532779|584245891|FG002|Overall Study|Drug noncompliance, moved, other|29|||
161782137|NCT00828516|584245898|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
161782138|NCT00689273|584245899|FG000|Overall Study|Adverse Event|3|||
161896137|NCT00237692|584668338|FG002|Overall Study|Lost to Follow-up|5|||
161896138|NCT00237692|584668339|FG003|Overall Study|Lost to Follow-up|3|||
161896139|NCT00237692|584668336|FG000|Overall Study|Death|1|||
161896140|NCT00237692|584668337|FG001|Overall Study|Death|2|||
161782139|NCT00689273|584245900|FG001|Overall Study|Adverse Event|1|||
161782140|NCT00689273|584245899|FG000|Overall Study|Lack of Efficacy|3|||
161782141|NCT00689273|584245900|FG001|Overall Study|Lack of Efficacy|0|||
161782142|NCT00689273|584245899|FG000|Overall Study|Lost to Follow-up|0|||
161782143|NCT00689273|584245900|FG001|Overall Study|Lost to Follow-up|2|||
161782144|NCT00689273|584245899|FG000|Overall Study|Other|6|||
161782145|NCT00689273|584245900|FG001|Overall Study|Other|2|||
161782146|NCT00689273|584245899|FG000|Overall Study|Randomized but not Treated|1|||
161782147|NCT00689273|584245900|FG001|Overall Study|Randomized but not Treated|0|||
161782148|NCT02787746|584245903|FG000|Overall Study|Adverse Event|42|||
161782149|NCT02787746|584245903|FG000|Overall Study|Withdrawal by Subject|65|||
161782150|NCT02787746|584245903|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
161782151|NCT03703297|584245906|FG000|Overall Study|Death|115|||
161782152|NCT03703297|584245907|FG001|Overall Study|Death|0|||
161782153|NCT03703297|584245908|FG002|Overall Study|Death|144|||
161782154|NCT03703297|584245906|FG000|Overall Study|Withdrawal by Subject|9|||
161782155|NCT03703297|584245907|FG001|Overall Study|Withdrawal by Subject|0|||
161782156|NCT03703297|584245908|FG002|Overall Study|Withdrawal by Subject|11|||
161782157|NCT03703297|584245906|FG000|Overall Study|Ongoing at the time of DCO|140|||
161782158|NCT03703297|584245907|FG001|Overall Study|Ongoing at the time of DCO|200|||
161782159|NCT03703297|584245908|FG002|Overall Study|Ongoing at the time of DCO|111|||
161782160|NCT00700310|584248007|FG000|Overall Study|Adverse Event|6|||
161782161|NCT00700310|584248008|FG001|Overall Study|Adverse Event|10|||
161782162|NCT00700310|584248009|FG002|Overall Study|Adverse Event|5|||
161782163|NCT00700310|584248010|FG003|Overall Study|Adverse Event|11|||
161782164|NCT00700310|584248007|FG000|Overall Study|Lost to Follow-up|4|||
161782165|NCT00700310|584248008|FG001|Overall Study|Lost to Follow-up|1|||
161782166|NCT00700310|584248009|FG002|Overall Study|Lost to Follow-up|0|||
161782167|NCT00700310|584248010|FG003|Overall Study|Lost to Follow-up|1|||
161782168|NCT00700310|584248007|FG000|Overall Study|Withdrawal by Subject|8|||
161782169|NCT00700310|584248008|FG001|Overall Study|Withdrawal by Subject|9|||
161782170|NCT00700310|584248009|FG002|Overall Study|Withdrawal by Subject|8|||
161782171|NCT00700310|584248010|FG003|Overall Study|Withdrawal by Subject|8|||
161782172|NCT00700310|584248007|FG000|Overall Study|Lack of Efficacy|0|||
161782173|NCT00700310|584248008|FG001|Overall Study|Lack of Efficacy|3|||
161782174|NCT00700310|584248009|FG002|Overall Study|Lack of Efficacy|0|||
161782175|NCT00700310|584248010|FG003|Overall Study|Lack of Efficacy|1|||
161782176|NCT00700310|584248007|FG000|Overall Study|Administrative/Other|1|||
161782177|NCT00700310|584248008|FG001|Overall Study|Administrative/Other|3|||
161782178|NCT00700310|584248009|FG002|Overall Study|Administrative/Other|1|||
161782179|NCT00700310|584248010|FG003|Overall Study|Administrative/Other|3|||
161782180|NCT00700310|584248007|FG000|Overall Study|Randomized, Not Treated|2|||
161782181|NCT00700310|584248008|FG001|Overall Study|Randomized, Not Treated|0|||
161782182|NCT00700310|584248009|FG002|Overall Study|Randomized, Not Treated|2|||
161782183|NCT00700310|584248010|FG003|Overall Study|Randomized, Not Treated|2|||
161782184|NCT02162511|584248012|FG000|Overall Study|Lack of Efficacy|0|||
161782185|NCT02162511|584248013|FG001|Overall Study|Lack of Efficacy|0|||
161782186|NCT02162511|584248014|FG002|Overall Study|Lack of Efficacy|2|||
161782187|NCT01160198|584248015|FG000|Overall Study|Withdrawal by Subject|2|||
161782188|NCT01160198|584248016|FG001|Overall Study|Withdrawal by Subject|1|||
161782189|NCT01160198|584248017|FG002|Overall Study|Withdrawal by Subject|0|||
161782190|NCT01160198|584248015|FG000|Overall Study|Adverse Event|0|||
161782191|NCT01160198|584248016|FG001|Overall Study|Adverse Event|1|||
161782192|NCT01160198|584248017|FG002|Overall Study|Adverse Event|0|||
161782193|NCT01160198|584248015|FG000|Overall Study|Lost to Follow-up|0|||
161782194|NCT01160198|584248016|FG001|Overall Study|Lost to Follow-up|1|||
161782195|NCT01160198|584248017|FG002|Overall Study|Lost to Follow-up|0|||
161782196|NCT01160198|584248015|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
161782197|NCT01160198|584248016|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
161782198|NCT01160198|584248017|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
161782199|NCT00802529|584248018|FG000|Overall Study|Lost to Follow-up|0|||
161782200|NCT00802529|584248019|FG001|Overall Study|Lost to Follow-up|1|||
161896141|NCT00237692|584668338|FG002|Overall Study|Death|2|||
161896142|NCT00237692|584668339|FG003|Overall Study|Death|3|||
161782201|NCT00552617|584248021|FG000|Overall Study|Not Treated|0|||
161782202|NCT00552617|584248022|FG001|Overall Study|Not Treated|0|||
161782203|NCT00552617|584248023|FG002|Overall Study|Not Treated|1|||
161782204|NCT00552617|584248024|FG003|Overall Study|Not Treated|0|||
161782205|NCT00552617|584248025|FG004|Overall Study|Not Treated|0|||
161782206|NCT00552617|584248026|FG005|Overall Study|Not Treated|0|||
161782207|NCT00552617|584248027|FG006|Overall Study|Not Treated|0|||
161896143|NCT00237692|584668336|FG000|Overall Study|Excluded - did not meet criteria|4|||
161782208|NCT00552617|584248028|FG007|Overall Study|Not Treated|0|||
161782209|NCT00552617|584248029|FG008|Overall Study|Not Treated|0|||
161782210|NCT00552617|584248030|FG009|Overall Study|Not Treated|1|||
161782211|NCT00552617|584248021|FG000|Overall Study|Lost to Follow-up|0|||
161782212|NCT00552617|584248022|FG001|Overall Study|Lost to Follow-up|0|||
161782213|NCT00552617|584248023|FG002|Overall Study|Lost to Follow-up|0|||
161896144|NCT00237692|584668337|FG001|Overall Study|Excluded - did not meet criteria|3|||
161782214|NCT00552617|584248024|FG003|Overall Study|Lost to Follow-up|1|||
161782215|NCT00552617|584248025|FG004|Overall Study|Lost to Follow-up|0|||
161782216|NCT00552617|584248026|FG005|Overall Study|Lost to Follow-up|2|||
161782217|NCT00552617|584248027|FG006|Overall Study|Lost to Follow-up|0|||
161782218|NCT00552617|584248028|FG007|Overall Study|Lost to Follow-up|0|||
161782219|NCT00552617|584248029|FG008|Overall Study|Lost to Follow-up|2|||
161782220|NCT00552617|584248030|FG009|Overall Study|Lost to Follow-up|0|||
161782221|NCT04651218|584248031|FG000|Overall Study|Withdrawal by Subject|0|||
161782222|NCT04651218|584248032|FG001|Overall Study|Withdrawal by Subject|2|||
161782223|NCT01902134|584248035|FG000|Overall Study|Adverse Event|3|||
161782224|NCT01902134|584248036|FG001|Overall Study|Adverse Event|1|||
161782225|NCT01902134|584248037|FG002|Overall Study|Adverse Event|2|||
161782226|NCT01902134|584248038|FG003|Overall Study|Adverse Event|1|||
161782227|NCT01902134|584248039|FG004|Overall Study|Adverse Event|1|||
161782228|NCT01902134|584248040|FG005|Overall Study|Adverse Event|3|||
161782229|NCT01902134|584248035|FG000|Overall Study|Lack of Efficacy|0|||
161782230|NCT01902134|584248036|FG001|Overall Study|Lack of Efficacy|0|||
161782231|NCT01902134|584248037|FG002|Overall Study|Lack of Efficacy|2|||
161782232|NCT01902134|584248038|FG003|Overall Study|Lack of Efficacy|0|||
161782233|NCT01902134|584248039|FG004|Overall Study|Lack of Efficacy|0|||
161782234|NCT01902134|584248040|FG005|Overall Study|Lack of Efficacy|1|||
161782235|NCT01902134|584248035|FG000|Overall Study|Physician Decision|0|||
161782236|NCT01902134|584248036|FG001|Overall Study|Physician Decision|1|||
161782237|NCT01902134|584248037|FG002|Overall Study|Physician Decision|0|||
161782238|NCT01902134|584248038|FG003|Overall Study|Physician Decision|0|||
161782239|NCT01902134|584248039|FG004|Overall Study|Physician Decision|0|||
161782240|NCT01902134|584248040|FG005|Overall Study|Physician Decision|0|||
161782241|NCT01902134|584248035|FG000|Overall Study|Protocol Violation|0|||
161782242|NCT01902134|584248036|FG001|Overall Study|Protocol Violation|0|||
161782243|NCT01902134|584248037|FG002|Overall Study|Protocol Violation|0|||
161782244|NCT01902134|584248038|FG003|Overall Study|Protocol Violation|0|||
161782245|NCT01902134|584248039|FG004|Overall Study|Protocol Violation|0|||
161896145|NCT00237692|584668338|FG002|Overall Study|Excluded - did not meet criteria|5|||
161896146|NCT00237692|584668339|FG003|Overall Study|Excluded - did not meet criteria|9|||
161896147|NCT00237692|584668336|FG000|Overall Study|Withdrawal by Subject|4|||
161896148|NCT00237692|584668337|FG001|Overall Study|Withdrawal by Subject|6|||
161896149|NCT00237692|584668338|FG002|Overall Study|Withdrawal by Subject|10|||
161896150|NCT00237692|584668339|FG003|Overall Study|Withdrawal by Subject|4|||
161896151|NCT00685360|584668340|FG000|Overall Study|Lost to Follow-up|0|||
161896152|NCT00685360|584668341|FG001|Overall Study|Lost to Follow-up|1|||
161896153|NCT00685360|584668342|FG002|Overall Study|Lost to Follow-up|2|||
161896154|NCT00685360|584668340|FG000|Overall Study|Adverse Event|4|||
161896155|NCT00685360|584668341|FG001|Overall Study|Adverse Event|6|||
161896156|NCT00685360|584668342|FG002|Overall Study|Adverse Event|4|||
161896157|NCT00685360|584668340|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
161896158|NCT00685360|584668341|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
161896159|NCT00685360|584668342|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
161896160|NCT00685360|584668340|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
161896161|NCT00685360|584668341|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
161896162|NCT00685360|584668342|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
161896163|NCT00685360|584668340|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
161896164|NCT00685360|584668341|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
161896165|NCT00685360|584668342|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
161896166|NCT00685360|584668340|FG000|Overall Study|Protocol Deviation|0|||
161896167|NCT00685360|584668341|FG001|Overall Study|Protocol Deviation|1|||
161896168|NCT00685360|584668342|FG002|Overall Study|Protocol Deviation|1|||
161896169|NCT01386944|584668349|FG000|Overall Study|Adverse Event|26|||
161896170|NCT01386944|584668349|FG000|Overall Study|Lack of Efficacy|14|||
161896171|NCT01386944|584668349|FG000|Overall Study|Lost to Follow-up|8|||
161896172|NCT01386944|584668349|FG000|Overall Study|Unspecified reason|8|||
161896173|NCT03883477|584668350|FG000|Overall Study|Death|1|||
161896174|NCT03883477|584668351|FG001|Overall Study|Death|0|||
161896175|NCT03883477|584668350|FG000|Overall Study|Protocol Violation|0|||
161782246|NCT01902134|584248040|FG005|Overall Study|Protocol Violation|1|||
161782247|NCT01902134|584248035|FG000|Overall Study|Withdrawal by Subject|4|||
161782248|NCT01902134|584248036|FG001|Overall Study|Withdrawal by Subject|8|||
161782249|NCT01902134|584248037|FG002|Overall Study|Withdrawal by Subject|9|||
161782250|NCT01902134|584248038|FG003|Overall Study|Withdrawal by Subject|1|||
161896176|NCT03883477|584668351|FG001|Overall Study|Protocol Violation|1|||
161782251|NCT01902134|584248039|FG004|Overall Study|Withdrawal by Subject|5|||
161782252|NCT01902134|584248040|FG005|Overall Study|Withdrawal by Subject|4|||
161782253|NCT01902134|584248035|FG000|Overall Study|no compliance|1|||
161782254|NCT01902134|584248036|FG001|Overall Study|no compliance|0|||
161896177|NCT04186221|584668352|FG000|Overall Study|Death|1|||
161896178|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
161782255|NCT01902134|584248037|FG002|Overall Study|no compliance|0|||
161782256|NCT01902134|584248038|FG003|Overall Study|no compliance|0|||
161782257|NCT01902134|584248039|FG004|Overall Study|no compliance|0|||
161782258|NCT01902134|584248040|FG005|Overall Study|no compliance|0|||
161782259|NCT01902134|584248035|FG000|Overall Study|Other|0|||
161782260|NCT01902134|584248036|FG001|Overall Study|Other|1|||
161782261|NCT01902134|584248037|FG002|Overall Study|Other|2|||
161782262|NCT01902134|584248038|FG003|Overall Study|Other|0|||
161782263|NCT01902134|584248039|FG004|Overall Study|Other|1|||
161782264|NCT01902134|584248040|FG005|Overall Study|Other|0|||
161782265|NCT00305110|584248041|FG000|Overall Study|Missing data|29|||
161782266|NCT00337129|584248042|FG000|Overall Study|Adverse Event|4|||
161782267|NCT00337129|584248042|FG000|Overall Study|Withdrawal by Subject|1|||
161782268|NCT00337129|584248042|FG000|Overall Study|Lack of Efficacy|32|||
161782269|NCT00337129|584248042|FG000|Overall Study|Death|2|||
161782270|NCT00337129|584248042|FG000|Overall Study|not protocol specified|1|||
161782271|NCT01272193|584248045|FG000|Overall Study|Adverse Event|1|||
161782272|NCT01272193|584248046|FG001|Overall Study|Adverse Event|1|||
161782273|NCT01272193|584248045|FG000|Overall Study|Lack of Efficacy|0|||
161782274|NCT01272193|584248046|FG001|Overall Study|Lack of Efficacy|3|||
161782275|NCT01272193|584248045|FG000|Overall Study|Withdrawal Criteria|1|||
161782276|NCT01272193|584248046|FG001|Overall Study|Withdrawal Criteria|1|||
161782277|NCT01272193|584248045|FG000|Overall Study|Unclassified|8|||
161782278|NCT01272193|584248046|FG001|Overall Study|Unclassified|7|||
161782279|NCT03578276|584248047|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
161782280|NCT03578276|584248048|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
161782281|NCT01084603|584248058|FG000|Baseline|Withdrawal by Subject|2|||
161782282|NCT01084603|584248058|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
161782283|NCT01084603|584248058|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
161782284|NCT01084603|584248058|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
161782285|NCT01084603|584248058|FG000|Washout Period 4|Adverse Event|1|||
161782286|NCT01508325|584248059|FG000|Overall Study|Withdrawal by Subject|8|||
161782287|NCT01508325|584248060|FG001|Overall Study|Withdrawal by Subject|9|||
161782288|NCT01508325|584248059|FG000|Overall Study|Protocol Violation|0|||
161782289|NCT01508325|584248060|FG001|Overall Study|Protocol Violation|3|||
161782290|NCT01508325|584248059|FG000|Overall Study|Physician Decision|2|||
161782291|NCT01508325|584248060|FG001|Overall Study|Physician Decision|1|||
161782292|NCT01508325|584248059|FG000|Overall Study|Adverse Event|1|||
161782293|NCT01508325|584248060|FG001|Overall Study|Adverse Event|0|||
161782294|NCT01508325|584248059|FG000|Overall Study|Lost to Follow-up|5|||
161782295|NCT01508325|584248060|FG001|Overall Study|Lost to Follow-up|6|||
161782296|NCT01508325|584248059|FG000|Overall Study|Other|2|||
161782297|NCT01508325|584248060|FG001|Overall Study|Other|2|||
161782298|NCT01392170|584248061|FG000|Overall Study|Withdrawal by Subject|1|||
161782299|NCT01392170|584248061|FG000|Overall Study|Ineligible|1|||
161782300|NCT04285983|584248065|FG000|Overall Study|Protocol Violation|6|||
161782301|NCT04936334|584248066|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
161782302|NCT02787785|584248067|FG000|Overall Study|Death|3|||
161782303|NCT02787785|584248068|FG001|Overall Study|Death|4|||
161782304|NCT02787785|584248067|FG000|Overall Study|Lost to Follow-up|1|||
161782305|NCT02787785|584248068|FG001|Overall Study|Lost to Follow-up|1|||
161782306|NCT02787785|584248067|FG000|Overall Study|Withdrawal by Subject|0|||
161782307|NCT02787785|584248068|FG001|Overall Study|Withdrawal by Subject|5|||
161782308|NCT01440595|584248079|FG000|Overall Study|Lost to Follow-up|0|||
161782309|NCT01440595|584248080|FG001|Overall Study|Lost to Follow-up|1|||
161782310|NCT01440595|584248081|FG002|Overall Study|Lost to Follow-up|0|||
161782311|NCT01440595|584248079|FG000|Overall Study|Study terminated by sponsor.|1|||
161782312|NCT01440595|584248080|FG001|Overall Study|Study terminated by sponsor.|2|||
161782313|NCT01440595|584248081|FG002|Overall Study|Study terminated by sponsor.|1|||
161782314|NCT01347879|584248082|FG000|Overall Study|Adverse Event|0|||
161782315|NCT01347879|584248083|FG001|Overall Study|Adverse Event|12|||
161782316|NCT01347879|584248082|FG000|Overall Study|Lost to Follow-up|2|||
161782317|NCT01347879|584248083|FG001|Overall Study|Lost to Follow-up|0|||
161782318|NCT01347879|584248082|FG000|Overall Study|Withdrawal by Subject|3|||
161782319|NCT01347879|584248083|FG001|Overall Study|Withdrawal by Subject|2|||
161782320|NCT01347879|584248082|FG000|Overall Study|Other|2|||
161782321|NCT01347879|584248083|FG001|Overall Study|Other|3|||
161782322|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161782323|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
161782324|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161782325|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161782326|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
161782327|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
161782328|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
161782329|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
161782330|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161782331|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
161782332|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161831480|NCT01730040|584424760|FG003|Overall Study|Adverse Event|3|||
161896179|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
161896180|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
161896181|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
161896182|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
161896183|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
161896184|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
161896185|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
161896186|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
161896187|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
161896188|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
161896189|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
161896190|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
161896191|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
161896192|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
161896193|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
161896194|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
161896195|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
161896196|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
161896197|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
161896198|NCT03124537|584668360|FG000|Overall Study|Lost to Follow-up|3|||
161436066|NCT01524796|582991275|FG000|Overall Study|Lack of Efficacy|3|||
161782333|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161782334|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
161782335|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
161782336|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
161782337|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
161782338|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
161782339|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
161782340|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
161782341|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
161782342|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161782343|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
161782344|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161782345|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161782346|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
161782347|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161782348|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161782349|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161782350|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
161782351|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
161782352|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
161782353|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
161782354|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161782355|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
161782356|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161782357|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161782358|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
161782359|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
161782360|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
161782361|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
161782362|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
161782363|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
161782364|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
161782365|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
161782366|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
161782367|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
161782368|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
161782369|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
161782370|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
161782371|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
161782372|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
161896199|NCT03124537|584668361|FG001|Overall Study|Lost to Follow-up|5|||
161896200|NCT03124537|584668360|FG000|Overall Study|App Crash, Incomplete Data|7|||
161782373|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
161782374|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161782375|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161782376|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161782377|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
161782378|NCT01850108|584248088|FG000|Overall Study|Lost to Follow-up|4|||
161782379|NCT01850108|584248088|FG000|Overall Study|Not eligible|1|||
161782380|NCT01850108|584248088|FG000|Overall Study|Failed engraftment|2|||
161782381|NCT01850108|584248088|FG000|Overall Study|Physician Decision|1|||
161782382|NCT01447628|584248091|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161782383|NCT01447628|584248092|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161782384|NCT01447628|584248093|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161782385|NCT01447628|584248094|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
161782386|NCT03273712|584248101|FG000|Overall Study|Death|5|||
161782387|NCT03273712|584248101|FG000|Overall Study|Adverse Event|1|||
161782388|NCT03273712|584248101|FG000|Overall Study|Disease Progression|1|||
161782389|NCT03496207|584248102|FG000|Base Study|Adverse Event|0|||
161782390|NCT03496207|584248103|FG001|Base Study|Adverse Event|0|||
161782391|NCT03496207|584248104|FG002|Base Study|Adverse Event|1|||
161782392|NCT03496207|584248105|FG003|Base Study|Adverse Event|1|||
161782393|NCT03496207|584248106|FG004|Base Study|Adverse Event|4|||
161782394|NCT03496207|584248102|FG000|Base Study|Death|0|||
161782395|NCT03496207|584248103|FG001|Base Study|Death|0|||
161782396|NCT03496207|584248104|FG002|Base Study|Death|0|||
161782397|NCT03496207|584248105|FG003|Base Study|Death|0|||
161782398|NCT03496207|584248106|FG004|Base Study|Death|1|||
161782399|NCT03496207|584248102|FG000|Base Study|Withdrawal by Subject|0|||
161782400|NCT03496207|584248103|FG001|Base Study|Withdrawal by Subject|0|||
161782401|NCT03496207|584248104|FG002|Base Study|Withdrawal by Subject|1|||
161782402|NCT03496207|584248105|FG003|Base Study|Withdrawal by Subject|0|||
161782403|NCT03496207|584248106|FG004|Base Study|Withdrawal by Subject|1|||
161782404|NCT03496207|584248102|FG000|Extension Period|Adverse Event|0|||
161782405|NCT03496207|584248103|FG001|Extension Period|Adverse Event|0|||
161782406|NCT03496207|584248104|FG002|Extension Period|Adverse Event|0|||
161782407|NCT03496207|584248105|FG003|Extension Period|Adverse Event|1|||
161782408|NCT03496207|584248106|FG004|Extension Period|Adverse Event|1|||
161782409|NCT03496207|584248102|FG000|Extension Period|Death|1|||
161782410|NCT03496207|584248103|FG001|Extension Period|Death|0|||
161782411|NCT03496207|584248104|FG002|Extension Period|Death|0|||
161782412|NCT03496207|584248105|FG003|Extension Period|Death|1|||
161782413|NCT03496207|584248106|FG004|Extension Period|Death|2|||
161782414|NCT03496207|584248102|FG000|Extension Period|Withdrawal by Subject|1|||
161782415|NCT03496207|584248103|FG001|Extension Period|Withdrawal by Subject|0|||
161782416|NCT03496207|584248104|FG002|Extension Period|Withdrawal by Subject|0|||
161782417|NCT03496207|584248105|FG003|Extension Period|Withdrawal by Subject|1|||
161782418|NCT03496207|584248106|FG004|Extension Period|Withdrawal by Subject|1|||
161782419|NCT03496207|584248102|FG000|Extension Period|Elevated hemoglobin levels|0|||
161782420|NCT03496207|584248103|FG001|Extension Period|Elevated hemoglobin levels|0|||
161782421|NCT03496207|584248104|FG002|Extension Period|Elevated hemoglobin levels|0|||
161782422|NCT03496207|584248105|FG003|Extension Period|Elevated hemoglobin levels|0|||
161782423|NCT03496207|584248106|FG004|Extension Period|Elevated hemoglobin levels|1|||
161782424|NCT01542736|584248107|FG000|Overall Study|Death|1|||
161782425|NCT03674827|584248108|FG000|Treatment Phase|Adverse Event|0|||
161782426|NCT03674827|584248109|FG001|Treatment Phase|Adverse Event|0|||
161782427|NCT03674827|584248110|FG002|Treatment Phase|Adverse Event|0|||
161782428|NCT03674827|584248111|FG003|Treatment Phase|Adverse Event|0|||
161782429|NCT03674827|584248112|FG004|Treatment Phase|Adverse Event|0|||
161782430|NCT03674827|584248113|FG005|Treatment Phase|Adverse Event|2|||
161782431|NCT03674827|584248108|FG000|Treatment Phase|Death|2|||
161782432|NCT03674827|584248109|FG001|Treatment Phase|Death|0|||
161782433|NCT03674827|584248110|FG002|Treatment Phase|Death|0|||
161782434|NCT03674827|584248111|FG003|Treatment Phase|Death|0|||
161782435|NCT03674827|584248112|FG004|Treatment Phase|Death|1|||
161782436|NCT03674827|584248113|FG005|Treatment Phase|Death|0|||
161782437|NCT03674827|584248108|FG000|Treatment Phase|Progressive Disease|0|||
161782438|NCT03674827|584248109|FG001|Treatment Phase|Progressive Disease|4|||
161782439|NCT03674827|584248110|FG002|Treatment Phase|Progressive Disease|3|||
161782440|NCT03674827|584248111|FG003|Treatment Phase|Progressive Disease|4|||
161782441|NCT03674827|584248112|FG004|Treatment Phase|Progressive Disease|4|||
161896201|NCT03124537|584668361|FG001|Overall Study|App Crash, Incomplete Data|8|||
161782442|NCT03674827|584248113|FG005|Treatment Phase|Progressive Disease|9|||
161782443|NCT03674827|584248108|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
161782444|NCT03674827|584248109|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
161782445|NCT03674827|584248110|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
161782446|NCT03674827|584248111|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
161782447|NCT03674827|584248112|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
161782448|NCT03674827|584248113|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
161782449|NCT03674827|584248108|FG000|Treatment Phase|Withdrawal by Subject|0|||
161782450|NCT03674827|584248109|FG001|Treatment Phase|Withdrawal by Subject|0|||
161782451|NCT03674827|584248110|FG002|Treatment Phase|Withdrawal by Subject|0|||
161782452|NCT03674827|584248111|FG003|Treatment Phase|Withdrawal by Subject|0|||
161782453|NCT03674827|584248112|FG004|Treatment Phase|Withdrawal by Subject|0|||
161782454|NCT03674827|584248113|FG005|Treatment Phase|Withdrawal by Subject|1|||
161782455|NCT03674827|584248108|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
161782456|NCT03674827|584248109|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
161782457|NCT03674827|584248110|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
161782458|NCT03674827|584248111|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
161782459|NCT03674827|584248112|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
161782460|NCT03674827|584248113|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
161782461|NCT03674827|584248108|FG000|Treatment Phase|Other|0|||
161782462|NCT03674827|584248109|FG001|Treatment Phase|Other|1|||
161782463|NCT03674827|584248110|FG002|Treatment Phase|Other|0|||
161782464|NCT03674827|584248111|FG003|Treatment Phase|Other|0|||
161782465|NCT03674827|584248112|FG004|Treatment Phase|Other|0|||
161782466|NCT03674827|584248113|FG005|Treatment Phase|Other|1|||
161782467|NCT03674827|584248108|FG000|Long-Term Follow-up Phase|Death|2|||
161782468|NCT03674827|584248109|FG001|Long-Term Follow-up Phase|Death|4|||
161782469|NCT03674827|584248110|FG002|Long-Term Follow-up Phase|Death|2|||
161782470|NCT03674827|584248111|FG003|Long-Term Follow-up Phase|Death|3|||
161782471|NCT03674827|584248112|FG004|Long-Term Follow-up Phase|Death|2|||
161782472|NCT03674827|584248113|FG005|Long-Term Follow-up Phase|Death|6|||
161782473|NCT03674827|584248108|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
161782474|NCT03674827|584248109|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
161782475|NCT03674827|584248110|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
161782476|NCT03674827|584248111|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
161782477|NCT03674827|584248112|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
161782478|NCT03674827|584248113|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
161782479|NCT03674827|584248108|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161896202|NCT00830518|584668364|FG000|Overall Study|Progressive Disease|18|||
161896203|NCT00830518|584668365|FG001|Overall Study|Progressive Disease|8|||
161896204|NCT00830518|584668364|FG000|Overall Study|Symptomatic Deterioration|4|||
161896205|NCT00830518|584668365|FG001|Overall Study|Symptomatic Deterioration|1|||
161896206|NCT00830518|584668364|FG000|Overall Study|Adverse Event|14|||
161896207|NCT00830518|584668365|FG001|Overall Study|Adverse Event|1|||
161896208|NCT00830518|584668364|FG000|Overall Study|Withdrawal by Patient|2|||
161896209|NCT00830518|584668365|FG001|Overall Study|Withdrawal by Patient|0|||
161896210|NCT00830518|584668364|FG000|Overall Study|Reason not Specified|8|||
161896211|NCT00830518|584668365|FG001|Overall Study|Reason not Specified|1|||
161896212|NCT03092791|584668366|FG000|Overall Study|Lost to Follow-up|0|||
161896213|NCT03092791|584668367|FG001|Overall Study|Lost to Follow-up|0|||
161896214|NCT03092791|584668368|FG002|Overall Study|Lost to Follow-up|0|||
161896215|NCT03092791|584668369|FG003|Overall Study|Lost to Follow-up|0|||
161896216|NCT03092791|584668370|FG004|Overall Study|Lost to Follow-up|0|||
161896217|NCT03092791|584668371|FG005|Overall Study|Lost to Follow-up|0|||
161896218|NCT03092791|584668372|FG006|Overall Study|Lost to Follow-up|1|||
161896219|NCT03092791|584668373|FG007|Overall Study|Lost to Follow-up|0|||
161896220|NCT03092791|584668366|FG000|Overall Study|Withdrawal of Consent|0|||
161896221|NCT03092791|584668367|FG001|Overall Study|Withdrawal of Consent|0|||
161896222|NCT03092791|584668368|FG002|Overall Study|Withdrawal of Consent|0|||
161896223|NCT03092791|584668369|FG003|Overall Study|Withdrawal of Consent|0|||
161896224|NCT03092791|584668370|FG004|Overall Study|Withdrawal of Consent|4|||
161896225|NCT03092791|584668371|FG005|Overall Study|Withdrawal of Consent|12|||
161896226|NCT03092791|584668372|FG006|Overall Study|Withdrawal of Consent|6|||
161896227|NCT03092791|584668373|FG007|Overall Study|Withdrawal of Consent|4|||
161896228|NCT03092791|584668366|FG000|Overall Study|Study Termination|0|||
161896229|NCT03092791|584668367|FG001|Overall Study|Study Termination|0|||
161896230|NCT03092791|584668368|FG002|Overall Study|Study Termination|0|||
161896231|NCT03092791|584668369|FG003|Overall Study|Study Termination|0|||
161896232|NCT03092791|584668370|FG004|Overall Study|Study Termination|55|||
161896233|NCT03092791|584668371|FG005|Overall Study|Study Termination|46|||
161896234|NCT03092791|584668372|FG006|Overall Study|Study Termination|53|||
161896235|NCT03092791|584668373|FG007|Overall Study|Study Termination|55|||
161896236|NCT03092791|584668366|FG000|Overall Study|Death|0|||
161896237|NCT03092791|584668367|FG001|Overall Study|Death|0|||
161896238|NCT03092791|584668368|FG002|Overall Study|Death|0|||
161896239|NCT03092791|584668369|FG003|Overall Study|Death|0|||
161896240|NCT03092791|584668370|FG004|Overall Study|Death|0|||
161896241|NCT03092791|584668371|FG005|Overall Study|Death|1|||
161782480|NCT03674827|584248109|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161782481|NCT03674827|584248110|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
161782482|NCT03674827|584248111|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
161782483|NCT03674827|584248112|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161896242|NCT03092791|584668372|FG006|Overall Study|Death|0|||
161896243|NCT03092791|584668373|FG007|Overall Study|Death|1|||
161896244|NCT03092791|584668366|FG000|Overall Study|Reason Not Specified|0|||
161896245|NCT03092791|584668367|FG001|Overall Study|Reason Not Specified|0|||
161896246|NCT03092791|584668368|FG002|Overall Study|Reason Not Specified|0|||
161896247|NCT03092791|584668369|FG003|Overall Study|Reason Not Specified|0|||
161896248|NCT03092791|584668370|FG004|Overall Study|Reason Not Specified|1|||
161896249|NCT03092791|584668371|FG005|Overall Study|Reason Not Specified|1|||
161896250|NCT03092791|584668372|FG006|Overall Study|Reason Not Specified|0|||
161896251|NCT03092791|584668373|FG007|Overall Study|Reason Not Specified|0|||
161896252|NCT02182830|584668377|FG000|Overall Study|Not Treated|1|||
161896253|NCT02182830|584668378|FG001|Overall Study|Not Treated|1|||
161896254|NCT02182830|584668377|FG000|Overall Study|Trial stopped, reason missing|3|||
161896255|NCT02182830|584668378|FG001|Overall Study|Trial stopped, reason missing|3|||
161896256|NCT02182830|584668377|FG000|Overall Study|Consent withdrawn|8|||
161896257|NCT02182830|584668378|FG001|Overall Study|Consent withdrawn|8|||
161896258|NCT02182830|584668377|FG000|Overall Study|Lost to Follow-up|3|||
161896259|NCT02182830|584668378|FG001|Overall Study|Lost to Follow-up|3|||
161896260|NCT04399538|584668379|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
161896261|NCT04399538|584668380|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
161896262|NCT04399538|584668381|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
161896263|NCT04399538|584668382|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
161896264|NCT04399538|584668383|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
161896265|NCT04399538|584668379|FG000|Double-Blind Treatment|Adverse Event|0|||
161896266|NCT04399538|584668380|FG001|Double-Blind Treatment|Adverse Event|0|||
161896267|NCT04399538|584668381|FG002|Double-Blind Treatment|Adverse Event|0|||
161896268|NCT04399538|584668382|FG003|Double-Blind Treatment|Adverse Event|0|||
161896269|NCT04399538|584668383|FG004|Double-Blind Treatment|Adverse Event|1|||
161896270|NCT04399538|584668379|FG000|Follow-Up|Adverse Event|0|||
161896271|NCT04399538|584668380|FG001|Follow-Up|Adverse Event|0|||
161896272|NCT04399538|584668381|FG002|Follow-Up|Adverse Event|0|||
161896273|NCT04399538|584668382|FG003|Follow-Up|Adverse Event|0|||
161896274|NCT04399538|584668383|FG004|Follow-Up|Adverse Event|1|||
161896275|NCT04399538|584668379|FG000|Follow-Up|Withdrawal by Subject|0|||
161896276|NCT04399538|584668380|FG001|Follow-Up|Withdrawal by Subject|0|||
161896277|NCT04399538|584668381|FG002|Follow-Up|Withdrawal by Subject|0|||
161896278|NCT04399538|584668382|FG003|Follow-Up|Withdrawal by Subject|2|||
161896279|NCT04399538|584668383|FG004|Follow-Up|Withdrawal by Subject|0|||
161896280|NCT00586898|584668388|FG000|Overall Study|Adverse Event|1|||
161896281|NCT00586898|584668388|FG000|Overall Study|Patiemt Non-compliance|1|||
161896282|NCT00586898|584668388|FG000|Overall Study|Evaluable for Toxicity Only|5|||
161896283|NCT01588405|584668389|FG000|Overall Study|Adverse Event|1|||
161896284|NCT01588405|584668389|FG000|Overall Study|Clinical Worsening|1|||
161896285|NCT03268005|584668390|FG000|Overall Study|Death|2|||
161896286|NCT03268005|584668391|FG001|Overall Study|Death|1|||
161896287|NCT03268005|584668390|FG000|Overall Study|Lost to Follow-up|2|||
161896288|NCT03268005|584668391|FG001|Overall Study|Lost to Follow-up|2|||
161896289|NCT03268005|584668390|FG000|Overall Study|Withdrawal by Subject|11|||
161896290|NCT03268005|584668391|FG001|Overall Study|Withdrawal by Subject|11|||
161896291|NCT01926197|584668393|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
161896292|NCT01926197|584668394|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
161896293|NCT01926197|584668393|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
161896294|NCT01926197|584668394|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
161896295|NCT00492232|584668395|FG000|Placebo Run-in|Adverse Event|0|||
161896296|NCT00492232|584668396|FG001|Placebo Run-in|Adverse Event|2|||
161896297|NCT00492232|584668395|FG000|Placebo Run-in|Protocol Violation|0|||
161896298|NCT00492232|584668396|FG001|Placebo Run-in|Protocol Violation|3|||
161896299|NCT00492232|584668395|FG000|Placebo Run-in|Lost to Follow-up|0|||
161896300|NCT00492232|584668396|FG001|Placebo Run-in|Lost to Follow-up|3|||
161896301|NCT00492232|584668395|FG000|Placebo Run-in|Withdrawal by Subject|0|||
161896302|NCT00492232|584668396|FG001|Placebo Run-in|Withdrawal by Subject|8|||
161896303|NCT00492232|584668395|FG000|Placebo Run-in|Pregnancy|0|||
161896304|NCT00492232|584668396|FG001|Placebo Run-in|Pregnancy|1|||
161896305|NCT00492232|584668395|FG000|Placebo Run-in|Entrance criteria not met|0|||
161896306|NCT00492232|584668396|FG001|Placebo Run-in|Entrance criteria not met|45|||
161896307|NCT00492232|584668395|FG000|Placebo Run-in|Other|0|||
161896308|NCT00492232|584668396|FG001|Placebo Run-in|Other|6|||
161896309|NCT00492232|584668395|FG000|Placebo Run-in|Missing|0|||
161896310|NCT00492232|584668396|FG001|Placebo Run-in|Missing|2|||
161896311|NCT00492232|584668395|FG000|Double-Blind Treatment|Adverse Event|1|||
161896312|NCT00492232|584668396|FG001|Double-Blind Treatment|Adverse Event|2|||
161896313|NCT00492232|584668395|FG000|Double-Blind Treatment|Protocol Violation|3|||
161896314|NCT00492232|584668396|FG001|Double-Blind Treatment|Protocol Violation|7|||
161896315|NCT00492232|584668395|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
161896316|NCT00492232|584668396|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
161896317|NCT00492232|584668395|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
161896318|NCT00492232|584668396|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
161896319|NCT00492232|584668395|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
161896320|NCT00492232|584668396|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
161896321|NCT00492232|584668395|FG000|Double-Blind Treatment|Other|6|||
161896322|NCT00492232|584668396|FG001|Double-Blind Treatment|Other|5|||
161896323|NCT00492232|584668395|FG000|Double-Blind Treatment|Randomized not treated|1|||
161896324|NCT00492232|584668396|FG001|Double-Blind Treatment|Randomized not treated|0|||
161896325|NCT00492232|584668395|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
161782484|NCT03674827|584248113|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
161782485|NCT01289990|584248114|FG000|Overall Study|Death|0|||
161782486|NCT01289990|584248115|FG001|Overall Study|Death|0|||
161782487|NCT01289990|584248116|FG002|Overall Study|Death|0|||
161782488|NCT01289990|584248117|FG003|Overall Study|Death|1|||
161782489|NCT01289990|584248118|FG004|Overall Study|Death|2|||
161782490|NCT01289990|584248119|FG005|Overall Study|Death|1|||
161782491|NCT01289990|584248120|FG006|Overall Study|Death|0|||
161782492|NCT01289990|584248121|FG007|Overall Study|Death|0|||
161782493|NCT01289990|584248122|FG008|Overall Study|Death|0|||
161782494|NCT01289990|584248123|FG009|Overall Study|Death|0|||
161782495|NCT01289990|584248124|FG010|Overall Study|Death|0|||
161782496|NCT01289990|584248125|FG011|Overall Study|Death|1|||
161782497|NCT01289990|584248126|FG012|Overall Study|Death|0|||
161782498|NCT01289990|584248114|FG000|Overall Study|Lost to Follow-up|3|||
161782499|NCT01289990|584248115|FG001|Overall Study|Lost to Follow-up|2|||
161782500|NCT01289990|584248116|FG002|Overall Study|Lost to Follow-up|5|||
161782501|NCT01289990|584248117|FG003|Overall Study|Lost to Follow-up|5|||
161782502|NCT01289990|584248118|FG004|Overall Study|Lost to Follow-up|3|||
161782503|NCT01289990|584248119|FG005|Overall Study|Lost to Follow-up|4|||
161782504|NCT01289990|584248120|FG006|Overall Study|Lost to Follow-up|2|||
161782505|NCT01289990|584248121|FG007|Overall Study|Lost to Follow-up|2|||
161782506|NCT01289990|584248122|FG008|Overall Study|Lost to Follow-up|1|||
161782507|NCT01289990|584248123|FG009|Overall Study|Lost to Follow-up|4|||
161782508|NCT01289990|584248124|FG010|Overall Study|Lost to Follow-up|2|||
161782509|NCT01289990|584248125|FG011|Overall Study|Lost to Follow-up|1|||
161782510|NCT01289990|584248126|FG012|Overall Study|Lost to Follow-up|2|||
161782511|NCT01289990|584248114|FG000|Overall Study|Withdrawal by Subject|15|||
161782512|NCT01289990|584248115|FG001|Overall Study|Withdrawal by Subject|14|||
161782513|NCT01289990|584248116|FG002|Overall Study|Withdrawal by Subject|12|||
161782514|NCT01289990|584248117|FG003|Overall Study|Withdrawal by Subject|13|||
161782515|NCT01289990|584248118|FG004|Overall Study|Withdrawal by Subject|8|||
161782516|NCT01289990|584248119|FG005|Overall Study|Withdrawal by Subject|7|||
161782517|NCT01289990|584248120|FG006|Overall Study|Withdrawal by Subject|13|||
161782518|NCT01289990|584248121|FG007|Overall Study|Withdrawal by Subject|9|||
161782519|NCT01289990|584248122|FG008|Overall Study|Withdrawal by Subject|12|||
161782520|NCT01289990|584248123|FG009|Overall Study|Withdrawal by Subject|13|||
161782521|NCT01289990|584248124|FG010|Overall Study|Withdrawal by Subject|11|||
161782522|NCT01289990|584248125|FG011|Overall Study|Withdrawal by Subject|13|||
161782523|NCT01289990|584248126|FG012|Overall Study|Withdrawal by Subject|16|||
161782524|NCT01289990|584248114|FG000|Overall Study|discontinued in preceding trial|18|||
161782525|NCT01289990|584248115|FG001|Overall Study|discontinued in preceding trial|20|||
161782526|NCT01289990|584248116|FG002|Overall Study|discontinued in preceding trial|41|||
161782527|NCT01289990|584248117|FG003|Overall Study|discontinued in preceding trial|17|||
161782528|NCT01289990|584248118|FG004|Overall Study|discontinued in preceding trial|11|||
161782529|NCT01289990|584248119|FG005|Overall Study|discontinued in preceding trial|12|||
161782530|NCT01289990|584248120|FG006|Overall Study|discontinued in preceding trial|18|||
161782531|NCT01289990|584248121|FG007|Overall Study|discontinued in preceding trial|8|||
161782532|NCT01289990|584248122|FG008|Overall Study|discontinued in preceding trial|17|||
161782533|NCT01289990|584248123|FG009|Overall Study|discontinued in preceding trial|21|||
161782534|NCT01289990|584248124|FG010|Overall Study|discontinued in preceding trial|17|||
161782535|NCT01289990|584248125|FG011|Overall Study|discontinued in preceding trial|17|||
161782536|NCT01289990|584248126|FG012|Overall Study|discontinued in preceding trial|24|||
161782537|NCT01289990|584248114|FG000|Overall Study|did not continue in extension|41|||
161782538|NCT01289990|584248115|FG001|Overall Study|did not continue in extension|45|||
161782539|NCT01289990|584248116|FG002|Overall Study|did not continue in extension|51|||
161782540|NCT01289990|584248117|FG003|Overall Study|did not continue in extension|51|||
161782541|NCT01289990|584248118|FG004|Overall Study|did not continue in extension|48|||
161782542|NCT01289990|584248119|FG005|Overall Study|did not continue in extension|50|||
161782543|NCT01289990|584248120|FG006|Overall Study|did not continue in extension|54|||
161782544|NCT01289990|584248121|FG007|Overall Study|did not continue in extension|36|||
161782545|NCT01289990|584248122|FG008|Overall Study|did not continue in extension|44|||
161782546|NCT01289990|584248123|FG009|Overall Study|did not continue in extension|48|||
161782547|NCT01289990|584248124|FG010|Overall Study|did not continue in extension|45|||
161782548|NCT01289990|584248125|FG011|Overall Study|did not continue in extension|34|||
161782549|NCT01289990|584248126|FG012|Overall Study|did not continue in extension|56|||
161782550|NCT01289990|584248114|FG000|Overall Study|Not treated|0|||
161782551|NCT01289990|584248115|FG001|Overall Study|Not treated|0|||
161782552|NCT01289990|584248116|FG002|Overall Study|Not treated|0|||
161782553|NCT01289990|584248117|FG003|Overall Study|Not treated|0|||
161782554|NCT01289990|584248118|FG004|Overall Study|Not treated|0|||
161782555|NCT01289990|584248119|FG005|Overall Study|Not treated|0|||
161782556|NCT01289990|584248120|FG006|Overall Study|Not treated|1|||
161782557|NCT01289990|584248121|FG007|Overall Study|Not treated|0|||
161782558|NCT01289990|584248122|FG008|Overall Study|Not treated|1|||
161782559|NCT01289990|584248123|FG009|Overall Study|Not treated|0|||
161782560|NCT01289990|584248124|FG010|Overall Study|Not treated|1|||
161782561|NCT01289990|584248125|FG011|Overall Study|Not treated|2|||
161782562|NCT01289990|584248126|FG012|Overall Study|Not treated|0|||
161782563|NCT02441179|584248127|FG000|Overall Study|Withdrawal by Subject|1|||
161782564|NCT02441179|584248128|FG001|Overall Study|Withdrawal by Subject|1|||
161782565|NCT03454672|584248129|FG000|Overall Study|Adverse Event|1|||
161782566|NCT03454672|584248130|FG001|Overall Study|Adverse Event|1|||
161782567|NCT03454672|584248129|FG000|Overall Study|Lost to Follow-up|1|||
161782568|NCT03454672|584248130|FG001|Overall Study|Lost to Follow-up|3|||
161782569|NCT03454672|584248129|FG000|Overall Study|painful|1|||
161782570|NCT03454672|584248130|FG001|Overall Study|painful|2|||
161896326|NCT00492232|584668396|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161896327|NCT00980655|584668397|FG000|Overall Study|Adverse Event|13|||
161896328|NCT00980655|584668398|FG001|Overall Study|Adverse Event|31|||
161896329|NCT00980655|584668397|FG000|Overall Study|Death|0|||
161896330|NCT00980655|584668398|FG001|Overall Study|Death|7|||
161896331|NCT00980655|584668397|FG000|Overall Study|Protocol Violation|2|||
161896332|NCT00980655|584668398|FG001|Overall Study|Protocol Violation|7|||
161896333|NCT00980655|584668397|FG000|Overall Study|Withdrawal by Subject|0|||
161896334|NCT00980655|584668398|FG001|Overall Study|Withdrawal by Subject|4|||
161896335|NCT00980655|584668397|FG000|Overall Study|Lost to Follow-up|0|||
161896336|NCT00980655|584668398|FG001|Overall Study|Lost to Follow-up|1|||
161896337|NCT00980655|584668397|FG000|Overall Study|Parent/legal guardian request|1|||
161896338|NCT00980655|584668398|FG001|Overall Study|Parent/legal guardian request|0|||
161896339|NCT00980655|584668397|FG000|Overall Study|Other|0|||
161896340|NCT00980655|584668398|FG001|Overall Study|Other|1|||
161896341|NCT04162795|584668399|FG000|Overall Study|Other|16|||
161896342|NCT04162795|584668399|FG000|Overall Study|Screen failures|10|||
161896343|NCT02029274|584668403|FG000|Overall Study|Adverse Event|1|||
161896344|NCT02029274|584668404|FG001|Overall Study|Adverse Event|0|||
161896345|NCT02029274|584668405|FG002|Overall Study|Adverse Event|2|||
161896346|NCT02029274|584668406|FG003|Overall Study|Adverse Event|2|||
161896347|NCT02984267|584668408|FG000|Overall Study|Protocol Violation|1|||
161896348|NCT02984267|584668409|FG001|Overall Study|Protocol Violation|0|||
161896349|NCT02984267|584668408|FG000|Overall Study|Withdrawal by Subject|0|||
161896350|NCT02984267|584668409|FG001|Overall Study|Withdrawal by Subject|1|||
161896351|NCT02685072|584668410|FG000|Treatment Period|Lost to Follow-up|12|||
161896352|NCT02685072|584668411|FG001|Treatment Period|Lost to Follow-up|6|||
161896353|NCT02685072|584668410|FG000|Treatment Period|Withdrawal by Subject|1|||
161896354|NCT02685072|584668411|FG001|Treatment Period|Withdrawal by Subject|3|||
161896355|NCT02685072|584668410|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
161896356|NCT02685072|584668411|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
161896357|NCT01994902|584668412|FG000|Test Period 1|Withdrawal by Subject|3|||
161896358|NCT01994902|584668413|FG001|Test Period 1|Withdrawal by Subject|0|||
161896359|NCT01994902|584668412|FG000|Test Period 1|device deficiency with adverse event|0|||
161896360|NCT01994902|584668413|FG001|Test Period 1|device deficiency with adverse event|1|||
161896361|NCT01994902|584668412|FG000|Test Period 1|Adverse Event|2|||
161896362|NCT01994902|584668413|FG001|Test Period 1|Adverse Event|1|||
161896363|NCT01994902|584668412|FG000|Test Period 1|Lack of Efficacy|0|||
161896364|NCT01994902|584668413|FG001|Test Period 1|Lack of Efficacy|1|||
161896365|NCT01994902|584668412|FG000|Test Period 1|bag too small|1|||
161896366|NCT01994902|584668413|FG001|Test Period 1|bag too small|0|||
161896367|NCT01994902|584668412|FG000|Test Period 2|Withdrawal by Subject|0|||
161896368|NCT01994902|584668413|FG001|Test Period 2|Withdrawal by Subject|2|||
161896369|NCT01994902|584668412|FG000|Test Period 2|Lack of Efficacy|0|||
161896370|NCT01994902|584668413|FG001|Test Period 2|Lack of Efficacy|1|||
161896371|NCT01994902|584668412|FG000|Test Period 2|Other|0|||
161896372|NCT01994902|584668413|FG001|Test Period 2|Other|3|||
161896373|NCT03597139|584668414|FG000|Overall Study|Adverse Event|3|||
161896374|NCT03597139|584668415|FG001|Overall Study|Adverse Event|0|||
161782571|NCT03454672|584248129|FG000|Overall Study|Non-compliance|2|||
161896375|NCT03597139|584668414|FG000|Overall Study|Protocol Non-compliance|1|||
161896376|NCT03597139|584668415|FG001|Overall Study|Protocol Non-compliance|0|||
161896377|NCT00248833|584668419|FG000|Overall Study|Adverse Event|2|||
161896378|NCT00248833|584668420|FG001|Overall Study|Adverse Event|0|||
161896379|NCT00248833|584668421|FG002|Overall Study|Adverse Event|0|||
161896380|NCT00248833|584668419|FG000|Overall Study|Withdrawal by Subject|0|||
161896381|NCT00248833|584668420|FG001|Overall Study|Withdrawal by Subject|1|||
161896382|NCT00248833|584668421|FG002|Overall Study|Withdrawal by Subject|1|||
161896383|NCT00248833|584668419|FG000|Overall Study|Lost to Follow-up|1|||
161896384|NCT00248833|584668420|FG001|Overall Study|Lost to Follow-up|1|||
161896385|NCT00248833|584668421|FG002|Overall Study|Lost to Follow-up|1|||
161782572|NCT03454672|584248130|FG001|Overall Study|Non-compliance|4|||
161896386|NCT00248833|584668419|FG000|Overall Study|Other|0|||
161896387|NCT00248833|584668420|FG001|Overall Study|Other|1|||
161896388|NCT00248833|584668421|FG002|Overall Study|Other|0|||
161896389|NCT02427802|584668425|FG000|Overall Study|Adverse Event|11|||
161782573|NCT03454672|584248129|FG000|Overall Study|personal reasons|3|||
161782574|NCT03454672|584248130|FG001|Overall Study|personal reasons|2|||
161896390|NCT02427802|584668426|FG001|Overall Study|Adverse Event|3|||
161896391|NCT02427802|584668427|FG002|Overall Study|Adverse Event|7|||
161896392|NCT02427802|584668425|FG000|Overall Study|Death|0|||
161896393|NCT02427802|584668426|FG001|Overall Study|Death|4|||
161896394|NCT02427802|584668427|FG002|Overall Study|Death|1|||
161896395|NCT02427802|584668425|FG000|Overall Study|Lost to Follow-up|13|||
161896396|NCT02427802|584668426|FG001|Overall Study|Lost to Follow-up|8|||
161896397|NCT02427802|584668427|FG002|Overall Study|Lost to Follow-up|8|||
161896398|NCT02427802|584668425|FG000|Overall Study|Physician Decision|4|||
161896399|NCT02427802|584668426|FG001|Overall Study|Physician Decision|2|||
161896400|NCT02427802|584668427|FG002|Overall Study|Physician Decision|4|||
161896401|NCT02427802|584668425|FG000|Overall Study|Withdrawal by Subject|10|||
161896402|NCT02427802|584668426|FG001|Overall Study|Withdrawal by Subject|5|||
161896403|NCT02427802|584668427|FG002|Overall Study|Withdrawal by Subject|11|||
161896404|NCT02427802|584668425|FG000|Overall Study|Protocol Violation|3|||
161896405|NCT02427802|584668426|FG001|Overall Study|Protocol Violation|1|||
161896406|NCT02427802|584668427|FG002|Overall Study|Protocol Violation|1|||
161896407|NCT02427802|584668425|FG000|Overall Study|protocol specific treatment unrelated|18|||
161896408|NCT02427802|584668426|FG001|Overall Study|protocol specific treatment unrelated|11|||
161896409|NCT02427802|584668427|FG002|Overall Study|protocol specific treatment unrelated|11|||
161896410|NCT02226120|584668428|FG000|Overall Study|Adverse Event|60|||
161896411|NCT02226120|584668428|FG000|Overall Study|Death|172|||
161896412|NCT02226120|584668428|FG000|Overall Study|Study terminated by sponsor|1|||
161896413|NCT02226120|584668428|FG000|Overall Study|Technical problems|4|||
161896414|NCT02226120|584668428|FG000|Overall Study|Lost to Follow-up|13|||
161896415|NCT02226120|584668428|FG000|Overall Study|Physician Decision|21|||
161896416|NCT02226120|584668428|FG000|Overall Study|Withdrawal by parent/guardian|36|||
161896417|NCT02226120|584668428|FG000|Overall Study|Non-compliance with study drug|10|||
161896418|NCT02226120|584668428|FG000|Overall Study|Protocol deviation|1|||
161896419|NCT02226120|584668428|FG000|Overall Study|missing treatment disposition pages|2|||
161896420|NCT00467558|584668431|FG000|Overall Study|Lost to Follow-up|2|||
161896421|NCT00467558|584668432|FG001|Overall Study|Lost to Follow-up|0|||
161896422|NCT02636439|584668434|FG000|Overall Study|Adverse Event|2|||
161896423|NCT02636439|584668435|FG001|Overall Study|Adverse Event|2|||
161896424|NCT02636439|584668434|FG000|Overall Study|Lost to Follow-up|1|||
161896425|NCT02636439|584668435|FG001|Overall Study|Lost to Follow-up|0|||
161896426|NCT02636439|584668434|FG000|Overall Study|Non-compliance|1|||
161896427|NCT02636439|584668435|FG001|Overall Study|Non-compliance|1|||
161896428|NCT02636439|584668434|FG000|Overall Study|Personal reasons|2|||
161896429|NCT02636439|584668435|FG001|Overall Study|Personal reasons|0|||
161896430|NCT02494401|584668436|FG000|Overall Study|Lost to Follow-up|22|||
161896431|NCT02494401|584668437|FG001|Overall Study|Lost to Follow-up|25|||
161896432|NCT02494401|584668436|FG000|Overall Study|Withdrawal by Subject|3|||
161896433|NCT02494401|584668437|FG001|Overall Study|Withdrawal by Subject|2|||
161896434|NCT05188729|584668438|FG000|Overall Study|Withdrawal by Subject|0|||
161896435|NCT05188729|584668439|FG001|Overall Study|Withdrawal by Subject|0|||
161896436|NCT05188729|584668440|FG002|Overall Study|Withdrawal by Subject|0|||
161896437|NCT05188729|584668441|FG003|Overall Study|Withdrawal by Subject|0|||
161896438|NCT05188729|584668442|FG004|Overall Study|Withdrawal by Subject|0|||
161896439|NCT05188729|584668443|FG005|Overall Study|Withdrawal by Subject|0|||
161896440|NCT05188729|584668444|FG006|Overall Study|Withdrawal by Subject|0|||
161896441|NCT05188729|584668445|FG007|Overall Study|Withdrawal by Subject|0|||
161896442|NCT05188729|584668446|FG008|Overall Study|Withdrawal by Subject|0|||
161896443|NCT05188729|584668447|FG009|Overall Study|Withdrawal by Subject|1|||
161896444|NCT05188729|584668448|FG010|Overall Study|Withdrawal by Subject|0|||
161896445|NCT05188729|584668449|FG011|Overall Study|Withdrawal by Subject|0|||
161896446|NCT05188729|584668450|FG012|Overall Study|Withdrawal by Subject|0|||
161896447|NCT05188729|584668438|FG000|Overall Study|Lost to Follow-up|0|||
161896448|NCT05188729|584668439|FG001|Overall Study|Lost to Follow-up|0|||
161896449|NCT05188729|584668440|FG002|Overall Study|Lost to Follow-up|0|||
161896450|NCT05188729|584668441|FG003|Overall Study|Lost to Follow-up|0|||
161896451|NCT05188729|584668442|FG004|Overall Study|Lost to Follow-up|0|||
161896452|NCT05188729|584668443|FG005|Overall Study|Lost to Follow-up|0|||
161896453|NCT05188729|584668444|FG006|Overall Study|Lost to Follow-up|0|||
161896454|NCT05188729|584668445|FG007|Overall Study|Lost to Follow-up|0|||
161896455|NCT05188729|584668446|FG008|Overall Study|Lost to Follow-up|0|||
161896456|NCT05188729|584668447|FG009|Overall Study|Lost to Follow-up|0|||
161896457|NCT05188729|584668448|FG010|Overall Study|Lost to Follow-up|1|||
161896458|NCT05188729|584668449|FG011|Overall Study|Lost to Follow-up|1|||
161896459|NCT05188729|584668450|FG012|Overall Study|Lost to Follow-up|0|||
161896460|NCT01073163|584669714|FG000|Overall Study|Adverse Event|1|||
161896461|NCT01073163|584669714|FG000|Overall Study|Disease Progression|1|||
161896462|NCT01073163|584669714|FG000|Overall Study|Early termination|1|||
161896463|NCT00802672|584669715|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
161896464|NCT00802672|584669716|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
161896465|NCT00802672|584669717|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
161896466|NCT00802672|584669715|FG000|Overall Study|Adverse Event|1|||
161896467|NCT00802672|584669716|FG001|Overall Study|Adverse Event|1|||
161896468|NCT00802672|584669717|FG002|Overall Study|Adverse Event|1|||
161896469|NCT00802672|584669715|FG000|Overall Study|Protocol Violation|2|||
161896470|NCT00802672|584669716|FG001|Overall Study|Protocol Violation|1|||
161782575|NCT03454672|584248129|FG000|Overall Study|Withdrawal by Subject|1|||
161782576|NCT03454672|584248130|FG001|Overall Study|Withdrawal by Subject|0|||
161782577|NCT05166512|584248131|FG000|Randomized|Lost to Follow-up|2|||
161782578|NCT05166512|584248132|FG001|Randomized|Lost to Follow-up|0|||
161782579|NCT05166512|584248131|FG000|Randomized|Withdrawal by Subject|1|||
161782580|NCT05166512|584248132|FG001|Randomized|Withdrawal by Subject|0|||
161782581|NCT05166512|584248131|FG000|Baseline Data Collection|Lost to Follow-up|0|||
161782582|NCT05166512|584248132|FG001|Baseline Data Collection|Lost to Follow-up|3|||
161782583|NCT05166512|584248131|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
161782584|NCT05166512|584248132|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
161782585|NCT05166512|584248131|FG000|Baseline Data Collection|Protocol Violation|2|||
161782586|NCT05166512|584248132|FG001|Baseline Data Collection|Protocol Violation|0|||
161782587|NCT05166512|584248131|FG000|4 Month Data Collection|Lost to Follow-up|1|||
161782588|NCT05166512|584248132|FG001|4 Month Data Collection|Lost to Follow-up|0|||
161782589|NCT05166512|584248131|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
161782590|NCT05166512|584248132|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
161782591|NCT05166512|584248131|FG000|12 Month Data Collection|Lost to Follow-up|3|||
161782592|NCT05166512|584248132|FG001|12 Month Data Collection|Lost to Follow-up|1|||
161782593|NCT05166512|584248131|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
161782594|NCT05166512|584248132|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
161782595|NCT00420849|584248133|FG000|Overall Study|Lack of Efficacy|154|||
161782596|NCT00420849|584248133|FG000|Overall Study|Adverse Event|107|||
161782597|NCT00420849|584248133|FG000|Overall Study|Withdrawal by Subject|28|||
161782598|NCT00420849|584248133|FG000|Overall Study|Death|18|||
161782599|NCT00420849|584248133|FG000|Overall Study|Other|14|||
161782600|NCT00420849|584248133|FG000|Overall Study|Transplant|8|||
161782601|NCT00420849|584248133|FG000|Overall Study|Protocol Violation|1|||
161782602|NCT00420849|584248133|FG000|Overall Study|Lost to Follow-up|1|||
161782603|NCT00659581|584248134|FG000|Overall Study|Adverse Event|1006|||
161782604|NCT00659581|584248134|FG000|Overall Study|Lack of Efficacy|1183|||
161782605|NCT00659581|584248134|FG000|Overall Study|Other|6393|||
161782606|NCT05473247|584248135|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
161782607|NCT01892020|584248137|FG000|Period 1|Adverse Event|1|||
161782608|NCT01892020|584248138|FG001|Period 1|Adverse Event|1|||
161782609|NCT01892020|584248137|FG000|Period 1|Protocol Violation|2|||
161782610|NCT01892020|584248138|FG001|Period 1|Protocol Violation|4|||
161782611|NCT01892020|584248137|FG000|Period 1|Unclassified|0|||
161782612|NCT01892020|584248138|FG001|Period 1|Unclassified|1|||
161782613|NCT01892020|584248137|FG000|Period 2|Protocol Violation|1|||
161782614|NCT01892020|584248138|FG001|Period 2|Protocol Violation|0|||
161782615|NCT01831596|584248140|FG000|Overall Study|Other|8|||
161782616|NCT02508649|584248141|FG000|Overall Study|Withdrawal by Subject|4|||
161782617|NCT02508649|584248142|FG001|Overall Study|Withdrawal by Subject|6|||
161782618|NCT02508649|584248143|FG002|Overall Study|Withdrawal by Subject|5|||
161782619|NCT02508649|584248144|FG003|Overall Study|Withdrawal by Subject|6|||
161782620|NCT02508649|584248141|FG000|Overall Study|Investigator withdrew the subject|1|||
161782621|NCT02508649|584248142|FG001|Overall Study|Investigator withdrew the subject|2|||
161782622|NCT02508649|584248143|FG002|Overall Study|Investigator withdrew the subject|1|||
161782623|NCT02508649|584248144|FG003|Overall Study|Investigator withdrew the subject|0|||
161782624|NCT02508649|584248141|FG000|Overall Study|Post randomization screening failure|12|||
161782625|NCT02508649|584248142|FG001|Overall Study|Post randomization screening failure|4|||
161782626|NCT02508649|584248143|FG002|Overall Study|Post randomization screening failure|9|||
161782627|NCT02508649|584248144|FG003|Overall Study|Post randomization screening failure|3|||
161782628|NCT02508649|584248141|FG000|Overall Study|Lost to Follow-up|1|||
161782629|NCT02508649|584248142|FG001|Overall Study|Lost to Follow-up|1|||
161782630|NCT02508649|584248143|FG002|Overall Study|Lost to Follow-up|0|||
161782631|NCT02508649|584248144|FG003|Overall Study|Lost to Follow-up|1|||
161782632|NCT00446134|584248145|FG000|Overall Study|Adverse Event|7|||
161782633|NCT00446134|584248146|FG001|Overall Study|Adverse Event|17|||
161782634|NCT00446134|584248147|FG002|Overall Study|Adverse Event|13|||
161782635|NCT00446134|584248148|FG003|Overall Study|Adverse Event|18|||
161782636|NCT00446134|584248145|FG000|Overall Study|Lack of Efficacy|19|||
161782637|NCT00446134|584248146|FG001|Overall Study|Lack of Efficacy|19|||
161782638|NCT00446134|584248147|FG002|Overall Study|Lack of Efficacy|24|||
161782639|NCT00446134|584248148|FG003|Overall Study|Lack of Efficacy|19|||
161782640|NCT00446134|584248145|FG000|Overall Study|Protocol Violation|0|||
161782641|NCT00446134|584248146|FG001|Overall Study|Protocol Violation|2|||
161782642|NCT00446134|584248147|FG002|Overall Study|Protocol Violation|1|||
161782643|NCT00446134|584248148|FG003|Overall Study|Protocol Violation|0|||
161782644|NCT00446134|584248145|FG000|Overall Study|Lost to Follow-up|1|||
161782645|NCT00446134|584248146|FG001|Overall Study|Lost to Follow-up|3|||
161782646|NCT00446134|584248147|FG002|Overall Study|Lost to Follow-up|1|||
161782647|NCT00446134|584248148|FG003|Overall Study|Lost to Follow-up|1|||
161782648|NCT00446134|584248145|FG000|Overall Study|Withdrawal by Subject|3|||
161782649|NCT00446134|584248146|FG001|Overall Study|Withdrawal by Subject|3|||
161896471|NCT00802672|584669717|FG002|Overall Study|Protocol Violation|1|||
161782650|NCT00446134|584248147|FG002|Overall Study|Withdrawal by Subject|1|||
161782651|NCT00446134|584248148|FG003|Overall Study|Withdrawal by Subject|3|||
161782652|NCT00446134|584248145|FG000|Overall Study|Physician Decision|0|||
161782653|NCT00446134|584248146|FG001|Overall Study|Physician Decision|0|||
161782654|NCT00446134|584248147|FG002|Overall Study|Physician Decision|0|||
161782655|NCT00446134|584248148|FG003|Overall Study|Physician Decision|2|||
161782656|NCT00446134|584248145|FG000|Overall Study|Adverse Event-Diarrhea|1|||
161782657|NCT00446134|584248146|FG001|Overall Study|Adverse Event-Diarrhea|1|||
161782658|NCT00446134|584248147|FG002|Overall Study|Adverse Event-Diarrhea|2|||
161782659|NCT00446134|584248148|FG003|Overall Study|Adverse Event-Diarrhea|0|||
161782660|NCT00446134|584248145|FG000|Overall Study|Reason Not Completed|3|||
161782661|NCT00446134|584248146|FG001|Overall Study|Reason Not Completed|0|||
161782662|NCT00446134|584248147|FG002|Overall Study|Reason Not Completed|1|||
161782663|NCT00446134|584248148|FG003|Overall Study|Reason Not Completed|2|||
161782664|NCT00567996|584248152|FG000|Overall Study|Adverse Event|18|||
161782665|NCT00567996|584248153|FG001|Overall Study|Adverse Event|16|||
161782666|NCT00567996|584248154|FG002|Overall Study|Adverse Event|13|||
161782667|NCT00567996|584248152|FG000|Overall Study|Protocol Deviation|9|||
161782668|NCT00567996|584248153|FG001|Overall Study|Protocol Deviation|11|||
161782669|NCT00567996|584248154|FG002|Overall Study|Protocol Deviation|13|||
161782670|NCT00567996|584248152|FG000|Overall Study|Withdrawal by Subject|8|||
161782671|NCT00567996|584248153|FG001|Overall Study|Withdrawal by Subject|12|||
161782672|NCT00567996|584248154|FG002|Overall Study|Withdrawal by Subject|22|||
161782673|NCT00567996|584248152|FG000|Overall Study|Abnormal Lab value(s)|2|||
161782674|NCT00567996|584248153|FG001|Overall Study|Abnormal Lab value(s)|1|||
161782675|NCT00567996|584248154|FG002|Overall Study|Abnormal Lab value(s)|2|||
161782676|NCT00567996|584248152|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161782677|NCT00567996|584248153|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161782678|NCT00567996|584248154|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161782679|NCT00567996|584248152|FG000|Overall Study|Lost to Follow-up|2|||
161782680|NCT00567996|584248153|FG001|Overall Study|Lost to Follow-up|5|||
161782681|NCT00567996|584248154|FG002|Overall Study|Lost to Follow-up|2|||
161782682|NCT00567996|584248152|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161782683|NCT00567996|584248153|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161782684|NCT00567996|584248154|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
161782685|NCT00567996|584248152|FG000|Overall Study|Administrative problems|1|||
161782686|NCT00567996|584248153|FG001|Overall Study|Administrative problems|1|||
161782687|NCT00567996|584248154|FG002|Overall Study|Administrative problems|0|||
161782688|NCT00567996|584248152|FG000|Overall Study|Death|1|||
161782689|NCT00567996|584248153|FG001|Overall Study|Death|0|||
161782690|NCT00567996|584248154|FG002|Overall Study|Death|2|||
161782691|NCT00567996|584248152|FG000|Overall Study|Patient's inability to use the device|0|||
161782692|NCT00567996|584248153|FG001|Overall Study|Patient's inability to use the device|1|||
161782693|NCT00567996|584248154|FG002|Overall Study|Patient's inability to use the device|0|||
161782694|NCT02956005|584248155|FG000|Overall Study|Not eligible|1|||
161782695|NCT02956005|584248155|FG000|Overall Study|Withdrawal by Subject|3|||
161436067|NCT01524796|582991275|FG000|Overall Study|Lost to Follow-up|1|||
161436068|NCT01524796|582991275|FG000|Overall Study|The price|1|||
161436069|NCT01524796|582991275|FG000|Overall Study|Withdrawal by Subject|4|||
161436070|NCT01524796|582991275|FG000|Overall Study|Move|1|||
161436071|NCT01524796|582991275|FG000|Overall Study|Deterioration of pains|1|||
161436072|NCT01524796|582991275|FG000|Overall Study|Gall stone surgery|1|||
161436073|NCT01524796|582991275|FG000|Overall Study|Nervous about confidentiality|1|||
161436074|NCT01524796|582991275|FG000|Overall Study|Switch to carbamazapine|1|||
161782696|NCT02956005|584248155|FG000|Overall Study|Physician Decision|12|||
161782697|NCT03125629|584248156|FG000|Overall Study|Withdrawal by Subject|2|||
161782698|NCT03125629|584248156|FG000|Overall Study|Equipment malfunction|1|||
161782699|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782700|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782701|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782702|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782703|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782704|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782705|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782706|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782707|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782708|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782709|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782710|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782711|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161436075|NCT01524796|582991275|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
161436076|NCT02435992|582991278|FG000|Overall Study|non compliance with protocol|2|||
161782712|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
161782713|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782714|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
161782715|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
161782716|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
161782717|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782718|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782719|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782720|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782721|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782722|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782723|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161782724|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782725|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782726|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782727|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782728|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782729|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782730|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782731|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161782732|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782733|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161782734|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782735|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782736|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782737|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161782738|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782739|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782740|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782741|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782742|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161782743|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782744|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782745|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782746|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782747|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782748|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782749|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782750|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782751|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161782752|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782753|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782754|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
161782755|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782756|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782757|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782758|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782759|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782760|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782761|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782762|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782763|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782764|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782765|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782766|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782767|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782768|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782769|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782770|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782771|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161896472|NCT00802672|584669715|FG000|Overall Study|Lost to Follow-up|5|||
161896473|NCT00802672|584669716|FG001|Overall Study|Lost to Follow-up|5|||
161896474|NCT00802672|584669717|FG002|Overall Study|Lost to Follow-up|3|||
161896475|NCT00802672|584669715|FG000|Overall Study|Withdrawal by Subject|1|||
161896476|NCT00802672|584669716|FG001|Overall Study|Withdrawal by Subject|1|||
161782772|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782773|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782774|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782775|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782776|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161782777|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782778|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782779|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782780|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782781|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782782|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782783|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782784|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782785|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782786|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782787|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782788|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
161782789|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
161782790|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161782791|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161782792|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
161782793|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782794|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782795|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782796|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
161782797|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782798|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782799|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782800|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782801|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782802|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782803|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782804|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782805|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782806|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782807|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782808|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782809|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782810|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
161782811|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
161782812|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782813|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782814|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782815|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782816|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782817|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
161782818|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782819|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782820|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782821|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782822|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
161782823|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782824|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782825|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782826|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782827|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782828|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782829|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782830|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782831|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782832|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161782833|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782834|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782835|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782836|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782837|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161782838|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782839|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782840|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782841|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782842|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161782843|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782844|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782845|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
161782846|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782847|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
161782848|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
161782849|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
161782850|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782851|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782852|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782853|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782854|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782855|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782856|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782857|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782858|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782859|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782860|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782861|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
161782862|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782863|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782864|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782865|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782866|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782867|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782868|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782869|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782870|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782871|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782872|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782873|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782874|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782875|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782876|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782877|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161782878|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782879|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782880|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782881|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782882|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782883|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161782884|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782885|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161782886|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782887|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
161782888|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782889|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
161782890|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782891|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782892|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
161782893|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
161782894|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
161782895|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
161782896|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
161782897|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
161782898|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
161782899|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782900|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
161831481|NCT01730040|584424761|FG004|Overall Study|Adverse Event|1|||
161782901|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782902|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
161782903|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
161782904|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
161782905|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
161782906|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
161782907|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
161782908|NCT01915498|584248159|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782909|NCT01915498|584248160|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782910|NCT01915498|584248161|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782911|NCT01915498|584248162|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782912|NCT01915498|584248163|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782913|NCT01915498|584248164|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782914|NCT01915498|584248165|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782915|NCT01915498|584248166|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782916|NCT01915498|584248167|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782917|NCT01915498|584248168|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782918|NCT01915498|584248169|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782919|NCT01915498|584248170|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782920|NCT01915498|584248171|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782921|NCT01915498|584248172|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782922|NCT01915498|584248173|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782923|NCT01915498|584248174|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782924|NCT01915498|584248175|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782925|NCT01915498|584248176|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782926|NCT01915498|584248177|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
161782927|NCT01915498|584248159|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782928|NCT01915498|584248160|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782929|NCT01915498|584248161|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782930|NCT01915498|584248162|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782931|NCT01915498|584248163|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782932|NCT01915498|584248164|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782933|NCT01915498|584248165|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782934|NCT01915498|584248166|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782935|NCT01915498|584248167|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782936|NCT01915498|584248168|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782937|NCT01915498|584248169|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782938|NCT01915498|584248170|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782939|NCT01915498|584248171|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782940|NCT01915498|584248172|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782941|NCT01915498|584248173|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782942|NCT01915498|584248174|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782943|NCT01915498|584248175|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782944|NCT01915498|584248176|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782945|NCT01915498|584248177|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
161782946|NCT01915498|584248159|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782947|NCT01915498|584248160|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782948|NCT01915498|584248161|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782949|NCT01915498|584248162|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782950|NCT01915498|584248163|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782951|NCT01915498|584248164|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782952|NCT01915498|584248165|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782953|NCT01915498|584248166|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782954|NCT01915498|584248167|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782955|NCT01915498|584248168|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782956|NCT01915498|584248169|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782957|NCT01915498|584248170|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782958|NCT01915498|584248171|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782959|NCT01915498|584248172|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782960|NCT01915498|584248173|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782961|NCT01915498|584248174|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782962|NCT01915498|584248175|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782963|NCT01915498|584248176|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782964|NCT01915498|584248177|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
161782965|NCT02524665|584248180|FG000|Overall Study|Lost to Follow-up|1|||
161782966|NCT00314262|584248184|FG000|Overall Study|Adverse Event|2|||
161782967|NCT00314262|584248184|FG000|Overall Study|Withdrawal by Subject|2|||
161782968|NCT00314262|584248184|FG000|Overall Study|Physician Decision|1|||
161782969|NCT01185639|584248185|FG000|Overall Study|Progressed and didn't receive therapy|2|||
161782970|NCT02662556|584248186|FG000|Overall Study|Adverse Event|4|||
161782971|NCT02662556|584248186|FG000|Overall Study|Lack of Efficacy|4|||
161782972|NCT02499406|584249930|FG000|Overall Study|missed 3 treatment sessions|4|||
161782973|NCT01399125|584249931|FG000|Overall Study|Adverse Event|32|||
161782974|NCT01399125|584249932|FG001|Overall Study|Adverse Event|30|||
161782975|NCT01399125|584249931|FG000|Overall Study|Abnormal Lab values|0|||
161782976|NCT01399125|584249932|FG001|Overall Study|Abnormal Lab values|1|||
161782977|NCT01399125|584249931|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161782978|NCT01399125|584249932|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161782979|NCT01399125|584249931|FG000|Overall Study|Withdrawal by Subject|5|||
161782980|NCT01399125|584249932|FG001|Overall Study|Withdrawal by Subject|8|||
161782981|NCT01399125|584249931|FG000|Overall Study|Lost to Follow-up|2|||
161782982|NCT01399125|584249932|FG001|Overall Study|Lost to Follow-up|3|||
161782983|NCT01399125|584249931|FG000|Overall Study|Administrative Problems|7|||
161782984|NCT01399125|584249932|FG001|Overall Study|Administrative Problems|11|||
161782985|NCT01399125|584249931|FG000|Overall Study|Death|0|||
161782986|NCT01399125|584249932|FG001|Overall Study|Death|1|||
161782987|NCT01399125|584249931|FG000|Overall Study|Protocol Deviation|5|||
161782988|NCT01399125|584249932|FG001|Overall Study|Protocol Deviation|2|||
161782989|NCT00563524|584249935|FG000|Overall Study|Adverse Event|0|||
161782990|NCT00563524|584249936|FG001|Overall Study|Adverse Event|1|||
161782991|NCT00563524|584249937|FG002|Overall Study|Adverse Event|0|||
161782992|NCT00563524|584249938|FG003|Overall Study|Adverse Event|0|||
161782993|NCT00563524|584249939|FG004|Overall Study|Adverse Event|2|||
161782994|NCT00563524|584249940|FG005|Overall Study|Adverse Event|0|||
161782995|NCT00563524|584249935|FG000|Overall Study|Lost to Follow-up|1|||
161782996|NCT00563524|584249936|FG001|Overall Study|Lost to Follow-up|0|||
161782997|NCT00563524|584249937|FG002|Overall Study|Lost to Follow-up|0|||
161782998|NCT00563524|584249938|FG003|Overall Study|Lost to Follow-up|0|||
161782999|NCT00563524|584249939|FG004|Overall Study|Lost to Follow-up|0|||
161783000|NCT00563524|584249940|FG005|Overall Study|Lost to Follow-up|0|||
161783001|NCT00563524|584249935|FG000|Overall Study|Protocol Violation|0|||
161783002|NCT00563524|584249936|FG001|Overall Study|Protocol Violation|1|||
161783003|NCT00563524|584249937|FG002|Overall Study|Protocol Violation|0|||
161783004|NCT00563524|584249938|FG003|Overall Study|Protocol Violation|0|||
161783005|NCT00563524|584249939|FG004|Overall Study|Protocol Violation|0|||
161783006|NCT00563524|584249940|FG005|Overall Study|Protocol Violation|0|||
161783007|NCT00563524|584249935|FG000|Overall Study|Withdrawal by Subject|1|||
161783008|NCT00563524|584249936|FG001|Overall Study|Withdrawal by Subject|1|||
161783009|NCT00563524|584249937|FG002|Overall Study|Withdrawal by Subject|3|||
161783010|NCT00563524|584249938|FG003|Overall Study|Withdrawal by Subject|0|||
161783011|NCT00563524|584249939|FG004|Overall Study|Withdrawal by Subject|0|||
161783012|NCT00563524|584249940|FG005|Overall Study|Withdrawal by Subject|1|||
161783013|NCT01467570|584249942|FG000|Overall Study|Lost to Follow-up|8|||
161783014|NCT01467570|584249943|FG001|Overall Study|Lost to Follow-up|9|||
161783015|NCT02626182|584249952|FG000|Overall Study|Adverse Event|2|||
161783016|NCT02626182|584249953|FG001|Overall Study|Adverse Event|0|||
161783017|NCT02766088|584249958|FG000|Overall Study|Sponsor study termination|498|||
161783018|NCT02766088|584249958|FG000|Overall Study|Migrated/moved from the study area|1|||
161783019|NCT02766088|584249958|FG000|Overall Study|Lost to Follow-up|5|||
161783020|NCT02766088|584249958|FG000|Overall Study|Other|1|||
161783021|NCT02766088|584249958|FG000|Overall Study|Death|1|||
161783022|NCT01222715|584249959|FG000|Overall Study|Adverse Event|0|||
161783023|NCT01222715|584249960|FG001|Overall Study|Adverse Event|4|||
161783024|NCT01222715|584249959|FG000|Overall Study|Death|0|||
161783025|NCT01222715|584249960|FG001|Overall Study|Death|1|||
161783026|NCT01222715|584249959|FG000|Overall Study|Lack of Efficacy|22|||
161896477|NCT00802672|584669717|FG002|Overall Study|Withdrawal by Subject|2|||
161783027|NCT01222715|584249960|FG001|Overall Study|Lack of Efficacy|14|||
161783028|NCT01222715|584249959|FG000|Overall Study|Physician Decision|12|||
161783029|NCT01222715|584249960|FG001|Overall Study|Physician Decision|2|||
161783030|NCT01222715|584249959|FG000|Overall Study|Refusal of further protocol therapy|0|||
161783031|NCT01222715|584249960|FG001|Overall Study|Refusal of further protocol therapy|4|||
161783032|NCT01222715|584249959|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
161783033|NCT01222715|584249960|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
161783034|NCT01222715|584249959|FG000|Overall Study|Ineligible|0|||
161783035|NCT01222715|584249960|FG001|Overall Study|Ineligible|1|||
161783036|NCT01222715|584249959|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
161783037|NCT01222715|584249960|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
161783038|NCT03836729|584249961|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
161783039|NCT00763269|584249968|FG000|Overall Study|Lost to Follow-up|12|||
161783040|NCT00763269|584249969|FG001|Overall Study|Lost to Follow-up|13|||
161783041|NCT00520494|584249975|FG000|Overall Study|Withdrawal by Subject|1|||
161783042|NCT00544557|584249978|FG000|Overall Study|Adverse Event|140|||
161783043|NCT00544557|584249978|FG000|Overall Study|Lack of Efficacy|196|||
161783044|NCT00544557|584249978|FG000|Overall Study|Other|98|||
161783045|NCT00467818|584249979|FG000|Overall Study|Adverse Event|1|||
161783046|NCT00467818|584249980|FG001|Overall Study|Adverse Event|0|||
161783047|NCT00467818|584249979|FG000|Overall Study|Lost to Follow-up|2|||
161783048|NCT00467818|584249980|FG001|Overall Study|Lost to Follow-up|2|||
161783049|NCT01830920|584249982|FG000|Overall Study|Adverse Event|1|||
161783050|NCT01830920|584249983|FG001|Overall Study|Adverse Event|0|||
161783051|NCT01830920|584249984|FG002|Overall Study|Adverse Event|1|||
161783052|NCT01830920|584249985|FG003|Overall Study|Adverse Event|0|||
161783053|NCT01830920|584249986|FG004|Overall Study|Adverse Event|0|||
161783054|NCT01830920|584249982|FG000|Overall Study|Withdrawal by Subject|2|||
161783055|NCT01830920|584249983|FG001|Overall Study|Withdrawal by Subject|2|||
161783056|NCT01830920|584249984|FG002|Overall Study|Withdrawal by Subject|1|||
161783057|NCT01830920|584249985|FG003|Overall Study|Withdrawal by Subject|7|||
161783058|NCT01830920|584249986|FG004|Overall Study|Withdrawal by Subject|1|||
161783059|NCT01830920|584249982|FG000|Overall Study|Death|3|||
161783060|NCT01830920|584249983|FG001|Overall Study|Death|3|||
161783061|NCT01830920|584249984|FG002|Overall Study|Death|5|||
161783062|NCT01830920|584249985|FG003|Overall Study|Death|4|||
161783063|NCT01830920|584249986|FG004|Overall Study|Death|4|||
161783064|NCT01830920|584249982|FG000|Overall Study|Other|15|||
161783065|NCT01830920|584249983|FG001|Overall Study|Other|1|||
161783066|NCT01830920|584249984|FG002|Overall Study|Other|1|||
161783067|NCT01830920|584249985|FG003|Overall Study|Other|5|||
161783068|NCT01830920|584249986|FG004|Overall Study|Other|3|||
161783069|NCT01313728|584249987|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
161783070|NCT02216214|584249988|FG000|Overall Study|Randomized Never Received Study Drug|1|||
161783071|NCT02216214|584249989|FG001|Overall Study|Randomized Never Received Study Drug|0|||
161783072|NCT02216214|584249988|FG000|Overall Study|Adverse Event|10|||
161783073|NCT02216214|584249989|FG001|Overall Study|Adverse Event|8|||
161783074|NCT02216214|584249988|FG000|Overall Study|Lack of Efficacy|2|||
161783075|NCT02216214|584249989|FG001|Overall Study|Lack of Efficacy|2|||
161783076|NCT02216214|584249988|FG000|Overall Study|Lost to Follow-up|3|||
161783077|NCT02216214|584249989|FG001|Overall Study|Lost to Follow-up|2|||
161783078|NCT02216214|584249988|FG000|Overall Study|Protocol Violation|4|||
161783079|NCT02216214|584249989|FG001|Overall Study|Protocol Violation|2|||
161783080|NCT02216214|584249988|FG000|Overall Study|Withdrawal by Subject|22|||
161783081|NCT02216214|584249989|FG001|Overall Study|Withdrawal by Subject|20|||
161783082|NCT02216214|584249988|FG000|Overall Study|Study Terminated By Sponsor|0|||
161783083|NCT02216214|584249989|FG001|Overall Study|Study Terminated By Sponsor|1|||
161783084|NCT02216214|584249988|FG000|Overall Study|Miscellaneous|1|||
161783085|NCT02216214|584249989|FG001|Overall Study|Miscellaneous|1|||
161783086|NCT05354206|584249991|FG000|Overall Study|Withdrawal by Subject|1|||
161783087|NCT05354206|584249992|FG001|Overall Study|Withdrawal by Subject|0|||
161783088|NCT00713830|584249993|FG000|Overall Study|Adverse Event|23|||
161783089|NCT00713830|584249994|FG001|Overall Study|Adverse Event|71|||
161783090|NCT00713830|584249993|FG000|Overall Study|Lack of Efficacy|24|||
161783091|NCT00713830|584249994|FG001|Overall Study|Lack of Efficacy|16|||
161783092|NCT00713830|584249993|FG000|Overall Study|Lost to Follow-up|2|||
161783093|NCT00713830|584249994|FG001|Overall Study|Lost to Follow-up|9|||
161783094|NCT00713830|584249993|FG000|Overall Study|Withdrawal by Subject|13|||
161783095|NCT00713830|584249994|FG001|Overall Study|Withdrawal by Subject|23|||
161783096|NCT00713830|584249993|FG000|Overall Study|Poor Compliance to Protocol|7|||
161783097|NCT00713830|584249994|FG001|Overall Study|Poor Compliance to Protocol|14|||
161783098|NCT00713830|584249993|FG000|Overall Study|Familial and Personal Reasons|9|||
161783099|NCT00713830|584249994|FG001|Overall Study|Familial and Personal Reasons|34|||
161783100|NCT00713830|584249993|FG000|Overall Study|Sponsor Decision|4|||
161783101|NCT00713830|584249994|FG001|Overall Study|Sponsor Decision|10|||
161783102|NCT02702271|584250000|FG000|Overall Study|Death|36|||
161783103|NCT02702271|584250001|FG001|Overall Study|Death|7|||
161783104|NCT02702271|584250000|FG000|Overall Study|Lost to Follow-up|12|||
161783105|NCT02702271|584250001|FG001|Overall Study|Lost to Follow-up|0|||
161783106|NCT02702271|584250000|FG000|Overall Study|Withdrawal by Subject|8|||
161783107|NCT02702271|584250001|FG001|Overall Study|Withdrawal by Subject|1|||
161783108|NCT02702271|584250000|FG000|Overall Study|Physician Decision|2|||
161783109|NCT02702271|584250001|FG001|Overall Study|Physician Decision|0|||
161783110|NCT02702271|584250000|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
161783111|NCT02702271|584250001|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
161783112|NCT01494649|584250002|FG000|Overall Study|Lost to Follow-up|0|||
161783113|NCT01494649|584250003|FG001|Overall Study|Lost to Follow-up|1|||
161783114|NCT00363129|584250006|FG000|Overall Study|Withdrawal by Subject|11|||
161783115|NCT00363129|584250007|FG001|Overall Study|Withdrawal by Subject|18|||
161783116|NCT00363129|584250006|FG000|Overall Study|Adverse Event|8|||
161783117|NCT00363129|584250007|FG001|Overall Study|Adverse Event|3|||
161783118|NCT00363129|584250006|FG000|Overall Study|Alternate Treatment|2|||
161783119|NCT00363129|584250007|FG001|Overall Study|Alternate Treatment|4|||
161783120|NCT00363129|584250006|FG000|Overall Study|Other Medical Problems|2|||
161783121|NCT00363129|584250007|FG001|Overall Study|Other Medical Problems|4|||
161783122|NCT00363129|584250006|FG000|Overall Study|Death|0|||
161783123|NCT00363129|584250007|FG001|Overall Study|Death|1|||
161783124|NCT00363129|584250006|FG000|Overall Study|Other Reasons|6|||
161783125|NCT00363129|584250007|FG001|Overall Study|Other Reasons|3|||
161783126|NCT01345058|584250011|FG000|Overall Study|Withdrawal by Subject|1|||
161783127|NCT01345058|584250012|FG001|Overall Study|Withdrawal by Subject|0|||
161783128|NCT01345058|584250011|FG000|Overall Study|Participant Reported Increase in Events|1|||
161783129|NCT01345058|584250012|FG001|Overall Study|Participant Reported Increase in Events|0|||
161783130|NCT01345058|584250011|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
161783131|NCT01345058|584250012|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
161783132|NCT01345058|584250011|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
161783133|NCT01345058|584250012|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
161783134|NCT01345058|584250011|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
161783135|NCT01345058|584250012|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
161783136|NCT00000135|584250013|FG000|Overall Study|Death|27|||
161783137|NCT00000135|584250014|FG001|Overall Study|Death|14|||
161783138|NCT02149199|584250021|FG000|Overall Study|Study specific withdrawal criteria|4|||
161783139|NCT02149199|584250022|FG001|Overall Study|Study specific withdrawal criteria|21|||
161783140|NCT02149199|584250023|FG002|Overall Study|Study specific withdrawal criteria|6|||
161783141|NCT02149199|584250021|FG000|Overall Study|Other|20|||
161783142|NCT02149199|584250022|FG001|Overall Study|Other|25|||
161783143|NCT02149199|584250023|FG002|Overall Study|Other|20|||
161783144|NCT02149199|584250021|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
161783145|NCT02149199|584250022|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
161783146|NCT02149199|584250023|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
161783147|NCT02149199|584250021|FG000|Overall Study|Withdrawal by Subject|75|||
161783148|NCT02149199|584250022|FG001|Overall Study|Withdrawal by Subject|93|||
161783149|NCT02149199|584250023|FG002|Overall Study|Withdrawal by Subject|77|||
161783150|NCT02149199|584250021|FG000|Overall Study|Protocol Violation|16|||
161783151|NCT02149199|584250022|FG001|Overall Study|Protocol Violation|13|||
161783152|NCT02149199|584250023|FG002|Overall Study|Protocol Violation|15|||
161783153|NCT02149199|584250021|FG000|Overall Study|Lost to Follow-up|3|||
161783154|NCT02149199|584250022|FG001|Overall Study|Lost to Follow-up|12|||
161783155|NCT02149199|584250023|FG002|Overall Study|Lost to Follow-up|11|||
161783156|NCT02149199|584250021|FG000|Overall Study|Death|0|||
161783157|NCT02149199|584250022|FG001|Overall Study|Death|0|||
161783158|NCT02149199|584250023|FG002|Overall Study|Death|1|||
161783159|NCT02149199|584250021|FG000|Overall Study|Adverse Event|6|||
161783160|NCT02149199|584250022|FG001|Overall Study|Adverse Event|15|||
161783161|NCT02149199|584250023|FG002|Overall Study|Adverse Event|9|||
161783162|NCT00743119|584250024|FG000|Overall Study|unreliable|3|||
161783163|NCT00743119|584250024|FG000|Overall Study|Withdrawal by Subject|1|||
161783164|NCT02989610|584250025|FG000|Overall Study|Withdrawal by Subject|20|||
161783165|NCT02989610|584250025|FG000|Overall Study|Departure of PI from Site|8|||
161783166|NCT02989610|584250025|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
161783167|NCT02989610|584250025|FG000|Overall Study|Lost to Follow-up|3|||
161783168|NCT02989610|584250025|FG000|Overall Study|Death|3|||
161783169|NCT02989610|584250025|FG000|Overall Study|System Explant|3|||
161783170|NCT02989610|584250025|FG000|Overall Study|Subject Non-Compliance|2|||
161783171|NCT02989610|584250025|FG000|Overall Study|System Revision|2|||
161783172|NCT02989610|584250025|FG000|Overall Study|PI Left, Study Closing|1|||
161783173|NCT02989610|584250025|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
161783174|NCT02989610|584250025|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
161783175|NCT04881448|584250029|FG000|Overall Study|Study cancelled by sponsor|220|||
161783176|NCT04881448|584250029|FG000|Overall Study|Withdrawal by Subject|2|||
161783177|NCT04881448|584250029|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
161783178|NCT01966107|584250031|FG000|Overall Study|excluded from FAS|21|||
161783179|NCT01966107|584250032|FG001|Overall Study|excluded from FAS|20|||
161783180|NCT01966107|584250031|FG000|Overall Study|discontinued treatment|345|||
161783181|NCT01966107|584250032|FG001|Overall Study|discontinued treatment|372|||
161783182|NCT01966107|584250031|FG000|Overall Study|due to study closure|164|||
161783183|NCT01966107|584250032|FG001|Overall Study|due to study closure|186|||
161783184|NCT01966107|584250031|FG000|Overall Study|withdrew from the study|272|||
161783185|NCT01966107|584250032|FG001|Overall Study|withdrew from the study|303|||
161783186|NCT02200614|584250033|FG000|Double Blind Treatment|Adverse Event|86|||
161783187|NCT02200614|584250034|FG001|Double Blind Treatment|Adverse Event|48|||
161783188|NCT02200614|584250033|FG000|Double Blind Treatment|Confirmed metastasis|120|||
161783189|NCT02200614|584250034|FG001|Double Blind Treatment|Confirmed metastasis|140|||
161783190|NCT02200614|584250033|FG000|Double Blind Treatment|Judgment of the investigator|59|||
161783191|NCT02200614|584250034|FG001|Double Blind Treatment|Judgment of the investigator|99|||
161783192|NCT02200614|584250033|FG000|Double Blind Treatment|Metastasis by local reading|1|||
161783193|NCT02200614|584250034|FG001|Double Blind Treatment|Metastasis by local reading|3|||
161783194|NCT02200614|584250033|FG000|Double Blind Treatment|Other reason|6|||
161783195|NCT02200614|584250034|FG001|Double Blind Treatment|Other reason|2|||
161783196|NCT02200614|584250033|FG000|Double Blind Treatment|Personal reason|77|||
161783197|NCT02200614|584250034|FG001|Double Blind Treatment|Personal reason|85|||
161783198|NCT02200614|584250033|FG000|Double Blind Treatment|Protocol deviation|14|||
161783199|NCT02200614|584250034|FG001|Double Blind Treatment|Protocol deviation|7|||
161783200|NCT02200614|584250033|FG000|Double Blind Treatment|Not treated|1|||
161783201|NCT02200614|584250034|FG001|Double Blind Treatment|Not treated|0|||
161783202|NCT02200614|584250033|FG000|Open Label|Adverse Event|41|||
161783203|NCT02200614|584250034|FG001|Open Label|Adverse Event|11|||
161783204|NCT02200614|584250033|FG000|Open Label|Confirmed metastasis|1|||
161783205|NCT02200614|584250034|FG001|Open Label|Confirmed metastasis|0|||
161783206|NCT02200614|584250033|FG000|Open Label|Judgment of the investigator|29|||
161783207|NCT02200614|584250034|FG001|Open Label|Judgment of the investigator|2|||
161783208|NCT02200614|584250033|FG000|Open Label|Metastasis by local reading|138|||
161783209|NCT02200614|584250034|FG001|Open Label|Metastasis by local reading|27|||
161783210|NCT02200614|584250033|FG000|Open Label|Other reason|22|||
161783211|NCT02200614|584250034|FG001|Open Label|Other reason|4|||
161783212|NCT02200614|584250033|FG000|Open Label|Personal reason|60|||
161783213|NCT02200614|584250034|FG001|Open Label|Personal reason|8|||
161783214|NCT02200614|584250033|FG000|Open Label|Protocol deviation|3|||
161783215|NCT02200614|584250034|FG001|Open Label|Protocol deviation|2|||
161783216|NCT02200614|584250033|FG000|Open Label|Missing|2|||
161783217|NCT02200614|584250034|FG001|Open Label|Missing|2|||
161783218|NCT01898884|584250035|FG000|Multiple Dose Period|Adverse Event|0|||
161783219|NCT01898884|584250036|FG001|Multiple Dose Period|Adverse Event|0|||
161783220|NCT01898884|584250037|FG002|Multiple Dose Period|Adverse Event|0|||
161783221|NCT01898884|584250038|FG003|Multiple Dose Period|Adverse Event|0|||
161783222|NCT01898884|584250039|FG004|Multiple Dose Period|Adverse Event|0|||
161783223|NCT01898884|584250040|FG005|Multiple Dose Period|Adverse Event|0|||
161783224|NCT01898884|584250041|FG006|Multiple Dose Period|Adverse Event|1|||
161783225|NCT01898884|584250042|FG007|Multiple Dose Period|Adverse Event|0|||
161783226|NCT01898884|584250043|FG008|Multiple Dose Period|Adverse Event|0|||
161783227|NCT01898884|584250035|FG000|Multiple Dose Period|Randomized Not Treated|0|||
161783228|NCT01898884|584250036|FG001|Multiple Dose Period|Randomized Not Treated|0|||
161783229|NCT01898884|584250037|FG002|Multiple Dose Period|Randomized Not Treated|0|||
161783230|NCT01898884|584250038|FG003|Multiple Dose Period|Randomized Not Treated|0|||
161783231|NCT01898884|584250039|FG004|Multiple Dose Period|Randomized Not Treated|0|||
161783232|NCT01898884|584250040|FG005|Multiple Dose Period|Randomized Not Treated|0|||
161783233|NCT01898884|584250041|FG006|Multiple Dose Period|Randomized Not Treated|0|||
161783234|NCT01898884|584250042|FG007|Multiple Dose Period|Randomized Not Treated|0|||
161783235|NCT01898884|584250043|FG008|Multiple Dose Period|Randomized Not Treated|1|||
161783236|NCT00434148|584250044|FG000|Overall Study|Adverse Event|18|||
161783237|NCT00434148|584250045|FG001|Overall Study|Adverse Event|18|||
161783238|NCT00434148|584250044|FG000|Overall Study|Lack of Efficacy|25|||
161783239|NCT00434148|584250045|FG001|Overall Study|Lack of Efficacy|28|||
161783240|NCT00434148|584250044|FG000|Overall Study|Withdrawal by Subject|15|||
161783241|NCT00434148|584250045|FG001|Overall Study|Withdrawal by Subject|15|||
161783242|NCT00434148|584250044|FG000|Overall Study|Protocol Violation|4|||
161783243|NCT00434148|584250045|FG001|Overall Study|Protocol Violation|0|||
161783244|NCT00434148|584250044|FG000|Overall Study|Administrative problems|6|||
161783245|NCT00434148|584250045|FG001|Overall Study|Administrative problems|10|||
161783246|NCT00434148|584250044|FG000|Overall Study|Lost to Follow-up|0|||
161783247|NCT00434148|584250045|FG001|Overall Study|Lost to Follow-up|1|||
161783248|NCT00434148|584250044|FG000|Overall Study|Condition no longer requires study drug|1|||
161783249|NCT00434148|584250045|FG001|Overall Study|Condition no longer requires study drug|0|||
161783250|NCT00434148|584250044|FG000|Overall Study|Abnormal test procedure result|0|||
161783251|NCT00434148|584250045|FG001|Overall Study|Abnormal test procedure result|1|||
161783252|NCT00759759|584250046|FG000|Overall Study|didn't return for period 2|1|||
161783253|NCT00759759|584250047|FG001|Overall Study|didn't return for period 2|0|||
161783254|NCT00759759|584250046|FG000|Overall Study|Didn't receive drug in period 2|1|||
161783255|NCT00759759|584250047|FG001|Overall Study|Didn't receive drug in period 2|0|||
161783256|NCT00759759|584250046|FG000|Overall Study|Withdrawal by Subject|2|||
161783257|NCT00759759|584250047|FG001|Overall Study|Withdrawal by Subject|1|||
161783258|NCT01556165|584250051|FG000|Overall Study|Adverse Event|5|||
161783259|NCT01556165|584250052|FG001|Overall Study|Adverse Event|3|||
161783260|NCT01556165|584250051|FG000|Overall Study|Protocol Violation|0|||
161783261|NCT01556165|584250052|FG001|Overall Study|Protocol Violation|3|||
161783262|NCT01556165|584250051|FG000|Overall Study|Withdrawal of Consent|7|||
161783263|NCT01556165|584250052|FG001|Overall Study|Withdrawal of Consent|1|||
161783264|NCT02531698|584250055|FG000|Overall Study|Adverse Event|2|||
161783265|NCT02531698|584250056|FG001|Overall Study|Adverse Event|1|||
161783266|NCT02531698|584250055|FG000|Overall Study|Withdrawal by Subject|6|||
161783267|NCT02531698|584250056|FG001|Overall Study|Withdrawal by Subject|1|||
161783268|NCT02531698|584250055|FG000|Overall Study|Protocol Violation|2|||
161783269|NCT02531698|584250056|FG001|Overall Study|Protocol Violation|0|||
161783270|NCT02531698|584250055|FG000|Overall Study|Lost to Follow-up|1|||
161783271|NCT02531698|584250056|FG001|Overall Study|Lost to Follow-up|0|||
161783272|NCT01861717|584250057|FG000|Overall Study|Lost to Follow-up|1|||
161783273|NCT01861717|584250057|FG000|Overall Study|Withdrawal by Subject|1|||
161783274|NCT02395536|584250063|FG000|Overall Study|Lost to Follow-up|4|||
161783275|NCT02395536|584250064|FG001|Overall Study|Lost to Follow-up|4|||
161783276|NCT02395536|584250063|FG000|Overall Study|Death|2|||
161783277|NCT02395536|584250064|FG001|Overall Study|Death|0|||
161783278|NCT02395536|584250063|FG000|Overall Study|Physician Decision|4|||
161783279|NCT02395536|584250064|FG001|Overall Study|Physician Decision|6|||
161783280|NCT02395536|584250063|FG000|Overall Study|Withdrawal by Subject|9|||
161783281|NCT02395536|584250064|FG001|Overall Study|Withdrawal by Subject|17|||
161783282|NCT02395536|584250063|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
161783283|NCT02395536|584250064|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
161783284|NCT02395536|584250063|FG000|Overall Study|Insurance issue|0|||
161783285|NCT02395536|584250064|FG001|Overall Study|Insurance issue|1|||
161783286|NCT00701558|584250065|FG000|Overall Study|Death|7|||
161783287|NCT00701558|584250065|FG000|Overall Study|Lost to Follow-up|8|||
161783288|NCT01640964|584250068|FG000|Overall Study|Lost to Follow-up|0|||
161783289|NCT01640964|584250069|FG001|Overall Study|Lost to Follow-up|0|||
161783290|NCT01640964|584250070|FG002|Overall Study|Lost to Follow-up|1|||
161783291|NCT01640964|584250068|FG000|Overall Study|Protocol Deviation|1|||
161783292|NCT01640964|584250069|FG001|Overall Study|Protocol Deviation|1|||
161783293|NCT01640964|584250070|FG002|Overall Study|Protocol Deviation|2|||
161783294|NCT00304954|584252565|FG000|Overall Study|Withdrawal by Subject|0|||
161783295|NCT00304954|584252566|FG001|Overall Study|Withdrawal by Subject|0|||
161783296|NCT00304954|584252567|FG002|Overall Study|Withdrawal by Subject|1|||
161783297|NCT00304954|584252568|FG003|Overall Study|Withdrawal by Subject|0|||
161783298|NCT00304954|584252565|FG000|Overall Study|Adverse Event|1|||
161783299|NCT00304954|584252566|FG001|Overall Study|Adverse Event|0|||
161783300|NCT00304954|584252567|FG002|Overall Study|Adverse Event|0|||
161783301|NCT00304954|584252568|FG003|Overall Study|Adverse Event|0|||
161783302|NCT00350519|584252569|FG000|Overall Study|Death|0|||
161783303|NCT00350519|584252570|FG001|Overall Study|Death|1|||
161783304|NCT00350519|584252569|FG000|Overall Study|Physician Decision|0|||
161783305|NCT00350519|584252570|FG001|Overall Study|Physician Decision|1|||
161783306|NCT00350519|584252569|FG000|Overall Study|Protocol Violation|1|||
161783307|NCT00350519|584252570|FG001|Overall Study|Protocol Violation|2|||
161783308|NCT00350519|584252569|FG000|Overall Study|Withdrawal by Subject|3|||
161783309|NCT00350519|584252570|FG001|Overall Study|Withdrawal by Subject|2|||
161783310|NCT00736099|584252572|FG000|Overall Study|Adverse Event|61|||
161783311|NCT00736099|584252573|FG001|Overall Study|Adverse Event|18|||
161783312|NCT00736099|584252572|FG000|Overall Study|Protocol Violation|10|||
161783313|NCT00736099|584252573|FG001|Overall Study|Protocol Violation|4|||
161783314|NCT00736099|584252572|FG000|Overall Study|Lost to Follow-up|12|||
161783315|NCT00736099|584252573|FG001|Overall Study|Lost to Follow-up|5|||
161783316|NCT00736099|584252572|FG000|Overall Study|Withdrawal by Subject|42|||
161783317|NCT00736099|584252573|FG001|Overall Study|Withdrawal by Subject|13|||
161783318|NCT00736099|584252572|FG000|Overall Study|Lack of Efficacy|15|||
161783319|NCT00736099|584252573|FG001|Overall Study|Lack of Efficacy|8|||
161896478|NCT00802672|584669715|FG000|Overall Study|other|3|||
161896479|NCT00802672|584669716|FG001|Overall Study|other|1|||
161783320|NCT00736099|584252572|FG000|Overall Study|Other reason|43|||
161783321|NCT00736099|584252573|FG001|Overall Study|Other reason|10|||
161783322|NCT00948025|584252574|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
161783323|NCT00948025|584252575|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
161783324|NCT00948025|584252574|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
161783325|NCT00948025|584252575|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
161783326|NCT00948025|584252574|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
161783327|NCT00948025|584252575|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
161896480|NCT00802672|584669717|FG002|Overall Study|other|2|||
161783328|NCT04006847|584252578|FG000|Overall Study|Product issue|1|||
161783329|NCT03555890|584252586|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161783330|NCT03555890|584252587|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161783331|NCT03555890|584252588|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161783332|NCT03555890|584252589|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161783333|NCT03372369|584252590|FG000|Qualification Period|Withdrawal by Subject|16|||
161783334|NCT03372369|584252591|FG001|Qualification Period|Withdrawal by Subject|13|||
161783335|NCT03372369|584252590|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
161783336|NCT03372369|584252591|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
161783337|NCT03372369|584252590|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
161783338|NCT03372369|584252591|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
161783339|NCT02239601|584252592|FG000|Overall Study|Withdrawal by Subject|3|||
161783340|NCT02239601|584252593|FG001|Overall Study|Withdrawal by Subject|4|||
161783341|NCT02239601|584252592|FG000|Overall Study|Protocol Violation|4|||
161783342|NCT02239601|584252593|FG001|Overall Study|Protocol Violation|2|||
161783343|NCT01383954|584252594|FG000|Overall Study|Lack of Efficacy|2|||
161783344|NCT01383954|584252594|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
161783345|NCT01383954|584252594|FG000|Overall Study|Adverse Event|1|||
161783346|NCT01383954|584252594|FG000|Overall Study|Reason Not Specified|9|||
161783347|NCT01791127|584252595|FG000|Overall Study|Death|356|||
161783348|NCT01791127|584252595|FG000|Overall Study|Patient has withdrawn from study|293|||
161783349|NCT01791127|584252595|FG000|Overall Study|Lost to Follow-up|42|||
161783350|NCT01791127|584252595|FG000|Overall Study|All Siello leads are explanted|31|||
161783351|NCT01791127|584252595|FG000|Overall Study|Completion of 30 day safety registry|1|||
161783352|NCT01791127|584252595|FG000|Overall Study|Study terminated for EP Passion|749|||
161783353|NCT04023994|584252604|FG000|Overall Study|Lost to Follow-up|0|||
161783354|NCT04023994|584252605|FG001|Overall Study|Lost to Follow-up|1|||
161783355|NCT04023994|584252606|FG002|Overall Study|Lost to Follow-up|2|||
161783356|NCT04023994|584252607|FG003|Overall Study|Lost to Follow-up|0|||
161783357|NCT04023994|584252608|FG004|Overall Study|Lost to Follow-up|0|||
161783358|NCT04023994|584252609|FG005|Overall Study|Lost to Follow-up|0|||
161783359|NCT04023994|584252604|FG000|Overall Study|Withdrawal by Subject|0|||
161783360|NCT04023994|584252605|FG001|Overall Study|Withdrawal by Subject|0|||
161783361|NCT04023994|584252606|FG002|Overall Study|Withdrawal by Subject|0|||
161783362|NCT04023994|584252607|FG003|Overall Study|Withdrawal by Subject|1|||
161783363|NCT04023994|584252608|FG004|Overall Study|Withdrawal by Subject|0|||
161783364|NCT04023994|584252609|FG005|Overall Study|Withdrawal by Subject|0|||
161783365|NCT00707174|584252610|FG000|Overall Study|Adverse Event|1|||
161783366|NCT00707174|584252611|FG001|Overall Study|Adverse Event|6|||
161783367|NCT00707174|584252610|FG000|Overall Study|Withdrawal by Subject|4|||
161783368|NCT00707174|584252611|FG001|Overall Study|Withdrawal by Subject|1|||
161783369|NCT01017029|584252612|FG000|Overall Study|Lost to Follow-up|1|||
161783370|NCT01017029|584252613|FG001|Overall Study|Lost to Follow-up|0|||
161783371|NCT01017029|584252612|FG000|Overall Study|Administrative problem|0|||
161783372|NCT01017029|584252613|FG001|Overall Study|Administrative problem|1|||
161783373|NCT01017029|584252612|FG000|Overall Study|Death|3|||
161783374|NCT01017029|584252613|FG001|Overall Study|Death|1|||
161783375|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
161783376|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
161783377|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
161783378|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
161783379|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
161783380|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
161783381|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
161783382|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
161783383|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
161783384|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
161783385|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
161783386|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
161783387|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
161783388|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161783389|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161783390|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
161783391|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
161783392|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161783393|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Other|11|||
161783394|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Other|3|||
161783395|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Other|8|||
161783396|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Other|8|||
161783397|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Other|4|||
161783398|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Other|10|||
161783399|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
161783400|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
161783401|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
161783402|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
161783403|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
161783404|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
161783405|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
161783406|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
161783407|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
161783408|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
161783409|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
161783410|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
161783411|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
161783412|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
161783413|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
161783414|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
161783415|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
161783416|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
161783417|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
161783418|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
161783419|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
161783420|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
161783421|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
161783422|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
161783423|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Other|13|||
161783424|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Other|14|||
161783425|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Other|6|||
161783426|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Other|13|||
161783427|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Other|16|||
161783428|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Other|18|||
161783429|NCT04057118|584252622|FG000|Overall Study|Adverse Event|1|||
161783430|NCT04057118|584252623|FG001|Overall Study|Adverse Event|0|||
161783431|NCT04057118|584252624|FG002|Overall Study|Adverse Event|1|||
161783432|NCT04057118|584252625|FG003|Overall Study|Adverse Event|1|||
161783433|NCT04057118|584252622|FG000|Overall Study|Physician Decision|0|||
161783434|NCT04057118|584252623|FG001|Overall Study|Physician Decision|0|||
161783435|NCT04057118|584252624|FG002|Overall Study|Physician Decision|1|||
161783436|NCT04057118|584252625|FG003|Overall Study|Physician Decision|1|||
161783437|NCT04057118|584252622|FG000|Overall Study|Withdrawal by Subject|2|||
161783438|NCT04057118|584252623|FG001|Overall Study|Withdrawal by Subject|2|||
161783439|NCT04057118|584252624|FG002|Overall Study|Withdrawal by Subject|0|||
161783440|NCT04057118|584252625|FG003|Overall Study|Withdrawal by Subject|2|||
161783441|NCT04057118|584252622|FG000|Overall Study|Not Specific|0|||
161783442|NCT04057118|584252623|FG001|Overall Study|Not Specific|0|||
161783443|NCT04057118|584252624|FG002|Overall Study|Not Specific|1|||
161783444|NCT04057118|584252625|FG003|Overall Study|Not Specific|1|||
161783445|NCT03402126|584252628|FG000|Overall Study|Lost to Follow-up|6|||
161783446|NCT03402126|584252628|FG000|Overall Study|Protocol Violation|10|||
161783447|NCT03402126|584252628|FG000|Overall Study|Sponsor request/Study termination|29|||
161783448|NCT03402126|584252628|FG000|Overall Study|Study product no longer in use|1|||
161783449|NCT03402126|584252628|FG000|Overall Study|Technical problems|1|||
161783450|NCT03402126|584252628|FG000|Overall Study|Withdrawal by Subject|6|||
161783451|NCT03402126|584252628|FG000|Overall Study|Physician Decision|2|||
161783452|NCT03402126|584252628|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
161783453|NCT03402126|584252628|FG000|Overall Study|Death|4|||
161783454|NCT00572156|584252629|FG000|Overall Study|Adverse Event|3|||
161783455|NCT00572156|584252630|FG001|Overall Study|Adverse Event|1|||
161783456|NCT00572156|584252631|FG002|Overall Study|Adverse Event|5|||
161783457|NCT00572156|584252632|FG003|Overall Study|Adverse Event|1|||
161783458|NCT00572156|584252629|FG000|Overall Study|Lost to Follow-up|1|||
161783459|NCT00572156|584252630|FG001|Overall Study|Lost to Follow-up|1|||
161783460|NCT00572156|584252631|FG002|Overall Study|Lost to Follow-up|1|||
161783461|NCT00572156|584252632|FG003|Overall Study|Lost to Follow-up|0|||
161783462|NCT00572156|584252629|FG000|Overall Study|Protocol Violation|1|||
161783463|NCT00572156|584252630|FG001|Overall Study|Protocol Violation|2|||
161783464|NCT00572156|584252631|FG002|Overall Study|Protocol Violation|0|||
161783465|NCT00572156|584252632|FG003|Overall Study|Protocol Violation|2|||
161783466|NCT00572156|584252629|FG000|Overall Study|Patient/Parent Decision|1|||
161783467|NCT00572156|584252630|FG001|Overall Study|Patient/Parent Decision|6|||
161783468|NCT00572156|584252631|FG002|Overall Study|Patient/Parent Decision|4|||
161783469|NCT00572156|584252632|FG003|Overall Study|Patient/Parent Decision|3|||
161783470|NCT00572156|584252629|FG000|Overall Study|Sponsor Decision|20|||
161783471|NCT00572156|584252630|FG001|Overall Study|Sponsor Decision|16|||
161783472|NCT00572156|584252631|FG002|Overall Study|Sponsor Decision|17|||
161783473|NCT00572156|584252632|FG003|Overall Study|Sponsor Decision|19|||
161783474|NCT02261974|584252633|FG000|Overall Study|Withdrawal by Subject|3|||
161783475|NCT02261974|584252634|FG001|Overall Study|Withdrawal by Subject|2|||
161783476|NCT02261974|584252633|FG000|Overall Study|Pregnancy|0|||
161783477|NCT02261974|584252634|FG001|Overall Study|Pregnancy|1|||
161783478|NCT02261974|584252633|FG000|Overall Study|Missed treatment cut-off date|6|||
161783479|NCT02261974|584252634|FG001|Overall Study|Missed treatment cut-off date|3|||
161783480|NCT02261974|584252633|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
161783481|NCT02261974|584252634|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
161783482|NCT02261974|584252633|FG000|Overall Study|Lost to Follow-up|2|||
161783483|NCT02261974|584252634|FG001|Overall Study|Lost to Follow-up|0|||
161783484|NCT02261974|584252633|FG000|Overall Study|Adverse Event|1|||
161783485|NCT02261974|584252634|FG001|Overall Study|Adverse Event|0|||
161783486|NCT02030834|584252635|FG000|Overall Study|Death|4|||
161783487|NCT02030834|584252636|FG001|Overall Study|Death|0|||
161783488|NCT02030834|584252637|FG002|Overall Study|Death|0|||
161783489|NCT02030834|584252635|FG000|Overall Study|Manufacturing failure|2|||
161783490|NCT02030834|584252636|FG001|Overall Study|Manufacturing failure|0|||
161783491|NCT02030834|584252637|FG002|Overall Study|Manufacturing failure|1|||
161783492|NCT02030834|584252635|FG000|Overall Study|Disease progression|2|||
161783493|NCT02030834|584252636|FG001|Overall Study|Disease progression|0|||
161783494|NCT02030834|584252637|FG002|Overall Study|Disease progression|2|||
161783495|NCT02030834|584252635|FG000|Overall Study|Lost to Follow-up|1|||
161783496|NCT02030834|584252636|FG001|Overall Study|Lost to Follow-up|0|||
161783497|NCT02030834|584252637|FG002|Overall Study|Lost to Follow-up|0|||
161783498|NCT02030834|584252635|FG000|Overall Study|Withdrawal by Subject|1|||
161783499|NCT02030834|584252636|FG001|Overall Study|Withdrawal by Subject|0|||
161783500|NCT02030834|584252637|FG002|Overall Study|Withdrawal by Subject|0|||
161783501|NCT02030834|584252635|FG000|Overall Study|Lack of funding|1|||
161783502|NCT02030834|584252636|FG001|Overall Study|Lack of funding|0|||
161783503|NCT02030834|584252637|FG002|Overall Study|Lack of funding|0|||
161783504|NCT03216954|584252640|FG000|Overall Study|Adverse Event|0|||
161783505|NCT03216954|584252641|FG001|Overall Study|Adverse Event|0|||
161783506|NCT03216954|584252642|FG002|Overall Study|Adverse Event|1|||
161783507|NCT03216954|584252643|FG003|Overall Study|Adverse Event|0|||
161783508|NCT03216954|584252644|FG004|Overall Study|Adverse Event|1|||
161783509|NCT03216954|584252640|FG000|Overall Study|Withdrawal by Subject|2|||
161783510|NCT03216954|584252641|FG001|Overall Study|Withdrawal by Subject|0|||
161783511|NCT03216954|584252642|FG002|Overall Study|Withdrawal by Subject|0|||
161783512|NCT03216954|584252643|FG003|Overall Study|Withdrawal by Subject|0|||
161783513|NCT03216954|584252644|FG004|Overall Study|Withdrawal by Subject|0|||
161783514|NCT03216954|584252640|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783515|NCT03216954|584252641|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
161783516|NCT03216954|584252642|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783517|NCT03216954|584252643|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783518|NCT03216954|584252644|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783519|NCT04333199|584252647|FG000|Evaluated Patients|Lost to Follow-up|0|||
161783520|NCT04333199|584252648|FG001|Evaluated Patients|Lost to Follow-up|1|||
161783521|NCT04333199|584252649|FG002|Evaluated Patients|Lost to Follow-up|2|||
161783522|NCT00709735|584252650|FG000|Overall Study|Lost to Follow-up|1|||
161783523|NCT00709735|584252651|FG001|Overall Study|Lost to Follow-up|1|||
161783524|NCT00709735|584252650|FG000|Overall Study|Relapse into Opioid Abuse|0|||
161783525|NCT00709735|584252651|FG001|Overall Study|Relapse into Opioid Abuse|1|||
161783526|NCT00709735|584252650|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
161783527|NCT00709735|584252651|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
161783528|NCT01333475|584252653|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
161783529|NCT01333475|584252654|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
161783530|NCT01333475|584252653|FG000|Overall Study|Toxicity|1|||
161783531|NCT01333475|584252654|FG001|Overall Study|Toxicity|3|||
161783532|NCT04440007|584252655|FG000|Overall Study|Adverse Event|0|||
161783533|NCT04440007|584252656|FG001|Overall Study|Adverse Event|1|||
161783534|NCT04440007|584252655|FG000|Overall Study|Lost to Follow-up|1|||
161783535|NCT04440007|584252656|FG001|Overall Study|Lost to Follow-up|3|||
161783536|NCT04440007|584252655|FG000|Overall Study|Death|7|||
161783537|NCT04440007|584252656|FG001|Overall Study|Death|2|||
161783538|NCT04440007|584252655|FG000|Overall Study|Physician Decision|1|||
161783539|NCT04440007|584252656|FG001|Overall Study|Physician Decision|1|||
161783540|NCT04440007|584252655|FG000|Overall Study|Withdrawal by Subject|2|||
161783541|NCT04440007|584252656|FG001|Overall Study|Withdrawal by Subject|1|||
161896481|NCT00703677|584669718|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
161896482|NCT03859648|584669723|FG000|Overall Study|Lost to Follow-up|1|||
161783542|NCT04440007|584252655|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
161783543|NCT04440007|584252656|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
161783544|NCT04440007|584252655|FG000|Overall Study|Discontinued prior to dosing|0|||
161783545|NCT04440007|584252656|FG001|Overall Study|Discontinued prior to dosing|2|||
161896483|NCT03859648|584669723|FG000|Overall Study|Adverse Event|1|||
161896484|NCT01990573|584669731|FG000|Overall Study|Physician Decision|0|||
161783546|NCT01466673|584252657|FG000|Overall Study|Non-compliance with study treatment|2|||
161783547|NCT01466673|584252658|FG001|Overall Study|Non-compliance with study treatment|0|||
161783548|NCT01466673|584252657|FG000|Overall Study|Lost to Follow-up|3|||
161783549|NCT01466673|584252658|FG001|Overall Study|Lost to Follow-up|5|||
161783550|NCT01466673|584252657|FG000|Overall Study|Adverse Event|2|||
161783551|NCT01466673|584252658|FG001|Overall Study|Adverse Event|1|||
161783552|NCT02981602|584252659|FG000|Overall Study|Adverse Event|0|||
161783553|NCT02981602|584252660|FG001|Overall Study|Adverse Event|0|||
161783554|NCT02981602|584252661|FG002|Overall Study|Adverse Event|0|||
161783555|NCT02981602|584252662|FG003|Overall Study|Adverse Event|1|||
161783556|NCT02981602|584252663|FG004|Overall Study|Adverse Event|0|||
161783557|NCT00666718|584252664|FG000|Overall Study|Adverse Event|0|||
161783558|NCT00666718|584252665|FG001|Overall Study|Adverse Event|1|||
161783559|NCT00666718|584252664|FG000|Overall Study|Death|1|||
161783560|NCT00666718|584252665|FG001|Overall Study|Death|0|||
161783561|NCT00666718|584252664|FG000|Overall Study|Lost to Follow-up|1|||
161783562|NCT00666718|584252665|FG001|Overall Study|Lost to Follow-up|0|||
161783563|NCT00666718|584252664|FG000|Overall Study|Entry Criteria Not Met|2|||
161783564|NCT00666718|584252665|FG001|Overall Study|Entry Criteria Not Met|0|||
161783565|NCT00666718|584252664|FG000|Overall Study|Protocol Violation|1|||
161783566|NCT00666718|584252665|FG001|Overall Study|Protocol Violation|3|||
161783567|NCT00666718|584252664|FG000|Overall Study|Withdrawal by Subject|7|||
161783568|NCT00666718|584252665|FG001|Overall Study|Withdrawal by Subject|12|||
161783569|NCT00666718|584252664|FG000|Overall Study|Physician Decision|0|||
161783570|NCT00666718|584252665|FG001|Overall Study|Physician Decision|2|||
161783571|NCT02567266|584252677|FG000|Overall Study|Withdrawal by Subject|10|||
161783572|NCT02567266|584252678|FG001|Overall Study|Withdrawal by Subject|7|||
161783573|NCT02567266|584252679|FG002|Overall Study|Withdrawal by Subject|6|||
161783574|NCT02567266|584252677|FG000|Overall Study|Lost to Follow-up|13|||
161783575|NCT02567266|584252678|FG001|Overall Study|Lost to Follow-up|8|||
161783576|NCT02567266|584252679|FG002|Overall Study|Lost to Follow-up|10|||
161783577|NCT02983227|584252680|FG000|Overall Study|Adverse Event|21|||
161783578|NCT02983227|584252681|FG001|Overall Study|Adverse Event|3|||
161783579|NCT02983227|584252680|FG000|Overall Study|Death|3|||
161783580|NCT02983227|584252681|FG001|Overall Study|Death|0|||
161783581|NCT02983227|584252680|FG000|Overall Study|Lack of Efficacy|8|||
161783582|NCT02983227|584252681|FG001|Overall Study|Lack of Efficacy|1|||
161783583|NCT02983227|584252680|FG000|Overall Study|Lost to Follow-up|3|||
161783584|NCT02983227|584252681|FG001|Overall Study|Lost to Follow-up|0|||
161783585|NCT02983227|584252680|FG000|Overall Study|Multiple Reasons|2|||
161783586|NCT02983227|584252681|FG001|Overall Study|Multiple Reasons|1|||
161783587|NCT02983227|584252680|FG000|Overall Study|Physician Decision|3|||
161783588|NCT02983227|584252681|FG001|Overall Study|Physician Decision|1|||
161783589|NCT02983227|584252680|FG000|Overall Study|Withdrawal by Subject|19|||
161783590|NCT02983227|584252681|FG001|Overall Study|Withdrawal by Subject|8|||
161783591|NCT02164539|584252684|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
161783592|NCT02164539|584252685|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
161783593|NCT02164539|584252686|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
161783594|NCT02164539|584252687|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
161783595|NCT02164539|584252688|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
161783596|NCT02164539|584252689|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
161783597|NCT02164539|584252690|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
161783598|NCT02164539|584252684|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
161783599|NCT02164539|584252685|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
161783600|NCT02164539|584252686|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
161783601|NCT02164539|584252687|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
161783602|NCT02164539|584252688|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
161783603|NCT02164539|584252689|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
161783604|NCT02164539|584252690|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
161783605|NCT02164539|584252684|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
161783606|NCT02164539|584252685|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
161783607|NCT02164539|584252686|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
161783608|NCT02164539|584252687|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
161783609|NCT02164539|584252688|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
161783610|NCT02164539|584252689|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
161783611|NCT02164539|584252690|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
161783612|NCT02164539|584252684|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
161783613|NCT02164539|584252685|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783614|NCT02164539|584252686|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783615|NCT02164539|584252687|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783616|NCT02164539|584252688|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783617|NCT02164539|584252689|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161896485|NCT01990573|584669732|FG001|Overall Study|Physician Decision|0|||
161783618|NCT02164539|584252690|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783619|NCT02164539|584252684|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
161783620|NCT02164539|584252685|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
161783621|NCT02164539|584252686|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
161783622|NCT02164539|584252687|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
161783623|NCT02164539|584252688|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
161783624|NCT02164539|584252689|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
161783625|NCT02164539|584252690|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
161783626|NCT02164539|584252684|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
161783627|NCT02164539|584252685|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
161783628|NCT02164539|584252686|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
161783629|NCT02164539|584252687|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
161783630|NCT02164539|584252688|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
161783631|NCT02164539|584252689|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
161783632|NCT02164539|584252690|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
161783633|NCT01255722|584252691|FG000|Overall Study|Adverse Event|0|||
161783634|NCT01255722|584252692|FG001|Overall Study|Adverse Event|1|||
161783635|NCT01255722|584252693|FG002|Overall Study|Adverse Event|1|||
161783636|NCT01255722|584252691|FG000|Overall Study|asymptomatic patient|1|||
161783637|NCT01255722|584252692|FG001|Overall Study|asymptomatic patient|0|||
161783638|NCT01255722|584252693|FG002|Overall Study|asymptomatic patient|0|||
161783639|NCT01255722|584252691|FG000|Overall Study|beta-blocker contraindicated|2|||
161783640|NCT01255722|584252692|FG001|Overall Study|beta-blocker contraindicated|0|||
161783641|NCT01255722|584252693|FG002|Overall Study|beta-blocker contraindicated|0|||
161783642|NCT00527397|584252696|FG000|Overall Study|Adverse Event|3|||
161783643|NCT00527397|584252696|FG000|Overall Study|Lack of Efficacy|1|||
161783644|NCT00527397|584252696|FG000|Overall Study|Protocol Violation|1|||
161783645|NCT00527397|584252696|FG000|Overall Study|Withdrawal by Subject|6|||
161783646|NCT00527397|584252696|FG000|Overall Study|Study terminated by sponsor|13|||
161783647|NCT02065791|584252700|FG000|Overall Study|Closed Site|1|||
161783648|NCT02065791|584252701|FG001|Overall Study|Closed Site|1|||
161783649|NCT02065791|584252700|FG000|Overall Study|Withdrawal by Subject|11|||
161783650|NCT02065791|584252701|FG001|Overall Study|Withdrawal by Subject|5|||
161783651|NCT02065791|584252700|FG000|Overall Study|Lost to Follow-up|13|||
161783652|NCT02065791|584252701|FG001|Overall Study|Lost to Follow-up|9|||
161783653|NCT04529096|584252702|FG000|Overall Study|Adverse Event|6|||
161783654|NCT04529096|584252703|FG001|Overall Study|Adverse Event|1|||
161783655|NCT04529096|584252702|FG000|Overall Study|Lack of Efficacy|1|||
161783656|NCT04529096|584252703|FG001|Overall Study|Lack of Efficacy|0|||
161783657|NCT04529096|584252702|FG000|Overall Study|Lost to Follow-up|1|||
161783658|NCT04529096|584252703|FG001|Overall Study|Lost to Follow-up|1|||
161783659|NCT04529096|584252702|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161783660|NCT04529096|584252703|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161783661|NCT04529096|584252702|FG000|Overall Study|Physician Decision|1|||
161783662|NCT04529096|584252703|FG001|Overall Study|Physician Decision|3|||
161783663|NCT04529096|584252702|FG000|Overall Study|Withdrawal by Subject|5|||
161896486|NCT01990573|584669733|FG002|Overall Study|Physician Decision|1|||
161896487|NCT01025284|584669747|FG000|Overall Study|Investigator Decision|0|||
161783664|NCT04529096|584252703|FG001|Overall Study|Withdrawal by Subject|0|||
161783665|NCT04529499|584252704|FG000|Overall Study|Withdrawal by Subject|9|||
161783666|NCT04529499|584252705|FG001|Overall Study|Withdrawal by Subject|11|||
161783667|NCT04529499|584252704|FG000|Overall Study|Physician Decision|1|||
161783668|NCT04529499|584252705|FG001|Overall Study|Physician Decision|2|||
161783669|NCT04529499|584252704|FG000|Overall Study|Adverse Event|4|||
161783670|NCT04529499|584252705|FG001|Overall Study|Adverse Event|4|||
161783671|NCT04529499|584252704|FG000|Overall Study|Death|14|||
161783672|NCT04529499|584252705|FG001|Overall Study|Death|11|||
161783673|NCT04529499|584252704|FG000|Overall Study|Lost to Follow-up|1|||
161783674|NCT04529499|584252705|FG001|Overall Study|Lost to Follow-up|1|||
161783675|NCT04529499|584252704|FG000|Overall Study|Others|7|||
161783676|NCT04529499|584252705|FG001|Overall Study|Others|11|||
161783677|NCT00683904|584252706|FG000|Dose Level 1|Disease progression|2|||
161783678|NCT00683904|584252707|FG001|Dose Level 1|Disease progression|0|||
161783679|NCT00683904|584252706|FG000|Dose Level 1|Adverse Event|1|||
161783680|NCT00683904|584252707|FG001|Dose Level 1|Adverse Event|0|||
161783681|NCT00683904|584252706|FG000|Dose Level 2|Adverse Event|0|||
161783682|NCT00683904|584252707|FG001|Dose Level 2|Adverse Event|2|||
161783683|NCT03091400|584252708|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
161783684|NCT03091400|584252709|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
161783685|NCT03467971|584252710|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161896488|NCT01025284|584669748|FG001|Overall Study|Investigator Decision|1|||
161783686|NCT03467971|584252711|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161783687|NCT00975884|584252712|FG000|Overall Study|Adverse Event|1|||
161783688|NCT00975884|584252713|FG001|Overall Study|Adverse Event|0|||
161783689|NCT00975884|584252712|FG000|Overall Study|Lost to Follow-up|5|||
161783690|NCT00975884|584252713|FG001|Overall Study|Lost to Follow-up|3|||
161896489|NCT01025284|584669749|FG002|Overall Study|Investigator Decision|0|||
161896490|NCT01025284|584669747|FG000|Overall Study|Withdrawal by Subject|0|||
161783691|NCT00975884|584252712|FG000|Overall Study|Withdrawal by Subject|9|||
161783692|NCT00975884|584252713|FG001|Overall Study|Withdrawal by Subject|9|||
161783693|NCT00975884|584252712|FG000|Overall Study|Other|1|||
161783694|NCT00975884|584252713|FG001|Overall Study|Other|3|||
161783695|NCT03707522|584252714|FG000|Overall Study|Lost to Follow-up|24|||
161783696|NCT03707522|584252715|FG001|Overall Study|Lost to Follow-up|27|||
161783697|NCT03707522|584252716|FG002|Overall Study|Lost to Follow-up|41|||
161783698|NCT03707522|584252717|FG003|Overall Study|Lost to Follow-up|36|||
161783699|NCT00383019|584252718|FG000|Overall Study|Adverse Event|5|||
161783700|NCT00383019|584252719|FG001|Overall Study|Adverse Event|1|||
161783701|NCT00383019|584252718|FG000|Overall Study|Withdrawal by Subject|0|||
161783702|NCT00383019|584252719|FG001|Overall Study|Withdrawal by Subject|1|||
161896491|NCT01025284|584669748|FG001|Overall Study|Withdrawal by Subject|1|||
161896492|NCT01025284|584669749|FG002|Overall Study|Withdrawal by Subject|0|||
161896493|NCT00547248|584669754|FG000|Overall Study|Protocol Violation|0|||
161896494|NCT00547248|584669755|FG001|Overall Study|Protocol Violation|0|||
161896495|NCT00547248|584669756|FG002|Overall Study|Protocol Violation|1|||
161896496|NCT00547248|584669757|FG003|Overall Study|Protocol Violation|1|||
161896497|NCT00547248|584669754|FG000|Overall Study|Migrated/moved from study area|0|||
161896498|NCT00547248|584669755|FG001|Overall Study|Migrated/moved from study area|0|||
161896499|NCT00547248|584669756|FG002|Overall Study|Migrated/moved from study area|2|||
161896500|NCT00547248|584669757|FG003|Overall Study|Migrated/moved from study area|0|||
161896501|NCT00547248|584669754|FG000|Overall Study|Withdrawal by Subject|0|||
161896502|NCT00547248|584669755|FG001|Overall Study|Withdrawal by Subject|0|||
161896503|NCT00547248|584669756|FG002|Overall Study|Withdrawal by Subject|7|||
161896504|NCT00547248|584669757|FG003|Overall Study|Withdrawal by Subject|1|||
161896505|NCT00305227|584669761|FG000|Overall Study|Lost to Follow-up|7|||
161896506|NCT00305227|584669762|FG001|Overall Study|Lost to Follow-up|6|||
161896507|NCT05133323|584669764|FG000|Overall Study|Lack of Efficacy|0|||
161896508|NCT05133323|584669765|FG001|Overall Study|Lack of Efficacy|0|||
161896509|NCT05133323|584669766|FG002|Overall Study|Lack of Efficacy|1|||
161896510|NCT05133323|584669764|FG000|Overall Study|Withdrawal by Subject|2|||
161896511|NCT05133323|584669765|FG001|Overall Study|Withdrawal by Subject|1|||
161896512|NCT05133323|584669766|FG002|Overall Study|Withdrawal by Subject|0|||
161896513|NCT04152083|584669779|FG000|Overall Study|Lost to Follow-up|2|||
161896514|NCT04152083|584669780|FG001|Overall Study|Lost to Follow-up|1|||
161896515|NCT04152083|584669779|FG000|Overall Study|Adverse Event|1|||
161896516|NCT04152083|584669780|FG001|Overall Study|Adverse Event|0|||
161896517|NCT04152083|584669779|FG000|Overall Study|Randomized but not treated|3|||
161896518|NCT04152083|584669780|FG001|Overall Study|Randomized but not treated|2|||
161896519|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
161896520|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
161896521|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
161896522|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
161896523|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
161896524|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161896525|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161896526|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161896527|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
161896528|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
161896529|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
161896530|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
161896531|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161896532|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161896533|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
161896534|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161896535|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
161896536|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161896537|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161896538|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161896539|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161896540|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161896541|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
161896542|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161896543|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
161896544|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161896545|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161783703|NCT01619085|584252720|FG000|Overall Study|Adverse Event|231|||
161896546|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161896547|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161783704|NCT01619085|584252720|FG000|Overall Study|Protocol Violation|4|||
161783705|NCT01619085|584252720|FG000|Overall Study|Lost to Follow-up|3|||
161783706|NCT01619085|584252720|FG000|Overall Study|Withdrawal by Subject|45|||
161783707|NCT01619085|584252720|FG000|Overall Study|Other than specified|96|||
161783708|NCT01619085|584252720|FG000|Overall Study|Not treated|1|||
161783709|NCT01619085|584252720|FG000|Overall Study|Death|145|||
161783710|NCT02602080|584252723|FG000|Overall Study|Protocol Violation|6|||
161783711|NCT02602080|584252724|FG001|Overall Study|Protocol Violation|1|||
161783712|NCT02602080|584252725|FG002|Overall Study|Protocol Violation|3|||
161783713|NCT04508621|584252730|FG000|Overall Study|Adverse Event|39|||
161783714|NCT04508621|584252731|FG001|Overall Study|Adverse Event|16|||
161783715|NCT04508621|584252730|FG000|Overall Study|Lack of Efficacy|2|||
161783716|NCT04508621|584252731|FG001|Overall Study|Lack of Efficacy|8|||
161783717|NCT04508621|584252730|FG000|Overall Study|Physician Decision|0|||
161783718|NCT04508621|584252731|FG001|Overall Study|Physician Decision|1|||
161783719|NCT04508621|584252730|FG000|Overall Study|Withdrawal by Subject|10|||
161783720|NCT04508621|584252731|FG001|Overall Study|Withdrawal by Subject|14|||
161783721|NCT04508621|584252730|FG000|Overall Study|Lost to Follow-up|12|||
161783722|NCT04508621|584252731|FG001|Overall Study|Lost to Follow-up|9|||
161783723|NCT04508621|584252730|FG000|Overall Study|COVID-19 related crisis|3|||
161783724|NCT04508621|584252731|FG001|Overall Study|COVID-19 related crisis|0|||
161783725|NCT04508621|584252730|FG000|Overall Study|Subject non-compliance|1|||
161783726|NCT04508621|584252731|FG001|Overall Study|Subject non-compliance|0|||
161783727|NCT01066039|584252732|FG000|Overall Study|Adverse Event|6|||
161783728|NCT01066039|584252732|FG000|Overall Study|Withdrawal by Subject|17|||
161783729|NCT01066039|584252732|FG000|Overall Study|Protocol Violation|2|||
161783730|NCT01066039|584252732|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
161783731|NCT01066039|584252732|FG000|Overall Study|Investigator's Request|1|||
161783732|NCT01066039|584252732|FG000|Overall Study|Dropout due to Insulin Administration|1|||
161783733|NCT01066039|584252732|FG000|Overall Study|Additional Antihypertensive Required|4|||
161783734|NCT01066039|584252732|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
161783735|NCT01066039|584252732|FG000|Overall Study|Failure to Control Blood Pressure|1|||
161783736|NCT01066039|584252732|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
161783737|NCT02574260|584252733|FG000|Overall Study|Disease Progression|1|||
161783738|NCT00752895|584252734|FG000|Overall Study|Withdrawal by Subject|8|||
161783739|NCT00752895|584252735|FG001|Overall Study|Withdrawal by Subject|3|||
161783740|NCT03022799|584252736|FG000|Overall Study|Adverse Event|0|||
161783741|NCT03022799|584252737|FG001|Overall Study|Adverse Event|0|||
161783742|NCT03022799|584252738|FG002|Overall Study|Adverse Event|0|||
161783743|NCT03022799|584252739|FG003|Overall Study|Adverse Event|0|||
161783744|NCT03022799|584252740|FG004|Overall Study|Adverse Event|0|||
161783745|NCT03022799|584252741|FG005|Overall Study|Adverse Event|0|||
161783746|NCT03022799|584252742|FG006|Overall Study|Adverse Event|0|||
161783747|NCT03022799|584252743|FG007|Overall Study|Adverse Event|0|||
161783748|NCT03022799|584252744|FG008|Overall Study|Adverse Event|0|||
161783749|NCT03022799|584252745|FG009|Overall Study|Adverse Event|1|||
161783750|NCT03022799|584252746|FG010|Overall Study|Adverse Event|1|||
161783751|NCT03022799|584252747|FG011|Overall Study|Adverse Event|0|||
161783752|NCT03022799|584252748|FG012|Overall Study|Adverse Event|0|||
161783753|NCT00883129|584252751|FG000|Overall Study|Adverse Event|7|||
161783754|NCT00883129|584252752|FG001|Overall Study|Adverse Event|15|||
161783755|NCT00883129|584252751|FG000|Overall Study|Withdrawal by Subject|8|||
161783756|NCT00883129|584252752|FG001|Overall Study|Withdrawal by Subject|9|||
161783757|NCT00883129|584252751|FG000|Overall Study|Non-compliance|3|||
161783758|NCT00883129|584252752|FG001|Overall Study|Non-compliance|6|||
161783759|NCT00883129|584252751|FG000|Overall Study|Lost to Follow-up|1|||
161783760|NCT00883129|584252752|FG001|Overall Study|Lost to Follow-up|2|||
161783761|NCT00883129|584252751|FG000|Overall Study|Death|1|||
161783762|NCT00883129|584252752|FG001|Overall Study|Death|2|||
161783763|NCT00883129|584252751|FG000|Overall Study|Defined Treatment Failure|0|||
161783764|NCT00883129|584252752|FG001|Overall Study|Defined Treatment Failure|2|||
161783765|NCT03273257|584252753|FG000|Overall Study|Death|0|||
161783766|NCT03273257|584252754|FG001|Overall Study|Death|1|||
161783767|NCT03273257|584252753|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
161783768|NCT03273257|584252754|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
161783769|NCT03273257|584252753|FG000|Overall Study|Study terminated|3|||
161783770|NCT03273257|584252754|FG001|Overall Study|Study terminated|2|||
161783771|NCT01416142|584254213|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
161783772|NCT01416142|584254214|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
161783773|NCT01416142|584254215|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
161783774|NCT02464059|584254216|FG000|Overall Study|Lost to Follow-up|6|||
161783775|NCT03591107|584254220|FG000|Overall Study|Same patient in both arms|1|||
161783776|NCT03591107|584254221|FG001|Overall Study|Same patient in both arms|1|||
161783777|NCT03591107|584254220|FG000|Overall Study|Sought care at other clinics|0|||
161783778|NCT03591107|584254221|FG001|Overall Study|Sought care at other clinics|2|||
161783779|NCT03591107|584254220|FG000|Overall Study|Discharged from clinic|0|||
161783780|NCT03591107|584254221|FG001|Overall Study|Discharged from clinic|1|||
161783781|NCT03591107|584254220|FG000|Overall Study|Withdrawal by Subject|0|||
161783782|NCT03591107|584254221|FG001|Overall Study|Withdrawal by Subject|1|||
161783783|NCT00678379|584254222|FG000|Overall Study|Injection performed after tonsillectomy|2|||
161783784|NCT00678379|584254223|FG001|Overall Study|Injection performed after tonsillectomy|0|||
161783785|NCT00678379|584254224|FG002|Overall Study|Injection performed after tonsillectomy|1|||
161783786|NCT00678379|584254222|FG000|Overall Study|Incomplete Data|4|||
161783787|NCT00678379|584254223|FG001|Overall Study|Incomplete Data|3|||
161783788|NCT00678379|584254224|FG002|Overall Study|Incomplete Data|3|||
161783789|NCT01835470|584254225|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
161783790|NCT01835470|584254225|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
161783791|NCT01011907|584254226|FG000|Overall Study|Withdrawal by Subject|13|||
161783792|NCT01011907|584254227|FG001|Overall Study|Withdrawal by Subject|11|||
161783793|NCT01011907|584254226|FG000|Overall Study|Adverse Event|1|||
161783794|NCT01011907|584254227|FG001|Overall Study|Adverse Event|4|||
161783795|NCT01637961|584254232|FG000|Overall Study|Ineligible: wrong primary|1|||
161783796|NCT01637961|584254232|FG000|Overall Study|Ineligible: inadequate pathology|1|||
161783797|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
161783798|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161783799|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
161783800|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161783801|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161783802|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161783803|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161783804|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161783805|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161783806|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161783807|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
161783808|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161783809|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161783810|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161783811|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161783812|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783813|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
161783814|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783815|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783816|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783817|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
161783818|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783819|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783820|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783821|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783822|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161783823|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161783824|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161783825|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161783826|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161783827|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
161783828|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
161783829|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
161783830|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
161783831|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
161783832|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Other|1|||
161783833|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Other|2|||
161783834|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Other|0|||
161783835|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Other|0|||
161783836|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Other|1|||
161783837|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
161783838|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
161783839|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161896548|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161896549|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
161896550|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161896551|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
161896552|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161783840|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161783841|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161783842|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
161783843|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
161783844|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161783845|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161783846|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161783847|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161783848|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
161783849|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161783850|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161783851|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161783852|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
161783853|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
161783854|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
161783855|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
161783856|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
161783857|NCT02773446|584254238|FG000|First Admission|Withdrawal by Subject|0|||
161783858|NCT02773446|584254239|FG001|First Admission|Withdrawal by Subject|0|||
161783859|NCT02773446|584254240|FG002|First Admission|Withdrawal by Subject|0|||
161783860|NCT02773446|584254241|FG003|First Admission|Withdrawal by Subject|1|||
161783861|NCT02773446|584254242|FG004|First Admission|Withdrawal by Subject|0|||
161783862|NCT02773446|584254243|FG005|First Admission|Withdrawal by Subject|0|||
161783863|NCT02773446|584254238|FG000|First Admission|Lost to Follow-up|1|||
161783864|NCT02773446|584254239|FG001|First Admission|Lost to Follow-up|0|||
161783865|NCT02773446|584254240|FG002|First Admission|Lost to Follow-up|0|||
161783866|NCT02773446|584254241|FG003|First Admission|Lost to Follow-up|0|||
161783867|NCT02773446|584254242|FG004|First Admission|Lost to Follow-up|0|||
161783868|NCT02773446|584254243|FG005|First Admission|Lost to Follow-up|0|||
161783869|NCT01613131|584254244|FG000|Overall Study|Withdrawal by Subject|3|||
161783870|NCT01613131|584254245|FG001|Overall Study|Withdrawal by Subject|5|||
161783871|NCT02454972|584254246|FG000|Overall Study|Progressive disease|17|||
161783872|NCT02454972|584254247|FG001|Overall Study|Progressive disease|16|||
161783873|NCT02454972|584254248|FG002|Overall Study|Progressive disease|59|||
161783874|NCT02454972|584254249|FG003|Overall Study|Progressive disease|23|||
161783875|NCT02454972|584254250|FG004|Overall Study|Progressive disease|16|||
161783876|NCT02454972|584254251|FG005|Overall Study|Progressive disease|12|||
161783877|NCT02454972|584254252|FG006|Overall Study|Progressive disease|19|||
161783878|NCT02454972|584254253|FG007|Overall Study|Progressive disease|27|||
161783879|NCT02454972|584254254|FG008|Overall Study|Progressive disease|0|||
161783880|NCT02454972|584254246|FG000|Overall Study|Death|0|||
161783881|NCT02454972|584254247|FG001|Overall Study|Death|0|||
161783882|NCT02454972|584254248|FG002|Overall Study|Death|5|||
161783883|NCT02454972|584254249|FG003|Overall Study|Death|1|||
161783884|NCT02454972|584254250|FG004|Overall Study|Death|0|||
161783885|NCT02454972|584254251|FG005|Overall Study|Death|0|||
161783886|NCT02454972|584254252|FG006|Overall Study|Death|0|||
161783887|NCT02454972|584254253|FG007|Overall Study|Death|0|||
161783888|NCT02454972|584254254|FG008|Overall Study|Death|95|||
161783889|NCT02454972|584254246|FG000|Overall Study|Physician Decision|0|||
161783890|NCT02454972|584254247|FG001|Overall Study|Physician Decision|1|||
161783891|NCT02454972|584254248|FG002|Overall Study|Physician Decision|2|||
161783892|NCT02454972|584254249|FG003|Overall Study|Physician Decision|1|||
161783893|NCT02454972|584254250|FG004|Overall Study|Physician Decision|2|||
161783894|NCT02454972|584254251|FG005|Overall Study|Physician Decision|0|||
161783895|NCT02454972|584254252|FG006|Overall Study|Physician Decision|0|||
161783896|NCT02454972|584254253|FG007|Overall Study|Physician Decision|1|||
161783897|NCT02454972|584254254|FG008|Overall Study|Physician Decision|0|||
161783898|NCT02454972|584254246|FG000|Overall Study|Non treatment-related adverse event|2|||
161896553|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161783899|NCT02454972|584254247|FG001|Overall Study|Non treatment-related adverse event|0|||
161783900|NCT02454972|584254248|FG002|Overall Study|Non treatment-related adverse event|1|||
161896554|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161896555|NCT03318003|584669785|FG000|Overall Study|Withdrawal by Subject|1|||
161896556|NCT03318003|584669786|FG001|Overall Study|Withdrawal by Subject|1|||
161896557|NCT03318003|584669785|FG000|Overall Study|fetal loss|0|||
161896558|NCT03318003|584669786|FG001|Overall Study|fetal loss|1|||
161896559|NCT00614874|584669790|FG000|Overall Study|Protocol Violation|1|||
161896560|NCT00614874|584669790|FG000|Overall Study|Withdrawal by Subject|1|||
161896561|NCT00807612|584669792|FG000|Overall Study|Death|8|||
161783901|NCT02454972|584254249|FG003|Overall Study|Non treatment-related adverse event|0|||
161783902|NCT02454972|584254250|FG004|Overall Study|Non treatment-related adverse event|0|||
161783903|NCT02454972|584254251|FG005|Overall Study|Non treatment-related adverse event|1|||
161783904|NCT02454972|584254252|FG006|Overall Study|Non treatment-related adverse event|0|||
161783905|NCT02454972|584254253|FG007|Overall Study|Non treatment-related adverse event|1|||
161783906|NCT02454972|584254254|FG008|Overall Study|Non treatment-related adverse event|0|||
161783907|NCT02454972|584254246|FG000|Overall Study|Treatment-related adverse events|0|||
161783908|NCT02454972|584254247|FG001|Overall Study|Treatment-related adverse events|1|||
161783909|NCT02454972|584254248|FG002|Overall Study|Treatment-related adverse events|1|||
161783910|NCT02454972|584254249|FG003|Overall Study|Treatment-related adverse events|0|||
161896562|NCT00807612|584669792|FG000|Overall Study|Study early termination|5|||
161896563|NCT00807612|584669792|FG000|Overall Study|Withdrawal by Subject|1|||
161896564|NCT02768792|584669793|FG000|Overall Study|Adverse Event|1|||
161896565|NCT04607135|584669795|FG000|Overall Study|Physician Decision|1|||
161896566|NCT04607135|584669795|FG000|Overall Study|Withdrawal by Subject|1|||
161896567|NCT04607135|584669795|FG000|Overall Study|Equipment not working|3|||
161783911|NCT02454972|584254250|FG004|Overall Study|Treatment-related adverse events|2|||
161783912|NCT02454972|584254251|FG005|Overall Study|Treatment-related adverse events|0|||
161783913|NCT02454972|584254252|FG006|Overall Study|Treatment-related adverse events|0|||
161783914|NCT02454972|584254253|FG007|Overall Study|Treatment-related adverse events|2|||
161783915|NCT02454972|584254254|FG008|Overall Study|Treatment-related adverse events|0|||
161783916|NCT02454972|584254246|FG000|Overall Study|Patient moves to compassionate use|0|||
161783917|NCT02454972|584254247|FG001|Overall Study|Patient moves to compassionate use|0|||
161783918|NCT02454972|584254248|FG002|Overall Study|Patient moves to compassionate use|0|||
161783919|NCT02454972|584254249|FG003|Overall Study|Patient moves to compassionate use|0|||
161783920|NCT02454972|584254250|FG004|Overall Study|Patient moves to compassionate use|0|||
161783921|NCT02454972|584254251|FG005|Overall Study|Patient moves to compassionate use|0|||
161783922|NCT02454972|584254252|FG006|Overall Study|Patient moves to compassionate use|2|||
161783923|NCT02454972|584254253|FG007|Overall Study|Patient moves to compassionate use|0|||
161783924|NCT02454972|584254254|FG008|Overall Study|Patient moves to compassionate use|0|||
161783925|NCT02454972|584254246|FG000|Overall Study|Withdrawal by Subject|0|||
161783926|NCT02454972|584254247|FG001|Overall Study|Withdrawal by Subject|1|||
161783927|NCT02454972|584254248|FG002|Overall Study|Withdrawal by Subject|5|||
161783928|NCT02454972|584254249|FG003|Overall Study|Withdrawal by Subject|2|||
161783929|NCT02454972|584254250|FG004|Overall Study|Withdrawal by Subject|3|||
161783930|NCT02454972|584254251|FG005|Overall Study|Withdrawal by Subject|2|||
161783931|NCT02454972|584254252|FG006|Overall Study|Withdrawal by Subject|0|||
161783932|NCT02454972|584254253|FG007|Overall Study|Withdrawal by Subject|1|||
161783933|NCT02454972|584254254|FG008|Overall Study|Withdrawal by Subject|2|||
161783934|NCT02454972|584254246|FG000|Overall Study|Multiple delay/holds on treatment|0|||
161783935|NCT02454972|584254247|FG001|Overall Study|Multiple delay/holds on treatment|0|||
161783936|NCT02454972|584254248|FG002|Overall Study|Multiple delay/holds on treatment|0|||
161783937|NCT02454972|584254249|FG003|Overall Study|Multiple delay/holds on treatment|1|||
161783938|NCT02454972|584254250|FG004|Overall Study|Multiple delay/holds on treatment|0|||
161783939|NCT02454972|584254251|FG005|Overall Study|Multiple delay/holds on treatment|0|||
161783940|NCT02454972|584254252|FG006|Overall Study|Multiple delay/holds on treatment|0|||
161783941|NCT02454972|584254253|FG007|Overall Study|Multiple delay/holds on treatment|0|||
161783942|NCT02454972|584254254|FG008|Overall Study|Multiple delay/holds on treatment|0|||
161783943|NCT02454972|584254246|FG000|Overall Study|Never treated|0|||
161783944|NCT02454972|584254247|FG001|Overall Study|Never treated|0|||
161783945|NCT02454972|584254248|FG002|Overall Study|Never treated|3|||
161783946|NCT02454972|584254249|FG003|Overall Study|Never treated|1|||
161783947|NCT02454972|584254250|FG004|Overall Study|Never treated|1|||
161783948|NCT02454972|584254251|FG005|Overall Study|Never treated|0|||
161783949|NCT02454972|584254252|FG006|Overall Study|Never treated|0|||
161783950|NCT02454972|584254253|FG007|Overall Study|Never treated|0|||
161783951|NCT02454972|584254254|FG008|Overall Study|Never treated|5|||
161783952|NCT02454972|584254246|FG000|Overall Study|Lost to Follow-up|0|||
161783953|NCT02454972|584254247|FG001|Overall Study|Lost to Follow-up|0|||
161783954|NCT02454972|584254248|FG002|Overall Study|Lost to Follow-up|0|||
161783955|NCT02454972|584254249|FG003|Overall Study|Lost to Follow-up|0|||
161783956|NCT02454972|584254250|FG004|Overall Study|Lost to Follow-up|0|||
161783957|NCT02454972|584254251|FG005|Overall Study|Lost to Follow-up|0|||
161783958|NCT02454972|584254252|FG006|Overall Study|Lost to Follow-up|0|||
161783959|NCT02454972|584254253|FG007|Overall Study|Lost to Follow-up|0|||
161783960|NCT02454972|584254254|FG008|Overall Study|Lost to Follow-up|2|||
161783961|NCT02454972|584254246|FG000|Overall Study|Study termination|0|||
161783962|NCT02454972|584254247|FG001|Overall Study|Study termination|0|||
161783963|NCT02454972|584254248|FG002|Overall Study|Study termination|0|||
161783964|NCT02454972|584254249|FG003|Overall Study|Study termination|0|||
161783965|NCT02454972|584254250|FG004|Overall Study|Study termination|0|||
161783966|NCT02454972|584254251|FG005|Overall Study|Study termination|0|||
161783967|NCT02454972|584254252|FG006|Overall Study|Study termination|0|||
161783968|NCT02454972|584254253|FG007|Overall Study|Study termination|0|||
161783969|NCT02454972|584254254|FG008|Overall Study|Study termination|6|||
161783970|NCT01020305|584254261|FG000|Overall Study|Adverse Event|2|||
161896568|NCT03465709|584669796|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
161896569|NCT03465709|584669796|FG000|Overall Study|Withdrawal by Subject|3|||
161783971|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
161783972|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Off-label use|9|||
161783973|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
161783974|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
161783975|NCT01070966|584254264|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
161896570|NCT05359952|584669797|FG000|Overall Study|Lost to Follow-up|1|||
161896571|NCT05359952|584669798|FG001|Overall Study|Lost to Follow-up|0|||
161783976|NCT01070966|584254264|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
161783977|NCT01070966|584254264|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
161783978|NCT01070966|584254264|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
161783979|NCT01725113|584254265|FG000|Overall Study|Kidney Transplant|1|||
161783980|NCT01725113|584254266|FG001|Overall Study|Kidney Transplant|1|||
161783981|NCT01725113|584254265|FG000|Overall Study|Withdrawal by Subject|0|||
161783982|NCT01725113|584254266|FG001|Overall Study|Withdrawal by Subject|1|||
161783983|NCT02753400|584254268|FG000|Overall Study|Adverse Event|3|||
161783984|NCT02753400|584254269|FG001|Overall Study|Adverse Event|0|||
161783985|NCT02753400|584254268|FG000|Overall Study|Withdrawal by Subject|2|||
161783986|NCT02753400|584254269|FG001|Overall Study|Withdrawal by Subject|1|||
161783987|NCT03989115|584254270|FG000|Overall Study|Withdrawal by Subject|2|||
161783988|NCT03989115|584254271|FG001|Overall Study|Withdrawal by Subject|1|||
161783989|NCT03989115|584254272|FG002|Overall Study|Withdrawal by Subject|3|||
161783990|NCT03989115|584254273|FG003|Overall Study|Withdrawal by Subject|0|||
161783991|NCT03989115|584254274|FG004|Overall Study|Withdrawal by Subject|17|||
161783992|NCT03989115|584254275|FG005|Overall Study|Withdrawal by Subject|1|||
161783993|NCT03989115|584254276|FG006|Overall Study|Withdrawal by Subject|0|||
161783994|NCT03989115|584254277|FG007|Overall Study|Withdrawal by Subject|0|||
161783995|NCT03989115|584254270|FG000|Overall Study|Sponsor decision to terminate the study|1|||
161783996|NCT03989115|584254271|FG001|Overall Study|Sponsor decision to terminate the study|1|||
161783997|NCT03989115|584254272|FG002|Overall Study|Sponsor decision to terminate the study|0|||
161783998|NCT03989115|584254273|FG003|Overall Study|Sponsor decision to terminate the study|1|||
161783999|NCT03989115|584254274|FG004|Overall Study|Sponsor decision to terminate the study|11|||
161784000|NCT03989115|584254275|FG005|Overall Study|Sponsor decision to terminate the study|0|||
161784001|NCT03989115|584254276|FG006|Overall Study|Sponsor decision to terminate the study|2|||
161784002|NCT03989115|584254277|FG007|Overall Study|Sponsor decision to terminate the study|1|||
161784003|NCT03989115|584254270|FG000|Overall Study|Lost to Follow-up|2|||
161784004|NCT03989115|584254271|FG001|Overall Study|Lost to Follow-up|0|||
161784005|NCT03989115|584254272|FG002|Overall Study|Lost to Follow-up|0|||
161784006|NCT03989115|584254273|FG003|Overall Study|Lost to Follow-up|0|||
161784007|NCT03989115|584254274|FG004|Overall Study|Lost to Follow-up|1|||
161784008|NCT03989115|584254275|FG005|Overall Study|Lost to Follow-up|0|||
161784009|NCT03989115|584254276|FG006|Overall Study|Lost to Follow-up|0|||
161784010|NCT03989115|584254277|FG007|Overall Study|Lost to Follow-up|0|||
161784011|NCT03989115|584254270|FG000|Overall Study|Death|2|||
161784012|NCT03989115|584254271|FG001|Overall Study|Death|2|||
161784013|NCT03989115|584254272|FG002|Overall Study|Death|9|||
161784014|NCT03989115|584254273|FG003|Overall Study|Death|6|||
161896572|NCT00705341|584669799|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
161896573|NCT00705341|584669800|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
161896574|NCT00705341|584669801|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
161896575|NCT00705341|584669802|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
161896576|NCT00705341|584669799|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161896577|NCT00705341|584669800|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161784015|NCT03989115|584254274|FG004|Overall Study|Death|31|||
161784016|NCT03989115|584254275|FG005|Overall Study|Death|6|||
161784017|NCT03989115|584254276|FG006|Overall Study|Death|2|||
161784018|NCT03989115|584254277|FG007|Overall Study|Death|3|||
161784019|NCT03989115|584254270|FG000|Overall Study|Other|1|||
161784020|NCT03989115|584254271|FG001|Overall Study|Other|2|||
161784021|NCT03989115|584254272|FG002|Overall Study|Other|0|||
161784022|NCT03989115|584254273|FG003|Overall Study|Other|0|||
161784023|NCT03989115|584254274|FG004|Overall Study|Other|5|||
161784024|NCT03989115|584254275|FG005|Overall Study|Other|0|||
161784025|NCT03989115|584254276|FG006|Overall Study|Other|0|||
161784026|NCT03989115|584254277|FG007|Overall Study|Other|0|||
161784027|NCT01415921|584254278|FG000|Overall Study|Adverse Event|0|||
161784028|NCT01415921|584254279|FG001|Overall Study|Adverse Event|1|||
161784029|NCT01415921|584254278|FG000|Overall Study|Physician Decision|1|||
161784030|NCT01415921|584254279|FG001|Overall Study|Physician Decision|1|||
161784031|NCT01415921|584254278|FG000|Overall Study|Withdrawal by Subject|0|||
161784032|NCT01415921|584254279|FG001|Overall Study|Withdrawal by Subject|1|||
161784033|NCT01415921|584254278|FG000|Overall Study|Other|2|||
161784034|NCT01415921|584254279|FG001|Overall Study|Other|0|||
161784035|NCT02143947|584254280|FG000|Overall Study|Lost to Follow-up|4|||
161784036|NCT02143947|584254281|FG001|Overall Study|Lost to Follow-up|2|||
161784037|NCT00697112|584254286|FG000|Overall Study|Adverse Event|8|||
161784038|NCT00697112|584254286|FG000|Overall Study|Lost to Follow-up|1|||
161784039|NCT00697112|584254286|FG000|Overall Study|Did not meet inclusion criteria|1|||
161896578|NCT00705341|584669801|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
161896579|NCT00705341|584669802|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161784040|NCT04736576|584254289|FG000|Overall Study|Progressive disease|3|||
161784041|NCT04736576|584254290|FG001|Overall Study|Progressive disease|1|||
161784042|NCT04736576|584254289|FG000|Overall Study|Death|1|||
161784043|NCT04736576|584254290|FG001|Overall Study|Death|0|||
161784044|NCT00720304|584254291|FG000|Overall Study|Withdrawal by Subject|14|||
161784045|NCT00720304|584254292|FG001|Overall Study|Withdrawal by Subject|1|||
161784046|NCT00720304|584254291|FG000|Overall Study|Death|1|||
161784047|NCT00720304|584254292|FG001|Overall Study|Death|0|||
161784048|NCT00720304|584254291|FG000|Overall Study|Physician Decision|5|||
161784049|NCT00720304|584254292|FG001|Overall Study|Physician Decision|2|||
161784050|NCT00720304|584254291|FG000|Overall Study|Adverse Event|3|||
161784051|NCT00720304|584254292|FG001|Overall Study|Adverse Event|1|||
161784052|NCT00720304|584254291|FG000|Overall Study|Disease progression|6|||
161784053|NCT00720304|584254292|FG001|Overall Study|Disease progression|1|||
161784054|NCT04330482|584254295|FG000|Overall Study|Lost to Follow-up|2|||
161784055|NCT04330482|584254296|FG001|Overall Study|Lost to Follow-up|1|||
161784056|NCT04330482|584254295|FG000|Overall Study|Withdrawal by Subject|0|||
161784057|NCT04330482|584254296|FG001|Overall Study|Withdrawal by Subject|3|||
161784058|NCT05180630|584254297|FG000|First Intervention|Physician Decision|0|||
161784059|NCT05180630|584254298|FG001|First Intervention|Physician Decision|0|||
161784060|NCT05180630|584254299|FG002|First Intervention|Physician Decision|3|||
161784061|NCT02725671|584254303|FG000|Overall Study|Lost to Follow-up|1|||
161784062|NCT00963599|584254304|FG000|Overall Study|Adverse Event|2|||
161784063|NCT00963599|584254305|FG001|Overall Study|Adverse Event|0|||
161784064|NCT00963599|584254306|FG002|Overall Study|Adverse Event|1|||
161784065|NCT00963599|584254307|FG003|Overall Study|Adverse Event|2|||
161784066|NCT00963599|584254304|FG000|Overall Study|Lack of Efficacy|0|||
161784067|NCT00963599|584254305|FG001|Overall Study|Lack of Efficacy|2|||
161784068|NCT00963599|584254306|FG002|Overall Study|Lack of Efficacy|1|||
161784069|NCT00963599|584254307|FG003|Overall Study|Lack of Efficacy|4|||
161784070|NCT00963599|584254304|FG000|Overall Study|Lost to Follow-up|0|||
161784071|NCT00963599|584254305|FG001|Overall Study|Lost to Follow-up|1|||
161784072|NCT00963599|584254306|FG002|Overall Study|Lost to Follow-up|1|||
161784073|NCT00963599|584254307|FG003|Overall Study|Lost to Follow-up|1|||
161784074|NCT00963599|584254304|FG000|Overall Study|Protocol Violation|2|||
161784075|NCT00963599|584254305|FG001|Overall Study|Protocol Violation|2|||
161784076|NCT00963599|584254306|FG002|Overall Study|Protocol Violation|3|||
161784077|NCT00963599|584254307|FG003|Overall Study|Protocol Violation|4|||
161784078|NCT00963599|584254304|FG000|Overall Study|Withdrawal by Subject|2|||
161784079|NCT00963599|584254305|FG001|Overall Study|Withdrawal by Subject|1|||
161784080|NCT00963599|584254306|FG002|Overall Study|Withdrawal by Subject|3|||
161784081|NCT00963599|584254307|FG003|Overall Study|Withdrawal by Subject|3|||
161784082|NCT00190684|584254310|FG000|Overall Study|Adverse Event|86|||
161784083|NCT00190684|584254310|FG000|Overall Study|Satisfactory response|80|||
161784084|NCT00190684|584254310|FG000|Overall Study|Lack of efficacy|204|||
161784085|NCT00190684|584254310|FG000|Overall Study|Lost to Follow-up|232|||
161784086|NCT00190684|584254310|FG000|Overall Study|Patient moved|60|||
161784087|NCT00190684|584254310|FG000|Overall Study|Patient Decision|432|||
161784088|NCT00190684|584254310|FG000|Overall Study|Clinical relapse|67|||
161784089|NCT00190684|584254310|FG000|Overall Study|Sponsor's decision|17|||
161784090|NCT00190684|584254310|FG000|Overall Study|Physician Decision|84|||
161784091|NCT00190684|584254310|FG000|Overall Study|Protocol Violation|123|||
161784092|NCT00190684|584254310|FG000|Overall Study|Study Period III Completed|103|||
161784093|NCT00190684|584254310|FG000|Overall Study|Study Period V Completed|1|||
161784094|NCT02354976|584254314|FG000|Overall Study|Other - reason not specified|1|||
161784095|NCT02354976|584254315|FG001|Overall Study|Other - reason not specified|0|||
161784096|NCT02354976|584254316|FG002|Overall Study|Other - reason not specified|1|||
161784097|NCT02354976|584254314|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
161784098|NCT02354976|584254315|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
161784099|NCT02354976|584254316|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
161784100|NCT02354976|584254314|FG000|Overall Study|Adverse Event|1|||
161784101|NCT02354976|584254315|FG001|Overall Study|Adverse Event|0|||
161784102|NCT02354976|584254316|FG002|Overall Study|Adverse Event|2|||
161784103|NCT01706770|584254317|FG000|Overall Study|Lost to Follow-up|1|||
161784104|NCT01706770|584254318|FG001|Overall Study|Lost to Follow-up|0|||
161784105|NCT01706770|584254317|FG000|Overall Study|Physician Decision|1|||
161784106|NCT01706770|584254318|FG001|Overall Study|Physician Decision|0|||
161784107|NCT00068445|584254319|FG000|Randomization|Cancel|1|||
161784108|NCT00068445|584254320|FG001|Randomization|Cancel|3|||
161784109|NCT00068445|584254319|FG000|Randomization|Ineligible|1|||
161784110|NCT00068445|584254320|FG001|Randomization|Ineligible|1|||
161784111|NCT00068445|584254319|FG000|Treatment|Refused Further Treatment|13|||
161784112|NCT00068445|584254320|FG001|Treatment|Refused Further Treatment|10|||
161784113|NCT00068445|584254319|FG000|Treatment|Adverse Event|7|||
161784114|NCT00068445|584254320|FG001|Treatment|Adverse Event|1|||
161784115|NCT00068445|584254319|FG000|Treatment|Other (Specifics not available)|9|||
161784116|NCT00068445|584254320|FG001|Treatment|Other (Specifics not available)|5|||
161784117|NCT01155284|584254321|FG000|Overall Study|Withdrawal by Subject|4|||
161784118|NCT01155284|584254322|FG001|Overall Study|Withdrawal by Subject|3|||
161784119|NCT01155284|584254321|FG000|Overall Study|Lost to Follow-up|1|||
161784120|NCT01155284|584254322|FG001|Overall Study|Lost to Follow-up|2|||
161784121|NCT01155284|584254321|FG000|Overall Study|Physician Decision|1|||
161784122|NCT01155284|584254322|FG001|Overall Study|Physician Decision|0|||
161784123|NCT01155284|584254321|FG000|Overall Study|Adverse Event|1|||
161784124|NCT01155284|584254322|FG001|Overall Study|Adverse Event|0|||
161784125|NCT01896700|584254323|FG000|Overall Study|Adverse Event|4|||
161784126|NCT01896700|584254324|FG001|Overall Study|Adverse Event|5|||
161784127|NCT01896700|584254323|FG000|Overall Study|Withdrawal by Subject|0|||
161784128|NCT01896700|584254324|FG001|Overall Study|Withdrawal by Subject|1|||
161896580|NCT03173456|584669805|FG000|Baseline|Medication dispensing system malfunction'|0|||
161896581|NCT03173456|584669806|FG001|Baseline|Medication dispensing system malfunction'|1|||
161784129|NCT00123487|584254325|FG000|Randomized|Death prior to starting treatment|0|||
161784130|NCT00123487|584254326|FG001|Randomized|Death prior to starting treatment|1|||
161784131|NCT00123487|584254325|FG000|Randomized|SAE prior to starting treatment|1|||
161784132|NCT00123487|584254326|FG001|Randomized|SAE prior to starting treatment|0|||
161784133|NCT00123487|584254325|FG000|Treated With Study Drug|Adverse Event|23|||
161784134|NCT00123487|584254326|FG001|Treated With Study Drug|Adverse Event|22|||
161784135|NCT00123487|584254325|FG000|Treated With Study Drug|Disease Progression|141|||
161784136|NCT00123487|584254326|FG001|Treated With Study Drug|Disease Progression|122|||
161784137|NCT00123487|584254325|FG000|Treated With Study Drug|Physician Decision|8|||
161784138|NCT00123487|584254326|FG001|Treated With Study Drug|Physician Decision|9|||
161784139|NCT00123487|584254325|FG000|Treated With Study Drug|Other|59|||
161784140|NCT00123487|584254326|FG001|Treated With Study Drug|Other|58|||
161784141|NCT00123487|584254325|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
161784142|NCT00123487|584254326|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
161784143|NCT00123487|584254325|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
161831482|NCT01730040|584424762|FG005|Overall Study|Adverse Event|1|||
161831483|NCT01730040|584424763|FG006|Overall Study|Adverse Event|2|||
161831484|NCT01730040|584424757|FG000|Overall Study|Poor compliance to protocol|2|||
161831485|NCT01730040|584424758|FG001|Overall Study|Poor compliance to protocol|4|||
161831486|NCT01730040|584424759|FG002|Overall Study|Poor compliance to protocol|0|||
161831487|NCT01730040|584424760|FG003|Overall Study|Poor compliance to protocol|0|||
161831488|NCT01730040|584424761|FG004|Overall Study|Poor compliance to protocol|0|||
161831489|NCT01730040|584424762|FG005|Overall Study|Poor compliance to protocol|0|||
161831490|NCT01730040|584424763|FG006|Overall Study|Poor compliance to protocol|1|||
161831491|NCT00544817|584424766|FG000|Combined Modality|Lack of Efficacy|2|||
161831492|NCT00544817|584424766|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
161831493|NCT00544817|584424766|FG000|Combined Modality|Adverse Event|2|||
161831494|NCT00544817|584424766|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
161831495|NCT00544817|584424766|FG000|No Treatment Interval|Lack of Efficacy|8|||
161831496|NCT00544817|584424766|FG000|No Treatment Interval|Physician Decision|3|||
161831497|NCT00544817|584424766|FG000|No Treatment Interval|Adverse Event|1|||
161831498|NCT00544817|584424766|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
161831499|NCT00544817|584424766|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
161831500|NCT00544817|584424766|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
161831501|NCT01552369|584424767|FG000|Overall Study|Did not consent to extended follow up|8|||
161831502|NCT01552369|584424768|FG001|Overall Study|Did not consent to extended follow up|9|||
161831503|NCT00754013|584424780|FG000|Overall Study|Lost to Follow-up|1|||
161831504|NCT00754013|584424781|FG001|Overall Study|Lost to Follow-up|1|||
161831505|NCT00754013|584424780|FG000|Overall Study|didn't return after study termed|3|||
161831506|NCT00754013|584424781|FG001|Overall Study|didn't return after study termed|4|||
161831507|NCT01432574|584424785|FG000|Overall Study|Moved|2|||
161831508|NCT01432574|584424785|FG000|Overall Study|Not interested|1|||
161831509|NCT03135899|584424792|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831510|NCT03135899|584424793|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831511|NCT03135899|584424794|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831512|NCT03135899|584424795|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831513|NCT03135899|584424796|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831514|NCT03135899|584424797|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
161896582|NCT03173456|584669807|FG002|Baseline|Medication dispensing system malfunction'|0|||
161896583|NCT03173456|584669808|FG003|Baseline|Medication dispensing system malfunction'|0|||
161896584|NCT03173456|584669809|FG004|Baseline|Medication dispensing system malfunction'|2|||
161896585|NCT03173456|584669805|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
161896586|NCT03173456|584669806|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
161896587|NCT03173456|584669807|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
161896588|NCT03173456|584669808|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
161896589|NCT03173456|584669809|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
161896590|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
161896591|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
161896592|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
161896593|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
161896594|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
161896595|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
161896596|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161896597|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
161896598|NCT01737879|584669814|FG000|Overall Study|Death|1|||
161896599|NCT01737879|584669814|FG000|Overall Study|Sponsor decision|40|||
161896600|NCT04978337|584669817|FG000|Overall Study|Withdrawal by Subject|0|||
161896601|NCT04978337|584669818|FG001|Overall Study|Withdrawal by Subject|1|||
161896602|NCT01436227|584669822|FG000|Overall Study|Adverse Event|7|||
161896603|NCT01436227|584669822|FG000|Overall Study|Death|1|||
161896604|NCT01436227|584669822|FG000|Overall Study|Lack of Efficacy|1|||
161896605|NCT01436227|584669822|FG000|Overall Study|Lost to Follow-up|3|||
161896606|NCT01436227|584669822|FG000|Overall Study|Physician Decision|1|||
161896607|NCT01436227|584669822|FG000|Overall Study|Withdrawal by Subject|7|||
161896608|NCT01436227|584669822|FG000|Overall Study|Disease progression, relapse|6|||
161896609|NCT04865419|584669825|FG000|Overall Study|Other|1|||
161896610|NCT04865419|584669826|FG001|Overall Study|Other|2|||
161896611|NCT04865419|584669827|FG002|Overall Study|Other|2|||
161896612|NCT04865419|584669828|FG003|Overall Study|Other|1|||
161896613|NCT04865419|584669829|FG004|Overall Study|Other|3|||
161896614|NCT04865419|584669830|FG005|Overall Study|Other|0|||
161896615|NCT04865419|584669831|FG006|Overall Study|Other|0|||
161896616|NCT04865419|584669832|FG007|Overall Study|Other|1|||
161896617|NCT04865419|584669833|FG008|Overall Study|Other|0|||
161896618|NCT04865419|584669834|FG009|Overall Study|Other|0|||
161896619|NCT04865419|584669835|FG010|Overall Study|Other|0|||
161896620|NCT04865419|584669825|FG000|Overall Study|Withdrawal by Subject|0|||
161896621|NCT04865419|584669826|FG001|Overall Study|Withdrawal by Subject|1|||
161896622|NCT04865419|584669827|FG002|Overall Study|Withdrawal by Subject|1|||
161896623|NCT04865419|584669828|FG003|Overall Study|Withdrawal by Subject|0|||
161896624|NCT04865419|584669829|FG004|Overall Study|Withdrawal by Subject|0|||
161896625|NCT04865419|584669830|FG005|Overall Study|Withdrawal by Subject|0|||
161896626|NCT04865419|584669831|FG006|Overall Study|Withdrawal by Subject|0|||
161896627|NCT04865419|584669832|FG007|Overall Study|Withdrawal by Subject|1|||
161896628|NCT04865419|584669833|FG008|Overall Study|Withdrawal by Subject|2|||
161896629|NCT04865419|584669834|FG009|Overall Study|Withdrawal by Subject|1|||
161896630|NCT04865419|584669835|FG010|Overall Study|Withdrawal by Subject|0|||
161896631|NCT04865419|584669825|FG000|Overall Study|Study terminated by Sponsor|0|||
161896632|NCT04865419|584669826|FG001|Overall Study|Study terminated by Sponsor|0|||
161896633|NCT04865419|584669827|FG002|Overall Study|Study terminated by Sponsor|0|||
161896634|NCT04865419|584669828|FG003|Overall Study|Study terminated by Sponsor|2|||
161896635|NCT04865419|584669829|FG004|Overall Study|Study terminated by Sponsor|2|||
161896636|NCT04865419|584669830|FG005|Overall Study|Study terminated by Sponsor|0|||
161896637|NCT04865419|584669831|FG006|Overall Study|Study terminated by Sponsor|0|||
161896638|NCT04865419|584669832|FG007|Overall Study|Study terminated by Sponsor|0|||
161896639|NCT04865419|584669833|FG008|Overall Study|Study terminated by Sponsor|0|||
161896640|NCT04865419|584669834|FG009|Overall Study|Study terminated by Sponsor|0|||
161896641|NCT04865419|584669835|FG010|Overall Study|Study terminated by Sponsor|1|||
161896642|NCT04865419|584669825|FG000|Overall Study|Death|3|||
161896643|NCT04865419|584669826|FG001|Overall Study|Death|1|||
161896644|NCT04865419|584669827|FG002|Overall Study|Death|4|||
161896645|NCT04865419|584669828|FG003|Overall Study|Death|2|||
161896646|NCT04865419|584669829|FG004|Overall Study|Death|5|||
161896647|NCT04865419|584669830|FG005|Overall Study|Death|2|||
161896648|NCT04865419|584669831|FG006|Overall Study|Death|1|||
161896649|NCT04865419|584669832|FG007|Overall Study|Death|1|||
161896650|NCT04865419|584669833|FG008|Overall Study|Death|2|||
161552431|NCT02733042|583410435|FG008|Overall Study|Death|1|||
161896651|NCT04865419|584669834|FG009|Overall Study|Death|2|||
161896652|NCT04865419|584669835|FG010|Overall Study|Death|1|||
161896653|NCT04865419|584669825|FG000|Overall Study|Lost to Follow-up|0|||
161896654|NCT04865419|584669826|FG001|Overall Study|Lost to Follow-up|0|||
161896655|NCT04865419|584669827|FG002|Overall Study|Lost to Follow-up|0|||
161896656|NCT04865419|584669828|FG003|Overall Study|Lost to Follow-up|0|||
161896657|NCT04865419|584669829|FG004|Overall Study|Lost to Follow-up|0|||
161896658|NCT04865419|584669830|FG005|Overall Study|Lost to Follow-up|0|||
161896659|NCT04865419|584669831|FG006|Overall Study|Lost to Follow-up|0|||
161896660|NCT04865419|584669832|FG007|Overall Study|Lost to Follow-up|0|||
161896661|NCT04865419|584669833|FG008|Overall Study|Lost to Follow-up|0|||
161896662|NCT04865419|584669834|FG009|Overall Study|Lost to Follow-up|1|||
161896663|NCT04865419|584669835|FG010|Overall Study|Lost to Follow-up|0|||
161896664|NCT05446142|584669836|FG000|Period 2|Adverse Event|1|||
161896665|NCT05446142|584669837|FG001|Period 2|Adverse Event|0|||
161896666|NCT05446142|584669838|FG002|Period 2|Adverse Event|0|||
161896667|NCT05446142|584669839|FG003|Period 2|Adverse Event|0|||
161896668|NCT05446142|584669840|FG004|Period 2|Adverse Event|0|||
161896669|NCT05446142|584669841|FG005|Period 2|Adverse Event|0|||
161896670|NCT00547157|584669846|FG000|Overall Study|Other|1|||
161896671|NCT00547157|584669847|FG001|Overall Study|Other|0|||
161896672|NCT00547157|584669846|FG000|Overall Study|Death|38|||
161896673|NCT00547157|584669847|FG001|Overall Study|Death|18|||
161896674|NCT00547157|584669846|FG000|Overall Study|Withdrawal by Subject|3|||
161896675|NCT00547157|584669847|FG001|Overall Study|Withdrawal by Subject|1|||
161896676|NCT00547157|584669846|FG000|Overall Study|Administrative decision|3|||
161896677|NCT00547157|584669847|FG001|Overall Study|Administrative decision|2|||
161896678|NCT00547157|584669846|FG000|Overall Study|Lost to Follow-up|4|||
161896679|NCT00547157|584669847|FG001|Overall Study|Lost to Follow-up|2|||
161896680|NCT03853291|584669848|FG000|Overall Study|Lost to Follow-up|1|||
161896681|NCT03853291|584669849|FG001|Overall Study|Lost to Follow-up|2|||
161896682|NCT03853291|584669850|FG002|Overall Study|Lost to Follow-up|0|||
161896683|NCT03853291|584669851|FG003|Overall Study|Lost to Follow-up|0|||
161896684|NCT03853291|584669852|FG004|Overall Study|Lost to Follow-up|0|||
161896685|NCT03853291|584669853|FG005|Overall Study|Lost to Follow-up|0|||
161896686|NCT03853291|584669848|FG000|Overall Study|Determined to be ineligible|1|||
161896687|NCT03853291|584669849|FG001|Overall Study|Determined to be ineligible|1|||
161896688|NCT03853291|584669850|FG002|Overall Study|Determined to be ineligible|0|||
161896689|NCT03853291|584669851|FG003|Overall Study|Determined to be ineligible|0|||
161896690|NCT03853291|584669852|FG004|Overall Study|Determined to be ineligible|0|||
161896691|NCT03853291|584669853|FG005|Overall Study|Determined to be ineligible|0|||
161896692|NCT01990768|584669854|FG000|Intervention Started|Found to be ineligible|14|||
161896693|NCT01990768|584669855|FG001|Intervention Started|Found to be ineligible|13|||
161896694|NCT01990768|584669856|FG002|Intervention Started|Found to be ineligible|11|||
161896695|NCT01990768|584669854|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
161896696|NCT01990768|584669855|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
161896697|NCT01990768|584669856|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
161896698|NCT01990768|584669854|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
161896699|NCT01990768|584669855|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
161896700|NCT01990768|584669856|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
161896701|NCT01990768|584669854|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
161896702|NCT01990768|584669855|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
161896703|NCT01990768|584669856|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
161896704|NCT01990768|584669854|FG000|Intervention Started|Patient care priority|1|||
161896705|NCT01990768|584669855|FG001|Intervention Started|Patient care priority|2|||
161896706|NCT01990768|584669856|FG002|Intervention Started|Patient care priority|3|||
161896707|NCT01990768|584669854|FG000|Intervention Started|IV lost|2|||
161896708|NCT01990768|584669855|FG001|Intervention Started|IV lost|2|||
161896709|NCT01990768|584669856|FG002|Intervention Started|IV lost|2|||
161896710|NCT01990768|584669854|FG000|Intervention Started|Required CPR|1|||
161896711|NCT01990768|584669855|FG001|Intervention Started|Required CPR|1|||
161896712|NCT01990768|584669856|FG002|Intervention Started|Required CPR|0|||
161896713|NCT01990768|584669854|FG000|Intervention Started|Seizure or hx of seizure|0|||
161896714|NCT01990768|584669855|FG001|Intervention Started|Seizure or hx of seizure|0|||
161896715|NCT01990768|584669856|FG002|Intervention Started|Seizure or hx of seizure|2|||
161896716|NCT01990768|584669854|FG000|Intervention Started|Discovered to be pregnant|0|||
161896717|NCT01990768|584669855|FG001|Intervention Started|Discovered to be pregnant|1|||
161896718|NCT01990768|584669856|FG002|Intervention Started|Discovered to be pregnant|0|||
161896719|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
161896720|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
161896721|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
161896722|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
161896723|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
161896724|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
161896725|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
161896726|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
161896727|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
161896728|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
161896729|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
161896730|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
161896731|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Death|3|||
161896732|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Death|1|||
161896733|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Death|1|||
161896734|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Discharged|2|||
161896735|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Discharged|1|||
161896736|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Discharged|0|||
161896737|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
161896738|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
161896739|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
161896740|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
161896741|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
161896742|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
161896743|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
161896744|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
161896745|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
161896746|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
161896747|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
161896748|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
161896749|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
161896750|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
161896751|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
161896752|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
161896753|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
161896754|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
161896755|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
161896756|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
161896757|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
161896758|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
161896759|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
161896760|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
161896761|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
161896762|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
161896763|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
161896764|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
161896765|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
161896766|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
161896767|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
161896768|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
161896769|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
161896770|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
161896771|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
161896772|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
161896773|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
161896774|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
161896775|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
161896776|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161896777|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161896778|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161896779|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
161896780|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
161896781|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
161896782|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
161896783|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
161896784|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
161896785|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
161896786|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
161896787|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
161896788|NCT01990768|584669854|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
161896789|NCT01990768|584669855|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
161896790|NCT01990768|584669856|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
161896791|NCT01990768|584669854|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
161896792|NCT01990768|584669855|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
161896793|NCT01990768|584669856|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
161896794|NCT01990768|584669854|FG000|6-Month Follow-up|No contact information|5|||
161896795|NCT01990768|584669855|FG001|6-Month Follow-up|No contact information|6|||
161896796|NCT01990768|584669856|FG002|6-Month Follow-up|No contact information|5|||
161896797|NCT01990768|584669854|FG000|6-Month Follow-up|Homeless|4|||
161896798|NCT01990768|584669855|FG001|6-Month Follow-up|Homeless|3|||
161896799|NCT01990768|584669856|FG002|6-Month Follow-up|Homeless|6|||
161896800|NCT01990768|584669854|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
161896801|NCT01990768|584669855|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
161896802|NCT01990768|584669856|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
161896803|NCT01990768|584669854|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
161896804|NCT01990768|584669855|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
161896805|NCT01990768|584669856|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
161896806|NCT01990768|584669854|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
161896807|NCT01990768|584669855|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
161896808|NCT01990768|584669856|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
161896809|NCT02348008|584669857|FG000|Overall Study|Adverse Event|2|||
161896810|NCT02348008|584669858|FG001|Overall Study|Adverse Event|3|||
161896811|NCT02348008|584669859|FG002|Overall Study|Adverse Event|3|||
161896812|NCT02348008|584669857|FG000|Overall Study|Disease Progression|1|||
161896813|NCT02348008|584669858|FG001|Overall Study|Disease Progression|5|||
161896814|NCT02348008|584669859|FG002|Overall Study|Disease Progression|16|||
161896815|NCT02348008|584669857|FG000|Overall Study|Withdrawal by Subject|0|||
161896816|NCT02348008|584669858|FG001|Overall Study|Withdrawal by Subject|1|||
161896817|NCT02348008|584669859|FG002|Overall Study|Withdrawal by Subject|0|||
161896818|NCT02348008|584669857|FG000|Overall Study|Symptomatic Deterioration|0|||
161896819|NCT02348008|584669858|FG001|Overall Study|Symptomatic Deterioration|1|||
161896820|NCT02348008|584669859|FG002|Overall Study|Symptomatic Deterioration|0|||
161896821|NCT00845676|584669863|FG000|Overall Study|Virologic breakthrough at week 20|1|||
161896822|NCT00845676|584669863|FG000|Overall Study|Adverse Event|1|||
161896823|NCT02756364|584669864|FG000|Overall Study|Site Terminated by Sponsor|24|||
161896824|NCT02756364|584669865|FG001|Overall Study|Site Terminated by Sponsor|30|||
161896825|NCT02756364|584669866|FG002|Overall Study|Site Terminated by Sponsor|21|||
161896826|NCT02756364|584669864|FG000|Overall Study|Death|20|||
161896827|NCT02756364|584669865|FG001|Overall Study|Death|15|||
161896828|NCT02756364|584669866|FG002|Overall Study|Death|18|||
161896829|NCT02756364|584669864|FG000|Overall Study|Withdrawal by Patient|2|||
161896830|NCT02756364|584669865|FG001|Overall Study|Withdrawal by Patient|1|||
161896831|NCT02756364|584669866|FG002|Overall Study|Withdrawal by Patient|8|||
161896832|NCT02756364|584669864|FG000|Overall Study|Lost to Follow-up|0|||
161896833|NCT02756364|584669865|FG001|Overall Study|Lost to Follow-up|1|||
161896834|NCT02756364|584669866|FG002|Overall Study|Lost to Follow-up|1|||
161896835|NCT02223364|584669867|FG000|Overall Study|Protocol Violation|3|||
161896836|NCT02223364|584669868|FG001|Overall Study|Protocol Violation|0|||
161896837|NCT02223364|584669869|FG002|Overall Study|Protocol Violation|3|||
161896838|NCT02223364|584669867|FG000|Overall Study|subject expired before surgery|1|||
161896839|NCT02223364|584669868|FG001|Overall Study|subject expired before surgery|0|||
161896840|NCT02223364|584669869|FG002|Overall Study|subject expired before surgery|0|||
161896841|NCT02223364|584669867|FG000|Overall Study|Physician Decision|1|||
161896842|NCT02223364|584669868|FG001|Overall Study|Physician Decision|0|||
161896843|NCT02223364|584669869|FG002|Overall Study|Physician Decision|0|||
161896844|NCT00463801|584671557|FG000|Overall Study|Protocol Violation|1|||
161896845|NCT00463801|584671557|FG000|Overall Study|Lack of Efficacy|2|||
161896846|NCT00463801|584671557|FG000|Overall Study|Adverse Event|4|||
161896847|NCT00463801|584671557|FG000|Overall Study|Lost to Follow-up|5|||
161896848|NCT00463801|584671557|FG000|Overall Study|No longer require therapy|1|||
161896849|NCT00669318|584671558|FG000|Overall Study|Withdrawal by Subject|2|||
161896850|NCT04441788|584671561|FG000|Overall Study|Voluntary Withdrawl|0|||
161896851|NCT04441788|584671562|FG001|Overall Study|Voluntary Withdrawl|1|||
161896852|NCT04441788|584671563|FG002|Overall Study|Voluntary Withdrawl|0|||
161896853|NCT04441788|584671561|FG000|Overall Study|Ineligibility|1|||
161896854|NCT04441788|584671562|FG001|Overall Study|Ineligibility|0|||
161896855|NCT04441788|584671563|FG002|Overall Study|Ineligibility|0|||
161896856|NCT04441788|584671561|FG000|Overall Study|Adverse Event|0|||
161896857|NCT04441788|584671562|FG001|Overall Study|Adverse Event|0|||
161896858|NCT04441788|584671563|FG002|Overall Study|Adverse Event|4|||
161896859|NCT04441788|584671561|FG000|Overall Study|Study Terminated by Sponsor|16|||
161896860|NCT04441788|584671562|FG001|Overall Study|Study Terminated by Sponsor|16|||
161896861|NCT04441788|584671563|FG002|Overall Study|Study Terminated by Sponsor|12|||
161896862|NCT01677182|584671564|FG000|Overall Study|Adverse Event|2|||
161896863|NCT01677182|584671565|FG001|Overall Study|Adverse Event|1|||
161896864|NCT01677182|584671566|FG002|Overall Study|Adverse Event|8|||
161896865|NCT01677182|584671564|FG000|Overall Study|Protocol Violation|5|||
161896866|NCT01677182|584671565|FG001|Overall Study|Protocol Violation|1|||
161896867|NCT01677182|584671566|FG002|Overall Study|Protocol Violation|4|||
161896868|NCT01677182|584671564|FG000|Overall Study|Lost to Follow-up|4|||
161896869|NCT01677182|584671565|FG001|Overall Study|Lost to Follow-up|0|||
161896870|NCT01677182|584671566|FG002|Overall Study|Lost to Follow-up|3|||
161896871|NCT01677182|584671564|FG000|Overall Study|Withdrawal by Subject|7|||
161896872|NCT01677182|584671565|FG001|Overall Study|Withdrawal by Subject|12|||
161896873|NCT01677182|584671566|FG002|Overall Study|Withdrawal by Subject|10|||
161896874|NCT01677182|584671564|FG000|Overall Study|Study termination|12|||
161896875|NCT01677182|584671565|FG001|Overall Study|Study termination|9|||
161896876|NCT01677182|584671566|FG002|Overall Study|Study termination|11|||
161896877|NCT01677182|584671564|FG000|Overall Study|Lack of Efficacy|3|||
161896878|NCT01677182|584671565|FG001|Overall Study|Lack of Efficacy|0|||
161896879|NCT01677182|584671566|FG002|Overall Study|Lack of Efficacy|1|||
161896880|NCT01677182|584671564|FG000|Overall Study|Other reasons|1|||
161896881|NCT01677182|584671565|FG001|Overall Study|Other reasons|5|||
161896882|NCT01677182|584671566|FG002|Overall Study|Other reasons|2|||
161896883|NCT02489448|584671569|FG000|Overall Study|Death|3|||
161896884|NCT02489448|584671569|FG000|Overall Study|Withdrawal by Subject|2|||
161896885|NCT02748057|584671570|FG000|Overall Study|Adverse Event|1|||
161896886|NCT02748057|584671571|FG001|Overall Study|Adverse Event|0|||
161896887|NCT02748057|584671570|FG000|Overall Study|Physician Decision|0|||
161896888|NCT02748057|584671571|FG001|Overall Study|Physician Decision|1|||
161896889|NCT02748057|584671570|FG000|Overall Study|Protocol Violation|2|||
161896890|NCT02748057|584671571|FG001|Overall Study|Protocol Violation|1|||
161896891|NCT02748057|584671570|FG000|Overall Study|Participant Moved|1|||
161896892|NCT02748057|584671571|FG001|Overall Study|Participant Moved|0|||
161896893|NCT02748057|584671570|FG000|Overall Study|Withdrawal by Subject|1|||
161896894|NCT02748057|584671571|FG001|Overall Study|Withdrawal by Subject|0|||
161896895|NCT03335813|584671572|FG000|Overall Study|Withdrawal by Subject|1|||
161896896|NCT02793947|584671573|FG000|Overall Study|Death|1|||
161896897|NCT02793947|584671574|FG001|Overall Study|Death|0|||
161896898|NCT02793947|584671573|FG000|Overall Study|Physician Decision|1|||
161896899|NCT02793947|584671574|FG001|Overall Study|Physician Decision|5|||
161896900|NCT02542397|584671575|FG000|Overall Study|Death|2|||
161896901|NCT02542397|584671575|FG000|Overall Study|Physician Decision|6|||
161896902|NCT02542397|584671575|FG000|Overall Study|Withdrawal by Subject|6|||
161896903|NCT02542397|584671575|FG000|Overall Study|Lost to Follow-up|2|||
161896904|NCT02090283|584671578|FG000|Overall Study|Withdrawal by Subject|6|||
161896905|NCT02090283|584671579|FG001|Overall Study|Withdrawal by Subject|6|||
161896906|NCT02090283|584671580|FG002|Overall Study|Withdrawal by Subject|6|||
161896907|NCT02090283|584671578|FG000|Overall Study|Sponsor Terminated Study|6|||
161896908|NCT02090283|584671579|FG001|Overall Study|Sponsor Terminated Study|6|||
161896909|NCT02090283|584671580|FG002|Overall Study|Sponsor Terminated Study|1|||
161896910|NCT02090283|584671578|FG000|Overall Study|Lost to Follow-up|2|||
161896911|NCT02090283|584671579|FG001|Overall Study|Lost to Follow-up|2|||
161896912|NCT02090283|584671580|FG002|Overall Study|Lost to Follow-up|3|||
161896913|NCT02090283|584671578|FG000|Overall Study|Adverse Event|1|||
161896914|NCT02090283|584671579|FG001|Overall Study|Adverse Event|1|||
161896915|NCT02090283|584671580|FG002|Overall Study|Adverse Event|0|||
161896916|NCT02090283|584671578|FG000|Overall Study|Protocol Violation|2|||
161896917|NCT02090283|584671579|FG001|Overall Study|Protocol Violation|0|||
161896918|NCT02090283|584671580|FG002|Overall Study|Protocol Violation|0|||
161896919|NCT00697593|584671582|FG000|Overall Study|Adverse Event|3|||
161896920|NCT00697593|584671582|FG000|Overall Study|Protocol Violation|1|||
161896921|NCT00697593|584671582|FG000|Overall Study|Lack of Efficacy|3|||
161896922|NCT00697593|584671582|FG000|Overall Study|Suspension of the study by sponsor|12|||
161896923|NCT00281697|584671585|FG000|Overall Study|> 60 days since last dose of study drug|4|||
161896924|NCT00281697|584671586|FG001|Overall Study|> 60 days since last dose of study drug|4|||
161896925|NCT00281697|584671585|FG000|Overall Study|Adverse Event|54|||
161896926|NCT00281697|584671586|FG001|Overall Study|Adverse Event|15|||
161896927|NCT00281697|584671585|FG000|Overall Study|Death|8|||
161896928|NCT00281697|584671586|FG001|Overall Study|Death|3|||
161896929|NCT00281697|584671585|FG000|Overall Study|Disease progression|279|||
161896930|NCT00281697|584671586|FG001|Overall Study|Disease progression|149|||
161896931|NCT00281697|584671585|FG000|Overall Study|Other|5|||
161896932|NCT00281697|584671586|FG001|Overall Study|Other|6|||
161896933|NCT00281697|584671585|FG000|Overall Study|Physician's decision to withdraw|15|||
161896934|NCT00281697|584671586|FG001|Overall Study|Physician's decision to withdraw|12|||
161896935|NCT00281697|584671585|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
161896936|NCT00281697|584671586|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
161896937|NCT00281697|584671585|FG000|Overall Study|Did not receive study drug|3|||
161896938|NCT00281697|584671586|FG001|Overall Study|Did not receive study drug|2|||
161896939|NCT00632125|584671587|FG000|Overall Study|Death|82|||
161896940|NCT00632125|584671587|FG000|Overall Study|Withdrawal by Subject|44|||
161896941|NCT00632125|584671587|FG000|Overall Study|Adverse Event|36|||
161896942|NCT00632125|584671587|FG000|Overall Study|Renal transplantation|17|||
161896943|NCT00632125|584671587|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
161896944|NCT00632125|584671587|FG000|Overall Study|Non-compliance|8|||
161896945|NCT00632125|584671587|FG000|Overall Study|Development of uncontrolled hypertension|5|||
161896946|NCT00632125|584671587|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
161896947|NCT00577772|584671590|FG000|Overall Study|Lost to Follow-up|0|||
161896948|NCT00577772|584671591|FG001|Overall Study|Lost to Follow-up|1|||
161896949|NCT00540644|584671595|FG000|Overall Study|Adverse Event|3|||
161896950|NCT00540644|584671596|FG001|Overall Study|Adverse Event|1|||
161896951|NCT00540644|584671595|FG000|Overall Study|Disease Progression|3|||
161896952|NCT00540644|584671596|FG001|Overall Study|Disease Progression|1|||
161896953|NCT00540644|584671595|FG000|Overall Study|Physician Decision|0|||
161896954|NCT00540644|584671596|FG001|Overall Study|Physician Decision|5|||
161896955|NCT00540644|584671595|FG000|Overall Study|Withdrawal by Subject|2|||
161896956|NCT00540644|584671596|FG001|Overall Study|Withdrawal by Subject|2|||
161896957|NCT00540644|584671595|FG000|Overall Study|Noncomplilance|1|||
161896958|NCT00540644|584671596|FG001|Overall Study|Noncomplilance|0|||
161896959|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
161896960|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
161896961|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
161896962|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
161896963|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
161896964|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
161896965|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
161896966|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
161896967|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
161896968|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
161896969|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
161896970|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
161896971|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
161896972|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
161896973|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Death|1|||
161896974|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Death|0|||
161896975|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
161896976|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
161896977|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
161896978|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
161896979|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
161896980|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
161896981|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
161896982|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
161896983|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
161896984|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
161896985|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
161896986|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
161896987|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
161896988|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
161896989|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
161896990|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
161896991|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
161896992|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
161896993|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Death|0|||
161896994|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Death|0|||
161896995|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
161896996|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
161896997|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
161896998|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
161896999|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
161897000|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
161897001|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
161897002|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
161897003|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
161897004|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
161897005|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
161897006|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
161897007|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
161897008|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
161897009|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
161897010|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
161897011|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
161897012|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
161897013|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
161897014|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
161897015|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
161897016|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
161897017|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
161897018|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
161897019|NCT00411450|584671599|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
161897020|NCT01716663|584671600|FG000|Overall Study|Withdrawn prior to procedure|4|||
161897021|NCT01716663|584671600|FG000|Overall Study|Treated with non-study catheter|2|||
161897022|NCT01059773|584671601|FG000|Overall Study|Adverse Event|2|||
161897023|NCT01059773|584671602|FG001|Overall Study|Adverse Event|2|||
161897024|NCT01059773|584671601|FG000|Overall Study|Withdrawal by Subject|1|||
161897025|NCT01059773|584671602|FG001|Overall Study|Withdrawal by Subject|5|||
161897026|NCT01059773|584671601|FG000|Overall Study|Lost to Follow-up|1|||
161897027|NCT01059773|584671602|FG001|Overall Study|Lost to Follow-up|1|||
161897028|NCT01059773|584671601|FG000|Overall Study|Pregnancy|1|||
161897029|NCT01059773|584671602|FG001|Overall Study|Pregnancy|1|||
161897030|NCT01059773|584671601|FG000|Overall Study|Protocol Violation|6|||
161897031|NCT01059773|584671602|FG001|Overall Study|Protocol Violation|2|||
161897032|NCT01059773|584671601|FG000|Overall Study|Physician Decision|5|||
161897033|NCT01059773|584671602|FG001|Overall Study|Physician Decision|4|||
161897034|NCT01059773|584671601|FG000|Overall Study|Lack of Efficacy|3|||
161897035|NCT01059773|584671602|FG001|Overall Study|Lack of Efficacy|3|||
161897036|NCT01059773|584671601|FG000|Overall Study|Death|0|||
161897037|NCT01059773|584671602|FG001|Overall Study|Death|1|||
161897038|NCT01059773|584671601|FG000|Overall Study|Malignancy including squamous cell skin|0|||
161897039|NCT01059773|584671602|FG001|Overall Study|Malignancy including squamous cell skin|1|||
161897040|NCT01059773|584671601|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
161897041|NCT01059773|584671602|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
161897042|NCT01059773|584671601|FG000|Overall Study|Other|1|||
161897043|NCT01059773|584671602|FG001|Overall Study|Other|3|||
161897044|NCT01806168|584671605|FG000|Overall Study|Adverse Event|1|||
161897045|NCT01806168|584671606|FG001|Overall Study|Adverse Event|0|||
161897046|NCT01806168|584671607|FG002|Overall Study|Adverse Event|0|||
161897047|NCT01806168|584671605|FG000|Overall Study|Withdrawal by Subject|0|||
161897048|NCT01806168|584671606|FG001|Overall Study|Withdrawal by Subject|1|||
161897049|NCT01806168|584671607|FG002|Overall Study|Withdrawal by Subject|2|||
161897050|NCT01806168|584671605|FG000|Overall Study|Protocol Violation|0|||
161897051|NCT01806168|584671606|FG001|Overall Study|Protocol Violation|0|||
161897052|NCT01806168|584671607|FG002|Overall Study|Protocol Violation|1|||
161897053|NCT03904420|584671610|FG000|Overall Study|Study terminated|2|||
161897054|NCT03904420|584671611|FG001|Overall Study|Study terminated|2|||
161897055|NCT04435808|584671612|FG000|Overall Study|Study stopped by DSMB|0|||
161897056|NCT04435808|584671613|FG001|Overall Study|Study stopped by DSMB|1|||
161897057|NCT02620787|584671614|FG000|Overall Study|Adverse Event|1|||
161897058|NCT02620787|584671615|FG001|Overall Study|Adverse Event|0|||
161897059|NCT02620787|584671614|FG000|Overall Study|Eligibility Criteria Not Met|1|||
161897060|NCT02620787|584671615|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161897061|NCT02959918|584671617|FG000|Overall Study|Adverse Event|1|||
161897062|NCT02959918|584671618|FG001|Overall Study|Adverse Event|1|||
161897063|NCT02959918|584671619|FG002|Overall Study|Adverse Event|2|||
161897064|NCT02959918|584671620|FG003|Overall Study|Adverse Event|0|||
161897065|NCT02959918|584671621|FG004|Overall Study|Adverse Event|0|||
161897066|NCT02959918|584671622|FG005|Overall Study|Adverse Event|2|||
161897067|NCT02959918|584671623|FG006|Overall Study|Adverse Event|2|||
161897068|NCT02959918|584671624|FG007|Overall Study|Adverse Event|1|||
161897069|NCT02959918|584671625|FG008|Overall Study|Adverse Event|2|||
161897070|NCT02959918|584671626|FG009|Overall Study|Adverse Event|1|||
161897071|NCT02959918|584671627|FG010|Overall Study|Adverse Event|1|||
161897072|NCT02959918|584671628|FG011|Overall Study|Adverse Event|3|||
161897073|NCT02959918|584671629|FG012|Overall Study|Adverse Event|2|||
161897074|NCT02959918|584671630|FG013|Overall Study|Adverse Event|4|||
161897075|NCT02959918|584671617|FG000|Overall Study|Lost to Follow-up|0|||
161897076|NCT02959918|584671618|FG001|Overall Study|Lost to Follow-up|0|||
161897077|NCT02959918|584671619|FG002|Overall Study|Lost to Follow-up|0|||
161897078|NCT02959918|584671620|FG003|Overall Study|Lost to Follow-up|0|||
161897079|NCT02959918|584671621|FG004|Overall Study|Lost to Follow-up|0|||
161897080|NCT02959918|584671622|FG005|Overall Study|Lost to Follow-up|0|||
161897081|NCT02959918|584671623|FG006|Overall Study|Lost to Follow-up|0|||
161897082|NCT02959918|584671624|FG007|Overall Study|Lost to Follow-up|0|||
161897083|NCT02959918|584671625|FG008|Overall Study|Lost to Follow-up|0|||
161897084|NCT02959918|584671626|FG009|Overall Study|Lost to Follow-up|1|||
161897085|NCT02959918|584671627|FG010|Overall Study|Lost to Follow-up|0|||
161897086|NCT02959918|584671628|FG011|Overall Study|Lost to Follow-up|0|||
161552432|NCT02733042|583410436|FG009|Overall Study|Death|0|||
161897087|NCT02959918|584671629|FG012|Overall Study|Lost to Follow-up|1|||
161897088|NCT02959918|584671630|FG013|Overall Study|Lost to Follow-up|0|||
161897089|NCT02959918|584671617|FG000|Overall Study|Withdrawal by Subject|0|||
161897090|NCT02959918|584671618|FG001|Overall Study|Withdrawal by Subject|0|||
161897091|NCT02959918|584671619|FG002|Overall Study|Withdrawal by Subject|1|||
161897092|NCT02959918|584671620|FG003|Overall Study|Withdrawal by Subject|2|||
161552433|NCT02733042|583410437|FG010|Overall Study|Death|1|||
161897093|NCT02959918|584671621|FG004|Overall Study|Withdrawal by Subject|0|||
161897094|NCT02959918|584671622|FG005|Overall Study|Withdrawal by Subject|0|||
161897095|NCT02959918|584671623|FG006|Overall Study|Withdrawal by Subject|1|||
161897096|NCT02959918|584671624|FG007|Overall Study|Withdrawal by Subject|0|||
161897097|NCT02959918|584671625|FG008|Overall Study|Withdrawal by Subject|1|||
161897098|NCT02959918|584671626|FG009|Overall Study|Withdrawal by Subject|1|||
161897099|NCT02959918|584671627|FG010|Overall Study|Withdrawal by Subject|2|||
161897100|NCT02959918|584671628|FG011|Overall Study|Withdrawal by Subject|3|||
161897101|NCT02959918|584671629|FG012|Overall Study|Withdrawal by Subject|1|||
161897102|NCT02959918|584671630|FG013|Overall Study|Withdrawal by Subject|1|||
161897103|NCT02959918|584671617|FG000|Overall Study|Protocol Violation|0|||
161897104|NCT02959918|584671618|FG001|Overall Study|Protocol Violation|0|||
161897105|NCT02959918|584671619|FG002|Overall Study|Protocol Violation|1|||
161897106|NCT02959918|584671620|FG003|Overall Study|Protocol Violation|0|||
161897107|NCT02959918|584671621|FG004|Overall Study|Protocol Violation|0|||
161897108|NCT02959918|584671622|FG005|Overall Study|Protocol Violation|1|||
161897109|NCT02959918|584671623|FG006|Overall Study|Protocol Violation|0|||
161897110|NCT02959918|584671624|FG007|Overall Study|Protocol Violation|0|||
161897111|NCT02959918|584671625|FG008|Overall Study|Protocol Violation|2|||
161897112|NCT02959918|584671626|FG009|Overall Study|Protocol Violation|1|||
161897113|NCT02959918|584671627|FG010|Overall Study|Protocol Violation|0|||
161897114|NCT02959918|584671628|FG011|Overall Study|Protocol Violation|1|||
161897115|NCT02959918|584671629|FG012|Overall Study|Protocol Violation|1|||
161897116|NCT02959918|584671630|FG013|Overall Study|Protocol Violation|0|||
161897117|NCT02959918|584671617|FG000|Overall Study|Stopping Rule Met|1|||
161897118|NCT02959918|584671618|FG001|Overall Study|Stopping Rule Met|0|||
161897119|NCT02959918|584671619|FG002|Overall Study|Stopping Rule Met|3|||
161897120|NCT02959918|584671620|FG003|Overall Study|Stopping Rule Met|4|||
161897121|NCT02959918|584671621|FG004|Overall Study|Stopping Rule Met|5|||
161897122|NCT02959918|584671622|FG005|Overall Study|Stopping Rule Met|3|||
161897123|NCT02959918|584671623|FG006|Overall Study|Stopping Rule Met|2|||
161897124|NCT02959918|584671624|FG007|Overall Study|Stopping Rule Met|4|||
161897125|NCT02959918|584671625|FG008|Overall Study|Stopping Rule Met|1|||
161897126|NCT02959918|584671626|FG009|Overall Study|Stopping Rule Met|1|||
161897127|NCT02959918|584671627|FG010|Overall Study|Stopping Rule Met|3|||
161897128|NCT02959918|584671628|FG011|Overall Study|Stopping Rule Met|5|||
161897129|NCT02959918|584671629|FG012|Overall Study|Stopping Rule Met|2|||
161897130|NCT02959918|584671630|FG013|Overall Study|Stopping Rule Met|1|||
161897131|NCT02959918|584671617|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
161897132|NCT02959918|584671618|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
161897133|NCT02959918|584671619|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
161897134|NCT02959918|584671620|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
161897135|NCT02959918|584671621|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897136|NCT02959918|584671622|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897137|NCT02959918|584671623|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897138|NCT02959918|584671624|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897139|NCT02959918|584671625|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897140|NCT02959918|584671626|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897141|NCT02959918|584671627|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161784144|NCT00123487|584254326|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
161784145|NCT00123487|584254325|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
161784146|NCT00123487|584254326|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
161784147|NCT00423488|584254327|FG000|Overall Study|No evidence of study drug intake|2|||
161784148|NCT00423488|584254328|FG001|Overall Study|No evidence of study drug intake|1|||
161784149|NCT00423488|584254327|FG000|Overall Study|No post baseline data|3|||
161784150|NCT00423488|584254328|FG001|Overall Study|No post baseline data|0|||
161784151|NCT03118765|584254329|FG000|Overall Study|Withdrawal by Subject|0|||
161784152|NCT03118765|584254330|FG001|Overall Study|Withdrawal by Subject|0|||
161784153|NCT03118765|584254331|FG002|Overall Study|Withdrawal by Subject|1|||
161784154|NCT03118765|584254332|FG003|Overall Study|Withdrawal by Subject|0|||
161784155|NCT03118765|584254333|FG004|Overall Study|Withdrawal by Subject|0|||
161784156|NCT03118765|584254329|FG000|Overall Study|Adverse Event|1|||
161784157|NCT03118765|584254330|FG001|Overall Study|Adverse Event|1|||
161784158|NCT03118765|584254331|FG002|Overall Study|Adverse Event|1|||
161784159|NCT03118765|584254332|FG003|Overall Study|Adverse Event|1|||
161784160|NCT03118765|584254333|FG004|Overall Study|Adverse Event|1|||
161784161|NCT03118765|584254329|FG000|Overall Study|Non compliance with Study Procedures|0|||
161784162|NCT03118765|584254330|FG001|Overall Study|Non compliance with Study Procedures|0|||
161784163|NCT03118765|584254331|FG002|Overall Study|Non compliance with Study Procedures|0|||
161784164|NCT03118765|584254332|FG003|Overall Study|Non compliance with Study Procedures|1|||
161784165|NCT03118765|584254333|FG004|Overall Study|Non compliance with Study Procedures|0|||
161897142|NCT02959918|584671628|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897143|NCT02959918|584671629|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897144|NCT02959918|584671630|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897145|NCT02959918|584671617|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897146|NCT02959918|584671618|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897147|NCT02959918|584671619|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897148|NCT02959918|584671620|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897149|NCT02959918|584671621|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897150|NCT02959918|584671622|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897151|NCT02959918|584671623|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897152|NCT02959918|584671624|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
161897153|NCT02959918|584671625|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897154|NCT02959918|584671626|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897155|NCT02959918|584671627|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897156|NCT02959918|584671628|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897157|NCT02959918|584671629|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897158|NCT02959918|584671630|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897159|NCT02959918|584671617|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897160|NCT02959918|584671618|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897161|NCT02959918|584671619|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897162|NCT02959918|584671620|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897163|NCT02959918|584671621|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897164|NCT02959918|584671622|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897165|NCT02959918|584671623|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897166|NCT02959918|584671624|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897167|NCT02959918|584671625|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
161897168|NCT02959918|584671626|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897169|NCT02959918|584671627|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897170|NCT02959918|584671628|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897171|NCT02959918|584671629|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897172|NCT02959918|584671630|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897173|NCT02959918|584671617|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897174|NCT02959918|584671618|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897175|NCT02959918|584671619|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897176|NCT02959918|584671620|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897177|NCT02959918|584671621|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897178|NCT02959918|584671622|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897179|NCT02959918|584671623|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897180|NCT02959918|584671624|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897181|NCT02959918|584671625|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897182|NCT02959918|584671626|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
161897183|NCT02959918|584671627|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897184|NCT02959918|584671628|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897185|NCT02959918|584671629|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897186|NCT02959918|584671630|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897187|NCT03061188|584671632|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
161897188|NCT03061188|584671633|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
161897189|NCT03061188|584671634|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
161897190|NCT03061188|584671635|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
161897191|NCT03061188|584671632|FG000|On Follow-up for 3 Years|Death|0|||
161897192|NCT03061188|584671633|FG001|On Follow-up for 3 Years|Death|3|||
161897193|NCT03061188|584671634|FG002|On Follow-up for 3 Years|Death|5|||
161897194|NCT03061188|584671635|FG003|On Follow-up for 3 Years|Death|4|||
161897195|NCT03061188|584671632|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161897196|NCT03061188|584671633|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161897197|NCT03061188|584671634|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161897198|NCT03061188|584671635|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
161897199|NCT01151345|584671637|FG000|First Intervention Period|Protocol Violation|0|||
161897200|NCT01151345|584671638|FG001|First Intervention Period|Protocol Violation|1|||
161897201|NCT01765569|584671639|FG000|Period B|Withdrawal by Subject|1|||
161897202|NCT01765569|584671639|FG000|Period C|Death|1|||
161897203|NCT05415462|584671640|FG000|Overall Study|Death|18|||
161897204|NCT05415462|584671641|FG001|Overall Study|Death|10|||
161897205|NCT05415462|584671640|FG000|Overall Study|Lost to Follow-up|72|||
161897206|NCT05415462|584671641|FG001|Overall Study|Lost to Follow-up|64|||
161897207|NCT05415462|584671640|FG000|Overall Study|Physician Decision|5|||
161897208|NCT05415462|584671641|FG001|Overall Study|Physician Decision|5|||
161897209|NCT05415462|584671640|FG000|Overall Study|Protocol Deviation|1|||
161897210|NCT05415462|584671641|FG001|Overall Study|Protocol Deviation|0|||
161897211|NCT05415462|584671640|FG000|Overall Study|Withdrawal by Subject|129|||
161897212|NCT05415462|584671641|FG001|Overall Study|Withdrawal by Subject|101|||
161897213|NCT05415462|584671640|FG000|Overall Study|Other Than Specified|8|||
161897214|NCT05415462|584671641|FG001|Overall Study|Other Than Specified|8|||
161897215|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
161897216|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
161897217|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
161897218|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
161897219|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
161897220|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
161897221|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|Death|0|||
161897222|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|Death|1|||
161897223|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|Death|0|||
161897224|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
161897225|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
161897226|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
161897227|NCT01030718|584671642|FG000|Study CA180-036 Only|insufficient effect|1|||
161897228|NCT01030718|584671643|FG001|Study CA180-036 Only|insufficient effect|1|||
161897229|NCT01030718|584671644|FG002|Study CA180-036 Only|insufficient effect|5|||
161897230|NCT01030718|584671642|FG000|Study CA180-036 Only|Adverse Event|2|||
161897231|NCT01030718|584671643|FG001|Study CA180-036 Only|Adverse Event|3|||
161897232|NCT01030718|584671644|FG002|Study CA180-036 Only|Adverse Event|0|||
161897233|NCT01030718|584671642|FG000|Study CA180-036 Only|Death|0|||
161897234|NCT01030718|584671643|FG001|Study CA180-036 Only|Death|1|||
161897235|NCT01030718|584671644|FG002|Study CA180-036 Only|Death|0|||
161897236|NCT01030718|584671642|FG000|Study CA180-036 Only|Other Reasons|0|||
161897237|NCT01030718|584671643|FG001|Study CA180-036 Only|Other Reasons|2|||
161897238|NCT01030718|584671644|FG002|Study CA180-036 Only|Other Reasons|0|||
161897239|NCT00423813|584671645|FG000|Overall Study|Adverse Event|11|||
161897240|NCT00423813|584671646|FG001|Overall Study|Adverse Event|30|||
161897241|NCT00423813|584671647|FG002|Overall Study|Adverse Event|40|||
161897242|NCT00423813|584671645|FG000|Overall Study|Withdrawal by Subject|6|||
161897243|NCT00423813|584671646|FG001|Overall Study|Withdrawal by Subject|8|||
161897244|NCT00423813|584671647|FG002|Overall Study|Withdrawal by Subject|5|||
161897245|NCT00423813|584671645|FG000|Overall Study|Lost to Follow-up|5|||
161897246|NCT00423813|584671646|FG001|Overall Study|Lost to Follow-up|4|||
161897247|NCT00423813|584671647|FG002|Overall Study|Lost to Follow-up|4|||
161897248|NCT00423813|584671645|FG000|Overall Study|Lack of Efficacy|23|||
161897249|NCT00423813|584671646|FG001|Overall Study|Lack of Efficacy|18|||
161897250|NCT00423813|584671647|FG002|Overall Study|Lack of Efficacy|19|||
161897251|NCT00423813|584671645|FG000|Overall Study|Physician Decision|2|||
161897252|NCT00423813|584671646|FG001|Overall Study|Physician Decision|0|||
161897253|NCT00423813|584671647|FG002|Overall Study|Physician Decision|0|||
161897254|NCT00423813|584671645|FG000|Overall Study|Sponsor Decision|0|||
161897255|NCT00423813|584671646|FG001|Overall Study|Sponsor Decision|1|||
161897256|NCT00423813|584671647|FG002|Overall Study|Sponsor Decision|0|||
161897257|NCT00423813|584671645|FG000|Overall Study|Protocol Violation|9|||
161897258|NCT00423813|584671646|FG001|Overall Study|Protocol Violation|4|||
161897259|NCT00423813|584671647|FG002|Overall Study|Protocol Violation|4|||
161897260|NCT00423813|584671645|FG000|Overall Study|Pregnancy|0|||
161897261|NCT00423813|584671646|FG001|Overall Study|Pregnancy|0|||
161897262|NCT00423813|584671647|FG002|Overall Study|Pregnancy|1|||
161897263|NCT00423813|584671645|FG000|Overall Study|Subject started night shift work|1|||
161897264|NCT00423813|584671646|FG001|Overall Study|Subject started night shift work|0|||
161897265|NCT00423813|584671647|FG002|Overall Study|Subject started night shift work|0|||
161897266|NCT00423813|584671645|FG000|Overall Study|Will start exclusionary medications|0|||
161897267|NCT00423813|584671646|FG001|Overall Study|Will start exclusionary medications|1|||
161897268|NCT00423813|584671647|FG002|Overall Study|Will start exclusionary medications|0|||
161897269|NCT00423813|584671645|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
161897270|NCT00423813|584671646|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
161897271|NCT00423813|584671647|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
161897272|NCT01904032|584671655|FG000|Overall Study|Adverse Event|3|||
161897273|NCT01904032|584671656|FG001|Overall Study|Adverse Event|1|||
161897274|NCT01904032|584671655|FG000|Overall Study|Lost to Follow-up|4|||
161897275|NCT01904032|584671656|FG001|Overall Study|Lost to Follow-up|2|||
161897276|NCT01658904|584671657|FG000|Overall Study|Principal Investigator discretion|2|||
161897277|NCT01658904|584671658|FG001|Overall Study|Principal Investigator discretion|0|||
161897278|NCT01658904|584671659|FG002|Overall Study|Principal Investigator discretion|0|||
161897279|NCT02998996|584671662|FG000|Overall Study|Lost to Follow-up|0|||
161897280|NCT02998996|584671663|FG001|Overall Study|Lost to Follow-up|0|||
161897281|NCT02998996|584671664|FG002|Overall Study|Lost to Follow-up|1|||
161897282|NCT02998996|584671665|FG003|Overall Study|Lost to Follow-up|0|||
161897283|NCT02998996|584671666|FG004|Overall Study|Lost to Follow-up|0|||
161897284|NCT02998996|584671667|FG005|Overall Study|Lost to Follow-up|0|||
161897285|NCT02998996|584671662|FG000|Overall Study|Pregnancy|0|||
161897286|NCT02998996|584671663|FG001|Overall Study|Pregnancy|1|||
161897287|NCT02998996|584671664|FG002|Overall Study|Pregnancy|0|||
161897288|NCT02998996|584671665|FG003|Overall Study|Pregnancy|0|||
161897289|NCT02998996|584671666|FG004|Overall Study|Pregnancy|0|||
161897290|NCT02998996|584671667|FG005|Overall Study|Pregnancy|0|||
161897291|NCT02998996|584671662|FG000|Overall Study|Family reasons|0|||
161897292|NCT02998996|584671663|FG001|Overall Study|Family reasons|0|||
161897293|NCT02998996|584671664|FG002|Overall Study|Family reasons|0|||
161897294|NCT02998996|584671665|FG003|Overall Study|Family reasons|0|||
161897295|NCT02998996|584671666|FG004|Overall Study|Family reasons|1|||
161897296|NCT02998996|584671667|FG005|Overall Study|Family reasons|0|||
161897297|NCT01087203|584671668|FG000|Overall Study|Lost to Follow-up|2|||
161897298|NCT01087203|584671669|FG001|Overall Study|Lost to Follow-up|0|||
161897299|NCT01087203|584671668|FG000|Overall Study|Withdrawal by Subject|2|||
161897300|NCT01087203|584671669|FG001|Overall Study|Withdrawal by Subject|6|||
161897301|NCT01087203|584671668|FG000|Overall Study|Lack of Efficacy|1|||
161897302|NCT01087203|584671669|FG001|Overall Study|Lack of Efficacy|2|||
161897303|NCT01087203|584671668|FG000|Overall Study|Study terminated by sponsor|27|||
161897304|NCT01087203|584671669|FG001|Overall Study|Study terminated by sponsor|27|||
161897305|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
161897306|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
161897307|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
161897308|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
161897309|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
161897310|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
161897311|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
161897312|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
161897313|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
161897314|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
161897315|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897316|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897317|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897318|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
161897319|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897320|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897321|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
161897322|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897323|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897324|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897325|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897326|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897327|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
161897328|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897329|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897330|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897331|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897332|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897333|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897334|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897335|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897336|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897337|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897338|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897339|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897340|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
161897341|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897342|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
161897343|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897344|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897345|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897346|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897347|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897348|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897349|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
161897350|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897351|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897352|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897353|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897354|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897355|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897356|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897357|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897358|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897359|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897360|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897361|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897362|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897363|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897364|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897365|NCT04074330|584671673|FG000|Dose Expansion (up to 42 Months)|Death|0|||
161897366|NCT04074330|584671674|FG001|Dose Expansion (up to 42 Months)|Death|0|||
161897367|NCT04074330|584671675|FG002|Dose Expansion (up to 42 Months)|Death|0|||
161897368|NCT04074330|584671676|FG003|Dose Expansion (up to 42 Months)|Death|0|||
161897369|NCT04074330|584671677|FG004|Dose Expansion (up to 42 Months)|Death|0|||
161897370|NCT04074330|584671678|FG005|Dose Expansion (up to 42 Months)|Death|0|||
161897371|NCT04074330|584671679|FG006|Dose Expansion (up to 42 Months)|Death|0|||
161897372|NCT04074330|584671680|FG007|Dose Expansion (up to 42 Months)|Death|0|||
161897373|NCT04074330|584671681|FG008|Dose Expansion (up to 42 Months)|Death|1|||
161897374|NCT04074330|584671682|FG009|Dose Expansion (up to 42 Months)|Death|0|||
161897375|NCT04074330|584671673|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897376|NCT04074330|584671674|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897377|NCT04074330|584671675|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897378|NCT04074330|584671676|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897379|NCT04074330|584671677|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897380|NCT04074330|584671678|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897381|NCT04074330|584671679|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897382|NCT04074330|584671680|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897383|NCT04074330|584671681|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
161897384|NCT04074330|584671682|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
161897385|NCT01429298|584671687|FG000|Overall Study|Protocol Violation|4|||
161897386|NCT01429298|584671688|FG001|Overall Study|Protocol Violation|6|||
161897387|NCT02903420|584671689|FG000|Overall Study|Death|3|||
161897388|NCT00181883|584671692|FG000|Overall Study|Lack of Efficacy|2|||
161897389|NCT00181883|584671692|FG000|Overall Study|Treatment Limiting AEs|3|||
161897390|NCT00181883|584671692|FG000|Overall Study|Withdrawal by Subject|4|||
161897391|NCT00181883|584671692|FG000|Overall Study|Lost to Follow-up|1|||
161897392|NCT05305989|584671693|FG000|Overall Study|Other|3|||
161897393|NCT05305989|584671694|FG001|Overall Study|Other|2|||
161897394|NCT05305989|584671695|FG002|Overall Study|Other|0|||
161897395|NCT05305989|584671693|FG000|Overall Study|Sponsor decision|2|||
161897396|NCT05305989|584671694|FG001|Overall Study|Sponsor decision|1|||
161897397|NCT05305989|584671695|FG002|Overall Study|Sponsor decision|0|||
161897398|NCT05305989|584671693|FG000|Overall Study|Protocol Violation|0|||
161897399|NCT05305989|584671694|FG001|Overall Study|Protocol Violation|1|||
161897400|NCT05305989|584671695|FG002|Overall Study|Protocol Violation|0|||
161897401|NCT05305989|584671693|FG000|Overall Study|Investigator decision|1|||
161897402|NCT05305989|584671694|FG001|Overall Study|Investigator decision|2|||
161897403|NCT05305989|584671695|FG002|Overall Study|Investigator decision|0|||
161897404|NCT05305989|584671693|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
161897405|NCT05305989|584671694|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
161897406|NCT05305989|584671695|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
161897407|NCT05305989|584671693|FG000|Overall Study|Adverse Event|1|||
161897408|NCT05305989|584671694|FG001|Overall Study|Adverse Event|1|||
161897409|NCT05305989|584671695|FG002|Overall Study|Adverse Event|0|||
161897410|NCT05305989|584671693|FG000|Overall Study|Enrolled but never dosed|3|||
161897411|NCT05305989|584671694|FG001|Overall Study|Enrolled but never dosed|2|||
161897412|NCT05305989|584671695|FG002|Overall Study|Enrolled but never dosed|1|||
161897413|NCT03162328|584671696|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
161897414|NCT03162328|584671697|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
161897415|NCT03162328|584671698|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
161897416|NCT03162328|584671696|FG000|Screening Period|Withdrawal by Subject|1|||
161897417|NCT03162328|584671697|FG001|Screening Period|Withdrawal by Subject|0|||
161897418|NCT03162328|584671698|FG002|Screening Period|Withdrawal by Subject|0|||
161897419|NCT03162328|584671696|FG000|Study Period|Withdrawal by Subject|0|||
161897420|NCT03162328|584671697|FG001|Study Period|Withdrawal by Subject|0|||
161552434|NCT02733042|583410438|FG011|Overall Study|Death|0|||
161897421|NCT03162328|584671698|FG002|Study Period|Withdrawal by Subject|1|||
161897422|NCT00913770|584671699|FG000|Overall Study|Unable to contact|24|||
161897423|NCT00913770|584671700|FG001|Overall Study|Unable to contact|19|||
161897424|NCT00913770|584671701|FG002|Overall Study|Unable to contact|13|||
161897425|NCT00913770|584671699|FG000|Overall Study|Refused|11|||
161897426|NCT00913770|584671700|FG001|Overall Study|Refused|10|||
161897427|NCT00913770|584671701|FG002|Overall Study|Refused|8|||
161897428|NCT01066871|584671703|FG000|Overall Study|Lost to Follow-up|0|||
161897429|NCT01066871|584671704|FG001|Overall Study|Lost to Follow-up|2|||
161897430|NCT01066871|584671705|FG002|Overall Study|Lost to Follow-up|2|||
161897431|NCT01066871|584671706|FG003|Overall Study|Lost to Follow-up|0|||
161897432|NCT01066871|584671703|FG000|Overall Study|Protocol Violation|1|||
161897433|NCT01066871|584671704|FG001|Overall Study|Protocol Violation|0|||
161897434|NCT01066871|584671705|FG002|Overall Study|Protocol Violation|3|||
161897435|NCT01066871|584671706|FG003|Overall Study|Protocol Violation|2|||
161897436|NCT01066871|584671703|FG000|Overall Study|Lack of Efficacy|0|||
161897437|NCT01066871|584671704|FG001|Overall Study|Lack of Efficacy|0|||
161897438|NCT01066871|584671705|FG002|Overall Study|Lack of Efficacy|0|||
161897439|NCT01066871|584671706|FG003|Overall Study|Lack of Efficacy|1|||
161897440|NCT01066871|584671703|FG000|Overall Study|Withdrawal by Subject|3|||
161897441|NCT01066871|584671704|FG001|Overall Study|Withdrawal by Subject|1|||
161897442|NCT01066871|584671705|FG002|Overall Study|Withdrawal by Subject|0|||
161897443|NCT01066871|584671706|FG003|Overall Study|Withdrawal by Subject|0|||
161897444|NCT01066871|584671703|FG000|Overall Study|Other|0|||
161897445|NCT01066871|584671704|FG001|Overall Study|Other|2|||
161897446|NCT01066871|584671705|FG002|Overall Study|Other|1|||
161897447|NCT01066871|584671706|FG003|Overall Study|Other|2|||
161897448|NCT03373461|584671712|FG000|Part 2|Adverse Event|0|||
161897449|NCT03373461|584671713|FG001|Part 2|Adverse Event|1|||
161897450|NCT03373461|584671714|FG002|Part 2|Adverse Event|0|||
161897451|NCT03373461|584671715|FG003|Part 2|Adverse Event|0|||
161897452|NCT03373461|584671716|FG004|Part 2|Adverse Event|1|||
161897453|NCT01366638|584671717|FG000|Overall Study|Withdrawal by Subject|0|||
161897454|NCT01366638|584671718|FG001|Overall Study|Withdrawal by Subject|0|||
161897455|NCT01366638|584671719|FG002|Overall Study|Withdrawal by Subject|6|||
161897456|NCT01366638|584671717|FG000|Overall Study|Other|1|||
161897457|NCT01366638|584671718|FG001|Overall Study|Other|0|||
161897458|NCT01366638|584671719|FG002|Overall Study|Other|0|||
161897459|NCT01554163|584671721|FG000|Overall Study|Adverse Event|3|||
161897460|NCT01554163|584671722|FG001|Overall Study|Adverse Event|0|||
161897461|NCT01554163|584671721|FG000|Overall Study|Lack of Efficacy|1|||
161897462|NCT01554163|584671722|FG001|Overall Study|Lack of Efficacy|0|||
161897463|NCT01554163|584671721|FG000|Overall Study|Lost to Follow-up|1|||
161897464|NCT01554163|584671722|FG001|Overall Study|Lost to Follow-up|0|||
161897465|NCT01554163|584671721|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161897466|NCT01554163|584671722|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161897467|NCT01554163|584671721|FG000|Overall Study|Protocol Violation|0|||
161897468|NCT01554163|584671722|FG001|Overall Study|Protocol Violation|4|||
161897469|NCT01554163|584671721|FG000|Overall Study|Withdrawal by Subject|1|||
161897470|NCT01554163|584671722|FG001|Overall Study|Withdrawal by Subject|5|||
161897471|NCT01554163|584671721|FG000|Overall Study|Not Treated|1|||
161897472|NCT01554163|584671722|FG001|Overall Study|Not Treated|0|||
161897473|NCT01941537|584671723|FG000|Overall Study|Lack of Efficacy|1|||
161897474|NCT01941537|584671724|FG001|Overall Study|Lack of Efficacy|2|||
161897475|NCT01941537|584671723|FG000|Overall Study|Lost to Follow-up|1|||
161897476|NCT01941537|584671724|FG001|Overall Study|Lost to Follow-up|0|||
161897477|NCT01941537|584671723|FG000|Overall Study|Pregnancy|1|||
161897478|NCT01941537|584671724|FG001|Overall Study|Pregnancy|0|||
161897479|NCT01941537|584671723|FG000|Overall Study|Adverse Event|1|||
161897480|NCT01941537|584671724|FG001|Overall Study|Adverse Event|0|||
161897481|NCT01941537|584671723|FG000|Overall Study|Withdrawal by Subject|0|||
161897482|NCT01941537|584671724|FG001|Overall Study|Withdrawal by Subject|1|||
161897483|NCT02634983|584671726|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
161897484|NCT02634983|584671727|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
161897485|NCT02315664|584673362|FG000|Overall Study|Lost to Follow-up|1|||
161897486|NCT02315664|584673363|FG001|Overall Study|Lost to Follow-up|1|||
161897487|NCT02315664|584673362|FG000|Overall Study|Withdrawal by Subject|0|||
161897488|NCT02315664|584673363|FG001|Overall Study|Withdrawal by Subject|3|||
161897489|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
161897490|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
161897491|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
161897492|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
161897493|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161897494|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161897495|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
161897496|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
161897497|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161897498|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161897499|NCT00667992|584673364|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
161784166|NCT03118765|584254329|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161784167|NCT03118765|584254330|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
161784168|NCT03118765|584254331|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
161784169|NCT03118765|584254332|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161784170|NCT03118765|584254333|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161784171|NCT03118765|584254329|FG000|Overall Study|COPD Exacerbation|1|||
161784172|NCT03118765|584254330|FG001|Overall Study|COPD Exacerbation|0|||
161784173|NCT03118765|584254331|FG002|Overall Study|COPD Exacerbation|0|||
161784174|NCT03118765|584254332|FG003|Overall Study|COPD Exacerbation|1|||
161784175|NCT03118765|584254333|FG004|Overall Study|COPD Exacerbation|0|||
161784176|NCT03118765|584254329|FG000|Overall Study|Lost to Follow-up|1|||
161784177|NCT03118765|584254330|FG001|Overall Study|Lost to Follow-up|0|||
161784178|NCT03118765|584254331|FG002|Overall Study|Lost to Follow-up|1|||
161784179|NCT03118765|584254332|FG003|Overall Study|Lost to Follow-up|0|||
161784180|NCT03118765|584254333|FG004|Overall Study|Lost to Follow-up|0|||
161784181|NCT03118765|584254329|FG000|Overall Study|Sponsor Decision|1|||
161784182|NCT03118765|584254330|FG001|Overall Study|Sponsor Decision|0|||
161784183|NCT03118765|584254331|FG002|Overall Study|Sponsor Decision|1|||
161784184|NCT03118765|584254332|FG003|Overall Study|Sponsor Decision|0|||
161784185|NCT03118765|584254333|FG004|Overall Study|Sponsor Decision|1|||
161784186|NCT03070431|584254336|FG000|Overall Study|Withdrawal by Subject|2|||
161784187|NCT03070431|584254336|FG000|Overall Study|Lost to Follow-up|2|||
161784188|NCT00995488|584254342|FG000|Overall Study|Withdrawal by Subject|1|||
161784189|NCT01656967|584254343|FG000|Overall Study|faulty monitor|1|||
161784190|NCT01656967|584254344|FG001|Overall Study|faulty monitor|0|||
161784191|NCT01656967|584254343|FG000|Overall Study|unsuccessful ETT insertion|3|||
161784192|NCT01656967|584254344|FG001|Overall Study|unsuccessful ETT insertion|2|||
161784193|NCT00833976|584255362|FG000|Overall Study|Withdrawal by Subject|5|||
161784194|NCT00833976|584255362|FG000|Overall Study|Lost to Follow-up|4|||
161784195|NCT00833976|584255362|FG000|Overall Study|Did not meet eligibility criteria|41|||
161784196|NCT00833976|584255362|FG000|Overall Study|Physician Decision|1|||
161784197|NCT01246973|584255367|FG000|Overall Study|Other|38|||
161784198|NCT01246973|584255368|FG001|Overall Study|Other|25|||
161784199|NCT01246973|584255367|FG000|Overall Study|Adverse Event|16|||
161784200|NCT01246973|584255368|FG001|Overall Study|Adverse Event|9|||
161784201|NCT01246973|584255367|FG000|Overall Study|Withdrawal by Subject|7|||
161784202|NCT01246973|584255368|FG001|Overall Study|Withdrawal by Subject|13|||
161784203|NCT02598622|584255369|FG000|Overall Study|Withdrawal by Subject|3|||
161784204|NCT02598622|584255370|FG001|Overall Study|Withdrawal by Subject|0|||
161784205|NCT02598622|584255369|FG000|Overall Study|Physician Decision|3|||
161784206|NCT02598622|584255370|FG001|Overall Study|Physician Decision|0|||
161784207|NCT00681824|584255374|FG000|Overall Study|withdrawn by investigator|0|||
161784208|NCT00681824|584255375|FG001|Overall Study|withdrawn by investigator|0|||
161784209|NCT00681824|584255376|FG002|Overall Study|withdrawn by investigator|1|||
161784210|NCT00681824|584255374|FG000|Overall Study|scheduling conflict|1|||
161784211|NCT00681824|584255375|FG001|Overall Study|scheduling conflict|0|||
161784212|NCT00681824|584255376|FG002|Overall Study|scheduling conflict|0|||
161784213|NCT00681824|584255374|FG000|Overall Study|Death|0|||
161784214|NCT00681824|584255375|FG001|Overall Study|Death|1|||
161784215|NCT00681824|584255376|FG002|Overall Study|Death|0|||
161784216|NCT03724916|584255377|FG000|Overall Study|Withdrawal by Subject|0|||
161784217|NCT03724916|584255378|FG001|Overall Study|Withdrawal by Subject|1|||
161784218|NCT03724916|584255379|FG002|Overall Study|Withdrawal by Subject|1|||
161784219|NCT03724916|584255380|FG003|Overall Study|Withdrawal by Subject|2|||
161784220|NCT03724916|584255377|FG000|Overall Study|Randomized but not Treated|1|||
161784221|NCT03724916|584255378|FG001|Overall Study|Randomized but not Treated|0|||
161784222|NCT03724916|584255379|FG002|Overall Study|Randomized but not Treated|0|||
161784223|NCT03724916|584255380|FG003|Overall Study|Randomized but not Treated|0|||
161784224|NCT04575038|584255381|FG000|Overall Study|Withdrawal by Subject|1|||
161784225|NCT04575038|584255382|FG001|Overall Study|Withdrawal by Subject|1|||
161784226|NCT03101293|584255391|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
161784227|NCT03101293|584255392|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
161784228|NCT04388527|584255394|FG000|Overall Study|Death|14|||
161784229|NCT04388527|584255394|FG000|Overall Study|Withdrawal by Subject|2|||
161784230|NCT04388527|584255394|FG000|Overall Study|Lost to Follow-up|1|||
161784231|NCT03333382|584255395|FG000|Overall Study|Lost to Follow-up|1|||
161784232|NCT03333382|584255396|FG001|Overall Study|Lost to Follow-up|0|||
161784233|NCT03471182|584255397|FG000|Overall Study|Withdrawal by Subject|1|||
161784234|NCT03471182|584255398|FG001|Overall Study|Withdrawal by Subject|1|||
161784235|NCT03471182|584255399|FG002|Overall Study|Withdrawal by Subject|0|||
161784236|NCT03471182|584255397|FG000|Overall Study|Technical failure|2|||
161784237|NCT03471182|584255398|FG001|Overall Study|Technical failure|0|||
161784238|NCT03471182|584255399|FG002|Overall Study|Technical failure|0|||
161784239|NCT00331773|584255403|FG000|Overall Study|Withdrawal by Subject|6|||
161784240|NCT00331773|584255404|FG001|Overall Study|Withdrawal by Subject|4|||
161784241|NCT00331773|584255403|FG000|Overall Study|Protocol Violation|10|||
161552435|NCT02733042|583410439|FG012|Overall Study|Death|0|||
161784242|NCT00331773|584255404|FG001|Overall Study|Protocol Violation|3|||
161897500|NCT00667992|584673365|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
161897501|NCT00667992|584673364|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
161897502|NCT00667992|584673365|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
161897503|NCT00667992|584673364|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
161897504|NCT00667992|584673365|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
161897505|NCT00667992|584673364|FG000|Wash-out|Not within one doubling dilution|4|||
161897506|NCT00667992|584673365|FG001|Wash-out|Not within one doubling dilution|3|||
161897507|NCT00667992|584673364|FG000|Wash-out|Failure to wash-out|2|||
161897508|NCT00667992|584673365|FG001|Wash-out|Failure to wash-out|2|||
161897509|NCT00667992|584673364|FG000|Wash-out|Withdrawal by Subject|1|||
161897510|NCT00667992|584673365|FG001|Wash-out|Withdrawal by Subject|0|||
161897511|NCT00667992|584673364|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
161897512|NCT00667992|584673365|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
161897513|NCT00667992|584673364|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161897514|NCT00667992|584673365|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161897515|NCT00762762|584673369|FG000|Overall Study|Did not return for appointments|6|||
161897516|NCT00762762|584673370|FG001|Overall Study|Did not return for appointments|8|||
161897517|NCT02964338|584673373|FG000|Overall Study|Sponsor terminated study for futility|12|||
161897518|NCT02964338|584673374|FG001|Overall Study|Sponsor terminated study for futility|15|||
161897519|NCT02964338|584673375|FG002|Overall Study|Sponsor terminated study for futility|14|||
161897520|NCT02964338|584673373|FG000|Overall Study|Lack of Efficacy|0|||
161897521|NCT02964338|584673374|FG001|Overall Study|Lack of Efficacy|3|||
161897522|NCT02964338|584673375|FG002|Overall Study|Lack of Efficacy|0|||
161897523|NCT02964338|584673373|FG000|Overall Study|Lost to Follow-up|1|||
161897524|NCT02964338|584673374|FG001|Overall Study|Lost to Follow-up|0|||
161897525|NCT02964338|584673375|FG002|Overall Study|Lost to Follow-up|3|||
161897526|NCT02964338|584673373|FG000|Overall Study|Protocol Violation|0|||
161897527|NCT02964338|584673374|FG001|Overall Study|Protocol Violation|1|||
161897528|NCT02964338|584673375|FG002|Overall Study|Protocol Violation|0|||
161897529|NCT02964338|584673373|FG000|Overall Study|Withdrawal by Subject|1|||
161897530|NCT02964338|584673374|FG001|Overall Study|Withdrawal by Subject|3|||
161897531|NCT02964338|584673375|FG002|Overall Study|Withdrawal by Subject|1|||
161897532|NCT02964338|584673373|FG000|Overall Study|Adverse Event|2|||
161897533|NCT02964338|584673374|FG001|Overall Study|Adverse Event|1|||
161897534|NCT02964338|584673375|FG002|Overall Study|Adverse Event|1|||
161897535|NCT02964338|584673373|FG000|Overall Study|Non-compliant with e-diary|0|||
161897536|NCT02964338|584673374|FG001|Overall Study|Non-compliant with e-diary|1|||
161897537|NCT02964338|584673375|FG002|Overall Study|Non-compliant with e-diary|0|||
161897538|NCT02964338|584673373|FG000|Overall Study|Did not meet criteria|1|||
161897539|NCT02964338|584673374|FG001|Overall Study|Did not meet criteria|0|||
161897540|NCT02964338|584673375|FG002|Overall Study|Did not meet criteria|0|||
161897541|NCT03872843|584673376|FG000|Overall Study|Lost to Follow-up|5|||
161897542|NCT03872843|584673377|FG001|Overall Study|Lost to Follow-up|7|||
161897543|NCT02609386|584673378|FG000|Overall Study|Withdrawal by Subject|6|||
161897544|NCT02609386|584673379|FG001|Overall Study|Withdrawal by Subject|1|||
161897545|NCT02609386|584673378|FG000|Overall Study|Lost to Follow-up|3|||
161897546|NCT02609386|584673379|FG001|Overall Study|Lost to Follow-up|5|||
161897547|NCT02609386|584673378|FG000|Overall Study|Death|19|||
161897548|NCT02609386|584673379|FG001|Overall Study|Death|9|||
161897549|NCT02609386|584673378|FG000|Overall Study|Physician Decision|0|||
161897550|NCT02609386|584673379|FG001|Overall Study|Physician Decision|2|||
161897551|NCT00610168|584673380|FG000|Overall Study|Withdrawal by Subject|2|||
161897552|NCT00610168|584673381|FG001|Overall Study|Withdrawal by Subject|0|||
161897553|NCT01029262|584673385|FG000|Overall Study|Adverse Event|9|||
161897554|NCT01029262|584673386|FG001|Overall Study|Adverse Event|52|||
161897555|NCT01029262|584673385|FG000|Overall Study|Lack of therapeutic effect|57|||
161897556|NCT01029262|584673386|FG001|Overall Study|Lack of therapeutic effect|76|||
161897557|NCT01029262|584673385|FG000|Overall Study|Withdrawal by Subject|10|||
161897558|NCT01029262|584673386|FG001|Overall Study|Withdrawal by Subject|17|||
161897559|NCT01029262|584673385|FG000|Overall Study|Protocol Violation|2|||
161897560|NCT01029262|584673386|FG001|Overall Study|Protocol Violation|3|||
161897561|NCT01029262|584673385|FG000|Overall Study|Miscellaneous|1|||
161897562|NCT01029262|584673386|FG001|Overall Study|Miscellaneous|9|||
161897563|NCT01029262|584673385|FG000|Overall Study|Death|0|||
161897564|NCT01029262|584673386|FG001|Overall Study|Death|3|||
161897565|NCT01468454|584673387|FG000|Overall Study|Did not have surgery after PET|9|||
161897566|NCT02896569|584673389|FG000|Overall Study|Lost to Follow-up|2|||
161897567|NCT02896569|584673390|FG001|Overall Study|Lost to Follow-up|1|||
161897568|NCT02896569|584673389|FG000|Overall Study|Physician Decision|1|||
161897569|NCT02896569|584673390|FG001|Overall Study|Physician Decision|3|||
161897570|NCT02896569|584673389|FG000|Overall Study|Adverse Event|0|||
161897571|NCT02896569|584673390|FG001|Overall Study|Adverse Event|1|||
161897572|NCT02896569|584673389|FG000|Overall Study|Withdrawal by Subject|1|||
161897573|NCT02896569|584673390|FG001|Overall Study|Withdrawal by Subject|0|||
161897574|NCT01462630|584673391|FG000|Overall Study|Did not initiate therapy|3|||
161784243|NCT00289731|584255405|FG000|Overall Study|Adverse Event|1|||
161784244|NCT00289731|584255406|FG001|Overall Study|Adverse Event|2|||
161784245|NCT00289731|584255407|FG002|Overall Study|Adverse Event|2|||
161784246|NCT00289731|584255405|FG000|Overall Study|Other|1|||
161784247|NCT00289731|584255406|FG001|Overall Study|Other|0|||
161784248|NCT00289731|584255407|FG002|Overall Study|Other|0|||
161784249|NCT02513459|584255408|FG000|Overall Study|Adverse Event|7|||
161784250|NCT02513459|584255408|FG000|Overall Study|Withdrew consent|5|||
161784251|NCT02513459|584255408|FG000|Overall Study|Loss of efficacy|2|||
161784252|NCT02513459|584255408|FG000|Overall Study|Pregnancy|2|||
161784253|NCT02513459|584255408|FG000|Overall Study|Subject decision|2|||
161784254|NCT02513459|584255408|FG000|Overall Study|Lack of response|1|||
161784255|NCT02513459|584255408|FG000|Overall Study|Reproductive plans|1|||
161784256|NCT02513459|584255408|FG000|Overall Study|Surgery planned-- not done|1|||
161784257|NCT00923195|584255409|FG000|Overall Study|Death|0|||
161784258|NCT00923195|584255410|FG001|Overall Study|Death|1|||
161784259|NCT00525031|584255411|FG000|Overall Study|Disease Progression|1|||
161784260|NCT00525031|584255412|FG001|Overall Study|Disease Progression|1|||
161784261|NCT00787566|584255415|FG000|Overall Study|AE related to chemotherapy|0|||
161784262|NCT00787566|584255416|FG001|Overall Study|AE related to chemotherapy|1|||
161784263|NCT00787566|584255417|FG002|Overall Study|AE related to chemotherapy|0|||
161784264|NCT02140164|584255418|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
161784265|NCT01814761|584255419|FG000|Overall Study|Other Reasons|1|||
161784266|NCT01814761|584255420|FG001|Overall Study|Other Reasons|10|||
161784267|NCT01814761|584255419|FG000|Overall Study|Ocular Adverse Event|6|||
161784268|NCT01814761|584255420|FG001|Overall Study|Ocular Adverse Event|15|||
161784269|NCT01814761|584255419|FG000|Overall Study|Lost to Follow-up|1|||
161784270|NCT01814761|584255420|FG001|Overall Study|Lost to Follow-up|5|||
161784271|NCT00775983|584255421|FG000|Overall Study|Protocol Violation|1|||
161784272|NCT00775983|584255422|FG001|Overall Study|Protocol Violation|2|||
161784273|NCT00660790|584255431|FG000|Baseline to 3 Months|Death|1|||
161784274|NCT00660790|584255431|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
161784275|NCT00660790|584255431|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
161784276|NCT00686374|584255436|FG000|Overall Study|Lack of Efficacy|10|||
161784277|NCT00686374|584255436|FG000|Overall Study|Adverse Event|8|||
161784278|NCT00686374|584255436|FG000|Overall Study|Withdrew consent|5|||
161784279|NCT00686374|584255436|FG000|Overall Study|Lost to Follow-up|1|||
161784280|NCT00686374|584255436|FG000|Overall Study|Missing reason|33|||
161784281|NCT00686374|584255436|FG000|Overall Study|Other, not specified|4|||
161784282|NCT02643966|584255438|FG000|First Screening Round|ineligible|1|||
161784283|NCT02643966|584255438|FG000|First Screening Round|excluded from analysis|2|||
161784284|NCT02643966|584255438|FG000|First Screening Round|Lost to Follow-up|56|||
161784285|NCT02643966|584255438|FG000|First Screening Round|Withdrawal by Subject|28|||
161784286|NCT02643966|584255438|FG000|First Screening Round|Death|1|||
161784287|NCT02643966|584255438|FG000|Between First and Second Screening|Lost to Follow-up|65|||
161784288|NCT02643966|584255438|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
161784289|NCT02643966|584255438|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
161784290|NCT02643966|584255438|FG000|Second Screening Round|Withdrawal by Subject|20|||
161784291|NCT02643966|584255438|FG000|Second Screening Round|Lost to Follow-up|57|||
161784292|NCT02643966|584255438|FG000|Second Screening Round|Physician Decision|2|||
161784293|NCT02643966|584255438|FG000|Second Screening Round|Death|4|||
161784294|NCT02643966|584255438|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
161784295|NCT02643966|584255438|FG000|Between Second and Third Screening|Death|1|||
161784296|NCT02643966|584255438|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
161784297|NCT02643966|584255438|FG000|Third Screening Round|PI excluded|2|||
161784298|NCT02643966|584255438|FG000|Third Screening Round|Lost to Follow-up|241|||
161784299|NCT01493531|584255439|FG000|Overall Study|Adverse Event|4|||
161784300|NCT01493531|584255440|FG001|Overall Study|Adverse Event|12|||
161784301|NCT01493531|584255441|FG002|Overall Study|Adverse Event|9|||
161784302|NCT01493531|584255439|FG000|Overall Study|Gout flare|3|||
161784303|NCT01493531|584255440|FG001|Overall Study|Gout flare|0|||
161784304|NCT01493531|584255441|FG002|Overall Study|Gout flare|2|||
161784305|NCT01493531|584255439|FG000|Overall Study|Protocol Violation|8|||
161784306|NCT01493531|584255440|FG001|Overall Study|Protocol Violation|15|||
161784307|NCT01493531|584255441|FG002|Overall Study|Protocol Violation|12|||
161784308|NCT01493531|584255439|FG000|Overall Study|Sponsor terminated study|5|||
161784309|NCT01493531|584255440|FG001|Overall Study|Sponsor terminated study|2|||
161784310|NCT01493531|584255441|FG002|Overall Study|Sponsor terminated study|3|||
161784311|NCT01493531|584255439|FG000|Overall Study|Lost to Follow-up|5|||
161784312|NCT01493531|584255440|FG001|Overall Study|Lost to Follow-up|7|||
161784313|NCT01493531|584255441|FG002|Overall Study|Lost to Follow-up|11|||
161784314|NCT01493531|584255439|FG000|Overall Study|Withdrawal by Subject|16|||
161784315|NCT01493531|584255440|FG001|Overall Study|Withdrawal by Subject|13|||
161784316|NCT01493531|584255441|FG002|Overall Study|Withdrawal by Subject|11|||
161784317|NCT01493531|584255439|FG000|Overall Study|Death|0|||
161784318|NCT01493531|584255440|FG001|Overall Study|Death|1|||
161784319|NCT01493531|584255441|FG002|Overall Study|Death|0|||
161552436|NCT02733042|583410440|FG013|Overall Study|Death|0|||
161897575|NCT01462630|584673391|FG000|Overall Study|Death|1|||
161897576|NCT01462630|584673391|FG000|Overall Study|Protocol Violation|2|||
161897577|NCT01462630|584673391|FG000|Overall Study|Adverse Event|1|||
161897578|NCT03060291|584673394|FG000|3-month Follow-up|Declined to respond|8|||
161897579|NCT03060291|584673395|FG001|3-month Follow-up|Declined to respond|10|||
161897580|NCT03060291|584673396|FG002|3-month Follow-up|Declined to respond|2|||
161897581|NCT03060291|584673394|FG000|6-month Follow-up|Declined to respond|7|||
161897582|NCT03060291|584673395|FG001|6-month Follow-up|Declined to respond|13|||
161897583|NCT03060291|584673396|FG002|6-month Follow-up|Declined to respond|4|||
161897584|NCT03060291|584673394|FG000|12-month Follow-up|Declined to respond|7|||
161897585|NCT03060291|584673395|FG001|12-month Follow-up|Declined to respond|16|||
161897586|NCT03060291|584673396|FG002|12-month Follow-up|Declined to respond|6|||
161897587|NCT01509664|584673399|FG000|Overall Study|Lost to Follow-up|15|||
161897588|NCT01509664|584673400|FG001|Overall Study|Lost to Follow-up|21|||
161897589|NCT03665077|584673403|FG000|Overall Study|Lost to Follow-up|2|||
161897590|NCT03665077|584673403|FG000|Overall Study|Physician Decision|2|||
161897591|NCT02364388|584673406|FG000|Overall Study|Protocol Violation|1|||
161897592|NCT02364388|584673406|FG000|Overall Study|Technical Failure|3|||
161897593|NCT02364388|584673406|FG000|Overall Study|No OA/US data|2|||
161897594|NCT02364388|584673406|FG000|Overall Study|No Biopsy|2|||
161897595|NCT00837967|584673407|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
161897596|NCT00837967|584673408|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
161897597|NCT02504320|584673412|FG000|Treatment Period 1|Positive Drug Screen|0|||
161897598|NCT02504320|584673413|FG001|Treatment Period 1|Positive Drug Screen|0|||
161897599|NCT02504320|584673414|FG002|Treatment Period 1|Positive Drug Screen|1|||
161897600|NCT02504320|584673415|FG003|Treatment Period 1|Positive Drug Screen|0|||
161897601|NCT02504320|584673412|FG000|Treatment Period 2|Positive Drug Screen|0|||
161897602|NCT02504320|584673413|FG001|Treatment Period 2|Positive Drug Screen|1|||
161897603|NCT02504320|584673414|FG002|Treatment Period 2|Positive Drug Screen|0|||
161897604|NCT02504320|584673415|FG003|Treatment Period 2|Positive Drug Screen|0|||
161897605|NCT02504320|584673412|FG000|Treatment Period 3|Positive Drug Screen|0|||
161897606|NCT02504320|584673413|FG001|Treatment Period 3|Positive Drug Screen|0|||
161897607|NCT02504320|584673414|FG002|Treatment Period 3|Positive Drug Screen|0|||
161897608|NCT02504320|584673415|FG003|Treatment Period 3|Positive Drug Screen|1|||
161897609|NCT02504320|584673412|FG000|Treatment Period 3|Adverse Event|0|||
161897610|NCT02504320|584673413|FG001|Treatment Period 3|Adverse Event|0|||
161897611|NCT02504320|584673414|FG002|Treatment Period 3|Adverse Event|1|||
161897612|NCT02504320|584673415|FG003|Treatment Period 3|Adverse Event|0|||
161897613|NCT02306850|584673418|FG000|Overall Study|Lack of Efficacy|2|||
161897614|NCT02420262|584673419|FG000|Overall Study|Adverse Event|1|||
161897615|NCT02420262|584673420|FG001|Overall Study|Adverse Event|0|||
161897616|NCT02420262|584673419|FG000|Overall Study|Withdrawal by Subject|1|||
161897617|NCT02420262|584673420|FG001|Overall Study|Withdrawal by Subject|4|||
161897618|NCT02420262|584673419|FG000|Overall Study|Unclassified|0|||
161897619|NCT02420262|584673420|FG001|Overall Study|Unclassified|1|||
161897620|NCT01210222|584673421|FG000|Overall Study|Ineligible|2|||
161897621|NCT01210222|584673421|FG000|Overall Study|Never treated|1|||
161897622|NCT00941304|584673422|FG000|Overall Study|Lost to Follow-up|1|||
161897623|NCT00941304|584673423|FG001|Overall Study|Lost to Follow-up|0|||
161897624|NCT00941304|584673424|FG002|Overall Study|Lost to Follow-up|0|||
161897625|NCT00941304|584673425|FG003|Overall Study|Lost to Follow-up|0|||
161897626|NCT00941304|584673426|FG004|Overall Study|Lost to Follow-up|0|||
161897627|NCT03293394|584673427|FG000|Follow-up (6 Months)|Adverse Event|4|||
161897628|NCT03293394|584673428|FG001|Follow-up (6 Months)|Adverse Event|2|||
161897629|NCT02497404|584673429|FG000|Overall Study|Adverse Event|1|||
161897630|NCT01408901|584673430|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
161897631|NCT01408901|584673431|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
161897632|NCT01408901|584673432|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
161897633|NCT01408901|584673433|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
161897634|NCT01408901|584673430|FG000|6-Week Follow-Up|Death|1|||
161897635|NCT01408901|584673431|FG001|6-Week Follow-Up|Death|0|||
161897636|NCT01408901|584673432|FG002|6-Week Follow-Up|Death|0|||
161897637|NCT01408901|584673433|FG003|6-Week Follow-Up|Death|0|||
161897638|NCT01408901|584673430|FG000|6-Week Follow-Up|Cancelled visit|0|||
161897639|NCT01408901|584673431|FG001|6-Week Follow-Up|Cancelled visit|1|||
161897640|NCT01408901|584673432|FG002|6-Week Follow-Up|Cancelled visit|0|||
161897641|NCT01408901|584673433|FG003|6-Week Follow-Up|Cancelled visit|2|||
161897642|NCT01408901|584673430|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
161897643|NCT01408901|584673431|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
161897644|NCT01408901|584673432|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
161897645|NCT01408901|584673433|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
161897646|NCT01408901|584673430|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
161897647|NCT01408901|584673431|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161897648|NCT01408901|584673432|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161897649|NCT01408901|584673433|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161897650|NCT01408901|584673430|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
161897651|NCT01408901|584673431|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
161897652|NCT01408901|584673432|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
161897653|NCT01408901|584673433|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
161897654|NCT01408901|584673430|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
161897655|NCT01408901|584673431|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
161897656|NCT01408901|584673432|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
161897657|NCT01408901|584673433|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
161897658|NCT01408901|584673430|FG000|26-Week Follow-Up|Death|0|||
161897659|NCT01408901|584673431|FG001|26-Week Follow-Up|Death|1|||
161897660|NCT01408901|584673432|FG002|26-Week Follow-Up|Death|0|||
161897661|NCT01408901|584673433|FG003|26-Week Follow-Up|Death|0|||
161897662|NCT02098395|584673436|FG000|Overall Study|Protocol Violation|2|||
161897663|NCT02098395|584673437|FG001|Overall Study|Protocol Violation|2|||
161897664|NCT02098395|584673438|FG002|Overall Study|Protocol Violation|0|||
161897665|NCT02098395|584673439|FG003|Overall Study|Protocol Violation|7|||
161897666|NCT02098395|584673436|FG000|Overall Study|Withdrawal by Subject|10|||
161897667|NCT02098395|584673437|FG001|Overall Study|Withdrawal by Subject|10|||
161897668|NCT02098395|584673438|FG002|Overall Study|Withdrawal by Subject|5|||
161897669|NCT02098395|584673439|FG003|Overall Study|Withdrawal by Subject|13|||
161897670|NCT02098395|584673436|FG000|Overall Study|Adverse Event|12|||
161897671|NCT02098395|584673437|FG001|Overall Study|Adverse Event|19|||
161897672|NCT02098395|584673438|FG002|Overall Study|Adverse Event|34|||
161897673|NCT02098395|584673439|FG003|Overall Study|Adverse Event|2|||
161897674|NCT02098395|584673436|FG000|Overall Study|Lost to Follow-up|2|||
161897675|NCT02098395|584673437|FG001|Overall Study|Lost to Follow-up|1|||
161897676|NCT02098395|584673438|FG002|Overall Study|Lost to Follow-up|0|||
161897677|NCT02098395|584673439|FG003|Overall Study|Lost to Follow-up|3|||
161897678|NCT02098395|584673436|FG000|Overall Study|Unclassified|0|||
161897679|NCT02098395|584673437|FG001|Overall Study|Unclassified|0|||
161897680|NCT02098395|584673438|FG002|Overall Study|Unclassified|3|||
161897681|NCT02098395|584673439|FG003|Overall Study|Unclassified|2|||
161897682|NCT00110357|584673445|FG000|Overall Study|Deterioration without progression|2|||
161897683|NCT00110357|584673446|FG001|Overall Study|Deterioration without progression|0|||
161897684|NCT00110357|584673445|FG000|Overall Study|Disease progression/relapse|20|||
161897685|NCT00110357|584673446|FG001|Overall Study|Disease progression/relapse|15|||
161897686|NCT00110357|584673445|FG000|Overall Study|Study Closure|1|||
161897687|NCT00110357|584673446|FG001|Overall Study|Study Closure|0|||
161897688|NCT00110357|584673445|FG000|Overall Study|Study Drug Toxicity|1|||
161897689|NCT00110357|584673446|FG001|Overall Study|Study Drug Toxicity|3|||
161897690|NCT00110357|584673445|FG000|Overall Study|Withdrawal by Subject|3|||
161897691|NCT00110357|584673446|FG001|Overall Study|Withdrawal by Subject|1|||
161897692|NCT05285787|584673447|FG000|Overall Study|Withdrawal by Subject|1|||
161897693|NCT04004260|584673451|FG000|Overall Study|Withdrawal by Subject|7|||
161897694|NCT04004260|584673452|FG001|Overall Study|Withdrawal by Subject|3|||
161897695|NCT04004260|584673451|FG000|Overall Study|Lost to Follow-up|22|||
161897696|NCT04004260|584673452|FG001|Overall Study|Lost to Follow-up|12|||
161897697|NCT04004260|584673451|FG000|Overall Study|Did not engage in intervention|13|||
161897698|NCT04004260|584673452|FG001|Overall Study|Did not engage in intervention|17|||
161897699|NCT02360280|584673456|FG000|Overall Study|Withdrawal by Subject|2|||
161897700|NCT02360280|584673457|FG001|Overall Study|Withdrawal by Subject|0|||
161897701|NCT02360280|584673456|FG000|Overall Study|Adverse Event|0|||
161897702|NCT02360280|584673457|FG001|Overall Study|Adverse Event|1|||
161897703|NCT02360280|584673456|FG000|Overall Study|Lost to Follow-up|1|||
161897704|NCT02360280|584673457|FG001|Overall Study|Lost to Follow-up|0|||
161897705|NCT00320788|584673458|FG000|Overall Study|Adverse Event|0|||
161897706|NCT00320788|584673459|FG001|Overall Study|Adverse Event|0|||
161897707|NCT00320788|584673460|FG002|Overall Study|Adverse Event|0|||
161897708|NCT00320788|584673461|FG003|Overall Study|Adverse Event|1|||
161897709|NCT00320788|584673462|FG004|Overall Study|Adverse Event|0|||
161897710|NCT00320788|584673458|FG000|Overall Study|Death|0|||
161897711|NCT00320788|584673459|FG001|Overall Study|Death|0|||
161897712|NCT00320788|584673460|FG002|Overall Study|Death|1|||
161897713|NCT00320788|584673461|FG003|Overall Study|Death|0|||
161897714|NCT00320788|584673462|FG004|Overall Study|Death|1|||
161897715|NCT00320788|584673458|FG000|Overall Study|Lost to Follow-up|0|||
161897716|NCT00320788|584673459|FG001|Overall Study|Lost to Follow-up|2|||
161897717|NCT00320788|584673460|FG002|Overall Study|Lost to Follow-up|1|||
161897718|NCT00320788|584673461|FG003|Overall Study|Lost to Follow-up|0|||
161897719|NCT00320788|584673462|FG004|Overall Study|Lost to Follow-up|0|||
161897720|NCT00320788|584673458|FG000|Overall Study|Decision by the Sponsor|1|||
161897721|NCT00320788|584673459|FG001|Overall Study|Decision by the Sponsor|1|||
161897722|NCT00320788|584673460|FG002|Overall Study|Decision by the Sponsor|0|||
161897723|NCT00320788|584673461|FG003|Overall Study|Decision by the Sponsor|0|||
161897724|NCT00320788|584673462|FG004|Overall Study|Decision by the Sponsor|1|||
161897725|NCT00320788|584673458|FG000|Overall Study|Other|1|||
161897726|NCT00320788|584673459|FG001|Overall Study|Other|2|||
161897727|NCT00320788|584673460|FG002|Overall Study|Other|1|||
161897728|NCT00320788|584673461|FG003|Overall Study|Other|1|||
161897729|NCT00320788|584673462|FG004|Overall Study|Other|1|||
161897730|NCT00320788|584673458|FG000|Overall Study|Physician Decision|1|||
161897731|NCT00320788|584673459|FG001|Overall Study|Physician Decision|1|||
161897732|NCT00320788|584673460|FG002|Overall Study|Physician Decision|0|||
161897733|NCT00320788|584673461|FG003|Overall Study|Physician Decision|0|||
161897734|NCT00320788|584673462|FG004|Overall Study|Physician Decision|0|||
161897735|NCT00320788|584673458|FG000|Overall Study|Protocol Violation|0|||
161897736|NCT00320788|584673459|FG001|Overall Study|Protocol Violation|0|||
161897737|NCT00320788|584673460|FG002|Overall Study|Protocol Violation|0|||
161897738|NCT00320788|584673461|FG003|Overall Study|Protocol Violation|0|||
161897739|NCT00320788|584673462|FG004|Overall Study|Protocol Violation|1|||
161897740|NCT00320788|584673458|FG000|Overall Study|Withdrawal by Subject|3|||
161897741|NCT00320788|584673459|FG001|Overall Study|Withdrawal by Subject|0|||
161897742|NCT00320788|584673460|FG002|Overall Study|Withdrawal by Subject|0|||
161897743|NCT00320788|584673461|FG003|Overall Study|Withdrawal by Subject|3|||
161897744|NCT00320788|584673462|FG004|Overall Study|Withdrawal by Subject|1|||
161897745|NCT04633226|584673464|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161897746|NCT04633226|584673464|FG000|Overall Study|Randomized by mistake without study treatment|1|||
161897747|NCT01398358|584673477|FG000|Overall Study|Lost to Follow-up|11|||
161897748|NCT01398358|584673478|FG001|Overall Study|Lost to Follow-up|21|||
161897749|NCT01398358|584673479|FG002|Overall Study|Lost to Follow-up|18|||
161897750|NCT01398358|584673477|FG000|Overall Study|Withdrawal by Subject|3|||
161897751|NCT01398358|584673478|FG001|Overall Study|Withdrawal by Subject|2|||
161897752|NCT01398358|584673479|FG002|Overall Study|Withdrawal by Subject|2|||
161897753|NCT01398358|584673477|FG000|Overall Study|no longer eligible|1|||
161897754|NCT01398358|584673478|FG001|Overall Study|no longer eligible|0|||
161897755|NCT01398358|584673479|FG002|Overall Study|no longer eligible|1|||
161897756|NCT00003896|584673480|FG000|Overall Study|Adverse Event|16|||
161897757|NCT00003896|584673480|FG000|Overall Study|Withdrawal by Subject|1|||
161897758|NCT00003896|584673480|FG000|Overall Study|Lack of Efficacy|1|||
161897759|NCT00003896|584673480|FG000|Overall Study|Death|3|||
161897760|NCT00003896|584673480|FG000|Overall Study|not protocol specified|3|||
161897761|NCT00003896|584673480|FG000|Overall Study|ineligible|5|||
161897762|NCT02559570|584673485|FG000|Overall Study|Adverse Event|0|||
161897763|NCT02559570|584673486|FG001|Overall Study|Adverse Event|2|||
161897764|NCT02559570|584673487|FG002|Overall Study|Adverse Event|0|||
161897765|NCT02559570|584673488|FG003|Overall Study|Adverse Event|1|||
161897766|NCT02559570|584673489|FG004|Overall Study|Adverse Event|0|||
161897767|NCT02559570|584673485|FG000|Overall Study|Withdrawal of Consent|0|||
161897768|NCT02559570|584673486|FG001|Overall Study|Withdrawal of Consent|0|||
161897769|NCT02559570|584673487|FG002|Overall Study|Withdrawal of Consent|1|||
161897770|NCT02559570|584673488|FG003|Overall Study|Withdrawal of Consent|2|||
161897771|NCT02559570|584673489|FG004|Overall Study|Withdrawal of Consent|1|||
161897772|NCT02559570|584673485|FG000|Overall Study|Lost to Follow-up|1|||
161897773|NCT02559570|584673486|FG001|Overall Study|Lost to Follow-up|0|||
161897774|NCT02559570|584673487|FG002|Overall Study|Lost to Follow-up|0|||
161897775|NCT02559570|584673488|FG003|Overall Study|Lost to Follow-up|0|||
161897776|NCT02559570|584673489|FG004|Overall Study|Lost to Follow-up|0|||
161897777|NCT02559570|584673485|FG000|Overall Study|Protocol Violation|1|||
161897778|NCT02559570|584673486|FG001|Overall Study|Protocol Violation|0|||
161897779|NCT02559570|584673487|FG002|Overall Study|Protocol Violation|0|||
161897780|NCT02559570|584673488|FG003|Overall Study|Protocol Violation|0|||
161897781|NCT02559570|584673489|FG004|Overall Study|Protocol Violation|1|||
161897782|NCT02559570|584673485|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161897783|NCT02559570|584673486|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161897784|NCT02559570|584673487|FG002|Overall Study|Other Miscellaneous Reasons|1|||
161897785|NCT02559570|584673488|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161897786|NCT02559570|584673489|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161897787|NCT01903993|584673496|FG000|Overall Study|Death|118|||
161897788|NCT01903993|584673497|FG001|Overall Study|Death|121|||
161897789|NCT01903993|584673496|FG000|Overall Study|Withdrawal by Subject|15|||
161897790|NCT01903993|584673497|FG001|Overall Study|Withdrawal by Subject|4|||
161897791|NCT01903993|584673496|FG000|Overall Study|Lost to Follow-up|2|||
161897792|NCT01903993|584673497|FG001|Overall Study|Lost to Follow-up|3|||
161897793|NCT01903993|584673496|FG000|Overall Study|Study Terminated by Sponsor|8|||
161897794|NCT01903993|584673497|FG001|Overall Study|Study Terminated by Sponsor|14|||
161897795|NCT01903993|584673496|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
161897796|NCT01903993|584673497|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
161897797|NCT00184093|584673500|FG000|Overall Study|Adverse Event|3|||
161897798|NCT00184093|584673500|FG000|Overall Study|Lost to Follow-up|3|||
161897799|NCT00184093|584673500|FG000|Overall Study|Physician Decision|1|||
161897800|NCT00184093|584673500|FG000|Overall Study|Withdrawal by Subject|2|||
161897801|NCT02787083|584673511|FG000|Overall Study|Adverse Event|1|||
161897802|NCT02787083|584673512|FG001|Overall Study|Adverse Event|0|||
161897803|NCT02787083|584673511|FG000|Overall Study|Withdrawal by Subject|2|||
161897804|NCT02787083|584673512|FG001|Overall Study|Withdrawal by Subject|2|||
161897805|NCT02710084|584673513|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
161897806|NCT02710084|584673514|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
161897807|NCT02453256|584673519|FG000|Double Blind Period|Death|1|||
161897808|NCT02453256|584673520|FG001|Double Blind Period|Death|1|||
161897809|NCT02453256|584673519|FG000|Double Blind Period|Adverse Event|3|||
161897810|NCT02453256|584673520|FG001|Double Blind Period|Adverse Event|2|||
161552437|NCT02733042|583410441|FG014|Overall Study|Death|1|||
161897811|NCT02453256|584673519|FG000|Double Blind Period|Withdrawal by Subject|9|||
161897812|NCT02453256|584673520|FG001|Double Blind Period|Withdrawal by Subject|5|||
161897813|NCT02453256|584673519|FG000|Double Blind Period|Other|0|||
161897814|NCT02453256|584673520|FG001|Double Blind Period|Other|1|||
161897815|NCT02453256|584673519|FG000|Open Label Period|Adverse Event|1|||
161897816|NCT02453256|584673520|FG001|Open Label Period|Adverse Event|3|||
161897817|NCT02453256|584673519|FG000|Open Label Period|Death|0|||
161897818|NCT02453256|584673520|FG001|Open Label Period|Death|1|||
161897819|NCT02453256|584673519|FG000|Open Label Period|Lost to Follow-up|1|||
161897820|NCT02453256|584673520|FG001|Open Label Period|Lost to Follow-up|0|||
161897821|NCT02453256|584673519|FG000|Open Label Period|Other|0|||
161897822|NCT02453256|584673520|FG001|Open Label Period|Other|2|||
161897823|NCT02453256|584673519|FG000|Open Label Period|Withdrawal by Subject|5|||
161897824|NCT02453256|584673520|FG001|Open Label Period|Withdrawal by Subject|1|||
161897825|NCT01243177|584673521|FG000|Overall Study|Lack of Efficacy|47|||
161897826|NCT01243177|584673522|FG001|Overall Study|Lack of Efficacy|31|||
161897827|NCT01243177|584673521|FG000|Overall Study|Protocol Violation|11|||
161897828|NCT01243177|584673522|FG001|Overall Study|Protocol Violation|10|||
161897829|NCT01243177|584673521|FG000|Overall Study|Lost to Follow-up|15|||
161897830|NCT01243177|584673522|FG001|Overall Study|Lost to Follow-up|18|||
161897831|NCT01243177|584673521|FG000|Overall Study|Withdrawal by Subject|46|||
161897832|NCT01243177|584673522|FG001|Overall Study|Withdrawal by Subject|38|||
161897833|NCT01243177|584673521|FG000|Overall Study|AE, serious fatal|0|||
161897834|NCT01243177|584673522|FG001|Overall Study|AE, serious fatal|1|||
161897835|NCT01243177|584673521|FG000|Overall Study|SAE, non-fatal|7|||
161897836|NCT01243177|584673522|FG001|Overall Study|SAE, non-fatal|9|||
161897837|NCT01243177|584673521|FG000|Overall Study|AE, non-serious non-fatal|40|||
161897838|NCT01243177|584673522|FG001|Overall Study|AE, non-serious non-fatal|58|||
161897839|NCT01243177|584673521|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
161897840|NCT01243177|584673522|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
161897841|NCT01243177|584673521|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161897842|NCT01243177|584673522|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161897843|NCT01243177|584673521|FG000|Overall Study|Other Reason|11|||
161897844|NCT01243177|584673522|FG001|Overall Study|Other Reason|12|||
161897845|NCT05259163|584675471|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
161897846|NCT05259163|584675472|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
161897847|NCT05251233|584675473|FG000|Overall Study|Disease progression - did not start treatment|0|||
161897848|NCT05251233|584675474|FG001|Overall Study|Disease progression - did not start treatment|0|||
161897849|NCT05251233|584675475|FG002|Overall Study|Disease progression - did not start treatment|5|||
161897850|NCT05251233|584675473|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
161897851|NCT05251233|584675474|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
161897852|NCT05251233|584675475|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
161897853|NCT05251233|584675473|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
161897854|NCT05251233|584675474|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
161897855|NCT05251233|584675475|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
161897856|NCT05251233|584675473|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
161897857|NCT05251233|584675474|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
161897858|NCT05251233|584675475|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
161897859|NCT05251233|584675473|FG000|Overall Study|Death - did not start treatment|3|||
161897860|NCT05251233|584675474|FG001|Overall Study|Death - did not start treatment|0|||
161897861|NCT05251233|584675475|FG002|Overall Study|Death - did not start treatment|0|||
161897862|NCT05251233|584675473|FG000|Overall Study|Withdrawal by Subject|2|||
161897863|NCT05251233|584675474|FG001|Overall Study|Withdrawal by Subject|2|||
161897864|NCT05251233|584675475|FG002|Overall Study|Withdrawal by Subject|0|||
161897865|NCT05251233|584675473|FG000|Overall Study|Other complicating disease|2|||
161897866|NCT05251233|584675474|FG001|Overall Study|Other complicating disease|1|||
161897867|NCT05251233|584675475|FG002|Overall Study|Other complicating disease|0|||
161897868|NCT05251233|584675473|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
161897869|NCT05251233|584675474|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
161897870|NCT05251233|584675475|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
161897871|NCT05251233|584675473|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
161897872|NCT05251233|584675474|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
161897873|NCT05251233|584675475|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
161897874|NCT00452439|584675479|FG000|Overall Study|Lost to Follow-up|1|||
161897875|NCT00452439|584675480|FG001|Overall Study|Lost to Follow-up|1|||
161897876|NCT00452439|584675479|FG000|Overall Study|Refused Treatment|4|||
161784320|NCT03835975|584255444|FG000|Overall Study|Lost to Follow-up|1|||
161784321|NCT03835975|584255445|FG001|Overall Study|Lost to Follow-up|1|||
161784322|NCT03835975|584255446|FG002|Overall Study|Lost to Follow-up|0|||
161784323|NCT03835975|584255447|FG003|Overall Study|Lost to Follow-up|0|||
161784324|NCT03835975|584255448|FG004|Overall Study|Lost to Follow-up|0|||
161784325|NCT03835975|584255444|FG000|Overall Study|No longer met eligibility criteria|0|||
161784326|NCT03835975|584255445|FG001|Overall Study|No longer met eligibility criteria|1|||
161784327|NCT03835975|584255446|FG002|Overall Study|No longer met eligibility criteria|0|||
161784328|NCT03835975|584255447|FG003|Overall Study|No longer met eligibility criteria|0|||
161784329|NCT03835975|584255448|FG004|Overall Study|No longer met eligibility criteria|0|||
161784330|NCT03835975|584255444|FG000|Overall Study|Protocol Violation|1|||
161784331|NCT03835975|584255445|FG001|Overall Study|Protocol Violation|1|||
161784332|NCT03835975|584255446|FG002|Overall Study|Protocol Violation|2|||
161784333|NCT03835975|584255447|FG003|Overall Study|Protocol Violation|0|||
161784334|NCT03835975|584255448|FG004|Overall Study|Protocol Violation|0|||
161784335|NCT03835975|584255444|FG000|Overall Study|Withdrawal by Subject|1|||
161784336|NCT03835975|584255445|FG001|Overall Study|Withdrawal by Subject|0|||
161784337|NCT03835975|584255446|FG002|Overall Study|Withdrawal by Subject|1|||
161784338|NCT03835975|584255447|FG003|Overall Study|Withdrawal by Subject|1|||
161784339|NCT03835975|584255448|FG004|Overall Study|Withdrawal by Subject|0|||
161784340|NCT03031431|584255451|FG000|Overall Study|Infant removed by maternal request|1|||
161784341|NCT01612702|584255452|FG000|Overall Study|Protocol Violation|11|||
161784342|NCT01612702|584255453|FG001|Overall Study|Protocol Violation|11|||
161784343|NCT00370396|584255454|FG000|Overall Study|Withdrawal by Subject|0|||
161784344|NCT00370396|584255455|FG001|Overall Study|Withdrawal by Subject|0|||
161784345|NCT00370396|584255456|FG002|Overall Study|Withdrawal by Subject|1|||
161784346|NCT00370396|584255454|FG000|Overall Study|Lost to Follow-up|11|||
161784347|NCT00370396|584255455|FG001|Overall Study|Lost to Follow-up|1|||
161784348|NCT00370396|584255456|FG002|Overall Study|Lost to Follow-up|0|||
161784349|NCT01462695|584255457|FG000|Overall Study|Adverse Event|1|||
161784350|NCT01462695|584255458|FG001|Overall Study|Adverse Event|1|||
161784351|NCT01462695|584255457|FG000|Overall Study|Death|2|||
161784352|NCT01462695|584255458|FG001|Overall Study|Death|0|||
161784353|NCT01462695|584255457|FG000|Overall Study|Lack of Efficacy|6|||
161784354|NCT01462695|584255458|FG001|Overall Study|Lack of Efficacy|12|||
161784355|NCT01462695|584255457|FG000|Overall Study|Physician Decision|5|||
161784356|NCT01462695|584255458|FG001|Overall Study|Physician Decision|0|||
161897877|NCT00452439|584675480|FG001|Overall Study|Refused Treatment|3|||
161897878|NCT00452439|584675479|FG000|Overall Study|Death|3|||
161897879|NCT00452439|584675480|FG001|Overall Study|Death|1|||
161897880|NCT00452439|584675479|FG000|Overall Study|Bone Marrow Transplant|0|||
161897881|NCT00452439|584675480|FG001|Overall Study|Bone Marrow Transplant|1|||
161897882|NCT00452439|584675479|FG000|Overall Study|Too Ill to Continue|0|||
161897883|NCT00452439|584675480|FG001|Overall Study|Too Ill to Continue|1|||
161897884|NCT00452439|584675479|FG000|Overall Study|Failed to achieve complete response|2|||
161897885|NCT00452439|584675480|FG001|Overall Study|Failed to achieve complete response|0|||
161897886|NCT00452439|584675479|FG000|Overall Study|Relapse|3|||
161897887|NCT00452439|584675480|FG001|Overall Study|Relapse|0|||
161897888|NCT00452439|584675479|FG000|Overall Study|Fracture|1|||
161897889|NCT00452439|584675480|FG001|Overall Study|Fracture|0|||
161897890|NCT01381926|584675481|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
161897891|NCT01381926|584675482|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
161897892|NCT01381926|584675481|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
161897893|NCT01381926|584675482|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
161897894|NCT02624947|584675486|FG000|Maternal Participants|Adverse Event|5|||
161897895|NCT02624947|584675487|FG001|Maternal Participants|Adverse Event|0|||
161897896|NCT02624947|584675486|FG000|Maternal Participants|Investigator Decision|5|||
161897897|NCT02624947|584675487|FG001|Maternal Participants|Investigator Decision|3|||
161897898|NCT02624947|584675486|FG000|Maternal Participants|Lost to Follow-up|54|||
161897899|NCT02624947|584675487|FG001|Maternal Participants|Lost to Follow-up|24|||
161897900|NCT02624947|584675486|FG000|Maternal Participants|Non Compliance|8|||
161897901|NCT02624947|584675487|FG001|Maternal Participants|Non Compliance|5|||
161897902|NCT02624947|584675486|FG000|Maternal Participants|Sponsor Request|1|||
161897903|NCT02624947|584675487|FG001|Maternal Participants|Sponsor Request|1|||
161897904|NCT02624947|584675486|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
161897905|NCT02624947|584675487|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
161897906|NCT02624947|584675486|FG000|Maternal Participants|Miscellaneous|23|||
161897907|NCT02624947|584675487|FG001|Maternal Participants|Miscellaneous|15|||
161897908|NCT02624947|584675486|FG000|Infant Participants|Adverse Event|18|||
161897909|NCT02624947|584675487|FG001|Infant Participants|Adverse Event|11|||
161897910|NCT02624947|584675486|FG000|Infant Participants|Investigator Decision|5|||
161897911|NCT02624947|584675487|FG001|Infant Participants|Investigator Decision|4|||
161897912|NCT02624947|584675486|FG000|Infant Participants|Lost to Follow-up|93|||
161897913|NCT02624947|584675487|FG001|Infant Participants|Lost to Follow-up|58|||
161897914|NCT02624947|584675486|FG000|Infant Participants|Non Compliance|17|||
161897915|NCT02624947|584675487|FG001|Infant Participants|Non Compliance|7|||
161897916|NCT02624947|584675486|FG000|Infant Participants|Sponsor Request|0|||
161897917|NCT02624947|584675487|FG001|Infant Participants|Sponsor Request|1|||
161897918|NCT02624947|584675486|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
161897919|NCT02624947|584675487|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
161897920|NCT02624947|584675486|FG000|Infant Participants|Miscellaneous|50|||
161897921|NCT02624947|584675487|FG001|Infant Participants|Miscellaneous|26|||
161897922|NCT00215644|584675490|FG000|Overall Study|Disease Progression|28|||
161897923|NCT00215644|584675491|FG001|Overall Study|Disease Progression|10|||
161897924|NCT00215644|584675490|FG000|Overall Study|Adverse Event|2|||
161897925|NCT00215644|584675491|FG001|Overall Study|Adverse Event|9|||
161897926|NCT00215644|584675490|FG000|Overall Study|Death|1|||
161897927|NCT00215644|584675491|FG001|Overall Study|Death|2|||
161897928|NCT00215644|584675490|FG000|Overall Study|Withdrawal by Subject|1|||
161897929|NCT00215644|584675491|FG001|Overall Study|Withdrawal by Subject|0|||
161897930|NCT00215644|584675490|FG000|Overall Study|Other|3|||
161897931|NCT00215644|584675491|FG001|Overall Study|Other|15|||
161897932|NCT00215644|584675490|FG000|Overall Study|Randomized but Not Treated|1|||
161897933|NCT00215644|584675491|FG001|Overall Study|Randomized but Not Treated|0|||
161897934|NCT02861664|584675494|FG000|Overall Study|Withdrawal of Consent|0|||
161897935|NCT02861664|584675495|FG001|Overall Study|Withdrawal of Consent|1|||
161897936|NCT03512353|584675496|FG000|Overall Study|Sponsor Decision|3|||
161897937|NCT03512353|584675496|FG000|Overall Study|Death|1|||
161897938|NCT01000974|584675497|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
161897939|NCT01000974|584675498|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
161897940|NCT01000974|584675499|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
161897941|NCT01000974|584675497|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
161897942|NCT01000974|584675498|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
161897943|NCT01000974|584675499|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
161897944|NCT01000974|584675497|FG000|Primary Vaccination Phase|Protocol Violation|40|||
161897945|NCT01000974|584675498|FG001|Primary Vaccination Phase|Protocol Violation|3|||
161897946|NCT01000974|584675499|FG002|Primary Vaccination Phase|Protocol Violation|2|||
161897947|NCT01000974|584675497|FG000|Primary Vaccination Phase|Adverse Event|14|||
161897948|NCT01000974|584675498|FG001|Primary Vaccination Phase|Adverse Event|2|||
161897949|NCT01000974|584675499|FG002|Primary Vaccination Phase|Adverse Event|2|||
161897950|NCT01000974|584675497|FG000|Primary Vaccination Phase|Other|4|||
161897951|NCT01000974|584675498|FG001|Primary Vaccination Phase|Other|9|||
161897952|NCT01000974|584675499|FG002|Primary Vaccination Phase|Other|12|||
161897953|NCT01000974|584675497|FG000|Booster Vaccination Phase|Protocol Violation|0|||
161897954|NCT01000974|584675498|FG001|Booster Vaccination Phase|Protocol Violation|0|||
161897955|NCT01000974|584675499|FG002|Booster Vaccination Phase|Protocol Violation|2|||
161897956|NCT01000974|584675497|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
161897957|NCT01000974|584675498|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
161897958|NCT01000974|584675499|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
161897959|NCT01000974|584675497|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
161897960|NCT01000974|584675498|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
161897961|NCT01000974|584675499|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
161897962|NCT01000974|584675497|FG000|Booster Vaccination Phase|Other|24|||
161897963|NCT01000974|584675498|FG001|Booster Vaccination Phase|Other|6|||
161897964|NCT01000974|584675499|FG002|Booster Vaccination Phase|Other|4|||
161897965|NCT01639144|584675502|FG000|Overall Study|Withdrawal by Subject|4|||
161897966|NCT01639144|584675503|FG001|Overall Study|Withdrawal by Subject|2|||
161897967|NCT01639144|584675502|FG000|Overall Study|Physician Decision|2|||
161897968|NCT01639144|584675503|FG001|Overall Study|Physician Decision|0|||
161897969|NCT01639144|584675502|FG000|Overall Study|Met postoperative exclusion criteria|4|||
161897970|NCT01639144|584675503|FG001|Overall Study|Met postoperative exclusion criteria|3|||
161897971|NCT03365934|584675505|FG000|Overall Study|Adverse Event|1|||
161897972|NCT03365934|584675505|FG000|Overall Study|Withdrawal by Subject|1|||
161897973|NCT01307891|584675506|FG000|Overall Study|Progressive Disease|3|||
161897974|NCT01307891|584675507|FG001|Overall Study|Progressive Disease|1|||
161897975|NCT02937740|584675508|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
161897976|NCT02937740|584675509|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
161897977|NCT02937740|584675508|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
161897978|NCT02937740|584675509|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
161897979|NCT02937740|584675508|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
161897980|NCT02937740|584675509|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
161897981|NCT02937740|584675508|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
161897982|NCT02937740|584675509|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
161897983|NCT02937740|584675508|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
161897984|NCT02937740|584675509|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
161897985|NCT02937740|584675508|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
161897986|NCT02937740|584675509|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
161897987|NCT02239640|584675516|FG000|Overall Study|Withdrawal by Subject|3|||
161897988|NCT02239640|584675516|FG000|Overall Study|Lost to Follow-up|72|||
161784357|NCT01462695|584255457|FG000|Overall Study|Withdrawal by Subject|2|||
161784358|NCT01462695|584255458|FG001|Overall Study|Withdrawal by Subject|0|||
161784359|NCT01462695|584255457|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
161897989|NCT02239640|584675516|FG000|Overall Study|Death|142|||
161897990|NCT02291029|584675523|FG000|Overall Study|Withdrawal by Subject|0|||
161897991|NCT02291029|584675524|FG001|Overall Study|Withdrawal by Subject|0|||
161897992|NCT02291029|584675525|FG002|Overall Study|Withdrawal by Subject|1|||
161897993|NCT02291029|584675526|FG003|Overall Study|Withdrawal by Subject|0|||
161897994|NCT02291029|584675527|FG004|Overall Study|Withdrawal by Subject|0|||
161897995|NCT02291029|584675528|FG005|Overall Study|Withdrawal by Subject|0|||
161897996|NCT02291029|584675523|FG000|Overall Study|Adverse Event|0|||
161897997|NCT02291029|584675524|FG001|Overall Study|Adverse Event|1|||
161897998|NCT02291029|584675525|FG002|Overall Study|Adverse Event|0|||
161897999|NCT02291029|584675526|FG003|Overall Study|Adverse Event|0|||
161898000|NCT02291029|584675527|FG004|Overall Study|Adverse Event|0|||
161898001|NCT02291029|584675528|FG005|Overall Study|Adverse Event|0|||
161898002|NCT02171429|584675529|FG000|Overall Study|Other|0|||
161898003|NCT02171429|584675530|FG001|Overall Study|Other|1|||
161898004|NCT02171429|584675531|FG002|Overall Study|Other|1|||
161898005|NCT02171429|584675529|FG000|Overall Study|Non-Compliance|0|||
161898006|NCT02171429|584675530|FG001|Overall Study|Non-Compliance|0|||
161898007|NCT02171429|584675531|FG002|Overall Study|Non-Compliance|1|||
161898008|NCT02171429|584675529|FG000|Overall Study|Physician Decision|0|||
161898009|NCT02171429|584675530|FG001|Overall Study|Physician Decision|0|||
161898010|NCT02171429|584675531|FG002|Overall Study|Physician Decision|1|||
161898011|NCT02171429|584675529|FG000|Overall Study|Withdrawal by Subject|1|||
161898012|NCT02171429|584675530|FG001|Overall Study|Withdrawal by Subject|1|||
161898013|NCT02171429|584675531|FG002|Overall Study|Withdrawal by Subject|1|||
161898014|NCT02171429|584675529|FG000|Overall Study|Lost to Follow-up|0|||
161898015|NCT02171429|584675530|FG001|Overall Study|Lost to Follow-up|1|||
161898016|NCT02171429|584675531|FG002|Overall Study|Lost to Follow-up|0|||
161898017|NCT02171429|584675529|FG000|Overall Study|Death|0|||
161898018|NCT02171429|584675530|FG001|Overall Study|Death|0|||
161898019|NCT02171429|584675531|FG002|Overall Study|Death|1|||
161898020|NCT00493012|584675533|FG000|Overall Study|Lost to Follow-up|18|||
161898021|NCT00493012|584675534|FG001|Overall Study|Lost to Follow-up|17|||
161898022|NCT01724177|584675535|FG000|Overall Study|Adverse Event|8|||
161898023|NCT01724177|584675535|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
161898024|NCT01724177|584675535|FG000|Overall Study|Nervous participant|1|||
161898025|NCT01724177|584675535|FG000|Overall Study|Serious Adverse Event Related|1|||
161898026|NCT04147247|584675536|FG000|Overall Study|Progressive disease|3|||
161898027|NCT04147247|584675537|FG001|Overall Study|Progressive disease|3|||
161898028|NCT04147247|584675538|FG002|Overall Study|Progressive disease|4|||
161898029|NCT04147247|584675539|FG003|Overall Study|Progressive disease|4|||
161898030|NCT04147247|584675540|FG004|Overall Study|Progressive disease|3|||
161898031|NCT04147247|584675536|FG000|Overall Study|Physician Decision|0|||
161898032|NCT04147247|584675537|FG001|Overall Study|Physician Decision|1|||
161898033|NCT04147247|584675538|FG002|Overall Study|Physician Decision|0|||
161552438|NCT02733042|583410442|FG015|Overall Study|Death|2|||
161898034|NCT04147247|584675539|FG003|Overall Study|Physician Decision|0|||
161898035|NCT04147247|584675540|FG004|Overall Study|Physician Decision|0|||
161898036|NCT04147247|584675536|FG000|Overall Study|Clinical Disease Progression|0|||
161898037|NCT04147247|584675537|FG001|Overall Study|Clinical Disease Progression|0|||
161898038|NCT04147247|584675538|FG002|Overall Study|Clinical Disease Progression|0|||
161898039|NCT04147247|584675539|FG003|Overall Study|Clinical Disease Progression|0|||
161898040|NCT04147247|584675540|FG004|Overall Study|Clinical Disease Progression|1|||
161898041|NCT04147247|584675536|FG000|Overall Study|Adverse Event|0|||
161898042|NCT04147247|584675537|FG001|Overall Study|Adverse Event|0|||
161898043|NCT04147247|584675538|FG002|Overall Study|Adverse Event|1|||
161898044|NCT04147247|584675539|FG003|Overall Study|Adverse Event|0|||
161898045|NCT04147247|584675540|FG004|Overall Study|Adverse Event|1|||
161898046|NCT00327340|584675545|FG000|Overall Study|Withdrawal by Subject|1|||
161898047|NCT00327340|584675546|FG001|Overall Study|Withdrawal by Subject|5|||
161898048|NCT00327340|584675545|FG000|Overall Study|Physician Decision|1|||
161898049|NCT00327340|584675546|FG001|Overall Study|Physician Decision|1|||
161898050|NCT00327340|584675545|FG000|Overall Study|Disease Progression|10|||
161898051|NCT00327340|584675546|FG001|Overall Study|Disease Progression|19|||
161898052|NCT00327340|584675545|FG000|Overall Study|Symptomatic Disease|0|||
161898053|NCT00327340|584675546|FG001|Overall Study|Symptomatic Disease|2|||
161898054|NCT00327340|584675545|FG000|Overall Study|Adverse Event|3|||
161898055|NCT00327340|584675546|FG001|Overall Study|Adverse Event|3|||
161898056|NCT04085601|584675550|FG000|Overall Study|Lost to Follow-up|1|||
161898057|NCT04085601|584675551|FG001|Overall Study|Lost to Follow-up|0|||
161898058|NCT04085601|584675550|FG000|Overall Study|Death|1|||
161898059|NCT04085601|584675551|FG001|Overall Study|Death|1|||
161898060|NCT00206427|584675552|FG000|Overall Study|Adverse Event|2|||
161898061|NCT03492437|584675553|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161898062|NCT03492437|584675554|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161898063|NCT04534517|584675556|FG000|Overall Study|Adverse Event|1|||
161898064|NCT04534517|584675556|FG000|Overall Study|Withdrawal by Subject|1|||
161898065|NCT04534517|584675556|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161898066|NCT04534517|584675556|FG000|Overall Study|COVID-19 Related|1|||
161898067|NCT02121795|584675557|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
161898068|NCT02121795|584675558|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
161898069|NCT02121795|584675557|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
161898070|NCT02121795|584675558|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
161898071|NCT02121795|584675557|FG000|Double-Blind Phase|Lost to Follow-up|7|||
161898072|NCT02121795|584675558|FG001|Double-Blind Phase|Lost to Follow-up|4|||
161898073|NCT02121795|584675557|FG000|Double-Blind Phase|Physician Decision|2|||
161898074|NCT02121795|584675558|FG001|Double-Blind Phase|Physician Decision|5|||
161898075|NCT02121795|584675557|FG000|Double-Blind Phase|Adverse Event|5|||
161898076|NCT02121795|584675558|FG001|Double-Blind Phase|Adverse Event|0|||
161898077|NCT02121795|584675557|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161898078|NCT02121795|584675558|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161898079|NCT02121795|584675557|FG000|Double-Blind Phase|Protocol Violation|0|||
161898080|NCT02121795|584675558|FG001|Double-Blind Phase|Protocol Violation|3|||
161898081|NCT02121795|584675557|FG000|Double-Blind Phase|Death|1|||
161898082|NCT02121795|584675558|FG001|Double-Blind Phase|Death|1|||
161898083|NCT02121795|584675557|FG000|Open-Label Phase|Physician Decision|8|||
161898084|NCT02121795|584675558|FG001|Open-Label Phase|Physician Decision|8|||
161898085|NCT02121795|584675557|FG000|Open-Label Phase|Withdrawal by Subject|3|||
161898086|NCT02121795|584675558|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161898087|NCT02121795|584675557|FG000|Open-Label Phase|Lost to Follow-up|1|||
161898088|NCT02121795|584675558|FG001|Open-Label Phase|Lost to Follow-up|0|||
161898089|NCT00823264|584675559|FG000|Overall Study|Protocol Violation|2|||
161898090|NCT00823264|584675560|FG001|Overall Study|Protocol Violation|0|||
161898091|NCT01914393|584675561|FG000|Overall Study|Protocol Violation|11|||
161898092|NCT01914393|584675562|FG001|Overall Study|Protocol Violation|3|||
161898093|NCT01914393|584675563|FG002|Overall Study|Protocol Violation|19|||
161898094|NCT01914393|584675561|FG000|Overall Study|Lack of Efficacy|11|||
161898095|NCT01914393|584675562|FG001|Overall Study|Lack of Efficacy|16|||
161898096|NCT01914393|584675563|FG002|Overall Study|Lack of Efficacy|5|||
161898097|NCT01914393|584675561|FG000|Overall Study|no reason given|14|||
161898098|NCT01914393|584675562|FG001|Overall Study|no reason given|8|||
161898099|NCT01914393|584675563|FG002|Overall Study|no reason given|16|||
161898100|NCT01914393|584675561|FG000|Overall Study|Adverse Event|29|||
161898101|NCT01914393|584675562|FG001|Overall Study|Adverse Event|18|||
161898102|NCT01914393|584675563|FG002|Overall Study|Adverse Event|31|||
161898103|NCT01914393|584675561|FG000|Overall Study|Withdrawal by Subject|38|||
161898104|NCT01914393|584675562|FG001|Overall Study|Withdrawal by Subject|20|||
161898105|NCT01914393|584675563|FG002|Overall Study|Withdrawal by Subject|47|||
161898106|NCT01914393|584675561|FG000|Overall Study|Lost to Follow-up|12|||
161898107|NCT01914393|584675562|FG001|Overall Study|Lost to Follow-up|6|||
161898108|NCT01914393|584675563|FG002|Overall Study|Lost to Follow-up|19|||
161898109|NCT01914393|584675561|FG000|Overall Study|subject never dosed|0|||
161898110|NCT01914393|584675562|FG001|Overall Study|subject never dosed|0|||
161898111|NCT01914393|584675563|FG002|Overall Study|subject never dosed|1|||
161898112|NCT00572455|584675564|FG000|Stage I (14 Days)|Adverse Event|0|||
161898113|NCT00572455|584675565|FG001|Stage I (14 Days)|Adverse Event|0|||
161898114|NCT00572455|584675566|FG002|Stage I (14 Days)|Adverse Event|0|||
161898115|NCT00572455|584675567|FG003|Stage I (14 Days)|Adverse Event|0|||
161898116|NCT00572455|584675568|FG004|Stage I (14 Days)|Adverse Event|0|||
161898117|NCT00572455|584675569|FG005|Stage I (14 Days)|Adverse Event|3|||
161898118|NCT00572455|584675570|FG006|Stage I (14 Days)|Adverse Event|0|||
161898119|NCT00572455|584675571|FG007|Stage I (14 Days)|Adverse Event|0|||
161898120|NCT00572455|584675572|FG008|Stage I (14 Days)|Adverse Event|0|||
161898121|NCT00572455|584675573|FG009|Stage I (14 Days)|Adverse Event|0|||
161552439|NCT02733042|583410443|FG016|Overall Study|Death|0|||
161436077|NCT02435992|582991279|FG001|Overall Study|non compliance with protocol|0|||
161436078|NCT02435992|582991280|FG002|Overall Study|non compliance with protocol|1|||
161436079|NCT02435992|582991281|FG003|Overall Study|non compliance with protocol|0|||
161436080|NCT02435992|582991282|FG004|Overall Study|non compliance with protocol|0|||
161436081|NCT02435992|582991278|FG000|Overall Study|Adverse Event|11|||
161784360|NCT01462695|584255458|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
161784361|NCT03196791|584255461|FG000|Overall Study|Protocol Violation|7|||
161784362|NCT03196791|584255462|FG001|Overall Study|Protocol Violation|3|||
161784363|NCT03196791|584255461|FG000|Overall Study|Withdrawal by Subject|3|||
161784364|NCT03196791|584255462|FG001|Overall Study|Withdrawal by Subject|2|||
161784365|NCT00051636|584255464|FG000|Period 1 - Core|Adverse Event|2|||
161784366|NCT00051636|584255465|FG001|Period 1 - Core|Adverse Event|2|||
161784367|NCT00051636|584255464|FG000|Period 1 - Core|Protocol Violation|1|||
161784368|NCT00051636|584255465|FG001|Period 1 - Core|Protocol Violation|0|||
161784369|NCT00051636|584255464|FG000|Period 1 - Core|Withdrawal by Subject|1|||
161784370|NCT00051636|584255465|FG001|Period 1 - Core|Withdrawal by Subject|2|||
161784371|NCT00051636|584255464|FG000|Period 1 - Core|Lost to Follow-up|0|||
161784372|NCT00051636|584255465|FG001|Period 1 - Core|Lost to Follow-up|2|||
161784373|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
161784374|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
161784375|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
161784376|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
161784377|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
161784378|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
161784379|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Death|4|||
161784380|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Death|5|||
161784381|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
161784382|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
161784383|NCT02340078|584255466|FG000|Overall Study|Protocol Violation|1|||
161784384|NCT00944125|584255469|FG000|3 to 6 Months|Withdrawal by Subject|0|||
161784385|NCT00944125|584255470|FG001|3 to 6 Months|Withdrawal by Subject|2|||
161784386|NCT00944125|584255469|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
161784387|NCT00944125|584255470|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
161784388|NCT03338673|584255473|FG000|Overall Study|Lost to Follow-up|1|||
161784389|NCT03338673|584255474|FG001|Overall Study|Lost to Follow-up|1|||
161784390|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161784391|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
161784392|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161784393|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161784394|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161784395|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
161784396|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161784397|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161784398|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
161784399|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
161784400|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
161784401|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
161784402|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
161784403|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
161784404|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
161784405|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
161784406|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Death|0|||
161784407|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Death|1|||
161784408|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Death|0|||
161784409|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Death|0|||
161784410|NCT05788237|584255477|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161784411|NCT05788237|584255478|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161784412|NCT05788237|584255479|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
161784413|NCT05788237|584255480|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161784414|NCT05788237|584255477|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161784415|NCT05788237|584255478|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161784416|NCT05788237|584255479|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161784417|NCT05788237|584255480|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
161784418|NCT05788237|584255477|FG000|SSB (Approximately 1 Month)|Other|0|||
161784419|NCT05788237|584255478|FG001|SSB (Approximately 1 Month)|Other|0|||
161784420|NCT05788237|584255479|FG002|SSB (Approximately 1 Month)|Other|0|||
161784421|NCT05788237|584255480|FG003|SSB (Approximately 1 Month)|Other|1|||
161784422|NCT04335110|584257319|FG000|Overall Study|Withdrawal by Subject|1|||
161784423|NCT04335110|584257320|FG001|Overall Study|Withdrawal by Subject|1|||
161784424|NCT04335110|584257319|FG000|Overall Study|Death|0|||
161784425|NCT04335110|584257320|FG001|Overall Study|Death|1|||
161898122|NCT00572455|584675574|FG010|Stage I (14 Days)|Adverse Event|0|||
161552440|NCT02733042|583410444|FG017|Overall Study|Death|0|||
161784426|NCT03451331|584257328|FG000|Overall Study|Withdrawal by Subject|1|||
161784427|NCT03451331|584257329|FG001|Overall Study|Withdrawal by Subject|0|||
161898123|NCT00572455|584675575|FG011|Stage I (14 Days)|Adverse Event|0|||
161784428|NCT03451331|584257328|FG000|Overall Study|Unable to start treatment.|1|||
161784429|NCT03451331|584257329|FG001|Overall Study|Unable to start treatment.|1|||
161784430|NCT00618774|584257333|FG000|Overall Study|Adverse Event|5|||
161784431|NCT00618774|584257334|FG001|Overall Study|Adverse Event|3|||
161784432|NCT00618774|584257333|FG000|Overall Study|Withdrawal by Subject|1|||
161784433|NCT00618774|584257334|FG001|Overall Study|Withdrawal by Subject|0|||
161784434|NCT02424565|584257335|FG000|Period 1 (D0)|Protocol Violation|0|||
161784435|NCT02424565|584257336|FG001|Period 1 (D0)|Protocol Violation|1|||
161784436|NCT01808209|584257337|FG000|Overall Study|Lost to Follow-up|0|||
161784437|NCT01808209|584257338|FG001|Overall Study|Lost to Follow-up|1|||
161784438|NCT04228302|584257345|FG000|Overall Study|Adverse Event|0|||
161898124|NCT00572455|584675576|FG012|Stage I (14 Days)|Adverse Event|0|||
161898125|NCT00572455|584675577|FG013|Stage I (14 Days)|Adverse Event|0|||
161552441|NCT02733042|583410445|FG018|Overall Study|Death|0|||
161784439|NCT04228302|584257346|FG001|Overall Study|Adverse Event|0|||
161784440|NCT04228302|584257347|FG002|Overall Study|Adverse Event|0|||
161898126|NCT00572455|584675564|FG000|Stage I (14 Days)|Other|0|||
161898127|NCT00572455|584675565|FG001|Stage I (14 Days)|Other|0|||
161898128|NCT00572455|584675566|FG002|Stage I (14 Days)|Other|0|||
161898129|NCT00572455|584675567|FG003|Stage I (14 Days)|Other|0|||
161898130|NCT00572455|584675568|FG004|Stage I (14 Days)|Other|1|||
161898131|NCT00572455|584675569|FG005|Stage I (14 Days)|Other|0|||
161898132|NCT00572455|584675570|FG006|Stage I (14 Days)|Other|0|||
161898133|NCT00572455|584675571|FG007|Stage I (14 Days)|Other|0|||
161898134|NCT00572455|584675572|FG008|Stage I (14 Days)|Other|0|||
161898135|NCT00572455|584675573|FG009|Stage I (14 Days)|Other|0|||
161898136|NCT00572455|584675574|FG010|Stage I (14 Days)|Other|0|||
161898137|NCT00572455|584675575|FG011|Stage I (14 Days)|Other|0|||
161898138|NCT00572455|584675576|FG012|Stage I (14 Days)|Other|0|||
161898139|NCT00572455|584675577|FG013|Stage I (14 Days)|Other|0|||
161898140|NCT00572455|584675564|FG000|Stage II (28 Days)|Adverse Event|0|||
161898141|NCT00572455|584675565|FG001|Stage II (28 Days)|Adverse Event|0|||
161898142|NCT00572455|584675566|FG002|Stage II (28 Days)|Adverse Event|0|||
161898143|NCT00572455|584675567|FG003|Stage II (28 Days)|Adverse Event|0|||
161898144|NCT00572455|584675568|FG004|Stage II (28 Days)|Adverse Event|0|||
161898145|NCT00572455|584675569|FG005|Stage II (28 Days)|Adverse Event|0|||
161898146|NCT00572455|584675570|FG006|Stage II (28 Days)|Adverse Event|0|||
161898147|NCT00572455|584675571|FG007|Stage II (28 Days)|Adverse Event|0|||
161898148|NCT00572455|584675572|FG008|Stage II (28 Days)|Adverse Event|1|||
161898149|NCT00572455|584675573|FG009|Stage II (28 Days)|Adverse Event|3|||
161898150|NCT00572455|584675574|FG010|Stage II (28 Days)|Adverse Event|3|||
161898151|NCT00572455|584675575|FG011|Stage II (28 Days)|Adverse Event|4|||
161898152|NCT00572455|584675576|FG012|Stage II (28 Days)|Adverse Event|5|||
161898153|NCT00572455|584675577|FG013|Stage II (28 Days)|Adverse Event|1|||
161898154|NCT00572455|584675564|FG000|Stage II (28 Days)|Death|0|||
161898155|NCT00572455|584675565|FG001|Stage II (28 Days)|Death|0|||
161898156|NCT00572455|584675566|FG002|Stage II (28 Days)|Death|0|||
161898157|NCT00572455|584675567|FG003|Stage II (28 Days)|Death|0|||
161898158|NCT00572455|584675568|FG004|Stage II (28 Days)|Death|0|||
161898159|NCT00572455|584675569|FG005|Stage II (28 Days)|Death|0|||
161898160|NCT00572455|584675570|FG006|Stage II (28 Days)|Death|0|||
161898161|NCT00572455|584675571|FG007|Stage II (28 Days)|Death|0|||
161898162|NCT00572455|584675572|FG008|Stage II (28 Days)|Death|1|||
161898163|NCT00572455|584675573|FG009|Stage II (28 Days)|Death|0|||
161898164|NCT00572455|584675574|FG010|Stage II (28 Days)|Death|0|||
161898165|NCT00572455|584675575|FG011|Stage II (28 Days)|Death|0|||
161898166|NCT00572455|584675576|FG012|Stage II (28 Days)|Death|0|||
161898167|NCT00572455|584675577|FG013|Stage II (28 Days)|Death|0|||
161898168|NCT00572455|584675564|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
161898169|NCT00572455|584675565|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
161898170|NCT00572455|584675566|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
161898171|NCT00572455|584675567|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
161898172|NCT00572455|584675568|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
161898173|NCT00572455|584675569|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
161898174|NCT00572455|584675570|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
161898175|NCT00572455|584675571|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
161898176|NCT00572455|584675572|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
161898177|NCT00572455|584675573|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
161898178|NCT00572455|584675574|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
161898179|NCT00572455|584675575|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
161898180|NCT00572455|584675576|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
161898181|NCT00572455|584675577|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
161898182|NCT00572455|584675564|FG000|Stage II (28 Days)|Other|0|||
161898183|NCT00572455|584675565|FG001|Stage II (28 Days)|Other|0|||
161898184|NCT00572455|584675566|FG002|Stage II (28 Days)|Other|0|||
161898185|NCT00572455|584675567|FG003|Stage II (28 Days)|Other|0|||
161898186|NCT00572455|584675568|FG004|Stage II (28 Days)|Other|0|||
161898187|NCT00572455|584675569|FG005|Stage II (28 Days)|Other|0|||
161898188|NCT00572455|584675570|FG006|Stage II (28 Days)|Other|0|||
161898189|NCT00572455|584675571|FG007|Stage II (28 Days)|Other|0|||
161436082|NCT02435992|582991279|FG001|Overall Study|Adverse Event|6|||
161436083|NCT02435992|582991280|FG002|Overall Study|Adverse Event|12|||
161436084|NCT02435992|582991281|FG003|Overall Study|Adverse Event|0|||
161436085|NCT02435992|582991282|FG004|Overall Study|Adverse Event|0|||
161436086|NCT02435992|582991278|FG000|Overall Study|Lack of Efficacy|4|||
161436087|NCT02435992|582991279|FG001|Overall Study|Lack of Efficacy|10|||
161436088|NCT02435992|582991280|FG002|Overall Study|Lack of Efficacy|9|||
161436089|NCT02435992|582991281|FG003|Overall Study|Lack of Efficacy|0|||
161436090|NCT02435992|582991282|FG004|Overall Study|Lack of Efficacy|0|||
161436091|NCT02435992|582991278|FG000|Overall Study|Withdrawal by Subject|10|||
161436092|NCT02435992|582991279|FG001|Overall Study|Withdrawal by Subject|8|||
161436093|NCT02435992|582991280|FG002|Overall Study|Withdrawal by Subject|20|||
161436094|NCT02435992|582991281|FG003|Overall Study|Withdrawal by Subject|0|||
161436095|NCT02435992|582991282|FG004|Overall Study|Withdrawal by Subject|0|||
161436096|NCT02435992|582991278|FG000|Overall Study|Other Reason|1|||
161436097|NCT02435992|582991279|FG001|Overall Study|Other Reason|0|||
161436098|NCT02435992|582991280|FG002|Overall Study|Other Reason|0|||
161436099|NCT02435992|582991281|FG003|Overall Study|Other Reason|0|||
161436100|NCT02435992|582991282|FG004|Overall Study|Other Reason|0|||
161436101|NCT02435992|582991278|FG000|Overall Study|Physician Decision|0|||
161436102|NCT02435992|582991279|FG001|Overall Study|Physician Decision|0|||
161436103|NCT02435992|582991280|FG002|Overall Study|Physician Decision|1|||
161436104|NCT02435992|582991281|FG003|Overall Study|Physician Decision|0|||
161436105|NCT02435992|582991282|FG004|Overall Study|Physician Decision|0|||
161436106|NCT02224560|582991285|FG000|Overall Study|Protocol Deviation|1|||
161436107|NCT02224560|582991286|FG001|Overall Study|Protocol Deviation|0|||
161436108|NCT02224560|582991287|FG002|Overall Study|Protocol Deviation|0|||
161436109|NCT02224560|582991285|FG000|Overall Study|Withdrawal by Subject|2|||
161436110|NCT02224560|582991286|FG001|Overall Study|Withdrawal by Subject|0|||
161436111|NCT02224560|582991287|FG002|Overall Study|Withdrawal by Subject|1|||
161436112|NCT02224560|582991285|FG000|Overall Study|Met Withdrawal Criteria|1|||
161436113|NCT02224560|582991286|FG001|Overall Study|Met Withdrawal Criteria|0|||
161436114|NCT02224560|582991287|FG002|Overall Study|Met Withdrawal Criteria|0|||
161436115|NCT02224560|582991285|FG000|Overall Study|Adverse Event|4|||
161436116|NCT02224560|582991286|FG001|Overall Study|Adverse Event|1|||
161436117|NCT02224560|582991287|FG002|Overall Study|Adverse Event|1|||
161436118|NCT02224560|582991285|FG000|Overall Study|Withdrawn by Investigator|1|||
161436119|NCT02224560|582991286|FG001|Overall Study|Withdrawn by Investigator|1|||
161436120|NCT02224560|582991287|FG002|Overall Study|Withdrawn by Investigator|0|||
161436121|NCT00728689|582991288|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
161436122|NCT00728689|582991289|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
161436123|NCT01523366|582991290|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161784441|NCT04228302|584257348|FG003|Overall Study|Adverse Event|0|||
161784442|NCT04228302|584257349|FG004|Overall Study|Adverse Event|1|||
161436124|NCT01523366|582991291|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161784443|NCT04228302|584257350|FG005|Overall Study|Adverse Event|0|||
161436125|NCT01523366|582991290|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
161436126|NCT01523366|582991291|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
161436127|NCT02461758|582991292|FG000|Overall Study|Lost to Follow-up|0|||
161436128|NCT02461758|582991293|FG001|Overall Study|Lost to Follow-up|1|||
161436129|NCT02461758|582991294|FG002|Overall Study|Lost to Follow-up|1|||
161784444|NCT00685919|584257351|FG000|Overall Study|Withdrawal by Subject|0|||
161784445|NCT00685919|584257352|FG001|Overall Study|Withdrawal by Subject|0|||
161436130|NCT02461758|582991295|FG003|Overall Study|Lost to Follow-up|0|||
161436131|NCT04543279|582991297|FG000|Overall Study|Withdrawal by Subject|1|||
161436132|NCT04543279|582991298|FG001|Overall Study|Withdrawal by Subject|0|||
161436133|NCT04543279|582991297|FG000|Overall Study|Adverse Event|1|||
161436134|NCT04543279|582991298|FG001|Overall Study|Adverse Event|0|||
161436135|NCT04543279|582991297|FG000|Overall Study|Physician Decision|1|||
161436136|NCT04543279|582991298|FG001|Overall Study|Physician Decision|0|||
161436137|NCT00929695|582991301|FG000|Overall Study|Death|2|||
161436138|NCT00929695|582991302|FG001|Overall Study|Death|1|||
161436139|NCT00929695|582991301|FG000|Overall Study|Withdrawal by Subject|0|||
161436140|NCT00929695|582991302|FG001|Overall Study|Withdrawal by Subject|2|||
161436141|NCT00929695|582991301|FG000|Overall Study|discharge home|4|||
161436142|NCT00929695|582991302|FG001|Overall Study|discharge home|3|||
161436143|NCT00929695|582991301|FG000|Overall Study|incorrect stratification|2|||
161436144|NCT00929695|582991302|FG001|Overall Study|incorrect stratification|0|||
161436145|NCT04030143|582991303|FG000|Overall Study|Adverse Event|5|||
161436146|NCT04030143|582991304|FG001|Overall Study|Adverse Event|10|||
161436147|NCT04030143|582991303|FG000|Overall Study|Lost to Follow-up|3|||
161436148|NCT04030143|582991304|FG001|Overall Study|Lost to Follow-up|7|||
161436149|NCT04030143|582991303|FG000|Overall Study|Protocol Deviation|2|||
161436150|NCT04030143|582991304|FG001|Overall Study|Protocol Deviation|2|||
161436151|NCT04030143|582991303|FG000|Overall Study|Withdrawal by Subject|16|||
161436152|NCT04030143|582991304|FG001|Overall Study|Withdrawal by Subject|18|||
161436153|NCT04030143|582991303|FG000|Overall Study|Physician Decision|1|||
161436154|NCT04030143|582991304|FG001|Overall Study|Physician Decision|1|||
161436155|NCT04030143|582991303|FG000|Overall Study|Due to Covid-19|2|||
161436156|NCT04030143|582991304|FG001|Overall Study|Due to Covid-19|3|||
161436157|NCT04030143|582991303|FG000|Overall Study|Not Due to Covid-19|1|||
161436158|NCT04030143|582991304|FG001|Overall Study|Not Due to Covid-19|1|||
161436159|NCT03216226|582991305|FG000|Overall Study|Adverse Event|3|||
161436160|NCT03216226|582991306|FG001|Overall Study|Adverse Event|0|||
161436161|NCT03216226|582991305|FG000|Overall Study|Protocol Violation|1|||
161436162|NCT03216226|582991306|FG001|Overall Study|Protocol Violation|3|||
161436163|NCT03216226|582991305|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
161436164|NCT03216226|582991306|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
161436165|NCT03216226|582991305|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
161436166|NCT03216226|582991306|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
161436167|NCT03216226|582991305|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
161436168|NCT03216226|582991306|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
161436169|NCT01210313|582991312|FG000|Overall Study|Withdrawal by Subject|3|||
161436170|NCT01210313|582991312|FG000|Overall Study|Adverse Event|2|||
161436171|NCT01210313|582991312|FG000|Overall Study|Distant recurrence|4|||
161436172|NCT01210313|582991312|FG000|Overall Study|Non-compliance|7|||
161436173|NCT03113487|582991315|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
161436174|NCT01502293|582991316|FG000|Overall Study|Progressive Disease|20|||
161436175|NCT01502293|582991317|FG001|Overall Study|Progressive Disease|12|||
161436176|NCT01502293|582991318|FG002|Overall Study|Progressive Disease|2|||
161436177|NCT01502293|582991316|FG000|Overall Study|Withdrawal by Subject|3|||
161436178|NCT01502293|582991317|FG001|Overall Study|Withdrawal by Subject|3|||
161436179|NCT01502293|582991318|FG002|Overall Study|Withdrawal by Subject|1|||
161436180|NCT01502293|582991316|FG000|Overall Study|Adverse Event|0|||
161436181|NCT01502293|582991317|FG001|Overall Study|Adverse Event|2|||
161784446|NCT00685919|584257353|FG002|Overall Study|Withdrawal by Subject|1|||
161436182|NCT01502293|582991318|FG002|Overall Study|Adverse Event|0|||
161784447|NCT00685919|584257354|FG003|Overall Study|Withdrawal by Subject|0|||
161784448|NCT00685919|584257351|FG000|Overall Study|Physician Decision|1|||
161436183|NCT01502293|582991316|FG000|Overall Study|Reason Not Specified|2|||
161436184|NCT01502293|582991317|FG001|Overall Study|Reason Not Specified|0|||
161436185|NCT01502293|582991318|FG002|Overall Study|Reason Not Specified|0|||
161436186|NCT01502293|582991316|FG000|Overall Study|Physician Decision|0|||
161436187|NCT01502293|582991317|FG001|Overall Study|Physician Decision|0|||
161436188|NCT01502293|582991318|FG002|Overall Study|Physician Decision|1|||
161436189|NCT00391586|582991320|FG000|Overall Study|Progressive disease|13|||
161436190|NCT00391586|582991320|FG000|Overall Study|Adverse Event|5|||
161436191|NCT00391586|582991320|FG000|Overall Study|Physician Decision|2|||
161436192|NCT00391586|582991320|FG000|Overall Study|Death|4|||
161436193|NCT01409707|582991321|FG000|Overall Study|Withdrawal by Subject|5|||
161784449|NCT00685919|584257352|FG001|Overall Study|Physician Decision|0|||
161436194|NCT01409707|582991322|FG001|Overall Study|Withdrawal by Subject|17|||
161436195|NCT01409707|582991323|FG002|Overall Study|Withdrawal by Subject|16|||
161436196|NCT03058146|582991324|FG000|Overall Study|Withdrawal by Subject|4|||
161436197|NCT03058146|582991325|FG001|Overall Study|Withdrawal by Subject|1|||
161436198|NCT03058146|582991324|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
161436199|NCT03058146|582991325|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
161436200|NCT00632229|582991326|FG000|Overall Study|Adverse Event|6|||
161436201|NCT00632229|582991327|FG001|Overall Study|Adverse Event|0|||
161436202|NCT00632229|582991326|FG000|Overall Study|Lost to Follow-up|0|||
161436203|NCT00632229|582991327|FG001|Overall Study|Lost to Follow-up|3|||
161436204|NCT00632229|582991326|FG000|Overall Study|Lack of Efficacy|0|||
161436205|NCT00632229|582991327|FG001|Overall Study|Lack of Efficacy|2|||
161436206|NCT00632229|582991326|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
161436207|NCT00632229|582991327|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
161436208|NCT03041181|582991328|FG000|Overall Study|Disease Progression|1|||
161436209|NCT03041181|582991329|FG001|Overall Study|Disease Progression|2|||
161436210|NCT01716234|582991330|FG000|Overall Study|Protocol Violation|0|||
161436211|NCT01716234|582991331|FG001|Overall Study|Protocol Violation|0|||
161436212|NCT01716234|582991332|FG002|Overall Study|Protocol Violation|0|||
161436213|NCT01716234|582991333|FG003|Overall Study|Protocol Violation|1|||
161436214|NCT01716234|582991334|FG004|Overall Study|Protocol Violation|1|||
161436215|NCT01716234|582991335|FG005|Overall Study|Protocol Violation|1|||
161436216|NCT01716234|582991336|FG006|Overall Study|Protocol Violation|0|||
161436217|NCT01716234|582991330|FG000|Overall Study|Lack of Efficacy|0|||
161436218|NCT01716234|582991331|FG001|Overall Study|Lack of Efficacy|0|||
161436219|NCT01716234|582991332|FG002|Overall Study|Lack of Efficacy|0|||
161436220|NCT01716234|582991333|FG003|Overall Study|Lack of Efficacy|1|||
161436221|NCT01716234|582991334|FG004|Overall Study|Lack of Efficacy|0|||
161436222|NCT01716234|582991335|FG005|Overall Study|Lack of Efficacy|0|||
161436223|NCT01716234|582991336|FG006|Overall Study|Lack of Efficacy|0|||
161436224|NCT01716234|582991330|FG000|Overall Study|Did not meet protocol eligibility|0|||
161436225|NCT01716234|582991331|FG001|Overall Study|Did not meet protocol eligibility|0|||
161436226|NCT01716234|582991332|FG002|Overall Study|Did not meet protocol eligibility|1|||
161436227|NCT01716234|582991333|FG003|Overall Study|Did not meet protocol eligibility|0|||
161436228|NCT01716234|582991334|FG004|Overall Study|Did not meet protocol eligibility|0|||
161436229|NCT01716234|582991335|FG005|Overall Study|Did not meet protocol eligibility|4|||
161436230|NCT01716234|582991336|FG006|Overall Study|Did not meet protocol eligibility|0|||
161436231|NCT01716234|582991330|FG000|Overall Study|Adverse Event|7|||
161436232|NCT01716234|582991331|FG001|Overall Study|Adverse Event|10|||
161436233|NCT01716234|582991332|FG002|Overall Study|Adverse Event|2|||
161436234|NCT01716234|582991333|FG003|Overall Study|Adverse Event|8|||
161436235|NCT01716234|582991334|FG004|Overall Study|Adverse Event|3|||
161436236|NCT01716234|582991335|FG005|Overall Study|Adverse Event|6|||
161436237|NCT01716234|582991336|FG006|Overall Study|Adverse Event|0|||
161436238|NCT01716234|582991330|FG000|Overall Study|Withdrawal by Subject|3|||
161784450|NCT00685919|584257353|FG002|Overall Study|Physician Decision|0|||
161784451|NCT00685919|584257354|FG003|Overall Study|Physician Decision|0|||
161784452|NCT00736333|584257355|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
161784453|NCT00736333|584257355|FG000|Overall Study|Data Missing|2|||
161436239|NCT01716234|582991331|FG001|Overall Study|Withdrawal by Subject|0|||
161436240|NCT01716234|582991332|FG002|Overall Study|Withdrawal by Subject|2|||
161436241|NCT01716234|582991333|FG003|Overall Study|Withdrawal by Subject|2|||
161436242|NCT01716234|582991334|FG004|Overall Study|Withdrawal by Subject|1|||
161436243|NCT01716234|582991335|FG005|Overall Study|Withdrawal by Subject|3|||
161436244|NCT01716234|582991336|FG006|Overall Study|Withdrawal by Subject|0|||
161784454|NCT00736333|584257355|FG000|Overall Study|Tumor Progression|75|||
161436245|NCT02667119|582991337|FG000|Overall Study|Lost to Follow-up|3|||
161436246|NCT02667119|582991338|FG001|Overall Study|Lost to Follow-up|0|||
161436247|NCT00521079|582991341|FG000|Overall Study|Adverse Event|7|||
161436248|NCT00521079|582991342|FG001|Overall Study|Adverse Event|1|||
161436249|NCT00521079|582991341|FG000|Overall Study|Lost to Follow-up|2|||
161436250|NCT00521079|582991342|FG001|Overall Study|Lost to Follow-up|1|||
161436251|NCT00521079|582991341|FG000|Overall Study|Withdrawal by Subject|5|||
161436252|NCT00521079|582991342|FG001|Overall Study|Withdrawal by Subject|3|||
161552442|NCT02066532|583410450|FG000|Phase II|Withdrawal by Subject|1|||
161784455|NCT00736333|584257355|FG000|Overall Study|Toxicity|6|||
161436253|NCT04672239|582991345|FG000|Week 2 Survey|Failed survey check items|1|||
161436254|NCT04672239|582991346|FG001|Week 2 Survey|Failed survey check items|2|||
161436255|NCT04672239|582991347|FG002|Week 2 Survey|Failed survey check items|3|||
161436256|NCT04672239|582991345|FG000|Week 2 Survey|Partially completed survey|7|||
161436257|NCT04672239|582991346|FG001|Week 2 Survey|Partially completed survey|1|||
161436258|NCT04672239|582991347|FG002|Week 2 Survey|Partially completed survey|4|||
161436259|NCT04672239|582991345|FG000|Week 2 Survey|Withdrawal by Subject|0|||
161436260|NCT04672239|582991346|FG001|Week 2 Survey|Withdrawal by Subject|1|||
161436261|NCT04672239|582991347|FG002|Week 2 Survey|Withdrawal by Subject|0|||
161436262|NCT04672239|582991345|FG000|Week 2 Survey|Lost to Follow-up|3|||
161436263|NCT04672239|582991346|FG001|Week 2 Survey|Lost to Follow-up|2|||
161436264|NCT04672239|582991347|FG002|Week 2 Survey|Lost to Follow-up|5|||
161436265|NCT04672239|582991345|FG000|Week 6 Survey|Failed survey check items|2|||
161436266|NCT04672239|582991346|FG001|Week 6 Survey|Failed survey check items|2|||
161436267|NCT04672239|582991347|FG002|Week 6 Survey|Failed survey check items|2|||
161436268|NCT04672239|582991345|FG000|Week 6 Survey|Partially completed survey|3|||
161436269|NCT04672239|582991346|FG001|Week 6 Survey|Partially completed survey|3|||
161436270|NCT04672239|582991347|FG002|Week 6 Survey|Partially completed survey|2|||
161436271|NCT04672239|582991345|FG000|Week 6 Survey|Withdrawal by Subject|1|||
161436272|NCT04672239|582991346|FG001|Week 6 Survey|Withdrawal by Subject|1|||
161436273|NCT04672239|582991347|FG002|Week 6 Survey|Withdrawal by Subject|1|||
161436274|NCT04672239|582991345|FG000|Week 6 Survey|Withdrawn by PI|0|||
161436275|NCT04672239|582991346|FG001|Week 6 Survey|Withdrawn by PI|1|||
161436276|NCT04672239|582991347|FG002|Week 6 Survey|Withdrawn by PI|0|||
161436277|NCT04672239|582991345|FG000|Week 6 Survey|Lost to Follow-up|12|||
161436278|NCT04672239|582991346|FG001|Week 6 Survey|Lost to Follow-up|2|||
161436279|NCT04672239|582991347|FG002|Week 6 Survey|Lost to Follow-up|5|||
161436280|NCT04672239|582991345|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
161436281|NCT04672239|582991346|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
161436282|NCT04672239|582991347|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
161436283|NCT04672239|582991345|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
161436284|NCT04672239|582991346|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
161436285|NCT04672239|582991347|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
161436286|NCT04672239|582991345|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
161436287|NCT04672239|582991346|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
161436288|NCT04672239|582991347|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
161436289|NCT04672239|582991345|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
161436290|NCT04672239|582991346|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
161436291|NCT04672239|582991347|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
161436292|NCT04672239|582991345|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
161436293|NCT04672239|582991346|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
161436294|NCT04672239|582991347|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
161436295|NCT04672239|582991345|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
161436296|NCT04672239|582991346|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
161436297|NCT04672239|582991347|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
161436298|NCT04672239|582991345|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
161436299|NCT04672239|582991346|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
161436300|NCT04672239|582991347|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
161436301|NCT04123470|582991348|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
161436302|NCT04123470|582991349|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
161436303|NCT04123470|582991348|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
161436304|NCT04123470|582991349|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
161436305|NCT04123470|582991348|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
161436306|NCT04123470|582991349|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
161436307|NCT04123470|582991348|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
161436308|NCT04123470|582991349|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
161436309|NCT05972993|582991350|FG000|Overall Study|Lost to Follow-up|2|||
161436310|NCT05972993|582991351|FG001|Overall Study|Lost to Follow-up|0|||
161436311|NCT05972993|582991352|FG002|Overall Study|Lost to Follow-up|1|||
161436312|NCT05972993|582991353|FG003|Overall Study|Lost to Follow-up|0|||
161436313|NCT05972993|582991354|FG004|Overall Study|Lost to Follow-up|0|||
161436314|NCT05972993|582991355|FG005|Overall Study|Lost to Follow-up|0|||
161436315|NCT05972993|582991356|FG006|Overall Study|Lost to Follow-up|0|||
161436316|NCT05972993|582991357|FG007|Overall Study|Lost to Follow-up|2|||
161436317|NCT05972993|582991358|FG008|Overall Study|Lost to Follow-up|0|||
161552443|NCT02066532|583410451|FG001|Phase II|Withdrawal by Subject|0|||
161436318|NCT04825678|582991360|FG000|Overall Study|Decision by Sponsor|2|||
161436319|NCT04825678|582991361|FG001|Overall Study|Decision by Sponsor|3|||
161436320|NCT04825678|582991360|FG000|Overall Study|Withdrawal of Consent From Study|7|||
161436321|NCT04825678|582991361|FG001|Overall Study|Withdrawal of Consent From Study|9|||
161436322|NCT04825678|582991360|FG000|Overall Study|Lost to Follow-up|3|||
161436323|NCT04825678|582991361|FG001|Overall Study|Lost to Follow-up|4|||
161436324|NCT04825678|582991360|FG000|Overall Study|Never Received Investigational Product|1|||
161436325|NCT04825678|582991361|FG001|Overall Study|Never Received Investigational Product|1|||
161436326|NCT05430854|582991364|FG000|Overall Study|Trial terminated by Sponsor|39|||
161436327|NCT05430854|582991365|FG001|Overall Study|Trial terminated by Sponsor|50|||
161436328|NCT05430854|582991366|FG002|Overall Study|Trial terminated by Sponsor|46|||
161436329|NCT05430854|582991364|FG000|Overall Study|Withdrawal by Subject|0|||
161436330|NCT05430854|582991365|FG001|Overall Study|Withdrawal by Subject|3|||
161436331|NCT05430854|582991366|FG002|Overall Study|Withdrawal by Subject|0|||
161436332|NCT00911170|582991372|FG000|Treatment Period|Randomized in error|1|||
161436333|NCT00911170|582991373|FG001|Treatment Period|Randomized in error|1|||
161436334|NCT00911170|582991372|FG000|Treatment Period|Ineligibility determined|1|||
161436335|NCT00911170|582991373|FG001|Treatment Period|Ineligibility determined|3|||
161436336|NCT00911170|582991372|FG000|Treatment Period|Protocol deviation|1|||
161436337|NCT00911170|582991373|FG001|Treatment Period|Protocol deviation|2|||
161436338|NCT00911170|582991372|FG000|Treatment Period|Adverse Event|9|||
161436339|NCT00911170|582991373|FG001|Treatment Period|Adverse Event|10|||
161436340|NCT00911170|582991372|FG000|Treatment Period|Withdrawal by Subject|4|||
161436341|NCT00911170|582991373|FG001|Treatment Period|Withdrawal by Subject|4|||
161436342|NCT00911170|582991372|FG000|Treatment Period|Disease progression|0|||
161436343|NCT00911170|582991373|FG001|Treatment Period|Disease progression|2|||
161436344|NCT00911170|582991372|FG000|Treatment Period|Physician Decision|5|||
161436345|NCT00911170|582991373|FG001|Treatment Period|Physician Decision|5|||
161436346|NCT00911170|582991372|FG000|Treatment Period|Lost to Follow-up|0|||
161436347|NCT00911170|582991373|FG001|Treatment Period|Lost to Follow-up|1|||
161436348|NCT00911170|582991372|FG000|Treatment Period|Death|6|||
161436349|NCT00911170|582991373|FG001|Treatment Period|Death|9|||
161436350|NCT00911170|582991372|FG000|Long Term Follow-Up|Continuing in study|274|||
161436351|NCT00911170|582991373|FG001|Long Term Follow-Up|Continuing in study|269|||
161436352|NCT00911170|582991372|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
161436353|NCT00911170|582991373|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
161436354|NCT00911170|582991372|FG000|Long Term Follow-Up|Physician Decision|5|||
161436355|NCT00911170|582991373|FG001|Long Term Follow-Up|Physician Decision|4|||
161436356|NCT00911170|582991372|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
161436357|NCT00911170|582991373|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
161436358|NCT00911170|582991372|FG000|Long Term Follow-Up|Death|116|||
161436359|NCT00911170|582991373|FG001|Long Term Follow-Up|Death|121|||
161436360|NCT02681523|582991374|FG000|Overall Study|Adverse Event|1|||
161436361|NCT02681523|582991374|FG000|Overall Study|Patient Non-compliance|1|||
161436362|NCT03253393|582991378|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
161436363|NCT03253393|582991379|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
161436364|NCT03253393|582991380|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
161436365|NCT03312634|582992947|FG000|Overall Study|Adverse Event|11|||
161436366|NCT03312634|582992948|FG001|Overall Study|Adverse Event|0|||
161436367|NCT03312634|582992947|FG000|Overall Study|Sponsor request|2|||
161436368|NCT03312634|582992948|FG001|Overall Study|Sponsor request|0|||
161436369|NCT03312634|582992947|FG000|Overall Study|Withdrawal by Subject|31|||
161436370|NCT03312634|582992948|FG001|Overall Study|Withdrawal by Subject|9|||
161436371|NCT03312634|582992947|FG000|Overall Study|Enrolled in an interventional study|0|||
161436372|NCT03312634|582992948|FG001|Overall Study|Enrolled in an interventional study|52|||
161436373|NCT03312634|582992947|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
161436374|NCT03312634|582992948|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
161436375|NCT03312634|582992947|FG000|Overall Study|Death|0|||
161436376|NCT03312634|582992948|FG001|Overall Study|Death|1|||
161436377|NCT03312634|582992947|FG000|Overall Study|Non-compliance|0|||
161436378|NCT03312634|582992948|FG001|Overall Study|Non-compliance|2|||
161436379|NCT03312634|582992947|FG000|Overall Study|Lost to Follow-up|0|||
161436380|NCT03312634|582992948|FG001|Overall Study|Lost to Follow-up|1|||
161436381|NCT03312634|582992947|FG000|Overall Study|Enrolled into non-interventional study|0|||
161436382|NCT03312634|582992948|FG001|Overall Study|Enrolled into non-interventional study|5|||
161436383|NCT03312634|582992947|FG000|Overall Study|Worsening clinical condition|0|||
161436384|NCT03312634|582992948|FG001|Overall Study|Worsening clinical condition|1|||
161436385|NCT03312634|582992947|FG000|Overall Study|Participant did not want to travel|0|||
161436386|NCT03312634|582992948|FG001|Overall Study|Participant did not want to travel|1|||
161436387|NCT03312634|582992947|FG000|Overall Study|Physician Decision|1|||
161436388|NCT03312634|582992948|FG001|Overall Study|Physician Decision|0|||
161436389|NCT03312634|582992947|FG000|Overall Study|Other|13|||
161436390|NCT03312634|582992948|FG001|Overall Study|Other|0|||
161436391|NCT02079246|582992949|FG000|OLEX|Withdrawal before treatment|1|||
161436392|NCT02079246|582992950|FG001|OLEX|Withdrawal before treatment|0|||
161436393|NCT02079246|582992949|FG000|OLEX|Death|11|||
161436394|NCT02079246|582992950|FG001|OLEX|Death|0|||
161436395|NCT02079246|582992949|FG000|OLEX|Adverse Event|66|||
161436396|NCT02079246|582992950|FG001|OLEX|Adverse Event|0|||
161436397|NCT02079246|582992949|FG000|OLEX|Withdrawal by Subject|60|||
161436398|NCT02079246|582992950|FG001|OLEX|Withdrawal by Subject|0|||
161436399|NCT02079246|582992949|FG000|OLEX|Lost to Follow-up|6|||
161436400|NCT02079246|582992950|FG001|OLEX|Lost to Follow-up|0|||
161436401|NCT02079246|582992949|FG000|OLEX|Protocol Violation|6|||
161436402|NCT02079246|582992950|FG001|OLEX|Protocol Violation|0|||
161784456|NCT00736333|584257355|FG000|Overall Study|Withdrawal by Subject|10|||
161784457|NCT00736333|584257355|FG000|Overall Study|Death|7|||
161784458|NCT00736333|584257355|FG000|Overall Study|Other|4|||
161784459|NCT04991311|584257357|FG000|Overall Study|Adverse Event|1|||
161784460|NCT00054275|584257359|FG000|Overall Study|Withdrawal by Subject|4|||
161784461|NCT00054275|584257359|FG000|Overall Study|Adverse Event|5|||
161784462|NCT00054275|584257359|FG000|Overall Study|Progressive disease in cycle 1|1|||
161784463|NCT00054275|584257359|FG000|Overall Study|Physician Decision|1|||
161784464|NCT01106352|584257360|FG000|Overall Study|Subjects untreated|0|||
161784465|NCT01106352|584257361|FG001|Overall Study|Subjects untreated|0|||
161784466|NCT01106352|584257362|FG002|Overall Study|Subjects untreated|0|||
161784467|NCT01106352|584257363|FG003|Overall Study|Subjects untreated|3|||
161784468|NCT01106352|584257364|FG004|Overall Study|Subjects untreated|4|||
161784469|NCT01106352|584257360|FG000|Overall Study|Sponsor Decision|1|||
161784470|NCT01106352|584257361|FG001|Overall Study|Sponsor Decision|0|||
161784471|NCT01106352|584257362|FG002|Overall Study|Sponsor Decision|0|||
161784472|NCT01106352|584257363|FG003|Overall Study|Sponsor Decision|0|||
161784473|NCT01106352|584257364|FG004|Overall Study|Sponsor Decision|0|||
161784474|NCT01106352|584257360|FG000|Overall Study|Too ill to come in for the visit|0|||
161784475|NCT01106352|584257361|FG001|Overall Study|Too ill to come in for the visit|0|||
161784476|NCT01106352|584257362|FG002|Overall Study|Too ill to come in for the visit|1|||
161784477|NCT01106352|584257363|FG003|Overall Study|Too ill to come in for the visit|0|||
161784478|NCT01106352|584257364|FG004|Overall Study|Too ill to come in for the visit|0|||
161784479|NCT01106352|584257360|FG000|Overall Study|Lost to Follow-up|0|||
161784480|NCT01106352|584257361|FG001|Overall Study|Lost to Follow-up|0|||
161784481|NCT01106352|584257362|FG002|Overall Study|Lost to Follow-up|0|||
161784482|NCT01106352|584257363|FG003|Overall Study|Lost to Follow-up|0|||
161784483|NCT01106352|584257364|FG004|Overall Study|Lost to Follow-up|1|||
161784484|NCT01106352|584257360|FG000|Overall Study|Death|0|||
161784485|NCT01106352|584257361|FG001|Overall Study|Death|0|||
161784486|NCT01106352|584257362|FG002|Overall Study|Death|1|||
161784487|NCT01106352|584257363|FG003|Overall Study|Death|3|||
161784488|NCT01106352|584257364|FG004|Overall Study|Death|1|||
161784489|NCT01106352|584257360|FG000|Overall Study|Disease progression|0|||
161784490|NCT01106352|584257361|FG001|Overall Study|Disease progression|0|||
161784491|NCT01106352|584257362|FG002|Overall Study|Disease progression|0|||
161784492|NCT01106352|584257363|FG003|Overall Study|Disease progression|1|||
161784493|NCT01106352|584257364|FG004|Overall Study|Disease progression|0|||
161784494|NCT01106352|584257360|FG000|Overall Study|Withdrawal by Subject|0|||
161784495|NCT01106352|584257361|FG001|Overall Study|Withdrawal by Subject|0|||
161784496|NCT01106352|584257362|FG002|Overall Study|Withdrawal by Subject|0|||
161784497|NCT01106352|584257363|FG003|Overall Study|Withdrawal by Subject|3|||
161784498|NCT01106352|584257364|FG004|Overall Study|Withdrawal by Subject|2|||
161784499|NCT01106352|584257360|FG000|Overall Study|Went on hospice|0|||
161784500|NCT01106352|584257361|FG001|Overall Study|Went on hospice|0|||
161784501|NCT01106352|584257362|FG002|Overall Study|Went on hospice|0|||
161784502|NCT01106352|584257363|FG003|Overall Study|Went on hospice|1|||
161784503|NCT01106352|584257364|FG004|Overall Study|Went on hospice|0|||
161784504|NCT01106352|584257360|FG000|Overall Study|Subject entered hospice|0|||
161784505|NCT01106352|584257361|FG001|Overall Study|Subject entered hospice|0|||
161784506|NCT01106352|584257362|FG002|Overall Study|Subject entered hospice|0|||
161784507|NCT01106352|584257363|FG003|Overall Study|Subject entered hospice|1|||
161784508|NCT01106352|584257364|FG004|Overall Study|Subject entered hospice|0|||
161784509|NCT01106352|584257360|FG000|Overall Study|Home hospice since July 2013|0|||
161784510|NCT01106352|584257361|FG001|Overall Study|Home hospice since July 2013|0|||
161784511|NCT01106352|584257362|FG002|Overall Study|Home hospice since July 2013|0|||
161784512|NCT01106352|584257363|FG003|Overall Study|Home hospice since July 2013|1|||
161898190|NCT00572455|584675572|FG008|Stage II (28 Days)|Other|1|||
161898191|NCT00572455|584675573|FG009|Stage II (28 Days)|Other|0|||
161436403|NCT02079246|582992949|FG000|OLEX|Lack of Efficacy|3|||
161436404|NCT02079246|582992950|FG001|OLEX|Lack of Efficacy|0|||
161784513|NCT01106352|584257364|FG004|Overall Study|Home hospice since July 2013|0|||
161784514|NCT03944707|584257365|FG000|Overall Study|Adverse Event|0|||
161784515|NCT03944707|584257366|FG001|Overall Study|Adverse Event|2|||
161784516|NCT03944707|584257365|FG000|Overall Study|Study terminated by sponsor|12|||
161784517|NCT03944707|584257366|FG001|Overall Study|Study terminated by sponsor|7|||
161784518|NCT03944707|584257365|FG000|Overall Study|Subject decision|0|||
161784519|NCT03944707|584257366|FG001|Overall Study|Subject decision|1|||
161784520|NCT02444182|584257368|FG000|Overall Study|non-compliance|2|||
161898192|NCT00572455|584675574|FG010|Stage II (28 Days)|Other|0|||
161552444|NCT02066532|583410452|FG002|Phase II|Withdrawal by Subject|0|||
161784521|NCT02444182|584257369|FG001|Overall Study|non-compliance|1|||
161784522|NCT02444182|584257368|FG000|Overall Study|Lost to Follow-up|0|||
161784523|NCT02444182|584257369|FG001|Overall Study|Lost to Follow-up|4|||
161784524|NCT01453374|584257370|FG000|Overall Study|Adverse Event|7|||
161784525|NCT01453374|584257370|FG000|Overall Study|Lack of Efficacy|1|||
161784526|NCT01453374|584257370|FG000|Overall Study|Lost to Follow-up|3|||
161898193|NCT00572455|584675575|FG011|Stage II (28 Days)|Other|0|||
161436405|NCT02079246|582992949|FG000|OLEX|Results of the lead-in studies|58|||
161436406|NCT02079246|582992950|FG001|OLEX|Results of the lead-in studies|0|||
161436407|NCT02079246|582992949|FG000|OLEX|Other: Disallowed medication|8|||
161436408|NCT02079246|582992950|FG001|OLEX|Other: Disallowed medication|0|||
161436409|NCT02079246|582992949|FG000|OLEX|Other: Insufficient compliance|2|||
161436410|NCT02079246|582992950|FG001|OLEX|Other: Insufficient compliance|0|||
161436411|NCT02079246|582992949|FG000|OLEX|Other: Caregiver unavailable|3|||
161436412|NCT02079246|582992950|FG001|OLEX|Other: Caregiver unavailable|0|||
161436413|NCT02079246|582992949|FG000|OLEX|Other: Coordinator decision|1|||
161436414|NCT02079246|582992950|FG001|OLEX|Other: Coordinator decision|0|||
161436415|NCT02079246|582992949|FG000|OLEX|Other: Worsening of condition|1|||
161436416|NCT02079246|582992950|FG001|OLEX|Other: Worsening of condition|0|||
161436417|NCT02079246|582992949|FG000|OLEX|Other: Moved to nursing home|1|||
161436418|NCT02079246|582992950|FG001|OLEX|Other: Moved to nursing home|0|||
161436419|NCT02079246|582992949|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
161436420|NCT02079246|582992950|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
161436421|NCT02079246|582992949|FG000|OLEX-MEM|Adverse Event|0|||
161436422|NCT02079246|582992950|FG001|OLEX-MEM|Adverse Event|6|||
161436423|NCT02079246|582992949|FG000|OLEX-MEM|Withdrawal by Subject|0|||
161436424|NCT02079246|582992950|FG001|OLEX-MEM|Withdrawal by Subject|7|||
161436425|NCT02079246|582992949|FG000|OLEX-MEM|Protocol Violation|0|||
161436426|NCT02079246|582992950|FG001|OLEX-MEM|Protocol Violation|2|||
161436427|NCT02079246|582992949|FG000|OLEX-MEM|Lost to Follow-up|0|||
161436428|NCT02079246|582992950|FG001|OLEX-MEM|Lost to Follow-up|1|||
161436429|NCT02079246|582992949|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
161436430|NCT02079246|582992950|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
161436431|NCT03591406|582992955|FG000|Overall Study|Adverse Event|5|||
161436432|NCT03591406|582992956|FG001|Overall Study|Adverse Event|3|||
161436433|NCT03591406|582992955|FG000|Overall Study|Protocol Violation|2|||
161436434|NCT03591406|582992956|FG001|Overall Study|Protocol Violation|1|||
161436435|NCT03591406|582992955|FG000|Overall Study|Withdrawal by Subject|0|||
161436436|NCT03591406|582992956|FG001|Overall Study|Withdrawal by Subject|5|||
161436437|NCT01389596|582992957|FG000|Overall Study|Protocol Violation|3|||
161436438|NCT01389596|582992958|FG001|Overall Study|Protocol Violation|4|||
161436439|NCT01389596|582992959|FG002|Overall Study|Protocol Violation|3|||
161436440|NCT01389596|582992957|FG000|Overall Study|Withdrawal by Subject|1|||
161436441|NCT01389596|582992958|FG001|Overall Study|Withdrawal by Subject|2|||
161436442|NCT01389596|582992959|FG002|Overall Study|Withdrawal by Subject|2|||
161436443|NCT01389596|582992957|FG000|Overall Study|Insufficient Clinical Response|3|||
161436444|NCT01389596|582992958|FG001|Overall Study|Insufficient Clinical Response|4|||
161436445|NCT01389596|582992959|FG002|Overall Study|Insufficient Clinical Response|5|||
161436446|NCT01389596|582992957|FG000|Overall Study|Adverse Event|1|||
161436447|NCT01389596|582992958|FG001|Overall Study|Adverse Event|4|||
161436448|NCT01389596|582992959|FG002|Overall Study|Adverse Event|0|||
161436449|NCT01389596|582992957|FG000|Overall Study|Death|0|||
161436450|NCT01389596|582992958|FG001|Overall Study|Death|1|||
161436451|NCT01389596|582992959|FG002|Overall Study|Death|0|||
161436452|NCT01389596|582992957|FG000|Overall Study|Other Unspecified|2|||
161436453|NCT01389596|582992958|FG001|Overall Study|Other Unspecified|1|||
161436454|NCT01389596|582992959|FG002|Overall Study|Other Unspecified|0|||
161436455|NCT01709084|582992960|FG000|Overall Study|Lost to Follow-up|4|||
161436456|NCT01709084|582992961|FG001|Overall Study|Lost to Follow-up|7|||
161436457|NCT01709084|582992960|FG000|Overall Study|Withdrawal by Subject|2|||
161436458|NCT01709084|582992961|FG001|Overall Study|Withdrawal by Subject|2|||
161436459|NCT01709084|582992960|FG000|Overall Study|Adverse Event|5|||
161436460|NCT01709084|582992961|FG001|Overall Study|Adverse Event|0|||
161436461|NCT01709084|582992960|FG000|Overall Study|Other|5|||
161436462|NCT01709084|582992961|FG001|Overall Study|Other|3|||
161436463|NCT01709084|582992960|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
161436464|NCT01709084|582992961|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
161436465|NCT01709084|582992960|FG000|Overall Study|Not Treated|0|||
161436466|NCT01709084|582992961|FG001|Overall Study|Not Treated|2|||
161436467|NCT00214201|582992962|FG000|Overall Study|Withdrawal by Subject|2|||
161436468|NCT00214201|582992963|FG001|Overall Study|Withdrawal by Subject|0|||
161436469|NCT00214201|582992962|FG000|Overall Study|Death|0|||
161436470|NCT00214201|582992963|FG001|Overall Study|Death|2|||
161436471|NCT01357850|582992969|FG000|Overall Study|Lost to Follow-up|1|||
161436472|NCT01357850|582992970|FG001|Overall Study|Lost to Follow-up|0|||
161436473|NCT01357850|582992971|FG002|Overall Study|Lost to Follow-up|0|||
161436474|NCT01357850|582992972|FG003|Overall Study|Lost to Follow-up|0|||
161436475|NCT04610281|582992973|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
161436476|NCT04610281|582992974|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
161436477|NCT01942837|582992975|FG000|Overall Study|Death|1|||
161436478|NCT01942837|582992975|FG000|Overall Study|Symptomatic or radiographic progression|49|||
161436479|NCT01942837|582992975|FG000|Overall Study|Adverse Event|6|||
161436480|NCT01942837|582992975|FG000|Overall Study|Physician Decision|3|||
161436481|NCT01942837|582992975|FG000|Overall Study|Withdrawal by Subject|2|||
161436482|NCT01942837|582992975|FG000|Overall Study|Intercurrent Illness|1|||
161436483|NCT01942837|582992975|FG000|Overall Study|On treatment|3|||
161436484|NCT01942837|582992975|FG000|Overall Study|Never initiate the treatment|2|||
161436485|NCT01298648|582992976|FG000|Overall Study|Withdrawal by Subject|2|||
161436486|NCT01298648|582992976|FG000|Overall Study|Lost to Follow-up|21|||
161436487|NCT02351856|582992982|FG000|Overall Study|Adverse Event|2|||
161436488|NCT02351856|582992982|FG000|Overall Study|Physician Decision|5|||
161436489|NCT02351856|582992982|FG000|Overall Study|Study terminated by sponsor|1|||
161436490|NCT01458392|582992987|FG000|Overall Study|Death|2|||
161436491|NCT01458392|582992988|FG001|Overall Study|Death|11|||
161436492|NCT01458392|582992989|FG002|Overall Study|Death|22|||
161436493|NCT01458392|582992987|FG000|Overall Study|At the discretion of the sponsor|0|||
161436494|NCT01458392|582992988|FG001|Overall Study|At the discretion of the sponsor|2|||
161436495|NCT01458392|582992989|FG002|Overall Study|At the discretion of the sponsor|7|||
161436496|NCT01458392|582992987|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
161436497|NCT01458392|582992988|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
161436498|NCT01458392|582992989|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
161436499|NCT03038100|582992998|FG000|Overall Study|Death|289|||
161436500|NCT03038100|582992999|FG001|Overall Study|Death|272|||
161436501|NCT03038100|582992998|FG000|Overall Study|Lost to Follow-up|9|||
161436502|NCT03038100|582992999|FG001|Overall Study|Lost to Follow-up|10|||
161436503|NCT03038100|582992998|FG000|Overall Study|Protocol Deviation|1|||
161436504|NCT03038100|582992999|FG001|Overall Study|Protocol Deviation|4|||
161436505|NCT03038100|582992998|FG000|Overall Study|Withdrawal by Subject|45|||
161436506|NCT03038100|582992999|FG001|Overall Study|Withdrawal by Subject|51|||
161436507|NCT03038100|582992998|FG000|Overall Study|Study Terminated By Sponsor|305|||
161436508|NCT03038100|582992999|FG001|Overall Study|Study Terminated By Sponsor|311|||
161436509|NCT03038100|582992998|FG000|Overall Study|Physician Decision|1|||
161436510|NCT03038100|582992999|FG001|Overall Study|Physician Decision|3|||
161436511|NCT00918255|582993000|FG000|Overall Study|Adverse Event|1|||
161436512|NCT00918255|582993001|FG001|Overall Study|Adverse Event|0|||
161436513|NCT00918255|582993002|FG002|Overall Study|Adverse Event|0|||
161436514|NCT00918255|582993000|FG000|Overall Study|Withdrawal by Subject|1|||
161436515|NCT00918255|582993001|FG001|Overall Study|Withdrawal by Subject|0|||
161436516|NCT00918255|582993002|FG002|Overall Study|Withdrawal by Subject|2|||
161436517|NCT00918255|582993000|FG000|Overall Study|Lack of Efficacy|1|||
161436518|NCT00918255|582993001|FG001|Overall Study|Lack of Efficacy|0|||
161436519|NCT00918255|582993002|FG002|Overall Study|Lack of Efficacy|0|||
161436520|NCT00918255|582993000|FG000|Overall Study|Lost to Follow-up|1|||
161436521|NCT00918255|582993001|FG001|Overall Study|Lost to Follow-up|0|||
161436522|NCT00918255|582993002|FG002|Overall Study|Lost to Follow-up|2|||
161436523|NCT00918255|582993000|FG000|Overall Study|Exceeded allowed number of interventions|0|||
161436524|NCT00918255|582993001|FG001|Overall Study|Exceeded allowed number of interventions|0|||
161436525|NCT00918255|582993002|FG002|Overall Study|Exceeded allowed number of interventions|1|||
161436526|NCT00918255|582993000|FG000|Overall Study|Non-compliance|1|||
161436527|NCT00918255|582993001|FG001|Overall Study|Non-compliance|0|||
161436528|NCT00918255|582993002|FG002|Overall Study|Non-compliance|0|||
161436529|NCT00918255|582993000|FG000|Overall Study|Investigator discretion|1|||
161436530|NCT00918255|582993001|FG001|Overall Study|Investigator discretion|0|||
161436531|NCT00918255|582993002|FG002|Overall Study|Investigator discretion|0|||
161436532|NCT02038933|582993035|FG000|Overall Study|Disease progression|104|||
161436533|NCT02038933|582993035|FG000|Overall Study|Study drug toxicity|6|||
161436534|NCT02038933|582993035|FG000|Overall Study|Adverse event unrelated to study drug|6|||
161436535|NCT02038933|582993035|FG000|Overall Study|Participant request to discontinue treatment|2|||
161436536|NCT02038933|582993035|FG000|Overall Study|Lost to Follow-up|1|||
161436537|NCT02038933|582993035|FG000|Overall Study|Other reasons|2|||
161436538|NCT03250273|582993036|FG000|Overall Study|Disease Progression|2|||
161436539|NCT03250273|582993037|FG001|Overall Study|Disease Progression|11|||
161436540|NCT03250273|582993036|FG000|Overall Study|Death|0|||
161436541|NCT03250273|582993037|FG001|Overall Study|Death|1|||
161436542|NCT04154904|582993038|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
161436543|NCT04154904|582993039|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
161436544|NCT04154904|582993040|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
161436545|NCT02392624|582993041|FG000|Overall Study|Withdrawal by Subject|15|||
161436546|NCT02392624|582993042|FG001|Overall Study|Withdrawal by Subject|12|||
161436547|NCT02392624|582993043|FG002|Overall Study|Withdrawal by Subject|9|||
161436548|NCT02392624|582993041|FG000|Overall Study|Adverse Event|4|||
161436549|NCT02392624|582993042|FG001|Overall Study|Adverse Event|1|||
161436550|NCT02392624|582993043|FG002|Overall Study|Adverse Event|2|||
161436551|NCT02392624|582993041|FG000|Overall Study|Pregnancy|1|||
161784527|NCT01453374|584257370|FG000|Overall Study|Withdrawal by Subject|5|||
161436552|NCT02392624|582993042|FG001|Overall Study|Pregnancy|0|||
161436553|NCT02392624|582993043|FG002|Overall Study|Pregnancy|0|||
161436554|NCT02392624|582993041|FG000|Overall Study|Protocol Violation|0|||
161436555|NCT02392624|582993042|FG001|Overall Study|Protocol Violation|0|||
161436556|NCT02392624|582993043|FG002|Overall Study|Protocol Violation|1|||
161436557|NCT02392624|582993041|FG000|Overall Study|Sponsor/Investigator Decision|2|||
161436558|NCT02392624|582993042|FG001|Overall Study|Sponsor/Investigator Decision|1|||
161436559|NCT02392624|582993043|FG002|Overall Study|Sponsor/Investigator Decision|0|||
161436560|NCT02392624|582993041|FG000|Overall Study|Other|49|||
161436561|NCT02392624|582993042|FG001|Overall Study|Other|1|||
161436562|NCT02392624|582993043|FG002|Overall Study|Other|1|||
161436563|NCT00936715|582993044|FG000|Overall Study|Investigators Discretion|1|||
161436564|NCT00936715|582993044|FG000|Overall Study|Protocol Violation|1|||
161436565|NCT00936715|582993044|FG000|Overall Study|Safety or Tolerability Reasons|4|||
161436566|NCT03841604|582993047|FG000|Overall Study|Withdrawal by Subject|3|||
161436567|NCT03841604|582993048|FG001|Overall Study|Withdrawal by Subject|1|||
161436568|NCT03841604|582993047|FG000|Overall Study|Adverse Event|4|||
161436569|NCT03841604|582993048|FG001|Overall Study|Adverse Event|2|||
161436570|NCT03841604|582993047|FG000|Overall Study|Physician Decision|1|||
161436571|NCT03841604|582993048|FG001|Overall Study|Physician Decision|0|||
161436572|NCT01337960|582993049|FG000|Overall Study|Lost to Follow-up|1|||
161436573|NCT01337960|582993050|FG001|Overall Study|Lost to Follow-up|0|||
161436574|NCT01337960|582993051|FG002|Overall Study|Lost to Follow-up|0|||
161436575|NCT01337960|582993049|FG000|Overall Study|Withdrawal by Subject|1|||
161436576|NCT01337960|582993050|FG001|Overall Study|Withdrawal by Subject|0|||
161436577|NCT01337960|582993051|FG002|Overall Study|Withdrawal by Subject|0|||
161436578|NCT03763877|582993053|FG000|Overall Study|Withdrawal by Subject|3|||
161436579|NCT03763877|582993054|FG001|Overall Study|Withdrawal by Subject|1|||
161436580|NCT03763877|582993055|FG002|Overall Study|Withdrawal by Subject|3|||
161436581|NCT03763877|582993056|FG003|Overall Study|Withdrawal by Subject|4|||
161436582|NCT03763877|582993053|FG000|Overall Study|Adverse Event|1|||
161898194|NCT00572455|584675576|FG012|Stage II (28 Days)|Other|0|||
161898195|NCT00572455|584675577|FG013|Stage II (28 Days)|Other|0|||
161436583|NCT03763877|582993054|FG001|Overall Study|Adverse Event|1|||
161436584|NCT03763877|582993055|FG002|Overall Study|Adverse Event|3|||
161436585|NCT03763877|582993056|FG003|Overall Study|Adverse Event|1|||
161436586|NCT03763877|582993053|FG000|Overall Study|Protocol Violation|1|||
161436587|NCT03763877|582993054|FG001|Overall Study|Protocol Violation|1|||
161436588|NCT03763877|582993055|FG002|Overall Study|Protocol Violation|0|||
161436589|NCT03763877|582993056|FG003|Overall Study|Protocol Violation|0|||
161436590|NCT03763877|582993053|FG000|Overall Study|Lost to Follow-up|0|||
161436591|NCT03763877|582993054|FG001|Overall Study|Lost to Follow-up|1|||
161436592|NCT03763877|582993055|FG002|Overall Study|Lost to Follow-up|1|||
161436593|NCT03763877|582993056|FG003|Overall Study|Lost to Follow-up|0|||
161436594|NCT01774721|582993060|FG000|Overall Study|Death|133|||
161436595|NCT01774721|582993061|FG001|Overall Study|Death|152|||
161784528|NCT01453374|584257370|FG000|Overall Study|Incarcerated|2|||
161784529|NCT00996918|584257374|FG000|Overall Study|Lack of Efficacy|1|||
161784530|NCT00996918|584257375|FG001|Overall Study|Lack of Efficacy|1|||
161784531|NCT00996918|584257376|FG002|Overall Study|Lack of Efficacy|2|||
161784532|NCT00996918|584257377|FG003|Overall Study|Lack of Efficacy|2|||
161784533|NCT00996918|584257378|FG004|Overall Study|Lack of Efficacy|0|||
161784534|NCT00996918|584257374|FG000|Overall Study|Adverse Event|2|||
161784535|NCT00996918|584257375|FG001|Overall Study|Adverse Event|5|||
161784536|NCT00996918|584257376|FG002|Overall Study|Adverse Event|2|||
161784537|NCT00996918|584257377|FG003|Overall Study|Adverse Event|6|||
161784538|NCT00996918|584257378|FG004|Overall Study|Adverse Event|0|||
161784539|NCT00996918|584257374|FG000|Overall Study|Withdrawal by Subject|1|||
161784540|NCT00996918|584257375|FG001|Overall Study|Withdrawal by Subject|4|||
161784541|NCT00996918|584257376|FG002|Overall Study|Withdrawal by Subject|3|||
161784542|NCT00996918|584257377|FG003|Overall Study|Withdrawal by Subject|3|||
161784543|NCT00996918|584257378|FG004|Overall Study|Withdrawal by Subject|2|||
161784544|NCT00996918|584257374|FG000|Overall Study|Physician Decision|1|||
161784545|NCT00996918|584257375|FG001|Overall Study|Physician Decision|0|||
161784546|NCT00996918|584257376|FG002|Overall Study|Physician Decision|0|||
161784547|NCT00996918|584257377|FG003|Overall Study|Physician Decision|0|||
161784548|NCT00996918|584257378|FG004|Overall Study|Physician Decision|0|||
161784549|NCT00996918|584257374|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
161784550|NCT00996918|584257375|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
161784551|NCT00996918|584257376|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
161436596|NCT01774721|582993060|FG000|Overall Study|Withdrawal by Subject|20|||
161436597|NCT01774721|582993061|FG001|Overall Study|Withdrawal by Subject|14|||
161436598|NCT01774721|582993060|FG000|Overall Study|Lost to Follow-up|6|||
161436599|NCT01774721|582993061|FG001|Overall Study|Lost to Follow-up|7|||
161436600|NCT01774721|582993060|FG000|Overall Study|Did not meet eligibility criteria|0|||
161436601|NCT01774721|582993061|FG001|Overall Study|Did not meet eligibility criteria|3|||
161436602|NCT01774721|582993060|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
161784552|NCT00996918|584257377|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
161784553|NCT00996918|584257378|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
161784554|NCT00996918|584257374|FG000|Overall Study|Loss of Caregiver|0|||
161784555|NCT00996918|584257375|FG001|Overall Study|Loss of Caregiver|1|||
161784556|NCT00996918|584257376|FG002|Overall Study|Loss of Caregiver|0|||
161436603|NCT01774721|582993061|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
161436604|NCT01774721|582993060|FG000|Overall Study|Study terminated by sponsor|5|||
161898196|NCT00572455|584675564|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
161436605|NCT01774721|582993061|FG001|Overall Study|Study terminated by sponsor|0|||
161436606|NCT01774721|582993060|FG000|Overall Study|Disease progression|5|||
161436607|NCT01774721|582993061|FG001|Overall Study|Disease progression|0|||
161436608|NCT00084136|582993071|FG000|PI Comparison|Death|10|||
161436609|NCT00084136|582993072|FG001|PI Comparison|Death|9|||
161436610|NCT00084136|582993073|FG002|PI Comparison|Death|0|||
161436611|NCT00084136|582993071|FG000|PI Comparison|Lost to Follow-up|11|||
161436612|NCT00084136|582993072|FG001|PI Comparison|Lost to Follow-up|8|||
161436613|NCT00084136|582993073|FG002|PI Comparison|Lost to Follow-up|0|||
161436614|NCT00084136|582993071|FG000|PI Comparison|Withdrawal by Subject|33|||
161436615|NCT00084136|582993072|FG001|PI Comparison|Withdrawal by Subject|30|||
161436616|NCT00084136|582993073|FG002|PI Comparison|Withdrawal by Subject|0|||
161436617|NCT00084136|582993071|FG000|PI Comparison|Clinic site closed|1|||
161436618|NCT00084136|582993072|FG001|PI Comparison|Clinic site closed|0|||
161436619|NCT00084136|582993073|FG002|PI Comparison|Clinic site closed|0|||
161436620|NCT00084136|582993071|FG000|NRTI Comparison|Death|20|||
161436621|NCT00084136|582993072|FG001|NRTI Comparison|Death|0|||
161436622|NCT00084136|582993073|FG002|NRTI Comparison|Death|18|||
161436623|NCT00084136|582993071|FG000|NRTI Comparison|Lost to Follow-up|14|||
161436624|NCT00084136|582993072|FG001|NRTI Comparison|Lost to Follow-up|0|||
161436625|NCT00084136|582993073|FG002|NRTI Comparison|Lost to Follow-up|12|||
161436626|NCT00084136|582993071|FG000|NRTI Comparison|Withdrawal by Subject|54|||
161436627|NCT00084136|582993072|FG001|NRTI Comparison|Withdrawal by Subject|0|||
161436628|NCT00084136|582993073|FG002|NRTI Comparison|Withdrawal by Subject|38|||
161436629|NCT00084136|582993071|FG000|NRTI Comparison|Clinic site closed|12|||
161436630|NCT00084136|582993072|FG001|NRTI Comparison|Clinic site closed|0|||
161436631|NCT00084136|582993073|FG002|NRTI Comparison|Clinic site closed|14|||
161436632|NCT00084136|582993071|FG000|NRTI Comparison|Not reason above|1|||
161436633|NCT00084136|582993072|FG001|NRTI Comparison|Not reason above|0|||
161436634|NCT00084136|582993073|FG002|NRTI Comparison|Not reason above|0|||
161436635|NCT03938259|582993077|FG000|Overall Study|unable to establish baseline for ventilation|1|||
161436636|NCT03938259|582993078|FG001|Overall Study|unable to establish baseline for ventilation|1|||
161436637|NCT01213472|582993079|FG000|Overall Study|Recurrence/Progressive disease|25|||
161436638|NCT01213472|582993079|FG000|Overall Study|Withdrawal by Subject|1|||
161436639|NCT01213472|582993079|FG000|Overall Study|Physician Decision|1|||
161436640|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
161436641|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
161436642|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
161436643|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
161436644|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
161436645|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
161436646|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
161436647|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
161436648|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
161436649|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
161436650|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
161436651|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
161436652|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
161436653|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
161436654|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
161436655|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
161436656|NCT03773978|582993090|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
161436657|NCT03773978|582993091|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
161436658|NCT03773978|582993090|FG000|DBW Period|Adverse Event|2|||
161436659|NCT03773978|582993091|FG001|DBW Period|Adverse Event|2|||
161436660|NCT03773978|582993090|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
161436661|NCT03773978|582993091|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
161436662|NCT03773978|582993090|FG000|DBW Period|Withdrawal by Subject|2|||
161436663|NCT03773978|582993091|FG001|DBW Period|Withdrawal by Subject|1|||
161436664|NCT03773978|582993090|FG000|DBW Period|Due to epidemic or pandemic|5|||
161436665|NCT03773978|582993091|FG001|DBW Period|Due to epidemic or pandemic|6|||
161436666|NCT03773978|582993090|FG000|DBW Period|Study team decision|1|||
161436667|NCT03773978|582993091|FG001|DBW Period|Study team decision|0|||
161436668|NCT03777982|582993092|FG000|Overall Study|Physician Decision|0|||
161436669|NCT03777982|582993093|FG001|Overall Study|Physician Decision|1|||
161436670|NCT00198822|582993094|FG000|Overall Study|Lost to Follow-up|14|||
161436671|NCT00198822|582993095|FG001|Overall Study|Lost to Follow-up|20|||
161784557|NCT00996918|584257377|FG003|Overall Study|Loss of Caregiver|0|||
161436672|NCT00198822|582993096|FG002|Overall Study|Lost to Follow-up|21|||
161436673|NCT00453206|582993098|FG000|Overall Study|Death|1|||
161436674|NCT03866577|582993101|FG000|Overall Study|Protocol Violation|0|||
161436675|NCT03866577|582993102|FG001|Overall Study|Protocol Violation|0|||
161436676|NCT03866577|582993103|FG002|Overall Study|Protocol Violation|0|||
161436677|NCT03866577|582993104|FG003|Overall Study|Protocol Violation|0|||
161436678|NCT03866577|582993105|FG004|Overall Study|Protocol Violation|0|||
161436679|NCT03866577|582993106|FG005|Overall Study|Protocol Violation|0|||
161436680|NCT03866577|582993107|FG006|Overall Study|Protocol Violation|0|||
161436681|NCT03866577|582993108|FG007|Overall Study|Protocol Violation|0|||
161436682|NCT03866577|582993109|FG008|Overall Study|Protocol Violation|0|||
161436683|NCT03866577|582993110|FG009|Overall Study|Protocol Violation|0|||
161436684|NCT03866577|582993111|FG010|Overall Study|Protocol Violation|0|||
161436685|NCT03866577|582993112|FG011|Overall Study|Protocol Violation|1|||
161436686|NCT03866577|582993113|FG012|Overall Study|Protocol Violation|0|||
161436687|NCT03866577|582993101|FG000|Overall Study|Withdrawal by Subject|0|||
161436688|NCT03866577|582993102|FG001|Overall Study|Withdrawal by Subject|0|||
161436689|NCT03866577|582993103|FG002|Overall Study|Withdrawal by Subject|0|||
161436690|NCT03866577|582993104|FG003|Overall Study|Withdrawal by Subject|0|||
161436691|NCT03866577|582993105|FG004|Overall Study|Withdrawal by Subject|0|||
161436692|NCT03866577|582993106|FG005|Overall Study|Withdrawal by Subject|0|||
161436693|NCT03866577|582993107|FG006|Overall Study|Withdrawal by Subject|0|||
161436694|NCT03866577|582993108|FG007|Overall Study|Withdrawal by Subject|0|||
161436695|NCT03866577|582993109|FG008|Overall Study|Withdrawal by Subject|1|||
161436696|NCT03866577|582993110|FG009|Overall Study|Withdrawal by Subject|1|||
161436697|NCT03866577|582993111|FG010|Overall Study|Withdrawal by Subject|0|||
161436698|NCT03866577|582993112|FG011|Overall Study|Withdrawal by Subject|0|||
161436699|NCT03866577|582993113|FG012|Overall Study|Withdrawal by Subject|0|||
161436700|NCT03866577|582993101|FG000|Overall Study|Not qualified for IVIg infusion|0|||
161436701|NCT03866577|582993102|FG001|Overall Study|Not qualified for IVIg infusion|0|||
161436702|NCT03866577|582993103|FG002|Overall Study|Not qualified for IVIg infusion|0|||
161436703|NCT03866577|582993104|FG003|Overall Study|Not qualified for IVIg infusion|0|||
161436704|NCT03866577|582993105|FG004|Overall Study|Not qualified for IVIg infusion|0|||
161436705|NCT03866577|582993106|FG005|Overall Study|Not qualified for IVIg infusion|0|||
161436706|NCT03866577|582993107|FG006|Overall Study|Not qualified for IVIg infusion|0|||
161436707|NCT03866577|582993108|FG007|Overall Study|Not qualified for IVIg infusion|0|||
161436708|NCT03866577|582993109|FG008|Overall Study|Not qualified for IVIg infusion|0|||
161436709|NCT03866577|582993110|FG009|Overall Study|Not qualified for IVIg infusion|1|||
161436710|NCT03866577|582993111|FG010|Overall Study|Not qualified for IVIg infusion|0|||
161436711|NCT03866577|582993112|FG011|Overall Study|Not qualified for IVIg infusion|0|||
161436712|NCT03866577|582993113|FG012|Overall Study|Not qualified for IVIg infusion|0|||
161436713|NCT03818256|582993114|FG000|Overall Study|Withdrawal by Subject|2|||
161436714|NCT03818256|582993115|FG001|Overall Study|Withdrawal by Subject|2|||
161436715|NCT03818256|582993114|FG000|Overall Study|Adverse Event|3|||
161436716|NCT03818256|582993115|FG001|Overall Study|Adverse Event|1|||
161436717|NCT03818256|582993114|FG000|Overall Study|Lost to Follow-up|0|||
161436718|NCT03818256|582993115|FG001|Overall Study|Lost to Follow-up|5|||
161436719|NCT03818256|582993114|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
161436720|NCT03818256|582993115|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
161436721|NCT03818256|582993114|FG000|Overall Study|Not reporting for scheduled visits|1|||
161436722|NCT03818256|582993115|FG001|Overall Study|Not reporting for scheduled visits|0|||
161436723|NCT03818256|582993114|FG000|Overall Study|Non-compliant with investigational product|1|||
161436724|NCT03818256|582993115|FG001|Overall Study|Non-compliant with investigational product|0|||
161436725|NCT01342211|582993116|FG000|Overall Study|Lost to Follow-up|0|||
161436726|NCT01342211|582993117|FG001|Overall Study|Lost to Follow-up|0|||
161436727|NCT01342211|582993118|FG002|Overall Study|Lost to Follow-up|0|||
161436728|NCT01342211|582993119|FG003|Overall Study|Lost to Follow-up|1|||
161436729|NCT01342211|582993120|FG004|Overall Study|Lost to Follow-up|0|||
161436730|NCT01342211|582993116|FG000|Overall Study|Adverse Event|0|||
161436731|NCT01342211|582993117|FG001|Overall Study|Adverse Event|0|||
161436732|NCT01342211|582993118|FG002|Overall Study|Adverse Event|0|||
161436733|NCT01342211|582993119|FG003|Overall Study|Adverse Event|0|||
161436734|NCT01342211|582993120|FG004|Overall Study|Adverse Event|1|||
161436735|NCT01342211|582993116|FG000|Overall Study|Withdrawal by Subject|0|||
161436736|NCT01342211|582993117|FG001|Overall Study|Withdrawal by Subject|0|||
161436737|NCT01342211|582993118|FG002|Overall Study|Withdrawal by Subject|0|||
161436738|NCT01342211|582993119|FG003|Overall Study|Withdrawal by Subject|1|||
161436739|NCT01342211|582993120|FG004|Overall Study|Withdrawal by Subject|0|||
161436740|NCT01342211|582993116|FG000|Overall Study|Randomized, but not Treated|0|||
161436741|NCT01342211|582993117|FG001|Overall Study|Randomized, but not Treated|2|||
161436742|NCT01342211|582993118|FG002|Overall Study|Randomized, but not Treated|0|||
161436743|NCT01342211|582993119|FG003|Overall Study|Randomized, but not Treated|0|||
161436744|NCT01342211|582993120|FG004|Overall Study|Randomized, but not Treated|1|||
161436745|NCT02749422|582993123|FG000|Overall Study|Lost to Follow-up|0|||
161436746|NCT02749422|582993124|FG001|Overall Study|Lost to Follow-up|2|||
161436747|NCT02749422|582993123|FG000|Overall Study|Ineligible|0|||
161436748|NCT02749422|582993124|FG001|Overall Study|Ineligible|1|||
161436749|NCT01824836|582993125|FG000|Overall Study|Adverse Event|48|||
161436750|NCT01824836|582993125|FG000|Overall Study|Withdrawal by Subject|63|||
161436751|NCT01824836|582993125|FG000|Overall Study|Other complicating disease|116|||
161436752|NCT01824836|582993125|FG000|Overall Study|Disease progression|5|||
161436753|NCT01824836|582993125|FG000|Overall Study|Alternative therapy|2|||
161436754|NCT01824836|582993125|FG000|Overall Study|Depression|1|||
161436755|NCT01824836|582993125|FG000|Overall Study|Non-compliance|3|||
161436756|NCT01824836|582993125|FG000|Overall Study|Patient regained ovarian function|3|||
161436757|NCT01824836|582993125|FG000|Overall Study|Lost to Follow-up|8|||
161436758|NCT01824836|582993125|FG000|Overall Study|Physician Decision|2|||
161436759|NCT01824836|582993125|FG000|Overall Study|Research office was closed|3|||
161436760|NCT01824836|582993125|FG000|Overall Study|Relocation|3|||
161436761|NCT01824836|582993125|FG000|Overall Study|Insurance-related issue|1|||
161436762|NCT01824836|582993125|FG000|Overall Study|Transportation issue|1|||
161436763|NCT01824836|582993125|FG000|Overall Study|Patient transferred care|1|||
161436764|NCT01824836|582993125|FG000|Overall Study|Unknown reasons|4|||
161436765|NCT01824836|582993125|FG000|Overall Study|Never started treatment|16|||
161436766|NCT05530252|582993126|FG000|Overall Study|Lost to Follow-up|1|||
161436767|NCT05530252|582993127|FG001|Overall Study|Lost to Follow-up|1|||
161436768|NCT05530252|582993128|FG002|Overall Study|Lost to Follow-up|1|||
161436769|NCT01350999|582993129|FG000|Overall Study|Adverse Event|4|||
161436770|NCT01350999|582993130|FG001|Overall Study|Adverse Event|9|||
161436771|NCT01350999|582993131|FG002|Overall Study|Adverse Event|10|||
161436772|NCT01350999|582993129|FG000|Overall Study|Voluntary withdrawal|3|||
161436773|NCT01350999|582993130|FG001|Overall Study|Voluntary withdrawal|4|||
161436774|NCT01350999|582993131|FG002|Overall Study|Voluntary withdrawal|6|||
161436775|NCT01350999|582993129|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
161436776|NCT01350999|582993130|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
161436777|NCT01350999|582993131|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
161436778|NCT02144610|582995083|FG000|Overall Study|Physician Decision|1|||
161436779|NCT02144610|582995084|FG001|Overall Study|Physician Decision|0|||
161436780|NCT02144610|582995083|FG000|Overall Study|Withdrawal by Subject|1|||
161436781|NCT02144610|582995084|FG001|Overall Study|Withdrawal by Subject|5|||
161436782|NCT02144610|582995083|FG000|Overall Study|Death|2|||
161436783|NCT02144610|582995084|FG001|Overall Study|Death|2|||
161436784|NCT02144610|582995083|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
161436785|NCT02144610|582995084|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
161436786|NCT02144610|582995083|FG000|Overall Study|Other|0|||
161436787|NCT02144610|582995084|FG001|Overall Study|Other|1|||
161436788|NCT01354899|582995088|FG000|Overall Study|discharge from the hospital|2|||
161436789|NCT01354899|582995088|FG000|Overall Study|Protocol Violation|1|||
161436790|NCT00463567|582995091|FG000|Overall Study|Adverse Event|29|||
161436791|NCT00463567|582995092|FG001|Overall Study|Adverse Event|26|||
161436792|NCT00463567|582995093|FG002|Overall Study|Adverse Event|17|||
161436793|NCT00463567|582995094|FG003|Overall Study|Adverse Event|46|||
161436794|NCT00463567|582995095|FG004|Overall Study|Adverse Event|10|||
161436795|NCT00463567|582995096|FG005|Overall Study|Adverse Event|10|||
161436796|NCT00463567|582995097|FG006|Overall Study|Adverse Event|4|||
161436797|NCT00463567|582995091|FG000|Overall Study|Withdrawal by Subject|29|||
161436798|NCT00463567|582995092|FG001|Overall Study|Withdrawal by Subject|22|||
161436799|NCT00463567|582995093|FG002|Overall Study|Withdrawal by Subject|20|||
161436800|NCT00463567|582995094|FG003|Overall Study|Withdrawal by Subject|37|||
161436801|NCT00463567|582995095|FG004|Overall Study|Withdrawal by Subject|6|||
161436802|NCT00463567|582995096|FG005|Overall Study|Withdrawal by Subject|5|||
161436803|NCT00463567|582995097|FG006|Overall Study|Withdrawal by Subject|1|||
161436804|NCT00463567|582995091|FG000|Overall Study|Protocol Deviation|13|||
161436805|NCT00463567|582995092|FG001|Overall Study|Protocol Deviation|9|||
161436806|NCT00463567|582995093|FG002|Overall Study|Protocol Deviation|14|||
161436807|NCT00463567|582995094|FG003|Overall Study|Protocol Deviation|11|||
161436808|NCT00463567|582995095|FG004|Overall Study|Protocol Deviation|1|||
161436809|NCT00463567|582995096|FG005|Overall Study|Protocol Deviation|1|||
161436810|NCT00463567|582995097|FG006|Overall Study|Protocol Deviation|2|||
161436811|NCT00463567|582995091|FG000|Overall Study|Lost to Follow-up|12|||
161436812|NCT00463567|582995092|FG001|Overall Study|Lost to Follow-up|6|||
161436813|NCT00463567|582995093|FG002|Overall Study|Lost to Follow-up|13|||
161436814|NCT00463567|582995094|FG003|Overall Study|Lost to Follow-up|8|||
161436815|NCT00463567|582995095|FG004|Overall Study|Lost to Follow-up|1|||
161436816|NCT00463567|582995096|FG005|Overall Study|Lost to Follow-up|1|||
161436817|NCT00463567|582995097|FG006|Overall Study|Lost to Follow-up|1|||
161436818|NCT00463567|582995091|FG000|Overall Study|Administrative problems|5|||
161436819|NCT00463567|582995092|FG001|Overall Study|Administrative problems|3|||
161436820|NCT00463567|582995093|FG002|Overall Study|Administrative problems|6|||
161436821|NCT00463567|582995094|FG003|Overall Study|Administrative problems|9|||
161436822|NCT00463567|582995095|FG004|Overall Study|Administrative problems|3|||
161436823|NCT00463567|582995096|FG005|Overall Study|Administrative problems|2|||
161436824|NCT00463567|582995097|FG006|Overall Study|Administrative problems|2|||
161436825|NCT00463567|582995091|FG000|Overall Study|Lack of Efficacy|4|||
161436826|NCT00463567|582995092|FG001|Overall Study|Lack of Efficacy|9|||
161436827|NCT00463567|582995093|FG002|Overall Study|Lack of Efficacy|9|||
161436828|NCT00463567|582995094|FG003|Overall Study|Lack of Efficacy|17|||
161552445|NCT02066532|583410453|FG003|Phase II|Withdrawal by Subject|0|||
161436829|NCT00463567|582995095|FG004|Overall Study|Lack of Efficacy|1|||
161436830|NCT00463567|582995096|FG005|Overall Study|Lack of Efficacy|0|||
161436831|NCT00463567|582995097|FG006|Overall Study|Lack of Efficacy|1|||
161552446|NCT05033080|583410454|FG000|Overall Study|Adverse Event|4|||
161436832|NCT00463567|582995091|FG000|Overall Study|Abnormal lab value(s)|1|||
161436833|NCT00463567|582995092|FG001|Overall Study|Abnormal lab value(s)|1|||
161436834|NCT00463567|582995093|FG002|Overall Study|Abnormal lab value(s)|2|||
161436835|NCT00463567|582995094|FG003|Overall Study|Abnormal lab value(s)|1|||
161436836|NCT00463567|582995095|FG004|Overall Study|Abnormal lab value(s)|1|||
161436837|NCT00463567|582995096|FG005|Overall Study|Abnormal lab value(s)|0|||
161436838|NCT00463567|582995097|FG006|Overall Study|Abnormal lab value(s)|0|||
161436839|NCT00463567|582995091|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161436840|NCT00463567|582995092|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161436841|NCT00463567|582995093|FG002|Overall Study|Abnormal test procedure result(s)|6|||
161436842|NCT00463567|582995094|FG003|Overall Study|Abnormal test procedure result(s)|2|||
161436843|NCT00463567|582995095|FG004|Overall Study|Abnormal test procedure result(s)|0|||
161436844|NCT00463567|582995096|FG005|Overall Study|Abnormal test procedure result(s)|2|||
161436845|NCT00463567|582995097|FG006|Overall Study|Abnormal test procedure result(s)|0|||
161436846|NCT00463567|582995091|FG000|Overall Study|Death|1|||
161436847|NCT00463567|582995092|FG001|Overall Study|Death|0|||
161436848|NCT00463567|582995093|FG002|Overall Study|Death|2|||
161436849|NCT00463567|582995094|FG003|Overall Study|Death|0|||
161436850|NCT00463567|582995095|FG004|Overall Study|Death|0|||
161436851|NCT00463567|582995096|FG005|Overall Study|Death|0|||
161436852|NCT00463567|582995097|FG006|Overall Study|Death|0|||
161436853|NCT00641667|582995100|FG000|Overall Study|Withdrawal by Subject|1|||
161436854|NCT00641667|582995100|FG000|Overall Study|Adverse Event|1|||
161436855|NCT00641667|582995100|FG000|Overall Study|Physician Decision|1|||
161436856|NCT00641667|582995100|FG000|Overall Study|Worsening of underlying disease|3|||
161436857|NCT01235741|582995101|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
161436858|NCT01235741|582995102|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
161436859|NCT01235741|582995103|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
161436860|NCT01235741|582995101|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
161436861|NCT01235741|582995102|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
161436862|NCT01235741|582995103|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
161436863|NCT01235741|582995101|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
161436864|NCT01235741|582995102|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
161436865|NCT01235741|582995103|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
161436866|NCT01235741|582995101|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
161436867|NCT01235741|582995102|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
161436868|NCT01235741|582995103|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
161436869|NCT01235741|582995101|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
161436870|NCT01235741|582995102|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
161436871|NCT01235741|582995103|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
161436872|NCT01235741|582995101|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
161436873|NCT01235741|582995102|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
161436874|NCT01235741|582995103|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
161436875|NCT01235741|582995101|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
161436876|NCT01235741|582995102|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
161436877|NCT01235741|582995103|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
161436878|NCT01235741|582995101|FG000|Randomized to Treatment|Adverse Event|0|||
161436879|NCT01235741|582995102|FG001|Randomized to Treatment|Adverse Event|1|||
161436880|NCT01235741|582995103|FG002|Randomized to Treatment|Adverse Event|1|||
161436881|NCT01235741|582995101|FG000|Randomized to Treatment|Sponsor terminated study|0|||
161436882|NCT01235741|582995102|FG001|Randomized to Treatment|Sponsor terminated study|35|||
161436883|NCT01235741|582995103|FG002|Randomized to Treatment|Sponsor terminated study|34|||
161436884|NCT01235741|582995101|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
161436885|NCT01235741|582995102|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
161436886|NCT01235741|582995103|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
161436887|NCT01235741|582995101|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
161436888|NCT01235741|582995102|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
161436889|NCT01235741|582995103|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
161436890|NCT01235741|582995101|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
161436891|NCT01235741|582995102|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
161436892|NCT01235741|582995103|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
161436893|NCT01124006|582995104|FG000|Overall Study|Withdrawal by Subject|2|||
161436894|NCT01124006|582995105|FG001|Overall Study|Withdrawal by Subject|2|||
161436895|NCT01124006|582995106|FG002|Overall Study|Withdrawal by Subject|0|||
161436896|NCT01124006|582995104|FG000|Overall Study|Lost to Follow-up|1|||
161436897|NCT01124006|582995105|FG001|Overall Study|Lost to Follow-up|0|||
161436898|NCT01124006|582995106|FG002|Overall Study|Lost to Follow-up|1|||
161436899|NCT01124006|582995104|FG000|Overall Study|Other|0|||
161436900|NCT01124006|582995105|FG001|Overall Study|Other|0|||
161552447|NCT05033080|583410455|FG001|Overall Study|Adverse Event|4|||
161436901|NCT01124006|582995106|FG002|Overall Study|Other|1|||
161436902|NCT01712399|582995109|FG000|Overall Study|Lost to Follow-up|1|||
161436903|NCT01712399|582995109|FG000|Overall Study|Withdrawal by Subject|39|||
161436904|NCT01712399|582995109|FG000|Overall Study|Death|1|||
161436905|NCT01712399|582995109|FG000|Overall Study|Adverse Event|11|||
161436906|NCT01712399|582995109|FG000|Overall Study|Study closure|345|||
161436907|NCT01705509|582995115|FG000|Inclusion CPET|Screen Failure|5|||
161436908|NCT01705509|582995115|FG000|Inclusion CPET|Withdrawal by Subject|2|||
161436909|NCT01705509|582995115|FG000|CPET w/ Ranexa|Screen Failure|2|||
161436910|NCT00904033|582995116|FG000|Overall Study|Withdrawal by Subject|1|||
161436911|NCT00904033|582995117|FG001|Overall Study|Withdrawal by Subject|1|||
161436912|NCT00904033|582995118|FG002|Overall Study|Withdrawal by Subject|0|||
161436913|NCT00904033|582995119|FG003|Overall Study|Withdrawal by Subject|0|||
161436914|NCT00904033|582995116|FG000|Overall Study|Physician Decision|0|||
161436915|NCT00904033|582995117|FG001|Overall Study|Physician Decision|0|||
161436916|NCT00904033|582995118|FG002|Overall Study|Physician Decision|1|||
161436917|NCT00904033|582995119|FG003|Overall Study|Physician Decision|0|||
161436918|NCT00904033|582995116|FG000|Overall Study|Unable to obtain final blood draw|0|||
161436919|NCT00904033|582995117|FG001|Overall Study|Unable to obtain final blood draw|0|||
161436920|NCT00904033|582995118|FG002|Overall Study|Unable to obtain final blood draw|0|||
161436921|NCT00904033|582995119|FG003|Overall Study|Unable to obtain final blood draw|2|||
161436922|NCT02736890|582995120|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
161436923|NCT02736890|582995121|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
161436924|NCT02736890|582995120|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
161436925|NCT02736890|582995121|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
161436926|NCT01803607|582995123|FG000|Overall Study|Adverse Event|5|||
161436927|NCT01803607|582995124|FG001|Overall Study|Adverse Event|3|||
161436928|NCT01803607|582995123|FG000|Overall Study|Lack of Efficacy|0|||
161436929|NCT01803607|582995124|FG001|Overall Study|Lack of Efficacy|1|||
161436930|NCT01803607|582995123|FG000|Overall Study|Protocol Violation|3|||
161436931|NCT01803607|582995124|FG001|Overall Study|Protocol Violation|2|||
161436932|NCT01803607|582995123|FG000|Overall Study|Study terminated by sponsor|54|||
161436933|NCT01803607|582995124|FG001|Overall Study|Study terminated by sponsor|56|||
161436934|NCT01803607|582995123|FG000|Overall Study|Withdrawal by Subject|6|||
161436935|NCT01803607|582995124|FG001|Overall Study|Withdrawal by Subject|5|||
161436936|NCT03077412|582995125|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
161436937|NCT03077412|582995126|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
161436938|NCT03077412|582995127|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
161436939|NCT03077412|582995125|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
161436940|NCT03077412|582995126|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
161436941|NCT03077412|582995127|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
161436942|NCT03077412|582995125|FG000|Overall Study|Adverse Event|1|||
161436943|NCT03077412|582995126|FG001|Overall Study|Adverse Event|2|||
161436944|NCT03077412|582995127|FG002|Overall Study|Adverse Event|2|||
161436945|NCT03077412|582995125|FG000|Overall Study|Investigator's Discretion|0|||
161436946|NCT03077412|582995126|FG001|Overall Study|Investigator's Discretion|1|||
161436947|NCT03077412|582995127|FG002|Overall Study|Investigator's Discretion|1|||
161436948|NCT03077412|582995125|FG000|Overall Study|Withdrew Consent|0|||
161436949|NCT03077412|582995126|FG001|Overall Study|Withdrew Consent|2|||
161436950|NCT03077412|582995127|FG002|Overall Study|Withdrew Consent|0|||
161436951|NCT01936870|582995128|FG000|Overall Study|No Visit After Treatment|176|||
161436952|NCT01936870|582995128|FG000|Overall Study|Protocol Violation|12|||
161436953|NCT01936870|582995128|FG000|Overall Study|No Drug Administration|1|||
161436954|NCT00248040|582995129|FG000|Overall Study|transplantectomy|2|||
161436955|NCT00248040|582995130|FG001|Overall Study|transplantectomy|1|||
161436956|NCT00248040|582995131|FG002|Overall Study|transplantectomy|3|||
161436957|NCT00248040|582995129|FG000|Overall Study|transplant cancelled post treat start|1|||
161436958|NCT00248040|582995130|FG001|Overall Study|transplant cancelled post treat start|0|||
161436959|NCT00248040|582995131|FG002|Overall Study|transplant cancelled post treat start|0|||
161436960|NCT00248040|582995129|FG000|Overall Study|Death|0|||
161436961|NCT00248040|582995130|FG001|Overall Study|Death|0|||
161436962|NCT00248040|582995131|FG002|Overall Study|Death|1|||
161436963|NCT00118417|582995132|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
161436964|NCT00118417|582995133|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
161784558|NCT00996918|584257378|FG004|Overall Study|Loss of Caregiver|0|||
161436965|NCT00118417|582995132|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
161436966|NCT00118417|582995133|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
161784559|NCT00996918|584257374|FG000|Overall Study|Other|3|||
161784560|NCT00996918|584257375|FG001|Overall Study|Other|1|||
161784561|NCT00996918|584257376|FG002|Overall Study|Other|0|||
161436967|NCT00118417|582995132|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
161436968|NCT00118417|582995133|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
161436969|NCT00118417|582995132|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
161436970|NCT00118417|582995133|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
161784562|NCT00996918|584257377|FG003|Overall Study|Other|0|||
161436971|NCT00118417|582995132|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
161436972|NCT00118417|582995133|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
161436973|NCT02978781|582995134|FG000|Part A|Adverse Event|1|||
161436974|NCT02978781|582995135|FG001|Part A|Adverse Event|1|||
161436975|NCT02978781|582995136|FG002|Part A|Adverse Event|0|||
161436976|NCT02978781|582995137|FG003|Part A|Adverse Event|0|||
161436977|NCT02978781|582995138|FG004|Part A|Adverse Event|0|||
161436978|NCT02978781|582995134|FG000|Part A|Withdrawal by Subject|0|||
161436979|NCT02978781|582995135|FG001|Part A|Withdrawal by Subject|1|||
161436980|NCT02978781|582995136|FG002|Part A|Withdrawal by Subject|0|||
161436981|NCT02978781|582995137|FG003|Part A|Withdrawal by Subject|0|||
161436982|NCT02978781|582995138|FG004|Part A|Withdrawal by Subject|0|||
161436983|NCT02978781|582995134|FG000|Part B|Withdrawal by Subject|0|||
161436984|NCT02978781|582995135|FG001|Part B|Withdrawal by Subject|0|||
161436985|NCT02978781|582995136|FG002|Part B|Withdrawal by Subject|0|||
161436986|NCT02978781|582995137|FG003|Part B|Withdrawal by Subject|1|||
161436987|NCT02978781|582995138|FG004|Part B|Withdrawal by Subject|0|||
161436988|NCT02978781|582995134|FG000|Part C|Adverse Event|0|||
161436989|NCT02978781|582995135|FG001|Part C|Adverse Event|0|||
161436990|NCT02978781|582995136|FG002|Part C|Adverse Event|0|||
161436991|NCT02978781|582995137|FG003|Part C|Adverse Event|0|||
161436992|NCT02978781|582995138|FG004|Part C|Adverse Event|2|||
161436993|NCT02978781|582995134|FG000|Part C|Withdrawal by Subject|0|||
161436994|NCT02978781|582995135|FG001|Part C|Withdrawal by Subject|0|||
161436995|NCT02978781|582995136|FG002|Part C|Withdrawal by Subject|0|||
161436996|NCT02978781|582995137|FG003|Part C|Withdrawal by Subject|0|||
161436997|NCT02978781|582995138|FG004|Part C|Withdrawal by Subject|1|||
161436998|NCT02978781|582995134|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
161436999|NCT02978781|582995135|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
161437000|NCT02978781|582995136|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
161437001|NCT02978781|582995137|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
161437002|NCT02978781|582995138|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
161437003|NCT01383356|582995139|FG000|Period 1|Adverse Event|5|||
161437004|NCT01383356|582995140|FG001|Period 1|Adverse Event|3|||
161437005|NCT01383356|582995139|FG000|Period 1|Non-compliance|3|||
161437006|NCT01383356|582995140|FG001|Period 1|Non-compliance|0|||
161437007|NCT01383356|582995139|FG000|Period 1|Out of Range Mid-study-Test|0|||
161437008|NCT01383356|582995140|FG001|Period 1|Out of Range Mid-study-Test|1|||
161437009|NCT01383356|582995139|FG000|Period 1|Personal|0|||
161437010|NCT01383356|582995140|FG001|Period 1|Personal|2|||
161437011|NCT02054104|582995142|FG000|Overall Study|Did not want to continue due to college classes|1|||
161437012|NCT02054104|582995143|FG001|Overall Study|Did not want to continue due to college classes|0|||
161437013|NCT02054104|582995142|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
161437014|NCT02054104|582995143|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
161437015|NCT02054104|582995142|FG000|Overall Study|No evidence of immunologic response|2|||
161437016|NCT02054104|582995143|FG001|Overall Study|No evidence of immunologic response|2|||
161437017|NCT02054104|582995142|FG000|Overall Study|Disease Progression On Study|4|||
161437018|NCT02054104|582995143|FG001|Overall Study|Disease Progression On Study|5|||
161437019|NCT02054104|582995142|FG000|Overall Study|Diagnosis of lymphoma|0|||
161437020|NCT02054104|582995143|FG001|Overall Study|Diagnosis of lymphoma|1|||
161437021|NCT02054104|582995142|FG000|Overall Study|Inconclusive response|0|||
161437022|NCT02054104|582995143|FG001|Overall Study|Inconclusive response|1|||
161437023|NCT00836693|582995148|FG000|Overall Study|Adverse Event|4|||
161437024|NCT00836693|582995149|FG001|Overall Study|Adverse Event|1|||
161437025|NCT00836693|582995148|FG000|Overall Study|Sponsor Decision|0|||
161437026|NCT00836693|582995149|FG001|Overall Study|Sponsor Decision|1|||
161437027|NCT00836693|582995148|FG000|Overall Study|Physician Decision|2|||
161437028|NCT00836693|582995149|FG001|Overall Study|Physician Decision|0|||
161437029|NCT00836693|582995148|FG000|Overall Study|Withdrawal by Subject|9|||
161552448|NCT05033080|583410454|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
161437030|NCT00836693|582995149|FG001|Overall Study|Withdrawal by Subject|4|||
161437031|NCT00836693|582995148|FG000|Overall Study|Protocol Violation|1|||
161437032|NCT00836693|582995149|FG001|Overall Study|Protocol Violation|0|||
161437033|NCT00836693|582995148|FG000|Overall Study|Lost to Follow-up|1|||
161437034|NCT00836693|582995149|FG001|Overall Study|Lost to Follow-up|0|||
161437035|NCT02612779|582995150|FG000|Overall Study|Administrative reason by sponsor|4|||
161437036|NCT02612779|582995151|FG001|Overall Study|Administrative reason by sponsor|1|||
161437037|NCT02612779|582995150|FG000|Overall Study|No longer meet study criteria|0|||
161437038|NCT02612779|582995151|FG001|Overall Study|No longer meet study criteria|1|||
161437039|NCT02612779|582995150|FG000|Overall Study|Disease progression|29|||
161437040|NCT02612779|582995151|FG001|Overall Study|Disease progression|2|||
161437041|NCT02612779|582995150|FG000|Overall Study|Study drug toxicity|10|||
161437042|NCT02612779|582995151|FG001|Overall Study|Study drug toxicity|1|||
161437043|NCT02612779|582995150|FG000|Overall Study|Death|1|||
161437044|NCT02612779|582995151|FG001|Overall Study|Death|0|||
161437045|NCT02612779|582995150|FG000|Overall Study|Adverse event unrelated to study drug|5|||
161437046|NCT02612779|582995151|FG001|Overall Study|Adverse event unrelated to study drug|0|||
161437047|NCT02612779|582995150|FG000|Overall Study|Participant withdrew consent|4|||
161437048|NCT02612779|582995151|FG001|Overall Study|Participant withdrew consent|0|||
161437049|NCT02612779|582995150|FG000|Overall Study|Lost to Follow-up|1|||
161437050|NCT02612779|582995151|FG001|Overall Study|Lost to Follow-up|0|||
161437051|NCT02612779|582995150|FG000|Overall Study|Maximum clinical benefit|10|||
161437052|NCT02612779|582995151|FG001|Overall Study|Maximum clinical benefit|1|||
161437053|NCT02612779|582995150|FG000|Overall Study|Other reasons|4|||
161437054|NCT02612779|582995151|FG001|Overall Study|Other reasons|0|||
161437055|NCT02633306|582995154|FG000|Overall Study|Withdrawal by Subject|3|||
161437056|NCT00129402|582995171|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
161437057|NCT00129402|582995172|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
161437058|NCT00129402|582995173|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
161437059|NCT00129402|582995174|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
161437060|NCT00129402|582995175|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
161437061|NCT00129402|582995176|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
161437062|NCT00129402|582995177|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
161437063|NCT00129402|582995171|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
161437064|NCT00129402|582995172|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
161437065|NCT00129402|582995173|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
161437066|NCT00129402|582995174|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
161437067|NCT00129402|582995175|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
161437068|NCT00129402|582995176|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
161437069|NCT00129402|582995177|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
161437070|NCT00129402|582995171|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161437071|NCT00129402|582995172|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161437072|NCT00129402|582995173|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161437073|NCT00129402|582995174|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
161437074|NCT00129402|582995175|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161437075|NCT00129402|582995176|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161437076|NCT00129402|582995177|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161437077|NCT00129402|582995171|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
161437078|NCT00129402|582995172|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
161437079|NCT00129402|582995173|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
161437080|NCT00129402|582995174|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
161437081|NCT00129402|582995175|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
161437082|NCT00129402|582995176|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
161437083|NCT00129402|582995177|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
161437084|NCT00129402|582995171|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161437085|NCT00129402|582995172|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161437086|NCT00129402|582995173|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
161437087|NCT00129402|582995174|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161437088|NCT00129402|582995175|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161437089|NCT00129402|582995176|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161437090|NCT00129402|582995177|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161437091|NCT00129402|582995171|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
161437092|NCT00129402|582995172|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
161437093|NCT00129402|582995173|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
161437094|NCT00129402|582995174|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
161437095|NCT00129402|582995175|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
161437096|NCT00129402|582995176|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
161437097|NCT00129402|582995177|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
161437098|NCT00129402|582995171|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161437099|NCT00129402|582995172|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161437100|NCT00129402|582995173|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
161437101|NCT00129402|582995174|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161437102|NCT00129402|582995175|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161437103|NCT00129402|582995176|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161437104|NCT00129402|582995177|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161437105|NCT00129402|582995171|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
161437106|NCT00129402|582995172|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
161437107|NCT00129402|582995173|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
161898197|NCT00572455|584675565|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
161898198|NCT00572455|584675566|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
161898199|NCT00572455|584675567|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
161898200|NCT00572455|584675568|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
161437108|NCT00129402|582995174|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
161437109|NCT00129402|582995175|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
161437110|NCT00129402|582995176|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
161437111|NCT00129402|582995177|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
161437112|NCT00129402|582995171|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
161437113|NCT00129402|582995172|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
161437114|NCT00129402|582995173|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
161437115|NCT00129402|582995174|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
161437116|NCT00129402|582995175|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
161437117|NCT00129402|582995176|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
161437118|NCT00129402|582995177|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
161437119|NCT00129402|582995171|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
161437120|NCT00129402|582995172|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
161437121|NCT00129402|582995173|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
161437122|NCT00129402|582995174|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
161437123|NCT00129402|582995175|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
161437124|NCT00129402|582995176|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
161437125|NCT00129402|582995177|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
161437126|NCT00129402|582995171|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
161437127|NCT00129402|582995172|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
161437128|NCT00129402|582995173|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
161437129|NCT00129402|582995174|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
161437130|NCT00129402|582995175|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
161437131|NCT00129402|582995176|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
161437132|NCT00129402|582995177|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
161437133|NCT00129402|582995171|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
161437134|NCT00129402|582995172|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
161437135|NCT00129402|582995173|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
161437136|NCT00129402|582995174|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
161437137|NCT00129402|582995175|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
161437138|NCT00129402|582995176|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
161437139|NCT00129402|582995177|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
161437140|NCT00129402|582995171|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
161437141|NCT00129402|582995172|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
161437142|NCT00129402|582995173|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
161437143|NCT00129402|582995174|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
161437144|NCT00129402|582995175|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
161437145|NCT00129402|582995176|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
161437146|NCT00129402|582995177|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
161437147|NCT00763035|582995178|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
161437148|NCT00763035|582995179|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
161437149|NCT00763035|582995178|FG000|First Intervention|Adverse Event|0|||
161437150|NCT00763035|582995179|FG001|First Intervention|Adverse Event|1|||
161437151|NCT00763035|582995178|FG000|Second Intervention|Adverse Event|1|||
161437152|NCT00763035|582995179|FG001|Second Intervention|Adverse Event|0|||
161437153|NCT00763035|582995178|FG000|Second Intervention|Physician Decision|2|||
161437154|NCT00763035|582995179|FG001|Second Intervention|Physician Decision|0|||
161437155|NCT02131259|582995180|FG000|Overall Study|Progressive disease|751|||
161437156|NCT02131259|582995180|FG000|Overall Study|Adverse Event|341|||
161437157|NCT02131259|582995180|FG000|Overall Study|Lost to Follow-up|7|||
161437158|NCT02131259|582995180|FG000|Overall Study|Relocation|32|||
161437159|NCT02131259|582995180|FG000|Overall Study|Other|63|||
161437160|NCT02131259|582995180|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
161437161|NCT02131259|582995180|FG000|Overall Study|Progressive disease/relocation|1|||
161437162|NCT02131259|582995180|FG000|Overall Study|Progressive disease/other|2|||
161437163|NCT02131259|582995180|FG000|Overall Study|AE/lost to follow-up|1|||
161437164|NCT02131259|582995180|FG000|Overall Study|AE/other|1|||
161437165|NCT02131259|582995180|FG000|Overall Study|Progressive disease/AE/other|1|||
161437166|NCT02131259|582995180|FG000|Overall Study|Missing|3|||
161437167|NCT01472289|582995187|FG000|Overall Study|Death|2|||
161437168|NCT00907335|582995188|FG000|Overall Study|Withdrawal by Subject|2|||
161437169|NCT00907335|582995189|FG001|Overall Study|Withdrawal by Subject|0|||
161437170|NCT00907335|582995188|FG000|Overall Study|Adverse Event|4|||
161437171|NCT00907335|582995189|FG001|Overall Study|Adverse Event|1|||
161437172|NCT00907335|582995188|FG000|Overall Study|Lost to Follow-up|2|||
161437173|NCT00907335|582995189|FG001|Overall Study|Lost to Follow-up|0|||
161437174|NCT03879772|582995190|FG000|Overall Study|Adverse Event|2|||
161437175|NCT03879772|582995191|FG001|Overall Study|Adverse Event|2|||
161437176|NCT03879772|582995192|FG002|Overall Study|Adverse Event|3|||
161437177|NCT03879772|582995193|FG003|Overall Study|Adverse Event|4|||
161437178|NCT03879772|582995194|FG004|Overall Study|Adverse Event|3|||
161437179|NCT03879772|582995190|FG000|Overall Study|Treatment Failure|1|||
161437180|NCT03879772|582995191|FG001|Overall Study|Treatment Failure|0|||
161437181|NCT03879772|582995192|FG002|Overall Study|Treatment Failure|0|||
161437182|NCT03879772|582995193|FG003|Overall Study|Treatment Failure|2|||
161437183|NCT03879772|582995194|FG004|Overall Study|Treatment Failure|1|||
161437184|NCT03879772|582995190|FG000|Overall Study|Lost to Follow-up|0|||
161437185|NCT03879772|582995191|FG001|Overall Study|Lost to Follow-up|0|||
161437186|NCT03879772|582995192|FG002|Overall Study|Lost to Follow-up|0|||
161437187|NCT03879772|582995193|FG003|Overall Study|Lost to Follow-up|0|||
161437188|NCT03879772|582995194|FG004|Overall Study|Lost to Follow-up|1|||
161437189|NCT03879772|582995190|FG000|Overall Study|Withdrawal by Subject|0|||
161437190|NCT03879772|582995191|FG001|Overall Study|Withdrawal by Subject|1|||
161437191|NCT03879772|582995192|FG002|Overall Study|Withdrawal by Subject|3|||
161437192|NCT03879772|582995193|FG003|Overall Study|Withdrawal by Subject|1|||
161437193|NCT03879772|582995194|FG004|Overall Study|Withdrawal by Subject|1|||
161437194|NCT03879772|582995190|FG000|Overall Study|Protocol Violation|0|||
161437195|NCT03879772|582995191|FG001|Overall Study|Protocol Violation|0|||
161437196|NCT03879772|582995192|FG002|Overall Study|Protocol Violation|3|||
161437197|NCT03879772|582995193|FG003|Overall Study|Protocol Violation|1|||
161437198|NCT03879772|582995194|FG004|Overall Study|Protocol Violation|2|||
161437199|NCT03879772|582995190|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
161437200|NCT03879772|582995191|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
161437201|NCT03879772|582995192|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
161437202|NCT03879772|582995193|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
161437203|NCT03879772|582995194|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
161437204|NCT00389610|582995206|FG000|Overall Study|Disease Progression|0|||
161437205|NCT00389610|582995207|FG001|Overall Study|Disease Progression|19|||
161437206|NCT00389610|582995206|FG000|Overall Study|Death|0|||
161437207|NCT00389610|582995207|FG001|Overall Study|Death|1|||
161437208|NCT00389610|582995206|FG000|Overall Study|Physician Decision|0|||
161437209|NCT00389610|582995207|FG001|Overall Study|Physician Decision|1|||
161437210|NCT00389610|582995206|FG000|Overall Study|Withdrawal by Subject|0|||
161437211|NCT00389610|582995207|FG001|Overall Study|Withdrawal by Subject|1|||
161437212|NCT00887809|582995208|FG000|Overall Study|Patient Not Treated|3|||
161437213|NCT00887809|582995209|FG001|Overall Study|Patient Not Treated|0|||
161437214|NCT00887809|582995208|FG000|Overall Study|Death|1|||
161437215|NCT00887809|582995209|FG001|Overall Study|Death|0|||
161437216|NCT03131570|582995210|FG000|Overall Study|Adverse Event|1|||
161437217|NCT03131570|582995211|FG001|Overall Study|Adverse Event|0|||
161437218|NCT04596267|582995212|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
161437219|NCT04596267|582995213|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
161437220|NCT04596267|582995212|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
161437221|NCT04596267|582995213|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
161437222|NCT00071058|582995214|FG000|Overall Study|brain tumor-removed from study|1|||
161437223|NCT04189952|582995222|FG000|Follow-up Period|Death|1|||
161437224|NCT04189952|582995222|FG000|Follow-up Period|Withdrawal by Subject|1|||
161437225|NCT00870740|582995223|FG000|Overall Study|Adverse Event|2|||
161437226|NCT00870740|582995224|FG001|Overall Study|Adverse Event|1|||
161437227|NCT00870740|582995225|FG002|Overall Study|Adverse Event|3|||
161437228|NCT00870740|582995226|FG003|Overall Study|Adverse Event|2|||
161437229|NCT00870740|582995227|FG004|Overall Study|Adverse Event|1|||
161437230|NCT00870740|582995228|FG005|Overall Study|Adverse Event|6|||
161437231|NCT00870740|582995223|FG000|Overall Study|Consent Withdrawn|6|||
161437232|NCT00870740|582995224|FG001|Overall Study|Consent Withdrawn|3|||
161437233|NCT00870740|582995225|FG002|Overall Study|Consent Withdrawn|4|||
161437234|NCT00870740|582995226|FG003|Overall Study|Consent Withdrawn|6|||
161437235|NCT00870740|582995227|FG004|Overall Study|Consent Withdrawn|6|||
161437236|NCT00870740|582995228|FG005|Overall Study|Consent Withdrawn|5|||
161437237|NCT00870740|582995223|FG000|Overall Study|Investigator Decision|2|||
161437238|NCT00870740|582995224|FG001|Overall Study|Investigator Decision|0|||
161437239|NCT00870740|582995225|FG002|Overall Study|Investigator Decision|1|||
161437240|NCT00870740|582995226|FG003|Overall Study|Investigator Decision|0|||
161437241|NCT00870740|582995227|FG004|Overall Study|Investigator Decision|0|||
161437242|NCT00870740|582995228|FG005|Overall Study|Investigator Decision|0|||
161437243|NCT00870740|582995223|FG000|Overall Study|Subject Non-compliance|0|||
161437244|NCT00870740|582995224|FG001|Overall Study|Subject Non-compliance|0|||
161437245|NCT00870740|582995225|FG002|Overall Study|Subject Non-compliance|0|||
161437246|NCT00870740|582995226|FG003|Overall Study|Subject Non-compliance|0|||
161437247|NCT00870740|582995227|FG004|Overall Study|Subject Non-compliance|0|||
161437248|NCT00870740|582995228|FG005|Overall Study|Subject Non-compliance|1|||
161437249|NCT00870740|582995223|FG000|Overall Study|Death|0|||
161437250|NCT00870740|582995224|FG001|Overall Study|Death|0|||
161437251|NCT00870740|582995225|FG002|Overall Study|Death|0|||
161437252|NCT00870740|582995226|FG003|Overall Study|Death|0|||
161437253|NCT00870740|582995227|FG004|Overall Study|Death|1|||
161437254|NCT00870740|582995228|FG005|Overall Study|Death|0|||
161437255|NCT00870740|582995223|FG000|Overall Study|Other|2|||
161437256|NCT00870740|582995224|FG001|Overall Study|Other|5|||
161437257|NCT00870740|582995225|FG002|Overall Study|Other|2|||
161437258|NCT00870740|582995226|FG003|Overall Study|Other|4|||
161437259|NCT00870740|582995227|FG004|Overall Study|Other|3|||
161437260|NCT00870740|582995228|FG005|Overall Study|Other|5|||
161437261|NCT04298697|582995236|FG000|Overall Study|Lost to Follow-up|5|||
161437262|NCT04298697|582995237|FG001|Overall Study|Lost to Follow-up|5|||
161437263|NCT04298697|582995238|FG002|Overall Study|Lost to Follow-up|1|||
161437264|NCT04298697|582995239|FG003|Overall Study|Lost to Follow-up|0|||
161437265|NCT04298697|582995236|FG000|Overall Study|Withdrawal by Subject|0|||
161437266|NCT04298697|582995237|FG001|Overall Study|Withdrawal by Subject|3|||
161437267|NCT04298697|582995238|FG002|Overall Study|Withdrawal by Subject|2|||
161437268|NCT04298697|582995239|FG003|Overall Study|Withdrawal by Subject|3|||
161437269|NCT03995368|582995240|FG000|Overall Study|Lost to Follow-up|1|||
161437270|NCT03995368|582995241|FG001|Overall Study|Lost to Follow-up|4|||
161437271|NCT03995368|582995242|FG002|Overall Study|Lost to Follow-up|1|||
161437272|NCT03995368|582995240|FG000|Overall Study|Did not meet inclusion criteria|1|||
161437273|NCT03995368|582995241|FG001|Overall Study|Did not meet inclusion criteria|6|||
161437274|NCT03995368|582995242|FG002|Overall Study|Did not meet inclusion criteria|3|||
161437275|NCT03995368|582995240|FG000|Overall Study|Withdrawal by Subject|0|||
161437276|NCT03995368|582995241|FG001|Overall Study|Withdrawal by Subject|1|||
161437277|NCT03995368|582995242|FG002|Overall Study|Withdrawal by Subject|1|||
161437278|NCT04322526|582995243|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
161437279|NCT04322526|582995244|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161437280|NCT04322526|582995243|FG000|Washout (1 Week)|Lost to Follow-up|1|||
161437281|NCT04322526|582995244|FG001|Washout (1 Week)|Lost to Follow-up|2|||
161437282|NCT03205423|582995245|FG000|Overall Study|Personal|1|||
161437283|NCT03205423|582995246|FG001|Overall Study|Personal|1|||
161437284|NCT03205423|582995245|FG000|Overall Study|Physician Decision|0|||
161437285|NCT03205423|582995246|FG001|Overall Study|Physician Decision|2|||
161437286|NCT02594124|582995247|FG000|Overall Study|Adverse Event|0|||
161437287|NCT02594124|582995248|FG001|Overall Study|Adverse Event|5|||
161437288|NCT02594124|582995249|FG002|Overall Study|Adverse Event|8|||
161437289|NCT02594124|582995250|FG003|Overall Study|Adverse Event|1|||
161437290|NCT02594124|582995251|FG004|Overall Study|Adverse Event|0|||
161437291|NCT02594124|582995252|FG005|Overall Study|Adverse Event|0|||
161437292|NCT02594124|582995253|FG006|Overall Study|Adverse Event|2|||
161437293|NCT02594124|582995254|FG007|Overall Study|Adverse Event|2|||
161437294|NCT02594124|582995255|FG008|Overall Study|Adverse Event|0|||
161437295|NCT02594124|582995247|FG000|Overall Study|Withdrawal by Subject|2|||
161437296|NCT02594124|582995248|FG001|Overall Study|Withdrawal by Subject|3|||
161437297|NCT02594124|582995249|FG002|Overall Study|Withdrawal by Subject|5|||
161437298|NCT02594124|582995250|FG003|Overall Study|Withdrawal by Subject|1|||
161437299|NCT02594124|582995251|FG004|Overall Study|Withdrawal by Subject|8|||
161784563|NCT00996918|584257378|FG004|Overall Study|Other|0|||
161784564|NCT01965535|584257381|FG000|Overall Study|Lack of Efficacy|2|||
161784565|NCT01965535|584257382|FG001|Overall Study|Lack of Efficacy|1|||
161784566|NCT00829439|584257384|FG000|Overall Study|Adverse Event|0|||
161784567|NCT00829439|584257385|FG001|Overall Study|Adverse Event|0|||
161784568|NCT00829439|584257386|FG002|Overall Study|Adverse Event|1|||
161784569|NCT00829439|584257387|FG003|Overall Study|Adverse Event|0|||
161784570|NCT02525562|584257388|FG000|Overall Study|Death|9|||
161784571|NCT02525562|584257389|FG001|Overall Study|Death|0|||
161784572|NCT02525562|584257390|FG002|Overall Study|Death|0|||
161784573|NCT02525562|584257388|FG000|Overall Study|Lost to Follow-up|19|||
161784574|NCT02525562|584257389|FG001|Overall Study|Lost to Follow-up|0|||
161784575|NCT02525562|584257390|FG002|Overall Study|Lost to Follow-up|0|||
161784576|NCT02525562|584257388|FG000|Overall Study|Withdrawal by Subject|37|||
161784577|NCT02525562|584257389|FG001|Overall Study|Withdrawal by Subject|0|||
161784578|NCT02525562|584257390|FG002|Overall Study|Withdrawal by Subject|0|||
161784579|NCT02525562|584257388|FG000|Overall Study|Revision/Removal of Study Device|4|||
161784580|NCT02525562|584257389|FG001|Overall Study|Revision/Removal of Study Device|0|||
161437300|NCT02594124|582995252|FG005|Overall Study|Withdrawal by Subject|4|||
161784581|NCT02525562|584257390|FG002|Overall Study|Revision/Removal of Study Device|0|||
161784582|NCT02525562|584257388|FG000|Overall Study|Study Closed by Sponsor|154|||
161784583|NCT02525562|584257389|FG001|Overall Study|Study Closed by Sponsor|0|||
161784584|NCT02525562|584257390|FG002|Overall Study|Study Closed by Sponsor|0|||
161784585|NCT00886782|584257391|FG000|Overall Study|Disease progression|3|||
161437301|NCT02594124|582995253|FG006|Overall Study|Withdrawal by Subject|13|||
161437302|NCT02594124|582995254|FG007|Overall Study|Withdrawal by Subject|19|||
161437303|NCT02594124|582995255|FG008|Overall Study|Withdrawal by Subject|0|||
161437304|NCT02594124|582995247|FG000|Overall Study|Physician Decision|0|||
161437305|NCT02594124|582995248|FG001|Overall Study|Physician Decision|2|||
161437306|NCT02594124|582995249|FG002|Overall Study|Physician Decision|0|||
161437307|NCT02594124|582995250|FG003|Overall Study|Physician Decision|0|||
161437308|NCT02594124|582995251|FG004|Overall Study|Physician Decision|0|||
161437309|NCT02594124|582995252|FG005|Overall Study|Physician Decision|0|||
161437310|NCT02594124|582995253|FG006|Overall Study|Physician Decision|0|||
161437311|NCT02594124|582995254|FG007|Overall Study|Physician Decision|1|||
161437312|NCT02594124|582995255|FG008|Overall Study|Physician Decision|0|||
161437313|NCT02594124|582995247|FG000|Overall Study|Commercial drug|0|||
161437314|NCT02594124|582995248|FG001|Overall Study|Commercial drug|1|||
161437315|NCT02594124|582995249|FG002|Overall Study|Commercial drug|6|||
161437316|NCT02594124|582995250|FG003|Overall Study|Commercial drug|3|||
161437317|NCT02594124|582995251|FG004|Overall Study|Commercial drug|0|||
161437318|NCT02594124|582995252|FG005|Overall Study|Commercial drug|0|||
161437319|NCT02594124|582995253|FG006|Overall Study|Commercial drug|7|||
161437320|NCT02594124|582995254|FG007|Overall Study|Commercial drug|11|||
161437321|NCT02594124|582995255|FG008|Overall Study|Commercial drug|2|||
161437322|NCT02594124|582995247|FG000|Overall Study|Reason Not Specified|1|||
161437323|NCT02594124|582995248|FG001|Overall Study|Reason Not Specified|3|||
161437324|NCT02594124|582995249|FG002|Overall Study|Reason Not Specified|4|||
161437325|NCT02594124|582995250|FG003|Overall Study|Reason Not Specified|0|||
161437326|NCT02594124|582995251|FG004|Overall Study|Reason Not Specified|0|||
161437327|NCT02594124|582995252|FG005|Overall Study|Reason Not Specified|1|||
161437328|NCT02594124|582995253|FG006|Overall Study|Reason Not Specified|1|||
161437329|NCT02594124|582995254|FG007|Overall Study|Reason Not Specified|6|||
161437330|NCT02594124|582995255|FG008|Overall Study|Reason Not Specified|1|||
161437331|NCT05523089|582995256|FG000|Overall Study|Withdrawal by Subject|1|||
161437332|NCT05523089|582995257|FG001|Overall Study|Withdrawal by Subject|0|||
161437333|NCT05523089|582995258|FG002|Overall Study|Withdrawal by Subject|0|||
161437334|NCT05523089|582995256|FG000|Overall Study|Lost to Follow-up|1|||
161437335|NCT05523089|582995257|FG001|Overall Study|Lost to Follow-up|0|||
161437336|NCT05523089|582995258|FG002|Overall Study|Lost to Follow-up|0|||
161549029|NCT03176238|583399376|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
161549030|NCT03176238|583399377|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
161549031|NCT01351025|583399380|FG000|Week 0 - 20|Lost to Follow-up|2|||
161549032|NCT01351025|583399381|FG001|Week 0 - 20|Lost to Follow-up|1|||
161549033|NCT01351025|583399380|FG000|Week 0 - 20|Withdrawal by Subject|1|||
161549034|NCT01351025|583399381|FG001|Week 0 - 20|Withdrawal by Subject|0|||
161549035|NCT01351025|583399380|FG000|Week 24 - 44|Lost to Follow-up|0|||
161549036|NCT01351025|583399381|FG001|Week 24 - 44|Lost to Follow-up|2|||
161549037|NCT01351025|583399380|FG000|Week 24 - 44|Site closed|0|||
161549038|NCT01351025|583399381|FG001|Week 24 - 44|Site closed|1|||
161549039|NCT01351025|583399380|FG000|Week 24 - 44|unable to get to clinic|1|||
161549040|NCT01351025|583399381|FG001|Week 24 - 44|unable to get to clinic|1|||
161549041|NCT00180713|583399386|FG000|Overall Study|Withdrawal by Subject|2|||
161549042|NCT00180713|583399387|FG001|Overall Study|Withdrawal by Subject|0|||
161549043|NCT00180713|583399386|FG000|Overall Study|Adverse Event|3|||
161549044|NCT00180713|583399387|FG001|Overall Study|Adverse Event|3|||
161549045|NCT05295732|583399390|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
161549046|NCT05295732|583399391|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
161549047|NCT05295732|583399392|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
161549048|NCT05295732|583399393|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
161549049|NCT05295732|583399394|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
161549050|NCT05295732|583399390|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
161549051|NCT05295732|583399391|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
161549052|NCT05295732|583399392|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
161549053|NCT05295732|583399393|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
161549054|NCT05295732|583399394|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
161549055|NCT03311230|583399397|FG000|Overall Study|Withdrawal by Subject|1|||
161549056|NCT03311230|583399398|FG001|Overall Study|Withdrawal by Subject|4|||
161549057|NCT03311230|583399399|FG002|Overall Study|Withdrawal by Subject|2|||
161549058|NCT03311230|583399400|FG003|Overall Study|Withdrawal by Subject|7|||
161549059|NCT03311230|583399397|FG000|Overall Study|Unrelated injury|0|||
161549060|NCT03311230|583399398|FG001|Overall Study|Unrelated injury|1|||
161549061|NCT03311230|583399399|FG002|Overall Study|Unrelated injury|0|||
161549062|NCT03311230|583399400|FG003|Overall Study|Unrelated injury|0|||
161549063|NCT05200936|583399402|FG000|Overall Study|Withdrawal by Subject|2|||
161549064|NCT05200936|583399403|FG001|Overall Study|Withdrawal by Subject|2|||
161549065|NCT05200936|583399402|FG000|Overall Study|Lost to Follow-up|2|||
161549066|NCT05200936|583399403|FG001|Overall Study|Lost to Follow-up|0|||
161549067|NCT05200936|583399402|FG000|Overall Study|Pregnancy|0|||
161549068|NCT05200936|583399403|FG001|Overall Study|Pregnancy|1|||
161549069|NCT01338012|583399404|FG000|Overall Study|Death|4|||
161549070|NCT01338012|583399404|FG000|Overall Study|Study terminated|4|||
161549071|NCT02089230|583399405|FG000|Overall Study|Death|0|||
161549072|NCT02089230|583399406|FG001|Overall Study|Death|0|||
161549073|NCT02089230|583399407|FG002|Overall Study|Death|2|||
161549074|NCT02089230|583399405|FG000|Overall Study|Seeking Alternative Therapy|0|||
161549075|NCT02089230|583399406|FG001|Overall Study|Seeking Alternative Therapy|0|||
161549076|NCT02089230|583399407|FG002|Overall Study|Seeking Alternative Therapy|4|||
161549077|NCT01242176|583400993|FG000|Washout Period of 7 Days|Adverse Event|0|||
161549078|NCT01242176|583400994|FG001|Washout Period of 7 Days|Adverse Event|2|||
161549079|NCT01242176|583400993|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
161784586|NCT00886782|584257392|FG001|Overall Study|Disease progression|3|||
161784587|NCT00886782|584257393|FG002|Overall Study|Disease progression|3|||
161784588|NCT00886782|584257391|FG000|Overall Study|Study drug toxicity|0|||
161784589|NCT00886782|584257392|FG001|Overall Study|Study drug toxicity|0|||
161784590|NCT00886782|584257393|FG002|Overall Study|Study drug toxicity|1|||
161784591|NCT00886782|584257391|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
161784592|NCT00886782|584257392|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
161784593|NCT00886782|584257393|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
161784594|NCT01946282|584257394|FG000|Year 1|Did not return FIT kit|4186|||
161784595|NCT01946282|584257395|FG001|Year 1|Did not return FIT kit|608|||
161784596|NCT01946282|584257396|FG002|Year 1|Did not return FIT kit|654|||
161784597|NCT01946282|584257394|FG000|Year 2|Did not return FIT kit|803|||
161784598|NCT01946282|584257395|FG001|Year 2|Did not return FIT kit|131|||
161784599|NCT01946282|584257396|FG002|Year 2|Did not return FIT kit|115|||
161784600|NCT01946282|584257394|FG000|Year 3|Did not return FIT kit|288|||
161784601|NCT01946282|584257395|FG001|Year 3|Did not return FIT kit|43|||
161784602|NCT01946282|584257396|FG002|Year 3|Did not return FIT kit|30|||
161784603|NCT00078819|584257397|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161784604|NCT00078819|584257398|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
161784605|NCT00078819|584257399|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161784606|NCT00078819|584257400|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161784607|NCT00078819|584257397|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
161784608|NCT00078819|584257398|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161784609|NCT00078819|584257399|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161784610|NCT00078819|584257400|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161784611|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
161784612|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
161784613|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
161784614|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
161784615|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
161784616|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
161784617|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
161784618|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
161784619|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
161784620|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
161784621|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
161784622|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
161784623|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
161784624|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
161784625|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
161784626|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
161784627|NCT00078819|584257397|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
161784628|NCT00078819|584257398|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
161784629|NCT00078819|584257399|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
161784630|NCT00078819|584257400|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
161784631|NCT00078819|584257397|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161784632|NCT00078819|584257398|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161784633|NCT00078819|584257399|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161784634|NCT00078819|584257400|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
161784635|NCT04130919|584257401|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
161784636|NCT04130919|584257402|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
161784637|NCT04130919|584257403|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
161784638|NCT04130919|584257404|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
161784639|NCT04130919|584257405|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
161784640|NCT04130919|584257406|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
161784641|NCT04130919|584257401|FG000|Blinded Treatment Phase|Adverse Event|0|||
161784642|NCT04130919|584257402|FG001|Blinded Treatment Phase|Adverse Event|0|||
161784643|NCT04130919|584257403|FG002|Blinded Treatment Phase|Adverse Event|1|||
161784644|NCT04130919|584257404|FG003|Blinded Treatment Phase|Adverse Event|0|||
161784645|NCT04130919|584257405|FG004|Blinded Treatment Phase|Adverse Event|0|||
161784646|NCT04130919|584257406|FG005|Blinded Treatment Phase|Adverse Event|0|||
161784647|NCT04130919|584257401|FG000|Blinded Treatment Phase|Disease worsening|0|||
161784648|NCT04130919|584257402|FG001|Blinded Treatment Phase|Disease worsening|0|||
161784649|NCT04130919|584257403|FG002|Blinded Treatment Phase|Disease worsening|1|||
161898201|NCT00572455|584675569|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
161784650|NCT04130919|584257404|FG003|Blinded Treatment Phase|Disease worsening|0|||
161784651|NCT04130919|584257405|FG004|Blinded Treatment Phase|Disease worsening|0|||
161784652|NCT04130919|584257406|FG005|Blinded Treatment Phase|Disease worsening|0|||
161898202|NCT00572455|584675570|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
161784653|NCT04130919|584257401|FG000|Blinded Treatment Phase|Investigator's decision|0|||
161784654|NCT04130919|584257402|FG001|Blinded Treatment Phase|Investigator's decision|1|||
161784655|NCT04130919|584257403|FG002|Blinded Treatment Phase|Investigator's decision|0|||
161784656|NCT04130919|584257404|FG003|Blinded Treatment Phase|Investigator's decision|0|||
161784657|NCT04130919|584257405|FG004|Blinded Treatment Phase|Investigator's decision|0|||
161784658|NCT04130919|584257406|FG005|Blinded Treatment Phase|Investigator's decision|0|||
161784659|NCT04130919|584257401|FG000|Blinded Treatment Phase|Withdrew consent|1|||
161784660|NCT04130919|584257402|FG001|Blinded Treatment Phase|Withdrew consent|0|||
161784661|NCT04130919|584257403|FG002|Blinded Treatment Phase|Withdrew consent|0|||
161784662|NCT04130919|584257404|FG003|Blinded Treatment Phase|Withdrew consent|0|||
161784663|NCT04130919|584257405|FG004|Blinded Treatment Phase|Withdrew consent|0|||
161784664|NCT04130919|584257406|FG005|Blinded Treatment Phase|Withdrew consent|0|||
161784665|NCT04130919|584257401|FG000|Open-label Treatment Phase|Withdrew consent|0|||
161784666|NCT04130919|584257402|FG001|Open-label Treatment Phase|Withdrew consent|0|||
161784667|NCT04130919|584257403|FG002|Open-label Treatment Phase|Withdrew consent|0|||
161784668|NCT04130919|584257404|FG003|Open-label Treatment Phase|Withdrew consent|1|||
161784669|NCT04130919|584257405|FG004|Open-label Treatment Phase|Withdrew consent|1|||
161784670|NCT04130919|584257406|FG005|Open-label Treatment Phase|Withdrew consent|1|||
161784671|NCT04130919|584257401|FG000|Open-label Treatment Phase|Disease worsening|0|||
161784672|NCT04130919|584257402|FG001|Open-label Treatment Phase|Disease worsening|0|||
161784673|NCT04130919|584257403|FG002|Open-label Treatment Phase|Disease worsening|0|||
161784674|NCT04130919|584257404|FG003|Open-label Treatment Phase|Disease worsening|1|||
161784675|NCT04130919|584257405|FG004|Open-label Treatment Phase|Disease worsening|0|||
161784676|NCT04130919|584257406|FG005|Open-label Treatment Phase|Disease worsening|1|||
161784677|NCT04130919|584257401|FG000|Open-label Treatment Phase|Investigator's decision|0|||
161784678|NCT04130919|584257402|FG001|Open-label Treatment Phase|Investigator's decision|0|||
161784679|NCT04130919|584257403|FG002|Open-label Treatment Phase|Investigator's decision|0|||
161784680|NCT04130919|584257404|FG003|Open-label Treatment Phase|Investigator's decision|1|||
161784681|NCT04130919|584257405|FG004|Open-label Treatment Phase|Investigator's decision|0|||
161784682|NCT04130919|584257406|FG005|Open-label Treatment Phase|Investigator's decision|0|||
161784683|NCT04130919|584257401|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161784684|NCT04130919|584257402|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161784685|NCT04130919|584257403|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
161784686|NCT04130919|584257404|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
161784687|NCT04130919|584257405|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
161784688|NCT04130919|584257406|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
161784689|NCT04130919|584257401|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784690|NCT04130919|584257402|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784691|NCT04130919|584257403|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784692|NCT04130919|584257404|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784693|NCT04130919|584257405|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
161784694|NCT04130919|584257406|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784695|NCT03012815|584257407|FG000|Overall Study|Lost to Follow-up|1|||
161784696|NCT03012815|584257408|FG001|Overall Study|Lost to Follow-up|0|||
161784697|NCT03012815|584257407|FG000|Overall Study|Physician Decision|3|||
161784698|NCT03012815|584257408|FG001|Overall Study|Physician Decision|2|||
161784699|NCT03012815|584257407|FG000|Overall Study|Adverse Event|1|||
161784700|NCT03012815|584257408|FG001|Overall Study|Adverse Event|0|||
161784701|NCT02400905|584257410|FG000|Overall Study|Death|24|||
161784702|NCT02400905|584257410|FG000|Overall Study|Lost to Follow-up|18|||
161784703|NCT02400905|584257410|FG000|Overall Study|Withdrawal by Subject|16|||
161784704|NCT02400905|584257410|FG000|Overall Study|Physician Decision|4|||
161784705|NCT02400905|584257410|FG000|Overall Study|Other|1|||
161784706|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
161784707|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
161784708|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
161784709|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
161784710|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
161784711|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
161784712|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
161784713|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
161784714|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
161784715|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
161784716|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Death|2|||
161784717|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Death|1|||
161784718|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Death|0|||
161898203|NCT00572455|584675571|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
161784719|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Death|0|||
161784720|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Death|0|||
161898204|NCT00572455|584675572|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
161784721|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
161784722|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161784723|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
161784724|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161784725|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161784726|NCT00879970|584257411|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161784727|NCT00879970|584257412|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161784728|NCT00879970|584257413|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161784729|NCT00879970|584257414|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
161784730|NCT00879970|584257415|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
161784731|NCT00879970|584257411|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784732|NCT00879970|584257412|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784733|NCT00879970|584257413|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784734|NCT00879970|584257414|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784735|NCT00879970|584257415|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
161784736|NCT00879970|584257411|FG000|Period 2 Vitamin D Randomization|Death|0|||
161784737|NCT00879970|584257412|FG001|Period 2 Vitamin D Randomization|Death|0|||
161784738|NCT00879970|584257413|FG002|Period 2 Vitamin D Randomization|Death|0|||
161784739|NCT00879970|584257414|FG003|Period 2 Vitamin D Randomization|Death|2|||
161784740|NCT00879970|584257415|FG004|Period 2 Vitamin D Randomization|Death|0|||
161784741|NCT01749033|584257419|FG000|Overall Study|Did not receive allocated intervention|3|||
161784742|NCT01749033|584257420|FG001|Overall Study|Did not receive allocated intervention|3|||
161784743|NCT01749033|584257421|FG002|Overall Study|Did not receive allocated intervention|0|||
161784744|NCT01749033|584257419|FG000|Overall Study|Lost to Follow-up|0|||
161784745|NCT01749033|584257420|FG001|Overall Study|Lost to Follow-up|2|||
161784746|NCT01749033|584257421|FG002|Overall Study|Lost to Follow-up|1|||
161784747|NCT01256398|584257422|FG000|Overall Study|Withdrawal by Subject|1|||
161784748|NCT01039584|584257423|FG000|Overall Study|Withdrawal by Subject|4|||
161784749|NCT01039584|584257424|FG001|Overall Study|Withdrawal by Subject|2|||
161784750|NCT01039584|584257425|FG002|Overall Study|Withdrawal by Subject|1|||
161784751|NCT01039584|584257423|FG000|Overall Study|Protocol Violation|10|||
161784752|NCT01039584|584257424|FG001|Overall Study|Protocol Violation|4|||
161784753|NCT01039584|584257425|FG002|Overall Study|Protocol Violation|6|||
161784754|NCT01039584|584257423|FG000|Overall Study|Lost to Follow-up|5|||
161784755|NCT01039584|584257424|FG001|Overall Study|Lost to Follow-up|3|||
161784756|NCT01039584|584257425|FG002|Overall Study|Lost to Follow-up|4|||
161784757|NCT01039584|584257423|FG000|Overall Study|Negative Baseline culture for Candida|59|||
161784758|NCT01039584|584257424|FG001|Overall Study|Negative Baseline culture for Candida|59|||
161784759|NCT01039584|584257425|FG002|Overall Study|Negative Baseline culture for Candida|24|||
161784760|NCT01039584|584257423|FG000|Overall Study|Lack of Efficacy|7|||
161784761|NCT01039584|584257424|FG001|Overall Study|Lack of Efficacy|6|||
161784762|NCT01039584|584257425|FG002|Overall Study|Lack of Efficacy|10|||
161784763|NCT01039584|584257423|FG000|Overall Study|other|1|||
161784764|NCT01039584|584257424|FG001|Overall Study|other|3|||
161784765|NCT01039584|584257425|FG002|Overall Study|other|1|||
161784766|NCT01039584|584257423|FG000|Overall Study|Pap smear with significant pathology|10|||
161784767|NCT01039584|584257424|FG001|Overall Study|Pap smear with significant pathology|10|||
161784768|NCT01039584|584257425|FG002|Overall Study|Pap smear with significant pathology|3|||
161784769|NCT01039584|584257423|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
161784770|NCT01039584|584257424|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
161784771|NCT01039584|584257425|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
161784772|NCT01174368|584257428|FG000|Overall Study|Withdrawal by Subject|1|||
161784773|NCT00479765|584257429|FG000|Overall Study|study terminated|4|||
161784774|NCT04380701|584257432|FG000|Overall Study|Pregnancy|0|||
161784775|NCT04380701|584257433|FG001|Overall Study|Pregnancy|0|||
161784776|NCT04380701|584257434|FG002|Overall Study|Pregnancy|0|||
161784777|NCT04380701|584257435|FG003|Overall Study|Pregnancy|0|||
161784778|NCT04380701|584257436|FG004|Overall Study|Pregnancy|0|||
161784779|NCT04380701|584257437|FG005|Overall Study|Pregnancy|0|||
161784780|NCT04380701|584257438|FG006|Overall Study|Pregnancy|0|||
161784781|NCT04380701|584257439|FG007|Overall Study|Pregnancy|0|||
161784782|NCT04380701|584257440|FG008|Overall Study|Pregnancy|0|||
161437337|NCT00554216|582997068|FG000|Overall Study|Lost to Follow-up|92|||
161784783|NCT04380701|584257441|FG009|Overall Study|Pregnancy|0|||
161784784|NCT04380701|584257442|FG010|Overall Study|Pregnancy|0|||
161437338|NCT00554216|582997069|FG001|Overall Study|Lost to Follow-up|31|||
161437339|NCT00554216|582997070|FG002|Overall Study|Lost to Follow-up|63|||
161437340|NCT00554216|582997068|FG000|Overall Study|Adverse Event|16|||
161784785|NCT04380701|584257443|FG011|Overall Study|Pregnancy|0|||
161784786|NCT04380701|584257444|FG012|Overall Study|Pregnancy|0|||
161784787|NCT04380701|584257445|FG013|Overall Study|Pregnancy|0|||
161784788|NCT04380701|584257446|FG014|Overall Study|Pregnancy|0|||
161784789|NCT04380701|584257447|FG015|Overall Study|Pregnancy|0|||
161784790|NCT04380701|584257448|FG016|Overall Study|Pregnancy|0|||
161784791|NCT04380701|584257449|FG017|Overall Study|Pregnancy|0|||
161784792|NCT04380701|584257450|FG018|Overall Study|Pregnancy|0|||
161784793|NCT04380701|584257451|FG019|Overall Study|Pregnancy|0|||
161784794|NCT04380701|584257452|FG020|Overall Study|Pregnancy|0|||
161784795|NCT04380701|584257453|FG021|Overall Study|Pregnancy|0|||
161784796|NCT04380701|584257454|FG022|Overall Study|Pregnancy|0|||
161784797|NCT04380701|584257455|FG023|Overall Study|Pregnancy|0|||
161784798|NCT04380701|584257456|FG024|Overall Study|Pregnancy|0|||
161784799|NCT04380701|584257457|FG025|Overall Study|Pregnancy|0|||
161784800|NCT04380701|584257458|FG026|Overall Study|Pregnancy|0|||
161784801|NCT04380701|584257459|FG027|Overall Study|Pregnancy|0|||
161784802|NCT04380701|584257460|FG028|Overall Study|Pregnancy|0|||
161784803|NCT04380701|584257461|FG029|Overall Study|Pregnancy|0|||
161784804|NCT04380701|584257462|FG030|Overall Study|Pregnancy|0|||
161784805|NCT04380701|584257463|FG031|Overall Study|Pregnancy|0|||
161784806|NCT04380701|584257464|FG032|Overall Study|Pregnancy|1|||
161784807|NCT04380701|584257465|FG033|Overall Study|Pregnancy|0|||
161784808|NCT04380701|584257432|FG000|Overall Study|Lost to Follow-up|0|||
161784809|NCT04380701|584257433|FG001|Overall Study|Lost to Follow-up|0|||
161784810|NCT04380701|584257434|FG002|Overall Study|Lost to Follow-up|0|||
161784811|NCT04380701|584257435|FG003|Overall Study|Lost to Follow-up|0|||
161784812|NCT04380701|584257436|FG004|Overall Study|Lost to Follow-up|0|||
161784813|NCT04380701|584257437|FG005|Overall Study|Lost to Follow-up|0|||
161784814|NCT04380701|584257438|FG006|Overall Study|Lost to Follow-up|0|||
161784815|NCT04380701|584257439|FG007|Overall Study|Lost to Follow-up|0|||
161784816|NCT04380701|584257440|FG008|Overall Study|Lost to Follow-up|0|||
161784817|NCT04380701|584257441|FG009|Overall Study|Lost to Follow-up|0|||
161784818|NCT04380701|584257442|FG010|Overall Study|Lost to Follow-up|0|||
161784819|NCT04380701|584257443|FG011|Overall Study|Lost to Follow-up|0|||
161784820|NCT04380701|584257444|FG012|Overall Study|Lost to Follow-up|0|||
161784821|NCT04380701|584257445|FG013|Overall Study|Lost to Follow-up|0|||
161784822|NCT04380701|584257446|FG014|Overall Study|Lost to Follow-up|0|||
161784823|NCT04380701|584257447|FG015|Overall Study|Lost to Follow-up|0|||
161784824|NCT04380701|584257448|FG016|Overall Study|Lost to Follow-up|0|||
161784825|NCT04380701|584257449|FG017|Overall Study|Lost to Follow-up|0|||
161784826|NCT04380701|584257450|FG018|Overall Study|Lost to Follow-up|0|||
161784827|NCT04380701|584257451|FG019|Overall Study|Lost to Follow-up|0|||
161784828|NCT04380701|584257452|FG020|Overall Study|Lost to Follow-up|1|||
161784829|NCT04380701|584257453|FG021|Overall Study|Lost to Follow-up|0|||
161784830|NCT04380701|584257454|FG022|Overall Study|Lost to Follow-up|0|||
161784831|NCT04380701|584257455|FG023|Overall Study|Lost to Follow-up|1|||
161784832|NCT04380701|584257456|FG024|Overall Study|Lost to Follow-up|0|||
161784833|NCT04380701|584257457|FG025|Overall Study|Lost to Follow-up|0|||
161784834|NCT04380701|584257458|FG026|Overall Study|Lost to Follow-up|0|||
161784835|NCT04380701|584257459|FG027|Overall Study|Lost to Follow-up|0|||
161784836|NCT04380701|584257460|FG028|Overall Study|Lost to Follow-up|0|||
161784837|NCT04380701|584257461|FG029|Overall Study|Lost to Follow-up|1|||
161784838|NCT04380701|584257462|FG030|Overall Study|Lost to Follow-up|0|||
161784839|NCT04380701|584257463|FG031|Overall Study|Lost to Follow-up|0|||
161784840|NCT04380701|584257464|FG032|Overall Study|Lost to Follow-up|0|||
161437341|NCT00554216|582997069|FG001|Overall Study|Adverse Event|16|||
161437342|NCT00554216|582997070|FG002|Overall Study|Adverse Event|36|||
161437343|NCT00554216|582997068|FG000|Overall Study|Withdrawal by Subject|92|||
161437344|NCT00554216|582997069|FG001|Overall Study|Withdrawal by Subject|31|||
161437345|NCT00554216|582997070|FG002|Overall Study|Withdrawal by Subject|43|||
161437346|NCT00554216|582997068|FG000|Overall Study|Non compliance|10|||
161437347|NCT00554216|582997069|FG001|Overall Study|Non compliance|4|||
161437348|NCT00554216|582997070|FG002|Overall Study|Non compliance|5|||
161784841|NCT04380701|584257465|FG033|Overall Study|Lost to Follow-up|1|||
161784842|NCT04380701|584257432|FG000|Overall Study|Private reason(s)|0|||
161784843|NCT04380701|584257433|FG001|Overall Study|Private reason(s)|0|||
161784844|NCT04380701|584257434|FG002|Overall Study|Private reason(s)|0|||
161784845|NCT04380701|584257435|FG003|Overall Study|Private reason(s)|0|||
161784846|NCT04380701|584257436|FG004|Overall Study|Private reason(s)|0|||
161784847|NCT04380701|584257437|FG005|Overall Study|Private reason(s)|0|||
161784848|NCT04380701|584257438|FG006|Overall Study|Private reason(s)|1|||
161784849|NCT04380701|584257439|FG007|Overall Study|Private reason(s)|0|||
161784850|NCT04380701|584257440|FG008|Overall Study|Private reason(s)|1|||
161784851|NCT04380701|584257441|FG009|Overall Study|Private reason(s)|1|||
161437349|NCT00554216|582997068|FG000|Overall Study|Pregnancy|2|||
161437350|NCT00554216|582997069|FG001|Overall Study|Pregnancy|1|||
161784852|NCT04380701|584257442|FG010|Overall Study|Private reason(s)|0|||
161784853|NCT04380701|584257443|FG011|Overall Study|Private reason(s)|0|||
161784854|NCT04380701|584257444|FG012|Overall Study|Private reason(s)|0|||
161784855|NCT04380701|584257445|FG013|Overall Study|Private reason(s)|0|||
161784856|NCT04380701|584257446|FG014|Overall Study|Private reason(s)|0|||
161437351|NCT00554216|582997070|FG002|Overall Study|Pregnancy|14|||
161437352|NCT00554216|582997068|FG000|Overall Study|Restricted med|3|||
161784857|NCT04380701|584257447|FG015|Overall Study|Private reason(s)|0|||
161784858|NCT04380701|584257448|FG016|Overall Study|Private reason(s)|0|||
161784859|NCT04380701|584257449|FG017|Overall Study|Private reason(s)|0|||
161784860|NCT04380701|584257450|FG018|Overall Study|Private reason(s)|0|||
161784861|NCT04380701|584257451|FG019|Overall Study|Private reason(s)|0|||
161784862|NCT04380701|584257452|FG020|Overall Study|Private reason(s)|0|||
161784863|NCT04380701|584257453|FG021|Overall Study|Private reason(s)|0|||
161784864|NCT04380701|584257454|FG022|Overall Study|Private reason(s)|0|||
161784865|NCT04380701|584257455|FG023|Overall Study|Private reason(s)|1|||
161784866|NCT04380701|584257456|FG024|Overall Study|Private reason(s)|0|||
161784867|NCT04380701|584257457|FG025|Overall Study|Private reason(s)|0|||
161784868|NCT04380701|584257458|FG026|Overall Study|Private reason(s)|0|||
161784869|NCT04380701|584257459|FG027|Overall Study|Private reason(s)|0|||
161784870|NCT04380701|584257460|FG028|Overall Study|Private reason(s)|0|||
161784871|NCT04380701|584257461|FG029|Overall Study|Private reason(s)|1|||
161784872|NCT04380701|584257462|FG030|Overall Study|Private reason(s)|0|||
161784873|NCT04380701|584257463|FG031|Overall Study|Private reason(s)|0|||
161784874|NCT04380701|584257464|FG032|Overall Study|Private reason(s)|0|||
161784875|NCT04380701|584257465|FG033|Overall Study|Private reason(s)|0|||
161784876|NCT04380701|584257432|FG000|Overall Study|Withdrawal by Subject|0|||
161784877|NCT04380701|584257433|FG001|Overall Study|Withdrawal by Subject|0|||
161784878|NCT04380701|584257434|FG002|Overall Study|Withdrawal by Subject|0|||
161784879|NCT04380701|584257435|FG003|Overall Study|Withdrawal by Subject|0|||
161784880|NCT04380701|584257436|FG004|Overall Study|Withdrawal by Subject|0|||
161784881|NCT04380701|584257437|FG005|Overall Study|Withdrawal by Subject|0|||
161784882|NCT04380701|584257438|FG006|Overall Study|Withdrawal by Subject|1|||
161784883|NCT04380701|584257439|FG007|Overall Study|Withdrawal by Subject|1|||
161784884|NCT04380701|584257440|FG008|Overall Study|Withdrawal by Subject|0|||
161784885|NCT04380701|584257441|FG009|Overall Study|Withdrawal by Subject|0|||
161784886|NCT04380701|584257442|FG010|Overall Study|Withdrawal by Subject|0|||
161784887|NCT04380701|584257443|FG011|Overall Study|Withdrawal by Subject|1|||
161784888|NCT04380701|584257444|FG012|Overall Study|Withdrawal by Subject|0|||
161784889|NCT04380701|584257445|FG013|Overall Study|Withdrawal by Subject|1|||
161784890|NCT04380701|584257446|FG014|Overall Study|Withdrawal by Subject|0|||
161784891|NCT04380701|584257447|FG015|Overall Study|Withdrawal by Subject|0|||
161784892|NCT04380701|584257448|FG016|Overall Study|Withdrawal by Subject|1|||
161784893|NCT04380701|584257449|FG017|Overall Study|Withdrawal by Subject|0|||
161784894|NCT04380701|584257450|FG018|Overall Study|Withdrawal by Subject|0|||
161784895|NCT04380701|584257451|FG019|Overall Study|Withdrawal by Subject|0|||
161784896|NCT04380701|584257452|FG020|Overall Study|Withdrawal by Subject|0|||
161784897|NCT04380701|584257453|FG021|Overall Study|Withdrawal by Subject|0|||
161784898|NCT04380701|584257454|FG022|Overall Study|Withdrawal by Subject|2|||
161784899|NCT04380701|584257455|FG023|Overall Study|Withdrawal by Subject|2|||
161784900|NCT04380701|584257456|FG024|Overall Study|Withdrawal by Subject|1|||
161784901|NCT04380701|584257457|FG025|Overall Study|Withdrawal by Subject|1|||
161784902|NCT04380701|584257458|FG026|Overall Study|Withdrawal by Subject|0|||
161784903|NCT04380701|584257459|FG027|Overall Study|Withdrawal by Subject|0|||
161784904|NCT04380701|584257460|FG028|Overall Study|Withdrawal by Subject|0|||
161784905|NCT04380701|584257461|FG029|Overall Study|Withdrawal by Subject|0|||
161784906|NCT04380701|584257462|FG030|Overall Study|Withdrawal by Subject|0|||
161784907|NCT04380701|584257463|FG031|Overall Study|Withdrawal by Subject|0|||
161784908|NCT04380701|584257464|FG032|Overall Study|Withdrawal by Subject|0|||
161784909|NCT04380701|584257465|FG033|Overall Study|Withdrawal by Subject|0|||
161784910|NCT04380701|584257432|FG000|Overall Study|Adverse Event|0|||
161784911|NCT04380701|584257433|FG001|Overall Study|Adverse Event|0|||
161784912|NCT04380701|584257434|FG002|Overall Study|Adverse Event|0|||
161784913|NCT04380701|584257435|FG003|Overall Study|Adverse Event|0|||
161784914|NCT04380701|584257436|FG004|Overall Study|Adverse Event|0|||
161784915|NCT04380701|584257437|FG005|Overall Study|Adverse Event|1|||
161784916|NCT04380701|584257438|FG006|Overall Study|Adverse Event|0|||
161784917|NCT04380701|584257439|FG007|Overall Study|Adverse Event|0|||
161784918|NCT04380701|584257440|FG008|Overall Study|Adverse Event|0|||
161784919|NCT04380701|584257441|FG009|Overall Study|Adverse Event|0|||
161784920|NCT04380701|584257442|FG010|Overall Study|Adverse Event|0|||
161784921|NCT04380701|584257443|FG011|Overall Study|Adverse Event|0|||
161784922|NCT04380701|584257444|FG012|Overall Study|Adverse Event|0|||
161784923|NCT04380701|584257445|FG013|Overall Study|Adverse Event|0|||
161784924|NCT04380701|584257446|FG014|Overall Study|Adverse Event|0|||
161784925|NCT04380701|584257447|FG015|Overall Study|Adverse Event|1|||
161784926|NCT04380701|584257448|FG016|Overall Study|Adverse Event|0|||
161784927|NCT04380701|584257449|FG017|Overall Study|Adverse Event|0|||
161784928|NCT04380701|584257450|FG018|Overall Study|Adverse Event|0|||
161784929|NCT04380701|584257451|FG019|Overall Study|Adverse Event|1|||
161784930|NCT04380701|584257452|FG020|Overall Study|Adverse Event|0|||
161784931|NCT04380701|584257453|FG021|Overall Study|Adverse Event|0|||
161784932|NCT04380701|584257454|FG022|Overall Study|Adverse Event|0|||
161784933|NCT04380701|584257455|FG023|Overall Study|Adverse Event|0|||
161784934|NCT04380701|584257456|FG024|Overall Study|Adverse Event|0|||
161784935|NCT04380701|584257457|FG025|Overall Study|Adverse Event|0|||
161784936|NCT04380701|584257458|FG026|Overall Study|Adverse Event|0|||
161784937|NCT04380701|584257459|FG027|Overall Study|Adverse Event|0|||
161784938|NCT04380701|584257460|FG028|Overall Study|Adverse Event|0|||
161784939|NCT04380701|584257461|FG029|Overall Study|Adverse Event|0|||
161437353|NCT00554216|582997069|FG001|Overall Study|Restricted med|1|||
161437354|NCT00554216|582997070|FG002|Overall Study|Restricted med|1|||
161437355|NCT00554216|582997068|FG000|Overall Study|Other|12|||
161437356|NCT00554216|582997069|FG001|Overall Study|Other|7|||
161437357|NCT00554216|582997070|FG002|Overall Study|Other|10|||
161437358|NCT00554216|582997068|FG000|Overall Study|Lack of Efficacy|15|||
161437359|NCT00554216|582997069|FG001|Overall Study|Lack of Efficacy|3|||
161437360|NCT00554216|582997070|FG002|Overall Study|Lack of Efficacy|0|||
161437361|NCT05291520|582997071|FG000|Overall Study|Lost to Follow-up|0|||
161437362|NCT05291520|582997072|FG001|Overall Study|Lost to Follow-up|0|||
161437363|NCT05291520|582997073|FG002|Overall Study|Lost to Follow-up|1|||
161437364|NCT01347112|582997074|FG000|Overall Study|Withdrawal by Subject|1|||
161437365|NCT01347112|582997075|FG001|Overall Study|Withdrawal by Subject|7|||
161437366|NCT01347112|582997074|FG000|Overall Study|Lost to Follow-up|3|||
161437367|NCT01347112|582997075|FG001|Overall Study|Lost to Follow-up|5|||
161437368|NCT05462756|582997078|FG000|Treatment Period|Adverse Event|3|||
161437369|NCT05462756|582997079|FG001|Treatment Period|Adverse Event|0|||
161437370|NCT05462756|582997078|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
161437371|NCT05462756|582997079|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
161437372|NCT05462756|582997078|FG000|Treatment Period|Death|0|||
161437373|NCT05462756|582997079|FG001|Treatment Period|Death|1|||
161437374|NCT05462756|582997078|FG000|Treatment Period|Lost to Follow-up|2|||
161437375|NCT05462756|582997079|FG001|Treatment Period|Lost to Follow-up|1|||
161437376|NCT05462756|582997078|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
161437377|NCT05462756|582997079|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
161437378|NCT05462756|582997078|FG000|Treatment Period|Physician Decision|2|||
161437379|NCT05462756|582997079|FG001|Treatment Period|Physician Decision|0|||
161437380|NCT05462756|582997078|FG000|Treatment Period|Protocol Violation|0|||
161437381|NCT05462756|582997079|FG001|Treatment Period|Protocol Violation|1|||
161437382|NCT05462756|582997078|FG000|Treatment Period|Withdrawal by Subject|5|||
161437383|NCT05462756|582997079|FG001|Treatment Period|Withdrawal by Subject|12|||
161437384|NCT05462756|582997078|FG000|Follow-Up Period|Adverse Event|1|||
161437385|NCT05462756|582997079|FG001|Follow-Up Period|Adverse Event|0|||
161437386|NCT05462756|582997078|FG000|Follow-Up Period|Death|1|||
161437387|NCT05462756|582997079|FG001|Follow-Up Period|Death|0|||
161437388|NCT05462756|582997078|FG000|Follow-Up Period|Lost to Follow-up|3|||
161437389|NCT05462756|582997079|FG001|Follow-Up Period|Lost to Follow-up|1|||
161437390|NCT05462756|582997078|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161437391|NCT05462756|582997079|FG001|Follow-Up Period|Withdrawal by Subject|4|||
161437392|NCT01432730|582997082|FG000|Period 1|Adverse Event|2|||
161437393|NCT01432730|582997083|FG001|Period 1|Adverse Event|0|||
161437394|NCT01432730|582997082|FG000|Period 2|Adverse Event|0|||
161437395|NCT01432730|582997083|FG001|Period 2|Adverse Event|4|||
161437396|NCT01421719|582997084|FG000|Overall Study|Withdrawal by Subject|4|||
161437397|NCT01281124|582997089|FG000|Overall Study|Death|1|||
161437398|NCT01198795|582997090|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
161437399|NCT01198795|582997090|FG000|Overall Study|Withdrawal by Subject|17|||
161437400|NCT01198795|582997090|FG000|Overall Study|Lost to Follow-up|15|||
161437401|NCT01198795|582997090|FG000|Overall Study|Adverse Event|9|||
161437402|NCT01198795|582997090|FG000|Overall Study|Lack of Efficacy|5|||
161437403|NCT01198795|582997090|FG000|Overall Study|Protocol Violation|2|||
161437404|NCT01198795|582997090|FG000|Overall Study|Other Reason|4|||
161437405|NCT00706238|582997091|FG000|Overall Study|Disease progression|4|||
161437406|NCT00706238|582997091|FG000|Overall Study|Other|1|||
161437407|NCT04226742|582997092|FG000|Overall Study|Lost to Follow-up|16|||
161437408|NCT04226742|582997093|FG001|Overall Study|Lost to Follow-up|13|||
161437409|NCT04226742|582997092|FG000|Overall Study|Withdrawal by Subject|5|||
161437410|NCT04226742|582997093|FG001|Overall Study|Withdrawal by Subject|3|||
161784940|NCT04380701|584257462|FG030|Overall Study|Adverse Event|0|||
161784941|NCT04380701|584257463|FG031|Overall Study|Adverse Event|0|||
161784942|NCT04380701|584257464|FG032|Overall Study|Adverse Event|0|||
161784943|NCT04380701|584257465|FG033|Overall Study|Adverse Event|0|||
161784944|NCT04380701|584257432|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
161784945|NCT04380701|584257433|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
161437411|NCT05097963|582997096|FG000|Overall Study|Protocol Violation|13|||
161437412|NCT05097963|582997096|FG000|Overall Study|Withdrawal by Subject|21|||
161437413|NCT02492763|582997097|FG000|Overall Study|Withdrawal by Subject|0|||
161437414|NCT02492763|582997098|FG001|Overall Study|Withdrawal by Subject|2|||
161437415|NCT02492763|582997099|FG002|Overall Study|Withdrawal by Subject|1|||
161437416|NCT02492763|582997100|FG003|Overall Study|Withdrawal by Subject|0|||
161784946|NCT04380701|584257434|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
161437417|NCT02492763|582997097|FG000|Overall Study|Adverse Event|3|||
161437418|NCT02492763|582997098|FG001|Overall Study|Adverse Event|1|||
161437419|NCT02492763|582997099|FG002|Overall Study|Adverse Event|1|||
161437420|NCT02492763|582997100|FG003|Overall Study|Adverse Event|2|||
161437421|NCT02492763|582997097|FG000|Overall Study|Death|0|||
161437422|NCT02492763|582997098|FG001|Overall Study|Death|0|||
161437423|NCT02492763|582997099|FG002|Overall Study|Death|1|||
161784947|NCT04380701|584257435|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
161437424|NCT02492763|582997100|FG003|Overall Study|Death|0|||
161437425|NCT02492763|582997097|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
161437426|NCT02492763|582997098|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
161437427|NCT02492763|582997099|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
161437428|NCT02492763|582997100|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
161437429|NCT02492763|582997097|FG000|Overall Study|Lost to Follow-up|0|||
161437430|NCT02492763|582997098|FG001|Overall Study|Lost to Follow-up|0|||
161437431|NCT02492763|582997099|FG002|Overall Study|Lost to Follow-up|1|||
161437432|NCT02492763|582997100|FG003|Overall Study|Lost to Follow-up|0|||
161437433|NCT02492763|582997097|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161437434|NCT02492763|582997098|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161437435|NCT02492763|582997099|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161437436|NCT02492763|582997100|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161437437|NCT02492763|582997097|FG000|Overall Study|Screen Failure|0|||
161437438|NCT02492763|582997098|FG001|Overall Study|Screen Failure|0|||
161437439|NCT02492763|582997099|FG002|Overall Study|Screen Failure|0|||
161437440|NCT02492763|582997100|FG003|Overall Study|Screen Failure|1|||
161437441|NCT02492763|582997097|FG000|Overall Study|Study Terminated by Sponsor|13|||
161437442|NCT02492763|582997098|FG001|Overall Study|Study Terminated by Sponsor|10|||
161437443|NCT02492763|582997099|FG002|Overall Study|Study Terminated by Sponsor|6|||
161437444|NCT02492763|582997100|FG003|Overall Study|Study Terminated by Sponsor|10|||
161437445|NCT01193244|582997101|FG000|Overall Study|Withdrawal by Subject|79|||
161437446|NCT01193244|582997102|FG001|Overall Study|Withdrawal by Subject|97|||
161437447|NCT01193244|582997101|FG000|Overall Study|Other|303|||
161437448|NCT01193244|582997102|FG001|Overall Study|Other|278|||
161437449|NCT01193244|582997101|FG000|Overall Study|Lost to Follow-up|6|||
161437450|NCT01193244|582997102|FG001|Overall Study|Lost to Follow-up|15|||
161437451|NCT02395471|582997112|FG000|Overall Study|Lost to Follow-up|2|||
161437452|NCT02395471|582997113|FG001|Overall Study|Lost to Follow-up|0|||
161437453|NCT02395471|582997112|FG000|Overall Study|Withdrawal by Subject|2|||
161437454|NCT02395471|582997113|FG001|Overall Study|Withdrawal by Subject|1|||
161437455|NCT02395471|582997112|FG000|Overall Study|Physician Decision|1|||
161437456|NCT02395471|582997113|FG001|Overall Study|Physician Decision|0|||
161437457|NCT02395471|582997112|FG000|Overall Study|Protocol Violation|0|||
161437458|NCT02395471|582997113|FG001|Overall Study|Protocol Violation|1|||
161437459|NCT02395471|582997112|FG000|Overall Study|Failure to swollow sponge twice|1|||
161437460|NCT02395471|582997113|FG001|Overall Study|Failure to swollow sponge twice|0|||
161437461|NCT02395471|582997112|FG000|Overall Study|Patient did not return for procedure|0|||
161437462|NCT02395471|582997113|FG001|Overall Study|Patient did not return for procedure|1|||
161437463|NCT02395471|582997112|FG000|Overall Study|Subject not eligible|1|||
161437464|NCT02395471|582997113|FG001|Overall Study|Subject not eligible|0|||
161437465|NCT03847896|582997114|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
161437466|NCT03847896|582997115|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
161437467|NCT03847896|582997116|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
161437468|NCT03847896|582997117|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
161437469|NCT03847896|582997118|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
161437470|NCT03847896|582997114|FG000|Overall Study|Withdrawal by Subject|2|||
161437471|NCT03847896|582997115|FG001|Overall Study|Withdrawal by Subject|10|||
161437472|NCT03847896|582997116|FG002|Overall Study|Withdrawal by Subject|5|||
161437473|NCT03847896|582997117|FG003|Overall Study|Withdrawal by Subject|9|||
161437474|NCT03847896|582997118|FG004|Overall Study|Withdrawal by Subject|8|||
161437475|NCT03847896|582997114|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161437476|NCT03847896|582997115|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161437477|NCT03847896|582997116|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161437478|NCT03847896|582997117|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161437479|NCT03847896|582997118|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161437480|NCT03847896|582997114|FG000|Overall Study|Adverse Event|2|||
161437481|NCT03847896|582997115|FG001|Overall Study|Adverse Event|1|||
161437482|NCT03847896|582997116|FG002|Overall Study|Adverse Event|3|||
161437483|NCT03847896|582997117|FG003|Overall Study|Adverse Event|2|||
161437484|NCT03847896|582997118|FG004|Overall Study|Adverse Event|4|||
161437485|NCT03847896|582997114|FG000|Overall Study|A severe exacerbation event|0|||
161437486|NCT03847896|582997115|FG001|Overall Study|A severe exacerbation event|0|||
161437487|NCT03847896|582997116|FG002|Overall Study|A severe exacerbation event|0|||
161437488|NCT03847896|582997117|FG003|Overall Study|A severe exacerbation event|0|||
161437489|NCT03847896|582997118|FG004|Overall Study|A severe exacerbation event|3|||
161437490|NCT03847896|582997114|FG000|Overall Study|Protocol Violation|0|||
161437491|NCT03847896|582997115|FG001|Overall Study|Protocol Violation|2|||
161437492|NCT03847896|582997116|FG002|Overall Study|Protocol Violation|1|||
161437493|NCT03847896|582997117|FG003|Overall Study|Protocol Violation|0|||
161437494|NCT03847896|582997118|FG004|Overall Study|Protocol Violation|2|||
161437495|NCT03847896|582997114|FG000|Overall Study|Lost to Follow-up|0|||
161437496|NCT03847896|582997115|FG001|Overall Study|Lost to Follow-up|0|||
161437497|NCT03847896|582997116|FG002|Overall Study|Lost to Follow-up|0|||
161437498|NCT03847896|582997117|FG003|Overall Study|Lost to Follow-up|1|||
161437499|NCT03847896|582997118|FG004|Overall Study|Lost to Follow-up|0|||
161437500|NCT03847896|582997114|FG000|Overall Study|Condition under investigation worsened|0|||
161437501|NCT03847896|582997115|FG001|Overall Study|Condition under investigation worsened|0|||
161437502|NCT03847896|582997116|FG002|Overall Study|Condition under investigation worsened|0|||
161437503|NCT03847896|582997117|FG003|Overall Study|Condition under investigation worsened|1|||
161437504|NCT03847896|582997118|FG004|Overall Study|Condition under investigation worsened|1|||
161437505|NCT03847896|582997114|FG000|Overall Study|Lack of Efficacy|0|||
161437506|NCT03847896|582997115|FG001|Overall Study|Lack of Efficacy|0|||
161437507|NCT03847896|582997116|FG002|Overall Study|Lack of Efficacy|0|||
161437508|NCT03847896|582997117|FG003|Overall Study|Lack of Efficacy|2|||
161437509|NCT03847896|582997118|FG004|Overall Study|Lack of Efficacy|2|||
161437510|NCT03847896|582997114|FG000|Overall Study|Other reasons|3|||
161437511|NCT03847896|582997115|FG001|Overall Study|Other reasons|3|||
161437512|NCT03847896|582997116|FG002|Overall Study|Other reasons|1|||
161437513|NCT03847896|582997117|FG003|Overall Study|Other reasons|2|||
161437514|NCT03847896|582997118|FG004|Overall Study|Other reasons|1|||
161437515|NCT01039376|582997119|FG000|Overall Study|Lost to Follow-up|5|||
161437516|NCT01039376|582997120|FG001|Overall Study|Lost to Follow-up|12|||
161437517|NCT01039376|582997119|FG000|Overall Study|Physician Decision|15|||
161437518|NCT01039376|582997120|FG001|Overall Study|Physician Decision|10|||
161437519|NCT01039376|582997119|FG000|Overall Study|Withdrawal by Subject|20|||
161437520|NCT01039376|582997120|FG001|Overall Study|Withdrawal by Subject|32|||
161437521|NCT01039376|582997119|FG000|Overall Study|Study terminated by Sponsor|90|||
161437522|NCT01039376|582997120|FG001|Overall Study|Study terminated by Sponsor|72|||
161437523|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
161437524|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
161437525|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Adverse Event|31|||
161437526|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Adverse Event|21|||
161437527|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
161437528|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
161437529|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
161437530|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
161437531|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
161437532|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
161437533|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
161437534|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
161437535|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Administrative problems|3|||
161437536|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Administrative problems|3|||
161437537|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Death|5|||
161437538|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Death|8|||
161437539|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Disease progression|139|||
161437540|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Disease progression|119|||
161437541|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
161437542|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
161437543|NCT00785785|582997121|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
161437544|NCT00785785|582997122|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
161437545|NCT00785785|582997121|FG000|Optional Extension Phase|Adverse Event|4|||
161437546|NCT00785785|582997122|FG001|Optional Extension Phase|Adverse Event|5|||
161437547|NCT00785785|582997121|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
161437548|NCT00785785|582997122|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
161437549|NCT00785785|582997121|FG000|Optional Extension Phase|Lost to Follow-up|1|||
161437550|NCT00785785|582997122|FG001|Optional Extension Phase|Lost to Follow-up|0|||
161437551|NCT00785785|582997121|FG000|Optional Extension Phase|Administrative problems|2|||
161437552|NCT00785785|582997122|FG001|Optional Extension Phase|Administrative problems|0|||
161437553|NCT00785785|582997121|FG000|Optional Extension Phase|Death|1|||
161784948|NCT04380701|584257436|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
161784949|NCT04380701|584257437|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
161784950|NCT04380701|584257438|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
161784951|NCT04380701|584257439|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
161784952|NCT04380701|584257440|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
161437554|NCT00785785|582997122|FG001|Optional Extension Phase|Death|5|||
161437555|NCT00785785|582997121|FG000|Optional Extension Phase|Disease progression|22|||
161437556|NCT00785785|582997122|FG001|Optional Extension Phase|Disease progression|70|||
161437557|NCT00785785|582997121|FG000|Optional Extension Phase|Protocol deviation|0|||
161437558|NCT00785785|582997122|FG001|Optional Extension Phase|Protocol deviation|2|||
161437559|NCT00785785|582997121|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
161437560|NCT00785785|582997122|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
161437561|NCT03252925|582997123|FG000|Overall Study|Withdrawal by Subject|1|||
161437562|NCT03252925|582997124|FG001|Overall Study|Withdrawal by Subject|0|||
161437563|NCT03252925|582997123|FG000|Overall Study|Protocol Violation|6|||
161437564|NCT03252925|582997124|FG001|Overall Study|Protocol Violation|0|||
161437565|NCT03252925|582997123|FG000|Overall Study|Adverse Event|1|||
161437566|NCT03252925|582997124|FG001|Overall Study|Adverse Event|0|||
161437567|NCT03252925|582997123|FG000|Overall Study|Lost to Follow-up|6|||
161437568|NCT03252925|582997124|FG001|Overall Study|Lost to Follow-up|6|||
161437569|NCT01244893|582997125|FG000|Baseline|Protocol Violation|0|||
161437570|NCT01244893|582997126|FG001|Baseline|Protocol Violation|1|||
161437571|NCT01244893|582997125|FG000|1-Week Follow Up|Lost to Follow-up|1|||
161437572|NCT01244893|582997126|FG001|1-Week Follow Up|Lost to Follow-up|0|||
161437573|NCT00357552|582997127|FG000|Screening|Did not meet eligibility criteria|84|||
161437574|NCT00357552|582997127|FG000|Weeks 0 to 24|Death|1|||
161437575|NCT00357552|582997127|FG000|Weeks 24 to 104|Death|3|||
161437576|NCT00357552|582997127|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
161437577|NCT00521404|582997130|FG000|Overall Study|Adverse Event|13|||
161437578|NCT00521404|582997130|FG000|Overall Study|Disease Progression|33|||
161437579|NCT00521404|582997130|FG000|Overall Study|Investigator decision|5|||
161437580|NCT00521404|582997130|FG000|Overall Study|Withdrawal of consent|3|||
161437581|NCT00521404|582997130|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
161437582|NCT00521404|582997130|FG000|Overall Study|Other|7|||
161437583|NCT04555616|582997133|FG000|Overall Study|Death|1|||
161437584|NCT04555616|582997134|FG001|Overall Study|Death|0|||
161437585|NCT04555616|582997135|FG002|Overall Study|Death|1|||
161437586|NCT04555616|582997133|FG000|Overall Study|Withdrawal by Subject|2|||
161437587|NCT04555616|582997134|FG001|Overall Study|Withdrawal by Subject|1|||
161437588|NCT04555616|582997135|FG002|Overall Study|Withdrawal by Subject|0|||
161437589|NCT00882557|582997136|FG000|Overall Study|Withdrawal by Subject|1|||
161437590|NCT00882557|582997137|FG001|Overall Study|Withdrawal by Subject|0|||
161437591|NCT00882557|582997136|FG000|Overall Study|Trouble with Vein Access|1|||
161437592|NCT00882557|582997137|FG001|Overall Study|Trouble with Vein Access|0|||
161437593|NCT00882557|582997136|FG000|Overall Study|Randomized Not Treated|0|||
161437594|NCT00882557|582997137|FG001|Overall Study|Randomized Not Treated|1|||
161437595|NCT02282605|582997138|FG000|Overall Study|negative SA result on Day -1|3|||
161437596|NCT02282605|582997139|FG001|Overall Study|negative SA result on Day -1|0|||
161437597|NCT02282605|582997140|FG002|Overall Study|negative SA result on Day -1|0|||
161437598|NCT00711191|582997141|FG000|Overall Study|Adverse Event|1|||
161437599|NCT00711191|582997142|FG001|Overall Study|Adverse Event|1|||
161437600|NCT00711191|582997143|FG002|Overall Study|Adverse Event|2|||
161437601|NCT00711191|582997141|FG000|Overall Study|Objective progression or relapse|2|||
161437602|NCT00711191|582997142|FG001|Overall Study|Objective progression or relapse|3|||
161437603|NCT00711191|582997143|FG002|Overall Study|Objective progression or relapse|7|||
161437604|NCT00711191|582997141|FG000|Overall Study|Withdrawal by Subject|0|||
161437605|NCT00711191|582997142|FG001|Overall Study|Withdrawal by Subject|1|||
161437606|NCT00711191|582997143|FG002|Overall Study|Withdrawal by Subject|3|||
161437607|NCT02035267|582997144|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
161437608|NCT02035267|582997145|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
161437609|NCT02035267|582997146|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
161437610|NCT02035267|582997147|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
161437611|NCT02035267|582997144|FG000|Overall Study|Adverse Event|0|||
161437612|NCT02035267|582997145|FG001|Overall Study|Adverse Event|0|||
161437613|NCT02035267|582997146|FG002|Overall Study|Adverse Event|1|||
161437614|NCT02035267|582997147|FG003|Overall Study|Adverse Event|0|||
161437615|NCT02035267|582997144|FG000|Overall Study|Lost to Follow-up|0|||
161437616|NCT02035267|582997145|FG001|Overall Study|Lost to Follow-up|0|||
161437617|NCT02035267|582997146|FG002|Overall Study|Lost to Follow-up|0|||
161437618|NCT02035267|582997147|FG003|Overall Study|Lost to Follow-up|1|||
161437619|NCT02035267|582997144|FG000|Overall Study|Other unspecified|0|||
161437620|NCT02035267|582997145|FG001|Overall Study|Other unspecified|1|||
161437621|NCT02035267|582997146|FG002|Overall Study|Other unspecified|0|||
161437622|NCT02035267|582997147|FG003|Overall Study|Other unspecified|0|||
161437623|NCT03038880|582997153|FG000|Overall Study|Death|1|||
161437624|NCT03038880|582997154|FG001|Overall Study|Death|2|||
161437625|NCT03038880|582997155|FG002|Overall Study|Death|0|||
161437626|NCT03038880|582997153|FG000|Overall Study|Physician Decision|2|||
161437627|NCT03038880|582997154|FG001|Overall Study|Physician Decision|1|||
161437628|NCT03038880|582997155|FG002|Overall Study|Physician Decision|0|||
161437629|NCT03926611|582997160|FG000|Overall Study|Adverse Event|0|||
161437630|NCT03926611|582997161|FG001|Overall Study|Adverse Event|0|||
161437631|NCT03926611|582997162|FG002|Overall Study|Adverse Event|0|||
161437632|NCT03926611|582997163|FG003|Overall Study|Adverse Event|3|||
161437633|NCT03926611|582997164|FG004|Overall Study|Adverse Event|1|||
161437634|NCT03926611|582997165|FG005|Overall Study|Adverse Event|3|||
161437635|NCT03926611|582997166|FG006|Overall Study|Adverse Event|0|||
161437636|NCT03926611|582997160|FG000|Overall Study|Lack of Efficacy|1|||
161437637|NCT03926611|582997161|FG001|Overall Study|Lack of Efficacy|2|||
161437638|NCT03926611|582997162|FG002|Overall Study|Lack of Efficacy|0|||
161437639|NCT03926611|582997163|FG003|Overall Study|Lack of Efficacy|0|||
161437640|NCT03926611|582997164|FG004|Overall Study|Lack of Efficacy|1|||
161437641|NCT03926611|582997165|FG005|Overall Study|Lack of Efficacy|0|||
161437642|NCT03926611|582997166|FG006|Overall Study|Lack of Efficacy|1|||
161437643|NCT03926611|582997160|FG000|Overall Study|Physician Decision|0|||
161437644|NCT03926611|582997161|FG001|Overall Study|Physician Decision|0|||
161437645|NCT03926611|582997162|FG002|Overall Study|Physician Decision|0|||
161437646|NCT03926611|582997163|FG003|Overall Study|Physician Decision|0|||
161437647|NCT03926611|582997164|FG004|Overall Study|Physician Decision|0|||
161437648|NCT03926611|582997165|FG005|Overall Study|Physician Decision|1|||
161437649|NCT03926611|582997166|FG006|Overall Study|Physician Decision|0|||
161437650|NCT03926611|582997160|FG000|Overall Study|Protocol Violation|1|||
161437651|NCT03926611|582997161|FG001|Overall Study|Protocol Violation|0|||
161437652|NCT03926611|582997162|FG002|Overall Study|Protocol Violation|0|||
161437653|NCT03926611|582997163|FG003|Overall Study|Protocol Violation|1|||
161437654|NCT03926611|582997164|FG004|Overall Study|Protocol Violation|1|||
161437655|NCT03926611|582997165|FG005|Overall Study|Protocol Violation|1|||
161437656|NCT03926611|582997166|FG006|Overall Study|Protocol Violation|1|||
161437657|NCT03926611|582997160|FG000|Overall Study|Technical problems|0|||
161437658|NCT03926611|582997161|FG001|Overall Study|Technical problems|0|||
161437659|NCT03926611|582997162|FG002|Overall Study|Technical problems|0|||
161437660|NCT03926611|582997163|FG003|Overall Study|Technical problems|0|||
161437661|NCT03926611|582997164|FG004|Overall Study|Technical problems|0|||
161437662|NCT03926611|582997165|FG005|Overall Study|Technical problems|1|||
161437663|NCT03926611|582997166|FG006|Overall Study|Technical problems|0|||
161437664|NCT03926611|582997160|FG000|Overall Study|Withdrawal by Subject|1|||
161437665|NCT03926611|582997161|FG001|Overall Study|Withdrawal by Subject|1|||
161437666|NCT03926611|582997162|FG002|Overall Study|Withdrawal by Subject|1|||
161437667|NCT03926611|582997163|FG003|Overall Study|Withdrawal by Subject|0|||
161437668|NCT03926611|582997164|FG004|Overall Study|Withdrawal by Subject|0|||
161437669|NCT03926611|582997165|FG005|Overall Study|Withdrawal by Subject|1|||
161437670|NCT03926611|582997166|FG006|Overall Study|Withdrawal by Subject|3|||
161437671|NCT03926611|582997160|FG000|Overall Study|Covid-19 pandemic|0|||
161437672|NCT03926611|582997161|FG001|Overall Study|Covid-19 pandemic|0|||
161437673|NCT03926611|582997162|FG002|Overall Study|Covid-19 pandemic|1|||
161437674|NCT03926611|582997163|FG003|Overall Study|Covid-19 pandemic|0|||
161437675|NCT03926611|582997164|FG004|Overall Study|Covid-19 pandemic|1|||
161437676|NCT03926611|582997165|FG005|Overall Study|Covid-19 pandemic|2|||
161437677|NCT03926611|582997166|FG006|Overall Study|Covid-19 pandemic|0|||
161437678|NCT01657019|582997167|FG000|Overall Study|Withdrawal by Subject|65|||
161437679|NCT01657019|582997167|FG000|Overall Study|Adverse Event|55|||
161437680|NCT01657019|582997167|FG000|Overall Study|Lost to Follow-up|48|||
161437681|NCT01657019|582997167|FG000|Overall Study|Protocol Violation|6|||
161437682|NCT01657019|582997167|FG000|Overall Study|Lack of Efficacy|3|||
161437683|NCT01657019|582997167|FG000|Overall Study|Other|58|||
161437684|NCT01744977|582997168|FG000|Overall Study|Withdrawal by Subject|1|||
161437685|NCT01744977|582997169|FG001|Overall Study|Withdrawal by Subject|2|||
161437686|NCT01744977|582997168|FG000|Overall Study|Death|2|||
161437687|NCT01744977|582997169|FG001|Overall Study|Death|3|||
161437688|NCT01744977|582997168|FG000|Overall Study|Lost to Follow-up|2|||
161437689|NCT01744977|582997169|FG001|Overall Study|Lost to Follow-up|0|||
161437690|NCT01744977|582997168|FG000|Overall Study|No longer meets inclusion|6|||
161437691|NCT01744977|582997169|FG001|Overall Study|No longer meets inclusion|0|||
161437692|NCT01750229|582997172|FG000|Randomized Crossover Phase|Adverse Event|1|||
161437693|NCT01750229|582997172|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
161437694|NCT01750229|582997172|FG000|Long-term Follow-up Phase|Adverse Event|2|||
161437695|NCT01750229|582997172|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
161437696|NCT03774576|582997173|FG000|Period 2|Adverse Event|1|||
161437697|NCT02796170|582997174|FG000|Overall Study|Lost to Follow-up|3|||
161437698|NCT02796170|582997175|FG001|Overall Study|Lost to Follow-up|0|||
161437699|NCT01527370|582997176|FG000|Overall Study|Withdrawal by Subject|4|||
161437700|NCT01527370|582997176|FG000|Overall Study|Physician Decision|1|||
161437701|NCT01527370|582997176|FG000|Overall Study|Death|1|||
161437702|NCT00912808|582997177|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
161437703|NCT00912808|582997178|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
161437704|NCT00912808|582997177|FG000|Washout|Withdrawal by Subject|0|||
161437705|NCT00912808|582997178|FG001|Washout|Withdrawal by Subject|1|||
161784953|NCT04380701|584257441|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
161437706|NCT00912808|582997177|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
161437707|NCT00912808|582997178|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
161437708|NCT00912808|582997177|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
161437709|NCT00912808|582997178|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
161437710|NCT00702221|582997179|FG000|Overall Study|Adverse Event|4|||
161437711|NCT00702221|582997180|FG001|Overall Study|Adverse Event|3|||
161437712|NCT02900378|582997181|FG000|Randomization (Visit 2)|Adverse Event|14|||
161437713|NCT02900378|582997182|FG001|Randomization (Visit 2)|Adverse Event|11|||
161437714|NCT02900378|582997181|FG000|Randomization (Visit 2)|Death|1|||
161437715|NCT02900378|582997182|FG001|Randomization (Visit 2)|Death|4|||
161437716|NCT02900378|582997181|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
161437717|NCT02900378|582997182|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
161437718|NCT02900378|582997181|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
161437719|NCT02900378|582997182|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
161437720|NCT02900378|582997181|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
161437721|NCT02900378|582997182|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
161437722|NCT02900378|582997181|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
161437723|NCT02900378|582997182|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
161437724|NCT02900378|582997181|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
161437725|NCT02900378|582997182|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
161437726|NCT01134055|582997185|FG000|Overall Study|Adverse Event|5|||
161437727|NCT01134055|582997186|FG001|Overall Study|Adverse Event|2|||
161437728|NCT01134055|582997187|FG002|Overall Study|Adverse Event|2|||
161437729|NCT01134055|582997188|FG003|Overall Study|Adverse Event|2|||
161437730|NCT01134055|582997189|FG004|Overall Study|Adverse Event|5|||
161437731|NCT01134055|582997190|FG005|Overall Study|Adverse Event|7|||
161437732|NCT01134055|582997191|FG006|Overall Study|Adverse Event|2|||
161437733|NCT01134055|582997185|FG000|Overall Study|Lost to Follow-up|0|||
161437734|NCT01134055|582997186|FG001|Overall Study|Lost to Follow-up|1|||
161437735|NCT01134055|582997187|FG002|Overall Study|Lost to Follow-up|0|||
161437736|NCT01134055|582997188|FG003|Overall Study|Lost to Follow-up|1|||
161437737|NCT01134055|582997189|FG004|Overall Study|Lost to Follow-up|0|||
161437738|NCT01134055|582997190|FG005|Overall Study|Lost to Follow-up|0|||
161437739|NCT01134055|582997191|FG006|Overall Study|Lost to Follow-up|0|||
161437740|NCT01134055|582997185|FG000|Overall Study|Withdrawal by Subject|3|||
161437741|NCT01134055|582997186|FG001|Overall Study|Withdrawal by Subject|3|||
161437742|NCT01134055|582997187|FG002|Overall Study|Withdrawal by Subject|1|||
161437743|NCT01134055|582997188|FG003|Overall Study|Withdrawal by Subject|2|||
161437744|NCT01134055|582997189|FG004|Overall Study|Withdrawal by Subject|0|||
161437745|NCT01134055|582997190|FG005|Overall Study|Withdrawal by Subject|0|||
161437746|NCT01134055|582997191|FG006|Overall Study|Withdrawal by Subject|8|||
161437747|NCT01134055|582997185|FG000|Overall Study|Protocol Violation|0|||
161437748|NCT01134055|582997186|FG001|Overall Study|Protocol Violation|0|||
161437749|NCT01134055|582997187|FG002|Overall Study|Protocol Violation|0|||
161437750|NCT01134055|582997188|FG003|Overall Study|Protocol Violation|1|||
161437751|NCT01134055|582997189|FG004|Overall Study|Protocol Violation|1|||
161437752|NCT01134055|582997190|FG005|Overall Study|Protocol Violation|0|||
161437753|NCT01134055|582997191|FG006|Overall Study|Protocol Violation|0|||
161437754|NCT01134055|582997185|FG000|Overall Study|Physician Decision|0|||
161437755|NCT01134055|582997186|FG001|Overall Study|Physician Decision|0|||
161437756|NCT01134055|582997187|FG002|Overall Study|Physician Decision|0|||
161437757|NCT01134055|582997188|FG003|Overall Study|Physician Decision|0|||
161437758|NCT01134055|582997189|FG004|Overall Study|Physician Decision|0|||
161437759|NCT01134055|582997190|FG005|Overall Study|Physician Decision|0|||
161437760|NCT01134055|582997191|FG006|Overall Study|Physician Decision|1|||
161437761|NCT03345784|582997194|FG000|Overall Study|Withdrawal by Subject|2|||
161437762|NCT03345784|582997195|FG001|Overall Study|Withdrawal by Subject|1|||
161437763|NCT04798196|582997197|FG000|Overall Study|Lost to Follow-up|3|||
161437764|NCT04798196|582997198|FG001|Overall Study|Lost to Follow-up|1|||
161437765|NCT04798196|582997199|FG002|Overall Study|Lost to Follow-up|3|||
161437766|NCT00001959|582997207|FG000|Overall Study|newly diagnosed colon cancer|1|||
161437767|NCT00001959|582997207|FG000|Overall Study|disabling sedation|1|||
161437768|NCT00001959|582997207|FG000|Overall Study|non-compliance|1|||
161437769|NCT03592186|582997208|FG000|Overall Study|Withdrawal by Subject|1|||
161437770|NCT03592186|582997209|FG001|Overall Study|Withdrawal by Subject|0|||
161437771|NCT03592186|582997208|FG000|Overall Study|Lost to Follow-up|16|||
161437772|NCT03592186|582997209|FG001|Overall Study|Lost to Follow-up|11|||
161437773|NCT03755934|582997210|FG000|Overall Study|Adverse Event|4|||
161437774|NCT03755934|582997211|FG001|Overall Study|Adverse Event|1|||
161437775|NCT03755934|582997212|FG002|Overall Study|Adverse Event|1|||
161437776|NCT03755934|582997213|FG003|Overall Study|Adverse Event|3|||
161437777|NCT03755934|582997210|FG000|Overall Study|Physician Decision|2|||
161437778|NCT03755934|582997211|FG001|Overall Study|Physician Decision|0|||
161437779|NCT03755934|582997212|FG002|Overall Study|Physician Decision|0|||
161437780|NCT03755934|582997213|FG003|Overall Study|Physician Decision|1|||
161437781|NCT03755934|582997210|FG000|Overall Study|Withdrawal by Subject|5|||
161437782|NCT03755934|582997211|FG001|Overall Study|Withdrawal by Subject|0|||
161437783|NCT03755934|582997212|FG002|Overall Study|Withdrawal by Subject|0|||
161437784|NCT03755934|582997213|FG003|Overall Study|Withdrawal by Subject|1|||
161437785|NCT03755934|582997210|FG000|Overall Study|Other|3|||
161437786|NCT03755934|582997211|FG001|Overall Study|Other|1|||
161437787|NCT03755934|582997212|FG002|Overall Study|Other|3|||
161437788|NCT03755934|582997213|FG003|Overall Study|Other|1|||
161437789|NCT01498068|582997214|FG000|Overall Study|Withdrawal by Subject|1|||
161437790|NCT01498068|582997215|FG001|Overall Study|Withdrawal by Subject|1|||
161437791|NCT00361296|582997218|FG000|Overall Study|Physician Decision|1|||
161437792|NCT00361296|582997218|FG000|Overall Study|Lack of Efficacy|2|||
161437793|NCT00904982|582997220|FG000|Overall Study|Withdrawal by Subject|2|||
161437794|NCT00904982|582997221|FG001|Overall Study|Withdrawal by Subject|0|||
161437795|NCT00904982|582997222|FG002|Overall Study|Withdrawal by Subject|0|||
161437796|NCT00904982|582997223|FG003|Overall Study|Withdrawal by Subject|0|||
161437797|NCT01353898|582997226|FG000|Overall Study|Study site terminated|0|||
161784954|NCT04380701|584257442|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
161784955|NCT04380701|584257443|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
161784956|NCT04380701|584257444|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
161784957|NCT04380701|584257445|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
161784958|NCT04380701|584257446|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
161784959|NCT04380701|584257447|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
161784960|NCT04380701|584257448|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
161784961|NCT04380701|584257449|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
161437798|NCT01353898|582997227|FG001|Overall Study|Study site terminated|0|||
161437799|NCT01353898|582997228|FG002|Overall Study|Study site terminated|0|||
161437800|NCT01353898|582997229|FG003|Overall Study|Study site terminated|0|||
161437801|NCT01353898|582997230|FG004|Overall Study|Study site terminated|0|||
161437802|NCT01353898|582997231|FG005|Overall Study|Study site terminated|1|||
161437803|NCT02072668|582997232|FG000|Second Intervention|Lost to Follow-up|1|||
161437804|NCT02072668|582997233|FG001|Second Intervention|Lost to Follow-up|0|||
161437805|NCT02668653|582997234|FG000|Overall Study|Refractory disease|41|||
161437806|NCT02668653|582997235|FG001|Overall Study|Refractory disease|70|||
161784962|NCT04380701|584257450|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
161784963|NCT04380701|584257451|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
161784964|NCT04380701|584257452|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
161784965|NCT04380701|584257453|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
161437807|NCT02668653|582997234|FG000|Overall Study|Relapse|44|||
161437808|NCT02668653|582997235|FG001|Overall Study|Relapse|65|||
161437809|NCT02668653|582997234|FG000|Overall Study|Adverse Event|58|||
161437810|NCT02668653|582997235|FG001|Overall Study|Adverse Event|23|||
161437811|NCT02668653|582997234|FG000|Overall Study|Subject decision to stop study drug|25|||
161437812|NCT02668653|582997235|FG001|Overall Study|Subject decision to stop study drug|23|||
161437813|NCT02668653|582997234|FG000|Overall Study|Other reasons not specified|16|||
161437814|NCT02668653|582997235|FG001|Overall Study|Other reasons not specified|11|||
161437815|NCT02668653|582997234|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
161437816|NCT02668653|582997235|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
161437817|NCT02668653|582997234|FG000|Overall Study|Investigator decision|10|||
161437818|NCT02668653|582997235|FG001|Overall Study|Investigator decision|7|||
161437819|NCT02668653|582997234|FG000|Overall Study|Failure to meet continuation criteria|5|||
161437820|NCT02668653|582997235|FG001|Overall Study|Failure to meet continuation criteria|12|||
161437821|NCT02668653|582997234|FG000|Overall Study|Lost to Follow-up|1|||
161437822|NCT02668653|582997235|FG001|Overall Study|Lost to Follow-up|0|||
161437823|NCT02668653|582997234|FG000|Overall Study|Pregnancy|0|||
161437824|NCT02668653|582997235|FG001|Overall Study|Pregnancy|1|||
161437825|NCT02668653|582997234|FG000|Overall Study|Death|0|||
161437826|NCT02668653|582997235|FG001|Overall Study|Death|1|||
161437827|NCT01352793|582997241|FG000|Overall Study|Lost to Follow-up|289|||
161437828|NCT01352793|582997242|FG001|Overall Study|Lost to Follow-up|125|||
161437829|NCT01352793|582997241|FG000|Overall Study|Withdrawal by Subject|120|||
161437830|NCT01352793|582997242|FG001|Overall Study|Withdrawal by Subject|55|||
161437831|NCT01352793|582997241|FG000|Overall Study|Protocol Violation|44|||
161437832|NCT01352793|582997242|FG001|Overall Study|Protocol Violation|23|||
161437833|NCT01352793|582997241|FG000|Overall Study|Adverse Event|44|||
161437834|NCT01352793|582997242|FG001|Overall Study|Adverse Event|10|||
161437835|NCT01352793|582997241|FG000|Overall Study|Physician Decision|1|||
161437836|NCT01352793|582997242|FG001|Overall Study|Physician Decision|0|||
161784966|NCT04380701|584257454|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
161784967|NCT04380701|584257455|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
161784968|NCT04380701|584257456|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
161784969|NCT04380701|584257457|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
161784970|NCT04380701|584257458|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
161784971|NCT04380701|584257459|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
161437837|NCT01352793|582997241|FG000|Overall Study|Pregnancy|26|||
161437838|NCT01352793|582997242|FG001|Overall Study|Pregnancy|8|||
161437839|NCT01352793|582997241|FG000|Overall Study|Other|25|||
161437840|NCT01352793|582997242|FG001|Overall Study|Other|7|||
161437841|NCT01352793|582997241|FG000|Overall Study|Medication error|2|||
161437842|NCT01352793|582997242|FG001|Overall Study|Medication error|2|||
161437843|NCT01352793|582997241|FG000|Overall Study|Death|1|||
161437844|NCT01352793|582997242|FG001|Overall Study|Death|0|||
161437845|NCT01352793|582997241|FG000|Overall Study|Randomized but not vaccinated|8|||
161437846|NCT01352793|582997242|FG001|Overall Study|Randomized but not vaccinated|0|||
161437847|NCT01352793|582997241|FG000|Overall Study|No longer meets eligibility criteria|25|||
161437848|NCT01352793|582997242|FG001|Overall Study|No longer meets eligibility criteria|15|||
161437849|NCT01987453|582999412|FG000|Overall Study|Death|0|||
161437850|NCT01987453|582999413|FG001|Overall Study|Death|0|||
161437851|NCT01987453|582999414|FG002|Overall Study|Death|1|||
161437852|NCT01987453|582999412|FG000|Overall Study|Lack of Efficacy|1|||
161437853|NCT01987453|582999413|FG001|Overall Study|Lack of Efficacy|12|||
161437854|NCT01987453|582999414|FG002|Overall Study|Lack of Efficacy|0|||
161437855|NCT02083354|582999415|FG000|Overall Study|Withdrawal by Subject|9|||
161437856|NCT02083354|582999415|FG000|Overall Study|Lost to Follow-up|1|||
161437857|NCT02083354|582999415|FG000|Overall Study|Adverse Event|3|||
161437858|NCT02083354|582999415|FG000|Overall Study|Disease progression|46|||
161437859|NCT02083354|582999415|FG000|Overall Study|Study closed/terminated|5|||
161437860|NCT04040933|582999418|FG000|Overall Study|Protocol Violation|1|||
161437861|NCT04040933|582999418|FG000|Overall Study|Withdrawal by Subject|2|||
161437862|NCT02066181|582999419|FG000|Overall Study|Withdrawal by Subject|1|||
161437863|NCT02066181|582999420|FG001|Overall Study|Withdrawal by Subject|1|||
161437864|NCT00775190|582999425|FG000|Overall Study|Lost to Follow-up|2|||
161437865|NCT00775190|582999426|FG001|Overall Study|Lost to Follow-up|3|||
161437866|NCT00775190|582999425|FG000|Overall Study|Withdrawal by Subject|1|||
161437867|NCT00775190|582999426|FG001|Overall Study|Withdrawal by Subject|2|||
161437868|NCT00775190|582999425|FG000|Overall Study|Protocol Violation|1|||
161437869|NCT00775190|582999426|FG001|Overall Study|Protocol Violation|0|||
161437870|NCT02141295|582999427|FG000|Overall Study|Adverse Event|1|||
161437871|NCT02141295|582999428|FG001|Overall Study|Adverse Event|18|||
161437872|NCT02141295|582999429|FG002|Overall Study|Adverse Event|11|||
161437873|NCT02141295|582999427|FG000|Overall Study|Physician Decision|2|||
161437874|NCT02141295|582999428|FG001|Overall Study|Physician Decision|19|||
161437875|NCT02141295|582999429|FG002|Overall Study|Physician Decision|14|||
161437876|NCT02141295|582999427|FG000|Overall Study|Study terminated by sponsor|0|||
161437877|NCT02141295|582999428|FG001|Overall Study|Study terminated by sponsor|6|||
161437878|NCT02141295|582999429|FG002|Overall Study|Study terminated by sponsor|6|||
161437879|NCT02141295|582999427|FG000|Overall Study|Non-compliance|0|||
161437880|NCT02141295|582999428|FG001|Overall Study|Non-compliance|1|||
161437881|NCT02141295|582999429|FG002|Overall Study|Non-compliance|0|||
161437882|NCT02141295|582999427|FG000|Overall Study|Progressive disease|3|||
161437883|NCT02141295|582999428|FG001|Overall Study|Progressive disease|32|||
161437884|NCT02141295|582999429|FG002|Overall Study|Progressive disease|50|||
161437885|NCT02141295|582999427|FG000|Overall Study|Reason not specified|0|||
161437886|NCT02141295|582999428|FG001|Overall Study|Reason not specified|9|||
161437887|NCT02141295|582999429|FG002|Overall Study|Reason not specified|10|||
161437888|NCT02141295|582999427|FG000|Overall Study|Withdrawal by Subject|0|||
161437889|NCT02141295|582999428|FG001|Overall Study|Withdrawal by Subject|9|||
161437890|NCT02141295|582999429|FG002|Overall Study|Withdrawal by Subject|4|||
161437891|NCT01710501|582999430|FG000|Overall Study|Lost to Follow-up|2|||
161437892|NCT01710501|582999431|FG001|Overall Study|Lost to Follow-up|0|||
161437893|NCT01710501|582999432|FG002|Overall Study|Lost to Follow-up|0|||
161437894|NCT02536976|582999433|FG000|Overall Study|Physician Decision|0|||
161437895|NCT02536976|582999434|FG001|Overall Study|Physician Decision|1|||
161437896|NCT01671319|582999437|FG000|Overall Study|Withdrawal by Subject|1|||
161437897|NCT01376804|582999438|FG000|Treatment Period|Withdrawal by Subject|1|||
161437898|NCT01376804|582999438|FG000|Treatment Period|Adverse Event|6|||
161437899|NCT01376804|582999438|FG000|Treatment Period|Patient did not receive study drug|1|||
161437900|NCT02904954|582999443|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
161437901|NCT02904954|582999444|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
161437902|NCT02904954|582999443|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
161437903|NCT02904954|582999444|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
161437904|NCT02904954|582999443|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
161437905|NCT02904954|582999444|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
161437906|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Recurrence|2|||
161437907|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Recurrence|0|||
161437908|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Adverse Event|2|||
161437909|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Adverse Event|6|||
161437910|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Participant wishes|12|||
161437911|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Participant wishes|7|||
161437912|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Physician Decision|2|||
161784972|NCT04380701|584257460|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
161784973|NCT04380701|584257461|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
161437913|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Physician Decision|1|||
161437914|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
161437915|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
161437916|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Death|0|||
161437917|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Death|1|||
161437918|NCT02904954|582999443|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
161784974|NCT04380701|584257462|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
161784975|NCT04380701|584257463|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
161437919|NCT02904954|582999444|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
161437920|NCT00753506|582999445|FG000|Overall Study|Withdrawal by Subject|4|||
161437921|NCT00753506|582999446|FG001|Overall Study|Withdrawal by Subject|1|||
161437922|NCT00753506|582999445|FG000|Overall Study|Lost to Follow-up|2|||
161437923|NCT00753506|582999446|FG001|Overall Study|Lost to Follow-up|0|||
161437924|NCT00753506|582999445|FG000|Overall Study|Other reason|1|||
161437925|NCT00753506|582999446|FG001|Overall Study|Other reason|1|||
161437926|NCT03819114|582999447|FG000|Overall Study|Protocol Violation|0|||
161437927|NCT03819114|582999448|FG001|Overall Study|Protocol Violation|1|||
161437928|NCT03819114|582999449|FG002|Overall Study|Protocol Violation|1|||
161437929|NCT03819114|582999450|FG003|Overall Study|Protocol Violation|0|||
161437930|NCT03819114|582999447|FG000|Overall Study|Lost to Follow-up|0|||
161437931|NCT03819114|582999448|FG001|Overall Study|Lost to Follow-up|0|||
161437932|NCT03819114|582999449|FG002|Overall Study|Lost to Follow-up|1|||
161437933|NCT03819114|582999450|FG003|Overall Study|Lost to Follow-up|0|||
161437934|NCT00628108|582999451|FG000|Overall Study|Adverse Event|0|||
161437935|NCT00628108|582999452|FG001|Overall Study|Adverse Event|3|||
161437936|NCT00628108|582999451|FG000|Overall Study|Withdrawal by Subject|1|||
161437937|NCT00628108|582999452|FG001|Overall Study|Withdrawal by Subject|0|||
161437938|NCT03848832|582999453|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
161437939|NCT03848832|582999454|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
161437940|NCT03848832|582999455|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
161437941|NCT03848832|582999453|FG000|Overall Study|Withdrawal by Subject|0|||
161437942|NCT03848832|582999454|FG001|Overall Study|Withdrawal by Subject|0|||
161437943|NCT03848832|582999455|FG002|Overall Study|Withdrawal by Subject|1|||
161437944|NCT03848832|582999453|FG000|Overall Study|Withdrawal (Covid-19)|0|||
161437945|NCT03848832|582999454|FG001|Overall Study|Withdrawal (Covid-19)|2|||
161437946|NCT03848832|582999455|FG002|Overall Study|Withdrawal (Covid-19)|0|||
161437947|NCT03848832|582999453|FG000|Overall Study|Physician Decision|2|||
161437948|NCT03848832|582999454|FG001|Overall Study|Physician Decision|1|||
161437949|NCT03848832|582999455|FG002|Overall Study|Physician Decision|3|||
161437950|NCT03848832|582999453|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
161437951|NCT03848832|582999454|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
161437952|NCT03848832|582999455|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
161437953|NCT03848832|582999453|FG000|Overall Study|Adverse Event|1|||
161437954|NCT03848832|582999454|FG001|Overall Study|Adverse Event|0|||
161437955|NCT03848832|582999455|FG002|Overall Study|Adverse Event|0|||
161437956|NCT00865566|582999456|FG000|Overall Study|Death|1|||
161437957|NCT00865566|582999457|FG001|Overall Study|Death|11|||
161437958|NCT00865566|582999456|FG000|Overall Study|Lost to Follow-up|314|||
161437959|NCT00865566|582999457|FG001|Overall Study|Lost to Follow-up|315|||
161437960|NCT00865566|582999456|FG000|Overall Study|Withdrawal by Subject|45|||
161437961|NCT00865566|582999457|FG001|Overall Study|Withdrawal by Subject|65|||
161437962|NCT00865566|582999456|FG000|Overall Study|Physician Decision|0|||
161437963|NCT00865566|582999457|FG001|Overall Study|Physician Decision|1|||
161437964|NCT00865566|582999456|FG000|Overall Study|Participant relocated|78|||
161437965|NCT00865566|582999457|FG001|Overall Study|Participant relocated|107|||
161437966|NCT00865566|582999456|FG000|Overall Study|Participant unable to adhere|27|||
161437967|NCT00865566|582999457|FG001|Overall Study|Participant unable to adhere|42|||
161437968|NCT00865566|582999456|FG000|Overall Study|Other; N=245 due to early study closure|154|||
161437969|NCT00865566|582999457|FG001|Overall Study|Other; N=245 due to early study closure|139|||
161437970|NCT00865566|582999456|FG000|Overall Study|HIV infection|5|||
161437971|NCT00865566|582999457|FG001|Overall Study|HIV infection|7|||
161437972|NCT02453321|582999458|FG000|Overall Study|Weakness|1|||
161437973|NCT02453321|582999459|FG001|Overall Study|Weakness|1|||
161437974|NCT02453321|582999460|FG002|Overall Study|Weakness|2|||
161437975|NCT02453321|582999458|FG000|Overall Study|Deep Venous Thrombosis|0|||
161437976|NCT02453321|582999459|FG001|Overall Study|Deep Venous Thrombosis|1|||
161437977|NCT02453321|582999460|FG002|Overall Study|Deep Venous Thrombosis|0|||
161437978|NCT02404025|582999461|FG000|Overall Study|Adverse Event|1|||
161437979|NCT02404025|582999461|FG000|Overall Study|Lack of Efficacy|3|||
161437980|NCT00098813|582999462|FG000|Overall Study|Death|8|||
161437981|NCT00098813|582999462|FG000|Overall Study|Protocol Violation|1|||
161437982|NCT00098813|582999462|FG000|Overall Study|Withdrawal by Subject|7|||
161437983|NCT00098813|582999462|FG000|Overall Study|Progression of Disease|1|||
161437984|NCT00098813|582999462|FG000|Overall Study|Other complicating disease|1|||
161437985|NCT00098813|582999462|FG000|Overall Study|Reversal of RAI resistance|1|||
161437986|NCT02230670|582999464|FG000|Overall Study|Adverse Event|1|||
161437987|NCT02230670|582999465|FG001|Overall Study|Adverse Event|2|||
161784976|NCT04380701|584257464|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
161784977|NCT04380701|584257465|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
161784978|NCT04380701|584257432|FG000|Overall Study|Physician Decision|0|||
161437988|NCT02230670|582999464|FG000|Overall Study|Withdrawal by Subject|2|||
161437989|NCT02230670|582999465|FG001|Overall Study|Withdrawal by Subject|2|||
161437990|NCT02230670|582999464|FG000|Overall Study|Physician Decision|0|||
161437991|NCT02230670|582999465|FG001|Overall Study|Physician Decision|1|||
161437992|NCT02230670|582999464|FG000|Overall Study|Protocol Violation|0|||
161437993|NCT02230670|582999465|FG001|Overall Study|Protocol Violation|1|||
161437994|NCT02230670|582999464|FG000|Overall Study|Progression to Child-Pugh C|1|||
161437995|NCT02230670|582999465|FG001|Overall Study|Progression to Child-Pugh C|2|||
161437996|NCT01907854|582999470|FG000|Overall Study|Protocol Violation|1|||
161437997|NCT01907854|582999471|FG001|Overall Study|Protocol Violation|1|||
161437998|NCT01907854|582999470|FG000|Overall Study|Withdrawal by Subject|9|||
161437999|NCT01907854|582999471|FG001|Overall Study|Withdrawal by Subject|7|||
161438000|NCT01907854|582999470|FG000|Overall Study|Lost to Follow-up|2|||
161438001|NCT01907854|582999471|FG001|Overall Study|Lost to Follow-up|2|||
161438002|NCT01907854|582999470|FG000|Overall Study|Unclassified|4|||
161438003|NCT01907854|582999471|FG001|Overall Study|Unclassified|3|||
161438004|NCT02215252|582999472|FG000|Overall Study|Adverse Event|1|||
161438005|NCT02215252|582999473|FG001|Overall Study|Adverse Event|5|||
161438006|NCT02215252|582999474|FG002|Overall Study|Adverse Event|2|||
161438007|NCT02215252|582999472|FG000|Overall Study|Lost to Follow-up|0|||
161438008|NCT02215252|582999473|FG001|Overall Study|Lost to Follow-up|0|||
161438009|NCT02215252|582999474|FG002|Overall Study|Lost to Follow-up|1|||
161438010|NCT02215252|582999472|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
161438011|NCT02215252|582999473|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
161438012|NCT02215252|582999474|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
161438013|NCT02215252|582999472|FG000|Overall Study|Protocol Violation|0|||
161438014|NCT02215252|582999473|FG001|Overall Study|Protocol Violation|1|||
161438015|NCT02215252|582999474|FG002|Overall Study|Protocol Violation|0|||
161438016|NCT02215252|582999472|FG000|Overall Study|Withdrawal by Subject|1|||
161438017|NCT02215252|582999473|FG001|Overall Study|Withdrawal by Subject|0|||
161438018|NCT02215252|582999474|FG002|Overall Study|Withdrawal by Subject|0|||
161438019|NCT02215252|582999472|FG000|Overall Study|Other|0|||
161438020|NCT02215252|582999473|FG001|Overall Study|Other|1|||
161438021|NCT02215252|582999474|FG002|Overall Study|Other|1|||
161438022|NCT00892099|582999476|FG000|Overall Study|Death|1|||
161438023|NCT00892099|582999477|FG001|Overall Study|Death|0|||
161438024|NCT00892099|582999478|FG002|Overall Study|Death|1|||
161438025|NCT00892099|582999476|FG000|Overall Study|Adverse Event|1|||
161438026|NCT00892099|582999477|FG001|Overall Study|Adverse Event|0|||
161438027|NCT00892099|582999478|FG002|Overall Study|Adverse Event|0|||
161438028|NCT00892099|582999476|FG000|Overall Study|replocated|1|||
161438029|NCT00892099|582999477|FG001|Overall Study|replocated|0|||
161438030|NCT00892099|582999478|FG002|Overall Study|replocated|2|||
161438031|NCT00892099|582999476|FG000|Overall Study|Prolonged hospitalization|1|||
161438032|NCT00892099|582999477|FG001|Overall Study|Prolonged hospitalization|0|||
161438033|NCT00892099|582999478|FG002|Overall Study|Prolonged hospitalization|1|||
161438034|NCT00892099|582999476|FG000|Overall Study|no further details|1|||
161438035|NCT00892099|582999477|FG001|Overall Study|no further details|0|||
161438036|NCT00892099|582999478|FG002|Overall Study|no further details|1|||
161438037|NCT00892099|582999476|FG000|Overall Study|kidney function recovered|0|||
161438038|NCT00892099|582999477|FG001|Overall Study|kidney function recovered|1|||
161438039|NCT00892099|582999478|FG002|Overall Study|kidney function recovered|0|||
161438040|NCT00892099|582999476|FG000|Overall Study|investigator decision|0|||
161438041|NCT00892099|582999477|FG001|Overall Study|investigator decision|0|||
161438042|NCT00892099|582999478|FG002|Overall Study|investigator decision|1|||
161438043|NCT00892099|582999476|FG000|Overall Study|Lost to Follow-up|0|||
161438044|NCT00892099|582999477|FG001|Overall Study|Lost to Follow-up|0|||
161438045|NCT00892099|582999478|FG002|Overall Study|Lost to Follow-up|1|||
161438046|NCT01746901|582999479|FG000|Naloxone Challenge Phase|Adverse Event|2|||
161438047|NCT01746901|582999480|FG001|Naloxone Challenge Phase|Adverse Event|0|||
161438048|NCT01746901|582999481|FG002|Naloxone Challenge Phase|Adverse Event|0|||
161438049|NCT01746901|582999482|FG003|Naloxone Challenge Phase|Adverse Event|0|||
161438050|NCT01746901|582999483|FG004|Naloxone Challenge Phase|Adverse Event|0|||
161438051|NCT01746901|582999484|FG005|Naloxone Challenge Phase|Adverse Event|0|||
161438052|NCT01746901|582999485|FG006|Naloxone Challenge Phase|Adverse Event|0|||
161438053|NCT01746901|582999486|FG007|Naloxone Challenge Phase|Adverse Event|0|||
161438054|NCT01746901|582999487|FG008|Naloxone Challenge Phase|Adverse Event|0|||
161438055|NCT01746901|582999479|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
161438056|NCT01746901|582999480|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438057|NCT01746901|582999481|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438058|NCT01746901|582999482|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438059|NCT01746901|582999483|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438060|NCT01746901|582999484|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438061|NCT01746901|582999485|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438062|NCT01746901|582999486|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161784979|NCT04380701|584257433|FG001|Overall Study|Physician Decision|0|||
161784980|NCT04380701|584257434|FG002|Overall Study|Physician Decision|0|||
161784981|NCT04380701|584257435|FG003|Overall Study|Physician Decision|0|||
161438063|NCT01746901|582999487|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
161438064|NCT01746901|582999479|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438065|NCT01746901|582999480|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
161438066|NCT01746901|582999481|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438067|NCT01746901|582999482|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438068|NCT01746901|582999483|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438069|NCT01746901|582999484|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438070|NCT01746901|582999485|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438071|NCT01746901|582999486|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438072|NCT01746901|582999487|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161438073|NCT01746901|582999479|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438074|NCT01746901|582999480|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
161784982|NCT04380701|584257436|FG004|Overall Study|Physician Decision|0|||
161438075|NCT01746901|582999481|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
161438076|NCT01746901|582999482|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438077|NCT01746901|582999483|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438078|NCT01746901|582999484|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438079|NCT01746901|582999485|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438080|NCT01746901|582999486|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438081|NCT01746901|582999487|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
161438082|NCT01746901|582999479|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438083|NCT01746901|582999480|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
161438084|NCT01746901|582999481|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
161438085|NCT01746901|582999482|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438086|NCT01746901|582999483|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438087|NCT01746901|582999484|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438088|NCT01746901|582999485|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438089|NCT01746901|582999486|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438090|NCT01746901|582999487|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
161438091|NCT01746901|582999479|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438092|NCT01746901|582999480|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
161438093|NCT01746901|582999481|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
161438094|NCT01746901|582999482|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438095|NCT01746901|582999483|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438096|NCT01746901|582999484|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438097|NCT01746901|582999485|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438098|NCT01746901|582999486|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438099|NCT01746901|582999487|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161438100|NCT01746901|582999479|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
161438101|NCT01746901|582999480|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
161438102|NCT01746901|582999481|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
161438103|NCT01746901|582999482|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
161438104|NCT01746901|582999483|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
161438105|NCT01746901|582999484|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
161438106|NCT01746901|582999485|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
161438107|NCT01746901|582999486|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
161438108|NCT01746901|582999487|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
161438109|NCT01746901|582999479|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438110|NCT01746901|582999480|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438111|NCT01746901|582999481|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438112|NCT01746901|582999482|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438113|NCT01746901|582999483|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438114|NCT01746901|582999484|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438115|NCT01746901|582999485|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438116|NCT01746901|582999486|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
161438117|NCT01746901|582999487|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
161438118|NCT01746901|582999479|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438119|NCT01746901|582999480|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438120|NCT01746901|582999481|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438121|NCT01746901|582999482|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438122|NCT01746901|582999483|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438123|NCT01746901|582999484|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
161438124|NCT01746901|582999485|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
161438125|NCT01746901|582999486|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438126|NCT01746901|582999487|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
161438127|NCT01746901|582999479|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438128|NCT01746901|582999480|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438129|NCT01746901|582999481|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438130|NCT01746901|582999482|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
161438131|NCT01746901|582999483|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438132|NCT01746901|582999484|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161784983|NCT04380701|584257437|FG005|Overall Study|Physician Decision|0|||
161784984|NCT04380701|584257438|FG006|Overall Study|Physician Decision|0|||
161438133|NCT01746901|582999485|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438134|NCT01746901|582999486|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438135|NCT01746901|582999487|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
161438136|NCT01746901|582999479|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438137|NCT01746901|582999480|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438138|NCT01746901|582999481|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438139|NCT01746901|582999482|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438140|NCT01746901|582999483|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438141|NCT01746901|582999484|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
161438142|NCT01746901|582999485|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438143|NCT01746901|582999486|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
161438144|NCT01746901|582999487|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
161438145|NCT01746901|582999479|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438146|NCT01746901|582999480|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438147|NCT01746901|582999481|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438148|NCT01746901|582999482|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438149|NCT01746901|582999483|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438150|NCT01746901|582999484|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438151|NCT01746901|582999485|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
161438152|NCT01746901|582999486|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
161438153|NCT01746901|582999487|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
161438154|NCT04455815|582999488|FG000|Randomisation Phase|Adverse Event|1|||
161438155|NCT04455815|582999489|FG001|Randomisation Phase|Adverse Event|0|||
161438156|NCT04455815|582999488|FG000|Treatment Phase|Adverse Event|0|||
161438157|NCT04455815|582999489|FG001|Treatment Phase|Adverse Event|1|||
161438158|NCT04455815|582999488|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
161438159|NCT04455815|582999489|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
161438160|NCT04455815|582999488|FG000|Treatment Phase|Withdrawal by Subject|1|||
161438161|NCT04455815|582999489|FG001|Treatment Phase|Withdrawal by Subject|1|||
161438162|NCT02106390|582999490|FG000|Overall Study|Withdrawal by Subject|15|||
161438163|NCT02106390|582999491|FG001|Overall Study|Withdrawal by Subject|16|||
161438164|NCT02106390|582999492|FG002|Overall Study|Withdrawal by Subject|15|||
161438165|NCT02106390|582999490|FG000|Overall Study|Lost to Follow-up|25|||
161438166|NCT02106390|582999491|FG001|Overall Study|Lost to Follow-up|20|||
161438167|NCT02106390|582999492|FG002|Overall Study|Lost to Follow-up|13|||
161438168|NCT02106390|582999490|FG000|Overall Study|Other: Administrative Reason|8|||
161438169|NCT02106390|582999491|FG001|Overall Study|Other: Administrative Reason|5|||
161438170|NCT02106390|582999492|FG002|Overall Study|Other: Administrative Reason|12|||
161438171|NCT02106390|582999490|FG000|Overall Study|Other: Unspecified|1|||
161438172|NCT02106390|582999491|FG001|Overall Study|Other: Unspecified|4|||
161438173|NCT02106390|582999492|FG002|Overall Study|Other: Unspecified|2|||
161438174|NCT02106390|582999490|FG000|Overall Study|Adverse Event|0|||
161438175|NCT02106390|582999491|FG001|Overall Study|Adverse Event|2|||
161438176|NCT02106390|582999492|FG002|Overall Study|Adverse Event|1|||
161438177|NCT02106390|582999490|FG000|Overall Study|Protocol Violation|0|||
161438178|NCT02106390|582999491|FG001|Overall Study|Protocol Violation|1|||
161438179|NCT02106390|582999492|FG002|Overall Study|Protocol Violation|0|||
161438180|NCT03594110|582999493|FG000|Interventional Part|Participant concerned about study treatment|23|||
161438181|NCT03594110|582999494|FG001|Interventional Part|Participant concerned about study treatment|28|||
161438182|NCT03594110|582999493|FG000|Interventional Part|Doctor advice|38|||
161438183|NCT03594110|582999494|FG001|Interventional Part|Doctor advice|40|||
161438184|NCT03594110|582999493|FG000|Interventional Part|Participants' wish|89|||
161438185|NCT03594110|582999494|FG001|Interventional Part|Participants' wish|68|||
161438186|NCT03594110|582999493|FG000|Interventional Part|Adverse event-non-fatal events|119|||
161438187|NCT03594110|582999494|FG001|Interventional Part|Adverse event-non-fatal events|116|||
161438188|NCT03594110|582999493|FG000|Interventional Part|Study drug stopped, reason missing|336|||
161438189|NCT03594110|582999494|FG001|Interventional Part|Study drug stopped, reason missing|294|||
161438190|NCT03594110|582999493|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
161438191|NCT03594110|582999494|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
161438192|NCT03594110|582999493|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
161438193|NCT03594110|582999494|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
161438194|NCT03594110|582999493|FG000|Interventional Part|Contraindicated drug started|32|||
161438195|NCT03594110|582999494|FG001|Interventional Part|Contraindicated drug started|18|||
161438196|NCT03594110|582999493|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
161438197|NCT03594110|582999494|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
161438198|NCT03594110|582999493|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
161438199|NCT03594110|582999494|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
161438200|NCT03594110|582999493|FG000|Non-interventional Part|Withdrawal by Subject|3|||
161438201|NCT03594110|582999494|FG001|Non-interventional Part|Withdrawal by Subject|4|||
161438202|NCT03594110|582999493|FG000|Non-interventional Part|Lost to Follow-up|45|||
161438203|NCT03594110|582999494|FG001|Non-interventional Part|Lost to Follow-up|41|||
161438204|NCT03041038|582999495|FG000|Overall Study|Withdrawal by Subject|4|||
161438205|NCT03041038|582999496|FG001|Overall Study|Withdrawal by Subject|0|||
161438206|NCT03041038|582999495|FG000|Overall Study|Lost to Follow-up|1|||
161438207|NCT03041038|582999496|FG001|Overall Study|Lost to Follow-up|1|||
161438208|NCT03041038|582999495|FG000|Overall Study|Protocol Violation|1|||
161438209|NCT03041038|582999496|FG001|Overall Study|Protocol Violation|1|||
161438210|NCT00803569|582999497|FG000|Overall Study|Progressive Disease|3|||
161438211|NCT00803569|582999497|FG000|Overall Study|Noncompliance|1|||
161438212|NCT02177032|582999498|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
161438213|NCT02177032|582999499|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
161438214|NCT02177032|582999500|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
161438215|NCT02177032|582999501|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
161438216|NCT02177032|582999498|FG000|Overall Study|Lost to Follow-up|0|||
161438217|NCT02177032|582999499|FG001|Overall Study|Lost to Follow-up|2|||
161438218|NCT02177032|582999500|FG002|Overall Study|Lost to Follow-up|0|||
161438219|NCT02177032|582999501|FG003|Overall Study|Lost to Follow-up|0|||
161438220|NCT02177032|582999498|FG000|Overall Study|OTHER|2|||
161438221|NCT02177032|582999499|FG001|Overall Study|OTHER|0|||
161438222|NCT02177032|582999500|FG002|Overall Study|OTHER|1|||
161438223|NCT02177032|582999501|FG003|Overall Study|OTHER|0|||
161438224|NCT02177032|582999498|FG000|Overall Study|Withdrawal by Subject|1|||
161438225|NCT02177032|582999499|FG001|Overall Study|Withdrawal by Subject|0|||
161438226|NCT02177032|582999500|FG002|Overall Study|Withdrawal by Subject|1|||
161438227|NCT02177032|582999501|FG003|Overall Study|Withdrawal by Subject|0|||
161438228|NCT00930046|582999502|FG000|Overall Study|Wound catheter malfunctioned|1|||
161438229|NCT00930046|582999503|FG001|Overall Study|Wound catheter malfunctioned|2|||
161438230|NCT01598532|582999504|FG000|Overall Study|Lost to Follow-up|3|||
161438231|NCT01598532|582999504|FG000|Overall Study|Did not meet inclusion criteria|8|||
161438232|NCT01249261|582999505|FG000|Overall Study|Withdrawal by Subject|1|||
161438233|NCT01249261|582999506|FG001|Overall Study|Withdrawal by Subject|0|||
161438234|NCT01967940|582999513|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
161438235|NCT01967940|582999514|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
161438236|NCT01967940|582999515|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
161438237|NCT01967940|582999516|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
161438238|NCT01967940|582999513|FG000|Part 2|Adverse Event|0|||
161438239|NCT01967940|582999514|FG001|Part 2|Adverse Event|0|||
161438240|NCT01967940|582999515|FG002|Part 2|Adverse Event|0|||
161438241|NCT01967940|582999516|FG003|Part 2|Adverse Event|1|||
161438242|NCT01967940|582999513|FG000|Part 2|Unknown Reason|0|||
161438243|NCT01967940|582999514|FG001|Part 2|Unknown Reason|0|||
161438244|NCT01967940|582999515|FG002|Part 2|Unknown Reason|0|||
161438245|NCT01967940|582999516|FG003|Part 2|Unknown Reason|1|||
161438246|NCT04109547|582999517|FG000|Overall Study|Withdrawal by Subject|3|||
161438247|NCT04109547|582999518|FG001|Overall Study|Withdrawal by Subject|2|||
161438248|NCT04109547|582999519|FG002|Overall Study|Withdrawal by Subject|6|||
161438249|NCT04109547|582999520|FG003|Overall Study|Withdrawal by Subject|6|||
161438250|NCT04109547|582999517|FG000|Overall Study|Lost to Follow-up|0|||
161438251|NCT04109547|582999518|FG001|Overall Study|Lost to Follow-up|0|||
161438252|NCT04109547|582999519|FG002|Overall Study|Lost to Follow-up|0|||
161438253|NCT04109547|582999520|FG003|Overall Study|Lost to Follow-up|1|||
161438254|NCT04109547|582999517|FG000|Overall Study|Physician Decision|1|||
161438255|NCT04109547|582999518|FG001|Overall Study|Physician Decision|2|||
161438256|NCT04109547|582999519|FG002|Overall Study|Physician Decision|0|||
161438257|NCT04109547|582999520|FG003|Overall Study|Physician Decision|0|||
161438258|NCT01550003|582999521|FG000|Overall Study|Adverse Event|0|||
161438259|NCT01550003|582999522|FG001|Overall Study|Adverse Event|9|||
161438260|NCT01550003|582999523|FG002|Overall Study|Adverse Event|15|||
161438261|NCT01550003|582999521|FG000|Overall Study|Lack of Efficacy|4|||
161438262|NCT01550003|582999522|FG001|Overall Study|Lack of Efficacy|11|||
161438263|NCT01550003|582999523|FG002|Overall Study|Lack of Efficacy|15|||
161438264|NCT01550003|582999521|FG000|Overall Study|Protocol Violation|0|||
161438265|NCT01550003|582999522|FG001|Overall Study|Protocol Violation|3|||
161438266|NCT01550003|582999523|FG002|Overall Study|Protocol Violation|2|||
161438267|NCT01550003|582999521|FG000|Overall Study|Lost to Follow-up|1|||
161438268|NCT01550003|582999522|FG001|Overall Study|Lost to Follow-up|4|||
161438269|NCT01550003|582999523|FG002|Overall Study|Lost to Follow-up|8|||
161438270|NCT01550003|582999521|FG000|Overall Study|Consent withdrawn|2|||
161438271|NCT01550003|582999522|FG001|Overall Study|Consent withdrawn|11|||
161438272|NCT01550003|582999523|FG002|Overall Study|Consent withdrawn|23|||
161438273|NCT01550003|582999521|FG000|Overall Study|Missing|1|||
161438274|NCT01550003|582999522|FG001|Overall Study|Missing|0|||
161438275|NCT01550003|582999523|FG002|Overall Study|Missing|2|||
161438276|NCT01550003|582999521|FG000|Overall Study|Study closure as announced by sponsor|7|||
161438277|NCT01550003|582999522|FG001|Overall Study|Study closure as announced by sponsor|6|||
161438278|NCT01550003|582999523|FG002|Overall Study|Study closure as announced by sponsor|24|||
161438279|NCT01550003|582999521|FG000|Overall Study|Protocol Noncompliance|1|||
161438280|NCT01550003|582999522|FG001|Overall Study|Protocol Noncompliance|0|||
161438281|NCT01550003|582999523|FG002|Overall Study|Protocol Noncompliance|0|||
161438282|NCT01550003|582999521|FG000|Overall Study|Study closure|0|||
161438283|NCT01550003|582999522|FG001|Overall Study|Study closure|1|||
161438284|NCT01550003|582999523|FG002|Overall Study|Study closure|1|||
161438285|NCT01550003|582999521|FG000|Overall Study|Patient reached adulthood|0|||
161438286|NCT01550003|582999522|FG001|Overall Study|Patient reached adulthood|1|||
161438287|NCT01550003|582999523|FG002|Overall Study|Patient reached adulthood|0|||
161438288|NCT01550003|582999521|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
161438289|NCT01550003|582999522|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
161438290|NCT01550003|582999523|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
161438291|NCT01550003|582999521|FG000|Overall Study|Sponsor's order|0|||
161438292|NCT01550003|582999522|FG001|Overall Study|Sponsor's order|3|||
161438293|NCT01550003|582999523|FG002|Overall Study|Sponsor's order|3|||
161438294|NCT01550003|582999521|FG000|Overall Study|Sponsor's decision|1|||
161438295|NCT01550003|582999522|FG001|Overall Study|Sponsor's decision|5|||
161438296|NCT01550003|582999523|FG002|Overall Study|Sponsor's decision|4|||
161438297|NCT01550003|582999521|FG000|Overall Study|Subject mother passed away|0|||
161438298|NCT01550003|582999522|FG001|Overall Study|Subject mother passed away|1|||
161438299|NCT01550003|582999523|FG002|Overall Study|Subject mother passed away|0|||
161438300|NCT01550003|582999521|FG000|Overall Study|Discontinuation|0|||
161438301|NCT01550003|582999522|FG001|Overall Study|Discontinuation|1|||
161438302|NCT01550003|582999523|FG002|Overall Study|Discontinuation|0|||
161438303|NCT01550003|582999521|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
161438304|NCT01550003|582999522|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
161438305|NCT01550003|582999523|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
161438306|NCT01550003|582999521|FG000|Overall Study|Site closure|0|||
161438307|NCT01550003|582999522|FG001|Overall Study|Site closure|2|||
161438308|NCT01550003|582999523|FG002|Overall Study|Site closure|0|||
161438309|NCT01550003|582999521|FG000|Overall Study|Pregnancy|0|||
161438310|NCT01550003|582999522|FG001|Overall Study|Pregnancy|1|||
161438311|NCT01550003|582999523|FG002|Overall Study|Pregnancy|0|||
161438312|NCT01550003|582999521|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
161438313|NCT01550003|582999522|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
161438314|NCT01550003|582999523|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
161438315|NCT01550003|582999521|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
161438316|NCT01550003|582999522|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
161438317|NCT01550003|582999523|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
161438318|NCT01550003|582999521|FG000|Overall Study|Switching to adult rheumatologist|0|||
161438319|NCT01550003|582999522|FG001|Overall Study|Switching to adult rheumatologist|0|||
161438320|NCT01550003|582999523|FG002|Overall Study|Switching to adult rheumatologist|1|||
161438321|NCT01550003|582999521|FG000|Overall Study|Patient transition to adult care|0|||
161438322|NCT01550003|582999522|FG001|Overall Study|Patient transition to adult care|0|||
161438323|NCT01550003|582999523|FG002|Overall Study|Patient transition to adult care|1|||
161438324|NCT01550003|582999521|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
161438325|NCT01550003|582999522|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
161438326|NCT01550003|582999523|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
161438327|NCT01550003|582999521|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
161438328|NCT01550003|582999522|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
161438329|NCT01550003|582999523|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
161438330|NCT01550003|582999521|FG000|Overall Study|Per Sponsor request|1|||
161438331|NCT01550003|582999522|FG001|Overall Study|Per Sponsor request|0|||
161438332|NCT01550003|582999523|FG002|Overall Study|Per Sponsor request|1|||
161438333|NCT01550003|582999521|FG000|Overall Study|Patient not compliance|0|||
161438334|NCT01550003|582999522|FG001|Overall Study|Patient not compliance|0|||
161438335|NCT01550003|582999523|FG002|Overall Study|Patient not compliance|1|||
161438336|NCT01550003|582999521|FG000|Overall Study|Non-compliance|0|||
161438337|NCT01550003|582999522|FG001|Overall Study|Non-compliance|0|||
161438338|NCT01550003|582999523|FG002|Overall Study|Non-compliance|1|||
161438339|NCT01550003|582999521|FG000|Overall Study|Study closed|0|||
161438340|NCT01550003|582999522|FG001|Overall Study|Study closed|1|||
161784985|NCT04380701|584257439|FG007|Overall Study|Physician Decision|0|||
161784986|NCT04380701|584257440|FG008|Overall Study|Physician Decision|0|||
161784987|NCT04380701|584257441|FG009|Overall Study|Physician Decision|0|||
161784988|NCT04380701|584257442|FG010|Overall Study|Physician Decision|0|||
161784989|NCT04380701|584257443|FG011|Overall Study|Physician Decision|0|||
161784990|NCT04380701|584257444|FG012|Overall Study|Physician Decision|0|||
161438341|NCT01550003|582999523|FG002|Overall Study|Study closed|0|||
161438342|NCT01550003|582999521|FG000|Overall Study|Transitioned to adult rheumatology|0|||
161438343|NCT01550003|582999522|FG001|Overall Study|Transitioned to adult rheumatology|0|||
161438344|NCT01550003|582999523|FG002|Overall Study|Transitioned to adult rheumatology|1|||
161438345|NCT05567783|582999524|FG000|Overall Study|Death|2|||
161438346|NCT05567783|582999525|FG001|Overall Study|Death|3|||
161784991|NCT04380701|584257445|FG013|Overall Study|Physician Decision|0|||
161438347|NCT05567783|582999526|FG002|Overall Study|Death|0|||
161438348|NCT05567783|582999524|FG000|Overall Study|Lost to Follow-up|25|||
161438349|NCT05567783|582999525|FG001|Overall Study|Lost to Follow-up|19|||
161438350|NCT05567783|582999526|FG002|Overall Study|Lost to Follow-up|17|||
161438351|NCT05567783|582999524|FG000|Overall Study|Physician Decision|10|||
161438352|NCT05567783|582999525|FG001|Overall Study|Physician Decision|7|||
161438353|NCT05567783|582999526|FG002|Overall Study|Physician Decision|9|||
161438354|NCT05567783|582999524|FG000|Overall Study|Study Terminated by Sponsor|924|||
161438355|NCT05567783|582999525|FG001|Overall Study|Study Terminated by Sponsor|937|||
161438356|NCT05567783|582999526|FG002|Overall Study|Study Terminated by Sponsor|941|||
161438357|NCT05567783|582999524|FG000|Overall Study|Withdrawal by Subject|23|||
161438358|NCT05567783|582999525|FG001|Overall Study|Withdrawal by Subject|27|||
161438359|NCT05567783|582999526|FG002|Overall Study|Withdrawal by Subject|24|||
161438360|NCT05567783|582999524|FG000|Overall Study|Incarcerated|1|||
161438361|NCT05567783|582999525|FG001|Overall Study|Incarcerated|0|||
161438362|NCT05567783|582999526|FG002|Overall Study|Incarcerated|0|||
161438363|NCT05567783|582999524|FG000|Overall Study|Participant randomized in error|4|||
161438364|NCT05567783|582999525|FG001|Overall Study|Participant randomized in error|2|||
161438365|NCT05567783|582999526|FG002|Overall Study|Participant randomized in error|2|||
161438366|NCT03675126|582999529|FG000|Overall Study|Study Terminated by Sponsor|9|||
161438367|NCT03675126|582999529|FG000|Overall Study|Death|2|||
161438368|NCT03675126|582999529|FG000|Overall Study|Withdrawal by Subject|4|||
161438369|NCT00686712|582999533|FG000|Overall Study|Protocol Violation|8|||
161438370|NCT00686712|582999534|FG001|Overall Study|Protocol Violation|8|||
161438371|NCT00686712|582999535|FG002|Overall Study|Protocol Violation|10|||
161438372|NCT00686712|582999533|FG000|Overall Study|Lost to Follow-up|1|||
161438373|NCT00686712|582999534|FG001|Overall Study|Lost to Follow-up|2|||
161438374|NCT00686712|582999535|FG002|Overall Study|Lost to Follow-up|3|||
161438375|NCT00686712|582999533|FG000|Overall Study|Adverse Event|1|||
161438376|NCT00686712|582999534|FG001|Overall Study|Adverse Event|1|||
161438377|NCT00686712|582999535|FG002|Overall Study|Adverse Event|0|||
161784992|NCT04380701|584257446|FG014|Overall Study|Physician Decision|0|||
161784993|NCT04380701|584257447|FG015|Overall Study|Physician Decision|0|||
161784994|NCT04380701|584257448|FG016|Overall Study|Physician Decision|0|||
161784995|NCT04380701|584257449|FG017|Overall Study|Physician Decision|0|||
161784996|NCT04380701|584257450|FG018|Overall Study|Physician Decision|0|||
161784997|NCT04380701|584257451|FG019|Overall Study|Physician Decision|0|||
161784998|NCT04380701|584257452|FG020|Overall Study|Physician Decision|0|||
161784999|NCT04380701|584257453|FG021|Overall Study|Physician Decision|0|||
161785000|NCT04380701|584257454|FG022|Overall Study|Physician Decision|0|||
161785001|NCT04380701|584257455|FG023|Overall Study|Physician Decision|0|||
161785002|NCT04380701|584257456|FG024|Overall Study|Physician Decision|2|||
161785003|NCT04380701|584257457|FG025|Overall Study|Physician Decision|0|||
161785004|NCT04380701|584257458|FG026|Overall Study|Physician Decision|0|||
161785005|NCT04380701|584257459|FG027|Overall Study|Physician Decision|0|||
161785006|NCT04380701|584257460|FG028|Overall Study|Physician Decision|0|||
161785007|NCT04380701|584257461|FG029|Overall Study|Physician Decision|0|||
161785008|NCT04380701|584257462|FG030|Overall Study|Physician Decision|0|||
161785009|NCT04380701|584257463|FG031|Overall Study|Physician Decision|0|||
161785010|NCT04380701|584257464|FG032|Overall Study|Physician Decision|0|||
161785011|NCT04380701|584257465|FG033|Overall Study|Physician Decision|0|||
161785012|NCT04380701|584257432|FG000|Overall Study|Death|0|||
161785013|NCT04380701|584257433|FG001|Overall Study|Death|0|||
161785014|NCT04380701|584257434|FG002|Overall Study|Death|0|||
161785015|NCT04380701|584257435|FG003|Overall Study|Death|0|||
161785016|NCT04380701|584257436|FG004|Overall Study|Death|0|||
161785017|NCT04380701|584257437|FG005|Overall Study|Death|0|||
161785018|NCT04380701|584257438|FG006|Overall Study|Death|0|||
161785019|NCT04380701|584257439|FG007|Overall Study|Death|0|||
161785020|NCT04380701|584257440|FG008|Overall Study|Death|0|||
161785021|NCT04380701|584257441|FG009|Overall Study|Death|0|||
161785022|NCT04380701|584257442|FG010|Overall Study|Death|0|||
161785023|NCT04380701|584257443|FG011|Overall Study|Death|0|||
161785024|NCT04380701|584257444|FG012|Overall Study|Death|0|||
161785025|NCT04380701|584257445|FG013|Overall Study|Death|0|||
161785026|NCT04380701|584257446|FG014|Overall Study|Death|0|||
161785027|NCT04380701|584257447|FG015|Overall Study|Death|0|||
161785028|NCT04380701|584257448|FG016|Overall Study|Death|0|||
161785029|NCT04380701|584257449|FG017|Overall Study|Death|0|||
161785030|NCT04380701|584257450|FG018|Overall Study|Death|0|||
161785031|NCT04380701|584257451|FG019|Overall Study|Death|0|||
161438378|NCT04119414|582999536|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
161785032|NCT04380701|584257452|FG020|Overall Study|Death|0|||
161785033|NCT04380701|584257453|FG021|Overall Study|Death|0|||
161785034|NCT04380701|584257454|FG022|Overall Study|Death|0|||
161438379|NCT01929317|582999537|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
161438380|NCT01929317|582999538|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
161785035|NCT04380701|584257455|FG023|Overall Study|Death|0|||
161785036|NCT04380701|584257456|FG024|Overall Study|Death|1|||
161438381|NCT01929317|582999537|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
161438382|NCT01929317|582999538|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
161668037|NCT00406653|583837480|FG004|Induction Period|Pregnancy|0|||
161785037|NCT04380701|584257457|FG025|Overall Study|Death|0|||
161785038|NCT04380701|584257458|FG026|Overall Study|Death|0|||
161785039|NCT04380701|584257459|FG027|Overall Study|Death|0|||
161785040|NCT04380701|584257460|FG028|Overall Study|Death|0|||
161438383|NCT01929317|582999537|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
161438384|NCT01929317|582999538|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
161438385|NCT01929317|582999537|FG000|Long-term Phase|Adverse Event|5|||
161438386|NCT01929317|582999538|FG001|Long-term Phase|Adverse Event|1|||
161438387|NCT01929317|582999537|FG000|Long-term Phase|Physician Decision|3|||
161438388|NCT01929317|582999538|FG001|Long-term Phase|Physician Decision|0|||
161438389|NCT01929317|582999537|FG000|Long-term Phase|Withdrawal by Subject|4|||
161438390|NCT01929317|582999538|FG001|Long-term Phase|Withdrawal by Subject|0|||
161438391|NCT01929317|582999537|FG000|Long-term Phase|Protocol Violation|1|||
161438392|NCT01929317|582999538|FG001|Long-term Phase|Protocol Violation|0|||
161438393|NCT01929317|582999537|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
161438394|NCT01929317|582999538|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
161438395|NCT01929317|582999537|FG000|Long-term Phase|Study Closed/Terminated|5|||
161438396|NCT01929317|582999538|FG001|Long-term Phase|Study Closed/Terminated|3|||
161438397|NCT00993967|582999544|FG000|Overall Study|Adverse Event|8|||
161438398|NCT00993967|582999544|FG000|Overall Study|Death|1|||
161438399|NCT00993967|582999544|FG000|Overall Study|Lost to Follow-up|14|||
161438400|NCT00993967|582999544|FG000|Overall Study|Withdrawal by Subject|36|||
161438401|NCT00993967|582999544|FG000|Overall Study|Protocol Violation|2|||
161438402|NCT03815929|582999545|FG000|Overall Study|Lost to Follow-up|2|||
161438403|NCT03815929|582999546|FG001|Overall Study|Lost to Follow-up|1|||
161438404|NCT03815929|582999547|FG002|Overall Study|Lost to Follow-up|0|||
161438405|NCT03815929|582999545|FG000|Overall Study|Physician Decision|2|||
161438406|NCT03815929|582999546|FG001|Overall Study|Physician Decision|2|||
161438407|NCT03815929|582999547|FG002|Overall Study|Physician Decision|0|||
161438408|NCT03815929|582999545|FG000|Overall Study|Withdrawal by Subject|0|||
161438409|NCT03815929|582999546|FG001|Overall Study|Withdrawal by Subject|0|||
161438410|NCT03815929|582999547|FG002|Overall Study|Withdrawal by Subject|1|||
161438411|NCT02205736|582999548|FG000|Overall Study|Lost to Follow-up|106|||
161438412|NCT02638220|582999556|FG000|Overall Study|Lost to Follow-up|6|||
161438413|NCT02638220|582999556|FG000|Overall Study|Withdrawal by Subject|3|||
161438414|NCT02638220|582999556|FG000|Overall Study|Physician Decision|1|||
161438415|NCT02638220|582999556|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
161438416|NCT04323124|582999557|FG000|Overall Study|Adverse Event|0|||
161438417|NCT04323124|582999558|FG001|Overall Study|Adverse Event|0|||
161438418|NCT04323124|582999559|FG002|Overall Study|Adverse Event|0|||
161438419|NCT04323124|582999560|FG003|Overall Study|Adverse Event|0|||
161438420|NCT04323124|582999561|FG004|Overall Study|Adverse Event|0|||
161438421|NCT04323124|582999562|FG005|Overall Study|Adverse Event|1|||
161438422|NCT04323124|582999563|FG006|Overall Study|Adverse Event|0|||
161438423|NCT04323124|582999564|FG007|Overall Study|Adverse Event|1|||
161438424|NCT04323124|582999565|FG008|Overall Study|Adverse Event|1|||
161438425|NCT04323124|582999566|FG009|Overall Study|Adverse Event|0|||
161438426|NCT04323124|582999567|FG010|Overall Study|Adverse Event|0|||
161438427|NCT04323124|582999568|FG011|Overall Study|Adverse Event|0|||
161438428|NCT04323124|582999569|FG012|Overall Study|Adverse Event|0|||
161438429|NCT04323124|582999570|FG013|Overall Study|Adverse Event|0|||
161438430|NCT04323124|582999571|FG014|Overall Study|Adverse Event|0|||
161438431|NCT04323124|582999557|FG000|Overall Study|Other|0|||
161438432|NCT04323124|582999558|FG001|Overall Study|Other|0|||
161438433|NCT04323124|582999559|FG002|Overall Study|Other|0|||
161438434|NCT04323124|582999560|FG003|Overall Study|Other|0|||
161438435|NCT04323124|582999561|FG004|Overall Study|Other|1|||
161438436|NCT04323124|582999562|FG005|Overall Study|Other|0|||
161438437|NCT04323124|582999563|FG006|Overall Study|Other|0|||
161438438|NCT04323124|582999564|FG007|Overall Study|Other|0|||
161438439|NCT04323124|582999565|FG008|Overall Study|Other|1|||
161438440|NCT04323124|582999566|FG009|Overall Study|Other|0|||
161785041|NCT04380701|584257461|FG029|Overall Study|Death|0|||
161785042|NCT04380701|584257462|FG030|Overall Study|Death|0|||
161785043|NCT04380701|584257463|FG031|Overall Study|Death|0|||
161785044|NCT04380701|584257464|FG032|Overall Study|Death|0|||
161785045|NCT04380701|584257465|FG033|Overall Study|Death|0|||
161438441|NCT04323124|582999567|FG010|Overall Study|Other|0|||
161438442|NCT04323124|582999568|FG011|Overall Study|Other|0|||
161438443|NCT04323124|582999569|FG012|Overall Study|Other|0|||
161438444|NCT04323124|582999570|FG013|Overall Study|Other|0|||
161438445|NCT04323124|582999571|FG014|Overall Study|Other|0|||
161438446|NCT04323124|582999557|FG000|Overall Study|Coming from a red zone (COVID)|0|||
161438447|NCT04323124|582999558|FG001|Overall Study|Coming from a red zone (COVID)|0|||
161438448|NCT04323124|582999559|FG002|Overall Study|Coming from a red zone (COVID)|0|||
161785046|NCT04380701|584257432|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785047|NCT04380701|584257433|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785048|NCT04380701|584257434|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161438449|NCT04323124|582999560|FG003|Overall Study|Coming from a red zone (COVID)|0|||
161438450|NCT04323124|582999561|FG004|Overall Study|Coming from a red zone (COVID)|1|||
161438451|NCT04323124|582999562|FG005|Overall Study|Coming from a red zone (COVID)|1|||
161438452|NCT04323124|582999563|FG006|Overall Study|Coming from a red zone (COVID)|0|||
161438453|NCT04323124|582999564|FG007|Overall Study|Coming from a red zone (COVID)|0|||
161438454|NCT04323124|582999565|FG008|Overall Study|Coming from a red zone (COVID)|0|||
161438455|NCT04323124|582999566|FG009|Overall Study|Coming from a red zone (COVID)|0|||
161438456|NCT04323124|582999567|FG010|Overall Study|Coming from a red zone (COVID)|0|||
161438457|NCT04323124|582999568|FG011|Overall Study|Coming from a red zone (COVID)|0|||
161438458|NCT04323124|582999569|FG012|Overall Study|Coming from a red zone (COVID)|0|||
161438459|NCT04323124|582999570|FG013|Overall Study|Coming from a red zone (COVID)|0|||
161438460|NCT04323124|582999571|FG014|Overall Study|Coming from a red zone (COVID)|0|||
161438461|NCT04323124|582999557|FG000|Overall Study|No longer meets eligibility criteria|0|||
161438462|NCT04323124|582999558|FG001|Overall Study|No longer meets eligibility criteria|0|||
161438463|NCT04323124|582999559|FG002|Overall Study|No longer meets eligibility criteria|0|||
161438464|NCT04323124|582999560|FG003|Overall Study|No longer meets eligibility criteria|0|||
161438465|NCT04323124|582999561|FG004|Overall Study|No longer meets eligibility criteria|0|||
161438466|NCT04323124|582999562|FG005|Overall Study|No longer meets eligibility criteria|0|||
161438467|NCT04323124|582999563|FG006|Overall Study|No longer meets eligibility criteria|0|||
161438468|NCT04323124|582999564|FG007|Overall Study|No longer meets eligibility criteria|1|||
161438469|NCT04323124|582999565|FG008|Overall Study|No longer meets eligibility criteria|0|||
161898205|NCT00572455|584675573|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
161438470|NCT04323124|582999566|FG009|Overall Study|No longer meets eligibility criteria|0|||
161438471|NCT04323124|582999567|FG010|Overall Study|No longer meets eligibility criteria|0|||
161438472|NCT04323124|582999568|FG011|Overall Study|No longer meets eligibility criteria|0|||
161438473|NCT04323124|582999569|FG012|Overall Study|No longer meets eligibility criteria|0|||
161438474|NCT04323124|582999570|FG013|Overall Study|No longer meets eligibility criteria|1|||
161438475|NCT04323124|582999571|FG014|Overall Study|No longer meets eligibility criteria|1|||
161438476|NCT04323124|582999557|FG000|Overall Study|Study terminated by sponsor|0|||
161438477|NCT04323124|582999558|FG001|Overall Study|Study terminated by sponsor|0|||
161438478|NCT04323124|582999559|FG002|Overall Study|Study terminated by sponsor|0|||
161438479|NCT04323124|582999560|FG003|Overall Study|Study terminated by sponsor|0|||
161438480|NCT04323124|582999561|FG004|Overall Study|Study terminated by sponsor|0|||
161438481|NCT04323124|582999562|FG005|Overall Study|Study terminated by sponsor|0|||
161438482|NCT04323124|582999563|FG006|Overall Study|Study terminated by sponsor|0|||
161438483|NCT04323124|582999564|FG007|Overall Study|Study terminated by sponsor|0|||
161438484|NCT04323124|582999565|FG008|Overall Study|Study terminated by sponsor|0|||
161438485|NCT04323124|582999566|FG009|Overall Study|Study terminated by sponsor|0|||
161438486|NCT04323124|582999567|FG010|Overall Study|Study terminated by sponsor|0|||
161438487|NCT04323124|582999568|FG011|Overall Study|Study terminated by sponsor|2|||
161438488|NCT04323124|582999569|FG012|Overall Study|Study terminated by sponsor|1|||
161438489|NCT04323124|582999570|FG013|Overall Study|Study terminated by sponsor|0|||
161438490|NCT04323124|582999571|FG014|Overall Study|Study terminated by sponsor|0|||
161438491|NCT03809104|583001209|FG000|Overall Study|Withdrawal by Subject|3|||
161438492|NCT02968004|583001210|FG000|Main Study Phase|Adverse Event|1|||
161438493|NCT02968004|583001211|FG001|Main Study Phase|Adverse Event|0|||
161438494|NCT02968004|583001210|FG000|Main Study Phase|Withdrawal by Subject|0|||
161438495|NCT02968004|583001211|FG001|Main Study Phase|Withdrawal by Subject|1|||
161438496|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
161438497|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
161438498|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
161438499|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
161438500|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
161438501|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
161438502|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
161438503|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
161438504|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
161438505|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
161438506|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
161438507|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
161438508|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
161438509|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
161438510|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
161438511|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
161438512|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
161438513|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
161438514|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
161438515|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
161438516|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
161438517|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
161898206|NCT00572455|584675574|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
161438518|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
161438519|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
161668038|NCT00406653|583837481|FG005|Induction Period|Pregnancy|0|||
161785049|NCT04380701|584257435|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785050|NCT04380701|584257436|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785051|NCT04380701|584257437|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785052|NCT04380701|584257438|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785053|NCT04380701|584257439|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785054|NCT04380701|584257440|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785055|NCT04380701|584257441|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785056|NCT04380701|584257442|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785057|NCT04380701|584257443|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785058|NCT04380701|584257444|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785059|NCT04380701|584257445|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785060|NCT04380701|584257446|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785061|NCT04380701|584257447|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785062|NCT04380701|584257448|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785063|NCT04380701|584257449|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785064|NCT04380701|584257450|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785065|NCT04380701|584257451|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785066|NCT04380701|584257452|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785067|NCT04380701|584257453|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
161785068|NCT04380701|584257454|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
161785069|NCT04380701|584257455|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
161785070|NCT04380701|584257456|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
161785071|NCT04380701|584257457|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785072|NCT04380701|584257458|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785073|NCT04380701|584257459|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161549080|NCT01242176|583400994|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
161785074|NCT04380701|584257460|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785075|NCT04380701|584257461|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785076|NCT04380701|584257462|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785077|NCT04380701|584257463|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785078|NCT04380701|584257464|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785079|NCT04380701|584257465|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785080|NCT03550794|584257466|FG000|Overall Study|No longer met inclusion criteria|1|||
161898207|NCT00572455|584675575|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
161898208|NCT00572455|584675576|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
161898209|NCT00572455|584675577|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
161898210|NCT02465437|584675578|FG000|Overall Study|Physician Decision|0|||
161898211|NCT02465437|584675579|FG001|Overall Study|Physician Decision|0|||
161898212|NCT02465437|584675580|FG002|Overall Study|Physician Decision|1|||
161898213|NCT02465437|584675581|FG003|Overall Study|Physician Decision|0|||
161898214|NCT02465437|584675578|FG000|Overall Study|Withdrawal by Subject|1|||
161898215|NCT02465437|584675579|FG001|Overall Study|Withdrawal by Subject|0|||
161898216|NCT02465437|584675580|FG002|Overall Study|Withdrawal by Subject|0|||
161898217|NCT02465437|584675581|FG003|Overall Study|Withdrawal by Subject|1|||
161898218|NCT02465437|584675578|FG000|Overall Study|Adverse Event|0|||
161898219|NCT02465437|584675579|FG001|Overall Study|Adverse Event|1|||
161898220|NCT02465437|584675580|FG002|Overall Study|Adverse Event|0|||
161898221|NCT02465437|584675581|FG003|Overall Study|Adverse Event|0|||
161898222|NCT03280056|584675584|FG000|Overall Study|Withdrawal by Subject|12|||
161898223|NCT03280056|584675585|FG001|Overall Study|Withdrawal by Subject|14|||
161898224|NCT03280056|584675584|FG000|Overall Study|Death|9|||
161898225|NCT03280056|584675585|FG001|Overall Study|Death|2|||
161898226|NCT03280056|584675584|FG000|Overall Study|Adverse Event|1|||
161898227|NCT03280056|584675585|FG001|Overall Study|Adverse Event|3|||
161898228|NCT03280056|584675584|FG000|Overall Study|Lost to Follow-up|1|||
161898229|NCT03280056|584675585|FG001|Overall Study|Lost to Follow-up|1|||
161898230|NCT03280056|584675584|FG000|Overall Study|Physician Decision|0|||
161898231|NCT03280056|584675585|FG001|Overall Study|Physician Decision|1|||
161898232|NCT03280056|584675584|FG000|Overall Study|Early Discontinuation|1|||
161898233|NCT03280056|584675585|FG001|Overall Study|Early Discontinuation|0|||
161898234|NCT01135524|584675591|FG000|Overall Study|Withdrawal by Subject|14|||
161898235|NCT01135524|584675591|FG000|Overall Study|Adverse Event|20|||
161898236|NCT01135524|584675591|FG000|Overall Study|Lost to Follow-up|3|||
161898237|NCT01135524|584675591|FG000|Overall Study|Administrative|151|||
161898238|NCT01135524|584675591|FG000|Overall Study|Lack of Efficacy|8|||
161898239|NCT00613821|584675592|FG000|Overall Study|Withdrawal by Subject|1|||
161898240|NCT00613821|584675593|FG001|Overall Study|Withdrawal by Subject|0|||
161898241|NCT00613821|584675592|FG000|Overall Study|Physician Decision|1|||
161898242|NCT00613821|584675593|FG001|Overall Study|Physician Decision|1|||
161898243|NCT02907463|584675594|FG000|Overall Study|Lost to Follow-up|17|||
161898244|NCT02907463|584675594|FG000|Overall Study|Death|10|||
161898245|NCT02907463|584675594|FG000|Overall Study|Withdrawal by Subject|4|||
161898246|NCT02907463|584675594|FG000|Overall Study|MIS Approach was not used|2|||
161898247|NCT02907463|584675594|FG000|Overall Study|Not Implanted with Study Device|2|||
161898248|NCT02907463|584675594|FG000|Overall Study|Device Explanted|1|||
161898249|NCT02907463|584675594|FG000|Overall Study|Missing Exit Form|1|||
161898250|NCT01266824|584675595|FG000|Overall Study|Study terminated prior to completion|2|||
161898251|NCT01266824|584675596|FG001|Overall Study|Study terminated prior to completion|3|||
161898252|NCT02302846|584675597|FG000|Overall Study|Withdrawal by Subject|1|||
161898253|NCT00397189|584675598|FG000|3 Weeks Period|Lost to Follow-up|5|||
161898254|NCT00397189|584675599|FG001|3 Weeks Period|Lost to Follow-up|4|||
161898255|NCT00397189|584675598|FG000|3 Weeks Period|Adverse Event|3|||
161898256|NCT00397189|584675599|FG001|3 Weeks Period|Adverse Event|2|||
161898257|NCT00397189|584675598|FG000|3 Weeks Period|Withdrawal by Subject|13|||
161898258|NCT00397189|584675599|FG001|3 Weeks Period|Withdrawal by Subject|9|||
161898259|NCT00397189|584675598|FG000|3 Weeks Period|Physician Decision|0|||
161898260|NCT00397189|584675599|FG001|3 Weeks Period|Physician Decision|2|||
161898261|NCT00397189|584675598|FG000|3 Weeks Period|Protocol Violation|0|||
161898262|NCT00397189|584675599|FG001|3 Weeks Period|Protocol Violation|3|||
161898263|NCT00397189|584675598|FG000|3 Weeks Period|Other|0|||
161898264|NCT00397189|584675599|FG001|3 Weeks Period|Other|2|||
161898265|NCT01447407|584675602|FG000|Overall Study|Withdrawal by Subject|2|||
161898266|NCT01447407|584675603|FG001|Overall Study|Withdrawal by Subject|0|||
161898267|NCT01447407|584675604|FG002|Overall Study|Withdrawal by Subject|0|||
161898268|NCT01447407|584675605|FG003|Overall Study|Withdrawal by Subject|1|||
161898269|NCT01447407|584675602|FG000|Overall Study|Physician Decision|0|||
161898270|NCT01447407|584675603|FG001|Overall Study|Physician Decision|0|||
161898271|NCT01447407|584675604|FG002|Overall Study|Physician Decision|1|||
161898272|NCT01447407|584675605|FG003|Overall Study|Physician Decision|1|||
161898273|NCT00141518|584675608|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
161898274|NCT00141518|584675609|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
161898275|NCT00141518|584675610|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
161438520|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
161438521|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
161438522|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
161438523|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
161438524|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
161438525|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
161438526|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
161438527|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
161438528|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
161438529|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
161438530|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
161438531|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
161438532|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
161438533|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
161438534|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
161438535|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
161438536|NCT02968004|583001210|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
161438537|NCT02968004|583001211|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
161438538|NCT03722238|583001216|FG000|Overall Study|Protocol Violation|1|||
161438539|NCT03722238|583001217|FG001|Overall Study|Protocol Violation|0|||
161438540|NCT03722238|583001216|FG000|Overall Study|Physician Decision|1|||
161438541|NCT03722238|583001217|FG001|Overall Study|Physician Decision|0|||
161438542|NCT03722238|583001216|FG000|Overall Study|Death|1|||
161438543|NCT03722238|583001217|FG001|Overall Study|Death|0|||
161438544|NCT03722238|583001216|FG000|Overall Study|Lost to Follow-up|6|||
161438545|NCT03722238|583001217|FG001|Overall Study|Lost to Follow-up|0|||
161438546|NCT03722238|583001216|FG000|Overall Study|Partial missing data|44|||
161438547|NCT03722238|583001217|FG001|Overall Study|Partial missing data|1|||
161438548|NCT03722238|583001216|FG000|Overall Study|Withdrawal by Subject|2|||
161438549|NCT03722238|583001217|FG001|Overall Study|Withdrawal by Subject|0|||
161438550|NCT03722238|583001216|FG000|Overall Study|Other|4|||
161438551|NCT03722238|583001217|FG001|Overall Study|Other|0|||
161438552|NCT03722238|583001216|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
161438553|NCT03722238|583001217|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
161438554|NCT03722238|583001216|FG000|Overall Study|Did not meet risk classification group criteria|90|||
161438555|NCT03722238|583001217|FG001|Overall Study|Did not meet risk classification group criteria|0|||
161438556|NCT03722238|583001216|FG000|Overall Study|Did not sign consent|17|||
161438557|NCT03722238|583001217|FG001|Overall Study|Did not sign consent|0|||
161438558|NCT03722238|583001216|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
161438559|NCT03722238|583001217|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
161438560|NCT03722238|583001216|FG000|Overall Study|Not willing to purchase study medication|142|||
161438561|NCT03722238|583001217|FG001|Overall Study|Not willing to purchase study medication|0|||
161438562|NCT03722238|583001216|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
161438563|NCT03722238|583001217|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
161785081|NCT03550794|584257467|FG001|Overall Study|No longer met inclusion criteria|2|||
161785082|NCT03550794|584257466|FG000|Overall Study|Goals of care changed|1|||
161785083|NCT03550794|584257467|FG001|Overall Study|Goals of care changed|0|||
161785084|NCT03550794|584257466|FG000|Overall Study|Withdrawal by Subject|2|||
161785085|NCT03550794|584257467|FG001|Overall Study|Withdrawal by Subject|0|||
161785086|NCT03550794|584257466|FG000|Overall Study|Death|0|||
161785087|NCT03550794|584257467|FG001|Overall Study|Death|1|||
161785088|NCT01864525|584257468|FG000|Overall Study|Adverse Event|1|||
161785089|NCT01864525|584257469|FG001|Overall Study|Adverse Event|0|||
161785090|NCT01890785|584257470|FG000|Third Intervention|Withdrawal by Subject|0|||
161785091|NCT01890785|584257471|FG001|Third Intervention|Withdrawal by Subject|1|||
161785092|NCT01890785|584257472|FG002|Third Intervention|Withdrawal by Subject|0|||
161785093|NCT01890785|584257473|FG003|Third Intervention|Withdrawal by Subject|0|||
161785094|NCT01890785|584257474|FG004|Third Intervention|Withdrawal by Subject|0|||
161438564|NCT02085460|583001218|FG000|Overall Study|Adverse Event|2|||
161438565|NCT02085460|583001219|FG001|Overall Study|Adverse Event|2|||
161438566|NCT02085460|583001220|FG002|Overall Study|Adverse Event|1|||
161785095|NCT01890785|584257475|FG005|Third Intervention|Withdrawal by Subject|0|||
161438567|NCT02085460|583001218|FG000|Overall Study|Physician Decision|1|||
161438568|NCT02085460|583001219|FG001|Overall Study|Physician Decision|1|||
161438569|NCT02085460|583001220|FG002|Overall Study|Physician Decision|2|||
161785096|NCT03296553|584257476|FG000|Overall Study|Withdrawal by Subject|1|||
161785097|NCT03296553|584257477|FG001|Overall Study|Withdrawal by Subject|1|||
161785098|NCT03296553|584257476|FG000|Overall Study|Death|1|||
161785099|NCT03296553|584257477|FG001|Overall Study|Death|0|||
161785100|NCT00558519|584257478|FG000|Overall Study|Ph+|20|||
161785101|NCT00558519|584257478|FG000|Overall Study|Ineligible|1|||
161785102|NCT00558519|584257478|FG000|Overall Study|Insufficient data|1|||
161438570|NCT02085460|583001218|FG000|Overall Study|Withdrawal by Subject|11|||
161438571|NCT02085460|583001219|FG001|Overall Study|Withdrawal by Subject|5|||
161438572|NCT02085460|583001220|FG002|Overall Study|Withdrawal by Subject|7|||
161438573|NCT01285323|583001221|FG000|Overall Study|Adverse Event|9|||
161438574|NCT01285323|583001222|FG001|Overall Study|Adverse Event|8|||
161438575|NCT01285323|583001221|FG000|Overall Study|Lack of Efficacy|4|||
161438576|NCT01285323|583001222|FG001|Overall Study|Lack of Efficacy|2|||
161438577|NCT01285323|583001221|FG000|Overall Study|Withdrawal by Subject|15|||
161438578|NCT01285323|583001222|FG001|Overall Study|Withdrawal by Subject|11|||
161438579|NCT01285323|583001221|FG000|Overall Study|Protocol Violation|1|||
161438580|NCT01285323|583001222|FG001|Overall Study|Protocol Violation|2|||
161438581|NCT01285323|583001221|FG000|Overall Study|Non-compliance with study procedures|2|||
161438582|NCT01285323|583001222|FG001|Overall Study|Non-compliance with study procedures|3|||
161438583|NCT01285323|583001221|FG000|Overall Study|Lost to Follow-up|1|||
161438584|NCT01285323|583001222|FG001|Overall Study|Lost to Follow-up|1|||
161438585|NCT01285323|583001221|FG000|Overall Study|Other|1|||
161438586|NCT01285323|583001222|FG001|Overall Study|Other|3|||
161438587|NCT02606643|583001223|FG000|Overall Study|did not meet inclusion criteria|1|||
161438588|NCT02606643|583001224|FG001|Overall Study|did not meet inclusion criteria|3|||
161438589|NCT02158546|583001232|FG000|Overall Study|Physician Decision|0|||
161438590|NCT02158546|583001233|FG001|Overall Study|Physician Decision|1|||
161438591|NCT02158546|583001234|FG002|Overall Study|Physician Decision|0|||
161438592|NCT02158546|583001235|FG003|Overall Study|Physician Decision|0|||
161438593|NCT02158546|583001232|FG000|Overall Study|Non-compliance|0|||
161438594|NCT02158546|583001233|FG001|Overall Study|Non-compliance|1|||
161438595|NCT02158546|583001234|FG002|Overall Study|Non-compliance|0|||
161438596|NCT02158546|583001235|FG003|Overall Study|Non-compliance|1|||
161438597|NCT02158546|583001232|FG000|Overall Study|Failure to meet eligibility criteria|0|||
161438598|NCT02158546|583001233|FG001|Overall Study|Failure to meet eligibility criteria|1|||
161438599|NCT02158546|583001234|FG002|Overall Study|Failure to meet eligibility criteria|0|||
161438600|NCT02158546|583001235|FG003|Overall Study|Failure to meet eligibility criteria|0|||
161438601|NCT02158546|583001232|FG000|Overall Study|Lack of Efficacy|1|||
161438602|NCT02158546|583001233|FG001|Overall Study|Lack of Efficacy|1|||
161438603|NCT02158546|583001234|FG002|Overall Study|Lack of Efficacy|0|||
161438604|NCT02158546|583001235|FG003|Overall Study|Lack of Efficacy|0|||
161438605|NCT02158546|583001232|FG000|Overall Study|Adverse Event|2|||
161438606|NCT02158546|583001233|FG001|Overall Study|Adverse Event|2|||
161438607|NCT02158546|583001234|FG002|Overall Study|Adverse Event|0|||
161438608|NCT02158546|583001235|FG003|Overall Study|Adverse Event|0|||
161438609|NCT02158546|583001232|FG000|Overall Study|Withdrawal by Subject|6|||
161438610|NCT02158546|583001233|FG001|Overall Study|Withdrawal by Subject|2|||
161438611|NCT02158546|583001234|FG002|Overall Study|Withdrawal by Subject|1|||
161438612|NCT02158546|583001235|FG003|Overall Study|Withdrawal by Subject|0|||
161438613|NCT02158546|583001232|FG000|Overall Study|Lost to Follow-up|5|||
161438614|NCT02158546|583001233|FG001|Overall Study|Lost to Follow-up|4|||
161438615|NCT02158546|583001234|FG002|Overall Study|Lost to Follow-up|0|||
161438616|NCT02158546|583001235|FG003|Overall Study|Lost to Follow-up|1|||
161438617|NCT02158546|583001232|FG000|Overall Study|Site Excluded|5|||
161438618|NCT02158546|583001233|FG001|Overall Study|Site Excluded|5|||
161438619|NCT02158546|583001234|FG002|Overall Study|Site Excluded|3|||
161438620|NCT02158546|583001235|FG003|Overall Study|Site Excluded|4|||
161438621|NCT00891904|583001240|FG000|Overall Study|Death|1|||
161438622|NCT00891904|583001240|FG000|Overall Study|Adverse Event|1|||
161438623|NCT01046396|583001241|FG000|Overall Study|Withdrawal by Subject|5|||
161438624|NCT01605799|583001252|FG000|Overall Study|Withdrawal by Subject|2|||
161438625|NCT01605799|583001253|FG001|Overall Study|Withdrawal by Subject|1|||
161438626|NCT01055197|583001256|FG000|Overall Study|Protocol Violation|7|||
161438627|NCT01055197|583001257|FG001|Overall Study|Protocol Violation|2|||
161438628|NCT01055197|583001256|FG000|Overall Study|Withdrawal by Subject|2|||
161438629|NCT01055197|583001257|FG001|Overall Study|Withdrawal by Subject|0|||
161438630|NCT00734539|583001258|FG000|Main Study|Death|33|||
161438631|NCT00734539|583001259|FG001|Main Study|Death|32|||
161438632|NCT00734539|583001258|FG000|Main Study|Physician Decision|2|||
161438633|NCT00734539|583001259|FG001|Main Study|Physician Decision|0|||
161438634|NCT00734539|583001258|FG000|Main Study|Withdrawal by Subject|1|||
161438635|NCT00734539|583001259|FG001|Main Study|Withdrawal by Subject|3|||
161438636|NCT00734539|583001258|FG000|Main Study|Enrolled in error; ineligible|1|||
161438637|NCT00734539|583001259|FG001|Main Study|Enrolled in error; ineligible|0|||
161438638|NCT02504151|583001260|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
161438639|NCT02504151|583001261|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
161438640|NCT02504151|583001260|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161438641|NCT02504151|583001261|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
161438642|NCT02504151|583001260|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161438643|NCT02504151|583001261|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161438644|NCT02504151|583001260|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
161438645|NCT02504151|583001261|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
161668039|NCT00406653|583837482|FG006|Induction Period|Pregnancy|0|||
161785103|NCT00558519|584257478|FG000|Overall Study|Never received treatment|1|||
161785104|NCT00065065|584257479|FG000|Overall Study|Adverse Event|3|||
161785105|NCT00065065|584257480|FG001|Overall Study|Adverse Event|2|||
161785106|NCT00065065|584257479|FG000|Overall Study|Withdrawal by Subject|1|||
161785107|NCT00065065|584257480|FG001|Overall Study|Withdrawal by Subject|5|||
161785108|NCT00065065|584257479|FG000|Overall Study|Lack of Efficacy|4|||
161785109|NCT00065065|584257480|FG001|Overall Study|Lack of Efficacy|11|||
161785110|NCT00065065|584257479|FG000|Overall Study|Other|2|||
161785111|NCT00065065|584257480|FG001|Overall Study|Other|2|||
161785112|NCT01050673|584257481|FG000|Overall Study|Physician Decision|4|||
161785113|NCT01050673|584257482|FG001|Overall Study|Physician Decision|5|||
161785114|NCT03077828|584257487|FG000|Treatment Cycles|Death|1|||
161438646|NCT00538902|583001262|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
161438647|NCT00538902|583001263|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
161438648|NCT00538902|583001264|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
161438649|NCT00538902|583001262|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
161438650|NCT00538902|583001263|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
161438651|NCT00538902|583001264|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
161438652|NCT00538902|583001262|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
161438653|NCT00538902|583001263|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
161438654|NCT00538902|583001264|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
161785115|NCT03077828|584257487|FG000|Treatment Cycles|Withdrawal by Subject|1|||
161785116|NCT03077828|584257487|FG000|Treatment Cycles|Screen Fail|2|||
161438655|NCT00538902|583001262|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
161785117|NCT03077828|584257487|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
161785118|NCT03077828|584257487|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
161438656|NCT00538902|583001263|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
161438657|NCT00538902|583001264|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
161438658|NCT00538902|583001262|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
161438659|NCT00538902|583001263|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
161438660|NCT00538902|583001264|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
161438661|NCT00538902|583001262|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
161438662|NCT00538902|583001263|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
161438663|NCT00538902|583001264|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
161438664|NCT00538902|583001262|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
161438665|NCT00538902|583001263|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
161438666|NCT00538902|583001264|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
161438667|NCT00538902|583001262|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
161438668|NCT00538902|583001263|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
161438669|NCT00538902|583001264|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
161438670|NCT01454102|583001265|FG000|Overall Study|Continuing in the treatment period|0|||
161438671|NCT01454102|583001266|FG001|Overall Study|Continuing in the treatment period|0|||
161785119|NCT03077828|584257487|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
161785120|NCT03077828|584257487|FG000|Follow-up|Patients still in follow-up|15|||
161785121|NCT02392559|584257488|FG000|Overall Study|Withdrawal by Subject|0|||
161785122|NCT02392559|584257489|FG001|Overall Study|Withdrawal by Subject|1|||
161438672|NCT01454102|583001267|FG002|Overall Study|Continuing in the treatment period|0|||
161438673|NCT01454102|583001268|FG003|Overall Study|Continuing in the treatment period|0|||
161438674|NCT01454102|583001269|FG004|Overall Study|Continuing in the treatment period|3|||
161438675|NCT01454102|583001270|FG005|Overall Study|Continuing in the treatment period|3|||
161438676|NCT01454102|583001271|FG006|Overall Study|Continuing in the treatment period|2|||
161438677|NCT01454102|583001272|FG007|Overall Study|Continuing in the treatment period|0|||
161785123|NCT03125915|584257495|FG000|1 Month Follow up|Lost to Follow-up|3|||
161785124|NCT03125915|584257496|FG001|1 Month Follow up|Lost to Follow-up|3|||
161785125|NCT03125915|584257497|FG002|1 Month Follow up|Lost to Follow-up|2|||
161785126|NCT03125915|584257498|FG003|1 Month Follow up|Lost to Follow-up|3|||
161785127|NCT03125915|584257495|FG000|3 Month Follow-up|Lost to Follow-up|6|||
161785128|NCT03125915|584257496|FG001|3 Month Follow-up|Lost to Follow-up|4|||
161785129|NCT03125915|584257497|FG002|3 Month Follow-up|Lost to Follow-up|4|||
161438678|NCT01454102|583001273|FG008|Overall Study|Continuing in the treatment period|1|||
161438679|NCT01454102|583001274|FG009|Overall Study|Continuing in the treatment period|0|||
161438680|NCT01454102|583001275|FG010|Overall Study|Continuing in the treatment period|0|||
161438681|NCT01454102|583001276|FG011|Overall Study|Continuing in the treatment period|4|||
161438682|NCT01454102|583001277|FG012|Overall Study|Continuing in the treatment period|7|||
161438683|NCT01454102|583001278|FG013|Overall Study|Continuing in the treatment period|4|||
161438684|NCT01454102|583001279|FG014|Overall Study|Continuing in the treatment period|3|||
161785130|NCT03125915|584257498|FG003|3 Month Follow-up|Lost to Follow-up|2|||
161785131|NCT03125915|584257495|FG000|6 Month Follow-up|Lost to Follow-up|7|||
161785132|NCT03125915|584257496|FG001|6 Month Follow-up|Lost to Follow-up|3|||
161785133|NCT03125915|584257497|FG002|6 Month Follow-up|Lost to Follow-up|6|||
161785134|NCT03125915|584257498|FG003|6 Month Follow-up|Lost to Follow-up|3|||
161438685|NCT01454102|583001280|FG015|Overall Study|Continuing in the treatment period|1|||
161438686|NCT01782378|583001283|FG000|First Series|Lost to Follow-up|7|||
161438687|NCT01782378|583001284|FG001|First Series|Lost to Follow-up|8|||
161438688|NCT01782378|583001283|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
161438689|NCT01782378|583001284|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
161438690|NCT01782378|583001283|FG000|Second Series|Lost to Follow-up|8|||
161438691|NCT01782378|583001284|FG001|Second Series|Lost to Follow-up|7|||
161438692|NCT01782378|583001283|FG000|Second Series|Did not choose to complete S2 Optional|18|||
161438693|NCT01782378|583001284|FG001|Second Series|Did not choose to complete S2 Optional|0|||
161438694|NCT00705016|583001285|FG000|Overall Study|Adverse Event|6|||
161438695|NCT00705016|583001286|FG001|Overall Study|Adverse Event|11|||
161438696|NCT00705016|583001287|FG002|Overall Study|Adverse Event|10|||
161438697|NCT00705016|583001285|FG000|Overall Study|Death|5|||
161438698|NCT00705016|583001286|FG001|Overall Study|Death|7|||
161438699|NCT00705016|583001287|FG002|Overall Study|Death|5|||
161438700|NCT00705016|583001285|FG000|Overall Study|Protocol Violation|0|||
161438701|NCT00705016|583001286|FG001|Overall Study|Protocol Violation|1|||
161438702|NCT00705016|583001287|FG002|Overall Study|Protocol Violation|1|||
161438703|NCT00705016|583001285|FG000|Overall Study|Withdrawal by Subject|4|||
161438704|NCT00705016|583001286|FG001|Overall Study|Withdrawal by Subject|3|||
161438705|NCT00705016|583001287|FG002|Overall Study|Withdrawal by Subject|2|||
161438706|NCT00705016|583001285|FG000|Overall Study|Progressive Disease|33|||
161438707|NCT00705016|583001286|FG001|Overall Study|Progressive Disease|29|||
161438708|NCT00705016|583001287|FG002|Overall Study|Progressive Disease|33|||
161438709|NCT00705016|583001285|FG000|Overall Study|Symptomatic Deterioration|3|||
161438710|NCT00705016|583001286|FG001|Overall Study|Symptomatic Deterioration|1|||
161438711|NCT00705016|583001287|FG002|Overall Study|Symptomatic Deterioration|1|||
161438712|NCT00705016|583001285|FG000|Overall Study|Other|9|||
161438713|NCT00705016|583001286|FG001|Overall Study|Other|6|||
161438714|NCT00705016|583001287|FG002|Overall Study|Other|6|||
161438715|NCT00942604|583001290|FG000|Overall Study|Protocol Violation|1|||
161438716|NCT00942604|583001291|FG001|Overall Study|Protocol Violation|1|||
161438717|NCT00942604|583001290|FG000|Overall Study|Adverse Event|0|||
161438718|NCT00942604|583001291|FG001|Overall Study|Adverse Event|1|||
161438719|NCT00942604|583001290|FG000|Overall Study|Withdrawal by Subject|0|||
161438720|NCT00942604|583001291|FG001|Overall Study|Withdrawal by Subject|1|||
161438721|NCT00942604|583001290|FG000|Overall Study|Patient relocation|1|||
161438722|NCT00942604|583001291|FG001|Overall Study|Patient relocation|1|||
161438723|NCT01188343|583001292|FG000|Overall Study|Not vaccinated|0|||
161438724|NCT01188343|583001293|FG001|Overall Study|Not vaccinated|2|||
161438725|NCT01188343|583001294|FG002|Overall Study|Not vaccinated|1|||
161438726|NCT01188343|583001292|FG000|Overall Study|Withdrawal by Subject|1|||
161438727|NCT01188343|583001293|FG001|Overall Study|Withdrawal by Subject|24|||
161438728|NCT01188343|583001294|FG002|Overall Study|Withdrawal by Subject|0|||
161438729|NCT01663103|583001295|FG000|Overall Study|Withdrawal by Subject|1|||
161438730|NCT01663103|583001296|FG001|Overall Study|Withdrawal by Subject|2|||
161438731|NCT01663103|583001295|FG000|Overall Study|Adverse Event|1|||
161438732|NCT01663103|583001296|FG001|Overall Study|Adverse Event|0|||
161438733|NCT01663103|583001295|FG000|Overall Study|dog bite|1|||
161438734|NCT01663103|583001296|FG001|Overall Study|dog bite|0|||
161438735|NCT01721044|583001301|FG000|Treatment Period|Adverse Event|7|||
161438736|NCT01721044|583001302|FG001|Treatment Period|Adverse Event|7|||
161438737|NCT01721044|583001303|FG002|Treatment Period|Adverse Event|10|||
161438738|NCT01721044|583001301|FG000|Treatment Period|Death|0|||
161438739|NCT01721044|583001302|FG001|Treatment Period|Death|0|||
161438740|NCT01721044|583001303|FG002|Treatment Period|Death|1|||
161438741|NCT01721044|583001301|FG000|Treatment Period|Lack of Efficacy|16|||
161438742|NCT01721044|583001302|FG001|Treatment Period|Lack of Efficacy|4|||
161438743|NCT01721044|583001303|FG002|Treatment Period|Lack of Efficacy|4|||
161438744|NCT01721044|583001301|FG000|Treatment Period|Lost to Follow-up|0|||
161438745|NCT01721044|583001302|FG001|Treatment Period|Lost to Follow-up|0|||
161438746|NCT01721044|583001303|FG002|Treatment Period|Lost to Follow-up|1|||
161438747|NCT01721044|583001301|FG000|Treatment Period|Physician Decision|1|||
161438748|NCT01721044|583001302|FG001|Treatment Period|Physician Decision|0|||
161438749|NCT01721044|583001303|FG002|Treatment Period|Physician Decision|2|||
161438750|NCT01721044|583001301|FG000|Treatment Period|Protocol Violation|1|||
161438751|NCT01721044|583001302|FG001|Treatment Period|Protocol Violation|0|||
161438752|NCT01721044|583001303|FG002|Treatment Period|Protocol Violation|0|||
161438753|NCT01721044|583001301|FG000|Treatment Period|Withdrawal by Subject|7|||
161438754|NCT01721044|583001302|FG001|Treatment Period|Withdrawal by Subject|6|||
161438755|NCT01721044|583001303|FG002|Treatment Period|Withdrawal by Subject|1|||
161438756|NCT04634253|583001304|FG000|Overall Study|Adverse Event|1|||
161438757|NCT04634253|583001305|FG001|Overall Study|Adverse Event|1|||
161438758|NCT04634253|583001306|FG002|Overall Study|Adverse Event|0|||
161438759|NCT04634253|583001304|FG000|Overall Study|Physician Decision|0|||
161438760|NCT04634253|583001305|FG001|Overall Study|Physician Decision|1|||
161438761|NCT04634253|583001306|FG002|Overall Study|Physician Decision|0|||
161438762|NCT04634253|583001304|FG000|Overall Study|Withdrawal by Subject|1|||
161438763|NCT04634253|583001305|FG001|Overall Study|Withdrawal by Subject|0|||
161438764|NCT04634253|583001306|FG002|Overall Study|Withdrawal by Subject|3|||
161438765|NCT01499355|583001310|FG000|Run-In Period|Study Termination|15|||
161438766|NCT01499355|583001311|FG001|Run-In Period|Study Termination|0|||
161438767|NCT01499355|583001312|FG002|Run-In Period|Study Termination|0|||
161438768|NCT01499355|583001313|FG003|Run-In Period|Study Termination|0|||
161438769|NCT01499355|583001310|FG000|Run-In Period|Other|3|||
161438770|NCT01499355|583001311|FG001|Run-In Period|Other|0|||
161438771|NCT01499355|583001312|FG002|Run-In Period|Other|0|||
161438772|NCT01499355|583001313|FG003|Run-In Period|Other|0|||
161438773|NCT01499355|583001310|FG000|Run-In Period|Death|2|||
161438774|NCT01499355|583001311|FG001|Run-In Period|Death|0|||
161438775|NCT01499355|583001312|FG002|Run-In Period|Death|0|||
161438776|NCT01499355|583001313|FG003|Run-In Period|Death|0|||
161438777|NCT01499355|583001310|FG000|Run-In Period|Investigator Decision|2|||
161438778|NCT01499355|583001311|FG001|Run-In Period|Investigator Decision|0|||
161438779|NCT01499355|583001312|FG002|Run-In Period|Investigator Decision|0|||
161438780|NCT01499355|583001313|FG003|Run-In Period|Investigator Decision|0|||
161438781|NCT01499355|583001310|FG000|Run-In Period|Consent Withdrawn|1|||
161438782|NCT01499355|583001311|FG001|Run-In Period|Consent Withdrawn|0|||
161438783|NCT01499355|583001312|FG002|Run-In Period|Consent Withdrawn|0|||
161438784|NCT01499355|583001313|FG003|Run-In Period|Consent Withdrawn|0|||
161438785|NCT01499355|583001310|FG000|Run-In Period|Adverse Event|8|||
161438786|NCT01499355|583001311|FG001|Run-In Period|Adverse Event|0|||
161438787|NCT01499355|583001312|FG002|Run-In Period|Adverse Event|0|||
161438788|NCT01499355|583001313|FG003|Run-In Period|Adverse Event|0|||
161438789|NCT01499355|583001310|FG000|Double-Blind Period|Adverse Event|0|||
161438790|NCT01499355|583001311|FG001|Double-Blind Period|Adverse Event|2|||
161438791|NCT01499355|583001312|FG002|Double-Blind Period|Adverse Event|3|||
161438792|NCT01499355|583001313|FG003|Double-Blind Period|Adverse Event|2|||
161438793|NCT01499355|583001310|FG000|Double-Blind Period|Study Termination|0|||
161438794|NCT01499355|583001311|FG001|Double-Blind Period|Study Termination|18|||
161438795|NCT01499355|583001312|FG002|Double-Blind Period|Study Termination|16|||
161438796|NCT01499355|583001313|FG003|Double-Blind Period|Study Termination|14|||
161438797|NCT01499355|583001310|FG000|Double-Blind Period|Other|0|||
161438798|NCT01499355|583001311|FG001|Double-Blind Period|Other|1|||
161438799|NCT01499355|583001312|FG002|Double-Blind Period|Other|2|||
161438800|NCT01499355|583001313|FG003|Double-Blind Period|Other|2|||
161438801|NCT01499355|583001310|FG000|Double-Blind Period|Death|0|||
161438802|NCT01499355|583001311|FG001|Double-Blind Period|Death|1|||
161438803|NCT01499355|583001312|FG002|Double-Blind Period|Death|0|||
161438804|NCT01499355|583001313|FG003|Double-Blind Period|Death|0|||
161438805|NCT01499355|583001310|FG000|Double-Blind Period|Investigator Decision|0|||
161438806|NCT01499355|583001311|FG001|Double-Blind Period|Investigator Decision|0|||
161438807|NCT01499355|583001312|FG002|Double-Blind Period|Investigator Decision|3|||
161438808|NCT01499355|583001313|FG003|Double-Blind Period|Investigator Decision|3|||
161438809|NCT01499355|583001310|FG000|Double-Blind Period|Consent Withdrawn|0|||
161438810|NCT01499355|583001311|FG001|Double-Blind Period|Consent Withdrawn|0|||
161438811|NCT01499355|583001312|FG002|Double-Blind Period|Consent Withdrawn|1|||
161438812|NCT01499355|583001313|FG003|Double-Blind Period|Consent Withdrawn|2|||
161438813|NCT01499355|583001310|FG000|Double-Blind Period|Lost to Follow-up|0|||
161438814|NCT01499355|583001311|FG001|Double-Blind Period|Lost to Follow-up|1|||
161438815|NCT01499355|583001312|FG002|Double-Blind Period|Lost to Follow-up|0|||
161438816|NCT01499355|583001313|FG003|Double-Blind Period|Lost to Follow-up|0|||
161438817|NCT01457703|583001320|FG000|Overall Study|Screen Failure|5|||
161438818|NCT01457703|583001321|FG001|Overall Study|Screen Failure|7|||
161438819|NCT01457703|583001320|FG000|Overall Study|Withdrawal by Subject|1|||
161438820|NCT01457703|583001321|FG001|Overall Study|Withdrawal by Subject|4|||
161438821|NCT01658436|583001322|FG000|Overall Study|Adverse Event|6|||
161438822|NCT01658436|583001323|FG001|Overall Study|Adverse Event|5|||
161438823|NCT01658436|583001322|FG000|Overall Study|Physician Decision|1|||
161438824|NCT01658436|583001323|FG001|Overall Study|Physician Decision|0|||
161438825|NCT01658436|583001322|FG000|Overall Study|Progressive disease|12|||
161438826|NCT01658436|583001323|FG001|Overall Study|Progressive disease|4|||
161438827|NCT01658436|583001322|FG000|Overall Study|Study terminated by sponsor|0|||
161438828|NCT01658436|583001323|FG001|Overall Study|Study terminated by sponsor|1|||
161438829|NCT01658436|583001322|FG000|Overall Study|Subject/guardian decision|0|||
161438830|NCT01658436|583001323|FG001|Overall Study|Subject/guardian decision|1|||
161438831|NCT01658436|583001322|FG000|Overall Study|Death|1|||
161438832|NCT01658436|583001323|FG001|Overall Study|Death|0|||
161438833|NCT01318915|583001324|FG000|Overall Study|Lost to Follow-up|1|||
161438834|NCT03313037|583001340|FG000|Overall Study|Protocol Violation|4|||
161438835|NCT03313037|583001341|FG001|Overall Study|Protocol Violation|1|||
161438836|NCT03313037|583001340|FG000|Overall Study|Other|1|||
161438837|NCT03313037|583001341|FG001|Overall Study|Other|1|||
161438838|NCT03313037|583001340|FG000|Overall Study|Withdrawal by Subject|4|||
161438839|NCT03313037|583001341|FG001|Overall Study|Withdrawal by Subject|3|||
161438840|NCT03313037|583001340|FG000|Overall Study|No longer meets eligibility criteria|1|||
161438841|NCT03313037|583001341|FG001|Overall Study|No longer meets eligibility criteria|7|||
161438842|NCT03313037|583001340|FG000|Overall Study|Lost to Follow-up|9|||
161438843|NCT03313037|583001341|FG001|Overall Study|Lost to Follow-up|8|||
161438844|NCT03313037|583001340|FG000|Overall Study|Randomized but not treated|1|||
161438845|NCT03313037|583001341|FG001|Overall Study|Randomized but not treated|0|||
161438846|NCT02760498|583001342|FG000|Overall Study|Adverse Event|3|||
161438847|NCT02760498|583001343|FG001|Overall Study|Adverse Event|3|||
161438848|NCT02760498|583001344|FG002|Overall Study|Adverse Event|1|||
161438849|NCT02760498|583001345|FG003|Overall Study|Adverse Event|1|||
161438850|NCT02760498|583001346|FG004|Overall Study|Adverse Event|0|||
161438851|NCT02760498|583001347|FG005|Overall Study|Adverse Event|6|||
161438852|NCT02760498|583001342|FG000|Overall Study|Death|7|||
161438853|NCT02760498|583001343|FG001|Overall Study|Death|5|||
161438854|NCT02760498|583001344|FG002|Overall Study|Death|5|||
161438855|NCT02760498|583001345|FG003|Overall Study|Death|7|||
161438856|NCT02760498|583001346|FG004|Overall Study|Death|0|||
161438857|NCT02760498|583001347|FG005|Overall Study|Death|23|||
161438858|NCT02760498|583001342|FG000|Overall Study|Lost to Follow-up|0|||
161438859|NCT02760498|583001343|FG001|Overall Study|Lost to Follow-up|0|||
161438860|NCT02760498|583001344|FG002|Overall Study|Lost to Follow-up|0|||
161438861|NCT02760498|583001345|FG003|Overall Study|Lost to Follow-up|0|||
161438862|NCT02760498|583001346|FG004|Overall Study|Lost to Follow-up|0|||
161438863|NCT02760498|583001347|FG005|Overall Study|Lost to Follow-up|3|||
161438864|NCT02760498|583001342|FG000|Overall Study|Non-compliance with study drug|0|||
161438865|NCT02760498|583001343|FG001|Overall Study|Non-compliance with study drug|2|||
161438866|NCT02760498|583001344|FG002|Overall Study|Non-compliance with study drug|0|||
161438867|NCT02760498|583001345|FG003|Overall Study|Non-compliance with study drug|0|||
161438868|NCT02760498|583001346|FG004|Overall Study|Non-compliance with study drug|0|||
161438869|NCT02760498|583001347|FG005|Overall Study|Non-compliance with study drug|0|||
161438870|NCT02760498|583001342|FG000|Overall Study|Participant decision|1|||
161438871|NCT02760498|583001343|FG001|Overall Study|Participant decision|4|||
161438872|NCT02760498|583001344|FG002|Overall Study|Participant decision|2|||
161438873|NCT02760498|583001345|FG003|Overall Study|Participant decision|2|||
161438874|NCT02760498|583001346|FG004|Overall Study|Participant decision|1|||
161438875|NCT02760498|583001347|FG005|Overall Study|Participant decision|6|||
161438876|NCT02760498|583001342|FG000|Overall Study|Sponsor decision|0|||
161438877|NCT02760498|583001343|FG001|Overall Study|Sponsor decision|0|||
161438878|NCT02760498|583001344|FG002|Overall Study|Sponsor decision|0|||
161438879|NCT02760498|583001345|FG003|Overall Study|Sponsor decision|3|||
161438880|NCT02760498|583001346|FG004|Overall Study|Sponsor decision|0|||
161438881|NCT02760498|583001347|FG005|Overall Study|Sponsor decision|0|||
161438882|NCT02760498|583001342|FG000|Overall Study|Physician Decision|3|||
161438883|NCT02760498|583001343|FG001|Overall Study|Physician Decision|4|||
161438884|NCT02760498|583001344|FG002|Overall Study|Physician Decision|1|||
161438885|NCT02760498|583001345|FG003|Overall Study|Physician Decision|4|||
161438886|NCT02760498|583001346|FG004|Overall Study|Physician Decision|0|||
161438887|NCT02760498|583001347|FG005|Overall Study|Physician Decision|2|||
161438888|NCT02760498|583001342|FG000|Overall Study|Disease progression|21|||
161438889|NCT02760498|583001343|FG001|Overall Study|Disease progression|19|||
161438890|NCT02760498|583001344|FG002|Overall Study|Disease progression|20|||
161438891|NCT02760498|583001345|FG003|Overall Study|Disease progression|18|||
161438892|NCT02760498|583001346|FG004|Overall Study|Disease progression|4|||
161438893|NCT02760498|583001347|FG005|Overall Study|Disease progression|55|||
161438894|NCT02760498|583001342|FG000|Overall Study|Withdrawal by Subject|4|||
161438895|NCT02760498|583001343|FG001|Overall Study|Withdrawal by Subject|7|||
161438896|NCT02760498|583001344|FG002|Overall Study|Withdrawal by Subject|5|||
161438897|NCT02760498|583001345|FG003|Overall Study|Withdrawal by Subject|1|||
161438898|NCT02760498|583001346|FG004|Overall Study|Withdrawal by Subject|0|||
161438899|NCT02760498|583001347|FG005|Overall Study|Withdrawal by Subject|6|||
161438900|NCT02760498|583001342|FG000|Overall Study|Other than specified|1|||
161438901|NCT02760498|583001343|FG001|Overall Study|Other than specified|6|||
161438902|NCT02760498|583001344|FG002|Overall Study|Other than specified|0|||
161438903|NCT02760498|583001345|FG003|Overall Study|Other than specified|3|||
161438904|NCT02760498|583001346|FG004|Overall Study|Other than specified|1|||
161438905|NCT02760498|583001347|FG005|Overall Study|Other than specified|0|||
161438906|NCT02760498|583001342|FG000|Overall Study|Not treated|0|||
161785135|NCT04816877|584257499|FG000|Overall Study|Withdrawal by Subject|1|||
161438907|NCT02760498|583001343|FG001|Overall Study|Not treated|0|||
161438908|NCT02760498|583001344|FG002|Overall Study|Not treated|0|||
161438909|NCT02760498|583001345|FG003|Overall Study|Not treated|0|||
161438910|NCT02760498|583001346|FG004|Overall Study|Not treated|0|||
161785136|NCT04816877|584257500|FG001|Overall Study|Withdrawal by Subject|0|||
161785137|NCT02176642|584257504|FG000|Overall Study|Withdrawal by Subject|0|||
161438911|NCT02760498|583001347|FG005|Overall Study|Not treated|2|||
161438912|NCT03067077|583001348|FG000|Overall Study|Did not receive surgery|4|||
161438913|NCT03067077|583001349|FG001|Overall Study|Did not receive surgery|5|||
161438914|NCT03067077|583001348|FG000|Overall Study|Lost to Follow-up|3|||
161438915|NCT03067077|583001349|FG001|Overall Study|Lost to Follow-up|2|||
161438916|NCT01198977|583001357|FG000|Overall Study|Lost to Follow-up|1|||
161438917|NCT01198977|583001358|FG001|Overall Study|Lost to Follow-up|0|||
161438918|NCT01588522|583001364|FG000|Overall Study|Withdrawal by Subject|1|||
161438919|NCT01588522|583001365|FG001|Overall Study|Withdrawal by Subject|5|||
161438920|NCT01588522|583001366|FG002|Overall Study|Withdrawal by Subject|3|||
161438921|NCT01588522|583001367|FG003|Overall Study|Withdrawal by Subject|1|||
161438922|NCT01588522|583001368|FG004|Overall Study|Withdrawal by Subject|2|||
161438923|NCT01588522|583001369|FG005|Overall Study|Withdrawal by Subject|0|||
161438924|NCT01588522|583001364|FG000|Overall Study|Lack of Efficacy|0|||
161438925|NCT01588522|583001365|FG001|Overall Study|Lack of Efficacy|0|||
161438926|NCT01588522|583001366|FG002|Overall Study|Lack of Efficacy|0|||
161438927|NCT01588522|583001367|FG003|Overall Study|Lack of Efficacy|0|||
161438928|NCT01588522|583001368|FG004|Overall Study|Lack of Efficacy|1|||
161438929|NCT01588522|583001369|FG005|Overall Study|Lack of Efficacy|0|||
161438930|NCT01588522|583001364|FG000|Overall Study|Adverse Event|0|||
161438931|NCT01588522|583001365|FG001|Overall Study|Adverse Event|0|||
161438932|NCT01588522|583001366|FG002|Overall Study|Adverse Event|0|||
161438933|NCT01588522|583001367|FG003|Overall Study|Adverse Event|1|||
161438934|NCT01588522|583001368|FG004|Overall Study|Adverse Event|0|||
161438935|NCT01588522|583001369|FG005|Overall Study|Adverse Event|0|||
161438936|NCT01588522|583001364|FG000|Overall Study|Grade 2 alopecia|1|||
161438937|NCT01588522|583001365|FG001|Overall Study|Grade 2 alopecia|0|||
161438938|NCT01588522|583001366|FG002|Overall Study|Grade 2 alopecia|0|||
161438939|NCT01588522|583001367|FG003|Overall Study|Grade 2 alopecia|0|||
161438940|NCT01588522|583001368|FG004|Overall Study|Grade 2 alopecia|0|||
161438941|NCT01588522|583001369|FG005|Overall Study|Grade 2 alopecia|0|||
161438942|NCT01588522|583001364|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
161438943|NCT01588522|583001365|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
161438944|NCT01588522|583001366|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
161438945|NCT01588522|583001367|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
161438946|NCT01588522|583001368|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
161438947|NCT01588522|583001369|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
161438948|NCT01588522|583001364|FG000|Overall Study|Taken off taxane-based regimen|0|||
161438949|NCT01588522|583001365|FG001|Overall Study|Taken off taxane-based regimen|0|||
161438950|NCT01588522|583001366|FG002|Overall Study|Taken off taxane-based regimen|0|||
161438951|NCT01588522|583001367|FG003|Overall Study|Taken off taxane-based regimen|1|||
161438952|NCT01588522|583001368|FG004|Overall Study|Taken off taxane-based regimen|0|||
161438953|NCT01588522|583001369|FG005|Overall Study|Taken off taxane-based regimen|0|||
161438954|NCT01588522|583001364|FG000|Overall Study|Did not initiate chemotherapy|0|||
161438955|NCT01588522|583001365|FG001|Overall Study|Did not initiate chemotherapy|0|||
161438956|NCT01588522|583001366|FG002|Overall Study|Did not initiate chemotherapy|0|||
161438957|NCT01588522|583001367|FG003|Overall Study|Did not initiate chemotherapy|0|||
161438958|NCT01588522|583001368|FG004|Overall Study|Did not initiate chemotherapy|1|||
161438959|NCT01588522|583001369|FG005|Overall Study|Did not initiate chemotherapy|0|||
161438960|NCT02855125|583001374|FG000|Overall Study|Withdrawal by Subject|2|||
161438961|NCT02855125|583001375|FG001|Overall Study|Withdrawal by Subject|2|||
161438962|NCT02855125|583001374|FG000|Overall Study|Clinical Disease Progression|5|||
161438963|NCT02855125|583001375|FG001|Overall Study|Clinical Disease Progression|4|||
161438964|NCT02855125|583001374|FG000|Overall Study|Radiologic Disease Progression|36|||
161438965|NCT02855125|583001375|FG001|Overall Study|Radiologic Disease Progression|39|||
161438966|NCT02855125|583001374|FG000|Overall Study|Adverse Event|11|||
161438967|NCT02855125|583001375|FG001|Overall Study|Adverse Event|7|||
161438968|NCT02855125|583001374|FG000|Overall Study|Physician Decision|1|||
161438969|NCT02855125|583001375|FG001|Overall Study|Physician Decision|0|||
161438970|NCT02855125|583001374|FG000|Overall Study|On Treatment|9|||
161438971|NCT02855125|583001375|FG001|Overall Study|On Treatment|11|||
161438972|NCT02855125|583001374|FG000|Overall Study|Randomized but not treated|0|||
161438973|NCT02855125|583001375|FG001|Overall Study|Randomized but not treated|1|||
161438974|NCT04467905|583001376|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
161438975|NCT04467905|583001377|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
161438976|NCT04467905|583001378|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
161438977|NCT04467905|583001376|FG000|Overall Study|Conversion to SR|0|||
161438978|NCT04467905|583001377|FG001|Overall Study|Conversion to SR|0|||
161438979|NCT04467905|583001378|FG002|Overall Study|Conversion to SR|3|||
161438980|NCT04467905|583001376|FG000|Overall Study|Technical issue with Holter ECG|0|||
161898276|NCT00141518|584675608|FG000|Overall Study|Adverse Event|7|||
161438981|NCT04467905|583001377|FG001|Overall Study|Technical issue with Holter ECG|0|||
161438982|NCT04467905|583001378|FG002|Overall Study|Technical issue with Holter ECG|3|||
161438983|NCT04467905|583001376|FG000|Overall Study|Hemodynamic instability|0|||
161438984|NCT04467905|583001377|FG001|Overall Study|Hemodynamic instability|0|||
161438985|NCT04467905|583001378|FG002|Overall Study|Hemodynamic instability|1|||
161438986|NCT04467905|583001376|FG000|Overall Study|Site misinterpretation of protocol|0|||
161438987|NCT04467905|583001377|FG001|Overall Study|Site misinterpretation of protocol|0|||
161438988|NCT04467905|583001378|FG002|Overall Study|Site misinterpretation of protocol|1|||
161438989|NCT02514083|583001384|FG000|Overall Study|Adverse Event|1|||
161438990|NCT02017405|583001385|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
161438991|NCT02017405|583001386|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
161438992|NCT02017405|583001387|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
161438993|NCT02017405|583001388|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
161785138|NCT02176642|584257505|FG001|Overall Study|Withdrawal by Subject|1|||
161785139|NCT01309828|584257506|FG000|Overall Study|Adverse Event|10|||
161785140|NCT01309828|584257507|FG001|Overall Study|Adverse Event|11|||
161785141|NCT01309828|584257506|FG000|Overall Study|Voluntary Withdrawal|5|||
161785142|NCT01309828|584257507|FG001|Overall Study|Voluntary Withdrawal|4|||
161785143|NCT01309828|584257506|FG000|Overall Study|Major Protocol Deviation|0|||
161785144|NCT01309828|584257507|FG001|Overall Study|Major Protocol Deviation|1|||
161785145|NCT01309828|584257506|FG000|Overall Study|Other|1|||
161785146|NCT01309828|584257507|FG001|Overall Study|Other|0|||
161785147|NCT00295620|584257508|FG000|Overall Study|Lost to Follow-up|9|||
161785148|NCT00295620|584257509|FG001|Overall Study|Lost to Follow-up|5|||
161785149|NCT00295620|584257508|FG000|Overall Study|Withdrawal by Subject|37|||
161785150|NCT00295620|584257509|FG001|Overall Study|Withdrawal by Subject|50|||
161785151|NCT00295620|584257508|FG000|Overall Study|Death|206|||
161785152|NCT00295620|584257509|FG001|Overall Study|Death|207|||
161785153|NCT00295620|584257508|FG000|Overall Study|Other reasons|10|||
161785154|NCT00295620|584257509|FG001|Overall Study|Other reasons|9|||
161785155|NCT00295620|584257508|FG000|Overall Study|Discontinuation by sponsor|580|||
161785156|NCT00295620|584257509|FG001|Overall Study|Discontinuation by sponsor|593|||
161785157|NCT00295620|584257508|FG000|Overall Study|Protocol Violation|30|||
161785158|NCT00295620|584257509|FG001|Overall Study|Protocol Violation|32|||
161785159|NCT00217971|584257510|FG000|Overall Study|Adverse Event|1|||
161785160|NCT00217971|584257511|FG001|Overall Study|Adverse Event|1|||
161785161|NCT00217971|584257510|FG000|Overall Study|Lost to Follow-up|15|||
161785162|NCT00217971|584257511|FG001|Overall Study|Lost to Follow-up|19|||
161785163|NCT00217971|584257510|FG000|Overall Study|Physician Decision|0|||
161785164|NCT00217971|584257511|FG001|Overall Study|Physician Decision|1|||
161785165|NCT00217971|584257510|FG000|Overall Study|Withdrawal by Subject|7|||
161785166|NCT00217971|584257511|FG001|Overall Study|Withdrawal by Subject|12|||
161785167|NCT00217971|584257510|FG000|Overall Study|non compliant|1|||
161785168|NCT00217971|584257511|FG001|Overall Study|non compliant|0|||
161785169|NCT00808015|584257512|FG000|Overall Study|Death|1|||
161785170|NCT00808015|584257512|FG000|Overall Study|Lack of Efficacy|58|||
161785171|NCT00808015|584257512|FG000|Overall Study|Lost to Follow-up|76|||
161785172|NCT00808015|584257512|FG000|Overall Study|Participants not willing to participate|158|||
161785173|NCT00808015|584257512|FG000|Overall Study|Adverse Event|22|||
161438994|NCT02017405|583001389|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
161438995|NCT02017405|583001390|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
161438996|NCT02017405|583001385|FG000|Open-label Phase|Adverse Event|1|||
161438997|NCT02017405|583001386|FG001|Open-label Phase|Adverse Event|1|||
161438998|NCT02017405|583001387|FG002|Open-label Phase|Adverse Event|0|||
161438999|NCT02017405|583001388|FG003|Open-label Phase|Adverse Event|0|||
161439000|NCT02017405|583001389|FG004|Open-label Phase|Adverse Event|0|||
161439001|NCT02017405|583001390|FG005|Open-label Phase|Adverse Event|0|||
161439002|NCT01899040|583001391|FG000|Overall Study|Randomized in error|0|||
161439003|NCT01899040|583001392|FG001|Overall Study|Randomized in error|1|||
161439004|NCT01899040|583001393|FG002|Overall Study|Randomized in error|1|||
161439005|NCT01899040|583001391|FG000|Overall Study|Adverse Event|3|||
161439006|NCT01899040|583001392|FG001|Overall Study|Adverse Event|1|||
161439007|NCT01899040|583001393|FG002|Overall Study|Adverse Event|2|||
161439008|NCT01899040|583001391|FG000|Overall Study|Unspecified reasons|4|||
161439009|NCT01899040|583001392|FG001|Overall Study|Unspecified reasons|4|||
161439010|NCT01899040|583001393|FG002|Overall Study|Unspecified reasons|0|||
161439011|NCT01899040|583001391|FG000|Overall Study|Compliance issues|1|||
161439012|NCT01899040|583001392|FG001|Overall Study|Compliance issues|2|||
161439013|NCT01899040|583001393|FG002|Overall Study|Compliance issues|0|||
161439014|NCT04586205|583001402|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
161439015|NCT04586205|583001403|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
161439016|NCT02202759|583003182|FG000|Overall Study|Study Terminated by Sponsor|3|||
161439017|NCT02202759|583003183|FG001|Overall Study|Study Terminated by Sponsor|3|||
161439018|NCT02202759|583003184|FG002|Overall Study|Study Terminated by Sponsor|3|||
161439019|NCT02202759|583003182|FG000|Overall Study|Withdrawal by Subject|2|||
161439020|NCT02202759|583003183|FG001|Overall Study|Withdrawal by Subject|1|||
161439021|NCT02202759|583003184|FG002|Overall Study|Withdrawal by Subject|1|||
161439022|NCT02202759|583003182|FG000|Overall Study|Reason not Specified|4|||
161439023|NCT02202759|583003183|FG001|Overall Study|Reason not Specified|11|||
161439024|NCT02202759|583003184|FG002|Overall Study|Reason not Specified|10|||
161439025|NCT01590888|583003185|FG000|Overall Study|Adverse Event|3|||
161439026|NCT01590888|583003186|FG001|Overall Study|Adverse Event|0|||
161439027|NCT01590888|583003187|FG002|Overall Study|Adverse Event|1|||
161439028|NCT01590888|583003185|FG000|Overall Study|Lost to Follow-up|1|||
161439029|NCT01590888|583003186|FG001|Overall Study|Lost to Follow-up|0|||
161439030|NCT01590888|583003187|FG002|Overall Study|Lost to Follow-up|0|||
161439031|NCT04953728|583003188|FG000|Overall Study|Withdrawal by Subject|3|||
161439032|NCT04953728|583003188|FG000|Overall Study|Physician Decision|1|||
161439033|NCT01646125|583003189|FG000|Overall Study|Untreated|2|||
161439034|NCT01646125|583003190|FG001|Overall Study|Untreated|5|||
161439035|NCT01646125|583003189|FG000|Overall Study|Adverse Event|2|||
161439036|NCT01646125|583003190|FG001|Overall Study|Adverse Event|1|||
161439037|NCT01646125|583003189|FG000|Overall Study|Death|1|||
161439038|NCT01646125|583003190|FG001|Overall Study|Death|1|||
161439039|NCT01646125|583003189|FG000|Overall Study|Physician Decision|1|||
161439040|NCT01646125|583003190|FG001|Overall Study|Physician Decision|3|||
161439041|NCT01646125|583003189|FG000|Overall Study|Progressive disease|22|||
161439042|NCT01646125|583003190|FG001|Overall Study|Progressive disease|16|||
161439043|NCT01646125|583003189|FG000|Overall Study|Study terminated by sponsor|2|||
161439044|NCT01646125|583003190|FG001|Overall Study|Study terminated by sponsor|1|||
161439045|NCT01646125|583003189|FG000|Overall Study|Subject/Guardian decision|1|||
161439046|NCT01646125|583003190|FG001|Overall Study|Subject/Guardian decision|1|||
161439047|NCT02105662|583003191|FG000|Overall Study|Lost to Follow-up|5|||
161439048|NCT02105662|583003191|FG000|Overall Study|Withdrawal by Subject|1|||
161439049|NCT01417377|583003194|FG000|Overall Study|Lost to Follow-up|12|||
161439050|NCT01417377|583003194|FG000|Overall Study|Enrolled, but not treated|1|||
161439051|NCT02113982|583003196|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
161439052|NCT02113982|583003197|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
161439053|NCT02113982|583003198|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
161785174|NCT00808015|584257512|FG000|Overall Study|Other|25|||
161785175|NCT00808015|584257512|FG000|Overall Study|Enrolled but not treated|4|||
161785176|NCT00084617|584257524|FG000|Overall Study|Withdrawal by Subject|7|||
161785177|NCT00084617|584257524|FG000|Overall Study|Lack of Efficacy|1|||
161439054|NCT02113982|583003199|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
161439055|NCT02113982|583003200|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
161785178|NCT00084617|584257524|FG000|Overall Study|Protocol Violation|1|||
161439056|NCT02113982|583003201|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
161439057|NCT02113982|583003202|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
161785179|NCT01625286|584257525|FG000|Overall Study|Adverse Event|0|||
161439058|NCT02113982|583003203|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
161439059|NCT02113982|583003204|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
161439060|NCT02113982|583003205|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
161439061|NCT02113982|583003206|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
161439062|NCT02113982|583003207|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
161439063|NCT02113982|583003208|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
161439064|NCT02113982|583003209|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
161785180|NCT01625286|584257526|FG001|Overall Study|Adverse Event|0|||
161898277|NCT00141518|584675609|FG001|Overall Study|Adverse Event|5|||
161898278|NCT00141518|584675610|FG002|Overall Study|Adverse Event|2|||
161898279|NCT00141518|584675608|FG000|Overall Study|Withdrawal by Subject|2|||
161898280|NCT00141518|584675609|FG001|Overall Study|Withdrawal by Subject|0|||
161898281|NCT00141518|584675610|FG002|Overall Study|Withdrawal by Subject|2|||
161898282|NCT00141518|584675608|FG000|Overall Study|Protocol Violation|1|||
161898283|NCT00141518|584675609|FG001|Overall Study|Protocol Violation|1|||
161898284|NCT00141518|584675610|FG002|Overall Study|Protocol Violation|2|||
161898285|NCT00141518|584675608|FG000|Overall Study|Lack of Efficacy|5|||
161898286|NCT00141518|584675609|FG001|Overall Study|Lack of Efficacy|0|||
161898287|NCT00141518|584675610|FG002|Overall Study|Lack of Efficacy|0|||
161898288|NCT01001910|584675611|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
161898289|NCT03200548|584675612|FG000|Overall Study|Withdrawal by Subject|5|||
161898290|NCT03200548|584675613|FG001|Overall Study|Withdrawal by Subject|11|||
161898291|NCT03200548|584675614|FG002|Overall Study|Withdrawal by Subject|7|||
161898292|NCT03200548|584675615|FG003|Overall Study|Withdrawal by Subject|6|||
161898293|NCT01048541|584675619|FG000|Overall Study|Withdrawal by Subject|1|||
161898294|NCT01048541|584675620|FG001|Overall Study|Withdrawal by Subject|0|||
161898295|NCT01411852|584675622|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
161898296|NCT01411852|584675623|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
161898297|NCT01411852|584675622|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
161898298|NCT01411852|584675623|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
161898299|NCT01411852|584675622|FG000|Prehospital Intervention Phase|Found to be under age|0|||
161898300|NCT01411852|584675623|FG001|Prehospital Intervention Phase|Found to be under age|1|||
161898301|NCT01411852|584675622|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
161898302|NCT01411852|584675623|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
161898303|NCT01411852|584675622|FG000|Hospital Intervention Phase|Severe head injury|5|||
161898304|NCT01411852|584675623|FG001|Hospital Intervention Phase|Severe head injury|4|||
161898305|NCT01411852|584675622|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
161898306|NCT01411852|584675623|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
161898307|NCT01411852|584675622|FG000|Hospital Intervention Phase|Miscommunication error|1|||
161898308|NCT01411852|584675623|FG001|Hospital Intervention Phase|Miscommunication error|2|||
161898309|NCT01411852|584675622|FG000|Hospital Intervention Phase|CPR administered|3|||
161898310|NCT01411852|584675623|FG001|Hospital Intervention Phase|CPR administered|1|||
161898311|NCT01411852|584675622|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
161898312|NCT01411852|584675623|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
161898313|NCT01411852|584675622|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
161898314|NCT01411852|584675623|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
161898315|NCT01411852|584675622|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
161898316|NCT01411852|584675623|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
161898317|NCT01411852|584675622|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
161898318|NCT01411852|584675623|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
161898319|NCT01411852|584675622|FG000|Hospital Intervention Phase|Other ineligible|2|||
161898320|NCT01411852|584675623|FG001|Hospital Intervention Phase|Other ineligible|2|||
161898321|NCT01411852|584675622|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
161898322|NCT01411852|584675623|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
161898323|NCT01411852|584675622|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
161898324|NCT01411852|584675623|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
161898325|NCT01411852|584675622|FG000|Hospital Intervention Phase|Vascular access failed|1|||
161898326|NCT01411852|584675623|FG001|Hospital Intervention Phase|Vascular access failed|0|||
161898327|NCT05095311|584675624|FG000|Overall Study|Lost to Follow-up|7|||
161898328|NCT05095311|584675625|FG001|Overall Study|Lost to Follow-up|0|||
161898329|NCT05095311|584675626|FG002|Overall Study|Lost to Follow-up|0|||
161898330|NCT03283930|584675627|FG000|Overall Study|Scheduling conflict|8|||
161898331|NCT03283930|584675628|FG001|Overall Study|Scheduling conflict|10|||
161898332|NCT03283930|584675627|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
161898333|NCT03283930|584675628|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
161898334|NCT03283930|584675627|FG000|Overall Study|Technical software issue|2|||
161898335|NCT03283930|584675628|FG001|Overall Study|Technical software issue|2|||
161898336|NCT00805129|584675629|FG000|Overall Study|Not treated|1|||
161898337|NCT00571662|584675630|FG000|Overall Study|Withdrawal by Subject|2|||
161898338|NCT00571662|584675630|FG000|Overall Study|psychiatric instability|1|||
161898339|NCT00571662|584675630|FG000|Overall Study|Adverse Event|5|||
161898340|NCT02588664|584675631|FG000|Overall Study|Death|56|||
161898341|NCT02588664|584675632|FG001|Overall Study|Death|55|||
161898342|NCT02588664|584675631|FG000|Overall Study|Lost to Follow-up|1305|||
161898343|NCT02588664|584675632|FG001|Overall Study|Lost to Follow-up|990|||
161898344|NCT03681184|584675633|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
161898345|NCT03681184|584675634|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
161898346|NCT02500719|584675635|FG000|Overall Study|Lost to Follow-up|2|||
161898347|NCT02500719|584675636|FG001|Overall Study|Lost to Follow-up|3|||
161439065|NCT02113982|583003196|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
161439066|NCT02113982|583003197|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
161439067|NCT02113982|583003198|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
161439068|NCT02113982|583003199|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
161785181|NCT01625286|584257527|FG002|Overall Study|Adverse Event|0|||
161785182|NCT01625286|584257528|FG003|Overall Study|Adverse Event|0|||
161785183|NCT01625286|584257529|FG004|Overall Study|Adverse Event|1|||
161785184|NCT01625286|584257530|FG005|Overall Study|Adverse Event|2|||
161785185|NCT01625286|584257531|FG006|Overall Study|Adverse Event|1|||
161785186|NCT01625286|584257525|FG000|Overall Study|Death|0|||
161785187|NCT01625286|584257526|FG001|Overall Study|Death|0|||
161785188|NCT01625286|584257527|FG002|Overall Study|Death|1|||
161785189|NCT01625286|584257528|FG003|Overall Study|Death|1|||
161785190|NCT01625286|584257529|FG004|Overall Study|Death|0|||
161785191|NCT01625286|584257530|FG005|Overall Study|Death|11|||
161785192|NCT01625286|584257531|FG006|Overall Study|Death|16|||
161439069|NCT02113982|583003200|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
161439070|NCT02113982|583003201|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
161439071|NCT02113982|583003202|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
161439072|NCT02113982|583003203|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
161439073|NCT02113982|583003204|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
161439074|NCT02113982|583003205|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
161439075|NCT02113982|583003206|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
161439076|NCT02113982|583003207|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
161439077|NCT02113982|583003208|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
161439078|NCT02113982|583003209|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
161439079|NCT02113982|583003196|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439080|NCT02113982|583003197|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439081|NCT02113982|583003198|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439082|NCT02113982|583003199|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439083|NCT02113982|583003200|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439084|NCT02113982|583003201|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439085|NCT02113982|583003202|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
161439086|NCT02113982|583003203|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439087|NCT02113982|583003204|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439088|NCT02113982|583003205|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439089|NCT02113982|583003206|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439090|NCT02113982|583003207|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439091|NCT02113982|583003208|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439092|NCT02113982|583003209|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161439093|NCT02113982|583003196|FG000|Stage 1: Dose Escalation|Transplant|0|||
161439094|NCT02113982|583003197|FG001|Stage 1: Dose Escalation|Transplant|1|||
161439095|NCT02113982|583003198|FG002|Stage 1: Dose Escalation|Transplant|0|||
161439096|NCT02113982|583003199|FG003|Stage 1: Dose Escalation|Transplant|0|||
161439097|NCT02113982|583003200|FG004|Stage 1: Dose Escalation|Transplant|0|||
161439098|NCT02113982|583003201|FG005|Stage 1: Dose Escalation|Transplant|1|||
161439099|NCT02113982|583003202|FG006|Stage 1: Dose Escalation|Transplant|0|||
161439100|NCT02113982|583003203|FG007|Stage 1: Dose Escalation|Transplant|0|||
161439101|NCT02113982|583003204|FG008|Stage 1: Dose Escalation|Transplant|0|||
161439102|NCT02113982|583003205|FG009|Stage 1: Dose Escalation|Transplant|0|||
161439103|NCT02113982|583003206|FG010|Stage 1: Dose Escalation|Transplant|0|||
161439104|NCT02113982|583003207|FG011|Stage 1: Dose Escalation|Transplant|0|||
161439105|NCT02113982|583003208|FG012|Stage 1: Dose Escalation|Transplant|0|||
161439106|NCT02113982|583003209|FG013|Stage 1: Dose Escalation|Transplant|0|||
161439107|NCT02113982|583003196|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
161439108|NCT02113982|583003197|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
161439109|NCT02113982|583003198|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
161439110|NCT02113982|583003199|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
161439111|NCT02113982|583003200|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
161785193|NCT01625286|584257525|FG000|Overall Study|Withdrawal by Subject|0|||
161785194|NCT01625286|584257526|FG001|Overall Study|Withdrawal by Subject|1|||
161785195|NCT01625286|584257527|FG002|Overall Study|Withdrawal by Subject|0|||
161439112|NCT02113982|583003201|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
161439113|NCT02113982|583003202|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
161439114|NCT02113982|583003203|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
161439115|NCT02113982|583003204|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
161439116|NCT02113982|583003205|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
161439117|NCT02113982|583003206|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
161785196|NCT01625286|584257528|FG003|Overall Study|Withdrawal by Subject|1|||
161439118|NCT02113982|583003207|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
161785197|NCT01625286|584257529|FG004|Overall Study|Withdrawal by Subject|0|||
161785198|NCT01625286|584257530|FG005|Overall Study|Withdrawal by Subject|0|||
161785199|NCT01625286|584257531|FG006|Overall Study|Withdrawal by Subject|1|||
161785200|NCT01625286|584257525|FG000|Overall Study|Any reason not specifically recorded|0|||
161898348|NCT02500719|584675635|FG000|Overall Study|Trauma history|1|||
161898349|NCT02500719|584675636|FG001|Overall Study|Trauma history|0|||
161898350|NCT02500719|584675635|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
161898351|NCT02500719|584675636|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
161898352|NCT02500719|584675635|FG000|Overall Study|Did not meet criteria for PTSD|0|||
161898353|NCT02500719|584675636|FG001|Overall Study|Did not meet criteria for PTSD|1|||
161898354|NCT02500719|584675635|FG000|Overall Study|Claustrophobia|0|||
161898355|NCT02500719|584675636|FG001|Overall Study|Claustrophobia|1|||
161898356|NCT02500719|584675635|FG000|Overall Study|History of head trauma|0|||
161898357|NCT02500719|584675636|FG001|Overall Study|History of head trauma|1|||
161898358|NCT00154375|584675637|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
161898359|NCT00154375|584675638|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
161898360|NCT00154375|584675637|FG000|Overall Study|Adverse Event|18|||
161898361|NCT00154375|584675638|FG001|Overall Study|Adverse Event|20|||
161898362|NCT00154375|584675637|FG000|Overall Study|Withdrawal by Subject|14|||
161898363|NCT00154375|584675638|FG001|Overall Study|Withdrawal by Subject|10|||
161898364|NCT00154375|584675637|FG000|Overall Study|Death|5|||
161898365|NCT00154375|584675638|FG001|Overall Study|Death|13|||
161898366|NCT00154375|584675637|FG000|Overall Study|Study drug no longer required|5|||
161898367|NCT00154375|584675638|FG001|Overall Study|Study drug no longer required|3|||
161898368|NCT00154375|584675637|FG000|Overall Study|Lost to Follow-up|2|||
161898369|NCT00154375|584675638|FG001|Overall Study|Lost to Follow-up|1|||
161898370|NCT00154375|584675637|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161898371|NCT00154375|584675638|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161898372|NCT00154375|584675637|FG000|Overall Study|Protocol Violation|0|||
161898373|NCT00154375|584675638|FG001|Overall Study|Protocol Violation|1|||
161898374|NCT00154375|584675637|FG000|Overall Study|Suspected progression of disease|44|||
161898375|NCT00154375|584675638|FG001|Overall Study|Suspected progression of disease|30|||
161898376|NCT00792116|584675639|FG000|Overall Study|Lost to Follow-up|0|||
161898377|NCT00792116|584675640|FG001|Overall Study|Lost to Follow-up|1|||
161898378|NCT00792116|584675639|FG000|Overall Study|Discontnued intervention|1|||
161898379|NCT00792116|584675640|FG001|Overall Study|Discontnued intervention|0|||
161898380|NCT00103285|584677791|FG000|Induction|Adverse Event|14|||
161898381|NCT00103285|584677792|FG001|Induction|Adverse Event|0|||
161898382|NCT00103285|584677793|FG002|Induction|Adverse Event|0|||
161898383|NCT00103285|584677794|FG003|Induction|Adverse Event|0|||
161898384|NCT00103285|584677795|FG004|Induction|Adverse Event|0|||
161898385|NCT00103285|584677796|FG005|Induction|Adverse Event|0|||
161898386|NCT00103285|584677797|FG006|Induction|Adverse Event|0|||
161898387|NCT00103285|584677798|FG007|Induction|Adverse Event|0|||
161898388|NCT00103285|584677791|FG000|Induction|Death|24|||
161898389|NCT00103285|584677792|FG001|Induction|Death|0|||
161898390|NCT00103285|584677793|FG002|Induction|Death|0|||
161898391|NCT00103285|584677794|FG003|Induction|Death|0|||
161898392|NCT00103285|584677795|FG004|Induction|Death|0|||
161898393|NCT00103285|584677796|FG005|Induction|Death|0|||
161898394|NCT00103285|584677797|FG006|Induction|Death|0|||
161898395|NCT00103285|584677798|FG007|Induction|Death|0|||
161898396|NCT00103285|584677791|FG000|Induction|Physician Decision|103|||
161898397|NCT00103285|584677792|FG001|Induction|Physician Decision|0|||
161898398|NCT00103285|584677793|FG002|Induction|Physician Decision|0|||
161898399|NCT00103285|584677794|FG003|Induction|Physician Decision|0|||
161898400|NCT00103285|584677795|FG004|Induction|Physician Decision|0|||
161898401|NCT00103285|584677796|FG005|Induction|Physician Decision|0|||
161898402|NCT00103285|584677797|FG006|Induction|Physician Decision|0|||
161898403|NCT00103285|584677798|FG007|Induction|Physician Decision|0|||
161898404|NCT00103285|584677791|FG000|Induction|Withdrawal by Subject|1|||
161898405|NCT00103285|584677792|FG001|Induction|Withdrawal by Subject|0|||
161898406|NCT00103285|584677793|FG002|Induction|Withdrawal by Subject|0|||
161898407|NCT00103285|584677794|FG003|Induction|Withdrawal by Subject|0|||
161898408|NCT00103285|584677795|FG004|Induction|Withdrawal by Subject|0|||
161898409|NCT00103285|584677796|FG005|Induction|Withdrawal by Subject|0|||
161898410|NCT00103285|584677797|FG006|Induction|Withdrawal by Subject|0|||
161898411|NCT00103285|584677798|FG007|Induction|Withdrawal by Subject|0|||
161898412|NCT00103285|584677791|FG000|Induction|Ineligible|43|||
161898413|NCT00103285|584677792|FG001|Induction|Ineligible|0|||
161898414|NCT00103285|584677793|FG002|Induction|Ineligible|0|||
161898415|NCT00103285|584677794|FG003|Induction|Ineligible|0|||
161898416|NCT00103285|584677795|FG004|Induction|Ineligible|0|||
161898417|NCT00103285|584677796|FG005|Induction|Ineligible|0|||
161898418|NCT00103285|584677797|FG006|Induction|Ineligible|0|||
161898419|NCT00103285|584677798|FG007|Induction|Ineligible|0|||
161898420|NCT00103285|584677791|FG000|Induction|Refusal|906|||
161898421|NCT00103285|584677792|FG001|Induction|Refusal|0|||
161898422|NCT00103285|584677793|FG002|Induction|Refusal|0|||
161898423|NCT00103285|584677794|FG003|Induction|Refusal|0|||
161898424|NCT00103285|584677795|FG004|Induction|Refusal|0|||
161898425|NCT00103285|584677796|FG005|Induction|Refusal|0|||
161898426|NCT00103285|584677797|FG006|Induction|Refusal|0|||
161898427|NCT00103285|584677798|FG007|Induction|Refusal|0|||
161898428|NCT00103285|584677791|FG000|Induction|Other|258|||
161898429|NCT00103285|584677792|FG001|Induction|Other|0|||
161898430|NCT00103285|584677793|FG002|Induction|Other|0|||
161785201|NCT01625286|584257526|FG001|Overall Study|Any reason not specifically recorded|0|||
161785202|NCT01625286|584257527|FG002|Overall Study|Any reason not specifically recorded|0|||
161785203|NCT01625286|584257528|FG003|Overall Study|Any reason not specifically recorded|0|||
161785204|NCT01625286|584257529|FG004|Overall Study|Any reason not specifically recorded|0|||
161785205|NCT01625286|584257530|FG005|Overall Study|Any reason not specifically recorded|1|||
161785206|NCT01625286|584257531|FG006|Overall Study|Any reason not specifically recorded|0|||
161785207|NCT01625286|584257525|FG000|Overall Study|Progressive disease|6|||
161785208|NCT01625286|584257526|FG001|Overall Study|Progressive disease|3|||
161785209|NCT01625286|584257527|FG002|Overall Study|Progressive disease|4|||
161785210|NCT01625286|584257528|FG003|Overall Study|Progressive disease|5|||
161785211|NCT01625286|584257529|FG004|Overall Study|Progressive disease|5|||
161785212|NCT01625286|584257530|FG005|Overall Study|Progressive disease|0|||
161785213|NCT01625286|584257531|FG006|Overall Study|Progressive disease|0|||
161785214|NCT01625286|584257525|FG000|Overall Study|Lost to Follow-up|0|||
161785215|NCT01625286|584257526|FG001|Overall Study|Lost to Follow-up|0|||
161785216|NCT01625286|584257527|FG002|Overall Study|Lost to Follow-up|0|||
161785217|NCT01625286|584257528|FG003|Overall Study|Lost to Follow-up|0|||
161785218|NCT01625286|584257529|FG004|Overall Study|Lost to Follow-up|0|||
161785219|NCT01625286|584257530|FG005|Overall Study|Lost to Follow-up|0|||
161785220|NCT01625286|584257531|FG006|Overall Study|Lost to Follow-up|1|||
161785221|NCT04355767|584257532|FG000|Overall Study|Withdrawal by Subject|2|||
161785222|NCT04355767|584257533|FG001|Overall Study|Withdrawal by Subject|2|||
161785223|NCT04355767|584257532|FG000|Overall Study|Death|5|||
161785224|NCT04355767|584257533|FG001|Overall Study|Death|1|||
161785225|NCT04523831|584257540|FG000|Overall Study|Lost to Follow-up|15|||
161785226|NCT04523831|584257541|FG001|Overall Study|Lost to Follow-up|17|||
161785227|NCT04523831|584257540|FG000|Overall Study|Death|0|||
161785228|NCT04523831|584257541|FG001|Overall Study|Death|3|||
161785229|NCT04523831|584257540|FG000|Overall Study|Adverse Event|2|||
161785230|NCT04523831|584257541|FG001|Overall Study|Adverse Event|0|||
161785231|NCT00995930|584257542|FG000|Overall Study|Protocol deviation|2|||
161785232|NCT00995930|584257543|FG001|Overall Study|Protocol deviation|5|||
161785233|NCT00995930|584257542|FG000|Overall Study|Death|0|||
161785234|NCT00995930|584257543|FG001|Overall Study|Death|1|||
161898431|NCT00103285|584677794|FG003|Induction|Other|0|||
161898432|NCT00103285|584677795|FG004|Induction|Other|0|||
161785235|NCT00995930|584257542|FG000|Overall Study|Administrative problems|4|||
161785236|NCT00995930|584257543|FG001|Overall Study|Administrative problems|2|||
161785237|NCT00995930|584257542|FG000|Overall Study|Lost to Follow-up|1|||
161785238|NCT00995930|584257543|FG001|Overall Study|Lost to Follow-up|2|||
161785239|NCT00995930|584257542|FG000|Overall Study|Withdrawal by Subject|3|||
161785240|NCT00995930|584257543|FG001|Overall Study|Withdrawal by Subject|4|||
161785241|NCT00995930|584257542|FG000|Overall Study|Adverse Event|11|||
161785242|NCT00995930|584257543|FG001|Overall Study|Adverse Event|14|||
161785243|NCT00550420|584259178|FG000|Overall Study|Adverse Event|28|||
161785244|NCT00550420|584259178|FG000|Overall Study|Lost to Follow-up|8|||
161785245|NCT00550420|584259178|FG000|Overall Study|Protocol Violation|11|||
161785246|NCT00550420|584259178|FG000|Overall Study|Withdrawal by Subject|30|||
161785247|NCT00550420|584259178|FG000|Overall Study|Still in study at termination|206|||
161785248|NCT00550420|584259178|FG000|Overall Study|Missing|2|||
161785249|NCT00550420|584259178|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
161785250|NCT00550420|584259178|FG000|Overall Study|Investigators opinion|1|||
161785251|NCT00550420|584259178|FG000|Overall Study|Lack of curative effect|1|||
161785252|NCT00550420|584259178|FG000|Overall Study|Unethical stop of enrollment|2|||
161785253|NCT00550420|584259178|FG000|Overall Study|Caregiver's decision to withdraw|1|||
161785254|NCT00550420|584259178|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
161785255|NCT00550420|584259178|FG000|Overall Study|Exclusion criteria|1|||
161785256|NCT00550420|584259178|FG000|Overall Study|Prohibited medicine|1|||
161785257|NCT01169649|584259186|FG000|Overall Study|Patient Not Treated|3|||
161785258|NCT00534092|584259187|FG000|Overall Study|Lost to Follow-up|1|||
161785259|NCT00534092|584259188|FG001|Overall Study|Lost to Follow-up|0|||
161785260|NCT00534092|584259187|FG000|Overall Study|personal reasons/family concerns|1|||
161785261|NCT00534092|584259188|FG001|Overall Study|personal reasons/family concerns|0|||
161785262|NCT02919475|584259189|FG000|Overall Study|Adverse Event|3|||
161785263|NCT02919475|584259190|FG001|Overall Study|Adverse Event|3|||
161898433|NCT00103285|584677796|FG005|Induction|Other|0|||
161439119|NCT02113982|583003208|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
161439120|NCT02113982|583003209|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
161439121|NCT02113982|583003196|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
161439122|NCT02113982|583003197|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
161439123|NCT02113982|583003198|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
161439124|NCT02113982|583003199|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
161439125|NCT02113982|583003200|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
161439126|NCT02113982|583003201|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
161439127|NCT02113982|583003202|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
161439128|NCT02113982|583003203|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
161439129|NCT02113982|583003204|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
161439130|NCT02113982|583003205|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
161439131|NCT02113982|583003206|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
161439132|NCT02113982|583003207|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
161439133|NCT02113982|583003208|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
161439134|NCT02113982|583003209|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
161439135|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
161439136|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
161439137|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
161439138|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
161439139|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
161439140|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
161439141|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
161439142|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
161439143|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
161439144|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
161439145|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
161439146|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
161439147|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
161439148|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
161439149|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
161785264|NCT02919475|584259191|FG002|Overall Study|Adverse Event|3|||
161785265|NCT02919475|584259192|FG003|Overall Study|Adverse Event|9|||
161785266|NCT02919475|584259193|FG004|Overall Study|Adverse Event|2|||
161898434|NCT00103285|584677797|FG006|Induction|Other|0|||
161439150|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
161439151|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
161439152|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
161439153|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
161439154|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
161785267|NCT02919475|584259189|FG000|Overall Study|Death|0|||
161785268|NCT02919475|584259190|FG001|Overall Study|Death|1|||
161785269|NCT02919475|584259191|FG002|Overall Study|Death|0|||
161785270|NCT02919475|584259192|FG003|Overall Study|Death|0|||
161785271|NCT02919475|584259193|FG004|Overall Study|Death|0|||
161898435|NCT00103285|584677798|FG007|Induction|Other|0|||
161439155|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
161439156|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
161439157|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
161439158|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
161439159|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
161439160|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
161439161|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
161439162|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
161439163|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439164|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439165|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439166|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439167|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439168|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439169|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439170|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
161439171|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439172|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
161439173|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
161439174|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439175|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439176|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
161439177|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439178|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439179|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439180|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439181|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439182|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439183|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439184|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
161439185|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439186|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
161439187|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439188|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439189|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439190|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161439191|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439192|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439193|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439194|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439195|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439196|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439197|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439198|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
161439199|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439200|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439201|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439202|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439203|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439204|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
161439205|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Transplant|0|||
161439206|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Transplant|0|||
161439207|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Transplant|0|||
161439208|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Transplant|0|||
161439209|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Transplant|0|||
161439210|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Transplant|0|||
161439211|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Transplant|0|||
161439212|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Transplant|0|||
161439213|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Transplant|0|||
161439214|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Transplant|4|||
161439215|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Transplant|2|||
161439216|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Transplant|0|||
161439217|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Transplant|0|||
161439218|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Transplant|0|||
161439219|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
161439220|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
161439221|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
161439222|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
161439223|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
161439224|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
161439225|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
161439226|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
161439227|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
161439228|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
161439229|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
161439230|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
161439231|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
161439232|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
161439233|NCT02113982|583003196|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
161439234|NCT02113982|583003197|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
161439235|NCT02113982|583003198|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
161439236|NCT02113982|583003199|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
161439237|NCT02113982|583003200|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
161898436|NCT00103285|584677791|FG000|Response Assignment|Adverse Event|0|||
161898437|NCT00103285|584677792|FG001|Response Assignment|Adverse Event|8|||
161898438|NCT00103285|584677793|FG002|Response Assignment|Adverse Event|3|||
161898439|NCT00103285|584677794|FG003|Response Assignment|Adverse Event|2|||
161898440|NCT00103285|584677795|FG004|Response Assignment|Adverse Event|3|||
161898441|NCT00103285|584677796|FG005|Response Assignment|Adverse Event|1|||
161898442|NCT00103285|584677797|FG006|Response Assignment|Adverse Event|1|||
161898443|NCT00103285|584677798|FG007|Response Assignment|Adverse Event|2|||
161898444|NCT00103285|584677791|FG000|Response Assignment|Death|0|||
161898445|NCT00103285|584677792|FG001|Response Assignment|Death|5|||
161898446|NCT00103285|584677793|FG002|Response Assignment|Death|2|||
161898447|NCT00103285|584677794|FG003|Response Assignment|Death|2|||
161898448|NCT00103285|584677795|FG004|Response Assignment|Death|3|||
161898449|NCT00103285|584677796|FG005|Response Assignment|Death|1|||
161898450|NCT00103285|584677797|FG006|Response Assignment|Death|0|||
161898451|NCT00103285|584677798|FG007|Response Assignment|Death|8|||
161898452|NCT00103285|584677791|FG000|Response Assignment|Lost to Follow-up|0|||
161898453|NCT00103285|584677792|FG001|Response Assignment|Lost to Follow-up|9|||
161898454|NCT00103285|584677793|FG002|Response Assignment|Lost to Follow-up|5|||
161898455|NCT00103285|584677794|FG003|Response Assignment|Lost to Follow-up|5|||
161898456|NCT00103285|584677795|FG004|Response Assignment|Lost to Follow-up|1|||
161898457|NCT00103285|584677796|FG005|Response Assignment|Lost to Follow-up|2|||
161898458|NCT00103285|584677797|FG006|Response Assignment|Lost to Follow-up|2|||
161898459|NCT00103285|584677798|FG007|Response Assignment|Lost to Follow-up|5|||
161898460|NCT00103285|584677791|FG000|Response Assignment|Physician Decision|0|||
161898461|NCT00103285|584677792|FG001|Response Assignment|Physician Decision|13|||
161898462|NCT00103285|584677793|FG002|Response Assignment|Physician Decision|14|||
161898463|NCT00103285|584677794|FG003|Response Assignment|Physician Decision|9|||
161898464|NCT00103285|584677795|FG004|Response Assignment|Physician Decision|13|||
161898465|NCT00103285|584677796|FG005|Response Assignment|Physician Decision|7|||
161898466|NCT00103285|584677797|FG006|Response Assignment|Physician Decision|4|||
161898467|NCT00103285|584677798|FG007|Response Assignment|Physician Decision|35|||
161898468|NCT00103285|584677791|FG000|Response Assignment|Protocol Violation|0|||
161898469|NCT00103285|584677792|FG001|Response Assignment|Protocol Violation|2|||
161898470|NCT00103285|584677793|FG002|Response Assignment|Protocol Violation|0|||
161898471|NCT00103285|584677794|FG003|Response Assignment|Protocol Violation|0|||
161898472|NCT00103285|584677795|FG004|Response Assignment|Protocol Violation|0|||
161898473|NCT00103285|584677796|FG005|Response Assignment|Protocol Violation|0|||
161898474|NCT00103285|584677797|FG006|Response Assignment|Protocol Violation|0|||
161898475|NCT00103285|584677798|FG007|Response Assignment|Protocol Violation|0|||
161898476|NCT00103285|584677791|FG000|Response Assignment|Withdrawal by Subject|0|||
161898477|NCT00103285|584677792|FG001|Response Assignment|Withdrawal by Subject|4|||
161898478|NCT00103285|584677793|FG002|Response Assignment|Withdrawal by Subject|1|||
161898479|NCT00103285|584677794|FG003|Response Assignment|Withdrawal by Subject|1|||
161898480|NCT00103285|584677795|FG004|Response Assignment|Withdrawal by Subject|2|||
161898481|NCT00103285|584677796|FG005|Response Assignment|Withdrawal by Subject|2|||
161898482|NCT00103285|584677797|FG006|Response Assignment|Withdrawal by Subject|0|||
161898483|NCT00103285|584677798|FG007|Response Assignment|Withdrawal by Subject|2|||
161898484|NCT00103285|584677791|FG000|Response Assignment|Ineligible|0|||
161898485|NCT00103285|584677792|FG001|Response Assignment|Ineligible|8|||
161898486|NCT00103285|584677793|FG002|Response Assignment|Ineligible|6|||
161898487|NCT00103285|584677794|FG003|Response Assignment|Ineligible|2|||
161439238|NCT02113982|583003201|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
161439239|NCT02113982|583003202|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
161898488|NCT00103285|584677795|FG004|Response Assignment|Ineligible|0|||
161898489|NCT00103285|584677796|FG005|Response Assignment|Ineligible|3|||
161898490|NCT00103285|584677797|FG006|Response Assignment|Ineligible|1|||
161439240|NCT02113982|583003203|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
161439241|NCT02113982|583003204|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
161898491|NCT00103285|584677798|FG007|Response Assignment|Ineligible|5|||
161898492|NCT00103285|584677791|FG000|Response Assignment|Refusal|0|||
161898493|NCT00103285|584677792|FG001|Response Assignment|Refusal|53|||
161898494|NCT00103285|584677793|FG002|Response Assignment|Refusal|5|||
161898495|NCT00103285|584677794|FG003|Response Assignment|Refusal|3|||
161898496|NCT00103285|584677795|FG004|Response Assignment|Refusal|25|||
161439242|NCT02113982|583003205|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
161439243|NCT02113982|583003206|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
161439244|NCT02113982|583003207|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
161439245|NCT02113982|583003208|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
161439246|NCT02113982|583003209|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
161439247|NCT02113982|583003196|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439248|NCT02113982|583003197|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439249|NCT02113982|583003198|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439250|NCT02113982|583003199|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439251|NCT02113982|583003200|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439252|NCT02113982|583003201|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439253|NCT02113982|583003202|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439254|NCT02113982|583003203|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439255|NCT02113982|583003204|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439256|NCT02113982|583003205|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439257|NCT02113982|583003206|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439258|NCT02113982|583003207|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
161439259|NCT02113982|583003208|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439260|NCT02113982|583003209|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
161439261|NCT02113982|583003196|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439262|NCT02113982|583003197|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439263|NCT02113982|583003198|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439264|NCT02113982|583003199|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439265|NCT02113982|583003200|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439266|NCT02113982|583003201|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439267|NCT02113982|583003202|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439268|NCT02113982|583003203|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439269|NCT02113982|583003204|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439270|NCT02113982|583003205|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439271|NCT02113982|583003206|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439272|NCT02113982|583003207|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
161439273|NCT02113982|583003208|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439274|NCT02113982|583003209|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
161439275|NCT02113982|583003196|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439276|NCT02113982|583003197|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439277|NCT02113982|583003198|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439278|NCT02113982|583003199|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439279|NCT02113982|583003200|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439280|NCT02113982|583003201|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439281|NCT02113982|583003202|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439282|NCT02113982|583003203|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439283|NCT02113982|583003204|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439284|NCT02113982|583003205|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439285|NCT02113982|583003206|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439286|NCT02113982|583003207|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
161439287|NCT02113982|583003208|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439288|NCT02113982|583003209|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161439289|NCT02113982|583003196|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
161439290|NCT02113982|583003197|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
161439291|NCT02113982|583003198|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
161439292|NCT02113982|583003199|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
161439293|NCT02113982|583003200|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
161439294|NCT02113982|583003201|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
161439295|NCT02113982|583003202|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
161439296|NCT02113982|583003203|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
161439297|NCT02113982|583003204|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
161439298|NCT02113982|583003205|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
161439299|NCT02113982|583003206|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
161439300|NCT02113982|583003207|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
161439301|NCT02113982|583003208|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
161439302|NCT02113982|583003209|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
161439303|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439304|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439305|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439306|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439307|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439308|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439309|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439310|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439311|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439312|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439313|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161785272|NCT02919475|584259189|FG000|Overall Study|Lost to Follow-up|0|||
161785273|NCT02919475|584259190|FG001|Overall Study|Lost to Follow-up|0|||
161785274|NCT02919475|584259191|FG002|Overall Study|Lost to Follow-up|0|||
161785275|NCT02919475|584259192|FG003|Overall Study|Lost to Follow-up|1|||
161785276|NCT02919475|584259193|FG004|Overall Study|Lost to Follow-up|0|||
161785277|NCT02919475|584259189|FG000|Overall Study|Withdrawal by Subject|2|||
161785278|NCT02919475|584259190|FG001|Overall Study|Withdrawal by Subject|3|||
161785279|NCT02919475|584259191|FG002|Overall Study|Withdrawal by Subject|1|||
161785280|NCT02919475|584259192|FG003|Overall Study|Withdrawal by Subject|2|||
161785281|NCT02919475|584259193|FG004|Overall Study|Withdrawal by Subject|2|||
161785282|NCT02919475|584259189|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785283|NCT02919475|584259190|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785284|NCT02919475|584259191|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785285|NCT02919475|584259192|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785286|NCT02919475|584259193|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161785287|NCT02323295|584259194|FG000|Overall Study|Adverse Event|0|||
161785288|NCT02323295|584259195|FG001|Overall Study|Adverse Event|1|||
161785289|NCT02323295|584259194|FG000|Overall Study|Withdrawal by Subject|0|||
161785290|NCT02323295|584259195|FG001|Overall Study|Withdrawal by Subject|1|||
161785291|NCT02323295|584259194|FG000|Overall Study|Patient did not have surgery as planned.|0|||
161785292|NCT02323295|584259195|FG001|Overall Study|Patient did not have surgery as planned.|1|||
161785293|NCT02370784|584259196|FG000|Overall Study|Patient started prohibited medication|0|||
161785294|NCT02370784|584259197|FG001|Overall Study|Patient started prohibited medication|1|||
161785295|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161785296|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
161785297|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161785298|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161785299|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
161785300|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
161785301|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
161785302|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
161785303|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
161785304|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
161785305|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
161785306|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
161785307|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
161785308|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
161785309|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
161785310|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
161785311|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
161785312|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
161785313|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
161785314|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
161785315|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
161785316|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
161785317|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
161785318|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
161785319|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
161785320|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
161785321|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
161785322|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
161785323|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
161785324|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
161785325|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
161785326|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
161785327|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
161785328|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
161785329|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
161785330|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
161785331|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
161785332|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
161785333|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
161785334|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
161898497|NCT00103285|584677796|FG005|Response Assignment|Refusal|15|||
161898498|NCT00103285|584677797|FG006|Response Assignment|Refusal|30|||
161898499|NCT00103285|584677798|FG007|Response Assignment|Refusal|10|||
161898500|NCT00103285|584677791|FG000|Response Assignment|Other|0|||
161898501|NCT00103285|584677792|FG001|Response Assignment|Other|30|||
161785335|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161785336|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
161785337|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161785338|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161785339|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
161785340|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
161785341|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
161785342|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
161785343|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
161785344|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
161785345|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
161785346|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
161785347|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
161785348|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
161785349|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
161785350|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
161785351|NCT01456052|584259203|FG000|Overall Study|Adverse Event|1|||
161785352|NCT01456052|584259204|FG001|Overall Study|Adverse Event|1|||
161785353|NCT01456052|584259205|FG002|Overall Study|Adverse Event|2|||
161785354|NCT01456052|584259203|FG000|Overall Study|Consent withdrawn|0|||
161785355|NCT01456052|584259204|FG001|Overall Study|Consent withdrawn|2|||
161785356|NCT01456052|584259205|FG002|Overall Study|Consent withdrawn|1|||
161785357|NCT01456052|584259203|FG000|Overall Study|Protocol Violation|0|||
161785358|NCT01456052|584259204|FG001|Overall Study|Protocol Violation|1|||
161785359|NCT01456052|584259205|FG002|Overall Study|Protocol Violation|0|||
161785360|NCT01456052|584259203|FG000|Overall Study|Physician Decision|1|||
161785361|NCT01456052|584259204|FG001|Overall Study|Physician Decision|0|||
161785362|NCT01456052|584259205|FG002|Overall Study|Physician Decision|1|||
161785363|NCT01456052|584259203|FG000|Overall Study|Treatment Failure|0|||
161785364|NCT01456052|584259204|FG001|Overall Study|Treatment Failure|1|||
161785365|NCT01456052|584259205|FG002|Overall Study|Treatment Failure|1|||
161785366|NCT02762565|584259208|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
161785367|NCT01113710|584259209|FG000|Overall Study|Adverse Event|64|||
161785368|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy|41|||
161785369|NCT01113710|584259209|FG000|Overall Study|No Information Available|40|||
161785370|NCT01113710|584259209|FG000|Overall Study|Withdrawal by Subject|28|||
161785371|NCT01113710|584259209|FG000|Overall Study|Lost to Follow-up|20|||
161785372|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
161785373|NCT01113710|584259209|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
161785374|NCT01113710|584259209|FG000|Overall Study|Lack of Patient's Compliance|8|||
161785375|NCT01113710|584259209|FG000|Overall Study|Other|7|||
161785376|NCT01113710|584259209|FG000|Overall Study|Adverse Event/Other|5|||
161785377|NCT01113710|584259209|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
161785378|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy/Other|4|||
161785379|NCT01113710|584259209|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
161785380|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
161785381|NCT01113710|584259209|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
161785382|NCT01113710|584259209|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
161785383|NCT01113710|584259209|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
161785384|NCT01113710|584259209|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
161785385|NCT01113710|584259209|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
161785386|NCT01113710|584259209|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
161785387|NCT01113710|584259209|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
161785388|NCT01113710|584259209|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
161785389|NCT01113710|584259209|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
161785390|NCT01113710|584259209|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
161785391|NCT01113710|584259209|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
161785392|NCT02770716|584259211|FG000|Overall Study|Death|101|||
161439314|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439315|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
161439316|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
161439317|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161785393|NCT02770716|584259212|FG001|Overall Study|Death|45|||
161785394|NCT02770716|584259211|FG000|Overall Study|Withdrawal by Subject|4|||
161785395|NCT02770716|584259212|FG001|Overall Study|Withdrawal by Subject|2|||
161439318|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439319|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439320|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439321|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439322|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439323|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161785396|NCT02770716|584259211|FG000|Overall Study|Lost to Follow-up|1|||
161785397|NCT02770716|584259212|FG001|Overall Study|Lost to Follow-up|0|||
161785398|NCT02770716|584259211|FG000|Overall Study|Various reasons|6|||
161439324|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439325|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439326|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439327|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439328|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
161439329|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
161439330|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
161439331|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439332|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439333|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439334|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439335|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439336|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439337|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439338|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439339|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439340|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439341|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439342|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161439343|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
161439344|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
161439345|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439346|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439347|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439348|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439349|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439350|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439351|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439352|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439353|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439354|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439355|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161439356|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
161785399|NCT02770716|584259212|FG001|Overall Study|Various reasons|2|||
161785400|NCT01042977|584259213|FG000|Overall Study|Adverse Event|4|||
161785401|NCT01042977|584259214|FG001|Overall Study|Adverse Event|12|||
161785402|NCT01042977|584259213|FG000|Overall Study|Death|2|||
161785403|NCT01042977|584259214|FG001|Overall Study|Death|1|||
161785404|NCT01042977|584259213|FG000|Overall Study|Withdrawal by Subject|8|||
161785405|NCT01042977|584259214|FG001|Overall Study|Withdrawal by Subject|16|||
161785406|NCT01042977|584259213|FG000|Overall Study|Lost to Follow-up|0|||
161785407|NCT01042977|584259214|FG001|Overall Study|Lost to Follow-up|2|||
161785408|NCT01042977|584259213|FG000|Overall Study|Poor/non-compliance|3|||
161785409|NCT01042977|584259214|FG001|Overall Study|Poor/non-compliance|4|||
161785410|NCT01042977|584259213|FG000|Overall Study|Subject no longer meets study criteria|15|||
161785411|NCT01042977|584259214|FG001|Overall Study|Subject no longer meets study criteria|13|||
161785412|NCT01042977|584259213|FG000|Overall Study|Incorrect enrollment|6|||
161785413|NCT01042977|584259214|FG001|Overall Study|Incorrect enrollment|4|||
161785414|NCT01042977|584259213|FG000|Overall Study|Safety|0|||
161785415|NCT01042977|584259214|FG001|Overall Study|Safety|2|||
161785416|NCT01042977|584259213|FG000|Overall Study|Administrative reason by sponsor|0|||
161785417|NCT01042977|584259214|FG001|Overall Study|Administrative reason by sponsor|1|||
161785418|NCT01042977|584259213|FG000|Overall Study|Various|3|||
161785419|NCT01042977|584259214|FG001|Overall Study|Various|0|||
161785420|NCT02499354|584259215|FG000|Overall Study|Withdrawal by Subject|1|||
161785421|NCT02499354|584259216|FG001|Overall Study|Withdrawal by Subject|0|||
161785422|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Adverse Event|6|||
161785423|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161785424|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Adverse Event|3|||
161785425|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161785426|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161785427|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Physician Decision|0|||
161785428|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Physician Decision|1|||
161785429|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161785430|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
161785431|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
161785432|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
161785433|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
161785434|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
161785435|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
161785436|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
161785437|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
161785438|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
161785439|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
161785440|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
161785441|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
161785442|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161785443|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161785444|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161785445|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
161785446|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161785447|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161785448|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161785449|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
161785450|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161785451|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161785452|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161785453|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
161785454|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
161785455|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
161785456|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
161785457|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
161785458|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161785459|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161785460|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161785461|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
161785462|NCT01703741|584259223|FG000|Overall Study|Withdrawal by Subject|6|||
161785463|NCT01703741|584259223|FG000|Overall Study|Adverse Event|2|||
161785464|NCT01703741|584259223|FG000|Overall Study|Physician Decision|2|||
161785465|NCT01703741|584259223|FG000|Overall Study|Protocol Violation|1|||
161785466|NCT01703741|584259223|FG000|Overall Study|Lost to Follow-up|3|||
161785467|NCT01703741|584259223|FG000|Overall Study|Subject did not want to continue|2|||
161785468|NCT01703741|584259223|FG000|Overall Study|Subject cannot comply with study visits|1|||
161785469|NCT01703741|584259223|FG000|Overall Study|Subject started testosterone injections|1|||
161785470|NCT01170364|584259224|FG000|Overall Study|Protocol Violation|4|||
161785471|NCT01170364|584259225|FG001|Overall Study|Protocol Violation|1|||
161785472|NCT04132232|584259226|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
161785473|NCT04132232|584259227|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
161785474|NCT04132232|584259226|FG000|Overall Study|Lost to Follow-up|6|||
161785475|NCT04132232|584259227|FG001|Overall Study|Lost to Follow-up|7|||
161785476|NCT00368537|584259229|FG000|Randomization|No study drug dosed|13|||
161785477|NCT00368537|584259230|FG001|Randomization|No study drug dosed|6|||
161785478|NCT00368537|584259229|FG000|Baseline Participants|Lost to Follow-up|16|||
161785479|NCT00368537|584259230|FG001|Baseline Participants|Lost to Follow-up|17|||
161785480|NCT00368537|584259229|FG000|Baseline Participants|Withdrawal by Subject|6|||
161785481|NCT00368537|584259230|FG001|Baseline Participants|Withdrawal by Subject|4|||
161785482|NCT00368537|584259229|FG000|Baseline Participants|Death|1|||
161785483|NCT00368537|584259230|FG001|Baseline Participants|Death|2|||
161785484|NCT00368537|584259229|FG000|Baseline Participants|No susceptibility|1|||
161785485|NCT00368537|584259230|FG001|Baseline Participants|No susceptibility|0|||
161785486|NCT00368537|584259229|FG000|Baseline Participants|Patient uncompliant|0|||
161785487|NCT00368537|584259230|FG001|Baseline Participants|Patient uncompliant|1|||
161785488|NCT01368276|584259240|FG000|Overall Study|Death|1|||
161785489|NCT01368276|584259241|FG001|Overall Study|Death|10|||
161785490|NCT01427920|584259244|FG000|Overall Study|Adverse Event|1|||
161785491|NCT01427920|584259245|FG001|Overall Study|Adverse Event|2|||
161785492|NCT01427920|584259244|FG000|Overall Study|Lack of Efficacy|1|||
161785493|NCT01427920|584259245|FG001|Overall Study|Lack of Efficacy|0|||
161785494|NCT01427920|584259244|FG000|Overall Study|Protocol Violation|1|||
161785495|NCT01427920|584259245|FG001|Overall Study|Protocol Violation|3|||
161785496|NCT01427920|584259244|FG000|Overall Study|Withdrawal Criteria|4|||
161785497|NCT01427920|584259245|FG001|Overall Study|Withdrawal Criteria|4|||
161785498|NCT01427920|584259244|FG000|Overall Study|Unclassified|2|||
161785499|NCT01427920|584259245|FG001|Overall Study|Unclassified|8|||
161785500|NCT03341273|584259246|FG000|Overall Study|Lost to Follow-up|7|||
161785501|NCT03341273|584259247|FG001|Overall Study|Lost to Follow-up|7|||
161785502|NCT03341273|584259246|FG000|Overall Study|Withdrawal by Subject|4|||
161785503|NCT03341273|584259247|FG001|Overall Study|Withdrawal by Subject|2|||
161785504|NCT03341273|584259246|FG000|Overall Study|Physician Decision|1|||
161785505|NCT03341273|584259247|FG001|Overall Study|Physician Decision|0|||
161785506|NCT03341273|584259246|FG000|Overall Study|Protocol Violation|0|||
161785507|NCT03341273|584259247|FG001|Overall Study|Protocol Violation|1|||
161785508|NCT03341273|584259246|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161785509|NCT03341273|584259247|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
161785510|NCT03341273|584259246|FG000|Overall Study|Became ineligible after enrollment|1|||
161785511|NCT03341273|584259247|FG001|Overall Study|Became ineligible after enrollment|0|||
161785512|NCT03341273|584259246|FG000|Overall Study|Not Eligible at Enrollment|0|||
161785513|NCT03341273|584259247|FG001|Overall Study|Not Eligible at Enrollment|1|||
161785514|NCT03341273|584259246|FG000|Overall Study|Participant incarcerated|1|||
161785515|NCT03341273|584259247|FG001|Overall Study|Participant incarcerated|0|||
161785516|NCT01717456|584259254|FG000|End of Treatment|Physician Decision|0|||
161785517|NCT01717456|584259255|FG001|End of Treatment|Physician Decision|1|||
161785518|NCT01717456|584259254|FG000|End of Treatment|Lost to Follow-up|0|||
161785519|NCT01717456|584259255|FG001|End of Treatment|Lost to Follow-up|1|||
161785520|NCT01717456|584259254|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
161785521|NCT01717456|584259255|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
161785522|NCT02732561|584259256|FG000|Overall Study|Lost to Follow-up|1|||
161785523|NCT02732561|584259257|FG001|Overall Study|Lost to Follow-up|1|||
161785524|NCT02732561|584259256|FG000|Overall Study|Withdrawal by Subject|1|||
161785525|NCT02732561|584259257|FG001|Overall Study|Withdrawal by Subject|0|||
161785526|NCT03066440|584259260|FG000|Overall Study|Physician Decision|1|||
161785527|NCT03066440|584259261|FG001|Overall Study|Physician Decision|1|||
161785528|NCT03066440|584259260|FG000|Overall Study|Protocol Violation|0|||
161785529|NCT03066440|584259261|FG001|Overall Study|Protocol Violation|2|||
161785530|NCT00755937|584259262|FG000|Recruitment|Unknown if infliximab received|164|||
161785531|NCT00755937|584259262|FG000|Observational Follow-up|Lost to Follow-up|148|||
161785532|NCT03876873|584259263|FG000|Overall Study|Physician Decision|0|||
161785533|NCT03876873|584259264|FG001|Overall Study|Physician Decision|1|||
161785534|NCT03547531|584259265|FG000|Overall Study|not coming in data collection : sick|2|||
161785535|NCT03547531|584259266|FG001|Overall Study|not coming in data collection : sick|2|||
161785536|NCT03547531|584259265|FG000|Overall Study|having family occasion|0|||
161785537|NCT03547531|584259266|FG001|Overall Study|having family occasion|2|||
161785538|NCT02117479|584259276|FG000|Overall Study|Death|13|||
161785539|NCT02117479|584259277|FG001|Overall Study|Death|8|||
161785540|NCT02117479|584259276|FG000|Overall Study|Adverse Event|8|||
161785541|NCT02117479|584259277|FG001|Overall Study|Adverse Event|16|||
161785542|NCT02117479|584259276|FG000|Overall Study|Subject decision|8|||
161785543|NCT02117479|584259277|FG001|Overall Study|Subject decision|9|||
161785544|NCT02117479|584259276|FG000|Overall Study|Disease progression|104|||
161785545|NCT02117479|584259277|FG001|Overall Study|Disease progression|108|||
161785546|NCT02117479|584259276|FG000|Overall Study|Noncompliance with study treatment|1|||
161785547|NCT02117479|584259277|FG001|Overall Study|Noncompliance with study treatment|0|||
161785548|NCT02117479|584259276|FG000|Overall Study|Study terminated by the sponsor|4|||
161785549|NCT02117479|584259277|FG001|Overall Study|Study terminated by the sponsor|6|||
161785550|NCT02117479|584259276|FG000|Overall Study|Physician Decision|7|||
161785551|NCT02117479|584259277|FG001|Overall Study|Physician Decision|2|||
161785552|NCT02117479|584259276|FG000|Overall Study|Other unspecified|11|||
161785553|NCT02117479|584259277|FG001|Overall Study|Other unspecified|7|||
161785554|NCT01959230|584259280|FG000|Overall Study|Failure to follow study procedures|0|||
161785555|NCT01959230|584259281|FG001|Overall Study|Failure to follow study procedures|1|||
161785556|NCT01959230|584259280|FG000|Overall Study|Administrative reasons|2|||
161785557|NCT01959230|584259281|FG001|Overall Study|Administrative reasons|0|||
161785558|NCT01959230|584259280|FG000|Overall Study|Withdrawal by Subject|2|||
161785559|NCT01959230|584259281|FG001|Overall Study|Withdrawal by Subject|0|||
161785560|NCT00751998|584259284|FG000|Overall Study|Lost to Follow-up|7|||
161785561|NCT00751998|584259284|FG000|Overall Study|Death|11|||
161785562|NCT00751998|584259284|FG000|Overall Study|Withdrawal by Subject|2|||
161785563|NCT01223196|584259286|FG000|Overall Study|Lost to Follow-up|2|||
161785564|NCT01223196|584259287|FG001|Overall Study|Lost to Follow-up|0|||
161785565|NCT01223196|584259286|FG000|Overall Study|Physician Decision|1|||
161785566|NCT01223196|584259287|FG001|Overall Study|Physician Decision|0|||
161785567|NCT01223196|584259286|FG000|Overall Study|Withdrawal by Subject|1|||
161785568|NCT01223196|584259287|FG001|Overall Study|Withdrawal by Subject|0|||
161785569|NCT02629133|584259288|FG000|Overall Study|Lost to Follow-up|3|||
161785570|NCT02629133|584259289|FG001|Overall Study|Lost to Follow-up|1|||
161785571|NCT02629133|584259288|FG000|Overall Study|Withdrawal by Subject|1|||
161785572|NCT02629133|584259289|FG001|Overall Study|Withdrawal by Subject|1|||
161785573|NCT01238822|584259290|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
161785574|NCT02598193|584259291|FG000|Overall Study|Adverse Event|13|||
161785575|NCT02598193|584259291|FG000|Overall Study|Withdrawal by Subject|1|||
161785576|NCT02598193|584259291|FG000|Overall Study|Listed in active lung transplant list|1|||
161785577|NCT02598193|584259291|FG000|Overall Study|Does not want to take Nintedanib|1|||
161785578|NCT00447694|584259294|FG000|Overall Study|Adverse Event|2|||
161785579|NCT00447694|584259294|FG000|Overall Study|Abnormal laboratory value|1|||
161785580|NCT00447694|584259294|FG000|Overall Study|Abnormal test procedure result|1|||
161785581|NCT00447694|584259294|FG000|Overall Study|Withdrawal by Subject|2|||
161785582|NCT01169987|584259295|FG000|Overall Study|Withdrawal by Subject|3|||
161785583|NCT01169987|584259295|FG000|Overall Study|Lost to Follow-up|24|||
161785584|NCT01169987|584259295|FG000|Overall Study|Other|4|||
161785585|NCT00386100|584259297|FG000|Overall Study|Did not receive study medication|6|||
161785586|NCT00386100|584259298|FG001|Overall Study|Did not receive study medication|4|||
161785587|NCT00386100|584259297|FG000|Overall Study|Adverse Event|15|||
161785588|NCT00386100|584259298|FG001|Overall Study|Adverse Event|25|||
161785589|NCT00386100|584259297|FG000|Overall Study|Death|0|||
161785590|NCT00386100|584259298|FG001|Overall Study|Death|1|||
161785591|NCT00386100|584259297|FG000|Overall Study|Insufficient therapeutic effect|30|||
161785592|NCT00386100|584259298|FG001|Overall Study|Insufficient therapeutic effect|6|||
161785593|NCT00386100|584259297|FG000|Overall Study|Lost to Follow-up|29|||
161785594|NCT00386100|584259298|FG001|Overall Study|Lost to Follow-up|29|||
161785595|NCT00386100|584259297|FG000|Overall Study|Non-compliance|18|||
161785596|NCT00386100|584259298|FG001|Overall Study|Non-compliance|19|||
161785597|NCT00386100|584259297|FG000|Overall Study|Protocol Violation|5|||
161785598|NCT00386100|584259298|FG001|Overall Study|Protocol Violation|3|||
161785599|NCT00386100|584259297|FG000|Overall Study|Withdrawal by Subject|32|||
161785600|NCT00386100|584259298|FG001|Overall Study|Withdrawal by Subject|31|||
161785601|NCT00386100|584259297|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
161785602|NCT00386100|584259298|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
161785603|NCT00386100|584259297|FG000|Overall Study|BMD <2.5|1|||
161785604|NCT00386100|584259298|FG001|Overall Study|BMD <2.5|0|||
161785605|NCT00386100|584259297|FG000|Overall Study|Consecutive elevated Hba1C|1|||
161785606|NCT00386100|584259298|FG001|Overall Study|Consecutive elevated Hba1C|0|||
161785607|NCT00386100|584259297|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
161785608|NCT00386100|584259298|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
161785609|NCT00386100|584259297|FG000|Overall Study|Laboratory findings|1|||
161439357|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
161785610|NCT00386100|584259298|FG001|Overall Study|Laboratory findings|0|||
161785611|NCT00386100|584259297|FG000|Overall Study|Participant's concern due to CPK levels|1|||
161439358|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
161785612|NCT00386100|584259298|FG001|Overall Study|Participant's concern due to CPK levels|0|||
161785613|NCT00386100|584259297|FG000|Overall Study|Participant moving out of state|2|||
161785614|NCT00386100|584259298|FG001|Overall Study|Participant moving out of state|0|||
161785615|NCT00386100|584259297|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
161785616|NCT00386100|584259298|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
161785617|NCT00386100|584259297|FG000|Overall Study|Didn't meet entry criteria|1|||
161785618|NCT00386100|584259298|FG001|Overall Study|Didn't meet entry criteria|1|||
161785619|NCT00386100|584259297|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
161785620|NCT00386100|584259298|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
161785621|NCT00386100|584259297|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
161785622|NCT00386100|584259298|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
161785623|NCT00386100|584259297|FG000|Overall Study|Bad metabolic control & patient security|1|||
161785624|NCT00386100|584259298|FG001|Overall Study|Bad metabolic control & patient security|0|||
161785625|NCT00386100|584259297|FG000|Overall Study|Bone loss by DXA bone scan|1|||
161785626|NCT00386100|584259298|FG001|Overall Study|Bone loss by DXA bone scan|0|||
161785627|NCT00386100|584259297|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
161785628|NCT00386100|584259298|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
161785629|NCT00386100|584259297|FG000|Overall Study|7.6% bone loss|1|||
161785630|NCT00386100|584259298|FG001|Overall Study|7.6% bone loss|0|||
161785631|NCT00386100|584259297|FG000|Overall Study|Osteoporosis|0|||
161785632|NCT00386100|584259298|FG001|Overall Study|Osteoporosis|1|||
161785633|NCT00386100|584259297|FG000|Overall Study|Positive pregnancy test|1|||
161785634|NCT00386100|584259298|FG001|Overall Study|Positive pregnancy test|3|||
161785635|NCT00386100|584259297|FG000|Overall Study|Out of country for 5 months|1|||
161785636|NCT00386100|584259298|FG001|Overall Study|Out of country for 5 months|0|||
161785637|NCT00386100|584259297|FG000|Overall Study|Hb1Ac >8%|0|||
161785638|NCT00386100|584259298|FG001|Overall Study|Hb1Ac >8%|1|||
161785639|NCT00386100|584259297|FG000|Overall Study|Participant randomized in error|1|||
161785640|NCT00386100|584259298|FG001|Overall Study|Participant randomized in error|0|||
161785641|NCT00061945|584259302|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
161785642|NCT00061945|584259303|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
161785643|NCT00061945|584259302|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
161785644|NCT00061945|584259303|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
161785645|NCT00061945|584259302|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
161785646|NCT00061945|584259303|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
161785647|NCT00061945|584259302|FG000|Course IV: Alemtuzumab|Early exits|6|||
161785648|NCT00061945|584259303|FG001|Course IV: Alemtuzumab|Early exits|15|||
161785649|NCT03672396|584259304|FG000|Overall Study|Withdrawal by Subject|4|||
161785650|NCT03672396|584259304|FG000|Overall Study|Physician Decision|1|||
161785651|NCT03672396|584259304|FG000|Overall Study|Adverse Event|1|||
161785652|NCT03001011|584259309|FG000|Overall Study|Adverse Event|9|||
161785653|NCT03001011|584259310|FG001|Overall Study|Adverse Event|3|||
161785654|NCT03001011|584259309|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
161785655|NCT03001011|584259310|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
161785656|NCT03001011|584259309|FG000|Overall Study|Other than specified above|3|||
161785657|NCT03001011|584259310|FG001|Overall Study|Other than specified above|8|||
161785658|NCT04363736|584259311|FG000|Overall Study|Withdrawal by Subject|1|||
161785659|NCT04363736|584259312|FG001|Overall Study|Withdrawal by Subject|0|||
161785660|NCT04363736|584259311|FG000|Overall Study|Lost to Follow-up|10|||
161785661|NCT04363736|584259312|FG001|Overall Study|Lost to Follow-up|7|||
161785662|NCT04363736|584259311|FG000|Overall Study|Death|8|||
161785663|NCT04363736|584259312|FG001|Overall Study|Death|6|||
161785664|NCT03797222|584259313|FG000|Overall Study|Withdrawal by Subject|1|||
161785665|NCT01021137|584259314|FG000|Overall Study|Lost to Follow-up|9|||
161785666|NCT01021137|584259315|FG001|Overall Study|Lost to Follow-up|4|||
161785667|NCT01021137|584259316|FG002|Overall Study|Lost to Follow-up|2|||
161785668|NCT01021137|584259317|FG003|Overall Study|Lost to Follow-up|6|||
161785669|NCT01021137|584259314|FG000|Overall Study|Withdrawal by Subject|1|||
161785670|NCT01021137|584259315|FG001|Overall Study|Withdrawal by Subject|0|||
161785671|NCT01021137|584259316|FG002|Overall Study|Withdrawal by Subject|0|||
161785672|NCT01021137|584259317|FG003|Overall Study|Withdrawal by Subject|3|||
161785673|NCT00725725|584259318|FG000|Overall Study|Adverse Event|1|||
161785674|NCT00725725|584259319|FG001|Overall Study|Adverse Event|3|||
161785675|NCT00725725|584259320|FG002|Overall Study|Adverse Event|2|||
161785676|NCT00725725|584259318|FG000|Overall Study|Lost to Follow-up|2|||
161785677|NCT00725725|584259319|FG001|Overall Study|Lost to Follow-up|0|||
161785678|NCT00725725|584259320|FG002|Overall Study|Lost to Follow-up|2|||
161785679|NCT00725725|584259318|FG000|Overall Study|Withdrawal by Subject|1|||
161785680|NCT00725725|584259319|FG001|Overall Study|Withdrawal by Subject|0|||
161785681|NCT00725725|584259320|FG002|Overall Study|Withdrawal by Subject|1|||
161785682|NCT00725725|584259318|FG000|Overall Study|Protocol Violation|0|||
161785683|NCT00725725|584259319|FG001|Overall Study|Protocol Violation|1|||
161785684|NCT00725725|584259320|FG002|Overall Study|Protocol Violation|0|||
161785685|NCT00729365|584259322|FG000|Overall Study|Physician Decision|33|||
161785686|NCT00729365|584259323|FG001|Overall Study|Physician Decision|6|||
161785687|NCT00729365|584259324|FG002|Overall Study|Physician Decision|7|||
161785688|NCT02556632|584259325|FG000|Overall Study|Lost to Follow-up|1|||
161785689|NCT02556632|584259326|FG001|Overall Study|Lost to Follow-up|0|||
161785690|NCT02556632|584259327|FG002|Overall Study|Lost to Follow-up|0|||
161785691|NCT02556632|584259325|FG000|Overall Study|Disliked Intervention|1|||
161785692|NCT02556632|584259326|FG001|Overall Study|Disliked Intervention|1|||
161785693|NCT02556632|584259327|FG002|Overall Study|Disliked Intervention|1|||
161785694|NCT02556632|584259325|FG000|Overall Study|No Reason|1|||
161785695|NCT02556632|584259326|FG001|Overall Study|No Reason|0|||
161785696|NCT02556632|584259327|FG002|Overall Study|No Reason|1|||
161785697|NCT02556632|584259325|FG000|Overall Study|Personal Issues|0|||
161785698|NCT02556632|584259326|FG001|Overall Study|Personal Issues|1|||
161785699|NCT02556632|584259327|FG002|Overall Study|Personal Issues|1|||
161785700|NCT02556632|584259325|FG000|Overall Study|Changed Mind|0|||
161785701|NCT02556632|584259326|FG001|Overall Study|Changed Mind|1|||
161785702|NCT02556632|584259327|FG002|Overall Study|Changed Mind|0|||
161785703|NCT02556632|584259325|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
161785704|NCT02556632|584259326|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
161785705|NCT02556632|584259327|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
161785706|NCT02556632|584259325|FG000|Overall Study|Unrelated Adverse Event|1|||
161785707|NCT02556632|584259326|FG001|Overall Study|Unrelated Adverse Event|0|||
161785708|NCT02556632|584259327|FG002|Overall Study|Unrelated Adverse Event|3|||
161785709|NCT02556632|584259325|FG000|Overall Study|Related Adverse Event|0|||
161785710|NCT02556632|584259326|FG001|Overall Study|Related Adverse Event|1|||
161785711|NCT02556632|584259327|FG002|Overall Study|Related Adverse Event|0|||
161785712|NCT02556632|584259325|FG000|Overall Study|Possibly Related Adverse Event|0|||
161785713|NCT02556632|584259326|FG001|Overall Study|Possibly Related Adverse Event|0|||
161785714|NCT02556632|584259327|FG002|Overall Study|Possibly Related Adverse Event|1|||
161785715|NCT02556632|584259325|FG000|Overall Study|Did Not Start RT|0|||
161785716|NCT02556632|584259326|FG001|Overall Study|Did Not Start RT|1|||
161785717|NCT02556632|584259327|FG002|Overall Study|Did Not Start RT|0|||
161785718|NCT02556632|584259325|FG000|Overall Study|Ineligible|0|||
161785719|NCT02556632|584259326|FG001|Overall Study|Ineligible|1|||
161785720|NCT02556632|584259327|FG002|Overall Study|Ineligible|0|||
161785721|NCT02556632|584259325|FG000|Overall Study|Disliked Study Procedures|0|||
161785722|NCT02556632|584259326|FG001|Overall Study|Disliked Study Procedures|0|||
161785723|NCT02556632|584259327|FG002|Overall Study|Disliked Study Procedures|1|||
161785724|NCT02556632|584259325|FG000|Overall Study|Treatment or Change Delay|0|||
161785725|NCT02556632|584259326|FG001|Overall Study|Treatment or Change Delay|0|||
161785726|NCT02556632|584259327|FG002|Overall Study|Treatment or Change Delay|1|||
161785727|NCT00928135|584259328|FG000|Overall Study|Withdrawal by Subject|1|||
161785728|NCT00928135|584259329|FG001|Overall Study|Withdrawal by Subject|0|||
161785729|NCT01999322|584259330|FG000|Overall Study|Adverse Event|1|||
161785730|NCT01999322|584259331|FG001|Overall Study|Adverse Event|0|||
161785731|NCT01963676|584260701|FG000|Overall Study|Withdrawal by Subject|1|||
161785732|NCT01963676|584260702|FG001|Overall Study|Withdrawal by Subject|0|||
161785733|NCT00766506|584260703|FG000|Overall Study|Use rescue medication after 3 hours|3|||
161785734|NCT00766506|584260704|FG001|Overall Study|Use rescue medication after 3 hours|0|||
161785735|NCT00766506|584260703|FG000|Overall Study|Other|2|||
161785736|NCT00766506|584260704|FG001|Overall Study|Other|2|||
161785737|NCT03053622|584260705|FG000|Overall Study|Lost to Follow-up|0|||
161785738|NCT03053622|584260706|FG001|Overall Study|Lost to Follow-up|0|||
161785739|NCT03053622|584260707|FG002|Overall Study|Lost to Follow-up|0|||
161785740|NCT03053622|584260708|FG003|Overall Study|Lost to Follow-up|1|||
161785741|NCT01246986|584260709|FG000|Overall Study|Lost to Follow-up|0|||
161785742|NCT01246986|584260710|FG001|Overall Study|Lost to Follow-up|1|||
161785743|NCT01246986|584260711|FG002|Overall Study|Lost to Follow-up|3|||
161785744|NCT01246986|584260712|FG003|Overall Study|Lost to Follow-up|0|||
161785745|NCT01246986|584260713|FG004|Overall Study|Lost to Follow-up|0|||
161785746|NCT01246986|584260714|FG005|Overall Study|Lost to Follow-up|1|||
161785747|NCT01246986|584260715|FG006|Overall Study|Lost to Follow-up|0|||
161785748|NCT01246986|584260709|FG000|Overall Study|Withdrawal by Subject|3|||
161785749|NCT01246986|584260710|FG001|Overall Study|Withdrawal by Subject|4|||
161785750|NCT01246986|584260711|FG002|Overall Study|Withdrawal by Subject|3|||
161785751|NCT01246986|584260712|FG003|Overall Study|Withdrawal by Subject|0|||
161785752|NCT01246986|584260713|FG004|Overall Study|Withdrawal by Subject|4|||
161785753|NCT01246986|584260714|FG005|Overall Study|Withdrawal by Subject|0|||
161785754|NCT01246986|584260715|FG006|Overall Study|Withdrawal by Subject|0|||
161785755|NCT01440647|584260720|FG000|Overall Study|Death|2|||
161785756|NCT01440647|584260721|FG001|Overall Study|Death|3|||
161785757|NCT01406873|584260735|FG000|Overall Study|Withdrawal by Subject|1|||
161785758|NCT01406873|584260736|FG001|Overall Study|Withdrawal by Subject|1|||
161785759|NCT03990389|584260737|FG000|Overall Study|Lost to Follow-up|3|||
161785760|NCT03990389|584260738|FG001|Overall Study|Lost to Follow-up|0|||
161785761|NCT00207714|584260739|FG000|Overall Study|Adverse Event|6|||
161785762|NCT00207714|584260740|FG001|Overall Study|Adverse Event|2|||
161785763|NCT00207714|584260741|FG002|Overall Study|Adverse Event|4|||
161785764|NCT00207714|584260742|FG003|Overall Study|Adverse Event|3|||
161785765|NCT00207714|584260743|FG004|Overall Study|Adverse Event|1|||
161785766|NCT00207714|584260739|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161785767|NCT00207714|584260740|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161785768|NCT00207714|584260741|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161785769|NCT00207714|584260742|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
161785770|NCT00207714|584260743|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
161785771|NCT00207714|584260739|FG000|Overall Study|Other|3|||
161785772|NCT00207714|584260740|FG001|Overall Study|Other|2|||
161785773|NCT00207714|584260741|FG002|Overall Study|Other|5|||
161785774|NCT00207714|584260742|FG003|Overall Study|Other|1|||
161785775|NCT00207714|584260743|FG004|Overall Study|Other|0|||
161785776|NCT03627195|584260744|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
161785777|NCT03627195|584260745|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785778|NCT03627195|584260746|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785779|NCT03627195|584260747|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785780|NCT03627195|584260748|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785781|NCT03627195|584260749|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785782|NCT02595528|584260751|FG000|Overall Study|Withdrawal by Subject|1|||
161785783|NCT02595528|584260752|FG001|Overall Study|Withdrawal by Subject|2|||
161785784|NCT02595528|584260753|FG002|Overall Study|Withdrawal by Subject|1|||
161785785|NCT02595528|584260754|FG003|Overall Study|Withdrawal by Subject|3|||
161785786|NCT02595528|584260751|FG000|Overall Study|Lost to Follow-up|1|||
161785787|NCT02595528|584260752|FG001|Overall Study|Lost to Follow-up|1|||
161785788|NCT02595528|584260753|FG002|Overall Study|Lost to Follow-up|0|||
161785789|NCT02595528|584260754|FG003|Overall Study|Lost to Follow-up|1|||
161785790|NCT03202511|584260755|FG000|Overall Study|Withdrawal by Subject|1|||
161785791|NCT03202511|584260756|FG001|Overall Study|Withdrawal by Subject|0|||
161785792|NCT00686790|584260757|FG000|Overall Study|Adverse Event|2|||
161785793|NCT00686790|584260757|FG000|Overall Study|Withdrawal by Subject|1|||
161785794|NCT00686790|584260757|FG000|Overall Study|Death|1|||
161785795|NCT00686790|584260757|FG000|Overall Study|Lost to Follow-up|12|||
161785796|NCT00096382|584260760|FG000|Overall Study|Not treated|1|||
161785797|NCT00096382|584260761|FG001|Overall Study|Not treated|0|||
161785798|NCT00096382|584260760|FG000|Overall Study|Death during treatment|1|||
161785799|NCT00096382|584260761|FG001|Overall Study|Death during treatment|0|||
161785800|NCT03862625|584260762|FG000|Overall Study|Lost to Follow-up|0|||
161785801|NCT03862625|584260763|FG001|Overall Study|Lost to Follow-up|1|||
161785802|NCT02082912|584260764|FG000|Overall Study|Physician Decision|0|||
161785803|NCT02082912|584260765|FG001|Overall Study|Physician Decision|1|||
161785804|NCT02614703|584260766|FG000|Overall Study|Withdrawal by Subject|7|||
161785805|NCT02614703|584260767|FG001|Overall Study|Withdrawal by Subject|1|||
161785806|NCT01977352|584260776|FG000|Overall Study|Lost to Follow-up|1|||
161785807|NCT01977352|584260777|FG001|Overall Study|Lost to Follow-up|2|||
161785808|NCT00409188|584260783|FG000|Overall Study|Ongoing at data cut-off|383|||
161785809|NCT00409188|584260784|FG001|Overall Study|Ongoing at data cut-off|175|||
161785810|NCT01835132|584260785|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
161785811|NCT00856778|584260786|FG000|Overall Study|Adverse Event|7|||
161785812|NCT00856778|584260786|FG000|Overall Study|Withdrawal by Subject|10|||
161785813|NCT00856778|584260786|FG000|Overall Study|Study deviation|2|||
161785814|NCT00856778|584260786|FG000|Overall Study|Lost to Follow-up|5|||
161785815|NCT01681771|584260787|FG000|Overall Study|Lost to Follow-up|4|||
161785816|NCT01681771|584260788|FG001|Overall Study|Lost to Follow-up|2|||
161785817|NCT00265083|584260789|FG000|Overall Study|Adverse Event|5|||
161785818|NCT00265083|584260790|FG001|Overall Study|Adverse Event|13|||
161785819|NCT00265083|584260791|FG002|Overall Study|Adverse Event|15|||
161785820|NCT00265083|584260789|FG000|Overall Study|Lost to Follow-up|3|||
161785821|NCT00265083|584260790|FG001|Overall Study|Lost to Follow-up|4|||
161785822|NCT00265083|584260791|FG002|Overall Study|Lost to Follow-up|4|||
161785823|NCT00265083|584260789|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
161785824|NCT00265083|584260790|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161785825|NCT00265083|584260791|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
161785826|NCT00265083|584260789|FG000|Overall Study|Other|1|||
161785827|NCT00265083|584260790|FG001|Overall Study|Other|12|||
161785828|NCT00265083|584260791|FG002|Overall Study|Other|9|||
161785829|NCT03208933|584260795|FG000|Overall Study|Death|3|||
161785830|NCT03208933|584260795|FG000|Overall Study|Withdrawal by Subject|3|||
161785831|NCT03208933|584260795|FG000|Overall Study|Adverse Event|1|||
161785832|NCT03208933|584260795|FG000|Overall Study|Lost to Follow-up|2|||
161785833|NCT03208933|584260795|FG000|Overall Study|Physician Decision|3|||
161785834|NCT03208933|584260795|FG000|Overall Study|Protocol Violation|1|||
161785835|NCT00854620|584260796|FG000|Overall Study|Adverse Event|1|||
161785836|NCT04242186|584260800|FG000|Overall Study|Death|5|||
161785837|NCT00782275|584260803|FG000|Overall Study|Adverse Event|11|||
161439359|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161785838|NCT00782275|584260803|FG000|Overall Study|Withdrawal by Subject|1|||
161785839|NCT00782275|584260803|FG000|Overall Study|Progressive Disease|21|||
161785840|NCT00782275|584260803|FG000|Overall Study|Physician Decision|4|||
161785841|NCT00782275|584260803|FG000|Overall Study|Not started treatment|1|||
161785842|NCT00782275|584260803|FG000|Overall Study|Other|3|||
161785843|NCT04378010|584260804|FG000|Overall Study|Adverse Event|8|||
161785844|NCT04378010|584260805|FG001|Overall Study|Adverse Event|14|||
161785845|NCT04378010|584260806|FG002|Overall Study|Adverse Event|4|||
161785846|NCT04378010|584260804|FG000|Overall Study|Withdrawal by Subject|0|||
161785847|NCT04378010|584260805|FG001|Overall Study|Withdrawal by Subject|2|||
161785848|NCT04378010|584260806|FG002|Overall Study|Withdrawal by Subject|1|||
161785849|NCT04378010|584260804|FG000|Overall Study|Protocol Violation|2|||
161785850|NCT04378010|584260805|FG001|Overall Study|Protocol Violation|1|||
161785851|NCT04378010|584260806|FG002|Overall Study|Protocol Violation|4|||
161785852|NCT04378010|584260804|FG000|Overall Study|Study terminated by Sponsor|22|||
161785853|NCT04378010|584260805|FG001|Overall Study|Study terminated by Sponsor|16|||
161785854|NCT04378010|584260806|FG002|Overall Study|Study terminated by Sponsor|22|||
161785855|NCT04378010|584260804|FG000|Overall Study|Subject inability to complete study visit|0|||
161785856|NCT04378010|584260805|FG001|Overall Study|Subject inability to complete study visit|0|||
161785857|NCT04378010|584260806|FG002|Overall Study|Subject inability to complete study visit|1|||
161785858|NCT04378010|584260804|FG000|Overall Study|Subject never dosed|0|||
161785859|NCT04378010|584260805|FG001|Overall Study|Subject never dosed|1|||
161785860|NCT04378010|584260806|FG002|Overall Study|Subject never dosed|0|||
161785861|NCT01792284|584260807|FG000|Lead-in Period|Adverse Event|15|||
161785862|NCT01792284|584260808|FG001|Lead-in Period|Adverse Event|0|||
161785863|NCT01792284|584260809|FG002|Lead-in Period|Adverse Event|0|||
161785864|NCT01792284|584260807|FG000|Lead-in Period|Lost to Follow-up|2|||
161785865|NCT01792284|584260808|FG001|Lead-in Period|Lost to Follow-up|0|||
161785866|NCT01792284|584260809|FG002|Lead-in Period|Lost to Follow-up|0|||
161785867|NCT01792284|584260807|FG000|Lead-in Period|Protocol Violation|1|||
161785868|NCT01792284|584260808|FG001|Lead-in Period|Protocol Violation|0|||
161785869|NCT01792284|584260809|FG002|Lead-in Period|Protocol Violation|0|||
161785870|NCT01792284|584260807|FG000|Lead-in Period|Withdrawal by Subject|10|||
161785871|NCT01792284|584260808|FG001|Lead-in Period|Withdrawal by Subject|0|||
161785872|NCT01792284|584260809|FG002|Lead-in Period|Withdrawal by Subject|0|||
161785873|NCT01792284|584260807|FG000|Lead-in Period|Physician Decision|1|||
161785874|NCT01792284|584260808|FG001|Lead-in Period|Physician Decision|0|||
161785875|NCT01792284|584260809|FG002|Lead-in Period|Physician Decision|0|||
161785876|NCT01792284|584260807|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
161785877|NCT01792284|584260808|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
161785878|NCT01792284|584260809|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
161785879|NCT01792284|584260807|FG000|Randomization Period 1|Withdrawal by Subject|0|||
161785880|NCT01792284|584260808|FG001|Randomization Period 1|Withdrawal by Subject|1|||
161785881|NCT01792284|584260809|FG002|Randomization Period 1|Withdrawal by Subject|1|||
161785882|NCT01792284|584260807|FG000|Randomization Period 1|Physician Decision|0|||
161785883|NCT01792284|584260808|FG001|Randomization Period 1|Physician Decision|1|||
161785884|NCT01792284|584260809|FG002|Randomization Period 1|Physician Decision|1|||
161785885|NCT01792284|584260807|FG000|Randomization Period 1|Adverse Event|0|||
161785886|NCT01792284|584260808|FG001|Randomization Period 1|Adverse Event|0|||
161785887|NCT01792284|584260809|FG002|Randomization Period 1|Adverse Event|2|||
161785888|NCT01792284|584260807|FG000|Randomization Period 1|Lost to Follow-up|0|||
161785889|NCT01792284|584260808|FG001|Randomization Period 1|Lost to Follow-up|0|||
161785890|NCT01792284|584260809|FG002|Randomization Period 1|Lost to Follow-up|1|||
161785891|NCT01792284|584260807|FG000|Randomization Period 2|Protocol Violation|0|||
161785892|NCT01792284|584260808|FG001|Randomization Period 2|Protocol Violation|1|||
161785893|NCT01792284|584260809|FG002|Randomization Period 2|Protocol Violation|0|||
161785894|NCT01792284|584260807|FG000|Randomization Period 2|Withdrawal by Subject|0|||
161785895|NCT01792284|584260808|FG001|Randomization Period 2|Withdrawal by Subject|2|||
161785896|NCT01792284|584260809|FG002|Randomization Period 2|Withdrawal by Subject|0|||
161785897|NCT02019979|584260810|FG000|Overall Study|study terminated|14|||
161785898|NCT00379587|584260812|FG000|Overall Study|Lost to Follow-up|2|||
161785899|NCT03237611|584260813|FG000|Overall Study|Withdrawal by Subject|1|||
161785900|NCT03237611|584260813|FG000|Overall Study|Ineligible|1|||
161785901|NCT00275028|584260817|FG000|Overall Study|Withdrew consent before treatment began|1|||
161785902|NCT00275028|584260817|FG000|Overall Study|Withdrawal by Subject|5|||
161785903|NCT00275028|584260817|FG000|Overall Study|Adverse Event|9|||
161785904|NCT00275028|584260817|FG000|Overall Study|Progressive Disease|30|||
161785905|NCT00275028|584260817|FG000|Overall Study|Physician Decision|2|||
161785906|NCT04356573|584260826|FG000|Overall Study|Didn't Qualify|1|||
161785907|NCT04356573|584260827|FG001|Overall Study|Didn't Qualify|0|||
161785908|NCT01244815|584260830|FG000|Overall Study|Not Treated|0|||
161785909|NCT01244815|584260831|FG001|Overall Study|Not Treated|1|||
161785910|NCT01244815|584260832|FG002|Overall Study|Not Treated|0|||
161785911|NCT01244815|584260833|FG003|Overall Study|Not Treated|0|||
161785912|NCT01244815|584260830|FG000|Overall Study|Adverse Event|4|||
161785913|NCT01244815|584260831|FG001|Overall Study|Adverse Event|7|||
161785914|NCT01244815|584260832|FG002|Overall Study|Adverse Event|5|||
161785915|NCT01244815|584260833|FG003|Overall Study|Adverse Event|5|||
161785916|NCT01244815|584260830|FG000|Overall Study|Treatment Failure|0|||
161785917|NCT01244815|584260831|FG001|Overall Study|Treatment Failure|0|||
161785918|NCT01244815|584260832|FG002|Overall Study|Treatment Failure|0|||
161785919|NCT01244815|584260833|FG003|Overall Study|Treatment Failure|1|||
161785920|NCT01244815|584260830|FG000|Overall Study|Lost to Follow-up|3|||
161785921|NCT01244815|584260831|FG001|Overall Study|Lost to Follow-up|2|||
161785922|NCT01244815|584260832|FG002|Overall Study|Lost to Follow-up|3|||
161785923|NCT01244815|584260833|FG003|Overall Study|Lost to Follow-up|2|||
161785924|NCT01244815|584260830|FG000|Overall Study|Withdrawal by Subject|0|||
161785925|NCT01244815|584260831|FG001|Overall Study|Withdrawal by Subject|2|||
161785926|NCT01244815|584260832|FG002|Overall Study|Withdrawal by Subject|0|||
161785927|NCT01244815|584260833|FG003|Overall Study|Withdrawal by Subject|3|||
161785928|NCT01244815|584260830|FG000|Overall Study|Protocol Violation|7|||
161785929|NCT01244815|584260831|FG001|Overall Study|Protocol Violation|4|||
161785930|NCT01244815|584260832|FG002|Overall Study|Protocol Violation|3|||
161785931|NCT01244815|584260833|FG003|Overall Study|Protocol Violation|1|||
161785932|NCT01244815|584260830|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161785933|NCT01244815|584260831|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161898502|NCT00103285|584677793|FG002|Response Assignment|Other|48|||
161898503|NCT00103285|584677794|FG003|Response Assignment|Other|38|||
161898504|NCT00103285|584677795|FG004|Response Assignment|Other|37|||
161898505|NCT00103285|584677796|FG005|Response Assignment|Other|17|||
161898506|NCT00103285|584677797|FG006|Response Assignment|Other|11|||
161898507|NCT00103285|584677798|FG007|Response Assignment|Other|53|||
161898508|NCT03654729|584677812|FG000|Overall Study|Death|9|||
161898509|NCT03654729|584677813|FG001|Overall Study|Death|9|||
161898510|NCT03654729|584677814|FG002|Overall Study|Death|16|||
161898511|NCT03654729|584677812|FG000|Overall Study|Withdrawal by Subject|8|||
161898512|NCT03654729|584677813|FG001|Overall Study|Withdrawal by Subject|6|||
161898513|NCT03654729|584677814|FG002|Overall Study|Withdrawal by Subject|4|||
161785934|NCT01244815|584260832|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
161785935|NCT01244815|584260833|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
161785936|NCT02041494|584260835|FG000|Overall Study|Death|1|||
161785937|NCT02041494|584260836|FG001|Overall Study|Death|3|||
161785938|NCT02041494|584260835|FG000|Overall Study|Lost to Follow-up|2|||
161785939|NCT02041494|584260836|FG001|Overall Study|Lost to Follow-up|6|||
161785940|NCT02041494|584260835|FG000|Overall Study|study terminated|16|||
161785941|NCT02041494|584260836|FG001|Overall Study|study terminated|11|||
161785942|NCT02487979|584260841|FG000|Overall Study|Physician Decision|2|||
161785943|NCT02487979|584260841|FG000|Overall Study|Withdrawal by Subject|2|||
161785944|NCT02487979|584260841|FG000|Overall Study|Progressive Disease|17|||
161785945|NCT02410837|584260842|FG000|Overall Study|Death|387|||
161785946|NCT02410837|584260842|FG000|Overall Study|Lost to Follow-up|50|||
161785947|NCT02410837|584260842|FG000|Overall Study|Withdrawal by Subject|44|||
161785948|NCT02410837|584260842|FG000|Overall Study|Physician Decision|6|||
161785949|NCT02410837|584260842|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
161785950|NCT00849524|584260847|FG000|Overall Study|Lack of Efficacy|3|||
161785951|NCT01825876|584260848|FG000|Period 2|Withdrawal by Subject|0|||
161785952|NCT01825876|584260849|FG001|Period 2|Withdrawal by Subject|1|||
161785953|NCT01027884|584260853|FG000|Overall Study|Adverse Event|2|||
161785954|NCT01027884|584260854|FG001|Overall Study|Adverse Event|1|||
161785955|NCT01027884|584260853|FG000|Overall Study|Protocol Violation|1|||
161785956|NCT01027884|584260854|FG001|Overall Study|Protocol Violation|0|||
161785957|NCT01027884|584260853|FG000|Overall Study|Non-compliance|1|||
161785958|NCT01027884|584260854|FG001|Overall Study|Non-compliance|1|||
161785959|NCT01027884|584260853|FG000|Overall Study|Withdrawal by Subject|0|||
161785960|NCT01027884|584260854|FG001|Overall Study|Withdrawal by Subject|1|||
161785961|NCT01027884|584260853|FG000|Overall Study|Lost to Follow-up|0|||
161898514|NCT03654729|584677812|FG000|Overall Study|Study terminated by Sponsor|3|||
161898515|NCT03654729|584677813|FG001|Overall Study|Study terminated by Sponsor|5|||
161785962|NCT01027884|584260854|FG001|Overall Study|Lost to Follow-up|1|||
161785963|NCT01027884|584260853|FG000|Overall Study|Spinal fixation surgery|0|||
161785964|NCT01027884|584260854|FG001|Overall Study|Spinal fixation surgery|3|||
161785965|NCT03636542|584260856|FG000|Overall Study|Lost to Follow-up|1|||
161785966|NCT03636542|584260857|FG001|Overall Study|Lost to Follow-up|1|||
161785967|NCT03636542|584260856|FG000|Overall Study|Physician Decision|0|||
161898516|NCT03654729|584677814|FG002|Overall Study|Study terminated by Sponsor|4|||
161898517|NCT03654729|584677812|FG000|Overall Study|Not reported|2|||
161785968|NCT03636542|584260857|FG001|Overall Study|Physician Decision|1|||
161785969|NCT03636542|584260856|FG000|Overall Study|Withdrawal by Subject|1|||
161898518|NCT03654729|584677813|FG001|Overall Study|Not reported|4|||
161898519|NCT03654729|584677814|FG002|Overall Study|Not reported|5|||
161785970|NCT03636542|584260857|FG001|Overall Study|Withdrawal by Subject|0|||
161785971|NCT00845026|584260858|FG000|Study Period III|Adverse Event|23|||
161785972|NCT00845026|584260859|FG001|Study Period III|Adverse Event|19|||
161785973|NCT00845026|584260858|FG000|Study Period III|Perceived lack of efficacy|27|||
161785974|NCT00845026|584260859|FG001|Study Period III|Perceived lack of efficacy|15|||
161785975|NCT00845026|584260858|FG000|Study Period III|Withdrawal by Subject|19|||
161785976|NCT00845026|584260859|FG001|Study Period III|Withdrawal by Subject|15|||
161785977|NCT00845026|584260858|FG000|Study Period III|Entry Criteria not met|8|||
161785978|NCT00845026|584260859|FG001|Study Period III|Entry Criteria not met|11|||
161785979|NCT00845026|584260858|FG000|Study Period III|Lost to Follow-up|4|||
161785980|NCT00845026|584260859|FG001|Study Period III|Lost to Follow-up|5|||
161785981|NCT00845026|584260858|FG000|Study Period III|Protocol Violation|8|||
161785982|NCT00845026|584260859|FG001|Study Period III|Protocol Violation|1|||
161785983|NCT00845026|584260858|FG000|Study Period III|Scheduled conflict|3|||
161785984|NCT00845026|584260859|FG001|Study Period III|Scheduled conflict|1|||
161785985|NCT00845026|584260858|FG000|Study Period III|Subject is moving or has moved|2|||
161785986|NCT00845026|584260859|FG001|Study Period III|Subject is moving or has moved|4|||
161785987|NCT00845026|584260858|FG000|Study Period III|Transportation issues|1|||
161785988|NCT00845026|584260859|FG001|Study Period III|Transportation issues|1|||
161785989|NCT00845026|584260858|FG000|Study Period IV|Adverse Event|4|||
161785990|NCT00845026|584260859|FG001|Study Period IV|Adverse Event|0|||
161785991|NCT00845026|584260858|FG000|Study Period IV|Perceived lack of efficacy|2|||
161785992|NCT00845026|584260859|FG001|Study Period IV|Perceived lack of efficacy|1|||
161785993|NCT00845026|584260858|FG000|Study Period IV|Protocol Violation|3|||
161785994|NCT00845026|584260859|FG001|Study Period IV|Protocol Violation|1|||
161785995|NCT00845026|584260858|FG000|Study Period IV|Lost to Follow-up|1|||
161785996|NCT00845026|584260859|FG001|Study Period IV|Lost to Follow-up|0|||
161785997|NCT00845026|584260858|FG000|Study Period IV|Withdrawal by Subject|4|||
161785998|NCT00845026|584260859|FG001|Study Period IV|Withdrawal by Subject|1|||
161785999|NCT00845026|584260858|FG000|Study Period IV|Entry Criteria Not Met|1|||
161786000|NCT00845026|584260859|FG001|Study Period IV|Entry Criteria Not Met|0|||
161786001|NCT00845026|584260858|FG000|Study Period IV|Subject is moving or has moved|0|||
161786002|NCT00845026|584260859|FG001|Study Period IV|Subject is moving or has moved|1|||
161786003|NCT00845026|584260858|FG000|Study Period IV|Scheduling conflict|1|||
161786004|NCT00845026|584260859|FG001|Study Period IV|Scheduling conflict|0|||
161786005|NCT01325532|584260860|FG000|Overall Study|Withdrawal by Subject|2|||
161786006|NCT01325532|584260861|FG001|Overall Study|Withdrawal by Subject|0|||
161786007|NCT04556838|584260868|FG000|Overall Study|Withdrawal by Subject|3|||
161786008|NCT04556838|584260869|FG001|Overall Study|Withdrawal by Subject|1|||
161786009|NCT04556838|584260870|FG002|Overall Study|Withdrawal by Subject|2|||
161786010|NCT04556838|584260868|FG000|Overall Study|Adverse Event|0|||
161786011|NCT04556838|584260869|FG001|Overall Study|Adverse Event|1|||
161786012|NCT04556838|584260870|FG002|Overall Study|Adverse Event|1|||
161786013|NCT04556838|584260868|FG000|Overall Study|Lost to Follow-up|0|||
161786014|NCT04556838|584260869|FG001|Overall Study|Lost to Follow-up|0|||
161786015|NCT04556838|584260870|FG002|Overall Study|Lost to Follow-up|2|||
161786016|NCT04556838|584260868|FG000|Overall Study|Subject travel|0|||
161786017|NCT04556838|584260869|FG001|Overall Study|Subject travel|1|||
161439360|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439361|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439362|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439363|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439364|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439365|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439366|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439367|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439368|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439369|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439370|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439371|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
161439372|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161439373|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439374|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439375|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439376|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161786018|NCT04556838|584260870|FG002|Overall Study|Subject travel|0|||
161786019|NCT04556838|584260868|FG000|Overall Study|Physician Decision|1|||
161786020|NCT04556838|584260869|FG001|Overall Study|Physician Decision|0|||
161786021|NCT04556838|584260870|FG002|Overall Study|Physician Decision|0|||
161439377|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439378|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439379|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161786022|NCT01458119|584260871|FG000|Overall Study|Physician Decision|4|||
161786023|NCT01458119|584260871|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
161786024|NCT01458119|584260871|FG000|Overall Study|Pregnancy|1|||
161786025|NCT01458119|584260871|FG000|Overall Study|Death|2|||
161786026|NCT01458119|584260871|FG000|Overall Study|Adverse Event|1|||
161786027|NCT01458119|584260871|FG000|Overall Study|Consent Withdrawn by Participant|8|||
161786028|NCT01458119|584260871|FG000|Overall Study|Non-compliance With Study Drug|3|||
161786029|NCT00382291|584263155|FG000|Overall Study|Adverse Event|1|||
161786030|NCT00382291|584263156|FG001|Overall Study|Adverse Event|2|||
161786031|NCT00382291|584263157|FG002|Overall Study|Adverse Event|2|||
161786032|NCT00382291|584263155|FG000|Overall Study|Protocol Violation|1|||
161786033|NCT00382291|584263156|FG001|Overall Study|Protocol Violation|0|||
161786034|NCT00382291|584263157|FG002|Overall Study|Protocol Violation|0|||
161786035|NCT00382291|584263155|FG000|Overall Study|Temporary study suspension|2|||
161786036|NCT00382291|584263156|FG001|Overall Study|Temporary study suspension|2|||
161786037|NCT00382291|584263157|FG002|Overall Study|Temporary study suspension|5|||
161786038|NCT00382291|584263155|FG000|Overall Study|Withdrawal by Subject|0|||
161786039|NCT00382291|584263156|FG001|Overall Study|Withdrawal by Subject|2|||
161786040|NCT00382291|584263157|FG002|Overall Study|Withdrawal by Subject|0|||
161786041|NCT00382291|584263155|FG000|Overall Study|Physician Decision|0|||
161786042|NCT00382291|584263156|FG001|Overall Study|Physician Decision|1|||
161786043|NCT00382291|584263157|FG002|Overall Study|Physician Decision|0|||
161786044|NCT00382291|584263155|FG000|Overall Study|Lack of Efficacy|0|||
161786045|NCT00382291|584263156|FG001|Overall Study|Lack of Efficacy|0|||
161786046|NCT00382291|584263157|FG002|Overall Study|Lack of Efficacy|1|||
161786047|NCT01326702|584263158|FG000|Overall Study|Other|1|||
161786048|NCT01326702|584263159|FG001|Overall Study|Other|0|||
161786049|NCT01326702|584263160|FG002|Overall Study|Other|0|||
161786050|NCT01326702|584263161|FG003|Overall Study|Other|0|||
161786051|NCT01326702|584263162|FG004|Overall Study|Other|0|||
161786052|NCT01326702|584263163|FG005|Overall Study|Other|1|||
161786053|NCT01326702|584263164|FG006|Overall Study|Other|0|||
161786054|NCT01326702|584263158|FG000|Overall Study|progressive disease|1|||
161786055|NCT01326702|584263159|FG001|Overall Study|progressive disease|1|||
161786056|NCT01326702|584263160|FG002|Overall Study|progressive disease|3|||
161786057|NCT01326702|584263161|FG003|Overall Study|progressive disease|1|||
161786058|NCT01326702|584263162|FG004|Overall Study|progressive disease|3|||
161786059|NCT01326702|584263163|FG005|Overall Study|progressive disease|2|||
161786060|NCT01326702|584263164|FG006|Overall Study|progressive disease|3|||
161786061|NCT01326702|584263158|FG000|Overall Study|Death|0|||
161786062|NCT01326702|584263159|FG001|Overall Study|Death|1|||
161786063|NCT01326702|584263160|FG002|Overall Study|Death|0|||
161786064|NCT01326702|584263161|FG003|Overall Study|Death|0|||
161786065|NCT01326702|584263162|FG004|Overall Study|Death|0|||
161786066|NCT01326702|584263163|FG005|Overall Study|Death|0|||
161786067|NCT01326702|584263164|FG006|Overall Study|Death|0|||
161786068|NCT01326702|584263158|FG000|Overall Study|Adverse Event|0|||
161786069|NCT01326702|584263159|FG001|Overall Study|Adverse Event|0|||
161786070|NCT01326702|584263160|FG002|Overall Study|Adverse Event|1|||
161786071|NCT01326702|584263161|FG003|Overall Study|Adverse Event|1|||
161786072|NCT01326702|584263162|FG004|Overall Study|Adverse Event|0|||
161786073|NCT01326702|584263163|FG005|Overall Study|Adverse Event|3|||
161786074|NCT01326702|584263164|FG006|Overall Study|Adverse Event|1|||
161786075|NCT01326702|584263158|FG000|Overall Study|Withdrawal by Subject|0|||
161786076|NCT01326702|584263159|FG001|Overall Study|Withdrawal by Subject|0|||
161786077|NCT01326702|584263160|FG002|Overall Study|Withdrawal by Subject|1|||
161786078|NCT01326702|584263161|FG003|Overall Study|Withdrawal by Subject|0|||
161786079|NCT01326702|584263162|FG004|Overall Study|Withdrawal by Subject|1|||
161786080|NCT01326702|584263163|FG005|Overall Study|Withdrawal by Subject|1|||
161786081|NCT01326702|584263164|FG006|Overall Study|Withdrawal by Subject|3|||
161786082|NCT01326702|584263158|FG000|Overall Study|Not Treated|0|||
161786083|NCT01326702|584263159|FG001|Overall Study|Not Treated|0|||
161786084|NCT01326702|584263160|FG002|Overall Study|Not Treated|0|||
161786085|NCT01326702|584263161|FG003|Overall Study|Not Treated|1|||
161786086|NCT01326702|584263162|FG004|Overall Study|Not Treated|0|||
161786087|NCT01326702|584263163|FG005|Overall Study|Not Treated|1|||
161786088|NCT01326702|584263164|FG006|Overall Study|Not Treated|0|||
161786089|NCT02266706|584263165|FG000|Overall Study|Withdrawal by Subject|0|||
161786090|NCT02266706|584263166|FG001|Overall Study|Withdrawal by Subject|1|||
161786091|NCT02266706|584263167|FG002|Overall Study|Withdrawal by Subject|1|||
161786092|NCT02266706|584263168|FG003|Overall Study|Withdrawal by Subject|0|||
161786093|NCT02266706|584263169|FG004|Overall Study|Withdrawal by Subject|0|||
161786094|NCT02266706|584263170|FG005|Overall Study|Withdrawal by Subject|1|||
161786095|NCT02266706|584263171|FG006|Overall Study|Withdrawal by Subject|0|||
161786096|NCT02266706|584263172|FG007|Overall Study|Withdrawal by Subject|0|||
161786097|NCT02266706|584263173|FG008|Overall Study|Withdrawal by Subject|0|||
161786098|NCT02266706|584263165|FG000|Overall Study|Screen failure|0|||
161786099|NCT02266706|584263166|FG001|Overall Study|Screen failure|0|||
161786100|NCT02266706|584263167|FG002|Overall Study|Screen failure|0|||
161786101|NCT02266706|584263168|FG003|Overall Study|Screen failure|0|||
161786102|NCT02266706|584263169|FG004|Overall Study|Screen failure|0|||
161786103|NCT02266706|584263170|FG005|Overall Study|Screen failure|1|||
161786104|NCT02266706|584263171|FG006|Overall Study|Screen failure|1|||
161786105|NCT02266706|584263172|FG007|Overall Study|Screen failure|0|||
161786106|NCT02266706|584263173|FG008|Overall Study|Screen failure|0|||
161786107|NCT02266706|584263165|FG000|Overall Study|Enrollment in another study|0|||
161786108|NCT02266706|584263166|FG001|Overall Study|Enrollment in another study|0|||
161786109|NCT02266706|584263167|FG002|Overall Study|Enrollment in another study|0|||
161786110|NCT02266706|584263168|FG003|Overall Study|Enrollment in another study|1|||
161786111|NCT02266706|584263169|FG004|Overall Study|Enrollment in another study|0|||
161786112|NCT02266706|584263170|FG005|Overall Study|Enrollment in another study|0|||
161786113|NCT02266706|584263171|FG006|Overall Study|Enrollment in another study|0|||
161786114|NCT02266706|584263172|FG007|Overall Study|Enrollment in another study|0|||
161786115|NCT02266706|584263173|FG008|Overall Study|Enrollment in another study|0|||
161786116|NCT02270983|584263174|FG000|Overall Study|Adverse Event|3|||
161786117|NCT02270983|584263175|FG001|Overall Study|Adverse Event|2|||
161786118|NCT02270983|584263176|FG002|Overall Study|Adverse Event|6|||
161786119|NCT02270983|584263174|FG000|Overall Study|Lack of Efficacy|2|||
161786120|NCT02270983|584263175|FG001|Overall Study|Lack of Efficacy|1|||
161786121|NCT02270983|584263176|FG002|Overall Study|Lack of Efficacy|1|||
161786122|NCT02270983|584263174|FG000|Overall Study|Withdrawal by Subject|1|||
161786123|NCT02270983|584263175|FG001|Overall Study|Withdrawal by Subject|0|||
161786124|NCT02270983|584263176|FG002|Overall Study|Withdrawal by Subject|2|||
161786125|NCT02270983|584263174|FG000|Overall Study|Lost to Follow-up|1|||
161786126|NCT02270983|584263175|FG001|Overall Study|Lost to Follow-up|1|||
161786127|NCT02270983|584263176|FG002|Overall Study|Lost to Follow-up|2|||
161786128|NCT02270983|584263174|FG000|Overall Study|Protocol Violation|1|||
161786129|NCT02270983|584263175|FG001|Overall Study|Protocol Violation|1|||
161786130|NCT02270983|584263176|FG002|Overall Study|Protocol Violation|1|||
161786131|NCT02270983|584263174|FG000|Overall Study|family emergency|0|||
161786132|NCT02270983|584263175|FG001|Overall Study|family emergency|1|||
161786133|NCT02270983|584263176|FG002|Overall Study|family emergency|0|||
161786134|NCT02270983|584263174|FG000|Overall Study|study procedure non-compliance|1|||
161786135|NCT02270983|584263175|FG001|Overall Study|study procedure non-compliance|0|||
161786136|NCT02270983|584263176|FG002|Overall Study|study procedure non-compliance|0|||
161786137|NCT02270983|584263174|FG000|Overall Study|moved away from study site|0|||
161786138|NCT02270983|584263175|FG001|Overall Study|moved away from study site|1|||
161786139|NCT02270983|584263176|FG002|Overall Study|moved away from study site|0|||
161786140|NCT04741503|584263180|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
161786141|NCT04741503|584263181|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
161786142|NCT04741503|584263182|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
161786143|NCT04741503|584263180|FG000|Initial Enrollment|Overquotas removed|0|||
161786144|NCT04741503|584263181|FG001|Initial Enrollment|Overquotas removed|0|||
161786145|NCT04741503|584263182|FG002|Initial Enrollment|Overquotas removed|186|||
161786146|NCT04741503|584263180|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
161786147|NCT04741503|584263181|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
161786148|NCT04741503|584263182|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
161786149|NCT03840811|584263185|FG000|Overall Study|Lost to Follow-up|0|||
161786150|NCT03840811|584263186|FG001|Overall Study|Lost to Follow-up|0|||
161786151|NCT03840811|584263187|FG002|Overall Study|Lost to Follow-up|1|||
161786152|NCT04313283|584263190|FG000|Overall Study|did not complete intervention|4|||
161786153|NCT04126733|584263191|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
161786154|NCT04126733|584263191|FG000|Treatment Period|Adverse Event|8|||
161786155|NCT04126733|584263191|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
161786156|NCT04126733|584263191|FG000|Treatment Period|Physician Decision|5|||
161786157|NCT04126733|584263191|FG000|Treatment Period|Death|1|||
161786158|NCT04126733|584263191|FG000|Treatment Period|Other Reasons|2|||
161786159|NCT04126733|584263191|FG000|Active Follow-up Period|Death|13|||
161786160|NCT04126733|584263191|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
161786161|NCT04126733|584263191|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
161786162|NCT04126733|584263191|FG000|Active Follow-up Period|Other Reasons|1|||
161786163|NCT04126733|584263191|FG000|Long-term Follow-up Period|Death|22|||
161786164|NCT04126733|584263191|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
161786165|NCT04126733|584263191|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
161786166|NCT00837577|584263192|FG000|Double-blind Period|Clinical Adverse Event|1|||
161786167|NCT00837577|584263193|FG001|Double-blind Period|Clinical Adverse Event|0|||
161786168|NCT00837577|584263192|FG000|Double-blind Period|Withdrawal by Subject|1|||
161786169|NCT00837577|584263193|FG001|Double-blind Period|Withdrawal by Subject|0|||
161786170|NCT00837577|584263192|FG000|Open-label Period|Clinical Adverse Event|2|||
161786171|NCT00837577|584263193|FG001|Open-label Period|Clinical Adverse Event|2|||
161786172|NCT00837577|584263192|FG000|Open-label Period|Laboratory Adverse Event|0|||
161786173|NCT00837577|584263193|FG001|Open-label Period|Laboratory Adverse Event|1|||
161786174|NCT00837577|584263192|FG000|Open-label Period|Lack of Efficacy|4|||
161786175|NCT00837577|584263193|FG001|Open-label Period|Lack of Efficacy|3|||
161786176|NCT00837577|584263192|FG000|Open-label Period|Withdrawal by Subject|1|||
161439380|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439381|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439382|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439383|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439384|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439385|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
161439386|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
161439387|NCT02113982|583003196|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439388|NCT02113982|583003197|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439389|NCT02113982|583003198|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439390|NCT02113982|583003199|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439391|NCT02113982|583003200|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439392|NCT02113982|583003201|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439393|NCT02113982|583003202|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439394|NCT02113982|583003203|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439395|NCT02113982|583003204|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439396|NCT02113982|583003205|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439397|NCT02113982|583003206|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439398|NCT02113982|583003207|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439399|NCT02113982|583003208|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
161439400|NCT02113982|583003209|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161439401|NCT01772316|583003210|FG000|Overall Study|Serious adverse event|1|||
161439402|NCT01772316|583003210|FG000|Overall Study|Inform consent withdrawn|1|||
161439403|NCT01772316|583003210|FG000|Overall Study|Withdrawn by sponsor decision|5|||
161439404|NCT02085161|583003211|FG000|Overall Study|Not Treated|1|||
161439405|NCT02085161|583003212|FG001|Overall Study|Not Treated|0|||
161439406|NCT02085161|583003213|FG002|Overall Study|Not Treated|0|||
161439407|NCT02085161|583003214|FG003|Overall Study|Not Treated|0|||
161439408|NCT02085161|583003211|FG000|Overall Study|Adverse Event|8|||
161439409|NCT02085161|583003212|FG001|Overall Study|Adverse Event|5|||
161439410|NCT02085161|583003213|FG002|Overall Study|Adverse Event|4|||
161439411|NCT02085161|583003214|FG003|Overall Study|Adverse Event|5|||
161439412|NCT02085161|583003211|FG000|Overall Study|Protocol Violation|0|||
161439413|NCT02085161|583003212|FG001|Overall Study|Protocol Violation|1|||
161439414|NCT02085161|583003213|FG002|Overall Study|Protocol Violation|0|||
161439415|NCT02085161|583003214|FG003|Overall Study|Protocol Violation|1|||
161439416|NCT02085161|583003211|FG000|Overall Study|Withdrawal by Subject|2|||
161439417|NCT02085161|583003212|FG001|Overall Study|Withdrawal by Subject|4|||
161439418|NCT02085161|583003213|FG002|Overall Study|Withdrawal by Subject|0|||
161439419|NCT02085161|583003214|FG003|Overall Study|Withdrawal by Subject|3|||
161439420|NCT02085161|583003211|FG000|Overall Study|Other Reason|1|||
161439421|NCT02085161|583003212|FG001|Overall Study|Other Reason|0|||
161439422|NCT02085161|583003213|FG002|Overall Study|Other Reason|1|||
161439423|NCT02085161|583003214|FG003|Overall Study|Other Reason|1|||
161439424|NCT00068692|583003225|FG000|Step 1: Registration|Disese progression/relapse|5|||
161439425|NCT00068692|583003226|FG001|Step 1: Registration|Disese progression/relapse|0|||
161439426|NCT00068692|583003227|FG002|Step 1: Registration|Disese progression/relapse|0|||
161439427|NCT00068692|583003228|FG003|Step 1: Registration|Disese progression/relapse|0|||
161439428|NCT00068692|583003229|FG004|Step 1: Registration|Disese progression/relapse|0|||
161439429|NCT00068692|583003230|FG005|Step 1: Registration|Disese progression/relapse|0|||
161439430|NCT00068692|583003231|FG006|Step 1: Registration|Disese progression/relapse|0|||
161439431|NCT00068692|583003232|FG007|Step 1: Registration|Disese progression/relapse|0|||
161439432|NCT00068692|583003225|FG000|Step 1: Registration|Adverse Event|7|||
161439433|NCT00068692|583003226|FG001|Step 1: Registration|Adverse Event|0|||
161439434|NCT00068692|583003227|FG002|Step 1: Registration|Adverse Event|0|||
161439435|NCT00068692|583003228|FG003|Step 1: Registration|Adverse Event|0|||
161439436|NCT00068692|583003229|FG004|Step 1: Registration|Adverse Event|0|||
161439437|NCT00068692|583003230|FG005|Step 1: Registration|Adverse Event|0|||
161439438|NCT00068692|583003231|FG006|Step 1: Registration|Adverse Event|0|||
161439439|NCT00068692|583003232|FG007|Step 1: Registration|Adverse Event|0|||
161439440|NCT00068692|583003225|FG000|Step 1: Registration|Death|1|||
161439441|NCT00068692|583003226|FG001|Step 1: Registration|Death|0|||
161439442|NCT00068692|583003227|FG002|Step 1: Registration|Death|0|||
161439443|NCT00068692|583003228|FG003|Step 1: Registration|Death|0|||
161439444|NCT00068692|583003229|FG004|Step 1: Registration|Death|0|||
161439445|NCT00068692|583003230|FG005|Step 1: Registration|Death|0|||
161439446|NCT00068692|583003231|FG006|Step 1: Registration|Death|0|||
161439447|NCT00068692|583003232|FG007|Step 1: Registration|Death|0|||
161439448|NCT00068692|583003225|FG000|Step 1: Registration|Withdrawal by Subject|11|||
161439449|NCT00068692|583003226|FG001|Step 1: Registration|Withdrawal by Subject|0|||
161439450|NCT00068692|583003227|FG002|Step 1: Registration|Withdrawal by Subject|0|||
161439451|NCT00068692|583003228|FG003|Step 1: Registration|Withdrawal by Subject|0|||
161439452|NCT00068692|583003229|FG004|Step 1: Registration|Withdrawal by Subject|0|||
161786177|NCT00837577|584263193|FG001|Open-label Period|Withdrawal by Subject|2|||
161786178|NCT00837577|584263192|FG000|Open-label Period|Other Reason|1|||
161786179|NCT00837577|584263193|FG001|Open-label Period|Other Reason|1|||
161786180|NCT03670537|584263196|FG000|Overall Study|Protocol Violation|1|||
161786181|NCT02059187|584263199|FG000|Overall Study|Adverse Event|0|||
161786182|NCT02059187|584263200|FG001|Overall Study|Adverse Event|3|||
161786183|NCT02059187|584263199|FG000|Overall Study|Death|1|||
161786184|NCT02059187|584263200|FG001|Overall Study|Death|1|||
161786185|NCT02059187|584263199|FG000|Overall Study|Lost to Follow-up|9|||
161786186|NCT02059187|584263200|FG001|Overall Study|Lost to Follow-up|8|||
161786187|NCT02059187|584263199|FG000|Overall Study|Non-compliance with study drug|1|||
161786188|NCT02059187|584263200|FG001|Overall Study|Non-compliance with study drug|0|||
161786189|NCT02059187|584263199|FG000|Overall Study|Physician Decision|1|||
161786190|NCT02059187|584263200|FG001|Overall Study|Physician Decision|2|||
161786191|NCT02059187|584263199|FG000|Overall Study|Protocol Violation|1|||
161786192|NCT02059187|584263200|FG001|Overall Study|Protocol Violation|0|||
161786193|NCT02059187|584263199|FG000|Overall Study|Withdrawal by Subject|12|||
161786194|NCT02059187|584263200|FG001|Overall Study|Withdrawal by Subject|8|||
161786195|NCT03751020|584263201|FG000|Overall Study|Withdrawal by Subject|2|||
161786196|NCT03751020|584263202|FG001|Overall Study|Withdrawal by Subject|0|||
161786197|NCT03751020|584263203|FG002|Overall Study|Withdrawal by Subject|0|||
161786198|NCT03751020|584263201|FG000|Overall Study|Lost to Follow-up|7|||
161786199|NCT03751020|584263202|FG001|Overall Study|Lost to Follow-up|4|||
161786200|NCT03751020|584263203|FG002|Overall Study|Lost to Follow-up|10|||
161786201|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
161786202|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161786203|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
161786204|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161786205|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161786206|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161786207|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
161786208|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161786209|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
161786210|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
161786211|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
161786212|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
161786213|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
161786214|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161786215|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161786216|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
161786217|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161786218|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161786219|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
161786220|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161786221|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
161786222|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
161786223|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
161786224|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
161786225|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161786226|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161786227|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
161786228|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161786229|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
161786230|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
161786231|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
161786232|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
161786233|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
161786234|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
161786235|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
161786236|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
161786237|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
161786238|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
161786239|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
161786240|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
161786241|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
161786242|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
161786243|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
161898520|NCT03654729|584677812|FG000|Overall Study|Progressive disease|3|||
161898521|NCT03654729|584677813|FG001|Overall Study|Progressive disease|0|||
161786244|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
161786245|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
161786246|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
161786247|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
161786248|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
161786249|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
161786250|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
161786251|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
161786252|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
161786253|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
161786254|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
161786255|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
161786256|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
161786257|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
161786258|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161786259|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161786260|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161786261|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161786262|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161786263|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161786264|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
161786265|NCT01159769|584263208|FG000|Overall Study|Adverse Event|1|||
161786266|NCT02555618|584263209|FG000|Overall Study|Sponsor's Circumstances|1|||
161786267|NCT02555618|584263210|FG001|Overall Study|Sponsor's Circumstances|0|||
161786268|NCT02217345|584263211|FG000|Overall Study|Lost to Follow-up|2|||
161786269|NCT02217345|584263212|FG001|Overall Study|Lost to Follow-up|1|||
161786270|NCT02217345|584263211|FG000|Overall Study|Withdrawal by Subject|3|||
161786271|NCT02217345|584263212|FG001|Overall Study|Withdrawal by Subject|2|||
161786272|NCT02217345|584263211|FG000|Overall Study|Adverse Event|2|||
161786273|NCT02217345|584263212|FG001|Overall Study|Adverse Event|1|||
161786274|NCT02217345|584263211|FG000|Overall Study|Physician Decision|0|||
161786275|NCT02217345|584263212|FG001|Overall Study|Physician Decision|1|||
161786276|NCT00971204|584263213|FG000|Overall Study|Did not meet all criteria-not treated|14|||
161786277|NCT00971204|584263213|FG000|Overall Study|Lost to Follow-up|10|||
161786278|NCT02624518|584263214|FG000|Overall Study|Physician Decision|1|||
161786279|NCT02729194|584263215|FG000|Overall Study|Withdrawal by Subject|3|||
161786280|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
161786281|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786282|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786283|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786284|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786285|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
161786286|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786287|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786288|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786289|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786290|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
161786291|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786292|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786293|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786294|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786295|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
161786296|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786297|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786298|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786299|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786300|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
161786301|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786302|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786303|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786304|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786305|NCT00272961|584263216|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
161786306|NCT00272961|584263217|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
161786307|NCT00272961|584263218|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
161786308|NCT00272961|584263219|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
161786309|NCT00272961|584263220|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
161786310|NCT00272961|584263216|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
161786311|NCT00272961|584263217|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161786312|NCT00272961|584263218|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
161786313|NCT00272961|584263219|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161786314|NCT00272961|584263220|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161786315|NCT00272961|584263216|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
161786316|NCT00272961|584263217|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
161786317|NCT00272961|584263218|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
161786318|NCT00272961|584263219|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
161786319|NCT00272961|584263220|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
161786320|NCT01507831|584263221|FG000|Overall Study|Randomized but not treated|0|||
161786321|NCT01507831|584263222|FG001|Overall Study|Randomized but not treated|3|||
161786322|NCT01507831|584263221|FG000|Overall Study|Adverse Event|48|||
161786323|NCT01507831|584263222|FG001|Overall Study|Adverse Event|113|||
161786324|NCT01507831|584263221|FG000|Overall Study|Death|6|||
161786325|NCT01507831|584263222|FG001|Overall Study|Death|2|||
161786326|NCT01507831|584263221|FG000|Overall Study|Poor compliance to protocol|38|||
161786327|NCT01507831|584263222|FG001|Overall Study|Poor compliance to protocol|60|||
161786328|NCT01507831|584263221|FG000|Overall Study|Physician Decision|0|||
161786329|NCT01507831|584263222|FG001|Overall Study|Physician Decision|4|||
161786330|NCT01507831|584263221|FG000|Overall Study|Participant moved|5|||
161786331|NCT01507831|584263222|FG001|Overall Study|Participant moved|19|||
161786332|NCT01507831|584263221|FG000|Overall Study|Consent withdrawn by participant|34|||
161786333|NCT01507831|584263222|FG001|Overall Study|Consent withdrawn by participant|72|||
161786334|NCT01507831|584263221|FG000|Overall Study|Related to study drug administration|5|||
161786335|NCT01507831|584263222|FG001|Overall Study|Related to study drug administration|14|||
161786336|NCT01507831|584263221|FG000|Overall Study|Last visit outside protocol visit window|51|||
161786337|NCT01507831|584263222|FG001|Overall Study|Last visit outside protocol visit window|143|||
161786338|NCT01507831|584263221|FG000|Overall Study|Selection criteria finally not met|0|||
161786339|NCT01507831|584263222|FG001|Overall Study|Selection criteria finally not met|1|||
161786340|NCT01507831|584263221|FG000|Overall Study|Site closure|0|||
161786341|NCT01507831|584263222|FG001|Overall Study|Site closure|3|||
161786342|NCT01507831|584263221|FG000|Overall Study|Potential lost to follow-up|3|||
161786343|NCT01507831|584263222|FG001|Overall Study|Potential lost to follow-up|0|||
161786344|NCT01507831|584263221|FG000|Overall Study|Other|3|||
161786345|NCT01507831|584263222|FG001|Overall Study|Other|6|||
161786346|NCT03652961|584263223|FG000|Overall Study|Lost to Follow-up|3|||
161786347|NCT03652961|584263223|FG000|Overall Study|Screen Failure|1|||
161786348|NCT01280981|584263226|FG000|Overall Study|Withdrawal by Subject|11|||
161786349|NCT01280981|584263226|FG000|Overall Study|Protocol Violation|2|||
161786350|NCT01280981|584263226|FG000|Overall Study|Lack of Efficacy|13|||
161786351|NCT01280981|584263226|FG000|Overall Study|Lost to Follow-up|3|||
161786352|NCT01280981|584263226|FG000|Overall Study|Adverse Event|6|||
161786353|NCT01280981|584263226|FG000|Overall Study|Irregular or discontinued menses|3|||
161786354|NCT01280981|584263226|FG000|Overall Study|Failed to return|45|||
161786355|NCT01280981|584263226|FG000|Overall Study|Non-compliance with protocol|3|||
161786356|NCT01280981|584263226|FG000|Overall Study|Withdrawal of consent|3|||
161786357|NCT01280981|584263226|FG000|Overall Study|Elective surgery|2|||
161786358|NCT01280981|584263226|FG000|Overall Study|Study site closure|1|||
161786359|NCT01252238|584263229|FG000|Overall Study|Sponsor terminated study|4|||
161786360|NCT01252238|584263230|FG001|Overall Study|Sponsor terminated study|4|||
161786361|NCT01252238|584263231|FG002|Overall Study|Sponsor terminated study|4|||
161786362|NCT01610167|584263232|FG000|Overall Study|Scheduling conflict.|0|||
161786363|NCT01610167|584263233|FG001|Overall Study|Scheduling conflict.|0|||
161439453|NCT00068692|583003230|FG005|Step 1: Registration|Withdrawal by Subject|0|||
161439454|NCT00068692|583003231|FG006|Step 1: Registration|Withdrawal by Subject|0|||
161439455|NCT00068692|583003232|FG007|Step 1: Registration|Withdrawal by Subject|0|||
161439456|NCT00068692|583003225|FG000|Step 1: Registration|Alternative therapy|2|||
161439457|NCT00068692|583003226|FG001|Step 1: Registration|Alternative therapy|0|||
161439458|NCT00068692|583003227|FG002|Step 1: Registration|Alternative therapy|0|||
161439459|NCT00068692|583003228|FG003|Step 1: Registration|Alternative therapy|0|||
161439460|NCT00068692|583003229|FG004|Step 1: Registration|Alternative therapy|0|||
161439461|NCT00068692|583003230|FG005|Step 1: Registration|Alternative therapy|0|||
161786364|NCT01610167|584263234|FG002|Overall Study|Scheduling conflict.|2|||
161786365|NCT03276962|584263239|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
161786366|NCT03276962|584263240|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
161786367|NCT03276962|584263241|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
161786368|NCT03276962|584263242|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
161786369|NCT03276962|584263243|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
161786370|NCT03276962|584263239|FG000|Overall Study|Protocol Deviation|2|||
161786371|NCT03276962|584263240|FG001|Overall Study|Protocol Deviation|0|||
161786372|NCT03276962|584263241|FG002|Overall Study|Protocol Deviation|1|||
161786373|NCT03276962|584263242|FG003|Overall Study|Protocol Deviation|2|||
161786374|NCT03276962|584263243|FG004|Overall Study|Protocol Deviation|1|||
161439462|NCT00068692|583003231|FG006|Step 1: Registration|Alternative therapy|0|||
161786375|NCT03276962|584263239|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
161786376|NCT03276962|584263240|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161786377|NCT03276962|584263241|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
161786378|NCT03276962|584263242|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161786379|NCT03276962|584263243|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
161786380|NCT03276962|584263239|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
161786381|NCT03276962|584263240|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
161786382|NCT03276962|584263241|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
161786383|NCT03276962|584263242|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
161786384|NCT03276962|584263243|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
161786385|NCT03276962|584263239|FG000|Overall Study|Lost to Follow-up|10|||
161786386|NCT03276962|584263240|FG001|Overall Study|Lost to Follow-up|10|||
161786387|NCT03276962|584263241|FG002|Overall Study|Lost to Follow-up|4|||
161786388|NCT03276962|584263242|FG003|Overall Study|Lost to Follow-up|6|||
161786389|NCT03276962|584263243|FG004|Overall Study|Lost to Follow-up|10|||
161786390|NCT03276962|584263239|FG000|Overall Study|Other|0|||
161786391|NCT03276962|584263240|FG001|Overall Study|Other|2|||
161786392|NCT03276962|584263241|FG002|Overall Study|Other|0|||
161786393|NCT03276962|584263242|FG003|Overall Study|Other|2|||
161786394|NCT03276962|584263243|FG004|Overall Study|Other|1|||
161786395|NCT01358708|584263244|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161786396|NCT01358708|584263245|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161786397|NCT01358708|584263244|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161786398|NCT01358708|584263245|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
161786399|NCT03056001|584263249|FG000|Overall Study|Death|24|||
161786400|NCT01364298|584263252|FG000|Overall Study|Adverse Event|3|||
161786401|NCT01364298|584263253|FG001|Overall Study|Adverse Event|4|||
161786402|NCT01364298|584263252|FG000|Overall Study|Lack of adherence to treatment|1|||
161786403|NCT01364298|584263253|FG001|Overall Study|Lack of adherence to treatment|3|||
161786404|NCT01364298|584263252|FG000|Overall Study|Lack of Efficacy|1|||
161786405|NCT01364298|584263253|FG001|Overall Study|Lack of Efficacy|0|||
161786406|NCT01364298|584263252|FG000|Overall Study|Lost to Follow-up|5|||
161786407|NCT01364298|584263253|FG001|Overall Study|Lost to Follow-up|10|||
161786408|NCT01364298|584263252|FG000|Overall Study|Withdrawal by Subject|3|||
161786409|NCT01364298|584263253|FG001|Overall Study|Withdrawal by Subject|3|||
161786410|NCT01364298|584263252|FG000|Overall Study|Other|1|||
161786411|NCT01364298|584263253|FG001|Overall Study|Other|3|||
161786412|NCT03712228|584263254|FG000|Treatment Period 1|Lack of Efficacy|0|||
161786413|NCT03712228|584263255|FG001|Treatment Period 1|Lack of Efficacy|0|||
161786414|NCT03712228|584263256|FG002|Treatment Period 1|Lack of Efficacy|0|||
161786415|NCT03712228|584263257|FG003|Treatment Period 1|Lack of Efficacy|0|||
161786416|NCT03712228|584263258|FG004|Treatment Period 1|Lack of Efficacy|0|||
161786417|NCT03712228|584263259|FG005|Treatment Period 1|Lack of Efficacy|1|||
161786418|NCT03712228|584263254|FG000|Treatment Period 2|Pregnancy|0|||
161786419|NCT03712228|584263255|FG001|Treatment Period 2|Pregnancy|0|||
161786420|NCT03712228|584263256|FG002|Treatment Period 2|Pregnancy|0|||
161786421|NCT03712228|584263257|FG003|Treatment Period 2|Pregnancy|1|||
161786422|NCT03712228|584263258|FG004|Treatment Period 2|Pregnancy|0|||
161786423|NCT03712228|584263259|FG005|Treatment Period 2|Pregnancy|0|||
161786424|NCT03712228|584263254|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161786425|NCT03712228|584263255|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161786426|NCT03712228|584263256|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161786427|NCT03712228|584263257|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161786428|NCT03712228|584263258|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161786429|NCT03712228|584263259|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161786430|NCT01964105|584263260|FG000|Overall Study|Lost to Follow-up|2|||
161786431|NCT01964105|584263261|FG001|Overall Study|Lost to Follow-up|13|||
161786432|NCT01964105|584263262|FG002|Overall Study|Lost to Follow-up|0|||
161786433|NCT01254045|584263265|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
161786434|NCT01254045|584263266|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786435|NCT01254045|584263267|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786436|NCT01254045|584263268|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786437|NCT01254045|584263269|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786438|NCT01254045|584263270|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786439|NCT00597207|584263271|FG000|Overall Study|Lost to Follow-up|5|||
161786440|NCT00597207|584263272|FG001|Overall Study|Lost to Follow-up|7|||
161786441|NCT00520351|584263273|FG000|First Intervention|Withdrawal by Subject|1|||
161786442|NCT00520351|584263274|FG001|First Intervention|Withdrawal by Subject|1|||
161786443|NCT04288115|584263283|FG000|Overall Study|Withdrawal by Subject|0|||
161786444|NCT04288115|584263284|FG001|Overall Study|Withdrawal by Subject|1|||
161786445|NCT04288115|584263283|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
161786446|NCT04288115|584263284|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
161786447|NCT02766400|584263287|FG000|Overall Study|Death|1|||
161786448|NCT02766400|584263288|FG001|Overall Study|Death|2|||
161786449|NCT02766400|584263287|FG000|Overall Study|Withdrawal by Subject|1|||
161786450|NCT02766400|584263288|FG001|Overall Study|Withdrawal by Subject|0|||
161786451|NCT03499249|584263289|FG000|Overall Study|Physician Decision|1|||
161786452|NCT01374906|584263290|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161786453|NCT01374906|584263291|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161786454|NCT01374906|584263290|FG000|Overall Study|Administrative problems|2|||
161786455|NCT01374906|584263291|FG001|Overall Study|Administrative problems|2|||
161786456|NCT01374906|584263290|FG000|Overall Study|Adverse Event|10|||
161786457|NCT01374906|584263291|FG001|Overall Study|Adverse Event|11|||
161786458|NCT01374906|584263290|FG000|Overall Study|Death|0|||
161786459|NCT01374906|584263291|FG001|Overall Study|Death|2|||
161786460|NCT01374906|584263290|FG000|Overall Study|Protocol Violation|2|||
161786461|NCT01374906|584263291|FG001|Overall Study|Protocol Violation|2|||
161786462|NCT01374906|584263290|FG000|Overall Study|Withdrawal by Subject|15|||
161786463|NCT01374906|584263291|FG001|Overall Study|Withdrawal by Subject|9|||
161786464|NCT01374906|584263290|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
161786465|NCT01374906|584263291|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
161786466|NCT02475980|584263296|FG000|Overall Study|Lost to Follow-up|4|||
161786467|NCT02475980|584263296|FG000|Overall Study|Withdrawal by Subject|1|||
161786468|NCT01529749|584263301|FG000|Overall Study|Lost to Follow-up|0|||
161786469|NCT01529749|584263302|FG001|Overall Study|Lost to Follow-up|1|||
161786470|NCT01529749|584263303|FG002|Overall Study|Lost to Follow-up|1|||
161786471|NCT01529749|584263304|FG003|Overall Study|Lost to Follow-up|0|||
161786472|NCT01529749|584263301|FG000|Overall Study|Physician Decision|0|||
161786473|NCT01529749|584263302|FG001|Overall Study|Physician Decision|0|||
161786474|NCT01529749|584263303|FG002|Overall Study|Physician Decision|0|||
161786475|NCT01529749|584263304|FG003|Overall Study|Physician Decision|1|||
161786476|NCT01529749|584263301|FG000|Overall Study|Withdrawal by Subject|0|||
161786477|NCT01529749|584263302|FG001|Overall Study|Withdrawal by Subject|1|||
161786478|NCT01529749|584263303|FG002|Overall Study|Withdrawal by Subject|1|||
161786479|NCT01529749|584263304|FG003|Overall Study|Withdrawal by Subject|0|||
161786480|NCT01529749|584263301|FG000|Overall Study|Protocol Violation|0|||
161786481|NCT01529749|584263302|FG001|Overall Study|Protocol Violation|0|||
161786482|NCT01529749|584263303|FG002|Overall Study|Protocol Violation|0|||
161786483|NCT01529749|584263304|FG003|Overall Study|Protocol Violation|1|||
161786484|NCT00789828|584263305|FG000|Core Period (48 Weeks)|Administrative problems|0|||
161786485|NCT00789828|584263306|FG001|Core Period (48 Weeks)|Administrative problems|1|||
161786486|NCT00789828|584263305|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
161786487|NCT00789828|584263306|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
161786488|NCT00789828|584263305|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
161786489|NCT00789828|584263306|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
161786490|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
161786491|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
161786492|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
161786493|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
161786494|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
161786495|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
161786496|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
161786497|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
161786498|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Death|1|||
161786499|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Death|0|||
161786500|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
161786501|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
161786502|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
161786503|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
161786504|NCT02623426|584263307|FG000|Overall Study|Lost to Follow-up|0|||
161786505|NCT02623426|584263308|FG001|Overall Study|Lost to Follow-up|0|||
161786506|NCT02623426|584263309|FG002|Overall Study|Lost to Follow-up|1|||
161786507|NCT02623426|584263307|FG000|Overall Study|Withdrawal by Subject|1|||
161786508|NCT02623426|584263308|FG001|Overall Study|Withdrawal by Subject|2|||
161786509|NCT02623426|584263309|FG002|Overall Study|Withdrawal by Subject|2|||
161786510|NCT02094937|584263310|FG000|8 Weeks in Period 1|Adverse Event|9|||
161439463|NCT00068692|583003232|FG007|Step 1: Registration|Alternative therapy|0|||
161439464|NCT00068692|583003225|FG000|Step 1: Registration|Complicating disease|2|||
161439465|NCT00068692|583003226|FG001|Step 1: Registration|Complicating disease|0|||
161786511|NCT02094937|584263311|FG001|8 Weeks in Period 1|Adverse Event|0|||
161786512|NCT02094937|584263312|FG002|8 Weeks in Period 1|Adverse Event|0|||
161439466|NCT00068692|583003227|FG002|Step 1: Registration|Complicating disease|0|||
161786513|NCT02094937|584263313|FG003|8 Weeks in Period 1|Adverse Event|0|||
161786514|NCT02094937|584263310|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
161786515|NCT02094937|584263311|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
161786516|NCT02094937|584263312|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
161786517|NCT02094937|584263313|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
161786518|NCT02094937|584263310|FG000|8 Weeks in Period 1|Protocol Violation|2|||
161786519|NCT02094937|584263311|FG001|8 Weeks in Period 1|Protocol Violation|0|||
161786520|NCT02094937|584263312|FG002|8 Weeks in Period 1|Protocol Violation|0|||
161786521|NCT02094937|584263313|FG003|8 Weeks in Period 1|Protocol Violation|0|||
161786522|NCT02094937|584263310|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
161786523|NCT02094937|584263311|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161786524|NCT02094937|584263312|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161786525|NCT02094937|584263313|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161786526|NCT02094937|584263310|FG000|8 Weeks in Period 1|Physician Decision|1|||
161786527|NCT02094937|584263311|FG001|8 Weeks in Period 1|Physician Decision|0|||
161786528|NCT02094937|584263312|FG002|8 Weeks in Period 1|Physician Decision|0|||
161786529|NCT02094937|584263313|FG003|8 Weeks in Period 1|Physician Decision|0|||
161786530|NCT02094937|584263310|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
161786531|NCT02094937|584263311|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
161786532|NCT02094937|584263312|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
161786533|NCT02094937|584263313|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
161786534|NCT02094937|584263310|FG000|12 Weeks in Period 2|Adverse Event|0|||
161786535|NCT02094937|584263311|FG001|12 Weeks in Period 2|Adverse Event|2|||
161786536|NCT02094937|584263312|FG002|12 Weeks in Period 2|Adverse Event|4|||
161786537|NCT02094937|584263313|FG003|12 Weeks in Period 2|Adverse Event|1|||
161786538|NCT02094937|584263310|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
161786539|NCT02094937|584263311|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
161786540|NCT02094937|584263312|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
161786541|NCT02094937|584263313|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
161786542|NCT02094937|584263310|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
161786543|NCT02094937|584263311|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
161786544|NCT02094937|584263312|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
161786545|NCT02094937|584263313|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
161786546|NCT02094937|584263310|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
161786547|NCT02094937|584263311|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
161786548|NCT02094937|584263312|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
161786549|NCT02094937|584263313|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
161786550|NCT02094937|584263310|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
161786551|NCT02094937|584263311|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
161786552|NCT02094937|584263312|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
161786553|NCT02094937|584263313|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
161786554|NCT01133392|584263314|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
161786555|NCT01133392|584263315|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
161786556|NCT01133392|584263314|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
161786557|NCT01133392|584263315|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
161786558|NCT03751124|584263316|FG000|Overall Study|Adverse Event|4|||
161786559|NCT03751124|584263317|FG001|Overall Study|Adverse Event|3|||
161786560|NCT03751124|584263316|FG000|Overall Study|Protocol Deviation|0|||
161786561|NCT03751124|584263317|FG001|Overall Study|Protocol Deviation|1|||
161786562|NCT03751124|584263316|FG000|Overall Study|Lost to Follow-up|6|||
161786563|NCT03751124|584263317|FG001|Overall Study|Lost to Follow-up|4|||
161786564|NCT03751124|584263316|FG000|Overall Study|Withdrawal by Subject|6|||
161786565|NCT03751124|584263317|FG001|Overall Study|Withdrawal by Subject|8|||
161786566|NCT03751124|584263316|FG000|Overall Study|Lack of Efficacy|1|||
161786567|NCT03751124|584263317|FG001|Overall Study|Lack of Efficacy|1|||
161786568|NCT03751124|584263316|FG000|Overall Study|Pregnancy|0|||
161786569|NCT03751124|584263317|FG001|Overall Study|Pregnancy|1|||
161786570|NCT03751124|584263316|FG000|Overall Study|Other|9|||
161786571|NCT03751124|584263317|FG001|Overall Study|Other|9|||
161786572|NCT03751124|584263316|FG000|Overall Study|Participants who did not receive any study drug|0|||
161786573|NCT03751124|584263317|FG001|Overall Study|Participants who did not receive any study drug|1|||
161786574|NCT00555399|584263320|FG000|Overall Study|Withdrawal by Subject|0|||
161786575|NCT00555399|584263321|FG001|Overall Study|Withdrawal by Subject|0|||
161786576|NCT00555399|584263322|FG002|Overall Study|Withdrawal by Subject|1|||
161786577|NCT00555399|584263323|FG003|Overall Study|Withdrawal by Subject|0|||
161786578|NCT00555399|584263324|FG004|Overall Study|Withdrawal by Subject|0|||
161786579|NCT00555399|584263325|FG005|Overall Study|Withdrawal by Subject|0|||
161786580|NCT00555399|584263326|FG006|Overall Study|Withdrawal by Subject|0|||
161898522|NCT03654729|584677814|FG002|Overall Study|Progressive disease|0|||
161786581|NCT00555399|584263327|FG007|Overall Study|Withdrawal by Subject|0|||
161786582|NCT00555399|584263328|FG008|Overall Study|Withdrawal by Subject|0|||
161786583|NCT00555399|584263329|FG009|Overall Study|Withdrawal by Subject|0|||
161786584|NCT00555399|584263330|FG010|Overall Study|Withdrawal by Subject|0|||
161786585|NCT00555399|584263331|FG011|Overall Study|Withdrawal by Subject|1|||
161786586|NCT00555399|584263320|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
161786587|NCT00555399|584263321|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
161786588|NCT00555399|584263322|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
161898523|NCT03654729|584677812|FG000|Overall Study|Lost to Follow-up|2|||
161898524|NCT03654729|584677813|FG001|Overall Study|Lost to Follow-up|0|||
161898525|NCT03654729|584677814|FG002|Overall Study|Lost to Follow-up|0|||
161786589|NCT00555399|584263323|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
161786590|NCT00555399|584263324|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
161786591|NCT00555399|584263325|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
161786592|NCT00555399|584263326|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
161786593|NCT00555399|584263327|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
161786594|NCT00555399|584263328|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
161786595|NCT00555399|584263329|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
161786596|NCT00555399|584263330|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
161786597|NCT00555399|584263331|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
161786598|NCT05458895|584263332|FG000|Overall Study|Withdrawal by Subject|8|||
161786599|NCT05458895|584263332|FG000|Overall Study|Lost to Follow-up|17|||
161786600|NCT05458895|584263332|FG000|Overall Study|Pregnancy|2|||
161786601|NCT05458895|584263332|FG000|Overall Study|Withdrawal by Study Team|1|||
161786602|NCT04639310|584263333|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
161786603|NCT04639310|584263334|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
161786604|NCT05166421|584263335|FG000|Overall Study|Other|3|||
161786605|NCT05166421|584263336|FG001|Overall Study|Other|1|||
161786606|NCT05166421|584263337|FG002|Overall Study|Other|1|||
161439467|NCT00068692|583003228|FG003|Step 1: Registration|Complicating disease|0|||
161439468|NCT00068692|583003229|FG004|Step 1: Registration|Complicating disease|0|||
161439469|NCT00068692|583003230|FG005|Step 1: Registration|Complicating disease|0|||
161786607|NCT05166421|584263335|FG000|Overall Study|Withdrawal by Subject|5|||
161786608|NCT05166421|584263336|FG001|Overall Study|Withdrawal by Subject|3|||
161786609|NCT05166421|584263337|FG002|Overall Study|Withdrawal by Subject|6|||
161786610|NCT05166421|584263335|FG000|Overall Study|Lost to Follow-up|4|||
161786611|NCT05166421|584263336|FG001|Overall Study|Lost to Follow-up|1|||
161786612|NCT05166421|584263337|FG002|Overall Study|Lost to Follow-up|7|||
161786613|NCT03770000|584265355|FG000|Overall Study|Premature discontinuation due to PD|0|||
161786614|NCT03770000|584265356|FG001|Overall Study|Premature discontinuation due to PD|0|||
161786615|NCT03770000|584265357|FG002|Overall Study|Premature discontinuation due to PD|1|||
161786616|NCT03770000|584265358|FG003|Overall Study|Premature discontinuation due to PD|3|||
161786617|NCT03770000|584265359|FG004|Overall Study|Premature discontinuation due to PD|2|||
161786618|NCT02290028|584265360|FG000|Overall Study|Death|217|||
161786619|NCT02290028|584265360|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
161786620|NCT02290028|584265360|FG000|Overall Study|No longer under care of study physician|76|||
161786621|NCT02290028|584265360|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
161786622|NCT02290028|584265360|FG000|Overall Study|Withdrawal by Subject|52|||
161786623|NCT02290028|584265360|FG000|Overall Study|Study site closure|44|||
161786624|NCT02290028|584265360|FG000|Overall Study|Lost to Follow-up|34|||
161786625|NCT02290028|584265360|FG000|Overall Study|Miscellaneous|10|||
161786626|NCT02290028|584265360|FG000|Overall Study|Transition to EP PASSION|1295|||
161786627|NCT02290028|584265360|FG000|Overall Study|Planned study completion at 12 months|257|||
161786628|NCT00833547|584265361|FG000|Overall Study|Withdrawal by Subject|2|||
161786629|NCT00833547|584265362|FG001|Overall Study|Withdrawal by Subject|2|||
161786630|NCT01375010|584265365|FG000|Overall Study|Lost to Follow-up|8|||
161786631|NCT01375010|584265366|FG001|Overall Study|Lost to Follow-up|2|||
161786632|NCT01375010|584265365|FG000|Overall Study|Withdrawal by Subject|4|||
161786633|NCT01375010|584265366|FG001|Overall Study|Withdrawal by Subject|2|||
161786634|NCT02402933|584265368|FG000|Overall Study|Withdrawal by Subject|4|||
161786635|NCT02402933|584265368|FG000|Overall Study|Discontinued; Site Termination|10|||
161786636|NCT00830063|584265369|FG000|Overall Study|Adverse Event|7|||
161786637|NCT00830063|584265370|FG001|Overall Study|Adverse Event|13|||
161786638|NCT00830063|584265371|FG002|Overall Study|Adverse Event|16|||
161786639|NCT00830063|584265372|FG003|Overall Study|Adverse Event|13|||
161898526|NCT03654729|584677812|FG000|Overall Study|Physician Decision|2|||
161439470|NCT00068692|583003231|FG006|Step 1: Registration|Complicating disease|0|||
161439471|NCT00068692|583003232|FG007|Step 1: Registration|Complicating disease|0|||
161439472|NCT00068692|583003225|FG000|Step 1: Registration|Protocol Violation|1|||
161439473|NCT00068692|583003226|FG001|Step 1: Registration|Protocol Violation|0|||
161439474|NCT00068692|583003227|FG002|Step 1: Registration|Protocol Violation|0|||
161439475|NCT00068692|583003228|FG003|Step 1: Registration|Protocol Violation|0|||
161439476|NCT00068692|583003229|FG004|Step 1: Registration|Protocol Violation|0|||
161439477|NCT00068692|583003230|FG005|Step 1: Registration|Protocol Violation|0|||
161439478|NCT00068692|583003231|FG006|Step 1: Registration|Protocol Violation|0|||
161439479|NCT00068692|583003232|FG007|Step 1: Registration|Protocol Violation|0|||
161786640|NCT00830063|584265369|FG000|Overall Study|Death|1|||
161898527|NCT03654729|584677813|FG001|Overall Study|Physician Decision|0|||
161898528|NCT03654729|584677814|FG002|Overall Study|Physician Decision|0|||
161898529|NCT03654729|584677812|FG000|Overall Study|Protocol Violation|1|||
161786641|NCT00830063|584265370|FG001|Overall Study|Death|0|||
161786642|NCT00830063|584265371|FG002|Overall Study|Death|0|||
161786643|NCT00830063|584265372|FG003|Overall Study|Death|0|||
161786644|NCT00830063|584265369|FG000|Overall Study|Lost to Follow-up|0|||
161786645|NCT00830063|584265370|FG001|Overall Study|Lost to Follow-up|0|||
161786646|NCT00830063|584265371|FG002|Overall Study|Lost to Follow-up|3|||
161786647|NCT00830063|584265372|FG003|Overall Study|Lost to Follow-up|1|||
161786648|NCT00830063|584265369|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
161786649|NCT00830063|584265370|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
161786650|NCT00830063|584265371|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
161786651|NCT00830063|584265372|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
161786652|NCT00830063|584265369|FG000|Overall Study|Lack of Efficacy|51|||
161786653|NCT00830063|584265370|FG001|Overall Study|Lack of Efficacy|23|||
161786654|NCT00830063|584265371|FG002|Overall Study|Lack of Efficacy|25|||
161786655|NCT00830063|584265372|FG003|Overall Study|Lack of Efficacy|32|||
161786656|NCT00830063|584265369|FG000|Overall Study|Other|5|||
161786657|NCT00830063|584265370|FG001|Overall Study|Other|5|||
161786658|NCT00830063|584265371|FG002|Overall Study|Other|8|||
161786659|NCT00830063|584265372|FG003|Overall Study|Other|6|||
161786660|NCT00830063|584265369|FG000|Overall Study|Withdrawal by Subject|16|||
161786661|NCT00830063|584265370|FG001|Overall Study|Withdrawal by Subject|10|||
161786662|NCT00830063|584265371|FG002|Overall Study|Withdrawal by Subject|16|||
161786663|NCT00830063|584265372|FG003|Overall Study|Withdrawal by Subject|13|||
161786664|NCT00830063|584265369|FG000|Overall Study|Protocol Violation|1|||
161786665|NCT00830063|584265370|FG001|Overall Study|Protocol Violation|0|||
161786666|NCT00830063|584265371|FG002|Overall Study|Protocol Violation|3|||
161786667|NCT00830063|584265372|FG003|Overall Study|Protocol Violation|2|||
161786668|NCT00830063|584265369|FG000|Overall Study|Randomized But Not Treated|0|||
161786669|NCT00830063|584265370|FG001|Overall Study|Randomized But Not Treated|2|||
161786670|NCT00830063|584265371|FG002|Overall Study|Randomized But Not Treated|0|||
161786671|NCT00830063|584265372|FG003|Overall Study|Randomized But Not Treated|2|||
161786672|NCT01847313|584265373|FG000|Overall Study|Death|0|||
161786673|NCT01847313|584265374|FG001|Overall Study|Death|1|||
161786674|NCT01847313|584265373|FG000|Overall Study|Withdrawal by Subject|0|||
161786675|NCT01847313|584265374|FG001|Overall Study|Withdrawal by Subject|1|||
161786676|NCT00598559|584265375|FG000|Overall Study|Adverse Event|11|||
161786677|NCT00598559|584265376|FG001|Overall Study|Adverse Event|7|||
161786678|NCT00598559|584265377|FG002|Overall Study|Adverse Event|0|||
161786679|NCT00598559|584265375|FG000|Overall Study|Withdrawal by Subject|2|||
161786680|NCT00598559|584265376|FG001|Overall Study|Withdrawal by Subject|2|||
161786681|NCT00598559|584265377|FG002|Overall Study|Withdrawal by Subject|0|||
161439480|NCT00068692|583003225|FG000|Step 1: Registration|Not eligible|6|||
161439481|NCT00068692|583003226|FG001|Step 1: Registration|Not eligible|0|||
161439482|NCT00068692|583003227|FG002|Step 1: Registration|Not eligible|0|||
161439483|NCT00068692|583003228|FG003|Step 1: Registration|Not eligible|0|||
161439484|NCT00068692|583003229|FG004|Step 1: Registration|Not eligible|0|||
161439485|NCT00068692|583003230|FG005|Step 1: Registration|Not eligible|0|||
161439486|NCT00068692|583003231|FG006|Step 1: Registration|Not eligible|0|||
161786682|NCT00598559|584265375|FG000|Overall Study|Protocol Non-compliance|1|||
161786683|NCT00598559|584265376|FG001|Overall Study|Protocol Non-compliance|0|||
161786684|NCT00598559|584265377|FG002|Overall Study|Protocol Non-compliance|0|||
161439487|NCT00068692|583003232|FG007|Step 1: Registration|Not eligible|0|||
161439488|NCT00068692|583003225|FG000|Step 1: Registration|Other|2|||
161439489|NCT00068692|583003226|FG001|Step 1: Registration|Other|0|||
161439490|NCT00068692|583003227|FG002|Step 1: Registration|Other|0|||
161439491|NCT00068692|583003228|FG003|Step 1: Registration|Other|0|||
161439492|NCT00068692|583003229|FG004|Step 1: Registration|Other|0|||
161439493|NCT00068692|583003230|FG005|Step 1: Registration|Other|0|||
161439494|NCT00068692|583003231|FG006|Step 1: Registration|Other|0|||
161439495|NCT00068692|583003232|FG007|Step 1: Registration|Other|0|||
161439496|NCT00068692|583003225|FG000|Step 1: Registration|Not start protocol therapy|3|||
161439497|NCT00068692|583003226|FG001|Step 1: Registration|Not start protocol therapy|0|||
161439498|NCT00068692|583003227|FG002|Step 1: Registration|Not start protocol therapy|0|||
161439499|NCT00068692|583003228|FG003|Step 1: Registration|Not start protocol therapy|0|||
161439500|NCT00068692|583003229|FG004|Step 1: Registration|Not start protocol therapy|0|||
161439501|NCT00068692|583003230|FG005|Step 1: Registration|Not start protocol therapy|0|||
161439502|NCT00068692|583003231|FG006|Step 1: Registration|Not start protocol therapy|0|||
161439503|NCT00068692|583003232|FG007|Step 1: Registration|Not start protocol therapy|0|||
161439504|NCT00068692|583003225|FG000|Step 1: Registration|Registered but not randomized|0|||
161786685|NCT00598559|584265375|FG000|Overall Study|Early discharge from hospital|9|||
161786686|NCT00598559|584265376|FG001|Overall Study|Early discharge from hospital|12|||
161786687|NCT00598559|584265377|FG002|Overall Study|Early discharge from hospital|3|||
161786688|NCT00598559|584265375|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
161786689|NCT00598559|584265376|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
161786690|NCT00598559|584265377|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
161898530|NCT03654729|584677813|FG001|Overall Study|Protocol Violation|1|||
161786691|NCT01059071|584265378|FG000|Overall Study|Lack of Efficacy|1|||
161786692|NCT01059071|584265379|FG001|Overall Study|Lack of Efficacy|4|||
161786693|NCT01059071|584265380|FG002|Overall Study|Lack of Efficacy|2|||
161786694|NCT01059071|584265381|FG003|Overall Study|Lack of Efficacy|3|||
161786695|NCT01059071|584265378|FG000|Overall Study|Withdrawal by Subject|1|||
161786696|NCT01059071|584265379|FG001|Overall Study|Withdrawal by Subject|0|||
161786697|NCT01059071|584265380|FG002|Overall Study|Withdrawal by Subject|0|||
161786698|NCT01059071|584265381|FG003|Overall Study|Withdrawal by Subject|2|||
161786699|NCT01059071|584265378|FG000|Overall Study|Physician Decision|0|||
161786700|NCT01059071|584265379|FG001|Overall Study|Physician Decision|0|||
161786701|NCT01059071|584265380|FG002|Overall Study|Physician Decision|0|||
161786702|NCT01059071|584265381|FG003|Overall Study|Physician Decision|1|||
161786703|NCT02962882|584265382|FG000|Overall Study|Adverse Event|2|||
161786704|NCT02962882|584265382|FG000|Overall Study|Withdrawal by Subject|2|||
161786705|NCT02962882|584265382|FG000|Overall Study|Transfer from ICU|32|||
161786706|NCT03763331|584265387|FG000|Overall Study|Lost to Follow-up|1|||
161786707|NCT03763331|584265388|FG001|Overall Study|Lost to Follow-up|0|||
161786708|NCT03763331|584265387|FG000|Overall Study|Withdrawal by Subject|1|||
161786709|NCT03763331|584265388|FG001|Overall Study|Withdrawal by Subject|0|||
161786710|NCT03763331|584265387|FG000|Overall Study|Non-compliance|0|||
161786711|NCT03763331|584265388|FG001|Overall Study|Non-compliance|3|||
161786712|NCT01155063|584265389|FG000|Overall Study|Adverse Event|1|||
161786713|NCT01155063|584265389|FG000|Overall Study|Withdrawal by Subject|1|||
161786714|NCT01155063|584265389|FG000|Overall Study|Study terminated by sponsor|87|||
161786715|NCT00936884|584265390|FG000|Double-blind|Withdrawal by Subject|6|||
161786716|NCT00936884|584265391|FG001|Double-blind|Withdrawal by Subject|4|||
161786717|NCT00936884|584265392|FG002|Double-blind|Withdrawal by Subject|0|||
161786718|NCT00936884|584265390|FG000|Double-blind|Death|2|||
161786719|NCT00936884|584265391|FG001|Double-blind|Death|1|||
161786720|NCT00936884|584265392|FG002|Double-blind|Death|0|||
161786721|NCT00936884|584265390|FG000|Double-blind|Lack of Efficacy|1|||
161786722|NCT00936884|584265391|FG001|Double-blind|Lack of Efficacy|1|||
161786723|NCT00936884|584265392|FG002|Double-blind|Lack of Efficacy|0|||
161786724|NCT00936884|584265390|FG000|Double-blind|Adverse Event|1|||
161786725|NCT00936884|584265391|FG001|Double-blind|Adverse Event|0|||
161786726|NCT00936884|584265392|FG002|Double-blind|Adverse Event|0|||
161786727|NCT00936884|584265390|FG000|Double-blind|Physician Decision|1|||
161786728|NCT00936884|584265391|FG001|Double-blind|Physician Decision|0|||
161786729|NCT00936884|584265392|FG002|Double-blind|Physician Decision|0|||
161786730|NCT00936884|584265390|FG000|Double-blind|No post baseline diary entry|1|||
161786731|NCT00936884|584265391|FG001|Double-blind|No post baseline diary entry|0|||
161786732|NCT00936884|584265392|FG002|Double-blind|No post baseline diary entry|0|||
161786733|NCT00936884|584265390|FG000|Double-blind|Did not receive study drug|0|||
161786734|NCT00936884|584265391|FG001|Double-blind|Did not receive study drug|1|||
161786735|NCT00936884|584265392|FG002|Double-blind|Did not receive study drug|0|||
161786736|NCT01663714|584265393|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
161786737|NCT01663714|584265393|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
161786738|NCT01663714|584265393|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
161786739|NCT01663714|584265393|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
161786740|NCT01663714|584265393|FG000|Long-Term Follow-Up|Death|4|||
161786741|NCT01663714|584265393|FG000|Long-Term Follow-Up|Non-compliance|1|||
161786742|NCT00597584|584265394|FG000|Overall Study|Adverse Event|4|||
161786743|NCT00597584|584265395|FG001|Overall Study|Adverse Event|2|||
161786744|NCT00597584|584265394|FG000|Overall Study|Death|53|||
161786745|NCT00597584|584265395|FG001|Overall Study|Death|30|||
161786746|NCT00597584|584265394|FG000|Overall Study|Lack of Efficacy|1|||
161786747|NCT00597584|584265395|FG001|Overall Study|Lack of Efficacy|0|||
161786748|NCT00597584|584265394|FG000|Overall Study|Lost to Follow-up|2|||
161786749|NCT00597584|584265395|FG001|Overall Study|Lost to Follow-up|4|||
161786750|NCT00597584|584265394|FG000|Overall Study|Physician Decision|3|||
161786751|NCT00597584|584265395|FG001|Overall Study|Physician Decision|0|||
161786752|NCT00597584|584265394|FG000|Overall Study|Pregnancy|2|||
161786753|NCT00597584|584265395|FG001|Overall Study|Pregnancy|0|||
161786754|NCT00597584|584265394|FG000|Overall Study|Withdrawal by Subject|44|||
161786755|NCT00597584|584265395|FG001|Overall Study|Withdrawal by Subject|12|||
161786756|NCT00597584|584265394|FG000|Overall Study|Discontinued Dialysis|0|||
161786757|NCT00597584|584265395|FG001|Overall Study|Discontinued Dialysis|1|||
161786758|NCT00597584|584265394|FG000|Overall Study|Lost ability to consent|1|||
161786759|NCT00597584|584265395|FG001|Overall Study|Lost ability to consent|1|||
161786760|NCT00597584|584265394|FG000|Overall Study|Never dosed|1|||
161786761|NCT00597584|584265395|FG001|Overall Study|Never dosed|0|||
161786762|NCT00597584|584265394|FG000|Overall Study|Relocation|8|||
161786763|NCT00597584|584265395|FG001|Overall Study|Relocation|6|||
161786764|NCT00597584|584265394|FG000|Overall Study|Renal transplant|9|||
161786765|NCT00597584|584265395|FG001|Overall Study|Renal transplant|7|||
161786766|NCT02280421|584265396|FG000|Washout (2 Weeks)|Adverse Event|0|||
161786767|NCT02280421|584265397|FG001|Washout (2 Weeks)|Adverse Event|1|||
161786768|NCT02280421|584265396|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161786769|NCT02280421|584265397|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
161786770|NCT02791659|584265409|FG000|Overall Study|Protocol Violation|0|||
161786771|NCT02791659|584265410|FG001|Overall Study|Protocol Violation|1|||
161786772|NCT00881959|584265411|FG000|Overall Study|Lost to Follow-up|2|||
161786773|NCT00881959|584265412|FG001|Overall Study|Lost to Follow-up|4|||
161786774|NCT01904383|584265413|FG000|Overall Study|CRF not collected|117|||
161786775|NCT01904383|584265413|FG000|Overall Study|Reason not listed|147|||
161786776|NCT01904383|584265413|FG000|Overall Study|Lost to Follow-up|674|||
161786777|NCT01904383|584265413|FG000|Overall Study|Lack of Efficacy|370|||
161786778|NCT01904383|584265413|FG000|Overall Study|Improvement|141|||
161786779|NCT01904383|584265413|FG000|Overall Study|Adverse Event|271|||
161786780|NCT01904383|584265413|FG000|Overall Study|No patient visit after entry|54|||
161786781|NCT00472446|584265414|FG000|Overall Study|Protocol Violation|0|||
161786782|NCT00472446|584265415|FG001|Overall Study|Protocol Violation|0|||
161786783|NCT00472446|584265416|FG002|Overall Study|Protocol Violation|0|||
161786784|NCT00472446|584265417|FG003|Overall Study|Protocol Violation|1|||
161786785|NCT00472446|584265414|FG000|Overall Study|Reintervention|0|||
161786786|NCT00472446|584265415|FG001|Overall Study|Reintervention|0|||
161786787|NCT00472446|584265416|FG002|Overall Study|Reintervention|1|||
161786788|NCT00472446|584265417|FG003|Overall Study|Reintervention|1|||
161786789|NCT00472446|584265414|FG000|Overall Study|Questionnaires not returned|5|||
161786790|NCT00472446|584265415|FG001|Overall Study|Questionnaires not returned|6|||
161786791|NCT00472446|584265416|FG002|Overall Study|Questionnaires not returned|6|||
161786792|NCT00472446|584265417|FG003|Overall Study|Questionnaires not returned|4|||
161786793|NCT03211156|584265418|FG000|Overall Study|Withdrawal by Subject|0|||
161786794|NCT03211156|584265419|FG001|Overall Study|Withdrawal by Subject|2|||
161786795|NCT03211156|584265418|FG000|Overall Study|Lost to Follow-up|1|||
161786796|NCT03211156|584265419|FG001|Overall Study|Lost to Follow-up|1|||
161786797|NCT03211156|584265418|FG000|Overall Study|Adverse Event|1|||
161786798|NCT03211156|584265419|FG001|Overall Study|Adverse Event|0|||
161786799|NCT03870997|584265433|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
161786800|NCT03870997|584265434|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
161786801|NCT03870997|584265435|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
161786802|NCT03870997|584265436|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
161786803|NCT03870997|584265437|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
161786804|NCT03870997|584265438|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
161786805|NCT03726437|584265439|FG000|Overall Study|Lost to Follow-up|85|||
161786806|NCT03726437|584265440|FG001|Overall Study|Lost to Follow-up|76|||
161786807|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
161786808|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786809|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786810|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786811|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786812|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
161786813|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786814|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786815|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786816|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786817|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
161786818|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786819|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786820|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786821|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786822|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
161786823|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786824|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786825|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786826|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786827|NCT01889862|584265449|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786828|NCT01889862|584265450|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786829|NCT01889862|584265451|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
161786830|NCT01889862|584265452|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786831|NCT01889862|584265453|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786832|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786833|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786834|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786835|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786836|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
161786837|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161786838|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161439505|NCT00068692|583003226|FG001|Step 1: Registration|Registered but not randomized|1|||
161786839|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161786840|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161786841|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
161786842|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786843|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786844|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786845|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786846|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
161786847|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786848|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786849|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786850|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786851|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
161786852|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786853|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786854|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786855|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786856|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
161786857|NCT00033631|584265454|FG000|Overall Study|Protocol Violation|14|||
161786858|NCT00033631|584265455|FG001|Overall Study|Protocol Violation|11|||
161786859|NCT00033631|584265454|FG000|Overall Study|Withdrawal by Subject|4|||
161786860|NCT00033631|584265455|FG001|Overall Study|Withdrawal by Subject|4|||
161786861|NCT00667719|584265456|FG000|Overall Study|Adverse Event|39|||
161786862|NCT00667719|584265456|FG000|Overall Study|Abnormal Test Procedure|1|||
161786863|NCT00667719|584265456|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161786864|NCT00667719|584265456|FG000|Overall Study|Protocol Violation|3|||
161786865|NCT00667719|584265456|FG000|Overall Study|Withdrawal by Subject|17|||
161786866|NCT00667719|584265456|FG000|Overall Study|Lost to Follow-up|8|||
161786867|NCT01827371|584265457|FG000|Overall Study|Adverse Event|0|||
161786868|NCT01827371|584265458|FG001|Overall Study|Adverse Event|0|||
161786869|NCT01827371|584265459|FG002|Overall Study|Adverse Event|4|||
161786870|NCT01827371|584265460|FG003|Overall Study|Adverse Event|2|||
161786871|NCT01827371|584265457|FG000|Overall Study|Lost to Follow-up|0|||
161786872|NCT01827371|584265458|FG001|Overall Study|Lost to Follow-up|2|||
161786873|NCT01827371|584265459|FG002|Overall Study|Lost to Follow-up|0|||
161786874|NCT01827371|584265460|FG003|Overall Study|Lost to Follow-up|4|||
161786875|NCT01827371|584265457|FG000|Overall Study|Protocol Violation|1|||
161786876|NCT01827371|584265458|FG001|Overall Study|Protocol Violation|0|||
161786877|NCT01827371|584265459|FG002|Overall Study|Protocol Violation|0|||
161786878|NCT01827371|584265460|FG003|Overall Study|Protocol Violation|0|||
161786879|NCT01827371|584265457|FG000|Overall Study|Withdrawal by Subject|1|||
161786880|NCT01827371|584265458|FG001|Overall Study|Withdrawal by Subject|2|||
161786881|NCT01827371|584265459|FG002|Overall Study|Withdrawal by Subject|2|||
161786882|NCT01827371|584265460|FG003|Overall Study|Withdrawal by Subject|3|||
161786883|NCT01827371|584265457|FG000|Overall Study|Physician Decision|0|||
161786884|NCT01827371|584265458|FG001|Overall Study|Physician Decision|1|||
161786885|NCT01827371|584265459|FG002|Overall Study|Physician Decision|0|||
161786886|NCT01827371|584265460|FG003|Overall Study|Physician Decision|1|||
161786887|NCT01827371|584265457|FG000|Overall Study|Temporary study halt to vaccinations|11|||
161786888|NCT01827371|584265458|FG001|Overall Study|Temporary study halt to vaccinations|2|||
161786889|NCT01827371|584265459|FG002|Overall Study|Temporary study halt to vaccinations|5|||
161786890|NCT01827371|584265460|FG003|Overall Study|Temporary study halt to vaccinations|13|||
161786891|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786892|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786893|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786894|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
161786895|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786896|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786897|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786898|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786899|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786900|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786901|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161786902|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161786903|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Adverse Event|1|||
161786904|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Adverse Event|1|||
161786905|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Adverse Event|1|||
161786906|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Adverse Event|1|||
161786907|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Adverse Event|0|||
161786908|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Adverse Event|0|||
161786909|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Adverse Event|0|||
161786910|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Adverse Event|0|||
161786911|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
161786912|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
161786913|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
161786914|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
161786915|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
161786916|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
161786917|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
161786918|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
161898531|NCT03654729|584677814|FG002|Overall Study|Protocol Violation|0|||
161786919|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
161786920|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
161786921|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786922|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786923|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786924|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
161786925|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
161786926|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
161786927|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786928|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
161786929|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786930|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786931|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161786932|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161786933|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786934|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786935|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786936|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786937|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786938|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161786939|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786940|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786941|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786942|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786943|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786944|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786945|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
161786946|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
161786947|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786948|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786949|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786950|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786951|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
161786952|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161786953|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161786954|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
161786955|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
161786956|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
161786957|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161786958|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161786959|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161786960|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161786961|NCT00950599|584265461|FG000|Follow-Up Period|Adverse Event|0|||
161786962|NCT00950599|584265462|FG001|Follow-Up Period|Adverse Event|0|||
161786963|NCT00950599|584265463|FG002|Follow-Up Period|Adverse Event|0|||
161786964|NCT00950599|584265464|FG003|Follow-Up Period|Adverse Event|0|||
161786965|NCT00950599|584265465|FG004|Follow-Up Period|Adverse Event|0|||
161786966|NCT00950599|584265466|FG005|Follow-Up Period|Adverse Event|0|||
161786967|NCT00950599|584265467|FG006|Follow-Up Period|Adverse Event|0|||
161786968|NCT00950599|584265468|FG007|Follow-Up Period|Adverse Event|0|||
161786969|NCT00950599|584265469|FG008|Follow-Up Period|Adverse Event|1|||
161786970|NCT00950599|584265470|FG009|Follow-Up Period|Adverse Event|0|||
161786971|NCT00950599|584265461|FG000|Follow-Up Period|Lack of Efficacy|0|||
161786972|NCT00950599|584265462|FG001|Follow-Up Period|Lack of Efficacy|0|||
161786973|NCT00950599|584265463|FG002|Follow-Up Period|Lack of Efficacy|0|||
161786974|NCT00950599|584265464|FG003|Follow-Up Period|Lack of Efficacy|0|||
161786975|NCT00950599|584265465|FG004|Follow-Up Period|Lack of Efficacy|0|||
161786976|NCT00950599|584265466|FG005|Follow-Up Period|Lack of Efficacy|0|||
161786977|NCT00950599|584265467|FG006|Follow-Up Period|Lack of Efficacy|0|||
161786978|NCT00950599|584265468|FG007|Follow-Up Period|Lack of Efficacy|0|||
161786979|NCT00950599|584265469|FG008|Follow-Up Period|Lack of Efficacy|3|||
161786980|NCT00950599|584265470|FG009|Follow-Up Period|Lack of Efficacy|0|||
161786981|NCT00950599|584265461|FG000|Follow-Up Period|Lost to Follow-up|0|||
161786982|NCT00950599|584265462|FG001|Follow-Up Period|Lost to Follow-up|0|||
161786983|NCT00950599|584265463|FG002|Follow-Up Period|Lost to Follow-up|0|||
161786984|NCT00950599|584265464|FG003|Follow-Up Period|Lost to Follow-up|0|||
161786985|NCT00950599|584265465|FG004|Follow-Up Period|Lost to Follow-up|0|||
161786986|NCT00950599|584265466|FG005|Follow-Up Period|Lost to Follow-up|0|||
161786987|NCT00950599|584265467|FG006|Follow-Up Period|Lost to Follow-up|0|||
161786988|NCT00950599|584265468|FG007|Follow-Up Period|Lost to Follow-up|0|||
161786989|NCT00950599|584265469|FG008|Follow-Up Period|Lost to Follow-up|5|||
161786990|NCT00950599|584265470|FG009|Follow-Up Period|Lost to Follow-up|1|||
161786991|NCT00950599|584265461|FG000|Follow-Up Period|Physician Decision|0|||
161786992|NCT00950599|584265462|FG001|Follow-Up Period|Physician Decision|0|||
161786993|NCT00950599|584265463|FG002|Follow-Up Period|Physician Decision|0|||
161786994|NCT00950599|584265464|FG003|Follow-Up Period|Physician Decision|0|||
161786995|NCT00950599|584265465|FG004|Follow-Up Period|Physician Decision|0|||
161786996|NCT00950599|584265466|FG005|Follow-Up Period|Physician Decision|0|||
161786997|NCT00950599|584265467|FG006|Follow-Up Period|Physician Decision|0|||
161786998|NCT00950599|584265468|FG007|Follow-Up Period|Physician Decision|0|||
161786999|NCT00950599|584265469|FG008|Follow-Up Period|Physician Decision|1|||
161787000|NCT00950599|584265470|FG009|Follow-Up Period|Physician Decision|0|||
161787001|NCT00950599|584265461|FG000|Follow-Up Period|Poor/Noncompliance|0|||
161787002|NCT00950599|584265462|FG001|Follow-Up Period|Poor/Noncompliance|0|||
161787003|NCT00950599|584265463|FG002|Follow-Up Period|Poor/Noncompliance|0|||
161787004|NCT00950599|584265464|FG003|Follow-Up Period|Poor/Noncompliance|0|||
161787005|NCT00950599|584265465|FG004|Follow-Up Period|Poor/Noncompliance|0|||
161787006|NCT00950599|584265466|FG005|Follow-Up Period|Poor/Noncompliance|0|||
161787007|NCT00950599|584265467|FG006|Follow-Up Period|Poor/Noncompliance|0|||
161787008|NCT00950599|584265468|FG007|Follow-Up Period|Poor/Noncompliance|0|||
161787009|NCT00950599|584265469|FG008|Follow-Up Period|Poor/Noncompliance|1|||
161787010|NCT00950599|584265470|FG009|Follow-Up Period|Poor/Noncompliance|0|||
161787011|NCT00950599|584265461|FG000|Follow-Up Period|Subject withdrew Consent|0|||
161787012|NCT00950599|584265462|FG001|Follow-Up Period|Subject withdrew Consent|0|||
161787013|NCT00950599|584265463|FG002|Follow-Up Period|Subject withdrew Consent|0|||
161787014|NCT00950599|584265464|FG003|Follow-Up Period|Subject withdrew Consent|0|||
161787015|NCT00950599|584265465|FG004|Follow-Up Period|Subject withdrew Consent|0|||
161787016|NCT00950599|584265466|FG005|Follow-Up Period|Subject withdrew Consent|0|||
161787017|NCT00950599|584265467|FG006|Follow-Up Period|Subject withdrew Consent|0|||
161787018|NCT00950599|584265468|FG007|Follow-Up Period|Subject withdrew Consent|0|||
161787019|NCT00950599|584265469|FG008|Follow-Up Period|Subject withdrew Consent|2|||
161787020|NCT00950599|584265470|FG009|Follow-Up Period|Subject withdrew Consent|1|||
161787021|NCT01361607|584265471|FG000|Overall Study|Adverse Event|38|||
161787022|NCT01361607|584265472|FG001|Overall Study|Adverse Event|29|||
161787023|NCT01361607|584265471|FG000|Overall Study|Withdrawal by Subject|19|||
161787024|NCT01361607|584265472|FG001|Overall Study|Withdrawal by Subject|8|||
161787025|NCT01361607|584265471|FG000|Overall Study|Withdrawal by Investigator|5|||
161787026|NCT01361607|584265472|FG001|Overall Study|Withdrawal by Investigator|3|||
161787027|NCT01361607|584265471|FG000|Overall Study|Lost to Follow-up|1|||
161787028|NCT01361607|584265472|FG001|Overall Study|Lost to Follow-up|0|||
161787029|NCT01361607|584265471|FG000|Overall Study|Met Withdrawal Criteria|1|||
161787030|NCT01361607|584265472|FG001|Overall Study|Met Withdrawal Criteria|1|||
161787031|NCT02741271|584265483|FG000|Overall Study|Lost to Follow-up|2|||
161787032|NCT02741271|584265484|FG001|Overall Study|Lost to Follow-up|0|||
161787033|NCT02741271|584265483|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161787034|NCT02741271|584265484|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161787035|NCT00373685|584265485|FG000|Overall Study|Death|2|||
161787036|NCT00373685|584265486|FG001|Overall Study|Death|1|||
161787037|NCT00373685|584265485|FG000|Overall Study|Adverse Event|278|||
161787038|NCT00373685|584265486|FG001|Overall Study|Adverse Event|253|||
161787039|NCT00373685|584265485|FG000|Overall Study|Insufficient clinical response|169|||
161787040|NCT00373685|584265486|FG001|Overall Study|Insufficient clinical response|119|||
161787041|NCT00373685|584265485|FG000|Overall Study|Did not meet entrance criteria|167|||
161787042|NCT00373685|584265486|FG001|Overall Study|Did not meet entrance criteria|184|||
161787043|NCT00373685|584265485|FG000|Overall Study|Lost to follow up|83|||
161787044|NCT00373685|584265486|FG001|Overall Study|Lost to follow up|103|||
161787045|NCT00373685|584265485|FG000|Overall Study|No longer willing to participate|337|||
161787046|NCT00373685|584265486|FG001|Overall Study|No longer willing to participate|352|||
161787047|NCT00373685|584265485|FG000|Overall Study|Other|149|||
161787048|NCT00373685|584265486|FG001|Overall Study|Other|146|||
161787049|NCT00373685|584265485|FG000|Overall Study|Protocol Violation|191|||
161787050|NCT00373685|584265486|FG001|Overall Study|Protocol Violation|182|||
161787051|NCT00373685|584265485|FG000|Overall Study|Final Status Unknown|12|||
161787052|NCT00373685|584265486|FG001|Overall Study|Final Status Unknown|4|||
161787053|NCT00373685|584265485|FG000|Overall Study|Randomized, not treated|51|||
161787054|NCT00373685|584265486|FG001|Overall Study|Randomized, not treated|77|||
161787055|NCT02570165|584265487|FG000|Overall Study|Adverse Event|1|||
161787056|NCT02570165|584265488|FG001|Overall Study|Adverse Event|0|||
161787057|NCT02570165|584265489|FG002|Overall Study|Adverse Event|2|||
161787058|NCT02570165|584265490|FG003|Overall Study|Adverse Event|0|||
161787059|NCT02570165|584265491|FG004|Overall Study|Adverse Event|0|||
161787060|NCT02570165|584265492|FG005|Overall Study|Adverse Event|0|||
161787061|NCT02570165|584265493|FG006|Overall Study|Adverse Event|0|||
161787062|NCT02570165|584265487|FG000|Overall Study|Lack of Efficacy|0|||
161787063|NCT02570165|584265488|FG001|Overall Study|Lack of Efficacy|1|||
161787064|NCT02570165|584265489|FG002|Overall Study|Lack of Efficacy|0|||
161787065|NCT02570165|584265490|FG003|Overall Study|Lack of Efficacy|0|||
161787066|NCT02570165|584265491|FG004|Overall Study|Lack of Efficacy|4|||
161787067|NCT02570165|584265492|FG005|Overall Study|Lack of Efficacy|0|||
161787068|NCT02570165|584265493|FG006|Overall Study|Lack of Efficacy|0|||
161787069|NCT02570165|584265487|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
161787070|NCT02570165|584265488|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
161787071|NCT02570165|584265489|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
161787072|NCT02570165|584265490|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
161787073|NCT02570165|584265491|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
161787074|NCT02570165|584265492|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
161787075|NCT02570165|584265493|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
161787076|NCT02570165|584265487|FG000|Overall Study|Lost to Follow-up|0|||
161787077|NCT02570165|584265488|FG001|Overall Study|Lost to Follow-up|0|||
161787078|NCT02570165|584265489|FG002|Overall Study|Lost to Follow-up|1|||
161787079|NCT02570165|584265490|FG003|Overall Study|Lost to Follow-up|1|||
161787080|NCT02570165|584265491|FG004|Overall Study|Lost to Follow-up|0|||
161787081|NCT02570165|584265492|FG005|Overall Study|Lost to Follow-up|0|||
161787082|NCT02570165|584265493|FG006|Overall Study|Lost to Follow-up|0|||
161787083|NCT02570165|584265487|FG000|Overall Study|Physician Decision|0|||
161787084|NCT02570165|584265488|FG001|Overall Study|Physician Decision|1|||
161787085|NCT02570165|584265489|FG002|Overall Study|Physician Decision|0|||
161787086|NCT02570165|584265490|FG003|Overall Study|Physician Decision|0|||
161787087|NCT02570165|584265491|FG004|Overall Study|Physician Decision|0|||
161787088|NCT02570165|584265492|FG005|Overall Study|Physician Decision|0|||
161787089|NCT02570165|584265493|FG006|Overall Study|Physician Decision|0|||
161787090|NCT02570165|584265487|FG000|Overall Study|Withdrawal by Subject|0|||
161787091|NCT02570165|584265488|FG001|Overall Study|Withdrawal by Subject|0|||
161787092|NCT02570165|584265489|FG002|Overall Study|Withdrawal by Subject|0|||
161787093|NCT02570165|584265490|FG003|Overall Study|Withdrawal by Subject|2|||
161787094|NCT02570165|584265491|FG004|Overall Study|Withdrawal by Subject|1|||
161787095|NCT02570165|584265492|FG005|Overall Study|Withdrawal by Subject|0|||
161787096|NCT02570165|584265493|FG006|Overall Study|Withdrawal by Subject|0|||
161787097|NCT02570165|584265487|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787098|NCT02570165|584265488|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787099|NCT02570165|584265489|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787100|NCT02570165|584265490|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787101|NCT02570165|584265491|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787102|NCT02570165|584265492|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
161787103|NCT02570165|584265493|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787104|NCT02570165|584265487|FG000|Overall Study|Withdrawal Request by GSK|0|||
161787105|NCT02570165|584265488|FG001|Overall Study|Withdrawal Request by GSK|0|||
161787106|NCT02570165|584265489|FG002|Overall Study|Withdrawal Request by GSK|2|||
161787107|NCT02570165|584265490|FG003|Overall Study|Withdrawal Request by GSK|0|||
161787108|NCT02570165|584265491|FG004|Overall Study|Withdrawal Request by GSK|0|||
161787109|NCT02570165|584265492|FG005|Overall Study|Withdrawal Request by GSK|0|||
161787110|NCT02570165|584265493|FG006|Overall Study|Withdrawal Request by GSK|0|||
161787111|NCT01953783|584265494|FG000|Overall Study|Progressive disease|2|||
161787112|NCT01789281|584265495|FG000|Overall Study|Disease progression|15|||
161787113|NCT01789281|584265496|FG001|Overall Study|Disease progression|4|||
161787114|NCT01789281|584265495|FG000|Overall Study|Adverse Event|5|||
161787115|NCT01789281|584265496|FG001|Overall Study|Adverse Event|5|||
161787116|NCT01789281|584265495|FG000|Overall Study|Withdrawal by Subject|1|||
161787117|NCT01789281|584265496|FG001|Overall Study|Withdrawal by Subject|0|||
161787118|NCT01789281|584265495|FG000|Overall Study|Lost to Follow-up|1|||
161787119|NCT01789281|584265496|FG001|Overall Study|Lost to Follow-up|0|||
161787120|NCT01789281|584265495|FG000|Overall Study|Administrative problems|0|||
161787121|NCT01789281|584265496|FG001|Overall Study|Administrative problems|1|||
161787122|NCT00411762|584265498|FG000|Overall Study|Withdrawal by Subject|5|||
161787123|NCT04428502|584265499|FG000|Overall Study|Did not meet entrance criteria|14|||
161787124|NCT02295280|584265501|FG000|Overall Study|Adverse Event|0|||
161787125|NCT02295280|584265502|FG001|Overall Study|Adverse Event|1|||
161787126|NCT02875067|584265503|FG000|Overall Study|Withdrawal by Subject|1|||
161787127|NCT02875067|584265503|FG000|Overall Study|Withdrawal by Termination of Study|5|||
161787128|NCT01430104|584265504|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
161787129|NCT02713243|584265506|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
161787130|NCT02713243|584265507|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
161787131|NCT02713243|584265506|FG000|Overall Study|Administrative problems|0|||
161787132|NCT02713243|584265507|FG001|Overall Study|Administrative problems|1|||
161787133|NCT02713243|584265506|FG000|Overall Study|Protocol deviation|0|||
161787134|NCT02713243|584265507|FG001|Overall Study|Protocol deviation|1|||
161787135|NCT03056352|584265508|FG000|Overall Study|Lost to Follow-up|1|||
161787136|NCT02971605|584265509|FG000|Overall Study|Withdrawal by Subject|1|||
161787137|NCT00435825|584265524|FG000|Overall Study|Abnormality of Laboratory Test|0|||
161787138|NCT00435825|584265525|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161787139|NCT00435825|584265526|FG002|Overall Study|Abnormality of Laboratory Test|0|||
161787140|NCT00435825|584265527|FG003|Overall Study|Abnormality of Laboratory Test|0|||
161787141|NCT00435825|584265524|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161787142|NCT00435825|584265525|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161787143|NCT00435825|584265526|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161787144|NCT00435825|584265527|FG003|Overall Study|Insufficient Therapeutic Response|3|||
161787145|NCT00435825|584265524|FG000|Overall Study|Other Protocol Violation|1|||
161787146|NCT00435825|584265525|FG001|Overall Study|Other Protocol Violation|0|||
161787147|NCT00435825|584265526|FG002|Overall Study|Other Protocol Violation|0|||
161787148|NCT00435825|584265527|FG003|Overall Study|Other Protocol Violation|0|||
161787149|NCT00435825|584265524|FG000|Overall Study|Refused treatment|2|||
161787150|NCT00435825|584265525|FG001|Overall Study|Refused treatment|0|||
161787151|NCT00435825|584265526|FG002|Overall Study|Refused treatment|0|||
161787152|NCT00435825|584265527|FG003|Overall Study|Refused treatment|5|||
161787153|NCT00435825|584265524|FG000|Overall Study|Failure to return|5|||
161787154|NCT00435825|584265525|FG001|Overall Study|Failure to return|0|||
161787155|NCT00435825|584265526|FG002|Overall Study|Failure to return|4|||
161787156|NCT00435825|584265527|FG003|Overall Study|Failure to return|0|||
161787157|NCT00435825|584265524|FG000|Overall Study|Did not receive study drug|1|||
161787158|NCT00435825|584265525|FG001|Overall Study|Did not receive study drug|0|||
161787159|NCT00435825|584265526|FG002|Overall Study|Did not receive study drug|2|||
161787160|NCT00435825|584265527|FG003|Overall Study|Did not receive study drug|0|||
161787161|NCT00435825|584265524|FG000|Overall Study|Did not enter follow-up|0|||
161787162|NCT00435825|584265525|FG001|Overall Study|Did not enter follow-up|4|||
161787163|NCT00435825|584265526|FG002|Overall Study|Did not enter follow-up|1|||
161787164|NCT00435825|584265527|FG003|Overall Study|Did not enter follow-up|3|||
161787165|NCT00435825|584265524|FG000|Overall Study|Did not complete full follow-up period|6|||
161787166|NCT00435825|584265525|FG001|Overall Study|Did not complete full follow-up period|6|||
161787167|NCT00435825|584265526|FG002|Overall Study|Did not complete full follow-up period|4|||
161787168|NCT00435825|584265527|FG003|Overall Study|Did not complete full follow-up period|5|||
161787169|NCT03033069|584265528|FG000|Overall Study|Adverse Event|6|||
161787170|NCT03033069|584265529|FG001|Overall Study|Adverse Event|7|||
161787171|NCT03033069|584265530|FG002|Overall Study|Adverse Event|4|||
161787172|NCT03033069|584265531|FG003|Overall Study|Adverse Event|6|||
161787173|NCT03033069|584265528|FG000|Overall Study|Lack of Efficacy|0|||
161787174|NCT03033069|584265529|FG001|Overall Study|Lack of Efficacy|0|||
161898532|NCT03654729|584677812|FG000|Overall Study|Non-compliance with study drug|0|||
161898533|NCT03654729|584677813|FG001|Overall Study|Non-compliance with study drug|1|||
161898534|NCT03654729|584677814|FG002|Overall Study|Non-compliance with study drug|0|||
161898535|NCT03654729|584677812|FG000|Overall Study|Site terminated by Sponsor|1|||
161787175|NCT03033069|584265530|FG002|Overall Study|Lack of Efficacy|1|||
161787176|NCT03033069|584265531|FG003|Overall Study|Lack of Efficacy|0|||
161787177|NCT03033069|584265528|FG000|Overall Study|Lost to Follow-up|6|||
161787178|NCT03033069|584265529|FG001|Overall Study|Lost to Follow-up|5|||
161787179|NCT03033069|584265530|FG002|Overall Study|Lost to Follow-up|5|||
161787180|NCT03033069|584265531|FG003|Overall Study|Lost to Follow-up|6|||
161787181|NCT03033069|584265528|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161787182|NCT03033069|584265529|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161787183|NCT03033069|584265530|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161787184|NCT03033069|584265531|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161787185|NCT03033069|584265528|FG000|Overall Study|Protocol Deviation|0|||
161787186|NCT03033069|584265529|FG001|Overall Study|Protocol Deviation|1|||
161787187|NCT03033069|584265530|FG002|Overall Study|Protocol Deviation|0|||
161787188|NCT03033069|584265531|FG003|Overall Study|Protocol Deviation|0|||
161787189|NCT03033069|584265528|FG000|Overall Study|Withdrawal by Subject|10|||
161787190|NCT03033069|584265529|FG001|Overall Study|Withdrawal by Subject|10|||
161787191|NCT03033069|584265530|FG002|Overall Study|Withdrawal by Subject|11|||
161787192|NCT03033069|584265531|FG003|Overall Study|Withdrawal by Subject|6|||
161787193|NCT03033069|584265528|FG000|Overall Study|Withdrawal By Caregiver|1|||
161787194|NCT03033069|584265529|FG001|Overall Study|Withdrawal By Caregiver|0|||
161787195|NCT03033069|584265530|FG002|Overall Study|Withdrawal By Caregiver|0|||
161787196|NCT03033069|584265531|FG003|Overall Study|Withdrawal By Caregiver|0|||
161787197|NCT03033069|584265528|FG000|Overall Study|Reason not Specified|0|||
161787198|NCT03033069|584265529|FG001|Overall Study|Reason not Specified|1|||
161787199|NCT03033069|584265530|FG002|Overall Study|Reason not Specified|0|||
161787200|NCT03033069|584265531|FG003|Overall Study|Reason not Specified|1|||
161787201|NCT00430638|584265532|FG000|Overall Study|Adverse Event|15|||
161787202|NCT00430638|584265533|FG001|Overall Study|Adverse Event|15|||
161787203|NCT00430638|584265532|FG000|Overall Study|Uncontrolled blood pressure|48|||
161787204|NCT00430638|584265533|FG001|Overall Study|Uncontrolled blood pressure|13|||
161898536|NCT03654729|584677813|FG001|Overall Study|Site terminated by Sponsor|0|||
161787205|NCT00430638|584265532|FG000|Overall Study|Lost to Follow-up|1|||
161787206|NCT00430638|584265533|FG001|Overall Study|Lost to Follow-up|7|||
161787207|NCT00430638|584265532|FG000|Overall Study|Protocol Violation|6|||
161898537|NCT03654729|584677814|FG002|Overall Study|Site terminated by Sponsor|0|||
161787208|NCT00430638|584265533|FG001|Overall Study|Protocol Violation|4|||
161787209|NCT00430638|584265532|FG000|Overall Study|Withdrawal by Subject|4|||
161787210|NCT00430638|584265533|FG001|Overall Study|Withdrawal by Subject|6|||
161787211|NCT00430638|584265532|FG000|Overall Study|Non-compliant|2|||
161787212|NCT00430638|584265533|FG001|Overall Study|Non-compliant|1|||
161787213|NCT00430638|584265532|FG000|Overall Study|Other|2|||
161787214|NCT00430638|584265533|FG001|Overall Study|Other|2|||
161787215|NCT02367781|584265536|FG000|Overall Study|Withdrawal by Subject|20|||
161787216|NCT02367781|584265537|FG001|Overall Study|Withdrawal by Subject|13|||
161787217|NCT02367781|584265536|FG000|Overall Study|Protocol Violation|0|||
161787218|NCT02367781|584265537|FG001|Overall Study|Protocol Violation|1|||
161787219|NCT02367781|584265536|FG000|Overall Study|Physician Decision|7|||
161787220|NCT02367781|584265537|FG001|Overall Study|Physician Decision|0|||
161787221|NCT02367781|584265536|FG000|Overall Study|Randomized in Error|5|||
161787222|NCT02367781|584265537|FG001|Overall Study|Randomized in Error|4|||
161787223|NCT02367781|584265536|FG000|Overall Study|Non-Compliance|1|||
161787224|NCT02367781|584265537|FG001|Overall Study|Non-Compliance|0|||
161787225|NCT02367781|584265536|FG000|Overall Study|Lost to Follow-up|1|||
161787226|NCT02367781|584265537|FG001|Overall Study|Lost to Follow-up|2|||
161787227|NCT02367781|584265536|FG000|Overall Study|Death|330|||
161787228|NCT02367781|584265537|FG001|Overall Study|Death|176|||
161787229|NCT02367781|584265536|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
161787230|NCT02367781|584265537|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
161787231|NCT02367781|584265536|FG000|Overall Study|Prolonged Hospitalization|1|||
161787232|NCT02367781|584265537|FG001|Overall Study|Prolonged Hospitalization|0|||
161787233|NCT02367781|584265536|FG000|Overall Study|Death Prior First Dose|1|||
161787234|NCT02367781|584265537|FG001|Overall Study|Death Prior First Dose|0|||
161787235|NCT02367781|584265536|FG000|Overall Study|Administrative-Change Facility|1|||
161787236|NCT02367781|584265537|FG001|Overall Study|Administrative-Change Facility|0|||
161787237|NCT02367781|584265536|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
161787238|NCT02367781|584265537|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
161787239|NCT02367781|584265536|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
161787240|NCT02367781|584265537|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
161787241|NCT02367781|584265536|FG000|Overall Study|Study Terminated by Sponsor|3|||
161787242|NCT02367781|584265537|FG001|Overall Study|Study Terminated by Sponsor|1|||
161787243|NCT02367781|584265536|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
161787244|NCT02367781|584265537|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
161787245|NCT02367781|584265536|FG000|Overall Study|Sponsor Decision|2|||
161787246|NCT02367781|584265537|FG001|Overall Study|Sponsor Decision|0|||
161787247|NCT02367781|584265536|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
161787248|NCT02367781|584265537|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
161787249|NCT03262233|584266625|FG000|Overall Study|Withdrawal by Subject|12|||
161787250|NCT03262233|584266626|FG001|Overall Study|Withdrawal by Subject|8|||
161787251|NCT03262233|584266627|FG002|Overall Study|Withdrawal by Subject|21|||
161787252|NCT03262233|584266628|FG003|Overall Study|Withdrawal by Subject|13|||
161787253|NCT03262233|584266625|FG000|Overall Study|Declined due to shock|1|||
161787254|NCT03262233|584266626|FG001|Overall Study|Declined due to shock|2|||
161787255|NCT03262233|584266627|FG002|Overall Study|Declined due to shock|2|||
161787256|NCT03262233|584266628|FG003|Overall Study|Declined due to shock|3|||
161787257|NCT03262233|584266625|FG000|Overall Study|Protocol Violation|5|||
161787258|NCT03262233|584266626|FG001|Overall Study|Protocol Violation|10|||
161787259|NCT03262233|584266627|FG002|Overall Study|Protocol Violation|2|||
161787260|NCT03262233|584266628|FG003|Overall Study|Protocol Violation|13|||
161787261|NCT03262233|584266625|FG000|Overall Study|data collection artifact|0|||
161787262|NCT03262233|584266626|FG001|Overall Study|data collection artifact|1|||
161787263|NCT03262233|584266627|FG002|Overall Study|data collection artifact|0|||
161787264|NCT03262233|584266628|FG003|Overall Study|data collection artifact|0|||
161787265|NCT03877237|584266629|FG000|Overall Study|Adverse Event|1|||
161787266|NCT03877237|584266630|FG001|Overall Study|Adverse Event|2|||
161787267|NCT03877237|584266629|FG000|Overall Study|Death|3|||
161787268|NCT03877237|584266630|FG001|Overall Study|Death|2|||
161787269|NCT03877237|584266629|FG000|Overall Study|Physician Decision|1|||
161787270|NCT03877237|584266630|FG001|Overall Study|Physician Decision|0|||
161787271|NCT03877237|584266629|FG000|Overall Study|Withdrawal by Subject|0|||
161787272|NCT03877237|584266630|FG001|Overall Study|Withdrawal by Subject|2|||
161787273|NCT00566098|584266632|FG000|Collection of MILs|Withdrawal by Subject|1|||
161787274|NCT00566098|584266632|FG000|Collection of MILs|Relapsed|1|||
161787275|NCT00566098|584266632|FG000|Generation of MILs Product|Relapsed|1|||
161787276|NCT00566098|584266632|FG000|Administration of ASCT+MILs|Death|10|||
161787277|NCT00566098|584266632|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
161787278|NCT02236754|584266633|FG000|Overall Study|Withdrawal by Subject|1|||
161787279|NCT02236754|584266634|FG001|Overall Study|Withdrawal by Subject|0|||
161787280|NCT01270841|584266635|FG000|Overall Study|Adverse Event|0|||
161787281|NCT01270841|584266636|FG001|Overall Study|Adverse Event|1|||
161787282|NCT01270841|584266637|FG002|Overall Study|Adverse Event|0|||
161787283|NCT01270841|584266638|FG003|Overall Study|Adverse Event|3|||
161787284|NCT01270841|584266635|FG000|Overall Study|Withdrawal by Subject|3|||
161787285|NCT01270841|584266636|FG001|Overall Study|Withdrawal by Subject|2|||
161787286|NCT01270841|584266637|FG002|Overall Study|Withdrawal by Subject|3|||
161787287|NCT01270841|584266638|FG003|Overall Study|Withdrawal by Subject|3|||
161787288|NCT01270841|584266635|FG000|Overall Study|Lost to Follow-up|3|||
161787289|NCT01270841|584266636|FG001|Overall Study|Lost to Follow-up|1|||
161787290|NCT01270841|584266637|FG002|Overall Study|Lost to Follow-up|4|||
161787291|NCT01270841|584266638|FG003|Overall Study|Lost to Follow-up|2|||
161787292|NCT01270841|584266635|FG000|Overall Study|Physician Decision|0|||
161787293|NCT01270841|584266636|FG001|Overall Study|Physician Decision|1|||
161787294|NCT01270841|584266637|FG002|Overall Study|Physician Decision|0|||
161787295|NCT01270841|584266638|FG003|Overall Study|Physician Decision|0|||
161787296|NCT01270841|584266635|FG000|Overall Study|Did not qualify|6|||
161787297|NCT01270841|584266636|FG001|Overall Study|Did not qualify|3|||
161787298|NCT01270841|584266637|FG002|Overall Study|Did not qualify|4|||
161787299|NCT01270841|584266638|FG003|Overall Study|Did not qualify|5|||
161787300|NCT01270841|584266635|FG000|Overall Study|Protocol Violation|1|||
161787301|NCT01270841|584266636|FG001|Overall Study|Protocol Violation|5|||
161787302|NCT01270841|584266637|FG002|Overall Study|Protocol Violation|0|||
161787303|NCT01270841|584266638|FG003|Overall Study|Protocol Violation|0|||
161787304|NCT01270841|584266635|FG000|Overall Study|Enrolled in error|0|||
161787305|NCT01270841|584266636|FG001|Overall Study|Enrolled in error|1|||
161787306|NCT01270841|584266637|FG002|Overall Study|Enrolled in error|0|||
161787307|NCT01270841|584266638|FG003|Overall Study|Enrolled in error|0|||
161787308|NCT00515073|584266641|FG000|Overall Study|Withdrawal by Subject|1|||
161787309|NCT00515073|584266641|FG000|Overall Study|Physician Decision|1|||
161787310|NCT02764489|584266642|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
161787311|NCT02764489|584266643|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
161787312|NCT02764489|584266642|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
161787313|NCT02764489|584266643|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
161787314|NCT02764489|584266642|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
161787315|NCT02764489|584266643|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
161787316|NCT02764489|584266642|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
161787317|NCT02764489|584266643|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
161787318|NCT01625845|584266644|FG000|Overall Study|Adverse Event|1|||
161787319|NCT01625845|584266645|FG001|Overall Study|Adverse Event|2|||
161787320|NCT01625845|584266644|FG000|Overall Study|Lost to Follow-up|2|||
161787321|NCT01625845|584266645|FG001|Overall Study|Lost to Follow-up|1|||
161787322|NCT01625845|584266644|FG000|Overall Study|Withdrawal by Subject|2|||
161787323|NCT01625845|584266645|FG001|Overall Study|Withdrawal by Subject|0|||
161787324|NCT01294592|584266646|FG000|Overall Study|Adverse Event|28|||
161787325|NCT01294592|584266647|FG001|Overall Study|Adverse Event|13|||
161787326|NCT01294592|584266646|FG000|Overall Study|Lack of Efficacy|7|||
161787327|NCT01294592|584266647|FG001|Overall Study|Lack of Efficacy|5|||
161787328|NCT01294592|584266646|FG000|Overall Study|Protocol Violation|1|||
161787329|NCT01294592|584266647|FG001|Overall Study|Protocol Violation|7|||
161787330|NCT01294592|584266646|FG000|Overall Study|Lost to Follow-up|7|||
161787331|NCT01294592|584266647|FG001|Overall Study|Lost to Follow-up|9|||
161787332|NCT01294592|584266646|FG000|Overall Study|Physician Decision|6|||
161787333|NCT01294592|584266647|FG001|Overall Study|Physician Decision|11|||
161787334|NCT01294592|584266646|FG000|Overall Study|Withdrawal by Subject|28|||
161787335|NCT01294592|584266647|FG001|Overall Study|Withdrawal by Subject|28|||
161787336|NCT02853929|584266648|FG000|Overall Study|Lost to Follow-up|3|||
161787337|NCT02853929|584266649|FG001|Overall Study|Lost to Follow-up|0|||
161787338|NCT02853929|584266648|FG000|Overall Study|Withdrawal by Subject|1|||
161787339|NCT02853929|584266649|FG001|Overall Study|Withdrawal by Subject|0|||
161787340|NCT02853929|584266648|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
161787341|NCT02853929|584266649|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
161787342|NCT00623623|584266650|FG000|Overall Study|Previous enrolment into this study|1|||
161787343|NCT00623623|584266651|FG001|Overall Study|Previous enrolment into this study|1|||
161787344|NCT00693784|584266652|FG000|Overall Study|Lost to Follow-up|2|||
161787345|NCT00693784|584266652|FG000|Overall Study|Withdrawal by Subject|2|||
161787346|NCT02265952|584266653|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
161787347|NCT02265952|584266654|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
161787348|NCT02265952|584266653|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
161787349|NCT02265952|584266654|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
161787350|NCT00326885|584266657|FG000|Overall Study|Adverse Event|1|||
161787351|NCT00326885|584266657|FG000|Overall Study|Withdrawal by Subject|3|||
161787352|NCT00326885|584266657|FG000|Overall Study|Physician Decision|1|||
161787353|NCT00326885|584266657|FG000|Overall Study|Hospice withdrew consent|2|||
161787354|NCT00738673|584266669|FG000|Overall Study|Adverse Event|1|||
161787355|NCT00738673|584266670|FG001|Overall Study|Adverse Event|0|||
161787356|NCT00738673|584266669|FG000|Overall Study|Lack of Efficacy|19|||
161787357|NCT00738673|584266670|FG001|Overall Study|Lack of Efficacy|8|||
161787358|NCT00738673|584266669|FG000|Overall Study|Protocol Violation|1|||
161787359|NCT00738673|584266670|FG001|Overall Study|Protocol Violation|2|||
161787360|NCT00738673|584266669|FG000|Overall Study|Withdrawal by Subject|3|||
161787361|NCT00738673|584266670|FG001|Overall Study|Withdrawal by Subject|1|||
161787362|NCT02736227|584266671|FG000|Overall Study|Withdrawal by Subject|0|||
161787363|NCT02736227|584266672|FG001|Overall Study|Withdrawal by Subject|0|||
161787364|NCT02736227|584266673|FG002|Overall Study|Withdrawal by Subject|1|||
161787365|NCT02736227|584266671|FG000|Overall Study|Physician Decision|0|||
161787366|NCT02736227|584266672|FG001|Overall Study|Physician Decision|0|||
161787367|NCT02736227|584266673|FG002|Overall Study|Physician Decision|5|||
161787368|NCT02736227|584266671|FG000|Overall Study|Non Compliant|0|||
161787369|NCT02736227|584266672|FG001|Overall Study|Non Compliant|0|||
161787370|NCT02736227|584266673|FG002|Overall Study|Non Compliant|2|||
161787371|NCT01205529|584266674|FG000|Overall Study|Procedure Cancelled|4|||
161787372|NCT01205529|584266674|FG000|Overall Study|Withdrawal by Subject|2|||
161787373|NCT01205529|584266674|FG000|Overall Study|Physician Decision|4|||
161787374|NCT01205529|584266674|FG000|Overall Study|Unstable post op|15|||
161787375|NCT01205529|584266674|FG000|Overall Study|No longer met criteria|30|||
161787376|NCT04133519|584266677|FG000|Overall Study|Withdrawal by Subject|5|||
161787377|NCT04133519|584266678|FG001|Overall Study|Withdrawal by Subject|4|||
161787378|NCT04133519|584266677|FG000|Overall Study|Protocol Violation|0|||
161787379|NCT04133519|584266678|FG001|Overall Study|Protocol Violation|1|||
161787380|NCT04133519|584266677|FG000|Overall Study|Never started treatment|1|||
161787381|NCT04133519|584266678|FG001|Overall Study|Never started treatment|1|||
161787382|NCT03840135|584266679|FG000|Overall Study|Protocol Violation|6|||
161787383|NCT03840135|584266680|FG001|Overall Study|Protocol Violation|1|||
161787384|NCT03840135|584266679|FG000|Overall Study|Withdrawal by Subject|1|||
161787385|NCT03840135|584266680|FG001|Overall Study|Withdrawal by Subject|0|||
161787386|NCT00323609|584266681|FG000|Overall Study|Death|16|||
161787387|NCT00323609|584266682|FG001|Overall Study|Death|21|||
161787388|NCT00323609|584266683|FG002|Overall Study|Death|0|||
161787389|NCT00323609|584266684|FG003|Overall Study|Death|0|||
161787390|NCT00323609|584266681|FG000|Overall Study|Lost to Follow-up|9|||
161787391|NCT00323609|584266682|FG001|Overall Study|Lost to Follow-up|10|||
161787392|NCT00323609|584266683|FG002|Overall Study|Lost to Follow-up|0|||
161787393|NCT00323609|584266684|FG003|Overall Study|Lost to Follow-up|0|||
161787394|NCT00323609|584266681|FG000|Overall Study|Physician Decision|2|||
161787395|NCT00323609|584266682|FG001|Overall Study|Physician Decision|0|||
161787396|NCT00323609|584266683|FG002|Overall Study|Physician Decision|0|||
161787397|NCT00323609|584266684|FG003|Overall Study|Physician Decision|1|||
161787398|NCT00323609|584266681|FG000|Overall Study|Withdrawal by Subject|11|||
161787399|NCT00323609|584266682|FG001|Overall Study|Withdrawal by Subject|23|||
161787400|NCT00323609|584266683|FG002|Overall Study|Withdrawal by Subject|4|||
161787401|NCT00323609|584266684|FG003|Overall Study|Withdrawal by Subject|4|||
161787402|NCT00323609|584266681|FG000|Overall Study|Other non-VCF-related medical condition|3|||
161787403|NCT00323609|584266682|FG001|Overall Study|Other non-VCF-related medical condition|2|||
161787404|NCT00323609|584266683|FG002|Overall Study|Other non-VCF-related medical condition|0|||
161787405|NCT00323609|584266684|FG003|Overall Study|Other non-VCF-related medical condition|0|||
161787406|NCT00323609|584266681|FG000|Overall Study|Sponsor discontinued trial|29|||
161787407|NCT00323609|584266682|FG001|Overall Study|Sponsor discontinued trial|29|||
161787408|NCT00323609|584266683|FG002|Overall Study|Sponsor discontinued trial|0|||
161787409|NCT00323609|584266684|FG003|Overall Study|Sponsor discontinued trial|0|||
161787410|NCT00323609|584266681|FG000|Overall Study|Unrelenting or severe back pain|1|||
161787411|NCT00323609|584266682|FG001|Overall Study|Unrelenting or severe back pain|1|||
161787412|NCT00323609|584266683|FG002|Overall Study|Unrelenting or severe back pain|0|||
161787413|NCT00323609|584266684|FG003|Overall Study|Unrelenting or severe back pain|0|||
161787414|NCT00323609|584266681|FG000|Overall Study|Logistical withdrawal|9|||
161787415|NCT00323609|584266682|FG001|Overall Study|Logistical withdrawal|5|||
161787416|NCT00323609|584266683|FG002|Overall Study|Logistical withdrawal|0|||
161787417|NCT00323609|584266684|FG003|Overall Study|Logistical withdrawal|1|||
161439506|NCT00068692|583003227|FG002|Step 1: Registration|Registered but not randomized|0|||
161439507|NCT00068692|583003228|FG003|Step 1: Registration|Registered but not randomized|0|||
161439508|NCT00068692|583003229|FG004|Step 1: Registration|Registered but not randomized|0|||
161439509|NCT00068692|583003230|FG005|Step 1: Registration|Registered but not randomized|0|||
161439510|NCT00068692|583003231|FG006|Step 1: Registration|Registered but not randomized|0|||
161439511|NCT00068692|583003232|FG007|Step 1: Registration|Registered but not randomized|0|||
161787418|NCT00323609|584266681|FG000|Overall Study|Other reason|11|||
161787419|NCT00323609|584266682|FG001|Overall Study|Other reason|8|||
161787420|NCT00323609|584266683|FG002|Overall Study|Other reason|4|||
161787421|NCT00323609|584266684|FG003|Overall Study|Other reason|9|||
161439512|NCT00068692|583003225|FG000|Step 2: Randomization|Disesae progression/replase|0|||
161787422|NCT00068237|584266687|FG000|Overall Study|Ineligible|3|||
161787423|NCT00068237|584266687|FG000|Overall Study|No protocol treatment received|2|||
161787424|NCT05288673|584266688|FG000|Overall Study|Consent withdrawn by subject|0|||
161787425|NCT05288673|584266689|FG001|Overall Study|Consent withdrawn by subject|0|||
161787426|NCT05288673|584266690|FG002|Overall Study|Consent withdrawn by subject|1|||
161787427|NCT00571922|584266691|FG000|Overall Study|Completion unknown|36|||
161787428|NCT00571922|584266692|FG001|Overall Study|Completion unknown|36|||
161787429|NCT01154153|584266695|FG000|Overall Study|Poor compliance to protocol|2|||
161787430|NCT01154153|584266696|FG001|Overall Study|Poor compliance to protocol|0|||
161787431|NCT01154153|584266695|FG000|Overall Study|Unable to use labs|2|||
161787432|NCT01154153|584266696|FG001|Overall Study|Unable to use labs|3|||
161787433|NCT01154153|584266695|FG000|Overall Study|Withdrew consent|1|||
161787434|NCT01154153|584266696|FG001|Overall Study|Withdrew consent|0|||
161787435|NCT00964223|584266697|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
161787436|NCT03439293|584266698|FG000|Overall Study|Death|22|||
161787437|NCT03439293|584266698|FG000|Overall Study|Withdrawal by Subject|8|||
161787438|NCT03439293|584266698|FG000|Overall Study|Lost to Follow-up|2|||
161787439|NCT03439293|584266698|FG000|Overall Study|Reason Not Specified|28|||
161787440|NCT03439293|584266698|FG000|Overall Study|Missing|1|||
161787441|NCT03404206|584266701|FG000|Overall Study|Withdrawal by Subject|1|||
161787442|NCT03404206|584266702|FG001|Overall Study|Withdrawal by Subject|1|||
161787443|NCT03404206|584266703|FG002|Overall Study|Withdrawal by Subject|0|||
161787444|NCT03404206|584266701|FG000|Overall Study|Lost to Follow-up|3|||
161787445|NCT03404206|584266702|FG001|Overall Study|Lost to Follow-up|1|||
161787446|NCT03404206|584266703|FG002|Overall Study|Lost to Follow-up|0|||
161787447|NCT05478603|584266704|FG000|Overall Study|Withdrawal by Subject|0|||
161787448|NCT05478603|584266705|FG001|Overall Study|Withdrawal by Subject|1|||
161787449|NCT05478603|584266706|FG002|Overall Study|Withdrawal by Subject|0|||
161787450|NCT05478603|584266707|FG003|Overall Study|Withdrawal by Subject|0|||
161787451|NCT03634488|584266710|FG000|Overall Study|Death|1|||
161787452|NCT03634488|584266711|FG001|Overall Study|Death|0|||
161787453|NCT03634488|584266712|FG002|Overall Study|Death|0|||
161787454|NCT03634488|584266710|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
161787455|NCT03634488|584266711|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
161787456|NCT03634488|584266712|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
161787457|NCT00869089|584266713|FG000|Overall Study|Lost to Follow-up|1|||
161787458|NCT00869089|584266713|FG000|Overall Study|Withdrawal by Subject|1|||
161787459|NCT00869089|584266713|FG000|Overall Study|Screen Fail|1|||
161787460|NCT01169844|584266721|FG000|Overall Study|Adverse Event|0|||
161787461|NCT01169844|584266722|FG001|Overall Study|Adverse Event|1|||
161787462|NCT01169844|584266721|FG000|Overall Study|Patient withdrew consent|4|||
161787463|NCT01169844|584266722|FG001|Overall Study|Patient withdrew consent|0|||
161787464|NCT01169844|584266721|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161787465|NCT01169844|584266722|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161787466|NCT05003167|584266726|FG000|Overall Study|Withdrawal by Subject|1|||
161787467|NCT01010230|584266727|FG000|Overall Study|Withdrawal by Subject|6|||
161787468|NCT01010230|584266728|FG001|Overall Study|Withdrawal by Subject|5|||
161787469|NCT01010230|584266727|FG000|Overall Study|Lost to Follow-up|4|||
161787470|NCT01010230|584266728|FG001|Overall Study|Lost to Follow-up|2|||
161787471|NCT00530439|584266729|FG000|Overall Study|GDM|9|||
161787472|NCT00530439|584266730|FG001|Overall Study|GDM|3|||
161787473|NCT00530439|584266729|FG000|Overall Study|Withdraw|18|||
161787474|NCT00530439|584266730|FG001|Overall Study|Withdraw|14|||
161787475|NCT00530439|584266729|FG000|Overall Study|Missed abortion|1|||
161787476|NCT00530439|584266730|FG001|Overall Study|Missed abortion|4|||
161787477|NCT00530439|584266729|FG000|Overall Study|Misclassification|2|||
161787478|NCT00530439|584266730|FG001|Overall Study|Misclassification|0|||
161787479|NCT00530439|584266729|FG000|Overall Study|Twin pregnancy|0|||
161787480|NCT00530439|584266730|FG001|Overall Study|Twin pregnancy|2|||
161787481|NCT00530439|584266729|FG000|Overall Study|Severe malformation/abortion|0|||
161787482|NCT00530439|584266730|FG001|Overall Study|Severe malformation/abortion|3|||
161787483|NCT00378482|584266735|FG000|Overall Study|Lost to Follow-up|1|||
161787484|NCT00378482|584266735|FG000|Overall Study|Lack of Efficacy|8|||
161787485|NCT00378482|584266735|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
161787486|NCT00378482|584266735|FG000|Overall Study|Withdrawal by Subject|4|||
161787487|NCT00378482|584266735|FG000|Overall Study|Adverse Event|9|||
161787488|NCT00343642|584268541|FG000|Overall Study|Lost to Follow-up|0|||
161787489|NCT00343642|584268542|FG001|Overall Study|Lost to Follow-up|1|||
161787490|NCT00343642|584268543|FG002|Overall Study|Lost to Follow-up|0|||
161787491|NCT00343642|584268541|FG000|Overall Study|Pregnancy|1|||
161787492|NCT00343642|584268542|FG001|Overall Study|Pregnancy|0|||
161787493|NCT00343642|584268543|FG002|Overall Study|Pregnancy|2|||
161787494|NCT00343642|584268541|FG000|Overall Study|Withdrawal by Subject|2|||
161787495|NCT00343642|584268542|FG001|Overall Study|Withdrawal by Subject|3|||
161787496|NCT00343642|584268543|FG002|Overall Study|Withdrawal by Subject|4|||
161787497|NCT00343642|584268541|FG000|Overall Study|Adverse Event|0|||
161787498|NCT00343642|584268542|FG001|Overall Study|Adverse Event|0|||
161787499|NCT00343642|584268543|FG002|Overall Study|Adverse Event|1|||
161787500|NCT00343642|584268541|FG000|Overall Study|Flare up|6|||
161787501|NCT00343642|584268542|FG001|Overall Study|Flare up|4|||
161787502|NCT00343642|584268543|FG002|Overall Study|Flare up|0|||
161787503|NCT00860574|584268546|FG000|Overall Study|Death|2|||
161787504|NCT00860574|584268546|FG000|Overall Study|Relapse|1|||
161787505|NCT02496221|584268547|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
161787506|NCT02496221|584268548|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
161787507|NCT02496221|584268547|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
161787508|NCT02496221|584268548|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
161787509|NCT02496221|584268547|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
161787510|NCT02496221|584268548|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
161787511|NCT01335399|584268549|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
161787512|NCT01335399|584268550|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
161787513|NCT01335399|584268549|FG000|Pre-treatment Period|Participant request to discontinue|0|||
161787514|NCT01335399|584268550|FG001|Pre-treatment Period|Participant request to discontinue|1|||
161787515|NCT01335399|584268549|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
161787516|NCT01335399|584268550|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
161787517|NCT01335399|584268549|FG000|Pre-treatment Period|Consent withdrawal|3|||
161787518|NCT01335399|584268550|FG001|Pre-treatment Period|Consent withdrawal|0|||
161787519|NCT01335399|584268549|FG000|Treatment Period|Disease progression|117|||
161787520|NCT01335399|584268550|FG001|Treatment Period|Disease progression|145|||
161787521|NCT01335399|584268549|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
161787522|NCT01335399|584268550|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
161787523|NCT01335399|584268549|FG000|Treatment Period|Study drug toxicity|52|||
161787524|NCT01335399|584268550|FG001|Treatment Period|Study drug toxicity|64|||
161787525|NCT01335399|584268549|FG000|Treatment Period|Participant request to discontinue|30|||
161787526|NCT01335399|584268550|FG001|Treatment Period|Participant request to discontinue|22|||
161787527|NCT01335399|584268549|FG000|Treatment Period|Other reasons|30|||
161787528|NCT01335399|584268550|FG001|Treatment Period|Other reasons|30|||
161787529|NCT01335399|584268549|FG000|Treatment Period|Consent withdrawal|10|||
161787530|NCT01335399|584268550|FG001|Treatment Period|Consent withdrawal|7|||
161787531|NCT01335399|584268549|FG000|Treatment Period|Death|7|||
161787532|NCT01335399|584268550|FG001|Treatment Period|Death|6|||
161787533|NCT01335399|584268549|FG000|Treatment Period|Poor/Non-compliance|3|||
161787534|NCT01335399|584268550|FG001|Treatment Period|Poor/Non-compliance|4|||
161787535|NCT01335399|584268549|FG000|Treatment Period|Lost to Follow-up|2|||
161787536|NCT01335399|584268550|FG001|Treatment Period|Lost to Follow-up|2|||
161787537|NCT01335399|584268549|FG000|Treatment Period|Maximum clinical benefit|1|||
161787538|NCT01335399|584268550|FG001|Treatment Period|Maximum clinical benefit|1|||
161787539|NCT01335399|584268549|FG000|Treatment Period|No longer meet study criteria|1|||
161787540|NCT01335399|584268550|FG001|Treatment Period|No longer meet study criteria|1|||
161787541|NCT01335399|584268549|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
161787542|NCT01335399|584268550|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
161787543|NCT01120600|584268553|FG000|Overall Study|Adverse Event|7|||
161787544|NCT01120600|584268554|FG001|Overall Study|Adverse Event|7|||
161787545|NCT01120600|584268553|FG000|Overall Study|Excessive Bone Loss|0|||
161787546|NCT01120600|584268554|FG001|Overall Study|Excessive Bone Loss|4|||
161787547|NCT01120600|584268553|FG000|Overall Study|Lost to Follow-up|1|||
161787548|NCT01120600|584268554|FG001|Overall Study|Lost to Follow-up|3|||
161787549|NCT01120600|584268553|FG000|Overall Study|Physician Decision|1|||
161787550|NCT01120600|584268554|FG001|Overall Study|Physician Decision|3|||
161787551|NCT01120600|584268553|FG000|Overall Study|Protocol Violation|0|||
161787552|NCT01120600|584268554|FG001|Overall Study|Protocol Violation|4|||
161787553|NCT01120600|584268553|FG000|Overall Study|Withdrawal by Subject|10|||
161787554|NCT01120600|584268554|FG001|Overall Study|Withdrawal by Subject|11|||
161787555|NCT01165242|584268557|FG000|Overall Study|Unreachable Subjects|1|||
161787556|NCT01165242|584268558|FG001|Overall Study|Unreachable Subjects|0|||
161787557|NCT01165242|584268559|FG002|Overall Study|Unreachable Subjects|0|||
161787558|NCT01165242|584268557|FG000|Overall Study|Incarcerated Subjects|0|||
161787559|NCT01165242|584268558|FG001|Overall Study|Incarcerated Subjects|1|||
161787560|NCT01165242|584268559|FG002|Overall Study|Incarcerated Subjects|0|||
161787561|NCT01165242|584268557|FG000|Overall Study|Visit 2 Declined by Subject|0|||
161787562|NCT01165242|584268558|FG001|Overall Study|Visit 2 Declined by Subject|0|||
161787563|NCT01165242|584268559|FG002|Overall Study|Visit 2 Declined by Subject|1|||
161787564|NCT01165242|584268557|FG000|Overall Study|Withdrawal by Subject|0|||
161898538|NCT00588146|584677823|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
161787565|NCT01165242|584268558|FG001|Overall Study|Withdrawal by Subject|2|||
161787566|NCT01165242|584268559|FG002|Overall Study|Withdrawal by Subject|2|||
161898539|NCT00588146|584677824|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
161787567|NCT01165242|584268557|FG000|Overall Study|Extended Holiday|0|||
161787568|NCT01165242|584268558|FG001|Overall Study|Extended Holiday|0|||
161787569|NCT01165242|584268559|FG002|Overall Study|Extended Holiday|1|||
161787570|NCT01165242|584268557|FG000|Overall Study|Lost to Follow-up|9|||
161787571|NCT01165242|584268558|FG001|Overall Study|Lost to Follow-up|7|||
161787572|NCT01165242|584268559|FG002|Overall Study|Lost to Follow-up|10|||
161787573|NCT03372083|584268560|FG000|Overall Study|Adverse Event|3|||
161898540|NCT02100839|584677825|FG000|Multiple Ascending Dose|Adverse Event|2|||
161787574|NCT03372083|584268560|FG000|Overall Study|Physician Decision|1|||
161787575|NCT03372083|584268560|FG000|Overall Study|Withdrawal by Subject|1|||
161787576|NCT01690520|584268561|FG000|Overall Study|Death|25|||
161787577|NCT01690520|584268562|FG001|Overall Study|Death|21|||
161787578|NCT01690520|584268561|FG000|Overall Study|Lost to Follow-up|2|||
161787579|NCT01690520|584268562|FG001|Overall Study|Lost to Follow-up|3|||
161787580|NCT01690520|584268561|FG000|Overall Study|Withdrawal by Subject|2|||
161787581|NCT01690520|584268562|FG001|Overall Study|Withdrawal by Subject|0|||
161787582|NCT01690520|584268561|FG000|Overall Study|Relapse|0|||
161787583|NCT01690520|584268562|FG001|Overall Study|Relapse|1|||
161787584|NCT01690520|584268561|FG000|Overall Study|Other|0|||
161787585|NCT01690520|584268562|FG001|Overall Study|Other|1|||
161787586|NCT01690520|584268561|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
161787587|NCT01690520|584268562|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
161787588|NCT02544633|584268565|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
161787589|NCT02544633|584268566|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
161787590|NCT02544633|584268567|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
161787591|NCT02544633|584268568|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
161787592|NCT02544633|584268565|FG000|Treatment Period|Adverse Event|7|||
161787593|NCT02544633|584268566|FG001|Treatment Period|Adverse Event|4|||
161787594|NCT02544633|584268567|FG002|Treatment Period|Adverse Event|0|||
161787595|NCT02544633|584268568|FG003|Treatment Period|Adverse Event|5|||
161787596|NCT02544633|584268565|FG000|Treatment Period|Lack of Efficacy|17|||
161787597|NCT02544633|584268566|FG001|Treatment Period|Lack of Efficacy|11|||
161787598|NCT02544633|584268567|FG002|Treatment Period|Lack of Efficacy|5|||
161787599|NCT02544633|584268568|FG003|Treatment Period|Lack of Efficacy|5|||
161787600|NCT02544633|584268565|FG000|Treatment Period|Global Deterioration of Health|3|||
161787601|NCT02544633|584268566|FG001|Treatment Period|Global Deterioration of Health|3|||
161787602|NCT02544633|584268567|FG002|Treatment Period|Global Deterioration of Health|0|||
161787603|NCT02544633|584268568|FG003|Treatment Period|Global Deterioration of Health|1|||
161787604|NCT02544633|584268565|FG000|Treatment Period|Withdrawal by Subject|1|||
161787605|NCT02544633|584268566|FG001|Treatment Period|Withdrawal by Subject|0|||
161787606|NCT02544633|584268567|FG002|Treatment Period|Withdrawal by Subject|0|||
161787607|NCT02544633|584268568|FG003|Treatment Period|Withdrawal by Subject|0|||
161787608|NCT02544633|584268565|FG000|Treatment Period|Lost to Follow-up|0|||
161787609|NCT02544633|584268566|FG001|Treatment Period|Lost to Follow-up|1|||
161787610|NCT02544633|584268567|FG002|Treatment Period|Lost to Follow-up|0|||
161787611|NCT02544633|584268568|FG003|Treatment Period|Lost to Follow-up|0|||
161787612|NCT02544633|584268565|FG000|Treatment Period|Death|0|||
161787613|NCT02544633|584268566|FG001|Treatment Period|Death|0|||
161787614|NCT02544633|584268567|FG002|Treatment Period|Death|1|||
161787615|NCT02544633|584268568|FG003|Treatment Period|Death|0|||
161787616|NCT02544633|584268565|FG000|Treatment Period|Non-compliance|0|||
161787617|NCT02544633|584268566|FG001|Treatment Period|Non-compliance|0|||
161787618|NCT02544633|584268567|FG002|Treatment Period|Non-compliance|1|||
161787619|NCT02544633|584268568|FG003|Treatment Period|Non-compliance|0|||
161787620|NCT02544633|584268565|FG000|Treatment Period|Clinical Disease Progression|0|||
161787621|NCT02544633|584268566|FG001|Treatment Period|Clinical Disease Progression|0|||
161787622|NCT02544633|584268567|FG002|Treatment Period|Clinical Disease Progression|0|||
161787623|NCT02544633|584268568|FG003|Treatment Period|Clinical Disease Progression|1|||
161787624|NCT02544633|584268565|FG000|Survival Follow-up Period|Death|12|||
161787625|NCT02544633|584268566|FG001|Survival Follow-up Period|Death|14|||
161787626|NCT02544633|584268567|FG002|Survival Follow-up Period|Death|3|||
161787627|NCT02544633|584268568|FG003|Survival Follow-up Period|Death|9|||
161787628|NCT02544633|584268565|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
161787629|NCT02544633|584268566|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
161787630|NCT02544633|584268567|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
161787631|NCT02544633|584268568|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
161787632|NCT02544633|584268565|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
161787633|NCT02544633|584268566|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
161787634|NCT02544633|584268567|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
161787635|NCT02544633|584268568|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
161787636|NCT02544633|584268565|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
161787637|NCT02544633|584268566|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
161787638|NCT02544633|584268567|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
161787639|NCT02544633|584268568|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
161787640|NCT02092961|584268569|FG000|Overall Study|Not reported|1|||
161787641|NCT02092961|584268570|FG001|Overall Study|Not reported|0|||
161787642|NCT02092961|584268571|FG002|Overall Study|Not reported|1|||
161787643|NCT02092961|584268569|FG000|Overall Study|Study stopped|13|||
161787644|NCT02092961|584268570|FG001|Overall Study|Study stopped|9|||
161787645|NCT02092961|584268571|FG002|Overall Study|Study stopped|12|||
161787646|NCT02092961|584268569|FG000|Overall Study|Lack of therapeutic response|2|||
161787647|NCT02092961|584268570|FG001|Overall Study|Lack of therapeutic response|1|||
161787648|NCT02092961|584268571|FG002|Overall Study|Lack of therapeutic response|3|||
161787649|NCT02092961|584268569|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
161787650|NCT02092961|584268570|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
161787651|NCT02092961|584268571|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
161787652|NCT02092961|584268569|FG000|Overall Study|Adverse Event|2|||
161787653|NCT02092961|584268570|FG001|Overall Study|Adverse Event|4|||
161787654|NCT02092961|584268571|FG002|Overall Study|Adverse Event|0|||
161787655|NCT01623830|584268574|FG000|Overall Study|Withdrawal by Subject|6|||
161787656|NCT01623830|584268575|FG001|Overall Study|Withdrawal by Subject|7|||
161787657|NCT01623830|584268574|FG000|Overall Study|Exclusion from Study|1|||
161787658|NCT01623830|584268575|FG001|Overall Study|Exclusion from Study|2|||
161787659|NCT02468557|584268576|FG000|Overall Study|Adverse Event|1|||
161787660|NCT02468557|584268576|FG000|Overall Study|Death|1|||
161787661|NCT02468557|584268576|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
161787662|NCT02468557|584268576|FG000|Overall Study|All Enrolled but Never Dosed|4|||
161787663|NCT01605461|584268577|FG000|Overall Study|Lost to Follow-up|3|||
161787664|NCT01605461|584268577|FG000|Overall Study|Withdrawal by Subject|1|||
161787665|NCT02024698|584268578|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
161787666|NCT02024698|584268579|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
161787667|NCT03322462|584268580|FG000|Overall Study|Technical difficulties|2|||
161787668|NCT03322462|584268580|FG000|Overall Study|Other|1|||
161787669|NCT01859390|584268589|FG000|Overall Study|Insufficient Sputum Collected|1|||
161787670|NCT01859390|584268590|FG001|Overall Study|Insufficient Sputum Collected|3|||
161787671|NCT01859390|584268589|FG000|Overall Study|Sample Missing Collection Date|0|||
161787672|NCT01859390|584268590|FG001|Overall Study|Sample Missing Collection Date|1|||
161787673|NCT01859390|584268589|FG000|Overall Study|Tube Cracked|0|||
161787674|NCT01859390|584268590|FG001|Overall Study|Tube Cracked|2|||
161787675|NCT01859390|584268589|FG000|Overall Study|Shipment Error|0|||
161787676|NCT01859390|584268590|FG001|Overall Study|Shipment Error|1|||
161787677|NCT02451670|584268591|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
161787678|NCT02451670|584268592|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
161787679|NCT00463866|584268596|FG000|Overall Study|Adverse Event|70|||
161787680|NCT00463866|584268597|FG001|Overall Study|Adverse Event|93|||
161787681|NCT00463866|584268596|FG000|Overall Study|Withdrawal by Subject|81|||
161787682|NCT00463866|584268597|FG001|Overall Study|Withdrawal by Subject|79|||
161787683|NCT00463866|584268596|FG000|Overall Study|Lost to Follow-up|46|||
161787684|NCT00463866|584268597|FG001|Overall Study|Lost to Follow-up|55|||
161787685|NCT00463866|584268596|FG000|Overall Study|Incorrect Enrolment|64|||
161787686|NCT00463866|584268597|FG001|Overall Study|Incorrect Enrolment|66|||
161787687|NCT00463866|584268596|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
161787688|NCT00463866|584268597|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
161787689|NCT00463866|584268596|FG000|Overall Study|Safety Reason|1|||
161787690|NCT00463866|584268597|FG001|Overall Study|Safety Reason|3|||
161787691|NCT00463866|584268596|FG000|Overall Study|Mis-Randomization of subject|0|||
161787692|NCT00463866|584268597|FG001|Overall Study|Mis-Randomization of subject|1|||
161787693|NCT00463866|584268596|FG000|Overall Study|Other|22|||
161787694|NCT00463866|584268597|FG001|Overall Study|Other|22|||
161787695|NCT01084005|584268598|FG000|Overall Study|Adverse Event|1|||
161787696|NCT01084005|584268599|FG001|Overall Study|Adverse Event|8|||
161787697|NCT01084005|584268598|FG000|Overall Study|Protocol Violation|3|||
161787698|NCT01084005|584268599|FG001|Overall Study|Protocol Violation|7|||
161787699|NCT01084005|584268598|FG000|Overall Study|Withdrawal by Subject|1|||
161787700|NCT01084005|584268599|FG001|Overall Study|Withdrawal by Subject|1|||
161787701|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
161787702|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787703|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787704|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787705|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787706|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787707|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787708|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
161898541|NCT02100839|584677826|FG001|Multiple Ascending Dose|Adverse Event|0|||
161439513|NCT00068692|583003226|FG001|Step 2: Randomization|Disesae progression/replase|0|||
161439514|NCT00068692|583003227|FG002|Step 2: Randomization|Disesae progression/replase|1|||
161439515|NCT00068692|583003228|FG003|Step 2: Randomization|Disesae progression/replase|1|||
161787709|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787710|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787711|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787712|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787713|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787714|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787715|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
161787716|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
161898542|NCT02100839|584677825|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
161787717|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787718|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787719|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787720|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787721|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787722|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
161787723|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787724|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787725|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787726|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787727|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787728|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787729|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
161787730|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787731|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787732|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787733|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787734|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787735|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787736|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
161787737|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787738|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787739|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787740|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787741|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787742|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
161439516|NCT00068692|583003229|FG004|Step 2: Randomization|Disesae progression/replase|0|||
161439517|NCT00068692|583003230|FG005|Step 2: Randomization|Disesae progression/replase|0|||
161439518|NCT00068692|583003231|FG006|Step 2: Randomization|Disesae progression/replase|0|||
161439519|NCT00068692|583003232|FG007|Step 2: Randomization|Disesae progression/replase|0|||
161439520|NCT00068692|583003225|FG000|Step 2: Randomization|Adverse Event|0|||
161787743|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
161787744|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787745|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787746|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787747|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787748|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787749|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787750|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161787751|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Adverse Event|3|||
161787752|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Adverse Event|2|||
161787753|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Adverse Event|4|||
161787754|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Adverse Event|2|||
161787755|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Adverse Event|0|||
161787756|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Adverse Event|1|||
161787757|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787758|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161787759|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787760|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787761|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
161787762|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787763|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787764|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161787765|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
161787766|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
161787767|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
161787768|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
161787769|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
161787770|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
161787771|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
161787772|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161787773|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
161787774|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161787775|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
161787776|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
161787777|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161787778|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161787779|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Physician Decision|5|||
161787780|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Physician Decision|1|||
161787781|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161787782|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Physician Decision|3|||
161787783|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Physician Decision|1|||
161787784|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Physician Decision|2|||
161787785|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161787786|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161787787|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161787788|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161787789|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161787790|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161787791|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161787792|NCT03568500|584268607|FG000|Overall Study|Lost to Follow-up|1|||
161787793|NCT03568500|584268608|FG001|Overall Study|Lost to Follow-up|1|||
161787794|NCT03568500|584268609|FG002|Overall Study|Lost to Follow-up|2|||
161787795|NCT03568500|584268607|FG000|Overall Study|Adverse Event|1|||
161787796|NCT03568500|584268608|FG001|Overall Study|Adverse Event|1|||
161787797|NCT03568500|584268609|FG002|Overall Study|Adverse Event|2|||
161787798|NCT03568500|584268607|FG000|Overall Study|Physician Decision|1|||
161787799|NCT03568500|584268608|FG001|Overall Study|Physician Decision|0|||
161787800|NCT03568500|584268609|FG002|Overall Study|Physician Decision|0|||
161787801|NCT03568500|584268607|FG000|Overall Study|Withdrawal by Subject|4|||
161787802|NCT03568500|584268608|FG001|Overall Study|Withdrawal by Subject|2|||
161787803|NCT03568500|584268609|FG002|Overall Study|Withdrawal by Subject|0|||
161787804|NCT03568500|584268607|FG000|Overall Study|Technical Problems|2|||
161787805|NCT03568500|584268608|FG001|Overall Study|Technical Problems|1|||
161787806|NCT03568500|584268609|FG002|Overall Study|Technical Problems|0|||
161787807|NCT03568500|584268607|FG000|Overall Study|Participant Noncompliance|1|||
161787808|NCT03568500|584268608|FG001|Overall Study|Participant Noncompliance|1|||
161787809|NCT03568500|584268609|FG002|Overall Study|Participant Noncompliance|0|||
161787810|NCT00827827|584268614|FG000|Overall Study|Lost to Follow-up|3|||
161787811|NCT00827827|584268615|FG001|Overall Study|Lost to Follow-up|0|||
161787812|NCT00827827|584268614|FG000|Overall Study|Fall at home- hospitalization|1|||
161787813|NCT00827827|584268615|FG001|Overall Study|Fall at home- hospitalization|0|||
161787814|NCT00827827|584268614|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
161787815|NCT00827827|584268615|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
161787816|NCT00827827|584268614|FG000|Overall Study|Gout|1|||
161787817|NCT00827827|584268615|FG001|Overall Study|Gout|0|||
161787818|NCT00827827|584268614|FG000|Overall Study|Transportation issues|1|||
161787819|NCT00827827|584268615|FG001|Overall Study|Transportation issues|0|||
161787820|NCT00827827|584268614|FG000|Overall Study|Burned with water at home|1|||
161787821|NCT00827827|584268615|FG001|Overall Study|Burned with water at home|0|||
161787822|NCT00295854|584268616|FG000|Overall Study|Adverse Event|7|||
161787823|NCT00295854|584268617|FG001|Overall Study|Adverse Event|7|||
161787824|NCT00295854|584268618|FG002|Overall Study|Adverse Event|6|||
161787825|NCT00295854|584268616|FG000|Overall Study|Protocol Violation|1|||
161787826|NCT00295854|584268617|FG001|Overall Study|Protocol Violation|1|||
161787827|NCT00295854|584268618|FG002|Overall Study|Protocol Violation|1|||
161787828|NCT00295854|584268616|FG000|Overall Study|Lost to Follow-up|2|||
161787829|NCT00295854|584268617|FG001|Overall Study|Lost to Follow-up|0|||
161787830|NCT00295854|584268618|FG002|Overall Study|Lost to Follow-up|1|||
161787831|NCT00295854|584268616|FG000|Overall Study|Withdrawal by Subject|3|||
161787832|NCT00295854|584268617|FG001|Overall Study|Withdrawal by Subject|7|||
161787833|NCT00295854|584268618|FG002|Overall Study|Withdrawal by Subject|4|||
161787834|NCT00295854|584268616|FG000|Overall Study|did not continue to meet criteria|1|||
161787835|NCT00295854|584268617|FG001|Overall Study|did not continue to meet criteria|1|||
161787836|NCT00295854|584268618|FG002|Overall Study|did not continue to meet criteria|2|||
161439521|NCT00068692|583003226|FG001|Step 2: Randomization|Adverse Event|0|||
161439522|NCT00068692|583003227|FG002|Step 2: Randomization|Adverse Event|4|||
161439523|NCT00068692|583003228|FG003|Step 2: Randomization|Adverse Event|2|||
161439524|NCT00068692|583003229|FG004|Step 2: Randomization|Adverse Event|2|||
161439525|NCT00068692|583003230|FG005|Step 2: Randomization|Adverse Event|3|||
161787837|NCT00295854|584268616|FG000|Overall Study|required a prohibited medication|1|||
161787838|NCT00295854|584268617|FG001|Overall Study|required a prohibited medication|0|||
161787839|NCT00295854|584268618|FG002|Overall Study|required a prohibited medication|0|||
161787840|NCT00295854|584268616|FG000|Overall Study|Other|3|||
161787841|NCT00295854|584268617|FG001|Overall Study|Other|5|||
161787842|NCT00295854|584268618|FG002|Overall Study|Other|1|||
161787843|NCT01967888|584268620|FG000|Overall Study|Lost to Follow-up|6|||
161787844|NCT01967888|584268621|FG001|Overall Study|Lost to Follow-up|4|||
161787845|NCT01967888|584268620|FG000|Overall Study|Withdrawal by Subject|1|||
161787846|NCT01967888|584268621|FG001|Overall Study|Withdrawal by Subject|1|||
161787847|NCT01967888|584268620|FG000|Overall Study|Did Not Have Transplant|1|||
161787848|NCT01967888|584268621|FG001|Overall Study|Did Not Have Transplant|0|||
161787849|NCT01967888|584268620|FG000|Overall Study|Research visit not done, data recorded|1|||
161787850|NCT01967888|584268621|FG001|Overall Study|Research visit not done, data recorded|0|||
161787851|NCT01967888|584268620|FG000|Overall Study|Subject excluded after randomization|1|||
161787852|NCT01967888|584268621|FG001|Overall Study|Subject excluded after randomization|0|||
161787853|NCT01967888|584268620|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
161787854|NCT01967888|584268621|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
161787855|NCT01967888|584268620|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
161787856|NCT01967888|584268621|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
161787857|NCT03175120|584268625|FG000|Overall Study|Adverse Event|2|||
161787858|NCT03175120|584268626|FG001|Overall Study|Adverse Event|2|||
161787859|NCT03175120|584268625|FG000|Overall Study|Protocol Violation|5|||
161787860|NCT03175120|584268626|FG001|Overall Study|Protocol Violation|2|||
161787861|NCT03175120|584268625|FG000|Overall Study|Lost to Follow-up|1|||
161787862|NCT03175120|584268626|FG001|Overall Study|Lost to Follow-up|0|||
161787863|NCT03175120|584268625|FG000|Overall Study|Withdrawal by Subject|2|||
161787864|NCT03175120|584268626|FG001|Overall Study|Withdrawal by Subject|5|||
161787865|NCT03175120|584268625|FG000|Overall Study|Other|2|||
161787866|NCT03175120|584268626|FG001|Overall Study|Other|3|||
161787867|NCT04120194|584268627|FG000|Overall Study|Lost to Follow-up|11|||
161787868|NCT04120194|584268628|FG001|Overall Study|Lost to Follow-up|8|||
161787869|NCT04120194|584268627|FG000|Overall Study|Adverse Event|4|||
161787870|NCT04120194|584268628|FG001|Overall Study|Adverse Event|5|||
161787871|NCT04120194|584268627|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
161787872|NCT04120194|584268628|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
161787873|NCT04120194|584268627|FG000|Overall Study|Miscellaneous|4|||
161787874|NCT04120194|584268628|FG001|Overall Study|Miscellaneous|5|||
161787875|NCT02622074|584268629|FG000|Overall Study|Death|4|||
161787876|NCT02622074|584268630|FG001|Overall Study|Death|0|||
161787877|NCT02622074|584268631|FG002|Overall Study|Death|0|||
161787878|NCT02622074|584268632|FG003|Overall Study|Death|1|||
161787879|NCT02622074|584268633|FG004|Overall Study|Death|1|||
161787880|NCT02622074|584268634|FG005|Overall Study|Death|0|||
161787881|NCT02622074|584268629|FG000|Overall Study|Withdrawal by Subject|0|||
161787882|NCT02622074|584268630|FG001|Overall Study|Withdrawal by Subject|1|||
161787883|NCT02622074|584268631|FG002|Overall Study|Withdrawal by Subject|0|||
161787884|NCT02622074|584268632|FG003|Overall Study|Withdrawal by Subject|0|||
161787885|NCT02622074|584268633|FG004|Overall Study|Withdrawal by Subject|0|||
161787886|NCT02622074|584268634|FG005|Overall Study|Withdrawal by Subject|0|||
161787887|NCT02114931|584268635|FG000|Overall Study|Withdrawal by Subject|15|||
161787888|NCT02114931|584268636|FG001|Overall Study|Withdrawal by Subject|18|||
161787889|NCT02114931|584268635|FG000|Overall Study|Adverse Event|4|||
161787890|NCT02114931|584268636|FG001|Overall Study|Adverse Event|6|||
161787891|NCT02114931|584268635|FG000|Overall Study|Lost to Follow-up|3|||
161787892|NCT02114931|584268636|FG001|Overall Study|Lost to Follow-up|3|||
161787893|NCT02114931|584268635|FG000|Overall Study|Physician Decision|1|||
161787894|NCT02114931|584268636|FG001|Overall Study|Physician Decision|2|||
161787895|NCT02114931|584268635|FG000|Overall Study|Other|2|||
161787896|NCT02114931|584268636|FG001|Overall Study|Other|1|||
161787897|NCT03565211|584268640|FG000|Overall Study|Withdrawal by Subject|2|||
161787898|NCT03565211|584268640|FG000|Overall Study|Lost to Follow-up|1|||
161787899|NCT03565211|584268640|FG000|Overall Study|Adverse Event|44|||
161787900|NCT03565211|584268640|FG000|Overall Study|Personal issues|1|||
161787901|NCT00986154|584268641|FG000|Overall Study|Death|136|||
161787902|NCT00986154|584268642|FG001|Overall Study|Death|127|||
161787903|NCT00986154|584268641|FG000|Overall Study|Lost to Follow-up|7|||
161787904|NCT00986154|584268642|FG001|Overall Study|Lost to Follow-up|4|||
161787905|NCT00986154|584268641|FG000|Overall Study|Withdrawal by Subject|32|||
161787906|NCT00986154|584268642|FG001|Overall Study|Withdrawal by Subject|33|||
161898543|NCT02100839|584677826|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
161898544|NCT03272347|584677828|FG000|Overall Study|Death|0|||
161787907|NCT00986154|584268641|FG000|Overall Study|investigator/subject decide not continue|6|||
161787908|NCT00986154|584268642|FG001|Overall Study|investigator/subject decide not continue|3|||
161787909|NCT00986154|584268641|FG000|Overall Study|never received study drug|25|||
161787910|NCT00986154|584268642|FG001|Overall Study|never received study drug|27|||
161787911|NCT00267007|584268643|FG000|Overall Study|Withdrawal by Subject|6|||
161787912|NCT00267007|584268644|FG001|Overall Study|Withdrawal by Subject|0|||
161787913|NCT00267007|584268643|FG000|Overall Study|Lost to Follow-up|1|||
161787914|NCT00267007|584268644|FG001|Overall Study|Lost to Follow-up|0|||
161787915|NCT00267007|584268643|FG000|Overall Study|Non-compliance|0|||
161787916|NCT00267007|584268644|FG001|Overall Study|Non-compliance|1|||
161787917|NCT00267007|584268643|FG000|Overall Study|Adverse Event|1|||
161787918|NCT00267007|584268644|FG001|Overall Study|Adverse Event|0|||
161787919|NCT01684722|584268651|FG000|Overall Study|Lost to Follow-up|78|||
161787920|NCT01684722|584268652|FG001|Overall Study|Lost to Follow-up|56|||
161898545|NCT03272347|584677829|FG001|Overall Study|Death|0|||
161787921|NCT01684722|584268653|FG002|Overall Study|Lost to Follow-up|75|||
161787922|NCT01684722|584268654|FG003|Overall Study|Lost to Follow-up|89|||
161787923|NCT01684722|584268651|FG000|Overall Study|Death|19|||
161787924|NCT01684722|584268652|FG001|Overall Study|Death|21|||
161787925|NCT01684722|584268653|FG002|Overall Study|Death|19|||
161787926|NCT01684722|584268654|FG003|Overall Study|Death|21|||
161787927|NCT01664494|584268655|FG000|Overall Study|Withdrawal by Subject|27|||
161787928|NCT01664494|584268655|FG000|Overall Study|Death|18|||
161787929|NCT01664494|584268655|FG000|Overall Study|Other|49|||
161787930|NCT01664494|584268655|FG000|Overall Study|Lost to Follow-up|99|||
161787931|NCT00219557|584268656|FG000|Phase 1|Lack of Efficacy|3|||
161787932|NCT00219557|584268657|FG001|Phase 1|Lack of Efficacy|0|||
161787933|NCT00219557|584268658|FG002|Phase 1|Lack of Efficacy|0|||
161787934|NCT00219557|584268656|FG000|Phase 1|Adverse Event|2|||
161787935|NCT00219557|584268657|FG001|Phase 1|Adverse Event|0|||
161787936|NCT00219557|584268658|FG002|Phase 1|Adverse Event|0|||
161787937|NCT00219557|584268656|FG000|Phase 1|Withdrawal by Subject|1|||
161787938|NCT00219557|584268657|FG001|Phase 1|Withdrawal by Subject|0|||
161787939|NCT00219557|584268658|FG002|Phase 1|Withdrawal by Subject|0|||
161787940|NCT00219557|584268656|FG000|Phase 1|Started chemotherapy at other institute|1|||
161787941|NCT00219557|584268657|FG001|Phase 1|Started chemotherapy at other institute|0|||
161787942|NCT00219557|584268658|FG002|Phase 1|Started chemotherapy at other institute|0|||
161787943|NCT00219557|584268656|FG000|Phase 2|Lack of Efficacy|0|||
161787944|NCT00219557|584268657|FG001|Phase 2|Lack of Efficacy|21|||
161787945|NCT00219557|584268658|FG002|Phase 2|Lack of Efficacy|15|||
161787946|NCT00219557|584268656|FG000|Phase 2|Adverse Event|0|||
161787947|NCT00219557|584268657|FG001|Phase 2|Adverse Event|22|||
161787948|NCT00219557|584268658|FG002|Phase 2|Adverse Event|2|||
161787949|NCT00219557|584268656|FG000|Phase 2|Death|0|||
161787950|NCT00219557|584268657|FG001|Phase 2|Death|8|||
161787951|NCT00219557|584268658|FG002|Phase 2|Death|2|||
161787952|NCT00219557|584268656|FG000|Phase 2|Other|0|||
161787953|NCT00219557|584268657|FG001|Phase 2|Other|8|||
161787954|NCT00219557|584268658|FG002|Phase 2|Other|6|||
161787955|NCT00219557|584268656|FG000|Phase 2|Withdrawal by Subject|0|||
161787956|NCT00219557|584268657|FG001|Phase 2|Withdrawal by Subject|9|||
161787957|NCT00219557|584268658|FG002|Phase 2|Withdrawal by Subject|5|||
161787958|NCT00219557|584268656|FG000|Phase 2|Treatment not received|0|||
161787959|NCT00219557|584268657|FG001|Phase 2|Treatment not received|1|||
161787960|NCT00219557|584268658|FG002|Phase 2|Treatment not received|3|||
161787961|NCT03063632|584268659|FG000|Overall Study|Death|4|||
161787962|NCT03063632|584268660|FG001|Overall Study|Death|6|||
161787963|NCT03063632|584268659|FG000|Overall Study|Lost to Follow-up|0|||
161787964|NCT03063632|584268660|FG001|Overall Study|Lost to Follow-up|1|||
161787965|NCT03063632|584268659|FG000|Overall Study|Withdrawal by Subject|0|||
161787966|NCT03063632|584268660|FG001|Overall Study|Withdrawal by Subject|2|||
161787967|NCT03063632|584268659|FG000|Overall Study|Physician Decision|2|||
161787968|NCT03063632|584268660|FG001|Overall Study|Physician Decision|0|||
161787969|NCT03063632|584268659|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
161787970|NCT03063632|584268660|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
161787971|NCT01612156|584268661|FG000|Overall Study|Protocol Violation|2|||
161787972|NCT01612156|584268662|FG001|Overall Study|Protocol Violation|0|||
161787973|NCT00410410|584268663|FG000|Induction Period (IP)|Death|1|||
161787974|NCT00410410|584268664|FG001|Induction Period (IP)|Death|0|||
161787975|NCT00410410|584268665|FG002|Induction Period (IP)|Death|0|||
161787976|NCT00410410|584268666|FG003|Induction Period (IP)|Death|0|||
161787977|NCT00410410|584268667|FG004|Induction Period (IP)|Death|0|||
161787978|NCT00410410|584268668|FG005|Induction Period (IP)|Death|0|||
161787979|NCT00410410|584268669|FG006|Induction Period (IP)|Death|0|||
161787980|NCT00410410|584268670|FG007|Induction Period (IP)|Death|0|||
161787981|NCT00410410|584268671|FG008|Induction Period (IP)|Death|0|||
161787982|NCT00410410|584268663|FG000|Induction Period (IP)|Adverse Event|3|||
161787983|NCT00410410|584268664|FG001|Induction Period (IP)|Adverse Event|4|||
161787984|NCT00410410|584268665|FG002|Induction Period (IP)|Adverse Event|2|||
161787985|NCT00410410|584268666|FG003|Induction Period (IP)|Adverse Event|4|||
161787986|NCT00410410|584268667|FG004|Induction Period (IP)|Adverse Event|1|||
161787987|NCT00410410|584268668|FG005|Induction Period (IP)|Adverse Event|0|||
161787988|NCT00410410|584268669|FG006|Induction Period (IP)|Adverse Event|0|||
161787989|NCT00410410|584268670|FG007|Induction Period (IP)|Adverse Event|0|||
161787990|NCT00410410|584268671|FG008|Induction Period (IP)|Adverse Event|0|||
161787991|NCT00410410|584268663|FG000|Induction Period (IP)|Lack of Efficacy|26|||
161787992|NCT00410410|584268664|FG001|Induction Period (IP)|Lack of Efficacy|24|||
161787993|NCT00410410|584268665|FG002|Induction Period (IP)|Lack of Efficacy|8|||
161787994|NCT00410410|584268666|FG003|Induction Period (IP)|Lack of Efficacy|8|||
161787995|NCT00410410|584268667|FG004|Induction Period (IP)|Lack of Efficacy|7|||
161787996|NCT00410410|584268668|FG005|Induction Period (IP)|Lack of Efficacy|7|||
161787997|NCT00410410|584268669|FG006|Induction Period (IP)|Lack of Efficacy|0|||
161787998|NCT00410410|584268670|FG007|Induction Period (IP)|Lack of Efficacy|0|||
161787999|NCT00410410|584268671|FG008|Induction Period (IP)|Lack of Efficacy|0|||
161788000|NCT00410410|584268663|FG000|Induction Period (IP)|Lost to Follow-up|2|||
161788001|NCT00410410|584268664|FG001|Induction Period (IP)|Lost to Follow-up|2|||
161788002|NCT00410410|584268665|FG002|Induction Period (IP)|Lost to Follow-up|2|||
161788003|NCT00410410|584268666|FG003|Induction Period (IP)|Lost to Follow-up|3|||
161788004|NCT00410410|584268667|FG004|Induction Period (IP)|Lost to Follow-up|0|||
161788005|NCT00410410|584268668|FG005|Induction Period (IP)|Lost to Follow-up|1|||
161788006|NCT00410410|584268669|FG006|Induction Period (IP)|Lost to Follow-up|0|||
161788007|NCT00410410|584268670|FG007|Induction Period (IP)|Lost to Follow-up|0|||
161788008|NCT00410410|584268671|FG008|Induction Period (IP)|Lost to Follow-up|0|||
161788009|NCT00410410|584268663|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
161788010|NCT00410410|584268664|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
161788011|NCT00410410|584268665|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
161788012|NCT00410410|584268666|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
161788013|NCT00410410|584268667|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
161788014|NCT00410410|584268668|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
161788015|NCT00410410|584268669|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
161788016|NCT00410410|584268670|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
161788017|NCT00410410|584268671|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
161788018|NCT00410410|584268663|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788019|NCT00410410|584268664|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788020|NCT00410410|584268665|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
161788021|NCT00410410|584268666|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788022|NCT00410410|584268667|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788023|NCT00410410|584268668|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788024|NCT00410410|584268669|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788025|NCT00410410|584268670|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788026|NCT00410410|584268671|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788027|NCT00410410|584268663|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788028|NCT00410410|584268664|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788029|NCT00410410|584268665|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788030|NCT00410410|584268666|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788031|NCT00410410|584268667|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
161788032|NCT00410410|584268668|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
161788033|NCT00410410|584268669|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788034|NCT00410410|584268670|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788035|NCT00410410|584268671|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788036|NCT00410410|584268663|FG000|Induction Period (IP)|Other|0|||
161788037|NCT00410410|584268664|FG001|Induction Period (IP)|Other|0|||
161788038|NCT00410410|584268665|FG002|Induction Period (IP)|Other|1|||
161788039|NCT00410410|584268666|FG003|Induction Period (IP)|Other|0|||
161788040|NCT00410410|584268667|FG004|Induction Period (IP)|Other|0|||
161788041|NCT00410410|584268668|FG005|Induction Period (IP)|Other|0|||
161788042|NCT00410410|584268669|FG006|Induction Period (IP)|Other|0|||
161788043|NCT00410410|584268670|FG007|Induction Period (IP)|Other|0|||
161788044|NCT00410410|584268671|FG008|Induction Period (IP)|Other|0|||
161788045|NCT00410410|584268663|FG000|Maintenance Period (MP)|Death|0|||
161788046|NCT00410410|584268664|FG001|Maintenance Period (MP)|Death|0|||
161788047|NCT00410410|584268665|FG002|Maintenance Period (MP)|Death|0|||
161788048|NCT00410410|584268666|FG003|Maintenance Period (MP)|Death|0|||
161788049|NCT00410410|584268667|FG004|Maintenance Period (MP)|Death|0|||
161788050|NCT00410410|584268668|FG005|Maintenance Period (MP)|Death|0|||
161788051|NCT00410410|584268669|FG006|Maintenance Period (MP)|Death|1|||
161788052|NCT00410410|584268670|FG007|Maintenance Period (MP)|Death|0|||
161788053|NCT00410410|584268671|FG008|Maintenance Period (MP)|Death|0|||
161788054|NCT00410410|584268663|FG000|Maintenance Period (MP)|Adverse Event|0|||
161788055|NCT00410410|584268664|FG001|Maintenance Period (MP)|Adverse Event|0|||
161788056|NCT00410410|584268665|FG002|Maintenance Period (MP)|Adverse Event|0|||
161788057|NCT00410410|584268666|FG003|Maintenance Period (MP)|Adverse Event|0|||
161788058|NCT00410410|584268667|FG004|Maintenance Period (MP)|Adverse Event|0|||
161788059|NCT00410410|584268668|FG005|Maintenance Period (MP)|Adverse Event|0|||
161788060|NCT00410410|584268669|FG006|Maintenance Period (MP)|Adverse Event|1|||
161788061|NCT00410410|584268670|FG007|Maintenance Period (MP)|Adverse Event|3|||
161788062|NCT00410410|584268671|FG008|Maintenance Period (MP)|Adverse Event|0|||
161788063|NCT00410410|584268663|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
161788064|NCT00410410|584268664|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
161788065|NCT00410410|584268665|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
161788066|NCT00410410|584268666|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
161788067|NCT00410410|584268667|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
161788068|NCT00410410|584268668|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
161788069|NCT00410410|584268669|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
161788070|NCT00410410|584268670|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
161788071|NCT00410410|584268671|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
161788072|NCT00410410|584268663|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
161788073|NCT00410410|584268664|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
161788074|NCT00410410|584268665|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
161788075|NCT00410410|584268666|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
161788076|NCT00410410|584268667|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
161788077|NCT00410410|584268668|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
161788078|NCT00410410|584268669|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
161788079|NCT00410410|584268670|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
161788080|NCT00410410|584268671|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
161788081|NCT00410410|584268663|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788082|NCT00410410|584268664|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788083|NCT00410410|584268665|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788084|NCT00410410|584268666|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788085|NCT00410410|584268667|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788086|NCT00410410|584268668|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788087|NCT00410410|584268669|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
161788088|NCT00410410|584268670|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
161788089|NCT00410410|584268671|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788090|NCT00410410|584268663|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788091|NCT00410410|584268664|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788092|NCT00410410|584268665|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788093|NCT00410410|584268666|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788094|NCT00410410|584268667|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788095|NCT00410410|584268668|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788096|NCT00410410|584268669|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
161788097|NCT00410410|584268670|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
161788098|NCT00410410|584268671|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788099|NCT00410410|584268663|FG000|Open-Label Period (OL)|Death|0|||
161788100|NCT00410410|584268664|FG001|Open-Label Period (OL)|Death|0|||
161788101|NCT00410410|584268665|FG002|Open-Label Period (OL)|Death|0|||
161788102|NCT00410410|584268666|FG003|Open-Label Period (OL)|Death|0|||
161788103|NCT00410410|584268667|FG004|Open-Label Period (OL)|Death|0|||
161788104|NCT00410410|584268668|FG005|Open-Label Period (OL)|Death|0|||
161788105|NCT00410410|584268669|FG006|Open-Label Period (OL)|Death|0|||
161788106|NCT00410410|584268670|FG007|Open-Label Period (OL)|Death|0|||
161788107|NCT00410410|584268671|FG008|Open-Label Period (OL)|Death|1|||
161788108|NCT00410410|584268663|FG000|Open-Label Period (OL)|Adverse Event|0|||
161788109|NCT00410410|584268664|FG001|Open-Label Period (OL)|Adverse Event|0|||
161788110|NCT00410410|584268665|FG002|Open-Label Period (OL)|Adverse Event|0|||
161788111|NCT00410410|584268666|FG003|Open-Label Period (OL)|Adverse Event|0|||
161788112|NCT00410410|584268667|FG004|Open-Label Period (OL)|Adverse Event|0|||
161788113|NCT00410410|584268668|FG005|Open-Label Period (OL)|Adverse Event|0|||
161788114|NCT00410410|584268669|FG006|Open-Label Period (OL)|Adverse Event|0|||
161788115|NCT00410410|584268670|FG007|Open-Label Period (OL)|Adverse Event|0|||
161788116|NCT00410410|584268671|FG008|Open-Label Period (OL)|Adverse Event|10|||
161788117|NCT00410410|584268663|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
161788118|NCT00410410|584268664|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
161788119|NCT00410410|584268665|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
161788120|NCT00410410|584268666|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
161788121|NCT00410410|584268667|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
161788122|NCT00410410|584268668|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
161788123|NCT00410410|584268669|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
161788124|NCT00410410|584268670|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
161788125|NCT00410410|584268671|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
161788126|NCT00410410|584268663|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
161788127|NCT00410410|584268664|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
161788128|NCT00410410|584268665|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
161788129|NCT00410410|584268666|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
161788130|NCT00410410|584268667|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
161788131|NCT00410410|584268668|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
161788132|NCT00410410|584268669|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
161788133|NCT00410410|584268670|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
161788134|NCT00410410|584268671|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
161788135|NCT00410410|584268663|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788136|NCT00410410|584268664|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788137|NCT00410410|584268665|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788138|NCT00410410|584268666|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788139|NCT00410410|584268667|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788140|NCT00410410|584268668|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788141|NCT00410410|584268669|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788142|NCT00410410|584268670|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788143|NCT00410410|584268671|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
161788144|NCT00410410|584268663|FG000|Open-Label Period (OL)|Pregnancy|0|||
161788145|NCT00410410|584268664|FG001|Open-Label Period (OL)|Pregnancy|0|||
161788146|NCT00410410|584268665|FG002|Open-Label Period (OL)|Pregnancy|0|||
161788147|NCT00410410|584268666|FG003|Open-Label Period (OL)|Pregnancy|0|||
161788148|NCT00410410|584268667|FG004|Open-Label Period (OL)|Pregnancy|0|||
161788149|NCT00410410|584268668|FG005|Open-Label Period (OL)|Pregnancy|0|||
161788150|NCT00410410|584268669|FG006|Open-Label Period (OL)|Pregnancy|0|||
161788151|NCT00410410|584268670|FG007|Open-Label Period (OL)|Pregnancy|0|||
161788152|NCT00410410|584268671|FG008|Open-Label Period (OL)|Pregnancy|1|||
161788153|NCT00410410|584268663|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788154|NCT00410410|584268664|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788155|NCT00410410|584268665|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788156|NCT00410410|584268666|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788157|NCT00410410|584268667|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788158|NCT00410410|584268668|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788159|NCT00410410|584268669|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788160|NCT00410410|584268670|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788161|NCT00410410|584268671|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
161788162|NCT00410410|584268663|FG000|Open-Label Period (OL)|Other|0|||
161788163|NCT00410410|584268664|FG001|Open-Label Period (OL)|Other|0|||
161788164|NCT00410410|584268665|FG002|Open-Label Period (OL)|Other|0|||
161788165|NCT00410410|584268666|FG003|Open-Label Period (OL)|Other|0|||
161788166|NCT00410410|584268667|FG004|Open-Label Period (OL)|Other|0|||
161788167|NCT00410410|584268668|FG005|Open-Label Period (OL)|Other|0|||
161788168|NCT00410410|584268669|FG006|Open-Label Period (OL)|Other|0|||
161788169|NCT00410410|584268670|FG007|Open-Label Period (OL)|Other|0|||
161788170|NCT00410410|584268671|FG008|Open-Label Period (OL)|Other|7|||
161788171|NCT01783496|584268672|FG000|Overall Study|Lost to Follow-up|0|||
161788172|NCT01783496|584268673|FG001|Overall Study|Lost to Follow-up|0|||
161788173|NCT01783496|584268674|FG002|Overall Study|Lost to Follow-up|0|||
161788174|NCT01783496|584268675|FG003|Overall Study|Lost to Follow-up|2|||
161788175|NCT01783496|584268676|FG004|Overall Study|Lost to Follow-up|0|||
161788176|NCT01783496|584268677|FG005|Overall Study|Lost to Follow-up|1|||
161788177|NCT01783496|584268672|FG000|Overall Study|Withdrawal by Subject|1|||
161788178|NCT01783496|584268673|FG001|Overall Study|Withdrawal by Subject|0|||
161788179|NCT01783496|584268674|FG002|Overall Study|Withdrawal by Subject|0|||
161788180|NCT01783496|584268675|FG003|Overall Study|Withdrawal by Subject|0|||
161788181|NCT01783496|584268676|FG004|Overall Study|Withdrawal by Subject|0|||
161788182|NCT01783496|584268677|FG005|Overall Study|Withdrawal by Subject|0|||
161788183|NCT01023269|584268678|FG000|Overall Study|early termination of the study|2|||
161788184|NCT01023269|584268679|FG001|Overall Study|early termination of the study|0|||
161788185|NCT00106028|584268680|FG000|Overall Study|Adverse Event|3|||
161439526|NCT00068692|583003231|FG006|Step 2: Randomization|Adverse Event|4|||
161439527|NCT00068692|583003232|FG007|Step 2: Randomization|Adverse Event|4|||
161439528|NCT00068692|583003225|FG000|Step 2: Randomization|Death|0|||
161439529|NCT00068692|583003226|FG001|Step 2: Randomization|Death|0|||
161439530|NCT00068692|583003227|FG002|Step 2: Randomization|Death|0|||
161439531|NCT00068692|583003228|FG003|Step 2: Randomization|Death|0|||
161439532|NCT00068692|583003229|FG004|Step 2: Randomization|Death|1|||
161439533|NCT00068692|583003230|FG005|Step 2: Randomization|Death|0|||
161439534|NCT00068692|583003231|FG006|Step 2: Randomization|Death|0|||
161439535|NCT00068692|583003232|FG007|Step 2: Randomization|Death|1|||
161439536|NCT00068692|583003225|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
161788186|NCT00106028|584268681|FG001|Overall Study|Adverse Event|2|||
161788187|NCT00106028|584268680|FG000|Overall Study|Protocol Violation|1|||
161788188|NCT00106028|584268681|FG001|Overall Study|Protocol Violation|1|||
161788189|NCT00106028|584268680|FG000|Overall Study|Withdrawal by Subject|2|||
161788190|NCT00106028|584268681|FG001|Overall Study|Withdrawal by Subject|8|||
161788191|NCT00106028|584268680|FG000|Overall Study|Lost to Follow-up|0|||
161439537|NCT00068692|583003226|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
161788192|NCT00106028|584268681|FG001|Overall Study|Lost to Follow-up|1|||
161788193|NCT00947011|584268682|FG000|Overall Study|Study was terminated,PI left institution|12|||
161788194|NCT05266456|584268685|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
161788195|NCT05266456|584268686|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
161788196|NCT05266456|584268687|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
161788197|NCT05266456|584268688|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
161788198|NCT05266456|584268685|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161788199|NCT05266456|584268686|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161788200|NCT05266456|584268687|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161788201|NCT05266456|584268688|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
161788202|NCT05266456|584268685|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
161788203|NCT05266456|584268686|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
161788204|NCT05266456|584268687|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
161788205|NCT05266456|584268688|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
161788206|NCT05266456|584268685|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161788207|NCT05266456|584268686|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161788208|NCT05266456|584268687|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
161788209|NCT05266456|584268688|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161788210|NCT05266456|584268685|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
161788211|NCT05266456|584268686|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
161788212|NCT05266456|584268687|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
161788213|NCT05266456|584268688|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
161788214|NCT02746705|584268695|FG000|Overall Study|Physician Decision|1|||
161788215|NCT02746705|584268696|FG001|Overall Study|Physician Decision|1|||
161788216|NCT02746705|584268695|FG000|Overall Study|Lost to Follow-up|1|||
161788217|NCT02746705|584268696|FG001|Overall Study|Lost to Follow-up|0|||
161788218|NCT02746705|584268695|FG000|Overall Study|outlier scores deemed not valid|0|||
161788219|NCT02746705|584268696|FG001|Overall Study|outlier scores deemed not valid|1|||
161788220|NCT00479401|584268697|FG000|Overall Study|Adverse Event|24|||
161788221|NCT00479401|584268698|FG001|Overall Study|Adverse Event|20|||
161788222|NCT00479401|584268699|FG002|Overall Study|Adverse Event|4|||
161788223|NCT00479401|584268697|FG000|Overall Study|Lack of Efficacy|2|||
161788224|NCT00479401|584268698|FG001|Overall Study|Lack of Efficacy|2|||
161788225|NCT00479401|584268699|FG002|Overall Study|Lack of Efficacy|4|||
161788226|NCT00479401|584268697|FG000|Overall Study|Protocol Violation|2|||
161788227|NCT00479401|584268698|FG001|Overall Study|Protocol Violation|1|||
161788228|NCT00479401|584268699|FG002|Overall Study|Protocol Violation|1|||
161788229|NCT00479401|584268697|FG000|Overall Study|Lost to Follow-up|1|||
161788230|NCT00479401|584268698|FG001|Overall Study|Lost to Follow-up|1|||
161788231|NCT00479401|584268699|FG002|Overall Study|Lost to Follow-up|1|||
161788232|NCT00479401|584268697|FG000|Overall Study|Withdrawal by Subject|16|||
161788233|NCT00479401|584268698|FG001|Overall Study|Withdrawal by Subject|10|||
161788234|NCT00479401|584268699|FG002|Overall Study|Withdrawal by Subject|2|||
161788235|NCT00479401|584268697|FG000|Overall Study|Exclusion criteria, relocation|4|||
161788236|NCT00479401|584268698|FG001|Overall Study|Exclusion criteria, relocation|3|||
161788237|NCT00479401|584268699|FG002|Overall Study|Exclusion criteria, relocation|0|||
161788238|NCT01504867|584268700|FG000|Overall Study|Inclusion criteria not met|2|||
161788239|NCT01504867|584268701|FG001|Overall Study|Inclusion criteria not met|2|||
161788240|NCT01504867|584268700|FG000|Overall Study|Consent revoked|5|||
161788241|NCT01504867|584268701|FG001|Overall Study|Consent revoked|1|||
161788242|NCT02473510|584268704|FG000|Overall Study|Lost to Follow-up|1|||
161788243|NCT02473510|584268705|FG001|Overall Study|Lost to Follow-up|2|||
161788244|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
161788245|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
161788246|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
161788247|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
161788248|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Other|1|||
161788249|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Other|0|||
161788250|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
161788251|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
161788252|NCT00990093|584268706|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
161788253|NCT00990093|584268707|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
161788254|NCT00990093|584268706|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
161788255|NCT00990093|584268707|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
161788256|NCT00990093|584268706|FG000|Test Period 2 (15-28 Days)|Other|0|||
161788257|NCT00990093|584268707|FG001|Test Period 2 (15-28 Days)|Other|1|||
161788258|NCT03185949|584268708|FG000|ITT Analysis|Withdrawal by Subject|4|||
161788259|NCT03185949|584268709|FG001|ITT Analysis|Withdrawal by Subject|3|||
161788260|NCT03185949|584268708|FG000|PP Analysis|Protocol Violation|2|||
161788261|NCT03185949|584268709|FG001|PP Analysis|Protocol Violation|2|||
161788262|NCT03185949|584268708|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
161788263|NCT03185949|584268709|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
161788264|NCT00928252|584270576|FG000|Overall Study|Physician Decision|3|||
161788265|NCT02257632|584270577|FG000|Overall Study|Withdrawal by Subject|0|||
161788266|NCT02257632|584270578|FG001|Overall Study|Withdrawal by Subject|1|||
161788267|NCT02257632|584270577|FG000|Overall Study|Adverse Event|1|||
161788268|NCT02257632|584270578|FG001|Overall Study|Adverse Event|2|||
161788269|NCT01393990|584270582|FG000|Overall Study|Adverse Event|0|||
161788270|NCT01393990|584270583|FG001|Overall Study|Adverse Event|0|||
161788271|NCT01393990|584270584|FG002|Overall Study|Adverse Event|0|||
161788272|NCT01393990|584270585|FG003|Overall Study|Adverse Event|0|||
161788273|NCT01393990|584270586|FG004|Overall Study|Adverse Event|0|||
161788274|NCT01393990|584270587|FG005|Overall Study|Adverse Event|0|||
161788275|NCT01393990|584270588|FG006|Overall Study|Adverse Event|0|||
161788276|NCT01393990|584270589|FG007|Overall Study|Adverse Event|0|||
161788277|NCT01393990|584270590|FG008|Overall Study|Adverse Event|0|||
161788278|NCT01393990|584270591|FG009|Overall Study|Adverse Event|0|||
161788279|NCT01393990|584270592|FG010|Overall Study|Adverse Event|0|||
161788280|NCT01393990|584270593|FG011|Overall Study|Adverse Event|0|||
161788281|NCT01393990|584270594|FG012|Overall Study|Adverse Event|0|||
161788282|NCT01393990|584270595|FG013|Overall Study|Adverse Event|0|||
161788283|NCT01393990|584270596|FG014|Overall Study|Adverse Event|1|||
161788284|NCT01393990|584270597|FG015|Overall Study|Adverse Event|1|||
161788285|NCT01393990|584270598|FG016|Overall Study|Adverse Event|0|||
161788286|NCT01393990|584270599|FG017|Overall Study|Adverse Event|0|||
161788287|NCT01393990|584270582|FG000|Overall Study|Progressive Disease|1|||
161788288|NCT01393990|584270583|FG001|Overall Study|Progressive Disease|0|||
161788289|NCT01393990|584270584|FG002|Overall Study|Progressive Disease|0|||
161788290|NCT01393990|584270585|FG003|Overall Study|Progressive Disease|1|||
161788291|NCT01393990|584270586|FG004|Overall Study|Progressive Disease|1|||
161788292|NCT01393990|584270587|FG005|Overall Study|Progressive Disease|1|||
161788293|NCT01393990|584270588|FG006|Overall Study|Progressive Disease|1|||
161788294|NCT01393990|584270589|FG007|Overall Study|Progressive Disease|1|||
161788295|NCT01393990|584270590|FG008|Overall Study|Progressive Disease|3|||
161788296|NCT01393990|584270591|FG009|Overall Study|Progressive Disease|1|||
161788297|NCT01393990|584270592|FG010|Overall Study|Progressive Disease|0|||
161788298|NCT01393990|584270593|FG011|Overall Study|Progressive Disease|0|||
161788299|NCT01393990|584270594|FG012|Overall Study|Progressive Disease|0|||
161788300|NCT01393990|584270595|FG013|Overall Study|Progressive Disease|1|||
161788301|NCT01393990|584270596|FG014|Overall Study|Progressive Disease|6|||
161788302|NCT01393990|584270597|FG015|Overall Study|Progressive Disease|1|||
161788303|NCT01393990|584270598|FG016|Overall Study|Progressive Disease|0|||
161788304|NCT01393990|584270599|FG017|Overall Study|Progressive Disease|0|||
161788305|NCT01393990|584270582|FG000|Overall Study|Death|0|||
161788306|NCT01393990|584270583|FG001|Overall Study|Death|0|||
161788307|NCT01393990|584270584|FG002|Overall Study|Death|0|||
161788308|NCT01393990|584270585|FG003|Overall Study|Death|0|||
161788309|NCT01393990|584270586|FG004|Overall Study|Death|1|||
161788310|NCT01393990|584270587|FG005|Overall Study|Death|0|||
161788311|NCT01393990|584270588|FG006|Overall Study|Death|0|||
161788312|NCT01393990|584270589|FG007|Overall Study|Death|0|||
161788313|NCT01393990|584270590|FG008|Overall Study|Death|0|||
161788314|NCT01393990|584270591|FG009|Overall Study|Death|0|||
161788315|NCT01393990|584270592|FG010|Overall Study|Death|0|||
161788316|NCT01393990|584270593|FG011|Overall Study|Death|0|||
161788317|NCT01393990|584270594|FG012|Overall Study|Death|0|||
161788318|NCT01393990|584270595|FG013|Overall Study|Death|1|||
161788319|NCT01393990|584270596|FG014|Overall Study|Death|1|||
161788320|NCT01393990|584270597|FG015|Overall Study|Death|0|||
161788321|NCT01393990|584270598|FG016|Overall Study|Death|0|||
161788322|NCT01393990|584270599|FG017|Overall Study|Death|0|||
161788323|NCT01393990|584270582|FG000|Overall Study|Withdrawal by Subject|0|||
161788324|NCT01393990|584270583|FG001|Overall Study|Withdrawal by Subject|0|||
161788325|NCT01393990|584270584|FG002|Overall Study|Withdrawal by Subject|0|||
161788326|NCT01393990|584270585|FG003|Overall Study|Withdrawal by Subject|0|||
161788327|NCT01393990|584270586|FG004|Overall Study|Withdrawal by Subject|0|||
161788328|NCT01393990|584270587|FG005|Overall Study|Withdrawal by Subject|0|||
161788329|NCT01393990|584270588|FG006|Overall Study|Withdrawal by Subject|0|||
161788330|NCT01393990|584270589|FG007|Overall Study|Withdrawal by Subject|0|||
161788331|NCT01393990|584270590|FG008|Overall Study|Withdrawal by Subject|0|||
161788332|NCT01393990|584270591|FG009|Overall Study|Withdrawal by Subject|0|||
161788333|NCT01393990|584270592|FG010|Overall Study|Withdrawal by Subject|0|||
161788334|NCT01393990|584270593|FG011|Overall Study|Withdrawal by Subject|0|||
161788335|NCT01393990|584270594|FG012|Overall Study|Withdrawal by Subject|0|||
161788336|NCT01393990|584270595|FG013|Overall Study|Withdrawal by Subject|0|||
161788337|NCT01393990|584270596|FG014|Overall Study|Withdrawal by Subject|1|||
161788338|NCT01393990|584270597|FG015|Overall Study|Withdrawal by Subject|1|||
161788339|NCT01393990|584270598|FG016|Overall Study|Withdrawal by Subject|0|||
161788340|NCT01393990|584270599|FG017|Overall Study|Withdrawal by Subject|0|||
161788341|NCT00331630|584270604|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
161788342|NCT00331630|584270604|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
161788343|NCT00331630|584270604|FG000|Follow up for 5 Years|Death|5|||
161788344|NCT00331630|584270604|FG000|Follow up for 5 Years|Data collection was stopped|24|||
161788345|NCT00720798|584270605|FG000|Overall Study|Adverse Event|304|||
161788346|NCT00720798|584270605|FG000|Overall Study|Death|39|||
161788347|NCT00720798|584270605|FG000|Overall Study|Insufficient Therapeutic Response|129|||
161788348|NCT00720798|584270605|FG000|Overall Study|Protocol Violation|4|||
161788349|NCT00720798|584270605|FG000|Overall Study|Refused Treatment|151|||
161788350|NCT00720798|584270605|FG000|Overall Study|Failure to Return|46|||
161788351|NCT00720798|584270605|FG000|Overall Study|Reason not Specified|83|||
161788352|NCT02806232|584270608|FG000|Overall Study|Lost to Follow-up|1|||
161788353|NCT02806232|584270609|FG001|Overall Study|Lost to Follow-up|2|||
161788354|NCT02806232|584270610|FG002|Overall Study|Lost to Follow-up|1|||
161788355|NCT02806232|584270611|FG003|Overall Study|Lost to Follow-up|0|||
161788356|NCT02806232|584270612|FG004|Overall Study|Lost to Follow-up|0|||
161788357|NCT02806232|584270613|FG005|Overall Study|Lost to Follow-up|1|||
161788358|NCT02806232|584270614|FG006|Overall Study|Lost to Follow-up|0|||
161788359|NCT02806232|584270615|FG007|Overall Study|Lost to Follow-up|0|||
161788360|NCT02806232|584270616|FG008|Overall Study|Lost to Follow-up|0|||
161788361|NCT02806232|584270608|FG000|Overall Study|Withdrawal by Subject|0|||
161788362|NCT02806232|584270609|FG001|Overall Study|Withdrawal by Subject|2|||
161788363|NCT02806232|584270610|FG002|Overall Study|Withdrawal by Subject|0|||
161788364|NCT02806232|584270611|FG003|Overall Study|Withdrawal by Subject|0|||
161788365|NCT02806232|584270612|FG004|Overall Study|Withdrawal by Subject|2|||
161788366|NCT02806232|584270613|FG005|Overall Study|Withdrawal by Subject|1|||
161788367|NCT02806232|584270614|FG006|Overall Study|Withdrawal by Subject|0|||
161788368|NCT02806232|584270615|FG007|Overall Study|Withdrawal by Subject|0|||
161788369|NCT02806232|584270616|FG008|Overall Study|Withdrawal by Subject|0|||
161788370|NCT00434161|584270617|FG000|Overall Study|Adverse Event|5|||
161788371|NCT00434161|584270618|FG001|Overall Study|Adverse Event|1|||
161788372|NCT00434161|584270619|FG002|Overall Study|Adverse Event|4|||
161788373|NCT00434161|584270617|FG000|Overall Study|Lost to Follow-up|0|||
161788374|NCT00434161|584270618|FG001|Overall Study|Lost to Follow-up|1|||
161788375|NCT00434161|584270619|FG002|Overall Study|Lost to Follow-up|0|||
161788376|NCT00434161|584270617|FG000|Overall Study|Death|1|||
161788377|NCT00434161|584270618|FG001|Overall Study|Death|0|||
161788378|NCT00434161|584270619|FG002|Overall Study|Death|1|||
161788379|NCT00434161|584270617|FG000|Overall Study|Non-Compliance|1|||
161788380|NCT00434161|584270618|FG001|Overall Study|Non-Compliance|1|||
161788381|NCT00434161|584270619|FG002|Overall Study|Non-Compliance|0|||
161788382|NCT00434161|584270617|FG000|Overall Study|Withdrawal by Subject|2|||
161788383|NCT00434161|584270618|FG001|Overall Study|Withdrawal by Subject|0|||
161788384|NCT00434161|584270619|FG002|Overall Study|Withdrawal by Subject|3|||
161788385|NCT00434161|584270617|FG000|Overall Study|Logistical error study assessments|1|||
161788386|NCT00434161|584270618|FG001|Overall Study|Logistical error study assessments|0|||
161788387|NCT00434161|584270619|FG002|Overall Study|Logistical error study assessments|3|||
161788388|NCT01312779|584270620|FG000|Overall Study|Withdrawal by Subject|2|||
161788389|NCT01312779|584270620|FG000|Overall Study|Death|3|||
161788390|NCT01312779|584270620|FG000|Overall Study|Not Implanted with Device|27|||
161788391|NCT00506753|584270621|FG000|Overall Study|Lost to Follow-up|21|||
161788392|NCT00506753|584270622|FG001|Overall Study|Lost to Follow-up|15|||
161788393|NCT02482805|584270628|FG000|Overall Study|Lost to Follow-up|4|||
161788394|NCT02482805|584270629|FG001|Overall Study|Lost to Follow-up|4|||
161788395|NCT02482805|584270630|FG002|Overall Study|Lost to Follow-up|0|||
161788396|NCT01267266|584270632|FG000|Enrollment Phase|Withdrawal by Subject|2|||
161788397|NCT01267266|584270633|FG001|Enrollment Phase|Withdrawal by Subject|0|||
161788398|NCT01267266|584270632|FG000|Lead-in Phase|Lack of Efficacy|20|||
161788399|NCT01267266|584270633|FG001|Lead-in Phase|Lack of Efficacy|0|||
161788400|NCT01267266|584270632|FG000|Lead-in Phase|Adverse Event|2|||
161788401|NCT01267266|584270633|FG001|Lead-in Phase|Adverse Event|0|||
161788402|NCT01267266|584270632|FG000|Lead-in Phase|Withdrawal by Subject|1|||
161788403|NCT01267266|584270633|FG001|Lead-in Phase|Withdrawal by Subject|0|||
161788404|NCT03549130|584270635|FG000|Overall Study|Adverse Event|0|||
161788405|NCT03549130|584270636|FG001|Overall Study|Adverse Event|1|||
161788406|NCT03549130|584270635|FG000|Overall Study|Lost to Follow-up|0|||
161788407|NCT03549130|584270636|FG001|Overall Study|Lost to Follow-up|1|||
161788408|NCT01078623|584270637|FG000|Treatment Period 1|Adverse Event|1|||
161788409|NCT01078623|584270638|FG001|Treatment Period 1|Adverse Event|1|||
161439538|NCT00068692|583003227|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
161788410|NCT01078623|584270639|FG002|Treatment Period 1|Adverse Event|1|||
161788411|NCT01078623|584270640|FG003|Treatment Period 1|Adverse Event|0|||
161788412|NCT01078623|584270641|FG004|Treatment Period 1|Adverse Event|0|||
161788413|NCT01078623|584270642|FG005|Treatment Period 1|Adverse Event|0|||
161788414|NCT01078623|584270643|FG006|Treatment Period 1|Adverse Event|1|||
161788415|NCT01078623|584270644|FG007|Treatment Period 1|Adverse Event|0|||
161788416|NCT01078623|584270645|FG008|Treatment Period 1|Adverse Event|1|||
161788417|NCT01078623|584270646|FG009|Treatment Period 1|Adverse Event|1|||
161788418|NCT01078623|584270647|FG010|Treatment Period 1|Adverse Event|0|||
161788419|NCT01078623|584270648|FG011|Treatment Period 1|Adverse Event|0|||
161788420|NCT01078623|584270649|FG012|Treatment Period 1|Adverse Event|0|||
161788421|NCT01078623|584270650|FG013|Treatment Period 1|Adverse Event|0|||
161788422|NCT01078623|584270651|FG014|Treatment Period 1|Adverse Event|0|||
161788423|NCT01078623|584270652|FG015|Treatment Period 1|Adverse Event|0|||
161439539|NCT00068692|583003228|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
161439540|NCT00068692|583003229|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
161439541|NCT00068692|583003230|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
161439542|NCT00068692|583003231|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
161439543|NCT00068692|583003232|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
161439544|NCT00068692|583003225|FG000|Step 2: Randomization|alternative therapy|0|||
161439545|NCT00068692|583003226|FG001|Step 2: Randomization|alternative therapy|0|||
161439546|NCT00068692|583003227|FG002|Step 2: Randomization|alternative therapy|0|||
161439547|NCT00068692|583003228|FG003|Step 2: Randomization|alternative therapy|1|||
161439548|NCT00068692|583003229|FG004|Step 2: Randomization|alternative therapy|1|||
161788424|NCT01078623|584270653|FG016|Treatment Period 1|Adverse Event|0|||
161439549|NCT00068692|583003230|FG005|Step 2: Randomization|alternative therapy|0|||
161439550|NCT00068692|583003231|FG006|Step 2: Randomization|alternative therapy|0|||
161439551|NCT00068692|583003232|FG007|Step 2: Randomization|alternative therapy|0|||
161439552|NCT00068692|583003225|FG000|Step 2: Randomization|Physician Decision|0|||
161439553|NCT00068692|583003226|FG001|Step 2: Randomization|Physician Decision|0|||
161439554|NCT00068692|583003227|FG002|Step 2: Randomization|Physician Decision|0|||
161439555|NCT00068692|583003228|FG003|Step 2: Randomization|Physician Decision|1|||
161439556|NCT00068692|583003229|FG004|Step 2: Randomization|Physician Decision|1|||
161439557|NCT00068692|583003230|FG005|Step 2: Randomization|Physician Decision|0|||
161439558|NCT00068692|583003231|FG006|Step 2: Randomization|Physician Decision|0|||
161439559|NCT00068692|583003232|FG007|Step 2: Randomization|Physician Decision|0|||
161439560|NCT00068692|583003225|FG000|Step 2: Randomization|Other|0|||
161439561|NCT00068692|583003226|FG001|Step 2: Randomization|Other|0|||
161439562|NCT00068692|583003227|FG002|Step 2: Randomization|Other|0|||
161439563|NCT00068692|583003228|FG003|Step 2: Randomization|Other|1|||
161439564|NCT00068692|583003229|FG004|Step 2: Randomization|Other|0|||
161439565|NCT00068692|583003230|FG005|Step 2: Randomization|Other|1|||
161439566|NCT00068692|583003231|FG006|Step 2: Randomization|Other|0|||
161439567|NCT00068692|583003232|FG007|Step 2: Randomization|Other|0|||
161439568|NCT00068692|583003225|FG000|Step 2: Randomization|never start protocol therapy|0|||
161439569|NCT00068692|583003226|FG001|Step 2: Randomization|never start protocol therapy|0|||
161439570|NCT00068692|583003227|FG002|Step 2: Randomization|never start protocol therapy|1|||
161439571|NCT00068692|583003228|FG003|Step 2: Randomization|never start protocol therapy|0|||
161439572|NCT00068692|583003229|FG004|Step 2: Randomization|never start protocol therapy|1|||
161439573|NCT00068692|583003230|FG005|Step 2: Randomization|never start protocol therapy|0|||
161439574|NCT00068692|583003231|FG006|Step 2: Randomization|never start protocol therapy|0|||
161439575|NCT00068692|583003232|FG007|Step 2: Randomization|never start protocol therapy|0|||
161439576|NCT01600716|583003234|FG000|Overall Study|Other Reasons|3|||
161439577|NCT01600716|583003235|FG001|Overall Study|Other Reasons|1|||
161439578|NCT01600716|583003234|FG000|Overall Study|Personal Reasons|0|||
161439579|NCT01600716|583003235|FG001|Overall Study|Personal Reasons|2|||
161439580|NCT01600716|583003234|FG000|Overall Study|Lost to Follow-up|0|||
161439581|NCT01600716|583003235|FG001|Overall Study|Lost to Follow-up|2|||
161439582|NCT01600716|583003234|FG000|Overall Study|Pregnancy|1|||
161439583|NCT01600716|583003235|FG001|Overall Study|Pregnancy|0|||
161439584|NCT01600716|583003234|FG000|Overall Study|Lack of Efficacy|2|||
161439585|NCT01600716|583003235|FG001|Overall Study|Lack of Efficacy|1|||
161439586|NCT01600716|583003234|FG000|Overall Study|Adverse Event|1|||
161439587|NCT01600716|583003235|FG001|Overall Study|Adverse Event|1|||
161439588|NCT03557034|583003238|FG000|Overall Study|Withdrawal by Subject|1|||
161788425|NCT01078623|584270654|FG017|Treatment Period 1|Adverse Event|0|||
161788426|NCT01078623|584270655|FG018|Treatment Period 1|Adverse Event|0|||
161788427|NCT01078623|584270656|FG019|Treatment Period 1|Adverse Event|0|||
161788428|NCT01078623|584270637|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161788429|NCT01078623|584270638|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161788430|NCT01078623|584270639|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161788431|NCT01078623|584270640|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161788432|NCT01078623|584270641|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161788433|NCT01078623|584270642|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161788434|NCT01078623|584270643|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161788435|NCT01078623|584270644|FG007|Treatment Period 1|Withdrawal by Subject|1|||
161439589|NCT03557034|583003239|FG001|Overall Study|Withdrawal by Subject|0|||
161439590|NCT03349034|583003242|FG000|Overall Study|catheters dislodged during transport|2|||
161439591|NCT03349034|583003243|FG001|Overall Study|catheters dislodged during transport|0|||
161439592|NCT03349034|583003242|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
161439593|NCT03349034|583003243|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
161439594|NCT03349034|583003242|FG000|Overall Study|soft tissue flap used|1|||
161439595|NCT03349034|583003243|FG001|Overall Study|soft tissue flap used|0|||
161439596|NCT03349034|583003242|FG000|Overall Study|Other|0|||
161439597|NCT03349034|583003243|FG001|Overall Study|Other|1|||
161439598|NCT01759446|583003244|FG000|Overall Study|Protocol Violation|1|||
161439599|NCT01759446|583003245|FG001|Overall Study|Protocol Violation|0|||
161788436|NCT01078623|584270645|FG008|Treatment Period 1|Withdrawal by Subject|0|||
161788437|NCT01078623|584270646|FG009|Treatment Period 1|Withdrawal by Subject|0|||
161788438|NCT01078623|584270647|FG010|Treatment Period 1|Withdrawal by Subject|1|||
161788439|NCT01078623|584270648|FG011|Treatment Period 1|Withdrawal by Subject|0|||
161788440|NCT01078623|584270649|FG012|Treatment Period 1|Withdrawal by Subject|0|||
161788441|NCT01078623|584270650|FG013|Treatment Period 1|Withdrawal by Subject|0|||
161788442|NCT01078623|584270651|FG014|Treatment Period 1|Withdrawal by Subject|0|||
161788443|NCT01078623|584270652|FG015|Treatment Period 1|Withdrawal by Subject|0|||
161788444|NCT01078623|584270653|FG016|Treatment Period 1|Withdrawal by Subject|0|||
161788445|NCT01078623|584270654|FG017|Treatment Period 1|Withdrawal by Subject|0|||
161788446|NCT01078623|584270655|FG018|Treatment Period 1|Withdrawal by Subject|0|||
161788447|NCT01078623|584270656|FG019|Treatment Period 1|Withdrawal by Subject|0|||
161788448|NCT01078623|584270637|FG000|Treatment Period 1|Protocol Violation|0|||
161788449|NCT01078623|584270638|FG001|Treatment Period 1|Protocol Violation|0|||
161788450|NCT01078623|584270639|FG002|Treatment Period 1|Protocol Violation|0|||
161788451|NCT01078623|584270640|FG003|Treatment Period 1|Protocol Violation|0|||
161788452|NCT01078623|584270641|FG004|Treatment Period 1|Protocol Violation|0|||
161788453|NCT01078623|584270642|FG005|Treatment Period 1|Protocol Violation|1|||
161788454|NCT01078623|584270643|FG006|Treatment Period 1|Protocol Violation|0|||
161788455|NCT01078623|584270644|FG007|Treatment Period 1|Protocol Violation|0|||
161788456|NCT01078623|584270645|FG008|Treatment Period 1|Protocol Violation|0|||
161788457|NCT01078623|584270646|FG009|Treatment Period 1|Protocol Violation|0|||
161788458|NCT01078623|584270647|FG010|Treatment Period 1|Protocol Violation|0|||
161788459|NCT01078623|584270648|FG011|Treatment Period 1|Protocol Violation|0|||
161788460|NCT01078623|584270649|FG012|Treatment Period 1|Protocol Violation|0|||
161788461|NCT01078623|584270650|FG013|Treatment Period 1|Protocol Violation|0|||
161788462|NCT01078623|584270651|FG014|Treatment Period 1|Protocol Violation|0|||
161788463|NCT01078623|584270652|FG015|Treatment Period 1|Protocol Violation|0|||
161788464|NCT01078623|584270653|FG016|Treatment Period 1|Protocol Violation|0|||
161788465|NCT01078623|584270654|FG017|Treatment Period 1|Protocol Violation|0|||
161788466|NCT01078623|584270655|FG018|Treatment Period 1|Protocol Violation|0|||
161788467|NCT01078623|584270656|FG019|Treatment Period 1|Protocol Violation|0|||
161788468|NCT01078623|584270637|FG000|Treatment Period 2|Adverse Event|0|||
161788469|NCT01078623|584270638|FG001|Treatment Period 2|Adverse Event|0|||
161788470|NCT01078623|584270639|FG002|Treatment Period 2|Adverse Event|0|||
161788471|NCT01078623|584270640|FG003|Treatment Period 2|Adverse Event|0|||
161788472|NCT01078623|584270641|FG004|Treatment Period 2|Adverse Event|0|||
161788473|NCT01078623|584270642|FG005|Treatment Period 2|Adverse Event|0|||
161788474|NCT01078623|584270643|FG006|Treatment Period 2|Adverse Event|1|||
161788475|NCT01078623|584270644|FG007|Treatment Period 2|Adverse Event|0|||
161788476|NCT01078623|584270645|FG008|Treatment Period 2|Adverse Event|0|||
161788477|NCT01078623|584270646|FG009|Treatment Period 2|Adverse Event|0|||
161788478|NCT01078623|584270647|FG010|Treatment Period 2|Adverse Event|0|||
161788479|NCT01078623|584270648|FG011|Treatment Period 2|Adverse Event|0|||
161788480|NCT01078623|584270649|FG012|Treatment Period 2|Adverse Event|0|||
161788481|NCT01078623|584270650|FG013|Treatment Period 2|Adverse Event|0|||
161788482|NCT01078623|584270651|FG014|Treatment Period 2|Adverse Event|0|||
161788483|NCT01078623|584270652|FG015|Treatment Period 2|Adverse Event|0|||
161788484|NCT01078623|584270653|FG016|Treatment Period 2|Adverse Event|0|||
161788485|NCT01078623|584270654|FG017|Treatment Period 2|Adverse Event|0|||
161788486|NCT01078623|584270655|FG018|Treatment Period 2|Adverse Event|1|||
161788487|NCT01078623|584270656|FG019|Treatment Period 2|Adverse Event|0|||
161788488|NCT01078623|584270637|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161788489|NCT01078623|584270638|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161788490|NCT01078623|584270639|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161788491|NCT01078623|584270640|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161788492|NCT01078623|584270641|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161788493|NCT01078623|584270642|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161788494|NCT01078623|584270643|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161788495|NCT01078623|584270644|FG007|Treatment Period 2|Withdrawal by Subject|0|||
161788496|NCT01078623|584270645|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161788497|NCT01078623|584270646|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161788498|NCT01078623|584270647|FG010|Treatment Period 2|Withdrawal by Subject|0|||
161788499|NCT01078623|584270648|FG011|Treatment Period 2|Withdrawal by Subject|0|||
161788500|NCT01078623|584270649|FG012|Treatment Period 2|Withdrawal by Subject|0|||
161788501|NCT01078623|584270650|FG013|Treatment Period 2|Withdrawal by Subject|0|||
161788502|NCT01078623|584270651|FG014|Treatment Period 2|Withdrawal by Subject|0|||
161788503|NCT01078623|584270652|FG015|Treatment Period 2|Withdrawal by Subject|0|||
161788504|NCT01078623|584270653|FG016|Treatment Period 2|Withdrawal by Subject|0|||
161788505|NCT01078623|584270654|FG017|Treatment Period 2|Withdrawal by Subject|0|||
161788506|NCT01078623|584270655|FG018|Treatment Period 2|Withdrawal by Subject|0|||
161788507|NCT01078623|584270656|FG019|Treatment Period 2|Withdrawal by Subject|0|||
161788508|NCT01078623|584270637|FG000|Treatment Period 3|Adverse Event|0|||
161788509|NCT01078623|584270638|FG001|Treatment Period 3|Adverse Event|0|||
161788510|NCT01078623|584270639|FG002|Treatment Period 3|Adverse Event|0|||
161788511|NCT01078623|584270640|FG003|Treatment Period 3|Adverse Event|0|||
161788512|NCT01078623|584270641|FG004|Treatment Period 3|Adverse Event|1|||
161788513|NCT01078623|584270642|FG005|Treatment Period 3|Adverse Event|0|||
161788514|NCT01078623|584270643|FG006|Treatment Period 3|Adverse Event|0|||
161788515|NCT01078623|584270644|FG007|Treatment Period 3|Adverse Event|0|||
161788516|NCT01078623|584270645|FG008|Treatment Period 3|Adverse Event|0|||
161788517|NCT01078623|584270646|FG009|Treatment Period 3|Adverse Event|0|||
161788518|NCT01078623|584270647|FG010|Treatment Period 3|Adverse Event|0|||
161788519|NCT01078623|584270648|FG011|Treatment Period 3|Adverse Event|0|||
161788520|NCT01078623|584270649|FG012|Treatment Period 3|Adverse Event|0|||
161788521|NCT01078623|584270650|FG013|Treatment Period 3|Adverse Event|1|||
161788522|NCT01078623|584270651|FG014|Treatment Period 3|Adverse Event|0|||
161439600|NCT01759446|583003246|FG002|Overall Study|Protocol Violation|1|||
161439601|NCT01759446|583003247|FG003|Overall Study|Protocol Violation|0|||
161439602|NCT01759446|583003248|FG004|Overall Study|Protocol Violation|0|||
161439603|NCT01759446|583003244|FG000|Overall Study|Withdrawal by Subject|0|||
161439604|NCT01759446|583003245|FG001|Overall Study|Withdrawal by Subject|1|||
161439605|NCT01759446|583003246|FG002|Overall Study|Withdrawal by Subject|0|||
161439606|NCT01759446|583003247|FG003|Overall Study|Withdrawal by Subject|1|||
161439607|NCT01759446|583003248|FG004|Overall Study|Withdrawal by Subject|0|||
161439608|NCT01760733|583003249|FG000|Waiting List|Death|18|||
161439609|NCT01760733|583003249|FG000|Waiting List|Removed from waiting list|41|||
161439610|NCT01760733|583003249|FG000|Waiting List|Not received a transplant yet|13|||
161439611|NCT01760733|583003249|FG000|Transplanted|Not reached 10 years post transplant|184|||
161439612|NCT01760733|583003249|FG000|Transplanted|Death|26|||
161439613|NCT01760733|583003249|FG000|Transplanted|Graft loss|7|||
161439614|NCT00815659|583003252|FG000|Overall Study|Adverse Event|9|||
161439615|NCT00815659|583003252|FG000|Overall Study|Withdrawal by Subject|9|||
161439616|NCT00815659|583003252|FG000|Overall Study|Lost to Follow-up|4|||
161439617|NCT00815659|583003252|FG000|Overall Study|Protocol Violation|1|||
161439618|NCT00719472|583003253|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
161439619|NCT00719472|583003253|FG000|Enrolled in Study|Subject decision to withdraw|8|||
161439620|NCT00719472|583003253|FG000|Enrolled in Study|Various Reasons|17|||
161439621|NCT00719472|583003253|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
161439622|NCT00719472|583003253|FG000|Received Cycle 1 Treatment|Death|5|||
161439623|NCT00719472|583003253|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
161439624|NCT00719472|583003253|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
161439625|NCT00719472|583003253|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
161439626|NCT00719472|583003253|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
161439627|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
161439628|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Death|6|||
161439629|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Disease progression|3|||
161439630|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
161439631|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
161439632|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
161439633|NCT00719472|583003253|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
161439634|NCT00123422|583003254|FG000|Overall Study|Physician Decision|2|||
161439635|NCT00123422|583003255|FG001|Overall Study|Physician Decision|2|||
161439636|NCT00123422|583003256|FG002|Overall Study|Physician Decision|6|||
161439637|NCT00123422|583003254|FG000|Overall Study|Withdrawal by Subject|1|||
161439638|NCT00123422|583003255|FG001|Overall Study|Withdrawal by Subject|2|||
161439639|NCT00123422|583003256|FG002|Overall Study|Withdrawal by Subject|2|||
161439640|NCT00123422|583003254|FG000|Overall Study|Lost to Follow-up|1|||
161439641|NCT00123422|583003255|FG001|Overall Study|Lost to Follow-up|2|||
161439642|NCT00123422|583003256|FG002|Overall Study|Lost to Follow-up|2|||
161788523|NCT01078623|584270652|FG015|Treatment Period 3|Adverse Event|0|||
161788524|NCT01078623|584270653|FG016|Treatment Period 3|Adverse Event|0|||
161788525|NCT01078623|584270654|FG017|Treatment Period 3|Adverse Event|0|||
161788526|NCT01078623|584270655|FG018|Treatment Period 3|Adverse Event|0|||
161788527|NCT01078623|584270656|FG019|Treatment Period 3|Adverse Event|0|||
161788528|NCT01078623|584270637|FG000|Treatment Period 4|Adverse Event|0|||
161439643|NCT03584789|583003264|FG000|Overall Study|refused EHR permission|19|||
161439644|NCT03584789|583003265|FG001|Overall Study|refused EHR permission|28|||
161439645|NCT03584789|583003266|FG002|Overall Study|refused EHR permission|23|||
161439646|NCT03584789|583003264|FG000|Overall Study|patients tied to a provider who retired|0|||
161439647|NCT03584789|583003265|FG001|Overall Study|patients tied to a provider who retired|0|||
161439648|NCT03584789|583003266|FG002|Overall Study|patients tied to a provider who retired|3|||
161439649|NCT04646044|583003268|FG000|Overall Study|Lost to Follow-up|0|||
161439650|NCT04646044|583003269|FG001|Overall Study|Lost to Follow-up|0|||
161439651|NCT04646044|583003270|FG002|Overall Study|Lost to Follow-up|1|||
161439652|NCT04646044|583003271|FG003|Overall Study|Lost to Follow-up|0|||
161439653|NCT04646044|583003268|FG000|Overall Study|Withdrawal by Subject|0|||
161439654|NCT04646044|583003269|FG001|Overall Study|Withdrawal by Subject|1|||
161439655|NCT04646044|583003270|FG002|Overall Study|Withdrawal by Subject|0|||
161439656|NCT04646044|583003271|FG003|Overall Study|Withdrawal by Subject|0|||
161439657|NCT00602472|583003272|FG000|Overall Study|Adverse Event|5|||
161788529|NCT01078623|584270638|FG001|Treatment Period 4|Adverse Event|0|||
161788530|NCT01078623|584270639|FG002|Treatment Period 4|Adverse Event|1|||
161788531|NCT01078623|584270640|FG003|Treatment Period 4|Adverse Event|0|||
161788532|NCT01078623|584270641|FG004|Treatment Period 4|Adverse Event|0|||
161788533|NCT01078623|584270642|FG005|Treatment Period 4|Adverse Event|0|||
161788534|NCT01078623|584270643|FG006|Treatment Period 4|Adverse Event|0|||
161788535|NCT01078623|584270644|FG007|Treatment Period 4|Adverse Event|0|||
161788536|NCT01078623|584270645|FG008|Treatment Period 4|Adverse Event|0|||
161788537|NCT01078623|584270646|FG009|Treatment Period 4|Adverse Event|0|||
161788538|NCT01078623|584270647|FG010|Treatment Period 4|Adverse Event|0|||
161788539|NCT01078623|584270648|FG011|Treatment Period 4|Adverse Event|0|||
161788540|NCT01078623|584270649|FG012|Treatment Period 4|Adverse Event|0|||
161788541|NCT01078623|584270650|FG013|Treatment Period 4|Adverse Event|0|||
161788542|NCT01078623|584270651|FG014|Treatment Period 4|Adverse Event|0|||
161788543|NCT01078623|584270652|FG015|Treatment Period 4|Adverse Event|0|||
161788544|NCT01078623|584270653|FG016|Treatment Period 4|Adverse Event|0|||
161788545|NCT01078623|584270654|FG017|Treatment Period 4|Adverse Event|0|||
161788546|NCT01078623|584270655|FG018|Treatment Period 4|Adverse Event|0|||
161788547|NCT01078623|584270656|FG019|Treatment Period 4|Adverse Event|0|||
161788548|NCT01078623|584270637|FG000|Treatment Period 4|Withdrawal by Subject|0|||
161788549|NCT01078623|584270638|FG001|Treatment Period 4|Withdrawal by Subject|0|||
161788550|NCT01078623|584270639|FG002|Treatment Period 4|Withdrawal by Subject|0|||
161788551|NCT01078623|584270640|FG003|Treatment Period 4|Withdrawal by Subject|0|||
161788552|NCT01078623|584270641|FG004|Treatment Period 4|Withdrawal by Subject|0|||
161788553|NCT01078623|584270642|FG005|Treatment Period 4|Withdrawal by Subject|0|||
161788554|NCT01078623|584270643|FG006|Treatment Period 4|Withdrawal by Subject|0|||
161788555|NCT01078623|584270644|FG007|Treatment Period 4|Withdrawal by Subject|0|||
161788556|NCT01078623|584270645|FG008|Treatment Period 4|Withdrawal by Subject|0|||
161788557|NCT01078623|584270646|FG009|Treatment Period 4|Withdrawal by Subject|0|||
161788558|NCT01078623|584270647|FG010|Treatment Period 4|Withdrawal by Subject|0|||
161788559|NCT01078623|584270648|FG011|Treatment Period 4|Withdrawal by Subject|0|||
161788560|NCT01078623|584270649|FG012|Treatment Period 4|Withdrawal by Subject|0|||
161788561|NCT01078623|584270650|FG013|Treatment Period 4|Withdrawal by Subject|0|||
161788562|NCT01078623|584270651|FG014|Treatment Period 4|Withdrawal by Subject|0|||
161788563|NCT01078623|584270652|FG015|Treatment Period 4|Withdrawal by Subject|1|||
161788564|NCT01078623|584270653|FG016|Treatment Period 4|Withdrawal by Subject|0|||
161788565|NCT01078623|584270654|FG017|Treatment Period 4|Withdrawal by Subject|0|||
161788566|NCT01078623|584270655|FG018|Treatment Period 4|Withdrawal by Subject|0|||
161788567|NCT01078623|584270656|FG019|Treatment Period 4|Withdrawal by Subject|0|||
161788568|NCT02480010|584270663|FG000|Overall Study|Adverse Event|3|||
161788569|NCT02480010|584270664|FG001|Overall Study|Adverse Event|1|||
161788570|NCT02480010|584270663|FG000|Overall Study|Death|1|||
161788571|NCT02480010|584270664|FG001|Overall Study|Death|0|||
161788572|NCT02480010|584270663|FG000|Overall Study|Insufficient therapeutic response|31|||
161788573|NCT02480010|584270664|FG001|Overall Study|Insufficient therapeutic response|29|||
161788574|NCT02480010|584270663|FG000|Overall Study|Refused Treatment|0|||
161788575|NCT02480010|584270664|FG001|Overall Study|Refused Treatment|3|||
161788576|NCT01759381|584270671|FG000|Overall Study|Death|1|||
161788577|NCT01759381|584270672|FG001|Overall Study|Death|0|||
161788578|NCT03377556|584270685|FG000|Overall Study|Adverse Event|5|||
161788579|NCT03377556|584270685|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161788580|NCT03377556|584270685|FG000|Overall Study|Progression/relapse|38|||
161788581|NCT03377556|584270685|FG000|Overall Study|Death|3|||
161788582|NCT00910858|584270686|FG000|Pharmacokinetic Phase|Adverse Event|1|||
161788583|NCT00910858|584270687|FG001|Pharmacokinetic Phase|Adverse Event|0|||
161788584|NCT00910858|584270688|FG002|Pharmacokinetic Phase|Adverse Event|0|||
161788585|NCT00910858|584270686|FG000|Monotherapy Phase|Adverse Event|3|||
161788586|NCT00910858|584270687|FG001|Monotherapy Phase|Adverse Event|2|||
161788587|NCT00910858|584270688|FG002|Monotherapy Phase|Adverse Event|0|||
161788588|NCT00910858|584270686|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
161788589|NCT00910858|584270687|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
161788590|NCT00910858|584270688|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
161788591|NCT00910858|584270686|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
161788592|NCT00910858|584270687|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
161788593|NCT00910858|584270688|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
161788594|NCT00910858|584270686|FG000|Monotherapy Phase|Protocol Violation|1|||
161898546|NCT03272347|584677830|FG002|Overall Study|Death|0|||
161439658|NCT00602472|583003273|FG001|Overall Study|Adverse Event|23|||
161439659|NCT00602472|583003272|FG000|Overall Study|Protocol Violation|4|||
161439660|NCT00602472|583003273|FG001|Overall Study|Protocol Violation|19|||
161788595|NCT00910858|584270687|FG001|Monotherapy Phase|Protocol Violation|0|||
161788596|NCT00910858|584270688|FG002|Monotherapy Phase|Protocol Violation|0|||
161788597|NCT00910858|584270686|FG000|Monotherapy Phase|Other|3|||
161788598|NCT00910858|584270687|FG001|Monotherapy Phase|Other|4|||
161788599|NCT00910858|584270688|FG002|Monotherapy Phase|Other|2|||
161788600|NCT00910858|584270686|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
161788601|NCT00910858|584270687|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
161788602|NCT00910858|584270688|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
161788603|NCT00910858|584270686|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
161788604|NCT00910858|584270687|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
161788605|NCT00910858|584270688|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
161898547|NCT03272347|584677831|FG003|Overall Study|Death|1|||
161788606|NCT00910858|584270686|FG000|Combined Treatment Phase|Protocol Violation|1|||
161788607|NCT00910858|584270687|FG001|Combined Treatment Phase|Protocol Violation|0|||
161788608|NCT00910858|584270688|FG002|Combined Treatment Phase|Protocol Violation|0|||
161788609|NCT00910858|584270686|FG000|Combined Treatment Phase|Other|0|||
161788610|NCT00910858|584270687|FG001|Combined Treatment Phase|Other|2|||
161788611|NCT00910858|584270688|FG002|Combined Treatment Phase|Other|1|||
161788612|NCT00447603|584270695|FG000|Screening|Withdrawal by Subject|1|||
161788613|NCT00447603|584270696|FG001|Screening|Withdrawal by Subject|0|||
161788614|NCT00447603|584270697|FG002|Screening|Withdrawal by Subject|0|||
161788615|NCT00447603|584270695|FG000|Screening|Protocol Violation|1|||
161788616|NCT00447603|584270696|FG001|Screening|Protocol Violation|0|||
161788617|NCT00447603|584270697|FG002|Screening|Protocol Violation|0|||
161788618|NCT00447603|584270695|FG000|Screening|Screen Failure|4|||
161788619|NCT00447603|584270696|FG001|Screening|Screen Failure|0|||
161788620|NCT00447603|584270697|FG002|Screening|Screen Failure|0|||
161788621|NCT00447603|584270695|FG000|Screening|Study Terminated by Sponsor|15|||
161788622|NCT00447603|584270696|FG001|Screening|Study Terminated by Sponsor|0|||
161788623|NCT00447603|584270697|FG002|Screening|Study Terminated by Sponsor|0|||
161788624|NCT00447603|584270695|FG000|Filter Period|Adverse Event|0|||
161788625|NCT00447603|584270696|FG001|Filter Period|Adverse Event|0|||
161788626|NCT00447603|584270697|FG002|Filter Period|Adverse Event|1|||
161788627|NCT00447603|584270695|FG000|Filter Period|Screen Failure|0|||
161788628|NCT00447603|584270696|FG001|Filter Period|Screen Failure|3|||
161788629|NCT00447603|584270697|FG002|Filter Period|Screen Failure|4|||
161788630|NCT00447603|584270695|FG000|Filter Period|Study terminated by Sponsor|0|||
161788631|NCT00447603|584270696|FG001|Filter Period|Study terminated by Sponsor|1|||
161788632|NCT00447603|584270697|FG002|Filter Period|Study terminated by Sponsor|10|||
161788633|NCT01907737|584270708|FG000|Overall Study|Withdrawal by Subject|1|||
161788634|NCT01165684|584270709|FG000|Overall Study|Adverse Event|1|||
161788635|NCT01165684|584270710|FG001|Overall Study|Adverse Event|1|||
161788636|NCT01165684|584270709|FG000|Overall Study|Lack of Efficacy|2|||
161788637|NCT01165684|584270710|FG001|Overall Study|Lack of Efficacy|1|||
161788638|NCT01165684|584270709|FG000|Overall Study|Protocol Violation|7|||
161788639|NCT01165684|584270710|FG001|Overall Study|Protocol Violation|15|||
161788640|NCT01165684|584270709|FG000|Overall Study|Withdrawal Criteria|2|||
161788641|NCT01165684|584270710|FG001|Overall Study|Withdrawal Criteria|13|||
161788642|NCT01165684|584270709|FG000|Overall Study|Unclassified|16|||
161788643|NCT01165684|584270710|FG001|Overall Study|Unclassified|22|||
161788644|NCT01886300|584270731|FG000|Overall Study|Trial terminated by sponsor|16|||
161788645|NCT00901628|584270732|FG000|Overall Study|disconnection of catheter|4|||
161788646|NCT00901628|584270733|FG001|Overall Study|disconnection of catheter|8|||
161788647|NCT00901628|584270732|FG000|Overall Study|disconnection of drain|0|||
161788648|NCT00901628|584270733|FG001|Overall Study|disconnection of drain|1|||
161788649|NCT00901628|584270732|FG000|Overall Study|peroneal nerve palsy|0|||
161788650|NCT00901628|584270733|FG001|Overall Study|peroneal nerve palsy|1|||
161788651|NCT00608205|584270734|FG000|Overall Study|Adverse Event|3|||
161788652|NCT00608205|584270735|FG001|Overall Study|Adverse Event|2|||
161788653|NCT00608205|584270734|FG000|Overall Study|Patient non-compliant|0|||
161788654|NCT00608205|584270735|FG001|Overall Study|Patient non-compliant|1|||
161788655|NCT02008721|584270738|FG000|Overall Study|Withdrawal by Subject|5|||
161788656|NCT02008721|584270739|FG001|Overall Study|Withdrawal by Subject|1|||
161788657|NCT02008721|584270738|FG000|Overall Study|Death|4|||
161788658|NCT02008721|584270739|FG001|Overall Study|Death|2|||
161788659|NCT02008721|584270738|FG000|Overall Study|Adverse Event|3|||
161788660|NCT02008721|584270739|FG001|Overall Study|Adverse Event|5|||
161788661|NCT02008721|584270738|FG000|Overall Study|Protocol Violation|3|||
161788662|NCT02008721|584270739|FG001|Overall Study|Protocol Violation|2|||
161788663|NCT01797120|584270742|FG000|Overall Study|Disesae progression|37|||
161788664|NCT01797120|584270743|FG001|Overall Study|Disesae progression|49|||
161788665|NCT01797120|584270742|FG000|Overall Study|Adverse Event|13|||
161788666|NCT01797120|584270743|FG001|Overall Study|Adverse Event|5|||
161788667|NCT01797120|584270742|FG000|Overall Study|Withdrawal by Subject|6|||
161788668|NCT01797120|584270743|FG001|Overall Study|Withdrawal by Subject|6|||
161788669|NCT01797120|584270742|FG000|Overall Study|Symptomatic progression|2|||
161788670|NCT01797120|584270743|FG001|Overall Study|Symptomatic progression|1|||
161788671|NCT01797120|584270742|FG000|Overall Study|Non-compliance|1|||
161788672|NCT01797120|584270743|FG001|Overall Study|Non-compliance|0|||
161788673|NCT01797120|584270742|FG000|Overall Study|Physician Decision|3|||
161788674|NCT01797120|584270743|FG001|Overall Study|Physician Decision|0|||
161788675|NCT01797120|584270742|FG000|Overall Study|still on treatment|2|||
161788676|NCT01797120|584270743|FG001|Overall Study|still on treatment|4|||
161788677|NCT01797120|584270742|FG000|Overall Study|never start protocol therapy|2|||
161788678|NCT01797120|584270743|FG001|Overall Study|never start protocol therapy|0|||
161788679|NCT01003886|584270744|FG000|Overall Study|Lack of Efficacy|5|||
161788680|NCT01003886|584270744|FG000|Overall Study|Lost to Follow-up|169|||
161788681|NCT01003886|584270744|FG000|Overall Study|Withdrawal by Subject|39|||
161788682|NCT01003886|584270744|FG000|Overall Study|Other|14|||
161788683|NCT01003886|584270744|FG000|Overall Study|Adverse Event|3|||
161788684|NCT00909727|584270762|FG000|Overall Study|Adverse Event|1|||
161788685|NCT00909727|584270763|FG001|Overall Study|Adverse Event|0|||
161788686|NCT00909727|584270762|FG000|Overall Study|Wrong Genotype|1|||
161788687|NCT00909727|584270763|FG001|Overall Study|Wrong Genotype|0|||
161788688|NCT00909727|584270762|FG000|Overall Study|Withdrawal of Consent|1|||
161788689|NCT00909727|584270763|FG001|Overall Study|Withdrawal of Consent|0|||
161788690|NCT00909727|584270762|FG000|Overall Study|Prohibited Medication|1|||
161788691|NCT00909727|584270763|FG001|Overall Study|Prohibited Medication|0|||
161788692|NCT05751629|584270764|FG000|Overall Study|Withdrawal by Subject|6|||
161788693|NCT05751629|584270764|FG000|Overall Study|Death|25|||
161788694|NCT05751629|584270764|FG000|Overall Study|Study Site Closed|9|||
161788695|NCT05751629|584270764|FG000|Overall Study|Physician Decision|1|||
161788696|NCT01909466|584270766|FG000|Overall Study|Lost to Follow-up|5|||
161788697|NCT01909466|584270767|FG001|Overall Study|Lost to Follow-up|7|||
161788698|NCT01909466|584270766|FG000|Overall Study|Adverse Event|3|||
161788699|NCT01909466|584270767|FG001|Overall Study|Adverse Event|4|||
161788700|NCT01909466|584270766|FG000|Overall Study|Met Withdrawal Criteria|0|||
161788701|NCT01909466|584270767|FG001|Overall Study|Met Withdrawal Criteria|3|||
161788702|NCT01909466|584270766|FG000|Overall Study|Physician Decision|2|||
161788703|NCT01909466|584270767|FG001|Overall Study|Physician Decision|0|||
161788704|NCT01909466|584270766|FG000|Overall Study|Withdrawal by Subject|11|||
161788705|NCT01909466|584270767|FG001|Overall Study|Withdrawal by Subject|9|||
161788706|NCT01909466|584270766|FG000|Overall Study|Lack of Efficacy|1|||
161788707|NCT01909466|584270767|FG001|Overall Study|Lack of Efficacy|0|||
161788708|NCT00772577|584270773|FG000|Overall Study|Adverse Event|6|||
161788709|NCT00772577|584270774|FG001|Overall Study|Adverse Event|3|||
161788710|NCT00772577|584270773|FG000|Overall Study|Abnormal laboratory values|0|||
161788711|NCT00772577|584270774|FG001|Overall Study|Abnormal laboratory values|1|||
161788712|NCT00772577|584270773|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161788713|NCT00772577|584270774|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161788714|NCT00772577|584270773|FG000|Overall Study|Patient withdrew consent|8|||
161788715|NCT00772577|584270774|FG001|Overall Study|Patient withdrew consent|5|||
161788716|NCT00772577|584270773|FG000|Overall Study|Lost to Follow-up|4|||
161788717|NCT00772577|584270774|FG001|Overall Study|Lost to Follow-up|3|||
161788718|NCT00772577|584270773|FG000|Overall Study|Administrative problems|2|||
161788719|NCT00772577|584270774|FG001|Overall Study|Administrative problems|1|||
161788720|NCT00772577|584270773|FG000|Overall Study|Protocol Deviation|3|||
161788721|NCT00772577|584270774|FG001|Overall Study|Protocol Deviation|2|||
161788722|NCT00672620|584270775|FG000|Overall Study|Adverse Event|7|||
161788723|NCT00672620|584270776|FG001|Overall Study|Adverse Event|7|||
161788724|NCT00672620|584270777|FG002|Overall Study|Adverse Event|12|||
161788725|NCT00672620|584270778|FG003|Overall Study|Adverse Event|17|||
161788726|NCT00672620|584270775|FG000|Overall Study|Lack of Efficacy|1|||
161788727|NCT00672620|584270776|FG001|Overall Study|Lack of Efficacy|2|||
161788728|NCT00672620|584270777|FG002|Overall Study|Lack of Efficacy|2|||
161788729|NCT00672620|584270778|FG003|Overall Study|Lack of Efficacy|0|||
161788730|NCT00672620|584270775|FG000|Overall Study|Noncompliance with Study Drug|3|||
161788731|NCT00672620|584270776|FG001|Overall Study|Noncompliance with Study Drug|4|||
161788732|NCT00672620|584270777|FG002|Overall Study|Noncompliance with Study Drug|0|||
161788733|NCT00672620|584270778|FG003|Overall Study|Noncompliance with Study Drug|2|||
161788734|NCT00672620|584270775|FG000|Overall Study|Protocol Deviations|5|||
161788735|NCT00672620|584270776|FG001|Overall Study|Protocol Deviations|7|||
161788736|NCT00672620|584270777|FG002|Overall Study|Protocol Deviations|2|||
161788737|NCT00672620|584270778|FG003|Overall Study|Protocol Deviations|5|||
161788738|NCT00672620|584270775|FG000|Overall Study|Withdrawal of Consent|6|||
161788739|NCT00672620|584270776|FG001|Overall Study|Withdrawal of Consent|12|||
161788740|NCT00672620|584270777|FG002|Overall Study|Withdrawal of Consent|5|||
161788741|NCT00672620|584270778|FG003|Overall Study|Withdrawal of Consent|6|||
161788742|NCT00672620|584270775|FG000|Overall Study|Lost to Follow-up|8|||
161788743|NCT00672620|584270776|FG001|Overall Study|Lost to Follow-up|19|||
161788744|NCT00672620|584270777|FG002|Overall Study|Lost to Follow-up|8|||
161788745|NCT00672620|584270778|FG003|Overall Study|Lost to Follow-up|11|||
161788746|NCT00672620|584270775|FG000|Overall Study|Reason not Specified|3|||
161788747|NCT00672620|584270776|FG001|Overall Study|Reason not Specified|3|||
161788748|NCT00672620|584270777|FG002|Overall Study|Reason not Specified|2|||
161788749|NCT00672620|584270778|FG003|Overall Study|Reason not Specified|1|||
161788750|NCT02965820|584270779|FG000|Period 2, Second 30 Days|Adverse Event|1|||
161788751|NCT02965820|584270780|FG001|Period 2, Second 30 Days|Adverse Event|1|||
161788752|NCT01567306|584270781|FG000|Overall Study|Protocol Violation|2|||
161788753|NCT01567306|584270782|FG001|Overall Study|Protocol Violation|2|||
161788754|NCT01567306|584270783|FG002|Overall Study|Protocol Violation|0|||
161788755|NCT01567306|584270784|FG003|Overall Study|Protocol Violation|3|||
161788756|NCT01567306|584270785|FG004|Overall Study|Protocol Violation|1|||
161788757|NCT01567306|584270786|FG005|Overall Study|Protocol Violation|1|||
161788758|NCT01567306|584270781|FG000|Overall Study|Change site living|1|||
161788759|NCT01567306|584270782|FG001|Overall Study|Change site living|0|||
161788760|NCT01567306|584270783|FG002|Overall Study|Change site living|0|||
161788761|NCT01567306|584270784|FG003|Overall Study|Change site living|0|||
161788762|NCT01567306|584270785|FG004|Overall Study|Change site living|0|||
161788763|NCT01567306|584270786|FG005|Overall Study|Change site living|0|||
161788764|NCT01567306|584270781|FG000|Overall Study|Adverse Event|0|||
161439661|NCT00602472|583003272|FG000|Overall Study|Withdrawal by Subject|8|||
161439662|NCT00602472|583003273|FG001|Overall Study|Withdrawal by Subject|14|||
161439663|NCT00602472|583003272|FG000|Overall Study|Other incl. lack of efficacy|4|||
161439664|NCT00602472|583003273|FG001|Overall Study|Other incl. lack of efficacy|2|||
161439665|NCT01938716|583003274|FG000|Overall Study|Physician Decision|2|||
161439666|NCT01938716|583003274|FG000|Overall Study|Withdrawal by Subject|2|||
161439667|NCT01908803|583003275|FG000|Overall Study|Adverse Event|1|||
161439668|NCT01908803|583003276|FG001|Overall Study|Adverse Event|0|||
161439669|NCT01908803|583003275|FG000|Overall Study|Physician Decision|0|||
161439670|NCT01908803|583003276|FG001|Overall Study|Physician Decision|1|||
161439671|NCT01908803|583003275|FG000|Overall Study|Withdrawal by Subject|1|||
161439672|NCT01908803|583003276|FG001|Overall Study|Withdrawal by Subject|0|||
161439673|NCT01908803|583003275|FG000|Overall Study|Randomization Error|1|||
161439674|NCT01908803|583003276|FG001|Overall Study|Randomization Error|0|||
161439675|NCT01908803|583003275|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
161439676|NCT01908803|583003276|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
161439677|NCT00823615|583003277|FG000|Period 2|Lost to Follow-up|2|||
161439678|NCT00823615|583003278|FG001|Period 2|Lost to Follow-up|0|||
161439679|NCT00823615|583003277|FG000|Period 2|Time/Job Conflict|1|||
161439680|NCT00823615|583003278|FG001|Period 2|Time/Job Conflict|2|||
161439681|NCT02446899|583003279|FG000|Overall Study|Adverse Event|4|||
161439682|NCT02446899|583003280|FG001|Overall Study|Adverse Event|7|||
161439683|NCT02446899|583003279|FG000|Overall Study|Condition Under Investigation Worsened|1|||
161788765|NCT01567306|584270782|FG001|Overall Study|Adverse Event|0|||
161788766|NCT01567306|584270783|FG002|Overall Study|Adverse Event|0|||
161788767|NCT01567306|584270784|FG003|Overall Study|Adverse Event|2|||
161439684|NCT02446899|583003280|FG001|Overall Study|Condition Under Investigation Worsened|4|||
161439685|NCT02446899|583003279|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
161439686|NCT02446899|583003280|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
161439687|NCT02446899|583003279|FG000|Overall Study|Lack of Efficacy|2|||
161439688|NCT02446899|583003280|FG001|Overall Study|Lack of Efficacy|8|||
161439689|NCT02446899|583003279|FG000|Overall Study|Lost to Follow-up|1|||
161439690|NCT02446899|583003280|FG001|Overall Study|Lost to Follow-up|3|||
161439691|NCT02446899|583003279|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
161439692|NCT02446899|583003280|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
161439693|NCT02446899|583003279|FG000|Overall Study|Withdrawal by Subject|11|||
161439694|NCT02446899|583003280|FG001|Overall Study|Withdrawal by Subject|19|||
161439695|NCT02446899|583003279|FG000|Overall Study|Miscellaneous|5|||
161439696|NCT02446899|583003280|FG001|Overall Study|Miscellaneous|4|||
161439697|NCT02446899|583003279|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161439698|NCT02446899|583003280|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161439699|NCT01002339|583003281|FG000|Overall Study|Withdrawal by Subject|0|||
161439700|NCT01002339|583003282|FG001|Overall Study|Withdrawal by Subject|1|||
161439701|NCT01002339|583003283|FG002|Overall Study|Withdrawal by Subject|0|||
161439702|NCT01002339|583003281|FG000|Overall Study|Incorrect treatment assignment|0|||
161439703|NCT01002339|583003282|FG001|Overall Study|Incorrect treatment assignment|0|||
161439704|NCT01002339|583003283|FG002|Overall Study|Incorrect treatment assignment|1|||
161439705|NCT01002339|583003281|FG000|Overall Study|Protocol Violation|0|||
161439706|NCT01002339|583003282|FG001|Overall Study|Protocol Violation|0|||
161439707|NCT01002339|583003283|FG002|Overall Study|Protocol Violation|2|||
161439708|NCT01002339|583003281|FG000|Overall Study|Lung cancer detected before transplant|0|||
161439709|NCT01002339|583003282|FG001|Overall Study|Lung cancer detected before transplant|0|||
161439710|NCT01002339|583003283|FG002|Overall Study|Lung cancer detected before transplant|1|||
161439711|NCT01002339|583003281|FG000|Overall Study|Randomized. Not transplanted|0|||
161439712|NCT01002339|583003282|FG001|Overall Study|Randomized. Not transplanted|0|||
161439713|NCT01002339|583003283|FG002|Overall Study|Randomized. Not transplanted|1|||
161439714|NCT00742235|583003284|FG000|Overall Study|Lost to Follow-up|0|||
161439715|NCT00742235|583003285|FG001|Overall Study|Lost to Follow-up|31|||
161439716|NCT00433004|583003286|FG000|Overall Study|Lost to Follow-up|5|||
161439717|NCT00433004|583003287|FG001|Overall Study|Lost to Follow-up|7|||
161439718|NCT03910244|583003289|FG000|Overall Study|Adverse Event|14|||
161788768|NCT01567306|584270785|FG004|Overall Study|Adverse Event|4|||
161439719|NCT03910244|583003290|FG001|Overall Study|Adverse Event|0|||
161439720|NCT03910244|583003289|FG000|Overall Study|Death|1|||
161439721|NCT03910244|583003290|FG001|Overall Study|Death|0|||
161439722|NCT03910244|583003289|FG000|Overall Study|Lost to Follow-up|0|||
161439723|NCT03910244|583003290|FG001|Overall Study|Lost to Follow-up|2|||
161439724|NCT03910244|583003289|FG000|Overall Study|Joint withdrawal decision|1|||
161439725|NCT03910244|583003290|FG001|Overall Study|Joint withdrawal decision|0|||
161439726|NCT03910244|583003289|FG000|Overall Study|Study Terminated by Sponsor|7|||
161439727|NCT03910244|583003290|FG001|Overall Study|Study Terminated by Sponsor|4|||
161439728|NCT03910244|583003289|FG000|Overall Study|Physician Decision|1|||
161439729|NCT03910244|583003290|FG001|Overall Study|Physician Decision|0|||
161788769|NCT01567306|584270786|FG005|Overall Study|Adverse Event|1|||
161898548|NCT03272347|584677828|FG000|Overall Study|Lost to Follow-up|1|||
161898549|NCT03272347|584677829|FG001|Overall Study|Lost to Follow-up|3|||
161898550|NCT03272347|584677830|FG002|Overall Study|Lost to Follow-up|5|||
161898551|NCT03272347|584677831|FG003|Overall Study|Lost to Follow-up|1|||
161898552|NCT03272347|584677828|FG000|Overall Study|Physician Decision|4|||
161898553|NCT03272347|584677829|FG001|Overall Study|Physician Decision|2|||
161898554|NCT03272347|584677830|FG002|Overall Study|Physician Decision|5|||
161898555|NCT03272347|584677831|FG003|Overall Study|Physician Decision|4|||
161898556|NCT03272347|584677828|FG000|Overall Study|Screen Failure|1|||
161898557|NCT03272347|584677829|FG001|Overall Study|Screen Failure|0|||
161898558|NCT03272347|584677830|FG002|Overall Study|Screen Failure|0|||
161898559|NCT03272347|584677831|FG003|Overall Study|Screen Failure|0|||
161898560|NCT03272347|584677828|FG000|Overall Study|Withdrawal by Subject|5|||
161898561|NCT03272347|584677829|FG001|Overall Study|Withdrawal by Subject|1|||
161898562|NCT03272347|584677830|FG002|Overall Study|Withdrawal by Subject|2|||
161898563|NCT03272347|584677831|FG003|Overall Study|Withdrawal by Subject|1|||
161898564|NCT01971567|584677832|FG000|Overall Study|Withdrawal by Subject|3|||
161898565|NCT01971567|584677833|FG001|Overall Study|Withdrawal by Subject|2|||
161898566|NCT01971567|584677832|FG000|Overall Study|Lost to Follow-up|1|||
161898567|NCT01971567|584677833|FG001|Overall Study|Lost to Follow-up|0|||
161898568|NCT00391872|584677834|FG000|Overall Study|Protocol Violation|7|||
161898569|NCT00391872|584677835|FG001|Overall Study|Protocol Violation|2|||
161898570|NCT00391872|584677834|FG000|Overall Study|Withdrawal by Subject|296|||
161898571|NCT00391872|584677835|FG001|Overall Study|Withdrawal by Subject|249|||
161898572|NCT00391872|584677834|FG000|Overall Study|Reason unknown|2|||
161898573|NCT00391872|584677835|FG001|Overall Study|Reason unknown|4|||
161898574|NCT00391872|584677834|FG000|Overall Study|Lost to Follow-up|2|||
161898575|NCT00391872|584677835|FG001|Overall Study|Lost to Follow-up|0|||
161898576|NCT04826484|584677836|FG000|Overall Study|Lost to Follow-up|2|||
161898577|NCT04826484|584677837|FG001|Overall Study|Lost to Follow-up|0|||
161898578|NCT01239394|584677838|FG000|Overall Study|Adverse Event|1|||
161898579|NCT00905632|584677840|FG000|Overall Study|Adverse Event|0|||
161898580|NCT00905632|584677841|FG001|Overall Study|Adverse Event|0|||
161898581|NCT00905632|584677842|FG002|Overall Study|Adverse Event|0|||
161898582|NCT00905632|584677843|FG003|Overall Study|Adverse Event|0|||
161898583|NCT00905632|584677844|FG004|Overall Study|Adverse Event|0|||
161898584|NCT00905632|584677845|FG005|Overall Study|Adverse Event|1|||
161898585|NCT00905632|584677846|FG006|Overall Study|Adverse Event|4|||
161898586|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
161898587|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
161898588|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
161898589|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
161898590|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
161898591|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
161898592|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
161898593|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
161898594|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
161898595|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
161898596|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
161898597|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
161898598|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
161898599|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
161898600|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
161898601|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
161898602|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
161898603|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
161898604|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Other|1|||
161898605|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Other|0|||
161898606|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Other|1|||
161898607|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
161898608|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
161439730|NCT03910244|583003289|FG000|Overall Study|Protocol Violation|1|||
161898609|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
161898610|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
161898611|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
161898612|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
161898613|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
161898614|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
161898615|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
161898616|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
161898617|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
161898618|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
161898619|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
161898620|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
161788770|NCT01567306|584270781|FG000|Overall Study|Lost to Follow-up|0|||
161788771|NCT01567306|584270782|FG001|Overall Study|Lost to Follow-up|0|||
161788772|NCT01567306|584270783|FG002|Overall Study|Lost to Follow-up|0|||
161788773|NCT01567306|584270784|FG003|Overall Study|Lost to Follow-up|0|||
161788774|NCT01567306|584270785|FG004|Overall Study|Lost to Follow-up|2|||
161788775|NCT01567306|584270786|FG005|Overall Study|Lost to Follow-up|0|||
161788776|NCT01567306|584270781|FG000|Overall Study|Withdrawal by Subject|0|||
161788777|NCT01567306|584270782|FG001|Overall Study|Withdrawal by Subject|0|||
161788778|NCT01567306|584270783|FG002|Overall Study|Withdrawal by Subject|0|||
161788779|NCT01567306|584270784|FG003|Overall Study|Withdrawal by Subject|0|||
161788780|NCT01567306|584270785|FG004|Overall Study|Withdrawal by Subject|0|||
161788781|NCT01567306|584270786|FG005|Overall Study|Withdrawal by Subject|1|||
161788782|NCT04272775|584270794|FG000|Overall Study|Study Terminated by Sponsor|1|||
161788783|NCT04272775|584270795|FG001|Overall Study|Study Terminated by Sponsor|0|||
161788784|NCT04272775|584270794|FG000|Overall Study|Protocol Violation|0|||
161788785|NCT04272775|584270795|FG001|Overall Study|Protocol Violation|1|||
161788786|NCT04272775|584270794|FG000|Overall Study|Symptomatic Deterioration|1|||
161788787|NCT04272775|584270795|FG001|Overall Study|Symptomatic Deterioration|1|||
161788788|NCT04272775|584270794|FG000|Overall Study|Withdrawal by Subject|1|||
161788789|NCT04272775|584270795|FG001|Overall Study|Withdrawal by Subject|2|||
161788790|NCT04272775|584270794|FG000|Overall Study|Adverse Event|1|||
161788791|NCT04272775|584270795|FG001|Overall Study|Adverse Event|2|||
161788792|NCT04272775|584270794|FG000|Overall Study|Progressive Disease|3|||
161788793|NCT04272775|584270795|FG001|Overall Study|Progressive Disease|1|||
161788794|NCT02063698|584270798|FG000|Overall Study|did not complete booklet for days 2-8|1|||
161439731|NCT03910244|583003290|FG001|Overall Study|Protocol Violation|0|||
161439732|NCT03910244|583003289|FG000|Overall Study|Withdrawal by Subject|7|||
161439733|NCT03910244|583003290|FG001|Overall Study|Withdrawal by Subject|2|||
161439734|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
161439735|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
161439736|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
161439737|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
161439738|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
161439739|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161439740|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
161439741|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
161439742|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161439743|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
161439744|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
161439745|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
161439746|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
161439747|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
161439748|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
161439749|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161439750|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161439751|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161439752|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161439753|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161439754|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161439755|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
161439756|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161439757|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161439758|NCT01106690|583003291|FG000|Core Period: Baseline to Week 26|Other|10|||
161439759|NCT01106690|583003292|FG001|Core Period: Baseline to Week 26|Other|2|||
161439760|NCT01106690|583003293|FG002|Core Period: Baseline to Week 26|Other|6|||
161439761|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161439762|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161439763|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161439764|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161439765|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161439766|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161439767|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161788795|NCT02063698|584270799|FG001|Overall Study|did not complete booklet for days 2-8|2|||
161788796|NCT02124746|584270800|FG000|Overall Study|Adverse Event|2|||
161439768|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161788797|NCT02124746|584270801|FG001|Overall Study|Adverse Event|1|||
161788798|NCT02124746|584270802|FG002|Overall Study|Adverse Event|2|||
161788799|NCT02124746|584270800|FG000|Overall Study|Death|2|||
161439769|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161439770|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161439771|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161439772|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
161439773|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161439774|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161439775|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161439776|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Other|8|||
161439777|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Other|3|||
161439778|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161439779|NCT01106690|583003291|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161439780|NCT01106690|583003292|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161439781|NCT01106690|583003293|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161439782|NCT02346721|583003294|FG000|Overall Study|Withdrew Consent|3|||
161439783|NCT02346721|583003294|FG000|Overall Study|Lack of Efficacy|1|||
161439784|NCT03219528|583003304|FG000|Overall Study|Lost to Follow-up|5|||
161439785|NCT03219528|583003305|FG001|Overall Study|Lost to Follow-up|4|||
161439786|NCT03219528|583003304|FG000|Overall Study|Withdrawal by Subject|4|||
161439787|NCT03219528|583003305|FG001|Overall Study|Withdrawal by Subject|4|||
161439788|NCT00790842|583003306|FG000|Dose Level 1|Adverse Event|1|||
161439789|NCT00790842|583003307|FG001|Dose Level 1|Adverse Event|0|||
161439790|NCT00790842|583003308|FG002|Dose Level 1|Adverse Event|0|||
161439791|NCT00790842|583003309|FG003|Dose Level 1|Adverse Event|2|||
161439792|NCT00790842|583003310|FG004|Dose Level 1|Adverse Event|0|||
161439793|NCT00790842|583003311|FG005|Dose Level 1|Adverse Event|0|||
161439794|NCT00790842|583003312|FG006|Dose Level 1|Adverse Event|0|||
161439795|NCT00790842|583003313|FG007|Dose Level 1|Adverse Event|1|||
161439796|NCT00790842|583003314|FG008|Dose Level 1|Adverse Event|0|||
161439797|NCT00790842|583003315|FG009|Dose Level 1|Adverse Event|0|||
161439798|NCT00790842|583003316|FG010|Dose Level 1|Adverse Event|0|||
161439799|NCT00790842|583003306|FG000|Dose Level 1|Physician Decision|1|||
161439800|NCT00790842|583003307|FG001|Dose Level 1|Physician Decision|0|||
161439801|NCT00790842|583003308|FG002|Dose Level 1|Physician Decision|0|||
161439802|NCT00790842|583003309|FG003|Dose Level 1|Physician Decision|0|||
161439803|NCT00790842|583003310|FG004|Dose Level 1|Physician Decision|0|||
161439804|NCT00790842|583003311|FG005|Dose Level 1|Physician Decision|0|||
161439805|NCT00790842|583003312|FG006|Dose Level 1|Physician Decision|0|||
161439806|NCT00790842|583003313|FG007|Dose Level 1|Physician Decision|1|||
161439807|NCT00790842|583003314|FG008|Dose Level 1|Physician Decision|0|||
161439808|NCT00790842|583003315|FG009|Dose Level 1|Physician Decision|0|||
161788800|NCT02124746|584270801|FG001|Overall Study|Death|1|||
161788801|NCT02124746|584270802|FG002|Overall Study|Death|3|||
161788802|NCT02124746|584270800|FG000|Overall Study|Lack of Efficacy|3|||
161788803|NCT02124746|584270801|FG001|Overall Study|Lack of Efficacy|2|||
161788804|NCT02124746|584270802|FG002|Overall Study|Lack of Efficacy|2|||
161788805|NCT02124746|584270800|FG000|Overall Study|Physician Decision|6|||
161788806|NCT02124746|584270801|FG001|Overall Study|Physician Decision|4|||
161788807|NCT02124746|584270802|FG002|Overall Study|Physician Decision|5|||
161788808|NCT02124746|584270800|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161788809|NCT02124746|584270801|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161788810|NCT02124746|584270802|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161788811|NCT02124746|584270800|FG000|Overall Study|Withdrawal by Subject|3|||
161788812|NCT02124746|584270801|FG001|Overall Study|Withdrawal by Subject|3|||
161788813|NCT02124746|584270802|FG002|Overall Study|Withdrawal by Subject|0|||
161788814|NCT02124746|584270800|FG000|Overall Study|Study Terminated by Sponsor|0|||
161788815|NCT02124746|584270801|FG001|Overall Study|Study Terminated by Sponsor|0|||
161788816|NCT02124746|584270802|FG002|Overall Study|Study Terminated by Sponsor|6|||
161788817|NCT02124746|584270800|FG000|Overall Study|Disease Progression|3|||
161788818|NCT02124746|584270801|FG001|Overall Study|Disease Progression|6|||
161788819|NCT02124746|584270802|FG002|Overall Study|Disease Progression|4|||
161788820|NCT03124381|584270803|FG000|Overall Study|Lost to Follow-up|1|||
161788821|NCT03124381|584270804|FG001|Overall Study|Lost to Follow-up|1|||
161439809|NCT00790842|583003316|FG010|Dose Level 1|Physician Decision|0|||
161439810|NCT00790842|583003306|FG000|Dose Level 1|Withdrawal by Subject|1|||
161439811|NCT00790842|583003307|FG001|Dose Level 1|Withdrawal by Subject|0|||
161788822|NCT03124381|584270803|FG000|Overall Study|Withdrawal by Subject|6|||
161788823|NCT03124381|584270804|FG001|Overall Study|Withdrawal by Subject|3|||
161788824|NCT03124381|584270803|FG000|Overall Study|Protocol Violation|0|||
161788825|NCT03124381|584270804|FG001|Overall Study|Protocol Violation|1|||
161788826|NCT03124381|584270803|FG000|Overall Study|Adverse Event|1|||
161788827|NCT03124381|584270804|FG001|Overall Study|Adverse Event|1|||
161788828|NCT03124381|584270803|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
161439812|NCT00790842|583003308|FG002|Dose Level 1|Withdrawal by Subject|0|||
161439813|NCT00790842|583003309|FG003|Dose Level 1|Withdrawal by Subject|0|||
161439814|NCT00790842|583003310|FG004|Dose Level 1|Withdrawal by Subject|0|||
161439815|NCT00790842|583003311|FG005|Dose Level 1|Withdrawal by Subject|0|||
161439816|NCT00790842|583003312|FG006|Dose Level 1|Withdrawal by Subject|0|||
161788829|NCT03124381|584270804|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
161439817|NCT00790842|583003313|FG007|Dose Level 1|Withdrawal by Subject|0|||
161439818|NCT00790842|583003314|FG008|Dose Level 1|Withdrawal by Subject|0|||
161439819|NCT00790842|583003315|FG009|Dose Level 1|Withdrawal by Subject|0|||
161439820|NCT00790842|583003316|FG010|Dose Level 1|Withdrawal by Subject|0|||
161439821|NCT00790842|583003306|FG000|Dose Level 2|Death|0|||
161439822|NCT00790842|583003307|FG001|Dose Level 2|Death|1|||
161439823|NCT00790842|583003308|FG002|Dose Level 2|Death|0|||
161439824|NCT00790842|583003309|FG003|Dose Level 2|Death|0|||
161439825|NCT00790842|583003310|FG004|Dose Level 2|Death|1|||
161439826|NCT00790842|583003311|FG005|Dose Level 2|Death|0|||
161439827|NCT00790842|583003312|FG006|Dose Level 2|Death|0|||
161439828|NCT00790842|583003313|FG007|Dose Level 2|Death|0|||
161439829|NCT00790842|583003314|FG008|Dose Level 2|Death|0|||
161439830|NCT00790842|583003315|FG009|Dose Level 2|Death|0|||
161439831|NCT00790842|583003316|FG010|Dose Level 2|Death|0|||
161439832|NCT00790842|583003306|FG000|Dose Level 2|Physician Decision|0|||
161439833|NCT00790842|583003307|FG001|Dose Level 2|Physician Decision|1|||
161439834|NCT00790842|583003308|FG002|Dose Level 2|Physician Decision|0|||
161439835|NCT00790842|583003309|FG003|Dose Level 2|Physician Decision|0|||
161439836|NCT00790842|583003310|FG004|Dose Level 2|Physician Decision|0|||
161439837|NCT00790842|583003311|FG005|Dose Level 2|Physician Decision|0|||
161439838|NCT00790842|583003312|FG006|Dose Level 2|Physician Decision|0|||
161439839|NCT00790842|583003313|FG007|Dose Level 2|Physician Decision|0|||
161439840|NCT00790842|583003314|FG008|Dose Level 2|Physician Decision|0|||
161439841|NCT00790842|583003315|FG009|Dose Level 2|Physician Decision|0|||
161439842|NCT00790842|583003316|FG010|Dose Level 2|Physician Decision|0|||
161439843|NCT00790842|583003306|FG000|Dose Level 2|Withdrawal by Subject|0|||
161439844|NCT00790842|583003307|FG001|Dose Level 2|Withdrawal by Subject|1|||
161439845|NCT00790842|583003308|FG002|Dose Level 2|Withdrawal by Subject|0|||
161439846|NCT00790842|583003309|FG003|Dose Level 2|Withdrawal by Subject|0|||
161439847|NCT00790842|583003310|FG004|Dose Level 2|Withdrawal by Subject|0|||
161439848|NCT00790842|583003311|FG005|Dose Level 2|Withdrawal by Subject|0|||
161439849|NCT00790842|583003312|FG006|Dose Level 2|Withdrawal by Subject|0|||
161439850|NCT00790842|583003313|FG007|Dose Level 2|Withdrawal by Subject|0|||
161439851|NCT00790842|583003314|FG008|Dose Level 2|Withdrawal by Subject|0|||
161439852|NCT00790842|583003315|FG009|Dose Level 2|Withdrawal by Subject|0|||
161439853|NCT00790842|583003316|FG010|Dose Level 2|Withdrawal by Subject|0|||
161439854|NCT00790842|583003306|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439855|NCT00790842|583003307|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439856|NCT00790842|583003308|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439857|NCT00790842|583003309|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439858|NCT00790842|583003310|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439859|NCT00790842|583003311|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439860|NCT00790842|583003312|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439861|NCT00790842|583003313|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439862|NCT00790842|583003314|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
161439863|NCT00790842|583003315|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439864|NCT00790842|583003316|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
161439865|NCT00790842|583003306|FG000|Dose Level 3|Adverse Event|0|||
161439866|NCT00790842|583003307|FG001|Dose Level 3|Adverse Event|0|||
161439867|NCT00790842|583003308|FG002|Dose Level 3|Adverse Event|1|||
161439868|NCT00790842|583003309|FG003|Dose Level 3|Adverse Event|0|||
161439869|NCT00790842|583003310|FG004|Dose Level 3|Adverse Event|0|||
161439870|NCT00790842|583003311|FG005|Dose Level 3|Adverse Event|0|||
161439871|NCT00790842|583003312|FG006|Dose Level 3|Adverse Event|0|||
161439872|NCT00790842|583003313|FG007|Dose Level 3|Adverse Event|0|||
161439873|NCT00790842|583003314|FG008|Dose Level 3|Adverse Event|0|||
161439874|NCT00790842|583003315|FG009|Dose Level 3|Adverse Event|0|||
161439875|NCT00790842|583003316|FG010|Dose Level 3|Adverse Event|0|||
161439876|NCT00790842|583003306|FG000|Dose Level 3|Withdrawal by Subject|0|||
161439877|NCT00790842|583003307|FG001|Dose Level 3|Withdrawal by Subject|0|||
161439878|NCT00790842|583003308|FG002|Dose Level 3|Withdrawal by Subject|3|||
161439879|NCT00790842|583003309|FG003|Dose Level 3|Withdrawal by Subject|0|||
161439880|NCT00790842|583003310|FG004|Dose Level 3|Withdrawal by Subject|0|||
161439881|NCT00790842|583003311|FG005|Dose Level 3|Withdrawal by Subject|0|||
161439882|NCT00790842|583003312|FG006|Dose Level 3|Withdrawal by Subject|0|||
161439883|NCT00790842|583003313|FG007|Dose Level 3|Withdrawal by Subject|0|||
161439884|NCT00790842|583003314|FG008|Dose Level 3|Withdrawal by Subject|0|||
161439885|NCT00790842|583003315|FG009|Dose Level 3|Withdrawal by Subject|2|||
161439886|NCT00790842|583003316|FG010|Dose Level 3|Withdrawal by Subject|0|||
161439887|NCT00790842|583003306|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439888|NCT00790842|583003307|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439889|NCT00790842|583003308|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439890|NCT00790842|583003309|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439891|NCT00790842|583003310|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439892|NCT00790842|583003311|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
161439893|NCT00790842|583003312|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439894|NCT00790842|583003313|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439895|NCT00790842|583003314|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439896|NCT00790842|583003315|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439897|NCT00790842|583003316|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161439898|NCT00790842|583003306|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439899|NCT00790842|583003307|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439900|NCT00790842|583003308|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
161439901|NCT00790842|583003309|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439902|NCT00790842|583003310|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439903|NCT00790842|583003311|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439904|NCT00790842|583003312|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439905|NCT00790842|583003313|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439906|NCT00790842|583003314|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439907|NCT00790842|583003315|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439908|NCT00790842|583003316|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
161439909|NCT00790842|583003306|FG000|Dose Level 4|Adverse Event|0|||
161439910|NCT00790842|583003307|FG001|Dose Level 4|Adverse Event|0|||
161439911|NCT00790842|583003308|FG002|Dose Level 4|Adverse Event|0|||
161439912|NCT00790842|583003309|FG003|Dose Level 4|Adverse Event|0|||
161439913|NCT00790842|583003310|FG004|Dose Level 4|Adverse Event|0|||
161439914|NCT00790842|583003311|FG005|Dose Level 4|Adverse Event|0|||
161439915|NCT00790842|583003312|FG006|Dose Level 4|Adverse Event|1|||
161439916|NCT00790842|583003313|FG007|Dose Level 4|Adverse Event|0|||
161439917|NCT00790842|583003314|FG008|Dose Level 4|Adverse Event|0|||
161439918|NCT00790842|583003315|FG009|Dose Level 4|Adverse Event|0|||
161439919|NCT00790842|583003316|FG010|Dose Level 4|Adverse Event|0|||
161439920|NCT00790842|583003306|FG000|Dose Level 4|Physician Decision|0|||
161439921|NCT00790842|583003307|FG001|Dose Level 4|Physician Decision|0|||
161439922|NCT00790842|583003308|FG002|Dose Level 4|Physician Decision|0|||
161439923|NCT00790842|583003309|FG003|Dose Level 4|Physician Decision|0|||
161439924|NCT00790842|583003310|FG004|Dose Level 4|Physician Decision|0|||
161439925|NCT00790842|583003311|FG005|Dose Level 4|Physician Decision|0|||
161439926|NCT00790842|583003312|FG006|Dose Level 4|Physician Decision|1|||
161439927|NCT00790842|583003313|FG007|Dose Level 4|Physician Decision|0|||
161439928|NCT00790842|583003314|FG008|Dose Level 4|Physician Decision|0|||
161439929|NCT00790842|583003315|FG009|Dose Level 4|Physician Decision|0|||
161439930|NCT00790842|583003316|FG010|Dose Level 4|Physician Decision|1|||
161788830|NCT02533999|584270810|FG000|Overall Study|Lost to Follow-up|3|||
161788831|NCT02533999|584270811|FG001|Overall Study|Lost to Follow-up|5|||
161788832|NCT02533999|584270810|FG000|Overall Study|Protocol Violation|3|||
161439931|NCT00790842|583003306|FG000|Dose Level 4|Withdrawal by Subject|0|||
161439932|NCT00790842|583003307|FG001|Dose Level 4|Withdrawal by Subject|0|||
161439933|NCT00790842|583003308|FG002|Dose Level 4|Withdrawal by Subject|0|||
161439934|NCT00790842|583003309|FG003|Dose Level 4|Withdrawal by Subject|0|||
161439935|NCT00790842|583003310|FG004|Dose Level 4|Withdrawal by Subject|0|||
161439936|NCT00790842|583003311|FG005|Dose Level 4|Withdrawal by Subject|0|||
161439937|NCT00790842|583003312|FG006|Dose Level 4|Withdrawal by Subject|0|||
161439938|NCT00790842|583003313|FG007|Dose Level 4|Withdrawal by Subject|0|||
161439939|NCT00790842|583003314|FG008|Dose Level 4|Withdrawal by Subject|0|||
161439940|NCT00790842|583003315|FG009|Dose Level 4|Withdrawal by Subject|0|||
161439941|NCT00790842|583003316|FG010|Dose Level 4|Withdrawal by Subject|1|||
161439942|NCT00790842|583003306|FG000|Expansion Cohort|Adverse Event|0|||
161439943|NCT00790842|583003307|FG001|Expansion Cohort|Adverse Event|0|||
161439944|NCT00790842|583003308|FG002|Expansion Cohort|Adverse Event|0|||
161439945|NCT00790842|583003309|FG003|Expansion Cohort|Adverse Event|0|||
161439946|NCT00790842|583003310|FG004|Expansion Cohort|Adverse Event|0|||
161439947|NCT00790842|583003311|FG005|Expansion Cohort|Adverse Event|0|||
161439948|NCT00790842|583003312|FG006|Expansion Cohort|Adverse Event|1|||
161439949|NCT00790842|583003313|FG007|Expansion Cohort|Adverse Event|0|||
161439950|NCT00790842|583003314|FG008|Expansion Cohort|Adverse Event|0|||
161788833|NCT02533999|584270811|FG001|Overall Study|Protocol Violation|0|||
161788834|NCT02533999|584270810|FG000|Overall Study|Adverse Event|0|||
161788835|NCT02533999|584270811|FG001|Overall Study|Adverse Event|1|||
161439951|NCT00790842|583003315|FG009|Expansion Cohort|Adverse Event|0|||
161439952|NCT00790842|583003316|FG010|Expansion Cohort|Adverse Event|0|||
161439953|NCT00790842|583003306|FG000|Expansion Cohort|Death|0|||
161439954|NCT00790842|583003307|FG001|Expansion Cohort|Death|0|||
161439955|NCT00790842|583003308|FG002|Expansion Cohort|Death|2|||
161439956|NCT00790842|583003309|FG003|Expansion Cohort|Death|0|||
161439957|NCT00790842|583003310|FG004|Expansion Cohort|Death|0|||
161439958|NCT00790842|583003311|FG005|Expansion Cohort|Death|0|||
161439959|NCT00790842|583003312|FG006|Expansion Cohort|Death|0|||
161439960|NCT00790842|583003313|FG007|Expansion Cohort|Death|0|||
161439961|NCT00790842|583003314|FG008|Expansion Cohort|Death|0|||
161439962|NCT00790842|583003315|FG009|Expansion Cohort|Death|0|||
161439963|NCT00790842|583003316|FG010|Expansion Cohort|Death|0|||
161439964|NCT00790842|583003306|FG000|Expansion Cohort|Physician Decision|0|||
161439965|NCT00790842|583003307|FG001|Expansion Cohort|Physician Decision|0|||
161439966|NCT00790842|583003308|FG002|Expansion Cohort|Physician Decision|1|||
161439967|NCT00790842|583003309|FG003|Expansion Cohort|Physician Decision|0|||
161439968|NCT00790842|583003310|FG004|Expansion Cohort|Physician Decision|0|||
161439969|NCT00790842|583003311|FG005|Expansion Cohort|Physician Decision|0|||
161439970|NCT00790842|583003312|FG006|Expansion Cohort|Physician Decision|0|||
161439971|NCT00790842|583003313|FG007|Expansion Cohort|Physician Decision|0|||
161439972|NCT00790842|583003314|FG008|Expansion Cohort|Physician Decision|0|||
161439973|NCT00790842|583003315|FG009|Expansion Cohort|Physician Decision|0|||
161439974|NCT00790842|583003316|FG010|Expansion Cohort|Physician Decision|0|||
161439975|NCT00790842|583003306|FG000|Expansion Cohort|Withdrawal by Subject|0|||
161439976|NCT00790842|583003307|FG001|Expansion Cohort|Withdrawal by Subject|0|||
161439977|NCT00790842|583003308|FG002|Expansion Cohort|Withdrawal by Subject|3|||
161439978|NCT00790842|583003309|FG003|Expansion Cohort|Withdrawal by Subject|0|||
161439979|NCT00790842|583003310|FG004|Expansion Cohort|Withdrawal by Subject|0|||
161439980|NCT00790842|583003311|FG005|Expansion Cohort|Withdrawal by Subject|0|||
161439981|NCT00790842|583003312|FG006|Expansion Cohort|Withdrawal by Subject|0|||
161439982|NCT00790842|583003313|FG007|Expansion Cohort|Withdrawal by Subject|0|||
161439983|NCT00790842|583003314|FG008|Expansion Cohort|Withdrawal by Subject|0|||
161439984|NCT00790842|583003315|FG009|Expansion Cohort|Withdrawal by Subject|0|||
161439985|NCT00790842|583003316|FG010|Expansion Cohort|Withdrawal by Subject|0|||
161439986|NCT00790842|583003306|FG000|Expansion Cohort|Study Closure|0|||
161439987|NCT00790842|583003307|FG001|Expansion Cohort|Study Closure|0|||
161439988|NCT00790842|583003308|FG002|Expansion Cohort|Study Closure|1|||
161439989|NCT00790842|583003309|FG003|Expansion Cohort|Study Closure|0|||
161439990|NCT00790842|583003310|FG004|Expansion Cohort|Study Closure|0|||
161439991|NCT00790842|583003311|FG005|Expansion Cohort|Study Closure|0|||
161439992|NCT00790842|583003312|FG006|Expansion Cohort|Study Closure|0|||
161439993|NCT00790842|583003313|FG007|Expansion Cohort|Study Closure|0|||
161439994|NCT00790842|583003314|FG008|Expansion Cohort|Study Closure|0|||
161439995|NCT00790842|583003315|FG009|Expansion Cohort|Study Closure|0|||
161439996|NCT00790842|583003316|FG010|Expansion Cohort|Study Closure|0|||
161439997|NCT05029362|583003317|FG000|Overall Study|Lost to Follow-up|9|||
161439998|NCT00419952|583003319|FG000|Overall Study|Adverse Event|8|||
161439999|NCT00419952|583003320|FG001|Overall Study|Adverse Event|10|||
161440000|NCT00419952|583003319|FG000|Overall Study|Withdrawal by Subject|44|||
161440001|NCT00419952|583003320|FG001|Overall Study|Withdrawal by Subject|43|||
161440002|NCT00419952|583003319|FG000|Overall Study|Lost to Follow-up|43|||
161440003|NCT00419952|583003320|FG001|Overall Study|Lost to Follow-up|34|||
161440004|NCT00419952|583003319|FG000|Overall Study|Protocol Violation|32|||
161440005|NCT00419952|583003320|FG001|Overall Study|Protocol Violation|24|||
161440006|NCT00419952|583003319|FG000|Overall Study|Pregnancy|4|||
161440007|NCT00419952|583003320|FG001|Overall Study|Pregnancy|2|||
161440008|NCT00419952|583003319|FG000|Overall Study|Physician Decision|1|||
161440009|NCT00419952|583003320|FG001|Overall Study|Physician Decision|3|||
161440010|NCT00419952|583003319|FG000|Overall Study|Incorrectly enrolled|10|||
161440011|NCT00419952|583003320|FG001|Overall Study|Incorrectly enrolled|3|||
161788836|NCT02533999|584270810|FG000|Overall Study|Randomized but intervention not received|0|||
161788837|NCT02533999|584270811|FG001|Overall Study|Randomized but intervention not received|1|||
161788838|NCT01154127|584270812|FG000|Period 1 (21 Days)|Adverse Event|3|||
161788839|NCT01154127|584270813|FG001|Period 1 (21 Days)|Adverse Event|4|||
161788840|NCT01154127|584270812|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
161788841|NCT01154127|584270813|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
161788842|NCT01154127|584270812|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
161788843|NCT01154127|584270813|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
161788844|NCT01154127|584270812|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
161788845|NCT01154127|584270813|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
161788846|NCT01154127|584270812|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
161788847|NCT01154127|584270813|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
161440012|NCT00419952|583003319|FG000|Overall Study|Intake of prohibited medication|2|||
161440013|NCT00419952|583003320|FG001|Overall Study|Intake of prohibited medication|2|||
161440014|NCT00419952|583003319|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
161440015|NCT00419952|583003320|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
161440016|NCT00419952|583003319|FG000|Overall Study|Diary or medication non-compliance|2|||
161440017|NCT00419952|583003320|FG001|Overall Study|Diary or medication non-compliance|4|||
161440018|NCT00419952|583003319|FG000|Overall Study|Abnormal ECG|1|||
161788848|NCT01697449|584270814|FG000|Overall Study|Disease progression|47|||
161788849|NCT01697449|584270814|FG000|Overall Study|Adverse Event|7|||
161440019|NCT00419952|583003320|FG001|Overall Study|Abnormal ECG|0|||
161440020|NCT03126591|583003325|FG000|Overall Study|Death|6|||
161440021|NCT03126591|583003326|FG001|Overall Study|Death|3|||
161440022|NCT03126591|583003327|FG002|Overall Study|Death|17|||
161440023|NCT03126591|583003325|FG000|Overall Study|Progressive Disease|0|||
161440024|NCT03126591|583003326|FG001|Overall Study|Progressive Disease|1|||
161788850|NCT01697449|584270814|FG000|Overall Study|Lost to Follow-up|5|||
161788851|NCT01697449|584270814|FG000|Overall Study|Withdrawal by Subject|2|||
161788852|NCT01697449|584270814|FG000|Overall Study|Physician Decision|1|||
161440025|NCT03126591|583003327|FG002|Overall Study|Progressive Disease|2|||
161788853|NCT01697449|584270814|FG000|Overall Study|Death|2|||
161788854|NCT01697449|584270814|FG000|Overall Study|Other|1|||
161788855|NCT01697449|584270814|FG000|Overall Study|Missing|25|||
161788856|NCT01123980|584270817|FG000|Overall Study|Adverse Event|1|||
161788857|NCT01123980|584270818|FG001|Overall Study|Adverse Event|1|||
161788858|NCT01123980|584270817|FG000|Overall Study|Lack of Efficacy|1|||
161788859|NCT01123980|584270818|FG001|Overall Study|Lack of Efficacy|0|||
161788860|NCT01123980|584270817|FG000|Overall Study|Physician Decision|0|||
161788861|NCT01123980|584270818|FG001|Overall Study|Physician Decision|1|||
161788862|NCT01123980|584270817|FG000|Overall Study|Lost to Follow-up|0|||
161788863|NCT01123980|584270818|FG001|Overall Study|Lost to Follow-up|6|||
161788864|NCT01123980|584270817|FG000|Overall Study|Protocol Violation|6|||
161788865|NCT01123980|584270818|FG001|Overall Study|Protocol Violation|6|||
161788866|NCT01123980|584270817|FG000|Overall Study|Withdrawal by Subject|5|||
161788867|NCT01123980|584270818|FG001|Overall Study|Withdrawal by Subject|3|||
161788868|NCT01123980|584270817|FG000|Overall Study|Unclassified|6|||
161788869|NCT01123980|584270818|FG001|Overall Study|Unclassified|7|||
161788870|NCT04385199|584270819|FG000|Overall Study|Withdrawal by Subject|1|||
161788871|NCT04385199|584270820|FG001|Overall Study|Withdrawal by Subject|0|||
161788872|NCT02557672|584270821|FG000|Overall Study|Withdrawal by Subject|4|||
161788873|NCT02557672|584270822|FG001|Overall Study|Withdrawal by Subject|2|||
161788874|NCT03705169|584270823|FG000|Overall Study|Lost to Follow-up|0|||
161788875|NCT03705169|584270824|FG001|Overall Study|Lost to Follow-up|0|||
161788876|NCT03705169|584270825|FG002|Overall Study|Lost to Follow-up|0|||
161788877|NCT03705169|584270826|FG003|Overall Study|Lost to Follow-up|2|||
161788878|NCT03705169|584270827|FG004|Overall Study|Lost to Follow-up|0|||
161788879|NCT03705169|584270828|FG005|Overall Study|Lost to Follow-up|2|||
161788880|NCT03705169|584270829|FG006|Overall Study|Lost to Follow-up|1|||
161788881|NCT03705169|584270830|FG007|Overall Study|Lost to Follow-up|0|||
161788882|NCT03705169|584270831|FG008|Overall Study|Lost to Follow-up|0|||
161788883|NCT03705169|584270832|FG009|Overall Study|Lost to Follow-up|1|||
161788884|NCT03705169|584270823|FG000|Overall Study|Adverse Event|0|||
161788885|NCT03705169|584270824|FG001|Overall Study|Adverse Event|0|||
161788886|NCT03705169|584270825|FG002|Overall Study|Adverse Event|0|||
161788887|NCT03705169|584270826|FG003|Overall Study|Adverse Event|1|||
161788888|NCT03705169|584270827|FG004|Overall Study|Adverse Event|0|||
161788889|NCT03705169|584270828|FG005|Overall Study|Adverse Event|0|||
161788890|NCT03705169|584270829|FG006|Overall Study|Adverse Event|0|||
161788891|NCT03705169|584270830|FG007|Overall Study|Adverse Event|0|||
161788892|NCT03705169|584270831|FG008|Overall Study|Adverse Event|0|||
161788893|NCT03705169|584270832|FG009|Overall Study|Adverse Event|0|||
161788894|NCT03705169|584270823|FG000|Overall Study|Site Closure|0|||
161788895|NCT03705169|584270824|FG001|Overall Study|Site Closure|0|||
161788896|NCT03705169|584270825|FG002|Overall Study|Site Closure|0|||
161788897|NCT03705169|584270826|FG003|Overall Study|Site Closure|1|||
161788898|NCT03705169|584270827|FG004|Overall Study|Site Closure|0|||
161788899|NCT03705169|584270828|FG005|Overall Study|Site Closure|0|||
161788900|NCT03705169|584270829|FG006|Overall Study|Site Closure|0|||
161788901|NCT03705169|584270830|FG007|Overall Study|Site Closure|0|||
161788902|NCT03705169|584270831|FG008|Overall Study|Site Closure|0|||
161788903|NCT03705169|584270832|FG009|Overall Study|Site Closure|0|||
161788904|NCT03705169|584270823|FG000|Overall Study|Did not receive study treatment|0|||
161788905|NCT03705169|584270824|FG001|Overall Study|Did not receive study treatment|0|||
161788906|NCT03705169|584270825|FG002|Overall Study|Did not receive study treatment|0|||
161788907|NCT03705169|584270826|FG003|Overall Study|Did not receive study treatment|1|||
161788908|NCT03705169|584270827|FG004|Overall Study|Did not receive study treatment|0|||
161788909|NCT03705169|584270828|FG005|Overall Study|Did not receive study treatment|0|||
161788910|NCT03705169|584270829|FG006|Overall Study|Did not receive study treatment|0|||
161788911|NCT03705169|584270830|FG007|Overall Study|Did not receive study treatment|0|||
161788912|NCT03705169|584270831|FG008|Overall Study|Did not receive study treatment|0|||
161788913|NCT03705169|584270832|FG009|Overall Study|Did not receive study treatment|0|||
161788914|NCT03705169|584270823|FG000|Overall Study|Concerns about study visit compliance|0|||
161788915|NCT03705169|584270824|FG001|Overall Study|Concerns about study visit compliance|0|||
161788916|NCT03705169|584270825|FG002|Overall Study|Concerns about study visit compliance|0|||
161788917|NCT03705169|584270826|FG003|Overall Study|Concerns about study visit compliance|1|||
161788918|NCT03705169|584270827|FG004|Overall Study|Concerns about study visit compliance|0|||
161788919|NCT03705169|584270828|FG005|Overall Study|Concerns about study visit compliance|0|||
161788920|NCT03705169|584270829|FG006|Overall Study|Concerns about study visit compliance|0|||
161788921|NCT03705169|584270830|FG007|Overall Study|Concerns about study visit compliance|0|||
161788922|NCT03705169|584270831|FG008|Overall Study|Concerns about study visit compliance|0|||
161788923|NCT03705169|584270832|FG009|Overall Study|Concerns about study visit compliance|0|||
161788924|NCT01133821|584272760|FG000|Overall Study|Lost to Follow-up|8|||
161788925|NCT01133821|584272761|FG001|Overall Study|Lost to Follow-up|11|||
161788926|NCT01133821|584272760|FG000|Overall Study|Withdrawal by Subject|8|||
161788927|NCT01133821|584272761|FG001|Overall Study|Withdrawal by Subject|3|||
161788928|NCT01133821|584272760|FG000|Overall Study|preferred other treatment|1|||
161788929|NCT01133821|584272761|FG001|Overall Study|preferred other treatment|1|||
161788930|NCT01133821|584272760|FG000|Overall Study|Protocol Violation|0|||
161788931|NCT01133821|584272761|FG001|Overall Study|Protocol Violation|1|||
161788932|NCT01133821|584272760|FG000|Overall Study|Refused participation|1|||
161788933|NCT01133821|584272761|FG001|Overall Study|Refused participation|3|||
161788934|NCT03342898|584272762|FG000|Overall Study|Adverse Event|3|||
161788935|NCT03342898|584272763|FG001|Overall Study|Adverse Event|1|||
161788936|NCT03342898|584272764|FG002|Overall Study|Adverse Event|0|||
161788937|NCT03342898|584272762|FG000|Overall Study|Lost to Follow-up|44|||
161788938|NCT03342898|584272763|FG001|Overall Study|Lost to Follow-up|40|||
161788939|NCT03342898|584272764|FG002|Overall Study|Lost to Follow-up|42|||
161788940|NCT03342898|584272762|FG000|Overall Study|Withdrawal of Consent|5|||
161788941|NCT03342898|584272763|FG001|Overall Study|Withdrawal of Consent|9|||
161788942|NCT03342898|584272764|FG002|Overall Study|Withdrawal of Consent|11|||
161788943|NCT03342898|584272762|FG000|Overall Study|Death|0|||
161788944|NCT03342898|584272763|FG001|Overall Study|Death|1|||
161788945|NCT03342898|584272764|FG002|Overall Study|Death|1|||
161788946|NCT03342898|584272762|FG000|Overall Study|Reason not Specified|2|||
161788947|NCT03342898|584272763|FG001|Overall Study|Reason not Specified|2|||
161788948|NCT03342898|584272764|FG002|Overall Study|Reason not Specified|0|||
161788949|NCT03997448|584272765|FG000|Study Treatment|Disease Progression|1|||
161788950|NCT03997448|584272765|FG000|Study Treatment|Symptomatic Deterioration|1|||
161788951|NCT03997448|584272765|FG000|Follow up|Death|2|||
161788952|NCT03997448|584272765|FG000|Follow up|study terminated|1|||
161788953|NCT01621490|584272766|FG000|Overall Study|Subject no longer meets study criteria|0|||
161788954|NCT01621490|584272767|FG001|Overall Study|Subject no longer meets study criteria|0|||
161788955|NCT01621490|584272768|FG002|Overall Study|Subject no longer meets study criteria|0|||
161788956|NCT01621490|584272769|FG003|Overall Study|Subject no longer meets study criteria|0|||
161788957|NCT01621490|584272770|FG004|Overall Study|Subject no longer meets study criteria|1|||
161788958|NCT01621490|584272771|FG005|Overall Study|Subject no longer meets study criteria|0|||
161788959|NCT01621490|584272772|FG006|Overall Study|Subject no longer meets study criteria|0|||
161788960|NCT01621490|584272773|FG007|Overall Study|Subject no longer meets study criteria|0|||
161788961|NCT01621490|584272774|FG008|Overall Study|Subject no longer meets study criteria|0|||
161788962|NCT01621490|584272775|FG009|Overall Study|Subject no longer meets study criteria|0|||
161788963|NCT01621490|584272776|FG010|Overall Study|Subject no longer meets study criteria|0|||
161788964|NCT01621490|584272766|FG000|Overall Study|Maximum clinical benefit|3|||
161788965|NCT01621490|584272767|FG001|Overall Study|Maximum clinical benefit|2|||
161788966|NCT01621490|584272768|FG002|Overall Study|Maximum clinical benefit|0|||
161788967|NCT01621490|584272769|FG003|Overall Study|Maximum clinical benefit|0|||
161788968|NCT01621490|584272770|FG004|Overall Study|Maximum clinical benefit|0|||
161788969|NCT01621490|584272771|FG005|Overall Study|Maximum clinical benefit|0|||
161788970|NCT01621490|584272772|FG006|Overall Study|Maximum clinical benefit|1|||
161788971|NCT01621490|584272773|FG007|Overall Study|Maximum clinical benefit|2|||
161788972|NCT01621490|584272774|FG008|Overall Study|Maximum clinical benefit|2|||
161788973|NCT01621490|584272775|FG009|Overall Study|Maximum clinical benefit|0|||
161788974|NCT01621490|584272776|FG010|Overall Study|Maximum clinical benefit|0|||
161788975|NCT01621490|584272766|FG000|Overall Study|Withdrawal by Subject|1|||
161788976|NCT01621490|584272767|FG001|Overall Study|Withdrawal by Subject|0|||
161788977|NCT01621490|584272768|FG002|Overall Study|Withdrawal by Subject|0|||
161788978|NCT01621490|584272769|FG003|Overall Study|Withdrawal by Subject|0|||
161788979|NCT01621490|584272770|FG004|Overall Study|Withdrawal by Subject|0|||
161788980|NCT01621490|584272771|FG005|Overall Study|Withdrawal by Subject|1|||
161788981|NCT01621490|584272772|FG006|Overall Study|Withdrawal by Subject|0|||
161788982|NCT01621490|584272773|FG007|Overall Study|Withdrawal by Subject|0|||
161788983|NCT01621490|584272774|FG008|Overall Study|Withdrawal by Subject|0|||
161788984|NCT01621490|584272775|FG009|Overall Study|Withdrawal by Subject|0|||
161788985|NCT01621490|584272776|FG010|Overall Study|Withdrawal by Subject|0|||
161788986|NCT01621490|584272766|FG000|Overall Study|Subject request to discontinue study|1|||
161788987|NCT01621490|584272767|FG001|Overall Study|Subject request to discontinue study|3|||
161788988|NCT01621490|584272768|FG002|Overall Study|Subject request to discontinue study|1|||
161788989|NCT01621490|584272769|FG003|Overall Study|Subject request to discontinue study|1|||
161788990|NCT01621490|584272770|FG004|Overall Study|Subject request to discontinue study|0|||
161788991|NCT01621490|584272771|FG005|Overall Study|Subject request to discontinue study|2|||
161788992|NCT01621490|584272772|FG006|Overall Study|Subject request to discontinue study|1|||
161788993|NCT01621490|584272773|FG007|Overall Study|Subject request to discontinue study|0|||
161788994|NCT01621490|584272774|FG008|Overall Study|Subject request to discontinue study|1|||
161788995|NCT01621490|584272775|FG009|Overall Study|Subject request to discontinue study|0|||
161788996|NCT01621490|584272776|FG010|Overall Study|Subject request to discontinue study|0|||
161788997|NCT01621490|584272766|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161788998|NCT01621490|584272767|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161788999|NCT01621490|584272768|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161789000|NCT01621490|584272769|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161789001|NCT01621490|584272770|FG004|Overall Study|Adverse event unrelated to study drug|0|||
161789002|NCT01621490|584272771|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161789003|NCT01621490|584272772|FG006|Overall Study|Adverse event unrelated to study drug|0|||
161789004|NCT01621490|584272773|FG007|Overall Study|Adverse event unrelated to study drug|2|||
161789005|NCT01621490|584272774|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161789006|NCT01621490|584272775|FG009|Overall Study|Adverse event unrelated to study drug|0|||
161789007|NCT01621490|584272776|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161789008|NCT01621490|584272766|FG000|Overall Study|Disease progression|27|||
161789009|NCT01621490|584272767|FG001|Overall Study|Disease progression|28|||
161789010|NCT01621490|584272768|FG002|Overall Study|Disease progression|1|||
161789011|NCT01621490|584272769|FG003|Overall Study|Disease progression|5|||
161789012|NCT01621490|584272770|FG004|Overall Study|Disease progression|3|||
161789013|NCT01621490|584272771|FG005|Overall Study|Disease progression|8|||
161789014|NCT01621490|584272772|FG006|Overall Study|Disease progression|7|||
161789015|NCT01621490|584272773|FG007|Overall Study|Disease progression|1|||
161789016|NCT01621490|584272774|FG008|Overall Study|Disease progression|4|||
161789017|NCT01621490|584272775|FG009|Overall Study|Disease progression|1|||
161789018|NCT01621490|584272776|FG010|Overall Study|Disease progression|1|||
161789019|NCT01621490|584272766|FG000|Overall Study|Study drug toxicity|1|||
161789020|NCT01621490|584272767|FG001|Overall Study|Study drug toxicity|4|||
161789021|NCT01621490|584272768|FG002|Overall Study|Study drug toxicity|5|||
161789022|NCT01621490|584272769|FG003|Overall Study|Study drug toxicity|3|||
161789023|NCT01621490|584272770|FG004|Overall Study|Study drug toxicity|1|||
161789024|NCT01621490|584272771|FG005|Overall Study|Study drug toxicity|10|||
161789025|NCT01621490|584272772|FG006|Overall Study|Study drug toxicity|1|||
161789026|NCT01621490|584272773|FG007|Overall Study|Study drug toxicity|4|||
161789027|NCT01621490|584272774|FG008|Overall Study|Study drug toxicity|1|||
161789028|NCT01621490|584272775|FG009|Overall Study|Study drug toxicity|0|||
161789029|NCT01621490|584272776|FG010|Overall Study|Study drug toxicity|0|||
161789030|NCT01621490|584272766|FG000|Overall Study|Death|0|||
161789031|NCT01621490|584272767|FG001|Overall Study|Death|0|||
161789032|NCT01621490|584272768|FG002|Overall Study|Death|0|||
161789033|NCT01621490|584272769|FG003|Overall Study|Death|0|||
161789034|NCT01621490|584272770|FG004|Overall Study|Death|0|||
161789035|NCT01621490|584272771|FG005|Overall Study|Death|0|||
161789036|NCT01621490|584272772|FG006|Overall Study|Death|0|||
161789037|NCT01621490|584272773|FG007|Overall Study|Death|0|||
161789038|NCT01621490|584272774|FG008|Overall Study|Death|1|||
161789039|NCT01621490|584272775|FG009|Overall Study|Death|0|||
161789040|NCT01621490|584272776|FG010|Overall Study|Death|0|||
161789041|NCT01621490|584272766|FG000|Overall Study|Other reasons|7|||
161789042|NCT01621490|584272767|FG001|Overall Study|Other reasons|6|||
161789043|NCT01621490|584272768|FG002|Overall Study|Other reasons|4|||
161789044|NCT01621490|584272769|FG003|Overall Study|Other reasons|1|||
161789045|NCT01621490|584272770|FG004|Overall Study|Other reasons|1|||
161789046|NCT01621490|584272771|FG005|Overall Study|Other reasons|3|||
161789047|NCT01621490|584272772|FG006|Overall Study|Other reasons|1|||
161789048|NCT01621490|584272773|FG007|Overall Study|Other reasons|1|||
161789049|NCT01621490|584272774|FG008|Overall Study|Other reasons|1|||
161789050|NCT01621490|584272775|FG009|Overall Study|Other reasons|0|||
161789051|NCT01621490|584272776|FG010|Overall Study|Other reasons|0|||
161440026|NCT03126591|583003325|FG000|Overall Study|Terminated by Sponsor|0|||
161440027|NCT03126591|583003326|FG001|Overall Study|Terminated by Sponsor|1|||
161440028|NCT03126591|583003327|FG002|Overall Study|Terminated by Sponsor|4|||
161789052|NCT00461500|584272777|FG000|Overall Study|Adverse Event|1|||
161789053|NCT00461500|584272778|FG001|Overall Study|Adverse Event|0|||
161789054|NCT00461500|584272777|FG000|Overall Study|Lack of Efficacy|0|||
161789055|NCT00461500|584272778|FG001|Overall Study|Lack of Efficacy|1|||
161789056|NCT00461500|584272777|FG000|Overall Study|Expired Drug Treatment|1|||
161789057|NCT00461500|584272778|FG001|Overall Study|Expired Drug Treatment|1|||
161789058|NCT00461500|584272777|FG000|Overall Study|Study Stopped|1|||
161789059|NCT00461500|584272778|FG001|Overall Study|Study Stopped|2|||
161789060|NCT00461500|584272777|FG000|Overall Study|Drug Treatment Misuse|1|||
161789061|NCT00461500|584272778|FG001|Overall Study|Drug Treatment Misuse|0|||
161789062|NCT00461500|584272777|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
161789063|NCT00461500|584272778|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
161789064|NCT00461500|584272777|FG000|Overall Study|Lost to Follow-up|2|||
161789065|NCT00461500|584272778|FG001|Overall Study|Lost to Follow-up|2|||
161789066|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
161789067|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
161789068|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161789069|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161789070|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
161789071|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161789072|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
161789073|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789074|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789075|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789076|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
161440029|NCT03126591|583003325|FG000|Overall Study|Withdrawal by Subject|1|||
161440030|NCT03126591|583003326|FG001|Overall Study|Withdrawal by Subject|1|||
161789077|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789078|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789079|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
161789080|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789081|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789082|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789083|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789084|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
161789085|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
161789086|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161789087|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161789088|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
161789089|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161789090|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789091|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
161789092|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789093|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789094|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789095|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789096|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
161789097|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
161789098|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
161789099|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
161789100|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
161789101|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
161789102|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
161789103|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
161789104|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
161789105|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
161789106|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
161789107|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
161789108|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
161789109|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789110|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789111|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789112|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789113|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789114|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
161789115|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
161789116|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789117|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789118|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789119|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789120|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
161789121|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789122|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789123|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789124|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789125|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789126|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789127|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
161789128|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789129|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
161789130|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789131|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789132|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
161789133|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
161440031|NCT03126591|583003327|FG002|Overall Study|Withdrawal by Subject|4|||
161440032|NCT02351817|583003328|FG000|Period 1|Adverse Event|1|||
161440033|NCT02351817|583003329|FG001|Period 1|Adverse Event|2|||
161440034|NCT02351817|583003328|FG000|Period 1|Lack of Efficacy|0|||
161440035|NCT02351817|583003329|FG001|Period 1|Lack of Efficacy|1|||
161440036|NCT02351817|583003328|FG000|Period 2|Adverse Event|0|||
161789134|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
161789135|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
161789136|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
161789137|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
161789138|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
161789139|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
161789140|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
161789141|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
161789142|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
161789143|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
161789144|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
161789145|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789146|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789147|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789148|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789149|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789150|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789151|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789152|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789153|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789154|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789155|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
161789156|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789157|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789158|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789159|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789160|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789161|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
161440037|NCT02351817|583003329|FG001|Period 2|Adverse Event|2|||
161440038|NCT02351817|583003328|FG000|Period 2|Protocol Violation|1|||
161440039|NCT02351817|583003329|FG001|Period 2|Protocol Violation|0|||
161440040|NCT02488915|583003332|FG000|Overall Study|Death|21|||
161440041|NCT02488915|583003332|FG000|Overall Study|Lost to Follow-up|4|||
161440042|NCT02488915|583003332|FG000|Overall Study|Withdrawal by Subject|1|||
161440043|NCT01208207|583003336|FG000|Part I|Adverse Event|19|||
161440044|NCT01208207|583003337|FG001|Part I|Adverse Event|2|||
161440045|NCT01208207|583003338|FG002|Part I|Adverse Event|6|||
161440046|NCT01208207|583003339|FG003|Part I|Adverse Event|0|||
161440047|NCT01208207|583003340|FG004|Part I|Adverse Event|0|||
161789162|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789163|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789164|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789165|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789166|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789167|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
161789168|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789169|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789170|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789171|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789172|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789173|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
161789174|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789175|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789176|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789177|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789178|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789179|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
161789180|NCT01144663|584272785|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
161789181|NCT01144663|584272786|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
161789182|NCT01144663|584272787|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
161789183|NCT01144663|584272788|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
161440048|NCT01208207|583003341|FG005|Part I|Adverse Event|0|||
161440049|NCT01208207|583003342|FG006|Part I|Adverse Event|0|||
161440050|NCT01208207|583003336|FG000|Part I|Lack of Efficacy|21|||
161440051|NCT01208207|583003337|FG001|Part I|Lack of Efficacy|3|||
161440052|NCT01208207|583003338|FG002|Part I|Lack of Efficacy|2|||
161440053|NCT01208207|583003339|FG003|Part I|Lack of Efficacy|0|||
161440054|NCT01208207|583003340|FG004|Part I|Lack of Efficacy|0|||
161789184|NCT01144663|584272785|FG000|Primary Vaccination Phase|Adverse Event|1|||
161789185|NCT01144663|584272786|FG001|Primary Vaccination Phase|Adverse Event|0|||
161789186|NCT01144663|584272787|FG002|Primary Vaccination Phase|Adverse Event|0|||
161789187|NCT01144663|584272788|FG003|Primary Vaccination Phase|Adverse Event|1|||
161789188|NCT01144663|584272785|FG000|Primary Vaccination Phase|Protocol Violation|2|||
161789189|NCT01144663|584272786|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161789190|NCT01144663|584272787|FG002|Primary Vaccination Phase|Protocol Violation|1|||
161789191|NCT01144663|584272788|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161789192|NCT01144663|584272785|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
161789193|NCT01144663|584272786|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
161789194|NCT01144663|584272787|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
161789195|NCT01144663|584272788|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
161789196|NCT01144663|584272785|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
161789197|NCT01144663|584272786|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
161789198|NCT01144663|584272787|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
161789199|NCT01144663|584272788|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
161789200|NCT01144663|584272785|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
161789201|NCT01144663|584272786|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
161789202|NCT01144663|584272787|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
161789203|NCT01144663|584272788|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
161789204|NCT01144663|584272785|FG000|Primary Vaccination Phase|Other|0|||
161789205|NCT01144663|584272786|FG001|Primary Vaccination Phase|Other|1|||
161789206|NCT01144663|584272787|FG002|Primary Vaccination Phase|Other|0|||
161789207|NCT01144663|584272788|FG003|Primary Vaccination Phase|Other|2|||
161789208|NCT01144663|584272785|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
161789209|NCT01144663|584272786|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161789210|NCT01144663|584272787|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
161789211|NCT01144663|584272788|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
161789212|NCT01144663|584272785|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
161789213|NCT01144663|584272786|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
161789214|NCT01144663|584272787|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
161789215|NCT01144663|584272788|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
161789216|NCT01144663|584272785|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
161789217|NCT01144663|584272786|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
161789218|NCT01144663|584272787|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
161789219|NCT01144663|584272788|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
161789220|NCT01144663|584272785|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
161789221|NCT01144663|584272786|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
161789222|NCT01144663|584272787|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
161789223|NCT01144663|584272788|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
161789224|NCT01144663|584272785|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
161789225|NCT01144663|584272786|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
161789226|NCT01144663|584272787|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
161789227|NCT01144663|584272788|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
161789228|NCT01144663|584272785|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
161789229|NCT01144663|584272786|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
161789230|NCT01144663|584272787|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
161789231|NCT01144663|584272788|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
161789232|NCT01335477|584272790|FG000|Overall Study|Adverse Event|30|||
161789233|NCT01335477|584272791|FG001|Overall Study|Adverse Event|42|||
161789234|NCT01335477|584272790|FG000|Overall Study|Non compliant with protocol|0|||
161789235|NCT01335477|584272791|FG001|Overall Study|Non compliant with protocol|2|||
161789236|NCT01335477|584272790|FG000|Overall Study|Lost to Follow-up|1|||
161789237|NCT01335477|584272791|FG001|Overall Study|Lost to Follow-up|2|||
161789238|NCT01335477|584272790|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
161789239|NCT01335477|584272791|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
161789240|NCT01335477|584272790|FG000|Overall Study|Not treated|1|||
161789241|NCT01335477|584272791|FG001|Overall Study|Not treated|2|||
161789242|NCT01335477|584272790|FG000|Overall Study|Reason other than those stated above|2|||
161789243|NCT01335477|584272791|FG001|Overall Study|Reason other than those stated above|2|||
161789244|NCT01473758|584272794|FG000|Cycle 1|Adverse Event|10|||
161789245|NCT01473758|584272795|FG001|Cycle 1|Adverse Event|2|||
161789246|NCT01473758|584272796|FG002|Cycle 1|Adverse Event|0|||
161789247|NCT01473758|584272797|FG003|Cycle 1|Adverse Event|0|||
161789248|NCT01473758|584272794|FG000|Cycle 1|Withdrawal by Subject|1|||
161789249|NCT01473758|584272795|FG001|Cycle 1|Withdrawal by Subject|1|||
161789250|NCT01473758|584272796|FG002|Cycle 1|Withdrawal by Subject|0|||
161789251|NCT01473758|584272797|FG003|Cycle 1|Withdrawal by Subject|0|||
161789252|NCT01473758|584272794|FG000|Cycle 2|Adverse Event|0|||
161789253|NCT01473758|584272795|FG001|Cycle 2|Adverse Event|0|||
161789254|NCT01473758|584272796|FG002|Cycle 2|Adverse Event|5|||
161789255|NCT01473758|584272797|FG003|Cycle 2|Adverse Event|0|||
161789256|NCT02763579|584272798|FG000|Global Period|Death|167|||
161789257|NCT02763579|584272799|FG001|Global Period|Death|151|||
161789258|NCT02763579|584272800|FG002|Global Period|Death|0|||
161789259|NCT02763579|584272801|FG003|Global Period|Death|0|||
161789260|NCT02763579|584272798|FG000|Global Period|Lost to Follow-up|2|||
161789261|NCT02763579|584272799|FG001|Global Period|Lost to Follow-up|4|||
161789262|NCT02763579|584272800|FG002|Global Period|Lost to Follow-up|0|||
161789263|NCT02763579|584272801|FG003|Global Period|Lost to Follow-up|0|||
161789264|NCT02763579|584272798|FG000|Global Period|Physician Decision|0|||
161789265|NCT02763579|584272799|FG001|Global Period|Physician Decision|2|||
161789266|NCT02763579|584272800|FG002|Global Period|Physician Decision|0|||
161789267|NCT02763579|584272801|FG003|Global Period|Physician Decision|0|||
161789268|NCT02763579|584272798|FG000|Global Period|Study Terminated By Sponsor|21|||
161789269|NCT02763579|584272799|FG001|Global Period|Study Terminated By Sponsor|26|||
161789270|NCT02763579|584272800|FG002|Global Period|Study Terminated By Sponsor|0|||
161789271|NCT02763579|584272801|FG003|Global Period|Study Terminated By Sponsor|0|||
161789272|NCT02763579|584272798|FG000|Global Period|Withdrawal by Subject|12|||
161789273|NCT02763579|584272799|FG001|Global Period|Withdrawal by Subject|18|||
161789274|NCT02763579|584272800|FG002|Global Period|Withdrawal by Subject|0|||
161789275|NCT02763579|584272801|FG003|Global Period|Withdrawal by Subject|0|||
161789276|NCT02763579|584272798|FG000|China Period|Death|0|||
161789277|NCT02763579|584272799|FG001|China Period|Death|0|||
161789278|NCT02763579|584272800|FG002|China Period|Death|46|||
161789279|NCT02763579|584272801|FG003|China Period|Death|48|||
161789280|NCT02763579|584272798|FG000|China Period|Lost to Follow-up|0|||
161789281|NCT02763579|584272799|FG001|China Period|Lost to Follow-up|0|||
161789282|NCT02763579|584272800|FG002|China Period|Lost to Follow-up|1|||
161789283|NCT02763579|584272801|FG003|China Period|Lost to Follow-up|1|||
161789284|NCT02763579|584272798|FG000|China Period|Physician Decision|0|||
161789285|NCT02763579|584272799|FG001|China Period|Physician Decision|0|||
161789286|NCT02763579|584272800|FG002|China Period|Physician Decision|0|||
161789287|NCT02763579|584272801|FG003|China Period|Physician Decision|1|||
161789288|NCT02763579|584272798|FG000|China Period|Study Terminated By Sponsor|0|||
161789289|NCT02763579|584272799|FG001|China Period|Study Terminated By Sponsor|0|||
161789290|NCT02763579|584272800|FG002|China Period|Study Terminated By Sponsor|3|||
161789291|NCT02763579|584272801|FG003|China Period|Study Terminated By Sponsor|4|||
161789292|NCT02763579|584272798|FG000|China Period|Withdrawal by Subject|0|||
161789293|NCT02763579|584272799|FG001|China Period|Withdrawal by Subject|0|||
161789294|NCT02763579|584272800|FG002|China Period|Withdrawal by Subject|3|||
161789295|NCT02763579|584272801|FG003|China Period|Withdrawal by Subject|3|||
161789296|NCT00829413|584272805|FG000|Overall Study|No study drug admimnistered|13|||
161789297|NCT00829413|584272805|FG000|Overall Study|Training Patients|67|||
161789298|NCT00829413|584272805|FG000|Overall Study|No truth standard procedure available|9|||
161789299|NCT00829413|584272805|FG000|Overall Study|Technically inadequate truth standard|2|||
161789300|NCT00829413|584272805|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
161789301|NCT00891774|584272813|FG000|Overall Study|Lost to Follow-up|5|||
161789302|NCT00891774|584272813|FG000|Overall Study|Illness (Self/Mother)|3|||
161789303|NCT00891774|584272813|FG000|Overall Study|Withdrawal by Subject|2|||
161789304|NCT00891774|584272813|FG000|Overall Study|Protocol Violation|4|||
161789305|NCT03255031|584272815|FG000|Overall Study|Adverse Event|5|||
161789306|NCT03255031|584272816|FG001|Overall Study|Adverse Event|3|||
161789307|NCT03255031|584272815|FG000|Overall Study|Physician Decision|2|||
161898621|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
161898622|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
161898623|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
161440055|NCT01208207|583003341|FG005|Part I|Lack of Efficacy|0|||
161898624|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
161898625|NCT02581488|584677854|FG000|Overall Study|Adverse Event|6|||
161898626|NCT02581488|584677855|FG001|Overall Study|Adverse Event|7|||
161898627|NCT02581488|584677854|FG000|Overall Study|Lost to Follow-up|1|||
161898628|NCT02581488|584677855|FG001|Overall Study|Lost to Follow-up|0|||
161898629|NCT02581488|584677854|FG000|Overall Study|Withdrawal by Subject|1|||
161898630|NCT02581488|584677855|FG001|Overall Study|Withdrawal by Subject|0|||
161898631|NCT02581488|584677854|FG000|Overall Study|Non-Compliance|1|||
161898632|NCT02581488|584677855|FG001|Overall Study|Non-Compliance|0|||
161898633|NCT02581488|584677854|FG000|Overall Study|Protocol Violation|0|||
161898634|NCT02581488|584677855|FG001|Overall Study|Protocol Violation|4|||
161898635|NCT00522548|584677856|FG000|Overall Study|Adverse Event|2|||
161898636|NCT00522548|584677857|FG001|Overall Study|Adverse Event|2|||
161898637|NCT00522548|584677856|FG000|Overall Study|Withdrawal by Subject|0|||
161898638|NCT00522548|584677857|FG001|Overall Study|Withdrawal by Subject|2|||
161898639|NCT02915159|584677858|FG000|Overall Study|Participant no longer meets criteria|2|||
161440056|NCT01208207|583003342|FG006|Part I|Lack of Efficacy|0|||
161440057|NCT01208207|583003336|FG000|Part I|Lost to Follow-up|6|||
161789308|NCT03255031|584272816|FG001|Overall Study|Physician Decision|1|||
161789309|NCT03255031|584272815|FG000|Overall Study|Withdrawal by Subject|9|||
161789310|NCT03255031|584272816|FG001|Overall Study|Withdrawal by Subject|3|||
161789311|NCT01809314|584272817|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
161440058|NCT01208207|583003337|FG001|Part I|Lost to Follow-up|1|||
161440059|NCT01208207|583003338|FG002|Part I|Lost to Follow-up|0|||
161440060|NCT01208207|583003339|FG003|Part I|Lost to Follow-up|0|||
161440061|NCT01208207|583003340|FG004|Part I|Lost to Follow-up|0|||
161440062|NCT01208207|583003341|FG005|Part I|Lost to Follow-up|0|||
161440063|NCT01208207|583003342|FG006|Part I|Lost to Follow-up|0|||
161440064|NCT01208207|583003336|FG000|Part I|Non-Compliance With Study Drug|1|||
161440065|NCT01208207|583003337|FG001|Part I|Non-Compliance With Study Drug|0|||
161440066|NCT01208207|583003338|FG002|Part I|Non-Compliance With Study Drug|1|||
161440067|NCT01208207|583003339|FG003|Part I|Non-Compliance With Study Drug|0|||
161440068|NCT01208207|583003340|FG004|Part I|Non-Compliance With Study Drug|0|||
161440069|NCT01208207|583003341|FG005|Part I|Non-Compliance With Study Drug|0|||
161440070|NCT01208207|583003342|FG006|Part I|Non-Compliance With Study Drug|0|||
161440071|NCT01208207|583003336|FG000|Part I|Physician Decision|0|||
161440072|NCT01208207|583003337|FG001|Part I|Physician Decision|1|||
161440073|NCT01208207|583003338|FG002|Part I|Physician Decision|0|||
161440074|NCT01208207|583003339|FG003|Part I|Physician Decision|0|||
161440075|NCT01208207|583003340|FG004|Part I|Physician Decision|0|||
161440076|NCT01208207|583003341|FG005|Part I|Physician Decision|0|||
161440077|NCT01208207|583003342|FG006|Part I|Physician Decision|0|||
161440078|NCT01208207|583003336|FG000|Part I|Progressive Disease|1|||
161440079|NCT01208207|583003337|FG001|Part I|Progressive Disease|0|||
161440080|NCT01208207|583003338|FG002|Part I|Progressive Disease|0|||
161440081|NCT01208207|583003339|FG003|Part I|Progressive Disease|0|||
161440082|NCT01208207|583003340|FG004|Part I|Progressive Disease|0|||
161440083|NCT01208207|583003341|FG005|Part I|Progressive Disease|0|||
161440084|NCT01208207|583003342|FG006|Part I|Progressive Disease|0|||
161440085|NCT01208207|583003336|FG000|Part I|Protocol Violation|8|||
161440086|NCT01208207|583003337|FG001|Part I|Protocol Violation|0|||
161440087|NCT01208207|583003338|FG002|Part I|Protocol Violation|2|||
161440088|NCT01208207|583003339|FG003|Part I|Protocol Violation|0|||
161440089|NCT01208207|583003340|FG004|Part I|Protocol Violation|0|||
161440090|NCT01208207|583003341|FG005|Part I|Protocol Violation|0|||
161440091|NCT01208207|583003342|FG006|Part I|Protocol Violation|0|||
161440092|NCT01208207|583003336|FG000|Part I|Withdrawal by Subject|14|||
161440093|NCT01208207|583003337|FG001|Part I|Withdrawal by Subject|4|||
161440094|NCT01208207|583003338|FG002|Part I|Withdrawal by Subject|4|||
161440095|NCT01208207|583003339|FG003|Part I|Withdrawal by Subject|0|||
161440096|NCT01208207|583003340|FG004|Part I|Withdrawal by Subject|0|||
161440097|NCT01208207|583003341|FG005|Part I|Withdrawal by Subject|0|||
161440098|NCT01208207|583003342|FG006|Part I|Withdrawal by Subject|0|||
161440099|NCT01208207|583003336|FG000|Part II|Withdrawal by Subject|0|||
161440100|NCT01208207|583003337|FG001|Part II|Withdrawal by Subject|0|||
161440101|NCT01208207|583003338|FG002|Part II|Withdrawal by Subject|0|||
161440102|NCT01208207|583003339|FG003|Part II|Withdrawal by Subject|10|||
161440103|NCT01208207|583003340|FG004|Part II|Withdrawal by Subject|9|||
161440104|NCT01208207|583003341|FG005|Part II|Withdrawal by Subject|3|||
161440105|NCT01208207|583003342|FG006|Part II|Withdrawal by Subject|5|||
161440106|NCT01208207|583003336|FG000|Part II|Adverse Event|0|||
161440107|NCT01208207|583003337|FG001|Part II|Adverse Event|0|||
161440108|NCT01208207|583003338|FG002|Part II|Adverse Event|0|||
161440109|NCT01208207|583003339|FG003|Part II|Adverse Event|5|||
161440110|NCT01208207|583003340|FG004|Part II|Adverse Event|9|||
161440111|NCT01208207|583003341|FG005|Part II|Adverse Event|4|||
161440112|NCT01208207|583003342|FG006|Part II|Adverse Event|2|||
161440113|NCT01208207|583003336|FG000|Part II|Lack of Efficacy|0|||
161440114|NCT01208207|583003337|FG001|Part II|Lack of Efficacy|0|||
161440115|NCT01208207|583003338|FG002|Part II|Lack of Efficacy|0|||
161440116|NCT01208207|583003339|FG003|Part II|Lack of Efficacy|6|||
161440117|NCT01208207|583003340|FG004|Part II|Lack of Efficacy|4|||
161440118|NCT01208207|583003341|FG005|Part II|Lack of Efficacy|3|||
161440119|NCT01208207|583003342|FG006|Part II|Lack of Efficacy|3|||
161440120|NCT01208207|583003336|FG000|Part II|Lost to Follow-up|0|||
161440121|NCT01208207|583003337|FG001|Part II|Lost to Follow-up|0|||
161440122|NCT01208207|583003338|FG002|Part II|Lost to Follow-up|0|||
161440123|NCT01208207|583003339|FG003|Part II|Lost to Follow-up|4|||
161440124|NCT01208207|583003340|FG004|Part II|Lost to Follow-up|0|||
161440125|NCT01208207|583003341|FG005|Part II|Lost to Follow-up|2|||
161440126|NCT01208207|583003342|FG006|Part II|Lost to Follow-up|1|||
161440127|NCT01208207|583003336|FG000|Part II|Non-Compliance With Study Drug|0|||
161440128|NCT01208207|583003337|FG001|Part II|Non-Compliance With Study Drug|0|||
161440129|NCT01208207|583003338|FG002|Part II|Non-Compliance With Study Drug|0|||
161440130|NCT01208207|583003339|FG003|Part II|Non-Compliance With Study Drug|4|||
161440131|NCT01208207|583003340|FG004|Part II|Non-Compliance With Study Drug|1|||
161440132|NCT01208207|583003341|FG005|Part II|Non-Compliance With Study Drug|1|||
161440133|NCT01208207|583003342|FG006|Part II|Non-Compliance With Study Drug|0|||
161440134|NCT01208207|583003336|FG000|Part II|Physician Decision|0|||
161440135|NCT01208207|583003337|FG001|Part II|Physician Decision|0|||
161440136|NCT01208207|583003338|FG002|Part II|Physician Decision|0|||
161440137|NCT01208207|583003339|FG003|Part II|Physician Decision|1|||
161440138|NCT01208207|583003340|FG004|Part II|Physician Decision|0|||
161440139|NCT01208207|583003341|FG005|Part II|Physician Decision|2|||
161440140|NCT01208207|583003342|FG006|Part II|Physician Decision|0|||
161440141|NCT01208207|583003336|FG000|Part II|Protocol Violation|0|||
161440142|NCT01208207|583003337|FG001|Part II|Protocol Violation|0|||
161440143|NCT01208207|583003338|FG002|Part II|Protocol Violation|0|||
161440144|NCT01208207|583003339|FG003|Part II|Protocol Violation|1|||
161440145|NCT01208207|583003340|FG004|Part II|Protocol Violation|0|||
161440146|NCT01208207|583003341|FG005|Part II|Protocol Violation|0|||
161440147|NCT01208207|583003342|FG006|Part II|Protocol Violation|0|||
161440148|NCT01208207|583003336|FG000|Part II|Technical Problems|0|||
161440149|NCT01208207|583003337|FG001|Part II|Technical Problems|0|||
161440150|NCT01208207|583003338|FG002|Part II|Technical Problems|0|||
161440151|NCT01208207|583003339|FG003|Part II|Technical Problems|1|||
161440152|NCT01208207|583003340|FG004|Part II|Technical Problems|0|||
161440153|NCT01208207|583003341|FG005|Part II|Technical Problems|1|||
161789312|NCT01809314|584272817|FG000|Overall Study|Adverse Event|6|||
161789313|NCT01809314|584272817|FG000|Overall Study|Insufficient Therapeutic Response|14|||
161789314|NCT01809314|584272817|FG000|Overall Study|Lost to Follow-up|724|||
161789315|NCT01092702|584272818|FG000|Overall Study|Withdrawal by Subject|7|||
161789316|NCT01092702|584272818|FG000|Overall Study|Lost to Follow-up|2|||
161789317|NCT00863057|584272821|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161789318|NCT00863057|584272822|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161789319|NCT00863057|584272823|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
161789320|NCT00863057|584272824|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161789321|NCT00863057|584272821|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161789322|NCT00863057|584272822|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
161789323|NCT00863057|584272823|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161789324|NCT00863057|584272824|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161789325|NCT00863057|584272821|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
161789326|NCT00863057|584272822|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
161789327|NCT00863057|584272823|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
161789328|NCT00863057|584272824|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
161789329|NCT00863057|584272821|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
161789330|NCT00863057|584272822|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
161789331|NCT00863057|584272823|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
161789332|NCT00863057|584272824|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
161789333|NCT00545233|584272828|FG000|Overall Study|Adverse Event|10|||
161789334|NCT00545233|584272829|FG001|Overall Study|Adverse Event|5|||
161789335|NCT00545233|584272828|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
161789336|NCT00545233|584272829|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161789337|NCT00545233|584272828|FG000|Overall Study|Protocol Violation|2|||
161789338|NCT00545233|584272829|FG001|Overall Study|Protocol Violation|0|||
161789339|NCT00545233|584272828|FG000|Overall Study|Refused Treatment|9|||
161789340|NCT00545233|584272829|FG001|Overall Study|Refused Treatment|7|||
161789341|NCT00545233|584272828|FG000|Overall Study|Failure to Return|4|||
161789342|NCT00545233|584272829|FG001|Overall Study|Failure to Return|6|||
161789343|NCT00545233|584272828|FG000|Overall Study|Insufficient response|14|||
161789344|NCT00545233|584272829|FG001|Overall Study|Insufficient response|15|||
161789345|NCT00545233|584272828|FG000|Overall Study|Physician Decision|2|||
161789346|NCT00545233|584272829|FG001|Overall Study|Physician Decision|1|||
161789347|NCT06371079|584272830|FG000|Overall Study|Missing data|88|||
161789348|NCT06371079|584272831|FG001|Overall Study|Missing data|247|||
161789349|NCT01238211|584272832|FG000|Overall Study|Continues active treatment|31|||
161789350|NCT01238211|584272832|FG000|Overall Study|Adverse Event|7|||
161789351|NCT01238211|584272832|FG000|Overall Study|Death|4|||
161789352|NCT01238211|584272832|FG000|Overall Study|Relapse/Progression|2|||
161789353|NCT01238211|584272832|FG000|Overall Study|Withdrawal by Subject|7|||
161789354|NCT01238211|584272832|FG000|Overall Study|Non-protocol treatment|4|||
161789355|NCT01238211|584272832|FG000|Overall Study|Investigator/Patient Decision|3|||
161789356|NCT00449930|584272833|FG000|Overall Study|Adverse Event|9|||
161789357|NCT00449930|584272834|FG001|Overall Study|Adverse Event|19|||
161789358|NCT00449930|584272833|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
161789359|NCT00449930|584272834|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
161789360|NCT00449930|584272833|FG000|Overall Study|Lack of Efficacy|10|||
161789361|NCT00449930|584272834|FG001|Overall Study|Lack of Efficacy|1|||
161789362|NCT00449930|584272833|FG000|Overall Study|Lost to Follow-up|9|||
161789363|NCT00449930|584272834|FG001|Overall Study|Lost to Follow-up|14|||
161440154|NCT01208207|583003342|FG006|Part II|Technical Problems|0|||
161440155|NCT04041414|583003345|FG000|Overall Study|Lost to Follow-up|1|||
161789364|NCT00449930|584272833|FG000|Overall Study|Physician Decision|1|||
161789365|NCT00449930|584272834|FG001|Overall Study|Physician Decision|2|||
161789366|NCT00449930|584272833|FG000|Overall Study|Protocol Violation|14|||
161789367|NCT00449930|584272834|FG001|Overall Study|Protocol Violation|15|||
161440156|NCT04041414|583003346|FG001|Overall Study|Lost to Follow-up|2|||
161440157|NCT00665652|583003347|FG000|Overall Study|Adverse Event|4|||
161789368|NCT00449930|584272833|FG000|Overall Study|Withdrawal by Subject|16|||
161789369|NCT00449930|584272834|FG001|Overall Study|Withdrawal by Subject|23|||
161440158|NCT00665652|583003347|FG000|Overall Study|Death|1|||
161440159|NCT00665652|583003347|FG000|Overall Study|No longer met inclusion criteria.|1|||
161789370|NCT00449930|584272833|FG000|Overall Study|Glycemic discontinuation criteria|1|||
161440160|NCT00830440|583003348|FG000|Overall Study|Protocol Violation|1|||
161440161|NCT00830440|583003349|FG001|Overall Study|Protocol Violation|0|||
161440162|NCT00830440|583003348|FG000|Overall Study|Withdrawal by Subject|1|||
161440163|NCT00830440|583003349|FG001|Overall Study|Withdrawal by Subject|0|||
161440164|NCT00830440|583003348|FG000|Overall Study|unsuccessful procedure|4|||
161440165|NCT00830440|583003349|FG001|Overall Study|unsuccessful procedure|0|||
161440166|NCT00830440|583003348|FG000|Overall Study|Adverse Event|2|||
161440167|NCT00830440|583003349|FG001|Overall Study|Adverse Event|0|||
161440168|NCT01656408|583003350|FG000|Overall Study|Adverse Event|0|||
161440169|NCT01656408|583003351|FG001|Overall Study|Adverse Event|0|||
161440170|NCT01656408|583003352|FG002|Overall Study|Adverse Event|1|||
161440171|NCT01656408|583003353|FG003|Overall Study|Adverse Event|0|||
161440172|NCT01656408|583003354|FG004|Overall Study|Adverse Event|0|||
161440173|NCT01656408|583003355|FG005|Overall Study|Adverse Event|1|||
161440174|NCT01656408|583003356|FG006|Overall Study|Adverse Event|1|||
161440175|NCT01656408|583003357|FG007|Overall Study|Adverse Event|0|||
161440176|NCT01656408|583003358|FG008|Overall Study|Adverse Event|1|||
161440177|NCT01656408|583003359|FG009|Overall Study|Adverse Event|0|||
161440178|NCT01656408|583003350|FG000|Overall Study|Physician Decision|1|||
161440179|NCT01656408|583003351|FG001|Overall Study|Physician Decision|0|||
161440180|NCT01656408|583003352|FG002|Overall Study|Physician Decision|1|||
161440181|NCT01656408|583003353|FG003|Overall Study|Physician Decision|0|||
161440182|NCT01656408|583003354|FG004|Overall Study|Physician Decision|1|||
161440183|NCT01656408|583003355|FG005|Overall Study|Physician Decision|1|||
161440184|NCT01656408|583003356|FG006|Overall Study|Physician Decision|0|||
161440185|NCT01656408|583003357|FG007|Overall Study|Physician Decision|1|||
161440186|NCT01656408|583003358|FG008|Overall Study|Physician Decision|1|||
161440187|NCT01656408|583003359|FG009|Overall Study|Physician Decision|3|||
161440188|NCT02420821|583003361|FG000|Overall Study|Lost to Follow-up|6|||
161440189|NCT02420821|583003362|FG001|Overall Study|Lost to Follow-up|6|||
161440190|NCT02420821|583003361|FG000|Overall Study|Non-compliance|0|||
161440191|NCT02420821|583003362|FG001|Overall Study|Non-compliance|2|||
161440192|NCT02420821|583003361|FG000|Overall Study|Physician Decision|6|||
161440193|NCT02420821|583003362|FG001|Overall Study|Physician Decision|2|||
161440194|NCT02420821|583003361|FG000|Overall Study|Withdrawal by Subject|32|||
161440195|NCT02420821|583003362|FG001|Overall Study|Withdrawal by Subject|25|||
161440196|NCT02420821|583003361|FG000|Overall Study|Death|270|||
161440197|NCT02420821|583003362|FG001|Overall Study|Death|263|||
161440198|NCT02420821|583003361|FG000|Overall Study|Study Terminated By Sponsor|145|||
161440199|NCT02420821|583003362|FG001|Overall Study|Study Terminated By Sponsor|149|||
161440200|NCT02420821|583003361|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
161440201|NCT02420821|583003362|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
161440202|NCT02420821|583003361|FG000|Overall Study|Adverse Event|0|||
161440203|NCT02420821|583003362|FG001|Overall Study|Adverse Event|1|||
161440204|NCT02420821|583003361|FG000|Overall Study|Protinuria|0|||
161440205|NCT02420821|583003362|FG001|Overall Study|Protinuria|1|||
161440206|NCT02420821|583003361|FG000|Overall Study|Progressive Disease|1|||
161440207|NCT02420821|583003362|FG001|Overall Study|Progressive Disease|1|||
161440208|NCT02420821|583003361|FG000|Overall Study|Disease Progression|0|||
161440209|NCT02420821|583003362|FG001|Overall Study|Disease Progression|1|||
161440210|NCT02420821|583003361|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
161440211|NCT02420821|583003362|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
161440212|NCT03987503|583003366|FG000|Overall Study|Lost to Follow-up|20|||
161440213|NCT03987503|583003366|FG000|Overall Study|Withdrawal by Subject|2|||
161440214|NCT00926237|583003367|FG000|Overall Study|Withdrawal by Subject|2|||
161440215|NCT00926237|583003368|FG001|Overall Study|Withdrawal by Subject|1|||
161440216|NCT03085797|583005051|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
161440217|NCT03085797|583005052|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
161440218|NCT03085797|583005051|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
161440219|NCT03085797|583005052|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
161440220|NCT03085797|583005051|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
161440221|NCT03085797|583005052|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
161440222|NCT05661409|583005057|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
161440223|NCT05661409|583005058|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
161440224|NCT05661409|583005059|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
161440225|NCT05661409|583005060|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
161440226|NCT05661409|583005061|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
161440227|NCT05661409|583005062|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
161440228|NCT05661409|583005057|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
161440229|NCT05661409|583005058|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
161440230|NCT05661409|583005059|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
161440231|NCT05661409|583005060|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
161440232|NCT05661409|583005061|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
161440233|NCT05661409|583005062|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
161440234|NCT05661409|583005057|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
161440235|NCT05661409|583005058|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
161440236|NCT05661409|583005059|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
161440237|NCT05661409|583005060|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
161440238|NCT05661409|583005061|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
161440239|NCT05661409|583005062|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
161440240|NCT05661409|583005057|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
161440241|NCT05661409|583005058|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
161440242|NCT05661409|583005059|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
161440243|NCT05661409|583005060|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
161440244|NCT05661409|583005061|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
161440245|NCT05661409|583005062|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
161440246|NCT05661409|583005057|FG000|Overall Study|Miscommu-nication about administration|0|||
161440247|NCT05661409|583005058|FG001|Overall Study|Miscommu-nication about administration|0|||
161440248|NCT05661409|583005059|FG002|Overall Study|Miscommu-nication about administration|0|||
161440249|NCT05661409|583005060|FG003|Overall Study|Miscommu-nication about administration|0|||
161440250|NCT05661409|583005061|FG004|Overall Study|Miscommu-nication about administration|0|||
161440251|NCT05661409|583005062|FG005|Overall Study|Miscommu-nication about administration|1|||
161440252|NCT04730271|583005065|FG000|Overall Study|Adverse Event|0|||
161440253|NCT04730271|583005066|FG001|Overall Study|Adverse Event|2|||
161440254|NCT04730271|583005065|FG000|Overall Study|Withdrawal by Subject|1|||
161440255|NCT04730271|583005066|FG001|Overall Study|Withdrawal by Subject|1|||
161440256|NCT04730271|583005065|FG000|Overall Study|Protocol Violation|7|||
161440257|NCT04730271|583005066|FG001|Overall Study|Protocol Violation|13|||
161440258|NCT04730271|583005065|FG000|Overall Study|Lost to Follow-up|3|||
161440259|NCT04730271|583005066|FG001|Overall Study|Lost to Follow-up|3|||
161440260|NCT04730271|583005065|FG000|Overall Study|Death|1|||
161440261|NCT04730271|583005066|FG001|Overall Study|Death|0|||
161440262|NCT00998296|583005067|FG000|Overall Study|Progressive disease|0|||
161440263|NCT00998296|583005068|FG001|Overall Study|Progressive disease|1|||
161440264|NCT00998296|583005069|FG002|Overall Study|Progressive disease|0|||
161440265|NCT00998296|583005070|FG003|Overall Study|Progressive disease|0|||
161440266|NCT00998296|583005071|FG004|Overall Study|Progressive disease|0|||
161440267|NCT00998296|583005072|FG005|Overall Study|Progressive disease|0|||
161440268|NCT00998296|583005073|FG006|Overall Study|Progressive disease|1|||
161440269|NCT00998296|583005074|FG007|Overall Study|Progressive disease|0|||
161440270|NCT00998296|583005075|FG008|Overall Study|Progressive disease|0|||
161440271|NCT00998296|583005076|FG009|Overall Study|Progressive disease|14|||
161440272|NCT00998296|583005077|FG010|Overall Study|Progressive disease|5|||
161440273|NCT00998296|583005067|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440274|NCT00998296|583005068|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440275|NCT00998296|583005069|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440276|NCT00998296|583005070|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440277|NCT00998296|583005071|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
161440278|NCT00998296|583005072|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440279|NCT00998296|583005073|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440280|NCT00998296|583005074|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
161440281|NCT00998296|583005075|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
161440282|NCT00998296|583005076|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440283|NCT00998296|583005077|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
161440284|NCT00998296|583005067|FG000|Overall Study|Other adverse event|0|||
161440285|NCT00998296|583005068|FG001|Overall Study|Other adverse event|0|||
161440286|NCT00998296|583005069|FG002|Overall Study|Other adverse event|0|||
161440287|NCT00998296|583005070|FG003|Overall Study|Other adverse event|0|||
161440288|NCT00998296|583005071|FG004|Overall Study|Other adverse event|1|||
161789371|NCT00449930|584272834|FG001|Overall Study|Glycemic discontinuation criteria|1|||
161789372|NCT00575328|584272836|FG000|Overall Study|Adverse Event|1|||
161789373|NCT00575328|584272837|FG001|Overall Study|Adverse Event|1|||
161789374|NCT00575328|584272836|FG000|Overall Study|Lost to Follow-up|2|||
161440289|NCT00998296|583005072|FG005|Overall Study|Other adverse event|0|||
161440290|NCT00998296|583005073|FG006|Overall Study|Other adverse event|0|||
161440291|NCT00998296|583005074|FG007|Overall Study|Other adverse event|0|||
161440292|NCT00998296|583005075|FG008|Overall Study|Other adverse event|0|||
161440293|NCT00998296|583005076|FG009|Overall Study|Other adverse event|1|||
161440294|NCT00998296|583005077|FG010|Overall Study|Other adverse event|2|||
161440295|NCT00998296|583005067|FG000|Overall Study|Refused to continue taking trial med.|0|||
161440296|NCT00998296|583005068|FG001|Overall Study|Refused to continue taking trial med.|0|||
161440297|NCT00998296|583005069|FG002|Overall Study|Refused to continue taking trial med.|0|||
161440298|NCT00998296|583005070|FG003|Overall Study|Refused to continue taking trial med.|0|||
161440299|NCT00998296|583005071|FG004|Overall Study|Refused to continue taking trial med.|0|||
161440300|NCT00998296|583005072|FG005|Overall Study|Refused to continue taking trial med.|0|||
161440301|NCT00998296|583005073|FG006|Overall Study|Refused to continue taking trial med.|0|||
161440302|NCT00998296|583005074|FG007|Overall Study|Refused to continue taking trial med.|0|||
161440303|NCT00998296|583005075|FG008|Overall Study|Refused to continue taking trial med.|0|||
161440304|NCT00998296|583005076|FG009|Overall Study|Refused to continue taking trial med.|2|||
161440305|NCT00998296|583005077|FG010|Overall Study|Refused to continue taking trial med.|0|||
161440306|NCT00998296|583005067|FG000|Overall Study|Reason other than those specified above|0|||
161440307|NCT00998296|583005068|FG001|Overall Study|Reason other than those specified above|0|||
161440308|NCT00998296|583005069|FG002|Overall Study|Reason other than those specified above|0|||
161440309|NCT00998296|583005070|FG003|Overall Study|Reason other than those specified above|0|||
161440310|NCT00998296|583005071|FG004|Overall Study|Reason other than those specified above|0|||
161440311|NCT00998296|583005072|FG005|Overall Study|Reason other than those specified above|0|||
161440312|NCT00998296|583005073|FG006|Overall Study|Reason other than those specified above|0|||
161440313|NCT00998296|583005074|FG007|Overall Study|Reason other than those specified above|0|||
161440314|NCT00998296|583005075|FG008|Overall Study|Reason other than those specified above|0|||
161440315|NCT00998296|583005076|FG009|Overall Study|Reason other than those specified above|1|||
161440316|NCT00998296|583005077|FG010|Overall Study|Reason other than those specified above|0|||
161440317|NCT04396639|583005078|FG000|Overall Study|Withdrawal by Subject|1|||
161440318|NCT04396639|583005078|FG000|Overall Study|Other|1|||
161440319|NCT01544335|583005081|FG000|Overall Study|Lost to Follow-up|27|||
161440320|NCT01544335|583005081|FG000|Overall Study|Death|4|||
161440321|NCT01544335|583005081|FG000|Overall Study|Disease progression|3|||
161440322|NCT01544335|583005081|FG000|Overall Study|Baseline Measurements not Available|19|||
161440323|NCT01532986|583005082|FG000|Overall Study|Death|9|||
161440324|NCT01532986|583005083|FG001|Overall Study|Death|9|||
161440325|NCT01532986|583005082|FG000|Overall Study|Withdrawal by Subject|7|||
161440326|NCT01532986|583005083|FG001|Overall Study|Withdrawal by Subject|10|||
161789375|NCT00575328|584272837|FG001|Overall Study|Lost to Follow-up|1|||
161440327|NCT01532986|583005082|FG000|Overall Study|Physician Decision|7|||
161440328|NCT01532986|583005083|FG001|Overall Study|Physician Decision|5|||
161440329|NCT00885170|583005086|FG000|Overall Study|Adverse Event|12|||
161440330|NCT00885170|583005087|FG001|Overall Study|Adverse Event|4|||
161440331|NCT00885170|583005086|FG000|Overall Study|Excessive bone loss|6|||
161440332|NCT00885170|583005087|FG001|Overall Study|Excessive bone loss|3|||
161440333|NCT00885170|583005086|FG000|Overall Study|Lost to Follow-up|2|||
161440334|NCT00885170|583005087|FG001|Overall Study|Lost to Follow-up|1|||
161440335|NCT00885170|583005086|FG000|Overall Study|Physician Decision|2|||
161440336|NCT00885170|583005087|FG001|Overall Study|Physician Decision|1|||
161440337|NCT00885170|583005086|FG000|Overall Study|Protocol Violation|3|||
161440338|NCT00885170|583005087|FG001|Overall Study|Protocol Violation|1|||
161440339|NCT00885170|583005086|FG000|Overall Study|Withdrawal by Subject|13|||
161440340|NCT00885170|583005087|FG001|Overall Study|Withdrawal by Subject|13|||
161440341|NCT03771664|583005088|FG000|Overall Study|Adverse Event|1|||
161440342|NCT03771664|583005089|FG001|Overall Study|Adverse Event|0|||
161440343|NCT03771664|583005088|FG000|Overall Study|Lost to Follow-up|1|||
161440344|NCT03771664|583005089|FG001|Overall Study|Lost to Follow-up|0|||
161440345|NCT03771664|583005088|FG000|Overall Study|Withdrawal by Participant|1|||
161440346|NCT03771664|583005089|FG001|Overall Study|Withdrawal by Participant|4|||
161440347|NCT03771664|583005088|FG000|Overall Study|Randomized but not Treated|0|||
161440348|NCT03771664|583005089|FG001|Overall Study|Randomized but not Treated|1|||
161440349|NCT02120898|583005090|FG000|Overall Study|Withdrawal by Subject|4|||
161440350|NCT02120898|583005091|FG001|Overall Study|Withdrawal by Subject|2|||
161440351|NCT02120898|583005092|FG002|Overall Study|Withdrawal by Subject|2|||
161440352|NCT02120898|583005090|FG000|Overall Study|Non-compliance with study drug|3|||
161440353|NCT02120898|583005091|FG001|Overall Study|Non-compliance with study drug|0|||
161440354|NCT02120898|583005092|FG002|Overall Study|Non-compliance with study drug|0|||
161440355|NCT02120898|583005090|FG000|Overall Study|Adverse Event|1|||
161440356|NCT02120898|583005091|FG001|Overall Study|Adverse Event|2|||
161440357|NCT02120898|583005092|FG002|Overall Study|Adverse Event|1|||
161440358|NCT02120898|583005090|FG000|Overall Study|Protocol Violation|1|||
161440359|NCT02120898|583005091|FG001|Overall Study|Protocol Violation|2|||
161440360|NCT02120898|583005092|FG002|Overall Study|Protocol Violation|0|||
161440361|NCT02120898|583005090|FG000|Overall Study|Lost to Follow-up|0|||
161440362|NCT02120898|583005091|FG001|Overall Study|Lost to Follow-up|0|||
161440363|NCT02120898|583005092|FG002|Overall Study|Lost to Follow-up|1|||
161440364|NCT00561925|583005093|FG000|14 Day Lead-In Period|Adverse Event|38|||
161440365|NCT00561925|583005094|FG001|14 Day Lead-In Period|Adverse Event|0|||
161440366|NCT00561925|583005095|FG002|14 Day Lead-In Period|Adverse Event|0|||
161440367|NCT00561925|583005096|FG003|14 Day Lead-In Period|Adverse Event|0|||
161440368|NCT00561925|583005097|FG004|14 Day Lead-In Period|Adverse Event|0|||
161440369|NCT00561925|583005093|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
161440370|NCT00561925|583005094|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
161440371|NCT00561925|583005095|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
161440372|NCT00561925|583005096|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
161440373|NCT00561925|583005097|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
161440374|NCT00561925|583005093|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
161440375|NCT00561925|583005094|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
161440376|NCT00561925|583005095|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
161440377|NCT00561925|583005096|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
161440378|NCT00561925|583005097|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
161440379|NCT00561925|583005093|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
161440380|NCT00561925|583005094|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
161440381|NCT00561925|583005095|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
161440382|NCT00561925|583005096|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
161440383|NCT00561925|583005097|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
161440384|NCT00561925|583005093|FG000|14 Day Lead-In Period|Other|5|||
161440385|NCT00561925|583005094|FG001|14 Day Lead-In Period|Other|0|||
161440386|NCT00561925|583005095|FG002|14 Day Lead-In Period|Other|0|||
161440387|NCT00561925|583005096|FG003|14 Day Lead-In Period|Other|0|||
161440388|NCT00561925|583005097|FG004|14 Day Lead-In Period|Other|0|||
161440389|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
161440390|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
161440391|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
161440392|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
161440393|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
161440394|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
161440395|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
161440396|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
161440397|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
161440398|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
161440399|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
161440400|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
161440401|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
161440402|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
161440403|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
161440404|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
161440405|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
161440406|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
161440407|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
161440408|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
161440409|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
161440410|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
161440411|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
161440412|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
161440413|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
161440414|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
161440415|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
161440416|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
161440417|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
161440418|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
161440419|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Death|0|||
161440420|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Death|6|||
161440421|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Death|3|||
161440422|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Death|0|||
161440423|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Death|0|||
161440424|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
161440425|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
161440426|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
161440427|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
161440428|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
161440429|NCT00561925|583005093|FG000|144-week Double-blind, Double-dummy|Other|0|||
161440430|NCT00561925|583005094|FG001|144-week Double-blind, Double-dummy|Other|8|||
161440431|NCT00561925|583005095|FG002|144-week Double-blind, Double-dummy|Other|11|||
161440432|NCT00561925|583005096|FG003|144-week Double-blind, Double-dummy|Other|0|||
161440433|NCT00561925|583005097|FG004|144-week Double-blind, Double-dummy|Other|0|||
161440434|NCT00561925|583005093|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
161440435|NCT00561925|583005094|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
161440436|NCT00561925|583005095|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
161440437|NCT00561925|583005096|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
161440438|NCT00561925|583005097|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
161440439|NCT00684021|583005098|FG000|Overall Study|MRI Contraindicated|1|||
161440440|NCT00684021|583005099|FG001|Overall Study|MRI Contraindicated|1|||
161440441|NCT00684021|583005100|FG002|Overall Study|MRI Contraindicated|1|||
161440442|NCT00684021|583005101|FG003|Overall Study|MRI Contraindicated|0|||
161440443|NCT00684021|583005098|FG000|Overall Study|MRI not performed|0|||
161440444|NCT00684021|583005099|FG001|Overall Study|MRI not performed|1|||
161440445|NCT00684021|583005100|FG002|Overall Study|MRI not performed|1|||
161440446|NCT00684021|583005101|FG003|Overall Study|MRI not performed|2|||
161440447|NCT00684021|583005098|FG000|Overall Study|Death|1|||
161440448|NCT00684021|583005099|FG001|Overall Study|Death|0|||
161440449|NCT00684021|583005100|FG002|Overall Study|Death|0|||
161440450|NCT00684021|583005101|FG003|Overall Study|Death|0|||
161440451|NCT02161016|583005105|FG000|Overall Study|withdrawn by IRB|1|||
161440452|NCT02556177|583005109|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
161440453|NCT02556177|583005110|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
161440454|NCT03818321|583005113|FG000|Overall Study|Withdrawal by Subject|1|||
161440455|NCT03818321|583005114|FG001|Overall Study|Withdrawal by Subject|2|||
161440456|NCT00275509|583005115|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
161440457|NCT00275509|583005116|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
161440458|NCT00380367|583005118|FG000|Overall Study|Lost to Follow-up|1|||
161440459|NCT00380367|583005118|FG000|Overall Study|Withdrawal by Subject|1|||
161440460|NCT01812252|583005126|FG000|Overall Study|Persistent Disease|1|||
161440461|NCT01812252|583005127|FG001|Overall Study|Persistent Disease|0|||
161440462|NCT01812252|583005126|FG000|Overall Study|Not transplanted|11|||
161440463|NCT01812252|583005127|FG001|Overall Study|Not transplanted|11|||
161440464|NCT01812252|583005126|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
161440465|NCT01812252|583005127|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
161440466|NCT01812252|583005126|FG000|Overall Study|Withdrawal by Subject|1|||
161440467|NCT01812252|583005127|FG001|Overall Study|Withdrawal by Subject|1|||
161440468|NCT01812252|583005126|FG000|Overall Study|Screen Failure|1|||
161440469|NCT01812252|583005127|FG001|Overall Study|Screen Failure|0|||
161440470|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
161440471|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
161440472|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
161440473|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161440474|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161440475|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161440476|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
161440477|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
161440478|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
161440479|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161440480|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161440481|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
161440482|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
161440483|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
161440484|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
161440485|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
161440486|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
161440487|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
161440488|NCT03739203|583005132|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
161440489|NCT03739203|583005133|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
161440490|NCT03739203|583005134|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
161440491|NCT03739203|583005132|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
161440492|NCT03739203|583005133|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
161440493|NCT03739203|583005134|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
161440494|NCT03739203|583005132|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
161440495|NCT03739203|583005133|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
161440496|NCT03739203|583005134|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
161440497|NCT03739203|583005132|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
161440498|NCT03739203|583005133|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
161440499|NCT03739203|583005134|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
161440500|NCT03739203|583005132|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
161440501|NCT03739203|583005133|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
161440502|NCT03739203|583005134|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
161440503|NCT03023397|583005135|FG000|Run-In|Failed screening allergen challenge|1|||
161440504|NCT03023397|583005136|FG001|Run-In|Failed screening allergen challenge|0|||
161440505|NCT03023397|583005137|FG002|Run-In|Failed screening allergen challenge|0|||
161440506|NCT03023397|583005135|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
161440507|NCT03023397|583005136|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
161440508|NCT03023397|583005137|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
161440509|NCT01519921|583005141|FG000|Overall Study|Adverse Event|10|||
161440510|NCT01519921|583005142|FG001|Overall Study|Adverse Event|9|||
161440511|NCT01519921|583005141|FG000|Overall Study|Lack of Efficacy|4|||
161440512|NCT01519921|583005142|FG001|Overall Study|Lack of Efficacy|3|||
161440513|NCT01519921|583005141|FG000|Overall Study|Withdrawal by Subject|3|||
161440514|NCT01519921|583005142|FG001|Overall Study|Withdrawal by Subject|0|||
161440515|NCT01519921|583005141|FG000|Overall Study|Lost to Follow-up|2|||
161440516|NCT01519921|583005142|FG001|Overall Study|Lost to Follow-up|1|||
161440517|NCT01519921|583005141|FG000|Overall Study|Treatment refusal|2|||
161440518|NCT01519921|583005142|FG001|Overall Study|Treatment refusal|1|||
161440519|NCT01519921|583005141|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
161440520|NCT01519921|583005142|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
161440521|NCT00363480|583005143|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
161440522|NCT00363480|583005143|FG000|Overall Study|Adverse Event|4|||
161440523|NCT00363480|583005143|FG000|Overall Study|Lost to Follow-up|5|||
161440524|NCT00363480|583005143|FG000|Overall Study|Withdrawal by Subject|5|||
161440525|NCT00363480|583005143|FG000|Overall Study|Non-compliance of subject|1|||
161440526|NCT00363480|583005143|FG000|Overall Study|Participant discontinued on its own|1|||
161440527|NCT03133793|583005148|FG000|Overall Study|Withdrawal by Subject|0|||
161440528|NCT03133793|583005149|FG001|Overall Study|Withdrawal by Subject|4|||
161440529|NCT03133793|583005150|FG002|Overall Study|Withdrawal by Subject|2|||
161440530|NCT03133793|583005151|FG003|Overall Study|Withdrawal by Subject|4|||
161440531|NCT03133793|583005148|FG000|Overall Study|Lost to Follow-up|1|||
161440532|NCT03133793|583005149|FG001|Overall Study|Lost to Follow-up|0|||
161440533|NCT03133793|583005150|FG002|Overall Study|Lost to Follow-up|2|||
161440534|NCT03133793|583005151|FG003|Overall Study|Lost to Follow-up|0|||
161440535|NCT03133793|583005148|FG000|Overall Study|Death|0|||
161440536|NCT03133793|583005149|FG001|Overall Study|Death|0|||
161440537|NCT03133793|583005150|FG002|Overall Study|Death|0|||
161440538|NCT03133793|583005151|FG003|Overall Study|Death|1|||
161440539|NCT03486834|583005152|FG000|Overall Study|Withdrawal by Subject|46|||
161440540|NCT03486834|583005153|FG001|Overall Study|Withdrawal by Subject|46|||
161440541|NCT03486834|583005154|FG002|Overall Study|Withdrawal by Subject|52|||
161440542|NCT03486834|583005152|FG000|Overall Study|Adverse Event|8|||
161440543|NCT03486834|583005153|FG001|Overall Study|Adverse Event|7|||
161440544|NCT03486834|583005154|FG002|Overall Study|Adverse Event|0|||
161440545|NCT03486834|583005152|FG000|Overall Study|Lost to Follow-up|41|||
161440546|NCT03486834|583005153|FG001|Overall Study|Lost to Follow-up|24|||
161440547|NCT03486834|583005154|FG002|Overall Study|Lost to Follow-up|39|||
161440548|NCT03486834|583005152|FG000|Overall Study|Non-compliance with Study Drug|2|||
161440549|NCT03486834|583005153|FG001|Overall Study|Non-compliance with Study Drug|2|||
161440550|NCT03486834|583005154|FG002|Overall Study|Non-compliance with Study Drug|0|||
161440551|NCT03486834|583005152|FG000|Overall Study|Physician Decision|5|||
161440552|NCT03486834|583005153|FG001|Overall Study|Physician Decision|2|||
161440553|NCT03486834|583005154|FG002|Overall Study|Physician Decision|3|||
161440554|NCT03486834|583005152|FG000|Overall Study|Pregnancy|10|||
161440555|NCT03486834|583005153|FG001|Overall Study|Pregnancy|12|||
161440556|NCT03486834|583005154|FG002|Overall Study|Pregnancy|12|||
161440557|NCT03486834|583005152|FG000|Overall Study|Protocol Deviation|2|||
161440558|NCT03486834|583005153|FG001|Overall Study|Protocol Deviation|3|||
161440559|NCT03486834|583005154|FG002|Overall Study|Protocol Deviation|3|||
161440560|NCT03486834|583005152|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161440561|NCT03486834|583005153|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161440562|NCT03486834|583005154|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161440563|NCT03486834|583005152|FG000|Overall Study|Randomized but not treated|4|||
161440564|NCT03486834|583005153|FG001|Overall Study|Randomized but not treated|4|||
161440565|NCT03486834|583005154|FG002|Overall Study|Randomized but not treated|1|||
161440566|NCT00888940|583005156|FG000|Overall Study|Adverse Event|12|||
161440567|NCT00888940|583005157|FG001|Overall Study|Adverse Event|3|||
161440568|NCT00888940|583005156|FG000|Overall Study|Lost to Follow-up|5|||
161440569|NCT00888940|583005157|FG001|Overall Study|Lost to Follow-up|5|||
161440570|NCT00888940|583005156|FG000|Overall Study|Randomized Not Treated|11|||
161440571|NCT00888940|583005157|FG001|Overall Study|Randomized Not Treated|13|||
161440572|NCT00432172|583005158|FG000|Overall Study|Physician Decision|0|||
161440573|NCT00432172|583005159|FG001|Overall Study|Physician Decision|0|||
161440574|NCT00432172|583005160|FG002|Overall Study|Physician Decision|2|||
161440575|NCT00432172|583005161|FG003|Overall Study|Physician Decision|0|||
161440576|NCT00432172|583005158|FG000|Overall Study|Adverse Event|4|||
161440577|NCT00432172|583005159|FG001|Overall Study|Adverse Event|2|||
161440578|NCT00432172|583005160|FG002|Overall Study|Adverse Event|4|||
161440579|NCT00432172|583005161|FG003|Overall Study|Adverse Event|3|||
161440580|NCT00432172|583005158|FG000|Overall Study|Disease progression|0|||
161440581|NCT00432172|583005159|FG001|Overall Study|Disease progression|2|||
161440582|NCT00432172|583005160|FG002|Overall Study|Disease progression|5|||
161440583|NCT00432172|583005161|FG003|Overall Study|Disease progression|1|||
161440584|NCT00432172|583005158|FG000|Overall Study|Withdrawal by Subject|0|||
161440585|NCT00432172|583005159|FG001|Overall Study|Withdrawal by Subject|1|||
161440586|NCT00432172|583005160|FG002|Overall Study|Withdrawal by Subject|0|||
161440587|NCT00432172|583005161|FG003|Overall Study|Withdrawal by Subject|2|||
161440588|NCT00432172|583005158|FG000|Overall Study|No treatment received|2|||
161440589|NCT00432172|583005159|FG001|Overall Study|No treatment received|2|||
161440590|NCT00432172|583005160|FG002|Overall Study|No treatment received|0|||
161440591|NCT00432172|583005161|FG003|Overall Study|No treatment received|1|||
161440592|NCT02141204|583005162|FG000|Overall Study|Lost to Follow-up|2|||
161440593|NCT02141204|583005163|FG001|Overall Study|Lost to Follow-up|1|||
161440594|NCT02141204|583005162|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
161440595|NCT02141204|583005163|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
161440596|NCT02141204|583005162|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
161440597|NCT02141204|583005163|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
161440598|NCT02141204|583005162|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
161440599|NCT02141204|583005163|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
161440600|NCT00515619|583005166|FG000|Overall Study|Adverse Event|34|||
161440601|NCT00515619|583005166|FG000|Overall Study|Lack of Efficacy|92|||
161440602|NCT00515619|583005166|FG000|Overall Study|Withdrawal by Subject|66|||
161440603|NCT00515619|583005166|FG000|Overall Study|Protocol Violation|3|||
161440604|NCT00515619|583005166|FG000|Overall Study|Lost to Follow-up|4|||
161440605|NCT00515619|583005166|FG000|Overall Study|Unsatisfactory compliance|6|||
161440606|NCT00515619|583005166|FG000|Overall Study|Other: Site discontinuing trials|2|||
161440607|NCT00515619|583005166|FG000|Overall Study|Other: Subject cannot attend visits|2|||
161440608|NCT00515619|583005166|FG000|Overall Study|Other: Subject required surgery|1|||
161440609|NCT00515619|583005166|FG000|Overall Study|Other: Subject moved to another country|1|||
161440610|NCT00515619|583005166|FG000|Overall Study|Other: Investigator decision|1|||
161440611|NCT00515619|583005166|FG000|Overall Study|Other: Subject became pregnant|1|||
161440612|NCT00515619|583005166|FG000|Overall Study|Other: Request from sponsor|1|||
161440613|NCT00515619|583005166|FG000|Overall Study|Other: Drug available on license|1|||
161440614|NCT00515619|583005166|FG000|Overall Study|Other: Subject interested in other AED|1|||
161440615|NCT02379091|583005167|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161440616|NCT02379091|583005168|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
161440617|NCT02379091|583005169|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161440618|NCT02379091|583005170|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161440619|NCT02379091|583005167|FG000|Overall Study|Principal Investigator Discretion|0|||
161440620|NCT02379091|583005168|FG001|Overall Study|Principal Investigator Discretion|1|||
161440621|NCT02379091|583005169|FG002|Overall Study|Principal Investigator Discretion|0|||
161898640|NCT02915159|584677859|FG001|Overall Study|Participant no longer meets criteria|0|||
161898641|NCT02915159|584677858|FG000|Overall Study|poor/non-compliance|1|||
161898642|NCT02915159|584677859|FG001|Overall Study|poor/non-compliance|0|||
161898643|NCT02915159|584677858|FG000|Overall Study|Participant withdrew consent|5|||
161898644|NCT02915159|584677859|FG001|Overall Study|Participant withdrew consent|1|||
161898645|NCT02915159|584677858|FG000|Overall Study|Request to discontinue treatment|1|||
161898646|NCT02915159|584677859|FG001|Overall Study|Request to discontinue treatment|2|||
161898647|NCT02915159|584677858|FG000|Overall Study|Adverse Event|2|||
161898648|NCT02915159|584677859|FG001|Overall Study|Adverse Event|2|||
161898649|NCT02915159|584677858|FG000|Overall Study|Lack of Efficacy|0|||
161898650|NCT02915159|584677859|FG001|Overall Study|Lack of Efficacy|3|||
161898651|NCT00856999|584677860|FG000|Overall Study|Withdrawal by Subject|5|||
161898652|NCT00003483|584677861|FG000|Overall Study|Not evaluable|1|||
161898653|NCT01308463|584677862|FG000|Overall Study|Study Discontinued|23|||
161898654|NCT01308463|584677862|FG000|Overall Study|Death|4|||
161898655|NCT01308463|584677862|FG000|Overall Study|Revision|2|||
161898656|NCT00103662|584677863|FG000|Overall Study|Entered Rescue Procedure|0|||
161898657|NCT00103662|584677864|FG001|Overall Study|Entered Rescue Procedure|7|||
161898658|NCT00103662|584677863|FG000|Overall Study|Death|7|||
161898659|NCT00103662|584677864|FG001|Overall Study|Death|7|||
161898660|NCT00103662|584677863|FG000|Overall Study|Elective Withdrawal|5|||
161898661|NCT00103662|584677864|FG001|Overall Study|Elective Withdrawal|5|||
161898662|NCT00103662|584677863|FG000|Overall Study|Lost to Follow-up|0|||
161898663|NCT00103662|584677864|FG001|Overall Study|Lost to Follow-up|1|||
161898664|NCT00103662|584677863|FG000|Overall Study|Other|6|||
161898665|NCT00103662|584677864|FG001|Overall Study|Other|9|||
161898666|NCT00103662|584677863|FG000|Overall Study|Failed mobilization|0|||
161898667|NCT00103662|584677864|FG001|Overall Study|Failed mobilization|4|||
161898668|NCT00103662|584677863|FG000|Overall Study|Intercurrent illness|1|||
161898669|NCT00103662|584677864|FG001|Overall Study|Intercurrent illness|0|||
161898670|NCT03373760|584677867|FG000|Overall Study|Adverse Event|8|||
161898671|NCT03373760|584677867|FG000|Overall Study|Disease Progression|46|||
161898672|NCT03373760|584677867|FG000|Overall Study|Death|4|||
161898673|NCT00872521|584677878|FG000|Completed PAD Induction|Patient choice|0|||
161898674|NCT00872521|584677879|FG001|Completed PAD Induction|Patient choice|1|||
161898675|NCT00872521|584677880|FG002|Completed PAD Induction|Patient choice|0|||
161898676|NCT00872521|584677878|FG000|Completed PAD Induction|Disease progression|0|||
161898677|NCT00872521|584677879|FG001|Completed PAD Induction|Disease progression|2|||
161898678|NCT00872521|584677880|FG002|Completed PAD Induction|Disease progression|0|||
161898679|NCT00872521|584677878|FG000|Completed PAD Induction|Adverse Event|4|||
161898680|NCT00872521|584677879|FG001|Completed PAD Induction|Adverse Event|0|||
161898681|NCT00872521|584677880|FG002|Completed PAD Induction|Adverse Event|0|||
161898682|NCT00872521|584677878|FG000|Completed PAD Induction|Death|1|||
161898683|NCT00872521|584677879|FG001|Completed PAD Induction|Death|1|||
161898684|NCT00872521|584677880|FG002|Completed PAD Induction|Death|0|||
161898685|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Other|1|||
161898686|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Other|2|||
161898687|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Other|0|||
161898688|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Patient choice|0|||
161898689|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Patient choice|1|||
161898690|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Patient choice|0|||
161898691|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
161898692|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
161898693|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
161440622|NCT02379091|583005170|FG003|Overall Study|Principal Investigator Discretion|0|||
161440623|NCT02379091|583005167|FG000|Overall Study|Lost to Follow-up|0|||
161440624|NCT02379091|583005168|FG001|Overall Study|Lost to Follow-up|0|||
161440625|NCT02379091|583005169|FG002|Overall Study|Lost to Follow-up|0|||
161440626|NCT02379091|583005170|FG003|Overall Study|Lost to Follow-up|1|||
161440627|NCT02379091|583005167|FG000|Overall Study|Voluntary Withdrawal|2|||
161440628|NCT02379091|583005168|FG001|Overall Study|Voluntary Withdrawal|5|||
161440629|NCT02379091|583005169|FG002|Overall Study|Voluntary Withdrawal|2|||
161440630|NCT02379091|583005170|FG003|Overall Study|Voluntary Withdrawal|4|||
161440631|NCT02379091|583005167|FG000|Overall Study|Study Termination|7|||
161440632|NCT02379091|583005168|FG001|Overall Study|Study Termination|2|||
161440633|NCT02379091|583005169|FG002|Overall Study|Study Termination|5|||
161440634|NCT02379091|583005170|FG003|Overall Study|Study Termination|8|||
161440635|NCT02379091|583005167|FG000|Overall Study|Lack of Efficacy|3|||
161440636|NCT02379091|583005168|FG001|Overall Study|Lack of Efficacy|0|||
161440637|NCT02379091|583005169|FG002|Overall Study|Lack of Efficacy|0|||
161440638|NCT02379091|583005170|FG003|Overall Study|Lack of Efficacy|0|||
161440639|NCT03326713|583005172|FG000|Overall Study|Death|2|||
161440640|NCT03326713|583005173|FG001|Overall Study|Death|1|||
161440641|NCT03326713|583005174|FG002|Overall Study|Death|0|||
161440642|NCT03326713|583005172|FG000|Overall Study|Lost to Follow-up|20|||
161440643|NCT03326713|583005173|FG001|Overall Study|Lost to Follow-up|21|||
161440644|NCT03326713|583005174|FG002|Overall Study|Lost to Follow-up|33|||
161440645|NCT03326713|583005172|FG000|Overall Study|Withdrawal by Subject|1|||
161440646|NCT03326713|583005173|FG001|Overall Study|Withdrawal by Subject|2|||
161440647|NCT03326713|583005174|FG002|Overall Study|Withdrawal by Subject|11|||
161440648|NCT03326713|583005172|FG000|Overall Study|Found Ineligible|11|||
161440649|NCT03326713|583005173|FG001|Overall Study|Found Ineligible|11|||
161440650|NCT03326713|583005174|FG002|Overall Study|Found Ineligible|8|||
161440651|NCT00771758|583005175|FG000|Overall Study|Adverse Event|2|||
161440652|NCT00771758|583005176|FG001|Overall Study|Adverse Event|8|||
161440653|NCT00771758|583005177|FG002|Overall Study|Adverse Event|1|||
161440654|NCT00771758|583005175|FG000|Overall Study|Lack of Efficacy|0|||
161440655|NCT00771758|583005176|FG001|Overall Study|Lack of Efficacy|2|||
161440656|NCT00771758|583005177|FG002|Overall Study|Lack of Efficacy|1|||
161440657|NCT00771758|583005175|FG000|Overall Study|Lost to Follow-up|1|||
161440658|NCT00771758|583005176|FG001|Overall Study|Lost to Follow-up|0|||
161440659|NCT00771758|583005177|FG002|Overall Study|Lost to Follow-up|0|||
161440660|NCT00771758|583005175|FG000|Overall Study|Protocol Violation|1|||
161440661|NCT00771758|583005176|FG001|Overall Study|Protocol Violation|0|||
161440662|NCT00771758|583005177|FG002|Overall Study|Protocol Violation|0|||
161440663|NCT00771758|583005175|FG000|Overall Study|Withdrawal by Subject|1|||
161440664|NCT00771758|583005176|FG001|Overall Study|Withdrawal by Subject|0|||
161440665|NCT00771758|583005177|FG002|Overall Study|Withdrawal by Subject|0|||
161440666|NCT00771758|583005175|FG000|Overall Study|Other|3|||
161440667|NCT00771758|583005176|FG001|Overall Study|Other|2|||
161440668|NCT00771758|583005177|FG002|Overall Study|Other|0|||
161440669|NCT00935584|583005178|FG000|Overall Study|Withdrawal by Subject|9|||
161440670|NCT00935584|583005179|FG001|Overall Study|Withdrawal by Subject|0|||
161440671|NCT00935584|583005178|FG000|Overall Study|Death|3|||
161440672|NCT00935584|583005179|FG001|Overall Study|Death|0|||
161440673|NCT00935584|583005178|FG000|Overall Study|Lost to Follow-up|8|||
161440674|NCT00935584|583005179|FG001|Overall Study|Lost to Follow-up|0|||
161440675|NCT00935584|583005178|FG000|Overall Study|No show|9|||
161440676|NCT00935584|583005179|FG001|Overall Study|No show|0|||
161440677|NCT00935584|583005178|FG000|Overall Study|Relocated|3|||
161440678|NCT00935584|583005179|FG001|Overall Study|Relocated|0|||
161440679|NCT00935584|583005178|FG000|Overall Study|Patient changed provider|3|||
161440680|NCT00935584|583005179|FG001|Overall Study|Patient changed provider|0|||
161440681|NCT00935584|583005178|FG000|Overall Study|Provider dropped out of study|14|||
161440682|NCT00935584|583005179|FG001|Overall Study|Provider dropped out of study|4|||
161440683|NCT00687193|583005180|FG000|Overall Study|Adverse Event|0|||
161440684|NCT00687193|583005181|FG001|Overall Study|Adverse Event|1|||
161440685|NCT00687193|583005182|FG002|Overall Study|Adverse Event|2|||
161440686|NCT00687193|583005183|FG003|Overall Study|Adverse Event|3|||
161440687|NCT00687193|583005184|FG004|Overall Study|Adverse Event|0|||
161440688|NCT00687193|583005185|FG005|Overall Study|Adverse Event|2|||
161440689|NCT00687193|583005180|FG000|Overall Study|Lack of Efficacy|1|||
161440690|NCT00687193|583005181|FG001|Overall Study|Lack of Efficacy|1|||
161440691|NCT00687193|583005182|FG002|Overall Study|Lack of Efficacy|0|||
161440692|NCT00687193|583005183|FG003|Overall Study|Lack of Efficacy|0|||
161789376|NCT02868281|584272838|FG000|Overall Study|Adverse Event|2|||
161440693|NCT00687193|583005184|FG004|Overall Study|Lack of Efficacy|0|||
161440694|NCT00687193|583005185|FG005|Overall Study|Lack of Efficacy|2|||
161440695|NCT00687193|583005180|FG000|Overall Study|Protocol Violation|1|||
161440696|NCT00687193|583005181|FG001|Overall Study|Protocol Violation|2|||
161440697|NCT00687193|583005182|FG002|Overall Study|Protocol Violation|0|||
161440698|NCT00687193|583005183|FG003|Overall Study|Protocol Violation|1|||
161440699|NCT00687193|583005184|FG004|Overall Study|Protocol Violation|2|||
161440700|NCT00687193|583005185|FG005|Overall Study|Protocol Violation|0|||
161789377|NCT02868281|584272839|FG001|Overall Study|Adverse Event|2|||
161440701|NCT02129699|583005186|FG000|Overall Study|Did not start treatment|3|||
161440702|NCT02129699|583005187|FG001|Overall Study|Did not start treatment|2|||
161440703|NCT01394016|583005188|FG000|Overall Study|Progressive Disease|2|||
161440704|NCT01394016|583005189|FG001|Overall Study|Progressive Disease|0|||
161440705|NCT01394016|583005190|FG002|Overall Study|Progressive Disease|0|||
161440706|NCT01394016|583005191|FG003|Overall Study|Progressive Disease|0|||
161440707|NCT01394016|583005192|FG004|Overall Study|Progressive Disease|0|||
161440708|NCT01394016|583005193|FG005|Overall Study|Progressive Disease|0|||
161440709|NCT01394016|583005194|FG006|Overall Study|Progressive Disease|0|||
161440710|NCT01394016|583005195|FG007|Overall Study|Progressive Disease|0|||
161440711|NCT01394016|583005196|FG008|Overall Study|Progressive Disease|0|||
161440712|NCT01394016|583005197|FG009|Overall Study|Progressive Disease|0|||
161440713|NCT01394016|583005198|FG010|Overall Study|Progressive Disease|0|||
161440714|NCT01394016|583005199|FG011|Overall Study|Progressive Disease|0|||
161440715|NCT01394016|583005200|FG012|Overall Study|Progressive Disease|0|||
161440716|NCT01394016|583005201|FG013|Overall Study|Progressive Disease|0|||
161440717|NCT01394016|583005202|FG014|Overall Study|Progressive Disease|0|||
161440718|NCT01394016|583005203|FG015|Overall Study|Progressive Disease|0|||
161440719|NCT01394016|583005204|FG016|Overall Study|Progressive Disease|0|||
161440720|NCT01394016|583005205|FG017|Overall Study|Progressive Disease|0|||
161440721|NCT01394016|583005206|FG018|Overall Study|Progressive Disease|0|||
161440722|NCT01394016|583005188|FG000|Overall Study|Withdrawal by Subject|0|||
161440723|NCT01394016|583005189|FG001|Overall Study|Withdrawal by Subject|0|||
161440724|NCT01394016|583005190|FG002|Overall Study|Withdrawal by Subject|0|||
161440725|NCT01394016|583005191|FG003|Overall Study|Withdrawal by Subject|0|||
161440726|NCT01394016|583005192|FG004|Overall Study|Withdrawal by Subject|0|||
161440727|NCT01394016|583005193|FG005|Overall Study|Withdrawal by Subject|0|||
161440728|NCT01394016|583005194|FG006|Overall Study|Withdrawal by Subject|0|||
161440729|NCT01394016|583005195|FG007|Overall Study|Withdrawal by Subject|1|||
161440730|NCT01394016|583005196|FG008|Overall Study|Withdrawal by Subject|1|||
161440731|NCT01394016|583005197|FG009|Overall Study|Withdrawal by Subject|1|||
161440732|NCT01394016|583005198|FG010|Overall Study|Withdrawal by Subject|4|||
161440733|NCT01394016|583005199|FG011|Overall Study|Withdrawal by Subject|0|||
161440734|NCT01394016|583005200|FG012|Overall Study|Withdrawal by Subject|0|||
161440735|NCT01394016|583005201|FG013|Overall Study|Withdrawal by Subject|3|||
161440736|NCT01394016|583005202|FG014|Overall Study|Withdrawal by Subject|1|||
161440737|NCT01394016|583005203|FG015|Overall Study|Withdrawal by Subject|3|||
161440738|NCT01394016|583005204|FG016|Overall Study|Withdrawal by Subject|1|||
161440739|NCT01394016|583005205|FG017|Overall Study|Withdrawal by Subject|1|||
161440740|NCT01394016|583005206|FG018|Overall Study|Withdrawal by Subject|2|||
161440741|NCT01394016|583005188|FG000|Overall Study|Adverse Event|0|||
161440742|NCT01394016|583005189|FG001|Overall Study|Adverse Event|0|||
161440743|NCT01394016|583005190|FG002|Overall Study|Adverse Event|0|||
161440744|NCT01394016|583005191|FG003|Overall Study|Adverse Event|0|||
161440745|NCT01394016|583005192|FG004|Overall Study|Adverse Event|0|||
161440746|NCT01394016|583005193|FG005|Overall Study|Adverse Event|0|||
161440747|NCT01394016|583005194|FG006|Overall Study|Adverse Event|0|||
161440748|NCT01394016|583005195|FG007|Overall Study|Adverse Event|0|||
161440749|NCT01394016|583005196|FG008|Overall Study|Adverse Event|0|||
161440750|NCT01394016|583005197|FG009|Overall Study|Adverse Event|1|||
161440751|NCT01394016|583005198|FG010|Overall Study|Adverse Event|0|||
161440752|NCT01394016|583005199|FG011|Overall Study|Adverse Event|0|||
161440753|NCT01394016|583005200|FG012|Overall Study|Adverse Event|0|||
161440754|NCT01394016|583005201|FG013|Overall Study|Adverse Event|0|||
161440755|NCT01394016|583005202|FG014|Overall Study|Adverse Event|0|||
161440756|NCT01394016|583005203|FG015|Overall Study|Adverse Event|0|||
161440757|NCT01394016|583005204|FG016|Overall Study|Adverse Event|1|||
161440758|NCT01394016|583005205|FG017|Overall Study|Adverse Event|1|||
161440759|NCT01394016|583005206|FG018|Overall Study|Adverse Event|0|||
161440760|NCT01394016|583005188|FG000|Overall Study|Sponsor Decision|0|||
161440761|NCT01394016|583005189|FG001|Overall Study|Sponsor Decision|0|||
161440762|NCT01394016|583005190|FG002|Overall Study|Sponsor Decision|0|||
161440763|NCT01394016|583005191|FG003|Overall Study|Sponsor Decision|0|||
161440764|NCT01394016|583005192|FG004|Overall Study|Sponsor Decision|0|||
161440765|NCT01394016|583005193|FG005|Overall Study|Sponsor Decision|0|||
161789378|NCT02868281|584272838|FG000|Overall Study|Protocol Violation|13|||
161440766|NCT01394016|583005194|FG006|Overall Study|Sponsor Decision|0|||
161440767|NCT01394016|583005195|FG007|Overall Study|Sponsor Decision|0|||
161440768|NCT01394016|583005196|FG008|Overall Study|Sponsor Decision|0|||
161440769|NCT01394016|583005197|FG009|Overall Study|Sponsor Decision|0|||
161440770|NCT01394016|583005198|FG010|Overall Study|Sponsor Decision|0|||
161440771|NCT01394016|583005199|FG011|Overall Study|Sponsor Decision|0|||
161440772|NCT01394016|583005200|FG012|Overall Study|Sponsor Decision|1|||
161440773|NCT01394016|583005201|FG013|Overall Study|Sponsor Decision|0|||
161440774|NCT01394016|583005202|FG014|Overall Study|Sponsor Decision|0|||
161440775|NCT01394016|583005203|FG015|Overall Study|Sponsor Decision|0|||
161440776|NCT01394016|583005204|FG016|Overall Study|Sponsor Decision|0|||
161440777|NCT01394016|583005205|FG017|Overall Study|Sponsor Decision|0|||
161440778|NCT01394016|583005206|FG018|Overall Study|Sponsor Decision|0|||
161440779|NCT01394016|583005188|FG000|Overall Study|Lost to Follow-up|0|||
161440780|NCT01394016|583005189|FG001|Overall Study|Lost to Follow-up|0|||
161440781|NCT01394016|583005190|FG002|Overall Study|Lost to Follow-up|0|||
161440782|NCT01394016|583005191|FG003|Overall Study|Lost to Follow-up|0|||
161440783|NCT01394016|583005192|FG004|Overall Study|Lost to Follow-up|0|||
161440784|NCT01394016|583005193|FG005|Overall Study|Lost to Follow-up|0|||
161440785|NCT01394016|583005194|FG006|Overall Study|Lost to Follow-up|0|||
161440786|NCT01394016|583005195|FG007|Overall Study|Lost to Follow-up|0|||
161440787|NCT01394016|583005196|FG008|Overall Study|Lost to Follow-up|0|||
161440788|NCT01394016|583005197|FG009|Overall Study|Lost to Follow-up|0|||
161440789|NCT01394016|583005198|FG010|Overall Study|Lost to Follow-up|0|||
161440790|NCT01394016|583005199|FG011|Overall Study|Lost to Follow-up|0|||
161440791|NCT01394016|583005200|FG012|Overall Study|Lost to Follow-up|0|||
161440792|NCT01394016|583005201|FG013|Overall Study|Lost to Follow-up|0|||
161440793|NCT01394016|583005202|FG014|Overall Study|Lost to Follow-up|0|||
161440794|NCT01394016|583005203|FG015|Overall Study|Lost to Follow-up|0|||
161440795|NCT01394016|583005204|FG016|Overall Study|Lost to Follow-up|0|||
161440796|NCT01394016|583005205|FG017|Overall Study|Lost to Follow-up|0|||
161440797|NCT01394016|583005206|FG018|Overall Study|Lost to Follow-up|1|||
161440798|NCT03534804|583005207|FG000|Overall Study|Withdrawal by Subject|1|||
161440799|NCT04161157|583005211|FG000|Overall Study|Lost to Follow-up|4|||
161440800|NCT04161157|583005211|FG000|Overall Study|Death|3|||
161440801|NCT04161157|583005211|FG000|Overall Study|Ineligible|2|||
161440802|NCT04161157|583005211|FG000|Overall Study|Withdrawal by Subject|4|||
161440803|NCT05786651|583005215|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
161440804|NCT02331277|583006381|FG000|Overall Study|Withdrawal by Subject|1|||
161440805|NCT02331277|583006382|FG001|Overall Study|Withdrawal by Subject|0|||
161440806|NCT01071798|583006384|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
161440807|NCT01071798|583006384|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
161440808|NCT01071798|583006384|FG000|Participants Who Received One Cycle|Patient requirement|20|||
161440809|NCT01071798|583006384|FG000|Participants Who Received One Cycle|Death|5|||
161440810|NCT01071798|583006384|FG000|Participants Who Received One Cycle|Change of therapy|6|||
161440811|NCT01071798|583006384|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
161440812|NCT01071798|583006384|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
161440813|NCT01071798|583006384|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
161440814|NCT01071798|583006384|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
161440815|NCT01071798|583006384|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
161440816|NCT02873702|583006388|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
161440817|NCT02873702|583006389|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
161440818|NCT02873702|583006390|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
161440819|NCT02873702|583006391|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
161440820|NCT02873702|583006388|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
161440821|NCT02873702|583006389|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
161440822|NCT02873702|583006390|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
161440823|NCT02873702|583006391|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
161440824|NCT02873702|583006388|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
161440825|NCT02873702|583006389|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
161440826|NCT02873702|583006390|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
161440827|NCT02873702|583006391|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
161440828|NCT02873702|583006388|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
161440829|NCT02873702|583006389|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
161440830|NCT02873702|583006390|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
161440831|NCT02873702|583006391|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
161440832|NCT02873702|583006388|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
161440833|NCT02873702|583006389|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
161440834|NCT02873702|583006390|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
161440835|NCT02873702|583006391|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
161440836|NCT01177397|583006392|FG000|Overall Study|Protocol Violation|0|||
161440837|NCT01177397|583006393|FG001|Overall Study|Protocol Violation|0|||
161440838|NCT01177397|583006394|FG002|Overall Study|Protocol Violation|0|||
161440839|NCT01177397|583006395|FG003|Overall Study|Protocol Violation|0|||
161440840|NCT01177397|583006396|FG004|Overall Study|Protocol Violation|0|||
161440841|NCT01177397|583006397|FG005|Overall Study|Protocol Violation|1|||
161440842|NCT01177397|583006398|FG006|Overall Study|Protocol Violation|0|||
161440843|NCT01177397|583006399|FG007|Overall Study|Protocol Violation|0|||
161440844|NCT01177397|583006400|FG008|Overall Study|Protocol Violation|0|||
161440845|NCT01177397|583006401|FG009|Overall Study|Protocol Violation|0|||
161440846|NCT01177397|583006402|FG010|Overall Study|Protocol Violation|0|||
161440847|NCT01177397|583006403|FG011|Overall Study|Protocol Violation|0|||
161440848|NCT01177397|583006392|FG000|Overall Study|Lost to Follow-up|0|||
161440849|NCT01177397|583006393|FG001|Overall Study|Lost to Follow-up|0|||
161440850|NCT01177397|583006394|FG002|Overall Study|Lost to Follow-up|0|||
161440851|NCT01177397|583006395|FG003|Overall Study|Lost to Follow-up|0|||
161789379|NCT02868281|584272839|FG001|Overall Study|Protocol Violation|10|||
161440852|NCT01177397|583006396|FG004|Overall Study|Lost to Follow-up|1|||
161440853|NCT01177397|583006397|FG005|Overall Study|Lost to Follow-up|0|||
161440854|NCT01177397|583006398|FG006|Overall Study|Lost to Follow-up|0|||
161440855|NCT01177397|583006399|FG007|Overall Study|Lost to Follow-up|2|||
161440856|NCT01177397|583006400|FG008|Overall Study|Lost to Follow-up|0|||
161440857|NCT01177397|583006401|FG009|Overall Study|Lost to Follow-up|0|||
161440858|NCT01177397|583006402|FG010|Overall Study|Lost to Follow-up|0|||
161440859|NCT01177397|583006403|FG011|Overall Study|Lost to Follow-up|0|||
161440860|NCT01177397|583006392|FG000|Overall Study|Death|0|||
161440861|NCT01177397|583006393|FG001|Overall Study|Death|0|||
161440862|NCT01177397|583006394|FG002|Overall Study|Death|1|||
161440863|NCT01177397|583006395|FG003|Overall Study|Death|1|||
161440864|NCT01177397|583006396|FG004|Overall Study|Death|0|||
161440865|NCT01177397|583006397|FG005|Overall Study|Death|0|||
161440866|NCT01177397|583006398|FG006|Overall Study|Death|0|||
161440867|NCT01177397|583006399|FG007|Overall Study|Death|5|||
161440868|NCT01177397|583006400|FG008|Overall Study|Death|2|||
161440869|NCT01177397|583006401|FG009|Overall Study|Death|1|||
161440870|NCT01177397|583006402|FG010|Overall Study|Death|0|||
161440871|NCT01177397|583006403|FG011|Overall Study|Death|0|||
161440872|NCT01177397|583006392|FG000|Overall Study|Withdrawal by Subject|0|||
161440873|NCT01177397|583006393|FG001|Overall Study|Withdrawal by Subject|0|||
161440874|NCT01177397|583006394|FG002|Overall Study|Withdrawal by Subject|1|||
161440875|NCT01177397|583006395|FG003|Overall Study|Withdrawal by Subject|1|||
161440876|NCT01177397|583006396|FG004|Overall Study|Withdrawal by Subject|1|||
161440877|NCT01177397|583006397|FG005|Overall Study|Withdrawal by Subject|2|||
161440878|NCT01177397|583006398|FG006|Overall Study|Withdrawal by Subject|0|||
161440879|NCT01177397|583006399|FG007|Overall Study|Withdrawal by Subject|5|||
161440880|NCT01177397|583006400|FG008|Overall Study|Withdrawal by Subject|9|||
161440881|NCT01177397|583006401|FG009|Overall Study|Withdrawal by Subject|1|||
161440882|NCT01177397|583006402|FG010|Overall Study|Withdrawal by Subject|1|||
161440883|NCT01177397|583006403|FG011|Overall Study|Withdrawal by Subject|0|||
161440884|NCT01177397|583006392|FG000|Overall Study|Adverse Event|0|||
161440885|NCT01177397|583006393|FG001|Overall Study|Adverse Event|0|||
161440886|NCT01177397|583006394|FG002|Overall Study|Adverse Event|1|||
161440887|NCT01177397|583006395|FG003|Overall Study|Adverse Event|2|||
161440888|NCT01177397|583006396|FG004|Overall Study|Adverse Event|0|||
161440889|NCT01177397|583006397|FG005|Overall Study|Adverse Event|12|||
161440890|NCT01177397|583006398|FG006|Overall Study|Adverse Event|1|||
161440891|NCT01177397|583006399|FG007|Overall Study|Adverse Event|14|||
161440892|NCT01177397|583006400|FG008|Overall Study|Adverse Event|8|||
161440893|NCT01177397|583006401|FG009|Overall Study|Adverse Event|6|||
161440894|NCT01177397|583006402|FG010|Overall Study|Adverse Event|3|||
161440895|NCT01177397|583006403|FG011|Overall Study|Adverse Event|7|||
161440896|NCT01177397|583006392|FG000|Overall Study|Disease progression|1|||
161440897|NCT01177397|583006393|FG001|Overall Study|Disease progression|2|||
161440898|NCT01177397|583006394|FG002|Overall Study|Disease progression|5|||
161440899|NCT01177397|583006395|FG003|Overall Study|Disease progression|5|||
161440900|NCT01177397|583006396|FG004|Overall Study|Disease progression|4|||
161440901|NCT01177397|583006397|FG005|Overall Study|Disease progression|10|||
161440902|NCT01177397|583006398|FG006|Overall Study|Disease progression|10|||
161440903|NCT01177397|583006399|FG007|Overall Study|Disease progression|21|||
161440904|NCT01177397|583006400|FG008|Overall Study|Disease progression|18|||
161440905|NCT01177397|583006401|FG009|Overall Study|Disease progression|12|||
161440906|NCT01177397|583006402|FG010|Overall Study|Disease progression|10|||
161898694|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Patient response missing|0|||
161898695|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Patient response missing|0|||
161898696|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Patient response missing|1|||
161898697|NCT00872521|584677878|FG000|Completed 3-month Follow up|Other|0|||
161898698|NCT00872521|584677879|FG001|Completed 3-month Follow up|Other|2|||
161898699|NCT00872521|584677880|FG002|Completed 3-month Follow up|Other|0|||
161898700|NCT00872521|584677878|FG000|Completed 3-month Follow up|Physician Decision|0|||
161898701|NCT00872521|584677879|FG001|Completed 3-month Follow up|Physician Decision|1|||
161898702|NCT00872521|584677880|FG002|Completed 3-month Follow up|Physician Decision|0|||
161440907|NCT01177397|583006403|FG011|Overall Study|Disease progression|8|||
161440908|NCT01177397|583006392|FG000|Overall Study|Other reasons|0|||
161440909|NCT01177397|583006393|FG001|Overall Study|Other reasons|0|||
161440910|NCT01177397|583006394|FG002|Overall Study|Other reasons|1|||
161440911|NCT01177397|583006395|FG003|Overall Study|Other reasons|0|||
161440912|NCT01177397|583006396|FG004|Overall Study|Other reasons|1|||
161440913|NCT01177397|583006397|FG005|Overall Study|Other reasons|1|||
161440914|NCT01177397|583006398|FG006|Overall Study|Other reasons|2|||
161440915|NCT01177397|583006399|FG007|Overall Study|Other reasons|6|||
161440916|NCT01177397|583006400|FG008|Overall Study|Other reasons|10|||
161440917|NCT01177397|583006401|FG009|Overall Study|Other reasons|8|||
161440918|NCT01177397|583006402|FG010|Overall Study|Other reasons|0|||
161440919|NCT01177397|583006403|FG011|Overall Study|Other reasons|2|||
161440920|NCT01528969|583006404|FG000|Overall Study|absent from the school at baseline|2|||
161440921|NCT01528969|583006405|FG001|Overall Study|absent from the school at baseline|0|||
161440922|NCT02803580|583006406|FG000|Overall Study|Death|13|||
161440923|NCT02803580|583006406|FG000|Overall Study|Lost to Follow-up|19|||
161440924|NCT02803580|583006406|FG000|Overall Study|Withdrawal by Subject|3|||
161440925|NCT02803580|583006406|FG000|Overall Study|Inclusion in clinical trial|1|||
161440926|NCT04050202|583006407|FG000|Overall Study|Lost to Follow-up|2|||
161440927|NCT01554241|583006408|FG000|Overall Study|Death|3|||
161440928|NCT01554241|583006409|FG001|Overall Study|Death|1|||
161440929|NCT01554241|583006410|FG002|Overall Study|Death|1|||
161440930|NCT01554241|583006411|FG003|Overall Study|Death|0|||
161440931|NCT01554241|583006408|FG000|Overall Study|protocol specified renal stone|0|||
161440932|NCT01554241|583006409|FG001|Overall Study|protocol specified renal stone|0|||
161440933|NCT01554241|583006410|FG002|Overall Study|protocol specified renal stone|0|||
161440934|NCT01554241|583006411|FG003|Overall Study|protocol specified renal stone|1|||
161440935|NCT01554241|583006408|FG000|Overall Study|protocol specified change in eGFR|0|||
161440936|NCT01554241|583006409|FG001|Overall Study|protocol specified change in eGFR|0|||
161440937|NCT01554241|583006410|FG002|Overall Study|protocol specified change in eGFR|1|||
161440938|NCT01554241|583006411|FG003|Overall Study|protocol specified change in eGFR|0|||
161440939|NCT01554241|583006408|FG000|Overall Study|Withdrawal by Subject|0|||
161440940|NCT01554241|583006409|FG001|Overall Study|Withdrawal by Subject|0|||
161440941|NCT01554241|583006410|FG002|Overall Study|Withdrawal by Subject|2|||
161440942|NCT01554241|583006411|FG003|Overall Study|Withdrawal by Subject|0|||
161440943|NCT03198507|583006414|FG000|Overall Study|Withdrawal by Subject|1|||
161440944|NCT03198507|583006415|FG001|Overall Study|Withdrawal by Subject|0|||
161440945|NCT00724698|583006416|FG000|Overall Study|Adverse Event|9|||
161440946|NCT00724698|583006416|FG000|Overall Study|Failure of Therapy|4|||
161440947|NCT00724698|583006416|FG000|Overall Study|Poor Compliance|16|||
161440948|NCT00724698|583006416|FG000|Overall Study|Lost to Follow-up|36|||
161440949|NCT00724698|583006416|FG000|Overall Study|No Info|25|||
161440950|NCT01411891|583006419|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
161440951|NCT01411891|583006420|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
161440952|NCT01075685|583006421|FG000|Overall Study|Protocol Violation|9|||
161440953|NCT01075685|583006422|FG001|Overall Study|Protocol Violation|1|||
161440954|NCT01075685|583006421|FG000|Overall Study|Withdrawal by Subject|20|||
161440955|NCT01075685|583006422|FG001|Overall Study|Withdrawal by Subject|5|||
161440956|NCT01075685|583006421|FG000|Overall Study|Lost to Follow-up|563|||
161440957|NCT01075685|583006422|FG001|Overall Study|Lost to Follow-up|220|||
161440958|NCT03196349|583006425|FG000|Overall Study|Did not receive study drug|0|||
161440959|NCT03196349|583006426|FG001|Overall Study|Did not receive study drug|1|||
161440960|NCT03196349|583006427|FG002|Overall Study|Did not receive study drug|2|||
161440961|NCT03196349|583006425|FG000|Overall Study|No data entered|2|||
161440962|NCT03196349|583006426|FG001|Overall Study|No data entered|4|||
161440963|NCT03196349|583006427|FG002|Overall Study|No data entered|0|||
161440964|NCT03196349|583006425|FG000|Overall Study|Study Terminated early|15|||
161440965|NCT03196349|583006426|FG001|Overall Study|Study Terminated early|9|||
161440966|NCT03196349|583006427|FG002|Overall Study|Study Terminated early|11|||
161440967|NCT03388164|583006432|FG000|Overall Study|Withdrawal by Subject|3|||
161440968|NCT03388164|583006433|FG001|Overall Study|Withdrawal by Subject|1|||
161440969|NCT03967444|583006434|FG000|Overall Study|Lost to Follow-up|1|||
161440970|NCT03967444|583006435|FG001|Overall Study|Lost to Follow-up|2|||
161440971|NCT00499083|583006443|FG000|Overall Study|Not evaluable|3|||
161440972|NCT00686686|583006444|FG000|Overall Study|Non-compliance|1|||
161440973|NCT00686686|583006444|FG000|Overall Study|Adverse Event|2|||
161440974|NCT00686686|583006444|FG000|Overall Study|Lost to Follow-up|3|||
161440975|NCT00477386|583006445|FG000|Overall Study|Adverse Event|4|||
161440976|NCT00477386|583006446|FG001|Overall Study|Adverse Event|8|||
161440977|NCT00477386|583006445|FG000|Overall Study|Disease progression, relapse|3|||
161440978|NCT00477386|583006446|FG001|Overall Study|Disease progression, relapse|4|||
161440979|NCT00477386|583006445|FG000|Overall Study|Disease progression, refractory|1|||
161440980|NCT00477386|583006446|FG001|Overall Study|Disease progression, refractory|3|||
161440981|NCT00477386|583006445|FG000|Overall Study|Other|1|||
161440982|NCT00477386|583006446|FG001|Overall Study|Other|2|||
161440983|NCT00477386|583006445|FG000|Overall Study|Physician Decision|1|||
161440984|NCT00477386|583006446|FG001|Overall Study|Physician Decision|0|||
161440985|NCT00477386|583006445|FG000|Overall Study|Withdrawal by Subject|1|||
161440986|NCT00477386|583006446|FG001|Overall Study|Withdrawal by Subject|0|||
161440987|NCT01254422|583006447|FG000|Overall Study|Protocol Violation|1|||
161440988|NCT01254422|583006448|FG001|Overall Study|Protocol Violation|0|||
161440989|NCT01254422|583006447|FG000|Overall Study|Adverse Event|1|||
161440990|NCT01254422|583006448|FG001|Overall Study|Adverse Event|0|||
161440991|NCT01254422|583006447|FG000|Overall Study|Serious adverse event|0|||
161668040|NCT00406653|583837476|FG000|Induction Period|Declined participation but followup done|0|||
161440992|NCT01254422|583006448|FG001|Overall Study|Serious adverse event|1|||
161440993|NCT01254422|583006447|FG000|Overall Study|Lost to Follow-up|1|||
161440994|NCT01254422|583006448|FG001|Overall Study|Lost to Follow-up|0|||
161440995|NCT00643162|583006449|FG000|Overall Study|Withdrawal by Subject|1|||
161440996|NCT00643162|583006450|FG001|Overall Study|Withdrawal by Subject|1|||
161440997|NCT05038982|583006451|FG000|Overall Study|Withdrawal by Subject|0|||
161440998|NCT05038982|583006452|FG001|Overall Study|Withdrawal by Subject|2|||
161440999|NCT02592798|583006455|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
161441000|NCT02592798|583006456|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
161441001|NCT02592798|583006455|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
161441002|NCT02592798|583006456|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
161441003|NCT02592798|583006455|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
161441004|NCT02592798|583006456|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
161441005|NCT02592798|583006455|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
161441006|NCT02592798|583006456|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
161441007|NCT02592798|583006455|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
161441008|NCT02592798|583006456|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
161441009|NCT02592798|583006455|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
161441010|NCT02592798|583006456|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
161441011|NCT02592798|583006455|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
161441012|NCT02592798|583006456|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
161441013|NCT02592798|583006455|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
161441014|NCT02592798|583006456|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
161441015|NCT02592798|583006455|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
161441016|NCT02592798|583006456|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
161441017|NCT02592798|583006455|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
161441018|NCT02592798|583006456|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
161441019|NCT02592798|583006455|FG000|Transition From DB2 to OLE|Other reasons|1|||
161441020|NCT02592798|583006456|FG001|Transition From DB2 to OLE|Other reasons|0|||
161441021|NCT02592798|583006455|FG000|Open Label Period (OLE)|Other reasons|0|||
161441022|NCT02592798|583006456|FG001|Open Label Period (OLE)|Other reasons|2|||
161441023|NCT02592798|583006455|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
161441024|NCT02592798|583006456|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
161441025|NCT02592798|583006455|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
161441026|NCT02592798|583006456|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
161441027|NCT02592798|583006455|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
161441028|NCT02592798|583006456|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
161441029|NCT02592798|583006455|FG000|Open Label Period (OLE)|Adverse Event|0|||
161441030|NCT02592798|583006456|FG001|Open Label Period (OLE)|Adverse Event|1|||
161441031|NCT01143246|583006457|FG000|Overall Study|Adverse Event|24|||
161441032|NCT01143246|583006458|FG001|Overall Study|Adverse Event|28|||
161441033|NCT01143246|583006457|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
161441034|NCT01143246|583006458|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
161441035|NCT01143246|583006457|FG000|Overall Study|Lost to Follow-up|0|||
161441036|NCT01143246|583006458|FG001|Overall Study|Lost to Follow-up|1|||
161441037|NCT01143246|583006457|FG000|Overall Study|Death|16|||
161441038|NCT01143246|583006458|FG001|Overall Study|Death|15|||
161441039|NCT01143246|583006457|FG000|Overall Study|Reason not Specified|3|||
161441040|NCT01143246|583006458|FG001|Overall Study|Reason not Specified|5|||
161441041|NCT01146795|583006459|FG000|Overall Study|Withdrawal by Subject|4|||
161441042|NCT01146795|583006459|FG000|Overall Study|Adverse Event|6|||
161441043|NCT01146795|583006459|FG000|Overall Study|Still in treatment at study closure|10|||
161441044|NCT05375760|583006460|FG000|Overall Study|Adverse Event|1|||
161441045|NCT05375760|583006461|FG001|Overall Study|Adverse Event|0|||
161441046|NCT05375760|583006460|FG000|Overall Study|Death|0|||
161441047|NCT05375760|583006461|FG001|Overall Study|Death|1|||
161441048|NCT05375760|583006460|FG000|Overall Study|Lost to Follow-up|6|||
161441049|NCT05375760|583006461|FG001|Overall Study|Lost to Follow-up|6|||
161441050|NCT05375760|583006460|FG000|Overall Study|Withdrawal by Subject|17|||
161441051|NCT05375760|583006461|FG001|Overall Study|Withdrawal by Subject|19|||
161441052|NCT05375760|583006460|FG000|Overall Study|Dosing halted by FDA|96|||
161441053|NCT05375760|583006461|FG001|Overall Study|Dosing halted by FDA|100|||
161441054|NCT05375760|583006460|FG000|Overall Study|Not compliant with study visit|2|||
161441055|NCT05375760|583006461|FG001|Overall Study|Not compliant with study visit|0|||
161441056|NCT05375760|583006460|FG000|Overall Study|Physician Decision|1|||
161441057|NCT05375760|583006461|FG001|Overall Study|Physician Decision|0|||
161441058|NCT05375760|583006460|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
161441059|NCT05375760|583006461|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
161441060|NCT05375760|583006460|FG000|Overall Study|Participant moved|1|||
161441061|NCT05375760|583006461|FG001|Overall Study|Participant moved|0|||
161441062|NCT03853109|583006462|FG000|Overall Study|Withdrawal by Subject|0|||
161441063|NCT03853109|583006463|FG001|Overall Study|Withdrawal by Subject|0|||
161441064|NCT03853109|583006464|FG002|Overall Study|Withdrawal by Subject|1|||
161441065|NCT03853109|583006465|FG003|Overall Study|Withdrawal by Subject|2|||
161441066|NCT03853109|583006466|FG004|Overall Study|Withdrawal by Subject|1|||
161441067|NCT03853109|583006467|FG005|Overall Study|Withdrawal by Subject|4|||
161441068|NCT03853109|583006468|FG006|Overall Study|Withdrawal by Subject|5|||
161441069|NCT03853109|583006469|FG007|Overall Study|Withdrawal by Subject|3|||
161441070|NCT03853109|583006462|FG000|Overall Study|Decision by Sponsor|0|||
161441071|NCT03853109|583006463|FG001|Overall Study|Decision by Sponsor|0|||
161441072|NCT03853109|583006464|FG002|Overall Study|Decision by Sponsor|1|||
161441073|NCT03853109|583006465|FG003|Overall Study|Decision by Sponsor|0|||
161441074|NCT03853109|583006466|FG004|Overall Study|Decision by Sponsor|1|||
161441075|NCT03853109|583006467|FG005|Overall Study|Decision by Sponsor|1|||
161441076|NCT03853109|583006468|FG006|Overall Study|Decision by Sponsor|10|||
161441077|NCT03853109|583006469|FG007|Overall Study|Decision by Sponsor|2|||
161441078|NCT03853109|583006462|FG000|Overall Study|Lost to Follow-up|0|||
161441079|NCT03853109|583006463|FG001|Overall Study|Lost to Follow-up|0|||
161441080|NCT03853109|583006464|FG002|Overall Study|Lost to Follow-up|0|||
161441081|NCT03853109|583006465|FG003|Overall Study|Lost to Follow-up|0|||
161441082|NCT03853109|583006466|FG004|Overall Study|Lost to Follow-up|1|||
161441083|NCT03853109|583006467|FG005|Overall Study|Lost to Follow-up|3|||
161441084|NCT03853109|583006468|FG006|Overall Study|Lost to Follow-up|0|||
161441085|NCT03853109|583006469|FG007|Overall Study|Lost to Follow-up|0|||
161441086|NCT03853109|583006462|FG000|Overall Study|Death|2|||
161441087|NCT03853109|583006463|FG001|Overall Study|Death|5|||
161441088|NCT03853109|583006464|FG002|Overall Study|Death|8|||
161441089|NCT03853109|583006465|FG003|Overall Study|Death|10|||
161441090|NCT03853109|583006466|FG004|Overall Study|Death|3|||
161441091|NCT03853109|583006467|FG005|Overall Study|Death|20|||
161441092|NCT03853109|583006468|FG006|Overall Study|Death|10|||
161441093|NCT03853109|583006469|FG007|Overall Study|Death|5|||
161441094|NCT02745119|583006474|FG000|Overall Study|Adverse Event|1|||
161441095|NCT02745119|583006475|FG001|Overall Study|Adverse Event|0|||
161441096|NCT02745119|583006476|FG002|Overall Study|Adverse Event|1|||
161441097|NCT02745119|583006477|FG003|Overall Study|Adverse Event|3|||
161441098|NCT02745119|583006474|FG000|Overall Study|Death|3|||
161441099|NCT02745119|583006475|FG001|Overall Study|Death|3|||
161441100|NCT02745119|583006476|FG002|Overall Study|Death|0|||
161441101|NCT02745119|583006477|FG003|Overall Study|Death|4|||
161441102|NCT02745119|583006474|FG000|Overall Study|Lost to Follow-up|0|||
161441103|NCT02745119|583006475|FG001|Overall Study|Lost to Follow-up|0|||
161441104|NCT02745119|583006476|FG002|Overall Study|Lost to Follow-up|0|||
161441105|NCT02745119|583006477|FG003|Overall Study|Lost to Follow-up|1|||
161441106|NCT02745119|583006474|FG000|Overall Study|Protocol Deviation|0|||
161441107|NCT02745119|583006475|FG001|Overall Study|Protocol Deviation|0|||
161441108|NCT02745119|583006476|FG002|Overall Study|Protocol Deviation|0|||
161441109|NCT02745119|583006477|FG003|Overall Study|Protocol Deviation|1|||
161441110|NCT02745119|583006474|FG000|Overall Study|Withdrawal by Subject|7|||
161441111|NCT02745119|583006475|FG001|Overall Study|Withdrawal by Subject|15|||
161441112|NCT02745119|583006476|FG002|Overall Study|Withdrawal by Subject|8|||
161441113|NCT02745119|583006477|FG003|Overall Study|Withdrawal by Subject|14|||
161441114|NCT02745119|583006474|FG000|Overall Study|Study Terminated by Sponsor|134|||
161441115|NCT02745119|583006475|FG001|Overall Study|Study Terminated by Sponsor|252|||
161441116|NCT02745119|583006476|FG002|Overall Study|Study Terminated by Sponsor|135|||
161441117|NCT02745119|583006477|FG003|Overall Study|Study Terminated by Sponsor|251|||
161441118|NCT02745119|583006474|FG000|Overall Study|Physician Decision|0|||
161441119|NCT02745119|583006475|FG001|Overall Study|Physician Decision|2|||
161441120|NCT02745119|583006476|FG002|Overall Study|Physician Decision|2|||
161441121|NCT02745119|583006477|FG003|Overall Study|Physician Decision|2|||
161441122|NCT02745119|583006474|FG000|Overall Study|Reason Not Specified|0|||
161441123|NCT02745119|583006475|FG001|Overall Study|Reason Not Specified|2|||
161441124|NCT02745119|583006476|FG002|Overall Study|Reason Not Specified|0|||
161441125|NCT02745119|583006477|FG003|Overall Study|Reason Not Specified|1|||
161441126|NCT00960999|583006478|FG000|Overall Study|Withdrawal by Subject|1|||
161441127|NCT00960999|583006479|FG001|Overall Study|Withdrawal by Subject|0|||
161441128|NCT00960999|583006478|FG000|Overall Study|Protocol Violation|5|||
161441129|NCT00960999|583006479|FG001|Overall Study|Protocol Violation|2|||
161441130|NCT00960999|583006478|FG000|Overall Study|RT dose constraints not met|2|||
161441131|NCT00960999|583006479|FG001|Overall Study|RT dose constraints not met|0|||
161441132|NCT02536963|583006480|FG000|Overall Study|Withdrawal by Subject|18|||
161441133|NCT02668393|583006481|FG000|Overall Study|Progressive disease|6|||
161441134|NCT02668393|583006482|FG001|Overall Study|Progressive disease|3|||
161789380|NCT02868281|584272838|FG000|Overall Study|Lost to Follow-up|3|||
161789381|NCT02868281|584272839|FG001|Overall Study|Lost to Follow-up|6|||
161789382|NCT02868281|584272838|FG000|Overall Study|Withdrawal by Subject|11|||
161441135|NCT02668393|583006481|FG000|Overall Study|Adverse Event|0|||
161441136|NCT02668393|583006482|FG001|Overall Study|Adverse Event|2|||
161441137|NCT02668393|583006481|FG000|Overall Study|Withdrawal from the trial|0|||
161441138|NCT02668393|583006482|FG001|Overall Study|Withdrawal from the trial|1|||
161441139|NCT02668393|583006481|FG000|Overall Study|Lack of benefit and side effects|1|||
161441140|NCT02668393|583006482|FG001|Overall Study|Lack of benefit and side effects|0|||
161441141|NCT00174187|583006483|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
161441142|NCT00174187|583006484|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
161441143|NCT00174187|583006485|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
161441144|NCT00174187|583006483|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
161441145|NCT00174187|583006484|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
161441146|NCT00174187|583006485|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
161441147|NCT00174187|583006483|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
161441148|NCT00174187|583006484|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
161441149|NCT00174187|583006485|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
161441150|NCT00174187|583006483|FG000|Period 1 (up to 3 Years)|Other|0|||
161441151|NCT00174187|583006484|FG001|Period 1 (up to 3 Years)|Other|1|||
161441152|NCT00174187|583006485|FG002|Period 1 (up to 3 Years)|Other|0|||
161441153|NCT00174187|583006483|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
161441154|NCT00174187|583006484|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
161441155|NCT00174187|583006485|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
161441156|NCT00174187|583006483|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
161441157|NCT00174187|583006484|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
161441158|NCT00174187|583006485|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
161441159|NCT00174187|583006483|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
161441160|NCT00174187|583006484|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
161441161|NCT00174187|583006485|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
161441162|NCT00174187|583006483|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
161441163|NCT00174187|583006484|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
161441164|NCT00174187|583006485|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
161441165|NCT00174187|583006483|FG000|Period 2 (After 3 Years)|Other|0|||
161441166|NCT00174187|583006484|FG001|Period 2 (After 3 Years)|Other|0|||
161441167|NCT00174187|583006485|FG002|Period 2 (After 3 Years)|Other|5|||
161441168|NCT01285557|583006486|FG000|Overall Study|Death|173|||
161441169|NCT01285557|583006487|FG001|Overall Study|Death|90|||
161441170|NCT01285557|583006486|FG000|Overall Study|Lost to Follow-up|6|||
161441171|NCT01285557|583006487|FG001|Overall Study|Lost to Follow-up|2|||
161441172|NCT01285557|583006486|FG000|Overall Study|Withdrew Consent|6|||
161441173|NCT01285557|583006487|FG001|Overall Study|Withdrew Consent|1|||
161441174|NCT01285557|583006486|FG000|Overall Study|Sponsor Study Termination|23|||
161441175|NCT01285557|583006487|FG001|Overall Study|Sponsor Study Termination|13|||
161441176|NCT01285557|583006486|FG000|Overall Study|Randomized but not treated|1|||
161441177|NCT01285557|583006487|FG001|Overall Study|Randomized but not treated|1|||
161441178|NCT01285557|583006486|FG000|Overall Study|Study follow-up ongoing|28|||
161441179|NCT01285557|583006487|FG001|Overall Study|Study follow-up ongoing|14|||
161441180|NCT01285557|583006486|FG000|Overall Study|Sponsor Decision|2|||
161441181|NCT01285557|583006487|FG001|Overall Study|Sponsor Decision|1|||
161441182|NCT02991768|583006493|FG000|Overall Study|Physician Decision|4|||
161441183|NCT02273596|583008502|FG000|24-Week Treatment Period|Adverse Event|3|||
161441184|NCT02273596|583008502|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
161441185|NCT02273596|583008502|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
161441186|NCT02273596|583008502|FG000|24-Week Treatment Period|Physician Decision|1|||
161441187|NCT02273596|583008502|FG000|24-Week Treatment Period|Protocol Deviation|1|||
161441188|NCT02273596|583008502|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
161441189|NCT02273596|583008502|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
161441190|NCT02273596|583008502|FG000|Extension Period|Lost to Follow-up|1|||
161441191|NCT02273596|583008502|FG000|Extension Period|Protocol Deviation|1|||
161441192|NCT02139592|583008504|FG000|Overall Study|Case Report Forms Uncollected|8|||
161441193|NCT01358721|583008510|FG000|Overall Study|Withdrawal by Subject|0|||
161441194|NCT01358721|583008511|FG001|Overall Study|Withdrawal by Subject|0|||
161441195|NCT01358721|583008512|FG002|Overall Study|Withdrawal by Subject|0|||
161441196|NCT01358721|583008513|FG003|Overall Study|Withdrawal by Subject|1|||
161441197|NCT01358721|583008510|FG000|Overall Study|Death|0|||
161441198|NCT01358721|583008511|FG001|Overall Study|Death|2|||
161441199|NCT01358721|583008512|FG002|Overall Study|Death|0|||
161441200|NCT01358721|583008513|FG003|Overall Study|Death|0|||
161441201|NCT01358721|583008510|FG000|Overall Study|Study Drug Toxicity|1|||
161441202|NCT01358721|583008511|FG001|Overall Study|Study Drug Toxicity|3|||
161441203|NCT01358721|583008512|FG002|Overall Study|Study Drug Toxicity|4|||
161441204|NCT01358721|583008513|FG003|Overall Study|Study Drug Toxicity|5|||
161441205|NCT01358721|583008510|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
161441206|NCT01358721|583008511|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
161441207|NCT01358721|583008512|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
161441208|NCT01358721|583008513|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
161441209|NCT01358721|583008510|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161441210|NCT01358721|583008511|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
161441211|NCT01358721|583008512|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
161441212|NCT01358721|583008513|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
161441213|NCT01358721|583008510|FG000|Overall Study|Adverse Event related to study drug|1|||
161441214|NCT01358721|583008511|FG001|Overall Study|Adverse Event related to study drug|0|||
161441215|NCT01358721|583008512|FG002|Overall Study|Adverse Event related to study drug|0|||
161441216|NCT01358721|583008513|FG003|Overall Study|Adverse Event related to study drug|1|||
161441217|NCT01358721|583008510|FG000|Overall Study|Disease Progression|19|||
161441218|NCT01358721|583008511|FG001|Overall Study|Disease Progression|15|||
161441219|NCT01358721|583008512|FG002|Overall Study|Disease Progression|17|||
161441220|NCT01358721|583008513|FG003|Overall Study|Disease Progression|15|||
161441221|NCT01358721|583008510|FG000|Overall Study|Out of State/Unmet Criteria|0|||
161441222|NCT01358721|583008511|FG001|Overall Study|Out of State/Unmet Criteria|0|||
161441223|NCT01358721|583008512|FG002|Overall Study|Out of State/Unmet Criteria|1|||
161441224|NCT01358721|583008513|FG003|Overall Study|Out of State/Unmet Criteria|0|||
161441225|NCT04614974|583008514|FG000|Overall Study|Lost to Follow-up|14|||
161441226|NCT04614974|583008515|FG001|Overall Study|Lost to Follow-up|11|||
161441227|NCT00658359|583008517|FG000|Overall Study|Death|3|||
161441228|NCT00658359|583008518|FG001|Overall Study|Death|1|||
161441229|NCT00658359|583008519|FG002|Overall Study|Death|2|||
161441230|NCT00658359|583008517|FG000|Overall Study|Adverse Event|13|||
161441231|NCT00658359|583008518|FG001|Overall Study|Adverse Event|6|||
161441232|NCT00658359|583008519|FG002|Overall Study|Adverse Event|9|||
161441233|NCT00658359|583008517|FG000|Overall Study|Protocol Violation|1|||
161441234|NCT00658359|583008518|FG001|Overall Study|Protocol Violation|0|||
161441235|NCT00658359|583008519|FG002|Overall Study|Protocol Violation|0|||
161441236|NCT00658359|583008517|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
161441237|NCT00658359|583008518|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
161441238|NCT00658359|583008519|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
161441239|NCT00658359|583008517|FG000|Overall Study|Withdrawal by Subject|7|||
161441240|NCT00658359|583008518|FG001|Overall Study|Withdrawal by Subject|4|||
161441241|NCT00658359|583008519|FG002|Overall Study|Withdrawal by Subject|2|||
161441242|NCT00658359|583008517|FG000|Overall Study|Lost to Follow-up|2|||
161441243|NCT00658359|583008518|FG001|Overall Study|Lost to Follow-up|2|||
161441244|NCT00658359|583008519|FG002|Overall Study|Lost to Follow-up|4|||
161441245|NCT00658359|583008517|FG000|Overall Study|Lack of Efficacy|0|||
161441246|NCT00658359|583008518|FG001|Overall Study|Lack of Efficacy|1|||
161441247|NCT00658359|583008519|FG002|Overall Study|Lack of Efficacy|0|||
161441248|NCT02754440|583008520|FG000|Overall Study|Protocol Violation|3|||
161441249|NCT02754440|583008521|FG001|Overall Study|Protocol Violation|2|||
161441250|NCT02754440|583008522|FG002|Overall Study|Protocol Violation|2|||
161441251|NCT02754440|583008523|FG003|Overall Study|Protocol Violation|6|||
161441252|NCT02754440|583008520|FG000|Overall Study|Adverse Event|3|||
161441253|NCT02754440|583008521|FG001|Overall Study|Adverse Event|1|||
161441254|NCT02754440|583008522|FG002|Overall Study|Adverse Event|0|||
161441255|NCT02754440|583008523|FG003|Overall Study|Adverse Event|9|||
161441256|NCT02754440|583008520|FG000|Overall Study|Withdrawal by Subject|0|||
161441257|NCT02754440|583008521|FG001|Overall Study|Withdrawal by Subject|0|||
161441258|NCT02754440|583008522|FG002|Overall Study|Withdrawal by Subject|0|||
161441259|NCT02754440|583008523|FG003|Overall Study|Withdrawal by Subject|1|||
161441260|NCT02754440|583008520|FG000|Overall Study|Equipment failure|0|||
161441261|NCT02754440|583008521|FG001|Overall Study|Equipment failure|5|||
161441262|NCT02754440|583008522|FG002|Overall Study|Equipment failure|5|||
161441263|NCT02754440|583008523|FG003|Overall Study|Equipment failure|7|||
161441264|NCT02754440|583008520|FG000|Overall Study|Subject issues not resulting in AE|0|||
161441265|NCT02754440|583008521|FG001|Overall Study|Subject issues not resulting in AE|0|||
161441266|NCT02754440|583008522|FG002|Overall Study|Subject issues not resulting in AE|0|||
161441267|NCT02754440|583008523|FG003|Overall Study|Subject issues not resulting in AE|12|||
161441268|NCT02560558|583008524|FG000|Overall Study|Adverse Event|1|||
161441269|NCT02560558|583008525|FG001|Overall Study|Adverse Event|0|||
161441270|NCT02560558|583008524|FG000|Overall Study|Death|0|||
161441271|NCT02560558|583008525|FG001|Overall Study|Death|2|||
161441272|NCT02560558|583008524|FG000|Overall Study|Lost to Follow-up|0|||
161441273|NCT02560558|583008525|FG001|Overall Study|Lost to Follow-up|4|||
161441274|NCT02560558|583008524|FG000|Overall Study|Protocol Violation|3|||
161441275|NCT02560558|583008525|FG001|Overall Study|Protocol Violation|0|||
161441276|NCT02560558|583008524|FG000|Overall Study|Withdrawal by Subject|3|||
161441277|NCT02560558|583008525|FG001|Overall Study|Withdrawal by Subject|0|||
161441278|NCT01189032|583008530|FG000|Overall Study|Adverse Event|1|||
161441279|NCT01189032|583008531|FG001|Overall Study|Adverse Event|3|||
161441280|NCT01189032|583008532|FG002|Overall Study|Adverse Event|4|||
161441281|NCT01189032|583008530|FG000|Overall Study|Lack of Efficacy|2|||
161441282|NCT01189032|583008531|FG001|Overall Study|Lack of Efficacy|3|||
161441283|NCT01189032|583008532|FG002|Overall Study|Lack of Efficacy|0|||
161441284|NCT01189032|583008530|FG000|Overall Study|Withdrawal by Subject|1|||
161441285|NCT01189032|583008531|FG001|Overall Study|Withdrawal by Subject|0|||
161441286|NCT01189032|583008532|FG002|Overall Study|Withdrawal by Subject|1|||
161441287|NCT01189032|583008530|FG000|Overall Study|Protocol Violation|1|||
161441288|NCT01189032|583008531|FG001|Overall Study|Protocol Violation|1|||
161441289|NCT01189032|583008532|FG002|Overall Study|Protocol Violation|1|||
161441290|NCT01995838|583008533|FG000|Overall Study|Lost to Follow-up|0|||
161441291|NCT01995838|583008534|FG001|Overall Study|Lost to Follow-up|1|||
161441292|NCT01995838|583008535|FG002|Overall Study|Lost to Follow-up|0|||
161441293|NCT01995838|583008536|FG003|Overall Study|Lost to Follow-up|0|||
161441294|NCT01995838|583008537|FG004|Overall Study|Lost to Follow-up|0|||
161441295|NCT01995838|583008538|FG005|Overall Study|Lost to Follow-up|0|||
161441296|NCT01995838|583008539|FG006|Overall Study|Lost to Follow-up|1|||
161441297|NCT01995838|583008533|FG000|Overall Study|Participant choice|2|||
161441298|NCT01995838|583008534|FG001|Overall Study|Participant choice|0|||
161441299|NCT01995838|583008535|FG002|Overall Study|Participant choice|0|||
161441300|NCT01995838|583008536|FG003|Overall Study|Participant choice|0|||
161441301|NCT01995838|583008537|FG004|Overall Study|Participant choice|0|||
161441302|NCT01995838|583008538|FG005|Overall Study|Participant choice|1|||
161441303|NCT01995838|583008539|FG006|Overall Study|Participant choice|1|||
161441304|NCT01995838|583008533|FG000|Overall Study|Adverse Event|0|||
161441305|NCT01995838|583008534|FG001|Overall Study|Adverse Event|0|||
161441306|NCT01995838|583008535|FG002|Overall Study|Adverse Event|0|||
161441307|NCT01995838|583008536|FG003|Overall Study|Adverse Event|0|||
161441308|NCT01995838|583008537|FG004|Overall Study|Adverse Event|0|||
161441309|NCT01995838|583008538|FG005|Overall Study|Adverse Event|0|||
161441310|NCT01995838|583008539|FG006|Overall Study|Adverse Event|1|||
161441311|NCT01995838|583008533|FG000|Overall Study|Withdrawal by Subject|0|||
161441312|NCT01995838|583008534|FG001|Overall Study|Withdrawal by Subject|0|||
161441313|NCT01995838|583008535|FG002|Overall Study|Withdrawal by Subject|0|||
161441314|NCT01995838|583008536|FG003|Overall Study|Withdrawal by Subject|0|||
161441315|NCT01995838|583008537|FG004|Overall Study|Withdrawal by Subject|1|||
161441316|NCT01995838|583008538|FG005|Overall Study|Withdrawal by Subject|0|||
161441317|NCT01995838|583008539|FG006|Overall Study|Withdrawal by Subject|0|||
161441318|NCT01995838|583008533|FG000|Overall Study|Other|3|||
161441319|NCT01995838|583008534|FG001|Overall Study|Other|1|||
161441320|NCT01995838|583008535|FG002|Overall Study|Other|0|||
161441321|NCT01995838|583008536|FG003|Overall Study|Other|2|||
161441322|NCT01995838|583008537|FG004|Overall Study|Other|1|||
161441323|NCT01995838|583008538|FG005|Overall Study|Other|1|||
161441324|NCT01995838|583008539|FG006|Overall Study|Other|2|||
161441325|NCT01967576|583008544|FG000|Overall Study|Withdrawal by Subject|3|||
161441326|NCT01967576|583008544|FG000|Overall Study|Progressed/Removed from treatment|1|||
161441327|NCT01967576|583008544|FG000|Overall Study|Study closing at site|1|||
161441328|NCT01967576|583008544|FG000|Overall Study|Adverse Event|1|||
161441329|NCT01967576|583008544|FG000|Overall Study|Refused further treatment|1|||
161441330|NCT02819804|583008545|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
161441331|NCT02858362|583008546|FG000|Overall Study|Protocol Violation|0|||
161441332|NCT02858362|583008547|FG001|Overall Study|Protocol Violation|1|||
161441333|NCT02858362|583008548|FG002|Overall Study|Protocol Violation|0|||
161441334|NCT02858362|583008546|FG000|Overall Study|Withdrawal by Subject|1|||
161441335|NCT02858362|583008547|FG001|Overall Study|Withdrawal by Subject|0|||
161441336|NCT02858362|583008548|FG002|Overall Study|Withdrawal by Subject|0|||
161441337|NCT02858362|583008546|FG000|Overall Study|Early Study Termination|0|||
161441338|NCT02858362|583008547|FG001|Overall Study|Early Study Termination|0|||
161441339|NCT02858362|583008548|FG002|Overall Study|Early Study Termination|3|||
161441340|NCT02858362|583008546|FG000|Overall Study|Lost to Follow-up|1|||
161441341|NCT02858362|583008547|FG001|Overall Study|Lost to Follow-up|0|||
161441342|NCT02858362|583008548|FG002|Overall Study|Lost to Follow-up|0|||
161441343|NCT01821118|583008549|FG000|Overall Study|Death|0|||
161441344|NCT01821118|583008550|FG001|Overall Study|Death|1|||
161441345|NCT00345358|583008551|FG000|Primary Vaccination Phase|Other|0|||
161441346|NCT00345358|583008552|FG001|Primary Vaccination Phase|Other|1|||
161441347|NCT00345358|583008553|FG002|Primary Vaccination Phase|Other|1|||
161441348|NCT00345358|583008554|FG003|Primary Vaccination Phase|Other|0|||
161441349|NCT00345358|583008551|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
161441350|NCT00345358|583008552|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
161441351|NCT00345358|583008553|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
161441352|NCT00345358|583008554|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
161441353|NCT00345358|583008551|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
161441354|NCT00345358|583008552|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
161441355|NCT00345358|583008553|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
161441356|NCT00345358|583008554|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
161441357|NCT00345358|583008551|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
161441358|NCT00345358|583008552|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
161441359|NCT00345358|583008553|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
161441360|NCT00345358|583008554|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
161441361|NCT00345358|583008551|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
161441362|NCT00345358|583008552|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161441363|NCT00345358|583008553|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
161441364|NCT00345358|583008554|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
161441365|NCT00345358|583008551|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
161441366|NCT00345358|583008552|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
161441367|NCT00345358|583008553|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
161441368|NCT00345358|583008554|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
161441369|NCT00346697|583008555|FG000|Overall Study|Lost to Follow-up|0|||
161441370|NCT00346697|583008556|FG001|Overall Study|Lost to Follow-up|1|||
161441371|NCT01012440|583008557|FG000|Overall Study|Withdrawal by Subject|2|||
161441372|NCT00131248|583008558|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
161441373|NCT00131248|583008559|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
161441374|NCT00318643|583008564|FG000|Overall Study|Adverse Event|0|||
161441375|NCT00318643|583008565|FG001|Overall Study|Adverse Event|0|||
161441376|NCT00318643|583008566|FG002|Overall Study|Adverse Event|0|||
161441377|NCT00318643|583008567|FG003|Overall Study|Adverse Event|0|||
161441378|NCT00318643|583008568|FG004|Overall Study|Adverse Event|1|||
161441379|NCT00318643|583008564|FG000|Overall Study|Participant's Decision|0|||
161441380|NCT00318643|583008565|FG001|Overall Study|Participant's Decision|0|||
161441381|NCT00318643|583008566|FG002|Overall Study|Participant's Decision|0|||
161441382|NCT00318643|583008567|FG003|Overall Study|Participant's Decision|0|||
161441383|NCT00318643|583008568|FG004|Overall Study|Participant's Decision|1|||
161441384|NCT00318643|583008564|FG000|Overall Study|Investigator's Decision|0|||
161441385|NCT00318643|583008565|FG001|Overall Study|Investigator's Decision|0|||
161441386|NCT00318643|583008566|FG002|Overall Study|Investigator's Decision|0|||
161441387|NCT00318643|583008567|FG003|Overall Study|Investigator's Decision|0|||
161441388|NCT00318643|583008568|FG004|Overall Study|Investigator's Decision|1|||
161441389|NCT02691507|583008571|FG000|Overall Study|Missed Visit 3|0|||
161441390|NCT02691507|583008572|FG001|Overall Study|Missed Visit 3|1|||
161441391|NCT02557139|583008573|FG000|Overall Study|Significant liver elevation|1|||
161441392|NCT02557139|583008574|FG001|Overall Study|Significant liver elevation|0|||
161441393|NCT02557139|583008575|FG002|Overall Study|Significant liver elevation|1|||
161441394|NCT02557139|583008573|FG000|Overall Study|Withdrawal by Subject|1|||
161441395|NCT02557139|583008574|FG001|Overall Study|Withdrawal by Subject|0|||
161441396|NCT02557139|583008575|FG002|Overall Study|Withdrawal by Subject|0|||
161441397|NCT02557139|583008573|FG000|Overall Study|Illness of prohibited medication|0|||
161441398|NCT02557139|583008574|FG001|Overall Study|Illness of prohibited medication|0|||
161441399|NCT02557139|583008575|FG002|Overall Study|Illness of prohibited medication|1|||
161441400|NCT02284243|583008576|FG000|Overall Study|Lack of Efficacy|3|||
161441401|NCT02284243|583008577|FG001|Overall Study|Lack of Efficacy|3|||
161441402|NCT02284243|583008576|FG000|Overall Study|Adverse Event|1|||
161441403|NCT02284243|583008577|FG001|Overall Study|Adverse Event|0|||
161441404|NCT01216189|583008578|FG000|Overall Study|Lost to Follow-up|21|||
161441405|NCT01216189|583008579|FG001|Overall Study|Lost to Follow-up|3|||
161441406|NCT01216189|583008578|FG000|Overall Study|Death|4|||
161441407|NCT01216189|583008579|FG001|Overall Study|Death|2|||
161441408|NCT04032093|583008580|FG000|Overall Study|Lost to Follow-up|7|||
161441409|NCT04032093|583008581|FG001|Overall Study|Lost to Follow-up|7|||
161441410|NCT04032093|583008582|FG002|Overall Study|Lost to Follow-up|6|||
161441411|NCT04032093|583008583|FG003|Overall Study|Lost to Follow-up|10|||
161441412|NCT04032093|583008584|FG004|Overall Study|Lost to Follow-up|13|||
161441413|NCT04032093|583008585|FG005|Overall Study|Lost to Follow-up|7|||
161441414|NCT04032093|583008586|FG006|Overall Study|Lost to Follow-up|7|||
161441415|NCT04032093|583008587|FG007|Overall Study|Lost to Follow-up|5|||
161441416|NCT04032093|583008588|FG008|Overall Study|Lost to Follow-up|9|||
161441417|NCT04032093|583008589|FG009|Overall Study|Lost to Follow-up|12|||
161441418|NCT04032093|583008580|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161441419|NCT04032093|583008581|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161441420|NCT04032093|583008582|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
161441421|NCT04032093|583008583|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
161441422|NCT04032093|583008584|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
161441423|NCT04032093|583008585|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161441424|NCT04032093|583008586|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
161441425|NCT04032093|583008587|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
161441426|NCT04032093|583008588|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
161441427|NCT04032093|583008589|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
161441428|NCT04032093|583008580|FG000|Overall Study|Other|1|||
161441429|NCT04032093|583008581|FG001|Overall Study|Other|0|||
161441430|NCT04032093|583008582|FG002|Overall Study|Other|0|||
161441431|NCT04032093|583008583|FG003|Overall Study|Other|1|||
161441432|NCT04032093|583008584|FG004|Overall Study|Other|1|||
161441433|NCT04032093|583008585|FG005|Overall Study|Other|0|||
161441434|NCT04032093|583008586|FG006|Overall Study|Other|0|||
161441435|NCT04032093|583008587|FG007|Overall Study|Other|0|||
161441436|NCT04032093|583008588|FG008|Overall Study|Other|0|||
161441437|NCT04032093|583008589|FG009|Overall Study|Other|1|||
161441438|NCT04032093|583008580|FG000|Overall Study|Withdrawal by Subject|1|||
161441439|NCT04032093|583008581|FG001|Overall Study|Withdrawal by Subject|3|||
161441440|NCT04032093|583008582|FG002|Overall Study|Withdrawal by Subject|2|||
161441441|NCT04032093|583008583|FG003|Overall Study|Withdrawal by Subject|2|||
161441442|NCT04032093|583008584|FG004|Overall Study|Withdrawal by Subject|3|||
161441443|NCT04032093|583008585|FG005|Overall Study|Withdrawal by Subject|0|||
161441444|NCT04032093|583008586|FG006|Overall Study|Withdrawal by Subject|0|||
161441445|NCT04032093|583008587|FG007|Overall Study|Withdrawal by Subject|0|||
161441446|NCT04032093|583008588|FG008|Overall Study|Withdrawal by Subject|0|||
161441447|NCT04032093|583008589|FG009|Overall Study|Withdrawal by Subject|0|||
161441448|NCT04032093|583008580|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161441449|NCT04032093|583008581|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161441450|NCT04032093|583008582|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161789383|NCT02868281|584272839|FG001|Overall Study|Withdrawal by Subject|15|||
161789384|NCT02868281|584272838|FG000|Overall Study|Physician Decision|2|||
161441451|NCT04032093|583008583|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161441452|NCT04032093|583008584|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161441453|NCT04032093|583008585|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161441454|NCT04032093|583008586|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
161441455|NCT04032093|583008587|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
161441456|NCT04032093|583008588|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
161441457|NCT04032093|583008589|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
161441458|NCT04032093|583008580|FG000|Overall Study|Adverse Event|0|||
161441459|NCT04032093|583008581|FG001|Overall Study|Adverse Event|0|||
161441460|NCT04032093|583008582|FG002|Overall Study|Adverse Event|0|||
161441461|NCT04032093|583008583|FG003|Overall Study|Adverse Event|0|||
161441462|NCT04032093|583008584|FG004|Overall Study|Adverse Event|0|||
161441463|NCT04032093|583008585|FG005|Overall Study|Adverse Event|0|||
161441464|NCT04032093|583008586|FG006|Overall Study|Adverse Event|0|||
161441465|NCT04032093|583008587|FG007|Overall Study|Adverse Event|0|||
161441466|NCT04032093|583008588|FG008|Overall Study|Adverse Event|0|||
161441467|NCT04032093|583008589|FG009|Overall Study|Adverse Event|1|||
161441468|NCT04032093|583008580|FG000|Overall Study|Physician Decision|0|||
161441469|NCT04032093|583008581|FG001|Overall Study|Physician Decision|0|||
161441470|NCT04032093|583008582|FG002|Overall Study|Physician Decision|0|||
161441471|NCT04032093|583008583|FG003|Overall Study|Physician Decision|0|||
161441472|NCT04032093|583008584|FG004|Overall Study|Physician Decision|0|||
161441473|NCT04032093|583008585|FG005|Overall Study|Physician Decision|1|||
161441474|NCT04032093|583008586|FG006|Overall Study|Physician Decision|0|||
161441475|NCT04032093|583008587|FG007|Overall Study|Physician Decision|0|||
161441476|NCT04032093|583008588|FG008|Overall Study|Physician Decision|0|||
161441477|NCT04032093|583008589|FG009|Overall Study|Physician Decision|0|||
161441478|NCT02699749|583008592|FG000|Overall Study|Other|0|||
161441479|NCT02699749|583008593|FG001|Overall Study|Other|0|||
161441480|NCT02699749|583008594|FG002|Overall Study|Other|2|||
161441481|NCT02699749|583008595|FG003|Overall Study|Other|0|||
161441482|NCT02699749|583008596|FG004|Overall Study|Other|0|||
161441483|NCT02699749|583008597|FG005|Overall Study|Other|1|||
161441484|NCT02699749|583008598|FG006|Overall Study|Other|1|||
161441485|NCT02699749|583008599|FG007|Overall Study|Other|0|||
161441486|NCT02699749|583008600|FG008|Overall Study|Other|0|||
161441487|NCT02699749|583008601|FG009|Overall Study|Other|0|||
161441488|NCT02699749|583008602|FG010|Overall Study|Other|1|||
161441489|NCT02699749|583008603|FG011|Overall Study|Other|0|||
161441490|NCT02699749|583008604|FG012|Overall Study|Other|0|||
161441491|NCT02699749|583008605|FG013|Overall Study|Other|0|||
161441492|NCT02699749|583008592|FG000|Overall Study|Progressive Disease|3|||
161441493|NCT02699749|583008593|FG001|Overall Study|Progressive Disease|3|||
161441494|NCT02699749|583008594|FG002|Overall Study|Progressive Disease|14|||
161441495|NCT02699749|583008595|FG003|Overall Study|Progressive Disease|3|||
161441496|NCT02699749|583008596|FG004|Overall Study|Progressive Disease|3|||
161441497|NCT02699749|583008597|FG005|Overall Study|Progressive Disease|7|||
161441498|NCT02699749|583008598|FG006|Overall Study|Progressive Disease|5|||
161441499|NCT02699749|583008599|FG007|Overall Study|Progressive Disease|5|||
161441500|NCT02699749|583008600|FG008|Overall Study|Progressive Disease|6|||
161441501|NCT02699749|583008601|FG009|Overall Study|Progressive Disease|6|||
161441502|NCT02699749|583008602|FG010|Overall Study|Progressive Disease|5|||
161441503|NCT02699749|583008603|FG011|Overall Study|Progressive Disease|4|||
161441504|NCT02699749|583008604|FG012|Overall Study|Progressive Disease|3|||
161441505|NCT02699749|583008605|FG013|Overall Study|Progressive Disease|5|||
161441506|NCT02699749|583008592|FG000|Overall Study|Death|0|||
161441507|NCT02699749|583008593|FG001|Overall Study|Death|0|||
161441508|NCT02699749|583008594|FG002|Overall Study|Death|0|||
161441509|NCT02699749|583008595|FG003|Overall Study|Death|0|||
161441510|NCT02699749|583008596|FG004|Overall Study|Death|0|||
161441511|NCT02699749|583008597|FG005|Overall Study|Death|0|||
161441512|NCT02699749|583008598|FG006|Overall Study|Death|0|||
161441513|NCT02699749|583008599|FG007|Overall Study|Death|0|||
161441514|NCT02699749|583008600|FG008|Overall Study|Death|0|||
161441515|NCT02699749|583008601|FG009|Overall Study|Death|0|||
161441516|NCT02699749|583008602|FG010|Overall Study|Death|0|||
161441517|NCT02699749|583008603|FG011|Overall Study|Death|0|||
161898703|NCT00872521|584677878|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
161441518|NCT02699749|583008604|FG012|Overall Study|Death|0|||
161441519|NCT02699749|583008605|FG013|Overall Study|Death|1|||
161441520|NCT02699749|583008592|FG000|Overall Study|Lost to Follow-up|0|||
161441521|NCT02699749|583008593|FG001|Overall Study|Lost to Follow-up|0|||
161441522|NCT02699749|583008594|FG002|Overall Study|Lost to Follow-up|0|||
161441523|NCT02699749|583008595|FG003|Overall Study|Lost to Follow-up|0|||
161441524|NCT02699749|583008596|FG004|Overall Study|Lost to Follow-up|0|||
161441525|NCT02699749|583008597|FG005|Overall Study|Lost to Follow-up|1|||
161441526|NCT02699749|583008598|FG006|Overall Study|Lost to Follow-up|0|||
161441527|NCT02699749|583008599|FG007|Overall Study|Lost to Follow-up|1|||
161441528|NCT02699749|583008600|FG008|Overall Study|Lost to Follow-up|0|||
161441529|NCT02699749|583008601|FG009|Overall Study|Lost to Follow-up|0|||
161441530|NCT02699749|583008602|FG010|Overall Study|Lost to Follow-up|0|||
161441531|NCT02699749|583008603|FG011|Overall Study|Lost to Follow-up|0|||
161441532|NCT02699749|583008604|FG012|Overall Study|Lost to Follow-up|0|||
161441533|NCT02699749|583008605|FG013|Overall Study|Lost to Follow-up|0|||
161441534|NCT02377817|583008607|FG000|Overall Study|Transportation/childcare barriers.|2|||
161441535|NCT02377817|583008608|FG001|Overall Study|Transportation/childcare barriers.|0|||
161441536|NCT02377817|583008607|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
161441537|NCT02377817|583008608|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
161441538|NCT04139018|583008609|FG000|Overall Study|Screen fail|1|||
161441539|NCT04139018|583008610|FG001|Overall Study|Screen fail|0|||
161441540|NCT04139018|583008609|FG000|Overall Study|Withdrawal by Subject|2|||
161441541|NCT04139018|583008610|FG001|Overall Study|Withdrawal by Subject|0|||
161441542|NCT04139018|583008609|FG000|Overall Study|Lost to Follow-up|0|||
161441543|NCT04139018|583008610|FG001|Overall Study|Lost to Follow-up|1|||
161441544|NCT02565108|583008611|FG000|Overall Study|Adverse Event|1|||
161441545|NCT02565108|583008612|FG001|Overall Study|Adverse Event|0|||
161441546|NCT02565108|583008611|FG000|Overall Study|Withdrew Consent|1|||
161441547|NCT02565108|583008612|FG001|Overall Study|Withdrew Consent|0|||
161441548|NCT01310075|583008629|FG000|Overall Study|Lost to Follow-up|1|||
161441549|NCT01310075|583008630|FG001|Overall Study|Lost to Follow-up|0|||
161441550|NCT01310075|583008629|FG000|Overall Study|Physician Decision|10|||
161441551|NCT01310075|583008630|FG001|Overall Study|Physician Decision|7|||
161441552|NCT01310075|583008629|FG000|Overall Study|Protocol Violation|2|||
161441553|NCT01310075|583008630|FG001|Overall Study|Protocol Violation|2|||
161441554|NCT01310075|583008629|FG000|Overall Study|Withdrawal by Subject|1|||
161441555|NCT01310075|583008630|FG001|Overall Study|Withdrawal by Subject|1|||
161441556|NCT01696188|583008632|FG000|Overall Study|Protocol Violation|1|||
161441557|NCT01696188|583008633|FG001|Overall Study|Protocol Violation|1|||
161441558|NCT02425943|583008634|FG000|Overall Study|Adverse Event|3|||
161441559|NCT02425943|583008635|FG001|Overall Study|Adverse Event|1|||
161441560|NCT02425943|583008634|FG000|Overall Study|Lost to Follow-up|59|||
161441561|NCT02425943|583008635|FG001|Overall Study|Lost to Follow-up|37|||
161441562|NCT02425943|583008634|FG000|Overall Study|Protocol Violation|4|||
161441563|NCT02425943|583008635|FG001|Overall Study|Protocol Violation|1|||
161441564|NCT02425943|583008634|FG000|Overall Study|Withdrawal by Subject|64|||
161441565|NCT02425943|583008635|FG001|Overall Study|Withdrawal by Subject|31|||
161441566|NCT02425943|583008634|FG000|Overall Study|Other|6|||
161441567|NCT02425943|583008635|FG001|Overall Study|Other|0|||
161441568|NCT01106248|583008637|FG000|Overall Study|Adverse Event|1|||
161441569|NCT01106248|583008637|FG000|Overall Study|Administrative|2|||
161441570|NCT01209325|583008638|FG000|Overall Study|Lost to Follow-up|24|||
161441571|NCT01209325|583008638|FG000|Overall Study|Adverse Event|1|||
161441572|NCT01209325|583008638|FG000|Overall Study|Relocated|3|||
161441573|NCT01209325|583008638|FG000|Overall Study|Refusal after starting therapy|8|||
161441574|NCT01209325|583008638|FG000|Overall Study|Protocol Violation|4|||
161441575|NCT01209325|583008638|FG000|Overall Study|Refusal prior to therapy|1|||
161441576|NCT01209325|583008638|FG000|Overall Study|Incarceration|2|||
161441577|NCT01160822|583008639|FG000|Overall Study|Adverse Event|0|||
161441578|NCT01160822|583008640|FG001|Overall Study|Adverse Event|0|||
161441579|NCT01160822|583008641|FG002|Overall Study|Adverse Event|0|||
161441580|NCT01160822|583008642|FG003|Overall Study|Adverse Event|0|||
161441581|NCT01160822|583008643|FG004|Overall Study|Adverse Event|1|||
161441582|NCT01160822|583008644|FG005|Overall Study|Adverse Event|2|||
161441583|NCT01160822|583008645|FG006|Overall Study|Adverse Event|5|||
161441584|NCT01160822|583008639|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161441585|NCT01160822|583008640|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161441586|NCT01160822|583008641|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161441587|NCT01160822|583008642|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161441588|NCT01160822|583008643|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
161441589|NCT01160822|583008644|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
161441590|NCT01160822|583008645|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
161441591|NCT01160822|583008639|FG000|Overall Study|Withdrawal by Subject|0|||
161441592|NCT01160822|583008640|FG001|Overall Study|Withdrawal by Subject|0|||
161441593|NCT01160822|583008641|FG002|Overall Study|Withdrawal by Subject|0|||
161441594|NCT01160822|583008642|FG003|Overall Study|Withdrawal by Subject|0|||
161441595|NCT01160822|583008643|FG004|Overall Study|Withdrawal by Subject|0|||
161441596|NCT01160822|583008644|FG005|Overall Study|Withdrawal by Subject|0|||
161441597|NCT01160822|583008645|FG006|Overall Study|Withdrawal by Subject|1|||
161441598|NCT01160822|583008639|FG000|Overall Study|Lost to Follow-up|0|||
161441599|NCT01160822|583008640|FG001|Overall Study|Lost to Follow-up|0|||
161441600|NCT01160822|583008641|FG002|Overall Study|Lost to Follow-up|0|||
161441601|NCT01160822|583008642|FG003|Overall Study|Lost to Follow-up|0|||
161441602|NCT01160822|583008643|FG004|Overall Study|Lost to Follow-up|1|||
161441603|NCT01160822|583008644|FG005|Overall Study|Lost to Follow-up|0|||
161441604|NCT01160822|583008645|FG006|Overall Study|Lost to Follow-up|0|||
161441605|NCT01160822|583008639|FG000|Overall Study|Administrative problems|0|||
161441606|NCT01160822|583008640|FG001|Overall Study|Administrative problems|0|||
161441607|NCT01160822|583008641|FG002|Overall Study|Administrative problems|0|||
161898704|NCT00872521|584677879|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
161441608|NCT01160822|583008642|FG003|Overall Study|Administrative problems|0|||
161441609|NCT01160822|583008643|FG004|Overall Study|Administrative problems|1|||
161441610|NCT01160822|583008644|FG005|Overall Study|Administrative problems|0|||
161441611|NCT01160822|583008645|FG006|Overall Study|Administrative problems|0|||
161441612|NCT01160822|583008639|FG000|Overall Study|Protocol deviation|0|||
161441613|NCT01160822|583008640|FG001|Overall Study|Protocol deviation|0|||
161441614|NCT01160822|583008641|FG002|Overall Study|Protocol deviation|0|||
161441615|NCT01160822|583008642|FG003|Overall Study|Protocol deviation|0|||
161441616|NCT01160822|583008643|FG004|Overall Study|Protocol deviation|2|||
161441617|NCT01160822|583008644|FG005|Overall Study|Protocol deviation|0|||
161441618|NCT01160822|583008645|FG006|Overall Study|Protocol deviation|0|||
161441619|NCT01648751|583008658|FG000|Overall Study|Withdrawal by Subject|2|||
161441620|NCT01648751|583008659|FG001|Overall Study|Withdrawal by Subject|3|||
161441621|NCT03467750|583008661|FG000|Overall Study|Surgery canceled|1|||
161441622|NCT03467750|583008662|FG001|Overall Study|Surgery canceled|0|||
161441623|NCT03467750|583008661|FG000|Overall Study|Protocol Violation|1|||
161441624|NCT03467750|583008662|FG001|Overall Study|Protocol Violation|1|||
161441625|NCT03467750|583008661|FG000|Overall Study|Withdrawal by Subject|0|||
161441626|NCT03467750|583008662|FG001|Overall Study|Withdrawal by Subject|1|||
161441627|NCT05673876|583008663|FG000|Overall Study|Death|3|||
161441628|NCT05673876|583008664|FG001|Overall Study|Death|1|||
161441629|NCT05673876|583008663|FG000|Overall Study|Study Terminated by Sponsor|0|||
161441630|NCT05673876|583008664|FG001|Overall Study|Study Terminated by Sponsor|1|||
161441631|NCT05673876|583008663|FG000|Overall Study|Physician Decision|0|||
161441632|NCT05673876|583008664|FG001|Overall Study|Physician Decision|1|||
161441633|NCT03529422|583008665|FG000|Overall Study|Withdrawal by Subject|1|||
161441634|NCT03529422|583008665|FG000|Overall Study|Protocol Violation|1|||
161441635|NCT03529422|583008665|FG000|Overall Study|Disease progression|2|||
161441636|NCT02000115|583008668|FG000|Overall Study|Death|56|||
161441637|NCT02000115|583008669|FG001|Overall Study|Death|45|||
161441638|NCT02000115|583008670|FG002|Overall Study|Death|0|||
161441639|NCT02000115|583008671|FG003|Overall Study|Death|0|||
161441640|NCT02000115|583008668|FG000|Overall Study|Missed Visit|6|||
161441641|NCT02000115|583008669|FG001|Overall Study|Missed Visit|8|||
161441642|NCT02000115|583008670|FG002|Overall Study|Missed Visit|1|||
161441643|NCT02000115|583008671|FG003|Overall Study|Missed Visit|0|||
161441644|NCT02000115|583008668|FG000|Overall Study|Protocol Violation|2|||
161441645|NCT02000115|583008669|FG001|Overall Study|Protocol Violation|1|||
161441646|NCT02000115|583008670|FG002|Overall Study|Protocol Violation|0|||
161441647|NCT02000115|583008671|FG003|Overall Study|Protocol Violation|0|||
161441648|NCT02000115|583008668|FG000|Overall Study|Physician Decision|2|||
161441649|NCT02000115|583008669|FG001|Overall Study|Physician Decision|0|||
161441650|NCT02000115|583008670|FG002|Overall Study|Physician Decision|0|||
161441651|NCT02000115|583008671|FG003|Overall Study|Physician Decision|0|||
161441652|NCT02000115|583008668|FG000|Overall Study|Withdrawal by Subject|11|||
161441653|NCT02000115|583008669|FG001|Overall Study|Withdrawal by Subject|11|||
161441654|NCT02000115|583008670|FG002|Overall Study|Withdrawal by Subject|0|||
161441655|NCT02000115|583008671|FG003|Overall Study|Withdrawal by Subject|0|||
161441656|NCT02000115|583008668|FG000|Overall Study|Lost to Follow-up|0|||
161441657|NCT02000115|583008669|FG001|Overall Study|Lost to Follow-up|1|||
161441658|NCT02000115|583008670|FG002|Overall Study|Lost to Follow-up|0|||
161441659|NCT02000115|583008671|FG003|Overall Study|Lost to Follow-up|0|||
161441660|NCT02000115|583008668|FG000|Overall Study|Non-compliance|2|||
161441661|NCT02000115|583008669|FG001|Overall Study|Non-compliance|1|||
161441662|NCT02000115|583008670|FG002|Overall Study|Non-compliance|0|||
161441663|NCT02000115|583008671|FG003|Overall Study|Non-compliance|0|||
161441664|NCT02000115|583008668|FG000|Overall Study|Withdrawn on day of randomization|0|||
161441665|NCT02000115|583008669|FG001|Overall Study|Withdrawn on day of randomization|1|||
161441666|NCT02000115|583008670|FG002|Overall Study|Withdrawn on day of randomization|0|||
161441667|NCT02000115|583008671|FG003|Overall Study|Withdrawn on day of randomization|0|||
161441668|NCT02000115|583008668|FG000|Overall Study|Still on Study|0|||
161441669|NCT02000115|583008669|FG001|Overall Study|Still on Study|0|||
161441670|NCT02000115|583008670|FG002|Overall Study|Still on Study|0|||
161789385|NCT02868281|584272839|FG001|Overall Study|Physician Decision|0|||
161441671|NCT02000115|583008671|FG003|Overall Study|Still on Study|53|||
161441672|NCT05006573|583008674|FG000|Double-blind Treatment Period|Physician Decision|2|||
161441673|NCT05006573|583008675|FG001|Double-blind Treatment Period|Physician Decision|0|||
161441674|NCT05006573|583008674|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
161441675|NCT05006573|583008675|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
161441676|NCT05006573|583008674|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
161441677|NCT05006573|583008675|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161441678|NCT05006573|583008674|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161441679|NCT05006573|583008675|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161441680|NCT05006573|583008674|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
161441681|NCT05006573|583008675|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
161441682|NCT05006573|583008674|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
161441683|NCT05006573|583008675|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
161441684|NCT01967238|583008676|FG000|Overall Study|Adverse Event|1|||
161441685|NCT01967238|583008677|FG001|Overall Study|Adverse Event|1|||
161441686|NCT01967238|583008678|FG002|Overall Study|Adverse Event|0|||
161441687|NCT01967238|583008676|FG000|Overall Study|Lost to Follow-up|1|||
161441688|NCT01967238|583008677|FG001|Overall Study|Lost to Follow-up|0|||
161441689|NCT01967238|583008678|FG002|Overall Study|Lost to Follow-up|1|||
161441690|NCT01967238|583008676|FG000|Overall Study|Withdrawal by Subject|0|||
161441691|NCT01967238|583008677|FG001|Overall Study|Withdrawal by Subject|0|||
161441692|NCT01967238|583008678|FG002|Overall Study|Withdrawal by Subject|1|||
161441693|NCT02484391|583008679|FG000|Overall Study|Lack of Efficacy|15|||
161441694|NCT02484391|583008680|FG001|Overall Study|Lack of Efficacy|14|||
161441695|NCT02484391|583008681|FG002|Overall Study|Lack of Efficacy|3|||
161441696|NCT02484391|583008679|FG000|Overall Study|Lost to Follow-up|0|||
161441697|NCT02484391|583008680|FG001|Overall Study|Lost to Follow-up|0|||
161441698|NCT02484391|583008681|FG002|Overall Study|Lost to Follow-up|2|||
161441699|NCT02484391|583008679|FG000|Overall Study|Physician Decision|1|||
161441700|NCT02484391|583008680|FG001|Overall Study|Physician Decision|3|||
161441701|NCT02484391|583008681|FG002|Overall Study|Physician Decision|0|||
161441702|NCT02484391|583008679|FG000|Overall Study|Went to Transplant|5|||
161441703|NCT02484391|583008680|FG001|Overall Study|Went to Transplant|3|||
161441704|NCT02484391|583008681|FG002|Overall Study|Went to Transplant|2|||
161441705|NCT04922216|583008685|FG000|Overall Study|Withdrawal by Subject|0|||
161441706|NCT04922216|583008686|FG001|Overall Study|Withdrawal by Subject|1|||
161441707|NCT04922216|583008687|FG002|Overall Study|Withdrawal by Subject|0|||
161441708|NCT04922216|583008688|FG003|Overall Study|Withdrawal by Subject|0|||
161441709|NCT04922216|583008689|FG004|Overall Study|Withdrawal by Subject|0|||
161441710|NCT04922216|583008690|FG005|Overall Study|Withdrawal by Subject|0|||
161441711|NCT04922216|583008691|FG006|Overall Study|Withdrawal by Subject|0|||
161441712|NCT04922216|583008692|FG007|Overall Study|Withdrawal by Subject|2|||
161441713|NCT04922216|583008693|FG008|Overall Study|Withdrawal by Subject|0|||
161441714|NCT04922216|583008694|FG009|Overall Study|Withdrawal by Subject|0|||
161441715|NCT04922216|583008695|FG010|Overall Study|Withdrawal by Subject|0|||
161441716|NCT04922216|583008696|FG011|Overall Study|Withdrawal by Subject|0|||
161441717|NCT04922216|583008697|FG012|Overall Study|Withdrawal by Subject|1|||
161441718|NCT04922216|583008698|FG013|Overall Study|Withdrawal by Subject|1|||
161441719|NCT04922216|583008699|FG014|Overall Study|Withdrawal by Subject|1|||
161441720|NCT04922216|583008700|FG015|Overall Study|Withdrawal by Subject|0|||
161441721|NCT04922216|583008701|FG016|Overall Study|Withdrawal by Subject|0|||
161441722|NCT04922216|583008702|FG017|Overall Study|Withdrawal by Subject|1|||
161441723|NCT04922216|583008703|FG018|Overall Study|Withdrawal by Subject|1|||
161441724|NCT04922216|583008704|FG019|Overall Study|Withdrawal by Subject|1|||
161441725|NCT04922216|583008705|FG020|Overall Study|Withdrawal by Subject|1|||
161441726|NCT04922216|583008706|FG021|Overall Study|Withdrawal by Subject|0|||
161441727|NCT04922216|583008707|FG022|Overall Study|Withdrawal by Subject|0|||
161441728|NCT04922216|583008708|FG023|Overall Study|Withdrawal by Subject|2|||
161441729|NCT04922216|583008709|FG024|Overall Study|Withdrawal by Subject|0|||
161441730|NCT04922216|583008710|FG025|Overall Study|Withdrawal by Subject|0|||
161441731|NCT04922216|583008711|FG026|Overall Study|Withdrawal by Subject|1|||
161441732|NCT04922216|583008712|FG027|Overall Study|Withdrawal by Subject|0|||
161441733|NCT04922216|583008713|FG028|Overall Study|Withdrawal by Subject|0|||
161441734|NCT04922216|583008714|FG029|Overall Study|Withdrawal by Subject|0|||
161441735|NCT04922216|583008715|FG030|Overall Study|Withdrawal by Subject|1|||
161441736|NCT04922216|583008716|FG031|Overall Study|Withdrawal by Subject|0|||
161441737|NCT04922216|583008685|FG000|Overall Study|Lost to Follow-up|1|||
161441738|NCT04922216|583008686|FG001|Overall Study|Lost to Follow-up|0|||
161441739|NCT04922216|583008687|FG002|Overall Study|Lost to Follow-up|2|||
161441740|NCT04922216|583008688|FG003|Overall Study|Lost to Follow-up|0|||
161441741|NCT04922216|583008689|FG004|Overall Study|Lost to Follow-up|0|||
161441742|NCT04922216|583008690|FG005|Overall Study|Lost to Follow-up|2|||
161441743|NCT04922216|583008691|FG006|Overall Study|Lost to Follow-up|0|||
161441744|NCT04922216|583008692|FG007|Overall Study|Lost to Follow-up|1|||
161441745|NCT04922216|583008693|FG008|Overall Study|Lost to Follow-up|1|||
161441746|NCT04922216|583008694|FG009|Overall Study|Lost to Follow-up|2|||
161441747|NCT04922216|583008695|FG010|Overall Study|Lost to Follow-up|2|||
161441748|NCT04922216|583008696|FG011|Overall Study|Lost to Follow-up|1|||
161441749|NCT04922216|583008697|FG012|Overall Study|Lost to Follow-up|1|||
161441750|NCT04922216|583008698|FG013|Overall Study|Lost to Follow-up|0|||
161441751|NCT04922216|583008699|FG014|Overall Study|Lost to Follow-up|1|||
161898705|NCT00872521|584677880|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
161898706|NCT05225558|584677881|FG000|Overall Study|Withdrawal by Subject|4|||
161441752|NCT04922216|583008700|FG015|Overall Study|Lost to Follow-up|0|||
161441753|NCT04922216|583008701|FG016|Overall Study|Lost to Follow-up|0|||
161441754|NCT04922216|583008702|FG017|Overall Study|Lost to Follow-up|2|||
161441755|NCT04922216|583008703|FG018|Overall Study|Lost to Follow-up|1|||
161441756|NCT04922216|583008704|FG019|Overall Study|Lost to Follow-up|0|||
161441757|NCT04922216|583008705|FG020|Overall Study|Lost to Follow-up|1|||
161441758|NCT04922216|583008706|FG021|Overall Study|Lost to Follow-up|0|||
161441759|NCT04922216|583008707|FG022|Overall Study|Lost to Follow-up|2|||
161441760|NCT04922216|583008708|FG023|Overall Study|Lost to Follow-up|1|||
161441761|NCT04922216|583008709|FG024|Overall Study|Lost to Follow-up|0|||
161441762|NCT04922216|583008710|FG025|Overall Study|Lost to Follow-up|2|||
161441763|NCT04922216|583008711|FG026|Overall Study|Lost to Follow-up|0|||
161441764|NCT04922216|583008712|FG027|Overall Study|Lost to Follow-up|0|||
161441765|NCT04922216|583008713|FG028|Overall Study|Lost to Follow-up|1|||
161441766|NCT04922216|583008714|FG029|Overall Study|Lost to Follow-up|0|||
161441767|NCT04922216|583008715|FG030|Overall Study|Lost to Follow-up|2|||
161441768|NCT04922216|583008716|FG031|Overall Study|Lost to Follow-up|1|||
161441769|NCT03278249|583008717|FG000|Overall Study|Withdrawal by Subject|2|||
161441770|NCT03278249|583008717|FG000|Overall Study|Lost to Follow-up|1|||
161441771|NCT01442103|583010257|FG000|Overall Study|Lost to Follow-up|2|||
161441772|NCT03207763|583010263|FG000|Overall Study|Lost to Follow-up|1|||
161441773|NCT03207763|583010264|FG001|Overall Study|Lost to Follow-up|0|||
161441774|NCT02102204|583010265|FG000|Overall Study|Withdrawal by Subject|137|||
161441775|NCT02102204|583010265|FG000|Overall Study|Death|92|||
161441776|NCT02102204|583010265|FG000|Overall Study|Lost to Follow-up|65|||
161441777|NCT02102204|583010265|FG000|Overall Study|Sponsor Decision|5|||
161441778|NCT02102204|583010265|FG000|Overall Study|Ongoing|5|||
161441779|NCT02605122|583010266|FG000|Overall Study|Withdrawal by Subject|4|||
161441780|NCT02605122|583010267|FG001|Overall Study|Withdrawal by Subject|1|||
161441781|NCT02605122|583010266|FG000|Overall Study|Lost to Follow-up|1|||
161441782|NCT02605122|583010267|FG001|Overall Study|Lost to Follow-up|1|||
161441783|NCT00990704|583010268|FG000|Overall Study|Adverse Event|1|||
161441784|NCT00990704|583010269|FG001|Overall Study|Adverse Event|1|||
161441785|NCT00990704|583010268|FG000|Overall Study|Physician Decision|0|||
161441786|NCT00990704|583010269|FG001|Overall Study|Physician Decision|1|||
161441787|NCT00807001|583010271|FG000|Overall Study|Non-compliance|0|||
161441788|NCT00807001|583010272|FG001|Overall Study|Non-compliance|1|||
161441789|NCT00807001|583010273|FG002|Overall Study|Non-compliance|0|||
161441790|NCT00807001|583010274|FG003|Overall Study|Non-compliance|0|||
161441791|NCT00807001|583010275|FG004|Overall Study|Non-compliance|0|||
161441792|NCT01399372|583010277|FG000|Overall Study|Protocol Violation|3|||
161441793|NCT01399372|583010278|FG001|Overall Study|Protocol Violation|1|||
161441794|NCT03773796|583010279|FG000|Overall Study|Adverse Event|1|||
161441795|NCT03773796|583010279|FG000|Overall Study|Withdrawal by Subject|1|||
161441796|NCT03773796|583010279|FG000|Overall Study|Lack of Efficacy|1|||
161441797|NCT03805659|583010281|FG000|Overall Study|Withdrawal by Subject|0|||
161441798|NCT03805659|583010282|FG001|Overall Study|Withdrawal by Subject|1|||
161441799|NCT01027273|583010284|FG000|Overall Study|Lost to Follow-up|57|||
161441800|NCT01027273|583010285|FG001|Overall Study|Lost to Follow-up|31|||
161441801|NCT01027273|583010284|FG000|Overall Study|Death|2|||
161441802|NCT01027273|583010285|FG001|Overall Study|Death|2|||
161441803|NCT00499616|583010293|FG000|Overall Study|Death|1|||
161441804|NCT00499616|583010294|FG001|Overall Study|Death|5|||
161441805|NCT00499616|583010295|FG002|Overall Study|Death|3|||
161441806|NCT00499616|583010296|FG003|Overall Study|Death|1|||
161441807|NCT00499616|583010293|FG000|Overall Study|Lack of Efficacy|5|||
161441808|NCT00499616|583010294|FG001|Overall Study|Lack of Efficacy|0|||
161789386|NCT02868281|584272838|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
161789387|NCT02868281|584272839|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
161789388|NCT02868281|584272838|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
161789389|NCT02868281|584272839|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
161789390|NCT02868281|584272838|FG000|Overall Study|Long journey/moving away|1|||
161789391|NCT02868281|584272839|FG001|Overall Study|Long journey/moving away|1|||
161789392|NCT01722266|584272844|FG000|Overall Study|Withdrawal by Subject|1|||
161789393|NCT01722266|584272845|FG001|Overall Study|Withdrawal by Subject|2|||
161789394|NCT01722266|584272846|FG002|Overall Study|Withdrawal by Subject|0|||
161789395|NCT01722266|584272847|FG003|Overall Study|Withdrawal by Subject|0|||
161789396|NCT01722266|584272844|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
161789397|NCT01722266|584272845|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
161789398|NCT01722266|584272846|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
161441809|NCT00499616|583010295|FG002|Overall Study|Lack of Efficacy|19|||
161441810|NCT00499616|583010296|FG003|Overall Study|Lack of Efficacy|0|||
161441811|NCT00499616|583010293|FG000|Overall Study|Lost to Follow-up|0|||
161441812|NCT00499616|583010294|FG001|Overall Study|Lost to Follow-up|0|||
161441813|NCT00499616|583010295|FG002|Overall Study|Lost to Follow-up|1|||
161441814|NCT00499616|583010296|FG003|Overall Study|Lost to Follow-up|0|||
161441815|NCT00499616|583010293|FG000|Overall Study|Physician Decision|6|||
161441816|NCT00499616|583010294|FG001|Overall Study|Physician Decision|16|||
161789399|NCT01722266|584272847|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
161789400|NCT01722266|584272844|FG000|Overall Study|Dropped out due to Nausea|0|||
161789401|NCT01722266|584272845|FG001|Overall Study|Dropped out due to Nausea|0|||
161441817|NCT00499616|583010295|FG002|Overall Study|Physician Decision|9|||
161441818|NCT00499616|583010296|FG003|Overall Study|Physician Decision|0|||
161441819|NCT00499616|583010293|FG000|Overall Study|Withdrawal by Subject|1|||
161441820|NCT00499616|583010294|FG001|Overall Study|Withdrawal by Subject|0|||
161441821|NCT00499616|583010295|FG002|Overall Study|Withdrawal by Subject|1|||
161441822|NCT00499616|583010296|FG003|Overall Study|Withdrawal by Subject|0|||
161441823|NCT00499616|583010293|FG000|Overall Study|Ineligible|1|||
161441824|NCT00499616|583010294|FG001|Overall Study|Ineligible|2|||
161441825|NCT00499616|583010295|FG002|Overall Study|Ineligible|0|||
161441826|NCT00499616|583010296|FG003|Overall Study|Ineligible|15|||
161441827|NCT00499616|583010293|FG000|Overall Study|Not evaluable|0|||
161441828|NCT00499616|583010294|FG001|Overall Study|Not evaluable|0|||
161441829|NCT00499616|583010295|FG002|Overall Study|Not evaluable|0|||
161441830|NCT00499616|583010296|FG003|Overall Study|Not evaluable|41|||
161441831|NCT00499616|583010293|FG000|Overall Study|Patient/Parent Refusal|1|||
161441832|NCT00499616|583010294|FG001|Overall Study|Patient/Parent Refusal|5|||
161441833|NCT00499616|583010295|FG002|Overall Study|Patient/Parent Refusal|3|||
161441834|NCT00499616|583010296|FG003|Overall Study|Patient/Parent Refusal|0|||
161441835|NCT02636595|583010297|FG000|Overall Study|Lost to Follow-up|1|||
161441836|NCT02636595|583010297|FG000|Overall Study|Other|1|||
161441837|NCT02223858|583010298|FG000|Overall Study|Death|1|||
161441838|NCT02223858|583010299|FG001|Overall Study|Death|1|||
161441839|NCT02223858|583010298|FG000|Overall Study|Lost to Follow-up|6|||
161441840|NCT02223858|583010299|FG001|Overall Study|Lost to Follow-up|11|||
161441841|NCT02223858|583010298|FG000|Overall Study|Withdrawal by Subject|8|||
161441842|NCT02223858|583010299|FG001|Overall Study|Withdrawal by Subject|5|||
161441843|NCT02223858|583010298|FG000|Overall Study|Refused|9|||
161441844|NCT02223858|583010299|FG001|Overall Study|Refused|9|||
161441845|NCT00241839|583010301|FG000|Overall Study|Withdrawal by Subject|18|||
161441846|NCT00241839|583010302|FG001|Overall Study|Withdrawal by Subject|17|||
161441847|NCT00241839|583010301|FG000|Overall Study|Adverse Event|1|||
161441848|NCT00241839|583010302|FG001|Overall Study|Adverse Event|1|||
161441849|NCT00831181|583010305|FG000|Overall Study|Adverse Event|12|||
161441850|NCT04313244|583010306|FG000|Overall Study|Withdrawal of Consent|3|||
161441851|NCT04313244|583010307|FG001|Overall Study|Withdrawal of Consent|3|||
161441852|NCT04313244|583010306|FG000|Overall Study|Met Exclusion Criteria|1|||
161441853|NCT04313244|583010307|FG001|Overall Study|Met Exclusion Criteria|0|||
161441854|NCT04313244|583010306|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
161441855|NCT04313244|583010307|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
161441856|NCT02976038|583010308|FG000|Overall Study|Physician Decision|22|||
161441857|NCT02976038|583010308|FG000|Overall Study|Withdrawal by Subject|3|||
161441858|NCT02976038|583010308|FG000|Overall Study|Lost to Follow-up|2|||
161441859|NCT02976038|583010308|FG000|Overall Study|Adverse Event|1|||
161441860|NCT05021978|583010311|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
161441861|NCT05021978|583010312|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
161441862|NCT05021978|583010313|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
161441863|NCT05021978|583010314|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
161441864|NCT05021978|583010311|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
161441865|NCT05021978|583010312|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
161441866|NCT05021978|583010313|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
161441867|NCT05021978|583010314|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
161441868|NCT00196313|583010315|FG000|Overall Study|Protocol Violation|2|||
161441869|NCT00196313|583010316|FG001|Overall Study|Protocol Violation|3|||
161441870|NCT00196313|583010315|FG000|Overall Study|Withdrawal by Subject|3|||
161441871|NCT00196313|583010316|FG001|Overall Study|Withdrawal by Subject|1|||
161441872|NCT00196313|583010315|FG000|Overall Study|Adverse Event|3|||
161441873|NCT00196313|583010316|FG001|Overall Study|Adverse Event|1|||
161441874|NCT00196313|583010315|FG000|Overall Study|Subject Pregnant|1|||
161441875|NCT00196313|583010316|FG001|Overall Study|Subject Pregnant|1|||
161441876|NCT00196313|583010315|FG000|Overall Study|Lost to Follow-up|2|||
161441877|NCT00196313|583010316|FG001|Overall Study|Lost to Follow-up|2|||
161441878|NCT00043979|583010317|FG000|Period 1|recipient with progressive disease|7|||
161441879|NCT00043979|583010318|FG001|Period 1|recipient with progressive disease|4|||
161441880|NCT00043979|583010319|FG002|Period 1|recipient with progressive disease|3|||
161441881|NCT03096288|583010321|FG000|Overall Study|Withdrawal by Subject|0|||
161441882|NCT03096288|583010322|FG001|Overall Study|Withdrawal by Subject|1|||
161441883|NCT03096288|583010323|FG002|Overall Study|Withdrawal by Subject|0|||
161441884|NCT03096288|583010324|FG003|Overall Study|Withdrawal by Subject|1|||
161441885|NCT04639258|583010325|FG000|Overall Study|Screen failure|5|||
161441886|NCT04639258|583010325|FG000|Overall Study|Physician Decision|2|||
161441887|NCT04639258|583010325|FG000|Overall Study|Early study termination|3|||
161441888|NCT04639258|583010325|FG000|Overall Study|Withdrawal by Subject|1|||
161441889|NCT00414596|583010326|FG000|Overall Study|Protocol Violation|2|||
161441890|NCT01635153|583010329|FG000|Overall Study|Lost to Follow-up|40|||
161441891|NCT01635153|583010330|FG001|Overall Study|Lost to Follow-up|43|||
161441892|NCT02558296|583010331|FG000|Completed the Study Through Week 24|Adverse Event|9|||
161441893|NCT02558296|583010332|FG001|Completed the Study Through Week 24|Adverse Event|3|||
161441894|NCT02558296|583010331|FG000|Completed the Study Through Week 24|Death|7|||
161441895|NCT02558296|583010332|FG001|Completed the Study Through Week 24|Death|7|||
161441896|NCT02558296|583010331|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
161441897|NCT02558296|583010332|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
161441898|NCT02558296|583010331|FG000|Completed the Study Through Week 24|Physician Decision|1|||
161441899|NCT02558296|583010332|FG001|Completed the Study Through Week 24|Physician Decision|0|||
161441900|NCT02558296|583010331|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
161441901|NCT02558296|583010332|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
161441902|NCT02558296|583010331|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
161441903|NCT02558296|583010332|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
161441904|NCT02558296|583010331|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
161441905|NCT02558296|583010332|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
161441906|NCT02558296|583010331|FG000|Completed the Study|Adverse Event|14|||
161441907|NCT02558296|583010332|FG001|Completed the Study|Adverse Event|5|||
161441908|NCT02558296|583010331|FG000|Completed the Study|Death|39|||
161441909|NCT02558296|583010332|FG001|Completed the Study|Death|25|||
161441910|NCT02558296|583010331|FG000|Completed the Study|Lost to Follow-up|31|||
161441911|NCT02558296|583010332|FG001|Completed the Study|Lost to Follow-up|23|||
161441912|NCT02558296|583010331|FG000|Completed the Study|Physician Decision|6|||
161441913|NCT02558296|583010332|FG001|Completed the Study|Physician Decision|0|||
161441914|NCT02558296|583010331|FG000|Completed the Study|Protocol Violation|2|||
161441915|NCT02558296|583010332|FG001|Completed the Study|Protocol Violation|1|||
161441916|NCT02558296|583010331|FG000|Completed the Study|Withdrawal by Subject|53|||
161441917|NCT02558296|583010332|FG001|Completed the Study|Withdrawal by Subject|31|||
161441918|NCT02558296|583010331|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
161441919|NCT02558296|583010332|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
161441920|NCT02919995|583010335|FG000|Overall Study|Adverse Event|0|||
161441921|NCT02919995|583010336|FG001|Overall Study|Adverse Event|0|||
161441922|NCT02919995|583010337|FG002|Overall Study|Adverse Event|0|||
161441923|NCT02919995|583010338|FG003|Overall Study|Adverse Event|0|||
161441924|NCT02919995|583010339|FG004|Overall Study|Adverse Event|0|||
161441925|NCT02919995|583010340|FG005|Overall Study|Adverse Event|1|||
161441926|NCT01263197|583010352|FG000|First Intervention (Period 1)|Adverse Event|0|||
161441927|NCT01263197|583010353|FG001|First Intervention (Period 1)|Adverse Event|0|||
161441928|NCT01263197|583010354|FG002|First Intervention (Period 1)|Adverse Event|0|||
161441929|NCT01263197|583010355|FG003|First Intervention (Period 1)|Adverse Event|0|||
161441930|NCT01263197|583010356|FG004|First Intervention (Period 1)|Adverse Event|0|||
161441931|NCT01263197|583010357|FG005|First Intervention (Period 1)|Adverse Event|1|||
161441932|NCT01263197|583010352|FG000|Washout Period 1|Protocol Violation|0|||
161441933|NCT01263197|583010353|FG001|Washout Period 1|Protocol Violation|0|||
161441934|NCT01263197|583010354|FG002|Washout Period 1|Protocol Violation|0|||
161441935|NCT01263197|583010355|FG003|Washout Period 1|Protocol Violation|0|||
161441936|NCT01263197|583010356|FG004|Washout Period 1|Protocol Violation|1|||
161441937|NCT01263197|583010357|FG005|Washout Period 1|Protocol Violation|0|||
161441938|NCT01263197|583010352|FG000|Washout Period 2|Physician Decision|0|||
161441939|NCT01263197|583010353|FG001|Washout Period 2|Physician Decision|0|||
161441940|NCT01263197|583010354|FG002|Washout Period 2|Physician Decision|0|||
161441941|NCT01263197|583010355|FG003|Washout Period 2|Physician Decision|0|||
161441942|NCT01263197|583010356|FG004|Washout Period 2|Physician Decision|0|||
161441943|NCT01263197|583010357|FG005|Washout Period 2|Physician Decision|1|||
161441944|NCT01263197|583010352|FG000|Washout Period 2|Protocol Violation|0|||
161441945|NCT01263197|583010353|FG001|Washout Period 2|Protocol Violation|0|||
161441946|NCT01263197|583010354|FG002|Washout Period 2|Protocol Violation|0|||
161441947|NCT01263197|583010355|FG003|Washout Period 2|Protocol Violation|1|||
161441948|NCT01263197|583010356|FG004|Washout Period 2|Protocol Violation|0|||
161441949|NCT01263197|583010357|FG005|Washout Period 2|Protocol Violation|0|||
161441950|NCT01263197|583010352|FG000|Third Intervention (Period 3)|Adverse Event|0|||
161441951|NCT01263197|583010353|FG001|Third Intervention (Period 3)|Adverse Event|1|||
161441952|NCT01263197|583010354|FG002|Third Intervention (Period 3)|Adverse Event|0|||
161441953|NCT01263197|583010355|FG003|Third Intervention (Period 3)|Adverse Event|0|||
161441954|NCT01263197|583010356|FG004|Third Intervention (Period 3)|Adverse Event|0|||
161441955|NCT01263197|583010357|FG005|Third Intervention (Period 3)|Adverse Event|0|||
161441956|NCT02577718|583010358|FG000|Overall Study|Death|6|||
161441957|NCT02577718|583010358|FG000|Overall Study|Withdrawal by Subject|2|||
161441958|NCT00594815|583010360|FG000|Overall Study|Never Treated|3|||
161441959|NCT00594815|583010360|FG000|Overall Study|Withdrawal by Subject|2|||
161441960|NCT00594815|583010360|FG000|Overall Study|Toxicity|4|||
161441961|NCT01932437|583010362|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
161441962|NCT01932437|583010363|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
161441963|NCT01932437|583010364|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
161441964|NCT01932437|583010365|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
161441965|NCT01932437|583010366|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
161441966|NCT01932437|583010367|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
161441967|NCT04269889|583010368|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
161441968|NCT00949702|583010373|FG000|Overall Study|Death|40|||
161441969|NCT00949702|583010373|FG000|Overall Study|Disease progression|7|||
161441970|NCT00949702|583010373|FG000|Overall Study|Withdrawal of consent|1|||
161441971|NCT01654302|583010374|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
161441972|NCT01654302|583010375|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
161441973|NCT01286480|583010376|FG000|Overall Study|Withdrawal by Subject|5|||
161441974|NCT01286480|583010377|FG001|Overall Study|Withdrawal by Subject|3|||
161441975|NCT01918306|583010378|FG000|Overall Study|progresive disease|4|||
161441976|NCT01918306|583010379|FG001|Overall Study|progresive disease|0|||
161441977|NCT01918306|583010380|FG002|Overall Study|progresive disease|1|||
161441978|NCT01918306|583010381|FG003|Overall Study|progresive disease|1|||
161441979|NCT01918306|583010378|FG000|Overall Study|Withdrawal by Subject|0|||
161441980|NCT01918306|583010379|FG001|Overall Study|Withdrawal by Subject|0|||
161441981|NCT01918306|583010380|FG002|Overall Study|Withdrawal by Subject|0|||
161441982|NCT01918306|583010381|FG003|Overall Study|Withdrawal by Subject|2|||
161441983|NCT01918306|583010378|FG000|Overall Study|neutropenia|1|||
161441984|NCT01918306|583010379|FG001|Overall Study|neutropenia|0|||
161441985|NCT01918306|583010380|FG002|Overall Study|neutropenia|0|||
161441986|NCT01918306|583010381|FG003|Overall Study|neutropenia|0|||
161441987|NCT01918306|583010378|FG000|Overall Study|Lack of Efficacy|1|||
161441988|NCT01918306|583010379|FG001|Overall Study|Lack of Efficacy|0|||
161441989|NCT01918306|583010380|FG002|Overall Study|Lack of Efficacy|0|||
161441990|NCT01918306|583010381|FG003|Overall Study|Lack of Efficacy|0|||
161441991|NCT01918306|583010378|FG000|Overall Study|progress disease, crossover|0|||
161441992|NCT01918306|583010379|FG001|Overall Study|progress disease, crossover|0|||
161441993|NCT01918306|583010380|FG002|Overall Study|progress disease, crossover|1|||
161441994|NCT01918306|583010381|FG003|Overall Study|progress disease, crossover|0|||
161441995|NCT02908672|583010386|FG000|Run-in Period|Death|12|||
161441996|NCT02908672|583010387|FG001|Run-in Period|Death|10|||
161441997|NCT02908672|583010388|FG002|Run-in Period|Death|0|||
161441998|NCT02908672|583010389|FG003|Run-in Period|Death|0|||
161441999|NCT02908672|583010386|FG000|Run-in Period|Lost to Follow-up|1|||
161442000|NCT02908672|583010387|FG001|Run-in Period|Lost to Follow-up|1|||
161442001|NCT02908672|583010388|FG002|Run-in Period|Lost to Follow-up|0|||
161442002|NCT02908672|583010389|FG003|Run-in Period|Lost to Follow-up|0|||
161442003|NCT02908672|583010386|FG000|Run-in Period|Reason Not Specified|2|||
161442004|NCT02908672|583010387|FG001|Run-in Period|Reason Not Specified|0|||
161442005|NCT02908672|583010388|FG002|Run-in Period|Reason Not Specified|0|||
161442006|NCT02908672|583010389|FG003|Run-in Period|Reason Not Specified|0|||
161442007|NCT02908672|583010386|FG000|Run-in Period|Protocol Violation|1|||
161442008|NCT02908672|583010387|FG001|Run-in Period|Protocol Violation|1|||
161442009|NCT02908672|583010388|FG002|Run-in Period|Protocol Violation|0|||
161442010|NCT02908672|583010389|FG003|Run-in Period|Protocol Violation|0|||
161442011|NCT02908672|583010386|FG000|Run-in Period|Study Ended by Sponsor|5|||
161442012|NCT02908672|583010387|FG001|Run-in Period|Study Ended by Sponsor|1|||
161442013|NCT02908672|583010388|FG002|Run-in Period|Study Ended by Sponsor|0|||
161442014|NCT02908672|583010389|FG003|Run-in Period|Study Ended by Sponsor|0|||
161442015|NCT02908672|583010386|FG000|Run-in Period|Withdrawal by Subject|3|||
161442016|NCT02908672|583010387|FG001|Run-in Period|Withdrawal by Subject|9|||
161442017|NCT02908672|583010388|FG002|Run-in Period|Withdrawal by Subject|0|||
161442018|NCT02908672|583010389|FG003|Run-in Period|Withdrawal by Subject|0|||
161442019|NCT02908672|583010386|FG000|Triple Combination Period|Death|0|||
161442020|NCT02908672|583010387|FG001|Triple Combination Period|Death|0|||
161442021|NCT02908672|583010388|FG002|Triple Combination Period|Death|150|||
161442022|NCT02908672|583010389|FG003|Triple Combination Period|Death|127|||
161442023|NCT02908672|583010386|FG000|Triple Combination Period|Lost to Follow-up|0|||
161442024|NCT02908672|583010387|FG001|Triple Combination Period|Lost to Follow-up|0|||
161442025|NCT02908672|583010388|FG002|Triple Combination Period|Lost to Follow-up|6|||
161442026|NCT02908672|583010389|FG003|Triple Combination Period|Lost to Follow-up|8|||
161442027|NCT02908672|583010386|FG000|Triple Combination Period|Reason Not Specified|0|||
161442028|NCT02908672|583010387|FG001|Triple Combination Period|Reason Not Specified|0|||
161442029|NCT02908672|583010388|FG002|Triple Combination Period|Reason Not Specified|0|||
161442030|NCT02908672|583010389|FG003|Triple Combination Period|Reason Not Specified|1|||
161442031|NCT02908672|583010386|FG000|Triple Combination Period|Physician Decision|0|||
161442032|NCT02908672|583010387|FG001|Triple Combination Period|Physician Decision|0|||
161442033|NCT02908672|583010388|FG002|Triple Combination Period|Physician Decision|1|||
161442034|NCT02908672|583010389|FG003|Triple Combination Period|Physician Decision|1|||
161442035|NCT02908672|583010386|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
161442036|NCT02908672|583010387|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
161442037|NCT02908672|583010388|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
161442038|NCT02908672|583010389|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
161442039|NCT02908672|583010386|FG000|Triple Combination Period|Withdrawal by Subject|0|||
161442040|NCT02908672|583010387|FG001|Triple Combination Period|Withdrawal by Subject|0|||
161442041|NCT02908672|583010388|FG002|Triple Combination Period|Withdrawal by Subject|13|||
161442042|NCT02908672|583010389|FG003|Triple Combination Period|Withdrawal by Subject|16|||
161442043|NCT01185080|583010393|FG000|Overall Study|Adverse Event|1|||
161442044|NCT01185080|583010394|FG001|Overall Study|Adverse Event|1|||
161442045|NCT01185080|583010395|FG002|Overall Study|Adverse Event|0|||
161442046|NCT01185080|583010393|FG000|Overall Study|Personal reasons|0|||
161442047|NCT01185080|583010394|FG001|Overall Study|Personal reasons|0|||
161442048|NCT01185080|583010395|FG002|Overall Study|Personal reasons|1|||
161442049|NCT02876601|583010396|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
161442050|NCT02876601|583010397|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
161442051|NCT02876601|583010398|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
161442052|NCT02876601|583010399|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
161442053|NCT06083506|583010401|FG000|Overall Study|Physician Decision|2|||
161442054|NCT06083506|583010401|FG000|Overall Study|Lack of Efficacy|1|||
161442055|NCT02864394|583010403|FG000|Overall Study|Death|184|||
161442056|NCT02864394|583010404|FG001|Overall Study|Death|189|||
161442057|NCT02864394|583010403|FG000|Overall Study|Lost to Follow-up|0|||
161442058|NCT02864394|583010404|FG001|Overall Study|Lost to Follow-up|2|||
161442059|NCT02864394|583010403|FG000|Overall Study|Sponsor Decision|26|||
161442060|NCT02864394|583010404|FG001|Overall Study|Sponsor Decision|11|||
161442061|NCT02864394|583010403|FG000|Overall Study|Withdrawal by Subject|3|||
161442062|NCT02864394|583010404|FG001|Overall Study|Withdrawal by Subject|10|||
161442063|NCT00905164|583010405|FG000|Period 1|Protocol Violation|0|||
161442064|NCT00905164|583010406|FG001|Period 1|Protocol Violation|1|||
161442065|NCT03751657|583011888|FG000|Overall Study|Physician Decision|0|||
161442066|NCT03751657|583011889|FG001|Overall Study|Physician Decision|1|||
161442067|NCT03751657|583011888|FG000|Overall Study|Withdrawal by Subject|1|||
161442068|NCT03751657|583011889|FG001|Overall Study|Withdrawal by Subject|1|||
161442069|NCT03751657|583011888|FG000|Overall Study|Lost to Follow-up|2|||
161442070|NCT03751657|583011889|FG001|Overall Study|Lost to Follow-up|1|||
161442071|NCT03894813|583011896|FG000|Overall Study|Adverse Event|1|||
161442072|NCT03894813|583011897|FG001|Overall Study|Adverse Event|1|||
161442073|NCT03894813|583011896|FG000|Overall Study|Lack of Efficacy|3|||
161442074|NCT03894813|583011897|FG001|Overall Study|Lack of Efficacy|3|||
161442075|NCT03894813|583011896|FG000|Overall Study|Lost to Follow-up|1|||
161442076|NCT03894813|583011897|FG001|Overall Study|Lost to Follow-up|0|||
161442077|NCT03894813|583011896|FG000|Overall Study|Pregnancy|2|||
161442078|NCT03894813|583011897|FG001|Overall Study|Pregnancy|1|||
161442079|NCT03894813|583011896|FG000|Overall Study|Protocol Violation|3|||
161442080|NCT03894813|583011897|FG001|Overall Study|Protocol Violation|7|||
161442081|NCT03894813|583011896|FG000|Overall Study|Withdrawal by Subject|1|||
161442082|NCT03894813|583011897|FG001|Overall Study|Withdrawal by Subject|3|||
161442083|NCT03894813|583011896|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
161442084|NCT03894813|583011897|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
161442085|NCT02269267|583011912|FG000|Overall Study|Death|5|||
161442086|NCT02604160|583011913|FG000|Overall Study|Protocol Violation|0|||
161442087|NCT02604160|583011914|FG001|Overall Study|Protocol Violation|1|||
161442088|NCT02604160|583011913|FG000|Overall Study|Physician Decision|0|||
161442089|NCT02604160|583011914|FG001|Overall Study|Physician Decision|1|||
161442090|NCT01069900|583011917|FG000|Overall Study|Technical problems|0|||
161442091|NCT01069900|583011918|FG001|Overall Study|Technical problems|1|||
161442092|NCT01069900|583011917|FG000|Overall Study|Lost to Follow-up|7|||
161442093|NCT01069900|583011918|FG001|Overall Study|Lost to Follow-up|1|||
161442094|NCT01069900|583011917|FG000|Overall Study|Withdrawal by Subject|6|||
161442095|NCT01069900|583011918|FG001|Overall Study|Withdrawal by Subject|1|||
161442096|NCT01069900|583011917|FG000|Overall Study|Protocol Violation|4|||
161442097|NCT01069900|583011918|FG001|Overall Study|Protocol Violation|1|||
161442098|NCT01069900|583011917|FG000|Overall Study|Insufficient Therapeutic effect|1|||
161442099|NCT01069900|583011918|FG001|Overall Study|Insufficient Therapeutic effect|0|||
161442100|NCT00145158|583011919|FG000|Overall Study|premature withdrawal|2|||
161442101|NCT00145158|583011920|FG001|Overall Study|premature withdrawal|3|||
161442102|NCT02741518|583011921|FG000|Overall Study|Withdrawal by Subject|1|||
161442103|NCT02741518|583011922|FG001|Overall Study|Withdrawal by Subject|1|||
161442104|NCT00476008|583011925|FG000|Overall Study|Adverse Event|4|||
161442105|NCT00476008|583011926|FG001|Overall Study|Adverse Event|4|||
161442106|NCT00476008|583011925|FG000|Overall Study|Placebo concerns|2|||
161442107|NCT00476008|583011926|FG001|Overall Study|Placebo concerns|2|||
161442108|NCT00476008|583011925|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
161442109|NCT00476008|583011926|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
161442110|NCT00476008|583011925|FG000|Overall Study|Withdrawal by Subject|0|||
161442111|NCT00476008|583011926|FG001|Overall Study|Withdrawal by Subject|1|||
161442112|NCT00476008|583011925|FG000|Overall Study|Death|1|||
161442113|NCT00476008|583011926|FG001|Overall Study|Death|0|||
161442114|NCT01788358|583011927|FG000|Overall Study|Other|11|||
161442115|NCT01788358|583011927|FG000|Overall Study|Logistical difficulties|1|||
161442116|NCT01788358|583011927|FG000|Overall Study|Lost to Follow-up|5|||
161442117|NCT01788358|583011927|FG000|Overall Study|Protocol Violation|3|||
161442118|NCT01788358|583011927|FG000|Overall Study|Withdrawal by Subject|26|||
161442119|NCT01788358|583011927|FG000|Overall Study|Lack of Efficacy|1|||
161442120|NCT01788358|583011927|FG000|Overall Study|Adverse Event|51|||
161442121|NCT01168219|583011928|FG000|Overall Study|off study before starting treatment|2|||
161442122|NCT01168219|583011928|FG000|Overall Study|withdrew before transplant|1|||
161442123|NCT01168219|583011928|FG000|Overall Study|ineligible due to CML|2|||
161442124|NCT01227018|583011929|FG000|Overall Study|Disease progression|9|||
161442125|NCT01227018|583011929|FG000|Overall Study|Toxicity|2|||
161442126|NCT01227018|583011929|FG000|Overall Study|Withdrew after beginning treatment|4|||
161442127|NCT02948634|583011932|FG000|Overall Study|Lack of efficacy and study suspended|10|||
161442128|NCT02948634|583011933|FG001|Overall Study|Lack of efficacy and study suspended|2|||
161442129|NCT00753649|583011938|FG000|Overall Study|Migrated/moved from study area|1|||
161442130|NCT00753649|583011939|FG001|Overall Study|Migrated/moved from study area|0|||
161442131|NCT00753649|583011938|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
161442132|NCT00753649|583011939|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
161789402|NCT01722266|584272846|FG002|Overall Study|Dropped out due to Nausea|2|||
161789403|NCT01722266|584272847|FG003|Overall Study|Dropped out due to Nausea|0|||
161789404|NCT03811249|584272848|FG000|Overall Study|Withdrawal by Subject|44|||
161789405|NCT03811249|584272848|FG000|Overall Study|Missed Visit|24|||
161789406|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
161789407|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
161789408|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
161789409|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
161789410|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
161789411|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
161789412|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
161789413|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
161789414|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
161789415|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
161789416|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
161789417|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
161789418|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
161789419|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
161789420|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
161789421|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
161789422|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
161789423|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
161789424|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
161789425|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
161789426|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
161789427|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
161789428|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Relocated|1|||
161789429|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Relocated|0|||
161789430|NCT03210259|584272860|FG000|12-Week Run-in Period|Adverse Event|1|||
161789431|NCT03210259|584272861|FG001|12-Week Run-in Period|Adverse Event|0|||
161789432|NCT03210259|584272862|FG002|12-Week Run-in Period|Adverse Event|0|||
161789433|NCT03210259|584272860|FG000|12-Week Run-in Period|Death|1|||
161789434|NCT03210259|584272861|FG001|12-Week Run-in Period|Death|0|||
161789435|NCT03210259|584272862|FG002|12-Week Run-in Period|Death|0|||
161789436|NCT03210259|584272860|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
161789437|NCT03210259|584272861|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
161789438|NCT03210259|584272862|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
161789439|NCT03210259|584272860|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
161789440|NCT03210259|584272861|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
161789441|NCT03210259|584272862|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
161789442|NCT03210259|584272860|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
161789443|NCT03210259|584272861|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
161789444|NCT03210259|584272862|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
161789445|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
161789446|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
161789447|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
161789448|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
161789449|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
161789450|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
161789451|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
161789452|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
161789453|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
161789454|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
161789455|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
161789456|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
161898707|NCT05225558|584677882|FG001|Overall Study|Withdrawal by Subject|3|||
161898708|NCT05225558|584677881|FG000|Overall Study|Adverse Event|1|||
161898709|NCT05225558|584677882|FG001|Overall Study|Adverse Event|0|||
161442133|NCT00753649|583011938|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
161442134|NCT00753649|583011939|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
161442135|NCT00753649|583011938|FG000|Overall Study|Protocol Violation|2|||
161442136|NCT00753649|583011939|FG001|Overall Study|Protocol Violation|0|||
161442137|NCT01039519|583011942|FG000|Treatment|Progressive disease|20|||
161442138|NCT01039519|583011942|FG000|Treatment|Treatment failure|2|||
161442139|NCT01039519|583011942|FG000|Treatment|Adverse Event|3|||
161442140|NCT01039519|583011942|FG000|Treatment|Physician Decision|2|||
161442141|NCT01039519|583011942|FG000|Survival Follow-up|Death|23|||
161442142|NCT01039519|583011942|FG000|Survival Follow-up|Sponsor decision|4|||
161442143|NCT01255436|583011948|FG000|Overall Study|Lost to Follow-up|178|||
161442144|NCT01255436|583011949|FG001|Overall Study|Lost to Follow-up|191|||
161442145|NCT01255436|583011948|FG000|Overall Study|Death, stroke, or MI|4|||
161442146|NCT01255436|583011949|FG001|Overall Study|Death, stroke, or MI|3|||
161442147|NCT04816669|583011950|FG000|Part 1|Adverse Event|1|||
161442148|NCT04816669|583011951|FG001|Part 1|Adverse Event|1|||
161442149|NCT04816669|583011952|FG002|Part 1|Adverse Event|0|||
161442150|NCT04816669|583011953|FG003|Part 1|Adverse Event|0|||
161442151|NCT04816669|583011950|FG000|Part 1|Lost to Follow-up|2|||
161442152|NCT04816669|583011951|FG001|Part 1|Lost to Follow-up|2|||
161442153|NCT04816669|583011952|FG002|Part 1|Lost to Follow-up|0|||
161442154|NCT04816669|583011953|FG003|Part 1|Lost to Follow-up|0|||
161442155|NCT04816669|583011950|FG000|Part 1|Protocol Violation|0|||
161442156|NCT04816669|583011951|FG001|Part 1|Protocol Violation|1|||
161442157|NCT04816669|583011952|FG002|Part 1|Protocol Violation|0|||
161442158|NCT04816669|583011953|FG003|Part 1|Protocol Violation|0|||
161442159|NCT04816669|583011950|FG000|Part 1|Withdrawal by Subject|1|||
161442160|NCT04816669|583011951|FG001|Part 1|Withdrawal by Subject|2|||
161442161|NCT04816669|583011952|FG002|Part 1|Withdrawal by Subject|0|||
161442162|NCT04816669|583011953|FG003|Part 1|Withdrawal by Subject|0|||
161442163|NCT04816669|583011950|FG000|Part 2|Other|0|||
161442164|NCT04816669|583011951|FG001|Part 2|Other|0|||
161442165|NCT04816669|583011952|FG002|Part 2|Other|1|||
161442166|NCT04816669|583011953|FG003|Part 2|Other|0|||
161442167|NCT04816669|583011950|FG000|Part 2|Withdrawal by Subject|0|||
161442168|NCT04816669|583011951|FG001|Part 2|Withdrawal by Subject|0|||
161442169|NCT04816669|583011952|FG002|Part 2|Withdrawal by Subject|0|||
161442170|NCT04816669|583011953|FG003|Part 2|Withdrawal by Subject|1|||
161442171|NCT04816669|583011950|FG000|Part 2|Lost to Follow-up|0|||
161442172|NCT04816669|583011951|FG001|Part 2|Lost to Follow-up|0|||
161442173|NCT04816669|583011952|FG002|Part 2|Lost to Follow-up|1|||
161442174|NCT04816669|583011953|FG003|Part 2|Lost to Follow-up|0|||
161442175|NCT01229267|583011954|FG000|Overall Study|Adverse Event|4|||
161442176|NCT01229267|583011955|FG001|Overall Study|Adverse Event|6|||
161442177|NCT01229267|583011956|FG002|Overall Study|Adverse Event|3|||
161442178|NCT01229267|583011957|FG003|Overall Study|Adverse Event|2|||
161442179|NCT01229267|583011958|FG004|Overall Study|Adverse Event|10|||
161442180|NCT01229267|583011954|FG000|Overall Study|Death|40|||
161442181|NCT01229267|583011955|FG001|Overall Study|Death|37|||
161442182|NCT01229267|583011956|FG002|Overall Study|Death|35|||
161442183|NCT01229267|583011957|FG003|Overall Study|Death|13|||
161442184|NCT01229267|583011958|FG004|Overall Study|Death|103|||
161442185|NCT01229267|583011954|FG000|Overall Study|Withdrawal by Subject|23|||
161442186|NCT01229267|583011955|FG001|Overall Study|Withdrawal by Subject|22|||
161442187|NCT01229267|583011956|FG002|Overall Study|Withdrawal by Subject|32|||
161442188|NCT01229267|583011957|FG003|Overall Study|Withdrawal by Subject|14|||
161442189|NCT01229267|583011958|FG004|Overall Study|Withdrawal by Subject|59|||
161442190|NCT01229267|583011954|FG000|Overall Study|Protocol Violation|0|||
161442191|NCT01229267|583011955|FG001|Overall Study|Protocol Violation|1|||
161442192|NCT01229267|583011956|FG002|Overall Study|Protocol Violation|0|||
161442193|NCT01229267|583011957|FG003|Overall Study|Protocol Violation|0|||
161442194|NCT01229267|583011958|FG004|Overall Study|Protocol Violation|0|||
161442195|NCT01229267|583011954|FG000|Overall Study|Progressive disease|0|||
161442196|NCT01229267|583011955|FG001|Overall Study|Progressive disease|0|||
161442197|NCT01229267|583011956|FG002|Overall Study|Progressive disease|0|||
161442198|NCT01229267|583011957|FG003|Overall Study|Progressive disease|0|||
161442199|NCT01229267|583011958|FG004|Overall Study|Progressive disease|1|||
161442200|NCT01229267|583011954|FG000|Overall Study|Physician Decision|8|||
161442201|NCT01229267|583011955|FG001|Overall Study|Physician Decision|11|||
161442202|NCT01229267|583011956|FG002|Overall Study|Physician Decision|8|||
161442203|NCT01229267|583011957|FG003|Overall Study|Physician Decision|3|||
161898710|NCT05225558|584677881|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
161442204|NCT01229267|583011958|FG004|Overall Study|Physician Decision|25|||
161442205|NCT01229267|583011954|FG000|Overall Study|Lost to Follow-up|6|||
161442206|NCT01229267|583011955|FG001|Overall Study|Lost to Follow-up|5|||
161442207|NCT01229267|583011956|FG002|Overall Study|Lost to Follow-up|8|||
161442208|NCT01229267|583011957|FG003|Overall Study|Lost to Follow-up|3|||
161442209|NCT01229267|583011958|FG004|Overall Study|Lost to Follow-up|22|||
161442210|NCT00808080|583011962|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
161442211|NCT01837823|583011965|FG000|Overall Study|Lost to Follow-up|6|||
161442212|NCT03052400|583011966|FG000|Overall Study|Lost to Follow-up|1|||
161442213|NCT03052400|583011967|FG001|Overall Study|Lost to Follow-up|0|||
161442214|NCT03052400|583011966|FG000|Overall Study|Withdrawal by Subject|0|||
161442215|NCT03052400|583011967|FG001|Overall Study|Withdrawal by Subject|1|||
161442216|NCT00867815|583011968|FG000|Overall Study|Lost to Follow-up|1|||
161442217|NCT00001213|583011969|FG000|Overall Study|Death|18|||
161442218|NCT00859456|583011970|FG000|Overall Study|Adverse Event|3|||
161442219|NCT00859456|583011970|FG000|Overall Study|Progressive disease|2|||
161442220|NCT00859456|583011970|FG000|Overall Study|Non-compliance|3|||
161442221|NCT05782179|583011974|FG000|Overall Study|Adverse Event|0|||
161442222|NCT05782179|583011975|FG001|Overall Study|Adverse Event|0|||
161442223|NCT05782179|583011976|FG002|Overall Study|Adverse Event|2|||
161442224|NCT05782179|583011977|FG003|Overall Study|Adverse Event|0|||
161442225|NCT05782179|583011978|FG004|Overall Study|Adverse Event|0|||
161442226|NCT05782179|583011979|FG005|Overall Study|Adverse Event|0|||
161442227|NCT06170242|583011980|FG000|Overall Study|Lost to Follow-up|0|||
161442228|NCT06170242|583011981|FG001|Overall Study|Lost to Follow-up|0|||
161442229|NCT06170242|583011982|FG002|Overall Study|Lost to Follow-up|1|||
161442230|NCT06170242|583011983|FG003|Overall Study|Lost to Follow-up|1|||
161442231|NCT00927953|583011984|FG000|Overall Study|Death|2|||
161442232|NCT00927953|583011985|FG001|Overall Study|Death|1|||
161442233|NCT01491607|583011986|FG000|Overall Study|Lost to Follow-up|7|||
161442234|NCT01491607|583011986|FG000|Overall Study|Withdrawal by Subject|3|||
161442235|NCT02194985|583011989|FG000|Overall Study|Adverse Event|1|||
161442236|NCT02194985|583011989|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
161442237|NCT02194985|583011989|FG000|Overall Study|Physician Decision|4|||
161442238|NCT02194985|583011989|FG000|Overall Study|Lost to Follow-up|1|||
161442239|NCT02194985|583011989|FG000|Overall Study|Withdrawal by Subject|2|||
161442240|NCT01733680|583011992|FG000|Overall Study|Withdrawal by Subject|0|||
161442241|NCT01733680|583011993|FG001|Overall Study|Withdrawal by Subject|1|||
161442242|NCT02839200|583011996|FG000|Overall Study|Withdrawal by Subject|2|||
161442243|NCT02839200|583011997|FG001|Overall Study|Withdrawal by Subject|0|||
161442244|NCT02839200|583011998|FG002|Overall Study|Withdrawal by Subject|1|||
161442245|NCT02839200|583011999|FG003|Overall Study|Withdrawal by Subject|0|||
161442246|NCT02839200|583012000|FG004|Overall Study|Withdrawal by Subject|0|||
161442247|NCT02839200|583012001|FG005|Overall Study|Withdrawal by Subject|1|||
161442248|NCT02839200|583011996|FG000|Overall Study|Lost to Follow-up|2|||
161442249|NCT02839200|583011997|FG001|Overall Study|Lost to Follow-up|0|||
161442250|NCT02839200|583011998|FG002|Overall Study|Lost to Follow-up|0|||
161442251|NCT02839200|583011999|FG003|Overall Study|Lost to Follow-up|0|||
161442252|NCT02839200|583012000|FG004|Overall Study|Lost to Follow-up|1|||
161442253|NCT02839200|583012001|FG005|Overall Study|Lost to Follow-up|0|||
161442254|NCT02839200|583011996|FG000|Overall Study|Adverse Event|0|||
161442255|NCT02839200|583011997|FG001|Overall Study|Adverse Event|0|||
161442256|NCT02839200|583011998|FG002|Overall Study|Adverse Event|0|||
161442257|NCT02839200|583011999|FG003|Overall Study|Adverse Event|0|||
161442258|NCT02839200|583012000|FG004|Overall Study|Adverse Event|1|||
161442259|NCT02839200|583012001|FG005|Overall Study|Adverse Event|0|||
161442260|NCT02839200|583011996|FG000|Overall Study|Randomized in error|0|||
161442261|NCT02839200|583011997|FG001|Overall Study|Randomized in error|1|||
161442262|NCT02839200|583011998|FG002|Overall Study|Randomized in error|0|||
161442263|NCT02839200|583011999|FG003|Overall Study|Randomized in error|0|||
161442264|NCT02839200|583012000|FG004|Overall Study|Randomized in error|0|||
161442265|NCT02839200|583012001|FG005|Overall Study|Randomized in error|0|||
161442266|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
161442267|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
161442268|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
161442269|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
161442270|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
161442271|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
161442272|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
161442273|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
161442274|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
161442275|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
161442276|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
161442277|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
161442278|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
161442279|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
161442280|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
161442281|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
161442282|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
161442283|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
161442284|NCT02952820|583012002|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
161442285|NCT02952820|583012003|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
161442286|NCT02952820|583012004|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
161442287|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
161442288|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
161442289|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
161442290|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
161442291|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
161442292|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
161442293|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
161442294|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
161442295|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
161442296|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
161442297|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
161442298|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
161442299|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
161442300|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
161442301|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
161442302|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
161442303|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
161442304|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
161442305|NCT02952820|583012002|FG000|Active Treatment Period (6 Months)|Not treated|0|||
161442306|NCT02952820|583012003|FG001|Active Treatment Period (6 Months)|Not treated|0|||
161442307|NCT02952820|583012004|FG002|Active Treatment Period (6 Months)|Not treated|1|||
161442308|NCT03614156|583012005|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
161442309|NCT03614156|583012006|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
161442310|NCT03614156|583012007|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
161442311|NCT03614156|583012008|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
161442312|NCT03614156|583012005|FG000|Open-Label Treatment Period|Adverse Event|7|||
161442313|NCT03614156|583012006|FG001|Open-Label Treatment Period|Adverse Event|0|||
161442314|NCT03614156|583012007|FG002|Open-Label Treatment Period|Adverse Event|0|||
161442315|NCT03614156|583012008|FG003|Open-Label Treatment Period|Adverse Event|0|||
161442316|NCT03614156|583012005|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
161442317|NCT03614156|583012006|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161442318|NCT03614156|583012007|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161442319|NCT03614156|583012008|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
161442320|NCT03614156|583012005|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
161442321|NCT03614156|583012006|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
161442322|NCT03614156|583012007|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
161442323|NCT03614156|583012008|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
161442324|NCT03614156|583012005|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
161442325|NCT03614156|583012006|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
161442326|NCT03614156|583012007|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
161442327|NCT03614156|583012008|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
161442328|NCT03614156|583012005|FG000|Open-Label Treatment Period|Protocol Violation|2|||
161442329|NCT03614156|583012006|FG001|Open-Label Treatment Period|Protocol Violation|0|||
161442330|NCT03614156|583012007|FG002|Open-Label Treatment Period|Protocol Violation|0|||
161442331|NCT03614156|583012008|FG003|Open-Label Treatment Period|Protocol Violation|0|||
161442332|NCT03614156|583012005|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
161442333|NCT03614156|583012006|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
161442334|NCT03614156|583012007|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
161442335|NCT03614156|583012008|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
161442336|NCT03614156|583012005|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
161442337|NCT03614156|583012006|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
161442338|NCT03614156|583012007|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
161442339|NCT03614156|583012008|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
161442340|NCT03614156|583012005|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
161442341|NCT03614156|583012006|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
161442342|NCT03614156|583012007|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
161442343|NCT03614156|583012008|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
161442344|NCT03614156|583012005|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161442345|NCT03614156|583012006|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
161442346|NCT03614156|583012007|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161442347|NCT03614156|583012008|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161442348|NCT03614156|583012005|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161442349|NCT03614156|583012006|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161442350|NCT03614156|583012007|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
161442351|NCT03614156|583012008|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
161442352|NCT03614156|583012005|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
161442353|NCT03614156|583012006|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
161442354|NCT03614156|583012007|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
161442355|NCT03614156|583012008|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
161442356|NCT03614156|583012005|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
161442357|NCT03614156|583012006|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
161442358|NCT03614156|583012007|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
161442359|NCT03614156|583012008|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
161442360|NCT03614156|583012005|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
161442361|NCT03614156|583012006|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
161442362|NCT03614156|583012007|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
161442363|NCT03614156|583012008|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
161442364|NCT03614156|583012005|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
161442365|NCT03614156|583012006|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
161442366|NCT03614156|583012007|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
161442367|NCT03614156|583012008|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
161442368|NCT03614156|583012005|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
161442369|NCT03614156|583012006|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
161442370|NCT03614156|583012007|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
161442371|NCT03614156|583012008|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
161442372|NCT03614156|583012005|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
161442373|NCT03614156|583012006|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
161442374|NCT03614156|583012007|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
161442375|NCT03614156|583012008|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
161442376|NCT03070964|583012010|FG000|Overall Study|Progressive disease|8|||
161442377|NCT03070964|583012010|FG000|Overall Study|Treatment-unrelated adverse event|2|||
161442378|NCT03070964|583012010|FG000|Overall Study|Never treated|1|||
161442379|NCT03070964|583012010|FG000|Overall Study|Physician Decision|1|||
161442380|NCT03070964|583012010|FG000|Overall Study|Withdrawal by Subject|1|||
161442381|NCT03070964|583012010|FG000|Overall Study|Adverse Event|1|||
161442382|NCT01094119|583012011|FG000|Overall Study|Lack of Efficacy|2|||
161442383|NCT01094119|583012012|FG001|Overall Study|Lack of Efficacy|4|||
161442384|NCT00834093|583012013|FG000|Overall Study|Progressive Disease|3|||
161442385|NCT00834093|583012013|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
161442386|NCT01587924|583012014|FG000|Overall Study|Adverse Event|0|||
161442387|NCT01587924|583012015|FG001|Overall Study|Adverse Event|2|||
161442388|NCT01587924|583012016|FG002|Overall Study|Adverse Event|0|||
161442389|NCT01587924|583012017|FG003|Overall Study|Adverse Event|0|||
161442390|NCT01587924|583012014|FG000|Overall Study|Protocol Violation|2|||
161442391|NCT01587924|583012015|FG001|Overall Study|Protocol Violation|1|||
161442392|NCT01587924|583012016|FG002|Overall Study|Protocol Violation|2|||
161442393|NCT01587924|583012017|FG003|Overall Study|Protocol Violation|1|||
161442394|NCT01587924|583012014|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
161442395|NCT01587924|583012015|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
161442396|NCT01587924|583012016|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
161442397|NCT01587924|583012017|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
161442398|NCT01587924|583012014|FG000|Overall Study|Withdrawal by Subject|0|||
161442399|NCT01587924|583012015|FG001|Overall Study|Withdrawal by Subject|1|||
161442400|NCT01587924|583012016|FG002|Overall Study|Withdrawal by Subject|1|||
161442401|NCT01587924|583012017|FG003|Overall Study|Withdrawal by Subject|0|||
161442402|NCT01578486|583012018|FG000|Overall Study|Physician Decision|3|||
161442403|NCT01578486|583012018|FG000|Overall Study|Withdrawal by Subject|2|||
161442404|NCT00357903|583012020|FG000|Overall Study|Adverse Event|87|||
161442405|NCT00357903|583012021|FG001|Overall Study|Adverse Event|4|||
161442406|NCT00357903|583012020|FG000|Overall Study|Death|33|||
161442407|NCT00357903|583012021|FG001|Overall Study|Death|0|||
161442408|NCT00357903|583012020|FG000|Overall Study|Lost to Follow-up|23|||
161442409|NCT00357903|583012021|FG001|Overall Study|Lost to Follow-up|4|||
161442410|NCT00357903|583012020|FG000|Overall Study|Physician Decision|39|||
161442411|NCT00357903|583012021|FG001|Overall Study|Physician Decision|5|||
161442412|NCT00357903|583012020|FG000|Overall Study|Withdrawal by Subject|57|||
161442413|NCT00357903|583012021|FG001|Overall Study|Withdrawal by Subject|7|||
161442414|NCT00357903|583012020|FG000|Overall Study|Completed month 12 only|0|||
161442415|NCT00357903|583012021|FG001|Overall Study|Completed month 12 only|1|||
161442416|NCT00357903|583012020|FG000|Overall Study|Protocol issues|14|||
161442417|NCT00357903|583012021|FG001|Overall Study|Protocol issues|3|||
161442418|NCT00357903|583012020|FG000|Overall Study|Response status|61|||
161442419|NCT00357903|583012021|FG001|Overall Study|Response status|9|||
161442420|NCT00357903|583012020|FG000|Overall Study|Other|49|||
161442421|NCT00357903|583012021|FG001|Overall Study|Other|10|||
161442422|NCT00606593|583012022|FG000|Overall Study|Adverse Event|0|||
161442423|NCT00606593|583012023|FG001|Overall Study|Adverse Event|0|||
161442424|NCT00606593|583012024|FG002|Overall Study|Adverse Event|0|||
161442425|NCT00606593|583012025|FG003|Overall Study|Adverse Event|1|||
161442426|NCT00606593|583012026|FG004|Overall Study|Adverse Event|1|||
161442427|NCT00606593|583012027|FG005|Overall Study|Adverse Event|0|||
161442428|NCT00606593|583012028|FG006|Overall Study|Adverse Event|1|||
161442429|NCT00606593|583012029|FG007|Overall Study|Adverse Event|2|||
161442430|NCT00606593|583012030|FG008|Overall Study|Adverse Event|1|||
161442431|NCT00606593|583012031|FG009|Overall Study|Adverse Event|0|||
161442432|NCT00606593|583012022|FG000|Overall Study|Withdrawal of consent|1|||
161442433|NCT00606593|583012023|FG001|Overall Study|Withdrawal of consent|0|||
161442434|NCT00606593|583012024|FG002|Overall Study|Withdrawal of consent|1|||
161442435|NCT00606593|583012025|FG003|Overall Study|Withdrawal of consent|0|||
161442436|NCT00606593|583012026|FG004|Overall Study|Withdrawal of consent|0|||
161442437|NCT00606593|583012027|FG005|Overall Study|Withdrawal of consent|0|||
161442438|NCT00606593|583012028|FG006|Overall Study|Withdrawal of consent|0|||
161442439|NCT00606593|583012029|FG007|Overall Study|Withdrawal of consent|0|||
161442440|NCT00606593|583012030|FG008|Overall Study|Withdrawal of consent|0|||
161442441|NCT00606593|583012031|FG009|Overall Study|Withdrawal of consent|0|||
161442442|NCT00606593|583012022|FG000|Overall Study|Administrative/Other|0|||
161442443|NCT00606593|583012023|FG001|Overall Study|Administrative/Other|0|||
161442444|NCT00606593|583012024|FG002|Overall Study|Administrative/Other|1|||
161442445|NCT00606593|583012025|FG003|Overall Study|Administrative/Other|0|||
161442446|NCT00606593|583012026|FG004|Overall Study|Administrative/Other|0|||
161442447|NCT00606593|583012027|FG005|Overall Study|Administrative/Other|0|||
161442448|NCT00606593|583012028|FG006|Overall Study|Administrative/Other|0|||
161442449|NCT00606593|583012029|FG007|Overall Study|Administrative/Other|0|||
161442450|NCT00606593|583012030|FG008|Overall Study|Administrative/Other|0|||
161442451|NCT00606593|583012031|FG009|Overall Study|Administrative/Other|0|||
161442452|NCT03181529|583012032|FG000|Overall Study|Withdrawal by Subject|1|||
161442453|NCT03181529|583012033|FG001|Overall Study|Withdrawal by Subject|1|||
161442454|NCT03181529|583012032|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
161442455|NCT03181529|583012033|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
161442456|NCT00607373|583012036|FG000|Treatment Period|Adverse Event|0|||
161442457|NCT00607373|583012037|FG001|Treatment Period|Adverse Event|4|||
161442458|NCT00607373|583012036|FG000|Treatment Period|Physician Decision|0|||
161442459|NCT00607373|583012037|FG001|Treatment Period|Physician Decision|1|||
161442460|NCT00607373|583012036|FG000|Treatment Period|Withdrawal by Subject|0|||
161442461|NCT00607373|583012037|FG001|Treatment Period|Withdrawal by Subject|1|||
161442462|NCT00607373|583012036|FG000|Follow-up Period|Other|0|||
161442463|NCT00607373|583012037|FG001|Follow-up Period|Other|1|||
161442464|NCT00607373|583012036|FG000|Follow-up Period|Protocol Violation|0|||
161442465|NCT00607373|583012037|FG001|Follow-up Period|Protocol Violation|1|||
161442466|NCT00607373|583012036|FG000|Follow-up Period|Withdrawal by Subject|1|||
161442467|NCT00607373|583012037|FG001|Follow-up Period|Withdrawal by Subject|3|||
161442468|NCT04949490|583012038|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
161442469|NCT04949490|583012039|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
161442470|NCT04949490|583012040|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
161442471|NCT04949490|583012041|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
161442472|NCT04949490|583012042|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
161442473|NCT04949490|583012043|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
161442474|NCT04949490|583012038|FG000|Group A and Group B|Withdrawal by Subject|0|||
161442475|NCT04949490|583012039|FG001|Group A and Group B|Withdrawal by Subject|0|||
161442476|NCT04949490|583012040|FG002|Group A and Group B|Withdrawal by Subject|1|||
161442477|NCT04949490|583012041|FG003|Group A and Group B|Withdrawal by Subject|0|||
161442478|NCT04949490|583012042|FG004|Group A and Group B|Withdrawal by Subject|0|||
161442479|NCT04949490|583012043|FG005|Group A and Group B|Withdrawal by Subject|0|||
161442480|NCT04949490|583012038|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
161442481|NCT04949490|583012039|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
161442482|NCT04949490|583012040|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
161442483|NCT04949490|583012041|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
161442484|NCT04949490|583012042|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
161442485|NCT04949490|583012043|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
161442486|NCT04949490|583012038|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
161442487|NCT04949490|583012039|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
161442488|NCT04949490|583012040|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
161442489|NCT04949490|583012041|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
161442490|NCT04949490|583012042|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
161442491|NCT04949490|583012043|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
161442492|NCT05232682|583012044|FG000|Overall Study|Lost to Follow-up|2|||
161442493|NCT04730804|583012045|FG000|Overall Study|Physician Decision|0|||
161442494|NCT04730804|583012046|FG001|Overall Study|Physician Decision|0|||
161442495|NCT04730804|583012047|FG002|Overall Study|Physician Decision|0|||
161442496|NCT04730804|583012048|FG003|Overall Study|Physician Decision|0|||
161442497|NCT04730804|583012049|FG004|Overall Study|Physician Decision|0|||
161442498|NCT04730804|583012050|FG005|Overall Study|Physician Decision|1|||
161442499|NCT04730804|583012045|FG000|Overall Study|Withdrawal by Subject|0|||
161442500|NCT04730804|583012046|FG001|Overall Study|Withdrawal by Subject|0|||
161442501|NCT04730804|583012047|FG002|Overall Study|Withdrawal by Subject|0|||
161442502|NCT04730804|583012048|FG003|Overall Study|Withdrawal by Subject|0|||
161442503|NCT04730804|583012049|FG004|Overall Study|Withdrawal by Subject|1|||
161442504|NCT04730804|583012050|FG005|Overall Study|Withdrawal by Subject|2|||
161442505|NCT02656693|583013855|FG000|Overall Study|Pregnancy|1|||
161442506|NCT02656693|583013856|FG001|Overall Study|Pregnancy|1|||
161442507|NCT02656693|583013857|FG002|Overall Study|Pregnancy|1|||
161442508|NCT02656693|583013855|FG000|Overall Study|Bariatric surgery|0|||
161442509|NCT02656693|583013856|FG001|Overall Study|Bariatric surgery|1|||
161442510|NCT02656693|583013857|FG002|Overall Study|Bariatric surgery|2|||
161442511|NCT02565784|583013858|FG000|First Treatment|Adverse Event|1|||
161442512|NCT02565784|583013858|FG000|First Treatment|Withdrawal by Subject|1|||
161442513|NCT02565784|583013858|FG000|Second Treatment|Withdrawal by Subject|2|||
161442514|NCT01596062|583013859|FG000|Overall Study|Adverse Event|1|||
161442515|NCT01596062|583013860|FG001|Overall Study|Adverse Event|0|||
161442516|NCT01596062|583013861|FG002|Overall Study|Adverse Event|2|||
161442517|NCT01596062|583013859|FG000|Overall Study|Lack of Efficacy|0|||
161442518|NCT01596062|583013860|FG001|Overall Study|Lack of Efficacy|0|||
161442519|NCT01596062|583013861|FG002|Overall Study|Lack of Efficacy|1|||
161442520|NCT03180840|583013862|FG000|Overall Study|Withdrawal by Subject|1|||
161442521|NCT00337675|583013869|FG000|Overall Study|Adverse Event|10|||
161442522|NCT00337675|583013870|FG001|Overall Study|Adverse Event|9|||
161442523|NCT00337675|583013871|FG002|Overall Study|Adverse Event|19|||
161442524|NCT00337675|583013869|FG000|Overall Study|Lack of Efficacy|10|||
161442525|NCT00337675|583013870|FG001|Overall Study|Lack of Efficacy|7|||
161442526|NCT00337675|583013871|FG002|Overall Study|Lack of Efficacy|9|||
161442527|NCT00337675|583013869|FG000|Overall Study|Lost to Follow-up|22|||
161442528|NCT00337675|583013870|FG001|Overall Study|Lost to Follow-up|19|||
161442529|NCT00337675|583013871|FG002|Overall Study|Lost to Follow-up|17|||
161442530|NCT00337675|583013869|FG000|Overall Study|Physician Decision|9|||
161442531|NCT00337675|583013870|FG001|Overall Study|Physician Decision|17|||
161442532|NCT00337675|583013871|FG002|Overall Study|Physician Decision|14|||
161442533|NCT00337675|583013869|FG000|Overall Study|Protocol Violation|21|||
161442534|NCT00337675|583013870|FG001|Overall Study|Protocol Violation|24|||
161442535|NCT00337675|583013871|FG002|Overall Study|Protocol Violation|19|||
161442536|NCT00337675|583013869|FG000|Overall Study|Withdrawal by Subject|25|||
161442537|NCT00337675|583013870|FG001|Overall Study|Withdrawal by Subject|25|||
161442538|NCT00337675|583013871|FG002|Overall Study|Withdrawal by Subject|19|||
161442539|NCT00337675|583013869|FG000|Overall Study|Progressive Disease|0|||
161442540|NCT00337675|583013870|FG001|Overall Study|Progressive Disease|2|||
161442541|NCT00337675|583013871|FG002|Overall Study|Progressive Disease|0|||
161442542|NCT00337675|583013869|FG000|Overall Study|Trial Terminated|0|||
161442543|NCT00337675|583013870|FG001|Overall Study|Trial Terminated|0|||
161442544|NCT00337675|583013871|FG002|Overall Study|Trial Terminated|2|||
161442545|NCT02015637|583013875|FG000|Overall Study|Lost to Follow-up|3|||
161442546|NCT02015637|583013876|FG001|Overall Study|Lost to Follow-up|5|||
161442547|NCT02015637|583013875|FG000|Overall Study|Adverse Event|3|||
161442548|NCT02015637|583013876|FG001|Overall Study|Adverse Event|0|||
161442549|NCT02015637|583013875|FG000|Overall Study|Did not take study drug|2|||
161442550|NCT02015637|583013876|FG001|Overall Study|Did not take study drug|0|||
161442551|NCT02863419|583013879|FG000|Overall Study|Lost to Follow-up|0|||
161442552|NCT02863419|583013880|FG001|Overall Study|Lost to Follow-up|1|||
161442553|NCT02863419|583013881|FG002|Overall Study|Lost to Follow-up|4|||
161442554|NCT02863419|583013879|FG000|Overall Study|Withdrawal by Subject|5|||
161442555|NCT02863419|583013880|FG001|Overall Study|Withdrawal by Subject|5|||
161442556|NCT02863419|583013881|FG002|Overall Study|Withdrawal by Subject|3|||
161442557|NCT02863419|583013879|FG000|Overall Study|Died|3|||
161442558|NCT02863419|583013880|FG001|Overall Study|Died|4|||
161442559|NCT02863419|583013881|FG002|Overall Study|Died|1|||
161442560|NCT00297258|583013884|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
161442561|NCT00297258|583013884|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
161442562|NCT00297258|583013884|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
161442563|NCT00297258|583013884|FG000|Overall Study|Intercurrent Illness|3|||
161442564|NCT00297258|583013884|FG000|Overall Study|Intercurrent Death|2|||
161442565|NCT00297258|583013884|FG000|Overall Study|Deteriorization of General Condition|1|||
161442566|NCT00297258|583013884|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
161442567|NCT00297258|583013884|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
161442568|NCT00297258|583013884|FG000|Overall Study|Switch to Commercial Treatment|1|||
161442569|NCT00297258|583013884|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
161442570|NCT02454517|583013885|FG000|Overall Study|Withdrawal by Subject|3|||
161442571|NCT02454517|583013886|FG001|Overall Study|Withdrawal by Subject|0|||
161442572|NCT02454517|583013885|FG000|Overall Study|Lost to Follow-up|4|||
161442573|NCT02454517|583013886|FG001|Overall Study|Lost to Follow-up|7|||
161442574|NCT02454517|583013885|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
161442575|NCT02454517|583013886|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
161442576|NCT00473382|583013887|FG000|Core Study|Adverse Event|3|||
161442577|NCT00473382|583013888|FG001|Core Study|Adverse Event|1|||
161442578|NCT00473382|583013889|FG002|Core Study|Adverse Event|1|||
161442579|NCT00473382|583013887|FG000|Core Study|Death|3|||
161442580|NCT00473382|583013888|FG001|Core Study|Death|5|||
161442581|NCT00473382|583013889|FG002|Core Study|Death|10|||
161442582|NCT00473382|583013887|FG000|Core Study|Lost to Follow-up|3|||
161442583|NCT00473382|583013888|FG001|Core Study|Lost to Follow-up|3|||
161442584|NCT00473382|583013889|FG002|Core Study|Lost to Follow-up|3|||
161442585|NCT00473382|583013887|FG000|Core Study|Physician Decision|1|||
161442586|NCT00473382|583013888|FG001|Core Study|Physician Decision|2|||
161442587|NCT00473382|583013889|FG002|Core Study|Physician Decision|2|||
161442588|NCT00473382|583013887|FG000|Core Study|Subject non-compliance|5|||
161442589|NCT00473382|583013888|FG001|Core Study|Subject non-compliance|2|||
161442590|NCT00473382|583013889|FG002|Core Study|Subject non-compliance|1|||
161442591|NCT00473382|583013887|FG000|Core Study|Subject needed other treatment|1|||
161442592|NCT00473382|583013888|FG001|Core Study|Subject needed other treatment|3|||
161442593|NCT00473382|583013889|FG002|Core Study|Subject needed other treatment|2|||
161442594|NCT00473382|583013887|FG000|Core Study|Subject's decision|12|||
161442595|NCT00473382|583013888|FG001|Core Study|Subject's decision|11|||
161442596|NCT00473382|583013889|FG002|Core Study|Subject's decision|10|||
161442597|NCT00473382|583013887|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
161442598|NCT00473382|583013888|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
161442599|NCT00473382|583013889|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
161442600|NCT00473382|583013887|FG000|Open-label Extension Through Month 48|Death|1|||
161442601|NCT00473382|583013888|FG001|Open-label Extension Through Month 48|Death|3|||
161442602|NCT00473382|583013889|FG002|Open-label Extension Through Month 48|Death|3|||
161442603|NCT00473382|583013887|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
161442604|NCT00473382|583013888|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
161442605|NCT00473382|583013889|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
161442606|NCT00473382|583013887|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
161442607|NCT00473382|583013888|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
161442608|NCT00473382|583013889|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
161442609|NCT00473382|583013887|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
161442610|NCT00473382|583013888|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
161442611|NCT00473382|583013889|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
161442612|NCT00473382|583013887|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
161442613|NCT00473382|583013888|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
161442614|NCT00473382|583013889|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
161442615|NCT00473382|583013887|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
161442616|NCT00473382|583013888|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
161442617|NCT00473382|583013889|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
161442618|NCT00473382|583013887|FG000|Open-label Extension Through Month 60|Death|1|||
161442619|NCT00473382|583013888|FG001|Open-label Extension Through Month 60|Death|7|||
161442620|NCT00473382|583013889|FG002|Open-label Extension Through Month 60|Death|4|||
161442621|NCT00473382|583013887|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
161442622|NCT00473382|583013888|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
161442623|NCT00473382|583013889|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
161442624|NCT00473382|583013887|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
161442625|NCT00473382|583013888|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
161442626|NCT00473382|583013889|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
161442627|NCT00473382|583013887|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
161442628|NCT00473382|583013888|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
161442629|NCT00473382|583013889|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
161442630|NCT00473382|583013887|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
161442631|NCT00473382|583013888|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
161442632|NCT00473382|583013889|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
161442633|NCT02999672|583013890|FG000|Overall Study|Death|0|||
161442634|NCT02999672|583013891|FG001|Overall Study|Death|1|||
161442635|NCT02999672|583013890|FG000|Overall Study|Study Terminated by Sponsor|0|||
161442636|NCT02999672|583013891|FG001|Overall Study|Study Terminated by Sponsor|1|||
161442637|NCT02999672|583013890|FG000|Overall Study|Progressive Disease|9|||
161442638|NCT02999672|583013891|FG001|Overall Study|Progressive Disease|5|||
161789457|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
161789458|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
161442639|NCT02999672|583013890|FG000|Overall Study|Adverse Event|4|||
161442640|NCT02999672|583013891|FG001|Overall Study|Adverse Event|0|||
161442641|NCT03565497|583013892|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
161442642|NCT03565497|583013893|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
161442643|NCT03565497|583013894|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
161442644|NCT03565497|583013892|FG000|Overall Study|Lost to Follow-up|1|||
161442645|NCT03565497|583013893|FG001|Overall Study|Lost to Follow-up|1|||
161442646|NCT03565497|583013894|FG002|Overall Study|Lost to Follow-up|2|||
161442647|NCT03565497|583013892|FG000|Overall Study|Withdrawal by Subject|1|||
161442648|NCT03565497|583013893|FG001|Overall Study|Withdrawal by Subject|1|||
161442649|NCT03565497|583013894|FG002|Overall Study|Withdrawal by Subject|1|||
161442650|NCT01470326|583013895|FG000|Overall Study|Protocol Violation|32|||
161442651|NCT01470326|583013895|FG000|Overall Study|No Drug Administration Information|2|||
161442652|NCT01470326|583013895|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
161442653|NCT01166282|583013896|FG000|Open-label Period|Adverse Event|0|||
161442654|NCT01166282|583013897|FG001|Open-label Period|Adverse Event|0|||
161442655|NCT01166282|583013898|FG002|Open-label Period|Adverse Event|6|||
161442656|NCT01166282|583013896|FG000|Open-label Period|Withdrawal by Subject|0|||
161442657|NCT01166282|583013897|FG001|Open-label Period|Withdrawal by Subject|0|||
161442658|NCT01166282|583013898|FG002|Open-label Period|Withdrawal by Subject|4|||
161442659|NCT01166282|583013896|FG000|Open-label Period|Lack of Efficacy|0|||
161442660|NCT01166282|583013897|FG001|Open-label Period|Lack of Efficacy|0|||
161442661|NCT01166282|583013898|FG002|Open-label Period|Lack of Efficacy|2|||
161442662|NCT01166282|583013896|FG000|Open-label Period|Remission|0|||
161442663|NCT01166282|583013897|FG001|Open-label Period|Remission|0|||
161442664|NCT01166282|583013898|FG002|Open-label Period|Remission|4|||
161442665|NCT01166282|583013896|FG000|Open-label Period|Irregular Compliance|0|||
161442666|NCT01166282|583013897|FG001|Open-label Period|Irregular Compliance|0|||
161442667|NCT01166282|583013898|FG002|Open-label Period|Irregular Compliance|1|||
161442668|NCT02561832|583013899|FG000|Overall Study|Withdrawal by Subject|1|||
161442669|NCT02561832|583013900|FG001|Overall Study|Withdrawal by Subject|1|||
161442670|NCT02561832|583013899|FG000|Overall Study|Adverse Event|3|||
161442671|NCT02561832|583013900|FG001|Overall Study|Adverse Event|0|||
161442672|NCT02561832|583013899|FG000|Overall Study|Disease progression|3|||
161442673|NCT02561832|583013900|FG001|Overall Study|Disease progression|3|||
161442674|NCT02892448|583013907|FG000|Overall Study|Screening failure|2|||
161442675|NCT02892448|583013908|FG001|Overall Study|Screening failure|2|||
161442676|NCT02892448|583013909|FG002|Overall Study|Screening failure|1|||
161442677|NCT02023697|583013911|FG000|Treatment Period|Radiological progression|13|||
161442678|NCT02023697|583013912|FG001|Treatment Period|Radiological progression|17|||
161442679|NCT02023697|583013913|FG002|Treatment Period|Radiological progression|26|||
161442680|NCT02023697|583013911|FG000|Treatment Period|Never Treated|5|||
161442681|NCT02023697|583013912|FG001|Treatment Period|Never Treated|6|||
161442682|NCT02023697|583013913|FG002|Treatment Period|Never Treated|10|||
161442683|NCT02023697|583013911|FG000|Treatment Period|Adverse Event|13|||
161442684|NCT02023697|583013912|FG001|Treatment Period|Adverse Event|25|||
161442685|NCT02023697|583013913|FG002|Treatment Period|Adverse Event|23|||
161442686|NCT02023697|583013911|FG000|Treatment Period|Logistical difficulties|1|||
161442687|NCT02023697|583013912|FG001|Treatment Period|Logistical difficulties|1|||
161442688|NCT02023697|583013913|FG002|Treatment Period|Logistical difficulties|1|||
161442689|NCT02023697|583013911|FG000|Treatment Period|Clinical progression|10|||
161442690|NCT02023697|583013912|FG001|Treatment Period|Clinical progression|8|||
161442691|NCT02023697|583013913|FG002|Treatment Period|Clinical progression|28|||
161442692|NCT02023697|583013911|FG000|Treatment Period|Withdrawal by Subject|4|||
161442693|NCT02023697|583013912|FG001|Treatment Period|Withdrawal by Subject|5|||
161442694|NCT02023697|583013913|FG002|Treatment Period|Withdrawal by Subject|13|||
161442695|NCT02023697|583013911|FG000|Treatment Period|Safety outcome reached|0|||
161442696|NCT02023697|583013912|FG001|Treatment Period|Safety outcome reached|1|||
161442697|NCT02023697|583013913|FG002|Treatment Period|Safety outcome reached|0|||
161442698|NCT02023697|583013911|FG000|Treatment Period|Physician Decision|0|||
161442699|NCT02023697|583013912|FG001|Treatment Period|Physician Decision|0|||
161442700|NCT02023697|583013913|FG002|Treatment Period|Physician Decision|1|||
161442701|NCT02023697|583013911|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
161442702|NCT02023697|583013912|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
161442703|NCT02023697|583013913|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
161442704|NCT02023697|583013911|FG000|Active Follow-up Period|Lost to Follow-up|1|||
161442705|NCT02023697|583013912|FG001|Active Follow-up Period|Lost to Follow-up|1|||
161442706|NCT02023697|583013913|FG002|Active Follow-up Period|Lost to Follow-up|1|||
161442707|NCT02023697|583013911|FG000|Active Follow-up Period|Deterioration of general condition|1|||
161442708|NCT02023697|583013912|FG001|Active Follow-up Period|Deterioration of general condition|1|||
161442709|NCT02023697|583013913|FG002|Active Follow-up Period|Deterioration of general condition|1|||
161442710|NCT02023697|583013911|FG000|Active Follow-up Period|Other unspecified|2|||
161442711|NCT02023697|583013912|FG001|Active Follow-up Period|Other unspecified|0|||
161442712|NCT02023697|583013913|FG002|Active Follow-up Period|Other unspecified|1|||
161442713|NCT02023697|583013911|FG000|Active Follow-up Period|Clinical progression|0|||
161442714|NCT02023697|583013912|FG001|Active Follow-up Period|Clinical progression|2|||
161442715|NCT02023697|583013913|FG002|Active Follow-up Period|Clinical progression|1|||
161442716|NCT02023697|583013911|FG000|Active Follow-up Period|Radiological progression|0|||
161442717|NCT02023697|583013912|FG001|Active Follow-up Period|Radiological progression|0|||
161442718|NCT02023697|583013913|FG002|Active Follow-up Period|Radiological progression|1|||
161442719|NCT02023697|583013911|FG000|Active Follow-up Period|Death|83|||
161442720|NCT02023697|583013912|FG001|Active Follow-up Period|Death|82|||
161442721|NCT02023697|583013913|FG002|Active Follow-up Period|Death|87|||
161442722|NCT02023697|583013911|FG000|Long-term Follow-up Period|Death|9|||
161442723|NCT02023697|583013912|FG001|Long-term Follow-up Period|Death|6|||
161442724|NCT02023697|583013913|FG002|Long-term Follow-up Period|Death|4|||
161442725|NCT02023697|583013911|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
161442726|NCT02023697|583013912|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
161442727|NCT02023697|583013913|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
161442728|NCT02023697|583013911|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
161442729|NCT02023697|583013912|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
161442730|NCT02023697|583013913|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
161442731|NCT02023697|583013911|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
161442732|NCT02023697|583013912|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
161442733|NCT02023697|583013913|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
161442734|NCT02023697|583013911|FG000|Long-term Follow-up Period|Technical problems|0|||
161442735|NCT02023697|583013912|FG001|Long-term Follow-up Period|Technical problems|0|||
161442736|NCT02023697|583013913|FG002|Long-term Follow-up Period|Technical problems|1|||
161442737|NCT02023697|583013911|FG000|Long-term Follow-up Period|Other unspecified|6|||
161442738|NCT02023697|583013912|FG001|Long-term Follow-up Period|Other unspecified|3|||
161442739|NCT02023697|583013913|FG002|Long-term Follow-up Period|Other unspecified|5|||
161442740|NCT00541385|583013914|FG000|Overall Study|Adverse Event|6|||
161442741|NCT00541385|583013915|FG001|Overall Study|Adverse Event|3|||
161442742|NCT00541385|583013914|FG000|Overall Study|Withdrawal by Subject|2|||
161442743|NCT00541385|583013915|FG001|Overall Study|Withdrawal by Subject|2|||
161442744|NCT00541385|583013914|FG000|Overall Study|Lost to Follow-up|6|||
161442745|NCT00541385|583013915|FG001|Overall Study|Lost to Follow-up|1|||
161442746|NCT00541385|583013914|FG000|Overall Study|Parasite reappearance/malaria|67|||
161442747|NCT00541385|583013915|FG001|Overall Study|Parasite reappearance/malaria|32|||
161442748|NCT01469377|583013916|FG000|Overall Study|Protocol Deviation|7|||
161442749|NCT01469377|583013917|FG001|Overall Study|Protocol Deviation|10|||
161442750|NCT01469377|583013918|FG002|Overall Study|Protocol Deviation|10|||
161442751|NCT01469377|583013916|FG000|Overall Study|Lost to Follow-up|3|||
161442752|NCT01469377|583013917|FG001|Overall Study|Lost to Follow-up|2|||
161442753|NCT01469377|583013918|FG002|Overall Study|Lost to Follow-up|5|||
161442754|NCT01469377|583013916|FG000|Overall Study|Withdrawal of Consent|12|||
161442755|NCT01469377|583013917|FG001|Overall Study|Withdrawal of Consent|14|||
161442756|NCT01469377|583013918|FG002|Overall Study|Withdrawal of Consent|15|||
161442757|NCT01469377|583013916|FG000|Overall Study|Adverse Event|8|||
161442758|NCT01469377|583013917|FG001|Overall Study|Adverse Event|18|||
161442759|NCT01469377|583013918|FG002|Overall Study|Adverse Event|36|||
161442760|NCT01469377|583013916|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161442761|NCT01469377|583013917|FG001|Overall Study|Insufficient Therapeutic Response|4|||
161442762|NCT01469377|583013918|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161442763|NCT01469377|583013916|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161442764|NCT01469377|583013917|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161442765|NCT01469377|583013918|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161442766|NCT04139798|583013919|FG000|Overall Study|Withdrawal by Subject|6|||
161442767|NCT04139798|583013920|FG001|Overall Study|Withdrawal by Subject|5|||
161442768|NCT04139798|583013919|FG000|Overall Study|Lost to Follow-up|2|||
161442769|NCT04139798|583013920|FG001|Overall Study|Lost to Follow-up|5|||
161442770|NCT04139798|583013919|FG000|Overall Study|Discontinued|4|||
161789459|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
161789460|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
161789461|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
161789462|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
161789463|NCT05017493|584272863|FG000|Overall Study|Withdrawal by Subject|26|||
161789464|NCT05017493|584272864|FG001|Overall Study|Withdrawal by Subject|0|||
161789465|NCT05017493|584272863|FG000|Overall Study|Physician Decision|15|||
161789466|NCT05017493|584272864|FG001|Overall Study|Physician Decision|0|||
161789467|NCT05017493|584272863|FG000|Overall Study|Protocol Violation|81|||
161789468|NCT05017493|584272864|FG001|Overall Study|Protocol Violation|0|||
161789469|NCT03940586|584272868|FG000|Overall Study|Death|3|||
161789470|NCT03940586|584272869|FG001|Overall Study|Death|2|||
161789471|NCT03940586|584272870|FG002|Overall Study|Death|0|||
161789472|NCT03940586|584272868|FG000|Overall Study|Physician Decision|1|||
161789473|NCT03940586|584272869|FG001|Overall Study|Physician Decision|0|||
161789474|NCT03940586|584272870|FG002|Overall Study|Physician Decision|1|||
161789475|NCT03940586|584272868|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
161789476|NCT03940586|584272869|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
161789477|NCT03940586|584272870|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
161789478|NCT03940586|584272868|FG000|Overall Study|Not Treated|0|||
161442771|NCT04139798|583013920|FG001|Overall Study|Discontinued|2|||
161442772|NCT04139798|583013919|FG000|Overall Study|Adverse Event|1|||
161442773|NCT04139798|583013920|FG001|Overall Study|Adverse Event|3|||
161442774|NCT04139798|583013919|FG000|Overall Study|Protocol Violation|1|||
161442775|NCT04139798|583013920|FG001|Overall Study|Protocol Violation|0|||
161442776|NCT01526733|583013921|FG000|Phase 1|Protocol Violation|1|||
161442777|NCT01526733|583013922|FG001|Phase 1|Protocol Violation|0|||
161442778|NCT01526733|583013921|FG000|Phase 1|Withdrawal by Subject|1|||
161789479|NCT03940586|584272869|FG001|Overall Study|Not Treated|2|||
161442779|NCT01526733|583013922|FG001|Phase 1|Withdrawal by Subject|1|||
161442780|NCT03857867|583013923|FG000|Overall Study|Physician Decision|1|||
161442781|NCT00885534|583013924|FG000|Overall Study|Patient deemed ineligible|1|||
161442782|NCT02453711|583013925|FG000|Overall Study|Withdrawal by Subject|5|||
161442783|NCT02453711|583013926|FG001|Overall Study|Withdrawal by Subject|4|||
161442784|NCT02453711|583013927|FG002|Overall Study|Withdrawal by Subject|6|||
161442785|NCT02453711|583013928|FG003|Overall Study|Withdrawal by Subject|4|||
161442786|NCT02453711|583013929|FG004|Overall Study|Withdrawal by Subject|1|||
161442787|NCT02453711|583013930|FG005|Overall Study|Withdrawal by Subject|1|||
161442788|NCT02453711|583013931|FG006|Overall Study|Withdrawal by Subject|0|||
161442789|NCT02453711|583013932|FG007|Overall Study|Withdrawal by Subject|1|||
161442790|NCT02453711|583013933|FG008|Overall Study|Withdrawal by Subject|7|||
161442791|NCT02453711|583013925|FG000|Overall Study|Lost to Follow-up|5|||
161442792|NCT02453711|583013926|FG001|Overall Study|Lost to Follow-up|3|||
161442793|NCT02453711|583013927|FG002|Overall Study|Lost to Follow-up|2|||
161442794|NCT02453711|583013928|FG003|Overall Study|Lost to Follow-up|3|||
161442795|NCT02453711|583013929|FG004|Overall Study|Lost to Follow-up|1|||
161442796|NCT02453711|583013930|FG005|Overall Study|Lost to Follow-up|5|||
161442797|NCT02453711|583013931|FG006|Overall Study|Lost to Follow-up|2|||
161442798|NCT02453711|583013932|FG007|Overall Study|Lost to Follow-up|6|||
161442799|NCT02453711|583013933|FG008|Overall Study|Lost to Follow-up|6|||
161442800|NCT02453711|583013925|FG000|Overall Study|Death|0|||
161442801|NCT02453711|583013926|FG001|Overall Study|Death|0|||
161442802|NCT02453711|583013927|FG002|Overall Study|Death|0|||
161442803|NCT02453711|583013928|FG003|Overall Study|Death|0|||
161442804|NCT02453711|583013929|FG004|Overall Study|Death|0|||
161442805|NCT02453711|583013930|FG005|Overall Study|Death|0|||
161442806|NCT02453711|583013931|FG006|Overall Study|Death|1|||
161442807|NCT02453711|583013932|FG007|Overall Study|Death|0|||
161442808|NCT02453711|583013933|FG008|Overall Study|Death|0|||
161442809|NCT02453711|583013925|FG000|Overall Study|Unclassified|1|||
161442810|NCT02453711|583013926|FG001|Overall Study|Unclassified|0|||
161442811|NCT02453711|583013927|FG002|Overall Study|Unclassified|1|||
161442812|NCT02453711|583013928|FG003|Overall Study|Unclassified|0|||
161442813|NCT02453711|583013929|FG004|Overall Study|Unclassified|0|||
161442814|NCT02453711|583013930|FG005|Overall Study|Unclassified|0|||
161442815|NCT02453711|583013931|FG006|Overall Study|Unclassified|0|||
161442816|NCT02453711|583013932|FG007|Overall Study|Unclassified|0|||
161442817|NCT02453711|583013933|FG008|Overall Study|Unclassified|0|||
161442818|NCT00314795|583013938|FG000|Overall Study|Adverse Event|8|||
161442819|NCT00314795|583013938|FG000|Overall Study|Death|4|||
161442820|NCT00314795|583013938|FG000|Overall Study|Reason not Specified|3|||
161442821|NCT00314795|583013938|FG000|Overall Study|Renal Transplant|3|||
161442822|NCT00314795|583013938|FG000|Overall Study|Participants Withdrew Consent|2|||
161442823|NCT02170077|583013943|FG000|Overall Study|Withdrawal by Subject|3|||
161442824|NCT02170077|583013944|FG001|Overall Study|Withdrawal by Subject|4|||
161442825|NCT02170077|583013945|FG002|Overall Study|Withdrawal by Subject|2|||
161442826|NCT02170077|583013943|FG000|Overall Study|Adverse Event|4|||
161442827|NCT02170077|583013944|FG001|Overall Study|Adverse Event|4|||
161442828|NCT02170077|583013945|FG002|Overall Study|Adverse Event|4|||
161442829|NCT02170077|583013943|FG000|Overall Study|Lost to Follow-up|0|||
161442830|NCT02170077|583013944|FG001|Overall Study|Lost to Follow-up|1|||
161442831|NCT02170077|583013945|FG002|Overall Study|Lost to Follow-up|0|||
161442832|NCT02170077|583013943|FG000|Overall Study|Exclusion criteria|2|||
161442833|NCT02170077|583013944|FG001|Overall Study|Exclusion criteria|2|||
161442834|NCT02170077|583013945|FG002|Overall Study|Exclusion criteria|5|||
161442835|NCT02170077|583013943|FG000|Overall Study|Exacerbation of seizures|0|||
161442836|NCT02170077|583013944|FG001|Overall Study|Exacerbation of seizures|2|||
161442837|NCT02170077|583013945|FG002|Overall Study|Exacerbation of seizures|1|||
161442838|NCT01780974|583013950|FG000|Overall Study|Death|1|||
161442839|NCT01780974|583013951|FG001|Overall Study|Death|0|||
161442840|NCT01780974|583013950|FG000|Overall Study|Adverse Event|1|||
161442841|NCT01780974|583013951|FG001|Overall Study|Adverse Event|3|||
161442842|NCT02447003|583013959|FG000|Overall Study|Other|0|||
161442843|NCT02447003|583013960|FG001|Overall Study|Other|4|||
161442844|NCT02447003|583013959|FG000|Overall Study|Site discontinued|0|||
161442845|NCT02447003|583013960|FG001|Overall Study|Site discontinued|2|||
161442846|NCT02447003|583013959|FG000|Overall Study|Physician Decision|0|||
161442847|NCT02447003|583013960|FG001|Overall Study|Physician Decision|1|||
161442848|NCT02447003|583013959|FG000|Overall Study|Withdrawal by Subject|4|||
161442849|NCT02447003|583013960|FG001|Overall Study|Withdrawal by Subject|3|||
161442850|NCT02447003|583013959|FG000|Overall Study|Sponsor Decision|6|||
161442851|NCT02447003|583013960|FG001|Overall Study|Sponsor Decision|11|||
161442852|NCT02447003|583013959|FG000|Overall Study|Progressive Disease|1|||
161442853|NCT02447003|583013960|FG001|Overall Study|Progressive Disease|0|||
161442854|NCT02447003|583013959|FG000|Overall Study|Lost to Follow-up|5|||
161442855|NCT02447003|583013960|FG001|Overall Study|Lost to Follow-up|0|||
161442856|NCT02447003|583013959|FG000|Overall Study|Death|154|||
161442857|NCT02447003|583013960|FG001|Overall Study|Death|63|||
161442858|NCT00750438|583013961|FG000|Overall Study|Protocol Violation|4|||
161442859|NCT00750438|583013962|FG001|Overall Study|Protocol Violation|1|||
161442860|NCT00750438|583013961|FG000|Overall Study|Physician Decision|2|||
161442861|NCT00750438|583013962|FG001|Overall Study|Physician Decision|2|||
161442862|NCT00750438|583013961|FG000|Overall Study|Withdrawal by Subject|1|||
161442863|NCT00750438|583013962|FG001|Overall Study|Withdrawal by Subject|1|||
161442864|NCT03848728|583013963|FG000|Overall Study|Death|16|||
161442865|NCT03848728|583013964|FG001|Overall Study|Death|13|||
161442866|NCT03848728|583013963|FG000|Overall Study|Outmigrated to non-study community|98|||
161442867|NCT03848728|583013964|FG001|Overall Study|Outmigrated to non-study community|106|||
161442868|NCT03848728|583013963|FG000|Overall Study|Transfered to non-study clinic|32|||
161442869|NCT03848728|583013964|FG001|Overall Study|Transfered to non-study clinic|48|||
161442870|NCT03848728|583013963|FG000|Overall Study|Withdrawal by Subject|1|||
161442871|NCT03848728|583013964|FG001|Overall Study|Withdrawal by Subject|0|||
161442872|NCT00536744|583013967|FG000|Overall Study|Adverse Event|13|||
161442873|NCT00536744|583013968|FG001|Overall Study|Adverse Event|10|||
161442874|NCT00536744|583013967|FG000|Overall Study|Death|2|||
161442875|NCT00536744|583013968|FG001|Overall Study|Death|1|||
161442876|NCT00536744|583013967|FG000|Overall Study|Physician Decision|3|||
161442877|NCT00536744|583013968|FG001|Overall Study|Physician Decision|1|||
161442878|NCT00536744|583013967|FG000|Overall Study|Lost to Follow-up|3|||
161442879|NCT00536744|583013968|FG001|Overall Study|Lost to Follow-up|5|||
161442880|NCT00536744|583013967|FG000|Overall Study|Withdrawal by Subject|7|||
161442881|NCT00536744|583013968|FG001|Overall Study|Withdrawal by Subject|8|||
161442882|NCT00536744|583013967|FG000|Overall Study|PI tried alternative treatment|1|||
161442883|NCT00536744|583013968|FG001|Overall Study|PI tried alternative treatment|3|||
161442884|NCT00787644|583013969|FG000|Overall Study|Lost to Follow-up|1|||
161442885|NCT00787644|583013970|FG001|Overall Study|Lost to Follow-up|1|||
161442886|NCT00787644|583013969|FG000|Overall Study|Withdrawal by Subject|1|||
161442887|NCT00787644|583013970|FG001|Overall Study|Withdrawal by Subject|1|||
161442888|NCT01642589|583013974|FG000|Overall Study|Withdrawal by Subject|1|||
161442889|NCT01642589|583013975|FG001|Overall Study|Withdrawal by Subject|1|||
161442890|NCT01108185|583013976|FG000|Overall Study|Non-compliance|15|||
161442891|NCT01108185|583013976|FG000|Overall Study|Lost to Follow-up|12|||
161442892|NCT02581410|583013981|FG000|Vaccination Phase|Adverse Event|2|||
161442893|NCT02581410|583013982|FG001|Vaccination Phase|Adverse Event|1|||
161442894|NCT02581410|583013981|FG000|Vaccination Phase|Withdrawal by Subject|0|||
161442895|NCT02581410|583013982|FG001|Vaccination Phase|Withdrawal by Subject|1|||
161442896|NCT02581410|583013981|FG000|Vaccination Phase|Migrated/moved from study area|0|||
161442897|NCT02581410|583013982|FG001|Vaccination Phase|Migrated/moved from study area|1|||
161442898|NCT02581410|583013981|FG000|End of Study Phase|Adverse Event|4|||
161442899|NCT02581410|583013982|FG001|End of Study Phase|Adverse Event|3|||
161442900|NCT02581410|583013981|FG000|End of Study Phase|Withdrawal by Subject|1|||
161442901|NCT02581410|583013982|FG001|End of Study Phase|Withdrawal by Subject|2|||
161442902|NCT02581410|583013981|FG000|End of Study Phase|Migrated/moved from study area|0|||
161442903|NCT02581410|583013982|FG001|End of Study Phase|Migrated/moved from study area|3|||
161442904|NCT02581410|583013981|FG000|End of Study Phase|Lost to Follow-up|0|||
161442905|NCT02581410|583013982|FG001|End of Study Phase|Lost to Follow-up|2|||
161442906|NCT02581410|583013981|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
161442907|NCT02581410|583013982|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
161442908|NCT00670748|583013984|FG000|Overall Study|Death during treatment|1|||
161442909|NCT00670748|583013985|FG001|Overall Study|Death during treatment|1|||
161442910|NCT00670748|583013986|FG002|Overall Study|Death during treatment|1|||
161442911|NCT00670748|583013987|FG003|Overall Study|Death during treatment|0|||
161442912|NCT00670748|583013984|FG000|Overall Study|Not off study|2|||
161442913|NCT00670748|583013985|FG001|Overall Study|Not off study|1|||
161442914|NCT00670748|583013986|FG002|Overall Study|Not off study|1|||
161442915|NCT00670748|583013987|FG003|Overall Study|Not off study|1|||
161442916|NCT00759941|583013988|FG000|Overall Study|Use of medication|1|||
161442917|NCT00759941|583013989|FG001|Overall Study|Use of medication|0|||
161442918|NCT00759941|583013988|FG000|Overall Study|Adverse Event|1|||
161442919|NCT00759941|583013989|FG001|Overall Study|Adverse Event|0|||
161442920|NCT00759941|583013988|FG000|Overall Study|Exited in error by site|1|||
161442921|NCT00759941|583013989|FG001|Overall Study|Exited in error by site|1|||
161442922|NCT00354432|583013990|FG000|Overall Study|Adverse Event|3|||
161442923|NCT00354432|583013991|FG001|Overall Study|Adverse Event|1|||
161442924|NCT00354432|583013992|FG002|Overall Study|Adverse Event|5|||
161442925|NCT00354432|583013993|FG003|Overall Study|Adverse Event|5|||
161442926|NCT00354432|583013990|FG000|Overall Study|Off/Toxicity|3|||
161442927|NCT00354432|583013991|FG001|Overall Study|Off/Toxicity|7|||
161442928|NCT00354432|583013992|FG002|Overall Study|Off/Toxicity|5|||
161442929|NCT00354432|583013993|FG003|Overall Study|Off/Toxicity|5|||
161442930|NCT02736578|583013994|FG000|Overall Study|Adverse Event|1|||
161442931|NCT02736578|583013995|FG001|Overall Study|Adverse Event|0|||
161442932|NCT03863080|583013996|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
161442933|NCT03863080|583013997|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
161442934|NCT03863080|583013998|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
161442935|NCT03863080|583013999|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
161789480|NCT03940586|584272870|FG002|Overall Study|Not Treated|0|||
161442936|NCT03863080|583013996|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
161442937|NCT03863080|583013997|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
161442938|NCT03863080|583013998|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
161442939|NCT03863080|583013999|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
161442940|NCT03863080|583013996|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
161442941|NCT03863080|583013997|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
161442942|NCT03863080|583013998|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
161442943|NCT03863080|583013999|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
161442944|NCT00802945|583014002|FG000|Overall Study|Death|27|||
161442945|NCT00802945|583014003|FG001|Overall Study|Death|23|||
161442946|NCT00802945|583014002|FG000|Overall Study|Terminated by sponsor|8|||
161442947|NCT00802945|583014003|FG001|Overall Study|Terminated by sponsor|12|||
161442948|NCT05307692|583014004|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
161442949|NCT05307692|583014005|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
161442950|NCT05307692|583014006|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
161442951|NCT05307692|583014007|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
161442952|NCT05307692|583014004|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
161442953|NCT05307692|583014005|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
161442954|NCT05307692|583014006|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
161442955|NCT05307692|583014007|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
161442956|NCT05307692|583014004|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
161442957|NCT05307692|583014005|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
161442958|NCT05307692|583014006|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
161442959|NCT05307692|583014007|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
161442960|NCT05307692|583014004|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
161442961|NCT05307692|583014005|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
161442962|NCT05307692|583014006|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
161442963|NCT05307692|583014007|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
161442964|NCT05307692|583014004|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
161442965|NCT05307692|583014005|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
161442966|NCT05307692|583014006|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
161442967|NCT05307692|583014007|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
161442968|NCT05307692|583014004|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
161442969|NCT05307692|583014005|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
161442970|NCT05307692|583014006|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
161442971|NCT05307692|583014007|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
161442972|NCT05307692|583014004|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
161442973|NCT05307692|583014005|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
161442974|NCT05307692|583014006|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
161442975|NCT05307692|583014007|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
161442976|NCT05307692|583014004|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
161442977|NCT05307692|583014005|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
161442978|NCT05307692|583014006|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
161442979|NCT05307692|583014007|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
161442980|NCT04500158|583014008|FG000|Overall Study|Physician Decision|17|||
161442981|NCT04500158|583014009|FG001|Overall Study|Physician Decision|11|||
161442982|NCT03493464|583014012|FG000|Overall Study|Surgery not performed|1|||
161442983|NCT01077050|583015617|FG000|Overall Study|Subjects signed ICF could not be located|1|||
161442984|NCT01077050|583015617|FG000|Overall Study|Screen failure|8|||
161442985|NCT00684060|583015621|FG000|Overall Study|Lost to Follow-up|1|||
161442986|NCT00684060|583015622|FG001|Overall Study|Lost to Follow-up|0|||
161442987|NCT00684060|583015621|FG000|Overall Study|New stenosis identified|1|||
161442988|NCT00684060|583015622|FG001|Overall Study|New stenosis identified|0|||
161442989|NCT00684060|583015621|FG000|Overall Study|Unable to collect MRI|1|||
161442990|NCT00684060|583015622|FG001|Overall Study|Unable to collect MRI|2|||
161442991|NCT00684060|583015621|FG000|Overall Study|Death|0|||
161442992|NCT00684060|583015622|FG001|Overall Study|Death|1|||
161442993|NCT00702715|583015623|FG000|Overall Study|Lost to Follow-up|1|||
161442994|NCT00702715|583015624|FG001|Overall Study|Lost to Follow-up|0|||
161442995|NCT03126344|583015639|FG000|Overall Study|Lost to Follow-up|0|||
161442996|NCT03126344|583015640|FG001|Overall Study|Lost to Follow-up|0|||
161442997|NCT03126344|583015641|FG002|Overall Study|Lost to Follow-up|5|||
161442998|NCT01715857|583015642|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
161442999|NCT02563067|583015643|FG000|Overall Study|Subject/guardian decision|14|||
161443000|NCT02563067|583015644|FG001|Overall Study|Subject/guardian decision|20|||
161789481|NCT04304950|584272871|FG000|Overall Study|Lost to Follow-up|1|||
161443001|NCT02563067|583015645|FG002|Overall Study|Subject/guardian decision|16|||
161443002|NCT02563067|583015643|FG000|Overall Study|Physician Decision|0|||
161443003|NCT02563067|583015644|FG001|Overall Study|Physician Decision|1|||
161443004|NCT02563067|583015645|FG002|Overall Study|Physician Decision|3|||
161443005|NCT02563067|583015643|FG000|Overall Study|Lost to Follow-up|1|||
161443006|NCT02563067|583015644|FG001|Overall Study|Lost to Follow-up|2|||
161443007|NCT02563067|583015645|FG002|Overall Study|Lost to Follow-up|0|||
161443008|NCT02563067|583015643|FG000|Overall Study|Technical problems|0|||
161443009|NCT02563067|583015644|FG001|Overall Study|Technical problems|1|||
161443010|NCT02563067|583015645|FG002|Overall Study|Technical problems|0|||
161443011|NCT02563067|583015643|FG000|Overall Study|Lack of Efficacy|1|||
161443012|NCT02563067|583015644|FG001|Overall Study|Lack of Efficacy|0|||
161443013|NCT02563067|583015645|FG002|Overall Study|Lack of Efficacy|0|||
161443014|NCT02563067|583015643|FG000|Overall Study|Death|0|||
161443015|NCT02563067|583015644|FG001|Overall Study|Death|1|||
161443016|NCT02563067|583015645|FG002|Overall Study|Death|1|||
161443017|NCT02563067|583015643|FG000|Overall Study|Adverse Event|2|||
161443018|NCT02563067|583015644|FG001|Overall Study|Adverse Event|1|||
161443019|NCT02563067|583015645|FG002|Overall Study|Adverse Event|0|||
161443020|NCT02563067|583015643|FG000|Overall Study|Death post Treatment/safety period|1|||
161443021|NCT02563067|583015644|FG001|Overall Study|Death post Treatment/safety period|0|||
161443022|NCT02563067|583015645|FG002|Overall Study|Death post Treatment/safety period|0|||
161443023|NCT03544333|583015650|FG000|Overall Study|Withdrawal by Subject|1|||
161443024|NCT03544333|583015651|FG001|Overall Study|Withdrawal by Subject|0|||
161443025|NCT00475306|583015652|FG000|Overall Study|Protocol Violation|1|||
161443026|NCT00475306|583015653|FG001|Overall Study|Protocol Violation|1|||
161443027|NCT00475306|583015654|FG002|Overall Study|Protocol Violation|0|||
161443028|NCT00475306|583015655|FG003|Overall Study|Protocol Violation|1|||
161443029|NCT02405442|583015657|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
161443030|NCT02405442|583015658|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
161443031|NCT02405442|583015659|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
161443032|NCT02405442|583015660|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
161443033|NCT02405442|583015657|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
161443034|NCT02405442|583015658|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
161443035|NCT02405442|583015659|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
161443036|NCT02405442|583015660|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
161443037|NCT02405442|583015657|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
161443038|NCT02405442|583015658|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
161443039|NCT02405442|583015659|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
161443040|NCT02405442|583015660|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
161443041|NCT02405442|583015657|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
161443042|NCT02405442|583015658|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
161443043|NCT02405442|583015659|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
161443044|NCT02405442|583015660|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
161443045|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
161443046|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
161443047|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
161443048|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
161443049|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
161443050|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
161443051|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
161443052|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
161443053|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
161443054|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
161443055|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
161443056|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
161443057|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
161443058|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
161443059|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
161443060|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
161443061|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
161443062|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
161443063|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
161789482|NCT04304950|584272872|FG001|Overall Study|Lost to Follow-up|1|||
161443064|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
161443065|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
161789483|NCT02006147|584272873|FG000|Overall Study|Protocol Violation|1|||
161443066|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
161443067|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
161443068|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
161443069|NCT02405442|583015657|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
161443070|NCT02405442|583015658|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
161443071|NCT02405442|583015659|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
161443072|NCT02405442|583015660|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
161443073|NCT02405442|583015657|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
161443074|NCT02405442|583015658|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
161443075|NCT02405442|583015659|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
161443076|NCT02405442|583015660|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
161443077|NCT02405442|583015657|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
161443078|NCT02405442|583015658|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
161443079|NCT02405442|583015659|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
161443080|NCT02405442|583015660|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
161443081|NCT02405442|583015657|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
161443082|NCT02405442|583015658|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
161443083|NCT02405442|583015659|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
161443084|NCT02405442|583015660|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
161443085|NCT03830892|583015664|FG000|Overall Study|Physician Decision|2|||
161443086|NCT03830892|583015665|FG001|Overall Study|Physician Decision|3|||
161443087|NCT03830892|583015664|FG000|Overall Study|Study terminated due to COVID|4|||
161443088|NCT03830892|583015665|FG001|Overall Study|Study terminated due to COVID|0|||
161443089|NCT03830892|583015664|FG000|Overall Study|Protocol Violation|0|||
161443090|NCT03830892|583015665|FG001|Overall Study|Protocol Violation|1|||
161443091|NCT03830892|583015664|FG000|Overall Study|Withdrawal by Subject|0|||
161443092|NCT03830892|583015665|FG001|Overall Study|Withdrawal by Subject|2|||
161443093|NCT01499277|583015666|FG000|Overall Study|Adverse Event|3|||
161443094|NCT01499277|583015667|FG001|Overall Study|Adverse Event|6|||
161443095|NCT01499277|583015666|FG000|Overall Study|Death|3|||
161443096|NCT01499277|583015667|FG001|Overall Study|Death|2|||
161443097|NCT01499277|583015666|FG000|Overall Study|Lost to Follow-up|15|||
161443098|NCT01499277|583015667|FG001|Overall Study|Lost to Follow-up|8|||
161443099|NCT01499277|583015666|FG000|Overall Study|Protocol Violation|2|||
161443100|NCT01499277|583015667|FG001|Overall Study|Protocol Violation|3|||
161443101|NCT01499277|583015666|FG000|Overall Study|Withdrawal by Subject|16|||
161443102|NCT01499277|583015667|FG001|Overall Study|Withdrawal by Subject|6|||
161443103|NCT01499277|583015666|FG000|Overall Study|Lack of therapeutic response and other|8|||
161443104|NCT01499277|583015667|FG001|Overall Study|Lack of therapeutic response and other|7|||
161443105|NCT00975689|583015668|FG000|Overall Study|Adverse Event|0|||
161443106|NCT00975689|583015669|FG001|Overall Study|Adverse Event|3|||
161443107|NCT00975689|583015668|FG000|Overall Study|Withdrawal by Subject|1|||
161443108|NCT00975689|583015669|FG001|Overall Study|Withdrawal by Subject|0|||
161443109|NCT00975689|583015668|FG000|Overall Study|Physician Decision|1|||
161443110|NCT00975689|583015669|FG001|Overall Study|Physician Decision|0|||
161443111|NCT00372593|583015672|FG000|Overall Study|Adverse Event|43|||
161443112|NCT00372593|583015673|FG001|Overall Study|Adverse Event|45|||
161443113|NCT00372593|583015674|FG002|Overall Study|Adverse Event|0|||
161443114|NCT00372593|583015672|FG000|Overall Study|Death|16|||
161443115|NCT00372593|583015673|FG001|Overall Study|Death|20|||
161443116|NCT00372593|583015674|FG002|Overall Study|Death|1|||
161443117|NCT00372593|583015672|FG000|Overall Study|Lack of Efficacy|82|||
161443118|NCT00372593|583015673|FG001|Overall Study|Lack of Efficacy|71|||
161443119|NCT00372593|583015674|FG002|Overall Study|Lack of Efficacy|2|||
161443120|NCT00372593|583015672|FG000|Overall Study|Lost to Follow-up|1|||
161443121|NCT00372593|583015673|FG001|Overall Study|Lost to Follow-up|0|||
161443122|NCT00372593|583015674|FG002|Overall Study|Lost to Follow-up|0|||
161443123|NCT00372593|583015672|FG000|Overall Study|Physician Decision|42|||
161443124|NCT00372593|583015673|FG001|Overall Study|Physician Decision|41|||
161443125|NCT00372593|583015674|FG002|Overall Study|Physician Decision|0|||
161789484|NCT02006147|584272874|FG001|Overall Study|Protocol Violation|1|||
161789485|NCT02006147|584272875|FG002|Overall Study|Protocol Violation|0|||
161789486|NCT02006147|584272876|FG003|Overall Study|Protocol Violation|0|||
161789487|NCT02006147|584272873|FG000|Overall Study|Withdrawal by Subject|0|||
161789488|NCT02006147|584272874|FG001|Overall Study|Withdrawal by Subject|1|||
161789489|NCT02006147|584272875|FG002|Overall Study|Withdrawal by Subject|0|||
161789490|NCT02006147|584272876|FG003|Overall Study|Withdrawal by Subject|0|||
161789491|NCT02006147|584272873|FG000|Overall Study|Withdrawal by Sponsor|1|||
161789492|NCT02006147|584272874|FG001|Overall Study|Withdrawal by Sponsor|0|||
161443126|NCT00372593|583015672|FG000|Overall Study|Ineligible|20|||
161443127|NCT00372593|583015673|FG001|Overall Study|Ineligible|21|||
161443128|NCT00372593|583015674|FG002|Overall Study|Ineligible|1|||
161789493|NCT02006147|584272875|FG002|Overall Study|Withdrawal by Sponsor|0|||
161789494|NCT02006147|584272876|FG003|Overall Study|Withdrawal by Sponsor|0|||
161898711|NCT05225558|584677882|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
161443129|NCT02974543|583015675|FG000|Overall Study|Withdrawal by Subject|1|||
161789495|NCT00345683|584272881|FG000|Overall Study|Lost to Follow-up|19|||
161443130|NCT02974543|583015676|FG001|Overall Study|Withdrawal by Subject|0|||
161443131|NCT03534180|583015677|FG000|Overall Study|Withdrawal by Subject|1|||
161789496|NCT00345683|584272882|FG001|Overall Study|Lost to Follow-up|7|||
161789497|NCT00345683|584272881|FG000|Overall Study|Other|6|||
161789498|NCT00345683|584272882|FG001|Overall Study|Other|2|||
161789499|NCT03182686|584272883|FG000|Overall Study|Lost to Follow-up|2|||
161789500|NCT03182686|584272884|FG001|Overall Study|Lost to Follow-up|0|||
161789501|NCT03182686|584272883|FG000|Overall Study|Adverse Event|2|||
161789502|NCT03182686|584272884|FG001|Overall Study|Adverse Event|0|||
161789503|NCT03182686|584272883|FG000|Overall Study|Withdrawal by Subject|3|||
161789504|NCT03182686|584272884|FG001|Overall Study|Withdrawal by Subject|0|||
161789505|NCT01337050|584272885|FG000|Overall Study|Death|0|||
161789506|NCT01337050|584272886|FG001|Overall Study|Death|0|||
161789507|NCT01337050|584272887|FG002|Overall Study|Death|4|||
161789508|NCT01337050|584272885|FG000|Overall Study|Other|4|||
161789509|NCT01337050|584272886|FG001|Overall Study|Other|6|||
161789510|NCT01337050|584272887|FG002|Overall Study|Other|8|||
161789511|NCT01337050|584272885|FG000|Overall Study|Participants refused further follow-up|0|||
161789512|NCT01337050|584272886|FG001|Overall Study|Participants refused further follow-up|7|||
161789513|NCT01337050|584272887|FG002|Overall Study|Participants refused further follow-up|7|||
161789514|NCT00003102|584272888|FG000|Overall Study|Physician Decision|1|||
161789515|NCT00003102|584272889|FG001|Overall Study|Physician Decision|1|||
161789516|NCT00003102|584272890|FG002|Overall Study|Physician Decision|0|||
161789517|NCT00003102|584272888|FG000|Overall Study|Progressive Disease|0|||
161789518|NCT00003102|584272889|FG001|Overall Study|Progressive Disease|1|||
161789519|NCT00003102|584272890|FG002|Overall Study|Progressive Disease|0|||
161789520|NCT00003102|584272888|FG000|Overall Study|Adverse Event|0|||
161789521|NCT00003102|584272889|FG001|Overall Study|Adverse Event|1|||
161789522|NCT00003102|584272890|FG002|Overall Study|Adverse Event|1|||
161789523|NCT00003102|584272888|FG000|Overall Study|Death|0|||
161789524|NCT00003102|584272889|FG001|Overall Study|Death|0|||
161789525|NCT00003102|584272890|FG002|Overall Study|Death|1|||
161789526|NCT05037409|584272891|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
161789527|NCT05037409|584272892|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
161789528|NCT05037409|584272893|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
161789529|NCT01559818|584272896|FG000|Overall Study|Physician Decision|1|||
161789530|NCT01559818|584272896|FG000|Overall Study|Pregnancy|1|||
161443132|NCT00220636|583015678|FG000|Overall Study|Withdrawal by Subject|4|||
161443133|NCT00330967|583015679|FG000|Overall Study|Withdrawal by Subject|0|||
161443134|NCT00330967|583015680|FG001|Overall Study|Withdrawal by Subject|5|||
161789531|NCT01559818|584272896|FG000|Overall Study|Study terminated by Sponsor|4|||
161789532|NCT01559818|584272896|FG000|Overall Study|Withdrawal by Subject|1|||
161789533|NCT01512979|584272898|FG000|Overall Study|Adverse Event|2|||
161789534|NCT01512979|584272899|FG001|Overall Study|Adverse Event|2|||
161789535|NCT01512979|584272898|FG000|Overall Study|Protocol Violation|1|||
161789536|NCT01512979|584272899|FG001|Overall Study|Protocol Violation|4|||
161789537|NCT01512979|584272898|FG000|Overall Study|Lost to Follow-up|2|||
161789538|NCT01512979|584272899|FG001|Overall Study|Lost to Follow-up|5|||
161789539|NCT01512979|584272898|FG000|Overall Study|Withdrawal by Subject|1|||
161789540|NCT01512979|584272899|FG001|Overall Study|Withdrawal by Subject|2|||
161789541|NCT01512979|584272898|FG000|Overall Study|Reason other than stated above|13|||
161789542|NCT01512979|584272899|FG001|Overall Study|Reason other than stated above|9|||
161789543|NCT00125359|584272900|FG000|Overall Study|Death|4|||
161789544|NCT00125359|584272900|FG000|Overall Study|Adverse Event|5|||
161789545|NCT00125359|584272900|FG000|Overall Study|Physician Decision|14|||
161789546|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
161789547|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
161789548|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
161789549|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
161789550|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
161789551|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
161789552|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
161789553|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
161789554|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
161789555|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
161789556|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
161789557|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
161789558|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
161898712|NCT05225558|584677881|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
161898713|NCT05225558|584677882|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
161898714|NCT00313846|584677885|FG000|Overall Study|Withdrawal by Subject|2|||
161443135|NCT00330967|583015679|FG000|Overall Study|Physician Decision|0|||
161443136|NCT00330967|583015680|FG001|Overall Study|Physician Decision|9|||
161443137|NCT01237899|583015681|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
161789559|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
161789560|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
161789561|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
161789562|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
161789563|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
161789564|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
161443138|NCT01237899|583015682|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
161443139|NCT01237899|583015683|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
161443140|NCT01237899|583015684|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
161443141|NCT01237899|583015685|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
161443142|NCT01237899|583015686|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
161443143|NCT01237899|583015687|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
161443144|NCT01237899|583015688|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
161443145|NCT01237899|583015689|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
161443146|NCT01237899|583015690|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
161443147|NCT01237899|583015691|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
161443148|NCT00790088|583015692|FG000|Overall Study|Protocol Violation|11|||
161443149|NCT00790088|583015692|FG000|Overall Study|Withdrawal by Subject|17|||
161443150|NCT00790088|583015692|FG000|Overall Study|Lost to Follow-up|7|||
161443151|NCT00790088|583015692|FG000|Overall Study|Physician Decision|4|||
161443152|NCT03682770|583015703|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
161443153|NCT03682770|583015704|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
161443154|NCT03682770|583015705|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
161443155|NCT03682770|583015706|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
161443156|NCT03682770|583015707|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
161443157|NCT03682770|583015708|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
161443158|NCT03682770|583015709|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
161443159|NCT03682770|583015703|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
161443160|NCT03682770|583015704|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
161443161|NCT03682770|583015705|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161443162|NCT03682770|583015706|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161443163|NCT03682770|583015707|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161443164|NCT03682770|583015708|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161443165|NCT03682770|583015709|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161443166|NCT03682770|583015703|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161443167|NCT03682770|583015704|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161789565|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
161789566|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
161443168|NCT03682770|583015705|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
161443169|NCT03682770|583015706|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
161443170|NCT03682770|583015707|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161443171|NCT03682770|583015708|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161443172|NCT03682770|583015709|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161443173|NCT03682770|583015703|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161443174|NCT03682770|583015704|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161443175|NCT03682770|583015705|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161443176|NCT03682770|583015706|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
161443177|NCT03682770|583015707|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161443178|NCT03682770|583015708|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161443179|NCT03682770|583015709|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161443180|NCT03682770|583015703|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
161443181|NCT03682770|583015704|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
161443182|NCT03682770|583015705|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
161443183|NCT03682770|583015706|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
161443184|NCT03682770|583015707|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
161789567|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
161789568|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
161789569|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
161789570|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
161898715|NCT00313846|584677886|FG001|Overall Study|Withdrawal by Subject|0|||
161443185|NCT03682770|583015708|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
161443186|NCT03682770|583015709|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
161443187|NCT03682770|583015703|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
161443188|NCT03682770|583015704|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
161789571|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
161789572|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
161789573|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
161789574|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
161789575|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
161789576|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
161789577|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
161789578|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
161789579|NCT04049552|584272904|FG000|Overall Study|Lost to Follow-up|1|||
161789580|NCT04147611|584272906|FG000|Overall Study|Physician Decision|0|||
161789581|NCT04147611|584272907|FG001|Overall Study|Physician Decision|1|||
161789582|NCT01585831|584272910|FG000|Overall Study|Physician Decision|0|||
161789583|NCT01585831|584272911|FG001|Overall Study|Physician Decision|1|||
161789584|NCT01585831|584272910|FG000|Overall Study|Withdrawal by Subject|2|||
161789585|NCT01585831|584272911|FG001|Overall Study|Withdrawal by Subject|1|||
161789586|NCT01225991|584272912|FG000|Overall Study|Withdrawal by Subject|6|||
161789587|NCT02133352|584272913|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
161789588|NCT04444752|584272914|FG000|Overall Study|Adverse Event|1|||
161789589|NCT04444752|584272915|FG001|Overall Study|Adverse Event|0|||
161789590|NCT04444752|584272916|FG002|Overall Study|Adverse Event|0|||
161789591|NCT04444752|584272917|FG003|Overall Study|Adverse Event|2|||
161789592|NCT04444752|584272914|FG000|Overall Study|Lost to Follow-up|2|||
161789593|NCT04444752|584272915|FG001|Overall Study|Lost to Follow-up|6|||
161789594|NCT04444752|584272916|FG002|Overall Study|Lost to Follow-up|2|||
161789595|NCT04444752|584272917|FG003|Overall Study|Lost to Follow-up|5|||
161789596|NCT04444752|584272914|FG000|Overall Study|Physician Decision|0|||
161789597|NCT04444752|584272915|FG001|Overall Study|Physician Decision|0|||
161789598|NCT04444752|584272916|FG002|Overall Study|Physician Decision|0|||
161789599|NCT04444752|584272917|FG003|Overall Study|Physician Decision|2|||
161789600|NCT04444752|584272914|FG000|Overall Study|Pregnancy|0|||
161789601|NCT04444752|584272915|FG001|Overall Study|Pregnancy|0|||
161789602|NCT04444752|584272916|FG002|Overall Study|Pregnancy|0|||
161789603|NCT04444752|584272917|FG003|Overall Study|Pregnancy|1|||
161789604|NCT04444752|584272914|FG000|Overall Study|Withdrawal by Subject|6|||
161443189|NCT03682770|583015705|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
161443190|NCT03682770|583015706|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
161443191|NCT03682770|583015707|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
161443192|NCT03682770|583015708|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
161443193|NCT03682770|583015709|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
161443194|NCT03682770|583015703|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
161443195|NCT03682770|583015704|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
161443196|NCT03682770|583015705|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
161443197|NCT03682770|583015706|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
161443198|NCT03682770|583015707|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
161443199|NCT03682770|583015708|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
161443200|NCT03682770|583015709|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
161443201|NCT03682770|583015703|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
161443202|NCT03682770|583015704|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
161443203|NCT03682770|583015705|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
161443204|NCT03682770|583015706|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
161443205|NCT03682770|583015707|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
161443206|NCT03682770|583015708|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
161443207|NCT03682770|583015709|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
161443208|NCT03682770|583015703|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
161443209|NCT03682770|583015704|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
161443210|NCT03682770|583015705|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
161443211|NCT03682770|583015706|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
161443212|NCT03682770|583015707|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
161443213|NCT03682770|583015708|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
161443214|NCT03682770|583015709|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
161789605|NCT04444752|584272915|FG001|Overall Study|Withdrawal by Subject|5|||
161789606|NCT04444752|584272916|FG002|Overall Study|Withdrawal by Subject|3|||
161789607|NCT04444752|584272917|FG003|Overall Study|Withdrawal by Subject|4|||
161789608|NCT04444752|584272914|FG000|Overall Study|Protocol Violation|1|||
161443215|NCT03682770|583015703|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
161443216|NCT03682770|583015704|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
161443217|NCT03682770|583015705|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
161549081|NCT00358215|583400995|FG000|Overall Study|Ineligibility determined|4|||
161789609|NCT04444752|584272915|FG001|Overall Study|Protocol Violation|1|||
161789610|NCT04444752|584272916|FG002|Overall Study|Protocol Violation|0|||
161789611|NCT04444752|584272917|FG003|Overall Study|Protocol Violation|0|||
161789612|NCT04444752|584272914|FG000|Overall Study|Patient moving out of town|1|||
161789613|NCT04444752|584272915|FG001|Overall Study|Patient moving out of town|0|||
161789614|NCT04444752|584272916|FG002|Overall Study|Patient moving out of town|0|||
161789615|NCT04444752|584272917|FG003|Overall Study|Patient moving out of town|1|||
161789616|NCT04444752|584272914|FG000|Overall Study|Lack of Efficacy|0|||
161789617|NCT04444752|584272915|FG001|Overall Study|Lack of Efficacy|0|||
161789618|NCT04444752|584272916|FG002|Overall Study|Lack of Efficacy|0|||
161789619|NCT04444752|584272917|FG003|Overall Study|Lack of Efficacy|1|||
161789620|NCT04444752|584272914|FG000|Overall Study|Death|0|||
161789621|NCT04444752|584272915|FG001|Overall Study|Death|0|||
161789622|NCT04444752|584272916|FG002|Overall Study|Death|1|||
161789623|NCT04444752|584272917|FG003|Overall Study|Death|0|||
161789624|NCT00579254|584272918|FG000|Overall Study|Lost to Follow-up|39|||
161789625|NCT00579254|584272918|FG000|Overall Study|Discontinued when study terminated|73|||
161789626|NCT00433381|584274760|FG000|Overall Study|Ineligible / no protocol treatment|3|||
161789627|NCT00433381|584274761|FG001|Overall Study|Ineligible / no protocol treatment|3|||
161789628|NCT01387282|584274762|FG000|Overall Study|Death|47|||
161789629|NCT01387282|584274763|FG001|Overall Study|Death|16|||
161789630|NCT01387282|584274762|FG000|Overall Study|Other|5|||
161789631|NCT01387282|584274763|FG001|Overall Study|Other|1|||
161789632|NCT01387282|584274762|FG000|Overall Study|Unrelated AE|6|||
161789633|NCT01387282|584274763|FG001|Overall Study|Unrelated AE|4|||
161443218|NCT03682770|583015706|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
161443219|NCT03682770|583015707|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
161443220|NCT03682770|583015708|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
161443221|NCT03682770|583015709|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
161443222|NCT03682770|583015703|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
161443223|NCT03682770|583015704|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
161443224|NCT03682770|583015705|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
161443225|NCT03682770|583015706|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
161443226|NCT03682770|583015707|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
161443227|NCT03682770|583015708|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
161443228|NCT03682770|583015709|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
161443229|NCT03682770|583015703|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
161443230|NCT03682770|583015704|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
161443231|NCT03682770|583015705|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
161443232|NCT03682770|583015706|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
161443233|NCT03682770|583015707|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
161443234|NCT03682770|583015708|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
161443235|NCT03682770|583015709|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
161443236|NCT02362282|583015710|FG000|Overall Study|Withdrawal by Subject|1|||
161443237|NCT02362282|583015711|FG001|Overall Study|Withdrawal by Subject|0|||
161443238|NCT02004093|583015712|FG000|Overall Study|Death|2|||
161443239|NCT02004093|583015713|FG001|Overall Study|Death|1|||
161443240|NCT02004093|583015712|FG000|Overall Study|Lack of Efficacy|66|||
161443241|NCT02004093|583015713|FG001|Overall Study|Lack of Efficacy|62|||
161443242|NCT02004093|583015712|FG000|Overall Study|Protocol Violation|0|||
161443243|NCT02004093|583015713|FG001|Overall Study|Protocol Violation|1|||
161443244|NCT02004093|583015712|FG000|Overall Study|Lost to Follow-up|0|||
161443245|NCT02004093|583015713|FG001|Overall Study|Lost to Follow-up|1|||
161443246|NCT02004093|583015712|FG000|Overall Study|Withdrawal by Subject|3|||
161443247|NCT02004093|583015713|FG001|Overall Study|Withdrawal by Subject|7|||
161443248|NCT02004093|583015712|FG000|Overall Study|Other|3|||
161443249|NCT02004093|583015713|FG001|Overall Study|Other|1|||
161443250|NCT04085289|583015714|FG000|Overall Study|Withdrawal by Subject|0|||
161443251|NCT04085289|583015715|FG001|Overall Study|Withdrawal by Subject|0|||
161443252|NCT04085289|583015716|FG002|Overall Study|Withdrawal by Subject|1|||
161443253|NCT01317277|583015719|FG000|Overall Study|Lost to Follow-up|3|||
161443254|NCT01317277|583015720|FG001|Overall Study|Lost to Follow-up|1|||
161443255|NCT01317277|583015719|FG000|Overall Study|Lost MEMS|1|||
161443256|NCT01317277|583015720|FG001|Overall Study|Lost MEMS|1|||
161443257|NCT01317277|583015719|FG000|Overall Study|Unable to comply with intervention|1|||
161443258|NCT01317277|583015720|FG001|Overall Study|Unable to comply with intervention|0|||
161443259|NCT01317277|583015719|FG000|Overall Study|Withdrawal by Subject|1|||
161443260|NCT01317277|583015720|FG001|Overall Study|Withdrawal by Subject|0|||
161443261|NCT01317277|583015719|FG000|Overall Study|Adverse Event|1|||
161789634|NCT01387282|584274762|FG000|Overall Study|Withdrawal by patient|33|||
161789635|NCT01387282|584274763|FG001|Overall Study|Withdrawal by patient|23|||
161789636|NCT01387282|584274762|FG000|Overall Study|Study drug-related AE|2|||
161789637|NCT01387282|584274763|FG001|Overall Study|Study drug-related AE|2|||
161789638|NCT01387282|584274762|FG000|Overall Study|Lost to Follow-up|4|||
161789639|NCT01387282|584274763|FG001|Overall Study|Lost to Follow-up|1|||
161789640|NCT00458302|584274764|FG000|Overall Study|Adverse Event|4|||
161789641|NCT00458302|584274765|FG001|Overall Study|Adverse Event|14|||
161789642|NCT00458302|584274764|FG000|Overall Study|Pregnancy|2|||
161443262|NCT01317277|583015720|FG001|Overall Study|Adverse Event|0|||
161443263|NCT00774566|583015721|FG000|Overall Study|Protocol Violation|18|||
161443264|NCT00774566|583015722|FG001|Overall Study|Protocol Violation|15|||
161789643|NCT00458302|584274765|FG001|Overall Study|Pregnancy|1|||
161789644|NCT00458302|584274764|FG000|Overall Study|Protocol Violation|0|||
161789645|NCT00458302|584274765|FG001|Overall Study|Protocol Violation|2|||
161789646|NCT00458302|584274764|FG000|Overall Study|Withdrawal by Subject|6|||
161789647|NCT00458302|584274765|FG001|Overall Study|Withdrawal by Subject|4|||
161789648|NCT00458302|584274764|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
161789649|NCT00458302|584274765|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
161789650|NCT00458302|584274764|FG000|Overall Study|Study Termination By Sponsor|1|||
161789651|NCT00458302|584274765|FG001|Overall Study|Study Termination By Sponsor|0|||
161789652|NCT00458302|584274764|FG000|Overall Study|Lost to Follow-up|2|||
161789653|NCT00458302|584274765|FG001|Overall Study|Lost to Follow-up|0|||
161789654|NCT00458302|584274764|FG000|Overall Study|Other|4|||
161789655|NCT00458302|584274765|FG001|Overall Study|Other|2|||
161789656|NCT01513551|584274768|FG000|Overall Study|Death|0|||
161789657|NCT01513551|584274769|FG001|Overall Study|Death|1|||
161789658|NCT01513551|584274770|FG002|Overall Study|Death|0|||
161789659|NCT01513551|584274768|FG000|Overall Study|Lost to Follow-up|3|||
161789660|NCT01513551|584274769|FG001|Overall Study|Lost to Follow-up|5|||
161789661|NCT01513551|584274770|FG002|Overall Study|Lost to Follow-up|2|||
161789662|NCT01513551|584274768|FG000|Overall Study|Withdrawal by Subject|1|||
161789663|NCT01513551|584274769|FG001|Overall Study|Withdrawal by Subject|0|||
161789664|NCT01513551|584274770|FG002|Overall Study|Withdrawal by Subject|2|||
161789665|NCT01513551|584274768|FG000|Overall Study|Randomized but not vaccinated|0|||
161789666|NCT01513551|584274769|FG001|Overall Study|Randomized but not vaccinated|0|||
161789667|NCT01513551|584274770|FG002|Overall Study|Randomized but not vaccinated|1|||
161789668|NCT02038634|584274773|FG000|Overall Study|Lost to Follow-up|0|||
161789669|NCT02038634|584274774|FG001|Overall Study|Lost to Follow-up|1|||
161789670|NCT01706198|584274775|FG000|Overall Study|Adverse Event|12|||
161789671|NCT01706198|584274776|FG001|Overall Study|Adverse Event|15|||
161789672|NCT01706198|584274775|FG000|Overall Study|Protocol Violation|7|||
161789673|NCT01706198|584274776|FG001|Overall Study|Protocol Violation|5|||
161789674|NCT01706198|584274775|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
161789675|NCT01706198|584274776|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
161789676|NCT01706198|584274775|FG000|Overall Study|Lost to Follow-up|97|||
161789677|NCT01706198|584274776|FG001|Overall Study|Lost to Follow-up|93|||
161789678|NCT01706198|584274775|FG000|Overall Study|Physician Decision|23|||
161789679|NCT01706198|584274776|FG001|Overall Study|Physician Decision|37|||
161789680|NCT01706198|584274775|FG000|Overall Study|Withdrawal by Subject|23|||
161789681|NCT01706198|584274776|FG001|Overall Study|Withdrawal by Subject|31|||
161789682|NCT00549198|584274777|FG000|Overall Study|Adverse Event|28|||
161789683|NCT00549198|584274778|FG001|Overall Study|Adverse Event|26|||
161789684|NCT00549198|584274777|FG000|Overall Study|Insufficient Viral Load Response|4|||
161789685|NCT00549198|584274778|FG001|Overall Study|Insufficient Viral Load Response|2|||
161789686|NCT00549198|584274777|FG000|Overall Study|Protocol-defined Virological Failure|7|||
161789687|NCT00549198|584274778|FG001|Overall Study|Protocol-defined Virological Failure|0|||
161789688|NCT00549198|584274777|FG000|Overall Study|Non-compliance|2|||
161789689|NCT00549198|584274778|FG001|Overall Study|Non-compliance|4|||
161789690|NCT00549198|584274777|FG000|Overall Study|Lost to Follow-up|7|||
161789691|NCT00549198|584274778|FG001|Overall Study|Lost to Follow-up|8|||
161789692|NCT00549198|584274777|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
161789693|NCT00549198|584274778|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161789694|NCT00549198|584274777|FG000|Overall Study|Protocol Violation|7|||
161789695|NCT00549198|584274778|FG001|Overall Study|Protocol Violation|2|||
161789696|NCT00549198|584274777|FG000|Overall Study|Investigator Decision|4|||
161789697|NCT00549198|584274778|FG001|Overall Study|Investigator Decision|3|||
161789698|NCT00549198|584274777|FG000|Overall Study|Withdrawal by Subject|7|||
161789699|NCT00549198|584274778|FG001|Overall Study|Withdrawal by Subject|7|||
161789700|NCT00549198|584274777|FG000|Overall Study|Disease Progression|1|||
161789701|NCT00549198|584274778|FG001|Overall Study|Disease Progression|0|||
161789702|NCT00549198|584274777|FG000|Overall Study|Participant Moved|2|||
161789703|NCT00549198|584274778|FG001|Overall Study|Participant Moved|0|||
161789704|NCT00549198|584274777|FG000|Overall Study|Participant not able to perform Week 96|1|||
161789705|NCT00549198|584274778|FG001|Overall Study|Participant not able to perform Week 96|0|||
161789706|NCT00549198|584274777|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
161789707|NCT00549198|584274778|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
161789708|NCT00549198|584274777|FG000|Overall Study|Prohibited Medication|1|||
161789709|NCT00549198|584274778|FG001|Overall Study|Prohibited Medication|2|||
161789710|NCT00549198|584274777|FG000|Overall Study|Participant planning pregnancy|1|||
161789711|NCT00549198|584274778|FG001|Overall Study|Participant planning pregnancy|0|||
161789712|NCT00549198|584274777|FG000|Overall Study|Participant overweight, no scan possible|1|||
161789713|NCT00549198|584274778|FG001|Overall Study|Participant overweight, no scan possible|0|||
161789714|NCT00549198|584274777|FG000|Overall Study|No scan facilities|0|||
161789715|NCT00549198|584274778|FG001|Overall Study|No scan facilities|2|||
161789716|NCT00549198|584274777|FG000|Overall Study|Pregnancy|0|||
161789717|NCT00549198|584274778|FG001|Overall Study|Pregnancy|3|||
161789718|NCT00549198|584274777|FG000|Overall Study|Not Exposed to Study Drug|3|||
161789719|NCT00549198|584274778|FG001|Overall Study|Not Exposed to Study Drug|4|||
161789720|NCT01034137|584274790|FG000|Overall Study|Adverse Event|9|||
161789721|NCT01034137|584274791|FG001|Overall Study|Adverse Event|10|||
161789722|NCT01034137|584274792|FG002|Overall Study|Adverse Event|8|||
161789723|NCT01034137|584274790|FG000|Overall Study|Withdrawal by Subject|4|||
161789724|NCT01034137|584274791|FG001|Overall Study|Withdrawal by Subject|3|||
161789725|NCT01034137|584274792|FG002|Overall Study|Withdrawal by Subject|3|||
161789726|NCT01034137|584274790|FG000|Overall Study|Lack of Efficacy|9|||
161789727|NCT01034137|584274791|FG001|Overall Study|Lack of Efficacy|4|||
161789728|NCT01034137|584274792|FG002|Overall Study|Lack of Efficacy|13|||
161789729|NCT01034137|584274790|FG000|Overall Study|Protocol Violation|2|||
161789730|NCT01034137|584274791|FG001|Overall Study|Protocol Violation|2|||
161789731|NCT01034137|584274792|FG002|Overall Study|Protocol Violation|1|||
161789732|NCT01034137|584274790|FG000|Overall Study|Refused treatment or did not cooperate|2|||
161789733|NCT01034137|584274791|FG001|Overall Study|Refused treatment or did not cooperate|0|||
161789734|NCT01034137|584274792|FG002|Overall Study|Refused treatment or did not cooperate|1|||
161789735|NCT01034137|584274790|FG000|Overall Study|Administrative or other|2|||
161789736|NCT01034137|584274791|FG001|Overall Study|Administrative or other|3|||
161789737|NCT01034137|584274792|FG002|Overall Study|Administrative or other|4|||
161789738|NCT03572933|584274793|FG000|Overall Study|Adverse Event|4|||
161789739|NCT03572933|584274794|FG001|Overall Study|Adverse Event|1|||
161789740|NCT03572933|584274793|FG000|Overall Study|Withdrawal by Subject|0|||
161789741|NCT03572933|584274794|FG001|Overall Study|Withdrawal by Subject|1|||
161789742|NCT01764854|584274795|FG000|Overall Study|Adverse Event|0|||
161789743|NCT01764854|584274796|FG001|Overall Study|Adverse Event|0|||
161789744|NCT01764854|584274797|FG002|Overall Study|Adverse Event|2|||
161789745|NCT01764854|584274798|FG003|Overall Study|Adverse Event|0|||
161789746|NCT01764854|584274795|FG000|Overall Study|Withdrawal by Subject|0|||
161789747|NCT01764854|584274796|FG001|Overall Study|Withdrawal by Subject|0|||
161789748|NCT01764854|584274797|FG002|Overall Study|Withdrawal by Subject|1|||
161789749|NCT01764854|584274798|FG003|Overall Study|Withdrawal by Subject|0|||
161789750|NCT01764854|584274795|FG000|Overall Study|relocation|0|||
161789751|NCT01764854|584274796|FG001|Overall Study|relocation|0|||
161789752|NCT01764854|584274797|FG002|Overall Study|relocation|2|||
161789753|NCT01764854|584274798|FG003|Overall Study|relocation|0|||
161789754|NCT01764854|584274795|FG000|Overall Study|Protocol Violation|0|||
161789755|NCT01764854|584274796|FG001|Overall Study|Protocol Violation|0|||
161789756|NCT01764854|584274797|FG002|Overall Study|Protocol Violation|1|||
161789757|NCT01764854|584274798|FG003|Overall Study|Protocol Violation|2|||
161789758|NCT03273387|584274799|FG000|Overall Study|Death|2|||
161789759|NCT03273387|584274800|FG001|Overall Study|Death|2|||
161789760|NCT03273387|584274799|FG000|Overall Study|Withdrawal by Subject|1|||
161789761|NCT03273387|584274800|FG001|Overall Study|Withdrawal by Subject|1|||
161789762|NCT01405950|584274801|FG000|Overall Study|Withdrawal by Subject|1|||
161789763|NCT01405950|584274802|FG001|Overall Study|Withdrawal by Subject|0|||
161789764|NCT01405950|584274803|FG002|Overall Study|Withdrawal by Subject|0|||
161789765|NCT01405950|584274804|FG003|Overall Study|Withdrawal by Subject|0|||
161789766|NCT01381900|584274805|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
161789767|NCT01381900|584274806|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
161789768|NCT01381900|584274807|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
161789769|NCT01381900|584274805|FG000|Overall Study|Adverse Event|4|||
161789770|NCT01381900|584274806|FG001|Overall Study|Adverse Event|6|||
161789771|NCT01381900|584274807|FG002|Overall Study|Adverse Event|7|||
161789772|NCT01381900|584274805|FG000|Overall Study|Noncompliance with study drug|0|||
161789773|NCT01381900|584274806|FG001|Overall Study|Noncompliance with study drug|0|||
161789774|NCT01381900|584274807|FG002|Overall Study|Noncompliance with study drug|1|||
161789775|NCT01381900|584274805|FG000|Overall Study|Physician Decision|0|||
161789776|NCT01381900|584274806|FG001|Overall Study|Physician Decision|1|||
161789777|NCT01381900|584274807|FG002|Overall Study|Physician Decision|1|||
161789778|NCT01381900|584274805|FG000|Overall Study|Protocol Violation|0|||
161789779|NCT01381900|584274806|FG001|Overall Study|Protocol Violation|1|||
161789780|NCT01381900|584274807|FG002|Overall Study|Protocol Violation|1|||
161789781|NCT01381900|584274805|FG000|Overall Study|Withdrawal by Subject|0|||
161898716|NCT00313846|584677885|FG000|Overall Study|Adverse Event|1|||
161898717|NCT00313846|584677886|FG001|Overall Study|Adverse Event|8|||
161789782|NCT01381900|584274806|FG001|Overall Study|Withdrawal by Subject|0|||
161789783|NCT01381900|584274807|FG002|Overall Study|Withdrawal by Subject|1|||
161789784|NCT01381900|584274805|FG000|Overall Study|Early withdraw|3|||
161789785|NCT01381900|584274806|FG001|Overall Study|Early withdraw|1|||
161789786|NCT01381900|584274807|FG002|Overall Study|Early withdraw|1|||
161789787|NCT02668783|584274808|FG000|Overall Study|Pregnancy|0|||
161789788|NCT02668783|584274809|FG001|Overall Study|Pregnancy|1|||
161789789|NCT02668783|584274808|FG000|Overall Study|Protocol Violation|2|||
161789790|NCT02668783|584274809|FG001|Overall Study|Protocol Violation|1|||
161789791|NCT02668783|584274808|FG000|Overall Study|Study terminated by sponsor|9|||
161789792|NCT02668783|584274809|FG001|Overall Study|Study terminated by sponsor|10|||
161789793|NCT02668783|584274808|FG000|Overall Study|Subject moved|1|||
161789794|NCT02668783|584274809|FG001|Overall Study|Subject moved|0|||
161789795|NCT02668783|584274808|FG000|Overall Study|Withdrawal by Subject|1|||
161789796|NCT02668783|584274809|FG001|Overall Study|Withdrawal by Subject|0|||
161789797|NCT02891200|584274810|FG000|Overall Study|Lost to Follow-up|31|||
161789798|NCT02891200|584274811|FG001|Overall Study|Lost to Follow-up|36|||
161789799|NCT02891200|584274810|FG000|Overall Study|Death|10|||
161789800|NCT02891200|584274811|FG001|Overall Study|Death|9|||
161789801|NCT02891200|584274810|FG000|Overall Study|Withdrawal by Subject|1|||
161789802|NCT02891200|584274811|FG001|Overall Study|Withdrawal by Subject|4|||
161789803|NCT04480463|584274812|FG000|Overall Study|Death|0|||
161789804|NCT04480463|584274813|FG001|Overall Study|Death|1|||
161789805|NCT04480463|584274812|FG000|Overall Study|Adverse Event|6|||
161789806|NCT04480463|584274813|FG001|Overall Study|Adverse Event|8|||
161789807|NCT04480463|584274812|FG000|Overall Study|Lost to Follow-up|3|||
161789808|NCT04480463|584274813|FG001|Overall Study|Lost to Follow-up|2|||
161789809|NCT04480463|584274812|FG000|Overall Study|Physician Decision|2|||
161789810|NCT04480463|584274813|FG001|Overall Study|Physician Decision|5|||
161789811|NCT04480463|584274812|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
161789812|NCT04480463|584274813|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
161789813|NCT04480463|584274812|FG000|Overall Study|Protocol Violation|2|||
161789814|NCT04480463|584274813|FG001|Overall Study|Protocol Violation|1|||
161789815|NCT04480463|584274812|FG000|Overall Study|Withdrawal by Subject|6|||
161789816|NCT04480463|584274813|FG001|Overall Study|Withdrawal by Subject|7|||
161789817|NCT04480463|584274812|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
161789818|NCT04480463|584274813|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
161789819|NCT04480463|584274812|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
161789820|NCT04480463|584274813|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
161789821|NCT04480463|584274812|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
161789822|NCT04480463|584274813|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
161789823|NCT04480463|584274812|FG000|Overall Study|Other|6|||
161789824|NCT04480463|584274813|FG001|Overall Study|Other|4|||
161789825|NCT00673361|584274814|FG000|Overall Study|Screen Failure|2|||
161789826|NCT01799590|584274816|FG000|Overall Study|Adverse Event|13|||
161443265|NCT04896073|583015727|FG000|Overall Study|Screen failure|0|||
161443266|NCT04896073|583015728|FG001|Overall Study|Screen failure|2|||
161443267|NCT04896073|583015727|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161443268|NCT04896073|583015728|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
161443269|NCT01262989|583015729|FG000|Period 1|Lost to Follow-up|1|||
161443270|NCT01262989|583015730|FG001|Period 1|Lost to Follow-up|1|||
161443271|NCT01262989|583015729|FG000|Period 1|Intercurrent disease|0|||
161789827|NCT01799590|584274817|FG001|Overall Study|Adverse Event|7|||
161789828|NCT01799590|584274818|FG002|Overall Study|Adverse Event|5|||
161789829|NCT01799590|584274816|FG000|Overall Study|Pregnancy|2|||
161789830|NCT01799590|584274817|FG001|Overall Study|Pregnancy|0|||
161789831|NCT01799590|584274818|FG002|Overall Study|Pregnancy|0|||
161789832|NCT01799590|584274816|FG000|Overall Study|Lack of Efficacy|3|||
161789833|NCT01799590|584274817|FG001|Overall Study|Lack of Efficacy|1|||
161789834|NCT01799590|584274818|FG002|Overall Study|Lack of Efficacy|3|||
161789835|NCT01799590|584274816|FG000|Overall Study|Participants convenience|4|||
161789836|NCT01799590|584274817|FG001|Overall Study|Participants convenience|4|||
161789837|NCT01799590|584274818|FG002|Overall Study|Participants convenience|2|||
161789838|NCT01799590|584274816|FG000|Overall Study|Aggravation of complications|0|||
161789839|NCT01799590|584274817|FG001|Overall Study|Aggravation of complications|1|||
161789840|NCT01799590|584274818|FG002|Overall Study|Aggravation of complications|1|||
161789841|NCT01799590|584274816|FG000|Overall Study|Using drugs with restricted days of use|0|||
161789842|NCT01799590|584274817|FG001|Overall Study|Using drugs with restricted days of use|3|||
161789843|NCT01799590|584274818|FG002|Overall Study|Using drugs with restricted days of use|2|||
161443272|NCT01262989|583015730|FG001|Period 1|Intercurrent disease|1|||
161789844|NCT01799590|584274816|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
161789845|NCT01799590|584274817|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
161789846|NCT01799590|584274818|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
161789847|NCT01799590|584274816|FG000|Overall Study|Other|3|||
161789848|NCT01799590|584274817|FG001|Overall Study|Other|0|||
161789849|NCT01799590|584274818|FG002|Overall Study|Other|1|||
161789850|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
161789851|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
161789852|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
161789853|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
161789854|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
161443273|NCT01262989|583015729|FG000|Period 1|Positive answer for exclusion criteria|0|||
161789855|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
161789856|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
161898718|NCT00313846|584677885|FG000|Overall Study|Administrative|2|||
161443274|NCT01262989|583015730|FG001|Period 1|Positive answer for exclusion criteria|1|||
161443275|NCT01262989|583015729|FG000|Period 2|Intercurrent disease|0|||
161443276|NCT01262989|583015730|FG001|Period 2|Intercurrent disease|1|||
161443277|NCT03599089|583015731|FG000|Overall Study|Lost to Follow-up|1|||
161443278|NCT03599089|583015732|FG001|Overall Study|Lost to Follow-up|0|||
161443279|NCT03599089|583015733|FG002|Overall Study|Lost to Follow-up|0|||
161443280|NCT03599089|583015734|FG003|Overall Study|Lost to Follow-up|0|||
161443281|NCT03599089|583015731|FG000|Overall Study|Withdrawal by Subject|2|||
161443282|NCT03599089|583015732|FG001|Overall Study|Withdrawal by Subject|1|||
161443283|NCT03599089|583015733|FG002|Overall Study|Withdrawal by Subject|0|||
161443284|NCT03599089|583015734|FG003|Overall Study|Withdrawal by Subject|0|||
161443285|NCT03599089|583015731|FG000|Overall Study|Lack of Efficacy|0|||
161443286|NCT03599089|583015732|FG001|Overall Study|Lack of Efficacy|0|||
161443287|NCT03599089|583015733|FG002|Overall Study|Lack of Efficacy|1|||
161443288|NCT03599089|583015734|FG003|Overall Study|Lack of Efficacy|2|||
161443289|NCT03214666|583015735|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
161443290|NCT03214666|583015736|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
161443291|NCT03214666|583015737|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
161443292|NCT03214666|583015738|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
161443293|NCT03214666|583015739|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
161443294|NCT03214666|583015740|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
161443295|NCT03048578|583015741|FG000|Overall Study|Withdrawal by Subject|5|||
161443296|NCT03048578|583015742|FG001|Overall Study|Withdrawal by Subject|6|||
161443297|NCT03048578|583015741|FG000|Overall Study|Lost to Follow-up|22|||
161443298|NCT03048578|583015742|FG001|Overall Study|Lost to Follow-up|10|||
161443299|NCT03048578|583015741|FG000|Overall Study|Adverse Event|1|||
161443300|NCT03048578|583015742|FG001|Overall Study|Adverse Event|2|||
161443301|NCT03048578|583015741|FG000|Overall Study|Terminated|3|||
161443302|NCT03048578|583015742|FG001|Overall Study|Terminated|2|||
161443303|NCT00459186|583015748|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
161443304|NCT00459186|583015748|FG000|PET Imaging and Assessment|Adverse Event|3|||
161443305|NCT02500797|583015749|FG000|Overall Study|Cancel (rapid disease progression)|0|||
161443306|NCT02500797|583015750|FG001|Overall Study|Cancel (rapid disease progression)|0|||
161443307|NCT02500797|583015751|FG002|Overall Study|Cancel (rapid disease progression)|0|||
161443308|NCT02500797|583015752|FG003|Overall Study|Cancel (rapid disease progression)|0|||
161443309|NCT02500797|583015753|FG004|Overall Study|Cancel (rapid disease progression)|1|||
161443310|NCT02500797|583015754|FG005|Overall Study|Cancel (rapid disease progression)|1|||
161443311|NCT02500797|583015755|FG006|Overall Study|Cancel (rapid disease progression)|0|||
161443312|NCT02500797|583015756|FG007|Overall Study|Cancel (rapid disease progression)|0|||
161443313|NCT02500797|583015749|FG000|Overall Study|Withdrawal by Subject|1|||
161443314|NCT02500797|583015750|FG001|Overall Study|Withdrawal by Subject|0|||
161443315|NCT02500797|583015751|FG002|Overall Study|Withdrawal by Subject|0|||
161443316|NCT02500797|583015752|FG003|Overall Study|Withdrawal by Subject|0|||
161443317|NCT02500797|583015753|FG004|Overall Study|Withdrawal by Subject|0|||
161443318|NCT02500797|583015754|FG005|Overall Study|Withdrawal by Subject|0|||
161443319|NCT02500797|583015755|FG006|Overall Study|Withdrawal by Subject|0|||
161443320|NCT02500797|583015756|FG007|Overall Study|Withdrawal by Subject|0|||
161443321|NCT00357006|583015763|FG000|Overall Study|Lost to Follow-up|1|||
161443322|NCT00357006|583015764|FG001|Overall Study|Lost to Follow-up|2|||
161443323|NCT00357006|583015765|FG002|Overall Study|Lost to Follow-up|1|||
161443324|NCT00357006|583015763|FG000|Overall Study|Withdrawal by Subject|1|||
161443325|NCT00357006|583015764|FG001|Overall Study|Withdrawal by Subject|3|||
161443326|NCT00357006|583015765|FG002|Overall Study|Withdrawal by Subject|2|||
161443327|NCT03710161|583015766|FG000|Overall Study|Study halted due to COVID pandemic|3|||
161443328|NCT03710161|583015767|FG001|Overall Study|Study halted due to COVID pandemic|2|||
161443329|NCT02637037|583015770|FG000|Overall Study|Positive drug screen at admission|1|||
161789857|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
161789858|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
161789859|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
161443330|NCT02637037|583015771|FG001|Overall Study|Positive drug screen at admission|0|||
161443331|NCT02637037|583015770|FG000|Overall Study|Withdrawal by Subject|2|||
161443332|NCT02637037|583015771|FG001|Overall Study|Withdrawal by Subject|1|||
161443333|NCT02637037|583015770|FG000|Overall Study|Adverse Event|1|||
161443334|NCT02637037|583015771|FG001|Overall Study|Adverse Event|0|||
161443335|NCT00074490|583015779|FG000|Overall Study|Progressive malignancy|0|||
161443336|NCT00074490|583015780|FG001|Overall Study|Progressive malignancy|7|||
161443337|NCT00074490|583015781|FG002|Overall Study|Progressive malignancy|0|||
161443338|NCT00074490|583015782|FG003|Overall Study|Progressive malignancy|0|||
161789860|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
161789861|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
161789862|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
161443339|NCT00074490|583015783|FG004|Overall Study|Progressive malignancy|3|||
161443340|NCT00074490|583015784|FG005|Overall Study|Progressive malignancy|0|||
161443341|NCT02506244|583015787|FG000|Overall Study|Did not undergo active monitoring|458|||
161789863|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
161789864|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
161789865|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
161789866|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
161789867|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
161789868|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
161789869|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
161789870|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
161789871|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
161789872|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
161789873|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
161789874|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
161789875|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
161789876|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
161789877|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
161789878|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
161789879|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
161789880|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161789881|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161789882|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161789883|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
161789884|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
161789885|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
161789886|NCT01769378|584274824|FG000|Overall Study|Adverse Event|10|||
161789887|NCT01769378|584274825|FG001|Overall Study|Adverse Event|0|||
161789888|NCT01769378|584274824|FG000|Overall Study|Entry criteria not met|1|||
161789889|NCT01769378|584274825|FG001|Overall Study|Entry criteria not met|0|||
161789890|NCT01769378|584274824|FG000|Overall Study|Protocol Violation|1|||
161789891|NCT01769378|584274825|FG001|Overall Study|Protocol Violation|1|||
161789892|NCT01769378|584274824|FG000|Overall Study|Withdrawal by Subject|10|||
161789893|NCT01769378|584274825|FG001|Overall Study|Withdrawal by Subject|3|||
161789894|NCT01769378|584274824|FG000|Overall Study|Sponsor Decision|1|||
161789895|NCT01769378|584274825|FG001|Overall Study|Sponsor Decision|0|||
161789896|NCT01769378|584274824|FG000|Overall Study|Lost to Follow-up|2|||
161789897|NCT01769378|584274825|FG001|Overall Study|Lost to Follow-up|0|||
161789898|NCT01977092|584274826|FG000|Overall Study|Death|3|||
161789899|NCT01977092|584274827|FG001|Overall Study|Death|4|||
161789900|NCT01977092|584274826|FG000|Overall Study|Lost to Follow-up|23|||
161789901|NCT01977092|584274827|FG001|Overall Study|Lost to Follow-up|14|||
161789902|NCT01977092|584274826|FG000|Overall Study|Withdrawal by Subject|2|||
161789903|NCT01977092|584274827|FG001|Overall Study|Withdrawal by Subject|1|||
161789904|NCT01977092|584274826|FG000|Overall Study|In prison|3|||
161789905|NCT01977092|584274827|FG001|Overall Study|In prison|11|||
161789906|NCT01958281|584274828|FG000|Overall Study|Lack of Efficacy|5|||
161789907|NCT01958281|584274829|FG001|Overall Study|Lack of Efficacy|2|||
161789908|NCT01958281|584274830|FG002|Overall Study|Lack of Efficacy|0|||
161789909|NCT01958281|584274828|FG000|Overall Study|Adverse Event|0|||
161789910|NCT01958281|584274829|FG001|Overall Study|Adverse Event|2|||
161898719|NCT00313846|584677886|FG001|Overall Study|Administrative|3|||
161898720|NCT01896193|584677889|FG000|Overall Study|Lack of Efficacy|20|||
161898721|NCT01896193|584677890|FG001|Overall Study|Lack of Efficacy|11|||
161789911|NCT01958281|584274830|FG002|Overall Study|Adverse Event|0|||
161789912|NCT01958281|584274828|FG000|Overall Study|Withdrew Consent|1|||
161789913|NCT01958281|584274829|FG001|Overall Study|Withdrew Consent|0|||
161789914|NCT01958281|584274830|FG002|Overall Study|Withdrew Consent|0|||
161789915|NCT03038113|584274831|FG000|Overall Study|Withdrawal by Subject|0|||
161789916|NCT03038113|584274832|FG001|Overall Study|Withdrawal by Subject|0|||
161789917|NCT03038113|584274833|FG002|Overall Study|Withdrawal by Subject|1|||
161789918|NCT03038113|584274834|FG003|Overall Study|Withdrawal by Subject|0|||
161789919|NCT03038113|584274835|FG004|Overall Study|Withdrawal by Subject|0|||
161789920|NCT03038113|584274836|FG005|Overall Study|Withdrawal by Subject|0|||
161789921|NCT03038113|584274837|FG006|Overall Study|Withdrawal by Subject|0|||
161789922|NCT03038113|584274838|FG007|Overall Study|Withdrawal by Subject|0|||
161789923|NCT03038113|584274839|FG008|Overall Study|Withdrawal by Subject|0|||
161789924|NCT03038113|584274840|FG009|Overall Study|Withdrawal by Subject|0|||
161789925|NCT03038113|584274841|FG010|Overall Study|Withdrawal by Subject|0|||
161789926|NCT03038113|584274842|FG011|Overall Study|Withdrawal by Subject|0|||
161789927|NCT03038113|584274843|FG012|Overall Study|Withdrawal by Subject|0|||
161789928|NCT03038113|584274844|FG013|Overall Study|Withdrawal by Subject|1|||
161789929|NCT03038113|584274831|FG000|Overall Study|Lost to Follow-up|0|||
161789930|NCT03038113|584274832|FG001|Overall Study|Lost to Follow-up|0|||
161789931|NCT03038113|584274833|FG002|Overall Study|Lost to Follow-up|0|||
161789932|NCT03038113|584274834|FG003|Overall Study|Lost to Follow-up|0|||
161898722|NCT01896193|584677889|FG000|Overall Study|Protocol Violation|0|||
161789933|NCT03038113|584274835|FG004|Overall Study|Lost to Follow-up|0|||
161789934|NCT03038113|584274836|FG005|Overall Study|Lost to Follow-up|0|||
161789935|NCT03038113|584274837|FG006|Overall Study|Lost to Follow-up|1|||
161789936|NCT03038113|584274838|FG007|Overall Study|Lost to Follow-up|0|||
161789937|NCT03038113|584274839|FG008|Overall Study|Lost to Follow-up|0|||
161789938|NCT03038113|584274840|FG009|Overall Study|Lost to Follow-up|0|||
161789939|NCT03038113|584274841|FG010|Overall Study|Lost to Follow-up|0|||
161789940|NCT03038113|584274842|FG011|Overall Study|Lost to Follow-up|0|||
161789941|NCT03038113|584274843|FG012|Overall Study|Lost to Follow-up|0|||
161789942|NCT03038113|584274844|FG013|Overall Study|Lost to Follow-up|0|||
161789943|NCT03882047|584274845|FG000|Overall Study|Adverse Event|0|||
161789944|NCT03882047|584274846|FG001|Overall Study|Adverse Event|2|||
161789945|NCT03882047|584274847|FG002|Overall Study|Adverse Event|2|||
161789946|NCT03882047|584274845|FG000|Overall Study|Treatment Failure|3|||
161789947|NCT03882047|584274846|FG001|Overall Study|Treatment Failure|3|||
161789948|NCT03882047|584274847|FG002|Overall Study|Treatment Failure|12|||
161789949|NCT03882047|584274845|FG000|Overall Study|Lost to Follow-up|0|||
161789950|NCT03882047|584274846|FG001|Overall Study|Lost to Follow-up|1|||
161789951|NCT03882047|584274847|FG002|Overall Study|Lost to Follow-up|0|||
161789952|NCT03882047|584274845|FG000|Overall Study|Did Not Wish to Continue|1|||
161789953|NCT03882047|584274846|FG001|Overall Study|Did Not Wish to Continue|4|||
161789954|NCT03882047|584274847|FG002|Overall Study|Did Not Wish to Continue|1|||
161789955|NCT03882047|584274845|FG000|Overall Study|Noncompliance With Protocol|2|||
161789956|NCT03882047|584274846|FG001|Overall Study|Noncompliance With Protocol|0|||
161789957|NCT03882047|584274847|FG002|Overall Study|Noncompliance With Protocol|0|||
161789958|NCT03882047|584274845|FG000|Overall Study|Did Not Meet Eligibility|0|||
161789959|NCT03882047|584274846|FG001|Overall Study|Did Not Meet Eligibility|0|||
161789960|NCT03882047|584274847|FG002|Overall Study|Did Not Meet Eligibility|1|||
161789961|NCT00175019|584274849|FG000|Overall Study|Adverse Event|54|||
161789962|NCT00175019|584274850|FG001|Overall Study|Adverse Event|22|||
161789963|NCT00175019|584274851|FG002|Overall Study|Adverse Event|2|||
161789964|NCT00175019|584274849|FG000|Overall Study|Protocol Violation|6|||
161789965|NCT00175019|584274850|FG001|Overall Study|Protocol Violation|3|||
161789966|NCT00175019|584274851|FG002|Overall Study|Protocol Violation|3|||
161789967|NCT00175019|584274849|FG000|Overall Study|Lost to Follow-up|42|||
161789968|NCT00175019|584274850|FG001|Overall Study|Lost to Follow-up|39|||
161789969|NCT00175019|584274851|FG002|Overall Study|Lost to Follow-up|9|||
161789970|NCT00175019|584274849|FG000|Overall Study|Did not continue under Amendment 4|1|||
161789971|NCT00175019|584274850|FG001|Overall Study|Did not continue under Amendment 4|1|||
161789972|NCT00175019|584274851|FG002|Overall Study|Did not continue under Amendment 4|2|||
161789973|NCT00175019|584274849|FG000|Overall Study|Personal Reason(s)|39|||
161789974|NCT00175019|584274850|FG001|Overall Study|Personal Reason(s)|31|||
161789975|NCT00175019|584274851|FG002|Overall Study|Personal Reason(s)|8|||
161789976|NCT00175019|584274849|FG000|Overall Study|Therapeutic Failure|10|||
161789977|NCT00175019|584274850|FG001|Overall Study|Therapeutic Failure|38|||
161789978|NCT00175019|584274851|FG002|Overall Study|Therapeutic Failure|22|||
161789979|NCT00175019|584274849|FG000|Overall Study|Gout Flare|2|||
161789980|NCT00175019|584274850|FG001|Overall Study|Gout Flare|3|||
161789981|NCT00175019|584274851|FG002|Overall Study|Gout Flare|0|||
161789982|NCT00175019|584274849|FG000|Overall Study|Reason Not Specified|40|||
161789983|NCT00175019|584274850|FG001|Overall Study|Reason Not Specified|34|||
161789984|NCT00175019|584274851|FG002|Overall Study|Reason Not Specified|11|||
161789985|NCT00475852|584274857|FG000|Overall Study|Death|444|||
161789986|NCT00475852|584274858|FG001|Overall Study|Death|456|||
161789987|NCT00475852|584274857|FG000|Overall Study|Withdrawal by Subject|19|||
161789988|NCT00475852|584274858|FG001|Overall Study|Withdrawal by Subject|24|||
161789989|NCT00475852|584274857|FG000|Overall Study|Lost to Follow-up|54|||
161789990|NCT00475852|584274858|FG001|Overall Study|Lost to Follow-up|68|||
161789991|NCT00297479|584274859|FG000|Overall Study|Lost to Follow-up|37|||
161789992|NCT00297479|584274860|FG001|Overall Study|Lost to Follow-up|54|||
161789993|NCT00297479|584274861|FG002|Overall Study|Lost to Follow-up|51|||
161789994|NCT03263819|584274862|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
161789995|NCT03263819|584274863|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
161789996|NCT00686920|584274865|FG000|Overall Study|Death|45|||
161789997|NCT00686920|584274866|FG001|Overall Study|Death|14|||
161789998|NCT00686920|584274865|FG000|Overall Study|Liver Transplant|23|||
161443342|NCT02506244|583015788|FG001|Overall Study|Did not undergo active monitoring|459|||
161443343|NCT02506244|583015789|FG002|Overall Study|Did not undergo active monitoring|0|||
161789999|NCT00686920|584274866|FG001|Overall Study|Liver Transplant|8|||
161790000|NCT00686920|584274865|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
161790001|NCT00686920|584274866|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
161790002|NCT00686920|584274865|FG000|Overall Study|Withdrawal by Subject|23|||
161790003|NCT00686920|584274866|FG001|Overall Study|Withdrawal by Subject|5|||
161790004|NCT00686920|584274865|FG000|Overall Study|Protocol Violation|2|||
161790005|NCT00686920|584274866|FG001|Overall Study|Protocol Violation|1|||
161790006|NCT00686920|584274865|FG000|Overall Study|Adverse Event|10|||
161790007|NCT00686920|584274866|FG001|Overall Study|Adverse Event|2|||
161790008|NCT00686920|584274865|FG000|Overall Study|Personal Reason|0|||
161790009|NCT00686920|584274866|FG001|Overall Study|Personal Reason|1|||
161790010|NCT00686920|584274865|FG000|Overall Study|Lost to Follow-up|15|||
161790011|NCT00686920|584274866|FG001|Overall Study|Lost to Follow-up|3|||
161443344|NCT05615922|583015794|FG000|Overall Study|Lost to Follow-up|1|||
161790012|NCT00686920|584274865|FG000|Overall Study|Moved to Another State|1|||
161790013|NCT00686920|584274866|FG001|Overall Study|Moved to Another State|0|||
161790014|NCT00686920|584274865|FG000|Overall Study|Transferred to Nursing Home|1|||
161790015|NCT00686920|584274866|FG001|Overall Study|Transferred to Nursing Home|0|||
161790016|NCT00686920|584274865|FG000|Overall Study|Noncompliance|9|||
161790017|NCT00686920|584274866|FG001|Overall Study|Noncompliance|0|||
161790018|NCT00686920|584274865|FG000|Overall Study|Principal Investigator Decision|2|||
161790019|NCT00686920|584274866|FG001|Overall Study|Principal Investigator Decision|0|||
161790020|NCT00814658|584274870|FG000|Overall Study|Lost to Follow-up|0|||
161443345|NCT04774094|583015800|FG000|Overall Study|Other|2|||
161443346|NCT04774094|583015800|FG000|Overall Study|Withdrawal by Subject|9|||
161443347|NCT04774094|583015800|FG000|Overall Study|Lost to Follow-up|7|||
161443348|NCT04774094|583015800|FG000|Overall Study|Lack of Efficacy|5|||
161443349|NCT04774094|583015800|FG000|Overall Study|Death|17|||
161443350|NCT04774094|583015800|FG000|Overall Study|Adverse Event|4|||
161443351|NCT02374450|583015801|FG000|Overall Study|Protocol Violation|0|||
161443352|NCT02374450|583015802|FG001|Overall Study|Protocol Violation|1|||
161443353|NCT02374450|583015803|FG002|Overall Study|Protocol Violation|0|||
161443354|NCT02374450|583015801|FG000|Overall Study|Withdrawal by Subject|91|||
161443355|NCT02374450|583015802|FG001|Overall Study|Withdrawal by Subject|110|||
161443356|NCT02374450|583015803|FG002|Overall Study|Withdrawal by Subject|4|||
161443357|NCT02374450|583015801|FG000|Overall Study|Lost to Follow-up|168|||
161443358|NCT02374450|583015802|FG001|Overall Study|Lost to Follow-up|194|||
161443359|NCT02374450|583015803|FG002|Overall Study|Lost to Follow-up|138|||
161443360|NCT02374450|583015801|FG000|Overall Study|Death|173|||
161443361|NCT02374450|583015802|FG001|Overall Study|Death|185|||
161443362|NCT02374450|583015803|FG002|Overall Study|Death|81|||
161443363|NCT02374450|583015801|FG000|Overall Study|Migrated from the study area|538|||
161443364|NCT02374450|583015802|FG001|Overall Study|Migrated from the study area|648|||
161443365|NCT02374450|583015803|FG002|Overall Study|Migrated from the study area|181|||
161790021|NCT00814658|584274871|FG001|Overall Study|Lost to Follow-up|1|||
161790022|NCT00814658|584274870|FG000|Overall Study|Physician Decision|1|||
161790023|NCT00814658|584274871|FG001|Overall Study|Physician Decision|0|||
161790024|NCT00814658|584274870|FG000|Overall Study|Adverse Event|3|||
161790025|NCT00814658|584274871|FG001|Overall Study|Adverse Event|3|||
161790026|NCT01141283|584274872|FG000|Overall Study|Adverse Event|56|||
161790027|NCT01141283|584274872|FG000|Overall Study|Lost to Follow-up|4|||
161790028|NCT01141283|584274872|FG000|Overall Study|Withdrawal by Subject|14|||
161790029|NCT01141283|584274872|FG000|Overall Study|Administrative|4|||
161790030|NCT01141283|584274872|FG000|Overall Study|Lack of Efficacy|10|||
161790031|NCT02974114|584274875|FG000|Overall Study|Other (Not specified)|0|||
161790032|NCT02974114|584274876|FG001|Overall Study|Other (Not specified)|1|||
161790033|NCT02974114|584274877|FG002|Overall Study|Other (Not specified)|2|||
161443366|NCT02374450|583015801|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
161443367|NCT02374450|583015802|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
161443368|NCT02374450|583015803|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
161443369|NCT02374450|583015801|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
161443370|NCT02374450|583015802|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
161443371|NCT02374450|583015803|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
161443372|NCT02374450|583015801|FG000|Overall Study|Other|0|||
161443373|NCT02374450|583015802|FG001|Overall Study|Other|21|||
161443374|NCT02374450|583015803|FG002|Overall Study|Other|79|||
161443375|NCT01006291|583017166|FG000|Overall Study|Adverse Event|2|||
161443376|NCT01006291|583017167|FG001|Overall Study|Adverse Event|1|||
161443377|NCT01006291|583017168|FG002|Overall Study|Adverse Event|2|||
161443378|NCT01006291|583017166|FG000|Overall Study|Lack of Efficacy|2|||
161443379|NCT01006291|583017167|FG001|Overall Study|Lack of Efficacy|2|||
161443380|NCT01006291|583017168|FG002|Overall Study|Lack of Efficacy|1|||
161790034|NCT01335464|584274881|FG000|Overall Study|Adverse Event|15|||
161790035|NCT01335464|584274882|FG001|Overall Study|Adverse Event|25|||
161790036|NCT01335464|584274881|FG000|Overall Study|Non compliant with protocol|2|||
161790037|NCT01335464|584274882|FG001|Overall Study|Non compliant with protocol|0|||
161790038|NCT01335464|584274881|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
161790039|NCT01335464|584274882|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
161790040|NCT01335464|584274881|FG000|Overall Study|Not treated|2|||
161790041|NCT01335464|584274882|FG001|Overall Study|Not treated|0|||
161790042|NCT01335464|584274881|FG000|Overall Study|Reason other than those stated above|1|||
161443381|NCT01006291|583017166|FG000|Overall Study|Protocol Violation|3|||
161443382|NCT01006291|583017167|FG001|Overall Study|Protocol Violation|3|||
161443383|NCT01006291|583017168|FG002|Overall Study|Protocol Violation|3|||
161443384|NCT01006291|583017166|FG000|Overall Study|Withdrawal criteria|5|||
161443385|NCT01006291|583017167|FG001|Overall Study|Withdrawal criteria|4|||
161443386|NCT01006291|583017168|FG002|Overall Study|Withdrawal criteria|4|||
161443387|NCT01006291|583017166|FG000|Overall Study|Other|14|||
161790043|NCT01335464|584274882|FG001|Overall Study|Reason other than those stated above|1|||
161790044|NCT00096486|584274887|FG000|Overall Study|Withdrawal by Subject|0|||
161790045|NCT00096486|584274888|FG001|Overall Study|Withdrawal by Subject|0|||
161790046|NCT00096486|584274889|FG002|Overall Study|Withdrawal by Subject|1|||
161790047|NCT00096486|584274890|FG003|Overall Study|Withdrawal by Subject|1|||
161790048|NCT00096486|584274887|FG000|Overall Study|Not Treated|0|||
161790049|NCT00096486|584274888|FG001|Overall Study|Not Treated|0|||
161790050|NCT00096486|584274889|FG002|Overall Study|Not Treated|1|||
161790051|NCT00096486|584274890|FG003|Overall Study|Not Treated|1|||
161790052|NCT01201356|584274891|FG000|Overall Study|Adverse Event|170|||
161790053|NCT01201356|584274891|FG000|Overall Study|Abnormal laboratory value(s)|51|||
161790054|NCT01201356|584274891|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161790055|NCT01201356|584274891|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
161790056|NCT01201356|584274891|FG000|Overall Study|Condition no longer requires study drug|12|||
161790057|NCT01201356|584274891|FG000|Overall Study|Withdrawal by Subject|144|||
161790058|NCT01201356|584274891|FG000|Overall Study|Lost to Follow-up|50|||
161790059|NCT01201356|584274891|FG000|Overall Study|administrative problems|74|||
161790060|NCT01201356|584274891|FG000|Overall Study|Death|16|||
161790061|NCT01201356|584274891|FG000|Overall Study|Protocol Violation|12|||
161790062|NCT00738920|584274893|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
161790063|NCT00738920|584274894|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
161790064|NCT00738920|584274895|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
161790065|NCT00738920|584274893|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
161790066|NCT00738920|584274894|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
161790067|NCT00738920|584274895|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
161790068|NCT00738920|584274893|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
161790069|NCT00738920|584274894|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
161790070|NCT00738920|584274895|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
161790071|NCT00738920|584274893|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
161790072|NCT00738920|584274894|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
161790073|NCT00738920|584274895|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
161790074|NCT00738920|584274893|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
161790075|NCT00738920|584274894|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
161790076|NCT00738920|584274895|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
161790077|NCT00738920|584274893|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
161790078|NCT00738920|584274894|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
161790079|NCT00738920|584274895|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
161790080|NCT00738920|584274893|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
161790081|NCT00738920|584274894|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
161790082|NCT00738920|584274895|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
161790083|NCT00738920|584274893|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
161790084|NCT00738920|584274894|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
161790085|NCT00738920|584274895|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
161790086|NCT00738920|584274893|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
161790087|NCT00738920|584274894|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
161790088|NCT00738920|584274895|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
161790089|NCT00738920|584274893|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
161790090|NCT00738920|584274894|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
161790091|NCT00738920|584274895|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
161790092|NCT00585039|584274898|FG000|Overall Study|medication spilled|2|||
161790093|NCT00585039|584274899|FG001|Overall Study|medication spilled|0|||
161790094|NCT02173301|584274900|FG000|Overall Study|Adverse Event|7|||
161790095|NCT02173301|584274901|FG001|Overall Study|Adverse Event|8|||
161790096|NCT02173301|584274902|FG002|Overall Study|Adverse Event|13|||
161790097|NCT02173301|584274903|FG003|Overall Study|Adverse Event|5|||
161790098|NCT02173301|584274900|FG000|Overall Study|Withdrawal by Subject|8|||
161790099|NCT02173301|584274901|FG001|Overall Study|Withdrawal by Subject|10|||
161790100|NCT02173301|584274902|FG002|Overall Study|Withdrawal by Subject|4|||
161790101|NCT02173301|584274903|FG003|Overall Study|Withdrawal by Subject|8|||
161790102|NCT02173301|584274900|FG000|Overall Study|Lost to Follow-up|4|||
161790103|NCT02173301|584274901|FG001|Overall Study|Lost to Follow-up|4|||
161790104|NCT02173301|584274902|FG002|Overall Study|Lost to Follow-up|2|||
161790105|NCT02173301|584274903|FG003|Overall Study|Lost to Follow-up|2|||
161790106|NCT02173301|584274900|FG000|Overall Study|Protocol Violation|0|||
161443388|NCT01006291|583017167|FG001|Overall Study|Other|14|||
161443389|NCT01006291|583017168|FG002|Overall Study|Other|17|||
161790107|NCT02173301|584274901|FG001|Overall Study|Protocol Violation|1|||
161790108|NCT02173301|584274902|FG002|Overall Study|Protocol Violation|0|||
161790109|NCT02173301|584274903|FG003|Overall Study|Protocol Violation|0|||
161443390|NCT01677377|583017169|FG000|Overall Study|Protocol Violation|1|||
161443391|NCT01677377|583017170|FG001|Overall Study|Protocol Violation|0|||
161790110|NCT02173301|584274900|FG000|Overall Study|Physician Decision|0|||
161790111|NCT02173301|584274901|FG001|Overall Study|Physician Decision|0|||
161790112|NCT02173301|584274902|FG002|Overall Study|Physician Decision|1|||
161790113|NCT02173301|584274903|FG003|Overall Study|Physician Decision|0|||
161790114|NCT02173301|584274900|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
161790115|NCT02173301|584274901|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161790116|NCT02173301|584274902|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161790117|NCT02173301|584274903|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161790118|NCT04079842|584274904|FG000|Overall Study|Request of subject|2|||
161790119|NCT04079842|584274904|FG000|Overall Study|Unable to draw Arterial samples|1|||
161790120|NCT02904200|584274905|FG000|Overall Study|Withdrawal by Subject|1|||
161790121|NCT02904200|584274906|FG001|Overall Study|Withdrawal by Subject|0|||
161790122|NCT04582266|584276819|FG000|Overall Study|Lost to Follow-up|7|||
161790123|NCT04582266|584276820|FG001|Overall Study|Lost to Follow-up|5|||
161790124|NCT04582266|584276819|FG000|Overall Study|Withdrawal by Subject|1|||
161790125|NCT04582266|584276820|FG001|Overall Study|Withdrawal by Subject|0|||
161790126|NCT04582266|584276819|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
161790127|NCT04582266|584276820|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
161790128|NCT02049359|584276821|FG000|Overall Study|Lost to Follow-up|26|||
161790129|NCT02049359|584276822|FG001|Overall Study|Lost to Follow-up|19|||
161790130|NCT00387712|584276825|FG000|Overall Study|Physician Decision|6|||
161790131|NCT00387712|584276826|FG001|Overall Study|Physician Decision|4|||
161790132|NCT00387712|584276825|FG000|Overall Study|Lost to Follow-up|17|||
161790133|NCT00387712|584276826|FG001|Overall Study|Lost to Follow-up|20|||
161790134|NCT00387712|584276825|FG000|Overall Study|Withdrawal by Subject|6|||
161790135|NCT00387712|584276826|FG001|Overall Study|Withdrawal by Subject|12|||
161790136|NCT01772368|584276828|FG000|Overall Study|Adverse Event|1|||
161790137|NCT01772368|584276828|FG000|Overall Study|Withdrawal by Subject|3|||
161790138|NCT01772368|584276828|FG000|Overall Study|Protocol Violation|2|||
161790139|NCT01772368|584276828|FG000|Overall Study|Other|1|||
161790140|NCT00112489|584276832|FG000|Overall Study|Refused further treatment|8|||
161790141|NCT00112489|584276832|FG000|Overall Study|Adverse Event|12|||
161790142|NCT00112489|584276832|FG000|Overall Study|Death|2|||
161790143|NCT00112489|584276832|FG000|Overall Study|Other, Not Specified|9|||
161790144|NCT00112489|584276832|FG000|Overall Study|Patient never treated|2|||
161790145|NCT00112489|584276832|FG000|Overall Study|Ineligible|7|||
161790146|NCT02231710|584276837|FG000|Overall Study|Physician Decision|1|||
161790147|NCT01339910|584276838|FG000|Overall Study|Withdrawal by Subject|1|||
161790148|NCT01339910|584276839|FG001|Overall Study|Withdrawal by Subject|0|||
161790149|NCT01339910|584276838|FG000|Overall Study|Physician Decision|1|||
161790150|NCT01339910|584276839|FG001|Overall Study|Physician Decision|0|||
161790151|NCT01339910|584276838|FG000|Overall Study|Disease relapse|1|||
161790152|NCT01339910|584276839|FG001|Overall Study|Disease relapse|4|||
161790153|NCT01399723|584276840|FG000|Overall Study|Lost to Follow-up|0|||
161790154|NCT01399723|584276841|FG001|Overall Study|Lost to Follow-up|1|||
161790155|NCT02322879|584276842|FG000|First Intervention|Physician Decision|1|||
161790156|NCT02322879|584276843|FG001|First Intervention|Physician Decision|0|||
161790157|NCT00124020|584276850|FG000|Overall Study|Death|67|||
161790158|NCT00124020|584276851|FG001|Overall Study|Death|71|||
161790159|NCT00124020|584276850|FG000|Overall Study|Withdrawal by Subject|13|||
161790160|NCT00124020|584276851|FG001|Overall Study|Withdrawal by Subject|11|||
161790161|NCT00124020|584276850|FG000|Overall Study|Lost to Follow-up|5|||
161790162|NCT00124020|584276851|FG001|Overall Study|Lost to Follow-up|8|||
161790163|NCT00124020|584276850|FG000|Overall Study|Other|1|||
161790164|NCT00124020|584276851|FG001|Overall Study|Other|1|||
161443392|NCT01677377|583017171|FG002|Overall Study|Protocol Violation|0|||
161443393|NCT01677377|583017169|FG000|Overall Study|Lost to Follow-up|0|||
161443394|NCT01677377|583017170|FG001|Overall Study|Lost to Follow-up|1|||
161443395|NCT01677377|583017171|FG002|Overall Study|Lost to Follow-up|1|||
161443396|NCT01677377|583017169|FG000|Overall Study|Withdrawal by Subject|0|||
161443397|NCT01677377|583017170|FG001|Overall Study|Withdrawal by Subject|0|||
161443398|NCT01677377|583017171|FG002|Overall Study|Withdrawal by Subject|3|||
161443399|NCT01677377|583017169|FG000|Overall Study|Lack of Efficacy|0|||
161790165|NCT00124020|584276850|FG000|Overall Study|Transfer to another hospital|2|||
161790166|NCT00124020|584276851|FG001|Overall Study|Transfer to another hospital|0|||
161790167|NCT00268346|584276852|FG000|Overall Study|Adverse Event|0|||
161790168|NCT00268346|584276853|FG001|Overall Study|Adverse Event|1|||
161790169|NCT00268346|584276852|FG000|Overall Study|Death|0|||
161790170|NCT00268346|584276853|FG001|Overall Study|Death|1|||
161790171|NCT00268346|584276852|FG000|Overall Study|Withdrawal by Subject|0|||
161790172|NCT00268346|584276853|FG001|Overall Study|Withdrawal by Subject|1|||
161790173|NCT00752791|584276856|FG000|Overall Study|Adverse Event|7|||
161790174|NCT00752791|584276856|FG000|Overall Study|Withdrawal by Subject|1|||
161790175|NCT00752791|584276856|FG000|Overall Study|Physician Decision|1|||
161790176|NCT00752791|584276856|FG000|Overall Study|Death|1|||
161790177|NCT00752791|584276856|FG000|Overall Study|Renal transplant|3|||
161443400|NCT01677377|583017170|FG001|Overall Study|Lack of Efficacy|0|||
161790178|NCT00752791|584276856|FG000|Overall Study|Switched to hemodialysis|2|||
161790179|NCT00752791|584276856|FG000|Overall Study|Protocol deviation|1|||
161790180|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
161790181|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
161790182|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161790183|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161790184|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
161790185|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161790186|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161790187|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161790188|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
161790189|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161790190|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161790191|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161790192|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
161790193|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161790194|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161790195|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161790196|NCT02784106|584276861|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
161790197|NCT02784106|584276862|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
161790198|NCT02784106|584276863|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
161790199|NCT02784106|584276864|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
161790200|NCT02784106|584276861|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
161790201|NCT02784106|584276862|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
161790202|NCT02784106|584276863|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
161790203|NCT02784106|584276864|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
161790204|NCT02927847|584276866|FG000|Overall Study|Lost to Follow-up|1|||
161790205|NCT02927847|584276867|FG001|Overall Study|Lost to Follow-up|0|||
161790206|NCT02927847|584276866|FG000|Overall Study|Withdrawal by Subject|4|||
161790207|NCT02927847|584276867|FG001|Overall Study|Withdrawal by Subject|2|||
161790208|NCT02927847|584276866|FG000|Overall Study|PI withdrawn due to missed visits|1|||
161790209|NCT02927847|584276867|FG001|Overall Study|PI withdrawn due to missed visits|1|||
161790210|NCT00553540|584276868|FG000|Overall Study|discharged after first visit|2|||
161790211|NCT00553540|584276869|FG001|Overall Study|discharged after first visit|5|||
161790212|NCT01755858|584276872|FG000|Overall Study|Adverse Event|1|||
161790213|NCT01755858|584276873|FG001|Overall Study|Adverse Event|1|||
161790214|NCT02087046|584276878|FG000|Overall Study|Adverse Event|4|||
161790215|NCT02087046|584276878|FG000|Overall Study|Death|1|||
161790216|NCT02087046|584276878|FG000|Overall Study|Lost to Follow-up|3|||
161790217|NCT02087046|584276878|FG000|Overall Study|Withdrawal by Subject|2|||
161790218|NCT02087046|584276878|FG000|Overall Study|Physician Decision|1|||
161790219|NCT02444533|584276879|FG000|Overall Study|Not able to complete forms|0|||
161790220|NCT02444533|584276880|FG001|Overall Study|Not able to complete forms|2|||
161790221|NCT02444533|584276879|FG000|Overall Study|Only gave post-procedure complications|2|||
161790222|NCT02444533|584276880|FG001|Overall Study|Only gave post-procedure complications|2|||
161790223|NCT01155583|584276881|FG000|Phase I|Screen failure - did not start treatment|0|||
161790224|NCT01155583|584276882|FG001|Phase I|Screen failure - did not start treatment|0|||
161790225|NCT01155583|584276883|FG002|Phase I|Screen failure - did not start treatment|0|||
161790226|NCT01155583|584276884|FG003|Phase I|Screen failure - did not start treatment|0|||
161790227|NCT01155583|584276885|FG004|Phase I|Screen failure - did not start treatment|1|||
161790228|NCT01155583|584276886|FG005|Phase I|Screen failure - did not start treatment|0|||
161790229|NCT01155583|584276887|FG006|Phase I|Screen failure - did not start treatment|0|||
161790230|NCT01155583|584276888|FG007|Phase I|Screen failure - did not start treatment|2|||
161790231|NCT01155583|584276889|FG008|Phase I|Screen failure - did not start treatment|0|||
161790232|NCT01155583|584276881|FG000|Phase I|Withdrawal by Subject|0|||
161790233|NCT01155583|584276882|FG001|Phase I|Withdrawal by Subject|0|||
161790234|NCT01155583|584276883|FG002|Phase I|Withdrawal by Subject|0|||
161790235|NCT01155583|584276884|FG003|Phase I|Withdrawal by Subject|0|||
161790236|NCT01155583|584276885|FG004|Phase I|Withdrawal by Subject|0|||
161790237|NCT01155583|584276886|FG005|Phase I|Withdrawal by Subject|0|||
161790238|NCT01155583|584276887|FG006|Phase I|Withdrawal by Subject|0|||
161790239|NCT01155583|584276888|FG007|Phase I|Withdrawal by Subject|1|||
161790240|NCT01155583|584276889|FG008|Phase I|Withdrawal by Subject|0|||
161790241|NCT00602030|584276890|FG000|Lead-in Phase|Disease Progression|2|||
161790242|NCT00602030|584276891|FG001|Lead-in Phase|Disease Progression|3|||
161790243|NCT00602030|584276892|FG002|Lead-in Phase|Disease Progression|0|||
161790244|NCT00602030|584276893|FG003|Lead-in Phase|Disease Progression|0|||
161790245|NCT00602030|584276894|FG004|Lead-in Phase|Disease Progression|0|||
161790246|NCT00602030|584276890|FG000|Lead-in Phase|Adverse Event|0|||
161790247|NCT00602030|584276891|FG001|Lead-in Phase|Adverse Event|2|||
161790248|NCT00602030|584276892|FG002|Lead-in Phase|Adverse Event|0|||
161790249|NCT00602030|584276893|FG003|Lead-in Phase|Adverse Event|0|||
161790250|NCT00602030|584276894|FG004|Lead-in Phase|Adverse Event|0|||
161790251|NCT00602030|584276890|FG000|Double-blind Phase|Disease progression|0|||
161790252|NCT00602030|584276891|FG001|Double-blind Phase|Disease progression|0|||
161790253|NCT00602030|584276892|FG002|Double-blind Phase|Disease progression|33|||
161790254|NCT00602030|584276893|FG003|Double-blind Phase|Disease progression|30|||
161790255|NCT00602030|584276894|FG004|Double-blind Phase|Disease progression|0|||
161790256|NCT00602030|584276890|FG000|Double-blind Phase|Adverse Event|0|||
161790257|NCT00602030|584276891|FG001|Double-blind Phase|Adverse Event|0|||
161790258|NCT00602030|584276892|FG002|Double-blind Phase|Adverse Event|9|||
161790259|NCT00602030|584276893|FG003|Double-blind Phase|Adverse Event|18|||
161790260|NCT00602030|584276894|FG004|Double-blind Phase|Adverse Event|0|||
161790261|NCT00602030|584276890|FG000|Double-blind Phase|Consent withdrawal|0|||
161790262|NCT00602030|584276891|FG001|Double-blind Phase|Consent withdrawal|0|||
161790263|NCT00602030|584276892|FG002|Double-blind Phase|Consent withdrawal|4|||
161790264|NCT00602030|584276893|FG003|Double-blind Phase|Consent withdrawal|3|||
161790265|NCT00602030|584276894|FG004|Double-blind Phase|Consent withdrawal|0|||
161790266|NCT00602030|584276890|FG000|Double-blind Phase|Death|0|||
161790267|NCT00602030|584276891|FG001|Double-blind Phase|Death|0|||
161790268|NCT00602030|584276892|FG002|Double-blind Phase|Death|3|||
161790269|NCT00602030|584276893|FG003|Double-blind Phase|Death|3|||
161790270|NCT00602030|584276894|FG004|Double-blind Phase|Death|0|||
161790271|NCT00602030|584276890|FG000|Double-blind Phase|Administrative decision|0|||
161790272|NCT00602030|584276891|FG001|Double-blind Phase|Administrative decision|0|||
161790273|NCT00602030|584276892|FG002|Double-blind Phase|Administrative decision|0|||
161790274|NCT00602030|584276893|FG003|Double-blind Phase|Administrative decision|2|||
161790275|NCT00602030|584276894|FG004|Double-blind Phase|Administrative decision|0|||
161790276|NCT00602030|584276890|FG000|Double-blind Phase|Ineligibility|0|||
161790277|NCT00602030|584276891|FG001|Double-blind Phase|Ineligibility|0|||
161790278|NCT00602030|584276892|FG002|Double-blind Phase|Ineligibility|0|||
161790279|NCT00602030|584276893|FG003|Double-blind Phase|Ineligibility|1|||
161790280|NCT00602030|584276894|FG004|Double-blind Phase|Ineligibility|0|||
161790281|NCT00602030|584276890|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790282|NCT00602030|584276891|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790283|NCT00602030|584276892|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
161790284|NCT00602030|584276893|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790285|NCT00602030|584276894|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790286|NCT00602030|584276890|FG000|Double-blind Phase|Reason not specified|0|||
161790287|NCT00602030|584276891|FG001|Double-blind Phase|Reason not specified|0|||
161790288|NCT00602030|584276892|FG002|Double-blind Phase|Reason not specified|4|||
161790289|NCT00602030|584276893|FG003|Double-blind Phase|Reason not specified|2|||
161790290|NCT00602030|584276894|FG004|Double-blind Phase|Reason not specified|0|||
161790291|NCT00602030|584276890|FG000|Crossover Phase|Disease Progression|0|||
161790292|NCT00602030|584276891|FG001|Crossover Phase|Disease Progression|0|||
161790293|NCT00602030|584276892|FG002|Crossover Phase|Disease Progression|0|||
161790294|NCT00602030|584276893|FG003|Crossover Phase|Disease Progression|0|||
161790295|NCT00602030|584276894|FG004|Crossover Phase|Disease Progression|11|||
161790296|NCT00602030|584276890|FG000|Crossover Phase|Adverse Event|0|||
161790297|NCT00602030|584276891|FG001|Crossover Phase|Adverse Event|0|||
161790298|NCT00602030|584276892|FG002|Crossover Phase|Adverse Event|0|||
161790299|NCT00602030|584276893|FG003|Crossover Phase|Adverse Event|0|||
161790300|NCT00602030|584276894|FG004|Crossover Phase|Adverse Event|3|||
161790301|NCT00602030|584276890|FG000|Crossover Phase|Consent withdrawal|0|||
161790302|NCT00602030|584276891|FG001|Crossover Phase|Consent withdrawal|0|||
161790303|NCT00602030|584276892|FG002|Crossover Phase|Consent withdrawal|0|||
161790304|NCT00602030|584276893|FG003|Crossover Phase|Consent withdrawal|0|||
161790305|NCT00602030|584276894|FG004|Crossover Phase|Consent withdrawal|2|||
161790306|NCT01580020|584276895|FG000|Overall Study|Lack of Efficacy|0|||
161790307|NCT01580020|584276896|FG001|Overall Study|Lack of Efficacy|5|||
161790308|NCT01580020|584276897|FG002|Overall Study|Lack of Efficacy|0|||
161790309|NCT01580020|584276898|FG003|Overall Study|Lack of Efficacy|1|||
161790310|NCT01580020|584276895|FG000|Overall Study|Withdrawal by Subject|0|||
161790311|NCT01580020|584276896|FG001|Overall Study|Withdrawal by Subject|1|||
161790312|NCT01580020|584276897|FG002|Overall Study|Withdrawal by Subject|1|||
161790313|NCT01580020|584276898|FG003|Overall Study|Withdrawal by Subject|0|||
161790314|NCT01580020|584276895|FG000|Overall Study|Adverse Event|1|||
161790315|NCT01580020|584276896|FG001|Overall Study|Adverse Event|1|||
161790316|NCT01580020|584276897|FG002|Overall Study|Adverse Event|1|||
161790317|NCT01580020|584276898|FG003|Overall Study|Adverse Event|1|||
161790318|NCT01580020|584276895|FG000|Overall Study|Administrative Problems|0|||
161790319|NCT01580020|584276896|FG001|Overall Study|Administrative Problems|0|||
161790320|NCT01580020|584276897|FG002|Overall Study|Administrative Problems|1|||
161443401|NCT01677377|583017171|FG002|Overall Study|Lack of Efficacy|1|||
161790321|NCT01580020|584276898|FG003|Overall Study|Administrative Problems|0|||
161790322|NCT01580020|584276895|FG000|Overall Study|Lost to Follow-up|0|||
161790323|NCT01580020|584276896|FG001|Overall Study|Lost to Follow-up|0|||
161790324|NCT01580020|584276897|FG002|Overall Study|Lost to Follow-up|1|||
161790325|NCT01580020|584276898|FG003|Overall Study|Lost to Follow-up|0|||
161790326|NCT01208402|584276902|FG000|Overall Study|Withdrawal by Subject|1|||
161790327|NCT01208402|584276903|FG001|Overall Study|Withdrawal by Subject|0|||
161790328|NCT01571635|584276904|FG000|Overall Study|Adverse Event|3|||
161790329|NCT01571635|584276905|FG001|Overall Study|Adverse Event|0|||
161790330|NCT01571635|584276906|FG002|Overall Study|Adverse Event|2|||
161790331|NCT01571635|584276907|FG003|Overall Study|Adverse Event|3|||
161790332|NCT01571635|584276908|FG004|Overall Study|Adverse Event|5|||
161790333|NCT01571635|584276904|FG000|Overall Study|Other reasons|2|||
161790334|NCT01571635|584276905|FG001|Overall Study|Other reasons|1|||
161790335|NCT01571635|584276906|FG002|Overall Study|Other reasons|2|||
161790336|NCT01571635|584276907|FG003|Overall Study|Other reasons|2|||
161790337|NCT01571635|584276908|FG004|Overall Study|Other reasons|1|||
161790338|NCT01571635|584276904|FG000|Overall Study|Study terminated by sponsor|0|||
161790339|NCT01571635|584276905|FG001|Overall Study|Study terminated by sponsor|4|||
161790340|NCT01571635|584276906|FG002|Overall Study|Study terminated by sponsor|1|||
161790341|NCT01571635|584276907|FG003|Overall Study|Study terminated by sponsor|3|||
161790342|NCT01571635|584276908|FG004|Overall Study|Study terminated by sponsor|1|||
161790343|NCT01571635|584276904|FG000|Overall Study|Withdrew consent|1|||
161790344|NCT01571635|584276905|FG001|Overall Study|Withdrew consent|1|||
161790345|NCT01571635|584276906|FG002|Overall Study|Withdrew consent|2|||
161790346|NCT01571635|584276907|FG003|Overall Study|Withdrew consent|3|||
161790347|NCT01571635|584276908|FG004|Overall Study|Withdrew consent|0|||
161790348|NCT01571635|584276904|FG000|Overall Study|Lack of Efficacy|0|||
161790349|NCT01571635|584276905|FG001|Overall Study|Lack of Efficacy|2|||
161790350|NCT01571635|584276906|FG002|Overall Study|Lack of Efficacy|0|||
161790351|NCT01571635|584276907|FG003|Overall Study|Lack of Efficacy|1|||
161790352|NCT01571635|584276908|FG004|Overall Study|Lack of Efficacy|2|||
161790353|NCT01783730|584276912|FG000|Overall Study|Failed to meet inclusion criteria|6|||
161790354|NCT01841359|584276913|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
161790355|NCT01841359|584276913|FG000|Overall Study|Concommitant medical issues|2|||
161790356|NCT01841359|584276913|FG000|Overall Study|Adverse Event|3|||
161790357|NCT01841359|584276913|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
161790358|NCT02151461|584276914|FG000|Overall Study|Adverse Event|5|||
161790359|NCT02151461|584276915|FG001|Overall Study|Adverse Event|1|||
161790360|NCT02151461|584276916|FG002|Overall Study|Adverse Event|0|||
161790361|NCT02151461|584276917|FG003|Overall Study|Adverse Event|2|||
161790362|NCT02151461|584276914|FG000|Overall Study|Lost to Follow-up|0|||
161790363|NCT02151461|584276915|FG001|Overall Study|Lost to Follow-up|0|||
161790364|NCT02151461|584276916|FG002|Overall Study|Lost to Follow-up|1|||
161790365|NCT02151461|584276917|FG003|Overall Study|Lost to Follow-up|1|||
161790366|NCT02151461|584276914|FG000|Overall Study|Withdrawal by Subject|1|||
161790367|NCT02151461|584276915|FG001|Overall Study|Withdrawal by Subject|0|||
161790368|NCT02151461|584276916|FG002|Overall Study|Withdrawal by Subject|1|||
161790369|NCT02151461|584276917|FG003|Overall Study|Withdrawal by Subject|1|||
161790370|NCT02151461|584276914|FG000|Overall Study|Treatment discontinuation|0|||
161790371|NCT02151461|584276915|FG001|Overall Study|Treatment discontinuation|0|||
161790372|NCT02151461|584276916|FG002|Overall Study|Treatment discontinuation|1|||
161790373|NCT02151461|584276917|FG003|Overall Study|Treatment discontinuation|0|||
161790374|NCT02168270|584276918|FG000|Overall Study|Lack of Efficacy|4|||
161790375|NCT01738581|584276919|FG000|Overall Study|Lost to Follow-up|1|||
161790376|NCT01738581|584276920|FG001|Overall Study|Lost to Follow-up|0|||
161790377|NCT00947856|584276927|FG000|Treatment Period|Progressive Disease|33|||
161790378|NCT00947856|584276928|FG001|Treatment Period|Progressive Disease|12|||
161790379|NCT00947856|584276927|FG000|Treatment Period|Adverse Event|15|||
161790380|NCT00947856|584276928|FG001|Treatment Period|Adverse Event|9|||
161790381|NCT00947856|584276927|FG000|Treatment Period|Physician Decision|14|||
161790382|NCT00947856|584276928|FG001|Treatment Period|Physician Decision|6|||
161790383|NCT00947856|584276927|FG000|Treatment Period|Study Stopped by Sponsor|4|||
161790384|NCT00947856|584276928|FG001|Treatment Period|Study Stopped by Sponsor|4|||
161790385|NCT00947856|584276927|FG000|Treatment Period|Withdrawal by Subject|12|||
161790386|NCT00947856|584276928|FG001|Treatment Period|Withdrawal by Subject|1|||
161790387|NCT00947856|584276927|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
161790388|NCT00947856|584276928|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
161790389|NCT00947856|584276927|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
161790390|NCT00947856|584276928|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
161790391|NCT00947856|584276927|FG000|Follow-up Period|Lost to Follow-up|7|||
161443402|NCT01677377|583017169|FG000|Overall Study|Pregnancy|0|||
161443403|NCT01677377|583017170|FG001|Overall Study|Pregnancy|0|||
161790392|NCT00947856|584276928|FG001|Follow-up Period|Lost to Follow-up|0|||
161790393|NCT00947856|584276927|FG000|Follow-up Period|Patient unavailable for site visits|1|||
161790394|NCT00947856|584276928|FG001|Follow-up Period|Patient unavailable for site visits|0|||
161790395|NCT00947856|584276927|FG000|Follow-up Period|Withdrawal by Subject|1|||
161790396|NCT00947856|584276928|FG001|Follow-up Period|Withdrawal by Subject|0|||
161790397|NCT02191579|584276929|FG000|Treatment 1|Multiple Reasons Specified|27|||
161790398|NCT02191579|584276930|FG001|Treatment 1|Multiple Reasons Specified|58|||
161790399|NCT02191579|584276929|FG000|Treatment 2|Multiple Reasons Specified|0|||
161790400|NCT02191579|584276930|FG001|Treatment 2|Multiple Reasons Specified|25|||
161790401|NCT02280356|584276933|FG000|Overall Study|Not Treated|2|||
161790402|NCT02280356|584276933|FG000|Overall Study|Withdrawal by Subject|1|||
161790403|NCT02280356|584276933|FG000|Overall Study|Not evaluable|2|||
161790404|NCT01086215|584276934|FG000|Overall Study|Death|14|||
161790405|NCT01086215|584276935|FG001|Overall Study|Death|8|||
161790406|NCT01086215|584276936|FG002|Overall Study|Death|8|||
161790407|NCT01086215|584276937|FG003|Overall Study|Death|1|||
161790408|NCT01086215|584276934|FG000|Overall Study|Lost to Follow-up|22|||
161790409|NCT01086215|584276935|FG001|Overall Study|Lost to Follow-up|39|||
161790410|NCT01086215|584276936|FG002|Overall Study|Lost to Follow-up|18|||
161790411|NCT01086215|584276937|FG003|Overall Study|Lost to Follow-up|2|||
161790412|NCT01965652|584276938|FG000|Overall Study|Adverse Event|40|||
161790413|NCT01965652|584276939|FG001|Overall Study|Adverse Event|37|||
161790414|NCT01965652|584276938|FG000|Overall Study|Withdrawal by Subject|62|||
161790415|NCT01965652|584276939|FG001|Overall Study|Withdrawal by Subject|69|||
161790416|NCT01965652|584276938|FG000|Overall Study|Lost to Follow-up|53|||
161790417|NCT01965652|584276939|FG001|Overall Study|Lost to Follow-up|40|||
161790418|NCT01965652|584276938|FG000|Overall Study|Protocol Violation|34|||
161790419|NCT01965652|584276939|FG001|Overall Study|Protocol Violation|38|||
161790420|NCT01965652|584276938|FG000|Overall Study|Death|3|||
161790421|NCT01965652|584276939|FG001|Overall Study|Death|4|||
161790422|NCT01965652|584276938|FG000|Overall Study|Other - Miscellaneous|18|||
161790423|NCT01965652|584276939|FG001|Overall Study|Other - Miscellaneous|21|||
161790424|NCT01965652|584276938|FG000|Overall Study|Pregnancy|0|||
161790425|NCT01965652|584276939|FG001|Overall Study|Pregnancy|1|||
161790426|NCT01121900|584276944|FG000|First Intervention Period|Adverse Event|1|||
161790427|NCT01121900|584276945|FG001|First Intervention Period|Adverse Event|1|||
161790428|NCT01121900|584276944|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161790429|NCT01121900|584276945|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161790430|NCT03493698|584276946|FG000|Treatment Period C|Adverse Event|1|||
161790431|NCT03493698|584276946|FG000|Treatment Period C|Withdrawal by Subject|1|||
161790432|NCT00408876|584276947|FG000|Overall Study|Adverse Event|9|||
161790433|NCT00408876|584276948|FG001|Overall Study|Adverse Event|17|||
161790434|NCT00408876|584276949|FG002|Overall Study|Adverse Event|27|||
161790435|NCT00408876|584276950|FG003|Overall Study|Adverse Event|10|||
161790436|NCT00408876|584276947|FG000|Overall Study|Withdrawal by Subject|3|||
161790437|NCT00408876|584276948|FG001|Overall Study|Withdrawal by Subject|6|||
161790438|NCT00408876|584276949|FG002|Overall Study|Withdrawal by Subject|6|||
161790439|NCT00408876|584276950|FG003|Overall Study|Withdrawal by Subject|14|||
161790440|NCT00408876|584276947|FG000|Overall Study|Lack of Efficacy|2|||
161790441|NCT00408876|584276948|FG001|Overall Study|Lack of Efficacy|4|||
161790442|NCT00408876|584276949|FG002|Overall Study|Lack of Efficacy|5|||
161790443|NCT00408876|584276950|FG003|Overall Study|Lack of Efficacy|6|||
161790444|NCT00408876|584276947|FG000|Overall Study|Lost to Follow-up|1|||
161790445|NCT00408876|584276948|FG001|Overall Study|Lost to Follow-up|6|||
161790446|NCT00408876|584276949|FG002|Overall Study|Lost to Follow-up|5|||
161790447|NCT00408876|584276950|FG003|Overall Study|Lost to Follow-up|2|||
161790448|NCT00408876|584276947|FG000|Overall Study|Protocol Violation|0|||
161790449|NCT00408876|584276948|FG001|Overall Study|Protocol Violation|3|||
161790450|NCT00408876|584276949|FG002|Overall Study|Protocol Violation|4|||
161790451|NCT00408876|584276950|FG003|Overall Study|Protocol Violation|3|||
161790452|NCT00408876|584276947|FG000|Overall Study|Physician Decision|1|||
161790453|NCT00408876|584276948|FG001|Overall Study|Physician Decision|0|||
161790454|NCT00408876|584276949|FG002|Overall Study|Physician Decision|3|||
161790455|NCT00408876|584276950|FG003|Overall Study|Physician Decision|0|||
161790456|NCT00291330|584276951|FG000|Overall Study|Adverse Event|47|||
161790457|NCT00291330|584276952|FG001|Overall Study|Adverse Event|40|||
161790458|NCT00291330|584276951|FG000|Overall Study|Protocol Violation|13|||
161790459|NCT00291330|584276952|FG001|Overall Study|Protocol Violation|20|||
161790460|NCT00291330|584276951|FG000|Overall Study|Lost to Follow-up|16|||
161790461|NCT00291330|584276952|FG001|Overall Study|Lost to Follow-up|11|||
161790462|NCT00291330|584276951|FG000|Overall Study|Withdrawal by Subject|22|||
161790463|NCT00291330|584276952|FG001|Overall Study|Withdrawal by Subject|25|||
161790464|NCT00291330|584276951|FG000|Overall Study|Other|3|||
161790465|NCT00291330|584276952|FG001|Overall Study|Other|1|||
161790466|NCT04071626|584276956|FG000|Overall Study|Withdrawal by Subject|1|||
161790467|NCT04071626|584276957|FG001|Overall Study|Withdrawal by Subject|1|||
161790468|NCT04071626|584276956|FG000|Overall Study|Protocol Violation|0|||
161790469|NCT04071626|584276957|FG001|Overall Study|Protocol Violation|1|||
161790470|NCT00931385|584276958|FG000|Overall Study|Adverse Event|2|||
161790471|NCT00931385|584276959|FG001|Overall Study|Adverse Event|1|||
161790472|NCT00931385|584276960|FG002|Overall Study|Adverse Event|0|||
161790473|NCT00931385|584276961|FG003|Overall Study|Adverse Event|3|||
161790474|NCT00931385|584276958|FG000|Overall Study|Protocol Violation|0|||
161790475|NCT00931385|584276959|FG001|Overall Study|Protocol Violation|0|||
161790476|NCT00931385|584276960|FG002|Overall Study|Protocol Violation|1|||
161790477|NCT00931385|584276961|FG003|Overall Study|Protocol Violation|0|||
161790478|NCT00931385|584276958|FG000|Overall Study|Withdrawal by Subject|0|||
161790479|NCT00931385|584276959|FG001|Overall Study|Withdrawal by Subject|1|||
161790480|NCT00931385|584276960|FG002|Overall Study|Withdrawal by Subject|0|||
161790481|NCT00931385|584276961|FG003|Overall Study|Withdrawal by Subject|1|||
161790482|NCT00931385|584276958|FG000|Overall Study|Lost to Follow-up|0|||
161790483|NCT00931385|584276959|FG001|Overall Study|Lost to Follow-up|0|||
161790484|NCT00931385|584276960|FG002|Overall Study|Lost to Follow-up|0|||
161790485|NCT00931385|584276961|FG003|Overall Study|Lost to Follow-up|1|||
161790486|NCT02230085|584276964|FG000|Overall Study|Physician Decision|1|||
161790487|NCT02230085|584276964|FG000|Overall Study|Withdrawal by Subject|3|||
161790488|NCT00580983|584276965|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
161790489|NCT00811070|584276966|FG000|Overall Study|Death|0|||
161790490|NCT00811070|584276967|FG001|Overall Study|Death|0|||
161790491|NCT00811070|584276968|FG002|Overall Study|Death|0|||
161790492|NCT00811070|584276969|FG003|Overall Study|Death|2|||
161790493|NCT00811070|584276970|FG004|Overall Study|Death|5|||
161790494|NCT00811070|584276971|FG005|Overall Study|Death|0|||
161790495|NCT00811070|584276966|FG000|Overall Study|Other|1|||
161790496|NCT00811070|584276967|FG001|Overall Study|Other|0|||
161790497|NCT00811070|584276968|FG002|Overall Study|Other|0|||
161790498|NCT00811070|584276969|FG003|Overall Study|Other|0|||
161790499|NCT00811070|584276970|FG004|Overall Study|Other|0|||
161790500|NCT00811070|584276971|FG005|Overall Study|Other|0|||
161790501|NCT00811070|584276966|FG000|Overall Study|Withdrawal by Subject|0|||
161790502|NCT00811070|584276967|FG001|Overall Study|Withdrawal by Subject|1|||
161790503|NCT00811070|584276968|FG002|Overall Study|Withdrawal by Subject|0|||
161790504|NCT00811070|584276969|FG003|Overall Study|Withdrawal by Subject|0|||
161790505|NCT00811070|584276970|FG004|Overall Study|Withdrawal by Subject|0|||
161790506|NCT00811070|584276971|FG005|Overall Study|Withdrawal by Subject|0|||
161790507|NCT00811070|584276966|FG000|Overall Study|Physician Decision|0|||
161790508|NCT00811070|584276967|FG001|Overall Study|Physician Decision|0|||
161790509|NCT00811070|584276968|FG002|Overall Study|Physician Decision|0|||
161790510|NCT00811070|584276969|FG003|Overall Study|Physician Decision|0|||
161790511|NCT00811070|584276970|FG004|Overall Study|Physician Decision|0|||
161790512|NCT00811070|584276971|FG005|Overall Study|Physician Decision|1|||
161790513|NCT00665626|584276974|FG000|Overall Study|Lack of Efficacy|8|||
161790514|NCT00665626|584276975|FG001|Overall Study|Lack of Efficacy|5|||
161790515|NCT00665626|584276974|FG000|Overall Study|Lost to Follow-up|0|||
161790516|NCT00665626|584276975|FG001|Overall Study|Lost to Follow-up|2|||
161790517|NCT00665626|584276974|FG000|Overall Study|Withdrawal by Subject|0|||
161790518|NCT00665626|584276975|FG001|Overall Study|Withdrawal by Subject|1|||
161790519|NCT00665626|584276974|FG000|Overall Study|Protocol Violation|0|||
161790520|NCT00665626|584276975|FG001|Overall Study|Protocol Violation|2|||
161790521|NCT00665626|584276974|FG000|Overall Study|Adverse Event|1|||
161790522|NCT00665626|584276975|FG001|Overall Study|Adverse Event|9|||
161790523|NCT00665626|584276974|FG000|Overall Study|Due to exclusion criteria|0|||
161790524|NCT00665626|584276975|FG001|Overall Study|Due to exclusion criteria|1|||
161790525|NCT00665626|584276974|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
161790526|NCT00665626|584276975|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
161790527|NCT00665626|584276974|FG000|Overall Study|Unably to comply with dosing regimen|0|||
161790528|NCT00665626|584276975|FG001|Overall Study|Unably to comply with dosing regimen|1|||
161790529|NCT00665626|584276974|FG000|Overall Study|Death|1|||
161790530|NCT00665626|584276975|FG001|Overall Study|Death|0|||
161790531|NCT02046369|584276976|FG000|Overall Study|Adverse Event|3|||
161790532|NCT02046369|584276977|FG001|Overall Study|Adverse Event|3|||
161790533|NCT02046369|584276976|FG000|Overall Study|Lack of Efficacy|3|||
161790534|NCT02046369|584276977|FG001|Overall Study|Lack of Efficacy|3|||
161790535|NCT02046369|584276976|FG000|Overall Study|Lost to Follow-up|3|||
161790536|NCT02046369|584276977|FG001|Overall Study|Lost to Follow-up|3|||
161790537|NCT02046369|584276976|FG000|Overall Study|Protocol Violation|1|||
161790538|NCT02046369|584276977|FG001|Overall Study|Protocol Violation|2|||
161790539|NCT02046369|584276976|FG000|Overall Study|Withdrawal by Subject|3|||
161443404|NCT01677377|583017171|FG002|Overall Study|Pregnancy|1|||
161790540|NCT02046369|584276977|FG001|Overall Study|Withdrawal by Subject|6|||
161790541|NCT02046369|584276976|FG000|Overall Study|never received study drug|0|||
161790542|NCT02046369|584276977|FG001|Overall Study|never received study drug|1|||
161790543|NCT02046369|584276976|FG000|Overall Study|non compliance|1|||
161898723|NCT01896193|584677890|FG001|Overall Study|Protocol Violation|1|||
161790544|NCT02046369|584276977|FG001|Overall Study|non compliance|0|||
161790545|NCT03120520|584276978|FG000|Overall Study|Lost to Follow-up|1|||
161790546|NCT03120520|584276979|FG001|Overall Study|Lost to Follow-up|1|||
161790547|NCT03120520|584276980|FG002|Overall Study|Lost to Follow-up|1|||
161790548|NCT03120520|584276981|FG003|Overall Study|Lost to Follow-up|1|||
161790549|NCT03120520|584276978|FG000|Overall Study|Withdrawal by Subject|3|||
161790550|NCT03120520|584276979|FG001|Overall Study|Withdrawal by Subject|2|||
161790551|NCT03120520|584276980|FG002|Overall Study|Withdrawal by Subject|3|||
161790552|NCT03120520|584276981|FG003|Overall Study|Withdrawal by Subject|2|||
161790553|NCT03120520|584276978|FG000|Overall Study|Other|0|||
161790554|NCT03120520|584276979|FG001|Overall Study|Other|1|||
161790555|NCT03120520|584276980|FG002|Overall Study|Other|0|||
161790556|NCT03120520|584276981|FG003|Overall Study|Other|0|||
161790557|NCT01025193|584276983|FG000|Overall Study|Protocol Violation|1|||
161790558|NCT01025193|584276983|FG000|Overall Study|Adverse Event|3|||
161790559|NCT04345471|584276984|FG000|Overall Study|Adverse Event|8|||
161790560|NCT04345471|584276985|FG001|Overall Study|Adverse Event|5|||
161790561|NCT04345471|584276986|FG002|Overall Study|Adverse Event|6|||
161790562|NCT04345471|584276984|FG000|Overall Study|Lack of Efficacy|1|||
161790563|NCT04345471|584276985|FG001|Overall Study|Lack of Efficacy|1|||
161790564|NCT04345471|584276986|FG002|Overall Study|Lack of Efficacy|0|||
161790565|NCT04345471|584276984|FG000|Overall Study|Protocol Violation|0|||
161790566|NCT04345471|584276985|FG001|Overall Study|Protocol Violation|1|||
161790567|NCT04345471|584276986|FG002|Overall Study|Protocol Violation|2|||
161790568|NCT04345471|584276984|FG000|Overall Study|Withdrawal by Subject|10|||
161790569|NCT04345471|584276985|FG001|Overall Study|Withdrawal by Subject|5|||
161790570|NCT04345471|584276986|FG002|Overall Study|Withdrawal by Subject|10|||
161790571|NCT02378506|584276991|FG000|Overall Study|Lack of Efficacy|3|||
161790572|NCT02378506|584276991|FG000|Overall Study|Withdrawal by Subject|4|||
161790573|NCT02378506|584276991|FG000|Overall Study|Protocol Violation|2|||
161790574|NCT02378506|584276991|FG000|Overall Study|Death|1|||
161790575|NCT02378506|584276991|FG000|Overall Study|Adverse Event|14|||
161790576|NCT02378506|584276991|FG000|Overall Study|Randomized But Not Treated|1|||
161790577|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
161790578|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
161790579|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
161790580|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
161790581|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
161790582|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
161790583|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
161790584|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
161790585|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
161790586|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
161790587|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
161790588|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
161790589|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
161790590|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
161790591|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
161790592|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
161790593|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
161790594|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
161790595|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
161790596|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
161790597|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
161790598|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
161790599|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
161790600|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
161790601|NCT01759537|584276994|FG000|Overall Study|Death|1|||
161790602|NCT01759537|584276995|FG001|Overall Study|Death|1|||
161790603|NCT01759537|584276994|FG000|Overall Study|Pregnancy|1|||
161790604|NCT01759537|584276995|FG001|Overall Study|Pregnancy|1|||
161790605|NCT01759537|584276994|FG000|Overall Study|Lost to Follow-up|9|||
161790606|NCT01759537|584276995|FG001|Overall Study|Lost to Follow-up|9|||
161790607|NCT01759537|584276994|FG000|Overall Study|Accident involving jaw fracture|1|||
161790608|NCT01759537|584276995|FG001|Overall Study|Accident involving jaw fracture|1|||
161790609|NCT01759537|584276994|FG000|Overall Study|Subcrestal implant too coronal|1|||
161790610|NCT01759537|584276995|FG001|Overall Study|Subcrestal implant too coronal|1|||
161790611|NCT01015612|584276996|FG000|Overall Study|Death|113|||
161790612|NCT01015612|584276996|FG000|Overall Study|Withdrawal by Subject|40|||
161790613|NCT00420290|584276997|FG000|Overall Study|Adverse Event|3|||
161790614|NCT00420290|584276998|FG001|Overall Study|Adverse Event|1|||
161790615|NCT00420290|584276997|FG000|Overall Study|Withdrawal by Subject|0|||
161790616|NCT00420290|584276998|FG001|Overall Study|Withdrawal by Subject|2|||
161790617|NCT00420290|584276997|FG000|Overall Study|did not meet inclusion/exclusion|1|||
161790618|NCT00420290|584276998|FG001|Overall Study|did not meet inclusion/exclusion|1|||
161790619|NCT00972153|584277001|FG000|Overall Study|Equipment malfunction during case|0|||
161790620|NCT00972153|584277002|FG001|Overall Study|Equipment malfunction during case|1|||
161790621|NCT00972153|584277003|FG002|Overall Study|Equipment malfunction during case|0|||
161790622|NCT01077713|584277004|FG000|Overall Study|Withdrawal by Subject|1|||
161790623|NCT01077713|584277005|FG001|Overall Study|Withdrawal by Subject|2|||
161790624|NCT01077713|584277004|FG000|Overall Study|Progressive Disease (PD)|0|||
161790625|NCT01077713|584277005|FG001|Overall Study|Progressive Disease (PD)|1|||
161790626|NCT01077713|584277004|FG000|Overall Study|Death|28|||
161790627|NCT01077713|584277005|FG001|Overall Study|Death|29|||
161790628|NCT01077713|584277004|FG000|Overall Study|Lost to Follow-up|1|||
161790629|NCT01077713|584277005|FG001|Overall Study|Lost to Follow-up|1|||
161790630|NCT01077713|584277004|FG000|Overall Study|Adverse Event|2|||
161790631|NCT01077713|584277005|FG001|Overall Study|Adverse Event|1|||
161790632|NCT01077713|584277004|FG000|Overall Study|Other|4|||
161790633|NCT01077713|584277005|FG001|Overall Study|Other|2|||
161790634|NCT04136626|584277006|FG000|Treatment Phase|Withdrawal by Subject|1|||
161790635|NCT04136626|584277007|FG001|Treatment Phase|Withdrawal by Subject|9|||
161790636|NCT04136626|584277006|FG000|Treatment Phase|Adverse Event|1|||
161790637|NCT04136626|584277007|FG001|Treatment Phase|Adverse Event|0|||
161790638|NCT04136626|584277006|FG000|Treatment Phase|Lost to Follow-up|1|||
161790639|NCT04136626|584277007|FG001|Treatment Phase|Lost to Follow-up|5|||
161790640|NCT04136626|584277006|FG000|12-month Follow-up|Lost to Follow-up|8|||
161790641|NCT04136626|584277007|FG001|12-month Follow-up|Lost to Follow-up|7|||
161790642|NCT01466686|584278529|FG000|Overall Study|Withdrawal by Subject|1|||
161790643|NCT02043366|584278533|FG000|Overall Study|Lost to Follow-up|2|||
161790644|NCT02043366|584278534|FG001|Overall Study|Lost to Follow-up|2|||
161790645|NCT02043366|584278535|FG002|Overall Study|Lost to Follow-up|2|||
161790646|NCT02043366|584278536|FG003|Overall Study|Lost to Follow-up|2|||
161790647|NCT02043366|584278537|FG004|Overall Study|Lost to Follow-up|2|||
161790648|NCT02043366|584278538|FG005|Overall Study|Lost to Follow-up|2|||
161790649|NCT01489956|584278539|FG000|Overall Study|Lost to Follow-up|1|||
161790650|NCT01489956|584278540|FG001|Overall Study|Lost to Follow-up|0|||
161790651|NCT01489956|584278541|FG002|Overall Study|Lost to Follow-up|0|||
161790652|NCT01489956|584278539|FG000|Overall Study|Withdrawal by Subject|0|||
161790653|NCT01489956|584278540|FG001|Overall Study|Withdrawal by Subject|0|||
161790654|NCT01489956|584278541|FG002|Overall Study|Withdrawal by Subject|1|||
161790655|NCT00723554|584278543|FG000|Overall Study|Adverse Event|12|||
161790656|NCT00723554|584278543|FG000|Overall Study|Investigator's judgement|5|||
161790657|NCT00723554|584278543|FG000|Overall Study|Inhaled medication other than iloprost|4|||
161790658|NCT00723554|584278543|FG000|Overall Study|Withdrawal of consent|3|||
161790659|NCT00723554|584278543|FG000|Overall Study|Other|3|||
161790660|NCT00723554|584278543|FG000|Overall Study|Lost to Follow-up|1|||
161790661|NCT00723554|584278543|FG000|Overall Study|Non-compliance|1|||
161790662|NCT01405820|584278544|FG000|Randomized Treatment Period|Adverse Event|3|||
161790663|NCT01405820|584278545|FG001|Randomized Treatment Period|Adverse Event|3|||
161790664|NCT01405820|584278546|FG002|Randomized Treatment Period|Adverse Event|3|||
161790665|NCT01405820|584278547|FG003|Randomized Treatment Period|Adverse Event|0|||
161790666|NCT01405820|584278548|FG004|Randomized Treatment Period|Adverse Event|2|||
161790667|NCT01405820|584278549|FG005|Randomized Treatment Period|Adverse Event|1|||
161790668|NCT01405820|584278544|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
161790669|NCT01405820|584278545|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
161790670|NCT01405820|584278546|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
161790671|NCT01405820|584278547|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
161790672|NCT01405820|584278548|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
161790673|NCT01405820|584278549|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
161790674|NCT01405820|584278544|FG000|Randomized Treatment Period|Other|2|||
161790675|NCT01405820|584278545|FG001|Randomized Treatment Period|Other|2|||
161790676|NCT01405820|584278546|FG002|Randomized Treatment Period|Other|1|||
161790677|NCT01405820|584278547|FG003|Randomized Treatment Period|Other|1|||
161790678|NCT01405820|584278548|FG004|Randomized Treatment Period|Other|0|||
161790679|NCT01405820|584278549|FG005|Randomized Treatment Period|Other|0|||
161790680|NCT01405820|584278544|FG000|Randomized Treatment Period|Physician Decision|0|||
161790681|NCT01405820|584278545|FG001|Randomized Treatment Period|Physician Decision|2|||
161790682|NCT01405820|584278546|FG002|Randomized Treatment Period|Physician Decision|1|||
161443405|NCT02260180|583017172|FG000|Overall Study|Adverse Event|2|||
161443406|NCT02260180|583017173|FG001|Overall Study|Adverse Event|0|||
161443407|NCT02260180|583017174|FG002|Overall Study|Adverse Event|1|||
161443408|NCT01193257|583017175|FG000|Overall Study|Death|202|||
161443409|NCT01193257|583017176|FG001|Overall Study|Death|391|||
161443410|NCT01193257|583017175|FG000|Overall Study|Study termination by sponsor|0|||
161443411|NCT01193257|583017176|FG001|Overall Study|Study termination by sponsor|3|||
161443412|NCT01193257|583017175|FG000|Overall Study|Withdrawal by Subject|26|||
161443413|NCT01193257|583017176|FG001|Overall Study|Withdrawal by Subject|86|||
161443414|NCT01193257|583017175|FG000|Overall Study|Lost to Follow-up|2|||
161443415|NCT01193257|583017176|FG001|Overall Study|Lost to Follow-up|3|||
161443416|NCT01193257|583017175|FG000|Overall Study|Unblinded due to futility|135|||
161790683|NCT01405820|584278547|FG003|Randomized Treatment Period|Physician Decision|0|||
161790684|NCT01405820|584278548|FG004|Randomized Treatment Period|Physician Decision|0|||
161790685|NCT01405820|584278549|FG005|Randomized Treatment Period|Physician Decision|0|||
161790686|NCT01405820|584278544|FG000|Randomized Treatment Period|Rescue|0|||
161790687|NCT01405820|584278545|FG001|Randomized Treatment Period|Rescue|1|||
161790688|NCT01405820|584278546|FG002|Randomized Treatment Period|Rescue|13|||
161790689|NCT01405820|584278547|FG003|Randomized Treatment Period|Rescue|10|||
161790690|NCT01405820|584278548|FG004|Randomized Treatment Period|Rescue|8|||
161790691|NCT01405820|584278549|FG005|Randomized Treatment Period|Rescue|8|||
161790692|NCT01405820|584278544|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
161898724|NCT01896193|584677889|FG000|Overall Study|Withdrew Consent|1|||
161898725|NCT01896193|584677890|FG001|Overall Study|Withdrew Consent|0|||
161898726|NCT02592447|584677891|FG000|Overall Study|Lost to Follow-up|1|||
161443417|NCT01193257|583017176|FG001|Overall Study|Unblinded due to futility|251|||
161443418|NCT01330108|583017192|FG000|Overall Study|Withdrawal by Subject|4|||
161443419|NCT04849559|583017197|FG000|Overall Study|Withdrawal by Subject|2|||
161443420|NCT04849559|583017198|FG001|Overall Study|Withdrawal by Subject|1|||
161443421|NCT02910986|583017199|FG000|Overall Study|non-Latina|14|||
161443422|NCT02910986|583017200|FG001|Overall Study|non-Latina|13|||
161443423|NCT02910986|583017201|FG002|Overall Study|non-Latina|12|||
161443424|NCT02910986|583017199|FG000|Overall Study|Failure to return T! survey|72|||
161443425|NCT02910986|583017200|FG001|Overall Study|Failure to return T! survey|84|||
161443426|NCT02910986|583017201|FG002|Overall Study|Failure to return T! survey|72|||
161443427|NCT02910986|583017199|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
161443428|NCT02910986|583017200|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
161443429|NCT02910986|583017201|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
161443430|NCT02910986|583017199|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
161443431|NCT02910986|583017200|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
161443432|NCT02910986|583017201|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
161443433|NCT02304367|583017202|FG000|Overall Study|Lack of Response to Bruosumab|1|||
161443434|NCT02304367|583017202|FG000|Overall Study|Sponsor Decision|3|||
161443435|NCT02304367|583017202|FG000|Overall Study|Death|2|||
161443436|NCT02304367|583017202|FG000|Overall Study|Physician Decision|1|||
161443437|NCT02304367|583017202|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
161443438|NCT03527732|583017203|FG000|Overall Study|Lost to Follow-up|21|||
161443439|NCT03527732|583017204|FG001|Overall Study|Lost to Follow-up|23|||
161443440|NCT03527732|583017205|FG002|Overall Study|Lost to Follow-up|80|||
161443441|NCT03527732|583017206|FG003|Overall Study|Lost to Follow-up|62|||
161443442|NCT03527732|583017207|FG004|Overall Study|Lost to Follow-up|12|||
161443443|NCT03527732|583017208|FG005|Overall Study|Lost to Follow-up|20|||
161443444|NCT00470275|583017209|FG000|Overall Study|Death|1|||
161443445|NCT00470275|583017209|FG000|Overall Study|Lack of Efficacy|7|||
161443446|NCT00470275|583017209|FG000|Overall Study|Withdrawal by Subject|2|||
161443447|NCT02207088|583017210|FG000|Overall Study|Adverse Event|2|||
161443448|NCT03306173|583017212|FG000|Overall Study|Lost to Follow-up|16|||
161443449|NCT03306173|583017213|FG001|Overall Study|Lost to Follow-up|23|||
161443450|NCT03306173|583017212|FG000|Overall Study|Withdrawal by Subject|4|||
161443451|NCT03306173|583017213|FG001|Overall Study|Withdrawal by Subject|3|||
161443452|NCT03306173|583017212|FG000|Overall Study|Discontinued|4|||
161443453|NCT03306173|583017213|FG001|Overall Study|Discontinued|4|||
161443454|NCT00573144|583017214|FG000|Overall Study|Withdrawal by Subject|2|||
161443455|NCT00573144|583017215|FG001|Overall Study|Withdrawal by Subject|3|||
161443456|NCT03339219|583017218|FG000|Overall Study|Death|12|||
161443457|NCT03339219|583017218|FG000|Overall Study|Site Terminated by Sponsor|22|||
161443458|NCT03339219|583017218|FG000|Overall Study|Withdrawal by Subject|1|||
161443459|NCT03155841|583017224|FG000|Overall Study|Protocol Violation|3|||
161443460|NCT03155841|583017225|FG001|Overall Study|Protocol Violation|4|||
161443461|NCT04308291|583017226|FG000|Run-In Phase|Withdrawal by Subject|4|||
161443462|NCT04308291|583017226|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
161443463|NCT04308291|583017226|FG000|Study Phase 6-M|Physician Decision|2|||
161443464|NCT04308291|583017226|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
161443465|NCT04308291|583017226|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
161443466|NCT04308291|583017226|FG000|Study Phase 12-M|Physician Decision|2|||
161443467|NCT04308291|583017226|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
161790693|NCT01405820|584278545|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
161790694|NCT01405820|584278546|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
161790695|NCT01405820|584278547|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
161790696|NCT01405820|584278548|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
161790697|NCT01405820|584278549|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
161790698|NCT01405820|584278544|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
161790699|NCT01405820|584278545|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
161790700|NCT01405820|584278546|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
161790701|NCT01405820|584278547|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
161790702|NCT01405820|584278548|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
161790703|NCT01405820|584278549|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
161790704|NCT01405820|584278544|FG000|Randomized Treatment Period|Death|0|||
161790705|NCT01405820|584278545|FG001|Randomized Treatment Period|Death|0|||
161443468|NCT04411667|583017227|FG000|Overall Study|Physician Decision|1|||
161443469|NCT04411667|583017228|FG001|Overall Study|Physician Decision|0|||
161443470|NCT00714870|583017232|FG000|Overall Study|Lost to Follow-up|22|||
161443471|NCT00714870|583017233|FG001|Overall Study|Lost to Follow-up|5|||
161790706|NCT01405820|584278546|FG002|Randomized Treatment Period|Death|0|||
161790707|NCT01405820|584278547|FG003|Randomized Treatment Period|Death|1|||
161790708|NCT01405820|584278548|FG004|Randomized Treatment Period|Death|0|||
161790709|NCT01405820|584278549|FG005|Randomized Treatment Period|Death|0|||
161443472|NCT00714870|583017232|FG000|Overall Study|patient unable to come b/c back pain|1|||
161443473|NCT00714870|583017233|FG001|Overall Study|patient unable to come b/c back pain|0|||
161443474|NCT00714870|583017232|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
161790710|NCT01405820|584278544|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790711|NCT01405820|584278545|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790712|NCT01405820|584278546|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790713|NCT01405820|584278547|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
161790714|NCT01405820|584278548|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790715|NCT01405820|584278549|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790716|NCT01405820|584278544|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
161790717|NCT01405820|584278545|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790718|NCT01405820|584278546|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790719|NCT01405820|584278547|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790720|NCT01405820|584278548|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
161790721|NCT01405820|584278549|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790722|NCT01405820|584278544|FG000|Open-Label Treatment Period|Other|1|||
161790723|NCT01405820|584278545|FG001|Open-Label Treatment Period|Other|1|||
161790724|NCT01405820|584278546|FG002|Open-Label Treatment Period|Other|1|||
161790725|NCT01405820|584278547|FG003|Open-Label Treatment Period|Other|1|||
161790726|NCT01405820|584278548|FG004|Open-Label Treatment Period|Other|1|||
161790727|NCT01405820|584278549|FG005|Open-Label Treatment Period|Other|1|||
161790728|NCT01405820|584278544|FG000|Open-Label Treatment Period|Physician Decision|0|||
161790729|NCT01405820|584278545|FG001|Open-Label Treatment Period|Physician Decision|0|||
161790730|NCT01405820|584278546|FG002|Open-Label Treatment Period|Physician Decision|1|||
161790731|NCT01405820|584278547|FG003|Open-Label Treatment Period|Physician Decision|2|||
161790732|NCT01405820|584278548|FG004|Open-Label Treatment Period|Physician Decision|1|||
161790733|NCT01405820|584278549|FG005|Open-Label Treatment Period|Physician Decision|0|||
161790734|NCT01405820|584278544|FG000|Open-Label Treatment Period|Adverse Event|0|||
161790735|NCT01405820|584278545|FG001|Open-Label Treatment Period|Adverse Event|0|||
161790736|NCT01405820|584278546|FG002|Open-Label Treatment Period|Adverse Event|0|||
161790737|NCT01405820|584278547|FG003|Open-Label Treatment Period|Adverse Event|1|||
161790738|NCT01405820|584278548|FG004|Open-Label Treatment Period|Adverse Event|0|||
161790739|NCT01405820|584278549|FG005|Open-Label Treatment Period|Adverse Event|0|||
161790740|NCT03222141|584278552|FG000|Overall Study|Death|15|||
161790741|NCT03222141|584278552|FG000|Overall Study|Lost to Follow-up|3|||
161790742|NCT01894984|584278556|FG000|Overall Study|Other|314|||
161790743|NCT01894984|584278557|FG001|Overall Study|Other|175|||
161790744|NCT00827359|584278558|FG000|Overall Study|Progressive Diseas|19|||
161790745|NCT00827359|584278558|FG000|Overall Study|Unacceptable Toxicity|5|||
161790746|NCT00827359|584278558|FG000|Overall Study|Ineligible|1|||
161790747|NCT02436135|584278559|FG000|Overall Study|Progressive Disease|3|||
161790748|NCT02436135|584278560|FG001|Overall Study|Progressive Disease|1|||
161790749|NCT02436135|584278559|FG000|Overall Study|Investigator Discretion|1|||
161790750|NCT02436135|584278560|FG001|Overall Study|Investigator Discretion|2|||
161790751|NCT02436135|584278559|FG000|Overall Study|Adverse Event|1|||
161790752|NCT02436135|584278560|FG001|Overall Study|Adverse Event|0|||
161790753|NCT02436135|584278559|FG000|Overall Study|Withdrawal by Participant|1|||
161790754|NCT02436135|584278560|FG001|Overall Study|Withdrawal by Participant|0|||
161790755|NCT02436135|584278559|FG000|Overall Study|Study Terminated By Sponsor|0|||
161790756|NCT02436135|584278560|FG001|Overall Study|Study Terminated By Sponsor|1|||
161790757|NCT01427803|584278561|FG000|Overall Study|Lost to Follow-up|32|||
161790758|NCT01427803|584278562|FG001|Overall Study|Lost to Follow-up|26|||
161790759|NCT01427803|584278561|FG000|Overall Study|Withdrawal by Subject|20|||
161790760|NCT01427803|584278562|FG001|Overall Study|Withdrawal by Subject|0|||
161790761|NCT01427803|584278561|FG000|Overall Study|Unable to complete full treatment period|6|||
161790762|NCT01427803|584278562|FG001|Overall Study|Unable to complete full treatment period|0|||
161790763|NCT01427803|584278561|FG000|Overall Study|Protocol Violation|1|||
161790764|NCT01427803|584278562|FG001|Overall Study|Protocol Violation|0|||
161790765|NCT01427803|584278561|FG000|Overall Study|Physician Decision|3|||
161790766|NCT01427803|584278562|FG001|Overall Study|Physician Decision|0|||
161790767|NCT01427803|584278561|FG000|Overall Study|did not take product|1|||
161790768|NCT01427803|584278562|FG001|Overall Study|did not take product|0|||
161790769|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
161790770|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
161790771|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
161790772|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
161790773|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
161790774|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
161790775|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
161790776|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
161790777|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
161790778|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
161790779|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
161790780|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
161790781|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Adverse Event|0|||
161790782|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Adverse Event|1|||
161898727|NCT02592447|584677892|FG001|Overall Study|Lost to Follow-up|0|||
161790783|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Adverse Event|1|||
161790784|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
161790785|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
161790786|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
161790787|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
161790788|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
161790789|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
161790790|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Pregnancy|0|||
161790791|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Pregnancy|1|||
161790792|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Pregnancy|1|||
161790793|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
161790794|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
161790795|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
161790796|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
161790797|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
161790798|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
161790799|NCT01698320|584278566|FG000|40-Week Open-Label Period|Adverse Event|0|||
161790800|NCT01698320|584278567|FG001|40-Week Open-Label Period|Adverse Event|3|||
161790801|NCT01698320|584278568|FG002|40-Week Open-Label Period|Adverse Event|2|||
161790802|NCT01698320|584278566|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
161790803|NCT01698320|584278567|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
161790804|NCT01698320|584278568|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
161790805|NCT01698320|584278566|FG000|40-Week Open-Label Period|Pregnancy|0|||
161790806|NCT01698320|584278567|FG001|40-Week Open-Label Period|Pregnancy|2|||
161790807|NCT01698320|584278568|FG002|40-Week Open-Label Period|Pregnancy|1|||
161790808|NCT01698320|584278566|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
161790809|NCT01698320|584278567|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
161790810|NCT01698320|584278568|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
161790811|NCT01698320|584278566|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
161790812|NCT01698320|584278567|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
161790813|NCT01698320|584278568|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
161790814|NCT01107535|584278569|FG000|Overall Study|Death|5|||
161790815|NCT03567057|584278570|FG000|Overall Study|Adverse Event|56|||
161790816|NCT03567057|584278571|FG001|Overall Study|Adverse Event|53|||
161790817|NCT03567057|584278572|FG002|Overall Study|Adverse Event|28|||
161790818|NCT03567057|584278570|FG000|Overall Study|Withdrawal by Subject|22|||
161790819|NCT03567057|584278571|FG001|Overall Study|Withdrawal by Subject|24|||
161790820|NCT03567057|584278572|FG002|Overall Study|Withdrawal by Subject|13|||
161790821|NCT03567057|584278570|FG000|Overall Study|Lost to Follow-up|3|||
161790822|NCT03567057|584278571|FG001|Overall Study|Lost to Follow-up|5|||
161790823|NCT03567057|584278572|FG002|Overall Study|Lost to Follow-up|2|||
161790824|NCT03567057|584278570|FG000|Overall Study|COVID-19 pandemic|4|||
161790825|NCT03567057|584278571|FG001|Overall Study|COVID-19 pandemic|3|||
161790826|NCT03567057|584278572|FG002|Overall Study|COVID-19 pandemic|0|||
161790827|NCT03567057|584278570|FG000|Overall Study|Non-compliance with study drug|4|||
161790828|NCT03567057|584278571|FG001|Overall Study|Non-compliance with study drug|2|||
161790829|NCT03567057|584278572|FG002|Overall Study|Non-compliance with study drug|0|||
161790830|NCT03567057|584278570|FG000|Overall Study|Lack of Efficacy|3|||
161790831|NCT03567057|584278571|FG001|Overall Study|Lack of Efficacy|0|||
161790832|NCT03567057|584278572|FG002|Overall Study|Lack of Efficacy|1|||
161790833|NCT03567057|584278570|FG000|Overall Study|Death|1|||
161790834|NCT03567057|584278571|FG001|Overall Study|Death|0|||
161790835|NCT03567057|584278572|FG002|Overall Study|Death|0|||
161790836|NCT03567057|584278570|FG000|Overall Study|Physician Decision|1|||
161790837|NCT03567057|584278571|FG001|Overall Study|Physician Decision|0|||
161790838|NCT03567057|584278572|FG002|Overall Study|Physician Decision|0|||
161790839|NCT03567057|584278570|FG000|Overall Study|Unstable medical condition|1|||
161790840|NCT03567057|584278571|FG001|Overall Study|Unstable medical condition|0|||
161790841|NCT03567057|584278572|FG002|Overall Study|Unstable medical condition|0|||
161790842|NCT03567057|584278570|FG000|Overall Study|Medical history event|0|||
161790843|NCT03567057|584278571|FG001|Overall Study|Medical history event|0|||
161790844|NCT03567057|584278572|FG002|Overall Study|Medical history event|1|||
161790845|NCT03567057|584278570|FG000|Overall Study|Other|0|||
161790846|NCT03567057|584278571|FG001|Overall Study|Other|0|||
161790847|NCT03567057|584278572|FG002|Overall Study|Other|1|||
161790848|NCT00886483|584278579|FG000|Overall Study|Lost to Follow-up|0|||
161790849|NCT00886483|584278580|FG001|Overall Study|Lost to Follow-up|1|||
161790850|NCT00886483|584278579|FG000|Overall Study|Pursue medications|1|||
161790851|NCT00886483|584278580|FG001|Overall Study|Pursue medications|2|||
161790852|NCT00886483|584278579|FG000|Overall Study|Distance to center, poor grades|1|||
161790853|NCT00886483|584278580|FG001|Overall Study|Distance to center, poor grades|0|||
161790854|NCT01001169|584278581|FG000|Overall Study|Withdrawal by Subject|2|||
161790855|NCT01001169|584278582|FG001|Overall Study|Withdrawal by Subject|1|||
161790856|NCT02040766|584278583|FG000|Overall Study|Adverse Event|1|||
161790857|NCT02040766|584278584|FG001|Overall Study|Adverse Event|1|||
161790858|NCT02040766|584278585|FG002|Overall Study|Adverse Event|1|||
161790859|NCT02040766|584278586|FG003|Overall Study|Adverse Event|0|||
161790860|NCT02040766|584278587|FG004|Overall Study|Adverse Event|2|||
161790861|NCT02040766|584278583|FG000|Overall Study|Withdrawal by Subject|4|||
161790862|NCT02040766|584278584|FG001|Overall Study|Withdrawal by Subject|3|||
161790863|NCT02040766|584278585|FG002|Overall Study|Withdrawal by Subject|2|||
161790864|NCT02040766|584278586|FG003|Overall Study|Withdrawal by Subject|3|||
161790865|NCT02040766|584278587|FG004|Overall Study|Withdrawal by Subject|2|||
161790866|NCT02040766|584278583|FG000|Overall Study|Non-compliance|0|||
161790867|NCT02040766|584278584|FG001|Overall Study|Non-compliance|1|||
161790868|NCT02040766|584278585|FG002|Overall Study|Non-compliance|0|||
161790869|NCT02040766|584278586|FG003|Overall Study|Non-compliance|0|||
161790870|NCT02040766|584278587|FG004|Overall Study|Non-compliance|0|||
161790871|NCT02040766|584278583|FG000|Overall Study|Protocol Violation|2|||
161790872|NCT02040766|584278584|FG001|Overall Study|Protocol Violation|1|||
161790873|NCT02040766|584278585|FG002|Overall Study|Protocol Violation|2|||
161790874|NCT02040766|584278586|FG003|Overall Study|Protocol Violation|3|||
161790875|NCT02040766|584278587|FG004|Overall Study|Protocol Violation|0|||
161790876|NCT02040766|584278583|FG000|Overall Study|Lost to Follow-up|4|||
161790877|NCT02040766|584278584|FG001|Overall Study|Lost to Follow-up|1|||
161790878|NCT02040766|584278585|FG002|Overall Study|Lost to Follow-up|3|||
161790879|NCT02040766|584278586|FG003|Overall Study|Lost to Follow-up|1|||
161790880|NCT02040766|584278587|FG004|Overall Study|Lost to Follow-up|4|||
161790881|NCT02040766|584278583|FG000|Overall Study|Not reported|1|||
161790882|NCT02040766|584278584|FG001|Overall Study|Not reported|0|||
161790883|NCT02040766|584278585|FG002|Overall Study|Not reported|0|||
161790884|NCT02040766|584278586|FG003|Overall Study|Not reported|0|||
161790885|NCT02040766|584278587|FG004|Overall Study|Not reported|0|||
161790886|NCT02040766|584278583|FG000|Overall Study|Lack of Efficacy|6|||
161790887|NCT02040766|584278584|FG001|Overall Study|Lack of Efficacy|3|||
161790888|NCT02040766|584278585|FG002|Overall Study|Lack of Efficacy|4|||
161790889|NCT02040766|584278586|FG003|Overall Study|Lack of Efficacy|6|||
161790890|NCT02040766|584278587|FG004|Overall Study|Lack of Efficacy|5|||
161790891|NCT01271933|584278588|FG000|Single-Blind Phase|Lack of Efficacy|37|||
161790892|NCT01271933|584278589|FG001|Single-Blind Phase|Lack of Efficacy|0|||
161790893|NCT01271933|584278590|FG002|Single-Blind Phase|Lack of Efficacy|0|||
161790894|NCT01271933|584278588|FG000|Single-Blind Phase|Lost to Follow-up|10|||
161790895|NCT01271933|584278589|FG001|Single-Blind Phase|Lost to Follow-up|0|||
161790896|NCT01271933|584278590|FG002|Single-Blind Phase|Lost to Follow-up|0|||
161790897|NCT01271933|584278588|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
161790898|NCT01271933|584278589|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
161790899|NCT01271933|584278590|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
161790900|NCT01271933|584278588|FG000|Single-Blind Phase|Protocol Violation|3|||
161790901|NCT01271933|584278589|FG001|Single-Blind Phase|Protocol Violation|0|||
161790902|NCT01271933|584278590|FG002|Single-Blind Phase|Protocol Violation|0|||
161790903|NCT01271933|584278588|FG000|Single-Blind Phase|Adverse Event|52|||
161790904|NCT01271933|584278589|FG001|Single-Blind Phase|Adverse Event|0|||
161790905|NCT01271933|584278590|FG002|Single-Blind Phase|Adverse Event|0|||
161790906|NCT01271933|584278588|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
161790907|NCT01271933|584278589|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
161790908|NCT01271933|584278590|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
161790909|NCT01271933|584278588|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
161790910|NCT01271933|584278589|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
161443475|NCT00714870|583017233|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
161443476|NCT03399552|583017234|FG000|Overall Study|No evidence of disease|1|||
161443477|NCT03399552|583017234|FG000|Overall Study|Unevaluable|1|||
161443478|NCT02357368|583017235|FG000|Overall Study|Lost to Follow-up|0|||
161443479|NCT02357368|583017236|FG001|Overall Study|Lost to Follow-up|0|||
161443480|NCT02357368|583017237|FG002|Overall Study|Lost to Follow-up|0|||
161443481|NCT02357368|583017238|FG003|Overall Study|Lost to Follow-up|1|||
161443482|NCT02357368|583017235|FG000|Overall Study|Pregnancy|3|||
161443483|NCT02357368|583017236|FG001|Overall Study|Pregnancy|2|||
161443484|NCT02357368|583017237|FG002|Overall Study|Pregnancy|0|||
161443485|NCT02357368|583017238|FG003|Overall Study|Pregnancy|0|||
161443486|NCT02357368|583017235|FG000|Overall Study|Withdrawal by Subject|3|||
161443487|NCT02357368|583017236|FG001|Overall Study|Withdrawal by Subject|1|||
161790911|NCT01271933|584278590|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
161790912|NCT01271933|584278588|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
161443488|NCT02357368|583017237|FG002|Overall Study|Withdrawal by Subject|1|||
161443489|NCT02357368|583017238|FG003|Overall Study|Withdrawal by Subject|2|||
161443490|NCT01931566|583017239|FG000|Overall Study|Randomized But Not Treated|6|||
161443491|NCT01931566|583017240|FG001|Overall Study|Randomized But Not Treated|9|||
161443492|NCT01931566|583017241|FG002|Overall Study|Randomized But Not Treated|14|||
161790913|NCT01271933|584278589|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
161790914|NCT01271933|584278590|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
161790915|NCT01271933|584278588|FG000|Double-Blind Phase|Randomized but not treated|0|||
161790916|NCT01271933|584278589|FG001|Double-Blind Phase|Randomized but not treated|0|||
161790917|NCT01271933|584278590|FG002|Double-Blind Phase|Randomized but not treated|1|||
161790918|NCT01271933|584278588|FG000|Double-Blind Phase|Lack of Efficacy|0|||
161790919|NCT01271933|584278589|FG001|Double-Blind Phase|Lack of Efficacy|6|||
161790920|NCT01271933|584278590|FG002|Double-Blind Phase|Lack of Efficacy|9|||
161790921|NCT01271933|584278588|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161790922|NCT01271933|584278589|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161790923|NCT01271933|584278590|FG002|Double-Blind Phase|Lost to Follow-up|1|||
161790924|NCT01271933|584278588|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161790925|NCT01271933|584278589|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161790926|NCT01271933|584278590|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
161790927|NCT01271933|584278588|FG000|Double-Blind Phase|Adverse Event|0|||
161790928|NCT01271933|584278589|FG001|Double-Blind Phase|Adverse Event|3|||
161790929|NCT01271933|584278590|FG002|Double-Blind Phase|Adverse Event|0|||
161790930|NCT01271933|584278588|FG000|Double-Blind Phase|Participant request-personal reason|0|||
161790931|NCT01271933|584278589|FG001|Double-Blind Phase|Participant request-personal reason|1|||
161790932|NCT01271933|584278590|FG002|Double-Blind Phase|Participant request-personal reason|0|||
161790933|NCT01138150|584278591|FG000|Overall Study|blood unable to be processed|0|||
161790934|NCT01138150|584278592|FG001|Overall Study|blood unable to be processed|1|||
161790935|NCT01138150|584278591|FG000|Overall Study|Physician Decision|1|||
161790936|NCT01138150|584278592|FG001|Overall Study|Physician Decision|0|||
161790937|NCT01620983|584278593|FG000|Overall Study|Lost to Follow-up|8|||
161790938|NCT01620983|584278594|FG001|Overall Study|Lost to Follow-up|4|||
161790939|NCT01620983|584278595|FG002|Overall Study|Lost to Follow-up|9|||
161790940|NCT01620983|584278593|FG000|Overall Study|Withdrawal by Subject|6|||
161790941|NCT01620983|584278594|FG001|Overall Study|Withdrawal by Subject|8|||
161790942|NCT01620983|584278595|FG002|Overall Study|Withdrawal by Subject|1|||
161790943|NCT01620983|584278593|FG000|Overall Study|Death|2|||
161790944|NCT01620983|584278594|FG001|Overall Study|Death|0|||
161790945|NCT01620983|584278595|FG002|Overall Study|Death|0|||
161790946|NCT01620983|584278593|FG000|Overall Study|Physician Decision|3|||
161790947|NCT01620983|584278594|FG001|Overall Study|Physician Decision|10|||
161790948|NCT01620983|584278595|FG002|Overall Study|Physician Decision|5|||
161790949|NCT00798889|584278597|FG000|Overall Study|Adverse Event|53|||
161790950|NCT00798889|584278597|FG000|Overall Study|Protocol Violation|2|||
161790951|NCT00798889|584278597|FG000|Overall Study|Withdrawal by Subject|31|||
161790952|NCT00798889|584278597|FG000|Overall Study|Lost to Follow-up|1|||
161790953|NCT00798889|584278597|FG000|Overall Study|Lack of Efficacy|213|||
161790954|NCT00798889|584278597|FG000|Overall Study|Decision of Sponsor|11|||
161790955|NCT00798889|584278597|FG000|Overall Study|Enrolled, Not treated|3|||
161790956|NCT00617461|584278598|FG000|First Treatment Intervention Period|Adverse Event|2|||
161790957|NCT00617461|584278599|FG001|First Treatment Intervention Period|Adverse Event|0|||
161790958|NCT00617461|584278598|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
161790959|NCT00617461|584278599|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
161790960|NCT00617461|584278598|FG000|First Treatment Intervention Period|Protocol Violation|2|||
161790961|NCT00617461|584278599|FG001|First Treatment Intervention Period|Protocol Violation|1|||
161790962|NCT00617461|584278598|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
161790963|NCT00617461|584278599|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
161790964|NCT00617461|584278598|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
161790965|NCT00617461|584278599|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
161790966|NCT00617461|584278598|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
161790967|NCT00617461|584278599|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
161790968|NCT00617461|584278598|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
161790969|NCT00617461|584278599|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
161790970|NCT00617461|584278598|FG000|Second Treatment Intervention Period|Adverse Event|0|||
161790971|NCT00617461|584278599|FG001|Second Treatment Intervention Period|Adverse Event|1|||
161790972|NCT00617461|584278598|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
161790973|NCT00617461|584278599|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
161790974|NCT00617461|584278598|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
161790975|NCT00617461|584278599|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
161790976|NCT00617461|584278598|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
161790977|NCT00617461|584278599|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
161790978|NCT01724359|584278600|FG000|Overall Study|Adverse Event|10|||
161790979|NCT01724359|584278600|FG000|Overall Study|Death|1|||
161790980|NCT01724359|584278600|FG000|Overall Study|Other|20|||
161790981|NCT05085964|584278601|FG000|Overall Study|Premature termination of study|21|||
161443493|NCT01931566|583017239|FG000|Overall Study|Adverse Event|37|||
161443494|NCT01931566|583017240|FG001|Overall Study|Adverse Event|167|||
161790982|NCT05085964|584278602|FG001|Overall Study|Premature termination of study|0|||
161790983|NCT03156270|584278609|FG000|Overall Study|Failed pre-treatment screening|1|||
161790984|NCT03156270|584278609|FG000|Overall Study|Lost to Follow-up|1|||
161790985|NCT00591253|584278610|FG000|Overall Study|Adverse Event|3|||
161443495|NCT01931566|583017241|FG002|Overall Study|Adverse Event|132|||
161443496|NCT01931566|583017239|FG000|Overall Study|Major Protocol Deviation|5|||
161790986|NCT00591253|584278611|FG001|Overall Study|Adverse Event|3|||
161790987|NCT00591253|584278612|FG002|Overall Study|Adverse Event|1|||
161790988|NCT00591253|584278610|FG000|Overall Study|Protocol Violation|2|||
161790989|NCT00591253|584278611|FG001|Overall Study|Protocol Violation|2|||
161790990|NCT00591253|584278612|FG002|Overall Study|Protocol Violation|2|||
161790991|NCT00591253|584278610|FG000|Overall Study|Lost to Follow-up|2|||
161790992|NCT00591253|584278611|FG001|Overall Study|Lost to Follow-up|4|||
161790993|NCT00591253|584278612|FG002|Overall Study|Lost to Follow-up|0|||
161790994|NCT00591253|584278610|FG000|Overall Study|Withdrawal by Subject|1|||
161790995|NCT00591253|584278611|FG001|Overall Study|Withdrawal by Subject|7|||
161790996|NCT00591253|584278612|FG002|Overall Study|Withdrawal by Subject|6|||
161790997|NCT00591253|584278610|FG000|Overall Study|Lack of Efficacy|1|||
161790998|NCT00591253|584278611|FG001|Overall Study|Lack of Efficacy|0|||
161790999|NCT00591253|584278612|FG002|Overall Study|Lack of Efficacy|3|||
161791000|NCT00591253|584278610|FG000|Overall Study|Other|5|||
161791001|NCT00591253|584278611|FG001|Overall Study|Other|5|||
161791002|NCT00591253|584278612|FG002|Overall Study|Other|3|||
161791003|NCT00252187|584278613|FG000|Overall Study|Adverse Event|3|||
161791004|NCT00252187|584278614|FG001|Overall Study|Adverse Event|1|||
161791005|NCT00252187|584278613|FG000|Overall Study|Withdrawal by Subject|1|||
161791006|NCT00252187|584278614|FG001|Overall Study|Withdrawal by Subject|0|||
161791007|NCT01752920|584278617|FG000|Overall Study|Adverse Event|1|||
161791008|NCT01752920|584278618|FG001|Overall Study|Adverse Event|0|||
161791009|NCT01752920|584278619|FG002|Overall Study|Adverse Event|5|||
161791010|NCT01752920|584278620|FG003|Overall Study|Adverse Event|10|||
161791011|NCT01752920|584278617|FG000|Overall Study|Clinical Disease Progression|6|||
161791012|NCT01752920|584278618|FG001|Overall Study|Clinical Disease Progression|4|||
161791013|NCT01752920|584278619|FG002|Overall Study|Clinical Disease Progression|1|||
161791014|NCT01752920|584278620|FG003|Overall Study|Clinical Disease Progression|13|||
161791015|NCT01752920|584278617|FG000|Overall Study|Physician Decision|1|||
161791016|NCT01752920|584278618|FG001|Overall Study|Physician Decision|0|||
161791017|NCT01752920|584278619|FG002|Overall Study|Physician Decision|0|||
161791018|NCT01752920|584278620|FG003|Overall Study|Physician Decision|3|||
161791019|NCT01752920|584278617|FG000|Overall Study|Radiographic Disease Progression|20|||
161791020|NCT01752920|584278618|FG001|Overall Study|Radiographic Disease Progression|7|||
161791021|NCT01752920|584278619|FG002|Overall Study|Radiographic Disease Progression|12|||
161791022|NCT01752920|584278620|FG003|Overall Study|Radiographic Disease Progression|29|||
161791023|NCT01752920|584278617|FG000|Overall Study|Study Terminated by Sponsor|0|||
161791024|NCT01752920|584278618|FG001|Overall Study|Study Terminated by Sponsor|0|||
161791025|NCT01752920|584278619|FG002|Overall Study|Study Terminated by Sponsor|0|||
161791026|NCT01752920|584278620|FG003|Overall Study|Study Terminated by Sponsor|1|||
161791027|NCT01752920|584278617|FG000|Overall Study|Withdrawal by Subject|0|||
161791028|NCT01752920|584278618|FG001|Overall Study|Withdrawal by Subject|1|||
161791029|NCT01752920|584278619|FG002|Overall Study|Withdrawal by Subject|0|||
161791030|NCT01752920|584278620|FG003|Overall Study|Withdrawal by Subject|1|||
161791031|NCT01752920|584278617|FG000|Overall Study|Lack of clinical benefit|1|||
161791032|NCT01752920|584278618|FG001|Overall Study|Lack of clinical benefit|1|||
161791033|NCT01752920|584278619|FG002|Overall Study|Lack of clinical benefit|1|||
161791034|NCT01752920|584278620|FG003|Overall Study|Lack of clinical benefit|1|||
161791035|NCT00771901|584278621|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
161791036|NCT00771901|584278622|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
161791037|NCT00771901|584278623|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
161791038|NCT02862535|584278624|FG000|Overall Study|Death|7|||
161791039|NCT02862535|584278625|FG001|Overall Study|Death|3|||
161791040|NCT02862535|584278626|FG002|Overall Study|Death|2|||
161791041|NCT02862535|584278627|FG003|Overall Study|Death|5|||
161791042|NCT02862535|584278624|FG000|Overall Study|Study Terminated by Sponsor|1|||
161791043|NCT02862535|584278625|FG001|Overall Study|Study Terminated by Sponsor|3|||
161791044|NCT02862535|584278626|FG002|Overall Study|Study Terminated by Sponsor|8|||
161791045|NCT02862535|584278627|FG003|Overall Study|Study Terminated by Sponsor|5|||
161791046|NCT02862535|584278624|FG000|Overall Study|Enrolled, not Treated|1|||
161791047|NCT02862535|584278625|FG001|Overall Study|Enrolled, not Treated|0|||
161791048|NCT02862535|584278626|FG002|Overall Study|Enrolled, not Treated|0|||
161791049|NCT02862535|584278627|FG003|Overall Study|Enrolled, not Treated|1|||
161791050|NCT00566709|584278633|FG000|Overall Study|Protocol Violation|5|||
161791051|NCT00566709|584278634|FG001|Overall Study|Protocol Violation|0|||
161791052|NCT03443869|584278635|FG000|Overall Study|Death|3|||
161791053|NCT03443869|584278636|FG001|Overall Study|Death|3|||
161791054|NCT03443869|584278635|FG000|Overall Study|Withdrawal by Subject|34|||
161791055|NCT03443869|584278636|FG001|Overall Study|Withdrawal by Subject|22|||
161791056|NCT03443869|584278635|FG000|Overall Study|Lost to Follow-up|1|||
161791057|NCT03443869|584278636|FG001|Overall Study|Lost to Follow-up|2|||
161791058|NCT03443869|584278635|FG000|Overall Study|Physician Decision|3|||
161791059|NCT03443869|584278636|FG001|Overall Study|Physician Decision|3|||
161791060|NCT03443869|584278635|FG000|Overall Study|Other|4|||
161898728|NCT02592447|584677891|FG000|Overall Study|Ineligible after randomization|1|||
161791061|NCT03443869|584278636|FG001|Overall Study|Other|4|||
161791062|NCT02390219|584278637|FG000|Overall Study|Death|1|||
161791063|NCT02390219|584278637|FG000|Overall Study|Physician Decision|1|||
161791064|NCT02390219|584278637|FG000|Overall Study|Adverse Event|6|||
161791065|NCT02390219|584278637|FG000|Overall Study|Withdrawal by Subject|1|||
161791066|NCT02390219|584278637|FG000|Overall Study|Lost to Follow-up|2|||
161791067|NCT02390219|584278637|FG000|Overall Study|Other|2|||
161791068|NCT00299728|584278638|FG000|Overall Study|Lost to Follow-up|0|||
161791069|NCT00299728|584278639|FG001|Overall Study|Lost to Follow-up|1|||
161791070|NCT00299728|584278638|FG000|Overall Study|Withdrawal by Subject|0|||
161791071|NCT00299728|584278639|FG001|Overall Study|Withdrawal by Subject|1|||
161791072|NCT00299728|584278638|FG000|Overall Study|Progressive disease|0|||
161791073|NCT00299728|584278639|FG001|Overall Study|Progressive disease|1|||
161791074|NCT01855126|584278642|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
161791075|NCT01855126|584278643|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
161443497|NCT01931566|583017240|FG001|Overall Study|Major Protocol Deviation|14|||
161443498|NCT01931566|583017241|FG002|Overall Study|Major Protocol Deviation|21|||
161443499|NCT01931566|583017239|FG000|Overall Study|Lost to Follow-up|3|||
161443500|NCT01931566|583017240|FG001|Overall Study|Lost to Follow-up|26|||
161443501|NCT01931566|583017241|FG002|Overall Study|Lost to Follow-up|23|||
161443502|NCT01931566|583017239|FG000|Overall Study|Voluntary Withdrawal|78|||
161443503|NCT01931566|583017240|FG001|Overall Study|Voluntary Withdrawal|245|||
161443504|NCT01931566|583017241|FG002|Overall Study|Voluntary Withdrawal|225|||
161443505|NCT01931566|583017239|FG000|Overall Study|Study Termination|289|||
161443506|NCT01931566|583017240|FG001|Overall Study|Study Termination|968|||
161443507|NCT01931566|583017241|FG002|Overall Study|Study Termination|1037|||
161443508|NCT01931566|583017239|FG000|Overall Study|Reason Not Specified|11|||
161443509|NCT01931566|583017240|FG001|Overall Study|Reason Not Specified|47|||
161443510|NCT01931566|583017241|FG002|Overall Study|Reason Not Specified|53|||
161443511|NCT01931566|583017239|FG000|Overall Study|Missing|0|||
161443512|NCT01931566|583017240|FG001|Overall Study|Missing|0|||
161443513|NCT01931566|583017241|FG002|Overall Study|Missing|1|||
161443514|NCT01147874|583017244|FG000|Overall Study|Adverse Event|5|||
161443515|NCT01147874|583017244|FG000|Overall Study|Investigator's Request|1|||
161443516|NCT01147874|583017244|FG000|Overall Study|Lost to Follow-up|25|||
161443517|NCT01147874|583017244|FG000|Overall Study|Other|5|||
161443518|NCT01147874|583017244|FG000|Overall Study|Protocol Violation|5|||
161443519|NCT01147874|583017244|FG000|Overall Study|Sponsor's Decision|2|||
161443520|NCT01147874|583017244|FG000|Overall Study|Withdrawal by Subject|24|||
161443521|NCT02991040|583017247|FG000|Overall Study|Withdrawal by Subject|2|||
161443522|NCT02991040|583017247|FG000|Overall Study|Lost to Follow-up|2|||
161443523|NCT04287517|583017248|FG000|Overall Study|Withdrawal by Subject|1|||
161443524|NCT04287517|583017249|FG001|Overall Study|Withdrawal by Subject|1|||
161443525|NCT01869764|583017256|FG000|Overall Study|Withdrawal by Subject|0|||
161443526|NCT01869764|583017257|FG001|Overall Study|Withdrawal by Subject|2|||
161443527|NCT02175030|583017258|FG000|Overall Study|Failed screen after consent|7|||
161443528|NCT02175030|583017259|FG001|Overall Study|Failed screen after consent|6|||
161443529|NCT02175030|583017258|FG000|Overall Study|Failed IUD Insertion|20|||
161443530|NCT02175030|583017259|FG001|Overall Study|Failed IUD Insertion|21|||
161443531|NCT02175030|583017258|FG000|Overall Study|Physician Decision|1|||
161443532|NCT02175030|583017259|FG001|Overall Study|Physician Decision|1|||
161443533|NCT02175030|583017258|FG000|Overall Study|Lost to Follow-up|6|||
161443534|NCT02175030|583017259|FG001|Overall Study|Lost to Follow-up|6|||
161443535|NCT02175030|583017258|FG000|Overall Study|Withdrawal by Subject|1|||
161443536|NCT02175030|583017259|FG001|Overall Study|Withdrawal by Subject|4|||
161443537|NCT02533453|583017260|FG000|Overall Study|Adverse Event|6|||
161443538|NCT02533453|583017260|FG000|Overall Study|Protocol Violation|1|||
161443539|NCT02533453|583017260|FG000|Overall Study|Withdrawal by Subject|2|||
161443540|NCT01273519|583017265|FG000|Overall Study|Adverse Event|3|||
161443541|NCT01273519|583017266|FG001|Overall Study|Adverse Event|0|||
161443542|NCT01273519|583017267|FG002|Overall Study|Adverse Event|0|||
161791076|NCT01855126|584278642|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161898729|NCT02592447|584677892|FG001|Overall Study|Ineligible after randomization|0|||
161443543|NCT01273519|583017265|FG000|Overall Study|Lost to Follow-up|2|||
161443544|NCT01273519|583017266|FG001|Overall Study|Lost to Follow-up|1|||
161443545|NCT01273519|583017267|FG002|Overall Study|Lost to Follow-up|3|||
161443546|NCT01273519|583017265|FG000|Overall Study|Lack of Efficacy|8|||
161443547|NCT01273519|583017266|FG001|Overall Study|Lack of Efficacy|3|||
161443548|NCT01273519|583017267|FG002|Overall Study|Lack of Efficacy|4|||
161443549|NCT01273519|583017265|FG000|Overall Study|Other|6|||
161443550|NCT01273519|583017266|FG001|Overall Study|Other|1|||
161898730|NCT02592447|584677891|FG000|Overall Study|Withdrawal by Subject|0|||
161443551|NCT01273519|583017267|FG002|Overall Study|Other|1|||
161443552|NCT03695367|583017268|FG000|Overall Study|Missed the Day 28 visit.|1|||
161791077|NCT01855126|584278643|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161443553|NCT03695367|583017269|FG001|Overall Study|Missed the Day 28 visit.|0|||
161443554|NCT03695367|583017268|FG000|Overall Study|Lost to Follow-up|0|||
161443555|NCT03695367|583017269|FG001|Overall Study|Lost to Follow-up|1|||
161443556|NCT03695367|583017268|FG000|Overall Study|Withdrawal by Subject|0|||
161443557|NCT03695367|583017269|FG001|Overall Study|Withdrawal by Subject|1|||
161791078|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
161791079|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791080|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791081|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791082|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791083|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Adverse Event|60|||
161791084|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Adverse Event|0|||
161791085|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Adverse Event|0|||
161791086|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Adverse Event|0|||
161791087|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Adverse Event|0|||
161791088|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
161791089|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791090|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791091|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791092|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791093|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Physician Decision|10|||
161791094|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Physician Decision|0|||
161791095|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Physician Decision|0|||
161791096|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Physician Decision|0|||
161791097|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Physician Decision|0|||
161791098|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
161791099|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791100|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791101|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791102|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791103|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
161791104|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
161791105|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
161791106|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
161791107|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
161791108|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
161791109|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
161791110|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
161791111|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
161791112|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
161791113|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Adverse Event|0|||
161791114|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Adverse Event|3|||
161791115|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Adverse Event|9|||
161791116|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Adverse Event|3|||
161791117|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Adverse Event|0|||
161791118|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161791119|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161791120|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
161791121|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
161791122|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161791123|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Physician Decision|0|||
161791124|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Physician Decision|0|||
161791125|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Physician Decision|0|||
161791126|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Physician Decision|1|||
161791127|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Physician Decision|0|||
161791128|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161791129|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
161791130|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
161791131|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
161791132|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161791133|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
161791134|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
161791135|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
161791136|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
161791137|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
161791138|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791139|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
161791140|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791141|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791142|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791143|NCT01360632|584278644|FG000|Phase A+|Lost to Follow-up|0|||
161791144|NCT01360632|584278645|FG001|Phase A+|Lost to Follow-up|0|||
161791145|NCT01360632|584278646|FG002|Phase A+|Lost to Follow-up|0|||
161791146|NCT01360632|584278647|FG003|Phase A+|Lost to Follow-up|0|||
161791147|NCT01360632|584278648|FG004|Phase A+|Lost to Follow-up|2|||
161791148|NCT01360632|584278644|FG000|Phase A+|Adverse Event|0|||
161791149|NCT01360632|584278645|FG001|Phase A+|Adverse Event|0|||
161898731|NCT02592447|584677892|FG001|Overall Study|Withdrawal by Subject|1|||
161791150|NCT01360632|584278646|FG002|Phase A+|Adverse Event|0|||
161791151|NCT01360632|584278647|FG003|Phase A+|Adverse Event|0|||
161791152|NCT01360632|584278648|FG004|Phase A+|Adverse Event|2|||
161791153|NCT01360632|584278644|FG000|Phase A+|Met Withdrawal Criteria|0|||
161791154|NCT01360632|584278645|FG001|Phase A+|Met Withdrawal Criteria|0|||
161791155|NCT01360632|584278646|FG002|Phase A+|Met Withdrawal Criteria|0|||
161791156|NCT01360632|584278647|FG003|Phase A+|Met Withdrawal Criteria|0|||
161791157|NCT01360632|584278648|FG004|Phase A+|Met Withdrawal Criteria|7|||
161791158|NCT01360632|584278644|FG000|Phase A+|Physician Decision|0|||
161791159|NCT01360632|584278645|FG001|Phase A+|Physician Decision|0|||
161791160|NCT01360632|584278646|FG002|Phase A+|Physician Decision|0|||
161791161|NCT01360632|584278647|FG003|Phase A+|Physician Decision|0|||
161791162|NCT01360632|584278648|FG004|Phase A+|Physician Decision|3|||
161791163|NCT01360632|584278644|FG000|Phase A+|Withdrawal by Subject|0|||
161791164|NCT01360632|584278645|FG001|Phase A+|Withdrawal by Subject|0|||
161791165|NCT01360632|584278646|FG002|Phase A+|Withdrawal by Subject|0|||
161791166|NCT01360632|584278647|FG003|Phase A+|Withdrawal by Subject|0|||
161791167|NCT01360632|584278648|FG004|Phase A+|Withdrawal by Subject|8|||
161791168|NCT01360632|584278644|FG000|Phase A+|Protocol Deviation|0|||
161791169|NCT01360632|584278645|FG001|Phase A+|Protocol Deviation|0|||
161791170|NCT01360632|584278646|FG002|Phase A+|Protocol Deviation|0|||
161791171|NCT01360632|584278647|FG003|Phase A+|Protocol Deviation|0|||
161791172|NCT01360632|584278648|FG004|Phase A+|Protocol Deviation|3|||
161791173|NCT01298596|584278651|FG000|Overall Study|Withdrawal by Subject|1|||
161791174|NCT01298596|584278652|FG001|Overall Study|Withdrawal by Subject|1|||
161791175|NCT01298596|584278651|FG000|Overall Study|Death|5|||
161791176|NCT01298596|584278652|FG001|Overall Study|Death|3|||
161791177|NCT01298596|584278651|FG000|Overall Study|Lost to Follow-up|6|||
161791178|NCT01298596|584278652|FG001|Overall Study|Lost to Follow-up|14|||
161791179|NCT01298596|584278651|FG000|Overall Study|Referred for further management|16|||
161791180|NCT01298596|584278652|FG001|Overall Study|Referred for further management|15|||
161791181|NCT01629693|584278653|FG000|Overall Study|Lost to Follow-up|2|||
161791182|NCT01629693|584278654|FG001|Overall Study|Lost to Follow-up|4|||
161791183|NCT01629693|584278653|FG000|Overall Study|Withdrawal by Subject|2|||
161791184|NCT01629693|584278654|FG001|Overall Study|Withdrawal by Subject|2|||
161791185|NCT01629693|584278653|FG000|Overall Study|Adverse Event|1|||
161791186|NCT01629693|584278654|FG001|Overall Study|Adverse Event|0|||
161791187|NCT01629693|584278653|FG000|Overall Study|Investigator decision|0|||
161791188|NCT01629693|584278654|FG001|Overall Study|Investigator decision|1|||
161791189|NCT01629693|584278653|FG000|Overall Study|Poor comfort of study lenses|0|||
161791190|NCT01629693|584278654|FG001|Overall Study|Poor comfort of study lenses|2|||
161791191|NCT01629693|584278653|FG000|Overall Study|Subject decision unrelated to AE|0|||
161791192|NCT01629693|584278654|FG001|Overall Study|Subject decision unrelated to AE|1|||
161791193|NCT03740100|584278655|FG000|Overall Study|Adverse Event|1|||
161791194|NCT03740100|584278655|FG000|Overall Study|Death|1|||
161791195|NCT03387059|584278661|FG000|Overall Study|Study termination|5|||
161791196|NCT03387059|584278662|FG001|Overall Study|Study termination|4|||
161791197|NCT01606137|584278663|FG000|Overall Study|Adverse Event|85|||
161791198|NCT01606137|584278663|FG000|Overall Study|Withdrawal by Subject|74|||
161791199|NCT01606137|584278663|FG000|Overall Study|Lack of Efficacy|56|||
161791200|NCT01606137|584278663|FG000|Overall Study|Lost to Follow-up|15|||
161791201|NCT01606137|584278663|FG000|Overall Study|Protocol Violation|1|||
161791202|NCT01606137|584278663|FG000|Overall Study|Patient non-compliance|9|||
161791203|NCT01606137|584278663|FG000|Overall Study|Death|1|||
161791204|NCT01606137|584278663|FG000|Overall Study|Decreased/no pain|4|||
161791205|NCT01606137|584278663|FG000|Overall Study|Issues with driving|4|||
161791206|NCT01606137|584278663|FG000|Overall Study|multiple sclerosis less stable|1|||
161791207|NCT01606137|584278663|FG000|Overall Study|Increased bilirubin|1|||
161791208|NCT01606137|584278663|FG000|Overall Study|Spray causes nausea|1|||
161791209|NCT01606137|584278663|FG000|Overall Study|Not enough improvement|4|||
161791210|NCT01606137|584278663|FG000|Overall Study|Wanted to try another treatment|1|||
161791211|NCT01606137|584278663|FG000|Overall Study|Patient leaving country|1|||
161791212|NCT01606137|584278663|FG000|Overall Study|Personal reasons|1|||
161791213|NCT01606137|584278663|FG000|Overall Study|Unable to tolerate study med. taste|1|||
161791214|NCT01606137|584278663|FG000|Overall Study|Patient moving|1|||
161791215|NCT01606137|584278663|FG000|Overall Study|Unable to collect consistent data|1|||
161791216|NCT01715415|584278669|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
161791217|NCT01715415|584278670|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
161791218|NCT01715415|584278669|FG000|Double-blind Treatment|Adverse Event|3|||
161791219|NCT01715415|584278670|FG001|Double-blind Treatment|Adverse Event|0|||
161791220|NCT01715415|584278669|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
161791221|NCT01715415|584278670|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
161791222|NCT01715415|584278669|FG000|Double-blind Treatment|Other|1|||
161791223|NCT01715415|584278670|FG001|Double-blind Treatment|Other|0|||
161791224|NCT01715415|584278669|FG000|Open-label Treatment|Adverse Event|0|||
161791225|NCT01715415|584278670|FG001|Open-label Treatment|Adverse Event|1|||
161791226|NCT01715415|584278669|FG000|Open-label Treatment|Subject Noncompliant|0|||
161791227|NCT01715415|584278670|FG001|Open-label Treatment|Subject Noncompliant|1|||
161791228|NCT04578548|584278671|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161791229|NCT04578548|584278672|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161791230|NCT04578548|584278671|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
161791231|NCT04578548|584278672|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
161791232|NCT04578548|584278671|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
161791233|NCT04578548|584278672|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161791234|NCT04578548|584278671|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
161791235|NCT04578548|584278672|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
161791236|NCT04578548|584278671|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
161791237|NCT04578548|584278672|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161791238|NCT04578548|584278671|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
161791239|NCT04578548|584278672|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
161791240|NCT01241461|584280250|FG000|Overall Study|Progressive Disease|3|||
161791241|NCT01241461|584280251|FG001|Overall Study|Progressive Disease|6|||
161791242|NCT01379781|584280252|FG000|Overall Study|Lost to Follow-up|11|||
161791243|NCT01379781|584280253|FG001|Overall Study|Lost to Follow-up|8|||
161791244|NCT02247479|584280254|FG000|Overall Study|Adverse Event|8|||
161791245|NCT02247479|584280255|FG001|Overall Study|Adverse Event|9|||
161791246|NCT02247479|584280256|FG002|Overall Study|Adverse Event|8|||
161791247|NCT02247479|584280254|FG000|Overall Study|Death|5|||
161791248|NCT02247479|584280255|FG001|Overall Study|Death|4|||
161791249|NCT02247479|584280256|FG002|Overall Study|Death|6|||
161791250|NCT02247479|584280254|FG000|Overall Study|Lost to Follow-up|3|||
161791251|NCT02247479|584280255|FG001|Overall Study|Lost to Follow-up|3|||
161791252|NCT02247479|584280256|FG002|Overall Study|Lost to Follow-up|1|||
161791253|NCT02247479|584280254|FG000|Overall Study|Non-compliance|0|||
161791254|NCT02247479|584280255|FG001|Overall Study|Non-compliance|0|||
161791255|NCT02247479|584280256|FG002|Overall Study|Non-compliance|1|||
161791256|NCT02247479|584280254|FG000|Overall Study|Withdrawal by Subject|25|||
161791257|NCT02247479|584280255|FG001|Overall Study|Withdrawal by Subject|29|||
161791258|NCT02247479|584280256|FG002|Overall Study|Withdrawal by Subject|24|||
161791259|NCT02247479|584280254|FG000|Overall Study|Study Terminated by Sponsor|98|||
161791260|NCT02247479|584280255|FG001|Overall Study|Study Terminated by Sponsor|88|||
161791261|NCT02247479|584280256|FG002|Overall Study|Study Terminated by Sponsor|94|||
161791262|NCT02247479|584280254|FG000|Overall Study|Physician Decision|1|||
161791263|NCT02247479|584280255|FG001|Overall Study|Physician Decision|0|||
161791264|NCT02247479|584280256|FG002|Overall Study|Physician Decision|2|||
161791265|NCT02247479|584280254|FG000|Overall Study|Unspecified Reason|2|||
161791266|NCT02247479|584280255|FG001|Overall Study|Unspecified Reason|5|||
161791267|NCT02247479|584280256|FG002|Overall Study|Unspecified Reason|2|||
161791268|NCT03740698|584280257|FG000|Overall Study|Physician Decision|0|||
161791269|NCT03740698|584280258|FG001|Overall Study|Physician Decision|1|||
161791270|NCT03740698|584280259|FG002|Overall Study|Physician Decision|1|||
161791271|NCT05216978|584280269|FG000|Overall Study|Withdrawal by Subject|3|||
161791272|NCT05216978|584280269|FG000|Overall Study|Lost to Follow-up|5|||
161791273|NCT00658320|584280271|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
161791274|NCT00658320|584280272|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
161791275|NCT00658320|584280271|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
161791276|NCT00658320|584280272|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
161791277|NCT00658320|584280271|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
161791278|NCT00658320|584280272|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
161791279|NCT00658320|584280271|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
161791280|NCT00658320|584280272|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
161791281|NCT02410252|584280280|FG000|Overall Study|Withdrawal by Subject|4|||
161791282|NCT02410252|584280280|FG000|Overall Study|Physician Decision|2|||
161791283|NCT03433001|584280292|FG000|Overall Study|Lack of Efficacy|109|||
161791284|NCT03433001|584280292|FG000|Overall Study|Adverse Event|69|||
161791285|NCT03433001|584280292|FG000|Overall Study|Withdrawal by Subject|10|||
161791286|NCT03433001|584280292|FG000|Overall Study|Death|12|||
161791287|NCT03433001|584280292|FG000|Overall Study|Lost to Follow-up|4|||
161791288|NCT03433001|584280292|FG000|Overall Study|Other|25|||
161791289|NCT01007916|584280296|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
161791290|NCT01007916|584280297|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
161791291|NCT01007916|584280296|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
161791292|NCT01007916|584280297|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
161791293|NCT01299038|584280298|FG000|Overall Study|Withdrawal by Subject|1|||
161791294|NCT01299038|584280299|FG001|Overall Study|Withdrawal by Subject|0|||
161791295|NCT01162499|584280304|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
161791296|NCT01162499|584280305|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
161791297|NCT03347695|584280322|FG000|Overall Study|Death|0|||
161791298|NCT03347695|584280323|FG001|Overall Study|Death|4|||
161791299|NCT03347695|584280322|FG000|Overall Study|Lost to Follow-up|0|||
161791300|NCT03347695|584280323|FG001|Overall Study|Lost to Follow-up|1|||
161791301|NCT04633837|584280326|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
161791302|NCT04633837|584280327|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
161791303|NCT02884206|584280330|FG000|Valsartan Run-in Period|Death|1|||
161791304|NCT02884206|584280331|FG001|Valsartan Run-in Period|Death|0|||
161791305|NCT02884206|584280332|FG002|Valsartan Run-in Period|Death|0|||
161791306|NCT02884206|584280330|FG000|Valsartan Run-in Period|Adverse Event|31|||
161791307|NCT02884206|584280331|FG001|Valsartan Run-in Period|Adverse Event|0|||
161791308|NCT02884206|584280332|FG002|Valsartan Run-in Period|Adverse Event|0|||
161791309|NCT02884206|584280330|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
161791310|NCT02884206|584280331|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
161791311|NCT02884206|584280332|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
161791312|NCT02884206|584280330|FG000|Valsartan Run-in Period|Protocol deviation|4|||
161791313|NCT02884206|584280331|FG001|Valsartan Run-in Period|Protocol deviation|0|||
161791314|NCT02884206|584280332|FG002|Valsartan Run-in Period|Protocol deviation|0|||
161791315|NCT02884206|584280330|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
161791316|NCT02884206|584280331|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
161791317|NCT02884206|584280332|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
161791318|NCT02884206|584280330|FG000|Valsartan Run-in Period|Physician Decision|1|||
161791319|NCT02884206|584280331|FG001|Valsartan Run-in Period|Physician Decision|0|||
161791320|NCT02884206|584280332|FG002|Valsartan Run-in Period|Physician Decision|0|||
161791321|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Adverse Event|38|||
161791322|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Adverse Event|0|||
161791323|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Adverse Event|0|||
161791324|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Death|2|||
161791325|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Death|0|||
161791326|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Death|0|||
161791327|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
161791328|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
161791329|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
161791330|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
161791331|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
161791332|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
161791333|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
161791334|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
161791335|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
161791336|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Physician Decision|1|||
161791337|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Physician Decision|0|||
161791338|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Physician Decision|0|||
161791339|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
161791340|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
161791341|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
161791342|NCT02884206|584280330|FG000|Double-Blind Period|Death|0|||
161791343|NCT02884206|584280331|FG001|Double-Blind Period|Death|28|||
161791344|NCT02884206|584280332|FG002|Double-Blind Period|Death|39|||
161791345|NCT02884206|584280330|FG000|Double-Blind Period|Patient/guardian decision|0|||
161791346|NCT02884206|584280331|FG001|Double-Blind Period|Patient/guardian decision|10|||
161791347|NCT02884206|584280332|FG002|Double-Blind Period|Patient/guardian decision|13|||
161791348|NCT02884206|584280330|FG000|Double-Blind Period|Lost to Follow-up|0|||
161791349|NCT02884206|584280331|FG001|Double-Blind Period|Lost to Follow-up|4|||
161791350|NCT02884206|584280332|FG002|Double-Blind Period|Lost to Follow-up|4|||
161791351|NCT02884206|584280330|FG000|Double-Blind Period|Physician Decision|0|||
161791352|NCT02884206|584280331|FG001|Double-Blind Period|Physician Decision|2|||
161791353|NCT02884206|584280332|FG002|Double-Blind Period|Physician Decision|0|||
161791354|NCT02884206|584280330|FG000|Double-Blind Period|Adverse Event|0|||
161791355|NCT02884206|584280331|FG001|Double-Blind Period|Adverse Event|0|||
161791356|NCT02884206|584280332|FG002|Double-Blind Period|Adverse Event|3|||
161791357|NCT02884206|584280330|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
161791358|NCT02884206|584280331|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
161791359|NCT02884206|584280332|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
161791360|NCT04467697|584280333|FG000|Overall Study|Adverse Event|2|||
161791361|NCT04467697|584280333|FG000|Overall Study|Lost to Follow-up|6|||
161791362|NCT04467697|584280333|FG000|Overall Study|Withdrawal by Subject|9|||
161791363|NCT04467697|584280333|FG000|Overall Study|Protocol Violation|3|||
161791364|NCT03907280|584280334|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
161791365|NCT03907280|584280335|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
161791366|NCT03907280|584280336|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
161791367|NCT03487796|584280340|FG000|Overall Study|Lost to Follow-up|18|||
161791368|NCT03487796|584280341|FG001|Overall Study|Lost to Follow-up|6|||
161791369|NCT00613574|584280342|FG000|Overall Study|Adverse Event|3|||
161791370|NCT00613574|584280342|FG000|Overall Study|Lost to Follow-up|2|||
161791371|NCT00613574|584280342|FG000|Overall Study|Other|1|||
161791372|NCT00582036|584280345|FG000|Overall Study|Withdrawal by Subject|0|||
161791373|NCT00582036|584280346|FG001|Overall Study|Withdrawal by Subject|1|||
161791374|NCT02711956|584280347|FG000|Overall Study|Adverse Event|0|||
161791375|NCT02711956|584280348|FG001|Overall Study|Adverse Event|0|||
161791376|NCT02711956|584280349|FG002|Overall Study|Adverse Event|0|||
161791377|NCT02711956|584280350|FG003|Overall Study|Adverse Event|1|||
161791378|NCT02711956|584280351|FG004|Overall Study|Adverse Event|2|||
161791379|NCT02711956|584280352|FG005|Overall Study|Adverse Event|0|||
161791380|NCT02711956|584280353|FG006|Overall Study|Adverse Event|0|||
161791381|NCT02711956|584280354|FG007|Overall Study|Adverse Event|1|||
161791382|NCT02711956|584280355|FG008|Overall Study|Adverse Event|1|||
161791383|NCT02711956|584280356|FG009|Overall Study|Adverse Event|1|||
161791384|NCT02711956|584280357|FG010|Overall Study|Adverse Event|1|||
161791385|NCT02711956|584280358|FG011|Overall Study|Adverse Event|0|||
161791386|NCT02711956|584280359|FG012|Overall Study|Adverse Event|0|||
161791387|NCT02711956|584280360|FG013|Overall Study|Adverse Event|0|||
161791388|NCT02711956|584280361|FG014|Overall Study|Adverse Event|2|||
161791389|NCT02711956|584280347|FG000|Overall Study|Physician Decision|0|||
161791390|NCT02711956|584280348|FG001|Overall Study|Physician Decision|0|||
161791391|NCT02711956|584280349|FG002|Overall Study|Physician Decision|0|||
161791392|NCT02711956|584280350|FG003|Overall Study|Physician Decision|2|||
161791393|NCT02711956|584280351|FG004|Overall Study|Physician Decision|0|||
161791394|NCT02711956|584280352|FG005|Overall Study|Physician Decision|0|||
161791395|NCT02711956|584280353|FG006|Overall Study|Physician Decision|0|||
161791396|NCT02711956|584280354|FG007|Overall Study|Physician Decision|0|||
161791397|NCT02711956|584280355|FG008|Overall Study|Physician Decision|0|||
161791398|NCT02711956|584280356|FG009|Overall Study|Physician Decision|0|||
161791399|NCT02711956|584280357|FG010|Overall Study|Physician Decision|0|||
161791400|NCT02711956|584280358|FG011|Overall Study|Physician Decision|0|||
161791401|NCT02711956|584280359|FG012|Overall Study|Physician Decision|0|||
161791402|NCT02711956|584280360|FG013|Overall Study|Physician Decision|0|||
161791403|NCT02711956|584280361|FG014|Overall Study|Physician Decision|0|||
161791404|NCT02711956|584280347|FG000|Overall Study|Withdrawal by Subject|0|||
161791405|NCT02711956|584280348|FG001|Overall Study|Withdrawal by Subject|0|||
161791406|NCT02711956|584280349|FG002|Overall Study|Withdrawal by Subject|0|||
161791407|NCT02711956|584280350|FG003|Overall Study|Withdrawal by Subject|0|||
161791408|NCT02711956|584280351|FG004|Overall Study|Withdrawal by Subject|0|||
161791409|NCT02711956|584280352|FG005|Overall Study|Withdrawal by Subject|0|||
161791410|NCT02711956|584280353|FG006|Overall Study|Withdrawal by Subject|1|||
161791411|NCT02711956|584280354|FG007|Overall Study|Withdrawal by Subject|0|||
161791412|NCT02711956|584280355|FG008|Overall Study|Withdrawal by Subject|0|||
161791413|NCT02711956|584280356|FG009|Overall Study|Withdrawal by Subject|0|||
161791414|NCT02711956|584280357|FG010|Overall Study|Withdrawal by Subject|0|||
161791415|NCT02711956|584280358|FG011|Overall Study|Withdrawal by Subject|1|||
161791416|NCT02711956|584280359|FG012|Overall Study|Withdrawal by Subject|6|||
161791417|NCT02711956|584280360|FG013|Overall Study|Withdrawal by Subject|0|||
161791418|NCT02711956|584280361|FG014|Overall Study|Withdrawal by Subject|1|||
161791419|NCT02711956|584280347|FG000|Overall Study|Clinical progression|1|||
161791420|NCT02711956|584280348|FG001|Overall Study|Clinical progression|0|||
161791421|NCT02711956|584280349|FG002|Overall Study|Clinical progression|0|||
161791422|NCT02711956|584280350|FG003|Overall Study|Clinical progression|0|||
161791423|NCT02711956|584280351|FG004|Overall Study|Clinical progression|0|||
161791424|NCT02711956|584280352|FG005|Overall Study|Clinical progression|0|||
161791425|NCT02711956|584280353|FG006|Overall Study|Clinical progression|1|||
161791426|NCT02711956|584280354|FG007|Overall Study|Clinical progression|0|||
161791427|NCT02711956|584280355|FG008|Overall Study|Clinical progression|1|||
161791428|NCT02711956|584280356|FG009|Overall Study|Clinical progression|0|||
161791429|NCT02711956|584280357|FG010|Overall Study|Clinical progression|0|||
161791430|NCT02711956|584280358|FG011|Overall Study|Clinical progression|2|||
161791431|NCT02711956|584280359|FG012|Overall Study|Clinical progression|4|||
161791432|NCT02711956|584280360|FG013|Overall Study|Clinical progression|1|||
161791433|NCT02711956|584280361|FG014|Overall Study|Clinical progression|1|||
161791434|NCT02711956|584280347|FG000|Overall Study|Radiographic progression|1|||
161791435|NCT02711956|584280348|FG001|Overall Study|Radiographic progression|1|||
161791436|NCT02711956|584280349|FG002|Overall Study|Radiographic progression|2|||
161791437|NCT02711956|584280350|FG003|Overall Study|Radiographic progression|0|||
161898732|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
161898733|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161791438|NCT02711956|584280351|FG004|Overall Study|Radiographic progression|1|||
161791439|NCT02711956|584280352|FG005|Overall Study|Radiographic progression|0|||
161791440|NCT02711956|584280353|FG006|Overall Study|Radiographic progression|0|||
161791441|NCT02711956|584280354|FG007|Overall Study|Radiographic progression|0|||
161791442|NCT02711956|584280355|FG008|Overall Study|Radiographic progression|2|||
161898734|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
161898735|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
161791443|NCT02711956|584280356|FG009|Overall Study|Radiographic progression|1|||
161791444|NCT02711956|584280357|FG010|Overall Study|Radiographic progression|0|||
161791445|NCT02711956|584280358|FG011|Overall Study|Radiographic progression|5|||
161791446|NCT02711956|584280359|FG012|Overall Study|Radiographic progression|3|||
161791447|NCT02711956|584280360|FG013|Overall Study|Radiographic progression|0|||
161791448|NCT02711956|584280361|FG014|Overall Study|Radiographic progression|1|||
161443558|NCT03695367|583017268|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
161791449|NCT02711956|584280347|FG000|Overall Study|PSA progression with clinical progression|0|||
161791450|NCT02711956|584280348|FG001|Overall Study|PSA progression with clinical progression|0|||
161791451|NCT02711956|584280349|FG002|Overall Study|PSA progression with clinical progression|0|||
161791452|NCT02711956|584280350|FG003|Overall Study|PSA progression with clinical progression|0|||
161791453|NCT02711956|584280351|FG004|Overall Study|PSA progression with clinical progression|1|||
161791454|NCT02711956|584280352|FG005|Overall Study|PSA progression with clinical progression|0|||
161791455|NCT02711956|584280353|FG006|Overall Study|PSA progression with clinical progression|0|||
161791456|NCT02711956|584280354|FG007|Overall Study|PSA progression with clinical progression|0|||
161791457|NCT02711956|584280355|FG008|Overall Study|PSA progression with clinical progression|0|||
161791458|NCT02711956|584280356|FG009|Overall Study|PSA progression with clinical progression|0|||
161791459|NCT02711956|584280357|FG010|Overall Study|PSA progression with clinical progression|0|||
161791460|NCT02711956|584280358|FG011|Overall Study|PSA progression with clinical progression|0|||
161791461|NCT02711956|584280359|FG012|Overall Study|PSA progression with clinical progression|1|||
161791462|NCT02711956|584280360|FG013|Overall Study|PSA progression with clinical progression|1|||
161791463|NCT02711956|584280361|FG014|Overall Study|PSA progression with clinical progression|0|||
161791464|NCT02711956|584280347|FG000|Overall Study|PSA progression with radiographic progression|0|||
161791465|NCT02711956|584280348|FG001|Overall Study|PSA progression with radiographic progression|1|||
161791466|NCT02711956|584280349|FG002|Overall Study|PSA progression with radiographic progression|0|||
161791467|NCT02711956|584280350|FG003|Overall Study|PSA progression with radiographic progression|0|||
161791468|NCT02711956|584280351|FG004|Overall Study|PSA progression with radiographic progression|0|||
161791469|NCT02711956|584280352|FG005|Overall Study|PSA progression with radiographic progression|2|||
161791470|NCT02711956|584280353|FG006|Overall Study|PSA progression with radiographic progression|2|||
161791471|NCT02711956|584280354|FG007|Overall Study|PSA progression with radiographic progression|1|||
161791472|NCT02711956|584280355|FG008|Overall Study|PSA progression with radiographic progression|0|||
161791473|NCT02711956|584280356|FG009|Overall Study|PSA progression with radiographic progression|1|||
161791474|NCT02711956|584280357|FG010|Overall Study|PSA progression with radiographic progression|0|||
161791475|NCT02711956|584280358|FG011|Overall Study|PSA progression with radiographic progression|1|||
161791476|NCT02711956|584280359|FG012|Overall Study|PSA progression with radiographic progression|2|||
161791477|NCT02711956|584280360|FG013|Overall Study|PSA progression with radiographic progression|3|||
161791478|NCT02711956|584280361|FG014|Overall Study|PSA progression with radiographic progression|3|||
161791479|NCT05487456|584280362|FG000|Overall Study|Withdrawal by Subject|0|||
161791480|NCT05487456|584280363|FG001|Overall Study|Withdrawal by Subject|0|||
161791481|NCT05487456|584280364|FG002|Overall Study|Withdrawal by Subject|1|||
161791482|NCT05487456|584280365|FG003|Overall Study|Withdrawal by Subject|0|||
161791483|NCT03294538|584280370|FG000|Overall Study|Adverse Event|0|||
161791484|NCT03294538|584280371|FG001|Overall Study|Adverse Event|1|||
161791485|NCT03294538|584280372|FG002|Overall Study|Adverse Event|1|||
161791486|NCT03294538|584280370|FG000|Overall Study|Lost to Follow-up|1|||
161791487|NCT03294538|584280371|FG001|Overall Study|Lost to Follow-up|0|||
161791488|NCT03294538|584280372|FG002|Overall Study|Lost to Follow-up|0|||
161791489|NCT03294538|584280370|FG000|Overall Study|Outside of Visit Window|4|||
161791490|NCT03294538|584280371|FG001|Overall Study|Outside of Visit Window|4|||
161791491|NCT03294538|584280372|FG002|Overall Study|Outside of Visit Window|1|||
161791492|NCT01090765|584280374|FG000|Overall Study|Patient withdrew consent|0|||
161791493|NCT01090765|584280375|FG001|Overall Study|Patient withdrew consent|0|||
161791494|NCT01090765|584280376|FG002|Overall Study|Patient withdrew consent|0|||
161791495|NCT01090765|584280377|FG003|Overall Study|Patient withdrew consent|0|||
161791496|NCT01090765|584280378|FG004|Overall Study|Patient withdrew consent|1|||
161791497|NCT01090765|584280379|FG005|Overall Study|Patient withdrew consent|1|||
161791498|NCT01090765|584280374|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791499|NCT01090765|584280375|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791500|NCT01090765|584280376|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791501|NCT01090765|584280377|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
161791502|NCT01090765|584280378|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791503|NCT01090765|584280379|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791504|NCT01090765|584280374|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
161791505|NCT01090765|584280375|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
161791506|NCT01090765|584280376|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
161791507|NCT01090765|584280377|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
161791508|NCT01090765|584280378|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
161791509|NCT01090765|584280379|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
161791510|NCT01787825|584280380|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
161791511|NCT01787825|584280381|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
161791512|NCT01787825|584280380|FG000|Overall Study|Data Not Analyzable|5|||
161791513|NCT01787825|584280381|FG001|Overall Study|Data Not Analyzable|1|||
161791514|NCT00718159|584280386|FG000|Overall Study|Progressive Disease|3|||
161791515|NCT00718159|584280387|FG001|Overall Study|Progressive Disease|3|||
161791516|NCT00718159|584280388|FG002|Overall Study|Progressive Disease|2|||
161791517|NCT00718159|584280389|FG003|Overall Study|Progressive Disease|0|||
161791518|NCT00718159|584280390|FG004|Overall Study|Progressive Disease|6|||
161791519|NCT00718159|584280391|FG005|Overall Study|Progressive Disease|0|||
161791520|NCT00718159|584280392|FG006|Overall Study|Progressive Disease|0|||
161791521|NCT00718159|584280386|FG000|Overall Study|Death due to Adverse Event|0|||
161791522|NCT00718159|584280387|FG001|Overall Study|Death due to Adverse Event|0|||
161791523|NCT00718159|584280388|FG002|Overall Study|Death due to Adverse Event|0|||
161791524|NCT00718159|584280389|FG003|Overall Study|Death due to Adverse Event|2|||
161791525|NCT00718159|584280390|FG004|Overall Study|Death due to Adverse Event|2|||
161791526|NCT00718159|584280391|FG005|Overall Study|Death due to Adverse Event|0|||
161791527|NCT00718159|584280392|FG006|Overall Study|Death due to Adverse Event|0|||
161791528|NCT00718159|584280386|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
161791529|NCT00718159|584280387|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
161791530|NCT00718159|584280388|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
161791531|NCT00718159|584280389|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
161791532|NCT00718159|584280390|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
161791533|NCT00718159|584280391|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
161791534|NCT00718159|584280392|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
161791535|NCT00718159|584280386|FG000|Overall Study|Investigator Decision|0|||
161791536|NCT00718159|584280387|FG001|Overall Study|Investigator Decision|0|||
161791537|NCT00718159|584280388|FG002|Overall Study|Investigator Decision|0|||
161791538|NCT00718159|584280389|FG003|Overall Study|Investigator Decision|0|||
161791539|NCT00718159|584280390|FG004|Overall Study|Investigator Decision|0|||
161791540|NCT00718159|584280391|FG005|Overall Study|Investigator Decision|1|||
161791541|NCT00718159|584280392|FG006|Overall Study|Investigator Decision|1|||
161791542|NCT01238848|584280394|FG000|Overall Study|Physician Decision|13|||
161791543|NCT01238848|584280395|FG001|Overall Study|Physician Decision|5|||
161791544|NCT03412019|584280396|FG000|Overall Study|Withdrawal by Subject|1|||
161791545|NCT03412019|584280397|FG001|Overall Study|Withdrawal by Subject|1|||
161791546|NCT00415532|584280398|FG000|Treatment Period|Adverse Event|2|||
161791547|NCT00415532|584280399|FG001|Treatment Period|Adverse Event|3|||
161791548|NCT00415532|584280398|FG000|Treatment Period|Death|2|||
161791549|NCT00415532|584280399|FG001|Treatment Period|Death|1|||
161791550|NCT00415532|584280398|FG000|Treatment Period|Lost to Follow-up|1|||
161791551|NCT00415532|584280399|FG001|Treatment Period|Lost to Follow-up|1|||
161791552|NCT00415532|584280398|FG000|Treatment Period|Protocol Violation|1|||
161791553|NCT00415532|584280399|FG001|Treatment Period|Protocol Violation|0|||
161791554|NCT00415532|584280398|FG000|Treatment Period|Withdrawal by Subject|6|||
161791555|NCT00415532|584280399|FG001|Treatment Period|Withdrawal by Subject|6|||
161791556|NCT00415532|584280398|FG000|Treatment Period|Other|2|||
161791557|NCT00415532|584280399|FG001|Treatment Period|Other|2|||
161791558|NCT00415532|584280398|FG000|Treatment Period|Ineligibility determined|1|||
161791559|NCT00415532|584280399|FG001|Treatment Period|Ineligibility determined|1|||
161791560|NCT00415532|584280398|FG000|Treatment Period|Noncompliance|1|||
161791561|NCT00415532|584280399|FG001|Treatment Period|Noncompliance|1|||
161791562|NCT00415532|584280398|FG000|Treatment Period|Requirement for alternative therapy|1|||
161791563|NCT00415532|584280399|FG001|Treatment Period|Requirement for alternative therapy|0|||
161791564|NCT00415532|584280398|FG000|Safety Follow Up Period|Adverse Event|1|||
161791565|NCT00415532|584280399|FG001|Safety Follow Up Period|Adverse Event|3|||
161791566|NCT00415532|584280398|FG000|Safety Follow Up Period|Death|3|||
161791567|NCT00415532|584280399|FG001|Safety Follow Up Period|Death|0|||
161791568|NCT00415532|584280398|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
161791569|NCT00415532|584280399|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
161791570|NCT00415532|584280398|FG000|Safety Follow Up Period|Other|1|||
161791571|NCT00415532|584280399|FG001|Safety Follow Up Period|Other|4|||
161791572|NCT00415532|584280398|FG000|Safety Follow Up Period|Ineligibility determined|1|||
161791573|NCT00415532|584280399|FG001|Safety Follow Up Period|Ineligibility determined|1|||
161791574|NCT00415532|584280398|FG000|Safety Follow Up Period|Noncompliance|1|||
161791575|NCT00415532|584280399|FG001|Safety Follow Up Period|Noncompliance|0|||
161791576|NCT00415532|584280398|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
161791577|NCT00415532|584280399|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
161791578|NCT01952574|584280400|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
161791579|NCT01952574|584280401|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
161791580|NCT01952574|584280402|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
161791581|NCT01952574|584280403|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
161791582|NCT01952574|584280404|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161791583|NCT01952574|584280405|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161791584|NCT01952574|584280406|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161791585|NCT01952574|584280400|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
161791586|NCT01952574|584280401|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
161791587|NCT01952574|584280402|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
161898736|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898737|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161791588|NCT01952574|584280403|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
161791589|NCT01952574|584280404|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
161791590|NCT01952574|584280405|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
161791591|NCT01952574|584280406|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
161791592|NCT01952574|584280400|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
161791593|NCT01952574|584280401|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791594|NCT01952574|584280402|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
161791595|NCT01952574|584280403|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
161898738|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898739|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898740|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898741|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898742|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898743|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898744|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898745|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898746|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898747|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898748|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898749|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898750|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898751|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
161898752|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
161898753|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
161898754|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
161898755|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898756|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898757|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898758|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898759|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898760|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898761|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898762|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898763|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898764|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898765|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898766|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898767|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898768|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898769|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898770|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898771|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
161898772|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
161898773|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898774|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898775|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898776|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898777|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898778|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898779|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898780|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898781|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898782|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898783|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898784|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898785|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898786|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898787|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898788|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898789|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
161898790|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898791|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898792|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161791596|NCT01952574|584280404|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791597|NCT01952574|584280405|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791598|NCT01952574|584280406|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791599|NCT01952574|584280400|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791600|NCT01952574|584280401|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791601|NCT01952574|584280402|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791602|NCT01952574|584280403|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791603|NCT01952574|584280404|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
161791604|NCT01952574|584280405|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791605|NCT01952574|584280406|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791606|NCT01952574|584280400|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
161791607|NCT01952574|584280401|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
161791608|NCT01952574|584280402|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
161791609|NCT01952574|584280403|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
161791610|NCT01952574|584280404|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
161791611|NCT01952574|584280405|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
161791612|NCT01952574|584280406|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
161791613|NCT01952574|584280400|FG000|Open-label Treatment Phase|Missing|0|||
161791614|NCT01952574|584280401|FG001|Open-label Treatment Phase|Missing|0|||
161791615|NCT01952574|584280402|FG002|Open-label Treatment Phase|Missing|0|||
161791616|NCT01952574|584280403|FG003|Open-label Treatment Phase|Missing|0|||
161791617|NCT01952574|584280404|FG004|Open-label Treatment Phase|Missing|4|||
161791618|NCT01952574|584280405|FG005|Open-label Treatment Phase|Missing|0|||
161791619|NCT01952574|584280406|FG006|Open-label Treatment Phase|Missing|0|||
161791620|NCT01952574|584280400|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161791621|NCT01952574|584280401|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161791622|NCT01952574|584280402|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
161791623|NCT01952574|584280403|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
161791624|NCT01952574|584280404|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
161791625|NCT01952574|584280405|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
161791626|NCT01952574|584280406|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
161791627|NCT01952574|584280400|FG000|Open-label Treatment Phase|Death|0|||
161791628|NCT01952574|584280401|FG001|Open-label Treatment Phase|Death|0|||
161791629|NCT01952574|584280402|FG002|Open-label Treatment Phase|Death|0|||
161791630|NCT01952574|584280403|FG003|Open-label Treatment Phase|Death|0|||
161791631|NCT01952574|584280404|FG004|Open-label Treatment Phase|Death|1|||
161791632|NCT01952574|584280405|FG005|Open-label Treatment Phase|Death|0|||
161791633|NCT01952574|584280406|FG006|Open-label Treatment Phase|Death|0|||
161791634|NCT01952574|584280400|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791635|NCT01952574|584280401|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791636|NCT01952574|584280402|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791637|NCT01952574|584280403|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791638|NCT01952574|584280404|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791639|NCT01952574|584280405|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
161791640|NCT01952574|584280406|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791641|NCT01952574|584280400|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791642|NCT01952574|584280401|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791643|NCT01952574|584280402|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791644|NCT01952574|584280403|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791645|NCT01952574|584280404|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791646|NCT01952574|584280405|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
161791647|NCT01952574|584280406|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
161791648|NCT01821625|584280414|FG000|Overall Study|Withdrawal by Subject|2|||
161791649|NCT01821625|584280414|FG000|Overall Study|Lack of Efficacy|2|||
161791650|NCT01821625|584280414|FG000|Overall Study|Adverse Event|1|||
161791651|NCT01821625|584280414|FG000|Overall Study|Medical contraindication|1|||
161791652|NCT01620489|584280416|FG000|Overall Study|Adverse Event|17|||
161791653|NCT01620489|584280417|FG001|Overall Study|Adverse Event|4|||
161791654|NCT01620489|584280416|FG000|Overall Study|Protocol Violation|0|||
161791655|NCT01620489|584280417|FG001|Overall Study|Protocol Violation|3|||
161791656|NCT01620489|584280416|FG000|Overall Study|Withdrawal Criteria|17|||
161791657|NCT01620489|584280417|FG001|Overall Study|Withdrawal Criteria|25|||
161791658|NCT01620489|584280416|FG000|Overall Study|Unclassified|1|||
161791659|NCT01620489|584280417|FG001|Overall Study|Unclassified|2|||
161791660|NCT00871169|584280418|FG000|Overall Study|Protocol Violation|1|||
161791661|NCT00871169|584280418|FG000|Overall Study|Patient did not receive study treatment|2|||
161791662|NCT00593333|584280419|FG000|Overall Study|Lost to Follow-up|10|||
161791663|NCT00593333|584280420|FG001|Overall Study|Lost to Follow-up|11|||
161791664|NCT01328054|584280421|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
161791665|NCT01328054|584280422|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
161791666|NCT01328054|584280421|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
161791667|NCT01328054|584280422|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
161791668|NCT01328054|584280421|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
161791669|NCT01328054|584280422|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
161791670|NCT01829295|584280423|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
161791671|NCT01829295|584280424|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
161791672|NCT01829295|584280425|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
161791673|NCT01829295|584280426|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
161791674|NCT01829295|584280423|FG000|6-12 Months|Adverse Event|0|||
161791675|NCT01829295|584280424|FG001|6-12 Months|Adverse Event|0|||
161791676|NCT01829295|584280425|FG002|6-12 Months|Adverse Event|3|||
161791677|NCT01829295|584280426|FG003|6-12 Months|Adverse Event|2|||
161791678|NCT01829295|584280423|FG000|6-12 Months|Lost to Follow-up|2|||
161791679|NCT01829295|584280424|FG001|6-12 Months|Lost to Follow-up|0|||
161791680|NCT01829295|584280425|FG002|6-12 Months|Lost to Follow-up|0|||
161791681|NCT01829295|584280426|FG003|6-12 Months|Lost to Follow-up|0|||
161791682|NCT01829295|584280423|FG000|6-12 Months|Withdrawal by Subject|2|||
161791683|NCT01829295|584280424|FG001|6-12 Months|Withdrawal by Subject|2|||
161791684|NCT01829295|584280425|FG002|6-12 Months|Withdrawal by Subject|0|||
161791685|NCT01829295|584280426|FG003|6-12 Months|Withdrawal by Subject|0|||
161791686|NCT02629965|584280429|FG000|Period 1|Adverse Event|1|||
161791687|NCT02629965|584280430|FG001|Period 1|Adverse Event|0|||
161791688|NCT02629965|584280429|FG000|Period 1|Unexpected worsening of disease|2|||
161791689|NCT02629965|584280430|FG001|Period 1|Unexpected worsening of disease|0|||
161791690|NCT02629965|584280429|FG000|Period 1|Other than listed above|1|||
161791691|NCT02629965|584280430|FG001|Period 1|Other than listed above|2|||
161791692|NCT02629965|584280429|FG000|Period 2|Adverse Event|1|||
161791693|NCT02629965|584280430|FG001|Period 2|Adverse Event|0|||
161791694|NCT00254397|584280432|FG000|Overall Study|Disease Progression|4|||
161791695|NCT00254397|584280433|FG001|Overall Study|Disease Progression|1|||
161791696|NCT00254397|584280434|FG002|Overall Study|Disease Progression|16|||
161791697|NCT00254397|584280435|FG003|Overall Study|Disease Progression|23|||
161791698|NCT00254397|584280432|FG000|Overall Study|Non-Compliant|0|||
161791699|NCT00254397|584280433|FG001|Overall Study|Non-Compliant|0|||
161791700|NCT00254397|584280434|FG002|Overall Study|Non-Compliant|0|||
161791701|NCT00254397|584280435|FG003|Overall Study|Non-Compliant|1|||
161791702|NCT00254397|584280432|FG000|Overall Study|Adverse Event|2|||
161898793|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898794|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898795|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898796|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898797|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898798|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898799|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898800|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898801|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898802|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898803|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898804|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898805|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898806|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898807|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898808|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898809|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
161898810|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898811|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898812|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898813|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898814|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898815|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898816|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898817|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898818|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898819|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898820|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161791703|NCT00254397|584280433|FG001|Overall Study|Adverse Event|0|||
161791704|NCT00254397|584280434|FG002|Overall Study|Adverse Event|3|||
161791705|NCT00254397|584280435|FG003|Overall Study|Adverse Event|1|||
161791706|NCT05028751|584280443|FG000|Overall Study|Study Terminated by Sponsor|3|||
161898821|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161791707|NCT05028751|584280444|FG001|Overall Study|Study Terminated by Sponsor|0|||
161791708|NCT05028751|584280445|FG002|Overall Study|Study Terminated by Sponsor|0|||
161791709|NCT05028751|584280446|FG003|Overall Study|Study Terminated by Sponsor|0|||
161791710|NCT05028751|584280443|FG000|Overall Study|Death|9|||
161791711|NCT05028751|584280444|FG001|Overall Study|Death|3|||
161791712|NCT05028751|584280445|FG002|Overall Study|Death|2|||
161791713|NCT05028751|584280446|FG003|Overall Study|Death|4|||
161791714|NCT05028751|584280443|FG000|Overall Study|Withdrawal by Subject|0|||
161791715|NCT05028751|584280444|FG001|Overall Study|Withdrawal by Subject|0|||
161791716|NCT05028751|584280445|FG002|Overall Study|Withdrawal by Subject|1|||
161791717|NCT05028751|584280446|FG003|Overall Study|Withdrawal by Subject|0|||
161791718|NCT05028751|584280443|FG000|Overall Study|Miscellaneous|2|||
161791719|NCT05028751|584280444|FG001|Overall Study|Miscellaneous|0|||
161791720|NCT05028751|584280445|FG002|Overall Study|Miscellaneous|0|||
161791721|NCT05028751|584280446|FG003|Overall Study|Miscellaneous|0|||
161791722|NCT03586830|584280448|FG000|Overall Study|Site terminated by Sponsor|1|||
161791723|NCT03586830|584280449|FG001|Overall Study|Site terminated by Sponsor|4|||
161791724|NCT03586830|584280450|FG002|Overall Study|Site terminated by Sponsor|3|||
161791725|NCT03586830|584280451|FG003|Overall Study|Site terminated by Sponsor|3|||
161791726|NCT03586830|584280448|FG000|Overall Study|Lost to Follow-up|0|||
161791727|NCT03586830|584280449|FG001|Overall Study|Lost to Follow-up|2|||
161791728|NCT03586830|584280450|FG002|Overall Study|Lost to Follow-up|2|||
161791729|NCT03586830|584280451|FG003|Overall Study|Lost to Follow-up|1|||
161791730|NCT03586830|584280448|FG000|Overall Study|Withdrawal by Subject|1|||
161791731|NCT03586830|584280449|FG001|Overall Study|Withdrawal by Subject|0|||
161791732|NCT03586830|584280450|FG002|Overall Study|Withdrawal by Subject|3|||
161791733|NCT03586830|584280451|FG003|Overall Study|Withdrawal by Subject|1|||
161791734|NCT00395083|584280452|FG000|Overall Study|Withdrawal by Subject|6|||
161791735|NCT00395083|584280453|FG001|Overall Study|Withdrawal by Subject|5|||
161791736|NCT00395083|584280452|FG000|Overall Study|Developed another disease|4|||
161791737|NCT00395083|584280453|FG001|Overall Study|Developed another disease|3|||
161791738|NCT00628745|584280458|FG000|Overall Study|Withdrawal by Subject|63|||
161791739|NCT00628745|584280459|FG001|Overall Study|Withdrawal by Subject|3|||
161791740|NCT00628745|584280460|FG002|Overall Study|Withdrawal by Subject|9|||
161791741|NCT00628745|584280461|FG003|Overall Study|Withdrawal by Subject|2|||
161791742|NCT00628745|584280462|FG004|Overall Study|Withdrawal by Subject|69|||
161791743|NCT00628745|584280458|FG000|Overall Study|Does not meet inclusion criteria|0|||
161791744|NCT00628745|584280459|FG001|Overall Study|Does not meet inclusion criteria|12|||
161791745|NCT00628745|584280460|FG002|Overall Study|Does not meet inclusion criteria|0|||
161791746|NCT00628745|584280461|FG003|Overall Study|Does not meet inclusion criteria|0|||
161791747|NCT00628745|584280462|FG004|Overall Study|Does not meet inclusion criteria|18|||
161791748|NCT00628745|584280458|FG000|Overall Study|Participation in an interventional clinical trial|81|||
161791749|NCT00628745|584280459|FG001|Overall Study|Participation in an interventional clinical trial|4|||
161791750|NCT00628745|584280460|FG002|Overall Study|Participation in an interventional clinical trial|7|||
161791751|NCT00628745|584280461|FG003|Overall Study|Participation in an interventional clinical trial|0|||
161791752|NCT00628745|584280462|FG004|Overall Study|Participation in an interventional clinical trial|63|||
161791753|NCT00628745|584280458|FG000|Overall Study|Physician Decision|8|||
161791754|NCT00628745|584280459|FG001|Overall Study|Physician Decision|4|||
161791755|NCT00628745|584280460|FG002|Overall Study|Physician Decision|3|||
161791756|NCT00628745|584280461|FG003|Overall Study|Physician Decision|0|||
161791757|NCT00628745|584280462|FG004|Overall Study|Physician Decision|30|||
161791758|NCT00628745|584280458|FG000|Overall Study|Lost to Follow-up|109|||
161791759|NCT00628745|584280459|FG001|Overall Study|Lost to Follow-up|7|||
161791760|NCT00628745|584280460|FG002|Overall Study|Lost to Follow-up|7|||
161791761|NCT00628745|584280461|FG003|Overall Study|Lost to Follow-up|0|||
161791762|NCT00628745|584280462|FG004|Overall Study|Lost to Follow-up|498|||
161791763|NCT00628745|584280458|FG000|Overall Study|Death|197|||
161791764|NCT00628745|584280459|FG001|Overall Study|Death|81|||
161791765|NCT00628745|584280460|FG002|Overall Study|Death|12|||
161791766|NCT00628745|584280461|FG003|Overall Study|Death|4|||
161791767|NCT00628745|584280462|FG004|Overall Study|Death|939|||
161791768|NCT00628745|584280458|FG000|Overall Study|Participant transferred to another THAOS site|6|||
161791769|NCT00628745|584280459|FG001|Overall Study|Participant transferred to another THAOS site|0|||
161791770|NCT00628745|584280460|FG002|Overall Study|Participant transferred to another THAOS site|0|||
161791771|NCT00628745|584280461|FG003|Overall Study|Participant transferred to another THAOS site|0|||
161791772|NCT00628745|584280462|FG004|Overall Study|Participant transferred to another THAOS site|7|||
161791773|NCT00628745|584280458|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
161791774|NCT00628745|584280459|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
161791775|NCT00628745|584280460|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
161791776|NCT00628745|584280461|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
161791777|NCT00628745|584280462|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
161791778|NCT00628745|584280458|FG000|Overall Study|Site closure|152|||
161791779|NCT00628745|584280459|FG001|Overall Study|Site closure|146|||
161791780|NCT00628745|584280460|FG002|Overall Study|Site closure|6|||
161791781|NCT00628745|584280461|FG003|Overall Study|Site closure|8|||
161791782|NCT00628745|584280462|FG004|Overall Study|Site closure|691|||
161791783|NCT00628745|584280458|FG000|Overall Study|Duplicate participant|0|||
161791784|NCT00628745|584280459|FG001|Overall Study|Duplicate participant|0|||
161791785|NCT00628745|584280460|FG002|Overall Study|Duplicate participant|0|||
161791786|NCT00628745|584280461|FG003|Overall Study|Duplicate participant|0|||
161791787|NCT00628745|584280462|FG004|Overall Study|Duplicate participant|1|||
161791788|NCT00628745|584280458|FG000|Overall Study|Missing|4|||
161791789|NCT00628745|584280459|FG001|Overall Study|Missing|3|||
161791790|NCT00628745|584280460|FG002|Overall Study|Missing|0|||
161791791|NCT00628745|584280461|FG003|Overall Study|Missing|0|||
161791792|NCT00628745|584280462|FG004|Overall Study|Missing|10|||
161791793|NCT00628745|584280458|FG000|Overall Study|Othe reasons|987|||
161791794|NCT00628745|584280459|FG001|Overall Study|Othe reasons|373|||
161791795|NCT00628745|584280460|FG002|Overall Study|Othe reasons|105|||
161791796|NCT00628745|584280461|FG003|Overall Study|Othe reasons|1|||
161791797|NCT00628745|584280462|FG004|Overall Study|Othe reasons|1772|||
161791798|NCT00982410|584282240|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
161791799|NCT00982410|584282241|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
161791800|NCT00982410|584282240|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
161791801|NCT00982410|584282241|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
161791802|NCT00982410|584282240|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
161791803|NCT00982410|584282241|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
161791804|NCT00982410|584282240|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
161791805|NCT00982410|584282241|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
161791806|NCT00982410|584282240|FG000|6-month Follow-up Assessment|participant no transportation|1|||
161791807|NCT00982410|584282241|FG001|6-month Follow-up Assessment|participant no transportation|0|||
161791808|NCT00982410|584282240|FG000|6-month Follow-up Assessment|incarceration|0|||
161791809|NCT00982410|584282241|FG001|6-month Follow-up Assessment|incarceration|2|||
161791810|NCT00982410|584282240|FG000|6-month Follow-up Assessment|patent surgery|0|||
161791811|NCT00982410|584282241|FG001|6-month Follow-up Assessment|patent surgery|1|||
161791812|NCT00982410|584282240|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
161791813|NCT00982410|584282241|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
161791814|NCT00982410|584282240|FG000|12-month Follow-up Assessment|Death|0|||
161791815|NCT00982410|584282241|FG001|12-month Follow-up Assessment|Death|2|||
161791816|NCT00982410|584282240|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
161791817|NCT00982410|584282241|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
161791818|NCT00982410|584282240|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
161791819|NCT00982410|584282241|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
161791820|NCT00982410|584282240|FG000|12-month Follow-up Assessment|incarceration|2|||
161791821|NCT00982410|584282241|FG001|12-month Follow-up Assessment|incarceration|1|||
161791822|NCT00982410|584282240|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
161791823|NCT00982410|584282241|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
161791824|NCT02034799|584282244|FG000|Overall Study|Withdrawal by Subject|0|||
161791825|NCT02034799|584282245|FG001|Overall Study|Withdrawal by Subject|2|||
161791826|NCT02034799|584282244|FG000|Overall Study|Lost to Follow-up|0|||
161791827|NCT02034799|584282245|FG001|Overall Study|Lost to Follow-up|1|||
161791828|NCT02034799|584282244|FG000|Overall Study|Death|2|||
161791829|NCT02034799|584282245|FG001|Overall Study|Death|1|||
161791830|NCT03381248|584282253|FG000|0-6 Months|Withdrawal by Subject|4|||
161791831|NCT03381248|584282254|FG001|0-6 Months|Withdrawal by Subject|1|||
161791832|NCT03381248|584282253|FG000|0-6 Months|Lost to Follow-up|3|||
161791833|NCT03381248|584282254|FG001|0-6 Months|Lost to Follow-up|2|||
161791834|NCT03381248|584282253|FG000|0-6 Months|Lack of Efficacy|1|||
161791835|NCT03381248|584282254|FG001|0-6 Months|Lack of Efficacy|0|||
161791836|NCT03381248|584282253|FG000|0-6 Months|Adverse Event|1|||
161791837|NCT03381248|584282254|FG001|0-6 Months|Adverse Event|0|||
161791838|NCT03381248|584282253|FG000|0-6 Months|Protocol Violation|2|||
161791839|NCT03381248|584282254|FG001|0-6 Months|Protocol Violation|1|||
161791840|NCT03381248|584282253|FG000|0-6 Months|Physician Decision|1|||
161791841|NCT03381248|584282254|FG001|0-6 Months|Physician Decision|0|||
161791842|NCT03381248|584282253|FG000|0-6 Months|Planning another procedure|1|||
161791843|NCT03381248|584282254|FG001|0-6 Months|Planning another procedure|2|||
161791844|NCT03381248|584282253|FG000|6-12 Months|Withdrawal by Subject|1|||
161791845|NCT03381248|584282254|FG001|6-12 Months|Withdrawal by Subject|3|||
161791846|NCT03381248|584282253|FG000|6-12 Months|Lost to Follow-up|0|||
161791847|NCT03381248|584282254|FG001|6-12 Months|Lost to Follow-up|2|||
161791848|NCT03381248|584282253|FG000|6-12 Months|Protocol Violation|3|||
161791849|NCT03381248|584282254|FG001|6-12 Months|Protocol Violation|2|||
161791850|NCT03381248|584282253|FG000|6-12 Months|Planning another procedure|6|||
161791851|NCT03381248|584282254|FG001|6-12 Months|Planning another procedure|2|||
161791852|NCT03381248|584282253|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
161791853|NCT03381248|584282254|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
161791854|NCT03381248|584282253|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
161791855|NCT03381248|584282254|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
161791856|NCT03381248|584282253|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
161791857|NCT03381248|584282254|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
161791858|NCT05188521|584282259|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
161791859|NCT05188521|584282260|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
161791860|NCT01341639|584282261|FG000|Infant Series|Protocol Violation|1|||
161791861|NCT01341639|584282262|FG001|Infant Series|Protocol Violation|0|||
161791862|NCT01341639|584282261|FG000|Infant Series|Not Vaccinated|0|||
161791863|NCT01341639|584282262|FG001|Infant Series|Not Vaccinated|1|||
161791864|NCT01341639|584282261|FG000|Infant Series|Adverse Event|0|||
161791865|NCT01341639|584282262|FG001|Infant Series|Adverse Event|5|||
161791866|NCT01341639|584282261|FG000|Infant Series|Withdrawal by Subject|11|||
161791867|NCT01341639|584282262|FG001|Infant Series|Withdrawal by Subject|8|||
161791868|NCT01341639|584282261|FG000|Infant Series|Lost to Follow-up|0|||
161791869|NCT01341639|584282262|FG001|Infant Series|Lost to Follow-up|2|||
161791870|NCT01341639|584282261|FG000|Infant Series|Site 0048 Participants|17|||
161791871|NCT01341639|584282262|FG001|Infant Series|Site 0048 Participants|16|||
161791872|NCT01341639|584282261|FG000|Interim Period|Withdrawal by Subject|6|||
161791873|NCT01341639|584282262|FG001|Interim Period|Withdrawal by Subject|7|||
161791874|NCT01341639|584282261|FG000|Interim Period|Lost to Follow-up|2|||
161791875|NCT01341639|584282262|FG001|Interim Period|Lost to Follow-up|0|||
161791876|NCT01341639|584282261|FG000|Interim Period|Physician Decision|0|||
161791877|NCT01341639|584282262|FG001|Interim Period|Physician Decision|1|||
161791878|NCT01341639|584282261|FG000|Interim Period|Protocol Violation|0|||
161791879|NCT01341639|584282262|FG001|Interim Period|Protocol Violation|1|||
161791880|NCT01341639|584282261|FG000|Post-Treatment|Withdrawal by Subject|0|||
161791881|NCT01341639|584282262|FG001|Post-Treatment|Withdrawal by Subject|1|||
161791882|NCT01341639|584282261|FG000|Post-Treatment|Adverse Event|0|||
161791883|NCT01341639|584282262|FG001|Post-Treatment|Adverse Event|2|||
161791884|NCT02224456|584282263|FG000|Overall Study|Lack of Efficacy|1|||
161791885|NCT02224456|584282263|FG000|Overall Study|Lost to Follow-up|15|||
161791886|NCT02224456|584282263|FG000|Overall Study|Withdrawal by Subject|9|||
161791887|NCT02224456|584282263|FG000|Overall Study|Physician Decision|3|||
161791888|NCT02224456|584282263|FG000|Overall Study|Death|2|||
161791889|NCT02224456|584282263|FG000|Overall Study|Pregnancy|4|||
161791890|NCT02224456|584282263|FG000|Overall Study|Protocol Violation|1|||
161791891|NCT02224456|584282263|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
161791892|NCT01590433|584282264|FG000|Overall Study|Lost to Follow-up|20|||
161791893|NCT01590433|584282265|FG001|Overall Study|Lost to Follow-up|8|||
161791894|NCT01590433|584282264|FG000|Overall Study|Withdrawal by Subject|21|||
161791895|NCT01590433|584282265|FG001|Overall Study|Withdrawal by Subject|11|||
161791896|NCT01590433|584282264|FG000|Overall Study|Adverse Event|11|||
161791897|NCT01590433|584282265|FG001|Overall Study|Adverse Event|3|||
161791898|NCT00322556|584282266|FG000|Overall Study|Adverse Event|1|||
161791899|NCT00322556|584282266|FG000|Overall Study|Withdrawal by Subject|1|||
161791900|NCT00322556|584282266|FG000|Overall Study|Lost to Follow-up|3|||
161791901|NCT00322556|584282266|FG000|Overall Study|Other Reason|7|||
161791902|NCT00555009|584282267|FG000|Overall Study|Withdrawal by Subject|0|||
161791903|NCT00555009|584282268|FG001|Overall Study|Withdrawal by Subject|1|||
161791904|NCT00555009|584282267|FG000|Overall Study|Terminated by Sponsor|2|||
161791905|NCT00555009|584282268|FG001|Overall Study|Terminated by Sponsor|5|||
161791906|NCT02040428|584282269|FG000|Overall Study|Death|4|||
161791907|NCT02040428|584282270|FG001|Overall Study|Death|3|||
161791908|NCT02040428|584282269|FG000|Overall Study|Withdrawal by Subject|1|||
161791909|NCT02040428|584282270|FG001|Overall Study|Withdrawal by Subject|1|||
161791910|NCT02058628|584282271|FG000|Overall Study|Adverse Event|1|||
161791911|NCT02058628|584282272|FG001|Overall Study|Adverse Event|0|||
161791912|NCT02058628|584282271|FG000|Overall Study|Withdrawal by Subject|2|||
161791913|NCT02058628|584282272|FG001|Overall Study|Withdrawal by Subject|2|||
161791914|NCT02058628|584282271|FG000|Overall Study|Lost to Follow-up|2|||
161791915|NCT02058628|584282272|FG001|Overall Study|Lost to Follow-up|4|||
161791916|NCT02058628|584282271|FG000|Overall Study|Not in time schedule|0|||
161791917|NCT02058628|584282272|FG001|Overall Study|Not in time schedule|1|||
161791918|NCT02058628|584282271|FG000|Overall Study|The visit date was not in timeline|0|||
161791919|NCT02058628|584282272|FG001|Overall Study|The visit date was not in timeline|1|||
161791920|NCT02058628|584282271|FG000|Overall Study|A lot of time for study for participant|1|||
161791921|NCT02058628|584282272|FG001|Overall Study|A lot of time for study for participant|0|||
161791922|NCT02058628|584282271|FG000|Overall Study|Non compliance|1|||
161791923|NCT02058628|584282272|FG001|Overall Study|Non compliance|0|||
161791924|NCT00832078|584282273|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
161791925|NCT00832078|584282274|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
161791926|NCT00832078|584282273|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
161791927|NCT00832078|584282274|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
161791928|NCT02961920|584282277|FG000|Overall Study|did not achive stydy protocol schedule|1|||
161791929|NCT02961920|584282278|FG001|Overall Study|did not achive stydy protocol schedule|1|||
161791930|NCT01452529|584282279|FG000|Run-in Period|Adverse Event|96|||
161791931|NCT01452529|584282280|FG001|Run-in Period|Adverse Event|0|||
161791932|NCT01452529|584282281|FG002|Run-in Period|Adverse Event|0|||
161791933|NCT01452529|584282279|FG000|Run-in Period|Withdrawal by Subject|49|||
161791934|NCT01452529|584282280|FG001|Run-in Period|Withdrawal by Subject|0|||
161791935|NCT01452529|584282281|FG002|Run-in Period|Withdrawal by Subject|0|||
161791936|NCT01452529|584282279|FG000|Run-in Period|Lost to Follow-up|19|||
161791937|NCT01452529|584282280|FG001|Run-in Period|Lost to Follow-up|0|||
161791938|NCT01452529|584282281|FG002|Run-in Period|Lost to Follow-up|0|||
161791939|NCT01452529|584282279|FG000|Run-in Period|Lack of Efficacy|46|||
161791940|NCT01452529|584282280|FG001|Run-in Period|Lack of Efficacy|0|||
161791941|NCT01452529|584282281|FG002|Run-in Period|Lack of Efficacy|0|||
161791942|NCT01452529|584282279|FG000|Run-in Period|Confirmed or suspected diversion|23|||
161791943|NCT01452529|584282280|FG001|Run-in Period|Confirmed or suspected diversion|0|||
161791944|NCT01452529|584282281|FG002|Run-in Period|Confirmed or suspected diversion|0|||
161791945|NCT01452529|584282279|FG000|Run-in Period|Administrative|21|||
161791946|NCT01452529|584282280|FG001|Run-in Period|Administrative|0|||
161791947|NCT01452529|584282281|FG002|Run-in Period|Administrative|0|||
161791948|NCT01452529|584282279|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
161791949|NCT01452529|584282280|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
161791950|NCT01452529|584282281|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
161791951|NCT01452529|584282279|FG000|Double-blind (DB) Period|Adverse Event|0|||
161791952|NCT01452529|584282280|FG001|Double-blind (DB) Period|Adverse Event|18|||
161791953|NCT01452529|584282281|FG002|Double-blind (DB) Period|Adverse Event|11|||
161791954|NCT01452529|584282279|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
161791955|NCT01452529|584282280|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
161791956|NCT01452529|584282281|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
161791957|NCT01452529|584282279|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
161791958|NCT01452529|584282280|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
161791959|NCT01452529|584282281|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
161791960|NCT01452529|584282279|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
161791961|NCT01452529|584282280|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
161791962|NCT01452529|584282281|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
161791963|NCT01452529|584282279|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
161791964|NCT01452529|584282280|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
161791965|NCT01452529|584282281|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
161791966|NCT01452529|584282279|FG000|Double-blind (DB) Period|Administrative|0|||
161791967|NCT01452529|584282280|FG001|Double-blind (DB) Period|Administrative|11|||
161791968|NCT01452529|584282281|FG002|Double-blind (DB) Period|Administrative|7|||
161791969|NCT03551730|584282282|FG000|Overall Study|Adverse Event|1|||
161791970|NCT03551730|584282283|FG001|Overall Study|Adverse Event|0|||
161791971|NCT03551730|584282284|FG002|Overall Study|Adverse Event|0|||
161791972|NCT03551730|584282285|FG003|Overall Study|Adverse Event|0|||
161791973|NCT00671879|584282286|FG000|Overall Study|Withdrawal by Subject|0|||
161791974|NCT00671879|584282287|FG001|Overall Study|Withdrawal by Subject|4|||
161791975|NCT00671879|584282288|FG002|Overall Study|Withdrawal by Subject|6|||
161791976|NCT04527471|584282291|FG000|Overall Study|Adverse Event|1|||
161791977|NCT04527471|584282292|FG001|Overall Study|Adverse Event|0|||
161791978|NCT04527471|584282291|FG000|Overall Study|Lost to Follow-up|1|||
161791979|NCT04527471|584282292|FG001|Overall Study|Lost to Follow-up|0|||
161791980|NCT01628120|584282303|FG000|Overall Study|Withdrawal by Subject|7|||
161791981|NCT01628120|584282303|FG000|Overall Study|Adverse Event|12|||
161791982|NCT01628120|584282303|FG000|Overall Study|Lost to Follow-up|1|||
161791983|NCT01628120|584282303|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
161791984|NCT01628120|584282303|FG000|Overall Study|Non-compliant with Study Procedures|1|||
161791985|NCT01628120|584282303|FG000|Overall Study|Not Treated|3|||
161791986|NCT01628120|584282303|FG000|Overall Study|Sponsor Decision|5|||
161791987|NCT01628120|584282303|FG000|Overall Study|Switched Dialysis Method|2|||
161791988|NCT01628120|584282303|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
161791989|NCT01628120|584282303|FG000|Overall Study|Moved or Relocated|5|||
161791990|NCT01628120|584282303|FG000|Overall Study|Kidney Transplant|2|||
161791991|NCT01628120|584282303|FG000|Overall Study|Use of Standard of Care|1|||
161791992|NCT01165996|584282304|FG000|Overall Study|Death|1|||
161791993|NCT01165996|584282304|FG000|Overall Study|Physician Decision|1|||
161791994|NCT00096265|584282305|FG000|Overall Study|Ineligible|1|||
161791995|NCT00096265|584282306|FG001|Overall Study|Ineligible|0|||
161791996|NCT00096265|584282307|FG002|Overall Study|Ineligible|0|||
161791997|NCT01506323|584282308|FG000|Overall Study|Lost to Follow-up|5|||
161791998|NCT01506323|584282309|FG001|Overall Study|Lost to Follow-up|4|||
161791999|NCT01506323|584282308|FG000|Overall Study|Withdrawal by Subject|4|||
161792000|NCT01506323|584282309|FG001|Overall Study|Withdrawal by Subject|4|||
161792001|NCT01506323|584282308|FG000|Overall Study|Lack of Efficacy|1|||
161792002|NCT01506323|584282309|FG001|Overall Study|Lack of Efficacy|3|||
161792003|NCT01506323|584282308|FG000|Overall Study|Moved out of area|5|||
161792004|NCT01506323|584282309|FG001|Overall Study|Moved out of area|2|||
161792005|NCT01506323|584282308|FG000|Overall Study|Schedule or Transportation conflict|8|||
161792006|NCT01506323|584282309|FG001|Overall Study|Schedule or Transportation conflict|0|||
161792007|NCT01506323|584282308|FG000|Overall Study|Started another treatment|1|||
161792008|NCT01506323|584282309|FG001|Overall Study|Started another treatment|0|||
161792009|NCT02232074|584282312|FG000|Overall Study|Withdrawal by Subject|5|||
161792010|NCT02232074|584282313|FG001|Overall Study|Withdrawal by Subject|3|||
161792011|NCT02232074|584282312|FG000|Overall Study|No legal concerns at baseline|36|||
161443559|NCT03695367|583017269|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
161443560|NCT00068419|583017272|FG000|Overall Study|Adverse Event|3|||
161443561|NCT00068419|583017272|FG000|Overall Study|Lack of Efficacy|24|||
161443562|NCT00068419|583017272|FG000|Overall Study|Lost to Follow-up|1|||
161443563|NCT00068419|583017272|FG000|Overall Study|Physician Decision|7|||
161443564|NCT00068419|583017272|FG000|Overall Study|Withdrawal by Subject|14|||
161443565|NCT00068419|583017272|FG000|Overall Study|Ineligible|11|||
161443566|NCT00396253|583017276|FG000|Overall Study|Protocol Violation|1|||
161443567|NCT00396253|583017276|FG000|Overall Study|Withdrawal by Subject|7|||
161443568|NCT00396253|583017276|FG000|Overall Study|Death|3|||
161443569|NCT00396253|583017276|FG000|Overall Study|Physician Decision|1|||
161443570|NCT00396253|583017276|FG000|Overall Study|Change in eligibility status|1|||
161443571|NCT00092443|583017277|FG000|Overall Study|Adverse Event|9|||
161443572|NCT00092443|583017278|FG001|Overall Study|Adverse Event|13|||
161443573|NCT00092443|583017277|FG000|Overall Study|Lost to Follow-up|7|||
161443574|NCT00092443|583017278|FG001|Overall Study|Lost to Follow-up|3|||
161443575|NCT00092443|583017277|FG000|Overall Study|Protocol Violation|11|||
161443576|NCT00092443|583017278|FG001|Overall Study|Protocol Violation|9|||
161443577|NCT00092443|583017277|FG000|Overall Study|Withdrawal by Subject|9|||
161443578|NCT00092443|583017278|FG001|Overall Study|Withdrawal by Subject|11|||
161443579|NCT00092443|583017277|FG000|Overall Study|Moved|5|||
161443580|NCT00092443|583017278|FG001|Overall Study|Moved|5|||
161443581|NCT00092443|583017277|FG000|Overall Study|Other|17|||
161443582|NCT00092443|583017278|FG001|Overall Study|Other|13|||
161443583|NCT04717336|583017280|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
161443584|NCT04717336|583017281|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
161443585|NCT04717336|583017280|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
161443586|NCT04717336|583017281|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
161443587|NCT02039843|583017282|FG000|Randomization and Observation Period|Adverse Event|2|||
161443588|NCT02039843|583017283|FG001|Randomization and Observation Period|Adverse Event|0|||
161443589|NCT02039843|583017282|FG000|Randomization and Observation Period|Death|1|||
161443590|NCT02039843|583017283|FG001|Randomization and Observation Period|Death|0|||
161443591|NCT02039843|583017282|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
161443592|NCT02039843|583017283|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
161443593|NCT02039843|583017282|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
161443594|NCT02039843|583017283|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
161443595|NCT02039843|583017282|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
161443596|NCT02039843|583017283|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
161443597|NCT02039843|583017282|FG000|Pairing With a Study Dog|Death|1|||
161443598|NCT02039843|583017283|FG001|Pairing With a Study Dog|Death|0|||
161443599|NCT02039843|583017282|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
161443600|NCT02039843|583017283|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
161443601|NCT02039843|583017282|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
161443602|NCT02039843|583017283|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
161443603|NCT02039843|583017282|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
161443604|NCT02039843|583017283|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
161443605|NCT01958164|583017287|FG000|Overall Study|Adverse Event|0|||
161443606|NCT01958164|583017288|FG001|Overall Study|Adverse Event|2|||
161443607|NCT01958164|583017287|FG000|Overall Study|Lost to Follow-up|2|||
161443608|NCT01958164|583017288|FG001|Overall Study|Lost to Follow-up|3|||
161443609|NCT00740857|583017289|FG000|Overall Study|Withdrawal by Subject|1|||
161443610|NCT00740857|583017290|FG001|Overall Study|Withdrawal by Subject|0|||
161443611|NCT00740857|583017291|FG002|Overall Study|Withdrawal by Subject|0|||
161443612|NCT02963506|583017292|FG000|Double-Blind Period|Adverse Event|0|||
161443613|NCT02963506|583017293|FG001|Double-Blind Period|Adverse Event|0|||
161443614|NCT02963506|583017294|FG002|Double-Blind Period|Adverse Event|1|||
161443615|NCT02963506|583017295|FG003|Double-Blind Period|Adverse Event|0|||
161443616|NCT02963506|583017296|FG004|Double-Blind Period|Adverse Event|0|||
161443617|NCT02963506|583017297|FG005|Double-Blind Period|Adverse Event|0|||
161443618|NCT02963506|583017298|FG006|Double-Blind Period|Adverse Event|0|||
161443619|NCT02963506|583017299|FG007|Double-Blind Period|Adverse Event|0|||
161792012|NCT02232074|584282313|FG001|Overall Study|No legal concerns at baseline|41|||
161792013|NCT02232074|584282312|FG000|Overall Study|deemed ineligible|0|||
161792014|NCT02232074|584282313|FG001|Overall Study|deemed ineligible|1|||
161443620|NCT02963506|583017300|FG008|Double-Blind Period|Adverse Event|0|||
161443621|NCT02963506|583017301|FG009|Double-Blind Period|Adverse Event|0|||
161443622|NCT02963506|583017302|FG010|Double-Blind Period|Adverse Event|0|||
161443623|NCT02963506|583017303|FG011|Double-Blind Period|Adverse Event|0|||
161443624|NCT02963506|583017304|FG012|Double-Blind Period|Adverse Event|0|||
161443625|NCT02963506|583017292|FG000|Double-Blind Period|Death|0|||
161443626|NCT02963506|583017293|FG001|Double-Blind Period|Death|0|||
161443627|NCT02963506|583017294|FG002|Double-Blind Period|Death|0|||
161443628|NCT02963506|583017295|FG003|Double-Blind Period|Death|1|||
161443629|NCT02963506|583017296|FG004|Double-Blind Period|Death|0|||
161792015|NCT01927757|584282314|FG000|Overall Study|Withdrawal by Subject|14|||
161792016|NCT01927757|584282314|FG000|Overall Study|Lost to Follow-up|2|||
161792017|NCT01927757|584282314|FG000|Overall Study|Decision by Sponsor|2|||
161898822|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161792018|NCT01927757|584282314|FG000|Overall Study|Other|1|||
161792019|NCT01927757|584282314|FG000|Overall Study|Ethical Reasons|4|||
161792020|NCT00444795|584282316|FG000|Overall Study|Not Treated|1|||
161792021|NCT00444795|584282316|FG000|Overall Study|Treated Prior to the Contract Date|2|||
161443630|NCT02963506|583017297|FG005|Double-Blind Period|Death|0|||
161443631|NCT02963506|583017298|FG006|Double-Blind Period|Death|0|||
161443632|NCT02963506|583017299|FG007|Double-Blind Period|Death|0|||
161443633|NCT02963506|583017300|FG008|Double-Blind Period|Death|0|||
161792022|NCT00988169|584282317|FG000|Overall Study|Withdrawal by Subject|1|||
161792023|NCT00704418|584282318|FG000|Overall Study|Withdrawal by Subject|2|||
161443634|NCT02963506|583017301|FG009|Double-Blind Period|Death|0|||
161443635|NCT02963506|583017302|FG010|Double-Blind Period|Death|0|||
161443636|NCT02963506|583017303|FG011|Double-Blind Period|Death|0|||
161443637|NCT02963506|583017304|FG012|Double-Blind Period|Death|0|||
161443638|NCT02963506|583017292|FG000|Double-Blind Period|Lost to Follow-up|0|||
161443639|NCT02963506|583017293|FG001|Double-Blind Period|Lost to Follow-up|1|||
161443640|NCT02963506|583017294|FG002|Double-Blind Period|Lost to Follow-up|0|||
161443641|NCT02963506|583017295|FG003|Double-Blind Period|Lost to Follow-up|0|||
161443642|NCT02963506|583017296|FG004|Double-Blind Period|Lost to Follow-up|0|||
161443643|NCT02963506|583017297|FG005|Double-Blind Period|Lost to Follow-up|0|||
161443644|NCT02963506|583017298|FG006|Double-Blind Period|Lost to Follow-up|0|||
161443645|NCT02963506|583017299|FG007|Double-Blind Period|Lost to Follow-up|0|||
161443646|NCT02963506|583017300|FG008|Double-Blind Period|Lost to Follow-up|0|||
161443647|NCT02963506|583017301|FG009|Double-Blind Period|Lost to Follow-up|0|||
161443648|NCT02963506|583017302|FG010|Double-Blind Period|Lost to Follow-up|0|||
161443649|NCT02963506|583017303|FG011|Double-Blind Period|Lost to Follow-up|0|||
161443650|NCT02963506|583017304|FG012|Double-Blind Period|Lost to Follow-up|0|||
161443651|NCT02963506|583017292|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161443652|NCT02963506|583017293|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161443653|NCT02963506|583017294|FG002|Double-Blind Period|Withdrawal by Subject|1|||
161443654|NCT02963506|583017295|FG003|Double-Blind Period|Withdrawal by Subject|1|||
161443655|NCT02963506|583017296|FG004|Double-Blind Period|Withdrawal by Subject|0|||
161443656|NCT02963506|583017297|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161443657|NCT02963506|583017298|FG006|Double-Blind Period|Withdrawal by Subject|0|||
161443658|NCT02963506|583017299|FG007|Double-Blind Period|Withdrawal by Subject|0|||
161443659|NCT02963506|583017300|FG008|Double-Blind Period|Withdrawal by Subject|0|||
161443660|NCT02963506|583017301|FG009|Double-Blind Period|Withdrawal by Subject|0|||
161443661|NCT02963506|583017302|FG010|Double-Blind Period|Withdrawal by Subject|0|||
161443662|NCT02963506|583017303|FG011|Double-Blind Period|Withdrawal by Subject|0|||
161443663|NCT02963506|583017304|FG012|Double-Blind Period|Withdrawal by Subject|0|||
161443664|NCT02963506|583017292|FG000|Double-Blind Period|No compliance|0|||
161443665|NCT02963506|583017293|FG001|Double-Blind Period|No compliance|1|||
161443666|NCT02963506|583017294|FG002|Double-Blind Period|No compliance|0|||
161443667|NCT02963506|583017295|FG003|Double-Blind Period|No compliance|0|||
161443668|NCT02963506|583017296|FG004|Double-Blind Period|No compliance|0|||
161443669|NCT02963506|583017297|FG005|Double-Blind Period|No compliance|0|||
161443670|NCT02963506|583017298|FG006|Double-Blind Period|No compliance|0|||
161443671|NCT02963506|583017299|FG007|Double-Blind Period|No compliance|0|||
161443672|NCT02963506|583017300|FG008|Double-Blind Period|No compliance|0|||
161443673|NCT02963506|583017301|FG009|Double-Blind Period|No compliance|0|||
161443674|NCT02963506|583017302|FG010|Double-Blind Period|No compliance|0|||
161443675|NCT02963506|583017303|FG011|Double-Blind Period|No compliance|0|||
161443676|NCT02963506|583017304|FG012|Double-Blind Period|No compliance|0|||
161443677|NCT02963506|583017292|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443678|NCT02963506|583017293|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
161792024|NCT00704418|584282319|FG001|Overall Study|Withdrawal by Subject|0|||
161792025|NCT00704418|584282318|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
161792026|NCT00704418|584282319|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
161792027|NCT02637076|584282320|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
161792028|NCT02637076|584282321|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
161792029|NCT02637076|584282320|FG000|Overall Study|Withdrawal by Subject|0|||
161792030|NCT02637076|584282321|FG001|Overall Study|Withdrawal by Subject|4|||
161443679|NCT02963506|583017294|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443680|NCT02963506|583017295|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443681|NCT02963506|583017296|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443682|NCT02963506|583017297|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443683|NCT02963506|583017298|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443684|NCT02963506|583017299|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443685|NCT02963506|583017300|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443686|NCT02963506|583017301|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161792031|NCT00130520|584282322|FG000|Overall Study|Adverse Event|11|||
161792032|NCT00130520|584282322|FG000|Overall Study|Death|1|||
161792033|NCT00130520|584282322|FG000|Overall Study|Physician Decision|1|||
161792034|NCT00130520|584282322|FG000|Overall Study|Withdrawal by Subject|1|||
161792035|NCT00130520|584282322|FG000|Overall Study|Disease Progression|23|||
161792036|NCT00130520|584282322|FG000|Overall Study|Protocol non-compliance|1|||
161792037|NCT00130520|584282322|FG000|Overall Study|Did not meet re-treatment criteria|1|||
161792038|NCT01464827|584282323|FG000|Overall Study|Adverse Event|0|||
161792039|NCT01464827|584282324|FG001|Overall Study|Adverse Event|0|||
161792040|NCT01464827|584282325|FG002|Overall Study|Adverse Event|0|||
161792041|NCT01464827|584282326|FG003|Overall Study|Adverse Event|0|||
161792042|NCT01464827|584282327|FG004|Overall Study|Adverse Event|0|||
161792043|NCT01464827|584282328|FG005|Overall Study|Adverse Event|0|||
161792044|NCT01464827|584282329|FG006|Overall Study|Adverse Event|0|||
161792045|NCT01464827|584282330|FG007|Overall Study|Adverse Event|0|||
161792046|NCT01464827|584282331|FG008|Overall Study|Adverse Event|0|||
161792047|NCT01464827|584282332|FG009|Overall Study|Adverse Event|0|||
161792048|NCT01464827|584282333|FG010|Overall Study|Adverse Event|0|||
161792049|NCT01464827|584282334|FG011|Overall Study|Adverse Event|0|||
161792050|NCT01464827|584282335|FG012|Overall Study|Adverse Event|1|||
161792051|NCT01464827|584282336|FG013|Overall Study|Adverse Event|0|||
161792052|NCT01464827|584282323|FG000|Overall Study|Withdrawal by Subject|1|||
161792053|NCT01464827|584282324|FG001|Overall Study|Withdrawal by Subject|0|||
161792054|NCT01464827|584282325|FG002|Overall Study|Withdrawal by Subject|0|||
161792055|NCT01464827|584282326|FG003|Overall Study|Withdrawal by Subject|0|||
161792056|NCT01464827|584282327|FG004|Overall Study|Withdrawal by Subject|1|||
161792057|NCT01464827|584282328|FG005|Overall Study|Withdrawal by Subject|0|||
161792058|NCT01464827|584282329|FG006|Overall Study|Withdrawal by Subject|0|||
161792059|NCT01464827|584282330|FG007|Overall Study|Withdrawal by Subject|1|||
161792060|NCT01464827|584282331|FG008|Overall Study|Withdrawal by Subject|0|||
161792061|NCT01464827|584282332|FG009|Overall Study|Withdrawal by Subject|0|||
161792062|NCT01464827|584282333|FG010|Overall Study|Withdrawal by Subject|0|||
161792063|NCT01464827|584282334|FG011|Overall Study|Withdrawal by Subject|0|||
161792064|NCT01464827|584282335|FG012|Overall Study|Withdrawal by Subject|0|||
161792065|NCT01464827|584282336|FG013|Overall Study|Withdrawal by Subject|0|||
161792066|NCT01464827|584282323|FG000|Overall Study|Lost to Follow-up|0|||
161792067|NCT01464827|584282324|FG001|Overall Study|Lost to Follow-up|2|||
161792068|NCT01464827|584282325|FG002|Overall Study|Lost to Follow-up|0|||
161792069|NCT01464827|584282326|FG003|Overall Study|Lost to Follow-up|2|||
161792070|NCT01464827|584282327|FG004|Overall Study|Lost to Follow-up|3|||
161792071|NCT01464827|584282328|FG005|Overall Study|Lost to Follow-up|1|||
161792072|NCT01464827|584282329|FG006|Overall Study|Lost to Follow-up|2|||
161792073|NCT01464827|584282330|FG007|Overall Study|Lost to Follow-up|2|||
161792074|NCT01464827|584282331|FG008|Overall Study|Lost to Follow-up|0|||
161792075|NCT01464827|584282332|FG009|Overall Study|Lost to Follow-up|0|||
161792076|NCT01464827|584282333|FG010|Overall Study|Lost to Follow-up|0|||
161792077|NCT01464827|584282334|FG011|Overall Study|Lost to Follow-up|1|||
161792078|NCT01464827|584282335|FG012|Overall Study|Lost to Follow-up|0|||
161792079|NCT01464827|584282336|FG013|Overall Study|Lost to Follow-up|1|||
161792080|NCT01464827|584282323|FG000|Overall Study|Other|2|||
161792081|NCT01464827|584282324|FG001|Overall Study|Other|3|||
161443687|NCT02963506|583017302|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443688|NCT02963506|583017303|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161792082|NCT01464827|584282325|FG002|Overall Study|Other|0|||
161792083|NCT01464827|584282326|FG003|Overall Study|Other|2|||
161792084|NCT01464827|584282327|FG004|Overall Study|Other|3|||
161792085|NCT01464827|584282328|FG005|Overall Study|Other|0|||
161792086|NCT01464827|584282329|FG006|Overall Study|Other|1|||
161792087|NCT01464827|584282330|FG007|Overall Study|Other|0|||
161792088|NCT01464827|584282331|FG008|Overall Study|Other|3|||
161443689|NCT02963506|583017304|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161443690|NCT02963506|583017292|FG000|Dose-Blind Period|Adverse Event|0|||
161792089|NCT01464827|584282332|FG009|Overall Study|Other|1|||
161443691|NCT02963506|583017293|FG001|Dose-Blind Period|Adverse Event|0|||
161443692|NCT02963506|583017294|FG002|Dose-Blind Period|Adverse Event|0|||
161898823|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898824|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898825|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161443693|NCT02963506|583017295|FG003|Dose-Blind Period|Adverse Event|0|||
161792090|NCT01464827|584282333|FG010|Overall Study|Other|2|||
161792091|NCT01464827|584282334|FG011|Overall Study|Other|0|||
161792092|NCT01464827|584282335|FG012|Overall Study|Other|1|||
161792093|NCT01464827|584282336|FG013|Overall Study|Other|0|||
161792094|NCT01464827|584282323|FG000|Overall Study|Not Treated|0|||
161792095|NCT01464827|584282324|FG001|Overall Study|Not Treated|2|||
161792096|NCT01464827|584282325|FG002|Overall Study|Not Treated|0|||
161792097|NCT01464827|584282326|FG003|Overall Study|Not Treated|0|||
161792098|NCT01464827|584282327|FG004|Overall Study|Not Treated|1|||
161792099|NCT01464827|584282328|FG005|Overall Study|Not Treated|0|||
161443694|NCT02963506|583017296|FG004|Dose-Blind Period|Adverse Event|0|||
161443695|NCT02963506|583017297|FG005|Dose-Blind Period|Adverse Event|1|||
161443696|NCT02963506|583017298|FG006|Dose-Blind Period|Adverse Event|3|||
161443697|NCT02963506|583017299|FG007|Dose-Blind Period|Adverse Event|2|||
161443698|NCT02963506|583017300|FG008|Dose-Blind Period|Adverse Event|2|||
161443699|NCT02963506|583017301|FG009|Dose-Blind Period|Adverse Event|2|||
161443700|NCT02963506|583017302|FG010|Dose-Blind Period|Adverse Event|1|||
161443701|NCT02963506|583017303|FG011|Dose-Blind Period|Adverse Event|1|||
161443702|NCT02963506|583017304|FG012|Dose-Blind Period|Adverse Event|6|||
161443703|NCT02963506|583017292|FG000|Dose-Blind Period|Lack of Efficacy|0|||
161443704|NCT02963506|583017293|FG001|Dose-Blind Period|Lack of Efficacy|0|||
161443705|NCT02963506|583017294|FG002|Dose-Blind Period|Lack of Efficacy|0|||
161443706|NCT02963506|583017295|FG003|Dose-Blind Period|Lack of Efficacy|0|||
161443707|NCT02963506|583017296|FG004|Dose-Blind Period|Lack of Efficacy|0|||
161443708|NCT02963506|583017297|FG005|Dose-Blind Period|Lack of Efficacy|0|||
161443709|NCT02963506|583017298|FG006|Dose-Blind Period|Lack of Efficacy|0|||
161443710|NCT02963506|583017299|FG007|Dose-Blind Period|Lack of Efficacy|1|||
161443711|NCT02963506|583017300|FG008|Dose-Blind Period|Lack of Efficacy|0|||
161443712|NCT02963506|583017301|FG009|Dose-Blind Period|Lack of Efficacy|1|||
161443713|NCT02963506|583017302|FG010|Dose-Blind Period|Lack of Efficacy|0|||
161443714|NCT02963506|583017303|FG011|Dose-Blind Period|Lack of Efficacy|0|||
161443715|NCT02963506|583017304|FG012|Dose-Blind Period|Lack of Efficacy|0|||
161443716|NCT02963506|583017292|FG000|Dose-Blind Period|Lost to Follow-up|0|||
161443717|NCT02963506|583017293|FG001|Dose-Blind Period|Lost to Follow-up|0|||
161443718|NCT02963506|583017294|FG002|Dose-Blind Period|Lost to Follow-up|0|||
161443719|NCT02963506|583017295|FG003|Dose-Blind Period|Lost to Follow-up|0|||
161443720|NCT02963506|583017296|FG004|Dose-Blind Period|Lost to Follow-up|0|||
161443721|NCT02963506|583017297|FG005|Dose-Blind Period|Lost to Follow-up|1|||
161443722|NCT02963506|583017298|FG006|Dose-Blind Period|Lost to Follow-up|0|||
161443723|NCT02963506|583017299|FG007|Dose-Blind Period|Lost to Follow-up|0|||
161443724|NCT02963506|583017300|FG008|Dose-Blind Period|Lost to Follow-up|1|||
161443725|NCT02963506|583017301|FG009|Dose-Blind Period|Lost to Follow-up|0|||
161443726|NCT02963506|583017302|FG010|Dose-Blind Period|Lost to Follow-up|0|||
161443727|NCT02963506|583017303|FG011|Dose-Blind Period|Lost to Follow-up|1|||
161443728|NCT02963506|583017304|FG012|Dose-Blind Period|Lost to Follow-up|0|||
161443729|NCT02963506|583017292|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
161443730|NCT02963506|583017293|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
161443731|NCT02963506|583017294|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
161792100|NCT01464827|584282329|FG006|Overall Study|Not Treated|1|||
161792101|NCT01464827|584282330|FG007|Overall Study|Not Treated|0|||
161792102|NCT01464827|584282331|FG008|Overall Study|Not Treated|0|||
161792103|NCT01464827|584282332|FG009|Overall Study|Not Treated|2|||
161792104|NCT01464827|584282333|FG010|Overall Study|Not Treated|0|||
161792105|NCT01464827|584282334|FG011|Overall Study|Not Treated|1|||
161792106|NCT01464827|584282335|FG012|Overall Study|Not Treated|0|||
161792107|NCT01464827|584282336|FG013|Overall Study|Not Treated|2|||
161792108|NCT01075763|584282337|FG000|Overall Study|Lost to Follow-up|2|||
161792109|NCT01075763|584282338|FG001|Overall Study|Lost to Follow-up|1|||
161792110|NCT01075763|584282337|FG000|Overall Study|Lack of Efficacy|0|||
161792111|NCT01075763|584282338|FG001|Overall Study|Lack of Efficacy|1|||
161792112|NCT01075763|584282337|FG000|Overall Study|Withdrawal by Subject|2|||
161792113|NCT01075763|584282338|FG001|Overall Study|Withdrawal by Subject|2|||
161792114|NCT00586521|584282339|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
161792115|NCT03083483|584282343|FG000|Overall Study|Adverse Event|1|||
161792116|NCT03083483|584282344|FG001|Overall Study|Adverse Event|1|||
161792117|NCT03083483|584282345|FG002|Overall Study|Adverse Event|1|||
161792118|NCT03083483|584282343|FG000|Overall Study|Lost to Follow-up|2|||
161792119|NCT03083483|584282344|FG001|Overall Study|Lost to Follow-up|1|||
161792120|NCT03083483|584282345|FG002|Overall Study|Lost to Follow-up|1|||
161443732|NCT02963506|583017295|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
161443733|NCT02963506|583017296|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
161443734|NCT02963506|583017297|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
161443735|NCT02963506|583017298|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
161443736|NCT02963506|583017299|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
161443737|NCT02963506|583017300|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
161443738|NCT02963506|583017301|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
161443739|NCT02963506|583017302|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
161443740|NCT02963506|583017303|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
161443741|NCT02963506|583017304|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
161443742|NCT02963506|583017292|FG000|Dose-Blind Period|Sponsor decision|0|||
161443743|NCT02963506|583017293|FG001|Dose-Blind Period|Sponsor decision|0|||
161792121|NCT03083483|584282343|FG000|Overall Study|technological issues|1|||
161792122|NCT03083483|584282344|FG001|Overall Study|technological issues|0|||
161792123|NCT03083483|584282345|FG002|Overall Study|technological issues|1|||
161792124|NCT02710071|584282346|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
161792125|NCT02710071|584282347|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
161443744|NCT02963506|583017294|FG002|Dose-Blind Period|Sponsor decision|0|||
161792126|NCT02710071|584282346|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
161792127|NCT02710071|584282347|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
161792128|NCT04604184|584282354|FG000|Overall Study|Adverse Event|5|||
161792129|NCT04604184|584282355|FG001|Overall Study|Adverse Event|5|||
161792130|NCT04604184|584282354|FG000|Overall Study|Death|2|||
161792131|NCT04604184|584282355|FG001|Overall Study|Death|1|||
161792132|NCT04604184|584282354|FG000|Overall Study|Withdrawal by Subject|1|||
161792133|NCT04604184|584282355|FG001|Overall Study|Withdrawal by Subject|3|||
161792134|NCT04604184|584282354|FG000|Overall Study|Not treated|2|||
161792135|NCT04604184|584282355|FG001|Overall Study|Not treated|2|||
161898826|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898827|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898828|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898829|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161792136|NCT04604184|584282354|FG000|Overall Study|Due to sponsor decision|9|||
161792137|NCT04604184|584282355|FG001|Overall Study|Due to sponsor decision|7|||
161792138|NCT04604184|584282354|FG000|Overall Study|Physician Decision|0|||
161792139|NCT04604184|584282355|FG001|Overall Study|Physician Decision|1|||
161792140|NCT04604184|584282354|FG000|Overall Study|Transfer to healthcare|1|||
161792141|NCT04604184|584282355|FG001|Overall Study|Transfer to healthcare|0|||
161792142|NCT01751412|584282356|FG000|Overall Study|Disease Progression Before Treatment|1|||
161792143|NCT03734237|584282357|FG000|Overall Study|Lost to Follow-up|1|||
161792144|NCT03734237|584282358|FG001|Overall Study|Lost to Follow-up|3|||
161792145|NCT03734237|584282359|FG002|Overall Study|Lost to Follow-up|0|||
161792146|NCT03734237|584282357|FG000|Overall Study|Withdrawal by Subject|7|||
161792147|NCT03734237|584282358|FG001|Overall Study|Withdrawal by Subject|9|||
161792148|NCT03734237|584282359|FG002|Overall Study|Withdrawal by Subject|10|||
161792149|NCT01844583|584282360|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
161792150|NCT01844583|584282361|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
161792151|NCT01625377|584282362|FG000|Overall Study|Death|1|||
161792152|NCT01625377|584282363|FG001|Overall Study|Death|1|||
161792153|NCT01625377|584282362|FG000|Overall Study|Administrative Problem|1|||
161792154|NCT01625377|584282363|FG001|Overall Study|Administrative Problem|1|||
161792155|NCT01625377|584282362|FG000|Overall Study|Protocol Violation|0|||
161792156|NCT01625377|584282363|FG001|Overall Study|Protocol Violation|3|||
161792157|NCT01625377|584282362|FG000|Overall Study|Adverse Event|3|||
161792158|NCT01625377|584282363|FG001|Overall Study|Adverse Event|16|||
161792159|NCT01625377|584282362|FG000|Overall Study|Graft loss|1|||
161792160|NCT01625377|584282363|FG001|Overall Study|Graft loss|0|||
161792161|NCT01625377|584282362|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161792162|NCT01625377|584282363|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161792163|NCT01625377|584282362|FG000|Overall Study|Abnormal laboratory values|1|||
161792164|NCT01625377|584282363|FG001|Overall Study|Abnormal laboratory values|0|||
161792165|NCT00958256|584282365|FG000|Overall Study|Adverse Event|3|||
161792166|NCT05431153|584282366|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792167|NCT05431153|584282367|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792168|NCT05431153|584282368|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792169|NCT05431153|584282369|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792170|NCT05431153|584282370|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161792171|NCT05431153|584282371|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792172|NCT00678392|584282372|FG000|Overall Study|Adverse Event|0|||
161792173|NCT00678392|584282373|FG001|Overall Study|Adverse Event|6|||
161792174|NCT00678392|584282372|FG000|Overall Study|Death|280|||
161792175|NCT00678392|584282373|FG001|Overall Study|Death|269|||
161792176|NCT00678392|584282372|FG000|Overall Study|Lost to Follow-up|15|||
161792177|NCT00678392|584282373|FG001|Overall Study|Lost to Follow-up|13|||
161792178|NCT00678392|584282372|FG000|Overall Study|Objective Progression or Relapse|3|||
161792179|NCT00678392|584282373|FG001|Overall Study|Objective Progression or Relapse|8|||
161792180|NCT00678392|584282372|FG000|Overall Study|Sponsor's Decision|1|||
161792181|NCT00678392|584282373|FG001|Overall Study|Sponsor's Decision|2|||
161792182|NCT00678392|584282372|FG000|Overall Study|Withdrawal by Subject|4|||
161792183|NCT00678392|584282373|FG001|Overall Study|Withdrawal by Subject|4|||
161792184|NCT00678392|584282372|FG000|Overall Study|Randomized But Not Treated|2|||
161898830|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898831|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161792185|NCT00678392|584282373|FG001|Overall Study|Randomized But Not Treated|7|||
161792186|NCT00678392|584282372|FG000|Overall Study|Other|56|||
161792187|NCT00678392|584282373|FG001|Overall Study|Other|53|||
161898832|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
161792188|NCT03341507|584282374|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
161792189|NCT00989261|584282376|FG000|Overall Study|Still in follow up|12|||
161792190|NCT00989261|584282377|FG001|Overall Study|Still in follow up|21|||
161792191|NCT00989261|584282376|FG000|Overall Study|Withdrawal by Subject|0|||
161792192|NCT00989261|584282377|FG001|Overall Study|Withdrawal by Subject|1|||
161792193|NCT00989261|584282376|FG000|Overall Study|Lost to Follow-up|3|||
161792194|NCT00989261|584282377|FG001|Overall Study|Lost to Follow-up|0|||
161792195|NCT00782509|584282378|FG000|Overall Study|Adverse Event|20|||
161792196|NCT00782509|584282379|FG001|Overall Study|Adverse Event|10|||
161792197|NCT00782509|584282380|FG002|Overall Study|Adverse Event|20|||
161792198|NCT00782509|584282378|FG000|Overall Study|Lost to Follow-up|1|||
161792199|NCT00782509|584282379|FG001|Overall Study|Lost to Follow-up|2|||
161792200|NCT00782509|584282380|FG002|Overall Study|Lost to Follow-up|3|||
161792201|NCT00782509|584282378|FG000|Overall Study|Withdrawal by Subject|3|||
161792202|NCT00782509|584282379|FG001|Overall Study|Withdrawal by Subject|5|||
161792203|NCT00782509|584282380|FG002|Overall Study|Withdrawal by Subject|8|||
161792204|NCT00782509|584282378|FG000|Overall Study|Non compliance with protocol|2|||
161792205|NCT00782509|584282379|FG001|Overall Study|Non compliance with protocol|0|||
161792206|NCT00782509|584282380|FG002|Overall Study|Non compliance with protocol|0|||
161792207|NCT00782509|584282378|FG000|Overall Study|Other reasons not stated above|5|||
161792208|NCT00782509|584282379|FG001|Overall Study|Other reasons not stated above|2|||
161792209|NCT00782509|584282380|FG002|Overall Study|Other reasons not stated above|3|||
161792210|NCT00782509|584282378|FG000|Overall Study|Lack of Efficacy|10|||
161792211|NCT00782509|584282379|FG001|Overall Study|Lack of Efficacy|5|||
161792212|NCT00782509|584282380|FG002|Overall Study|Lack of Efficacy|2|||
161792213|NCT01401478|584282391|FG000|Overall Study|Study drug not available|6|||
161792214|NCT01401478|584282391|FG000|Overall Study|Adverse Event|5|||
161792215|NCT01401478|584282391|FG000|Overall Study|Hyperphosphatemia|5|||
161792216|NCT01401478|584282391|FG000|Overall Study|Lost to Follow-up|5|||
161792217|NCT01401478|584282391|FG000|Overall Study|Kidney transplantation|3|||
161792218|NCT01401478|584282391|FG000|Overall Study|Withdrawal by Subject|3|||
161792219|NCT01401478|584282391|FG000|Overall Study|Blood samples not available|1|||
161792220|NCT01401478|584282391|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
161792221|NCT01401478|584282391|FG000|Overall Study|Low intact parathyroid hormone|1|||
161792222|NCT01401478|584282391|FG000|Overall Study|Serious adverse event|1|||
161792223|NCT01814137|584282393|FG000|Overall Study|Adverse Event|0|||
161792224|NCT01814137|584282394|FG001|Overall Study|Adverse Event|1|||
161792225|NCT01814137|584282393|FG000|Overall Study|Withdrawal by Subject|2|||
161792226|NCT01814137|584282394|FG001|Overall Study|Withdrawal by Subject|2|||
161792227|NCT01814137|584282393|FG000|Overall Study|Physician Decision|1|||
161792228|NCT01814137|584282394|FG001|Overall Study|Physician Decision|1|||
161792229|NCT01814137|584282393|FG000|Overall Study|Unclassified|2|||
161792230|NCT01814137|584282394|FG001|Overall Study|Unclassified|1|||
161792231|NCT01798485|584282395|FG000|Overall Study|Adverse Event|32|||
161792232|NCT01798485|584282396|FG001|Overall Study|Adverse Event|40|||
161792233|NCT01798485|584282395|FG000|Overall Study|Withdrawal by Subject|27|||
161792234|NCT01798485|584282396|FG001|Overall Study|Withdrawal by Subject|31|||
161792235|NCT01798485|584282395|FG000|Overall Study|Lost to Follow-up|0|||
161792236|NCT01798485|584282396|FG001|Overall Study|Lost to Follow-up|3|||
161792237|NCT01798485|584282395|FG000|Overall Study|Physician Decision|14|||
161792238|NCT01798485|584282396|FG001|Overall Study|Physician Decision|10|||
161792239|NCT01798485|584282395|FG000|Overall Study|Objective Disease Progression|152|||
161792240|NCT01798485|584282396|FG001|Overall Study|Objective Disease Progression|106|||
161792241|NCT01798485|584282395|FG000|Overall Study|Death|25|||
161792242|NCT01798485|584282396|FG001|Overall Study|Death|22|||
161792243|NCT01798485|584282395|FG000|Overall Study|Sponsor Decision|61|||
161792244|NCT01798485|584282396|FG001|Overall Study|Sponsor Decision|54|||
161792245|NCT01798485|584282395|FG000|Overall Study|Clinical Progression|35|||
161792246|NCT01798485|584282396|FG001|Overall Study|Clinical Progression|24|||
161792247|NCT00770991|584282397|FG000|Overall Study|Physician Decision|2|||
161792248|NCT00770991|584282398|FG001|Overall Study|Physician Decision|0|||
161792249|NCT00770991|584282397|FG000|Overall Study|Withdrawal by Subject|1|||
161792250|NCT00770991|584282398|FG001|Overall Study|Withdrawal by Subject|0|||
161792251|NCT00770991|584282397|FG000|Overall Study|Adverse Event|1|||
161792252|NCT00770991|584282398|FG001|Overall Study|Adverse Event|5|||
161792253|NCT00770991|584282397|FG000|Overall Study|Pregnancy|1|||
161792254|NCT00770991|584282398|FG001|Overall Study|Pregnancy|0|||
161792255|NCT03687125|584282399|FG000|Overall Study|Progressive Disease|2|||
161792256|NCT03687125|584282400|FG001|Overall Study|Progressive Disease|1|||
161792257|NCT03687125|584282399|FG000|Overall Study|Protocol Violation|1|||
161792258|NCT03687125|584282400|FG001|Overall Study|Protocol Violation|0|||
161792259|NCT00633152|584284347|FG000|Overall Study|Adverse Event|1|||
161792260|NCT00633152|584284348|FG001|Overall Study|Adverse Event|0|||
161792261|NCT00633152|584284347|FG000|Overall Study|Randomized, did not receive study drug|5|||
161792262|NCT00633152|584284348|FG001|Overall Study|Randomized, did not receive study drug|2|||
161792263|NCT00633152|584284347|FG000|Overall Study|Withdrawal by Subject|1|||
161792264|NCT00633152|584284348|FG001|Overall Study|Withdrawal by Subject|1|||
161792265|NCT00633152|584284347|FG000|Overall Study|Lost to Follow-up|4|||
161792266|NCT00633152|584284348|FG001|Overall Study|Lost to Follow-up|1|||
161792267|NCT00633152|584284347|FG000|Overall Study|Miscellaneous Other|3|||
161792268|NCT00633152|584284348|FG001|Overall Study|Miscellaneous Other|2|||
161792269|NCT02180061|584284349|FG000|Overall Study|Adverse Event|4|||
161792270|NCT02180061|584284350|FG001|Overall Study|Adverse Event|2|||
161792271|NCT02180061|584284349|FG000|Overall Study|Clinical Progression|5|||
161792272|NCT02180061|584284350|FG001|Overall Study|Clinical Progression|1|||
161792273|NCT02180061|584284349|FG000|Overall Study|Progressive Disease|15|||
161792274|NCT02180061|584284350|FG001|Overall Study|Progressive Disease|5|||
161792275|NCT02180061|584284349|FG000|Overall Study|Physician Decision|1|||
161792276|NCT02180061|584284350|FG001|Overall Study|Physician Decision|0|||
161792277|NCT01579474|584284351|FG000|Overall Study|Adverse Event|1|||
161792278|NCT01579474|584284352|FG001|Overall Study|Adverse Event|13|||
161792279|NCT01579474|584284353|FG002|Overall Study|Adverse Event|2|||
161792280|NCT01579474|584284354|FG003|Overall Study|Adverse Event|0|||
161792281|NCT01579474|584284355|FG004|Overall Study|Adverse Event|0|||
161792282|NCT01579474|584284356|FG005|Overall Study|Adverse Event|1|||
161792283|NCT01579474|584284351|FG000|Overall Study|Lack of Efficacy|1|||
161792284|NCT01579474|584284352|FG001|Overall Study|Lack of Efficacy|0|||
161792285|NCT01579474|584284353|FG002|Overall Study|Lack of Efficacy|0|||
161792286|NCT01579474|584284354|FG003|Overall Study|Lack of Efficacy|0|||
161792287|NCT01579474|584284355|FG004|Overall Study|Lack of Efficacy|1|||
161792288|NCT01579474|584284356|FG005|Overall Study|Lack of Efficacy|0|||
161792289|NCT01579474|584284351|FG000|Overall Study|Withdrawal by Subject|1|||
161792290|NCT01579474|584284352|FG001|Overall Study|Withdrawal by Subject|0|||
161792291|NCT01579474|584284353|FG002|Overall Study|Withdrawal by Subject|0|||
161792292|NCT01579474|584284354|FG003|Overall Study|Withdrawal by Subject|0|||
161792293|NCT01579474|584284355|FG004|Overall Study|Withdrawal by Subject|0|||
161792294|NCT01579474|584284356|FG005|Overall Study|Withdrawal by Subject|0|||
161792295|NCT02295774|584284357|FG000|Overall Study|Physician Decision|1|||
161792296|NCT02295774|584284357|FG000|Overall Study|Withdrawal by Subject|2|||
161792297|NCT03532009|584284361|FG000|Overall Study|Other|1|||
161792298|NCT03532009|584284362|FG001|Overall Study|Other|1|||
161792299|NCT03532009|584284361|FG000|Overall Study|Death|1|||
161792300|NCT03532009|584284362|FG001|Overall Study|Death|1|||
161792301|NCT03532009|584284361|FG000|Overall Study|Withdrawal by Patient|0|||
161792302|NCT03532009|584284362|FG001|Overall Study|Withdrawal by Patient|2|||
161792303|NCT00368966|584284363|FG000|Infant Series|Withdrawal by Subject|11|||
161792304|NCT00368966|584284364|FG001|Infant Series|Withdrawal by Subject|6|||
161792305|NCT00368966|584284363|FG000|Infant Series|Protocol Violation|2|||
161792306|NCT00368966|584284364|FG001|Infant Series|Protocol Violation|1|||
161792307|NCT00368966|584284363|FG000|Infant Series|Lost to Follow-up|2|||
161792308|NCT00368966|584284364|FG001|Infant Series|Lost to Follow-up|0|||
161792309|NCT00368966|584284363|FG000|Infant Series|Randomization error|0|||
161792310|NCT00368966|584284364|FG001|Infant Series|Randomization error|1|||
161792311|NCT00368966|584284363|FG000|Infant Series|Failed to meet eligibility criteria|0|||
161792312|NCT00368966|584284364|FG001|Infant Series|Failed to meet eligibility criteria|1|||
161792313|NCT00368966|584284363|FG000|Infant Series|Adverse Event|0|||
161792314|NCT00368966|584284364|FG001|Infant Series|Adverse Event|1|||
161792315|NCT00368966|584284363|FG000|Infant Series|Failed to return|1|||
161792316|NCT00368966|584284364|FG001|Infant Series|Failed to return|0|||
161792317|NCT00368966|584284363|FG000|After Infant|Failed to return|3|||
161792318|NCT00368966|584284364|FG001|After Infant|Failed to return|1|||
161792319|NCT00368966|584284363|FG000|After Infant|Adverse Event|1|||
161792320|NCT00368966|584284364|FG001|After Infant|Adverse Event|2|||
161792321|NCT00368966|584284363|FG000|After Infant|Withdrawal by Subject|1|||
161792322|NCT00368966|584284364|FG001|After Infant|Withdrawal by Subject|1|||
161792323|NCT00368966|584284363|FG000|After Infant|Death|1|||
161792324|NCT00368966|584284364|FG001|After Infant|Death|0|||
161792325|NCT00368966|584284363|FG000|After Infant|Lost to Follow-up|0|||
161792326|NCT00368966|584284364|FG001|After Infant|Lost to Follow-up|1|||
161792327|NCT00368966|584284363|FG000|Toddler Dose|Withdrawal by Subject|1|||
161792328|NCT00368966|584284364|FG001|Toddler Dose|Withdrawal by Subject|1|||
161792329|NCT00368966|584284363|FG000|Toddler Dose|Lost to Follow-up|0|||
161792330|NCT00368966|584284364|FG001|Toddler Dose|Lost to Follow-up|2|||
161792331|NCT02866175|584284365|FG000|Overall Study|Adverse Event|56|||
161792332|NCT02866175|584284366|FG001|Overall Study|Adverse Event|54|||
161792333|NCT02866175|584284365|FG000|Overall Study|Withdrawal by Subject|31|||
161792334|NCT02866175|584284366|FG001|Overall Study|Withdrawal by Subject|52|||
161792335|NCT02866175|584284365|FG000|Overall Study|Death|30|||
161792336|NCT02866175|584284366|FG001|Overall Study|Death|23|||
161792337|NCT02866175|584284365|FG000|Overall Study|Other|7|||
161792338|NCT02866175|584284366|FG001|Overall Study|Other|14|||
161792339|NCT02866175|584284365|FG000|Overall Study|Progressive disease|1|||
161792340|NCT02866175|584284366|FG001|Overall Study|Progressive disease|1|||
161792341|NCT02866175|584284365|FG000|Overall Study|Lost to Follow-up|2|||
161792342|NCT02866175|584284366|FG001|Overall Study|Lost to Follow-up|0|||
161792343|NCT02866175|584284365|FG000|Overall Study|Lack of Efficacy|0|||
161792344|NCT02866175|584284366|FG001|Overall Study|Lack of Efficacy|1|||
161792345|NCT02866175|584284365|FG000|Overall Study|Physician Decision|3|||
161792346|NCT02866175|584284366|FG001|Overall Study|Physician Decision|15|||
161792347|NCT02866175|584284365|FG000|Overall Study|Did not receive treatment|5|||
161792348|NCT02866175|584284366|FG001|Overall Study|Did not receive treatment|15|||
161792349|NCT01694485|584284373|FG000|Overall Study|Withdrawal by Subject|20|||
161792350|NCT01694485|584284374|FG001|Overall Study|Withdrawal by Subject|6|||
161792351|NCT01694485|584284375|FG002|Overall Study|Withdrawal by Subject|7|||
161792352|NCT01694485|584284376|FG003|Overall Study|Withdrawal by Subject|25|||
161792353|NCT01694485|584284377|FG004|Overall Study|Withdrawal by Subject|18|||
161792354|NCT01694485|584284373|FG000|Overall Study|Sponsor Decision|3|||
161792355|NCT01694485|584284374|FG001|Overall Study|Sponsor Decision|0|||
161792356|NCT01694485|584284375|FG002|Overall Study|Sponsor Decision|0|||
161792357|NCT01694485|584284376|FG003|Overall Study|Sponsor Decision|2|||
161792358|NCT01694485|584284377|FG004|Overall Study|Sponsor Decision|0|||
161792359|NCT01694485|584284373|FG000|Overall Study|Lost to Follow-up|9|||
161792360|NCT01694485|584284374|FG001|Overall Study|Lost to Follow-up|1|||
161792361|NCT01694485|584284375|FG002|Overall Study|Lost to Follow-up|6|||
161792362|NCT01694485|584284376|FG003|Overall Study|Lost to Follow-up|10|||
161792363|NCT01694485|584284377|FG004|Overall Study|Lost to Follow-up|7|||
161792364|NCT01694485|584284373|FG000|Overall Study|Death|1|||
161792365|NCT01694485|584284374|FG001|Overall Study|Death|0|||
161443745|NCT02963506|583017295|FG003|Dose-Blind Period|Sponsor decision|0|||
161792366|NCT01694485|584284375|FG002|Overall Study|Death|0|||
161792367|NCT01694485|584284376|FG003|Overall Study|Death|1|||
161792368|NCT01694485|584284377|FG004|Overall Study|Death|0|||
161792369|NCT02907203|584284378|FG000|Overall Study|Death|1|||
161792370|NCT02907203|584284378|FG000|Overall Study|Lost to Follow-up|3|||
161792371|NCT02907203|584284378|FG000|Overall Study|Withdrawal by Subject|3|||
161792372|NCT02907203|584284378|FG000|Overall Study|Surgical bypass|1|||
161792373|NCT01418352|584284379|FG000|Overall Study|Lost to Follow-up|2|||
161792374|NCT01418352|584284380|FG001|Overall Study|Lost to Follow-up|0|||
161792375|NCT01418352|584284381|FG002|Overall Study|Lost to Follow-up|0|||
161792376|NCT01418352|584284382|FG003|Overall Study|Lost to Follow-up|0|||
161792377|NCT01418352|584284379|FG000|Overall Study|Adverse Event|0|||
161792378|NCT01418352|584284380|FG001|Overall Study|Adverse Event|1|||
161792379|NCT01418352|584284381|FG002|Overall Study|Adverse Event|0|||
161792380|NCT01418352|584284382|FG003|Overall Study|Adverse Event|0|||
161792381|NCT01418352|584284379|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
161792382|NCT01418352|584284380|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
161792383|NCT01418352|584284381|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
161792384|NCT01418352|584284382|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
161792385|NCT01418352|584284379|FG000|Overall Study|Subject Withdrew Consent|0|||
161792386|NCT01418352|584284380|FG001|Overall Study|Subject Withdrew Consent|1|||
161792387|NCT01418352|584284381|FG002|Overall Study|Subject Withdrew Consent|2|||
161792388|NCT01418352|584284382|FG003|Overall Study|Subject Withdrew Consent|1|||
161792389|NCT01418352|584284379|FG000|Overall Study|Protocol Deviation|0|||
161792390|NCT01418352|584284380|FG001|Overall Study|Protocol Deviation|0|||
161792391|NCT01418352|584284381|FG002|Overall Study|Protocol Deviation|1|||
161792392|NCT01418352|584284382|FG003|Overall Study|Protocol Deviation|0|||
161792393|NCT01418352|584284379|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
161792394|NCT01418352|584284380|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161792395|NCT01418352|584284381|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161792396|NCT01418352|584284382|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161792397|NCT00619619|584284383|FG000|Overall Study|Physician Decision|0|||
161792398|NCT00619619|584284384|FG001|Overall Study|Physician Decision|0|||
161792399|NCT00619619|584284385|FG002|Overall Study|Physician Decision|1|||
161792400|NCT00619619|584284386|FG003|Overall Study|Physician Decision|0|||
161792401|NCT00619619|584284387|FG004|Overall Study|Physician Decision|0|||
161792402|NCT00619619|584284388|FG005|Overall Study|Physician Decision|0|||
161792403|NCT00619619|584284389|FG006|Overall Study|Physician Decision|0|||
161792404|NCT00619619|584284390|FG007|Overall Study|Physician Decision|0|||
161792405|NCT00619619|584284383|FG000|Overall Study|Protocol Violation|0|||
161792406|NCT00619619|584284384|FG001|Overall Study|Protocol Violation|0|||
161792407|NCT00619619|584284385|FG002|Overall Study|Protocol Violation|0|||
161792408|NCT00619619|584284386|FG003|Overall Study|Protocol Violation|1|||
161792409|NCT00619619|584284387|FG004|Overall Study|Protocol Violation|0|||
161792410|NCT00619619|584284388|FG005|Overall Study|Protocol Violation|0|||
161792411|NCT00619619|584284389|FG006|Overall Study|Protocol Violation|1|||
161792412|NCT00619619|584284390|FG007|Overall Study|Protocol Violation|1|||
161792413|NCT00619619|584284383|FG000|Overall Study|Adverse Event|0|||
161792414|NCT00619619|584284384|FG001|Overall Study|Adverse Event|0|||
161792415|NCT00619619|584284385|FG002|Overall Study|Adverse Event|0|||
161792416|NCT00619619|584284386|FG003|Overall Study|Adverse Event|0|||
161792417|NCT00619619|584284387|FG004|Overall Study|Adverse Event|2|||
161792418|NCT00619619|584284388|FG005|Overall Study|Adverse Event|0|||
161792419|NCT00619619|584284389|FG006|Overall Study|Adverse Event|0|||
161792420|NCT00619619|584284390|FG007|Overall Study|Adverse Event|2|||
161792421|NCT01992107|584284391|FG000|Overall Study|Administrative reasons|2|||
161792422|NCT01992107|584284392|FG001|Overall Study|Administrative reasons|0|||
161792423|NCT01992107|584284393|FG002|Overall Study|Administrative reasons|0|||
161792424|NCT01992107|584284391|FG000|Overall Study|Adverse Event|0|||
161792425|NCT01992107|584284392|FG001|Overall Study|Adverse Event|1|||
161792426|NCT01992107|584284393|FG002|Overall Study|Adverse Event|0|||
161792427|NCT01992107|584284391|FG000|Overall Study|Lost to Follow-up|46|||
161792428|NCT01992107|584284392|FG001|Overall Study|Lost to Follow-up|22|||
161792429|NCT01992107|584284393|FG002|Overall Study|Lost to Follow-up|26|||
161792430|NCT01992107|584284391|FG000|Overall Study|noncompliance and were unavailable|7|||
161792431|NCT01992107|584284392|FG001|Overall Study|noncompliance and were unavailable|3|||
161792432|NCT01992107|584284393|FG002|Overall Study|noncompliance and were unavailable|2|||
161792433|NCT01992107|584284391|FG000|Overall Study|Withdrawal by Subject|13|||
161792434|NCT01992107|584284392|FG001|Overall Study|Withdrawal by Subject|7|||
161792435|NCT01992107|584284393|FG002|Overall Study|Withdrawal by Subject|8|||
161792436|NCT02022007|584284394|FG000|Overall Study|Withdrawal by Subject|1|||
161792437|NCT02022007|584284395|FG001|Overall Study|Withdrawal by Subject|1|||
161792438|NCT02022007|584284396|FG002|Overall Study|Withdrawal by Subject|1|||
161792439|NCT02022007|584284394|FG000|Overall Study|Noncompliant|0|||
161792440|NCT02022007|584284395|FG001|Overall Study|Noncompliant|0|||
161792441|NCT02022007|584284396|FG002|Overall Study|Noncompliant|1|||
161792442|NCT01214603|584284398|FG000|Overall Study|Adverse Event|0|||
161792443|NCT01214603|584284399|FG001|Overall Study|Adverse Event|0|||
161792444|NCT01214603|584284400|FG002|Overall Study|Adverse Event|1|||
161792445|NCT01214603|584284398|FG000|Overall Study|Death|1|||
161792446|NCT01214603|584284399|FG001|Overall Study|Death|0|||
161792447|NCT01214603|584284400|FG002|Overall Study|Death|0|||
161792448|NCT01214603|584284398|FG000|Overall Study|Progressive Disease|4|||
161792449|NCT01214603|584284399|FG001|Overall Study|Progressive Disease|1|||
161792450|NCT01214603|584284400|FG002|Overall Study|Progressive Disease|3|||
161792451|NCT01507896|584284401|FG000|Overall Study|Withdrawal by Subject|1|||
161792452|NCT01507896|584284401|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
161792453|NCT00490061|584284402|FG000|Overall Study|Physician Decision|1|||
161792454|NCT00952484|584284403|FG000|Overall Study|Withdrawal by Subject|0|||
161792455|NCT00952484|584284404|FG001|Overall Study|Withdrawal by Subject|1|||
161792456|NCT00952484|584284405|FG002|Overall Study|Withdrawal by Subject|0|||
161792457|NCT02750306|584284410|FG000|Overall Study|Withdrawal by Subject|5|||
161792458|NCT02750306|584284411|FG001|Overall Study|Withdrawal by Subject|2|||
161792459|NCT02750306|584284410|FG000|Overall Study|Protocol Violation|1|||
161792460|NCT02750306|584284411|FG001|Overall Study|Protocol Violation|0|||
161792461|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
161792462|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
161792463|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
161792464|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
161792465|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
161792466|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
161792467|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
161792468|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
161792469|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
161792470|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
161792471|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
161792472|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
161792473|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
161792474|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
161792475|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
161792476|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
161792477|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
161792478|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
161792479|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
161792480|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
161792481|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
161792482|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
161792483|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
161792484|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
161792485|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
161792486|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
161792487|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792488|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792489|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792490|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792491|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792492|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792493|NCT00585351|584284415|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792494|NCT00585351|584284416|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792495|NCT00585351|584284417|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792496|NCT00585351|584284418|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792497|NCT00585351|584284419|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792498|NCT00585351|584284420|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792499|NCT00585351|584284421|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
161792500|NCT00585351|584284422|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
161792501|NCT00585351|584284415|FG000|Enrollment Period (Intervention)|Death|0|||
161792502|NCT00585351|584284416|FG001|Enrollment Period (Intervention)|Death|0|||
161792503|NCT00585351|584284417|FG002|Enrollment Period (Intervention)|Death|0|||
161792504|NCT00585351|584284418|FG003|Enrollment Period (Intervention)|Death|0|||
161792505|NCT00585351|584284419|FG004|Enrollment Period (Intervention)|Death|1|||
161792506|NCT00585351|584284420|FG005|Enrollment Period (Intervention)|Death|0|||
161792507|NCT00585351|584284421|FG006|Enrollment Period (Intervention)|Death|1|||
161792508|NCT00585351|584284422|FG007|Enrollment Period (Intervention)|Death|0|||
161792509|NCT00585351|584284415|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792510|NCT00585351|584284416|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792511|NCT00585351|584284417|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792512|NCT00585351|584284418|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792513|NCT00585351|584284419|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
161792514|NCT00585351|584284420|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
161792515|NCT00585351|584284421|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792516|NCT00585351|584284422|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792517|NCT00192296|584284423|FG000|Overall Study|Withdrawal by Subject|0|||
161792518|NCT00192296|584284424|FG001|Overall Study|Withdrawal by Subject|1|||
161792519|NCT00192296|584284425|FG002|Overall Study|Withdrawal by Subject|0|||
161792520|NCT00192296|584284426|FG003|Overall Study|Withdrawal by Subject|0|||
161792521|NCT02536378|584284433|FG000|Overall Study|Physician Decision|0|||
161792522|NCT02536378|584284434|FG001|Overall Study|Physician Decision|2|||
161792523|NCT02536378|584284433|FG000|Overall Study|Withdrawal by Subject|0|||
161792524|NCT02536378|584284434|FG001|Overall Study|Withdrawal by Subject|1|||
161792525|NCT02536378|584284433|FG000|Overall Study|Death|1|||
161792526|NCT02536378|584284434|FG001|Overall Study|Death|2|||
161792527|NCT02536378|584284433|FG000|Overall Study|Patient refused further follow up|6|||
161792528|NCT02536378|584284434|FG001|Overall Study|Patient refused further follow up|2|||
161792529|NCT00457665|584284440|FG000|12 Months|Drug allergy|1|||
161792530|NCT00457665|584284441|FG001|12 Months|Drug allergy|1|||
161792531|NCT00457665|584284440|FG000|12 Months|High HIV viral load|5|||
161792532|NCT00457665|584284441|FG001|12 Months|High HIV viral load|1|||
161792533|NCT00457665|584284440|FG000|12 Months|Lipodystrophy|2|||
161792534|NCT00457665|584284441|FG001|12 Months|Lipodystrophy|0|||
161792535|NCT00457665|584284440|FG000|12 Months|Withdrawal by Subject|0|||
161792536|NCT00457665|584284441|FG001|12 Months|Withdrawal by Subject|2|||
161792537|NCT00457665|584284440|FG000|12 Months|Abnormal Liver function tests|0|||
161792538|NCT00457665|584284441|FG001|12 Months|Abnormal Liver function tests|5|||
161792539|NCT00457665|584284440|FG000|24 Months|Withdrawal by Subject|3|||
161792540|NCT00457665|584284441|FG001|24 Months|Withdrawal by Subject|2|||
161792541|NCT00457665|584284440|FG000|24 Months|Lipodystrophy|1|||
161792542|NCT00457665|584284441|FG001|24 Months|Lipodystrophy|1|||
161792543|NCT00457665|584284440|FG000|24 Months|Abnormal liver function tests|1|||
161792544|NCT00457665|584284441|FG001|24 Months|Abnormal liver function tests|5|||
161792545|NCT00446654|584284442|FG000|Overall Study|Withdrawal by Subject|1|||
161792546|NCT00446654|584284443|FG001|Overall Study|Withdrawal by Subject|0|||
161792547|NCT00446654|584284442|FG000|Overall Study|Adverse Event|1|||
161792548|NCT00446654|584284443|FG001|Overall Study|Adverse Event|0|||
161792549|NCT02535000|584284445|FG000|Overall Study|Cancellation of surgery.|1|||
161792550|NCT02535000|584284446|FG001|Overall Study|Cancellation of surgery.|2|||
161792551|NCT04317781|584284447|FG000|Overall Study|Adverse Event|1|||
161792552|NCT04317781|584284447|FG000|Overall Study|Disease relapse|1|||
161792553|NCT04317781|584284447|FG000|Overall Study|Withdrawal by Subject|1|||
161792554|NCT01875445|584284453|FG000|Overall Study|Lost to Follow-up|5|||
161792555|NCT01875445|584284454|FG001|Overall Study|Lost to Follow-up|0|||
161792556|NCT01875445|584284453|FG000|Overall Study|Withdrawal by Subject|2|||
161792557|NCT01875445|584284454|FG001|Overall Study|Withdrawal by Subject|0|||
161792558|NCT01102777|584284455|FG000|Overall Study|Death|2|||
161792559|NCT01102777|584284456|FG001|Overall Study|Death|6|||
161792560|NCT01102777|584284455|FG000|Overall Study|Lost to Follow-up|7|||
161792561|NCT01102777|584284456|FG001|Overall Study|Lost to Follow-up|10|||
161443746|NCT02963506|583017296|FG004|Dose-Blind Period|Sponsor decision|0|||
161792562|NCT00706706|584284457|FG000|Overall Study|Death|53|||
161792563|NCT00706706|584284457|FG000|Overall Study|Lost to Follow-up|7|||
161792564|NCT00706706|584284457|FG000|Overall Study|Study endpoint had reached|45|||
161792565|NCT02175966|584284462|FG000|Follow-up Period|Lack of Efficacy|10|||
161792566|NCT02175966|584284463|FG001|Follow-up Period|Lack of Efficacy|6|||
161792567|NCT00210626|584284464|FG000|Overall Study|Adverse Event|1|||
161792568|NCT00210626|584284465|FG001|Overall Study|Adverse Event|2|||
161792569|NCT00210626|584284464|FG000|Overall Study|Protocol Violation|1|||
161792570|NCT00210626|584284465|FG001|Overall Study|Protocol Violation|5|||
161792571|NCT00210626|584284464|FG000|Overall Study|Lost to Follow-up|11|||
161792572|NCT00210626|584284465|FG001|Overall Study|Lost to Follow-up|11|||
161792573|NCT00210626|584284464|FG000|Overall Study|Death|1|||
161792574|NCT00210626|584284465|FG001|Overall Study|Death|0|||
161792575|NCT00210626|584284464|FG000|Overall Study|Withdrawal by Subject|29|||
161792576|NCT00210626|584284465|FG001|Overall Study|Withdrawal by Subject|20|||
161792577|NCT00210626|584284464|FG000|Overall Study|Physician Decision|0|||
161792578|NCT00210626|584284465|FG001|Overall Study|Physician Decision|2|||
161792579|NCT00210626|584284464|FG000|Overall Study|Sponser Request|1|||
161792580|NCT00210626|584284465|FG001|Overall Study|Sponser Request|0|||
161792581|NCT00210626|584284464|FG000|Overall Study|Other|4|||
161792582|NCT00210626|584284465|FG001|Overall Study|Other|5|||
161792583|NCT03469271|584284466|FG000|Overall Study|Withdrawal by Subject|2|||
161792584|NCT03469271|584284467|FG001|Overall Study|Withdrawal by Subject|0|||
161792585|NCT03469271|584284468|FG002|Overall Study|Withdrawal by Subject|0|||
161792586|NCT03469271|584284469|FG003|Overall Study|Withdrawal by Subject|1|||
161792587|NCT03760510|584284470|FG000|Overall Study|Not ventilated for 24 hours|105|||
161792588|NCT03760510|584284471|FG001|Overall Study|Not ventilated for 24 hours|97|||
161792589|NCT03361956|584284472|FG000|Overall Study|Adverse Event|1|||
161792590|NCT03361956|584284473|FG001|Overall Study|Adverse Event|0|||
161792591|NCT03361956|584284474|FG002|Overall Study|Adverse Event|1|||
161792592|NCT03361956|584284475|FG003|Overall Study|Adverse Event|1|||
161792593|NCT03361956|584284476|FG004|Overall Study|Adverse Event|0|||
161792594|NCT03361956|584284472|FG000|Overall Study|Other|0|||
161792595|NCT03361956|584284473|FG001|Overall Study|Other|0|||
161792596|NCT03361956|584284474|FG002|Overall Study|Other|0|||
161792597|NCT03361956|584284475|FG003|Overall Study|Other|1|||
161792598|NCT03361956|584284476|FG004|Overall Study|Other|0|||
161792599|NCT03361956|584284472|FG000|Overall Study|Withdrawal by Subject|2|||
161792600|NCT03361956|584284473|FG001|Overall Study|Withdrawal by Subject|2|||
161792601|NCT03361956|584284474|FG002|Overall Study|Withdrawal by Subject|2|||
161792602|NCT03361956|584284475|FG003|Overall Study|Withdrawal by Subject|0|||
161792603|NCT03361956|584284476|FG004|Overall Study|Withdrawal by Subject|3|||
161792604|NCT03361956|584284472|FG000|Overall Study|Disease Relapse|0|||
161792605|NCT03361956|584284473|FG001|Overall Study|Disease Relapse|0|||
161792606|NCT03361956|584284474|FG002|Overall Study|Disease Relapse|1|||
161792607|NCT03361956|584284475|FG003|Overall Study|Disease Relapse|0|||
161792608|NCT03361956|584284476|FG004|Overall Study|Disease Relapse|0|||
161792609|NCT03361956|584284472|FG000|Overall Study|Physician Decision|0|||
161792610|NCT03361956|584284473|FG001|Overall Study|Physician Decision|2|||
161792611|NCT03361956|584284474|FG002|Overall Study|Physician Decision|0|||
161792612|NCT03361956|584284475|FG003|Overall Study|Physician Decision|1|||
161792613|NCT03361956|584284476|FG004|Overall Study|Physician Decision|0|||
161792614|NCT03361956|584284472|FG000|Overall Study|Lost to Follow-up|0|||
161792615|NCT03361956|584284473|FG001|Overall Study|Lost to Follow-up|0|||
161792616|NCT03361956|584284474|FG002|Overall Study|Lost to Follow-up|1|||
161792617|NCT03361956|584284475|FG003|Overall Study|Lost to Follow-up|1|||
161792618|NCT03361956|584284476|FG004|Overall Study|Lost to Follow-up|2|||
161792619|NCT00871728|584284478|FG000|Overall Study|Adverse Event|1|||
161792620|NCT00871728|584284478|FG000|Overall Study|Protocol Violation|7|||
161792621|NCT00871728|584284478|FG000|Overall Study|Lost to Follow-up|2|||
161792622|NCT00871728|584284478|FG000|Overall Study|Failed to Visit Hospital|4|||
161792623|NCT00871728|584284478|FG000|Overall Study|Participant Non-compliance|1|||
161792624|NCT00871728|584284478|FG000|Overall Study|Withdrawal of Informed Consent|5|||
161792625|NCT04147715|584284479|FG000|Overall Study|Adverse Event|0|||
161792626|NCT04147715|584284480|FG001|Overall Study|Adverse Event|0|||
161792627|NCT04147715|584284481|FG002|Overall Study|Adverse Event|0|||
161792628|NCT04147715|584284482|FG003|Overall Study|Adverse Event|0|||
161792629|NCT04147715|584284483|FG004|Overall Study|Adverse Event|0|||
161792630|NCT04147715|584284484|FG005|Overall Study|Adverse Event|0|||
161898833|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898834|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
161898835|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898836|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898837|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898838|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161792631|NCT04147715|584284485|FG006|Overall Study|Adverse Event|0|||
161898839|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
161792632|NCT04147715|584284486|FG007|Overall Study|Adverse Event|2|||
161792633|NCT04147715|584284487|FG008|Overall Study|Adverse Event|1|||
161792634|NCT04147715|584284488|FG009|Overall Study|Adverse Event|0|||
161792635|NCT04147715|584284489|FG010|Overall Study|Adverse Event|0|||
161792636|NCT04147715|584284490|FG011|Overall Study|Adverse Event|0|||
161792637|NCT02418910|584284494|FG000|Overall Study|Lost to Follow-up|3|||
161792638|NCT02418910|584284494|FG000|Overall Study|Withdrawal by Subject|4|||
161792639|NCT02472977|584284499|FG000|Overall Study|Disease progression|4|||
161792640|NCT02472977|584284500|FG001|Overall Study|Disease progression|25|||
161792641|NCT02472977|584284501|FG002|Overall Study|Disease progression|6|||
161792642|NCT02472977|584284499|FG000|Overall Study|Withdrawal by Subject|0|||
161792643|NCT02472977|584284500|FG001|Overall Study|Withdrawal by Subject|1|||
161792644|NCT02472977|584284501|FG002|Overall Study|Withdrawal by Subject|0|||
161792645|NCT02472977|584284499|FG000|Overall Study|Study drug toxicity|2|||
161792646|NCT02472977|584284500|FG001|Overall Study|Study drug toxicity|0|||
161792647|NCT02472977|584284501|FG002|Overall Study|Study drug toxicity|2|||
161792648|NCT02472977|584284499|FG000|Overall Study|Subject request to discontinue treatment|0|||
161792649|NCT02472977|584284500|FG001|Overall Study|Subject request to discontinue treatment|1|||
161792650|NCT02472977|584284501|FG002|Overall Study|Subject request to discontinue treatment|0|||
161792651|NCT02330081|584284506|FG000|Overall Study|Adverse Event|1|||
161792652|NCT02330081|584284506|FG000|Overall Study|Donation did not meet criteria|1|||
161792653|NCT02330081|584284506|FG000|Overall Study|Protocol Violation|6|||
161792654|NCT02277769|584284507|FG000|Overall Study|Protocol Violation|3|||
161792655|NCT02277769|584284508|FG001|Overall Study|Protocol Violation|3|||
161792656|NCT02277769|584284509|FG002|Overall Study|Protocol Violation|5|||
161792657|NCT02277769|584284507|FG000|Overall Study|Lack of Efficacy|17|||
161792658|NCT02277769|584284508|FG001|Overall Study|Lack of Efficacy|0|||
161792659|NCT02277769|584284509|FG002|Overall Study|Lack of Efficacy|4|||
161792660|NCT02277769|584284507|FG000|Overall Study|Adverse Event|14|||
161792661|NCT02277769|584284508|FG001|Overall Study|Adverse Event|2|||
161792662|NCT02277769|584284509|FG002|Overall Study|Adverse Event|4|||
161792663|NCT02277769|584284507|FG000|Overall Study|Other than specified above|12|||
161792664|NCT02277769|584284508|FG001|Overall Study|Other than specified above|8|||
161792665|NCT02277769|584284509|FG002|Overall Study|Other than specified above|5|||
161792666|NCT03775681|584284513|FG000|Overall Study|Physician Decision|3|||
161792667|NCT02123459|584284516|FG000|Washout Period (1 Day)|Adverse Event|1|||
161792668|NCT02123459|584284517|FG001|Washout Period (1 Day)|Adverse Event|0|||
161792669|NCT02196506|584284518|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
161792670|NCT02196506|584284519|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
161792671|NCT02196506|584284520|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
161792672|NCT02196506|584284521|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
161792673|NCT02196506|584284518|FG000|Phase A|Withdrawal by Subject|34|||
161792674|NCT02196506|584284519|FG001|Phase A|Withdrawal by Subject|0|||
161792675|NCT02196506|584284520|FG002|Phase A|Withdrawal by Subject|0|||
161792676|NCT02196506|584284521|FG003|Phase A|Withdrawal by Subject|0|||
161792677|NCT02196506|584284518|FG000|Phase A|Adverse Event|22|||
161792678|NCT02196506|584284519|FG001|Phase A|Adverse Event|0|||
161792679|NCT02196506|584284520|FG002|Phase A|Adverse Event|0|||
161792680|NCT02196506|584284521|FG003|Phase A|Adverse Event|0|||
161792681|NCT02196506|584284518|FG000|Phase A|Lost to Follow-up|9|||
161792682|NCT02196506|584284519|FG001|Phase A|Lost to Follow-up|0|||
161792683|NCT02196506|584284520|FG002|Phase A|Lost to Follow-up|0|||
161792684|NCT02196506|584284521|FG003|Phase A|Lost to Follow-up|0|||
161792685|NCT02196506|584284518|FG000|Phase A|Protocol deviation|12|||
161792686|NCT02196506|584284519|FG001|Phase A|Protocol deviation|0|||
161792687|NCT02196506|584284520|FG002|Phase A|Protocol deviation|0|||
161792688|NCT02196506|584284521|FG003|Phase A|Protocol deviation|0|||
161792689|NCT02196506|584284518|FG000|Phase A|Participant withdrawn by investigator|10|||
161792690|NCT02196506|584284519|FG001|Phase A|Participant withdrawn by investigator|0|||
161792691|NCT02196506|584284520|FG002|Phase A|Participant withdrawn by investigator|0|||
161792692|NCT02196506|584284521|FG003|Phase A|Participant withdrawn by investigator|0|||
161792693|NCT02196506|584284518|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
161792694|NCT02196506|584284519|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
161792695|NCT02196506|584284520|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
161792696|NCT02196506|584284521|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
161792697|NCT02196506|584284518|FG000|Phase B|Lack of Efficacy|0|||
161792698|NCT02196506|584284519|FG001|Phase B|Lack of Efficacy|1|||
161792699|NCT02196506|584284520|FG002|Phase B|Lack of Efficacy|2|||
161792700|NCT02196506|584284521|FG003|Phase B|Lack of Efficacy|0|||
161792701|NCT02196506|584284518|FG000|Phase B|Withdrawal by Participant|0|||
161792702|NCT02196506|584284519|FG001|Phase B|Withdrawal by Participant|8|||
161792703|NCT02196506|584284520|FG002|Phase B|Withdrawal by Participant|1|||
161792704|NCT02196506|584284521|FG003|Phase B|Withdrawal by Participant|0|||
161792705|NCT02196506|584284518|FG000|Phase B|Adverse Event|0|||
161792706|NCT02196506|584284519|FG001|Phase B|Adverse Event|4|||
161792707|NCT02196506|584284520|FG002|Phase B|Adverse Event|1|||
161898840|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161792708|NCT02196506|584284521|FG003|Phase B|Adverse Event|0|||
161792709|NCT02196506|584284518|FG000|Phase B|Lost to Follow-up|0|||
161792710|NCT02196506|584284519|FG001|Phase B|Lost to Follow-up|2|||
161792711|NCT02196506|584284520|FG002|Phase B|Lost to Follow-up|1|||
161792712|NCT02196506|584284521|FG003|Phase B|Lost to Follow-up|0|||
161792713|NCT02196506|584284518|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
161792714|NCT02196506|584284519|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
161792715|NCT02196506|584284520|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
161792716|NCT02196506|584284521|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
161792717|NCT02196506|584284518|FG000|Phase A+|Withdrawal by Participant|0|||
161792718|NCT02196506|584284519|FG001|Phase A+|Withdrawal by Participant|0|||
161792719|NCT02196506|584284520|FG002|Phase A+|Withdrawal by Participant|0|||
161792720|NCT02196506|584284521|FG003|Phase A+|Withdrawal by Participant|5|||
161792721|NCT02196506|584284518|FG000|Phase A+|Adverse Event|0|||
161792722|NCT02196506|584284519|FG001|Phase A+|Adverse Event|0|||
161792723|NCT02196506|584284520|FG002|Phase A+|Adverse Event|0|||
161792724|NCT02196506|584284521|FG003|Phase A+|Adverse Event|1|||
161792725|NCT02196506|584284518|FG000|Phase A+|Lost to Follow-up|0|||
161792726|NCT02196506|584284519|FG001|Phase A+|Lost to Follow-up|0|||
161792727|NCT02196506|584284520|FG002|Phase A+|Lost to Follow-up|0|||
161792728|NCT02196506|584284521|FG003|Phase A+|Lost to Follow-up|6|||
161792729|NCT02196506|584284518|FG000|Phase A+|Participant withdrawn by investigator|0|||
161792730|NCT02196506|584284519|FG001|Phase A+|Participant withdrawn by investigator|0|||
161792731|NCT02196506|584284520|FG002|Phase A+|Participant withdrawn by investigator|0|||
161792732|NCT02196506|584284521|FG003|Phase A+|Participant withdrawn by investigator|1|||
161792733|NCT01070394|584284522|FG000|Overall Study|Adverse Event|6|||
161792734|NCT01070394|584284522|FG000|Overall Study|Withdrawal by Subject|1|||
161792735|NCT01098240|584284523|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
161792736|NCT01098240|584284524|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161792737|NCT01098240|584284525|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161792738|NCT01098240|584284523|FG000|Open-Label Phase|Protocol Violation|4|||
161792739|NCT01098240|584284524|FG001|Open-Label Phase|Protocol Violation|0|||
161792740|NCT01098240|584284525|FG002|Open-Label Phase|Protocol Violation|0|||
161792741|NCT01098240|584284523|FG000|Open-Label Phase|Lost to Follow-up|13|||
161792742|NCT01098240|584284524|FG001|Open-Label Phase|Lost to Follow-up|0|||
161792743|NCT01098240|584284525|FG002|Open-Label Phase|Lost to Follow-up|0|||
161792744|NCT01098240|584284523|FG000|Open-Label Phase|Other|19|||
161792745|NCT01098240|584284524|FG001|Open-Label Phase|Other|0|||
161792746|NCT01098240|584284525|FG002|Open-Label Phase|Other|0|||
161792747|NCT01098240|584284523|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
161792748|NCT01098240|584284524|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161792749|NCT01098240|584284525|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161792750|NCT01098240|584284523|FG000|Open-Label Phase|Pregnancy|1|||
161792751|NCT01098240|584284524|FG001|Open-Label Phase|Pregnancy|0|||
161792752|NCT01098240|584284525|FG002|Open-Label Phase|Pregnancy|0|||
161792753|NCT01098240|584284523|FG000|Open-Label Phase|Withdrawal by Subject|9|||
161792754|NCT01098240|584284524|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161792755|NCT01098240|584284525|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161792756|NCT01098240|584284523|FG000|Open-Label Phase|Adverse Event|12|||
161792757|NCT01098240|584284524|FG001|Open-Label Phase|Adverse Event|0|||
161792758|NCT01098240|584284525|FG002|Open-Label Phase|Adverse Event|0|||
161792759|NCT01098240|584284523|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
161792760|NCT01098240|584284524|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
161792761|NCT01098240|584284525|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
161792762|NCT01098240|584284523|FG000|Double-Blind Phase|Protocol Violation|0|||
161792763|NCT01098240|584284524|FG001|Double-Blind Phase|Protocol Violation|2|||
161792764|NCT01098240|584284525|FG002|Double-Blind Phase|Protocol Violation|4|||
161792765|NCT01098240|584284523|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161792766|NCT01098240|584284524|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161792767|NCT01098240|584284525|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161792768|NCT01098240|584284523|FG000|Double-Blind Phase|Other|0|||
161792769|NCT01098240|584284524|FG001|Double-Blind Phase|Other|2|||
161792770|NCT01098240|584284525|FG002|Double-Blind Phase|Other|2|||
161792771|NCT01098240|584284523|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
161792772|NCT01098240|584284524|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
161792773|NCT01098240|584284525|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
161792774|NCT01098240|584284523|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
161792775|NCT01098240|584284524|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
161792776|NCT01098240|584284525|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
161792777|NCT01098240|584284523|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161792778|NCT01098240|584284524|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
161792779|NCT01098240|584284525|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
161792780|NCT01098240|584284523|FG000|Double-Blind Phase|Adverse Event|0|||
161792781|NCT01098240|584284524|FG001|Double-Blind Phase|Adverse Event|3|||
161792782|NCT01098240|584284525|FG002|Double-Blind Phase|Adverse Event|3|||
161792783|NCT00066807|584284526|FG000|Overall Study|Study was terminated early|14|||
161792784|NCT00066807|584284527|FG001|Overall Study|Study was terminated early|15|||
161792785|NCT03507439|584284528|FG000|Overall Study|Other|2|||
161792786|NCT03507439|584284529|FG001|Overall Study|Other|1|||
161792787|NCT03507439|584284528|FG000|Overall Study|Withdrawal by Subject|1|||
161792788|NCT03507439|584284529|FG001|Overall Study|Withdrawal by Subject|0|||
161792789|NCT03507439|584284528|FG000|Overall Study|Death|1|||
161792790|NCT03507439|584284529|FG001|Overall Study|Death|1|||
161792791|NCT00874757|584284530|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
161792792|NCT03346538|584285919|FG000|Overall Study|Physician Decision|0|||
161792793|NCT03346538|584285920|FG001|Overall Study|Physician Decision|1|||
161792794|NCT03346538|584285921|FG002|Overall Study|Physician Decision|0|||
161792795|NCT03346538|584285919|FG000|Overall Study|Withdrawal by Subject|3|||
161792796|NCT03346538|584285920|FG001|Overall Study|Withdrawal by Subject|2|||
161792797|NCT03346538|584285921|FG002|Overall Study|Withdrawal by Subject|0|||
161792798|NCT03346538|584285919|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
161792799|NCT03346538|584285920|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
161792800|NCT03346538|584285921|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
161792801|NCT04014959|584285923|FG000|Baseline MRI and Assessments|Physician Decision|2|||
161792802|NCT04014959|584285923|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
161792803|NCT04014959|584285923|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
161792804|NCT02004847|584285925|FG000|Overall Study|Protocol Violation|1|||
161792805|NCT02004847|584285926|FG001|Overall Study|Protocol Violation|1|||
161792806|NCT02220920|584285927|FG000|Overall Study|Adverse Event|1|||
161792807|NCT02220920|584285928|FG001|Overall Study|Adverse Event|0|||
161792808|NCT02220920|584285927|FG000|Overall Study|Lack of Efficacy|0|||
161792809|NCT02220920|584285928|FG001|Overall Study|Lack of Efficacy|1|||
161792810|NCT02220920|584285927|FG000|Overall Study|Withdrawal by Subject|1|||
161792811|NCT02220920|584285928|FG001|Overall Study|Withdrawal by Subject|0|||
161792812|NCT02220920|584285927|FG000|Overall Study|Conflict with the stopping criteria|1|||
161792813|NCT02220920|584285928|FG001|Overall Study|Conflict with the stopping criteria|2|||
161792814|NCT01132118|584285932|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
161792815|NCT01132118|584285933|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
161792816|NCT01132118|584285932|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161792817|NCT01132118|584285933|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
161792818|NCT01132118|584285932|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
161792819|NCT01132118|584285933|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
161792820|NCT01644890|584285934|FG000|Overall Study|Adverse Event|7|||
161792821|NCT01644890|584285935|FG001|Overall Study|Adverse Event|20|||
161792822|NCT01644890|584285934|FG000|Overall Study|Death|1|||
161792823|NCT01644890|584285935|FG001|Overall Study|Death|3|||
161792824|NCT01644890|584285934|FG000|Overall Study|Physician Decision|3|||
161792825|NCT01644890|584285935|FG001|Overall Study|Physician Decision|9|||
161792826|NCT01644890|584285934|FG000|Overall Study|Protocol Violation|6|||
161792827|NCT01644890|584285935|FG001|Overall Study|Protocol Violation|7|||
161792828|NCT01644890|584285934|FG000|Overall Study|Withdrawal by Subject|19|||
161792829|NCT01644890|584285935|FG001|Overall Study|Withdrawal by Subject|27|||
161792830|NCT01644890|584285934|FG000|Overall Study|Progression Disease|160|||
161792831|NCT01644890|584285935|FG001|Overall Study|Progression Disease|131|||
161792832|NCT01644890|584285934|FG000|Overall Study|Clinical Progression|6|||
161792833|NCT01644890|584285935|FG001|Overall Study|Clinical Progression|6|||
161792834|NCT01644890|584285934|FG000|Overall Study|> 28 days since last dose of study drug|6|||
161792835|NCT01644890|584285935|FG001|Overall Study|> 28 days since last dose of study drug|3|||
161792836|NCT01644890|584285934|FG000|Overall Study|Other|8|||
161792837|NCT01644890|584285935|FG001|Overall Study|Other|9|||
161792838|NCT01413204|584285938|FG000|Overall Study|Adverse Event|1|||
161792839|NCT01413204|584285939|FG001|Overall Study|Adverse Event|2|||
161792840|NCT01413204|584285940|FG002|Overall Study|Adverse Event|2|||
161792841|NCT01413204|584285938|FG000|Overall Study|Physician Decision|3|||
161792842|NCT01413204|584285939|FG001|Overall Study|Physician Decision|0|||
161792843|NCT01413204|584285940|FG002|Overall Study|Physician Decision|2|||
161792844|NCT01413204|584285938|FG000|Overall Study|Withdrawal by Subject|1|||
161792845|NCT01413204|584285939|FG001|Overall Study|Withdrawal by Subject|4|||
161792846|NCT01413204|584285940|FG002|Overall Study|Withdrawal by Subject|4|||
161792847|NCT01413204|584285938|FG000|Overall Study|Clearly not eligible for the study|0|||
161792848|NCT01413204|584285939|FG001|Overall Study|Clearly not eligible for the study|0|||
161792849|NCT01413204|584285940|FG002|Overall Study|Clearly not eligible for the study|1|||
161792850|NCT01413204|584285938|FG000|Overall Study|Fasting plasma glucose level increased|1|||
161792851|NCT01413204|584285939|FG001|Overall Study|Fasting plasma glucose level increased|0|||
161792852|NCT01413204|584285940|FG002|Overall Study|Fasting plasma glucose level increased|10|||
161792853|NCT00313703|584285942|FG000|Overall Study|Lost to Follow-up|11|||
161792854|NCT00313703|584285943|FG001|Overall Study|Lost to Follow-up|2|||
161792855|NCT00313703|584285944|FG002|Overall Study|Lost to Follow-up|5|||
161792856|NCT00313703|584285945|FG003|Overall Study|Lost to Follow-up|12|||
161792857|NCT02497391|584285946|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
161792858|NCT02497391|584285947|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792859|NCT02497391|584285948|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
161792860|NCT02497391|584285949|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792861|NCT02497391|584285950|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792862|NCT02497391|584285951|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792863|NCT02497391|584285946|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
161792864|NCT02497391|584285947|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
161792865|NCT02497391|584285948|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
161792866|NCT02497391|584285949|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
161792867|NCT02497391|584285950|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
161792868|NCT02497391|584285951|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
161792869|NCT02497391|584285946|FG000|Period 3 (14 Days)|Adverse Event|0|||
161792870|NCT02497391|584285947|FG001|Period 3 (14 Days)|Adverse Event|1|||
161792871|NCT02497391|584285948|FG002|Period 3 (14 Days)|Adverse Event|0|||
161792872|NCT02497391|584285949|FG003|Period 3 (14 Days)|Adverse Event|0|||
161792873|NCT02497391|584285950|FG004|Period 3 (14 Days)|Adverse Event|0|||
161792874|NCT02497391|584285951|FG005|Period 3 (14 Days)|Adverse Event|0|||
161792875|NCT02497391|584285946|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
161792876|NCT02497391|584285947|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
161792877|NCT02497391|584285948|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
161792878|NCT02497391|584285949|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
161792879|NCT02497391|584285950|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
161792880|NCT02497391|584285951|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
161792881|NCT02497391|584285946|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792882|NCT02497391|584285947|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792883|NCT02497391|584285948|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
161792884|NCT02497391|584285949|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792885|NCT02497391|584285950|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792886|NCT02497391|584285951|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792887|NCT03031899|584285954|FG000|Overall Study|Protocol Violation|1|||
161792888|NCT03031899|584285954|FG000|Overall Study|lesion disappeared after stopping habit|1|||
161792889|NCT01664052|584285955|FG000|Phase 1|No device placement|6|||
161792890|NCT01664052|584285956|FG001|Phase 1|No device placement|0|||
161792891|NCT01664052|584285955|FG000|Phase 1|No HSG 1 hr post placement|1|||
161792892|NCT01664052|584285956|FG001|Phase 1|No HSG 1 hr post placement|0|||
161792893|NCT01664052|584285955|FG000|Phase 2|No device placement|0|||
161792894|NCT01664052|584285956|FG001|Phase 2|No device placement|4|||
161792895|NCT01060670|584285957|FG000|Run In|screen failure|0|||
161792896|NCT01060670|584285958|FG001|Run In|screen failure|238|||
161792897|NCT03705351|584285964|FG000|Overall Study|Study termination|3|||
161792898|NCT03705351|584285964|FG000|Overall Study|Death|1|||
161792899|NCT03705351|584285964|FG000|Overall Study|Lack of Efficacy|2|||
161792900|NCT03705351|584285964|FG000|Overall Study|Withdrawal by Subject|1|||
161792901|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
161792902|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
161792903|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
161792904|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
161792905|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
161792906|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
161792907|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
161792908|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
161792909|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
161792910|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
161792911|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
161792912|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
161792913|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
161792914|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
161792915|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
161792916|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
161792917|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
161792918|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
161792919|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
161792920|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
161792921|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
161792922|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
161792923|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
161792924|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
161792925|NCT00056160|584285971|FG000|Final Follow-up|Transferred into expanded access study.|3|||
161792926|NCT00056160|584285972|FG001|Final Follow-up|Transferred into expanded access study.|0|||
161792927|NCT00056160|584285971|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
161792928|NCT00056160|584285972|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
161792929|NCT00056160|584285971|FG000|Final Follow-up|Adverse Event|1|||
161792930|NCT00056160|584285972|FG001|Final Follow-up|Adverse Event|0|||
161792931|NCT01469364|584285973|FG000|Overall Study|Adverse Event|1|||
161792932|NCT01469364|584285973|FG000|Overall Study|Withdrawal by Subject|1|||
161792933|NCT02811861|584285977|FG000|Overall Study|Radiological Disease Progression|123|||
161792934|NCT02811861|584285978|FG001|Overall Study|Radiological Disease Progression|97|||
161792935|NCT02811861|584285979|FG002|Overall Study|Radiological Disease Progression|174|||
161792936|NCT02811861|584285977|FG000|Overall Study|Clinical Disease Progression|20|||
161792937|NCT02811861|584285978|FG001|Overall Study|Clinical Disease Progression|19|||
161792938|NCT02811861|584285979|FG002|Overall Study|Clinical Disease Progression|22|||
161792939|NCT02811861|584285977|FG000|Overall Study|Adverse Event|63|||
161792940|NCT02811861|584285978|FG001|Overall Study|Adverse Event|60|||
161792941|NCT02811861|584285979|FG002|Overall Study|Adverse Event|41|||
161792942|NCT02811861|584285977|FG000|Overall Study|Lost to Follow-up|0|||
161792943|NCT02811861|584285978|FG001|Overall Study|Lost to Follow-up|0|||
161792944|NCT02811861|584285979|FG002|Overall Study|Lost to Follow-up|1|||
161792945|NCT02811861|584285977|FG000|Overall Study|Subject Choice|29|||
161792946|NCT02811861|584285978|FG001|Overall Study|Subject Choice|17|||
161792947|NCT02811861|584285979|FG002|Overall Study|Subject Choice|23|||
161792948|NCT02811861|584285977|FG000|Overall Study|Withdrawal by Subject|4|||
161792949|NCT02811861|584285978|FG001|Overall Study|Withdrawal by Subject|4|||
161792950|NCT02811861|584285979|FG002|Overall Study|Withdrawal by Subject|9|||
161792951|NCT02811861|584285977|FG000|Overall Study|Other|4|||
161792952|NCT02811861|584285978|FG001|Overall Study|Other|13|||
161792953|NCT02811861|584285979|FG002|Overall Study|Other|3|||
161792954|NCT02811861|584285977|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
161792955|NCT02811861|584285978|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
161792956|NCT02811861|584285979|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
161792957|NCT02811861|584285977|FG000|Overall Study|Randomized but not treated|2|||
161792958|NCT02811861|584285978|FG001|Overall Study|Randomized but not treated|3|||
161792959|NCT02811861|584285979|FG002|Overall Study|Randomized but not treated|17|||
161792960|NCT04081337|584285983|FG000|Overall Study|Adverse Event|0|||
161792961|NCT04081337|584285984|FG001|Overall Study|Adverse Event|1|||
161792962|NCT04081337|584285983|FG000|Overall Study|Withdrawal by Subject|2|||
161792963|NCT04081337|584285984|FG001|Overall Study|Withdrawal by Subject|0|||
161792964|NCT04081337|584285983|FG000|Overall Study|Physician Decision|1|||
161792965|NCT04081337|584285984|FG001|Overall Study|Physician Decision|2|||
161792966|NCT04081337|584285983|FG000|Overall Study|Lost to Follow-up|1|||
161792967|NCT04081337|584285984|FG001|Overall Study|Lost to Follow-up|0|||
161792968|NCT06624072|584285985|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
161792969|NCT06624072|584285986|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
161792970|NCT06624072|584285987|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
161792971|NCT00416520|584286000|FG000|Open-label Period|Adverse Event|28|||
161792972|NCT00416520|584286001|FG001|Open-label Period|Adverse Event|10|||
161792973|NCT00416520|584286002|FG002|Open-label Period|Adverse Event|0|||
161792974|NCT00416520|584286003|FG003|Open-label Period|Adverse Event|0|||
161898841|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898842|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898843|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
161898844|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898845|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898846|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
161898847|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
161898848|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
161898849|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
161898850|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
161898851|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
161898852|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
161898853|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
161898854|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
161898855|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
161898856|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
161898857|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
161898858|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
161898859|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
161898860|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
161898861|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
161898862|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
161898863|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
161898864|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
161898865|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898866|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161792975|NCT00416520|584286000|FG000|Open-label Period|Death|2|||
161792976|NCT00416520|584286001|FG001|Open-label Period|Death|1|||
161792977|NCT00416520|584286002|FG002|Open-label Period|Death|0|||
161792978|NCT00416520|584286003|FG003|Open-label Period|Death|0|||
161898867|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898868|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161792979|NCT00416520|584286000|FG000|Open-label Period|Lack of Efficacy|8|||
161792980|NCT00416520|584286001|FG001|Open-label Period|Lack of Efficacy|1|||
161792981|NCT00416520|584286002|FG002|Open-label Period|Lack of Efficacy|0|||
161792982|NCT00416520|584286003|FG003|Open-label Period|Lack of Efficacy|0|||
161792983|NCT00416520|584286000|FG000|Open-label Period|Protocol Violation|3|||
161792984|NCT00416520|584286001|FG001|Open-label Period|Protocol Violation|3|||
161898869|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
161898870|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
161792985|NCT00416520|584286002|FG002|Open-label Period|Protocol Violation|0|||
161792986|NCT00416520|584286003|FG003|Open-label Period|Protocol Violation|0|||
161792987|NCT00416520|584286000|FG000|Open-label Period|Withdrawal by Subject|16|||
161792988|NCT00416520|584286001|FG001|Open-label Period|Withdrawal by Subject|5|||
161792989|NCT00416520|584286002|FG002|Open-label Period|Withdrawal by Subject|0|||
161792990|NCT00416520|584286003|FG003|Open-label Period|Withdrawal by Subject|0|||
161792991|NCT00416520|584286000|FG000|Open-label Period|Other Reasons|3|||
161792992|NCT00416520|584286001|FG001|Open-label Period|Other Reasons|12|||
161792993|NCT00416520|584286002|FG002|Open-label Period|Other Reasons|0|||
161792994|NCT00416520|584286003|FG003|Open-label Period|Other Reasons|0|||
161792995|NCT00416520|584286000|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161792996|NCT00416520|584286001|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161792997|NCT00416520|584286002|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161792998|NCT00416520|584286003|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
161792999|NCT00416520|584286000|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161793000|NCT00416520|584286001|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161793001|NCT00416520|584286002|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161793002|NCT00416520|584286003|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
161793003|NCT00416520|584286000|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
161793004|NCT00416520|584286001|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
161793005|NCT00416520|584286002|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
161793006|NCT00416520|584286003|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
161793007|NCT01387737|584286004|FG000|Overall Study|Adverse Event|20|||
161793008|NCT01387737|584286005|FG001|Overall Study|Adverse Event|30|||
161793009|NCT01387737|584286004|FG000|Overall Study|Lack of Efficacy|1|||
161793010|NCT01387737|584286005|FG001|Overall Study|Lack of Efficacy|0|||
161793011|NCT01387737|584286004|FG000|Overall Study|Physician Decision|3|||
161793012|NCT01387737|584286005|FG001|Overall Study|Physician Decision|10|||
161793013|NCT01387737|584286004|FG000|Overall Study|Withdrawal by Subject|27|||
161793014|NCT01387737|584286005|FG001|Overall Study|Withdrawal by Subject|31|||
161793015|NCT01387737|584286004|FG000|Overall Study|Clearly not eligible for the study|1|||
161793016|NCT01387737|584286005|FG001|Overall Study|Clearly not eligible for the study|3|||
161793017|NCT00449072|584286007|FG000|Overall Study|Adverse Event|3|||
161793018|NCT00449072|584286008|FG001|Overall Study|Adverse Event|1|||
161793019|NCT00449072|584286007|FG000|Overall Study|Protocol Violation|14|||
161793020|NCT00449072|584286008|FG001|Overall Study|Protocol Violation|12|||
161793021|NCT00449072|584286007|FG000|Overall Study|Lost to Follow-up|5|||
161793022|NCT00449072|584286008|FG001|Overall Study|Lost to Follow-up|7|||
161793023|NCT00449072|584286007|FG000|Overall Study|Withdrawal by Subject|11|||
161793024|NCT00449072|584286008|FG001|Overall Study|Withdrawal by Subject|8|||
161793025|NCT00449072|584286007|FG000|Overall Study|Lack of Efficacy|1|||
161793026|NCT00449072|584286008|FG001|Overall Study|Lack of Efficacy|1|||
161793027|NCT00449072|584286007|FG000|Overall Study|Physician Decision|1|||
161793028|NCT00449072|584286008|FG001|Overall Study|Physician Decision|0|||
161793029|NCT00449072|584286007|FG000|Overall Study|Not treated|0|||
161793030|NCT00449072|584286008|FG001|Overall Study|Not treated|1|||
161793031|NCT00449072|584286007|FG000|Overall Study|Excluded medication|0|||
161793032|NCT00449072|584286008|FG001|Overall Study|Excluded medication|2|||
161793033|NCT00449072|584286007|FG000|Overall Study|Non-compliance|2|||
161793034|NCT00449072|584286008|FG001|Overall Study|Non-compliance|5|||
161793035|NCT00449072|584286007|FG000|Overall Study|Sponsor decision|1|||
161793036|NCT00449072|584286008|FG001|Overall Study|Sponsor decision|3|||
161793037|NCT00449072|584286007|FG000|Overall Study|Relocation|3|||
161793038|NCT00449072|584286008|FG001|Overall Study|Relocation|2|||
161793039|NCT05002569|584286011|FG000|Randomized|Withdrew Consent|3|||
161793040|NCT05002569|584286012|FG001|Randomized|Withdrew Consent|0|||
161793041|NCT05002569|584286011|FG000|Randomized|No longer meets study criteria|0|||
161793042|NCT05002569|584286012|FG001|Randomized|No longer meets study criteria|1|||
161793043|NCT05002569|584286011|FG000|Randomized|AE unrelated to study drug|1|||
161793044|NCT05002569|584286012|FG001|Randomized|AE unrelated to study drug|0|||
161793045|NCT05002569|584286011|FG000|Treatment Period|Requested to Discontinue|26|||
161793046|NCT05002569|584286012|FG001|Treatment Period|Requested to Discontinue|5|||
161793047|NCT05002569|584286011|FG000|Treatment Period|Withdrew Consent|7|||
161793048|NCT05002569|584286012|FG001|Treatment Period|Withdrew Consent|1|||
161793049|NCT05002569|584286011|FG000|Treatment Period|Study Drug Toxicity|114|||
161793050|NCT05002569|584286012|FG001|Treatment Period|Study Drug Toxicity|64|||
161793051|NCT05002569|584286011|FG000|Treatment Period|AE unrelated to study drug|6|||
161793052|NCT05002569|584286012|FG001|Treatment Period|AE unrelated to study drug|12|||
161793053|NCT05002569|584286011|FG000|Treatment Period|Disease Recurrence|102|||
161793054|NCT05002569|584286012|FG001|Treatment Period|Disease Recurrence|128|||
161793055|NCT05002569|584286011|FG000|Treatment Period|Other Reasons|4|||
161793056|NCT05002569|584286012|FG001|Treatment Period|Other Reasons|7|||
161793057|NCT05002569|584286011|FG000|Treatment Period|Death|1|||
161793058|NCT05002569|584286012|FG001|Treatment Period|Death|1|||
161793059|NCT05002569|584286011|FG000|Follow Up|Death|78|||
161793060|NCT05002569|584286012|FG001|Follow Up|Death|69|||
161793061|NCT05002569|584286011|FG000|Follow Up|Lost to Follow-up|3|||
161793062|NCT05002569|584286012|FG001|Follow Up|Lost to Follow-up|3|||
161793063|NCT05002569|584286011|FG000|Follow Up|Withdrew consent|17|||
161793064|NCT05002569|584286012|FG001|Follow Up|Withdrew consent|16|||
161793065|NCT05002569|584286011|FG000|Follow Up|Other Reasons|444|||
161793066|NCT05002569|584286012|FG001|Follow Up|Other Reasons|452|||
161793067|NCT04041570|584286020|FG000|Overall Study|Moved from Area|0|||
161793068|NCT04041570|584286021|FG001|Overall Study|Moved from Area|2|||
161793069|NCT05211336|584286022|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
161793070|NCT05211336|584286023|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
161793071|NCT05211336|584286022|FG000|Overall Study|Progressive disease|0|||
161793072|NCT05211336|584286023|FG001|Overall Study|Progressive disease|4|||
161793073|NCT05211336|584286022|FG000|Overall Study|Death due to myocardial infarction|0|||
161793074|NCT05211336|584286023|FG001|Overall Study|Death due to myocardial infarction|1|||
161793075|NCT05211336|584286022|FG000|Overall Study|Death due to unknown cause|0|||
161793076|NCT05211336|584286023|FG001|Overall Study|Death due to unknown cause|1|||
161793077|NCT05211336|584286022|FG000|Overall Study|Worsening kidney function and quality of response|0|||
161793078|NCT05211336|584286023|FG001|Overall Study|Worsening kidney function and quality of response|1|||
161793079|NCT02337829|584286024|FG000|Overall Study|Death|0|||
161793080|NCT02337829|584286025|FG001|Overall Study|Death|1|||
161793081|NCT02337829|584286026|FG002|Overall Study|Death|0|||
161793082|NCT02337829|584286027|FG003|Overall Study|Death|0|||
161793083|NCT02337829|584286024|FG000|Overall Study|Study terminated by sponsor|12|||
161793084|NCT02337829|584286025|FG001|Overall Study|Study terminated by sponsor|10|||
161793085|NCT02337829|584286026|FG002|Overall Study|Study terminated by sponsor|5|||
161793086|NCT02337829|584286027|FG003|Overall Study|Study terminated by sponsor|6|||
161793087|NCT02337829|584286024|FG000|Overall Study|discontinued for other reasons|6|||
161793088|NCT02337829|584286025|FG001|Overall Study|discontinued for other reasons|3|||
161793089|NCT02337829|584286026|FG002|Overall Study|discontinued for other reasons|1|||
161793090|NCT02337829|584286027|FG003|Overall Study|discontinued for other reasons|4|||
161793091|NCT00542386|584286030|FG000|Overall Study|Adverse Event|1|||
161793092|NCT00542386|584286031|FG001|Overall Study|Adverse Event|7|||
161793093|NCT00542386|584286032|FG002|Overall Study|Adverse Event|7|||
161793094|NCT00542386|584286033|FG003|Overall Study|Adverse Event|8|||
161793095|NCT00542386|584286034|FG004|Overall Study|Adverse Event|13|||
161793096|NCT00542386|584286035|FG005|Overall Study|Adverse Event|4|||
161793097|NCT00542386|584286030|FG000|Overall Study|Death|0|||
161793098|NCT00542386|584286031|FG001|Overall Study|Death|0|||
161793099|NCT00542386|584286032|FG002|Overall Study|Death|1|||
161793100|NCT00542386|584286033|FG003|Overall Study|Death|2|||
161793101|NCT00542386|584286034|FG004|Overall Study|Death|1|||
161793102|NCT00542386|584286035|FG005|Overall Study|Death|2|||
161793103|NCT00542386|584286030|FG000|Overall Study|Lack of Efficacy|32|||
161793104|NCT00542386|584286031|FG001|Overall Study|Lack of Efficacy|12|||
161793105|NCT00542386|584286032|FG002|Overall Study|Lack of Efficacy|10|||
161793106|NCT00542386|584286033|FG003|Overall Study|Lack of Efficacy|13|||
161793107|NCT00542386|584286034|FG004|Overall Study|Lack of Efficacy|7|||
161793108|NCT00542386|584286035|FG005|Overall Study|Lack of Efficacy|31|||
161793109|NCT00542386|584286030|FG000|Overall Study|Physician Decision|1|||
161793110|NCT00542386|584286031|FG001|Overall Study|Physician Decision|0|||
161793111|NCT00542386|584286032|FG002|Overall Study|Physician Decision|0|||
161793112|NCT00542386|584286033|FG003|Overall Study|Physician Decision|1|||
161793113|NCT00542386|584286034|FG004|Overall Study|Physician Decision|0|||
161793114|NCT00542386|584286035|FG005|Overall Study|Physician Decision|0|||
161793115|NCT00542386|584286030|FG000|Overall Study|Protocol Violation|0|||
161793116|NCT00542386|584286031|FG001|Overall Study|Protocol Violation|0|||
161793117|NCT00542386|584286032|FG002|Overall Study|Protocol Violation|1|||
161793118|NCT00542386|584286033|FG003|Overall Study|Protocol Violation|0|||
161793119|NCT00542386|584286034|FG004|Overall Study|Protocol Violation|0|||
161793120|NCT00542386|584286035|FG005|Overall Study|Protocol Violation|4|||
161793121|NCT00542386|584286030|FG000|Overall Study|Withdrawal by Subject|5|||
161793122|NCT00542386|584286031|FG001|Overall Study|Withdrawal by Subject|8|||
161793123|NCT00542386|584286032|FG002|Overall Study|Withdrawal by Subject|10|||
161793124|NCT00542386|584286033|FG003|Overall Study|Withdrawal by Subject|11|||
161793125|NCT00542386|584286034|FG004|Overall Study|Withdrawal by Subject|15|||
161793126|NCT00542386|584286035|FG005|Overall Study|Withdrawal by Subject|7|||
161793127|NCT00542386|584286030|FG000|Overall Study|Other Reasons|4|||
161793128|NCT00542386|584286031|FG001|Overall Study|Other Reasons|1|||
161793129|NCT00542386|584286032|FG002|Overall Study|Other Reasons|4|||
161793130|NCT00542386|584286033|FG003|Overall Study|Other Reasons|3|||
161793131|NCT00542386|584286034|FG004|Overall Study|Other Reasons|4|||
161793132|NCT00542386|584286035|FG005|Overall Study|Other Reasons|2|||
161793133|NCT02227849|584286038|FG000|Overall Study|Adverse Event|4|||
161793134|NCT02227849|584286038|FG000|Overall Study|Physician Decision|1|||
161793135|NCT02227849|584286038|FG000|Overall Study|Withdrawal by Subject|3|||
161793136|NCT00616928|584286039|FG000|Overall Study|Adverse Event|6|||
161793137|NCT00616928|584286040|FG001|Overall Study|Adverse Event|3|||
161793138|NCT00616928|584286041|FG002|Overall Study|Adverse Event|2|||
161793139|NCT00616928|584286042|FG003|Overall Study|Adverse Event|2|||
161793140|NCT00616928|584286039|FG000|Overall Study|Other|51|||
161793141|NCT00616928|584286040|FG001|Overall Study|Other|8|||
161793142|NCT00616928|584286041|FG002|Overall Study|Other|15|||
161793143|NCT00616928|584286042|FG003|Overall Study|Other|5|||
161793144|NCT00616928|584286039|FG000|Overall Study|Lost to Follow-up|5|||
161793145|NCT00616928|584286040|FG001|Overall Study|Lost to Follow-up|7|||
161793146|NCT00616928|584286041|FG002|Overall Study|Lost to Follow-up|0|||
161793147|NCT00616928|584286042|FG003|Overall Study|Lost to Follow-up|0|||
161793148|NCT00895583|584286043|FG000|Overall Study|Adverse Event|28|||
161793149|NCT00895583|584286044|FG001|Overall Study|Adverse Event|4|||
161793150|NCT00895583|584286043|FG000|Overall Study|Death|2|||
161793151|NCT00895583|584286044|FG001|Overall Study|Death|1|||
161793152|NCT00895583|584286043|FG000|Overall Study|Physician Decision|3|||
161793153|NCT00895583|584286044|FG001|Overall Study|Physician Decision|1|||
161793154|NCT00895583|584286043|FG000|Overall Study|Lost to Follow-up|1|||
161793155|NCT00895583|584286044|FG001|Overall Study|Lost to Follow-up|3|||
161793156|NCT00895583|584286043|FG000|Overall Study|Protocol Violation|1|||
161793157|NCT00895583|584286044|FG001|Overall Study|Protocol Violation|0|||
161793158|NCT00895583|584286043|FG000|Overall Study|Withdrawal by Subject|4|||
161793159|NCT00895583|584286044|FG001|Overall Study|Withdrawal by Subject|2|||
161793160|NCT00895583|584286043|FG000|Overall Study|Lack of Efficacy|5|||
161793161|NCT00895583|584286044|FG001|Overall Study|Lack of Efficacy|0|||
161793162|NCT00895583|584286043|FG000|Overall Study|Other|0|||
161793163|NCT00895583|584286044|FG001|Overall Study|Other|1|||
161793164|NCT04535583|584286053|FG000|Overall Study|Lost to Follow-up|1|||
161793165|NCT04535583|584286053|FG000|Overall Study|Physician Decision|1|||
161793166|NCT04535583|584286053|FG000|Overall Study|Withdrawal by Subject|1|||
161793167|NCT01078090|584286054|FG000|Overall Study|Lost to Follow-up|2363|||
161793168|NCT01078090|584286054|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
161793169|NCT01078090|584286054|FG000|Overall Study|Lack of Efficacy|1193|||
161793170|NCT01078090|584286054|FG000|Overall Study|ADR and lack of efficacy|61|||
161793171|NCT01078090|584286054|FG000|Overall Study|Other|523|||
161793172|NCT01748890|584286056|FG000|Overall Study|Insufficient recruitment for analysis|4|||
161793173|NCT02669264|584286057|FG000|Overall Study|Death|5|||
161793174|NCT02669264|584286058|FG001|Overall Study|Death|5|||
161793175|NCT02669264|584286059|FG002|Overall Study|Death|3|||
161793176|NCT02669264|584286060|FG003|Overall Study|Death|3|||
161793177|NCT02669264|584286061|FG004|Overall Study|Death|3|||
161793178|NCT02669264|584286062|FG005|Overall Study|Death|6|||
161793179|NCT02669264|584286063|FG006|Overall Study|Death|3|||
161793180|NCT02669264|584286057|FG000|Overall Study|Withdrawal by Subject|0|||
161793181|NCT02669264|584286058|FG001|Overall Study|Withdrawal by Subject|1|||
161793182|NCT02669264|584286059|FG002|Overall Study|Withdrawal by Subject|0|||
161793183|NCT02669264|584286060|FG003|Overall Study|Withdrawal by Subject|0|||
161793184|NCT02669264|584286061|FG004|Overall Study|Withdrawal by Subject|1|||
161793185|NCT02669264|584286062|FG005|Overall Study|Withdrawal by Subject|0|||
161793186|NCT02669264|584286063|FG006|Overall Study|Withdrawal by Subject|0|||
161793187|NCT02669264|584286057|FG000|Overall Study|Lost to Follow-up|0|||
161443747|NCT02963506|583017297|FG005|Dose-Blind Period|Sponsor decision|1|||
161443748|NCT02963506|583017298|FG006|Dose-Blind Period|Sponsor decision|0|||
161793188|NCT02669264|584286058|FG001|Overall Study|Lost to Follow-up|0|||
161793189|NCT02669264|584286059|FG002|Overall Study|Lost to Follow-up|0|||
161793190|NCT02669264|584286060|FG003|Overall Study|Lost to Follow-up|0|||
161793191|NCT02669264|584286061|FG004|Overall Study|Lost to Follow-up|1|||
161793192|NCT02669264|584286062|FG005|Overall Study|Lost to Follow-up|0|||
161793193|NCT02669264|584286063|FG006|Overall Study|Lost to Follow-up|0|||
161793194|NCT02669264|584286057|FG000|Overall Study|Miscellaneous|0|||
161793195|NCT02669264|584286058|FG001|Overall Study|Miscellaneous|0|||
161793196|NCT02669264|584286059|FG002|Overall Study|Miscellaneous|0|||
161793197|NCT02669264|584286060|FG003|Overall Study|Miscellaneous|0|||
161793198|NCT02669264|584286061|FG004|Overall Study|Miscellaneous|0|||
161793199|NCT02669264|584286062|FG005|Overall Study|Miscellaneous|0|||
161793200|NCT02669264|584286063|FG006|Overall Study|Miscellaneous|2|||
161793201|NCT03035227|584286064|FG000|Overall Study|study stopped due to PI leaving institut|1|||
161443749|NCT02963506|583017299|FG007|Dose-Blind Period|Sponsor decision|0|||
161443750|NCT02963506|583017300|FG008|Dose-Blind Period|Sponsor decision|0|||
161443751|NCT02963506|583017301|FG009|Dose-Blind Period|Sponsor decision|0|||
161443752|NCT02963506|583017302|FG010|Dose-Blind Period|Sponsor decision|0|||
161793202|NCT03035227|584286065|FG001|Overall Study|study stopped due to PI leaving institut|1|||
161793203|NCT02100956|584286066|FG000|At Least One Week Between Injections|Adverse Event|0|||
161793204|NCT02100956|584286067|FG001|At Least One Week Between Injections|Adverse Event|1|||
161793205|NCT03529955|584286068|FG000|Overall Study|Adverse Event|1|||
161793206|NCT03529955|584286068|FG000|Overall Study|Lack of Efficacy|1|||
161793207|NCT03016078|584286072|FG000|Overall Study|Protocol Violation|1|||
161793208|NCT03016078|584286072|FG000|Overall Study|Protocol Violation|1|||
161793209|NCT00707954|584286958|FG000|Overall Study|Physician Decision|0|||
161793210|NCT00707954|584286959|FG001|Overall Study|Physician Decision|0|||
161793211|NCT00707954|584286960|FG002|Overall Study|Physician Decision|0|||
161793212|NCT00707954|584286961|FG003|Overall Study|Physician Decision|0|||
161793213|NCT00707954|584286962|FG004|Overall Study|Physician Decision|1|||
161793214|NCT06509100|584286965|FG000|Overall Study|Withdrawal by Subject|1|||
161793215|NCT06509100|584286965|FG000|Overall Study|Lost to Follow-up|1|||
161793216|NCT05245617|584286969|FG000|Overall Study|Withdrawal by Subject|1|||
161793217|NCT03425331|584286970|FG000|Overall Study|Withdrawal by Subject|1|||
161793218|NCT03425331|584286970|FG000|Overall Study|Death|1|||
161793219|NCT03425331|584286970|FG000|Overall Study|Adverse Event|1|||
161793220|NCT03425331|584286970|FG000|Overall Study|Disease Progression|2|||
161793221|NCT03433274|584286971|FG000|Overall Study|Withdrawal by Subject|2|||
161793222|NCT03433274|584286971|FG000|Overall Study|Missed visit|5|||
161793223|NCT03433274|584286971|FG000|Overall Study|Death|23|||
161793224|NCT00441584|584286972|FG000|Overall Study|Lack of Efficacy|79|||
161793225|NCT00441584|584286972|FG000|Overall Study|Withdrawal by Subject|8|||
161793226|NCT00441584|584286972|FG000|Overall Study|Adverse Event|6|||
161793227|NCT00441584|584286972|FG000|Overall Study|Protocol Violation|5|||
161793228|NCT00441584|584286972|FG000|Overall Study|Lost to Follow-up|4|||
161793229|NCT00441584|584286972|FG000|Overall Study|Failure to meet eligibility criteria|3|||
161793230|NCT04864405|584286973|FG000|Overall Study|Withdrawal by Subject|4|||
161793231|NCT04864405|584286974|FG001|Overall Study|Withdrawal by Subject|6|||
161793232|NCT04864405|584286973|FG000|Overall Study|Did not want endocrine therapy|3|||
161793233|NCT04864405|584286974|FG001|Overall Study|Did not want endocrine therapy|5|||
161793234|NCT04029090|584286975|FG000|Overall Study|Protocol Violation|1|||
161793235|NCT04029090|584286976|FG001|Overall Study|Protocol Violation|0|||
161793236|NCT04029090|584286977|FG002|Overall Study|Protocol Violation|0|||
161793237|NCT04029090|584286975|FG000|Overall Study|Withdrawal by Subject|0|||
161793238|NCT04029090|584286976|FG001|Overall Study|Withdrawal by Subject|1|||
161793239|NCT04029090|584286977|FG002|Overall Study|Withdrawal by Subject|0|||
161793240|NCT00506441|584286978|FG000|Period 1; Open-label Period|Adverse Event|21|||
161793241|NCT00506441|584286979|FG001|Period 1; Open-label Period|Adverse Event|0|||
161793242|NCT00506441|584286978|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
161793243|NCT00506441|584286979|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
161793244|NCT00506441|584286978|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
161793245|NCT00506441|584286979|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
161793246|NCT00506441|584286978|FG000|Period 1; Open-label Period|Physician Decision|5|||
161793247|NCT00506441|584286979|FG001|Period 1; Open-label Period|Physician Decision|0|||
161793248|NCT00506441|584286978|FG000|Period 1; Open-label Period|Protocol Violation|9|||
161793249|NCT00506441|584286979|FG001|Period 1; Open-label Period|Protocol Violation|0|||
161793250|NCT00506441|584286978|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
161793251|NCT00506441|584286979|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
161793252|NCT00506441|584286978|FG000|Period 1; Open-label Period|Other Reasons|13|||
161793253|NCT00506441|584286979|FG001|Period 1; Open-label Period|Other Reasons|0|||
161793254|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Adverse Event|0|||
161793255|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Adverse Event|1|||
161793256|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
161793257|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
161793258|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Physician Decision|1|||
161793259|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Physician Decision|1|||
161793260|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
161793261|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
161793262|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Other Reason|1|||
161793263|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Other Reason|1|||
161793264|NCT00501046|584286980|FG000|Overall Study|Adverse Event|21|||
161793265|NCT00501046|584286981|FG001|Overall Study|Adverse Event|25|||
161793266|NCT00501046|584286980|FG000|Overall Study|Death|23|||
161793267|NCT00501046|584286981|FG001|Overall Study|Death|30|||
161793268|NCT00501046|584286980|FG000|Overall Study|Lost to Follow-up|14|||
161793269|NCT00501046|584286981|FG001|Overall Study|Lost to Follow-up|13|||
161793270|NCT00501046|584286980|FG000|Overall Study|Physician Decision|7|||
161793271|NCT00501046|584286981|FG001|Overall Study|Physician Decision|2|||
161793272|NCT00501046|584286980|FG000|Overall Study|Pregnancy|0|||
161793273|NCT00501046|584286981|FG001|Overall Study|Pregnancy|3|||
161898871|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
161793274|NCT00501046|584286980|FG000|Overall Study|Protocol Violation|2|||
161793275|NCT00501046|584286981|FG001|Overall Study|Protocol Violation|1|||
161793276|NCT00501046|584286980|FG000|Overall Study|Withdrawal by Subject|84|||
161793277|NCT00501046|584286981|FG001|Overall Study|Withdrawal by Subject|83|||
161793278|NCT00501046|584286980|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
161793279|NCT00501046|584286981|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
161793280|NCT05056727|584286982|FG000|Initiation Phase|Lost to Follow-up|1|||
161793281|NCT05056727|584286983|FG001|Initiation Phase|Lost to Follow-up|0|||
161793282|NCT05056727|584286984|FG002|Initiation Phase|Lost to Follow-up|0|||
161793283|NCT05056727|584286985|FG003|Initiation Phase|Lost to Follow-up|0|||
161793284|NCT05056727|584286982|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
161793285|NCT05056727|584286983|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
161793286|NCT05056727|584286984|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
161793287|NCT05056727|584286985|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
161793288|NCT05056727|584286982|FG000|Initiation Phase|Withdrawal by Subject|9|||
161793289|NCT05056727|584286983|FG001|Initiation Phase|Withdrawal by Subject|0|||
161793290|NCT05056727|584286984|FG002|Initiation Phase|Withdrawal by Subject|0|||
161793291|NCT05056727|584286985|FG003|Initiation Phase|Withdrawal by Subject|0|||
161793292|NCT05056727|584286982|FG000|Initiation Phase|Physician Decision|4|||
161793293|NCT05056727|584286983|FG001|Initiation Phase|Physician Decision|0|||
161793294|NCT05056727|584286984|FG002|Initiation Phase|Physician Decision|0|||
161793295|NCT05056727|584286985|FG003|Initiation Phase|Physician Decision|0|||
161793296|NCT05056727|584286982|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161793297|NCT05056727|584286983|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
161793298|NCT05056727|584286984|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161793299|NCT05056727|584286985|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161793300|NCT05056727|584286982|FG000|Run-in Phase|Death|0|||
161793301|NCT05056727|584286983|FG001|Run-in Phase|Death|3|||
161793302|NCT05056727|584286984|FG002|Run-in Phase|Death|0|||
161793303|NCT05056727|584286985|FG003|Run-in Phase|Death|0|||
161793304|NCT05056727|584286982|FG000|Run-in Phase|Withdrawal by Subject|0|||
161793305|NCT05056727|584286983|FG001|Run-in Phase|Withdrawal by Subject|25|||
161793306|NCT05056727|584286984|FG002|Run-in Phase|Withdrawal by Subject|0|||
161793307|NCT05056727|584286985|FG003|Run-in Phase|Withdrawal by Subject|0|||
161793308|NCT05056727|584286982|FG000|Run-in Phase|Physician Decision|0|||
161793309|NCT05056727|584286983|FG001|Run-in Phase|Physician Decision|20|||
161793310|NCT05056727|584286984|FG002|Run-in Phase|Physician Decision|0|||
161793311|NCT05056727|584286985|FG003|Run-in Phase|Physician Decision|0|||
161793312|NCT05056727|584286982|FG000|Run-in Phase|Lost to Follow-up|0|||
161793313|NCT05056727|584286983|FG001|Run-in Phase|Lost to Follow-up|1|||
161793314|NCT05056727|584286984|FG002|Run-in Phase|Lost to Follow-up|0|||
161793315|NCT05056727|584286985|FG003|Run-in Phase|Lost to Follow-up|0|||
161793316|NCT05056727|584286982|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
161793317|NCT05056727|584286983|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
161793318|NCT05056727|584286984|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
161793319|NCT05056727|584286985|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
161793320|NCT05056727|584286982|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161793321|NCT05056727|584286983|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161793322|NCT05056727|584286984|FG002|Maintenance Phase|Withdrawal by Subject|19|||
161793323|NCT05056727|584286985|FG003|Maintenance Phase|Withdrawal by Subject|21|||
161793324|NCT05056727|584286982|FG000|Maintenance Phase|Physician Decision|0|||
161793325|NCT05056727|584286983|FG001|Maintenance Phase|Physician Decision|0|||
161793326|NCT05056727|584286984|FG002|Maintenance Phase|Physician Decision|4|||
161793327|NCT05056727|584286985|FG003|Maintenance Phase|Physician Decision|16|||
161793328|NCT05056727|584286982|FG000|Maintenance Phase|Lost to Follow-up|0|||
161793329|NCT05056727|584286983|FG001|Maintenance Phase|Lost to Follow-up|0|||
161793330|NCT05056727|584286984|FG002|Maintenance Phase|Lost to Follow-up|2|||
161793331|NCT05056727|584286985|FG003|Maintenance Phase|Lost to Follow-up|2|||
161793332|NCT05056727|584286982|FG000|Maintenance Phase|Death|0|||
161793333|NCT05056727|584286983|FG001|Maintenance Phase|Death|0|||
161793334|NCT05056727|584286984|FG002|Maintenance Phase|Death|4|||
161793335|NCT05056727|584286985|FG003|Maintenance Phase|Death|2|||
161793336|NCT02622113|584286986|FG000|Overall Study|Adverse Event|4|||
161793337|NCT02622113|584286987|FG001|Overall Study|Adverse Event|4|||
161793338|NCT02622113|584286986|FG000|Overall Study|Physician Decision|0|||
161793339|NCT02622113|584286987|FG001|Overall Study|Physician Decision|1|||
161793340|NCT02622113|584286986|FG000|Overall Study|Withdrawal by Subject|0|||
161793341|NCT02622113|584286987|FG001|Overall Study|Withdrawal by Subject|2|||
161793342|NCT02622113|584286986|FG000|Overall Study|Stopping Criteria|1|||
161793343|NCT02622113|584286987|FG001|Overall Study|Stopping Criteria|3|||
161793344|NCT03289208|584286989|FG000|Overall Study|Adverse Event|1|||
161793345|NCT03289208|584286990|FG001|Overall Study|Adverse Event|0|||
161793346|NCT03289208|584286991|FG002|Overall Study|Adverse Event|0|||
161793347|NCT01840605|584286993|FG000|Overall Study|Adverse Event|0|||
161793348|NCT01840605|584286994|FG001|Overall Study|Adverse Event|1|||
161793349|NCT01840605|584286993|FG000|Overall Study|Physician Decision|2|||
161793350|NCT01840605|584286994|FG001|Overall Study|Physician Decision|1|||
161793351|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793352|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793353|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793354|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
161793355|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793356|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793357|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793358|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793359|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793360|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793361|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
161793362|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
161443753|NCT02963506|583017303|FG011|Dose-Blind Period|Sponsor decision|0|||
161443754|NCT02963506|583017304|FG012|Dose-Blind Period|Sponsor decision|0|||
161443755|NCT02963506|583017292|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443756|NCT02963506|583017293|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443757|NCT02963506|583017294|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443758|NCT02963506|583017295|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443759|NCT02963506|583017296|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443760|NCT02963506|583017297|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443761|NCT02963506|583017298|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443762|NCT02963506|583017299|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443763|NCT02963506|583017300|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443764|NCT02963506|583017301|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443765|NCT02963506|583017302|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443766|NCT02963506|583017303|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
161443767|NCT02963506|583017304|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
161443768|NCT01724346|583017305|FG000|Overall Study|Death|42|||
161443769|NCT01724346|583017306|FG001|Overall Study|Death|42|||
161443770|NCT01724346|583017305|FG000|Overall Study|Lost to Follow-up|5|||
161443771|NCT01724346|583017306|FG001|Overall Study|Lost to Follow-up|1|||
161443772|NCT01724346|583017305|FG000|Overall Study|Withdrawal by Subject|27|||
161443773|NCT01724346|583017306|FG001|Overall Study|Withdrawal by Subject|19|||
161443774|NCT01724346|583017305|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
161443775|NCT01724346|583017306|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
161443776|NCT00525161|583017309|FG000|Overall Study|Adverse Event|1|||
161443777|NCT01076361|583017310|FG000|Overall Study|22 leads were excluded from analysis|21|||
161443778|NCT00943072|583019393|FG000|Overall Study|Adverse Event|0|||
161443779|NCT00943072|583019394|FG001|Overall Study|Adverse Event|3|||
161443780|NCT00943072|583019393|FG000|Overall Study|Death|0|||
161443781|NCT00943072|583019394|FG001|Overall Study|Death|2|||
161443782|NCT00943072|583019393|FG000|Overall Study|Withdrawal by Subject|3|||
161443783|NCT00943072|583019394|FG001|Overall Study|Withdrawal by Subject|1|||
161443784|NCT00943072|583019393|FG000|Overall Study|Protocol Violation|0|||
161443785|NCT00943072|583019394|FG001|Overall Study|Protocol Violation|1|||
161443786|NCT00943072|583019393|FG000|Overall Study|Lost to Follow-up|1|||
161443787|NCT00943072|583019394|FG001|Overall Study|Lost to Follow-up|2|||
161443788|NCT00943072|583019393|FG000|Overall Study|Lack of Efficacy|0|||
161443789|NCT00943072|583019394|FG001|Overall Study|Lack of Efficacy|4|||
161443790|NCT00943072|583019393|FG000|Overall Study|Other|1|||
161443791|NCT00943072|583019394|FG001|Overall Study|Other|1|||
161443792|NCT00423917|583019395|FG000|Overall Study|Cancel|2|||
161443793|NCT00423917|583019395|FG000|Overall Study|Ineligible|1|||
161443794|NCT00555061|583019396|FG000|Overall Study|Adverse Event|3|||
161443795|NCT00555061|583019396|FG000|Overall Study|Protocol Violation|1|||
161443796|NCT00555061|583019396|FG000|Overall Study|Lost to Follow-up|2|||
161443797|NCT00555061|583019396|FG000|Overall Study|Withdrawal by Subject|2|||
161443798|NCT00555061|583019396|FG000|Overall Study|Participant enrolled, but never treated|1|||
161443799|NCT01175083|583019397|FG000|Primary Epoch|Withdrawal by Subject|0|||
161443800|NCT01175083|583019398|FG001|Primary Epoch|Withdrawal by Subject|0|||
161443801|NCT01175083|583019399|FG002|Primary Epoch|Withdrawal by Subject|0|||
161443802|NCT01175083|583019400|FG003|Primary Epoch|Withdrawal by Subject|0|||
161443803|NCT01175083|583019401|FG004|Primary Epoch|Withdrawal by Subject|0|||
161443804|NCT01175083|583019402|FG005|Primary Epoch|Withdrawal by Subject|2|||
161443805|NCT01175083|583019397|FG000|Primary Epoch|Lost to Follow-up|0|||
161443806|NCT01175083|583019398|FG001|Primary Epoch|Lost to Follow-up|0|||
161443807|NCT01175083|583019399|FG002|Primary Epoch|Lost to Follow-up|0|||
161443808|NCT01175083|583019400|FG003|Primary Epoch|Lost to Follow-up|0|||
161443809|NCT01175083|583019401|FG004|Primary Epoch|Lost to Follow-up|0|||
161443810|NCT01175083|583019402|FG005|Primary Epoch|Lost to Follow-up|1|||
161443811|NCT01175083|583019397|FG000|Booster Epoch|Death|0|||
161443812|NCT01175083|583019398|FG001|Booster Epoch|Death|0|||
161443813|NCT01175083|583019399|FG002|Booster Epoch|Death|1|||
161443814|NCT01175083|583019400|FG003|Booster Epoch|Death|0|||
161793363|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793364|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
161443815|NCT01175083|583019401|FG004|Booster Epoch|Death|0|||
161443816|NCT01175083|583019402|FG005|Booster Epoch|Death|0|||
161443817|NCT01175083|583019397|FG000|Booster Epoch|Withdrawal by Subject|0|||
161443818|NCT01175083|583019398|FG001|Booster Epoch|Withdrawal by Subject|0|||
161443819|NCT01175083|583019399|FG002|Booster Epoch|Withdrawal by Subject|0|||
161443820|NCT01175083|583019400|FG003|Booster Epoch|Withdrawal by Subject|1|||
161443821|NCT01175083|583019401|FG004|Booster Epoch|Withdrawal by Subject|0|||
161443822|NCT01175083|583019402|FG005|Booster Epoch|Withdrawal by Subject|0|||
161443823|NCT02881567|583019403|FG000|Overall Study|Adverse Event|1|||
161443824|NCT02881567|583019403|FG000|Overall Study|Lost to Follow-up|3|||
161443825|NCT02881567|583019403|FG000|Overall Study|Consent withdrawn|1|||
161443826|NCT02881567|583019403|FG000|Overall Study|Investigator decision|1|||
161443827|NCT02881567|583019403|FG000|Overall Study|Study terminated by sponsor|9|||
161793365|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793366|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793367|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793368|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
161793369|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793370|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793371|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793372|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793373|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793374|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793375|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
161793376|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793377|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793378|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793379|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793380|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793381|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793382|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
161793383|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793384|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793385|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793386|NCT04969939|584286995|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793387|NCT04969939|584286996|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793388|NCT04969939|584286997|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793389|NCT04969939|584286998|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161443828|NCT02881567|583019403|FG000|Overall Study|Reason not Specified|3|||
161443829|NCT00373113|583019405|FG000|Overall Study|Death|1|||
161443830|NCT00373113|583019406|FG001|Overall Study|Death|7|||
161443831|NCT00373113|583019405|FG000|Overall Study|Adverse Event|38|||
161443832|NCT00373113|583019406|FG001|Overall Study|Adverse Event|24|||
161443833|NCT00373113|583019405|FG000|Overall Study|Study terminated by sponsor|9|||
161793390|NCT04969939|584286999|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
161793391|NCT04969939|584287000|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
161793392|NCT04969939|584287001|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793393|NCT05308472|584287002|FG000|Overall Study|Adverse Event|0|||
161793394|NCT05308472|584287003|FG001|Overall Study|Adverse Event|0|||
161443834|NCT00373113|583019406|FG001|Overall Study|Study terminated by sponsor|1|||
161443835|NCT00373113|583019405|FG000|Overall Study|Global deterioration of health status|10|||
161443836|NCT00373113|583019406|FG001|Overall Study|Global deterioration of health status|7|||
161443837|NCT00373113|583019405|FG000|Overall Study|Lost to Follow-up|1|||
161443838|NCT00373113|583019406|FG001|Overall Study|Lost to Follow-up|3|||
161443839|NCT00373113|583019405|FG000|Overall Study|Objective progression or relapse|150|||
161443840|NCT00373113|583019406|FG001|Overall Study|Objective progression or relapse|169|||
161443841|NCT00373113|583019405|FG000|Overall Study|Other|14|||
161443842|NCT00373113|583019406|FG001|Overall Study|Other|17|||
161443843|NCT00373113|583019405|FG000|Overall Study|Protocol Violation|5|||
161443844|NCT00373113|583019406|FG001|Overall Study|Protocol Violation|1|||
161443845|NCT00373113|583019405|FG000|Overall Study|Withdrawal by Subject|10|||
161443846|NCT00373113|583019406|FG001|Overall Study|Withdrawal by Subject|15|||
161443847|NCT03275350|583019407|FG000|Overall Study|Lost to Follow-up|4|||
161443848|NCT03275350|583019408|FG001|Overall Study|Lost to Follow-up|6|||
161443849|NCT03275350|583019407|FG000|Overall Study|Death|2|||
161793395|NCT05308472|584287004|FG002|Overall Study|Adverse Event|3|||
161793396|NCT02717611|584287012|FG000|Overall Study|Death|13|||
161793397|NCT02717611|584287012|FG000|Overall Study|Withdrawal by Subject|6|||
161793398|NCT02717611|584287012|FG000|Overall Study|Active, not recruiting|40|||
161793399|NCT02717611|584287012|FG000|Overall Study|Complicating disease|1|||
161793400|NCT05182606|584287015|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
161793401|NCT02619682|584287016|FG000|Overall Study|Withdrawal by Subject|3|||
161793402|NCT02619682|584287016|FG000|Overall Study|Lack of Efficacy|8|||
161793403|NCT02619682|584287016|FG000|Overall Study|new secondary cancer|1|||
161793404|NCT02619682|584287016|FG000|Overall Study|post surgery complications|2|||
161793405|NCT01861522|584287017|FG000|Overall Study|Adverse Event|1|||
161793406|NCT01861522|584287018|FG001|Overall Study|Adverse Event|0|||
161793407|NCT01861522|584287017|FG000|Overall Study|Withdrawal by Subject|2|||
161793408|NCT01861522|584287018|FG001|Overall Study|Withdrawal by Subject|0|||
161793409|NCT00500682|584287019|FG000|Overall Study|Adverse Event|37|||
161793410|NCT00500682|584287020|FG001|Overall Study|Adverse Event|29|||
161793411|NCT00500682|584287019|FG000|Overall Study|Death|25|||
161793412|NCT00500682|584287020|FG001|Overall Study|Death|16|||
161443850|NCT03275350|583019408|FG001|Overall Study|Death|1|||
161443851|NCT03275350|583019407|FG000|Overall Study|Physician Decision|1|||
161443852|NCT03275350|583019408|FG001|Overall Study|Physician Decision|0|||
161443853|NCT03275350|583019407|FG000|Overall Study|Incarcerated|1|||
161443854|NCT03275350|583019408|FG001|Overall Study|Incarcerated|1|||
161443855|NCT03656562|583019409|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
161443856|NCT03656562|583019410|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
161443857|NCT03656562|583019411|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
161443858|NCT03656562|583019412|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
161443859|NCT03656562|583019409|FG000|Overall Study|Physician Decision|1|||
161443860|NCT03656562|583019410|FG001|Overall Study|Physician Decision|2|||
161443861|NCT03656562|583019411|FG002|Overall Study|Physician Decision|0|||
161443862|NCT03656562|583019412|FG003|Overall Study|Physician Decision|0|||
161443863|NCT03656562|583019409|FG000|Overall Study|Subject Decision|3|||
161443864|NCT03656562|583019410|FG001|Overall Study|Subject Decision|5|||
161443865|NCT03656562|583019411|FG002|Overall Study|Subject Decision|0|||
161443866|NCT03656562|583019412|FG003|Overall Study|Subject Decision|2|||
161443867|NCT00905645|583019413|FG000|Overall Study|Death (not device related)|10|||
161443868|NCT00905645|583019414|FG001|Overall Study|Death (not device related)|4|||
161443869|NCT00905645|583019415|FG002|Overall Study|Death (not device related)|15|||
161443870|NCT00905645|583019416|FG003|Overall Study|Death (not device related)|8|||
161443871|NCT00905645|583019413|FG000|Overall Study|Explantation of study device(s)|78|||
161443872|NCT00905645|583019414|FG001|Overall Study|Explantation of study device(s)|47|||
161443873|NCT00905645|583019415|FG002|Overall Study|Explantation of study device(s)|28|||
161443874|NCT00905645|583019416|FG003|Overall Study|Explantation of study device(s)|21|||
161443875|NCT00905645|583019413|FG000|Overall Study|Subject Request|41|||
161443876|NCT00905645|583019414|FG001|Overall Study|Subject Request|17|||
161443877|NCT00905645|583019415|FG002|Overall Study|Subject Request|13|||
161443878|NCT00905645|583019416|FG003|Overall Study|Subject Request|11|||
161443879|NCT00905645|583019413|FG000|Overall Study|Lost to Follow-up|299|||
161443880|NCT00905645|583019414|FG001|Overall Study|Lost to Follow-up|103|||
161443881|NCT00905645|583019415|FG002|Overall Study|Lost to Follow-up|51|||
161443882|NCT00905645|583019416|FG003|Overall Study|Lost to Follow-up|12|||
161443883|NCT01386970|583019417|FG000|Overall Study|Withdrawal by Subject|0|||
161443884|NCT01386970|583019418|FG001|Overall Study|Withdrawal by Subject|1|||
161443885|NCT01386970|583019417|FG000|Overall Study|Adverse Event|4|||
161443886|NCT01386970|583019418|FG001|Overall Study|Adverse Event|1|||
161443887|NCT04269265|583019419|FG000|Overall Study|Physician Decision|1|||
161443888|NCT04269265|583019419|FG000|Overall Study|Withdrawal by Subject|1|||
161443889|NCT04269265|583019419|FG000|Overall Study|Overenrolled (sample size reached)|4|||
161443890|NCT04439136|583019420|FG000|Overall Study|Ineligible|1|||
161443891|NCT04439136|583019420|FG000|Overall Study|Never Started Treatment|2|||
161443892|NCT04439136|583019420|FG000|Overall Study|Adverse Event|4|||
161443893|NCT04439136|583019420|FG000|Overall Study|Death|3|||
161443894|NCT04439136|583019420|FG000|Overall Study|Disease Progression|27|||
161443895|NCT04439136|583019420|FG000|Overall Study|Alternative Therapy|1|||
161443896|NCT04439136|583019420|FG000|Overall Study|Increased Tumor Burden|1|||
161443897|NCT04439136|583019420|FG000|Overall Study|Symptomatic Detrioration|1|||
161443898|NCT04693234|583019421|FG000|Overall Study|Death|79|||
161443899|NCT04693234|583019422|FG001|Overall Study|Death|19|||
161443900|NCT04693234|583019421|FG000|Overall Study|Sponsor Ended Study|47|||
161443901|NCT04693234|583019422|FG001|Overall Study|Sponsor Ended Study|18|||
161443902|NCT04693234|583019421|FG000|Overall Study|Withdrawal by Subject|10|||
161443903|NCT04693234|583019422|FG001|Overall Study|Withdrawal by Subject|2|||
161443904|NCT04693234|583019421|FG000|Overall Study|Lost to Follow-up|2|||
161443905|NCT04693234|583019422|FG001|Overall Study|Lost to Follow-up|1|||
161443906|NCT02578706|583019425|FG000|Overall Study|Withdrawal by Subject|1|||
161443907|NCT02578706|583019426|FG001|Overall Study|Withdrawal by Subject|0|||
161443908|NCT02578706|583019427|FG002|Overall Study|Withdrawal by Subject|0|||
161443909|NCT02578706|583019425|FG000|Overall Study|Lost to Follow-up|0|||
161443910|NCT02578706|583019426|FG001|Overall Study|Lost to Follow-up|4|||
161443911|NCT02578706|583019427|FG002|Overall Study|Lost to Follow-up|0|||
161443912|NCT02578706|583019425|FG000|Overall Study|Physician Decision|0|||
161443913|NCT02578706|583019426|FG001|Overall Study|Physician Decision|1|||
161443914|NCT02578706|583019427|FG002|Overall Study|Physician Decision|0|||
161443915|NCT00578292|583019428|FG000|Overall Study|Death|1|||
161443916|NCT00578292|583019428|FG000|Overall Study|Graft failure|2|||
161443917|NCT03901469|583019429|FG000|Overall Study|Radiographic Progression|4|||
161443918|NCT03901469|583019430|FG001|Overall Study|Radiographic Progression|6|||
161443919|NCT03901469|583019431|FG002|Overall Study|Radiographic Progression|3|||
161443920|NCT03901469|583019432|FG003|Overall Study|Radiographic Progression|30|||
161443921|NCT03901469|583019433|FG004|Overall Study|Radiographic Progression|7|||
161443922|NCT03901469|583019434|FG005|Overall Study|Radiographic Progression|2|||
161443923|NCT03901469|583019435|FG006|Overall Study|Radiographic Progression|11|||
161443924|NCT03901469|583019429|FG000|Overall Study|Clinical Progression|0|||
161443925|NCT03901469|583019430|FG001|Overall Study|Clinical Progression|2|||
161443926|NCT03901469|583019431|FG002|Overall Study|Clinical Progression|0|||
161443927|NCT03901469|583019432|FG003|Overall Study|Clinical Progression|7|||
161443928|NCT03901469|583019433|FG004|Overall Study|Clinical Progression|6|||
161443929|NCT03901469|583019434|FG005|Overall Study|Clinical Progression|0|||
161443930|NCT03901469|583019435|FG006|Overall Study|Clinical Progression|2|||
161443931|NCT03901469|583019429|FG000|Overall Study|Adverse Event|1|||
161443932|NCT03901469|583019430|FG001|Overall Study|Adverse Event|0|||
161443933|NCT03901469|583019431|FG002|Overall Study|Adverse Event|0|||
161443934|NCT03901469|583019432|FG003|Overall Study|Adverse Event|0|||
161443935|NCT03901469|583019433|FG004|Overall Study|Adverse Event|0|||
161443936|NCT03901469|583019434|FG005|Overall Study|Adverse Event|0|||
161443937|NCT03901469|583019435|FG006|Overall Study|Adverse Event|9|||
161443938|NCT03901469|583019429|FG000|Overall Study|Physician Decision|0|||
161443939|NCT03901469|583019430|FG001|Overall Study|Physician Decision|0|||
161443940|NCT03901469|583019431|FG002|Overall Study|Physician Decision|0|||
161443941|NCT03901469|583019432|FG003|Overall Study|Physician Decision|1|||
161443942|NCT03901469|583019433|FG004|Overall Study|Physician Decision|0|||
161443943|NCT03901469|583019434|FG005|Overall Study|Physician Decision|0|||
161443944|NCT03901469|583019435|FG006|Overall Study|Physician Decision|0|||
161443945|NCT03901469|583019429|FG000|Overall Study|Withdrawal by Subject|0|||
161443946|NCT03901469|583019430|FG001|Overall Study|Withdrawal by Subject|0|||
161443947|NCT03901469|583019431|FG002|Overall Study|Withdrawal by Subject|0|||
161443948|NCT03901469|583019432|FG003|Overall Study|Withdrawal by Subject|0|||
161793413|NCT00500682|584287019|FG000|Overall Study|Lost to Follow-up|11|||
161793414|NCT00500682|584287020|FG001|Overall Study|Lost to Follow-up|11|||
161443949|NCT03901469|583019433|FG004|Overall Study|Withdrawal by Subject|2|||
161443950|NCT03901469|583019434|FG005|Overall Study|Withdrawal by Subject|0|||
161443951|NCT03901469|583019435|FG006|Overall Study|Withdrawal by Subject|8|||
161443952|NCT03901469|583019429|FG000|Overall Study|Death|0|||
161443953|NCT03901469|583019430|FG001|Overall Study|Death|0|||
161443954|NCT03901469|583019431|FG002|Overall Study|Death|0|||
161443955|NCT03901469|583019432|FG003|Overall Study|Death|3|||
161443956|NCT03901469|583019433|FG004|Overall Study|Death|5|||
161443957|NCT03901469|583019434|FG005|Overall Study|Death|0|||
161443958|NCT03901469|583019435|FG006|Overall Study|Death|1|||
161443959|NCT03901469|583019429|FG000|Overall Study|Termination of study by sponsor|0|||
161443960|NCT03901469|583019430|FG001|Overall Study|Termination of study by sponsor|0|||
161443961|NCT03901469|583019431|FG002|Overall Study|Termination of study by sponsor|0|||
161443962|NCT03901469|583019432|FG003|Overall Study|Termination of study by sponsor|0|||
161443963|NCT03901469|583019433|FG004|Overall Study|Termination of study by sponsor|1|||
161443964|NCT03901469|583019434|FG005|Overall Study|Termination of study by sponsor|1|||
161443965|NCT03901469|583019435|FG006|Overall Study|Termination of study by sponsor|0|||
161443966|NCT03901469|583019429|FG000|Overall Study|Not Reported|1|||
161443967|NCT03901469|583019430|FG001|Overall Study|Not Reported|0|||
161443968|NCT03901469|583019431|FG002|Overall Study|Not Reported|0|||
161443969|NCT03901469|583019432|FG003|Overall Study|Not Reported|1|||
161443970|NCT03901469|583019433|FG004|Overall Study|Not Reported|0|||
161443971|NCT03901469|583019434|FG005|Overall Study|Not Reported|0|||
161443972|NCT03901469|583019435|FG006|Overall Study|Not Reported|1|||
161443973|NCT01662102|583019441|FG000|Overall Study|Sponsor's decision|1|||
161443974|NCT01662102|583019442|FG001|Overall Study|Sponsor's decision|0|||
161443975|NCT02586207|583019443|FG000|Overall Study|Physician Decision|1|||
161793415|NCT00500682|584287019|FG000|Overall Study|Physician Decision|6|||
161443976|NCT02586207|583019443|FG000|Overall Study|Withdrawal by Subject|1|||
161443977|NCT00392769|583019445|FG000|Overall Study|Clinical Deterioration|9|||
161443978|NCT00392769|583019445|FG000|Overall Study|Adverse Event|1|||
161443979|NCT00439517|583019447|FG000|Overall Study|Subject on treatment|1|||
161443980|NCT00439517|583019448|FG001|Overall Study|Subject on treatment|0|||
161443981|NCT00439517|583019447|FG000|Overall Study|Subject in survival follow-up|1|||
161443982|NCT00439517|583019448|FG001|Overall Study|Subject in survival follow-up|0|||
161443983|NCT01077076|583019451|FG000|First Intervention|Withdrawal by Subject|1|||
161443984|NCT01077076|583019452|FG001|First Intervention|Withdrawal by Subject|0|||
161443985|NCT01077076|583019453|FG002|First Intervention|Withdrawal by Subject|0|||
161443986|NCT01077076|583019454|FG003|First Intervention|Withdrawal by Subject|0|||
161443987|NCT01077076|583019455|FG004|First Intervention|Withdrawal by Subject|0|||
161443988|NCT01077076|583019456|FG005|First Intervention|Withdrawal by Subject|0|||
161443989|NCT01077076|583019451|FG000|Third Intervention|Death in the participant's family|0|||
161443990|NCT01077076|583019452|FG001|Third Intervention|Death in the participant's family|0|||
161443991|NCT01077076|583019453|FG002|Third Intervention|Death in the participant's family|0|||
161443992|NCT01077076|583019454|FG003|Third Intervention|Death in the participant's family|0|||
161793416|NCT00500682|584287020|FG001|Overall Study|Physician Decision|10|||
161793417|NCT00500682|584287019|FG000|Overall Study|Pregnancy|2|||
161793418|NCT00500682|584287020|FG001|Overall Study|Pregnancy|0|||
161793419|NCT00500682|584287019|FG000|Overall Study|Protocol Violation|1|||
161793420|NCT00500682|584287020|FG001|Overall Study|Protocol Violation|3|||
161793421|NCT00500682|584287019|FG000|Overall Study|Withdrawal by Subject|80|||
161443993|NCT01077076|583019455|FG004|Third Intervention|Death in the participant's family|0|||
161443994|NCT01077076|583019456|FG005|Third Intervention|Death in the participant's family|1|||
161443995|NCT00060840|583019459|FG000|Overall Study|Change in surgical plan|2|||
161443996|NCT00060840|583019460|FG001|Overall Study|Change in surgical plan|6|||
161443997|NCT00060840|583019459|FG000|Overall Study|Death|0|||
161443998|NCT00060840|583019460|FG001|Overall Study|Death|1|||
161443999|NCT00060840|583019459|FG000|Overall Study|Withdrawal by Subject|0|||
161444000|NCT00060840|583019460|FG001|Overall Study|Withdrawal by Subject|1|||
161444001|NCT00060840|583019459|FG000|Overall Study|Subinvestigator unavailable|0|||
161444002|NCT00060840|583019460|FG001|Overall Study|Subinvestigator unavailable|1|||
161444003|NCT00060840|583019459|FG000|Overall Study|Physician Decision|1|||
161444004|NCT00060840|583019460|FG001|Overall Study|Physician Decision|0|||
161444005|NCT00060840|583019459|FG000|Overall Study|Other|1|||
161444006|NCT00060840|583019460|FG001|Overall Study|Other|0|||
161444007|NCT01388335|583019461|FG000|Period 1|Progressive Disease|1|||
161444008|NCT01388335|583019461|FG000|Period 2|Progressive Disease|2|||
161444009|NCT01388335|583019461|FG000|Period 2|Sponsor Decision|1|||
161444010|NCT01388335|583019461|FG000|Safety Extension|Progressive Disease|7|||
161444011|NCT01415882|583019462|FG000|Overall Study|Ineligible|1|||
161444012|NCT01415882|583019463|FG001|Overall Study|Ineligible|0|||
161444013|NCT01415882|583019464|FG002|Overall Study|Ineligible|0|||
161444014|NCT01415882|583019465|FG003|Overall Study|Ineligible|3|||
161444015|NCT01415882|583019466|FG004|Overall Study|Ineligible|0|||
161444016|NCT01415882|583019462|FG000|Overall Study|Withdrawal by Subject|0|||
161444017|NCT01415882|583019463|FG001|Overall Study|Withdrawal by Subject|1|||
161444018|NCT01415882|583019464|FG002|Overall Study|Withdrawal by Subject|0|||
161444019|NCT01415882|583019465|FG003|Overall Study|Withdrawal by Subject|1|||
161444020|NCT01415882|583019466|FG004|Overall Study|Withdrawal by Subject|0|||
161444021|NCT00976560|583019467|FG000|Overall Study|Adverse Event|5|||
161444022|NCT00976560|583019468|FG001|Overall Study|Adverse Event|5|||
161444023|NCT00976560|583019467|FG000|Overall Study|Lack of Efficacy|3|||
161444024|NCT00976560|583019468|FG001|Overall Study|Lack of Efficacy|5|||
161444025|NCT00976560|583019467|FG000|Overall Study|Protocol Violation|1|||
161444026|NCT00976560|583019468|FG001|Overall Study|Protocol Violation|0|||
161444027|NCT00976560|583019467|FG000|Overall Study|Lost to Follow-up|1|||
161444028|NCT00976560|583019468|FG001|Overall Study|Lost to Follow-up|0|||
161444029|NCT00976560|583019467|FG000|Overall Study|Physician Decision|2|||
161444030|NCT00976560|583019468|FG001|Overall Study|Physician Decision|0|||
161444031|NCT00976560|583019467|FG000|Overall Study|Withdrawal by Subject|2|||
161444032|NCT00976560|583019468|FG001|Overall Study|Withdrawal by Subject|3|||
161444033|NCT00125164|583019471|FG000|Overall Study|Adverse Event|0|||
161444034|NCT00125164|583019472|FG001|Overall Study|Adverse Event|0|||
161444035|NCT00125164|583019473|FG002|Overall Study|Adverse Event|2|||
161793422|NCT00500682|584287020|FG001|Overall Study|Withdrawal by Subject|74|||
161793423|NCT00500682|584287019|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
161793424|NCT00500682|584287020|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
161793425|NCT01680159|584287021|FG000|Screening Period|Not meet criteria for dose-up period|7|||
161793426|NCT01680159|584287021|FG000|Increased Dose Period|Adverse Event|6|||
161793427|NCT01680159|584287021|FG000|Increased Dose Period|Withdrawal by Subject|2|||
161793428|NCT01995058|584287022|FG000|Overall Study|Sponsor Decision to terminate study|14|||
161793429|NCT01995058|584287023|FG001|Overall Study|Sponsor Decision to terminate study|12|||
161444036|NCT00125164|583019474|FG003|Overall Study|Adverse Event|4|||
161444037|NCT00125164|583019471|FG000|Overall Study|Lost to Follow-up|0|||
161444038|NCT00125164|583019472|FG001|Overall Study|Lost to Follow-up|0|||
161444039|NCT00125164|583019473|FG002|Overall Study|Lost to Follow-up|1|||
161444040|NCT00125164|583019474|FG003|Overall Study|Lost to Follow-up|1|||
161444041|NCT00125164|583019471|FG000|Overall Study|Withdrawal by Subject|2|||
161444042|NCT00125164|583019472|FG001|Overall Study|Withdrawal by Subject|0|||
161444043|NCT00125164|583019473|FG002|Overall Study|Withdrawal by Subject|1|||
161444044|NCT00125164|583019474|FG003|Overall Study|Withdrawal by Subject|1|||
161444045|NCT01339052|583019475|FG000|Overall Study|Disease progression|13|||
161444046|NCT01339052|583019476|FG001|Overall Study|Disease progression|46|||
161444047|NCT01339052|583019475|FG000|Overall Study|Adverse Event|1|||
161444048|NCT01339052|583019476|FG001|Overall Study|Adverse Event|1|||
161444049|NCT01339052|583019475|FG000|Overall Study|Withdrawal by Subject|0|||
161444050|NCT01339052|583019476|FG001|Overall Study|Withdrawal by Subject|3|||
161444051|NCT01339052|583019475|FG000|Overall Study|Physician Decision|1|||
161444052|NCT01339052|583019476|FG001|Overall Study|Physician Decision|0|||
161444053|NCT01301027|583019482|FG000|Overall Study|Physician Decision|2|||
161444054|NCT01301027|583019483|FG001|Overall Study|Physician Decision|0|||
161444055|NCT01301027|583019482|FG000|Overall Study|Withdrawal by Subject|2|||
161444056|NCT01301027|583019483|FG001|Overall Study|Withdrawal by Subject|3|||
161793430|NCT01995058|584287024|FG002|Overall Study|Sponsor Decision to terminate study|12|||
161444057|NCT01301027|583019482|FG000|Overall Study|Adverse Event|0|||
161444058|NCT01301027|583019483|FG001|Overall Study|Adverse Event|2|||
161444059|NCT01301027|583019482|FG000|Overall Study|Fracture|1|||
161444060|NCT01301027|583019483|FG001|Overall Study|Fracture|3|||
161444061|NCT01301027|583019482|FG000|Overall Study|Transplant|0|||
161444062|NCT01301027|583019483|FG001|Overall Study|Transplant|2|||
161444063|NCT01301027|583019482|FG000|Overall Study|Volume Overload|3|||
161444064|NCT01301027|583019483|FG001|Overall Study|Volume Overload|0|||
161444065|NCT04939415|583019484|FG000|Overall Study|Withdrawal by Subject|1|||
161444066|NCT04939415|583019485|FG001|Overall Study|Withdrawal by Subject|3|||
161444067|NCT04939415|583019484|FG000|Overall Study|Lost to Follow-up|0|||
161444068|NCT04939415|583019485|FG001|Overall Study|Lost to Follow-up|2|||
161444069|NCT01354314|583019489|FG000|Overall Study|Lost to Follow-up|1|||
161444070|NCT01354314|583019490|FG001|Overall Study|Lost to Follow-up|0|||
161444071|NCT01354314|583019491|FG002|Overall Study|Lost to Follow-up|1|||
161793431|NCT01995058|584287025|FG003|Overall Study|Sponsor Decision to terminate study|10|||
161793432|NCT01995058|584287022|FG000|Overall Study|Progressive Disease|0|||
161793433|NCT01995058|584287023|FG001|Overall Study|Progressive Disease|1|||
161793434|NCT01995058|584287024|FG002|Overall Study|Progressive Disease|1|||
161793435|NCT01995058|584287025|FG003|Overall Study|Progressive Disease|1|||
161793436|NCT01995058|584287022|FG000|Overall Study|Adverse Event|0|||
161444072|NCT01354314|583019492|FG003|Overall Study|Lost to Follow-up|1|||
161444073|NCT01354314|583019489|FG000|Overall Study|Withdrawal by Subject|0|||
161444074|NCT01354314|583019490|FG001|Overall Study|Withdrawal by Subject|0|||
161444075|NCT01354314|583019491|FG002|Overall Study|Withdrawal by Subject|1|||
161444076|NCT01354314|583019492|FG003|Overall Study|Withdrawal by Subject|0|||
161444077|NCT01354314|583019489|FG000|Overall Study|Adverse Event|0|||
161444078|NCT01354314|583019490|FG001|Overall Study|Adverse Event|0|||
161444079|NCT01354314|583019491|FG002|Overall Study|Adverse Event|0|||
161444080|NCT01354314|583019492|FG003|Overall Study|Adverse Event|1|||
161444081|NCT01354314|583019489|FG000|Overall Study|Protocol Violation|1|||
161444082|NCT01354314|583019490|FG001|Overall Study|Protocol Violation|1|||
161444083|NCT01354314|583019491|FG002|Overall Study|Protocol Violation|0|||
161444084|NCT01354314|583019492|FG003|Overall Study|Protocol Violation|0|||
161444085|NCT01354314|583019489|FG000|Overall Study|Less than 90% Adherence|4|||
161444086|NCT01354314|583019490|FG001|Overall Study|Less than 90% Adherence|2|||
161444087|NCT01354314|583019491|FG002|Overall Study|Less than 90% Adherence|6|||
161444088|NCT01354314|583019492|FG003|Overall Study|Less than 90% Adherence|4|||
161444089|NCT00478023|583019493|FG000|Overall Study|Adverse Event|11|||
161444090|NCT00478023|583019494|FG001|Overall Study|Adverse Event|7|||
161444091|NCT00478023|583019495|FG002|Overall Study|Adverse Event|8|||
161444092|NCT00478023|583019496|FG003|Overall Study|Adverse Event|14|||
161444093|NCT00478023|583019497|FG004|Overall Study|Adverse Event|6|||
161444094|NCT00478023|583019493|FG000|Overall Study|Death|1|||
161444095|NCT00478023|583019494|FG001|Overall Study|Death|0|||
161444096|NCT00478023|583019495|FG002|Overall Study|Death|0|||
161444097|NCT00478023|583019496|FG003|Overall Study|Death|0|||
161444098|NCT00478023|583019497|FG004|Overall Study|Death|0|||
161444099|NCT00478023|583019493|FG000|Overall Study|Lack of Efficacy|11|||
161444100|NCT00478023|583019494|FG001|Overall Study|Lack of Efficacy|10|||
161444101|NCT00478023|583019495|FG002|Overall Study|Lack of Efficacy|4|||
161444102|NCT00478023|583019496|FG003|Overall Study|Lack of Efficacy|5|||
161793437|NCT01995058|584287023|FG001|Overall Study|Adverse Event|0|||
161793438|NCT01995058|584287024|FG002|Overall Study|Adverse Event|0|||
161793439|NCT01995058|584287025|FG003|Overall Study|Adverse Event|1|||
161793440|NCT01995058|584287022|FG000|Overall Study|Lack of Efficacy|0|||
161793441|NCT01995058|584287023|FG001|Overall Study|Lack of Efficacy|0|||
161793442|NCT01995058|584287024|FG002|Overall Study|Lack of Efficacy|0|||
161793443|NCT01995058|584287025|FG003|Overall Study|Lack of Efficacy|1|||
161793444|NCT01995058|584287022|FG000|Overall Study|No Treatment Given|0|||
161793445|NCT01995058|584287023|FG001|Overall Study|No Treatment Given|0|||
161793446|NCT01995058|584287024|FG002|Overall Study|No Treatment Given|0|||
161793447|NCT01995058|584287025|FG003|Overall Study|No Treatment Given|1|||
161444103|NCT00478023|583019497|FG004|Overall Study|Lack of Efficacy|41|||
161444104|NCT00478023|583019493|FG000|Overall Study|Lost to Follow-up|3|||
161444105|NCT00478023|583019494|FG001|Overall Study|Lost to Follow-up|1|||
161444106|NCT00478023|583019495|FG002|Overall Study|Lost to Follow-up|1|||
161444107|NCT00478023|583019496|FG003|Overall Study|Lost to Follow-up|1|||
161444108|NCT00478023|583019497|FG004|Overall Study|Lost to Follow-up|0|||
161444109|NCT00478023|583019493|FG000|Overall Study|Withdrawal by Subject|2|||
161444110|NCT00478023|583019494|FG001|Overall Study|Withdrawal by Subject|3|||
161444111|NCT00478023|583019495|FG002|Overall Study|Withdrawal by Subject|2|||
161444112|NCT00478023|583019496|FG003|Overall Study|Withdrawal by Subject|4|||
161444113|NCT00478023|583019497|FG004|Overall Study|Withdrawal by Subject|5|||
161444114|NCT00478023|583019493|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
161444115|NCT00478023|583019494|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
161444116|NCT00478023|583019495|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
161444117|NCT00478023|583019496|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
161793448|NCT03611309|584287031|FG000|Overall Study|Lost to Follow-up|16|||
161793449|NCT03611309|584287032|FG001|Overall Study|Lost to Follow-up|8|||
161793450|NCT03611309|584287031|FG000|Overall Study|Withdrawal by Subject|5|||
161793451|NCT03611309|584287032|FG001|Overall Study|Withdrawal by Subject|5|||
161793452|NCT03611309|584287031|FG000|Overall Study|Physician Decision|0|||
161793453|NCT03611309|584287032|FG001|Overall Study|Physician Decision|2|||
161793454|NCT00772382|584287033|FG000|Overall Study|Adverse Event|19|||
161793455|NCT00772382|584287033|FG000|Overall Study|Death|6|||
161444118|NCT00478023|583019497|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
161444119|NCT00369265|583019499|FG000|Overall Study|Study terminated|4|||
161444120|NCT00369265|583019500|FG001|Overall Study|Study terminated|7|||
161444121|NCT03895840|583019503|FG000|Overall Study|Withdrawal by Subject|21|||
161444122|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
161793456|NCT00772382|584287033|FG000|Overall Study|Lack of Efficacy|4|||
161793457|NCT00772382|584287033|FG000|Overall Study|Physician Decision|5|||
161793458|NCT00772382|584287033|FG000|Overall Study|Protocol Violation|1|||
161793459|NCT00772382|584287033|FG000|Overall Study|Withdrawal by Subject|10|||
161793460|NCT00772382|584287033|FG000|Overall Study|Other Reasons|10|||
161793461|NCT04526899|584287034|FG000|Overall Study|Withdrawal by Subject|3|||
161793462|NCT04526899|584287035|FG001|Overall Study|Withdrawal by Subject|2|||
161793463|NCT04526899|584287036|FG002|Overall Study|Withdrawal by Subject|2|||
161793464|NCT04526899|584287034|FG000|Overall Study|Lost to Follow-up|3|||
161793465|NCT04526899|584287035|FG001|Overall Study|Lost to Follow-up|3|||
161793466|NCT04526899|584287036|FG002|Overall Study|Lost to Follow-up|1|||
161793467|NCT04526899|584287034|FG000|Overall Study|Investigator's decision|1|||
161793468|NCT04526899|584287035|FG001|Overall Study|Investigator's decision|0|||
161793469|NCT04526899|584287036|FG002|Overall Study|Investigator's decision|0|||
161793470|NCT04526899|584287034|FG000|Overall Study|Death|33|||
161793471|NCT04526899|584287035|FG001|Overall Study|Death|17|||
161793472|NCT04526899|584287036|FG002|Overall Study|Death|13|||
161793473|NCT04526899|584287034|FG000|Overall Study|Other|1|||
161793474|NCT04526899|584287035|FG001|Overall Study|Other|0|||
161793475|NCT04526899|584287036|FG002|Overall Study|Other|0|||
161793476|NCT04526899|584287034|FG000|Overall Study|On-Treatment|19|||
161898872|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161444123|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
161444124|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
161444125|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
161444126|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
161444127|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
161444128|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
161444129|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
161444130|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
161444131|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444132|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
161444133|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444134|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444135|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444136|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
161444137|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
161444138|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
161444139|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
161444140|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
161444141|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
161444142|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
161444143|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
161444144|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
161444145|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
161444146|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
161444147|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
161444148|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
161444149|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
161444150|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
161444151|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
161444152|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
161444153|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
161444154|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
161444155|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
161444156|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
161444157|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
161444158|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444159|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161793477|NCT04526899|584287035|FG001|Overall Study|On-Treatment|10|||
161793478|NCT04526899|584287036|FG002|Overall Study|On-Treatment|12|||
161793479|NCT04526899|584287034|FG000|Overall Study|Survival Follow-up|34|||
161793480|NCT04526899|584287035|FG001|Overall Study|Survival Follow-up|14|||
161793481|NCT04526899|584287036|FG002|Overall Study|Survival Follow-up|16|||
161898873|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898874|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898875|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898876|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898877|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
161444160|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444161|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444162|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444163|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444164|NCT05019521|583019504|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
161444165|NCT05019521|583019505|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444166|NCT05019521|583019506|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
161444167|NCT05019521|583019507|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
161444168|NCT05019521|583019508|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444169|NCT05019521|583019509|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444170|NCT05019521|583019510|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444171|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
161444172|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
161444173|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
161444174|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
161444175|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
161444176|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
161898878|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
161898879|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
161898880|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
161898881|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898882|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898883|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
161898884|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898885|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898886|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898887|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898888|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898889|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898890|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898891|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161898892|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898893|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898894|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898895|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
161898896|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161898897|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898898|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
161898899|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898900|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898901|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161898902|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898903|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
161898904|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
161898905|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
161898906|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
161898907|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
161898908|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
161898909|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
161898910|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
161898911|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
161898912|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
161898913|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
161898914|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
161898915|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
161898916|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
161898917|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
161444177|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
161444178|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
161444179|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
161444180|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
161444181|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444182|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444183|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
161444184|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
161444185|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
161444186|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
161444187|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
161444188|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
161444189|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
161444190|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
161444191|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
161444192|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
161444193|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
161444194|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
161444195|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
161444196|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
161444197|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
161444198|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
161444199|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
161444200|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
161444201|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
161444202|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
161444203|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
161444204|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
161444205|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
161444206|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444207|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444208|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444209|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444210|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444211|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
161444212|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161444213|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
161444214|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
161444215|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
161444216|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444217|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444218|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
161444219|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
161444220|NCT05019521|583019504|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
161444221|NCT05019521|583019505|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
161444222|NCT05019521|583019506|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
161444223|NCT05019521|583019507|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
161444224|NCT05019521|583019508|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
161444225|NCT05019521|583019509|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
161444226|NCT05019521|583019510|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
161444227|NCT00611026|583019511|FG000|Randomized to Double-blind Treatment|Not treated|2|||
161444228|NCT00611026|583019512|FG001|Randomized to Double-blind Treatment|Not treated|1|||
161444229|NCT00611026|583019513|FG002|Randomized to Double-blind Treatment|Not treated|3|||
161444230|NCT00611026|583019511|FG000|Double-blind Treatment Period|Death|1|||
161444231|NCT00611026|583019512|FG001|Double-blind Treatment Period|Death|0|||
161444232|NCT00611026|583019513|FG002|Double-blind Treatment Period|Death|0|||
161444233|NCT00611026|583019511|FG000|Double-blind Treatment Period|Adverse Event|9|||
161444234|NCT00611026|583019512|FG001|Double-blind Treatment Period|Adverse Event|28|||
161444235|NCT00611026|583019513|FG002|Double-blind Treatment Period|Adverse Event|46|||
161444236|NCT00611026|583019511|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
161444237|NCT00611026|583019512|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
161444238|NCT00611026|583019513|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
161444239|NCT00611026|583019511|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
161444240|NCT00611026|583019512|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
161444241|NCT00611026|583019513|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
161444242|NCT00611026|583019511|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
161444243|NCT00611026|583019512|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
161444244|NCT00611026|583019513|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
161444245|NCT00611026|583019511|FG000|Double-blind Treatment Period|Other|13|||
161444246|NCT00611026|583019512|FG001|Double-blind Treatment Period|Other|20|||
161444247|NCT00611026|583019513|FG002|Double-blind Treatment Period|Other|18|||
161444248|NCT00760617|583019514|FG000|Overall Study|Adverse Event|5|||
161444249|NCT00760617|583019515|FG001|Overall Study|Adverse Event|2|||
161444250|NCT00760617|583019516|FG002|Overall Study|Adverse Event|0|||
161444251|NCT00760617|583019514|FG000|Overall Study|Lost to Follow-up|0|||
161444252|NCT00760617|583019515|FG001|Overall Study|Lost to Follow-up|0|||
161444253|NCT00760617|583019516|FG002|Overall Study|Lost to Follow-up|5|||
161444254|NCT04625101|583019517|FG000|Overall Study|Withdrawal by Subject|0|||
161444255|NCT04625101|583019518|FG001|Overall Study|Withdrawal by Subject|1|||
161444256|NCT04625101|583019517|FG000|Overall Study|Protocol Deviation|1|||
161444257|NCT04625101|583019518|FG001|Overall Study|Protocol Deviation|0|||
161444258|NCT00467753|583019520|FG000|Overall Study|Lost to Follow-up|1|||
161444259|NCT00467753|583019521|FG001|Overall Study|Lost to Follow-up|2|||
161444260|NCT00467753|583019520|FG000|Overall Study|Adverse Event|2|||
161444261|NCT00467753|583019521|FG001|Overall Study|Adverse Event|0|||
161444262|NCT02817464|583019522|FG000|Overall Study|Lost to Follow-up|1|||
161444263|NCT02817464|583019523|FG001|Overall Study|Lost to Follow-up|0|||
161444264|NCT02817464|583019522|FG000|Overall Study|Discontinued early due to personal decision|1|||
161444265|NCT02817464|583019523|FG001|Overall Study|Discontinued early due to personal decision|1|||
161444266|NCT01026324|583019525|FG000|Follow up/Survival|Withdrawal by Subject|1|||
161444267|NCT01026324|583019526|FG001|Follow up/Survival|Withdrawal by Subject|0|||
161444268|NCT01026324|583019527|FG002|Follow up/Survival|Withdrawal by Subject|0|||
161444269|NCT01500720|583019532|FG000|Overall Study|Randomized But Not Treated|1|||
161444270|NCT01500720|583019533|FG001|Overall Study|Randomized But Not Treated|1|||
161444271|NCT01500720|583019532|FG000|Overall Study|Other|4|||
161444272|NCT01500720|583019533|FG001|Overall Study|Other|8|||
161444273|NCT02624986|583019535|FG000|Overall Study|Death|0|||
161444274|NCT02624986|583019536|FG001|Overall Study|Death|1|||
161444275|NCT02624986|583019537|FG002|Overall Study|Death|2|||
161444276|NCT02624986|583019538|FG003|Overall Study|Death|2|||
161444277|NCT02624986|583019539|FG004|Overall Study|Death|2|||
161444278|NCT02624986|583019540|FG005|Overall Study|Death|0|||
161444279|NCT02624986|583019541|FG006|Overall Study|Death|0|||
161444280|NCT02624986|583019542|FG007|Overall Study|Death|1|||
161444281|NCT02624986|583019535|FG000|Overall Study|Study Terminated by Sponsor|1|||
161444282|NCT02624986|583019536|FG001|Overall Study|Study Terminated by Sponsor|1|||
161444283|NCT02624986|583019537|FG002|Overall Study|Study Terminated by Sponsor|0|||
161444284|NCT02624986|583019538|FG003|Overall Study|Study Terminated by Sponsor|1|||
161444285|NCT02624986|583019539|FG004|Overall Study|Study Terminated by Sponsor|2|||
161444286|NCT02624986|583019540|FG005|Overall Study|Study Terminated by Sponsor|2|||
161444287|NCT02624986|583019541|FG006|Overall Study|Study Terminated by Sponsor|4|||
161444288|NCT02624986|583019542|FG007|Overall Study|Study Terminated by Sponsor|3|||
161444289|NCT02624986|583019535|FG000|Overall Study|Progressive Disease|0|||
161444290|NCT02624986|583019536|FG001|Overall Study|Progressive Disease|1|||
161444291|NCT02624986|583019537|FG002|Overall Study|Progressive Disease|0|||
161444292|NCT02624986|583019538|FG003|Overall Study|Progressive Disease|0|||
161444293|NCT02624986|583019539|FG004|Overall Study|Progressive Disease|0|||
161444294|NCT02624986|583019540|FG005|Overall Study|Progressive Disease|0|||
161444295|NCT02624986|583019541|FG006|Overall Study|Progressive Disease|0|||
161444296|NCT02624986|583019542|FG007|Overall Study|Progressive Disease|0|||
161444297|NCT02624986|583019535|FG000|Overall Study|Protocol Violation|1|||
161444298|NCT02624986|583019536|FG001|Overall Study|Protocol Violation|0|||
161444299|NCT02624986|583019537|FG002|Overall Study|Protocol Violation|0|||
161444300|NCT02624986|583019538|FG003|Overall Study|Protocol Violation|0|||
161444301|NCT02624986|583019539|FG004|Overall Study|Protocol Violation|0|||
161444302|NCT02624986|583019540|FG005|Overall Study|Protocol Violation|0|||
161444303|NCT02624986|583019541|FG006|Overall Study|Protocol Violation|0|||
161444304|NCT02624986|583019542|FG007|Overall Study|Protocol Violation|0|||
161444305|NCT02624986|583019535|FG000|Overall Study|Withdrawal by Subject|0|||
161444306|NCT02624986|583019536|FG001|Overall Study|Withdrawal by Subject|0|||
161444307|NCT02624986|583019537|FG002|Overall Study|Withdrawal by Subject|0|||
161444308|NCT02624986|583019538|FG003|Overall Study|Withdrawal by Subject|0|||
161444309|NCT02624986|583019539|FG004|Overall Study|Withdrawal by Subject|0|||
161444310|NCT02624986|583019540|FG005|Overall Study|Withdrawal by Subject|0|||
161444311|NCT02624986|583019541|FG006|Overall Study|Withdrawal by Subject|0|||
161444312|NCT02624986|583019542|FG007|Overall Study|Withdrawal by Subject|1|||
161444313|NCT03532451|583019543|FG000|Overall Study|Withdrawal by Subject|0|||
161444314|NCT03532451|583019544|FG001|Overall Study|Withdrawal by Subject|1|||
161444315|NCT03532451|583019543|FG000|Overall Study|Did not undergo surgery|1|||
161444316|NCT03532451|583019544|FG001|Overall Study|Did not undergo surgery|1|||
161444317|NCT00630838|583019554|FG000|Overall Study|Death|0|||
161444318|NCT00630838|583019555|FG001|Overall Study|Death|1|||
161444319|NCT00630838|583019554|FG000|Overall Study|Lost to Follow-up|0|||
161444320|NCT00630838|583019555|FG001|Overall Study|Lost to Follow-up|1|||
161444321|NCT00928408|583019556|FG000|Overall Study|Other|2|||
161444322|NCT00928408|583019556|FG000|Overall Study|Withdrawal by Subject|4|||
161444323|NCT00928408|583019556|FG000|Overall Study|Death|5|||
161898918|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
161444324|NCT00928408|583019556|FG000|Overall Study|Lost to Follow-up|12|||
161444325|NCT01287741|583019563|FG000|Overall Study|Withdrawal by Subject|35|||
161444326|NCT01287741|583019564|FG001|Overall Study|Withdrawal by Subject|38|||
161444327|NCT01287741|583019563|FG000|Overall Study|Protocol Violation|2|||
161444328|NCT01287741|583019564|FG001|Overall Study|Protocol Violation|0|||
161444329|NCT01287741|583019563|FG000|Overall Study|Physician Decision|15|||
161444330|NCT01287741|583019564|FG001|Overall Study|Physician Decision|23|||
161444331|NCT01287741|583019563|FG000|Overall Study|Non-compliance|8|||
161444332|NCT01287741|583019564|FG001|Overall Study|Non-compliance|6|||
161444333|NCT01287741|583019563|FG000|Overall Study|Lost to Follow-up|10|||
161444334|NCT01287741|583019564|FG001|Overall Study|Lost to Follow-up|8|||
161444335|NCT01287741|583019563|FG000|Overall Study|Death|32|||
161444336|NCT01287741|583019564|FG001|Overall Study|Death|44|||
161444337|NCT01287741|583019563|FG000|Overall Study|Adverse Event|4|||
161444338|NCT01287741|583019564|FG001|Overall Study|Adverse Event|6|||
161444339|NCT01287741|583019563|FG000|Overall Study|Study terminated by Sponsor|307|||
161444340|NCT01287741|583019564|FG001|Overall Study|Study terminated by Sponsor|315|||
161444341|NCT01287741|583019563|FG000|Overall Study|Progressive disease|190|||
161444342|NCT01287741|583019564|FG001|Overall Study|Progressive disease|166|||
161444343|NCT01287741|583019563|FG000|Overall Study|Reason not specified|23|||
161444344|NCT01287741|583019564|FG001|Overall Study|Reason not specified|9|||
161444345|NCT02930018|583019565|FG000|Overall Study|Lost to Follow-up|1|||
161444346|NCT02930018|583019566|FG001|Overall Study|Lost to Follow-up|1|||
161444347|NCT02930018|583019565|FG000|Overall Study|Withdrawal by Subject|5|||
161444348|NCT02930018|583019566|FG001|Overall Study|Withdrawal by Subject|2|||
161444349|NCT02807402|583019567|FG000|Overall Study|Failure to Return|1|||
161444350|NCT02807402|583019567|FG000|Overall Study|Death|3|||
161444351|NCT02807402|583019567|FG000|Overall Study|Other|2|||
161444352|NCT01865552|583021165|FG000|Period 1|Adverse Event|1|||
161444353|NCT01865552|583021166|FG001|Period 1|Adverse Event|0|||
161444354|NCT01865552|583021167|FG002|Period 1|Adverse Event|0|||
161444355|NCT01865552|583021168|FG003|Period 1|Adverse Event|1|||
161444356|NCT01865552|583021169|FG004|Period 1|Adverse Event|1|||
161444357|NCT01865552|583021170|FG005|Period 1|Adverse Event|1|||
161444358|NCT01865552|583021165|FG000|Period 1|Pathological lab|0|||
161444359|NCT01865552|583021166|FG001|Period 1|Pathological lab|0|||
161444360|NCT01865552|583021167|FG002|Period 1|Pathological lab|0|||
161444361|NCT01865552|583021168|FG003|Period 1|Pathological lab|0|||
161444362|NCT01865552|583021169|FG004|Period 1|Pathological lab|1|||
161444363|NCT01865552|583021170|FG005|Period 1|Pathological lab|0|||
161444364|NCT01865552|583021165|FG000|Period 1|Other|0|||
161793482|NCT05576012|584287041|FG000|Overall Study|Physician Decision|0|||
161793483|NCT05576012|584287042|FG001|Overall Study|Physician Decision|0|||
161793484|NCT05576012|584287043|FG002|Overall Study|Physician Decision|0|||
161793485|NCT05576012|584287044|FG003|Overall Study|Physician Decision|0|||
161793486|NCT05576012|584287045|FG004|Overall Study|Physician Decision|0|||
161793487|NCT05576012|584287046|FG005|Overall Study|Physician Decision|0|||
161793488|NCT05576012|584287047|FG006|Overall Study|Physician Decision|0|||
161793489|NCT05576012|584287048|FG007|Overall Study|Physician Decision|0|||
161793490|NCT05576012|584287049|FG008|Overall Study|Physician Decision|1|||
161793491|NCT05576012|584287050|FG009|Overall Study|Physician Decision|0|||
161793492|NCT03731182|584287717|FG000|Overall Study|Lost to Follow-up|2|||
161793493|NCT03731182|584287718|FG001|Overall Study|Lost to Follow-up|0|||
161793494|NCT03731182|584287717|FG000|Overall Study|Physician Decision|1|||
161793495|NCT03731182|584287718|FG001|Overall Study|Physician Decision|0|||
161793496|NCT03731182|584287717|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
161793497|NCT03731182|584287718|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161793498|NCT03036579|584287725|FG000|2 Years|Lost to Follow-up|1|||
161793499|NCT03036579|584287726|FG001|2 Years|Lost to Follow-up|0|||
161793500|NCT03036579|584287725|FG000|3 Years|Lost to Follow-up|0|||
161793501|NCT03036579|584287726|FG001|3 Years|Lost to Follow-up|1|||
161793502|NCT02352337|584287727|FG000|Overall Study|Patients never treated|4|||
161793503|NCT02352337|584287728|FG001|Overall Study|Patients never treated|1|||
161793504|NCT02352337|584287729|FG002|Overall Study|Patients never treated|2|||
161793505|NCT02458638|584287732|FG000|Overall Study|Death|309|||
161793506|NCT02458638|584287732|FG000|Overall Study|End of Cohort/End of Study|67|||
161898919|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
161898920|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
161898921|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
161444365|NCT01865552|583021166|FG001|Period 1|Other|0|||
161444366|NCT01865552|583021167|FG002|Period 1|Other|0|||
161444367|NCT01865552|583021168|FG003|Period 1|Other|0|||
161444368|NCT01865552|583021169|FG004|Period 1|Other|1|||
161444369|NCT01865552|583021170|FG005|Period 1|Other|0|||
161444370|NCT03079102|583021173|FG000|Overall Study|Physician Decision|0|||
161444371|NCT03079102|583021174|FG001|Overall Study|Physician Decision|1|||
161793507|NCT02458638|584287732|FG000|Overall Study|Lost to Follow-up|31|||
161793508|NCT02458638|584287732|FG000|Overall Study|Other Reasons|4|||
161793509|NCT02458638|584287732|FG000|Overall Study|Physician Decision|1|||
161793510|NCT02458638|584287732|FG000|Overall Study|Withdrawal by Subject|47|||
161793511|NCT00576901|584287744|FG000|Overall Study|Withdrawal by Subject|1|||
161793512|NCT00576901|584287744|FG000|Overall Study|Disease course|1|||
161444372|NCT02923921|583021175|FG000|Overall Study|Sponsor Decision|39|||
161444373|NCT02923921|583021176|FG001|Overall Study|Sponsor Decision|38|||
161444374|NCT02923921|583021175|FG000|Overall Study|Lost to Follow-up|1|||
161444375|NCT02923921|583021176|FG001|Overall Study|Lost to Follow-up|0|||
161444376|NCT02923921|583021175|FG000|Overall Study|Withdrawal by Subject|6|||
161444377|NCT02923921|583021176|FG001|Overall Study|Withdrawal by Subject|13|||
161444378|NCT02923921|583021175|FG000|Overall Study|Unknown, Not Collected|7|||
161444379|NCT02923921|583021176|FG001|Overall Study|Unknown, Not Collected|6|||
161444380|NCT03083873|583021177|FG000|Overall Study|Death|6|||
161444381|NCT03083873|583021178|FG001|Overall Study|Death|15|||
161444382|NCT03083873|583021179|FG002|Overall Study|Death|13|||
161444383|NCT03083873|583021180|FG003|Overall Study|Death|9|||
161444384|NCT03083873|583021181|FG004|Overall Study|Death|0|||
161444385|NCT03083873|583021177|FG000|Overall Study|Sponsor Terminated Study|0|||
161444386|NCT03083873|583021178|FG001|Overall Study|Sponsor Terminated Study|1|||
161444387|NCT03083873|583021179|FG002|Overall Study|Sponsor Terminated Study|2|||
161444388|NCT03083873|583021180|FG003|Overall Study|Sponsor Terminated Study|3|||
161444389|NCT03083873|583021181|FG004|Overall Study|Sponsor Terminated Study|0|||
161444390|NCT03083873|583021177|FG000|Overall Study|Lost to Follow-up|0|||
161444391|NCT03083873|583021178|FG001|Overall Study|Lost to Follow-up|1|||
161444392|NCT03083873|583021179|FG002|Overall Study|Lost to Follow-up|1|||
161444393|NCT03083873|583021180|FG003|Overall Study|Lost to Follow-up|0|||
161444394|NCT03083873|583021181|FG004|Overall Study|Lost to Follow-up|0|||
161444395|NCT03083873|583021177|FG000|Overall Study|Withdrawal by Subject|2|||
161444396|NCT03083873|583021178|FG001|Overall Study|Withdrawal by Subject|0|||
161444397|NCT03083873|583021179|FG002|Overall Study|Withdrawal by Subject|0|||
161793513|NCT00576901|584287744|FG000|Overall Study|Protocol Violation|1|||
161793514|NCT02398188|584287745|FG000|Overall Study|Adverse Event|2|||
161793515|NCT02398188|584287746|FG001|Overall Study|Adverse Event|3|||
161793516|NCT02398188|584287745|FG000|Overall Study|Lost to Follow-up|5|||
161793517|NCT02398188|584287746|FG001|Overall Study|Lost to Follow-up|0|||
161793518|NCT02398188|584287745|FG000|Overall Study|Non-compliance|4|||
161793519|NCT02398188|584287746|FG001|Overall Study|Non-compliance|4|||
161793520|NCT02398188|584287745|FG000|Overall Study|Protocol Violation|6|||
161898922|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898923|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161444398|NCT03083873|583021180|FG003|Overall Study|Withdrawal by Subject|0|||
161444399|NCT03083873|583021181|FG004|Overall Study|Withdrawal by Subject|0|||
161444400|NCT03083873|583021177|FG000|Overall Study|Did Not Receive TIL|2|||
161444401|NCT03083873|583021178|FG001|Overall Study|Did Not Receive TIL|5|||
161444402|NCT03083873|583021179|FG002|Overall Study|Did Not Receive TIL|3|||
161444403|NCT03083873|583021180|FG003|Overall Study|Did Not Receive TIL|1|||
161444404|NCT03083873|583021181|FG004|Overall Study|Did Not Receive TIL|0|||
161444405|NCT00479687|583021182|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
161444406|NCT00479687|583021183|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
161444407|NCT00479687|583021184|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
161444408|NCT00479687|583021182|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
161444409|NCT00479687|583021183|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
161444410|NCT00479687|583021184|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
161444411|NCT00479687|583021182|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
161444412|NCT00479687|583021183|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
161444413|NCT00479687|583021184|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
161444414|NCT00479687|583021182|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
161444415|NCT00479687|583021183|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
161444416|NCT00479687|583021184|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
161444417|NCT00479687|583021182|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
161444418|NCT00479687|583021183|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
161444419|NCT00479687|583021184|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
161444420|NCT00479687|583021182|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
161444421|NCT00479687|583021183|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
161444422|NCT00479687|583021184|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
161444423|NCT00479687|583021182|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
161444424|NCT00479687|583021183|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
161444425|NCT00479687|583021184|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
161444426|NCT00479687|583021182|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
161444427|NCT00479687|583021183|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
161444428|NCT00479687|583021184|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
161444429|NCT00479687|583021182|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
161444430|NCT00479687|583021183|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
161444431|NCT00479687|583021184|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
161444432|NCT00295880|583021185|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
161444433|NCT00295880|583021185|FG000|Overall Study|Unit randomization did not occur|1|||
161444434|NCT01474239|583021186|FG000|Overall Study|Disease Progression|37|||
161444435|NCT01474239|583021187|FG001|Overall Study|Disease Progression|25|||
161444436|NCT01474239|583021186|FG000|Overall Study|Adverse Event|12|||
161898924|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161444437|NCT01474239|583021187|FG001|Overall Study|Adverse Event|3|||
161444438|NCT01474239|583021186|FG000|Overall Study|Withdrawal by Subject|1|||
161444439|NCT01474239|583021187|FG001|Overall Study|Withdrawal by Subject|2|||
161444440|NCT01474239|583021186|FG000|Overall Study|Death|1|||
161444441|NCT01474239|583021187|FG001|Overall Study|Death|1|||
161444442|NCT01474239|583021186|FG000|Overall Study|Clinical Disease Progression|7|||
161444443|NCT01474239|583021187|FG001|Overall Study|Clinical Disease Progression|1|||
161444444|NCT01474239|583021186|FG000|Overall Study|Withdrawal for Economic Reason|1|||
161444445|NCT01474239|583021187|FG001|Overall Study|Withdrawal for Economic Reason|0|||
161898925|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898926|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161444446|NCT00854113|583021188|FG000|Overall Study|Adverse Event|0|||
161444447|NCT00854113|583021189|FG001|Overall Study|Adverse Event|0|||
161444448|NCT00854113|583021190|FG002|Overall Study|Adverse Event|0|||
161444449|NCT00854113|583021191|FG003|Overall Study|Adverse Event|0|||
161444450|NCT00854113|583021192|FG004|Overall Study|Adverse Event|0|||
161444451|NCT00854113|583021193|FG005|Overall Study|Adverse Event|0|||
161444452|NCT00854113|583021194|FG006|Overall Study|Adverse Event|0|||
161444453|NCT00854113|583021195|FG007|Overall Study|Adverse Event|2|||
161444454|NCT00854113|583021196|FG008|Overall Study|Adverse Event|0|||
161444455|NCT00854113|583021197|FG009|Overall Study|Adverse Event|0|||
161444456|NCT00854113|583021198|FG010|Overall Study|Adverse Event|0|||
161444457|NCT00854113|583021188|FG000|Overall Study|Withdrawal by Subject|0|||
161444458|NCT00854113|583021189|FG001|Overall Study|Withdrawal by Subject|0|||
161444459|NCT00854113|583021190|FG002|Overall Study|Withdrawal by Subject|0|||
161444460|NCT00854113|583021191|FG003|Overall Study|Withdrawal by Subject|0|||
161444461|NCT00854113|583021192|FG004|Overall Study|Withdrawal by Subject|0|||
161444462|NCT00854113|583021193|FG005|Overall Study|Withdrawal by Subject|0|||
161444463|NCT00854113|583021194|FG006|Overall Study|Withdrawal by Subject|0|||
161444464|NCT00854113|583021195|FG007|Overall Study|Withdrawal by Subject|1|||
161444465|NCT00854113|583021196|FG008|Overall Study|Withdrawal by Subject|1|||
161444466|NCT00854113|583021197|FG009|Overall Study|Withdrawal by Subject|0|||
161444467|NCT00854113|583021198|FG010|Overall Study|Withdrawal by Subject|0|||
161444468|NCT00796419|583021200|FG000|Overall Study|Death|0|||
161444469|NCT00796419|583021201|FG001|Overall Study|Death|1|||
161444470|NCT00539864|583021204|FG000|Overall Study|Lost to Follow-up|0|||
161444471|NCT00539864|583021205|FG001|Overall Study|Lost to Follow-up|1|||
161444472|NCT00539864|583021204|FG000|Overall Study|Withdrawal by Subject|1|||
161444473|NCT00539864|583021205|FG001|Overall Study|Withdrawal by Subject|1|||
161444474|NCT01250145|583021206|FG000|Overall Study|Adverse Event|2|||
161444475|NCT01250145|583021207|FG001|Overall Study|Adverse Event|1|||
161444476|NCT01250145|583021206|FG000|Overall Study|Withdrawal by Subject|0|||
161444477|NCT01250145|583021207|FG001|Overall Study|Withdrawal by Subject|4|||
161444478|NCT02840799|583021210|FG000|Phase 1|Physician Decision|1|||
161444479|NCT02840799|583021211|FG001|Phase 1|Physician Decision|3|||
161444480|NCT02840799|583021210|FG000|Phase 1|Withdrawal by Subject|4|||
161444481|NCT02840799|583021211|FG001|Phase 1|Withdrawal by Subject|0|||
161444482|NCT02840799|583021210|FG000|Phase 2 (Crossover)|Adverse Event|0|||
161444483|NCT02840799|583021211|FG001|Phase 2 (Crossover)|Adverse Event|1|||
161444484|NCT02840799|583021210|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
161444485|NCT02840799|583021211|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
161444486|NCT03983317|583021212|FG000|Overall Study|Physician Decision|5|||
161444487|NCT02687191|583021217|FG000|Overall Study|Death|0|||
161444488|NCT02687191|583021218|FG001|Overall Study|Death|1|||
161444489|NCT02687191|583021219|FG002|Overall Study|Death|1|||
161444490|NCT02687191|583021220|FG003|Overall Study|Death|0|||
161444491|NCT02687191|583021221|FG004|Overall Study|Death|1|||
161444492|NCT02687191|583021222|FG005|Overall Study|Death|1|||
161444493|NCT02687191|583021217|FG000|Overall Study|Withdrawal by Subject|0|||
161444494|NCT02687191|583021218|FG001|Overall Study|Withdrawal by Subject|0|||
161444495|NCT02687191|583021219|FG002|Overall Study|Withdrawal by Subject|0|||
161444496|NCT02687191|583021220|FG003|Overall Study|Withdrawal by Subject|1|||
161444497|NCT02687191|583021221|FG004|Overall Study|Withdrawal by Subject|0|||
161898927|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898928|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
161444498|NCT02687191|583021222|FG005|Overall Study|Withdrawal by Subject|0|||
161444499|NCT01864603|583021225|FG000|Stage 2|DSMB design modification|86056|||
161444500|NCT01864603|583021226|FG001|Stage 2|DSMB design modification|92558|||
161444501|NCT04661579|583021229|FG000|Overall Study|Lost to Follow-up|19|||
161444502|NCT04661579|583021230|FG001|Overall Study|Lost to Follow-up|10|||
161444503|NCT04661579|583021231|FG002|Overall Study|Lost to Follow-up|2|||
161444504|NCT04661579|583021232|FG003|Overall Study|Lost to Follow-up|7|||
161444505|NCT04661579|583021233|FG004|Overall Study|Lost to Follow-up|11|||
161444506|NCT04661579|583021229|FG000|Overall Study|Physician Decision|2|||
161444507|NCT04661579|583021230|FG001|Overall Study|Physician Decision|0|||
161444508|NCT04661579|583021231|FG002|Overall Study|Physician Decision|0|||
161444509|NCT04661579|583021232|FG003|Overall Study|Physician Decision|1|||
161444510|NCT04661579|583021233|FG004|Overall Study|Physician Decision|0|||
161444511|NCT04661579|583021229|FG000|Overall Study|Withdrawal by Subject|1|||
161444512|NCT04661579|583021230|FG001|Overall Study|Withdrawal by Subject|4|||
161444513|NCT04661579|583021231|FG002|Overall Study|Withdrawal by Subject|0|||
161444514|NCT04661579|583021232|FG003|Overall Study|Withdrawal by Subject|2|||
161444515|NCT04661579|583021233|FG004|Overall Study|Withdrawal by Subject|0|||
161444516|NCT04661579|583021229|FG000|Overall Study|Death|1|||
161444517|NCT04661579|583021230|FG001|Overall Study|Death|0|||
161444518|NCT04661579|583021231|FG002|Overall Study|Death|0|||
161444519|NCT04661579|583021232|FG003|Overall Study|Death|0|||
161444520|NCT04661579|583021233|FG004|Overall Study|Death|0|||
161444521|NCT04661579|583021229|FG000|Overall Study|Other|1|||
161444522|NCT04661579|583021230|FG001|Overall Study|Other|2|||
161444523|NCT04661579|583021231|FG002|Overall Study|Other|1|||
161444524|NCT04661579|583021232|FG003|Overall Study|Other|1|||
161444525|NCT04661579|583021233|FG004|Overall Study|Other|1|||
161444526|NCT04661579|583021229|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
161444527|NCT04661579|583021230|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
161444528|NCT04661579|583021231|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
161444529|NCT04661579|583021232|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
161444530|NCT04661579|583021233|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
161444531|NCT04335136|583021234|FG000|Overall Study|Death|8|||
161444532|NCT04335136|583021235|FG001|Overall Study|Death|4|||
161444533|NCT04335136|583021234|FG000|Overall Study|Lost to Follow-up|2|||
161444534|NCT04335136|583021235|FG001|Overall Study|Lost to Follow-up|0|||
161444535|NCT04335136|583021234|FG000|Overall Study|Protocol Violation|1|||
161444536|NCT04335136|583021235|FG001|Overall Study|Protocol Violation|0|||
161444537|NCT04335136|583021234|FG000|Overall Study|Withdrawal by Subject|1|||
161444538|NCT04335136|583021235|FG001|Overall Study|Withdrawal by Subject|1|||
161444539|NCT04335136|583021234|FG000|Overall Study|Health-threatening condition|0|||
161444540|NCT04335136|583021235|FG001|Overall Study|Health-threatening condition|1|||
161444541|NCT04335136|583021234|FG000|Overall Study|Adverse Event|0|||
161444542|NCT04335136|583021235|FG001|Overall Study|Adverse Event|1|||
161444543|NCT04335136|583021234|FG000|Overall Study|Erroneously randomized|2|||
161444544|NCT04335136|583021235|FG001|Overall Study|Erroneously randomized|0|||
161444545|NCT01396447|583021236|FG000|Overall Study|Did Not Receive Treatment|3|||
161444546|NCT01396447|583021237|FG001|Overall Study|Did Not Receive Treatment|2|||
161444547|NCT01396447|583021238|FG002|Overall Study|Did Not Receive Treatment|1|||
161444548|NCT01396447|583021239|FG003|Overall Study|Did Not Receive Treatment|0|||
161444549|NCT01396447|583021236|FG000|Overall Study|Adverse Event|15|||
161444550|NCT01396447|583021237|FG001|Overall Study|Adverse Event|12|||
161444551|NCT01396447|583021238|FG002|Overall Study|Adverse Event|12|||
161444552|NCT01396447|583021239|FG003|Overall Study|Adverse Event|17|||
161444553|NCT01396447|583021236|FG000|Overall Study|Insufficient Therapeutic Response|5|||
161444554|NCT01396447|583021237|FG001|Overall Study|Insufficient Therapeutic Response|5|||
161444555|NCT01396447|583021238|FG002|Overall Study|Insufficient Therapeutic Response|2|||
161444556|NCT01396447|583021239|FG003|Overall Study|Insufficient Therapeutic Response|4|||
161444557|NCT01396447|583021236|FG000|Overall Study|Protocol Violation|5|||
161444558|NCT01396447|583021237|FG001|Overall Study|Protocol Violation|2|||
161444559|NCT01396447|583021238|FG002|Overall Study|Protocol Violation|3|||
161444560|NCT01396447|583021239|FG003|Overall Study|Protocol Violation|7|||
161444561|NCT01396447|583021236|FG000|Overall Study|Withdrawal of Consent|11|||
161444562|NCT01396447|583021237|FG001|Overall Study|Withdrawal of Consent|9|||
161444563|NCT01396447|583021238|FG002|Overall Study|Withdrawal of Consent|4|||
161444564|NCT01396447|583021239|FG003|Overall Study|Withdrawal of Consent|15|||
161444565|NCT01396447|583021236|FG000|Overall Study|Lost to Follow-up|4|||
161444566|NCT01396447|583021237|FG001|Overall Study|Lost to Follow-up|8|||
161444567|NCT01396447|583021238|FG002|Overall Study|Lost to Follow-up|7|||
161444568|NCT01396447|583021239|FG003|Overall Study|Lost to Follow-up|9|||
161444569|NCT01396447|583021236|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161444570|NCT01396447|583021237|FG001|Overall Study|Other Miscellaneous Reasons|2|||
161444571|NCT01396447|583021238|FG002|Overall Study|Other Miscellaneous Reasons|1|||
161444572|NCT01396447|583021239|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161444573|NCT01402102|583021240|FG000|Overall Study|Protocol Violation|1|||
161793521|NCT02398188|584287746|FG001|Overall Study|Protocol Violation|10|||
161793522|NCT02398188|584287745|FG000|Overall Study|Sponsor Decision|2|||
161793523|NCT02398188|584287746|FG001|Overall Study|Sponsor Decision|1|||
161793524|NCT02398188|584287745|FG000|Overall Study|Pregnancy|1|||
161793525|NCT02398188|584287746|FG001|Overall Study|Pregnancy|0|||
161793526|NCT02398188|584287745|FG000|Overall Study|Withdrawal by Subject|7|||
161793527|NCT02398188|584287746|FG001|Overall Study|Withdrawal by Subject|16|||
161444574|NCT01402102|583021241|FG001|Overall Study|Protocol Violation|0|||
161444575|NCT01402102|583021240|FG000|Overall Study|Insufficiency of compliance|1|||
161444576|NCT01402102|583021241|FG001|Overall Study|Insufficiency of compliance|1|||
161444577|NCT01402102|583021240|FG000|Overall Study|Withdrawal by Subject|0|||
161444578|NCT01402102|583021241|FG001|Overall Study|Withdrawal by Subject|2|||
161444579|NCT04838626|583021242|FG000|Overall Study|Adverse Event|2|||
161444580|NCT04838626|583021242|FG000|Overall Study|Physician Decision|6|||
161793528|NCT01259869|584287747|FG000|Overall Study|Duplicated registration|1|||
161444581|NCT04838626|583021242|FG000|Overall Study|Protocol Violation|3|||
161444582|NCT04838626|583021242|FG000|Overall Study|Withdrawal by Subject|9|||
161444583|NCT04838626|583021242|FG000|Overall Study|Technical Problems|2|||
161444584|NCT00670306|583021245|FG000|Overall Study|Adverse Event|8|||
161444585|NCT00670306|583021245|FG000|Overall Study|Lack of Efficacy|10|||
161444586|NCT00670306|583021245|FG000|Overall Study|Withdrawal by Subject|9|||
161444587|NCT00670306|583021245|FG000|Overall Study|Physician Decision|1|||
161444588|NCT00670306|583021245|FG000|Overall Study|Lost to Follow-up|8|||
161444589|NCT00670306|583021245|FG000|Overall Study|incl/excl criterias did not meet|19|||
161444590|NCT00067002|583021248|FG000|Overall Study|Early Death|1|||
161444591|NCT00067002|583021249|FG001|Overall Study|Early Death|2|||
161444592|NCT00067002|583021248|FG000|Overall Study|Delayed|1|||
161444593|NCT00067002|583021249|FG001|Overall Study|Delayed|1|||
161444594|NCT00067002|583021248|FG000|Overall Study|Graft Failure|5|||
161444595|NCT00067002|583021249|FG001|Overall Study|Graft Failure|6|||
161444596|NCT03350672|583021250|FG000|Overall Study|Withdrawal by Subject|7|||
161444597|NCT03350672|583021251|FG001|Overall Study|Withdrawal by Subject|0|||
161444598|NCT03350672|583021252|FG002|Overall Study|Withdrawal by Subject|0|||
161444599|NCT01599637|583021253|FG000|Overall Study|administrative problems|0|||
161444600|NCT01599637|583021254|FG001|Overall Study|administrative problems|2|||
161444601|NCT01599637|583021255|FG002|Overall Study|administrative problems|0|||
161444602|NCT01599637|583021253|FG000|Overall Study|Adverse Event|1|||
161444603|NCT01599637|583021254|FG001|Overall Study|Adverse Event|0|||
161444604|NCT01599637|583021255|FG002|Overall Study|Adverse Event|0|||
161444605|NCT01192191|583021256|FG000|Overall Study|Adverse Event|7|||
161444606|NCT01192191|583021257|FG001|Overall Study|Adverse Event|12|||
161444607|NCT01192191|583021256|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
161444608|NCT01192191|583021257|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
161444609|NCT01192191|583021256|FG000|Overall Study|Lost to Follow-up|0|||
161444610|NCT01192191|583021257|FG001|Overall Study|Lost to Follow-up|1|||
161444611|NCT01192191|583021256|FG000|Overall Study|Withdrawal by Subject|1|||
161444612|NCT01192191|583021257|FG001|Overall Study|Withdrawal by Subject|6|||
161444613|NCT01047553|583021258|FG000|Overall Study|Adverse Event|10|||
161444614|NCT01047553|583021259|FG001|Overall Study|Adverse Event|5|||
161444615|NCT01047553|583021258|FG000|Overall Study|Withdrawal by Subject|4|||
161444616|NCT01047553|583021259|FG001|Overall Study|Withdrawal by Subject|2|||
161444617|NCT01047553|583021258|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
161444618|NCT01047553|583021259|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
161444619|NCT01047553|583021258|FG000|Overall Study|Lost to Follow-up|1|||
161444620|NCT01047553|583021259|FG001|Overall Study|Lost to Follow-up|0|||
161793529|NCT00220701|584287748|FG000|Overall Study|Lost to Follow-up|5|||
161793530|NCT00220701|584287749|FG001|Overall Study|Lost to Follow-up|4|||
161444621|NCT01047553|583021258|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
161444622|NCT01047553|583021259|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
161444623|NCT01047553|583021258|FG000|Overall Study|PI's decision|0|||
161444624|NCT01047553|583021259|FG001|Overall Study|PI's decision|1|||
161444625|NCT04292899|583021261|FG000|Overall Study|Death|21|||
161444626|NCT04292899|583021262|FG001|Overall Study|Death|28|||
161444627|NCT04292899|583021263|FG002|Overall Study|Death|188|||
161444628|NCT04292899|583021264|FG003|Overall Study|Death|371|||
161444629|NCT04292899|583021261|FG000|Overall Study|Lost to Follow-up|8|||
161444630|NCT04292899|583021262|FG001|Overall Study|Lost to Follow-up|4|||
161444631|NCT04292899|583021263|FG002|Overall Study|Lost to Follow-up|22|||
161444632|NCT04292899|583021264|FG003|Overall Study|Lost to Follow-up|235|||
161444633|NCT04292899|583021261|FG000|Overall Study|Withdrew consent|1|||
161444634|NCT04292899|583021262|FG001|Overall Study|Withdrew consent|0|||
161444635|NCT04292899|583021263|FG002|Overall Study|Withdrew consent|11|||
161444636|NCT04292899|583021264|FG003|Overall Study|Withdrew consent|32|||
161444637|NCT04292899|583021261|FG000|Overall Study|Adverse Event|2|||
161444638|NCT04292899|583021262|FG001|Overall Study|Adverse Event|1|||
161444639|NCT04292899|583021263|FG002|Overall Study|Adverse Event|2|||
161444640|NCT04292899|583021264|FG003|Overall Study|Adverse Event|2|||
161444641|NCT04292899|583021261|FG000|Overall Study|Investigator's Discretion|0|||
161444642|NCT04292899|583021262|FG001|Overall Study|Investigator's Discretion|0|||
161444643|NCT04292899|583021263|FG002|Overall Study|Investigator's Discretion|0|||
161444644|NCT04292899|583021264|FG003|Overall Study|Investigator's Discretion|3|||
161444645|NCT04292899|583021261|FG000|Overall Study|Non-compliance With Study Drug|0|||
161444646|NCT04292899|583021262|FG001|Overall Study|Non-compliance With Study Drug|0|||
161444647|NCT04292899|583021263|FG002|Overall Study|Non-compliance With Study Drug|0|||
161444648|NCT04292899|583021264|FG003|Overall Study|Non-compliance With Study Drug|1|||
161444649|NCT04292899|583021261|FG000|Overall Study|Protocol Violation|0|||
161444650|NCT04292899|583021262|FG001|Overall Study|Protocol Violation|0|||
161444651|NCT04292899|583021263|FG002|Overall Study|Protocol Violation|0|||
161444652|NCT04292899|583021264|FG003|Overall Study|Protocol Violation|1|||
161444653|NCT00948441|583021265|FG000|Overall Study|no longer meet inclusion criteria|1|||
161444654|NCT00948441|583021266|FG001|Overall Study|no longer meet inclusion criteria|4|||
161444655|NCT05340478|583021271|FG000|Overall Study|Scheduling Issues|10|||
161444656|NCT05340478|583021272|FG001|Overall Study|Scheduling Issues|4|||
161444657|NCT05340478|583021271|FG000|Overall Study|Neither member of dyad started treatment|2|||
161444658|NCT05340478|583021272|FG001|Overall Study|Neither member of dyad started treatment|2|||
161444659|NCT05340478|583021271|FG000|Overall Study|Withdrawn from study|2|||
161444660|NCT05340478|583021272|FG001|Overall Study|Withdrawn from study|2|||
161444661|NCT05340478|583021271|FG000|Overall Study|Lost to Follow-up|1|||
161444662|NCT05340478|583021272|FG001|Overall Study|Lost to Follow-up|4|||
161444663|NCT01032889|583021273|FG000|Overall Study|Adverse Event|2|||
161444664|NCT01032889|583021274|FG001|Overall Study|Adverse Event|2|||
161444665|NCT01032889|583021275|FG002|Overall Study|Adverse Event|0|||
161444666|NCT01032889|583021273|FG000|Overall Study|Withdrawal of Consent|1|||
161444667|NCT01032889|583021274|FG001|Overall Study|Withdrawal of Consent|2|||
161444668|NCT01032889|583021275|FG002|Overall Study|Withdrawal of Consent|1|||
161444669|NCT01032889|583021273|FG000|Overall Study|Patient Request|0|||
161444670|NCT01032889|583021274|FG001|Overall Study|Patient Request|1|||
161444671|NCT01032889|583021275|FG002|Overall Study|Patient Request|0|||
161793531|NCT01612000|584287751|FG000|Overall Study|Lost to Follow-up|6|||
161793532|NCT01612000|584287752|FG001|Overall Study|Lost to Follow-up|4|||
161793533|NCT01612000|584287753|FG002|Overall Study|Lost to Follow-up|4|||
161444672|NCT01032889|583021273|FG000|Overall Study|Lost to Follow-up|1|||
161444673|NCT01032889|583021274|FG001|Overall Study|Lost to Follow-up|1|||
161444674|NCT01032889|583021275|FG002|Overall Study|Lost to Follow-up|0|||
161444675|NCT01032889|583021273|FG000|Overall Study|Lack of Submental Fat|2|||
161444676|NCT01032889|583021274|FG001|Overall Study|Lack of Submental Fat|8|||
161444677|NCT01032889|583021275|FG002|Overall Study|Lack of Submental Fat|1|||
161793534|NCT01612000|584287754|FG003|Overall Study|Lost to Follow-up|8|||
161793535|NCT01612000|584287751|FG000|Overall Study|Physician Decision|0|||
161793536|NCT01612000|584287752|FG001|Overall Study|Physician Decision|0|||
161793537|NCT01612000|584287753|FG002|Overall Study|Physician Decision|1|||
161793538|NCT01612000|584287754|FG003|Overall Study|Physician Decision|0|||
161793539|NCT01612000|584287751|FG000|Overall Study|Withdrawal by Subject|3|||
161444678|NCT01032889|583021273|FG000|Overall Study|Miscellaneous Reasons|2|||
161444679|NCT01032889|583021274|FG001|Overall Study|Miscellaneous Reasons|1|||
161444680|NCT01032889|583021275|FG002|Overall Study|Miscellaneous Reasons|1|||
161444681|NCT02116205|583021276|FG000|Overall Study|Withdrawal by Subject|2|||
161444682|NCT02116205|583021277|FG001|Overall Study|Withdrawal by Subject|4|||
161444683|NCT02116205|583021278|FG002|Overall Study|Withdrawal by Subject|1|||
161444684|NCT02116205|583021279|FG003|Overall Study|Withdrawal by Subject|3|||
161444685|NCT02116205|583021276|FG000|Overall Study|Lost to Follow-up|0|||
161444686|NCT02116205|583021277|FG001|Overall Study|Lost to Follow-up|2|||
161444687|NCT02116205|583021278|FG002|Overall Study|Lost to Follow-up|1|||
161444688|NCT02116205|583021279|FG003|Overall Study|Lost to Follow-up|2|||
161444689|NCT02116205|583021276|FG000|Overall Study|Physician Decision|0|||
161444690|NCT02116205|583021277|FG001|Overall Study|Physician Decision|1|||
161444691|NCT02116205|583021278|FG002|Overall Study|Physician Decision|1|||
161444692|NCT02116205|583021279|FG003|Overall Study|Physician Decision|1|||
161444693|NCT02116205|583021276|FG000|Overall Study|Exclusion criteria|0|||
161444694|NCT02116205|583021277|FG001|Overall Study|Exclusion criteria|0|||
161444695|NCT02116205|583021278|FG002|Overall Study|Exclusion criteria|1|||
161444696|NCT02116205|583021279|FG003|Overall Study|Exclusion criteria|0|||
161444697|NCT00256997|583021280|FG000|Overall Study|Protocol Violation|1|||
161444698|NCT00256997|583021281|FG001|Overall Study|Protocol Violation|4|||
161444699|NCT00256997|583021280|FG000|Overall Study|Lack of Efficacy|1|||
161444700|NCT00256997|583021281|FG001|Overall Study|Lack of Efficacy|4|||
161444701|NCT00256997|583021280|FG000|Overall Study|Death|2|||
161444702|NCT00256997|583021281|FG001|Overall Study|Death|0|||
161444703|NCT00256997|583021280|FG000|Overall Study|Adverse Event|4|||
161444704|NCT00256997|583021281|FG001|Overall Study|Adverse Event|0|||
161444705|NCT00256997|583021280|FG000|Overall Study|Lost to Follow-up|3|||
161444706|NCT00256997|583021281|FG001|Overall Study|Lost to Follow-up|5|||
161444707|NCT00256997|583021280|FG000|Overall Study|Withdrawal by Subject|13|||
161444708|NCT00256997|583021281|FG001|Overall Study|Withdrawal by Subject|3|||
161444709|NCT00256997|583021280|FG000|Overall Study|Started but not treated|2|||
161444710|NCT00256997|583021281|FG001|Overall Study|Started but not treated|0|||
161444711|NCT00256997|583021280|FG000|Overall Study|Other|5|||
161444712|NCT00256997|583021281|FG001|Overall Study|Other|8|||
161444713|NCT00256997|583021280|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
161444714|NCT00256997|583021281|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
161444715|NCT00256997|583021280|FG000|Overall Study|Participant Non-compliant|3|||
161444716|NCT00256997|583021281|FG001|Overall Study|Participant Non-compliant|6|||
161444717|NCT00256997|583021280|FG000|Overall Study|Investigator Withdrew Participant|2|||
161444718|NCT00256997|583021281|FG001|Overall Study|Investigator Withdrew Participant|1|||
161444719|NCT04672655|583021284|FG000|Overall Study|Lost to Follow-up|12|||
161444720|NCT04672655|583021285|FG001|Overall Study|Lost to Follow-up|17|||
161444721|NCT04672655|583021284|FG000|Overall Study|Withdrawal by Subject|1|||
161444722|NCT04672655|583021285|FG001|Overall Study|Withdrawal by Subject|0|||
161444723|NCT04672655|583021284|FG000|Overall Study|Withdrawal by Study|1|||
161444724|NCT04672655|583021285|FG001|Overall Study|Withdrawal by Study|0|||
161444725|NCT01326104|583021286|FG000|Overall Study|progressed prior to vaccine|0|||
161444726|NCT01326104|583021287|FG001|Overall Study|progressed prior to vaccine|2|||
161444727|NCT01326104|583021286|FG000|Overall Study|unable to make vaccine|0|||
161444728|NCT01326104|583021287|FG001|Overall Study|unable to make vaccine|2|||
161444729|NCT03843541|583021288|FG000|Overall Study|Adverse Event|4|||
161444730|NCT03843541|583021289|FG001|Overall Study|Adverse Event|2|||
161444731|NCT03843541|583021290|FG002|Overall Study|Adverse Event|3|||
161444732|NCT03843541|583021288|FG000|Overall Study|Death|1|||
161444733|NCT03843541|583021289|FG001|Overall Study|Death|0|||
161444734|NCT03843541|583021290|FG002|Overall Study|Death|0|||
161444735|NCT03843541|583021288|FG000|Overall Study|Lack of adherence to study medication|0|||
161444736|NCT03843541|583021289|FG001|Overall Study|Lack of adherence to study medication|0|||
161444737|NCT03843541|583021290|FG002|Overall Study|Lack of adherence to study medication|1|||
161444738|NCT03843541|583021288|FG000|Overall Study|Physician Decision|1|||
161444739|NCT03843541|583021289|FG001|Overall Study|Physician Decision|2|||
161444740|NCT03843541|583021290|FG002|Overall Study|Physician Decision|2|||
161444741|NCT03843541|583021288|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
161444742|NCT03843541|583021289|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
161444743|NCT03843541|583021290|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
161444744|NCT03843541|583021288|FG000|Overall Study|Withdrawal by Subject|6|||
161444745|NCT03843541|583021289|FG001|Overall Study|Withdrawal by Subject|9|||
161444746|NCT03843541|583021290|FG002|Overall Study|Withdrawal by Subject|7|||
161444747|NCT03843541|583021288|FG000|Overall Study|Administration of rescue mucolytic|0|||
161444748|NCT03843541|583021289|FG001|Overall Study|Administration of rescue mucolytic|0|||
161444749|NCT03843541|583021290|FG002|Overall Study|Administration of rescue mucolytic|1|||
161444750|NCT03843541|583021288|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
161444751|NCT03843541|583021289|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
161444752|NCT03843541|583021290|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
161444753|NCT04163016|583021291|FG000|Enrollment|Adverse Event|1|||
161444754|NCT04163016|583021292|FG001|Enrollment|Adverse Event|0|||
161444755|NCT04163016|583021293|FG002|Enrollment|Adverse Event|0|||
161444756|NCT04163016|583021294|FG003|Enrollment|Adverse Event|0|||
161444757|NCT04163016|583021291|FG000|Treatment|Adverse Event|0|||
161444758|NCT04163016|583021292|FG001|Treatment|Adverse Event|1|||
161444759|NCT04163016|583021293|FG002|Treatment|Adverse Event|0|||
161444760|NCT04163016|583021294|FG003|Treatment|Adverse Event|0|||
161444761|NCT04163016|583021291|FG000|Treatment|Withdrawal by Subject|0|||
161444762|NCT04163016|583021292|FG001|Treatment|Withdrawal by Subject|2|||
161444763|NCT04163016|583021293|FG002|Treatment|Withdrawal by Subject|0|||
161444764|NCT04163016|583021294|FG003|Treatment|Withdrawal by Subject|0|||
161444765|NCT04163016|583021291|FG000|Treatment|Indeterminate TB-test|0|||
161444766|NCT04163016|583021292|FG001|Treatment|Indeterminate TB-test|0|||
161444767|NCT04163016|583021293|FG002|Treatment|Indeterminate TB-test|0|||
161444768|NCT04163016|583021294|FG003|Treatment|Indeterminate TB-test|1|||
161444769|NCT04163016|583021291|FG000|Treatment|Participant did not want to continue in study|0|||
161444770|NCT04163016|583021292|FG001|Treatment|Participant did not want to continue in study|0|||
161444771|NCT04163016|583021293|FG002|Treatment|Participant did not want to continue in study|0|||
161444772|NCT04163016|583021294|FG003|Treatment|Participant did not want to continue in study|1|||
161444773|NCT01104311|583021301|FG000|Overall Study|Withdrawal by Subject|6|||
161444774|NCT01104311|583021302|FG001|Overall Study|Withdrawal by Subject|6|||
161444775|NCT01104311|583021301|FG000|Overall Study|Protocol Violation|0|||
161444776|NCT01104311|583021302|FG001|Overall Study|Protocol Violation|1|||
161444777|NCT01104311|583021301|FG000|Overall Study|Physician Decision|2|||
161444778|NCT01104311|583021302|FG001|Overall Study|Physician Decision|2|||
161444779|NCT01104311|583021301|FG000|Overall Study|low compliance|1|||
161444780|NCT01104311|583021302|FG001|Overall Study|low compliance|1|||
161444781|NCT01104311|583021301|FG000|Overall Study|Adverse Event|1|||
161444782|NCT01104311|583021302|FG001|Overall Study|Adverse Event|2|||
161444783|NCT04434937|583021304|FG000|Overall Study|Death|4|||
161444784|NCT04434937|583021304|FG000|Overall Study|Withdrawal by Subject|1|||
161444785|NCT04434937|583021304|FG000|Overall Study|Transitioned to Rollover Study|19|||
161444786|NCT04434937|583021304|FG000|Overall Study|Progressive Disease|18|||
161444787|NCT04193189|583021309|FG000|Overall Study|Lost to Follow-up|9|||
161444788|NCT04193189|583021310|FG001|Overall Study|Lost to Follow-up|7|||
161444789|NCT04193189|583021311|FG002|Overall Study|Lost to Follow-up|9|||
161444790|NCT04193189|583021312|FG003|Overall Study|Lost to Follow-up|0|||
161444791|NCT04193189|583021309|FG000|Overall Study|Withdrawal by Subject|1|||
161444792|NCT04193189|583021310|FG001|Overall Study|Withdrawal by Subject|2|||
161444793|NCT04193189|583021311|FG002|Overall Study|Withdrawal by Subject|2|||
161444794|NCT04193189|583021312|FG003|Overall Study|Withdrawal by Subject|0|||
161444795|NCT04193189|583021309|FG000|Overall Study|Death|1|||
161444796|NCT04193189|583021310|FG001|Overall Study|Death|1|||
161444797|NCT04193189|583021311|FG002|Overall Study|Death|0|||
161444798|NCT04193189|583021312|FG003|Overall Study|Death|0|||
161444799|NCT04193189|583021309|FG000|Overall Study|Protocol Violation|0|||
161444800|NCT04193189|583021310|FG001|Overall Study|Protocol Violation|0|||
161444801|NCT04193189|583021311|FG002|Overall Study|Protocol Violation|0|||
161444802|NCT04193189|583021312|FG003|Overall Study|Protocol Violation|1|||
161444803|NCT01243242|583022743|FG000|Overall Study|Adverse Event|1|||
161444804|NCT01243242|583022744|FG001|Overall Study|Adverse Event|1|||
161793540|NCT01612000|584287752|FG001|Overall Study|Withdrawal by Subject|1|||
161793541|NCT01612000|584287753|FG002|Overall Study|Withdrawal by Subject|2|||
161793542|NCT01612000|584287754|FG003|Overall Study|Withdrawal by Subject|2|||
161793543|NCT03843359|584287755|FG000|Escalation Phase|Lost to Follow-up|0|||
161793544|NCT03843359|584287756|FG001|Escalation Phase|Lost to Follow-up|0|||
161793545|NCT03843359|584287757|FG002|Escalation Phase|Lost to Follow-up|0|||
161793546|NCT03843359|584287758|FG003|Escalation Phase|Lost to Follow-up|0|||
161444805|NCT01243242|583022743|FG000|Overall Study|Withdrawal by Subject|1|||
161444806|NCT01243242|583022744|FG001|Overall Study|Withdrawal by Subject|1|||
161444807|NCT01243242|583022743|FG000|Overall Study|Physician Decision|0|||
161444808|NCT01243242|583022744|FG001|Overall Study|Physician Decision|1|||
161444809|NCT01243242|583022743|FG000|Overall Study|sponsor decision|0|||
161444810|NCT01243242|583022744|FG001|Overall Study|sponsor decision|1|||
161444811|NCT01243242|583022743|FG000|Overall Study|non compliance|1|||
161444812|NCT01243242|583022744|FG001|Overall Study|non compliance|0|||
161444813|NCT01349049|583022750|FG000|Overall Study|Disease progression|3|||
161444814|NCT01349049|583022751|FG001|Overall Study|Disease progression|5|||
161444815|NCT01349049|583022752|FG002|Overall Study|Disease progression|3|||
161444816|NCT01349049|583022753|FG003|Overall Study|Disease progression|2|||
161444817|NCT01349049|583022754|FG004|Overall Study|Disease progression|2|||
161444818|NCT01349049|583022755|FG005|Overall Study|Disease progression|2|||
161444819|NCT01349049|583022756|FG006|Overall Study|Disease progression|3|||
161444820|NCT01349049|583022757|FG007|Overall Study|Disease progression|2|||
161444821|NCT01349049|583022758|FG008|Overall Study|Disease progression|33|||
161444822|NCT01349049|583022750|FG000|Overall Study|Adverse Event|0|||
161444823|NCT01349049|583022751|FG001|Overall Study|Adverse Event|1|||
161444824|NCT01349049|583022752|FG002|Overall Study|Adverse Event|0|||
161444825|NCT01349049|583022753|FG003|Overall Study|Adverse Event|0|||
161444826|NCT01349049|583022754|FG004|Overall Study|Adverse Event|0|||
161444827|NCT01349049|583022755|FG005|Overall Study|Adverse Event|3|||
161444828|NCT01349049|583022756|FG006|Overall Study|Adverse Event|1|||
161444829|NCT01349049|583022757|FG007|Overall Study|Adverse Event|0|||
161444830|NCT01349049|583022758|FG008|Overall Study|Adverse Event|4|||
161444831|NCT01349049|583022750|FG000|Overall Study|Physician Decision|0|||
161444832|NCT01349049|583022751|FG001|Overall Study|Physician Decision|1|||
161444833|NCT01349049|583022752|FG002|Overall Study|Physician Decision|0|||
161444834|NCT01349049|583022753|FG003|Overall Study|Physician Decision|0|||
161444835|NCT01349049|583022754|FG004|Overall Study|Physician Decision|0|||
161444836|NCT01349049|583022755|FG005|Overall Study|Physician Decision|0|||
161444837|NCT01349049|583022756|FG006|Overall Study|Physician Decision|0|||
161444838|NCT01349049|583022757|FG007|Overall Study|Physician Decision|0|||
161444839|NCT01349049|583022758|FG008|Overall Study|Physician Decision|2|||
161444840|NCT01349049|583022750|FG000|Overall Study|Protocol Violation|0|||
161444841|NCT01349049|583022751|FG001|Overall Study|Protocol Violation|0|||
161444842|NCT01349049|583022752|FG002|Overall Study|Protocol Violation|0|||
161444843|NCT01349049|583022753|FG003|Overall Study|Protocol Violation|0|||
161444844|NCT01349049|583022754|FG004|Overall Study|Protocol Violation|0|||
161444845|NCT01349049|583022755|FG005|Overall Study|Protocol Violation|0|||
161444846|NCT01349049|583022756|FG006|Overall Study|Protocol Violation|0|||
161444847|NCT01349049|583022757|FG007|Overall Study|Protocol Violation|0|||
161444848|NCT01349049|583022758|FG008|Overall Study|Protocol Violation|1|||
161444849|NCT01349049|583022750|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
161444850|NCT01349049|583022751|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
161444851|NCT01349049|583022752|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
161444852|NCT01349049|583022753|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
161444853|NCT01349049|583022754|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
161444854|NCT01349049|583022755|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
161444855|NCT01349049|583022756|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
161444856|NCT01349049|583022757|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
161444857|NCT01349049|583022758|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
161444858|NCT01349049|583022750|FG000|Overall Study|Other|0|||
161444859|NCT01349049|583022751|FG001|Overall Study|Other|0|||
161444860|NCT01349049|583022752|FG002|Overall Study|Other|0|||
161444861|NCT01349049|583022753|FG003|Overall Study|Other|0|||
161444862|NCT01349049|583022754|FG004|Overall Study|Other|0|||
161444863|NCT01349049|583022755|FG005|Overall Study|Other|1|||
161444864|NCT01349049|583022756|FG006|Overall Study|Other|0|||
161444865|NCT01349049|583022757|FG007|Overall Study|Other|0|||
161444866|NCT01349049|583022758|FG008|Overall Study|Other|4|||
161444867|NCT01349049|583022750|FG000|Overall Study|Death|0|||
161444868|NCT01349049|583022751|FG001|Overall Study|Death|0|||
161444869|NCT01349049|583022752|FG002|Overall Study|Death|0|||
161444870|NCT01349049|583022753|FG003|Overall Study|Death|0|||
161444871|NCT01349049|583022754|FG004|Overall Study|Death|0|||
161444872|NCT01349049|583022755|FG005|Overall Study|Death|0|||
161444873|NCT01349049|583022756|FG006|Overall Study|Death|0|||
161444874|NCT01349049|583022757|FG007|Overall Study|Death|1|||
161444875|NCT01349049|583022758|FG008|Overall Study|Death|5|||
161444876|NCT01349049|583022750|FG000|Overall Study|Non-compliance|0|||
161444877|NCT01349049|583022751|FG001|Overall Study|Non-compliance|0|||
161444878|NCT01349049|583022752|FG002|Overall Study|Non-compliance|0|||
161444879|NCT01349049|583022753|FG003|Overall Study|Non-compliance|1|||
161444880|NCT01349049|583022754|FG004|Overall Study|Non-compliance|0|||
161444881|NCT01349049|583022755|FG005|Overall Study|Non-compliance|0|||
161444882|NCT01349049|583022756|FG006|Overall Study|Non-compliance|0|||
161444883|NCT01349049|583022757|FG007|Overall Study|Non-compliance|0|||
161444884|NCT01349049|583022758|FG008|Overall Study|Non-compliance|0|||
161444885|NCT01349049|583022750|FG000|Overall Study|Withdrawal by Subject|0|||
161444886|NCT01349049|583022751|FG001|Overall Study|Withdrawal by Subject|0|||
161444887|NCT01349049|583022752|FG002|Overall Study|Withdrawal by Subject|0|||
161444888|NCT01349049|583022753|FG003|Overall Study|Withdrawal by Subject|0|||
161444889|NCT01349049|583022754|FG004|Overall Study|Withdrawal by Subject|0|||
161444890|NCT01349049|583022755|FG005|Overall Study|Withdrawal by Subject|0|||
161444891|NCT01349049|583022756|FG006|Overall Study|Withdrawal by Subject|0|||
161444892|NCT01349049|583022757|FG007|Overall Study|Withdrawal by Subject|0|||
161444893|NCT01349049|583022758|FG008|Overall Study|Withdrawal by Subject|6|||
161444894|NCT00552188|583022762|FG000|Overall Study|Adverse Event|0|||
161444895|NCT00552188|583022763|FG001|Overall Study|Adverse Event|2|||
161444896|NCT00552188|583022762|FG000|Overall Study|Lost to Follow-up|2|||
161444897|NCT00552188|583022763|FG001|Overall Study|Lost to Follow-up|1|||
161444898|NCT00552188|583022762|FG000|Overall Study|Withdrawal of consent|0|||
161444899|NCT00552188|583022763|FG001|Overall Study|Withdrawal of consent|1|||
161444900|NCT00552188|583022762|FG000|Overall Study|Subject returned to home country|0|||
161444901|NCT00552188|583022763|FG001|Overall Study|Subject returned to home country|1|||
161444902|NCT01256294|583022764|FG000|Overall Study|Adverse Event|1|||
161444903|NCT01256294|583022765|FG001|Overall Study|Adverse Event|0|||
161444904|NCT01256294|583022764|FG000|Overall Study|Withdrawal by Subject|1|||
161444905|NCT01256294|583022765|FG001|Overall Study|Withdrawal by Subject|1|||
161444906|NCT01256294|583022764|FG000|Overall Study|Protocol deviation|2|||
161444907|NCT01256294|583022765|FG001|Overall Study|Protocol deviation|1|||
161444908|NCT04681352|583022766|FG000|Overall Study|Lost to Follow-up|2|||
161444909|NCT04681352|583022766|FG000|Overall Study|Withdrawal by Subject|22|||
161444910|NCT03887702|583022767|FG000|Overall Study|Study terminated|0|||
161444911|NCT03887702|583022768|FG001|Overall Study|Study terminated|0|||
161444912|NCT03887702|583022769|FG002|Overall Study|Study terminated|2|||
161444913|NCT03887702|583022770|FG003|Overall Study|Study terminated|2|||
161444914|NCT01643772|583022771|FG000|Overall Study|Protocol Violation|0|||
161444915|NCT01643772|583022772|FG001|Overall Study|Protocol Violation|0|||
161898929|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898930|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898931|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898932|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898933|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898934|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898935|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898936|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161444916|NCT01643772|583022773|FG002|Overall Study|Protocol Violation|0|||
161444917|NCT01643772|583022774|FG003|Overall Study|Protocol Violation|1|||
161444918|NCT01643772|583022771|FG000|Overall Study|Adverse Event|0|||
161444919|NCT01643772|583022772|FG001|Overall Study|Adverse Event|0|||
161444920|NCT01643772|583022773|FG002|Overall Study|Adverse Event|0|||
161444921|NCT01643772|583022774|FG003|Overall Study|Adverse Event|1|||
161444922|NCT01675544|583022777|FG000|Overall Study|Withdrawal by Subject|2|||
161444923|NCT03860818|583022778|FG000|Overall Study|Death|144|||
161444924|NCT03860818|583022779|FG001|Overall Study|Death|195|||
161444925|NCT03860818|583022778|FG000|Overall Study|Graft Loss|32|||
161444926|NCT03860818|583022779|FG001|Overall Study|Graft Loss|45|||
161444927|NCT00792571|583022780|FG000|Overall Study|Death|1|||
161444928|NCT00792571|583022780|FG000|Overall Study|Adverse Event|4|||
161444929|NCT00792571|583022780|FG000|Overall Study|Withdrawal by Subject|1|||
161444930|NCT00792571|583022780|FG000|Overall Study|Other|4|||
161444931|NCT02600819|583022781|FG000|GEN Phase|Adverse Event|2|||
161444932|NCT02600819|583022782|FG001|GEN Phase|Adverse Event|0|||
161444933|NCT02600819|583022781|FG000|GEN Phase|Death|2|||
161444934|NCT02600819|583022782|FG001|GEN Phase|Death|0|||
161444935|NCT02600819|583022781|FG000|GEN Phase|Investigator's Discretion|4|||
161444936|NCT02600819|583022782|FG001|GEN Phase|Investigator's Discretion|0|||
161444937|NCT02600819|583022781|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
161444938|NCT02600819|583022782|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
161444939|NCT02600819|583022781|FG000|GEN Phase|Withdrew Consent|5|||
161444940|NCT02600819|583022782|FG001|GEN Phase|Withdrew Consent|0|||
161444941|NCT02600819|583022781|FG000|GEN Phase|Lost to Follow-up|2|||
161444942|NCT02600819|583022782|FG001|GEN Phase|Lost to Follow-up|0|||
161444943|NCT00505778|583022783|FG000|Overall Study|Adverse Event|2|||
161444944|NCT00505778|583022784|FG001|Overall Study|Adverse Event|7|||
161444945|NCT00505778|583022783|FG000|Overall Study|Physician Decision|8|||
161444946|NCT00505778|583022784|FG001|Overall Study|Physician Decision|14|||
161444947|NCT00505778|583022783|FG000|Overall Study|Lost to Follow-up|17|||
161444948|NCT00505778|583022784|FG001|Overall Study|Lost to Follow-up|23|||
161444949|NCT00505778|583022783|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
161444950|NCT00505778|583022784|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
161444951|NCT00505778|583022783|FG000|Overall Study|Protocol Violation|7|||
161444952|NCT00505778|583022784|FG001|Overall Study|Protocol Violation|9|||
161444953|NCT00505778|583022783|FG000|Overall Study|Withdrawal by Subject|29|||
161444954|NCT00505778|583022784|FG001|Overall Study|Withdrawal by Subject|14|||
161444955|NCT00505778|583022783|FG000|Overall Study|Relapse|65|||
161444956|NCT00505778|583022784|FG001|Overall Study|Relapse|65|||
161444957|NCT00505778|583022783|FG000|Overall Study|Took No Study Drug|2|||
161444958|NCT00505778|583022784|FG001|Overall Study|Took No Study Drug|2|||
161444959|NCT01621802|583022786|FG000|Overall Study|Protocol Violation|0|||
161444960|NCT01621802|583022787|FG001|Overall Study|Protocol Violation|0|||
161444961|NCT01621802|583022788|FG002|Overall Study|Protocol Violation|0|||
161444962|NCT01621802|583022789|FG003|Overall Study|Protocol Violation|0|||
161444963|NCT01621802|583022790|FG004|Overall Study|Protocol Violation|0|||
161444964|NCT01621802|583022791|FG005|Overall Study|Protocol Violation|1|||
161444965|NCT01621802|583022786|FG000|Overall Study|Withdrawal by Subject|8|||
161444966|NCT01621802|583022787|FG001|Overall Study|Withdrawal by Subject|4|||
161444967|NCT01621802|583022788|FG002|Overall Study|Withdrawal by Subject|4|||
161444968|NCT01621802|583022789|FG003|Overall Study|Withdrawal by Subject|2|||
161444969|NCT01621802|583022790|FG004|Overall Study|Withdrawal by Subject|2|||
161444970|NCT01621802|583022791|FG005|Overall Study|Withdrawal by Subject|0|||
161444971|NCT01621802|583022786|FG000|Overall Study|Migrated/moved from study area|0|||
161444972|NCT01621802|583022787|FG001|Overall Study|Migrated/moved from study area|0|||
161444973|NCT01621802|583022788|FG002|Overall Study|Migrated/moved from study area|2|||
161444974|NCT01621802|583022789|FG003|Overall Study|Migrated/moved from study area|0|||
161444975|NCT01621802|583022790|FG004|Overall Study|Migrated/moved from study area|1|||
161444976|NCT01621802|583022791|FG005|Overall Study|Migrated/moved from study area|0|||
161444977|NCT01621802|583022786|FG000|Overall Study|Others|3|||
161444978|NCT01621802|583022787|FG001|Overall Study|Others|3|||
161444979|NCT01621802|583022788|FG002|Overall Study|Others|3|||
161444980|NCT01621802|583022789|FG003|Overall Study|Others|2|||
161444981|NCT01621802|583022790|FG004|Overall Study|Others|1|||
161444982|NCT01621802|583022791|FG005|Overall Study|Others|0|||
161444983|NCT01621802|583022786|FG000|Overall Study|Lost to Follow-up|36|||
161444984|NCT01621802|583022787|FG001|Overall Study|Lost to Follow-up|16|||
161444985|NCT01621802|583022788|FG002|Overall Study|Lost to Follow-up|24|||
161444986|NCT01621802|583022789|FG003|Overall Study|Lost to Follow-up|7|||
161444987|NCT01621802|583022790|FG004|Overall Study|Lost to Follow-up|31|||
161444988|NCT01621802|583022791|FG005|Overall Study|Lost to Follow-up|11|||
161444989|NCT03790696|583022792|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
161444990|NCT03790696|583022793|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
161444991|NCT01149148|583022794|FG000|Overall Study|Lost to Follow-up|1|||
161444992|NCT01149148|583022795|FG001|Overall Study|Lost to Follow-up|2|||
161444993|NCT01149148|583022794|FG000|Overall Study|Death|1|||
161444994|NCT01149148|583022795|FG001|Overall Study|Death|0|||
161444995|NCT03436082|583022796|FG000|Overall Study|Did not undergo procedure|1|||
161444996|NCT03436082|583022797|FG001|Overall Study|Did not undergo procedure|0|||
161444997|NCT04896086|583022798|FG000|Overall Study|Lost to Follow-up|0|||
161444998|NCT04896086|583022799|FG001|Overall Study|Lost to Follow-up|2|||
161444999|NCT04896086|583022800|FG002|Overall Study|Lost to Follow-up|1|||
161445000|NCT04896086|583022801|FG003|Overall Study|Lost to Follow-up|0|||
161445001|NCT04896086|583022802|FG004|Overall Study|Lost to Follow-up|0|||
161445002|NCT04896086|583022798|FG000|Overall Study|Physician Decision|0|||
161445003|NCT04896086|583022799|FG001|Overall Study|Physician Decision|1|||
161445004|NCT04896086|583022800|FG002|Overall Study|Physician Decision|0|||
161445005|NCT04896086|583022801|FG003|Overall Study|Physician Decision|0|||
161445006|NCT04896086|583022802|FG004|Overall Study|Physician Decision|0|||
161445007|NCT04896086|583022798|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
161445008|NCT04896086|583022799|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
161445009|NCT04896086|583022800|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
161445010|NCT04896086|583022801|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
161445011|NCT04896086|583022802|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
161445012|NCT04896086|583022798|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
161445013|NCT04896086|583022799|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
161445014|NCT04896086|583022800|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
161445015|NCT04896086|583022801|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
161445016|NCT04896086|583022802|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
161445017|NCT02249832|583022805|FG000|Overall Study|Withdrawal by Subject|3|||
161445018|NCT02249832|583022805|FG000|Overall Study|Lost to Follow-up|10|||
161445019|NCT04881942|583022812|FG000|Overall Study|Adverse Event|0|||
161445020|NCT04881942|583022813|FG001|Overall Study|Adverse Event|0|||
161445021|NCT04881942|583022814|FG002|Overall Study|Adverse Event|0|||
161445022|NCT04881942|583022815|FG003|Overall Study|Adverse Event|0|||
161445023|NCT04881942|583022816|FG004|Overall Study|Adverse Event|1|||
161445024|NCT04881942|583022812|FG000|Overall Study|Alternates|0|||
161898937|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898938|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898939|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898940|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
161898941|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898942|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898943|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898944|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898945|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
161445025|NCT04881942|583022813|FG001|Overall Study|Alternates|0|||
161445026|NCT04881942|583022814|FG002|Overall Study|Alternates|0|||
161445027|NCT04881942|583022815|FG003|Overall Study|Alternates|0|||
161445028|NCT04881942|583022816|FG004|Overall Study|Alternates|2|||
161445029|NCT02423902|583022817|FG000|Overall Study|Disease progression|1|||
161445030|NCT02423902|583022818|FG001|Overall Study|Disease progression|4|||
161445031|NCT02136069|583022819|FG000|Overall Study|UC flare-up|1|||
161445032|NCT02136069|583022820|FG001|Overall Study|UC flare-up|0|||
161445033|NCT02136069|583022819|FG000|Overall Study|Adverse Event|6|||
161445034|NCT02136069|583022820|FG001|Overall Study|Adverse Event|8|||
161445035|NCT02136069|583022819|FG000|Overall Study|Death|0|||
161445036|NCT02136069|583022820|FG001|Overall Study|Death|1|||
161445037|NCT02136069|583022819|FG000|Overall Study|Lack of Efficacy|10|||
161445038|NCT02136069|583022820|FG001|Overall Study|Lack of Efficacy|4|||
161445039|NCT02136069|583022819|FG000|Overall Study|Lost to Follow-up|1|||
161445040|NCT02136069|583022820|FG001|Overall Study|Lost to Follow-up|0|||
161445041|NCT02136069|583022819|FG000|Overall Study|Non-Compliance|1|||
161445042|NCT02136069|583022820|FG001|Overall Study|Non-Compliance|0|||
161445043|NCT02136069|583022819|FG000|Overall Study|Physician Decision|5|||
161445044|NCT02136069|583022820|FG001|Overall Study|Physician Decision|4|||
161445045|NCT02136069|583022819|FG000|Overall Study|Withdrawal by Subject|10|||
161445046|NCT02136069|583022820|FG001|Overall Study|Withdrawal by Subject|11|||
161445047|NCT02675634|583022821|FG000|Test Period 1|Adverse Event|0|||
161445048|NCT02675634|583022822|FG001|Test Period 1|Adverse Event|1|||
161445049|NCT02675634|583022823|FG002|Test Period 1|Adverse Event|0|||
161445050|NCT02675634|583022824|FG003|Test Period 1|Adverse Event|1|||
161445051|NCT02675634|583022825|FG004|Test Period 1|Adverse Event|0|||
161445052|NCT02675634|583022826|FG005|Test Period 1|Adverse Event|0|||
161445053|NCT02675634|583022821|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
161445054|NCT02675634|583022822|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
161445055|NCT02675634|583022823|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
161445056|NCT02675634|583022824|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
161445057|NCT02675634|583022825|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
161445058|NCT02675634|583022826|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
161445059|NCT02675634|583022821|FG000|Test Period 2|Lack of Efficacy|1|||
161898946|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
161898947|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161898948|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161898949|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
161898950|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
161898951|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
161898952|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
161898953|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161898954|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
161445060|NCT02675634|583022822|FG001|Test Period 2|Lack of Efficacy|0|||
161445061|NCT02675634|583022823|FG002|Test Period 2|Lack of Efficacy|0|||
161445062|NCT02675634|583022824|FG003|Test Period 2|Lack of Efficacy|0|||
161445063|NCT02675634|583022825|FG004|Test Period 2|Lack of Efficacy|0|||
161445064|NCT02675634|583022826|FG005|Test Period 2|Lack of Efficacy|0|||
161445065|NCT02675634|583022821|FG000|Test Period 2|Adverse Event|0|||
161445066|NCT02675634|583022822|FG001|Test Period 2|Adverse Event|0|||
161445067|NCT02675634|583022823|FG002|Test Period 2|Adverse Event|0|||
161445068|NCT02675634|583022824|FG003|Test Period 2|Adverse Event|0|||
161445069|NCT02675634|583022825|FG004|Test Period 2|Adverse Event|0|||
161445070|NCT02675634|583022826|FG005|Test Period 2|Adverse Event|1|||
161445071|NCT00811018|583022827|FG000|Overall Study|Additional Chronic Treatment|31|||
161445072|NCT00811018|583022827|FG000|Overall Study|Adverse Event|79|||
161445073|NCT00811018|583022827|FG000|Overall Study|Death|147|||
161445074|NCT00811018|583022827|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
161445075|NCT00811018|583022827|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
161793547|NCT03843359|584287759|FG004|Escalation Phase|Lost to Follow-up|0|||
161445076|NCT00811018|583022827|FG000|Overall Study|Investigator Decision|57|||
161445077|NCT00811018|583022827|FG000|Overall Study|Lost to Follow-up|19|||
161445078|NCT00811018|583022827|FG000|Overall Study|Pregnancy|6|||
161445079|NCT00811018|583022827|FG000|Overall Study|Sponsor Decision|450|||
161445080|NCT00811018|583022827|FG000|Overall Study|Withdrawal by Subject|70|||
161445081|NCT00811018|583022827|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
161445082|NCT00811018|583022827|FG000|Overall Study|Other|26|||
161445083|NCT04154189|583022828|FG000|Overall Study|Withdrawal by Subject|4|||
161445084|NCT04154189|583022829|FG001|Overall Study|Withdrawal by Subject|6|||
161445085|NCT04154189|583022828|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
161445086|NCT04154189|583022829|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
161445087|NCT04154189|583022828|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
161445088|NCT04154189|583022829|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
161445089|NCT04154189|583022828|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
161445090|NCT04154189|583022829|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
161445091|NCT04154189|583022828|FG000|Overall Study|Death|25|||
161445092|NCT04154189|583022829|FG001|Overall Study|Death|25|||
161445093|NCT00845897|583022832|FG000|Overall Study|Lost to Follow-up|1|||
161445094|NCT00845897|583022833|FG001|Overall Study|Lost to Follow-up|1|||
161445095|NCT00845897|583022834|FG002|Overall Study|Lost to Follow-up|0|||
161445096|NCT00845897|583022832|FG000|Overall Study|Withdrawal by Subject|0|||
161445097|NCT00845897|583022833|FG001|Overall Study|Withdrawal by Subject|3|||
161445098|NCT00845897|583022834|FG002|Overall Study|Withdrawal by Subject|2|||
161445099|NCT00845897|583022832|FG000|Overall Study|Ulcer did not heal|1|||
161445100|NCT00845897|583022833|FG001|Overall Study|Ulcer did not heal|0|||
161445101|NCT00845897|583022834|FG002|Overall Study|Ulcer did not heal|1|||
161445102|NCT00845897|583022832|FG000|Overall Study|Too ill to participate|0|||
161445103|NCT00845897|583022833|FG001|Overall Study|Too ill to participate|1|||
161445104|NCT00845897|583022834|FG002|Overall Study|Too ill to participate|0|||
161445105|NCT02722499|583022836|FG000|Overall Study|Lost to Follow-up|2|||
161445106|NCT02722499|583022837|FG001|Overall Study|Lost to Follow-up|0|||
161445107|NCT02722499|583022838|FG002|Overall Study|Lost to Follow-up|1|||
161445108|NCT04999852|583022839|FG000|Overall Study|Withdrawal by Subject|11|||
161445109|NCT04999852|583022840|FG001|Overall Study|Withdrawal by Subject|1|||
161445110|NCT04999852|583022839|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
161445111|NCT04999852|583022840|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
161445112|NCT05626322|583022841|FG000|Overall Study|Death|2|||
161445113|NCT05626322|583022842|FG001|Overall Study|Death|0|||
161445114|NCT05626322|583022843|FG002|Overall Study|Death|0|||
161445115|NCT05626322|583022841|FG000|Overall Study|Physician Decision|1|||
161445116|NCT05626322|583022842|FG001|Overall Study|Physician Decision|0|||
161445117|NCT05626322|583022843|FG002|Overall Study|Physician Decision|0|||
161445118|NCT05626322|583022841|FG000|Overall Study|Progressive Disease|0|||
161445119|NCT05626322|583022842|FG001|Overall Study|Progressive Disease|1|||
161445120|NCT05626322|583022843|FG002|Overall Study|Progressive Disease|1|||
161445121|NCT05626322|583022841|FG000|Overall Study|Study terminated by sponsor|0|||
161445122|NCT05626322|583022842|FG001|Overall Study|Study terminated by sponsor|1|||
161445123|NCT05626322|583022843|FG002|Overall Study|Study terminated by sponsor|0|||
161445124|NCT04758637|583022844|FG000|Overall Study|Lost to Follow-up|0|||
161445125|NCT04758637|583022845|FG001|Overall Study|Lost to Follow-up|1|||
161445126|NCT04758637|583022846|FG002|Overall Study|Lost to Follow-up|0|||
161445127|NCT04758637|583022847|FG003|Overall Study|Lost to Follow-up|0|||
161445128|NCT03610269|583022848|FG000|Overall Study|Physician Decision|10|||
161445129|NCT03610269|583022848|FG000|Overall Study|Protocol Violation|1|||
161793548|NCT03843359|584287760|FG005|Escalation Phase|Lost to Follow-up|0|||
161793549|NCT03843359|584287761|FG006|Escalation Phase|Lost to Follow-up|0|||
161793550|NCT03843359|584287762|FG007|Escalation Phase|Lost to Follow-up|0|||
161445130|NCT03610269|583022848|FG000|Overall Study|Unable to draw blood|1|||
161445131|NCT03610269|583022848|FG000|Overall Study|Screen fail|4|||
161445132|NCT04476797|583022851|FG000|Overall Study|Withdrawal by Subject|1|||
161445133|NCT04476797|583022852|FG001|Overall Study|Withdrawal by Subject|0|||
161445134|NCT04476797|583022853|FG002|Overall Study|Withdrawal by Subject|0|||
161445135|NCT04476797|583022851|FG000|Overall Study|Death|0|||
161445136|NCT04476797|583022852|FG001|Overall Study|Death|1|||
161445137|NCT04476797|583022853|FG002|Overall Study|Death|2|||
161445138|NCT04476797|583022851|FG000|Overall Study|Sponsor Terminated Study|0|||
161445139|NCT04476797|583022852|FG001|Overall Study|Sponsor Terminated Study|18|||
161445140|NCT04476797|583022853|FG002|Overall Study|Sponsor Terminated Study|17|||
161445141|NCT02395081|583022854|FG000|Overall Study|Withdrawal by Subject|1|||
161445142|NCT02395081|583022855|FG001|Overall Study|Withdrawal by Subject|1|||
161445143|NCT02395081|583022856|FG002|Overall Study|Withdrawal by Subject|0|||
161445144|NCT02395081|583022854|FG000|Overall Study|Moved where blood couldn't be collected|4|||
161445145|NCT02395081|583022855|FG001|Overall Study|Moved where blood couldn't be collected|1|||
161445146|NCT02395081|583022856|FG002|Overall Study|Moved where blood couldn't be collected|3|||
161445147|NCT02395081|583022854|FG000|Overall Study|Fetal Loss|2|||
161445148|NCT02395081|583022855|FG001|Overall Study|Fetal Loss|3|||
161445149|NCT02395081|583022856|FG002|Overall Study|Fetal Loss|1|||
161445150|NCT02721966|583022857|FG000|Overall Study|Protocol Violation|1|||
161445151|NCT02721966|583022858|FG001|Overall Study|Protocol Violation|0|||
161445152|NCT02721966|583022859|FG002|Overall Study|Protocol Violation|0|||
161445153|NCT02721966|583022860|FG003|Overall Study|Protocol Violation|0|||
161445154|NCT02721966|583022861|FG004|Overall Study|Protocol Violation|0|||
161445155|NCT02721966|583022857|FG000|Overall Study|Withdrawal by Subject|9|||
161445156|NCT02721966|583022858|FG001|Overall Study|Withdrawal by Subject|2|||
161445157|NCT02721966|583022859|FG002|Overall Study|Withdrawal by Subject|3|||
161445158|NCT02721966|583022860|FG003|Overall Study|Withdrawal by Subject|7|||
161445159|NCT02721966|583022861|FG004|Overall Study|Withdrawal by Subject|0|||
161445160|NCT02721966|583022857|FG000|Overall Study|Adverse Event|4|||
161445161|NCT02721966|583022858|FG001|Overall Study|Adverse Event|4|||
161445162|NCT02721966|583022859|FG002|Overall Study|Adverse Event|3|||
161445163|NCT02721966|583022860|FG003|Overall Study|Adverse Event|0|||
161445164|NCT02721966|583022861|FG004|Overall Study|Adverse Event|0|||
161445165|NCT02721966|583022857|FG000|Overall Study|Death|1|||
161445166|NCT02721966|583022858|FG001|Overall Study|Death|0|||
161445167|NCT02721966|583022859|FG002|Overall Study|Death|0|||
161445168|NCT02721966|583022860|FG003|Overall Study|Death|0|||
161445169|NCT02721966|583022861|FG004|Overall Study|Death|0|||
161445170|NCT02721966|583022857|FG000|Overall Study|Lack of Efficacy|7|||
161445171|NCT02721966|583022858|FG001|Overall Study|Lack of Efficacy|4|||
161445172|NCT02721966|583022859|FG002|Overall Study|Lack of Efficacy|0|||
161445173|NCT02721966|583022860|FG003|Overall Study|Lack of Efficacy|0|||
161445174|NCT02721966|583022861|FG004|Overall Study|Lack of Efficacy|0|||
161445175|NCT02721966|583022857|FG000|Overall Study|Lost to Follow-up|0|||
161445176|NCT02721966|583022858|FG001|Overall Study|Lost to Follow-up|0|||
161445177|NCT02721966|583022859|FG002|Overall Study|Lost to Follow-up|3|||
161445178|NCT02721966|583022860|FG003|Overall Study|Lost to Follow-up|0|||
161445179|NCT02721966|583022861|FG004|Overall Study|Lost to Follow-up|0|||
161445180|NCT02721966|583022857|FG000|Overall Study|Physician Decision|1|||
161445181|NCT02721966|583022858|FG001|Overall Study|Physician Decision|1|||
161445182|NCT02721966|583022859|FG002|Overall Study|Physician Decision|0|||
161445183|NCT02721966|583022860|FG003|Overall Study|Physician Decision|0|||
161445184|NCT02721966|583022861|FG004|Overall Study|Physician Decision|0|||
161445185|NCT02721966|583022857|FG000|Overall Study|Pregnancy|1|||
161445186|NCT02721966|583022858|FG001|Overall Study|Pregnancy|0|||
161445187|NCT02721966|583022859|FG002|Overall Study|Pregnancy|0|||
161445188|NCT02721966|583022860|FG003|Overall Study|Pregnancy|0|||
161445189|NCT02721966|583022861|FG004|Overall Study|Pregnancy|0|||
161445190|NCT02721966|583022857|FG000|Overall Study|Did not continue to period 2|5|||
161445191|NCT02721966|583022858|FG001|Overall Study|Did not continue to period 2|12|||
161445192|NCT02721966|583022859|FG002|Overall Study|Did not continue to period 2|0|||
161445193|NCT02721966|583022860|FG003|Overall Study|Did not continue to period 2|0|||
161445194|NCT02721966|583022861|FG004|Overall Study|Did not continue to period 2|5|||
161445195|NCT02442804|583022862|FG000|Overall Study|Withdrawal by Subject|0|||
161445196|NCT02442804|583022863|FG001|Overall Study|Withdrawal by Subject|1|||
161445197|NCT02442804|583022862|FG000|Overall Study|Adverse Event|1|||
161445198|NCT02442804|583022863|FG001|Overall Study|Adverse Event|0|||
161445199|NCT04200352|583022864|FG000|Overall Study|Death|1|||
161445200|NCT04200352|583022864|FG000|Overall Study|Adverse Event|6|||
161445201|NCT04200352|583022864|FG000|Overall Study|Withdrawal by parent/guardian|6|||
161445202|NCT04200352|583022864|FG000|Overall Study|Lack of Efficacy|1|||
161898955|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
161898956|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
161445203|NCT04200352|583022864|FG000|Overall Study|Other than specified|6|||
161552449|NCT05033080|583410455|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
161552450|NCT05033080|583410454|FG000|Overall Study|Lost to Follow-up|1|||
161898957|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
161898958|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
161552451|NCT05033080|583410455|FG001|Overall Study|Lost to Follow-up|0|||
161552452|NCT05033080|583410454|FG000|Overall Study|Other non-compliance|0|||
161552453|NCT05033080|583410455|FG001|Overall Study|Other non-compliance|1|||
161445204|NCT02541604|583022865|FG000|Overall Study|Death|6|||
161445205|NCT02541604|583022866|FG001|Overall Study|Death|5|||
161445206|NCT02541604|583022867|FG002|Overall Study|Death|7|||
161445207|NCT02541604|583022868|FG003|Overall Study|Death|2|||
161445208|NCT02541604|583022869|FG004|Overall Study|Death|9|||
161445209|NCT02541604|583022870|FG005|Overall Study|Death|8|||
161445210|NCT02541604|583022871|FG006|Overall Study|Death|9|||
161445211|NCT02541604|583022872|FG007|Overall Study|Death|9|||
161445212|NCT02541604|583022873|FG008|Overall Study|Death|3|||
161445213|NCT02541604|583022874|FG009|Overall Study|Death|4|||
161445214|NCT02541604|583022875|FG010|Overall Study|Death|2|||
161445215|NCT02541604|583022876|FG011|Overall Study|Death|3|||
161445216|NCT02541604|583022865|FG000|Overall Study|Lost to Follow-up|2|||
161445217|NCT02541604|583022866|FG001|Overall Study|Lost to Follow-up|0|||
161445218|NCT02541604|583022867|FG002|Overall Study|Lost to Follow-up|1|||
161445219|NCT02541604|583022868|FG003|Overall Study|Lost to Follow-up|0|||
161445220|NCT02541604|583022869|FG004|Overall Study|Lost to Follow-up|0|||
161445221|NCT02541604|583022870|FG005|Overall Study|Lost to Follow-up|1|||
161445222|NCT02541604|583022871|FG006|Overall Study|Lost to Follow-up|1|||
161445223|NCT02541604|583022872|FG007|Overall Study|Lost to Follow-up|0|||
161445224|NCT02541604|583022873|FG008|Overall Study|Lost to Follow-up|0|||
161445225|NCT02541604|583022874|FG009|Overall Study|Lost to Follow-up|0|||
161445226|NCT02541604|583022875|FG010|Overall Study|Lost to Follow-up|0|||
161445227|NCT02541604|583022876|FG011|Overall Study|Lost to Follow-up|0|||
161445228|NCT02541604|583022865|FG000|Overall Study|Withdrawal by Subject|2|||
161445229|NCT02541604|583022866|FG001|Overall Study|Withdrawal by Subject|0|||
161445230|NCT02541604|583022867|FG002|Overall Study|Withdrawal by Subject|1|||
161445231|NCT02541604|583022868|FG003|Overall Study|Withdrawal by Subject|0|||
161445232|NCT02541604|583022869|FG004|Overall Study|Withdrawal by Subject|1|||
161445233|NCT02541604|583022870|FG005|Overall Study|Withdrawal by Subject|1|||
161445234|NCT02541604|583022871|FG006|Overall Study|Withdrawal by Subject|0|||
161445235|NCT02541604|583022872|FG007|Overall Study|Withdrawal by Subject|0|||
161445236|NCT02541604|583022873|FG008|Overall Study|Withdrawal by Subject|1|||
161445237|NCT02541604|583022874|FG009|Overall Study|Withdrawal by Subject|0|||
161445238|NCT02541604|583022875|FG010|Overall Study|Withdrawal by Subject|0|||
161445239|NCT02541604|583022876|FG011|Overall Study|Withdrawal by Subject|0|||
161445240|NCT02541604|583022865|FG000|Overall Study|Study Terminated by Sponsor|1|||
161445241|NCT02541604|583022866|FG001|Overall Study|Study Terminated by Sponsor|4|||
161445242|NCT02541604|583022867|FG002|Overall Study|Study Terminated by Sponsor|2|||
161445243|NCT02541604|583022868|FG003|Overall Study|Study Terminated by Sponsor|1|||
161445244|NCT02541604|583022869|FG004|Overall Study|Study Terminated by Sponsor|0|||
161445245|NCT02541604|583022870|FG005|Overall Study|Study Terminated by Sponsor|0|||
161445246|NCT02541604|583022871|FG006|Overall Study|Study Terminated by Sponsor|0|||
161445247|NCT02541604|583022872|FG007|Overall Study|Study Terminated by Sponsor|0|||
161445248|NCT02541604|583022873|FG008|Overall Study|Study Terminated by Sponsor|0|||
161445249|NCT02541604|583022874|FG009|Overall Study|Study Terminated by Sponsor|0|||
161445250|NCT02541604|583022875|FG010|Overall Study|Study Terminated by Sponsor|0|||
161445251|NCT02541604|583022876|FG011|Overall Study|Study Terminated by Sponsor|0|||
161445252|NCT02541604|583022865|FG000|Overall Study|Medical condition may jeopardize safety|0|||
161445253|NCT02541604|583022866|FG001|Overall Study|Medical condition may jeopardize safety|0|||
161445254|NCT02541604|583022867|FG002|Overall Study|Medical condition may jeopardize safety|0|||
161445255|NCT02541604|583022868|FG003|Overall Study|Medical condition may jeopardize safety|0|||
161445256|NCT02541604|583022869|FG004|Overall Study|Medical condition may jeopardize safety|0|||
161445257|NCT02541604|583022870|FG005|Overall Study|Medical condition may jeopardize safety|0|||
161445258|NCT02541604|583022871|FG006|Overall Study|Medical condition may jeopardize safety|0|||
161445259|NCT02541604|583022872|FG007|Overall Study|Medical condition may jeopardize safety|1|||
161445260|NCT02541604|583022873|FG008|Overall Study|Medical condition may jeopardize safety|0|||
161445261|NCT02541604|583022874|FG009|Overall Study|Medical condition may jeopardize safety|0|||
161445262|NCT02541604|583022875|FG010|Overall Study|Medical condition may jeopardize safety|0|||
161445263|NCT02541604|583022876|FG011|Overall Study|Medical condition may jeopardize safety|0|||
161445264|NCT00828204|583022877|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
161445265|NCT00828204|583022878|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
161445266|NCT00828204|583022877|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
161445267|NCT00828204|583022878|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
161445268|NCT00828204|583022877|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
161445269|NCT00828204|583022878|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
161445270|NCT00828204|583022877|FG000|Main Study: After Study Restart|Adverse Event|0|||
161445271|NCT00828204|583022878|FG001|Main Study: After Study Restart|Adverse Event|2|||
161445272|NCT00828204|583022877|FG000|Main Study: After Study Restart|Noncompliance|0|||
161445273|NCT00828204|583022878|FG001|Main Study: After Study Restart|Noncompliance|1|||
161445274|NCT00828204|583022877|FG000|Extension Study|Lost to Follow-up|0|||
161445275|NCT00828204|583022878|FG001|Extension Study|Lost to Follow-up|1|||
161445276|NCT00828204|583022877|FG000|Extension Study|Physician Decision|0|||
161445277|NCT00828204|583022878|FG001|Extension Study|Physician Decision|2|||
161445278|NCT00806819|583022879|FG000|Overall Study|progressive disease (modified RECIST )|217|||
161445279|NCT00806819|583022880|FG001|Overall Study|progressive disease (modified RECIST )|216|||
161445280|NCT00806819|583022879|FG000|Overall Study|Worsening or AE of underlying disease|18|||
161445281|NCT00806819|583022880|FG001|Overall Study|Worsening or AE of underlying disease|25|||
161445282|NCT00806819|583022879|FG000|Overall Study|Other AE|38|||
161445283|NCT00806819|583022880|FG001|Overall Study|Other AE|40|||
161445284|NCT00806819|583022879|FG000|Overall Study|Protocol Violation|9|||
161445285|NCT00806819|583022880|FG001|Overall Study|Protocol Violation|4|||
161445286|NCT00806819|583022879|FG000|Overall Study|Lost to Follow-up|1|||
161445287|NCT00806819|583022880|FG001|Overall Study|Lost to Follow-up|0|||
161898959|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
161898960|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898961|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898962|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898963|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898964|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898965|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898966|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161898967|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898968|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898969|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
161898970|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
161898971|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161898972|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898973|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161898974|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
161898975|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898976|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
161898977|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898978|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898979|NCT01300247|584677913|FG000|Overall Study|Death|1|||
161898980|NCT01300247|584677914|FG001|Overall Study|Death|1|||
161898981|NCT01300247|584677913|FG000|Overall Study|Lost to Follow-up|2|||
161898982|NCT01300247|584677914|FG001|Overall Study|Lost to Follow-up|0|||
161898983|NCT01300247|584677913|FG000|Overall Study|Withdrawal by Subject|1|||
161898984|NCT01300247|584677914|FG001|Overall Study|Withdrawal by Subject|0|||
161898985|NCT01300247|584677913|FG000|Overall Study|Non-Compliance|0|||
161898986|NCT01300247|584677914|FG001|Overall Study|Non-Compliance|1|||
161898987|NCT00922116|584677915|FG000|Overall Study|Adverse Event|4|||
161898988|NCT00922116|584677915|FG000|Overall Study|Death|1|||
161898989|NCT00922116|584677915|FG000|Overall Study|Lost to Follow-up|1|||
161898990|NCT00922116|584677915|FG000|Overall Study|Withdrawal by Subject|4|||
161898991|NCT00922116|584677915|FG000|Overall Study|Other|5|||
161898992|NCT02258659|584677916|FG000|Overall Study|Withdrawal by Subject|1|||
161898993|NCT03990051|584677917|FG000|Masked Period|Lost to Follow-up|1|||
161898994|NCT03990051|584677918|FG001|Masked Period|Lost to Follow-up|0|||
161898995|NCT03990051|584677917|FG000|Long Term Period|Death|1|||
161898996|NCT03990051|584677918|FG001|Long Term Period|Death|1|||
161898997|NCT03990051|584677917|FG000|Long Term Period|Lost to Follow-up|7|||
161898998|NCT03990051|584677918|FG001|Long Term Period|Lost to Follow-up|2|||
161898999|NCT00272844|584677919|FG000|Overall Study|Withdrawal by Subject|5|||
161899000|NCT03193047|584677920|FG000|Overall Study|Physician Decision|1|||
161899001|NCT03193047|584677921|FG001|Overall Study|Physician Decision|0|||
161899002|NCT03193047|584677920|FG000|Overall Study|Participant Left State|1|||
161899003|NCT03193047|584677921|FG001|Overall Study|Participant Left State|0|||
161899004|NCT03743025|584677925|FG000|Overall Study|Surgery was cancelled|2|||
161899005|NCT03743025|584677926|FG001|Overall Study|Surgery was cancelled|1|||
161899006|NCT00791700|584677927|FG000|Overall Study|Insufficient clinical response|1|||
161899007|NCT00791700|584677928|FG001|Overall Study|Insufficient clinical response|4|||
161899008|NCT00791700|584677929|FG002|Overall Study|Insufficient clinical response|1|||
161899009|NCT00791700|584677930|FG003|Overall Study|Insufficient clinical response|8|||
161899010|NCT00791700|584677927|FG000|Overall Study|No longer willing to participate|1|||
161445288|NCT00806819|583022879|FG000|Overall Study|Withdrawal by Subject|32|||
161445289|NCT00806819|583022880|FG001|Overall Study|Withdrawal by Subject|29|||
161445290|NCT00806819|583022879|FG000|Overall Study|Not treated|6|||
161445291|NCT00806819|583022880|FG001|Overall Study|Not treated|3|||
161445292|NCT00806819|583022879|FG000|Overall Study|Reasons other than stated above|25|||
161445293|NCT00806819|583022880|FG001|Overall Study|Reasons other than stated above|41|||
161445294|NCT02840461|583022883|FG000|Overall Study|Adverse Event|1|||
161445295|NCT02840461|583022884|FG001|Overall Study|Adverse Event|5|||
161445296|NCT02840461|583022885|FG002|Overall Study|Adverse Event|3|||
161445297|NCT02840461|583022883|FG000|Overall Study|Lost to Follow-up|10|||
161793551|NCT03843359|584287763|FG008|Escalation Phase|Lost to Follow-up|1|||
161793552|NCT03843359|584287764|FG009|Escalation Phase|Lost to Follow-up|0|||
161793553|NCT03843359|584287765|FG010|Escalation Phase|Lost to Follow-up|0|||
161793554|NCT03843359|584287766|FG011|Escalation Phase|Lost to Follow-up|0|||
161793555|NCT03843359|584287767|FG012|Escalation Phase|Lost to Follow-up|0|||
161793556|NCT03843359|584287768|FG013|Escalation Phase|Lost to Follow-up|0|||
161793557|NCT03843359|584287769|FG014|Escalation Phase|Lost to Follow-up|0|||
161793558|NCT03843359|584287770|FG015|Escalation Phase|Lost to Follow-up|0|||
161899011|NCT00791700|584677928|FG001|Overall Study|No longer willing to participate|1|||
161899012|NCT00791700|584677929|FG002|Overall Study|No longer willing to participate|0|||
161899013|NCT00791700|584677930|FG003|Overall Study|No longer willing to participate|8|||
161899014|NCT00791700|584677927|FG000|Overall Study|Non-compliance with study treatment|0|||
161899015|NCT00791700|584677928|FG001|Overall Study|Non-compliance with study treatment|2|||
161899016|NCT00791700|584677929|FG002|Overall Study|Non-compliance with study treatment|0|||
161899017|NCT00791700|584677930|FG003|Overall Study|Non-compliance with study treatment|4|||
161899018|NCT00791700|584677927|FG000|Overall Study|Withdrawn due to pregnancy|0|||
161899019|NCT00791700|584677928|FG001|Overall Study|Withdrawn due to pregnancy|0|||
161899020|NCT00791700|584677929|FG002|Overall Study|Withdrawn due to pregnancy|0|||
161899021|NCT00791700|584677930|FG003|Overall Study|Withdrawn due to pregnancy|1|||
161899022|NCT00791700|584677927|FG000|Overall Study|Other|0|||
161899023|NCT00791700|584677928|FG001|Overall Study|Other|1|||
161899024|NCT00791700|584677929|FG002|Overall Study|Other|0|||
161899025|NCT00791700|584677930|FG003|Overall Study|Other|1|||
161899026|NCT00791700|584677927|FG000|Overall Study|Death|0|||
161899027|NCT00791700|584677928|FG001|Overall Study|Death|0|||
161445298|NCT02840461|583022884|FG001|Overall Study|Lost to Follow-up|7|||
161445299|NCT02840461|583022885|FG002|Overall Study|Lost to Follow-up|6|||
161445300|NCT02840461|583022883|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
161445301|NCT02840461|583022884|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
161445302|NCT02840461|583022885|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
161445303|NCT02840461|583022883|FG000|Overall Study|Protocol Violation|2|||
161445304|NCT02840461|583022884|FG001|Overall Study|Protocol Violation|3|||
161445305|NCT02840461|583022885|FG002|Overall Study|Protocol Violation|1|||
161445306|NCT02840461|583022883|FG000|Overall Study|Withdrawal by Subject|10|||
161445307|NCT02840461|583022884|FG001|Overall Study|Withdrawal by Subject|6|||
161445308|NCT02840461|583022885|FG002|Overall Study|Withdrawal by Subject|2|||
161445309|NCT02840461|583022883|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
161445310|NCT02840461|583022884|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
161445311|NCT02840461|583022885|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
161445312|NCT01737502|583022886|FG000|Phase I|Disease progression|2|||
161445313|NCT01737502|583022887|FG001|Phase I|Disease progression|3|||
161445314|NCT01737502|583022886|FG000|Phase I|Complicating disease|1|||
161445315|NCT01737502|583022887|FG001|Phase I|Complicating disease|0|||
161445316|NCT01737502|583022886|FG000|Phase II|Adverse Event|0|||
161445317|NCT01737502|583022887|FG001|Phase II|Adverse Event|3|||
161445318|NCT01737502|583022886|FG000|Phase II|Disease progression|0|||
161445319|NCT01737502|583022887|FG001|Phase II|Disease progression|18|||
161445320|NCT01737502|583022886|FG000|Phase II|Death|0|||
161445321|NCT01737502|583022887|FG001|Phase II|Death|1|||
161445322|NCT01737502|583022886|FG000|Phase II|Transition to hospice care|0|||
161445323|NCT01737502|583022887|FG001|Phase II|Transition to hospice care|1|||
161445324|NCT04549545|583023865|FG000|Initial Period|Withdrawal by Subject|4|||
161445325|NCT04549545|583023866|FG001|Initial Period|Withdrawal by Subject|0|||
161445326|NCT04549545|583023865|FG000|Initial Period|Additional ENT Procedure|3|||
161445327|NCT04549545|583023866|FG001|Initial Period|Additional ENT Procedure|0|||
161445328|NCT04549545|583023865|FG000|Initial Period|Lost to Follow-up|3|||
161445329|NCT04549545|583023866|FG001|Initial Period|Lost to Follow-up|1|||
161445330|NCT04549545|583023865|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
161445331|NCT04549545|583023866|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
161445332|NCT04549545|583023865|FG000|Crossover Period|Additional ENT Procedure|0|||
161445333|NCT04549545|583023866|FG001|Crossover Period|Additional ENT Procedure|6|||
161445334|NCT04549545|583023865|FG000|Crossover Period|Lost to Follow-up|0|||
161445335|NCT04549545|583023866|FG001|Crossover Period|Lost to Follow-up|1|||
161445336|NCT04549545|583023865|FG000|Crossover Period|Withdrawal by Subject|0|||
161445337|NCT04549545|583023866|FG001|Crossover Period|Withdrawal by Subject|4|||
161445338|NCT00243269|583023871|FG000|Overall Study|Protocol Violation|2|||
161445339|NCT00243269|583023872|FG001|Overall Study|Protocol Violation|1|||
161445340|NCT00243269|583023873|FG002|Overall Study|Protocol Violation|0|||
161445341|NCT00243269|583023874|FG003|Overall Study|Protocol Violation|1|||
161445342|NCT00243269|583023871|FG000|Overall Study|Lost to Follow-up|1|||
161445343|NCT00243269|583023872|FG001|Overall Study|Lost to Follow-up|0|||
161445344|NCT00243269|583023873|FG002|Overall Study|Lost to Follow-up|1|||
161445345|NCT00243269|583023874|FG003|Overall Study|Lost to Follow-up|3|||
161445346|NCT00485134|583023880|FG000|Overall Study|Lost to Follow-up|1|||
161445347|NCT00485134|583023881|FG001|Overall Study|Lost to Follow-up|0|||
161445348|NCT00485134|583023882|FG002|Overall Study|Lost to Follow-up|0|||
161445349|NCT00485134|583023883|FG003|Overall Study|Lost to Follow-up|0|||
161445350|NCT00485134|583023884|FG004|Overall Study|Lost to Follow-up|0|||
161445351|NCT00485134|583023885|FG005|Overall Study|Lost to Follow-up|0|||
161445352|NCT00485134|583023886|FG006|Overall Study|Lost to Follow-up|0|||
161899028|NCT00791700|584677929|FG002|Overall Study|Death|0|||
161445353|NCT00485134|583023887|FG007|Overall Study|Lost to Follow-up|0|||
161445354|NCT00485134|583023880|FG000|Overall Study|Withdrawal by Subject|0|||
161445355|NCT00485134|583023881|FG001|Overall Study|Withdrawal by Subject|1|||
161445356|NCT00485134|583023882|FG002|Overall Study|Withdrawal by Subject|0|||
161899029|NCT00791700|584677930|FG003|Overall Study|Death|1|||
161899030|NCT00791700|584677927|FG000|Overall Study|Lost to Follow-up|4|||
161899031|NCT00791700|584677928|FG001|Overall Study|Lost to Follow-up|3|||
161445357|NCT00485134|583023883|FG003|Overall Study|Withdrawal by Subject|0|||
161445358|NCT00485134|583023884|FG004|Overall Study|Withdrawal by Subject|0|||
161445359|NCT00485134|583023885|FG005|Overall Study|Withdrawal by Subject|0|||
161445360|NCT00485134|583023886|FG006|Overall Study|Withdrawal by Subject|0|||
161445361|NCT00485134|583023887|FG007|Overall Study|Withdrawal by Subject|0|||
161445362|NCT00485134|583023880|FG000|Overall Study|Change in health status|0|||
161445363|NCT00485134|583023881|FG001|Overall Study|Change in health status|1|||
161445364|NCT00485134|583023882|FG002|Overall Study|Change in health status|2|||
161445365|NCT00485134|583023883|FG003|Overall Study|Change in health status|1|||
161445366|NCT00485134|583023884|FG004|Overall Study|Change in health status|0|||
161445367|NCT00485134|583023885|FG005|Overall Study|Change in health status|1|||
161445368|NCT00485134|583023886|FG006|Overall Study|Change in health status|0|||
161445369|NCT00485134|583023887|FG007|Overall Study|Change in health status|0|||
161445370|NCT00485134|583023880|FG000|Overall Study|Withdrew for adverse event|0|||
161445371|NCT00485134|583023881|FG001|Overall Study|Withdrew for adverse event|0|||
161899032|NCT00791700|584677929|FG002|Overall Study|Lost to Follow-up|4|||
161899033|NCT00791700|584677930|FG003|Overall Study|Lost to Follow-up|6|||
161899034|NCT00791700|584677927|FG000|Overall Study|Adverse Event|0|||
161899035|NCT00791700|584677928|FG001|Overall Study|Adverse Event|0|||
161899036|NCT00791700|584677929|FG002|Overall Study|Adverse Event|1|||
161899037|NCT00791700|584677930|FG003|Overall Study|Adverse Event|1|||
161899038|NCT00996034|584677931|FG000|Overall Study|Lost to Follow-up|2|||
161899039|NCT00996034|584677931|FG000|Overall Study|withdrawn by PI|1|||
161899040|NCT01720524|584677932|FG000|Part A|Insufficient Clinical Response|2|||
161899041|NCT01720524|584677933|FG001|Part A|Insufficient Clinical Response|4|||
161899042|NCT01720524|584677932|FG000|Part A|Adverse Event|2|||
161899043|NCT01720524|584677933|FG001|Part A|Adverse Event|2|||
161899044|NCT01720524|584677932|FG000|Part A|Death|2|||
161899045|NCT01720524|584677933|FG001|Part A|Death|1|||
161445372|NCT00485134|583023882|FG002|Overall Study|Withdrew for adverse event|1|||
161445373|NCT00485134|583023883|FG003|Overall Study|Withdrew for adverse event|0|||
161445374|NCT00485134|583023884|FG004|Overall Study|Withdrew for adverse event|0|||
161445375|NCT00485134|583023885|FG005|Overall Study|Withdrew for adverse event|0|||
161445376|NCT00485134|583023886|FG006|Overall Study|Withdrew for adverse event|0|||
161445377|NCT00485134|583023887|FG007|Overall Study|Withdrew for adverse event|0|||
161445378|NCT00485134|583023880|FG000|Overall Study|Positive drug test|0|||
161445379|NCT00485134|583023881|FG001|Overall Study|Positive drug test|0|||
161445380|NCT00485134|583023882|FG002|Overall Study|Positive drug test|0|||
161445381|NCT00485134|583023883|FG003|Overall Study|Positive drug test|0|||
161445382|NCT00485134|583023884|FG004|Overall Study|Positive drug test|2|||
161445383|NCT00485134|583023885|FG005|Overall Study|Positive drug test|1|||
161445384|NCT00485134|583023886|FG006|Overall Study|Positive drug test|0|||
161445385|NCT00485134|583023887|FG007|Overall Study|Positive drug test|0|||
161445386|NCT00485134|583023880|FG000|Overall Study|Non-compliance|0|||
161445387|NCT00485134|583023881|FG001|Overall Study|Non-compliance|0|||
161445388|NCT00485134|583023882|FG002|Overall Study|Non-compliance|0|||
161445389|NCT00485134|583023883|FG003|Overall Study|Non-compliance|0|||
161445390|NCT00485134|583023884|FG004|Overall Study|Non-compliance|1|||
161445391|NCT00485134|583023885|FG005|Overall Study|Non-compliance|2|||
161445392|NCT00485134|583023886|FG006|Overall Study|Non-compliance|2|||
161445393|NCT00485134|583023887|FG007|Overall Study|Non-compliance|0|||
161445394|NCT00485134|583023880|FG000|Overall Study|Unable to comply with study schedule|0|||
161899046|NCT01720524|584677932|FG000|Part A|Lost to Follow-up|0|||
161899047|NCT01720524|584677933|FG001|Part A|Lost to Follow-up|1|||
161899048|NCT01720524|584677932|FG000|Part A|Missed 28 day follow-up visit|1|||
161899049|NCT01720524|584677933|FG001|Part A|Missed 28 day follow-up visit|1|||
161899050|NCT01720524|584677932|FG000|Part A|Withdrawal by Subject|0|||
161899051|NCT01720524|584677933|FG001|Part A|Withdrawal by Subject|1|||
161899052|NCT01720524|584677932|FG000|Part A|Other|0|||
161899053|NCT01720524|584677933|FG001|Part A|Other|1|||
161899054|NCT01720524|584677932|FG000|Part A|Lost to Follow-up|0|||
161899055|NCT01720524|584677933|FG001|Part A|Lost to Follow-up|1|||
161899056|NCT01720524|584677932|FG000|Part B|No longer willing to participate in study|1|||
161899057|NCT01720524|584677933|FG001|Part B|No longer willing to participate in study|4|||
161899058|NCT01720524|584677932|FG000|Part B|Other|2|||
161899059|NCT01720524|584677933|FG001|Part B|Other|0|||
161899060|NCT01720524|584677932|FG000|Part B|Lost to Follow-up|2|||
161445395|NCT00485134|583023881|FG001|Overall Study|Unable to comply with study schedule|0|||
161445396|NCT00485134|583023882|FG002|Overall Study|Unable to comply with study schedule|0|||
161445397|NCT00485134|583023883|FG003|Overall Study|Unable to comply with study schedule|0|||
161552454|NCT05033080|583410454|FG000|Overall Study|Physician Decision|0|||
161899061|NCT01720524|584677933|FG001|Part B|Lost to Follow-up|3|||
161899062|NCT01720524|584677932|FG000|Part B|Death|0|||
161899063|NCT01720524|584677933|FG001|Part B|Death|2|||
161899064|NCT00527826|584677937|FG000|Overall Study|Adverse Event|10|||
161899065|NCT00527826|584677938|FG001|Overall Study|Adverse Event|10|||
161899066|NCT00527826|584677937|FG000|Overall Study|Lost to Follow-up|3|||
161899067|NCT00527826|584677938|FG001|Overall Study|Lost to Follow-up|2|||
161899068|NCT00527826|584677937|FG000|Overall Study|Withdrawal by Subject|5|||
161899069|NCT00527826|584677938|FG001|Overall Study|Withdrawal by Subject|8|||
161445398|NCT00485134|583023884|FG004|Overall Study|Unable to comply with study schedule|0|||
161445399|NCT00485134|583023885|FG005|Overall Study|Unable to comply with study schedule|0|||
161445400|NCT00485134|583023886|FG006|Overall Study|Unable to comply with study schedule|0|||
161445401|NCT00485134|583023887|FG007|Overall Study|Unable to comply with study schedule|1|||
161445402|NCT00485134|583023880|FG000|Overall Study|Pregnancy|0|||
161445403|NCT00485134|583023881|FG001|Overall Study|Pregnancy|0|||
161445404|NCT00485134|583023882|FG002|Overall Study|Pregnancy|0|||
161445405|NCT00485134|583023883|FG003|Overall Study|Pregnancy|0|||
161445406|NCT00485134|583023884|FG004|Overall Study|Pregnancy|0|||
161445407|NCT00485134|583023885|FG005|Overall Study|Pregnancy|0|||
161445408|NCT00485134|583023886|FG006|Overall Study|Pregnancy|1|||
161445409|NCT00485134|583023887|FG007|Overall Study|Pregnancy|0|||
161445410|NCT00970684|583023888|FG000|Overall Study|Lack of Efficacy|5|||
161445411|NCT00970684|583023888|FG000|Overall Study|Adverse Event|4|||
161445412|NCT00970684|583023888|FG000|Overall Study|Withdrawal by Subject|1|||
161445413|NCT00481091|583023889|FG000|Overall Study|Withdrawal by Subject|0|||
161445414|NCT00481091|583023890|FG001|Overall Study|Withdrawal by Subject|1|||
161445415|NCT00481091|583023891|FG002|Overall Study|Withdrawal by Subject|1|||
161445416|NCT00481091|583023892|FG003|Overall Study|Withdrawal by Subject|0|||
161899070|NCT00527826|584677937|FG000|Overall Study|Inclusion Criteria Not Met|3|||
161445417|NCT00481091|583023893|FG004|Overall Study|Withdrawal by Subject|0|||
161445418|NCT00481091|583023894|FG005|Overall Study|Withdrawal by Subject|0|||
161445419|NCT00481091|583023895|FG006|Overall Study|Withdrawal by Subject|0|||
161445420|NCT00481091|583023896|FG007|Overall Study|Withdrawal by Subject|0|||
161445421|NCT00481091|583023897|FG008|Overall Study|Withdrawal by Subject|1|||
161445422|NCT00481091|583023898|FG009|Overall Study|Withdrawal by Subject|6|||
161445423|NCT00481091|583023889|FG000|Overall Study|Other, Not Specified|0|||
161445424|NCT00481091|583023890|FG001|Overall Study|Other, Not Specified|1|||
161445425|NCT00481091|583023891|FG002|Overall Study|Other, Not Specified|1|||
161445426|NCT00481091|583023892|FG003|Overall Study|Other, Not Specified|0|||
161445427|NCT00481091|583023893|FG004|Overall Study|Other, Not Specified|0|||
161445428|NCT00481091|583023894|FG005|Overall Study|Other, Not Specified|1|||
161445429|NCT00481091|583023895|FG006|Overall Study|Other, Not Specified|0|||
161445430|NCT00481091|583023896|FG007|Overall Study|Other, Not Specified|0|||
161445431|NCT00481091|583023897|FG008|Overall Study|Other, Not Specified|0|||
161445432|NCT00481091|583023898|FG009|Overall Study|Other, Not Specified|4|||
161445433|NCT00481091|583023889|FG000|Overall Study|Adverse Event|1|||
161445434|NCT00481091|583023890|FG001|Overall Study|Adverse Event|2|||
161445435|NCT00481091|583023891|FG002|Overall Study|Adverse Event|0|||
161445436|NCT00481091|583023892|FG003|Overall Study|Adverse Event|1|||
161445437|NCT00481091|583023893|FG004|Overall Study|Adverse Event|1|||
161445438|NCT00481091|583023894|FG005|Overall Study|Adverse Event|1|||
161445439|NCT00481091|583023895|FG006|Overall Study|Adverse Event|2|||
161445440|NCT00481091|583023896|FG007|Overall Study|Adverse Event|1|||
161445441|NCT00481091|583023897|FG008|Overall Study|Adverse Event|1|||
161445442|NCT00481091|583023898|FG009|Overall Study|Adverse Event|6|||
161445443|NCT00481091|583023889|FG000|Overall Study|Progressive disease clinical|0|||
161445444|NCT00481091|583023890|FG001|Overall Study|Progressive disease clinical|0|||
161445445|NCT00481091|583023891|FG002|Overall Study|Progressive disease clinical|0|||
161445446|NCT00481091|583023892|FG003|Overall Study|Progressive disease clinical|0|||
161445447|NCT00481091|583023893|FG004|Overall Study|Progressive disease clinical|0|||
161445448|NCT00481091|583023894|FG005|Overall Study|Progressive disease clinical|0|||
161445449|NCT00481091|583023895|FG006|Overall Study|Progressive disease clinical|0|||
161445450|NCT00481091|583023896|FG007|Overall Study|Progressive disease clinical|0|||
161445451|NCT00481091|583023897|FG008|Overall Study|Progressive disease clinical|1|||
161445452|NCT00481091|583023898|FG009|Overall Study|Progressive disease clinical|7|||
161445453|NCT00481091|583023889|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
161445454|NCT00481091|583023890|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
161445455|NCT00481091|583023891|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445456|NCT00481091|583023892|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445457|NCT00481091|583023893|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445458|NCT00481091|583023894|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
161445459|NCT00481091|583023895|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445460|NCT00481091|583023896|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445461|NCT00481091|583023897|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445462|NCT00481091|583023898|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
161445463|NCT00481091|583023889|FG000|Overall Study|Progressive disease other|1|||
161445464|NCT00481091|583023890|FG001|Overall Study|Progressive disease other|1|||
161445465|NCT00481091|583023891|FG002|Overall Study|Progressive disease other|0|||
161445466|NCT00481091|583023892|FG003|Overall Study|Progressive disease other|1|||
161445467|NCT00481091|583023893|FG004|Overall Study|Progressive disease other|1|||
161445468|NCT00481091|583023894|FG005|Overall Study|Progressive disease other|1|||
161899071|NCT00527826|584677938|FG001|Overall Study|Inclusion Criteria Not Met|3|||
161899072|NCT00527826|584677937|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
161899073|NCT00527826|584677938|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
161899074|NCT00527826|584677937|FG000|Overall Study|Additional Intake of Viani forte|0|||
161899075|NCT00527826|584677938|FG001|Overall Study|Additional Intake of Viani forte|1|||
161899076|NCT00527826|584677937|FG000|Overall Study|Participant moved away|0|||
161899077|NCT00527826|584677938|FG001|Overall Study|Participant moved away|1|||
161899078|NCT00158262|584677939|FG000|Overall Study|Lost to Follow-up|1|||
161899079|NCT00158262|584677940|FG001|Overall Study|Lost to Follow-up|1|||
161899080|NCT02080364|584677944|FG000|Baseline Period|Protocol Violation|2|||
161899081|NCT02080364|584677945|FG001|Baseline Period|Protocol Violation|1|||
161899082|NCT02080364|584677946|FG002|Baseline Period|Protocol Violation|0|||
161899083|NCT02080364|584677947|FG003|Baseline Period|Protocol Violation|0|||
161899084|NCT02080364|584677944|FG000|Baseline Period|Other|0|||
161899085|NCT02080364|584677945|FG001|Baseline Period|Other|1|||
161899086|NCT02080364|584677946|FG002|Baseline Period|Other|1|||
161899087|NCT02080364|584677947|FG003|Baseline Period|Other|0|||
161899088|NCT02080364|584677944|FG000|Treatment Period|Adverse Event|10|||
161899089|NCT02080364|584677945|FG001|Treatment Period|Adverse Event|15|||
161899090|NCT02080364|584677946|FG002|Treatment Period|Adverse Event|11|||
161899091|NCT02080364|584677947|FG003|Treatment Period|Adverse Event|14|||
161899092|NCT02080364|584677944|FG000|Treatment Period|Lost to Follow-up|2|||
161899093|NCT02080364|584677945|FG001|Treatment Period|Lost to Follow-up|3|||
161899094|NCT02080364|584677946|FG002|Treatment Period|Lost to Follow-up|5|||
161899095|NCT02080364|584677947|FG003|Treatment Period|Lost to Follow-up|0|||
161899096|NCT02080364|584677944|FG000|Treatment Period|Protocol Violation|5|||
161899097|NCT02080364|584677945|FG001|Treatment Period|Protocol Violation|3|||
161899098|NCT02080364|584677946|FG002|Treatment Period|Protocol Violation|5|||
161899099|NCT02080364|584677947|FG003|Treatment Period|Protocol Violation|1|||
161899100|NCT02080364|584677944|FG000|Treatment Period|Withdrawal by Subject|16|||
161899101|NCT02080364|584677945|FG001|Treatment Period|Withdrawal by Subject|16|||
161899102|NCT02080364|584677946|FG002|Treatment Period|Withdrawal by Subject|15|||
161899103|NCT02080364|584677947|FG003|Treatment Period|Withdrawal by Subject|10|||
161899104|NCT02080364|584677944|FG000|Treatment Period|Study Terminated by Sponsor|0|||
161899105|NCT02080364|584677945|FG001|Treatment Period|Study Terminated by Sponsor|0|||
161899106|NCT02080364|584677946|FG002|Treatment Period|Study Terminated by Sponsor|180|||
161899107|NCT02080364|584677947|FG003|Treatment Period|Study Terminated by Sponsor|183|||
161899108|NCT02080364|584677944|FG000|Treatment Period|Other|14|||
161899109|NCT02080364|584677945|FG001|Treatment Period|Other|12|||
161899110|NCT02080364|584677946|FG002|Treatment Period|Other|21|||
161899111|NCT02080364|584677947|FG003|Treatment Period|Other|16|||
161899112|NCT00784719|584677948|FG000|Overall Study|Adverse Event|0|||
161899113|NCT00784719|584677949|FG001|Overall Study|Adverse Event|2|||
161899114|NCT00784719|584677950|FG002|Overall Study|Adverse Event|0|||
161899115|NCT00784719|584677951|FG003|Overall Study|Adverse Event|0|||
161899116|NCT00784719|584677952|FG004|Overall Study|Adverse Event|1|||
161899117|NCT00784719|584677953|FG005|Overall Study|Adverse Event|1|||
161899118|NCT00784719|584677954|FG006|Overall Study|Adverse Event|1|||
161899119|NCT00784719|584677948|FG000|Overall Study|Lost to Follow-up|0|||
161899120|NCT00784719|584677949|FG001|Overall Study|Lost to Follow-up|0|||
161899121|NCT00784719|584677950|FG002|Overall Study|Lost to Follow-up|0|||
161899122|NCT00784719|584677951|FG003|Overall Study|Lost to Follow-up|0|||
161899123|NCT00784719|584677952|FG004|Overall Study|Lost to Follow-up|1|||
161899124|NCT00784719|584677953|FG005|Overall Study|Lost to Follow-up|1|||
161445469|NCT00481091|583023895|FG006|Overall Study|Progressive disease other|0|||
161899125|NCT00784719|584677954|FG006|Overall Study|Lost to Follow-up|0|||
161899126|NCT00784719|584677948|FG000|Overall Study|Other|2|||
161899127|NCT00784719|584677949|FG001|Overall Study|Other|1|||
161899128|NCT00784719|584677950|FG002|Overall Study|Other|1|||
161899129|NCT00784719|584677951|FG003|Overall Study|Other|0|||
161899130|NCT00784719|584677952|FG004|Overall Study|Other|2|||
161899131|NCT00784719|584677953|FG005|Overall Study|Other|1|||
161445470|NCT00481091|583023896|FG007|Overall Study|Progressive disease other|2|||
161445471|NCT00481091|583023897|FG008|Overall Study|Progressive disease other|0|||
161899132|NCT00784719|584677954|FG006|Overall Study|Other|3|||
161899133|NCT00784719|584677948|FG000|Overall Study|Withdrawal by Subject|1|||
161899134|NCT00784719|584677949|FG001|Overall Study|Withdrawal by Subject|0|||
161899135|NCT00784719|584677950|FG002|Overall Study|Withdrawal by Subject|0|||
161899136|NCT00784719|584677951|FG003|Overall Study|Withdrawal by Subject|0|||
161899137|NCT00784719|584677952|FG004|Overall Study|Withdrawal by Subject|2|||
161899138|NCT00784719|584677953|FG005|Overall Study|Withdrawal by Subject|0|||
161445472|NCT00481091|583023898|FG009|Overall Study|Progressive disease other|0|||
161445473|NCT00481091|583023889|FG000|Overall Study|No reason given|0|||
161445474|NCT00481091|583023890|FG001|Overall Study|No reason given|0|||
161899139|NCT00784719|584677954|FG006|Overall Study|Withdrawal by Subject|1|||
161899140|NCT01189461|584677958|FG000|Overall Study|Lack of Efficacy|13|||
161899141|NCT01189461|584677958|FG000|Overall Study|Lost to Follow-up|1|||
161445475|NCT00481091|583023891|FG002|Overall Study|No reason given|1|||
161445476|NCT00481091|583023892|FG003|Overall Study|No reason given|1|||
161899142|NCT01189461|584677958|FG000|Overall Study|Withdrawal by Subject|6|||
161899143|NCT01189461|584677958|FG000|Overall Study|Protocol Violation|1|||
161899144|NCT01189461|584677958|FG000|Overall Study|Adverse Event|2|||
161899145|NCT01189461|584677958|FG000|Overall Study|Did not meet entrance criteria|3|||
161899146|NCT01189461|584677958|FG000|Overall Study|Other|8|||
161899147|NCT01919164|584679254|FG000|Overall Study|Adverse Event|6|||
161899148|NCT01919164|584679255|FG001|Overall Study|Adverse Event|4|||
161899149|NCT01919164|584679256|FG002|Overall Study|Adverse Event|9|||
161899150|NCT01919164|584679257|FG003|Overall Study|Adverse Event|3|||
161899151|NCT01919164|584679258|FG004|Overall Study|Adverse Event|2|||
161899152|NCT01919164|584679254|FG000|Overall Study|Lost to Follow-up|2|||
161899153|NCT01919164|584679255|FG001|Overall Study|Lost to Follow-up|2|||
161899154|NCT01919164|584679256|FG002|Overall Study|Lost to Follow-up|2|||
161899155|NCT01919164|584679257|FG003|Overall Study|Lost to Follow-up|0|||
161899156|NCT01919164|584679258|FG004|Overall Study|Lost to Follow-up|4|||
161899157|NCT01919164|584679254|FG000|Overall Study|Death|1|||
161899158|NCT01919164|584679255|FG001|Overall Study|Death|0|||
161899159|NCT01919164|584679256|FG002|Overall Study|Death|0|||
161899160|NCT01919164|584679257|FG003|Overall Study|Death|0|||
161899161|NCT01919164|584679258|FG004|Overall Study|Death|0|||
161899162|NCT01919164|584679254|FG000|Overall Study|Protocol Violation|6|||
161899163|NCT01919164|584679255|FG001|Overall Study|Protocol Violation|0|||
161899164|NCT01919164|584679256|FG002|Overall Study|Protocol Violation|3|||
161899165|NCT01919164|584679257|FG003|Overall Study|Protocol Violation|2|||
161899166|NCT01919164|584679258|FG004|Overall Study|Protocol Violation|2|||
161899167|NCT01919164|584679254|FG000|Overall Study|Disease progression|2|||
161899168|NCT01919164|584679255|FG001|Overall Study|Disease progression|2|||
161899169|NCT01919164|584679256|FG002|Overall Study|Disease progression|1|||
161899170|NCT01919164|584679257|FG003|Overall Study|Disease progression|2|||
161899171|NCT01919164|584679258|FG004|Overall Study|Disease progression|1|||
161899172|NCT01919164|584679254|FG000|Overall Study|Withdrew consent|13|||
161899173|NCT01919164|584679255|FG001|Overall Study|Withdrew consent|13|||
161899174|NCT01919164|584679256|FG002|Overall Study|Withdrew consent|14|||
161899175|NCT01919164|584679257|FG003|Overall Study|Withdrew consent|14|||
161899176|NCT01919164|584679258|FG004|Overall Study|Withdrew consent|9|||
161899177|NCT01919164|584679254|FG000|Overall Study|Other Un-specified|13|||
161899178|NCT01919164|584679255|FG001|Overall Study|Other Un-specified|9|||
161899179|NCT01919164|584679256|FG002|Overall Study|Other Un-specified|8|||
161899180|NCT01919164|584679257|FG003|Overall Study|Other Un-specified|7|||
161899181|NCT01919164|584679258|FG004|Overall Study|Other Un-specified|15|||
161899182|NCT01409915|584679262|FG000|Overall Study|Adverse Event|0|||
161899183|NCT01409915|584679263|FG001|Overall Study|Adverse Event|2|||
161899184|NCT01409915|584679262|FG000|Overall Study|Withdrawal by Subject|0|||
161899185|NCT01409915|584679263|FG001|Overall Study|Withdrawal by Subject|1|||
161899186|NCT01409915|584679262|FG000|Overall Study|Protocol Violation|1|||
161899187|NCT01409915|584679263|FG001|Overall Study|Protocol Violation|0|||
161899188|NCT01845597|584679265|FG000|Overall Study|Death|8|||
161899189|NCT01845597|584679265|FG000|Overall Study|Lost to Follow-up|22|||
161445477|NCT00481091|583023893|FG004|Overall Study|No reason given|1|||
161899190|NCT04194489|584679270|FG000|Overall Study|Withdrawal by Subject|5|||
161899191|NCT04194489|584679270|FG000|Overall Study|Lost to Follow-up|48|||
161899192|NCT02485483|584679271|FG000|Overall Study|Depression at baseline|15|||
161899193|NCT02485483|584679272|FG001|Overall Study|Depression at baseline|0|||
161899194|NCT02485483|584679271|FG000|Overall Study|Discontinued after baseline|39|||
161899195|NCT02485483|584679272|FG001|Overall Study|Discontinued after baseline|0|||
161899196|NCT00377637|584679273|FG000|Induction Phase|Adverse Event|12|||
161899197|NCT00377637|584679274|FG001|Induction Phase|Adverse Event|21|||
161899198|NCT00377637|584679275|FG002|Induction Phase|Adverse Event|0|||
161899199|NCT00377637|584679276|FG003|Induction Phase|Adverse Event|0|||
161899200|NCT00377637|584679273|FG000|Induction Phase|Deterioration/serum creatinine|2|||
161899201|NCT00377637|584679274|FG001|Induction Phase|Deterioration/serum creatinine|0|||
161899202|NCT00377637|584679275|FG002|Induction Phase|Deterioration/serum creatinine|0|||
161445478|NCT00481091|583023894|FG005|Overall Study|No reason given|0|||
161445479|NCT00481091|583023895|FG006|Overall Study|No reason given|1|||
161445480|NCT00481091|583023896|FG007|Overall Study|No reason given|1|||
161445481|NCT00481091|583023897|FG008|Overall Study|No reason given|1|||
161445482|NCT00481091|583023898|FG009|Overall Study|No reason given|4|||
161445483|NCT04294680|583023899|FG000|Overall Study|Withdrawal by Subject|2|||
161445484|NCT04294680|583023900|FG001|Overall Study|Withdrawal by Subject|1|||
161445485|NCT04294680|583023899|FG000|Overall Study|Follow-up visits completed outside of window|1|||
161445486|NCT04294680|583023900|FG001|Overall Study|Follow-up visits completed outside of window|0|||
161445487|NCT02078960|583023903|FG000|Treatment Period|Other|0|||
161445488|NCT02078960|583023904|FG001|Treatment Period|Other|0|||
161445489|NCT02078960|583023905|FG002|Treatment Period|Other|1|||
161899203|NCT00377637|584679276|FG003|Induction Phase|Deterioration/serum creatinine|0|||
161899204|NCT00377637|584679273|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161899205|NCT00377637|584679274|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
161899206|NCT00377637|584679275|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161899207|NCT00377637|584679276|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161899208|NCT00377637|584679273|FG000|Induction Phase|Lost to Follow-up|2|||
161899209|NCT00377637|584679274|FG001|Induction Phase|Lost to Follow-up|1|||
161899210|NCT00377637|584679275|FG002|Induction Phase|Lost to Follow-up|0|||
161899211|NCT00377637|584679276|FG003|Induction Phase|Lost to Follow-up|0|||
161899212|NCT00377637|584679273|FG000|Induction Phase|Death|1|||
161899213|NCT00377637|584679274|FG001|Induction Phase|Death|3|||
161899214|NCT00377637|584679275|FG002|Induction Phase|Death|0|||
161899215|NCT00377637|584679276|FG003|Induction Phase|Death|0|||
161899216|NCT00377637|584679273|FG000|Induction Phase|Withdrawal by Subject|5|||
161899217|NCT00377637|584679274|FG001|Induction Phase|Withdrawal by Subject|6|||
161899218|NCT00377637|584679275|FG002|Induction Phase|Withdrawal by Subject|0|||
161899219|NCT00377637|584679276|FG003|Induction Phase|Withdrawal by Subject|0|||
161899220|NCT00377637|584679273|FG000|Induction Phase|Physician Decision|3|||
161899221|NCT00377637|584679274|FG001|Induction Phase|Physician Decision|1|||
161899222|NCT00377637|584679275|FG002|Induction Phase|Physician Decision|0|||
161899223|NCT00377637|584679276|FG003|Induction Phase|Physician Decision|0|||
161899224|NCT00377637|584679273|FG000|Induction Phase|Sponsor decision|1|||
161899225|NCT00377637|584679274|FG001|Induction Phase|Sponsor decision|2|||
161899226|NCT00377637|584679275|FG002|Induction Phase|Sponsor decision|0|||
161899227|NCT00377637|584679276|FG003|Induction Phase|Sponsor decision|0|||
161899228|NCT00377637|584679273|FG000|Induction Phase|Non-Compliance|1|||
161899229|NCT00377637|584679274|FG001|Induction Phase|Non-Compliance|0|||
161899230|NCT00377637|584679275|FG002|Induction Phase|Non-Compliance|0|||
161899231|NCT00377637|584679276|FG003|Induction Phase|Non-Compliance|0|||
161899232|NCT00377637|584679273|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
161899233|NCT00377637|584679274|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
161899234|NCT00377637|584679275|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
161899235|NCT00377637|584679276|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
161899236|NCT00377637|584679273|FG000|Maintenance Phase|Adverse Event|0|||
161899237|NCT00377637|584679274|FG001|Maintenance Phase|Adverse Event|0|||
161899238|NCT00377637|584679275|FG002|Maintenance Phase|Adverse Event|29|||
161899239|NCT00377637|584679276|FG003|Maintenance Phase|Adverse Event|43|||
161899240|NCT00377637|584679273|FG000|Maintenance Phase|Physician Decision|0|||
161899241|NCT00377637|584679274|FG001|Maintenance Phase|Physician Decision|0|||
161899242|NCT00377637|584679275|FG002|Maintenance Phase|Physician Decision|5|||
161899243|NCT00377637|584679276|FG003|Maintenance Phase|Physician Decision|4|||
161899244|NCT00377637|584679273|FG000|Maintenance Phase|Lost to Follow-up|0|||
161899245|NCT00377637|584679274|FG001|Maintenance Phase|Lost to Follow-up|0|||
161899246|NCT00377637|584679275|FG002|Maintenance Phase|Lost to Follow-up|3|||
161899247|NCT00377637|584679276|FG003|Maintenance Phase|Lost to Follow-up|1|||
161899248|NCT00377637|584679273|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161899249|NCT00377637|584679274|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161899250|NCT00377637|584679275|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161899251|NCT00377637|584679276|FG003|Maintenance Phase|Withdrawal by Subject|3|||
161899252|NCT00377637|584679273|FG000|Maintenance Phase|Sponsor decision|0|||
161899253|NCT00377637|584679274|FG001|Maintenance Phase|Sponsor decision|0|||
161899254|NCT00377637|584679275|FG002|Maintenance Phase|Sponsor decision|2|||
161899255|NCT00377637|584679276|FG003|Maintenance Phase|Sponsor decision|3|||
161899256|NCT00377637|584679273|FG000|Maintenance Phase|Non-compliance|0|||
161899257|NCT00377637|584679274|FG001|Maintenance Phase|Non-compliance|0|||
161899258|NCT00377637|584679275|FG002|Maintenance Phase|Non-compliance|1|||
161899259|NCT00377637|584679276|FG003|Maintenance Phase|Non-compliance|1|||
161899260|NCT00377637|584679273|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
161899261|NCT00377637|584679274|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
161899262|NCT00377637|584679275|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
161899263|NCT00377637|584679276|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
161899264|NCT00377637|584679273|FG000|Maintenance Phase|Death|0|||
161899265|NCT00377637|584679274|FG001|Maintenance Phase|Death|0|||
161899266|NCT00377637|584679275|FG002|Maintenance Phase|Death|0|||
161899267|NCT00377637|584679276|FG003|Maintenance Phase|Death|1|||
161899268|NCT03506438|584679277|FG000|Overall Study|Lost to Follow-up|8|||
161899269|NCT03506438|584679278|FG001|Overall Study|Lost to Follow-up|7|||
161899270|NCT03506438|584679279|FG002|Overall Study|Lost to Follow-up|8|||
161899271|NCT03506438|584679280|FG003|Overall Study|Lost to Follow-up|7|||
161899272|NCT03506438|584679281|FG004|Overall Study|Lost to Follow-up|0|||
161899273|NCT03506438|584679282|FG005|Overall Study|Lost to Follow-up|0|||
161899274|NCT04155463|584679283|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
161899275|NCT04155463|584679284|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
161899276|NCT00113295|584679285|FG000|Overall Study|Adverse Event|4|||
161899277|NCT00113295|584679286|FG001|Overall Study|Adverse Event|1|||
161899278|NCT00113295|584679285|FG000|Overall Study|Unrelated Medical Illness|1|||
161899279|NCT00113295|584679286|FG001|Overall Study|Unrelated Medical Illness|0|||
161899280|NCT01089127|584679289|FG000|Overall Study|Adverse Event|5|||
161899281|NCT01089127|584679290|FG001|Overall Study|Adverse Event|1|||
161899282|NCT01089127|584679291|FG002|Overall Study|Adverse Event|1|||
161899283|NCT01089127|584679292|FG003|Overall Study|Adverse Event|0|||
161899284|NCT01089127|584679293|FG004|Overall Study|Adverse Event|0|||
161899285|NCT01089127|584679294|FG005|Overall Study|Adverse Event|1|||
161445490|NCT02078960|583023903|FG000|Treatment Period|Lack of Efficacy|0|||
161445491|NCT02078960|583023904|FG001|Treatment Period|Lack of Efficacy|1|||
161445492|NCT02078960|583023905|FG002|Treatment Period|Lack of Efficacy|0|||
161445493|NCT02078960|583023903|FG000|Treatment Period|Disease progression - accelerated phase|0|||
161445494|NCT02078960|583023904|FG001|Treatment Period|Disease progression - accelerated phase|1|||
161445495|NCT02078960|583023905|FG002|Treatment Period|Disease progression - accelerated phase|0|||
161445496|NCT02078960|583023903|FG000|Treatment Period|Disease progression - blast phase|1|||
161445497|NCT02078960|583023904|FG001|Treatment Period|Disease progression - blast phase|0|||
161445498|NCT02078960|583023905|FG002|Treatment Period|Disease progression - blast phase|0|||
161445499|NCT02078960|583023903|FG000|Treatment Period|Withdrawal by Subject|0|||
161445500|NCT02078960|583023904|FG001|Treatment Period|Withdrawal by Subject|1|||
161445501|NCT02078960|583023905|FG002|Treatment Period|Withdrawal by Subject|1|||
161445502|NCT02078960|583023903|FG000|Treatment Period|Adverse Event|1|||
161445503|NCT02078960|583023904|FG001|Treatment Period|Adverse Event|0|||
161445504|NCT02078960|583023905|FG002|Treatment Period|Adverse Event|0|||
161445505|NCT02078960|583023903|FG000|Treatment Period|Death|0|||
161445506|NCT02078960|583023904|FG001|Treatment Period|Death|0|||
161445507|NCT02078960|583023905|FG002|Treatment Period|Death|1|||
161445508|NCT02078960|583023903|FG000|Follow-up Period|Death|2|||
161445509|NCT02078960|583023904|FG001|Follow-up Period|Death|0|||
161445510|NCT02078960|583023905|FG002|Follow-up Period|Death|0|||
161445511|NCT02078960|583023903|FG000|Follow-up Period|Lost to Follow-up|0|||
161445512|NCT02078960|583023904|FG001|Follow-up Period|Lost to Follow-up|1|||
161445513|NCT02078960|583023905|FG002|Follow-up Period|Lost to Follow-up|0|||
161445514|NCT04605991|583023907|FG000|Overall Study|Adverse Event|5|||
161445515|NCT04605991|583023907|FG000|Overall Study|Lack of Efficacy|1|||
161445516|NCT04605991|583023907|FG000|Overall Study|Lost to Follow-up|8|||
161445517|NCT04605991|583023907|FG000|Overall Study|Physician Decision|4|||
161445518|NCT04605991|583023907|FG000|Overall Study|Withdrawal by Subject|14|||
161445519|NCT04605991|583023907|FG000|Overall Study|Non-compliance with study|1|||
161445520|NCT00859638|583023908|FG000|Overall Study|Lost to Follow-up|6|||
161445521|NCT00859638|583023909|FG001|Overall Study|Lost to Follow-up|1|||
161445522|NCT00859638|583023908|FG000|Overall Study|Withdrawal by Subject|3|||
161445523|NCT00859638|583023909|FG001|Overall Study|Withdrawal by Subject|2|||
161445524|NCT00859638|583023908|FG000|Overall Study|Ill health|1|||
161445525|NCT00859638|583023909|FG001|Overall Study|Ill health|1|||
161445526|NCT00771953|583023913|FG000|Overall Study|Adverse Event|5|||
161445527|NCT00771953|583023914|FG001|Overall Study|Adverse Event|3|||
161445528|NCT00771953|583023913|FG000|Overall Study|Death|2|||
161445529|NCT00771953|583023914|FG001|Overall Study|Death|2|||
161445530|NCT00771953|583023913|FG000|Overall Study|Progression before active Tx|1|||
161445531|NCT00771953|583023914|FG001|Overall Study|Progression before active Tx|2|||
161445532|NCT00771953|583023913|FG000|Overall Study|Sponsor decision|1|||
161445533|NCT00771953|583023914|FG001|Overall Study|Sponsor decision|0|||
161445534|NCT00771953|583023913|FG000|Overall Study|Other complicating disease|1|||
161445535|NCT00771953|583023914|FG001|Overall Study|Other complicating disease|0|||
161445536|NCT00771953|583023913|FG000|Overall Study|Withdrawal by Subject|0|||
161445537|NCT00771953|583023914|FG001|Overall Study|Withdrawal by Subject|3|||
161445538|NCT00947193|583023917|FG000|Overall Study|Lost to Follow-up|1|||
161445539|NCT00947193|583023918|FG001|Overall Study|Lost to Follow-up|0|||
161445540|NCT00947193|583023917|FG000|Overall Study|Withdrawal by Subject|1|||
161445541|NCT00947193|583023918|FG001|Overall Study|Withdrawal by Subject|0|||
161445542|NCT00947193|583023917|FG000|Overall Study|Factor VIII >1%|1|||
161445543|NCT00947193|583023918|FG001|Overall Study|Factor VIII >1%|0|||
161445544|NCT04364984|583023919|FG000|Overall Study|Death|2|||
161445545|NCT04364984|583023920|FG001|Overall Study|Death|2|||
161445546|NCT04364984|583023921|FG002|Overall Study|Death|0|||
161445547|NCT01349959|583023922|FG000|Overall Study|Adverse Event|7|||
161445548|NCT01652534|583023923|FG000|Overall Study|Lack of Efficacy|1|||
161445549|NCT01652534|583023924|FG001|Overall Study|Lack of Efficacy|0|||
161445550|NCT02722304|583023925|FG000|Overall Study|Study Terminated by Sponsor|1|||
161445551|NCT02722304|583023926|FG001|Overall Study|Study Terminated by Sponsor|0|||
161445552|NCT02722304|583023927|FG002|Overall Study|Study Terminated by Sponsor|2|||
161445553|NCT02722304|583023928|FG003|Overall Study|Study Terminated by Sponsor|1|||
161445554|NCT02722304|583023929|FG004|Overall Study|Study Terminated by Sponsor|1|||
161445555|NCT02722304|583023925|FG000|Overall Study|Other|0|||
161445556|NCT02722304|583023926|FG001|Overall Study|Other|0|||
161445557|NCT02722304|583023927|FG002|Overall Study|Other|0|||
161445558|NCT02722304|583023928|FG003|Overall Study|Other|1|||
161445559|NCT02722304|583023929|FG004|Overall Study|Other|1|||
161445560|NCT01727024|583023932|FG000|Period 1|Lost to Follow-up|1|||
161445561|NCT01727024|583023933|FG001|Period 1|Lost to Follow-up|1|||
161445562|NCT01727024|583023932|FG000|Period 1|Withdrawal by Subject|2|||
161445563|NCT01727024|583023933|FG001|Period 1|Withdrawal by Subject|3|||
161445564|NCT02920242|583023934|FG000|Overall Study|Withdrawal by Subject|1|||
161445565|NCT02920242|583023935|FG001|Overall Study|Withdrawal by Subject|0|||
161445566|NCT02920242|583023936|FG002|Overall Study|Withdrawal by Subject|1|||
161445567|NCT02920242|583023934|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
161445568|NCT02920242|583023935|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
161899286|NCT01089127|584679289|FG000|Overall Study|Subject withdrew consent|0|||
161899287|NCT01089127|584679290|FG001|Overall Study|Subject withdrew consent|1|||
161899288|NCT01089127|584679291|FG002|Overall Study|Subject withdrew consent|1|||
161899289|NCT01089127|584679292|FG003|Overall Study|Subject withdrew consent|1|||
161899290|NCT01089127|584679293|FG004|Overall Study|Subject withdrew consent|0|||
161899291|NCT01089127|584679294|FG005|Overall Study|Subject withdrew consent|2|||
161899292|NCT01089127|584679289|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161899293|NCT01089127|584679290|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161899294|NCT01089127|584679291|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161899295|NCT01089127|584679292|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161899296|NCT01089127|584679293|FG004|Overall Study|Abnormal test procedure result(s)|0|||
161899297|NCT01089127|584679294|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161899298|NCT01089127|584679289|FG000|Overall Study|Lost to Follow-up|1|||
161899299|NCT01089127|584679290|FG001|Overall Study|Lost to Follow-up|1|||
161899300|NCT01089127|584679291|FG002|Overall Study|Lost to Follow-up|0|||
161899301|NCT01089127|584679292|FG003|Overall Study|Lost to Follow-up|0|||
161899302|NCT01089127|584679293|FG004|Overall Study|Lost to Follow-up|1|||
161899303|NCT01089127|584679294|FG005|Overall Study|Lost to Follow-up|0|||
161899304|NCT01089127|584679289|FG000|Overall Study|Protocol deviation|0|||
161899305|NCT01089127|584679290|FG001|Overall Study|Protocol deviation|1|||
161899306|NCT01089127|584679291|FG002|Overall Study|Protocol deviation|0|||
161899307|NCT01089127|584679292|FG003|Overall Study|Protocol deviation|0|||
161899308|NCT01089127|584679293|FG004|Overall Study|Protocol deviation|1|||
161899309|NCT01089127|584679294|FG005|Overall Study|Protocol deviation|0|||
161899310|NCT00875563|584679296|FG000|Overall Study|Death|4|||
161899311|NCT00875563|584679296|FG000|Overall Study|Withdrawal by Subject|7|||
161899312|NCT00875563|584679296|FG000|Overall Study|No long-term (3-5 year) consent|6|||
161899313|NCT00875563|584679296|FG000|Overall Study|Still be eligible for follow-up|7|||
161899314|NCT00511810|584679297|FG000|Overall Study|Lost to Follow-up|1|||
161899315|NCT00511810|584679298|FG001|Overall Study|Lost to Follow-up|2|||
161899316|NCT00511810|584679297|FG000|Overall Study|Lack of Efficacy|0|||
161899317|NCT00511810|584679298|FG001|Overall Study|Lack of Efficacy|2|||
161899318|NCT00511810|584679297|FG000|Overall Study|Refused second scn|0|||
161899319|NCT00511810|584679298|FG001|Overall Study|Refused second scn|1|||
161899320|NCT00618826|584679300|FG000|Overall Study|Adverse Event|1|||
161899321|NCT03231306|584679303|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
161899322|NCT03231306|584679303|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
161899323|NCT03231306|584679303|FG000|Overall Study|Treatment delay > 21 days|2|||
161899324|NCT03231306|584679303|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
161899325|NCT03231306|584679303|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
161899326|NCT03231306|584679303|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
161899327|NCT03231306|584679303|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
161899328|NCT03231306|584679303|FG000|Overall Study|More than 1 Reason|2|||
161899329|NCT01808261|584679304|FG000|Overall Study|Physician Decision|0|||
161899330|NCT01808261|584679305|FG001|Overall Study|Physician Decision|2|||
161899331|NCT01808261|584679304|FG000|Overall Study|Study Closed/Terminated|25|||
161899332|NCT01808261|584679305|FG001|Overall Study|Study Closed/Terminated|23|||
161899333|NCT01808261|584679304|FG000|Overall Study|Adverse event, non-fatal|2|||
161899334|NCT01808261|584679305|FG001|Overall Study|Adverse event, non-fatal|0|||
161899335|NCT01808261|584679304|FG000|Overall Study|Consent withdrawn by subject|6|||
161899336|NCT01808261|584679305|FG001|Overall Study|Consent withdrawn by subject|7|||
161899337|NCT01808261|584679304|FG000|Overall Study|Lost to Follow-up|3|||
161899338|NCT01808261|584679305|FG001|Overall Study|Lost to Follow-up|1|||
161899339|NCT02585713|584679308|FG000|Overall Study|Withdrew prior to treatment|2|||
161899340|NCT02585713|584679309|FG001|Overall Study|Withdrew prior to treatment|7|||
161899341|NCT02585713|584679308|FG000|Overall Study|Other|3|||
161899342|NCT02585713|584679309|FG001|Overall Study|Other|1|||
161899343|NCT04501952|584679314|FG000|Overall Study|Adverse Event|0|||
161899344|NCT04501952|584679315|FG001|Overall Study|Adverse Event|3|||
161899345|NCT04501952|584679314|FG000|Overall Study|Investigator's Discretion|0|||
161899346|NCT04501952|584679315|FG001|Overall Study|Investigator's Discretion|1|||
161899347|NCT04501952|584679314|FG000|Overall Study|Protocol Violation|1|||
161899348|NCT04501952|584679315|FG001|Overall Study|Protocol Violation|1|||
161899349|NCT04501952|584679314|FG000|Overall Study|Withdrew Consent|5|||
161899350|NCT04501952|584679315|FG001|Overall Study|Withdrew Consent|4|||
161899351|NCT04501952|584679314|FG000|Overall Study|Lost to Follow-up|7|||
161899352|NCT04501952|584679315|FG001|Overall Study|Lost to Follow-up|2|||
161899353|NCT04501952|584679314|FG000|Overall Study|Randomized and Never Treated|13|||
161899354|NCT04501952|584679315|FG001|Overall Study|Randomized and Never Treated|9|||
161899355|NCT02609984|584679317|FG000|Overall Study|Death|29|||
161899356|NCT02609984|584679318|FG001|Overall Study|Death|26|||
161899357|NCT02609984|584679317|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
161899358|NCT02609984|584679318|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
161899359|NCT02609984|584679317|FG000|Overall Study|Lost to Follow-up|1|||
161445569|NCT02920242|583023936|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
161899360|NCT02609984|584679318|FG001|Overall Study|Lost to Follow-up|2|||
161899361|NCT02609984|584679317|FG000|Overall Study|Withdrawal by Subject|0|||
161899362|NCT02609984|584679318|FG001|Overall Study|Withdrawal by Subject|1|||
161899363|NCT02609984|584679317|FG000|Overall Study|Disease Progression|2|||
161899364|NCT02609984|584679318|FG001|Overall Study|Disease Progression|0|||
161899365|NCT02256839|584679320|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
161899366|NCT02256839|584679321|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
161899367|NCT01843803|584679322|FG000|Overall Study|not a Veteran, did not see provider|1|||
161899368|NCT01843803|584679323|FG001|Overall Study|not a Veteran, did not see provider|3|||
161899369|NCT00436826|584679329|FG000|Double Blind Period (DBP)|Adverse Event|2|||
161899370|NCT00436826|584679330|FG001|Double Blind Period (DBP)|Adverse Event|0|||
161899371|NCT00436826|584679331|FG002|Double Blind Period (DBP)|Adverse Event|0|||
161899372|NCT00436826|584679332|FG003|Double Blind Period (DBP)|Adverse Event|0|||
161899373|NCT00436826|584679333|FG004|Double Blind Period (DBP)|Adverse Event|0|||
161899374|NCT00436826|584679334|FG005|Double Blind Period (DBP)|Adverse Event|0|||
161899375|NCT00436826|584679329|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
161899376|NCT00436826|584679330|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
161899377|NCT00436826|584679331|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
161899378|NCT00436826|584679332|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
161899379|NCT00436826|584679333|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
161899380|NCT00436826|584679334|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
161899381|NCT00436826|584679329|FG000|Double Blind Period (DBP)|Other|10|||
161899382|NCT00436826|584679330|FG001|Double Blind Period (DBP)|Other|11|||
161899383|NCT00436826|584679331|FG002|Double Blind Period (DBP)|Other|0|||
161899384|NCT00436826|584679332|FG003|Double Blind Period (DBP)|Other|0|||
161899385|NCT00436826|584679333|FG004|Double Blind Period (DBP)|Other|0|||
161899386|NCT00436826|584679334|FG005|Double Blind Period (DBP)|Other|0|||
161899387|NCT00436826|584679329|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899388|NCT00436826|584679330|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899389|NCT00436826|584679331|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899390|NCT00436826|584679332|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
161899391|NCT00436826|584679333|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899392|NCT00436826|584679334|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899393|NCT00436826|584679329|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899394|NCT00436826|584679330|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899395|NCT00436826|584679331|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
161899396|NCT00436826|584679332|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
161899397|NCT00436826|584679333|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899398|NCT00436826|584679334|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899399|NCT00436826|584679329|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899400|NCT00436826|584679330|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899401|NCT00436826|584679331|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899402|NCT00436826|584679332|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899403|NCT00436826|584679333|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
161899404|NCT00436826|584679334|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
161899405|NCT03382418|584679337|FG000|Overall Study|Withdrawal by Subject|1|||
161899406|NCT03382418|584679338|FG001|Overall Study|Withdrawal by Subject|0|||
161899407|NCT03382418|584679339|FG002|Overall Study|Withdrawal by Subject|0|||
161899408|NCT03382418|584679337|FG000|Overall Study|Lost to Follow-up|2|||
161899409|NCT03382418|584679338|FG001|Overall Study|Lost to Follow-up|3|||
161899410|NCT03382418|584679339|FG002|Overall Study|Lost to Follow-up|0|||
161899411|NCT02716584|584679347|FG000|Overall Study|Lost to Follow-up|8|||
161445570|NCT04995419|583023942|FG000|Overall Study|Withdrawal by Subject|3|||
161445571|NCT04995419|583023942|FG000|Overall Study|Progressive Disease|19|||
161445572|NCT04995419|583023942|FG000|Overall Study|Adverse Event|2|||
161445573|NCT04995419|583023942|FG000|Overall Study|Ongoing|16|||
161445574|NCT02948088|583023943|FG000|Overall Study|Lost to Follow-up|8|||
161445575|NCT02948088|583023943|FG000|Overall Study|Death|1|||
161445576|NCT02948088|583023943|FG000|Overall Study|Withdrawal by Subject|4|||
161445577|NCT02948088|583023943|FG000|Overall Study|Other|2|||
161445578|NCT00634101|583023944|FG000|Overall Study|Study Terminated|3|||
161899412|NCT02716584|584679348|FG001|Overall Study|Lost to Follow-up|5|||
161899413|NCT00420628|584679349|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
161899414|NCT00420628|584679350|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
161445579|NCT00634101|583023945|FG001|Overall Study|Study Terminated|3|||
161445580|NCT00634101|583023944|FG000|Overall Study|Lost to Follow-up|2|||
161899415|NCT00420628|584679349|FG000|Overall Study|Lost to Follow-up|3|||
161899416|NCT00420628|584679350|FG001|Overall Study|Lost to Follow-up|2|||
161899417|NCT00420628|584679349|FG000|Overall Study|Adverse Event|1|||
161445581|NCT00634101|583023945|FG001|Overall Study|Lost to Follow-up|0|||
161445582|NCT00139477|583023946|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
161899418|NCT00420628|584679350|FG001|Overall Study|Adverse Event|0|||
161899419|NCT00282152|584679358|FG000|Overall Study|Withdrawal by Subject|1|||
161899420|NCT00282152|584679359|FG001|Overall Study|Withdrawal by Subject|0|||
161899421|NCT00585325|584679360|FG000|Overall Study|Withdrawal by Subject|1|||
161445583|NCT00139477|583023947|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
161445584|NCT00139477|583023946|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
161445585|NCT00139477|583023947|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
161899422|NCT00585325|584679361|FG001|Overall Study|Withdrawal by Subject|1|||
161899423|NCT03301831|584679362|FG000|Overall Study|Lost to Follow-up|5|||
161899424|NCT03301831|584679363|FG001|Overall Study|Lost to Follow-up|3|||
161899425|NCT03301831|584679362|FG000|Overall Study|Protocol Violation|4|||
161899426|NCT03301831|584679363|FG001|Overall Study|Protocol Violation|0|||
161899427|NCT03301831|584679362|FG000|Overall Study|Withdrawal by Subject|11|||
161899428|NCT03301831|584679363|FG001|Overall Study|Withdrawal by Subject|0|||
161899429|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
161899430|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161899431|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161899432|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161899433|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
161899434|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161899435|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161899436|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161899437|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
161899438|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161899439|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161899440|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161899441|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
161899442|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161899443|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161899444|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161899445|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
161899446|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161899447|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161899448|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161899449|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
161899450|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161899451|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161899452|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161899453|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
161899454|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161899455|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161899456|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161899457|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
161899458|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161445586|NCT00139477|583023946|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
161445587|NCT00139477|583023947|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
161445588|NCT00139477|583023946|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
161445589|NCT00139477|583023947|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
161445590|NCT00139477|583023946|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
161445591|NCT00139477|583023947|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
161445592|NCT00139477|583023946|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
161445593|NCT00139477|583023947|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
161445594|NCT00139477|583023946|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
161445595|NCT00139477|583023947|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
161445596|NCT03776812|583023948|FG000|Overall Study|Death|53|||
161445597|NCT03776812|583023949|FG001|Overall Study|Death|49|||
161445598|NCT03776812|583023950|FG002|Overall Study|Death|56|||
161445599|NCT03776812|583023948|FG000|Overall Study|Withdrawal by Subject|1|||
161445600|NCT03776812|583023949|FG001|Overall Study|Withdrawal by Subject|7|||
161445601|NCT03776812|583023950|FG002|Overall Study|Withdrawal by Subject|2|||
161445602|NCT03776812|583023948|FG000|Overall Study|Lost to Follow-up|1|||
161445603|NCT03776812|583023949|FG001|Overall Study|Lost to Follow-up|1|||
161445604|NCT03776812|583023950|FG002|Overall Study|Lost to Follow-up|0|||
161445605|NCT03776812|583023948|FG000|Overall Study|Did not enter long-term follow-up|3|||
161445606|NCT03776812|583023949|FG001|Overall Study|Did not enter long-term follow-up|3|||
161899459|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161445607|NCT03776812|583023950|FG002|Overall Study|Did not enter long-term follow-up|2|||
161899460|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161899461|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
161899462|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161899463|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161899464|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161899465|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161899466|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
161899467|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161899468|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161899469|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161899470|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
161899471|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161899472|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161899473|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161899474|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
161899475|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161899476|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161899477|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161899478|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
161445608|NCT02527421|583023957|FG000|Overall Study|Withdrawal by Subject|1|||
161445609|NCT02527421|583023958|FG001|Overall Study|Withdrawal by Subject|0|||
161445610|NCT00993148|583023959|FG000|Overall Study|Lost to Follow-up|2|||
161445611|NCT00993148|583023959|FG000|Overall Study|never initiated treatment|1|||
161445612|NCT00560352|583023973|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161445613|NCT00560352|583023974|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161445614|NCT00560352|583023975|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161445615|NCT00560352|583023973|FG000|Overall Study|Study drug toxicity|3|||
161445616|NCT00560352|583023974|FG001|Overall Study|Study drug toxicity|0|||
161445617|NCT00560352|583023975|FG002|Overall Study|Study drug toxicity|1|||
161445618|NCT00560352|583023973|FG000|Overall Study|Disease progression|0|||
161445619|NCT00560352|583023974|FG001|Overall Study|Disease progression|1|||
161445620|NCT00560352|583023975|FG002|Overall Study|Disease progression|1|||
161445621|NCT00560352|583023973|FG000|Overall Study|Withdrawal by Subject|1|||
161445622|NCT00560352|583023974|FG001|Overall Study|Withdrawal by Subject|1|||
161445623|NCT00560352|583023975|FG002|Overall Study|Withdrawal by Subject|1|||
161445624|NCT00560352|583023973|FG000|Overall Study|Maximum clinical benefit|1|||
161445625|NCT00560352|583023974|FG001|Overall Study|Maximum clinical benefit|0|||
161445626|NCT00560352|583023975|FG002|Overall Study|Maximum clinical benefit|0|||
161445627|NCT03892967|583023976|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
161445628|NCT03892967|583023977|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
161445629|NCT03892967|583023978|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
161445630|NCT03892967|583023979|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
161445631|NCT03892967|583023980|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
161445632|NCT03892967|583023976|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
161445633|NCT03892967|583023977|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
161445634|NCT03892967|583023978|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
161445635|NCT03892967|583023979|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
161899479|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161899480|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161899481|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161899482|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
161899483|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161899484|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161899485|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161445636|NCT03892967|583023980|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
161445637|NCT03892967|583023976|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
161445638|NCT03892967|583023977|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
161445639|NCT03892967|583023978|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
161899486|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
161899487|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161899488|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161899489|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161899490|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
161899491|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161899492|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161899493|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161899494|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
161899495|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161899496|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161899497|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161899498|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
161899499|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161899500|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161899501|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899502|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
161899503|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899504|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899505|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
161899506|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
161899507|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
161899508|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
161899509|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
161899510|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
161899511|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
161899512|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
161899513|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
161899514|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
161899515|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
161899516|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
161899517|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
161899518|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
161899519|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
161899520|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
161899521|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
161899522|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
161899523|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
161899524|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
161899525|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161899526|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161899527|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
161899528|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161899529|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
161899530|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
161899531|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
161899532|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
161899533|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161899534|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161899535|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161899536|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
161899537|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899538|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899539|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
161899540|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
161899541|NCT01124292|584679369|FG000|Overall Study|Lost to Follow-up|2|||
161899542|NCT01124292|584679370|FG001|Overall Study|Lost to Follow-up|4|||
161899543|NCT01124292|584679371|FG002|Overall Study|Lost to Follow-up|3|||
161899544|NCT01124292|584679369|FG000|Overall Study|Physician Decision|0|||
161445640|NCT03892967|583023979|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
161445641|NCT03892967|583023980|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
161445642|NCT03892967|583023976|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
161445643|NCT03892967|583023977|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
161445644|NCT03892967|583023978|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
161445645|NCT03892967|583023979|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
161445646|NCT03892967|583023980|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
161445647|NCT03892967|583023976|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
161445648|NCT03892967|583023977|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
161445649|NCT03892967|583023978|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
161445650|NCT03892967|583023979|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
161445651|NCT03892967|583023980|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
161445652|NCT03892967|583023976|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
161445653|NCT03892967|583023977|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
161445654|NCT03892967|583023978|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
161445655|NCT03892967|583023979|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
161445656|NCT03892967|583023980|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
161445657|NCT03568461|583023984|FG000|Overall Study|Death|7|||
161445658|NCT03568461|583023984|FG000|Overall Study|Physician Decision|5|||
161445659|NCT03568461|583023984|FG000|Overall Study|Subject decision|5|||
161445660|NCT03568461|583023984|FG000|Overall Study|Lost to Follow-up|1|||
161445661|NCT03387085|583023988|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
161445662|NCT01368562|583026063|FG000|Overall Study|Adverse Event|1|||
161445663|NCT01368562|583026063|FG000|Overall Study|Disease progression|1|||
161445664|NCT01368562|583026063|FG000|Overall Study|Lost to Follow-up|1|||
161445665|NCT01368562|583026063|FG000|Overall Study|Death|6|||
161445666|NCT01368562|583026063|FG000|Overall Study|Unresponsive to treatment|5|||
161445667|NCT01368562|583026063|FG000|Overall Study|Other|3|||
161445668|NCT01368562|583026063|FG000|Overall Study|Other than specified|2|||
161445669|NCT01296672|583026068|FG000|Overall Study|Lost to Follow-up|73|||
161445670|NCT01296672|583026069|FG001|Overall Study|Lost to Follow-up|18|||
161445671|NCT01311024|583026073|FG000|Overall Study|Protocol Violation|35|||
161445672|NCT01311024|583026074|FG001|Overall Study|Protocol Violation|22|||
161445673|NCT04643158|583026078|FG000|Overall Study|Study terminated by sponsor|0|||
161445674|NCT04643158|583026079|FG001|Overall Study|Study terminated by sponsor|0|||
161445675|NCT04643158|583026080|FG002|Overall Study|Study terminated by sponsor|1|||
161445676|NCT04643158|583026081|FG003|Overall Study|Study terminated by sponsor|0|||
161445677|NCT04643158|583026082|FG004|Overall Study|Study terminated by sponsor|0|||
161445678|NCT04643158|583026083|FG005|Overall Study|Study terminated by sponsor|1|||
161445679|NCT04643158|583026084|FG006|Overall Study|Study terminated by sponsor|0|||
161445680|NCT04643158|583026078|FG000|Overall Study|Global/country situation|0|||
161445681|NCT04643158|583026079|FG001|Overall Study|Global/country situation|0|||
161445682|NCT04643158|583026080|FG002|Overall Study|Global/country situation|1|||
161445683|NCT04643158|583026081|FG003|Overall Study|Global/country situation|0|||
161445684|NCT04643158|583026082|FG004|Overall Study|Global/country situation|0|||
161445685|NCT04643158|583026083|FG005|Overall Study|Global/country situation|0|||
161445686|NCT04643158|583026084|FG006|Overall Study|Global/country situation|0|||
161445687|NCT04643158|583026078|FG000|Overall Study|Withdrawal by Subject|0|||
161445688|NCT04643158|583026079|FG001|Overall Study|Withdrawal by Subject|0|||
161445689|NCT04643158|583026080|FG002|Overall Study|Withdrawal by Subject|0|||
161445690|NCT04643158|583026081|FG003|Overall Study|Withdrawal by Subject|0|||
161445691|NCT04643158|583026082|FG004|Overall Study|Withdrawal by Subject|0|||
161445692|NCT04643158|583026083|FG005|Overall Study|Withdrawal by Subject|1|||
161445693|NCT04643158|583026084|FG006|Overall Study|Withdrawal by Subject|0|||
161445694|NCT04329806|583026085|FG000|Overall Study|Physician Decision|3|||
161445695|NCT04329806|583026086|FG001|Overall Study|Physician Decision|4|||
161445696|NCT00622440|583026099|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
161445697|NCT00622440|583026100|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
161445698|NCT00622440|583026099|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
161445699|NCT00622440|583026100|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
161445700|NCT00622440|583026099|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
161445701|NCT00622440|583026100|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
161445702|NCT00622440|583026099|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
161445703|NCT00622440|583026100|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
161445704|NCT00856518|583026106|FG000|Overall Study|Lost to Follow-up|4|||
161445705|NCT00856518|583026107|FG001|Overall Study|Lost to Follow-up|2|||
161445706|NCT02867384|583026108|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
161445707|NCT02867384|583026109|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
161899545|NCT01124292|584679370|FG001|Overall Study|Physician Decision|3|||
161899546|NCT01124292|584679371|FG002|Overall Study|Physician Decision|2|||
161899547|NCT01124292|584679369|FG000|Overall Study|Withdrawal by Subject|0|||
161899548|NCT01124292|584679370|FG001|Overall Study|Withdrawal by Subject|6|||
161899549|NCT01124292|584679371|FG002|Overall Study|Withdrawal by Subject|2|||
161899550|NCT01124292|584679369|FG000|Overall Study|medical issue unrelated to the study|0|||
161899551|NCT01124292|584679370|FG001|Overall Study|medical issue unrelated to the study|0|||
161899552|NCT01124292|584679371|FG002|Overall Study|medical issue unrelated to the study|2|||
161899553|NCT01124292|584679369|FG000|Overall Study|piercing track closed|0|||
161899554|NCT01124292|584679370|FG001|Overall Study|piercing track closed|2|||
161899555|NCT01124292|584679371|FG002|Overall Study|piercing track closed|1|||
161899556|NCT00481767|584679372|FG000|Overall Study|Withdrawal by Subject|16|||
161899557|NCT00481767|584679373|FG001|Overall Study|Withdrawal by Subject|11|||
161899558|NCT00481767|584679372|FG000|Overall Study|Lost to Follow-up|16|||
161899559|NCT00481767|584679373|FG001|Overall Study|Lost to Follow-up|10|||
161899560|NCT00636636|584679374|FG000|Overall Study|Other reason|4|||
161899561|NCT00636636|584679375|FG001|Overall Study|Other reason|6|||
161899562|NCT00636636|584679374|FG000|Overall Study|Adverse Event|19|||
161899563|NCT00636636|584679375|FG001|Overall Study|Adverse Event|8|||
161899564|NCT00636636|584679374|FG000|Overall Study|Lack of Efficacy|7|||
161899565|NCT00636636|584679375|FG001|Overall Study|Lack of Efficacy|12|||
161899566|NCT00636636|584679374|FG000|Overall Study|Protocol Violation|2|||
161899567|NCT00636636|584679375|FG001|Overall Study|Protocol Violation|2|||
161899568|NCT00636636|584679374|FG000|Overall Study|Lost to Follow-up|0|||
161899569|NCT00636636|584679375|FG001|Overall Study|Lost to Follow-up|1|||
161899570|NCT00636636|584679374|FG000|Overall Study|Death|0|||
161899571|NCT00636636|584679375|FG001|Overall Study|Death|1|||
161899572|NCT00636636|584679374|FG000|Overall Study|Withdrawal by Subject|4|||
161899573|NCT00636636|584679375|FG001|Overall Study|Withdrawal by Subject|9|||
161899574|NCT00524173|584679376|FG000|Overall Study|Lost to Follow-up|0|||
161899575|NCT00524173|584679377|FG001|Overall Study|Lost to Follow-up|1|||
161899576|NCT00524173|584679376|FG000|Overall Study|Death|1|||
161899577|NCT00524173|584679377|FG001|Overall Study|Death|0|||
161899578|NCT00524173|584679376|FG000|Overall Study|Had not reached endpoint at study close|4|||
161899579|NCT00524173|584679377|FG001|Overall Study|Had not reached endpoint at study close|1|||
161899580|NCT03300180|584679378|FG000|Baseline|Withdrawal by Subject|4|||
161899581|NCT03300180|584679379|FG001|Baseline|Withdrawal by Subject|6|||
161899582|NCT03300180|584679380|FG002|Baseline|Withdrawal by Subject|4|||
161899583|NCT03300180|584679378|FG000|6 Month Outcome|Withdrawal by Subject|12|||
161899584|NCT03300180|584679379|FG001|6 Month Outcome|Withdrawal by Subject|12|||
161899585|NCT03300180|584679380|FG002|6 Month Outcome|Withdrawal by Subject|19|||
161899586|NCT03300180|584679378|FG000|6 Month Outcome|Death|2|||
161899587|NCT03300180|584679379|FG001|6 Month Outcome|Death|4|||
161899588|NCT03300180|584679380|FG002|6 Month Outcome|Death|3|||
161899589|NCT03300180|584679378|FG000|6 Month Outcome|Missed Assessment|43|||
161899590|NCT03300180|584679379|FG001|6 Month Outcome|Missed Assessment|52|||
161899591|NCT03300180|584679380|FG002|6 Month Outcome|Missed Assessment|46|||
161899592|NCT03300180|584679378|FG000|12 Month Outcome|Withdrawal by Subject|3|||
161899593|NCT03300180|584679379|FG001|12 Month Outcome|Withdrawal by Subject|6|||
161899594|NCT03300180|584679380|FG002|12 Month Outcome|Withdrawal by Subject|6|||
161899595|NCT03300180|584679378|FG000|12 Month Outcome|Death|9|||
161899596|NCT03300180|584679379|FG001|12 Month Outcome|Death|6|||
161899597|NCT03300180|584679380|FG002|12 Month Outcome|Death|6|||
161899598|NCT03300180|584679378|FG000|12 Month Outcome|Missed Assessment|62|||
161899599|NCT03300180|584679379|FG001|12 Month Outcome|Missed Assessment|59|||
161899600|NCT03300180|584679380|FG002|12 Month Outcome|Missed Assessment|58|||
161899601|NCT03300180|584679378|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
161899602|NCT03300180|584679379|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
161899603|NCT03300180|584679380|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
161899604|NCT03300180|584679378|FG000|18 Month Outcome Assessment|Death|8|||
161899605|NCT03300180|584679379|FG001|18 Month Outcome Assessment|Death|5|||
161899606|NCT03300180|584679380|FG002|18 Month Outcome Assessment|Death|5|||
161899607|NCT03300180|584679378|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
161899608|NCT03300180|584679379|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
161899609|NCT03300180|584679380|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
161899610|NCT03300180|584679378|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
161899611|NCT03300180|584679379|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
161899612|NCT03300180|584679380|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
161899613|NCT03300180|584679378|FG000|24 Month Outcome Assessment|Death|13|||
161899614|NCT03300180|584679379|FG001|24 Month Outcome Assessment|Death|13|||
161899615|NCT03300180|584679380|FG002|24 Month Outcome Assessment|Death|3|||
161899616|NCT03300180|584679378|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
161899617|NCT03300180|584679379|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
161899618|NCT03300180|584679380|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
161445708|NCT02867384|583026110|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
161445709|NCT02867384|583026108|FG000|Overall Study|Progression/ Relapse|15|||
161899619|NCT02557516|584679383|FG000|Overall Study|Adverse Event|1|||
161899620|NCT02557516|584679384|FG001|Overall Study|Adverse Event|0|||
161445710|NCT02867384|583026109|FG001|Overall Study|Progression/ Relapse|19|||
161793559|NCT03843359|584287755|FG000|Escalation Phase|Physician Decision|0|||
161793560|NCT03843359|584287756|FG001|Escalation Phase|Physician Decision|0|||
161793561|NCT03843359|584287757|FG002|Escalation Phase|Physician Decision|1|||
161793562|NCT03843359|584287758|FG003|Escalation Phase|Physician Decision|0|||
161793563|NCT03843359|584287759|FG004|Escalation Phase|Physician Decision|0|||
161793564|NCT03843359|584287760|FG005|Escalation Phase|Physician Decision|1|||
161445711|NCT02867384|583026110|FG002|Overall Study|Progression/ Relapse|0|||
161445712|NCT02867384|583026108|FG000|Overall Study|Adverse Event|13|||
161445713|NCT02867384|583026109|FG001|Overall Study|Adverse Event|1|||
161445714|NCT02867384|583026110|FG002|Overall Study|Adverse Event|0|||
161445715|NCT02867384|583026108|FG000|Overall Study|Withdrawal by Subject|6|||
161445716|NCT02867384|583026109|FG001|Overall Study|Withdrawal by Subject|5|||
161445717|NCT02867384|583026110|FG002|Overall Study|Withdrawal by Subject|0|||
161445718|NCT02867384|583026108|FG000|Overall Study|Physician Decision|1|||
161445719|NCT02867384|583026109|FG001|Overall Study|Physician Decision|2|||
161445720|NCT02867384|583026110|FG002|Overall Study|Physician Decision|0|||
161445721|NCT02867384|583026108|FG000|Overall Study|Patient compliance|1|||
161445722|NCT02867384|583026109|FG001|Overall Study|Patient compliance|0|||
161445723|NCT02867384|583026110|FG002|Overall Study|Patient compliance|0|||
161445724|NCT02867384|583026108|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
161445725|NCT02867384|583026109|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
161445726|NCT02867384|583026110|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
161445727|NCT02867384|583026108|FG000|Overall Study|Never start treatment|3|||
161445728|NCT02867384|583026109|FG001|Overall Study|Never start treatment|0|||
161445729|NCT02867384|583026110|FG002|Overall Study|Never start treatment|0|||
161445730|NCT01941186|583026111|FG000|Follow-up|Lost to Follow-up|1|||
161445731|NCT01941186|583026112|FG001|Follow-up|Lost to Follow-up|0|||
161445732|NCT02105961|583026113|FG000|Overall Study|Adverse Event|18|||
161445733|NCT02105961|583026114|FG001|Overall Study|Adverse Event|7|||
161445734|NCT02105961|583026115|FG002|Overall Study|Adverse Event|13|||
161445735|NCT02105961|583026113|FG000|Overall Study|Lack of Efficacy|3|||
161445736|NCT02105961|583026114|FG001|Overall Study|Lack of Efficacy|0|||
161445737|NCT02105961|583026115|FG002|Overall Study|Lack of Efficacy|3|||
161445738|NCT02105961|583026113|FG000|Overall Study|Lost to Follow-up|2|||
161445739|NCT02105961|583026114|FG001|Overall Study|Lost to Follow-up|0|||
161445740|NCT02105961|583026115|FG002|Overall Study|Lost to Follow-up|1|||
161445741|NCT02105961|583026113|FG000|Overall Study|Physician Decision|3|||
161445742|NCT02105961|583026114|FG001|Overall Study|Physician Decision|3|||
161445743|NCT02105961|583026115|FG002|Overall Study|Physician Decision|2|||
161445744|NCT02105961|583026113|FG000|Overall Study|Withdrawal by Subject|15|||
161445745|NCT02105961|583026114|FG001|Overall Study|Withdrawal by Subject|7|||
161445746|NCT02105961|583026115|FG002|Overall Study|Withdrawal by Subject|11|||
161445747|NCT00934362|583026119|FG000|Overall Study|Adverse Event|1|||
161445748|NCT00934362|583026120|FG001|Overall Study|Adverse Event|0|||
161445749|NCT01092117|583026123|FG000|Index Procedure to 1 Month|Death|1|||
161445750|NCT01092117|583026123|FG000|1 Month|Death|1|||
161445751|NCT01092117|583026123|FG000|1 Month|Withdrawal by Subject|1|||
161445752|NCT01092117|583026123|FG000|1 Month|Lost to Follow-up|1|||
161445753|NCT01092117|583026123|FG000|6 Months|Death|2|||
161445754|NCT01092117|583026123|FG000|6 Months|Withdrawal by Subject|3|||
161445755|NCT01092117|583026123|FG000|12 Month|Death|11|||
161445756|NCT01092117|583026123|FG000|12 Month|Withdrawal by Subject|2|||
161445757|NCT01092117|583026123|FG000|12 Month|Lost to Follow-up|1|||
161445758|NCT01092117|583026123|FG000|Year 2|Death|5|||
161445759|NCT01092117|583026123|FG000|Year 2|Withdrawal by Subject|4|||
161445760|NCT01092117|583026123|FG000|Year 2|Lost to Follow-up|1|||
161445761|NCT01092117|583026123|FG000|Year 3|Death|7|||
161445762|NCT01092117|583026123|FG000|Year 3|Withdrawal by Subject|9|||
161445763|NCT01092117|583026123|FG000|Year 3|Lost to Follow-up|3|||
161445764|NCT01092117|583026123|FG000|Year 4|Death|8|||
161445765|NCT01092117|583026123|FG000|Year 4|Withdrawal by Subject|4|||
161445766|NCT01092117|583026123|FG000|Year 4|Lost to Follow-up|4|||
161445767|NCT04380519|583026124|FG000|Overall Study|Withdrawal by Subject|4|||
161445768|NCT04380519|583026125|FG001|Overall Study|Withdrawal by Subject|0|||
161445769|NCT04380519|583026126|FG002|Overall Study|Withdrawal by Subject|1|||
161445770|NCT04380519|583026124|FG000|Overall Study|Death|14|||
161445771|NCT04380519|583026125|FG001|Overall Study|Death|9|||
161445772|NCT04380519|583026126|FG002|Overall Study|Death|6|||
161445773|NCT04380519|583026124|FG000|Overall Study|Adverse Event|0|||
161445774|NCT04380519|583026125|FG001|Overall Study|Adverse Event|1|||
161793565|NCT03843359|584287761|FG006|Escalation Phase|Physician Decision|0|||
161445775|NCT04380519|583026126|FG002|Overall Study|Adverse Event|0|||
161445776|NCT04380519|583026124|FG000|Overall Study|relatives' decision|0|||
161445777|NCT04380519|583026125|FG001|Overall Study|relatives' decision|1|||
161445778|NCT04380519|583026126|FG002|Overall Study|relatives' decision|0|||
161445779|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
161445780|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
161445781|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
161445782|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
161445783|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
161445784|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
161445785|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
161445786|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
161445787|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
161445788|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
161445789|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
161445790|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
161445791|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
161445792|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
161445793|NCT04173494|583026127|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
161445794|NCT04173494|583026128|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
161445795|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
161445796|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
161445797|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
161445798|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
161445799|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
161445800|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
161445801|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
161445802|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
161445803|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
161445804|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
161445805|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
161793566|NCT03843359|584287762|FG007|Escalation Phase|Physician Decision|0|||
161793567|NCT03843359|584287763|FG008|Escalation Phase|Physician Decision|0|||
161793568|NCT03843359|584287764|FG009|Escalation Phase|Physician Decision|0|||
161793569|NCT03843359|584287765|FG010|Escalation Phase|Physician Decision|0|||
161793570|NCT03843359|584287766|FG011|Escalation Phase|Physician Decision|0|||
161793571|NCT03843359|584287767|FG012|Escalation Phase|Physician Decision|0|||
161793572|NCT03843359|584287768|FG013|Escalation Phase|Physician Decision|0|||
161793573|NCT03843359|584287769|FG014|Escalation Phase|Physician Decision|0|||
161793574|NCT03843359|584287770|FG015|Escalation Phase|Physician Decision|0|||
161793575|NCT03843359|584287755|FG000|Escalation Phase|Investigator site closed|0|||
161793576|NCT03843359|584287756|FG001|Escalation Phase|Investigator site closed|1|||
161793577|NCT03843359|584287757|FG002|Escalation Phase|Investigator site closed|0|||
161793578|NCT03843359|584287758|FG003|Escalation Phase|Investigator site closed|1|||
161793579|NCT03843359|584287759|FG004|Escalation Phase|Investigator site closed|1|||
161793580|NCT03843359|584287760|FG005|Escalation Phase|Investigator site closed|0|||
161793581|NCT03843359|584287761|FG006|Escalation Phase|Investigator site closed|1|||
161793582|NCT03843359|584287762|FG007|Escalation Phase|Investigator site closed|0|||
161793583|NCT03843359|584287763|FG008|Escalation Phase|Investigator site closed|2|||
161793584|NCT03843359|584287764|FG009|Escalation Phase|Investigator site closed|0|||
161793585|NCT03843359|584287765|FG010|Escalation Phase|Investigator site closed|0|||
161793586|NCT03843359|584287766|FG011|Escalation Phase|Investigator site closed|0|||
161793587|NCT03843359|584287767|FG012|Escalation Phase|Investigator site closed|0|||
161793588|NCT03843359|584287768|FG013|Escalation Phase|Investigator site closed|0|||
161793589|NCT03843359|584287769|FG014|Escalation Phase|Investigator site closed|0|||
161793590|NCT03843359|584287770|FG015|Escalation Phase|Investigator site closed|0|||
161793591|NCT03843359|584287755|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
161793592|NCT03843359|584287756|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
161793593|NCT03843359|584287757|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
161793594|NCT03843359|584287758|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
161793595|NCT03843359|584287759|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
161793596|NCT03843359|584287760|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
161793597|NCT03843359|584287761|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
161793598|NCT03843359|584287762|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
161793599|NCT03843359|584287763|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
161793600|NCT03843359|584287764|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
161793601|NCT03843359|584287765|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
161793602|NCT03843359|584287766|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
161793603|NCT03843359|584287767|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
161793604|NCT03843359|584287768|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
161793605|NCT03843359|584287769|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
161793606|NCT03843359|584287770|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
161793607|NCT03843359|584287755|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793608|NCT03843359|584287756|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793609|NCT03843359|584287757|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
161793610|NCT03843359|584287758|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793611|NCT03843359|584287759|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
161793612|NCT03843359|584287760|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793613|NCT03843359|584287761|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793614|NCT03843359|584287762|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793615|NCT03843359|584287763|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793616|NCT03843359|584287764|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793617|NCT03843359|584287765|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793618|NCT03843359|584287766|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793619|NCT03843359|584287767|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793620|NCT03843359|584287768|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793621|NCT03843359|584287769|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793622|NCT03843359|584287770|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793623|NCT03843359|584287755|FG000|Crossover|Withdrawal by Subject|0|||
161793624|NCT03843359|584287756|FG001|Crossover|Withdrawal by Subject|0|||
161793625|NCT03843359|584287757|FG002|Crossover|Withdrawal by Subject|0|||
161793626|NCT03843359|584287758|FG003|Crossover|Withdrawal by Subject|0|||
161793627|NCT03843359|584287759|FG004|Crossover|Withdrawal by Subject|0|||
161793628|NCT03843359|584287760|FG005|Crossover|Withdrawal by Subject|0|||
161793629|NCT03843359|584287761|FG006|Crossover|Withdrawal by Subject|0|||
161793630|NCT03843359|584287762|FG007|Crossover|Withdrawal by Subject|0|||
161793631|NCT03843359|584287763|FG008|Crossover|Withdrawal by Subject|0|||
161793632|NCT03843359|584287764|FG009|Crossover|Withdrawal by Subject|0|||
161793633|NCT03843359|584287765|FG010|Crossover|Withdrawal by Subject|0|||
161793634|NCT03843359|584287766|FG011|Crossover|Withdrawal by Subject|0|||
161793635|NCT03843359|584287767|FG012|Crossover|Withdrawal by Subject|0|||
161793636|NCT03843359|584287768|FG013|Crossover|Withdrawal by Subject|0|||
161793637|NCT03843359|584287769|FG014|Crossover|Withdrawal by Subject|0|||
161793638|NCT03843359|584287770|FG015|Crossover|Withdrawal by Subject|1|||
161793639|NCT03843359|584287755|FG000|Crossover|Investigator site closed|0|||
161793640|NCT03843359|584287756|FG001|Crossover|Investigator site closed|0|||
161793641|NCT03843359|584287757|FG002|Crossover|Investigator site closed|0|||
161793642|NCT03843359|584287758|FG003|Crossover|Investigator site closed|0|||
161793643|NCT03843359|584287759|FG004|Crossover|Investigator site closed|0|||
161793644|NCT03843359|584287760|FG005|Crossover|Investigator site closed|0|||
161793645|NCT03843359|584287761|FG006|Crossover|Investigator site closed|0|||
161793646|NCT03843359|584287762|FG007|Crossover|Investigator site closed|0|||
161793647|NCT03843359|584287763|FG008|Crossover|Investigator site closed|0|||
161793648|NCT03843359|584287764|FG009|Crossover|Investigator site closed|0|||
161793649|NCT03843359|584287765|FG010|Crossover|Investigator site closed|0|||
161793650|NCT03843359|584287766|FG011|Crossover|Investigator site closed|0|||
161793651|NCT03843359|584287767|FG012|Crossover|Investigator site closed|0|||
161793652|NCT03843359|584287768|FG013|Crossover|Investigator site closed|0|||
161793653|NCT03843359|584287769|FG014|Crossover|Investigator site closed|2|||
161793654|NCT03843359|584287770|FG015|Crossover|Investigator site closed|2|||
161793655|NCT03843359|584287755|FG000|Crossover|Ongoing at the time of analysis|0|||
161793656|NCT03843359|584287756|FG001|Crossover|Ongoing at the time of analysis|0|||
161793657|NCT03843359|584287757|FG002|Crossover|Ongoing at the time of analysis|0|||
161793658|NCT03843359|584287758|FG003|Crossover|Ongoing at the time of analysis|0|||
161793659|NCT03843359|584287759|FG004|Crossover|Ongoing at the time of analysis|0|||
161793660|NCT03843359|584287760|FG005|Crossover|Ongoing at the time of analysis|0|||
161793661|NCT03843359|584287761|FG006|Crossover|Ongoing at the time of analysis|0|||
161793662|NCT03843359|584287762|FG007|Crossover|Ongoing at the time of analysis|0|||
161793663|NCT03843359|584287763|FG008|Crossover|Ongoing at the time of analysis|0|||
161793664|NCT03843359|584287764|FG009|Crossover|Ongoing at the time of analysis|0|||
161793665|NCT03843359|584287765|FG010|Crossover|Ongoing at the time of analysis|0|||
161793666|NCT03843359|584287766|FG011|Crossover|Ongoing at the time of analysis|0|||
161793667|NCT03843359|584287767|FG012|Crossover|Ongoing at the time of analysis|0|||
161793668|NCT03843359|584287768|FG013|Crossover|Ongoing at the time of analysis|1|||
161793669|NCT03843359|584287769|FG014|Crossover|Ongoing at the time of analysis|0|||
161793670|NCT03843359|584287770|FG015|Crossover|Ongoing at the time of analysis|0|||
161793671|NCT03075527|584287771|FG000|Overall Study|Death|1|||
161793672|NCT03075527|584287771|FG000|Overall Study|Withdrawal by Subject|1|||
161793673|NCT03075527|584287771|FG000|Overall Study|Physician Decision|3|||
161793674|NCT03075527|584287771|FG000|Overall Study|Progression/Relapse|14|||
161793675|NCT05359003|584287772|FG000|Overall Study|Withdrawal by Subject|1|||
161793676|NCT05359003|584287773|FG001|Overall Study|Withdrawal by Subject|3|||
161793677|NCT06202521|584287776|FG000|Overall Study|Withdrawal by Subject|0|||
161793678|NCT06202521|584287777|FG001|Overall Study|Withdrawal by Subject|1|||
161793679|NCT06202521|584287778|FG002|Overall Study|Withdrawal by Subject|0|||
161793680|NCT06202521|584287779|FG003|Overall Study|Withdrawal by Subject|1|||
161793681|NCT06202521|584287776|FG000|Overall Study|Adverse Event|0|||
161793682|NCT06202521|584287777|FG001|Overall Study|Adverse Event|0|||
161793683|NCT06202521|584287778|FG002|Overall Study|Adverse Event|1|||
161793684|NCT06202521|584287779|FG003|Overall Study|Adverse Event|0|||
161793685|NCT03996005|584287793|FG000|Overall Study|Withdrawal by Subject|1|||
161793686|NCT02623959|584289277|FG000|Overall Study|Progression|0|||
161793687|NCT02623959|584289278|FG001|Overall Study|Progression|1|||
161793688|NCT00135707|584289279|FG000|Overall Study|Lost to Follow-up|94|||
161793689|NCT00135707|584289280|FG001|Overall Study|Lost to Follow-up|89|||
161793690|NCT00135707|584289279|FG000|Overall Study|Withdrawal by Subject|0|||
161793691|NCT00135707|584289280|FG001|Overall Study|Withdrawal by Subject|1|||
161793692|NCT00135707|584289279|FG000|Overall Study|Institutional review board request|1|||
161793693|NCT00135707|584289280|FG001|Overall Study|Institutional review board request|0|||
161793694|NCT00620763|584289287|FG000|Period: First Intervention|Withdrawal by Subject|0|||
161899621|NCT02557516|584679385|FG002|Overall Study|Adverse Event|2|||
161793695|NCT00620763|584289288|FG001|Period: First Intervention|Withdrawal by Subject|2|||
161793696|NCT00620763|584289287|FG000|Period: First Intervention|Protocol Violation|0|||
161793697|NCT00620763|584289288|FG001|Period: First Intervention|Protocol Violation|3|||
161793698|NCT00620763|584289287|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
161899622|NCT02557516|584679386|FG003|Overall Study|Adverse Event|1|||
161899623|NCT02557516|584679383|FG000|Overall Study|Disease progression|0|||
161793699|NCT00620763|584289288|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
161793700|NCT00729859|584289291|FG000|Overall Study|Adverse Event|0|||
161793701|NCT00729859|584289292|FG001|Overall Study|Adverse Event|1|||
161899624|NCT02557516|584679384|FG001|Overall Study|Disease progression|2|||
161899625|NCT02557516|584679385|FG002|Overall Study|Disease progression|0|||
161899626|NCT02557516|584679386|FG003|Overall Study|Disease progression|0|||
161899627|NCT02557516|584679383|FG000|Overall Study|Physician Decision|0|||
161899628|NCT02557516|584679384|FG001|Overall Study|Physician Decision|2|||
161899629|NCT02557516|584679385|FG002|Overall Study|Physician Decision|0|||
161899630|NCT02557516|584679386|FG003|Overall Study|Physician Decision|0|||
161899631|NCT02557516|584679383|FG000|Overall Study|Sponsor decision|0|||
161899632|NCT02557516|584679384|FG001|Overall Study|Sponsor decision|1|||
161899633|NCT02557516|584679385|FG002|Overall Study|Sponsor decision|2|||
161899634|NCT02557516|584679386|FG003|Overall Study|Sponsor decision|8|||
161899635|NCT01972464|584679387|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
161899636|NCT01972464|584679388|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
161899637|NCT01972464|584679387|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
161899638|NCT01972464|584679388|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
161899639|NCT01972464|584679387|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
161899640|NCT01972464|584679388|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
161899641|NCT01972464|584679387|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
161899642|NCT01972464|584679388|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
161899643|NCT01957579|584680966|FG000|Overall Study|Withdrawal of concent|0|||
161899644|NCT01957579|584680967|FG001|Overall Study|Withdrawal of concent|1|||
161899645|NCT01957579|584680968|FG002|Overall Study|Withdrawal of concent|0|||
161899646|NCT01957579|584680969|FG003|Overall Study|Withdrawal of concent|0|||
161899647|NCT01957579|584680966|FG000|Overall Study|Death|0|||
161899648|NCT01957579|584680967|FG001|Overall Study|Death|0|||
161899649|NCT01957579|584680968|FG002|Overall Study|Death|2|||
161899650|NCT01957579|584680969|FG003|Overall Study|Death|0|||
161899651|NCT02019550|584680970|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161899652|NCT02019550|584680971|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
161899653|NCT02750332|584680972|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161899654|NCT02750332|584680973|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161899655|NCT02922153|584680974|FG000|Overall Study|Death|8|||
161899656|NCT02922153|584680975|FG001|Overall Study|Death|1|||
161899657|NCT02922153|584680974|FG000|Overall Study|Lost to Follow-up|1|||
161899658|NCT02922153|584680975|FG001|Overall Study|Lost to Follow-up|0|||
161899659|NCT02922153|584680974|FG000|Overall Study|Physician Decision|1|||
161899660|NCT02922153|584680975|FG001|Overall Study|Physician Decision|1|||
161899661|NCT01128296|584680976|FG000|Overall Study|Physician Decision|0|||
161899662|NCT01128296|584680977|FG001|Overall Study|Physician Decision|0|||
161899663|NCT01128296|584680978|FG002|Overall Study|Physician Decision|0|||
161793702|NCT00729859|584289293|FG002|Overall Study|Adverse Event|0|||
161793703|NCT00729859|584289291|FG000|Overall Study|Withdrawal by Subject|0|||
161793704|NCT00729859|584289292|FG001|Overall Study|Withdrawal by Subject|1|||
161793705|NCT00729859|584289293|FG002|Overall Study|Withdrawal by Subject|0|||
161793706|NCT01689974|584289297|FG000|Overall Study|Termination of Study|5|||
161793707|NCT01689974|584289298|FG001|Overall Study|Termination of Study|5|||
161793708|NCT00681863|584289299|FG000|Overall Study|Adverse Event|1|||
161793709|NCT00681863|584289299|FG000|Overall Study|Lost to Follow-up|2|||
161793710|NCT00681863|584289299|FG000|Overall Study|Lack of Efficacy|2|||
161793711|NCT00681863|584289299|FG000|Overall Study|Other|18|||
161793712|NCT01388647|584289302|FG000|Overall Study|Adverse Event|1|||
161899664|NCT01128296|584680979|FG003|Overall Study|Physician Decision|0|||
161899665|NCT01128296|584680980|FG004|Overall Study|Physician Decision|0|||
161899666|NCT01128296|584680981|FG005|Overall Study|Physician Decision|3|||
161793713|NCT01388647|584289303|FG001|Overall Study|Adverse Event|2|||
161793714|NCT01006707|584289304|FG000|Study Session 1|Lost to Follow-up|2|||
161793715|NCT01006707|584289305|FG001|Study Session 1|Lost to Follow-up|0|||
161793716|NCT01006707|584289306|FG002|Study Session 1|Lost to Follow-up|0|||
161793717|NCT01006707|584289304|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
161793718|NCT01006707|584289305|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
161793719|NCT01006707|584289306|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
161793720|NCT00760383|584289307|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
161793721|NCT00760383|584289308|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
161793722|NCT01336894|584289310|FG000|Follow-up|Study terminated prematurely|2|||
161793723|NCT01336894|584289311|FG001|Follow-up|Study terminated prematurely|7|||
161793724|NCT05034731|584289312|FG000|Overall Study|Screen fail|1|||
161793725|NCT05034731|584289313|FG001|Overall Study|Screen fail|1|||
161793726|NCT03937466|584289314|FG000|Overall Study|not eligbile after the 2-week diary|9|||
161793727|NCT03937466|584289314|FG000|Overall Study|never returned their diary|6|||
161793728|NCT03937466|584289314|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
161793729|NCT03937466|584289314|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
161793730|NCT00622908|584289315|FG000|Overall Study|Protocol Violation|1|||
161793731|NCT00622908|584289316|FG001|Overall Study|Protocol Violation|0|||
161793732|NCT00622908|584289315|FG000|Overall Study|Adverse Event|0|||
161793733|NCT00622908|584289316|FG001|Overall Study|Adverse Event|1|||
161793734|NCT00622908|584289315|FG000|Overall Study|Lack of Efficacy|1|||
161793735|NCT00622908|584289316|FG001|Overall Study|Lack of Efficacy|7|||
161445806|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
161793736|NCT00622908|584289315|FG000|Overall Study|Lost to Follow-up|1|||
161793737|NCT00622908|584289316|FG001|Overall Study|Lost to Follow-up|0|||
161793738|NCT00622908|584289315|FG000|Overall Study|Refusal|0|||
161445807|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
161445808|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
161445809|NCT04173494|583026127|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
161445810|NCT04173494|583026128|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
161445811|NCT01623050|583026129|FG000|Overall Study|Lost to Follow-up|9|||
161445812|NCT00526071|583026132|FG000|Overall Study|Adverse Event|1|||
161445813|NCT00526071|583026132|FG000|Overall Study|Withdrawal by Subject|1|||
161445814|NCT00526071|583026132|FG000|Overall Study|Lack of Response to Study Drug|4|||
161445815|NCT01191762|583026133|FG000|Overall Study|Adverse Event|1|||
161445816|NCT01191762|583026134|FG001|Overall Study|Adverse Event|0|||
161445817|NCT03023813|583026139|FG000|Overall Study|Lost to Follow-up|1|||
161445818|NCT03023813|583026140|FG001|Overall Study|Lost to Follow-up|2|||
161445819|NCT03023813|583026141|FG002|Overall Study|Lost to Follow-up|0|||
161445820|NCT00393861|583026142|FG000|Overall Study|Adverse Event|2|||
161445821|NCT00393861|583026142|FG000|Overall Study|Disease Progression|24|||
161445822|NCT03710083|583026143|FG000|Overall Study|Withdrawal by Subject|2|||
161445823|NCT03710083|583026143|FG000|Overall Study|Unsuccessful Procedure|1|||
161445824|NCT05300763|583026144|FG000|Overall Study|Adverse Event|0|||
161445825|NCT05300763|583026145|FG001|Overall Study|Adverse Event|1|||
161445826|NCT05300763|583026144|FG000|Overall Study|Major Protocol Deviation|1|||
161445827|NCT05300763|583026145|FG001|Overall Study|Major Protocol Deviation|0|||
161445828|NCT05300763|583026144|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
161445829|NCT05300763|583026145|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161445830|NCT01485172|583026146|FG000|Overall Study|Adverse Event|2|||
161445831|NCT01485172|583026147|FG001|Overall Study|Adverse Event|1|||
161445832|NCT01485172|583026148|FG002|Overall Study|Adverse Event|2|||
161445833|NCT01485172|583026149|FG003|Overall Study|Adverse Event|2|||
161445834|NCT01485172|583026150|FG004|Overall Study|Adverse Event|1|||
161445835|NCT01485172|583026151|FG005|Overall Study|Adverse Event|2|||
161445836|NCT01485172|583026146|FG000|Overall Study|Lack of Efficacy|2|||
161445837|NCT01485172|583026147|FG001|Overall Study|Lack of Efficacy|0|||
161445838|NCT01485172|583026148|FG002|Overall Study|Lack of Efficacy|0|||
161445839|NCT01485172|583026149|FG003|Overall Study|Lack of Efficacy|0|||
161445840|NCT01485172|583026150|FG004|Overall Study|Lack of Efficacy|0|||
161445841|NCT01485172|583026151|FG005|Overall Study|Lack of Efficacy|0|||
161445842|NCT01485172|583026146|FG000|Overall Study|Protocol Violation|0|||
161445843|NCT01485172|583026147|FG001|Overall Study|Protocol Violation|0|||
161445844|NCT01485172|583026148|FG002|Overall Study|Protocol Violation|4|||
161445845|NCT01485172|583026149|FG003|Overall Study|Protocol Violation|5|||
161445846|NCT01485172|583026150|FG004|Overall Study|Protocol Violation|1|||
161445847|NCT01485172|583026151|FG005|Overall Study|Protocol Violation|0|||
161445848|NCT01485172|583026146|FG000|Overall Study|Protocol defined stopping criteria|1|||
161445849|NCT01485172|583026147|FG001|Overall Study|Protocol defined stopping criteria|0|||
161445850|NCT01485172|583026148|FG002|Overall Study|Protocol defined stopping criteria|0|||
161445851|NCT01485172|583026149|FG003|Overall Study|Protocol defined stopping criteria|0|||
161793739|NCT00622908|584289316|FG001|Overall Study|Refusal|1|||
161793740|NCT00622908|584289315|FG000|Overall Study|Termination by study sponser|0|||
161793741|NCT00622908|584289316|FG001|Overall Study|Termination by study sponser|1|||
161793742|NCT01725451|584289324|FG000|Period 1|Withdrawal by Subject|1|||
161793743|NCT01725451|584289325|FG001|Period 1|Withdrawal by Subject|0|||
161793744|NCT01725451|584289326|FG002|Period 1|Withdrawal by Subject|0|||
161793745|NCT01725451|584289327|FG003|Period 1|Withdrawal by Subject|0|||
161793746|NCT01725451|584289324|FG000|Washout From Period 3|Protocol Violation|0|||
161793747|NCT01725451|584289325|FG001|Washout From Period 3|Protocol Violation|0|||
161793748|NCT01725451|584289326|FG002|Washout From Period 3|Protocol Violation|1|||
161793749|NCT01725451|584289327|FG003|Washout From Period 3|Protocol Violation|0|||
161793750|NCT01725451|584289324|FG000|Washout From Period 3|Adverse Event|0|||
161793751|NCT01725451|584289325|FG001|Washout From Period 3|Adverse Event|1|||
161793752|NCT01725451|584289326|FG002|Washout From Period 3|Adverse Event|0|||
161793753|NCT01725451|584289327|FG003|Washout From Period 3|Adverse Event|0|||
161793754|NCT01725451|584289324|FG000|Period 4|Adverse Event|0|||
161793755|NCT01725451|584289325|FG001|Period 4|Adverse Event|0|||
161793756|NCT01725451|584289326|FG002|Period 4|Adverse Event|1|||
161793757|NCT01725451|584289327|FG003|Period 4|Adverse Event|0|||
161793758|NCT00358826|584289331|FG000|Core Study|Adverse Event|1|||
161793759|NCT00358826|584289332|FG001|Core Study|Adverse Event|3|||
161793760|NCT00358826|584289333|FG002|Core Study|Adverse Event|1|||
161793761|NCT00358826|584289334|FG003|Core Study|Adverse Event|1|||
161793762|NCT00358826|584289335|FG004|Core Study|Adverse Event|0|||
161793763|NCT00358826|584289336|FG005|Core Study|Adverse Event|0|||
161793764|NCT00358826|584289337|FG006|Core Study|Adverse Event|0|||
161793765|NCT00358826|584289338|FG007|Core Study|Adverse Event|0|||
161793766|NCT00358826|584289331|FG000|Core Study|Withdrawal by Subject|2|||
161793767|NCT00358826|584289332|FG001|Core Study|Withdrawal by Subject|2|||
161793768|NCT00358826|584289333|FG002|Core Study|Withdrawal by Subject|0|||
161793769|NCT00358826|584289334|FG003|Core Study|Withdrawal by Subject|0|||
161793770|NCT00358826|584289335|FG004|Core Study|Withdrawal by Subject|0|||
161793771|NCT00358826|584289336|FG005|Core Study|Withdrawal by Subject|0|||
161793772|NCT00358826|584289337|FG006|Core Study|Withdrawal by Subject|0|||
161793773|NCT00358826|584289338|FG007|Core Study|Withdrawal by Subject|0|||
161793774|NCT00358826|584289331|FG000|Core Study|Lost to Follow-up|0|||
161793775|NCT00358826|584289332|FG001|Core Study|Lost to Follow-up|0|||
161793776|NCT00358826|584289333|FG002|Core Study|Lost to Follow-up|0|||
161793777|NCT00358826|584289334|FG003|Core Study|Lost to Follow-up|1|||
161793778|NCT00358826|584289335|FG004|Core Study|Lost to Follow-up|0|||
161793779|NCT00358826|584289336|FG005|Core Study|Lost to Follow-up|0|||
161793780|NCT00358826|584289337|FG006|Core Study|Lost to Follow-up|0|||
161793781|NCT00358826|584289338|FG007|Core Study|Lost to Follow-up|0|||
161793782|NCT00358826|584289331|FG000|Core Study|Physician Decision|0|||
161793783|NCT00358826|584289332|FG001|Core Study|Physician Decision|0|||
161793784|NCT00358826|584289333|FG002|Core Study|Physician Decision|1|||
161793785|NCT00358826|584289334|FG003|Core Study|Physician Decision|0|||
161793786|NCT00358826|584289335|FG004|Core Study|Physician Decision|0|||
161793787|NCT00358826|584289336|FG005|Core Study|Physician Decision|0|||
161793788|NCT00358826|584289337|FG006|Core Study|Physician Decision|0|||
161793789|NCT00358826|584289338|FG007|Core Study|Physician Decision|0|||
161793790|NCT00358826|584289331|FG000|MDCT Substudy|Adverse Event|0|||
161793791|NCT00358826|584289332|FG001|MDCT Substudy|Adverse Event|0|||
161793792|NCT00358826|584289333|FG002|MDCT Substudy|Adverse Event|0|||
161793793|NCT00358826|584289334|FG003|MDCT Substudy|Adverse Event|0|||
161793794|NCT00358826|584289335|FG004|MDCT Substudy|Adverse Event|1|||
161793795|NCT00358826|584289336|FG005|MDCT Substudy|Adverse Event|0|||
161793796|NCT00358826|584289337|FG006|MDCT Substudy|Adverse Event|0|||
161793797|NCT00358826|584289338|FG007|MDCT Substudy|Adverse Event|0|||
161793798|NCT00358826|584289331|FG000|MDCT Substudy|Lost to Follow-up|0|||
161793799|NCT00358826|584289332|FG001|MDCT Substudy|Lost to Follow-up|0|||
161793800|NCT00358826|584289333|FG002|MDCT Substudy|Lost to Follow-up|0|||
161793801|NCT00358826|584289334|FG003|MDCT Substudy|Lost to Follow-up|0|||
161793802|NCT00358826|584289335|FG004|MDCT Substudy|Lost to Follow-up|0|||
161793803|NCT00358826|584289336|FG005|MDCT Substudy|Lost to Follow-up|1|||
161793804|NCT00358826|584289337|FG006|MDCT Substudy|Lost to Follow-up|0|||
161793805|NCT00358826|584289338|FG007|MDCT Substudy|Lost to Follow-up|0|||
161793806|NCT00358826|584289331|FG000|MDCT Substudy|Withdrawal by Subject|0|||
161793807|NCT00358826|584289332|FG001|MDCT Substudy|Withdrawal by Subject|0|||
161793808|NCT00358826|584289333|FG002|MDCT Substudy|Withdrawal by Subject|0|||
161793809|NCT00358826|584289334|FG003|MDCT Substudy|Withdrawal by Subject|0|||
161793810|NCT00358826|584289335|FG004|MDCT Substudy|Withdrawal by Subject|0|||
161793811|NCT00358826|584289336|FG005|MDCT Substudy|Withdrawal by Subject|1|||
161793812|NCT00358826|584289337|FG006|MDCT Substudy|Withdrawal by Subject|0|||
161793813|NCT00358826|584289338|FG007|MDCT Substudy|Withdrawal by Subject|0|||
161793814|NCT00903383|584289342|FG000|Overall Study|Adverse Event|1|||
161793815|NCT00903383|584289343|FG001|Overall Study|Adverse Event|2|||
161793816|NCT00903383|584289344|FG002|Overall Study|Adverse Event|3|||
161793817|NCT00903383|584289345|FG003|Overall Study|Adverse Event|1|||
161793818|NCT00903383|584289342|FG000|Overall Study|Physician Decision|1|||
161793819|NCT00903383|584289343|FG001|Overall Study|Physician Decision|2|||
161793820|NCT00903383|584289344|FG002|Overall Study|Physician Decision|0|||
161793821|NCT00903383|584289345|FG003|Overall Study|Physician Decision|0|||
161793822|NCT00903383|584289342|FG000|Overall Study|Lost to Follow-up|0|||
161793823|NCT00903383|584289343|FG001|Overall Study|Lost to Follow-up|0|||
161793824|NCT00903383|584289344|FG002|Overall Study|Lost to Follow-up|0|||
161793825|NCT00903383|584289345|FG003|Overall Study|Lost to Follow-up|1|||
161793826|NCT00903383|584289342|FG000|Overall Study|Decision of Sponsor|1|||
161793827|NCT00903383|584289343|FG001|Overall Study|Decision of Sponsor|0|||
161793828|NCT00903383|584289344|FG002|Overall Study|Decision of Sponsor|0|||
161793829|NCT00903383|584289345|FG003|Overall Study|Decision of Sponsor|0|||
161793830|NCT00903383|584289342|FG000|Overall Study|Withdrawal by Subject|4|||
161793831|NCT00903383|584289343|FG001|Overall Study|Withdrawal by Subject|1|||
161793832|NCT00903383|584289344|FG002|Overall Study|Withdrawal by Subject|0|||
161793833|NCT00903383|584289345|FG003|Overall Study|Withdrawal by Subject|2|||
161793834|NCT00903383|584289342|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
161793835|NCT00903383|584289343|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
161793836|NCT00903383|584289344|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
161793837|NCT00903383|584289345|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
161793838|NCT00903383|584289342|FG000|Overall Study|Patient Decision|0|||
161793839|NCT00903383|584289343|FG001|Overall Study|Patient Decision|0|||
161793840|NCT00903383|584289344|FG002|Overall Study|Patient Decision|0|||
161793841|NCT00903383|584289345|FG003|Overall Study|Patient Decision|1|||
161793842|NCT00283686|584289348|FG000|Overall Study|Death|1|||
161793843|NCT00283686|584289349|FG001|Overall Study|Death|1|||
161793844|NCT00283686|584289350|FG002|Overall Study|Death|1|||
161793845|NCT00283686|584289351|FG003|Overall Study|Death|0|||
161793846|NCT00283686|584289348|FG000|Overall Study|Lost to Follow-up|21|||
161793847|NCT00283686|584289349|FG001|Overall Study|Lost to Follow-up|31|||
161793848|NCT00283686|584289350|FG002|Overall Study|Lost to Follow-up|26|||
161793849|NCT00283686|584289351|FG003|Overall Study|Lost to Follow-up|20|||
161793850|NCT00283686|584289348|FG000|Overall Study|Less than full participation|7|||
161793851|NCT00283686|584289349|FG001|Overall Study|Less than full participation|9|||
161793852|NCT00283686|584289350|FG002|Overall Study|Less than full participation|6|||
161793853|NCT00283686|584289351|FG003|Overall Study|Less than full participation|12|||
161793854|NCT02087059|584289352|FG000|Overall Study|Disease Progression|1|||
161793855|NCT02087059|584289352|FG000|Overall Study|Adverse Event|5|||
161793856|NCT02087059|584289352|FG000|Overall Study|Lost to Follow-up|1|||
161793857|NCT01851590|584289354|FG000|Overall Study|Withdrawal by Subject|0|||
161793858|NCT01851590|584289355|FG001|Overall Study|Withdrawal by Subject|0|||
161793859|NCT01851590|584289356|FG002|Overall Study|Withdrawal by Subject|1|||
161793860|NCT01851590|584289354|FG000|Overall Study|Adverse Event|0|||
161793861|NCT01851590|584289355|FG001|Overall Study|Adverse Event|0|||
161793862|NCT01851590|584289356|FG002|Overall Study|Adverse Event|2|||
161793863|NCT01851590|584289354|FG000|Overall Study|Lack of Efficacy|0|||
161793864|NCT01851590|584289355|FG001|Overall Study|Lack of Efficacy|1|||
161793865|NCT01851590|584289356|FG002|Overall Study|Lack of Efficacy|0|||
161793866|NCT00696709|584289357|FG000|Overall Study|Withdrawal by Subject|1|||
161793867|NCT00696709|584289358|FG001|Overall Study|Withdrawal by Subject|2|||
161793868|NCT00696709|584289359|FG002|Overall Study|Withdrawal by Subject|1|||
161793869|NCT00696709|584289360|FG003|Overall Study|Withdrawal by Subject|4|||
161793870|NCT00696709|584289361|FG004|Overall Study|Withdrawal by Subject|3|||
161793871|NCT00696709|584289357|FG000|Overall Study|Protocol Violation|1|||
161793872|NCT00696709|584289358|FG001|Overall Study|Protocol Violation|0|||
161793873|NCT00696709|584289359|FG002|Overall Study|Protocol Violation|0|||
161793874|NCT00696709|584289360|FG003|Overall Study|Protocol Violation|0|||
161793875|NCT00696709|584289361|FG004|Overall Study|Protocol Violation|0|||
161793876|NCT00696709|584289357|FG000|Overall Study|Lost to Follow-up|1|||
161793877|NCT00696709|584289358|FG001|Overall Study|Lost to Follow-up|1|||
161899667|NCT01128296|584680976|FG000|Overall Study|Withdrawal by Subject|0|||
161899668|NCT01128296|584680977|FG001|Overall Study|Withdrawal by Subject|0|||
161899669|NCT01128296|584680978|FG002|Overall Study|Withdrawal by Subject|0|||
161899670|NCT01128296|584680979|FG003|Overall Study|Withdrawal by Subject|0|||
161899671|NCT01128296|584680980|FG004|Overall Study|Withdrawal by Subject|0|||
161899672|NCT01128296|584680981|FG005|Overall Study|Withdrawal by Subject|2|||
161899673|NCT01714544|584680982|FG000|Overall Study|Lost to Follow-up|1|||
161899674|NCT01714544|584680982|FG000|Overall Study|Physician Decision|1|||
161899675|NCT01714544|584680982|FG000|Overall Study|Withdrawal by Subject|1|||
161899676|NCT01053741|584680983|FG000|2nd Study Intervention|Physician Decision|0|||
161899677|NCT01053741|584680984|FG001|2nd Study Intervention|Physician Decision|1|||
161899678|NCT00666211|584680985|FG000|Overall Study|Withdrawal by Subject|10|||
161793878|NCT00696709|584289359|FG002|Overall Study|Lost to Follow-up|0|||
161793879|NCT00696709|584289360|FG003|Overall Study|Lost to Follow-up|0|||
161793880|NCT00696709|584289361|FG004|Overall Study|Lost to Follow-up|0|||
161793881|NCT00696709|584289357|FG000|Overall Study|Adverse Event|0|||
161793882|NCT00696709|584289358|FG001|Overall Study|Adverse Event|0|||
161793883|NCT00696709|584289359|FG002|Overall Study|Adverse Event|0|||
161793884|NCT00696709|584289360|FG003|Overall Study|Adverse Event|1|||
161793885|NCT00696709|584289361|FG004|Overall Study|Adverse Event|0|||
161793886|NCT00310856|584289362|FG000|Overall Study|Withdrawal by Subject|2|||
161793887|NCT00310856|584289363|FG001|Overall Study|Withdrawal by Subject|2|||
161899679|NCT00666211|584680986|FG001|Overall Study|Withdrawal by Subject|13|||
161899680|NCT00666211|584680985|FG000|Overall Study|went off medication, no more pain|1|||
161899681|NCT00666211|584680986|FG001|Overall Study|went off medication, no more pain|0|||
161899682|NCT00666211|584680985|FG000|Overall Study|patient non-compliant|6|||
161793888|NCT00310856|584289364|FG002|Overall Study|Withdrawal by Subject|2|||
161793889|NCT00310856|584289362|FG000|Overall Study|Lost to Follow-up|1|||
161793890|NCT00310856|584289363|FG001|Overall Study|Lost to Follow-up|2|||
161793891|NCT00310856|584289364|FG002|Overall Study|Lost to Follow-up|6|||
161793892|NCT00310856|584289362|FG000|Overall Study|Inappropriate enrollment|1|||
161793893|NCT00310856|584289363|FG001|Overall Study|Inappropriate enrollment|1|||
161793894|NCT00310856|584289364|FG002|Overall Study|Inappropriate enrollment|0|||
161793895|NCT00310856|584289362|FG000|Overall Study|Unable to classify|1|||
161793896|NCT00310856|584289363|FG001|Overall Study|Unable to classify|0|||
161793897|NCT00310856|584289364|FG002|Overall Study|Unable to classify|0|||
161793898|NCT01306253|584289368|FG000|Overall Study|Lost to Follow-up|1|||
161793899|NCT01306253|584289369|FG001|Overall Study|Lost to Follow-up|1|||
161793900|NCT01261325|584289370|FG000|Overall Study|Lack of Efficacy|1|||
161793901|NCT01261325|584289371|FG001|Overall Study|Lack of Efficacy|1|||
161793902|NCT01261325|584289372|FG002|Overall Study|Lack of Efficacy|0|||
161793903|NCT01261325|584289370|FG000|Overall Study|Withdrawal by Subject|2|||
161793904|NCT01261325|584289371|FG001|Overall Study|Withdrawal by Subject|2|||
161793905|NCT01261325|584289372|FG002|Overall Study|Withdrawal by Subject|4|||
161793906|NCT01261325|584289370|FG000|Overall Study|SAE, non-fatal|1|||
161793907|NCT01261325|584289371|FG001|Overall Study|SAE, non-fatal|5|||
161793908|NCT01261325|584289372|FG002|Overall Study|SAE, non-fatal|1|||
161793909|NCT01261325|584289370|FG000|Overall Study|AE, non-serious non-fatal|9|||
161793910|NCT01261325|584289371|FG001|Overall Study|AE, non-serious non-fatal|15|||
161793911|NCT01261325|584289372|FG002|Overall Study|AE, non-serious non-fatal|13|||
161793912|NCT01261325|584289370|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161793913|NCT01261325|584289371|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161793914|NCT01261325|584289372|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161793915|NCT01261325|584289370|FG000|Overall Study|Non Compliance|2|||
161793916|NCT01261325|584289371|FG001|Overall Study|Non Compliance|0|||
161793917|NCT01261325|584289372|FG002|Overall Study|Non Compliance|0|||
161793918|NCT01261325|584289370|FG000|Overall Study|Patient Randomized by Mistake|0|||
161793919|NCT01261325|584289371|FG001|Overall Study|Patient Randomized by Mistake|1|||
161793920|NCT01261325|584289372|FG002|Overall Study|Patient Randomized by Mistake|0|||
161793921|NCT01261325|584289370|FG000|Overall Study|Erroneously Randomized|1|||
161899683|NCT00666211|584680986|FG001|Overall Study|patient non-compliant|6|||
161899684|NCT00666211|584680985|FG000|Overall Study|disease progression|1|||
161899685|NCT00666211|584680986|FG001|Overall Study|disease progression|8|||
161899686|NCT00666211|584680985|FG000|Overall Study|Lost to Follow-up|2|||
161899687|NCT00666211|584680986|FG001|Overall Study|Lost to Follow-up|0|||
161899688|NCT00666211|584680985|FG000|Overall Study|toxicity|0|||
161899689|NCT00666211|584680986|FG001|Overall Study|toxicity|2|||
161899690|NCT00666211|584680985|FG000|Overall Study|hospital admission|0|||
161899691|NCT00666211|584680986|FG001|Overall Study|hospital admission|5|||
161899692|NCT00666211|584680985|FG000|Overall Study|Death|0|||
161899693|NCT00666211|584680986|FG001|Overall Study|Death|2|||
161899694|NCT00666211|584680985|FG000|Overall Study|off tx for other complicating disease|0|||
161899695|NCT00666211|584680986|FG001|Overall Study|off tx for other complicating disease|1|||
161899696|NCT00666211|584680985|FG000|Overall Study|Physician Decision|0|||
161899697|NCT00666211|584680986|FG001|Overall Study|Physician Decision|1|||
161899698|NCT00003537|584680995|FG000|Overall Study|Not evalauable|1|||
161899699|NCT01001520|584680996|FG000|Medication Period 1|Withdrawal by Subject|2|||
161899700|NCT01001520|584680997|FG001|Medication Period 1|Withdrawal by Subject|2|||
161899701|NCT01001520|584680996|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
161899702|NCT01001520|584680997|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
161899703|NCT01001520|584680996|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
161899704|NCT01001520|584680997|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
161899705|NCT01001520|584680996|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
161899706|NCT01001520|584680997|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
161899707|NCT01001520|584680996|FG000|Washout Period|Withdrawal by Subject|2|||
161899708|NCT01001520|584680997|FG001|Washout Period|Withdrawal by Subject|1|||
161899709|NCT01001520|584680996|FG000|Medication Period 2|Withdrawal by Subject|0|||
161793922|NCT01261325|584289371|FG001|Overall Study|Erroneously Randomized|0|||
161793923|NCT01261325|584289372|FG002|Overall Study|Erroneously Randomized|0|||
161793924|NCT01261325|584289370|FG000|Overall Study|Screen Failure|1|||
161899710|NCT01001520|584680997|FG001|Medication Period 2|Withdrawal by Subject|3|||
161899711|NCT04668209|584680998|FG000|Overall Study|Withdrawal by Subject|2|||
161793925|NCT01261325|584289371|FG001|Overall Study|Screen Failure|0|||
161793926|NCT01261325|584289372|FG002|Overall Study|Screen Failure|0|||
161793927|NCT01261325|584289370|FG000|Overall Study|Randomized in Error|0|||
161793928|NCT01261325|584289371|FG001|Overall Study|Randomized in Error|0|||
161793929|NCT01261325|584289372|FG002|Overall Study|Randomized in Error|1|||
161793930|NCT01261325|584289370|FG000|Overall Study|Protocol Violation|0|||
161899712|NCT04668209|584680999|FG001|Overall Study|Withdrawal by Subject|2|||
161899713|NCT04668209|584680998|FG000|Overall Study|Lost to Follow-up|3|||
161899714|NCT04668209|584680999|FG001|Overall Study|Lost to Follow-up|4|||
161899715|NCT04668209|584680998|FG000|Overall Study|Subject Expired|2|||
161899716|NCT04668209|584680999|FG001|Overall Study|Subject Expired|0|||
161899717|NCT04668209|584680998|FG000|Overall Study|Withdrawn from study|0|||
161899718|NCT04668209|584680999|FG001|Overall Study|Withdrawn from study|1|||
161899719|NCT04668209|584680998|FG000|Overall Study|Adverse Event|0|||
161899720|NCT04668209|584680999|FG001|Overall Study|Adverse Event|1|||
161899721|NCT01004978|584681002|FG000|Overall Study|Disease progression|31|||
161899722|NCT01004978|584681003|FG001|Overall Study|Disease progression|48|||
161899723|NCT01004978|584681002|FG000|Overall Study|Adverse Event|42|||
161899724|NCT01004978|584681003|FG001|Overall Study|Adverse Event|22|||
161899725|NCT01004978|584681002|FG000|Overall Study|Death|3|||
161899726|NCT01004978|584681003|FG001|Overall Study|Death|2|||
161899727|NCT01004978|584681002|FG000|Overall Study|Withdrawal by Subject|16|||
161899728|NCT01004978|584681003|FG001|Overall Study|Withdrawal by Subject|16|||
161899729|NCT01004978|584681002|FG000|Overall Study|Alternative therapy|4|||
161899730|NCT01004978|584681003|FG001|Overall Study|Alternative therapy|8|||
161899731|NCT01004978|584681002|FG000|Overall Study|Physician Decision|6|||
161899732|NCT01004978|584681003|FG001|Overall Study|Physician Decision|3|||
161899733|NCT01004978|584681002|FG000|Overall Study|Other complicating disease|2|||
161899734|NCT01004978|584681003|FG001|Overall Study|Other complicating disease|2|||
161899735|NCT01004978|584681002|FG000|Overall Study|Protocol Violation|2|||
161899736|NCT01004978|584681003|FG001|Overall Study|Protocol Violation|3|||
161899737|NCT01004978|584681002|FG000|Overall Study|Non-compliance|3|||
161899738|NCT01004978|584681003|FG001|Overall Study|Non-compliance|2|||
161899739|NCT01004978|584681002|FG000|Overall Study|Ineligible|1|||
161899740|NCT01004978|584681003|FG001|Overall Study|Ineligible|0|||
161899741|NCT01004978|584681002|FG000|Overall Study|Unblinded|0|||
161899742|NCT01004978|584681003|FG001|Overall Study|Unblinded|1|||
161899743|NCT01004978|584681002|FG000|Overall Study|Performance status worsening|0|||
161899744|NCT01004978|584681003|FG001|Overall Study|Performance status worsening|1|||
161899745|NCT01004978|584681002|FG000|Overall Study|Never started treatment|8|||
161899746|NCT01004978|584681003|FG001|Overall Study|Never started treatment|9|||
161899747|NCT00369915|584681004|FG000|Overall Study|expected side effects|2|||
161899748|NCT00369915|584681005|FG001|Overall Study|expected side effects|1|||
161899749|NCT00369915|584681004|FG000|Overall Study|Withdrawal by Subject|4|||
161899750|NCT00369915|584681005|FG001|Overall Study|Withdrawal by Subject|1|||
161899751|NCT00369915|584681004|FG000|Overall Study|W/drawl by investigators|0|||
161899752|NCT00369915|584681005|FG001|Overall Study|W/drawl by investigators|1|||
161899753|NCT01719380|584681008|FG000|Overall Study|Adverse Event|0|||
161899754|NCT01719380|584681009|FG001|Overall Study|Adverse Event|0|||
161899755|NCT01719380|584681010|FG002|Overall Study|Adverse Event|1|||
161899756|NCT01719380|584681011|FG003|Overall Study|Adverse Event|2|||
161899757|NCT01719380|584681012|FG004|Overall Study|Adverse Event|0|||
161899758|NCT01719380|584681013|FG005|Overall Study|Adverse Event|1|||
161899759|NCT01719380|584681014|FG006|Overall Study|Adverse Event|0|||
161899760|NCT01719380|584681015|FG007|Overall Study|Adverse Event|1|||
161899761|NCT01719380|584681016|FG008|Overall Study|Adverse Event|4|||
161899762|NCT01719380|584681017|FG009|Overall Study|Adverse Event|3|||
161899763|NCT01719380|584681008|FG000|Overall Study|Death|0|||
161899764|NCT01719380|584681009|FG001|Overall Study|Death|1|||
161899765|NCT01719380|584681010|FG002|Overall Study|Death|0|||
161899766|NCT01719380|584681011|FG003|Overall Study|Death|0|||
161899767|NCT01719380|584681012|FG004|Overall Study|Death|0|||
161899768|NCT01719380|584681013|FG005|Overall Study|Death|0|||
161899769|NCT01719380|584681014|FG006|Overall Study|Death|0|||
161899770|NCT01719380|584681015|FG007|Overall Study|Death|0|||
161899771|NCT01719380|584681016|FG008|Overall Study|Death|3|||
161899772|NCT01719380|584681017|FG009|Overall Study|Death|3|||
161899773|NCT01719380|584681008|FG000|Overall Study|Participant/Guardian Decision|0|||
161899774|NCT01719380|584681009|FG001|Overall Study|Participant/Guardian Decision|0|||
161899775|NCT01719380|584681010|FG002|Overall Study|Participant/Guardian Decision|1|||
161899776|NCT01719380|584681011|FG003|Overall Study|Participant/Guardian Decision|0|||
161899777|NCT01719380|584681012|FG004|Overall Study|Participant/Guardian Decision|0|||
161899778|NCT01719380|584681013|FG005|Overall Study|Participant/Guardian Decision|0|||
161899779|NCT01719380|584681014|FG006|Overall Study|Participant/Guardian Decision|0|||
161899780|NCT01719380|584681015|FG007|Overall Study|Participant/Guardian Decision|0|||
161899781|NCT01719380|584681016|FG008|Overall Study|Participant/Guardian Decision|2|||
161899782|NCT01719380|584681017|FG009|Overall Study|Participant/Guardian Decision|2|||
161899783|NCT01719380|584681008|FG000|Overall Study|Physician Decision|0|||
161899784|NCT01719380|584681009|FG001|Overall Study|Physician Decision|0|||
161899785|NCT01719380|584681010|FG002|Overall Study|Physician Decision|2|||
161899786|NCT01719380|584681011|FG003|Overall Study|Physician Decision|0|||
161899787|NCT01719380|584681012|FG004|Overall Study|Physician Decision|0|||
161899788|NCT01719380|584681013|FG005|Overall Study|Physician Decision|0|||
161899789|NCT01719380|584681014|FG006|Overall Study|Physician Decision|0|||
161899790|NCT01719380|584681015|FG007|Overall Study|Physician Decision|0|||
161899791|NCT01719380|584681016|FG008|Overall Study|Physician Decision|1|||
161899792|NCT01719380|584681017|FG009|Overall Study|Physician Decision|1|||
161899793|NCT01719380|584681008|FG000|Overall Study|Lack of Efficacy|2|||
161899794|NCT01719380|584681009|FG001|Overall Study|Lack of Efficacy|6|||
161899795|NCT01719380|584681010|FG002|Overall Study|Lack of Efficacy|5|||
161899796|NCT01719380|584681011|FG003|Overall Study|Lack of Efficacy|6|||
161899797|NCT01719380|584681012|FG004|Overall Study|Lack of Efficacy|3|||
161899798|NCT01719380|584681013|FG005|Overall Study|Lack of Efficacy|7|||
161899799|NCT01719380|584681014|FG006|Overall Study|Lack of Efficacy|10|||
161899800|NCT01719380|584681015|FG007|Overall Study|Lack of Efficacy|6|||
161899801|NCT01719380|584681016|FG008|Overall Study|Lack of Efficacy|39|||
161899802|NCT01719380|584681017|FG009|Overall Study|Lack of Efficacy|42|||
161899803|NCT01719380|584681008|FG000|Overall Study|Progressive Disease|0|||
161899804|NCT01719380|584681009|FG001|Overall Study|Progressive Disease|0|||
161899805|NCT01719380|584681010|FG002|Overall Study|Progressive Disease|0|||
161899806|NCT01719380|584681011|FG003|Overall Study|Progressive Disease|0|||
161899807|NCT01719380|584681012|FG004|Overall Study|Progressive Disease|0|||
161899808|NCT01719380|584681013|FG005|Overall Study|Progressive Disease|0|||
161899809|NCT01719380|584681014|FG006|Overall Study|Progressive Disease|0|||
161899810|NCT01719380|584681015|FG007|Overall Study|Progressive Disease|0|||
161899811|NCT01719380|584681016|FG008|Overall Study|Progressive Disease|1|||
161899812|NCT01719380|584681017|FG009|Overall Study|Progressive Disease|0|||
161899813|NCT01096160|584681020|FG000|Overall Study|Adverse Event|0|||
161899814|NCT01096160|584681021|FG001|Overall Study|Adverse Event|0|||
161899815|NCT01096160|584681022|FG002|Overall Study|Adverse Event|1|||
161899816|NCT01096160|584681023|FG003|Overall Study|Adverse Event|0|||
161899817|NCT01096160|584681024|FG004|Overall Study|Adverse Event|0|||
161899818|NCT01096160|584681025|FG005|Overall Study|Adverse Event|0|||
161899819|NCT01096160|584681026|FG006|Overall Study|Adverse Event|0|||
161899820|NCT01096160|584681027|FG007|Overall Study|Adverse Event|0|||
161899821|NCT01096160|584681028|FG008|Overall Study|Adverse Event|0|||
161899822|NCT01096160|584681029|FG009|Overall Study|Adverse Event|1|||
161899823|NCT01096160|584681020|FG000|Overall Study|Met stopping criteria per protocol|0|||
161899824|NCT01096160|584681021|FG001|Overall Study|Met stopping criteria per protocol|0|||
161899825|NCT01096160|584681022|FG002|Overall Study|Met stopping criteria per protocol|0|||
161899826|NCT01096160|584681023|FG003|Overall Study|Met stopping criteria per protocol|0|||
161899827|NCT01096160|584681024|FG004|Overall Study|Met stopping criteria per protocol|1|||
161899828|NCT01096160|584681025|FG005|Overall Study|Met stopping criteria per protocol|0|||
161899829|NCT01096160|584681026|FG006|Overall Study|Met stopping criteria per protocol|2|||
161899830|NCT01096160|584681027|FG007|Overall Study|Met stopping criteria per protocol|0|||
161899831|NCT01096160|584681028|FG008|Overall Study|Met stopping criteria per protocol|2|||
161899832|NCT01096160|584681029|FG009|Overall Study|Met stopping criteria per protocol|0|||
161899833|NCT02028507|584681030|FG000|Overall Study|Progressive Disease|122|||
161899834|NCT02028507|584681031|FG001|Overall Study|Progressive Disease|90|||
161899835|NCT02028507|584681032|FG002|Overall Study|Progressive Disease|102|||
161899836|NCT02028507|584681033|FG003|Overall Study|Progressive Disease|89|||
161899837|NCT02028507|584681030|FG000|Overall Study|Adverse Event|8|||
161899838|NCT02028507|584681031|FG001|Overall Study|Adverse Event|25|||
161899839|NCT02028507|584681032|FG002|Overall Study|Adverse Event|3|||
161899840|NCT02028507|584681033|FG003|Overall Study|Adverse Event|16|||
161445852|NCT01485172|583026150|FG004|Overall Study|Protocol defined stopping criteria|1|||
161445853|NCT01485172|583026151|FG005|Overall Study|Protocol defined stopping criteria|0|||
161445854|NCT01485172|583026146|FG000|Overall Study|Lost to Follow-up|0|||
161445855|NCT01485172|583026147|FG001|Overall Study|Lost to Follow-up|0|||
161445856|NCT01485172|583026148|FG002|Overall Study|Lost to Follow-up|1|||
161445857|NCT01485172|583026149|FG003|Overall Study|Lost to Follow-up|0|||
161445858|NCT01485172|583026150|FG004|Overall Study|Lost to Follow-up|0|||
161445859|NCT01485172|583026151|FG005|Overall Study|Lost to Follow-up|1|||
161445860|NCT01485172|583026146|FG000|Overall Study|Physician Decision|0|||
161445861|NCT01485172|583026147|FG001|Overall Study|Physician Decision|0|||
161445862|NCT01485172|583026148|FG002|Overall Study|Physician Decision|0|||
161445863|NCT01485172|583026149|FG003|Overall Study|Physician Decision|0|||
161445864|NCT01485172|583026150|FG004|Overall Study|Physician Decision|1|||
161445865|NCT01485172|583026151|FG005|Overall Study|Physician Decision|0|||
161445866|NCT01485172|583026146|FG000|Overall Study|Withdrawal by Subject|2|||
161445867|NCT01485172|583026147|FG001|Overall Study|Withdrawal by Subject|0|||
161899841|NCT02028507|584681030|FG000|Overall Study|Withdrawal by Subject|6|||
161445868|NCT01485172|583026148|FG002|Overall Study|Withdrawal by Subject|0|||
161899842|NCT02028507|584681031|FG001|Overall Study|Withdrawal by Subject|8|||
161899843|NCT02028507|584681032|FG002|Overall Study|Withdrawal by Subject|5|||
161899844|NCT02028507|584681033|FG003|Overall Study|Withdrawal by Subject|9|||
161899845|NCT02028507|584681030|FG000|Overall Study|Protocol Violation|2|||
161899846|NCT02028507|584681031|FG001|Overall Study|Protocol Violation|4|||
161899847|NCT02028507|584681032|FG002|Overall Study|Protocol Violation|1|||
161899848|NCT02028507|584681033|FG003|Overall Study|Protocol Violation|3|||
161899849|NCT02028507|584681030|FG000|Overall Study|Physician Decision|0|||
161899850|NCT02028507|584681031|FG001|Overall Study|Physician Decision|4|||
161899851|NCT02028507|584681032|FG002|Overall Study|Physician Decision|0|||
161445869|NCT01485172|583026149|FG003|Overall Study|Withdrawal by Subject|1|||
161899852|NCT02028507|584681033|FG003|Overall Study|Physician Decision|0|||
161899853|NCT02028507|584681030|FG000|Overall Study|Death|1|||
161899854|NCT02028507|584681031|FG001|Overall Study|Death|0|||
161899855|NCT02028507|584681032|FG002|Overall Study|Death|1|||
161899856|NCT02028507|584681033|FG003|Overall Study|Death|3|||
161899857|NCT02028507|584681030|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
161899858|NCT02028507|584681031|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
161899859|NCT02028507|584681032|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
161899860|NCT02028507|584681033|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
161899861|NCT02028507|584681030|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
161899862|NCT02028507|584681031|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
161899863|NCT02028507|584681032|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
161899864|NCT02028507|584681033|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
161899865|NCT02028507|584681030|FG000|Overall Study|Randomized But Not Treated|3|||
161899866|NCT02028507|584681031|FG001|Overall Study|Randomized But Not Treated|6|||
161899867|NCT02028507|584681032|FG002|Overall Study|Randomized But Not Treated|0|||
161899868|NCT02028507|584681033|FG003|Overall Study|Randomized But Not Treated|4|||
161793931|NCT01261325|584289371|FG001|Overall Study|Protocol Violation|3|||
161793932|NCT01261325|584289372|FG002|Overall Study|Protocol Violation|1|||
161793933|NCT01261325|584289370|FG000|Overall Study|Lost to Follow-up|0|||
161793934|NCT01261325|584289371|FG001|Overall Study|Lost to Follow-up|1|||
161793935|NCT01261325|584289372|FG002|Overall Study|Lost to Follow-up|3|||
161793936|NCT01261325|584289370|FG000|Overall Study|AE, serious fatal|0|||
161793937|NCT01261325|584289371|FG001|Overall Study|AE, serious fatal|0|||
161793938|NCT01261325|584289372|FG002|Overall Study|AE, serious fatal|2|||
161793939|NCT00543439|584289373|FG000|Period 1|Adverse Event|0|||
161793940|NCT00543439|584289374|FG001|Period 1|Adverse Event|2|||
161793941|NCT00543439|584289375|FG002|Period 1|Adverse Event|1|||
161793942|NCT00543439|584289373|FG000|Period 1|Withdrawal by Subject|1|||
161793943|NCT00543439|584289374|FG001|Period 1|Withdrawal by Subject|1|||
161793944|NCT00543439|584289375|FG002|Period 1|Withdrawal by Subject|0|||
161793945|NCT00543439|584289373|FG000|Period 1|Physician Decision|0|||
161793946|NCT00543439|584289374|FG001|Period 1|Physician Decision|0|||
161793947|NCT00543439|584289375|FG002|Period 1|Physician Decision|1|||
161793948|NCT00543439|584289373|FG000|Period 2|Protocol Violation|1|||
161793949|NCT00543439|584289374|FG001|Period 2|Protocol Violation|0|||
161793950|NCT00543439|584289375|FG002|Period 2|Protocol Violation|1|||
161793951|NCT00543439|584289373|FG000|Period 2|Adverse Event|0|||
161793952|NCT00543439|584289374|FG001|Period 2|Adverse Event|1|||
161793953|NCT00543439|584289375|FG002|Period 2|Adverse Event|1|||
161793954|NCT01211769|584289378|FG000|Overall Study|Lost to Follow-up|7|||
161793955|NCT01211769|584289379|FG001|Overall Study|Lost to Follow-up|9|||
161793956|NCT01211769|584289380|FG002|Overall Study|Lost to Follow-up|5|||
161793957|NCT01211769|584289381|FG003|Overall Study|Lost to Follow-up|9|||
161793958|NCT01211769|584289378|FG000|Overall Study|Physician Decision|2|||
161793959|NCT01211769|584289379|FG001|Overall Study|Physician Decision|0|||
161793960|NCT01211769|584289380|FG002|Overall Study|Physician Decision|2|||
161793961|NCT01211769|584289381|FG003|Overall Study|Physician Decision|1|||
161793962|NCT01211769|584289378|FG000|Overall Study|Adverse Event|0|||
161793963|NCT01211769|584289379|FG001|Overall Study|Adverse Event|1|||
161793964|NCT01211769|584289380|FG002|Overall Study|Adverse Event|1|||
161899869|NCT02028507|584681030|FG000|Overall Study|Enzyme defect|0|||
161899870|NCT02028507|584681031|FG001|Overall Study|Enzyme defect|0|||
161899871|NCT02028507|584681032|FG002|Overall Study|Enzyme defect|0|||
161899872|NCT02028507|584681033|FG003|Overall Study|Enzyme defect|1|||
161899873|NCT02028507|584681030|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161899874|NCT02028507|584681031|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161899875|NCT02028507|584681032|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161899876|NCT02028507|584681033|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
161445870|NCT01485172|583026150|FG004|Overall Study|Withdrawal by Subject|1|||
161793965|NCT01211769|584289381|FG003|Overall Study|Adverse Event|1|||
161793966|NCT00146770|584289386|FG000|Overall Study|Adverse Event|2|||
161793967|NCT00146770|584289387|FG001|Overall Study|Adverse Event|0|||
161793968|NCT00146770|584289386|FG000|Overall Study|Pregnancy|1|||
161793969|NCT00146770|584289387|FG001|Overall Study|Pregnancy|0|||
161793970|NCT00146770|584289386|FG000|Overall Study|Withdrawal by Subject|2|||
161793971|NCT00146770|584289387|FG001|Overall Study|Withdrawal by Subject|0|||
161793972|NCT02826603|584289390|FG000|Overall Study|Adverse Event|17|||
161793973|NCT02826603|584289391|FG001|Overall Study|Adverse Event|9|||
161793974|NCT02826603|584289390|FG000|Overall Study|Lack of Efficacy|4|||
161793975|NCT02826603|584289391|FG001|Overall Study|Lack of Efficacy|9|||
161899877|NCT02028507|584681030|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
161899878|NCT02028507|584681031|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
161793976|NCT02826603|584289390|FG000|Overall Study|Lost to Follow-up|13|||
161793977|NCT02826603|584289391|FG001|Overall Study|Lost to Follow-up|12|||
161793978|NCT02826603|584289390|FG000|Overall Study|Noncompliance with treatment|0|||
161793979|NCT02826603|584289391|FG001|Overall Study|Noncompliance with treatment|2|||
161793980|NCT02826603|584289390|FG000|Overall Study|Physician Decision|1|||
161445871|NCT01485172|583026151|FG005|Overall Study|Withdrawal by Subject|1|||
161793981|NCT02826603|584289391|FG001|Overall Study|Physician Decision|7|||
161793982|NCT02826603|584289390|FG000|Overall Study|Pregnancy|1|||
161793983|NCT02826603|584289391|FG001|Overall Study|Pregnancy|2|||
161793984|NCT02826603|584289390|FG000|Overall Study|Protocol Violation|3|||
161793985|NCT02826603|584289391|FG001|Overall Study|Protocol Violation|3|||
161793986|NCT02826603|584289390|FG000|Overall Study|Withdrawal by Subject|20|||
161793987|NCT02826603|584289391|FG001|Overall Study|Withdrawal by Subject|19|||
161793988|NCT02826603|584289390|FG000|Overall Study|Death|2|||
161793989|NCT02826603|584289391|FG001|Overall Study|Death|0|||
161793990|NCT02826603|584289390|FG000|Overall Study|New therapy for study indication|0|||
161793991|NCT02826603|584289391|FG001|Overall Study|New therapy for study indication|1|||
161793992|NCT02668302|584289392|FG000|Overall Study|Withdrawal by Subject|1|||
161793993|NCT02668302|584289393|FG001|Overall Study|Withdrawal by Subject|0|||
161793994|NCT03558997|584289394|FG000|Overall Study|Adverse Event|0|||
161793995|NCT03558997|584289395|FG001|Overall Study|Adverse Event|2|||
161793996|NCT03558997|584289396|FG002|Overall Study|Adverse Event|5|||
161793997|NCT03558997|584289397|FG003|Overall Study|Adverse Event|1|||
161793998|NCT03558997|584289394|FG000|Overall Study|Physician Decision|0|||
161445872|NCT01587014|583026152|FG000|Overall Study|Death|2|||
161445873|NCT01409811|583026153|FG000|Overall Study|Insurance denial|1|||
161445874|NCT00838513|583026154|FG000|Screening Period|Screen Failure|3|||
161445875|NCT00838513|583026154|FG000|Extension Treatment Period|Death|1|||
161445876|NCT00838513|583026154|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
161445877|NCT00975780|583026160|FG000|Follow Up|Death|88|||
161445878|NCT00975780|583026161|FG001|Follow Up|Death|122|||
161445879|NCT00975780|583026160|FG000|Follow Up|Facility Withdrawal|7|||
161445880|NCT00975780|583026161|FG001|Follow Up|Facility Withdrawal|23|||
161445881|NCT00975780|583026160|FG000|Follow Up|Discharged from Facility|7|||
161445882|NCT00975780|583026161|FG001|Follow Up|Discharged from Facility|12|||
161445883|NCT00441064|583026162|FG000|Overall Study|Adverse Event|1|||
161445884|NCT00441064|583026163|FG001|Overall Study|Adverse Event|0|||
161445885|NCT00441064|583026162|FG000|Overall Study|Abnormal laboratory values|0|||
161445886|NCT00441064|583026163|FG001|Overall Study|Abnormal laboratory values|2|||
161445887|NCT00441064|583026162|FG000|Overall Study|Abnormal test procedure results|0|||
161445888|NCT00441064|583026163|FG001|Overall Study|Abnormal test procedure results|1|||
161445889|NCT00441064|583026162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161445890|NCT00441064|583026163|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161445891|NCT00441064|583026162|FG000|Overall Study|Protocol Deviation|3|||
161445892|NCT00441064|583026163|FG001|Overall Study|Protocol Deviation|2|||
161445893|NCT00441064|583026162|FG000|Overall Study|Patient withdrew consent|5|||
161445894|NCT00441064|583026163|FG001|Overall Study|Patient withdrew consent|2|||
161445895|NCT03051178|583026164|FG000|Overall Study|Withdrawal by Subject|5|||
161445896|NCT00953056|583026165|FG000|Overall Study|Withdrew Consent|0|||
161445897|NCT00953056|583026166|FG001|Overall Study|Withdrew Consent|0|||
161445898|NCT00953056|583026167|FG002|Overall Study|Withdrew Consent|0|||
161793999|NCT03558997|584289395|FG001|Overall Study|Physician Decision|0|||
161794000|NCT03558997|584289396|FG002|Overall Study|Physician Decision|1|||
161794001|NCT03558997|584289397|FG003|Overall Study|Physician Decision|0|||
161794002|NCT03558997|584289394|FG000|Overall Study|Withdrawal by Subject|1|||
161794003|NCT03558997|584289395|FG001|Overall Study|Withdrawal by Subject|0|||
161794004|NCT03558997|584289396|FG002|Overall Study|Withdrawal by Subject|1|||
161794005|NCT03558997|584289397|FG003|Overall Study|Withdrawal by Subject|1|||
161794006|NCT03558997|584289394|FG000|Overall Study|Lost to Follow-up|0|||
161794007|NCT03558997|584289395|FG001|Overall Study|Lost to Follow-up|0|||
161794008|NCT03558997|584289396|FG002|Overall Study|Lost to Follow-up|1|||
161794009|NCT03558997|584289397|FG003|Overall Study|Lost to Follow-up|0|||
161794010|NCT00526890|584289401|FG000|Overall Study|Adverse Event|2|||
161794011|NCT04128696|584289402|FG000|Overall Study|Lost to Follow-up|3|||
161794012|NCT04128696|584289403|FG001|Overall Study|Lost to Follow-up|7|||
161794013|NCT04128696|584289402|FG000|Overall Study|Withdrawal by Subject|12|||
161794014|NCT04128696|584289403|FG001|Overall Study|Withdrawal by Subject|11|||
161794015|NCT04128696|584289402|FG000|Overall Study|Study Closed/Terminated|26|||
161794016|NCT04128696|584289403|FG001|Overall Study|Study Closed/Terminated|38|||
161794017|NCT04128696|584289402|FG000|Overall Study|Physician Decision|2|||
161794018|NCT04128696|584289403|FG001|Overall Study|Physician Decision|3|||
161794019|NCT03280537|584289408|FG000|Overall Study|Withdrawal by Subject|2|||
161794020|NCT03280537|584289409|FG001|Overall Study|Withdrawal by Subject|4|||
161794021|NCT01588106|584289410|FG000|Overall Study|Withdrawal by Subject|5|||
161794022|NCT01588106|584289411|FG001|Overall Study|Withdrawal by Subject|4|||
161445899|NCT00953056|583026168|FG003|Overall Study|Withdrew Consent|0|||
161445900|NCT00953056|583026169|FG004|Overall Study|Withdrew Consent|2|||
161445901|NCT00953056|583026170|FG005|Overall Study|Withdrew Consent|3|||
161445902|NCT00953056|583026165|FG000|Overall Study|Serious Adverse Event|0|||
161794023|NCT03083132|584289412|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
161794024|NCT03083132|584289413|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
161445903|NCT00953056|583026166|FG001|Overall Study|Serious Adverse Event|0|||
161445904|NCT00953056|583026167|FG002|Overall Study|Serious Adverse Event|0|||
161445905|NCT00953056|583026168|FG003|Overall Study|Serious Adverse Event|0|||
161445906|NCT00953056|583026169|FG004|Overall Study|Serious Adverse Event|0|||
161445907|NCT00953056|583026170|FG005|Overall Study|Serious Adverse Event|1|||
161445908|NCT03962504|583026171|FG000|Overall Study|Other|11|||
161445909|NCT03962504|583026172|FG001|Overall Study|Other|32|||
161445910|NCT02813577|583026173|FG000|Overall Study|Study terminated|4|||
161445911|NCT01976741|583026174|FG000|Overall Study|Withdrawal by Subject|1|||
161445912|NCT01976741|583026175|FG001|Overall Study|Withdrawal by Subject|0|||
161445913|NCT01976741|583026176|FG002|Overall Study|Withdrawal by Subject|1|||
161445914|NCT01976741|583026177|FG003|Overall Study|Withdrawal by Subject|1|||
161794025|NCT03083132|584289412|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
161794026|NCT03083132|584289413|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
161794027|NCT03083132|584289412|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
161794028|NCT03083132|584289413|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
161794029|NCT03118739|584289414|FG000|Overall Study|Physician Decision|0|||
161794030|NCT03118739|584289415|FG001|Overall Study|Physician Decision|1|||
161794031|NCT03118739|584289414|FG000|Overall Study|Withdrawal by Subject|5|||
161794032|NCT03118739|584289415|FG001|Overall Study|Withdrawal by Subject|3|||
161794033|NCT03118739|584289414|FG000|Overall Study|Lost to Follow-up|2|||
161794034|NCT03118739|584289415|FG001|Overall Study|Lost to Follow-up|0|||
161794035|NCT02995837|584289416|FG000|Overall Study|Lost to Follow-up|9|||
161794036|NCT02995837|584289417|FG001|Overall Study|Lost to Follow-up|8|||
161794037|NCT01859702|584289418|FG000|Overall Study|Protocol deviation|3|||
161794038|NCT01859702|584289418|FG000|Overall Study|Adverse Event|2|||
161794039|NCT01893138|584289419|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161794040|NCT01893138|584289420|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161794041|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
161794042|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
161794043|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
161794044|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
161794045|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
161794046|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
161794047|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Adverse Event|1|||
161794048|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Adverse Event|0|||
161794049|NCT01326026|584289421|FG000|Overall Study|Adverse Event|4|||
161794050|NCT01326026|584289422|FG001|Overall Study|Adverse Event|3|||
161794051|NCT01326026|584289421|FG000|Overall Study|Withdrawal Criteria|5|||
161794052|NCT01326026|584289422|FG001|Overall Study|Withdrawal Criteria|7|||
161794053|NCT01326026|584289421|FG000|Overall Study|Other|3|||
161794054|NCT01326026|584289422|FG001|Overall Study|Other|3|||
161794055|NCT04567615|584289426|FG000|Randomization|Participant withdrew consent|1|||
161794056|NCT04567615|584289427|FG001|Randomization|Participant withdrew consent|0|||
161794057|NCT04567615|584289428|FG002|Randomization|Participant withdrew consent|0|||
161794058|NCT04567615|584289426|FG000|Randomization|Adverse event unrelated to study drug|0|||
161794059|NCT04567615|584289427|FG001|Randomization|Adverse event unrelated to study drug|1|||
161794060|NCT04567615|584289428|FG002|Randomization|Adverse event unrelated to study drug|0|||
161794061|NCT04567615|584289426|FG000|Treatment Period|Participant Withdrew Consent|2|||
161794062|NCT04567615|584289427|FG001|Treatment Period|Participant Withdrew Consent|5|||
161794063|NCT04567615|584289428|FG002|Treatment Period|Participant Withdrew Consent|1|||
161794064|NCT04567615|584289426|FG000|Treatment Period|Death|1|||
161794065|NCT04567615|584289427|FG001|Treatment Period|Death|2|||
161794066|NCT04567615|584289428|FG002|Treatment Period|Death|0|||
161794067|NCT04567615|584289426|FG000|Treatment Period|Lost to Follow-up|0|||
161794068|NCT04567615|584289427|FG001|Treatment Period|Lost to Follow-up|1|||
161794069|NCT04567615|584289428|FG002|Treatment Period|Lost to Follow-up|0|||
161794070|NCT04567615|584289426|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161794071|NCT04567615|584289427|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161794072|NCT04567615|584289428|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161794073|NCT04567615|584289426|FG000|Treatment Period|Disease Progression|85|||
161794074|NCT04567615|584289427|FG001|Treatment Period|Disease Progression|63|||
161794075|NCT04567615|584289428|FG002|Treatment Period|Disease Progression|16|||
161794076|NCT04567615|584289426|FG000|Treatment Period|Study Drug Toxicity|3|||
161794077|NCT04567615|584289427|FG001|Treatment Period|Study Drug Toxicity|10|||
161794078|NCT04567615|584289428|FG002|Treatment Period|Study Drug Toxicity|4|||
161794079|NCT04567615|584289426|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
161445915|NCT01976741|583026178|FG004|Overall Study|Withdrawal by Subject|0|||
161794080|NCT04567615|584289427|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
161794081|NCT04567615|584289428|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
161794082|NCT04567615|584289426|FG000|Treatment Period|Other Reasons|1|||
161794083|NCT04567615|584289427|FG001|Treatment Period|Other Reasons|2|||
161794084|NCT04567615|584289428|FG002|Treatment Period|Other Reasons|0|||
161794085|NCT04567615|584289426|FG000|Treatment Period|Still On-going Treatment|21|||
161794086|NCT04567615|584289427|FG001|Treatment Period|Still On-going Treatment|22|||
161445916|NCT01976741|583026179|FG005|Overall Study|Withdrawal by Subject|0|||
161794087|NCT04567615|584289428|FG002|Treatment Period|Still On-going Treatment|2|||
161794088|NCT04317053|584289429|FG000|Overall Study|Withdrawn (screen failure)|4|||
161794089|NCT04317053|584289430|FG001|Overall Study|Withdrawn (screen failure)|2|||
161794090|NCT01022112|584289431|FG000|Overall Study|Adverse Event|1|||
161794091|NCT01022112|584289432|FG001|Overall Study|Adverse Event|2|||
161794092|NCT01022112|584289433|FG002|Overall Study|Adverse Event|0|||
161794093|NCT01022112|584289434|FG003|Overall Study|Adverse Event|1|||
161794094|NCT01022112|584289435|FG004|Overall Study|Adverse Event|0|||
161794095|NCT01022112|584289431|FG000|Overall Study|Lack of Efficacy|1|||
161794096|NCT01022112|584289432|FG001|Overall Study|Lack of Efficacy|0|||
161794097|NCT01022112|584289433|FG002|Overall Study|Lack of Efficacy|0|||
161794098|NCT01022112|584289434|FG003|Overall Study|Lack of Efficacy|0|||
161794099|NCT01022112|584289435|FG004|Overall Study|Lack of Efficacy|1|||
161794100|NCT01022112|584289431|FG000|Overall Study|Physician Decision|0|||
161794101|NCT01022112|584289432|FG001|Overall Study|Physician Decision|0|||
161794102|NCT01022112|584289433|FG002|Overall Study|Physician Decision|1|||
161794103|NCT01022112|584289434|FG003|Overall Study|Physician Decision|0|||
161794104|NCT01022112|584289435|FG004|Overall Study|Physician Decision|1|||
161794105|NCT01022112|584289431|FG000|Overall Study|Withdrawal by Subject|0|||
161794106|NCT01022112|584289432|FG001|Overall Study|Withdrawal by Subject|1|||
161794107|NCT01022112|584289433|FG002|Overall Study|Withdrawal by Subject|2|||
161794108|NCT01022112|584289434|FG003|Overall Study|Withdrawal by Subject|2|||
161794109|NCT01022112|584289435|FG004|Overall Study|Withdrawal by Subject|1|||
161794110|NCT01022112|584289431|FG000|Overall Study|Fasting plasma glucose level increased|1|||
161794111|NCT01022112|584289432|FG001|Overall Study|Fasting plasma glucose level increased|0|||
161794112|NCT01022112|584289433|FG002|Overall Study|Fasting plasma glucose level increased|0|||
161794113|NCT01022112|584289434|FG003|Overall Study|Fasting plasma glucose level increased|0|||
161794114|NCT01022112|584289435|FG004|Overall Study|Fasting plasma glucose level increased|7|||
161794115|NCT00289458|584289436|FG000|Overall Study|Death|1|||
161794116|NCT00289458|584289437|FG001|Overall Study|Death|0|||
161794117|NCT00289458|584289438|FG002|Overall Study|Death|0|||
161794118|NCT00289458|584289436|FG000|Overall Study|Physician Decision|3|||
161794119|NCT00289458|584289437|FG001|Overall Study|Physician Decision|4|||
161794120|NCT00289458|584289438|FG002|Overall Study|Physician Decision|2|||
161794121|NCT00289458|584289436|FG000|Overall Study|Withdrawal by Subject|2|||
161794122|NCT00289458|584289437|FG001|Overall Study|Withdrawal by Subject|2|||
161794123|NCT00289458|584289438|FG002|Overall Study|Withdrawal by Subject|4|||
161794124|NCT04274192|584289439|FG000|Overall Study|Protocol Violation|1|||
161794125|NCT04274192|584289440|FG001|Overall Study|Protocol Violation|0|||
161794126|NCT07174544|584289441|FG000|Overall Study|Lost to Follow-up|43|||
161794127|NCT07174544|584289442|FG001|Overall Study|Lost to Follow-up|15|||
161794128|NCT03419234|584289443|FG000|Overall Study|Disease progression|37|||
161794129|NCT03419234|584289444|FG001|Overall Study|Disease progression|36|||
161794130|NCT03419234|584289443|FG000|Overall Study|Adverse Event|6|||
161794131|NCT03419234|584289444|FG001|Overall Study|Adverse Event|9|||
161794132|NCT03419234|584289443|FG000|Overall Study|Withdrawal by Subject|9|||
161445917|NCT01976741|583026180|FG006|Overall Study|Withdrawal by Subject|1|||
161445918|NCT01976741|583026181|FG007|Overall Study|Withdrawal by Subject|4|||
161445919|NCT01976741|583026182|FG008|Overall Study|Withdrawal by Subject|0|||
161445920|NCT01976741|583026183|FG009|Overall Study|Withdrawal by Subject|0|||
161445921|NCT01976741|583026174|FG000|Overall Study|Adverse Event|0|||
161445922|NCT01976741|583026175|FG001|Overall Study|Adverse Event|0|||
161445923|NCT01976741|583026176|FG002|Overall Study|Adverse Event|2|||
161445924|NCT01976741|583026177|FG003|Overall Study|Adverse Event|0|||
161445925|NCT01976741|583026178|FG004|Overall Study|Adverse Event|0|||
161445926|NCT01976741|583026179|FG005|Overall Study|Adverse Event|0|||
161445927|NCT01976741|583026180|FG006|Overall Study|Adverse Event|3|||
161445928|NCT01976741|583026181|FG007|Overall Study|Adverse Event|8|||
161445929|NCT01976741|583026182|FG008|Overall Study|Adverse Event|1|||
161445930|NCT01976741|583026183|FG009|Overall Study|Adverse Event|4|||
161445931|NCT03566485|583026194|FG000|Overall Study|Disease progression|5|||
161445932|NCT03566485|583026195|FG001|Overall Study|Disease progression|4|||
161445933|NCT03566485|583026194|FG000|Overall Study|Clinical progression|0|||
161445934|NCT03566485|583026195|FG001|Overall Study|Clinical progression|1|||
161794133|NCT03419234|584289444|FG001|Overall Study|Withdrawal by Subject|7|||
161794134|NCT03419234|584289443|FG000|Overall Study|Death|5|||
161794135|NCT03419234|584289444|FG001|Overall Study|Death|1|||
161794136|NCT03419234|584289443|FG000|Overall Study|Alternative therapy|4|||
161794137|NCT03419234|584289444|FG001|Overall Study|Alternative therapy|2|||
161794138|NCT03419234|584289443|FG000|Overall Study|PSA progression|8|||
161794139|NCT03419234|584289444|FG001|Overall Study|PSA progression|10|||
161794140|NCT03419234|584289443|FG000|Overall Study|Rising PSA and bone issues|3|||
161794141|NCT03419234|584289444|FG001|Overall Study|Rising PSA and bone issues|2|||
161794142|NCT03419234|584289443|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
161445935|NCT03566485|583026194|FG000|Overall Study|Toxicity|0|||
161445936|NCT03566485|583026195|FG001|Overall Study|Toxicity|2|||
161445937|NCT00048074|583026196|FG000|Overall Study|Adverse Event|46|||
161445938|NCT00048074|583026197|FG001|Overall Study|Adverse Event|41|||
161899879|NCT02028507|584681032|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
161899880|NCT02028507|584681033|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
161899881|NCT03361306|584681034|FG000|Overall Study|Death|6|||
161899882|NCT01556932|584681035|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
161899883|NCT01556932|584681036|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
161899884|NCT02105285|584681041|FG000|Overall Study|Adverse Event|1|||
161899885|NCT02105285|584681042|FG001|Overall Study|Adverse Event|1|||
161899886|NCT02105285|584681043|FG002|Overall Study|Adverse Event|0|||
161899887|NCT02105285|584681041|FG000|Overall Study|Protocol Violation|0|||
161899888|NCT02105285|584681042|FG001|Overall Study|Protocol Violation|1|||
161899889|NCT02105285|584681043|FG002|Overall Study|Protocol Violation|0|||
161899890|NCT02105285|584681041|FG000|Overall Study|Withdrawal by Subject|1|||
161899891|NCT02105285|584681042|FG001|Overall Study|Withdrawal by Subject|0|||
161899892|NCT02105285|584681043|FG002|Overall Study|Withdrawal by Subject|0|||
161899893|NCT01421641|584681044|FG000|Overall Study|Protocol Violation|2|||
161899894|NCT01421641|584681045|FG001|Overall Study|Protocol Violation|2|||
161899895|NCT02420119|584681046|FG000|Overall Study|insufficient laboratory data|5|||
161899896|NCT01502033|584681047|FG000|Overall Study|1 participant had scalp discomfort|1|||
161899897|NCT01502033|584681047|FG000|Overall Study|1 participant had worsening depression|1|||
161899898|NCT01502033|584681047|FG000|Overall Study|1 participant went back to school|1|||
161899899|NCT02983045|584681048|FG000|Overall Study|Withdrawal by Subject|0|||
161899900|NCT02983045|584681049|FG001|Overall Study|Withdrawal by Subject|1|||
161899901|NCT02983045|584681050|FG002|Overall Study|Withdrawal by Subject|0|||
161899902|NCT02983045|584681051|FG003|Overall Study|Withdrawal by Subject|5|||
161899903|NCT02983045|584681052|FG004|Overall Study|Withdrawal by Subject|0|||
161899904|NCT02983045|584681053|FG005|Overall Study|Withdrawal by Subject|72|||
161899905|NCT02983045|584681054|FG006|Overall Study|Withdrawal by Subject|0|||
161899906|NCT02983045|584681055|FG007|Overall Study|Withdrawal by Subject|0|||
161899907|NCT02983045|584681056|FG008|Overall Study|Withdrawal by Subject|0|||
161899908|NCT02983045|584681057|FG009|Overall Study|Withdrawal by Subject|2|||
161899909|NCT02983045|584681048|FG000|Overall Study|Lost to Follow-up|0|||
161899910|NCT02983045|584681049|FG001|Overall Study|Lost to Follow-up|0|||
161899911|NCT02983045|584681050|FG002|Overall Study|Lost to Follow-up|0|||
161899912|NCT02983045|584681051|FG003|Overall Study|Lost to Follow-up|0|||
161899913|NCT02983045|584681052|FG004|Overall Study|Lost to Follow-up|0|||
161899914|NCT02983045|584681053|FG005|Overall Study|Lost to Follow-up|10|||
161899915|NCT02983045|584681054|FG006|Overall Study|Lost to Follow-up|0|||
161899916|NCT02983045|584681055|FG007|Overall Study|Lost to Follow-up|0|||
161899917|NCT02983045|584681056|FG008|Overall Study|Lost to Follow-up|0|||
161899918|NCT02983045|584681057|FG009|Overall Study|Lost to Follow-up|0|||
161899919|NCT00991289|584681058|FG000|Overall Study|Adverse Event|1|||
161899920|NCT00991289|584681058|FG000|Overall Study|Physician Decision|2|||
161899921|NCT00991289|584681058|FG000|Overall Study|Withdrawal by Subject|3|||
161899922|NCT00991289|584681058|FG000|Overall Study|Lost to Follow-up|4|||
161899923|NCT00991289|584681058|FG000|Overall Study|Protocol Violation|2|||
161899924|NCT01051817|584681073|FG000|Overall Study|Adverse Event|0|||
161899925|NCT01051817|584681074|FG001|Overall Study|Adverse Event|2|||
161899926|NCT01051817|584681073|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
161899927|NCT01051817|584681074|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
161899928|NCT01051817|584681073|FG000|Overall Study|Withdrawal by Subject|3|||
161899929|NCT01051817|584681074|FG001|Overall Study|Withdrawal by Subject|5|||
161899930|NCT01051817|584681073|FG000|Overall Study|Protocol Violation|0|||
161899931|NCT01051817|584681074|FG001|Overall Study|Protocol Violation|1|||
161899932|NCT02472886|584681076|FG000|Overall Study|Lack of Efficacy|0|||
161899933|NCT02472886|584681077|FG001|Overall Study|Lack of Efficacy|2|||
161899934|NCT02472886|584681078|FG002|Overall Study|Lack of Efficacy|1|||
161899935|NCT04346199|584681079|FG000|Overall Study|Death|8|||
161899936|NCT04346199|584681080|FG001|Overall Study|Death|9|||
161899937|NCT04346199|584681079|FG000|Overall Study|Lost to Follow-up|0|||
161899938|NCT04346199|584681080|FG001|Overall Study|Lost to Follow-up|1|||
161899939|NCT04346199|584681079|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
161899940|NCT04346199|584681080|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
161899941|NCT04346199|584681079|FG000|Overall Study|Withdrawal by Subject|5|||
161899942|NCT04346199|584681080|FG001|Overall Study|Withdrawal by Subject|1|||
161899943|NCT00627926|584681081|FG000|Overall Study|Adverse Event|26|||
161899944|NCT00627926|584681082|FG001|Overall Study|Adverse Event|37|||
161899945|NCT00627926|584681083|FG002|Overall Study|Adverse Event|36|||
161899946|NCT00627926|584681081|FG000|Overall Study|Death|1|||
161899947|NCT00627926|584681082|FG001|Overall Study|Death|0|||
161899948|NCT00627926|584681083|FG002|Overall Study|Death|0|||
161899949|NCT00627926|584681081|FG000|Overall Study|Lost to Follow-up|4|||
161899950|NCT00627926|584681082|FG001|Overall Study|Lost to Follow-up|3|||
161899951|NCT00627926|584681083|FG002|Overall Study|Lost to Follow-up|4|||
161899952|NCT00627926|584681081|FG000|Overall Study|Withdrawal by Subject|2|||
161899953|NCT00627926|584681082|FG001|Overall Study|Withdrawal by Subject|1|||
161445939|NCT00048074|583026198|FG002|Overall Study|Adverse Event|53|||
161899954|NCT00627926|584681083|FG002|Overall Study|Withdrawal by Subject|0|||
161899955|NCT00627926|584681081|FG000|Overall Study|Lack of Efficacy|118|||
161899956|NCT00627926|584681082|FG001|Overall Study|Lack of Efficacy|40|||
161899957|NCT00627926|584681083|FG002|Overall Study|Lack of Efficacy|38|||
161899958|NCT00627926|584681081|FG000|Overall Study|Noncompliance/unspecified|8|||
161899959|NCT00627926|584681082|FG001|Overall Study|Noncompliance/unspecified|23|||
161899960|NCT00627926|584681083|FG002|Overall Study|Noncompliance/unspecified|17|||
161899961|NCT03414229|584681084|FG000|Overall Study|Adverse Event|1|||
161899962|NCT03414229|584681085|FG001|Overall Study|Adverse Event|0|||
161899963|NCT03414229|584681086|FG002|Overall Study|Adverse Event|2|||
161899964|NCT03414229|584681087|FG003|Overall Study|Adverse Event|1|||
161899965|NCT03414229|584681084|FG000|Overall Study|Lack of Efficacy|7|||
161899966|NCT03414229|584681085|FG001|Overall Study|Lack of Efficacy|4|||
161899967|NCT03414229|584681086|FG002|Overall Study|Lack of Efficacy|1|||
161899968|NCT03414229|584681087|FG003|Overall Study|Lack of Efficacy|9|||
161899969|NCT03414229|584681084|FG000|Overall Study|Change in therapy|1|||
161899970|NCT03414229|584681085|FG001|Overall Study|Change in therapy|0|||
161899971|NCT03414229|584681086|FG002|Overall Study|Change in therapy|0|||
161899972|NCT03414229|584681087|FG003|Overall Study|Change in therapy|0|||
161899973|NCT03414229|584681084|FG000|Overall Study|Pregnancy|0|||
161899974|NCT03414229|584681085|FG001|Overall Study|Pregnancy|0|||
161899975|NCT03414229|584681086|FG002|Overall Study|Pregnancy|1|||
161899976|NCT03414229|584681087|FG003|Overall Study|Pregnancy|0|||
161899977|NCT03414229|584681084|FG000|Overall Study|Withdrawal by Subject|0|||
161899978|NCT03414229|584681085|FG001|Overall Study|Withdrawal by Subject|1|||
161899979|NCT03414229|584681086|FG002|Overall Study|Withdrawal by Subject|1|||
161899980|NCT03414229|584681087|FG003|Overall Study|Withdrawal by Subject|0|||
161899981|NCT04533438|584681088|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
161899982|NCT04533438|584681089|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
161899983|NCT05568797|584681092|FG000|Overall Study|Adverse Event|0|||
161899984|NCT05568797|584681093|FG001|Overall Study|Adverse Event|8|||
161794143|NCT03419234|584289444|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
161794144|NCT03419234|584289443|FG000|Overall Study|Physician Decision|12|||
161794145|NCT03419234|584289444|FG001|Overall Study|Physician Decision|11|||
161794146|NCT03419234|584289443|FG000|Overall Study|Second malignancy|1|||
161794147|NCT03419234|584289444|FG001|Overall Study|Second malignancy|0|||
161794148|NCT03419234|584289443|FG000|Overall Study|Insurance status change/patient could not afford|2|||
161794149|NCT03419234|584289444|FG001|Overall Study|Insurance status change/patient could not afford|1|||
161794150|NCT03419234|584289443|FG000|Overall Study|Non-compliance|1|||
161794151|NCT03419234|584289444|FG001|Overall Study|Non-compliance|3|||
161794152|NCT03419234|584289443|FG000|Overall Study|Mistakenly off treatment|1|||
161794153|NCT03419234|584289444|FG001|Overall Study|Mistakenly off treatment|0|||
161794154|NCT03419234|584289443|FG000|Overall Study|Transition to hospice|1|||
161794155|NCT03419234|584289444|FG001|Overall Study|Transition to hospice|0|||
161794156|NCT03419234|584289443|FG000|Overall Study|Still on treatment|9|||
161794157|NCT03419234|584289444|FG001|Overall Study|Still on treatment|8|||
161794158|NCT03419234|584289443|FG000|Overall Study|Never received protocol therapy|2|||
161794159|NCT03419234|584289444|FG001|Overall Study|Never received protocol therapy|4|||
161794160|NCT03419234|584289443|FG000|Overall Study|Other complicating disease|0|||
161794161|NCT03419234|584289444|FG001|Overall Study|Other complicating disease|1|||
161794162|NCT03419234|584289443|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
161794163|NCT03419234|584289444|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
161794164|NCT04680052|584290947|FG000|Overall Study|Ongoing|244|||
161794165|NCT04680052|584290948|FG001|Overall Study|Ongoing|229|||
161794166|NCT04680052|584290949|FG002|Overall Study|Ongoing|39|||
161794167|NCT04680052|584290950|FG003|Overall Study|Ongoing|46|||
161794168|NCT04680052|584290947|FG000|Overall Study|Death|15|||
161794169|NCT04680052|584290948|FG001|Overall Study|Death|22|||
161794170|NCT04680052|584290949|FG002|Overall Study|Death|7|||
161794171|NCT04680052|584290950|FG003|Overall Study|Death|1|||
161794172|NCT04680052|584290947|FG000|Overall Study|Lost to Follow-up|3|||
161794173|NCT04680052|584290948|FG001|Overall Study|Lost to Follow-up|2|||
161899985|NCT05568797|584681092|FG000|Overall Study|Lost to Follow-up|2|||
161899986|NCT05568797|584681093|FG001|Overall Study|Lost to Follow-up|3|||
161899987|NCT05568797|584681092|FG000|Overall Study|Withdrawal by Subject|1|||
161899988|NCT05568797|584681093|FG001|Overall Study|Withdrawal by Subject|10|||
161899989|NCT05568797|584681092|FG000|Overall Study|Other|2|||
161794174|NCT04680052|584290949|FG002|Overall Study|Lost to Follow-up|0|||
161794175|NCT04680052|584290950|FG003|Overall Study|Lost to Follow-up|1|||
161794176|NCT04680052|584290947|FG000|Overall Study|Withdrawal by Subject|11|||
161899990|NCT05568797|584681093|FG001|Overall Study|Other|2|||
161899991|NCT02401035|584681095|FG000|Overall Study|Withdrawal by Subject|1|||
161899992|NCT02401035|584681096|FG001|Overall Study|Withdrawal by Subject|0|||
161899993|NCT00869128|584681097|FG000|Overall Study|lack of Compliance|6|||
161899994|NCT00869128|584681098|FG001|Overall Study|lack of Compliance|6|||
161899995|NCT00985686|584681104|FG000|Overall Study|Lost to Follow-up|1|||
161794177|NCT04680052|584290948|FG001|Overall Study|Withdrawal by Subject|19|||
161794178|NCT04680052|584290949|FG002|Overall Study|Withdrawal by Subject|7|||
161794179|NCT04680052|584290950|FG003|Overall Study|Withdrawal by Subject|5|||
161794180|NCT04680052|584290947|FG000|Overall Study|Missing|0|||
161794181|NCT04680052|584290948|FG001|Overall Study|Missing|1|||
161794182|NCT04680052|584290949|FG002|Overall Study|Missing|0|||
161794183|NCT04680052|584290950|FG003|Overall Study|Missing|0|||
161794184|NCT04680052|584290947|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161794185|NCT04680052|584290948|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
161794186|NCT04680052|584290949|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161794187|NCT04680052|584290950|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161794188|NCT04680052|584290947|FG000|Overall Study|Physician Decision|0|||
161794189|NCT04680052|584290948|FG001|Overall Study|Physician Decision|1|||
161794190|NCT04680052|584290949|FG002|Overall Study|Physician Decision|0|||
161794191|NCT04680052|584290950|FG003|Overall Study|Physician Decision|0|||
161794192|NCT00759148|584290952|FG000|Overall Study|Adverse Event|1|||
161794193|NCT00759148|584290953|FG001|Overall Study|Adverse Event|6|||
161794194|NCT00759148|584290952|FG000|Overall Study|Withdrawal by Subject|3|||
161794195|NCT00759148|584290953|FG001|Overall Study|Withdrawal by Subject|7|||
161794196|NCT00759148|584290952|FG000|Overall Study|Lost to Follow-up|3|||
161794197|NCT00759148|584290953|FG001|Overall Study|Lost to Follow-up|9|||
161794198|NCT00759148|584290952|FG000|Overall Study|Treatment Failure|6|||
161794199|NCT00759148|584290953|FG001|Overall Study|Treatment Failure|10|||
161794200|NCT00759148|584290952|FG000|Overall Study|Reason not given|1|||
161794201|NCT00759148|584290953|FG001|Overall Study|Reason not given|0|||
161794202|NCT01073020|584290954|FG000|Overall Study|Withdrawal by Subject|6|||
161794203|NCT01073020|584290955|FG001|Overall Study|Withdrawal by Subject|4|||
161794204|NCT01073020|584290956|FG002|Overall Study|Withdrawal by Subject|1|||
161794205|NCT01073020|584290957|FG003|Overall Study|Withdrawal by Subject|2|||
161794206|NCT01073020|584290954|FG000|Overall Study|Physician Decision|1|||
161794207|NCT01073020|584290955|FG001|Overall Study|Physician Decision|0|||
161794208|NCT01073020|584290956|FG002|Overall Study|Physician Decision|2|||
161794209|NCT01073020|584290957|FG003|Overall Study|Physician Decision|0|||
161794210|NCT01073020|584290954|FG000|Overall Study|Death|0|||
161794211|NCT01073020|584290955|FG001|Overall Study|Death|1|||
161794212|NCT01073020|584290956|FG002|Overall Study|Death|0|||
161794213|NCT01073020|584290957|FG003|Overall Study|Death|0|||
161794214|NCT00094302|584290960|FG000|Overall Study|Lost to Follow-up|43|||
161794215|NCT00094302|584290961|FG001|Overall Study|Lost to Follow-up|41|||
161794216|NCT00094302|584290960|FG000|Overall Study|Physician Decision|5|||
161794217|NCT00094302|584290961|FG001|Overall Study|Physician Decision|8|||
161794218|NCT00094302|584290960|FG000|Overall Study|Withdrawal by Subject|103|||
161794219|NCT00094302|584290961|FG001|Overall Study|Withdrawal by Subject|111|||
161794220|NCT00094302|584290960|FG000|Overall Study|Death|266|||
161794221|NCT00094302|584290961|FG001|Overall Study|Death|246|||
161794222|NCT03329027|584290964|FG000|Overall Study|Lost to Follow-up|1|||
161794223|NCT03329027|584290965|FG001|Overall Study|Lost to Follow-up|0|||
161794224|NCT03329027|584290966|FG002|Overall Study|Lost to Follow-up|1|||
161794225|NCT03329027|584290964|FG000|Overall Study|Protocol Violation|9|||
161794226|NCT03329027|584290965|FG001|Overall Study|Protocol Violation|5|||
161794227|NCT03329027|584290966|FG002|Overall Study|Protocol Violation|7|||
161794228|NCT02761980|584290971|FG000|Overall Study|Adverse Event|4|||
161794229|NCT02761980|584290972|FG001|Overall Study|Adverse Event|6|||
161794230|NCT02761980|584290973|FG002|Overall Study|Adverse Event|5|||
161794231|NCT02761980|584290974|FG003|Overall Study|Adverse Event|6|||
161794232|NCT02761980|584290971|FG000|Overall Study|Withdrawal by Subject|0|||
161794233|NCT02761980|584290972|FG001|Overall Study|Withdrawal by Subject|1|||
161794234|NCT02761980|584290973|FG002|Overall Study|Withdrawal by Subject|0|||
161794235|NCT02761980|584290974|FG003|Overall Study|Withdrawal by Subject|0|||
161794236|NCT02761980|584290971|FG000|Overall Study|Other|0|||
161794237|NCT02761980|584290972|FG001|Overall Study|Other|0|||
161794238|NCT02761980|584290973|FG002|Overall Study|Other|1|||
161794239|NCT02761980|584290974|FG003|Overall Study|Other|0|||
161794240|NCT00101582|584290979|FG000|Overall Study|Ineligibility determined|0|||
161794241|NCT00101582|584290980|FG001|Overall Study|Ineligibility determined|1|||
161794242|NCT00101582|584290979|FG000|Overall Study|Adverse Event|1|||
161794243|NCT00101582|584290980|FG001|Overall Study|Adverse Event|4|||
161794244|NCT00101582|584290979|FG000|Overall Study|Withdrawal by Subject|6|||
161794245|NCT00101582|584290980|FG001|Overall Study|Withdrawal by Subject|4|||
161794246|NCT00101582|584290979|FG000|Overall Study|Physician Decision|1|||
161794247|NCT00101582|584290980|FG001|Overall Study|Physician Decision|0|||
161794248|NCT00101582|584290979|FG000|Overall Study|Death|3|||
161794249|NCT00101582|584290980|FG001|Overall Study|Death|5|||
161794250|NCT00101582|584290979|FG000|Overall Study|Other|0|||
161794251|NCT00101582|584290980|FG001|Overall Study|Other|1|||
161794252|NCT01907087|584290981|FG000|Overall Study|Withdrawal by Subject|1|||
161794253|NCT01919190|584290982|FG000|Overall Study|Intra-op findings, etc.|3|||
161794254|NCT01919190|584290983|FG001|Overall Study|Intra-op findings, etc.|0|||
161794255|NCT03355742|584290984|FG000|Overall Study|Lost to Follow-up|4|||
161899996|NCT00985686|584681105|FG001|Overall Study|Lost to Follow-up|1|||
161899997|NCT00985686|584681106|FG002|Overall Study|Lost to Follow-up|0|||
161899998|NCT00985686|584681107|FG003|Overall Study|Lost to Follow-up|2|||
161899999|NCT01118663|584681108|FG000|Overall Study|Adverse Event|2|||
161900000|NCT01118663|584681109|FG001|Overall Study|Adverse Event|1|||
161900001|NCT01118663|584681108|FG000|Overall Study|Withdrawal by Subject|0|||
161900002|NCT01118663|584681109|FG001|Overall Study|Withdrawal by Subject|1|||
161900003|NCT03046953|584681116|FG000|Overall Study|Relapse/progressive disease|21|||
161900004|NCT03046953|584681116|FG000|Overall Study|Death|2|||
161900005|NCT03046953|584681116|FG000|Overall Study|Withdrawal by Subject|3|||
161900006|NCT04039204|584681117|FG000|Overall Study|Withdrawal by Subject|0|||
161900007|NCT04039204|584681118|FG001|Overall Study|Withdrawal by Subject|2|||
161900008|NCT00396383|584681126|FG000|Overall Study|Death|2|||
161900009|NCT00396383|584681126|FG000|Overall Study|Lost to Follow-up|1|||
161900010|NCT02385110|584681129|FG000|Overall Study|Early Death|1|||
161900011|NCT02385110|584681130|FG001|Overall Study|Early Death|0|||
161900012|NCT03472521|584681131|FG000|Overall Study|Lost to Follow-up|3|||
161900013|NCT03472521|584681132|FG001|Overall Study|Lost to Follow-up|2|||
161900014|NCT03472521|584681131|FG000|Overall Study|Discontinued intervention|3|||
161900015|NCT03472521|584681132|FG001|Overall Study|Discontinued intervention|1|||
161900016|NCT00534638|584681133|FG000|Overall Study|Withdrawal by Subject|3|||
161900017|NCT00534638|584681134|FG001|Overall Study|Withdrawal by Subject|4|||
161900018|NCT00534638|584681133|FG000|Overall Study|Migrated/moved from study area|13|||
161900019|NCT00534638|584681134|FG001|Overall Study|Migrated/moved from study area|11|||
161900020|NCT00534638|584681133|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
161900021|NCT00534638|584681134|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
161900022|NCT00534638|584681133|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
161900023|NCT00534638|584681134|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
161900024|NCT00534638|584681133|FG000|Overall Study|Other|1685|||
161900025|NCT00534638|584681134|FG001|Overall Study|Other|902|||
161900026|NCT01237327|584681135|FG000|Overall Study|Protocol Violation: Core Study|1|||
161900027|NCT01237327|584681136|FG001|Overall Study|Protocol Violation: Core Study|0|||
161900028|NCT01237327|584681135|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
161900029|NCT01237327|584681136|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
161900030|NCT01237327|584681135|FG000|Overall Study|Progression of Disease: Core Study|18|||
161900031|NCT01237327|584681136|FG001|Overall Study|Progression of Disease: Core Study|22|||
161900032|NCT01237327|584681135|FG000|Overall Study|Progression of Disease: Extension Study|15|||
161794256|NCT03355742|584290984|FG000|Overall Study|Withdrawal by Subject|29|||
161794257|NCT03355742|584290984|FG000|Overall Study|Physician Decision|6|||
161794258|NCT03355742|584290984|FG000|Overall Study|Death|55|||
161794259|NCT03355742|584290984|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
161794260|NCT02207621|584290986|FG000|Overall Study|Adverse Event|71|||
161794261|NCT02207621|584290987|FG001|Overall Study|Adverse Event|15|||
161794262|NCT02207621|584290988|FG002|Overall Study|Adverse Event|132|||
161794263|NCT02207621|584290986|FG000|Overall Study|Withdrawal by Subject|9|||
161794264|NCT02207621|584290987|FG001|Overall Study|Withdrawal by Subject|9|||
161794265|NCT02207621|584290988|FG002|Overall Study|Withdrawal by Subject|13|||
161794266|NCT02207621|584290986|FG000|Overall Study|Non-Compliant|3|||
161794267|NCT02207621|584290987|FG001|Overall Study|Non-Compliant|3|||
161794268|NCT02207621|584290988|FG002|Overall Study|Non-Compliant|1|||
161794269|NCT02207621|584290986|FG000|Overall Study|Lost to Follow-up|1|||
161794270|NCT02207621|584290987|FG001|Overall Study|Lost to Follow-up|0|||
161794271|NCT02207621|584290988|FG002|Overall Study|Lost to Follow-up|3|||
161794272|NCT02207621|584290986|FG000|Overall Study|Lack of Efficacy|10|||
161794273|NCT02207621|584290987|FG001|Overall Study|Lack of Efficacy|2|||
161794274|NCT02207621|584290988|FG002|Overall Study|Lack of Efficacy|4|||
161794275|NCT02207621|584290986|FG000|Overall Study|Disallowed Concurrent Medication|2|||
161794276|NCT02207621|584290987|FG001|Overall Study|Disallowed Concurrent Medication|5|||
161794277|NCT02207621|584290988|FG002|Overall Study|Disallowed Concurrent Medication|2|||
161794278|NCT02207621|584290986|FG000|Overall Study|Physician Decision|1|||
161794279|NCT02207621|584290987|FG001|Overall Study|Physician Decision|2|||
161794280|NCT02207621|584290988|FG002|Overall Study|Physician Decision|2|||
161900033|NCT01237327|584681136|FG001|Overall Study|Progression of Disease: Extension Study|13|||
161900034|NCT01237327|584681135|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
161900035|NCT01237327|584681136|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
161794281|NCT02207621|584290986|FG000|Overall Study|Protocol Violation|4|||
161794282|NCT02207621|584290987|FG001|Overall Study|Protocol Violation|10|||
161794283|NCT02207621|584290988|FG002|Overall Study|Protocol Violation|6|||
161794284|NCT02207621|584290986|FG000|Overall Study|Death|2|||
161794285|NCT02207621|584290987|FG001|Overall Study|Death|0|||
161794286|NCT02207621|584290988|FG002|Overall Study|Death|0|||
161794287|NCT02207621|584290986|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
161900036|NCT01237327|584681135|FG000|Overall Study|Withdrawal by Subject|1|||
161900037|NCT01237327|584681136|FG001|Overall Study|Withdrawal by Subject|3|||
161900038|NCT01237327|584681135|FG000|Overall Study|Lost to Follow-up|3|||
161900039|NCT01237327|584681136|FG001|Overall Study|Lost to Follow-up|0|||
161794288|NCT02207621|584290987|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
161794289|NCT02207621|584290988|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
161794290|NCT02848599|584290989|FG000|Overall Study|Protocol Violation|7|||
161794291|NCT02848599|584290990|FG001|Overall Study|Protocol Violation|9|||
161900040|NCT04980014|584682886|FG000|Overall Study|Participants who are Duplicated|1|||
161900041|NCT04980014|584682886|FG000|Overall Study|Follow-up Failure|13|||
161900042|NCT04980014|584682886|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
161445940|NCT00048074|583026196|FG000|Overall Study|Death|3|||
161445941|NCT00048074|583026197|FG001|Overall Study|Death|3|||
161445942|NCT00048074|583026198|FG002|Overall Study|Death|2|||
161794292|NCT01829464|584290999|FG000|Overall Study|Adverse Event|1|||
161794293|NCT01829464|584291000|FG001|Overall Study|Adverse Event|0|||
161794294|NCT01829464|584291001|FG002|Overall Study|Adverse Event|0|||
161794295|NCT01829464|584290999|FG000|Overall Study|Lost to Follow-up|0|||
161794296|NCT01829464|584291000|FG001|Overall Study|Lost to Follow-up|0|||
161794297|NCT01829464|584291001|FG002|Overall Study|Lost to Follow-up|1|||
161794298|NCT01829464|584290999|FG000|Overall Study|Withdrawal by Subject|2|||
161794299|NCT01829464|584291000|FG001|Overall Study|Withdrawal by Subject|0|||
161794300|NCT01829464|584291001|FG002|Overall Study|Withdrawal by Subject|0|||
161794301|NCT01829464|584290999|FG000|Overall Study|Study terminated by sponsor|25|||
161794302|NCT01829464|584291000|FG001|Overall Study|Study terminated by sponsor|28|||
161794303|NCT01829464|584291001|FG002|Overall Study|Study terminated by sponsor|25|||
161794304|NCT01829464|584290999|FG000|Overall Study|Lack of Efficacy|0|||
161794305|NCT01829464|584291000|FG001|Overall Study|Lack of Efficacy|1|||
161794306|NCT01829464|584291001|FG002|Overall Study|Lack of Efficacy|0|||
161794307|NCT00635778|584291006|FG000|Overall Study|Adverse Event|1|||
161794308|NCT00635778|584291007|FG001|Overall Study|Adverse Event|0|||
161794309|NCT00635778|584291008|FG002|Overall Study|Adverse Event|0|||
161794310|NCT00635778|584291009|FG003|Overall Study|Adverse Event|3|||
161794311|NCT00635778|584291010|FG004|Overall Study|Adverse Event|3|||
161794312|NCT00635778|584291011|FG005|Overall Study|Adverse Event|6|||
161794313|NCT00635778|584291012|FG006|Overall Study|Adverse Event|1|||
161794314|NCT00635778|584291006|FG000|Overall Study|Withdrawal by Subject|0|||
161794315|NCT00635778|584291007|FG001|Overall Study|Withdrawal by Subject|0|||
161794316|NCT00635778|584291008|FG002|Overall Study|Withdrawal by Subject|0|||
161794317|NCT00635778|584291009|FG003|Overall Study|Withdrawal by Subject|1|||
161794318|NCT00635778|584291010|FG004|Overall Study|Withdrawal by Subject|0|||
161794319|NCT00635778|584291011|FG005|Overall Study|Withdrawal by Subject|1|||
161794320|NCT00635778|584291012|FG006|Overall Study|Withdrawal by Subject|1|||
161445943|NCT00048074|583026196|FG000|Overall Study|Lost to Follow-up|2|||
161445944|NCT00048074|583026197|FG001|Overall Study|Lost to Follow-up|6|||
161445945|NCT00048074|583026198|FG002|Overall Study|Lost to Follow-up|6|||
161445946|NCT00048074|583026196|FG000|Overall Study|Withdrawal by Subject|28|||
161445947|NCT00048074|583026197|FG001|Overall Study|Withdrawal by Subject|30|||
161445948|NCT00048074|583026198|FG002|Overall Study|Withdrawal by Subject|35|||
161445949|NCT00048074|583026196|FG000|Overall Study|Protocol Violation|1|||
161445950|NCT00048074|583026197|FG001|Overall Study|Protocol Violation|3|||
161445951|NCT00048074|583026198|FG002|Overall Study|Protocol Violation|0|||
161445952|NCT00048074|583026196|FG000|Overall Study|Study participation was terminated|0|||
161445953|NCT00048074|583026197|FG001|Overall Study|Study participation was terminated|1|||
161445954|NCT00048074|583026198|FG002|Overall Study|Study participation was terminated|0|||
161445955|NCT00048074|583026196|FG000|Overall Study|Husband ill|0|||
161445956|NCT00048074|583026197|FG001|Overall Study|Husband ill|1|||
161445957|NCT00048074|583026198|FG002|Overall Study|Husband ill|0|||
161445958|NCT00048074|583026196|FG000|Overall Study|Poor compliance|0|||
161445959|NCT00048074|583026197|FG001|Overall Study|Poor compliance|1|||
161445960|NCT00048074|583026198|FG002|Overall Study|Poor compliance|0|||
161445961|NCT00048074|583026196|FG000|Overall Study|Out of station|0|||
161445962|NCT00048074|583026197|FG001|Overall Study|Out of station|1|||
161445963|NCT00048074|583026198|FG002|Overall Study|Out of station|1|||
161445964|NCT00048074|583026196|FG000|Overall Study|Social reasons|1|||
161445965|NCT00048074|583026197|FG001|Overall Study|Social reasons|0|||
161445966|NCT00048074|583026198|FG002|Overall Study|Social reasons|0|||
161794321|NCT00635778|584291006|FG000|Overall Study|Progressive disease|0|||
161794322|NCT00635778|584291007|FG001|Overall Study|Progressive disease|3|||
161794323|NCT00635778|584291008|FG002|Overall Study|Progressive disease|3|||
161794324|NCT00635778|584291009|FG003|Overall Study|Progressive disease|4|||
161445967|NCT02873377|583026199|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
161445968|NCT02873377|583026200|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
161794325|NCT00635778|584291010|FG004|Overall Study|Progressive disease|5|||
161445969|NCT02873377|583026199|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
161445970|NCT02873377|583026200|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
161445971|NCT01583296|583026201|FG000|Overall Study|Withdrawal by Subject|11|||
161445972|NCT01583296|583026202|FG001|Overall Study|Withdrawal by Subject|10|||
161794326|NCT00635778|584291011|FG005|Overall Study|Progressive disease|14|||
161794327|NCT00635778|584291012|FG006|Overall Study|Progressive disease|4|||
161794328|NCT00812253|584291013|FG000|Overall Study|Withdrawal by Subject|3|||
161794329|NCT00812253|584291014|FG001|Overall Study|Withdrawal by Subject|2|||
161794330|NCT00812253|584291013|FG000|Overall Study|Protocol Violation|1|||
161794331|NCT00812253|584291014|FG001|Overall Study|Protocol Violation|1|||
161794332|NCT00812253|584291013|FG000|Overall Study|Lost to Follow-up|2|||
161794333|NCT00812253|584291014|FG001|Overall Study|Lost to Follow-up|0|||
161794334|NCT04903288|584291015|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
161794335|NCT04903288|584291015|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
161794336|NCT04903288|584291015|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
161794337|NCT04903288|584291015|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
161794338|NCT00634907|584291023|FG000|Overall Study|Withdrawal by Subject|3|||
161794339|NCT00634907|584291024|FG001|Overall Study|Withdrawal by Subject|0|||
161794340|NCT00634907|584291023|FG000|Overall Study|Physician Decision|3|||
161794341|NCT00634907|584291024|FG001|Overall Study|Physician Decision|9|||
161794342|NCT00634907|584291023|FG000|Overall Study|Withdrawal by Subject|11|||
161794343|NCT00634907|584291024|FG001|Overall Study|Withdrawal by Subject|8|||
161794344|NCT01180244|584291030|FG000|Overall Study|Lack of Efficacy|0|||
161794345|NCT01180244|584291031|FG001|Overall Study|Lack of Efficacy|7|||
161794346|NCT01180244|584291030|FG000|Overall Study|Physician Decision|3|||
161794347|NCT01180244|584291031|FG001|Overall Study|Physician Decision|0|||
161794348|NCT01180244|584291030|FG000|Overall Study|Adverse Event|1|||
161794349|NCT01180244|584291031|FG001|Overall Study|Adverse Event|0|||
161794350|NCT01180244|584291030|FG000|Overall Study|Withdrawal by Subject|0|||
161794351|NCT01180244|584291031|FG001|Overall Study|Withdrawal by Subject|1|||
161794352|NCT01180244|584291030|FG000|Overall Study|Protocol Violation|1|||
161794353|NCT01180244|584291031|FG001|Overall Study|Protocol Violation|0|||
161794354|NCT01180244|584291030|FG000|Overall Study|Lost to Follow-up|1|||
161794355|NCT01180244|584291031|FG001|Overall Study|Lost to Follow-up|0|||
161794356|NCT01338636|584291032|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
161794357|NCT02385526|584291033|FG000|Overall Study|Withdrawal by Subject|0|||
161794358|NCT02385526|584291034|FG001|Overall Study|Withdrawal by Subject|2|||
161794359|NCT02385526|584291035|FG002|Overall Study|Withdrawal by Subject|0|||
161794360|NCT02385526|584291033|FG000|Overall Study|Lost to Follow-up|0|||
161794361|NCT02385526|584291034|FG001|Overall Study|Lost to Follow-up|1|||
161794362|NCT02385526|584291035|FG002|Overall Study|Lost to Follow-up|0|||
161794363|NCT02385526|584291033|FG000|Overall Study|Physician Decision|1|||
161794364|NCT02385526|584291034|FG001|Overall Study|Physician Decision|0|||
161794365|NCT02385526|584291035|FG002|Overall Study|Physician Decision|0|||
161794366|NCT02385526|584291033|FG000|Overall Study|Protocol Violation|1|||
161794367|NCT02385526|584291034|FG001|Overall Study|Protocol Violation|0|||
161794368|NCT02385526|584291035|FG002|Overall Study|Protocol Violation|0|||
161794369|NCT01595009|584291038|FG000|Core|Patients completed per protocol|85|||
161794370|NCT01595009|584291039|FG001|Core|Patients completed per protocol|44|||
161794371|NCT01595009|584291040|FG002|Core|Patients completed per protocol|0|||
161794372|NCT01595009|584291041|FG003|Core|Patients completed per protocol|0|||
161794373|NCT01595009|584291038|FG000|Core|Adverse Event|19|||
161794374|NCT01595009|584291039|FG001|Core|Adverse Event|23|||
161794375|NCT01595009|584291040|FG002|Core|Adverse Event|0|||
161794376|NCT01595009|584291041|FG003|Core|Adverse Event|0|||
161794377|NCT01595009|584291038|FG000|Core|Disease progression|14|||
161794378|NCT01595009|584291039|FG001|Core|Disease progression|26|||
161794379|NCT01595009|584291040|FG002|Core|Disease progression|0|||
161794380|NCT01595009|584291041|FG003|Core|Disease progression|0|||
161794381|NCT01595009|584291038|FG000|Core|Withdrawal by Subject|4|||
161794382|NCT01595009|584291039|FG001|Core|Withdrawal by Subject|17|||
161794383|NCT01595009|584291040|FG002|Core|Withdrawal by Subject|0|||
161794384|NCT01595009|584291041|FG003|Core|Withdrawal by Subject|0|||
161794385|NCT01595009|584291038|FG000|Core|Death|3|||
161794386|NCT01595009|584291039|FG001|Core|Death|6|||
161794387|NCT01595009|584291040|FG002|Core|Death|0|||
161794388|NCT01595009|584291041|FG003|Core|Death|0|||
161794389|NCT01595009|584291038|FG000|Core|Lost to Follow-up|1|||
161794390|NCT01595009|584291039|FG001|Core|Lost to Follow-up|2|||
161794391|NCT01595009|584291040|FG002|Core|Lost to Follow-up|0|||
161794392|NCT01595009|584291041|FG003|Core|Lost to Follow-up|0|||
161794393|NCT01595009|584291038|FG000|Core|Protocol deviation|0|||
161794394|NCT01595009|584291039|FG001|Core|Protocol deviation|1|||
161794395|NCT01595009|584291040|FG002|Core|Protocol deviation|0|||
161794396|NCT01595009|584291041|FG003|Core|Protocol deviation|0|||
161794397|NCT01595009|584291038|FG000|Core|Administrative problems|0|||
161794398|NCT01595009|584291039|FG001|Core|Administrative problems|1|||
161794399|NCT01595009|584291040|FG002|Core|Administrative problems|0|||
161794400|NCT01595009|584291041|FG003|Core|Administrative problems|0|||
161794401|NCT01595009|584291038|FG000|Extension|Administrative problems|0|||
161794402|NCT01595009|584291039|FG001|Extension|Administrative problems|0|||
161794403|NCT01595009|584291040|FG002|Extension|Administrative problems|0|||
161794404|NCT01595009|584291041|FG003|Extension|Administrative problems|1|||
161794405|NCT01595009|584291038|FG000|Extension|Patients completed per protocol|0|||
161794406|NCT01595009|584291039|FG001|Extension|Patients completed per protocol|0|||
161794407|NCT01595009|584291040|FG002|Extension|Patients completed per protocol|0|||
161794408|NCT01595009|584291041|FG003|Extension|Patients completed per protocol|2|||
161794409|NCT01595009|584291038|FG000|Extension|Disease progression|0|||
161794410|NCT01595009|584291039|FG001|Extension|Disease progression|0|||
161445973|NCT01063283|583026203|FG000|Cycle 1|Adverse Event|2|||
161445974|NCT01063283|583026204|FG001|Cycle 1|Adverse Event|0|||
161445975|NCT01063283|583026205|FG002|Cycle 1|Adverse Event|0|||
161445976|NCT01063283|583026203|FG000|Cycle 1|Technical failure in data collection|1|||
161445977|NCT01063283|583026204|FG001|Cycle 1|Technical failure in data collection|0|||
161445978|NCT01063283|583026205|FG002|Cycle 1|Technical failure in data collection|0|||
161445979|NCT02504216|583026208|FG000|Overall Study|Lost to Follow-up|3|||
161445980|NCT02504216|583026209|FG001|Overall Study|Lost to Follow-up|3|||
161445981|NCT02504216|583026208|FG000|Overall Study|Withdrawal by Subject|8|||
161445982|NCT02504216|583026209|FG001|Overall Study|Withdrawal by Subject|12|||
161445983|NCT00223080|583026210|FG000|Overall Study|Withdrawal by Subject|253|||
161445984|NCT00223080|583026211|FG001|Overall Study|Withdrawal by Subject|232|||
161445985|NCT00223080|583026210|FG000|Overall Study|Required contraindicated med|0|||
161445986|NCT00223080|583026211|FG001|Overall Study|Required contraindicated med|1|||
161445987|NCT00223080|583026210|FG000|Overall Study|Non-compliant|7|||
161445988|NCT00223080|583026211|FG001|Overall Study|Non-compliant|7|||
161445989|NCT00223080|583026210|FG000|Overall Study|Moved from study area|37|||
161445990|NCT00223080|583026211|FG001|Overall Study|Moved from study area|47|||
161445991|NCT00223080|583026210|FG000|Overall Study|Lost to Follow-up|259|||
161445992|NCT00223080|583026211|FG001|Overall Study|Lost to Follow-up|284|||
161445993|NCT00223080|583026210|FG000|Overall Study|Death|85|||
161445994|NCT00223080|583026211|FG001|Overall Study|Death|74|||
161445995|NCT00223080|583026210|FG000|Overall Study|Other|14|||
161794411|NCT01595009|584291040|FG002|Extension|Disease progression|4|||
161794412|NCT01595009|584291041|FG003|Extension|Disease progression|7|||
161794413|NCT01595009|584291038|FG000|Extension|Adverse Event|0|||
161445996|NCT00223080|583026211|FG001|Overall Study|Other|11|||
161445997|NCT00223080|583026210|FG000|Overall Study|Reason not provided|141|||
161445998|NCT00223080|583026211|FG001|Overall Study|Reason not provided|140|||
161445999|NCT00223080|583026210|FG000|Overall Study|Adverse Event|0|||
161446000|NCT00223080|583026211|FG001|Overall Study|Adverse Event|1|||
161446001|NCT02598583|583026212|FG000|Extension Period|Withdrawal by Subject|1|||
161446002|NCT02598583|583026213|FG001|Extension Period|Withdrawal by Subject|0|||
161446003|NCT03237286|583026214|FG000|Overall Study|Withdrawal by Subject|1|||
161446004|NCT03237286|583026215|FG001|Overall Study|Withdrawal by Subject|0|||
161446005|NCT03237286|583026216|FG002|Overall Study|Withdrawal by Subject|2|||
161446006|NCT03237286|583026214|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
161446007|NCT03237286|583026215|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
161446008|NCT03237286|583026216|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
161446009|NCT02792829|583026224|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161446010|NCT02792829|583026225|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
161446011|NCT02792829|583026226|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161446012|NCT02792829|583026227|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161446013|NCT02792829|583026228|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161446014|NCT02792829|583026229|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161794414|NCT01595009|584291039|FG001|Extension|Adverse Event|0|||
161794415|NCT01595009|584291040|FG002|Extension|Adverse Event|0|||
161794416|NCT01595009|584291041|FG003|Extension|Adverse Event|1|||
161794417|NCT01842958|584291044|FG000|Overall Study|Lost to Follow-up|1|||
161794418|NCT01842958|584291045|FG001|Overall Study|Lost to Follow-up|1|||
161794419|NCT01829477|584291046|FG000|Overall Study|Study Terminated by Sponsor|15|||
161794420|NCT01829477|584291047|FG001|Overall Study|Study Terminated by Sponsor|15|||
161794421|NCT01829477|584291046|FG000|Overall Study|Withdrawal by Subject|1|||
161794422|NCT01829477|584291047|FG001|Overall Study|Withdrawal by Subject|0|||
161794423|NCT03465891|584291049|FG000|Overall Study|Withdrawal by Subject|0|||
161794424|NCT03465891|584291050|FG001|Overall Study|Withdrawal by Subject|1|||
161794425|NCT03465891|584291049|FG000|Overall Study|Disease progression|1|||
161794426|NCT03465891|584291050|FG001|Overall Study|Disease progression|0|||
161794427|NCT02737306|584291052|FG000|Overall Study|Adverse Event|3|||
161794428|NCT02737306|584291053|FG001|Overall Study|Adverse Event|0|||
161794429|NCT02737306|584291052|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
161794430|NCT02737306|584291053|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
161794431|NCT03361423|584291054|FG000|Overall Study|Withdrawal by Subject|4|||
161794432|NCT03361423|584291055|FG001|Overall Study|Withdrawal by Subject|3|||
161446015|NCT02792829|583026230|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161446016|NCT02792829|583026231|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
161446017|NCT02792829|583026224|FG000|Treatment Period 2|Adverse Event|0|||
161794433|NCT03361423|584291054|FG000|Overall Study|Did not treat|19|||
161794434|NCT03361423|584291055|FG001|Overall Study|Did not treat|18|||
161794435|NCT03361423|584291054|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
161794436|NCT03361423|584291055|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
161794437|NCT03361423|584291054|FG000|Overall Study|Missing data|4|||
161794438|NCT03361423|584291055|FG001|Overall Study|Missing data|1|||
161794439|NCT00818623|584291056|FG000|Overall Study|Adverse Event|1|||
161794440|NCT00818623|584291057|FG001|Overall Study|Adverse Event|0|||
161794441|NCT00818623|584291058|FG002|Overall Study|Adverse Event|1|||
161794442|NCT00818623|584291059|FG003|Overall Study|Adverse Event|0|||
161794443|NCT00818623|584291060|FG004|Overall Study|Adverse Event|0|||
161794444|NCT00818623|584291061|FG005|Overall Study|Adverse Event|1|||
161794445|NCT00818623|584291062|FG006|Overall Study|Adverse Event|0|||
161794446|NCT00818623|584291063|FG007|Overall Study|Adverse Event|0|||
161794447|NCT00818623|584291056|FG000|Overall Study|Bad prostate specific antigen response|0|||
161794448|NCT00818623|584291057|FG001|Overall Study|Bad prostate specific antigen response|3|||
161794449|NCT00818623|584291058|FG002|Overall Study|Bad prostate specific antigen response|2|||
161794450|NCT00818623|584291059|FG003|Overall Study|Bad prostate specific antigen response|5|||
161794451|NCT00818623|584291060|FG004|Overall Study|Bad prostate specific antigen response|0|||
161794452|NCT00818623|584291061|FG005|Overall Study|Bad prostate specific antigen response|1|||
161794453|NCT00818623|584291062|FG006|Overall Study|Bad prostate specific antigen response|0|||
161794454|NCT00818623|584291063|FG007|Overall Study|Bad prostate specific antigen response|0|||
161794455|NCT00818623|584291056|FG000|Overall Study|Withdrawal by Subject|0|||
161794456|NCT00818623|584291057|FG001|Overall Study|Withdrawal by Subject|1|||
161794457|NCT00818623|584291058|FG002|Overall Study|Withdrawal by Subject|1|||
161794458|NCT00818623|584291059|FG003|Overall Study|Withdrawal by Subject|0|||
161794459|NCT00818623|584291060|FG004|Overall Study|Withdrawal by Subject|0|||
161794460|NCT00818623|584291061|FG005|Overall Study|Withdrawal by Subject|1|||
161794461|NCT00818623|584291062|FG006|Overall Study|Withdrawal by Subject|1|||
161794462|NCT00818623|584291063|FG007|Overall Study|Withdrawal by Subject|1|||
161794463|NCT00818623|584291056|FG000|Overall Study|Protocol Violation|1|||
161794464|NCT00818623|584291057|FG001|Overall Study|Protocol Violation|0|||
161794465|NCT00818623|584291058|FG002|Overall Study|Protocol Violation|0|||
161794466|NCT00818623|584291059|FG003|Overall Study|Protocol Violation|0|||
161794467|NCT00818623|584291060|FG004|Overall Study|Protocol Violation|1|||
161794468|NCT00818623|584291061|FG005|Overall Study|Protocol Violation|0|||
161794469|NCT00818623|584291062|FG006|Overall Study|Protocol Violation|1|||
161794470|NCT00818623|584291063|FG007|Overall Study|Protocol Violation|0|||
161794471|NCT00818623|584291056|FG000|Overall Study|Need of additional treatment|0|||
161794472|NCT00818623|584291057|FG001|Overall Study|Need of additional treatment|0|||
161794473|NCT00818623|584291058|FG002|Overall Study|Need of additional treatment|0|||
161794474|NCT00818623|584291059|FG003|Overall Study|Need of additional treatment|0|||
161794475|NCT00818623|584291060|FG004|Overall Study|Need of additional treatment|1|||
161794476|NCT00818623|584291061|FG005|Overall Study|Need of additional treatment|0|||
161794477|NCT00818623|584291062|FG006|Overall Study|Need of additional treatment|0|||
161794478|NCT00818623|584291063|FG007|Overall Study|Need of additional treatment|0|||
161794479|NCT00818623|584291056|FG000|Overall Study|Lack of trial drug at site|0|||
161794480|NCT00818623|584291057|FG001|Overall Study|Lack of trial drug at site|0|||
161794481|NCT00818623|584291058|FG002|Overall Study|Lack of trial drug at site|0|||
161794482|NCT00818623|584291059|FG003|Overall Study|Lack of trial drug at site|0|||
161794483|NCT00818623|584291060|FG004|Overall Study|Lack of trial drug at site|2|||
161794484|NCT00818623|584291061|FG005|Overall Study|Lack of trial drug at site|0|||
161794485|NCT00818623|584291062|FG006|Overall Study|Lack of trial drug at site|1|||
161794486|NCT00818623|584291063|FG007|Overall Study|Lack of trial drug at site|0|||
161794487|NCT00818623|584291056|FG000|Overall Study|Disease progression|0|||
161794488|NCT00818623|584291057|FG001|Overall Study|Disease progression|0|||
161794489|NCT00818623|584291058|FG002|Overall Study|Disease progression|0|||
161794490|NCT00818623|584291059|FG003|Overall Study|Disease progression|0|||
161794491|NCT00818623|584291060|FG004|Overall Study|Disease progression|0|||
161794492|NCT00818623|584291061|FG005|Overall Study|Disease progression|0|||
161794493|NCT00818623|584291062|FG006|Overall Study|Disease progression|1|||
161794494|NCT00818623|584291063|FG007|Overall Study|Disease progression|0|||
161794495|NCT00299156|584291064|FG000|Period 2 (Randomized)|Screen Failure|0|||
161794496|NCT00299156|584291065|FG001|Period 2 (Randomized)|Screen Failure|1|||
161794497|NCT00299156|584291066|FG002|Period 2 (Randomized)|Screen Failure|0|||
161794498|NCT01166568|584291067|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
161794499|NCT01166568|584291068|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
161794500|NCT01166568|584291069|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
161794501|NCT01166568|584291067|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
161794502|NCT01166568|584291068|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
161794503|NCT01166568|584291069|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
161794504|NCT01166568|584291067|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
161794505|NCT01166568|584291068|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161794506|NCT01166568|584291069|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
161794507|NCT02015793|584291072|FG000|Overall Study|Adverse Event|3|||
161794508|NCT02015793|584291073|FG001|Overall Study|Adverse Event|3|||
161794509|NCT02015793|584291072|FG000|Overall Study|Withdrawal by Subject|1|||
161794510|NCT02015793|584291073|FG001|Overall Study|Withdrawal by Subject|1|||
161794511|NCT00320593|584291074|FG000|Overall Study|Lost to Follow-up|3|||
161794512|NCT00320593|584291075|FG001|Overall Study|Lost to Follow-up|0|||
161794513|NCT00320593|584291074|FG000|Overall Study|Moved to another state|1|||
161794514|NCT00320593|584291075|FG001|Overall Study|Moved to another state|0|||
161794515|NCT00320593|584291074|FG000|Overall Study|Withdrawal by Subject|2|||
161794516|NCT00320593|584291075|FG001|Overall Study|Withdrawal by Subject|1|||
161794517|NCT00320593|584291074|FG000|Overall Study|Withdrawal by clinical center|1|||
161794518|NCT00320593|584291075|FG001|Overall Study|Withdrawal by clinical center|0|||
161794519|NCT01076166|584291076|FG000|Overall Study|Adverse Event|3|||
161794520|NCT01076166|584291076|FG000|Overall Study|Symptoms improved/resolved|6|||
161794521|NCT00321711|584291079|FG000|Part A|Adverse Event|3|||
161794522|NCT00321711|584291080|FG001|Part A|Adverse Event|3|||
161794523|NCT00321711|584291081|FG002|Part A|Adverse Event|2|||
161794524|NCT00321711|584291082|FG003|Part A|Adverse Event|0|||
161794525|NCT00321711|584291083|FG004|Part A|Adverse Event|0|||
161794526|NCT00321711|584291079|FG000|Part A|Withdrawal by Subject|1|||
161794527|NCT00321711|584291080|FG001|Part A|Withdrawal by Subject|1|||
161794528|NCT00321711|584291081|FG002|Part A|Withdrawal by Subject|1|||
161794529|NCT00321711|584291082|FG003|Part A|Withdrawal by Subject|0|||
161794530|NCT00321711|584291083|FG004|Part A|Withdrawal by Subject|0|||
161794531|NCT00321711|584291079|FG000|Part A|Disease progression|0|||
161794532|NCT00321711|584291080|FG001|Part A|Disease progression|1|||
161794533|NCT00321711|584291081|FG002|Part A|Disease progression|0|||
161794534|NCT00321711|584291082|FG003|Part A|Disease progression|0|||
161794535|NCT00321711|584291083|FG004|Part A|Disease progression|0|||
161794536|NCT00321711|584291079|FG000|Part A|Requirement for alternative therapy|0|||
161794537|NCT00321711|584291080|FG001|Part A|Requirement for alternative therapy|2|||
161794538|NCT00321711|584291081|FG002|Part A|Requirement for alternative therapy|1|||
161794539|NCT00321711|584291082|FG003|Part A|Requirement for alternative therapy|0|||
161794540|NCT00321711|584291083|FG004|Part A|Requirement for alternative therapy|0|||
161794541|NCT00321711|584291079|FG000|Part A|Physician Decision|0|||
161794542|NCT00321711|584291080|FG001|Part A|Physician Decision|1|||
161794543|NCT00321711|584291081|FG002|Part A|Physician Decision|3|||
161794544|NCT00321711|584291082|FG003|Part A|Physician Decision|0|||
161794545|NCT00321711|584291083|FG004|Part A|Physician Decision|0|||
161794546|NCT00321711|584291079|FG000|Part A|Other|1|||
161794547|NCT00321711|584291080|FG001|Part A|Other|2|||
161794548|NCT00321711|584291081|FG002|Part A|Other|3|||
161794549|NCT00321711|584291082|FG003|Part A|Other|0|||
161794550|NCT00321711|584291083|FG004|Part A|Other|0|||
161794551|NCT00321711|584291079|FG000|Part A|Protocol deviation|0|||
161794552|NCT00321711|584291080|FG001|Part A|Protocol deviation|0|||
161794553|NCT00321711|584291081|FG002|Part A|Protocol deviation|1|||
161794554|NCT00321711|584291082|FG003|Part A|Protocol deviation|0|||
161794555|NCT00321711|584291083|FG004|Part A|Protocol deviation|0|||
161794556|NCT00321711|584291079|FG000|Part B|Noncompliance|0|||
161794557|NCT00321711|584291080|FG001|Part B|Noncompliance|0|||
161794558|NCT00321711|584291081|FG002|Part B|Noncompliance|0|||
161794559|NCT00321711|584291082|FG003|Part B|Noncompliance|0|||
161794560|NCT00321711|584291083|FG004|Part B|Noncompliance|1|||
161794561|NCT00321711|584291079|FG000|Part B|Adverse Event|0|||
161794562|NCT00321711|584291080|FG001|Part B|Adverse Event|0|||
161794563|NCT00321711|584291081|FG002|Part B|Adverse Event|0|||
161794564|NCT00321711|584291082|FG003|Part B|Adverse Event|2|||
161794565|NCT00321711|584291083|FG004|Part B|Adverse Event|1|||
161794566|NCT00321711|584291079|FG000|Part B|Disease progression|0|||
161794567|NCT00321711|584291080|FG001|Part B|Disease progression|0|||
161794568|NCT00321711|584291081|FG002|Part B|Disease progression|0|||
161794569|NCT00321711|584291082|FG003|Part B|Disease progression|1|||
161794570|NCT00321711|584291083|FG004|Part B|Disease progression|0|||
161794571|NCT00321711|584291079|FG000|Part B|Physician Decision|0|||
161794572|NCT00321711|584291080|FG001|Part B|Physician Decision|0|||
161794573|NCT00321711|584291081|FG002|Part B|Physician Decision|0|||
161794574|NCT00321711|584291082|FG003|Part B|Physician Decision|1|||
161794575|NCT00321711|584291083|FG004|Part B|Physician Decision|2|||
161794576|NCT00321711|584291079|FG000|Part B|Death|0|||
161794577|NCT00321711|584291080|FG001|Part B|Death|0|||
161446018|NCT02792829|583026225|FG001|Treatment Period 2|Adverse Event|0|||
161446019|NCT02792829|583026226|FG002|Treatment Period 2|Adverse Event|0|||
161446020|NCT02792829|583026227|FG003|Treatment Period 2|Adverse Event|0|||
161446021|NCT02792829|583026228|FG004|Treatment Period 2|Adverse Event|1|||
161446022|NCT02792829|583026229|FG005|Treatment Period 2|Adverse Event|0|||
161446023|NCT02792829|583026230|FG006|Treatment Period 2|Adverse Event|1|||
161446024|NCT02792829|583026231|FG007|Treatment Period 2|Adverse Event|1|||
161794578|NCT00321711|584291081|FG002|Part B|Death|0|||
161794579|NCT00321711|584291082|FG003|Part B|Death|2|||
161794580|NCT00321711|584291083|FG004|Part B|Death|1|||
161794581|NCT01709383|584291088|FG000|Overall Study|Lost to Follow-up|1|||
161794582|NCT01709383|584291089|FG001|Overall Study|Lost to Follow-up|0|||
161794583|NCT03264066|584291090|FG000|Overall Study|Adverse Event|1|||
161794584|NCT03264066|584291091|FG001|Overall Study|Adverse Event|1|||
161794585|NCT03264066|584291092|FG002|Overall Study|Adverse Event|0|||
161794586|NCT03264066|584291093|FG003|Overall Study|Adverse Event|0|||
161794587|NCT03264066|584291094|FG004|Overall Study|Adverse Event|0|||
161794588|NCT03264066|584291095|FG005|Overall Study|Adverse Event|0|||
161794589|NCT03264066|584291090|FG000|Overall Study|Death|12|||
161794590|NCT03264066|584291091|FG001|Overall Study|Death|12|||
161446025|NCT02792829|583026224|FG000|Treatment Period 2|Use of proscribed medications|0|||
161446026|NCT02792829|583026225|FG001|Treatment Period 2|Use of proscribed medications|0|||
161446027|NCT02792829|583026226|FG002|Treatment Period 2|Use of proscribed medications|0|||
161446028|NCT02792829|583026227|FG003|Treatment Period 2|Use of proscribed medications|0|||
161446029|NCT02792829|583026228|FG004|Treatment Period 2|Use of proscribed medications|0|||
161794591|NCT03264066|584291092|FG002|Overall Study|Death|8|||
161794592|NCT03264066|584291093|FG003|Overall Study|Death|10|||
161794593|NCT03264066|584291094|FG004|Overall Study|Death|6|||
161794594|NCT03264066|584291095|FG005|Overall Study|Death|1|||
161794595|NCT03264066|584291090|FG000|Overall Study|Lost to Follow-up|1|||
161794596|NCT03264066|584291091|FG001|Overall Study|Lost to Follow-up|0|||
161794597|NCT03264066|584291092|FG002|Overall Study|Lost to Follow-up|0|||
161794598|NCT03264066|584291093|FG003|Overall Study|Lost to Follow-up|0|||
161794599|NCT03264066|584291094|FG004|Overall Study|Lost to Follow-up|0|||
161794600|NCT03264066|584291095|FG005|Overall Study|Lost to Follow-up|0|||
161794601|NCT03264066|584291090|FG000|Overall Study|Progressive Disease|0|||
161794602|NCT03264066|584291091|FG001|Overall Study|Progressive Disease|2|||
161794603|NCT03264066|584291092|FG002|Overall Study|Progressive Disease|1|||
161794604|NCT03264066|584291093|FG003|Overall Study|Progressive Disease|0|||
161794605|NCT03264066|584291094|FG004|Overall Study|Progressive Disease|0|||
161794606|NCT03264066|584291095|FG005|Overall Study|Progressive Disease|0|||
161794607|NCT03264066|584291090|FG000|Overall Study|Study Terminated by Sponsor|5|||
161794608|NCT03264066|584291091|FG001|Overall Study|Study Terminated by Sponsor|5|||
161794609|NCT03264066|584291092|FG002|Overall Study|Study Terminated by Sponsor|8|||
161794610|NCT03264066|584291093|FG003|Overall Study|Study Terminated by Sponsor|5|||
161794611|NCT03264066|584291094|FG004|Overall Study|Study Terminated by Sponsor|1|||
161794612|NCT03264066|584291095|FG005|Overall Study|Study Terminated by Sponsor|2|||
161794613|NCT03264066|584291090|FG000|Overall Study|Withdrawal by Subject|1|||
161794614|NCT03264066|584291091|FG001|Overall Study|Withdrawal by Subject|0|||
161794615|NCT03264066|584291092|FG002|Overall Study|Withdrawal by Subject|0|||
161794616|NCT03264066|584291093|FG003|Overall Study|Withdrawal by Subject|5|||
161794617|NCT03264066|584291094|FG004|Overall Study|Withdrawal by Subject|0|||
161794618|NCT03264066|584291095|FG005|Overall Study|Withdrawal by Subject|0|||
161794619|NCT01484028|584291096|FG000|Period 1|Lost to Follow-up|0|||
161794620|NCT01484028|584291097|FG001|Period 1|Lost to Follow-up|1|||
161794621|NCT01484028|584291098|FG002|Period 1|Lost to Follow-up|0|||
161794622|NCT01484028|584291099|FG003|Period 1|Lost to Follow-up|0|||
161794623|NCT01484028|584291096|FG000|Period 1|Non-Compliance to Protocol|0|||
161794624|NCT01484028|584291097|FG001|Period 1|Non-Compliance to Protocol|1|||
161794625|NCT01484028|584291098|FG002|Period 1|Non-Compliance to Protocol|0|||
161794626|NCT01484028|584291099|FG003|Period 1|Non-Compliance to Protocol|1|||
161794627|NCT01484028|584291096|FG000|Period 1|Lens Discomfort|0|||
161794628|NCT01484028|584291097|FG001|Period 1|Lens Discomfort|1|||
161794629|NCT01484028|584291098|FG002|Period 1|Lens Discomfort|0|||
161794630|NCT01484028|584291099|FG003|Period 1|Lens Discomfort|0|||
161794631|NCT01193517|584291113|FG000|Overall Study|Early Progression|1|||
161794632|NCT01193517|584291114|FG001|Overall Study|Early Progression|0|||
161794633|NCT01193517|584291115|FG002|Overall Study|Early Progression|0|||
161794634|NCT00905489|584291116|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
161794635|NCT00905489|584291116|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
161794636|NCT00905489|584291116|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
161794637|NCT00583596|584291117|FG000|Overall Study|Lost to Follow-up|110|||
161794638|NCT00583596|584291117|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
161794639|NCT00583596|584291117|FG000|Overall Study|Death|2|||
161794640|NCT00583596|584291117|FG000|Overall Study|Withdrawal by Subject|6|||
161794641|NCT00583596|584291117|FG000|Overall Study|Lost to Follow-up|94|||
161794642|NCT00583596|584291117|FG000|Overall Study|Data not complete|1|||
161794643|NCT00583596|584291117|FG000|Overall Study|Not consented|15|||
161794644|NCT00583596|584291117|FG000|Overall Study|Outside f-up window|26|||
161794645|NCT04828161|584292262|FG000|Overall Study|Withdrawal by Subject|0|||
161794646|NCT04828161|584292263|FG001|Overall Study|Withdrawal by Subject|3|||
161794647|NCT04828161|584292264|FG002|Overall Study|Withdrawal by Subject|3|||
161794648|NCT04828161|584292265|FG003|Overall Study|Withdrawal by Subject|4|||
161794649|NCT04828161|584292262|FG000|Overall Study|Lost to Follow-up|1|||
161794650|NCT04828161|584292263|FG001|Overall Study|Lost to Follow-up|4|||
161794651|NCT04828161|584292264|FG002|Overall Study|Lost to Follow-up|2|||
161794652|NCT04828161|584292265|FG003|Overall Study|Lost to Follow-up|2|||
161446030|NCT02792829|583026229|FG005|Treatment Period 2|Use of proscribed medications|0|||
161446031|NCT02792829|583026230|FG006|Treatment Period 2|Use of proscribed medications|0|||
161552455|NCT05033080|583410455|FG001|Overall Study|Physician Decision|1|||
161552456|NCT05033080|583410454|FG000|Overall Study|Other|1|||
161794653|NCT04828161|584292262|FG000|Overall Study|Other|2|||
161794654|NCT04828161|584292263|FG001|Overall Study|Other|0|||
161794655|NCT04828161|584292264|FG002|Overall Study|Other|2|||
161794656|NCT04828161|584292265|FG003|Overall Study|Other|0|||
161794657|NCT04828161|584292262|FG000|Overall Study|Death|0|||
161794658|NCT04828161|584292263|FG001|Overall Study|Death|0|||
161794659|NCT04828161|584292264|FG002|Overall Study|Death|0|||
161794660|NCT04828161|584292265|FG003|Overall Study|Death|2|||
161900043|NCT04980014|584682886|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
161900044|NCT04980014|584682886|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
161900045|NCT00940888|584682887|FG000|Overall Study|Unsuccessful Implant|4|||
161900046|NCT00940888|584682887|FG000|Overall Study|Death|461|||
161900047|NCT00940888|584682887|FG000|Overall Study|Withdrawn - Non-Death|364|||
161900048|NCT00940888|584682887|FG000|Overall Study|Lost to Follow-up|6|||
161900049|NCT02250300|584682891|FG000|Expansion Phase|Death|6|||
161900050|NCT02250300|584682892|FG001|Expansion Phase|Death|7|||
161900051|NCT02250300|584682893|FG002|Expansion Phase|Death|0|||
161900052|NCT02250300|584682894|FG003|Expansion Phase|Death|0|||
161900053|NCT00715559|584682896|FG000|Overall Study|medication not tolerated - nausea|1|||
161900054|NCT00758498|584682897|FG000|Overall Study|Adverse Event|2|||
161900055|NCT00758498|584682898|FG001|Overall Study|Adverse Event|2|||
161900056|NCT00758498|584682899|FG002|Overall Study|Adverse Event|3|||
161900057|NCT00758498|584682897|FG000|Overall Study|Subject legally detained out of state|1|||
161900058|NCT00758498|584682898|FG001|Overall Study|Subject legally detained out of state|0|||
161900059|NCT00758498|584682899|FG002|Overall Study|Subject legally detained out of state|0|||
161900060|NCT00758498|584682897|FG000|Overall Study|Withdrawal by Subject|0|||
161900061|NCT00758498|584682898|FG001|Overall Study|Withdrawal by Subject|0|||
161900062|NCT00758498|584682899|FG002|Overall Study|Withdrawal by Subject|1|||
161900063|NCT00758498|584682897|FG000|Overall Study|Noncompliance to study procedures|0|||
161900064|NCT00758498|584682898|FG001|Overall Study|Noncompliance to study procedures|0|||
161900065|NCT00758498|584682899|FG002|Overall Study|Noncompliance to study procedures|1|||
161900066|NCT01516736|584682901|FG000|Overall Study|Withdrawal by Subject|10|||
161900067|NCT01516736|584682902|FG001|Overall Study|Withdrawal by Subject|4|||
161900068|NCT01516736|584682901|FG000|Overall Study|Adverse Event|4|||
161900069|NCT01516736|584682902|FG001|Overall Study|Adverse Event|5|||
161900070|NCT01516736|584682901|FG000|Overall Study|Death|3|||
161900071|NCT01516736|584682902|FG001|Overall Study|Death|1|||
161900072|NCT01516736|584682901|FG000|Overall Study|Physician Decision|2|||
161900073|NCT01516736|584682902|FG001|Overall Study|Physician Decision|1|||
161900074|NCT01516736|584682901|FG000|Overall Study|Lack of Efficacy|1|||
161900075|NCT01516736|584682902|FG001|Overall Study|Lack of Efficacy|0|||
161900076|NCT01516736|584682901|FG000|Overall Study|Protocol Violation|0|||
161900077|NCT01516736|584682902|FG001|Overall Study|Protocol Violation|1|||
161900078|NCT01516736|584682901|FG000|Overall Study|Other (not specified)|0|||
161900079|NCT01516736|584682902|FG001|Overall Study|Other (not specified)|1|||
161900080|NCT02781818|584682903|FG000|Overall Study|Lost to Follow-up|4|||
161900081|NCT02781818|584682904|FG001|Overall Study|Lost to Follow-up|2|||
161900082|NCT02781818|584682905|FG002|Overall Study|Lost to Follow-up|1|||
161900083|NCT00524771|584682906|FG000|Overall Study|Protocol Violation|220|||
161900084|NCT00524771|584682907|FG001|Overall Study|Protocol Violation|585|||
161900085|NCT01877668|584682908|FG000|Overall Study|Death|0|||
161900086|NCT01877668|584682909|FG001|Overall Study|Death|0|||
161900087|NCT01877668|584682910|FG002|Overall Study|Death|0|||
161900088|NCT01877668|584682911|FG003|Overall Study|Death|1|||
161900089|NCT01877668|584682912|FG004|Overall Study|Death|0|||
161900090|NCT01877668|584682908|FG000|Overall Study|No longer met study criteria|1|||
161900091|NCT01877668|584682909|FG001|Overall Study|No longer met study criteria|0|||
161900092|NCT01877668|584682910|FG002|Overall Study|No longer met study criteria|1|||
161900093|NCT01877668|584682911|FG003|Overall Study|No longer met study criteria|0|||
161900094|NCT01877668|584682912|FG004|Overall Study|No longer met study criteria|0|||
161900095|NCT01877668|584682908|FG000|Overall Study|Insufficient clinical response|0|||
161900096|NCT01877668|584682909|FG001|Overall Study|Insufficient clinical response|1|||
161900097|NCT01877668|584682910|FG002|Overall Study|Insufficient clinical response|2|||
161900098|NCT01877668|584682911|FG003|Overall Study|Insufficient clinical response|2|||
161900099|NCT01877668|584682912|FG004|Overall Study|Insufficient clinical response|0|||
161900100|NCT01877668|584682908|FG000|Overall Study|Lost to Follow-up|0|||
161900101|NCT01877668|584682909|FG001|Overall Study|Lost to Follow-up|2|||
161900102|NCT01877668|584682910|FG002|Overall Study|Lost to Follow-up|1|||
161900103|NCT01877668|584682911|FG003|Overall Study|Lost to Follow-up|0|||
161900104|NCT01877668|584682912|FG004|Overall Study|Lost to Follow-up|0|||
161900105|NCT01877668|584682908|FG000|Overall Study|Withdrawal by Subject|2|||
161900106|NCT01877668|584682909|FG001|Overall Study|Withdrawal by Subject|0|||
161900107|NCT01877668|584682910|FG002|Overall Study|Withdrawal by Subject|3|||
161900108|NCT01877668|584682911|FG003|Overall Study|Withdrawal by Subject|2|||
161900109|NCT01877668|584682912|FG004|Overall Study|Withdrawal by Subject|2|||
161900110|NCT01877668|584682908|FG000|Overall Study|Other|1|||
161900111|NCT01877668|584682909|FG001|Overall Study|Other|1|||
161900112|NCT01877668|584682910|FG002|Overall Study|Other|1|||
161900113|NCT01877668|584682911|FG003|Overall Study|Other|1|||
161900114|NCT01877668|584682912|FG004|Overall Study|Other|3|||
161900115|NCT01877668|584682908|FG000|Overall Study|Protocol Violation|1|||
161900116|NCT01877668|584682909|FG001|Overall Study|Protocol Violation|1|||
161900117|NCT01877668|584682910|FG002|Overall Study|Protocol Violation|0|||
161900118|NCT01877668|584682911|FG003|Overall Study|Protocol Violation|0|||
161552457|NCT05033080|583410455|FG001|Overall Study|Other|1|||
161900119|NCT01877668|584682912|FG004|Overall Study|Protocol Violation|3|||
161794661|NCT03093454|584292266|FG000|Overall Study|Withdrawal by Subject|1|||
161794662|NCT03093454|584292267|FG001|Overall Study|Withdrawal by Subject|1|||
161794663|NCT03093454|584292266|FG000|Overall Study|Scheduling conflict|3|||
161794664|NCT03093454|584292267|FG001|Overall Study|Scheduling conflict|1|||
161794665|NCT03093454|584292266|FG000|Overall Study|Physician Decision|2|||
161794666|NCT03093454|584292267|FG001|Overall Study|Physician Decision|1|||
161794667|NCT02524379|584292268|FG000|Overall Study|Death|1|||
161794668|NCT01884025|584292269|FG000|Overall Study|Lost to Follow-up|3|||
161794669|NCT01884025|584292270|FG001|Overall Study|Lost to Follow-up|4|||
161794670|NCT03209570|584292271|FG000|Overall Study|Death|1|||
161794671|NCT03209570|584292272|FG001|Overall Study|Death|0|||
161794672|NCT03209570|584292271|FG000|Overall Study|Incomplete Data|8|||
161794673|NCT03209570|584292272|FG001|Overall Study|Incomplete Data|10|||
161794674|NCT03209570|584292271|FG000|Overall Study|Protocol Violation|1|||
161794675|NCT03209570|584292272|FG001|Overall Study|Protocol Violation|0|||
161794676|NCT03209570|584292271|FG000|Overall Study|Withdrawal by Subject|0|||
161794677|NCT03209570|584292272|FG001|Overall Study|Withdrawal by Subject|3|||
161794678|NCT00755326|584292274|FG000|Overall Study|Lost to Follow-up|2|||
161794679|NCT00755326|584292275|FG001|Overall Study|Lost to Follow-up|3|||
161794680|NCT02623829|584292281|FG000|Overall Study|Lost to Follow-up|1|||
161794681|NCT02623829|584292282|FG001|Overall Study|Lost to Follow-up|1|||
161794682|NCT00662025|584292283|FG000|Overall Study|Objective progression or relapse|51|||
161794683|NCT00662025|584292283|FG000|Overall Study|Adverse Event|7|||
161794684|NCT00662025|584292283|FG000|Overall Study|Withdrawal by Subject|1|||
161794685|NCT00662025|584292283|FG000|Overall Study|Results of other clinical study|2|||
161794686|NCT00662025|584292283|FG000|Overall Study|Target lesion cannot be evaluated|1|||
161794687|NCT00662025|584292283|FG000|Overall Study|Domestic circumstances|1|||
161794688|NCT01333033|584292287|FG000|Overall Study|Ineligible|0|||
161794689|NCT01333033|584292288|FG001|Overall Study|Ineligible|0|||
161794690|NCT01333033|584292289|FG002|Overall Study|Ineligible|0|||
161794691|NCT01333033|584292290|FG003|Overall Study|Ineligible|0|||
161794692|NCT01333033|584292291|FG004|Overall Study|Ineligible|6|||
161794693|NCT01333033|584292292|FG005|Overall Study|Ineligible|8|||
161794694|NCT01333033|584292287|FG000|Overall Study|Withdrawal by Subject|0|||
161794695|NCT01333033|584292288|FG001|Overall Study|Withdrawal by Subject|0|||
161794696|NCT01333033|584292289|FG002|Overall Study|Withdrawal by Subject|0|||
161794697|NCT01333033|584292290|FG003|Overall Study|Withdrawal by Subject|0|||
161794698|NCT01333033|584292291|FG004|Overall Study|Withdrawal by Subject|4|||
161794699|NCT01333033|584292292|FG005|Overall Study|Withdrawal by Subject|2|||
161794700|NCT01333033|584292287|FG000|Overall Study|PET inevaluable|0|||
161794701|NCT01333033|584292288|FG001|Overall Study|PET inevaluable|0|||
161794702|NCT01333033|584292289|FG002|Overall Study|PET inevaluable|0|||
161794703|NCT01333033|584292290|FG003|Overall Study|PET inevaluable|0|||
161794704|NCT01333033|584292291|FG004|Overall Study|PET inevaluable|2|||
161794705|NCT01333033|584292292|FG005|Overall Study|PET inevaluable|4|||
161794706|NCT01333033|584292287|FG000|Overall Study|Adverse Event|0|||
161794707|NCT01333033|584292288|FG001|Overall Study|Adverse Event|0|||
161794708|NCT01333033|584292289|FG002|Overall Study|Adverse Event|0|||
161794709|NCT01333033|584292290|FG003|Overall Study|Adverse Event|0|||
161794710|NCT01333033|584292291|FG004|Overall Study|Adverse Event|2|||
161794711|NCT01333033|584292292|FG005|Overall Study|Adverse Event|1|||
161794712|NCT01333033|584292287|FG000|Overall Study|Progression|0|||
161794713|NCT01333033|584292288|FG001|Overall Study|Progression|0|||
161794714|NCT01333033|584292289|FG002|Overall Study|Progression|0|||
161794715|NCT01333033|584292290|FG003|Overall Study|Progression|0|||
161794716|NCT01333033|584292291|FG004|Overall Study|Progression|0|||
161794717|NCT01333033|584292292|FG005|Overall Study|Progression|1|||
161794718|NCT01333033|584292287|FG000|Overall Study|MD Decision|0|||
161794719|NCT01333033|584292288|FG001|Overall Study|MD Decision|0|||
161794720|NCT01333033|584292289|FG002|Overall Study|MD Decision|0|||
161794721|NCT01333033|584292290|FG003|Overall Study|MD Decision|0|||
161794722|NCT01333033|584292291|FG004|Overall Study|MD Decision|0|||
161794723|NCT01333033|584292292|FG005|Overall Study|MD Decision|2|||
161794724|NCT02162758|584292307|FG000|Overall Study|Study termination|0|||
161794725|NCT02162758|584292308|FG001|Overall Study|Study termination|1|||
161794726|NCT03213210|584292309|FG000|Overall Study|Lost to Follow-up|2|||
161794727|NCT03213210|584292309|FG000|Overall Study|Study termination|3|||
161794728|NCT02843074|584292315|FG000|Overall Study|Withdrawal by Subject|5|||
161794729|NCT02843074|584292315|FG000|Overall Study|Progressive disease|1|||
161794730|NCT02843074|584292315|FG000|Overall Study|Physician Decision|1|||
161794731|NCT02843074|584292315|FG000|Overall Study|Lost to Follow-up|1|||
161794732|NCT02843074|584292315|FG000|Overall Study|Death|9|||
161794733|NCT01564758|584292316|FG000|Overall Study|Death|8|||
161794734|NCT01564758|584292316|FG000|Overall Study|Adverse Event|3|||
161794735|NCT01564758|584292316|FG000|Overall Study|Other|3|||
161794736|NCT01186978|584292317|FG000|Overall Study|Withdrawal by Subject|1|||
161794737|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
161794738|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
161794739|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
161794740|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
161794741|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
161900120|NCT01877668|584682908|FG000|Overall Study|Adverse event related to study drug|2|||
161900121|NCT01877668|584682909|FG001|Overall Study|Adverse event related to study drug|2|||
161900122|NCT01877668|584682910|FG002|Overall Study|Adverse event related to study drug|2|||
161900123|NCT01877668|584682911|FG003|Overall Study|Adverse event related to study drug|2|||
161900124|NCT01877668|584682912|FG004|Overall Study|Adverse event related to study drug|1|||
161900125|NCT01877668|584682908|FG000|Overall Study|Adverse event unrelated to study drug|4|||
161900126|NCT01877668|584682909|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161900127|NCT01877668|584682910|FG002|Overall Study|Adverse event unrelated to study drug|2|||
161900128|NCT01877668|584682911|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161900129|NCT01877668|584682912|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161900130|NCT02317991|584682913|FG000|Overall Study|Adverse Event|12|||
161900131|NCT02317991|584682913|FG000|Overall Study|Death|4|||
161900132|NCT02317991|584682913|FG000|Overall Study|Withdrawal by Subject|8|||
161900133|NCT02317991|584682913|FG000|Overall Study|Progressive Disease|41|||
161900134|NCT01223404|584682914|FG000|First Intervention (1 Day)|Adverse Event|0|||
161900135|NCT01223404|584682915|FG001|First Intervention (1 Day)|Adverse Event|0|||
161900136|NCT01223404|584682916|FG002|First Intervention (1 Day)|Adverse Event|0|||
161900137|NCT01223404|584682917|FG003|First Intervention (1 Day)|Adverse Event|1|||
161900138|NCT01223404|584682918|FG004|First Intervention (1 Day)|Adverse Event|0|||
161900139|NCT01223404|584682919|FG005|First Intervention (1 Day)|Adverse Event|0|||
161900140|NCT01223404|584682914|FG000|Second Intervention (1 Day)|Adverse Event|1|||
161900141|NCT01223404|584682915|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161900142|NCT01223404|584682916|FG002|Second Intervention (1 Day)|Adverse Event|0|||
161900143|NCT01223404|584682917|FG003|Second Intervention (1 Day)|Adverse Event|0|||
161900144|NCT01223404|584682918|FG004|Second Intervention (1 Day)|Adverse Event|0|||
161900145|NCT01223404|584682919|FG005|Second Intervention (1 Day)|Adverse Event|0|||
161900146|NCT01223404|584682914|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900147|NCT01223404|584682915|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900148|NCT01223404|584682916|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900149|NCT01223404|584682917|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
161900150|NCT01223404|584682918|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900151|NCT01223404|584682919|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900152|NCT00707057|584682920|FG000|Overall Study|Withdrawal by Subject|8|||
161900153|NCT00707057|584682921|FG001|Overall Study|Withdrawal by Subject|3|||
161900154|NCT00707057|584682920|FG000|Overall Study|Dosed incorrectly|0|||
161900155|NCT00707057|584682921|FG001|Overall Study|Dosed incorrectly|1|||
161900156|NCT02492165|584682922|FG000|Overall Study|Withdrawal by Subject|0|||
161900157|NCT02492165|584682923|FG001|Overall Study|Withdrawal by Subject|1|||
161900158|NCT02492165|584682924|FG002|Overall Study|Withdrawal by Subject|0|||
161900159|NCT02492165|584682925|FG003|Overall Study|Withdrawal by Subject|0|||
161900160|NCT01697800|584682926|FG000|Overall Study|Death|0|||
161900161|NCT01697800|584682927|FG001|Overall Study|Death|1|||
161900162|NCT00954122|584682928|FG000|Overall Study|Withdrawal by Subject|5|||
161900163|NCT00954122|584682928|FG000|Overall Study|Adverse Event|1|||
161900164|NCT00954122|584682928|FG000|Overall Study|Safety Reason|1|||
161900165|NCT00956839|584682938|FG000|Overall Study|Lost to Follow-up|3|||
161794742|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
161794743|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
161794744|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
161794745|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
161794746|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
161794747|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
161794748|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
161794749|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
161794750|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
161794751|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
161794752|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
161794753|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
161794754|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
161900166|NCT00956839|584682939|FG001|Overall Study|Lost to Follow-up|0|||
161900167|NCT00956839|584682940|FG002|Overall Study|Lost to Follow-up|3|||
161900168|NCT00619827|584682944|FG000|Overall Study|Adverse Event|1|||
161900169|NCT00619827|584682945|FG001|Overall Study|Adverse Event|2|||
161900170|NCT00619827|584682944|FG000|Overall Study|Withdrawal by Subject|2|||
161900171|NCT00619827|584682945|FG001|Overall Study|Withdrawal by Subject|2|||
161900172|NCT02806713|584682946|FG000|Overall Study|Urethral injury during procedure|1|||
161900173|NCT02806713|584682947|FG001|Overall Study|Urethral injury during procedure|0|||
161900174|NCT02806713|584682946|FG000|Overall Study|cancelled surgery|1|||
161446032|NCT02792829|583026231|FG007|Treatment Period 2|Use of proscribed medications|1|||
161900175|NCT02806713|584682947|FG001|Overall Study|cancelled surgery|2|||
161900176|NCT02999789|584682948|FG000|Overall Study|Withdrawal by Subject|0|||
161900177|NCT02999789|584682949|FG001|Overall Study|Withdrawal by Subject|1|||
161900178|NCT02999789|584682948|FG000|Overall Study|Became ineligible|1|||
161794755|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
161794756|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
161794757|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
161794758|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
161794759|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
161794760|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
161794761|NCT02115256|584292329|FG000|Overall Study|Withdrawal by Subject|0|||
161794762|NCT02115256|584292330|FG001|Overall Study|Withdrawal by Subject|1|||
161794763|NCT01789320|584292333|FG000|Overall Study|Re-enrolled into study|1|||
161794764|NCT01789320|584292333|FG000|Overall Study|Lost to Follow-up|1|||
161794765|NCT01533428|584292346|FG000|Overall Study|Adverse Event|0|||
161794766|NCT01533428|584292347|FG001|Overall Study|Adverse Event|1|||
161794767|NCT01533428|584292346|FG000|Overall Study|Lost to Follow-up|2|||
161794768|NCT01533428|584292347|FG001|Overall Study|Lost to Follow-up|1|||
161794769|NCT01533428|584292346|FG000|Overall Study|Withdrawal by Subject|7|||
161794770|NCT01533428|584292347|FG001|Overall Study|Withdrawal by Subject|6|||
161794771|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
161446033|NCT01262820|583026232|FG000|Overall Study|Adverse Event|5|||
161446034|NCT01262820|583026232|FG000|Overall Study|Lack of Efficacy|9|||
161446035|NCT01262820|583026232|FG000|Overall Study|Drug held for 21+ days|1|||
161794772|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
161794773|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
161794774|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
161794775|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
161794776|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
161900179|NCT02999789|584682949|FG001|Overall Study|Became ineligible|2|||
161900180|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
161900181|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900182|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900183|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900184|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900185|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
161900186|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900187|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900188|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900189|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900190|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
161900191|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900192|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900193|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900194|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900195|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
161900196|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161794777|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
161794778|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
161794779|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
161794780|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161900197|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161900198|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161446036|NCT00104520|583026233|FG000|Overall Study|Unrelated adverse event|34|||
161900199|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161900200|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
161900201|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161900202|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161900203|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161900204|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161446037|NCT00104520|583026234|FG001|Overall Study|Unrelated adverse event|47|||
161446038|NCT00104520|583026233|FG000|Overall Study|Study drug intolerance|0|||
161446039|NCT00104520|583026234|FG001|Overall Study|Study drug intolerance|1|||
161446040|NCT00104520|583026233|FG000|Overall Study|Related adverse event|13|||
161446041|NCT00104520|583026234|FG001|Overall Study|Related adverse event|15|||
161446042|NCT00104520|583026233|FG000|Overall Study|Lost to Follow-up|1|||
161794781|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
161900205|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
161794782|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161794783|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
161794784|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
161900206|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161446043|NCT00104520|583026234|FG001|Overall Study|Lost to Follow-up|0|||
161446044|NCT00104520|583026233|FG000|Overall Study|Noncompliance|0|||
161446045|NCT00104520|583026234|FG001|Overall Study|Noncompliance|2|||
161446046|NCT00104520|583026233|FG000|Overall Study|Personal/administrative|1|||
161900207|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161900208|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161900209|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161900210|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
161900211|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900212|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900213|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900214|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900215|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900216|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900217|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900218|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161900219|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900220|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900221|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900222|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
161900223|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900224|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900225|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161900226|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
161900227|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161900228|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
161900229|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161900230|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900231|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900232|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900233|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
161900234|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900235|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900236|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900237|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900238|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900239|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
161900240|NCT02824224|584682955|FG000|Overall Study|Discontinued, IUS expulsion|0|||
161900241|NCT02824224|584682956|FG001|Overall Study|Discontinued, IUS expulsion|1|||
161900242|NCT02824224|584682955|FG000|Overall Study|Did not show up for allocation visit|2|||
161900243|NCT02824224|584682956|FG001|Overall Study|Did not show up for allocation visit|0|||
161900244|NCT00368108|584682959|FG000|Overall Study|Adverse Event|38|||
161900245|NCT00368108|584682960|FG001|Overall Study|Adverse Event|26|||
161900246|NCT00368108|584682961|FG002|Overall Study|Adverse Event|44|||
161900247|NCT00368108|584682959|FG000|Overall Study|Abnormal Laboratory Value|0|||
161900248|NCT00368108|584682960|FG001|Overall Study|Abnormal Laboratory Value|0|||
161900249|NCT00368108|584682961|FG002|Overall Study|Abnormal Laboratory Value|3|||
161900250|NCT00368108|584682959|FG000|Overall Study|Protocol Violation|5|||
161900251|NCT00368108|584682960|FG001|Overall Study|Protocol Violation|9|||
161900252|NCT00368108|584682961|FG002|Overall Study|Protocol Violation|9|||
161900253|NCT00368108|584682959|FG000|Overall Study|Withdrawal by Subject|9|||
161900254|NCT00368108|584682960|FG001|Overall Study|Withdrawal by Subject|3|||
161900255|NCT00368108|584682961|FG002|Overall Study|Withdrawal by Subject|5|||
161900256|NCT00368108|584682959|FG000|Overall Study|Lack of Efficacy|7|||
161900257|NCT00368108|584682960|FG001|Overall Study|Lack of Efficacy|8|||
161900258|NCT00368108|584682961|FG002|Overall Study|Lack of Efficacy|5|||
161900259|NCT00368108|584682959|FG000|Overall Study|Physician Decision|2|||
161900260|NCT00368108|584682960|FG001|Overall Study|Physician Decision|0|||
161900261|NCT00368108|584682961|FG002|Overall Study|Physician Decision|1|||
161900262|NCT00368108|584682959|FG000|Overall Study|Other|3|||
161900263|NCT00368108|584682960|FG001|Overall Study|Other|7|||
161900264|NCT00368108|584682961|FG002|Overall Study|Other|1|||
161900265|NCT02299388|584682966|FG000|Overall Study|Withdrawal by Subject|0|||
161900266|NCT02299388|584682967|FG001|Overall Study|Withdrawal by Subject|1|||
161900267|NCT01093586|584682972|FG000|Overall Study|Failed to engraft|3|||
161900268|NCT03442088|584682973|FG000|Overall Study|Adverse Event|1|||
161446047|NCT00104520|583026234|FG001|Overall Study|Personal/administrative|1|||
161446048|NCT00104520|583026233|FG000|Overall Study|Other|1|||
161446049|NCT00104520|583026234|FG001|Overall Study|Other|5|||
161900269|NCT03442088|584682973|FG000|Overall Study|Lack of Efficacy|2|||
161900270|NCT03442088|584682973|FG000|Overall Study|Lost to Follow-up|2|||
161446050|NCT00912197|583026239|FG000|Overall Study|Withdrawal by Subject|3|||
161446051|NCT00912197|583026240|FG001|Overall Study|Withdrawal by Subject|3|||
161900271|NCT00357877|584682976|FG000|Overall Study|Death|2|||
161794785|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
161794786|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
161794787|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
161794788|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
161794789|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
161794790|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
161794791|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
161794792|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
161794793|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
161794794|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
161794795|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
161794796|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
161794797|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
161794798|NCT01688037|584292348|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
161794799|NCT01688037|584292349|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
161794800|NCT01688037|584292350|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
161794801|NCT02102490|584292356|FG000|Overall Study|Death|6|||
161794802|NCT02102490|584292356|FG000|Overall Study|Lost to Follow-up|1|||
161794803|NCT00095199|584292357|FG000|Overall Study|Adverse Event|40|||
161794804|NCT00095199|584292358|FG001|Overall Study|Adverse Event|22|||
161794805|NCT00095199|584292359|FG002|Overall Study|Adverse Event|26|||
161794806|NCT00095199|584292360|FG003|Overall Study|Adverse Event|11|||
161794807|NCT00095199|584292357|FG000|Overall Study|Progressive disease|213|||
161794808|NCT00095199|584292358|FG001|Overall Study|Progressive disease|179|||
161794809|NCT00095199|584292359|FG002|Overall Study|Progressive disease|105|||
161794810|NCT00095199|584292360|FG003|Overall Study|Progressive disease|98|||
161794811|NCT00095199|584292357|FG000|Overall Study|Death|10|||
161794812|NCT00095199|584292358|FG001|Overall Study|Death|6|||
161794813|NCT00095199|584292359|FG002|Overall Study|Death|11|||
161794814|NCT00095199|584292360|FG003|Overall Study|Death|9|||
161794815|NCT00095199|584292357|FG000|Overall Study|Withdrawal by Subject|21|||
161794816|NCT00095199|584292358|FG001|Overall Study|Withdrawal by Subject|16|||
161794817|NCT00095199|584292359|FG002|Overall Study|Withdrawal by Subject|13|||
161794818|NCT00095199|584292360|FG003|Overall Study|Withdrawal by Subject|22|||
161794819|NCT00095199|584292357|FG000|Overall Study|Protocol Violation|4|||
161794820|NCT00095199|584292358|FG001|Overall Study|Protocol Violation|4|||
161794821|NCT00095199|584292359|FG002|Overall Study|Protocol Violation|2|||
161794822|NCT00095199|584292360|FG003|Overall Study|Protocol Violation|0|||
161794823|NCT00095199|584292357|FG000|Overall Study|Liver function test results elevated|0|||
161794824|NCT00095199|584292358|FG001|Overall Study|Liver function test results elevated|0|||
161794825|NCT00095199|584292359|FG002|Overall Study|Liver function test results elevated|1|||
161794826|NCT00095199|584292360|FG003|Overall Study|Liver function test results elevated|1|||
161794827|NCT00095199|584292357|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
161794828|NCT00095199|584292358|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
161794829|NCT00095199|584292359|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
161794830|NCT00095199|584292360|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
161794831|NCT00095199|584292357|FG000|Overall Study|Physician Decision|5|||
161794832|NCT00095199|584292358|FG001|Overall Study|Physician Decision|6|||
161794833|NCT00095199|584292359|FG002|Overall Study|Physician Decision|1|||
161794834|NCT00095199|584292360|FG003|Overall Study|Physician Decision|1|||
161794835|NCT00095199|584292357|FG000|Overall Study|Not eligible|1|||
161794836|NCT00095199|584292358|FG001|Overall Study|Not eligible|7|||
161794837|NCT00095199|584292359|FG002|Overall Study|Not eligible|0|||
161794838|NCT00095199|584292360|FG003|Overall Study|Not eligible|1|||
161794839|NCT00095199|584292357|FG000|Overall Study|Started Palliative Radiotherapy|1|||
161794840|NCT00095199|584292358|FG001|Overall Study|Started Palliative Radiotherapy|0|||
161794841|NCT00095199|584292359|FG002|Overall Study|Started Palliative Radiotherapy|0|||
161794842|NCT00095199|584292360|FG003|Overall Study|Started Palliative Radiotherapy|0|||
161794843|NCT00095199|584292357|FG000|Overall Study|Started radiotherapy regimen|0|||
161794844|NCT00095199|584292358|FG001|Overall Study|Started radiotherapy regimen|1|||
161794845|NCT00095199|584292359|FG002|Overall Study|Started radiotherapy regimen|0|||
161794846|NCT00095199|584292360|FG003|Overall Study|Started radiotherapy regimen|0|||
161794847|NCT00095199|584292357|FG000|Overall Study|Primary tumor removed in other surgery|0|||
161794848|NCT00095199|584292358|FG001|Overall Study|Primary tumor removed in other surgery|1|||
161794849|NCT00095199|584292359|FG002|Overall Study|Primary tumor removed in other surgery|0|||
161794850|NCT00095199|584292360|FG003|Overall Study|Primary tumor removed in other surgery|0|||
161794851|NCT00095199|584292357|FG000|Overall Study|Data inadvertently lost by site|1|||
161794852|NCT00095199|584292358|FG001|Overall Study|Data inadvertently lost by site|0|||
161794853|NCT00095199|584292359|FG002|Overall Study|Data inadvertently lost by site|0|||
161794854|NCT00095199|584292360|FG003|Overall Study|Data inadvertently lost by site|0|||
161794855|NCT03896490|584292395|FG000|Overall Study|Withdrawal by Subject|1|||
161794856|NCT03896490|584292396|FG001|Overall Study|Withdrawal by Subject|1|||
161794857|NCT00385541|584292399|FG000|Overall Study|severe pain, clinician requested unblind|0|||
161900272|NCT00357877|584682977|FG001|Overall Study|Death|1|||
161900273|NCT00357877|584682976|FG000|Overall Study|Lost to Follow-up|20|||
161900274|NCT00357877|584682977|FG001|Overall Study|Lost to Follow-up|23|||
161900275|NCT00357877|584682976|FG000|Overall Study|Withdrawal by Subject|3|||
161900276|NCT00357877|584682977|FG001|Overall Study|Withdrawal by Subject|3|||
161900277|NCT00357877|584682976|FG000|Overall Study|Administrative withdrawal|1|||
161900278|NCT00357877|584682977|FG001|Overall Study|Administrative withdrawal|1|||
161900279|NCT00357877|584682976|FG000|Overall Study|Other|0|||
161900280|NCT00357877|584682977|FG001|Overall Study|Other|2|||
161900281|NCT01051557|584682978|FG000|Overall Study|Physician Decision|1|||
161900282|NCT01051557|584682979|FG001|Overall Study|Physician Decision|0|||
161900283|NCT01051557|584682980|FG002|Overall Study|Physician Decision|0|||
161900284|NCT01051557|584682981|FG003|Overall Study|Physician Decision|0|||
161900285|NCT01051557|584682982|FG004|Overall Study|Physician Decision|0|||
161900286|NCT01051557|584682983|FG005|Overall Study|Physician Decision|0|||
161900287|NCT01051557|584682984|FG006|Overall Study|Physician Decision|0|||
161900288|NCT01051557|584682978|FG000|Overall Study|disease progression|3|||
161900289|NCT01051557|584682979|FG001|Overall Study|disease progression|3|||
161900290|NCT01051557|584682980|FG002|Overall Study|disease progression|5|||
161900291|NCT01051557|584682981|FG003|Overall Study|disease progression|2|||
161900292|NCT01051557|584682982|FG004|Overall Study|disease progression|4|||
161900293|NCT01051557|584682983|FG005|Overall Study|disease progression|3|||
161900294|NCT01051557|584682984|FG006|Overall Study|disease progression|1|||
161900295|NCT01051557|584682978|FG000|Overall Study|Withdrawal by Subject|0|||
161900296|NCT01051557|584682979|FG001|Overall Study|Withdrawal by Subject|0|||
161900297|NCT01051557|584682980|FG002|Overall Study|Withdrawal by Subject|1|||
161900298|NCT01051557|584682981|FG003|Overall Study|Withdrawal by Subject|0|||
161900299|NCT01051557|584682982|FG004|Overall Study|Withdrawal by Subject|2|||
161900300|NCT01051557|584682983|FG005|Overall Study|Withdrawal by Subject|0|||
161900301|NCT01051557|584682984|FG006|Overall Study|Withdrawal by Subject|1|||
161900302|NCT01051557|584682978|FG000|Overall Study|Adverse Event|0|||
161900303|NCT01051557|584682979|FG001|Overall Study|Adverse Event|0|||
161900304|NCT01051557|584682980|FG002|Overall Study|Adverse Event|0|||
161900305|NCT01051557|584682981|FG003|Overall Study|Adverse Event|1|||
161900306|NCT01051557|584682982|FG004|Overall Study|Adverse Event|1|||
161900307|NCT01051557|584682983|FG005|Overall Study|Adverse Event|3|||
161900308|NCT01051557|584682984|FG006|Overall Study|Adverse Event|4|||
161900309|NCT00613366|584682991|FG000|Overall Study|Withdrawal by Subject|3|||
161900310|NCT00613366|584682992|FG001|Overall Study|Withdrawal by Subject|2|||
161900311|NCT00943397|584682993|FG000|Overall Study|Adverse Event|0|||
161900312|NCT00943397|584682994|FG001|Overall Study|Adverse Event|6|||
161900313|NCT00943397|584682993|FG000|Overall Study|Lost to Follow-up|0|||
161900314|NCT00943397|584682994|FG001|Overall Study|Lost to Follow-up|4|||
161900315|NCT00943397|584682993|FG000|Overall Study|Protocol Violation|2|||
161900316|NCT00943397|584682994|FG001|Overall Study|Protocol Violation|5|||
161900317|NCT00943397|584682993|FG000|Overall Study|Withdrawal by Subject|1|||
161900318|NCT00943397|584682994|FG001|Overall Study|Withdrawal by Subject|1|||
161900319|NCT00943397|584682993|FG000|Overall Study|Site terminated and other|12|||
161900320|NCT00943397|584682994|FG001|Overall Study|Site terminated and other|56|||
161900321|NCT04878055|584682995|FG000|Overall Study|Patient transferred in another department|0|||
161900322|NCT04878055|584682996|FG001|Overall Study|Patient transferred in another department|2|||
161900323|NCT04878055|584682995|FG000|Overall Study|Physician Decision|1|||
161900324|NCT04878055|584682996|FG001|Overall Study|Physician Decision|1|||
161900325|NCT04878055|584682995|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
161900326|NCT04878055|584682996|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
161900327|NCT04878055|584682995|FG000|Overall Study|Adverse Event|12|||
161900328|NCT04878055|584682996|FG001|Overall Study|Adverse Event|7|||
161900329|NCT04878055|584682995|FG000|Overall Study|Other|5|||
161900330|NCT04878055|584682996|FG001|Overall Study|Other|0|||
161900331|NCT04878055|584682995|FG000|Overall Study|Withdrawal by Subject|7|||
161900332|NCT04878055|584682996|FG001|Overall Study|Withdrawal by Subject|3|||
161446052|NCT03304249|583026245|FG000|Overall Study|Lost to Follow-up|8|||
161446053|NCT03304249|583026246|FG001|Overall Study|Lost to Follow-up|10|||
161446054|NCT03304249|583026245|FG000|Overall Study|Withdrawal by Subject|12|||
161446055|NCT03304249|583026246|FG001|Overall Study|Withdrawal by Subject|2|||
161900333|NCT04878055|584682995|FG000|Overall Study|Lost to Follow-up|10|||
161900334|NCT04878055|584682996|FG001|Overall Study|Lost to Follow-up|1|||
161900335|NCT01968811|584682997|FG000|Overall Study|Protocol Violation|4|||
161900336|NCT01968811|584682997|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
161900337|NCT01178125|584682998|FG000|Overall Study|Lost to Follow-up|397|||
161900338|NCT01178125|584682998|FG000|Overall Study|Adverse Event|244|||
161900339|NCT01178125|584682998|FG000|Overall Study|Withdrawal by Subject|209|||
161900340|NCT01178125|584682998|FG000|Overall Study|Noncompliance|184|||
161900341|NCT01178125|584682998|FG000|Overall Study|Pregnancy|55|||
161900342|NCT01178125|584682998|FG000|Overall Study|Other Reason|39|||
161900343|NCT01178125|584682998|FG000|Overall Study|Sponsor Decision|28|||
161900344|NCT01178125|584682998|FG000|Overall Study|Protocol Violation|17|||
161900345|NCT01178125|584682998|FG000|Overall Study|Investigator Decision|5|||
161446056|NCT03304249|583026245|FG000|Overall Study|Moved Out of District|4|||
161446057|NCT03304249|583026246|FG001|Overall Study|Moved Out of District|2|||
161446058|NCT05064358|583026250|FG000|Overall Study|Death|23|||
161446059|NCT05064358|583026251|FG001|Overall Study|Death|23|||
161446060|NCT05064358|583026252|FG002|Overall Study|Death|25|||
161446061|NCT05064358|583026253|FG003|Overall Study|Death|21|||
161446062|NCT05064358|583026254|FG004|Overall Study|Death|5|||
161446063|NCT05064358|583026250|FG000|Overall Study|Lost to Follow-up|1|||
161446064|NCT05064358|583026251|FG001|Overall Study|Lost to Follow-up|2|||
161446065|NCT05064358|583026252|FG002|Overall Study|Lost to Follow-up|0|||
161446066|NCT05064358|583026253|FG003|Overall Study|Lost to Follow-up|2|||
161446067|NCT05064358|583026254|FG004|Overall Study|Lost to Follow-up|0|||
161446068|NCT05064358|583026250|FG000|Overall Study|Physician Decision|1|||
161446069|NCT05064358|583026251|FG001|Overall Study|Physician Decision|1|||
161446070|NCT05064358|583026252|FG002|Overall Study|Physician Decision|2|||
161446071|NCT05064358|583026253|FG003|Overall Study|Physician Decision|0|||
161446072|NCT05064358|583026254|FG004|Overall Study|Physician Decision|0|||
161446073|NCT05064358|583026250|FG000|Overall Study|Withdrawal by Subject|4|||
161446074|NCT05064358|583026251|FG001|Overall Study|Withdrawal by Subject|5|||
161446075|NCT05064358|583026252|FG002|Overall Study|Withdrawal by Subject|3|||
161446076|NCT05064358|583026253|FG003|Overall Study|Withdrawal by Subject|6|||
161446077|NCT05064358|583026254|FG004|Overall Study|Withdrawal by Subject|3|||
161446078|NCT05064358|583026250|FG000|Overall Study|Ongoing at the time of analysis|1|||
161446079|NCT05064358|583026251|FG001|Overall Study|Ongoing at the time of analysis|2|||
161446080|NCT05064358|583026252|FG002|Overall Study|Ongoing at the time of analysis|2|||
161446081|NCT05064358|583026253|FG003|Overall Study|Ongoing at the time of analysis|2|||
161446082|NCT05064358|583026254|FG004|Overall Study|Ongoing at the time of analysis|2|||
161446083|NCT04976192|583026256|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446084|NCT04976192|583026257|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
161446085|NCT04976192|583026258|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446086|NCT04976192|583026259|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446087|NCT04976192|583026260|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446088|NCT04976192|583026261|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446089|NCT04976192|583026262|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446090|NCT04976192|583026263|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446091|NCT04976192|583026264|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446092|NCT04976192|583026265|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161446093|NCT04976192|583026256|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
161446094|NCT04976192|583026257|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
161446095|NCT04976192|583026258|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
161446096|NCT04976192|583026259|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161446097|NCT04976192|583026260|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446098|NCT04976192|583026261|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446099|NCT04976192|583026262|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446100|NCT04976192|583026263|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446101|NCT04976192|583026264|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446102|NCT04976192|583026265|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446103|NCT04976192|583026256|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
161446104|NCT04976192|583026257|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446105|NCT04976192|583026258|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
161446106|NCT04976192|583026259|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446107|NCT04976192|583026260|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446108|NCT04976192|583026261|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446109|NCT04976192|583026262|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446110|NCT04976192|583026263|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446111|NCT04976192|583026264|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446112|NCT04976192|583026265|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
161446113|NCT04976192|583026256|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446114|NCT04976192|583026257|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446115|NCT04976192|583026258|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446116|NCT04976192|583026259|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161446117|NCT04976192|583026260|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
161446118|NCT04976192|583026261|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
161446119|NCT04976192|583026262|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161446120|NCT04976192|583026263|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
161446121|NCT04976192|583026264|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
161446122|NCT04976192|583026265|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
161900346|NCT00268983|584683006|FG000|Overall Study|Death|3|||
161900347|NCT00268983|584683007|FG001|Overall Study|Death|0|||
161900348|NCT00249873|584683008|FG000|Overall Study|Not treated|7|||
161446123|NCT04976192|583026256|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446124|NCT04976192|583026257|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446125|NCT04976192|583026258|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446126|NCT04976192|583026259|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446127|NCT04976192|583026260|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
161446128|NCT04976192|583026261|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446129|NCT04976192|583026262|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446130|NCT04976192|583026263|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446131|NCT04976192|583026264|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446132|NCT04976192|583026265|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161446133|NCT04976192|583026256|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446134|NCT04976192|583026257|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446135|NCT04976192|583026258|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446136|NCT04976192|583026259|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446137|NCT04976192|583026260|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446138|NCT04976192|583026261|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161446139|NCT04976192|583026262|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446140|NCT04976192|583026263|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446141|NCT04976192|583026264|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446142|NCT04976192|583026265|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161446143|NCT01395524|583028140|FG000|Overall Study|Non-compliance with study schedule|1|||
161446144|NCT01395524|583028141|FG001|Overall Study|Non-compliance with study schedule|0|||
161446145|NCT01395524|583028142|FG002|Overall Study|Non-compliance with study schedule|1|||
161446146|NCT01395524|583028140|FG000|Overall Study|Lost to Follow-up|3|||
161446147|NCT01395524|583028141|FG001|Overall Study|Lost to Follow-up|1|||
161446148|NCT01395524|583028142|FG002|Overall Study|Lost to Follow-up|1|||
161446149|NCT01395524|583028140|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
161446150|NCT01395524|583028141|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
161446151|NCT01395524|583028142|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
161446152|NCT01395524|583028140|FG000|Overall Study|Severe noncompliance with protocol|1|||
161446153|NCT01395524|583028141|FG001|Overall Study|Severe noncompliance with protocol|0|||
161446154|NCT01395524|583028142|FG002|Overall Study|Severe noncompliance with protocol|0|||
161446155|NCT01395524|583028140|FG000|Overall Study|Adverse Event|4|||
161446156|NCT01395524|583028141|FG001|Overall Study|Adverse Event|4|||
161446157|NCT01395524|583028142|FG002|Overall Study|Adverse Event|3|||
161446158|NCT01395524|583028140|FG000|Overall Study|Death|1|||
161446159|NCT01395524|583028141|FG001|Overall Study|Death|0|||
161446160|NCT01395524|583028142|FG002|Overall Study|Death|0|||
161446161|NCT01395524|583028140|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
161446162|NCT01395524|583028141|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161446163|NCT01395524|583028142|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161446164|NCT01395524|583028140|FG000|Overall Study|Withdrawal by Subject|4|||
161446165|NCT01395524|583028141|FG001|Overall Study|Withdrawal by Subject|8|||
161446166|NCT01395524|583028142|FG002|Overall Study|Withdrawal by Subject|8|||
161446167|NCT01395524|583028140|FG000|Overall Study|Did not receive treatment|1|||
161446168|NCT01395524|583028141|FG001|Overall Study|Did not receive treatment|1|||
161446169|NCT01395524|583028142|FG002|Overall Study|Did not receive treatment|3|||
161446170|NCT01395524|583028140|FG000|Overall Study|Subject had spinal surgery|0|||
161446171|NCT01395524|583028141|FG001|Overall Study|Subject had spinal surgery|0|||
161446172|NCT01395524|583028142|FG002|Overall Study|Subject had spinal surgery|1|||
161446173|NCT00122980|583028153|FG000|Overall Study|Death|0|||
161446174|NCT00122980|583028154|FG001|Overall Study|Death|1|||
161446175|NCT00122980|583028153|FG000|Overall Study|Physician Decision|2|||
161446176|NCT00122980|583028154|FG001|Overall Study|Physician Decision|0|||
161446177|NCT00122980|583028153|FG000|Overall Study|Protocol Violation|5|||
161446178|NCT00122980|583028154|FG001|Overall Study|Protocol Violation|1|||
161446179|NCT00122980|583028153|FG000|Overall Study|Withdrawal by Subject|2|||
161446180|NCT00122980|583028154|FG001|Overall Study|Withdrawal by Subject|3|||
161446181|NCT00122980|583028153|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
161446182|NCT00122980|583028154|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
161446183|NCT00122980|583028153|FG000|Overall Study|Study termination|27|||
161446184|NCT00122980|583028154|FG001|Overall Study|Study termination|35|||
161446185|NCT02175199|583028155|FG000|Overall Study|Withdrawal by Subject|1|||
161446186|NCT02175199|583028156|FG001|Overall Study|Withdrawal by Subject|5|||
161446187|NCT02175199|583028155|FG000|Overall Study|Randomized in Error|1|||
161446188|NCT02175199|583028156|FG001|Overall Study|Randomized in Error|0|||
161446189|NCT02175199|583028155|FG000|Overall Study|Sponsor Decision|1|||
161446190|NCT02175199|583028156|FG001|Overall Study|Sponsor Decision|0|||
161446191|NCT01124864|583028159|FG000|Overall Study|Follow up phase competed as per protocol|18|||
161446192|NCT01124864|583028160|FG001|Overall Study|Follow up phase competed as per protocol|22|||
161446193|NCT01124864|583028161|FG002|Overall Study|Follow up phase competed as per protocol|24|||
161446194|NCT01124864|583028162|FG003|Overall Study|Follow up phase competed as per protocol|18|||
161446195|NCT01124864|583028163|FG004|Overall Study|Follow up phase competed as per protocol|26|||
161446196|NCT01124864|583028164|FG005|Overall Study|Follow up phase competed as per protocol|2|||
161446197|NCT01124864|583028159|FG000|Overall Study|Death|6|||
161446198|NCT01124864|583028160|FG001|Overall Study|Death|9|||
161446199|NCT01124864|583028161|FG002|Overall Study|Death|6|||
161446200|NCT01124864|583028162|FG003|Overall Study|Death|2|||
161446201|NCT01124864|583028163|FG004|Overall Study|Death|1|||
161446202|NCT01124864|583028164|FG005|Overall Study|Death|0|||
161446203|NCT01124864|583028159|FG000|Overall Study|Withdrawal by Subject|2|||
161446204|NCT01124864|583028160|FG001|Overall Study|Withdrawal by Subject|3|||
161446205|NCT01124864|583028161|FG002|Overall Study|Withdrawal by Subject|4|||
161446206|NCT01124864|583028162|FG003|Overall Study|Withdrawal by Subject|0|||
161446207|NCT01124864|583028163|FG004|Overall Study|Withdrawal by Subject|2|||
161446208|NCT01124864|583028164|FG005|Overall Study|Withdrawal by Subject|1|||
161446209|NCT01124864|583028159|FG000|Overall Study|Lost to Follow-up|1|||
161446210|NCT01124864|583028160|FG001|Overall Study|Lost to Follow-up|1|||
161446211|NCT01124864|583028161|FG002|Overall Study|Lost to Follow-up|0|||
161446212|NCT01124864|583028162|FG003|Overall Study|Lost to Follow-up|1|||
161446213|NCT01124864|583028163|FG004|Overall Study|Lost to Follow-up|0|||
161446214|NCT01124864|583028164|FG005|Overall Study|Lost to Follow-up|0|||
161446215|NCT01124864|583028159|FG000|Overall Study|Protocol Violation|1|||
161446216|NCT01124864|583028160|FG001|Overall Study|Protocol Violation|0|||
161446217|NCT01124864|583028161|FG002|Overall Study|Protocol Violation|0|||
161446218|NCT01124864|583028162|FG003|Overall Study|Protocol Violation|0|||
161446219|NCT01124864|583028163|FG004|Overall Study|Protocol Violation|1|||
161446220|NCT01124864|583028164|FG005|Overall Study|Protocol Violation|0|||
161446221|NCT00798759|583028167|FG000|Overall Study|Adverse Event|3|||
161446222|NCT00798759|583028168|FG001|Overall Study|Adverse Event|3|||
161446223|NCT00798759|583028167|FG000|Overall Study|Lost to Follow-up|1|||
161446224|NCT00798759|583028168|FG001|Overall Study|Lost to Follow-up|1|||
161446225|NCT00798759|583028167|FG000|Overall Study|Protocol Violation|4|||
161446226|NCT00798759|583028168|FG001|Overall Study|Protocol Violation|8|||
161446227|NCT00798759|583028167|FG000|Overall Study|Other|0|||
161446228|NCT00798759|583028168|FG001|Overall Study|Other|1|||
161446229|NCT00724711|583028169|FG000|Overall Study|Adverse Event|7|||
161446230|NCT00724711|583028170|FG001|Overall Study|Adverse Event|3|||
161446231|NCT00724711|583028169|FG000|Overall Study|Pregnancy|0|||
161446232|NCT00724711|583028170|FG001|Overall Study|Pregnancy|1|||
161446233|NCT00724711|583028169|FG000|Overall Study|Lack of Efficacy|0|||
161446234|NCT00724711|583028170|FG001|Overall Study|Lack of Efficacy|1|||
161446235|NCT00724711|583028169|FG000|Overall Study|Physician Decision|0|||
161446236|NCT00724711|583028170|FG001|Overall Study|Physician Decision|3|||
161446237|NCT00724711|583028169|FG000|Overall Study|Withdrawal by Subject|5|||
161446238|NCT00724711|583028170|FG001|Overall Study|Withdrawal by Subject|4|||
161446239|NCT00724711|583028169|FG000|Overall Study|Lost to Follow-up|4|||
161446240|NCT00724711|583028170|FG001|Overall Study|Lost to Follow-up|5|||
161446241|NCT00724711|583028169|FG000|Overall Study|Protocol Violation|1|||
161446242|NCT00724711|583028170|FG001|Overall Study|Protocol Violation|0|||
161446243|NCT03387111|583028171|FG000|Overall Study|Progressive Disease|3|||
161446244|NCT03387111|583028171|FG000|Overall Study|Other|1|||
161446245|NCT00727441|583028175|FG000|Overall Study|Disease Progression|11|||
161446246|NCT00727441|583028176|FG001|Overall Study|Disease Progression|14|||
161446247|NCT00727441|583028177|FG002|Overall Study|Disease Progression|17|||
161446248|NCT00727441|583028175|FG000|Overall Study|Eligibility|7|||
161446249|NCT00727441|583028176|FG001|Overall Study|Eligibility|5|||
161446250|NCT00727441|583028177|FG002|Overall Study|Eligibility|7|||
161446251|NCT00727441|583028175|FG000|Overall Study|Death|0|||
161446252|NCT00727441|583028176|FG001|Overall Study|Death|1|||
161446253|NCT00727441|583028177|FG002|Overall Study|Death|1|||
161446254|NCT00727441|583028175|FG000|Overall Study|Physician Decision|0|||
161446255|NCT00727441|583028176|FG001|Overall Study|Physician Decision|1|||
161446256|NCT00727441|583028177|FG002|Overall Study|Physician Decision|0|||
161446257|NCT00727441|583028175|FG000|Overall Study|Withdrawal by Subject|0|||
161446258|NCT00727441|583028176|FG001|Overall Study|Withdrawal by Subject|1|||
161446259|NCT00727441|583028177|FG002|Overall Study|Withdrawal by Subject|0|||
161446260|NCT01239992|583028178|FG000|Overall Study|Withdrawal by Subject|2|||
161446261|NCT00535288|583028179|FG000|Overall Study|Adverse Event|20|||
161446262|NCT00535288|583028180|FG001|Overall Study|Adverse Event|19|||
161446263|NCT00535288|583028181|FG002|Overall Study|Adverse Event|25|||
161446264|NCT00535288|583028182|FG003|Overall Study|Adverse Event|20|||
161446265|NCT00535288|583028183|FG004|Overall Study|Adverse Event|30|||
161446266|NCT00535288|583028179|FG000|Overall Study|Lost to Follow-up|0|||
161446267|NCT00535288|583028180|FG001|Overall Study|Lost to Follow-up|3|||
161446268|NCT00535288|583028181|FG002|Overall Study|Lost to Follow-up|0|||
161446269|NCT00535288|583028182|FG003|Overall Study|Lost to Follow-up|0|||
161446270|NCT00535288|583028183|FG004|Overall Study|Lost to Follow-up|0|||
161446271|NCT00535288|583028179|FG000|Overall Study|Lack of Efficacy|26|||
161446272|NCT00535288|583028180|FG001|Overall Study|Lack of Efficacy|3|||
161446273|NCT00535288|583028181|FG002|Overall Study|Lack of Efficacy|4|||
161446274|NCT00535288|583028182|FG003|Overall Study|Lack of Efficacy|4|||
161446275|NCT00535288|583028183|FG004|Overall Study|Lack of Efficacy|7|||
161446276|NCT00535288|583028179|FG000|Overall Study|Unwilling to cooperate|6|||
161446277|NCT00535288|583028180|FG001|Overall Study|Unwilling to cooperate|6|||
161446278|NCT00535288|583028181|FG002|Overall Study|Unwilling to cooperate|3|||
161446279|NCT00535288|583028182|FG003|Overall Study|Unwilling to cooperate|3|||
161446280|NCT00535288|583028183|FG004|Overall Study|Unwilling to cooperate|4|||
161446281|NCT00535288|583028179|FG000|Overall Study|Other|2|||
161446282|NCT00535288|583028180|FG001|Overall Study|Other|1|||
161446283|NCT00535288|583028181|FG002|Overall Study|Other|1|||
161446284|NCT00535288|583028182|FG003|Overall Study|Other|2|||
161446285|NCT00535288|583028183|FG004|Overall Study|Other|1|||
161446286|NCT02810444|583028184|FG000|Overall Study|Screen Failures|14|||
161446287|NCT02810444|583028184|FG000|Overall Study|Withdrawal by Subject|4|||
161446288|NCT02810444|583028184|FG000|Overall Study|Adverse Event|3|||
161446289|NCT02147561|583028185|FG000|Overall Study|Lost to Follow-up|3|||
161446290|NCT02147561|583028185|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
161446291|NCT02283762|583028186|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
161446292|NCT02283762|583028187|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
161446293|NCT02283762|583028186|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
161446294|NCT02283762|583028187|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
161446295|NCT02283762|583028186|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
161446296|NCT02283762|583028187|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
161446297|NCT02283762|583028186|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
161446298|NCT02283762|583028187|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
161446299|NCT02283762|583028186|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
161446300|NCT02283762|583028187|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
161446301|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
161446302|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
161446303|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
161446304|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
161446305|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
161446306|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
161446307|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
161446308|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
161446309|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
161446310|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
161446311|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
161446312|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
161446313|NCT02283762|583028186|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
161446314|NCT02283762|583028187|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
161446315|NCT00202878|583028191|FG000|Overall Study|Death|964|||
161446316|NCT00202878|583028192|FG001|Overall Study|Death|968|||
161446317|NCT00202878|583028191|FG000|Overall Study|Only Vital Status Known|357|||
161446318|NCT00202878|583028192|FG001|Overall Study|Only Vital Status Known|356|||
161446319|NCT00202878|583028191|FG000|Overall Study|Lost to Follow-up|44|||
161446320|NCT00202878|583028192|FG001|Overall Study|Lost to Follow-up|49|||
161446321|NCT00202878|583028191|FG000|Overall Study|Site Closure|39|||
161446322|NCT00202878|583028192|FG001|Overall Study|Site Closure|36|||
161446323|NCT00202878|583028191|FG000|Overall Study|Withdrawal by Subject|795|||
161446324|NCT00202878|583028192|FG001|Overall Study|Withdrawal by Subject|808|||
161446325|NCT02123472|583028193|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
161446326|NCT02123472|583028194|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
161446327|NCT00918736|583028195|FG000|Overall Study|Withdrawal by Subject|4|||
161446328|NCT00035932|583028199|FG000|Overall Study|Adverse Event|10|||
161446329|NCT00035932|583028200|FG001|Overall Study|Adverse Event|9|||
161446330|NCT00035932|583028201|FG002|Overall Study|Adverse Event|9|||
161446331|NCT00035932|583028199|FG000|Overall Study|Death|0|||
161446332|NCT00035932|583028200|FG001|Overall Study|Death|0|||
161446333|NCT00035932|583028201|FG002|Overall Study|Death|1|||
161446334|NCT00035932|583028199|FG000|Overall Study|Disease Progression / Relapse|1|||
161446335|NCT00035932|583028200|FG001|Overall Study|Disease Progression / Relapse|1|||
161446336|NCT00035932|583028201|FG002|Overall Study|Disease Progression / Relapse|0|||
161446337|NCT00035932|583028199|FG000|Overall Study|Lost to Follow-up|4|||
161446338|NCT00035932|583028200|FG001|Overall Study|Lost to Follow-up|4|||
161446339|NCT00035932|583028201|FG002|Overall Study|Lost to Follow-up|3|||
161446340|NCT00035932|583028199|FG000|Overall Study|Noncompliance|6|||
161446341|NCT00035932|583028200|FG001|Overall Study|Noncompliance|7|||
161446342|NCT00035932|583028201|FG002|Overall Study|Noncompliance|6|||
161446343|NCT00035932|583028199|FG000|Overall Study|Protocol Violation While on Study|0|||
161446344|NCT00035932|583028200|FG001|Overall Study|Protocol Violation While on Study|1|||
161446345|NCT00035932|583028201|FG002|Overall Study|Protocol Violation While on Study|2|||
161446346|NCT00035932|583028199|FG000|Overall Study|Withdrawal by Subject|1|||
161446347|NCT00035932|583028200|FG001|Overall Study|Withdrawal by Subject|5|||
161446348|NCT00035932|583028201|FG002|Overall Study|Withdrawal by Subject|0|||
161446349|NCT00035932|583028199|FG000|Overall Study|Study Termination by Sponsor|1|||
161446350|NCT00035932|583028200|FG001|Overall Study|Study Termination by Sponsor|0|||
161446351|NCT00035932|583028201|FG002|Overall Study|Study Termination by Sponsor|0|||
161446352|NCT00035932|583028199|FG000|Overall Study|Lack of Efficacy|33|||
161446353|NCT00035932|583028200|FG001|Overall Study|Lack of Efficacy|33|||
161446354|NCT00035932|583028201|FG002|Overall Study|Lack of Efficacy|28|||
161446355|NCT00889720|583028204|FG000|Overall Study|Withdrawal by Subject|4|||
161446356|NCT00889720|583028204|FG000|Overall Study|Other|4|||
161446357|NCT04080167|583028205|FG000|Overall Study|Lost to Follow-up-Patients|7|||
161446358|NCT04080167|583028206|FG001|Overall Study|Lost to Follow-up-Patients|14|||
161446359|NCT04080167|583028207|FG002|Overall Study|Lost to Follow-up-Patients|0|||
161446360|NCT04080167|583028205|FG000|Overall Study|Lost to Follow-up-Providers|2|||
161446361|NCT04080167|583028206|FG001|Overall Study|Lost to Follow-up-Providers|2|||
161446362|NCT04080167|583028207|FG002|Overall Study|Lost to Follow-up-Providers|0|||
161446363|NCT04080167|583028205|FG000|Overall Study|Withdrawal by Subject|1|||
161446364|NCT04080167|583028206|FG001|Overall Study|Withdrawal by Subject|2|||
161446365|NCT04080167|583028207|FG002|Overall Study|Withdrawal by Subject|0|||
161446366|NCT04080167|583028205|FG000|Overall Study|Withdrawal by Provider|0|||
161446367|NCT04080167|583028206|FG001|Overall Study|Withdrawal by Provider|0|||
161446368|NCT04080167|583028207|FG002|Overall Study|Withdrawal by Provider|4|||
161446369|NCT04080167|583028205|FG000|Overall Study|Death-Patient|2|||
161446370|NCT04080167|583028206|FG001|Overall Study|Death-Patient|1|||
161446371|NCT04080167|583028207|FG002|Overall Study|Death-Patient|0|||
161446372|NCT04080167|583028205|FG000|Overall Study|Hydroxyurea New Starts|0|||
161446373|NCT04080167|583028206|FG001|Overall Study|Hydroxyurea New Starts|0|||
161446374|NCT04080167|583028207|FG002|Overall Study|Hydroxyurea New Starts|1|||
161446375|NCT04080167|583028205|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
161446376|NCT04080167|583028206|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
161446377|NCT04080167|583028207|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
161446378|NCT02100696|583028208|FG000|Induction Phase|Adverse Event|0|||
161446379|NCT02100696|583028209|FG001|Induction Phase|Adverse Event|0|||
161446380|NCT02100696|583028210|FG002|Induction Phase|Adverse Event|1|||
161446381|NCT02100696|583028211|FG003|Induction Phase|Adverse Event|0|||
161446382|NCT02100696|583028212|FG004|Induction Phase|Adverse Event|0|||
161446383|NCT02100696|583028213|FG005|Induction Phase|Adverse Event|0|||
161446384|NCT02100696|583028208|FG000|Induction Phase|Lost to Follow-up|1|||
161446385|NCT02100696|583028209|FG001|Induction Phase|Lost to Follow-up|0|||
161446386|NCT02100696|583028210|FG002|Induction Phase|Lost to Follow-up|1|||
161446387|NCT02100696|583028211|FG003|Induction Phase|Lost to Follow-up|0|||
161446388|NCT02100696|583028212|FG004|Induction Phase|Lost to Follow-up|0|||
161446389|NCT02100696|583028213|FG005|Induction Phase|Lost to Follow-up|0|||
161446390|NCT02100696|583028208|FG000|Induction Phase|Protocol Violation|0|||
161446391|NCT02100696|583028209|FG001|Induction Phase|Protocol Violation|1|||
161446392|NCT02100696|583028210|FG002|Induction Phase|Protocol Violation|1|||
161446393|NCT02100696|583028211|FG003|Induction Phase|Protocol Violation|0|||
161446394|NCT02100696|583028212|FG004|Induction Phase|Protocol Violation|0|||
161446395|NCT02100696|583028213|FG005|Induction Phase|Protocol Violation|0|||
161446396|NCT02100696|583028208|FG000|Induction Phase|Withdrawal by Subject|8|||
161446397|NCT02100696|583028209|FG001|Induction Phase|Withdrawal by Subject|2|||
161446398|NCT02100696|583028210|FG002|Induction Phase|Withdrawal by Subject|13|||
161446399|NCT02100696|583028211|FG003|Induction Phase|Withdrawal by Subject|0|||
161446400|NCT02100696|583028212|FG004|Induction Phase|Withdrawal by Subject|0|||
161446401|NCT02100696|583028213|FG005|Induction Phase|Withdrawal by Subject|0|||
161446402|NCT02100696|583028208|FG000|Induction Phase|Physician Decision|1|||
161446403|NCT02100696|583028209|FG001|Induction Phase|Physician Decision|0|||
161446404|NCT02100696|583028210|FG002|Induction Phase|Physician Decision|2|||
161446405|NCT02100696|583028211|FG003|Induction Phase|Physician Decision|0|||
161446406|NCT02100696|583028212|FG004|Induction Phase|Physician Decision|0|||
161446407|NCT02100696|583028213|FG005|Induction Phase|Physician Decision|0|||
161446408|NCT02100696|583028208|FG000|Induction Phase|Multiple Reasons|5|||
161446409|NCT02100696|583028209|FG001|Induction Phase|Multiple Reasons|2|||
161446410|NCT02100696|583028210|FG002|Induction Phase|Multiple Reasons|8|||
161446411|NCT02100696|583028211|FG003|Induction Phase|Multiple Reasons|0|||
161446412|NCT02100696|583028212|FG004|Induction Phase|Multiple Reasons|0|||
161446413|NCT02100696|583028213|FG005|Induction Phase|Multiple Reasons|0|||
161446414|NCT02100696|583028208|FG000|Maintenance Phase|Adverse Event|0|||
161446415|NCT02100696|583028209|FG001|Maintenance Phase|Adverse Event|0|||
161446416|NCT02100696|583028210|FG002|Maintenance Phase|Adverse Event|0|||
161446417|NCT02100696|583028211|FG003|Maintenance Phase|Adverse Event|0|||
161446418|NCT02100696|583028212|FG004|Maintenance Phase|Adverse Event|0|||
161446419|NCT02100696|583028213|FG005|Maintenance Phase|Adverse Event|2|||
161446420|NCT02100696|583028208|FG000|Maintenance Phase|Lost to Follow-up|0|||
161446421|NCT02100696|583028209|FG001|Maintenance Phase|Lost to Follow-up|0|||
161446422|NCT02100696|583028210|FG002|Maintenance Phase|Lost to Follow-up|0|||
161446423|NCT02100696|583028211|FG003|Maintenance Phase|Lost to Follow-up|0|||
161446424|NCT02100696|583028212|FG004|Maintenance Phase|Lost to Follow-up|1|||
161446425|NCT02100696|583028213|FG005|Maintenance Phase|Lost to Follow-up|0|||
161446426|NCT02100696|583028208|FG000|Maintenance Phase|Protocol Violation|0|||
161446427|NCT02100696|583028209|FG001|Maintenance Phase|Protocol Violation|0|||
161446428|NCT02100696|583028210|FG002|Maintenance Phase|Protocol Violation|0|||
161446429|NCT02100696|583028211|FG003|Maintenance Phase|Protocol Violation|0|||
161446430|NCT02100696|583028212|FG004|Maintenance Phase|Protocol Violation|1|||
161446431|NCT02100696|583028213|FG005|Maintenance Phase|Protocol Violation|0|||
161446432|NCT02100696|583028208|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161446433|NCT02100696|583028209|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161446434|NCT02100696|583028210|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161446435|NCT02100696|583028211|FG003|Maintenance Phase|Withdrawal by Subject|1|||
161446436|NCT02100696|583028212|FG004|Maintenance Phase|Withdrawal by Subject|4|||
161446437|NCT02100696|583028213|FG005|Maintenance Phase|Withdrawal by Subject|2|||
161446438|NCT02100696|583028208|FG000|Maintenance Phase|Physician Decision|0|||
161446439|NCT02100696|583028209|FG001|Maintenance Phase|Physician Decision|0|||
161446440|NCT02100696|583028210|FG002|Maintenance Phase|Physician Decision|0|||
161446441|NCT02100696|583028211|FG003|Maintenance Phase|Physician Decision|0|||
161446442|NCT02100696|583028212|FG004|Maintenance Phase|Physician Decision|1|||
161446443|NCT02100696|583028213|FG005|Maintenance Phase|Physician Decision|0|||
161446444|NCT02100696|583028208|FG000|Maintenance Phase|Multiple Reasons|0|||
161446445|NCT02100696|583028209|FG001|Maintenance Phase|Multiple Reasons|0|||
161446446|NCT02100696|583028210|FG002|Maintenance Phase|Multiple Reasons|0|||
161446447|NCT02100696|583028211|FG003|Maintenance Phase|Multiple Reasons|0|||
161446448|NCT02100696|583028212|FG004|Maintenance Phase|Multiple Reasons|2|||
161446449|NCT02100696|583028213|FG005|Maintenance Phase|Multiple Reasons|1|||
161446450|NCT03865381|583028217|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
161446451|NCT03865381|583028217|FG000|Overall Study|Withdrawal by Subject|2|||
161446452|NCT00452361|583028226|FG000|Overall Study|Adverse Event|8|||
161446453|NCT00452361|583028227|FG001|Overall Study|Adverse Event|0|||
161446454|NCT00452361|583028226|FG000|Overall Study|Withdrawal by Subject|0|||
161446455|NCT00452361|583028227|FG001|Overall Study|Withdrawal by Subject|1|||
161446456|NCT00452361|583028226|FG000|Overall Study|Premature termination|13|||
161446457|NCT00452361|583028227|FG001|Overall Study|Premature termination|9|||
161446458|NCT01010867|583028230|FG000|Overall Study|< 50% adherence to probiotic|1|||
161446459|NCT01668589|583028231|FG000|Overall Study|Lost to Follow-up|29|||
161446460|NCT01668589|583028232|FG001|Overall Study|Lost to Follow-up|37|||
161446461|NCT01668589|583028233|FG002|Overall Study|Lost to Follow-up|15|||
161446462|NCT01668589|583028234|FG003|Overall Study|Lost to Follow-up|5|||
161446463|NCT01668589|583028231|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
161446464|NCT01668589|583028232|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
161794858|NCT00385541|584292400|FG001|Overall Study|severe pain, clinician requested unblind|1|||
161794859|NCT00929708|584292401|FG000|Overall Study|Protocol Violation|2|||
161794860|NCT00929708|584292402|FG001|Overall Study|Protocol Violation|1|||
161794861|NCT00929708|584292403|FG002|Overall Study|Protocol Violation|1|||
161794862|NCT00929708|584292404|FG003|Overall Study|Protocol Violation|1|||
161794863|NCT00929708|584292405|FG004|Overall Study|Protocol Violation|1|||
161794864|NCT00929708|584292401|FG000|Overall Study|Withdrawal by Subject|2|||
161794865|NCT00929708|584292402|FG001|Overall Study|Withdrawal by Subject|0|||
161794866|NCT00929708|584292403|FG002|Overall Study|Withdrawal by Subject|0|||
161446465|NCT01668589|583028233|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
161446466|NCT01668589|583028234|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
161446467|NCT01668589|583028231|FG000|Overall Study|Death|12|||
161446468|NCT01668589|583028232|FG001|Overall Study|Death|3|||
161446469|NCT01668589|583028233|FG002|Overall Study|Death|2|||
161446470|NCT01668589|583028234|FG003|Overall Study|Death|11|||
161446471|NCT01668589|583028231|FG000|Overall Study|Other|44|||
161446472|NCT01668589|583028232|FG001|Overall Study|Other|10|||
161446473|NCT01668589|583028233|FG002|Overall Study|Other|7|||
161446474|NCT01668589|583028234|FG003|Overall Study|Other|15|||
161446475|NCT02954172|583028235|FG000|Overall Study|Protocol Violation|3|||
161446476|NCT02954172|583028236|FG001|Overall Study|Protocol Violation|0|||
161446477|NCT02954172|583028235|FG000|Overall Study|allergic reaction|2|||
161446478|NCT02954172|583028236|FG001|Overall Study|allergic reaction|1|||
161446479|NCT02954172|583028235|FG000|Overall Study|non-measurable lesions at baseline|1|||
161446480|NCT02954172|583028236|FG001|Overall Study|non-measurable lesions at baseline|2|||
161446481|NCT00233064|583028237|FG000|Overall Study|Lost to Follow-up|7|||
161446482|NCT00233064|583028238|FG001|Overall Study|Lost to Follow-up|7|||
161446483|NCT00233064|583028237|FG000|Overall Study|Withdrawal by Subject|5|||
161446484|NCT00233064|583028238|FG001|Overall Study|Withdrawal by Subject|3|||
161446485|NCT00233064|583028237|FG000|Overall Study|Death|0|||
161446486|NCT00233064|583028238|FG001|Overall Study|Death|1|||
161446487|NCT00233064|583028237|FG000|Overall Study|Relocation|0|||
161446488|NCT00233064|583028238|FG001|Overall Study|Relocation|1|||
161794867|NCT00929708|584292404|FG003|Overall Study|Withdrawal by Subject|2|||
161446489|NCT00233064|583028237|FG000|Overall Study|Protocol Violation|1|||
161446490|NCT00233064|583028238|FG001|Overall Study|Protocol Violation|0|||
161794868|NCT00929708|584292405|FG004|Overall Study|Withdrawal by Subject|1|||
161794869|NCT00929708|584292401|FG000|Overall Study|Adverse Event|0|||
161794870|NCT00929708|584292402|FG001|Overall Study|Adverse Event|0|||
161446491|NCT00233064|583028237|FG000|Overall Study|Moved to Dom. Republic|1|||
161446492|NCT00233064|583028238|FG001|Overall Study|Moved to Dom. Republic|0|||
161446493|NCT02302339|583028239|FG000|Overall Study|Lost to Follow-up|1|||
161446494|NCT02302339|583028240|FG001|Overall Study|Lost to Follow-up|0|||
161446495|NCT02302339|583028241|FG002|Overall Study|Lost to Follow-up|0|||
161446496|NCT02302339|583028242|FG003|Overall Study|Lost to Follow-up|0|||
161446497|NCT02302339|583028239|FG000|Overall Study|Withdrawal by Subject|0|||
161446498|NCT02302339|583028240|FG001|Overall Study|Withdrawal by Subject|2|||
161446499|NCT02302339|583028241|FG002|Overall Study|Withdrawal by Subject|1|||
161446500|NCT02302339|583028242|FG003|Overall Study|Withdrawal by Subject|0|||
161446501|NCT02752165|583028246|FG000|Overall Study|Withdrawal by Subject|6|||
161446502|NCT02752165|583028247|FG001|Overall Study|Withdrawal by Subject|6|||
161446503|NCT02752165|583028246|FG000|Overall Study|Protocol Violation|6|||
161446504|NCT02752165|583028247|FG001|Overall Study|Protocol Violation|5|||
161446505|NCT02752165|583028246|FG000|Overall Study|Lost to Follow-up|33|||
161446506|NCT02752165|583028247|FG001|Overall Study|Lost to Follow-up|38|||
161900349|NCT00249873|584683009|FG001|Overall Study|Not treated|8|||
161900350|NCT00249873|584683008|FG000|Overall Study|Significant thrombocytopenia|9|||
161900351|NCT00249873|584683009|FG001|Overall Study|Significant thrombocytopenia|8|||
161900352|NCT00249873|584683008|FG000|Overall Study|Severe allergic reaction|8|||
161900353|NCT00249873|584683009|FG001|Overall Study|Severe allergic reaction|1|||
161900354|NCT00249873|584683008|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
161900355|NCT00249873|584683009|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
161900356|NCT00249873|584683008|FG000|Overall Study|Other Serious Adverse Event|86|||
161900357|NCT00249873|584683009|FG001|Overall Study|Other Serious Adverse Event|97|||
161900358|NCT00249873|584683008|FG000|Overall Study|Qualifying condition not present|20|||
161900359|NCT00249873|584683009|FG001|Overall Study|Qualifying condition not present|23|||
161900360|NCT00249873|584683008|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
161900361|NCT00249873|584683009|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
161900362|NCT00249873|584683008|FG000|Overall Study|Withdrawal by Subject|504|||
161900363|NCT00249873|584683009|FG001|Overall Study|Withdrawal by Subject|466|||
161900364|NCT00249873|584683008|FG000|Overall Study|Lost to Follow-up|4|||
161900365|NCT00249873|584683009|FG001|Overall Study|Lost to Follow-up|7|||
161900366|NCT00249873|584683008|FG000|Overall Study|Minor bleeding|99|||
161900367|NCT00249873|584683009|FG001|Overall Study|Minor bleeding|37|||
161900368|NCT00249873|584683008|FG000|Overall Study|Non-compliance|41|||
161900369|NCT00249873|584683009|FG001|Overall Study|Non-compliance|46|||
161900370|NCT00249873|584683008|FG000|Overall Study|Other non serious Adverse Event|112|||
161446507|NCT01120964|583028248|FG000|Overall Study|Did not receive full treatment|1|||
161446508|NCT01120964|583028249|FG001|Overall Study|Did not receive full treatment|0|||
161446509|NCT01704599|583028253|FG000|Overall Study|Adverse Event|1|||
161446510|NCT04421027|583028256|FG000|Treatment Period|Adverse Event|5|||
161446511|NCT04421027|583028257|FG001|Treatment Period|Adverse Event|3|||
161446512|NCT04421027|583028258|FG002|Treatment Period|Adverse Event|0|||
161446513|NCT04421027|583028259|FG003|Treatment Period|Adverse Event|0|||
161446514|NCT04421027|583028256|FG000|Treatment Period|Death|98|||
161446515|NCT04421027|583028257|FG001|Treatment Period|Death|61|||
161446516|NCT04421027|583028258|FG002|Treatment Period|Death|0|||
161446517|NCT04421027|583028259|FG003|Treatment Period|Death|0|||
161446518|NCT04421027|583028256|FG000|Treatment Period|Lost to Follow-up|22|||
161446519|NCT04421027|583028257|FG001|Treatment Period|Lost to Follow-up|20|||
161446520|NCT04421027|583028258|FG002|Treatment Period|Lost to Follow-up|0|||
161446521|NCT04421027|583028259|FG003|Treatment Period|Lost to Follow-up|0|||
161446522|NCT04421027|583028256|FG000|Treatment Period|Other-Unknown|15|||
161446523|NCT04421027|583028257|FG001|Treatment Period|Other-Unknown|9|||
161446524|NCT04421027|583028258|FG002|Treatment Period|Other-Unknown|0|||
161446525|NCT04421027|583028259|FG003|Treatment Period|Other-Unknown|0|||
161446526|NCT04421027|583028256|FG000|Treatment Period|Physician Decision|1|||
161446527|NCT04421027|583028257|FG001|Treatment Period|Physician Decision|1|||
161446528|NCT04421027|583028258|FG002|Treatment Period|Physician Decision|0|||
161446529|NCT04421027|583028259|FG003|Treatment Period|Physician Decision|0|||
161446530|NCT04421027|583028256|FG000|Treatment Period|Withdrawal by Subject|7|||
161446531|NCT04421027|583028257|FG001|Treatment Period|Withdrawal by Subject|12|||
161446532|NCT04421027|583028258|FG002|Treatment Period|Withdrawal by Subject|0|||
161900371|NCT00249873|584683009|FG001|Overall Study|Other non serious Adverse Event|108|||
161900372|NCT00249873|584683008|FG000|Overall Study|Other contraindicated medication|1|||
161446533|NCT04421027|583028259|FG003|Treatment Period|Withdrawal by Subject|0|||
161446534|NCT04421027|583028256|FG000|Treatment Period|Randomized Not Dosed|9|||
161446535|NCT04421027|583028257|FG001|Treatment Period|Randomized Not Dosed|14|||
161446536|NCT04421027|583028258|FG002|Treatment Period|Randomized Not Dosed|0|||
161446537|NCT04421027|583028259|FG003|Treatment Period|Randomized Not Dosed|0|||
161446538|NCT04421027|583028256|FG000|Follow-Up Period|Adverse Event|0|||
161446539|NCT04421027|583028257|FG001|Follow-Up Period|Adverse Event|0|||
161446540|NCT04421027|583028258|FG002|Follow-Up Period|Adverse Event|0|||
161446541|NCT04421027|583028259|FG003|Follow-Up Period|Adverse Event|3|||
161446542|NCT04421027|583028256|FG000|Follow-Up Period|Death|0|||
161900373|NCT00249873|584683009|FG001|Overall Study|Other contraindicated medication|0|||
161900374|NCT00249873|584683008|FG000|Overall Study|Patient not wish to continue after May08|3|||
161900375|NCT00249873|584683009|FG001|Overall Study|Patient not wish to continue after May08|4|||
161900376|NCT00249873|584683008|FG000|Overall Study|Physician withdrew consent|59|||
161900377|NCT00249873|584683009|FG001|Overall Study|Physician withdrew consent|60|||
161900378|NCT00249873|584683008|FG000|Overall Study|Open label clopidogrel required|31|||
161900379|NCT00249873|584683009|FG001|Overall Study|Open label clopidogrel required|42|||
161900380|NCT00249873|584683008|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
161900381|NCT00249873|584683009|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
161900382|NCT00249873|584683008|FG000|Overall Study|Oral anticoagulant required|159|||
161446543|NCT04421027|583028257|FG001|Follow-Up Period|Death|0|||
161446544|NCT04421027|583028258|FG002|Follow-Up Period|Death|16|||
161446545|NCT04421027|583028259|FG003|Follow-Up Period|Death|17|||
161446546|NCT04421027|583028256|FG000|Follow-Up Period|Lost to Follow-up|0|||
161446547|NCT04421027|583028257|FG001|Follow-Up Period|Lost to Follow-up|0|||
161446548|NCT04421027|583028258|FG002|Follow-Up Period|Lost to Follow-up|7|||
161446549|NCT04421027|583028259|FG003|Follow-Up Period|Lost to Follow-up|7|||
161446550|NCT04421027|583028256|FG000|Follow-Up Period|Protocol Deviation|0|||
161446551|NCT04421027|583028257|FG001|Follow-Up Period|Protocol Deviation|0|||
161446552|NCT04421027|583028258|FG002|Follow-Up Period|Protocol Deviation|1|||
161446553|NCT04421027|583028259|FG003|Follow-Up Period|Protocol Deviation|0|||
161446554|NCT04421027|583028256|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
161446555|NCT04421027|583028257|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
161446556|NCT04421027|583028258|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
161446557|NCT04421027|583028259|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
161446558|NCT04421027|583028256|FG000|Follow-Up Period|Left message, participant did not call back|0|||
161446559|NCT04421027|583028257|FG001|Follow-Up Period|Left message, participant did not call back|0|||
161446560|NCT04421027|583028258|FG002|Follow-Up Period|Left message, participant did not call back|0|||
161446561|NCT04421027|583028259|FG003|Follow-Up Period|Left message, participant did not call back|1|||
161446562|NCT04421027|583028256|FG000|Follow-Up Period|Participant died|0|||
161446563|NCT04421027|583028257|FG001|Follow-Up Period|Participant died|0|||
161446564|NCT04421027|583028258|FG002|Follow-Up Period|Participant died|0|||
161446565|NCT04421027|583028259|FG003|Follow-Up Period|Participant died|1|||
161446566|NCT04421027|583028256|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
161446567|NCT04421027|583028257|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
161446568|NCT04421027|583028258|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
161446569|NCT04421027|583028259|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
161446570|NCT00494676|583028260|FG000|Allocation|Withdrawal by Subject|2|||
161446571|NCT00494676|583028261|FG001|Allocation|Withdrawal by Subject|4|||
161446572|NCT00494676|583028260|FG000|First Intervention|Withdrawal by Subject|1|||
161446573|NCT00494676|583028261|FG001|First Intervention|Withdrawal by Subject|3|||
161446574|NCT00494676|583028260|FG000|Second Intervention|Withdrawal by Subject|1|||
161446575|NCT00494676|583028261|FG001|Second Intervention|Withdrawal by Subject|1|||
161446576|NCT04073225|583028262|FG000|Overall Study|Lost to Follow-up|4|||
161446577|NCT04073225|583028263|FG001|Overall Study|Lost to Follow-up|3|||
161446578|NCT04238819|583028270|FG000|Overall Study|Ongoing Treatment|0|||
161446579|NCT04238819|583028271|FG001|Overall Study|Ongoing Treatment|0|||
161446580|NCT04238819|583028272|FG002|Overall Study|Ongoing Treatment|0|||
161446581|NCT04238819|583028273|FG003|Overall Study|Ongoing Treatment|0|||
161446582|NCT04238819|583028274|FG004|Overall Study|Ongoing Treatment|1|||
161446583|NCT04238819|583028275|FG005|Overall Study|Ongoing Treatment|4|||
161446584|NCT04238819|583028276|FG006|Overall Study|Ongoing Treatment|0|||
161446585|NCT04238819|583028270|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
161446586|NCT04238819|583028271|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
161446587|NCT04238819|583028272|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
161446588|NCT04238819|583028273|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
161446589|NCT04238819|583028274|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
161446590|NCT04238819|583028275|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
161446591|NCT04238819|583028276|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
161446592|NCT02529553|583028280|FG000|Overall Study|Progressive Disease|1|||
161446593|NCT02529553|583028281|FG001|Overall Study|Progressive Disease|0|||
161446594|NCT02529553|583028282|FG002|Overall Study|Progressive Disease|1|||
161446595|NCT02529553|583028283|FG003|Overall Study|Progressive Disease|3|||
161446596|NCT02529553|583028284|FG004|Overall Study|Progressive Disease|2|||
161900383|NCT00249873|584683009|FG001|Overall Study|Oral anticoagulant required|157|||
161900384|NCT00249873|584683008|FG000|Overall Study|Study drug intolerance|5|||
161900385|NCT00249873|584683009|FG001|Overall Study|Study drug intolerance|0|||
161446597|NCT02529553|583028285|FG005|Overall Study|Progressive Disease|3|||
161446598|NCT02529553|583028286|FG006|Overall Study|Progressive Disease|3|||
161446599|NCT02529553|583028287|FG007|Overall Study|Progressive Disease|5|||
161446600|NCT02529553|583028288|FG008|Overall Study|Progressive Disease|3|||
161446601|NCT02529553|583028280|FG000|Overall Study|Physician Decision|0|||
161446602|NCT02529553|583028281|FG001|Overall Study|Physician Decision|1|||
161446603|NCT02529553|583028282|FG002|Overall Study|Physician Decision|0|||
161446604|NCT02529553|583028283|FG003|Overall Study|Physician Decision|0|||
161900386|NCT00249873|584683008|FG000|Overall Study|Surgery/ procedure|9|||
161900387|NCT00249873|584683009|FG001|Overall Study|Surgery/ procedure|9|||
161446605|NCT02529553|583028284|FG004|Overall Study|Physician Decision|1|||
161446606|NCT02529553|583028285|FG005|Overall Study|Physician Decision|0|||
161446607|NCT02529553|583028286|FG006|Overall Study|Physician Decision|0|||
161446608|NCT02529553|583028287|FG007|Overall Study|Physician Decision|0|||
161446609|NCT02529553|583028288|FG008|Overall Study|Physician Decision|0|||
161794871|NCT00929708|584292403|FG002|Overall Study|Adverse Event|0|||
161794872|NCT00929708|584292404|FG003|Overall Study|Adverse Event|0|||
161794873|NCT00929708|584292405|FG004|Overall Study|Adverse Event|3|||
161794874|NCT00929708|584292401|FG000|Overall Study|Physician Decision|0|||
161794875|NCT00929708|584292402|FG001|Overall Study|Physician Decision|2|||
161794876|NCT00929708|584292403|FG002|Overall Study|Physician Decision|2|||
161794877|NCT00929708|584292404|FG003|Overall Study|Physician Decision|2|||
161794878|NCT00929708|584292405|FG004|Overall Study|Physician Decision|1|||
161794879|NCT00929708|584292401|FG000|Overall Study|Lost to Follow-up|0|||
161794880|NCT00929708|584292402|FG001|Overall Study|Lost to Follow-up|0|||
161794881|NCT00929708|584292403|FG002|Overall Study|Lost to Follow-up|0|||
161794882|NCT00929708|584292404|FG003|Overall Study|Lost to Follow-up|1|||
161794883|NCT00929708|584292405|FG004|Overall Study|Lost to Follow-up|0|||
161794884|NCT03495869|584292406|FG000|Overall Study|Lost to Follow-up|4|||
161794885|NCT03495869|584292407|FG001|Overall Study|Lost to Follow-up|17|||
161794886|NCT03495869|584292408|FG002|Overall Study|Lost to Follow-up|8|||
161794887|NCT03495869|584292409|FG003|Overall Study|Lost to Follow-up|14|||
161794888|NCT03495869|584292406|FG000|Overall Study|Withdrawal by Subject|0|||
161794889|NCT03495869|584292407|FG001|Overall Study|Withdrawal by Subject|3|||
161794890|NCT03495869|584292408|FG002|Overall Study|Withdrawal by Subject|0|||
161794891|NCT03495869|584292409|FG003|Overall Study|Withdrawal by Subject|3|||
161794892|NCT03495869|584292406|FG000|Overall Study|Dropped from study|0|||
161794893|NCT03495869|584292407|FG001|Overall Study|Dropped from study|7|||
161794894|NCT03495869|584292408|FG002|Overall Study|Dropped from study|2|||
161794895|NCT03495869|584292409|FG003|Overall Study|Dropped from study|4|||
161794896|NCT02154529|584292410|FG000|Overall Study|Death|1|||
161794897|NCT02154529|584292411|FG001|Overall Study|Death|1|||
161794898|NCT02154529|584292412|FG002|Overall Study|Death|5|||
161794899|NCT02154529|584292413|FG003|Overall Study|Death|1|||
161794900|NCT02154529|584292410|FG000|Overall Study|Termination of study by sponsor|2|||
161794901|NCT02154529|584292411|FG001|Overall Study|Termination of study by sponsor|2|||
161794902|NCT02154529|584292412|FG002|Overall Study|Termination of study by sponsor|3|||
161794903|NCT02154529|584292413|FG003|Overall Study|Termination of study by sponsor|1|||
161794904|NCT02154529|584292410|FG000|Overall Study|Lost to Follow-up|1|||
161794905|NCT02154529|584292411|FG001|Overall Study|Lost to Follow-up|0|||
161794906|NCT02154529|584292412|FG002|Overall Study|Lost to Follow-up|0|||
161794907|NCT02154529|584292413|FG003|Overall Study|Lost to Follow-up|0|||
161794908|NCT05440097|584293604|FG000|Overall Study|Withdrawal by Subject|154|||
161794909|NCT05440097|584293604|FG000|Overall Study|Death|2|||
161794910|NCT05440097|584293604|FG000|Overall Study|Physician Decision|2|||
161794911|NCT05440097|584293604|FG000|Overall Study|Lost to Follow-up|56|||
161794912|NCT05440097|584293604|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
161794913|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Adverse Event|3|||
161794914|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Adverse Event|0|||
161794915|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
161794916|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
161794917|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Physician Decision|1|||
161794918|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Physician Decision|0|||
161794919|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
161794920|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
161794921|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
161794922|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
161794923|NCT02081599|584293605|FG000|Period 1：Double-blind Period|stopping criteria|1|||
161794924|NCT02081599|584293606|FG001|Period 1：Double-blind Period|stopping criteria|0|||
161794925|NCT02081599|584293605|FG000|Period 2：Open-label Period|Adverse Event|1|||
161794926|NCT02081599|584293606|FG001|Period 2：Open-label Period|Adverse Event|0|||
161794927|NCT02081599|584293605|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
161794928|NCT02081599|584293606|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
161794929|NCT02081599|584293605|FG000|Period 2：Open-label Period|Physician Decision|1|||
161794930|NCT02081599|584293606|FG001|Period 2：Open-label Period|Physician Decision|0|||
161794931|NCT02081599|584293605|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
161794932|NCT02081599|584293606|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
161794933|NCT02146430|584293616|FG000|Overall Study|Protocol Violation|5|||
161446610|NCT02529553|583028280|FG000|Overall Study|Withdrawal by Subject|0|||
161794934|NCT02146430|584293617|FG001|Overall Study|Protocol Violation|4|||
161794935|NCT02146430|584293618|FG002|Overall Study|Protocol Violation|8|||
161794936|NCT02146430|584293619|FG003|Overall Study|Protocol Violation|6|||
161794937|NCT02146430|584293616|FG000|Overall Study|Lack of Efficacy|13|||
161794938|NCT02146430|584293617|FG001|Overall Study|Lack of Efficacy|11|||
161794939|NCT02146430|584293618|FG002|Overall Study|Lack of Efficacy|8|||
161794940|NCT02146430|584293619|FG003|Overall Study|Lack of Efficacy|5|||
161794941|NCT02146430|584293616|FG000|Overall Study|Adverse Event|20|||
161900388|NCT00249873|584683008|FG000|Overall Study|Event related to cardiac condition|12|||
161900389|NCT00249873|584683009|FG001|Overall Study|Event related to cardiac condition|21|||
161900390|NCT00249873|584683008|FG000|Overall Study|Thromboembolic/outcome event|82|||
161900391|NCT00249873|584683009|FG001|Overall Study|Thromboembolic/outcome event|122|||
161900392|NCT02532374|584683010|FG000|Overall Study|Withdrawal by Subject|1|||
161900393|NCT02532374|584683010|FG000|Overall Study|Physician Decision|1|||
161900394|NCT02762084|584683011|FG000|Overall Study|Withdrawal by Subject|1|||
161900395|NCT02762084|584683012|FG001|Overall Study|Withdrawal by Subject|0|||
161900396|NCT02762084|584683013|FG002|Overall Study|Withdrawal by Subject|0|||
161900397|NCT02762084|584683011|FG000|Overall Study|Adverse Event|0|||
161900398|NCT02762084|584683012|FG001|Overall Study|Adverse Event|0|||
161900399|NCT02762084|584683013|FG002|Overall Study|Adverse Event|1|||
161900400|NCT02659943|584683014|FG000|Overall Study|Switched to alternative treatment|1|||
161900401|NCT02659943|584683015|FG001|Overall Study|Switched to alternative treatment|1|||
161900402|NCT02659943|584683016|FG002|Overall Study|Switched to alternative treatment|0|||
161900403|NCT02659943|584683017|FG003|Overall Study|Switched to alternative treatment|2|||
161900404|NCT02659943|584683018|FG004|Overall Study|Switched to alternative treatment|1|||
161900405|NCT02659943|584683019|FG005|Overall Study|Switched to alternative treatment|0|||
161900406|NCT02659943|584683020|FG006|Overall Study|Switched to alternative treatment|1|||
161900407|NCT02659943|584683014|FG000|Overall Study|Disease progression on study|0|||
161900408|NCT02659943|584683015|FG001|Overall Study|Disease progression on study|1|||
161900409|NCT02659943|584683016|FG002|Overall Study|Disease progression on study|1|||
161900410|NCT02659943|584683017|FG003|Overall Study|Disease progression on study|1|||
161900411|NCT02659943|584683018|FG004|Overall Study|Disease progression on study|1|||
161900412|NCT02659943|584683019|FG005|Overall Study|Disease progression on study|4|||
161900413|NCT02659943|584683020|FG006|Overall Study|Disease progression on study|0|||
161900414|NCT02659943|584683014|FG000|Overall Study|Patient's condition per principal investigator|0|||
161900415|NCT02659943|584683015|FG001|Overall Study|Patient's condition per principal investigator|0|||
161900416|NCT02659943|584683016|FG002|Overall Study|Patient's condition per principal investigator|0|||
161900417|NCT02659943|584683017|FG003|Overall Study|Patient's condition per principal investigator|0|||
161900418|NCT02659943|584683018|FG004|Overall Study|Patient's condition per principal investigator|0|||
161900419|NCT02659943|584683019|FG005|Overall Study|Patient's condition per principal investigator|1|||
161900420|NCT02659943|584683020|FG006|Overall Study|Patient's condition per principal investigator|0|||
161900421|NCT02659943|584683014|FG000|Overall Study|Ineligible|0|||
161900422|NCT02659943|584683015|FG001|Overall Study|Ineligible|0|||
161900423|NCT02659943|584683016|FG002|Overall Study|Ineligible|0|||
161900424|NCT02659943|584683017|FG003|Overall Study|Ineligible|0|||
161900425|NCT02659943|584683018|FG004|Overall Study|Ineligible|0|||
161900426|NCT02659943|584683019|FG005|Overall Study|Ineligible|0|||
161900427|NCT02659943|584683020|FG006|Overall Study|Ineligible|1|||
161900428|NCT02659943|584683014|FG000|Overall Study|No longer meets eligibility|0|||
161900429|NCT02659943|584683015|FG001|Overall Study|No longer meets eligibility|0|||
161900430|NCT02659943|584683016|FG002|Overall Study|No longer meets eligibility|0|||
161900431|NCT02659943|584683017|FG003|Overall Study|No longer meets eligibility|0|||
161900432|NCT02659943|584683018|FG004|Overall Study|No longer meets eligibility|0|||
161900433|NCT02659943|584683019|FG005|Overall Study|No longer meets eligibility|0|||
161900434|NCT02659943|584683020|FG006|Overall Study|No longer meets eligibility|1|||
161900435|NCT02659943|584683014|FG000|Overall Study|No treatment, per protocol|0|||
161900436|NCT02659943|584683015|FG001|Overall Study|No treatment, per protocol|0|||
161900437|NCT02659943|584683016|FG002|Overall Study|No treatment, per protocol|0|||
161900438|NCT02659943|584683017|FG003|Overall Study|No treatment, per protocol|0|||
161900439|NCT02659943|584683018|FG004|Overall Study|No treatment, per protocol|0|||
161900440|NCT02659943|584683019|FG005|Overall Study|No treatment, per protocol|0|||
161900441|NCT02659943|584683020|FG006|Overall Study|No treatment, per protocol|3|||
161900442|NCT03478371|584683021|FG000|Overall Study|non-compliance|1|||
161900443|NCT03478371|584683021|FG000|Overall Study|Lost to Follow-up|4|||
161900444|NCT00627497|584683025|FG000|Overall Study|Lost to Follow-up|1|||
161900445|NCT00627497|584683026|FG001|Overall Study|Lost to Follow-up|1|||
161900446|NCT00627497|584683027|FG002|Overall Study|Lost to Follow-up|0|||
161900447|NCT00627497|584683028|FG003|Overall Study|Lost to Follow-up|0|||
161900448|NCT04767373|584683031|FG000|Overall Study|Death|6|||
161900449|NCT04767373|584683032|FG001|Overall Study|Death|3|||
161900450|NCT04767373|584683031|FG000|Overall Study|Lost to Follow-up|67|||
161900451|NCT04767373|584683032|FG001|Overall Study|Lost to Follow-up|35|||
161900452|NCT04767373|584683031|FG000|Overall Study|Physician Decision|15|||
161900453|NCT04767373|584683032|FG001|Overall Study|Physician Decision|4|||
161900454|NCT04767373|584683031|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161900455|NCT04767373|584683032|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161900456|NCT04767373|584683031|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
161900457|NCT04767373|584683032|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
161900458|NCT04767373|584683031|FG000|Overall Study|Other|1|||
161900459|NCT04767373|584683032|FG001|Overall Study|Other|2|||
161900460|NCT00099632|584683037|FG000|Overall Study|Lost to Follow-up|1|||
161900461|NCT00099632|584683038|FG001|Overall Study|Lost to Follow-up|0|||
161900462|NCT00099632|584683039|FG002|Overall Study|Lost to Follow-up|3|||
161446611|NCT02529553|583028281|FG001|Overall Study|Withdrawal by Subject|0|||
161446612|NCT02529553|583028282|FG002|Overall Study|Withdrawal by Subject|0|||
161446613|NCT02529553|583028283|FG003|Overall Study|Withdrawal by Subject|0|||
161446614|NCT02529553|583028284|FG004|Overall Study|Withdrawal by Subject|0|||
161446615|NCT02529553|583028285|FG005|Overall Study|Withdrawal by Subject|1|||
161446616|NCT02529553|583028286|FG006|Overall Study|Withdrawal by Subject|0|||
161446617|NCT02529553|583028287|FG007|Overall Study|Withdrawal by Subject|1|||
161446618|NCT02529553|583028288|FG008|Overall Study|Withdrawal by Subject|0|||
161446619|NCT05767749|583028289|FG000|Overall Study|Withdrawal by Subject|0|||
161446620|NCT05767749|583028290|FG001|Overall Study|Withdrawal by Subject|0|||
161446621|NCT05767749|583028291|FG002|Overall Study|Withdrawal by Subject|2|||
161446622|NCT05767749|583028292|FG003|Overall Study|Withdrawal by Subject|2|||
161446623|NCT05767749|583028293|FG004|Overall Study|Withdrawal by Subject|2|||
161446624|NCT05767749|583028294|FG005|Overall Study|Withdrawal by Subject|2|||
161446625|NCT00114517|583028295|FG000|Overall Study|Adverse Event|6|||
161446626|NCT00114517|583028296|FG001|Overall Study|Adverse Event|1|||
161446627|NCT00114517|583028297|FG002|Overall Study|Adverse Event|6|||
161446628|NCT00114517|583028298|FG003|Overall Study|Adverse Event|3|||
161446629|NCT00114517|583028295|FG000|Overall Study|Lost to Follow-up|2|||
161446630|NCT00114517|583028296|FG001|Overall Study|Lost to Follow-up|2|||
161446631|NCT00114517|583028297|FG002|Overall Study|Lost to Follow-up|2|||
161446632|NCT00114517|583028298|FG003|Overall Study|Lost to Follow-up|1|||
161446633|NCT00114517|583028295|FG000|Overall Study|Too busy|3|||
161446634|NCT00114517|583028296|FG001|Overall Study|Too busy|1|||
161446635|NCT00114517|583028297|FG002|Overall Study|Too busy|1|||
161446636|NCT00114517|583028298|FG003|Overall Study|Too busy|2|||
161446637|NCT00114517|583028295|FG000|Overall Study|Moved from area|0|||
161446638|NCT00114517|583028296|FG001|Overall Study|Moved from area|3|||
161446639|NCT00114517|583028297|FG002|Overall Study|Moved from area|2|||
161446640|NCT00114517|583028298|FG003|Overall Study|Moved from area|1|||
161446641|NCT00114517|583028295|FG000|Overall Study|Did not want estradiol|1|||
161446642|NCT00114517|583028296|FG001|Overall Study|Did not want estradiol|1|||
161446643|NCT00114517|583028297|FG002|Overall Study|Did not want estradiol|0|||
161446644|NCT00114517|583028298|FG003|Overall Study|Did not want estradiol|0|||
161446645|NCT00114517|583028295|FG000|Overall Study|Armed-services duty|0|||
161446646|NCT00114517|583028296|FG001|Overall Study|Armed-services duty|1|||
161446647|NCT00114517|583028297|FG002|Overall Study|Armed-services duty|0|||
161446648|NCT00114517|583028298|FG003|Overall Study|Armed-services duty|1|||
161446649|NCT00114517|583028295|FG000|Overall Study|Competing family issue|0|||
161446650|NCT00114517|583028296|FG001|Overall Study|Competing family issue|1|||
161446651|NCT00114517|583028297|FG002|Overall Study|Competing family issue|0|||
161446652|NCT00114517|583028298|FG003|Overall Study|Competing family issue|1|||
161446653|NCT00114517|583028295|FG000|Overall Study|Physician Decision|0|||
161446654|NCT00114517|583028296|FG001|Overall Study|Physician Decision|1|||
161446655|NCT00114517|583028297|FG002|Overall Study|Physician Decision|0|||
161446656|NCT00114517|583028298|FG003|Overall Study|Physician Decision|0|||
161446657|NCT00114517|583028295|FG000|Overall Study|Lost interest|0|||
161446658|NCT00114517|583028296|FG001|Overall Study|Lost interest|0|||
161446659|NCT00114517|583028297|FG002|Overall Study|Lost interest|1|||
161446660|NCT00114517|583028298|FG003|Overall Study|Lost interest|0|||
161446661|NCT00114517|583028295|FG000|Overall Study|Weight increase|0|||
161446662|NCT00114517|583028296|FG001|Overall Study|Weight increase|0|||
161446663|NCT00114517|583028297|FG002|Overall Study|Weight increase|1|||
161446664|NCT00114517|583028298|FG003|Overall Study|Weight increase|0|||
161446665|NCT00114517|583028295|FG000|Overall Study|Concern about blood clots|0|||
161446666|NCT00114517|583028296|FG001|Overall Study|Concern about blood clots|0|||
161446667|NCT00114517|583028297|FG002|Overall Study|Concern about blood clots|1|||
161446668|NCT00114517|583028298|FG003|Overall Study|Concern about blood clots|0|||
161446669|NCT00114517|583028295|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
161446670|NCT00114517|583028296|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
161446671|NCT00114517|583028297|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
161446672|NCT00114517|583028298|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
161446673|NCT00924027|583028299|FG000|Overall Study|Lost to Further Follow-Up|4|||
161446674|NCT00924027|583028300|FG001|Overall Study|Lost to Further Follow-Up|0|||
161446675|NCT00924027|583028301|FG002|Overall Study|Lost to Further Follow-Up|0|||
161794942|NCT02146430|584293617|FG001|Overall Study|Adverse Event|40|||
161794943|NCT02146430|584293618|FG002|Overall Study|Adverse Event|32|||
161794944|NCT02146430|584293619|FG003|Overall Study|Adverse Event|49|||
161794945|NCT02146430|584293616|FG000|Overall Study|Reason missing or not reported|2|||
161794946|NCT02146430|584293617|FG001|Overall Study|Reason missing or not reported|3|||
161794947|NCT02146430|584293618|FG002|Overall Study|Reason missing or not reported|4|||
161794948|NCT02146430|584293619|FG003|Overall Study|Reason missing or not reported|5|||
161794949|NCT02146430|584293616|FG000|Overall Study|Withdrawal by Subject|27|||
161794950|NCT02146430|584293617|FG001|Overall Study|Withdrawal by Subject|29|||
161794951|NCT02146430|584293618|FG002|Overall Study|Withdrawal by Subject|30|||
161794952|NCT02146430|584293619|FG003|Overall Study|Withdrawal by Subject|34|||
161794953|NCT03312530|584293620|FG000|Overall Study|Death|5|||
161446676|NCT00924027|583028302|FG003|Overall Study|Lost to Further Follow-Up|0|||
161446677|NCT00924027|583028299|FG000|Overall Study|Physician Decision|1|||
161446678|NCT00924027|583028300|FG001|Overall Study|Physician Decision|0|||
161446679|NCT00924027|583028301|FG002|Overall Study|Physician Decision|0|||
161446680|NCT00924027|583028302|FG003|Overall Study|Physician Decision|1|||
161446681|NCT00924027|583028299|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
161446682|NCT00924027|583028300|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
161446683|NCT00924027|583028301|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
161446684|NCT00924027|583028302|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
161446685|NCT00924027|583028299|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
161446686|NCT00924027|583028300|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
161446687|NCT00924027|583028301|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
161446688|NCT00924027|583028302|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
161446689|NCT00924027|583028299|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
161446690|NCT00924027|583028300|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
161446691|NCT00924027|583028301|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
161446692|NCT00924027|583028302|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
161446693|NCT04236141|583029619|FG000|Overall Study|Death|18|||
161446694|NCT04236141|583029620|FG001|Overall Study|Death|10|||
161446695|NCT04236141|583029619|FG000|Overall Study|Withdrawal by Participant|1|||
161446696|NCT04236141|583029620|FG001|Overall Study|Withdrawal by Participant|0|||
161446697|NCT04236141|583029619|FG000|Overall Study|Reason not Specified|1|||
161446698|NCT04236141|583029620|FG001|Overall Study|Reason not Specified|0|||
161446699|NCT04236141|583029619|FG000|Overall Study|Study terminated by Sponsor|8|||
161446700|NCT04236141|583029620|FG001|Overall Study|Study terminated by Sponsor|4|||
161446701|NCT00745849|583029621|FG000|First Intervention|Withdrawal by Subject|0|||
161446702|NCT00745849|583029622|FG001|First Intervention|Withdrawal by Subject|1|||
161794954|NCT03312530|584293621|FG001|Overall Study|Death|5|||
161794955|NCT03312530|584293622|FG002|Overall Study|Death|4|||
161794956|NCT03312530|584293623|FG003|Overall Study|Death|10|||
161794957|NCT03312530|584293624|FG004|Overall Study|Death|8|||
161794958|NCT03312530|584293620|FG000|Overall Study|Lost to Follow-up|0|||
161794959|NCT03312530|584293621|FG001|Overall Study|Lost to Follow-up|0|||
161794960|NCT03312530|584293622|FG002|Overall Study|Lost to Follow-up|0|||
161794961|NCT03312530|584293623|FG003|Overall Study|Lost to Follow-up|1|||
161794962|NCT03312530|584293624|FG004|Overall Study|Lost to Follow-up|0|||
161794963|NCT03312530|584293620|FG000|Overall Study|Participant in another sponsor study.|0|||
161794964|NCT03312530|584293621|FG001|Overall Study|Participant in another sponsor study.|0|||
161794965|NCT03312530|584293622|FG002|Overall Study|Participant in another sponsor study.|0|||
161794966|NCT03312530|584293623|FG003|Overall Study|Participant in another sponsor study.|1|||
161794967|NCT03312530|584293624|FG004|Overall Study|Participant in another sponsor study.|0|||
161794968|NCT03312530|584293620|FG000|Overall Study|Study terminated by sponsor|1|||
161794969|NCT03312530|584293621|FG001|Overall Study|Study terminated by sponsor|0|||
161794970|NCT03312530|584293622|FG002|Overall Study|Study terminated by sponsor|2|||
161794971|NCT03312530|584293623|FG003|Overall Study|Study terminated by sponsor|3|||
161794972|NCT03312530|584293624|FG004|Overall Study|Study terminated by sponsor|7|||
161794973|NCT03312530|584293620|FG000|Overall Study|Withdrawal by Subject|0|||
161794974|NCT03312530|584293621|FG001|Overall Study|Withdrawal by Subject|1|||
161794975|NCT03312530|584293622|FG002|Overall Study|Withdrawal by Subject|0|||
161794976|NCT03312530|584293623|FG003|Overall Study|Withdrawal by Subject|0|||
161794977|NCT03312530|584293624|FG004|Overall Study|Withdrawal by Subject|0|||
161794978|NCT03312530|584293620|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794979|NCT03312530|584293621|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794980|NCT03312530|584293622|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794981|NCT03312530|584293623|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
161794982|NCT03312530|584293624|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794983|NCT03093324|584293625|FG000|Overall Study|Adverse Event|4|||
161794984|NCT03093324|584293626|FG001|Overall Study|Adverse Event|15|||
161794985|NCT03093324|584293625|FG000|Overall Study|Lost to Follow-up|1|||
161794986|NCT03093324|584293626|FG001|Overall Study|Lost to Follow-up|0|||
161794987|NCT03093324|584293625|FG000|Overall Study|Protocol Deviation|2|||
161794988|NCT03093324|584293626|FG001|Overall Study|Protocol Deviation|2|||
161794989|NCT03093324|584293625|FG000|Overall Study|Withdrawal by Subject|2|||
161446703|NCT00745849|583029621|FG000|First Intervention|Lost to Follow-up|1|||
161446704|NCT00745849|583029622|FG001|First Intervention|Lost to Follow-up|1|||
161794990|NCT03093324|584293626|FG001|Overall Study|Withdrawal by Subject|2|||
161794991|NCT01767597|584293627|FG000|Overall Study|Incomplete intervention|3|||
161794992|NCT01767597|584293628|FG001|Overall Study|Incomplete intervention|1|||
161794993|NCT01767597|584293627|FG000|Overall Study|Withdrawal by Subject|1|||
161794994|NCT01767597|584293628|FG001|Overall Study|Withdrawal by Subject|0|||
161794995|NCT05342753|584293629|FG000|Overall Study|Withdrawal by Subject|6|||
161446705|NCT00745849|583029621|FG000|Second Intervention|Lost to Follow-up|2|||
161446706|NCT00745849|583029622|FG001|Second Intervention|Lost to Follow-up|1|||
161446707|NCT01139008|583029623|FG000|Overall Study|Withdrawal by Subject|5|||
161446708|NCT01139008|583029623|FG000|Overall Study|Non-compliant, lost product|1|||
161446709|NCT02848729|583029626|FG000|Overall Study|Withdrawal by Subject|1|||
161446710|NCT02848729|583029627|FG001|Overall Study|Withdrawal by Subject|0|||
161446711|NCT02848729|583029626|FG000|Overall Study|Emesis|15|||
161446712|NCT02848729|583029627|FG001|Overall Study|Emesis|11|||
161446713|NCT03390101|583029628|FG000|Weeks 0-12|Withdrawal by Subject|0|||
161446714|NCT03390101|583029629|FG001|Weeks 0-12|Withdrawal by Subject|1|||
161446715|NCT03390101|583029630|FG002|Weeks 0-12|Withdrawal by Subject|1|||
161446716|NCT03390101|583029628|FG000|Weeks 0-12|Lost to Follow-up|0|||
161446717|NCT03390101|583029629|FG001|Weeks 0-12|Lost to Follow-up|1|||
161446718|NCT03390101|583029630|FG002|Weeks 0-12|Lost to Follow-up|0|||
161446719|NCT03390101|583029628|FG000|Weeks 12-54|Withdrawal by Subject|0|||
161446720|NCT03390101|583029629|FG001|Weeks 12-54|Withdrawal by Subject|3|||
161446721|NCT03390101|583029630|FG002|Weeks 12-54|Withdrawal by Subject|1|||
161446722|NCT03390101|583029628|FG000|Weeks 12-54|Pregnancy|1|||
161446723|NCT03390101|583029629|FG001|Weeks 12-54|Pregnancy|0|||
161446724|NCT03390101|583029630|FG002|Weeks 12-54|Pregnancy|0|||
161446725|NCT03390101|583029628|FG000|Weeks 12-54|Adverse Event|2|||
161446726|NCT03390101|583029629|FG001|Weeks 12-54|Adverse Event|1|||
161446727|NCT03390101|583029630|FG002|Weeks 12-54|Adverse Event|1|||
161446728|NCT04838977|583029631|FG000|Overall Study|Lost to Follow-up|2|||
161446729|NCT04838977|583029632|FG001|Overall Study|Lost to Follow-up|3|||
161446730|NCT04838977|583029631|FG000|Overall Study|Withdrawal by Subject|1|||
161446731|NCT04838977|583029632|FG001|Overall Study|Withdrawal by Subject|1|||
161446732|NCT05367492|583029633|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
161446733|NCT05367492|583029634|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
161446734|NCT05367492|583029635|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
161446735|NCT05367492|583029633|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
161446736|NCT05367492|583029634|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
161446737|NCT05367492|583029635|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
161446738|NCT05367492|583029633|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
161446739|NCT05367492|583029634|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
161446740|NCT05367492|583029635|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
161446741|NCT05367492|583029633|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
161446742|NCT05367492|583029634|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
161446743|NCT05367492|583029635|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
161446744|NCT00950859|583029639|FG000|Overall Study|Adverse Event|3|||
161446745|NCT00950859|583029640|FG001|Overall Study|Adverse Event|3|||
161446746|NCT00950859|583029639|FG000|Overall Study|Insufficient Viral Load Response|12|||
161446747|NCT00950859|583029640|FG001|Overall Study|Insufficient Viral Load Response|3|||
161446748|NCT00950859|583029639|FG000|Overall Study|Protocol Violation|1|||
161446749|NCT00950859|583029640|FG001|Overall Study|Protocol Violation|1|||
161446750|NCT00950859|583029639|FG000|Overall Study|Lost to Follow-up|0|||
161446751|NCT00950859|583029640|FG001|Overall Study|Lost to Follow-up|3|||
161446752|NCT01463007|583029642|FG000|Overall Study|Physician Decision|1|||
161446753|NCT03583385|583029643|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161446754|NCT03583385|583029644|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161446755|NCT03583385|583029643|FG000|Treatment Period 2|Adverse Event|1|||
161446756|NCT03583385|583029644|FG001|Treatment Period 2|Adverse Event|0|||
161446757|NCT00545272|583029648|FG000|Overall Study|Protocol deviation|0|||
161446758|NCT00545272|583029649|FG001|Overall Study|Protocol deviation|1|||
161446759|NCT00545272|583029650|FG002|Overall Study|Protocol deviation|0|||
161446760|NCT00545272|583029651|FG003|Overall Study|Protocol deviation|1|||
161446761|NCT00545272|583029652|FG004|Overall Study|Protocol deviation|0|||
161446762|NCT00545272|583029653|FG005|Overall Study|Protocol deviation|1|||
161446763|NCT00545272|583029648|FG000|Overall Study|Adverse Event|0|||
161446764|NCT00545272|583029649|FG001|Overall Study|Adverse Event|0|||
161446765|NCT00545272|583029650|FG002|Overall Study|Adverse Event|1|||
161446766|NCT00545272|583029651|FG003|Overall Study|Adverse Event|0|||
161446767|NCT00545272|583029652|FG004|Overall Study|Adverse Event|0|||
161446768|NCT00545272|583029653|FG005|Overall Study|Adverse Event|1|||
161446769|NCT00545272|583029648|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161446770|NCT00545272|583029649|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161446771|NCT00545272|583029650|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161446772|NCT00545272|583029651|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161446773|NCT00545272|583029652|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161446774|NCT00545272|583029653|FG005|Overall Study|Abnormal laboratory value(s)|1|||
161446775|NCT00545272|583029648|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161446776|NCT00545272|583029649|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161446777|NCT00545272|583029650|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161446778|NCT00545272|583029651|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161446779|NCT00545272|583029652|FG004|Overall Study|Abnormal test procedure result(s)|1|||
161446780|NCT00545272|583029653|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161446781|NCT00545272|583029648|FG000|Overall Study|Lost to Follow-up|0|||
161446782|NCT00545272|583029649|FG001|Overall Study|Lost to Follow-up|0|||
161446783|NCT00545272|583029650|FG002|Overall Study|Lost to Follow-up|0|||
161446784|NCT00545272|583029651|FG003|Overall Study|Lost to Follow-up|0|||
161446785|NCT00545272|583029652|FG004|Overall Study|Lost to Follow-up|1|||
161446786|NCT00545272|583029653|FG005|Overall Study|Lost to Follow-up|0|||
161446787|NCT02934503|583029654|FG000|Overall Study|progression of disease|3|||
161446788|NCT02934503|583029654|FG000|Overall Study|Withdrawal by Subject|1|||
161446789|NCT00724867|583029655|FG000|Overall Study|Adverse Event|25|||
161446790|NCT00724867|583029655|FG000|Overall Study|Lack of Efficacy|14|||
161446791|NCT00724867|583029655|FG000|Overall Study|Lost to Follow-up|12|||
161446792|NCT00724867|583029655|FG000|Overall Study|Non-compliance with study drug|6|||
161446793|NCT00724867|583029655|FG000|Overall Study|Physician Decision|17|||
161446794|NCT00724867|583029655|FG000|Overall Study|Protocol Violation|1|||
161446795|NCT00724867|583029655|FG000|Overall Study|Withdrawal by Subject|31|||
161794996|NCT05342753|584293629|FG000|Overall Study|Lost to Follow-up|1|||
161794997|NCT00836927|584293630|FG000|Overall Study|Progressive disease|2|||
161794998|NCT00836927|584293631|FG001|Overall Study|Progressive disease|0|||
161794999|NCT00836927|584293632|FG002|Overall Study|Progressive disease|0|||
161795000|NCT00836927|584293633|FG003|Overall Study|Progressive disease|1|||
161795001|NCT00836927|584293634|FG004|Overall Study|Progressive disease|1|||
161795002|NCT00836927|584293630|FG000|Overall Study|Withdrawal by Subject|1|||
161795003|NCT00836927|584293631|FG001|Overall Study|Withdrawal by Subject|0|||
161795004|NCT00836927|584293632|FG002|Overall Study|Withdrawal by Subject|0|||
161795005|NCT00836927|584293633|FG003|Overall Study|Withdrawal by Subject|0|||
161795006|NCT00836927|584293634|FG004|Overall Study|Withdrawal by Subject|0|||
161795007|NCT00614055|584293637|FG000|Overall Study|Adverse Event|1|||
161795008|NCT00614055|584293638|FG001|Overall Study|Adverse Event|0|||
161795009|NCT00614055|584293639|FG002|Overall Study|Adverse Event|0|||
161795010|NCT00614055|584293637|FG000|Overall Study|Protocol Violation|2|||
161795011|NCT00614055|584293638|FG001|Overall Study|Protocol Violation|2|||
161795012|NCT00614055|584293639|FG002|Overall Study|Protocol Violation|1|||
161795013|NCT00614055|584293637|FG000|Overall Study|Lack of Efficacy|0|||
161795014|NCT00614055|584293638|FG001|Overall Study|Lack of Efficacy|0|||
161795015|NCT00614055|584293639|FG002|Overall Study|Lack of Efficacy|2|||
161795016|NCT00614055|584293637|FG000|Overall Study|Unclassified|1|||
161795017|NCT00614055|584293638|FG001|Overall Study|Unclassified|4|||
161795018|NCT00614055|584293639|FG002|Overall Study|Unclassified|2|||
161795019|NCT04583579|584293642|FG000|Overall Study|Lost to Follow-up|4|||
161795020|NCT02006706|584293644|FG000|Overall Study|Lost to Follow-up|1|||
161795021|NCT05590585|584293645|FG000|Overall Study|Lost to Follow-up|3|||
161795022|NCT05590585|584293645|FG000|Overall Study|Withdrawal by Subject|1|||
161795023|NCT01673009|584293646|FG000|Overall Study|Physician Decision|5|||
161795024|NCT01673009|584293646|FG000|Overall Study|Withdrawal by Subject|8|||
161795025|NCT04161144|584293648|FG000|Overall Study|Withdrawal by Subject|0|||
161795026|NCT04161144|584293649|FG001|Overall Study|Withdrawal by Subject|1|||
161795027|NCT04161144|584293648|FG000|Overall Study|Protocol Violation|1|||
161795028|NCT04161144|584293649|FG001|Overall Study|Protocol Violation|0|||
161795029|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
161795030|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
161795031|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
161795032|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
161795033|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
161795034|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
161795035|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
161795036|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
161795037|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161795038|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161795039|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161795040|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
161795041|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
161446796|NCT00724867|583029655|FG000|Overall Study|Sponsor decision to end study|14|||
161446797|NCT00724867|583029655|FG000|Overall Study|Subject incarcerated|1|||
161446798|NCT00724867|583029655|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
161552458|NCT03560245|583410456|FG000|Overall Study|Withdrawal by Subject|3|||
161795042|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161795043|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161795044|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161795045|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
161795046|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
161795047|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
161795048|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
161795049|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Other|0|||
161795050|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Other|0|||
161795051|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Other|1|||
161446799|NCT00724867|583029655|FG000|Overall Study|Subject moved out of state|1|||
161795052|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Other|0|||
161900463|NCT00099632|584683040|FG003|Overall Study|Lost to Follow-up|1|||
161446800|NCT00724867|583029655|FG000|Overall Study|Elected to exit due to site closure|2|||
161446801|NCT03539549|583029656|FG000|Overall Study|Adverse Event|12|||
161446802|NCT03539549|583029656|FG000|Overall Study|Lost to Follow-up|1|||
161446803|NCT03539549|583029656|FG000|Overall Study|Death|2|||
161446804|NCT03539549|583029656|FG000|Overall Study|Progressive Disease|1|||
161446805|NCT03539549|583029656|FG000|Overall Study|Reason not Specified|1|||
161446806|NCT00436345|583029657|FG000|Overall Study|ICU resident beyond follow-up period|3|||
161446807|NCT00436345|583029658|FG001|Overall Study|ICU resident beyond follow-up period|0|||
161446808|NCT04027608|583029659|FG000|Overall Study|Withdrawal by Subject|13|||
161446809|NCT04027608|583029660|FG001|Overall Study|Withdrawal by Subject|2|||
161446810|NCT04027608|583029659|FG000|Overall Study|Protocol Violation|2|||
161446811|NCT04027608|583029660|FG001|Overall Study|Protocol Violation|1|||
161795053|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
161795054|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
161795055|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
161795056|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
161795057|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161795058|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161795059|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161795060|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
161795061|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161795062|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161795063|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
161795064|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161795065|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161795066|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161795067|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
161795068|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161795069|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Other|1|||
161795070|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Other|2|||
161795071|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Other|0|||
161795072|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Other|0|||
161795073|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
161795074|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
161795075|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
161795076|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
161795077|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161795078|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161795079|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161795080|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
161795081|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161795082|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161795083|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161795084|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
161795085|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161795086|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161795087|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161795088|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
161795089|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Other|0|||
161795090|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Other|0|||
161795091|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Other|0|||
161795092|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Other|5|||
161795093|NCT06041646|584293656|FG000|Overall Study|Withdrawal by Subject|1|||
161795094|NCT01000337|584293657|FG000|Overall Study|Lost to Follow-up|4|||
161795095|NCT01000337|584293658|FG001|Overall Study|Lost to Follow-up|3|||
161795096|NCT02173704|584293659|FG000|Overall Study|Adverse Event|1|||
161900464|NCT00099632|584683041|FG004|Overall Study|Lost to Follow-up|1|||
161446812|NCT04027608|583029659|FG000|Overall Study|Physician Decision|1|||
161446813|NCT04027608|583029660|FG001|Overall Study|Physician Decision|0|||
161446814|NCT04027608|583029659|FG000|Overall Study|Lost to Follow-up|20|||
161795097|NCT02173704|584293660|FG001|Overall Study|Adverse Event|0|||
161795098|NCT02173704|584293659|FG000|Overall Study|Lost to Follow-up|1|||
161795099|NCT02173704|584293660|FG001|Overall Study|Lost to Follow-up|0|||
161795100|NCT02173704|584293659|FG000|Overall Study|Other|1|||
161795101|NCT02173704|584293660|FG001|Overall Study|Other|0|||
161795102|NCT02173704|584293659|FG000|Overall Study|Protocol Violation|1|||
161795103|NCT02173704|584293660|FG001|Overall Study|Protocol Violation|0|||
161795104|NCT02173704|584293659|FG000|Overall Study|Withdrawal by Subject|9|||
161795105|NCT02173704|584293660|FG001|Overall Study|Withdrawal by Subject|4|||
161795106|NCT03901963|584293661|FG000|Overall Study|Lost to Follow-up|1|||
161795107|NCT03901963|584293662|FG001|Overall Study|Lost to Follow-up|1|||
161795108|NCT03901963|584293661|FG000|Overall Study|Physician Decision|1|||
161795109|NCT03901963|584293662|FG001|Overall Study|Physician Decision|2|||
161795110|NCT03901963|584293661|FG000|Overall Study|Protocol Violation|1|||
161795111|NCT03901963|584293662|FG001|Overall Study|Protocol Violation|1|||
161795112|NCT03901963|584293661|FG000|Overall Study|Withdrawal by Subject|4|||
161795113|NCT03901963|584293662|FG001|Overall Study|Withdrawal by Subject|11|||
161900465|NCT00099632|584683042|FG005|Overall Study|Lost to Follow-up|0|||
161446815|NCT04027608|583029660|FG001|Overall Study|Lost to Follow-up|4|||
161795114|NCT03901963|584293661|FG000|Overall Study|Ongoing|84|||
161795115|NCT03901963|584293662|FG001|Overall Study|Ongoing|73|||
161795116|NCT03901963|584293661|FG000|Overall Study|Randomized but not treated|3|||
161795117|NCT03901963|584293662|FG001|Overall Study|Randomized but not treated|3|||
161795118|NCT02854436|584293663|FG000|Overall Study|Adverse Event|1|||
161795119|NCT02854436|584293663|FG000|Overall Study|Death|208|||
161795120|NCT02854436|584293663|FG000|Overall Study|Lost to Follow-up|5|||
161795121|NCT02854436|584293663|FG000|Overall Study|Withdrawal by Subject|24|||
161795122|NCT02854436|584293663|FG000|Overall Study|Other|45|||
161795123|NCT02854436|584293663|FG000|Overall Study|Physician Decision|6|||
161795124|NCT04956666|584293664|FG000|Overall Study|Adverse Event|18|||
161446816|NCT04248491|583029661|FG000|Overall Study|Lost to Follow-up|1|||
161446817|NCT04248491|583029662|FG001|Overall Study|Lost to Follow-up|0|||
161446818|NCT01652469|583029671|FG000|Overall Study|Withdrawal by Subject|1|||
161446819|NCT01652469|583029672|FG001|Overall Study|Withdrawal by Subject|4|||
161446820|NCT01652469|583029671|FG000|Overall Study|Lost to Follow-up|0|||
161446821|NCT01652469|583029672|FG001|Overall Study|Lost to Follow-up|2|||
161446822|NCT01049009|583029673|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
161446823|NCT01049009|583029674|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
161446824|NCT01049009|583029673|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161446825|NCT01049009|583029674|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161446826|NCT01049009|583029673|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
161446827|NCT01049009|583029674|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
161446828|NCT01049009|583029673|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
161446829|NCT01049009|583029674|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
161446830|NCT02644109|583029676|FG000|Overall Study|Adverse Event|0|||
161446831|NCT02644109|583029677|FG001|Overall Study|Adverse Event|4|||
161446832|NCT02474069|583029678|FG000|Selection Phase (SP)|Adverse Event|8|||
161446833|NCT02474069|583029679|FG001|Selection Phase (SP)|Adverse Event|0|||
161446834|NCT02474069|583029680|FG002|Selection Phase (SP)|Adverse Event|0|||
161446835|NCT02474069|583029678|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
161446836|NCT02474069|583029679|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
161446837|NCT02474069|583029680|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
161446838|NCT02474069|583029678|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
161446839|NCT02474069|583029679|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
161446840|NCT02474069|583029680|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
161446841|NCT02474069|583029678|FG000|Selection Phase (SP)|Physician Decision|1|||
161446842|NCT02474069|583029679|FG001|Selection Phase (SP)|Physician Decision|0|||
161446843|NCT02474069|583029680|FG002|Selection Phase (SP)|Physician Decision|0|||
161446844|NCT02474069|583029678|FG000|Selection Phase (SP)|Protocol Violation|1|||
161446845|NCT02474069|583029679|FG001|Selection Phase (SP)|Protocol Violation|0|||
161446846|NCT02474069|583029680|FG002|Selection Phase (SP)|Protocol Violation|0|||
161446847|NCT02474069|583029678|FG000|Selection Phase (SP)|No longer requires treatment|1|||
161446848|NCT02474069|583029679|FG001|Selection Phase (SP)|No longer requires treatment|0|||
161446849|NCT02474069|583029680|FG002|Selection Phase (SP)|No longer requires treatment|0|||
161446850|NCT02474069|583029678|FG000|Selection Phase (SP)|Technical Problem|1|||
161446851|NCT02474069|583029679|FG001|Selection Phase (SP)|Technical Problem|0|||
161446852|NCT02474069|583029680|FG002|Selection Phase (SP)|Technical Problem|0|||
161446853|NCT02474069|583029678|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
161446854|NCT02474069|583029679|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
161446855|NCT02474069|583029680|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
161446856|NCT02474069|583029678|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
161446857|NCT02474069|583029679|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
161446858|NCT02474069|583029680|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
161446859|NCT02474069|583029678|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
161446860|NCT02474069|583029679|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
161446861|NCT02474069|583029680|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
161446862|NCT02474069|583029678|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
161446863|NCT02474069|583029679|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
161446864|NCT02474069|583029680|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
161446865|NCT02474069|583029678|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
161446866|NCT02474069|583029679|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
161446867|NCT02474069|583029680|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
161446868|NCT02474069|583029678|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
161446869|NCT02474069|583029679|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
161446870|NCT02474069|583029680|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
161446871|NCT01474018|583029681|FG000|Overall Study|Lost to Follow-up|0|||
161795125|NCT04956666|584293664|FG000|Overall Study|Physician Decision|5|||
161795126|NCT01700621|584293665|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
161795127|NCT01700621|584293666|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
161795128|NCT01700621|584293665|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
161446872|NCT01474018|583029682|FG001|Overall Study|Lost to Follow-up|1|||
161446873|NCT01474018|583029681|FG000|Overall Study|Withdrawal by Subject|0|||
161446874|NCT01474018|583029682|FG001|Overall Study|Withdrawal by Subject|2|||
161446875|NCT03801031|583029683|FG000|Overall Study|Lost to Follow-up|1|||
161446876|NCT03801031|583029684|FG001|Overall Study|Lost to Follow-up|0|||
161446877|NCT03801031|583029683|FG000|Overall Study|Unable to comply|1|||
161446878|NCT03801031|583029684|FG001|Overall Study|Unable to comply|0|||
161446879|NCT03801031|583029683|FG000|Overall Study|Withdrawal by Subject|0|||
161446880|NCT03801031|583029684|FG001|Overall Study|Withdrawal by Subject|1|||
161446881|NCT01942733|583029685|FG000|Overall Study|Lost to Follow-up|1|||
161446882|NCT01942733|583029685|FG000|Overall Study|Non-compliance with IMP|1|||
161446883|NCT01942733|583029685|FG000|Overall Study|Administrative|1|||
161446884|NCT00126490|583029686|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
161446885|NCT03462511|583029688|FG000|Overall Study|Withdrawal by Subject|2|||
161446886|NCT03462511|583029689|FG001|Overall Study|Withdrawal by Subject|3|||
161446887|NCT02925416|583029690|FG000|Overall Study|Adverse Event|2|||
161446888|NCT02925416|583029691|FG001|Overall Study|Adverse Event|0|||
161446889|NCT02625909|583029692|FG000|Overall Study|Death|2|||
161446890|NCT02625909|583029693|FG001|Overall Study|Death|0|||
161446891|NCT02625909|583029692|FG000|Overall Study|Lost to Follow-up|3|||
161446892|NCT02625909|583029693|FG001|Overall Study|Lost to Follow-up|5|||
161446893|NCT02625909|583029692|FG000|Overall Study|Lack of Efficacy|9|||
161446894|NCT02625909|583029693|FG001|Overall Study|Lack of Efficacy|2|||
161446895|NCT02625909|583029692|FG000|Overall Study|Reinfection|3|||
161446896|NCT02625909|583029693|FG001|Overall Study|Reinfection|2|||
161446897|NCT01598506|583029694|FG000|Overall Study|Withdrawal by Subject|2|||
161446898|NCT02067676|583029699|FG000|Overall Study|Withdrawal by Subject|1|||
161446899|NCT02067676|583029700|FG001|Overall Study|Withdrawal by Subject|0|||
161446900|NCT02067676|583029701|FG002|Overall Study|Withdrawal by Subject|0|||
161446901|NCT02067676|583029702|FG003|Overall Study|Withdrawal by Subject|0|||
161446902|NCT02067676|583029703|FG004|Overall Study|Withdrawal by Subject|0|||
161446903|NCT02067676|583029704|FG005|Overall Study|Withdrawal by Subject|0|||
161446904|NCT00476229|583029705|FG000|Overall Study|Progressive shortness of breath|1|||
161446905|NCT01387542|583029712|FG000|Overall Study|Adverse Event|3|||
161446906|NCT01387542|583029712|FG000|Overall Study|Withdrawal by Subject|1|||
161446907|NCT01387542|583029712|FG000|Overall Study|Changed diagnosis|1|||
161446908|NCT01387542|583029712|FG000|Overall Study|Insufficient response|1|||
161446909|NCT01387542|583029712|FG000|Overall Study|Non-compliant|1|||
161446910|NCT01387542|583029712|FG000|Overall Study|Lost to Follow-up|1|||
161446911|NCT01761240|583029715|FG000|Overall Study|Progressive disease:radiology assessment|3|||
161446912|NCT01761240|583029716|FG001|Overall Study|Progressive disease:radiology assessment|3|||
161446913|NCT01761240|583029717|FG002|Overall Study|Progressive disease:radiology assessment|0|||
161446914|NCT01761240|583029718|FG003|Overall Study|Progressive disease:radiology assessment|0|||
161446915|NCT01761240|583029719|FG004|Overall Study|Progressive disease:radiology assessment|0|||
161446916|NCT01761240|583029715|FG000|Overall Study|Progressive disease:clinical assessment|0|||
161446917|NCT01761240|583029716|FG001|Overall Study|Progressive disease:clinical assessment|0|||
161446918|NCT01761240|583029717|FG002|Overall Study|Progressive disease:clinical assessment|3|||
161446919|NCT01761240|583029718|FG003|Overall Study|Progressive disease:clinical assessment|1|||
161446920|NCT01761240|583029719|FG004|Overall Study|Progressive disease:clinical assessment|0|||
161446921|NCT01761240|583029715|FG000|Overall Study|Withdrawal by Subject|0|||
161446922|NCT01761240|583029716|FG001|Overall Study|Withdrawal by Subject|0|||
161446923|NCT01761240|583029717|FG002|Overall Study|Withdrawal by Subject|0|||
161446924|NCT01761240|583029718|FG003|Overall Study|Withdrawal by Subject|3|||
161446925|NCT01761240|583029719|FG004|Overall Study|Withdrawal by Subject|1|||
161446926|NCT01761240|583029715|FG000|Overall Study|Adverse Event|0|||
161446927|NCT01761240|583029716|FG001|Overall Study|Adverse Event|0|||
161446928|NCT01761240|583029717|FG002|Overall Study|Adverse Event|0|||
161446929|NCT01761240|583029718|FG003|Overall Study|Adverse Event|1|||
161446930|NCT01761240|583029719|FG004|Overall Study|Adverse Event|6|||
161446931|NCT01761240|583029715|FG000|Overall Study|Death|0|||
161446932|NCT01761240|583029716|FG001|Overall Study|Death|1|||
161446933|NCT01761240|583029717|FG002|Overall Study|Death|1|||
161446934|NCT01761240|583029718|FG003|Overall Study|Death|2|||
161446935|NCT01761240|583029719|FG004|Overall Study|Death|1|||
161446936|NCT01761240|583029715|FG000|Overall Study|Non-compliance|0|||
161446937|NCT01761240|583029716|FG001|Overall Study|Non-compliance|0|||
161446938|NCT01761240|583029717|FG002|Overall Study|Non-compliance|1|||
161446939|NCT01761240|583029718|FG003|Overall Study|Non-compliance|0|||
161446940|NCT01761240|583029719|FG004|Overall Study|Non-compliance|0|||
161446941|NCT05422638|583029720|FG000|Overall Study|Withdrawal by Subject|8|||
161446942|NCT05422638|583029721|FG001|Overall Study|Withdrawal by Subject|2|||
161446943|NCT01827956|583029722|FG000|Overall Study|Protocol Violation|3|||
161446944|NCT04393454|583029723|FG000|Overall Study|Death|1|||
161446945|NCT04393454|583029723|FG000|Overall Study|Lost to Follow-up|1|||
161446946|NCT02621151|583029724|FG000|Overall Study|Not eligible for trial|6|||
161446947|NCT04695977|583029729|FG000|Overall Study|Sponsor Decision|9|||
161446948|NCT04695977|583029730|FG001|Overall Study|Sponsor Decision|4|||
161446949|NCT04695977|583029729|FG000|Overall Study|Death|2|||
161446950|NCT04695977|583029730|FG001|Overall Study|Death|5|||
161446951|NCT01657461|583030946|FG000|Overall Study|Death|9|||
161446952|NCT01657461|583030947|FG001|Overall Study|Death|12|||
161446953|NCT01657461|583030946|FG000|Overall Study|Lost to Follow-up|0|||
161446954|NCT01657461|583030947|FG001|Overall Study|Lost to Follow-up|3|||
161446955|NCT01657461|583030946|FG000|Overall Study|Physician Decision|0|||
161446956|NCT01657461|583030947|FG001|Overall Study|Physician Decision|2|||
161446957|NCT01657461|583030946|FG000|Overall Study|Withdrawal by Subject|1|||
161446958|NCT01657461|583030947|FG001|Overall Study|Withdrawal by Subject|3|||
161446959|NCT00130247|583030948|FG000|Overall Study|Pregnancy|1|||
161446960|NCT00130247|583030949|FG001|Overall Study|Pregnancy|0|||
161446961|NCT00130247|583030948|FG000|Overall Study|Post-randomization exclusion|1|||
161446962|NCT00130247|583030949|FG001|Overall Study|Post-randomization exclusion|2|||
161446963|NCT00130247|583030948|FG000|Overall Study|Not compliant with DOT|0|||
161446964|NCT00130247|583030949|FG001|Overall Study|Not compliant with DOT|2|||
161446965|NCT01761162|583030954|FG000|Overall Study|Withdrawal by Subject|3|||
161446966|NCT02160899|583030959|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161446967|NCT02160899|583030960|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161446968|NCT02160899|583030961|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
161446969|NCT02160899|583030962|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
161446970|NCT02160899|583030963|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
161446971|NCT02160899|583030964|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
161446972|NCT04129151|583030965|FG000|Overall Study|Adverse Event|1|||
161446973|NCT04129151|583030965|FG000|Overall Study|Disease Progression|7|||
161446974|NCT04129151|583030965|FG000|Overall Study|Study closure|1|||
161446975|NCT04473235|583030966|FG000|Overall Study|Lost to Follow-up|6|||
161446976|NCT04473235|583030967|FG001|Overall Study|Lost to Follow-up|5|||
161446977|NCT04473235|583030966|FG000|Overall Study|Declined continuation|2|||
161446978|NCT04473235|583030967|FG001|Overall Study|Declined continuation|0|||
161446979|NCT04473235|583030966|FG000|Overall Study|Physician Decision|1|||
161446980|NCT04473235|583030967|FG001|Overall Study|Physician Decision|1|||
161446981|NCT04473235|583030966|FG000|Overall Study|Protocol Violation|10|||
161446982|NCT04473235|583030967|FG001|Overall Study|Protocol Violation|6|||
161446983|NCT01945710|583030970|FG000|Overall Study|Progressive Disease|5|||
161446984|NCT01945710|583030971|FG001|Overall Study|Progressive Disease|4|||
161446985|NCT01945710|583030972|FG002|Overall Study|Progressive Disease|3|||
161446986|NCT01945710|583030973|FG003|Overall Study|Progressive Disease|2|||
161446987|NCT01945710|583030974|FG004|Overall Study|Progressive Disease|7|||
161446988|NCT01945710|583030975|FG005|Overall Study|Progressive Disease|3|||
161446989|NCT01945710|583030976|FG006|Overall Study|Progressive Disease|19|||
161446990|NCT01945710|583030970|FG000|Overall Study|Adverse Event|0|||
161446991|NCT01945710|583030971|FG001|Overall Study|Adverse Event|1|||
161446992|NCT01945710|583030972|FG002|Overall Study|Adverse Event|0|||
161446993|NCT01945710|583030973|FG003|Overall Study|Adverse Event|0|||
161446994|NCT01945710|583030974|FG004|Overall Study|Adverse Event|0|||
161446995|NCT01945710|583030975|FG005|Overall Study|Adverse Event|0|||
161446996|NCT01945710|583030976|FG006|Overall Study|Adverse Event|0|||
161446997|NCT01945710|583030970|FG000|Overall Study|Other|2|||
161446998|NCT01945710|583030971|FG001|Overall Study|Other|0|||
161446999|NCT01945710|583030972|FG002|Overall Study|Other|3|||
161447000|NCT01945710|583030973|FG003|Overall Study|Other|1|||
161795129|NCT01700621|584293666|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
161795130|NCT01700621|584293665|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
161795131|NCT01700621|584293666|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
161795132|NCT00384033|584293673|FG000|Overall Study|Adverse Event|10|||
161795133|NCT00384033|584293674|FG001|Overall Study|Adverse Event|8|||
161795134|NCT00384033|584293675|FG002|Overall Study|Adverse Event|11|||
161795135|NCT00384033|584293676|FG003|Overall Study|Adverse Event|20|||
161795136|NCT00384033|584293673|FG000|Overall Study|Failed to return|1|||
161795137|NCT00384033|584293674|FG001|Overall Study|Failed to return|3|||
161795138|NCT00384033|584293675|FG002|Overall Study|Failed to return|2|||
161795139|NCT00384033|584293676|FG003|Overall Study|Failed to return|2|||
161795140|NCT00384033|584293673|FG000|Overall Study|Physician Decision|1|||
161795141|NCT00384033|584293674|FG001|Overall Study|Physician Decision|0|||
161795142|NCT00384033|584293675|FG002|Overall Study|Physician Decision|0|||
161795143|NCT00384033|584293676|FG003|Overall Study|Physician Decision|0|||
161795144|NCT00384033|584293673|FG000|Overall Study|Lost to Follow-up|6|||
161795145|NCT00384033|584293674|FG001|Overall Study|Lost to Follow-up|12|||
161795146|NCT00384033|584293675|FG002|Overall Study|Lost to Follow-up|7|||
161447001|NCT01945710|583030974|FG004|Overall Study|Other|1|||
161447002|NCT01945710|583030975|FG005|Overall Study|Other|0|||
161447003|NCT01945710|583030976|FG006|Overall Study|Other|4|||
161447004|NCT01945710|583030970|FG000|Overall Study|Withdrawal by Subject|0|||
161447005|NCT01945710|583030971|FG001|Overall Study|Withdrawal by Subject|1|||
161447006|NCT01945710|583030972|FG002|Overall Study|Withdrawal by Subject|1|||
161447007|NCT01945710|583030973|FG003|Overall Study|Withdrawal by Subject|0|||
161447008|NCT01945710|583030974|FG004|Overall Study|Withdrawal by Subject|1|||
161447009|NCT01945710|583030975|FG005|Overall Study|Withdrawal by Subject|0|||
161900466|NCT00099632|584683037|FG000|Overall Study|Withdrawal by Subject|0|||
161447010|NCT01945710|583030976|FG006|Overall Study|Withdrawal by Subject|0|||
161900467|NCT00099632|584683038|FG001|Overall Study|Withdrawal by Subject|1|||
161900468|NCT00099632|584683039|FG002|Overall Study|Withdrawal by Subject|0|||
161900469|NCT00099632|584683040|FG003|Overall Study|Withdrawal by Subject|0|||
161900470|NCT00099632|584683041|FG004|Overall Study|Withdrawal by Subject|0|||
161900471|NCT00099632|584683042|FG005|Overall Study|Withdrawal by Subject|1|||
161900472|NCT00099632|584683037|FG000|Overall Study|Protocol Violation|0|||
161900473|NCT00099632|584683038|FG001|Overall Study|Protocol Violation|0|||
161900474|NCT00099632|584683039|FG002|Overall Study|Protocol Violation|0|||
161900475|NCT00099632|584683040|FG003|Overall Study|Protocol Violation|0|||
161900476|NCT00099632|584683041|FG004|Overall Study|Protocol Violation|0|||
161900477|NCT00099632|584683042|FG005|Overall Study|Protocol Violation|1|||
161900478|NCT02797678|584683063|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
161900479|NCT02797678|584683064|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161900480|NCT02797678|584683065|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161900481|NCT02797678|584683066|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161900482|NCT02797678|584683063|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
161900483|NCT02797678|584683064|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
161900484|NCT02797678|584683065|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
161900485|NCT02797678|584683066|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
161900486|NCT02797678|584683063|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161900487|NCT02797678|584683064|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161900488|NCT02797678|584683065|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
161900489|NCT02797678|584683066|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161900490|NCT03131687|584683067|FG000|Overall Study|Adverse Event|0|||
161900491|NCT03131687|584683068|FG001|Overall Study|Adverse Event|1|||
161900492|NCT03131687|584683069|FG002|Overall Study|Adverse Event|0|||
161900493|NCT03131687|584683070|FG003|Overall Study|Adverse Event|1|||
161900494|NCT03131687|584683071|FG004|Overall Study|Adverse Event|2|||
161900495|NCT03131687|584683072|FG005|Overall Study|Adverse Event|2|||
161447011|NCT02730195|583030977|FG000|Overall Study|Withdrawal by Subject|1|||
161447012|NCT01754727|583030980|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
161447013|NCT02785770|583030981|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
161447014|NCT02785770|583030982|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
161447015|NCT02785770|583030983|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
161447016|NCT02785770|583030984|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
161447017|NCT02785770|583030981|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
161447018|NCT02785770|583030982|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
161447019|NCT02785770|583030983|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
161447020|NCT02785770|583030984|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
161447021|NCT02785770|583030981|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
161447022|NCT02785770|583030982|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
161447023|NCT02785770|583030983|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
161447024|NCT02785770|583030984|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
161447025|NCT00813943|583030988|FG000|Overall Study|Ongoing at cut-off date|5|||
161447026|NCT00813943|583030989|FG001|Overall Study|Ongoing at cut-off date|5|||
161447027|NCT00813943|583030990|FG002|Overall Study|Ongoing at cut-off date|3|||
161447028|NCT01088048|583030991|FG000|Overall Study|Adverse Event|7|||
161447029|NCT01088048|583030992|FG001|Overall Study|Adverse Event|9|||
161447030|NCT01088048|583030993|FG002|Overall Study|Adverse Event|7|||
161447031|NCT01088048|583030994|FG003|Overall Study|Adverse Event|5|||
161447032|NCT01088048|583030995|FG004|Overall Study|Adverse Event|6|||
161447033|NCT01088048|583030996|FG005|Overall Study|Adverse Event|3|||
161447034|NCT01088048|583030997|FG006|Overall Study|Adverse Event|3|||
161447035|NCT01088048|583030998|FG007|Overall Study|Adverse Event|0|||
161447036|NCT01088048|583030999|FG008|Overall Study|Adverse Event|2|||
161447037|NCT01088048|583031000|FG009|Overall Study|Adverse Event|2|||
161447038|NCT01088048|583030991|FG000|Overall Study|Withdrew Consent|1|||
161447039|NCT01088048|583030992|FG001|Overall Study|Withdrew Consent|1|||
161447040|NCT01088048|583030993|FG002|Overall Study|Withdrew Consent|1|||
161900496|NCT03131687|584683067|FG000|Overall Study|Death|1|||
161900497|NCT03131687|584683068|FG001|Overall Study|Death|0|||
161900498|NCT03131687|584683069|FG002|Overall Study|Death|0|||
161900499|NCT03131687|584683070|FG003|Overall Study|Death|0|||
161900500|NCT03131687|584683071|FG004|Overall Study|Death|0|||
161900501|NCT03131687|584683072|FG005|Overall Study|Death|0|||
161900502|NCT03131687|584683067|FG000|Overall Study|Withdrawal by Subject|3|||
161900503|NCT03131687|584683068|FG001|Overall Study|Withdrawal by Subject|3|||
161447041|NCT01088048|583030994|FG003|Overall Study|Withdrew Consent|1|||
161447042|NCT01088048|583030995|FG004|Overall Study|Withdrew Consent|2|||
161447043|NCT01088048|583030996|FG005|Overall Study|Withdrew Consent|1|||
161447044|NCT01088048|583030997|FG006|Overall Study|Withdrew Consent|0|||
161447045|NCT01088048|583030998|FG007|Overall Study|Withdrew Consent|2|||
161447046|NCT01088048|583030999|FG008|Overall Study|Withdrew Consent|2|||
161795147|NCT00384033|584293676|FG003|Overall Study|Lost to Follow-up|7|||
161795148|NCT00384033|584293673|FG000|Overall Study|Other|2|||
161795149|NCT00384033|584293674|FG001|Overall Study|Other|0|||
161795150|NCT00384033|584293675|FG002|Overall Study|Other|0|||
161795151|NCT00384033|584293676|FG003|Overall Study|Other|0|||
161795152|NCT00384033|584293673|FG000|Overall Study|Protocol Violation|5|||
161795153|NCT00384033|584293674|FG001|Overall Study|Protocol Violation|0|||
161795154|NCT00384033|584293675|FG002|Overall Study|Protocol Violation|5|||
161795155|NCT00384033|584293676|FG003|Overall Study|Protocol Violation|6|||
161795156|NCT00384033|584293673|FG000|Overall Study|Withdrawal by Subject|6|||
161795157|NCT00384033|584293674|FG001|Overall Study|Withdrawal by Subject|2|||
161795158|NCT00384033|584293675|FG002|Overall Study|Withdrawal by Subject|5|||
161795159|NCT00384033|584293676|FG003|Overall Study|Withdrawal by Subject|2|||
161795160|NCT00384033|584293673|FG000|Overall Study|Lack of Efficacy|7|||
161795161|NCT00384033|584293674|FG001|Overall Study|Lack of Efficacy|3|||
161795162|NCT00384033|584293675|FG002|Overall Study|Lack of Efficacy|3|||
161795163|NCT00384033|584293676|FG003|Overall Study|Lack of Efficacy|1|||
161795164|NCT00384033|584293673|FG000|Overall Study|Randomized but not treated|3|||
161795165|NCT00384033|584293674|FG001|Overall Study|Randomized but not treated|7|||
161795166|NCT00384033|584293675|FG002|Overall Study|Randomized but not treated|10|||
161795167|NCT00384033|584293676|FG003|Overall Study|Randomized but not treated|2|||
161795168|NCT03349333|584293677|FG000|Overall Study|Progression of Disease|36|||
161795169|NCT03349333|584293677|FG000|Overall Study|Adverse Event|11|||
161795170|NCT03349333|584293677|FG000|Overall Study|Other|6|||
161795171|NCT03349333|584293677|FG000|Overall Study|Withdrawal by Subject|5|||
161795172|NCT03349333|584293677|FG000|Overall Study|Conditions interfere with participation|2|||
161900504|NCT03131687|584683069|FG002|Overall Study|Withdrawal by Subject|3|||
161447047|NCT01088048|583031000|FG009|Overall Study|Withdrew Consent|1|||
161447048|NCT01088048|583030991|FG000|Overall Study|Concomitant Medication Prohibited|1|||
161447049|NCT01088048|583030992|FG001|Overall Study|Concomitant Medication Prohibited|0|||
161447050|NCT01088048|583030993|FG002|Overall Study|Concomitant Medication Prohibited|0|||
161447051|NCT01088048|583030994|FG003|Overall Study|Concomitant Medication Prohibited|0|||
161447052|NCT01088048|583030995|FG004|Overall Study|Concomitant Medication Prohibited|0|||
161447053|NCT01088048|583030996|FG005|Overall Study|Concomitant Medication Prohibited|0|||
161447054|NCT01088048|583030997|FG006|Overall Study|Concomitant Medication Prohibited|0|||
161447055|NCT01088048|583030998|FG007|Overall Study|Concomitant Medication Prohibited|0|||
161447056|NCT01088048|583030999|FG008|Overall Study|Concomitant Medication Prohibited|0|||
161447057|NCT01088048|583031000|FG009|Overall Study|Concomitant Medication Prohibited|0|||
161447058|NCT01088048|583030991|FG000|Overall Study|Investigator Request|2|||
161447059|NCT01088048|583030992|FG001|Overall Study|Investigator Request|2|||
161447060|NCT01088048|583030993|FG002|Overall Study|Investigator Request|0|||
161447061|NCT01088048|583030994|FG003|Overall Study|Investigator Request|0|||
161447062|NCT01088048|583030995|FG004|Overall Study|Investigator Request|3|||
161447063|NCT01088048|583030996|FG005|Overall Study|Investigator Request|1|||
161447064|NCT01088048|583030997|FG006|Overall Study|Investigator Request|1|||
161447065|NCT01088048|583030998|FG007|Overall Study|Investigator Request|0|||
161447066|NCT01088048|583030999|FG008|Overall Study|Investigator Request|0|||
161447067|NCT01088048|583031000|FG009|Overall Study|Investigator Request|0|||
161447068|NCT01088048|583030991|FG000|Overall Study|Patient Non-compliance|0|||
161447069|NCT01088048|583030992|FG001|Overall Study|Patient Non-compliance|1|||
161447070|NCT01088048|583030993|FG002|Overall Study|Patient Non-compliance|0|||
161447071|NCT01088048|583030994|FG003|Overall Study|Patient Non-compliance|0|||
161447072|NCT01088048|583030995|FG004|Overall Study|Patient Non-compliance|0|||
161447073|NCT01088048|583030996|FG005|Overall Study|Patient Non-compliance|0|||
161447074|NCT01088048|583030997|FG006|Overall Study|Patient Non-compliance|0|||
161447075|NCT01088048|583030998|FG007|Overall Study|Patient Non-compliance|0|||
161447076|NCT01088048|583030999|FG008|Overall Study|Patient Non-compliance|0|||
161447077|NCT01088048|583031000|FG009|Overall Study|Patient Non-compliance|0|||
161447078|NCT01088048|583030991|FG000|Overall Study|Disease Progression|7|||
161447079|NCT01088048|583030992|FG001|Overall Study|Disease Progression|4|||
161447080|NCT01088048|583030993|FG002|Overall Study|Disease Progression|3|||
161447081|NCT01088048|583030994|FG003|Overall Study|Disease Progression|5|||
161447082|NCT01088048|583030995|FG004|Overall Study|Disease Progression|3|||
161447083|NCT01088048|583030996|FG005|Overall Study|Disease Progression|3|||
161795173|NCT03349333|584293677|FG000|Overall Study|Physician Decision|2|||
161795174|NCT03349333|584293677|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
161795175|NCT03349333|584293677|FG000|Overall Study|Patients in treatment less than 24 month|8|||
161795176|NCT02985151|584293678|FG000|Original Randomization|Withdrawal by Subject|0|||
161795177|NCT02985151|584293679|FG001|Original Randomization|Withdrawal by Subject|1|||
161795178|NCT02752776|584293682|FG000|Overall Study|Adverse Event|15|||
161795179|NCT02752776|584293683|FG001|Overall Study|Adverse Event|23|||
161795180|NCT02752776|584293684|FG002|Overall Study|Adverse Event|11|||
161447084|NCT01088048|583030997|FG006|Overall Study|Disease Progression|2|||
161447085|NCT01088048|583030998|FG007|Overall Study|Disease Progression|1|||
161447086|NCT01088048|583030999|FG008|Overall Study|Disease Progression|0|||
161795181|NCT02752776|584293682|FG000|Overall Study|Lack of Efficacy|2|||
161795182|NCT02752776|584293683|FG001|Overall Study|Lack of Efficacy|6|||
161795183|NCT02752776|584293684|FG002|Overall Study|Lack of Efficacy|14|||
161795184|NCT02752776|584293682|FG000|Overall Study|Lost to Follow-up|11|||
161795185|NCT02752776|584293683|FG001|Overall Study|Lost to Follow-up|12|||
161795186|NCT02752776|584293684|FG002|Overall Study|Lost to Follow-up|4|||
161795187|NCT02752776|584293682|FG000|Overall Study|Non-compliance with study treatment|0|||
161795188|NCT02752776|584293683|FG001|Overall Study|Non-compliance with study treatment|0|||
161795189|NCT02752776|584293684|FG002|Overall Study|Non-compliance with study treatment|1|||
161795190|NCT02752776|584293682|FG000|Overall Study|Physician Decision|2|||
161795191|NCT02752776|584293683|FG001|Overall Study|Physician Decision|6|||
161795192|NCT02752776|584293684|FG002|Overall Study|Physician Decision|2|||
161795193|NCT02752776|584293682|FG000|Overall Study|Pregnancy|1|||
161795194|NCT02752776|584293683|FG001|Overall Study|Pregnancy|6|||
161795195|NCT02752776|584293684|FG002|Overall Study|Pregnancy|3|||
161795196|NCT02752776|584293682|FG000|Overall Study|Protocol Violation|10|||
161795197|NCT02752776|584293683|FG001|Overall Study|Protocol Violation|13|||
161795198|NCT02752776|584293684|FG002|Overall Study|Protocol Violation|6|||
161795199|NCT02752776|584293682|FG000|Overall Study|Subject/guardian decision|8|||
161795200|NCT02752776|584293683|FG001|Overall Study|Subject/guardian decision|6|||
161795201|NCT02752776|584293684|FG002|Overall Study|Subject/guardian decision|4|||
161795202|NCT02752776|584293682|FG000|Overall Study|Death|0|||
161795203|NCT02752776|584293683|FG001|Overall Study|Death|0|||
161795204|NCT02752776|584293684|FG002|Overall Study|Death|1|||
161795205|NCT02752776|584293682|FG000|Overall Study|Withdrawal by Subject|3|||
161795206|NCT02752776|584293683|FG001|Overall Study|Withdrawal by Subject|4|||
161795207|NCT02752776|584293684|FG002|Overall Study|Withdrawal by Subject|2|||
161795208|NCT01816477|584293685|FG000|Overall Study|Withdrawal by Subject|13|||
161795209|NCT01816477|584293686|FG001|Overall Study|Withdrawal by Subject|1|||
161795210|NCT01816477|584293685|FG000|Overall Study|Unable to tolerate catheter placement|3|||
161795211|NCT01816477|584293686|FG001|Overall Study|Unable to tolerate catheter placement|0|||
161795212|NCT02116803|584293687|FG000|Overall Study|Adverse Event|2|||
161795213|NCT02116803|584293688|FG001|Overall Study|Adverse Event|1|||
161795214|NCT02116803|584293687|FG000|Overall Study|Physician Decision|1|||
161795215|NCT02116803|584293688|FG001|Overall Study|Physician Decision|0|||
161795216|NCT02116803|584293687|FG000|Overall Study|Progressive disease|4|||
161795217|NCT02116803|584293688|FG001|Overall Study|Progressive disease|0|||
161795218|NCT02116803|584293687|FG000|Overall Study|Study terminated by sponsor|2|||
161795219|NCT02116803|584293688|FG001|Overall Study|Study terminated by sponsor|1|||
161795220|NCT02116803|584293687|FG000|Overall Study|Death|1|||
161447087|NCT01088048|583031000|FG009|Overall Study|Disease Progression|0|||
161447088|NCT01088048|583030991|FG000|Overall Study|Death|1|||
161447089|NCT01088048|583030992|FG001|Overall Study|Death|5|||
161447090|NCT01088048|583030993|FG002|Overall Study|Death|3|||
161447091|NCT01088048|583030994|FG003|Overall Study|Death|3|||
161447092|NCT01088048|583030995|FG004|Overall Study|Death|1|||
161447093|NCT01088048|583030996|FG005|Overall Study|Death|3|||
161447094|NCT01088048|583030997|FG006|Overall Study|Death|0|||
161447095|NCT01088048|583030998|FG007|Overall Study|Death|0|||
161447096|NCT01088048|583030999|FG008|Overall Study|Death|3|||
161447097|NCT01088048|583031000|FG009|Overall Study|Death|1|||
161447098|NCT01088048|583030991|FG000|Overall Study|Other|3|||
161447099|NCT01088048|583030992|FG001|Overall Study|Other|5|||
161447100|NCT01088048|583030993|FG002|Overall Study|Other|0|||
161447101|NCT01088048|583030994|FG003|Overall Study|Other|0|||
161447102|NCT01088048|583030995|FG004|Overall Study|Other|2|||
161447103|NCT01088048|583030996|FG005|Overall Study|Other|0|||
161447104|NCT01088048|583030997|FG006|Overall Study|Other|0|||
161447105|NCT01088048|583030998|FG007|Overall Study|Other|2|||
161447106|NCT01088048|583030999|FG008|Overall Study|Other|0|||
161447107|NCT01088048|583031000|FG009|Overall Study|Other|0|||
161447108|NCT01343693|583031001|FG000|Overall Study|Lost to Follow-up|9|||
161447109|NCT00265148|583031002|FG000|Overall Study|Adverse Event|2|||
161447110|NCT00265148|583031003|FG001|Overall Study|Adverse Event|2|||
161447111|NCT00265148|583031002|FG000|Overall Study|Lack of Efficacy|0|||
161447112|NCT00265148|583031003|FG001|Overall Study|Lack of Efficacy|2|||
161447113|NCT00265148|583031002|FG000|Overall Study|Protocol Violation|3|||
161795221|NCT02116803|584293688|FG001|Overall Study|Death|0|||
161795222|NCT00684671|584293689|FG000|Overall Study|Adverse Event|1|||
161795223|NCT00684671|584293690|FG001|Overall Study|Adverse Event|0|||
161795224|NCT00684671|584293691|FG002|Overall Study|Adverse Event|0|||
161795225|NCT00684671|584293689|FG000|Overall Study|Lost to Follow-up|1|||
161795226|NCT00684671|584293690|FG001|Overall Study|Lost to Follow-up|0|||
161795227|NCT00684671|584293691|FG002|Overall Study|Lost to Follow-up|0|||
161795228|NCT00684671|584293689|FG000|Overall Study|Alcoholic dependance|1|||
161795229|NCT00684671|584293690|FG001|Overall Study|Alcoholic dependance|0|||
161795230|NCT00684671|584293691|FG002|Overall Study|Alcoholic dependance|0|||
161795231|NCT04128007|584293692|FG000|Overall Study|Withdrawal by Subject|9|||
161795232|NCT04128007|584293693|FG001|Overall Study|Withdrawal by Subject|6|||
161447114|NCT00265148|583031003|FG001|Overall Study|Protocol Violation|2|||
161447115|NCT00265148|583031002|FG000|Overall Study|Lost to Follow-up|0|||
161447116|NCT00265148|583031003|FG001|Overall Study|Lost to Follow-up|1|||
161447117|NCT00265148|583031002|FG000|Overall Study|Withdrawal by Subject|2|||
161447118|NCT00265148|583031003|FG001|Overall Study|Withdrawal by Subject|1|||
161447119|NCT00265148|583031002|FG000|Overall Study|Physician Decision|1|||
161447120|NCT00265148|583031003|FG001|Overall Study|Physician Decision|0|||
161447121|NCT00265148|583031002|FG000|Overall Study|Increasing frailty|0|||
161447122|NCT00265148|583031003|FG001|Overall Study|Increasing frailty|1|||
161447123|NCT00265148|583031002|FG000|Overall Study|Subject chose to change of the dose|1|||
161447124|NCT00265148|583031003|FG001|Overall Study|Subject chose to change of the dose|0|||
161447125|NCT03760731|583031006|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
161795233|NCT04128007|584293692|FG000|Overall Study|Protocol Violation|1|||
161795234|NCT04128007|584293693|FG001|Overall Study|Protocol Violation|0|||
161795235|NCT04128007|584293692|FG000|Overall Study|Lost to Follow-up|8|||
161795236|NCT04128007|584293693|FG001|Overall Study|Lost to Follow-up|7|||
161795237|NCT04128007|584293692|FG000|Overall Study|Adverse Event|5|||
161795238|NCT04128007|584293693|FG001|Overall Study|Adverse Event|2|||
161795239|NCT04128007|584293692|FG000|Overall Study|Not reported|0|||
161795240|NCT04128007|584293693|FG001|Overall Study|Not reported|2|||
161795241|NCT00481247|584293696|FG000|Overall Study|Death|0|||
161795242|NCT00481247|584293697|FG001|Overall Study|Death|1|||
161795243|NCT00481247|584293696|FG000|Overall Study|Disease progression|18|||
161795244|NCT00481247|584293697|FG001|Overall Study|Disease progression|22|||
161795245|NCT00481247|584293696|FG000|Overall Study|Intolerance|42|||
161795246|NCT00481247|584293697|FG001|Overall Study|Intolerance|17|||
161795247|NCT00481247|584293696|FG000|Overall Study|Treatment failure|10|||
161795248|NCT00481247|584293697|FG001|Overall Study|Treatment failure|14|||
161795249|NCT00481247|584293696|FG000|Overall Study|AE unrelated to study drug|13|||
161795250|NCT00481247|584293697|FG001|Overall Study|AE unrelated to study drug|4|||
161795251|NCT00481247|584293696|FG000|Overall Study|Withdrawal by Subject|8|||
161795252|NCT00481247|584293697|FG001|Overall Study|Withdrawal by Subject|13|||
161795253|NCT00481247|584293696|FG000|Overall Study|Pregnancy|2|||
161795254|NCT00481247|584293697|FG001|Overall Study|Pregnancy|1|||
161795255|NCT00481247|584293696|FG000|Overall Study|Lost to Follow-up|1|||
161795256|NCT00481247|584293697|FG001|Overall Study|Lost to Follow-up|2|||
161795257|NCT00481247|584293696|FG000|Overall Study|Poor compliance/noncompliance|1|||
161795258|NCT00481247|584293697|FG001|Overall Study|Poor compliance/noncompliance|7|||
161795259|NCT00481247|584293696|FG000|Overall Study|Administrative reason by sponsor|157|||
161795260|NCT00481247|584293697|FG001|Overall Study|Administrative reason by sponsor|162|||
161795261|NCT00481247|584293696|FG000|Overall Study|Varied|6|||
161795262|NCT00481247|584293697|FG001|Overall Study|Varied|15|||
161795263|NCT00481247|584293696|FG000|Overall Study|Did not receive treatment|1|||
161795264|NCT00481247|584293697|FG001|Overall Study|Did not receive treatment|2|||
161795265|NCT01716754|584293698|FG000|Overall Study|Death|0|||
161795266|NCT01716754|584293699|FG001|Overall Study|Death|0|||
161795267|NCT01716754|584293700|FG002|Overall Study|Death|0|||
161795268|NCT01716754|584293701|FG003|Overall Study|Death|1|||
161795269|NCT01716754|584293698|FG000|Overall Study|Protocol deviation|0|||
161795270|NCT01716754|584293699|FG001|Overall Study|Protocol deviation|2|||
161795271|NCT01716754|584293700|FG002|Overall Study|Protocol deviation|7|||
161795272|NCT01716754|584293701|FG003|Overall Study|Protocol deviation|2|||
161795273|NCT01716754|584293698|FG000|Overall Study|Non-compliance with study treatment|0|||
161795274|NCT01716754|584293699|FG001|Overall Study|Non-compliance with study treatment|0|||
161795275|NCT01716754|584293700|FG002|Overall Study|Non-compliance with study treatment|1|||
161795276|NCT01716754|584293701|FG003|Overall Study|Non-compliance with study treatment|0|||
161795277|NCT01716754|584293698|FG000|Overall Study|Physician Decision|1|||
161795278|NCT01716754|584293699|FG001|Overall Study|Physician Decision|0|||
161795279|NCT01716754|584293700|FG002|Overall Study|Physician Decision|0|||
161795280|NCT01716754|584293701|FG003|Overall Study|Physician Decision|0|||
161795281|NCT01716754|584293698|FG000|Overall Study|Lost to Follow-up|1|||
161795282|NCT01716754|584293699|FG001|Overall Study|Lost to Follow-up|0|||
161795283|NCT01716754|584293700|FG002|Overall Study|Lost to Follow-up|0|||
161795284|NCT01716754|584293701|FG003|Overall Study|Lost to Follow-up|1|||
161795285|NCT01716754|584293698|FG000|Overall Study|Adverse Event|4|||
161795286|NCT01716754|584293699|FG001|Overall Study|Adverse Event|2|||
161795287|NCT01716754|584293700|FG002|Overall Study|Adverse Event|2|||
161795288|NCT01716754|584293701|FG003|Overall Study|Adverse Event|1|||
161795289|NCT01716754|584293698|FG000|Overall Study|Withdrawal by Subject|5|||
161795290|NCT01716754|584293699|FG001|Overall Study|Withdrawal by Subject|0|||
161795291|NCT01716754|584293700|FG002|Overall Study|Withdrawal by Subject|4|||
161795292|NCT01716754|584293701|FG003|Overall Study|Withdrawal by Subject|3|||
161795293|NCT02110706|584293719|FG000|Overall Study|Adverse Event|2|||
161795294|NCT02110706|584293720|FG001|Overall Study|Adverse Event|3|||
161795295|NCT02110706|584293719|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
161795296|NCT02110706|584293720|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
161795297|NCT04281485|584293722|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
161795298|NCT04281485|584293723|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
161795299|NCT04281485|584293722|FG000|Overall Study|Ongoing (Safety data collection)|10|||
161795300|NCT04281485|584293723|FG001|Overall Study|Ongoing (Safety data collection)|5|||
161795301|NCT04317599|584293724|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
161795302|NCT04317599|584293724|FG000|Overall Study|treatment outside standard of care|4|||
161795303|NCT03933202|584293725|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
161795304|NCT03933202|584293726|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
161795305|NCT03933202|584293725|FG000|Overall Study|Participant transferred care|1|||
161795306|NCT03933202|584293726|FG001|Overall Study|Participant transferred care|0|||
161795307|NCT03933202|584293725|FG000|Overall Study|Site research department closing|1|||
161795308|NCT03933202|584293726|FG001|Overall Study|Site research department closing|0|||
161795309|NCT03933202|584293725|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
161795310|NCT03933202|584293726|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
161795311|NCT03933202|584293725|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
161900505|NCT03131687|584683070|FG003|Overall Study|Withdrawal by Subject|1|||
161900506|NCT03131687|584683071|FG004|Overall Study|Withdrawal by Subject|2|||
161795312|NCT03933202|584293726|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
161795313|NCT03933202|584293725|FG000|Overall Study|Participant changed primary neurology provider|1|||
161795314|NCT03933202|584293726|FG001|Overall Study|Participant changed primary neurology provider|0|||
161795315|NCT03933202|584293725|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
161795316|NCT03933202|584293726|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
161795317|NCT03933202|584293725|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
161795318|NCT03933202|584293726|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
161795319|NCT03933202|584293725|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
161795320|NCT03933202|584293726|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
161795321|NCT03933202|584293725|FG000|Overall Study|Missed visit|0|||
161795322|NCT03933202|584293726|FG001|Overall Study|Missed visit|1|||
161795323|NCT03933202|584293725|FG000|Overall Study|Investigator decision|4|||
161795324|NCT03933202|584293726|FG001|Overall Study|Investigator decision|0|||
161795325|NCT03933202|584293725|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
161795326|NCT03933202|584293726|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
161795327|NCT03933202|584293725|FG000|Overall Study|Withdrawal by Subject|10|||
161795328|NCT03933202|584293726|FG001|Overall Study|Withdrawal by Subject|8|||
161795329|NCT03933202|584293725|FG000|Overall Study|Death|2|||
161795330|NCT03933202|584293726|FG001|Overall Study|Death|0|||
161795331|NCT03933202|584293725|FG000|Overall Study|Progressive disease|0|||
161795332|NCT03933202|584293726|FG001|Overall Study|Progressive disease|3|||
161795333|NCT03933202|584293725|FG000|Overall Study|Protocol non-compliance|6|||
161795334|NCT03933202|584293726|FG001|Overall Study|Protocol non-compliance|3|||
161795335|NCT03933202|584293725|FG000|Overall Study|Lost to Follow-up|16|||
161795336|NCT03933202|584293726|FG001|Overall Study|Lost to Follow-up|8|||
161795337|NCT03933202|584293725|FG000|Overall Study|Adverse Event|3|||
161795338|NCT03933202|584293726|FG001|Overall Study|Adverse Event|0|||
161795339|NCT00947427|584293727|FG000|Overall Study|Withdrawal by Subject|1|||
161795340|NCT00947427|584293728|FG001|Overall Study|Withdrawal by Subject|3|||
161795341|NCT00947427|584293727|FG000|Overall Study|Protocol Violation|0|||
161795342|NCT00947427|584293728|FG001|Overall Study|Protocol Violation|1|||
161795343|NCT01348542|584293730|FG000|Overall Study|Withdrawal by Subject|3|||
161795344|NCT01348542|584293731|FG001|Overall Study|Withdrawal by Subject|0|||
161795345|NCT05658523|584293732|FG000|Baseline|No blood draw|1|||
161795346|NCT05658523|584293733|FG001|Baseline|No blood draw|0|||
161795347|NCT05658523|584293734|FG002|Baseline|No blood draw|0|||
161900507|NCT03131687|584683072|FG005|Overall Study|Withdrawal by Subject|1|||
161900508|NCT03131687|584683067|FG000|Overall Study|Lost to Follow-up|1|||
161447126|NCT03760731|583031007|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
161447127|NCT03760731|583031006|FG000|Treatment|Attended less than 70% of sessions|10|||
161447128|NCT03760731|583031007|FG001|Treatment|Attended less than 70% of sessions|15|||
161447129|NCT01092546|583031008|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
161447130|NCT01970358|583031009|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
161447131|NCT01970358|583031009|FG000|Overall Study|Ineligible at time of second consent|4|||
161447132|NCT01667419|583031010|FG000|Overall Study|Reason Not Specified|1|||
161447133|NCT01667419|583031011|FG001|Overall Study|Reason Not Specified|0|||
161447134|NCT01667419|583031012|FG002|Overall Study|Reason Not Specified|0|||
161447135|NCT01667419|583031013|FG003|Overall Study|Reason Not Specified|0|||
161447136|NCT01667419|583031010|FG000|Overall Study|Withdrawal by Subject|16|||
161447137|NCT01667419|583031011|FG001|Overall Study|Withdrawal by Subject|8|||
161447138|NCT01667419|583031012|FG002|Overall Study|Withdrawal by Subject|9|||
161447139|NCT01667419|583031013|FG003|Overall Study|Withdrawal by Subject|8|||
161447140|NCT01667419|583031010|FG000|Overall Study|Non-compliance|0|||
161447141|NCT01667419|583031011|FG001|Overall Study|Non-compliance|0|||
161447142|NCT01667419|583031012|FG002|Overall Study|Non-compliance|0|||
161447143|NCT01667419|583031013|FG003|Overall Study|Non-compliance|1|||
161447144|NCT01667419|583031010|FG000|Overall Study|Protocol Violation|1|||
161447145|NCT01667419|583031011|FG001|Overall Study|Protocol Violation|0|||
161447146|NCT01667419|583031012|FG002|Overall Study|Protocol Violation|0|||
161447147|NCT01667419|583031013|FG003|Overall Study|Protocol Violation|0|||
161447148|NCT01667419|583031010|FG000|Overall Study|Lost to Follow-up|7|||
161447149|NCT01667419|583031011|FG001|Overall Study|Lost to Follow-up|6|||
161447150|NCT01667419|583031012|FG002|Overall Study|Lost to Follow-up|2|||
161447151|NCT01667419|583031013|FG003|Overall Study|Lost to Follow-up|4|||
161795348|NCT05658523|584293732|FG000|28 Days|Lost to Follow-up|1|||
161795349|NCT05658523|584293733|FG001|28 Days|Lost to Follow-up|0|||
161795350|NCT05658523|584293734|FG002|28 Days|Lost to Follow-up|0|||
161795351|NCT05658523|584293732|FG000|28 Days|Withdrawal by Subject|1|||
161795352|NCT05658523|584293733|FG001|28 Days|Withdrawal by Subject|1|||
161795353|NCT05658523|584293734|FG002|28 Days|Withdrawal by Subject|0|||
161795354|NCT05658523|584293732|FG000|28 Days|Visit missed|0|||
161900509|NCT03131687|584683068|FG001|Overall Study|Lost to Follow-up|4|||
161900510|NCT03131687|584683069|FG002|Overall Study|Lost to Follow-up|0|||
161447152|NCT01667419|583031010|FG000|Overall Study|Death|18|||
161447153|NCT01667419|583031011|FG001|Overall Study|Death|33|||
161447154|NCT01667419|583031012|FG002|Overall Study|Death|25|||
161447155|NCT01667419|583031013|FG003|Overall Study|Death|26|||
161447156|NCT03869216|583031015|FG000|Overall Study|prostate removed during the study|1|||
161447157|NCT03869216|583031016|FG001|Overall Study|prostate removed during the study|1|||
161447158|NCT03869216|583031015|FG000|Overall Study|Withdrawal by Subject|0|||
161447159|NCT03869216|583031016|FG001|Overall Study|Withdrawal by Subject|1|||
161447160|NCT03869216|583031015|FG000|Overall Study|Lost to Follow-up|3|||
161795355|NCT05658523|584293733|FG001|28 Days|Visit missed|4|||
161795356|NCT05658523|584293734|FG002|28 Days|Visit missed|0|||
161795357|NCT05658523|584293732|FG000|6 Months|Lost to Follow-up|1|||
161795358|NCT05658523|584293733|FG001|6 Months|Lost to Follow-up|7|||
161795359|NCT05658523|584293734|FG002|6 Months|Lost to Follow-up|2|||
161795360|NCT05658523|584293732|FG000|6 Months|Withdrawal by Subject|1|||
161795361|NCT05658523|584293733|FG001|6 Months|Withdrawal by Subject|3|||
161795362|NCT05658523|584293734|FG002|6 Months|Withdrawal by Subject|4|||
161795363|NCT05658523|584293732|FG000|6 Months|Visit missed|5|||
161795364|NCT05658523|584293733|FG001|6 Months|Visit missed|7|||
161795365|NCT05658523|584293734|FG002|6 Months|Visit missed|0|||
161795366|NCT05658523|584293732|FG000|6 Months|No blood draw|0|||
161795367|NCT05658523|584293733|FG001|6 Months|No blood draw|0|||
161795368|NCT05658523|584293734|FG002|6 Months|No blood draw|1|||
161795369|NCT05658523|584293732|FG000|12 Months|Lost to Follow-up|2|||
161795370|NCT05658523|584293733|FG001|12 Months|Lost to Follow-up|6|||
161795371|NCT05658523|584293734|FG002|12 Months|Lost to Follow-up|3|||
161795372|NCT05658523|584293732|FG000|12 Months|Withdrawal by Subject|4|||
161795373|NCT05658523|584293733|FG001|12 Months|Withdrawal by Subject|4|||
161795374|NCT05658523|584293734|FG002|12 Months|Withdrawal by Subject|2|||
161795375|NCT05658523|584293732|FG000|12 Months|Visit missed|4|||
161795376|NCT05658523|584293733|FG001|12 Months|Visit missed|8|||
161795377|NCT05658523|584293734|FG002|12 Months|Visit missed|8|||
161795378|NCT05658523|584293732|FG000|18 Months|Lost to Follow-up|5|||
161795379|NCT05658523|584293733|FG001|18 Months|Lost to Follow-up|8|||
161795380|NCT05658523|584293734|FG002|18 Months|Lost to Follow-up|2|||
161795381|NCT05658523|584293732|FG000|18 Months|Withdrawal by Subject|17|||
161795382|NCT05658523|584293733|FG001|18 Months|Withdrawal by Subject|9|||
161795383|NCT05658523|584293734|FG002|18 Months|Withdrawal by Subject|16|||
161795384|NCT05658523|584293732|FG000|18 Months|Visit missed|12|||
161795385|NCT05658523|584293733|FG001|18 Months|Visit missed|14|||
161795386|NCT05658523|584293734|FG002|18 Months|Visit missed|6|||
161795387|NCT00628212|584293737|FG000|Overall Study|Adverse Event|2|||
161795388|NCT00628212|584293738|FG001|Overall Study|Adverse Event|0|||
161795389|NCT00628212|584293739|FG002|Overall Study|Adverse Event|1|||
161795390|NCT00628212|584293740|FG003|Overall Study|Adverse Event|2|||
161795391|NCT00628212|584293737|FG000|Overall Study|Physician Decision|1|||
161795392|NCT00628212|584293738|FG001|Overall Study|Physician Decision|1|||
161795393|NCT00628212|584293739|FG002|Overall Study|Physician Decision|2|||
161795394|NCT00628212|584293740|FG003|Overall Study|Physician Decision|3|||
161795395|NCT02427607|584293741|FG000|Overall Study|Withdrawal by Subject|1|||
161795396|NCT03211416|584293742|FG000|Overall Study|Adverse Event|7|||
161795397|NCT03211416|584293742|FG000|Overall Study|Lack of Efficacy|2|||
161795398|NCT03211416|584293742|FG000|Overall Study|Physician Decision|1|||
161795399|NCT03199274|584293743|FG000|Overall Study|Withdrawal by Subject|4|||
161795400|NCT03199274|584293744|FG001|Overall Study|Withdrawal by Subject|0|||
161795401|NCT03199274|584293743|FG000|Overall Study|Lost to Follow-up|0|||
161795402|NCT03199274|584293744|FG001|Overall Study|Lost to Follow-up|1|||
161795403|NCT03199274|584293743|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
161795404|NCT03199274|584293744|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
161795405|NCT00356200|584294922|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
161447161|NCT03869216|583031016|FG001|Overall Study|Lost to Follow-up|12|||
161447162|NCT03869216|583031015|FG000|Overall Study|Changed clinical site or moved out of city|5|||
161447163|NCT03869216|583031016|FG001|Overall Study|Changed clinical site or moved out of city|9|||
161795406|NCT00356200|584294923|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
161795407|NCT00356200|584294922|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
161795408|NCT00356200|584294923|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
161795409|NCT02909673|584294924|FG000|Overall Study|Did not meet inclusion criteria|129|||
161795410|NCT02909673|584294925|FG001|Overall Study|Did not meet inclusion criteria|29|||
161795411|NCT02909673|584294924|FG000|Overall Study|Surveys lost by scanner|95|||
161795412|NCT02909673|584294925|FG001|Overall Study|Surveys lost by scanner|2|||
161795413|NCT02909673|584294924|FG000|Overall Study|Tracking info missing|0|||
161795414|NCT02909673|584294925|FG001|Overall Study|Tracking info missing|5|||
161795415|NCT00783796|584294928|FG000|Overall Study|Did not receive any stent|4|||
161795416|NCT00783796|584294928|FG000|Overall Study|Received non-XIENCE V stent|1|||
161795417|NCT00783796|584294928|FG000|Overall Study|Received commercial XIENCE V stent|1|||
161795418|NCT01215942|584294929|FG000|Treatment Period|Adverse Event|15|||
161795419|NCT01215942|584294930|FG001|Treatment Period|Adverse Event|26|||
161795420|NCT01215942|584294929|FG000|Treatment Period|Death|2|||
161795421|NCT01215942|584294930|FG001|Treatment Period|Death|4|||
161900511|NCT03131687|584683070|FG003|Overall Study|Lost to Follow-up|1|||
161900512|NCT03131687|584683071|FG004|Overall Study|Lost to Follow-up|4|||
161900513|NCT03131687|584683072|FG005|Overall Study|Lost to Follow-up|2|||
161900514|NCT03131687|584683067|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
161900515|NCT03131687|584683068|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
161900516|NCT03131687|584683069|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
161900517|NCT03131687|584683070|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
161900518|NCT03131687|584683071|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
161900519|NCT03131687|584683072|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
161900520|NCT03131687|584683067|FG000|Overall Study|Principle Investigator Decision|0|||
161900521|NCT03131687|584683068|FG001|Overall Study|Principle Investigator Decision|1|||
161900522|NCT03131687|584683069|FG002|Overall Study|Principle Investigator Decision|0|||
161900523|NCT03131687|584683070|FG003|Overall Study|Principle Investigator Decision|0|||
161900524|NCT03131687|584683071|FG004|Overall Study|Principle Investigator Decision|0|||
161900525|NCT03131687|584683072|FG005|Overall Study|Principle Investigator Decision|0|||
161900526|NCT03131687|584683067|FG000|Overall Study|Inadvertent Enrollment|0|||
161900527|NCT03131687|584683068|FG001|Overall Study|Inadvertent Enrollment|0|||
161900528|NCT03131687|584683069|FG002|Overall Study|Inadvertent Enrollment|0|||
161900529|NCT03131687|584683070|FG003|Overall Study|Inadvertent Enrollment|1|||
161900530|NCT03131687|584683071|FG004|Overall Study|Inadvertent Enrollment|0|||
161900531|NCT03131687|584683072|FG005|Overall Study|Inadvertent Enrollment|0|||
161900532|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
161900533|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
161900534|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
161900535|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
161900536|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
161900537|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
161900538|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
161900539|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161447164|NCT03869216|583031015|FG000|Overall Study|No primary care appointment scheduled|10|||
161447165|NCT03869216|583031016|FG001|Overall Study|No primary care appointment scheduled|4|||
161447166|NCT03869216|583031015|FG000|Overall Study|Death|1|||
161447167|NCT03869216|583031016|FG001|Overall Study|Death|1|||
161447168|NCT03646123|583031017|FG000|Overall Study|Withdrawal by Subject|2|||
161447169|NCT03646123|583031018|FG001|Overall Study|Withdrawal by Subject|2|||
161447170|NCT03646123|583031019|FG002|Overall Study|Withdrawal by Subject|3|||
161447171|NCT03646123|583031017|FG000|Overall Study|Study termination by sponsor|0|||
161447172|NCT03646123|583031018|FG001|Overall Study|Study termination by sponsor|45|||
161447173|NCT03646123|583031019|FG002|Overall Study|Study termination by sponsor|139|||
161447174|NCT03646123|583031017|FG000|Overall Study|Lost to Follow-up|4|||
161447175|NCT03646123|583031018|FG001|Overall Study|Lost to Follow-up|10|||
161447176|NCT03646123|583031019|FG002|Overall Study|Lost to Follow-up|10|||
161447177|NCT03646123|583031017|FG000|Overall Study|Death|2|||
161447178|NCT03646123|583031018|FG001|Overall Study|Death|1|||
161447179|NCT03646123|583031019|FG002|Overall Study|Death|1|||
161447180|NCT03646123|583031017|FG000|Overall Study|Other|2|||
161447181|NCT03646123|583031018|FG001|Overall Study|Other|0|||
161447182|NCT03646123|583031019|FG002|Overall Study|Other|2|||
161447183|NCT01068600|583031020|FG000|Overall Study|Withdrawal by Subject|5|||
161447184|NCT01068600|583031021|FG001|Overall Study|Withdrawal by Subject|6|||
161447185|NCT01068600|583031020|FG000|Overall Study|Adverse Event|3|||
161447186|NCT01068600|583031021|FG001|Overall Study|Adverse Event|3|||
161447187|NCT01068600|583031020|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161447188|NCT01068600|583031021|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161447189|NCT01068600|583031020|FG000|Overall Study|Lost to Follow-up|1|||
161447190|NCT01068600|583031021|FG001|Overall Study|Lost to Follow-up|2|||
161447191|NCT01068600|583031020|FG000|Overall Study|Protocol deviation|1|||
161447192|NCT01068600|583031021|FG001|Overall Study|Protocol deviation|1|||
161447193|NCT01068600|583031020|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161447194|NCT01068600|583031021|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161900540|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161900541|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161900542|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
161900543|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
161447195|NCT01068600|583031020|FG000|Overall Study|Administrative problems|0|||
161447196|NCT01068600|583031021|FG001|Overall Study|Administrative problems|1|||
161447197|NCT01519869|583031022|FG000|Overall Study|Lost to Follow-up|1|||
161900544|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
161447198|NCT04075734|583031023|FG000|Overall Study|Lost to Follow-up|1|||
161447199|NCT04075734|583031024|FG001|Overall Study|Lost to Follow-up|1|||
161447200|NCT04075734|583031025|FG002|Overall Study|Lost to Follow-up|0|||
161447201|NCT04075734|583031023|FG000|Overall Study|Withdrawal by Subject|3|||
161447202|NCT04075734|583031024|FG001|Overall Study|Withdrawal by Subject|0|||
161447203|NCT04075734|583031025|FG002|Overall Study|Withdrawal by Subject|0|||
161447204|NCT02433080|583031027|FG000|Overall Study|Lost to Follow-up|1|||
161447205|NCT02433080|583031028|FG001|Overall Study|Lost to Follow-up|2|||
161447206|NCT02433080|583031027|FG000|Overall Study|Withdrawal by Subject|0|||
161447207|NCT02433080|583031028|FG001|Overall Study|Withdrawal by Subject|2|||
161447208|NCT02367833|583031030|FG000|Overall Study|Withdrawal by Subject|1|||
161447209|NCT02367833|583031031|FG001|Overall Study|Withdrawal by Subject|1|||
161447210|NCT02367833|583031032|FG002|Overall Study|Withdrawal by Subject|0|||
161447211|NCT02167139|583031033|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
161447212|NCT02167139|583031034|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
161447213|NCT02167139|583031035|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
161447214|NCT02167139|583031036|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
161447215|NCT02167139|583031033|FG000|Randomised, Double-blind|Adverse Event|2|||
161447216|NCT02167139|583031034|FG001|Randomised, Double-blind|Adverse Event|9|||
161447217|NCT02167139|583031035|FG002|Randomised, Double-blind|Adverse Event|0|||
161447218|NCT02167139|583031036|FG003|Randomised, Double-blind|Adverse Event|0|||
161447219|NCT02167139|583031033|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
161447220|NCT02167139|583031034|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
161447221|NCT02167139|583031035|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
161447222|NCT02167139|583031036|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
161447223|NCT02167139|583031033|FG000|Randomised, Double-blind|Other|3|||
161447224|NCT02167139|583031034|FG001|Randomised, Double-blind|Other|0|||
161447225|NCT02167139|583031035|FG002|Randomised, Double-blind|Other|0|||
161447226|NCT02167139|583031036|FG003|Randomised, Double-blind|Other|0|||
161447227|NCT02167139|583031033|FG000|Transition-extension|Adverse Event|2|||
161447228|NCT02167139|583031034|FG001|Transition-extension|Adverse Event|0|||
161447229|NCT02167139|583031035|FG002|Transition-extension|Adverse Event|2|||
161447230|NCT02167139|583031036|FG003|Transition-extension|Adverse Event|3|||
161447231|NCT02167139|583031033|FG000|Transition-extension|Withdrawal by Subject|2|||
161447232|NCT02167139|583031034|FG001|Transition-extension|Withdrawal by Subject|0|||
161447233|NCT02167139|583031035|FG002|Transition-extension|Withdrawal by Subject|4|||
161447234|NCT02167139|583031036|FG003|Transition-extension|Withdrawal by Subject|1|||
161447235|NCT02167139|583031033|FG000|Transition-extension|Lack of Efficacy|0|||
161447236|NCT02167139|583031034|FG001|Transition-extension|Lack of Efficacy|0|||
161447237|NCT02167139|583031035|FG002|Transition-extension|Lack of Efficacy|1|||
161447238|NCT02167139|583031036|FG003|Transition-extension|Lack of Efficacy|1|||
161447239|NCT02167139|583031033|FG000|Transition-extension|Other|1|||
161447240|NCT02167139|583031034|FG001|Transition-extension|Other|0|||
161447241|NCT02167139|583031035|FG002|Transition-extension|Other|1|||
161447242|NCT02167139|583031036|FG003|Transition-extension|Other|0|||
161447243|NCT02167139|583031033|FG000|Transition-extension|Lost to Follow-up|1|||
161447244|NCT02167139|583031034|FG001|Transition-extension|Lost to Follow-up|0|||
161447245|NCT02167139|583031035|FG002|Transition-extension|Lost to Follow-up|0|||
161447246|NCT02167139|583031036|FG003|Transition-extension|Lost to Follow-up|0|||
161447247|NCT00996333|583031037|FG000|Overall Study|Screen failure|1|||
161447248|NCT00996333|583031037|FG000|Overall Study|Withdrawal by Subject|1|||
161447249|NCT00996333|583031037|FG000|Overall Study|Death|4|||
161447250|NCT00996333|583031037|FG000|Overall Study|Adverse Event|1|||
161447251|NCT00996333|583031037|FG000|Overall Study|Physician Decision|1|||
161447252|NCT00996333|583031037|FG000|Overall Study|Other|5|||
161447253|NCT01015638|583031038|FG000|Overall Study|Withdrawal by Subject|1|||
161447254|NCT01015638|583031039|FG001|Overall Study|Withdrawal by Subject|0|||
161447255|NCT02164461|583031040|FG000|Overall Study|Adverse Event|0|||
161447256|NCT02164461|583031041|FG001|Overall Study|Adverse Event|0|||
161447257|NCT02164461|583031042|FG002|Overall Study|Adverse Event|1|||
161447258|NCT02164461|583031040|FG000|Overall Study|Disease Progression|1|||
161447259|NCT02164461|583031041|FG001|Overall Study|Disease Progression|3|||
161447260|NCT02164461|583031042|FG002|Overall Study|Disease Progression|4|||
161447261|NCT02164461|583031040|FG000|Overall Study|Withdrawal by Subject|0|||
161447262|NCT02164461|583031041|FG001|Overall Study|Withdrawal by Subject|3|||
161447263|NCT02164461|583031042|FG002|Overall Study|Withdrawal by Subject|0|||
161447264|NCT00324961|583031046|FG000|Overall Study|Adverse Event|5|||
161447265|NCT00324961|583031046|FG000|Overall Study|Consent Withdrawn|11|||
161447266|NCT00324961|583031046|FG000|Overall Study|Lost to Follow-up|22|||
161447267|NCT00324961|583031046|FG000|Overall Study|Protocol Violation|3|||
161447268|NCT00324961|583031046|FG000|Overall Study|Other|2|||
161447269|NCT00344487|583031047|FG000|Overall Study|immunologic failure|1|||
161447270|NCT04927364|583031050|FG000|Overall Study|Withdrawal by Subject|3|||
161447271|NCT04927364|583031050|FG000|Overall Study|Unable to complete preassessment MRI|1|||
161447272|NCT05188053|583031054|FG000|Overall Study|Lost to Follow-up|23|||
161447273|NCT05188053|583031055|FG001|Overall Study|Lost to Follow-up|30|||
161447274|NCT05188053|583031054|FG000|Overall Study|Protocol Violation|16|||
161447275|NCT05188053|583031055|FG001|Overall Study|Protocol Violation|16|||
161447276|NCT05188053|583031054|FG000|Overall Study|Physician Decision|3|||
161447277|NCT05188053|583031055|FG001|Overall Study|Physician Decision|0|||
161447278|NCT05188053|583031054|FG000|Overall Study|Withdrawal by Subject|0|||
161795422|NCT01215942|584294929|FG000|Treatment Period|Lack of Efficacy|23|||
161795423|NCT01215942|584294930|FG001|Treatment Period|Lack of Efficacy|62|||
161795424|NCT01215942|584294929|FG000|Treatment Period|Lost to Follow-up|3|||
161795425|NCT01215942|584294930|FG001|Treatment Period|Lost to Follow-up|4|||
161795426|NCT01215942|584294929|FG000|Treatment Period|Withdrawal by Subject|17|||
161795427|NCT01215942|584294930|FG001|Treatment Period|Withdrawal by Subject|40|||
161795428|NCT01215942|584294929|FG000|Treatment Period|Physician Decision|5|||
161795429|NCT01215942|584294930|FG001|Treatment Period|Physician Decision|5|||
161795430|NCT01215942|584294929|FG000|Treatment Period|Protocol Violation|0|||
161795431|NCT01215942|584294930|FG001|Treatment Period|Protocol Violation|1|||
161795432|NCT01215942|584294929|FG000|Treatment Period|Sponsor Decision|349|||
161795433|NCT01215942|584294930|FG001|Treatment Period|Sponsor Decision|530|||
161795434|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Death|0|||
161795435|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Death|1|||
161795436|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161795437|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161795438|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
161795439|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
161795440|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
161795441|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
161795442|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
161795443|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
161795444|NCT03305055|584294931|FG000|Overall Study|Withdrawal by Subject|0|||
161795445|NCT03305055|584294932|FG001|Overall Study|Withdrawal by Subject|1|||
161795446|NCT03305055|584294931|FG000|Overall Study|Adverse Event|1|||
161795447|NCT03305055|584294932|FG001|Overall Study|Adverse Event|1|||
161795448|NCT02540356|584294933|FG000|Overall Study|Terminated due to disease progression|1|||
161795449|NCT02540356|584294934|FG001|Overall Study|Terminated due to disease progression|0|||
161795450|NCT01399736|584294935|FG000|Overall Study|Withdrawal by Subject|4|||
161795451|NCT01399736|584294936|FG001|Overall Study|Withdrawal by Subject|2|||
161795452|NCT01399736|584294935|FG000|Overall Study|Lost to Follow-up|0|||
161795453|NCT01399736|584294936|FG001|Overall Study|Lost to Follow-up|2|||
161795454|NCT03500484|584294937|FG000|Overall Study|Adverse Event|2|||
161795455|NCT03500484|584294938|FG001|Overall Study|Adverse Event|0|||
161795456|NCT03500484|584294937|FG000|Overall Study|Physician Decision|1|||
161795457|NCT03500484|584294938|FG001|Overall Study|Physician Decision|0|||
161795458|NCT03500484|584294937|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
161795459|NCT03500484|584294938|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
161795460|NCT02795104|584294939|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
161795461|NCT02795104|584294940|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
161795462|NCT02795104|584294941|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
161795463|NCT02795104|584294939|FG000|Overall Study|Withdrawal by Subject|0|||
161795464|NCT02795104|584294940|FG001|Overall Study|Withdrawal by Subject|2|||
161795465|NCT02795104|584294941|FG002|Overall Study|Withdrawal by Subject|0|||
161795466|NCT02795104|584294939|FG000|Overall Study|Lost to Follow-up|0|||
161795467|NCT02795104|584294940|FG001|Overall Study|Lost to Follow-up|0|||
161795468|NCT02795104|584294941|FG002|Overall Study|Lost to Follow-up|1|||
161795469|NCT03335371|584294942|FG000|Overall Study|Lost to Follow-up|0|||
161795470|NCT03335371|584294943|FG001|Overall Study|Lost to Follow-up|0|||
161795471|NCT03335371|584294944|FG002|Overall Study|Lost to Follow-up|0|||
161795472|NCT03335371|584294945|FG003|Overall Study|Lost to Follow-up|0|||
161795473|NCT03335371|584294946|FG004|Overall Study|Lost to Follow-up|1|||
161795474|NCT03335371|584294942|FG000|Overall Study|Withdrawal by Subject|0|||
161795475|NCT03335371|584294943|FG001|Overall Study|Withdrawal by Subject|0|||
161447279|NCT05188053|583031055|FG001|Overall Study|Withdrawal by Subject|1|||
161447280|NCT04198714|583031059|FG000|Overall Study|Physician Decision|0|||
161447281|NCT04198714|583031060|FG001|Overall Study|Physician Decision|1|||
161447282|NCT02355184|583031064|FG000|Overall Study|Lost to Follow-up|2|||
161447283|NCT02355184|583031064|FG000|Overall Study|Study Terminated|10|||
161447284|NCT01868542|583032512|FG000|Overall Study|Protocol Violation|0|||
161447285|NCT01868542|583032513|FG001|Overall Study|Protocol Violation|1|||
161447286|NCT01868542|583032512|FG000|Overall Study|Unclassified|0|||
161447287|NCT01868542|583032513|FG001|Overall Study|Unclassified|1|||
161447288|NCT03844945|583032514|FG000|Overall Study|Adverse Event|1|||
161795476|NCT03335371|584294944|FG002|Overall Study|Withdrawal by Subject|0|||
161795477|NCT03335371|584294945|FG003|Overall Study|Withdrawal by Subject|0|||
161795478|NCT03335371|584294946|FG004|Overall Study|Withdrawal by Subject|1|||
161795479|NCT03335371|584294942|FG000|Overall Study|Randomization Error|0|||
161795480|NCT03335371|584294943|FG001|Overall Study|Randomization Error|0|||
161795481|NCT03335371|584294944|FG002|Overall Study|Randomization Error|1|||
161795482|NCT03335371|584294945|FG003|Overall Study|Randomization Error|0|||
161795483|NCT03335371|584294946|FG004|Overall Study|Randomization Error|0|||
161795484|NCT00998881|584294950|FG000|Overall Study|Adverse Event|2|||
161795485|NCT00998881|584294951|FG001|Overall Study|Adverse Event|2|||
161795486|NCT00998881|584294950|FG000|Overall Study|Lack of Efficacy|1|||
161447289|NCT03844945|583032515|FG001|Overall Study|Adverse Event|1|||
161900545|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
161900546|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
161447290|NCT03844945|583032516|FG002|Overall Study|Adverse Event|4|||
161447291|NCT03844945|583032517|FG003|Overall Study|Adverse Event|0|||
161447292|NCT03844945|583032514|FG000|Overall Study|Withdrawal by Subject|0|||
161900547|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
161900548|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
161447293|NCT03844945|583032515|FG001|Overall Study|Withdrawal by Subject|0|||
161447294|NCT03844945|583032516|FG002|Overall Study|Withdrawal by Subject|1|||
161447295|NCT03844945|583032517|FG003|Overall Study|Withdrawal by Subject|0|||
161447296|NCT03844945|583032514|FG000|Overall Study|Lack of Efficacy|0|||
161447297|NCT03844945|583032515|FG001|Overall Study|Lack of Efficacy|0|||
161447298|NCT03844945|583032516|FG002|Overall Study|Lack of Efficacy|0|||
161447299|NCT03844945|583032517|FG003|Overall Study|Lack of Efficacy|1|||
161447300|NCT03254459|583032519|FG000|Overall Study|Adverse Event|7|||
161447301|NCT03254459|583032520|FG001|Overall Study|Adverse Event|20|||
161447302|NCT03254459|583032519|FG000|Overall Study|Withdrawal by Subject Consent|3|||
161447303|NCT03254459|583032520|FG001|Overall Study|Withdrawal by Subject Consent|1|||
161447304|NCT03254459|583032519|FG000|Overall Study|Lost to Follow-up|0|||
161447305|NCT03254459|583032520|FG001|Overall Study|Lost to Follow-up|1|||
161447306|NCT03254459|583032519|FG000|Overall Study|Miscellaneous|0|||
161447307|NCT03254459|583032520|FG001|Overall Study|Miscellaneous|1|||
161447308|NCT01904773|583032521|FG000|Screen|Screen failure|3|||
161447309|NCT01904773|583032522|FG001|Screen|Screen failure|0|||
161447310|NCT01904773|583032523|FG002|Screen|Screen failure|0|||
161447311|NCT01904773|583032524|FG003|Screen|Screen failure|0|||
161447312|NCT01904773|583032525|FG004|Screen|Screen failure|0|||
161447313|NCT01904773|583032526|FG005|Screen|Screen failure|0|||
161447314|NCT01904773|583032527|FG006|Screen|Screen failure|0|||
161447315|NCT01904773|583032528|FG007|Screen|Screen failure|0|||
161447316|NCT01904773|583032529|FG008|Screen|Screen failure|0|||
161447317|NCT01904773|583032521|FG000|Screen|Withdrawal by Subject|1|||
161447318|NCT01904773|583032522|FG001|Screen|Withdrawal by Subject|0|||
161447319|NCT01904773|583032523|FG002|Screen|Withdrawal by Subject|0|||
161447320|NCT01904773|583032524|FG003|Screen|Withdrawal by Subject|0|||
161447321|NCT01904773|583032525|FG004|Screen|Withdrawal by Subject|0|||
161447322|NCT01904773|583032526|FG005|Screen|Withdrawal by Subject|0|||
161447323|NCT01904773|583032527|FG006|Screen|Withdrawal by Subject|0|||
161447324|NCT01904773|583032528|FG007|Screen|Withdrawal by Subject|0|||
161447325|NCT01904773|583032529|FG008|Screen|Withdrawal by Subject|0|||
161447326|NCT01904773|583032521|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
161447327|NCT01904773|583032522|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447328|NCT01904773|583032523|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447329|NCT01904773|583032524|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447330|NCT01904773|583032525|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447331|NCT01904773|583032526|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447332|NCT01904773|583032527|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447333|NCT01904773|583032528|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447334|NCT01904773|583032529|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161447335|NCT01904773|583032521|FG000|First Intervention|Adverse Event|0|||
161447336|NCT01904773|583032522|FG001|First Intervention|Adverse Event|0|||
161447337|NCT01904773|583032523|FG002|First Intervention|Adverse Event|0|||
161447338|NCT01904773|583032524|FG003|First Intervention|Adverse Event|0|||
161447339|NCT01904773|583032525|FG004|First Intervention|Adverse Event|0|||
161447340|NCT01904773|583032526|FG005|First Intervention|Adverse Event|0|||
161447341|NCT01904773|583032527|FG006|First Intervention|Adverse Event|1|||
161447342|NCT01904773|583032528|FG007|First Intervention|Adverse Event|0|||
161447343|NCT01904773|583032529|FG008|First Intervention|Adverse Event|0|||
161447344|NCT01904773|583032521|FG000|Placebo Washout First Intervention|Condition worsened|0|||
161447345|NCT01904773|583032522|FG001|Placebo Washout First Intervention|Condition worsened|1|||
161447346|NCT01904773|583032523|FG002|Placebo Washout First Intervention|Condition worsened|0|||
161900549|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161447347|NCT01904773|583032524|FG003|Placebo Washout First Intervention|Condition worsened|0|||
161447348|NCT01904773|583032525|FG004|Placebo Washout First Intervention|Condition worsened|0|||
161900550|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161900551|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161900552|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
161447349|NCT01904773|583032526|FG005|Placebo Washout First Intervention|Condition worsened|0|||
161447350|NCT01904773|583032527|FG006|Placebo Washout First Intervention|Condition worsened|0|||
161447351|NCT01904773|583032528|FG007|Placebo Washout First Intervention|Condition worsened|0|||
161447352|NCT01904773|583032529|FG008|Placebo Washout First Intervention|Condition worsened|0|||
161447353|NCT01904773|583032521|FG000|Fifth Intervention|Adverse Event|0|||
161447354|NCT01904773|583032522|FG001|Fifth Intervention|Adverse Event|0|||
161447355|NCT01904773|583032523|FG002|Fifth Intervention|Adverse Event|0|||
161447356|NCT01904773|583032524|FG003|Fifth Intervention|Adverse Event|0|||
161900553|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900554|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900555|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900556|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900557|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
161900558|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
161900559|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
161900560|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
161447357|NCT01904773|583032525|FG004|Fifth Intervention|Adverse Event|0|||
161447358|NCT01904773|583032526|FG005|Fifth Intervention|Adverse Event|0|||
161447359|NCT01904773|583032527|FG006|Fifth Intervention|Adverse Event|0|||
161447360|NCT01904773|583032528|FG007|Fifth Intervention|Adverse Event|1|||
161447361|NCT01904773|583032529|FG008|Fifth Intervention|Adverse Event|0|||
161447362|NCT01904773|583032521|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447363|NCT01904773|583032522|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
161447364|NCT01904773|583032523|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447365|NCT01904773|583032524|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447366|NCT01904773|583032525|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447367|NCT01904773|583032526|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447368|NCT01904773|583032527|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447369|NCT01904773|583032528|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447370|NCT01904773|583032529|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161447371|NCT00220779|583032530|FG000|Overall Study|Adverse Event|1|||
161447372|NCT00220779|583032531|FG001|Overall Study|Adverse Event|0|||
161447373|NCT00220779|583032532|FG002|Overall Study|Adverse Event|0|||
161447374|NCT00220779|583032530|FG000|Overall Study|Withdrawal by Subject|1|||
161447375|NCT00220779|583032531|FG001|Overall Study|Withdrawal by Subject|4|||
161447376|NCT00220779|583032532|FG002|Overall Study|Withdrawal by Subject|1|||
161447377|NCT00220779|583032530|FG000|Overall Study|Non-compliance|1|||
161447378|NCT00220779|583032531|FG001|Overall Study|Non-compliance|0|||
161447379|NCT00220779|583032532|FG002|Overall Study|Non-compliance|0|||
161447380|NCT00220779|583032530|FG000|Overall Study|Too time consuming|1|||
161447381|NCT00220779|583032531|FG001|Overall Study|Too time consuming|0|||
161447382|NCT00220779|583032532|FG002|Overall Study|Too time consuming|0|||
161447383|NCT00220779|583032530|FG000|Overall Study|Pregnancy|0|||
161447384|NCT00220779|583032531|FG001|Overall Study|Pregnancy|0|||
161447385|NCT00220779|583032532|FG002|Overall Study|Pregnancy|2|||
161447386|NCT00220779|583032530|FG000|Overall Study|Lack of Efficacy|3|||
161447387|NCT00220779|583032531|FG001|Overall Study|Lack of Efficacy|0|||
161447388|NCT00220779|583032532|FG002|Overall Study|Lack of Efficacy|1|||
161447389|NCT04518995|583032533|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
161447390|NCT04518995|583032534|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
161447391|NCT04518995|583032535|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
161447392|NCT04518995|583032533|FG000|Overall Study|Lack of Efficacy|2|||
161447393|NCT04518995|583032534|FG001|Overall Study|Lack of Efficacy|1|||
161447394|NCT04518995|583032535|FG002|Overall Study|Lack of Efficacy|0|||
161447395|NCT04518995|583032533|FG000|Overall Study|Non-compliance With Study Drug|0|||
161447396|NCT04518995|583032534|FG001|Overall Study|Non-compliance With Study Drug|3|||
161447397|NCT04518995|583032535|FG002|Overall Study|Non-compliance With Study Drug|2|||
161447398|NCT04518995|583032533|FG000|Overall Study|Pregnancy|0|||
161447399|NCT04518995|583032534|FG001|Overall Study|Pregnancy|0|||
161447400|NCT04518995|583032535|FG002|Overall Study|Pregnancy|1|||
161447401|NCT04518995|583032533|FG000|Overall Study|Protocol Violation|2|||
161447402|NCT04518995|583032534|FG001|Overall Study|Protocol Violation|0|||
161447403|NCT04518995|583032535|FG002|Overall Study|Protocol Violation|1|||
161447404|NCT04518995|583032533|FG000|Overall Study|Reason not Specified|4|||
161447405|NCT04518995|583032534|FG001|Overall Study|Reason not Specified|11|||
161447406|NCT04518995|583032535|FG002|Overall Study|Reason not Specified|2|||
161447407|NCT04518995|583032533|FG000|Overall Study|Lost to Follow-up|1|||
161447408|NCT04518995|583032534|FG001|Overall Study|Lost to Follow-up|10|||
161447409|NCT04518995|583032535|FG002|Overall Study|Lost to Follow-up|6|||
161447410|NCT01511055|583032538|FG000|Overall Study|Withdrawal by Subject|6|||
161447411|NCT04590248|583032539|FG000|Overall Study|Lost to Follow-up|1|||
161447412|NCT04590248|583032539|FG000|Overall Study|Withdrawal by Subject|16|||
161447413|NCT04590248|583032539|FG000|Overall Study|Other|2|||
161447414|NCT02052414|583032542|FG000|Overall Study|Adverse Event|12|||
161447415|NCT02052414|583032542|FG000|Overall Study|Lack of Efficacy|2|||
161447416|NCT02052414|583032542|FG000|Overall Study|Withdrawal by Subject|3|||
161447417|NCT02891070|583032552|FG000|Overall Study|Adverse Event|1|||
161447418|NCT02891070|583032553|FG001|Overall Study|Adverse Event|0|||
161447419|NCT02891070|583032552|FG000|Overall Study|Physician Decision|0|||
161447420|NCT02891070|583032553|FG001|Overall Study|Physician Decision|1|||
161447421|NCT02891070|583032552|FG000|Overall Study|Lost to Follow-up|4|||
161900561|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
161795487|NCT00998881|584294951|FG001|Overall Study|Lack of Efficacy|0|||
161795488|NCT00998881|584294950|FG000|Overall Study|Physician Decision|3|||
161795489|NCT00998881|584294951|FG001|Overall Study|Physician Decision|0|||
161795490|NCT00998881|584294950|FG000|Overall Study|Withdrawal by Subject|1|||
161795491|NCT00998881|584294951|FG001|Overall Study|Withdrawal by Subject|0|||
161795492|NCT00998881|584294950|FG000|Overall Study|Personal matter|1|||
161795493|NCT00998881|584294951|FG001|Overall Study|Personal matter|0|||
161795494|NCT02649231|584294954|FG000|Overall Study|Adverse Event|0|||
161795495|NCT02649231|584294955|FG001|Overall Study|Adverse Event|0|||
161795496|NCT02649231|584294956|FG002|Overall Study|Adverse Event|0|||
161795497|NCT02649231|584294957|FG003|Overall Study|Adverse Event|1|||
161795498|NCT02649231|584294954|FG000|Overall Study|Lost to Follow-up|2|||
161795499|NCT02649231|584294955|FG001|Overall Study|Lost to Follow-up|1|||
161795500|NCT02649231|584294956|FG002|Overall Study|Lost to Follow-up|1|||
161795501|NCT02649231|584294957|FG003|Overall Study|Lost to Follow-up|0|||
161795502|NCT02649231|584294954|FG000|Overall Study|Withdrawal by Subject|0|||
161795503|NCT02649231|584294955|FG001|Overall Study|Withdrawal by Subject|1|||
161795504|NCT02649231|584294956|FG002|Overall Study|Withdrawal by Subject|0|||
161795505|NCT02649231|584294957|FG003|Overall Study|Withdrawal by Subject|1|||
161795506|NCT02649231|584294954|FG000|Overall Study|Protocol Violation|2|||
161795507|NCT02649231|584294955|FG001|Overall Study|Protocol Violation|1|||
161795508|NCT02649231|584294956|FG002|Overall Study|Protocol Violation|1|||
161900562|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
161447422|NCT02891070|583032553|FG001|Overall Study|Lost to Follow-up|4|||
161447423|NCT02891070|583032552|FG000|Overall Study|Other|1|||
161447424|NCT02891070|583032553|FG001|Overall Study|Other|0|||
161447425|NCT02891070|583032552|FG000|Overall Study|Protocol Violation|0|||
161447426|NCT02891070|583032553|FG001|Overall Study|Protocol Violation|1|||
161447427|NCT02891070|583032552|FG000|Overall Study|Withdrawal by Subject|1|||
161447428|NCT02891070|583032553|FG001|Overall Study|Withdrawal by Subject|2|||
161447429|NCT02891070|583032552|FG000|Overall Study|Death|3|||
161447430|NCT02891070|583032553|FG001|Overall Study|Death|0|||
161447431|NCT02704143|583032554|FG000|Overall Study|disease progression|10|||
161447432|NCT01235598|583032557|FG000|Overall Study|Adverse Event|0|||
161447433|NCT01235598|583032558|FG001|Overall Study|Adverse Event|3|||
161447434|NCT01235598|583032557|FG000|Overall Study|Lack of Efficacy|0|||
161447435|NCT01235598|583032558|FG001|Overall Study|Lack of Efficacy|1|||
161447436|NCT01235598|583032557|FG000|Overall Study|Withdrawal by Subject|1|||
161447437|NCT01235598|583032558|FG001|Overall Study|Withdrawal by Subject|0|||
161447438|NCT02551991|583032561|FG000|Overall Study|Death|5|||
161447439|NCT02551991|583032562|FG001|Overall Study|Death|7|||
161447440|NCT02551991|583032563|FG002|Overall Study|Death|8|||
161447441|NCT02551991|583032564|FG003|Overall Study|Death|7|||
161447442|NCT02551991|583032565|FG004|Overall Study|Death|17|||
161447443|NCT02551991|583032561|FG000|Overall Study|Withdrawal by Subject|1|||
161447444|NCT02551991|583032562|FG001|Overall Study|Withdrawal by Subject|0|||
161447445|NCT02551991|583032563|FG002|Overall Study|Withdrawal by Subject|0|||
161447446|NCT02551991|583032564|FG003|Overall Study|Withdrawal by Subject|0|||
161447447|NCT02551991|583032565|FG004|Overall Study|Withdrawal by Subject|2|||
161447448|NCT02551991|583032561|FG000|Overall Study|Lost to Follow-up|0|||
161447449|NCT02551991|583032562|FG001|Overall Study|Lost to Follow-up|0|||
161447450|NCT02551991|583032563|FG002|Overall Study|Lost to Follow-up|1|||
161447451|NCT02551991|583032564|FG003|Overall Study|Lost to Follow-up|0|||
161447452|NCT02551991|583032565|FG004|Overall Study|Lost to Follow-up|0|||
161447453|NCT02551991|583032561|FG000|Overall Study|Sponsor Decision|1|||
161447454|NCT02551991|583032562|FG001|Overall Study|Sponsor Decision|0|||
161447455|NCT02551991|583032563|FG002|Overall Study|Sponsor Decision|1|||
161447456|NCT02551991|583032564|FG003|Overall Study|Sponsor Decision|0|||
161447457|NCT02551991|583032565|FG004|Overall Study|Sponsor Decision|5|||
161447458|NCT02551991|583032561|FG000|Overall Study|Other|0|||
161447459|NCT02551991|583032562|FG001|Overall Study|Other|0|||
161447460|NCT02551991|583032563|FG002|Overall Study|Other|0|||
161447461|NCT02551991|583032564|FG003|Overall Study|Other|0|||
161447462|NCT02551991|583032565|FG004|Overall Study|Other|1|||
161447463|NCT00395343|583032566|FG000|Overall Study|Adverse Event|13|||
161447464|NCT00395343|583032567|FG001|Overall Study|Adverse Event|5|||
161447465|NCT00395343|583032566|FG000|Overall Study|Lack of Efficacy|0|||
161447466|NCT00395343|583032567|FG001|Overall Study|Lack of Efficacy|1|||
161447467|NCT00395343|583032566|FG000|Overall Study|Lost to Follow-up|4|||
161447468|NCT00395343|583032567|FG001|Overall Study|Lost to Follow-up|4|||
161447469|NCT00395343|583032566|FG000|Overall Study|Physician Decision|2|||
161447470|NCT00395343|583032567|FG001|Overall Study|Physician Decision|4|||
161795509|NCT02649231|584294957|FG003|Overall Study|Protocol Violation|0|||
161900563|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
161795510|NCT02970669|584294960|FG000|Double-blind Period|Adverse Event|4|||
161447471|NCT00395343|583032566|FG000|Overall Study|Protocol Violation|6|||
161447472|NCT00395343|583032567|FG001|Overall Study|Protocol Violation|8|||
161447473|NCT00395343|583032566|FG000|Overall Study|Withdrawal by Subject|11|||
161447474|NCT00395343|583032567|FG001|Overall Study|Withdrawal by Subject|12|||
161795511|NCT02970669|584294961|FG001|Double-blind Period|Adverse Event|0|||
161795512|NCT02970669|584294960|FG000|Double-blind Period|Death|1|||
161447475|NCT00395343|583032566|FG000|Overall Study|Other|5|||
161447476|NCT00395343|583032567|FG001|Overall Study|Other|2|||
161447477|NCT00387790|583032568|FG000|Overall Study|Adverse Event|5|||
161447478|NCT00387790|583032568|FG000|Overall Study|Lack of Efficacy|2|||
161447479|NCT00387790|583032568|FG000|Overall Study|Physician Decision|2|||
161447480|NCT00387790|583032568|FG000|Overall Study|Withdrawal by Subject|3|||
161447481|NCT00387790|583032568|FG000|Overall Study|Ineligible for study|2|||
161447482|NCT03860259|583032575|FG000|Overall Study|Lost to Follow-up|5|||
161447483|NCT03860259|583032576|FG001|Overall Study|Lost to Follow-up|5|||
161447484|NCT03860259|583032575|FG000|Overall Study|Protocol Violation|1|||
161447485|NCT03860259|583032576|FG001|Overall Study|Protocol Violation|0|||
161447486|NCT02280408|583032577|FG000|Overall Study|Lost to Follow-up|0|||
161447487|NCT02280408|583032578|FG001|Overall Study|Lost to Follow-up|2|||
161447488|NCT02280408|583032579|FG002|Overall Study|Lost to Follow-up|0|||
161447489|NCT02280408|583032580|FG003|Overall Study|Lost to Follow-up|0|||
161447490|NCT00486291|583032590|FG000|Overall Study|Adverse Event|3|||
161447491|NCT00486291|583032591|FG001|Overall Study|Adverse Event|4|||
161447492|NCT00486291|583032590|FG000|Overall Study|Lost to Follow-up|3|||
161447493|NCT00486291|583032591|FG001|Overall Study|Lost to Follow-up|7|||
161447494|NCT00486291|583032590|FG000|Overall Study|protocol non-compliance|10|||
161447495|NCT00486291|583032591|FG001|Overall Study|protocol non-compliance|15|||
161447496|NCT00486291|583032590|FG000|Overall Study|requirement for restricted medication|0|||
161447497|NCT00486291|583032591|FG001|Overall Study|requirement for restricted medication|3|||
161447498|NCT04413617|583032592|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
161447499|NCT04413617|583032593|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
161447500|NCT04413617|583032594|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
161447501|NCT04413617|583032595|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
161447502|NCT04413617|583032596|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
161447503|NCT04413617|583032592|FG000|Overall Study|Protocol Violation|0|||
161447504|NCT04413617|583032593|FG001|Overall Study|Protocol Violation|1|||
161447505|NCT04413617|583032594|FG002|Overall Study|Protocol Violation|0|||
161447506|NCT04413617|583032595|FG003|Overall Study|Protocol Violation|0|||
161447507|NCT04413617|583032596|FG004|Overall Study|Protocol Violation|1|||
161447508|NCT04413617|583032592|FG000|Overall Study|Lack of Efficacy|2|||
161447509|NCT04413617|583032593|FG001|Overall Study|Lack of Efficacy|0|||
161447510|NCT04413617|583032594|FG002|Overall Study|Lack of Efficacy|2|||
161447511|NCT04413617|583032595|FG003|Overall Study|Lack of Efficacy|1|||
161447512|NCT04413617|583032596|FG004|Overall Study|Lack of Efficacy|0|||
161447513|NCT04413617|583032592|FG000|Overall Study|Withdrawal by Subject|3|||
161447514|NCT04413617|583032593|FG001|Overall Study|Withdrawal by Subject|4|||
161447515|NCT04413617|583032594|FG002|Overall Study|Withdrawal by Subject|2|||
161447516|NCT04413617|583032595|FG003|Overall Study|Withdrawal by Subject|5|||
161447517|NCT04413617|583032596|FG004|Overall Study|Withdrawal by Subject|3|||
161447518|NCT04413617|583032592|FG000|Overall Study|Death|1|||
161795513|NCT02970669|584294961|FG001|Double-blind Period|Death|0|||
161795514|NCT02970669|584294960|FG000|Double-blind Period|Study terminated by sponsor|1|||
161795515|NCT02970669|584294961|FG001|Double-blind Period|Study terminated by sponsor|2|||
161795516|NCT02970669|584294960|FG000|Double-blind Period|Physician Decision|0|||
161795517|NCT02970669|584294961|FG001|Double-blind Period|Physician Decision|2|||
161795518|NCT02970669|584294960|FG000|Double-blind Period|Withdrawal by Subject|2|||
161795519|NCT02970669|584294961|FG001|Double-blind Period|Withdrawal by Subject|2|||
161795520|NCT02970669|584294960|FG000|Open-label Period|Withdrawal by Subject|2|||
161795521|NCT02970669|584294961|FG001|Open-label Period|Withdrawal by Subject|2|||
161795522|NCT02970669|584294960|FG000|Open-label Period|Adverse Event|1|||
161795523|NCT02970669|584294961|FG001|Open-label Period|Adverse Event|0|||
161795524|NCT02970669|584294960|FG000|Open-label Period|Physician Decision|1|||
161795525|NCT02970669|584294961|FG001|Open-label Period|Physician Decision|0|||
161795526|NCT00876733|584294964|FG000|Overall Study|Adverse Event|34|||
161795527|NCT00876733|584294965|FG001|Overall Study|Adverse Event|20|||
161795528|NCT00876733|584294966|FG002|Overall Study|Adverse Event|10|||
161795529|NCT00876733|584294967|FG003|Overall Study|Adverse Event|3|||
161795530|NCT00876733|584294964|FG000|Overall Study|Lack of Efficacy|17|||
161447519|NCT04413617|583032593|FG001|Overall Study|Death|0|||
161447520|NCT04413617|583032594|FG002|Overall Study|Death|0|||
161447521|NCT04413617|583032595|FG003|Overall Study|Death|0|||
161795531|NCT00876733|584294965|FG001|Overall Study|Lack of Efficacy|9|||
161795532|NCT00876733|584294966|FG002|Overall Study|Lack of Efficacy|10|||
161447522|NCT04413617|583032596|FG004|Overall Study|Death|0|||
161552459|NCT03560245|583410457|FG001|Overall Study|Withdrawal by Subject|2|||
161795533|NCT00876733|584294967|FG003|Overall Study|Lack of Efficacy|1|||
161795534|NCT00876733|584294964|FG000|Overall Study|Lost to Follow-up|26|||
161795535|NCT00876733|584294965|FG001|Overall Study|Lost to Follow-up|10|||
161795536|NCT00876733|584294966|FG002|Overall Study|Lost to Follow-up|3|||
161795537|NCT00876733|584294967|FG003|Overall Study|Lost to Follow-up|2|||
161447523|NCT04413617|583032592|FG000|Overall Study|Adverse Event|1|||
161447524|NCT04413617|583032593|FG001|Overall Study|Adverse Event|0|||
161447525|NCT04413617|583032594|FG002|Overall Study|Adverse Event|0|||
161447526|NCT04413617|583032595|FG003|Overall Study|Adverse Event|1|||
161447527|NCT04413617|583032596|FG004|Overall Study|Adverse Event|1|||
161447528|NCT04413617|583032592|FG000|Overall Study|COVID-19|0|||
161447529|NCT04413617|583032593|FG001|Overall Study|COVID-19|1|||
161447530|NCT04413617|583032594|FG002|Overall Study|COVID-19|0|||
161795538|NCT00876733|584294964|FG000|Overall Study|Data not available|14|||
161795539|NCT00876733|584294965|FG001|Overall Study|Data not available|3|||
161795540|NCT00876733|584294966|FG002|Overall Study|Data not available|7|||
161795541|NCT00876733|584294967|FG003|Overall Study|Data not available|1|||
161795542|NCT02611752|584294968|FG000|Overall Study|Adverse Event|0|||
161795543|NCT02611752|584294969|FG001|Overall Study|Adverse Event|1|||
161795544|NCT03521999|584294970|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
161795545|NCT03521999|584294971|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
161795546|NCT03521999|584294970|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
161795547|NCT03521999|584294971|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
161795548|NCT03521999|584294970|FG000|Completed 3 Month Follow up|Death|0|||
161795549|NCT03521999|584294971|FG001|Completed 3 Month Follow up|Death|1|||
161795550|NCT03521999|584294970|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
161795551|NCT03521999|584294971|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
161795552|NCT03495986|584294974|FG000|Overall Study|Physician Decision|1|||
161447531|NCT04413617|583032595|FG003|Overall Study|COVID-19|0|||
161447532|NCT04413617|583032596|FG004|Overall Study|COVID-19|0|||
161447533|NCT00775593|583032597|FG000|Overall Study|Unmet eligibility criteria|6|||
161447534|NCT00775593|583032597|FG000|Overall Study|Death|1|||
161447535|NCT00984620|583032598|FG000|Overall Study|Adverse Event|5|||
161447536|NCT00984620|583032599|FG001|Overall Study|Adverse Event|5|||
161447537|NCT00984620|583032598|FG000|Overall Study|Lost to Follow-up|1|||
161447538|NCT00984620|583032599|FG001|Overall Study|Lost to Follow-up|1|||
161447539|NCT00984620|583032598|FG000|Overall Study|Withdrawal by Subject|0|||
161447540|NCT00984620|583032599|FG001|Overall Study|Withdrawal by Subject|2|||
161447541|NCT00984620|583032598|FG000|Overall Study|reason other than listed above|0|||
161447542|NCT00984620|583032599|FG001|Overall Study|reason other than listed above|4|||
161447543|NCT01703754|583032600|FG000|Overall Study|Clinically significant disease progression|2|||
161447544|NCT01703754|583032601|FG001|Overall Study|Clinically significant disease progression|2|||
161447545|NCT01703754|583032602|FG002|Overall Study|Clinically significant disease progression|1|||
161447546|NCT01703754|583032600|FG000|Overall Study|Adverse Event|1|||
161447547|NCT01703754|583032601|FG001|Overall Study|Adverse Event|1|||
161447548|NCT01703754|583032602|FG002|Overall Study|Adverse Event|0|||
161447549|NCT01703754|583032600|FG000|Overall Study|Withdrawal by Subject|2|||
161447550|NCT01703754|583032601|FG001|Overall Study|Withdrawal by Subject|0|||
161447551|NCT01703754|583032602|FG002|Overall Study|Withdrawal by Subject|0|||
161447552|NCT01561313|583032603|FG000|Overall Study|Withdrawal by Subject|1|||
161447553|NCT01561313|583032604|FG001|Overall Study|Withdrawal by Subject|0|||
161447554|NCT01561313|583032603|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
161447555|NCT01561313|583032604|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
161447556|NCT06173063|583032609|FG000|Overall Study|Withdrawal by Subject|2|||
161447557|NCT01925131|583033935|FG000|Overall Study|Death|0|||
161447558|NCT01925131|583033936|FG001|Overall Study|Death|0|||
161447559|NCT01925131|583033937|FG002|Overall Study|Death|1|||
161447560|NCT01925131|583033938|FG003|Overall Study|Death|0|||
161447561|NCT01925131|583033939|FG004|Overall Study|Death|0|||
161447562|NCT01925131|583033940|FG005|Overall Study|Death|0|||
161447563|NCT01925131|583033935|FG000|Overall Study|Progression/Relapse|1|||
161447564|NCT01925131|583033936|FG001|Overall Study|Progression/Relapse|1|||
161447565|NCT01925131|583033937|FG002|Overall Study|Progression/Relapse|4|||
161447566|NCT01925131|583033938|FG003|Overall Study|Progression/Relapse|0|||
161447567|NCT01925131|583033939|FG004|Overall Study|Progression/Relapse|0|||
161447568|NCT01925131|583033940|FG005|Overall Study|Progression/Relapse|1|||
161447569|NCT01925131|583033935|FG000|Overall Study|Patient Refusal|1|||
161447570|NCT01925131|583033936|FG001|Overall Study|Patient Refusal|0|||
161447571|NCT01925131|583033937|FG002|Overall Study|Patient Refusal|0|||
161447572|NCT01925131|583033938|FG003|Overall Study|Patient Refusal|0|||
161447573|NCT01925131|583033939|FG004|Overall Study|Patient Refusal|0|||
161447574|NCT01925131|583033940|FG005|Overall Study|Patient Refusal|0|||
161447575|NCT01925131|583033935|FG000|Overall Study|Adverse Event|0|||
161447576|NCT01925131|583033936|FG001|Overall Study|Adverse Event|0|||
161447577|NCT01925131|583033937|FG002|Overall Study|Adverse Event|2|||
161447578|NCT01925131|583033938|FG003|Overall Study|Adverse Event|0|||
161447579|NCT01925131|583033939|FG004|Overall Study|Adverse Event|1|||
161795553|NCT03495986|584294975|FG001|Overall Study|Physician Decision|0|||
161795554|NCT03495986|584294974|FG000|Overall Study|Withdrawal by Subject|1|||
161795555|NCT03495986|584294975|FG001|Overall Study|Withdrawal by Subject|1|||
161795556|NCT03495986|584294974|FG000|Overall Study|Withdrawal by Subject|1|||
161447580|NCT01925131|583033940|FG005|Overall Study|Adverse Event|3|||
161447581|NCT01925131|583033935|FG000|Overall Study|Other - Not Protocol Specified|3|||
161447582|NCT01925131|583033936|FG001|Overall Study|Other - Not Protocol Specified|1|||
161447583|NCT01925131|583033937|FG002|Overall Study|Other - Not Protocol Specified|2|||
161447584|NCT01925131|583033938|FG003|Overall Study|Other - Not Protocol Specified|5|||
161447585|NCT01925131|583033939|FG004|Overall Study|Other - Not Protocol Specified|10|||
161447586|NCT01925131|583033940|FG005|Overall Study|Other - Not Protocol Specified|6|||
161447587|NCT05091567|583033941|FG000|Enrollment Phase|Death|37|||
161447588|NCT05091567|583033942|FG001|Enrollment Phase|Death|0|||
161447589|NCT05091567|583033943|FG002|Enrollment Phase|Death|0|||
161447590|NCT05091567|583033941|FG000|Enrollment Phase|Adverse Event|21|||
161447591|NCT05091567|583033942|FG001|Enrollment Phase|Adverse Event|0|||
161447592|NCT05091567|583033943|FG002|Enrollment Phase|Adverse Event|0|||
161447593|NCT05091567|583033941|FG000|Enrollment Phase|Progressive Disease|10|||
161447594|NCT05091567|583033942|FG001|Enrollment Phase|Progressive Disease|0|||
161447595|NCT05091567|583033943|FG002|Enrollment Phase|Progressive Disease|0|||
161447596|NCT05091567|583033941|FG000|Enrollment Phase|Withdrawal by Subject|8|||
161447597|NCT05091567|583033942|FG001|Enrollment Phase|Withdrawal by Subject|0|||
161447598|NCT05091567|583033943|FG002|Enrollment Phase|Withdrawal by Subject|0|||
161447599|NCT05091567|583033941|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
161447600|NCT05091567|583033942|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
161447601|NCT05091567|583033943|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
161447602|NCT05091567|583033941|FG000|Enrollment Phase|Physician Decision|3|||
161447603|NCT05091567|583033942|FG001|Enrollment Phase|Physician Decision|0|||
161447604|NCT05091567|583033943|FG002|Enrollment Phase|Physician Decision|0|||
161447605|NCT05091567|583033941|FG000|Enrollment Phase|Protocol Violation|2|||
161447606|NCT05091567|583033942|FG001|Enrollment Phase|Protocol Violation|0|||
161795557|NCT03495986|584294975|FG001|Overall Study|Withdrawal by Subject|0|||
161795558|NCT04182204|584294976|FG000|Safety Run-in|Lost to Follow-up|1|||
161447607|NCT05091567|583033943|FG002|Enrollment Phase|Protocol Violation|0|||
161447608|NCT05091567|583033941|FG000|Enrollment Phase|Reason not Specified|1|||
161447609|NCT05091567|583033942|FG001|Enrollment Phase|Reason not Specified|0|||
161447610|NCT05091567|583033943|FG002|Enrollment Phase|Reason not Specified|0|||
161795559|NCT04182204|584294977|FG001|Safety Run-in|Lost to Follow-up|0|||
161795560|NCT04182204|584294978|FG002|Safety Run-in|Lost to Follow-up|0|||
161795561|NCT04182204|584294976|FG000|Safety Run-in|Withdrawal by Subject|2|||
161795562|NCT04182204|584294977|FG001|Safety Run-in|Withdrawal by Subject|0|||
161795563|NCT04182204|584294978|FG002|Safety Run-in|Withdrawal by Subject|0|||
161795564|NCT04182204|584294976|FG000|Safety Run-in|Death|7|||
161795565|NCT04182204|584294977|FG001|Safety Run-in|Death|0|||
161795566|NCT04182204|584294978|FG002|Safety Run-in|Death|0|||
161795567|NCT04182204|584294976|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
161795568|NCT04182204|584294977|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
161795569|NCT04182204|584294978|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
161795570|NCT04182204|584294976|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
161795571|NCT04182204|584294977|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
161795572|NCT04182204|584294978|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
161795573|NCT04182204|584294976|FG000|Randomized Controlled Trial|Death|0|||
161795574|NCT04182204|584294977|FG001|Randomized Controlled Trial|Death|83|||
161795575|NCT04182204|584294978|FG002|Randomized Controlled Trial|Death|66|||
161795576|NCT05476679|584294979|FG000|Overall Study|Withdrawal by Subject|0|||
161795577|NCT05476679|584294980|FG001|Overall Study|Withdrawal by Subject|0|||
161795578|NCT05476679|584294981|FG002|Overall Study|Withdrawal by Subject|0|||
161795579|NCT05476679|584294982|FG003|Overall Study|Withdrawal by Subject|1|||
161795580|NCT05476679|584294983|FG004|Overall Study|Withdrawal by Subject|0|||
161795581|NCT05476679|584294979|FG000|Overall Study|Lost to Follow-up|0|||
161795582|NCT05476679|584294980|FG001|Overall Study|Lost to Follow-up|0|||
161795583|NCT05476679|584294981|FG002|Overall Study|Lost to Follow-up|0|||
161795584|NCT05476679|584294982|FG003|Overall Study|Lost to Follow-up|1|||
161795585|NCT05476679|584294983|FG004|Overall Study|Lost to Follow-up|0|||
161795586|NCT01214330|584294984|FG000|Overall Study|Withdrawal by Subject|2|||
161795587|NCT01214330|584294984|FG000|Overall Study|Withdrawal by Subject|2|||
161795588|NCT00249821|584294985|FG000|Overall Study|Technical problem|0|||
161795589|NCT00249821|584294986|FG001|Overall Study|Technical problem|1|||
161795590|NCT00686036|584294989|FG000|Overall Study|Adverse Event|3|||
161795591|NCT00686036|584294990|FG001|Overall Study|Adverse Event|0|||
161795592|NCT00686036|584294989|FG000|Overall Study|Withdrawal by Subject|3|||
161795593|NCT00686036|584294990|FG001|Overall Study|Withdrawal by Subject|1|||
161795594|NCT00686036|584294989|FG000|Overall Study|Study terminated by AstraZeneca|2|||
161795595|NCT00686036|584294990|FG001|Overall Study|Study terminated by AstraZeneca|1|||
161795596|NCT00686036|584294989|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
161795597|NCT00686036|584294990|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
161795598|NCT00686036|584294989|FG000|Overall Study|Other reasons not identified|0|||
161795599|NCT00686036|584294990|FG001|Overall Study|Other reasons not identified|4|||
161795600|NCT01411995|584294991|FG000|Overall Study|Failed IUD insertion|0|||
161795601|NCT01411995|584294992|FG001|Overall Study|Failed IUD insertion|1|||
161447611|NCT05091567|583033941|FG000|Randomized Phase|Death|0|||
161447612|NCT05091567|583033942|FG001|Randomized Phase|Death|135|||
161447613|NCT05091567|583033943|FG002|Randomized Phase|Death|112|||
161447614|NCT05091567|583033941|FG000|Randomized Phase|Progressive Disease|0|||
161447615|NCT05091567|583033942|FG001|Randomized Phase|Progressive Disease|2|||
161795602|NCT03212170|584294993|FG000|Overall Study|Withdrawal by Subject|1|||
161447616|NCT05091567|583033943|FG002|Randomized Phase|Progressive Disease|0|||
161447617|NCT05091567|583033941|FG000|Randomized Phase|Withdrawal by Subject|0|||
161447618|NCT05091567|583033942|FG001|Randomized Phase|Withdrawal by Subject|1|||
161447619|NCT05091567|583033943|FG002|Randomized Phase|Withdrawal by Subject|3|||
161447620|NCT05091567|583033941|FG000|Randomized Phase|Lost to Follow-up|0|||
161447621|NCT05091567|583033942|FG001|Randomized Phase|Lost to Follow-up|1|||
161447622|NCT05091567|583033943|FG002|Randomized Phase|Lost to Follow-up|1|||
161447623|NCT05091567|583033941|FG000|Randomized Phase|Ongoing in Study|0|||
161447624|NCT05091567|583033942|FG001|Randomized Phase|Ongoing in Study|102|||
161447625|NCT05091567|583033943|FG002|Randomized Phase|Ongoing in Study|126|||
161447626|NCT01217307|583033944|FG000|Overall Study|Withdrawal by Subject|0|||
161447627|NCT01217307|583033945|FG001|Overall Study|Withdrawal by Subject|1|||
161447628|NCT01696929|583033948|FG000|Overall Study|Physician Decision|1|||
161447629|NCT01129583|583033950|FG000|Overall Study|Death|1|||
161447630|NCT01129583|583033951|FG001|Overall Study|Death|0|||
161447631|NCT01129583|583033950|FG000|Overall Study|Lost to Follow-up|1|||
161447632|NCT01129583|583033951|FG001|Overall Study|Lost to Follow-up|1|||
161447633|NCT01129583|583033950|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
161447634|NCT01129583|583033951|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
161447635|NCT00942994|583033960|FG000|Overall Study|Adverse Event|7|||
161447636|NCT00942994|583033961|FG001|Overall Study|Adverse Event|4|||
161447637|NCT00942994|583033960|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161447638|NCT00942994|583033961|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161447639|NCT00942994|583033960|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161447640|NCT00942994|583033961|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161447641|NCT00942994|583033960|FG000|Overall Study|Patient withdrew consent|5|||
161447642|NCT00942994|583033961|FG001|Overall Study|Patient withdrew consent|8|||
161447643|NCT00942994|583033960|FG000|Overall Study|Lost to Follow-up|1|||
161447644|NCT00942994|583033961|FG001|Overall Study|Lost to Follow-up|4|||
161447645|NCT00942994|583033960|FG000|Overall Study|Protocol deviation|1|||
161447646|NCT00942994|583033961|FG001|Overall Study|Protocol deviation|2|||
161447647|NCT04491604|583033962|FG000|Overall Study|Withdrawal by Subject|3|||
161447648|NCT01874340|583033965|FG000|Overall Study|Study terminated by Sponsor|6|||
161447649|NCT01874340|583033966|FG001|Overall Study|Study terminated by Sponsor|8|||
161447650|NCT01874340|583033967|FG002|Overall Study|Study terminated by Sponsor|8|||
161447651|NCT01874340|583033968|FG003|Overall Study|Study terminated by Sponsor|4|||
161447652|NCT01874340|583033965|FG000|Overall Study|Withdrawal by Subject|0|||
161447653|NCT01874340|583033966|FG001|Overall Study|Withdrawal by Subject|0|||
161447654|NCT01874340|583033967|FG002|Overall Study|Withdrawal by Subject|0|||
161447655|NCT01874340|583033968|FG003|Overall Study|Withdrawal by Subject|1|||
161447656|NCT00689117|583033972|FG000|Overall Study|Adverse Event|6|||
161447657|NCT00689117|583033973|FG001|Overall Study|Adverse Event|0|||
161795603|NCT01937364|584294994|FG000|Overall Study|Adverse Event|2|||
161795604|NCT01937364|584294995|FG001|Overall Study|Adverse Event|1|||
161795605|NCT00467584|584294996|FG000|Overall Study|Withdrawal by Subject|4|||
161795606|NCT00467584|584294997|FG001|Overall Study|Withdrawal by Subject|5|||
161795607|NCT00467584|584294998|FG002|Overall Study|Withdrawal by Subject|1|||
161795608|NCT02482571|584294999|FG000|Overall Study|Adverse Event|1|||
161795609|NCT02482571|584294999|FG000|Overall Study|Scanner or Respiract failure|3|||
161795610|NCT02482571|584294999|FG000|Overall Study|Withdrawal by Subject|4|||
161795611|NCT01498484|584295003|FG000|Overall Study|Death|6|||
161795612|NCT01498484|584295004|FG001|Overall Study|Death|3|||
161795613|NCT01498484|584295005|FG002|Overall Study|Death|1|||
161795614|NCT01498484|584295006|FG003|Overall Study|Death|1|||
161795615|NCT01498484|584295007|FG004|Overall Study|Death|0|||
161795616|NCT01498484|584295008|FG005|Overall Study|Death|0|||
161795617|NCT01498484|584295009|FG006|Overall Study|Death|10|||
161795618|NCT01498484|584295010|FG007|Overall Study|Death|1|||
161795619|NCT01498484|584295011|FG008|Overall Study|Death|0|||
161795620|NCT01498484|584295003|FG000|Overall Study|Physician Decision|3|||
161795621|NCT01498484|584295004|FG001|Overall Study|Physician Decision|2|||
161795622|NCT01498484|584295005|FG002|Overall Study|Physician Decision|1|||
161795623|NCT01498484|584295006|FG003|Overall Study|Physician Decision|1|||
161447658|NCT00689117|583033974|FG002|Overall Study|Adverse Event|5|||
161447659|NCT00689117|583033975|FG003|Overall Study|Adverse Event|0|||
161447660|NCT00689117|583033972|FG000|Overall Study|Lost to Follow-up|26|||
161447661|NCT00689117|583033973|FG001|Overall Study|Lost to Follow-up|19|||
161447662|NCT00689117|583033974|FG002|Overall Study|Lost to Follow-up|17|||
161795624|NCT01498484|584295007|FG004|Overall Study|Physician Decision|0|||
161795625|NCT01498484|584295008|FG005|Overall Study|Physician Decision|0|||
161795626|NCT01498484|584295009|FG006|Overall Study|Physician Decision|8|||
161447663|NCT00689117|583033975|FG003|Overall Study|Lost to Follow-up|11|||
161447664|NCT00689117|583033972|FG000|Overall Study|Lack of Efficacy|1|||
161447665|NCT00689117|583033973|FG001|Overall Study|Lack of Efficacy|2|||
161447666|NCT00689117|583033974|FG002|Overall Study|Lack of Efficacy|2|||
161447667|NCT00689117|583033975|FG003|Overall Study|Lack of Efficacy|2|||
161447668|NCT00689117|583033972|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
161795627|NCT01498484|584295010|FG007|Overall Study|Physician Decision|13|||
161795628|NCT01498484|584295011|FG008|Overall Study|Physician Decision|1|||
161447669|NCT00689117|583033973|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
161447670|NCT00689117|583033974|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
161447671|NCT00689117|583033975|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
161447672|NCT00689117|583033972|FG000|Overall Study|Withdrawal by Subject|19|||
161447673|NCT00689117|583033973|FG001|Overall Study|Withdrawal by Subject|18|||
161447674|NCT00689117|583033974|FG002|Overall Study|Withdrawal by Subject|26|||
161447675|NCT00689117|583033975|FG003|Overall Study|Withdrawal by Subject|13|||
161447676|NCT00689117|583033972|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
161447677|NCT00689117|583033973|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
161447678|NCT00689117|583033974|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
161447679|NCT00689117|583033975|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
161447680|NCT00689117|583033972|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161447681|NCT00689117|583033973|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
161447682|NCT00689117|583033974|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161447683|NCT00689117|583033975|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161447684|NCT00689117|583033972|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
161447685|NCT00689117|583033973|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
161447686|NCT00689117|583033974|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
161447687|NCT00689117|583033975|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
161447688|NCT00689117|583033972|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
161447689|NCT00689117|583033973|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
161447690|NCT00689117|583033974|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
161447691|NCT00689117|583033975|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
161447692|NCT00689117|583033972|FG000|Overall Study|Use of Prohibitive Medication|2|||
161447693|NCT00689117|583033973|FG001|Overall Study|Use of Prohibitive Medication|1|||
161447694|NCT00689117|583033974|FG002|Overall Study|Use of Prohibitive Medication|3|||
161447695|NCT00689117|583033975|FG003|Overall Study|Use of Prohibitive Medication|0|||
161447696|NCT00689117|583033972|FG000|Overall Study|Pregnancy|0|||
161447697|NCT00689117|583033973|FG001|Overall Study|Pregnancy|2|||
161447698|NCT00689117|583033974|FG002|Overall Study|Pregnancy|0|||
161447699|NCT00689117|583033975|FG003|Overall Study|Pregnancy|2|||
161447700|NCT00689117|583033972|FG000|Overall Study|Incarceration|2|||
161447701|NCT00689117|583033973|FG001|Overall Study|Incarceration|0|||
161447702|NCT00689117|583033974|FG002|Overall Study|Incarceration|0|||
161447703|NCT00689117|583033975|FG003|Overall Study|Incarceration|0|||
161447704|NCT00689117|583033972|FG000|Overall Study|Fear of Birth Defects|0|||
161447705|NCT00689117|583033973|FG001|Overall Study|Fear of Birth Defects|0|||
161447706|NCT00689117|583033974|FG002|Overall Study|Fear of Birth Defects|1|||
161447707|NCT00689117|583033975|FG003|Overall Study|Fear of Birth Defects|0|||
161447708|NCT00689117|583033972|FG000|Overall Study|Transportation|1|||
161447709|NCT00689117|583033973|FG001|Overall Study|Transportation|0|||
161447710|NCT00689117|583033974|FG002|Overall Study|Transportation|0|||
161447711|NCT00689117|583033975|FG003|Overall Study|Transportation|0|||
161447712|NCT00689117|583033972|FG000|Overall Study|Patient Withdrew from Study|0|||
161447713|NCT00689117|583033973|FG001|Overall Study|Patient Withdrew from Study|0|||
161447714|NCT00689117|583033974|FG002|Overall Study|Patient Withdrew from Study|0|||
161447715|NCT00689117|583033975|FG003|Overall Study|Patient Withdrew from Study|1|||
161795629|NCT01498484|584295003|FG000|Overall Study|Adverse Event|0|||
161795630|NCT01498484|584295004|FG001|Overall Study|Adverse Event|0|||
161795631|NCT01498484|584295005|FG002|Overall Study|Adverse Event|0|||
161795632|NCT01498484|584295006|FG003|Overall Study|Adverse Event|0|||
161795633|NCT01498484|584295007|FG004|Overall Study|Adverse Event|0|||
161795634|NCT01498484|584295008|FG005|Overall Study|Adverse Event|1|||
161795635|NCT01498484|584295009|FG006|Overall Study|Adverse Event|0|||
161795636|NCT01498484|584295010|FG007|Overall Study|Adverse Event|0|||
161795637|NCT01498484|584295011|FG008|Overall Study|Adverse Event|0|||
161795638|NCT01498484|584295003|FG000|Overall Study|Withdrawal by Subject|0|||
161795639|NCT01498484|584295004|FG001|Overall Study|Withdrawal by Subject|0|||
161795640|NCT01498484|584295005|FG002|Overall Study|Withdrawal by Subject|0|||
161795641|NCT01498484|584295006|FG003|Overall Study|Withdrawal by Subject|1|||
161795642|NCT01498484|584295007|FG004|Overall Study|Withdrawal by Subject|0|||
161795643|NCT01498484|584295008|FG005|Overall Study|Withdrawal by Subject|0|||
161795644|NCT01498484|584295009|FG006|Overall Study|Withdrawal by Subject|1|||
161447716|NCT00689117|583033972|FG000|Overall Study|Personal Reason|0|||
161447717|NCT00689117|583033973|FG001|Overall Study|Personal Reason|1|||
161447718|NCT00689117|583033974|FG002|Overall Study|Personal Reason|0|||
161447719|NCT00689117|583033975|FG003|Overall Study|Personal Reason|0|||
161447720|NCT00689117|583033972|FG000|Overall Study|Dispensing Error|0|||
161447721|NCT00689117|583033973|FG001|Overall Study|Dispensing Error|1|||
161447722|NCT00689117|583033974|FG002|Overall Study|Dispensing Error|0|||
161447723|NCT00689117|583033975|FG003|Overall Study|Dispensing Error|0|||
161795645|NCT01498484|584295010|FG007|Overall Study|Withdrawal by Subject|0|||
161795646|NCT01498484|584295011|FG008|Overall Study|Withdrawal by Subject|0|||
161795647|NCT01498484|584295003|FG000|Overall Study|Other|5|||
161447724|NCT01536067|583033977|FG000|Overall Study|Disease Progression|1|||
161447725|NCT02597478|583033978|FG000|Overall Study|Withdrawal by Subject|2|||
161447726|NCT02597478|583033979|FG001|Overall Study|Withdrawal by Subject|0|||
161447727|NCT02597478|583033978|FG000|Overall Study|Change of opioid dose|1|||
161447728|NCT02597478|583033979|FG001|Overall Study|Change of opioid dose|0|||
161447729|NCT02597478|583033978|FG000|Overall Study|Insufficient exertional dyspnea|0|||
161447730|NCT02597478|583033979|FG001|Overall Study|Insufficient exertional dyspnea|1|||
161552460|NCT03560245|583410456|FG000|Overall Study|Adverse Event|1|||
161552461|NCT03560245|583410457|FG001|Overall Study|Adverse Event|1|||
161552462|NCT03560245|583410456|FG000|Overall Study|Protocol Violation|1|||
161552463|NCT03560245|583410457|FG001|Overall Study|Protocol Violation|0|||
161552464|NCT03560245|583410456|FG000|Overall Study|Death|0|||
161552465|NCT03560245|583410457|FG001|Overall Study|Death|1|||
161552466|NCT03560245|583410456|FG000|Overall Study|Lost to Follow-up|0|||
161552467|NCT03560245|583410457|FG001|Overall Study|Lost to Follow-up|1|||
161552468|NCT03560245|583410456|FG000|Overall Study|Physician Decision|0|||
161552469|NCT03560245|583410457|FG001|Overall Study|Physician Decision|1|||
161552470|NCT03560245|583410456|FG000|Overall Study|Other|0|||
161552471|NCT03560245|583410457|FG001|Overall Study|Other|1|||
161552472|NCT00960752|583410462|FG000|Overall Study|Adverse Event|0|||
161552473|NCT00960752|583410463|FG001|Overall Study|Adverse Event|0|||
161552474|NCT00960752|583410464|FG002|Overall Study|Adverse Event|1|||
161552475|NCT00960752|583410462|FG000|Overall Study|Progression|0|||
161552476|NCT00960752|583410463|FG001|Overall Study|Progression|0|||
161552477|NCT00960752|583410464|FG002|Overall Study|Progression|1|||
161552478|NCT02058290|583410468|FG000|Overall Study|Protocol Violation|2|||
161552479|NCT02058290|583410469|FG001|Overall Study|Protocol Violation|1|||
161552480|NCT02058290|583410468|FG000|Overall Study|Physician Decision|1|||
161552481|NCT02058290|583410469|FG001|Overall Study|Physician Decision|0|||
161552482|NCT02058290|583410468|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
161552483|NCT02058290|583410469|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
161552484|NCT02058290|583410468|FG000|Overall Study|Withdrawal by Subject|0|||
161552485|NCT02058290|583410469|FG001|Overall Study|Withdrawal by Subject|1|||
161552486|NCT00105586|583410473|FG000|Overall Study|Adverse Event|4|||
161552487|NCT00105586|583410474|FG001|Overall Study|Adverse Event|3|||
161552488|NCT00105586|583410473|FG000|Overall Study|Physician Decision|13|||
161552489|NCT00105586|583410474|FG001|Overall Study|Physician Decision|13|||
161552490|NCT02262260|583410475|FG000|Overall Study|Adverse Event|4|||
161552491|NCT02262260|583410476|FG001|Overall Study|Adverse Event|1|||
161552492|NCT02262260|583410475|FG000|Overall Study|Withdrawal of consent|4|||
161552493|NCT02262260|583410476|FG001|Overall Study|Withdrawal of consent|2|||
161552494|NCT02262260|583410475|FG000|Overall Study|Lost to Follow-up|1|||
161552495|NCT02262260|583410476|FG001|Overall Study|Lost to Follow-up|2|||
161552496|NCT02262260|583410475|FG000|Overall Study|Protocol deviation|2|||
161552497|NCT02262260|583410476|FG001|Overall Study|Protocol deviation|5|||
161552498|NCT01794117|583410479|FG000|Overall Study|Adverse Event|1|||
161552499|NCT01794117|583410480|FG001|Overall Study|Adverse Event|0|||
161552500|NCT01794117|583410481|FG002|Overall Study|Adverse Event|0|||
161447731|NCT04657666|583033982|FG000|Period 1|Withdrawal of participant consent|2|||
161447732|NCT04657666|583033983|FG001|Period 1|Withdrawal of participant consent|1|||
161447733|NCT04657666|583033982|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
161447734|NCT04657666|583033983|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
161552501|NCT01794117|583410482|FG003|Overall Study|Adverse Event|0|||
161447735|NCT04657666|583033982|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
161447736|NCT04657666|583033983|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
161447737|NCT04657666|583033982|FG000|Period 2|Other|2|||
161447738|NCT04657666|583033983|FG001|Period 2|Other|0|||
161447739|NCT04657666|583033982|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
161447740|NCT04657666|583033983|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
161447741|NCT00606905|583033985|FG000|Overall Study|No Pregnancy|9|||
161447742|NCT00606905|583033986|FG001|Overall Study|No Pregnancy|6|||
161447743|NCT00606905|583033985|FG000|Overall Study|Non-Index Pregnancy|1|||
161447744|NCT00606905|583033986|FG001|Overall Study|Non-Index Pregnancy|4|||
161447745|NCT00606905|583033985|FG000|Overall Study|Withdrew|5|||
161447746|NCT00606905|583033986|FG001|Overall Study|Withdrew|5|||
161552502|NCT01794117|583410479|FG000|Overall Study|Participant noncompliance|0|||
161552503|NCT01794117|583410480|FG001|Overall Study|Participant noncompliance|1|||
161552504|NCT01794117|583410481|FG002|Overall Study|Participant noncompliance|0|||
161552505|NCT01794117|583410482|FG003|Overall Study|Participant noncompliance|0|||
161447747|NCT02386189|583033987|FG000|Overall Study|Lost to Follow-up|2|||
161447748|NCT02386189|583033988|FG001|Overall Study|Lost to Follow-up|3|||
161447749|NCT02386189|583033987|FG000|Overall Study|Withdrawal by Subject|1|||
161552506|NCT01794117|583410479|FG000|Overall Study|Refused further treatment|0|||
161552507|NCT01794117|583410480|FG001|Overall Study|Refused further treatment|2|||
161552508|NCT01794117|583410481|FG002|Overall Study|Refused further treatment|0|||
161552509|NCT01794117|583410482|FG003|Overall Study|Refused further treatment|0|||
161552510|NCT03406702|583410483|FG000|Overall Study|Missed Day 27 Dosing|1|||
161552511|NCT01233609|583410486|FG000|Overall Study|Death|1|||
161552512|NCT01233609|583410487|FG001|Overall Study|Death|0|||
161795648|NCT01498484|584295004|FG001|Overall Study|Other|2|||
161795649|NCT01498484|584295005|FG002|Overall Study|Other|0|||
161795650|NCT01498484|584295006|FG003|Overall Study|Other|0|||
161795651|NCT01498484|584295007|FG004|Overall Study|Other|1|||
161795652|NCT01498484|584295008|FG005|Overall Study|Other|0|||
161795653|NCT01498484|584295009|FG006|Overall Study|Other|3|||
161795654|NCT01498484|584295010|FG007|Overall Study|Other|0|||
161795655|NCT01498484|584295011|FG008|Overall Study|Other|1|||
161795656|NCT00656019|584295017|FG000|Overall Study|Not Eligible|10|||
161795657|NCT00656019|584295018|FG001|Overall Study|Not Eligible|0|||
161795658|NCT00656019|584295019|FG002|Overall Study|Not Eligible|0|||
161795659|NCT00656019|584295020|FG003|Overall Study|Not Eligible|0|||
161795660|NCT00656019|584295017|FG000|Overall Study|Withdrawal by Subject|2|||
161795661|NCT00656019|584295018|FG001|Overall Study|Withdrawal by Subject|0|||
161795662|NCT00656019|584295019|FG002|Overall Study|Withdrawal by Subject|0|||
161795663|NCT00656019|584295020|FG003|Overall Study|Withdrawal by Subject|0|||
161795664|NCT00656019|584295017|FG000|Overall Study|Lost to Follow-up|2|||
161795665|NCT00656019|584295018|FG001|Overall Study|Lost to Follow-up|1|||
161795666|NCT00656019|584295019|FG002|Overall Study|Lost to Follow-up|0|||
161795667|NCT00656019|584295020|FG003|Overall Study|Lost to Follow-up|0|||
161795668|NCT05550532|584295023|FG000|Overall Study|Withdrawal by Subject|8|||
161795669|NCT05550532|584295024|FG001|Overall Study|Withdrawal by Subject|3|||
161795670|NCT05550532|584295023|FG000|Overall Study|Adverse Event|2|||
161795671|NCT05550532|584295024|FG001|Overall Study|Adverse Event|3|||
161795672|NCT05550532|584295023|FG000|Overall Study|Lost to Follow-up|4|||
161447750|NCT02386189|583033988|FG001|Overall Study|Withdrawal by Subject|0|||
161447751|NCT02386189|583033987|FG000|Overall Study|Death|1|||
161447752|NCT02386189|583033988|FG001|Overall Study|Death|0|||
161447753|NCT03120351|583033989|FG000|Overall Study|Physician Decision|1|||
161447754|NCT03120351|583033990|FG001|Overall Study|Physician Decision|1|||
161447755|NCT04931888|583033992|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
161447756|NCT04931888|583033993|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
161447757|NCT04931888|583033994|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
161447758|NCT04931888|583033995|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
161447759|NCT01022398|583033996|FG000|Overall Study|Study terminated|2|||
161447760|NCT01022398|583033997|FG001|Overall Study|Study terminated|2|||
161447761|NCT02969408|583033999|FG000|Overall Study|Adverse Event|2|||
161447762|NCT02969408|583033999|FG000|Overall Study|Withdrawal by Subject|8|||
161447763|NCT02969408|583033999|FG000|Overall Study|Lost to Follow-up|4|||
161447764|NCT02969408|583033999|FG000|Overall Study|Protocol Violation|1|||
161447765|NCT02969408|583033999|FG000|Overall Study|Other than specified|1|||
161447766|NCT04540198|583034000|FG000|Overall Study|Lost to Follow-up|25|||
161447767|NCT04540198|583034001|FG001|Overall Study|Lost to Follow-up|23|||
161447768|NCT04540198|583034000|FG000|Overall Study|Withdrawal by Subject|15|||
161447769|NCT04540198|583034001|FG001|Overall Study|Withdrawal by Subject|9|||
161447770|NCT04540198|583034000|FG000|Overall Study|Discontinued|1|||
161447771|NCT04540198|583034001|FG001|Overall Study|Discontinued|0|||
161447772|NCT02350478|583034002|FG000|Overall Study|Lost to Follow-up|5|||
161447773|NCT02350478|583034003|FG001|Overall Study|Lost to Follow-up|1|||
161447774|NCT02779556|583034004|FG000|Baseline|Partial baseline interview completed|1|||
161447775|NCT02779556|583034005|FG001|Baseline|Partial baseline interview completed|0|||
161447776|NCT02779556|583034004|FG000|3 Months|Lost to Follow-up|40|||
161447777|NCT02779556|583034005|FG001|3 Months|Lost to Follow-up|29|||
161447778|NCT02779556|583034004|FG000|3 Months|Missed 3 month clinic visit|27|||
161447779|NCT02779556|583034005|FG001|3 Months|Missed 3 month clinic visit|19|||
161447780|NCT02779556|583034004|FG000|6 Month|Lost to Follow-up|33|||
161447781|NCT02779556|583034005|FG001|6 Month|Lost to Follow-up|39|||
161447782|NCT02779556|583034004|FG000|6 Month HbA1c|No value collected during window|69|||
161447783|NCT02779556|583034005|FG001|6 Month HbA1c|No value collected during window|50|||
161447784|NCT02779556|583034004|FG000|12 Month HbA1c|No value collected during window|138|||
161447785|NCT02779556|583034005|FG001|12 Month HbA1c|No value collected during window|102|||
161447786|NCT03110770|583034006|FG000|Overall Study|Death|1|||
161447787|NCT03110770|583034007|FG001|Overall Study|Death|0|||
161447788|NCT03110770|583034008|FG002|Overall Study|Death|0|||
161447789|NCT03110770|583034009|FG003|Overall Study|Death|1|||
161447790|NCT03110770|583034010|FG004|Overall Study|Death|0|||
161447791|NCT03110770|583034006|FG000|Overall Study|Enrolled but did not receive product|0|||
161447792|NCT03110770|583034007|FG001|Overall Study|Enrolled but did not receive product|0|||
161447793|NCT03110770|583034008|FG002|Overall Study|Enrolled but did not receive product|0|||
161447794|NCT03110770|583034009|FG003|Overall Study|Enrolled but did not receive product|8|||
161447795|NCT03110770|583034010|FG004|Overall Study|Enrolled but did not receive product|7|||
161447796|NCT03110770|583034006|FG000|Overall Study|Lost to Follow-up|0|||
161447797|NCT03110770|583034007|FG001|Overall Study|Lost to Follow-up|0|||
161795673|NCT05550532|584295024|FG001|Overall Study|Lost to Follow-up|0|||
161795674|NCT05550532|584295023|FG000|Overall Study|Other|0|||
161795675|NCT05550532|584295024|FG001|Overall Study|Other|4|||
161795676|NCT00859469|584295025|FG000|Overall Study|Adverse Event|2|||
161795677|NCT00859469|584295025|FG000|Overall Study|Lack of Efficacy|9|||
161900564|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
161900565|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
161900566|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
161900567|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
161900568|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
161900569|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
161900570|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
161900571|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
161900572|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
161900573|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
161900574|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
161900575|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
161900576|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
161900577|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161900578|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161447798|NCT03110770|583034008|FG002|Overall Study|Lost to Follow-up|0|||
161447799|NCT03110770|583034009|FG003|Overall Study|Lost to Follow-up|53|||
161447800|NCT03110770|583034010|FG004|Overall Study|Lost to Follow-up|45|||
161447801|NCT03110770|583034006|FG000|Overall Study|Investigator Decision|0|||
161447802|NCT03110770|583034007|FG001|Overall Study|Investigator Decision|0|||
161447803|NCT03110770|583034008|FG002|Overall Study|Investigator Decision|0|||
161447804|NCT03110770|583034009|FG003|Overall Study|Investigator Decision|5|||
161447805|NCT03110770|583034010|FG004|Overall Study|Investigator Decision|3|||
161447806|NCT03110770|583034006|FG000|Overall Study|Withdrawal by Subject|0|||
161447807|NCT03110770|583034007|FG001|Overall Study|Withdrawal by Subject|0|||
161447808|NCT03110770|583034008|FG002|Overall Study|Withdrawal by Subject|0|||
161447809|NCT03110770|583034009|FG003|Overall Study|Withdrawal by Subject|24|||
161447810|NCT03110770|583034010|FG004|Overall Study|Withdrawal by Subject|24|||
161447811|NCT03110770|583034006|FG000|Overall Study|Moved from area|5|||
161447812|NCT03110770|583034007|FG001|Overall Study|Moved from area|0|||
161447813|NCT03110770|583034008|FG002|Overall Study|Moved from area|2|||
161447814|NCT03110770|583034009|FG003|Overall Study|Moved from area|42|||
161447815|NCT03110770|583034010|FG004|Overall Study|Moved from area|43|||
161447816|NCT03110770|583034006|FG000|Overall Study|Illness/Injury unrelated to product|0|||
161447817|NCT03110770|583034007|FG001|Overall Study|Illness/Injury unrelated to product|0|||
161447818|NCT03110770|583034008|FG002|Overall Study|Illness/Injury unrelated to product|0|||
161447819|NCT03110770|583034009|FG003|Overall Study|Illness/Injury unrelated to product|0|||
161447820|NCT03110770|583034010|FG004|Overall Study|Illness/Injury unrelated to product|1|||
161447821|NCT01086358|583034013|FG000|First Intervention|Lost to Follow-up|9|||
161447822|NCT01086358|583034014|FG001|First Intervention|Lost to Follow-up|4|||
161447823|NCT01086358|583034013|FG000|First Intervention|Withdrawal by Subject|0|||
161447824|NCT01086358|583034014|FG001|First Intervention|Withdrawal by Subject|1|||
161447825|NCT01086358|583034013|FG000|Second Intervention|Lost to Follow-up|4|||
161447826|NCT01086358|583034014|FG001|Second Intervention|Lost to Follow-up|4|||
161447827|NCT02888119|583034017|FG000|Overall Study|Lost to Follow-up|5|||
161447828|NCT02888119|583034018|FG001|Overall Study|Lost to Follow-up|4|||
161447829|NCT02888119|583034019|FG002|Overall Study|Lost to Follow-up|0|||
161447830|NCT03330002|583034023|FG000|Overall Study|Lost to Follow-up|15|||
161447831|NCT03330002|583034023|FG000|Overall Study|Death|7|||
161447832|NCT00833417|583034024|FG000|Overall Study|Adverse Event|5|||
161447833|NCT00833417|583034025|FG001|Overall Study|Adverse Event|16|||
161447834|NCT00833417|583034024|FG000|Overall Study|Death|1|||
161447835|NCT00833417|583034025|FG001|Overall Study|Death|3|||
161447836|NCT00833417|583034024|FG000|Overall Study|Lost to Follow-up|1|||
161447837|NCT00833417|583034025|FG001|Overall Study|Lost to Follow-up|2|||
161447838|NCT00833417|583034024|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
161447839|NCT00833417|583034025|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
161447840|NCT00833417|583034024|FG000|Overall Study|Patient Decision to Withdraw|4|||
161447841|NCT00833417|583034025|FG001|Overall Study|Patient Decision to Withdraw|23|||
161447842|NCT00833417|583034024|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
161447843|NCT00833417|583034025|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
161447844|NCT00833417|583034024|FG000|Overall Study|Disease Progression|18|||
161447845|NCT00833417|583034025|FG001|Overall Study|Disease Progression|17|||
161447846|NCT00833417|583034024|FG000|Overall Study|Reason Not Specified|0|||
161447847|NCT00833417|583034025|FG001|Overall Study|Reason Not Specified|1|||
161447848|NCT01625260|583034026|FG000|Overall Study|Adverse Event|3|||
161447849|NCT01625260|583034027|FG001|Overall Study|Adverse Event|0|||
161447850|NCT01625260|583034026|FG000|Overall Study|Study Terminated by Investigator|2|||
161447851|NCT01625260|583034027|FG001|Overall Study|Study Terminated by Investigator|0|||
161447852|NCT01625260|583034026|FG000|Overall Study|Disease Progression|2|||
161447853|NCT01625260|583034027|FG001|Overall Study|Disease Progression|0|||
161447854|NCT01625260|583034026|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
161552513|NCT01233609|583410486|FG000|Overall Study|Lost to Follow-up|3|||
161552514|NCT01233609|583410487|FG001|Overall Study|Lost to Follow-up|1|||
161552515|NCT01233609|583410486|FG000|Overall Study|Adverse Event|2|||
161552516|NCT01233609|583410487|FG001|Overall Study|Adverse Event|1|||
161552517|NCT01233609|583410486|FG000|Overall Study|Withdrawal by Subject|3|||
161552518|NCT01233609|583410487|FG001|Overall Study|Withdrawal by Subject|0|||
161552519|NCT00735644|583410488|FG000|Overall Study|Did not receive study vaccine|0|||
161552520|NCT00735644|583410489|FG001|Overall Study|Did not receive study vaccine|1|||
161552521|NCT00735644|583410490|FG002|Overall Study|Did not receive study vaccine|0|||
161552522|NCT00735644|583410491|FG003|Overall Study|Did not receive study vaccine|0|||
161552523|NCT00735644|583410492|FG004|Overall Study|Did not receive study vaccine|0|||
161552524|NCT00735644|583410488|FG000|Overall Study|Withdrawal by Subject|0|||
161552525|NCT00735644|583410489|FG001|Overall Study|Withdrawal by Subject|1|||
161552526|NCT00735644|583410490|FG002|Overall Study|Withdrawal by Subject|1|||
161552527|NCT00735644|583410491|FG003|Overall Study|Withdrawal by Subject|1|||
161552528|NCT00735644|583410492|FG004|Overall Study|Withdrawal by Subject|0|||
161552529|NCT01040780|583411720|FG000|Overall Study|Protocol Violation|1|||
161552530|NCT01040780|583411721|FG001|Overall Study|Protocol Violation|3|||
161552531|NCT03681639|583411722|FG000|Overall Study|Death|4|||
161552532|NCT03681639|583411722|FG000|Overall Study|Lost to Follow-up|2|||
161552533|NCT03681639|583411722|FG000|Overall Study|Withdrawal by Subject|1|||
161552534|NCT03681639|583411722|FG000|Overall Study|Adverse Event|2|||
161552535|NCT00654940|583411723|FG000|Period 1|Adverse Event|0|||
161552536|NCT00654940|583411724|FG001|Period 1|Adverse Event|1|||
161552537|NCT00654940|583411723|FG000|Period 1|Intolerable Pain Level|1|||
161552538|NCT00654940|583411724|FG001|Period 1|Intolerable Pain Level|0|||
161552539|NCT00581113|583411730|FG000|Overall Study|Withdrawal by Subject|0|||
161552540|NCT00581113|583411731|FG001|Overall Study|Withdrawal by Subject|1|||
161552541|NCT01818141|583411732|FG000|Overall Study|Withdrawal by Subject|2|||
161795678|NCT00859469|584295025|FG000|Overall Study|Withdrawal by Subject|1|||
161795679|NCT00859469|584295025|FG000|Overall Study|Death|16|||
161795680|NCT04071769|584295026|FG000|Overall Study|Lost to Follow-up|3|||
161795681|NCT04071769|584295026|FG000|Overall Study|Physician Decision|2|||
161795682|NCT04071769|584295026|FG000|Overall Study|Withdrawal by Subject|8|||
161795683|NCT01890707|584295027|FG000|Overall Study|Lost to Follow-up|1|||
161795684|NCT01890707|584295028|FG001|Overall Study|Lost to Follow-up|1|||
161795685|NCT00669955|584295029|FG000|Overall Study|Adverse Event|3|||
161795686|NCT00669955|584295030|FG001|Overall Study|Adverse Event|5|||
161795687|NCT00669955|584295029|FG000|Overall Study|Death|0|||
161795688|NCT00669955|584295030|FG001|Overall Study|Death|1|||
161795689|NCT00669955|584295029|FG000|Overall Study|Withdrawal by Subject|2|||
161795690|NCT00669955|584295030|FG001|Overall Study|Withdrawal by Subject|3|||
161795691|NCT00669955|584295029|FG000|Overall Study|Lost to Follow-up|5|||
161795692|NCT00669955|584295030|FG001|Overall Study|Lost to Follow-up|7|||
161795693|NCT00669955|584295029|FG000|Overall Study|Protocol Violation|2|||
161795694|NCT00669955|584295030|FG001|Overall Study|Protocol Violation|7|||
161795695|NCT00669955|584295029|FG000|Overall Study|Investigator Sponsor Judgement|0|||
161795696|NCT00669955|584295030|FG001|Overall Study|Investigator Sponsor Judgement|1|||
161795697|NCT00669955|584295029|FG000|Overall Study|not compliant with study drug/visit|2|||
161795698|NCT00669955|584295030|FG001|Overall Study|not compliant with study drug/visit|3|||
161795699|NCT04820842|584296374|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795700|NCT04820842|584296375|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
161795701|NCT04820842|584296376|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
161795702|NCT04820842|584296377|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795703|NCT04820842|584296378|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795704|NCT04820842|584296379|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795705|NCT04820842|584296380|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795706|NCT04820842|584296374|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
161795707|NCT04820842|584296375|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
161795708|NCT04820842|584296376|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
161795709|NCT04820842|584296377|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161552542|NCT01818141|583411733|FG001|Overall Study|Withdrawal by Subject|0|||
161552543|NCT01818141|583411732|FG000|Overall Study|No baseline C.diff colonies|1|||
161552544|NCT01818141|583411733|FG001|Overall Study|No baseline C.diff colonies|1|||
161552545|NCT01818141|583411732|FG000|Overall Study|Lost to Follow-up|0|||
161552546|NCT01818141|583411733|FG001|Overall Study|Lost to Follow-up|2|||
161552547|NCT04834362|583411736|FG000|Overall Study|Death|1|||
161552548|NCT04834362|583411737|FG001|Overall Study|Death|2|||
161552549|NCT00329719|583411740|FG000|Overall Study|Lost to Follow-up|0|||
161552550|NCT00329719|583411741|FG001|Overall Study|Lost to Follow-up|0|||
161831515|NCT03135899|584424798|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
161831516|NCT03135899|584424799|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831517|NCT03135899|584424792|FG000|Overall Study|Withdrawal by Subject|0|||
161552551|NCT00329719|583411742|FG002|Overall Study|Lost to Follow-up|0|||
161552552|NCT00329719|583411743|FG003|Overall Study|Lost to Follow-up|1|||
161552553|NCT01668147|583411746|FG000|Overall Study|Withdrawal by Subject|6|||
161552554|NCT01809210|583411747|FG000|Overall Study|Withdrawal by Subject|0|||
161552555|NCT01809210|583411748|FG001|Overall Study|Withdrawal by Subject|0|||
161795710|NCT04820842|584296378|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795711|NCT04820842|584296379|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795712|NCT04820842|584296380|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795713|NCT04820842|584296374|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795714|NCT04820842|584296375|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
161795715|NCT04820842|584296376|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795716|NCT04820842|584296377|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795717|NCT04820842|584296378|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795718|NCT04820842|584296379|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795719|NCT04820842|584296380|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795720|NCT04820842|584296374|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795721|NCT04820842|584296375|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795722|NCT04820842|584296376|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795723|NCT04820842|584296377|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
161795724|NCT04820842|584296378|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795725|NCT04820842|584296379|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795726|NCT04820842|584296380|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
161795727|NCT01691508|584296381|FG000|Overall Study|Adverse Event|3|||
161795728|NCT01691508|584296382|FG001|Overall Study|Adverse Event|3|||
161795729|NCT01691508|584296381|FG000|Overall Study|Withdrawal by Subject|1|||
161795730|NCT01691508|584296382|FG001|Overall Study|Withdrawal by Subject|0|||
161795731|NCT01296932|584296383|FG000|Overall Study|Dose limiting toxicity|0|||
161795732|NCT01296932|584296384|FG001|Overall Study|Dose limiting toxicity|0|||
161795733|NCT01296932|584296385|FG002|Overall Study|Dose limiting toxicity|0|||
161795734|NCT01296932|584296386|FG003|Overall Study|Dose limiting toxicity|0|||
161795735|NCT01296932|584296387|FG004|Overall Study|Dose limiting toxicity|0|||
161795736|NCT01296932|584296388|FG005|Overall Study|Dose limiting toxicity|0|||
161795737|NCT01296932|584296389|FG006|Overall Study|Dose limiting toxicity|1|||
161795738|NCT01296932|584296390|FG007|Overall Study|Dose limiting toxicity|0|||
161795739|NCT01296932|584296391|FG008|Overall Study|Dose limiting toxicity|1|||
161795740|NCT01296932|584296383|FG000|Overall Study|Progressive disease|2|||
161795741|NCT01296932|584296384|FG001|Overall Study|Progressive disease|0|||
161795742|NCT01296932|584296385|FG002|Overall Study|Progressive disease|1|||
161795743|NCT01296932|584296386|FG003|Overall Study|Progressive disease|1|||
161795744|NCT01296932|584296387|FG004|Overall Study|Progressive disease|2|||
161795745|NCT01296932|584296388|FG005|Overall Study|Progressive disease|3|||
161795746|NCT01296932|584296389|FG006|Overall Study|Progressive disease|1|||
161795747|NCT01296932|584296390|FG007|Overall Study|Progressive disease|0|||
161795748|NCT01296932|584296391|FG008|Overall Study|Progressive disease|0|||
161795749|NCT01296932|584296383|FG000|Overall Study|Withdrawal by Subject|0|||
161795750|NCT01296932|584296384|FG001|Overall Study|Withdrawal by Subject|0|||
161795751|NCT01296932|584296385|FG002|Overall Study|Withdrawal by Subject|1|||
161795752|NCT01296932|584296386|FG003|Overall Study|Withdrawal by Subject|1|||
161795753|NCT01296932|584296387|FG004|Overall Study|Withdrawal by Subject|0|||
161795754|NCT01296932|584296388|FG005|Overall Study|Withdrawal by Subject|0|||
161795755|NCT01296932|584296389|FG006|Overall Study|Withdrawal by Subject|3|||
161795756|NCT01296932|584296390|FG007|Overall Study|Withdrawal by Subject|0|||
161795757|NCT01296932|584296391|FG008|Overall Study|Withdrawal by Subject|0|||
161795758|NCT01296932|584296383|FG000|Overall Study|Adverse Event|1|||
161795759|NCT01296932|584296384|FG001|Overall Study|Adverse Event|1|||
161795760|NCT01296932|584296385|FG002|Overall Study|Adverse Event|1|||
161795761|NCT01296932|584296386|FG003|Overall Study|Adverse Event|2|||
161795762|NCT01296932|584296387|FG004|Overall Study|Adverse Event|1|||
161795763|NCT01296932|584296388|FG005|Overall Study|Adverse Event|0|||
161795764|NCT01296932|584296389|FG006|Overall Study|Adverse Event|0|||
161795765|NCT01296932|584296390|FG007|Overall Study|Adverse Event|0|||
161795766|NCT01296932|584296391|FG008|Overall Study|Adverse Event|1|||
161795767|NCT01296932|584296383|FG000|Overall Study|Investigator decision|0|||
161795768|NCT01296932|584296384|FG001|Overall Study|Investigator decision|1|||
161552556|NCT01809210|583411749|FG002|Overall Study|Withdrawal by Subject|1|||
161552557|NCT01809210|583411750|FG003|Overall Study|Withdrawal by Subject|1|||
161552558|NCT01809210|583411751|FG004|Overall Study|Withdrawal by Subject|1|||
161795769|NCT01296932|584296385|FG002|Overall Study|Investigator decision|0|||
161795770|NCT01296932|584296386|FG003|Overall Study|Investigator decision|1|||
161795771|NCT01296932|584296387|FG004|Overall Study|Investigator decision|0|||
161795772|NCT01296932|584296388|FG005|Overall Study|Investigator decision|0|||
161795773|NCT01296932|584296389|FG006|Overall Study|Investigator decision|1|||
161795774|NCT01296932|584296390|FG007|Overall Study|Investigator decision|0|||
161795775|NCT01296932|584296391|FG008|Overall Study|Investigator decision|1|||
161795776|NCT01296932|584296383|FG000|Overall Study|No clinical benefit anymore|0|||
161795777|NCT01296932|584296384|FG001|Overall Study|No clinical benefit anymore|1|||
161795778|NCT01296932|584296385|FG002|Overall Study|No clinical benefit anymore|0|||
161795779|NCT01296932|584296386|FG003|Overall Study|No clinical benefit anymore|0|||
161795780|NCT01296932|584296387|FG004|Overall Study|No clinical benefit anymore|0|||
161795781|NCT01296932|584296388|FG005|Overall Study|No clinical benefit anymore|0|||
161795782|NCT01296932|584296389|FG006|Overall Study|No clinical benefit anymore|0|||
161795783|NCT01296932|584296390|FG007|Overall Study|No clinical benefit anymore|0|||
161795784|NCT01296932|584296391|FG008|Overall Study|No clinical benefit anymore|0|||
161795785|NCT01296932|584296383|FG000|Overall Study|Physician Decision|0|||
161795786|NCT01296932|584296384|FG001|Overall Study|Physician Decision|0|||
161795787|NCT01296932|584296385|FG002|Overall Study|Physician Decision|1|||
161795788|NCT01296932|584296386|FG003|Overall Study|Physician Decision|0|||
161795789|NCT01296932|584296387|FG004|Overall Study|Physician Decision|0|||
161795790|NCT01296932|584296388|FG005|Overall Study|Physician Decision|0|||
161795791|NCT01296932|584296389|FG006|Overall Study|Physician Decision|0|||
161795792|NCT01296932|584296390|FG007|Overall Study|Physician Decision|0|||
161795793|NCT01296932|584296391|FG008|Overall Study|Physician Decision|0|||
161795794|NCT01296932|584296383|FG000|Overall Study|IV problems, administration not possible|0|||
161795795|NCT01296932|584296384|FG001|Overall Study|IV problems, administration not possible|0|||
161795796|NCT01296932|584296385|FG002|Overall Study|IV problems, administration not possible|1|||
161447855|NCT01625260|583034027|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
161447856|NCT05573386|583034028|FG000|Overall Study|Withdrawal by Subject|3|||
161447857|NCT05573386|583034029|FG001|Overall Study|Withdrawal by Subject|2|||
161447858|NCT01776307|583034035|FG000|Overall Study|Not dosed|0|||
161447859|NCT01776307|583034036|FG001|Overall Study|Not dosed|0|||
161447860|NCT01776307|583034037|FG002|Overall Study|Not dosed|1|||
161447861|NCT02745145|583034043|FG000|Overall Study|Adverse Event|1|||
161447862|NCT02745145|583034044|FG001|Overall Study|Adverse Event|0|||
161447863|NCT02745145|583034045|FG002|Overall Study|Adverse Event|0|||
161447864|NCT02745145|583034043|FG000|Overall Study|Death|0|||
161447865|NCT02745145|583034044|FG001|Overall Study|Death|1|||
161447866|NCT02745145|583034045|FG002|Overall Study|Death|0|||
161447867|NCT02745145|583034043|FG000|Overall Study|Progressive disease|0|||
161447868|NCT02745145|583034044|FG001|Overall Study|Progressive disease|0|||
161447869|NCT02745145|583034045|FG002|Overall Study|Progressive disease|1|||
161447870|NCT02745145|583034043|FG000|Overall Study|Withdrew consent|1|||
161447871|NCT02745145|583034044|FG001|Overall Study|Withdrew consent|1|||
161447872|NCT02745145|583034045|FG002|Overall Study|Withdrew consent|1|||
161447873|NCT02745145|583034043|FG000|Overall Study|Study Termination|8|||
161447874|NCT02745145|583034044|FG001|Overall Study|Study Termination|3|||
161447875|NCT02745145|583034045|FG002|Overall Study|Study Termination|7|||
161447876|NCT01297491|583034054|FG000|Overall Study|Adverse Event|11|||
161447877|NCT01297491|583034055|FG001|Overall Study|Adverse Event|6|||
161447878|NCT01297491|583034054|FG000|Overall Study|Physician Decision|3|||
161447879|NCT01297491|583034055|FG001|Overall Study|Physician Decision|2|||
161447880|NCT01297491|583034054|FG000|Overall Study|Progressive disease|11|||
161447881|NCT01297491|583034055|FG001|Overall Study|Progressive disease|20|||
161447882|NCT01297491|583034054|FG000|Overall Study|Patient/Guardian decision|3|||
161447883|NCT01297491|583034055|FG001|Overall Study|Patient/Guardian decision|4|||
161447884|NCT01297491|583034054|FG000|Overall Study|Death|2|||
161447885|NCT01297491|583034055|FG001|Overall Study|Death|1|||
161447886|NCT03530124|583034067|FG000|Overall Study|Withdrawal by Subject|0|||
161447887|NCT03530124|583034068|FG001|Overall Study|Withdrawal by Subject|1|||
161447888|NCT03530124|583034067|FG000|Overall Study|Protocol Violation|1|||
161447889|NCT03530124|583034068|FG001|Overall Study|Protocol Violation|0|||
161447890|NCT03530124|583034067|FG000|Overall Study|Discharged prior to study completion|1|||
161447891|NCT03530124|583034068|FG001|Overall Study|Discharged prior to study completion|0|||
161447892|NCT00862082|583034069|FG000|Overall Study|Sponsor decision to terminate the study|5|||
161447893|NCT00862082|583034070|FG001|Overall Study|Sponsor decision to terminate the study|0|||
161447894|NCT00862082|583034069|FG000|Overall Study|Withdrawal by Subject|0|||
161447895|NCT00862082|583034070|FG001|Overall Study|Withdrawal by Subject|1|||
161447896|NCT00947882|583034071|FG000|Overall Study|Adverse Event|0|||
161447897|NCT00947882|583034072|FG001|Overall Study|Adverse Event|1|||
161447898|NCT00947882|583034073|FG002|Overall Study|Adverse Event|4|||
161795797|NCT01296932|584296386|FG003|Overall Study|IV problems, administration not possible|0|||
161795798|NCT01296932|584296387|FG004|Overall Study|IV problems, administration not possible|0|||
161795799|NCT01296932|584296388|FG005|Overall Study|IV problems, administration not possible|0|||
161795800|NCT01296932|584296389|FG006|Overall Study|IV problems, administration not possible|0|||
161447899|NCT00947882|583034074|FG003|Overall Study|Adverse Event|4|||
161552559|NCT01809210|583411752|FG005|Overall Study|Withdrawal by Subject|0|||
161552560|NCT01809210|583411753|FG006|Overall Study|Withdrawal by Subject|4|||
161552561|NCT01809210|583411747|FG000|Overall Study|Death|1|||
161900579|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
161900580|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161900581|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161900582|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900583|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900584|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
161900585|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900586|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900587|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
161900588|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
161900589|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
161900590|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
161447900|NCT00947882|583034071|FG000|Overall Study|Withdrawal by Subject|2|||
161447901|NCT00947882|583034072|FG001|Overall Study|Withdrawal by Subject|0|||
161447902|NCT00947882|583034073|FG002|Overall Study|Withdrawal by Subject|8|||
161447903|NCT00947882|583034074|FG003|Overall Study|Withdrawal by Subject|2|||
161447904|NCT00947882|583034071|FG000|Overall Study|Protocol Violation|0|||
161447905|NCT00947882|583034072|FG001|Overall Study|Protocol Violation|0|||
161447906|NCT00947882|583034073|FG002|Overall Study|Protocol Violation|1|||
161447907|NCT00947882|583034074|FG003|Overall Study|Protocol Violation|0|||
161447908|NCT00947882|583034071|FG000|Overall Study|Lost to Follow-up|0|||
161447909|NCT00947882|583034072|FG001|Overall Study|Lost to Follow-up|2|||
161447910|NCT00947882|583034073|FG002|Overall Study|Lost to Follow-up|1|||
161447911|NCT00947882|583034074|FG003|Overall Study|Lost to Follow-up|0|||
161447912|NCT00947882|583034071|FG000|Overall Study|Other/Unknown|10|||
161447913|NCT00947882|583034072|FG001|Overall Study|Other/Unknown|13|||
161447914|NCT00947882|583034073|FG002|Overall Study|Other/Unknown|3|||
161447915|NCT00947882|583034074|FG003|Overall Study|Other/Unknown|6|||
161447916|NCT00947882|583034071|FG000|Overall Study|Trial Terminated by Sponsor|62|||
161447917|NCT00947882|583034072|FG001|Overall Study|Trial Terminated by Sponsor|61|||
161447918|NCT00947882|583034073|FG002|Overall Study|Trial Terminated by Sponsor|62|||
161447919|NCT00947882|583034074|FG003|Overall Study|Trial Terminated by Sponsor|70|||
161447920|NCT02379637|583034075|FG000|Overall Study|Protocol Violation|0|||
161447921|NCT02379637|583034076|FG001|Overall Study|Protocol Violation|1|||
161447922|NCT02379637|583034075|FG000|Overall Study|Adverse Event|1|||
161447923|NCT02379637|583034076|FG001|Overall Study|Adverse Event|0|||
161447924|NCT02379637|583034075|FG000|Overall Study|Withdrawal by Subject|1|||
161447925|NCT02379637|583034076|FG001|Overall Study|Withdrawal by Subject|0|||
161447926|NCT02447302|583034077|FG000|Overall Study|Physician Decision|1|||
161447927|NCT02447302|583034078|FG001|Overall Study|Physician Decision|0|||
161447928|NCT02447302|583034079|FG002|Overall Study|Physician Decision|0|||
161447929|NCT02447302|583034077|FG000|Overall Study|Adverse Event|4|||
161447930|NCT02447302|583034078|FG001|Overall Study|Adverse Event|3|||
161447931|NCT02447302|583034079|FG002|Overall Study|Adverse Event|0|||
161447932|NCT02447302|583034077|FG000|Overall Study|Withdrawal by Subject|0|||
161447933|NCT02447302|583034078|FG001|Overall Study|Withdrawal by Subject|1|||
161447934|NCT02447302|583034079|FG002|Overall Study|Withdrawal by Subject|5|||
161447935|NCT02447302|583034077|FG000|Overall Study|Sponsor Decision|0|||
161447936|NCT02447302|583034078|FG001|Overall Study|Sponsor Decision|0|||
161447937|NCT02447302|583034079|FG002|Overall Study|Sponsor Decision|1|||
161447938|NCT01742286|583034089|FG000|Escalation Phase|Administrative problems|1|||
161447939|NCT01742286|583034090|FG001|Escalation Phase|Administrative problems|1|||
161447940|NCT01742286|583034091|FG002|Escalation Phase|Administrative problems|0|||
161447941|NCT01742286|583034092|FG003|Escalation Phase|Administrative problems|0|||
161447942|NCT01742286|583034093|FG004|Escalation Phase|Administrative problems|0|||
161447943|NCT01742286|583034094|FG005|Escalation Phase|Administrative problems|0|||
161447944|NCT01742286|583034095|FG006|Escalation Phase|Administrative problems|2|||
161447945|NCT01742286|583034089|FG000|Escalation Phase|Adverse Event|0|||
161447946|NCT01742286|583034090|FG001|Escalation Phase|Adverse Event|1|||
161900591|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
161447947|NCT01742286|583034091|FG002|Escalation Phase|Adverse Event|2|||
161447948|NCT01742286|583034092|FG003|Escalation Phase|Adverse Event|0|||
161447949|NCT01742286|583034093|FG004|Escalation Phase|Adverse Event|0|||
161447950|NCT01742286|583034094|FG005|Escalation Phase|Adverse Event|1|||
161447951|NCT01742286|583034095|FG006|Escalation Phase|Adverse Event|0|||
161447952|NCT01742286|583034089|FG000|Escalation Phase|Disease progression|3|||
161447953|NCT01742286|583034090|FG001|Escalation Phase|Disease progression|7|||
161900592|NCT03134911|584683079|FG000|Overall Study|Screen failure|31|||
161447954|NCT01742286|583034091|FG002|Escalation Phase|Disease progression|4|||
161447955|NCT01742286|583034092|FG003|Escalation Phase|Disease progression|1|||
161447956|NCT01742286|583034093|FG004|Escalation Phase|Disease progression|4|||
161447957|NCT01742286|583034094|FG005|Escalation Phase|Disease progression|3|||
161447958|NCT01742286|583034095|FG006|Escalation Phase|Disease progression|2|||
161552562|NCT01809210|583411748|FG001|Overall Study|Death|1|||
161552563|NCT01809210|583411749|FG002|Overall Study|Death|2|||
161552564|NCT01809210|583411750|FG003|Overall Study|Death|0|||
161552565|NCT01809210|583411751|FG004|Overall Study|Death|1|||
161552566|NCT01809210|583411752|FG005|Overall Study|Death|3|||
161552567|NCT01809210|583411753|FG006|Overall Study|Death|1|||
161552568|NCT00224133|583411756|FG000|Overall Study|Adverse Event|93|||
161552569|NCT00224133|583411756|FG000|Overall Study|Protocol Violation|6|||
161552570|NCT00224133|583411756|FG000|Overall Study|Withdrawal by Subject|33|||
161552571|NCT00224133|583411756|FG000|Overall Study|Lack of Efficacy|58|||
161552572|NCT00224133|583411756|FG000|Overall Study|Lost to Follow-up|21|||
161552573|NCT00224133|583411756|FG000|Overall Study|Physician Decision|1|||
161552574|NCT00224133|583411756|FG000|Overall Study|Other|14|||
161552575|NCT01238575|583411760|FG000|Overall Study|Lack of Efficacy|2|||
161552576|NCT01238575|583411761|FG001|Overall Study|Lack of Efficacy|4|||
161552577|NCT01238575|583411760|FG000|Overall Study|Adverse Event|2|||
161552578|NCT01238575|583411761|FG001|Overall Study|Adverse Event|0|||
161552579|NCT00593554|583411763|FG000|Overall Study|Death|1|||
161552580|NCT00593554|583411764|FG001|Overall Study|Death|2|||
161552581|NCT00593554|583411763|FG000|Overall Study|Physician Decision|0|||
161552582|NCT00593554|583411764|FG001|Overall Study|Physician Decision|1|||
161552583|NCT00593554|583411763|FG000|Overall Study|Withdrawal by Subject|1|||
161552584|NCT00593554|583411764|FG001|Overall Study|Withdrawal by Subject|0|||
161552585|NCT00593554|583411763|FG000|Overall Study|Disease Progression|1|||
161552586|NCT00593554|583411764|FG001|Overall Study|Disease Progression|2|||
161552587|NCT00795132|583411767|FG000|Overall Study|Death|1|||
161795801|NCT01296932|584296390|FG007|Overall Study|IV problems, administration not possible|0|||
161795802|NCT01296932|584296391|FG008|Overall Study|IV problems, administration not possible|0|||
161795803|NCT01296932|584296383|FG000|Overall Study|per protocol|0|||
161795804|NCT01296932|584296384|FG001|Overall Study|per protocol|0|||
161447959|NCT01742286|583034089|FG000|Escalation Phase|Death|0|||
161447960|NCT01742286|583034090|FG001|Escalation Phase|Death|0|||
161447961|NCT01742286|583034091|FG002|Escalation Phase|Death|0|||
161447962|NCT01742286|583034092|FG003|Escalation Phase|Death|0|||
161447963|NCT01742286|583034093|FG004|Escalation Phase|Death|0|||
161447964|NCT01742286|583034094|FG005|Escalation Phase|Death|1|||
161447965|NCT01742286|583034095|FG006|Escalation Phase|Death|0|||
161447966|NCT01742286|583034089|FG000|Escalation Phase|Physician Decision|0|||
161447967|NCT01742286|583034090|FG001|Escalation Phase|Physician Decision|3|||
161447968|NCT01742286|583034091|FG002|Escalation Phase|Physician Decision|0|||
161447969|NCT01742286|583034092|FG003|Escalation Phase|Physician Decision|1|||
161447970|NCT01742286|583034093|FG004|Escalation Phase|Physician Decision|0|||
161447971|NCT01742286|583034094|FG005|Escalation Phase|Physician Decision|0|||
161447972|NCT01742286|583034095|FG006|Escalation Phase|Physician Decision|2|||
161447973|NCT01742286|583034089|FG000|Escalation Phase|Subject/guardian decision|1|||
161447974|NCT01742286|583034090|FG001|Escalation Phase|Subject/guardian decision|0|||
161447975|NCT01742286|583034091|FG002|Escalation Phase|Subject/guardian decision|0|||
161447976|NCT01742286|583034092|FG003|Escalation Phase|Subject/guardian decision|0|||
161447977|NCT01742286|583034093|FG004|Escalation Phase|Subject/guardian decision|0|||
161447978|NCT01742286|583034094|FG005|Escalation Phase|Subject/guardian decision|0|||
161447979|NCT01742286|583034095|FG006|Escalation Phase|Subject/guardian decision|0|||
161447980|NCT01742286|583034089|FG000|Expansion Phase|Administrative problems|0|||
161795805|NCT01296932|584296385|FG002|Overall Study|per protocol|1|||
161795806|NCT01296932|584296386|FG003|Overall Study|per protocol|1|||
161795807|NCT01296932|584296387|FG004|Overall Study|per protocol|0|||
161795808|NCT01296932|584296388|FG005|Overall Study|per protocol|0|||
161795809|NCT01296932|584296389|FG006|Overall Study|per protocol|0|||
161795810|NCT01296932|584296390|FG007|Overall Study|per protocol|0|||
161795811|NCT01296932|584296391|FG008|Overall Study|per protocol|0|||
161795812|NCT01296932|584296383|FG000|Overall Study|Low benefit and too many side effects|0|||
161447981|NCT01742286|583034090|FG001|Expansion Phase|Administrative problems|0|||
161447982|NCT01742286|583034091|FG002|Expansion Phase|Administrative problems|0|||
161447983|NCT01742286|583034092|FG003|Expansion Phase|Administrative problems|0|||
161447984|NCT01742286|583034093|FG004|Expansion Phase|Administrative problems|0|||
161447985|NCT01742286|583034094|FG005|Expansion Phase|Administrative problems|0|||
161447986|NCT01742286|583034095|FG006|Expansion Phase|Administrative problems|5|||
161447987|NCT01742286|583034089|FG000|Expansion Phase|Physician Decision|0|||
161447988|NCT01742286|583034090|FG001|Expansion Phase|Physician Decision|0|||
161447989|NCT01742286|583034091|FG002|Expansion Phase|Physician Decision|4|||
161447990|NCT01742286|583034092|FG003|Expansion Phase|Physician Decision|0|||
161447991|NCT01742286|583034093|FG004|Expansion Phase|Physician Decision|0|||
161447992|NCT01742286|583034094|FG005|Expansion Phase|Physician Decision|0|||
161447993|NCT01742286|583034095|FG006|Expansion Phase|Physician Decision|9|||
161447994|NCT01742286|583034089|FG000|Expansion Phase|Adverse Event|0|||
161552588|NCT00795132|583411767|FG000|Overall Study|Relapse|2|||
161552589|NCT00358150|583411772|FG000|Overall Study|Adverse Event|3|||
161552590|NCT00358150|583411772|FG000|Overall Study|Withdrawal by Subject|1|||
161552591|NCT00358150|583411772|FG000|Overall Study|Undefined|3|||
161795813|NCT01296932|584296384|FG001|Overall Study|Low benefit and too many side effects|0|||
161447995|NCT01742286|583034090|FG001|Expansion Phase|Adverse Event|0|||
161447996|NCT01742286|583034091|FG002|Expansion Phase|Adverse Event|0|||
161447997|NCT01742286|583034092|FG003|Expansion Phase|Adverse Event|0|||
161447998|NCT01742286|583034093|FG004|Expansion Phase|Adverse Event|0|||
161447999|NCT01742286|583034094|FG005|Expansion Phase|Adverse Event|0|||
161448000|NCT01742286|583034095|FG006|Expansion Phase|Adverse Event|6|||
161448001|NCT01742286|583034089|FG000|Expansion Phase|Disease progression|0|||
161448002|NCT01742286|583034090|FG001|Expansion Phase|Disease progression|0|||
161448003|NCT01742286|583034091|FG002|Expansion Phase|Disease progression|3|||
161448004|NCT01742286|583034092|FG003|Expansion Phase|Disease progression|0|||
161448005|NCT01742286|583034093|FG004|Expansion Phase|Disease progression|0|||
161448006|NCT01742286|583034094|FG005|Expansion Phase|Disease progression|0|||
161448007|NCT01742286|583034095|FG006|Expansion Phase|Disease progression|15|||
161448008|NCT01742286|583034089|FG000|Expansion Phase|Withdrawal by Subject|0|||
161448009|NCT01742286|583034090|FG001|Expansion Phase|Withdrawal by Subject|0|||
161448010|NCT01742286|583034091|FG002|Expansion Phase|Withdrawal by Subject|0|||
161448011|NCT01742286|583034092|FG003|Expansion Phase|Withdrawal by Subject|0|||
161448012|NCT01742286|583034093|FG004|Expansion Phase|Withdrawal by Subject|0|||
161448013|NCT01742286|583034094|FG005|Expansion Phase|Withdrawal by Subject|0|||
161448014|NCT01742286|583034095|FG006|Expansion Phase|Withdrawal by Subject|1|||
161448015|NCT01233232|583034096|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
161448016|NCT01233232|583034097|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
161448017|NCT01233232|583034098|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
161448018|NCT00843284|583037291|FG000|Overall Study|Adverse Event|39|||
161448019|NCT00843284|583037291|FG000|Overall Study|Lack of Efficacy|5|||
161448020|NCT00843284|583037291|FG000|Overall Study|Lost to Follow-up|11|||
161448021|NCT00843284|583037291|FG000|Overall Study|Other|10|||
161448022|NCT00843284|583037291|FG000|Overall Study|Withdrawal by Subject|4|||
161448023|NCT00843284|583037291|FG000|Overall Study|Death|3|||
161448024|NCT01794338|583037294|FG000|Overall Study|Death|2|||
161448025|NCT01794338|583037295|FG001|Overall Study|Death|0|||
161448026|NCT01794338|583037294|FG000|Overall Study|Lost to Follow-up|6|||
161448027|NCT01794338|583037295|FG001|Overall Study|Lost to Follow-up|9|||
161448028|NCT01282463|583037296|FG000|Overall Study|Lost to Follow-up|1|||
161448029|NCT01282463|583037297|FG001|Overall Study|Lost to Follow-up|0|||
161448030|NCT01282463|583037298|FG002|Overall Study|Lost to Follow-up|0|||
161448031|NCT01282463|583037296|FG000|Overall Study|Withdrawal by Subject|6|||
161448032|NCT01282463|583037297|FG001|Overall Study|Withdrawal by Subject|2|||
161448033|NCT01282463|583037298|FG002|Overall Study|Withdrawal by Subject|3|||
161795814|NCT01296932|584296385|FG002|Overall Study|Low benefit and too many side effects|0|||
161795815|NCT01296932|584296386|FG003|Overall Study|Low benefit and too many side effects|0|||
161795816|NCT01296932|584296387|FG004|Overall Study|Low benefit and too many side effects|0|||
161795817|NCT01296932|584296388|FG005|Overall Study|Low benefit and too many side effects|0|||
161795818|NCT01296932|584296389|FG006|Overall Study|Low benefit and too many side effects|0|||
161795819|NCT01296932|584296390|FG007|Overall Study|Low benefit and too many side effects|1|||
161795820|NCT01296932|584296391|FG008|Overall Study|Low benefit and too many side effects|0|||
161795821|NCT01296932|584296383|FG000|Overall Study|No adequate treatment response|0|||
161795822|NCT01296932|584296384|FG001|Overall Study|No adequate treatment response|0|||
161795823|NCT01296932|584296385|FG002|Overall Study|No adequate treatment response|0|||
161795824|NCT01296932|584296386|FG003|Overall Study|No adequate treatment response|0|||
161795825|NCT01296932|584296387|FG004|Overall Study|No adequate treatment response|0|||
161795826|NCT01296932|584296388|FG005|Overall Study|No adequate treatment response|0|||
161795827|NCT01296932|584296389|FG006|Overall Study|No adequate treatment response|0|||
161795828|NCT01296932|584296390|FG007|Overall Study|No adequate treatment response|1|||
161795829|NCT01296932|584296391|FG008|Overall Study|No adequate treatment response|0|||
161795830|NCT01296932|584296383|FG000|Overall Study|Dosage already reduced, AE still present|0|||
161795831|NCT01296932|584296384|FG001|Overall Study|Dosage already reduced, AE still present|0|||
161795832|NCT01296932|584296385|FG002|Overall Study|Dosage already reduced, AE still present|0|||
161795833|NCT01296932|584296386|FG003|Overall Study|Dosage already reduced, AE still present|0|||
161795834|NCT01296932|584296387|FG004|Overall Study|Dosage already reduced, AE still present|0|||
161795835|NCT01296932|584296388|FG005|Overall Study|Dosage already reduced, AE still present|0|||
161795836|NCT01296932|584296389|FG006|Overall Study|Dosage already reduced, AE still present|0|||
161795837|NCT01296932|584296390|FG007|Overall Study|Dosage already reduced, AE still present|0|||
161795838|NCT01296932|584296391|FG008|Overall Study|Dosage already reduced, AE still present|1|||
161795839|NCT02489318|584296394|FG000|Randomized|Withdrawal by Subject|0|||
161795840|NCT02489318|584296395|FG001|Randomized|Withdrawal by Subject|1|||
161795841|NCT02489318|584296394|FG000|Treated|Adverse Event|19|||
161795842|NCT02489318|584296395|FG001|Treated|Adverse Event|62|||
161795843|NCT02489318|584296394|FG000|Treated|Death|13|||
161795844|NCT02489318|584296395|FG001|Treated|Death|11|||
161795845|NCT02489318|584296394|FG000|Treated|Physician Decision|4|||
161448034|NCT01282463|583037296|FG000|Overall Study|"Never Treated Death"|0|||
161448035|NCT01282463|583037297|FG001|Overall Study|"Never Treated Death"|1|||
161448036|NCT01282463|583037298|FG002|Overall Study|"Never Treated Death"|0|||
161448037|NCT01282463|583037296|FG000|Overall Study|"Never Treated PD"|0|||
161448038|NCT01282463|583037297|FG001|Overall Study|"Never Treated PD"|1|||
161448039|NCT01282463|583037298|FG002|Overall Study|"Never Treated PD"|0|||
161448040|NCT01282463|583037296|FG000|Overall Study|Protocol Violation|0|||
161448041|NCT01282463|583037297|FG001|Overall Study|Protocol Violation|0|||
161448042|NCT01282463|583037298|FG002|Overall Study|Protocol Violation|1|||
161448043|NCT01282463|583037296|FG000|Overall Study|Physician Decision|1|||
161448044|NCT01282463|583037297|FG001|Overall Study|Physician Decision|0|||
161448045|NCT01282463|583037298|FG002|Overall Study|Physician Decision|0|||
161448046|NCT03320824|583037299|FG000|Overall Study|Withdrawal by Subject|8|||
161448047|NCT03320824|583037300|FG001|Overall Study|Withdrawal by Subject|1|||
161448048|NCT03320824|583037299|FG000|Overall Study|Lost to Follow-up|10|||
161448049|NCT03320824|583037300|FG001|Overall Study|Lost to Follow-up|1|||
161448050|NCT03320824|583037299|FG000|Overall Study|moved out of state|0|||
161448051|NCT03320824|583037300|FG001|Overall Study|moved out of state|1|||
161448052|NCT03320824|583037299|FG000|Overall Study|could not complete final visit|0|||
161448053|NCT03320824|583037300|FG001|Overall Study|could not complete final visit|1|||
161448054|NCT00955305|583037301|FG000|Overall Study|Disease progression|39|||
161448055|NCT00955305|583037302|FG001|Overall Study|Disease progression|41|||
161448056|NCT00955305|583037301|FG000|Overall Study|Adverse Event|22|||
161448057|NCT00955305|583037302|FG001|Overall Study|Adverse Event|22|||
161448058|NCT00955305|583037301|FG000|Overall Study|Death|2|||
161448059|NCT00955305|583037302|FG001|Overall Study|Death|1|||
161448060|NCT00955305|583037301|FG000|Overall Study|Withdrawal by Subject|5|||
161448061|NCT00955305|583037302|FG001|Overall Study|Withdrawal by Subject|4|||
161448062|NCT00955305|583037301|FG000|Overall Study|Alternative therapy|4|||
161448063|NCT00955305|583037302|FG001|Overall Study|Alternative therapy|0|||
161448064|NCT00955305|583037301|FG000|Overall Study|Other complicating disease|2|||
161448065|NCT00955305|583037302|FG001|Overall Study|Other complicating disease|4|||
161448066|NCT00955305|583037301|FG000|Overall Study|Physician Decision|1|||
161448067|NCT00955305|583037302|FG001|Overall Study|Physician Decision|0|||
161448068|NCT00955305|583037301|FG000|Overall Study|Continued presence of residual disease|0|||
161448069|NCT00955305|583037302|FG001|Overall Study|Continued presence of residual disease|1|||
161448070|NCT00955305|583037301|FG000|Overall Study|Functional decline|2|||
161448071|NCT00955305|583037302|FG001|Overall Study|Functional decline|0|||
161448072|NCT00955305|583037301|FG000|Overall Study|Maximum response achieved|0|||
161448073|NCT00955305|583037302|FG001|Overall Study|Maximum response achieved|1|||
161448074|NCT00955305|583037301|FG000|Overall Study|Lost to Follow-up|0|||
161448075|NCT00955305|583037302|FG001|Overall Study|Lost to Follow-up|1|||
161448076|NCT00955305|583037301|FG000|Overall Study|No off-treatment reason submitted|1|||
161448077|NCT00955305|583037302|FG001|Overall Study|No off-treatment reason submitted|0|||
161448078|NCT00955305|583037301|FG000|Overall Study|Never started protocol treatment|5|||
161448079|NCT00955305|583037302|FG001|Overall Study|Never started protocol treatment|5|||
161448080|NCT00955305|583037301|FG000|Overall Study|Ineligible|5|||
161448081|NCT00955305|583037302|FG001|Overall Study|Ineligible|7|||
161448082|NCT00109590|583037303|FG000|Overall Study|Lost to Follow-up|1|||
161448083|NCT00109590|583037304|FG001|Overall Study|Lost to Follow-up|0|||
161448084|NCT00109590|583037305|FG002|Overall Study|Lost to Follow-up|1|||
161448085|NCT00109590|583037303|FG000|Overall Study|Never Started Treatment|1|||
161448086|NCT00109590|583037304|FG001|Overall Study|Never Started Treatment|2|||
161448087|NCT00109590|583037305|FG002|Overall Study|Never Started Treatment|3|||
161448088|NCT01221285|583037306|FG000|Overall Study|Withdrawal by Subject|1|||
161448089|NCT00588861|583037307|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
161448090|NCT00588861|583037308|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
161448091|NCT00588861|583037307|FG000|6 Months|Patients did not return for follow-up|98|||
161448092|NCT00588861|583037308|FG001|6 Months|Patients did not return for follow-up|73|||
161448093|NCT00588861|583037307|FG000|1 Year|Patients did not return for follow-up|89|||
161448094|NCT00588861|583037308|FG001|1 Year|Patients did not return for follow-up|82|||
161448095|NCT00588861|583037307|FG000|2 Years|Patients did not return for follow-up|92|||
161448096|NCT00588861|583037308|FG001|2 Years|Patients did not return for follow-up|87|||
161448097|NCT00588861|583037307|FG000|4 Years|Patients did not return for follow-up|91|||
161448098|NCT00588861|583037308|FG001|4 Years|Patients did not return for follow-up|103|||
161448099|NCT00588861|583037307|FG000|6 Years|Patients did not return for follow-up|104|||
161795846|NCT02489318|584296395|FG001|Treated|Physician Decision|6|||
161795847|NCT02489318|584296394|FG000|Treated|Protocol Violation|1|||
161795848|NCT02489318|584296395|FG001|Treated|Protocol Violation|2|||
161795849|NCT02489318|584296394|FG000|Treated|Withdrawal by Subject|37|||
161795850|NCT02489318|584296395|FG001|Treated|Withdrawal by Subject|36|||
161795851|NCT02489318|584296394|FG000|Treated|Other: Progressive Disease|245|||
161448100|NCT00588861|583037308|FG001|6 Years|Patients did not return for follow-up|109|||
161448101|NCT00588861|583037307|FG000|8 Years|Patients did not return for follow-up|105|||
161448102|NCT00588861|583037308|FG001|8 Years|Patients did not return for follow-up|114|||
161795852|NCT02489318|584296395|FG001|Treated|Other: Progressive Disease|138|||
161795853|NCT02489318|584296394|FG000|Treated|Other|0|||
161795854|NCT02489318|584296395|FG001|Treated|Other|2|||
161795855|NCT02489318|584296394|FG000|Treated|Ongoing|0|||
161795856|NCT02489318|584296395|FG001|Treated|Ongoing|267|||
161795857|NCT02918162|584296399|FG000|Overall Study|Withdrawal by Subject|1|||
161795858|NCT02918162|584296399|FG000|Overall Study|Omental Disease|1|||
161795859|NCT00395226|584296400|FG000|Overall Study|Adverse Event|4|||
161795860|NCT00395226|584296401|FG001|Overall Study|Adverse Event|3|||
161795861|NCT00395226|584296400|FG000|Overall Study|Withdrawal by Subject|0|||
161795862|NCT00395226|584296401|FG001|Overall Study|Withdrawal by Subject|1|||
161795863|NCT00395226|584296400|FG000|Overall Study|Lost to Follow-up|0|||
161795864|NCT00395226|584296401|FG001|Overall Study|Lost to Follow-up|1|||
161795865|NCT02655237|584296404|FG000|Overall Study|Adverse Event|10|||
161795866|NCT02655237|584296405|FG001|Overall Study|Adverse Event|7|||
161795867|NCT02655237|584296404|FG000|Overall Study|Protocol Deviation|2|||
161795868|NCT02655237|584296405|FG001|Overall Study|Protocol Deviation|0|||
161795869|NCT02655237|584296404|FG000|Overall Study|Withdrawal by Participant|1|||
161795870|NCT02655237|584296405|FG001|Overall Study|Withdrawal by Participant|2|||
161900593|NCT03134911|584683079|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
161448103|NCT00588861|583037307|FG000|10 Years|Incomplete due to study termination|107|||
161448104|NCT00588861|583037308|FG001|10 Years|Incomplete due to study termination|114|||
161448105|NCT00490529|583037313|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
161448106|NCT00490529|583037313|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
161448107|NCT00490529|583037313|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
161448108|NCT00490529|583037313|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
161448109|NCT00490529|583037313|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
161448110|NCT00490529|583037313|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
161448111|NCT02617485|583037323|FG000|Treatment and Observation Period|Adverse Event|9|||
161448112|NCT02617485|583037324|FG001|Treatment and Observation Period|Adverse Event|1|||
161448113|NCT02617485|583037323|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
161448114|NCT02617485|583037324|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
161448115|NCT02617485|583037323|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
161448116|NCT02617485|583037324|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
161448117|NCT02617485|583037323|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
161795871|NCT02655237|584296404|FG000|Overall Study|Lack of Efficacy|0|||
161795872|NCT02655237|584296405|FG001|Overall Study|Lack of Efficacy|1|||
161900594|NCT00672633|584683080|FG000|Overall Study|Withdrawal by Subject|0|||
161900595|NCT00672633|584683081|FG001|Overall Study|Withdrawal by Subject|1|||
161900596|NCT02824627|584683082|FG000|Overall Study|Adverse Event|1|||
161900597|NCT02824627|584683083|FG001|Overall Study|Adverse Event|2|||
161900598|NCT02824627|584683082|FG000|Overall Study|Lost to Follow-up|2|||
161900599|NCT02824627|584683083|FG001|Overall Study|Lost to Follow-up|1|||
161900600|NCT01868165|584683084|FG000|Overall Study|Withdrawal by Subject|36|||
161900601|NCT01868165|584683084|FG000|Overall Study|Physician Decision|2|||
161900602|NCT01868165|584683084|FG000|Overall Study|Lost to Follow-up|3|||
161900603|NCT01868165|584683084|FG000|Overall Study|Death|4|||
161900604|NCT01603407|584683085|FG000|Overall Study|Adverse Event|1|||
161900605|NCT01603407|584683086|FG001|Overall Study|Adverse Event|1|||
161900606|NCT01603407|584683087|FG002|Overall Study|Adverse Event|1|||
161900607|NCT01603407|584683085|FG000|Overall Study|Protocol Violation|2|||
161900608|NCT01603407|584683086|FG001|Overall Study|Protocol Violation|2|||
161900609|NCT01603407|584683087|FG002|Overall Study|Protocol Violation|0|||
161900610|NCT01603407|584683085|FG000|Overall Study|Withdrawal by Subject|8|||
161900611|NCT01603407|584683086|FG001|Overall Study|Withdrawal by Subject|5|||
161900612|NCT01603407|584683087|FG002|Overall Study|Withdrawal by Subject|7|||
161900613|NCT01603407|584683085|FG000|Overall Study|Lost to Follow-up|0|||
161900614|NCT01603407|584683086|FG001|Overall Study|Lost to Follow-up|3|||
161900615|NCT01603407|584683087|FG002|Overall Study|Lost to Follow-up|2|||
161900616|NCT02358031|584685128|FG000|Overall Study|Death|253|||
161900617|NCT02358031|584685129|FG001|Overall Study|Death|237|||
161900618|NCT02358031|584685130|FG002|Overall Study|Death|266|||
161900619|NCT02358031|584685128|FG000|Overall Study|Lost to Follow-up|1|||
161900620|NCT02358031|584685129|FG001|Overall Study|Lost to Follow-up|1|||
161900621|NCT02358031|584685130|FG002|Overall Study|Lost to Follow-up|0|||
161900622|NCT02358031|584685128|FG000|Overall Study|Withdrawal by Subject|19|||
161900623|NCT02358031|584685129|FG001|Overall Study|Withdrawal by Subject|14|||
161900624|NCT02358031|584685130|FG002|Overall Study|Withdrawal by Subject|18|||
161900625|NCT02358031|584685128|FG000|Overall Study|Sponsor Decision|26|||
161900626|NCT02358031|584685129|FG001|Overall Study|Sponsor Decision|28|||
161900627|NCT02358031|584685130|FG002|Overall Study|Sponsor Decision|16|||
161900628|NCT00823134|584685137|FG000|Overall Study|Invalid measurement|1|||
161900629|NCT01325350|584685141|FG000|Overall Study|Adverse Event|3|||
161900630|NCT01325350|584685142|FG001|Overall Study|Adverse Event|3|||
161900631|NCT01325350|584685143|FG002|Overall Study|Adverse Event|3|||
161900632|NCT01325350|584685144|FG003|Overall Study|Adverse Event|1|||
161900633|NCT01325350|584685145|FG004|Overall Study|Adverse Event|2|||
161900634|NCT01325350|584685141|FG000|Overall Study|Pregnancy|0|||
161900635|NCT01325350|584685142|FG001|Overall Study|Pregnancy|0|||
161900636|NCT01325350|584685143|FG002|Overall Study|Pregnancy|1|||
161448118|NCT02617485|583037324|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
161448119|NCT02617485|583037323|FG000|Treatment and Observation Period|Physician Decision|0|||
161448120|NCT02617485|583037324|FG001|Treatment and Observation Period|Physician Decision|1|||
161448121|NCT02617485|583037323|FG000|Follow-up Period|Adverse Event|1|||
161448122|NCT02617485|583037324|FG001|Follow-up Period|Adverse Event|0|||
161448123|NCT02617485|583037323|FG000|Follow-up Period|Withdrawal by Subject|1|||
161448124|NCT02617485|583037324|FG001|Follow-up Period|Withdrawal by Subject|0|||
161448125|NCT02617485|583037323|FG000|Follow-up Period|Disease progression|2|||
161448126|NCT02617485|583037324|FG001|Follow-up Period|Disease progression|1|||
161448127|NCT02617485|583037323|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
161448128|NCT02617485|583037324|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
161448129|NCT02617485|583037323|FG000|Follow-up Period|Patient needed radiotherapy|9|||
161448130|NCT02617485|583037324|FG001|Follow-up Period|Patient needed radiotherapy|5|||
161448131|NCT02617485|583037323|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
161448132|NCT02617485|583037324|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
161448133|NCT00791076|583037328|FG000|Overall Study|Study was terminated,PI left institution|8|||
161448134|NCT00669409|583037329|FG000|Part 2|Withdrawal by Subject|0|||
161448135|NCT00669409|583037330|FG001|Part 2|Withdrawal by Subject|0|||
161448136|NCT00669409|583037331|FG002|Part 2|Withdrawal by Subject|0|||
161448137|NCT00669409|583037332|FG003|Part 2|Withdrawal by Subject|0|||
161448138|NCT00669409|583037333|FG004|Part 2|Withdrawal by Subject|0|||
161448139|NCT00669409|583037334|FG005|Part 2|Withdrawal by Subject|0|||
161448140|NCT00669409|583037335|FG006|Part 2|Withdrawal by Subject|0|||
161448141|NCT00669409|583037336|FG007|Part 2|Withdrawal by Subject|0|||
161448142|NCT00669409|583037337|FG008|Part 2|Withdrawal by Subject|0|||
161448143|NCT00669409|583037338|FG009|Part 2|Withdrawal by Subject|1|||
161448144|NCT00669409|583037339|FG010|Part 2|Withdrawal by Subject|0|||
161448145|NCT00095940|583037342|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
161448146|NCT00095940|583037343|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
161448147|NCT00095940|583037344|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
161448148|NCT00095940|583037345|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
161448149|NCT00095940|583037346|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
161448150|NCT00095940|583037347|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
161448151|NCT00095940|583037348|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
161448152|NCT00095940|583037349|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
161448153|NCT00095940|583037350|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
161448154|NCT00095940|583037342|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
161448155|NCT00095940|583037343|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
161448156|NCT00095940|583037344|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
161448157|NCT00095940|583037345|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
161448158|NCT00095940|583037346|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
161448159|NCT00095940|583037347|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
161448160|NCT00095940|583037348|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
161448161|NCT00095940|583037349|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
161448162|NCT00095940|583037350|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
161448163|NCT00095940|583037342|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448164|NCT00095940|583037343|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448165|NCT00095940|583037344|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448166|NCT00095940|583037345|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448167|NCT00095940|583037346|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448168|NCT00095940|583037347|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448169|NCT00095940|583037348|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448170|NCT00095940|583037349|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
161448171|NCT00095940|583037350|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
161448172|NCT01716052|583037351|FG000|Overall Study|Withdrawal of funding|1|||
161448173|NCT01716052|583037352|FG001|Overall Study|Withdrawal of funding|1|||
161448174|NCT02864862|583037358|FG000|Overall Study|Lost to Follow-up|1|||
161448175|NCT02864862|583037359|FG001|Overall Study|Lost to Follow-up|0|||
161448176|NCT02864862|583037360|FG002|Overall Study|Lost to Follow-up|1|||
161448177|NCT02864862|583037358|FG000|Overall Study|Protocol Violation|0|||
161448178|NCT02864862|583037359|FG001|Overall Study|Protocol Violation|0|||
161448179|NCT02864862|583037360|FG002|Overall Study|Protocol Violation|1|||
161448180|NCT01523275|583037364|FG000|Overall Study|Lost to Follow-up|1|||
161552592|NCT04747275|583411773|FG000|Overall Study|Study terminated|0|||
161448181|NCT01523275|583037365|FG001|Overall Study|Lost to Follow-up|2|||
161448182|NCT01523275|583037364|FG000|Overall Study|Withdrawal by Subject|1|||
161448183|NCT01523275|583037365|FG001|Overall Study|Withdrawal by Subject|0|||
161448184|NCT03263702|583037366|FG000|Overall Study|Lost to Follow-up|2|||
161448185|NCT03263702|583037367|FG001|Overall Study|Lost to Follow-up|2|||
161448186|NCT03263702|583037366|FG000|Overall Study|Withdrawal by Subject|1|||
161448187|NCT03263702|583037367|FG001|Overall Study|Withdrawal by Subject|2|||
161448188|NCT03598114|583037368|FG000|Overall Study|Staff turnover/left the program|3|||
161552593|NCT04747275|583411774|FG001|Overall Study|Study terminated|1|||
161552594|NCT00531011|583411777|FG000|Overall Study|Withdrawal by Subject|2|||
161552595|NCT00531011|583411778|FG001|Overall Study|Withdrawal by Subject|4|||
161552596|NCT00531011|583411777|FG000|Overall Study|Death|1|||
161552597|NCT00531011|583411778|FG001|Overall Study|Death|0|||
161552598|NCT00531011|583411777|FG000|Overall Study|Lost to Follow-up|1|||
161552599|NCT00531011|583411778|FG001|Overall Study|Lost to Follow-up|0|||
161552600|NCT00531011|583411777|FG000|Overall Study|Physician Decision|0|||
161552601|NCT00531011|583411778|FG001|Overall Study|Physician Decision|3|||
161552602|NCT03268590|583411779|FG000|Overall Study|Previously unknown exclusion criteria|1|||
161552603|NCT04254679|583411804|FG000|Overall Study|Protocol Violation|1|||
161552604|NCT04254679|583411805|FG001|Overall Study|Protocol Violation|1|||
161552605|NCT04254679|583411804|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
161552606|NCT04254679|583411805|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
161552607|NCT04076020|583411814|FG000|Overall Study|Death|4|||
161552608|NCT04076020|583411815|FG001|Overall Study|Death|6|||
161552609|NCT04076020|583411814|FG000|Overall Study|Withdrawal by Subject|12|||
161552610|NCT04076020|583411815|FG001|Overall Study|Withdrawal by Subject|8|||
161552611|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
161552612|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
161552613|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
161552614|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
161552615|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161552616|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
161552617|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161552618|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161552619|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
161552620|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
161552621|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161552622|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161795873|NCT02655237|584296404|FG000|Overall Study|Recovery Leading to Surgery|2|||
161795874|NCT02655237|584296405|FG001|Overall Study|Recovery Leading to Surgery|1|||
161795875|NCT02655237|584296404|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
161795876|NCT02655237|584296405|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
161795877|NCT02655237|584296404|FG000|Overall Study|Randomized but Not Treated|1|||
161795878|NCT02655237|584296405|FG001|Overall Study|Randomized but Not Treated|0|||
161795879|NCT03679741|584296406|FG000|Period 1|No longer meet eligibility criteria|1|||
161795880|NCT03679741|584296407|FG001|Period 1|No longer meet eligibility criteria|0|||
161795881|NCT03679741|584296406|FG000|Period 1|Lost to Follow-up|0|||
161795882|NCT03679741|584296407|FG001|Period 1|Lost to Follow-up|1|||
161795883|NCT03679741|584296406|FG000|Period 1|Adverse Event|1|||
161795884|NCT03679741|584296407|FG001|Period 1|Adverse Event|1|||
161795885|NCT03679741|584296406|FG000|Period 1|Withdrawal by Subject|0|||
161795886|NCT03679741|584296407|FG001|Period 1|Withdrawal by Subject|1|||
161795887|NCT03679741|584296406|FG000|Period 2|Adverse Event|2|||
161795888|NCT03679741|584296407|FG001|Period 2|Adverse Event|1|||
161795889|NCT03679741|584296406|FG000|Period 2|Withdrawal by Subject|1|||
161795890|NCT03679741|584296407|FG001|Period 2|Withdrawal by Subject|1|||
161795891|NCT02227862|584296409|FG000|Overall Study|Protocol Violation|7|||
161795892|NCT02227862|584296410|FG001|Overall Study|Protocol Violation|9|||
161795893|NCT02227862|584296409|FG000|Overall Study|Other|0|||
161795894|NCT02227862|584296410|FG001|Overall Study|Other|2|||
161795895|NCT02227862|584296409|FG000|Overall Study|Adverse Event|4|||
161795896|NCT02227862|584296410|FG001|Overall Study|Adverse Event|3|||
161795897|NCT02227862|584296409|FG000|Overall Study|Withdrawal by Subject|7|||
161795898|NCT02227862|584296410|FG001|Overall Study|Withdrawal by Subject|6|||
161795899|NCT02227862|584296409|FG000|Overall Study|Lost to Follow-up|1|||
161795900|NCT02227862|584296410|FG001|Overall Study|Lost to Follow-up|2|||
161795901|NCT05014204|584296411|FG000|Overall Study|Withdrawal by Subject|1|||
161795902|NCT05014204|584296411|FG000|Overall Study|Physician Decision|1|||
161795903|NCT02035137|584296412|FG000|Overall Study|Physician Decision|0|||
161795904|NCT02035137|584296413|FG001|Overall Study|Physician Decision|0|||
161795905|NCT02035137|584296414|FG002|Overall Study|Physician Decision|1|||
161795906|NCT02035137|584296412|FG000|Overall Study|Withdrawal by Subject|0|||
161795907|NCT02035137|584296413|FG001|Overall Study|Withdrawal by Subject|1|||
161795908|NCT02035137|584296414|FG002|Overall Study|Withdrawal by Subject|2|||
161795909|NCT02035137|584296412|FG000|Overall Study|Ineligible|0|||
161795910|NCT02035137|584296413|FG001|Overall Study|Ineligible|1|||
161552623|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
161552624|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
161552625|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161795911|NCT02035137|584296414|FG002|Overall Study|Ineligible|2|||
161795912|NCT02035137|584296412|FG000|Overall Study|Disease progression prior to treatment start|2|||
161795913|NCT02035137|584296413|FG001|Overall Study|Disease progression prior to treatment start|0|||
161795914|NCT02035137|584296414|FG002|Overall Study|Disease progression prior to treatment start|0|||
161795915|NCT00819247|584296418|FG000|Overall Study|Adverse Event|0|||
161795916|NCT00819247|584296419|FG001|Overall Study|Adverse Event|5|||
161795917|NCT00819247|584296420|FG002|Overall Study|Adverse Event|3|||
161795918|NCT00819247|584296418|FG000|Overall Study|Insufficient testosterone response|5|||
161795919|NCT00819247|584296419|FG001|Overall Study|Insufficient testosterone response|8|||
161795920|NCT00819247|584296420|FG002|Overall Study|Insufficient testosterone response|10|||
161795921|NCT00819247|584296418|FG000|Overall Study|Withdrawal by Subject|1|||
161795922|NCT00819247|584296419|FG001|Overall Study|Withdrawal by Subject|0|||
161795923|NCT00819247|584296420|FG002|Overall Study|Withdrawal by Subject|0|||
161795924|NCT00819247|584296418|FG000|Overall Study|Protocol Violation|1|||
161795925|NCT00819247|584296419|FG001|Overall Study|Protocol Violation|0|||
161795926|NCT00819247|584296420|FG002|Overall Study|Protocol Violation|1|||
161795927|NCT00819247|584296418|FG000|Overall Study|Mistakenly withdrawn|0|||
161795928|NCT00819247|584296419|FG001|Overall Study|Mistakenly withdrawn|1|||
161795929|NCT00819247|584296420|FG002|Overall Study|Mistakenly withdrawn|0|||
161795930|NCT00819247|584296418|FG000|Overall Study|Bad prostate-specific antigen response|3|||
161795931|NCT00819247|584296419|FG001|Overall Study|Bad prostate-specific antigen response|2|||
161795932|NCT00819247|584296420|FG002|Overall Study|Bad prostate-specific antigen response|0|||
161448189|NCT03598114|583037369|FG001|Overall Study|Staff turnover/left the program|39|||
161448190|NCT02527200|583037370|FG000|Overall Study|Withdrawal by Subject|3|||
161448191|NCT02527200|583037371|FG001|Overall Study|Withdrawal by Subject|2|||
161448192|NCT02527200|583037372|FG002|Overall Study|Withdrawal by Subject|1|||
161448193|NCT02527200|583037373|FG003|Overall Study|Withdrawal by Subject|0|||
161448194|NCT02527200|583037370|FG000|Overall Study|Unclassified|0|||
161448195|NCT02527200|583037371|FG001|Overall Study|Unclassified|1|||
161448196|NCT02527200|583037372|FG002|Overall Study|Unclassified|0|||
161448197|NCT02527200|583037373|FG003|Overall Study|Unclassified|0|||
161448198|NCT02527200|583037370|FG000|Overall Study|Lost to Follow-up|0|||
161448199|NCT02527200|583037371|FG001|Overall Study|Lost to Follow-up|0|||
161448200|NCT02527200|583037372|FG002|Overall Study|Lost to Follow-up|1|||
161448201|NCT02527200|583037373|FG003|Overall Study|Lost to Follow-up|0|||
161448202|NCT00966875|583037374|FG000|Part A|Adverse Event|2|||
161448203|NCT00966875|583037375|FG001|Part A|Adverse Event|1|||
161448204|NCT00966875|583037376|FG002|Part A|Adverse Event|0|||
161448205|NCT00966875|583037377|FG003|Part A|Adverse Event|1|||
161448206|NCT00966875|583037378|FG004|Part A|Adverse Event|0|||
161448207|NCT00966875|583037379|FG005|Part A|Adverse Event|1|||
161448208|NCT00966875|583037380|FG006|Part A|Adverse Event|0|||
161448209|NCT00966875|583037381|FG007|Part A|Adverse Event|3|||
161448210|NCT00966875|583037382|FG008|Part A|Adverse Event|3|||
161448211|NCT00966875|583037374|FG000|Part A|Entry Criteria|0|||
161448212|NCT00966875|583037375|FG001|Part A|Entry Criteria|0|||
161448213|NCT00966875|583037376|FG002|Part A|Entry Criteria|0|||
161448214|NCT00966875|583037377|FG003|Part A|Entry Criteria|0|||
161448215|NCT00966875|583037378|FG004|Part A|Entry Criteria|0|||
161448216|NCT00966875|583037379|FG005|Part A|Entry Criteria|2|||
161448217|NCT00966875|583037380|FG006|Part A|Entry Criteria|0|||
161448218|NCT00966875|583037381|FG007|Part A|Entry Criteria|0|||
161448219|NCT00966875|583037382|FG008|Part A|Entry Criteria|0|||
161448220|NCT00966875|583037374|FG000|Part A|Lack of Efficacy|0|||
161448221|NCT00966875|583037375|FG001|Part A|Lack of Efficacy|1|||
161448222|NCT00966875|583037376|FG002|Part A|Lack of Efficacy|0|||
161448223|NCT00966875|583037377|FG003|Part A|Lack of Efficacy|0|||
161448224|NCT00966875|583037378|FG004|Part A|Lack of Efficacy|0|||
161448225|NCT00966875|583037379|FG005|Part A|Lack of Efficacy|0|||
161448226|NCT00966875|583037380|FG006|Part A|Lack of Efficacy|4|||
161448227|NCT00966875|583037381|FG007|Part A|Lack of Efficacy|0|||
161448228|NCT00966875|583037382|FG008|Part A|Lack of Efficacy|0|||
161448229|NCT00966875|583037374|FG000|Part A|Lost to Follow-up|2|||
161448230|NCT00966875|583037375|FG001|Part A|Lost to Follow-up|0|||
161448231|NCT00966875|583037376|FG002|Part A|Lost to Follow-up|0|||
161448232|NCT00966875|583037377|FG003|Part A|Lost to Follow-up|0|||
161448233|NCT00966875|583037378|FG004|Part A|Lost to Follow-up|0|||
161448234|NCT00966875|583037379|FG005|Part A|Lost to Follow-up|1|||
161448235|NCT00966875|583037380|FG006|Part A|Lost to Follow-up|0|||
161448236|NCT00966875|583037381|FG007|Part A|Lost to Follow-up|0|||
161448237|NCT00966875|583037382|FG008|Part A|Lost to Follow-up|0|||
161448238|NCT00966875|583037374|FG000|Part A|Parent/Caregiver Decision|0|||
161448239|NCT00966875|583037375|FG001|Part A|Parent/Caregiver Decision|0|||
161448240|NCT00966875|583037376|FG002|Part A|Parent/Caregiver Decision|0|||
161448241|NCT00966875|583037377|FG003|Part A|Parent/Caregiver Decision|1|||
161448242|NCT00966875|583037378|FG004|Part A|Parent/Caregiver Decision|0|||
161448243|NCT00966875|583037379|FG005|Part A|Parent/Caregiver Decision|0|||
161448244|NCT00966875|583037380|FG006|Part A|Parent/Caregiver Decision|0|||
161448245|NCT00966875|583037381|FG007|Part A|Parent/Caregiver Decision|0|||
161448246|NCT00966875|583037382|FG008|Part A|Parent/Caregiver Decision|0|||
161448247|NCT00966875|583037374|FG000|Part A|Physician Decision|0|||
161448248|NCT00966875|583037375|FG001|Part A|Physician Decision|0|||
161448249|NCT00966875|583037376|FG002|Part A|Physician Decision|0|||
161448250|NCT00966875|583037377|FG003|Part A|Physician Decision|0|||
161448251|NCT00966875|583037378|FG004|Part A|Physician Decision|1|||
161448252|NCT00966875|583037379|FG005|Part A|Physician Decision|0|||
161448253|NCT00966875|583037380|FG006|Part A|Physician Decision|1|||
161448254|NCT00966875|583037381|FG007|Part A|Physician Decision|0|||
161448255|NCT00966875|583037382|FG008|Part A|Physician Decision|2|||
161448256|NCT00966875|583037374|FG000|Part A|Sponsor Decision|0|||
161448257|NCT00966875|583037375|FG001|Part A|Sponsor Decision|0|||
161448258|NCT00966875|583037376|FG002|Part A|Sponsor Decision|1|||
161448259|NCT00966875|583037377|FG003|Part A|Sponsor Decision|0|||
161448260|NCT00966875|583037378|FG004|Part A|Sponsor Decision|1|||
161448261|NCT00966875|583037379|FG005|Part A|Sponsor Decision|0|||
161448262|NCT00966875|583037380|FG006|Part A|Sponsor Decision|0|||
161448263|NCT00966875|583037381|FG007|Part A|Sponsor Decision|2|||
161448264|NCT00966875|583037382|FG008|Part A|Sponsor Decision|1|||
161448265|NCT00966875|583037374|FG000|Part A|Withdrawal by Subject|2|||
161552626|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161552627|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
161552628|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
161552629|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
161552630|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
161552631|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
161552632|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
161552633|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
161552634|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
161552635|NCT03230864|583411817|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
161552636|NCT03230864|583411818|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
161552637|NCT03230864|583411819|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
161552638|NCT03230864|583411820|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
161552639|NCT03230864|583411817|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
161552640|NCT03230864|583411818|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
161552641|NCT03230864|583411819|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
161552642|NCT03230864|583411820|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
161552643|NCT03230864|583411817|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161552644|NCT03230864|583411818|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161552645|NCT03230864|583411819|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
161552646|NCT03230864|583411820|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
161552647|NCT03230864|583411817|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
161552648|NCT03230864|583411818|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
161552649|NCT03230864|583411819|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
161552650|NCT03230864|583411820|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
161552651|NCT03537261|583411830|FG000|Overall Study|Lost to Follow-up|4|||
161552652|NCT03537261|583411831|FG001|Overall Study|Lost to Follow-up|5|||
161552653|NCT03537261|583411830|FG000|Overall Study|Withdrawal by Subject|4|||
161552654|NCT03537261|583411831|FG001|Overall Study|Withdrawal by Subject|6|||
161552655|NCT03537261|583411830|FG000|Overall Study|Did not return study questionnaires|0|||
161552656|NCT03537261|583411831|FG001|Overall Study|Did not return study questionnaires|1|||
161552657|NCT00502996|583411834|FG000|Overall Study|Lost to Follow-up|9|||
161552658|NCT00502996|583411834|FG000|Overall Study|Protocol Violation|2|||
161552659|NCT00502996|583411834|FG000|Overall Study|Treatment failure|25|||
161552660|NCT00502996|583411834|FG000|Overall Study|Withdrawal Informed Consent|6|||
161552661|NCT00502996|583411834|FG000|Overall Study|Adverse Event|2|||
161552662|NCT01729728|583411835|FG000|Overall Study|Adverse Event|0|||
161552663|NCT01729728|583411836|FG001|Overall Study|Adverse Event|6|||
161552664|NCT01729728|583411837|FG002|Overall Study|Adverse Event|0|||
161552665|NCT01729728|583411835|FG000|Overall Study|Protocol Violation|1|||
161552666|NCT01729728|583411836|FG001|Overall Study|Protocol Violation|0|||
161552667|NCT01729728|583411837|FG002|Overall Study|Protocol Violation|1|||
161552668|NCT01316692|583411838|FG000|Overall Study|Adverse Event|5|||
161552669|NCT01316692|583411838|FG000|Overall Study|Disease Progression|7|||
161552670|NCT02001974|583411851|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
161795933|NCT00819247|584296418|FG000|Overall Study|Other|1|||
161795934|NCT00819247|584296419|FG001|Overall Study|Other|0|||
161795935|NCT00819247|584296420|FG002|Overall Study|Other|0|||
161795936|NCT04471935|584296421|FG000|Overall Study|Withdrawal by Subject|1|||
161795937|NCT04471935|584296421|FG000|Overall Study|Deemed ineligible to participate|1|||
161795938|NCT00948675|584296422|FG000|Overall Study|Lost to Follow-up|1|||
161795939|NCT00948675|584296423|FG001|Overall Study|Lost to Follow-up|0|||
161448266|NCT00966875|583037375|FG001|Part A|Withdrawal by Subject|2|||
161448267|NCT00966875|583037376|FG002|Part A|Withdrawal by Subject|1|||
161448268|NCT00966875|583037377|FG003|Part A|Withdrawal by Subject|1|||
161448269|NCT00966875|583037378|FG004|Part A|Withdrawal by Subject|3|||
161448270|NCT00966875|583037379|FG005|Part A|Withdrawal by Subject|0|||
161448271|NCT00966875|583037380|FG006|Part A|Withdrawal by Subject|5|||
161448272|NCT00966875|583037381|FG007|Part A|Withdrawal by Subject|1|||
161448273|NCT00966875|583037382|FG008|Part A|Withdrawal by Subject|1|||
161552671|NCT02001974|583411852|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
161552672|NCT02001974|583411853|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
161552673|NCT02001974|583411851|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
161552674|NCT02001974|583411852|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
161552675|NCT02001974|583411853|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
161552676|NCT02001974|583411851|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
161552677|NCT02001974|583411852|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
161552678|NCT02001974|583411853|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
161552679|NCT02001974|583411851|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
161552680|NCT02001974|583411852|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
161552681|NCT02001974|583411853|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
161552682|NCT00993317|583411854|FG000|Overall Study|Adverse Event|2|||
161552683|NCT00993317|583411855|FG001|Overall Study|Adverse Event|4|||
161552684|NCT00993317|583411854|FG000|Overall Study|Lack of Efficacy|18|||
161552685|NCT00993317|583411855|FG001|Overall Study|Lack of Efficacy|18|||
161552686|NCT00993317|583411854|FG000|Overall Study|Withdrawal by Subject|0|||
161552687|NCT00993317|583411855|FG001|Overall Study|Withdrawal by Subject|2|||
161552688|NCT00993317|583411854|FG000|Overall Study|Investigator's opinion|0|||
161552689|NCT00993317|583411855|FG001|Overall Study|Investigator's opinion|1|||
161552690|NCT00993317|583411854|FG000|Overall Study|Early study termination at the site|1|||
161552691|NCT00993317|583411855|FG001|Overall Study|Early study termination at the site|0|||
161552692|NCT00672958|583411856|FG000|Overall Study|Adverse Event|11|||
161552693|NCT00672958|583411857|FG001|Overall Study|Adverse Event|9|||
161552694|NCT00672958|583411856|FG000|Overall Study|Lack of Efficacy|6|||
161552695|NCT00672958|583411857|FG001|Overall Study|Lack of Efficacy|11|||
161552696|NCT00672958|583411856|FG000|Overall Study|Non-compliance with study drug|2|||
161552697|NCT00672958|583411857|FG001|Overall Study|Non-compliance with study drug|3|||
161552698|NCT00672958|583411856|FG000|Overall Study|Protocol deviations|11|||
161552699|NCT00672958|583411857|FG001|Overall Study|Protocol deviations|5|||
161552700|NCT00672958|583411856|FG000|Overall Study|Voluntary withdrawal|12|||
161552701|NCT00672958|583411857|FG001|Overall Study|Voluntary withdrawal|8|||
161552702|NCT00672958|583411856|FG000|Overall Study|Lost to Follow-up|22|||
161552703|NCT00672958|583411857|FG001|Overall Study|Lost to Follow-up|17|||
161552704|NCT00672958|583411856|FG000|Overall Study|Reason not specified|0|||
161552705|NCT00672958|583411857|FG001|Overall Study|Reason not specified|3|||
161552706|NCT04422639|583411858|FG000|Overall Study|Death|1|||
161552707|NCT04422639|583411859|FG001|Overall Study|Death|0|||
161552708|NCT04422639|583411858|FG000|Overall Study|study closed prior to completion of FU visits|0|||
161552709|NCT04422639|583411859|FG001|Overall Study|study closed prior to completion of FU visits|2|||
161552710|NCT02374593|583411860|FG000|Overall Study|non-compliant|2|||
161552711|NCT02374593|583411861|FG001|Overall Study|non-compliant|0|||
161552712|NCT05376371|583411866|FG000|Overall Study|change in release date|10|||
161552713|NCT02169830|583414213|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
161552714|NCT02169830|583414214|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
161552715|NCT02169830|583414215|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
161552716|NCT02169830|583414213|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
161552717|NCT02169830|583414214|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161552718|NCT02169830|583414215|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161552719|NCT02169830|583414213|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161552720|NCT02169830|583414214|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
161552721|NCT02169830|583414215|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161552722|NCT02169830|583414213|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
161552723|NCT02169830|583414214|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
161552724|NCT02169830|583414215|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
161552725|NCT02169830|583414213|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
161552726|NCT02169830|583414214|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
161552727|NCT02169830|583414215|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
161552728|NCT03204695|583414216|FG000|Overall Study|Death|1|||
161552729|NCT03204695|583414216|FG000|Overall Study|Participant was treated with another device|1|||
161552730|NCT03204695|583414216|FG000|Overall Study|Physician Decision|2|||
161552731|NCT04781647|583414220|FG000|Overall Study|Study terminated by Sponsor|11|||
161552732|NCT04781647|583414221|FG001|Overall Study|Study terminated by Sponsor|9|||
161552733|NCT04781647|583414222|FG002|Overall Study|Study terminated by Sponsor|9|||
161552734|NCT04781647|583414220|FG000|Overall Study|Withdrawal by Subject|1|||
161552735|NCT04781647|583414221|FG001|Overall Study|Withdrawal by Subject|2|||
161900637|NCT01325350|584685144|FG003|Overall Study|Pregnancy|0|||
161552736|NCT04781647|583414222|FG002|Overall Study|Withdrawal by Subject|0|||
161552737|NCT04781647|583414220|FG000|Overall Study|Adverse Event|0|||
161552738|NCT04781647|583414221|FG001|Overall Study|Adverse Event|1|||
161552739|NCT04781647|583414222|FG002|Overall Study|Adverse Event|1|||
161552740|NCT04781647|583414220|FG000|Overall Study|Protocol Violation|1|||
161552741|NCT04781647|583414221|FG001|Overall Study|Protocol Violation|0|||
161552742|NCT04781647|583414222|FG002|Overall Study|Protocol Violation|0|||
161900638|NCT01325350|584685145|FG004|Overall Study|Pregnancy|1|||
161900639|NCT01325350|584685141|FG000|Overall Study|Lost to Follow-up|1|||
161900640|NCT01325350|584685142|FG001|Overall Study|Lost to Follow-up|0|||
161900641|NCT01325350|584685143|FG002|Overall Study|Lost to Follow-up|5|||
161900642|NCT01325350|584685144|FG003|Overall Study|Lost to Follow-up|1|||
161900643|NCT01325350|584685145|FG004|Overall Study|Lost to Follow-up|5|||
161900644|NCT01325350|584685141|FG000|Overall Study|Personal Reasons|2|||
161900645|NCT01325350|584685142|FG001|Overall Study|Personal Reasons|1|||
161900646|NCT01325350|584685143|FG002|Overall Study|Personal Reasons|6|||
161900647|NCT01325350|584685144|FG003|Overall Study|Personal Reasons|5|||
161900648|NCT01325350|584685145|FG004|Overall Study|Personal Reasons|3|||
161900649|NCT01325350|584685141|FG000|Overall Study|Protocol Violation|0|||
161900650|NCT01325350|584685142|FG001|Overall Study|Protocol Violation|0|||
161900651|NCT01325350|584685143|FG002|Overall Study|Protocol Violation|0|||
161900652|NCT01325350|584685144|FG003|Overall Study|Protocol Violation|1|||
161900653|NCT01325350|584685145|FG004|Overall Study|Protocol Violation|0|||
161448274|NCT00966875|583037374|FG000|Part A|Protocol Violation|0|||
161448275|NCT00966875|583037375|FG001|Part A|Protocol Violation|0|||
161448276|NCT00966875|583037376|FG002|Part A|Protocol Violation|0|||
161448277|NCT00966875|583037377|FG003|Part A|Protocol Violation|0|||
161448278|NCT00966875|583037378|FG004|Part A|Protocol Violation|0|||
161448279|NCT00966875|583037379|FG005|Part A|Protocol Violation|0|||
161448280|NCT00966875|583037380|FG006|Part A|Protocol Violation|2|||
161448281|NCT00966875|583037381|FG007|Part A|Protocol Violation|1|||
161448282|NCT00966875|583037382|FG008|Part A|Protocol Violation|1|||
161448283|NCT00966875|583037374|FG000|Part B|Adverse Event|0|||
161448284|NCT00966875|583037375|FG001|Part B|Adverse Event|1|||
161448285|NCT00966875|583037376|FG002|Part B|Adverse Event|1|||
161448286|NCT00966875|583037377|FG003|Part B|Adverse Event|0|||
161448287|NCT00966875|583037378|FG004|Part B|Adverse Event|1|||
161448288|NCT00966875|583037379|FG005|Part B|Adverse Event|0|||
161448289|NCT00966875|583037380|FG006|Part B|Adverse Event|5|||
161448290|NCT00966875|583037381|FG007|Part B|Adverse Event|2|||
161448291|NCT00966875|583037382|FG008|Part B|Adverse Event|2|||
161448292|NCT00966875|583037374|FG000|Part B|Death|0|||
161448293|NCT00966875|583037375|FG001|Part B|Death|0|||
161448294|NCT00966875|583037376|FG002|Part B|Death|1|||
161448295|NCT00966875|583037377|FG003|Part B|Death|0|||
161448296|NCT00966875|583037378|FG004|Part B|Death|0|||
161448297|NCT00966875|583037379|FG005|Part B|Death|0|||
161448298|NCT00966875|583037380|FG006|Part B|Death|0|||
161448299|NCT00966875|583037381|FG007|Part B|Death|1|||
161448300|NCT00966875|583037382|FG008|Part B|Death|0|||
161448301|NCT00966875|583037374|FG000|Part B|Lack of Efficacy|2|||
161448302|NCT00966875|583037375|FG001|Part B|Lack of Efficacy|1|||
161448303|NCT00966875|583037376|FG002|Part B|Lack of Efficacy|1|||
161448304|NCT00966875|583037377|FG003|Part B|Lack of Efficacy|1|||
161448305|NCT00966875|583037378|FG004|Part B|Lack of Efficacy|2|||
161448306|NCT00966875|583037379|FG005|Part B|Lack of Efficacy|3|||
161448307|NCT00966875|583037380|FG006|Part B|Lack of Efficacy|12|||
161448308|NCT00966875|583037381|FG007|Part B|Lack of Efficacy|9|||
161448309|NCT00966875|583037382|FG008|Part B|Lack of Efficacy|6|||
161448310|NCT00966875|583037374|FG000|Part B|Lost to Follow-up|0|||
161448311|NCT00966875|583037375|FG001|Part B|Lost to Follow-up|0|||
161448312|NCT00966875|583037376|FG002|Part B|Lost to Follow-up|0|||
161448313|NCT00966875|583037377|FG003|Part B|Lost to Follow-up|1|||
161448314|NCT00966875|583037378|FG004|Part B|Lost to Follow-up|0|||
161448315|NCT00966875|583037379|FG005|Part B|Lost to Follow-up|0|||
161448316|NCT00966875|583037380|FG006|Part B|Lost to Follow-up|0|||
161448317|NCT00966875|583037381|FG007|Part B|Lost to Follow-up|0|||
161448318|NCT00966875|583037382|FG008|Part B|Lost to Follow-up|1|||
161448319|NCT00966875|583037374|FG000|Part B|Physician Decision|0|||
161448320|NCT00966875|583037375|FG001|Part B|Physician Decision|0|||
161448321|NCT00966875|583037376|FG002|Part B|Physician Decision|1|||
161448322|NCT00966875|583037377|FG003|Part B|Physician Decision|0|||
161448323|NCT00966875|583037378|FG004|Part B|Physician Decision|2|||
161448324|NCT00966875|583037379|FG005|Part B|Physician Decision|1|||
161448325|NCT00966875|583037380|FG006|Part B|Physician Decision|0|||
161448326|NCT00966875|583037381|FG007|Part B|Physician Decision|0|||
161448327|NCT00966875|583037382|FG008|Part B|Physician Decision|2|||
161900654|NCT01325350|584685141|FG000|Overall Study|Withdrawal by Subject|0|||
161900655|NCT01325350|584685142|FG001|Overall Study|Withdrawal by Subject|0|||
161448328|NCT00966875|583037374|FG000|Part B|Sponsor Decision|1|||
161448329|NCT00966875|583037375|FG001|Part B|Sponsor Decision|0|||
161448330|NCT00966875|583037376|FG002|Part B|Sponsor Decision|0|||
161448331|NCT00966875|583037377|FG003|Part B|Sponsor Decision|0|||
161900656|NCT01325350|584685143|FG002|Overall Study|Withdrawal by Subject|1|||
161448332|NCT00966875|583037378|FG004|Part B|Sponsor Decision|0|||
161448333|NCT00966875|583037379|FG005|Part B|Sponsor Decision|1|||
161448334|NCT00966875|583037380|FG006|Part B|Sponsor Decision|0|||
161448335|NCT00966875|583037381|FG007|Part B|Sponsor Decision|2|||
161448336|NCT00966875|583037382|FG008|Part B|Sponsor Decision|1|||
161448337|NCT00966875|583037374|FG000|Part B|Withdrawal by Subject|2|||
161448338|NCT00966875|583037375|FG001|Part B|Withdrawal by Subject|1|||
161448339|NCT00966875|583037376|FG002|Part B|Withdrawal by Subject|2|||
161448340|NCT00966875|583037377|FG003|Part B|Withdrawal by Subject|1|||
161448341|NCT00966875|583037378|FG004|Part B|Withdrawal by Subject|2|||
161552743|NCT04781647|583414220|FG000|Overall Study|Pregnancy|0|||
161552744|NCT04781647|583414221|FG001|Overall Study|Pregnancy|0|||
161552745|NCT04781647|583414222|FG002|Overall Study|Pregnancy|1|||
161552746|NCT04781647|583414220|FG000|Overall Study|Virology rebounded|1|||
161552747|NCT04781647|583414221|FG001|Overall Study|Virology rebounded|0|||
161552748|NCT04781647|583414222|FG002|Overall Study|Virology rebounded|0|||
161552749|NCT00777803|583414223|FG000|Overall Study|Lost to Follow-up|12|||
161552750|NCT00777803|583414224|FG001|Overall Study|Lost to Follow-up|5|||
161552751|NCT00777803|583414223|FG000|Overall Study|Adverse Event|1|||
161552752|NCT00777803|583414224|FG001|Overall Study|Adverse Event|0|||
161552753|NCT00777803|583414223|FG000|Overall Study|Non-compliance|2|||
161552754|NCT00777803|583414224|FG001|Overall Study|Non-compliance|2|||
161552755|NCT01755689|583414225|FG000|Overall Study|Withdrawal by Subject|1|||
161552756|NCT01755689|583414226|FG001|Overall Study|Withdrawal by Subject|3|||
161552757|NCT01755689|583414227|FG002|Overall Study|Withdrawal by Subject|2|||
161552758|NCT01755689|583414228|FG003|Overall Study|Withdrawal by Subject|1|||
161552759|NCT01755689|583414229|FG004|Overall Study|Withdrawal by Subject|1|||
161552760|NCT01755689|583414225|FG000|Overall Study|Migrated/moved from study area|0|||
161552761|NCT01755689|583414226|FG001|Overall Study|Migrated/moved from study area|1|||
161552762|NCT01755689|583414227|FG002|Overall Study|Migrated/moved from study area|1|||
161552763|NCT01755689|583414228|FG003|Overall Study|Migrated/moved from study area|1|||
161552764|NCT01755689|583414229|FG004|Overall Study|Migrated/moved from study area|1|||
161552765|NCT01755689|583414225|FG000|Overall Study|Lost to Follow-up|1|||
161552766|NCT01755689|583414226|FG001|Overall Study|Lost to Follow-up|0|||
161552767|NCT01755689|583414227|FG002|Overall Study|Lost to Follow-up|1|||
161552768|NCT01755689|583414228|FG003|Overall Study|Lost to Follow-up|0|||
161552769|NCT01755689|583414229|FG004|Overall Study|Lost to Follow-up|2|||
161552770|NCT01755689|583414225|FG000|Overall Study|Pregnancy|1|||
161552771|NCT01755689|583414226|FG001|Overall Study|Pregnancy|1|||
161552772|NCT01755689|583414227|FG002|Overall Study|Pregnancy|2|||
161552773|NCT01755689|583414228|FG003|Overall Study|Pregnancy|4|||
161552774|NCT01755689|583414229|FG004|Overall Study|Pregnancy|2|||
161552775|NCT02930122|583414232|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
161552776|NCT02930122|583414233|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
161552777|NCT01995357|583414234|FG000|Period 5|Lack of Efficacy|1|||
161552778|NCT01995357|583414235|FG001|Period 5|Lack of Efficacy|0|||
161552779|NCT01995357|583414236|FG002|Period 5|Lack of Efficacy|0|||
161552780|NCT01995357|583414237|FG003|Period 5|Lack of Efficacy|0|||
161552781|NCT01995357|583414238|FG004|Period 5|Lack of Efficacy|0|||
161552782|NCT01995357|583414239|FG005|Period 5|Lack of Efficacy|0|||
161552783|NCT01995357|583414234|FG000|Period 5|Adverse Event|1|||
161552784|NCT01995357|583414235|FG001|Period 5|Adverse Event|0|||
161552785|NCT01995357|583414236|FG002|Period 5|Adverse Event|1|||
161552786|NCT01995357|583414237|FG003|Period 5|Adverse Event|0|||
161795940|NCT01654380|584296427|FG000|Part B, Period 1|Physician Decision|0|||
161795941|NCT01654380|584296428|FG001|Part B, Period 1|Physician Decision|0|||
161795942|NCT01654380|584296429|FG002|Part B, Period 1|Physician Decision|1|||
161795943|NCT01654380|584296430|FG003|Part B, Period 1|Physician Decision|0|||
161795944|NCT06331156|584296431|FG000|Overall Study|Adverse Event|1|||
161795945|NCT06331156|584296432|FG001|Overall Study|Adverse Event|0|||
161795946|NCT06331156|584296431|FG000|Overall Study|Lost to Follow-up|1|||
161795947|NCT06331156|584296432|FG001|Overall Study|Lost to Follow-up|0|||
161795948|NCT06331156|584296431|FG000|Overall Study|Migrated / Moved from the study area|4|||
161795949|NCT06331156|584296432|FG001|Overall Study|Migrated / Moved from the study area|3|||
161795950|NCT06331156|584296431|FG000|Overall Study|Other|7|||
161795951|NCT06331156|584296432|FG001|Overall Study|Other|0|||
161795952|NCT06331156|584296431|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
161795953|NCT06331156|584296432|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
161795954|NCT05845645|584296433|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795955|NCT05845645|584296434|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795956|NCT05845645|584296435|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
161795957|NCT05845645|584296436|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795958|NCT05845645|584296437|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795959|NCT05845645|584296438|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161552787|NCT01995357|583414238|FG004|Period 5|Adverse Event|0|||
161552788|NCT01995357|583414239|FG005|Period 5|Adverse Event|0|||
161552789|NCT02609659|583414240|FG000|Overall Study|Adverse Event|1|||
161552790|NCT02609659|583414240|FG000|Overall Study|Lost to Follow-up|6|||
161552791|NCT02609659|583414240|FG000|Overall Study|Other|1|||
161552792|NCT01004250|583414243|FG000|Induction Therapy Period|Adverse Event|10|||
161552793|NCT01004250|583414243|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
161552794|NCT01004250|583414243|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
161552795|NCT01004250|583414243|FG000|Induction Therapy Period|Physician Decision|2|||
161552796|NCT01004250|583414243|FG000|Maintenance Therapy Period|Adverse Event|15|||
161552797|NCT01004250|583414243|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
161552798|NCT01004250|583414243|FG000|Maintenance Therapy Period|Protocol Violation|1|||
161552799|NCT01004250|583414243|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
161552800|NCT01004250|583414243|FG000|Maintenance Therapy Period|Physician Decision|4|||
161552801|NCT01004250|583414243|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
161552802|NCT01853254|583414244|FG000|Overall Study|Abnormal Laboratory Test|1|||
161552803|NCT01853254|583414244|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
161552804|NCT01853254|583414244|FG000|Overall Study|Death|1|||
161552805|NCT01853254|583414244|FG000|Overall Study|Failure to Return|43|||
161552806|NCT01853254|583414244|FG000|Overall Study|Insufficient Therapeutic Response|22|||
161552807|NCT01853254|583414244|FG000|Overall Study|Refusal of Treatment|1|||
161552808|NCT01853254|583414244|FG000|Overall Study|Other Protocol Violation|1|||
161552809|NCT01853254|583414244|FG000|Overall Study|Withdrawal of Consent|16|||
161552810|NCT01853254|583414244|FG000|Overall Study|Administrative/Other|16|||
161552811|NCT02462083|583414245|FG000|Overall Study|Sponsor request|39|||
161552812|NCT02462083|583414245|FG000|Overall Study|Withdrawal by Subject|87|||
161552813|NCT02462083|583414245|FG000|Overall Study|Lost to Follow-up|41|||
161552814|NCT02462083|583414245|FG000|Overall Study|Lack of Efficacy|151|||
161552815|NCT02462083|583414245|FG000|Overall Study|Pregnancy|1|||
161552816|NCT02462083|583414245|FG000|Overall Study|Protocol Violation|6|||
161552817|NCT02462083|583414245|FG000|Overall Study|Adverse Event|33|||
161552818|NCT02462083|583414245|FG000|Overall Study|Worsening condition|16|||
161552819|NCT02462083|583414245|FG000|Overall Study|Other than specified|45|||
161552820|NCT02711995|583414248|FG000|Washout (90 Days)|Conflicting medication|1|||
161552821|NCT01115998|583414251|FG000|Overall Study|Lost to Follow-up|6|||
161552822|NCT01115998|583414252|FG001|Overall Study|Lost to Follow-up|6|||
161552823|NCT01383993|583414256|FG000|Overall Study|Adverse Event|1|||
161552824|NCT01383993|583414257|FG001|Overall Study|Adverse Event|1|||
161552825|NCT01383993|583414258|FG002|Overall Study|Adverse Event|0|||
161552826|NCT01383993|583414256|FG000|Overall Study|Withdrawal by Subject|0|||
161552827|NCT01383993|583414257|FG001|Overall Study|Withdrawal by Subject|0|||
161552828|NCT01383993|583414258|FG002|Overall Study|Withdrawal by Subject|1|||
161552829|NCT01383993|583414256|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
161552830|NCT01383993|583414257|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
161552831|NCT01383993|583414258|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
161552832|NCT01489020|583414263|FG000|Overall Study|Withdrawal by Subject|1|||
161552833|NCT01489020|583414264|FG001|Overall Study|Withdrawal by Subject|0|||
161552834|NCT01489020|583414265|FG002|Overall Study|Withdrawal by Subject|0|||
161552835|NCT01489020|583414266|FG003|Overall Study|Withdrawal by Subject|0|||
161552836|NCT01489020|583414267|FG004|Overall Study|Withdrawal by Subject|0|||
161552837|NCT01489020|583414268|FG005|Overall Study|Withdrawal by Subject|0|||
161552838|NCT01489020|583414263|FG000|Overall Study|Adverse Event|0|||
161552839|NCT01489020|583414264|FG001|Overall Study|Adverse Event|0|||
161552840|NCT01489020|583414265|FG002|Overall Study|Adverse Event|3|||
161552841|NCT01489020|583414266|FG003|Overall Study|Adverse Event|0|||
161552842|NCT01489020|583414267|FG004|Overall Study|Adverse Event|3|||
161552843|NCT01489020|583414268|FG005|Overall Study|Adverse Event|0|||
161552844|NCT01489020|583414263|FG000|Overall Study|Concomitant disease|0|||
161552845|NCT01489020|583414264|FG001|Overall Study|Concomitant disease|0|||
161552846|NCT01489020|583414265|FG002|Overall Study|Concomitant disease|0|||
161552847|NCT01489020|583414266|FG003|Overall Study|Concomitant disease|0|||
161552848|NCT01489020|583414267|FG004|Overall Study|Concomitant disease|3|||
161552849|NCT01489020|583414268|FG005|Overall Study|Concomitant disease|0|||
161552850|NCT02451930|583414270|FG000|Overall Study|Death|0|||
161552851|NCT02451930|583414271|FG001|Overall Study|Death|15|||
161552852|NCT02451930|583414270|FG000|Overall Study|Lost to Follow-up|0|||
161552853|NCT02451930|583414271|FG001|Overall Study|Lost to Follow-up|3|||
161552854|NCT02451930|583414270|FG000|Overall Study|Sponsor Decision|2|||
161552855|NCT02451930|583414271|FG001|Overall Study|Sponsor Decision|10|||
161552856|NCT02451930|583414270|FG000|Overall Study|Withdrawal by Subject|0|||
161552857|NCT02451930|583414271|FG001|Overall Study|Withdrawal by Subject|1|||
161552858|NCT02451930|583414270|FG000|Overall Study|Other|0|||
161552859|NCT02451930|583414271|FG001|Overall Study|Other|1|||
161552860|NCT00962585|583414272|FG000|Overall Study|Adverse Event|0|||
161552861|NCT00962585|583414273|FG001|Overall Study|Adverse Event|2|||
161552862|NCT00962585|583414274|FG002|Overall Study|Adverse Event|1|||
161552863|NCT00962585|583414275|FG003|Overall Study|Adverse Event|0|||
161552864|NCT00962585|583414272|FG000|Overall Study|Lost to Follow-up|3|||
161552865|NCT00962585|583414273|FG001|Overall Study|Lost to Follow-up|0|||
161552866|NCT00962585|583414274|FG002|Overall Study|Lost to Follow-up|1|||
161552867|NCT00962585|583414275|FG003|Overall Study|Lost to Follow-up|0|||
161552868|NCT00962585|583414272|FG000|Overall Study|Protocol Violation|0|||
161552869|NCT00962585|583414273|FG001|Overall Study|Protocol Violation|0|||
161552870|NCT00962585|583414274|FG002|Overall Study|Protocol Violation|1|||
161552871|NCT00962585|583414275|FG003|Overall Study|Protocol Violation|0|||
161552872|NCT00962585|583414272|FG000|Overall Study|Withdrawal by Subject|1|||
161552873|NCT00962585|583414273|FG001|Overall Study|Withdrawal by Subject|0|||
161552874|NCT00962585|583414274|FG002|Overall Study|Withdrawal by Subject|0|||
161795960|NCT05845645|584296439|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795961|NCT05845645|584296440|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795962|NCT05845645|584296441|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795963|NCT05845645|584296442|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795964|NCT05845645|584296443|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795965|NCT05845645|584296444|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795966|NCT05845645|584296433|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795967|NCT05845645|584296434|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795968|NCT05845645|584296435|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795969|NCT05845645|584296436|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795970|NCT05845645|584296437|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795971|NCT05845645|584296438|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795972|NCT05845645|584296439|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795973|NCT05845645|584296440|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795974|NCT05845645|584296441|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795975|NCT05845645|584296442|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
161795976|NCT05845645|584296443|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795977|NCT05845645|584296444|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795978|NCT01199601|584296450|FG000|Overall Study|Lost to Follow-up|47|||
161795979|NCT01199601|584296451|FG001|Overall Study|Lost to Follow-up|66|||
161795980|NCT01199601|584296450|FG000|Overall Study|Withdrawal by Subject|15|||
161795981|NCT01199601|584296451|FG001|Overall Study|Withdrawal by Subject|3|||
161795982|NCT01199601|584296450|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
161795983|NCT01199601|584296451|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
161795984|NCT00278512|584296452|FG000|Overall Study|Death|1|||
161795985|NCT00278512|584296453|FG001|Overall Study|Death|0|||
161795986|NCT01620177|584296454|FG000|Overall Study|Failure at Screening Visit|43|||
161795987|NCT01620177|584296454|FG000|Overall Study|Withdrawal by Subject|26|||
161795988|NCT01620177|584296454|FG000|Overall Study|Lost to Follow-up|7|||
161795989|NCT01620177|584296454|FG000|Overall Study|Physician Decision|2|||
161795990|NCT01620177|584296454|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
161795991|NCT00423800|584296455|FG000|Overall Study|Protocol Violation|0|||
161795992|NCT00423800|584296456|FG001|Overall Study|Protocol Violation|1|||
161795993|NCT00814320|584296457|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
161795994|NCT00814320|584296458|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
161795995|NCT00814320|584296457|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
161795996|NCT00814320|584296458|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
161795997|NCT00814320|584296457|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
161795998|NCT00814320|584296458|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
161795999|NCT00814320|584296457|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
161796000|NCT00814320|584296458|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
161796001|NCT00814320|584296457|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
161796002|NCT00814320|584296458|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
161796003|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
161796004|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
161796005|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
161796006|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
161796007|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
161796008|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
161796009|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
161796010|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
161796011|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
161796012|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
161796013|NCT00619385|584296459|FG000|Overall Study|Adverse Event|0|||
161796014|NCT00619385|584296460|FG001|Overall Study|Adverse Event|0|||
161796015|NCT00619385|584296461|FG002|Overall Study|Adverse Event|3|||
161796016|NCT00619385|584296459|FG000|Overall Study|Other|1|||
161796017|NCT00619385|584296460|FG001|Overall Study|Other|2|||
161796018|NCT00619385|584296461|FG002|Overall Study|Other|1|||
161796019|NCT02041702|584296466|FG000|Overall Study|Lost to Follow-up|1|||
161796020|NCT02041702|584296467|FG001|Overall Study|Lost to Follow-up|6|||
161796021|NCT02041702|584296466|FG000|Overall Study|Death|4|||
161796022|NCT02041702|584296467|FG001|Overall Study|Death|0|||
161796023|NCT02041702|584296466|FG000|Overall Study|Withdrawal by Subject|4|||
161796024|NCT02041702|584296467|FG001|Overall Study|Withdrawal by Subject|3|||
161796025|NCT02041702|584296466|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
161796026|NCT02041702|584296467|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
161796027|NCT02041702|584296466|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
161900657|NCT01325350|584685144|FG003|Overall Study|Withdrawal by Subject|1|||
161900658|NCT01325350|584685145|FG004|Overall Study|Withdrawal by Subject|0|||
161552875|NCT00962585|583414275|FG003|Overall Study|Withdrawal by Subject|0|||
161552876|NCT00962585|583414272|FG000|Overall Study|Withdrew Consent|2|||
161552877|NCT00962585|583414273|FG001|Overall Study|Withdrew Consent|0|||
161552878|NCT00962585|583414274|FG002|Overall Study|Withdrew Consent|0|||
161552879|NCT00962585|583414275|FG003|Overall Study|Withdrew Consent|0|||
161552880|NCT00262743|583414276|FG000|Overall Study|Adverse Event|0|||
161552881|NCT00262743|583414277|FG001|Overall Study|Adverse Event|9|||
161552882|NCT00262743|583414276|FG000|Overall Study|Disease progression|0|||
161552883|NCT00262743|583414277|FG001|Overall Study|Disease progression|3|||
161552884|NCT02485353|583414278|FG000|Overall Study|Death|1|||
161552885|NCT02485353|583414278|FG000|Overall Study|Disease Progression|1|||
161552886|NCT02823964|583414283|FG000|Overall Study|Adverse Event|2|||
161552887|NCT02823964|583414283|FG000|Overall Study|Physician Decision|1|||
161552888|NCT02823964|583414283|FG000|Overall Study|Lack of Efficacy|1|||
161552889|NCT02823964|583414283|FG000|Overall Study|Withdrawal by Subject|1|||
161552890|NCT00610675|583414286|FG000|Overall Study|Untreated|4|||
161552891|NCT00610675|583414286|FG000|Overall Study|Adverse Event|67|||
161552892|NCT00610675|583414286|FG000|Overall Study|Insufficient Effect|31|||
161552893|NCT00610675|583414286|FG000|Overall Study|Withdrawal by Subject|28|||
161552894|NCT00610675|583414286|FG000|Overall Study|Reasons unrelated to trial|27|||
161552895|NCT00610675|583414286|FG000|Overall Study|Lack of Compliance|7|||
161552896|NCT00610675|583414286|FG000|Overall Study|Lost to Follow-up|31|||
161552897|NCT00610675|583414286|FG000|Overall Study|Other reason (not specified)|25|||
161552898|NCT00983619|583414289|FG000|Overall Study|Lost to Follow-up|0|||
161552899|NCT00983619|583414290|FG001|Overall Study|Lost to Follow-up|1|||
161552900|NCT00983619|583414291|FG002|Overall Study|Lost to Follow-up|0|||
161552901|NCT00983619|583414292|FG003|Overall Study|Lost to Follow-up|0|||
161552902|NCT00983619|583414293|FG004|Overall Study|Lost to Follow-up|0|||
161552903|NCT00983619|583414294|FG005|Overall Study|Lost to Follow-up|2|||
161552904|NCT00983619|583414295|FG006|Overall Study|Lost to Follow-up|0|||
161552905|NCT00983619|583414296|FG007|Overall Study|Lost to Follow-up|0|||
161552906|NCT00983619|583414297|FG008|Overall Study|Lost to Follow-up|0|||
161552907|NCT00983619|583414298|FG009|Overall Study|Lost to Follow-up|0|||
161552908|NCT00983619|583414299|FG010|Overall Study|Lost to Follow-up|0|||
161552909|NCT00983619|583414300|FG011|Overall Study|Lost to Follow-up|2|||
161552910|NCT00983619|583414289|FG000|Overall Study|Withdrawal by Subject|2|||
161552911|NCT00983619|583414290|FG001|Overall Study|Withdrawal by Subject|1|||
161552912|NCT00983619|583414291|FG002|Overall Study|Withdrawal by Subject|1|||
161552913|NCT00983619|583414292|FG003|Overall Study|Withdrawal by Subject|3|||
161552914|NCT00983619|583414293|FG004|Overall Study|Withdrawal by Subject|1|||
161552915|NCT00983619|583414294|FG005|Overall Study|Withdrawal by Subject|23|||
161552916|NCT00983619|583414295|FG006|Overall Study|Withdrawal by Subject|0|||
161552917|NCT00983619|583414296|FG007|Overall Study|Withdrawal by Subject|0|||
161552918|NCT00983619|583414297|FG008|Overall Study|Withdrawal by Subject|0|||
161552919|NCT00983619|583414298|FG009|Overall Study|Withdrawal by Subject|0|||
161552920|NCT00983619|583414299|FG010|Overall Study|Withdrawal by Subject|1|||
161552921|NCT00983619|583414300|FG011|Overall Study|Withdrawal by Subject|1|||
161552922|NCT00983619|583414289|FG000|Overall Study|Death|0|||
161552923|NCT00983619|583414290|FG001|Overall Study|Death|2|||
161552924|NCT00983619|583414291|FG002|Overall Study|Death|2|||
161552925|NCT00983619|583414292|FG003|Overall Study|Death|1|||
161552926|NCT00983619|583414293|FG004|Overall Study|Death|2|||
161552927|NCT00983619|583414294|FG005|Overall Study|Death|30|||
161552928|NCT00983619|583414295|FG006|Overall Study|Death|1|||
161552929|NCT00983619|583414296|FG007|Overall Study|Death|0|||
161552930|NCT00983619|583414297|FG008|Overall Study|Death|1|||
161552931|NCT00983619|583414298|FG009|Overall Study|Death|2|||
161552932|NCT00983619|583414299|FG010|Overall Study|Death|9|||
161552933|NCT00983619|583414300|FG011|Overall Study|Death|8|||
161552934|NCT00983619|583414289|FG000|Overall Study|Other|1|||
161552935|NCT00983619|583414290|FG001|Overall Study|Other|0|||
161552936|NCT00983619|583414291|FG002|Overall Study|Other|0|||
161552937|NCT00983619|583414292|FG003|Overall Study|Other|1|||
161552938|NCT00983619|583414293|FG004|Overall Study|Other|0|||
161552939|NCT00983619|583414294|FG005|Overall Study|Other|12|||
161552940|NCT00983619|583414295|FG006|Overall Study|Other|2|||
161552941|NCT00983619|583414296|FG007|Overall Study|Other|2|||
161552942|NCT00983619|583414297|FG008|Overall Study|Other|0|||
161552943|NCT00983619|583414298|FG009|Overall Study|Other|1|||
161552944|NCT00983619|583414299|FG010|Overall Study|Other|1|||
161552945|NCT00983619|583414300|FG011|Overall Study|Other|0|||
161552946|NCT04844918|583414303|FG000|Overall Study|Adverse Event|7|||
161552947|NCT04844918|583414304|FG001|Overall Study|Adverse Event|8|||
161552948|NCT04844918|583414305|FG002|Overall Study|Adverse Event|5|||
161552949|NCT04844918|583414303|FG000|Overall Study|Physician Decision|0|||
161552950|NCT04844918|583414304|FG001|Overall Study|Physician Decision|1|||
161552951|NCT04844918|583414305|FG002|Overall Study|Physician Decision|0|||
161552952|NCT04844918|583414303|FG000|Overall Study|Withdrawal by Subject|6|||
161552953|NCT04844918|583414304|FG001|Overall Study|Withdrawal by Subject|3|||
161552954|NCT04844918|583414305|FG002|Overall Study|Withdrawal by Subject|3|||
161552955|NCT04844918|583414303|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
161552956|NCT04844918|583414304|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
161552957|NCT04844918|583414305|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
161552958|NCT01009047|583414306|FG000|Overall Study|Adverse Event|5|||
161552959|NCT01009047|583414307|FG001|Overall Study|Adverse Event|0|||
161552960|NCT01009047|583414306|FG000|Overall Study|Lost to Follow-up|0|||
161552961|NCT01009047|583414307|FG001|Overall Study|Lost to Follow-up|2|||
161552962|NCT01009047|583414306|FG000|Overall Study|Lack of Efficacy|4|||
161552963|NCT01009047|583414307|FG001|Overall Study|Lack of Efficacy|11|||
161552964|NCT01009047|583414306|FG000|Overall Study|Withdrawal by consent|16|||
161552965|NCT01009047|583414307|FG001|Overall Study|Withdrawal by consent|11|||
161552966|NCT01009047|583414306|FG000|Overall Study|Other|3|||
161552967|NCT01009047|583414307|FG001|Overall Study|Other|2|||
161552968|NCT02443103|583414310|FG000|Overall Study|Adverse Event|2|||
161552969|NCT02443103|583414310|FG000|Overall Study|Noncompliance|1|||
161552970|NCT01630590|583414311|FG000|Overall Study|Adverse Event|9|||
161552971|NCT01630590|583414311|FG000|Overall Study|Lack of Efficacy|37|||
161552972|NCT01630590|583414311|FG000|Overall Study|Withdrawal by Subject|4|||
161552973|NCT01630590|583414311|FG000|Overall Study|2nd primary tumor|2|||
161552974|NCT01630590|583414311|FG000|Overall Study|Automobile accident|1|||
161552975|NCT01630590|583414311|FG000|Overall Study|Maximum benefit|4|||
161552976|NCT02366936|583414313|FG000|Overall Study|Withdrawal by Subject|2|||
161552977|NCT02366936|583414313|FG000|Overall Study|Lost to Follow-up|4|||
161552978|NCT02366936|583414313|FG000|Overall Study|Physician Decision|2|||
161552979|NCT01751113|583414314|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161552980|NCT01751113|583414315|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161552981|NCT01751113|583414316|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161552982|NCT01751113|583414317|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
161552983|NCT01751113|583414318|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
161552984|NCT01751113|583414319|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161552985|NCT01751113|583414314|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
161552986|NCT01751113|583414315|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
161552987|NCT01751113|583414316|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
161552988|NCT01751113|583414317|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
161552989|NCT01751113|583414318|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
161552990|NCT01751113|583414319|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
161552991|NCT02878213|583414320|FG000|Overall Study|Withdrawal by Subject|2|||
161552992|NCT02878213|583414320|FG000|Overall Study|Adverse Event|1|||
161552993|NCT00363896|583414321|FG000|Overall Study|Withdrawal by Subject|29|||
161552994|NCT00363896|583414322|FG001|Overall Study|Withdrawal by Subject|16|||
161552995|NCT00363896|583414321|FG000|Overall Study|Adverse Event|24|||
161552996|NCT00363896|583414322|FG001|Overall Study|Adverse Event|13|||
161552997|NCT00363896|583414321|FG000|Overall Study|COPD exacerbation|13|||
161552998|NCT00363896|583414322|FG001|Overall Study|COPD exacerbation|7|||
161552999|NCT00363896|583414321|FG000|Overall Study|Lack of Efficacy|12|||
161553000|NCT00363896|583414322|FG001|Overall Study|Lack of Efficacy|8|||
161553001|NCT00363896|583414321|FG000|Overall Study|Protocol Violation|6|||
161553002|NCT00363896|583414322|FG001|Overall Study|Protocol Violation|1|||
161553003|NCT00363896|583414321|FG000|Overall Study|Lost to Follow-up|3|||
161553004|NCT00363896|583414322|FG001|Overall Study|Lost to Follow-up|0|||
161553005|NCT00363896|583414321|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
161553006|NCT00363896|583414322|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
161553007|NCT00363896|583414321|FG000|Overall Study|Other|1|||
161553008|NCT00363896|583414322|FG001|Overall Study|Other|2|||
161553009|NCT01558674|583414323|FG000|Part 1|Study Terminated by Sponsor|10|||
161553010|NCT01558674|583414324|FG001|Part 1|Study Terminated by Sponsor|0|||
161553011|NCT01558674|583414323|FG000|Part 1|Withdrawal by Subject|1|||
161553012|NCT01558674|583414324|FG001|Part 1|Withdrawal by Subject|0|||
161553013|NCT01555021|583414329|FG000|Overall Study|Lost to Follow-up|1|||
161553014|NCT01555021|583414330|FG001|Overall Study|Lost to Follow-up|2|||
161553015|NCT01313923|583414334|FG000|Overall Study|Physician Decision|3|||
161553016|NCT02471404|583414335|FG000|Overall Study|Adverse Event|7|||
161553017|NCT02471404|583414336|FG001|Overall Study|Adverse Event|1|||
161553018|NCT02471404|583414337|FG002|Overall Study|Adverse Event|2|||
161553019|NCT02471404|583414335|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
161553020|NCT02471404|583414336|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
161553021|NCT02471404|583414337|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
161553022|NCT02471404|583414335|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
161553023|NCT02471404|583414336|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161553024|NCT02471404|583414337|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
161553025|NCT02471404|583414335|FG000|Overall Study|Lost to Follow-up|1|||
161553026|NCT02471404|583414336|FG001|Overall Study|Lost to Follow-up|1|||
161553027|NCT02471404|583414337|FG002|Overall Study|Lost to Follow-up|3|||
161553028|NCT02471404|583414335|FG000|Overall Study|Protocol Violation|1|||
161553029|NCT02471404|583414336|FG001|Overall Study|Protocol Violation|0|||
161553030|NCT02471404|583414337|FG002|Overall Study|Protocol Violation|0|||
161553031|NCT02471404|583414335|FG000|Overall Study|Withdrawal by Subject|8|||
161553032|NCT02471404|583414336|FG001|Overall Study|Withdrawal by Subject|4|||
161796028|NCT02041702|584296467|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
161796029|NCT00203307|584296468|FG000|First Intervention|Adverse Event|2|||
161796030|NCT00203307|584296469|FG001|First Intervention|Adverse Event|0|||
161796031|NCT03730103|584296470|FG000|Overall Study|Did not meet inclusion criteria|0|||
161796032|NCT03730103|584296471|FG001|Overall Study|Did not meet inclusion criteria|5|||
161796033|NCT02789111|584296472|FG000|Overall Study|Withdrawal by Subject|1|||
161796034|NCT02789111|584296473|FG001|Overall Study|Withdrawal by Subject|4|||
161796035|NCT01488578|584296474|FG000|Overall Study|Protocol Violation|1836|||
161796036|NCT02308111|584296475|FG000|Overall Study|Adverse Event|31|||
161796037|NCT02308111|584296476|FG001|Overall Study|Adverse Event|19|||
161796038|NCT02308111|584296475|FG000|Overall Study|Death|9|||
161796039|NCT02308111|584296476|FG001|Overall Study|Death|6|||
161796040|NCT02308111|584296475|FG000|Overall Study|Lost to Follow-up|2|||
161796041|NCT02308111|584296476|FG001|Overall Study|Lost to Follow-up|7|||
161796042|NCT02308111|584296475|FG000|Overall Study|Physician Decision|6|||
161796043|NCT02308111|584296476|FG001|Overall Study|Physician Decision|17|||
161796044|NCT02308111|584296475|FG000|Overall Study|Protocol Violation|0|||
161796045|NCT02308111|584296476|FG001|Overall Study|Protocol Violation|1|||
161796046|NCT02308111|584296475|FG000|Overall Study|Withdrawal by Subject|28|||
161796047|NCT02308111|584296476|FG001|Overall Study|Withdrawal by Subject|38|||
161796048|NCT02308111|584296475|FG000|Overall Study|Study Terminated by Sponsor|72|||
161796049|NCT02308111|584296476|FG001|Overall Study|Study Terminated by Sponsor|61|||
161796050|NCT02308111|584296475|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
161796051|NCT02308111|584296476|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
161796052|NCT02308111|584296475|FG000|Overall Study|Site Closure|3|||
161796053|NCT02308111|584296476|FG001|Overall Study|Site Closure|3|||
161796054|NCT02308111|584296475|FG000|Overall Study|Non-compliance with Study Drug|3|||
161796055|NCT02308111|584296476|FG001|Overall Study|Non-compliance with Study Drug|1|||
161796056|NCT02308111|584296475|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
161796057|NCT02308111|584296476|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
161796058|NCT02308111|584296475|FG000|Overall Study|Liver Transplant|3|||
161796059|NCT02308111|584296476|FG001|Overall Study|Liver Transplant|3|||
161796060|NCT02308111|584296475|FG000|Overall Study|Liver Transplant Waitlist|2|||
161796061|NCT02308111|584296476|FG001|Overall Study|Liver Transplant Waitlist|2|||
161796062|NCT02308111|584296475|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
161796063|NCT02308111|584296476|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
161796064|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
161796065|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
161796066|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
161796067|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
161796068|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
161796069|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
161796070|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
161796071|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
161796072|NCT03271528|584296478|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
161796073|NCT03271528|584296479|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
161796074|NCT03271528|584296478|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
161796075|NCT03271528|584296479|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
161796076|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
161796077|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
161796078|NCT01896297|584296489|FG000|Overall Study|Died in post treatment phase|1|||
161796079|NCT00003782|584296492|FG000|Overall Study|No follow up data|30|||
161796080|NCT00003782|584296493|FG001|Overall Study|No follow up data|31|||
161796081|NCT00003782|584296494|FG002|Overall Study|No follow up data|26|||
161796082|NCT03626857|584296497|FG000|Overall Study|Adverse Event|9|||
161796083|NCT03626857|584296498|FG001|Overall Study|Adverse Event|7|||
161796084|NCT03626857|584296497|FG000|Overall Study|Lost to Follow-up|8|||
161796085|NCT03626857|584296498|FG001|Overall Study|Lost to Follow-up|8|||
161796086|NCT03626857|584296497|FG000|Overall Study|Withdrawal by Subject|2|||
161796087|NCT03626857|584296498|FG001|Overall Study|Withdrawal by Subject|2|||
161796088|NCT03626857|584296497|FG000|Overall Study|Protocol Violation|1|||
161796089|NCT03626857|584296498|FG001|Overall Study|Protocol Violation|3|||
161900659|NCT01325350|584685141|FG000|Overall Study|Did Not Receive Treatment|0|||
161900660|NCT01325350|584685142|FG001|Overall Study|Did Not Receive Treatment|1|||
161900661|NCT01325350|584685143|FG002|Overall Study|Did Not Receive Treatment|1|||
161900662|NCT01325350|584685144|FG003|Overall Study|Did Not Receive Treatment|0|||
161796090|NCT01301833|584296499|FG000|Overall Study|Adverse Event|7|||
161796091|NCT01301833|584296500|FG001|Overall Study|Adverse Event|5|||
161796092|NCT01301833|584296501|FG002|Overall Study|Adverse Event|5|||
161796093|NCT01301833|584296502|FG003|Overall Study|Adverse Event|5|||
161796094|NCT01301833|584296499|FG000|Overall Study|Lack of Efficacy|1|||
161900663|NCT01325350|584685145|FG004|Overall Study|Did Not Receive Treatment|1|||
161553033|NCT02471404|583414337|FG002|Overall Study|Withdrawal by Subject|5|||
161553034|NCT02471404|583414335|FG000|Overall Study|Other reasons not specified|10|||
161553035|NCT02471404|583414336|FG001|Overall Study|Other reasons not specified|7|||
161553036|NCT02471404|583414337|FG002|Overall Study|Other reasons not specified|12|||
161553037|NCT01388530|583414338|FG000|Overall Study|Lost to Follow-up|5|||
161553038|NCT02420327|583414339|FG000|Overall Study|Adverse Event|7|||
161553039|NCT02420327|583414339|FG000|Overall Study|Pregnancy|1|||
161553040|NCT02420327|583414339|FG000|Overall Study|Withdrawal by Subject|6|||
161553041|NCT02420327|583414339|FG000|Overall Study|Lost to Follow-up|1|||
161553042|NCT02420327|583414339|FG000|Overall Study|Protocol Violation|1|||
161553043|NCT02204293|583414340|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
161553044|NCT02204293|583414341|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
161553045|NCT02204293|583414342|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
161553046|NCT02204293|583414343|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
161553047|NCT02204293|583414344|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
161553048|NCT02204293|583414345|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
161553049|NCT02204293|583414340|FG000|Core Study Part I|Adverse Event|1|||
161553050|NCT02204293|583414341|FG001|Core Study Part I|Adverse Event|0|||
161553051|NCT02204293|583414342|FG002|Core Study Part I|Adverse Event|0|||
161553052|NCT02204293|583414343|FG003|Core Study Part I|Adverse Event|0|||
161553053|NCT02204293|583414344|FG004|Core Study Part I|Adverse Event|0|||
161553054|NCT02204293|583414345|FG005|Core Study Part I|Adverse Event|0|||
161553055|NCT02204293|583414340|FG000|Core Study Part I|Physician Decision|0|||
161553056|NCT02204293|583414341|FG001|Core Study Part I|Physician Decision|3|||
161553057|NCT02204293|583414342|FG002|Core Study Part I|Physician Decision|0|||
161553058|NCT02204293|583414343|FG003|Core Study Part I|Physician Decision|0|||
161553059|NCT02204293|583414344|FG004|Core Study Part I|Physician Decision|0|||
161553060|NCT02204293|583414345|FG005|Core Study Part I|Physician Decision|0|||
161553061|NCT02204293|583414340|FG000|LTE Phase|Study Suspended|0|||
161553062|NCT02204293|583414341|FG001|LTE Phase|Study Suspended|0|||
161553063|NCT02204293|583414342|FG002|LTE Phase|Study Suspended|0|||
161553064|NCT02204293|583414343|FG003|LTE Phase|Study Suspended|0|||
161553065|NCT02204293|583414344|FG004|LTE Phase|Study Suspended|0|||
161553066|NCT02204293|583414345|FG005|LTE Phase|Study Suspended|7|||
161553067|NCT01225835|583414348|FG000|Overall Study|Completed protocol|2|||
161553068|NCT01225835|583414349|FG001|Overall Study|Completed protocol|1|||
161553069|NCT01225835|583414348|FG000|Overall Study|Did not meet hCG criterion|2|||
161553070|NCT01225835|583414349|FG001|Overall Study|Did not meet hCG criterion|0|||
161553071|NCT01225835|583414348|FG000|Overall Study|Adverse Event|2|||
161553072|NCT01225835|583414349|FG001|Overall Study|Adverse Event|1|||
161553073|NCT01225835|583414348|FG000|Overall Study|Other|1|||
161553074|NCT01225835|583414349|FG001|Overall Study|Other|1|||
161553075|NCT01146574|583414350|FG000|Overall Study|Death|0|||
161553076|NCT01146574|583414351|FG001|Overall Study|Death|1|||
161553077|NCT01146574|583414352|FG002|Overall Study|Death|1|||
161553078|NCT01146574|583414353|FG003|Overall Study|Death|0|||
161553079|NCT01146574|583414354|FG004|Overall Study|Death|0|||
161553080|NCT01146574|583414355|FG005|Overall Study|Death|0|||
161553081|NCT01146574|583414356|FG006|Overall Study|Death|0|||
161553082|NCT01146574|583414350|FG000|Overall Study|Other reasons|0|||
161553083|NCT01146574|583414351|FG001|Overall Study|Other reasons|0|||
161553084|NCT01146574|583414352|FG002|Overall Study|Other reasons|3|||
161553085|NCT01146574|583414353|FG003|Overall Study|Other reasons|0|||
161553086|NCT01146574|583414354|FG004|Overall Study|Other reasons|0|||
161553087|NCT01146574|583414355|FG005|Overall Study|Other reasons|0|||
161553088|NCT01146574|583414356|FG006|Overall Study|Other reasons|0|||
161553089|NCT01146574|583414350|FG000|Overall Study|Kidney transplant|0|||
161553090|NCT01146574|583414351|FG001|Overall Study|Kidney transplant|0|||
161553091|NCT01146574|583414352|FG002|Overall Study|Kidney transplant|1|||
161553092|NCT01146574|583414353|FG003|Overall Study|Kidney transplant|1|||
161553093|NCT01146574|583414354|FG004|Overall Study|Kidney transplant|0|||
161553094|NCT01146574|583414355|FG005|Overall Study|Kidney transplant|0|||
161553095|NCT01146574|583414356|FG006|Overall Study|Kidney transplant|0|||
161553096|NCT01146574|583414350|FG000|Overall Study|Withdrew consent|0|||
161553097|NCT01146574|583414351|FG001|Overall Study|Withdrew consent|0|||
161553098|NCT01146574|583414352|FG002|Overall Study|Withdrew consent|1|||
161553099|NCT01146574|583414353|FG003|Overall Study|Withdrew consent|1|||
161553100|NCT01146574|583414354|FG004|Overall Study|Withdrew consent|2|||
161553101|NCT01146574|583414355|FG005|Overall Study|Withdrew consent|1|||
161553102|NCT01146574|583414356|FG006|Overall Study|Withdrew consent|1|||
161553103|NCT01266993|583414357|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
161553104|NCT01266993|583414358|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
161553105|NCT01266993|583414357|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
161553106|NCT01266993|583414358|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
161553107|NCT03051659|583414359|FG000|Treatment Period|Withdrawal by Subject|0|||
161553108|NCT03051659|583414360|FG001|Treatment Period|Withdrawal by Subject|2|||
161553109|NCT03051659|583414359|FG000|Survival Follow-up|Lost to Follow-up|23|||
161796095|NCT01301833|584296500|FG001|Overall Study|Lack of Efficacy|1|||
161796096|NCT01301833|584296501|FG002|Overall Study|Lack of Efficacy|0|||
161796097|NCT01301833|584296502|FG003|Overall Study|Lack of Efficacy|0|||
161796098|NCT01301833|584296499|FG000|Overall Study|Physician Decision|3|||
161796099|NCT01301833|584296500|FG001|Overall Study|Physician Decision|1|||
161796100|NCT01301833|584296501|FG002|Overall Study|Physician Decision|1|||
161796101|NCT01301833|584296502|FG003|Overall Study|Physician Decision|0|||
161796102|NCT01301833|584296499|FG000|Overall Study|Withdrawal by Subject|3|||
161796103|NCT01301833|584296500|FG001|Overall Study|Withdrawal by Subject|1|||
161796104|NCT01301833|584296501|FG002|Overall Study|Withdrawal by Subject|1|||
161796105|NCT01301833|584296502|FG003|Overall Study|Withdrawal by Subject|2|||
161796106|NCT01301833|584296499|FG000|Overall Study|Personal matter|1|||
161796107|NCT01301833|584296500|FG001|Overall Study|Personal matter|0|||
161796108|NCT01301833|584296501|FG002|Overall Study|Personal matter|0|||
161796109|NCT01301833|584296502|FG003|Overall Study|Personal matter|0|||
161796110|NCT02637557|584298157|FG000|Overall Study|Adverse Event|3|||
161796111|NCT02637557|584298158|FG001|Overall Study|Adverse Event|1|||
161796112|NCT02637557|584298159|FG002|Overall Study|Adverse Event|3|||
161796113|NCT02637557|584298160|FG003|Overall Study|Adverse Event|3|||
161796114|NCT02637557|584298157|FG000|Overall Study|Lost to Follow-up|1|||
161796115|NCT02637557|584298158|FG001|Overall Study|Lost to Follow-up|1|||
161796116|NCT02637557|584298159|FG002|Overall Study|Lost to Follow-up|0|||
161796117|NCT02637557|584298160|FG003|Overall Study|Lost to Follow-up|1|||
161796118|NCT02637557|584298157|FG000|Overall Study|Physician Decision|1|||
161796119|NCT02637557|584298158|FG001|Overall Study|Physician Decision|0|||
161796120|NCT02637557|584298159|FG002|Overall Study|Physician Decision|0|||
161796121|NCT02637557|584298160|FG003|Overall Study|Physician Decision|0|||
161796122|NCT02637557|584298157|FG000|Overall Study|Protocol Violation|2|||
161796123|NCT02637557|584298158|FG001|Overall Study|Protocol Violation|0|||
161796124|NCT02637557|584298159|FG002|Overall Study|Protocol Violation|2|||
161796125|NCT02637557|584298160|FG003|Overall Study|Protocol Violation|1|||
161796126|NCT02637557|584298157|FG000|Overall Study|Withdrawal by Subject|1|||
161796127|NCT02637557|584298158|FG001|Overall Study|Withdrawal by Subject|3|||
161796128|NCT02637557|584298159|FG002|Overall Study|Withdrawal by Subject|4|||
161796129|NCT02637557|584298160|FG003|Overall Study|Withdrawal by Subject|2|||
161796130|NCT05218655|584298161|FG000|Overall Study|Adverse Event|6|||
161796131|NCT05218655|584298161|FG000|Overall Study|Sponsor's decision|85|||
161796132|NCT05218655|584298161|FG000|Overall Study|Death|1|||
161796133|NCT05218655|584298161|FG000|Overall Study|Lost to Follow-up|3|||
161796134|NCT05218655|584298161|FG000|Overall Study|Withdrawal by Subject|3|||
161796135|NCT05218655|584298161|FG000|Overall Study|Other than specified|3|||
161796136|NCT02228382|584298164|FG000|Overall Study|Death|5|||
161796137|NCT02228382|584298165|FG001|Overall Study|Death|7|||
161796138|NCT02228382|584298166|FG002|Overall Study|Death|5|||
161796139|NCT02228382|584298167|FG003|Overall Study|Death|0|||
161796140|NCT02228382|584298168|FG004|Overall Study|Death|2|||
161796141|NCT02228382|584298164|FG000|Overall Study|Participant refused further follow-up|0|||
161796142|NCT02228382|584298165|FG001|Overall Study|Participant refused further follow-up|0|||
161796143|NCT02228382|584298166|FG002|Overall Study|Participant refused further follow-up|1|||
161448342|NCT00966875|583037379|FG005|Part B|Withdrawal by Subject|1|||
161448343|NCT00966875|583037380|FG006|Part B|Withdrawal by Subject|4|||
161448344|NCT00966875|583037381|FG007|Part B|Withdrawal by Subject|5|||
161448345|NCT00966875|583037382|FG008|Part B|Withdrawal by Subject|5|||
161448346|NCT00966875|583037374|FG000|Part B|Entry Criteria|0|||
161448347|NCT00966875|583037375|FG001|Part B|Entry Criteria|0|||
161448348|NCT00966875|583037376|FG002|Part B|Entry Criteria|0|||
161448349|NCT00966875|583037377|FG003|Part B|Entry Criteria|0|||
161448350|NCT00966875|583037378|FG004|Part B|Entry Criteria|0|||
161448351|NCT00966875|583037379|FG005|Part B|Entry Criteria|0|||
161448352|NCT00966875|583037380|FG006|Part B|Entry Criteria|1|||
161448353|NCT00966875|583037381|FG007|Part B|Entry Criteria|0|||
161448354|NCT00966875|583037382|FG008|Part B|Entry Criteria|1|||
161448355|NCT00444678|583037383|FG000|Overall Study|Toxicity|11|||
161448356|NCT00444678|583037383|FG000|Overall Study|Disease Progression|12|||
161448357|NCT00444678|583037383|FG000|Overall Study|Death|3|||
161448358|NCT00444678|583037383|FG000|Overall Study|Physician Decision|3|||
161448359|NCT00444678|583037383|FG000|Overall Study|Withdrawal by Subject|2|||
161796144|NCT02228382|584298167|FG003|Overall Study|Participant refused further follow-up|0|||
161796145|NCT02228382|584298168|FG004|Overall Study|Participant refused further follow-up|0|||
161796146|NCT02228382|584298164|FG000|Overall Study|Study terminated by sponsor|3|||
161796147|NCT02228382|584298165|FG001|Overall Study|Study terminated by sponsor|5|||
161796148|NCT02228382|584298166|FG002|Overall Study|Study terminated by sponsor|7|||
161796149|NCT02228382|584298167|FG003|Overall Study|Study terminated by sponsor|0|||
161796150|NCT02228382|584298168|FG004|Overall Study|Study terminated by sponsor|0|||
161796151|NCT02228382|584298164|FG000|Overall Study|Lost to Follow-up|0|||
161448360|NCT01305577|583037386|FG000|Overall Study|Adverse Event|2|||
161448361|NCT01305577|583037387|FG001|Overall Study|Adverse Event|2|||
161448362|NCT01305577|583037388|FG002|Overall Study|Adverse Event|1|||
161796152|NCT02228382|584298165|FG001|Overall Study|Lost to Follow-up|0|||
161796153|NCT02228382|584298166|FG002|Overall Study|Lost to Follow-up|3|||
161553110|NCT03051659|583414360|FG001|Survival Follow-up|Lost to Follow-up|22|||
161553111|NCT04779242|583414361|FG000|Overall Study|Adverse Event|1|||
161553112|NCT04779242|583414362|FG001|Overall Study|Adverse Event|1|||
161553113|NCT04779242|583414361|FG000|Overall Study|Lost to Follow-up|2|||
161553114|NCT04779242|583414362|FG001|Overall Study|Lost to Follow-up|4|||
161553115|NCT04779242|583414361|FG000|Overall Study|Withdrawal by Subject|7|||
161553116|NCT04779242|583414362|FG001|Overall Study|Withdrawal by Subject|9|||
161553117|NCT04779242|583414361|FG000|Overall Study|Death|6|||
161553118|NCT04779242|583414362|FG001|Overall Study|Death|6|||
161553119|NCT04779242|583414361|FG000|Overall Study|COVID-19 related reasons|2|||
161553120|NCT04779242|583414362|FG001|Overall Study|COVID-19 related reasons|1|||
161553121|NCT04779242|583414361|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
161553122|NCT04779242|583414362|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
161553123|NCT04779242|583414361|FG000|Overall Study|Martial Law in Ukraine|2|||
161553124|NCT04779242|583414362|FG001|Overall Study|Martial Law in Ukraine|3|||
161553125|NCT00849680|583414367|FG000|Overall Study|Adverse Event|0|||
161553126|NCT00849680|583414368|FG001|Overall Study|Adverse Event|0|||
161553127|NCT00849680|583414369|FG002|Overall Study|Adverse Event|0|||
161553128|NCT00849680|583414370|FG003|Overall Study|Adverse Event|0|||
161553129|NCT00849680|583414371|FG004|Overall Study|Adverse Event|0|||
161553130|NCT00849680|583414372|FG005|Overall Study|Adverse Event|0|||
161553131|NCT00849680|583414373|FG006|Overall Study|Adverse Event|2|||
161553132|NCT00849680|583414374|FG007|Overall Study|Adverse Event|0|||
161553133|NCT00849680|583414367|FG000|Overall Study|Lost to Follow-up|7|||
161553134|NCT00849680|583414368|FG001|Overall Study|Lost to Follow-up|3|||
161553135|NCT00849680|583414369|FG002|Overall Study|Lost to Follow-up|12|||
161553136|NCT00849680|583414370|FG003|Overall Study|Lost to Follow-up|11|||
161553137|NCT00849680|583414371|FG004|Overall Study|Lost to Follow-up|8|||
161553138|NCT00849680|583414372|FG005|Overall Study|Lost to Follow-up|11|||
161553139|NCT00849680|583414373|FG006|Overall Study|Lost to Follow-up|12|||
161553140|NCT00849680|583414374|FG007|Overall Study|Lost to Follow-up|5|||
161553141|NCT00849680|583414367|FG000|Overall Study|Subject moved|1|||
161553142|NCT00849680|583414368|FG001|Overall Study|Subject moved|0|||
161553143|NCT00849680|583414369|FG002|Overall Study|Subject moved|3|||
161553144|NCT00849680|583414370|FG003|Overall Study|Subject moved|1|||
161553145|NCT00849680|583414371|FG004|Overall Study|Subject moved|0|||
161553146|NCT00849680|583414372|FG005|Overall Study|Subject moved|2|||
161553147|NCT00849680|583414373|FG006|Overall Study|Subject moved|2|||
161553148|NCT00849680|583414374|FG007|Overall Study|Subject moved|2|||
161553149|NCT00849680|583414367|FG000|Overall Study|Withdrawal by Subject|2|||
161553150|NCT00849680|583414368|FG001|Overall Study|Withdrawal by Subject|0|||
161553151|NCT00849680|583414369|FG002|Overall Study|Withdrawal by Subject|0|||
161553152|NCT00849680|583414370|FG003|Overall Study|Withdrawal by Subject|2|||
161553153|NCT00849680|583414371|FG004|Overall Study|Withdrawal by Subject|2|||
161553154|NCT00849680|583414372|FG005|Overall Study|Withdrawal by Subject|2|||
161553155|NCT00849680|583414373|FG006|Overall Study|Withdrawal by Subject|1|||
161553156|NCT00849680|583414374|FG007|Overall Study|Withdrawal by Subject|1|||
161553157|NCT00849680|583414367|FG000|Overall Study|Subject unable to comply with protocol|1|||
161553158|NCT00849680|583414368|FG001|Overall Study|Subject unable to comply with protocol|0|||
161553159|NCT00849680|583414369|FG002|Overall Study|Subject unable to comply with protocol|0|||
161553160|NCT00849680|583414370|FG003|Overall Study|Subject unable to comply with protocol|0|||
161553161|NCT00849680|583414371|FG004|Overall Study|Subject unable to comply with protocol|0|||
161553162|NCT00849680|583414372|FG005|Overall Study|Subject unable to comply with protocol|0|||
161553163|NCT00849680|583414373|FG006|Overall Study|Subject unable to comply with protocol|0|||
161553164|NCT00849680|583414374|FG007|Overall Study|Subject unable to comply with protocol|0|||
161553165|NCT04285229|583414375|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161553166|NCT04285229|583414376|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161553167|NCT04285229|583414377|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161553168|NCT04285229|583414378|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161553169|NCT04285229|583414379|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161553170|NCT04285229|583414380|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161553171|NCT04285229|583414375|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
161553172|NCT04285229|583414376|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
161553173|NCT04285229|583414377|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
161553174|NCT04285229|583414378|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
161553175|NCT04285229|583414379|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
161553176|NCT04285229|583414380|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
161553177|NCT04285229|583414375|FG000|Extended Treatment Period|Adverse Event|0|||
161553178|NCT04285229|583414376|FG001|Extended Treatment Period|Adverse Event|0|||
161553179|NCT04285229|583414377|FG002|Extended Treatment Period|Adverse Event|0|||
161553180|NCT04285229|583414378|FG003|Extended Treatment Period|Adverse Event|1|||
161553181|NCT04285229|583414379|FG004|Extended Treatment Period|Adverse Event|0|||
161553182|NCT04285229|583414380|FG005|Extended Treatment Period|Adverse Event|0|||
161553183|NCT04285229|583414375|FG000|Extended Treatment Period|Physician Decision|0|||
161796154|NCT02228382|584298167|FG003|Overall Study|Lost to Follow-up|1|||
161553184|NCT04285229|583414376|FG001|Extended Treatment Period|Physician Decision|0|||
161553185|NCT04285229|583414377|FG002|Extended Treatment Period|Physician Decision|1|||
161553186|NCT04285229|583414378|FG003|Extended Treatment Period|Physician Decision|0|||
161553187|NCT04285229|583414379|FG004|Extended Treatment Period|Physician Decision|0|||
161553188|NCT04285229|583414380|FG005|Extended Treatment Period|Physician Decision|0|||
161553189|NCT04285229|583414375|FG000|Follow-up Period|Adverse Event|0|||
161553190|NCT04285229|583414376|FG001|Follow-up Period|Adverse Event|0|||
161553191|NCT04285229|583414377|FG002|Follow-up Period|Adverse Event|0|||
161553192|NCT04285229|583414378|FG003|Follow-up Period|Adverse Event|0|||
161553193|NCT04285229|583414379|FG004|Follow-up Period|Adverse Event|1|||
161553194|NCT04285229|583414380|FG005|Follow-up Period|Adverse Event|4|||
161553195|NCT04285229|583414375|FG000|Follow-up Period|Withdrawal by Subject|0|||
161553196|NCT04285229|583414376|FG001|Follow-up Period|Withdrawal by Subject|0|||
161553197|NCT04285229|583414377|FG002|Follow-up Period|Withdrawal by Subject|0|||
161553198|NCT04285229|583414378|FG003|Follow-up Period|Withdrawal by Subject|0|||
161553199|NCT04285229|583414379|FG004|Follow-up Period|Withdrawal by Subject|0|||
161553200|NCT04285229|583414380|FG005|Follow-up Period|Withdrawal by Subject|5|||
161553201|NCT04285229|583414375|FG000|Follow-up Period|Covid-19|0|||
161553202|NCT04285229|583414376|FG001|Follow-up Period|Covid-19|0|||
161553203|NCT04285229|583414377|FG002|Follow-up Period|Covid-19|0|||
161553204|NCT04285229|583414378|FG003|Follow-up Period|Covid-19|0|||
161553205|NCT04285229|583414379|FG004|Follow-up Period|Covid-19|0|||
161553206|NCT04285229|583414380|FG005|Follow-up Period|Covid-19|2|||
161553207|NCT04285229|583414375|FG000|Follow-up Period|Physician Decision|0|||
161553208|NCT04285229|583414376|FG001|Follow-up Period|Physician Decision|0|||
161553209|NCT04285229|583414377|FG002|Follow-up Period|Physician Decision|0|||
161553210|NCT04285229|583414378|FG003|Follow-up Period|Physician Decision|0|||
161553211|NCT04285229|583414379|FG004|Follow-up Period|Physician Decision|0|||
161553212|NCT04285229|583414380|FG005|Follow-up Period|Physician Decision|1|||
161553213|NCT00514046|583414387|FG000|Overall Study|transferred to another protocol|2|||
161553214|NCT00514046|583414388|FG001|Overall Study|transferred to another protocol|1|||
161553215|NCT00514046|583414389|FG002|Overall Study|transferred to another protocol|3|||
161553216|NCT00514046|583414390|FG003|Overall Study|transferred to another protocol|0|||
161553217|NCT00514046|583414391|FG004|Overall Study|transferred to another protocol|1|||
161553218|NCT00514046|583414392|FG005|Overall Study|transferred to another protocol|0|||
161553219|NCT00514046|583414393|FG006|Overall Study|transferred to another protocol|0|||
161553220|NCT00514046|583414394|FG007|Overall Study|transferred to another protocol|0|||
161553221|NCT00514046|583414395|FG008|Overall Study|transferred to another protocol|0|||
161553222|NCT00514046|583414387|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
161553223|NCT00514046|583414388|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
161553224|NCT00514046|583414389|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
161553225|NCT00514046|583414390|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
161553226|NCT00514046|583414391|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
161553227|NCT00514046|583414392|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
161553228|NCT00514046|583414393|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
161553229|NCT00514046|583414394|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
161553230|NCT00514046|583414395|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
161553231|NCT00514046|583414387|FG000|Overall Study|Disease progression on study|0|||
161553232|NCT00514046|583414388|FG001|Overall Study|Disease progression on study|0|||
161553233|NCT00514046|583414389|FG002|Overall Study|Disease progression on study|2|||
161553234|NCT00514046|583414390|FG003|Overall Study|Disease progression on study|0|||
161553235|NCT00514046|583414391|FG004|Overall Study|Disease progression on study|0|||
161553236|NCT00514046|583414392|FG005|Overall Study|Disease progression on study|1|||
161553237|NCT00514046|583414393|FG006|Overall Study|Disease progression on study|0|||
161553238|NCT00514046|583414394|FG007|Overall Study|Disease progression on study|0|||
161553239|NCT00514046|583414395|FG008|Overall Study|Disease progression on study|0|||
161553240|NCT00655551|583414396|FG000|All Periods Combined|Adverse Event|0|||
161553241|NCT00655551|583414397|FG001|All Periods Combined|Adverse Event|3|||
161553242|NCT00655551|583414398|FG002|All Periods Combined|Adverse Event|4|||
161553243|NCT00655551|583414396|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
161553244|NCT00655551|583414397|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
161553245|NCT00655551|583414398|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
161553246|NCT00655551|583414396|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
161553247|NCT00655551|583414397|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
161553248|NCT00655551|583414398|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
161553249|NCT00655551|583414396|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
161553250|NCT00655551|583414397|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
161553251|NCT00655551|583414398|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
161553252|NCT02855164|583414400|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
161553253|NCT02855164|583414401|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
161553254|NCT02855164|583414402|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
161553255|NCT02855164|583414403|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
161553256|NCT02855164|583414404|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
161553257|NCT02855164|583414405|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
161553258|NCT02855164|583414406|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
161553259|NCT02855164|583414407|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
161553260|NCT02855164|583414400|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
161553261|NCT02855164|583414401|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
161553262|NCT02855164|583414402|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
161553263|NCT02855164|583414403|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
161553264|NCT02855164|583414404|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
161553265|NCT02855164|583414405|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
161553266|NCT02855164|583414406|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
161553267|NCT02855164|583414407|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
161553268|NCT02855164|583414400|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
161553269|NCT02855164|583414401|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
161553270|NCT02855164|583414402|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
161553271|NCT02855164|583414403|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
161553272|NCT02855164|583414404|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
161553273|NCT02855164|583414405|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
161553274|NCT02855164|583414406|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
161553275|NCT02855164|583414407|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
161553276|NCT02855164|583414400|FG000|Part C (Randomized Set)|Adverse Event|0|||
161553277|NCT02855164|583414401|FG001|Part C (Randomized Set)|Adverse Event|0|||
161553278|NCT02855164|583414402|FG002|Part C (Randomized Set)|Adverse Event|0|||
161553279|NCT02855164|583414403|FG003|Part C (Randomized Set)|Adverse Event|0|||
161553280|NCT02855164|583414404|FG004|Part C (Randomized Set)|Adverse Event|0|||
161553281|NCT02855164|583414405|FG005|Part C (Randomized Set)|Adverse Event|5|||
161553282|NCT02855164|583414406|FG006|Part C (Randomized Set)|Adverse Event|9|||
161553283|NCT02855164|583414407|FG007|Part C (Randomized Set)|Adverse Event|2|||
161553284|NCT02855164|583414400|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
161553285|NCT02855164|583414401|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
161553286|NCT02855164|583414402|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
161553287|NCT02855164|583414403|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
161553288|NCT02855164|583414404|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
161553289|NCT02855164|583414405|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
161796155|NCT02228382|584298168|FG004|Overall Study|Lost to Follow-up|0|||
161796156|NCT02228382|584298164|FG000|Overall Study|Withdrawal by Subject|0|||
161796157|NCT02228382|584298165|FG001|Overall Study|Withdrawal by Subject|3|||
161796158|NCT02228382|584298166|FG002|Overall Study|Withdrawal by Subject|2|||
161796159|NCT02228382|584298167|FG003|Overall Study|Withdrawal by Subject|1|||
161796160|NCT02228382|584298168|FG004|Overall Study|Withdrawal by Subject|0|||
161796161|NCT02228382|584298164|FG000|Overall Study|Other|2|||
161796162|NCT02228382|584298165|FG001|Overall Study|Other|3|||
161796163|NCT02228382|584298166|FG002|Overall Study|Other|3|||
161796164|NCT02228382|584298167|FG003|Overall Study|Other|0|||
161796165|NCT02228382|584298168|FG004|Overall Study|Other|0|||
161796166|NCT02396381|584298169|FG000|Overall Study|Adverse Event|3|||
161796167|NCT02396381|584298170|FG001|Overall Study|Adverse Event|2|||
161796168|NCT02396381|584298169|FG000|Overall Study|Withdrawal by Subject|33|||
161796169|NCT02396381|584298170|FG001|Overall Study|Withdrawal by Subject|24|||
161796170|NCT02396381|584298169|FG000|Overall Study|Lost to Follow-up|49|||
161796171|NCT02396381|584298170|FG001|Overall Study|Lost to Follow-up|31|||
161796172|NCT02396381|584298169|FG000|Overall Study|Protocol Violation|1|||
161796173|NCT02396381|584298170|FG001|Overall Study|Protocol Violation|0|||
161796174|NCT02396381|584298169|FG000|Overall Study|Site terminated by sponsor|7|||
161796175|NCT02396381|584298170|FG001|Overall Study|Site terminated by sponsor|8|||
161796176|NCT02396381|584298169|FG000|Overall Study|Physician Decision|5|||
161796177|NCT02396381|584298170|FG001|Overall Study|Physician Decision|5|||
161796178|NCT02396381|584298169|FG000|Overall Study|Pregnancy|2|||
161796179|NCT02396381|584298170|FG001|Overall Study|Pregnancy|0|||
161796180|NCT02396381|584298169|FG000|Overall Study|Non-compliance with study procedures|1|||
161796181|NCT02396381|584298170|FG001|Overall Study|Non-compliance with study procedures|0|||
161796182|NCT02396381|584298169|FG000|Overall Study|Moved out of town/state|1|||
161796183|NCT02396381|584298170|FG001|Overall Study|Moved out of town/state|3|||
161796184|NCT02396381|584298169|FG000|Overall Study|Could not complete visit|1|||
161796185|NCT02396381|584298170|FG001|Overall Study|Could not complete visit|0|||
161796186|NCT02396381|584298169|FG000|Overall Study|Possible conflict of interest|1|||
161796187|NCT02396381|584298170|FG001|Overall Study|Possible conflict of interest|0|||
161553290|NCT02855164|583414406|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
161553291|NCT02855164|583414407|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
161796188|NCT02396381|584298169|FG000|Overall Study|Randomization/Screening Error|3|||
161553292|NCT02855164|583414400|FG000|Part C (Randomized Set)|Physician Decision|0|||
161796189|NCT02396381|584298170|FG001|Overall Study|Randomization/Screening Error|1|||
161796190|NCT00113490|584298171|FG000|Overall Study|Withdrawal by Subject|1|||
161448363|NCT01305577|583037386|FG000|Overall Study|Withdrawal by Subject|7|||
161448364|NCT01305577|583037387|FG001|Overall Study|Withdrawal by Subject|5|||
161448365|NCT01305577|583037388|FG002|Overall Study|Withdrawal by Subject|6|||
161448366|NCT01305577|583037386|FG000|Overall Study|Lost to Follow-up|4|||
161448367|NCT01305577|583037387|FG001|Overall Study|Lost to Follow-up|3|||
161448368|NCT01305577|583037388|FG002|Overall Study|Lost to Follow-up|2|||
161448369|NCT01305577|583037386|FG000|Overall Study|Protocol Deviation|0|||
161448370|NCT01305577|583037387|FG001|Overall Study|Protocol Deviation|1|||
161448371|NCT01305577|583037388|FG002|Overall Study|Protocol Deviation|1|||
161448372|NCT00796978|583037389|FG000|Overall Study|Cardiac adverse event|5|||
161448373|NCT00796978|583037389|FG000|Overall Study|Adverse Event|4|||
161448374|NCT00796978|583037389|FG000|Overall Study|Withdrawal by Subject|3|||
161448375|NCT01256190|583037390|FG000|Overall Study|Lost to Follow-up|2|||
161448376|NCT01256190|583037391|FG001|Overall Study|Lost to Follow-up|0|||
161448377|NCT02834793|583037392|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
161448378|NCT02834793|583037393|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
161448379|NCT02834793|583037394|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
161448380|NCT02834793|583037395|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
161448381|NCT02834793|583037392|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
161448382|NCT02834793|583037393|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
161448383|NCT02834793|583037394|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
161448384|NCT02834793|583037395|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
161448385|NCT02834793|583037392|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
161448386|NCT02834793|583037393|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
161448387|NCT02834793|583037394|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
161448388|NCT02834793|583037395|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
161448389|NCT02834793|583037392|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
161448390|NCT02834793|583037393|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
161448391|NCT02834793|583037394|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
161448392|NCT02834793|583037395|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
161448393|NCT02834793|583037392|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
161448394|NCT02834793|583037393|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
161448395|NCT02834793|583037394|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
161448396|NCT02834793|583037395|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
161448397|NCT02834793|583037392|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
161448398|NCT02834793|583037393|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
161448399|NCT02834793|583037394|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
161448400|NCT02834793|583037395|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
161448401|NCT02834793|583037392|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
161448402|NCT02834793|583037393|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
161448403|NCT02834793|583037394|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
161448404|NCT02834793|583037395|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
161448405|NCT02834793|583037392|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
161448406|NCT02834793|583037393|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
161448407|NCT02834793|583037394|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
161448408|NCT02834793|583037395|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
161448409|NCT02834793|583037392|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
161448410|NCT02834793|583037393|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
161448411|NCT02834793|583037394|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
161448412|NCT02834793|583037395|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
161448413|NCT02834793|583037392|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
161448414|NCT02834793|583037393|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
161448415|NCT02834793|583037394|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
161448416|NCT02834793|583037395|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
161448417|NCT02834793|583037392|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
161448418|NCT02834793|583037393|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
161448419|NCT02834793|583037394|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
161448420|NCT02834793|583037395|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
161448421|NCT02834793|583037392|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
161448422|NCT02834793|583037393|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
161448423|NCT02834793|583037394|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
161448424|NCT02834793|583037395|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
161448425|NCT02834793|583037392|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
161448426|NCT02834793|583037393|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
161448427|NCT02834793|583037394|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
161448428|NCT02834793|583037395|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
161448429|NCT02834793|583037392|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
161448430|NCT02834793|583037393|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
161448431|NCT02834793|583037394|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
161448432|NCT02834793|583037395|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
161448433|NCT02834793|583037392|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
161448434|NCT02834793|583037393|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
161448435|NCT02834793|583037394|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
161448436|NCT02834793|583037395|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
161448437|NCT02364336|583037396|FG000|Overall Study|Adverse Event|0|||
161448438|NCT02364336|583037397|FG001|Overall Study|Adverse Event|1|||
161448439|NCT01731938|583037398|FG000|Preliminary Part I|Withdrawal by Subject|2|||
161448440|NCT01731938|583037399|FG001|Preliminary Part I|Withdrawal by Subject|2|||
161448441|NCT01731938|583037398|FG000|Preliminary Part I|Physician Decision|1|||
161448442|NCT01731938|583037399|FG001|Preliminary Part I|Physician Decision|0|||
161448443|NCT01731938|583037398|FG000|Preliminary Part I|Lost to Follow-up|0|||
161448444|NCT01731938|583037399|FG001|Preliminary Part I|Lost to Follow-up|3|||
161448445|NCT01731938|583037398|FG000|Preliminary Part I|Missed Week 6 visit|0|||
161448446|NCT01731938|583037399|FG001|Preliminary Part I|Missed Week 6 visit|3|||
161448447|NCT01731938|583037398|FG000|Primary Part II|Withdrawal by Subject|5|||
161448448|NCT01731938|583037399|FG001|Primary Part II|Withdrawal by Subject|4|||
161448449|NCT01731938|583037398|FG000|Primary Part II|Lost to Follow-up|4|||
161448450|NCT01731938|583037399|FG001|Primary Part II|Lost to Follow-up|5|||
161448451|NCT01731938|583037398|FG000|Primary Part II|Death|2|||
161448452|NCT01731938|583037399|FG001|Primary Part II|Death|1|||
161448453|NCT01731938|583037398|FG000|Primary Part II|Missed Week 6 visit|2|||
161448454|NCT01731938|583037399|FG001|Primary Part II|Missed Week 6 visit|3|||
161448455|NCT03319745|583037400|FG000|Overall Study|Death|1|||
161448456|NCT03319745|583037400|FG000|Overall Study|Toxicity Precluding Surgery|1|||
161448457|NCT00870103|583037401|FG000|Overall Study|Physician Decision|2|||
161448458|NCT00870103|583037401|FG000|Overall Study|Lost to Follow-up|2|||
161448459|NCT01317550|583037402|FG000|Overall Study|Withdrawal by Subject|1|||
161448460|NCT01317550|583037403|FG001|Overall Study|Withdrawal by Subject|0|||
161448461|NCT01317550|583037404|FG002|Overall Study|Withdrawal by Subject|0|||
161448462|NCT01317550|583037405|FG003|Overall Study|Withdrawal by Subject|0|||
161448463|NCT01317550|583037402|FG000|Overall Study|Lack of compliance study med|1|||
161448464|NCT01317550|583037403|FG001|Overall Study|Lack of compliance study med|0|||
161448465|NCT01317550|583037404|FG002|Overall Study|Lack of compliance study med|0|||
161448466|NCT01317550|583037405|FG003|Overall Study|Lack of compliance study med|0|||
161448467|NCT03179202|583037406|FG000|Overall Study|Screen Failure|67|||
161448468|NCT03179202|583037406|FG000|Overall Study|Subject Lost to Follow Up|12|||
161448469|NCT03179202|583037406|FG000|Overall Study|Withdrawal by Subject|7|||
161448470|NCT03179202|583037406|FG000|Overall Study|Adverse Event|3|||
161448471|NCT03179202|583037406|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
161448472|NCT03179202|583037406|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
161448473|NCT03255629|583037407|FG000|Overall Study|Adverse Event|1|||
161448474|NCT03255629|583037408|FG001|Overall Study|Adverse Event|0|||
161448475|NCT03255629|583037407|FG000|Overall Study|did not experience hypoglycemia|2|||
161448476|NCT03255629|583037408|FG001|Overall Study|did not experience hypoglycemia|1|||
161448477|NCT02082340|583037410|FG000|Overall Study|Lost to Follow-up|1|||
161448478|NCT02082340|583037411|FG001|Overall Study|Lost to Follow-up|1|||
161448479|NCT03899805|583037412|FG000|Overall Study|Physician Decision|3|||
161448480|NCT03899805|583037413|FG001|Overall Study|Physician Decision|0|||
161448481|NCT03899805|583037414|FG002|Overall Study|Physician Decision|2|||
161448482|NCT03899805|583037412|FG000|Overall Study|Withdrawal by Subject|1|||
161448483|NCT03899805|583037413|FG001|Overall Study|Withdrawal by Subject|0|||
161448484|NCT03899805|583037414|FG002|Overall Study|Withdrawal by Subject|2|||
161448485|NCT03899805|583037412|FG000|Overall Study|Progressive Disease|10|||
161448486|NCT03899805|583037413|FG001|Overall Study|Progressive Disease|18|||
161448487|NCT03899805|583037414|FG002|Overall Study|Progressive Disease|12|||
161448488|NCT03899805|583037412|FG000|Overall Study|Adverse Event|3|||
161448489|NCT03899805|583037413|FG001|Overall Study|Adverse Event|1|||
161448490|NCT03899805|583037414|FG002|Overall Study|Adverse Event|0|||
161448491|NCT03899805|583037412|FG000|Overall Study|Death|2|||
161448492|NCT03899805|583037413|FG001|Overall Study|Death|0|||
161448493|NCT03899805|583037414|FG002|Overall Study|Death|0|||
161448494|NCT03899805|583037412|FG000|Overall Study|Came off for surgery|0|||
161448495|NCT03899805|583037413|FG001|Overall Study|Came off for surgery|0|||
161448496|NCT03899805|583037414|FG002|Overall Study|Came off for surgery|1|||
161448497|NCT05246514|583037415|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
161448498|NCT05246514|583037415|FG000|Overall Study|Withdrawal by Subject|1|||
161448499|NCT05246514|583037415|FG000|Overall Study|Death|13|||
161448500|NCT04195893|583037416|FG000|Second Intervention|Withdrawal by Subject|1|||
161448501|NCT04195893|583037417|FG001|Second Intervention|Withdrawal by Subject|0|||
161448502|NCT01802073|583037418|FG000|Overall Study|Lost to Follow-up|0|||
161448503|NCT01802073|583037419|FG001|Overall Study|Lost to Follow-up|1|||
161448504|NCT01802073|583037418|FG000|Overall Study|Non-compliant|4|||
161448505|NCT01802073|583037419|FG001|Overall Study|Non-compliant|2|||
161448506|NCT01802073|583037418|FG000|Overall Study|Withdrawal by Subject|1|||
161448507|NCT01802073|583037419|FG001|Overall Study|Withdrawal by Subject|1|||
161448508|NCT01802073|583037418|FG000|Overall Study|Physician Decision|0|||
161448509|NCT01802073|583037419|FG001|Overall Study|Physician Decision|7|||
161553293|NCT02855164|583414401|FG001|Part C (Randomized Set)|Physician Decision|0|||
161553294|NCT02855164|583414402|FG002|Part C (Randomized Set)|Physician Decision|0|||
161553295|NCT02855164|583414403|FG003|Part C (Randomized Set)|Physician Decision|0|||
161553296|NCT02855164|583414404|FG004|Part C (Randomized Set)|Physician Decision|0|||
161448510|NCT01137604|583037420|FG000|Overall Study|Adverse Event|3|||
161448511|NCT01137604|583037421|FG001|Overall Study|Adverse Event|6|||
161448512|NCT01137604|583037422|FG002|Overall Study|Adverse Event|9|||
161448513|NCT01137604|583037423|FG003|Overall Study|Adverse Event|9|||
161448514|NCT01137604|583037420|FG000|Overall Study|Participant Choice|0|||
161448515|NCT01137604|583037421|FG001|Overall Study|Participant Choice|2|||
161448516|NCT01137604|583037422|FG002|Overall Study|Participant Choice|2|||
161448517|NCT01137604|583037423|FG003|Overall Study|Participant Choice|0|||
161448518|NCT01137604|583037420|FG000|Overall Study|Withdrawal of consent|0|||
161448519|NCT01137604|583037421|FG001|Overall Study|Withdrawal of consent|0|||
161448520|NCT01137604|583037422|FG002|Overall Study|Withdrawal of consent|0|||
161448521|NCT01137604|583037423|FG003|Overall Study|Withdrawal of consent|2|||
161448522|NCT01137604|583037420|FG000|Overall Study|Clinical progression/deterioration|1|||
161448523|NCT01137604|583037421|FG001|Overall Study|Clinical progression/deterioration|2|||
161448524|NCT01137604|583037422|FG002|Overall Study|Clinical progression/deterioration|2|||
161448525|NCT01137604|583037423|FG003|Overall Study|Clinical progression/deterioration|0|||
161448526|NCT01327482|583037424|FG000|Overall Study|Adverse Event|1|||
161448527|NCT00312195|583037425|FG000|Overall Study|Adverse Event|4|||
161448528|NCT00312195|583037426|FG001|Overall Study|Adverse Event|6|||
161448529|NCT00312195|583037425|FG000|Overall Study|Lost to Follow-up|1|||
161448530|NCT00312195|583037426|FG001|Overall Study|Lost to Follow-up|0|||
161448531|NCT00312195|583037425|FG000|Overall Study|Protocol Violation|1|||
161448532|NCT00312195|583037426|FG001|Overall Study|Protocol Violation|0|||
161448533|NCT01018810|583037427|FG000|Overall Study|Withdrawal by Subject|0|||
161448534|NCT01018810|583037428|FG001|Overall Study|Withdrawal by Subject|1|||
161448535|NCT01018810|583037429|FG002|Overall Study|Withdrawal by Subject|0|||
161448536|NCT01018810|583037430|FG003|Overall Study|Withdrawal by Subject|0|||
161448537|NCT01018810|583037431|FG004|Overall Study|Withdrawal by Subject|0|||
161448538|NCT01018810|583037427|FG000|Overall Study|Sponsor Decision|2|||
161448539|NCT01018810|583037428|FG001|Overall Study|Sponsor Decision|0|||
161448540|NCT01018810|583037429|FG002|Overall Study|Sponsor Decision|1|||
161448541|NCT01018810|583037430|FG003|Overall Study|Sponsor Decision|1|||
161448542|NCT01018810|583037431|FG004|Overall Study|Sponsor Decision|1|||
161448543|NCT04145219|583037432|FG000|Overall Study|Adverse Event|18|||
161448544|NCT04145219|583037433|FG001|Overall Study|Adverse Event|6|||
161448545|NCT04145219|583037432|FG000|Overall Study|Lost to Follow-up|2|||
161448546|NCT04145219|583037433|FG001|Overall Study|Lost to Follow-up|3|||
161448547|NCT04145219|583037432|FG000|Overall Study|Physician Decision|0|||
161448548|NCT04145219|583037433|FG001|Overall Study|Physician Decision|2|||
161448549|NCT04145219|583037432|FG000|Overall Study|Withdrawal by Subject|12|||
161448550|NCT04145219|583037433|FG001|Overall Study|Withdrawal by Subject|8|||
161448551|NCT04145219|583037432|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
161448552|NCT04145219|583037433|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
161448553|NCT01459497|583037437|FG000|Overall Study|Inability to meet trial constraints.|1|||
161448554|NCT01459497|583037438|FG001|Overall Study|Inability to meet trial constraints.|0|||
161448555|NCT01459497|583037437|FG000|Overall Study|Physician Decision|1|||
161448556|NCT01459497|583037438|FG001|Overall Study|Physician Decision|1|||
161448557|NCT01459497|583037437|FG000|Overall Study|Hospitalization.|0|||
161448558|NCT01459497|583037438|FG001|Overall Study|Hospitalization.|3|||
161448559|NCT01459497|583037437|FG000|Overall Study|Disease progression.|0|||
161448560|NCT01459497|583037438|FG001|Overall Study|Disease progression.|1|||
161448561|NCT02791763|583037441|FG000|Overall Study|Protocol Violation|0|||
161448562|NCT02791763|583037442|FG001|Overall Study|Protocol Violation|0|||
161448563|NCT02791763|583037443|FG002|Overall Study|Protocol Violation|1|||
161448564|NCT02791763|583037441|FG000|Overall Study|Withdrawal by Subject|5|||
161448565|NCT02791763|583037442|FG001|Overall Study|Withdrawal by Subject|1|||
161448566|NCT02791763|583037443|FG002|Overall Study|Withdrawal by Subject|0|||
161448567|NCT02791763|583037441|FG000|Overall Study|Physician Decision|0|||
161448568|NCT02791763|583037442|FG001|Overall Study|Physician Decision|1|||
161448569|NCT02791763|583037443|FG002|Overall Study|Physician Decision|0|||
161448570|NCT02791763|583037441|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
161448571|NCT02791763|583037442|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
161448572|NCT02791763|583037443|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
161448573|NCT02791763|583037441|FG000|Overall Study|Cancer event|1|||
161448574|NCT02791763|583037442|FG001|Overall Study|Cancer event|3|||
161553297|NCT02855164|583414405|FG005|Part C (Randomized Set)|Physician Decision|1|||
161553298|NCT02855164|583414406|FG006|Part C (Randomized Set)|Physician Decision|0|||
161448575|NCT02791763|583037443|FG002|Overall Study|Cancer event|0|||
161448576|NCT02791763|583037441|FG000|Overall Study|Participant had renal transplant|3|||
161448577|NCT02791763|583037442|FG001|Overall Study|Participant had renal transplant|0|||
161448578|NCT02791763|583037443|FG002|Overall Study|Participant had renal transplant|0|||
161448579|NCT02791763|583037441|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
161553299|NCT02855164|583414407|FG007|Part C (Randomized Set)|Physician Decision|1|||
161553300|NCT02855164|583414400|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
161553301|NCT02855164|583414401|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
161553302|NCT02855164|583414402|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
161553303|NCT02855164|583414403|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
161553304|NCT02855164|583414404|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
161553305|NCT02855164|583414405|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
161553306|NCT02855164|583414406|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
161553307|NCT02855164|583414407|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
161553308|NCT00876460|583414408|FG000|Combination Therapy Phase|Progressive disease|2|||
161553309|NCT00876460|583414409|FG001|Combination Therapy Phase|Progressive disease|3|||
161553310|NCT00876460|583414410|FG002|Combination Therapy Phase|Progressive disease|3|||
161553311|NCT00876460|583414411|FG003|Combination Therapy Phase|Progressive disease|3|||
161553312|NCT00876460|583414412|FG004|Combination Therapy Phase|Progressive disease|3|||
161553313|NCT00876460|583414413|FG005|Combination Therapy Phase|Progressive disease|1|||
161553314|NCT00876460|583414414|FG006|Combination Therapy Phase|Progressive disease|1|||
161553315|NCT00876460|583414415|FG007|Combination Therapy Phase|Progressive disease|1|||
161553316|NCT00876460|583414408|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
161553317|NCT00876460|583414409|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
161553318|NCT00876460|583414410|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
161553319|NCT00876460|583414411|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
161553320|NCT00876460|583414412|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
161553321|NCT00876460|583414413|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
161553322|NCT00876460|583414414|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
161553323|NCT00876460|583414415|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
161553324|NCT00876460|583414408|FG000|Combination Therapy Phase|Adverse Event|0|||
161553325|NCT00876460|583414409|FG001|Combination Therapy Phase|Adverse Event|2|||
161553326|NCT00876460|583414410|FG002|Combination Therapy Phase|Adverse Event|0|||
161553327|NCT00876460|583414411|FG003|Combination Therapy Phase|Adverse Event|2|||
161553328|NCT00876460|583414412|FG004|Combination Therapy Phase|Adverse Event|2|||
161553329|NCT00876460|583414413|FG005|Combination Therapy Phase|Adverse Event|0|||
161553330|NCT00876460|583414414|FG006|Combination Therapy Phase|Adverse Event|3|||
161553331|NCT00876460|583414415|FG007|Combination Therapy Phase|Adverse Event|2|||
161553332|NCT00876460|583414408|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
161553333|NCT00876460|583414409|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
161553334|NCT00876460|583414410|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
161553335|NCT00876460|583414411|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
161553336|NCT00876460|583414412|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
161553337|NCT00876460|583414413|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
161553338|NCT00876460|583414414|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
161553339|NCT00876460|583414415|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
161553340|NCT00876460|583414408|FG000|Combination Therapy Phase|Other reason not defined above|0|||
161553341|NCT00876460|583414409|FG001|Combination Therapy Phase|Other reason not defined above|0|||
161553342|NCT00876460|583414410|FG002|Combination Therapy Phase|Other reason not defined above|0|||
161553343|NCT00876460|583414411|FG003|Combination Therapy Phase|Other reason not defined above|0|||
161553344|NCT00876460|583414412|FG004|Combination Therapy Phase|Other reason not defined above|0|||
161553345|NCT00876460|583414413|FG005|Combination Therapy Phase|Other reason not defined above|0|||
161553346|NCT00876460|583414414|FG006|Combination Therapy Phase|Other reason not defined above|1|||
161553347|NCT00876460|583414415|FG007|Combination Therapy Phase|Other reason not defined above|2|||
161553348|NCT00876460|583414408|FG000|Combination Therapy Phase|Not treated|0|||
161553349|NCT00876460|583414409|FG001|Combination Therapy Phase|Not treated|0|||
161553350|NCT00876460|583414410|FG002|Combination Therapy Phase|Not treated|0|||
161553351|NCT00876460|583414411|FG003|Combination Therapy Phase|Not treated|0|||
161553352|NCT00876460|583414412|FG004|Combination Therapy Phase|Not treated|0|||
161553353|NCT00876460|583414413|FG005|Combination Therapy Phase|Not treated|0|||
161553354|NCT00876460|583414414|FG006|Combination Therapy Phase|Not treated|1|||
161553355|NCT00876460|583414415|FG007|Combination Therapy Phase|Not treated|0|||
161553356|NCT00876460|583414408|FG000|Mono Therapy Phase|Progressive disease|0|||
161553357|NCT00876460|583414409|FG001|Mono Therapy Phase|Progressive disease|0|||
161553358|NCT00876460|583414410|FG002|Mono Therapy Phase|Progressive disease|0|||
161553359|NCT00876460|583414411|FG003|Mono Therapy Phase|Progressive disease|0|||
161900664|NCT02692586|584685146|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
161553360|NCT00876460|583414412|FG004|Mono Therapy Phase|Progressive disease|2|||
161553361|NCT00876460|583414413|FG005|Mono Therapy Phase|Progressive disease|0|||
161553362|NCT00876460|583414414|FG006|Mono Therapy Phase|Progressive disease|1|||
161553363|NCT00876460|583414415|FG007|Mono Therapy Phase|Progressive disease|3|||
161553364|NCT00876460|583414408|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
161553365|NCT00876460|583414409|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
161553366|NCT00876460|583414410|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
161553367|NCT00876460|583414411|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
161900665|NCT02692586|584685146|FG000|Overall Study|Received adjunctive thrombolytics|2|||
161553368|NCT00876460|583414412|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
161553369|NCT00876460|583414413|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
161553370|NCT00876460|583414414|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
161553371|NCT00876460|583414415|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
161553372|NCT00876460|583414408|FG000|Mono Therapy Phase|Adverse Event|0|||
161553373|NCT00876460|583414409|FG001|Mono Therapy Phase|Adverse Event|0|||
161553374|NCT00876460|583414410|FG002|Mono Therapy Phase|Adverse Event|0|||
161553375|NCT00876460|583414411|FG003|Mono Therapy Phase|Adverse Event|1|||
161553376|NCT00876460|583414412|FG004|Mono Therapy Phase|Adverse Event|0|||
161553377|NCT00876460|583414413|FG005|Mono Therapy Phase|Adverse Event|0|||
161553378|NCT00876460|583414414|FG006|Mono Therapy Phase|Adverse Event|0|||
161553379|NCT00876460|583414415|FG007|Mono Therapy Phase|Adverse Event|0|||
161553380|NCT00383240|583414420|FG000|Overall Study|Adverse Event|4|||
161553381|NCT00383240|583414421|FG001|Overall Study|Adverse Event|6|||
161553382|NCT00383240|583414422|FG002|Overall Study|Adverse Event|9|||
161553383|NCT00383240|583414423|FG003|Overall Study|Adverse Event|7|||
161448580|NCT02791763|583037442|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
161448581|NCT02791763|583037443|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
161448582|NCT02791763|583037441|FG000|Overall Study|Adverse Event|12|||
161448583|NCT02791763|583037442|FG001|Overall Study|Adverse Event|13|||
161448584|NCT02791763|583037443|FG002|Overall Study|Adverse Event|7|||
161448585|NCT05334212|583037444|FG000|Overall Study|Study terminated prematurely|7|||
161448586|NCT00910299|583037445|FG000|Overall Study|Withdrawal by Subject|16|||
161448587|NCT00910299|583037446|FG001|Overall Study|Withdrawal by Subject|13|||
161448588|NCT00910299|583037445|FG000|Overall Study|Sponsor Decision|58|||
161448589|NCT00910299|583037446|FG001|Overall Study|Sponsor Decision|60|||
161448590|NCT00910299|583037445|FG000|Overall Study|Didn't receive any study drug|2|||
161448591|NCT00910299|583037446|FG001|Overall Study|Didn't receive any study drug|1|||
161448592|NCT01456897|583037447|FG000|Overall Study|Adverse Event|19|||
161448593|NCT01456897|583037448|FG001|Overall Study|Adverse Event|22|||
161448594|NCT01456897|583037447|FG000|Overall Study|Protocol Violation|3|||
161448595|NCT01456897|583037448|FG001|Overall Study|Protocol Violation|4|||
161448596|NCT01456897|583037447|FG000|Overall Study|Physician Decision|5|||
161448597|NCT01456897|583037448|FG001|Overall Study|Physician Decision|3|||
161448598|NCT01456897|583037447|FG000|Overall Study|Withdrawal by Subject|44|||
161448599|NCT01456897|583037448|FG001|Overall Study|Withdrawal by Subject|17|||
161448600|NCT01456897|583037447|FG000|Overall Study|Lack of Efficacy|4|||
161448601|NCT01456897|583037448|FG001|Overall Study|Lack of Efficacy|11|||
161448602|NCT04535453|583037449|FG000|Overall Study|Death|0|||
161448603|NCT04535453|583037450|FG001|Overall Study|Death|1|||
161448604|NCT04535453|583037451|FG002|Overall Study|Death|0|||
161448605|NCT04535453|583037452|FG003|Overall Study|Death|0|||
161448606|NCT04535453|583037453|FG004|Overall Study|Death|0|||
161448607|NCT04535453|583037454|FG005|Overall Study|Death|0|||
161448608|NCT04535453|583037455|FG006|Overall Study|Death|0|||
161448609|NCT04535453|583037456|FG007|Overall Study|Death|0|||
161448610|NCT04535453|583037457|FG008|Overall Study|Death|0|||
161448611|NCT04535453|583037458|FG009|Overall Study|Death|0|||
161448612|NCT04535453|583037459|FG010|Overall Study|Death|0|||
161448613|NCT04535453|583037460|FG011|Overall Study|Death|0|||
161448614|NCT04535453|583037449|FG000|Overall Study|Lost to Follow-up|1|||
161448615|NCT04535453|583037450|FG001|Overall Study|Lost to Follow-up|1|||
161448616|NCT04535453|583037451|FG002|Overall Study|Lost to Follow-up|1|||
161448617|NCT04535453|583037452|FG003|Overall Study|Lost to Follow-up|0|||
161448618|NCT04535453|583037453|FG004|Overall Study|Lost to Follow-up|3|||
161448619|NCT04535453|583037454|FG005|Overall Study|Lost to Follow-up|1|||
161448620|NCT04535453|583037455|FG006|Overall Study|Lost to Follow-up|0|||
161448621|NCT04535453|583037456|FG007|Overall Study|Lost to Follow-up|0|||
161448622|NCT04535453|583037457|FG008|Overall Study|Lost to Follow-up|1|||
161448623|NCT04535453|583037458|FG009|Overall Study|Lost to Follow-up|1|||
161448624|NCT04535453|583037459|FG010|Overall Study|Lost to Follow-up|0|||
161448625|NCT04535453|583037460|FG011|Overall Study|Lost to Follow-up|0|||
161448626|NCT04535453|583037449|FG000|Overall Study|Physician Decision|0|||
161448627|NCT04535453|583037450|FG001|Overall Study|Physician Decision|0|||
161448628|NCT04535453|583037451|FG002|Overall Study|Physician Decision|0|||
161448629|NCT04535453|583037452|FG003|Overall Study|Physician Decision|1|||
161448630|NCT04535453|583037453|FG004|Overall Study|Physician Decision|0|||
161553384|NCT00383240|583414420|FG000|Overall Study|Treatment Failure|8|||
161553385|NCT00383240|583414421|FG001|Overall Study|Treatment Failure|13|||
161553386|NCT00383240|583414422|FG002|Overall Study|Treatment Failure|47|||
161448631|NCT04535453|583037454|FG005|Overall Study|Physician Decision|0|||
161448632|NCT04535453|583037455|FG006|Overall Study|Physician Decision|0|||
161448633|NCT04535453|583037456|FG007|Overall Study|Physician Decision|0|||
161448634|NCT04535453|583037457|FG008|Overall Study|Physician Decision|0|||
161448635|NCT04535453|583037458|FG009|Overall Study|Physician Decision|0|||
161448636|NCT04535453|583037459|FG010|Overall Study|Physician Decision|0|||
161448637|NCT04535453|583037460|FG011|Overall Study|Physician Decision|0|||
161448638|NCT04535453|583037449|FG000|Overall Study|Withdrawal by Subject|3|||
161448639|NCT04535453|583037450|FG001|Overall Study|Withdrawal by Subject|6|||
161553387|NCT00383240|583414423|FG003|Overall Study|Treatment Failure|46|||
161553388|NCT00383240|583414420|FG000|Overall Study|Lost to Follow-up|3|||
161553389|NCT00383240|583414421|FG001|Overall Study|Lost to Follow-up|0|||
161553390|NCT00383240|583414422|FG002|Overall Study|Lost to Follow-up|0|||
161553391|NCT00383240|583414423|FG003|Overall Study|Lost to Follow-up|2|||
161553392|NCT00383240|583414420|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
161553393|NCT00383240|583414421|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
161553394|NCT00383240|583414422|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
161553395|NCT00383240|583414423|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
161553396|NCT00383240|583414420|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
161553397|NCT00383240|583414421|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
161553398|NCT00383240|583414422|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
161553399|NCT00383240|583414423|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
161553400|NCT00383240|583414420|FG000|Overall Study|Protocol Violation|4|||
161553401|NCT00383240|583414421|FG001|Overall Study|Protocol Violation|5|||
161553402|NCT00383240|583414422|FG002|Overall Study|Protocol Violation|9|||
161553403|NCT00383240|583414423|FG003|Overall Study|Protocol Violation|6|||
161553404|NCT00383240|583414420|FG000|Overall Study|Did not meet protocol eligibility|9|||
161553405|NCT00383240|583414421|FG001|Overall Study|Did not meet protocol eligibility|4|||
161553406|NCT00383240|583414422|FG002|Overall Study|Did not meet protocol eligibility|9|||
161553407|NCT00383240|583414423|FG003|Overall Study|Did not meet protocol eligibility|3|||
161553408|NCT00383240|583414420|FG000|Overall Study|Administrative|1|||
161796191|NCT00113490|584298172|FG001|Overall Study|Withdrawal by Subject|3|||
161796192|NCT00113490|584298171|FG000|Overall Study|Lost to Follow-up|1|||
161796193|NCT00113490|584298172|FG001|Overall Study|Lost to Follow-up|0|||
161796194|NCT04652453|584298174|FG000|Overall Study|Death|8|||
161796195|NCT04652453|584298175|FG001|Overall Study|Death|2|||
161796196|NCT04652453|584298176|FG002|Overall Study|Death|0|||
161796197|NCT04652453|584298174|FG000|Overall Study|Hospice|5|||
161796198|NCT04652453|584298175|FG001|Overall Study|Hospice|5|||
161448640|NCT04535453|583037451|FG002|Overall Study|Withdrawal by Subject|3|||
161448641|NCT04535453|583037452|FG003|Overall Study|Withdrawal by Subject|3|||
161448642|NCT04535453|583037453|FG004|Overall Study|Withdrawal by Subject|2|||
161448643|NCT04535453|583037454|FG005|Overall Study|Withdrawal by Subject|1|||
161448644|NCT04535453|583037455|FG006|Overall Study|Withdrawal by Subject|1|||
161448645|NCT04535453|583037456|FG007|Overall Study|Withdrawal by Subject|1|||
161448646|NCT04535453|583037457|FG008|Overall Study|Withdrawal by Subject|1|||
161448647|NCT04535453|583037458|FG009|Overall Study|Withdrawal by Subject|1|||
161448648|NCT04535453|583037459|FG010|Overall Study|Withdrawal by Subject|0|||
161448649|NCT04535453|583037460|FG011|Overall Study|Withdrawal by Subject|1|||
161448650|NCT04535453|583037449|FG000|Overall Study|Other|0|||
161448651|NCT04535453|583037450|FG001|Overall Study|Other|0|||
161448652|NCT04535453|583037451|FG002|Overall Study|Other|1|||
161448653|NCT04535453|583037452|FG003|Overall Study|Other|0|||
161448654|NCT04535453|583037453|FG004|Overall Study|Other|1|||
161448655|NCT04535453|583037454|FG005|Overall Study|Other|0|||
161448656|NCT04535453|583037455|FG006|Overall Study|Other|1|||
161448657|NCT04535453|583037456|FG007|Overall Study|Other|1|||
161448658|NCT04535453|583037457|FG008|Overall Study|Other|1|||
161448659|NCT04535453|583037458|FG009|Overall Study|Other|0|||
161448660|NCT04535453|583037459|FG010|Overall Study|Other|0|||
161448661|NCT04535453|583037460|FG011|Overall Study|Other|0|||
161448662|NCT00916929|583037461|FG000|Overall Study|Lost to Follow-up|1|||
161448663|NCT00916929|583037462|FG001|Overall Study|Lost to Follow-up|3|||
161448664|NCT00916929|583037461|FG000|Overall Study|Death|5|||
161448665|NCT00916929|583037462|FG001|Overall Study|Death|10|||
161448666|NCT00916929|583037461|FG000|Overall Study|Withdrawal by Subject|1|||
161448667|NCT00916929|583037462|FG001|Overall Study|Withdrawal by Subject|5|||
161448668|NCT00916929|583037461|FG000|Overall Study|Left ventricular epicardial lead|1|||
161448669|NCT00916929|583037462|FG001|Overall Study|Left ventricular epicardial lead|2|||
161448670|NCT00916929|583037461|FG000|Overall Study|Transferred to hospice care|1|||
161448671|NCT00916929|583037462|FG001|Overall Study|Transferred to hospice care|1|||
161448672|NCT00916929|583037461|FG000|Overall Study|System explant|1|||
161448673|NCT00916929|583037462|FG001|Overall Study|System explant|0|||
161448674|NCT00916929|583037461|FG000|Overall Study|Moved to another state|0|||
161448675|NCT00916929|583037462|FG001|Overall Study|Moved to another state|1|||
161448676|NCT00916929|583037461|FG000|Overall Study|Device unable to process impedance data|0|||
161448677|NCT00916929|583037462|FG001|Overall Study|Device unable to process impedance data|7|||
161448678|NCT02929407|583037463|FG000|Overall Study|Adverse Event|1|||
161448679|NCT02878798|583037464|FG000|Overall Study|Withdrawal by Subject|5|||
161448680|NCT02878798|583037465|FG001|Overall Study|Withdrawal by Subject|4|||
161448681|NCT02878798|583037464|FG000|Overall Study|Lost to Follow-up|2|||
161448682|NCT02878798|583037465|FG001|Overall Study|Lost to Follow-up|2|||
161448683|NCT02878798|583037464|FG000|Overall Study|Protocol Violation|0|||
161448684|NCT02878798|583037465|FG001|Overall Study|Protocol Violation|1|||
161448685|NCT01309282|583037466|FG000|Overall Study|Lost to Follow-up|1|||
161448686|NCT01708902|583037470|FG000|Overall Study|Adverse Event|3|||
161448687|NCT01708902|583037471|FG001|Overall Study|Adverse Event|4|||
161448688|NCT01708902|583037472|FG002|Overall Study|Adverse Event|9|||
161796199|NCT04652453|584298176|FG002|Overall Study|Hospice|0|||
161553409|NCT00383240|583414421|FG001|Overall Study|Administrative|1|||
161553410|NCT00383240|583414422|FG002|Overall Study|Administrative|0|||
161553411|NCT00383240|583414423|FG003|Overall Study|Administrative|0|||
161553412|NCT02049710|583414424|FG000|Overall Study|Lost to Follow-up|319|||
161553413|NCT02049710|583414425|FG001|Overall Study|Lost to Follow-up|324|||
161553414|NCT00003458|583414426|FG000|Overall Study|Not evaluable|4|||
161553415|NCT06385483|583414430|FG000|Overall Study|Withdrawal by Subject|2|||
161553416|NCT06385483|583414430|FG000|Overall Study|Never start protocol therapy|2|||
161553417|NCT06385483|583414430|FG000|Overall Study|Disease progression|15|||
161553418|NCT01216293|583414431|FG000|Main Study|Adverse Event|1|||
161553419|NCT01216293|583414432|FG001|Main Study|Adverse Event|4|||
161553420|NCT01216293|583414433|FG002|Main Study|Adverse Event|2|||
161553421|NCT01216293|583414431|FG000|Main Study|Major Protocol Deviation|1|||
161553422|NCT01216293|583414432|FG001|Main Study|Major Protocol Deviation|0|||
161553423|NCT01216293|583414433|FG002|Main Study|Major Protocol Deviation|1|||
161553424|NCT01216293|583414431|FG000|Main Study|Lost to Follow-up|3|||
161553425|NCT01216293|583414432|FG001|Main Study|Lost to Follow-up|1|||
161553426|NCT01216293|583414433|FG002|Main Study|Lost to Follow-up|0|||
161553427|NCT01216293|583414431|FG000|Main Study|Voluntary Withdrawal|2|||
161553428|NCT01216293|583414432|FG001|Main Study|Voluntary Withdrawal|2|||
161553429|NCT01216293|583414433|FG002|Main Study|Voluntary Withdrawal|2|||
161553430|NCT01216293|583414431|FG000|Main Study|Other Reason Not Specified|0|||
161553431|NCT01216293|583414432|FG001|Main Study|Other Reason Not Specified|1|||
161553432|NCT01216293|583414433|FG002|Main Study|Other Reason Not Specified|1|||
161553433|NCT01216293|583414431|FG000|Main Study|Randomized, Not Treated|1|||
161553434|NCT01216293|583414432|FG001|Main Study|Randomized, Not Treated|0|||
161553435|NCT01216293|583414433|FG002|Main Study|Randomized, Not Treated|0|||
161553436|NCT01216293|583414431|FG000|Calcium Absorption Substudy|Adverse Event|0|||
161553437|NCT01216293|583414432|FG001|Calcium Absorption Substudy|Adverse Event|2|||
161553438|NCT01216293|583414433|FG002|Calcium Absorption Substudy|Adverse Event|0|||
161553439|NCT01216293|583414431|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
161553440|NCT01216293|583414432|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
161553441|NCT01216293|583414433|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
161553442|NCT01216293|583414431|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
161553443|NCT01216293|583414432|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
161553444|NCT01216293|583414433|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
161553445|NCT01349829|583416099|FG000|Overall Study|Lost to Follow-up|4|||
161553446|NCT01349829|583416100|FG001|Overall Study|Lost to Follow-up|8|||
161553447|NCT01349829|583416099|FG000|Overall Study|Consent withdrawal|3|||
161553448|NCT01349829|583416100|FG001|Overall Study|Consent withdrawal|8|||
161553449|NCT01349829|583416099|FG000|Overall Study|Migrated/moved|2|||
161553450|NCT01349829|583416100|FG001|Overall Study|Migrated/moved|7|||
161553451|NCT02555371|583416101|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
161553452|NCT02555371|583416102|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
161553453|NCT02555371|583416103|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
161553454|NCT02555371|583416104|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
161553455|NCT02555371|583416105|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
161553456|NCT02555371|583416101|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
161553457|NCT02555371|583416102|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
161553458|NCT02555371|583416103|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
161553459|NCT02555371|583416104|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
161553460|NCT02555371|583416105|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
161553461|NCT02555371|583416101|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
161553462|NCT02555371|583416102|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
161553463|NCT02555371|583416103|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
161553464|NCT02555371|583416104|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
161553465|NCT02555371|583416105|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
161553466|NCT02555371|583416101|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
161553467|NCT02555371|583416102|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
161553468|NCT02555371|583416103|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
161553469|NCT02555371|583416104|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
161553470|NCT02555371|583416105|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
161553471|NCT02555371|583416101|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
161553472|NCT02555371|583416102|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
161553473|NCT02555371|583416103|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
161553474|NCT02555371|583416104|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
161553475|NCT02555371|583416105|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
161553476|NCT02555371|583416101|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
161553477|NCT02555371|583416102|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
161553478|NCT02555371|583416103|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
161553479|NCT02555371|583416104|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
161900666|NCT03316586|584685151|FG000|Overall Study|Adverse Event|2|||
161900667|NCT03316586|584685151|FG000|Overall Study|Physician Decision|3|||
161900668|NCT03316586|584685151|FG000|Overall Study|Lack of Efficacy|10|||
161900669|NCT03316586|584685151|FG000|Overall Study|still on treatment|1|||
161448689|NCT01708902|583037473|FG003|Overall Study|Adverse Event|2|||
161448690|NCT01708902|583037474|FG004|Overall Study|Adverse Event|7|||
161448691|NCT01708902|583037475|FG005|Overall Study|Adverse Event|3|||
161448692|NCT01708902|583037476|FG006|Overall Study|Adverse Event|5|||
161448693|NCT01708902|583037470|FG000|Overall Study|Lack of Efficacy|3|||
161448694|NCT01708902|583037471|FG001|Overall Study|Lack of Efficacy|1|||
161448695|NCT01708902|583037472|FG002|Overall Study|Lack of Efficacy|0|||
161448696|NCT01708902|583037473|FG003|Overall Study|Lack of Efficacy|0|||
161448697|NCT01708902|583037474|FG004|Overall Study|Lack of Efficacy|0|||
161448698|NCT01708902|583037475|FG005|Overall Study|Lack of Efficacy|1|||
161448699|NCT01708902|583037476|FG006|Overall Study|Lack of Efficacy|0|||
161448700|NCT01708902|583037470|FG000|Overall Study|Non compliance with protocol|0|||
161448701|NCT01708902|583037471|FG001|Overall Study|Non compliance with protocol|2|||
161448702|NCT01708902|583037472|FG002|Overall Study|Non compliance with protocol|1|||
161448703|NCT01708902|583037473|FG003|Overall Study|Non compliance with protocol|3|||
161448704|NCT01708902|583037474|FG004|Overall Study|Non compliance with protocol|0|||
161448705|NCT01708902|583037475|FG005|Overall Study|Non compliance with protocol|0|||
161448706|NCT01708902|583037476|FG006|Overall Study|Non compliance with protocol|0|||
161448707|NCT01708902|583037470|FG000|Overall Study|Lost to Follow-up|2|||
161448708|NCT01708902|583037471|FG001|Overall Study|Lost to Follow-up|1|||
161448709|NCT01708902|583037472|FG002|Overall Study|Lost to Follow-up|2|||
161448710|NCT01708902|583037473|FG003|Overall Study|Lost to Follow-up|2|||
161448711|NCT01708902|583037474|FG004|Overall Study|Lost to Follow-up|0|||
161448712|NCT01708902|583037475|FG005|Overall Study|Lost to Follow-up|0|||
161448713|NCT01708902|583037476|FG006|Overall Study|Lost to Follow-up|1|||
161448714|NCT01708902|583037470|FG000|Overall Study|Refused to continue trial medication|8|||
161448715|NCT01708902|583037471|FG001|Overall Study|Refused to continue trial medication|0|||
161448716|NCT01708902|583037472|FG002|Overall Study|Refused to continue trial medication|4|||
161448717|NCT01708902|583037473|FG003|Overall Study|Refused to continue trial medication|2|||
161448718|NCT01708902|583037474|FG004|Overall Study|Refused to continue trial medication|8|||
161448719|NCT01708902|583037475|FG005|Overall Study|Refused to continue trial medication|1|||
161448720|NCT01708902|583037476|FG006|Overall Study|Refused to continue trial medication|1|||
161448721|NCT01708902|583037470|FG000|Overall Study|Other Reason|1|||
161448722|NCT01708902|583037471|FG001|Overall Study|Other Reason|0|||
161448723|NCT01708902|583037472|FG002|Overall Study|Other Reason|1|||
161448724|NCT01708902|583037473|FG003|Overall Study|Other Reason|1|||
161448725|NCT01708902|583037474|FG004|Overall Study|Other Reason|1|||
161448726|NCT01708902|583037475|FG005|Overall Study|Other Reason|2|||
161448727|NCT01708902|583037476|FG006|Overall Study|Other Reason|0|||
161448728|NCT02445794|583037480|FG000|Overall Study|Adverse Event|0|||
161448729|NCT02445794|583037481|FG001|Overall Study|Adverse Event|0|||
161448730|NCT02445794|583037482|FG002|Overall Study|Adverse Event|2|||
161448731|NCT02445794|583037483|FG003|Overall Study|Adverse Event|0|||
161448732|NCT01388985|583037484|FG000|Overall Study|Death|0|||
161448733|NCT01388985|583037485|FG001|Overall Study|Death|1|||
161448734|NCT01388985|583037484|FG000|Overall Study|Lost to Follow-up|30|||
161448735|NCT01388985|583037485|FG001|Overall Study|Lost to Follow-up|30|||
161448736|NCT01388985|583037484|FG000|Overall Study|Withdrawal by Subject|13|||
161448737|NCT01388985|583037485|FG001|Overall Study|Withdrawal by Subject|4|||
161448738|NCT01388985|583037484|FG000|Overall Study|Subject unavailable|1|||
161448739|NCT01388985|583037485|FG001|Overall Study|Subject unavailable|1|||
161448740|NCT01388985|583037484|FG000|Overall Study|Other (no reason)|0|||
161448741|NCT01388985|583037485|FG001|Overall Study|Other (no reason)|1|||
161448742|NCT01388985|583037484|FG000|Overall Study|Error of nurse|5|||
161448743|NCT01388985|583037485|FG001|Overall Study|Error of nurse|1|||
161448744|NCT01057589|583037486|FG000|Overall Study|Disease Progression|35|||
161448745|NCT01057589|583037486|FG000|Overall Study|Adverse Event|10|||
161448746|NCT01057589|583037486|FG000|Overall Study|Physician Decision|8|||
161448747|NCT01057589|583037486|FG000|Overall Study|Withdrawal by Subject|3|||
161448748|NCT01057589|583037486|FG000|Overall Study|Sponsor Decision|1|||
161448749|NCT01057589|583037486|FG000|Overall Study|Death|8|||
161448750|NCT01057589|583037486|FG000|Overall Study|Lost to Follow-up|1|||
161448751|NCT01519167|583037489|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
161448752|NCT01519167|583037490|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
161448753|NCT01519167|583037489|FG000|Overall Study|Adverse Event|0|||
161448754|NCT01519167|583037490|FG001|Overall Study|Adverse Event|1|||
161448755|NCT01519167|583037489|FG000|Overall Study|Lack of Efficacy|0|||
161448756|NCT01519167|583037490|FG001|Overall Study|Lack of Efficacy|1|||
161448757|NCT01519167|583037489|FG000|Overall Study|Medical condition changes&deep sedation|0|||
161900670|NCT03316586|584685151|FG000|Overall Study|Patient needed radiation therapy|1|||
161448758|NCT01519167|583037490|FG001|Overall Study|Medical condition changes&deep sedation|2|||
161448759|NCT01519167|583037489|FG000|Overall Study|Physician Decision|0|||
161448760|NCT01519167|583037490|FG001|Overall Study|Physician Decision|1|||
161448761|NCT00472030|583037495|FG000|Overall Study|Physician Decision|1|||
161553480|NCT02555371|583416105|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
161553481|NCT02555371|583416101|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
161553482|NCT02555371|583416102|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
161553483|NCT02555371|583416103|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
161553484|NCT02555371|583416104|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
161553485|NCT02555371|583416105|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
161553486|NCT02555371|583416101|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
161553487|NCT02555371|583416102|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
161553488|NCT02555371|583416103|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
161553489|NCT02555371|583416104|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
161553490|NCT02555371|583416105|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
161553491|NCT02555371|583416101|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
161553492|NCT02555371|583416102|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
161553493|NCT02555371|583416103|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
161553494|NCT02555371|583416104|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
161553495|NCT02555371|583416105|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
161553496|NCT02555371|583416101|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
161553497|NCT02555371|583416102|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
161553498|NCT02555371|583416103|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
161553499|NCT02555371|583416104|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
161553500|NCT02555371|583416105|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
161553501|NCT02555371|583416101|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
161553502|NCT02555371|583416102|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
161553503|NCT02555371|583416103|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
161553504|NCT02555371|583416104|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
161553505|NCT02555371|583416105|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
161553506|NCT02555371|583416101|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
161553507|NCT02555371|583416102|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
161553508|NCT02555371|583416103|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
161553509|NCT02555371|583416104|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
161553510|NCT02555371|583416105|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
161553511|NCT02555371|583416101|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
161553512|NCT02555371|583416102|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
161553513|NCT02555371|583416103|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
161553514|NCT02555371|583416104|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
161553515|NCT02555371|583416105|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
161553516|NCT02555371|583416101|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
161553517|NCT02555371|583416102|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
161553518|NCT02555371|583416103|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
161553519|NCT02555371|583416104|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
161553520|NCT02555371|583416105|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
161553521|NCT03095599|583416106|FG000|Overall Study|Withdrawal by Subject|1|||
161553522|NCT03095599|583416107|FG001|Overall Study|Withdrawal by Subject|0|||
161553523|NCT03095599|583416106|FG000|Overall Study|Lost to Follow-up|1|||
161553524|NCT03095599|583416107|FG001|Overall Study|Lost to Follow-up|0|||
161796200|NCT04652453|584298174|FG000|Overall Study|Withdrawal by Subject|2|||
161796201|NCT04652453|584298175|FG001|Overall Study|Withdrawal by Subject|0|||
161796202|NCT04652453|584298176|FG002|Overall Study|Withdrawal by Subject|0|||
161796203|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
161448762|NCT00472030|583037496|FG001|Overall Study|Physician Decision|0|||
161448763|NCT00829504|583037497|FG000|First Intervention|Adverse Event|1|||
161448764|NCT00829504|583037498|FG001|First Intervention|Adverse Event|0|||
161448765|NCT00829504|583037497|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161448766|NCT00829504|583037498|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161448767|NCT00829504|583037497|FG000|Second Intervention|Physician Decision|1|||
161448768|NCT00829504|583037498|FG001|Second Intervention|Physician Decision|0|||
161448769|NCT01031836|583038821|FG000|Stage I|Adverse Event|1|||
161448770|NCT01031836|583038822|FG001|Stage I|Adverse Event|1|||
161448771|NCT01031836|583038823|FG002|Stage I|Adverse Event|0|||
161448772|NCT01031836|583038824|FG003|Stage I|Adverse Event|0|||
161448773|NCT01031836|583038825|FG004|Stage I|Adverse Event|0|||
161448774|NCT01031836|583038826|FG005|Stage I|Adverse Event|0|||
161448775|NCT01031836|583038821|FG000|Stage I|Other|0|||
161448776|NCT01031836|583038822|FG001|Stage I|Other|1|||
161448777|NCT01031836|583038823|FG002|Stage I|Other|0|||
161448778|NCT01031836|583038824|FG003|Stage I|Other|0|||
161448779|NCT01031836|583038825|FG004|Stage I|Other|0|||
161448780|NCT01031836|583038826|FG005|Stage I|Other|1|||
161448781|NCT01031836|583038821|FG000|Stage II|Adverse Event|0|||
161448782|NCT01031836|583038822|FG001|Stage II|Adverse Event|0|||
161448783|NCT01031836|583038823|FG002|Stage II|Adverse Event|2|||
161448784|NCT01031836|583038824|FG003|Stage II|Adverse Event|2|||
161553525|NCT03095599|583416106|FG000|Overall Study|Withdrawal prior to vaccination|1|||
161553526|NCT03095599|583416107|FG001|Overall Study|Withdrawal prior to vaccination|0|||
161553527|NCT00742885|583416108|FG000|Overall Study|Lost to Follow-up|1|||
161553528|NCT00742885|583416109|FG001|Overall Study|Lost to Follow-up|0|||
161553529|NCT03615482|583416112|FG000|Overall Study|Death|1|||
161553530|NCT03615482|583416113|FG001|Overall Study|Death|0|||
161553531|NCT03615482|583416112|FG000|Overall Study|Lost to Follow-up|7|||
161553532|NCT03615482|583416113|FG001|Overall Study|Lost to Follow-up|7|||
161553533|NCT03615482|583416112|FG000|Overall Study|Physician Decision|2|||
161553534|NCT03615482|583416113|FG001|Overall Study|Physician Decision|3|||
161553535|NCT03615482|583416112|FG000|Overall Study|Withdrawal by Subject|7|||
161553536|NCT03615482|583416113|FG001|Overall Study|Withdrawal by Subject|7|||
161553537|NCT00163215|583416118|FG000|Overall Study|Lack of Efficacy|3|||
161553538|NCT00163215|583416118|FG000|Overall Study|Withdrawal by Subject|5|||
161553539|NCT00163215|583416118|FG000|Overall Study|Other|7|||
161553540|NCT01950273|583416131|FG000|Overall Study|Protocol Violation|1|||
161553541|NCT01950273|583416132|FG001|Overall Study|Protocol Violation|0|||
161553542|NCT01950273|583416131|FG000|Overall Study|Withdrawal by Subject|2|||
161553543|NCT01950273|583416132|FG001|Overall Study|Withdrawal by Subject|0|||
161553544|NCT01950273|583416131|FG000|Overall Study|Other not defined above|1|||
161448785|NCT01031836|583038825|FG004|Stage II|Adverse Event|1|||
161448786|NCT01031836|583038826|FG005|Stage II|Adverse Event|1|||
161448787|NCT01031836|583038821|FG000|Stage II|Other|2|||
161448788|NCT01031836|583038822|FG001|Stage II|Other|0|||
161448789|NCT01031836|583038823|FG002|Stage II|Other|0|||
161448790|NCT01031836|583038824|FG003|Stage II|Other|1|||
161448791|NCT01031836|583038825|FG004|Stage II|Other|1|||
161448792|NCT01031836|583038826|FG005|Stage II|Other|0|||
161448793|NCT01888432|583038831|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
161448794|NCT01888432|583038832|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
161448795|NCT01888432|583038831|FG000|12-month Analysis (FAS)|Physician Decision|1|||
161448796|NCT01888432|583038832|FG001|12-month Analysis (FAS)|Physician Decision|1|||
161448797|NCT01888432|583038831|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
161448798|NCT01888432|583038832|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
161448799|NCT01888432|583038831|FG000|12-month Analysis (FAS)|Death|4|||
161448800|NCT01888432|583038832|FG001|12-month Analysis (FAS)|Death|3|||
161448801|NCT01888432|583038831|FG000|24-month Analysis (FAS)|Graft loss|0|||
161448802|NCT01888432|583038832|FG001|24-month Analysis (FAS)|Graft loss|1|||
161448803|NCT01888432|583038831|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
161448804|NCT01888432|583038832|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
161448805|NCT01888432|583038831|FG000|24-month Analysis (FAS)|Physician Decision|2|||
161448806|NCT01888432|583038832|FG001|24-month Analysis (FAS)|Physician Decision|4|||
161448807|NCT01888432|583038831|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
161448808|NCT01888432|583038832|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
161448809|NCT01888432|583038831|FG000|24-month Analysis (FAS)|Death|8|||
161448810|NCT01888432|583038832|FG001|24-month Analysis (FAS)|Death|4|||
161448811|NCT01888432|583038831|FG000|36-month Analysis (Extension)|Death|1|||
161448812|NCT01888432|583038832|FG001|36-month Analysis (Extension)|Death|0|||
161448813|NCT01754402|583038836|FG000|Overall Study|Death|0|||
161448814|NCT01754402|583038837|FG001|Overall Study|Death|0|||
161448815|NCT01754402|583038838|FG002|Overall Study|Death|1|||
161448816|NCT01754402|583038836|FG000|Overall Study|Adverse Event|2|||
161448817|NCT01754402|583038837|FG001|Overall Study|Adverse Event|2|||
161448818|NCT01754402|583038838|FG002|Overall Study|Adverse Event|1|||
161448819|NCT01754402|583038836|FG000|Overall Study|Withdrawal by Subject|0|||
161448820|NCT01754402|583038837|FG001|Overall Study|Withdrawal by Subject|0|||
161448821|NCT01754402|583038838|FG002|Overall Study|Withdrawal by Subject|1|||
161448822|NCT01754402|583038836|FG000|Overall Study|Lack of Efficacy|0|||
161448823|NCT01754402|583038837|FG001|Overall Study|Lack of Efficacy|0|||
161448824|NCT01754402|583038838|FG002|Overall Study|Lack of Efficacy|1|||
161448825|NCT02051933|583038839|FG000|Overall Study|Physician Decision|0|||
161448826|NCT02051933|583038840|FG001|Overall Study|Physician Decision|1|||
161448827|NCT01954927|583038841|FG000|Overall Study|Withdrawal by Subject|3|||
161448828|NCT01954927|583038842|FG001|Overall Study|Withdrawal by Subject|1|||
161448829|NCT02156271|583038843|FG000|Overall Study|Physician Decision|4|||
161448830|NCT02156271|583038844|FG001|Overall Study|Physician Decision|3|||
161448831|NCT02123251|583038845|FG000|Overall Study|Death|1|||
161448832|NCT02123251|583038846|FG001|Overall Study|Death|1|||
161448833|NCT02123251|583038845|FG000|Overall Study|Withdrawal by Subject|0|||
161448834|NCT02123251|583038846|FG001|Overall Study|Withdrawal by Subject|3|||
161553545|NCT01950273|583416132|FG001|Overall Study|Other not defined above|0|||
161448835|NCT02123251|583038845|FG000|Overall Study|Lost Medicaid eligibility|29|||
161448836|NCT02123251|583038846|FG001|Overall Study|Lost Medicaid eligibility|22|||
161553546|NCT04430335|583416135|FG000|Overall Study|Withdrawal by Subject|1|||
161553547|NCT00179010|583416138|FG000|Overall Study|Muscle probe defective|1|||
161553548|NCT00179010|583416139|FG001|Overall Study|Muscle probe defective|1|||
161553549|NCT00179010|583416138|FG000|Overall Study|Failure to place arterial line|0|||
161553550|NCT00179010|583416139|FG001|Overall Study|Failure to place arterial line|1|||
161553551|NCT03249376|583416154|FG000|Overall Study|Adverse Event|11|||
161553552|NCT03249376|583416155|FG001|Overall Study|Adverse Event|5|||
161553553|NCT03249376|583416154|FG000|Overall Study|Lack of Efficacy|2|||
161553554|NCT03249376|583416155|FG001|Overall Study|Lack of Efficacy|4|||
161553555|NCT03249376|583416154|FG000|Overall Study|Protocol Violation|3|||
161553556|NCT03249376|583416155|FG001|Overall Study|Protocol Violation|2|||
161553557|NCT03249376|583416154|FG000|Overall Study|Physician Decision|0|||
161553558|NCT03249376|583416155|FG001|Overall Study|Physician Decision|2|||
161553559|NCT03249376|583416154|FG000|Overall Study|Withdrawal by Subject|3|||
161553560|NCT03249376|583416155|FG001|Overall Study|Withdrawal by Subject|9|||
161553561|NCT03249376|583416154|FG000|Overall Study|LTFU|2|||
161553562|NCT03249376|583416155|FG001|Overall Study|LTFU|1|||
161553563|NCT00627042|583416159|FG000|Overall Study|Withdrawal by Subject|2|||
161553564|NCT00794820|583416167|FG000|Overall Study|Adverse Event|11|||
161553565|NCT00794820|583416167|FG000|Overall Study|Secondary Malignancies|2|||
161553566|NCT00794820|583416167|FG000|Overall Study|Resistant Disease|2|||
161553567|NCT00794820|583416167|FG000|Overall Study|Ineligible/Screen Failure|1|||
161553568|NCT00432679|583416171|FG000|Overall Study|Adverse Event|2|||
161553569|NCT00432679|583416172|FG001|Overall Study|Adverse Event|1|||
161553570|NCT00432679|583416171|FG000|Overall Study|Withdrawal by Subject|3|||
161553571|NCT00432679|583416172|FG001|Overall Study|Withdrawal by Subject|2|||
161553572|NCT03405662|583416174|FG000|Overall Study|COVID-19 restriction|1|||
161553573|NCT03405662|583416175|FG001|Overall Study|COVID-19 restriction|0|||
161553574|NCT03405662|583416174|FG000|Overall Study|unblinding|0|||
161553575|NCT03405662|583416175|FG001|Overall Study|unblinding|1|||
161553576|NCT03405662|583416174|FG000|Overall Study|placement in memory care facility|0|||
161553577|NCT03405662|583416175|FG001|Overall Study|placement in memory care facility|2|||
161796204|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
161796205|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796206|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796207|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796208|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
161796209|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
161796210|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796211|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796212|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796213|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161448837|NCT02123251|583038845|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
161448838|NCT02123251|583038846|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
161448839|NCT00375609|583038853|FG000|Overall Study|Did not receive treatment|1|||
161448840|NCT00375609|583038854|FG001|Overall Study|Did not receive treatment|0|||
161448841|NCT00375609|583038855|FG002|Overall Study|Did not receive treatment|0|||
161448842|NCT00375609|583038853|FG000|Overall Study|Adverse Event|0|||
161448843|NCT00375609|583038854|FG001|Overall Study|Adverse Event|3|||
161448844|NCT00375609|583038855|FG002|Overall Study|Adverse Event|0|||
161448845|NCT00375609|583038853|FG000|Overall Study|Lost to Follow-up|1|||
161448846|NCT00375609|583038854|FG001|Overall Study|Lost to Follow-up|0|||
161448847|NCT00375609|583038855|FG002|Overall Study|Lost to Follow-up|0|||
161448848|NCT00375609|583038853|FG000|Overall Study|Physician Decision|0|||
161448849|NCT00375609|583038854|FG001|Overall Study|Physician Decision|0|||
161796214|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796215|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796216|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796217|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796218|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796219|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796220|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796221|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796222|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
161796223|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
161796224|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796225|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796226|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161448850|NCT00375609|583038855|FG002|Overall Study|Physician Decision|1|||
161448851|NCT00375609|583038853|FG000|Overall Study|Withdrawal by Subject|1|||
161448852|NCT00375609|583038854|FG001|Overall Study|Withdrawal by Subject|4|||
161448853|NCT00375609|583038855|FG002|Overall Study|Withdrawal by Subject|0|||
161448854|NCT00375609|583038853|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
161448855|NCT00375609|583038854|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
161553578|NCT00280293|583416176|FG000|Overall Study|Protocol Violation|3|||
161553579|NCT00280293|583416177|FG001|Overall Study|Protocol Violation|0|||
161553580|NCT00280293|583416176|FG000|Overall Study|Physician Decision|5|||
161553581|NCT00280293|583416177|FG001|Overall Study|Physician Decision|4|||
161553582|NCT00280293|583416176|FG000|Overall Study|Lost to Follow-up|14|||
161553583|NCT00280293|583416177|FG001|Overall Study|Lost to Follow-up|12|||
161448856|NCT00375609|583038855|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
161448857|NCT02338882|583038856|FG000|Overall Study|Death|1|||
161448858|NCT02338882|583038857|FG001|Overall Study|Death|0|||
161448859|NCT02338882|583038856|FG000|Overall Study|Lost to Follow-up|6|||
161448860|NCT02338882|583038857|FG001|Overall Study|Lost to Follow-up|3|||
161448861|NCT02184455|583038860|FG000|Overall Study|Lost to Follow-up|1|||
161448862|NCT02248675|583038867|FG000|Overall Study|Lost to Follow-up|3|||
161448863|NCT02248675|583038868|FG001|Overall Study|Lost to Follow-up|1|||
161448864|NCT00617669|583038869|FG000|Overall Study|Withdrawal by Subject|71|||
161448865|NCT00617669|583038870|FG001|Overall Study|Withdrawal by Subject|77|||
161448866|NCT00617669|583038869|FG000|Overall Study|Lost to Follow-up|3|||
161448867|NCT00617669|583038870|FG001|Overall Study|Lost to Follow-up|2|||
161448868|NCT00617669|583038869|FG000|Overall Study|Adverse Event|87|||
161448869|NCT00617669|583038870|FG001|Overall Study|Adverse Event|76|||
161448870|NCT00617669|583038869|FG000|Overall Study|Protocol Violation|2|||
161448871|NCT00617669|583038870|FG001|Overall Study|Protocol Violation|3|||
161448872|NCT00617669|583038869|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
161448873|NCT00617669|583038870|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
161448874|NCT00617669|583038869|FG000|Overall Study|Patients randomized but not treated|2|||
161448875|NCT00617669|583038870|FG001|Overall Study|Patients randomized but not treated|3|||
161796227|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796228|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796229|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796230|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796231|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
161796232|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796233|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796234|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796235|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796236|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796237|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
161796238|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796239|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796240|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796241|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796242|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796243|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796244|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796245|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796246|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796247|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796248|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796249|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796250|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
161796251|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
161796252|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796253|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796254|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796255|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796256|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796257|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796258|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796259|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796260|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796261|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796262|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796263|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796264|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796265|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
161796266|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161900671|NCT03316586|584685151|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
161448876|NCT03745820|583038873|FG000|Overall Study|Adverse Event|0|||
161448877|NCT03745820|583038874|FG001|Overall Study|Adverse Event|3|||
161448878|NCT03745820|583038875|FG002|Overall Study|Adverse Event|2|||
161448879|NCT03745820|583038873|FG000|Overall Study|Non-Compliance with Study Drug|4|||
161796267|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161900672|NCT00994110|584685152|FG000|Overall Study|Withdrawal by Subject|9|||
161448880|NCT03745820|583038874|FG001|Overall Study|Non-Compliance with Study Drug|3|||
161448881|NCT03745820|583038875|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161448882|NCT03745820|583038873|FG000|Overall Study|Withdrawal by Subject|4|||
161553584|NCT00280293|583416176|FG000|Overall Study|Withdrawal by Subject|3|||
161553585|NCT00280293|583416177|FG001|Overall Study|Withdrawal by Subject|5|||
161553586|NCT00280293|583416176|FG000|Overall Study|Incarceration/Legal Reasons|1|||
161553587|NCT00280293|583416177|FG001|Overall Study|Incarceration/Legal Reasons|1|||
161553588|NCT00280293|583416176|FG000|Overall Study|Adverse Event|0|||
161553589|NCT00280293|583416177|FG001|Overall Study|Adverse Event|1|||
161553590|NCT01177813|583416178|FG000|Overall Study|Adverse Event|8|||
161553591|NCT01177813|583416179|FG001|Overall Study|Adverse Event|2|||
161553592|NCT01177813|583416180|FG002|Overall Study|Adverse Event|4|||
161553593|NCT01177813|583416181|FG003|Overall Study|Adverse Event|6|||
161553594|NCT01177813|583416182|FG004|Overall Study|Adverse Event|3|||
161553595|NCT01177813|583416178|FG000|Overall Study|Lack of Efficacy|1|||
161553596|NCT01177813|583416179|FG001|Overall Study|Lack of Efficacy|0|||
161553597|NCT01177813|583416180|FG002|Overall Study|Lack of Efficacy|0|||
161553598|NCT01177813|583416181|FG003|Overall Study|Lack of Efficacy|0|||
161553599|NCT01177813|583416182|FG004|Overall Study|Lack of Efficacy|0|||
161553600|NCT01177813|583416178|FG000|Overall Study|Protocol Violation|3|||
161553601|NCT01177813|583416179|FG001|Overall Study|Protocol Violation|2|||
161553602|NCT01177813|583416180|FG002|Overall Study|Protocol Violation|2|||
161553603|NCT01177813|583416181|FG003|Overall Study|Protocol Violation|0|||
161553604|NCT01177813|583416182|FG004|Overall Study|Protocol Violation|1|||
161553605|NCT01177813|583416178|FG000|Overall Study|Lost to Follow-up|12|||
161553606|NCT01177813|583416179|FG001|Overall Study|Lost to Follow-up|5|||
161553607|NCT01177813|583416180|FG002|Overall Study|Lost to Follow-up|6|||
161553608|NCT01177813|583416181|FG003|Overall Study|Lost to Follow-up|3|||
161553609|NCT01177813|583416182|FG004|Overall Study|Lost to Follow-up|0|||
161553610|NCT01177813|583416178|FG000|Overall Study|Withdrawal by Subject|12|||
161553611|NCT01177813|583416179|FG001|Overall Study|Withdrawal by Subject|7|||
161553612|NCT01177813|583416180|FG002|Overall Study|Withdrawal by Subject|6|||
161553613|NCT01177813|583416181|FG003|Overall Study|Withdrawal by Subject|5|||
161553614|NCT01177813|583416182|FG004|Overall Study|Withdrawal by Subject|3|||
161553615|NCT01177813|583416178|FG000|Overall Study|Other reason not defined above|5|||
161553616|NCT01177813|583416179|FG001|Overall Study|Other reason not defined above|2|||
161553617|NCT01177813|583416180|FG002|Overall Study|Other reason not defined above|2|||
161553618|NCT01177813|583416181|FG003|Overall Study|Other reason not defined above|3|||
161553619|NCT01177813|583416182|FG004|Overall Study|Other reason not defined above|2|||
161553620|NCT01458249|583416185|FG000|Overall Study|Not treated|1|||
161553621|NCT01458249|583416185|FG000|Overall Study|Adverse Event|4|||
161553622|NCT01458249|583416185|FG000|Overall Study|Other|2|||
161553623|NCT01458249|583416185|FG000|Overall Study|Ongoing|1|||
161553624|NCT02056119|583416188|FG000|Overall Study|Death|1|||
161553625|NCT02056119|583416189|FG001|Overall Study|Death|2|||
161553626|NCT02056119|583416188|FG000|Overall Study|Intubated for less than 24 hrs|2|||
161553627|NCT02056119|583416189|FG001|Overall Study|Intubated for less than 24 hrs|7|||
161553628|NCT02056119|583416188|FG000|Overall Study|No aerosol treatments were given.|3|||
161553629|NCT02056119|583416189|FG001|Overall Study|No aerosol treatments were given.|2|||
161553630|NCT02056119|583416188|FG000|Overall Study|Received Metaneb treatment|0|||
161553631|NCT02056119|583416189|FG001|Overall Study|Received Metaneb treatment|2|||
161553632|NCT02056119|583416188|FG000|Overall Study|Protocol Violation|4|||
161553633|NCT02056119|583416189|FG001|Overall Study|Protocol Violation|7|||
161553634|NCT01348854|583416190|FG000|Overall Study|Lost to Follow-up|2|||
161553635|NCT01348854|583416191|FG001|Overall Study|Lost to Follow-up|1|||
161553636|NCT01348854|583416190|FG000|Overall Study|Withdrawal by Subject|1|||
161553637|NCT01348854|583416191|FG001|Overall Study|Withdrawal by Subject|0|||
161553638|NCT03220737|583416192|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
161553639|NCT03220737|583416193|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
161553640|NCT03220737|583416194|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
161553641|NCT03220737|583416195|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
161553642|NCT03220737|583416196|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
161553643|NCT03220737|583416197|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
161553644|NCT03220737|583416198|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
161553645|NCT03220737|583416192|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
161553646|NCT03220737|583416193|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
161553647|NCT03220737|583416194|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
161553648|NCT03220737|583416195|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
161553649|NCT03220737|583416196|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
161553650|NCT03220737|583416197|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
161553651|NCT03220737|583416198|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
161553652|NCT03220737|583416192|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
161553653|NCT03220737|583416193|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
161553654|NCT03220737|583416194|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
161553655|NCT03220737|583416195|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
161553656|NCT03220737|583416196|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
161553657|NCT03220737|583416197|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
161553658|NCT03220737|583416198|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
161553659|NCT03220737|583416192|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161553660|NCT03220737|583416193|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161553661|NCT03220737|583416194|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
161553662|NCT03220737|583416195|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161553663|NCT03220737|583416196|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161553664|NCT03220737|583416197|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161553665|NCT03220737|583416198|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161553666|NCT03220737|583416192|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
161553667|NCT03220737|583416193|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
161553668|NCT03220737|583416194|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
161553669|NCT03220737|583416195|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
161553670|NCT03220737|583416196|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
161553671|NCT03220737|583416197|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
161553672|NCT03220737|583416198|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
161553673|NCT03220737|583416192|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
161553674|NCT03220737|583416193|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
161553675|NCT03220737|583416194|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
161553676|NCT03220737|583416195|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
161553677|NCT03220737|583416196|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
161553678|NCT03220737|583416197|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
161553679|NCT03220737|583416198|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
161553680|NCT03220737|583416192|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
161553681|NCT03220737|583416193|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
161553682|NCT03220737|583416194|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
161553683|NCT03220737|583416195|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
161553684|NCT03220737|583416196|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
161553685|NCT03220737|583416197|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
161553686|NCT03220737|583416198|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
161553687|NCT03220737|583416192|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
161553688|NCT03220737|583416193|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161553689|NCT03220737|583416194|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161553690|NCT03220737|583416195|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161553691|NCT03220737|583416196|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161553692|NCT03220737|583416197|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161553693|NCT03220737|583416198|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161553694|NCT04011384|583416204|FG000|Overall Study|Withdrawal by Subject|2|||
161553695|NCT04011384|583416205|FG001|Overall Study|Withdrawal by Subject|0|||
161553696|NCT04716881|583416206|FG000|Overall Study|Adverse Event|1|||
161553697|NCT04716881|583416206|FG000|Overall Study|Lost to Follow-up|1|||
161553698|NCT04147260|583416209|FG000|Overall Study|Adverse Event|1|||
161553699|NCT04147260|583416210|FG001|Overall Study|Adverse Event|0|||
161553700|NCT04147260|583416211|FG002|Overall Study|Adverse Event|1|||
161553701|NCT04147260|583416212|FG003|Overall Study|Adverse Event|2|||
161553702|NCT04147260|583416213|FG004|Overall Study|Adverse Event|0|||
161553703|NCT04147260|583416209|FG000|Overall Study|Withdrawal by Subject|0|||
161553704|NCT04147260|583416210|FG001|Overall Study|Withdrawal by Subject|0|||
161553705|NCT04147260|583416211|FG002|Overall Study|Withdrawal by Subject|1|||
161553706|NCT04147260|583416212|FG003|Overall Study|Withdrawal by Subject|1|||
161553707|NCT04147260|583416213|FG004|Overall Study|Withdrawal by Subject|0|||
161553708|NCT02207374|583416216|FG000|Overall Study|Withdrawal by Subject|5|||
161553709|NCT02207374|583416217|FG001|Overall Study|Withdrawal by Subject|9|||
161553710|NCT02207374|583416218|FG002|Overall Study|Withdrawal by Subject|4|||
161553711|NCT02207374|583416216|FG000|Overall Study|Death|1|||
161553712|NCT02207374|583416217|FG001|Overall Study|Death|0|||
161553713|NCT02207374|583416218|FG002|Overall Study|Death|1|||
161553714|NCT02207374|583416216|FG000|Overall Study|Missing follow-up information|0|||
161553715|NCT02207374|583416217|FG001|Overall Study|Missing follow-up information|1|||
161553716|NCT02207374|583416218|FG002|Overall Study|Missing follow-up information|1|||
161553717|NCT02087150|583416219|FG000|Overall Study|Death|0|||
161553718|NCT02087150|583416220|FG001|Overall Study|Death|1|||
161553719|NCT02087150|583416221|FG002|Overall Study|Death|0|||
161553720|NCT02087150|583416219|FG000|Overall Study|Lost to Follow-up|6|||
161553721|NCT02087150|583416220|FG001|Overall Study|Lost to Follow-up|13|||
161553722|NCT02087150|583416221|FG002|Overall Study|Lost to Follow-up|7|||
161553723|NCT02087150|583416219|FG000|Overall Study|Withdrawal by Subject|2|||
161553724|NCT02087150|583416220|FG001|Overall Study|Withdrawal by Subject|5|||
161553725|NCT02087150|583416221|FG002|Overall Study|Withdrawal by Subject|3|||
161553726|NCT02087150|583416219|FG000|Overall Study|Physician Decision|0|||
161553727|NCT02087150|583416220|FG001|Overall Study|Physician Decision|1|||
161553728|NCT02087150|583416221|FG002|Overall Study|Physician Decision|0|||
161553729|NCT02087150|583416219|FG000|Overall Study|Procedure not done|1|||
161448883|NCT03745820|583038874|FG001|Overall Study|Withdrawal by Subject|4|||
161448884|NCT03745820|583038875|FG002|Overall Study|Withdrawal by Subject|4|||
161448885|NCT03745820|583038873|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
161448886|NCT03745820|583038874|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
161448887|NCT03745820|583038875|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
161448888|NCT03745820|583038873|FG000|Overall Study|Lost to Follow-up|2|||
161448889|NCT03745820|583038874|FG001|Overall Study|Lost to Follow-up|0|||
161448890|NCT03745820|583038875|FG002|Overall Study|Lost to Follow-up|3|||
161448891|NCT03745820|583038873|FG000|Overall Study|Reason not Specified|2|||
161448892|NCT03745820|583038874|FG001|Overall Study|Reason not Specified|4|||
161448893|NCT03745820|583038875|FG002|Overall Study|Reason not Specified|1|||
161448894|NCT04250077|583038884|FG000|Overall Study|Withdrawal by Subject|0|||
161448895|NCT04250077|583038885|FG001|Overall Study|Withdrawal by Subject|1|||
161448896|NCT04250077|583038886|FG002|Overall Study|Withdrawal by Subject|0|||
161448897|NCT04250077|583038884|FG000|Overall Study|Lost to Follow-up|2|||
161448898|NCT04250077|583038885|FG001|Overall Study|Lost to Follow-up|3|||
161448899|NCT04250077|583038886|FG002|Overall Study|Lost to Follow-up|0|||
161448900|NCT00926029|583038887|FG000|Overall Study|Lost to Follow-up|2|||
161448901|NCT00926029|583038888|FG001|Overall Study|Lost to Follow-up|1|||
161448902|NCT00926029|583038889|FG002|Overall Study|Lost to Follow-up|1|||
161448903|NCT02471612|583038890|FG000|Overall Study|Lost to Follow-up|2|||
161448904|NCT03206788|583038891|FG000|Overall Study|Withdrawal by Subject|0|||
161448905|NCT03206788|583038892|FG001|Overall Study|Withdrawal by Subject|1|||
161448906|NCT03206788|583038891|FG000|Overall Study|Adverse Event|0|||
161448907|NCT03206788|583038892|FG001|Overall Study|Adverse Event|1|||
161448908|NCT03206788|583038891|FG000|Overall Study|Physician Decision|0|||
161448909|NCT03206788|583038892|FG001|Overall Study|Physician Decision|1|||
161448910|NCT01598129|583038893|FG000|Overall Study|Disease progression|6|||
161448911|NCT01598129|583038893|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
161448912|NCT01598129|583038893|FG000|Overall Study|Withdrawal by Subject|1|||
161448913|NCT00591318|583038896|FG000|Overall Study|Lack of Efficacy|2|||
161448914|NCT00591318|583038897|FG001|Overall Study|Lack of Efficacy|0|||
161448915|NCT00591318|583038896|FG000|Overall Study|Adverse Event|2|||
161448916|NCT00591318|583038897|FG001|Overall Study|Adverse Event|0|||
161448917|NCT00647270|583038898|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
161448918|NCT00647270|583038899|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
161448919|NCT00647270|583038900|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
161448920|NCT00647270|583038898|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
161448921|NCT00647270|583038899|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
161448922|NCT00647270|583038900|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
161448923|NCT00647270|583038898|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
161448924|NCT00647270|583038899|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
161448925|NCT00647270|583038900|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
161448926|NCT00647270|583038898|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
161448927|NCT00647270|583038899|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
161448928|NCT00647270|583038900|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
161448929|NCT00647270|583038898|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
161448930|NCT00647270|583038899|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
161448931|NCT00647270|583038900|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
161448932|NCT00647270|583038898|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
161448933|NCT00647270|583038899|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
161448934|NCT00647270|583038900|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
161448935|NCT00647270|583038898|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
161448936|NCT00647270|583038899|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
161448937|NCT00647270|583038900|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
161448938|NCT03615040|583038901|FG000|Overall Study|Withdrawal by Subject|2|||
161448939|NCT03615040|583038902|FG001|Overall Study|Withdrawal by Subject|1|||
161448940|NCT03615040|583038901|FG000|Overall Study|Physician Decision|2|||
161448941|NCT03615040|583038902|FG001|Overall Study|Physician Decision|2|||
161448942|NCT03615040|583038901|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
161448943|NCT03615040|583038902|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
161448944|NCT03615040|583038901|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
161448945|NCT03615040|583038902|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
161448946|NCT03615040|583038901|FG000|Overall Study|Death|0|||
161448947|NCT03615040|583038902|FG001|Overall Study|Death|2|||
161448948|NCT01024309|583038905|FG000|Overall Study|Physician Decision|4|||
161448949|NCT01024309|583038906|FG001|Overall Study|Physician Decision|0|||
161448950|NCT01024309|583038905|FG000|Overall Study|Withdrawal by Subject|4|||
161448951|NCT01024309|583038906|FG001|Overall Study|Withdrawal by Subject|4|||
161448952|NCT00567255|583038907|FG000|Overall Study|Adverse Event|241|||
161448953|NCT00567255|583038908|FG001|Overall Study|Adverse Event|68|||
161448954|NCT00567255|583038907|FG000|Overall Study|Lost to Follow-up|77|||
161448955|NCT00567255|583038908|FG001|Overall Study|Lost to Follow-up|48|||
161553730|NCT02087150|583416220|FG001|Overall Study|Procedure not done|13|||
161553731|NCT02087150|583416221|FG002|Overall Study|Procedure not done|0|||
161553732|NCT02087150|583416219|FG000|Overall Study|F/U not completed w/in study window|0|||
161553733|NCT02087150|583416220|FG001|Overall Study|F/U not completed w/in study window|0|||
161553734|NCT02087150|583416221|FG002|Overall Study|F/U not completed w/in study window|1|||
161553735|NCT02087150|583416219|FG000|Overall Study|Other|1|||
161553736|NCT02087150|583416220|FG001|Overall Study|Other|0|||
161553737|NCT02087150|583416221|FG002|Overall Study|Other|0|||
161553738|NCT02087150|583416219|FG000|Overall Study|Pt moved out of town|0|||
161553739|NCT02087150|583416220|FG001|Overall Study|Pt moved out of town|1|||
161553740|NCT02087150|583416221|FG002|Overall Study|Pt moved out of town|0|||
161553741|NCT00785538|583416222|FG000|Treatment Period|Adverse Event|1|||
161553742|NCT00785538|583416223|FG001|Treatment Period|Adverse Event|2|||
161553743|NCT00785538|583416224|FG002|Treatment Period|Adverse Event|2|||
161553744|NCT00785538|583416225|FG003|Treatment Period|Adverse Event|0|||
161553745|NCT00785538|583416222|FG000|Treatment Period|Withdrawal by Subject|0|||
161553746|NCT00785538|583416223|FG001|Treatment Period|Withdrawal by Subject|0|||
161553747|NCT00785538|583416224|FG002|Treatment Period|Withdrawal by Subject|0|||
161553748|NCT00785538|583416225|FG003|Treatment Period|Withdrawal by Subject|1|||
161553749|NCT00683449|583416226|FG000|Overall Study|Lost to Follow-up|0|||
161553750|NCT00683449|583416227|FG001|Overall Study|Lost to Follow-up|1|||
161553751|NCT00683449|583416228|FG002|Overall Study|Lost to Follow-up|0|||
161553752|NCT00683449|583416229|FG003|Overall Study|Lost to Follow-up|0|||
161553753|NCT00683449|583416230|FG004|Overall Study|Lost to Follow-up|0|||
161553754|NCT01000376|583416236|FG000|Cycle 1 Day 1|Adverse Event|1|||
161553755|NCT01000376|583416237|FG001|Cycle 1 Day 1|Adverse Event|0|||
161553756|NCT01000376|583416236|FG000|Cycle 1 Day 1|Progressive Disease|1|||
161553757|NCT01000376|583416237|FG001|Cycle 1 Day 1|Progressive Disease|0|||
161553758|NCT00507026|583416238|FG000|Overall Study|Lack of Efficacy|6|||
161553759|NCT00507026|583416239|FG001|Overall Study|Lack of Efficacy|4|||
161553760|NCT00507026|583416240|FG002|Overall Study|Lack of Efficacy|21|||
161553761|NCT00507026|583416238|FG000|Overall Study|Withdrawal by Subject|2|||
161553762|NCT00507026|583416239|FG001|Overall Study|Withdrawal by Subject|0|||
161553763|NCT00507026|583416240|FG002|Overall Study|Withdrawal by Subject|0|||
161553764|NCT00507026|583416238|FG000|Overall Study|Investigator Decision|1|||
161553765|NCT00507026|583416239|FG001|Overall Study|Investigator Decision|0|||
161553766|NCT00507026|583416240|FG002|Overall Study|Investigator Decision|0|||
161553767|NCT00507026|583416238|FG000|Overall Study|Adverse Event|2|||
161553768|NCT00507026|583416239|FG001|Overall Study|Adverse Event|0|||
161553769|NCT00507026|583416240|FG002|Overall Study|Adverse Event|0|||
161553770|NCT00507026|583416238|FG000|Overall Study|Protocol Violation|1|||
161553771|NCT00507026|583416239|FG001|Overall Study|Protocol Violation|0|||
161553772|NCT00507026|583416240|FG002|Overall Study|Protocol Violation|0|||
161553773|NCT00507026|583416238|FG000|Overall Study|Other|1|||
161553774|NCT00507026|583416239|FG001|Overall Study|Other|0|||
161553775|NCT00507026|583416240|FG002|Overall Study|Other|0|||
161553776|NCT04230980|583416241|FG000|Overall Study|Lost to Follow-up|1|||
161553777|NCT04230980|583416242|FG001|Overall Study|Lost to Follow-up|2|||
161553778|NCT04230980|583416241|FG000|Overall Study|Adverse Event|0|||
161553779|NCT04230980|583416242|FG001|Overall Study|Adverse Event|1|||
161553780|NCT01680458|583416247|FG000|Overall Study|Protocol Violation|3|||
161553781|NCT02138747|583416248|FG000|Treatment Period 1|Adverse Event|10|||
161553782|NCT02138747|583416249|FG001|Treatment Period 1|Adverse Event|14|||
161553783|NCT02138747|583416250|FG002|Treatment Period 1|Adverse Event|2|||
161553784|NCT02138747|583416251|FG003|Treatment Period 1|Adverse Event|1|||
161553785|NCT02138747|583416248|FG000|Treatment Period 1|Lost to Follow-up|0|||
161553786|NCT02138747|583416249|FG001|Treatment Period 1|Lost to Follow-up|1|||
161553787|NCT02138747|583416250|FG002|Treatment Period 1|Lost to Follow-up|1|||
161553788|NCT02138747|583416251|FG003|Treatment Period 1|Lost to Follow-up|0|||
161553789|NCT02138747|583416248|FG000|Treatment Period 1|Protocol Violation|0|||
161553790|NCT02138747|583416249|FG001|Treatment Period 1|Protocol Violation|2|||
161553791|NCT02138747|583416250|FG002|Treatment Period 1|Protocol Violation|0|||
161553792|NCT02138747|583416251|FG003|Treatment Period 1|Protocol Violation|0|||
161553793|NCT02138747|583416248|FG000|Treatment Period 1|Withdrawal by Subject|8|||
161553794|NCT02138747|583416249|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161553795|NCT02138747|583416250|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161553796|NCT02138747|583416251|FG003|Treatment Period 1|Withdrawal by Subject|3|||
161553797|NCT02138747|583416248|FG000|Treatment Period 1|Other - Miscellaneous|2|||
161553798|NCT02138747|583416249|FG001|Treatment Period 1|Other - Miscellaneous|4|||
161553799|NCT02138747|583416250|FG002|Treatment Period 1|Other - Miscellaneous|0|||
161553800|NCT02138747|583416251|FG003|Treatment Period 1|Other - Miscellaneous|0|||
161553801|NCT02138747|583416248|FG000|Treatment Period 2|Adverse Event|6|||
161553802|NCT02138747|583416249|FG001|Treatment Period 2|Adverse Event|3|||
161553803|NCT02138747|583416250|FG002|Treatment Period 2|Adverse Event|1|||
161553804|NCT02138747|583416251|FG003|Treatment Period 2|Adverse Event|1|||
161553805|NCT02138747|583416248|FG000|Treatment Period 2|Lost to Follow-up|2|||
161553806|NCT02138747|583416249|FG001|Treatment Period 2|Lost to Follow-up|0|||
161553807|NCT02138747|583416250|FG002|Treatment Period 2|Lost to Follow-up|0|||
161553808|NCT02138747|583416251|FG003|Treatment Period 2|Lost to Follow-up|0|||
161553809|NCT02138747|583416248|FG000|Treatment Period 2|Protocol Violation|1|||
161553810|NCT02138747|583416249|FG001|Treatment Period 2|Protocol Violation|0|||
161553811|NCT02138747|583416250|FG002|Treatment Period 2|Protocol Violation|0|||
161553812|NCT02138747|583416251|FG003|Treatment Period 2|Protocol Violation|0|||
161553813|NCT02138747|583416248|FG000|Treatment Period 2|Withdrawal by Subject|5|||
161553814|NCT02138747|583416249|FG001|Treatment Period 2|Withdrawal by Subject|4|||
161553815|NCT02138747|583416250|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161553816|NCT02138747|583416251|FG003|Treatment Period 2|Withdrawal by Subject|2|||
161553817|NCT02138747|583416248|FG000|Treatment Period 2|Other - Miscellaneous|3|||
161553818|NCT02138747|583416249|FG001|Treatment Period 2|Other - Miscellaneous|0|||
161553819|NCT02138747|583416250|FG002|Treatment Period 2|Other - Miscellaneous|0|||
161553820|NCT02138747|583416251|FG003|Treatment Period 2|Other - Miscellaneous|0|||
161553821|NCT02302066|583416252|FG000|Overall Study|Adverse Event|1|||
161553822|NCT02302066|583416253|FG001|Overall Study|Adverse Event|1|||
161553823|NCT02302066|583416254|FG002|Overall Study|Adverse Event|3|||
161553824|NCT02302066|583416255|FG003|Overall Study|Adverse Event|0|||
161553825|NCT02302066|583416252|FG000|Overall Study|Lost to Follow-up|4|||
161553826|NCT02302066|583416253|FG001|Overall Study|Lost to Follow-up|5|||
161553827|NCT02302066|583416254|FG002|Overall Study|Lost to Follow-up|24|||
161553828|NCT02302066|583416255|FG003|Overall Study|Lost to Follow-up|7|||
161553829|NCT02302066|583416252|FG000|Overall Study|Withdrawal by Subject|25|||
161553830|NCT02302066|583416253|FG001|Overall Study|Withdrawal by Subject|58|||
161553831|NCT02302066|583416254|FG002|Overall Study|Withdrawal by Subject|124|||
161553832|NCT02302066|583416255|FG003|Overall Study|Withdrawal by Subject|33|||
161553833|NCT02302066|583416252|FG000|Overall Study|Pregnancy|2|||
161553834|NCT02302066|583416253|FG001|Overall Study|Pregnancy|10|||
161553835|NCT02302066|583416254|FG002|Overall Study|Pregnancy|12|||
161553836|NCT02302066|583416255|FG003|Overall Study|Pregnancy|0|||
161553837|NCT02302066|583416252|FG000|Overall Study|Reason Not Specified|1|||
161553838|NCT02302066|583416253|FG001|Overall Study|Reason Not Specified|1|||
161553839|NCT02302066|583416254|FG002|Overall Study|Reason Not Specified|9|||
161553840|NCT02302066|583416255|FG003|Overall Study|Reason Not Specified|1|||
161553841|NCT04793464|583416260|FG000|Overall Study|Lost to Follow-up|458|||
161553842|NCT04793464|583416261|FG001|Overall Study|Lost to Follow-up|168|||
161553843|NCT04793464|583416262|FG002|Overall Study|Lost to Follow-up|5|||
161553844|NCT04793464|583416260|FG000|Overall Study|Withdrawal by Subject|43|||
161553845|NCT04793464|583416261|FG001|Overall Study|Withdrawal by Subject|15|||
161553846|NCT04793464|583416262|FG002|Overall Study|Withdrawal by Subject|0|||
161553847|NCT02696902|583416266|FG000|Overall Study|Lost to Follow-up|0|||
161553848|NCT02696902|583416267|FG001|Overall Study|Lost to Follow-up|1|||
161553849|NCT02696902|583416268|FG002|Overall Study|Lost to Follow-up|1|||
161553850|NCT02696902|583416266|FG000|Overall Study|Withdrawal by Subject|0|||
161553851|NCT02696902|583416267|FG001|Overall Study|Withdrawal by Subject|0|||
161553852|NCT02696902|583416268|FG002|Overall Study|Withdrawal by Subject|1|||
161553853|NCT02696902|583416266|FG000|Overall Study|Death|19|||
161553854|NCT02696902|583416267|FG001|Overall Study|Death|3|||
161553855|NCT02696902|583416268|FG002|Overall Study|Death|24|||
161553856|NCT02696902|583416266|FG000|Overall Study|Participant not fit post-randomization|0|||
161553857|NCT02696902|583416267|FG001|Overall Study|Participant not fit post-randomization|0|||
161553858|NCT02696902|583416268|FG002|Overall Study|Participant not fit post-randomization|1|||
161553859|NCT02696902|583416266|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
161553860|NCT02696902|583416267|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
161553861|NCT02696902|583416268|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
161553862|NCT02696902|583416266|FG000|Overall Study|Principal investigator's decision|1|||
161553863|NCT02696902|583416267|FG001|Overall Study|Principal investigator's decision|0|||
161553864|NCT02696902|583416268|FG002|Overall Study|Principal investigator's decision|0|||
161553865|NCT02696902|583416266|FG000|Overall Study|Sponsor's decision|1|||
161553866|NCT02696902|583416267|FG001|Overall Study|Sponsor's decision|0|||
161553867|NCT02696902|583416268|FG002|Overall Study|Sponsor's decision|0|||
161553868|NCT02696902|583416266|FG000|Overall Study|Transferred to other hospital|1|||
161900673|NCT00994110|584685153|FG001|Overall Study|Withdrawal by Subject|9|||
161900674|NCT00994110|584685152|FG000|Overall Study|Not Treated|4|||
161900675|NCT00994110|584685153|FG001|Overall Study|Not Treated|8|||
161900676|NCT00994110|584685152|FG000|Overall Study|Adverse Event|1|||
161900677|NCT00994110|584685153|FG001|Overall Study|Adverse Event|0|||
161553869|NCT02696902|583416267|FG001|Overall Study|Transferred to other hospital|0|||
161553870|NCT02696902|583416268|FG002|Overall Study|Transferred to other hospital|0|||
161553871|NCT00845871|583416272|FG000|Assessment Period|Adverse Event|2|||
161553872|NCT00845871|583416272|FG000|Assessment Period|Abnormal laboratory values|1|||
161553873|NCT00845871|583416272|FG000|Assessment Period|Abnormal test procedure results|1|||
161553874|NCT00845871|583416272|FG000|Assessment Period|Patient withdrew consent|3|||
161553875|NCT01857622|583416273|FG000|Overall Study|Adverse Event|5|||
161553876|NCT01857622|583416274|FG001|Overall Study|Adverse Event|0|||
161553877|NCT01857622|583416275|FG002|Overall Study|Adverse Event|2|||
161553878|NCT01857622|583416273|FG000|Overall Study|Physician Decision|1|||
161900678|NCT00994110|584685152|FG000|Overall Study|Patient not resected|41|||
161900679|NCT00994110|584685153|FG001|Overall Study|Patient not resected|52|||
161553879|NCT01857622|583416274|FG001|Overall Study|Physician Decision|0|||
161553880|NCT01857622|583416275|FG002|Overall Study|Physician Decision|0|||
161553881|NCT01857622|583416273|FG000|Overall Study|Protocol Violation|4|||
161553882|NCT01857622|583416274|FG001|Overall Study|Protocol Violation|1|||
161553883|NCT01857622|583416275|FG002|Overall Study|Protocol Violation|0|||
161553884|NCT01857622|583416273|FG000|Overall Study|Withdrawal by Subject|1|||
161553885|NCT01857622|583416274|FG001|Overall Study|Withdrawal by Subject|0|||
161553886|NCT01857622|583416275|FG002|Overall Study|Withdrawal by Subject|0|||
161553887|NCT01291225|583416278|FG000|Overall Study|Lost to Follow-up|85|||
161553888|NCT01291225|583416279|FG001|Overall Study|Lost to Follow-up|39|||
161553889|NCT01734434|583416280|FG000|Overall Study|Death Infant|3|||
161553890|NCT01734434|583416281|FG001|Overall Study|Death Infant|1|||
161553891|NCT01734434|583416282|FG002|Overall Study|Death Infant|17|||
161553892|NCT01734434|583416283|FG003|Overall Study|Death Infant|5|||
161553893|NCT01734434|583416280|FG000|Overall Study|Lost to Follow-up|2|||
161553894|NCT01734434|583416281|FG001|Overall Study|Lost to Follow-up|9|||
161553895|NCT01734434|583416282|FG002|Overall Study|Lost to Follow-up|67|||
161553896|NCT01734434|583416283|FG003|Overall Study|Lost to Follow-up|11|||
161553897|NCT01734434|583416280|FG000|Overall Study|No Live Birth|1|||
161553898|NCT01734434|583416281|FG001|Overall Study|No Live Birth|2|||
161553899|NCT01734434|583416282|FG002|Overall Study|No Live Birth|32|||
161553900|NCT01734434|583416283|FG003|Overall Study|No Live Birth|6|||
161553901|NCT01734434|583416280|FG000|Overall Study|Withdrawal by Subject|4|||
161553902|NCT01734434|583416281|FG001|Overall Study|Withdrawal by Subject|0|||
161553903|NCT01734434|583416282|FG002|Overall Study|Withdrawal by Subject|8|||
161553904|NCT01734434|583416283|FG003|Overall Study|Withdrawal by Subject|1|||
161553905|NCT01734434|583416280|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
161553906|NCT01734434|583416281|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
161553907|NCT01734434|583416282|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
161553908|NCT01734434|583416283|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
161553909|NCT01734434|583416280|FG000|Overall Study|Subject Not Reachable|0|||
161553910|NCT01734434|583416281|FG001|Overall Study|Subject Not Reachable|0|||
161553911|NCT01734434|583416282|FG002|Overall Study|Subject Not Reachable|1|||
161553912|NCT01734434|583416283|FG003|Overall Study|Subject Not Reachable|0|||
161553913|NCT01734434|583416280|FG000|Overall Study|Treatment Defaulter|0|||
161553914|NCT01734434|583416281|FG001|Overall Study|Treatment Defaulter|0|||
161553915|NCT01734434|583416282|FG002|Overall Study|Treatment Defaulter|1|||
161553916|NCT01734434|583416283|FG003|Overall Study|Treatment Defaulter|0|||
161553917|NCT01734434|583416280|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
161553918|NCT01734434|583416281|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
161553919|NCT01734434|583416282|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
161553920|NCT01734434|583416283|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
161553921|NCT01734434|583416280|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
161553922|NCT01734434|583416281|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
161553923|NCT01734434|583416282|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
161553924|NCT01734434|583416283|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
161553925|NCT04714216|583418479|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
161553926|NCT04714216|583418479|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
161553927|NCT00513019|583418481|FG000|Overall Study|Adverse Event|1|||
161553928|NCT00513019|583418482|FG001|Overall Study|Adverse Event|0|||
161553929|NCT00513019|583418481|FG000|Overall Study|Withdrawal by Subject|4|||
161553930|NCT00513019|583418482|FG001|Overall Study|Withdrawal by Subject|5|||
161553931|NCT04129580|583418483|FG000|Overall Study|Lost to Follow-up|14|||
161553932|NCT04129580|583418484|FG001|Overall Study|Lost to Follow-up|25|||
161553933|NCT00322868|583418485|FG000|Overall Study|disease progression|1|||
161553934|NCT01852162|583418486|FG000|Overall Study|Adverse Event|1|||
161553935|NCT01852162|583418487|FG001|Overall Study|Adverse Event|0|||
161553936|NCT01852162|583418486|FG000|Overall Study|Withdrawal by Subject|3|||
161553937|NCT01852162|583418487|FG001|Overall Study|Withdrawal by Subject|1|||
161553938|NCT01500226|583418488|FG000|Overall Study|Adverse Event|31|||
161553939|NCT01500226|583418489|FG001|Overall Study|Adverse Event|38|||
161553940|NCT01500226|583418488|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
161553941|NCT01500226|583418489|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
161553942|NCT01500226|583418488|FG000|Overall Study|Withdrawal by Subject|93|||
161553943|NCT01500226|583418489|FG001|Overall Study|Withdrawal by Subject|96|||
161553944|NCT01500226|583418488|FG000|Overall Study|Death|12|||
161553945|NCT01500226|583418489|FG001|Overall Study|Death|4|||
161553946|NCT01500226|583418488|FG000|Overall Study|Disease Progression|16|||
161553947|NCT01500226|583418489|FG001|Overall Study|Disease Progression|14|||
161553948|NCT01500226|583418488|FG000|Overall Study|Protocol Violation|53|||
161553949|NCT01500226|583418489|FG001|Overall Study|Protocol Violation|39|||
161553950|NCT01500226|583418488|FG000|Overall Study|Physician Decision|17|||
161553951|NCT01500226|583418489|FG001|Overall Study|Physician Decision|15|||
161553952|NCT01500226|583418488|FG000|Overall Study|Lack of Efficacy|14|||
161553953|NCT01500226|583418489|FG001|Overall Study|Lack of Efficacy|30|||
161553954|NCT01500226|583418488|FG000|Overall Study|Lost to Follow-up|9|||
161553955|NCT01500226|583418489|FG001|Overall Study|Lost to Follow-up|5|||
161553956|NCT01500226|583418488|FG000|Overall Study|Other Reasons|19|||
161553957|NCT01500226|583418489|FG001|Overall Study|Other Reasons|16|||
161553958|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161553959|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
161553960|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
161553961|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
161553962|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
161553963|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
161553964|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161553965|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161553966|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161553967|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161553968|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553969|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553970|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553971|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
161553972|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
161553973|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553974|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553975|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553976|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553977|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161553978|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161553979|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
161553980|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
161553981|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
161553982|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
161553983|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
161553984|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161553985|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161553986|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161553987|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161553988|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
161553989|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553990|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553991|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
161553992|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
161553993|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553994|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553995|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553996|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553997|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
161553998|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161553999|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554000|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
161554001|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
161554002|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554003|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554004|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554005|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554006|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554007|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
161554008|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554009|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554010|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554011|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554012|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
161554013|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554014|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554015|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554016|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161900680|NCT00994110|584685152|FG000|Overall Study|Pt not eligible|10|||
161900681|NCT00994110|584685153|FG001|Overall Study|Pt not eligible|5|||
161448956|NCT00567255|583038907|FG000|Overall Study|Withdrawal by Subject|75|||
161448957|NCT00567255|583038908|FG001|Overall Study|Withdrawal by Subject|56|||
161448958|NCT00567255|583038907|FG000|Overall Study|Lack of Efficacy|19|||
161448959|NCT00567255|583038908|FG001|Overall Study|Lack of Efficacy|33|||
161448960|NCT00567255|583038907|FG000|Overall Study|Protocol Violation|20|||
161448961|NCT00567255|583038908|FG001|Overall Study|Protocol Violation|8|||
161448962|NCT00567255|583038907|FG000|Overall Study|Pregnancy|6|||
161448963|NCT00567255|583038908|FG001|Overall Study|Pregnancy|0|||
161448964|NCT00567255|583038907|FG000|Overall Study|Drug noncompliance,moved,other|25|||
161448965|NCT00567255|583038908|FG001|Overall Study|Drug noncompliance,moved,other|15|||
161448966|NCT01743001|583038911|FG000|Overall Study|Physician Decision|1|||
161448967|NCT01743001|583038912|FG001|Overall Study|Physician Decision|0|||
161448968|NCT01743001|583038911|FG000|Overall Study|Pregnancy|1|||
161448969|NCT01743001|583038912|FG001|Overall Study|Pregnancy|0|||
161448970|NCT01743001|583038911|FG000|Overall Study|Death|1|||
161448971|NCT01743001|583038912|FG001|Overall Study|Death|0|||
161448972|NCT02657408|583038915|FG000|Overall Study|Adverse Event|3|||
161448973|NCT02657408|583038916|FG001|Overall Study|Adverse Event|7|||
161448974|NCT03672097|583038917|FG000|Period 1|Withdrawal by Subject|2|||
161448975|NCT03672097|583038917|FG000|Period 1|Adverse Event|1|||
161448976|NCT03672097|583038917|FG000|Period 1|Did not receive treatment|1|||
161448977|NCT03672097|583038917|FG000|Period 2|Withdrawal by Subject|3|||
161448978|NCT03672097|583038917|FG000|Period 2|Other|1|||
161448979|NCT01403948|583038918|FG000|Overall Study|Progressive disease|0|||
161448980|NCT01403948|583038919|FG001|Overall Study|Progressive disease|2|||
161448981|NCT01403948|583038920|FG002|Overall Study|Progressive disease|2|||
161448982|NCT01403948|583038921|FG003|Overall Study|Progressive disease|4|||
161448983|NCT01403948|583038922|FG004|Overall Study|Progressive disease|2|||
161448984|NCT01403948|583038923|FG005|Overall Study|Progressive disease|6|||
161448985|NCT01403948|583038924|FG006|Overall Study|Progressive disease|2|||
161448986|NCT01403948|583038925|FG007|Overall Study|Progressive disease|4|||
161448987|NCT01403948|583038926|FG008|Overall Study|Progressive disease|5|||
161448988|NCT01403948|583038927|FG009|Overall Study|Progressive disease|5|||
161448989|NCT01403948|583038918|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448990|NCT01403948|583038919|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448991|NCT01403948|583038920|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448992|NCT01403948|583038921|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448993|NCT01403948|583038922|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
161448994|NCT01403948|583038923|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448995|NCT01403948|583038924|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
161448996|NCT01403948|583038925|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448997|NCT01403948|583038926|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
161448998|NCT01403948|583038927|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
161448999|NCT01403948|583038918|FG000|Overall Study|Lost to Follow-up|0|||
161449000|NCT01403948|583038919|FG001|Overall Study|Lost to Follow-up|0|||
161449001|NCT01403948|583038920|FG002|Overall Study|Lost to Follow-up|0|||
161449002|NCT01403948|583038921|FG003|Overall Study|Lost to Follow-up|0|||
161449003|NCT01403948|583038922|FG004|Overall Study|Lost to Follow-up|0|||
161449004|NCT01403948|583038923|FG005|Overall Study|Lost to Follow-up|0|||
161449005|NCT01403948|583038924|FG006|Overall Study|Lost to Follow-up|0|||
161449006|NCT01403948|583038925|FG007|Overall Study|Lost to Follow-up|0|||
161449007|NCT01403948|583038926|FG008|Overall Study|Lost to Follow-up|0|||
161449008|NCT01403948|583038927|FG009|Overall Study|Lost to Follow-up|1|||
161449009|NCT01403948|583038918|FG000|Overall Study|Refused cont. medication|0|||
161449010|NCT01403948|583038919|FG001|Overall Study|Refused cont. medication|0|||
161449011|NCT01403948|583038920|FG002|Overall Study|Refused cont. medication|0|||
161449012|NCT01403948|583038921|FG003|Overall Study|Refused cont. medication|0|||
161449013|NCT01403948|583038922|FG004|Overall Study|Refused cont. medication|1|||
161449014|NCT01403948|583038923|FG005|Overall Study|Refused cont. medication|0|||
161449015|NCT01403948|583038924|FG006|Overall Study|Refused cont. medication|0|||
161449016|NCT01403948|583038925|FG007|Overall Study|Refused cont. medication|0|||
161449017|NCT01403948|583038926|FG008|Overall Study|Refused cont. medication|0|||
161449018|NCT01403948|583038927|FG009|Overall Study|Refused cont. medication|1|||
161449019|NCT01403948|583038918|FG000|Overall Study|other than above|1|||
161449020|NCT01403948|583038919|FG001|Overall Study|other than above|2|||
161449021|NCT01403948|583038920|FG002|Overall Study|other than above|1|||
161449022|NCT01403948|583038921|FG003|Overall Study|other than above|0|||
161449023|NCT01403948|583038922|FG004|Overall Study|other than above|1|||
161449024|NCT01403948|583038923|FG005|Overall Study|other than above|1|||
161449025|NCT01403948|583038924|FG006|Overall Study|other than above|2|||
161449026|NCT01403948|583038925|FG007|Overall Study|other than above|0|||
161449027|NCT01403948|583038926|FG008|Overall Study|other than above|0|||
161449028|NCT01403948|583038927|FG009|Overall Study|other than above|0|||
161449029|NCT01090323|583038928|FG000|Overall Study|Adverse Event|12|||
161449030|NCT01090323|583038929|FG001|Overall Study|Adverse Event|2|||
161449031|NCT01090323|583038928|FG000|Overall Study|Abnormal Lab Values|3|||
161449032|NCT01090323|583038929|FG001|Overall Study|Abnormal Lab Values|1|||
161449033|NCT01090323|583038928|FG000|Overall Study|Abnormal Test Procedure Results|2|||
161554017|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161554018|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554019|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554020|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554021|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
161554022|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
161554023|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
161554024|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554025|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554026|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554027|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161554028|NCT02018861|583418490|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554029|NCT02018861|583418491|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554030|NCT02018861|583418492|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554031|NCT02018861|583418493|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
161554032|NCT02018861|583418494|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
161554033|NCT02018861|583418495|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554034|NCT02018861|583418496|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554035|NCT02018861|583418497|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554036|NCT02018861|583418498|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554037|NCT02018861|583418499|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
161554038|NCT02018861|583418490|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554039|NCT02018861|583418491|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554040|NCT02018861|583418492|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554041|NCT02018861|583418493|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554042|NCT02018861|583418494|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554043|NCT02018861|583418495|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554044|NCT02018861|583418496|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
161554045|NCT02018861|583418497|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
161554046|NCT02018861|583418498|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554047|NCT02018861|583418499|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
161554048|NCT02018861|583418490|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554049|NCT02018861|583418491|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554050|NCT02018861|583418492|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554051|NCT02018861|583418493|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554052|NCT02018861|583418494|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554053|NCT02018861|583418495|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554054|NCT02018861|583418496|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
161554055|NCT02018861|583418497|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
161554056|NCT02018861|583418498|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554057|NCT02018861|583418499|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
161554058|NCT02018861|583418490|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554059|NCT02018861|583418491|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554060|NCT02018861|583418492|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554061|NCT02018861|583418493|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554062|NCT02018861|583418494|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554063|NCT02018861|583418495|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554064|NCT02018861|583418496|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554065|NCT02018861|583418497|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554066|NCT02018861|583418498|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
161554067|NCT02018861|583418499|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
161554068|NCT02018861|583418490|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554069|NCT02018861|583418491|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554070|NCT02018861|583418492|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554071|NCT02018861|583418493|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554072|NCT02018861|583418494|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554073|NCT02018861|583418495|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554074|NCT02018861|583418496|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554075|NCT02018861|583418497|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554076|NCT02018861|583418498|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
161554077|NCT02018861|583418499|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161554078|NCT02018861|583418490|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554079|NCT02018861|583418491|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554080|NCT02018861|583418492|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554081|NCT02018861|583418493|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554082|NCT02018861|583418494|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554083|NCT02018861|583418495|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554084|NCT02018861|583418496|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554085|NCT02018861|583418497|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554086|NCT02018861|583418498|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
161554087|NCT02018861|583418499|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
161554088|NCT01642186|583418500|FG000|Overall Study|Death|0|||
161554089|NCT01642186|583418501|FG001|Overall Study|Death|2|||
161554090|NCT01642186|583418502|FG002|Overall Study|Death|2|||
161554091|NCT01642186|583418500|FG000|Overall Study|Lost to Follow-up|0|||
161554092|NCT01642186|583418501|FG001|Overall Study|Lost to Follow-up|0|||
161554093|NCT01642186|583418502|FG002|Overall Study|Lost to Follow-up|1|||
161554094|NCT00590980|583418505|FG000|Overall Study|Did not meet all inclusion criteria|10|||
161554095|NCT00504348|583418506|FG000|Overall Study|Adverse Event|3|||
161554096|NCT00504348|583418506|FG000|Overall Study|Lack of Efficacy|4|||
161554097|NCT00504348|583418506|FG000|Overall Study|Physician Decision|1|||
161554098|NCT00506285|583418509|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
161554099|NCT00506285|583418510|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
161554100|NCT00506285|583418509|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
161554101|NCT00506285|583418510|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
161554102|NCT00506285|583418509|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
161554103|NCT00506285|583418510|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
161554104|NCT00506285|583418509|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
161554105|NCT00506285|583418510|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
161554106|NCT00506285|583418509|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
161554107|NCT00506285|583418510|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
161554108|NCT01023308|583418513|FG000|Overall Study|Abnormal test proceedure results|3|||
161554109|NCT01023308|583418514|FG001|Overall Study|Abnormal test proceedure results|8|||
161554110|NCT01023308|583418513|FG000|Overall Study|Administrative problems|2|||
161554111|NCT01023308|583418514|FG001|Overall Study|Administrative problems|1|||
161554112|NCT01023308|583418513|FG000|Overall Study|Adverse Event|130|||
161554113|NCT01023308|583418514|FG001|Overall Study|Adverse Event|66|||
161554114|NCT01023308|583418513|FG000|Overall Study|Death|21|||
161554115|NCT01023308|583418514|FG001|Overall Study|Death|17|||
161554116|NCT01023308|583418513|FG000|Overall Study|Disease progression|82|||
161554117|NCT01023308|583418514|FG001|Overall Study|Disease progression|153|||
161554118|NCT01023308|583418513|FG000|Overall Study|New Cancer therapy|4|||
161554119|NCT01023308|583418514|FG001|Overall Study|New Cancer therapy|7|||
161554120|NCT01023308|583418513|FG000|Overall Study|Protocol Violation|3|||
161554121|NCT01023308|583418514|FG001|Overall Study|Protocol Violation|4|||
161554122|NCT01023308|583418513|FG000|Overall Study|Untreated|5|||
161554123|NCT01023308|583418514|FG001|Overall Study|Untreated|5|||
161554124|NCT01023308|583418513|FG000|Overall Study|Lost to Follow-up|1|||
161554125|NCT01023308|583418514|FG001|Overall Study|Lost to Follow-up|0|||
161554126|NCT01023308|583418513|FG000|Overall Study|Withdrawal by Subject|34|||
161554127|NCT01023308|583418514|FG001|Overall Study|Withdrawal by Subject|18|||
161554128|NCT00551213|583418515|FG000|Overall Study|Adverse Event|6|||
161554129|NCT00551213|583418516|FG001|Overall Study|Adverse Event|3|||
161554130|NCT00551213|583418515|FG000|Overall Study|Progressive Disease|41|||
161554131|NCT00551213|583418516|FG001|Overall Study|Progressive Disease|12|||
161554132|NCT00551213|583418515|FG000|Overall Study|Withdrawal by Subject|2|||
161554133|NCT00551213|583418516|FG001|Overall Study|Withdrawal by Subject|0|||
161554134|NCT00551213|583418515|FG000|Overall Study|Not Treated|1|||
161554135|NCT00551213|583418516|FG001|Overall Study|Not Treated|2|||
161554136|NCT01890967|583418517|FG000|Overall Study|Adverse Event|3|||
161554137|NCT01890967|583418518|FG001|Overall Study|Adverse Event|3|||
161554138|NCT01890967|583418519|FG002|Overall Study|Adverse Event|3|||
161554139|NCT01890967|583418520|FG003|Overall Study|Adverse Event|2|||
161554140|NCT01890967|583418521|FG004|Overall Study|Adverse Event|1|||
161554141|NCT01890967|583418522|FG005|Overall Study|Adverse Event|7|||
161554142|NCT01890967|583418517|FG000|Overall Study|Death|1|||
161554143|NCT01890967|583418518|FG001|Overall Study|Death|0|||
161554144|NCT01890967|583418519|FG002|Overall Study|Death|0|||
161554145|NCT01890967|583418520|FG003|Overall Study|Death|0|||
161554146|NCT01890967|583418521|FG004|Overall Study|Death|0|||
161554147|NCT01890967|583418522|FG005|Overall Study|Death|0|||
161554148|NCT01890967|583418517|FG000|Overall Study|Lost to Follow-up|1|||
161554149|NCT01890967|583418518|FG001|Overall Study|Lost to Follow-up|1|||
161554150|NCT01890967|583418519|FG002|Overall Study|Lost to Follow-up|1|||
161554151|NCT01890967|583418520|FG003|Overall Study|Lost to Follow-up|1|||
161554152|NCT01890967|583418521|FG004|Overall Study|Lost to Follow-up|0|||
161554153|NCT01890967|583418522|FG005|Overall Study|Lost to Follow-up|1|||
161554154|NCT01890967|583418517|FG000|Overall Study|Protocol Violation|0|||
161554155|NCT01890967|583418518|FG001|Overall Study|Protocol Violation|3|||
161554156|NCT01890967|583418519|FG002|Overall Study|Protocol Violation|3|||
161554157|NCT01890967|583418520|FG003|Overall Study|Protocol Violation|2|||
161554158|NCT01890967|583418521|FG004|Overall Study|Protocol Violation|4|||
161554159|NCT01890967|583418522|FG005|Overall Study|Protocol Violation|1|||
161554160|NCT01890967|583418517|FG000|Overall Study|Sponsor Decision|2|||
161554161|NCT01890967|583418518|FG001|Overall Study|Sponsor Decision|0|||
161554162|NCT01890967|583418519|FG002|Overall Study|Sponsor Decision|1|||
161554163|NCT01890967|583418520|FG003|Overall Study|Sponsor Decision|3|||
161554164|NCT01890967|583418521|FG004|Overall Study|Sponsor Decision|2|||
161554165|NCT01890967|583418522|FG005|Overall Study|Sponsor Decision|3|||
161554166|NCT01890967|583418517|FG000|Overall Study|Withdrawal by Subject|3|||
161554167|NCT01890967|583418518|FG001|Overall Study|Withdrawal by Subject|4|||
161554168|NCT01890967|583418519|FG002|Overall Study|Withdrawal by Subject|2|||
161554169|NCT01890967|583418520|FG003|Overall Study|Withdrawal by Subject|3|||
161554170|NCT01890967|583418521|FG004|Overall Study|Withdrawal by Subject|3|||
161554171|NCT01890967|583418522|FG005|Overall Study|Withdrawal by Subject|1|||
161554172|NCT01646320|583418523|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
161554173|NCT01646320|583418524|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
161796268|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161449034|NCT01090323|583038929|FG001|Overall Study|Abnormal Test Procedure Results|0|||
161449035|NCT01090323|583038928|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161449036|NCT01090323|583038929|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161449037|NCT01090323|583038928|FG000|Overall Study|Condition no longer requires drug|5|||
161449038|NCT01090323|583038929|FG001|Overall Study|Condition no longer requires drug|4|||
161449039|NCT01090323|583038928|FG000|Overall Study|Protocol Violation|2|||
161449040|NCT01090323|583038929|FG001|Overall Study|Protocol Violation|1|||
161449041|NCT01090323|583038928|FG000|Overall Study|Withdrew consent|33|||
161449042|NCT01090323|583038929|FG001|Overall Study|Withdrew consent|11|||
161449043|NCT01090323|583038928|FG000|Overall Study|Lost to Follow-up|11|||
161449044|NCT01090323|583038929|FG001|Overall Study|Lost to Follow-up|6|||
161449045|NCT01090323|583038928|FG000|Overall Study|Administrative problems|6|||
161449046|NCT01090323|583038929|FG001|Overall Study|Administrative problems|4|||
161449047|NCT01090323|583038928|FG000|Overall Study|Death|1|||
161449048|NCT01090323|583038929|FG001|Overall Study|Death|2|||
161449049|NCT01090323|583038928|FG000|Overall Study|Stopped end of core|7|||
161449050|NCT01090323|583038929|FG001|Overall Study|Stopped end of core|0|||
161449051|NCT01090323|583038928|FG000|Overall Study|Stopped end of extension 1#|3|||
161449052|NCT01090323|583038929|FG001|Overall Study|Stopped end of extension 1#|1|||
161449053|NCT05498701|583038930|FG000|Period 3|Adverse Event|1|||
161449054|NCT05498701|583038931|FG001|Period 3|Adverse Event|0|||
161449055|NCT02424578|583038932|FG000|Overall Study|Withdrawal by Subject|0|||
161449056|NCT02424578|583038933|FG001|Overall Study|Withdrawal by Subject|1|||
161449057|NCT00080899|583038935|FG000|Overall Study|Adverse Event|1|||
161449058|NCT02872935|583038936|FG000|Overall Study|Other|0|||
161449059|NCT02872935|583038937|FG001|Overall Study|Other|1|||
161449060|NCT03179319|583038938|FG000|Overall Study|Lost to Follow-up|6|||
161449061|NCT03179319|583038939|FG001|Overall Study|Lost to Follow-up|0|||
161449062|NCT05343624|583038940|FG000|Overall Study|Chart review not completed|1|||
161449063|NCT00711477|583038942|FG000|Overall Study|Adverse Event|3|||
161449064|NCT00711477|583038943|FG001|Overall Study|Adverse Event|1|||
161449065|NCT00711477|583038942|FG000|Overall Study|Lost to Follow-up|0|||
161449066|NCT00711477|583038943|FG001|Overall Study|Lost to Follow-up|1|||
161449067|NCT00711477|583038942|FG000|Overall Study|Noncompliance|0|||
161449068|NCT00711477|583038943|FG001|Overall Study|Noncompliance|1|||
161449069|NCT02695420|583038944|FG000|Overall Study|Death|0|||
161449070|NCT02695420|583038945|FG001|Overall Study|Death|1|||
161449071|NCT02695420|583038946|FG002|Overall Study|Death|0|||
161449072|NCT02695420|583038947|FG003|Overall Study|Death|0|||
161449073|NCT02087423|583038948|FG000|Overall Study|Withdrawal by Subject|20|||
161449074|NCT02087423|583038949|FG001|Overall Study|Withdrawal by Subject|20|||
161449075|NCT02087423|583038950|FG002|Overall Study|Withdrawal by Subject|3|||
161449076|NCT02087423|583038948|FG000|Overall Study|Death|68|||
161449077|NCT02087423|583038949|FG001|Overall Study|Death|207|||
161449078|NCT02087423|583038950|FG002|Overall Study|Death|40|||
161449079|NCT02087423|583038948|FG000|Overall Study|Lost to Follow-up|0|||
161449080|NCT02087423|583038949|FG001|Overall Study|Lost to Follow-up|2|||
161449081|NCT02087423|583038950|FG002|Overall Study|Lost to Follow-up|0|||
161449082|NCT02087423|583038948|FG000|Overall Study|Terminated from study at final DCO|23|||
161449083|NCT02087423|583038949|FG001|Overall Study|Terminated from study at final DCO|36|||
161449084|NCT02087423|583038950|FG002|Overall Study|Terminated from study at final DCO|25|||
161449085|NCT02762370|583038951|FG000|Overall Study|Protocol Violation|1|||
161449086|NCT02762370|583038952|FG001|Overall Study|Protocol Violation|0|||
161449087|NCT00530816|583038956|FG000|Overall Study|Progressive Disease|16|||
161449088|NCT00530816|583038957|FG001|Overall Study|Progressive Disease|24|||
161796269|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796270|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161449089|NCT00530816|583038958|FG002|Overall Study|Progressive Disease|24|||
161449090|NCT00530816|583038956|FG000|Overall Study|Adverse Event|6|||
161449091|NCT00530816|583038957|FG001|Overall Study|Adverse Event|13|||
161449092|NCT00530816|583038958|FG002|Overall Study|Adverse Event|7|||
161554174|NCT01646320|583418523|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
161554175|NCT01646320|583418524|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
161554176|NCT01646320|583418523|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
161554177|NCT01646320|583418524|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
161554178|NCT01646320|583418523|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
161554179|NCT01646320|583418524|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
161554180|NCT01646320|583418523|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161554181|NCT01646320|583418524|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161554182|NCT01646320|583418523|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
161554183|NCT01646320|583418524|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
161554184|NCT01646320|583418523|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
161554185|NCT01646320|583418524|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
161900682|NCT02163395|584685154|FG000|Overall Study|Withdrawal by Subject|1|||
161900683|NCT02163395|584685154|FG000|Overall Study|Lost to Follow-up|3|||
161900684|NCT02163395|584685154|FG000|Overall Study|Adverse Event|1|||
161900685|NCT03150082|584685155|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
161900686|NCT03150082|584685156|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
161900687|NCT04131712|584685157|FG000|Overall Study|COVID related|0|||
161554186|NCT01646320|583418523|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
161554187|NCT01646320|583418524|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
161554188|NCT01646320|583418523|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
161554189|NCT01646320|583418524|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
161554190|NCT01646320|583418523|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
161554191|NCT01646320|583418524|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
161554192|NCT01646320|583418523|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
161554193|NCT01646320|583418524|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
161554194|NCT02892409|583418525|FG000|Overall Study|Adverse Event|1|||
161554195|NCT02892409|583418526|FG001|Overall Study|Adverse Event|0|||
161554196|NCT02892409|583418525|FG000|Overall Study|Withdrawal by Subject|2|||
161554197|NCT02892409|583418526|FG001|Overall Study|Withdrawal by Subject|1|||
161554198|NCT02254421|583418527|FG000|Overall Study|Randomized but Not Treated|1|||
161554199|NCT02254421|583418528|FG001|Overall Study|Randomized but Not Treated|0|||
161554200|NCT02254421|583418527|FG000|Overall Study|Death|0|||
161554201|NCT02254421|583418528|FG001|Overall Study|Death|2|||
161554202|NCT02254421|583418527|FG000|Overall Study|Withdrew Consent|1|||
161554203|NCT02254421|583418528|FG001|Overall Study|Withdrew Consent|1|||
161554204|NCT00867490|583418529|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
161554205|NCT00867490|583418529|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
161554206|NCT00867490|583418529|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
161554207|NCT00867490|583418529|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
161554208|NCT00867490|583418529|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
161554209|NCT01154036|583418538|FG000|Phase I|Physician Decision|0|||
161554210|NCT01154036|583418539|FG001|Phase I|Physician Decision|1|||
161554211|NCT01154036|583418540|FG002|Phase I|Physician Decision|0|||
161554212|NCT01154036|583418541|FG003|Phase I|Physician Decision|0|||
161554213|NCT01154036|583418542|FG004|Phase I|Physician Decision|0|||
161554214|NCT01154036|583418543|FG005|Phase I|Physician Decision|0|||
161554215|NCT01154036|583418544|FG006|Phase I|Physician Decision|0|||
161554216|NCT01154036|583418545|FG007|Phase I|Physician Decision|0|||
161554217|NCT01154036|583418538|FG000|Phase I|Lost to Follow-up|0|||
161554218|NCT01154036|583418539|FG001|Phase I|Lost to Follow-up|3|||
161554219|NCT01154036|583418540|FG002|Phase I|Lost to Follow-up|6|||
161554220|NCT01154036|583418541|FG003|Phase I|Lost to Follow-up|0|||
161554221|NCT01154036|583418542|FG004|Phase I|Lost to Follow-up|0|||
161554222|NCT01154036|583418543|FG005|Phase I|Lost to Follow-up|0|||
161554223|NCT01154036|583418544|FG006|Phase I|Lost to Follow-up|0|||
161554224|NCT01154036|583418545|FG007|Phase I|Lost to Follow-up|0|||
161554225|NCT01154036|583418538|FG000|Phase I|Protocol Violation|0|||
161554226|NCT01154036|583418539|FG001|Phase I|Protocol Violation|3|||
161554227|NCT01154036|583418540|FG002|Phase I|Protocol Violation|9|||
161554228|NCT01154036|583418541|FG003|Phase I|Protocol Violation|0|||
161554229|NCT01154036|583418542|FG004|Phase I|Protocol Violation|0|||
161554230|NCT01154036|583418543|FG005|Phase I|Protocol Violation|0|||
161554231|NCT01154036|583418544|FG006|Phase I|Protocol Violation|0|||
161554232|NCT01154036|583418545|FG007|Phase I|Protocol Violation|0|||
161554233|NCT01154036|583418538|FG000|Phase I|Withdrawal by Subject|2|||
161554234|NCT01154036|583418539|FG001|Phase I|Withdrawal by Subject|10|||
161554235|NCT01154036|583418540|FG002|Phase I|Withdrawal by Subject|29|||
161554236|NCT01154036|583418541|FG003|Phase I|Withdrawal by Subject|0|||
161554237|NCT01154036|583418542|FG004|Phase I|Withdrawal by Subject|0|||
161900688|NCT04131712|584685158|FG001|Overall Study|COVID related|0|||
161554238|NCT01154036|583418543|FG005|Phase I|Withdrawal by Subject|0|||
161554239|NCT01154036|583418544|FG006|Phase I|Withdrawal by Subject|0|||
161554240|NCT01154036|583418545|FG007|Phase I|Withdrawal by Subject|0|||
161554241|NCT01154036|583418538|FG000|Phase I|Adverse Event|1|||
161554242|NCT01154036|583418539|FG001|Phase I|Adverse Event|11|||
161554243|NCT01154036|583418540|FG002|Phase I|Adverse Event|12|||
161554244|NCT01154036|583418541|FG003|Phase I|Adverse Event|0|||
161554245|NCT01154036|583418542|FG004|Phase I|Adverse Event|0|||
161449093|NCT00530816|583038956|FG000|Overall Study|Other|3|||
161449094|NCT00530816|583038957|FG001|Overall Study|Other|3|||
161449095|NCT00530816|583038958|FG002|Overall Study|Other|4|||
161449096|NCT00530816|583038956|FG000|Overall Study|Withdrawal by Subject|1|||
161449097|NCT00530816|583038957|FG001|Overall Study|Withdrawal by Subject|2|||
161449098|NCT00530816|583038958|FG002|Overall Study|Withdrawal by Subject|6|||
161449099|NCT01516034|583038959|FG000|Overall Study|Physician Decision|1|||
161449100|NCT01516034|583038959|FG000|Overall Study|Lack of Efficacy|7|||
161554246|NCT01154036|583418543|FG005|Phase I|Adverse Event|0|||
161554247|NCT01154036|583418544|FG006|Phase I|Adverse Event|0|||
161554248|NCT01154036|583418545|FG007|Phase I|Adverse Event|0|||
161554249|NCT01154036|583418538|FG000|Phase II|Adverse Event|0|||
161554250|NCT01154036|583418539|FG001|Phase II|Adverse Event|0|||
161554251|NCT01154036|583418540|FG002|Phase II|Adverse Event|0|||
161554252|NCT01154036|583418541|FG003|Phase II|Adverse Event|0|||
161554253|NCT01154036|583418542|FG004|Phase II|Adverse Event|1|||
161554254|NCT01154036|583418543|FG005|Phase II|Adverse Event|1|||
161554255|NCT01154036|583418544|FG006|Phase II|Adverse Event|1|||
161554256|NCT01154036|583418545|FG007|Phase II|Adverse Event|1|||
161554257|NCT01154036|583418538|FG000|Phase II|Physician Decision|0|||
161554258|NCT01154036|583418539|FG001|Phase II|Physician Decision|0|||
161554259|NCT01154036|583418540|FG002|Phase II|Physician Decision|0|||
161554260|NCT01154036|583418541|FG003|Phase II|Physician Decision|0|||
161554261|NCT01154036|583418542|FG004|Phase II|Physician Decision|0|||
161554262|NCT01154036|583418543|FG005|Phase II|Physician Decision|0|||
161554263|NCT01154036|583418544|FG006|Phase II|Physician Decision|1|||
161554264|NCT01154036|583418545|FG007|Phase II|Physician Decision|0|||
161554265|NCT01154036|583418538|FG000|Phase II|Lost to Follow-up|0|||
161554266|NCT01154036|583418539|FG001|Phase II|Lost to Follow-up|0|||
161554267|NCT01154036|583418540|FG002|Phase II|Lost to Follow-up|0|||
161554268|NCT01154036|583418541|FG003|Phase II|Lost to Follow-up|1|||
161554269|NCT01154036|583418542|FG004|Phase II|Lost to Follow-up|2|||
161554270|NCT01154036|583418543|FG005|Phase II|Lost to Follow-up|0|||
161554271|NCT01154036|583418544|FG006|Phase II|Lost to Follow-up|2|||
161554272|NCT01154036|583418545|FG007|Phase II|Lost to Follow-up|1|||
161554273|NCT01154036|583418538|FG000|Phase II|Protocol Violation|0|||
161554274|NCT01154036|583418539|FG001|Phase II|Protocol Violation|0|||
161554275|NCT01154036|583418540|FG002|Phase II|Protocol Violation|0|||
161554276|NCT01154036|583418541|FG003|Phase II|Protocol Violation|0|||
161554277|NCT01154036|583418542|FG004|Phase II|Protocol Violation|1|||
161554278|NCT01154036|583418543|FG005|Phase II|Protocol Violation|2|||
161554279|NCT01154036|583418544|FG006|Phase II|Protocol Violation|0|||
161554280|NCT01154036|583418545|FG007|Phase II|Protocol Violation|0|||
161554281|NCT01154036|583418538|FG000|Phase II|Withdrawal by Subject|0|||
161554282|NCT01154036|583418539|FG001|Phase II|Withdrawal by Subject|0|||
161449101|NCT01033448|583038960|FG000|Overall Study|Withdrawal by Subject|4|||
161449102|NCT01033448|583038960|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
161449103|NCT01033448|583038960|FG000|Overall Study|Lost to Follow-up|3|||
161449104|NCT01033448|583038960|FG000|Overall Study|Withdrew due to other reasons|3|||
161554283|NCT01154036|583418540|FG002|Phase II|Withdrawal by Subject|0|||
161554284|NCT01154036|583418541|FG003|Phase II|Withdrawal by Subject|0|||
161554285|NCT01154036|583418542|FG004|Phase II|Withdrawal by Subject|4|||
161554286|NCT01154036|583418543|FG005|Phase II|Withdrawal by Subject|2|||
161554287|NCT01154036|583418544|FG006|Phase II|Withdrawal by Subject|5|||
161554288|NCT01154036|583418545|FG007|Phase II|Withdrawal by Subject|4|||
161796271|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796272|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796273|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161796274|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161796275|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161554289|NCT02264574|583418546|FG000|Overall Study|Death|21|||
161796276|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161449105|NCT01033448|583038960|FG000|Overall Study|Unknown disposition|1|||
161554290|NCT02264574|583418547|FG001|Overall Study|Death|21|||
161554291|NCT02264574|583418546|FG000|Overall Study|Withdrawal by Subject|8|||
161554292|NCT02264574|583418547|FG001|Overall Study|Withdrawal by Subject|6|||
161554293|NCT02264574|583418546|FG000|Overall Study|Other, Not Specified|0|||
161554294|NCT02264574|583418547|FG001|Overall Study|Other, Not Specified|3|||
161554295|NCT02080520|583418548|FG000|Overall Study|Self-reported symptoms|5|||
161554296|NCT02080520|583418549|FG001|Overall Study|Self-reported symptoms|6|||
161554297|NCT02080520|583418548|FG000|Overall Study|Unable to contact|2|||
161554298|NCT02080520|583418549|FG001|Overall Study|Unable to contact|1|||
161554299|NCT02080520|583418548|FG000|Overall Study|Initiated aspirin|2|||
161554300|NCT02080520|583418549|FG001|Overall Study|Initiated aspirin|0|||
161554301|NCT02080520|583418548|FG000|Overall Study|Atrial fibrillation|1|||
161554302|NCT02080520|583418549|FG001|Overall Study|Atrial fibrillation|1|||
161554303|NCT02080520|583418548|FG000|Overall Study|Cancer|1|||
161554304|NCT02080520|583418549|FG001|Overall Study|Cancer|2|||
161554305|NCT02080520|583418548|FG000|Overall Study|Not interested in study|1|||
161554306|NCT02080520|583418549|FG001|Overall Study|Not interested in study|3|||
161554307|NCT02080520|583418548|FG000|Overall Study|Too busy|1|||
161554308|NCT02080520|583418549|FG001|Overall Study|Too busy|1|||
161449106|NCT00870584|583038964|FG000|Overall Study|Adverse Event|3|||
161449107|NCT00870584|583038965|FG001|Overall Study|Adverse Event|3|||
161449108|NCT00870584|583038964|FG000|Overall Study|Withdrawal by Subject|6|||
161449109|NCT00870584|583038965|FG001|Overall Study|Withdrawal by Subject|7|||
161449110|NCT00870584|583038964|FG000|Overall Study|Lost to Follow-up|5|||
161449111|NCT00870584|583038965|FG001|Overall Study|Lost to Follow-up|1|||
161449112|NCT00870584|583038964|FG000|Overall Study|Protocol Deviation|2|||
161449113|NCT00870584|583038965|FG001|Overall Study|Protocol Deviation|2|||
161449114|NCT02560025|583038966|FG000|Overall Study|Ineligible after consent/ registration|3|||
161449115|NCT01497366|583038967|FG000|Overall Study|Virologic failure|2|||
161449116|NCT01497366|583038968|FG001|Overall Study|Virologic failure|50|||
161449117|NCT01497366|583038967|FG000|Overall Study|Lost to Follow-up|11|||
161449118|NCT01497366|583038968|FG001|Overall Study|Lost to Follow-up|10|||
161449119|NCT01497366|583038967|FG000|Overall Study|Withdrawal by Subject|6|||
161449120|NCT01497366|583038968|FG001|Overall Study|Withdrawal by Subject|6|||
161449121|NCT01497366|583038967|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
161449122|NCT01497366|583038968|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
161449123|NCT01497366|583038967|FG000|Overall Study|Other|5|||
161449124|NCT01497366|583038968|FG001|Overall Study|Other|0|||
161449125|NCT01497366|583038967|FG000|Overall Study|Death|1|||
161449126|NCT01497366|583038968|FG001|Overall Study|Death|1|||
161449127|NCT01497366|583038967|FG000|Overall Study|Randomized but not treated|7|||
161449128|NCT01497366|583038968|FG001|Overall Study|Randomized but not treated|21|||
161449129|NCT02745080|583038978|FG000|Overall Study|Adverse Event|13|||
161449130|NCT02745080|583038979|FG001|Overall Study|Adverse Event|21|||
161449131|NCT02745080|583038978|FG000|Overall Study|Lack of Efficacy|11|||
161449132|NCT02745080|583038979|FG001|Overall Study|Lack of Efficacy|23|||
161449133|NCT02745080|583038978|FG000|Overall Study|Lost to Follow-up|3|||
161449134|NCT02745080|583038979|FG001|Overall Study|Lost to Follow-up|3|||
161449135|NCT02745080|583038978|FG000|Overall Study|Physician Decision|3|||
161449136|NCT02745080|583038979|FG001|Overall Study|Physician Decision|0|||
161449137|NCT02745080|583038978|FG000|Overall Study|Protocol Violation|3|||
161449138|NCT02745080|583038979|FG001|Overall Study|Protocol Violation|1|||
161449139|NCT02745080|583038978|FG000|Overall Study|Withdrawal by Subject|22|||
161449140|NCT02745080|583038979|FG001|Overall Study|Withdrawal by Subject|41|||
161449141|NCT01864005|583040306|FG000|Overall Study|Protocol Violation|0|||
161449142|NCT01864005|583040307|FG001|Overall Study|Protocol Violation|1|||
161449143|NCT01864005|583040306|FG000|Overall Study|Withdrawal by Subject|0|||
161449144|NCT01864005|583040307|FG001|Overall Study|Withdrawal by Subject|1|||
161449145|NCT01864005|583040306|FG000|Overall Study|Incorrect enrolment|1|||
161449146|NCT01864005|583040307|FG001|Overall Study|Incorrect enrolment|0|||
161449147|NCT01864005|583040306|FG000|Overall Study|Disease need|1|||
161449148|NCT01864005|583040307|FG001|Overall Study|Disease need|1|||
161449149|NCT01864005|583040306|FG000|Overall Study|Need GP IIb/IIIa|1|||
161449150|NCT01864005|583040307|FG001|Overall Study|Need GP IIb/IIIa|3|||
161449151|NCT00763698|583040310|FG000|Overall Study|Unsuccessful Implant|5|||
161449152|NCT00763698|583040310|FG000|Overall Study|Death|4|||
161449153|NCT00763698|583040310|FG000|Overall Study|Withdrawal by Subject|1|||
161449154|NCT02184572|583040311|FG000|Overall Study|Lost to Follow-up|29|||
161449155|NCT02184572|583040312|FG001|Overall Study|Lost to Follow-up|21|||
161449156|NCT02184572|583040311|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
161449157|NCT02184572|583040312|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
161554309|NCT02080520|583418548|FG000|Overall Study|Work-related injury|1|||
161554310|NCT02080520|583418549|FG001|Overall Study|Work-related injury|0|||
161449158|NCT02184572|583040311|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
161449159|NCT02184572|583040312|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
161449160|NCT02184572|583040311|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
161449161|NCT02184572|583040312|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
161449162|NCT02184572|583040311|FG000|Overall Study|Traveling Outside The Country|1|||
161449163|NCT02184572|583040312|FG001|Overall Study|Traveling Outside The Country|0|||
161449164|NCT02184572|583040311|FG000|Overall Study|Withdrawal by Subject|14|||
161554311|NCT02080520|583418548|FG000|Overall Study|Personal reasons|0|||
161554312|NCT02080520|583418549|FG001|Overall Study|Personal reasons|3|||
161554313|NCT00390455|583418550|FG000|Overall Study|Adverse Event|17|||
161554314|NCT00390455|583418551|FG001|Overall Study|Adverse Event|3|||
161796277|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796278|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
161449165|NCT02184572|583040312|FG001|Overall Study|Withdrawal by Subject|9|||
161449166|NCT03679754|583040316|FG000|Overall Study|Investigator request|1|||
161449167|NCT00964171|583040317|FG000|Overall Study|Death|5|||
161449168|NCT01120717|583040321|FG000|Overall Study|Withdrawal by Subject|11|||
161449169|NCT01120717|583040322|FG001|Overall Study|Withdrawal by Subject|6|||
161449170|NCT01120717|583040321|FG000|Overall Study|Adverse Event|10|||
161449171|NCT01120717|583040322|FG001|Overall Study|Adverse Event|6|||
161449172|NCT01120717|583040321|FG000|Overall Study|Protocol Deviation|2|||
161449173|NCT01120717|583040322|FG001|Overall Study|Protocol Deviation|5|||
161449174|NCT01120717|583040321|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161449175|NCT01120717|583040322|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161449176|NCT01120717|583040321|FG000|Overall Study|Lost to Follow-up|2|||
161449177|NCT01120717|583040322|FG001|Overall Study|Lost to Follow-up|3|||
161449178|NCT01120717|583040321|FG000|Overall Study|Death|3|||
161449179|NCT01120717|583040322|FG001|Overall Study|Death|1|||
161449180|NCT01120717|583040321|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
161449181|NCT01120717|583040322|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161449182|NCT02640508|583040327|FG000|Overall Study|Death|19|||
161449183|NCT02640508|583040327|FG000|Overall Study|Withdrawal by Subject|8|||
161449184|NCT02640508|583040327|FG000|Overall Study|Physician Decision|1|||
161449185|NCT02640508|583040327|FG000|Overall Study|Lost to Follow-up|1|||
161449186|NCT00865280|583040328|FG000|Overall Study|Withdrawal by Subject|4|||
161449187|NCT00865280|583040329|FG001|Overall Study|Withdrawal by Subject|1|||
161449188|NCT00865280|583040328|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
161449189|NCT00865280|583040329|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
161449190|NCT00865280|583040328|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
161449191|NCT00865280|583040329|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
161449192|NCT00865280|583040328|FG000|Overall Study|Exclusion Condition|1|||
161449193|NCT00865280|583040329|FG001|Overall Study|Exclusion Condition|0|||
161449194|NCT00865280|583040328|FG000|Overall Study|Adverse Event|0|||
161449195|NCT00865280|583040329|FG001|Overall Study|Adverse Event|1|||
161449196|NCT00329797|583040330|FG000|Overall Study|Protocol Violation|1|||
161449197|NCT00329797|583040331|FG001|Overall Study|Protocol Violation|0|||
161449198|NCT00329797|583040330|FG000|Overall Study|Withdrawal by Subject|6|||
161449199|NCT00329797|583040331|FG001|Overall Study|Withdrawal by Subject|6|||
161449200|NCT03091348|583040340|FG000|Overall Study|Lost to Follow-up|2|||
161449201|NCT03091348|583040341|FG001|Overall Study|Lost to Follow-up|1|||
161449202|NCT04534686|583040342|FG000|Baseline Measurement|Lost to Follow-up|4|||
161449203|NCT04534686|583040343|FG001|Baseline Measurement|Lost to Follow-up|6|||
161449204|NCT04534686|583040342|FG000|Baseline Measurement|Withdrawal by Subject|3|||
161449205|NCT04534686|583040343|FG001|Baseline Measurement|Withdrawal by Subject|1|||
161449206|NCT04534686|583040342|FG000|Intervention|Withdrawal by Subject|2|||
161449207|NCT04534686|583040343|FG001|Intervention|Withdrawal by Subject|2|||
161449208|NCT03179605|583040344|FG000|Overall Study|Withdrawal by Subject|1|||
161449209|NCT00635999|583040345|FG000|Overall Study|Withdrawal by Subject|4|||
161449210|NCT00635999|583040346|FG001|Overall Study|Withdrawal by Subject|2|||
161449211|NCT00635999|583040347|FG002|Overall Study|Withdrawal by Subject|1|||
161449212|NCT01396070|583040348|FG000|Overall Study|Withdrawal by Subject|2|||
161449213|NCT01396070|583040348|FG000|Overall Study|Death|2|||
161449214|NCT01396070|583040348|FG000|Overall Study|Adverse Event|8|||
161449215|NCT01396070|583040348|FG000|Overall Study|Physician Decision|3|||
161449216|NCT01396070|583040348|FG000|Overall Study|Lack of Efficacy|4|||
161449217|NCT02636361|583040350|FG000|Period 4|Physician Decision|0|||
161449218|NCT02636361|583040351|FG001|Period 4|Physician Decision|0|||
161449219|NCT02636361|583040352|FG002|Period 4|Physician Decision|0|||
161449220|NCT02636361|583040353|FG003|Period 4|Physician Decision|1|||
161449221|NCT02636361|583040354|FG004|Period 4|Physician Decision|0|||
161449222|NCT03037580|583040359|FG000|Overall Study|Withdrawal by Subject|3|||
161449223|NCT03037580|583040360|FG001|Overall Study|Withdrawal by Subject|0|||
161449224|NCT03037580|583040359|FG000|Overall Study|Adverse Event|1|||
161449225|NCT03037580|583040360|FG001|Overall Study|Adverse Event|0|||
161449226|NCT03037580|583040359|FG000|Overall Study|Study Terminated by Sponsor|12|||
161449227|NCT03037580|583040360|FG001|Overall Study|Study Terminated by Sponsor|15|||
161449228|NCT03037580|583040359|FG000|Overall Study|Death|0|||
161449229|NCT03037580|583040360|FG001|Overall Study|Death|1|||
161449230|NCT02036853|583040361|FG000|Overall Study|Adverse Event|0|||
161449231|NCT02036853|583040362|FG001|Overall Study|Adverse Event|2|||
161449232|NCT02036853|583040361|FG000|Overall Study|Lack of Efficacy|0|||
161449233|NCT02036853|583040362|FG001|Overall Study|Lack of Efficacy|2|||
161449234|NCT02036853|583040361|FG000|Overall Study|Physician Decision|0|||
161449235|NCT02036853|583040362|FG001|Overall Study|Physician Decision|1|||
161449236|NCT02036853|583040361|FG000|Overall Study|Withdrawal by Subject|0|||
161449237|NCT02036853|583040362|FG001|Overall Study|Withdrawal by Subject|1|||
161449238|NCT00228553|583040363|FG000|Overall Study|Adverse Event|112|||
161449239|NCT00228553|583040363|FG000|Overall Study|Lack of Efficacy|34|||
161449240|NCT00228553|583040363|FG000|Overall Study|Lost to Follow-up|67|||
161554315|NCT00390455|583418550|FG000|Overall Study|Withdrawal by Subject|8|||
161554316|NCT00390455|583418551|FG001|Overall Study|Withdrawal by Subject|8|||
161900689|NCT04131712|584685159|FG002|Overall Study|COVID related|2|||
161900690|NCT04131712|584685160|FG003|Overall Study|COVID related|0|||
161900691|NCT04131712|584685157|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161900692|NCT04131712|584685158|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161900693|NCT04131712|584685159|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
161449241|NCT00228553|583040363|FG000|Overall Study|Physician Decision|48|||
161449242|NCT00228553|583040363|FG000|Overall Study|Protocol Violation|6|||
161449243|NCT00228553|583040363|FG000|Overall Study|Withdrawal by Subject|115|||
161449244|NCT00228553|583040363|FG000|Overall Study|Pregnancy|2|||
161449245|NCT00228553|583040363|FG000|Overall Study|Miscellaneous|46|||
161449246|NCT04530136|583040364|FG000|Overall Study|Lost to Follow-up|2|||
161449247|NCT04530136|583040365|FG001|Overall Study|Lost to Follow-up|3|||
161449248|NCT04530136|583040364|FG000|Overall Study|Withdrawal by Subject|1|||
161449249|NCT04530136|583040365|FG001|Overall Study|Withdrawal by Subject|0|||
161449250|NCT04530136|583040364|FG000|Overall Study|Death|0|||
161449251|NCT04530136|583040365|FG001|Overall Study|Death|1|||
161449252|NCT00499590|583040369|FG000|Overall Study|Study Terminated|112|||
161449253|NCT00499590|583040370|FG001|Overall Study|Study Terminated|112|||
161449254|NCT00499590|583040371|FG002|Overall Study|Study Terminated|112|||
161449255|NCT00499590|583040369|FG000|Overall Study|Not treated|1|||
161449256|NCT00499590|583040370|FG001|Overall Study|Not treated|0|||
161449257|NCT00499590|583040371|FG002|Overall Study|Not treated|1|||
161449258|NCT02633020|583040375|FG000|Overall Study|Adverse Event|1|||
161449259|NCT02633020|583040376|FG001|Overall Study|Adverse Event|0|||
161449260|NCT00934440|583040377|FG000|Overall Study|Lost to Follow-up|1|||
161449261|NCT02152956|583040378|FG000|Overall Study|Adverse Event|0|||
161449262|NCT02152956|583040379|FG001|Overall Study|Adverse Event|0|||
161449263|NCT02152956|583040380|FG002|Overall Study|Adverse Event|0|||
161449264|NCT02152956|583040381|FG003|Overall Study|Adverse Event|0|||
161449265|NCT02152956|583040382|FG004|Overall Study|Adverse Event|0|||
161449266|NCT02152956|583040383|FG005|Overall Study|Adverse Event|0|||
161449267|NCT02152956|583040384|FG006|Overall Study|Adverse Event|0|||
161449268|NCT02152956|583040385|FG007|Overall Study|Adverse Event|0|||
161449269|NCT02152956|583040386|FG008|Overall Study|Adverse Event|0|||
161449270|NCT02152956|583040387|FG009|Overall Study|Adverse Event|0|||
161449271|NCT02152956|583040388|FG010|Overall Study|Adverse Event|0|||
161449272|NCT02152956|583040389|FG011|Overall Study|Adverse Event|4|||
161449273|NCT02152956|583040390|FG012|Overall Study|Adverse Event|0|||
161449274|NCT02152956|583040378|FG000|Overall Study|Death|0|||
161449275|NCT02152956|583040379|FG001|Overall Study|Death|3|||
161449276|NCT02152956|583040380|FG002|Overall Study|Death|3|||
161449277|NCT02152956|583040381|FG003|Overall Study|Death|4|||
161449278|NCT02152956|583040382|FG004|Overall Study|Death|1|||
161449279|NCT02152956|583040383|FG005|Overall Study|Death|2|||
161449280|NCT02152956|583040384|FG006|Overall Study|Death|6|||
161449281|NCT02152956|583040385|FG007|Overall Study|Death|6|||
161449282|NCT02152956|583040386|FG008|Overall Study|Death|4|||
161449283|NCT02152956|583040387|FG009|Overall Study|Death|5|||
161449284|NCT02152956|583040388|FG010|Overall Study|Death|3|||
161449285|NCT02152956|583040389|FG011|Overall Study|Death|143|||
161449286|NCT02152956|583040390|FG012|Overall Study|Death|12|||
161449287|NCT02152956|583040378|FG000|Overall Study|Lost to Follow-up|0|||
161449288|NCT02152956|583040379|FG001|Overall Study|Lost to Follow-up|1|||
161449289|NCT02152956|583040380|FG002|Overall Study|Lost to Follow-up|0|||
161449290|NCT02152956|583040381|FG003|Overall Study|Lost to Follow-up|0|||
161449291|NCT02152956|583040382|FG004|Overall Study|Lost to Follow-up|0|||
161449292|NCT02152956|583040383|FG005|Overall Study|Lost to Follow-up|0|||
161449293|NCT02152956|583040384|FG006|Overall Study|Lost to Follow-up|0|||
161449294|NCT02152956|583040385|FG007|Overall Study|Lost to Follow-up|0|||
161449295|NCT02152956|583040386|FG008|Overall Study|Lost to Follow-up|0|||
161449296|NCT02152956|583040387|FG009|Overall Study|Lost to Follow-up|0|||
161449297|NCT02152956|583040388|FG010|Overall Study|Lost to Follow-up|0|||
161449298|NCT02152956|583040389|FG011|Overall Study|Lost to Follow-up|3|||
161449299|NCT02152956|583040390|FG012|Overall Study|Lost to Follow-up|0|||
161449300|NCT02152956|583040378|FG000|Overall Study|Withdrawal by Subject|1|||
161449301|NCT02152956|583040379|FG001|Overall Study|Withdrawal by Subject|0|||
161449302|NCT02152956|583040380|FG002|Overall Study|Withdrawal by Subject|1|||
161449303|NCT02152956|583040381|FG003|Overall Study|Withdrawal by Subject|0|||
161449304|NCT02152956|583040382|FG004|Overall Study|Withdrawal by Subject|2|||
161449305|NCT02152956|583040383|FG005|Overall Study|Withdrawal by Subject|2|||
161554317|NCT00390455|583418550|FG000|Overall Study|Alternate Treatment|0|||
161449306|NCT02152956|583040384|FG006|Overall Study|Withdrawal by Subject|0|||
161449307|NCT02152956|583040385|FG007|Overall Study|Withdrawal by Subject|0|||
161449308|NCT02152956|583040386|FG008|Overall Study|Withdrawal by Subject|1|||
161449309|NCT02152956|583040387|FG009|Overall Study|Withdrawal by Subject|0|||
161449310|NCT02152956|583040388|FG010|Overall Study|Withdrawal by Subject|0|||
161449311|NCT02152956|583040389|FG011|Overall Study|Withdrawal by Subject|4|||
161554318|NCT00390455|583418551|FG001|Overall Study|Alternate Treatment|1|||
161449312|NCT02152956|583040390|FG012|Overall Study|Withdrawal by Subject|0|||
161449313|NCT02152956|583040378|FG000|Overall Study|Physician Decision|0|||
161449314|NCT02152956|583040379|FG001|Overall Study|Physician Decision|0|||
161449315|NCT02152956|583040380|FG002|Overall Study|Physician Decision|0|||
161449316|NCT02152956|583040381|FG003|Overall Study|Physician Decision|0|||
161449317|NCT02152956|583040382|FG004|Overall Study|Physician Decision|0|||
161449318|NCT02152956|583040383|FG005|Overall Study|Physician Decision|0|||
161449319|NCT02152956|583040384|FG006|Overall Study|Physician Decision|0|||
161449320|NCT02152956|583040385|FG007|Overall Study|Physician Decision|0|||
161449321|NCT02152956|583040386|FG008|Overall Study|Physician Decision|0|||
161449322|NCT02152956|583040387|FG009|Overall Study|Physician Decision|0|||
161449323|NCT02152956|583040388|FG010|Overall Study|Physician Decision|0|||
161449324|NCT02152956|583040389|FG011|Overall Study|Physician Decision|1|||
161449325|NCT02152956|583040390|FG012|Overall Study|Physician Decision|0|||
161449326|NCT02152956|583040378|FG000|Overall Study|Study terminated by sponsor|0|||
161449327|NCT02152956|583040379|FG001|Overall Study|Study terminated by sponsor|0|||
161449328|NCT02152956|583040380|FG002|Overall Study|Study terminated by sponsor|0|||
161449329|NCT02152956|583040381|FG003|Overall Study|Study terminated by sponsor|0|||
161449330|NCT02152956|583040382|FG004|Overall Study|Study terminated by sponsor|0|||
161449331|NCT02152956|583040383|FG005|Overall Study|Study terminated by sponsor|0|||
161449332|NCT02152956|583040384|FG006|Overall Study|Study terminated by sponsor|0|||
161554319|NCT00390455|583418550|FG000|Overall Study|Other Medical Reasons|7|||
161554320|NCT00390455|583418551|FG001|Overall Study|Other Medical Reasons|11|||
161554321|NCT01591460|583418554|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
161554322|NCT01591460|583418554|FG000|Overall Study|Futility Rule (Week 12)|7|||
161554323|NCT01591460|583418554|FG000|Overall Study|Futility Rule (Week 24)|3|||
161554324|NCT01591460|583418554|FG000|Overall Study|Rebound or Breakthrough|3|||
161554325|NCT01591460|583418554|FG000|Overall Study|Treatment Discontinued by Error|1|||
161554326|NCT01591460|583418554|FG000|Overall Study|Lost to Follow-up|1|||
161554327|NCT01591460|583418554|FG000|Overall Study|Noncompliance|1|||
161554328|NCT01591460|583418554|FG000|Overall Study|Participant Refusal|3|||
161554329|NCT01591460|583418554|FG000|Overall Study|Withdrawal by Subject|1|||
161554330|NCT01591460|583418554|FG000|Overall Study|Protocol Violation|1|||
161554331|NCT04102540|583418559|FG000|Overall Study|Withdrawn by PI|2|||
161554332|NCT04102540|583418559|FG000|Overall Study|Lost to Follow-up|6|||
161554333|NCT01686932|583418562|FG000|Period 1|Adverse Event|1|||
161554334|NCT01686932|583418563|FG001|Period 1|Adverse Event|1|||
161554335|NCT04827134|583418566|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
161554336|NCT04827134|583418567|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
161554337|NCT04827134|583418568|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
161554338|NCT04827134|583418569|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
161554339|NCT00924469|583418579|FG000|Overall Study|Adverse Event|2|||
161554340|NCT00924469|583418580|FG001|Overall Study|Adverse Event|0|||
161554341|NCT00924469|583418579|FG000|Overall Study|Withdrawal by Subject|0|||
161554342|NCT00924469|583418580|FG001|Overall Study|Withdrawal by Subject|1|||
161554343|NCT00924469|583418579|FG000|Overall Study|Lost to Follow-up|0|||
161554344|NCT00924469|583418580|FG001|Overall Study|Lost to Follow-up|1|||
161449333|NCT02152956|583040385|FG007|Overall Study|Study terminated by sponsor|0|||
161449334|NCT02152956|583040386|FG008|Overall Study|Study terminated by sponsor|0|||
161449335|NCT02152956|583040387|FG009|Overall Study|Study terminated by sponsor|0|||
161449336|NCT02152956|583040388|FG010|Overall Study|Study terminated by sponsor|0|||
161449337|NCT02152956|583040389|FG011|Overall Study|Study terminated by sponsor|29|||
161449338|NCT02152956|583040390|FG012|Overall Study|Study terminated by sponsor|0|||
161449339|NCT02152956|583040378|FG000|Overall Study|progressive disease|0|||
161449340|NCT02152956|583040379|FG001|Overall Study|progressive disease|0|||
161449341|NCT02152956|583040380|FG002|Overall Study|progressive disease|0|||
161449342|NCT02152956|583040381|FG003|Overall Study|progressive disease|0|||
161449343|NCT02152956|583040382|FG004|Overall Study|progressive disease|0|||
161449344|NCT02152956|583040383|FG005|Overall Study|progressive disease|0|||
161449345|NCT02152956|583040384|FG006|Overall Study|progressive disease|0|||
161449346|NCT02152956|583040385|FG007|Overall Study|progressive disease|0|||
161449347|NCT02152956|583040386|FG008|Overall Study|progressive disease|1|||
161449348|NCT02152956|583040387|FG009|Overall Study|progressive disease|0|||
161449349|NCT02152956|583040388|FG010|Overall Study|progressive disease|0|||
161449350|NCT02152956|583040389|FG011|Overall Study|progressive disease|1|||
161449351|NCT02152956|583040390|FG012|Overall Study|progressive disease|0|||
161449352|NCT05661851|583040391|FG000|Overall Study|Protocol Violation|1|||
161449353|NCT05661851|583040392|FG001|Overall Study|Protocol Violation|1|||
161449354|NCT05661851|583040391|FG000|Overall Study|Covid-19 Related|3|||
161449355|NCT05661851|583040392|FG001|Overall Study|Covid-19 Related|4|||
161449356|NCT05661851|583040391|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
161449357|NCT05661851|583040392|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
161449358|NCT05661851|583040391|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
161449359|NCT05661851|583040392|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
161554345|NCT01651936|583418581|FG000|Base Study|Adverse Event|3|||
161554346|NCT01651936|583418582|FG001|Base Study|Adverse Event|0|||
161554347|NCT01651936|583418583|FG002|Base Study|Adverse Event|0|||
161554348|NCT01651936|583418581|FG000|Base Study|Withdrawal by Subject|1|||
161554349|NCT01651936|583418582|FG001|Base Study|Withdrawal by Subject|1|||
161554350|NCT01651936|583418583|FG002|Base Study|Withdrawal by Subject|0|||
161554351|NCT01651936|583418581|FG000|Base Study|Early Escape|2|||
161554352|NCT01651936|583418582|FG001|Base Study|Early Escape|8|||
161554353|NCT01651936|583418583|FG002|Base Study|Early Escape|0|||
161554354|NCT01651936|583418581|FG000|Base Study|Study terminated by sponsor|21|||
161554355|NCT01651936|583418582|FG001|Base Study|Study terminated by sponsor|16|||
161554356|NCT01651936|583418583|FG002|Base Study|Study terminated by sponsor|0|||
161554357|NCT01651936|583418581|FG000|Extension Study|Lack of Efficacy|0|||
161554358|NCT01651936|583418582|FG001|Extension Study|Lack of Efficacy|0|||
161554359|NCT01651936|583418583|FG002|Extension Study|Lack of Efficacy|1|||
161554360|NCT01651936|583418581|FG000|Extension Study|Study terminated by sponsor|0|||
161554361|NCT01651936|583418582|FG001|Extension Study|Study terminated by sponsor|0|||
161554362|NCT01651936|583418583|FG002|Extension Study|Study terminated by sponsor|13|||
161554363|NCT03044353|583418584|FG000|Overall Study|Adverse Event|0|||
161554364|NCT03044353|583418585|FG001|Overall Study|Adverse Event|1|||
161554365|NCT03044353|583418586|FG002|Overall Study|Adverse Event|0|||
161554366|NCT03358329|583418587|FG000|Overall Study|Lost to Follow-up|2|||
161554367|NCT03358329|583418587|FG000|Overall Study|Withdrawal by Subject|2|||
161554368|NCT03875911|583418590|FG000|Overall Study|Lost to Follow-up|3|||
161554369|NCT03875911|583418591|FG001|Overall Study|Lost to Follow-up|6|||
161554370|NCT03875911|583418592|FG002|Overall Study|Lost to Follow-up|2|||
161554371|NCT03875911|583418590|FG000|Overall Study|Surgery cancelled|1|||
161554372|NCT03875911|583418591|FG001|Overall Study|Surgery cancelled|0|||
161554373|NCT03875911|583418592|FG002|Overall Study|Surgery cancelled|1|||
161554374|NCT03875911|583418590|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
161554375|NCT03875911|583418591|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
161554376|NCT03875911|583418592|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
161554377|NCT05284019|583418593|FG000|Overall Study|Study terminated|2|||
161554378|NCT05284019|583418594|FG001|Overall Study|Study terminated|2|||
161554379|NCT05284019|583418595|FG002|Overall Study|Study terminated|2|||
161554380|NCT05284019|583418596|FG003|Overall Study|Study terminated|5|||
161554381|NCT05284019|583418597|FG004|Overall Study|Study terminated|15|||
161554382|NCT05284019|583418593|FG000|Overall Study|Withdrawal by Subject|0|||
161554383|NCT05284019|583418594|FG001|Overall Study|Withdrawal by Subject|0|||
161554384|NCT05284019|583418595|FG002|Overall Study|Withdrawal by Subject|0|||
161554385|NCT05284019|583418596|FG003|Overall Study|Withdrawal by Subject|1|||
161554386|NCT05284019|583418597|FG004|Overall Study|Withdrawal by Subject|1|||
161554387|NCT05284019|583418593|FG000|Overall Study|Lost to Follow-up|1|||
161554388|NCT05284019|583418594|FG001|Overall Study|Lost to Follow-up|0|||
161554389|NCT05284019|583418595|FG002|Overall Study|Lost to Follow-up|0|||
161554390|NCT05284019|583418596|FG003|Overall Study|Lost to Follow-up|2|||
161554391|NCT05284019|583418597|FG004|Overall Study|Lost to Follow-up|1|||
161554392|NCT01990300|583418598|FG000|Overall Study|Case Report Forms Uncollected|89|||
161554393|NCT01990300|583418598|FG000|Overall Study|Protocol Deviation|53|||
161554394|NCT01231503|583418599|FG000|Overall Study|Adverse Event|0|||
161554395|NCT01231503|583418600|FG001|Overall Study|Adverse Event|0|||
161554396|NCT01231503|583418601|FG002|Overall Study|Adverse Event|0|||
161554397|NCT01231503|583418602|FG003|Overall Study|Adverse Event|0|||
161554398|NCT01231503|583418603|FG004|Overall Study|Adverse Event|0|||
161554399|NCT01231503|583418604|FG005|Overall Study|Adverse Event|1|||
161554400|NCT01231503|583418605|FG006|Overall Study|Adverse Event|0|||
161554401|NCT01231503|583418606|FG007|Overall Study|Adverse Event|0|||
161554402|NCT01231503|583418599|FG000|Overall Study|Adverse event, serious fatal|0|||
161554403|NCT01231503|583418600|FG001|Overall Study|Adverse event, serious fatal|0|||
161554404|NCT01231503|583418601|FG002|Overall Study|Adverse event, serious fatal|1|||
161554405|NCT01231503|583418602|FG003|Overall Study|Adverse event, serious fatal|1|||
161554406|NCT01231503|583418603|FG004|Overall Study|Adverse event, serious fatal|0|||
161554407|NCT01231503|583418604|FG005|Overall Study|Adverse event, serious fatal|1|||
161554408|NCT01231503|583418605|FG006|Overall Study|Adverse event, serious fatal|0|||
161554409|NCT01231503|583418606|FG007|Overall Study|Adverse event, serious fatal|0|||
161554410|NCT01231503|583418599|FG000|Overall Study|Withdrawal by Subject|6|||
161554411|NCT01231503|583418600|FG001|Overall Study|Withdrawal by Subject|3|||
161554412|NCT01231503|583418601|FG002|Overall Study|Withdrawal by Subject|3|||
161554413|NCT01231503|583418602|FG003|Overall Study|Withdrawal by Subject|1|||
161554414|NCT01231503|583418603|FG004|Overall Study|Withdrawal by Subject|3|||
161554415|NCT01231503|583418604|FG005|Overall Study|Withdrawal by Subject|5|||
161554416|NCT01231503|583418605|FG006|Overall Study|Withdrawal by Subject|1|||
161796279|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
161554417|NCT01231503|583418606|FG007|Overall Study|Withdrawal by Subject|2|||
161554418|NCT01231503|583418599|FG000|Overall Study|Lost to Follow-up|8|||
161554419|NCT01231503|583418600|FG001|Overall Study|Lost to Follow-up|10|||
161554420|NCT01231503|583418601|FG002|Overall Study|Lost to Follow-up|8|||
161554421|NCT01231503|583418602|FG003|Overall Study|Lost to Follow-up|5|||
161554422|NCT01231503|583418603|FG004|Overall Study|Lost to Follow-up|7|||
161554423|NCT01231503|583418604|FG005|Overall Study|Lost to Follow-up|9|||
161449360|NCT01014910|583040393|FG000|Overall Study|Withdrawal by Subject|0|||
161449361|NCT01014910|583040394|FG001|Overall Study|Withdrawal by Subject|2|||
161449362|NCT03753789|583040395|FG000|Overall Study|Withdrawal by Subject|2|||
161449363|NCT01136785|583040397|FG000|Overall Study|Protocol Violation|2|||
161449364|NCT01136785|583040398|FG001|Overall Study|Protocol Violation|1|||
161449365|NCT02873429|583040399|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
161449366|NCT02873429|583040400|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
161449367|NCT02873429|583040399|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
161449368|NCT02873429|583040400|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
161449369|NCT02873429|583040399|FG000|16 Weeks|Lost to Follow-up|3|||
161449370|NCT02873429|583040400|FG001|16 Weeks|Lost to Follow-up|0|||
161449371|NCT00612807|583040401|FG000|Overall Study|Withdrawal by Subject|2|||
161449372|NCT00612807|583040402|FG001|Overall Study|Withdrawal by Subject|0|||
161449373|NCT00744042|583040405|FG000|Overall Study|Withdrawal by Subject|1|||
161449374|NCT00853567|583040406|FG000|Overall Study|Study prematurely terminated|71|||
161449375|NCT02055118|583040410|FG000|Overall Study|Withdrawal by Subject|0|||
161449376|NCT02055118|583040411|FG001|Overall Study|Withdrawal by Subject|2|||
161449377|NCT02055118|583040412|FG002|Overall Study|Withdrawal by Subject|0|||
161449378|NCT02281383|583040414|FG000|Overall Study|Progressive Disease|1|||
161449379|NCT02281383|583040414|FG000|Overall Study|Withdrawal by Subject|6|||
161449380|NCT02281383|583040414|FG000|Overall Study|Protocol Violation|2|||
161449381|NCT02281383|583040414|FG000|Overall Study|Death|1|||
161449382|NCT02281383|583040414|FG000|Overall Study|Adverse Event|2|||
161449383|NCT00599339|583040417|FG000|Overall Study|Adverse Event|79|||
161449384|NCT00599339|583040417|FG000|Overall Study|Withdrawal by Subject|137|||
161449385|NCT00599339|583040417|FG000|Overall Study|Other Reason|179|||
161449386|NCT00599339|583040417|FG000|Overall Study|Lost to Follow-up|221|||
161449387|NCT00599339|583040417|FG000|Overall Study|No valid data consent|36|||
161449388|NCT00599339|583040417|FG000|Overall Study|Study Termination Status Unknown|12|||
161449389|NCT05564052|583040418|FG000|Overall Study|Withdrawal by Subject|0|||
161449390|NCT05564052|583040419|FG001|Overall Study|Withdrawal by Subject|0|||
161449391|NCT05564052|583040420|FG002|Overall Study|Withdrawal by Subject|0|||
161449392|NCT05564052|583040421|FG003|Overall Study|Withdrawal by Subject|1|||
161449393|NCT01821560|583040422|FG000|Overall Study|Lost to Follow-up|5|||
161449394|NCT01821560|583040423|FG001|Overall Study|Lost to Follow-up|5|||
161449395|NCT01821560|583040422|FG000|Overall Study|Withdrawal by Subject|1|||
161449396|NCT01821560|583040423|FG001|Overall Study|Withdrawal by Subject|1|||
161449397|NCT01821560|583040422|FG000|Overall Study|Protocol Violation|0|||
161449398|NCT01821560|583040423|FG001|Overall Study|Protocol Violation|1|||
161449399|NCT04189224|583040425|FG000|Period 2|Adverse Event|0|||
161449400|NCT04189224|583040426|FG001|Period 2|Adverse Event|1|||
161449401|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
161449402|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
161449403|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
161449404|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
161449405|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
161449406|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
161449407|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
161449408|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
161449409|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
161449410|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
161449411|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
161449412|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
161449413|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
161449414|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
161449415|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
161449416|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
161449417|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
161449418|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
161449419|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
161449420|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
161449421|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
161449422|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
161449423|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
161449424|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
161449425|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
161449426|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
161449427|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
161449428|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
161449429|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
161449430|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
161449431|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
161449432|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
161449433|NCT03818035|583040428|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
161554424|NCT01231503|583418605|FG006|Overall Study|Lost to Follow-up|6|||
161554425|NCT01231503|583418606|FG007|Overall Study|Lost to Follow-up|6|||
161554426|NCT01231503|583418599|FG000|Overall Study|Protocol Violation|0|||
161554427|NCT01231503|583418600|FG001|Overall Study|Protocol Violation|0|||
161554428|NCT01231503|583418601|FG002|Overall Study|Protocol Violation|0|||
161554429|NCT01231503|583418602|FG003|Overall Study|Protocol Violation|1|||
161554430|NCT01231503|583418603|FG004|Overall Study|Protocol Violation|0|||
161554431|NCT01231503|583418604|FG005|Overall Study|Protocol Violation|0|||
161554432|NCT01231503|583418605|FG006|Overall Study|Protocol Violation|0|||
161554433|NCT01231503|583418606|FG007|Overall Study|Protocol Violation|0|||
161554434|NCT02293837|583418607|FG000|Overall Study|Lost to Follow-up|0|||
161554435|NCT02293837|583418608|FG001|Overall Study|Lost to Follow-up|2|||
161554436|NCT02293837|583418609|FG002|Overall Study|Lost to Follow-up|1|||
161554437|NCT02293837|583418610|FG003|Overall Study|Lost to Follow-up|0|||
161554438|NCT02293837|583418607|FG000|Overall Study|Withdrawal by Subject|2|||
161554439|NCT02293837|583418608|FG001|Overall Study|Withdrawal by Subject|1|||
161554440|NCT02293837|583418609|FG002|Overall Study|Withdrawal by Subject|2|||
161554441|NCT02293837|583418610|FG003|Overall Study|Withdrawal by Subject|1|||
161554442|NCT02293837|583418607|FG000|Overall Study|COVID-19 Related|1|||
161554443|NCT02293837|583418608|FG001|Overall Study|COVID-19 Related|1|||
161554444|NCT02293837|583418609|FG002|Overall Study|COVID-19 Related|0|||
161554445|NCT02293837|583418610|FG003|Overall Study|COVID-19 Related|0|||
161554446|NCT02293837|583418607|FG000|Overall Study|Participant ill and could not be infused|0|||
161554447|NCT02293837|583418608|FG001|Overall Study|Participant ill and could not be infused|0|||
161554448|NCT02293837|583418609|FG002|Overall Study|Participant ill and could not be infused|1|||
161554449|NCT02293837|583418610|FG003|Overall Study|Participant ill and could not be infused|0|||
161554450|NCT03285113|583418611|FG000|Overall Study|Unable to implant leads|2|||
161554451|NCT01076088|583418612|FG000|Overall Study|Adverse Event|1|||
161554452|NCT01076088|583418613|FG001|Overall Study|Adverse Event|6|||
161554453|NCT01076088|583418614|FG002|Overall Study|Adverse Event|3|||
161554454|NCT01076088|583418615|FG003|Overall Study|Adverse Event|2|||
161554455|NCT01076088|583418616|FG004|Overall Study|Adverse Event|3|||
161554456|NCT01076088|583418617|FG005|Overall Study|Adverse Event|3|||
161554457|NCT01076088|583418612|FG000|Overall Study|Lost to Follow-up|1|||
161554458|NCT01076088|583418613|FG001|Overall Study|Lost to Follow-up|1|||
161554459|NCT01076088|583418614|FG002|Overall Study|Lost to Follow-up|0|||
161554460|NCT01076088|583418615|FG003|Overall Study|Lost to Follow-up|1|||
161554461|NCT01076088|583418616|FG004|Overall Study|Lost to Follow-up|1|||
161554462|NCT01076088|583418617|FG005|Overall Study|Lost to Follow-up|2|||
161554463|NCT01076088|583418612|FG000|Overall Study|Non-compliance with study drug|0|||
161554464|NCT01076088|583418613|FG001|Overall Study|Non-compliance with study drug|0|||
161554465|NCT01076088|583418614|FG002|Overall Study|Non-compliance with study drug|0|||
161554466|NCT01076088|583418615|FG003|Overall Study|Non-compliance with study drug|1|||
161554467|NCT01076088|583418616|FG004|Overall Study|Non-compliance with study drug|0|||
161554468|NCT01076088|583418617|FG005|Overall Study|Non-compliance with study drug|0|||
161554469|NCT01076088|583418612|FG000|Overall Study|Physician Decision|1|||
161554470|NCT01076088|583418613|FG001|Overall Study|Physician Decision|3|||
161554471|NCT01076088|583418614|FG002|Overall Study|Physician Decision|0|||
161554472|NCT01076088|583418615|FG003|Overall Study|Physician Decision|1|||
161554473|NCT01076088|583418616|FG004|Overall Study|Physician Decision|1|||
161554474|NCT01076088|583418617|FG005|Overall Study|Physician Decision|0|||
161554475|NCT01076088|583418612|FG000|Overall Study|Withdrawal by Subject|8|||
161554476|NCT01076088|583418613|FG001|Overall Study|Withdrawal by Subject|8|||
161554477|NCT01076088|583418614|FG002|Overall Study|Withdrawal by Subject|14|||
161554478|NCT01076088|583418615|FG003|Overall Study|Withdrawal by Subject|10|||
161554479|NCT01076088|583418616|FG004|Overall Study|Withdrawal by Subject|11|||
161554480|NCT01076088|583418617|FG005|Overall Study|Withdrawal by Subject|17|||
161554481|NCT01076088|583418612|FG000|Overall Study|Other protocol specified criteria|0|||
161554482|NCT01076088|583418613|FG001|Overall Study|Other protocol specified criteria|0|||
161554483|NCT01076088|583418614|FG002|Overall Study|Other protocol specified criteria|0|||
161554484|NCT01076088|583418615|FG003|Overall Study|Other protocol specified criteria|0|||
161554485|NCT01076088|583418616|FG004|Overall Study|Other protocol specified criteria|0|||
161554486|NCT01076088|583418617|FG005|Overall Study|Other protocol specified criteria|1|||
161554487|NCT03053492|583418618|FG000|Overall Study|Adverse Event|1|||
161554488|NCT03053492|583418619|FG001|Overall Study|Adverse Event|1|||
161554489|NCT03053492|583418618|FG000|Overall Study|Withdrawal by Subject|7|||
161554490|NCT03053492|583418619|FG001|Overall Study|Withdrawal by Subject|5|||
161554491|NCT01448044|583418624|FG000|Treatment Period|Adverse Event|4|||
161554492|NCT01448044|583418625|FG001|Treatment Period|Adverse Event|3|||
161554493|NCT01448044|583418624|FG000|Treatment Period|Lack of Efficacy|5|||
161554494|NCT01448044|583418625|FG001|Treatment Period|Lack of Efficacy|12|||
161554495|NCT01448044|583418624|FG000|Treatment Period|Subject requested discontinue study drug|1|||
161554496|NCT01448044|583418625|FG001|Treatment Period|Subject requested discontinue study drug|0|||
161554497|NCT01448044|583418624|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
161554498|NCT01448044|583418625|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
161554499|NCT01448044|583418624|FG000|Treatment Period|Participant does not meet study criteria|1|||
161554500|NCT01448044|583418625|FG001|Treatment Period|Participant does not meet study criteria|0|||
161554501|NCT01448044|583418624|FG000|Treatment Period|Lost to Follow-up|2|||
161554502|NCT01448044|583418625|FG001|Treatment Period|Lost to Follow-up|1|||
161554503|NCT01448044|583418624|FG000|Treatment Period|Other reason|2|||
161554504|NCT01448044|583418625|FG001|Treatment Period|Other reason|0|||
161554505|NCT01448044|583418624|FG000|Follow Up Period|Withdrawal by Subject|1|||
161554506|NCT01448044|583418625|FG001|Follow Up Period|Withdrawal by Subject|1|||
161554507|NCT01448044|583418624|FG000|Follow Up Period|Lost to Follow-up|6|||
161554508|NCT01448044|583418625|FG001|Follow Up Period|Lost to Follow-up|2|||
161554509|NCT01448044|583418624|FG000|Follow Up Period|Other|5|||
161554510|NCT01448044|583418625|FG001|Follow Up Period|Other|11|||
161554511|NCT01010217|583418627|FG000|Overall Study|Lost to Follow-up|4|||
161554512|NCT01010217|583418628|FG001|Overall Study|Lost to Follow-up|5|||
161554513|NCT01010217|583418629|FG002|Overall Study|Lost to Follow-up|1|||
161554514|NCT01010217|583418630|FG003|Overall Study|Lost to Follow-up|0|||
161554515|NCT01010217|583418631|FG004|Overall Study|Lost to Follow-up|0|||
161554516|NCT01010217|583418627|FG000|Overall Study|Withdrawal by Subject|1|||
161554517|NCT01010217|583418628|FG001|Overall Study|Withdrawal by Subject|0|||
161554518|NCT01010217|583418629|FG002|Overall Study|Withdrawal by Subject|0|||
161554519|NCT01010217|583418630|FG003|Overall Study|Withdrawal by Subject|0|||
161554520|NCT01010217|583418631|FG004|Overall Study|Withdrawal by Subject|0|||
161554521|NCT01010217|583418627|FG000|Overall Study|Physician Decision|0|||
161554522|NCT01010217|583418628|FG001|Overall Study|Physician Decision|0|||
161554523|NCT01010217|583418629|FG002|Overall Study|Physician Decision|0|||
161554524|NCT01010217|583418630|FG003|Overall Study|Physician Decision|6|||
161554525|NCT01010217|583418631|FG004|Overall Study|Physician Decision|3|||
161554526|NCT02061761|583418632|FG000|Overall Study|Disease progression|2|||
161554527|NCT02061761|583418633|FG001|Overall Study|Disease progression|8|||
161554528|NCT02061761|583418634|FG002|Overall Study|Disease progression|4|||
161554529|NCT02061761|583418635|FG003|Overall Study|Disease progression|5|||
161554530|NCT02061761|583418636|FG004|Overall Study|Disease progression|9|||
161554531|NCT02061761|583418637|FG005|Overall Study|Disease progression|3|||
161554532|NCT02061761|583418638|FG006|Overall Study|Disease progression|1|||
161554533|NCT02061761|583418639|FG007|Overall Study|Disease progression|2|||
161554534|NCT02061761|583418640|FG008|Overall Study|Disease progression|28|||
161554535|NCT02061761|583418632|FG000|Overall Study|Study Drug toxicity|0|||
161554536|NCT02061761|583418633|FG001|Overall Study|Study Drug toxicity|0|||
161554537|NCT02061761|583418634|FG002|Overall Study|Study Drug toxicity|0|||
161554538|NCT02061761|583418635|FG003|Overall Study|Study Drug toxicity|0|||
161554539|NCT02061761|583418636|FG004|Overall Study|Study Drug toxicity|0|||
161554540|NCT02061761|583418637|FG005|Overall Study|Study Drug toxicity|1|||
161554541|NCT02061761|583418638|FG006|Overall Study|Study Drug toxicity|0|||
161554542|NCT02061761|583418639|FG007|Overall Study|Study Drug toxicity|2|||
161554543|NCT02061761|583418640|FG008|Overall Study|Study Drug toxicity|6|||
161554544|NCT02061761|583418632|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
161554545|NCT02061761|583418633|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
161554546|NCT02061761|583418634|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
161554547|NCT02061761|583418635|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
161554548|NCT02061761|583418636|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
161554549|NCT02061761|583418637|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
161554550|NCT02061761|583418638|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
161554551|NCT02061761|583418639|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
161554552|NCT02061761|583418640|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
161554553|NCT02061761|583418632|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161554554|NCT02061761|583418633|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161554555|NCT02061761|583418634|FG002|Overall Study|Participant request to discontinue study treatment|2|||
161554556|NCT02061761|583418635|FG003|Overall Study|Participant request to discontinue study treatment|2|||
161554557|NCT02061761|583418636|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161554558|NCT02061761|583418637|FG005|Overall Study|Participant request to discontinue study treatment|1|||
161554559|NCT02061761|583418638|FG006|Overall Study|Participant request to discontinue study treatment|0|||
161554560|NCT02061761|583418639|FG007|Overall Study|Participant request to discontinue study treatment|0|||
161554561|NCT02061761|583418640|FG008|Overall Study|Participant request to discontinue study treatment|2|||
161554562|NCT02061761|583418632|FG000|Overall Study|Withdrawal by Subject|0|||
161554563|NCT02061761|583418633|FG001|Overall Study|Withdrawal by Subject|0|||
161554564|NCT02061761|583418634|FG002|Overall Study|Withdrawal by Subject|0|||
161554565|NCT02061761|583418635|FG003|Overall Study|Withdrawal by Subject|0|||
161554566|NCT02061761|583418636|FG004|Overall Study|Withdrawal by Subject|0|||
161554567|NCT02061761|583418637|FG005|Overall Study|Withdrawal by Subject|0|||
161554568|NCT02061761|583418638|FG006|Overall Study|Withdrawal by Subject|0|||
161554569|NCT02061761|583418639|FG007|Overall Study|Withdrawal by Subject|0|||
161554570|NCT02061761|583418640|FG008|Overall Study|Withdrawal by Subject|2|||
161554571|NCT02061761|583418632|FG000|Overall Study|Maximum clinical benefit|0|||
161554572|NCT02061761|583418633|FG001|Overall Study|Maximum clinical benefit|0|||
161554573|NCT02061761|583418634|FG002|Overall Study|Maximum clinical benefit|0|||
161449434|NCT03818035|583040429|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
161449435|NCT03818035|583040430|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
161449436|NCT03818035|583040431|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
161449437|NCT03818035|583040428|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
161449438|NCT03818035|583040429|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
161449439|NCT03818035|583040430|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
161449440|NCT03818035|583040431|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
161449441|NCT03818035|583040428|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
161449442|NCT03818035|583040429|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
161449443|NCT03818035|583040430|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
161449444|NCT03818035|583040431|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
161449445|NCT03818035|583040428|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
161449446|NCT03818035|583040429|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
161449447|NCT03818035|583040430|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
161449448|NCT03818035|583040431|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
161449449|NCT03818035|583040428|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
161449450|NCT03818035|583040429|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
161449451|NCT03818035|583040430|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
161449452|NCT03818035|583040431|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
161449453|NCT03818035|583040428|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
161449454|NCT03818035|583040429|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
161449455|NCT03818035|583040430|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
161449456|NCT03818035|583040431|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
161449457|NCT03818035|583040428|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
161449458|NCT03818035|583040429|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
161449459|NCT03818035|583040430|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
161449460|NCT03818035|583040431|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
161449461|NCT03338959|583041896|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
161449462|NCT03338959|583041896|FG000|Overall Study|Physician Decision|1|||
161449463|NCT00409331|583041898|FG000|Overall Study|Physician Decision|1|||
161449464|NCT00281658|583041899|FG000|Randomized Phase|Adverse Event|0|||
161449465|NCT00281658|583041900|FG001|Randomized Phase|Adverse Event|2|||
161449466|NCT00281658|583041901|FG002|Randomized Phase|Adverse Event|0|||
161449467|NCT00281658|583041902|FG003|Randomized Phase|Adverse Event|0|||
161449468|NCT00281658|583041899|FG000|Randomized Phase|Lost to Follow-up|34|||
161449469|NCT00281658|583041900|FG001|Randomized Phase|Lost to Follow-up|27|||
161449470|NCT00281658|583041901|FG002|Randomized Phase|Lost to Follow-up|0|||
161449471|NCT00281658|583041902|FG003|Randomized Phase|Lost to Follow-up|0|||
161449472|NCT00281658|583041899|FG000|Randomized Phase|Withdrawal by Subject|8|||
161449473|NCT00281658|583041900|FG001|Randomized Phase|Withdrawal by Subject|7|||
161449474|NCT00281658|583041901|FG002|Randomized Phase|Withdrawal by Subject|0|||
161449475|NCT00281658|583041902|FG003|Randomized Phase|Withdrawal by Subject|0|||
161449476|NCT00281658|583041899|FG000|Randomized Phase|Study closed/terminated|1|||
161449477|NCT00281658|583041900|FG001|Randomized Phase|Study closed/terminated|1|||
161449478|NCT00281658|583041901|FG002|Randomized Phase|Study closed/terminated|0|||
161449479|NCT00281658|583041902|FG003|Randomized Phase|Study closed/terminated|0|||
161449480|NCT00281658|583041899|FG000|Randomized Phase|Disease progression|36|||
161449481|NCT00281658|583041900|FG001|Randomized Phase|Disease progression|27|||
161449482|NCT00281658|583041901|FG002|Randomized Phase|Disease progression|0|||
161449483|NCT00281658|583041902|FG003|Randomized Phase|Disease progression|0|||
161449484|NCT00281658|583041899|FG000|Randomized Phase|Physician Decision|1|||
161449485|NCT00281658|583041900|FG001|Randomized Phase|Physician Decision|1|||
161449486|NCT00281658|583041901|FG002|Randomized Phase|Physician Decision|0|||
161449487|NCT00281658|583041902|FG003|Randomized Phase|Physician Decision|0|||
161449488|NCT00281658|583041899|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
161449489|NCT00281658|583041900|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
161449490|NCT00281658|583041901|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
161449491|NCT00281658|583041902|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
161449492|NCT00281658|583041899|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
161449493|NCT00281658|583041900|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
161449494|NCT00281658|583041901|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
161449495|NCT00281658|583041902|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
161449496|NCT00281658|583041899|FG000|Randomized Phase|Treatment ongoing|1|||
161449497|NCT00281658|583041900|FG001|Randomized Phase|Treatment ongoing|0|||
161449498|NCT00281658|583041901|FG002|Randomized Phase|Treatment ongoing|0|||
161449499|NCT00281658|583041902|FG003|Randomized Phase|Treatment ongoing|0|||
161449500|NCT00281658|583041899|FG000|Open Label Phase|Adverse Event|0|||
161449501|NCT00281658|583041900|FG001|Open Label Phase|Adverse Event|0|||
161449502|NCT00281658|583041901|FG002|Open Label Phase|Adverse Event|1|||
161449503|NCT00281658|583041902|FG003|Open Label Phase|Adverse Event|0|||
161449504|NCT00281658|583041899|FG000|Open Label Phase|Lost to Follow-up|0|||
161449505|NCT00281658|583041900|FG001|Open Label Phase|Lost to Follow-up|0|||
161554574|NCT02061761|583418635|FG003|Overall Study|Maximum clinical benefit|1|||
161554575|NCT02061761|583418636|FG004|Overall Study|Maximum clinical benefit|0|||
161554576|NCT02061761|583418637|FG005|Overall Study|Maximum clinical benefit|0|||
161554577|NCT02061761|583418638|FG006|Overall Study|Maximum clinical benefit|0|||
161554578|NCT02061761|583418639|FG007|Overall Study|Maximum clinical benefit|0|||
161554579|NCT02061761|583418640|FG008|Overall Study|Maximum clinical benefit|6|||
161554580|NCT02061761|583418632|FG000|Overall Study|Participant no longer meets study criteria|0|||
161554581|NCT02061761|583418633|FG001|Overall Study|Participant no longer meets study criteria|0|||
161554582|NCT02061761|583418634|FG002|Overall Study|Participant no longer meets study criteria|0|||
161554583|NCT02061761|583418635|FG003|Overall Study|Participant no longer meets study criteria|0|||
161554584|NCT02061761|583418636|FG004|Overall Study|Participant no longer meets study criteria|0|||
161554585|NCT02061761|583418637|FG005|Overall Study|Participant no longer meets study criteria|0|||
161554586|NCT02061761|583418638|FG006|Overall Study|Participant no longer meets study criteria|0|||
161554587|NCT02061761|583418639|FG007|Overall Study|Participant no longer meets study criteria|0|||
161554588|NCT02061761|583418640|FG008|Overall Study|Participant no longer meets study criteria|1|||
161554589|NCT02061761|583418632|FG000|Overall Study|Other reasons|0|||
161554590|NCT02061761|583418633|FG001|Overall Study|Other reasons|0|||
161554591|NCT02061761|583418634|FG002|Overall Study|Other reasons|0|||
161554592|NCT02061761|583418635|FG003|Overall Study|Other reasons|0|||
161554593|NCT02061761|583418636|FG004|Overall Study|Other reasons|2|||
161554594|NCT02061761|583418637|FG005|Overall Study|Other reasons|0|||
161554595|NCT02061761|583418638|FG006|Overall Study|Other reasons|0|||
161554596|NCT02061761|583418639|FG007|Overall Study|Other reasons|0|||
161554597|NCT02061761|583418640|FG008|Overall Study|Other reasons|6|||
161554598|NCT01024751|583418641|FG000|Enrolled Participants|Ineligible at baseline|3|||
161554599|NCT01024751|583418642|FG001|Enrolled Participants|Ineligible at baseline|4|||
161554600|NCT01024751|583418641|FG000|Eligible Participants|Withdrawal by Subject|0|||
161554601|NCT01024751|583418642|FG001|Eligible Participants|Withdrawal by Subject|1|||
161554602|NCT01024751|583418641|FG000|Eligible Participants|Lost to Follow-up|0|||
161554603|NCT01024751|583418642|FG001|Eligible Participants|Lost to Follow-up|1|||
161554604|NCT01024751|583418641|FG000|Eligible Participants|Ineligible|0|||
161554605|NCT01024751|583418642|FG001|Eligible Participants|Ineligible|1|||
161554606|NCT00577720|583418647|FG000|Overall Study|Adverse Event|2|||
161554607|NCT00577720|583418648|FG001|Overall Study|Adverse Event|1|||
161554608|NCT00577720|583418649|FG002|Overall Study|Adverse Event|0|||
161554609|NCT00577720|583418650|FG003|Overall Study|Adverse Event|4|||
161554610|NCT00577720|583418647|FG000|Overall Study|Lost to Follow-up|0|||
161554611|NCT00577720|583418648|FG001|Overall Study|Lost to Follow-up|0|||
161554612|NCT00577720|583418649|FG002|Overall Study|Lost to Follow-up|1|||
161554613|NCT00577720|583418650|FG003|Overall Study|Lost to Follow-up|0|||
161554614|NCT00577720|583418647|FG000|Overall Study|Protocol Violation|0|||
161554615|NCT00577720|583418648|FG001|Overall Study|Protocol Violation|0|||
161554616|NCT00577720|583418649|FG002|Overall Study|Protocol Violation|0|||
161554617|NCT00577720|583418650|FG003|Overall Study|Protocol Violation|1|||
161554618|NCT00577720|583418647|FG000|Overall Study|Withdrawal by Subject|2|||
161554619|NCT00577720|583418648|FG001|Overall Study|Withdrawal by Subject|0|||
161554620|NCT00577720|583418649|FG002|Overall Study|Withdrawal by Subject|0|||
161554621|NCT00577720|583418650|FG003|Overall Study|Withdrawal by Subject|2|||
161796280|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796281|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796282|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796283|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161449506|NCT00281658|583041901|FG002|Open Label Phase|Lost to Follow-up|16|||
161449507|NCT00281658|583041902|FG003|Open Label Phase|Lost to Follow-up|2|||
161449508|NCT00281658|583041899|FG000|Open Label Phase|Withdrawal by Subject|0|||
161449509|NCT00281658|583041900|FG001|Open Label Phase|Withdrawal by Subject|0|||
161449510|NCT00281658|583041901|FG002|Open Label Phase|Withdrawal by Subject|3|||
161449511|NCT00281658|583041902|FG003|Open Label Phase|Withdrawal by Subject|2|||
161449512|NCT00281658|583041899|FG000|Open Label Phase|Disease progression|0|||
161449513|NCT00281658|583041900|FG001|Open Label Phase|Disease progression|0|||
161449514|NCT00281658|583041901|FG002|Open Label Phase|Disease progression|18|||
161449515|NCT00281658|583041902|FG003|Open Label Phase|Disease progression|0|||
161449516|NCT00281658|583041899|FG000|Open Label Phase|Physician Decision|0|||
161449517|NCT00281658|583041900|FG001|Open Label Phase|Physician Decision|0|||
161449518|NCT00281658|583041901|FG002|Open Label Phase|Physician Decision|1|||
161449519|NCT00281658|583041902|FG003|Open Label Phase|Physician Decision|0|||
161449520|NCT00281658|583041899|FG000|Open Label Phase|Relocation of patient|0|||
161449521|NCT00281658|583041900|FG001|Open Label Phase|Relocation of patient|0|||
161554622|NCT03246672|583418651|FG000|Overall Study|Lost to Follow-up|2|||
161554623|NCT03260504|583418652|FG000|Overall Study|Adverse Event|0|||
161554624|NCT03260504|583418653|FG001|Overall Study|Adverse Event|1|||
161554625|NCT00967018|583418654|FG000|Overall Study|Adverse Event|2|||
161554626|NCT00967018|583418654|FG000|Overall Study|Physician Decision|7|||
161554627|NCT00967018|583418654|FG000|Overall Study|Lost to Follow-up|2|||
161796284|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161554628|NCT00967018|583418654|FG000|Overall Study|Withdrawal by Subject|1|||
161554629|NCT00967018|583418654|FG000|Overall Study|Miscellaneous Reasons|9|||
161554630|NCT04318093|583418665|FG000|Overall Study|Adverse Event|2|||
161554631|NCT04318093|583418666|FG001|Overall Study|Adverse Event|2|||
161554632|NCT04318093|583418665|FG000|Overall Study|Participant withdrew consent|1|||
161554633|NCT04318093|583418666|FG001|Overall Study|Participant withdrew consent|0|||
161554634|NCT04318093|583418665|FG000|Overall Study|Other reasons|0|||
161554635|NCT04318093|583418666|FG001|Overall Study|Other reasons|1|||
161554636|NCT01370603|583418667|FG000|Period 1|Adverse Event|5|||
161554637|NCT01370603|583418668|FG001|Period 1|Adverse Event|3|||
161554638|NCT01370603|583418667|FG000|Period 1|Lost to Follow-up|2|||
161554639|NCT01370603|583418668|FG001|Period 1|Lost to Follow-up|0|||
161554640|NCT01370603|583418667|FG000|Period 1|Protocol Violation|2|||
161554641|NCT01370603|583418668|FG001|Period 1|Protocol Violation|2|||
161554642|NCT01370603|583418667|FG000|Period 1|Withdrawal by Subject|5|||
161554643|NCT01370603|583418668|FG001|Period 1|Withdrawal by Subject|5|||
161554644|NCT01370603|583418667|FG000|Crossover Washout|Adverse Event|2|||
161554645|NCT01370603|583418668|FG001|Crossover Washout|Adverse Event|1|||
161554646|NCT01370603|583418667|FG000|Crossover Washout|Lost to Follow-up|2|||
161554647|NCT01370603|583418668|FG001|Crossover Washout|Lost to Follow-up|0|||
161554648|NCT01370603|583418667|FG000|Crossover Washout|Protocol Violation|1|||
161554649|NCT01370603|583418668|FG001|Crossover Washout|Protocol Violation|0|||
161554650|NCT01370603|583418667|FG000|Crossover Washout|Withdrawal by Subject|4|||
161554651|NCT01370603|583418668|FG001|Crossover Washout|Withdrawal by Subject|1|||
161554652|NCT01370603|583418667|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
161554653|NCT01370603|583418668|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
161554654|NCT01370603|583418667|FG000|Period 2|Adverse Event|1|||
161554655|NCT01370603|583418668|FG001|Period 2|Adverse Event|4|||
161554656|NCT01370603|583418667|FG000|Period 2|Lost to Follow-up|1|||
161554657|NCT01370603|583418668|FG001|Period 2|Lost to Follow-up|0|||
161554658|NCT01370603|583418667|FG000|Period 2|Withdrawal by Subject|1|||
161554659|NCT01370603|583418668|FG001|Period 2|Withdrawal by Subject|0|||
161554660|NCT02955277|583420310|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
161554661|NCT02955277|583420311|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
161554662|NCT02955277|583420310|FG000|Post to Follow-up|Lost to Follow-up|8|||
161554663|NCT02955277|583420311|FG001|Post to Follow-up|Lost to Follow-up|11|||
161554664|NCT04212169|583420314|FG000|Overall Study|Adverse Event|0|||
161554665|NCT04212169|583420315|FG001|Overall Study|Adverse Event|0|||
161554666|NCT04212169|583420316|FG002|Overall Study|Adverse Event|0|||
161554667|NCT04212169|583420317|FG003|Overall Study|Adverse Event|2|||
161554668|NCT04212169|583420314|FG000|Overall Study|Lost to Follow-up|1|||
161554669|NCT04212169|583420315|FG001|Overall Study|Lost to Follow-up|0|||
161554670|NCT04212169|583420316|FG002|Overall Study|Lost to Follow-up|0|||
161554671|NCT04212169|583420317|FG003|Overall Study|Lost to Follow-up|2|||
161554672|NCT04212169|583420314|FG000|Overall Study|Withdrawal by Subject|10|||
161554673|NCT04212169|583420315|FG001|Overall Study|Withdrawal by Subject|2|||
161554674|NCT04212169|583420316|FG002|Overall Study|Withdrawal by Subject|5|||
161554675|NCT04212169|583420317|FG003|Overall Study|Withdrawal by Subject|7|||
161554676|NCT04212169|583420314|FG000|Overall Study|Other reason, unspecified|3|||
161554677|NCT04212169|583420315|FG001|Overall Study|Other reason, unspecified|1|||
161554678|NCT04212169|583420316|FG002|Overall Study|Other reason, unspecified|0|||
161554679|NCT04212169|583420317|FG003|Overall Study|Other reason, unspecified|2|||
161554680|NCT02176928|583420318|FG000|Overall Study|Lost to Follow-up|2|||
161554681|NCT02176928|583420319|FG001|Overall Study|Lost to Follow-up|4|||
161554682|NCT02406261|583420334|FG000|Period 1|Lost to Follow-up|2|||
161554683|NCT02406261|583420335|FG001|Period 1|Lost to Follow-up|0|||
161554684|NCT02406261|583420334|FG000|Period 1|Adverse Event|1|||
161554685|NCT02406261|583420335|FG001|Period 1|Adverse Event|0|||
161554686|NCT02406261|583420334|FG000|Period 2|Physician Decision|0|||
161554687|NCT02406261|583420335|FG001|Period 2|Physician Decision|1|||
161554688|NCT02406261|583420334|FG000|Period 2|Protocol Violation|0|||
161554689|NCT02406261|583420335|FG001|Period 2|Protocol Violation|1|||
161554690|NCT02406261|583420334|FG000|Period 2|Withdrawal by Subject|0|||
161554691|NCT02406261|583420335|FG001|Period 2|Withdrawal by Subject|1|||
161554692|NCT01567163|583420339|FG000|Overall Study|Progressive Disease|2|||
161554693|NCT01567163|583420339|FG000|Overall Study|Lost to Follow-up|2|||
161554694|NCT01720797|583420340|FG000|Overall Study|Withdrawal by Subject|3|||
161554695|NCT01720797|583420341|FG001|Overall Study|Withdrawal by Subject|0|||
161554696|NCT00393094|583420345|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
161796285|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161554697|NCT00393094|583420345|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
161554698|NCT02019602|583420346|FG000|Screening Period|Ineligibility|4|||
161554699|NCT02019602|583420347|FG001|Screening Period|Ineligibility|0|||
161554700|NCT02019602|583420346|FG000|Screening Period|Adverse Event|1|||
161554701|NCT02019602|583420347|FG001|Screening Period|Adverse Event|0|||
161554702|NCT03207711|583420350|FG000|Overall Study|Withdrawal by Subject|1|||
161554703|NCT03207711|583420351|FG001|Overall Study|Withdrawal by Subject|2|||
161554704|NCT02372058|583420354|FG000|Overall Study|Withdrawal by Subject|3|||
161554705|NCT02788006|583420358|FG000|Overall Study|Patient not treated|1|||
161554706|NCT00318149|583420359|FG000|Overall Study|Adverse Event|0|||
161554707|NCT00318149|583420360|FG001|Overall Study|Adverse Event|0|||
161554708|NCT00318149|583420361|FG002|Overall Study|Adverse Event|0|||
161554709|NCT00318149|583420362|FG003|Overall Study|Adverse Event|0|||
161554710|NCT00318149|583420363|FG004|Overall Study|Adverse Event|0|||
161554711|NCT00318149|583420364|FG005|Overall Study|Adverse Event|2|||
161554712|NCT03541642|583420367|FG000|Overall Study|Withdrawal by Subject|1|||
161554713|NCT03541642|583420368|FG001|Overall Study|Withdrawal by Subject|2|||
161554714|NCT03541642|583420367|FG000|Overall Study|Lost to Follow-up|16|||
161554715|NCT03541642|583420368|FG001|Overall Study|Lost to Follow-up|12|||
161554716|NCT03541642|583420367|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
161554717|NCT03541642|583420368|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
161554718|NCT03050398|583420373|FG000|Overall Study|Study terminated by sponsor|8|||
161554719|NCT05108649|583420374|FG000|Overall Study|Lost to Follow-up|0|||
161554720|NCT05108649|583420375|FG001|Overall Study|Lost to Follow-up|4|||
161554721|NCT05108649|583420376|FG002|Overall Study|Lost to Follow-up|3|||
161554722|NCT05108649|583420377|FG003|Overall Study|Lost to Follow-up|6|||
161554723|NCT05108649|583420374|FG000|Overall Study|Not Interested|1|||
161554724|NCT05108649|583420375|FG001|Overall Study|Not Interested|1|||
161554725|NCT05108649|583420376|FG002|Overall Study|Not Interested|0|||
161554726|NCT05108649|583420377|FG003|Overall Study|Not Interested|1|||
161554727|NCT05108649|583420374|FG000|Overall Study|Out of area|0|||
161554728|NCT05108649|583420375|FG001|Overall Study|Out of area|0|||
161554729|NCT05108649|583420376|FG002|Overall Study|Out of area|0|||
161554730|NCT05108649|583420377|FG003|Overall Study|Out of area|1|||
161554731|NCT05108649|583420374|FG000|Overall Study|PI decision|1|||
161554732|NCT05108649|583420375|FG001|Overall Study|PI decision|0|||
161554733|NCT05108649|583420376|FG002|Overall Study|PI decision|0|||
161554734|NCT05108649|583420377|FG003|Overall Study|PI decision|0|||
161554735|NCT05108649|583420374|FG000|Overall Study|Significant Non-Compliance|0|||
161554736|NCT05108649|583420375|FG001|Overall Study|Significant Non-Compliance|1|||
161554737|NCT05108649|583420376|FG002|Overall Study|Significant Non-Compliance|0|||
161554738|NCT05108649|583420377|FG003|Overall Study|Significant Non-Compliance|0|||
161554739|NCT05108649|583420374|FG000|Overall Study|Unable to adhere to study protocol|0|||
161554740|NCT05108649|583420375|FG001|Overall Study|Unable to adhere to study protocol|2|||
161554741|NCT05108649|583420376|FG002|Overall Study|Unable to adhere to study protocol|0|||
161554742|NCT05108649|583420377|FG003|Overall Study|Unable to adhere to study protocol|0|||
161554743|NCT03523871|583420378|FG000|Overall Study|Death|1|||
161554744|NCT01083160|583420379|FG000|Overall Study|Adverse Event|1|||
161554745|NCT00918749|583420380|FG000|Overall Study|Adverse Event|1|||
161554746|NCT00918749|583420381|FG001|Overall Study|Adverse Event|0|||
161554747|NCT00918749|583420382|FG002|Overall Study|Adverse Event|1|||
161554748|NCT00918749|583420380|FG000|Overall Study|Lost to Follow-up|0|||
161554749|NCT00918749|583420381|FG001|Overall Study|Lost to Follow-up|0|||
161554750|NCT00918749|583420382|FG002|Overall Study|Lost to Follow-up|1|||
161554751|NCT00918749|583420380|FG000|Overall Study|Withdrawal by Subject|5|||
161554752|NCT00918749|583420381|FG001|Overall Study|Withdrawal by Subject|3|||
161554753|NCT00918749|583420382|FG002|Overall Study|Withdrawal by Subject|5|||
161554754|NCT00918749|583420380|FG000|Overall Study|No Study Medication Taken|1|||
161554755|NCT00918749|583420381|FG001|Overall Study|No Study Medication Taken|0|||
161554756|NCT00918749|583420382|FG002|Overall Study|No Study Medication Taken|0|||
161554757|NCT01951092|583420383|FG000|Overall Study|Lost to Follow-up|10|||
161554758|NCT01951092|583420383|FG000|Overall Study|Incarceration|1|||
161554759|NCT01951092|583420383|FG000|Overall Study|Transfer of Care|1|||
161554760|NCT01712789|583420384|FG000|Overall Study|Lack of Efficacy|2|||
161554761|NCT01712789|583420384|FG000|Overall Study|Lost to Follow-up|1|||
161554762|NCT01712789|583420384|FG000|Overall Study|Progressive Disease|504|||
161554763|NCT01712789|583420384|FG000|Overall Study|Death|57|||
161554764|NCT01712789|583420384|FG000|Overall Study|Adverse Event|52|||
161554765|NCT01712789|583420384|FG000|Overall Study|Miscellaneous|31|||
161554766|NCT01712789|583420384|FG000|Overall Study|Withdrawal by Subject|21|||
161554767|NCT01712789|583420384|FG000|Overall Study|Transition to Commercial Treatment|8|||
161554768|NCT01712789|583420384|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
161554769|NCT00219141|583420385|FG000|Overall Study|Adverse Event|4|||
161554770|NCT00219141|583420386|FG001|Overall Study|Adverse Event|10|||
161554771|NCT00219141|583420387|FG002|Overall Study|Adverse Event|5|||
161554772|NCT00219141|583420385|FG000|Overall Study|Lack of Efficacy|3|||
161554773|NCT00219141|583420386|FG001|Overall Study|Lack of Efficacy|2|||
161554774|NCT00219141|583420387|FG002|Overall Study|Lack of Efficacy|0|||
161554775|NCT00219141|583420385|FG000|Overall Study|Administrative problems|0|||
161554776|NCT00219141|583420386|FG001|Overall Study|Administrative problems|1|||
161554777|NCT00219141|583420387|FG002|Overall Study|Administrative problems|0|||
161554778|NCT00219141|583420385|FG000|Overall Study|Lost to Follow-up|2|||
161554779|NCT00219141|583420386|FG001|Overall Study|Lost to Follow-up|4|||
161554780|NCT00219141|583420387|FG002|Overall Study|Lost to Follow-up|1|||
161554781|NCT00219141|583420385|FG000|Overall Study|Protocol Violation|3|||
161449522|NCT00281658|583041901|FG002|Open Label Phase|Relocation of patient|1|||
161449523|NCT00281658|583041902|FG003|Open Label Phase|Relocation of patient|0|||
161449524|NCT00281658|583041899|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
161449525|NCT00281658|583041900|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
161449526|NCT00281658|583041901|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
161449527|NCT00281658|583041902|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
161449528|NCT02151773|583041903|FG000|Overall Study|Protocol Deviation|64|||
161449529|NCT03680742|583041904|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
161449530|NCT02894502|583041907|FG000|Baseline|Withdrawal by Subject|24|||
161449531|NCT02894502|583041908|FG001|Baseline|Withdrawal by Subject|31|||
161449532|NCT02894502|583041909|FG002|Baseline|Withdrawal by Subject|36|||
161449533|NCT02894502|583041907|FG000|Baseline|Death|3|||
161449534|NCT02894502|583041908|FG001|Baseline|Death|1|||
161449535|NCT02894502|583041909|FG002|Baseline|Death|9|||
161449536|NCT02894502|583041907|FG000|First Follow up|Withdrawal by Subject|32|||
161449537|NCT02894502|583041908|FG001|First Follow up|Withdrawal by Subject|29|||
161449538|NCT02894502|583041909|FG002|First Follow up|Withdrawal by Subject|37|||
161449539|NCT02894502|583041907|FG000|First Follow up|Death|2|||
161449540|NCT02894502|583041908|FG001|First Follow up|Death|2|||
161449541|NCT02894502|583041909|FG002|First Follow up|Death|3|||
161449542|NCT02894502|583041907|FG000|Second Follow up|Withdrawal by Subject|13|||
161449543|NCT02894502|583041908|FG001|Second Follow up|Withdrawal by Subject|15|||
161449544|NCT02894502|583041909|FG002|Second Follow up|Withdrawal by Subject|13|||
161449545|NCT02894502|583041907|FG000|Second Follow up|Death|2|||
161449546|NCT02894502|583041908|FG001|Second Follow up|Death|3|||
161449547|NCT02894502|583041909|FG002|Second Follow up|Death|1|||
161449548|NCT02894502|583041907|FG000|Third Follow up|Withdrawal by Subject|5|||
161449549|NCT02894502|583041908|FG001|Third Follow up|Withdrawal by Subject|6|||
161449550|NCT02894502|583041909|FG002|Third Follow up|Withdrawal by Subject|3|||
161449551|NCT02894502|583041907|FG000|Third Follow up|Death|1|||
161449552|NCT02894502|583041908|FG001|Third Follow up|Death|1|||
161449553|NCT02894502|583041909|FG002|Third Follow up|Death|0|||
161449554|NCT01410357|583041910|FG000|Overall Study|Death|2|||
161449555|NCT01410357|583041911|FG001|Overall Study|Death|1|||
161449556|NCT01410357|583041910|FG000|Overall Study|Withdrawal by Subject|1|||
161449557|NCT01410357|583041911|FG001|Overall Study|Withdrawal by Subject|2|||
161449558|NCT01410357|583041910|FG000|Overall Study|Lost to Follow-up|23|||
161449559|NCT01410357|583041911|FG001|Overall Study|Lost to Follow-up|21|||
161449560|NCT01206322|583041915|FG000|Overall Study|Adverse Event|0|||
161449561|NCT01206322|583041916|FG001|Overall Study|Adverse Event|0|||
161449562|NCT01206322|583041917|FG002|Overall Study|Adverse Event|0|||
161449563|NCT01206322|583041918|FG003|Overall Study|Adverse Event|1|||
161449564|NCT00003590|583041922|FG000|Overall Study|Ineligible Patient|1|||
161449565|NCT00003590|583041922|FG000|Overall Study|Adverse Event|7|||
161449566|NCT00003590|583041922|FG000|Overall Study|Withdrawal by Subject|1|||
161449567|NCT00003590|583041922|FG000|Overall Study|Lack of Efficacy|11|||
161449568|NCT00003590|583041922|FG000|Overall Study|Death|1|||
161449569|NCT00003590|583041922|FG000|Overall Study|Physician Decision|1|||
161449570|NCT01589653|583041925|FG000|Overall Study|Protocol Violation|3|||
161449571|NCT01589653|583041926|FG001|Overall Study|Protocol Violation|1|||
161449572|NCT01589653|583041925|FG000|Overall Study|Withdrawal criteria|4|||
161449573|NCT01589653|583041926|FG001|Overall Study|Withdrawal criteria|7|||
161449574|NCT01589653|583041925|FG000|Overall Study|Unclassified|0|||
161449575|NCT01589653|583041926|FG001|Overall Study|Unclassified|3|||
161449576|NCT03700684|583041929|FG000|Overall Study|COVID-19|0|||
161449577|NCT03700684|583041930|FG001|Overall Study|COVID-19|0|||
161449578|NCT03700684|583041931|FG002|Overall Study|COVID-19|2|||
161449579|NCT01120782|583041932|FG000|Overall Study|Test article shipping error|11|||
161449580|NCT04140227|583041933|FG000|Overall Study|Withdrawal by Subject|26|||
161449581|NCT04140227|583041933|FG000|Overall Study|Lost to Follow-up|8|||
161449582|NCT04140227|583041933|FG000|Overall Study|Adverse Event|8|||
161449583|NCT04140227|583041933|FG000|Overall Study|Death|1|||
161449584|NCT04140227|583041933|FG000|Overall Study|Other|3|||
161449585|NCT04140227|583041933|FG000|Overall Study|Protocol Violation|2|||
161449586|NCT00538785|583041934|FG000|Overall Study|Death|9|||
161449587|NCT00538785|583041935|FG001|Overall Study|Death|10|||
161449588|NCT00538785|583041934|FG000|Overall Study|Withdrawal of consent|9|||
161449589|NCT00538785|583041935|FG001|Overall Study|Withdrawal of consent|7|||
161449590|NCT00538785|583041934|FG000|Overall Study|Lost to Follow-up|1|||
161449591|NCT00538785|583041935|FG001|Overall Study|Lost to Follow-up|0|||
161449592|NCT01767142|583041937|FG000|Overall Study|Lost to Follow-up|3|||
161449593|NCT03317405|583041938|FG000|Overall Study|Withdrawal by Subject|1|||
161449594|NCT03317405|583041939|FG001|Overall Study|Withdrawal by Subject|0|||
161449595|NCT03317405|583041940|FG002|Overall Study|Withdrawal by Subject|0|||
161449596|NCT03317405|583041938|FG000|Overall Study|Physician Decision|0|||
161449597|NCT03317405|583041939|FG001|Overall Study|Physician Decision|0|||
161449598|NCT03317405|583041940|FG002|Overall Study|Physician Decision|1|||
161449599|NCT03317405|583041938|FG000|Overall Study|Surgery Rescheduled|0|||
161449600|NCT03317405|583041939|FG001|Overall Study|Surgery Rescheduled|1|||
161449601|NCT03317405|583041940|FG002|Overall Study|Surgery Rescheduled|0|||
161554782|NCT00219141|583420386|FG001|Overall Study|Protocol Violation|1|||
161554783|NCT00219141|583420387|FG002|Overall Study|Protocol Violation|1|||
161554784|NCT00219141|583420385|FG000|Overall Study|Withdrawal by Subject|1|||
161554785|NCT00219141|583420386|FG001|Overall Study|Withdrawal by Subject|3|||
161554786|NCT00219141|583420387|FG002|Overall Study|Withdrawal by Subject|5|||
161554787|NCT00219141|583420385|FG000|Overall Study|Condition no longer requires study drug|1|||
161554788|NCT00219141|583420386|FG001|Overall Study|Condition no longer requires study drug|0|||
161554789|NCT00219141|583420387|FG002|Overall Study|Condition no longer requires study drug|0|||
161554790|NCT03018106|583420388|FG000|Overall Study|Lost to Follow-up|0|||
161554791|NCT03018106|583420389|FG001|Overall Study|Lost to Follow-up|1|||
161554792|NCT00972179|583420390|FG000|Overall Study|Noncompliance|1|||
161554793|NCT00972179|583420391|FG001|Overall Study|Noncompliance|0|||
161554794|NCT00972179|583420392|FG002|Overall Study|Noncompliance|0|||
161554795|NCT00972179|583420393|FG003|Overall Study|Noncompliance|0|||
161554796|NCT00972179|583420394|FG004|Overall Study|Noncompliance|1|||
161554797|NCT00972179|583420395|FG005|Overall Study|Noncompliance|0|||
161554798|NCT00972179|583420396|FG006|Overall Study|Noncompliance|1|||
161554799|NCT00972179|583420390|FG000|Overall Study|Withdrawal by Subject|0|||
161554800|NCT00972179|583420391|FG001|Overall Study|Withdrawal by Subject|3|||
161554801|NCT00972179|583420392|FG002|Overall Study|Withdrawal by Subject|0|||
161554802|NCT00972179|583420393|FG003|Overall Study|Withdrawal by Subject|1|||
161554803|NCT00972179|583420394|FG004|Overall Study|Withdrawal by Subject|0|||
161554804|NCT00972179|583420395|FG005|Overall Study|Withdrawal by Subject|0|||
161554805|NCT00972179|583420396|FG006|Overall Study|Withdrawal by Subject|2|||
161554806|NCT00972179|583420390|FG000|Overall Study|Administrative Decision|0|||
161554807|NCT00972179|583420391|FG001|Overall Study|Administrative Decision|0|||
161554808|NCT00972179|583420392|FG002|Overall Study|Administrative Decision|0|||
161554809|NCT00972179|583420393|FG003|Overall Study|Administrative Decision|0|||
161554810|NCT00972179|583420394|FG004|Overall Study|Administrative Decision|1|||
161554811|NCT00972179|583420395|FG005|Overall Study|Administrative Decision|0|||
161554812|NCT00972179|583420396|FG006|Overall Study|Administrative Decision|0|||
161554813|NCT00972179|583420390|FG000|Overall Study|Lost to Follow-up|0|||
161554814|NCT00972179|583420391|FG001|Overall Study|Lost to Follow-up|0|||
161554815|NCT00972179|583420392|FG002|Overall Study|Lost to Follow-up|1|||
161554816|NCT00972179|583420393|FG003|Overall Study|Lost to Follow-up|0|||
161554817|NCT00972179|583420394|FG004|Overall Study|Lost to Follow-up|0|||
161554818|NCT00972179|583420395|FG005|Overall Study|Lost to Follow-up|3|||
161554819|NCT00972179|583420396|FG006|Overall Study|Lost to Follow-up|1|||
161554820|NCT03055832|583420397|FG000|Week 2|Withdrawal by Subject|1|||
161554821|NCT03055832|583420398|FG001|Week 2|Withdrawal by Subject|0|||
161554822|NCT00136916|583420399|FG000|Overall Study|Never received study treatment|3|||
161554823|NCT00136916|583420400|FG001|Overall Study|Never received study treatment|5|||
161554824|NCT00136916|583420399|FG000|Overall Study|Death|1|||
161554825|NCT00136916|583420400|FG001|Overall Study|Death|3|||
161554826|NCT00136916|583420399|FG000|Overall Study|Adverse Event|27|||
161554827|NCT00136916|583420400|FG001|Overall Study|Adverse Event|8|||
161554828|NCT00136916|583420399|FG000|Overall Study|Laboratory abnormality|0|||
161554829|NCT00136916|583420400|FG001|Overall Study|Laboratory abnormality|1|||
161554830|NCT00136916|583420399|FG000|Overall Study|Lack of Efficacy|13|||
161554831|NCT00136916|583420400|FG001|Overall Study|Lack of Efficacy|3|||
161554832|NCT00136916|583420399|FG000|Overall Study|Lost to Follow-up|12|||
161554833|NCT00136916|583420400|FG001|Overall Study|Lost to Follow-up|14|||
161554834|NCT00136916|583420399|FG000|Overall Study|Withdrawal by Subject|44|||
161554835|NCT00136916|583420400|FG001|Overall Study|Withdrawal by Subject|46|||
161554836|NCT00136916|583420399|FG000|Overall Study|Other|22|||
161554837|NCT00136916|583420400|FG001|Overall Study|Other|24|||
161554838|NCT00136916|583420399|FG000|Overall Study|Discontinued in follow up period|3|||
161900694|NCT04131712|584685160|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161900695|NCT03334188|584685161|FG000|Overall Study|Withdrawal by Subject|0|||
161554839|NCT00136916|583420400|FG001|Overall Study|Discontinued in follow up period|0|||
161554840|NCT01994720|583420401|FG000|Overall Study|Withdrawal by Subject|46|||
161554841|NCT01994720|583420402|FG001|Overall Study|Withdrawal by Subject|56|||
161554842|NCT01991197|583420403|FG000|Overall Study|Lost to Follow-up|1|||
161900696|NCT03334188|584685162|FG001|Overall Study|Withdrawal by Subject|1|||
161554843|NCT01991197|583420404|FG001|Overall Study|Lost to Follow-up|1|||
161554844|NCT01991197|583420403|FG000|Overall Study|Physician Decision|0|||
161554845|NCT01991197|583420404|FG001|Overall Study|Physician Decision|2|||
161554846|NCT01991197|583420403|FG000|Overall Study|Withdrawal by Subject|2|||
161554847|NCT01991197|583420404|FG001|Overall Study|Withdrawal by Subject|0|||
161554848|NCT01012973|583420405|FG000|Overall Study|Adverse Event|5|||
161554849|NCT01012973|583420406|FG001|Overall Study|Adverse Event|5|||
161554850|NCT01012973|583420405|FG000|Overall Study|Lack of Efficacy|0|||
161554851|NCT01012973|583420406|FG001|Overall Study|Lack of Efficacy|5|||
161554852|NCT01012973|583420405|FG000|Overall Study|Lost to Follow-up|1|||
161554853|NCT01012973|583420406|FG001|Overall Study|Lost to Follow-up|0|||
161554854|NCT01012973|583420405|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
161554855|NCT01012973|583420406|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
161449602|NCT00635219|583041941|FG000|Overall Study|Adverse Event|12|||
161449603|NCT00635219|583041942|FG001|Overall Study|Adverse Event|10|||
161449604|NCT00635219|583041943|FG002|Overall Study|Adverse Event|18|||
161449605|NCT00635219|583041944|FG003|Overall Study|Adverse Event|15|||
161449606|NCT00635219|583041945|FG004|Overall Study|Adverse Event|19|||
161449607|NCT00635219|583041941|FG000|Overall Study|Lack of Efficacy|5|||
161449608|NCT00635219|583041942|FG001|Overall Study|Lack of Efficacy|6|||
161449609|NCT00635219|583041943|FG002|Overall Study|Lack of Efficacy|3|||
161449610|NCT00635219|583041944|FG003|Overall Study|Lack of Efficacy|4|||
161449611|NCT00635219|583041945|FG004|Overall Study|Lack of Efficacy|6|||
161449612|NCT00635219|583041941|FG000|Overall Study|Non-compliance With Study Product|0|||
161449613|NCT00635219|583041942|FG001|Overall Study|Non-compliance With Study Product|0|||
161449614|NCT00635219|583041943|FG002|Overall Study|Non-compliance With Study Product|0|||
161449615|NCT00635219|583041944|FG003|Overall Study|Non-compliance With Study Product|2|||
161449616|NCT00635219|583041945|FG004|Overall Study|Non-compliance With Study Product|1|||
161449617|NCT00635219|583041941|FG000|Overall Study|Protocol Violation|0|||
161449618|NCT00635219|583041942|FG001|Overall Study|Protocol Violation|2|||
161449619|NCT00635219|583041943|FG002|Overall Study|Protocol Violation|3|||
161449620|NCT00635219|583041944|FG003|Overall Study|Protocol Violation|2|||
161449621|NCT00635219|583041945|FG004|Overall Study|Protocol Violation|4|||
161449622|NCT00635219|583041941|FG000|Overall Study|Withdrawal of Consent|8|||
161449623|NCT00635219|583041942|FG001|Overall Study|Withdrawal of Consent|6|||
161449624|NCT00635219|583041943|FG002|Overall Study|Withdrawal of Consent|8|||
161449625|NCT00635219|583041944|FG003|Overall Study|Withdrawal of Consent|11|||
161449626|NCT00635219|583041945|FG004|Overall Study|Withdrawal of Consent|8|||
161449627|NCT00635219|583041941|FG000|Overall Study|Lost to Follow-up|0|||
161449628|NCT00635219|583041942|FG001|Overall Study|Lost to Follow-up|0|||
161449629|NCT00635219|583041943|FG002|Overall Study|Lost to Follow-up|2|||
161449630|NCT00635219|583041944|FG003|Overall Study|Lost to Follow-up|0|||
161449631|NCT00635219|583041945|FG004|Overall Study|Lost to Follow-up|3|||
161449632|NCT00635219|583041941|FG000|Overall Study|Administrative or Other Reasons|0|||
161449633|NCT00635219|583041942|FG001|Overall Study|Administrative or Other Reasons|1|||
161449634|NCT00635219|583041943|FG002|Overall Study|Administrative or Other Reasons|1|||
161449635|NCT00635219|583041944|FG003|Overall Study|Administrative or Other Reasons|0|||
161449636|NCT00635219|583041945|FG004|Overall Study|Administrative or Other Reasons|1|||
161449637|NCT04093024|583041948|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
161449638|NCT04093024|583041949|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
161449639|NCT04093024|583041948|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
161449640|NCT04093024|583041949|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
161449641|NCT04093024|583041948|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
161449642|NCT04093024|583041949|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
161449643|NCT04093024|583041948|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
161449644|NCT04093024|583041949|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
161449645|NCT00435045|583041956|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
161449646|NCT00435045|583041957|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
161449647|NCT00435045|583041956|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
161449648|NCT00435045|583041957|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
161449649|NCT00435045|583041956|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
161449650|NCT00435045|583041957|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
161449651|NCT00435045|583041956|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
161449652|NCT00435045|583041957|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
161449653|NCT00435045|583041956|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
161449654|NCT00435045|583041957|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
161449655|NCT00435045|583041956|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
161449656|NCT00435045|583041957|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
161449657|NCT00435045|583041956|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
161449658|NCT00435045|583041957|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
161449659|NCT00435045|583041956|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
161449660|NCT00435045|583041957|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
161449661|NCT00435045|583041956|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
161449662|NCT00435045|583041957|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
161449663|NCT00435045|583041956|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
161449664|NCT00435045|583041957|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
161449665|NCT00435045|583041956|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
161796286|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161449666|NCT00435045|583041957|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
161449667|NCT03052426|583041958|FG000|Overall Study|Withdrawal by Subject|0|||
161449668|NCT03052426|583041959|FG001|Overall Study|Withdrawal by Subject|1|||
161796287|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161449669|NCT03052426|583041960|FG002|Overall Study|Withdrawal by Subject|0|||
161449670|NCT03052426|583041958|FG000|Overall Study|Lost to Follow-up|2|||
161449671|NCT03052426|583041959|FG001|Overall Study|Lost to Follow-up|0|||
161449672|NCT03052426|583041960|FG002|Overall Study|Lost to Follow-up|1|||
161449673|NCT01853839|583041967|FG000|Overall Study|Violated inclusion criteria|2|||
161449674|NCT01853839|583041967|FG000|Overall Study|Not meet ITT population definition|58|||
161449675|NCT01853839|583041967|FG000|Overall Study|End of treatment visit too early|33|||
161449676|NCT01853839|583041967|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
161449677|NCT01640314|583041968|FG000|Overall Study|Protocol Violation|0|||
161449678|NCT01640314|583041969|FG001|Overall Study|Protocol Violation|1|||
161449679|NCT01290796|583041970|FG000|Overall Study|Lost to Follow-up|21|||
161449680|NCT01290796|583041970|FG000|Overall Study|Withdrawal by Subject|4|||
161449681|NCT01290796|583041970|FG000|Overall Study|Physician Decision|2|||
161449682|NCT01290796|583041970|FG000|Overall Study|Secondary Surgical Intervention|2|||
161449683|NCT01290796|583041970|FG000|Overall Study|Withdrawal by Sponsor|1|||
161449684|NCT02709538|583041972|FG000|Overall Study|Adverse Event|13|||
161449685|NCT02709538|583041973|FG001|Overall Study|Adverse Event|2|||
161449686|NCT02709538|583041974|FG002|Overall Study|Adverse Event|3|||
161449687|NCT02709538|583041972|FG000|Overall Study|Lack of Efficacy|1|||
161449688|NCT02709538|583041973|FG001|Overall Study|Lack of Efficacy|0|||
161449689|NCT02709538|583041974|FG002|Overall Study|Lack of Efficacy|0|||
161449690|NCT02709538|583041972|FG000|Overall Study|Lost to Follow-up|24|||
161449691|NCT02709538|583041973|FG001|Overall Study|Lost to Follow-up|8|||
161449692|NCT02709538|583041974|FG002|Overall Study|Lost to Follow-up|4|||
161449693|NCT02709538|583041972|FG000|Overall Study|Physician Decision|1|||
161449694|NCT02709538|583041973|FG001|Overall Study|Physician Decision|0|||
161449695|NCT02709538|583041974|FG002|Overall Study|Physician Decision|0|||
161449696|NCT02709538|583041972|FG000|Overall Study|Withdrawal by Subject|40|||
161449697|NCT02709538|583041973|FG001|Overall Study|Withdrawal by Subject|7|||
161449698|NCT02709538|583041974|FG002|Overall Study|Withdrawal by Subject|4|||
161449699|NCT02709538|583041972|FG000|Overall Study|Non-compliance with study procedures|5|||
161449700|NCT02709538|583041973|FG001|Overall Study|Non-compliance with study procedures|0|||
161449701|NCT02709538|583041974|FG002|Overall Study|Non-compliance with study procedures|0|||
161449702|NCT02709538|583041972|FG000|Overall Study|Non-compliance with study drug|2|||
161449703|NCT02709538|583041973|FG001|Overall Study|Non-compliance with study drug|0|||
161449704|NCT02709538|583041974|FG002|Overall Study|Non-compliance with study drug|0|||
161449705|NCT02709538|583041972|FG000|Overall Study|Protocol deviation|10|||
161449706|NCT02709538|583041973|FG001|Overall Study|Protocol deviation|4|||
161449707|NCT02709538|583041974|FG002|Overall Study|Protocol deviation|4|||
161449708|NCT02709538|583041972|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
161449709|NCT02709538|583041973|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
161449710|NCT02709538|583041974|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
161449711|NCT02709538|583041972|FG000|Overall Study|Other|16|||
161449712|NCT02709538|583041973|FG001|Overall Study|Other|7|||
161449713|NCT02709538|583041974|FG002|Overall Study|Other|5|||
161449714|NCT00835211|583041976|FG000|First Intervention|Withdrawal by Subject|0|||
161449715|NCT00835211|583041977|FG001|First Intervention|Withdrawal by Subject|1|||
161449716|NCT00835211|583041976|FG000|Washout: 7 Days|Adverse Event|2|||
161449717|NCT00835211|583041977|FG001|Washout: 7 Days|Adverse Event|1|||
161449718|NCT00835211|583041976|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161449719|NCT00835211|583041977|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161449720|NCT02343549|583041978|FG000|Overall Study|Death|11|||
161449721|NCT02343549|583041978|FG000|Overall Study|Withdrawal by Subject|2|||
161449722|NCT03087617|583041979|FG000|Overall Study|Lost to Follow-up|32|||
161449723|NCT03087617|583041980|FG001|Overall Study|Lost to Follow-up|30|||
161449724|NCT03087617|583041981|FG002|Overall Study|Lost to Follow-up|30|||
161449725|NCT03087617|583041982|FG003|Overall Study|Lost to Follow-up|39|||
161449726|NCT02160041|583041984|FG000|Overall Study|Adverse Event|11|||
161449727|NCT02160041|583041984|FG000|Overall Study|Death|2|||
161449728|NCT02160041|583041984|FG000|Overall Study|disease progression|57|||
161449729|NCT02160041|583041984|FG000|Overall Study|Protocol Violation|1|||
161449730|NCT02160041|583041984|FG000|Overall Study|non-compliance with study|1|||
161449731|NCT02160041|583041984|FG000|Overall Study|Physician Decision|3|||
161449732|NCT02160041|583041984|FG000|Overall Study|Withdrawal by Subject|8|||
161449733|NCT02160041|583041984|FG000|Overall Study|study terminated by by sponsor|1|||
161449734|NCT04450381|583041985|FG000|Overall Study|Protocol Violation|4|||
161449735|NCT04450381|583041985|FG000|Overall Study|Wrong device setting|2|||
161449736|NCT00335764|583041993|FG000|Overall Study|wrong histology|1|||
161449737|NCT00335764|583041994|FG001|Overall Study|wrong histology|0|||
161449738|NCT00335764|583041995|FG002|Overall Study|wrong histology|0|||
161449739|NCT00335764|583041996|FG003|Overall Study|wrong histology|0|||
161449740|NCT00335764|583041997|FG004|Overall Study|wrong histology|1|||
161449741|NCT01578850|583041998|FG000|Period 1|Insufficient Clinical Response|1|||
161449742|NCT01578850|583041999|FG001|Period 1|Insufficient Clinical Response|0|||
161449743|NCT01578850|583042000|FG002|Period 1|Insufficient Clinical Response|0|||
161449744|NCT01578850|583041998|FG000|Period 1|Adverse Event|11|||
161449745|NCT01578850|583041999|FG001|Period 1|Adverse Event|0|||
161449746|NCT01578850|583042000|FG002|Period 1|Adverse Event|0|||
161449747|NCT01578850|583041998|FG000|Period 1|Death|1|||
161449748|NCT01578850|583041999|FG001|Period 1|Death|0|||
161449749|NCT01578850|583042000|FG002|Period 1|Death|0|||
161449750|NCT01578850|583041998|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
161449751|NCT01578850|583041999|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
161449752|NCT01578850|583042000|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
161449753|NCT01578850|583041998|FG000|Period 1|Withdrawal by Subject|9|||
161449754|NCT01578850|583041999|FG001|Period 1|Withdrawal by Subject|0|||
161449755|NCT01578850|583042000|FG002|Period 1|Withdrawal by Subject|0|||
161449756|NCT01578850|583041998|FG000|Period 1|Study Terminated by Sponsor|3|||
161449757|NCT01578850|583041999|FG001|Period 1|Study Terminated by Sponsor|0|||
161449758|NCT01578850|583042000|FG002|Period 1|Study Terminated by Sponsor|0|||
161449759|NCT01578850|583041998|FG000|Period 2|Insufficient Clinical Response|0|||
161449760|NCT01578850|583041999|FG001|Period 2|Insufficient Clinical Response|1|||
161449761|NCT01578850|583042000|FG002|Period 2|Insufficient Clinical Response|0|||
161449762|NCT01578850|583041998|FG000|Period 2|Adverse Event|0|||
161449763|NCT01578850|583041999|FG001|Period 2|Adverse Event|3|||
161449764|NCT01578850|583042000|FG002|Period 2|Adverse Event|6|||
161449765|NCT01578850|583041998|FG000|Period 2|Lost to Follow-up|0|||
161449766|NCT01578850|583041999|FG001|Period 2|Lost to Follow-up|1|||
161449767|NCT01578850|583042000|FG002|Period 2|Lost to Follow-up|2|||
161449768|NCT01578850|583041998|FG000|Period 2|Withdrawal by Subject|0|||
161449769|NCT01578850|583041999|FG001|Period 2|Withdrawal by Subject|2|||
161449770|NCT01578850|583042000|FG002|Period 2|Withdrawal by Subject|2|||
161449771|NCT01578850|583041998|FG000|Period 2|Study Terminated by Sponsor|0|||
161449772|NCT01578850|583041999|FG001|Period 2|Study Terminated by Sponsor|5|||
161449773|NCT01578850|583042000|FG002|Period 2|Study Terminated by Sponsor|4|||
161449774|NCT01578850|583041998|FG000|Period 2|Unspecified Reasons|0|||
161449775|NCT01578850|583041999|FG001|Period 2|Unspecified Reasons|1|||
161449776|NCT01578850|583042000|FG002|Period 2|Unspecified Reasons|0|||
161449777|NCT00782834|583042003|FG000|Treatment Phase|fibrous tumor not GIST|1|||
161449778|NCT02252939|583042004|FG000|Overall Study|Lost to Follow-up|3|||
161449779|NCT04270370|583042005|FG000|Overall Study|Lost to Follow-up|1|||
161449780|NCT04270370|583042006|FG001|Overall Study|Lost to Follow-up|0|||
161449781|NCT04270370|583042007|FG002|Overall Study|Lost to Follow-up|0|||
161449782|NCT04270370|583042008|FG003|Overall Study|Lost to Follow-up|0|||
161449783|NCT04270370|583042009|FG004|Overall Study|Lost to Follow-up|0|||
161449784|NCT04270370|583042010|FG005|Overall Study|Lost to Follow-up|0|||
161449785|NCT04270370|583042011|FG006|Overall Study|Lost to Follow-up|0|||
161449786|NCT04270370|583042012|FG007|Overall Study|Lost to Follow-up|0|||
161449787|NCT04270370|583042013|FG008|Overall Study|Lost to Follow-up|1|||
161449788|NCT04270370|583042014|FG009|Overall Study|Lost to Follow-up|0|||
161449789|NCT04270370|583042015|FG010|Overall Study|Lost to Follow-up|0|||
161449790|NCT04270370|583042016|FG011|Overall Study|Lost to Follow-up|0|||
161449791|NCT01324141|583042017|FG000|Overall Study|Declined to participate before treatment started|1|||
161449792|NCT01324141|583042017|FG000|Overall Study|Disease progression on study|1|||
161449793|NCT02703337|583042018|FG000|Period One (Part A)|Withdrawal by Subject|0|||
161449794|NCT02703337|583042019|FG001|Period One (Part A)|Withdrawal by Subject|0|||
161449795|NCT02703337|583042020|FG002|Period One (Part A)|Withdrawal by Subject|0|||
161449796|NCT02703337|583042021|FG003|Period One (Part A)|Withdrawal by Subject|0|||
161449797|NCT02703337|583042022|FG004|Period One (Part A)|Withdrawal by Subject|1|||
161449798|NCT02703337|583042023|FG005|Period One (Part A)|Withdrawal by Subject|0|||
161449799|NCT02703337|583042024|FG006|Period One (Part A)|Withdrawal by Subject|0|||
161449800|NCT02703337|583042025|FG007|Period One (Part A)|Withdrawal by Subject|0|||
161449801|NCT01001325|583042035|FG000|Overall Study|Lost to Follow-up|16|||
161449802|NCT01001325|583042036|FG001|Overall Study|Lost to Follow-up|10|||
161449803|NCT01001325|583042035|FG000|Overall Study|Protocol Violation|2|||
161449804|NCT01001325|583042036|FG001|Overall Study|Protocol Violation|0|||
161449805|NCT01584440|583042039|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
161449806|NCT01584440|583042040|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
161449807|NCT01584440|583042041|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
161449808|NCT01584440|583042042|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
161449809|NCT01584440|583042043|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
161449810|NCT01584440|583042039|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
161449811|NCT01584440|583042040|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
161449812|NCT01584440|583042041|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
161449813|NCT01584440|583042042|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
161449814|NCT01584440|583042043|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
161449815|NCT01584440|583042039|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
161449816|NCT01584440|583042040|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
161449817|NCT01584440|583042041|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
161449818|NCT01584440|583042042|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
161449819|NCT01584440|583042043|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
161449820|NCT01584440|583042039|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
161449821|NCT01584440|583042040|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
161449822|NCT01584440|583042041|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
161449823|NCT01584440|583042042|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
161449824|NCT01584440|583042043|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
161900697|NCT03334188|584685161|FG000|Overall Study|Death|1|||
161900698|NCT03334188|584685162|FG001|Overall Study|Death|0|||
161900699|NCT03334188|584685161|FG000|Overall Study|Never had qualifying clinic visit|7|||
161900700|NCT03334188|584685162|FG001|Overall Study|Never had qualifying clinic visit|7|||
161900701|NCT00766597|584685166|FG000|Overall Study|Unexpected closure of study|4|||
161900702|NCT00766597|584685166|FG000|Overall Study|Without CCR5-tropic virus|5|||
161900703|NCT05137717|584685167|FG000|Overall Study|Death|2|||
161900704|NCT05137717|584685167|FG000|Overall Study|Withdrawal by Subject|6|||
161900705|NCT02619617|584685168|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
161900706|NCT02619617|584685169|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
161900707|NCT02619617|584685168|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
161900708|NCT02619617|584685169|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
161900709|NCT00509899|584685170|FG000|Overall Study|Progressive disease|1|||
161900710|NCT00509899|584685171|FG001|Overall Study|Progressive disease|3|||
161900711|NCT00509899|584685172|FG002|Overall Study|Progressive disease|5|||
161900712|NCT00509899|584685173|FG003|Overall Study|Progressive disease|1|||
161900713|NCT00509899|584685174|FG004|Overall Study|Progressive disease|0|||
161900714|NCT00509899|584685175|FG005|Overall Study|Progressive disease|1|||
161900715|NCT00509899|584685176|FG006|Overall Study|Progressive disease|0|||
161900716|NCT00509899|584685177|FG007|Overall Study|Progressive disease|0|||
161900717|NCT00509899|584685170|FG000|Overall Study|Unacceptable Toxicity|1|||
161900718|NCT00509899|584685171|FG001|Overall Study|Unacceptable Toxicity|0|||
161900719|NCT00509899|584685172|FG002|Overall Study|Unacceptable Toxicity|0|||
161900720|NCT00509899|584685173|FG003|Overall Study|Unacceptable Toxicity|2|||
161900721|NCT00509899|584685174|FG004|Overall Study|Unacceptable Toxicity|0|||
161900722|NCT00509899|584685175|FG005|Overall Study|Unacceptable Toxicity|0|||
161900723|NCT00509899|584685176|FG006|Overall Study|Unacceptable Toxicity|0|||
161900724|NCT00509899|584685177|FG007|Overall Study|Unacceptable Toxicity|0|||
161900725|NCT00509899|584685170|FG000|Overall Study|Withdrawal by Subject|6|||
161900726|NCT00509899|584685171|FG001|Overall Study|Withdrawal by Subject|2|||
161900727|NCT00509899|584685172|FG002|Overall Study|Withdrawal by Subject|3|||
161900728|NCT00509899|584685173|FG003|Overall Study|Withdrawal by Subject|0|||
161900729|NCT00509899|584685174|FG004|Overall Study|Withdrawal by Subject|3|||
161900730|NCT00509899|584685175|FG005|Overall Study|Withdrawal by Subject|2|||
161900731|NCT00509899|584685176|FG006|Overall Study|Withdrawal by Subject|0|||
161900732|NCT00509899|584685177|FG007|Overall Study|Withdrawal by Subject|0|||
161900733|NCT00509899|584685170|FG000|Overall Study|Physician Decision|4|||
161900734|NCT00509899|584685171|FG001|Overall Study|Physician Decision|2|||
161900735|NCT00509899|584685172|FG002|Overall Study|Physician Decision|7|||
161900736|NCT00509899|584685173|FG003|Overall Study|Physician Decision|0|||
161900737|NCT00509899|584685174|FG004|Overall Study|Physician Decision|1|||
161900738|NCT00509899|584685175|FG005|Overall Study|Physician Decision|4|||
161900739|NCT00509899|584685176|FG006|Overall Study|Physician Decision|0|||
161900740|NCT00509899|584685177|FG007|Overall Study|Physician Decision|0|||
161900741|NCT00509899|584685170|FG000|Overall Study|Intercurrent Illness|1|||
161900742|NCT00509899|584685171|FG001|Overall Study|Intercurrent Illness|0|||
161900743|NCT00509899|584685172|FG002|Overall Study|Intercurrent Illness|0|||
161900744|NCT00509899|584685173|FG003|Overall Study|Intercurrent Illness|1|||
161900745|NCT00509899|584685174|FG004|Overall Study|Intercurrent Illness|0|||
161900746|NCT00509899|584685175|FG005|Overall Study|Intercurrent Illness|1|||
161900747|NCT00509899|584685176|FG006|Overall Study|Intercurrent Illness|0|||
161900748|NCT00509899|584685177|FG007|Overall Study|Intercurrent Illness|0|||
161900749|NCT00509899|584685170|FG000|Overall Study|Death|2|||
161900750|NCT00509899|584685171|FG001|Overall Study|Death|2|||
161900751|NCT00509899|584685172|FG002|Overall Study|Death|3|||
161900752|NCT00509899|584685173|FG003|Overall Study|Death|0|||
161900753|NCT00509899|584685174|FG004|Overall Study|Death|1|||
161900754|NCT00509899|584685175|FG005|Overall Study|Death|1|||
161900755|NCT00509899|584685176|FG006|Overall Study|Death|1|||
161900756|NCT00509899|584685177|FG007|Overall Study|Death|1|||
161900757|NCT00509899|584685170|FG000|Overall Study|Lack of Efficacy|1|||
161900758|NCT00509899|584685171|FG001|Overall Study|Lack of Efficacy|0|||
161900759|NCT00509899|584685172|FG002|Overall Study|Lack of Efficacy|2|||
161900760|NCT00509899|584685173|FG003|Overall Study|Lack of Efficacy|0|||
161900761|NCT00509899|584685174|FG004|Overall Study|Lack of Efficacy|0|||
161900762|NCT00509899|584685175|FG005|Overall Study|Lack of Efficacy|1|||
161900763|NCT00509899|584685176|FG006|Overall Study|Lack of Efficacy|0|||
161900764|NCT00509899|584685177|FG007|Overall Study|Lack of Efficacy|0|||
161900765|NCT01254656|584685178|FG000|Overall Study|Discontinued due to termination of study|40|||
161900766|NCT01254656|584685179|FG001|Overall Study|Discontinued due to termination of study|39|||
161900767|NCT01254656|584685180|FG002|Overall Study|Discontinued due to termination of study|13|||
161900768|NCT01254656|584685178|FG000|Overall Study|Lack of Efficacy|3|||
161900769|NCT01254656|584685179|FG001|Overall Study|Lack of Efficacy|0|||
161900770|NCT01254656|584685180|FG002|Overall Study|Lack of Efficacy|0|||
161900771|NCT01254656|584685178|FG000|Overall Study|Lost to Follow-up|1|||
161900772|NCT01254656|584685179|FG001|Overall Study|Lost to Follow-up|0|||
161900773|NCT01254656|584685180|FG002|Overall Study|Lost to Follow-up|2|||
161900774|NCT01254656|584685178|FG000|Overall Study|Withdrawal by Subject|2|||
161449825|NCT01584440|583042039|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
161449826|NCT01584440|583042040|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
161449827|NCT01584440|583042041|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
161449828|NCT01584440|583042042|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
161449829|NCT01584440|583042043|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
161449830|NCT01584440|583042039|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
161449831|NCT01584440|583042040|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
161449832|NCT01584440|583042041|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
161449833|NCT01584440|583042042|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
161449834|NCT01584440|583042043|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
161449835|NCT01584440|583042039|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
161449836|NCT01584440|583042040|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
161449837|NCT01584440|583042041|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
161449838|NCT01584440|583042042|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
161449839|NCT01584440|583042043|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
161449840|NCT01584440|583042039|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
161449841|NCT01584440|583042040|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
161449842|NCT01584440|583042041|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
161449843|NCT01584440|583042042|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
161449844|NCT01584440|583042043|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
161449845|NCT01584440|583042039|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
161449846|NCT01584440|583042040|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
161449847|NCT01584440|583042041|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
161449848|NCT01584440|583042042|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
161449849|NCT01584440|583042043|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
161449850|NCT04237116|583042044|FG000|Overall Study|Adverse Event|0|||
161449851|NCT04237116|583042045|FG001|Overall Study|Adverse Event|1|||
161449852|NCT04237116|583042044|FG000|Overall Study|Study terminated by Sponsor|4|||
161449853|NCT04237116|583042045|FG001|Overall Study|Study terminated by Sponsor|1|||
161449854|NCT00899431|583042046|FG000|Overall Study|Physician Decision|1|||
161449855|NCT00899431|583042047|FG001|Overall Study|Physician Decision|0|||
161449856|NCT00899431|583042048|FG002|Overall Study|Physician Decision|0|||
161449857|NCT03212144|583042049|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
161449858|NCT03212144|583042050|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
161449859|NCT03212144|583042049|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
161449860|NCT03212144|583042050|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
161449861|NCT00661427|583042054|FG000|Overall Study|Adverse Event|5|||
161449862|NCT00661427|583042055|FG001|Overall Study|Adverse Event|5|||
161449863|NCT00661427|583042054|FG000|Overall Study|Patient not treated|0|||
161449864|NCT00661427|583042055|FG001|Overall Study|Patient not treated|2|||
161449865|NCT01338298|583042056|FG000|Overall Study|Withdrawal by Subject|1|||
161449866|NCT01338298|583042057|FG001|Overall Study|Withdrawal by Subject|1|||
161449867|NCT01338298|583042056|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
161449868|NCT01338298|583042057|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
161449869|NCT01338298|583042056|FG000|Overall Study|Administrative error|0|||
161449870|NCT01338298|583042057|FG001|Overall Study|Administrative error|1|||
161449871|NCT01338298|583042056|FG000|Overall Study|Positive symptom worsening|1|||
161449872|NCT01338298|583042057|FG001|Overall Study|Positive symptom worsening|0|||
161449873|NCT01338298|583042056|FG000|Overall Study|Depressive symptoms and nausea|1|||
161449874|NCT01338298|583042057|FG001|Overall Study|Depressive symptoms and nausea|0|||
161449875|NCT01338298|583042056|FG000|Overall Study|Non-adherence|1|||
161449876|NCT01338298|583042057|FG001|Overall Study|Non-adherence|0|||
161449877|NCT02872285|583042058|FG000|Overall Study|Withdrawal by Subject|2|||
161554856|NCT01012973|583420405|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
161900775|NCT01254656|584685179|FG001|Overall Study|Withdrawal by Subject|2|||
161900776|NCT01254656|584685180|FG002|Overall Study|Withdrawal by Subject|1|||
161900777|NCT01254656|584685178|FG000|Overall Study|Pregnancy|0|||
161900778|NCT01254656|584685179|FG001|Overall Study|Pregnancy|0|||
161900779|NCT01254656|584685180|FG002|Overall Study|Pregnancy|2|||
161900780|NCT01254656|584685178|FG000|Overall Study|Adverse Event|1|||
161900781|NCT01254656|584685179|FG001|Overall Study|Adverse Event|1|||
161900782|NCT01254656|584685180|FG002|Overall Study|Adverse Event|0|||
161900783|NCT01254656|584685178|FG000|Overall Study|Death|0|||
161900784|NCT01254656|584685179|FG001|Overall Study|Death|1|||
161900785|NCT01254656|584685180|FG002|Overall Study|Death|0|||
161449878|NCT02872285|583042059|FG001|Overall Study|Withdrawal by Subject|0|||
161449879|NCT02872285|583042058|FG000|Overall Study|Lost to Follow-up|2|||
161449880|NCT02872285|583042059|FG001|Overall Study|Lost to Follow-up|2|||
161449881|NCT02872285|583042058|FG000|Overall Study|Discontinued due to back surgery|1|||
161449882|NCT02872285|583042059|FG001|Overall Study|Discontinued due to back surgery|0|||
161449883|NCT00531427|583042060|FG000|Overall Study|Withdrawal by Subject|7|||
161449884|NCT00531427|583042061|FG001|Overall Study|Withdrawal by Subject|13|||
161449885|NCT00531427|583042060|FG000|Overall Study|Adverse Event|44|||
161449886|NCT00531427|583042061|FG001|Overall Study|Adverse Event|30|||
161449887|NCT00531427|583042060|FG000|Overall Study|Lost to Follow-up|4|||
161449888|NCT00531427|583042061|FG001|Overall Study|Lost to Follow-up|3|||
161449889|NCT00531427|583042060|FG000|Overall Study|Lack of Efficacy|14|||
161449890|NCT00531427|583042061|FG001|Overall Study|Lack of Efficacy|39|||
161449891|NCT00531427|583042060|FG000|Overall Study|Administrative|4|||
161449892|NCT00531427|583042061|FG001|Overall Study|Administrative|9|||
161449893|NCT05477108|583042062|FG000|Overall Study|Participants randomized, not treated|1|||
161449894|NCT05477108|583042063|FG001|Overall Study|Participants randomized, not treated|1|||
161449895|NCT05477108|583042064|FG002|Overall Study|Participants randomized, not treated|1|||
161449896|NCT05477108|583042062|FG000|Overall Study|Physician Decision|0|||
161449897|NCT05477108|583042063|FG001|Overall Study|Physician Decision|0|||
161449898|NCT05477108|583042064|FG002|Overall Study|Physician Decision|1|||
161449899|NCT05477108|583042062|FG000|Overall Study|withdrawn from study|0|||
161449900|NCT05477108|583042063|FG001|Overall Study|withdrawn from study|0|||
161449901|NCT05477108|583042064|FG002|Overall Study|withdrawn from study|1|||
161449902|NCT01253577|583042065|FG000|Overall Study|Lost to Follow-up|3|||
161449903|NCT05688670|583042066|FG000|Overall Study|Change in surgery plan|1|||
161449904|NCT05688670|583042067|FG001|Overall Study|Change in surgery plan|4|||
161449905|NCT05688670|583042066|FG000|Overall Study|Inability to extubate|1|||
161449906|NCT05688670|583042067|FG001|Overall Study|Inability to extubate|2|||
161449907|NCT05688670|583042066|FG000|Overall Study|Day of surgery cancellation|0|||
161449908|NCT05688670|583042067|FG001|Overall Study|Day of surgery cancellation|1|||
161449909|NCT05688670|583042066|FG000|Overall Study|Reintubated on PCICU arrival|0|||
161449910|NCT05688670|583042067|FG001|Overall Study|Reintubated on PCICU arrival|1|||
161449911|NCT00488683|583042068|FG000|Overall Study|Withdrawal by Subject|1|||
161449912|NCT00488683|583042069|FG001|Overall Study|Withdrawal by Subject|2|||
161449913|NCT00488683|583042070|FG002|Overall Study|Withdrawal by Subject|2|||
161449914|NCT00488683|583042068|FG000|Overall Study|Lost to Follow-up|5|||
161449915|NCT00488683|583042069|FG001|Overall Study|Lost to Follow-up|3|||
161449916|NCT00488683|583042070|FG002|Overall Study|Lost to Follow-up|0|||
161449917|NCT00488683|583042068|FG000|Overall Study|Protocol Violation|5|||
161449918|NCT00488683|583042069|FG001|Overall Study|Protocol Violation|1|||
161449919|NCT00488683|583042070|FG002|Overall Study|Protocol Violation|0|||
161449920|NCT00488683|583042068|FG000|Overall Study|Unable to Classify|1|||
161449921|NCT00488683|583042069|FG001|Overall Study|Unable to Classify|0|||
161449922|NCT00488683|583042070|FG002|Overall Study|Unable to Classify|0|||
161449923|NCT00336856|583043574|FG000|Overall Study|Withdrawal by Subject|3|||
161449924|NCT00336856|583043574|FG000|Overall Study|Found ineligible at time of analysis|1|||
161449925|NCT00843778|583043587|FG000|Overall Study|Adverse Event|15|||
161449926|NCT00843778|583043587|FG000|Overall Study|Lack of Efficacy|14|||
161449927|NCT00843778|583043587|FG000|Overall Study|Loss of efficacy|2|||
161449928|NCT00843778|583043587|FG000|Overall Study|Withdrawal by Subject|4|||
161449929|NCT00830869|583043590|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
161449930|NCT00830869|583043591|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
161449931|NCT00830869|583043592|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
161449932|NCT00830869|583043593|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
161449933|NCT00830869|583043594|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
161449934|NCT00830869|583043595|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
161449935|NCT00830869|583043596|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
161449936|NCT00830869|583043597|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
161449937|NCT00830869|583043598|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
161449938|NCT00830869|583043599|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
161449939|NCT00830869|583043600|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
161449940|NCT00830869|583043601|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
161449941|NCT00830869|583043590|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
161449942|NCT00830869|583043591|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
161449943|NCT00830869|583043592|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
161449944|NCT00830869|583043593|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
161449945|NCT00830869|583043594|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
161449946|NCT00830869|583043595|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
161449947|NCT00830869|583043596|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
161449948|NCT00830869|583043597|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
161449949|NCT00830869|583043598|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
161449950|NCT00830869|583043599|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
161449951|NCT00830869|583043600|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
161449952|NCT00830869|583043601|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
161449953|NCT00830869|583043590|FG000|Period 1: Part 1|Adverse Event|0|||
161554857|NCT01012973|583420406|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
161449954|NCT00830869|583043591|FG001|Period 1: Part 1|Adverse Event|0|||
161449955|NCT00830869|583043592|FG002|Period 1: Part 1|Adverse Event|0|||
161900786|NCT02948829|584685183|FG000|Overall Study|Lost to Follow-up|2|||
161449956|NCT00830869|583043593|FG003|Period 1: Part 1|Adverse Event|0|||
161449957|NCT00830869|583043594|FG004|Period 1: Part 1|Adverse Event|0|||
161554858|NCT01012973|583420405|FG000|Overall Study|Protocol Violation|5|||
161449958|NCT00830869|583043595|FG005|Period 1: Part 1|Adverse Event|1|||
161554859|NCT01012973|583420406|FG001|Overall Study|Protocol Violation|2|||
161554860|NCT01012973|583420405|FG000|Overall Study|Withdrawal by Subject|4|||
161554861|NCT01012973|583420406|FG001|Overall Study|Withdrawal by Subject|6|||
161554862|NCT02213055|583420407|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
161554863|NCT02213055|583420408|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
161554864|NCT02213055|583420407|FG000|Overall Study|Protocol was not Followed during Study|1|||
161554865|NCT02213055|583420408|FG001|Overall Study|Protocol was not Followed during Study|0|||
161554866|NCT02213055|583420407|FG000|Overall Study|Documentation Issue at Enrollment|1|||
161554867|NCT02213055|583420408|FG001|Overall Study|Documentation Issue at Enrollment|0|||
161554868|NCT02213055|583420407|FG000|Overall Study|Documentation Issue during Study|10|||
161554869|NCT02213055|583420408|FG001|Overall Study|Documentation Issue during Study|0|||
161554870|NCT02213055|583420407|FG000|Overall Study|Did not have Live Lice|8|||
161554871|NCT02213055|583420408|FG001|Overall Study|Did not have Live Lice|0|||
161554872|NCT02213055|583420407|FG000|Overall Study|Had another Treatment during the Study|3|||
161554873|NCT02213055|583420408|FG001|Overall Study|Had another Treatment during the Study|0|||
161554874|NCT02213055|583420407|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
161554875|NCT02213055|583420408|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
161554876|NCT02213055|583420407|FG000|Overall Study|Did not Return to School|5|||
161554877|NCT02213055|583420408|FG001|Overall Study|Did not Return to School|0|||
161554878|NCT01932996|583420409|FG000|Overall Study|Protocol Violation|2|||
161554879|NCT01932996|583420410|FG001|Overall Study|Protocol Violation|0|||
161554880|NCT00846742|583420413|FG000|Overall Study|Withdrawal by Subject|1|||
161554881|NCT05868954|583420419|FG000|Overall Study|Lost to Follow-up|0|||
161554882|NCT05868954|583420420|FG001|Overall Study|Lost to Follow-up|1|||
161554883|NCT05868954|583420419|FG000|Overall Study|Withdrawal by Subject|2|||
161554884|NCT05868954|583420420|FG001|Overall Study|Withdrawal by Subject|2|||
161554885|NCT05868954|583420419|FG000|Overall Study|Participant delivered|1|||
161554886|NCT05868954|583420420|FG001|Overall Study|Participant delivered|1|||
161554887|NCT05868954|583420419|FG000|Overall Study|Miscarriage|0|||
161554888|NCT05868954|583420420|FG001|Overall Study|Miscarriage|1|||
161554889|NCT01435798|583420425|FG000|Overall Study|Withdrawal by Subject|1|||
161554890|NCT03257995|583420429|FG000|Overall Study|Adverse Event|0|||
161554891|NCT03257995|583420430|FG001|Overall Study|Adverse Event|1|||
161554892|NCT03257995|583420431|FG002|Overall Study|Adverse Event|0|||
161554893|NCT03257995|583420432|FG003|Overall Study|Adverse Event|0|||
161554894|NCT03257995|583420433|FG004|Overall Study|Adverse Event|0|||
161554895|NCT03257995|583420434|FG005|Overall Study|Adverse Event|0|||
161554896|NCT03257995|583420429|FG000|Overall Study|Protocol deviation|0|||
161554897|NCT03257995|583420430|FG001|Overall Study|Protocol deviation|0|||
161554898|NCT03257995|583420431|FG002|Overall Study|Protocol deviation|0|||
161554899|NCT03257995|583420432|FG003|Overall Study|Protocol deviation|0|||
161554900|NCT03257995|583420433|FG004|Overall Study|Protocol deviation|0|||
161554901|NCT03257995|583420434|FG005|Overall Study|Protocol deviation|2|||
161554902|NCT04170296|583420439|FG000|Overall Study|Adverse Event|1|||
161554903|NCT04170296|583420440|FG001|Overall Study|Adverse Event|0|||
161554904|NCT04170296|583420439|FG000|Overall Study|Withdrawal by Subject|3|||
161554905|NCT04170296|583420440|FG001|Overall Study|Withdrawal by Subject|2|||
161554906|NCT04170296|583420439|FG000|Overall Study|Lost to Follow-up|4|||
161796288|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
161796289|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161449959|NCT00830869|583043596|FG006|Period 1: Part 1|Adverse Event|1|||
161449960|NCT00830869|583043597|FG007|Period 1: Part 1|Adverse Event|0|||
161449961|NCT00830869|583043598|FG008|Period 1: Part 1|Adverse Event|0|||
161449962|NCT00830869|583043599|FG009|Period 1: Part 1|Adverse Event|0|||
161449963|NCT00830869|583043600|FG010|Period 1: Part 1|Adverse Event|0|||
161449964|NCT00830869|583043601|FG011|Period 1: Part 1|Adverse Event|0|||
161449965|NCT00830869|583043590|FG000|Period 1: Part 1|Progressive disease|1|||
161449966|NCT00830869|583043591|FG001|Period 1: Part 1|Progressive disease|0|||
161449967|NCT00830869|583043592|FG002|Period 1: Part 1|Progressive disease|1|||
161449968|NCT00830869|583043593|FG003|Period 1: Part 1|Progressive disease|6|||
161449969|NCT00830869|583043594|FG004|Period 1: Part 1|Progressive disease|4|||
161449970|NCT00830869|583043595|FG005|Period 1: Part 1|Progressive disease|4|||
161449971|NCT00830869|583043596|FG006|Period 1: Part 1|Progressive disease|1|||
161449972|NCT00830869|583043597|FG007|Period 1: Part 1|Progressive disease|0|||
161449973|NCT00830869|583043598|FG008|Period 1: Part 1|Progressive disease|0|||
161449974|NCT00830869|583043599|FG009|Period 1: Part 1|Progressive disease|0|||
161449975|NCT00830869|583043600|FG010|Period 1: Part 1|Progressive disease|0|||
161449976|NCT00830869|583043601|FG011|Period 1: Part 1|Progressive disease|0|||
161449977|NCT00830869|583043590|FG000|Period 2: Part 2|Protocol Violation|0|||
161449978|NCT00830869|583043591|FG001|Period 2: Part 2|Protocol Violation|0|||
161449979|NCT00830869|583043592|FG002|Period 2: Part 2|Protocol Violation|0|||
161554907|NCT04170296|583420440|FG001|Overall Study|Lost to Follow-up|2|||
161796290|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161449980|NCT00830869|583043593|FG003|Period 2: Part 2|Protocol Violation|0|||
161449981|NCT00830869|583043594|FG004|Period 2: Part 2|Protocol Violation|0|||
161796291|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796292|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
161554908|NCT03567993|583420441|FG000|Overall Study|Lost to Follow-up|4|||
161554909|NCT03567993|583420442|FG001|Overall Study|Lost to Follow-up|2|||
161554910|NCT03567993|583420441|FG000|Overall Study|Death|1|||
161554911|NCT03567993|583420442|FG001|Overall Study|Death|1|||
161554912|NCT03567993|583420441|FG000|Overall Study|Withdrawal by Subject|1|||
161554913|NCT03567993|583420442|FG001|Overall Study|Withdrawal by Subject|0|||
161554914|NCT00903786|583420443|FG000|Overall Study|Physician Decision|6|||
161554915|NCT00903786|583420443|FG000|Overall Study|Lack of Efficacy|5|||
161554916|NCT00903786|583420443|FG000|Overall Study|Reason other than lack of efficacy|4|||
161554917|NCT02285595|583420444|FG000|Overall Study|Lost to Follow-up|14|||
161554918|NCT02285595|583420444|FG000|Overall Study|Withdrawal by Subject|1|||
161554919|NCT01960790|583420445|FG000|Overall Study|Survey forms could not be recovered|3|||
161900787|NCT02948829|584685183|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
161449982|NCT00830869|583043595|FG005|Period 2: Part 2|Protocol Violation|0|||
161449983|NCT00830869|583043596|FG006|Period 2: Part 2|Protocol Violation|0|||
161449984|NCT00830869|583043597|FG007|Period 2: Part 2|Protocol Violation|1|||
161449985|NCT00830869|583043598|FG008|Period 2: Part 2|Protocol Violation|0|||
161449986|NCT00830869|583043599|FG009|Period 2: Part 2|Protocol Violation|1|||
161449987|NCT00830869|583043600|FG010|Period 2: Part 2|Protocol Violation|0|||
161449988|NCT00830869|583043601|FG011|Period 2: Part 2|Protocol Violation|0|||
161449989|NCT00830869|583043590|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
161449990|NCT00830869|583043591|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
161449991|NCT00830869|583043592|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
161449992|NCT00830869|583043593|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
161449993|NCT00830869|583043594|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
161449994|NCT00830869|583043595|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
161449995|NCT00830869|583043596|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
161449996|NCT00830869|583043597|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
161449997|NCT00830869|583043598|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
161449998|NCT00830869|583043599|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
161449999|NCT00830869|583043600|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
161450000|NCT00830869|583043601|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
161450001|NCT00830869|583043590|FG000|Period 2: Part 2|Adverse Event|0|||
161450002|NCT00830869|583043591|FG001|Period 2: Part 2|Adverse Event|0|||
161450003|NCT00830869|583043592|FG002|Period 2: Part 2|Adverse Event|0|||
161450004|NCT00830869|583043593|FG003|Period 2: Part 2|Adverse Event|0|||
161450005|NCT00830869|583043594|FG004|Period 2: Part 2|Adverse Event|0|||
161450006|NCT00830869|583043595|FG005|Period 2: Part 2|Adverse Event|0|||
161450007|NCT00830869|583043596|FG006|Period 2: Part 2|Adverse Event|0|||
161450008|NCT00830869|583043597|FG007|Period 2: Part 2|Adverse Event|4|||
161450009|NCT00830869|583043598|FG008|Period 2: Part 2|Adverse Event|3|||
161450010|NCT00830869|583043599|FG009|Period 2: Part 2|Adverse Event|2|||
161450011|NCT00830869|583043600|FG010|Period 2: Part 2|Adverse Event|2|||
161450012|NCT00830869|583043601|FG011|Period 2: Part 2|Adverse Event|0|||
161450013|NCT00830869|583043590|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
161450014|NCT00830869|583043591|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
161450015|NCT00830869|583043592|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
161450016|NCT00830869|583043593|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
161450017|NCT00830869|583043594|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
161450018|NCT00830869|583043595|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
161450019|NCT00830869|583043596|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
161450020|NCT00830869|583043597|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
161450021|NCT00830869|583043598|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
161450022|NCT00830869|583043599|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
161450023|NCT00830869|583043600|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
161450024|NCT00830869|583043601|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
161450025|NCT00830869|583043590|FG000|Period 2: Part 2|Progressive disease|0|||
161450026|NCT00830869|583043591|FG001|Period 2: Part 2|Progressive disease|0|||
161450027|NCT00830869|583043592|FG002|Period 2: Part 2|Progressive disease|0|||
161450028|NCT00830869|583043593|FG003|Period 2: Part 2|Progressive disease|0|||
161450029|NCT00830869|583043594|FG004|Period 2: Part 2|Progressive disease|0|||
161450030|NCT00830869|583043595|FG005|Period 2: Part 2|Progressive disease|0|||
161450031|NCT00830869|583043596|FG006|Period 2: Part 2|Progressive disease|0|||
161450032|NCT00830869|583043597|FG007|Period 2: Part 2|Progressive disease|14|||
161450033|NCT00830869|583043598|FG008|Period 2: Part 2|Progressive disease|11|||
161450034|NCT00830869|583043599|FG009|Period 2: Part 2|Progressive disease|12|||
161450035|NCT00830869|583043600|FG010|Period 2: Part 2|Progressive disease|8|||
161450036|NCT00830869|583043601|FG011|Period 2: Part 2|Progressive disease|15|||
161450037|NCT00830869|583043590|FG000|Period 2: Part 2|Other|0|||
161450038|NCT00830869|583043591|FG001|Period 2: Part 2|Other|0|||
161554920|NCT01960790|583420445|FG000|Overall Study|Treat with Humira outside survey period|3|||
161554921|NCT01960790|583420445|FG000|Overall Study|Transferred to another hospital|4|||
161900788|NCT02948829|584685183|FG000|Overall Study|Pregnancy|1|||
161450039|NCT00830869|583043592|FG002|Period 2: Part 2|Other|0|||
161450040|NCT00830869|583043593|FG003|Period 2: Part 2|Other|0|||
161450041|NCT00830869|583043594|FG004|Period 2: Part 2|Other|0|||
161554922|NCT01960790|583420445|FG000|Overall Study|Unevaluable for safety|1|||
161554923|NCT00064025|583420446|FG000|Overall Study|Ineligible|4|||
161554924|NCT00064025|583420446|FG000|Overall Study|Inevaluable|3|||
161554925|NCT02468934|583420447|FG000|Overall Study|Withdrawal by Subject|4|||
161554926|NCT02468934|583420447|FG000|Overall Study|Screen Failure|3|||
161554927|NCT00547911|583420452|FG000|Overall Study|Adverse Event|0|||
161554928|NCT00547911|583420453|FG001|Overall Study|Adverse Event|0|||
161554929|NCT00547911|583420454|FG002|Overall Study|Adverse Event|0|||
161554930|NCT00547911|583420455|FG003|Overall Study|Adverse Event|1|||
161554931|NCT00547911|583420456|FG004|Overall Study|Adverse Event|0|||
161554932|NCT00547911|583420457|FG005|Overall Study|Adverse Event|0|||
161554933|NCT02133924|583420458|FG000|Overall Study|Death|38|||
161554934|NCT02133924|583420458|FG000|Overall Study|Physician Decision|1|||
161554935|NCT02133924|583420458|FG000|Overall Study|Withdrawal by Subject|3|||
161554936|NCT01644474|583420460|FG000|Overall Study|Poor compliance to protocol|1|||
161554937|NCT01644474|583420461|FG001|Overall Study|Poor compliance to protocol|0|||
161554938|NCT01644474|583420460|FG000|Overall Study|Consent withdrawn by participant|0|||
161554939|NCT01644474|583420461|FG001|Overall Study|Consent withdrawn by participant|1|||
161554940|NCT01644474|583420460|FG000|Overall Study|Participant moved|0|||
161554941|NCT01644474|583420461|FG001|Overall Study|Participant moved|1|||
161554942|NCT01644474|583420460|FG000|Overall Study|Adverse Event|4|||
161554943|NCT01644474|583420461|FG001|Overall Study|Adverse Event|5|||
161554944|NCT01644474|583420460|FG000|Overall Study|Site scheduling error|1|||
161554945|NCT01644474|583420461|FG001|Overall Study|Site scheduling error|1|||
161554946|NCT01644474|583420460|FG000|Overall Study|Protocol Violation|1|||
161554947|NCT01644474|583420461|FG001|Overall Study|Protocol Violation|0|||
161554948|NCT01163747|583420467|FG000|Overall Study|Adverse Event|0|||
161554949|NCT01163747|583420468|FG001|Overall Study|Adverse Event|5|||
161554950|NCT01163747|583420467|FG000|Overall Study|Insufficient Therapeutic Response|0|||
161554951|NCT01163747|583420468|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161554952|NCT01163747|583420467|FG000|Overall Study|Protocol Violation|0|||
161554953|NCT01163747|583420468|FG001|Overall Study|Protocol Violation|1|||
161554954|NCT01163747|583420467|FG000|Overall Study|Refused Treatment|6|||
161554955|NCT01163747|583420468|FG001|Overall Study|Refused Treatment|4|||
161554956|NCT02044458|583420469|FG000|Overall Study|Protocol Violation|3|||
161554957|NCT02044458|583420470|FG001|Overall Study|Protocol Violation|8|||
161554958|NCT02819479|583422060|FG000|Overall Study|Adverse Event|2|||
161554959|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
161554960|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
161554961|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
161554962|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
161554963|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
161554964|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
161554965|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
161554966|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
161554967|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
161554968|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
161554969|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
161554970|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
161554971|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
161554972|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
161554973|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
161554974|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
161554975|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
161554976|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
161554977|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
161554978|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
161554979|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
161554980|NCT02718417|583422061|FG000|Chemotherapy Phase (CP)|Other|2|||
161554981|NCT02718417|583422062|FG001|Chemotherapy Phase (CP)|Other|0|||
161668041|NCT00406653|583837477|FG001|Induction Period|Declined participation but followup done|2|||
161668042|NCT00406653|583837478|FG002|Induction Period|Declined participation but followup done|1|||
161554982|NCT02718417|583422063|FG002|Chemotherapy Phase (CP)|Other|1|||
161554983|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Adverse Event|21|||
161554984|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Adverse Event|26|||
161554985|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Adverse Event|0|||
161554986|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
161554987|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
161554988|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
161554989|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
161554990|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
161554991|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
161554992|NCT02718417|583422061|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
161554993|NCT02718417|583422062|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
161554994|NCT02718417|583422063|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
161554995|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Physician's decision|6|||
161554996|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Physician's decision|7|||
161554997|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Physician's decision|0|||
161554998|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Progressive disease|100|||
161554999|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Progressive disease|88|||
161555000|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Progressive disease|0|||
161555001|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Other|2|||
161555002|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Other|1|||
161555003|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Other|0|||
161555004|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
161555005|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
161555006|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
161555007|NCT02718417|583422061|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
161555008|NCT02718417|583422062|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
161555009|NCT02718417|583422063|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
161555010|NCT02718417|583422061|FG000|Observation Phase (OP)|Adverse Event|0|||
161555011|NCT02718417|583422062|FG001|Observation Phase (OP)|Adverse Event|0|||
161555012|NCT02718417|583422063|FG002|Observation Phase (OP)|Adverse Event|1|||
161555013|NCT02718417|583422061|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
161555014|NCT02718417|583422062|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
161555015|NCT02718417|583422063|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
161555016|NCT02718417|583422061|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
161555017|NCT02718417|583422062|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
161796293|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796294|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796295|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796296|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796297|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796298|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796299|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796300|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161450042|NCT00830869|583043595|FG005|Period 2: Part 2|Other|0|||
161450043|NCT00830869|583043596|FG006|Period 2: Part 2|Other|0|||
161450044|NCT00830869|583043597|FG007|Period 2: Part 2|Other|0|||
161450045|NCT00830869|583043598|FG008|Period 2: Part 2|Other|0|||
161450046|NCT00830869|583043599|FG009|Period 2: Part 2|Other|1|||
161450047|NCT00830869|583043600|FG010|Period 2: Part 2|Other|0|||
161450048|NCT00830869|583043601|FG011|Period 2: Part 2|Other|0|||
161450049|NCT00507728|583043602|FG000|Randomization to Month 3|Lost to Follow-up|15|||
161450050|NCT00507728|583043603|FG001|Randomization to Month 3|Lost to Follow-up|14|||
161450051|NCT00507728|583043604|FG002|Randomization to Month 3|Lost to Follow-up|20|||
161450052|NCT00507728|583043602|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
161450053|NCT00507728|583043603|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
161450054|NCT00507728|583043604|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
161450055|NCT00730028|583043606|FG000|Overall Study|Adverse Event|23|||
161450056|NCT00730028|583043607|FG001|Overall Study|Adverse Event|26|||
161450057|NCT00730028|583043608|FG002|Overall Study|Adverse Event|16|||
161450058|NCT00730028|583043609|FG003|Overall Study|Adverse Event|20|||
161450059|NCT00730028|583043610|FG004|Overall Study|Adverse Event|43|||
161450060|NCT00730028|583043606|FG000|Overall Study|Lost to Follow-up|13|||
161450061|NCT00730028|583043607|FG001|Overall Study|Lost to Follow-up|26|||
161450062|NCT00730028|583043608|FG002|Overall Study|Lost to Follow-up|22|||
161450063|NCT00730028|583043609|FG003|Overall Study|Lost to Follow-up|26|||
161450064|NCT00730028|583043610|FG004|Overall Study|Lost to Follow-up|25|||
161450065|NCT00730028|583043606|FG000|Overall Study|Protocol Violation|6|||
161450066|NCT00730028|583043607|FG001|Overall Study|Protocol Violation|1|||
161450067|NCT00730028|583043608|FG002|Overall Study|Protocol Violation|1|||
161450068|NCT00730028|583043609|FG003|Overall Study|Protocol Violation|2|||
161450069|NCT00730028|583043610|FG004|Overall Study|Protocol Violation|0|||
161450070|NCT00730028|583043606|FG000|Overall Study|Withdrawal by Subject|9|||
161900789|NCT02948829|584685183|FG000|Overall Study|Other: Reason not Specified|8|||
161450071|NCT00730028|583043607|FG001|Overall Study|Withdrawal by Subject|5|||
161450072|NCT00730028|583043608|FG002|Overall Study|Withdrawal by Subject|4|||
161450073|NCT00730028|583043609|FG003|Overall Study|Withdrawal by Subject|5|||
161450074|NCT00730028|583043610|FG004|Overall Study|Withdrawal by Subject|9|||
161450075|NCT00730028|583043606|FG000|Overall Study|Physician Decision|3|||
161450076|NCT00730028|583043607|FG001|Overall Study|Physician Decision|3|||
161450077|NCT00730028|583043608|FG002|Overall Study|Physician Decision|2|||
161555018|NCT02718417|583422063|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
161555019|NCT02718417|583422061|FG000|Observation Phase (OP)|Physician Decision|0|||
161555020|NCT02718417|583422062|FG001|Observation Phase (OP)|Physician Decision|0|||
161900790|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161555021|NCT02718417|583422063|FG002|Observation Phase (OP)|Physician Decision|9|||
161555022|NCT02718417|583422061|FG000|Observation Phase (OP)|Progressive disease|0|||
161555023|NCT02718417|583422062|FG001|Observation Phase (OP)|Progressive disease|0|||
161555024|NCT02718417|583422063|FG002|Observation Phase (OP)|Progressive disease|92|||
161555025|NCT02718417|583422061|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
161555026|NCT02718417|583422062|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
161555027|NCT02718417|583422063|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
161555028|NCT02718417|583422061|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
161555029|NCT02718417|583422062|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
161555030|NCT02718417|583422063|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
161555031|NCT02718417|583422061|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
161555032|NCT02718417|583422062|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
161555033|NCT02718417|583422063|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
161555034|NCT02718417|583422061|FG000|Observation Phase (OP)|Other|0|||
161555035|NCT02718417|583422062|FG001|Observation Phase (OP)|Other|0|||
161555036|NCT02718417|583422063|FG002|Observation Phase (OP)|Other|7|||
161555037|NCT02718417|583422061|FG000|Follow-up Phase|Adverse Event|3|||
161555038|NCT02718417|583422062|FG001|Follow-up Phase|Adverse Event|1|||
161555039|NCT02718417|583422063|FG002|Follow-up Phase|Adverse Event|1|||
161555040|NCT02718417|583422061|FG000|Follow-up Phase|Other|4|||
161555041|NCT02718417|583422062|FG001|Follow-up Phase|Other|6|||
161555042|NCT02718417|583422063|FG002|Follow-up Phase|Other|4|||
161555043|NCT02718417|583422061|FG000|Follow-up Phase|Withdrawal by Subject|19|||
161555044|NCT02718417|583422062|FG001|Follow-up Phase|Withdrawal by Subject|17|||
161555045|NCT02718417|583422063|FG002|Follow-up Phase|Withdrawal by Subject|5|||
161555046|NCT02718417|583422061|FG000|Follow-up Phase|Study terminated by sponsor|100|||
161555047|NCT02718417|583422062|FG001|Follow-up Phase|Study terminated by sponsor|138|||
161555048|NCT02718417|583422063|FG002|Follow-up Phase|Study terminated by sponsor|6|||
161555049|NCT02718417|583422061|FG000|Follow-up Phase|Lost to Follow-up|2|||
161555050|NCT02718417|583422062|FG001|Follow-up Phase|Lost to Follow-up|3|||
161555051|NCT02718417|583422063|FG002|Follow-up Phase|Lost to Follow-up|0|||
161555052|NCT02718417|583422061|FG000|Follow-up Phase|Death leading to discontinuation|7|||
161555053|NCT02718417|583422062|FG001|Follow-up Phase|Death leading to discontinuation|7|||
161555054|NCT02718417|583422063|FG002|Follow-up Phase|Death leading to discontinuation|3|||
161555055|NCT02718417|583422061|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
161555056|NCT02718417|583422062|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
161555057|NCT02718417|583422063|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
161555058|NCT02718417|583422061|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
161555059|NCT02718417|583422062|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
161555060|NCT02718417|583422063|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
161555061|NCT02718417|583422061|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
161555062|NCT02718417|583422062|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
161555063|NCT02718417|583422063|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
161555064|NCT02718417|583422061|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
161555065|NCT02718417|583422062|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
161555066|NCT02718417|583422063|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
161555067|NCT02718417|583422061|FG000|Long-term Follow-up Phase|Other|0|||
161555068|NCT02718417|583422062|FG001|Long-term Follow-up Phase|Other|2|||
161555069|NCT02718417|583422063|FG002|Long-term Follow-up Phase|Other|0|||
161555070|NCT00724061|583422069|FG000|Dose Escalation Phase|Adverse Event|2|||
161555071|NCT00724061|583422069|FG000|Dose Escalation Phase|Disease Progression|3|||
161555072|NCT01536145|583422072|FG000|Overall Study|Progressive disease|3|||
161555073|NCT01536145|583422073|FG001|Overall Study|Progressive disease|4|||
161555074|NCT01536145|583422074|FG002|Overall Study|Progressive disease|1|||
161555075|NCT01536145|583422075|FG003|Overall Study|Progressive disease|2|||
161555076|NCT01536145|583422076|FG004|Overall Study|Progressive disease|1|||
161555077|NCT01536145|583422077|FG005|Overall Study|Progressive disease|2|||
161555078|NCT01536145|583422078|FG006|Overall Study|Progressive disease|1|||
161555079|NCT01536145|583422079|FG007|Overall Study|Progressive disease|2|||
161555080|NCT01536145|583422080|FG008|Overall Study|Progressive disease|1|||
161555081|NCT01536145|583422081|FG009|Overall Study|Progressive disease|3|||
161555082|NCT01536145|583422082|FG010|Overall Study|Progressive disease|3|||
161555083|NCT01536145|583422072|FG000|Overall Study|Withdrawal by Subject|0|||
161555084|NCT01536145|583422073|FG001|Overall Study|Withdrawal by Subject|0|||
161555085|NCT01536145|583422074|FG002|Overall Study|Withdrawal by Subject|1|||
161555086|NCT01536145|583422075|FG003|Overall Study|Withdrawal by Subject|0|||
161555087|NCT01536145|583422076|FG004|Overall Study|Withdrawal by Subject|0|||
161555088|NCT01536145|583422077|FG005|Overall Study|Withdrawal by Subject|1|||
161555089|NCT01536145|583422078|FG006|Overall Study|Withdrawal by Subject|0|||
161555090|NCT01536145|583422079|FG007|Overall Study|Withdrawal by Subject|0|||
161555091|NCT01536145|583422080|FG008|Overall Study|Withdrawal by Subject|2|||
161555092|NCT01536145|583422081|FG009|Overall Study|Withdrawal by Subject|0|||
161555093|NCT01536145|583422082|FG010|Overall Study|Withdrawal by Subject|2|||
161555094|NCT01536145|583422072|FG000|Overall Study|Other|0|||
161555095|NCT01536145|583422073|FG001|Overall Study|Other|0|||
161555096|NCT01536145|583422074|FG002|Overall Study|Other|0|||
161555097|NCT01536145|583422075|FG003|Overall Study|Other|0|||
161555098|NCT01536145|583422076|FG004|Overall Study|Other|1|||
161555099|NCT01536145|583422077|FG005|Overall Study|Other|0|||
161555100|NCT01536145|583422078|FG006|Overall Study|Other|0|||
161555101|NCT01536145|583422079|FG007|Overall Study|Other|0|||
161555102|NCT01536145|583422080|FG008|Overall Study|Other|0|||
161555103|NCT01536145|583422081|FG009|Overall Study|Other|3|||
161555104|NCT01536145|583422082|FG010|Overall Study|Other|2|||
161555105|NCT01536145|583422072|FG000|Overall Study|Death|0|||
161555106|NCT01536145|583422073|FG001|Overall Study|Death|0|||
161555107|NCT01536145|583422074|FG002|Overall Study|Death|0|||
161555108|NCT01536145|583422075|FG003|Overall Study|Death|0|||
161555109|NCT01536145|583422076|FG004|Overall Study|Death|0|||
161555110|NCT01536145|583422077|FG005|Overall Study|Death|0|||
161555111|NCT01536145|583422078|FG006|Overall Study|Death|1|||
161555112|NCT01536145|583422079|FG007|Overall Study|Death|0|||
161555113|NCT01536145|583422080|FG008|Overall Study|Death|0|||
161555114|NCT01536145|583422081|FG009|Overall Study|Death|0|||
161555115|NCT01536145|583422082|FG010|Overall Study|Death|0|||
161555116|NCT01536145|583422072|FG000|Overall Study|Adverse Event|0|||
161555117|NCT01536145|583422073|FG001|Overall Study|Adverse Event|0|||
161555118|NCT01536145|583422074|FG002|Overall Study|Adverse Event|0|||
161555119|NCT01536145|583422075|FG003|Overall Study|Adverse Event|0|||
161555120|NCT01536145|583422076|FG004|Overall Study|Adverse Event|0|||
161555121|NCT01536145|583422077|FG005|Overall Study|Adverse Event|0|||
161555122|NCT01536145|583422078|FG006|Overall Study|Adverse Event|0|||
161555123|NCT01536145|583422079|FG007|Overall Study|Adverse Event|2|||
161555124|NCT01536145|583422080|FG008|Overall Study|Adverse Event|0|||
161555125|NCT01536145|583422081|FG009|Overall Study|Adverse Event|0|||
161555126|NCT01536145|583422082|FG010|Overall Study|Adverse Event|3|||
161555127|NCT00088205|583422085|FG000|Overall Study|Adverse Event|4|||
161555128|NCT00088205|583422085|FG000|Overall Study|Progressive Disease|51|||
161555129|NCT00088205|583422085|FG000|Overall Study|Physician Decision|1|||
161555130|NCT00088205|583422085|FG000|Overall Study|Death Due to Study Disease|4|||
161555131|NCT05199233|583422086|FG000|Overall Study|Lack of Efficacy|1|||
161555132|NCT00688259|583422089|FG000|Overall Study|Lost to Follow-up|2|||
161555133|NCT00688259|583422090|FG001|Overall Study|Lost to Follow-up|4|||
161555134|NCT00688259|583422089|FG000|Overall Study|Physician Decision|1|||
161555135|NCT00688259|583422090|FG001|Overall Study|Physician Decision|0|||
161555136|NCT00688259|583422089|FG000|Overall Study|Withdrawal by Subject|2|||
161555137|NCT00688259|583422090|FG001|Overall Study|Withdrawal by Subject|0|||
161555138|NCT00688259|583422089|FG000|Overall Study|Declined Interview|2|||
161555139|NCT00688259|583422090|FG001|Overall Study|Declined Interview|3|||
161555140|NCT00688259|583422089|FG000|Overall Study|Hospitalized at Follow-up|0|||
161555141|NCT00688259|583422090|FG001|Overall Study|Hospitalized at Follow-up|1|||
161555142|NCT02491892|583422093|FG000|Overall Study|Adverse Event|1|||
161555143|NCT02491892|583422094|FG001|Overall Study|Adverse Event|1|||
161555144|NCT02491892|583422093|FG000|Overall Study|Death|1|||
161555145|NCT02491892|583422094|FG001|Overall Study|Death|1|||
161555146|NCT02491892|583422093|FG000|Overall Study|Lack of Efficacy|37|||
161555147|NCT02491892|583422094|FG001|Overall Study|Lack of Efficacy|36|||
161555148|NCT02491892|583422093|FG000|Overall Study|Refused Treatment|1|||
161555149|NCT02491892|583422094|FG001|Overall Study|Refused Treatment|0|||
161555150|NCT02491892|583422093|FG000|Overall Study|Lost to Follow-up|1|||
161555151|NCT02491892|583422094|FG001|Overall Study|Lost to Follow-up|0|||
161555152|NCT02982720|583422095|FG000|Overall Study|Adverse Event|3|||
161555153|NCT02982720|583422095|FG000|Overall Study|Death|1|||
161555154|NCT01734850|583422100|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
161555155|NCT01734850|583422101|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
161555156|NCT01734850|583422102|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
161555157|NCT01734850|583422100|FG000|Overall Study|Not infused due to manufacturing failure|0|||
161555158|NCT01734850|583422101|FG001|Overall Study|Not infused due to manufacturing failure|0|||
161555159|NCT01734850|583422102|FG002|Overall Study|Not infused due to manufacturing failure|1|||
161555160|NCT03824938|583422103|FG000|Overall Study|Withdrawal by Subject|2|||
161555161|NCT03824938|583422104|FG001|Overall Study|Withdrawal by Subject|1|||
161555162|NCT03824938|583422105|FG002|Overall Study|Withdrawal by Subject|0|||
161555163|NCT03824938|583422106|FG003|Overall Study|Withdrawal by Subject|2|||
161555164|NCT03824938|583422107|FG004|Overall Study|Withdrawal by Subject|0|||
161555165|NCT03824938|583422108|FG005|Overall Study|Withdrawal by Subject|1|||
161555166|NCT03824938|583422103|FG000|Overall Study|Lost to Follow-up|0|||
161555167|NCT03824938|583422104|FG001|Overall Study|Lost to Follow-up|1|||
161555168|NCT03824938|583422105|FG002|Overall Study|Lost to Follow-up|0|||
161555169|NCT03824938|583422106|FG003|Overall Study|Lost to Follow-up|0|||
161555170|NCT03824938|583422107|FG004|Overall Study|Lost to Follow-up|1|||
161555171|NCT03824938|583422108|FG005|Overall Study|Lost to Follow-up|0|||
161555172|NCT00287469|583422109|FG000|Overall Study|serious adverse event|1|||
161555173|NCT00287469|583422110|FG001|Overall Study|serious adverse event|6|||
161796301|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
161796302|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796303|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796304|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796305|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796306|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
161796307|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796308|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796309|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796310|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796311|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796312|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796313|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796314|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796315|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796316|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796317|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796318|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
161450078|NCT00730028|583043609|FG003|Overall Study|Physician Decision|3|||
161796319|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
161796320|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796321|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796322|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
161796323|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
161796324|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796325|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796326|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796327|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796328|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796329|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796330|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796331|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161450079|NCT00730028|583043610|FG004|Overall Study|Physician Decision|2|||
161450080|NCT00730028|583043606|FG000|Overall Study|Treatment Failure|5|||
161450081|NCT00730028|583043607|FG001|Overall Study|Treatment Failure|5|||
161450082|NCT00730028|583043608|FG002|Overall Study|Treatment Failure|0|||
161450083|NCT00730028|583043609|FG003|Overall Study|Treatment Failure|0|||
161450084|NCT00730028|583043610|FG004|Overall Study|Treatment Failure|1|||
161450085|NCT00730028|583043606|FG000|Overall Study|Randomization Error|1|||
161450086|NCT00730028|583043607|FG001|Overall Study|Randomization Error|0|||
161450087|NCT00730028|583043608|FG002|Overall Study|Randomization Error|0|||
161450088|NCT00730028|583043609|FG003|Overall Study|Randomization Error|0|||
161450089|NCT00730028|583043610|FG004|Overall Study|Randomization Error|2|||
161450090|NCT00615901|583043611|FG000|Overall Study|Withdrawal by Subject|2|||
161450091|NCT00615901|583043611|FG000|Overall Study|Adverse Event|7|||
161450092|NCT01250496|583043612|FG000|Overall Study|Study terminated|124|||
161450093|NCT01250496|583043613|FG001|Overall Study|Study terminated|124|||
161450094|NCT01425463|583043619|FG000|Overall Study|Adverse Event|5|||
161450095|NCT01425463|583043620|FG001|Overall Study|Adverse Event|7|||
161450096|NCT01425463|583043619|FG000|Overall Study|Lack of Efficacy|1|||
161450097|NCT01425463|583043620|FG001|Overall Study|Lack of Efficacy|1|||
161450098|NCT01425463|583043619|FG000|Overall Study|Protocol Violation|2|||
161450099|NCT01425463|583043620|FG001|Overall Study|Protocol Violation|2|||
161450100|NCT01425463|583043619|FG000|Overall Study|Lost to Follow-up|5|||
161450101|NCT01425463|583043620|FG001|Overall Study|Lost to Follow-up|2|||
161450102|NCT01425463|583043619|FG000|Overall Study|Withdrawal by Subject|7|||
161450103|NCT01425463|583043620|FG001|Overall Study|Withdrawal by Subject|5|||
161450104|NCT01425463|583043619|FG000|Overall Study|Unknown Reason|4|||
161450105|NCT01425463|583043620|FG001|Overall Study|Unknown Reason|7|||
161450106|NCT01332799|583043621|FG000|Overall Study|Insufficient funding|10|||
161450107|NCT01332799|583043622|FG001|Overall Study|Insufficient funding|10|||
161450108|NCT03467152|583043623|FG000|Overall Study|Adverse Event|4|||
161450109|NCT03467152|583043624|FG001|Overall Study|Adverse Event|5|||
161450110|NCT03467152|583043625|FG002|Overall Study|Adverse Event|0|||
161450111|NCT03467152|583043623|FG000|Overall Study|Subject Choice|1|||
161450112|NCT03467152|583043624|FG001|Overall Study|Subject Choice|3|||
161450113|NCT03467152|583043625|FG002|Overall Study|Subject Choice|0|||
161450114|NCT03467152|583043623|FG000|Overall Study|Lost to Follow-up|1|||
161450115|NCT03467152|583043624|FG001|Overall Study|Lost to Follow-up|0|||
161450116|NCT03467152|583043625|FG002|Overall Study|Lost to Follow-up|0|||
161450117|NCT03467152|583043623|FG000|Overall Study|Withdrawal by Subject|4|||
161450118|NCT03467152|583043624|FG001|Overall Study|Withdrawal by Subject|2|||
161555174|NCT00287469|583422109|FG000|Overall Study|Adverse Event|1|||
161555175|NCT00287469|583422110|FG001|Overall Study|Adverse Event|1|||
161555176|NCT00287469|583422109|FG000|Overall Study|moved from area|144|||
161555177|NCT00287469|583422110|FG001|Overall Study|moved from area|138|||
161555178|NCT00287469|583422109|FG000|Overall Study|Lost to Follow-up|74|||
161555179|NCT00287469|583422110|FG001|Overall Study|Lost to Follow-up|69|||
161555180|NCT01058863|583422111|FG000|Overall Study|Lost to Follow-up|1|||
161555181|NCT01058863|583422111|FG000|Overall Study|Withdrawal by Subject|1|||
161555182|NCT01058863|583422111|FG000|Overall Study|Sponsor requested withdrawal|1|||
161555183|NCT01058863|583422111|FG000|Overall Study|Randomized in error|1|||
161555184|NCT03653416|583422112|FG000|Overall Study|Protocol Violation|6|||
161555185|NCT03653416|583422113|FG001|Overall Study|Protocol Violation|1|||
161555186|NCT03619174|583422114|FG000|Overall Study|Lost to Follow-up|3|||
161555187|NCT03619174|583422115|FG001|Overall Study|Lost to Follow-up|0|||
161555188|NCT03619174|583422114|FG000|Overall Study|Withdrawal by Subject|4|||
161555189|NCT03619174|583422115|FG001|Overall Study|Withdrawal by Subject|3|||
161555190|NCT03619174|583422114|FG000|Overall Study|Pregnancy|1|||
161555191|NCT03619174|583422115|FG001|Overall Study|Pregnancy|1|||
161555192|NCT03619174|583422114|FG000|Overall Study|Discomfort during treatment|1|||
161555193|NCT03619174|583422115|FG001|Overall Study|Discomfort during treatment|0|||
161555194|NCT02448719|583422121|FG000|Overall Study|Withdrawal by Subject|0|||
161555195|NCT02448719|583422122|FG001|Overall Study|Withdrawal by Subject|0|||
161555196|NCT02448719|583422123|FG002|Overall Study|Withdrawal by Subject|0|||
161555197|NCT02448719|583422124|FG003|Overall Study|Withdrawal by Subject|0|||
161555198|NCT02448719|583422125|FG004|Overall Study|Withdrawal by Subject|1|||
161555199|NCT02448719|583422126|FG005|Overall Study|Withdrawal by Subject|0|||
161555200|NCT02448719|583422127|FG006|Overall Study|Withdrawal by Subject|0|||
161555201|NCT02448719|583422128|FG007|Overall Study|Withdrawal by Subject|0|||
161555202|NCT02448719|583422129|FG008|Overall Study|Withdrawal by Subject|0|||
161555203|NCT02448719|583422130|FG009|Overall Study|Withdrawal by Subject|0|||
161555204|NCT02448719|583422131|FG010|Overall Study|Withdrawal by Subject|0|||
161555205|NCT01556763|583422135|FG000|Overall Study|Withdrawal by Subject|0|||
161555206|NCT01556763|583422136|FG001|Overall Study|Withdrawal by Subject|1|||
161555207|NCT01556763|583422137|FG002|Overall Study|Withdrawal by Subject|0|||
161555208|NCT02258464|583422138|FG000|Overall Study|Progressive disease (PD)|9|||
161555209|NCT02258464|583422139|FG001|Overall Study|Progressive disease (PD)|17|||
161555210|NCT02258464|583422138|FG000|Overall Study|Study drug never administered|1|||
161555211|NCT02258464|583422139|FG001|Overall Study|Study drug never administered|1|||
161555212|NCT02258464|583422138|FG000|Overall Study|AE not related to clinical PD|1|||
161555213|NCT02258464|583422139|FG001|Overall Study|AE not related to clinical PD|3|||
161555214|NCT02258464|583422138|FG000|Overall Study|Withdrawal by Subject|5|||
161555215|NCT02258464|583422139|FG001|Overall Study|Withdrawal by Subject|4|||
161555216|NCT02258464|583422138|FG000|Overall Study|AE related to clinical PD|1|||
161555217|NCT02258464|583422139|FG001|Overall Study|AE related to clinical PD|0|||
161555218|NCT00932646|583422140|FG000|Overall Study|Adverse Event|2|||
161555219|NCT00932646|583422141|FG001|Overall Study|Adverse Event|1|||
161555220|NCT00932646|583422142|FG002|Overall Study|Adverse Event|1|||
161555221|NCT00932646|583422143|FG003|Overall Study|Adverse Event|1|||
161555222|NCT00932646|583422140|FG000|Overall Study|Lost to Follow-up|2|||
161555223|NCT00932646|583422141|FG001|Overall Study|Lost to Follow-up|1|||
161555224|NCT00932646|583422142|FG002|Overall Study|Lost to Follow-up|0|||
161555225|NCT00932646|583422143|FG003|Overall Study|Lost to Follow-up|0|||
161555226|NCT00932646|583422140|FG000|Overall Study|Withdrawal by Subject|1|||
161555227|NCT00932646|583422141|FG001|Overall Study|Withdrawal by Subject|1|||
161555228|NCT00932646|583422142|FG002|Overall Study|Withdrawal by Subject|3|||
161555229|NCT00932646|583422143|FG003|Overall Study|Withdrawal by Subject|0|||
161555230|NCT00653263|583422144|FG000|Overall Study|Withdrawal by Subject|1|||
161555231|NCT00653263|583422144|FG000|Overall Study|Physician Decision|1|||
161555232|NCT00776100|583422145|FG000|Overall Study|Disease Progression|1|||
161555233|NCT00776100|583422146|FG001|Overall Study|Disease Progression|0|||
161555234|NCT04759885|583422153|FG000|Overall Study|Other|1|||
161555235|NCT04759885|583422154|FG001|Overall Study|Other|0|||
161555236|NCT04759885|583422155|FG002|Overall Study|Other|2|||
161555237|NCT04759885|583422156|FG003|Overall Study|Other|0|||
161555238|NCT04759885|583422157|FG004|Overall Study|Other|0|||
161555239|NCT04759885|583422153|FG000|Overall Study|Withdrawal by Subject|0|||
161555240|NCT04759885|583422154|FG001|Overall Study|Withdrawal by Subject|0|||
161555241|NCT04759885|583422155|FG002|Overall Study|Withdrawal by Subject|1|||
161555242|NCT04759885|583422156|FG003|Overall Study|Withdrawal by Subject|9|||
161555243|NCT04759885|583422157|FG004|Overall Study|Withdrawal by Subject|6|||
161555244|NCT04759885|583422153|FG000|Overall Study|Adverse Event|0|||
161555245|NCT04759885|583422154|FG001|Overall Study|Adverse Event|0|||
161555246|NCT04759885|583422155|FG002|Overall Study|Adverse Event|0|||
161555247|NCT04759885|583422156|FG003|Overall Study|Adverse Event|3|||
161555248|NCT04759885|583422157|FG004|Overall Study|Adverse Event|0|||
161555249|NCT04759885|583422153|FG000|Overall Study|Physician Decision|0|||
161555250|NCT04759885|583422154|FG001|Overall Study|Physician Decision|0|||
161555251|NCT04759885|583422155|FG002|Overall Study|Physician Decision|0|||
161555252|NCT04759885|583422156|FG003|Overall Study|Physician Decision|2|||
161555253|NCT04759885|583422157|FG004|Overall Study|Physician Decision|0|||
161555254|NCT00195715|583422158|FG000|Overall Study|Adverse Event|122|||
161555255|NCT00195715|583422158|FG000|Overall Study|Withdrawal by Subject|58|||
161555256|NCT00195715|583422158|FG000|Overall Study|Lost to Follow-up|27|||
161555257|NCT00195715|583422158|FG000|Overall Study|Protocol Violation|13|||
161555258|NCT00195715|583422158|FG000|Overall Study|Lack of Efficacy|93|||
161555259|NCT00195715|583422158|FG000|Overall Study|Pregnancy|14|||
161555260|NCT00195715|583422158|FG000|Overall Study|Investigative site closure|8|||
161555261|NCT00195715|583422158|FG000|Overall Study|Subject moved/relocated|7|||
161555262|NCT00195715|583422158|FG000|Overall Study|Subject non-compliance|6|||
161555263|NCT00195715|583422158|FG000|Overall Study|Subject started commercial Humira|5|||
161555264|NCT00195715|583422158|FG000|Overall Study|Subject choice|3|||
161555265|NCT00195715|583422158|FG000|Overall Study|Loss of response/no improvement|3|||
161555266|NCT00195715|583422158|FG000|Overall Study|Sponsor stopped study|1|||
161555267|NCT00195715|583422158|FG000|Overall Study|Administrative reasons|2|||
161555268|NCT00195715|583422158|FG000|Overall Study|Investigator's decision|2|||
161555269|NCT00195715|583422158|FG000|Overall Study|Subject wants to get pregnant|4|||
161555270|NCT00195715|583422158|FG000|Overall Study|Use of prohibited medication|2|||
161555271|NCT00195715|583422158|FG000|Overall Study|Planned surgery|2|||
161555272|NCT00195715|583422158|FG000|Overall Study|Increased infection rate|1|||
161555273|NCT00195715|583422158|FG000|Overall Study|Ineligible|1|||
161555274|NCT00195715|583422158|FG000|Overall Study|Colonic stricture|1|||
161555275|NCT00195715|583422158|FG000|Overall Study|Sponsor discontinued trial|1|||
161555276|NCT00195715|583422158|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
161555277|NCT05822921|583422163|FG000|Overall Study|Lost to Follow-up|1|||
161555278|NCT05822921|583422164|FG001|Overall Study|Lost to Follow-up|1|||
161555279|NCT01267253|583422167|FG000|Overall Study|Ineligible - required test not done|1|||
161555280|NCT01267253|583422167|FG000|Overall Study|Inevaluable-never received study treatme|2|||
161555281|NCT00996580|583422168|FG000|Overall Study|Adverse Event|466|||
161555282|NCT00996580|583422168|FG000|Overall Study|Lost to Follow-up|480|||
161555283|NCT00996580|583422168|FG000|Overall Study|Noncompliance with the protocol|137|||
161555284|NCT00996580|583422168|FG000|Overall Study|Physician Decision|5|||
161555285|NCT00996580|583422168|FG000|Overall Study|Pregnancy|68|||
161555286|NCT00996580|583422168|FG000|Overall Study|Protocol Violation|16|||
161555287|NCT00996580|583422168|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
161555288|NCT00996580|583422168|FG000|Overall Study|Withdrawal by Subject|217|||
161555289|NCT00996580|583422168|FG000|Overall Study|Other|29|||
161555290|NCT02036515|583422169|FG000|Overall Study|Adverse Event|1|||
161555291|NCT02036515|583422170|FG001|Overall Study|Adverse Event|1|||
161555292|NCT02036515|583422171|FG002|Overall Study|Adverse Event|2|||
161555293|NCT02036515|583422169|FG000|Overall Study|Lost to Follow-up|0|||
161900791|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
161900792|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161900793|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900794|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900795|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900796|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900797|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900798|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900799|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900800|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900801|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900802|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900803|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900804|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900805|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161900806|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
161900807|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900808|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900809|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161555294|NCT02036515|583422170|FG001|Overall Study|Lost to Follow-up|2|||
161555295|NCT02036515|583422171|FG002|Overall Study|Lost to Follow-up|0|||
161900810|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161555296|NCT02036515|583422169|FG000|Overall Study|Non-compliance with study drug|0|||
161555297|NCT02036515|583422170|FG001|Overall Study|Non-compliance with study drug|0|||
161555298|NCT02036515|583422171|FG002|Overall Study|Non-compliance with study drug|2|||
161555299|NCT02036515|583422169|FG000|Overall Study|Screen failure|0|||
161555300|NCT02036515|583422170|FG001|Overall Study|Screen failure|2|||
161555301|NCT02036515|583422171|FG002|Overall Study|Screen failure|0|||
161555302|NCT02036515|583422169|FG000|Overall Study|Withdrawal by Subject|4|||
161555303|NCT02036515|583422170|FG001|Overall Study|Withdrawal by Subject|7|||
161900811|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161555304|NCT02036515|583422171|FG002|Overall Study|Withdrawal by Subject|9|||
161555305|NCT02036515|583422169|FG000|Overall Study|Hyperglycemia|0|||
161555306|NCT02036515|583422170|FG001|Overall Study|Hyperglycemia|0|||
161555307|NCT02036515|583422171|FG002|Overall Study|Hyperglycemia|1|||
161555308|NCT02218489|583422178|FG000|Overall Study|Withdrawal by Subject|4|||
161555309|NCT02218489|583422179|FG001|Overall Study|Withdrawal by Subject|3|||
161555310|NCT02218489|583422178|FG000|Overall Study|Lost to Follow-up|1|||
161555311|NCT02218489|583422179|FG001|Overall Study|Lost to Follow-up|0|||
161555312|NCT04039503|583422180|FG000|Overall Study|Adverse Event|3|||
161555313|NCT04039503|583422181|FG001|Overall Study|Adverse Event|0|||
161555314|NCT04039503|583422182|FG002|Overall Study|Adverse Event|2|||
161555315|NCT04039503|583422183|FG003|Overall Study|Adverse Event|0|||
161555316|NCT04039503|583422180|FG000|Overall Study|Lost to Follow-up|0|||
161555317|NCT04039503|583422181|FG001|Overall Study|Lost to Follow-up|0|||
161555318|NCT04039503|583422182|FG002|Overall Study|Lost to Follow-up|1|||
161555319|NCT04039503|583422183|FG003|Overall Study|Lost to Follow-up|0|||
161555320|NCT04039503|583422180|FG000|Overall Study|Protocol Violation|0|||
161555321|NCT04039503|583422181|FG001|Overall Study|Protocol Violation|1|||
161555322|NCT04039503|583422182|FG002|Overall Study|Protocol Violation|2|||
161555323|NCT04039503|583422183|FG003|Overall Study|Protocol Violation|1|||
161555324|NCT04039503|583422180|FG000|Overall Study|Withdrawal by Subject|4|||
161555325|NCT04039503|583422181|FG001|Overall Study|Withdrawal by Subject|3|||
161555326|NCT04039503|583422182|FG002|Overall Study|Withdrawal by Subject|5|||
161555327|NCT04039503|583422183|FG003|Overall Study|Withdrawal by Subject|2|||
161555328|NCT02601937|583422190|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555329|NCT02601937|583422191|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555330|NCT02601937|583422192|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555331|NCT02601937|583422193|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555332|NCT02601937|583422194|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555333|NCT02601937|583422195|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
161555334|NCT02601937|583422196|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555335|NCT02601937|583422197|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555336|NCT02601937|583422198|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555337|NCT02601937|583422199|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555338|NCT02601937|583422200|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
161555339|NCT02601937|583422190|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
161555340|NCT02601937|583422191|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555341|NCT02601937|583422192|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555342|NCT02601937|583422193|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555343|NCT02601937|583422194|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555344|NCT02601937|583422195|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555345|NCT02601937|583422196|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
161555346|NCT02601937|583422197|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555347|NCT02601937|583422198|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555348|NCT02601937|583422199|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555349|NCT02601937|583422200|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
161555350|NCT02601937|583422190|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555351|NCT02601937|583422191|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555352|NCT02601937|583422192|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
161555353|NCT02601937|583422193|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555354|NCT02601937|583422194|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555355|NCT02601937|583422195|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555356|NCT02601937|583422196|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555357|NCT02601937|583422197|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555358|NCT02601937|583422198|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555359|NCT02601937|583422199|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161555360|NCT02601937|583422200|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161796332|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796333|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796334|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796335|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796336|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
161796337|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
161796338|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161555361|NCT02601937|583422190|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
161796339|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796340|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796341|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161450119|NCT03467152|583043625|FG002|Overall Study|Withdrawal by Subject|0|||
161450120|NCT03467152|583043623|FG000|Overall Study|Others|3|||
161450121|NCT03467152|583043624|FG001|Overall Study|Others|0|||
161450122|NCT03467152|583043625|FG002|Overall Study|Others|0|||
161450123|NCT03467152|583043623|FG000|Overall Study|Not treated|3|||
161450124|NCT03467152|583043624|FG001|Overall Study|Not treated|1|||
161450125|NCT03467152|583043625|FG002|Overall Study|Not treated|6|||
161450126|NCT00945906|583043626|FG000|Overall Study|Withdrawal by Subject|1|||
161450127|NCT00945906|583043626|FG000|Overall Study|Did not want to return for last visit|2|||
161450128|NCT00945906|583043626|FG000|Overall Study|Unable to return for last visit|2|||
161450129|NCT00945906|583043626|FG000|Overall Study|Moved to another country|2|||
161450130|NCT01236547|583043628|FG000|Overall Study|Protocol Violation|0|||
161450131|NCT01236547|583043629|FG001|Overall Study|Protocol Violation|1|||
161450132|NCT01236547|583043630|FG002|Overall Study|Protocol Violation|1|||
161450133|NCT01236547|583043631|FG003|Overall Study|Protocol Violation|6|||
161450134|NCT01236547|583043632|FG004|Overall Study|Protocol Violation|12|||
161450135|NCT04022733|583043633|FG000|Overall Study|conversion to open surgery|3|||
161450136|NCT04022733|583043634|FG001|Overall Study|conversion to open surgery|2|||
161450137|NCT04022733|583043633|FG000|Overall Study|bradycardia|0|||
161450138|NCT04022733|583043634|FG001|Overall Study|bradycardia|1|||
161450139|NCT01541397|583043635|FG000|Overall Study|Study ended prior to data collection|4|||
161450140|NCT01541397|583043636|FG001|Overall Study|Study ended prior to data collection|2|||
161450141|NCT00233454|583043637|FG000|Overall Study|Death|6|||
161450142|NCT04224688|583043638|FG000|Overall Study|Withdrawal by Subject|1|||
161450143|NCT04224688|583043639|FG001|Overall Study|Withdrawal by Subject|3|||
161450144|NCT04224688|583043638|FG000|Overall Study|Lack of Efficacy|1|||
161450145|NCT04224688|583043639|FG001|Overall Study|Lack of Efficacy|1|||
161450146|NCT04224688|583043638|FG000|Overall Study|Adverse event, not fatal|0|||
161450147|NCT04224688|583043639|FG001|Overall Study|Adverse event, not fatal|2|||
161450148|NCT04224688|583043638|FG000|Overall Study|COVID-19|0|||
161796342|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796343|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796344|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796345|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796346|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796347|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796348|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796349|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796350|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796351|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
161796352|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796353|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796354|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796355|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796356|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796357|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796358|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796359|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796360|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
161796361|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796362|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796363|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796364|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796365|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796366|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796367|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796368|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796369|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796370|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796371|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796372|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796373|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796374|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161450149|NCT04224688|583043639|FG001|Overall Study|COVID-19|1|||
161450150|NCT03083990|583043640|FG000|Overall Study|Adverse Event|1|||
161450151|NCT03083990|583043641|FG001|Overall Study|Adverse Event|0|||
161450152|NCT00006409|583043642|FG000|Baseline|Protocol Violation|48|||
161450153|NCT00006409|583043643|FG001|Baseline|Protocol Violation|70|||
161555362|NCT02601937|583422191|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
161450154|NCT00006409|583043644|FG002|Baseline|Protocol Violation|0|||
161450155|NCT00006409|583043645|FG003|Baseline|Protocol Violation|0|||
161555363|NCT02601937|583422192|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
161555364|NCT02601937|583422193|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
161555365|NCT02601937|583422194|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
161555366|NCT02601937|583422195|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
161555367|NCT02601937|583422196|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
161555368|NCT02601937|583422197|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
161555369|NCT02601937|583422198|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
161555370|NCT02601937|583422199|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
161555371|NCT02601937|583422200|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
161555372|NCT02601937|583422190|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555373|NCT02601937|583422191|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555374|NCT02601937|583422192|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555375|NCT02601937|583422193|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161796375|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796376|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796377|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796378|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
161796379|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
161796380|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796381|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796382|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796383|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796384|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796385|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796386|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796387|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796388|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796389|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796390|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796391|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796392|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
161796393|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796394|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796395|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796396|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796397|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796398|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796399|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796400|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796401|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796402|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796403|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796404|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796405|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796406|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
161796407|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796408|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796409|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796410|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796411|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796412|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796413|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796414|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796415|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796416|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796417|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796418|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796419|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796420|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796421|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161555376|NCT02601937|583422194|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555377|NCT02601937|583422195|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555378|NCT02601937|583422196|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555379|NCT02601937|583422197|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161450156|NCT00006409|583043646|FG004|Baseline|Protocol Violation|0|||
161450157|NCT00006409|583043647|FG005|Baseline|Protocol Violation|0|||
161450158|NCT00006409|583043642|FG000|Post-2 Year Intervention|Protocol Violation|0|||
161450159|NCT00006409|583043643|FG001|Post-2 Year Intervention|Protocol Violation|0|||
161450160|NCT00006409|583043644|FG002|Post-2 Year Intervention|Protocol Violation|251|||
161450161|NCT00006409|583043645|FG003|Post-2 Year Intervention|Protocol Violation|168|||
161450162|NCT00006409|583043646|FG004|Post-2 Year Intervention|Protocol Violation|0|||
161450163|NCT00006409|583043647|FG005|Post-2 Year Intervention|Protocol Violation|0|||
161450164|NCT00006409|583043642|FG000|Post-3 Year Intervention|Protocol Violation|0|||
161450165|NCT00006409|583043643|FG001|Post-3 Year Intervention|Protocol Violation|0|||
161450166|NCT00006409|583043644|FG002|Post-3 Year Intervention|Protocol Violation|0|||
161450167|NCT00006409|583043645|FG003|Post-3 Year Intervention|Protocol Violation|0|||
161450168|NCT00006409|583043646|FG004|Post-3 Year Intervention|Protocol Violation|62|||
161450169|NCT00006409|583043647|FG005|Post-3 Year Intervention|Protocol Violation|62|||
161450170|NCT02059291|583043648|FG000|Epoch 2|Lack of Efficacy|0|||
161450171|NCT02059291|583043649|FG001|Epoch 2|Lack of Efficacy|0|||
161450172|NCT02059291|583043650|FG002|Epoch 2|Lack of Efficacy|0|||
161450173|NCT02059291|583043651|FG003|Epoch 2|Lack of Efficacy|1|||
161450174|NCT02059291|583043652|FG004|Epoch 2|Lack of Efficacy|0|||
161450175|NCT02059291|583043653|FG005|Epoch 2|Lack of Efficacy|1|||
161450176|NCT02059291|583043654|FG006|Epoch 2|Lack of Efficacy|0|||
161450177|NCT02059291|583043655|FG007|Epoch 2|Lack of Efficacy|0|||
161450178|NCT02059291|583043656|FG008|Epoch 2|Lack of Efficacy|0|||
161450179|NCT02059291|583043657|FG009|Epoch 2|Lack of Efficacy|0|||
161450180|NCT02059291|583043658|FG010|Epoch 2|Lack of Efficacy|0|||
161450181|NCT02059291|583043659|FG011|Epoch 2|Lack of Efficacy|0|||
161450182|NCT02059291|583043660|FG012|Epoch 2|Lack of Efficacy|0|||
161450183|NCT02059291|583043661|FG013|Epoch 2|Lack of Efficacy|0|||
161450184|NCT02059291|583043662|FG014|Epoch 2|Lack of Efficacy|0|||
161450185|NCT02059291|583043663|FG015|Epoch 2|Lack of Efficacy|0|||
161450186|NCT02059291|583043664|FG016|Epoch 2|Lack of Efficacy|0|||
161450187|NCT02059291|583043665|FG017|Epoch 2|Lack of Efficacy|0|||
161450188|NCT02059291|583043666|FG018|Epoch 2|Lack of Efficacy|0|||
161450189|NCT02059291|583043667|FG019|Epoch 2|Lack of Efficacy|0|||
161450190|NCT02059291|583043668|FG020|Epoch 2|Lack of Efficacy|0|||
161450191|NCT02059291|583043669|FG021|Epoch 2|Lack of Efficacy|0|||
161450192|NCT02059291|583043670|FG022|Epoch 2|Lack of Efficacy|0|||
161450193|NCT02059291|583043671|FG023|Epoch 2|Lack of Efficacy|0|||
161450194|NCT02059291|583043672|FG024|Epoch 2|Lack of Efficacy|0|||
161450195|NCT02059291|583043648|FG000|Epoch 2|Adverse Event|0|||
161450196|NCT02059291|583043649|FG001|Epoch 2|Adverse Event|0|||
161450197|NCT02059291|583043650|FG002|Epoch 2|Adverse Event|1|||
161450198|NCT02059291|583043651|FG003|Epoch 2|Adverse Event|1|||
161450199|NCT02059291|583043652|FG004|Epoch 2|Adverse Event|0|||
161450200|NCT02059291|583043653|FG005|Epoch 2|Adverse Event|0|||
161450201|NCT02059291|583043654|FG006|Epoch 2|Adverse Event|0|||
161450202|NCT02059291|583043655|FG007|Epoch 2|Adverse Event|1|||
161450203|NCT02059291|583043656|FG008|Epoch 2|Adverse Event|1|||
161450204|NCT02059291|583043657|FG009|Epoch 2|Adverse Event|0|||
161450205|NCT02059291|583043658|FG010|Epoch 2|Adverse Event|0|||
161450206|NCT02059291|583043659|FG011|Epoch 2|Adverse Event|0|||
161450207|NCT02059291|583043660|FG012|Epoch 2|Adverse Event|0|||
161450208|NCT02059291|583043661|FG013|Epoch 2|Adverse Event|0|||
161450209|NCT02059291|583043662|FG014|Epoch 2|Adverse Event|0|||
161450210|NCT02059291|583043663|FG015|Epoch 2|Adverse Event|0|||
161450211|NCT02059291|583043664|FG016|Epoch 2|Adverse Event|0|||
161450212|NCT02059291|583043665|FG017|Epoch 2|Adverse Event|0|||
161450213|NCT02059291|583043666|FG018|Epoch 2|Adverse Event|0|||
161450214|NCT02059291|583043667|FG019|Epoch 2|Adverse Event|0|||
161450215|NCT02059291|583043668|FG020|Epoch 2|Adverse Event|0|||
161450216|NCT02059291|583043669|FG021|Epoch 2|Adverse Event|0|||
161450217|NCT02059291|583043670|FG022|Epoch 2|Adverse Event|0|||
161450218|NCT02059291|583043671|FG023|Epoch 2|Adverse Event|0|||
161450219|NCT02059291|583043672|FG024|Epoch 2|Adverse Event|0|||
161450220|NCT02059291|583043648|FG000|Epoch 2|Withdrawal by Subject|0|||
161450221|NCT02059291|583043649|FG001|Epoch 2|Withdrawal by Subject|1|||
161450222|NCT02059291|583043650|FG002|Epoch 2|Withdrawal by Subject|0|||
161450223|NCT02059291|583043651|FG003|Epoch 2|Withdrawal by Subject|0|||
161450224|NCT02059291|583043652|FG004|Epoch 2|Withdrawal by Subject|0|||
161450225|NCT02059291|583043653|FG005|Epoch 2|Withdrawal by Subject|1|||
161450226|NCT02059291|583043654|FG006|Epoch 2|Withdrawal by Subject|0|||
161450227|NCT02059291|583043655|FG007|Epoch 2|Withdrawal by Subject|0|||
161450228|NCT02059291|583043656|FG008|Epoch 2|Withdrawal by Subject|1|||
161450229|NCT02059291|583043657|FG009|Epoch 2|Withdrawal by Subject|0|||
161450230|NCT02059291|583043658|FG010|Epoch 2|Withdrawal by Subject|0|||
161450231|NCT02059291|583043659|FG011|Epoch 2|Withdrawal by Subject|0|||
161450232|NCT02059291|583043660|FG012|Epoch 2|Withdrawal by Subject|0|||
161450233|NCT02059291|583043661|FG013|Epoch 2|Withdrawal by Subject|0|||
161450234|NCT02059291|583043662|FG014|Epoch 2|Withdrawal by Subject|0|||
161450235|NCT02059291|583043663|FG015|Epoch 2|Withdrawal by Subject|0|||
161450236|NCT02059291|583043664|FG016|Epoch 2|Withdrawal by Subject|0|||
161450237|NCT02059291|583043665|FG017|Epoch 2|Withdrawal by Subject|0|||
161555380|NCT02601937|583422198|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555381|NCT02601937|583422199|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
161555382|NCT02601937|583422200|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
161555383|NCT02601937|583422190|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555384|NCT02601937|583422191|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555385|NCT02601937|583422192|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555386|NCT02601937|583422193|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555387|NCT02601937|583422194|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555388|NCT02601937|583422195|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555389|NCT02601937|583422196|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555390|NCT02601937|583422197|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
161555391|NCT02601937|583422198|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555392|NCT02601937|583422199|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555393|NCT02601937|583422200|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161555394|NCT02601937|583422190|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555395|NCT02601937|583422191|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555396|NCT02601937|583422192|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555397|NCT02601937|583422193|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555398|NCT02601937|583422194|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555399|NCT02601937|583422195|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555400|NCT02601937|583422196|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555401|NCT02601937|583422197|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555402|NCT02601937|583422198|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161555403|NCT02601937|583422199|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
161555404|NCT02601937|583422200|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
161555405|NCT02601937|583422190|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555406|NCT02601937|583422191|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555407|NCT02601937|583422192|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555408|NCT02601937|583422193|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555409|NCT02601937|583422194|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555410|NCT02601937|583422195|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555411|NCT02601937|583422196|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
161555412|NCT02601937|583422197|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
161555413|NCT02601937|583422198|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
161555414|NCT02601937|583422199|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
161555415|NCT02601937|583422200|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
161555416|NCT02601937|583422190|FG000|Period 2: Dose Expansion Cohort|Other|0|||
161555417|NCT02601937|583422191|FG001|Period 2: Dose Expansion Cohort|Other|0|||
161555418|NCT02601937|583422192|FG002|Period 2: Dose Expansion Cohort|Other|0|||
161555419|NCT02601937|583422193|FG003|Period 2: Dose Expansion Cohort|Other|0|||
161555420|NCT02601937|583422194|FG004|Period 2: Dose Expansion Cohort|Other|0|||
161555421|NCT02601937|583422195|FG005|Period 2: Dose Expansion Cohort|Other|0|||
161555422|NCT02601937|583422196|FG006|Period 2: Dose Expansion Cohort|Other|0|||
161555423|NCT02601937|583422197|FG007|Period 2: Dose Expansion Cohort|Other|0|||
161555424|NCT02601937|583422198|FG008|Period 2: Dose Expansion Cohort|Other|2|||
161555425|NCT02601937|583422199|FG009|Period 2: Dose Expansion Cohort|Other|2|||
161555426|NCT02601937|583422200|FG010|Period 2: Dose Expansion Cohort|Other|0|||
161555427|NCT02601937|583422190|FG000|Period 2: Dose Expansion Cohort|Death|0|||
161555428|NCT02601937|583422191|FG001|Period 2: Dose Expansion Cohort|Death|0|||
161555429|NCT02601937|583422192|FG002|Period 2: Dose Expansion Cohort|Death|0|||
161555430|NCT02601937|583422193|FG003|Period 2: Dose Expansion Cohort|Death|0|||
161555431|NCT02601937|583422194|FG004|Period 2: Dose Expansion Cohort|Death|0|||
161555432|NCT02601937|583422195|FG005|Period 2: Dose Expansion Cohort|Death|0|||
161555433|NCT02601937|583422196|FG006|Period 2: Dose Expansion Cohort|Death|0|||
161555434|NCT02601937|583422197|FG007|Period 2: Dose Expansion Cohort|Death|0|||
161555435|NCT02601937|583422198|FG008|Period 2: Dose Expansion Cohort|Death|1|||
161555436|NCT02601937|583422199|FG009|Period 2: Dose Expansion Cohort|Death|0|||
161555437|NCT02601937|583422200|FG010|Period 2: Dose Expansion Cohort|Death|0|||
161555438|NCT02924389|583422202|FG000|Overall Study|Lost to Follow-up|1|||
161900812|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900813|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161555439|NCT02924389|583422203|FG001|Overall Study|Lost to Follow-up|0|||
161555440|NCT02924389|583422202|FG000|Overall Study|Physician Decision|2|||
161555441|NCT02924389|583422203|FG001|Overall Study|Physician Decision|0|||
161555442|NCT02924389|583422202|FG000|Overall Study|Withdrawal by Subject|3|||
161555443|NCT02924389|583422203|FG001|Overall Study|Withdrawal by Subject|0|||
161900814|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161555444|NCT02924389|583422202|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
161555445|NCT02924389|583422203|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
161555446|NCT03038672|583423416|FG000|Initial Treatment|Unacceptable chemistry|0|||
161555447|NCT03038672|583423417|FG001|Initial Treatment|Unacceptable chemistry|1|||
161555448|NCT03038672|583423416|FG000|Initial Treatment|Progression prior to treatment|1|||
161555449|NCT03038672|583423417|FG001|Initial Treatment|Progression prior to treatment|0|||
161555450|NCT03038672|583423416|FG000|Initial Treatment|No treatment per protocol|1|||
161555451|NCT03038672|583423417|FG001|Initial Treatment|No treatment per protocol|0|||
161555452|NCT05220501|583423418|FG000|Overall Study|Withdrawal by Subject|11|||
161555453|NCT05220501|583423419|FG001|Overall Study|Withdrawal by Subject|21|||
161555454|NCT05220501|583423420|FG002|Overall Study|Withdrawal by Subject|32|||
161555455|NCT05220501|583423418|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
161555456|NCT05220501|583423419|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
161555457|NCT05220501|583423420|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
161555458|NCT02692235|583423421|FG000|Overall Study|Withdrawal by Subject|2|||
161555459|NCT02692235|583423422|FG001|Overall Study|Withdrawal by Subject|1|||
161555460|NCT02692235|583423421|FG000|Overall Study|Adverse Event|1|||
161555461|NCT02692235|583423422|FG001|Overall Study|Adverse Event|2|||
161555462|NCT00802841|583423423|FG000|Overall Study|Administrative problems|1|||
161555463|NCT00802841|583423424|FG001|Overall Study|Administrative problems|0|||
161555464|NCT00802841|583423423|FG000|Overall Study|Lost to Follow-up|2|||
161555465|NCT00802841|583423424|FG001|Overall Study|Lost to Follow-up|1|||
161555466|NCT00802841|583423423|FG000|Overall Study|Death|1|||
161555467|NCT00802841|583423424|FG001|Overall Study|Death|2|||
161555468|NCT00802841|583423423|FG000|Overall Study|Adverse Event|8|||
161555469|NCT00802841|583423424|FG001|Overall Study|Adverse Event|2|||
161555470|NCT00802841|583423423|FG000|Overall Study|Disease progression|7|||
161555471|NCT00802841|583423424|FG001|Overall Study|Disease progression|3|||
161555472|NCT00802841|583423423|FG000|Overall Study|Withdrawal by Subject|9|||
161555473|NCT00802841|583423424|FG001|Overall Study|Withdrawal by Subject|5|||
161555474|NCT00802841|583423423|FG000|Overall Study|Protocol deviation|2|||
161555475|NCT00802841|583423424|FG001|Overall Study|Protocol deviation|6|||
161555476|NCT00802841|583423423|FG000|Overall Study|Treatment duration completed|66|||
161555477|NCT00802841|583423424|FG001|Overall Study|Treatment duration completed|76|||
161555478|NCT01929993|583423426|FG000|Overall Study|Protocol Violation|4|||
161555479|NCT01929993|583423427|FG001|Overall Study|Protocol Violation|6|||
161555480|NCT01929993|583423426|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
161555481|NCT01929993|583423427|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
161555482|NCT01268059|583423428|FG000|Overall Study|Lost to Follow-up|0|||
161555483|NCT01268059|583423429|FG001|Overall Study|Lost to Follow-up|1|||
161555484|NCT01268059|583423430|FG002|Overall Study|Lost to Follow-up|0|||
161555485|NCT01268059|583423431|FG003|Overall Study|Lost to Follow-up|0|||
161555486|NCT01268059|583423428|FG000|Overall Study|Withdrawal by Subject|7|||
161555487|NCT01268059|583423429|FG001|Overall Study|Withdrawal by Subject|4|||
161555488|NCT01268059|583423430|FG002|Overall Study|Withdrawal by Subject|0|||
161555489|NCT01268059|583423431|FG003|Overall Study|Withdrawal by Subject|0|||
161555490|NCT01268059|583423428|FG000|Overall Study|Death|20|||
161555491|NCT01268059|583423429|FG001|Overall Study|Death|30|||
161555492|NCT01268059|583423430|FG002|Overall Study|Death|3|||
161555493|NCT01268059|583423431|FG003|Overall Study|Death|5|||
161555494|NCT01268059|583423428|FG000|Overall Study|Progression of disease|1|||
161555495|NCT01268059|583423429|FG001|Overall Study|Progression of disease|0|||
161555496|NCT01268059|583423430|FG002|Overall Study|Progression of disease|0|||
161555497|NCT01268059|583423431|FG003|Overall Study|Progression of disease|0|||
161555498|NCT03660943|583423432|FG000|Overall Study|Adverse Event|5|||
161555499|NCT03660943|583423433|FG001|Overall Study|Adverse Event|3|||
161555500|NCT03660943|583423432|FG000|Overall Study|Death|0|||
161555501|NCT03660943|583423433|FG001|Overall Study|Death|2|||
161555502|NCT03660943|583423432|FG000|Overall Study|Lost to Follow-up|7|||
161555503|NCT03660943|583423433|FG001|Overall Study|Lost to Follow-up|3|||
161555504|NCT03660943|583423432|FG000|Overall Study|Protocol Violation|3|||
161555505|NCT03660943|583423433|FG001|Overall Study|Protocol Violation|5|||
161555506|NCT03660943|583423432|FG000|Overall Study|Withdrawal by Subject|8|||
161796422|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
161796423|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
161555507|NCT03660943|583423433|FG001|Overall Study|Withdrawal by Subject|15|||
161555508|NCT03660943|583423432|FG000|Overall Study|Lack of Efficacy|9|||
161555509|NCT03660943|583423433|FG001|Overall Study|Lack of Efficacy|12|||
161555510|NCT03660943|583423432|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
161555511|NCT03660943|583423433|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
161555512|NCT03699124|583423434|FG000|Overall Study|Adverse Event|6|||
161555513|NCT03699124|583423435|FG001|Overall Study|Adverse Event|5|||
161555514|NCT03699124|583423436|FG002|Overall Study|Adverse Event|2|||
161555515|NCT03699124|583423434|FG000|Overall Study|Death|0|||
161900815|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900816|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900817|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900818|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900819|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900820|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
161900821|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
161900822|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161450238|NCT02059291|583043666|FG018|Epoch 2|Withdrawal by Subject|0|||
161450239|NCT02059291|583043667|FG019|Epoch 2|Withdrawal by Subject|0|||
161450240|NCT02059291|583043668|FG020|Epoch 2|Withdrawal by Subject|0|||
161450241|NCT02059291|583043669|FG021|Epoch 2|Withdrawal by Subject|0|||
161450242|NCT02059291|583043670|FG022|Epoch 2|Withdrawal by Subject|0|||
161450243|NCT02059291|583043671|FG023|Epoch 2|Withdrawal by Subject|0|||
161450244|NCT02059291|583043672|FG024|Epoch 2|Withdrawal by Subject|0|||
161450245|NCT02059291|583043648|FG000|Epoch 3|Physician Decision|0|||
161450246|NCT02059291|583043649|FG001|Epoch 3|Physician Decision|0|||
161450247|NCT02059291|583043650|FG002|Epoch 3|Physician Decision|0|||
161450248|NCT02059291|583043651|FG003|Epoch 3|Physician Decision|0|||
161450249|NCT02059291|583043652|FG004|Epoch 3|Physician Decision|0|||
161450250|NCT02059291|583043653|FG005|Epoch 3|Physician Decision|0|||
161450251|NCT02059291|583043654|FG006|Epoch 3|Physician Decision|0|||
161450252|NCT02059291|583043655|FG007|Epoch 3|Physician Decision|0|||
161450253|NCT02059291|583043656|FG008|Epoch 3|Physician Decision|0|||
161450254|NCT02059291|583043657|FG009|Epoch 3|Physician Decision|0|||
161450255|NCT02059291|583043658|FG010|Epoch 3|Physician Decision|0|||
161450256|NCT02059291|583043659|FG011|Epoch 3|Physician Decision|0|||
161450257|NCT02059291|583043660|FG012|Epoch 3|Physician Decision|0|||
161450258|NCT02059291|583043661|FG013|Epoch 3|Physician Decision|1|||
161450259|NCT02059291|583043662|FG014|Epoch 3|Physician Decision|0|||
161450260|NCT02059291|583043663|FG015|Epoch 3|Physician Decision|1|||
161450261|NCT02059291|583043664|FG016|Epoch 3|Physician Decision|0|||
161450262|NCT02059291|583043665|FG017|Epoch 3|Physician Decision|0|||
161450263|NCT02059291|583043666|FG018|Epoch 3|Physician Decision|0|||
161450264|NCT02059291|583043667|FG019|Epoch 3|Physician Decision|0|||
161450265|NCT02059291|583043668|FG020|Epoch 3|Physician Decision|0|||
161450266|NCT02059291|583043669|FG021|Epoch 3|Physician Decision|0|||
161450267|NCT02059291|583043670|FG022|Epoch 3|Physician Decision|0|||
161450268|NCT02059291|583043671|FG023|Epoch 3|Physician Decision|0|||
161450269|NCT02059291|583043672|FG024|Epoch 3|Physician Decision|0|||
161450270|NCT02059291|583043648|FG000|Epoch 3|Adverse Event|0|||
161450271|NCT02059291|583043649|FG001|Epoch 3|Adverse Event|0|||
161450272|NCT02059291|583043650|FG002|Epoch 3|Adverse Event|0|||
161450273|NCT02059291|583043651|FG003|Epoch 3|Adverse Event|0|||
161450274|NCT02059291|583043652|FG004|Epoch 3|Adverse Event|0|||
161450275|NCT02059291|583043653|FG005|Epoch 3|Adverse Event|0|||
161450276|NCT02059291|583043654|FG006|Epoch 3|Adverse Event|0|||
161450277|NCT02059291|583043655|FG007|Epoch 3|Adverse Event|0|||
161450278|NCT02059291|583043656|FG008|Epoch 3|Adverse Event|0|||
161450279|NCT02059291|583043657|FG009|Epoch 3|Adverse Event|0|||
161450280|NCT02059291|583043658|FG010|Epoch 3|Adverse Event|0|||
161450281|NCT02059291|583043659|FG011|Epoch 3|Adverse Event|0|||
161450282|NCT02059291|583043660|FG012|Epoch 3|Adverse Event|0|||
161450283|NCT02059291|583043661|FG013|Epoch 3|Adverse Event|0|||
161450284|NCT02059291|583043662|FG014|Epoch 3|Adverse Event|0|||
161450285|NCT02059291|583043663|FG015|Epoch 3|Adverse Event|1|||
161450286|NCT02059291|583043664|FG016|Epoch 3|Adverse Event|0|||
161450287|NCT02059291|583043665|FG017|Epoch 3|Adverse Event|0|||
161450288|NCT02059291|583043666|FG018|Epoch 3|Adverse Event|0|||
161450289|NCT02059291|583043667|FG019|Epoch 3|Adverse Event|0|||
161450290|NCT02059291|583043668|FG020|Epoch 3|Adverse Event|0|||
161450291|NCT02059291|583043669|FG021|Epoch 3|Adverse Event|0|||
161450292|NCT02059291|583043670|FG022|Epoch 3|Adverse Event|0|||
161450293|NCT02059291|583043671|FG023|Epoch 3|Adverse Event|0|||
161450294|NCT02059291|583043672|FG024|Epoch 3|Adverse Event|0|||
161450295|NCT02059291|583043648|FG000|Epoch 3|Lack of Efficacy|0|||
161450296|NCT02059291|583043649|FG001|Epoch 3|Lack of Efficacy|0|||
161450297|NCT02059291|583043650|FG002|Epoch 3|Lack of Efficacy|0|||
161450298|NCT02059291|583043651|FG003|Epoch 3|Lack of Efficacy|0|||
161450299|NCT02059291|583043652|FG004|Epoch 3|Lack of Efficacy|0|||
161450300|NCT02059291|583043653|FG005|Epoch 3|Lack of Efficacy|0|||
161450301|NCT02059291|583043654|FG006|Epoch 3|Lack of Efficacy|0|||
161450302|NCT02059291|583043655|FG007|Epoch 3|Lack of Efficacy|0|||
161450303|NCT02059291|583043656|FG008|Epoch 3|Lack of Efficacy|0|||
161900823|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161450304|NCT02059291|583043657|FG009|Epoch 3|Lack of Efficacy|0|||
161450305|NCT02059291|583043658|FG010|Epoch 3|Lack of Efficacy|0|||
161450306|NCT02059291|583043659|FG011|Epoch 3|Lack of Efficacy|0|||
161450307|NCT02059291|583043660|FG012|Epoch 3|Lack of Efficacy|0|||
161450308|NCT02059291|583043661|FG013|Epoch 3|Lack of Efficacy|0|||
161450309|NCT02059291|583043662|FG014|Epoch 3|Lack of Efficacy|0|||
161796424|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
161796425|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
161796426|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
161796427|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796428|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796429|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796430|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796431|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796432|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796433|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796434|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796435|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796436|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
161796437|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
161796438|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
161796439|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
161796440|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
161796441|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796442|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796443|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796444|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796445|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796446|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796447|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796448|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796449|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161450310|NCT02059291|583043663|FG015|Epoch 3|Lack of Efficacy|3|||
161450311|NCT02059291|583043664|FG016|Epoch 3|Lack of Efficacy|0|||
161450312|NCT02059291|583043665|FG017|Epoch 3|Lack of Efficacy|0|||
161450313|NCT02059291|583043666|FG018|Epoch 3|Lack of Efficacy|0|||
161450314|NCT02059291|583043667|FG019|Epoch 3|Lack of Efficacy|0|||
161450315|NCT02059291|583043668|FG020|Epoch 3|Lack of Efficacy|0|||
161450316|NCT02059291|583043669|FG021|Epoch 3|Lack of Efficacy|0|||
161450317|NCT02059291|583043670|FG022|Epoch 3|Lack of Efficacy|0|||
161450318|NCT02059291|583043671|FG023|Epoch 3|Lack of Efficacy|0|||
161450319|NCT02059291|583043672|FG024|Epoch 3|Lack of Efficacy|0|||
161450320|NCT02059291|583043648|FG000|Epoch 3|Withdrawal by Subject|0|||
161450321|NCT02059291|583043649|FG001|Epoch 3|Withdrawal by Subject|0|||
161450322|NCT02059291|583043650|FG002|Epoch 3|Withdrawal by Subject|0|||
161450323|NCT02059291|583043651|FG003|Epoch 3|Withdrawal by Subject|0|||
161450324|NCT02059291|583043652|FG004|Epoch 3|Withdrawal by Subject|0|||
161450325|NCT02059291|583043653|FG005|Epoch 3|Withdrawal by Subject|0|||
161450326|NCT02059291|583043654|FG006|Epoch 3|Withdrawal by Subject|0|||
161450327|NCT02059291|583043655|FG007|Epoch 3|Withdrawal by Subject|0|||
161450328|NCT02059291|583043656|FG008|Epoch 3|Withdrawal by Subject|0|||
161450329|NCT02059291|583043657|FG009|Epoch 3|Withdrawal by Subject|0|||
161450330|NCT02059291|583043658|FG010|Epoch 3|Withdrawal by Subject|0|||
161450331|NCT02059291|583043659|FG011|Epoch 3|Withdrawal by Subject|0|||
161450332|NCT02059291|583043660|FG012|Epoch 3|Withdrawal by Subject|0|||
161450333|NCT02059291|583043661|FG013|Epoch 3|Withdrawal by Subject|0|||
161450334|NCT02059291|583043662|FG014|Epoch 3|Withdrawal by Subject|0|||
161450335|NCT02059291|583043663|FG015|Epoch 3|Withdrawal by Subject|1|||
161450336|NCT02059291|583043664|FG016|Epoch 3|Withdrawal by Subject|0|||
161450337|NCT02059291|583043665|FG017|Epoch 3|Withdrawal by Subject|0|||
161450338|NCT02059291|583043666|FG018|Epoch 3|Withdrawal by Subject|0|||
161450339|NCT02059291|583043667|FG019|Epoch 3|Withdrawal by Subject|0|||
161450340|NCT02059291|583043668|FG020|Epoch 3|Withdrawal by Subject|0|||
161450341|NCT02059291|583043669|FG021|Epoch 3|Withdrawal by Subject|0|||
161450342|NCT02059291|583043670|FG022|Epoch 3|Withdrawal by Subject|0|||
161450343|NCT02059291|583043671|FG023|Epoch 3|Withdrawal by Subject|0|||
161450344|NCT02059291|583043672|FG024|Epoch 3|Withdrawal by Subject|0|||
161450345|NCT02059291|583043648|FG000|Epoch 4|Adverse Event|0|||
161450346|NCT02059291|583043649|FG001|Epoch 4|Adverse Event|0|||
161450347|NCT02059291|583043650|FG002|Epoch 4|Adverse Event|0|||
161450348|NCT02059291|583043651|FG003|Epoch 4|Adverse Event|0|||
161450349|NCT02059291|583043652|FG004|Epoch 4|Adverse Event|0|||
161450350|NCT02059291|583043653|FG005|Epoch 4|Adverse Event|0|||
161900824|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900825|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161450351|NCT02059291|583043654|FG006|Epoch 4|Adverse Event|0|||
161450352|NCT02059291|583043655|FG007|Epoch 4|Adverse Event|0|||
161450353|NCT02059291|583043656|FG008|Epoch 4|Adverse Event|0|||
161450354|NCT02059291|583043657|FG009|Epoch 4|Adverse Event|0|||
161450355|NCT02059291|583043658|FG010|Epoch 4|Adverse Event|0|||
161450356|NCT02059291|583043659|FG011|Epoch 4|Adverse Event|0|||
161450357|NCT02059291|583043660|FG012|Epoch 4|Adverse Event|0|||
161900826|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900827|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900828|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161450358|NCT02059291|583043661|FG013|Epoch 4|Adverse Event|0|||
161450359|NCT02059291|583043662|FG014|Epoch 4|Adverse Event|0|||
161450360|NCT02059291|583043663|FG015|Epoch 4|Adverse Event|0|||
161450361|NCT02059291|583043664|FG016|Epoch 4|Adverse Event|1|||
161450362|NCT02059291|583043665|FG017|Epoch 4|Adverse Event|0|||
161450363|NCT02059291|583043666|FG018|Epoch 4|Adverse Event|0|||
161450364|NCT02059291|583043667|FG019|Epoch 4|Adverse Event|0|||
161450365|NCT02059291|583043668|FG020|Epoch 4|Adverse Event|0|||
161450366|NCT02059291|583043669|FG021|Epoch 4|Adverse Event|0|||
161450367|NCT02059291|583043670|FG022|Epoch 4|Adverse Event|1|||
161450368|NCT02059291|583043671|FG023|Epoch 4|Adverse Event|0|||
161450369|NCT02059291|583043672|FG024|Epoch 4|Adverse Event|0|||
161450370|NCT02059291|583043648|FG000|Epoch 4|Pregnancy|0|||
161450371|NCT02059291|583043649|FG001|Epoch 4|Pregnancy|0|||
161450372|NCT02059291|583043650|FG002|Epoch 4|Pregnancy|0|||
161450373|NCT02059291|583043651|FG003|Epoch 4|Pregnancy|0|||
161450374|NCT02059291|583043652|FG004|Epoch 4|Pregnancy|0|||
161450375|NCT02059291|583043653|FG005|Epoch 4|Pregnancy|0|||
161450376|NCT02059291|583043654|FG006|Epoch 4|Pregnancy|0|||
161450377|NCT02059291|583043655|FG007|Epoch 4|Pregnancy|0|||
161450378|NCT02059291|583043656|FG008|Epoch 4|Pregnancy|0|||
161450379|NCT02059291|583043657|FG009|Epoch 4|Pregnancy|0|||
161450380|NCT02059291|583043658|FG010|Epoch 4|Pregnancy|0|||
161450381|NCT02059291|583043659|FG011|Epoch 4|Pregnancy|0|||
161450382|NCT02059291|583043660|FG012|Epoch 4|Pregnancy|0|||
161450383|NCT02059291|583043661|FG013|Epoch 4|Pregnancy|0|||
161450384|NCT02059291|583043662|FG014|Epoch 4|Pregnancy|0|||
161450385|NCT02059291|583043663|FG015|Epoch 4|Pregnancy|0|||
161450386|NCT02059291|583043664|FG016|Epoch 4|Pregnancy|1|||
161450387|NCT02059291|583043665|FG017|Epoch 4|Pregnancy|0|||
161450388|NCT02059291|583043666|FG018|Epoch 4|Pregnancy|0|||
161450389|NCT02059291|583043667|FG019|Epoch 4|Pregnancy|0|||
161450390|NCT02059291|583043668|FG020|Epoch 4|Pregnancy|0|||
161450391|NCT02059291|583043669|FG021|Epoch 4|Pregnancy|0|||
161450392|NCT02059291|583043670|FG022|Epoch 4|Pregnancy|0|||
161450393|NCT02059291|583043671|FG023|Epoch 4|Pregnancy|0|||
161450394|NCT02059291|583043672|FG024|Epoch 4|Pregnancy|0|||
161450395|NCT02059291|583043648|FG000|Epoch 4|Withdrawal by Subject|0|||
161450396|NCT02059291|583043649|FG001|Epoch 4|Withdrawal by Subject|0|||
161450397|NCT02059291|583043650|FG002|Epoch 4|Withdrawal by Subject|0|||
161450398|NCT02059291|583043651|FG003|Epoch 4|Withdrawal by Subject|0|||
161450399|NCT02059291|583043652|FG004|Epoch 4|Withdrawal by Subject|0|||
161450400|NCT02059291|583043653|FG005|Epoch 4|Withdrawal by Subject|0|||
161450401|NCT02059291|583043654|FG006|Epoch 4|Withdrawal by Subject|0|||
161450402|NCT02059291|583043655|FG007|Epoch 4|Withdrawal by Subject|0|||
161450403|NCT02059291|583043656|FG008|Epoch 4|Withdrawal by Subject|0|||
161450404|NCT02059291|583043657|FG009|Epoch 4|Withdrawal by Subject|0|||
161450405|NCT02059291|583043658|FG010|Epoch 4|Withdrawal by Subject|0|||
161450406|NCT02059291|583043659|FG011|Epoch 4|Withdrawal by Subject|0|||
161450407|NCT02059291|583043660|FG012|Epoch 4|Withdrawal by Subject|0|||
161450408|NCT02059291|583043661|FG013|Epoch 4|Withdrawal by Subject|0|||
161450409|NCT02059291|583043662|FG014|Epoch 4|Withdrawal by Subject|0|||
161450410|NCT02059291|583043663|FG015|Epoch 4|Withdrawal by Subject|0|||
161450411|NCT02059291|583043664|FG016|Epoch 4|Withdrawal by Subject|0|||
161450412|NCT02059291|583043665|FG017|Epoch 4|Withdrawal by Subject|0|||
161450413|NCT02059291|583043666|FG018|Epoch 4|Withdrawal by Subject|0|||
161450414|NCT02059291|583043667|FG019|Epoch 4|Withdrawal by Subject|0|||
161450415|NCT02059291|583043668|FG020|Epoch 4|Withdrawal by Subject|1|||
161555516|NCT03699124|583423435|FG001|Overall Study|Death|2|||
161450416|NCT02059291|583043669|FG021|Epoch 4|Withdrawal by Subject|0|||
161450417|NCT02059291|583043670|FG022|Epoch 4|Withdrawal by Subject|0|||
161450418|NCT02059291|583043671|FG023|Epoch 4|Withdrawal by Subject|0|||
161450419|NCT02059291|583043672|FG024|Epoch 4|Withdrawal by Subject|0|||
161555517|NCT03699124|583423436|FG002|Overall Study|Death|0|||
161555518|NCT03699124|583423434|FG000|Overall Study|Lost to Follow-up|20|||
161900829|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161450420|NCT02059291|583043648|FG000|Epoch 4|Lack of Efficacy|0|||
161450421|NCT02059291|583043649|FG001|Epoch 4|Lack of Efficacy|0|||
161450422|NCT02059291|583043650|FG002|Epoch 4|Lack of Efficacy|0|||
161450423|NCT02059291|583043651|FG003|Epoch 4|Lack of Efficacy|0|||
161450424|NCT02059291|583043652|FG004|Epoch 4|Lack of Efficacy|0|||
161450425|NCT02059291|583043653|FG005|Epoch 4|Lack of Efficacy|0|||
161450426|NCT02059291|583043654|FG006|Epoch 4|Lack of Efficacy|0|||
161450427|NCT02059291|583043655|FG007|Epoch 4|Lack of Efficacy|0|||
161450428|NCT02059291|583043656|FG008|Epoch 4|Lack of Efficacy|0|||
161450429|NCT02059291|583043657|FG009|Epoch 4|Lack of Efficacy|0|||
161450430|NCT02059291|583043658|FG010|Epoch 4|Lack of Efficacy|0|||
161450431|NCT02059291|583043659|FG011|Epoch 4|Lack of Efficacy|0|||
161450432|NCT02059291|583043660|FG012|Epoch 4|Lack of Efficacy|0|||
161450433|NCT02059291|583043661|FG013|Epoch 4|Lack of Efficacy|0|||
161450434|NCT02059291|583043662|FG014|Epoch 4|Lack of Efficacy|0|||
161450435|NCT02059291|583043663|FG015|Epoch 4|Lack of Efficacy|0|||
161450436|NCT02059291|583043664|FG016|Epoch 4|Lack of Efficacy|0|||
161555519|NCT03699124|583423435|FG001|Overall Study|Lost to Follow-up|16|||
161900830|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900831|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900832|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900833|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900834|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900835|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161450437|NCT02059291|583043665|FG017|Epoch 4|Lack of Efficacy|0|||
161450438|NCT02059291|583043666|FG018|Epoch 4|Lack of Efficacy|0|||
161450439|NCT02059291|583043667|FG019|Epoch 4|Lack of Efficacy|0|||
161450440|NCT02059291|583043668|FG020|Epoch 4|Lack of Efficacy|0|||
161450441|NCT02059291|583043669|FG021|Epoch 4|Lack of Efficacy|0|||
161450442|NCT02059291|583043670|FG022|Epoch 4|Lack of Efficacy|0|||
161450443|NCT02059291|583043671|FG023|Epoch 4|Lack of Efficacy|1|||
161450444|NCT02059291|583043672|FG024|Epoch 4|Lack of Efficacy|0|||
161450445|NCT01276054|583043677|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
161450446|NCT01276054|583043678|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
161450447|NCT04343235|583043679|FG000|Overall Study|Lost to Follow-up|3|||
161450448|NCT04343235|583043680|FG001|Overall Study|Lost to Follow-up|2|||
161450449|NCT00787267|583043681|FG000|Overall Study|Screen failure/Ineligible|10|||
161450450|NCT00787267|583043681|FG000|Overall Study|No Reason Provided|1|||
161450451|NCT00787267|583043681|FG000|Overall Study|Withdrawal by Subject|1|||
161450452|NCT01763996|583043682|FG000|Treatment Period 2|Adverse Event|0|||
161450453|NCT01763996|583043683|FG001|Treatment Period 2|Adverse Event|1|||
161450454|NCT05405257|583043687|FG000|Overall Study|Withdrawal by Subject|1|||
161450455|NCT00776919|583043690|FG000|Overall Study|Withdrawal by Subject|16|||
161450456|NCT00776919|583043691|FG001|Overall Study|Withdrawal by Subject|14|||
161450457|NCT00776919|583043692|FG002|Overall Study|Withdrawal by Subject|15|||
161450458|NCT00776919|583043693|FG003|Overall Study|Withdrawal by Subject|26|||
161450459|NCT00776919|583043690|FG000|Overall Study|Lost to Follow-up|8|||
161450460|NCT00776919|583043691|FG001|Overall Study|Lost to Follow-up|12|||
161450461|NCT00776919|583043692|FG002|Overall Study|Lost to Follow-up|11|||
161450462|NCT00776919|583043693|FG003|Overall Study|Lost to Follow-up|8|||
161450463|NCT00776919|583043690|FG000|Overall Study|Adverse Event|1|||
161450464|NCT00776919|583043691|FG001|Overall Study|Adverse Event|0|||
161450465|NCT00776919|583043692|FG002|Overall Study|Adverse Event|2|||
161450466|NCT00776919|583043693|FG003|Overall Study|Adverse Event|2|||
161450467|NCT00776919|583043690|FG000|Overall Study|Protocol Violation|1|||
161450468|NCT00776919|583043691|FG001|Overall Study|Protocol Violation|2|||
161450469|NCT00776919|583043692|FG002|Overall Study|Protocol Violation|0|||
161450470|NCT00776919|583043693|FG003|Overall Study|Protocol Violation|1|||
161450471|NCT00776919|583043690|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
161450472|NCT00776919|583043691|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
161450473|NCT00776919|583043692|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
161450474|NCT00776919|583043693|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
161450475|NCT01788215|583043694|FG000|Overall Study|Withdrawal by Subject|0|||
161450476|NCT01788215|583043695|FG001|Overall Study|Withdrawal by Subject|1|||
161450477|NCT01788215|583043694|FG000|Overall Study|Lost to Follow-up|2|||
161450478|NCT01788215|583043695|FG001|Overall Study|Lost to Follow-up|0|||
161450479|NCT03116152|583043696|FG000|Overall Study|Disease Progression|49|||
161450480|NCT03116152|583043697|FG001|Overall Study|Disease Progression|47|||
161450481|NCT03116152|583043696|FG000|Overall Study|Death|5|||
161796450|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796451|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161796452|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161796453|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796454|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161796455|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796456|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796457|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796458|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796459|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796460|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796461|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796462|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796463|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796464|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161450482|NCT03116152|583043697|FG001|Overall Study|Death|2|||
161450483|NCT03116152|583043696|FG000|Overall Study|Adverse Event|21|||
161796465|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
161796466|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
161450484|NCT03116152|583043697|FG001|Overall Study|Adverse Event|7|||
161450485|NCT03116152|583043696|FG000|Overall Study|Protocol Violation|2|||
161450486|NCT03116152|583043697|FG001|Overall Study|Protocol Violation|2|||
161450487|NCT03116152|583043696|FG000|Overall Study|Withdrawal by Subject|0|||
161555520|NCT03699124|583423436|FG002|Overall Study|Lost to Follow-up|15|||
161555521|NCT03699124|583423434|FG000|Overall Study|Protocol Violation|1|||
161555522|NCT03699124|583423435|FG001|Overall Study|Protocol Violation|0|||
161555523|NCT03699124|583423436|FG002|Overall Study|Protocol Violation|0|||
161555524|NCT03699124|583423434|FG000|Overall Study|Withdrawal by Subject|13|||
161555525|NCT03699124|583423435|FG001|Overall Study|Withdrawal by Subject|14|||
161555526|NCT03699124|583423436|FG002|Overall Study|Withdrawal by Subject|13|||
161555527|NCT03699124|583423434|FG000|Overall Study|Other reasons|5|||
161555528|NCT03699124|583423435|FG001|Overall Study|Other reasons|3|||
161555529|NCT03699124|583423436|FG002|Overall Study|Other reasons|10|||
161555530|NCT03595683|583423437|FG000|Overall Study|Adverse Event|1|||
161555531|NCT03595683|583423438|FG001|Overall Study|Adverse Event|0|||
161555532|NCT03595683|583423437|FG000|Overall Study|Pursue alternative therapy|1|||
161555533|NCT03595683|583423438|FG001|Overall Study|Pursue alternative therapy|1|||
161555534|NCT03595683|583423437|FG000|Overall Study|Progressive disease|1|||
161555535|NCT03595683|583423438|FG001|Overall Study|Progressive disease|3|||
161555536|NCT01021878|583423439|FG000|Overall Study|Lost to Follow-up|4|||
161555537|NCT01021878|583423440|FG001|Overall Study|Lost to Follow-up|3|||
161555538|NCT01021878|583423439|FG000|Overall Study|Death|0|||
161555539|NCT01021878|583423440|FG001|Overall Study|Death|1|||
161555540|NCT01021878|583423439|FG000|Overall Study|Adverse Event|6|||
161555541|NCT01021878|583423440|FG001|Overall Study|Adverse Event|5|||
161555542|NCT01021878|583423439|FG000|Overall Study|Transplantation|6|||
161555543|NCT01021878|583423440|FG001|Overall Study|Transplantation|1|||
161555544|NCT03158948|583423442|FG000|Overall Study|Death|1|||
161555545|NCT03158948|583423443|FG001|Overall Study|Death|1|||
161555546|NCT03158948|583423444|FG002|Overall Study|Death|3|||
161555547|NCT03158948|583423445|FG003|Overall Study|Death|2|||
161555548|NCT03158948|583423442|FG000|Overall Study|Physician Decision|0|||
161796467|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
161796468|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
161796469|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796470|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796471|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796472|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796473|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796474|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796475|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796476|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796477|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796478|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
161796479|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
161796480|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
161796481|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
161796482|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
161796483|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796484|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796485|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796486|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796487|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796488|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796489|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796490|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796491|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796492|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796493|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796494|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796495|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796496|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
161796497|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
161555549|NCT03158948|583423443|FG001|Overall Study|Physician Decision|0|||
161555550|NCT03158948|583423444|FG002|Overall Study|Physician Decision|0|||
161555551|NCT03158948|583423445|FG003|Overall Study|Physician Decision|1|||
161555552|NCT00472186|583423446|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
161555553|NCT00472186|583423447|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
161555554|NCT05876351|583423448|FG000|Overall Study|Other than specified|2|||
161555555|NCT05876351|583423448|FG000|Overall Study|Study specific discontinuation criteria|1|||
161555556|NCT00997243|583423449|FG000|Overall Study|Early termination of study by sponsor|7|||
161555557|NCT03415022|583423452|FG000|Overall Study|Withdrawal by Subject|1|||
161555558|NCT03415022|583423453|FG001|Overall Study|Withdrawal by Subject|2|||
161555559|NCT03415022|583423452|FG000|Overall Study|COVID-19 Suspension|2|||
161555560|NCT03415022|583423453|FG001|Overall Study|COVID-19 Suspension|3|||
161555561|NCT03415022|583423452|FG000|Overall Study|Lost to Follow-up|2|||
161555562|NCT03415022|583423453|FG001|Overall Study|Lost to Follow-up|0|||
161555563|NCT02086552|583423456|FG000|Overall Study|Withdrawal by Subject|1|||
161555564|NCT02206152|583423457|FG000|Pre-Randomization|Withdrawal by Subject|2|||
161555565|NCT00478608|583423458|FG000|Overall Study|Adverse Event|1|||
161555566|NCT00478608|583423458|FG000|Overall Study|Serious Adverse Event|14|||
161555567|NCT00478608|583423458|FG000|Overall Study|Withdrawal by Subject|2|||
161555568|NCT00478608|583423458|FG000|Overall Study|Protocol Violation|3|||
161555569|NCT01349907|583423459|FG000|Overall Study|Adverse Event|37|||
161555570|NCT01349907|583423460|FG001|Overall Study|Adverse Event|11|||
161555571|NCT01349907|583423459|FG000|Overall Study|Treatment failure|13|||
161555572|NCT01349907|583423460|FG001|Overall Study|Treatment failure|4|||
161555573|NCT01349907|583423459|FG000|Overall Study|Lost to Follow-up|25|||
161555574|NCT01349907|583423460|FG001|Overall Study|Lost to Follow-up|6|||
161555575|NCT01349907|583423459|FG000|Overall Study|Withdrawal by Subject|30|||
161555576|NCT01349907|583423460|FG001|Overall Study|Withdrawal by Subject|8|||
161555577|NCT01349907|583423459|FG000|Overall Study|Protocol Violation|33|||
161555578|NCT01349907|583423460|FG001|Overall Study|Protocol Violation|13|||
161555579|NCT01349907|583423459|FG000|Overall Study|Administrative|1|||
161555580|NCT01349907|583423460|FG001|Overall Study|Administrative|1|||
161555581|NCT03583541|583423468|FG000|Overall Study|Lost to Follow-up|31|||
161555582|NCT03583541|583423469|FG001|Overall Study|Lost to Follow-up|65|||
161555583|NCT00884286|583423471|FG000|Overall Study|Progressive disease|21|||
161555584|NCT00884286|583423472|FG001|Overall Study|Progressive disease|28|||
161555585|NCT00884286|583423471|FG000|Overall Study|Toxicity|4|||
161555586|NCT00884286|583423472|FG001|Overall Study|Toxicity|1|||
161555587|NCT00884286|583423471|FG000|Overall Study|Death|2|||
161555588|NCT00884286|583423472|FG001|Overall Study|Death|2|||
161555589|NCT00884286|583423471|FG000|Overall Study|Physician Decision|1|||
161555590|NCT00884286|583423472|FG001|Overall Study|Physician Decision|0|||
161555591|NCT00884286|583423471|FG000|Overall Study|Septic shock|1|||
161555592|NCT00884286|583423472|FG001|Overall Study|Septic shock|0|||
161555593|NCT00884286|583423471|FG000|Overall Study|Thrombus in right auricle|1|||
161555594|NCT00884286|583423472|FG001|Overall Study|Thrombus in right auricle|0|||
161555595|NCT00884286|583423471|FG000|Overall Study|Not treated|2|||
161555596|NCT00884286|583423472|FG001|Overall Study|Not treated|1|||
161555597|NCT00884286|583423471|FG000|Overall Study|Comprised lung carcinoma|0|||
161555598|NCT00884286|583423472|FG001|Overall Study|Comprised lung carcinoma|1|||
161555599|NCT01196104|583423473|FG000|Overall Study|Lost to Follow-up|1|||
161555600|NCT01196104|583423474|FG001|Overall Study|Lost to Follow-up|0|||
161555601|NCT01196104|583423473|FG000|Overall Study|Physician Decision|0|||
161555602|NCT01196104|583423474|FG001|Overall Study|Physician Decision|1|||
161555603|NCT01196104|583423473|FG000|Overall Study|Withdrawal by Subject|3|||
161555604|NCT01196104|583423474|FG001|Overall Study|Withdrawal by Subject|3|||
161555605|NCT01196104|583423473|FG000|Overall Study|Various|0|||
161555606|NCT01196104|583423474|FG001|Overall Study|Various|1|||
161555607|NCT00594932|583423480|FG000|First 3 Months|Withdrawal by Subject|1|||
161555608|NCT00594932|583423481|FG001|First 3 Months|Withdrawal by Subject|3|||
161555609|NCT00594932|583423480|FG000|Final 3 Months|Withdrawal by Subject|4|||
161555610|NCT00594932|583423481|FG001|Final 3 Months|Withdrawal by Subject|3|||
161555611|NCT01094171|583423482|FG000|Overall Study|Lost to Follow-up|2|||
161555612|NCT01094171|583423482|FG000|Overall Study|Informed consent withdrawal|4|||
161555613|NCT01094171|583423482|FG000|Overall Study|Migration from the study area|3|||
161555614|NCT01094171|583423482|FG000|Overall Study|Other|1|||
161555615|NCT00065468|583423488|FG000|Overall Study|Death|172|||
161555616|NCT00065468|583423489|FG001|Overall Study|Death|169|||
161555617|NCT00065468|583423490|FG002|Overall Study|Death|171|||
161555618|NCT00065468|583423488|FG000|Overall Study|Withdrawal by Subject|3|||
161555619|NCT00065468|583423489|FG001|Overall Study|Withdrawal by Subject|4|||
161555620|NCT00065468|583423490|FG002|Overall Study|Withdrawal by Subject|5|||
161555621|NCT00065468|583423488|FG000|Overall Study|Lost to Follow-up|5|||
161555622|NCT00065468|583423489|FG001|Overall Study|Lost to Follow-up|3|||
161555623|NCT00065468|583423490|FG002|Overall Study|Lost to Follow-up|2|||
161555624|NCT00065468|583423488|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
161555625|NCT00065468|583423489|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
161555626|NCT00065468|583423490|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
161555627|NCT00065468|583423488|FG000|Overall Study|Disease progression|0|||
161555628|NCT00065468|583423489|FG001|Overall Study|Disease progression|0|||
161555629|NCT00065468|583423490|FG002|Overall Study|Disease progression|1|||
161555630|NCT00065468|583423488|FG000|Overall Study|Other|14|||
161900836|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161555631|NCT00065468|583423489|FG001|Overall Study|Other|24|||
161555632|NCT00065468|583423490|FG002|Overall Study|Other|18|||
161555633|NCT04496167|583423491|FG000|Overall Study|Adverse Event|6|||
161555634|NCT04496167|583423492|FG001|Overall Study|Adverse Event|2|||
161555635|NCT04496167|583423491|FG000|Overall Study|Withdrawal by Subject|7|||
161555636|NCT04496167|583423492|FG001|Overall Study|Withdrawal by Subject|6|||
161555637|NCT04496167|583423491|FG000|Overall Study|Lost to Follow-up|3|||
161555638|NCT04496167|583423492|FG001|Overall Study|Lost to Follow-up|5|||
161555639|NCT04496167|583423491|FG000|Overall Study|Not Treated|1|||
161555640|NCT04496167|583423492|FG001|Overall Study|Not Treated|2|||
161555641|NCT04496167|583423491|FG000|Overall Study|Other Than Specified|1|||
161555642|NCT04496167|583423492|FG001|Overall Study|Other Than Specified|1|||
161796498|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796499|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796500|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796501|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796502|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796503|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796504|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796505|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796506|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
161796507|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
161796508|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
161796509|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
161796510|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
161796511|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796512|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796513|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796514|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796515|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796516|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796517|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796518|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796519|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796520|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161796521|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796522|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161796523|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161796524|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796525|NCT02985957|584298196|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796526|NCT02985957|584298197|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796527|NCT02985957|584298198|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796528|NCT02985957|584298199|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796529|NCT02985957|584298200|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161796530|NCT02985957|584298201|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796531|NCT02985957|584298202|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796532|NCT02985957|584298196|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161796533|NCT02985957|584298197|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161796534|NCT02985957|584298198|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
161796535|NCT02985957|584298199|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
161796536|NCT02985957|584298200|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
161796537|NCT02985957|584298201|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
161796538|NCT02985957|584298202|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
161796539|NCT02985957|584298196|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796540|NCT02985957|584298197|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796541|NCT02985957|584298198|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796542|NCT02985957|584298199|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796543|NCT02985957|584298200|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796544|NCT02985957|584298201|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796545|NCT02985957|584298202|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161796546|NCT02985957|584298196|FG000|Treatment Period|Death|0|||
161796547|NCT02985957|584298197|FG001|Treatment Period|Death|0|||
161796548|NCT02985957|584298198|FG002|Treatment Period|Death|0|||
161796549|NCT02985957|584298199|FG003|Treatment Period|Death|0|||
161796550|NCT02985957|584298200|FG004|Treatment Period|Death|1|||
161796551|NCT02985957|584298201|FG005|Treatment Period|Death|0|||
161796552|NCT02985957|584298202|FG006|Treatment Period|Death|0|||
161796553|NCT02985957|584298196|FG000|Treatment Period|Participant withdrew consent|0|||
161796554|NCT02985957|584298197|FG001|Treatment Period|Participant withdrew consent|0|||
161796555|NCT02985957|584298198|FG002|Treatment Period|Participant withdrew consent|0|||
161796556|NCT02985957|584298199|FG003|Treatment Period|Participant withdrew consent|1|||
161555643|NCT00681187|583423493|FG000|Overall Study|Withdrawal by Subject|1|||
161555644|NCT00681187|583423494|FG001|Overall Study|Withdrawal by Subject|0|||
161555645|NCT00681187|583423493|FG000|Overall Study|Death|0|||
161555646|NCT00681187|583423494|FG001|Overall Study|Death|1|||
161555647|NCT00681187|583423493|FG000|Overall Study|Adverse Event|0|||
161555648|NCT00681187|583423494|FG001|Overall Study|Adverse Event|1|||
161555649|NCT00598481|583423495|FG000|Treatment|Physician Decision|1|||
161555650|NCT02500316|583423501|FG000|Overall Study|Adverse Event|3|||
161555651|NCT02500316|583423501|FG000|Overall Study|Lost to Follow-up|2|||
161555652|NCT02500316|583423501|FG000|Overall Study|Protocol Violation|1|||
161555653|NCT02500316|583423501|FG000|Overall Study|Withdrawal by Subject|15|||
161555654|NCT02500316|583423501|FG000|Overall Study|Final height achieved|5|||
161555655|NCT02500316|583423501|FG000|Overall Study|Due to war activity|1|||
161555656|NCT01406717|583423502|FG000|Overall Study|Subject non-compliance|4|||
161555657|NCT01406717|583423503|FG001|Overall Study|Subject non-compliance|3|||
161555658|NCT01406717|583423502|FG000|Overall Study|Protocol Violation|5|||
161555659|NCT01406717|583423503|FG001|Overall Study|Protocol Violation|1|||
161555660|NCT01406717|583423502|FG000|Overall Study|Lost to Follow-up|14|||
161555661|NCT01406717|583423503|FG001|Overall Study|Lost to Follow-up|8|||
161555662|NCT01406717|583423502|FG000|Overall Study|Withdrawal by Subject|19|||
161555663|NCT01406717|583423503|FG001|Overall Study|Withdrawal by Subject|15|||
161555664|NCT01406717|583423502|FG000|Overall Study|Adverse Event|1|||
161555665|NCT01406717|583423503|FG001|Overall Study|Adverse Event|2|||
161555666|NCT01406717|583423502|FG000|Overall Study|Lack of Efficacy|0|||
161555667|NCT01406717|583423503|FG001|Overall Study|Lack of Efficacy|1|||
161555668|NCT01406717|583423502|FG000|Overall Study|Non-completion of visit activity|0|||
161555669|NCT01406717|583423503|FG001|Overall Study|Non-completion of visit activity|1|||
161555670|NCT02040090|583423504|FG000|Overall Study|Adverse Event|2|||
161555671|NCT02040090|583423505|FG001|Overall Study|Adverse Event|0|||
161555672|NCT02040090|583423504|FG000|Overall Study|Physician Decision|1|||
161555673|NCT02040090|583423505|FG001|Overall Study|Physician Decision|0|||
161555674|NCT02040090|583423504|FG000|Overall Study|Withdrawal by Subject|0|||
161555675|NCT02040090|583423505|FG001|Overall Study|Withdrawal by Subject|1|||
161555676|NCT02040090|583423504|FG000|Overall Study|Lost to Follow-up|0|||
161555677|NCT02040090|583423505|FG001|Overall Study|Lost to Follow-up|1|||
161555678|NCT02275533|583423506|FG000|Overall Study|Protocol Violation|2|||
161555679|NCT02275533|583423507|FG001|Overall Study|Protocol Violation|0|||
161555680|NCT02275533|583423506|FG000|Overall Study|Never received study treatment|1|||
161555681|NCT02275533|583423507|FG001|Overall Study|Never received study treatment|0|||
161555682|NCT01570868|583423508|FG000|Overall Study|Adverse Event|8|||
161555683|NCT01570868|583423509|FG001|Overall Study|Adverse Event|1|||
161555684|NCT01570868|583423508|FG000|Overall Study|FDA Recommendation|23|||
161555685|NCT01570868|583423509|FG001|Overall Study|FDA Recommendation|3|||
161555686|NCT01570868|583423508|FG000|Overall Study|Physician Decision|10|||
161555687|NCT01570868|583423509|FG001|Overall Study|Physician Decision|4|||
161555688|NCT01570868|583423508|FG000|Overall Study|Lost to Follow-up|1|||
161555689|NCT01570868|583423509|FG001|Overall Study|Lost to Follow-up|0|||
161555690|NCT01570868|583423508|FG000|Overall Study|Withdrawal by Subject|1|||
161555691|NCT01570868|583423509|FG001|Overall Study|Withdrawal by Subject|0|||
161555692|NCT03370276|583423510|FG000|Overall Study|Death|0|||
161555693|NCT03370276|583423511|FG001|Overall Study|Death|2|||
161450488|NCT03116152|583043697|FG001|Overall Study|Withdrawal by Subject|1|||
161450489|NCT03116152|583043696|FG000|Overall Study|Physician Decision|3|||
161450490|NCT03116152|583043697|FG001|Overall Study|Physician Decision|2|||
161450491|NCT03116152|583043696|FG000|Overall Study|other|11|||
161450492|NCT03116152|583043697|FG001|Overall Study|other|34|||
161450493|NCT01396057|583043706|FG000|Overall Study|Adverse Event|2|||
161450494|NCT01396057|583043707|FG001|Overall Study|Adverse Event|6|||
161450495|NCT01396057|583043706|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161450496|NCT01396057|583043707|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161450497|NCT01396057|583043706|FG000|Overall Study|Protocol deviation|4|||
161555694|NCT03370276|583423512|FG002|Overall Study|Death|5|||
161450498|NCT01396057|583043707|FG001|Overall Study|Protocol deviation|4|||
161450499|NCT01396057|583043706|FG000|Overall Study|Consent withdrawn|3|||
161555695|NCT00895843|583423516|FG000|Overall Study|Protocol Violation|12|||
161555696|NCT00895843|583423517|FG001|Overall Study|Protocol Violation|12|||
161555697|NCT04963062|583423518|FG000|Overall Study|withdrew by the study team|4|||
161555698|NCT04963062|583423519|FG001|Overall Study|withdrew by the study team|2|||
161555699|NCT00544544|583423520|FG000|Overall Study|Withdrawal by Subject|1|||
161555700|NCT00544544|583423520|FG000|Overall Study|Adverse Event|1|||
161555701|NCT00544544|583423520|FG000|Overall Study|Lost to Follow-up|1|||
161796557|NCT02985957|584298200|FG004|Treatment Period|Participant withdrew consent|3|||
161796558|NCT02985957|584298201|FG005|Treatment Period|Participant withdrew consent|0|||
161796559|NCT02985957|584298202|FG006|Treatment Period|Participant withdrew consent|1|||
161450500|NCT01396057|583043707|FG001|Overall Study|Consent withdrawn|2|||
161555702|NCT04145349|583425262|FG000|Overall Study|Withdrawal by Subject|3|||
161555703|NCT04145349|583425263|FG001|Overall Study|Withdrawal by Subject|0|||
161796560|NCT02985957|584298196|FG000|Treatment Period|Lost to Follow-up|0|||
161555704|NCT04145349|583425262|FG000|Overall Study|Lost to Follow-up|0|||
161555705|NCT04145349|583425263|FG001|Overall Study|Lost to Follow-up|1|||
161555706|NCT04145349|583425262|FG000|Overall Study|On study treatment (Ongoing)|0|||
161555707|NCT04145349|583425263|FG001|Overall Study|On study treatment (Ongoing)|1|||
161900837|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
161900838|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900839|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900840|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161555708|NCT05567952|583425264|FG000|Overall Study|Lost to Follow-up|3|||
161555709|NCT05567952|583425265|FG001|Overall Study|Lost to Follow-up|2|||
161555710|NCT05567952|583425264|FG000|Overall Study|Withdrawal by Subject|6|||
161555711|NCT05567952|583425265|FG001|Overall Study|Withdrawal by Subject|3|||
161555712|NCT05567952|583425264|FG000|Overall Study|Other|3|||
161555713|NCT05567952|583425265|FG001|Overall Study|Other|1|||
161555714|NCT03280563|583425267|FG000|Stage 1|Death|2|||
161555715|NCT03280563|583425268|FG001|Stage 1|Death|1|||
161555716|NCT03280563|583425269|FG002|Stage 1|Death|0|||
161555717|NCT03280563|583425270|FG003|Stage 1|Death|0|||
161555718|NCT03280563|583425271|FG004|Stage 1|Death|0|||
161555719|NCT03280563|583425272|FG005|Stage 1|Death|3|||
161555720|NCT03280563|583425273|FG006|Stage 1|Death|0|||
161555721|NCT03280563|583425274|FG007|Stage 1|Death|0|||
161555722|NCT03280563|583425275|FG008|Stage 1|Death|0|||
161555723|NCT03280563|583425267|FG000|Stage 1|Study Ended by Sponsor|0|||
161555724|NCT03280563|583425268|FG001|Stage 1|Study Ended by Sponsor|0|||
161555725|NCT03280563|583425269|FG002|Stage 1|Study Ended by Sponsor|1|||
161555726|NCT03280563|583425270|FG003|Stage 1|Study Ended by Sponsor|0|||
161555727|NCT03280563|583425271|FG004|Stage 1|Study Ended by Sponsor|0|||
161555728|NCT03280563|583425272|FG005|Stage 1|Study Ended by Sponsor|1|||
161555729|NCT03280563|583425273|FG006|Stage 1|Study Ended by Sponsor|0|||
161555730|NCT03280563|583425274|FG007|Stage 1|Study Ended by Sponsor|0|||
161555731|NCT03280563|583425275|FG008|Stage 1|Study Ended by Sponsor|0|||
161555732|NCT03280563|583425267|FG000|Stage 1|Withdrawal by Subject|5|||
161555733|NCT03280563|583425268|FG001|Stage 1|Withdrawal by Subject|1|||
161555734|NCT03280563|583425269|FG002|Stage 1|Withdrawal by Subject|2|||
161555735|NCT03280563|583425270|FG003|Stage 1|Withdrawal by Subject|0|||
161555736|NCT03280563|583425271|FG004|Stage 1|Withdrawal by Subject|0|||
161555737|NCT03280563|583425272|FG005|Stage 1|Withdrawal by Subject|2|||
161900841|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900842|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900843|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161555738|NCT03280563|583425273|FG006|Stage 1|Withdrawal by Subject|0|||
161555739|NCT03280563|583425274|FG007|Stage 1|Withdrawal by Subject|0|||
161555740|NCT03280563|583425275|FG008|Stage 1|Withdrawal by Subject|0|||
161555741|NCT03280563|583425267|FG000|Stage 1|Reason Not Specified|0|||
161555742|NCT03280563|583425268|FG001|Stage 1|Reason Not Specified|0|||
161555743|NCT03280563|583425269|FG002|Stage 1|Reason Not Specified|0|||
161555744|NCT03280563|583425270|FG003|Stage 1|Reason Not Specified|0|||
161555745|NCT03280563|583425271|FG004|Stage 1|Reason Not Specified|0|||
161555746|NCT03280563|583425272|FG005|Stage 1|Reason Not Specified|1|||
161555747|NCT03280563|583425273|FG006|Stage 1|Reason Not Specified|0|||
161900844|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900845|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900846|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900847|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900848|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900849|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900850|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900851|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900852|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
161900853|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900854|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900855|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900856|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900857|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900858|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900859|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900860|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900861|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900862|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161555748|NCT03280563|583425274|FG007|Stage 1|Reason Not Specified|0|||
161555749|NCT03280563|583425275|FG008|Stage 1|Reason Not Specified|0|||
161555750|NCT03280563|583425267|FG000|Stage 1|Physician Decision|0|||
161555751|NCT03280563|583425268|FG001|Stage 1|Physician Decision|1|||
161555752|NCT03280563|583425269|FG002|Stage 1|Physician Decision|0|||
161555753|NCT03280563|583425270|FG003|Stage 1|Physician Decision|0|||
161555754|NCT03280563|583425271|FG004|Stage 1|Physician Decision|0|||
161555755|NCT03280563|583425272|FG005|Stage 1|Physician Decision|0|||
161796561|NCT02985957|584298197|FG001|Treatment Period|Lost to Follow-up|0|||
161796562|NCT02985957|584298198|FG002|Treatment Period|Lost to Follow-up|0|||
161796563|NCT02985957|584298199|FG003|Treatment Period|Lost to Follow-up|0|||
161796564|NCT02985957|584298200|FG004|Treatment Period|Lost to Follow-up|1|||
161796565|NCT02985957|584298201|FG005|Treatment Period|Lost to Follow-up|0|||
161796566|NCT02985957|584298202|FG006|Treatment Period|Lost to Follow-up|0|||
161796567|NCT02985957|584298196|FG000|Treatment Period|Other reasons|0|||
161900863|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900864|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900865|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900866|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161555756|NCT03280563|583425273|FG006|Stage 1|Physician Decision|0|||
161555757|NCT03280563|583425274|FG007|Stage 1|Physician Decision|0|||
161555758|NCT03280563|583425275|FG008|Stage 1|Physician Decision|0|||
161555759|NCT03280563|583425267|FG000|Stage 2|Death|0|||
161555760|NCT03280563|583425268|FG001|Stage 2|Death|0|||
161555761|NCT03280563|583425269|FG002|Stage 2|Death|0|||
161555762|NCT03280563|583425270|FG003|Stage 2|Death|0|||
161555763|NCT03280563|583425271|FG004|Stage 2|Death|0|||
161555764|NCT03280563|583425272|FG005|Stage 2|Death|0|||
161555765|NCT03280563|583425273|FG006|Stage 2|Death|0|||
161555766|NCT03280563|583425274|FG007|Stage 2|Death|1|||
161555767|NCT03280563|583425275|FG008|Stage 2|Death|0|||
161555768|NCT03280563|583425267|FG000|Stage 2|Progressive Disease|0|||
161555769|NCT03280563|583425268|FG001|Stage 2|Progressive Disease|0|||
161555770|NCT03280563|583425269|FG002|Stage 2|Progressive Disease|0|||
161555771|NCT03280563|583425270|FG003|Stage 2|Progressive Disease|0|||
161555772|NCT03280563|583425271|FG004|Stage 2|Progressive Disease|0|||
161555773|NCT03280563|583425272|FG005|Stage 2|Progressive Disease|0|||
161555774|NCT03280563|583425273|FG006|Stage 2|Progressive Disease|2|||
161555775|NCT03280563|583425274|FG007|Stage 2|Progressive Disease|0|||
161555776|NCT03280563|583425275|FG008|Stage 2|Progressive Disease|0|||
161555777|NCT03280563|583425267|FG000|Long-term Survival Follow-up|Death|10|||
161555778|NCT03280563|583425268|FG001|Long-term Survival Follow-up|Death|14|||
161555779|NCT03280563|583425269|FG002|Long-term Survival Follow-up|Death|15|||
161555780|NCT03280563|583425270|FG003|Long-term Survival Follow-up|Death|3|||
161555781|NCT03280563|583425271|FG004|Long-term Survival Follow-up|Death|6|||
161555782|NCT03280563|583425272|FG005|Long-term Survival Follow-up|Death|18|||
161555783|NCT03280563|583425273|FG006|Long-term Survival Follow-up|Death|11|||
161555784|NCT03280563|583425274|FG007|Long-term Survival Follow-up|Death|1|||
161555785|NCT03280563|583425275|FG008|Long-term Survival Follow-up|Death|3|||
161555786|NCT03280563|583425267|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
161555787|NCT03280563|583425268|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
161555788|NCT03280563|583425269|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
161555789|NCT03280563|583425270|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
161555790|NCT03280563|583425271|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
161555791|NCT03280563|583425272|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
161555792|NCT03280563|583425273|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
161555793|NCT03280563|583425274|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
161555794|NCT03280563|583425275|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
161555795|NCT03280563|583425267|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
161555796|NCT03280563|583425268|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
161555797|NCT03280563|583425269|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
161555798|NCT03280563|583425270|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
161796568|NCT02985957|584298197|FG001|Treatment Period|Other reasons|0|||
161796569|NCT02985957|584298198|FG002|Treatment Period|Other reasons|1|||
161796570|NCT02985957|584298199|FG003|Treatment Period|Other reasons|3|||
161796571|NCT02985957|584298200|FG004|Treatment Period|Other reasons|5|||
161796572|NCT02985957|584298201|FG005|Treatment Period|Other reasons|0|||
161796573|NCT02985957|584298202|FG006|Treatment Period|Other reasons|1|||
161796574|NCT02985957|584298196|FG000|Treatment Period|Not reported|0|||
161796575|NCT02985957|584298197|FG001|Treatment Period|Not reported|2|||
161796576|NCT02985957|584298198|FG002|Treatment Period|Not reported|2|||
161796577|NCT02985957|584298199|FG003|Treatment Period|Not reported|5|||
161796578|NCT02985957|584298200|FG004|Treatment Period|Not reported|0|||
161796579|NCT02985957|584298201|FG005|Treatment Period|Not reported|0|||
161900867|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
161900868|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161555799|NCT03280563|583425271|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
161555800|NCT03280563|583425272|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
161555801|NCT03280563|583425273|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
161796580|NCT02985957|584298202|FG006|Treatment Period|Not reported|0|||
161796581|NCT02985957|584298196|FG000|Treatment Period|Maximum clinical benefit|0|||
161796582|NCT02985957|584298197|FG001|Treatment Period|Maximum clinical benefit|0|||
161555802|NCT03280563|583425274|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
161796583|NCT02985957|584298198|FG002|Treatment Period|Maximum clinical benefit|1|||
161796584|NCT02985957|584298199|FG003|Treatment Period|Maximum clinical benefit|1|||
161796585|NCT02985957|584298200|FG004|Treatment Period|Maximum clinical benefit|0|||
161796586|NCT02985957|584298201|FG005|Treatment Period|Maximum clinical benefit|0|||
161796587|NCT02985957|584298202|FG006|Treatment Period|Maximum clinical benefit|2|||
161796588|NCT02985957|584298196|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
161796589|NCT02985957|584298197|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
161796590|NCT02985957|584298198|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
161796591|NCT02985957|584298199|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
161796592|NCT02985957|584298200|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
161796593|NCT02985957|584298201|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
161796594|NCT02985957|584298202|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
161796595|NCT02985957|584298196|FG000|Treatment Period|Study drug toxicity|1|||
161796596|NCT02985957|584298197|FG001|Treatment Period|Study drug toxicity|23|||
161796597|NCT02985957|584298198|FG002|Treatment Period|Study drug toxicity|20|||
161796598|NCT02985957|584298199|FG003|Treatment Period|Study drug toxicity|12|||
161796599|NCT02985957|584298200|FG004|Treatment Period|Study drug toxicity|20|||
161796600|NCT02985957|584298201|FG005|Treatment Period|Study drug toxicity|3|||
161796601|NCT02985957|584298202|FG006|Treatment Period|Study drug toxicity|5|||
161796602|NCT02985957|584298196|FG000|Treatment Period|Disease progression|0|||
161796603|NCT02985957|584298197|FG001|Treatment Period|Disease progression|16|||
161796604|NCT02985957|584298198|FG002|Treatment Period|Disease progression|20|||
161796605|NCT02985957|584298199|FG003|Treatment Period|Disease progression|40|||
161796606|NCT02985957|584298200|FG004|Treatment Period|Disease progression|29|||
161796607|NCT02985957|584298201|FG005|Treatment Period|Disease progression|11|||
161796608|NCT02985957|584298202|FG006|Treatment Period|Disease progression|28|||
161796609|NCT02985957|584298196|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
161796610|NCT02985957|584298197|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
161796611|NCT02985957|584298198|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
161796612|NCT02985957|584298199|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
161796613|NCT02985957|584298200|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
161796614|NCT02985957|584298201|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
161796615|NCT02985957|584298202|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
161796616|NCT02985957|584298196|FG000|Treatment Period|Poor/Non-Compliance|0|||
161796617|NCT02985957|584298197|FG001|Treatment Period|Poor/Non-Compliance|0|||
161796618|NCT02985957|584298198|FG002|Treatment Period|Poor/Non-Compliance|0|||
161796619|NCT02985957|584298199|FG003|Treatment Period|Poor/Non-Compliance|0|||
161796620|NCT02985957|584298200|FG004|Treatment Period|Poor/Non-Compliance|1|||
161796621|NCT02985957|584298201|FG005|Treatment Period|Poor/Non-Compliance|1|||
161796622|NCT02985957|584298202|FG006|Treatment Period|Poor/Non-Compliance|0|||
161796623|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
161796624|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
161796625|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
161796626|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
161796627|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
161796628|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
161796629|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
161796630|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
161796631|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
161796632|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
161796633|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
161796634|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
161796635|NCT03748641|584298208|FG000|Overall Study|Ongoing|155|||
161796636|NCT03748641|584298209|FG001|Overall Study|Ongoing|148|||
161796637|NCT03748641|584298210|FG002|Overall Study|Ongoing|66|||
161796638|NCT03748641|584298211|FG003|Overall Study|Ongoing|79|||
161796639|NCT03748641|584298212|FG004|Overall Study|Ongoing|84|||
161796640|NCT03748641|584298208|FG000|Overall Study|Death|54|||
161796641|NCT03748641|584298209|FG001|Overall Study|Death|59|||
161796642|NCT03748641|584298210|FG002|Overall Study|Death|51|||
161796643|NCT03748641|584298211|FG003|Overall Study|Death|42|||
161796644|NCT03748641|584298212|FG004|Overall Study|Death|9|||
161796645|NCT03748641|584298208|FG000|Overall Study|Lost to Follow-up|0|||
161796646|NCT03748641|584298209|FG001|Overall Study|Lost to Follow-up|2|||
161796647|NCT03748641|584298210|FG002|Overall Study|Lost to Follow-up|1|||
161796648|NCT03748641|584298211|FG003|Overall Study|Lost to Follow-up|0|||
161796649|NCT03748641|584298212|FG004|Overall Study|Lost to Follow-up|0|||
161796650|NCT03748641|584298208|FG000|Overall Study|Withdrawal by Subject|3|||
161796651|NCT03748641|584298209|FG001|Overall Study|Withdrawal by Subject|2|||
161796652|NCT03748641|584298210|FG002|Overall Study|Withdrawal by Subject|5|||
161796653|NCT03748641|584298211|FG003|Overall Study|Withdrawal by Subject|3|||
161796654|NCT03748641|584298212|FG004|Overall Study|Withdrawal by Subject|2|||
161796655|NCT00437281|584298213|FG000|Overall Study|Adverse Event|0|||
161450501|NCT00884741|583043710|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
161450502|NCT00884741|583043711|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
161450503|NCT00884741|583043712|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
161450504|NCT00884741|583043713|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
161450505|NCT00884741|583043710|FG000|Step 1 Registration: Tissue Screening|Death|3|||
161450506|NCT00884741|583043711|FG001|Step 1 Registration: Tissue Screening|Death|0|||
161450507|NCT00884741|583043712|FG002|Step 1 Registration: Tissue Screening|Death|0|||
161450508|NCT00884741|583043713|FG003|Step 1 Registration: Tissue Screening|Death|0|||
161450509|NCT00884741|583043710|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
161450510|NCT00884741|583043711|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
161450511|NCT00884741|583043712|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
161450512|NCT00884741|583043713|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
161450513|NCT00884741|583043710|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
161450514|NCT00884741|583043711|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
161450515|NCT00884741|583043712|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
161450516|NCT00884741|583043713|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
161450517|NCT00884741|583043710|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
161450518|NCT00884741|583043711|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
161450519|NCT00884741|583043712|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
161450520|NCT00884741|583043713|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
161450521|NCT00884741|583043710|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
161450522|NCT00884741|583043711|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
161450523|NCT00884741|583043712|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
161450524|NCT00884741|583043713|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
161450525|NCT00884741|583043710|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
161450526|NCT00884741|583043711|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
161450527|NCT00884741|583043712|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
161450528|NCT00884741|583043713|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
161450529|NCT00884741|583043710|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
161450530|NCT00884741|583043711|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
161450531|NCT00884741|583043712|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
161450532|NCT00884741|583043713|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
161450533|NCT00884741|583043710|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
161450534|NCT00884741|583043711|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
161450535|NCT00884741|583043712|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
161450536|NCT00884741|583043713|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
161450537|NCT00884741|583043710|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
161450538|NCT00884741|583043711|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
161450539|NCT00884741|583043712|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
161450540|NCT00884741|583043713|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
161450541|NCT00884741|583043710|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
161450542|NCT00884741|583043711|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
161450543|NCT00884741|583043712|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
161450544|NCT00884741|583043713|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
161450545|NCT00884741|583043710|FG000|Randomization|Protocol Violation|0|||
161450546|NCT00884741|583043711|FG001|Randomization|Protocol Violation|0|||
161450547|NCT00884741|583043712|FG002|Randomization|Protocol Violation|8|||
161450548|NCT00884741|583043713|FG003|Randomization|Protocol Violation|8|||
161450549|NCT01324401|583043714|FG000|Overall Study|Withdrawn before any treatment|0|||
161450550|NCT01324401|583043715|FG001|Overall Study|Withdrawn before any treatment|3|||
161450551|NCT01324401|583043714|FG000|Overall Study|Adverse Event|1|||
161450552|NCT01324401|583043715|FG001|Overall Study|Adverse Event|3|||
161450553|NCT02969655|583043716|FG000|Overall Study|Withdrawal by Subject|3|||
161450554|NCT02969655|583043717|FG001|Overall Study|Withdrawal by Subject|2|||
161450555|NCT02969655|583043716|FG000|Overall Study|Physician Decision|4|||
161450556|NCT02969655|583043717|FG001|Overall Study|Physician Decision|3|||
161450557|NCT02969655|583043716|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
161450558|NCT02969655|583043717|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
161450559|NCT02969655|583043716|FG000|Overall Study|Adverse Event|10|||
161450560|NCT02969655|583043717|FG001|Overall Study|Adverse Event|8|||
161450561|NCT01215097|583043728|FG000|Overall Study|Adverse Event|1|||
161450562|NCT01215097|583043729|FG001|Overall Study|Adverse Event|3|||
161450563|NCT01215097|583043728|FG000|Overall Study|Protocol Violation|0|||
161450564|NCT01215097|583043729|FG001|Overall Study|Protocol Violation|2|||
161450565|NCT01215097|583043728|FG000|Overall Study|Lost to Follow-up|2|||
161450566|NCT01215097|583043729|FG001|Overall Study|Lost to Follow-up|0|||
161555803|NCT03280563|583425275|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
161555804|NCT03280563|583425267|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
161450567|NCT01215097|583043728|FG000|Overall Study|Withdrawal by Subject|6|||
161450568|NCT01215097|583043729|FG001|Overall Study|Withdrawal by Subject|3|||
161555805|NCT03280563|583425268|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
161555806|NCT03280563|583425269|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
161555807|NCT03280563|583425270|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
161555808|NCT03280563|583425271|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
161555809|NCT03280563|583425272|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
161555810|NCT03280563|583425273|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
161555811|NCT03280563|583425274|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
161555812|NCT03280563|583425275|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
161555813|NCT04423393|583425276|FG000|Overall Study|Withdrawal by Subject|0|||
161555814|NCT04423393|583425277|FG001|Overall Study|Withdrawal by Subject|0|||
161555815|NCT04423393|583425278|FG002|Overall Study|Withdrawal by Subject|0|||
161555816|NCT04423393|583425279|FG003|Overall Study|Withdrawal by Subject|0|||
161555817|NCT04423393|583425280|FG004|Overall Study|Withdrawal by Subject|0|||
161555818|NCT04423393|583425281|FG005|Overall Study|Withdrawal by Subject|1|||
161555819|NCT04423393|583425282|FG006|Overall Study|Withdrawal by Subject|0|||
161555820|NCT04423393|583425283|FG007|Overall Study|Withdrawal by Subject|0|||
161555821|NCT04423393|583425284|FG008|Overall Study|Withdrawal by Subject|0|||
161555822|NCT04423393|583425285|FG009|Overall Study|Withdrawal by Subject|0|||
161555823|NCT04423393|583425286|FG010|Overall Study|Withdrawal by Subject|0|||
161555824|NCT04423393|583425287|FG011|Overall Study|Withdrawal by Subject|0|||
161555825|NCT04423393|583425288|FG012|Overall Study|Withdrawal by Subject|0|||
161555826|NCT04423393|583425289|FG013|Overall Study|Withdrawal by Subject|1|||
161555827|NCT04423393|583425290|FG014|Overall Study|Withdrawal by Subject|0|||
161555828|NCT04423393|583425291|FG015|Overall Study|Withdrawal by Subject|0|||
161555829|NCT04423393|583425292|FG016|Overall Study|Withdrawal by Subject|0|||
161555830|NCT04423393|583425293|FG017|Overall Study|Withdrawal by Subject|0|||
161555831|NCT04423393|583425276|FG000|Overall Study|Sponsor Decision|0|||
161555832|NCT04423393|583425277|FG001|Overall Study|Sponsor Decision|0|||
161555833|NCT04423393|583425278|FG002|Overall Study|Sponsor Decision|0|||
161555834|NCT04423393|583425279|FG003|Overall Study|Sponsor Decision|0|||
161555835|NCT04423393|583425280|FG004|Overall Study|Sponsor Decision|0|||
161555836|NCT04423393|583425281|FG005|Overall Study|Sponsor Decision|0|||
161555837|NCT04423393|583425282|FG006|Overall Study|Sponsor Decision|0|||
161555838|NCT04423393|583425283|FG007|Overall Study|Sponsor Decision|0|||
161555839|NCT04423393|583425284|FG008|Overall Study|Sponsor Decision|0|||
161555840|NCT04423393|583425285|FG009|Overall Study|Sponsor Decision|0|||
161555841|NCT04423393|583425286|FG010|Overall Study|Sponsor Decision|0|||
161555842|NCT04423393|583425287|FG011|Overall Study|Sponsor Decision|0|||
161555843|NCT04423393|583425288|FG012|Overall Study|Sponsor Decision|0|||
161555844|NCT04423393|583425289|FG013|Overall Study|Sponsor Decision|1|||
161555845|NCT04423393|583425290|FG014|Overall Study|Sponsor Decision|0|||
161555846|NCT04423393|583425291|FG015|Overall Study|Sponsor Decision|0|||
161555847|NCT04423393|583425292|FG016|Overall Study|Sponsor Decision|0|||
161555848|NCT04423393|583425293|FG017|Overall Study|Sponsor Decision|0|||
161555849|NCT00432159|583425294|FG000|Overall Study|Death|0|||
161555850|NCT00432159|583425295|FG001|Overall Study|Death|1|||
161555851|NCT00432159|583425296|FG002|Overall Study|Death|0|||
161555852|NCT00432159|583425297|FG003|Overall Study|Death|0|||
161555853|NCT00432159|583425298|FG004|Overall Study|Death|0|||
161555854|NCT00432159|583425294|FG000|Overall Study|Failure|9|||
161555855|NCT00432159|583425295|FG001|Overall Study|Failure|5|||
161555856|NCT00432159|583425296|FG002|Overall Study|Failure|3|||
161555857|NCT00432159|583425297|FG003|Overall Study|Failure|2|||
161555858|NCT00432159|583425298|FG004|Overall Study|Failure|3|||
161555859|NCT00432159|583425294|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
161555860|NCT00432159|583425295|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
161555861|NCT00432159|583425296|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
161555862|NCT00432159|583425297|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
161555863|NCT00432159|583425298|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
161555864|NCT00107380|583425299|FG000|Overall Study|Adverse Event|7|||
161555865|NCT00107380|583425299|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
161555866|NCT00107380|583425299|FG000|Overall Study|Progression/relapse|4|||
161555867|NCT00107380|583425299|FG000|Overall Study|Death|3|||
161555868|NCT00107380|583425299|FG000|Overall Study|Other - not protocol specified|7|||
161555869|NCT00107380|583425299|FG000|Overall Study|Ineligible|2|||
161555870|NCT03673098|583425300|FG000|Overall Study|Lost to Follow-up|2|||
161555871|NCT03673098|583425301|FG001|Overall Study|Lost to Follow-up|3|||
161555872|NCT03673098|583425300|FG000|Overall Study|Withdrawal by Subject|6|||
161555873|NCT03673098|583425301|FG001|Overall Study|Withdrawal by Subject|1|||
161555874|NCT03673098|583425300|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
161555875|NCT03673098|583425301|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
161555876|NCT03850444|583425302|FG000|Overall Study|Adverse Event|16|||
161555877|NCT03850444|583425303|FG001|Overall Study|Adverse Event|10|||
161555878|NCT03850444|583425302|FG000|Overall Study|Death|87|||
161555879|NCT03850444|583425303|FG001|Overall Study|Death|107|||
161555880|NCT03850444|583425302|FG000|Overall Study|Lost to Follow-up|1|||
161555881|NCT03850444|583425303|FG001|Overall Study|Lost to Follow-up|1|||
161555882|NCT03850444|583425302|FG000|Overall Study|Withdrawal by Subject|1|||
161555883|NCT03850444|583425303|FG001|Overall Study|Withdrawal by Subject|5|||
161555884|NCT03850444|583425302|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
161555885|NCT03850444|583425303|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
161555886|NCT01518257|583425304|FG000|Overall Study|Lost to Follow-up|1|||
161555887|NCT01518257|583425305|FG001|Overall Study|Lost to Follow-up|0|||
161555888|NCT01518257|583425304|FG000|Overall Study|Other Miscellaneous Reason|1|||
161555889|NCT01518257|583425305|FG001|Overall Study|Other Miscellaneous Reason|0|||
161555890|NCT01155726|583425309|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
161555891|NCT01155726|583425310|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
161555892|NCT01155726|583425311|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
161555893|NCT01155726|583425312|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
161555894|NCT02424344|583425316|FG000|Overall Study|Lack of Efficacy|0|||
161555895|NCT02424344|583425317|FG001|Overall Study|Lack of Efficacy|1|||
161555896|NCT02424344|583425316|FG000|Overall Study|Withdrawal by Subject|2|||
161555897|NCT02424344|583425317|FG001|Overall Study|Withdrawal by Subject|1|||
161555898|NCT02424344|583425316|FG000|Overall Study|Lost to Follow-up|1|||
161555899|NCT02424344|583425317|FG001|Overall Study|Lost to Follow-up|0|||
161555900|NCT02424344|583425316|FG000|Overall Study|Adverse Event|4|||
161555901|NCT02424344|583425317|FG001|Overall Study|Adverse Event|8|||
161555902|NCT04730947|583425318|FG000|Overall Study|Withdrawal by Subject|0|||
161555903|NCT04730947|583425319|FG001|Overall Study|Withdrawal by Subject|1|||
161555904|NCT02123966|583425320|FG000|Overall Study|Intercurrent Illness|1|||
161555905|NCT05257837|583425321|FG000|Overall Study|Excluded (did not find the guns)|4|||
161555906|NCT05257837|583425322|FG001|Overall Study|Excluded (did not find the guns)|2|||
161555907|NCT05257837|583425323|FG002|Overall Study|Excluded (did not find the guns)|4|||
161555908|NCT05257837|583425324|FG003|Overall Study|Excluded (did not find the guns)|0|||
161555909|NCT02561455|583425325|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
161555910|NCT02561455|583425326|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
161555911|NCT02561455|583425327|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
161555912|NCT02561455|583425328|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
161555913|NCT02561455|583425325|FG000|Overall Study|Withdrawal by Subject|1|||
161555914|NCT02561455|583425326|FG001|Overall Study|Withdrawal by Subject|0|||
161555915|NCT02561455|583425327|FG002|Overall Study|Withdrawal by Subject|1|||
161555916|NCT02561455|583425328|FG003|Overall Study|Withdrawal by Subject|0|||
161555917|NCT02561455|583425325|FG000|Overall Study|Disease Progression|0|||
161555918|NCT02561455|583425326|FG001|Overall Study|Disease Progression|1|||
161555919|NCT02561455|583425327|FG002|Overall Study|Disease Progression|0|||
161555920|NCT02561455|583425328|FG003|Overall Study|Disease Progression|0|||
161555921|NCT03639675|583425331|FG000|Overall Study|Withdrawal by Subject|1|||
161555922|NCT05675709|583425332|FG000|Overall Study|incomplete outcome data|2|||
161555923|NCT05675709|583425333|FG001|Overall Study|incomplete outcome data|8|||
161555924|NCT05343455|583425336|FG000|Overall Study|Withdrawal by Subject|4|||
161555925|NCT05343455|583425337|FG001|Overall Study|Withdrawal by Subject|9|||
161555926|NCT05343455|583425338|FG002|Overall Study|Withdrawal by Subject|7|||
161555927|NCT05343455|583425336|FG000|Overall Study|Adverse Event|2|||
161555928|NCT05343455|583425337|FG001|Overall Study|Adverse Event|1|||
161555929|NCT05343455|583425338|FG002|Overall Study|Adverse Event|2|||
161555930|NCT05343455|583425336|FG000|Overall Study|Lost to Follow-up|1|||
161555931|NCT05343455|583425337|FG001|Overall Study|Lost to Follow-up|1|||
161555932|NCT05343455|583425338|FG002|Overall Study|Lost to Follow-up|3|||
161555933|NCT05343455|583425336|FG000|Overall Study|Pregnancy|1|||
161555934|NCT05343455|583425337|FG001|Overall Study|Pregnancy|0|||
161555935|NCT05343455|583425338|FG002|Overall Study|Pregnancy|0|||
161555936|NCT05343455|583425336|FG000|Overall Study|Physician Decision|0|||
161555937|NCT05343455|583425337|FG001|Overall Study|Physician Decision|0|||
161555938|NCT05343455|583425338|FG002|Overall Study|Physician Decision|1|||
161555939|NCT05343455|583425336|FG000|Overall Study|Protocol Violation|0|||
161555940|NCT05343455|583425337|FG001|Overall Study|Protocol Violation|1|||
161555941|NCT05343455|583425338|FG002|Overall Study|Protocol Violation|1|||
161555942|NCT01254565|583425340|FG000|Overall Study|Non-compliance to Study Procedures|0|||
161555943|NCT01254565|583425341|FG001|Overall Study|Non-compliance to Study Procedures|0|||
161555944|NCT01254565|583425342|FG002|Overall Study|Non-compliance to Study Procedures|0|||
161555945|NCT01254565|583425343|FG003|Overall Study|Non-compliance to Study Procedures|0|||
161555946|NCT01254565|583425344|FG004|Overall Study|Non-compliance to Study Procedures|1|||
161555947|NCT01254565|583425345|FG005|Overall Study|Non-compliance to Study Procedures|0|||
161555948|NCT01254565|583425340|FG000|Overall Study|Did not Receive Treatment|1|||
161555949|NCT01254565|583425341|FG001|Overall Study|Did not Receive Treatment|1|||
161796656|NCT00437281|584298214|FG001|Overall Study|Adverse Event|0|||
161796657|NCT00437281|584298215|FG002|Overall Study|Adverse Event|0|||
161555950|NCT01254565|583425342|FG002|Overall Study|Did not Receive Treatment|0|||
161555951|NCT01254565|583425343|FG003|Overall Study|Did not Receive Treatment|0|||
161555952|NCT01254565|583425344|FG004|Overall Study|Did not Receive Treatment|3|||
161555953|NCT01254565|583425345|FG005|Overall Study|Did not Receive Treatment|4|||
161555954|NCT01254565|583425340|FG000|Overall Study|Other|0|||
161796658|NCT00437281|584298216|FG003|Overall Study|Adverse Event|1|||
161900869|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900870|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900871|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900872|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900873|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900874|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900875|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900876|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161450569|NCT01215097|583043728|FG000|Overall Study|Lack of Efficacy|0|||
161450570|NCT01215097|583043729|FG001|Overall Study|Lack of Efficacy|3|||
161450571|NCT01215097|583043728|FG000|Overall Study|patient's refusal to come|2|||
161450572|NCT01215097|583043729|FG001|Overall Study|patient's refusal to come|2|||
161450573|NCT01215097|583043728|FG000|Overall Study|patient's private reason|1|||
161450574|NCT01215097|583043729|FG001|Overall Study|patient's private reason|1|||
161450575|NCT02259088|583043730|FG000|Overall Study|Adverse Event|6|||
161450576|NCT02259088|583043731|FG001|Overall Study|Adverse Event|4|||
161450577|NCT02259088|583043730|FG000|Overall Study|Lost to Follow-up|2|||
161450578|NCT02259088|583043731|FG001|Overall Study|Lost to Follow-up|0|||
161450579|NCT02259088|583043730|FG000|Overall Study|Death|2|||
161450580|NCT02259088|583043731|FG001|Overall Study|Death|0|||
161450581|NCT02259088|583043730|FG000|Overall Study|Physician Decision|5|||
161450582|NCT02259088|583043731|FG001|Overall Study|Physician Decision|2|||
161450583|NCT02259088|583043730|FG000|Overall Study|Protocol deviation|5|||
161450584|NCT02259088|583043731|FG001|Overall Study|Protocol deviation|0|||
161450585|NCT02259088|583043730|FG000|Overall Study|Subject/guardian decision|8|||
161450586|NCT02259088|583043731|FG001|Overall Study|Subject/guardian decision|8|||
161450587|NCT01818752|583043733|FG000|Overall Study|Adverse Event|64|||
161450588|NCT01818752|583043734|FG001|Overall Study|Adverse Event|74|||
161450589|NCT01818752|583043733|FG000|Overall Study|Death|14|||
161450590|NCT01818752|583043734|FG001|Overall Study|Death|18|||
161450591|NCT01818752|583043733|FG000|Overall Study|Non-compliance|16|||
161450592|NCT01818752|583043734|FG001|Overall Study|Non-compliance|20|||
161450593|NCT01818752|583043733|FG000|Overall Study|Withdrawal by Subject|15|||
161450594|NCT01818752|583043734|FG001|Overall Study|Withdrawal by Subject|14|||
161450595|NCT01818752|583043733|FG000|Overall Study|Physician Decision|9|||
161450596|NCT01818752|583043734|FG001|Overall Study|Physician Decision|8|||
161450597|NCT01818752|583043733|FG000|Overall Study|Disease Progression|54|||
161450598|NCT01818752|583043734|FG001|Overall Study|Disease Progression|48|||
161450599|NCT01818752|583043733|FG000|Overall Study|Other|7|||
161450600|NCT01818752|583043734|FG001|Overall Study|Other|8|||
161450601|NCT01818752|583043733|FG000|Overall Study|Continuing Treatment|1|||
161450602|NCT01818752|583043734|FG001|Overall Study|Continuing Treatment|4|||
161450603|NCT01818752|583043733|FG000|Overall Study|Randomized but not Dosed|7|||
161450604|NCT01818752|583043734|FG001|Overall Study|Randomized but not Dosed|4|||
161450605|NCT04629066|583043735|FG000|Overall Study|Lost to Follow-up|3|||
161450606|NCT04629066|583043736|FG001|Overall Study|Lost to Follow-up|2|||
161450607|NCT00282308|583043739|FG000|Treatment Period|Lost to Follow-up|1|||
161450608|NCT00282308|583043740|FG001|Treatment Period|Lost to Follow-up|0|||
161450609|NCT00282308|583043741|FG002|Treatment Period|Lost to Follow-up|0|||
161450610|NCT00282308|583043739|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
161450611|NCT00282308|583043740|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
161450612|NCT00282308|583043741|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
161450613|NCT00282308|583043739|FG000|Treatment Period|Adverse Event|0|||
161450614|NCT00282308|583043740|FG001|Treatment Period|Adverse Event|2|||
161450615|NCT00282308|583043741|FG002|Treatment Period|Adverse Event|0|||
161450616|NCT00282308|583043739|FG000|Treatment Period|Not Treated with Study Drug|1|||
161450617|NCT00282308|583043740|FG001|Treatment Period|Not Treated with Study Drug|0|||
161450618|NCT00282308|583043741|FG002|Treatment Period|Not Treated with Study Drug|0|||
161450619|NCT00282308|583043739|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
161450620|NCT00282308|583043740|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
161450621|NCT00282308|583043741|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
161450622|NCT00282308|583043739|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
161450623|NCT00282308|583043740|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
161450624|NCT00282308|583043741|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
161450625|NCT00282308|583043739|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
161450626|NCT00282308|583043740|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
161450627|NCT00282308|583043741|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
161450628|NCT00282308|583043739|FG000|Safety Follow-up Period|Adverse Event|0|||
161450629|NCT00282308|583043740|FG001|Safety Follow-up Period|Adverse Event|0|||
161450630|NCT00282308|583043741|FG002|Safety Follow-up Period|Adverse Event|1|||
161450631|NCT00282308|583043739|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
161450632|NCT00282308|583043740|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161900877|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900878|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900879|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900880|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900881|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900882|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
161900883|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900884|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900885|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900886|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900887|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900888|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900889|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900890|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900891|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900892|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900893|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900894|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900895|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161796659|NCT00437281|584298217|FG004|Overall Study|Adverse Event|0|||
161796660|NCT00437281|584298218|FG005|Overall Study|Adverse Event|1|||
161900896|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900897|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900898|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900899|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161900900|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
161900901|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
161900902|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161900903|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161900904|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900905|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900906|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900907|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900908|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900909|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900910|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900911|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900912|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900913|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900914|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900915|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
161900916|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161900917|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161796661|NCT00437281|584298219|FG006|Overall Study|Adverse Event|0|||
161796662|NCT00437281|584298220|FG007|Overall Study|Adverse Event|0|||
161796663|NCT00437281|584298221|FG008|Overall Study|Adverse Event|0|||
161796664|NCT00437281|584298222|FG009|Overall Study|Adverse Event|1|||
161796665|NCT00437281|584298223|FG010|Overall Study|Adverse Event|0|||
161796666|NCT00437281|584298224|FG011|Overall Study|Adverse Event|0|||
161796667|NCT00437281|584298225|FG012|Overall Study|Adverse Event|0|||
161796668|NCT00437281|584298226|FG013|Overall Study|Adverse Event|1|||
161796669|NCT00437281|584298227|FG014|Overall Study|Adverse Event|1|||
161796670|NCT00437281|584298228|FG015|Overall Study|Adverse Event|0|||
161796671|NCT00437281|584298229|FG016|Overall Study|Adverse Event|0|||
161796672|NCT00437281|584298230|FG017|Overall Study|Adverse Event|0|||
161796673|NCT00437281|584298231|FG018|Overall Study|Adverse Event|1|||
161796674|NCT00437281|584298232|FG019|Overall Study|Adverse Event|0|||
161796675|NCT00437281|584298213|FG000|Overall Study|Lost to Follow-up|0|||
161796676|NCT00437281|584298214|FG001|Overall Study|Lost to Follow-up|0|||
161796677|NCT00437281|584298215|FG002|Overall Study|Lost to Follow-up|0|||
161450633|NCT00282308|583043741|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
161450634|NCT00282308|583043739|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
161555955|NCT01254565|583425341|FG001|Overall Study|Other|0|||
161796678|NCT00437281|584298216|FG003|Overall Study|Lost to Follow-up|0|||
161796679|NCT00437281|584298217|FG004|Overall Study|Lost to Follow-up|0|||
161796680|NCT00437281|584298218|FG005|Overall Study|Lost to Follow-up|0|||
161900918|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161900919|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161900920|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900921|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900922|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900923|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900924|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900925|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900926|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900927|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900928|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900929|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900930|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161900931|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900932|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161900933|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900934|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900935|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900936|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900937|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900938|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900939|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900940|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900941|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900942|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900943|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900944|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900945|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
161900946|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900947|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900948|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900949|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900950|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900951|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900952|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900953|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900954|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900955|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900956|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900957|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900958|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900959|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900960|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900961|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900962|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
161900963|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900964|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900965|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900966|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900967|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900968|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900969|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900970|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900971|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900972|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900973|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900974|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900975|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900976|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
161900977|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900978|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900979|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161555956|NCT01254565|583425342|FG002|Overall Study|Other|0|||
161796681|NCT00437281|584298219|FG006|Overall Study|Lost to Follow-up|0|||
161796682|NCT00437281|584298220|FG007|Overall Study|Lost to Follow-up|0|||
161796683|NCT00437281|584298221|FG008|Overall Study|Lost to Follow-up|0|||
161796684|NCT00437281|584298222|FG009|Overall Study|Lost to Follow-up|0|||
161796685|NCT00437281|584298223|FG010|Overall Study|Lost to Follow-up|0|||
161796686|NCT00437281|584298224|FG011|Overall Study|Lost to Follow-up|0|||
161796687|NCT00437281|584298225|FG012|Overall Study|Lost to Follow-up|0|||
161796688|NCT00437281|584298226|FG013|Overall Study|Lost to Follow-up|0|||
161796689|NCT00437281|584298227|FG014|Overall Study|Lost to Follow-up|0|||
161796690|NCT00437281|584298228|FG015|Overall Study|Lost to Follow-up|0|||
161796691|NCT00437281|584298229|FG016|Overall Study|Lost to Follow-up|0|||
161796692|NCT00437281|584298230|FG017|Overall Study|Lost to Follow-up|0|||
161796693|NCT00437281|584298231|FG018|Overall Study|Lost to Follow-up|0|||
161796694|NCT00437281|584298232|FG019|Overall Study|Lost to Follow-up|1|||
161796695|NCT00926289|584298233|FG000|Overall Study|Adverse Event|9|||
161796696|NCT00926289|584298234|FG001|Overall Study|Adverse Event|11|||
161796697|NCT00926289|584298233|FG000|Overall Study|Protocol Violation|8|||
161796698|NCT00926289|584298234|FG001|Overall Study|Protocol Violation|12|||
161796699|NCT00926289|584298233|FG000|Overall Study|Lost to Follow-up|3|||
161796700|NCT00926289|584298234|FG001|Overall Study|Lost to Follow-up|6|||
161796701|NCT00926289|584298233|FG000|Overall Study|Withdrawal by Subject|4|||
161796702|NCT00926289|584298234|FG001|Overall Study|Withdrawal by Subject|4|||
161796703|NCT00926289|584298233|FG000|Overall Study|Other|1|||
161796704|NCT00926289|584298234|FG001|Overall Study|Other|3|||
161796705|NCT04104646|584298235|FG000|Overall Study|Withdrawal by Subject|1|||
161796706|NCT04104646|584298236|FG001|Overall Study|Withdrawal by Subject|1|||
161796707|NCT04104646|584298235|FG000|Overall Study|Lost to Follow-up|1|||
161796708|NCT04104646|584298236|FG001|Overall Study|Lost to Follow-up|0|||
161796709|NCT04104646|584298235|FG000|Overall Study|Physician Decision|2|||
161796710|NCT04104646|584298236|FG001|Overall Study|Physician Decision|0|||
161796711|NCT00753714|584298237|FG000|Overall Study|Lack of Efficacy|21|||
161796712|NCT00753714|584298238|FG001|Overall Study|Lack of Efficacy|34|||
161796713|NCT00753714|584298237|FG000|Overall Study|Adverse Event|26|||
161796714|NCT00753714|584298238|FG001|Overall Study|Adverse Event|18|||
161796715|NCT00753714|584298237|FG000|Overall Study|Protocol Violation|1|||
161796716|NCT00753714|584298238|FG001|Overall Study|Protocol Violation|0|||
161796717|NCT00753714|584298237|FG000|Overall Study|Lost to Follow-up|0|||
161796718|NCT00753714|584298238|FG001|Overall Study|Lost to Follow-up|1|||
161796719|NCT00753714|584298237|FG000|Overall Study|Withdrawal by Subject|2|||
161796720|NCT00753714|584298238|FG001|Overall Study|Withdrawal by Subject|1|||
161796721|NCT00753714|584298237|FG000|Overall Study|Death|3|||
161796722|NCT00753714|584298238|FG001|Overall Study|Death|3|||
161796723|NCT00753714|584298237|FG000|Overall Study|Other|7|||
161796724|NCT00753714|584298238|FG001|Overall Study|Other|5|||
161796725|NCT03387098|584298239|FG000|Overall Study|progressive disease|1|||
161796726|NCT03387098|584298239|FG000|Overall Study|Withdrawal by Subject|2|||
161796727|NCT03387098|584298239|FG000|Overall Study|study terminated by sponsor|1|||
161796728|NCT02292238|584298240|FG000|Overall Study|Protocol Violation|1|||
161796729|NCT02292238|584298241|FG001|Overall Study|Protocol Violation|2|||
161796730|NCT02292238|584298240|FG000|Overall Study|Withdrawal by Subject|2|||
161796731|NCT02292238|584298241|FG001|Overall Study|Withdrawal by Subject|1|||
161796732|NCT02292238|584298240|FG000|Overall Study|Lost to Follow-up|1|||
161796733|NCT02292238|584298241|FG001|Overall Study|Lost to Follow-up|0|||
161796734|NCT02292238|584298240|FG000|Overall Study|Physician Decision|0|||
161796735|NCT02292238|584298241|FG001|Overall Study|Physician Decision|1|||
161796736|NCT04000009|584298242|FG000|Overall Study|Adverse Event|13|||
161796737|NCT04000009|584298242|FG000|Overall Study|Lack of Efficacy|7|||
161796738|NCT04000009|584298242|FG000|Overall Study|Lost to Follow-up|8|||
161796739|NCT04000009|584298242|FG000|Overall Study|Noncompliance with study drug|4|||
161796740|NCT04000009|584298242|FG000|Overall Study|Physician Decision|1|||
161796741|NCT04000009|584298242|FG000|Overall Study|Use of prohibited medication|3|||
161796742|NCT04000009|584298242|FG000|Overall Study|Pregnancy|1|||
161796743|NCT04000009|584298242|FG000|Overall Study|Withdrawal by Subject|22|||
161796744|NCT04000009|584298242|FG000|Overall Study|Study terminated by sponsor|98|||
161796745|NCT04000009|584298242|FG000|Overall Study|Not further specified|8|||
161796746|NCT01754259|584298245|FG000|Overall Study|Withdrawal by Subject|2|||
161796747|NCT01754259|584298246|FG001|Overall Study|Withdrawal by Subject|4|||
161796748|NCT01754259|584298245|FG000|Overall Study|Adverse Event|3|||
161796749|NCT01754259|584298246|FG001|Overall Study|Adverse Event|1|||
161796750|NCT01754259|584298245|FG000|Overall Study|Lost to Follow-up|0|||
161796751|NCT01754259|584298246|FG001|Overall Study|Lost to Follow-up|1|||
161796752|NCT02829918|584298247|FG000|Overall Study|Death|2|||
161796753|NCT02829918|584298247|FG000|Overall Study|Withdrawal by Subject|4|||
161796754|NCT02829918|584298247|FG000|Overall Study|Adverse Event|1|||
161796755|NCT02829918|584298247|FG000|Overall Study|Progression|1|||
161796756|NCT00491504|584298250|FG000|Overall Study|Adverse Event|0|||
161796757|NCT00491504|584298251|FG001|Overall Study|Adverse Event|1|||
161796758|NCT00491504|584298252|FG002|Overall Study|Adverse Event|0|||
161796759|NCT00491504|584298253|FG003|Overall Study|Adverse Event|0|||
161796760|NCT00491504|584298250|FG000|Overall Study|Withdrawal by Subject|0|||
161900980|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900981|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900982|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900983|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900984|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900985|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900986|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900987|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900988|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900989|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900990|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900991|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900992|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900993|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
161900994|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900995|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900996|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900997|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900998|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900999|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161901000|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901001|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901002|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901003|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901004|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901005|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
161901006|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
161901007|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
161901008|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
161901009|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901010|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901011|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901012|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901013|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901014|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901015|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901016|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901017|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901018|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901019|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901020|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
161901021|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901022|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901023|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901024|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901025|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901026|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901027|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901028|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901029|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901030|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901031|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901032|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901033|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901034|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901035|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161450635|NCT00282308|583043740|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
161901036|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
161450636|NCT00282308|583043741|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
161450637|NCT00282308|583043739|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
161901037|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901038|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901039|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901040|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901041|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901042|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901043|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901044|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901045|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
161901046|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
161901047|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
161901048|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
161901049|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
161901050|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
161901051|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
161901052|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
161901053|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
161901054|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
161901055|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
161901056|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
161901057|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
161901058|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
161901059|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
161901060|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901061|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901062|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901063|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901064|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901065|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901066|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901067|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901068|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901069|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901070|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
161901071|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
161901072|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161901073|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901074|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
161901075|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901076|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901077|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901078|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901079|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901080|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901081|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901082|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901083|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901084|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901085|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161901086|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901087|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161901088|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901089|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901090|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901091|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901092|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901093|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901094|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901095|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901096|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901097|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161555957|NCT01254565|583425343|FG003|Overall Study|Other|1|||
161901098|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901099|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901100|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901101|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
161901102|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901103|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901104|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901105|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901106|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901107|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901108|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901109|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901110|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901111|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901112|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901113|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901114|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901115|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
161901116|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901117|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
161901118|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901119|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
161901120|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901121|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901122|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901123|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901124|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901125|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901126|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901127|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901128|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901129|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901130|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901131|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
161901132|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901133|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901134|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
161901135|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901136|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901137|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901138|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901139|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901140|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901141|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901142|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901143|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901144|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901145|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901146|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
161901147|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161901148|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901149|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161901150|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901151|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901152|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901153|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901154|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901155|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901156|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901157|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901158|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901159|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901160|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901161|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
161555958|NCT01254565|583425344|FG004|Overall Study|Other|0|||
161555959|NCT01254565|583425345|FG005|Overall Study|Other|0|||
161555960|NCT03354637|583425350|FG000|Double-blind Period|Protocol Violation|2|||
161555961|NCT03354637|583425351|FG001|Double-blind Period|Protocol Violation|0|||
161555962|NCT03354637|583425352|FG002|Double-blind Period|Protocol Violation|0|||
161796761|NCT00491504|584298251|FG001|Overall Study|Withdrawal by Subject|0|||
161796762|NCT00491504|584298252|FG002|Overall Study|Withdrawal by Subject|1|||
161796763|NCT00491504|584298253|FG003|Overall Study|Withdrawal by Subject|2|||
161796764|NCT00491504|584298250|FG000|Overall Study|Protocol Violation|0|||
161796765|NCT00491504|584298251|FG001|Overall Study|Protocol Violation|0|||
161796766|NCT00491504|584298252|FG002|Overall Study|Protocol Violation|3|||
161796767|NCT00491504|584298253|FG003|Overall Study|Protocol Violation|2|||
161796768|NCT00673790|584298254|FG000|Overall Study|Adverse Event|23|||
161796769|NCT00673790|584298255|FG001|Overall Study|Adverse Event|14|||
161796770|NCT00673790|584298256|FG002|Overall Study|Adverse Event|2|||
161796771|NCT00673790|584298254|FG000|Overall Study|Lack of Efficacy|2|||
161796772|NCT00673790|584298255|FG001|Overall Study|Lack of Efficacy|2|||
161796773|NCT00673790|584298256|FG002|Overall Study|Lack of Efficacy|2|||
161796774|NCT00673790|584298254|FG000|Overall Study|Protocol Violation|6|||
161796775|NCT00673790|584298255|FG001|Overall Study|Protocol Violation|9|||
161796776|NCT00673790|584298256|FG002|Overall Study|Protocol Violation|1|||
161796777|NCT00673790|584298254|FG000|Overall Study|Withdrawal by Subject|7|||
161796778|NCT00673790|584298255|FG001|Overall Study|Withdrawal by Subject|4|||
161796779|NCT00673790|584298256|FG002|Overall Study|Withdrawal by Subject|1|||
161796780|NCT00673790|584298254|FG000|Overall Study|Lost to Follow-up|6|||
161796781|NCT00673790|584298255|FG001|Overall Study|Lost to Follow-up|6|||
161796782|NCT00673790|584298256|FG002|Overall Study|Lost to Follow-up|5|||
161796783|NCT00673790|584298254|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
161796784|NCT00673790|584298255|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
161796785|NCT00673790|584298256|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
161796786|NCT00673790|584298254|FG000|Overall Study|Poor compliance|1|||
161796787|NCT00673790|584298255|FG001|Overall Study|Poor compliance|0|||
161796788|NCT00673790|584298256|FG002|Overall Study|Poor compliance|0|||
161796789|NCT00673790|584298254|FG000|Overall Study|Participated in two Nebivolol studies|0|||
161796790|NCT00673790|584298255|FG001|Overall Study|Participated in two Nebivolol studies|0|||
161796791|NCT00673790|584298256|FG002|Overall Study|Participated in two Nebivolol studies|1|||
161796792|NCT00673790|584298254|FG000|Overall Study|Unconfirmed pregnancy|0|||
161796793|NCT00673790|584298255|FG001|Overall Study|Unconfirmed pregnancy|1|||
161796794|NCT00673790|584298256|FG002|Overall Study|Unconfirmed pregnancy|0|||
161796795|NCT00673790|584298254|FG000|Overall Study|Randomization criteria not met|0|||
161796796|NCT00673790|584298255|FG001|Overall Study|Randomization criteria not met|1|||
161796797|NCT00673790|584298256|FG002|Overall Study|Randomization criteria not met|0|||
161796798|NCT00717756|584298257|FG000|Overall Study|Withdrawal by Subject|1|||
161796799|NCT01364870|584298258|FG000|Overall Study|Withdrawal by Subject|13|||
161796800|NCT01364870|584298259|FG001|Overall Study|Withdrawal by Subject|24|||
161796801|NCT01364870|584298260|FG002|Overall Study|Withdrawal by Subject|10|||
161796802|NCT01364870|584298258|FG000|Overall Study|Adverse Event|8|||
161796803|NCT01364870|584298259|FG001|Overall Study|Adverse Event|6|||
161796804|NCT01364870|584298260|FG002|Overall Study|Adverse Event|4|||
161796805|NCT01364870|584298258|FG000|Overall Study|Protocol Violation|1|||
161796806|NCT01364870|584298259|FG001|Overall Study|Protocol Violation|0|||
161796807|NCT01364870|584298260|FG002|Overall Study|Protocol Violation|0|||
161796808|NCT01873859|584298261|FG000|Overall Study|Withdrawal by Subject|0|||
161796809|NCT01873859|584298262|FG001|Overall Study|Withdrawal by Subject|4|||
161796810|NCT03977584|584298263|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
161796811|NCT03977584|584298264|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
161796812|NCT03977584|584298265|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
161796813|NCT02257736|584298269|FG000|Overall Study|Progressive disease|365|||
161796814|NCT02257736|584298270|FG001|Overall Study|Progressive disease|327|||
161796815|NCT02257736|584298269|FG000|Overall Study|Adverse Event|45|||
161796816|NCT02257736|584298270|FG001|Overall Study|Adverse Event|56|||
161796817|NCT02257736|584298269|FG000|Overall Study|Withdrawal by Subject|21|||
161555963|NCT03354637|583425350|FG000|Double-blind Period|Adverse Event|1|||
161796818|NCT02257736|584298270|FG001|Overall Study|Withdrawal by Subject|38|||
161796819|NCT02257736|584298269|FG000|Overall Study|Death|11|||
161796820|NCT02257736|584298270|FG001|Overall Study|Death|6|||
161796821|NCT02257736|584298269|FG000|Overall Study|Physician Decision|5|||
161796822|NCT02257736|584298270|FG001|Overall Study|Physician Decision|9|||
161796823|NCT02257736|584298269|FG000|Overall Study|Non-Compliance with study drug|1|||
161796824|NCT02257736|584298270|FG001|Overall Study|Non-Compliance with study drug|2|||
161796825|NCT02257736|584298269|FG000|Overall Study|Protocol Violation|1|||
161796826|NCT02257736|584298270|FG001|Overall Study|Protocol Violation|0|||
161796827|NCT02257736|584298269|FG000|Overall Study|Other|1|||
161796828|NCT02257736|584298270|FG001|Overall Study|Other|7|||
161555964|NCT03354637|583425351|FG001|Double-blind Period|Adverse Event|2|||
161555965|NCT03354637|583425352|FG002|Double-blind Period|Adverse Event|0|||
161796829|NCT02257736|584298269|FG000|Overall Study|Randomized, not treated|1|||
161796830|NCT02257736|584298270|FG001|Overall Study|Randomized, not treated|2|||
161796831|NCT00745251|584298278|FG000|Overall Study|Adverse Event|1|||
161796832|NCT00745251|584298279|FG001|Overall Study|Adverse Event|2|||
161796833|NCT00745251|584298278|FG000|Overall Study|Withdrawal by Subject|1|||
161796834|NCT00745251|584298279|FG001|Overall Study|Withdrawal by Subject|1|||
161796835|NCT03390504|584298280|FG000|Overall Study|Lost to Follow-up|2|||
161796836|NCT03390504|584298281|FG001|Overall Study|Lost to Follow-up|4|||
161796837|NCT03390504|584298282|FG002|Overall Study|Lost to Follow-up|0|||
161796838|NCT03390504|584298283|FG003|Overall Study|Lost to Follow-up|1|||
161796839|NCT03390504|584298280|FG000|Overall Study|Withdrawal by Subject|3|||
161796840|NCT03390504|584298281|FG001|Overall Study|Withdrawal by Subject|15|||
161796841|NCT03390504|584298282|FG002|Overall Study|Withdrawal by Subject|5|||
161796842|NCT03390504|584298283|FG003|Overall Study|Withdrawal by Subject|2|||
161796843|NCT03390504|584298280|FG000|Overall Study|Other|1|||
161796844|NCT03390504|584298281|FG001|Overall Study|Other|2|||
161796845|NCT03390504|584298282|FG002|Overall Study|Other|2|||
161796846|NCT03390504|584298283|FG003|Overall Study|Other|6|||
161796847|NCT03850509|584298284|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
161796848|NCT03850509|584298285|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
161796849|NCT02666430|584298286|FG000|Period 1|Lost to Follow-up|1|||
161796850|NCT02666430|584298287|FG001|Period 1|Lost to Follow-up|0|||
161796851|NCT02666430|584298286|FG000|Period 1|Adverse Event|0|||
161796852|NCT02666430|584298287|FG001|Period 1|Adverse Event|1|||
161796853|NCT02666430|584298286|FG000|Period 2|Withdrawal by Subject|1|||
161796854|NCT02666430|584298287|FG001|Period 2|Withdrawal by Subject|4|||
161796855|NCT02666430|584298286|FG000|Period 3|Lost to Follow-up|1|||
161796856|NCT02666430|584298287|FG001|Period 3|Lost to Follow-up|0|||
161796857|NCT03922477|584298288|FG000|Overall Study|Death|9|||
161796858|NCT03922477|584298288|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
161796859|NCT03922477|584298288|FG000|Overall Study|Physician Decision|1|||
161796860|NCT03922477|584298288|FG000|Overall Study|Withdrawal by Subject|2|||
161796861|NCT01618305|584298292|FG000|Overall Study|Death|0|||
161796862|NCT01618305|584298293|FG001|Overall Study|Death|1|||
161796863|NCT01618305|584298292|FG000|Overall Study|Lost to Follow-up|11|||
161796864|NCT01618305|584298293|FG001|Overall Study|Lost to Follow-up|7|||
161796865|NCT01618305|584298292|FG000|Overall Study|Protocol Violation|1|||
161796866|NCT01618305|584298293|FG001|Overall Study|Protocol Violation|0|||
161796867|NCT01618305|584298292|FG000|Overall Study|Withdrawal by Subject|3|||
161796868|NCT01618305|584298293|FG001|Overall Study|Withdrawal by Subject|2|||
161796869|NCT01565083|584298294|FG000|Overall Study|Withdrawal by Subject|6|||
161796870|NCT01565083|584298295|FG001|Overall Study|Withdrawal by Subject|4|||
161796871|NCT01565083|584298294|FG000|Overall Study|Lost to Follow-up|2|||
161796872|NCT01565083|584298295|FG001|Overall Study|Lost to Follow-up|7|||
161796873|NCT01565083|584298294|FG000|Overall Study|Death|22|||
161796874|NCT01565083|584298295|FG001|Overall Study|Death|23|||
161796875|NCT01565083|584298294|FG000|Overall Study|Other|3|||
161796876|NCT01565083|584298295|FG001|Overall Study|Other|5|||
161796877|NCT01960816|584298296|FG000|Overall Study|Lost to Follow-up|1|||
161796878|NCT05431686|584298297|FG000|Overall Study|unable to schedule|10|||
161796879|NCT01118728|584298312|FG000|Overall Study|Adverse Event|17|||
161796880|NCT01118728|584298312|FG000|Overall Study|Lack of Efficacy|27|||
161796881|NCT01118728|584298312|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
161796882|NCT01118728|584298312|FG000|Overall Study|Withdrawal by Subject|3|||
161796883|NCT01118728|584298312|FG000|Overall Study|Lost to Follow-up|4|||
161796884|NCT01309919|584298313|FG000|Overall Study|Did not receive a postpartum IUD|17|||
161796885|NCT01309919|584298314|FG001|Overall Study|Did not receive a postpartum IUD|48|||
161796886|NCT01736553|584298319|FG000|Overall Study|Death|12|||
161796887|NCT01736553|584298320|FG001|Overall Study|Death|0|||
161796888|NCT01736553|584298319|FG000|Overall Study|Withdrawal by Subject|5|||
161796889|NCT01736553|584298320|FG001|Overall Study|Withdrawal by Subject|2|||
161796890|NCT01736553|584298319|FG000|Overall Study|Lost to Follow-up|2|||
161796891|NCT01736553|584298320|FG001|Overall Study|Lost to Follow-up|2|||
161796892|NCT02178709|584299590|FG000|Overall Study|Adverse Event|5|||
161796893|NCT02178709|584299590|FG000|Overall Study|Death|2|||
161796894|NCT02178709|584299590|FG000|Overall Study|Withdrawal by Subject|2|||
161796895|NCT02178709|584299590|FG000|Overall Study|Physician Decision|2|||
161796896|NCT02178709|584299590|FG000|Overall Study|Disease Progression|5|||
161796897|NCT02192905|584299593|FG000|Overall Study|Lost to Follow-up|1|||
161796898|NCT01691859|584299594|FG000|Overall Study|Adverse Event|19|||
161796899|NCT01691859|584299594|FG000|Overall Study|Lack of Efficacy|11|||
161796900|NCT01691859|584299594|FG000|Overall Study|Protocol Violation|4|||
161796901|NCT01691859|584299594|FG000|Overall Study|Product commercially available|221|||
161796902|NCT01691859|584299594|FG000|Overall Study|Study closed/terminated|50|||
161796903|NCT01691859|584299594|FG000|Overall Study|Lost to Follow-up|5|||
161796904|NCT01691859|584299594|FG000|Overall Study|Physician Decision|6|||
161796905|NCT01691859|584299594|FG000|Overall Study|Withdrawal by Subject|31|||
161796906|NCT00862979|584299595|FG000|Overall Study|Adverse Event|6|||
161796907|NCT00862979|584299596|FG001|Overall Study|Adverse Event|3|||
161796908|NCT00862979|584299595|FG000|Overall Study|Protocol Violation|0|||
161796909|NCT00862979|584299596|FG001|Overall Study|Protocol Violation|1|||
161796910|NCT00862979|584299595|FG000|Overall Study|Patient withdrew consent|2|||
161796911|NCT00862979|584299596|FG001|Overall Study|Patient withdrew consent|1|||
161796912|NCT00862979|584299595|FG000|Overall Study|Administrative problems|0|||
161796913|NCT00862979|584299596|FG001|Overall Study|Administrative problems|1|||
161796914|NCT00862979|584299595|FG000|Overall Study|Death|0|||
161796915|NCT00862979|584299596|FG001|Overall Study|Death|1|||
161796916|NCT00992407|584299599|FG000|Overall Study|Protocol Violation|2|||
161796917|NCT00992407|584299600|FG001|Overall Study|Protocol Violation|1|||
161796918|NCT00992407|584299599|FG000|Overall Study|Lost to Follow-up|3|||
161796919|NCT00992407|584299600|FG001|Overall Study|Lost to Follow-up|3|||
161796920|NCT00992407|584299599|FG000|Overall Study|Adverse Event|3|||
161796921|NCT00992407|584299600|FG001|Overall Study|Adverse Event|2|||
161796922|NCT00992407|584299599|FG000|Overall Study|protocol Violation & Adverse events|2|||
161796923|NCT00992407|584299600|FG001|Overall Study|protocol Violation & Adverse events|4|||
161796924|NCT00992407|584299599|FG000|Overall Study|Other|2|||
161796925|NCT00992407|584299600|FG001|Overall Study|Other|0|||
161796926|NCT00992407|584299599|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
161796927|NCT00992407|584299600|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
161796928|NCT00992407|584299599|FG000|Overall Study|Study medication not administered|17|||
161796929|NCT00992407|584299600|FG001|Overall Study|Study medication not administered|13|||
161796930|NCT03738332|584299601|FG000|Overall Study|Withdrawal by Subject|1|||
161796931|NCT01521559|584299602|FG000|Overall Study|Adverse Event|0|||
161796932|NCT01521559|584299603|FG001|Overall Study|Adverse Event|4|||
161796933|NCT01521559|584299602|FG000|Overall Study|Death|1|||
161796934|NCT01521559|584299603|FG001|Overall Study|Death|0|||
161796935|NCT01521559|584299602|FG000|Overall Study|Withdrawal by Subject|9|||
161796936|NCT01521559|584299603|FG001|Overall Study|Withdrawal by Subject|11|||
161796937|NCT01521559|584299602|FG000|Overall Study|Lost to Follow-up|3|||
161796938|NCT01521559|584299603|FG001|Overall Study|Lost to Follow-up|1|||
161796939|NCT01521559|584299602|FG000|Overall Study|Protocol Violation|1|||
161796940|NCT01521559|584299603|FG001|Overall Study|Protocol Violation|0|||
161796941|NCT01521559|584299602|FG000|Overall Study|Other|1|||
161796942|NCT01521559|584299603|FG001|Overall Study|Other|2|||
161796943|NCT02336737|584299604|FG000|Overall Study|Withdrawal by Subject|5|||
161796944|NCT02336737|584299604|FG000|Overall Study|Physician Decision|8|||
161796945|NCT00275002|584299606|FG000|Overall Study|Death|1|||
161796946|NCT00275002|584299607|FG001|Overall Study|Death|0|||
161796947|NCT00275002|584299606|FG000|Overall Study|Disease progression|21|||
161796948|NCT00275002|584299607|FG001|Overall Study|Disease progression|15|||
161796949|NCT00275002|584299606|FG000|Overall Study|Adverse Event|0|||
161796950|NCT00275002|584299607|FG001|Overall Study|Adverse Event|1|||
161796951|NCT04543136|584299621|FG000|Overall Study|Withdrawal by Subject|0|||
161796952|NCT04543136|584299622|FG001|Overall Study|Withdrawal by Subject|1|||
161796953|NCT04543136|584299623|FG002|Overall Study|Withdrawal by Subject|0|||
161796954|NCT04543136|584299624|FG003|Overall Study|Withdrawal by Subject|1|||
161796955|NCT04543136|584299625|FG004|Overall Study|Withdrawal by Subject|0|||
161796956|NCT04543136|584299626|FG005|Overall Study|Withdrawal by Subject|0|||
161796957|NCT00638157|584299631|FG000|Overall Study|Adverse Event|0|||
161796958|NCT00638157|584299632|FG001|Overall Study|Adverse Event|1|||
161796959|NCT00638157|584299631|FG000|Overall Study|Clinical (symptomatic) failure|1|||
161796960|NCT00638157|584299632|FG001|Overall Study|Clinical (symptomatic) failure|1|||
161796961|NCT00638157|584299631|FG000|Overall Study|Microbiological failure|1|||
161796962|NCT00638157|584299632|FG001|Overall Study|Microbiological failure|0|||
161796963|NCT00638157|584299631|FG000|Overall Study|Lost to Follow-up|1|||
161796964|NCT00638157|584299632|FG001|Overall Study|Lost to Follow-up|0|||
161796965|NCT00638157|584299631|FG000|Overall Study|Physician Decision|1|||
161796966|NCT00638157|584299632|FG001|Overall Study|Physician Decision|0|||
161796967|NCT00638157|584299631|FG000|Overall Study|Other|1|||
161796968|NCT00638157|584299632|FG001|Overall Study|Other|2|||
161796969|NCT00638157|584299631|FG000|Overall Study|Randomized, not treated|2|||
161796970|NCT00638157|584299632|FG001|Overall Study|Randomized, not treated|0|||
161796971|NCT02365597|584299633|FG000|Overall Study|Lost to Follow-up|0|||
161796972|NCT02365597|584299634|FG001|Overall Study|Lost to Follow-up|1|||
161796973|NCT02365597|584299635|FG002|Overall Study|Lost to Follow-up|0|||
161796974|NCT02365597|584299636|FG003|Overall Study|Lost to Follow-up|1|||
161796975|NCT02365597|584299633|FG000|Overall Study|Withdrawal by Subject|1|||
161796976|NCT02365597|584299634|FG001|Overall Study|Withdrawal by Subject|8|||
161796977|NCT02365597|584299635|FG002|Overall Study|Withdrawal by Subject|5|||
161796978|NCT02365597|584299636|FG003|Overall Study|Withdrawal by Subject|1|||
161796979|NCT02365597|584299633|FG000|Overall Study|Sponsor's decision|1|||
161796980|NCT02365597|584299634|FG001|Overall Study|Sponsor's decision|3|||
161796981|NCT02365597|584299635|FG002|Overall Study|Sponsor's decision|13|||
161796982|NCT02365597|584299636|FG003|Overall Study|Sponsor's decision|0|||
161796983|NCT02365597|584299633|FG000|Overall Study|Other|0|||
161796984|NCT02365597|584299634|FG001|Overall Study|Other|4|||
161796985|NCT02365597|584299635|FG002|Overall Study|Other|0|||
161796986|NCT02365597|584299636|FG003|Overall Study|Other|0|||
161796987|NCT02365597|584299633|FG000|Overall Study|Enrolled but not treated|0|||
161796988|NCT02365597|584299634|FG001|Overall Study|Enrolled but not treated|1|||
161901162|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901163|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161796989|NCT02365597|584299635|FG002|Overall Study|Enrolled but not treated|1|||
161796990|NCT02365597|584299636|FG003|Overall Study|Enrolled but not treated|0|||
161796991|NCT02365597|584299633|FG000|Overall Study|Ongoing|0|||
161796992|NCT02365597|584299634|FG001|Overall Study|Ongoing|0|||
161796993|NCT02365597|584299635|FG002|Overall Study|Ongoing|0|||
161796994|NCT02365597|584299636|FG003|Overall Study|Ongoing|17|||
161796995|NCT04309474|584299637|FG000|Overall Study|Randomized but not treated|0|||
161796996|NCT04309474|584299638|FG001|Overall Study|Randomized but not treated|2|||
161796997|NCT04309474|584299637|FG000|Overall Study|Adverse Event|4|||
161796998|NCT04309474|584299638|FG001|Overall Study|Adverse Event|1|||
161796999|NCT04309474|584299637|FG000|Overall Study|Withdrawal by Subject|6|||
161797000|NCT04309474|584299638|FG001|Overall Study|Withdrawal by Subject|9|||
161797001|NCT04309474|584299637|FG000|Overall Study|Lost to Follow-up|1|||
161797002|NCT04309474|584299638|FG001|Overall Study|Lost to Follow-up|2|||
161797003|NCT04309474|584299637|FG000|Overall Study|Not disclosed|10|||
161797004|NCT04309474|584299638|FG001|Overall Study|Not disclosed|6|||
161797005|NCT04670068|584299639|FG000|Overall Study|Progressive Disease|1|||
161797006|NCT04670068|584299640|FG001|Overall Study|Progressive Disease|1|||
161797007|NCT04670068|584299639|FG000|Overall Study|Withdrawal by Subject|1|||
161797008|NCT04670068|584299640|FG001|Overall Study|Withdrawal by Subject|0|||
161797009|NCT04684524|584299641|FG000|Overall Study|Other|2|||
161797010|NCT04684524|584299642|FG001|Overall Study|Other|0|||
161797011|NCT04684524|584299641|FG000|Overall Study|Withdrawal by Subject|5|||
161797012|NCT04684524|584299642|FG001|Overall Study|Withdrawal by Subject|3|||
161797013|NCT04684524|584299641|FG000|Overall Study|Adverse Event|1|||
161797014|NCT04684524|584299642|FG001|Overall Study|Adverse Event|1|||
161797015|NCT00601354|584299646|FG000|Overall Study|Lost to Follow-up|4|||
161797016|NCT00601354|584299647|FG001|Overall Study|Lost to Follow-up|5|||
161797017|NCT03466411|584299648|FG000|Overall Study|Lost to Follow-up|0|||
161797018|NCT03466411|584299649|FG001|Overall Study|Lost to Follow-up|1|||
161797019|NCT03466411|584299650|FG002|Overall Study|Lost to Follow-up|1|||
161797020|NCT03466411|584299651|FG003|Overall Study|Lost to Follow-up|0|||
161797021|NCT03466411|584299652|FG004|Overall Study|Lost to Follow-up|0|||
161797022|NCT03466411|584299653|FG005|Overall Study|Lost to Follow-up|0|||
161797023|NCT03466411|584299654|FG006|Overall Study|Lost to Follow-up|1|||
161797024|NCT03466411|584299655|FG007|Overall Study|Lost to Follow-up|1|||
161797025|NCT03466411|584299656|FG008|Overall Study|Lost to Follow-up|0|||
161797026|NCT03466411|584299657|FG009|Overall Study|Lost to Follow-up|1|||
161797027|NCT03466411|584299658|FG010|Overall Study|Lost to Follow-up|1|||
161797028|NCT03466411|584299659|FG011|Overall Study|Lost to Follow-up|1|||
161797029|NCT03466411|584299660|FG012|Overall Study|Lost to Follow-up|0|||
161797030|NCT03466411|584299648|FG000|Overall Study|Withdrawal by Subject|14|||
161797031|NCT03466411|584299649|FG001|Overall Study|Withdrawal by Subject|7|||
161797032|NCT03466411|584299650|FG002|Overall Study|Withdrawal by Subject|8|||
161797033|NCT03466411|584299651|FG003|Overall Study|Withdrawal by Subject|4|||
161797034|NCT03466411|584299652|FG004|Overall Study|Withdrawal by Subject|6|||
161797035|NCT03466411|584299653|FG005|Overall Study|Withdrawal by Subject|3|||
161797036|NCT03466411|584299654|FG006|Overall Study|Withdrawal by Subject|6|||
161797037|NCT03466411|584299655|FG007|Overall Study|Withdrawal by Subject|9|||
161797038|NCT03466411|584299656|FG008|Overall Study|Withdrawal by Subject|6|||
161797039|NCT03466411|584299657|FG009|Overall Study|Withdrawal by Subject|11|||
161797040|NCT03466411|584299658|FG010|Overall Study|Withdrawal by Subject|14|||
161797041|NCT03466411|584299659|FG011|Overall Study|Withdrawal by Subject|12|||
161797042|NCT03466411|584299660|FG012|Overall Study|Withdrawal by Subject|7|||
161797043|NCT03466411|584299648|FG000|Overall Study|Other|1|||
161797044|NCT03466411|584299649|FG001|Overall Study|Other|1|||
161797045|NCT03466411|584299650|FG002|Overall Study|Other|0|||
161797046|NCT03466411|584299651|FG003|Overall Study|Other|1|||
161797047|NCT03466411|584299652|FG004|Overall Study|Other|2|||
161797048|NCT03466411|584299653|FG005|Overall Study|Other|0|||
161797049|NCT03466411|584299654|FG006|Overall Study|Other|0|||
161901164|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901165|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901166|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901167|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797050|NCT03466411|584299655|FG007|Overall Study|Other|0|||
161797051|NCT03466411|584299656|FG008|Overall Study|Other|0|||
161797052|NCT03466411|584299657|FG009|Overall Study|Other|1|||
161901168|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901169|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797053|NCT03466411|584299658|FG010|Overall Study|Other|2|||
161797054|NCT03466411|584299659|FG011|Overall Study|Other|0|||
161797055|NCT03466411|584299660|FG012|Overall Study|Other|0|||
161901170|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797056|NCT03466411|584299648|FG000|Overall Study|Randomized but not Treated|0|||
161797057|NCT03466411|584299649|FG001|Overall Study|Randomized but not Treated|0|||
161797058|NCT03466411|584299650|FG002|Overall Study|Randomized but not Treated|0|||
161797059|NCT03466411|584299651|FG003|Overall Study|Randomized but not Treated|0|||
161797060|NCT03466411|584299652|FG004|Overall Study|Randomized but not Treated|0|||
161797061|NCT03466411|584299653|FG005|Overall Study|Randomized but not Treated|0|||
161797062|NCT03466411|584299654|FG006|Overall Study|Randomized but not Treated|1|||
161797063|NCT03466411|584299655|FG007|Overall Study|Randomized but not Treated|0|||
161797064|NCT03466411|584299656|FG008|Overall Study|Randomized but not Treated|0|||
161797065|NCT03466411|584299657|FG009|Overall Study|Randomized but not Treated|0|||
161797066|NCT03466411|584299658|FG010|Overall Study|Randomized but not Treated|0|||
161797067|NCT03466411|584299659|FG011|Overall Study|Randomized but not Treated|0|||
161797068|NCT03466411|584299660|FG012|Overall Study|Randomized but not Treated|0|||
161797069|NCT00319956|584299661|FG000|Overall Study|Death|20|||
161797070|NCT00319956|584299662|FG001|Overall Study|Death|24|||
161797071|NCT02607800|584299663|FG000|Overall Study|Lost to Follow-up|7|||
161797072|NCT02607800|584299664|FG001|Overall Study|Lost to Follow-up|10|||
161797073|NCT02607800|584299663|FG000|Overall Study|Withdrew Consent|2|||
161797074|NCT02607800|584299664|FG001|Overall Study|Withdrew Consent|0|||
161797075|NCT02607800|584299663|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
161797076|NCT02607800|584299664|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
161797077|NCT01185288|584299665|FG000|Overall Study|Adverse Event|7|||
161797078|NCT01185288|584299666|FG001|Overall Study|Adverse Event|6|||
161797079|NCT01185288|584299665|FG000|Overall Study|Withdrawal by Subject|6|||
161797080|NCT01185288|584299666|FG001|Overall Study|Withdrawal by Subject|4|||
161797081|NCT01185288|584299665|FG000|Overall Study|Lost to Follow-up|2|||
161797082|NCT01185288|584299666|FG001|Overall Study|Lost to Follow-up|5|||
161797083|NCT01185288|584299665|FG000|Overall Study|Lack of Efficacy|2|||
161797084|NCT01185288|584299666|FG001|Overall Study|Lack of Efficacy|0|||
161797085|NCT01185288|584299665|FG000|Overall Study|Investigator discretion|1|||
161797086|NCT01185288|584299666|FG001|Overall Study|Investigator discretion|0|||
161797087|NCT01185288|584299665|FG000|Overall Study|Did not meet inclusion criteria|1|||
161797088|NCT01185288|584299666|FG001|Overall Study|Did not meet inclusion criteria|0|||
161797089|NCT01185288|584299665|FG000|Overall Study|Noncompliance|0|||
161797090|NCT01185288|584299666|FG001|Overall Study|Noncompliance|1|||
161797091|NCT02974153|584299667|FG000|Overall Study|Adverse Event|6|||
161797092|NCT02974153|584299668|FG001|Overall Study|Adverse Event|0|||
161797093|NCT02974153|584299669|FG002|Overall Study|Adverse Event|1|||
161797094|NCT02974153|584299667|FG000|Overall Study|Lack of Efficacy|6|||
161797095|NCT02974153|584299668|FG001|Overall Study|Lack of Efficacy|5|||
161797096|NCT02974153|584299669|FG002|Overall Study|Lack of Efficacy|10|||
161797097|NCT02974153|584299667|FG000|Overall Study|Lost to Follow-up|9|||
161797098|NCT02974153|584299668|FG001|Overall Study|Lost to Follow-up|10|||
161797099|NCT02974153|584299669|FG002|Overall Study|Lost to Follow-up|17|||
161797100|NCT02974153|584299667|FG000|Overall Study|Physician Decision|0|||
161797101|NCT02974153|584299668|FG001|Overall Study|Physician Decision|2|||
161797102|NCT02974153|584299669|FG002|Overall Study|Physician Decision|1|||
161797103|NCT02974153|584299667|FG000|Overall Study|Withdrawal by Subject|9|||
161797104|NCT02974153|584299668|FG001|Overall Study|Withdrawal by Subject|16|||
161797105|NCT02974153|584299669|FG002|Overall Study|Withdrawal by Subject|11|||
161797106|NCT02974153|584299667|FG000|Overall Study|Study Burden|8|||
161797107|NCT02974153|584299668|FG001|Overall Study|Study Burden|7|||
161797108|NCT02974153|584299669|FG002|Overall Study|Study Burden|3|||
161797109|NCT02974153|584299667|FG000|Overall Study|Other|14|||
161797110|NCT02974153|584299668|FG001|Overall Study|Other|8|||
161797111|NCT02974153|584299669|FG002|Overall Study|Other|7|||
161797112|NCT01202747|584299670|FG000|Overall Study|Withdrawal by Subject|1|||
161797113|NCT01446913|584299671|FG000|Overall Study|Significant illness|1|||
161797114|NCT01446913|584299672|FG001|Overall Study|Significant illness|1|||
161797115|NCT01446913|584299673|FG002|Overall Study|Significant illness|1|||
161797116|NCT01446913|584299671|FG000|Overall Study|Withdrawal by Subject|5|||
161797117|NCT01446913|584299672|FG001|Overall Study|Withdrawal by Subject|3|||
161797118|NCT01446913|584299673|FG002|Overall Study|Withdrawal by Subject|5|||
161797119|NCT01446913|584299671|FG000|Overall Study|Physician Decision|0|||
161797120|NCT01446913|584299672|FG001|Overall Study|Physician Decision|0|||
161797121|NCT01446913|584299673|FG002|Overall Study|Physician Decision|2|||
161797122|NCT01446913|584299671|FG000|Overall Study|Lost to Follow-up|3|||
161797123|NCT01446913|584299672|FG001|Overall Study|Lost to Follow-up|5|||
161797124|NCT01446913|584299673|FG002|Overall Study|Lost to Follow-up|3|||
161797125|NCT02521948|584299674|FG000|Overall Study|Adverse Event|2|||
161797126|NCT02521948|584299674|FG000|Overall Study|Death|4|||
161797127|NCT02521948|584299674|FG000|Overall Study|Lost to Follow-up|1|||
161797128|NCT02521948|584299674|FG000|Overall Study|Did not attend one or both follow-ups|6|||
161797129|NCT04471428|584299677|FG000|Overall Study|Withdrawal by Subject|29|||
161797130|NCT04471428|584299678|FG001|Overall Study|Withdrawal by Subject|4|||
161797131|NCT04471428|584299677|FG000|Overall Study|Physician Decision|0|||
161797132|NCT04471428|584299678|FG001|Overall Study|Physician Decision|1|||
161797133|NCT04471428|584299677|FG000|Overall Study|Reason Not Specified|0|||
161797134|NCT04471428|584299678|FG001|Overall Study|Reason Not Specified|2|||
161797135|NCT04471428|584299677|FG000|Overall Study|Death|131|||
161797136|NCT04471428|584299678|FG001|Overall Study|Death|147|||
161797137|NCT04471428|584299677|FG000|Overall Study|Lost to Follow-up|0|||
161555966|NCT03354637|583425350|FG000|Double-blind Period|Lost to Follow-up|3|||
161555967|NCT03354637|583425351|FG001|Double-blind Period|Lost to Follow-up|4|||
161555968|NCT03354637|583425352|FG002|Double-blind Period|Lost to Follow-up|3|||
161555969|NCT03354637|583425350|FG000|Double-blind Period|Withdrawal by Subject|10|||
161555970|NCT03354637|583425351|FG001|Double-blind Period|Withdrawal by Subject|6|||
161555971|NCT03354637|583425352|FG002|Double-blind Period|Withdrawal by Subject|4|||
161555972|NCT03354637|583425350|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
161555973|NCT03354637|583425351|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
161555974|NCT03354637|583425352|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
161555975|NCT03354637|583425350|FG000|Open Label Extension|Adverse Event|0|||
161555976|NCT03354637|583425351|FG001|Open Label Extension|Adverse Event|0|||
161797138|NCT04471428|584299678|FG001|Overall Study|Lost to Follow-up|3|||
161797139|NCT04471428|584299677|FG000|Overall Study|Study Terminated by Sponsor|20|||
161797140|NCT04471428|584299678|FG001|Overall Study|Study Terminated by Sponsor|29|||
161797141|NCT03504852|584299679|FG000|Overall Study|Withdrawal of informed consent|2|||
161797142|NCT03504852|584299680|FG001|Overall Study|Withdrawal of informed consent|1|||
161797143|NCT03504852|584299681|FG002|Overall Study|Withdrawal of informed consent|0|||
161797144|NCT03504852|584299679|FG000|Overall Study|Withdrawal by Subject|5|||
161797145|NCT03504852|584299680|FG001|Overall Study|Withdrawal by Subject|5|||
161797146|NCT03504852|584299681|FG002|Overall Study|Withdrawal by Subject|1|||
161797147|NCT03504852|584299679|FG000|Overall Study|Lost to Follow-up|4|||
161797148|NCT03504852|584299680|FG001|Overall Study|Lost to Follow-up|1|||
161797149|NCT03504852|584299681|FG002|Overall Study|Lost to Follow-up|0|||
161797150|NCT03504852|584299679|FG000|Overall Study|New therapy for study indication|1|||
161797151|NCT03504852|584299680|FG001|Overall Study|New therapy for study indication|0|||
161797152|NCT03504852|584299681|FG002|Overall Study|New therapy for study indication|0|||
161797153|NCT03504852|584299679|FG000|Overall Study|Lack of Efficacy|1|||
161797154|NCT03504852|584299680|FG001|Overall Study|Lack of Efficacy|2|||
161797155|NCT03504852|584299681|FG002|Overall Study|Lack of Efficacy|0|||
161797156|NCT03504852|584299679|FG000|Overall Study|Death|0|||
161797157|NCT03504852|584299680|FG001|Overall Study|Death|1|||
161797158|NCT03504852|584299681|FG002|Overall Study|Death|0|||
161797159|NCT03504852|584299679|FG000|Overall Study|Adverse Event|4|||
161797160|NCT03504852|584299680|FG001|Overall Study|Adverse Event|8|||
161797161|NCT03504852|584299681|FG002|Overall Study|Adverse Event|2|||
161797162|NCT03290079|584299682|FG000|Overall Study|Death|2|||
161797163|NCT00969332|584299683|FG000|Overall Study|Physician Decision|8|||
161797164|NCT00969332|584299683|FG000|Overall Study|Withdrawal by Subject|3|||
161797165|NCT03828461|584299684|FG000|Overall Study|Lost to Follow-up|1|||
161797166|NCT03828461|584299684|FG000|Overall Study|Withdrawal by Subject|3|||
161797167|NCT00576199|584299685|FG000|Overall Study|Adverse Event|12|||
161797168|NCT00576199|584299685|FG000|Overall Study|Insufficient Therapeutic Response|14|||
161797169|NCT00576199|584299685|FG000|Overall Study|Refused Treatment|2|||
161797170|NCT00576199|584299685|FG000|Overall Study|Reason Unspecified|2|||
161797171|NCT00663871|584299687|FG000|Overall Study|Lost to Follow-up|5|||
161797172|NCT00663871|584299688|FG001|Overall Study|Lost to Follow-up|5|||
161797173|NCT00663871|584299687|FG000|Overall Study|Withdrawal by Subject|5|||
161797174|NCT00663871|584299688|FG001|Overall Study|Withdrawal by Subject|2|||
161797175|NCT00582309|584299689|FG000|Overall Study|Protocol Violation|0|||
161797176|NCT00582309|584299690|FG001|Overall Study|Protocol Violation|0|||
161797177|NCT00582309|584299691|FG002|Overall Study|Protocol Violation|2|||
161797178|NCT03095352|584299695|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
161797179|NCT03095352|584299696|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
161797180|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
161797181|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
161797182|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
161797183|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
161797184|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
161797185|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
161797186|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
161797187|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
161797188|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
161797189|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
161555977|NCT03354637|583425352|FG002|Open Label Extension|Adverse Event|1|||
161555978|NCT03354637|583425350|FG000|Open Label Extension|Lost to Follow-up|0|||
161797190|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
161797191|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
161797192|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
161797193|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
161797194|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
161797195|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
161797196|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
161901171|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797197|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
161797198|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
161797199|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
161797200|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
161797201|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
161797202|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
161797203|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
161797204|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
161797205|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
161797206|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
161797207|NCT00455533|584299697|FG000|Period Two: Randomized Period|Death|0|||
161797208|NCT00455533|584299698|FG001|Period Two: Randomized Period|Death|0|||
161797209|NCT00455533|584299699|FG002|Period Two: Randomized Period|Death|3|||
161797210|NCT00455533|584299697|FG000|Period Two: Randomized Period|Disease Progression|0|||
161797211|NCT00455533|584299698|FG001|Period Two: Randomized Period|Disease Progression|1|||
161797212|NCT00455533|584299699|FG002|Period Two: Randomized Period|Disease Progression|1|||
161797213|NCT00455533|584299697|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
161797214|NCT00455533|584299698|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
161797215|NCT00455533|584299699|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
161797216|NCT00455533|584299697|FG000|Period Two: Randomized Period|Other - need reasons|0|||
161797217|NCT00455533|584299698|FG001|Period Two: Randomized Period|Other - need reasons|1|||
161797218|NCT00455533|584299699|FG002|Period Two: Randomized Period|Other - need reasons|0|||
161797219|NCT00455533|584299697|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
161797220|NCT00455533|584299698|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
161797221|NCT00455533|584299699|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
161797222|NCT00455533|584299697|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
161797223|NCT00455533|584299698|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
161797224|NCT00455533|584299699|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
161797225|NCT02415959|584299700|FG000|Overall Study|Adverse Event|0|||
161797226|NCT02415959|584299701|FG001|Overall Study|Adverse Event|1|||
161797227|NCT02415959|584299702|FG002|Overall Study|Adverse Event|0|||
161797228|NCT02415959|584299703|FG003|Overall Study|Adverse Event|0|||
161797229|NCT02415959|584299704|FG004|Overall Study|Adverse Event|0|||
161797230|NCT02415959|584299700|FG000|Overall Study|Protocol Violation|0|||
161797231|NCT02415959|584299701|FG001|Overall Study|Protocol Violation|0|||
161797232|NCT02415959|584299702|FG002|Overall Study|Protocol Violation|0|||
161797233|NCT02415959|584299703|FG003|Overall Study|Protocol Violation|1|||
161797234|NCT02415959|584299704|FG004|Overall Study|Protocol Violation|0|||
161797235|NCT01497938|584299706|FG000|Overall Study|Adverse Event|0|||
161797236|NCT01497938|584299707|FG001|Overall Study|Adverse Event|1|||
161797237|NCT01497938|584299706|FG000|Overall Study|Physician Decision|0|||
161797238|NCT01497938|584299707|FG001|Overall Study|Physician Decision|1|||
161797239|NCT01497938|584299706|FG000|Overall Study|Withdrawal by Subject|4|||
161797240|NCT01497938|584299707|FG001|Overall Study|Withdrawal by Subject|0|||
161797241|NCT01497938|584299706|FG000|Overall Study|Device Violation|1|||
161797242|NCT01497938|584299707|FG001|Overall Study|Device Violation|0|||
161797243|NCT03708211|584299708|FG000|Overall Study|Progressive Disease|10|||
161797244|NCT03708211|584299709|FG001|Overall Study|Progressive Disease|7|||
161797245|NCT03708211|584299708|FG000|Overall Study|Withdrawal by Subject|0|||
161797246|NCT03708211|584299709|FG001|Overall Study|Withdrawal by Subject|1|||
161797247|NCT03708211|584299708|FG000|Overall Study|Other|2|||
161797248|NCT03708211|584299709|FG001|Overall Study|Other|0|||
161797249|NCT00365352|584299710|FG000|Overall Study|Adverse Event|6|||
161797250|NCT00365352|584299711|FG001|Overall Study|Adverse Event|7|||
161797251|NCT00365352|584299712|FG002|Overall Study|Adverse Event|8|||
161797252|NCT00365352|584299710|FG000|Overall Study|Participant Withdrew Consent|8|||
161797253|NCT00365352|584299711|FG001|Overall Study|Participant Withdrew Consent|3|||
161797254|NCT00365352|584299712|FG002|Overall Study|Participant Withdrew Consent|4|||
161797255|NCT00365352|584299710|FG000|Overall Study|Lack of Efficacy|3|||
161797256|NCT00365352|584299711|FG001|Overall Study|Lack of Efficacy|0|||
161797257|NCT00365352|584299712|FG002|Overall Study|Lack of Efficacy|0|||
161450638|NCT00282308|583043740|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
161797258|NCT00365352|584299710|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
161797259|NCT00365352|584299711|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
161797260|NCT00365352|584299712|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
161797261|NCT00365352|584299710|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
161797262|NCT00365352|584299711|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
161797263|NCT00365352|584299712|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
161797264|NCT00365352|584299710|FG000|Overall Study|Lost to Follow-up|1|||
161797265|NCT00365352|584299711|FG001|Overall Study|Lost to Follow-up|1|||
161797266|NCT00365352|584299712|FG002|Overall Study|Lost to Follow-up|0|||
161450639|NCT00282308|583043741|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
161555979|NCT03354637|583425351|FG001|Open Label Extension|Lost to Follow-up|0|||
161555980|NCT03354637|583425352|FG002|Open Label Extension|Lost to Follow-up|2|||
161555981|NCT03354637|583425350|FG000|Open Label Extension|Withdrawal by Subject|0|||
161555982|NCT03354637|583425351|FG001|Open Label Extension|Withdrawal by Subject|0|||
161555983|NCT03354637|583425352|FG002|Open Label Extension|Withdrawal by Subject|5|||
161555984|NCT03354637|583425350|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
161555985|NCT03354637|583425351|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
161555986|NCT03354637|583425352|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
161555987|NCT03354637|583425350|FG000|Open Label Extension|Subject Noncompliance|0|||
161555988|NCT03354637|583425351|FG001|Open Label Extension|Subject Noncompliance|0|||
161555989|NCT03354637|583425352|FG002|Open Label Extension|Subject Noncompliance|1|||
161555990|NCT03354637|583425350|FG000|Open Label Extension|Lack of Efficacy|0|||
161797267|NCT00365352|584299710|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
161797268|NCT00365352|584299711|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
161797269|NCT00365352|584299712|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
161797270|NCT05328375|584301046|FG000|Overall Study|Withdrawal by Subject|0|||
161797271|NCT05328375|584301047|FG001|Overall Study|Withdrawal by Subject|1|||
161797272|NCT05514119|584301052|FG000|Overall Study|Ineligible due to disease progression|1|||
161797273|NCT02946385|584301053|FG000|Overall Study|Lost to Follow-up|0|||
161797274|NCT02946385|584301054|FG001|Overall Study|Lost to Follow-up|0|||
161797275|NCT02946385|584301055|FG002|Overall Study|Lost to Follow-up|3|||
161797276|NCT02946385|584301056|FG003|Overall Study|Lost to Follow-up|0|||
161797277|NCT02946385|584301057|FG004|Overall Study|Lost to Follow-up|2|||
161797278|NCT02946385|584301058|FG005|Overall Study|Lost to Follow-up|1|||
161797279|NCT04849988|584301059|FG000|Overall Study|Lack of Efficacy|3|||
161797280|NCT04849988|584301060|FG001|Overall Study|Lack of Efficacy|4|||
161797281|NCT04849988|584301061|FG002|Overall Study|Lack of Efficacy|1|||
161797282|NCT04849988|584301062|FG003|Overall Study|Lack of Efficacy|4|||
161797283|NCT04849988|584301059|FG000|Overall Study|Other reasons|1|||
161797284|NCT04849988|584301060|FG001|Overall Study|Other reasons|2|||
161797285|NCT04849988|584301061|FG002|Overall Study|Other reasons|2|||
161797286|NCT04849988|584301062|FG003|Overall Study|Other reasons|1|||
161797287|NCT01402908|584301067|FG000|Overall Study|Withdrawal by Subject|30|||
161797288|NCT01402908|584301068|FG001|Overall Study|Withdrawal by Subject|17|||
161797289|NCT01402908|584301067|FG000|Overall Study|Lost to Follow-up|3|||
161797290|NCT01402908|584301068|FG001|Overall Study|Lost to Follow-up|1|||
161797291|NCT01402908|584301067|FG000|Overall Study|Physician Decision|1|||
161797292|NCT01402908|584301068|FG001|Overall Study|Physician Decision|0|||
161797293|NCT01739790|584301069|FG000|Overall Study|Early Trial Termination|2|||
161797294|NCT01739790|584301070|FG001|Overall Study|Early Trial Termination|4|||
161797295|NCT01893905|584301071|FG000|Overall Study|Withdrawal by Subject|1|||
161797296|NCT01893905|584301072|FG001|Overall Study|Withdrawal by Subject|0|||
161797297|NCT01893905|584301071|FG000|Overall Study|Adverse Event|9|||
161797298|NCT01893905|584301072|FG001|Overall Study|Adverse Event|3|||
161797299|NCT01893905|584301071|FG000|Overall Study|Lack of Efficacy|5|||
161797300|NCT01893905|584301072|FG001|Overall Study|Lack of Efficacy|7|||
161797301|NCT01893905|584301071|FG000|Overall Study|Lost to Follow-up|1|||
161797302|NCT01893905|584301072|FG001|Overall Study|Lost to Follow-up|0|||
161797303|NCT01893905|584301071|FG000|Overall Study|Protocol Violation|6|||
161797304|NCT01893905|584301072|FG001|Overall Study|Protocol Violation|1|||
161797305|NCT01893905|584301071|FG000|Overall Study|Lack of adherence to treatment|2|||
161797306|NCT01893905|584301072|FG001|Overall Study|Lack of adherence to treatment|0|||
161797307|NCT01893905|584301071|FG000|Overall Study|Other reason|1|||
161797308|NCT01893905|584301072|FG001|Overall Study|Other reason|3|||
161797309|NCT00278200|584301074|FG000|Overall Study|Death|1|||
161797310|NCT00278200|584301075|FG001|Overall Study|Death|3|||
161797311|NCT00278200|584301074|FG000|Overall Study|Physician Decision|0|||
161797312|NCT00278200|584301075|FG001|Overall Study|Physician Decision|1|||
161797313|NCT02688400|584301081|FG000|Overall Study|Protocol Violation|2|||
161555991|NCT03354637|583425351|FG001|Open Label Extension|Lack of Efficacy|0|||
161555992|NCT03354637|583425352|FG002|Open Label Extension|Lack of Efficacy|1|||
161555993|NCT03354637|583425350|FG000|Open Label Extension|Physician Decision|0|||
161555994|NCT03354637|583425351|FG001|Open Label Extension|Physician Decision|0|||
161797314|NCT02688400|584301082|FG001|Overall Study|Protocol Violation|5|||
161797315|NCT02688400|584301081|FG000|Overall Study|Lack of Efficacy|7|||
161797316|NCT02688400|584301082|FG001|Overall Study|Lack of Efficacy|7|||
161797317|NCT02688400|584301081|FG000|Overall Study|Adverse Event|21|||
161797318|NCT02688400|584301082|FG001|Overall Study|Adverse Event|12|||
161797319|NCT02688400|584301081|FG000|Overall Study|Withdrawal by Subject|15|||
161797320|NCT02688400|584301082|FG001|Overall Study|Withdrawal by Subject|13|||
161797321|NCT02688400|584301081|FG000|Overall Study|No study medication intake|1|||
161797322|NCT02688400|584301082|FG001|Overall Study|No study medication intake|4|||
161555995|NCT03354637|583425352|FG002|Open Label Extension|Physician Decision|1|||
161797323|NCT02688400|584301081|FG000|Overall Study|Lost to Follow-up|0|||
161797324|NCT02688400|584301082|FG001|Overall Study|Lost to Follow-up|3|||
161797325|NCT05568225|584301087|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
161901172|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901173|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901174|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901175|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901176|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901177|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
161901178|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901179|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901180|NCT01348139|584685204|FG000|Period 1|Adverse Event|1|||
161901181|NCT01348139|584685205|FG001|Period 1|Adverse Event|0|||
161901182|NCT01348139|584685206|FG002|Period 1|Adverse Event|0|||
161901183|NCT01348139|584685207|FG003|Period 1|Adverse Event|0|||
161901184|NCT01348139|584685208|FG004|Period 1|Adverse Event|0|||
161901185|NCT01348139|584685209|FG005|Period 1|Adverse Event|0|||
161901186|NCT02254772|584685210|FG000|Overall Study|Ineligible|1|||
161901187|NCT02254772|584685210|FG000|Overall Study|Withdrawal by Subject|1|||
161901188|NCT00928434|584685211|FG000|Overall Study|Adverse Event|14|||
161901189|NCT00928434|584685212|FG001|Overall Study|Adverse Event|5|||
161901190|NCT00928434|584685213|FG002|Overall Study|Adverse Event|18|||
161901191|NCT00928434|584685211|FG000|Overall Study|Protocol Violation|5|||
161901192|NCT00928434|584685212|FG001|Overall Study|Protocol Violation|0|||
161901193|NCT00928434|584685213|FG002|Overall Study|Protocol Violation|8|||
161901194|NCT00928434|584685211|FG000|Overall Study|Physician Decision|2|||
161901195|NCT00928434|584685212|FG001|Overall Study|Physician Decision|0|||
161901196|NCT00928434|584685213|FG002|Overall Study|Physician Decision|3|||
161901197|NCT00928434|584685211|FG000|Overall Study|Lost to Follow-up|1|||
161901198|NCT00928434|584685212|FG001|Overall Study|Lost to Follow-up|0|||
161901199|NCT00928434|584685213|FG002|Overall Study|Lost to Follow-up|3|||
161901200|NCT00928434|584685211|FG000|Overall Study|Withdrawal by Subject|5|||
161901201|NCT00928434|584685212|FG001|Overall Study|Withdrawal by Subject|3|||
161901202|NCT00928434|584685213|FG002|Overall Study|Withdrawal by Subject|2|||
161901203|NCT00928434|584685211|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
161901204|NCT00928434|584685212|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
161901205|NCT00928434|584685213|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
161901206|NCT00928434|584685211|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
161901207|NCT00928434|584685212|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
161901208|NCT00928434|584685213|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
161901209|NCT00928434|584685211|FG000|Overall Study|Other (not meeting above criteria)|5|||
161901210|NCT00928434|584685212|FG001|Overall Study|Other (not meeting above criteria)|1|||
161901211|NCT00928434|584685213|FG002|Overall Study|Other (not meeting above criteria)|2|||
161901212|NCT03006562|584685214|FG000|Overall Study|Lost to Follow-up|0|||
161901213|NCT03006562|584685215|FG001|Overall Study|Lost to Follow-up|1|||
161901214|NCT00716456|584685220|FG000|Overall Study|Adverse Event|0|||
161901215|NCT00716456|584685221|FG001|Overall Study|Adverse Event|2|||
161901216|NCT00716456|584685222|FG002|Overall Study|Adverse Event|0|||
161901217|NCT00447772|584685223|FG000|Overall Study|Lack of Efficacy|3|||
161901218|NCT00447772|584685223|FG000|Overall Study|Insufficient compliance|6|||
161901219|NCT00447772|584685223|FG000|Overall Study|Discontinuation of drug therapy|1|||
161901220|NCT00447772|584685223|FG000|Overall Study|Lost to Follow-up|9|||
161901221|NCT00447772|584685223|FG000|Overall Study|Withdrawal by Subject|1|||
161901222|NCT00447772|584685223|FG000|Overall Study|Unable to attend all study visits|2|||
161901223|NCT00447772|584685223|FG000|Overall Study|Adverse Event|1|||
161901224|NCT00447772|584685223|FG000|Overall Study|Patient relocated|1|||
161901225|NCT00447772|584685223|FG000|Overall Study|Incomplete documentation at visit 1|1|||
161901226|NCT00447772|584685223|FG000|Overall Study|Chemotherapy for lung cancer|1|||
161901227|NCT00447772|584685223|FG000|Overall Study|Premature re-injection required|1|||
161901228|NCT02427841|584685228|FG000|Overall Study|Lack of Efficacy|5|||
161901229|NCT02427841|584685228|FG000|Overall Study|Physician Decision|2|||
161901230|NCT02427841|584685228|FG000|Overall Study|Withdrawal by Subject|1|||
161901231|NCT01765296|584685229|FG000|Overall Study|Protocol Violation|0|||
161901232|NCT01765296|584685230|FG001|Overall Study|Protocol Violation|5|||
161901233|NCT01765296|584685231|FG002|Overall Study|Protocol Violation|4|||
161901234|NCT01765296|584685229|FG000|Overall Study|Withdrawal by Subject|4|||
161901235|NCT01765296|584685230|FG001|Overall Study|Withdrawal by Subject|2|||
161901236|NCT01765296|584685231|FG002|Overall Study|Withdrawal by Subject|2|||
161901237|NCT01765296|584685229|FG000|Overall Study|Adverse Event|1|||
161901238|NCT01765296|584685230|FG001|Overall Study|Adverse Event|13|||
161901239|NCT01765296|584685231|FG002|Overall Study|Adverse Event|5|||
161901240|NCT01765296|584685229|FG000|Overall Study|Lack of Efficacy|0|||
161901241|NCT01765296|584685230|FG001|Overall Study|Lack of Efficacy|0|||
161901242|NCT01765296|584685231|FG002|Overall Study|Lack of Efficacy|2|||
161901243|NCT03257436|584685232|FG000|Overall Study|Withdrawal by Subject|76|||
161901244|NCT03257436|584685232|FG000|Overall Study|Death|19|||
161901245|NCT01619852|584685233|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
161901246|NCT01619852|584685234|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
161901247|NCT01619852|584685233|FG000|3 Month Follow up|Lost to Follow-up|31|||
161901248|NCT01619852|584685234|FG001|3 Month Follow up|Lost to Follow-up|34|||
161901249|NCT00970489|584685235|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
161901250|NCT00970489|584685236|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
161901251|NCT03489343|584685240|FG000|Overall Study|Documented progressive disease|1|||
161901252|NCT03489343|584685241|FG001|Overall Study|Documented progressive disease|0|||
161901253|NCT03489343|584685242|FG002|Overall Study|Documented progressive disease|3|||
161901254|NCT03489343|584685243|FG003|Overall Study|Documented progressive disease|1|||
161901255|NCT03489343|584685244|FG004|Overall Study|Documented progressive disease|3|||
161901256|NCT03489343|584685245|FG005|Overall Study|Documented progressive disease|5|||
161901257|NCT03489343|584685246|FG006|Overall Study|Documented progressive disease|4|||
161901258|NCT03489343|584685240|FG000|Overall Study|Adverse Event|0|||
161901259|NCT03489343|584685241|FG001|Overall Study|Adverse Event|1|||
161901260|NCT03489343|584685242|FG002|Overall Study|Adverse Event|0|||
161901261|NCT03489343|584685243|FG003|Overall Study|Adverse Event|0|||
161901262|NCT03489343|584685244|FG004|Overall Study|Adverse Event|0|||
161901263|NCT03489343|584685245|FG005|Overall Study|Adverse Event|1|||
161901264|NCT03489343|584685246|FG006|Overall Study|Adverse Event|0|||
161901265|NCT03489343|584685240|FG000|Overall Study|Withdrawal by Subject|0|||
161901266|NCT03489343|584685241|FG001|Overall Study|Withdrawal by Subject|0|||
161901267|NCT03489343|584685242|FG002|Overall Study|Withdrawal by Subject|0|||
161901268|NCT03489343|584685243|FG003|Overall Study|Withdrawal by Subject|1|||
161901269|NCT03489343|584685244|FG004|Overall Study|Withdrawal by Subject|0|||
161901270|NCT03489343|584685245|FG005|Overall Study|Withdrawal by Subject|1|||
161901271|NCT03489343|584685246|FG006|Overall Study|Withdrawal by Subject|1|||
161901272|NCT03489343|584685240|FG000|Overall Study|Clinical progression|0|||
161901273|NCT03489343|584685241|FG001|Overall Study|Clinical progression|0|||
161901274|NCT03489343|584685242|FG002|Overall Study|Clinical progression|0|||
161901275|NCT03489343|584685243|FG003|Overall Study|Clinical progression|1|||
161901276|NCT03489343|584685244|FG004|Overall Study|Clinical progression|0|||
161901277|NCT03489343|584685245|FG005|Overall Study|Clinical progression|0|||
161555996|NCT02726399|583425355|FG000|Overall Study|Participant Non-Compliance|1|||
161555997|NCT02726399|583425355|FG000|Overall Study|Adverse Event|2|||
161797326|NCT05568225|584301088|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
161797327|NCT05568225|584301089|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
161797328|NCT05568225|584301087|FG000|Primary Treatment Period|Physician Decision|0|||
161797329|NCT05568225|584301088|FG001|Primary Treatment Period|Physician Decision|1|||
161797330|NCT05568225|584301089|FG002|Primary Treatment Period|Physician Decision|0|||
161797331|NCT05568225|584301087|FG000|Primary Treatment Period|Disease progression|0|||
161797332|NCT05568225|584301088|FG001|Primary Treatment Period|Disease progression|1|||
161797333|NCT05568225|584301089|FG002|Primary Treatment Period|Disease progression|0|||
161797334|NCT05568225|584301087|FG000|Primary Treatment Period|Lack of Efficacy|0|||
161797335|NCT05568225|584301088|FG001|Primary Treatment Period|Lack of Efficacy|1|||
161797336|NCT05568225|584301089|FG002|Primary Treatment Period|Lack of Efficacy|0|||
161797337|NCT05568225|584301087|FG000|Primary Treatment Period|Withdrawal of conset|1|||
161797338|NCT05568225|584301088|FG001|Primary Treatment Period|Withdrawal of conset|0|||
161797339|NCT05568225|584301089|FG002|Primary Treatment Period|Withdrawal of conset|4|||
161797340|NCT05568225|584301087|FG000|Primary Treatment Period|Adverse Event|1|||
161797341|NCT05568225|584301088|FG001|Primary Treatment Period|Adverse Event|0|||
161797342|NCT05568225|584301089|FG002|Primary Treatment Period|Adverse Event|0|||
161797343|NCT05568225|584301087|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
161797344|NCT05568225|584301088|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
161797345|NCT05568225|584301089|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
161797346|NCT05568225|584301087|FG000|Extension Treatment Period|Protocol Violation|0|||
161797347|NCT05568225|584301088|FG001|Extension Treatment Period|Protocol Violation|0|||
161797348|NCT05568225|584301089|FG002|Extension Treatment Period|Protocol Violation|1|||
161797349|NCT05568225|584301087|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161797350|NCT05568225|584301088|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161797351|NCT05568225|584301089|FG002|Extension Treatment Period|Lack of Efficacy|1|||
161797352|NCT01027143|584301092|FG000|Overall Study|Lost to Follow-up|9|||
161797353|NCT01027143|584301093|FG001|Overall Study|Lost to Follow-up|4|||
161797354|NCT03519256|584301102|FG000|Overall Study|Disease recurrence|4|||
161797355|NCT03519256|584301103|FG001|Overall Study|Disease recurrence|4|||
161797356|NCT03519256|584301104|FG002|Overall Study|Disease recurrence|5|||
161797357|NCT03519256|584301105|FG003|Overall Study|Disease recurrence|2|||
161797358|NCT03519256|584301102|FG000|Overall Study|Study drug toxicity|0|||
161797359|NCT03519256|584301103|FG001|Overall Study|Study drug toxicity|2|||
161797360|NCT03519256|584301104|FG002|Overall Study|Study drug toxicity|5|||
161901278|NCT03489343|584685246|FG006|Overall Study|Clinical progression|1|||
161901279|NCT00327717|584685247|FG000|Overall Study|Adverse Event|6|||
161901280|NCT00327717|584685248|FG001|Overall Study|Adverse Event|6|||
161901281|NCT00327717|584685247|FG000|Overall Study|Lack of Efficacy|0|||
161901282|NCT00327717|584685248|FG001|Overall Study|Lack of Efficacy|1|||
161901283|NCT00327717|584685247|FG000|Overall Study|Withdrawal by Subject|3|||
161797361|NCT03519256|584301105|FG003|Overall Study|Study drug toxicity|2|||
161797362|NCT03519256|584301102|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161797363|NCT03519256|584301103|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161797364|NCT03519256|584301104|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161797365|NCT03519256|584301105|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161797366|NCT03519256|584301102|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161797367|NCT03519256|584301103|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161797368|NCT03519256|584301104|FG002|Overall Study|Participant request to discontinue study treatment|0|||
161797369|NCT03519256|584301105|FG003|Overall Study|Participant request to discontinue study treatment|2|||
161797370|NCT03519256|584301102|FG000|Overall Study|Other reasons|0|||
161797371|NCT03519256|584301103|FG001|Overall Study|Other reasons|0|||
161797372|NCT03519256|584301104|FG002|Overall Study|Other reasons|2|||
161797373|NCT03519256|584301105|FG003|Overall Study|Other reasons|0|||
161797374|NCT03519256|584301102|FG000|Overall Study|Disease progression|6|||
161797375|NCT03519256|584301103|FG001|Overall Study|Disease progression|3|||
161797376|NCT03519256|584301104|FG002|Overall Study|Disease progression|2|||
161797377|NCT03519256|584301105|FG003|Overall Study|Disease progression|1|||
161797378|NCT03519256|584301102|FG000|Overall Study|Lost to Follow-up|0|||
161797379|NCT03519256|584301103|FG001|Overall Study|Lost to Follow-up|1|||
161797380|NCT03519256|584301104|FG002|Overall Study|Lost to Follow-up|0|||
161797381|NCT03519256|584301105|FG003|Overall Study|Lost to Follow-up|0|||
161797382|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
161797383|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
161797384|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
161797385|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
161797386|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
161797387|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
161797388|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
161797389|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
161797390|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161797391|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161797392|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161797393|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
161797394|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
161797395|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
161797396|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
161797397|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
161797398|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161797399|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161797400|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
161797401|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161797402|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
161797403|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
161797404|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
161797405|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
161797406|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
161797407|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
161797408|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
161797409|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
161797410|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161797411|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161797412|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
161797413|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161797414|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
161797415|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
161797416|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
161797417|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
161797418|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
161797419|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
161797420|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
161797421|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
161797422|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
161450640|NCT02660983|583043742|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
161450641|NCT02660983|583043743|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
161450642|NCT02660983|583043742|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
161450643|NCT02660983|583043743|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
161450644|NCT02660983|583043742|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
161450645|NCT02660983|583043743|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
161797423|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
161797424|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
161797425|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
161797426|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161797427|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
161797428|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161797429|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161797430|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
161797431|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
161797432|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
161797433|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
161797434|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
161797435|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
161797436|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
161797437|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
161797438|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
161797439|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
161797440|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
161797441|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
161797442|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
161797443|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
161797444|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
161797445|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
161797446|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
161797447|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
161797448|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
161797449|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
161797450|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
161797451|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
161797452|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
161797453|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
161797454|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
161797455|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
161797456|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
161797457|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
161797458|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
161797459|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
161797460|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
161797461|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
161797462|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
161450646|NCT02660983|583043742|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
161450647|NCT02660983|583043743|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
161450648|NCT02660983|583043742|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
161450649|NCT02660983|583043743|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
161450650|NCT02660983|583043742|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
161797463|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
161797464|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
161797465|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
161797466|NCT00421174|584301110|FG000|Overall Study|Withdrawal by Subject|0|||
161797467|NCT00421174|584301111|FG001|Overall Study|Withdrawal by Subject|1|||
161797468|NCT00421174|584301110|FG000|Overall Study|Ineligible due to infection|2|||
161797469|NCT00421174|584301111|FG001|Overall Study|Ineligible due to infection|0|||
161797470|NCT01290263|584301114|FG000|Overall Study|Adverse Event|0|||
161797471|NCT01290263|584301115|FG001|Overall Study|Adverse Event|0|||
161450651|NCT02660983|583043743|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
161450652|NCT02660983|583043742|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
161450653|NCT02660983|583043743|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
161450654|NCT00721968|583043746|FG000|Overall Study|Lost to Follow-up|2|||
161450655|NCT00721968|583043747|FG001|Overall Study|Lost to Follow-up|0|||
161450656|NCT03374202|583043748|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
161450657|NCT03374202|583043749|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
161450658|NCT03374202|583043750|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
161450659|NCT03374202|583043748|FG000|Five Year Long Term Follow Up|Death|0|||
161450660|NCT03374202|583043749|FG001|Five Year Long Term Follow Up|Death|1|||
161450661|NCT03374202|583043750|FG002|Five Year Long Term Follow Up|Death|0|||
161450662|NCT00361634|583045778|FG000|Overall Study|Lost to Follow-up|1|||
161797472|NCT01290263|584301116|FG002|Overall Study|Adverse Event|0|||
161797473|NCT01290263|584301117|FG003|Overall Study|Adverse Event|1|||
161555998|NCT02726399|583425355|FG000|Overall Study|Progression of disease|4|||
161555999|NCT04006366|583425358|FG000|Overall Study|Withdrawal by Subject|1|||
161556000|NCT03468426|583425359|FG000|Overall Study|Progressive disease|3|||
161556001|NCT03468426|583425360|FG001|Overall Study|Progressive disease|0|||
161556002|NCT03468426|583425361|FG002|Overall Study|Progressive disease|4|||
161556003|NCT03468426|583425362|FG003|Overall Study|Progressive disease|20|||
161556004|NCT03468426|583425363|FG004|Overall Study|Progressive disease|23|||
161556005|NCT03468426|583425364|FG005|Overall Study|Progressive disease|15|||
161556006|NCT03468426|583425365|FG006|Overall Study|Progressive disease|24|||
161556007|NCT03468426|583425366|FG007|Overall Study|Progressive disease|27|||
161556008|NCT03468426|583425367|FG008|Overall Study|Progressive disease|13|||
161556009|NCT03468426|583425368|FG009|Overall Study|Progressive disease|13|||
161556010|NCT03468426|583425369|FG010|Overall Study|Progressive disease|0|||
161556011|NCT03468426|583425359|FG000|Overall Study|Other adverse event or clinical progression|0|||
161556012|NCT03468426|583425360|FG001|Overall Study|Other adverse event or clinical progression|1|||
161556013|NCT03468426|583425361|FG002|Overall Study|Other adverse event or clinical progression|3|||
161556014|NCT03468426|583425362|FG003|Overall Study|Other adverse event or clinical progression|14|||
161556015|NCT03468426|583425363|FG004|Overall Study|Other adverse event or clinical progression|10|||
161556016|NCT03468426|583425364|FG005|Overall Study|Other adverse event or clinical progression|8|||
161556017|NCT03468426|583425365|FG006|Overall Study|Other adverse event or clinical progression|5|||
161556018|NCT03468426|583425366|FG007|Overall Study|Other adverse event or clinical progression|4|||
161556019|NCT03468426|583425367|FG008|Overall Study|Other adverse event or clinical progression|6|||
161556020|NCT03468426|583425368|FG009|Overall Study|Other adverse event or clinical progression|11|||
161556021|NCT03468426|583425369|FG010|Overall Study|Other adverse event or clinical progression|0|||
161556022|NCT03468426|583425359|FG000|Overall Study|Refused to continue taking trial medication|0|||
161556023|NCT03468426|583425360|FG001|Overall Study|Refused to continue taking trial medication|0|||
161556024|NCT03468426|583425361|FG002|Overall Study|Refused to continue taking trial medication|0|||
161556025|NCT03468426|583425362|FG003|Overall Study|Refused to continue taking trial medication|2|||
161556026|NCT03468426|583425363|FG004|Overall Study|Refused to continue taking trial medication|0|||
161556027|NCT03468426|583425364|FG005|Overall Study|Refused to continue taking trial medication|3|||
161556028|NCT03468426|583425365|FG006|Overall Study|Refused to continue taking trial medication|0|||
161556029|NCT03468426|583425366|FG007|Overall Study|Refused to continue taking trial medication|0|||
161556030|NCT03468426|583425367|FG008|Overall Study|Refused to continue taking trial medication|1|||
161556031|NCT03468426|583425368|FG009|Overall Study|Refused to continue taking trial medication|0|||
161556032|NCT03468426|583425369|FG010|Overall Study|Refused to continue taking trial medication|0|||
161556033|NCT03468426|583425359|FG000|Overall Study|Other than listed|0|||
161556034|NCT03468426|583425360|FG001|Overall Study|Other than listed|1|||
161556035|NCT03468426|583425361|FG002|Overall Study|Other than listed|0|||
161556036|NCT03468426|583425362|FG003|Overall Study|Other than listed|0|||
161556037|NCT03468426|583425363|FG004|Overall Study|Other than listed|2|||
161556038|NCT03468426|583425364|FG005|Overall Study|Other than listed|2|||
161556039|NCT03468426|583425365|FG006|Overall Study|Other than listed|0|||
161556040|NCT03468426|583425366|FG007|Overall Study|Other than listed|0|||
161556041|NCT03468426|583425367|FG008|Overall Study|Other than listed|4|||
161556042|NCT03468426|583425368|FG009|Overall Study|Other than listed|4|||
161556043|NCT03468426|583425369|FG010|Overall Study|Other than listed|1|||
161556044|NCT03468426|583425359|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556045|NCT03468426|583425360|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556046|NCT03468426|583425361|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161556047|NCT03468426|583425362|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556048|NCT03468426|583425363|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556049|NCT03468426|583425364|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556050|NCT03468426|583425365|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556051|NCT03468426|583425366|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556052|NCT03468426|583425367|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556053|NCT03468426|583425368|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556054|NCT03468426|583425369|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161556055|NCT03468426|583425359|FG000|Overall Study|missing reason|0|||
161556056|NCT03468426|583425360|FG001|Overall Study|missing reason|0|||
161797474|NCT01290263|584301118|FG004|Overall Study|Adverse Event|1|||
161797475|NCT01290263|584301114|FG000|Overall Study|Lack of Efficacy|8|||
161797476|NCT01290263|584301115|FG001|Overall Study|Lack of Efficacy|2|||
161797477|NCT01290263|584301116|FG002|Overall Study|Lack of Efficacy|7|||
161556057|NCT03468426|583425361|FG002|Overall Study|missing reason|0|||
161556058|NCT03468426|583425362|FG003|Overall Study|missing reason|0|||
161556059|NCT03468426|583425363|FG004|Overall Study|missing reason|0|||
161556060|NCT03468426|583425364|FG005|Overall Study|missing reason|0|||
161556061|NCT03468426|583425365|FG006|Overall Study|missing reason|0|||
161556062|NCT03468426|583425366|FG007|Overall Study|missing reason|0|||
161556063|NCT03468426|583425367|FG008|Overall Study|missing reason|0|||
161556064|NCT03468426|583425368|FG009|Overall Study|missing reason|1|||
161556065|NCT03468426|583425369|FG010|Overall Study|missing reason|0|||
161797478|NCT01290263|584301117|FG003|Overall Study|Lack of Efficacy|24|||
161797479|NCT01290263|584301118|FG004|Overall Study|Lack of Efficacy|33|||
161901284|NCT00327717|584685248|FG001|Overall Study|Withdrawal by Subject|7|||
161901285|NCT01630135|584685250|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
161901286|NCT01630135|584685251|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
161901287|NCT02658669|584685253|FG000|Overall Study|Lost to Follow-up|7|||
161901288|NCT02658669|584685254|FG001|Overall Study|Lost to Follow-up|5|||
161901289|NCT00838097|584685263|FG000|Overall Study|Ineligibility determined|6|||
161901290|NCT00838097|584685263|FG000|Overall Study|Adverse Event|2|||
161901291|NCT00838097|584685263|FG000|Overall Study|Withdrawal by Subject|3|||
161901292|NCT00838097|584685263|FG000|Overall Study|Requirement for alternative therapy|2|||
161901293|NCT00838097|584685263|FG000|Overall Study|Physician Decision|4|||
161901294|NCT00838097|584685263|FG000|Overall Study|Lost to Follow-up|11|||
161901295|NCT00838097|584685263|FG000|Overall Study|Death|6|||
161901296|NCT00838097|584685263|FG000|Overall Study|Protocol-specified criteria|142|||
161901297|NCT03311841|584685264|FG000|14-day Wash-out|Adverse Event|0|||
161901298|NCT03311841|584685265|FG001|14-day Wash-out|Adverse Event|1|||
161901299|NCT03311841|584685266|FG002|14-day Wash-out|Adverse Event|0|||
161901300|NCT03311841|584685267|FG003|14-day Wash-out|Adverse Event|0|||
161797480|NCT01290263|584301114|FG000|Overall Study|Withdrawal by Subject|3|||
161797481|NCT01290263|584301115|FG001|Overall Study|Withdrawal by Subject|1|||
161797482|NCT01290263|584301116|FG002|Overall Study|Withdrawal by Subject|0|||
161797483|NCT01290263|584301117|FG003|Overall Study|Withdrawal by Subject|1|||
161797484|NCT01290263|584301118|FG004|Overall Study|Withdrawal by Subject|2|||
161797485|NCT01290263|584301114|FG000|Overall Study|Participant Non-Compliance|0|||
161797486|NCT01290263|584301115|FG001|Overall Study|Participant Non-Compliance|0|||
161797487|NCT01290263|584301116|FG002|Overall Study|Participant Non-Compliance|0|||
161797488|NCT01290263|584301117|FG003|Overall Study|Participant Non-Compliance|1|||
161797489|NCT01290263|584301118|FG004|Overall Study|Participant Non-Compliance|1|||
161797490|NCT00576381|584301125|FG000|Overall Study|Reoperation|3|||
161797491|NCT00576381|584301125|FG000|Overall Study|Adverse Event|4|||
161797492|NCT02518113|584301126|FG000|Overall Study|Adverse Event|1|||
161797493|NCT02518113|584301127|FG001|Overall Study|Adverse Event|0|||
161797494|NCT02518113|584301128|FG002|Overall Study|Adverse Event|1|||
161797495|NCT02518113|584301129|FG003|Overall Study|Adverse Event|0|||
161797496|NCT02518113|584301126|FG000|Overall Study|Death|1|||
161797497|NCT02518113|584301127|FG001|Overall Study|Death|2|||
161797498|NCT02518113|584301128|FG002|Overall Study|Death|0|||
161797499|NCT02518113|584301129|FG003|Overall Study|Death|0|||
161797500|NCT02518113|584301126|FG000|Overall Study|Physician Decision|0|||
161797501|NCT02518113|584301127|FG001|Overall Study|Physician Decision|1|||
161797502|NCT02518113|584301128|FG002|Overall Study|Physician Decision|0|||
161797503|NCT02518113|584301129|FG003|Overall Study|Physician Decision|0|||
161797504|NCT02518113|584301126|FG000|Overall Study|Progressive Disease|1|||
161797505|NCT02518113|584301127|FG001|Overall Study|Progressive Disease|2|||
161797506|NCT02518113|584301128|FG002|Overall Study|Progressive Disease|3|||
161797507|NCT02518113|584301129|FG003|Overall Study|Progressive Disease|0|||
161797508|NCT00797108|584301130|FG000|Overall Study|Adverse Event|1|||
161797509|NCT00797108|584301131|FG001|Overall Study|Adverse Event|0|||
161797510|NCT00797108|584301132|FG002|Overall Study|Adverse Event|3|||
161797511|NCT00797108|584301130|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
161797512|NCT00797108|584301131|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
161797513|NCT00797108|584301132|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
161797514|NCT00797108|584301130|FG000|Overall Study|Global Deterioration of Health Status|0|||
161797515|NCT00797108|584301131|FG001|Overall Study|Global Deterioration of Health Status|1|||
161797516|NCT00797108|584301132|FG002|Overall Study|Global Deterioration of Health Status|0|||
161797517|NCT00797108|584301130|FG000|Overall Study|Lack of Efficacy|1|||
161797518|NCT00797108|584301131|FG001|Overall Study|Lack of Efficacy|0|||
161797519|NCT00797108|584301132|FG002|Overall Study|Lack of Efficacy|1|||
161797520|NCT00797108|584301130|FG000|Overall Study|Other|0|||
161797521|NCT00797108|584301131|FG001|Overall Study|Other|0|||
161797522|NCT00797108|584301132|FG002|Overall Study|Other|2|||
161797523|NCT00797108|584301130|FG000|Overall Study|Randomized but not Treated|2|||
161797524|NCT00797108|584301131|FG001|Overall Study|Randomized but not Treated|0|||
161797525|NCT00797108|584301132|FG002|Overall Study|Randomized but not Treated|0|||
161797526|NCT00287118|584301133|FG000|Overall Study|Adverse Event|30|||
161797527|NCT00287118|584301133|FG000|Overall Study|Death|1|||
161797528|NCT00287118|584301133|FG000|Overall Study|Lack of Efficacy|11|||
161797529|NCT00287118|584301133|FG000|Overall Study|Lost to Follow-up|1|||
161901301|NCT03311841|584685268|FG004|14-day Wash-out|Adverse Event|0|||
161901302|NCT03311841|584685264|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
161901303|NCT03311841|584685265|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
161901304|NCT03311841|584685266|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
161797530|NCT00287118|584301133|FG000|Overall Study|Protocol Violation|2|||
161797531|NCT00287118|584301133|FG000|Overall Study|Other|7|||
161797532|NCT02324465|584301134|FG000|Overall Study|device failure|0|||
161797533|NCT02324465|584301135|FG001|Overall Study|device failure|1|||
161901305|NCT03311841|584685267|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
161556066|NCT01440049|583425371|FG000|Overall Study|Adverse Event|5|||
161556067|NCT02268552|583425372|FG000|Part 1|Death|1|||
161797534|NCT01631864|584301136|FG000|Overall Study|Withdrawal by Subject|0|||
161797535|NCT01631864|584301137|FG001|Overall Study|Withdrawal by Subject|1|||
161797536|NCT01631864|584301136|FG000|Overall Study|Adverse Event|2|||
161797537|NCT01631864|584301137|FG001|Overall Study|Adverse Event|3|||
161797538|NCT01031537|584301138|FG000|Overall Study|medical reasons not related to study|3|||
161797539|NCT01031537|584301138|FG000|Overall Study|Lack of Efficacy|1|||
161797540|NCT01031537|584301138|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
161797541|NCT01031537|584301138|FG000|Overall Study|moved, met exclusion criteria|10|||
161797542|NCT01031537|584301138|FG000|Overall Study|Withdrawal by Subject|5|||
161797543|NCT01031537|584301138|FG000|Overall Study|PI removal, no longer met eligibility|12|||
161797544|NCT02187042|584301145|FG000|Overall Study|Death|1|||
161797545|NCT02187042|584301146|FG001|Overall Study|Death|1|||
161797546|NCT02187042|584301145|FG000|Overall Study|Toxicity|6|||
161797547|NCT02187042|584301146|FG001|Overall Study|Toxicity|5|||
161797548|NCT02187042|584301145|FG000|Overall Study|Participant choice|1|||
161797549|NCT02187042|584301146|FG001|Overall Study|Participant choice|0|||
161797550|NCT02187042|584301145|FG000|Overall Study|Doctor choice|1|||
161797551|NCT02187042|584301146|FG001|Overall Study|Doctor choice|0|||
161797552|NCT02187042|584301145|FG000|Overall Study|Progressive disease|4|||
161797553|NCT02187042|584301146|FG001|Overall Study|Progressive disease|8|||
161797554|NCT01766921|584301149|FG000|Overall Study|Administrative Reason|5|||
161797555|NCT01766921|584301150|FG001|Overall Study|Administrative Reason|5|||
161797556|NCT01766921|584301149|FG000|Overall Study|Death|1|||
161797557|NCT01766921|584301150|FG001|Overall Study|Death|1|||
161797558|NCT01766921|584301149|FG000|Overall Study|Lost to Follow-up|1|||
161797559|NCT01766921|584301150|FG001|Overall Study|Lost to Follow-up|3|||
161797560|NCT01766921|584301149|FG000|Overall Study|Unclassified|2|||
161797561|NCT01766921|584301150|FG001|Overall Study|Unclassified|2|||
161797562|NCT01766921|584301149|FG000|Overall Study|Protocol Violation|1|||
161797563|NCT01766921|584301150|FG001|Overall Study|Protocol Violation|1|||
161797564|NCT01766921|584301149|FG000|Overall Study|Withdrawal by Subject|14|||
161797565|NCT01766921|584301150|FG001|Overall Study|Withdrawal by Subject|5|||
161797566|NCT02549495|584301153|FG000|Overall Study|Death|2|||
161797567|NCT02549495|584301153|FG000|Overall Study|Withdrawal by Subject|5|||
161797568|NCT02549495|584301153|FG000|Overall Study|Physician Decision|22|||
161797569|NCT02549495|584301153|FG000|Overall Study|Lost to Follow-up|6|||
161797570|NCT02549495|584301153|FG000|Overall Study|Protocol Violation|6|||
161797571|NCT05876091|584301154|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
161797572|NCT03402893|584301155|FG000|Overall Study|Withdrawal by Subject|1|||
161797573|NCT03462719|584301156|FG000|Overall Study|Withdrawal by Subject|4|||
161797574|NCT03462719|584301157|FG001|Overall Study|Withdrawal by Subject|3|||
161797575|NCT03462719|584301156|FG000|Overall Study|Ongoing|87|||
161797576|NCT03462719|584301157|FG001|Overall Study|Ongoing|72|||
161797577|NCT04799158|584301158|FG000|Run-In Period|Adverse Event|6|||
161797578|NCT04799158|584301159|FG001|Run-In Period|Adverse Event|0|||
161797579|NCT04799158|584301160|FG002|Run-In Period|Adverse Event|0|||
161797580|NCT04799158|584301161|FG003|Run-In Period|Adverse Event|0|||
161450663|NCT00361634|583045778|FG000|Overall Study|Withdrawal by Subject|1|||
161450664|NCT05315908|583045779|FG000|Overall Study|Lost to Follow-up|4477|||
161450665|NCT05315908|583045780|FG001|Overall Study|Lost to Follow-up|4606|||
161450666|NCT00505076|583045789|FG000|Overall Study|Adverse Event|1|||
161450667|NCT00505076|583045790|FG001|Overall Study|Adverse Event|0|||
161450668|NCT00505076|583045791|FG002|Overall Study|Adverse Event|1|||
161450669|NCT00505076|583045789|FG000|Overall Study|Protocol Violation|2|||
161450670|NCT00505076|583045790|FG001|Overall Study|Protocol Violation|1|||
161450671|NCT00505076|583045791|FG002|Overall Study|Protocol Violation|2|||
161450672|NCT00505076|583045789|FG000|Overall Study|Withdrawal by Subject|0|||
161450673|NCT00505076|583045790|FG001|Overall Study|Withdrawal by Subject|1|||
161450674|NCT00505076|583045791|FG002|Overall Study|Withdrawal by Subject|2|||
161450675|NCT01128621|583045794|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
161450676|NCT01128621|583045795|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
161556068|NCT02268552|583425373|FG001|Part 1|Death|1|||
161797581|NCT04799158|584301162|FG004|Run-In Period|Adverse Event|0|||
161797582|NCT04799158|584301158|FG000|Run-In Period|Lost to Follow-up|4|||
161797583|NCT04799158|584301159|FG001|Run-In Period|Lost to Follow-up|0|||
161797584|NCT04799158|584301160|FG002|Run-In Period|Lost to Follow-up|0|||
161797585|NCT04799158|584301161|FG003|Run-In Period|Lost to Follow-up|0|||
161797586|NCT04799158|584301162|FG004|Run-In Period|Lost to Follow-up|0|||
161797587|NCT04799158|584301158|FG000|Run-In Period|Significant Protocol Deviation|1|||
161797588|NCT04799158|584301159|FG001|Run-In Period|Significant Protocol Deviation|0|||
161797589|NCT04799158|584301160|FG002|Run-In Period|Significant Protocol Deviation|0|||
161797590|NCT04799158|584301161|FG003|Run-In Period|Significant Protocol Deviation|0|||
161797591|NCT04799158|584301162|FG004|Run-In Period|Significant Protocol Deviation|0|||
161797592|NCT04799158|584301158|FG000|Run-In Period|Withdrawal by Subject|11|||
161556069|NCT02268552|583425374|FG002|Part 1|Death|1|||
161556070|NCT02268552|583425375|FG003|Part 1|Death|2|||
161797593|NCT04799158|584301159|FG001|Run-In Period|Withdrawal by Subject|0|||
161556071|NCT02268552|583425376|FG004|Part 1|Death|0|||
161556072|NCT02268552|583425377|FG005|Part 1|Death|0|||
161556073|NCT02268552|583425378|FG006|Part 1|Death|0|||
161556074|NCT02268552|583425372|FG000|Part 1|Subject/guardian decision|0|||
161556075|NCT02268552|583425373|FG001|Part 1|Subject/guardian decision|0|||
161556076|NCT02268552|583425374|FG002|Part 1|Subject/guardian decision|0|||
161556077|NCT02268552|583425375|FG003|Part 1|Subject/guardian decision|1|||
161556078|NCT02268552|583425376|FG004|Part 1|Subject/guardian decision|0|||
161556079|NCT02268552|583425377|FG005|Part 1|Subject/guardian decision|0|||
161556080|NCT02268552|583425378|FG006|Part 1|Subject/guardian decision|0|||
161556081|NCT02268552|583425372|FG000|Part 2|Death|0|||
161556082|NCT02268552|583425373|FG001|Part 2|Death|0|||
161556083|NCT02268552|583425374|FG002|Part 2|Death|0|||
161797594|NCT04799158|584301160|FG002|Run-In Period|Withdrawal by Subject|0|||
161797595|NCT04799158|584301161|FG003|Run-In Period|Withdrawal by Subject|0|||
161797596|NCT04799158|584301162|FG004|Run-In Period|Withdrawal by Subject|0|||
161797597|NCT04799158|584301158|FG000|Run-In Period|Miscellaneous|3|||
161797598|NCT04799158|584301159|FG001|Run-In Period|Miscellaneous|0|||
161797599|NCT04799158|584301160|FG002|Run-In Period|Miscellaneous|0|||
161797600|NCT04799158|584301161|FG003|Run-In Period|Miscellaneous|0|||
161797601|NCT04799158|584301162|FG004|Run-In Period|Miscellaneous|0|||
161797602|NCT04799158|584301158|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
161797603|NCT04799158|584301159|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797604|NCT04799158|584301160|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797605|NCT04799158|584301161|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797606|NCT04799158|584301162|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797607|NCT04799158|584301158|FG000|On-Demand Treatment Period|Adverse Event|0|||
161797608|NCT04799158|584301159|FG001|On-Demand Treatment Period|Adverse Event|1|||
161797609|NCT04799158|584301160|FG002|On-Demand Treatment Period|Adverse Event|0|||
161797610|NCT04799158|584301161|FG003|On-Demand Treatment Period|Adverse Event|0|||
161797611|NCT04799158|584301162|FG004|On-Demand Treatment Period|Adverse Event|1|||
161797612|NCT04799158|584301158|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
161797613|NCT04799158|584301159|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
161797614|NCT04799158|584301160|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
161797615|NCT04799158|584301161|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
161797616|NCT04799158|584301162|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
161797617|NCT04799158|584301158|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797618|NCT04799158|584301159|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797619|NCT04799158|584301160|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797620|NCT04799158|584301161|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
161797621|NCT04799158|584301162|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797622|NCT04799158|584301158|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797623|NCT04799158|584301159|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797624|NCT04799158|584301160|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797625|NCT04799158|584301161|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
161797626|NCT04799158|584301162|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797627|NCT04799158|584301158|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
161797628|NCT04799158|584301159|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
161797629|NCT04799158|584301160|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
161797630|NCT04799158|584301161|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
161797631|NCT04799158|584301162|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
161797632|NCT04799158|584301158|FG000|On-Demand Treatment Period|Miscellaneous|0|||
161797633|NCT04799158|584301159|FG001|On-Demand Treatment Period|Miscellaneous|0|||
161797634|NCT04799158|584301160|FG002|On-Demand Treatment Period|Miscellaneous|0|||
161797635|NCT04799158|584301161|FG003|On-Demand Treatment Period|Miscellaneous|0|||
161797636|NCT04799158|584301162|FG004|On-Demand Treatment Period|Miscellaneous|1|||
161797637|NCT00679783|584301167|FG000|Overall Study|Adverse Event|0|||
161797638|NCT00679783|584301168|FG001|Overall Study|Adverse Event|0|||
161797639|NCT00679783|584301169|FG002|Overall Study|Adverse Event|0|||
161797640|NCT00679783|584301170|FG003|Overall Study|Adverse Event|3|||
161797641|NCT00679783|584301171|FG004|Overall Study|Adverse Event|0|||
161797642|NCT00679783|584301172|FG005|Overall Study|Adverse Event|0|||
161797643|NCT00679783|584301173|FG006|Overall Study|Adverse Event|1|||
161797644|NCT00679783|584301167|FG000|Overall Study|Lack of Efficacy|0|||
161797645|NCT00679783|584301168|FG001|Overall Study|Lack of Efficacy|1|||
161797646|NCT00679783|584301169|FG002|Overall Study|Lack of Efficacy|0|||
161797647|NCT00679783|584301170|FG003|Overall Study|Lack of Efficacy|2|||
161797648|NCT00679783|584301171|FG004|Overall Study|Lack of Efficacy|0|||
161797649|NCT00679783|584301172|FG005|Overall Study|Lack of Efficacy|0|||
161797650|NCT00679783|584301173|FG006|Overall Study|Lack of Efficacy|0|||
161797651|NCT00679783|584301167|FG000|Overall Study|Withdrawal by Subject|0|||
161797652|NCT00679783|584301168|FG001|Overall Study|Withdrawal by Subject|0|||
161556084|NCT02268552|583425375|FG003|Part 2|Death|0|||
161556085|NCT02268552|583425376|FG004|Part 2|Death|0|||
161556086|NCT02268552|583425377|FG005|Part 2|Death|0|||
161556087|NCT02268552|583425378|FG006|Part 2|Death|2|||
161556088|NCT02268552|583425372|FG000|Part 2|Subject/guardian decision|0|||
161556089|NCT02268552|583425373|FG001|Part 2|Subject/guardian decision|0|||
161556090|NCT02268552|583425374|FG002|Part 2|Subject/guardian decision|0|||
161556091|NCT02268552|583425375|FG003|Part 2|Subject/guardian decision|0|||
161556092|NCT02268552|583425376|FG004|Part 2|Subject/guardian decision|0|||
161556093|NCT02268552|583425377|FG005|Part 2|Subject/guardian decision|0|||
161556094|NCT02268552|583425378|FG006|Part 2|Subject/guardian decision|1|||
161556095|NCT02268552|583425372|FG000|Part 3 Extension|Death|0|||
161556096|NCT02268552|583425373|FG001|Part 3 Extension|Death|1|||
161797653|NCT00679783|584301169|FG002|Overall Study|Withdrawal by Subject|1|||
161797654|NCT00679783|584301170|FG003|Overall Study|Withdrawal by Subject|1|||
161797655|NCT00679783|584301171|FG004|Overall Study|Withdrawal by Subject|0|||
161797656|NCT00679783|584301172|FG005|Overall Study|Withdrawal by Subject|0|||
161797657|NCT00679783|584301173|FG006|Overall Study|Withdrawal by Subject|0|||
161797658|NCT00679783|584301167|FG000|Overall Study|Not Captured|0|||
161797659|NCT00679783|584301168|FG001|Overall Study|Not Captured|0|||
161797660|NCT00679783|584301169|FG002|Overall Study|Not Captured|0|||
161797661|NCT00679783|584301170|FG003|Overall Study|Not Captured|5|||
161797662|NCT00679783|584301171|FG004|Overall Study|Not Captured|0|||
161797663|NCT00679783|584301172|FG005|Overall Study|Not Captured|0|||
161797664|NCT00679783|584301173|FG006|Overall Study|Not Captured|0|||
161797665|NCT00679783|584301167|FG000|Overall Study|Ongoing at data cut-off|2|||
161797666|NCT00679783|584301168|FG001|Overall Study|Ongoing at data cut-off|2|||
161797667|NCT00679783|584301169|FG002|Overall Study|Ongoing at data cut-off|0|||
161797668|NCT00679783|584301170|FG003|Overall Study|Ongoing at data cut-off|9|||
161797669|NCT00679783|584301171|FG004|Overall Study|Ongoing at data cut-off|1|||
161797670|NCT00679783|584301172|FG005|Overall Study|Ongoing at data cut-off|0|||
161797671|NCT00679783|584301173|FG006|Overall Study|Ongoing at data cut-off|0|||
161797672|NCT01485536|584301174|FG000|Overall Study|Withdrawal by Subject|3|||
161797673|NCT01485536|584301174|FG000|Overall Study|Adverse Event|1|||
161797674|NCT02626949|584301175|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
161797675|NCT02626949|584301176|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
161797676|NCT02626949|584301175|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
161797677|NCT02626949|584301176|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
161797678|NCT02626949|584301175|FG000|Enrolled|Lost to Follow-up|7|||
161797679|NCT02626949|584301176|FG001|Enrolled|Lost to Follow-up|6|||
161797680|NCT02626949|584301175|FG000|Enrolled|Withdrawal by Subject|3|||
161797681|NCT02626949|584301176|FG001|Enrolled|Withdrawal by Subject|2|||
161797682|NCT00601484|584301177|FG000|Overall Study|Adverse Event|0|||
161797683|NCT00601484|584301178|FG001|Overall Study|Adverse Event|1|||
161797684|NCT00601484|584301177|FG000|Overall Study|Lost to Follow-up|4|||
161797685|NCT00601484|584301178|FG001|Overall Study|Lost to Follow-up|3|||
161797686|NCT00601484|584301177|FG000|Overall Study|Lack of Efficacy|0|||
161797687|NCT00601484|584301178|FG001|Overall Study|Lack of Efficacy|2|||
161797688|NCT00601484|584301177|FG000|Overall Study|Withdrawal by Subject|1|||
161797689|NCT00601484|584301178|FG001|Overall Study|Withdrawal by Subject|1|||
161797690|NCT00601484|584301177|FG000|Overall Study|Randomized, but not treated|0|||
161797691|NCT00601484|584301178|FG001|Overall Study|Randomized, but not treated|1|||
161797692|NCT02928848|584301179|FG000|Arm 2|Withdrawal by Subject|1|||
161797693|NCT02928848|584301180|FG001|Arm 2|Withdrawal by Subject|0|||
161797694|NCT02779855|584301181|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
161797695|NCT02779855|584301182|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
161797696|NCT02779855|584301183|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
161797697|NCT00319449|584301192|FG000|Overall Study|Subject did not wish to continue|1|||
161797698|NCT00319449|584301193|FG001|Overall Study|Subject did not wish to continue|0|||
161797699|NCT00319449|584301192|FG000|Overall Study|Noncompliance with the protocol|1|||
161797700|NCT00319449|584301193|FG001|Overall Study|Noncompliance with the protocol|0|||
161797701|NCT00462982|584301200|FG000|Overall Study|Adverse Event|1|||
161797702|NCT00462982|584301200|FG000|Overall Study|Patient Not Treated|2|||
161797703|NCT03471078|584302659|FG000|Overall Study|Withdrawal by Subject|9|||
161797704|NCT03471078|584302660|FG001|Overall Study|Withdrawal by Subject|1|||
161797705|NCT03471078|584302659|FG000|Overall Study|Adverse Event|4|||
161797706|NCT03471078|584302660|FG001|Overall Study|Adverse Event|1|||
161797707|NCT03471078|584302659|FG000|Overall Study|Physician Decision|3|||
161797708|NCT03471078|584302660|FG001|Overall Study|Physician Decision|2|||
161797709|NCT03471078|584302659|FG000|Overall Study|Death|2|||
161797710|NCT03471078|584302660|FG001|Overall Study|Death|0|||
161797711|NCT03471078|584302659|FG000|Overall Study|Other|3|||
161797712|NCT03471078|584302660|FG001|Overall Study|Other|2|||
161797713|NCT02309099|584302668|FG000|Overall Study|Adverse Event|2|||
161797714|NCT02309099|584302669|FG001|Overall Study|Adverse Event|0|||
161797715|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
161797716|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
161797717|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
161797718|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
161556097|NCT02268552|583425374|FG002|Part 3 Extension|Death|1|||
161556098|NCT02268552|583425375|FG003|Part 3 Extension|Death|1|||
161901306|NCT03311841|584685268|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
161901307|NCT00977613|584685271|FG000|Overall Study|Lost to Follow-up|16|||
161901308|NCT05464420|584685274|FG000|Overall Study|Death|0|||
161901309|NCT05464420|584685275|FG001|Overall Study|Death|0|||
161901310|NCT05464420|584685276|FG002|Overall Study|Death|0|||
161901311|NCT05464420|584685277|FG003|Overall Study|Death|1|||
161901312|NCT05464420|584685274|FG000|Overall Study|Lost to Follow-up|16|||
161901313|NCT05464420|584685275|FG001|Overall Study|Lost to Follow-up|11|||
161901314|NCT05464420|584685276|FG002|Overall Study|Lost to Follow-up|11|||
161901315|NCT05464420|584685277|FG003|Overall Study|Lost to Follow-up|11|||
161901316|NCT05464420|584685274|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
161901317|NCT05464420|584685275|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
161901318|NCT05464420|584685276|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
161901319|NCT05464420|584685277|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
161901320|NCT05464420|584685274|FG000|Overall Study|Withdrawal by Subject|4|||
161901321|NCT05464420|584685275|FG001|Overall Study|Withdrawal by Subject|8|||
161901322|NCT05464420|584685276|FG002|Overall Study|Withdrawal by Subject|3|||
161901323|NCT05464420|584685277|FG003|Overall Study|Withdrawal by Subject|1|||
161901324|NCT05464420|584685274|FG000|Overall Study|Protocol Violation|0|||
161901325|NCT05464420|584685275|FG001|Overall Study|Protocol Violation|0|||
161901326|NCT05464420|584685276|FG002|Overall Study|Protocol Violation|1|||
161901327|NCT05464420|584685277|FG003|Overall Study|Protocol Violation|1|||
161901328|NCT05464420|584685274|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
161901329|NCT05464420|584685275|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
161901330|NCT05464420|584685276|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
161901331|NCT05464420|584685277|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
161901332|NCT01383018|584685278|FG000|Overall Study|Adverse Event|14|||
161901333|NCT01383018|584685278|FG000|Overall Study|Death|10|||
161901334|NCT01383018|584685278|FG000|Overall Study|Lost to Follow-up|5|||
161901335|NCT01383018|584685278|FG000|Overall Study|Physician Decision|5|||
161901336|NCT01383018|584685278|FG000|Overall Study|Withdrawal by Subject|9|||
161901337|NCT01383018|584685278|FG000|Overall Study|Subject not implanted|76|||
161901338|NCT01383018|584685278|FG000|Overall Study|Missed Visit|247|||
161901339|NCT01383018|584685278|FG000|Overall Study|Site closed early-not compliance related|7|||
161901340|NCT01383018|584685278|FG000|Overall Study|Patient moved away from site|1|||
161901341|NCT01383018|584685278|FG000|Overall Study|Subject Incarcerated|1|||
161901342|NCT01598610|584685283|FG000|Overall Study|Adverse Event|1|||
161901343|NCT03066830|584685289|FG000|Overall Study|At the Participant's own Request|16|||
161901344|NCT03066830|584685290|FG001|Overall Study|At the Participant's own Request|17|||
161901345|NCT03066830|584685289|FG000|Overall Study|Other|3|||
161901346|NCT03066830|584685290|FG001|Overall Study|Other|0|||
161901347|NCT03066830|584685289|FG000|Overall Study|Poor Compliance to Protocol|1|||
161901348|NCT03066830|584685290|FG001|Overall Study|Poor Compliance to Protocol|0|||
161901349|NCT03066830|584685289|FG000|Overall Study|Adverse Event|2|||
161901350|NCT03066830|584685290|FG001|Overall Study|Adverse Event|2|||
161901351|NCT03066830|584685289|FG000|Overall Study|Lost to Follow-up|11|||
161901352|NCT03066830|584685290|FG001|Overall Study|Lost to Follow-up|3|||
161901353|NCT02989402|584685291|FG000|Overall Study|Adverse event, or serious adverse event|4|||
161901354|NCT02989402|584685291|FG000|Overall Study|Death|2|||
161901355|NCT02989402|584685291|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
161901356|NCT02989402|584685291|FG000|Overall Study|Lost to Follow-up|8|||
161901357|NCT02989402|584685291|FG000|Overall Study|Patient no longer on monotherapy|1|||
161901358|NCT02989402|584685291|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
161901359|NCT02989402|584685291|FG000|Overall Study|Withdrawal by Subject|7|||
161901360|NCT02989402|584685291|FG000|Overall Study|Other|2|||
161901361|NCT02039778|584685293|FG000|Overall Study|Death|2|||
161901362|NCT02039778|584685293|FG000|Overall Study|Withdrawal by Subject|1|||
161901363|NCT02039778|584685293|FG000|Overall Study|Never started the protocol treatment|1|||
161901364|NCT00656175|584685303|FG000|Overall Study|Adverse Event|1|||
161901365|NCT00656175|584685304|FG001|Overall Study|Adverse Event|0|||
161901366|NCT00656175|584685303|FG000|Overall Study|Transportation issues|0|||
161901367|NCT00656175|584685304|FG001|Overall Study|Transportation issues|1|||
161901368|NCT02149264|584685310|FG000|Overall Study|Withdrawal by Subject|9|||
161901369|NCT02149264|584685310|FG000|Overall Study|Adverse Event|7|||
161901370|NCT02149264|584685310|FG000|Overall Study|Physician Decision|3|||
161450677|NCT04074161|583045796|FG000|Overall Study|Withdrawal by Subject|2|||
161450678|NCT04074161|583045797|FG001|Overall Study|Withdrawal by Subject|4|||
161450679|NCT04074161|583045798|FG002|Overall Study|Withdrawal by Subject|1|||
161450680|NCT04074161|583045796|FG000|Overall Study|Lost to Follow-up|4|||
161450681|NCT04074161|583045797|FG001|Overall Study|Lost to Follow-up|5|||
161450682|NCT04074161|583045798|FG002|Overall Study|Lost to Follow-up|3|||
161450683|NCT03595228|583045801|FG000|Overall Study|Death|2|||
161450684|NCT03595228|583045801|FG000|Overall Study|Lack of Efficacy|13|||
161450685|NCT03595228|583045801|FG000|Overall Study|Withdrawal by Subject|3|||
161450686|NCT03595228|583045801|FG000|Overall Study|Withdrawal by Sponsor|1|||
161450687|NCT01639729|583045802|FG000|Overall Study|Withdrawal by Subject|1|||
161450688|NCT01639729|583045803|FG001|Overall Study|Withdrawal by Subject|0|||
161450689|NCT01639729|583045804|FG002|Overall Study|Withdrawal by Subject|1|||
161450690|NCT01639729|583045805|FG003|Overall Study|Withdrawal by Subject|1|||
161450691|NCT01639729|583045806|FG004|Overall Study|Withdrawal by Subject|0|||
161450692|NCT01639729|583045807|FG005|Overall Study|Withdrawal by Subject|0|||
161450693|NCT03232333|583045808|FG000|Overall Study|Infection or Osteomyelitis|9|||
161450694|NCT03232333|583045808|FG000|Overall Study|Lost to Follow-up|4|||
161450695|NCT03232333|583045808|FG000|Overall Study|Withdrawal by Subject|2|||
161450696|NCT01155011|583045809|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
161450697|NCT01155011|583045810|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
161450698|NCT01155011|583045809|FG000|Baseline to 6 Months|investigator decision, moved|4|||
161450699|NCT01155011|583045810|FG001|Baseline to 6 Months|investigator decision, moved|5|||
161450700|NCT01155011|583045809|FG000|Baseline to 6 Months|Death|0|||
161450701|NCT01155011|583045810|FG001|Baseline to 6 Months|Death|1|||
161450702|NCT01155011|583045809|FG000|6 to 12 Months|Withdrawal by Subject|8|||
161450703|NCT01155011|583045810|FG001|6 to 12 Months|Withdrawal by Subject|5|||
161450704|NCT01155011|583045809|FG000|6 to 12 Months|Death|1|||
161450705|NCT01155011|583045810|FG001|6 to 12 Months|Death|5|||
161450706|NCT01087736|583045811|FG000|Overall Study|Lost to Follow-up|1|||
161797719|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
161797720|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
161797721|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
161797722|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
161797723|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
161797724|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
161797725|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
161797726|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
161797727|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
161797728|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
161797729|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
161797730|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
161797731|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797732|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797733|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797734|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797735|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
161797736|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797737|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797738|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797739|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797740|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797741|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797742|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797743|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
161797744|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797745|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
161797746|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
161797747|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
161797748|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
161797749|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
161797750|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161797751|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
161797752|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
161797753|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161797754|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161450707|NCT01087736|583045812|FG001|Overall Study|Lost to Follow-up|0|||
161450708|NCT01087736|583045811|FG000|Overall Study|Death|0|||
161450709|NCT01087736|583045812|FG001|Overall Study|Death|1|||
161450710|NCT01087736|583045811|FG000|Overall Study|Withdrawal by Subject|0|||
161450711|NCT01087736|583045812|FG001|Overall Study|Withdrawal by Subject|1|||
161797755|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
161797756|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
161797757|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
161797758|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
161797759|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
161797760|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
161797761|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
161797762|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
161797763|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
161450712|NCT01253811|583045813|FG000|Overall Study|Withdrawal criteria|1|||
161450713|NCT00759564|583045814|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
161450714|NCT00759564|583045815|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
161450715|NCT00759564|583045816|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
161450716|NCT00759564|583045817|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
161450717|NCT00759564|583045818|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
161450718|NCT01565343|583045821|FG000|Overall Study|Administrative decision/technical issues|1|||
161450719|NCT01565343|583045822|FG001|Overall Study|Administrative decision/technical issues|0|||
161450720|NCT01565343|583045823|FG002|Overall Study|Administrative decision/technical issues|0|||
161450721|NCT01989208|583045826|FG000|200 mg (7 Days)|Protocol Violation|0|||
161450722|NCT01989208|583045827|FG001|200 mg (7 Days)|Protocol Violation|1|||
161450723|NCT04975438|583045828|FG000|Overall Study|Lost to Follow-up|1|||
161450724|NCT04975438|583045829|FG001|Overall Study|Lost to Follow-up|0|||
161450725|NCT04975438|583045830|FG002|Overall Study|Lost to Follow-up|1|||
161450726|NCT04975438|583045831|FG003|Overall Study|Lost to Follow-up|0|||
161450727|NCT04975438|583045828|FG000|Overall Study|Withdrawal by Subject|1|||
161450728|NCT04975438|583045829|FG001|Overall Study|Withdrawal by Subject|0|||
161450729|NCT04975438|583045830|FG002|Overall Study|Withdrawal by Subject|0|||
161450730|NCT04975438|583045831|FG003|Overall Study|Withdrawal by Subject|0|||
161450731|NCT04973436|583045832|FG000|Overall Study|Lost to Follow-up|3|||
161450732|NCT04973436|583045832|FG000|Overall Study|Withdrawal by Subject|1|||
161450733|NCT04973436|583045832|FG000|Overall Study|Death|2|||
161450734|NCT01798849|583045836|FG000|Overall Study|Physician Decision|0|||
161450735|NCT01798849|583045837|FG001|Overall Study|Physician Decision|0|||
161450736|NCT01798849|583045838|FG002|Overall Study|Physician Decision|1|||
161450737|NCT00743106|583045839|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
161450738|NCT00743106|583045840|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
161450739|NCT04784442|583045850|FG000|Overall Study|Adverse Event|1|||
161450740|NCT04784442|583045851|FG001|Overall Study|Adverse Event|0|||
161450741|NCT04784442|583045852|FG002|Overall Study|Adverse Event|2|||
161450742|NCT04784442|583045853|FG003|Overall Study|Adverse Event|1|||
161450743|NCT04784442|583045850|FG000|Overall Study|Protocol Violation|1|||
161450744|NCT04784442|583045851|FG001|Overall Study|Protocol Violation|0|||
161450745|NCT04784442|583045852|FG002|Overall Study|Protocol Violation|0|||
161450746|NCT04784442|583045853|FG003|Overall Study|Protocol Violation|0|||
161450747|NCT04784442|583045850|FG000|Overall Study|Non-compliance with study drug|1|||
161450748|NCT04784442|583045851|FG001|Overall Study|Non-compliance with study drug|0|||
161450749|NCT04784442|583045852|FG002|Overall Study|Non-compliance with study drug|0|||
161450750|NCT04784442|583045853|FG003|Overall Study|Non-compliance with study drug|0|||
161450751|NCT03500224|583045854|FG000|Overall Study|Withdrawal by Subject|2|||
161450752|NCT00929643|583045855|FG000|Overall Study|Protocol Violation|2|||
161450753|NCT00145977|583045859|FG000|Overall Study|Lack of Efficacy|0|||
161450754|NCT00145977|583045860|FG001|Overall Study|Lack of Efficacy|4|||
161450755|NCT00145977|583045859|FG000|Overall Study|Lost to Follow-up|1|||
161450756|NCT00145977|583045860|FG001|Overall Study|Lost to Follow-up|0|||
161450757|NCT00145977|583045859|FG000|Overall Study|Withdrawal by Subject|1|||
161450758|NCT00145977|583045860|FG001|Overall Study|Withdrawal by Subject|0|||
161450759|NCT02717832|583045863|FG000|Overall Study|Inability to place IV|3|||
161450760|NCT01711216|583045864|FG000|Overall Study|Adverse Event|4|||
161450761|NCT01711216|583045864|FG000|Overall Study|Pregnancy|56|||
161450762|NCT01711216|583045864|FG000|Overall Study|Withdrawal by Subject|6|||
161450763|NCT01711216|583045864|FG000|Overall Study|Lost to Follow-up|46|||
161450764|NCT01711216|583045864|FG000|Overall Study|variety of other minor reasons|83|||
161450765|NCT01711216|583045864|FG000|Overall Study|no reason specified|22|||
161450766|NCT03060551|583045865|FG000|Overall Study|Withdrawal by Subject|1|||
161450767|NCT03060551|583045865|FG000|Overall Study|Adverse Event|1|||
161450768|NCT03698591|583045868|FG000|Overall Study|Withdrawal by Subject|2|||
161450769|NCT03698591|583045869|FG001|Overall Study|Withdrawal by Subject|2|||
161450770|NCT03698591|583045868|FG000|Overall Study|Failed drug screen|1|||
161450771|NCT03698591|583045869|FG001|Overall Study|Failed drug screen|1|||
161450772|NCT03698591|583045868|FG000|Overall Study|Failed health screen|0|||
161450773|NCT03698591|583045869|FG001|Overall Study|Failed health screen|1|||
161450774|NCT03698591|583045868|FG000|Overall Study|Ineligible for financial compensation|1|||
161450775|NCT03698591|583045869|FG001|Overall Study|Ineligible for financial compensation|0|||
161450776|NCT03698591|583045868|FG000|Overall Study|Equipment Error|1|||
161901371|NCT02149264|584685310|FG000|Overall Study|Protocol Violation|1|||
161901372|NCT01938846|584685314|FG000|Overall Study|Progressive disease|26|||
161901373|NCT01938846|584685315|FG001|Overall Study|Progressive disease|18|||
161901374|NCT01938846|584685316|FG002|Overall Study|Progressive disease|16|||
161901375|NCT01938846|584685314|FG000|Overall Study|Adverse Event|8|||
161901376|NCT01938846|584685315|FG001|Overall Study|Adverse Event|4|||
161901377|NCT01938846|584685316|FG002|Overall Study|Adverse Event|3|||
161901378|NCT01938846|584685314|FG000|Overall Study|Withdrawal by Subject|2|||
161901379|NCT01938846|584685315|FG001|Overall Study|Withdrawal by Subject|2|||
161901380|NCT01938846|584685316|FG002|Overall Study|Withdrawal by Subject|1|||
161901381|NCT01938846|584685314|FG000|Overall Study|Other than listed|5|||
161901382|NCT01938846|584685315|FG001|Overall Study|Other than listed|1|||
161901383|NCT01938846|584685316|FG002|Overall Study|Other than listed|4|||
161901384|NCT02499120|584685320|FG000|Overall Study|Death|52|||
161556099|NCT02268552|583425376|FG004|Part 3 Extension|Death|1|||
161556100|NCT02268552|583425377|FG005|Part 3 Extension|Death|1|||
161901385|NCT02499120|584685321|FG001|Overall Study|Death|43|||
161901386|NCT02499120|584685320|FG000|Overall Study|Lost to Follow-up|1|||
161901387|NCT02499120|584685321|FG001|Overall Study|Lost to Follow-up|2|||
161901388|NCT02499120|584685320|FG000|Overall Study|Participant refused further follow-up|1|||
161901389|NCT02499120|584685321|FG001|Overall Study|Participant refused further follow-up|0|||
161901390|NCT02499120|584685320|FG000|Overall Study|Withdrawal by Subject|2|||
161901391|NCT02499120|584685321|FG001|Overall Study|Withdrawal by Subject|5|||
161901392|NCT02499120|584685320|FG000|Overall Study|Other|9|||
161901393|NCT02499120|584685321|FG001|Overall Study|Other|10|||
161901394|NCT02282163|584685322|FG000|Overall Study|Protocol Violation|1|||
161901395|NCT01839916|584685323|FG000|Overall Study|Death|9|||
161901396|NCT01839916|584685323|FG000|Overall Study|Physician Decision|17|||
161901397|NCT01839916|584685323|FG000|Overall Study|Relapse|12|||
161901398|NCT01839916|584685323|FG000|Overall Study|GVHD|2|||
161901399|NCT01839916|584685323|FG000|Overall Study|Graft Failure|1|||
161901400|NCT03877224|584685326|FG000|Overall Study|Death|3|||
161901401|NCT03877224|584685327|FG001|Overall Study|Death|2|||
161901402|NCT03877224|584685326|FG000|Overall Study|Withdrawal by Subject|1|||
161450777|NCT03698591|583045869|FG001|Overall Study|Equipment Error|0|||
161450778|NCT03698591|583045868|FG000|Overall Study|Could not establish TMS dosage|0|||
161450779|NCT03698591|583045869|FG001|Overall Study|Could not establish TMS dosage|1|||
161450780|NCT04303195|583045876|FG000|Overall Study|Adverse Event|1|||
161450781|NCT04303195|583045877|FG001|Overall Study|Adverse Event|3|||
161450782|NCT04303195|583045878|FG002|Overall Study|Adverse Event|7|||
161450783|NCT04303195|583045879|FG003|Overall Study|Adverse Event|0|||
161450784|NCT04303195|583045876|FG000|Overall Study|Lost to Follow-up|1|||
161450785|NCT04303195|583045877|FG001|Overall Study|Lost to Follow-up|0|||
161450786|NCT04303195|583045878|FG002|Overall Study|Lost to Follow-up|1|||
161450787|NCT04303195|583045879|FG003|Overall Study|Lost to Follow-up|4|||
161450788|NCT04303195|583045876|FG000|Overall Study|Withdrawal by Subject|3|||
161450789|NCT04303195|583045877|FG001|Overall Study|Withdrawal by Subject|1|||
161450790|NCT04303195|583045878|FG002|Overall Study|Withdrawal by Subject|1|||
161450791|NCT04303195|583045879|FG003|Overall Study|Withdrawal by Subject|1|||
161450792|NCT04303195|583045876|FG000|Overall Study|No study drug administered or protocol deviation|0|||
161450793|NCT04303195|583045877|FG001|Overall Study|No study drug administered or protocol deviation|2|||
161450794|NCT04303195|583045878|FG002|Overall Study|No study drug administered or protocol deviation|0|||
161450795|NCT04303195|583045879|FG003|Overall Study|No study drug administered or protocol deviation|2|||
161450796|NCT01064947|583045880|FG000|Overall Study|negative culture|41|||
161450797|NCT02970942|583045883|FG000|Overall Study|Death|0|||
161450798|NCT02970942|583045884|FG001|Overall Study|Death|1|||
161450799|NCT02970942|583045885|FG002|Overall Study|Death|0|||
161450800|NCT02970942|583045886|FG003|Overall Study|Death|0|||
161450801|NCT02970942|583045883|FG000|Overall Study|Lost to Follow-up|1|||
161556101|NCT02268552|583425378|FG006|Part 3 Extension|Death|0|||
161556102|NCT02268552|583425372|FG000|Part 3 Extension|Early termination of trial|1|||
161901403|NCT03877224|584685327|FG001|Overall Study|Withdrawal by Subject|6|||
161901404|NCT03877224|584685326|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
161901405|NCT03877224|584685327|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
161901406|NCT04587336|584685328|FG000|Overall Study|Lost to Follow-up|1|||
161901407|NCT04587336|584685329|FG001|Overall Study|Lost to Follow-up|0|||
161901408|NCT00379834|584687043|FG000|Overall Study|Time constraints|2|||
161901409|NCT01519817|584687044|FG000|Overall Study|Withdrawal by Subject|1|||
161901410|NCT01519817|584687045|FG001|Overall Study|Withdrawal by Subject|0|||
161901411|NCT01519817|584687046|FG002|Overall Study|Withdrawal by Subject|0|||
161901412|NCT01519817|584687047|FG003|Overall Study|Withdrawal by Subject|0|||
161901413|NCT01519817|584687044|FG000|Overall Study|Off study due to infection|0|||
161450802|NCT02970942|583045884|FG001|Overall Study|Lost to Follow-up|0|||
161450803|NCT02970942|583045885|FG002|Overall Study|Lost to Follow-up|2|||
161450804|NCT02970942|583045886|FG003|Overall Study|Lost to Follow-up|1|||
161450805|NCT02970942|583045883|FG000|Overall Study|Withdrawal by Subject|3|||
161556103|NCT02268552|583425373|FG001|Part 3 Extension|Early termination of trial|0|||
161901414|NCT01519817|584687045|FG001|Overall Study|Off study due to infection|0|||
161797764|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
161797765|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
161797766|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Physician Decision|2|||
161797767|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
161797768|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
161797769|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
161797770|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
161797771|NCT00561730|584302678|FG000|Overall Study|Adverse Event|2|||
161797772|NCT00561730|584302678|FG000|Overall Study|Handling of the drug|1|||
161797773|NCT00561730|584302678|FG000|Overall Study|Lost to Follow-up|5|||
161797774|NCT00561730|584302678|FG000|Overall Study|Not specified reasons|1|||
161797775|NCT03194464|584302681|FG000|Overall Study|data not usable|2|||
161797776|NCT02750761|584302685|FG000|Overall Study|Lost to Follow-up|0|||
161797777|NCT02750761|584302686|FG001|Overall Study|Lost to Follow-up|0|||
161797778|NCT02750761|584302687|FG002|Overall Study|Lost to Follow-up|1|||
161797779|NCT02750761|584302688|FG003|Overall Study|Lost to Follow-up|0|||
161797780|NCT02750761|584302689|FG004|Overall Study|Lost to Follow-up|0|||
161797781|NCT02750761|584302690|FG005|Overall Study|Lost to Follow-up|0|||
161797782|NCT01860976|584302691|FG000|Blinded Treatment|Adverse Event|1|||
161797783|NCT01860976|584302692|FG001|Blinded Treatment|Adverse Event|3|||
161797784|NCT01860976|584302691|FG000|Blinded Treatment|Lack of Efficacy|5|||
161797785|NCT01860976|584302692|FG001|Blinded Treatment|Lack of Efficacy|12|||
161797786|NCT01860976|584302691|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
161797787|NCT01860976|584302692|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
161797788|NCT01860976|584302691|FG000|Blinded Treatment|Withdrawal by Subject|3|||
161797789|NCT01860976|584302692|FG001|Blinded Treatment|Withdrawal by Subject|5|||
161797790|NCT01860976|584302691|FG000|Blinded Treatment|Subject no longer met criteria|1|||
161797791|NCT01860976|584302692|FG001|Blinded Treatment|Subject no longer met criteria|0|||
161797792|NCT01860976|584302691|FG000|Blinded Treatment|Entered Open-Label in error|0|||
161797793|NCT01860976|584302692|FG001|Blinded Treatment|Entered Open-Label in error|1|||
161797794|NCT01860976|584302691|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
161797795|NCT01860976|584302692|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
161797796|NCT01860976|584302691|FG000|Open-Label|Adverse Event|2|||
161797797|NCT01860976|584302692|FG001|Open-Label|Adverse Event|4|||
161797798|NCT01860976|584302691|FG000|Open-Label|Lack of Efficacy|16|||
161797799|NCT01860976|584302692|FG001|Open-Label|Lack of Efficacy|8|||
161797800|NCT01860976|584302691|FG000|Open-Label|Lost to Follow-up|1|||
161797801|NCT01860976|584302692|FG001|Open-Label|Lost to Follow-up|2|||
161797802|NCT01860976|584302691|FG000|Open-Label|Subject request discontinue treatment|4|||
161797803|NCT01860976|584302692|FG001|Open-Label|Subject request discontinue treatment|3|||
161797804|NCT01860976|584302691|FG000|Open-Label|Withdrawal by Subject|4|||
161797805|NCT01860976|584302692|FG001|Open-Label|Withdrawal by Subject|1|||
161797806|NCT01860976|584302691|FG000|Open-Label|Other Reasons|1|||
161797807|NCT01860976|584302692|FG001|Open-Label|Other Reasons|1|||
161797808|NCT01860976|584302691|FG000|Long Term Extension|Adverse Event|4|||
161797809|NCT01860976|584302692|FG001|Long Term Extension|Adverse Event|0|||
161797810|NCT01860976|584302691|FG000|Long Term Extension|Lack of Efficacy|2|||
161797811|NCT01860976|584302692|FG001|Long Term Extension|Lack of Efficacy|0|||
161797812|NCT01860976|584302691|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
161797813|NCT01860976|584302692|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
161797814|NCT01860976|584302691|FG000|Long Term Extension|Lost to Follow-up|2|||
161797815|NCT01860976|584302692|FG001|Long Term Extension|Lost to Follow-up|0|||
161797816|NCT01860976|584302691|FG000|Long Term Extension|subject withdrew consent|7|||
161797817|NCT01860976|584302692|FG001|Long Term Extension|subject withdrew consent|0|||
161797818|NCT02153398|584302693|FG000|Overall Study|Withdrawal by Subject|1|||
161797819|NCT02153398|584302694|FG001|Overall Study|Withdrawal by Subject|0|||
161797820|NCT02153398|584302695|FG002|Overall Study|Withdrawal by Subject|0|||
161797821|NCT02153398|584302696|FG003|Overall Study|Withdrawal by Subject|0|||
161797822|NCT02153398|584302697|FG004|Overall Study|Withdrawal by Subject|0|||
161797823|NCT02153398|584302693|FG000|Overall Study|Adverse Event|0|||
161797824|NCT02153398|584302694|FG001|Overall Study|Adverse Event|0|||
161797825|NCT02153398|584302695|FG002|Overall Study|Adverse Event|1|||
161797826|NCT02153398|584302696|FG003|Overall Study|Adverse Event|1|||
161797827|NCT02153398|584302697|FG004|Overall Study|Adverse Event|0|||
161797828|NCT02204371|584302698|FG000|Overall Study|Adverse Event|1|||
161797829|NCT01506947|584302699|FG000|Overall Study|Lost to Follow-up|7|||
161797830|NCT01506947|584302699|FG000|Overall Study|Adverse Event|5|||
161797831|NCT01506947|584302699|FG000|Overall Study|Death|1|||
161797832|NCT01506947|584302699|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
161797833|NCT03803943|584302702|FG000|Overall Study|Withdrawal by Subject|2|||
161797834|NCT03803943|584302703|FG001|Overall Study|Withdrawal by Subject|2|||
161797835|NCT03803943|584302704|FG002|Overall Study|Withdrawal by Subject|2|||
161797836|NCT03803943|584302705|FG003|Overall Study|Withdrawal by Subject|2|||
161797837|NCT01781286|584302708|FG000|Overall Study|Lost to Follow-up|0|||
161797838|NCT01781286|584302709|FG001|Overall Study|Lost to Follow-up|0|||
161797839|NCT01781286|584302710|FG002|Overall Study|Lost to Follow-up|0|||
161797840|NCT01781286|584302711|FG003|Overall Study|Lost to Follow-up|0|||
161797841|NCT01781286|584302712|FG004|Overall Study|Lost to Follow-up|0|||
161797842|NCT01781286|584302713|FG005|Overall Study|Lost to Follow-up|1|||
161797843|NCT01781286|584302708|FG000|Overall Study|Time Constraints|2|||
161797844|NCT01781286|584302709|FG001|Overall Study|Time Constraints|0|||
161797845|NCT01781286|584302710|FG002|Overall Study|Time Constraints|2|||
161797846|NCT01781286|584302711|FG003|Overall Study|Time Constraints|0|||
161797847|NCT01781286|584302712|FG004|Overall Study|Time Constraints|0|||
161797848|NCT01781286|584302713|FG005|Overall Study|Time Constraints|0|||
161797849|NCT01781286|584302708|FG000|Overall Study|Noncompliance|0|||
161797850|NCT01781286|584302709|FG001|Overall Study|Noncompliance|0|||
161797851|NCT01781286|584302710|FG002|Overall Study|Noncompliance|0|||
161797852|NCT01781286|584302711|FG003|Overall Study|Noncompliance|1|||
161797853|NCT01781286|584302712|FG004|Overall Study|Noncompliance|0|||
161797854|NCT01781286|584302713|FG005|Overall Study|Noncompliance|0|||
161797855|NCT00995410|584302714|FG000|Overall Study|Adverse Event|51|||
161797856|NCT00995410|584302714|FG000|Overall Study|Withdrawal by Subject|7|||
161797857|NCT00995410|584302714|FG000|Overall Study|Lost to Follow-up|2|||
161797858|NCT00995410|584302714|FG000|Overall Study|Misc|28|||
161797859|NCT03594123|584302715|FG000|Overall Study|Lost to Follow-up|0|||
161797860|NCT03594123|584302716|FG001|Overall Study|Lost to Follow-up|1|||
161797861|NCT03594123|584302715|FG000|Overall Study|Adverse Event|8|||
161797862|NCT03594123|584302716|FG001|Overall Study|Adverse Event|5|||
161797863|NCT03594123|584302715|FG000|Overall Study|Site Terminated by Sponsor|4|||
161797864|NCT03594123|584302716|FG001|Overall Study|Site Terminated by Sponsor|1|||
161797865|NCT03594123|584302715|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
161797866|NCT03594123|584302716|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
161797867|NCT03594123|584302715|FG000|Overall Study|Lack of Efficacy|1|||
161797868|NCT03594123|584302716|FG001|Overall Study|Lack of Efficacy|0|||
161797869|NCT03594123|584302715|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
161797870|NCT03594123|584302716|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
161797871|NCT03019965|584302719|FG000|Overall Study|Withdrawal by Subject|1|||
161797872|NCT03019965|584302720|FG001|Overall Study|Withdrawal by Subject|0|||
161797873|NCT03019965|584302719|FG000|Overall Study|Protocol Violation|1|||
161797874|NCT03019965|584302720|FG001|Overall Study|Protocol Violation|3|||
161797875|NCT03019965|584302719|FG000|Overall Study|viral or fungal infection|3|||
161797876|NCT03019965|584302720|FG001|Overall Study|viral or fungal infection|4|||
161797877|NCT03019965|584302719|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
161797878|NCT03019965|584302720|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
161797879|NCT03019965|584302719|FG000|Overall Study|Physician Decision|1|||
161797880|NCT03019965|584302720|FG001|Overall Study|Physician Decision|1|||
161797881|NCT01513148|584302726|FG000|Overall Study|Protocol Violation|2|||
161797882|NCT01513148|584302727|FG001|Overall Study|Protocol Violation|2|||
161797883|NCT03552757|584302728|FG000|Overall Study|Withdrawal by Subject|10|||
161797884|NCT03552757|584302729|FG001|Overall Study|Withdrawal by Subject|5|||
161797885|NCT03552757|584302730|FG002|Overall Study|Withdrawal by Subject|12|||
161797886|NCT03552757|584302728|FG000|Overall Study|Lost to Follow-up|2|||
161797887|NCT03552757|584302729|FG001|Overall Study|Lost to Follow-up|7|||
161797888|NCT03552757|584302730|FG002|Overall Study|Lost to Follow-up|7|||
161797889|NCT03552757|584302728|FG000|Overall Study|Death|1|||
161797890|NCT03552757|584302729|FG001|Overall Study|Death|1|||
161797891|NCT03552757|584302730|FG002|Overall Study|Death|1|||
161797892|NCT02192099|584302733|FG000|Overall Study|Adverse Event|1|||
161901415|NCT01519817|584687046|FG002|Overall Study|Off study due to infection|0|||
161450806|NCT02970942|583045884|FG001|Overall Study|Withdrawal by Subject|5|||
161450807|NCT02970942|583045885|FG002|Overall Study|Withdrawal by Subject|3|||
161450808|NCT02970942|583045886|FG003|Overall Study|Withdrawal by Subject|2|||
161450809|NCT06457204|583045889|FG000|Washout|Adverse Event|0|||
161450810|NCT06457204|583045890|FG001|Washout|Adverse Event|2|||
161450811|NCT01457352|583045893|FG000|Period 1|Adverse Event|2|||
161797893|NCT02192099|584302733|FG000|Overall Study|Lost to Follow-up|2|||
161797894|NCT02192099|584302733|FG000|Overall Study|Physician Decision|1|||
161797895|NCT02192099|584302733|FG000|Overall Study|Pregnancy|1|||
161797896|NCT02192099|584302733|FG000|Overall Study|Protocol Violation|8|||
161797897|NCT02192099|584302733|FG000|Overall Study|Study Terminated by Sponsor|32|||
161797898|NCT02192099|584302733|FG000|Overall Study|Withdrawal by Subject|11|||
161797899|NCT02192099|584302733|FG000|Overall Study|Miscellaneous Reasons|5|||
161797900|NCT00386009|584302734|FG000|Overall Study|Adverse Event|0|||
161797901|NCT00386009|584302735|FG001|Overall Study|Adverse Event|2|||
161797902|NCT00386009|584302734|FG000|Overall Study|Death|1|||
161797903|NCT00386009|584302735|FG001|Overall Study|Death|0|||
161797904|NCT00386009|584302734|FG000|Overall Study|Entry Criteria Not Met|0|||
161797905|NCT00386009|584302735|FG001|Overall Study|Entry Criteria Not Met|2|||
161797906|NCT00386009|584302734|FG000|Overall Study|Lost to Follow-up|1|||
161797907|NCT00386009|584302735|FG001|Overall Study|Lost to Follow-up|1|||
161797908|NCT00386009|584302734|FG000|Overall Study|Protocol Violation|1|||
161797909|NCT00386009|584302735|FG001|Overall Study|Protocol Violation|0|||
161797910|NCT00386009|584302734|FG000|Overall Study|Sponsor Decision|1|||
161901416|NCT01519817|584687047|FG003|Overall Study|Off study due to infection|1|||
161901417|NCT03934216|584687050|FG000|Overall Study|Other Reasons|5|||
161901418|NCT03934216|584687051|FG001|Overall Study|Other Reasons|5|||
161901419|NCT03934216|584687050|FG000|Overall Study|Adverse Event|22|||
161901420|NCT03934216|584687051|FG001|Overall Study|Adverse Event|11|||
161901421|NCT03934216|584687050|FG000|Overall Study|Lack of Efficacy|8|||
161901422|NCT03934216|584687051|FG001|Overall Study|Lack of Efficacy|7|||
161901423|NCT03934216|584687050|FG000|Overall Study|Lost to Follow-up|2|||
161901424|NCT03934216|584687051|FG001|Overall Study|Lost to Follow-up|0|||
161901425|NCT03934216|584687050|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161901426|NCT03934216|584687051|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161901427|NCT03934216|584687050|FG000|Overall Study|Pregnancy|1|||
161901428|NCT03934216|584687051|FG001|Overall Study|Pregnancy|0|||
161901429|NCT03934216|584687050|FG000|Overall Study|Withdrawal by Subject|18|||
161901430|NCT03934216|584687051|FG001|Overall Study|Withdrawal by Subject|6|||
161901431|NCT03934216|584687050|FG000|Overall Study|Randomized but not treated|1|||
161901432|NCT03934216|584687051|FG001|Overall Study|Randomized but not treated|1|||
161556104|NCT02268552|583425374|FG002|Part 3 Extension|Early termination of trial|0|||
161556105|NCT02268552|583425375|FG003|Part 3 Extension|Early termination of trial|0|||
161556106|NCT02268552|583425376|FG004|Part 3 Extension|Early termination of trial|2|||
161556107|NCT02268552|583425377|FG005|Part 3 Extension|Early termination of trial|9|||
161556108|NCT02268552|583425378|FG006|Part 3 Extension|Early termination of trial|11|||
161556109|NCT02268552|583425372|FG000|Part 3 Extension|Subject/guardian decision|0|||
161556110|NCT02268552|583425373|FG001|Part 3 Extension|Subject/guardian decision|0|||
161556111|NCT02268552|583425374|FG002|Part 3 Extension|Subject/guardian decision|0|||
161556112|NCT02268552|583425375|FG003|Part 3 Extension|Subject/guardian decision|0|||
161556113|NCT02268552|583425376|FG004|Part 3 Extension|Subject/guardian decision|0|||
161556114|NCT02268552|583425377|FG005|Part 3 Extension|Subject/guardian decision|0|||
161556115|NCT02268552|583425378|FG006|Part 3 Extension|Subject/guardian decision|1|||
161556116|NCT04168385|583425380|FG000|Overall Study|Withdrawal by Subject|1|||
161556117|NCT04168385|583425381|FG001|Overall Study|Withdrawal by Subject|0|||
161556118|NCT04168385|583425380|FG000|Overall Study|Adverse Event|2|||
161556119|NCT04168385|583425381|FG001|Overall Study|Adverse Event|1|||
161556120|NCT04168385|583425380|FG000|Overall Study|Liver transplant|3|||
161556121|NCT04168385|583425381|FG001|Overall Study|Liver transplant|1|||
161556122|NCT04168385|583425380|FG000|Overall Study|Listed for liver transplant|1|||
161556123|NCT04168385|583425381|FG001|Overall Study|Listed for liver transplant|0|||
161556124|NCT02139982|583425382|FG000|Overall Study|Lack of Efficacy|0|||
161556125|NCT02139982|583425383|FG001|Overall Study|Lack of Efficacy|1|||
161556126|NCT02139982|583425384|FG002|Overall Study|Lack of Efficacy|0|||
161556127|NCT02139982|583425385|FG003|Overall Study|Lack of Efficacy|1|||
161901433|NCT01396083|584687056|FG000|Overall Study|Adverse Event|2|||
161901434|NCT01396083|584687057|FG001|Overall Study|Adverse Event|28|||
161901435|NCT01396083|584687056|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161901436|NCT01396083|584687057|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161450812|NCT01457352|583045894|FG001|Period 1|Adverse Event|0|||
161450813|NCT01457352|583045893|FG000|Period 1|Withdrawal by Subject|2|||
161450814|NCT01457352|583045894|FG001|Period 1|Withdrawal by Subject|0|||
161450815|NCT01457352|583045893|FG000|Period 1|Physician Decision|2|||
161450816|NCT01457352|583045894|FG001|Period 1|Physician Decision|0|||
161450817|NCT01457352|583045893|FG000|Period 1|MS related disease progression|1|||
161450818|NCT01457352|583045894|FG001|Period 1|MS related disease progression|0|||
161450819|NCT01457352|583045893|FG000|Period 1|Withdrawn|1|||
161450820|NCT01457352|583045894|FG001|Period 1|Withdrawn|0|||
161450821|NCT01457352|583045893|FG000|Period 1|withdrew per sponsor|1|||
161450822|NCT01457352|583045894|FG001|Period 1|withdrew per sponsor|0|||
161450823|NCT01457352|583045893|FG000|Period 1|Protocol Violation|4|||
161450824|NCT01457352|583045894|FG001|Period 1|Protocol Violation|0|||
161450825|NCT01457352|583045893|FG000|Period 1|Did not meet eligibility criteria|3|||
161450826|NCT01457352|583045894|FG001|Period 1|Did not meet eligibility criteria|0|||
161450827|NCT01457352|583045893|FG000|Period 2|Withdrawal by Subject|23|||
161450828|NCT01457352|583045894|FG001|Period 2|Withdrawal by Subject|0|||
161450829|NCT01457352|583045893|FG000|Period 2|Adverse Event|22|||
161450830|NCT01457352|583045894|FG001|Period 2|Adverse Event|0|||
161450831|NCT01457352|583045893|FG000|Period 2|no analysis|10|||
161556128|NCT02139982|583425386|FG004|Overall Study|Lack of Efficacy|0|||
161901437|NCT01396083|584687056|FG000|Overall Study|Consent withdrawn|4|||
161901438|NCT01396083|584687057|FG001|Overall Study|Consent withdrawn|5|||
161901439|NCT01396083|584687056|FG000|Overall Study|Protocol deviation(s)|0|||
161901440|NCT01396083|584687057|FG001|Overall Study|Protocol deviation(s)|1|||
161450832|NCT01457352|583045894|FG001|Period 2|no analysis|0|||
161450833|NCT01457352|583045893|FG000|Period 2|Lack of Efficacy|8|||
161450834|NCT01457352|583045894|FG001|Period 2|Lack of Efficacy|0|||
161450835|NCT01457352|583045893|FG000|Period 2|Protocol Violation|4|||
161450836|NCT01457352|583045894|FG001|Period 2|Protocol Violation|0|||
161556129|NCT02139982|583425387|FG005|Overall Study|Lack of Efficacy|0|||
161556130|NCT02139982|583425388|FG006|Overall Study|Lack of Efficacy|0|||
161556131|NCT02139982|583425389|FG007|Overall Study|Lack of Efficacy|0|||
161797911|NCT00386009|584302735|FG001|Overall Study|Sponsor Decision|1|||
161797912|NCT00386009|584302734|FG000|Overall Study|Withdrawal by Subject|5|||
161797913|NCT00386009|584302735|FG001|Overall Study|Withdrawal by Subject|4|||
161797914|NCT01862328|584302745|FG000|Overall Study|Progressive Disease|3|||
161797915|NCT01862328|584302746|FG001|Overall Study|Progressive Disease|11|||
161797916|NCT01862328|584302747|FG002|Overall Study|Progressive Disease|5|||
161797917|NCT01862328|584302748|FG003|Overall Study|Progressive Disease|6|||
161797918|NCT01862328|584302749|FG004|Overall Study|Progressive Disease|7|||
161797919|NCT01862328|584302750|FG005|Overall Study|Progressive Disease|4|||
161797920|NCT01862328|584302751|FG006|Overall Study|Progressive Disease|3|||
161797921|NCT01862328|584302745|FG000|Overall Study|Adverse Event|0|||
161797922|NCT01862328|584302746|FG001|Overall Study|Adverse Event|4|||
161797923|NCT01862328|584302747|FG002|Overall Study|Adverse Event|0|||
161797924|NCT01862328|584302748|FG003|Overall Study|Adverse Event|1|||
161797925|NCT01862328|584302749|FG004|Overall Study|Adverse Event|0|||
161797926|NCT01862328|584302750|FG005|Overall Study|Adverse Event|2|||
161797927|NCT01862328|584302751|FG006|Overall Study|Adverse Event|4|||
161797928|NCT01862328|584302745|FG000|Overall Study|Other|0|||
161797929|NCT01862328|584302746|FG001|Overall Study|Other|2|||
161797930|NCT01862328|584302747|FG002|Overall Study|Other|1|||
161797931|NCT01862328|584302748|FG003|Overall Study|Other|0|||
161797932|NCT01862328|584302749|FG004|Overall Study|Other|4|||
161797933|NCT01862328|584302750|FG005|Overall Study|Other|0|||
161797934|NCT01862328|584302751|FG006|Overall Study|Other|1|||
161797935|NCT01862328|584302745|FG000|Overall Study|Withdrawal by Subject|1|||
161797936|NCT01862328|584302746|FG001|Overall Study|Withdrawal by Subject|1|||
161797937|NCT01862328|584302747|FG002|Overall Study|Withdrawal by Subject|0|||
161797938|NCT01862328|584302748|FG003|Overall Study|Withdrawal by Subject|0|||
161797939|NCT01862328|584302749|FG004|Overall Study|Withdrawal by Subject|1|||
161797940|NCT01862328|584302750|FG005|Overall Study|Withdrawal by Subject|1|||
161797941|NCT01862328|584302751|FG006|Overall Study|Withdrawal by Subject|1|||
161797942|NCT01862328|584302745|FG000|Overall Study|Symptomatic Deterioration|0|||
161797943|NCT01862328|584302746|FG001|Overall Study|Symptomatic Deterioration|0|||
161797944|NCT01862328|584302747|FG002|Overall Study|Symptomatic Deterioration|0|||
161797945|NCT01862328|584302748|FG003|Overall Study|Symptomatic Deterioration|0|||
161797946|NCT01862328|584302749|FG004|Overall Study|Symptomatic Deterioration|0|||
161797947|NCT01862328|584302750|FG005|Overall Study|Symptomatic Deterioration|0|||
161797948|NCT01862328|584302751|FG006|Overall Study|Symptomatic Deterioration|1|||
161797949|NCT00936975|584302752|FG000|Overall Study|Withdrawal by Subject|1|||
161797950|NCT00936975|584302752|FG000|Overall Study|Disease progression|3|||
161797951|NCT00936975|584302752|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
161797952|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
161797953|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
161797954|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Death|0|||
161797955|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Death|1|||
161797956|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
161797957|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
161797958|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
161797959|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
161797960|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
161797961|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
161797962|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
161797963|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
161797964|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
161797965|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
161797966|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
161797967|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
161797968|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
161797969|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
161797970|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
161797971|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
161797972|NCT02486796|584302758|FG000|Overall Study|Withdrawal by Subject|1|||
161797973|NCT02486796|584302759|FG001|Overall Study|Withdrawal by Subject|1|||
161901441|NCT01396083|584687056|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161797974|NCT02486796|584302758|FG000|Overall Study|Physician Decision|1|||
161797975|NCT02486796|584302759|FG001|Overall Study|Physician Decision|0|||
161797976|NCT03276975|584302760|FG000|Overall Study|Withdrawal by Subject|1|||
161797977|NCT03276975|584302761|FG001|Overall Study|Withdrawal by Subject|0|||
161797978|NCT00306384|584302764|FG000|Overall Study|Adverse Event|103|||
161797979|NCT00306384|584302765|FG001|Overall Study|Adverse Event|87|||
161797980|NCT00306384|584302766|FG002|Overall Study|Adverse Event|40|||
161797981|NCT00306384|584302764|FG000|Overall Study|Major protocol deviation|43|||
161797982|NCT00306384|584302765|FG001|Overall Study|Major protocol deviation|51|||
161797983|NCT00306384|584302766|FG002|Overall Study|Major protocol deviation|18|||
161797984|NCT00306384|584302764|FG000|Overall Study|Lost to Follow-up|57|||
161797985|NCT00306384|584302765|FG001|Overall Study|Lost to Follow-up|41|||
161901442|NCT01396083|584687057|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161901443|NCT01396083|584687056|FG000|Overall Study|Administrative problems|1|||
161901444|NCT01396083|584687057|FG001|Overall Study|Administrative problems|0|||
161901445|NCT01396083|584687056|FG000|Overall Study|Lost to Follow-up|1|||
161901446|NCT01396083|584687057|FG001|Overall Study|Lost to Follow-up|0|||
161901447|NCT01063855|584687058|FG000|Overall Study|Adverse Event|4|||
161901448|NCT01063855|584687059|FG001|Overall Study|Adverse Event|4|||
161901449|NCT01063855|584687058|FG000|Overall Study|Death|0|||
161901450|NCT01063855|584687059|FG001|Overall Study|Death|1|||
161901451|NCT01063855|584687058|FG000|Overall Study|Lost to Follow-up|8|||
161901452|NCT01063855|584687059|FG001|Overall Study|Lost to Follow-up|4|||
161901453|NCT01063855|584687058|FG000|Overall Study|Pregnancy|1|||
161901454|NCT01063855|584687059|FG001|Overall Study|Pregnancy|0|||
161901455|NCT01063855|584687058|FG000|Overall Study|Lack of Efficacy|0|||
161901456|NCT01063855|584687059|FG001|Overall Study|Lack of Efficacy|1|||
161901457|NCT01063855|584687058|FG000|Overall Study|Withdrawal by Subject|11|||
161901458|NCT01063855|584687059|FG001|Overall Study|Withdrawal by Subject|8|||
161901459|NCT01063855|584687058|FG000|Overall Study|Reason not specified|13|||
161901460|NCT01063855|584687059|FG001|Overall Study|Reason not specified|11|||
161901461|NCT01165307|584687060|FG000|Overall Study|Lost to Follow-up|11|||
161901462|NCT01165307|584687061|FG001|Overall Study|Lost to Follow-up|3|||
161901463|NCT01165307|584687060|FG000|Overall Study|Withdrawal by Subject|2|||
161901464|NCT01165307|584687061|FG001|Overall Study|Withdrawal by Subject|0|||
161901465|NCT01165307|584687060|FG000|Overall Study|Subject not available for contact|1|||
161901466|NCT01165307|584687061|FG001|Overall Study|Subject not available for contact|0|||
161901467|NCT03234036|584687063|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
161901468|NCT03234036|584687064|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
161901469|NCT03234036|584687065|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
161901470|NCT03234036|584687066|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
161901471|NCT02683239|584687086|FG000|Overall Study|Protocol Violation|35|||
161901472|NCT02683239|584687087|FG001|Overall Study|Protocol Violation|23|||
161901473|NCT02683239|584687088|FG002|Overall Study|Protocol Violation|26|||
161901474|NCT02683239|584687089|FG003|Overall Study|Protocol Violation|4|||
161901475|NCT02683239|584687090|FG004|Overall Study|Protocol Violation|35|||
161901476|NCT02683239|584687091|FG005|Overall Study|Protocol Violation|4|||
161901477|NCT02683239|584687092|FG006|Overall Study|Protocol Violation|5|||
161901478|NCT02683239|584687086|FG000|Overall Study|Adverse Event|64|||
161901479|NCT02683239|584687087|FG001|Overall Study|Adverse Event|39|||
161901480|NCT02683239|584687088|FG002|Overall Study|Adverse Event|42|||
161901481|NCT02683239|584687089|FG003|Overall Study|Adverse Event|16|||
161901482|NCT02683239|584687090|FG004|Overall Study|Adverse Event|189|||
161901483|NCT02683239|584687091|FG005|Overall Study|Adverse Event|9|||
161901484|NCT02683239|584687092|FG006|Overall Study|Adverse Event|9|||
161901485|NCT02683239|584687086|FG000|Overall Study|Physician Decision|38|||
161901486|NCT02683239|584687087|FG001|Overall Study|Physician Decision|19|||
161901487|NCT02683239|584687088|FG002|Overall Study|Physician Decision|14|||
161901488|NCT02683239|584687089|FG003|Overall Study|Physician Decision|73|||
161901489|NCT02683239|584687090|FG004|Overall Study|Physician Decision|143|||
161901490|NCT02683239|584687091|FG005|Overall Study|Physician Decision|14|||
161901491|NCT02683239|584687092|FG006|Overall Study|Physician Decision|15|||
161901492|NCT02683239|584687086|FG000|Overall Study|Withdrawal by Subject|187|||
161901493|NCT02683239|584687087|FG001|Overall Study|Withdrawal by Subject|99|||
161901494|NCT02683239|584687088|FG002|Overall Study|Withdrawal by Subject|91|||
161901495|NCT02683239|584687089|FG003|Overall Study|Withdrawal by Subject|18|||
161901496|NCT02683239|584687090|FG004|Overall Study|Withdrawal by Subject|248|||
161901497|NCT02683239|584687091|FG005|Overall Study|Withdrawal by Subject|22|||
161450837|NCT01457352|583045893|FG000|Period 2|Sponsor's withdrawal|7|||
161450838|NCT01457352|583045894|FG001|Period 2|Sponsor's withdrawal|0|||
161450839|NCT01457352|583045893|FG000|Period 2|Lost to Follow-up|1|||
161450840|NCT01457352|583045894|FG001|Period 2|Lost to Follow-up|0|||
161901498|NCT02683239|584687092|FG006|Overall Study|Withdrawal by Subject|28|||
161901499|NCT02683239|584687086|FG000|Overall Study|Lost to Follow-up|77|||
161901500|NCT02683239|584687087|FG001|Overall Study|Lost to Follow-up|24|||
161901501|NCT02683239|584687088|FG002|Overall Study|Lost to Follow-up|25|||
161901502|NCT02683239|584687089|FG003|Overall Study|Lost to Follow-up|7|||
161901503|NCT02683239|584687090|FG004|Overall Study|Lost to Follow-up|88|||
161901504|NCT02683239|584687091|FG005|Overall Study|Lost to Follow-up|8|||
161901505|NCT02683239|584687092|FG006|Overall Study|Lost to Follow-up|11|||
161901506|NCT02683239|584687086|FG000|Overall Study|Death|9|||
161901507|NCT02683239|584687087|FG001|Overall Study|Death|5|||
161901508|NCT02683239|584687088|FG002|Overall Study|Death|8|||
161901509|NCT02683239|584687089|FG003|Overall Study|Death|0|||
161901510|NCT02683239|584687090|FG004|Overall Study|Death|12|||
161901511|NCT02683239|584687091|FG005|Overall Study|Death|1|||
161901512|NCT02683239|584687092|FG006|Overall Study|Death|0|||
161901513|NCT02683239|584687086|FG000|Overall Study|Lack of Efficacy|50|||
161901514|NCT02683239|584687087|FG001|Overall Study|Lack of Efficacy|23|||
161901515|NCT02683239|584687088|FG002|Overall Study|Lack of Efficacy|12|||
161901516|NCT02683239|584687089|FG003|Overall Study|Lack of Efficacy|2|||
161901517|NCT02683239|584687090|FG004|Overall Study|Lack of Efficacy|29|||
161901518|NCT02683239|584687091|FG005|Overall Study|Lack of Efficacy|2|||
161901519|NCT02683239|584687092|FG006|Overall Study|Lack of Efficacy|3|||
161901520|NCT02683239|584687086|FG000|Overall Study|Missing data|0|||
161901521|NCT02683239|584687087|FG001|Overall Study|Missing data|1|||
161901522|NCT02683239|584687088|FG002|Overall Study|Missing data|1|||
161901523|NCT02683239|584687089|FG003|Overall Study|Missing data|0|||
161901524|NCT02683239|584687090|FG004|Overall Study|Missing data|1|||
161901525|NCT02683239|584687091|FG005|Overall Study|Missing data|0|||
161901526|NCT02683239|584687092|FG006|Overall Study|Missing data|0|||
161901527|NCT00521365|584687095|FG000|Overall Study|Adverse Event|3|||
161901528|NCT00521365|584687095|FG000|Overall Study|Lost to Follow-up|6|||
161901529|NCT00521365|584687095|FG000|Overall Study|Protocol deviation|2|||
161901530|NCT00521365|584687095|FG000|Overall Study|Drug compliance|3|||
161901531|NCT00521365|584687095|FG000|Overall Study|Usage of not allowed drugs|6|||
161901532|NCT01718483|584687096|FG000|Overall Study|Withdrawal by Subject|14|||
161901533|NCT01718483|584687097|FG001|Overall Study|Withdrawal by Subject|12|||
161797986|NCT00306384|584302766|FG002|Overall Study|Lost to Follow-up|35|||
161797987|NCT00306384|584302764|FG000|Overall Study|Voluntary withdrawal|199|||
161797988|NCT00306384|584302765|FG001|Overall Study|Voluntary withdrawal|187|||
161797989|NCT00306384|584302766|FG002|Overall Study|Voluntary withdrawal|91|||
161797990|NCT00306384|584302764|FG000|Overall Study|Study termination|1|||
161797991|NCT00306384|584302765|FG001|Overall Study|Study termination|0|||
161797992|NCT00306384|584302766|FG002|Overall Study|Study termination|1|||
161797993|NCT00306384|584302764|FG000|Overall Study|Pregnancy|3|||
161797994|NCT00306384|584302765|FG001|Overall Study|Pregnancy|1|||
161797995|NCT00306384|584302766|FG002|Overall Study|Pregnancy|1|||
161797996|NCT00306384|584302764|FG000|Overall Study|Lack of Efficacy|26|||
161797997|NCT00306384|584302765|FG001|Overall Study|Lack of Efficacy|40|||
161797998|NCT00306384|584302766|FG002|Overall Study|Lack of Efficacy|38|||
161797999|NCT00306384|584302764|FG000|Overall Study|Investigator discretion|28|||
161798000|NCT00306384|584302765|FG001|Overall Study|Investigator discretion|31|||
161798001|NCT00306384|584302766|FG002|Overall Study|Investigator discretion|21|||
161798002|NCT00306384|584302764|FG000|Overall Study|Other|80|||
161798003|NCT00306384|584302765|FG001|Overall Study|Other|70|||
161798004|NCT00306384|584302766|FG002|Overall Study|Other|32|||
161798005|NCT00306384|584302764|FG000|Overall Study|Site closure|2|||
161798006|NCT00306384|584302765|FG001|Overall Study|Site closure|0|||
161798007|NCT00306384|584302766|FG002|Overall Study|Site closure|0|||
161798008|NCT02275364|584302767|FG000|Period 1|Withdrawal by Subject|1|||
161901534|NCT01718483|584687096|FG000|Overall Study|Adverse Event|5|||
161901535|NCT01718483|584687097|FG001|Overall Study|Adverse Event|12|||
161450841|NCT01457352|583045893|FG000|Period 2|dose change|1|||
161450842|NCT01457352|583045894|FG001|Period 2|dose change|0|||
161450843|NCT01457352|583045893|FG000|Period 2|Physician Decision|1|||
161450844|NCT01457352|583045894|FG001|Period 2|Physician Decision|0|||
161450845|NCT01457352|583045893|FG000|Period 2|Did not meet eligibility criteria|3|||
161450846|NCT01457352|583045894|FG001|Period 2|Did not meet eligibility criteria|0|||
161450847|NCT01457352|583045893|FG000|Period 3|Adverse Event|1|||
161450848|NCT01457352|583045894|FG001|Period 3|Adverse Event|1|||
161450849|NCT01457352|583045893|FG000|Period 3|Withdrawal by Subject|0|||
161450850|NCT01457352|583045894|FG001|Period 3|Withdrawal by Subject|2|||
161450851|NCT01457352|583045893|FG000|Period 3|incorrect treatment|0|||
161450852|NCT01457352|583045894|FG001|Period 3|incorrect treatment|1|||
161450853|NCT01457352|583045893|FG000|Period 3|Sponsor's withdrawal|0|||
161450854|NCT01457352|583045894|FG001|Period 3|Sponsor's withdrawal|1|||
161450855|NCT01065454|583045895|FG000|Treatment|Adverse Event|7|||
161450856|NCT01065454|583045896|FG001|Treatment|Adverse Event|4|||
161450857|NCT01065454|583045897|FG002|Treatment|Adverse Event|3|||
161450858|NCT01065454|583045898|FG003|Treatment|Adverse Event|6|||
161450859|NCT01065454|583045895|FG000|Treatment|Death|1|||
161450860|NCT01065454|583045896|FG001|Treatment|Death|0|||
161450861|NCT01065454|583045897|FG002|Treatment|Death|0|||
161450862|NCT01065454|583045898|FG003|Treatment|Death|0|||
161798009|NCT02275364|584302768|FG001|Period 1|Withdrawal by Subject|0|||
161798010|NCT02275364|584302767|FG000|Period 1|Other reason|1|||
161901536|NCT01718483|584687096|FG000|Overall Study|Lost to Follow-up|8|||
161450863|NCT01065454|583045895|FG000|Treatment|Non-compliance|1|||
161450864|NCT01065454|583045896|FG001|Treatment|Non-compliance|0|||
161450865|NCT01065454|583045897|FG002|Treatment|Non-compliance|0|||
161450866|NCT01065454|583045898|FG003|Treatment|Non-compliance|1|||
161450867|NCT01065454|583045895|FG000|Treatment|Protocol Decision|0|||
161556132|NCT02139982|583425390|FG008|Overall Study|Lack of Efficacy|0|||
161450868|NCT01065454|583045896|FG001|Treatment|Protocol Decision|0|||
161450869|NCT01065454|583045897|FG002|Treatment|Protocol Decision|3|||
161450870|NCT01065454|583045898|FG003|Treatment|Protocol Decision|2|||
161798011|NCT02275364|584302768|FG001|Period 1|Other reason|0|||
161798012|NCT01463683|584302771|FG000|Overall Study|Adverse Event|2|||
161901537|NCT01718483|584687097|FG001|Overall Study|Lost to Follow-up|3|||
161901538|NCT01718483|584687096|FG000|Overall Study|Protocol Violation|4|||
161901539|NCT01718483|584687097|FG001|Overall Study|Protocol Violation|2|||
161901540|NCT01718483|584687096|FG000|Overall Study|Other|1|||
161901541|NCT01718483|584687097|FG001|Overall Study|Other|4|||
161901542|NCT01718483|584687096|FG000|Overall Study|Pregnancy|1|||
161901543|NCT01718483|584687097|FG001|Overall Study|Pregnancy|1|||
161901544|NCT01718483|584687096|FG000|Overall Study|Lack of Efficacy|1|||
161901545|NCT01718483|584687097|FG001|Overall Study|Lack of Efficacy|0|||
161901546|NCT00130689|584687100|FG000|Overall Study|Progressive Disease|29|||
161901547|NCT00130689|584687100|FG000|Overall Study|Death|1|||
161901548|NCT00130689|584687100|FG000|Overall Study|Clinical Deterioration|4|||
161901549|NCT00130689|584687100|FG000|Overall Study|Withdrawal by Subject|3|||
161901550|NCT00130689|584687100|FG000|Overall Study|Ineligible|6|||
161901551|NCT00048035|584687101|FG000|Core Period|Early Withdrawals|4|||
161901552|NCT00048035|584687102|FG001|Core Period|Early Withdrawals|2|||
161901553|NCT00048035|584687103|FG002|Core Period|Early Withdrawals|1|||
161901554|NCT00048035|584687104|FG003|Core Period|Early Withdrawals|1|||
161901555|NCT00048035|584687105|FG004|Core Period|Early Withdrawals|1|||
161901556|NCT00048035|584687106|FG005|Core Period|Early Withdrawals|1|||
161901557|NCT00048035|584687107|FG006|Core Period|Early Withdrawals|0|||
161901558|NCT00048035|584687108|FG007|Core Period|Early Withdrawals|0|||
161901559|NCT00048035|584687101|FG000|Extension Year 1|Early Withdrawals|0|||
161901560|NCT00048035|584687102|FG001|Extension Year 1|Early Withdrawals|0|||
161901561|NCT00048035|584687103|FG002|Extension Year 1|Early Withdrawals|0|||
161901562|NCT00048035|584687104|FG003|Extension Year 1|Early Withdrawals|0|||
161901563|NCT00048035|584687105|FG004|Extension Year 1|Early Withdrawals|0|||
161901564|NCT00048035|584687106|FG005|Extension Year 1|Early Withdrawals|0|||
161901565|NCT00048035|584687107|FG006|Extension Year 1|Early Withdrawals|11|||
161901566|NCT00048035|584687108|FG007|Extension Year 1|Early Withdrawals|11|||
161901567|NCT00048035|584687101|FG000|Extension Year 2|Early Withdrawals|0|||
161901568|NCT00048035|584687102|FG001|Extension Year 2|Early Withdrawals|0|||
161901569|NCT00048035|584687103|FG002|Extension Year 2|Early Withdrawals|0|||
161901570|NCT00048035|584687104|FG003|Extension Year 2|Early Withdrawals|0|||
161901571|NCT00048035|584687105|FG004|Extension Year 2|Early Withdrawals|0|||
161901572|NCT00048035|584687106|FG005|Extension Year 2|Early Withdrawals|0|||
161901573|NCT00048035|584687107|FG006|Extension Year 2|Early Withdrawals|3|||
161901574|NCT00048035|584687108|FG007|Extension Year 2|Early Withdrawals|3|||
161901575|NCT01265394|584687123|FG000|Overall Study|Subjects withdrawn|37|||
161901576|NCT05417412|584687129|FG000|Overall Study|Lost to Follow-up|2|||
161901577|NCT01576575|584687130|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
161901578|NCT01576575|584687130|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
161901579|NCT01576575|584687130|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
161901580|NCT01723072|584687135|FG000|Overall Study|Withdrawal by Subject|7|||
161901581|NCT01723072|584687136|FG001|Overall Study|Withdrawal by Subject|13|||
161901582|NCT01723072|584687135|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
161901583|NCT01723072|584687136|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
161901584|NCT01723072|584687135|FG000|Overall Study|Other|4|||
161901585|NCT01723072|584687136|FG001|Overall Study|Other|3|||
161901586|NCT01841970|584687137|FG000|Overall Study|Withdrawal by Subject|1|||
161901587|NCT01841970|584687137|FG000|Overall Study|Physician Decision|2|||
161901588|NCT01841970|584687137|FG000|Overall Study|Lost to Follow-up|8|||
161901589|NCT01610037|584687144|FG000|All Patients|Adverse Event|27|||
161901590|NCT01610037|584687145|FG001|All Patients|Adverse Event|22|||
161901591|NCT01610037|584687146|FG002|All Patients|Adverse Event|26|||
161901592|NCT01610037|584687144|FG000|All Patients|Withdrawal by Subject|12|||
161901593|NCT01610037|584687145|FG001|All Patients|Withdrawal by Subject|10|||
161901594|NCT01610037|584687146|FG002|All Patients|Withdrawal by Subject|20|||
161901595|NCT01610037|584687144|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
161901596|NCT01610037|584687145|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
161901597|NCT01610037|584687146|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
161450871|NCT01065454|583045895|FG000|Treatment|Protocol Violation|1|||
161450872|NCT01065454|583045896|FG001|Treatment|Protocol Violation|0|||
161450873|NCT01065454|583045897|FG002|Treatment|Protocol Violation|1|||
161450874|NCT01065454|583045898|FG003|Treatment|Protocol Violation|0|||
161450875|NCT01065454|583045895|FG000|Treatment|Withdrawal by Subject|3|||
161450876|NCT01065454|583045896|FG001|Treatment|Withdrawal by Subject|1|||
161450877|NCT01065454|583045897|FG002|Treatment|Withdrawal by Subject|2|||
161901598|NCT01610037|584687144|FG000|All Patients|Death|4|||
161901599|NCT01610037|584687145|FG001|All Patients|Death|2|||
161901600|NCT01610037|584687146|FG002|All Patients|Death|1|||
161901601|NCT01610037|584687144|FG000|All Patients|Protocol deviation|4|||
161901602|NCT01610037|584687145|FG001|All Patients|Protocol deviation|3|||
161901603|NCT01610037|584687146|FG002|All Patients|Protocol deviation|3|||
161901604|NCT01610037|584687144|FG000|All Patients|Abnormal laboratory value|1|||
161556133|NCT02139982|583425391|FG009|Overall Study|Lack of Efficacy|0|||
161901605|NCT01610037|584687145|FG001|All Patients|Abnormal laboratory value|1|||
161901606|NCT01610037|584687146|FG002|All Patients|Abnormal laboratory value|0|||
161901607|NCT01610037|584687144|FG000|All Patients|Administrative problems|1|||
161901608|NCT01610037|584687145|FG001|All Patients|Administrative problems|4|||
161450878|NCT01065454|583045898|FG003|Treatment|Withdrawal by Subject|3|||
161901609|NCT01610037|584687146|FG002|All Patients|Administrative problems|4|||
161901610|NCT01610037|584687144|FG000|All Patients|Lost to Follow-up|1|||
161901611|NCT01610037|584687145|FG001|All Patients|Lost to Follow-up|0|||
161901612|NCT01610037|584687146|FG002|All Patients|Lost to Follow-up|0|||
161901613|NCT01610037|584687144|FG000|All Patients|Abnormal test procedure result(s)|0|||
161901614|NCT01610037|584687145|FG001|All Patients|Abnormal test procedure result(s)|1|||
161901615|NCT01610037|584687146|FG002|All Patients|Abnormal test procedure result(s)|3|||
161901616|NCT01610037|584687144|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
161901617|NCT01610037|584687145|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
161901618|NCT01610037|584687146|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
161901619|NCT01610037|584687144|FG000|Treatment and Follow up Period|Death|10|||
161901620|NCT01610037|584687145|FG001|Treatment and Follow up Period|Death|5|||
161901621|NCT01610037|584687146|FG002|Treatment and Follow up Period|Death|4|||
161901622|NCT01610037|584687144|FG000|Treatment and Follow up Period|Administrative problems|1|||
161901623|NCT01610037|584687145|FG001|Treatment and Follow up Period|Administrative problems|3|||
161901624|NCT01610037|584687146|FG002|Treatment and Follow up Period|Administrative problems|2|||
161901625|NCT01610037|584687144|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
161901626|NCT01610037|584687145|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
161901627|NCT01610037|584687146|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
161901628|NCT00274742|584687147|FG000|Overall Study|Adverse Event|0|||
161901629|NCT00274742|584687148|FG001|Overall Study|Adverse Event|4|||
161901630|NCT00274742|584687149|FG002|Overall Study|Adverse Event|1|||
161901631|NCT00274742|584687150|FG003|Overall Study|Adverse Event|4|||
161901632|NCT00274742|584687151|FG004|Overall Study|Adverse Event|12|||
161901633|NCT00274742|584687152|FG005|Overall Study|Adverse Event|3|||
161901634|NCT00274742|584687147|FG000|Overall Study|Lost to Follow-up|0|||
161901635|NCT00274742|584687148|FG001|Overall Study|Lost to Follow-up|0|||
161901636|NCT00274742|584687149|FG002|Overall Study|Lost to Follow-up|0|||
161901637|NCT00274742|584687150|FG003|Overall Study|Lost to Follow-up|0|||
161901638|NCT00274742|584687151|FG004|Overall Study|Lost to Follow-up|1|||
161901639|NCT00274742|584687152|FG005|Overall Study|Lost to Follow-up|0|||
161901640|NCT00274742|584687147|FG000|Overall Study|End of Study|0|||
161901641|NCT00274742|584687148|FG001|Overall Study|End of Study|0|||
161901642|NCT00274742|584687149|FG002|Overall Study|End of Study|0|||
161901643|NCT00274742|584687150|FG003|Overall Study|End of Study|1|||
161901644|NCT00274742|584687151|FG004|Overall Study|End of Study|0|||
161901645|NCT00274742|584687152|FG005|Overall Study|End of Study|0|||
161901646|NCT00274742|584687147|FG000|Overall Study|Disease Progression|0|||
161901647|NCT00274742|584687148|FG001|Overall Study|Disease Progression|1|||
161901648|NCT00274742|584687149|FG002|Overall Study|Disease Progression|1|||
161901649|NCT00274742|584687150|FG003|Overall Study|Disease Progression|0|||
161901650|NCT00274742|584687151|FG004|Overall Study|Disease Progression|1|||
161901651|NCT00274742|584687152|FG005|Overall Study|Disease Progression|0|||
161901652|NCT00274742|584687147|FG000|Overall Study|Other|0|||
161901653|NCT00274742|584687148|FG001|Overall Study|Other|3|||
161901654|NCT00274742|584687149|FG002|Overall Study|Other|0|||
161901655|NCT00274742|584687150|FG003|Overall Study|Other|0|||
161901656|NCT00274742|584687151|FG004|Overall Study|Other|2|||
161901657|NCT00274742|584687152|FG005|Overall Study|Other|0|||
161901658|NCT00069823|584687163|FG000|Overall Study|Did not have follow-up diary cards|6|||
161901659|NCT00069823|584687164|FG001|Overall Study|Did not have follow-up diary cards|3|||
161901660|NCT01801111|584687165|FG000|Overall Study|Adverse Event|12|||
161901661|NCT01801111|584687165|FG000|Overall Study|Death|8|||
161901662|NCT01801111|584687165|FG000|Overall Study|Physician Decision|5|||
161901663|NCT01801111|584687165|FG000|Overall Study|Other|1|||
161901664|NCT01801111|584687165|FG000|Overall Study|Withdrawal by Subject|4|||
161901665|NCT01801111|584687165|FG000|Overall Study|Study Terminated by Sponsor|27|||
161901666|NCT01801111|584687165|FG000|Overall Study|Progressive Disease|81|||
161901667|NCT01210482|584687166|FG000|Overall Study|Protocol Violation|1|||
161901668|NCT01210482|584687166|FG000|Overall Study|Case Report Forms were not collected|18|||
161901669|NCT01210482|584687166|FG000|Overall Study|Duplicated|2|||
161901670|NCT01210482|584687166|FG000|Overall Study|No Drug Administration|28|||
161450879|NCT01065454|583045895|FG000|Follow up|Adverse Event|1|||
161450880|NCT01065454|583045896|FG001|Follow up|Adverse Event|0|||
161450881|NCT01065454|583045897|FG002|Follow up|Adverse Event|0|||
161901671|NCT01223937|584687167|FG000|Overall Study|Withdrawal by Subject|3|||
161901672|NCT01223937|584687168|FG001|Overall Study|Withdrawal by Subject|2|||
161901673|NCT01223937|584687167|FG000|Overall Study|Lost to Follow-up|1|||
161901674|NCT01223937|584687168|FG001|Overall Study|Lost to Follow-up|4|||
161901675|NCT01223937|584687167|FG000|Overall Study|Adverse Event|1|||
161901676|NCT01223937|584687168|FG001|Overall Study|Adverse Event|4|||
161901677|NCT01223937|584687167|FG000|Overall Study|Protocol Violation|8|||
161901678|NCT01223937|584687168|FG001|Overall Study|Protocol Violation|7|||
161901679|NCT01223937|584687167|FG000|Overall Study|Other|4|||
161901680|NCT01223937|584687168|FG001|Overall Study|Other|1|||
161901681|NCT05176717|584687169|FG000|Overall Study|Sponsor Decision|1|||
161901682|NCT05176717|584687170|FG001|Overall Study|Sponsor Decision|2|||
161450882|NCT01065454|583045898|FG003|Follow up|Adverse Event|1|||
161450883|NCT01065454|583045895|FG000|Follow up|Death|0|||
161556134|NCT02748512|583425394|FG000|Overall Study|Lost to Follow-up|1|||
161556135|NCT02748512|583425395|FG001|Overall Study|Lost to Follow-up|1|||
161556136|NCT01310868|583425408|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
161556137|NCT01708187|583425411|FG000|Overall Study|Lost to Follow-up|0|||
161556138|NCT01708187|583425412|FG001|Overall Study|Lost to Follow-up|1|||
161556139|NCT02408549|583425414|FG000|Overall Study|Adverse Event|15|||
161556140|NCT02408549|583425414|FG000|Overall Study|Death|4|||
161556141|NCT02408549|583425414|FG000|Overall Study|Lack of Efficacy|17|||
161556142|NCT02408549|583425414|FG000|Overall Study|Protocol Violation|4|||
161901683|NCT05176717|584687171|FG002|Overall Study|Sponsor Decision|2|||
161901684|NCT03284853|584687172|FG000|Overall Study|Adverse Event|40|||
161901685|NCT03284853|584687173|FG001|Overall Study|Adverse Event|4|||
161901686|NCT03284853|584687172|FG000|Overall Study|Withdrawal by Subject|5|||
161901687|NCT03284853|584687173|FG001|Overall Study|Withdrawal by Subject|1|||
161901688|NCT03284853|584687172|FG000|Overall Study|Lost to Follow-up|1|||
161901689|NCT03284853|584687173|FG001|Overall Study|Lost to Follow-up|0|||
161901690|NCT03284853|584687172|FG000|Overall Study|Lack of Efficacy|1|||
161901691|NCT03284853|584687173|FG001|Overall Study|Lack of Efficacy|0|||
161901692|NCT03284853|584687172|FG000|Overall Study|Disallowed Concurrent Medication|1|||
161901693|NCT03284853|584687173|FG001|Overall Study|Disallowed Concurrent Medication|1|||
161901694|NCT03284853|584687172|FG000|Overall Study|Protocol Violation|3|||
161901695|NCT03284853|584687173|FG001|Overall Study|Protocol Violation|3|||
161901696|NCT03284853|584687172|FG000|Overall Study|Death|0|||
161556143|NCT02408549|583425414|FG000|Overall Study|Lost to Follow-up|6|||
161798013|NCT01463683|584302772|FG001|Overall Study|Adverse Event|0|||
161798014|NCT01463683|584302773|FG002|Overall Study|Adverse Event|0|||
161798015|NCT01463683|584302771|FG000|Overall Study|Lost to Follow-up|10|||
161798016|NCT01463683|584302772|FG001|Overall Study|Lost to Follow-up|9|||
161798017|NCT01463683|584302773|FG002|Overall Study|Lost to Follow-up|7|||
161798018|NCT01463683|584302771|FG000|Overall Study|Physician Decision|0|||
161798019|NCT01463683|584302772|FG001|Overall Study|Physician Decision|3|||
161798020|NCT01463683|584302773|FG002|Overall Study|Physician Decision|1|||
161798021|NCT01463683|584302771|FG000|Overall Study|Pregnancy|2|||
161798022|NCT01463683|584302772|FG001|Overall Study|Pregnancy|2|||
161798023|NCT01463683|584302773|FG002|Overall Study|Pregnancy|1|||
161798024|NCT01463683|584302771|FG000|Overall Study|Withdrawal by Subject|5|||
161798025|NCT01463683|584302772|FG001|Overall Study|Withdrawal by Subject|17|||
161798026|NCT01463683|584302773|FG002|Overall Study|Withdrawal by Subject|2|||
161798027|NCT03111147|584302774|FG000|Overall Study|Lost to Follow-up|2|||
161798028|NCT03111147|584302775|FG001|Overall Study|Lost to Follow-up|5|||
161798029|NCT03111147|584302774|FG000|Overall Study|Withdrawal by Subject|4|||
161798030|NCT03111147|584302775|FG001|Overall Study|Withdrawal by Subject|3|||
161798031|NCT03111147|584302774|FG000|Overall Study|Protocol Violation|2|||
161798032|NCT03111147|584302775|FG001|Overall Study|Protocol Violation|1|||
161798033|NCT03111147|584302774|FG000|Overall Study|Death|1|||
161798034|NCT03111147|584302775|FG001|Overall Study|Death|1|||
161798035|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798036|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798037|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
161798038|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
161798039|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798040|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798041|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798042|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798043|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798044|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798045|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
161798046|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
161798047|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161798048|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161798049|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161901697|NCT03284853|584687173|FG001|Overall Study|Death|1|||
161901698|NCT03284853|584687172|FG000|Overall Study|Other - Reason not reported in CSR|4|||
161556144|NCT02408549|583425414|FG000|Overall Study|Consent withdrawn|30|||
161798050|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161798051|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161798052|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161798053|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798054|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161901699|NCT03284853|584687173|FG001|Overall Study|Other - Reason not reported in CSR|3|||
161901700|NCT00765817|584687175|FG000|Overall Study|Adverse Event|13|||
161901701|NCT00765817|584687176|FG001|Overall Study|Adverse Event|1|||
161901702|NCT00765817|584687175|FG000|Overall Study|Death|0|||
161556145|NCT02408549|583425414|FG000|Overall Study|Neurology research program closing at site|1|||
161556146|NCT02408549|583425414|FG000|Overall Study|Site closure|1|||
161901703|NCT00765817|584687176|FG001|Overall Study|Death|1|||
161901704|NCT00765817|584687175|FG000|Overall Study|Entry criteria not met|2|||
161901705|NCT00765817|584687176|FG001|Overall Study|Entry criteria not met|2|||
161901706|NCT00765817|584687175|FG000|Overall Study|Loss of glucose control|0|||
161901707|NCT00765817|584687176|FG001|Overall Study|Loss of glucose control|2|||
161901708|NCT00765817|584687175|FG000|Overall Study|Lost to Follow-up|1|||
161901709|NCT00765817|584687176|FG001|Overall Study|Lost to Follow-up|3|||
161901710|NCT00765817|584687175|FG000|Overall Study|Physician Decision|2|||
161901711|NCT00765817|584687176|FG001|Overall Study|Physician Decision|1|||
161901712|NCT00765817|584687175|FG000|Overall Study|Protocol Violation|1|||
161901713|NCT00765817|584687176|FG001|Overall Study|Protocol Violation|1|||
161901714|NCT00765817|584687175|FG000|Overall Study|Subject decision|7|||
161901715|NCT00765817|584687176|FG001|Overall Study|Subject decision|11|||
161901716|NCT02058589|584687177|FG000|Overall Study|Serious Adverse Event|1|||
161901717|NCT02058589|584687178|FG001|Overall Study|Serious Adverse Event|1|||
161901718|NCT02058589|584687177|FG000|Overall Study|Non-Serious Adverse Event|1|||
161901719|NCT02058589|584687178|FG001|Overall Study|Non-Serious Adverse Event|0|||
161901720|NCT02058589|584687177|FG000|Overall Study|Withdrawal by Subject|0|||
161901721|NCT02058589|584687178|FG001|Overall Study|Withdrawal by Subject|1|||
161901722|NCT02308228|584687179|FG000|Overall Study|Adverse Event|3|||
161901723|NCT02308228|584687180|FG001|Overall Study|Adverse Event|4|||
161901724|NCT02308228|584687179|FG000|Overall Study|Withdrawal by Subject|5|||
161901725|NCT02308228|584687180|FG001|Overall Study|Withdrawal by Subject|3|||
161901726|NCT02143024|584687181|FG000|Overall Study|Lost to Follow-up|1|||
161901727|NCT02143024|584687182|FG001|Overall Study|Lost to Follow-up|1|||
161901728|NCT02143024|584687181|FG000|Overall Study|Withdrawal by Subject|1|||
161901729|NCT02143024|584687182|FG001|Overall Study|Withdrawal by Subject|0|||
161901730|NCT06597084|584687183|FG000|Overall Study|Withdrawal by Subject|4|||
161901731|NCT06597084|584687184|FG001|Overall Study|Withdrawal by Subject|9|||
161901732|NCT06597084|584687183|FG000|Overall Study|Consent was not given by the patient until V2|0|||
161901733|NCT06597084|584687184|FG001|Overall Study|Consent was not given by the patient until V2|3|||
161901734|NCT06597084|584687183|FG000|Overall Study|Physician Decision|1|||
161901735|NCT06597084|584687184|FG001|Overall Study|Physician Decision|0|||
161901736|NCT06597084|584687183|FG000|Overall Study|Adverse Event|3|||
161901737|NCT06597084|584687184|FG001|Overall Study|Adverse Event|2|||
161901738|NCT06597084|584687183|FG000|Overall Study|Death|4|||
161901739|NCT06597084|584687184|FG001|Overall Study|Death|0|||
161901740|NCT06597084|584687183|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
161901741|NCT06597084|584687184|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
161901742|NCT06597084|584687183|FG000|Overall Study|Lost to Follow-up|4|||
161901743|NCT06597084|584687184|FG001|Overall Study|Lost to Follow-up|2|||
161901744|NCT06597084|584687183|FG000|Overall Study|Other. Not specified|1|||
161901745|NCT06597084|584687184|FG001|Overall Study|Other. Not specified|0|||
161901746|NCT00490971|584687189|FG000|Acute/Continuation|Adverse Event|62|||
161901747|NCT00490971|584687190|FG001|Acute/Continuation|Adverse Event|13|||
161901748|NCT00490971|584687191|FG002|Acute/Continuation|Adverse Event|0|||
161901749|NCT00490971|584687192|FG003|Acute/Continuation|Adverse Event|0|||
161901750|NCT00490971|584687193|FG004|Acute/Continuation|Adverse Event|0|||
161901751|NCT00490971|584687189|FG000|Acute/Continuation|Death|2|||
161901752|NCT00490971|584687190|FG001|Acute/Continuation|Death|0|||
161901753|NCT00490971|584687191|FG002|Acute/Continuation|Death|0|||
161901754|NCT00490971|584687192|FG003|Acute/Continuation|Death|0|||
161901755|NCT00490971|584687193|FG004|Acute/Continuation|Death|0|||
161901756|NCT00490971|584687189|FG000|Acute/Continuation|Lack of Efficacy|106|||
161901757|NCT00490971|584687190|FG001|Acute/Continuation|Lack of Efficacy|12|||
161901758|NCT00490971|584687191|FG002|Acute/Continuation|Lack of Efficacy|0|||
161450884|NCT01065454|583045896|FG001|Follow up|Death|1|||
161450885|NCT01065454|583045897|FG002|Follow up|Death|1|||
161450886|NCT01065454|583045898|FG003|Follow up|Death|0|||
161450887|NCT01065454|583045895|FG000|Follow up|Lost to Follow-up|0|||
161450888|NCT01065454|583045896|FG001|Follow up|Lost to Follow-up|0|||
161901759|NCT00490971|584687192|FG003|Acute/Continuation|Lack of Efficacy|0|||
161901760|NCT00490971|584687193|FG004|Acute/Continuation|Lack of Efficacy|0|||
161901761|NCT00490971|584687189|FG000|Acute/Continuation|Lost to Follow-up|23|||
161901762|NCT00490971|584687190|FG001|Acute/Continuation|Lost to Follow-up|7|||
161901763|NCT00490971|584687191|FG002|Acute/Continuation|Lost to Follow-up|0|||
161901764|NCT00490971|584687192|FG003|Acute/Continuation|Lost to Follow-up|0|||
161901765|NCT00490971|584687193|FG004|Acute/Continuation|Lost to Follow-up|0|||
161901766|NCT00490971|584687189|FG000|Acute/Continuation|Protocol Violation|10|||
161450889|NCT01065454|583045897|FG002|Follow up|Lost to Follow-up|0|||
161901767|NCT00490971|584687190|FG001|Acute/Continuation|Protocol Violation|2|||
161901768|NCT00490971|584687191|FG002|Acute/Continuation|Protocol Violation|0|||
161901769|NCT00490971|584687192|FG003|Acute/Continuation|Protocol Violation|0|||
161450890|NCT01065454|583045898|FG003|Follow up|Lost to Follow-up|1|||
161450891|NCT01065454|583045895|FG000|Follow up|Progressive disease|0|||
161450892|NCT01065454|583045896|FG001|Follow up|Progressive disease|0|||
161901770|NCT00490971|584687193|FG004|Acute/Continuation|Protocol Violation|0|||
161901771|NCT00490971|584687189|FG000|Acute/Continuation|Withdrawal by Subject|92|||
161901772|NCT00490971|584687190|FG001|Acute/Continuation|Withdrawal by Subject|24|||
161901773|NCT00490971|584687191|FG002|Acute/Continuation|Withdrawal by Subject|0|||
161901774|NCT00490971|584687192|FG003|Acute/Continuation|Withdrawal by Subject|0|||
161901775|NCT00490971|584687193|FG004|Acute/Continuation|Withdrawal by Subject|0|||
161901776|NCT00490971|584687189|FG000|Acute/Continuation|Other|11|||
161901777|NCT00490971|584687190|FG001|Acute/Continuation|Other|4|||
161901778|NCT00490971|584687191|FG002|Acute/Continuation|Other|0|||
161901779|NCT00490971|584687192|FG003|Acute/Continuation|Other|0|||
161901780|NCT00490971|584687193|FG004|Acute/Continuation|Other|0|||
161901781|NCT00490971|584687189|FG000|Maintenance|Adverse Event|0|||
161901782|NCT00490971|584687190|FG001|Maintenance|Adverse Event|0|||
161901783|NCT00490971|584687191|FG002|Maintenance|Adverse Event|4|||
161901784|NCT00490971|584687192|FG003|Maintenance|Adverse Event|5|||
161901785|NCT00490971|584687193|FG004|Maintenance|Adverse Event|7|||
161901786|NCT00490971|584687189|FG000|Maintenance|Death|0|||
161901787|NCT00490971|584687190|FG001|Maintenance|Death|0|||
161901788|NCT00490971|584687191|FG002|Maintenance|Death|0|||
161901789|NCT00490971|584687192|FG003|Maintenance|Death|2|||
161901790|NCT00490971|584687193|FG004|Maintenance|Death|0|||
161901791|NCT00490971|584687189|FG000|Maintenance|Lost to Follow-up|0|||
161901792|NCT00490971|584687190|FG001|Maintenance|Lost to Follow-up|0|||
161901793|NCT00490971|584687191|FG002|Maintenance|Lost to Follow-up|5|||
161901794|NCT00490971|584687192|FG003|Maintenance|Lost to Follow-up|8|||
161901795|NCT00490971|584687193|FG004|Maintenance|Lost to Follow-up|10|||
161901796|NCT00490971|584687189|FG000|Maintenance|Pregnancy|0|||
161901797|NCT00490971|584687190|FG001|Maintenance|Pregnancy|0|||
161901798|NCT00490971|584687191|FG002|Maintenance|Pregnancy|1|||
161901799|NCT00490971|584687192|FG003|Maintenance|Pregnancy|0|||
161901800|NCT00490971|584687193|FG004|Maintenance|Pregnancy|0|||
161901801|NCT00490971|584687189|FG000|Maintenance|Protocol Violation|0|||
161901802|NCT00490971|584687190|FG001|Maintenance|Protocol Violation|0|||
161901803|NCT00490971|584687191|FG002|Maintenance|Protocol Violation|4|||
161901804|NCT00490971|584687192|FG003|Maintenance|Protocol Violation|1|||
161901805|NCT00490971|584687193|FG004|Maintenance|Protocol Violation|1|||
161901806|NCT00490971|584687189|FG000|Maintenance|Withdrawal by Subject|0|||
161901807|NCT00490971|584687190|FG001|Maintenance|Withdrawal by Subject|0|||
161901808|NCT00490971|584687191|FG002|Maintenance|Withdrawal by Subject|26|||
161901809|NCT00490971|584687192|FG003|Maintenance|Withdrawal by Subject|28|||
161901810|NCT00490971|584687193|FG004|Maintenance|Withdrawal by Subject|18|||
161901811|NCT00490971|584687189|FG000|Maintenance|Other|0|||
161901812|NCT00490971|584687190|FG001|Maintenance|Other|0|||
161901813|NCT00490971|584687191|FG002|Maintenance|Other|11|||
161901814|NCT00490971|584687192|FG003|Maintenance|Other|9|||
161901815|NCT00490971|584687193|FG004|Maintenance|Other|3|||
161901816|NCT01216332|584687200|FG000|Overall Study|Withdrawal by Subject|4|||
161901817|NCT01216332|584687201|FG001|Overall Study|Withdrawal by Subject|0|||
161901818|NCT03999749|584687202|FG000|Overall Study|Toxicity|16|||
161901819|NCT03999749|584687202|FG000|Overall Study|Withdrawal by Subject|3|||
161901820|NCT03999749|584687202|FG000|Overall Study|Disease progression|26|||
161901821|NCT03999749|584687202|FG000|Overall Study|Physician Decision|4|||
161798055|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
161798056|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798057|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798058|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798059|NCT03384745|584302778|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798060|NCT03384745|584302779|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798061|NCT03384745|584302780|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798062|NCT03384745|584302781|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
161798063|NCT03384745|584302782|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
161798064|NCT03384745|584302783|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798065|NCT03384745|584302778|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161901822|NCT03999749|584687202|FG000|Overall Study|Death|5|||
161901823|NCT03999749|584687202|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
161901824|NCT00255164|584687203|FG000|Overall Study|Adverse Event|10|||
161450893|NCT01065454|583045897|FG002|Follow up|Progressive disease|0|||
161901825|NCT00255164|584687204|FG001|Overall Study|Adverse Event|6|||
161901826|NCT00255164|584687205|FG002|Overall Study|Adverse Event|9|||
161798066|NCT03384745|584302779|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161798067|NCT03384745|584302780|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161798068|NCT03384745|584302781|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161901827|NCT00255164|584687203|FG000|Overall Study|Lost to Follow-up|4|||
161901828|NCT00255164|584687204|FG001|Overall Study|Lost to Follow-up|3|||
161901829|NCT00255164|584687205|FG002|Overall Study|Lost to Follow-up|4|||
161901830|NCT00255164|584687203|FG000|Overall Study|Withdrawal by Subject|18|||
161901831|NCT00255164|584687204|FG001|Overall Study|Withdrawal by Subject|17|||
161901832|NCT00255164|584687205|FG002|Overall Study|Withdrawal by Subject|8|||
161901833|NCT00255164|584687203|FG000|Overall Study|Noncompliance|0|||
161901834|NCT00255164|584687204|FG001|Overall Study|Noncompliance|1|||
161901835|NCT00255164|584687205|FG002|Overall Study|Noncompliance|2|||
161901836|NCT00255164|584687203|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
161901837|NCT00255164|584687204|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
161901838|NCT00255164|584687205|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
161901839|NCT00255164|584687203|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
161901840|NCT00255164|584687204|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
161901841|NCT00255164|584687205|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
161901842|NCT00255164|584687203|FG000|Overall Study|Possible Barrett's Esophagus|1|||
161901843|NCT00255164|584687204|FG001|Overall Study|Possible Barrett's Esophagus|3|||
161901844|NCT00255164|584687205|FG002|Overall Study|Possible Barrett's Esophagus|8|||
161901845|NCT00255164|584687203|FG000|Overall Study|Esophageal Stricture|0|||
161901846|NCT00255164|584687204|FG001|Overall Study|Esophageal Stricture|0|||
161901847|NCT00255164|584687205|FG002|Overall Study|Esophageal Stricture|1|||
161901848|NCT00255164|584687203|FG000|Overall Study|Therapeutic Failure|11|||
161901849|NCT00255164|584687204|FG001|Overall Study|Therapeutic Failure|2|||
161901850|NCT00255164|584687205|FG002|Overall Study|Therapeutic Failure|3|||
161901851|NCT03677869|584687206|FG000|Overall Study|Withdrawal by Subject|1|||
161901852|NCT05219968|584687207|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
161901853|NCT05219968|584687208|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901854|NCT05219968|584687209|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901855|NCT05219968|584687210|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901856|NCT05219968|584687211|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901857|NCT05219968|584687207|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
161901858|NCT05219968|584687208|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901859|NCT05219968|584687209|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901860|NCT05219968|584687210|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901861|NCT05219968|584687211|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901862|NCT05219968|584687207|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
161901863|NCT05219968|584687208|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
161901864|NCT05219968|584687209|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
161901865|NCT05219968|584687210|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
161901866|NCT05219968|584687211|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
161901867|NCT05219968|584687207|FG000|Week 24 Treatment Period|Adverse Event|3|||
161901868|NCT05219968|584687208|FG001|Week 24 Treatment Period|Adverse Event|0|||
161901869|NCT05219968|584687209|FG002|Week 24 Treatment Period|Adverse Event|0|||
161901870|NCT05219968|584687210|FG003|Week 24 Treatment Period|Adverse Event|0|||
161901871|NCT05219968|584687211|FG004|Week 24 Treatment Period|Adverse Event|0|||
161901872|NCT05219968|584687207|FG000|Week 24 Treatment Period|Physician Decision|0|||
161901873|NCT05219968|584687208|FG001|Week 24 Treatment Period|Physician Decision|1|||
161901874|NCT05219968|584687209|FG002|Week 24 Treatment Period|Physician Decision|0|||
161901875|NCT05219968|584687210|FG003|Week 24 Treatment Period|Physician Decision|0|||
161901876|NCT05219968|584687211|FG004|Week 24 Treatment Period|Physician Decision|0|||
161901877|NCT05219968|584687207|FG000|Week 24 Treatment Period|Other, not specified|3|||
161901878|NCT05219968|584687208|FG001|Week 24 Treatment Period|Other, not specified|0|||
161901879|NCT05219968|584687209|FG002|Week 24 Treatment Period|Other, not specified|0|||
161901880|NCT05219968|584687210|FG003|Week 24 Treatment Period|Other, not specified|0|||
161901881|NCT05219968|584687211|FG004|Week 24 Treatment Period|Other, not specified|0|||
161901882|NCT05219968|584687207|FG000|Safety Extension Period|Treatment administration failure|0|||
161901883|NCT05219968|584687208|FG001|Safety Extension Period|Treatment administration failure|0|||
161901884|NCT05219968|584687209|FG002|Safety Extension Period|Treatment administration failure|0|||
161901885|NCT05219968|584687210|FG003|Safety Extension Period|Treatment administration failure|1|||
161901886|NCT05219968|584687211|FG004|Safety Extension Period|Treatment administration failure|4|||
161901887|NCT05219968|584687207|FG000|Safety Extension Period|Bilateral dislodgement|0|||
161901888|NCT05219968|584687208|FG001|Safety Extension Period|Bilateral dislodgement|0|||
161901889|NCT05219968|584687209|FG002|Safety Extension Period|Bilateral dislodgement|4|||
161901890|NCT05219968|584687210|FG003|Safety Extension Period|Bilateral dislodgement|0|||
161901891|NCT05219968|584687211|FG004|Safety Extension Period|Bilateral dislodgement|1|||
161901892|NCT05219968|584687207|FG000|Safety Extension Period|Withdrawal by Subject|0|||
161901893|NCT05219968|584687208|FG001|Safety Extension Period|Withdrawal by Subject|0|||
161901894|NCT05219968|584687209|FG002|Safety Extension Period|Withdrawal by Subject|2|||
161901895|NCT05219968|584687210|FG003|Safety Extension Period|Withdrawal by Subject|0|||
161901896|NCT05219968|584687211|FG004|Safety Extension Period|Withdrawal by Subject|4|||
161901897|NCT05219968|584687207|FG000|Safety Extension Period|Adverse Event|0|||
161901898|NCT05219968|584687208|FG001|Safety Extension Period|Adverse Event|0|||
161901899|NCT05219968|584687209|FG002|Safety Extension Period|Adverse Event|2|||
161901900|NCT05219968|584687210|FG003|Safety Extension Period|Adverse Event|1|||
161901901|NCT05219968|584687211|FG004|Safety Extension Period|Adverse Event|1|||
161901902|NCT05219968|584687207|FG000|Safety Extension Period|Lost to Follow-up|0|||
161901903|NCT05219968|584687208|FG001|Safety Extension Period|Lost to Follow-up|0|||
161450894|NCT01065454|583045898|FG003|Follow up|Progressive disease|1|||
161450895|NCT01065454|583045895|FG000|Follow up|Withdrawal by Subject|1|||
161450896|NCT01065454|583045896|FG001|Follow up|Withdrawal by Subject|1|||
161556147|NCT02408549|583425414|FG000|Overall Study|Pregnancy|1|||
161798069|NCT03384745|584302782|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
161798070|NCT03384745|584302783|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161798071|NCT03384745|584302778|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798072|NCT03384745|584302779|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798073|NCT03384745|584302780|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
161798074|NCT03384745|584302781|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
161798075|NCT03384745|584302782|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798076|NCT03384745|584302783|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798077|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161798078|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161798079|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
161798080|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
161798081|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161798082|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
161798083|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
161798084|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
161798085|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
161798086|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
161798087|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
161798088|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
161798089|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798090|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798091|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798092|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
161798093|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798094|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798095|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798096|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
161798097|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798098|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798099|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798100|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798101|NCT01058421|584302784|FG000|1 Month Outcomes|Death|10|||
161798102|NCT01058421|584302785|FG001|1 Month Outcomes|Death|6|||
161798103|NCT01058421|584302784|FG000|1 Month Outcomes|Lost to Follow-up|8|||
161798104|NCT01058421|584302785|FG001|1 Month Outcomes|Lost to Follow-up|7|||
161798105|NCT01058421|584302784|FG000|1 Month Outcomes|Remained in Hospital|5|||
161798106|NCT01058421|584302785|FG001|1 Month Outcomes|Remained in Hospital|12|||
161798107|NCT01058421|584302784|FG000|1 Month Outcomes|Remained in Other Facility|16|||
161798108|NCT01058421|584302785|FG001|1 Month Outcomes|Remained in Other Facility|17|||
161798109|NCT01058421|584302784|FG000|3 Month Outcomes|Death|3|||
161798110|NCT01058421|584302785|FG001|3 Month Outcomes|Death|5|||
161798111|NCT01058421|584302784|FG000|3 Month Outcomes|Lost to Follow-up|12|||
161798112|NCT01058421|584302785|FG001|3 Month Outcomes|Lost to Follow-up|11|||
161798113|NCT01058421|584302784|FG000|3 Month Outcomes|Remained in Hospital|0|||
161798114|NCT01058421|584302785|FG001|3 Month Outcomes|Remained in Hospital|2|||
161798115|NCT01058421|584302784|FG000|3 Month Outcomes|Remained in Other Facility|5|||
161798116|NCT01058421|584302785|FG001|3 Month Outcomes|Remained in Other Facility|8|||
161798117|NCT01058421|584302784|FG000|6 Month Outcomes|Death|2|||
161798118|NCT01058421|584302785|FG001|6 Month Outcomes|Death|2|||
161798119|NCT01058421|584302784|FG000|6 Month Outcomes|Lost to Follow-up|16|||
161798120|NCT01058421|584302785|FG001|6 Month Outcomes|Lost to Follow-up|21|||
161798121|NCT01058421|584302784|FG000|6 Month Outcomes|Remained in Other Facility|1|||
161798122|NCT01058421|584302785|FG001|6 Month Outcomes|Remained in Other Facility|3|||
161798123|NCT02984683|584302786|FG000|Overall Study|Adverse Event|3|||
161798124|NCT02984683|584302787|FG001|Overall Study|Adverse Event|3|||
161798125|NCT02984683|584302786|FG000|Overall Study|Withdrawal by Subject|1|||
161798126|NCT02984683|584302787|FG001|Overall Study|Withdrawal by Subject|0|||
161798127|NCT02984683|584302786|FG000|Overall Study|Disease progression|7|||
161798128|NCT02984683|584302787|FG001|Overall Study|Disease progression|9|||
161798129|NCT03131999|584302788|FG000|Overall Study|Withdrawal by Subject|0|||
161798130|NCT03131999|584302789|FG001|Overall Study|Withdrawal by Subject|1|||
161901904|NCT05219968|584687209|FG002|Safety Extension Period|Lost to Follow-up|0|||
161901905|NCT05219968|584687210|FG003|Safety Extension Period|Lost to Follow-up|1|||
161798131|NCT02260492|584302790|FG000|Overall Study|Adverse Event|6|||
161798132|NCT02260492|584302791|FG001|Overall Study|Adverse Event|1|||
161798133|NCT02260492|584302792|FG002|Overall Study|Adverse Event|2|||
161798134|NCT02260492|584302790|FG000|Overall Study|Death|0|||
161798135|NCT02260492|584302791|FG001|Overall Study|Death|1|||
161798136|NCT02260492|584302792|FG002|Overall Study|Death|0|||
161798137|NCT02260492|584302790|FG000|Overall Study|Lost to Follow-up|12|||
161798138|NCT02260492|584302791|FG001|Overall Study|Lost to Follow-up|9|||
161901906|NCT05219968|584687211|FG004|Safety Extension Period|Lost to Follow-up|0|||
161798139|NCT02260492|584302792|FG002|Overall Study|Lost to Follow-up|0|||
161798140|NCT02260492|584302790|FG000|Overall Study|Physician Decision|2|||
161798141|NCT02260492|584302791|FG001|Overall Study|Physician Decision|0|||
161798142|NCT02260492|584302792|FG002|Overall Study|Physician Decision|1|||
161798143|NCT02260492|584302790|FG000|Overall Study|Withdrawal by Subject|3|||
161798144|NCT02260492|584302791|FG001|Overall Study|Withdrawal by Subject|2|||
161798145|NCT02260492|584302792|FG002|Overall Study|Withdrawal by Subject|2|||
161798146|NCT02683187|584302793|FG000|Overall Study|Failed IV access|3|||
161798147|NCT02683187|584302793|FG000|Overall Study|Withdrawal by Subject|5|||
161798148|NCT05665595|584304407|FG000|Overall Study|Ongoing|692|||
161798149|NCT05665595|584304408|FG001|Overall Study|Ongoing|698|||
161798150|NCT05665595|584304407|FG000|Overall Study|Withdrawal by Subject|2|||
161798151|NCT05665595|584304408|FG001|Overall Study|Withdrawal by Subject|2|||
161798152|NCT05665595|584304407|FG000|Overall Study|Lost to Follow-up|1|||
161798153|NCT05665595|584304408|FG001|Overall Study|Lost to Follow-up|0|||
161798154|NCT05665595|584304407|FG000|Overall Study|Death|6|||
161798155|NCT05665595|584304408|FG001|Overall Study|Death|1|||
161798156|NCT02581345|584304409|FG000|Part 1: up to Week 16|Adverse Event|3|||
161798157|NCT02581345|584304410|FG001|Part 1: up to Week 16|Adverse Event|8|||
161798158|NCT02581345|584304411|FG002|Part 1: up to Week 16|Adverse Event|0|||
161798159|NCT02581345|584304412|FG003|Part 1: up to Week 16|Adverse Event|0|||
161798160|NCT02581345|584304409|FG000|Part 1: up to Week 16|Physician Decision|2|||
161798161|NCT02581345|584304410|FG001|Part 1: up to Week 16|Physician Decision|4|||
161798162|NCT02581345|584304411|FG002|Part 1: up to Week 16|Physician Decision|0|||
161798163|NCT02581345|584304412|FG003|Part 1: up to Week 16|Physician Decision|0|||
161798164|NCT02581345|584304409|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
161798165|NCT02581345|584304410|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
161798166|NCT02581345|584304411|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
161798167|NCT02581345|584304412|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
161798168|NCT02581345|584304409|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
161798169|NCT02581345|584304410|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
161798170|NCT02581345|584304411|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
161798171|NCT02581345|584304412|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
161798172|NCT02581345|584304409|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
161798173|NCT02581345|584304410|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
161798174|NCT02581345|584304411|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
161798175|NCT02581345|584304412|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
161798176|NCT02581345|584304409|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
161798177|NCT02581345|584304410|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
161798178|NCT02581345|584304411|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
161798179|NCT02581345|584304412|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
161798180|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
161798181|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
161798182|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
161798183|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
161798184|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
161798185|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
161798186|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
161798187|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
161798188|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
161798189|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
161798190|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
161798191|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
161798192|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
161798193|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
161798194|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
161798195|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
161798196|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
161798197|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
161798198|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
161798199|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
161798200|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
161798201|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
161798202|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
161798203|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
161798204|NCT01768858|584304413|FG000|Overall Study|Lost to Follow-up|9|||
161798205|NCT01768858|584304413|FG000|Overall Study|Lack of Efficacy|8|||
161798206|NCT01768858|584304413|FG000|Overall Study|Serious Adverse Event|1|||
161798207|NCT01768858|584304413|FG000|Overall Study|Participant moved to Germany|1|||
161798208|NCT01768858|584304413|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
161798209|NCT01768858|584304413|FG000|Overall Study|Exanthema|1|||
161798210|NCT01768858|584304413|FG000|Overall Study|Withdrawal by Subject|1|||
161798211|NCT00502775|584304418|FG000|Overall Study|Adverse Event|1|||
161798212|NCT00502775|584304419|FG001|Overall Study|Adverse Event|2|||
161798213|NCT00502775|584304420|FG002|Overall Study|Adverse Event|1|||
161798214|NCT00502775|584304418|FG000|Overall Study|Protocol Violation|1|||
161798215|NCT00502775|584304419|FG001|Overall Study|Protocol Violation|5|||
161798216|NCT00502775|584304420|FG002|Overall Study|Protocol Violation|2|||
161798217|NCT00502775|584304418|FG000|Overall Study|Withdrawal by Subject|1|||
161798218|NCT00502775|584304419|FG001|Overall Study|Withdrawal by Subject|1|||
161798219|NCT00502775|584304420|FG002|Overall Study|Withdrawal by Subject|2|||
161798220|NCT00502775|584304418|FG000|Overall Study|Sponsor Terminated Study|1|||
161798221|NCT00502775|584304419|FG001|Overall Study|Sponsor Terminated Study|0|||
161798222|NCT00502775|584304420|FG002|Overall Study|Sponsor Terminated Study|1|||
161798223|NCT00502775|584304418|FG000|Overall Study|Non-compliance with eDiary|4|||
161798224|NCT00502775|584304419|FG001|Overall Study|Non-compliance with eDiary|1|||
161798225|NCT00502775|584304420|FG002|Overall Study|Non-compliance with eDiary|1|||
161798226|NCT00502775|584304418|FG000|Overall Study|Subject unable to swallow capsule|1|||
161798227|NCT00502775|584304419|FG001|Overall Study|Subject unable to swallow capsule|0|||
161798228|NCT00502775|584304420|FG002|Overall Study|Subject unable to swallow capsule|1|||
161798229|NCT00502775|584304418|FG000|Overall Study|Logpad compliance <80%|1|||
161798230|NCT00502775|584304419|FG001|Overall Study|Logpad compliance <80%|0|||
161798231|NCT00502775|584304420|FG002|Overall Study|Logpad compliance <80%|0|||
161798232|NCT00502775|584304418|FG000|Overall Study|Randomized in error|0|||
161798233|NCT00502775|584304419|FG001|Overall Study|Randomized in error|1|||
161798234|NCT00502775|584304420|FG002|Overall Study|Randomized in error|1|||
161798235|NCT00502775|584304418|FG000|Overall Study|Non-compliance|0|||
161798236|NCT00502775|584304419|FG001|Overall Study|Non-compliance|2|||
161798237|NCT00502775|584304420|FG002|Overall Study|Non-compliance|2|||
161798238|NCT00502775|584304418|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
161798239|NCT00502775|584304419|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
161798240|NCT00502775|584304420|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
161798241|NCT00502775|584304418|FG000|Overall Study|Declining pollen counts|0|||
161798242|NCT00502775|584304419|FG001|Overall Study|Declining pollen counts|1|||
161798243|NCT00502775|584304420|FG002|Overall Study|Declining pollen counts|1|||
161798244|NCT00502775|584304418|FG000|Overall Study|Subject in jail|0|||
161798245|NCT00502775|584304419|FG001|Overall Study|Subject in jail|1|||
161798246|NCT00502775|584304420|FG002|Overall Study|Subject in jail|0|||
161798247|NCT00502775|584304418|FG000|Overall Study|Subject took disallowed drug|0|||
161798248|NCT00502775|584304419|FG001|Overall Study|Subject took disallowed drug|0|||
161798249|NCT00502775|584304420|FG002|Overall Study|Subject took disallowed drug|1|||
161798250|NCT02819362|584304424|FG000|Overall Study|On-site MRI could not be performed|70|||
161798251|NCT02710123|584304425|FG000|Overall Study|Lost to Follow-up|3|||
161798252|NCT02710123|584304426|FG001|Overall Study|Lost to Follow-up|4|||
161798253|NCT02710123|584304425|FG000|Overall Study|Withdrawal by Subject|1|||
161798254|NCT02710123|584304426|FG001|Overall Study|Withdrawal by Subject|1|||
161798255|NCT02710123|584304425|FG000|Overall Study|Illness unrelated to study intervention|1|||
161798256|NCT02710123|584304426|FG001|Overall Study|Illness unrelated to study intervention|0|||
161798257|NCT00419926|584304427|FG000|Overall Study|Withdrawal by Subject|7|||
161798258|NCT00419926|584304428|FG001|Overall Study|Withdrawal by Subject|3|||
161798259|NCT00419926|584304427|FG000|Overall Study|Administrative Problem|4|||
161798260|NCT00419926|584304428|FG001|Overall Study|Administrative Problem|4|||
161798261|NCT00419926|584304427|FG000|Overall Study|Lost to Follow-up|1|||
161798262|NCT00419926|584304428|FG001|Overall Study|Lost to Follow-up|2|||
161798263|NCT00419926|584304427|FG000|Overall Study|Death|2|||
161798264|NCT00419926|584304428|FG001|Overall Study|Death|1|||
161798265|NCT02374918|584304430|FG000|Overall Study|Protocol Violation|2|||
161798266|NCT02374918|584304431|FG001|Overall Study|Protocol Violation|0|||
161798267|NCT02374918|584304432|FG002|Overall Study|Protocol Violation|2|||
161798268|NCT02374918|584304433|FG003|Overall Study|Protocol Violation|1|||
161798269|NCT02374918|584304430|FG000|Overall Study|Withdrawal by Subject|1|||
161798270|NCT02374918|584304431|FG001|Overall Study|Withdrawal by Subject|1|||
161798271|NCT02374918|584304432|FG002|Overall Study|Withdrawal by Subject|1|||
161798272|NCT02374918|584304433|FG003|Overall Study|Withdrawal by Subject|0|||
161798273|NCT02374918|584304430|FG000|Overall Study|Lack of Efficacy|0|||
161798274|NCT02374918|584304431|FG001|Overall Study|Lack of Efficacy|0|||
161798275|NCT02374918|584304432|FG002|Overall Study|Lack of Efficacy|1|||
161798276|NCT02374918|584304433|FG003|Overall Study|Lack of Efficacy|1|||
161798277|NCT00810368|584304435|FG000|Overall Study|Lost to Follow-up|4|||
161798278|NCT00810368|584304436|FG001|Overall Study|Lost to Follow-up|2|||
161798279|NCT00810368|584304435|FG000|Overall Study|Lack of Efficacy|2|||
161798280|NCT00810368|584304436|FG001|Overall Study|Lack of Efficacy|0|||
161798281|NCT03365375|584304437|FG000|Overall Study|Withdrawal by Subject|0|||
161901907|NCT01212094|584688722|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
161798282|NCT03365375|584304438|FG001|Overall Study|Withdrawal by Subject|1|||
161798283|NCT03365375|584304437|FG000|Overall Study|Lost to Follow-up|0|||
161798284|NCT03365375|584304438|FG001|Overall Study|Lost to Follow-up|4|||
161798285|NCT02166697|584304439|FG000|Overall Study|Protocol Violation|347|||
161798286|NCT01505530|584304440|FG000|Overall Study|Progressive Disease|19|||
161798287|NCT01505530|584304441|FG001|Overall Study|Progressive Disease|17|||
161901908|NCT01212094|584688723|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
161901909|NCT01212094|584688724|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
161901910|NCT01212094|584688722|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
161901911|NCT01212094|584688723|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
161901912|NCT01212094|584688724|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
161901913|NCT01212094|584688722|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
161901914|NCT01212094|584688723|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
161901915|NCT01212094|584688724|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
161901916|NCT01212094|584688722|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
161901917|NCT01212094|584688723|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
161901918|NCT01212094|584688724|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
161901919|NCT01212094|584688722|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
161901920|NCT01212094|584688723|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
161901921|NCT01212094|584688724|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
161901922|NCT01212094|584688722|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
161901923|NCT01212094|584688723|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
161901924|NCT01212094|584688724|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
161901925|NCT05664581|584688728|FG000|Overall Study|Withdrawal by Subject|2|||
161901926|NCT03101150|584688731|FG000|Overall Study|Lost to Follow-up|2|||
161901927|NCT03101150|584688732|FG001|Overall Study|Lost to Follow-up|4|||
161901928|NCT03101150|584688731|FG000|Overall Study|Miscarriage|3|||
161901929|NCT03101150|584688732|FG001|Overall Study|Miscarriage|6|||
161901930|NCT01317641|584688734|FG000|Overall Study|Not treated|0|||
161901931|NCT01317641|584688735|FG001|Overall Study|Not treated|0|||
161901932|NCT01317641|584688736|FG002|Overall Study|Not treated|0|||
161901933|NCT01317641|584688737|FG003|Overall Study|Not treated|0|||
161901934|NCT01317641|584688738|FG004|Overall Study|Not treated|0|||
161901935|NCT01317641|584688739|FG005|Overall Study|Not treated|0|||
161901936|NCT01317641|584688740|FG006|Overall Study|Not treated|0|||
161901937|NCT01317641|584688741|FG007|Overall Study|Not treated|1|||
161901938|NCT01317641|584688742|FG008|Overall Study|Not treated|1|||
161901939|NCT01317641|584688734|FG000|Overall Study|Adverse Event|0|||
161901940|NCT01317641|584688735|FG001|Overall Study|Adverse Event|1|||
161901941|NCT01317641|584688736|FG002|Overall Study|Adverse Event|0|||
161901942|NCT01317641|584688737|FG003|Overall Study|Adverse Event|1|||
161901943|NCT01317641|584688738|FG004|Overall Study|Adverse Event|0|||
161901944|NCT01317641|584688739|FG005|Overall Study|Adverse Event|0|||
161901945|NCT01317641|584688740|FG006|Overall Study|Adverse Event|2|||
161901946|NCT01317641|584688741|FG007|Overall Study|Adverse Event|1|||
161901947|NCT01317641|584688742|FG008|Overall Study|Adverse Event|0|||
161901948|NCT01317641|584688734|FG000|Overall Study|Protocol Violation|1|||
161901949|NCT01317641|584688735|FG001|Overall Study|Protocol Violation|0|||
161901950|NCT01317641|584688736|FG002|Overall Study|Protocol Violation|0|||
161901951|NCT01317641|584688737|FG003|Overall Study|Protocol Violation|0|||
161901952|NCT01317641|584688738|FG004|Overall Study|Protocol Violation|0|||
161901953|NCT01317641|584688739|FG005|Overall Study|Protocol Violation|0|||
161901954|NCT01317641|584688740|FG006|Overall Study|Protocol Violation|0|||
161901955|NCT01317641|584688741|FG007|Overall Study|Protocol Violation|0|||
161901956|NCT01317641|584688742|FG008|Overall Study|Protocol Violation|0|||
161901957|NCT01317641|584688734|FG000|Overall Study|Disease progression|0|||
161901958|NCT01317641|584688735|FG001|Overall Study|Disease progression|0|||
161901959|NCT01317641|584688736|FG002|Overall Study|Disease progression|0|||
161901960|NCT01317641|584688737|FG003|Overall Study|Disease progression|0|||
161901961|NCT01317641|584688738|FG004|Overall Study|Disease progression|0|||
161901962|NCT01317641|584688739|FG005|Overall Study|Disease progression|0|||
161901963|NCT01317641|584688740|FG006|Overall Study|Disease progression|0|||
161901964|NCT01317641|584688741|FG007|Overall Study|Disease progression|3|||
161901965|NCT01317641|584688742|FG008|Overall Study|Disease progression|4|||
161901966|NCT01317641|584688734|FG000|Overall Study|Withdrawal by Subject|0|||
161901967|NCT01317641|584688735|FG001|Overall Study|Withdrawal by Subject|0|||
161901968|NCT01317641|584688736|FG002|Overall Study|Withdrawal by Subject|0|||
161901969|NCT01317641|584688737|FG003|Overall Study|Withdrawal by Subject|0|||
161901970|NCT01317641|584688738|FG004|Overall Study|Withdrawal by Subject|0|||
161901971|NCT01317641|584688739|FG005|Overall Study|Withdrawal by Subject|0|||
161901972|NCT01317641|584688740|FG006|Overall Study|Withdrawal by Subject|1|||
161901973|NCT01317641|584688741|FG007|Overall Study|Withdrawal by Subject|0|||
161901974|NCT01317641|584688742|FG008|Overall Study|Withdrawal by Subject|0|||
161901975|NCT00329108|584688743|FG000|Overall Study|Adverse Event|2|||
161901976|NCT00329108|584688744|FG001|Overall Study|Adverse Event|2|||
161901977|NCT00329108|584688743|FG000|Overall Study|Lack of Efficacy|3|||
161901978|NCT00329108|584688744|FG001|Overall Study|Lack of Efficacy|3|||
161901979|NCT00329108|584688743|FG000|Overall Study|Withdrawal by Subject|0|||
161901980|NCT00329108|584688744|FG001|Overall Study|Withdrawal by Subject|2|||
161901981|NCT00329108|584688743|FG000|Overall Study|symptomatic deterioration|1|||
161901982|NCT00329108|584688744|FG001|Overall Study|symptomatic deterioration|1|||
161901983|NCT00329108|584688743|FG000|Overall Study|Subject no longer willing to participate|2|||
161901984|NCT00329108|584688744|FG001|Overall Study|Subject no longer willing to participate|2|||
161901985|NCT00329108|584688743|FG000|Overall Study|study terminated by sponsor|1|||
161798288|NCT01505530|584304442|FG002|Overall Study|Progressive Disease|18|||
161798289|NCT01505530|584304440|FG000|Overall Study|Adverse Event|1|||
161798290|NCT01505530|584304441|FG001|Overall Study|Adverse Event|1|||
161798291|NCT01505530|584304442|FG002|Overall Study|Adverse Event|0|||
161798292|NCT01505530|584304440|FG000|Overall Study|Withdrawal by Subject|7|||
161798293|NCT01505530|584304441|FG001|Overall Study|Withdrawal by Subject|8|||
161798294|NCT01505530|584304442|FG002|Overall Study|Withdrawal by Subject|6|||
161798295|NCT01505530|584304440|FG000|Overall Study|Physician Decision|6|||
161798296|NCT01505530|584304441|FG001|Overall Study|Physician Decision|2|||
161798297|NCT01505530|584304442|FG002|Overall Study|Physician Decision|5|||
161798298|NCT01505530|584304440|FG000|Overall Study|Sponsor Decision|1|||
161798299|NCT01505530|584304441|FG001|Overall Study|Sponsor Decision|8|||
161798300|NCT01505530|584304442|FG002|Overall Study|Sponsor Decision|7|||
161798301|NCT01505530|584304440|FG000|Overall Study|Death|7|||
161798302|NCT01505530|584304441|FG001|Overall Study|Death|6|||
161798303|NCT01505530|584304442|FG002|Overall Study|Death|5|||
161798304|NCT01505530|584304440|FG000|Overall Study|entry criteria not met|0|||
161798305|NCT01505530|584304441|FG001|Overall Study|entry criteria not met|1|||
161798306|NCT01505530|584304442|FG002|Overall Study|entry criteria not met|0|||
161798307|NCT01153984|584304445|FG000|Overall Study|Withdrawal by Subject|1|||
161798308|NCT01153984|584304445|FG000|Overall Study|Adverse Event|1|||
161798309|NCT00973700|584304446|FG000|Overall Study|Withdrawal by Subject|2|||
161798310|NCT00973700|584304447|FG001|Overall Study|Withdrawal by Subject|2|||
161798311|NCT00973700|584304448|FG002|Overall Study|Withdrawal by Subject|8|||
161798312|NCT00973700|584304449|FG003|Overall Study|Withdrawal by Subject|4|||
161798313|NCT00973700|584304450|FG004|Overall Study|Withdrawal by Subject|4|||
161798314|NCT00973700|584304446|FG000|Overall Study|Lost to Follow-up|5|||
161798315|NCT00973700|584304447|FG001|Overall Study|Lost to Follow-up|0|||
161798316|NCT00973700|584304448|FG002|Overall Study|Lost to Follow-up|1|||
161798317|NCT00973700|584304449|FG003|Overall Study|Lost to Follow-up|8|||
161798318|NCT00973700|584304450|FG004|Overall Study|Lost to Follow-up|5|||
161798319|NCT00973700|584304446|FG000|Overall Study|Inappropriate enrolment|0|||
161798320|NCT00973700|584304447|FG001|Overall Study|Inappropriate enrolment|0|||
161798321|NCT00973700|584304448|FG002|Overall Study|Inappropriate enrolment|0|||
161798322|NCT00973700|584304449|FG003|Overall Study|Inappropriate enrolment|4|||
161798323|NCT00973700|584304450|FG004|Overall Study|Inappropriate enrolment|0|||
161798324|NCT00973700|584304446|FG000|Overall Study|Unable to Classify|0|||
161798325|NCT00973700|584304447|FG001|Overall Study|Unable to Classify|0|||
161798326|NCT00973700|584304448|FG002|Overall Study|Unable to Classify|1|||
161798327|NCT00973700|584304449|FG003|Overall Study|Unable to Classify|2|||
161798328|NCT00973700|584304450|FG004|Overall Study|Unable to Classify|1|||
161450897|NCT01065454|583045897|FG002|Follow up|Withdrawal by Subject|1|||
161450898|NCT01065454|583045898|FG003|Follow up|Withdrawal by Subject|0|||
161450899|NCT01065454|583045895|FG000|Follow up|study ongoing|37|||
161450900|NCT01065454|583045896|FG001|Follow up|study ongoing|22|||
161450901|NCT01065454|583045897|FG002|Follow up|study ongoing|15|||
161450902|NCT01065454|583045898|FG003|Follow up|study ongoing|41|||
161450903|NCT04614324|583045899|FG000|Overall Study|Lost to Follow-up|3|||
161450904|NCT04614324|583045899|FG000|Overall Study|Physician Decision|1|||
161450905|NCT04614324|583045899|FG000|Overall Study|Withdrawal by Subject|2|||
161450906|NCT04614324|583045899|FG000|Overall Study|Remaining in Follow up|123|||
161450907|NCT03472547|583045900|FG000|Overall Study|Withdrawal by Subject|30|||
161450908|NCT05141448|583045901|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161450909|NCT05141448|583045902|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
161450910|NCT05141448|583045903|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161450911|NCT05141448|583045904|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161450912|NCT05141448|583045905|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161450913|NCT05141448|583045906|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161450914|NCT05141448|583045901|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161450915|NCT05141448|583045902|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161450916|NCT05141448|583045903|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161450917|NCT05141448|583045904|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161450918|NCT05141448|583045905|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
161450919|NCT05141448|583045906|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161798329|NCT00290745|584304460|FG000|Overall Study|Withdrawal by Subject|4|||
161798330|NCT00290745|584304460|FG000|Overall Study|Physician Decision|2|||
161798331|NCT00290745|584304460|FG000|Overall Study|Surgery after 3 months for progression|3|||
161798332|NCT00290745|584304460|FG000|Overall Study|Baseline MRI not available|3|||
161798333|NCT00626925|584304463|FG000|Overall Study|Lost to Follow-up|1|||
161798334|NCT00626925|584304464|FG001|Overall Study|Lost to Follow-up|2|||
161450920|NCT05141448|583045901|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161450921|NCT05141448|583045902|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
161798335|NCT00626925|584304463|FG000|Overall Study|relapse|1|||
161798336|NCT00626925|584304464|FG001|Overall Study|relapse|0|||
161901986|NCT00329108|584688744|FG001|Overall Study|study terminated by sponsor|0|||
161901987|NCT00329108|584688743|FG000|Overall Study|withdrew patient after SAE resolved|1|||
161901988|NCT00329108|584688744|FG001|Overall Study|withdrew patient after SAE resolved|0|||
161901989|NCT00329108|584688743|FG000|Overall Study|Protocol Violation|0|||
161901990|NCT00329108|584688744|FG001|Overall Study|Protocol Violation|2|||
161901991|NCT01302418|584688745|FG000|Overall Study|Protocol Violation|9|||
161901992|NCT01302418|584688745|FG000|Overall Study|Non-evaluable|9|||
161901993|NCT02787304|584688750|FG000|Overall Study|Adverse Event|9|||
161901994|NCT02787304|584688751|FG001|Overall Study|Adverse Event|3|||
161901995|NCT02787304|584688752|FG002|Overall Study|Adverse Event|8|||
161901996|NCT02787304|584688753|FG003|Overall Study|Adverse Event|1|||
161901997|NCT02787304|584688750|FG000|Overall Study|Withdrawal by Subject|1|||
161901998|NCT02787304|584688751|FG001|Overall Study|Withdrawal by Subject|4|||
161901999|NCT02787304|584688752|FG002|Overall Study|Withdrawal by Subject|0|||
161902000|NCT02787304|584688753|FG003|Overall Study|Withdrawal by Subject|0|||
161902001|NCT02787304|584688750|FG000|Overall Study|Lost to Follow-up|1|||
161902002|NCT02787304|584688751|FG001|Overall Study|Lost to Follow-up|0|||
161902003|NCT02787304|584688752|FG002|Overall Study|Lost to Follow-up|0|||
161902004|NCT02787304|584688753|FG003|Overall Study|Lost to Follow-up|1|||
161902005|NCT02787304|584688750|FG000|Overall Study|Noncompliance with study drug|0|||
161902006|NCT02787304|584688751|FG001|Overall Study|Noncompliance with study drug|0|||
161902007|NCT02787304|584688752|FG002|Overall Study|Noncompliance with study drug|1|||
161902008|NCT02787304|584688753|FG003|Overall Study|Noncompliance with study drug|0|||
161902009|NCT02787304|584688750|FG000|Overall Study|Physician Decision|0|||
161902010|NCT02787304|584688751|FG001|Overall Study|Physician Decision|0|||
161902011|NCT02787304|584688752|FG002|Overall Study|Physician Decision|1|||
161902012|NCT02787304|584688753|FG003|Overall Study|Physician Decision|0|||
161902013|NCT02787304|584688750|FG000|Overall Study|Study terminated by sponsor|25|||
161902014|NCT02787304|584688751|FG001|Overall Study|Study terminated by sponsor|31|||
161902015|NCT02787304|584688752|FG002|Overall Study|Study terminated by sponsor|31|||
161902016|NCT02787304|584688753|FG003|Overall Study|Study terminated by sponsor|32|||
161902017|NCT04771013|584688756|FG000|Overall Study|Withdrawal by Subject|2|||
161902018|NCT04771013|584688757|FG001|Overall Study|Withdrawal by Subject|0|||
161902019|NCT04771013|584688756|FG000|Overall Study|Death|0|||
161902020|NCT04771013|584688757|FG001|Overall Study|Death|5|||
161902021|NCT04771013|584688756|FG000|Overall Study|Referred to another hospital before day 20|0|||
161902022|NCT04771013|584688757|FG001|Overall Study|Referred to another hospital before day 20|1|||
161902023|NCT00419757|584688760|FG000|Overall Study|Adverse Event|1|||
161902024|NCT00419757|584688761|FG001|Overall Study|Adverse Event|4|||
161902025|NCT00419757|584688760|FG000|Overall Study|Lost to Follow-up|1|||
161902026|NCT00419757|584688761|FG001|Overall Study|Lost to Follow-up|4|||
161902027|NCT00419757|584688760|FG000|Overall Study|Withdrawal by Subject|7|||
161902028|NCT00419757|584688761|FG001|Overall Study|Withdrawal by Subject|1|||
161902029|NCT00419757|584688760|FG000|Overall Study|Protocol Violation|2|||
161902030|NCT00419757|584688761|FG001|Overall Study|Protocol Violation|3|||
161902031|NCT00419757|584688760|FG000|Overall Study|Study specific discontinuation criteria|4|||
161902032|NCT00419757|584688761|FG001|Overall Study|Study specific discontinuation criteria|8|||
161902033|NCT00419757|584688760|FG000|Overall Study|Multiple reasons|3|||
161902034|NCT00419757|584688761|FG001|Overall Study|Multiple reasons|1|||
161902035|NCT01051921|584688762|FG000|Overall Study|Physician Decision|9|||
161902036|NCT01051921|584688762|FG000|Overall Study|Adverse Event|8|||
161902037|NCT01051921|584688762|FG000|Overall Study|Withdrawal by Subject|7|||
161902038|NCT01051921|584688762|FG000|Overall Study|Lost to Follow-up|4|||
161902039|NCT01051921|584688762|FG000|Overall Study|virological failure|1|||
161902040|NCT01051921|584688762|FG000|Overall Study|patient moved|1|||
161902041|NCT01716806|584688765|FG000|Overall Study|Patient withdrawal of consent|4|||
161902042|NCT01716806|584688766|FG001|Overall Study|Patient withdrawal of consent|2|||
161902043|NCT01716806|584688767|FG002|Overall Study|Patient withdrawal of consent|4|||
161902044|NCT01716806|584688768|FG003|Overall Study|Patient withdrawal of consent|3|||
161902045|NCT01716806|584688769|FG004|Overall Study|Patient withdrawal of consent|2|||
161902046|NCT01716806|584688770|FG005|Overall Study|Patient withdrawal of consent|0|||
161902047|NCT01716806|584688765|FG000|Overall Study|Lost to Follow-up|3|||
161902048|NCT01716806|584688766|FG001|Overall Study|Lost to Follow-up|3|||
161902049|NCT01716806|584688767|FG002|Overall Study|Lost to Follow-up|0|||
161902050|NCT01716806|584688768|FG003|Overall Study|Lost to Follow-up|2|||
161902051|NCT01716806|584688769|FG004|Overall Study|Lost to Follow-up|1|||
161902052|NCT01716806|584688770|FG005|Overall Study|Lost to Follow-up|0|||
161556148|NCT02408549|583425414|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
161902053|NCT01716806|584688765|FG000|Overall Study|Death|13|||
161902054|NCT01716806|584688766|FG001|Overall Study|Death|9|||
161902055|NCT01716806|584688767|FG002|Overall Study|Death|12|||
161902056|NCT01716806|584688768|FG003|Overall Study|Death|4|||
161902057|NCT01716806|584688769|FG004|Overall Study|Death|10|||
161902058|NCT01716806|584688770|FG005|Overall Study|Death|5|||
161902059|NCT01716806|584688765|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902060|NCT01716806|584688766|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902061|NCT01716806|584688767|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902062|NCT01716806|584688768|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902063|NCT01716806|584688769|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
161902064|NCT01716806|584688770|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
161902065|NCT01716806|584688765|FG000|Overall Study|PI decision|0|||
161902066|NCT01716806|584688766|FG001|Overall Study|PI decision|0|||
161902067|NCT01716806|584688767|FG002|Overall Study|PI decision|0|||
161902068|NCT01716806|584688768|FG003|Overall Study|PI decision|0|||
161902069|NCT01716806|584688769|FG004|Overall Study|PI decision|1|||
161902070|NCT01716806|584688770|FG005|Overall Study|PI decision|0|||
161902071|NCT01716806|584688765|FG000|Overall Study|Change in performance status|1|||
161902072|NCT01716806|584688766|FG001|Overall Study|Change in performance status|0|||
161902073|NCT01716806|584688767|FG002|Overall Study|Change in performance status|0|||
161902074|NCT01716806|584688768|FG003|Overall Study|Change in performance status|0|||
161902075|NCT01716806|584688769|FG004|Overall Study|Change in performance status|0|||
161902076|NCT01716806|584688770|FG005|Overall Study|Change in performance status|0|||
161902077|NCT01716806|584688765|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902078|NCT01716806|584688766|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902079|NCT01716806|584688767|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
161902080|NCT01716806|584688768|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902081|NCT01716806|584688769|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902082|NCT01716806|584688770|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902083|NCT01716806|584688765|FG000|Overall Study|Sponsor direction|7|||
161902084|NCT01716806|584688766|FG001|Overall Study|Sponsor direction|8|||
161902085|NCT01716806|584688767|FG002|Overall Study|Sponsor direction|5|||
161902086|NCT01716806|584688768|FG003|Overall Study|Sponsor direction|12|||
161902087|NCT01716806|584688769|FG004|Overall Study|Sponsor direction|16|||
161902088|NCT01716806|584688770|FG005|Overall Study|Sponsor direction|1|||
161902089|NCT00735709|584688775|FG000|Overall Study|Adverse Event|2|||
161902090|NCT00735709|584688776|FG001|Overall Study|Adverse Event|3|||
161902091|NCT00735709|584688777|FG002|Overall Study|Adverse Event|1|||
161902092|NCT00735709|584688778|FG003|Overall Study|Adverse Event|5|||
161902093|NCT00735709|584688775|FG000|Overall Study|Lack of Efficacy|8|||
161902094|NCT00735709|584688776|FG001|Overall Study|Lack of Efficacy|4|||
161902095|NCT00735709|584688777|FG002|Overall Study|Lack of Efficacy|2|||
161902096|NCT00735709|584688778|FG003|Overall Study|Lack of Efficacy|3|||
161902097|NCT00735709|584688775|FG000|Overall Study|Noncompliance|0|||
161902098|NCT00735709|584688776|FG001|Overall Study|Noncompliance|0|||
161902099|NCT00735709|584688777|FG002|Overall Study|Noncompliance|1|||
161902100|NCT00735709|584688778|FG003|Overall Study|Noncompliance|0|||
161902101|NCT00735709|584688775|FG000|Overall Study|Protocol deviations|1|||
161902102|NCT00735709|584688776|FG001|Overall Study|Protocol deviations|2|||
161902103|NCT00735709|584688777|FG002|Overall Study|Protocol deviations|1|||
161902104|NCT00735709|584688778|FG003|Overall Study|Protocol deviations|1|||
161902105|NCT00735709|584688775|FG000|Overall Study|Voluntary Withdrawal|1|||
161902106|NCT00735709|584688776|FG001|Overall Study|Voluntary Withdrawal|3|||
161902107|NCT00735709|584688777|FG002|Overall Study|Voluntary Withdrawal|5|||
161902108|NCT00735709|584688778|FG003|Overall Study|Voluntary Withdrawal|7|||
161902109|NCT00735709|584688775|FG000|Overall Study|Lost to Follow-up|0|||
161902110|NCT00735709|584688776|FG001|Overall Study|Lost to Follow-up|1|||
161902111|NCT00735709|584688777|FG002|Overall Study|Lost to Follow-up|1|||
161902112|NCT00735709|584688778|FG003|Overall Study|Lost to Follow-up|1|||
161902113|NCT00735709|584688775|FG000|Overall Study|Excluded medication|1|||
161902114|NCT00735709|584688776|FG001|Overall Study|Excluded medication|0|||
161902115|NCT00735709|584688777|FG002|Overall Study|Excluded medication|0|||
161902116|NCT00735709|584688778|FG003|Overall Study|Excluded medication|1|||
161902117|NCT02498678|584688781|FG000|Overall Study|interference from the surgical team|0|||
161902118|NCT02498678|584688782|FG001|Overall Study|interference from the surgical team|2|||
161902119|NCT03627832|584688784|FG000|Overall Study|Withdrawal by Subject|10|||
161902120|NCT03627832|584688785|FG001|Overall Study|Withdrawal by Subject|1|||
161902121|NCT01145482|584688789|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161902122|NCT01145482|584688790|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161902123|NCT04547140|584688791|FG000|Overall Study|Adverse Event|0|||
161902124|NCT04547140|584688792|FG001|Overall Study|Adverse Event|1|||
161902125|NCT04547140|584688791|FG000|Overall Study|Withdrawal by Subject|0|||
161902126|NCT04547140|584688792|FG001|Overall Study|Withdrawal by Subject|1|||
161902127|NCT04547140|584688791|FG000|Overall Study|Lost to Follow-up|3|||
161902128|NCT04547140|584688792|FG001|Overall Study|Lost to Follow-up|1|||
161902129|NCT04547140|584688791|FG000|Overall Study|Death|2|||
161902130|NCT04547140|584688792|FG001|Overall Study|Death|1|||
161902131|NCT04547140|584688791|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
161902132|NCT04547140|584688792|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
161902133|NCT04547140|584688791|FG000|Overall Study|Pregnancy|1|||
161902134|NCT04547140|584688792|FG001|Overall Study|Pregnancy|0|||
161902135|NCT04547140|584688791|FG000|Overall Study|Reason Not Specified|4|||
161902136|NCT04547140|584688792|FG001|Overall Study|Reason Not Specified|1|||
161902137|NCT02119299|584688793|FG000|Overall Study|Withdrawal by Subject|7|||
161902138|NCT02119299|584688793|FG000|Overall Study|Lack of Efficacy|1|||
161902139|NCT02119299|584688793|FG000|Overall Study|Pregnancy|1|||
161902140|NCT04613739|584688794|FG000|Overall Study|Lost to Follow-up|6|||
161902141|NCT04613739|584688795|FG001|Overall Study|Lost to Follow-up|9|||
161902142|NCT04613739|584688794|FG000|Overall Study|potentially duplicative/fraudulent|1|||
161902143|NCT04613739|584688795|FG001|Overall Study|potentially duplicative/fraudulent|3|||
161902144|NCT00483652|584688796|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161902145|NCT00483652|584688797|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161902146|NCT00483652|584688796|FG000|Double-blind Treatment Period|Adverse Event|3|||
161902147|NCT00483652|584688797|FG001|Double-blind Treatment Period|Adverse Event|4|||
161902148|NCT00483652|584688796|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
161902149|NCT00483652|584688797|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
161902150|NCT00483652|584688796|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
161902151|NCT00483652|584688797|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
161902152|NCT02154139|584688798|FG000|Overall Study|Injection not administered|2|||
161902153|NCT02154139|584688798|FG000|Overall Study|Other|2|||
161902154|NCT02154139|584688798|FG000|Overall Study|Investigator transferred|3|||
161902155|NCT00891813|584688799|FG000|Overall Study|Adverse Event|3|||
161902156|NCT00891813|584688799|FG000|Overall Study|Withdrawal by Subject|1|||
161902157|NCT00891813|584688799|FG000|Overall Study|Patient Noncompliance|6|||
161902158|NCT00891813|584688799|FG000|Overall Study|Protocol Violation|2|||
161902159|NCT03075267|584688808|FG000|Overall Study|Protocol Violation|1|||
161902160|NCT03075267|584688809|FG001|Overall Study|Protocol Violation|0|||
161902161|NCT03075267|584688810|FG002|Overall Study|Protocol Violation|0|||
161902162|NCT03874013|584688811|FG000|Overall Study|Adverse Event|0|||
161902163|NCT03874013|584688812|FG001|Overall Study|Adverse Event|1|||
161902164|NCT01443858|584688819|FG000|Overall Study|Withdrawal by Subject|9|||
161902165|NCT01443858|584688820|FG001|Overall Study|Withdrawal by Subject|8|||
161902166|NCT01443858|584688821|FG002|Overall Study|Withdrawal by Subject|5|||
161902167|NCT01443858|584688819|FG000|Overall Study|Lack of Efficacy|1|||
161902168|NCT01443858|584688820|FG001|Overall Study|Lack of Efficacy|0|||
161902169|NCT01443858|584688821|FG002|Overall Study|Lack of Efficacy|0|||
161450922|NCT05141448|583045903|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161450923|NCT05141448|583045904|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161798337|NCT00626925|584304463|FG000|Overall Study|Adverse effect|6|||
161798338|NCT00626925|584304464|FG001|Overall Study|Adverse effect|2|||
161798339|NCT00626925|584304463|FG000|Overall Study|Lack of Efficacy|1|||
161798340|NCT00626925|584304464|FG001|Overall Study|Lack of Efficacy|4|||
161798341|NCT00626925|584304463|FG000|Overall Study|Time constraints|3|||
161798342|NCT00626925|584304464|FG001|Overall Study|Time constraints|1|||
161798343|NCT00625807|584304467|FG000|Overall Study|schedule conflict|2|||
161798344|NCT00625807|584304468|FG001|Overall Study|schedule conflict|8|||
161798345|NCT01802879|584304469|FG000|Overall Study|Administrative problems|2|||
161798346|NCT01802879|584304469|FG000|Overall Study|Disease progression|6|||
161798347|NCT00266409|584304470|FG000|Overall Study|Lack of Efficacy|2|||
161798348|NCT00266409|584304471|FG001|Overall Study|Lack of Efficacy|6|||
161798349|NCT00266409|584304472|FG002|Overall Study|Lack of Efficacy|1|||
161798350|NCT00266409|584304473|FG003|Overall Study|Lack of Efficacy|2|||
161798351|NCT00266409|584304470|FG000|Overall Study|Adverse Event|7|||
161798352|NCT00266409|584304471|FG001|Overall Study|Adverse Event|2|||
161798353|NCT00266409|584304472|FG002|Overall Study|Adverse Event|1|||
161798354|NCT00266409|584304473|FG003|Overall Study|Adverse Event|1|||
161798355|NCT00266409|584304470|FG000|Overall Study|Lost to Follow-up|18|||
161798356|NCT00266409|584304471|FG001|Overall Study|Lost to Follow-up|21|||
161798357|NCT00266409|584304472|FG002|Overall Study|Lost to Follow-up|6|||
161798358|NCT00266409|584304473|FG003|Overall Study|Lost to Follow-up|8|||
161798359|NCT00266409|584304470|FG000|Overall Study|Withdrawal by Subject|6|||
161798360|NCT00266409|584304471|FG001|Overall Study|Withdrawal by Subject|10|||
161798361|NCT00266409|584304472|FG002|Overall Study|Withdrawal by Subject|3|||
161798362|NCT00266409|584304473|FG003|Overall Study|Withdrawal by Subject|9|||
161798363|NCT00266409|584304470|FG000|Overall Study|Protocol Violation|5|||
161798364|NCT00266409|584304471|FG001|Overall Study|Protocol Violation|3|||
161798365|NCT00266409|584304472|FG002|Overall Study|Protocol Violation|4|||
161798366|NCT00266409|584304473|FG003|Overall Study|Protocol Violation|2|||
161798367|NCT00266409|584304470|FG000|Overall Study|Other|7|||
161798368|NCT00266409|584304471|FG001|Overall Study|Other|4|||
161798369|NCT00266409|584304472|FG002|Overall Study|Other|2|||
161798370|NCT00266409|584304473|FG003|Overall Study|Other|0|||
161798371|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
161798372|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
161902170|NCT01443858|584688819|FG000|Overall Study|Lost to Follow-up|5|||
161902171|NCT01443858|584688820|FG001|Overall Study|Lost to Follow-up|5|||
161798373|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
161798374|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
161798375|NCT00108732|584304476|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
161798376|NCT00108732|584304476|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
161798377|NCT00108732|584304476|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
161798378|NCT01946165|584304478|FG000|Overall Study|Physician Decision|2|||
161798379|NCT01946165|584304479|FG001|Overall Study|Physician Decision|0|||
161798380|NCT01946165|584304478|FG000|Overall Study|Withdrawal by Subject|0|||
161798381|NCT01946165|584304479|FG001|Overall Study|Withdrawal by Subject|2|||
161798382|NCT01901055|584304480|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
161798383|NCT01901055|584304481|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
161798384|NCT01901055|584304480|FG000|Randomization But Not Titrated|Physician Decision|0|||
161798385|NCT01901055|584304481|FG001|Randomization But Not Titrated|Physician Decision|1|||
161798386|NCT01901055|584304480|FG000|Started Protocol to Week 6|Physician Decision|2|||
161798387|NCT01901055|584304481|FG001|Started Protocol to Week 6|Physician Decision|1|||
161798388|NCT01901055|584304480|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
161798389|NCT01901055|584304481|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
161798390|NCT01901055|584304480|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
161798391|NCT01901055|584304481|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
161798392|NCT01901055|584304480|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
161798393|NCT01901055|584304481|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
161798394|NCT01901055|584304480|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
161798395|NCT01901055|584304481|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
161798396|NCT01901055|584304480|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
161798397|NCT01901055|584304481|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
161798398|NCT01901055|584304480|FG000|Week 24|Withdrawal by Subject|13|||
161798399|NCT01901055|584304481|FG001|Week 24|Withdrawal by Subject|19|||
161798400|NCT01901055|584304480|FG000|Week 24|Physician Decision|1|||
161798401|NCT01901055|584304481|FG001|Week 24|Physician Decision|0|||
161798402|NCT01901055|584304480|FG000|Week 36|Withdrawal by Subject|0|||
161798403|NCT01901055|584304481|FG001|Week 36|Withdrawal by Subject|5|||
161798404|NCT01659567|584304482|FG000|Overall Study|Lack of Efficacy|22|||
161798405|NCT01659567|584304482|FG000|Overall Study|Switched to Pegferon|6|||
161798406|NCT01659567|584304482|FG000|Overall Study|Adverse Event|12|||
161798407|NCT01659567|584304482|FG000|Overall Study|Good result at early stage of treatment|5|||
161798408|NCT01659567|584304482|FG000|Overall Study|Withdrawal by Subject|64|||
161798409|NCT01659567|584304482|FG000|Overall Study|Progression of the main disease|1|||
161798410|NCT01659567|584304482|FG000|Overall Study|Other|13|||
161798411|NCT01179919|584304485|FG000|Overall Study|Protocol Violation|1|||
161798412|NCT01179919|584304485|FG000|Overall Study|Adverse Event|1|||
161798413|NCT01915732|584304491|FG000|Overall Study|Withdrawal by Subject|18|||
161798414|NCT01915732|584304492|FG001|Overall Study|Withdrawal by Subject|18|||
161798415|NCT01915732|584304491|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161798416|NCT01915732|584304492|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161798417|NCT01915732|584304491|FG000|Overall Study|Adverse Event|12|||
161798418|NCT01915732|584304492|FG001|Overall Study|Adverse Event|4|||
161798419|NCT01915732|584304491|FG000|Overall Study|Protocol Violation|5|||
161798420|NCT01915732|584304492|FG001|Overall Study|Protocol Violation|5|||
161798421|NCT01915732|584304491|FG000|Overall Study|Lack of Efficacy|6|||
161798422|NCT01915732|584304492|FG001|Overall Study|Lack of Efficacy|11|||
161798423|NCT01915732|584304491|FG000|Overall Study|Lost to Follow-up|22|||
161798424|NCT01915732|584304492|FG001|Overall Study|Lost to Follow-up|26|||
161798425|NCT01915732|584304491|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
161798426|NCT01915732|584304492|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
161798427|NCT01915732|584304491|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
161798428|NCT01915732|584304492|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
161798429|NCT01915732|584304491|FG000|Overall Study|Drug Release Error|1|||
161798430|NCT01915732|584304492|FG001|Overall Study|Drug Release Error|0|||
161798431|NCT01915732|584304491|FG000|Overall Study|Recovered|1|||
161798432|NCT01915732|584304492|FG001|Overall Study|Recovered|0|||
161798433|NCT01915732|584304491|FG000|Overall Study|Pregnancy|1|||
161798434|NCT01915732|584304492|FG001|Overall Study|Pregnancy|0|||
161798435|NCT01915732|584304491|FG000|Overall Study|Poor Perceived Efficacy|1|||
161798436|NCT01915732|584304492|FG001|Overall Study|Poor Perceived Efficacy|0|||
161798437|NCT01915732|584304491|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
161798438|NCT01915732|584304492|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
161798439|NCT01915732|584304491|FG000|Overall Study|Got Well|0|||
161798440|NCT01915732|584304492|FG001|Overall Study|Got Well|1|||
161798441|NCT01915732|584304491|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
161798442|NCT01915732|584304492|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
161798443|NCT01915732|584304491|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
161798444|NCT01915732|584304492|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
161798445|NCT01915732|584304491|FG000|Overall Study|Job Transfer|0|||
161798446|NCT01915732|584304492|FG001|Overall Study|Job Transfer|1|||
161798447|NCT01915732|584304491|FG000|Overall Study|Improper Facial Procedure|0|||
161902172|NCT01443858|584688821|FG002|Overall Study|Lost to Follow-up|2|||
161902173|NCT06060496|584688822|FG000|Overall Study|Withdrawal by Subject|2|||
161902174|NCT06060496|584688822|FG000|Overall Study|Lost to Follow-up|2|||
161902175|NCT00149396|584688825|FG000|Overall Study|Death|15|||
161902176|NCT00149396|584688825|FG000|Overall Study|Withdrawal by Subject|1|||
161902177|NCT00149396|584688825|FG000|Overall Study|Subject noncompliance|2|||
161902178|NCT00149396|584688825|FG000|Overall Study|other treatment|5|||
161902179|NCT00807885|584688826|FG000|Overall Study|Lost to Follow-up|0|||
161902180|NCT00807885|584688827|FG001|Overall Study|Lost to Follow-up|0|||
161902181|NCT00807885|584688828|FG002|Overall Study|Lost to Follow-up|0|||
161902182|NCT00807885|584688829|FG003|Overall Study|Lost to Follow-up|0|||
161902183|NCT00807885|584688830|FG004|Overall Study|Lost to Follow-up|0|||
161902184|NCT00807885|584688831|FG005|Overall Study|Lost to Follow-up|1|||
161902185|NCT00807885|584688832|FG006|Overall Study|Lost to Follow-up|0|||
161902186|NCT00807885|584688833|FG007|Overall Study|Lost to Follow-up|0|||
161902187|NCT00807885|584688834|FG008|Overall Study|Lost to Follow-up|0|||
161902188|NCT01670045|584688838|FG000|Overall Study|Withdrawal by Subject|3|||
161902189|NCT01670045|584688838|FG000|Overall Study|Adverse Event|1|||
161902190|NCT01670045|584688838|FG000|Overall Study|Death|1|||
161902191|NCT01670045|584688838|FG000|Overall Study|Lost to Follow-up|11|||
161902192|NCT03360019|584688839|FG000|Overall Study|Withdrawal by Subject|2|||
161902193|NCT03360019|584688840|FG001|Overall Study|Withdrawal by Subject|0|||
161902194|NCT03360019|584688841|FG002|Overall Study|Withdrawal by Subject|0|||
161902195|NCT03360019|584688839|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
161798448|NCT01915732|584304492|FG001|Overall Study|Improper Facial Procedure|1|||
161798449|NCT01915732|584304491|FG000|Overall Study|Poor Conscious Effect|0|||
161798450|NCT01915732|584304492|FG001|Overall Study|Poor Conscious Effect|1|||
161798451|NCT00698685|584304493|FG000|Overall Study|Sister withdrew as donor|1|||
161798452|NCT00698685|584304493|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
161798453|NCT01325207|584304494|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798454|NCT01325207|584304495|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798455|NCT01325207|584304496|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798456|NCT01325207|584304497|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798457|NCT01325207|584304498|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
161798458|NCT01325207|584304499|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798459|NCT01325207|584304494|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
161798460|NCT01325207|584304495|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
161798461|NCT01325207|584304496|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
161798462|NCT01325207|584304497|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
161798463|NCT01325207|584304498|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
161798464|NCT01325207|584304499|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
161798465|NCT01325207|584304494|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798466|NCT01325207|584304495|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798467|NCT01325207|584304496|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798468|NCT01325207|584304497|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798469|NCT01325207|584304498|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
161798470|NCT01325207|584304499|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
161798471|NCT01325207|584304494|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798472|NCT01325207|584304495|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
161798473|NCT01325207|584304496|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798474|NCT01325207|584304497|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798475|NCT01325207|584304498|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798476|NCT01325207|584304499|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798477|NCT01325207|584304494|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798478|NCT01325207|584304495|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798479|NCT01325207|584304496|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798480|NCT01325207|584304497|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798481|NCT01325207|584304498|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798482|NCT01325207|584304499|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
161798483|NCT01325207|584304494|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798484|NCT01325207|584304495|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798485|NCT01325207|584304496|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798486|NCT01325207|584304497|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161902196|NCT03360019|584688840|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
161902197|NCT03360019|584688841|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
161902198|NCT00753675|584688844|FG000|Overall Study|other reason|11|||
161902199|NCT00753675|584688845|FG001|Overall Study|other reason|12|||
161556149|NCT02408549|583425414|FG000|Overall Study|Subject moved to another place, far from site|1|||
161902200|NCT00753675|584688846|FG002|Overall Study|other reason|13|||
161902201|NCT00753675|584688844|FG000|Overall Study|Death|1|||
161902202|NCT00753675|584688845|FG001|Overall Study|Death|2|||
161902203|NCT00753675|584688846|FG002|Overall Study|Death|4|||
161902204|NCT00753675|584688844|FG000|Overall Study|Adverse Event|11|||
161902205|NCT00753675|584688845|FG001|Overall Study|Adverse Event|9|||
161902206|NCT00753675|584688846|FG002|Overall Study|Adverse Event|4|||
161902207|NCT00753675|584688844|FG000|Overall Study|Objective progression of disease|35|||
161902208|NCT00753675|584688845|FG001|Overall Study|Objective progression of disease|35|||
161902209|NCT00753675|584688846|FG002|Overall Study|Objective progression of disease|35|||
161902210|NCT00753675|584688844|FG000|Overall Study|Withdrawal by Subject|0|||
161902211|NCT00753675|584688845|FG001|Overall Study|Withdrawal by Subject|1|||
161902212|NCT00753675|584688846|FG002|Overall Study|Withdrawal by Subject|0|||
161902213|NCT00753675|584688844|FG000|Overall Study|Lost to Follow-up|1|||
161902214|NCT00753675|584688845|FG001|Overall Study|Lost to Follow-up|0|||
161902215|NCT00753675|584688846|FG002|Overall Study|Lost to Follow-up|0|||
161902216|NCT01462110|584688847|FG000|Overall Study|Adverse Event|1|||
161902217|NCT01462110|584688848|FG001|Overall Study|Adverse Event|0|||
161902218|NCT05279131|584688849|FG000|Overall Study|Lost to Follow-up|1|||
161902219|NCT05279131|584688849|FG000|Overall Study|Death|1|||
161902220|NCT05279131|584688849|FG000|Overall Study|Physician Decision|1|||
161902221|NCT04754542|584688857|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
161902222|NCT04754542|584688858|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
161902223|NCT00873730|584690490|FG000|Overall Study|Protocol Deviation|5|||
161902224|NCT00873730|584690491|FG001|Overall Study|Protocol Deviation|2|||
161902225|NCT00873730|584690490|FG000|Overall Study|Adverse Event|0|||
161902226|NCT00873730|584690491|FG001|Overall Study|Adverse Event|2|||
161902227|NCT00873730|584690490|FG000|Overall Study|Withdrawal by Subject|0|||
161902228|NCT00873730|584690491|FG001|Overall Study|Withdrawal by Subject|1|||
161902229|NCT00873730|584690490|FG000|Overall Study|Sponsor decision|1|||
161902230|NCT00873730|584690491|FG001|Overall Study|Sponsor decision|0|||
161902231|NCT04110314|584690494|FG000|Overall Study|Did not meet inclusion criteria|35255|||
161902232|NCT04110314|584690495|FG001|Overall Study|Did not meet inclusion criteria|35104|||
161902233|NCT04110314|584690496|FG002|Overall Study|Did not meet inclusion criteria|35636|||
161450924|NCT05141448|583045905|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161450925|NCT05141448|583045906|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161450926|NCT05141448|583045901|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161450927|NCT05141448|583045902|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161450928|NCT05141448|583045903|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161450929|NCT05141448|583045904|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161450930|NCT05141448|583045905|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161450931|NCT05141448|583045906|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
161902234|NCT04110314|584690497|FG003|Overall Study|Did not meet inclusion criteria|35135|||
161902235|NCT04110314|584690498|FG004|Overall Study|Did not meet inclusion criteria|35247|||
161902236|NCT04110314|584690499|FG005|Overall Study|Did not meet inclusion criteria|35727|||
161902237|NCT01711983|584690507|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
161902238|NCT01711983|584690507|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
161902239|NCT01711983|584690507|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
161902240|NCT01711983|584690507|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
161902241|NCT00737100|584690508|FG000|Overall Study|Adverse Event|6|||
161902242|NCT00737100|584690509|FG001|Overall Study|Adverse Event|5|||
161902243|NCT00737100|584690510|FG002|Overall Study|Adverse Event|3|||
161902244|NCT00737100|584690508|FG000|Overall Study|Lost to Follow-up|0|||
161902245|NCT00737100|584690509|FG001|Overall Study|Lost to Follow-up|1|||
161902246|NCT00737100|584690510|FG002|Overall Study|Lost to Follow-up|0|||
161450932|NCT05141448|583045901|FG000|Period 2|COVID-19 Related|0|||
161450933|NCT05141448|583045902|FG001|Period 2|COVID-19 Related|0|||
161450934|NCT05141448|583045903|FG002|Period 2|COVID-19 Related|0|||
161902247|NCT00737100|584690508|FG000|Overall Study|Withdrawal by Subject|0|||
161902248|NCT00737100|584690509|FG001|Overall Study|Withdrawal by Subject|0|||
161902249|NCT00737100|584690510|FG002|Overall Study|Withdrawal by Subject|3|||
161902250|NCT00737100|584690508|FG000|Overall Study|Reason discontinued not explained above|1|||
161902251|NCT00737100|584690509|FG001|Overall Study|Reason discontinued not explained above|1|||
161902252|NCT00737100|584690510|FG002|Overall Study|Reason discontinued not explained above|1|||
161902253|NCT00735943|584690515|FG000|Overall Study|Lost to Follow-up|1|||
161902254|NCT00735943|584690515|FG000|Overall Study|Adverse Event|1|||
161450935|NCT05141448|583045904|FG003|Period 2|COVID-19 Related|1|||
161902255|NCT00115778|584690516|FG000|Overall Study|Withdrawal by Subject|0|||
161902256|NCT00115778|584690517|FG001|Overall Study|Withdrawal by Subject|1|||
161902257|NCT01607593|584690518|FG000|Overall Study|Adverse Event|15|||
161450936|NCT05141448|583045905|FG004|Period 2|COVID-19 Related|0|||
161450937|NCT05141448|583045906|FG005|Period 2|COVID-19 Related|1|||
161902258|NCT01607593|584690518|FG000|Overall Study|Lack of Efficacy|16|||
161902259|NCT01607593|584690518|FG000|Overall Study|Lost to Follow-up|25|||
161902260|NCT01607593|584690518|FG000|Overall Study|Continuation|33|||
161902261|NCT01607593|584690518|FG000|Overall Study|Other|4|||
161902262|NCT03713684|584690523|FG000|Overall Study|Adverse Event|1|||
161902263|NCT03713684|584690524|FG001|Overall Study|Adverse Event|3|||
161902264|NCT03713684|584690525|FG002|Overall Study|Adverse Event|1|||
161902265|NCT03713684|584690526|FG003|Overall Study|Adverse Event|0|||
161902266|NCT03713684|584690523|FG000|Overall Study|Poor compliance to protocol|2|||
161902267|NCT03713684|584690524|FG001|Overall Study|Poor compliance to protocol|1|||
161902268|NCT03713684|584690525|FG002|Overall Study|Poor compliance to protocol|0|||
161902269|NCT03713684|584690526|FG003|Overall Study|Poor compliance to protocol|1|||
161902270|NCT03713684|584690523|FG000|Overall Study|Withdrawal by Subject|14|||
161902271|NCT03713684|584690524|FG001|Overall Study|Withdrawal by Subject|6|||
161902272|NCT03713684|584690525|FG002|Overall Study|Withdrawal by Subject|14|||
161902273|NCT03713684|584690526|FG003|Overall Study|Withdrawal by Subject|16|||
161902274|NCT03713684|584690523|FG000|Overall Study|Other than specified|69|||
161902275|NCT03713684|584690524|FG001|Overall Study|Other than specified|77|||
161902276|NCT03713684|584690525|FG002|Overall Study|Other than specified|73|||
161902277|NCT03713684|584690526|FG003|Overall Study|Other than specified|70|||
161902278|NCT02515630|584690527|FG000|Overall Study|Withdrawal by Subject|5|||
161902279|NCT02515630|584690527|FG000|Overall Study|Adverse Event|4|||
161902280|NCT02515630|584690527|FG000|Overall Study|Physician Decision|4|||
161902281|NCT02515630|584690527|FG000|Overall Study|Death|2|||
161902282|NCT02515630|584690527|FG000|Overall Study|Disease Progression|1|||
161902283|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
161902284|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
161902285|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
161902286|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Death|0|||
161902287|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Death|1|||
161902288|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Death|0|||
161902289|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
161902290|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
161902291|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
161902292|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
161902293|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
161902294|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
161902295|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161902296|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161902297|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161902298|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Other|4|||
161902299|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Other|7|||
161902300|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Other|2|||
161902301|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161902302|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161902303|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161902304|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Death|0|||
161902305|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Death|1|||
161902306|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161450938|NCT05141448|583045901|FG000|3|Covid-19 related|2|||
161450939|NCT05141448|583045902|FG001|3|Covid-19 related|0|||
161450940|NCT05141448|583045903|FG002|3|Covid-19 related|0|||
161450941|NCT05141448|583045904|FG003|3|Covid-19 related|0|||
161450942|NCT05141448|583045905|FG004|3|Covid-19 related|0|||
161450943|NCT05141448|583045906|FG005|3|Covid-19 related|1|||
161450944|NCT05141448|583045901|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
161450945|NCT05141448|583045902|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
161450946|NCT05141448|583045903|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
161450947|NCT05141448|583045904|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
161450948|NCT05141448|583045905|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
161450949|NCT05141448|583045906|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
161450950|NCT01948193|583048082|FG000|Overall Study|Serious event|2|||
161450951|NCT01948193|583048082|FG000|Overall Study|Lost to Follow-up|7|||
161450952|NCT01325337|583048083|FG000|Overall Study|Adverse Event|0|||
161450953|NCT01325337|583048084|FG001|Overall Study|Adverse Event|2|||
161450954|NCT01325337|583048085|FG002|Overall Study|Adverse Event|2|||
161902307|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161902308|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161902309|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161902310|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161902311|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161902312|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161450955|NCT01325337|583048086|FG003|Overall Study|Adverse Event|1|||
161450956|NCT01325337|583048087|FG004|Overall Study|Adverse Event|2|||
161450957|NCT01325337|583048083|FG000|Overall Study|Lost to Follow-up|2|||
161450958|NCT01325337|583048084|FG001|Overall Study|Lost to Follow-up|2|||
161902313|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161902314|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161902315|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161902316|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
161902317|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161902318|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161902319|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161902320|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161902321|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161902322|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Other|5|||
161902323|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Other|2|||
161902324|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Other|1|||
161902325|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
161902326|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
161902327|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Death|561|||
161902328|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Death|298|||
161902329|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
161902330|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
161902331|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
161902332|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
161902333|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Other|1|||
161902334|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Other|0|||
161902335|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Death|14|||
161902336|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Death|21|||
161902337|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
161902338|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
161902339|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Other|15|||
161902340|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Other|2|||
161902341|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
161902342|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
161902343|NCT02595502|584690535|FG000|Period 1|Adverse Event|0|||
161902344|NCT02595502|584690536|FG001|Period 1|Adverse Event|1|||
161902345|NCT02595502|584690535|FG000|Period 1|Withdrawal by Subject|1|||
161902346|NCT02595502|584690536|FG001|Period 1|Withdrawal by Subject|0|||
161902347|NCT02595502|584690535|FG000|Period 1|Lost to Follow-up|0|||
161902348|NCT02595502|584690536|FG001|Period 1|Lost to Follow-up|1|||
161902349|NCT02595502|584690535|FG000|Period 2|Adverse Event|1|||
161902350|NCT02595502|584690536|FG001|Period 2|Adverse Event|1|||
161902351|NCT02595502|584690535|FG000|Period 2|Received incorrect lens at Period 1|0|||
161902352|NCT02595502|584690536|FG001|Period 2|Received incorrect lens at Period 1|1|||
161902353|NCT02595502|584690535|FG000|Period 3|Protocol Violation|0|||
161902354|NCT02595502|584690536|FG001|Period 3|Protocol Violation|1|||
161902355|NCT02595502|584690535|FG000|Period 3|Lost to Follow-up|1|||
161902356|NCT02595502|584690536|FG001|Period 3|Lost to Follow-up|0|||
161902357|NCT02595502|584690535|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
161902358|NCT02595502|584690536|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
161902359|NCT03286218|584690537|FG000|Qualification Phase Period 1|Adverse Event|1|||
161902360|NCT03286218|584690538|FG001|Qualification Phase Period 1|Adverse Event|0|||
161902361|NCT03286218|584690539|FG002|Qualification Phase Period 1|Adverse Event|0|||
161902362|NCT03286218|584690540|FG003|Qualification Phase Period 1|Adverse Event|0|||
161902363|NCT03286218|584690541|FG004|Qualification Phase Period 1|Adverse Event|0|||
161902364|NCT03286218|584690542|FG005|Qualification Phase Period 1|Adverse Event|0|||
161798487|NCT01325207|584304498|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798488|NCT01325207|584304499|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
161798489|NCT01325207|584304494|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798490|NCT01325207|584304495|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798491|NCT01325207|584304496|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798492|NCT01325207|584304497|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798493|NCT01325207|584304498|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
161798494|NCT01325207|584304499|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798495|NCT00708422|584304500|FG000|Overall Study|Adverse Event|3|||
161798496|NCT00708422|584304501|FG001|Overall Study|Adverse Event|1|||
161902365|NCT03286218|584690543|FG006|Qualification Phase Period 1|Adverse Event|0|||
161902366|NCT03286218|584690544|FG007|Qualification Phase Period 1|Adverse Event|0|||
161902367|NCT03286218|584690545|FG008|Qualification Phase Period 1|Adverse Event|0|||
161902368|NCT03286218|584690546|FG009|Qualification Phase Period 1|Adverse Event|0|||
161902369|NCT03286218|584690547|FG010|Qualification Phase Period 1|Adverse Event|0|||
161902370|NCT03286218|584690548|FG011|Qualification Phase Period 1|Adverse Event|0|||
161902371|NCT03286218|584690537|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902372|NCT03286218|584690538|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
161902373|NCT03286218|584690539|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902374|NCT03286218|584690540|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902375|NCT03286218|584690541|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902376|NCT03286218|584690542|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902377|NCT03286218|584690543|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902378|NCT03286218|584690544|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902379|NCT03286218|584690545|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902380|NCT03286218|584690546|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902381|NCT03286218|584690547|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902382|NCT03286218|584690548|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902383|NCT03286218|584690537|FG000|Qualification Phase Period 2|Adverse Event|0|||
161902384|NCT03286218|584690538|FG001|Qualification Phase Period 2|Adverse Event|1|||
161902385|NCT03286218|584690539|FG002|Qualification Phase Period 2|Adverse Event|0|||
161902386|NCT03286218|584690540|FG003|Qualification Phase Period 2|Adverse Event|0|||
161902387|NCT03286218|584690541|FG004|Qualification Phase Period 2|Adverse Event|0|||
161902388|NCT03286218|584690542|FG005|Qualification Phase Period 2|Adverse Event|0|||
161902389|NCT03286218|584690543|FG006|Qualification Phase Period 2|Adverse Event|0|||
161902390|NCT03286218|584690544|FG007|Qualification Phase Period 2|Adverse Event|0|||
161902391|NCT03286218|584690545|FG008|Qualification Phase Period 2|Adverse Event|0|||
161902392|NCT03286218|584690546|FG009|Qualification Phase Period 2|Adverse Event|0|||
161902393|NCT03286218|584690547|FG010|Qualification Phase Period 2|Adverse Event|0|||
161902394|NCT03286218|584690548|FG011|Qualification Phase Period 2|Adverse Event|0|||
161902395|NCT03286218|584690537|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
161902396|NCT03286218|584690538|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
161556150|NCT02408549|583425414|FG000|Overall Study|Study terminated at site|1|||
161556151|NCT00231894|583425415|FG000|Overall Study|Withdrawal by Subject|1|||
161556152|NCT00231894|583425416|FG001|Overall Study|Withdrawal by Subject|1|||
161556153|NCT02025205|583425417|FG000|Overall Study|Withdrawal by Subject|1|||
161556154|NCT02025205|583425418|FG001|Overall Study|Withdrawal by Subject|1|||
161556155|NCT02025205|583425417|FG000|Overall Study|Protocol Violation|2|||
161556156|NCT02025205|583425418|FG001|Overall Study|Protocol Violation|1|||
161556157|NCT02025205|583425417|FG000|Overall Study|Death|0|||
161556158|NCT02025205|583425418|FG001|Overall Study|Death|1|||
161556159|NCT01232556|583425421|FG000|Overall Study|Withdrawal by Subject|21|||
161556160|NCT01232556|583425422|FG001|Overall Study|Withdrawal by Subject|17|||
161556161|NCT01232556|583425421|FG000|Overall Study|Death|97|||
161902397|NCT03286218|584690539|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902398|NCT03286218|584690540|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902399|NCT03286218|584690541|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902400|NCT03286218|584690542|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161556162|NCT01232556|583425422|FG001|Overall Study|Death|97|||
161556163|NCT01232556|583425421|FG000|Overall Study|Lost to Follow-up|0|||
161556164|NCT01232556|583425422|FG001|Overall Study|Lost to Follow-up|2|||
161798497|NCT00708422|584304500|FG000|Overall Study|Withdrawal by Subject|1|||
161798498|NCT00708422|584304501|FG001|Overall Study|Withdrawal by Subject|0|||
161798499|NCT01254409|584304502|FG000|Overall Study|Adverse Event|0|||
161798500|NCT01254409|584304503|FG001|Overall Study|Adverse Event|1|||
161798501|NCT01254409|584304504|FG002|Overall Study|Adverse Event|0|||
161798502|NCT01254409|584304505|FG003|Overall Study|Adverse Event|0|||
161798503|NCT00337571|584304512|FG000|Overall Study|Lack of Efficacy|3|||
161798504|NCT00337571|584304513|FG001|Overall Study|Lack of Efficacy|0|||
161798505|NCT00337571|584304514|FG002|Overall Study|Lack of Efficacy|0|||
161798506|NCT00337571|584304515|FG003|Overall Study|Lack of Efficacy|0|||
161798507|NCT00337571|584304512|FG000|Overall Study|Adverse Event|4|||
161798508|NCT00337571|584304513|FG001|Overall Study|Adverse Event|5|||
161798509|NCT00337571|584304514|FG002|Overall Study|Adverse Event|8|||
161798510|NCT00337571|584304515|FG003|Overall Study|Adverse Event|4|||
161798511|NCT00337571|584304512|FG000|Overall Study|Withdrawal by Subject|2|||
161798512|NCT00337571|584304513|FG001|Overall Study|Withdrawal by Subject|2|||
161798513|NCT00337571|584304514|FG002|Overall Study|Withdrawal by Subject|1|||
161798514|NCT00337571|584304515|FG003|Overall Study|Withdrawal by Subject|0|||
161798515|NCT00337571|584304512|FG000|Overall Study|Lost to Follow-up|3|||
161556165|NCT01232556|583425421|FG000|Overall Study|Terminated by Sponsor|35|||
161798516|NCT00337571|584304513|FG001|Overall Study|Lost to Follow-up|1|||
161798517|NCT00337571|584304514|FG002|Overall Study|Lost to Follow-up|0|||
161798518|NCT00337571|584304515|FG003|Overall Study|Lost to Follow-up|1|||
161798519|NCT00337571|584304512|FG000|Overall Study|Poor/noncompliance|1|||
161556166|NCT01232556|583425422|FG001|Overall Study|Terminated by Sponsor|51|||
161556167|NCT01232556|583425421|FG000|Overall Study|Other|6|||
161556168|NCT01232556|583425422|FG001|Overall Study|Other|4|||
161556169|NCT04707391|583425423|FG000|Overall Study|Adverse Event|5|||
161902401|NCT03286218|584690543|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902402|NCT03286218|584690544|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902403|NCT03286218|584690545|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902404|NCT03286218|584690546|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902405|NCT03286218|584690547|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902406|NCT03286218|584690548|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902407|NCT03286218|584690537|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
161556170|NCT04707391|583425424|FG001|Overall Study|Adverse Event|8|||
161902408|NCT03286218|584690538|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
161902409|NCT03286218|584690539|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
161902410|NCT03286218|584690540|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
161902411|NCT03286218|584690541|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
161902412|NCT03286218|584690542|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
161902413|NCT03286218|584690543|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
161902414|NCT03286218|584690544|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
161902415|NCT03286218|584690545|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
161902416|NCT03286218|584690546|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
161902417|NCT03286218|584690547|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
161902418|NCT03286218|584690548|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
161902419|NCT03286218|584690537|FG000|Qualification Phase Period 2|Protocol Violation|2|||
161902420|NCT03286218|584690538|FG001|Qualification Phase Period 2|Protocol Violation|0|||
161902421|NCT03286218|584690539|FG002|Qualification Phase Period 2|Protocol Violation|0|||
161902422|NCT03286218|584690540|FG003|Qualification Phase Period 2|Protocol Violation|0|||
161902423|NCT03286218|584690541|FG004|Qualification Phase Period 2|Protocol Violation|0|||
161902424|NCT03286218|584690542|FG005|Qualification Phase Period 2|Protocol Violation|0|||
161902425|NCT03286218|584690543|FG006|Qualification Phase Period 2|Protocol Violation|0|||
161902426|NCT03286218|584690544|FG007|Qualification Phase Period 2|Protocol Violation|0|||
161902427|NCT03286218|584690545|FG008|Qualification Phase Period 2|Protocol Violation|0|||
161902428|NCT03286218|584690546|FG009|Qualification Phase Period 2|Protocol Violation|0|||
161902429|NCT03286218|584690547|FG010|Qualification Phase Period 2|Protocol Violation|0|||
161902430|NCT03286218|584690548|FG011|Qualification Phase Period 2|Protocol Violation|0|||
161902431|NCT03286218|584690537|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
161902432|NCT03286218|584690538|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
161902433|NCT03286218|584690539|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902434|NCT03286218|584690540|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902435|NCT03286218|584690541|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902436|NCT03286218|584690542|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902437|NCT03286218|584690543|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902438|NCT03286218|584690544|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902439|NCT03286218|584690545|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902440|NCT03286218|584690546|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902441|NCT03286218|584690547|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902442|NCT03286218|584690548|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902443|NCT03286218|584690537|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902444|NCT03286218|584690538|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902445|NCT03286218|584690539|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902446|NCT03286218|584690540|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902447|NCT03286218|584690541|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902448|NCT03286218|584690542|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902449|NCT03286218|584690543|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
161556171|NCT04707391|583425423|FG000|Overall Study|Lost to Follow-up|44|||
161556172|NCT04707391|583425424|FG001|Overall Study|Lost to Follow-up|31|||
161556173|NCT04707391|583425423|FG000|Overall Study|Protocol Violation|1|||
161556174|NCT04707391|583425424|FG001|Overall Study|Protocol Violation|5|||
161556175|NCT04707391|583425423|FG000|Overall Study|Withdrawal by Subject|27|||
161556176|NCT04707391|583425424|FG001|Overall Study|Withdrawal by Subject|25|||
161556177|NCT04707391|583425423|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
161556178|NCT04707391|583425424|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
161556179|NCT04707391|583425423|FG000|Overall Study|Other|0|||
161556180|NCT04707391|583425424|FG001|Overall Study|Other|2|||
161556181|NCT03785340|583425425|FG000|Overall Study|Lost to Follow-up|2|||
161902450|NCT03286218|584690544|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902451|NCT03286218|584690545|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902452|NCT03286218|584690546|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
161556182|NCT03785340|583425426|FG001|Overall Study|Lost to Follow-up|0|||
161556183|NCT03785340|583425425|FG000|Overall Study|Adverse Event|1|||
161556184|NCT03785340|583425426|FG001|Overall Study|Adverse Event|0|||
161556185|NCT01848834|583425427|FG000|Overall Study|Adverse Event|3|||
161556186|NCT01848834|583425428|FG001|Overall Study|Adverse Event|11|||
161902453|NCT03286218|584690547|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902454|NCT03286218|584690548|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902455|NCT03286218|584690537|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902456|NCT03286218|584690538|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902457|NCT03286218|584690539|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902458|NCT03286218|584690540|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902459|NCT03286218|584690541|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902460|NCT03286218|584690542|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902461|NCT03286218|584690543|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902462|NCT03286218|584690544|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902463|NCT03286218|584690545|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902464|NCT03286218|584690546|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902465|NCT03286218|584690547|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902466|NCT03286218|584690548|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
161902467|NCT03131167|584690551|FG000|Overall Study|Other (Unspecified)|0|||
161902468|NCT03131167|584690552|FG001|Overall Study|Other (Unspecified)|0|||
161902469|NCT03131167|584690553|FG002|Overall Study|Other (Unspecified)|0|||
161902470|NCT03131167|584690554|FG003|Overall Study|Other (Unspecified)|0|||
161902471|NCT03131167|584690555|FG004|Overall Study|Other (Unspecified)|0|||
161902472|NCT03131167|584690556|FG005|Overall Study|Other (Unspecified)|1|||
161902473|NCT03131167|584690557|FG006|Overall Study|Other (Unspecified)|0|||
161902474|NCT03131167|584690558|FG007|Overall Study|Other (Unspecified)|0|||
161902475|NCT03131167|584690559|FG008|Overall Study|Other (Unspecified)|0|||
161902476|NCT03131167|584690560|FG009|Overall Study|Other (Unspecified)|0|||
161902477|NCT03131167|584690561|FG010|Overall Study|Other (Unspecified)|0|||
161902478|NCT03131167|584690562|FG011|Overall Study|Other (Unspecified)|0|||
161902479|NCT03131167|584690563|FG012|Overall Study|Other (Unspecified)|0|||
161902480|NCT00458003|584690564|FG000|Overall Study|Non protocol spinal anesthesia|1|||
161902481|NCT00458003|584690565|FG001|Overall Study|Non protocol spinal anesthesia|1|||
161902482|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Death|20|||
161902483|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Death|26|||
161902484|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
161902485|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
161902486|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
161902487|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
161902488|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
161902489|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
161902490|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
161902491|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
161902492|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
161902493|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
161902494|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
161902495|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
161902496|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
161902497|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
161902498|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Other|107|||
161902499|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Other|107|||
161902500|NCT00643201|584690568|FG000|Completed Study Follow Up|Death|28|||
161902501|NCT00643201|584690569|FG001|Completed Study Follow Up|Death|34|||
161902502|NCT00643201|584690568|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
161902503|NCT00643201|584690569|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
161902504|NCT00643201|584690568|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
161902505|NCT00643201|584690569|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
161902506|NCT00643201|584690568|FG000|Completed Study Follow Up|non-specified|1|||
161902507|NCT00643201|584690569|FG001|Completed Study Follow Up|non-specified|0|||
161902508|NCT00165503|584690570|FG000|Overall Study|Death|1|||
161902509|NCT00165503|584690570|FG000|Overall Study|Lost to Follow-up|12|||
161902510|NCT00165503|584690570|FG000|Overall Study|Unresectable|3|||
161902511|NCT02346708|584690571|FG000|Overall Study|Adverse Event|2|||
161902512|NCT02346708|584690572|FG001|Overall Study|Adverse Event|0|||
161902513|NCT02346708|584690571|FG000|Overall Study|Protocol Violation|0|||
161902514|NCT02346708|584690572|FG001|Overall Study|Protocol Violation|1|||
161902515|NCT01781962|584690575|FG000|Overall Study|Other Miscellaneous Reasons|5|||
161902516|NCT00473655|584690582|FG000|Overall Study|Lost to Follow-up|9|||
161902517|NCT00473655|584690583|FG001|Overall Study|Lost to Follow-up|5|||
161902518|NCT00473655|584690584|FG002|Overall Study|Lost to Follow-up|8|||
161902519|NCT04556760|584690585|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902520|NCT04556760|584690586|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
161902521|NCT04556760|584690587|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902522|NCT04556760|584690588|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902523|NCT04556760|584690589|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902524|NCT04556760|584690590|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902525|NCT04556760|584690585|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902526|NCT04556760|584690586|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902527|NCT04556760|584690587|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902528|NCT04556760|584690588|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
161902529|NCT04556760|584690589|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902530|NCT04556760|584690590|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902531|NCT02513550|584690591|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
161902532|NCT02513550|584690592|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
161902533|NCT02513550|584690593|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
161902534|NCT02513550|584690594|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
161902535|NCT02513550|584690595|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161902536|NCT02513550|584690596|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
161902537|NCT02513550|584690591|FG000|Double Blind Treatment Period|Adverse Event|5|||
161902538|NCT02513550|584690592|FG001|Double Blind Treatment Period|Adverse Event|13|||
161902539|NCT02513550|584690593|FG002|Double Blind Treatment Period|Adverse Event|17|||
161902540|NCT02513550|584690594|FG003|Double Blind Treatment Period|Adverse Event|0|||
161902541|NCT02513550|584690595|FG004|Double Blind Treatment Period|Adverse Event|1|||
161902542|NCT02513550|584690596|FG005|Double Blind Treatment Period|Adverse Event|0|||
161902543|NCT02513550|584690591|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
161902544|NCT02513550|584690592|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
161902545|NCT02513550|584690593|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
161902546|NCT02513550|584690594|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
161902547|NCT02513550|584690595|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
161902548|NCT02513550|584690596|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
161902549|NCT02513550|584690591|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
161902550|NCT02513550|584690592|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
161902551|NCT02513550|584690593|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
161902552|NCT02513550|584690594|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
161902553|NCT02513550|584690595|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161902554|NCT02513550|584690596|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
161902555|NCT02513550|584690591|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161902556|NCT02513550|584690592|FG001|Double Blind Treatment Period|Protocol Violation|1|||
161902557|NCT02513550|584690593|FG002|Double Blind Treatment Period|Protocol Violation|4|||
161902558|NCT02513550|584690594|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161902559|NCT02513550|584690595|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161902560|NCT02513550|584690596|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161902561|NCT02513550|584690591|FG000|Double Blind Treatment Period|Physician Decision|2|||
161902562|NCT02513550|584690592|FG001|Double Blind Treatment Period|Physician Decision|0|||
161902563|NCT02513550|584690593|FG002|Double Blind Treatment Period|Physician Decision|4|||
161902564|NCT02513550|584690594|FG003|Double Blind Treatment Period|Physician Decision|0|||
161902565|NCT02513550|584690595|FG004|Double Blind Treatment Period|Physician Decision|0|||
161902566|NCT02513550|584690596|FG005|Double Blind Treatment Period|Physician Decision|0|||
161902567|NCT02513550|584690591|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
161902568|NCT02513550|584690592|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
161902569|NCT02513550|584690593|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
161902570|NCT02513550|584690594|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
161902571|NCT02513550|584690595|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
161902572|NCT02513550|584690596|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
161902573|NCT02513550|584690591|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902574|NCT02513550|584690592|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902575|NCT02513550|584690593|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
161902576|NCT02513550|584690594|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902577|NCT02513550|584690595|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902578|NCT02513550|584690596|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902579|NCT02513550|584690591|FG000|Double Blind Treatment Period|Due to personal business|2|||
161902580|NCT02513550|584690592|FG001|Double Blind Treatment Period|Due to personal business|0|||
161902581|NCT02513550|584690593|FG002|Double Blind Treatment Period|Due to personal business|1|||
161902582|NCT02513550|584690594|FG003|Double Blind Treatment Period|Due to personal business|0|||
161902583|NCT02513550|584690595|FG004|Double Blind Treatment Period|Due to personal business|0|||
161902584|NCT02513550|584690596|FG005|Double Blind Treatment Period|Due to personal business|0|||
161902585|NCT02513550|584690591|FG000|Double Blind Treatment Period|Death|1|||
161902586|NCT02513550|584690592|FG001|Double Blind Treatment Period|Death|0|||
161902587|NCT02513550|584690593|FG002|Double Blind Treatment Period|Death|2|||
161902588|NCT02513550|584690594|FG003|Double Blind Treatment Period|Death|0|||
161902589|NCT02513550|584690595|FG004|Double Blind Treatment Period|Death|0|||
161902590|NCT02513550|584690596|FG005|Double Blind Treatment Period|Death|0|||
161902591|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
161902592|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
161902593|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
161902594|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161902595|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161902596|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161902597|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
161902598|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
161902599|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
161902600|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161902601|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161902602|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161902603|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
161902604|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
161902605|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
161902606|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161902607|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161902608|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161902609|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
161902610|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
161902611|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
161902612|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
161902613|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
161902614|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
161902615|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
161902616|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
161902617|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
161902618|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
161902619|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
161902620|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
161902621|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Death|0|||
161902622|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Death|0|||
161902623|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Death|1|||
161902624|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Death|0|||
161902625|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Death|0|||
161902626|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Death|0|||
161902627|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902628|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902629|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
161902630|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902631|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902632|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902633|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902634|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902635|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
161902636|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902637|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902638|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902639|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902640|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902641|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
161902642|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902643|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902644|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902645|NCT02849743|584690597|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
161450959|NCT01325337|583048085|FG002|Overall Study|Lost to Follow-up|2|||
161450960|NCT01325337|583048086|FG003|Overall Study|Lost to Follow-up|1|||
161450961|NCT01325337|583048087|FG004|Overall Study|Lost to Follow-up|2|||
161450962|NCT01325337|583048083|FG000|Overall Study|Personal Reasons|2|||
161450963|NCT01325337|583048084|FG001|Overall Study|Personal Reasons|5|||
161450964|NCT01325337|583048085|FG002|Overall Study|Personal Reasons|4|||
161450965|NCT01325337|583048086|FG003|Overall Study|Personal Reasons|8|||
161450966|NCT01325337|583048087|FG004|Overall Study|Personal Reasons|3|||
161556187|NCT01848834|583425429|FG002|Overall Study|Adverse Event|3|||
161556188|NCT01848834|583425430|FG003|Overall Study|Adverse Event|5|||
161450967|NCT01325337|583048083|FG000|Overall Study|Withdrawal by Subject|1|||
161556189|NCT01848834|583425431|FG004|Overall Study|Adverse Event|9|||
161450968|NCT01325337|583048084|FG001|Overall Study|Withdrawal by Subject|0|||
161450969|NCT01325337|583048085|FG002|Overall Study|Withdrawal by Subject|1|||
161450970|NCT01325337|583048086|FG003|Overall Study|Withdrawal by Subject|0|||
161450971|NCT01325337|583048087|FG004|Overall Study|Withdrawal by Subject|1|||
161902646|NCT02849743|584690598|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
161902647|NCT02849743|584690597|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161902648|NCT02849743|584690598|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161902649|NCT02168491|584690601|FG000|Overall Study|Withdrawal by Subject|1|||
161902650|NCT00809445|584690602|FG000|1 Month Follow-up|Lost contact|1|||
161902651|NCT00809445|584690603|FG001|1 Month Follow-up|Lost contact|2|||
161902652|NCT00809445|584690604|FG002|1 Month Follow-up|Lost contact|1|||
161902653|NCT00809445|584690602|FG000|1 Month Follow-up|Withdrew consent|1|||
161902654|NCT00809445|584690603|FG001|1 Month Follow-up|Withdrew consent|1|||
161902655|NCT00809445|584690604|FG002|1 Month Follow-up|Withdrew consent|1|||
161902656|NCT00809445|584690602|FG000|1 Month Follow-up|Death|0|||
161902657|NCT00809445|584690603|FG001|1 Month Follow-up|Death|1|||
161902658|NCT00809445|584690604|FG002|1 Month Follow-up|Death|1|||
161902659|NCT00809445|584690602|FG000|1 Month Follow-up|Incarcerated|0|||
161902660|NCT00809445|584690603|FG001|1 Month Follow-up|Incarcerated|0|||
161902661|NCT00809445|584690604|FG002|1 Month Follow-up|Incarcerated|1|||
161902662|NCT00809445|584690602|FG000|6 Month Follow-up|Lost contact|16|||
161902663|NCT00809445|584690603|FG001|6 Month Follow-up|Lost contact|14|||
161902664|NCT00809445|584690604|FG002|6 Month Follow-up|Lost contact|14|||
161902665|NCT00809445|584690602|FG000|6 Month Follow-up|Death|2|||
161902666|NCT00809445|584690603|FG001|6 Month Follow-up|Death|1|||
161902667|NCT00809445|584690604|FG002|6 Month Follow-up|Death|1|||
161902668|NCT00809445|584690602|FG000|6 Month Follow-up|Incarcerated|6|||
161902669|NCT00809445|584690603|FG001|6 Month Follow-up|Incarcerated|8|||
161902670|NCT00809445|584690604|FG002|6 Month Follow-up|Incarcerated|8|||
161902671|NCT00809445|584690602|FG000|6 Month Follow-up|Withdrew consent|0|||
161902672|NCT00809445|584690603|FG001|6 Month Follow-up|Withdrew consent|0|||
161902673|NCT00809445|584690604|FG002|6 Month Follow-up|Withdrew consent|1|||
161902674|NCT04919317|584690605|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
161902675|NCT04919317|584690606|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
161902676|NCT04919317|584690605|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
161902677|NCT04919317|584690606|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
161902678|NCT01566604|584690607|FG000|Overall Study|Patient's inability to use the device|1|||
161902679|NCT01566604|584690608|FG001|Overall Study|Patient's inability to use the device|0|||
161902680|NCT01566604|584690607|FG000|Overall Study|Administrative problems|1|||
161902681|NCT01566604|584690608|FG001|Overall Study|Administrative problems|0|||
161902682|NCT01566604|584690607|FG000|Overall Study|Lack of Efficacy|1|||
161902683|NCT01566604|584690608|FG001|Overall Study|Lack of Efficacy|2|||
161902684|NCT01566604|584690607|FG000|Overall Study|Protocol deviation|2|||
161902685|NCT01566604|584690608|FG001|Overall Study|Protocol deviation|0|||
161902686|NCT01566604|584690607|FG000|Overall Study|Abnormal laboratory value|2|||
161902687|NCT01566604|584690608|FG001|Overall Study|Abnormal laboratory value|0|||
161902688|NCT01566604|584690607|FG000|Overall Study|Death|4|||
161902689|NCT01566604|584690608|FG001|Overall Study|Death|1|||
161902690|NCT01566604|584690607|FG000|Overall Study|Adverse Event|4|||
161902691|NCT01566604|584690608|FG001|Overall Study|Adverse Event|2|||
161902692|NCT01566604|584690607|FG000|Overall Study|Withdrawal by Subject|9|||
161902693|NCT01566604|584690608|FG001|Overall Study|Withdrawal by Subject|6|||
161902694|NCT00661089|584690613|FG000|Overall Study|1 subject withdrawal|0|||
161902695|NCT00661089|584690614|FG001|Overall Study|1 subject withdrawal|1|||
161902696|NCT00661089|584690613|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
161902697|NCT00661089|584690614|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
161902698|NCT00321906|584690620|FG000|Overall Study|Adverse Event|36|||
161902699|NCT00321906|584690621|FG001|Overall Study|Adverse Event|44|||
161902700|NCT00321906|584690620|FG000|Overall Study|Death|9|||
161902701|NCT00321906|584690621|FG001|Overall Study|Death|6|||
161902702|NCT00321906|584690620|FG000|Overall Study|Lost to Follow-up|1|||
161902703|NCT00321906|584690621|FG001|Overall Study|Lost to Follow-up|2|||
161902704|NCT00321906|584690620|FG000|Overall Study|Withdrawal by Subject|0|||
161902705|NCT00321906|584690621|FG001|Overall Study|Withdrawal by Subject|4|||
161902706|NCT00810069|584690622|FG000|Lead-in Period I|Adverse Event|43|||
161902707|NCT00810069|584690623|FG001|Lead-in Period I|Adverse Event|0|||
161902708|NCT00810069|584690624|FG002|Lead-in Period I|Adverse Event|0|||
161902709|NCT00810069|584690622|FG000|Lead-in Period I|Lack of Efficacy|1|||
161902710|NCT00810069|584690623|FG001|Lead-in Period I|Lack of Efficacy|0|||
161902711|NCT00810069|584690624|FG002|Lead-in Period I|Lack of Efficacy|0|||
161902712|NCT00810069|584690622|FG000|Lead-in Period I|Lost to Follow-up|19|||
161902713|NCT00810069|584690623|FG001|Lead-in Period I|Lost to Follow-up|0|||
161902714|NCT00810069|584690624|FG002|Lead-in Period I|Lost to Follow-up|0|||
161902715|NCT00810069|584690622|FG000|Lead-in Period I|Physician Decision|1|||
161902716|NCT00810069|584690623|FG001|Lead-in Period I|Physician Decision|0|||
161902717|NCT00810069|584690624|FG002|Lead-in Period I|Physician Decision|0|||
161902718|NCT00810069|584690622|FG000|Lead-in Period I|Protocol Violation|1|||
161902719|NCT00810069|584690623|FG001|Lead-in Period I|Protocol Violation|0|||
161902720|NCT00810069|584690624|FG002|Lead-in Period I|Protocol Violation|0|||
161902721|NCT00810069|584690622|FG000|Lead-in Period I|Withdrawal by Subject|46|||
161902722|NCT00810069|584690623|FG001|Lead-in Period I|Withdrawal by Subject|0|||
161902723|NCT00810069|584690624|FG002|Lead-in Period I|Withdrawal by Subject|0|||
161902724|NCT00810069|584690622|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
161902725|NCT00810069|584690623|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
161902726|NCT00810069|584690624|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
161556190|NCT01848834|583425427|FG000|Overall Study|Death|2|||
161556191|NCT01848834|583425428|FG001|Overall Study|Death|11|||
161556192|NCT01848834|583425429|FG002|Overall Study|Death|1|||
161556193|NCT01848834|583425430|FG003|Overall Study|Death|8|||
161556194|NCT01848834|583425431|FG004|Overall Study|Death|27|||
161556195|NCT01848834|583425427|FG000|Overall Study|Excluded Medication|5|||
161556196|NCT01848834|583425428|FG001|Overall Study|Excluded Medication|4|||
161556197|NCT01848834|583425429|FG002|Overall Study|Excluded Medication|3|||
161556198|NCT01848834|583425430|FG003|Overall Study|Excluded Medication|6|||
161556199|NCT01848834|583425431|FG004|Overall Study|Excluded Medication|6|||
161556200|NCT01848834|583425427|FG000|Overall Study|Lost to Follow-up|5|||
161556201|NCT01848834|583425428|FG001|Overall Study|Lost to Follow-up|5|||
161556202|NCT01848834|583425429|FG002|Overall Study|Lost to Follow-up|3|||
161556203|NCT01848834|583425430|FG003|Overall Study|Lost to Follow-up|0|||
161556204|NCT01848834|583425431|FG004|Overall Study|Lost to Follow-up|3|||
161556205|NCT01848834|583425427|FG000|Overall Study|Physician Decision|1|||
161556206|NCT01848834|583425428|FG001|Overall Study|Physician Decision|3|||
161556207|NCT01848834|583425429|FG002|Overall Study|Physician Decision|4|||
161556208|NCT01848834|583425430|FG003|Overall Study|Physician Decision|0|||
161556209|NCT01848834|583425431|FG004|Overall Study|Physician Decision|11|||
161556210|NCT01848834|583425427|FG000|Overall Study|Protocol Violation|0|||
161556211|NCT01848834|583425428|FG001|Overall Study|Protocol Violation|0|||
161556212|NCT01848834|583425429|FG002|Overall Study|Protocol Violation|0|||
161556213|NCT01848834|583425430|FG003|Overall Study|Protocol Violation|0|||
161556214|NCT01848834|583425431|FG004|Overall Study|Protocol Violation|1|||
161556215|NCT01848834|583425427|FG000|Overall Study|Sponsor Decision|1|||
161556216|NCT01848834|583425428|FG001|Overall Study|Sponsor Decision|1|||
161556217|NCT01848834|583425429|FG002|Overall Study|Sponsor Decision|0|||
161556218|NCT01848834|583425430|FG003|Overall Study|Sponsor Decision|1|||
161556219|NCT01848834|583425431|FG004|Overall Study|Sponsor Decision|1|||
161556220|NCT01848834|583425427|FG000|Overall Study|Withdrawal by Subject|2|||
161556221|NCT01848834|583425428|FG001|Overall Study|Withdrawal by Subject|13|||
161556222|NCT01848834|583425429|FG002|Overall Study|Withdrawal by Subject|10|||
161556223|NCT01848834|583425430|FG003|Overall Study|Withdrawal by Subject|6|||
161556224|NCT01848834|583425431|FG004|Overall Study|Withdrawal by Subject|36|||
161556225|NCT02584855|583425436|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
161556226|NCT02584855|583425437|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161556227|NCT02584855|583425438|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161556228|NCT02584855|583425439|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
161556229|NCT02584855|583425440|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
161556230|NCT02584855|583425441|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
161556231|NCT02584855|583425436|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
161556232|NCT02584855|583425437|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
161556233|NCT02584855|583425438|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
161556234|NCT02584855|583425439|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
161556235|NCT02584855|583425440|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
161556236|NCT02584855|583425441|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
161556237|NCT02584855|583425436|FG000|Open-Label Treatment Period|Adverse Event|14|||
161556238|NCT02584855|583425437|FG001|Open-Label Treatment Period|Adverse Event|0|||
161556239|NCT02584855|583425438|FG002|Open-Label Treatment Period|Adverse Event|0|||
161556240|NCT02584855|583425439|FG003|Open-Label Treatment Period|Adverse Event|0|||
161902727|NCT00810069|584690622|FG000|Lead-in Period I|Randomization criteria not met|158|||
161902728|NCT00810069|584690623|FG001|Lead-in Period I|Randomization criteria not met|0|||
161556241|NCT02584855|583425440|FG004|Open-Label Treatment Period|Adverse Event|0|||
161556242|NCT02584855|583425441|FG005|Open-Label Treatment Period|Adverse Event|0|||
161556243|NCT02584855|583425436|FG000|Open-Label Treatment Period|Death|2|||
161556244|NCT02584855|583425437|FG001|Open-Label Treatment Period|Death|0|||
161556245|NCT02584855|583425438|FG002|Open-Label Treatment Period|Death|0|||
161556246|NCT02584855|583425439|FG003|Open-Label Treatment Period|Death|0|||
161556247|NCT02584855|583425440|FG004|Open-Label Treatment Period|Death|0|||
161556248|NCT02584855|583425441|FG005|Open-Label Treatment Period|Death|0|||
161556249|NCT02584855|583425436|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
161556250|NCT02584855|583425437|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
161556251|NCT02584855|583425438|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
161556252|NCT02584855|583425439|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
161556253|NCT02584855|583425440|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
161556254|NCT02584855|583425441|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
161556255|NCT02584855|583425436|FG000|Open-Label Treatment Period|Protocol Violation|1|||
161556256|NCT02584855|583425437|FG001|Open-Label Treatment Period|Protocol Violation|0|||
161556257|NCT02584855|583425438|FG002|Open-Label Treatment Period|Protocol Violation|0|||
161556258|NCT02584855|583425439|FG003|Open-Label Treatment Period|Protocol Violation|0|||
161556259|NCT02584855|583425440|FG004|Open-Label Treatment Period|Protocol Violation|0|||
161556260|NCT02584855|583425441|FG005|Open-Label Treatment Period|Protocol Violation|0|||
161556261|NCT02584855|583425436|FG000|Open-Label Treatment Period|No PI Available|2|||
161556262|NCT02584855|583425437|FG001|Open-Label Treatment Period|No PI Available|0|||
161798520|NCT00337571|584304513|FG001|Overall Study|Poor/noncompliance|1|||
161798521|NCT00337571|584304514|FG002|Overall Study|Poor/noncompliance|1|||
161798522|NCT00337571|584304515|FG003|Overall Study|Poor/noncompliance|1|||
161798523|NCT00337571|584304512|FG000|Overall Study|No longer met study criteria|1|||
161798524|NCT00337571|584304513|FG001|Overall Study|No longer met study criteria|0|||
161798525|NCT00337571|584304514|FG002|Overall Study|No longer met study criteria|0|||
161798526|NCT00337571|584304515|FG003|Overall Study|No longer met study criteria|0|||
161798527|NCT00337571|584304512|FG000|Overall Study|High Potassium level|0|||
161798528|NCT00337571|584304513|FG001|Overall Study|High Potassium level|0|||
161798529|NCT00337571|584304514|FG002|Overall Study|High Potassium level|0|||
161798530|NCT00337571|584304515|FG003|Overall Study|High Potassium level|1|||
161798531|NCT01890915|584304517|FG000|Overall Study|Adverse Event|1|||
161798532|NCT01890915|584304518|FG001|Overall Study|Adverse Event|0|||
161798533|NCT01890915|584304517|FG000|Overall Study|Protocol Violation|2|||
161798534|NCT01890915|584304518|FG001|Overall Study|Protocol Violation|0|||
161798535|NCT01890915|584304517|FG000|Overall Study|Equipment Malfunction|0|||
161798536|NCT01890915|584304518|FG001|Overall Study|Equipment Malfunction|1|||
161798537|NCT01974895|584304519|FG000|Overall Study|Protocol Violation|1|||
161798538|NCT01974895|584304520|FG001|Overall Study|Protocol Violation|0|||
161798539|NCT01974895|584304519|FG000|Overall Study|Lost to Follow-up|4|||
161798540|NCT01974895|584304520|FG001|Overall Study|Lost to Follow-up|6|||
161798541|NCT01974895|584304519|FG000|Overall Study|Withdrawal by Subject|0|||
161798542|NCT01974895|584304520|FG001|Overall Study|Withdrawal by Subject|1|||
161798543|NCT01974895|584304519|FG000|Overall Study|Other (Missed Visit)|1|||
161798544|NCT01974895|584304520|FG001|Overall Study|Other (Missed Visit)|0|||
161798545|NCT01974895|584304519|FG000|Overall Study|Other (Reason unknown)|9|||
161798546|NCT01974895|584304520|FG001|Overall Study|Other (Reason unknown)|8|||
161798547|NCT00635154|584304521|FG000|Overall Study|Alternative Treatment|8|||
161798548|NCT00635154|584304521|FG000|Overall Study|Other|4|||
161798549|NCT00635154|584304521|FG000|Overall Study|Still on treatment|21|||
161798550|NCT02660242|584304526|FG000|Glucose Tabs|Lost to Follow-up|1|||
161798551|NCT02660242|584304526|FG000|Glucagon Injection|Lost to Follow-up|1|||
161798552|NCT02796664|584304528|FG000|Overall Study|Withdrawal by Subject|0|||
161798553|NCT02796664|584304529|FG001|Overall Study|Withdrawal by Subject|3|||
161798554|NCT02796664|584304528|FG000|Overall Study|Noncompliance|1|||
161798555|NCT02796664|584304529|FG001|Overall Study|Noncompliance|1|||
161798556|NCT02796664|584304528|FG000|Overall Study|Death|0|||
161798557|NCT02796664|584304529|FG001|Overall Study|Death|1|||
161798558|NCT02246478|584304530|FG000|Multiple-dose Phase|Protocol Violation|1|||
161798559|NCT02246478|584304531|FG001|Multiple-dose Phase|Protocol Violation|0|||
161798560|NCT02246478|584304532|FG002|Multiple-dose Phase|Protocol Violation|0|||
161798561|NCT02246478|584304533|FG003|Multiple-dose Phase|Protocol Violation|1|||
161798562|NCT00536575|584304534|FG000|Overall Study|Withdrawal by Subject|1|||
161798563|NCT00536575|584304534|FG000|Overall Study|Death|1|||
161798564|NCT00198029|584304538|FG000|Overall Study|Withdrawal by Subject|4|||
161798565|NCT04634409|584304545|FG000|Overall Study|Death|0|||
161798566|NCT04634409|584304546|FG001|Overall Study|Death|0|||
161798567|NCT04634409|584304547|FG002|Overall Study|Death|0|||
161798568|NCT04634409|584304548|FG003|Overall Study|Death|0|||
161798569|NCT04634409|584304549|FG004|Overall Study|Death|0|||
161798570|NCT04634409|584304550|FG005|Overall Study|Death|0|||
161798571|NCT04634409|584304551|FG006|Overall Study|Death|0|||
161798572|NCT04634409|584304552|FG007|Overall Study|Death|0|||
161798573|NCT04634409|584304553|FG008|Overall Study|Death|0|||
161798574|NCT04634409|584304554|FG009|Overall Study|Death|0|||
161798575|NCT04634409|584304555|FG010|Overall Study|Death|1|||
161798576|NCT04634409|584304556|FG011|Overall Study|Death|0|||
161798577|NCT04634409|584304557|FG012|Overall Study|Death|1|||
161798578|NCT04634409|584304558|FG013|Overall Study|Death|0|||
161798579|NCT04634409|584304559|FG014|Overall Study|Death|0|||
161798580|NCT04634409|584304560|FG015|Overall Study|Death|0|||
161798581|NCT04634409|584304561|FG016|Overall Study|Death|0|||
161798582|NCT04634409|584304562|FG017|Overall Study|Death|0|||
161798583|NCT04634409|584304563|FG018|Overall Study|Death|0|||
161798584|NCT04634409|584304564|FG019|Overall Study|Death|0|||
161798585|NCT04634409|584304565|FG020|Overall Study|Death|0|||
161798586|NCT04634409|584304566|FG021|Overall Study|Death|0|||
161798587|NCT04634409|584304567|FG022|Overall Study|Death|0|||
161798588|NCT04634409|584304568|FG023|Overall Study|Death|0|||
161798589|NCT04634409|584304569|FG024|Overall Study|Death|0|||
161798590|NCT04634409|584304570|FG025|Overall Study|Death|0|||
161798591|NCT04634409|584304571|FG026|Overall Study|Death|0|||
161798592|NCT04634409|584304545|FG000|Overall Study|Adverse Event|0|||
161798593|NCT04634409|584304546|FG001|Overall Study|Adverse Event|0|||
161798594|NCT04634409|584304547|FG002|Overall Study|Adverse Event|1|||
161798595|NCT04634409|584304548|FG003|Overall Study|Adverse Event|0|||
161798596|NCT04634409|584304549|FG004|Overall Study|Adverse Event|0|||
161798597|NCT04634409|584304550|FG005|Overall Study|Adverse Event|1|||
161798598|NCT04634409|584304551|FG006|Overall Study|Adverse Event|0|||
161798599|NCT04634409|584304552|FG007|Overall Study|Adverse Event|0|||
161798600|NCT04634409|584304553|FG008|Overall Study|Adverse Event|0|||
161798601|NCT04634409|584304554|FG009|Overall Study|Adverse Event|0|||
161798602|NCT04634409|584304555|FG010|Overall Study|Adverse Event|0|||
161798603|NCT04634409|584304556|FG011|Overall Study|Adverse Event|0|||
161798604|NCT04634409|584304557|FG012|Overall Study|Adverse Event|0|||
161798605|NCT04634409|584304558|FG013|Overall Study|Adverse Event|0|||
161798606|NCT04634409|584304559|FG014|Overall Study|Adverse Event|0|||
161798607|NCT04634409|584304560|FG015|Overall Study|Adverse Event|0|||
161798608|NCT04634409|584304561|FG016|Overall Study|Adverse Event|0|||
161798609|NCT04634409|584304562|FG017|Overall Study|Adverse Event|0|||
161798610|NCT04634409|584304563|FG018|Overall Study|Adverse Event|0|||
161798611|NCT04634409|584304564|FG019|Overall Study|Adverse Event|0|||
161798612|NCT04634409|584304565|FG020|Overall Study|Adverse Event|0|||
161798613|NCT04634409|584304566|FG021|Overall Study|Adverse Event|0|||
161798614|NCT04634409|584304567|FG022|Overall Study|Adverse Event|0|||
161798615|NCT04634409|584304568|FG023|Overall Study|Adverse Event|0|||
161798616|NCT04634409|584304569|FG024|Overall Study|Adverse Event|0|||
161798617|NCT04634409|584304570|FG025|Overall Study|Adverse Event|0|||
161798618|NCT04634409|584304571|FG026|Overall Study|Adverse Event|0|||
161798619|NCT04634409|584304545|FG000|Overall Study|Lost to Follow-up|3|||
161798620|NCT04634409|584304546|FG001|Overall Study|Lost to Follow-up|1|||
161798621|NCT04634409|584304547|FG002|Overall Study|Lost to Follow-up|1|||
161798622|NCT04634409|584304548|FG003|Overall Study|Lost to Follow-up|3|||
161798623|NCT04634409|584304549|FG004|Overall Study|Lost to Follow-up|1|||
161798624|NCT04634409|584304550|FG005|Overall Study|Lost to Follow-up|1|||
161798625|NCT04634409|584304551|FG006|Overall Study|Lost to Follow-up|1|||
161798626|NCT04634409|584304552|FG007|Overall Study|Lost to Follow-up|3|||
161798627|NCT04634409|584304553|FG008|Overall Study|Lost to Follow-up|3|||
161798628|NCT04634409|584304554|FG009|Overall Study|Lost to Follow-up|11|||
161798629|NCT04634409|584304555|FG010|Overall Study|Lost to Follow-up|8|||
161798630|NCT04634409|584304556|FG011|Overall Study|Lost to Follow-up|15|||
161798631|NCT04634409|584304557|FG012|Overall Study|Lost to Follow-up|3|||
161798632|NCT04634409|584304558|FG013|Overall Study|Lost to Follow-up|2|||
161798633|NCT04634409|584304559|FG014|Overall Study|Lost to Follow-up|7|||
161798634|NCT04634409|584304560|FG015|Overall Study|Lost to Follow-up|0|||
161798635|NCT04634409|584304561|FG016|Overall Study|Lost to Follow-up|0|||
161798636|NCT04634409|584304562|FG017|Overall Study|Lost to Follow-up|0|||
161798637|NCT04634409|584304563|FG018|Overall Study|Lost to Follow-up|0|||
161798638|NCT04634409|584304564|FG019|Overall Study|Lost to Follow-up|0|||
161798639|NCT04634409|584304565|FG020|Overall Study|Lost to Follow-up|0|||
161798640|NCT04634409|584304566|FG021|Overall Study|Lost to Follow-up|0|||
161798641|NCT04634409|584304567|FG022|Overall Study|Lost to Follow-up|0|||
161798642|NCT04634409|584304568|FG023|Overall Study|Lost to Follow-up|0|||
161798643|NCT04634409|584304569|FG024|Overall Study|Lost to Follow-up|0|||
161798644|NCT04634409|584304570|FG025|Overall Study|Lost to Follow-up|0|||
161798645|NCT04634409|584304571|FG026|Overall Study|Lost to Follow-up|0|||
161798646|NCT04634409|584304545|FG000|Overall Study|Withdrawal by Subject|3|||
161798647|NCT04634409|584304546|FG001|Overall Study|Withdrawal by Subject|1|||
161798648|NCT04634409|584304547|FG002|Overall Study|Withdrawal by Subject|6|||
161798649|NCT04634409|584304548|FG003|Overall Study|Withdrawal by Subject|4|||
161798650|NCT04634409|584304549|FG004|Overall Study|Withdrawal by Subject|2|||
161798651|NCT04634409|584304550|FG005|Overall Study|Withdrawal by Subject|0|||
161450972|NCT01604278|583048094|FG000|Overall Study|Lack of Efficacy|0|||
161798652|NCT04634409|584304551|FG006|Overall Study|Withdrawal by Subject|0|||
161798653|NCT04634409|584304552|FG007|Overall Study|Withdrawal by Subject|2|||
161798654|NCT04634409|584304553|FG008|Overall Study|Withdrawal by Subject|3|||
161450973|NCT01604278|583048095|FG001|Overall Study|Lack of Efficacy|1|||
161450974|NCT01604278|583048094|FG000|Overall Study|Lost to Follow-up|1|||
161450975|NCT01604278|583048095|FG001|Overall Study|Lost to Follow-up|0|||
161450976|NCT01604278|583048094|FG000|Overall Study|Administrative problems|2|||
161450977|NCT01604278|583048095|FG001|Overall Study|Administrative problems|1|||
161798655|NCT04634409|584304554|FG009|Overall Study|Withdrawal by Subject|2|||
161798656|NCT04634409|584304555|FG010|Overall Study|Withdrawal by Subject|3|||
161798657|NCT04634409|584304556|FG011|Overall Study|Withdrawal by Subject|2|||
161798658|NCT04634409|584304557|FG012|Overall Study|Withdrawal by Subject|2|||
161798659|NCT04634409|584304558|FG013|Overall Study|Withdrawal by Subject|1|||
161450978|NCT01604278|583048094|FG000|Overall Study|Withdrawal by Subject|3|||
161798660|NCT04634409|584304559|FG014|Overall Study|Withdrawal by Subject|5|||
161798661|NCT04634409|584304560|FG015|Overall Study|Withdrawal by Subject|0|||
161798662|NCT04634409|584304561|FG016|Overall Study|Withdrawal by Subject|0|||
161798663|NCT04634409|584304562|FG017|Overall Study|Withdrawal by Subject|1|||
161902729|NCT00810069|584690624|FG002|Lead-in Period I|Randomization criteria not met|0|||
161902730|NCT00810069|584690622|FG000|Double-Blind Period II|Adverse Event|0|||
161902731|NCT00810069|584690623|FG001|Double-Blind Period II|Adverse Event|9|||
161902732|NCT00810069|584690624|FG002|Double-Blind Period II|Adverse Event|8|||
161902733|NCT00810069|584690622|FG000|Double-Blind Period II|Lack of Efficacy|0|||
161902734|NCT00810069|584690623|FG001|Double-Blind Period II|Lack of Efficacy|7|||
161902735|NCT00810069|584690624|FG002|Double-Blind Period II|Lack of Efficacy|12|||
161902736|NCT00810069|584690622|FG000|Double-Blind Period II|Lost to Follow-up|0|||
161902737|NCT00810069|584690623|FG001|Double-Blind Period II|Lost to Follow-up|9|||
161902738|NCT00810069|584690624|FG002|Double-Blind Period II|Lost to Follow-up|9|||
161902739|NCT00810069|584690622|FG000|Double-Blind Period II|Physician Decision|0|||
161902740|NCT00810069|584690623|FG001|Double-Blind Period II|Physician Decision|0|||
161902741|NCT00810069|584690624|FG002|Double-Blind Period II|Physician Decision|1|||
161902742|NCT00810069|584690622|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
161902743|NCT00810069|584690623|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
161902744|NCT00810069|584690624|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
161902745|NCT00810069|584690622|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
161902746|NCT00810069|584690623|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
161902747|NCT00810069|584690624|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
161902748|NCT00810069|584690622|FG000|Double-Blind Period II|Clinical relapse|0|||
161902749|NCT00810069|584690623|FG001|Double-Blind Period II|Clinical relapse|3|||
161902750|NCT00810069|584690624|FG002|Double-Blind Period II|Clinical relapse|0|||
161902751|NCT00810069|584690622|FG000|Double-Blind Period II|Protocol Violation|0|||
161902752|NCT00810069|584690623|FG001|Double-Blind Period II|Protocol Violation|7|||
161902753|NCT00810069|584690624|FG002|Double-Blind Period II|Protocol Violation|6|||
161902754|NCT02899065|584690627|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
161902755|NCT02899065|584690628|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
161902756|NCT02899065|584690627|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
161902757|NCT02899065|584690628|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
161902758|NCT02899065|584690627|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
161902759|NCT02899065|584690628|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
161902760|NCT00186485|584690630|FG000|Overall Study|Lost to Follow-up|3|||
161902761|NCT01166750|584690631|FG000|Overall Study|Lost to Follow-up|1|||
161902762|NCT01166750|584690632|FG001|Overall Study|Lost to Follow-up|0|||
161902763|NCT05225389|584690633|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
161902764|NCT03113968|584690634|FG000|Overall Study|Withdrawal by Subject|31|||
161902765|NCT03113968|584690635|FG001|Overall Study|Withdrawal by Subject|4|||
161902766|NCT04805671|584690636|FG000|Overall Study|Death|2|||
161902767|NCT04805671|584690637|FG001|Overall Study|Death|7|||
161902768|NCT04805671|584690636|FG000|Overall Study|Lost to Follow-up|1|||
161902769|NCT04805671|584690637|FG001|Overall Study|Lost to Follow-up|0|||
161902770|NCT04805671|584690636|FG000|Overall Study|Withdrawal by Subject|9|||
161902771|NCT04805671|584690637|FG001|Overall Study|Withdrawal by Subject|7|||
161902772|NCT04805671|584690636|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
161902773|NCT04805671|584690637|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
161902774|NCT00901342|584690638|FG000|Overall Study|Adverse Event|1|||
161902775|NCT00901342|584690638|FG000|Overall Study|Death|4|||
161902776|NCT00901342|584690638|FG000|Overall Study|Disease progression|1|||
161902777|NCT00901342|584690638|FG000|Overall Study|Withdrawal by Subject|9|||
161902778|NCT03804268|584690639|FG000|Overall Study|Adverse Event|2|||
161902779|NCT03804268|584690640|FG001|Overall Study|Adverse Event|2|||
161902780|NCT03804268|584690639|FG000|Overall Study|Withdrawal by Subject|2|||
161902781|NCT03804268|584690640|FG001|Overall Study|Withdrawal by Subject|0|||
161902782|NCT03804268|584690639|FG000|Overall Study|Lost to Follow-up|1|||
161902783|NCT03804268|584690640|FG001|Overall Study|Lost to Follow-up|0|||
161902784|NCT03804268|584690639|FG000|Overall Study|Physician Decision|2|||
161902785|NCT03804268|584690640|FG001|Overall Study|Physician Decision|0|||
161902786|NCT02849587|584690641|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
161902787|NCT02849587|584690642|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
161902788|NCT02849587|584690643|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
161902789|NCT02849587|584690641|FG000|Overall Study|Withdrawal by Subject|0|||
161902790|NCT02849587|584690642|FG001|Overall Study|Withdrawal by Subject|1|||
161902791|NCT02849587|584690643|FG002|Overall Study|Withdrawal by Subject|0|||
161902792|NCT03380377|584690644|FG000|Overall Study|Physician Decision|1|||
161902793|NCT03380377|584690644|FG000|Overall Study|Withdrawal by Subject|1|||
161902794|NCT00385918|584690645|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
161902795|NCT00385918|584690646|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
161902796|NCT00385918|584690647|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
161556263|NCT02584855|583425438|FG002|Open-Label Treatment Period|No PI Available|0|||
161556264|NCT02584855|583425439|FG003|Open-Label Treatment Period|No PI Available|0|||
161902797|NCT00385918|584690645|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
161450979|NCT01604278|583048095|FG001|Overall Study|Withdrawal by Subject|3|||
161450980|NCT01604278|583048094|FG000|Overall Study|Adverse Event|3|||
161450981|NCT01604278|583048095|FG001|Overall Study|Adverse Event|5|||
161450982|NCT01604278|583048094|FG000|Overall Study|Protocol Deviation|5|||
161450983|NCT01604278|583048095|FG001|Overall Study|Protocol Deviation|3|||
161450984|NCT00668733|583048103|FG000|Overall Study|Lost to Follow-up|2|||
161450985|NCT00668733|583048104|FG001|Overall Study|Lost to Follow-up|3|||
161450986|NCT00668733|583048103|FG000|Overall Study|Withdrawal by Subject|0|||
161450987|NCT00668733|583048104|FG001|Overall Study|Withdrawal by Subject|4|||
161450988|NCT01122264|583048107|FG000|Overall Study|Adverse Event|6|||
161450989|NCT01122264|583048108|FG001|Overall Study|Adverse Event|5|||
161450990|NCT01122264|583048109|FG002|Overall Study|Adverse Event|7|||
161450991|NCT01122264|583048107|FG000|Overall Study|Death|1|||
161450992|NCT01122264|583048108|FG001|Overall Study|Death|0|||
161450993|NCT01122264|583048109|FG002|Overall Study|Death|0|||
161450994|NCT01122264|583048107|FG000|Overall Study|Lost to Follow-up|5|||
161450995|NCT01122264|583048108|FG001|Overall Study|Lost to Follow-up|9|||
161450996|NCT01122264|583048109|FG002|Overall Study|Lost to Follow-up|13|||
161450997|NCT01122264|583048107|FG000|Overall Study|Entry Criteria Not Met|1|||
161450998|NCT01122264|583048108|FG001|Overall Study|Entry Criteria Not Met|0|||
161450999|NCT01122264|583048109|FG002|Overall Study|Entry Criteria Not Met|0|||
161451000|NCT01122264|583048107|FG000|Overall Study|Protocol Violation|7|||
161451001|NCT01122264|583048108|FG001|Overall Study|Protocol Violation|7|||
161451002|NCT01122264|583048109|FG002|Overall Study|Protocol Violation|9|||
161451003|NCT01122264|583048107|FG000|Overall Study|Withdrawal by Subject|6|||
161451004|NCT01122264|583048108|FG001|Overall Study|Withdrawal by Subject|6|||
161451005|NCT01122264|583048109|FG002|Overall Study|Withdrawal by Subject|16|||
161451006|NCT01122264|583048107|FG000|Overall Study|Physician Decision|3|||
161451007|NCT01122264|583048108|FG001|Overall Study|Physician Decision|1|||
161451008|NCT01122264|583048109|FG002|Overall Study|Physician Decision|1|||
161451009|NCT01122264|583048107|FG000|Overall Study|Lack of Efficacy|3|||
161451010|NCT01122264|583048108|FG001|Overall Study|Lack of Efficacy|1|||
161451011|NCT01122264|583048109|FG002|Overall Study|Lack of Efficacy|1|||
161451012|NCT00097981|583048118|FG000|Overall Study|Adverse Event|31|||
161451013|NCT00097981|583048119|FG001|Overall Study|Adverse Event|44|||
161451014|NCT00097981|583048118|FG000|Overall Study|Withdrawal by Subject|10|||
161451015|NCT00097981|583048119|FG001|Overall Study|Withdrawal by Subject|8|||
161451016|NCT00097981|583048118|FG000|Overall Study|Protocol Violation|1|||
161451017|NCT00097981|583048119|FG001|Overall Study|Protocol Violation|1|||
161451018|NCT00097981|583048118|FG000|Overall Study|Death|2|||
161451019|NCT00097981|583048119|FG001|Overall Study|Death|4|||
161451020|NCT00097981|583048118|FG000|Overall Study|Physician Decision|7|||
161451021|NCT00097981|583048119|FG001|Overall Study|Physician Decision|1|||
161451022|NCT00097981|583048118|FG000|Overall Study|Disease Progression|8|||
161451023|NCT00097981|583048119|FG001|Overall Study|Disease Progression|2|||
161451024|NCT00097981|583048118|FG000|Overall Study|Transplant planned|28|||
161451025|NCT00097981|583048119|FG001|Overall Study|Transplant planned|27|||
161451026|NCT00097981|583048118|FG000|Overall Study|Other|19|||
161451027|NCT00097981|583048119|FG001|Overall Study|Other|13|||
161451028|NCT00796445|583048128|FG000|Overall Study|Protocol Violation|5|||
161451029|NCT00796445|583048129|FG001|Overall Study|Protocol Violation|3|||
161451030|NCT00796445|583048128|FG000|Overall Study|Adverse event, serious fatal|10|||
161451031|NCT00796445|583048129|FG001|Overall Study|Adverse event, serious fatal|5|||
161451032|NCT00796445|583048128|FG000|Overall Study|Adverse event, non-fatal|4|||
161451033|NCT00796445|583048129|FG001|Overall Study|Adverse event, non-fatal|0|||
161798664|NCT04634409|584304563|FG018|Overall Study|Withdrawal by Subject|0|||
161798665|NCT04634409|584304564|FG019|Overall Study|Withdrawal by Subject|0|||
161798666|NCT04634409|584304565|FG020|Overall Study|Withdrawal by Subject|0|||
161798667|NCT04634409|584304566|FG021|Overall Study|Withdrawal by Subject|0|||
161798668|NCT04634409|584304567|FG022|Overall Study|Withdrawal by Subject|0|||
161798669|NCT04634409|584304568|FG023|Overall Study|Withdrawal by Subject|1|||
161798670|NCT04634409|584304569|FG024|Overall Study|Withdrawal by Subject|0|||
161798671|NCT04634409|584304570|FG025|Overall Study|Withdrawal by Subject|0|||
161798672|NCT04634409|584304571|FG026|Overall Study|Withdrawal by Subject|0|||
161798673|NCT04634409|584304545|FG000|Overall Study|Other - As reported by Investigator|1|||
161798674|NCT04634409|584304546|FG001|Overall Study|Other - As reported by Investigator|0|||
161798675|NCT04634409|584304547|FG002|Overall Study|Other - As reported by Investigator|0|||
161798676|NCT04634409|584304548|FG003|Overall Study|Other - As reported by Investigator|0|||
161798677|NCT04634409|584304549|FG004|Overall Study|Other - As reported by Investigator|0|||
161798678|NCT04634409|584304550|FG005|Overall Study|Other - As reported by Investigator|0|||
161798679|NCT04634409|584304551|FG006|Overall Study|Other - As reported by Investigator|0|||
161798680|NCT04634409|584304552|FG007|Overall Study|Other - As reported by Investigator|6|||
161798681|NCT04634409|584304553|FG008|Overall Study|Other - As reported by Investigator|4|||
161798682|NCT04634409|584304554|FG009|Overall Study|Other - As reported by Investigator|0|||
161798683|NCT04634409|584304555|FG010|Overall Study|Other - As reported by Investigator|1|||
161798684|NCT04634409|584304556|FG011|Overall Study|Other - As reported by Investigator|2|||
161798685|NCT04634409|584304557|FG012|Overall Study|Other - As reported by Investigator|2|||
161451034|NCT00796445|583048128|FG000|Overall Study|Disease progression/recurrence|537|||
161451035|NCT00796445|583048129|FG001|Overall Study|Disease progression/recurrence|268|||
161451036|NCT00796445|583048128|FG000|Overall Study|Other|10|||
161451037|NCT00796445|583048129|FG001|Overall Study|Other|7|||
161451038|NCT00796445|583048128|FG000|Overall Study|Withdrawal by Subject|18|||
161451039|NCT00796445|583048129|FG001|Overall Study|Withdrawal by Subject|9|||
161451040|NCT00796445|583048128|FG000|Overall Study|Invalid Informed Consent Form|1|||
161451041|NCT00796445|583048129|FG001|Overall Study|Invalid Informed Consent Form|0|||
161451042|NCT00388583|583048132|FG000|Overall Study|Protocol Violation|1|||
161451043|NCT00388583|583048133|FG001|Overall Study|Protocol Violation|0|||
161451044|NCT00388583|583048132|FG000|Overall Study|Withdrawal by Subject|3|||
161451045|NCT00388583|583048133|FG001|Overall Study|Withdrawal by Subject|3|||
161451046|NCT00388583|583048132|FG000|Overall Study|Serious Adverse Event|2|||
161451047|NCT00388583|583048133|FG001|Overall Study|Serious Adverse Event|0|||
161451048|NCT00388583|583048132|FG000|Overall Study|Did not receive vaccine|0|||
161451049|NCT00388583|583048133|FG001|Overall Study|Did not receive vaccine|1|||
161451050|NCT05194579|583048134|FG000|Overall Study|Lost to Follow-up|2|||
161451051|NCT05194579|583048135|FG001|Overall Study|Lost to Follow-up|3|||
161451052|NCT05194579|583048134|FG000|Overall Study|Withdrawal by Subject|3|||
161451053|NCT05194579|583048135|FG001|Overall Study|Withdrawal by Subject|4|||
161451054|NCT05194579|583048134|FG000|Overall Study|Refused further study procedures|0|||
161451055|NCT05194579|583048135|FG001|Overall Study|Refused further study procedures|1|||
161451056|NCT05194579|583048134|FG000|Overall Study|Protocol deviation|1|||
161451057|NCT05194579|583048135|FG001|Overall Study|Protocol deviation|0|||
161798686|NCT04634409|584304558|FG013|Overall Study|Other - As reported by Investigator|1|||
161798687|NCT04634409|584304559|FG014|Overall Study|Other - As reported by Investigator|0|||
161798688|NCT04634409|584304560|FG015|Overall Study|Other - As reported by Investigator|0|||
161798689|NCT04634409|584304561|FG016|Overall Study|Other - As reported by Investigator|0|||
161798690|NCT04634409|584304562|FG017|Overall Study|Other - As reported by Investigator|0|||
161798691|NCT04634409|584304563|FG018|Overall Study|Other - As reported by Investigator|0|||
161798692|NCT04634409|584304564|FG019|Overall Study|Other - As reported by Investigator|0|||
161798693|NCT04634409|584304565|FG020|Overall Study|Other - As reported by Investigator|0|||
161798694|NCT04634409|584304566|FG021|Overall Study|Other - As reported by Investigator|0|||
161798695|NCT04634409|584304567|FG022|Overall Study|Other - As reported by Investigator|0|||
161798696|NCT04634409|584304568|FG023|Overall Study|Other - As reported by Investigator|0|||
161798697|NCT04634409|584304569|FG024|Overall Study|Other - As reported by Investigator|0|||
161798698|NCT04634409|584304570|FG025|Overall Study|Other - As reported by Investigator|0|||
161798699|NCT04634409|584304571|FG026|Overall Study|Other - As reported by Investigator|0|||
161798700|NCT02785913|584307089|FG000|Overall Study|Adverse Event|5|||
161798701|NCT02785913|584307089|FG000|Overall Study|Death|2|||
161798702|NCT02785913|584307089|FG000|Overall Study|Progression|18|||
161798703|NCT02785913|584307089|FG000|Overall Study|Not protocol specified|1|||
161798704|NCT01298570|584307090|FG000|Overall Study|Disease progression, relapse during acti|64|||
161798705|NCT01298570|584307091|FG001|Overall Study|Disease progression, relapse during acti|40|||
161798706|NCT01298570|584307090|FG000|Overall Study|Adverse Event|20|||
161798707|NCT01298570|584307091|FG001|Overall Study|Adverse Event|2|||
161798708|NCT01298570|584307090|FG000|Overall Study|Withdrawal by Subject|21|||
161798709|NCT01298570|584307091|FG001|Overall Study|Withdrawal by Subject|6|||
161798710|NCT01298570|584307090|FG000|Overall Study|Treatment delay > 4 weeks|4|||
161798711|NCT01298570|584307091|FG001|Overall Study|Treatment delay > 4 weeks|5|||
161798712|NCT01298570|584307090|FG000|Overall Study|Physician Decision|4|||
161798713|NCT01298570|584307091|FG001|Overall Study|Physician Decision|2|||
161798714|NCT01298570|584307090|FG000|Overall Study|Other complicating disease|2|||
161798715|NCT01298570|584307091|FG001|Overall Study|Other complicating disease|1|||
161798716|NCT01298570|584307090|FG000|Overall Study|Surgery|2|||
161798717|NCT01298570|584307091|FG001|Overall Study|Surgery|1|||
161798718|NCT01298570|584307090|FG000|Overall Study|Symptomatic progression/deterioration|3|||
161798719|NCT01298570|584307091|FG001|Overall Study|Symptomatic progression/deterioration|2|||
161798720|NCT01298570|584307090|FG000|Overall Study|Death|0|||
161798721|NCT01298570|584307091|FG001|Overall Study|Death|1|||
161798722|NCT01298570|584307090|FG000|Overall Study|Ineligibility|0|||
161798723|NCT01298570|584307091|FG001|Overall Study|Ineligibility|1|||
161798724|NCT00076102|584307092|FG000|Overall Study|Clinical progression|1|||
161798725|NCT00076102|584307092|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
161798726|NCT00076102|584307092|FG000|Overall Study|plexiform neurofibroma surgery|1|||
161798727|NCT00076102|584307092|FG000|Overall Study|refusal of further therapy|2|||
161798728|NCT01052116|584307093|FG000|Overall Study|Lost to Follow-up|11|||
161798729|NCT01052116|584307094|FG001|Overall Study|Lost to Follow-up|17|||
161798730|NCT01052116|584307093|FG000|Overall Study|Withdrawal by Subject|3|||
161798731|NCT01052116|584307094|FG001|Overall Study|Withdrawal by Subject|6|||
161798732|NCT01052116|584307093|FG000|Overall Study|Spirometry not performed|0|||
161798733|NCT01052116|584307094|FG001|Overall Study|Spirometry not performed|4|||
161798734|NCT02180711|584307095|FG000|Overall Study|Death|0|||
161798735|NCT02180711|584307096|FG001|Overall Study|Death|1|||
161798736|NCT02180711|584307097|FG002|Overall Study|Death|0|||
161451058|NCT02500056|583048136|FG000|Overall Study|Lost to Follow-up|3|||
161902798|NCT00385918|584690646|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
161902799|NCT00385918|584690647|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
161902800|NCT00385918|584690645|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
161902801|NCT00385918|584690646|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
161902802|NCT00385918|584690647|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
161902803|NCT00385918|584690645|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
161902804|NCT00385918|584690646|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
161902805|NCT00385918|584690647|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
161902806|NCT00385918|584690645|FG000|Intervention Phase After Randomization|Physician Decision|1|||
161902807|NCT00385918|584690646|FG001|Intervention Phase After Randomization|Physician Decision|0|||
161902808|NCT00385918|584690647|FG002|Intervention Phase After Randomization|Physician Decision|0|||
161902809|NCT00385918|584690645|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
161902810|NCT00385918|584690646|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
161902811|NCT00385918|584690647|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
161902812|NCT00128661|584690648|FG000|Overall Study|Adverse Event|14|||
161902813|NCT00128661|584690649|FG001|Overall Study|Adverse Event|11|||
161902814|NCT00128661|584690648|FG000|Overall Study|Lost to Follow-up|10|||
161902815|NCT00128661|584690649|FG001|Overall Study|Lost to Follow-up|7|||
161902816|NCT00128661|584690648|FG000|Overall Study|Withdrawal by Subject|243|||
161902817|NCT00128661|584690649|FG001|Overall Study|Withdrawal by Subject|232|||
161902818|NCT00128661|584690648|FG000|Overall Study|Other|7|||
161902819|NCT00128661|584690649|FG001|Overall Study|Other|8|||
161902820|NCT03421379|584690650|FG000|Period 1|Withdrawal by Subject|0|||
161902821|NCT03421379|584690651|FG001|Period 1|Withdrawal by Subject|1|||
161902822|NCT03421379|584690650|FG000|Period 1|Physician Decision|1|||
161902823|NCT03421379|584690651|FG001|Period 1|Physician Decision|1|||
161902824|NCT03421379|584690650|FG000|Period 1|Did not receive treatment|1|||
161902825|NCT03421379|584690651|FG001|Period 1|Did not receive treatment|2|||
161902826|NCT04010461|584690652|FG000|Overall Study|COVID based withdrawal|5|||
161902827|NCT04010461|584690652|FG000|Overall Study|Withdrawal by Subject|5|||
161902828|NCT04010461|584690652|FG000|Overall Study|Adverse Event|1|||
161902829|NCT04010461|584690652|FG000|Overall Study|No Motor Threshold obtainable|1|||
161902830|NCT04010461|584690652|FG000|Overall Study|Physician Decision|1|||
161902831|NCT03771963|584690653|FG000|Overall Study|Lost to Follow-up|22|||
161902832|NCT03771963|584690653|FG000|Overall Study|Withdrawal of Consent|10|||
161902833|NCT01026948|584690654|FG000|Overall Study|Physician Decision|8|||
161902834|NCT00102596|584690655|FG000|Part A|Screen failures|6|||
161902835|NCT00102596|584690656|FG001|Part A|Screen failures|0|||
161902836|NCT00102596|584690655|FG000|Part A|Adverse Event|1|||
161902837|NCT00102596|584690656|FG001|Part A|Adverse Event|0|||
161902838|NCT00964028|584690657|FG000|Overall Study|Withdrawal by Subject|0|||
161902839|NCT00964028|584690658|FG001|Overall Study|Withdrawal by Subject|1|||
161902840|NCT02106351|584690659|FG000|Treatment Cycle 1|Adverse Event|2|||
161902841|NCT02106351|584690660|FG001|Treatment Cycle 1|Adverse Event|0|||
161902842|NCT02106351|584690661|FG002|Treatment Cycle 1|Adverse Event|0|||
161902843|NCT02106351|584690659|FG000|Treatment Cycle 1|Consent withdrawn|1|||
161902844|NCT02106351|584690660|FG001|Treatment Cycle 1|Consent withdrawn|0|||
161902845|NCT02106351|584690661|FG002|Treatment Cycle 1|Consent withdrawn|2|||
161902846|NCT02106351|584690659|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
161902847|NCT02106351|584690660|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
161902848|NCT02106351|584690661|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
161902849|NCT02106351|584690659|FG000|Treatment Cycle 1|Other|0|||
161902850|NCT02106351|584690660|FG001|Treatment Cycle 1|Other|3|||
161902851|NCT02106351|584690661|FG002|Treatment Cycle 1|Other|1|||
161902852|NCT02106351|584690659|FG000|Treatment Cycle 1|Randomised but not treated|1|||
161902853|NCT02106351|584690660|FG001|Treatment Cycle 1|Randomised but not treated|0|||
161902854|NCT02106351|584690661|FG002|Treatment Cycle 1|Randomised but not treated|1|||
161902855|NCT02106351|584690659|FG000|Treatment Cycle 2|Adverse Event|0|||
161902856|NCT02106351|584690660|FG001|Treatment Cycle 2|Adverse Event|2|||
161902857|NCT02106351|584690661|FG002|Treatment Cycle 2|Adverse Event|0|||
161902858|NCT02106351|584690659|FG000|Treatment Cycle 2|Consent withdrawn|0|||
161902859|NCT02106351|584690660|FG001|Treatment Cycle 2|Consent withdrawn|1|||
161902860|NCT02106351|584690661|FG002|Treatment Cycle 2|Consent withdrawn|1|||
161902861|NCT02106351|584690659|FG000|Treatment Cycle 2|Other|0|||
161902862|NCT02106351|584690660|FG001|Treatment Cycle 2|Other|2|||
161902863|NCT02106351|584690661|FG002|Treatment Cycle 2|Other|2|||
161902864|NCT02106351|584690659|FG000|Treatment Cycle 3|Adverse Event|0|||
161902865|NCT02106351|584690660|FG001|Treatment Cycle 3|Adverse Event|1|||
161902866|NCT02106351|584690661|FG002|Treatment Cycle 3|Adverse Event|0|||
161902867|NCT02106351|584690659|FG000|Treatment Cycle 3|Consent withdrawn|0|||
161902868|NCT02106351|584690660|FG001|Treatment Cycle 3|Consent withdrawn|0|||
161902869|NCT02106351|584690661|FG002|Treatment Cycle 3|Consent withdrawn|2|||
161902870|NCT02106351|584690659|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
161902871|NCT02106351|584690660|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
161902872|NCT02106351|584690661|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
161902873|NCT02106351|584690659|FG000|Treatment Cycle 3|Other|0|||
161798737|NCT02180711|584307098|FG003|Overall Study|Death|0|||
161798738|NCT02180711|584307099|FG004|Overall Study|Death|7|||
161798739|NCT02180711|584307100|FG005|Overall Study|Death|0|||
161798740|NCT02180711|584307101|FG006|Overall Study|Death|1|||
161798741|NCT02180711|584307102|FG007|Overall Study|Death|3|||
161798742|NCT02180711|584307095|FG000|Overall Study|Lost to Follow-up|0|||
161798743|NCT02180711|584307096|FG001|Overall Study|Lost to Follow-up|1|||
161798744|NCT02180711|584307097|FG002|Overall Study|Lost to Follow-up|0|||
161798745|NCT02180711|584307098|FG003|Overall Study|Lost to Follow-up|0|||
161798746|NCT02180711|584307099|FG004|Overall Study|Lost to Follow-up|1|||
161798747|NCT02180711|584307100|FG005|Overall Study|Lost to Follow-up|1|||
161798748|NCT02180711|584307101|FG006|Overall Study|Lost to Follow-up|0|||
161798749|NCT02180711|584307102|FG007|Overall Study|Lost to Follow-up|3|||
161798750|NCT02180711|584307095|FG000|Overall Study|Withdrawal by Subject|2|||
161798751|NCT02180711|584307096|FG001|Overall Study|Withdrawal by Subject|1|||
161798752|NCT02180711|584307097|FG002|Overall Study|Withdrawal by Subject|0|||
161798753|NCT02180711|584307098|FG003|Overall Study|Withdrawal by Subject|4|||
161798754|NCT02180711|584307099|FG004|Overall Study|Withdrawal by Subject|3|||
161798755|NCT02180711|584307100|FG005|Overall Study|Withdrawal by Subject|0|||
161798756|NCT02180711|584307101|FG006|Overall Study|Withdrawal by Subject|3|||
161798757|NCT02180711|584307102|FG007|Overall Study|Withdrawal by Subject|2|||
161798758|NCT02180711|584307095|FG000|Overall Study|- Disease Progression|0|||
161798759|NCT02180711|584307096|FG001|Overall Study|- Disease Progression|1|||
161798760|NCT02180711|584307097|FG002|Overall Study|- Disease Progression|0|||
161798761|NCT02180711|584307098|FG003|Overall Study|- Disease Progression|0|||
161798762|NCT02180711|584307099|FG004|Overall Study|- Disease Progression|0|||
161798763|NCT02180711|584307100|FG005|Overall Study|- Disease Progression|0|||
161798764|NCT02180711|584307101|FG006|Overall Study|- Disease Progression|0|||
161798765|NCT02180711|584307102|FG007|Overall Study|- Disease Progression|0|||
161798766|NCT02180711|584307095|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
161798767|NCT02180711|584307096|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
161798768|NCT02180711|584307097|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
161798769|NCT02180711|584307098|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
161798770|NCT02180711|584307099|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798771|NCT02180711|584307100|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798772|NCT02180711|584307101|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798773|NCT02180711|584307102|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798774|NCT02180711|584307095|FG000|Overall Study|- Study Terminated by Sponsor|2|||
161798775|NCT02180711|584307096|FG001|Overall Study|- Study Terminated by Sponsor|3|||
161798776|NCT02180711|584307097|FG002|Overall Study|- Study Terminated by Sponsor|0|||
161798777|NCT02180711|584307098|FG003|Overall Study|- Study Terminated by Sponsor|5|||
161798778|NCT02180711|584307099|FG004|Overall Study|- Study Terminated by Sponsor|32|||
161798779|NCT02180711|584307100|FG005|Overall Study|- Study Terminated by Sponsor|0|||
161798780|NCT02180711|584307101|FG006|Overall Study|- Study Terminated by Sponsor|4|||
161798781|NCT02180711|584307102|FG007|Overall Study|- Study Terminated by Sponsor|13|||
161798782|NCT02180711|584307095|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
161798783|NCT02180711|584307096|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
161798784|NCT02180711|584307097|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
161798785|NCT02180711|584307098|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
161798786|NCT02180711|584307099|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
161798787|NCT02180711|584307100|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
161798788|NCT02180711|584307101|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
161798789|NCT02180711|584307102|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
161798790|NCT02180711|584307095|FG000|Overall Study|- Other|1|||
161798791|NCT02180711|584307096|FG001|Overall Study|- Other|0|||
161798792|NCT02180711|584307097|FG002|Overall Study|- Other|0|||
161451059|NCT02500056|583048137|FG001|Overall Study|Lost to Follow-up|7|||
161451060|NCT02500056|583048136|FG000|Overall Study|Recurrence|1|||
161451061|NCT02500056|583048137|FG001|Overall Study|Recurrence|0|||
161451062|NCT02500056|583048136|FG000|Overall Study|Death|3|||
161451063|NCT02500056|583048137|FG001|Overall Study|Death|1|||
161451064|NCT00638183|583048144|FG000|Overall Study|Adverse Event|23|||
161451065|NCT00638183|583048144|FG000|Overall Study|Lack of Efficacy|14|||
161451066|NCT00638183|583048144|FG000|Overall Study|Physician Decision|9|||
161451067|NCT00638183|583048144|FG000|Overall Study|Lost to Follow-up|46|||
161798793|NCT02180711|584307098|FG003|Overall Study|- Other|1|||
161798794|NCT02180711|584307099|FG004|Overall Study|- Other|0|||
161798795|NCT02180711|584307100|FG005|Overall Study|- Other|0|||
161798796|NCT02180711|584307101|FG006|Overall Study|- Other|0|||
161902874|NCT02106351|584690660|FG001|Treatment Cycle 3|Other|2|||
161902875|NCT02106351|584690661|FG002|Treatment Cycle 3|Other|3|||
161451068|NCT00638183|583048144|FG000|Overall Study|Other reason not defined above|27|||
161451069|NCT03180619|583048145|FG000|Overall Study|Withdrew Consent|5|||
161798797|NCT02180711|584307102|FG007|Overall Study|- Other|0|||
161798798|NCT00444145|584307103|FG000|Overall Study|Withdrawal by Subject|2|||
161798799|NCT00444145|584307103|FG000|Overall Study|Lost to Follow-up|1|||
161556265|NCT02584855|583425440|FG004|Open-Label Treatment Period|No PI Available|0|||
161556266|NCT02584855|583425441|FG005|Open-Label Treatment Period|No PI Available|0|||
161556267|NCT02584855|583425436|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
161556268|NCT02584855|583425437|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
161556269|NCT02584855|583425438|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
161556270|NCT02584855|583425439|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
161556271|NCT02584855|583425440|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
161798800|NCT00444145|584307103|FG000|Overall Study|non-compliant|11|||
161798801|NCT00444145|584307103|FG000|Overall Study|Screen Failures|5|||
161798802|NCT01619800|584307104|FG000|Overall Study|study terminated|2|||
161798803|NCT01619800|584307105|FG001|Overall Study|study terminated|0|||
161798804|NCT00414466|584307107|FG000|Overall Study|Adverse Event|0|||
161798805|NCT00414466|584307108|FG001|Overall Study|Adverse Event|0|||
161798806|NCT00414466|584307109|FG002|Overall Study|Adverse Event|1|||
161798807|NCT00414466|584307110|FG003|Overall Study|Adverse Event|1|||
161798808|NCT00414466|584307107|FG000|Overall Study|Lack of Efficacy|1|||
161798809|NCT00414466|584307108|FG001|Overall Study|Lack of Efficacy|0|||
161798810|NCT00414466|584307109|FG002|Overall Study|Lack of Efficacy|0|||
161798811|NCT00414466|584307110|FG003|Overall Study|Lack of Efficacy|0|||
161798812|NCT00414466|584307107|FG000|Overall Study|Withdrawn by Sponsor|1|||
161798813|NCT00414466|584307108|FG001|Overall Study|Withdrawn by Sponsor|0|||
161798814|NCT00414466|584307109|FG002|Overall Study|Withdrawn by Sponsor|0|||
161798815|NCT00414466|584307110|FG003|Overall Study|Withdrawn by Sponsor|0|||
161798816|NCT02742090|584307111|FG000|Overall Study|Adverse Event|10|||
161798817|NCT02742090|584307111|FG000|Overall Study|Death|3|||
161798818|NCT02742090|584307111|FG000|Overall Study|Disease Progression|25|||
161798819|NCT02742090|584307111|FG000|Overall Study|Investigator's Decision|1|||
161798820|NCT02742090|584307111|FG000|Overall Study|Lost to Follow-up|1|||
161798821|NCT02742090|584307111|FG000|Overall Study|Non-compliance with Study|1|||
161798822|NCT02742090|584307111|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
161798823|NCT02742090|584307111|FG000|Overall Study|Withdrawal by Subject|4|||
161798824|NCT02742090|584307111|FG000|Overall Study|Reason Not Specified|1|||
161798825|NCT02016300|584307114|FG000|Overall Study|Lost to Follow-up|0|||
161798826|NCT02016300|584307115|FG001|Overall Study|Lost to Follow-up|3|||
161798827|NCT05301751|584307120|FG000|Overall Study|Withdrawal by Subject|0|||
161798828|NCT05301751|584307121|FG001|Overall Study|Withdrawal by Subject|0|||
161798829|NCT05301751|584307122|FG002|Overall Study|Withdrawal by Subject|1|||
161798830|NCT05301751|584307123|FG003|Overall Study|Withdrawal by Subject|0|||
161798831|NCT06165744|584307126|FG000|Overall Study|Non device-related adverse event|1|||
161798832|NCT01546987|584307127|FG000|Overall Study|Protocol Violation|3|||
161798833|NCT01546987|584307128|FG001|Overall Study|Protocol Violation|4|||
161798834|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798835|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
161798836|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798837|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798838|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798839|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
161798840|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161798841|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
161902876|NCT02106351|584690659|FG000|Treatment Cycle 4|Consent withdrawn|0|||
161902877|NCT02106351|584690660|FG001|Treatment Cycle 4|Consent withdrawn|0|||
161902878|NCT02106351|584690661|FG002|Treatment Cycle 4|Consent withdrawn|2|||
161902879|NCT02106351|584690659|FG000|Treatment Cycle 4|Other|0|||
161556272|NCT02584855|583425441|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
161556273|NCT02584855|583425436|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161556274|NCT02584855|583425437|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161556275|NCT02584855|583425438|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
161556276|NCT02584855|583425439|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161556277|NCT02584855|583425440|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161556278|NCT02584855|583425441|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161556279|NCT02584855|583425436|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
161556280|NCT02584855|583425437|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
161556281|NCT02584855|583425438|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
161556282|NCT02584855|583425439|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
161556283|NCT02584855|583425440|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
161798842|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161556284|NCT02584855|583425441|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
161668043|NCT00406653|583837479|FG003|Induction Period|Declined participation but followup done|1|||
161798843|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161798844|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798845|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
161798846|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798847|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798848|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798849|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798850|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798851|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
161798852|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798853|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798854|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798855|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798856|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798857|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
161798858|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798859|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798860|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798861|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798862|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
161798863|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798864|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798865|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798866|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798867|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
161798868|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798869|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798870|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798871|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798872|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
161798873|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798874|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798875|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798876|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798877|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
161798878|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798879|NCT00262600|584307134|FG000|Overall Study|Lost to Follow-up|17|||
161798880|NCT00262600|584307135|FG001|Overall Study|Lost to Follow-up|31|||
161798881|NCT00262600|584307136|FG002|Overall Study|Lost to Follow-up|41|||
161798882|NCT00262600|584307134|FG000|Overall Study|Withdrawal by Subject|128|||
161798883|NCT00262600|584307135|FG001|Overall Study|Withdrawal by Subject|145|||
161798884|NCT00262600|584307136|FG002|Overall Study|Withdrawal by Subject|139|||
161798885|NCT00262600|584307134|FG000|Overall Study|Not Treated|32|||
161798886|NCT00262600|584307135|FG001|Overall Study|Not Treated|17|||
161798887|NCT00262600|584307136|FG002|Overall Study|Not Treated|24|||
161798888|NCT00262600|584307134|FG000|Overall Study|Other|58|||
161798889|NCT00262600|584307135|FG001|Overall Study|Other|59|||
161798890|NCT00262600|584307136|FG002|Overall Study|Other|62|||
161798891|NCT05381948|584307141|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
161798892|NCT05381948|584307142|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
161798893|NCT05381948|584307143|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
161798894|NCT05381948|584307141|FG000|Overall Study|Adverse Event: Non-ocular|0|||
161798895|NCT05381948|584307142|FG001|Overall Study|Adverse Event: Non-ocular|1|||
161798896|NCT05381948|584307143|FG002|Overall Study|Adverse Event: Non-ocular|0|||
161798897|NCT05381948|584307141|FG000|Overall Study|Lost to Follow-up|1|||
161798898|NCT05381948|584307142|FG001|Overall Study|Lost to Follow-up|0|||
161798899|NCT05381948|584307143|FG002|Overall Study|Lost to Follow-up|0|||
161798900|NCT05381948|584307141|FG000|Overall Study|Protocol Deviation|0|||
161798901|NCT05381948|584307142|FG001|Overall Study|Protocol Deviation|2|||
161798902|NCT05381948|584307143|FG002|Overall Study|Protocol Deviation|0|||
161798903|NCT05381948|584307141|FG000|Overall Study|Withdrawal by Subject|1|||
161798904|NCT05381948|584307142|FG001|Overall Study|Withdrawal by Subject|0|||
161798905|NCT05381948|584307143|FG002|Overall Study|Withdrawal by Subject|1|||
161798906|NCT05381948|584307141|FG000|Overall Study|Death|0|||
161798907|NCT05381948|584307142|FG001|Overall Study|Death|2|||
161798908|NCT05381948|584307143|FG002|Overall Study|Death|0|||
161798909|NCT05381948|584307141|FG000|Overall Study|Discontinued study without receiving study drug|0|||
161798910|NCT05381948|584307142|FG001|Overall Study|Discontinued study without receiving study drug|0|||
161798911|NCT05381948|584307143|FG002|Overall Study|Discontinued study without receiving study drug|1|||
161451070|NCT03180619|583048146|FG001|Overall Study|Withdrew Consent|0|||
161798912|NCT04471207|584307144|FG000|Overall Study|Lost to Follow-up|4|||
161798913|NCT04471207|584307145|FG001|Overall Study|Lost to Follow-up|1|||
161798914|NCT04471207|584307144|FG000|Overall Study|Medication Contraindication|0|||
161798915|NCT04471207|584307145|FG001|Overall Study|Medication Contraindication|1|||
161798916|NCT04471207|584307144|FG000|Overall Study|Loss of Interest|2|||
161798917|NCT04471207|584307145|FG001|Overall Study|Loss of Interest|1|||
161798918|NCT04471207|584307144|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
161798919|NCT04471207|584307145|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
161798920|NCT04471207|584307144|FG000|Overall Study|Scheduling Conflicts|3|||
161798921|NCT04471207|584307145|FG001|Overall Study|Scheduling Conflicts|1|||
161798922|NCT04471207|584307144|FG000|Overall Study|Physician Decision|1|||
161798923|NCT04471207|584307145|FG001|Overall Study|Physician Decision|0|||
161798924|NCT04471207|584307144|FG000|Overall Study|Unwilling to Use System|0|||
161798925|NCT04471207|584307145|FG001|Overall Study|Unwilling to Use System|1|||
161798926|NCT02132247|584307150|FG000|Overall Study|Protocol Violation|1|||
161798927|NCT02132247|584307151|FG001|Overall Study|Protocol Violation|0|||
161798928|NCT00520741|584307154|FG000|Overall Study|Adverse Event|16|||
161798929|NCT00520741|584307155|FG001|Overall Study|Adverse Event|56|||
161902880|NCT02106351|584690660|FG001|Treatment Cycle 4|Other|1|||
161902881|NCT02106351|584690661|FG002|Treatment Cycle 4|Other|0|||
161902882|NCT01386606|584692413|FG000|Overall Study|Adverse Event|0|||
161902883|NCT01386606|584692414|FG001|Overall Study|Adverse Event|1|||
161902884|NCT01386606|584692415|FG002|Overall Study|Adverse Event|0|||
161902885|NCT01386606|584692416|FG003|Overall Study|Adverse Event|0|||
161902886|NCT01386606|584692413|FG000|Overall Study|Withdrawal by Subject|0|||
161902887|NCT01386606|584692414|FG001|Overall Study|Withdrawal by Subject|1|||
161902888|NCT01386606|584692415|FG002|Overall Study|Withdrawal by Subject|1|||
161902889|NCT01386606|584692416|FG003|Overall Study|Withdrawal by Subject|0|||
161902890|NCT01386606|584692413|FG000|Overall Study|Protocol Violation|1|||
161902891|NCT01386606|584692414|FG001|Overall Study|Protocol Violation|0|||
161902892|NCT01386606|584692415|FG002|Overall Study|Protocol Violation|1|||
161902893|NCT01386606|584692416|FG003|Overall Study|Protocol Violation|1|||
161902894|NCT01386606|584692413|FG000|Overall Study|Lost to Follow-up|2|||
161902895|NCT01386606|584692414|FG001|Overall Study|Lost to Follow-up|0|||
161902896|NCT01386606|584692415|FG002|Overall Study|Lost to Follow-up|0|||
161902897|NCT01386606|584692416|FG003|Overall Study|Lost to Follow-up|0|||
161902898|NCT01386606|584692413|FG000|Overall Study|Subject incarcerated|0|||
161451071|NCT03180619|583048147|FG002|Overall Study|Withdrew Consent|2|||
161451072|NCT03180619|583048145|FG000|Overall Study|Death|2|||
161451073|NCT03180619|583048146|FG001|Overall Study|Death|1|||
161451074|NCT03180619|583048147|FG002|Overall Study|Death|2|||
161451075|NCT03180619|583048145|FG000|Overall Study|Adverse Event|2|||
161451076|NCT03180619|583048146|FG001|Overall Study|Adverse Event|0|||
161451077|NCT03180619|583048147|FG002|Overall Study|Adverse Event|1|||
161451078|NCT03180619|583048145|FG000|Overall Study|Investigator's discretion|2|||
161451079|NCT03180619|583048146|FG001|Overall Study|Investigator's discretion|0|||
161451080|NCT03180619|583048147|FG002|Overall Study|Investigator's discretion|1|||
161451081|NCT00275340|583048150|FG000|Overall Study|Lost to Follow-up|2|||
161451082|NCT00275340|583048151|FG001|Overall Study|Lost to Follow-up|4|||
161451083|NCT00862641|583048154|FG000|Overall Study|Randomized, but drug not received|1|||
161451084|NCT00862641|583048155|FG001|Overall Study|Randomized, but drug not received|4|||
161451085|NCT00862641|583048156|FG002|Overall Study|Randomized, but drug not received|1|||
161451086|NCT00862641|583048157|FG003|Overall Study|Randomized, but drug not received|4|||
161451087|NCT02365480|583048158|FG000|Overall Study|Withdrawal by Subject|2|||
161451088|NCT02365480|583048159|FG001|Overall Study|Withdrawal by Subject|0|||
161451089|NCT01419197|583048164|FG000|Overall Study|Death|247|||
161451090|NCT01419197|583048165|FG001|Overall Study|Death|122|||
161451091|NCT01419197|583048164|FG000|Overall Study|Physician Decision|4|||
161451092|NCT01419197|583048165|FG001|Overall Study|Physician Decision|4|||
161451093|NCT01419197|583048164|FG000|Overall Study|Non-compliance|3|||
161451094|NCT01419197|583048165|FG001|Overall Study|Non-compliance|1|||
161451095|NCT01419197|583048164|FG000|Overall Study|Withdrawal by Subject|33|||
161451096|NCT01419197|583048165|FG001|Overall Study|Withdrawal by Subject|32|||
161451097|NCT01419197|583048164|FG000|Overall Study|Study Completed by Sponsor|103|||
161451098|NCT01419197|583048165|FG001|Overall Study|Study Completed by Sponsor|34|||
161451099|NCT01419197|583048164|FG000|Overall Study|Reason Not Specified|0|||
161451100|NCT01419197|583048165|FG001|Overall Study|Reason Not Specified|1|||
161451101|NCT01419197|583048164|FG000|Overall Study|Lost to Follow-up|14|||
161451102|NCT01419197|583048165|FG001|Overall Study|Lost to Follow-up|4|||
161451103|NCT01781299|583048166|FG000|Overall Study|Withdrawal by Subject|0|||
161451104|NCT01781299|583048167|FG001|Overall Study|Withdrawal by Subject|1|||
161451105|NCT00146848|583048171|FG000|Pre-randomization|Death|19|||
161451106|NCT00146848|583048172|FG001|Pre-randomization|Death|0|||
161451107|NCT00146848|583048173|FG002|Pre-randomization|Death|0|||
161451108|NCT00146848|583048171|FG000|Pre-randomization|Lost to Follow-up|70|||
161451109|NCT00146848|583048172|FG001|Pre-randomization|Lost to Follow-up|0|||
161451110|NCT00146848|583048173|FG002|Pre-randomization|Lost to Follow-up|0|||
161451111|NCT00146848|583048171|FG000|Pre-randomization|Physician Decision|8|||
161451112|NCT00146848|583048172|FG001|Pre-randomization|Physician Decision|0|||
161451113|NCT00146848|583048173|FG002|Pre-randomization|Physician Decision|0|||
161451114|NCT00146848|583048171|FG000|Pre-randomization|Protocol Violation|172|||
161668044|NCT00406653|583837480|FG004|Induction Period|Declined participation but followup done|0|||
161451115|NCT00146848|583048172|FG001|Pre-randomization|Protocol Violation|0|||
161451116|NCT00146848|583048173|FG002|Pre-randomization|Protocol Violation|0|||
161798930|NCT00520741|584307154|FG000|Overall Study|Lack of Efficacy|11|||
161798931|NCT00520741|584307155|FG001|Overall Study|Lack of Efficacy|30|||
161798932|NCT00520741|584307154|FG000|Overall Study|Withdrawal by Subject|0|||
161902899|NCT01386606|584692414|FG001|Overall Study|Subject incarcerated|1|||
161798933|NCT00520741|584307155|FG001|Overall Study|Withdrawal by Subject|11|||
161798934|NCT00520741|584307154|FG000|Overall Study|Protocol Violation|2|||
161798935|NCT00520741|584307155|FG001|Overall Study|Protocol Violation|15|||
161798936|NCT00520741|584307154|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
161798937|NCT00520741|584307155|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
161798938|NCT00520741|584307154|FG000|Overall Study|Lost to Follow-up|4|||
161798939|NCT00520741|584307155|FG001|Overall Study|Lost to Follow-up|4|||
161798940|NCT00520741|584307154|FG000|Overall Study|Other reasons for premature termination|0|||
161798941|NCT00520741|584307155|FG001|Overall Study|Other reasons for premature termination|6|||
161798942|NCT03702621|584307156|FG000|Overall Study|Physician Decision|6|||
161798943|NCT03702621|584307157|FG001|Overall Study|Physician Decision|6|||
161798944|NCT03444038|584307158|FG000|Overall Study|Adverse Event|12|||
161798945|NCT03444038|584307158|FG000|Overall Study|Withdrawal by Subject|7|||
161798946|NCT03444038|584307158|FG000|Overall Study|Lost to Follow-up|1|||
161798947|NCT03444038|584307158|FG000|Overall Study|Physician Decision|2|||
161798948|NCT03444038|584307158|FG000|Overall Study|Lack of Efficacy|7|||
161798949|NCT02354586|584307160|FG000|Overall Study|Death|230|||
161798950|NCT02354586|584307160|FG000|Overall Study|Withdrawal by Subject|59|||
161798951|NCT02354586|584307160|FG000|Overall Study|Lost to Follow-up|11|||
161798952|NCT02354586|584307160|FG000|Overall Study|Sponsor decision|51|||
161798953|NCT02354586|584307160|FG000|Overall Study|Site closure|2|||
161798954|NCT02354586|584307160|FG000|Overall Study|Intercurrent illness|1|||
161798955|NCT02354586|584307160|FG000|Overall Study|Protocol Violation|3|||
161798956|NCT02354586|584307160|FG000|Overall Study|Physician Decision|13|||
161798957|NCT02354586|584307160|FG000|Overall Study|Lack of Efficacy|86|||
161798958|NCT02354586|584307160|FG000|Overall Study|Adverse Event|7|||
161798959|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
161798960|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161798961|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
161798962|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
161798963|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161798964|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161798965|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
161798966|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
161798967|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
161798968|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
161798969|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
161798970|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
161798971|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
161798972|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
161798973|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
161798974|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
161798975|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
161798976|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
161798977|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161798978|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161798979|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161798980|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161798981|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161798982|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
161798983|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798984|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798985|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798986|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798987|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
161798988|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798989|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
161798990|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
161798991|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
161798992|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
161798993|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
161798994|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
161798995|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
161798996|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161798997|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
161798998|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
161798999|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161902900|NCT01386606|584692415|FG002|Overall Study|Subject incarcerated|0|||
161902901|NCT01386606|584692416|FG003|Overall Study|Subject incarcerated|0|||
161902902|NCT01386606|584692413|FG000|Overall Study|Unable to draw PK|1|||
161799000|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161799001|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Other|1|||
161799002|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Other|0|||
161902903|NCT01386606|584692414|FG001|Overall Study|Unable to draw PK|0|||
161902904|NCT01386606|584692415|FG002|Overall Study|Unable to draw PK|0|||
161902905|NCT01386606|584692416|FG003|Overall Study|Unable to draw PK|0|||
161902906|NCT01386606|584692413|FG000|Overall Study|T levels too high|0|||
161902907|NCT01386606|584692414|FG001|Overall Study|T levels too high|1|||
161902908|NCT01386606|584692415|FG002|Overall Study|T levels too high|1|||
161902909|NCT01386606|584692416|FG003|Overall Study|T levels too high|0|||
161902910|NCT00593814|584692418|FG000|Overall Study|Death|7|||
161902911|NCT00593814|584692419|FG001|Overall Study|Death|0|||
161902912|NCT00593814|584692418|FG000|Overall Study|Withdrawal by Subject|7|||
161902913|NCT00593814|584692419|FG001|Overall Study|Withdrawal by Subject|0|||
161902914|NCT00593814|584692418|FG000|Overall Study|Lost to Follow-up|7|||
161902915|NCT00593814|584692419|FG001|Overall Study|Lost to Follow-up|0|||
161902916|NCT00593814|584692418|FG000|Overall Study|Physician Decision|3|||
161902917|NCT00593814|584692419|FG001|Overall Study|Physician Decision|0|||
161902918|NCT02723188|584692422|FG000|Overall Study|Withdrawal by Subject|1|||
161902919|NCT02723188|584692423|FG001|Overall Study|Withdrawal by Subject|0|||
161902920|NCT02723188|584692424|FG002|Overall Study|Withdrawal by Subject|0|||
161902921|NCT03110354|584692428|FG000|Overall Study|Death|1|||
161902922|NCT03110354|584692429|FG001|Overall Study|Death|0|||
161902923|NCT03110354|584692430|FG002|Overall Study|Death|0|||
161902924|NCT03110354|584692431|FG003|Overall Study|Death|1|||
161902925|NCT03110354|584692432|FG004|Overall Study|Death|0|||
161902926|NCT03110354|584692428|FG000|Overall Study|Start of new therapy|0|||
161902927|NCT03110354|584692429|FG001|Overall Study|Start of new therapy|0|||
161902928|NCT03110354|584692430|FG002|Overall Study|Start of new therapy|0|||
161902929|NCT03110354|584692431|FG003|Overall Study|Start of new therapy|0|||
161902930|NCT03110354|584692432|FG004|Overall Study|Start of new therapy|1|||
161902931|NCT03110354|584692428|FG000|Overall Study|Failure to achieve response|2|||
161902932|NCT03110354|584692429|FG001|Overall Study|Failure to achieve response|3|||
161902933|NCT03110354|584692430|FG002|Overall Study|Failure to achieve response|0|||
161902934|NCT03110354|584692431|FG003|Overall Study|Failure to achieve response|2|||
161902935|NCT03110354|584692432|FG004|Overall Study|Failure to achieve response|1|||
161902936|NCT03110354|584692428|FG000|Overall Study|Progressive disease|1|||
161902937|NCT03110354|584692429|FG001|Overall Study|Progressive disease|1|||
161902938|NCT03110354|584692430|FG002|Overall Study|Progressive disease|3|||
161902939|NCT03110354|584692431|FG003|Overall Study|Progressive disease|4|||
161902940|NCT03110354|584692432|FG004|Overall Study|Progressive disease|2|||
161902941|NCT03110354|584692428|FG000|Overall Study|Adverse Event|0|||
161902942|NCT03110354|584692429|FG001|Overall Study|Adverse Event|0|||
161902943|NCT03110354|584692430|FG002|Overall Study|Adverse Event|0|||
161902944|NCT03110354|584692431|FG003|Overall Study|Adverse Event|2|||
161902945|NCT03110354|584692432|FG004|Overall Study|Adverse Event|2|||
161902946|NCT03110354|584692428|FG000|Overall Study|Other|0|||
161902947|NCT03110354|584692429|FG001|Overall Study|Other|0|||
161902948|NCT03110354|584692430|FG002|Overall Study|Other|0|||
161902949|NCT03110354|584692431|FG003|Overall Study|Other|1|||
161902950|NCT03110354|584692432|FG004|Overall Study|Other|1|||
161902951|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
161902952|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
161902953|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
161902954|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
161902955|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
161902956|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
161902957|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
161902958|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
161902959|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
161902960|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
161902961|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
161902962|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
161902963|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
161902964|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
161902965|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
161902966|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
161902967|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
161902968|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
161902969|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
161902970|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
161902971|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
161902972|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
161902973|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
161902974|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
161902975|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
161902976|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
161902977|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
161902978|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
161902979|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
161556285|NCT02584855|583425436|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
161556286|NCT02584855|583425437|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
161556287|NCT02584855|583425438|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
161556288|NCT02584855|583425439|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
161556289|NCT02584855|583425440|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
161556290|NCT02584855|583425441|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
161556291|NCT02584855|583425436|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
161556292|NCT02584855|583425437|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
161556293|NCT02584855|583425438|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
161556294|NCT02584855|583425439|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
161556295|NCT02584855|583425440|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
161556296|NCT02584855|583425441|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
161556297|NCT02584855|583425436|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161556298|NCT02584855|583425437|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161556299|NCT02584855|583425438|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161556300|NCT02584855|583425439|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161556301|NCT02584855|583425440|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
161556302|NCT02584855|583425441|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161799003|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Other|0|||
161799004|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Other|0|||
161799005|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Other|0|||
161799006|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Other|0|||
161799007|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799008|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
161799009|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799010|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799011|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799012|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799013|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799014|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799015|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799016|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799017|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
161799018|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799019|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799020|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799021|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799022|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799023|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799024|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
161799025|NCT01957488|584307161|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
161799026|NCT01957488|584307162|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799027|NCT01957488|584307163|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799028|NCT01957488|584307164|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799029|NCT01957488|584307165|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799030|NCT01957488|584307166|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799031|NCT01957488|584307161|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799032|NCT01957488|584307162|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
161799033|NCT01957488|584307163|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799034|NCT01957488|584307164|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799035|NCT01957488|584307165|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799036|NCT01957488|584307166|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799037|NCT00721409|584307167|FG000|Overall Study|Global deterioration of health status|2|||
161799038|NCT00721409|584307168|FG001|Overall Study|Global deterioration of health status|6|||
161799039|NCT00721409|584307169|FG002|Overall Study|Global deterioration of health status|3|||
161799040|NCT00721409|584307167|FG000|Overall Study|Death|0|||
161799041|NCT00721409|584307168|FG001|Overall Study|Death|1|||
161799042|NCT00721409|584307169|FG002|Overall Study|Death|0|||
161799043|NCT00721409|584307167|FG000|Overall Study|Randomized not Treated|0|||
161799044|NCT00721409|584307168|FG001|Overall Study|Randomized not Treated|1|||
161799045|NCT00721409|584307169|FG002|Overall Study|Randomized not Treated|4|||
161799046|NCT00721409|584307167|FG000|Overall Study|Reason not specified|1|||
161799047|NCT00721409|584307168|FG001|Overall Study|Reason not specified|0|||
161799048|NCT00721409|584307169|FG002|Overall Study|Reason not specified|2|||
161799049|NCT00721409|584307167|FG000|Overall Study|Adverse Event|0|||
161799050|NCT00721409|584307168|FG001|Overall Study|Adverse Event|13|||
161799051|NCT00721409|584307169|FG002|Overall Study|Adverse Event|2|||
161799052|NCT00721409|584307167|FG000|Overall Study|Lost to Follow-up|0|||
161799053|NCT00721409|584307168|FG001|Overall Study|Lost to Follow-up|0|||
161799054|NCT00721409|584307169|FG002|Overall Study|Lost to Follow-up|1|||
161799055|NCT00721409|584307167|FG000|Overall Study|Withdrawal by Subject|1|||
161799056|NCT00721409|584307168|FG001|Overall Study|Withdrawal by Subject|6|||
161799057|NCT00721409|584307169|FG002|Overall Study|Withdrawal by Subject|5|||
161799058|NCT00721409|584307167|FG000|Overall Study|Objective progression or relapse|8|||
161799059|NCT00721409|584307168|FG001|Overall Study|Objective progression or relapse|55|||
161799060|NCT00721409|584307169|FG002|Overall Study|Objective progression or relapse|62|||
161799061|NCT02402166|584307170|FG000|Overall Study|Adverse Event|2|||
161799062|NCT02402166|584307170|FG000|Overall Study|Withdrawal by Subject|2|||
161799063|NCT02402166|584307170|FG000|Overall Study|Lost to Follow-up|1|||
161799064|NCT00623103|584307171|FG000|Overall Study|Adverse Event|70|||
161799065|NCT00623103|584307172|FG001|Overall Study|Adverse Event|60|||
161799066|NCT00623103|584307171|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161799067|NCT00623103|584307172|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
161799068|NCT00623103|584307171|FG000|Overall Study|Withdrawal by Subject|18|||
161799069|NCT00623103|584307172|FG001|Overall Study|Withdrawal by Subject|24|||
161799070|NCT00623103|584307171|FG000|Overall Study|Lost to Follow-up|4|||
161799071|NCT00623103|584307172|FG001|Overall Study|Lost to Follow-up|1|||
161799072|NCT00623103|584307171|FG000|Overall Study|Administrative problems|2|||
161799073|NCT00623103|584307172|FG001|Overall Study|Administrative problems|4|||
161451117|NCT00146848|583048171|FG000|Pre-randomization|Withdrawal by Subject|40|||
161451118|NCT00146848|583048172|FG001|Pre-randomization|Withdrawal by Subject|0|||
161451119|NCT00146848|583048173|FG002|Pre-randomization|Withdrawal by Subject|0|||
161451120|NCT00146848|583048171|FG000|Post-randomization|Lost to Follow-up|12|||
161451121|NCT00146848|583048172|FG001|Post-randomization|Lost to Follow-up|15|||
161451122|NCT00146848|583048173|FG002|Post-randomization|Lost to Follow-up|12|||
161451123|NCT00146848|583048171|FG000|Post-randomization|Withdrawn|26|||
161451124|NCT00146848|583048172|FG001|Post-randomization|Withdrawn|32|||
161451125|NCT00146848|583048173|FG002|Post-randomization|Withdrawn|27|||
161451126|NCT02395172|583048174|FG000|Overall Study|Participants randomized but not treated|3|||
161451127|NCT02395172|583048175|FG001|Overall Study|Participants randomized but not treated|31|||
161451128|NCT02032238|583048176|FG000|Overall Study|Lost to Follow-up|2|||
161451129|NCT02032238|583048177|FG001|Overall Study|Lost to Follow-up|0|||
161451130|NCT00653939|583048178|FG000|Overall Study|Adverse Event|1|||
161451131|NCT00653939|583048179|FG001|Overall Study|Adverse Event|3|||
161451132|NCT00653939|583048178|FG000|Overall Study|Withdrawal by Subject|3|||
161451133|NCT00653939|583048179|FG001|Overall Study|Withdrawal by Subject|3|||
161451134|NCT00653939|583048178|FG000|Overall Study|Physician Decision|4|||
161451135|NCT00653939|583048179|FG001|Overall Study|Physician Decision|0|||
161451136|NCT00653939|583048178|FG000|Overall Study|Disease Progression|2|||
161451137|NCT00653939|583048179|FG001|Overall Study|Disease Progression|3|||
161451138|NCT00653939|583048178|FG000|Overall Study|Other|2|||
161451139|NCT00653939|583048179|FG001|Overall Study|Other|6|||
161451140|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
161451141|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
161451142|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
161451143|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
161451144|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
161451145|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
161451146|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
161451147|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
161451148|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
161451149|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
161451150|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
161451151|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
161451152|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
161451153|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
161451154|NCT00612105|583048180|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
161451155|NCT00612105|583048181|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
161451156|NCT00612105|583048180|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
161451157|NCT00612105|583048181|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
161451158|NCT00612105|583048180|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
161451159|NCT00612105|583048181|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
161451160|NCT00612105|583048180|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
161451161|NCT00612105|583048181|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
161451162|NCT00612105|583048180|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
161451163|NCT00612105|583048181|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
161451164|NCT00717236|583048182|FG000|Double-Blind Period|Adverse Event|33|||
161451165|NCT00717236|583048183|FG001|Double-Blind Period|Adverse Event|6|||
161799074|NCT00623103|584307171|FG000|Overall Study|Death|11|||
161799075|NCT00623103|584307172|FG001|Overall Study|Death|11|||
161799076|NCT00623103|584307171|FG000|Overall Study|Protocol deviation|2|||
161799077|NCT00623103|584307172|FG001|Overall Study|Protocol deviation|1|||
161799078|NCT02433678|584307177|FG000|Overall Study|Lost to Follow-up|1|||
161902980|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
161902981|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
161902982|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
161902983|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
161902984|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
161902985|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
161902986|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
161902987|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
161902988|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
161902989|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
161902990|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
161902991|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
161902992|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
161902993|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
161902994|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
161902995|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
161902996|NCT03353792|584692442|FG000|Overall Study|Lost to Follow-up|1|||
161902997|NCT03353792|584692443|FG001|Overall Study|Lost to Follow-up|0|||
161902998|NCT03353792|584692442|FG000|Overall Study|Participant Unable to Manage Device|1|||
161902999|NCT03353792|584692443|FG001|Overall Study|Participant Unable to Manage Device|0|||
161903000|NCT01965327|584692444|FG000|Overall Study|Physician Decision|2|||
161903001|NCT00528424|584692445|FG000|Overall Study|Lost to Follow-up|13|||
161903002|NCT00528424|584692445|FG000|Overall Study|Withdrew consent|2|||
161903003|NCT00528424|584692445|FG000|Overall Study|Administrative reason|2|||
161903004|NCT00528424|584692445|FG000|Overall Study|Other|12|||
161903005|NCT02185417|584692446|FG000|Overall Study|Death|448|||
161903006|NCT02185417|584692447|FG001|Overall Study|Death|446|||
161903007|NCT02185417|584692448|FG002|Overall Study|Death|0|||
161903008|NCT02185417|584692446|FG000|Overall Study|Withdrawal by Subject|7|||
161903009|NCT02185417|584692447|FG001|Overall Study|Withdrawal by Subject|12|||
161903010|NCT02185417|584692448|FG002|Overall Study|Withdrawal by Subject|0|||
161903011|NCT02976519|584692451|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903012|NCT02976519|584692452|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
161903013|NCT02976519|584692453|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903014|NCT02976519|584692454|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903015|NCT02976519|584692455|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903016|NCT02976519|584692456|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903017|NCT02976519|584692457|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903018|NCT02976519|584692451|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903019|NCT02976519|584692452|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903020|NCT02976519|584692453|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903021|NCT02976519|584692454|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
161903022|NCT02976519|584692455|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903023|NCT02976519|584692456|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903024|NCT02976519|584692457|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903025|NCT02976519|584692451|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903026|NCT02976519|584692452|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903027|NCT02976519|584692453|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903028|NCT02976519|584692454|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903029|NCT02976519|584692455|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903030|NCT02976519|584692456|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903031|NCT02976519|584692457|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
161903032|NCT02976519|584692451|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903033|NCT02976519|584692452|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903034|NCT02976519|584692453|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903035|NCT02976519|584692454|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903036|NCT02976519|584692455|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161451166|NCT00717236|583048182|FG000|Double-Blind Period|Lack of Efficacy|6|||
161451167|NCT00717236|583048183|FG001|Double-Blind Period|Lack of Efficacy|6|||
161451168|NCT00717236|583048182|FG000|Double-Blind Period|Lost to Follow-up|3|||
161451169|NCT00717236|583048183|FG001|Double-Blind Period|Lost to Follow-up|5|||
161451170|NCT00717236|583048182|FG000|Double-Blind Period|Withdrawal by Subject|10|||
161451171|NCT00717236|583048183|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161451172|NCT00717236|583048182|FG000|Double-Blind Period|Loss of efficacy|3|||
161451173|NCT00717236|583048183|FG001|Double-Blind Period|Loss of efficacy|0|||
161903037|NCT02976519|584692456|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903038|NCT02976519|584692457|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
161903039|NCT02976519|584692451|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903040|NCT02976519|584692452|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161556303|NCT02584855|583425436|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
161556304|NCT02584855|583425437|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
161556305|NCT02584855|583425438|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
161556306|NCT02584855|583425439|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
161556307|NCT02584855|583425440|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
161556308|NCT02584855|583425441|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
161556309|NCT02337478|583425442|FG000|Overall Study|Lack of Efficacy|5|||
161556310|NCT02611830|583425443|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
161556311|NCT02611830|583425444|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
161556312|NCT02611830|583425445|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
161556313|NCT02611830|583425446|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
161556314|NCT02611830|583425443|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
161556315|NCT02611830|583425444|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
161556316|NCT02611830|583425445|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
161556317|NCT02611830|583425446|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
161556318|NCT02611830|583425443|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
161799079|NCT02433678|584307178|FG001|Overall Study|Lost to Follow-up|2|||
161799080|NCT01424722|584307182|FG000|Overall Study|Sponsor terminated investigation|2258|||
161799081|NCT02483975|584307183|FG000|Overall Study|Adverse Event|0|||
161799082|NCT02483975|584307184|FG001|Overall Study|Adverse Event|1|||
161799083|NCT02483975|584307183|FG000|Overall Study|Lost to Follow-up|0|||
161799084|NCT02483975|584307184|FG001|Overall Study|Lost to Follow-up|1|||
161799085|NCT02483975|584307183|FG000|Overall Study|Physician Decision|2|||
161799086|NCT02483975|584307184|FG001|Overall Study|Physician Decision|0|||
161799087|NCT00818883|584307185|FG000|Overall Study|Adverse Event|28|||
161799088|NCT00818883|584307186|FG001|Overall Study|Adverse Event|19|||
161799089|NCT00818883|584307185|FG000|Overall Study|Protocol Violation|2|||
161799090|NCT00818883|584307186|FG001|Overall Study|Protocol Violation|2|||
161799091|NCT00818883|584307185|FG000|Overall Study|Lost to Follow-up|3|||
161799092|NCT00818883|584307186|FG001|Overall Study|Lost to Follow-up|2|||
161799093|NCT00818883|584307185|FG000|Overall Study|Withdrawal by Subject|16|||
161799094|NCT00818883|584307186|FG001|Overall Study|Withdrawal by Subject|14|||
161799095|NCT00818883|584307185|FG000|Overall Study|Lack of Efficacy|0|||
161799096|NCT00818883|584307186|FG001|Overall Study|Lack of Efficacy|2|||
161799097|NCT00818883|584307185|FG000|Overall Study|Other|2|||
161799098|NCT00818883|584307186|FG001|Overall Study|Other|7|||
161799099|NCT02684578|584307190|FG000|Overall Study|Withdrawal by Subject|10|||
161799100|NCT02684578|584307191|FG001|Overall Study|Withdrawal by Subject|7|||
161799101|NCT02684578|584307190|FG000|Overall Study|Lost to Follow-up|0|||
161799102|NCT02684578|584307191|FG001|Overall Study|Lost to Follow-up|3|||
161799103|NCT02684578|584307190|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
161799104|NCT02684578|584307191|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
161799105|NCT02684578|584307190|FG000|Overall Study|Missing follow-up data|0|||
161799106|NCT02684578|584307191|FG001|Overall Study|Missing follow-up data|1|||
161799107|NCT01618266|584307195|FG000|Overall Study|Lost to Follow-up|9|||
161799108|NCT01618266|584307195|FG000|Overall Study|Treatment satisfaction|10|||
161799109|NCT01618266|584307195|FG000|Overall Study|Other reasons|11|||
161799110|NCT01618266|584307195|FG000|Overall Study|Lack of Efficacy|23|||
161799111|NCT01618266|584307195|FG000|Overall Study|Protocol Violation|43|||
161799112|NCT01966042|584307196|FG000|Overall Study|Death|2|||
161799113|NCT03267264|584307197|FG000|Overall Study|Withdrawal by Subject|1|||
161799114|NCT03267264|584307198|FG001|Overall Study|Withdrawal by Subject|0|||
161799115|NCT03267264|584307199|FG002|Overall Study|Withdrawal by Subject|2|||
161799116|NCT03267264|584307200|FG003|Overall Study|Withdrawal by Subject|4|||
161799117|NCT02224391|584307201|FG000|Overall Study|Lost to Follow-up|26|||
161799118|NCT02224391|584307202|FG001|Overall Study|Lost to Follow-up|19|||
161799119|NCT02224391|584307201|FG000|Overall Study|Withdrawal by Subject|6|||
161799120|NCT02224391|584307202|FG001|Overall Study|Withdrawal by Subject|5|||
161799121|NCT02492958|584307203|FG000|Overall Study|Withdrawal by Subject|0|||
161799122|NCT02492958|584307204|FG001|Overall Study|Withdrawal by Subject|0|||
161799123|NCT02492958|584307205|FG002|Overall Study|Withdrawal by Subject|1|||
161799124|NCT02492958|584307206|FG003|Overall Study|Withdrawal by Subject|0|||
161799125|NCT02492958|584307203|FG000|Overall Study|Adverse Event|1|||
161556319|NCT02611830|583425444|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
161799126|NCT02492958|584307204|FG001|Overall Study|Adverse Event|0|||
161799127|NCT02492958|584307205|FG002|Overall Study|Adverse Event|1|||
161556320|NCT02611830|583425445|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
161799128|NCT02492958|584307206|FG003|Overall Study|Adverse Event|0|||
161799129|NCT03522948|584307207|FG000|Overall Study|Lost to Follow-up|1|||
161556321|NCT02611830|583425446|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
161799130|NCT02236130|584307212|FG000|Overall Study|Lost to Follow-up|7|||
161799131|NCT02236130|584307213|FG001|Overall Study|Lost to Follow-up|12|||
161799132|NCT02114697|584307223|FG000|Overall Study|Study terminated|5|||
161799133|NCT02114697|584307224|FG001|Overall Study|Study terminated|4|||
161799134|NCT00424489|584307225|FG000|Overall Study|Death|3|||
161799135|NCT01984242|584307226|FG000|Overall Study|Death|52|||
161903041|NCT02976519|584692453|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903042|NCT02976519|584692454|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903043|NCT02976519|584692455|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903044|NCT02976519|584692456|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903045|NCT02976519|584692457|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
161903046|NCT01278342|584692458|FG000|Overall Study|Physician Decision|0|||
161903047|NCT01278342|584692459|FG001|Overall Study|Physician Decision|1|||
161903048|NCT01278342|584692460|FG002|Overall Study|Physician Decision|0|||
161903049|NCT01278342|584692458|FG000|Overall Study|Lost to Follow-up|1|||
161903050|NCT01278342|584692459|FG001|Overall Study|Lost to Follow-up|0|||
161903051|NCT01278342|584692460|FG002|Overall Study|Lost to Follow-up|0|||
161903052|NCT01278342|584692458|FG000|Overall Study|Administrative problems|2|||
161903053|NCT01278342|584692459|FG001|Overall Study|Administrative problems|0|||
161903054|NCT01278342|584692460|FG002|Overall Study|Administrative problems|0|||
161903055|NCT01278342|584692458|FG000|Overall Study|Other|1|||
161903056|NCT01278342|584692459|FG001|Overall Study|Other|0|||
161903057|NCT01278342|584692460|FG002|Overall Study|Other|0|||
161903058|NCT00243919|584692475|FG000|Overall Study|Death|3|||
161903059|NCT00243919|584692476|FG001|Overall Study|Death|4|||
161903060|NCT00243919|584692477|FG002|Overall Study|Death|6|||
161903061|NCT00243919|584692475|FG000|Overall Study|Withdrawal by Subject|6|||
161903062|NCT00243919|584692476|FG001|Overall Study|Withdrawal by Subject|6|||
161903063|NCT00243919|584692477|FG002|Overall Study|Withdrawal by Subject|2|||
161903064|NCT00243919|584692475|FG000|Overall Study|Lost to Follow-up|6|||
161903065|NCT00243919|584692476|FG001|Overall Study|Lost to Follow-up|7|||
161903066|NCT00243919|584692477|FG002|Overall Study|Lost to Follow-up|3|||
161903067|NCT00243919|584692475|FG000|Overall Study|Administrative Error|1|||
161903068|NCT00243919|584692476|FG001|Overall Study|Administrative Error|0|||
161903069|NCT00243919|584692477|FG002|Overall Study|Administrative Error|0|||
161903070|NCT00243919|584692475|FG000|Overall Study|Physician Decision|1|||
161903071|NCT00243919|584692476|FG001|Overall Study|Physician Decision|1|||
161903072|NCT00243919|584692477|FG002|Overall Study|Physician Decision|0|||
161903073|NCT04176939|584692478|FG000|Overall Study|Withdrawal by Subject|5|||
161903074|NCT04176939|584692478|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
161903075|NCT04176939|584692478|FG000|Overall Study|Lost to Follow-up|2|||
161903076|NCT04176939|584692478|FG000|Overall Study|Unspecified reason|4|||
161903077|NCT04176939|584692478|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
161903078|NCT02221648|584692482|FG000|Overall Study|Withdrawal by Subject|3|||
161903079|NCT02221648|584692483|FG001|Overall Study|Withdrawal by Subject|3|||
161903080|NCT00905424|584692485|FG000|Overall Study|Lost to Follow-up|3|||
161451174|NCT00717236|583048182|FG000|Double-Blind Period|Other: Death|1|||
161451175|NCT00717236|583048183|FG001|Double-Blind Period|Other: Death|0|||
161451176|NCT00717236|583048182|FG000|Double-Blind Period|Other: Pregnancy|1|||
161451177|NCT00717236|583048183|FG001|Double-Blind Period|Other: Pregnancy|0|||
161451178|NCT00717236|583048182|FG000|Double-Blind Period|Other: Protocol Violation|2|||
161451179|NCT00717236|583048183|FG001|Double-Blind Period|Other: Protocol Violation|0|||
161451180|NCT00717236|583048182|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
161451181|NCT00717236|583048183|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
161451182|NCT00717236|583048182|FG000|Double-Blind Period|Other: Site withdrew|2|||
161451183|NCT00717236|583048183|FG001|Double-Blind Period|Other: Site withdrew|0|||
161451184|NCT00717236|583048182|FG000|Double-Blind Period|Other: Screening failure|1|||
161451185|NCT00717236|583048183|FG001|Double-Blind Period|Other: Screening failure|0|||
161451186|NCT00717236|583048182|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
161451187|NCT00717236|583048183|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
161451188|NCT00717236|583048182|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
161451189|NCT00717236|583048183|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
161451190|NCT00717236|583048182|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
161451191|NCT00717236|583048183|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
161451192|NCT00717236|583048182|FG000|Double-Blind Period|Other: History of cancer|1|||
161451193|NCT00717236|583048183|FG001|Double-Blind Period|Other: History of cancer|0|||
161451194|NCT00717236|583048182|FG000|Double-Blind Period|Other: Sponsor request|1|||
161451195|NCT00717236|583048183|FG001|Double-Blind Period|Other: Sponsor request|0|||
161451196|NCT00717236|583048182|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
161451197|NCT00717236|583048183|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
161451198|NCT00717236|583048182|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
161451199|NCT00717236|583048183|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
161451200|NCT00717236|583048182|FG000|Double-Blind Period|Other: Subject moved|1|||
161451201|NCT00717236|583048183|FG001|Double-Blind Period|Other: Subject moved|1|||
161451202|NCT00717236|583048182|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
161451203|NCT00717236|583048183|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
161451204|NCT00717236|583048182|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
161451205|NCT00717236|583048183|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
161903081|NCT00905424|584692486|FG001|Overall Study|Lost to Follow-up|3|||
161903082|NCT00905424|584692485|FG000|Overall Study|Withdrawal by Subject|1|||
161451206|NCT00717236|583048182|FG000|Double-Blind Period|Other: Transportation problems|0|||
161451207|NCT00717236|583048183|FG001|Double-Blind Period|Other: Transportation problems|1|||
161451208|NCT00717236|583048182|FG000|Double-Blind Period|Other: Investigator Decision|0|||
161451209|NCT00717236|583048183|FG001|Double-Blind Period|Other: Investigator Decision|1|||
161451210|NCT00717236|583048182|FG000|Open-Label Period|Adverse Event|29|||
161451211|NCT00717236|583048183|FG001|Open-Label Period|Adverse Event|4|||
161451212|NCT00717236|583048182|FG000|Open-Label Period|Lack of Efficacy|30|||
161451213|NCT00717236|583048183|FG001|Open-Label Period|Lack of Efficacy|8|||
161451214|NCT00717236|583048182|FG000|Open-Label Period|Lost to Follow-up|28|||
161451215|NCT00717236|583048183|FG001|Open-Label Period|Lost to Follow-up|4|||
161451216|NCT00717236|583048182|FG000|Open-Label Period|Withdrawal by Subject|20|||
161451217|NCT00717236|583048183|FG001|Open-Label Period|Withdrawal by Subject|2|||
161451218|NCT00717236|583048182|FG000|Open-Label Period|Loss of Efficacy|6|||
161451219|NCT00717236|583048183|FG001|Open-Label Period|Loss of Efficacy|1|||
161451220|NCT00717236|583048182|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
161451221|NCT00717236|583048183|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
161451222|NCT00717236|583048182|FG000|Open-Label Period|Other: Lack of Compliance|1|||
161451223|NCT00717236|583048183|FG001|Open-Label Period|Other: Lack of Compliance|1|||
161451224|NCT00717236|583048182|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
161799136|NCT01984242|584307227|FG001|Overall Study|Death|50|||
161799137|NCT01984242|584307228|FG002|Overall Study|Death|52|||
161799138|NCT01984242|584307226|FG000|Overall Study|Withdrawal by Subject|5|||
161799139|NCT01984242|584307227|FG001|Overall Study|Withdrawal by Subject|3|||
161799140|NCT01984242|584307228|FG002|Overall Study|Withdrawal by Subject|10|||
161799141|NCT01984242|584307226|FG000|Overall Study|Physician Decision|0|||
161799142|NCT01984242|584307227|FG001|Overall Study|Physician Decision|0|||
161799143|NCT01984242|584307228|FG002|Overall Study|Physician Decision|1|||
161799144|NCT01984242|584307226|FG000|Overall Study|Lost to Follow-up|4|||
161799145|NCT01984242|584307227|FG001|Overall Study|Lost to Follow-up|0|||
161799146|NCT01984242|584307228|FG002|Overall Study|Lost to Follow-up|3|||
161799147|NCT01984242|584307226|FG000|Overall Study|Sponsor Decision|1|||
161799148|NCT01984242|584307227|FG001|Overall Study|Sponsor Decision|0|||
161799149|NCT01984242|584307228|FG002|Overall Study|Sponsor Decision|0|||
161799150|NCT01984242|584307226|FG000|Overall Study|Non-Compliance|1|||
161799151|NCT01984242|584307227|FG001|Overall Study|Non-Compliance|0|||
161799152|NCT01984242|584307228|FG002|Overall Study|Non-Compliance|0|||
161799153|NCT01984242|584307226|FG000|Overall Study|Study terminated by Sponsor|38|||
161799154|NCT01984242|584307227|FG001|Overall Study|Study terminated by Sponsor|50|||
161799155|NCT01984242|584307228|FG002|Overall Study|Study terminated by Sponsor|34|||
161799156|NCT01984242|584307226|FG000|Overall Study|Disease Progression|0|||
161799157|NCT01984242|584307227|FG001|Overall Study|Disease Progression|0|||
161799158|NCT01984242|584307228|FG002|Overall Study|Disease Progression|1|||
161799159|NCT00449150|584307231|FG000|Overall Study|Adverse Event|11|||
161799160|NCT00449150|584307232|FG001|Overall Study|Adverse Event|18|||
161799161|NCT00449150|584307233|FG002|Overall Study|Adverse Event|9|||
161799162|NCT00449150|584307231|FG000|Overall Study|Lack of Efficacy|1|||
161799163|NCT00449150|584307232|FG001|Overall Study|Lack of Efficacy|2|||
161799164|NCT00449150|584307233|FG002|Overall Study|Lack of Efficacy|2|||
161799165|NCT00449150|584307231|FG000|Overall Study|Other|16|||
161799166|NCT00449150|584307232|FG001|Overall Study|Other|13|||
161799167|NCT00449150|584307233|FG002|Overall Study|Other|14|||
161799168|NCT00449150|584307231|FG000|Overall Study|Withdrawal by Subject|17|||
161799169|NCT00449150|584307232|FG001|Overall Study|Withdrawal by Subject|18|||
161799170|NCT00449150|584307233|FG002|Overall Study|Withdrawal by Subject|21|||
161799171|NCT00449150|584307231|FG000|Overall Study|Protocol Violation|1|||
161799172|NCT00449150|584307232|FG001|Overall Study|Protocol Violation|2|||
161799173|NCT00449150|584307233|FG002|Overall Study|Protocol Violation|1|||
161799174|NCT00770510|584307234|FG000|Overall Study|Lost to Follow-up|2|||
161799175|NCT00770510|584307234|FG000|Overall Study|Pregnancy|1|||
161799176|NCT00770510|584307234|FG000|Overall Study|Withdrawal by Subject|2|||
161799177|NCT04117607|584307241|FG000|Overall Study|Early Termination|0|||
161799178|NCT04117607|584307242|FG001|Overall Study|Early Termination|1|||
161799179|NCT04117607|584307243|FG002|Overall Study|Early Termination|0|||
161799180|NCT04117607|584307244|FG003|Overall Study|Early Termination|0|||
161799181|NCT04117607|584307245|FG004|Overall Study|Early Termination|0|||
161799182|NCT04117607|584307246|FG005|Overall Study|Early Termination|0|||
161799183|NCT04117607|584307247|FG006|Overall Study|Early Termination|1|||
161799184|NCT04117607|584307248|FG007|Overall Study|Early Termination|0|||
161799185|NCT04117607|584307249|FG008|Overall Study|Early Termination|0|||
161799186|NCT04117607|584307250|FG009|Overall Study|Early Termination|0|||
161799187|NCT04117607|584307251|FG010|Overall Study|Early Termination|0|||
161799188|NCT04117607|584307252|FG011|Overall Study|Early Termination|0|||
161799189|NCT04117607|584307253|FG012|Overall Study|Early Termination|0|||
161799190|NCT04117607|584307254|FG013|Overall Study|Early Termination|0|||
161799191|NCT01626079|584307255|FG000|Overall Study|Death|167|||
161799192|NCT01626079|584307256|FG001|Overall Study|Death|192|||
161903083|NCT00905424|584692486|FG001|Overall Study|Withdrawal by Subject|2|||
161903084|NCT00905424|584692485|FG000|Overall Study|Adverse Event|4|||
161903085|NCT00905424|584692486|FG001|Overall Study|Adverse Event|2|||
161903086|NCT00905424|584692485|FG000|Overall Study|Non-compliance with study medication|2|||
161903087|NCT00905424|584692486|FG001|Overall Study|Non-compliance with study medication|0|||
161903088|NCT00905424|584692485|FG000|Overall Study|Sponsor decision|1|||
161903089|NCT00905424|584692486|FG001|Overall Study|Sponsor decision|0|||
161903090|NCT00905424|584692485|FG000|Overall Study|Positive urine drug screen|0|||
161903091|NCT00905424|584692486|FG001|Overall Study|Positive urine drug screen|1|||
161903092|NCT00905424|584692485|FG000|Overall Study|Non-adherence to visit schedule|0|||
161903093|NCT00905424|584692486|FG001|Overall Study|Non-adherence to visit schedule|1|||
161903094|NCT00426764|584692487|FG000|Overall Study|Protocol Violation|1|||
161903095|NCT00426764|584692487|FG000|Overall Study|Withdrawal by Subject|4|||
161903096|NCT00426764|584692487|FG000|Overall Study|Physician Decision|6|||
161903097|NCT00426764|584692487|FG000|Overall Study|Compassionate Use|1|||
161903098|NCT00426764|584692487|FG000|Overall Study|Progressive Disease|83|||
161903099|NCT00426764|584692487|FG000|Overall Study|Adverse Event|24|||
161903100|NCT00426764|584692487|FG000|Overall Study|Other|1|||
161903101|NCT00426764|584692487|FG000|Overall Study|Death|1|||
161903102|NCT00426764|584692487|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
161903103|NCT00379899|584692488|FG000|Overall Study|Adverse Event|7|||
161903104|NCT00379899|584692489|FG001|Overall Study|Adverse Event|3|||
161903105|NCT00379899|584692488|FG000|Overall Study|Death|10|||
161903106|NCT00379899|584692489|FG001|Overall Study|Death|10|||
161903107|NCT00379899|584692488|FG000|Overall Study|Lost to Follow-up|2|||
161903108|NCT00379899|584692489|FG001|Overall Study|Lost to Follow-up|4|||
161903109|NCT00379899|584692488|FG000|Overall Study|Physician Decision|3|||
161903110|NCT00379899|584692489|FG001|Overall Study|Physician Decision|4|||
161903111|NCT00379899|584692488|FG000|Overall Study|Withdrawal by Subject|5|||
161903112|NCT00379899|584692489|FG001|Overall Study|Withdrawal by Subject|5|||
161903113|NCT00379899|584692488|FG000|Overall Study|Ineligibility determined|0|||
161903114|NCT00379899|584692489|FG001|Overall Study|Ineligibility determined|1|||
161903115|NCT00379899|584692488|FG000|Overall Study|Noncompliance|1|||
161903116|NCT00379899|584692489|FG001|Overall Study|Noncompliance|1|||
161903117|NCT00379899|584692488|FG000|Overall Study|Parathyroidectomy|0|||
161903118|NCT00379899|584692489|FG001|Overall Study|Parathyroidectomy|2|||
161903119|NCT00379899|584692488|FG000|Overall Study|Renal transplantation|5|||
161903120|NCT00379899|584692489|FG001|Overall Study|Renal transplantation|4|||
161903121|NCT00379899|584692488|FG000|Overall Study|Coronary artery bypass graft|1|||
161903122|NCT00379899|584692489|FG001|Overall Study|Coronary artery bypass graft|1|||
161451225|NCT00717236|583048183|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
161451226|NCT00717236|583048182|FG000|Open-Label Period|Other: Moved|1|||
161451227|NCT00717236|583048183|FG001|Open-Label Period|Other: Moved|0|||
161451228|NCT00717236|583048182|FG000|Open-Label Period|Other: Investigator Decision|1|||
161451229|NCT00717236|583048183|FG001|Open-Label Period|Other: Investigator Decision|0|||
161451230|NCT00717236|583048182|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
161451231|NCT00717236|583048183|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
161451232|NCT00717236|583048182|FG000|Open-Label Period|Other: Sponsor Request|3|||
161451233|NCT00717236|583048183|FG001|Open-Label Period|Other: Sponsor Request|0|||
161451234|NCT00717236|583048182|FG000|Open-Label Period|Other: Cataract Surgery|1|||
161451235|NCT00717236|583048183|FG001|Open-Label Period|Other: Cataract Surgery|0|||
161451236|NCT00717236|583048182|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
161451237|NCT00717236|583048183|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
161451238|NCT00717236|583048182|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
161451239|NCT00717236|583048183|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
161451240|NCT00717236|583048182|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
161451241|NCT00717236|583048183|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
161451242|NCT01105767|583048184|FG000|Overall Study|Lost to Follow-up|1160|||
161451243|NCT01105767|583048185|FG001|Overall Study|Lost to Follow-up|1614|||
161451244|NCT01105767|583048186|FG002|Overall Study|Lost to Follow-up|1184|||
161451245|NCT00475982|583048187|FG000|Overall Study|surgery rescheduled|7|||
161451246|NCT00475982|583048188|FG001|Overall Study|surgery rescheduled|3|||
161451247|NCT02410343|583048193|FG000|Core Period (24 Weeks)|Adverse Event|1|||
161668045|NCT00406653|583837481|FG005|Induction Period|Declined participation but followup done|0|||
161903123|NCT00379899|584692488|FG000|Overall Study|Other protocol-specified criteria|3|||
161903124|NCT00379899|584692489|FG001|Overall Study|Other protocol-specified criteria|4|||
161903125|NCT00379899|584692488|FG000|Overall Study|Other|3|||
161903126|NCT00379899|584692489|FG001|Overall Study|Other|1|||
161903127|NCT01922258|584692490|FG000|Overall Study|Lost to Follow-up|1|||
161903128|NCT01922258|584692491|FG001|Overall Study|Lost to Follow-up|1|||
161903129|NCT01922258|584692490|FG000|Overall Study|Adverse Event|9|||
161903130|NCT01922258|584692491|FG001|Overall Study|Adverse Event|2|||
161903131|NCT01922258|584692490|FG000|Overall Study|Met Withdrawal Criteria|0|||
161903132|NCT01922258|584692491|FG001|Overall Study|Met Withdrawal Criteria|4|||
161903133|NCT01922258|584692490|FG000|Overall Study|Withdrawn by the Investigator|1|||
161903134|NCT01922258|584692491|FG001|Overall Study|Withdrawn by the Investigator|4|||
161451248|NCT02410343|583048194|FG001|Core Period (24 Weeks)|Adverse Event|0|||
161799193|NCT01626079|584307257|FG002|Overall Study|Death|39|||
161799194|NCT01626079|584307255|FG000|Overall Study|Withdrawal by Subject|23|||
161799195|NCT01626079|584307256|FG001|Overall Study|Withdrawal by Subject|37|||
161799196|NCT01626079|584307257|FG002|Overall Study|Withdrawal by Subject|5|||
161799197|NCT01626079|584307255|FG000|Overall Study|Lost to Follow-up|7|||
161799198|NCT01626079|584307256|FG001|Overall Study|Lost to Follow-up|4|||
161799199|NCT01626079|584307257|FG002|Overall Study|Lost to Follow-up|2|||
161799200|NCT01626079|584307255|FG000|Overall Study|Missed Visits|1|||
161799201|NCT01626079|584307256|FG001|Overall Study|Missed Visits|4|||
161799202|NCT01626079|584307257|FG002|Overall Study|Missed Visits|6|||
161799203|NCT02073643|584307260|FG000|Overall Study|Lost to Follow-up|24|||
161799204|NCT02430870|584307261|FG000|Part 2|Voluntary Withdrawal|0|||
161799205|NCT02430870|584307262|FG001|Part 2|Voluntary Withdrawal|0|||
161799206|NCT02430870|584307263|FG002|Part 2|Voluntary Withdrawal|0|||
161799207|NCT02430870|584307264|FG003|Part 2|Voluntary Withdrawal|0|||
161799208|NCT02430870|584307265|FG004|Part 2|Voluntary Withdrawal|0|||
161799209|NCT02430870|584307266|FG005|Part 2|Voluntary Withdrawal|0|||
161799210|NCT02430870|584307267|FG006|Part 2|Voluntary Withdrawal|1|||
161799211|NCT02430870|584307268|FG007|Part 2|Voluntary Withdrawal|0|||
161799212|NCT02430870|584307261|FG000|Part 2|Other Reason Not Specified|0|||
161799213|NCT02430870|584307262|FG001|Part 2|Other Reason Not Specified|0|||
161799214|NCT02430870|584307263|FG002|Part 2|Other Reason Not Specified|0|||
161799215|NCT02430870|584307264|FG003|Part 2|Other Reason Not Specified|0|||
161799216|NCT02430870|584307265|FG004|Part 2|Other Reason Not Specified|0|||
161799217|NCT02430870|584307266|FG005|Part 2|Other Reason Not Specified|0|||
161799218|NCT02430870|584307267|FG006|Part 2|Other Reason Not Specified|0|||
161799219|NCT02430870|584307268|FG007|Part 2|Other Reason Not Specified|1|||
161799220|NCT00865709|584307269|FG000|Treatment|Adverse Event|9|||
161799221|NCT00865709|584307270|FG001|Treatment|Adverse Event|6|||
161799222|NCT00865709|584307269|FG000|Treatment|Withdrawal by Subject|10|||
161799223|NCT00865709|584307270|FG001|Treatment|Withdrawal by Subject|7|||
161799224|NCT00865709|584307269|FG000|Treatment|Physician Decision|3|||
161799225|NCT00865709|584307270|FG001|Treatment|Physician Decision|2|||
161799226|NCT00865709|584307269|FG000|Treatment|Surgery|8|||
161799227|NCT00865709|584307270|FG001|Treatment|Surgery|3|||
161799228|NCT00429923|584307271|FG000|Overall Study|Adverse Event|0|||
161799229|NCT00429923|584307272|FG001|Overall Study|Adverse Event|2|||
161799230|NCT00429923|584307273|FG002|Overall Study|Adverse Event|3|||
161799231|NCT00429923|584307271|FG000|Overall Study|Lack of Efficacy|4|||
161799232|NCT00429923|584307272|FG001|Overall Study|Lack of Efficacy|1|||
161799233|NCT00429923|584307273|FG002|Overall Study|Lack of Efficacy|33|||
161799234|NCT00429923|584307271|FG000|Overall Study|Lost to Follow-up|0|||
161799235|NCT00429923|584307272|FG001|Overall Study|Lost to Follow-up|0|||
161799236|NCT00429923|584307273|FG002|Overall Study|Lost to Follow-up|2|||
161799237|NCT00429923|584307271|FG000|Overall Study|Withdrew Consent|1|||
161799238|NCT00429923|584307272|FG001|Overall Study|Withdrew Consent|0|||
161799239|NCT00429923|584307273|FG002|Overall Study|Withdrew Consent|1|||
161799240|NCT00429923|584307271|FG000|Overall Study|Early Termination|0|||
161799241|NCT00429923|584307272|FG001|Overall Study|Early Termination|1|||
161451249|NCT02410343|583048193|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
161451250|NCT02410343|583048194|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
161451251|NCT02410343|583048193|FG000|Extension Period (12 Months)|Adverse Event|1|||
161451252|NCT02410343|583048194|FG001|Extension Period (12 Months)|Adverse Event|0|||
161451253|NCT02410343|583048193|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
161451254|NCT02410343|583048194|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
161451255|NCT00029146|583048195|FG000|Overall Study|Lost to Follow-up|2|||
161451256|NCT00029146|583048196|FG001|Overall Study|Lost to Follow-up|1|||
161451257|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
161451258|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
161451259|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
161451260|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
161451261|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
161451262|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
161799242|NCT00429923|584307273|FG002|Overall Study|Early Termination|0|||
161799243|NCT01265784|584307274|FG000|Overall Study|Lost to Follow-up|5|||
161799244|NCT01265784|584307275|FG001|Overall Study|Lost to Follow-up|3|||
161799245|NCT01265784|584307276|FG002|Overall Study|Lost to Follow-up|2|||
161799246|NCT01265784|584307274|FG000|Overall Study|Withdrawal by Subject|0|||
161799247|NCT01265784|584307275|FG001|Overall Study|Withdrawal by Subject|5|||
161799248|NCT01265784|584307276|FG002|Overall Study|Withdrawal by Subject|0|||
161799249|NCT01265784|584307274|FG000|Overall Study|Physician Decision|1|||
161799250|NCT01265784|584307275|FG001|Overall Study|Physician Decision|0|||
161799251|NCT01265784|584307276|FG002|Overall Study|Physician Decision|1|||
161799252|NCT01265784|584307274|FG000|Overall Study|Adverse Event|1|||
161799253|NCT01265784|584307275|FG001|Overall Study|Adverse Event|0|||
161799254|NCT01265784|584307276|FG002|Overall Study|Adverse Event|0|||
161799255|NCT01265784|584307274|FG000|Overall Study|Death|3|||
161903135|NCT01922258|584692490|FG000|Overall Study|Withdrawal by participant|5|||
161903136|NCT01922258|584692491|FG001|Overall Study|Withdrawal by participant|5|||
161903137|NCT02417753|584692492|FG000|Overall Study|Death|1|||
161903138|NCT02716779|584692495|FG000|Monotherapy|Adverse Event|0|||
161903139|NCT02716779|584692496|FG001|Monotherapy|Adverse Event|1|||
161903140|NCT02716779|584692497|FG002|Monotherapy|Adverse Event|1|||
161903141|NCT02716779|584692495|FG000|Combination Therapy|Adverse Event|0|||
161903142|NCT02716779|584692496|FG001|Combination Therapy|Adverse Event|2|||
161903143|NCT02716779|584692497|FG002|Combination Therapy|Adverse Event|1|||
161903144|NCT01261390|584692500|FG000|Overall Study|Significant Concurrent Illness|1|||
161903145|NCT01261390|584692501|FG001|Overall Study|Significant Concurrent Illness|0|||
161903146|NCT01261390|584692502|FG002|Overall Study|Significant Concurrent Illness|1|||
161903147|NCT01261390|584692503|FG003|Overall Study|Significant Concurrent Illness|0|||
161903148|NCT01261390|584692500|FG000|Overall Study|Dissatisfaction with Treatment|2|||
161903149|NCT01261390|584692501|FG001|Overall Study|Dissatisfaction with Treatment|1|||
161903150|NCT01261390|584692502|FG002|Overall Study|Dissatisfaction with Treatment|1|||
161903151|NCT01261390|584692503|FG003|Overall Study|Dissatisfaction with Treatment|2|||
161903152|NCT01261390|584692500|FG000|Overall Study|Relocation|0|||
161903153|NCT01261390|584692501|FG001|Overall Study|Relocation|1|||
161903154|NCT01261390|584692502|FG002|Overall Study|Relocation|0|||
161903155|NCT01261390|584692503|FG003|Overall Study|Relocation|0|||
161903156|NCT01261390|584692500|FG000|Overall Study|Loss of Interest in the Study|3|||
161903157|NCT01261390|584692501|FG001|Overall Study|Loss of Interest in the Study|1|||
161903158|NCT01261390|584692502|FG002|Overall Study|Loss of Interest in the Study|0|||
161903159|NCT01261390|584692503|FG003|Overall Study|Loss of Interest in the Study|0|||
161903160|NCT01261390|584692500|FG000|Overall Study|Lost to Follow-up|1|||
161903161|NCT01261390|584692501|FG001|Overall Study|Lost to Follow-up|6|||
161903162|NCT01261390|584692502|FG002|Overall Study|Lost to Follow-up|5|||
161903163|NCT01261390|584692503|FG003|Overall Study|Lost to Follow-up|6|||
161903164|NCT02782741|584692505|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
161903165|NCT02782741|584692506|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
161903166|NCT02782741|584692507|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
161903167|NCT02782741|584692505|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
161903168|NCT02782741|584692506|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
161903169|NCT02782741|584692507|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
161903170|NCT02782741|584692505|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
161903171|NCT02782741|584692506|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
161903172|NCT02782741|584692507|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
161903173|NCT02782741|584692505|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
161903174|NCT02782741|584692506|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
161903175|NCT02782741|584692507|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
161903176|NCT02782741|584692505|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
161903177|NCT02782741|584692506|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
161903178|NCT02782741|584692507|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
161903179|NCT01951417|584692509|FG000|Overall Study|Withdrawal by Subject|1|||
161903180|NCT01951417|584692509|FG000|Overall Study|Protocol Violation|2|||
161903181|NCT01951417|584692509|FG000|Overall Study|Lost to Follow-up|6|||
161903182|NCT01497067|584692511|FG000|Overall Study|Lost to Follow-up|56|||
161903183|NCT01497067|584692511|FG000|Overall Study|Adverse Event|3|||
161903184|NCT01497067|584692511|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
161903185|NCT01497067|584692511|FG000|Overall Study|Other|13|||
161903186|NCT01275144|584692512|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
161903187|NCT01275144|584692513|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
161903188|NCT05116202|584692514|FG000|Overall Study|Study Terminated by Sponsor|21|||
161903189|NCT05116202|584692515|FG001|Overall Study|Study Terminated by Sponsor|38|||
161903190|NCT05116202|584692516|FG002|Overall Study|Study Terminated by Sponsor|17|||
161903191|NCT05116202|584692517|FG003|Overall Study|Study Terminated by Sponsor|18|||
161903192|NCT05116202|584692518|FG004|Overall Study|Study Terminated by Sponsor|0|||
161903193|NCT05116202|584692514|FG000|Overall Study|Withdrawal by Subject|0|||
161903194|NCT05116202|584692515|FG001|Overall Study|Withdrawal by Subject|1|||
161903195|NCT05116202|584692516|FG002|Overall Study|Withdrawal by Subject|1|||
161903196|NCT05116202|584692517|FG003|Overall Study|Withdrawal by Subject|1|||
161903197|NCT05116202|584692518|FG004|Overall Study|Withdrawal by Subject|1|||
161903198|NCT05116202|584692514|FG000|Overall Study|Lost to Follow-up|0|||
161903199|NCT05116202|584692515|FG001|Overall Study|Lost to Follow-up|0|||
161903200|NCT05116202|584692516|FG002|Overall Study|Lost to Follow-up|0|||
161903201|NCT05116202|584692517|FG003|Overall Study|Lost to Follow-up|0|||
161903202|NCT05116202|584692518|FG004|Overall Study|Lost to Follow-up|2|||
161903203|NCT05116202|584692514|FG000|Overall Study|Death|1|||
161903204|NCT05116202|584692515|FG001|Overall Study|Death|1|||
161903205|NCT05116202|584692516|FG002|Overall Study|Death|2|||
161903206|NCT05116202|584692517|FG003|Overall Study|Death|1|||
161903207|NCT05116202|584692518|FG004|Overall Study|Death|5|||
161903208|NCT02864407|584692525|FG000|Overall Study|Protocol Violation|3|||
161903209|NCT02864407|584692525|FG000|Overall Study|Lost to Follow-up|115|||
161903210|NCT02864407|584692525|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
161903211|NCT02864407|584692525|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
161903212|NCT02864407|584692525|FG000|Overall Study|Consent prior to the contract date|1|||
161903213|NCT00096538|584692533|FG000|Overall Study|Withdrawal by Subject|1|||
161903214|NCT02686164|584692537|FG000|Overall Study|Adverse Event|1|||
161903215|NCT02686164|584692537|FG000|Overall Study|Withdrawal of consent|1|||
161903216|NCT02686164|584692537|FG000|Overall Study|Clinical progression|1|||
161903217|NCT01827592|584692542|FG000|Overall Study|Adverse Event|11|||
161903218|NCT01827592|584692543|FG001|Overall Study|Adverse Event|9|||
161903219|NCT01827592|584692544|FG002|Overall Study|Adverse Event|2|||
161903220|NCT01827592|584692542|FG000|Overall Study|Physician Decision|0|||
161903221|NCT01827592|584692543|FG001|Overall Study|Physician Decision|2|||
161903222|NCT01827592|584692544|FG002|Overall Study|Physician Decision|1|||
161903223|NCT01827592|584692542|FG000|Overall Study|Protocol Violation|2|||
161903224|NCT01827592|584692543|FG001|Overall Study|Protocol Violation|1|||
161903225|NCT01827592|584692544|FG002|Overall Study|Protocol Violation|0|||
161903226|NCT01827592|584692542|FG000|Overall Study|Lost to Follow-up|1|||
161903227|NCT01827592|584692543|FG001|Overall Study|Lost to Follow-up|2|||
161903228|NCT01827592|584692544|FG002|Overall Study|Lost to Follow-up|2|||
161903229|NCT01827592|584692542|FG000|Overall Study|Withdrawal by Subject|12|||
161903230|NCT01827592|584692543|FG001|Overall Study|Withdrawal by Subject|11|||
161903231|NCT01827592|584692544|FG002|Overall Study|Withdrawal by Subject|11|||
161903232|NCT01827592|584692542|FG000|Overall Study|Patient's substantial non-compliance|1|||
161903233|NCT01827592|584692543|FG001|Overall Study|Patient's substantial non-compliance|1|||
161903234|NCT01827592|584692544|FG002|Overall Study|Patient's substantial non-compliance|6|||
161903235|NCT01827592|584692542|FG000|Overall Study|Trial terminated by Sponsor|47|||
161903236|NCT01827592|584692543|FG001|Overall Study|Trial terminated by Sponsor|53|||
161903237|NCT01827592|584692544|FG002|Overall Study|Trial terminated by Sponsor|51|||
161903238|NCT01827592|584692542|FG000|Overall Study|Others|0|||
161903239|NCT01827592|584692543|FG001|Overall Study|Others|1|||
161903240|NCT01827592|584692544|FG002|Overall Study|Others|3|||
161903241|NCT02324361|584692545|FG000|Overall Study|Lost to Follow-up|5|||
161903242|NCT02324361|584692546|FG001|Overall Study|Lost to Follow-up|2|||
161903243|NCT00003471|584692557|FG000|Overall Study|Not evaluable|4|||
161903244|NCT00715403|584692562|FG000|Overall Study|Progressive disease|0|||
161903245|NCT00715403|584692563|FG001|Overall Study|Progressive disease|1|||
161903246|NCT00715403|584692564|FG002|Overall Study|Progressive disease|3|||
161903247|NCT00715403|584692565|FG003|Overall Study|Progressive disease|9|||
161903248|NCT00715403|584692566|FG004|Overall Study|Progressive disease|5|||
161903249|NCT00715403|584692567|FG005|Overall Study|Progressive disease|14|||
161903250|NCT00715403|584692568|FG006|Overall Study|Progressive disease|1|||
161903251|NCT00715403|584692562|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903252|NCT00715403|584692563|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903253|NCT00715403|584692564|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903254|NCT00715403|584692565|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903255|NCT00715403|584692566|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903256|NCT00715403|584692567|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
161903257|NCT00715403|584692568|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903258|NCT00715403|584692562|FG000|Overall Study|Other Adverse Event than DLT|1|||
161903259|NCT00715403|584692563|FG001|Overall Study|Other Adverse Event than DLT|0|||
161903260|NCT00715403|584692564|FG002|Overall Study|Other Adverse Event than DLT|0|||
161903261|NCT00715403|584692565|FG003|Overall Study|Other Adverse Event than DLT|0|||
161903262|NCT00715403|584692566|FG004|Overall Study|Other Adverse Event than DLT|0|||
161903263|NCT00715403|584692567|FG005|Overall Study|Other Adverse Event than DLT|2|||
161903264|NCT00715403|584692568|FG006|Overall Study|Other Adverse Event than DLT|0|||
161903265|NCT00715403|584692562|FG000|Overall Study|Protocol Violation|0|||
161903266|NCT00715403|584692563|FG001|Overall Study|Protocol Violation|0|||
161903267|NCT00715403|584692564|FG002|Overall Study|Protocol Violation|0|||
161903268|NCT00715403|584692565|FG003|Overall Study|Protocol Violation|0|||
161903269|NCT00715403|584692566|FG004|Overall Study|Protocol Violation|0|||
161903270|NCT00715403|584692567|FG005|Overall Study|Protocol Violation|1|||
161451263|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
161451264|NCT00946985|583048197|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
161451265|NCT00946985|583048197|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
161903271|NCT00715403|584692568|FG006|Overall Study|Protocol Violation|0|||
161903272|NCT00715403|584692562|FG000|Overall Study|Other reason not defined above|0|||
161903273|NCT00715403|584692563|FG001|Overall Study|Other reason not defined above|0|||
161903274|NCT00715403|584692564|FG002|Overall Study|Other reason not defined above|1|||
161903275|NCT00715403|584692565|FG003|Overall Study|Other reason not defined above|0|||
161903276|NCT00715403|584692566|FG004|Overall Study|Other reason not defined above|1|||
161903277|NCT00715403|584692567|FG005|Overall Study|Other reason not defined above|1|||
161903278|NCT00715403|584692568|FG006|Overall Study|Other reason not defined above|0|||
161903279|NCT00520039|584692571|FG000|Overall Study|Exclusion criteria met at first visit|7|||
161903280|NCT00520039|584692572|FG001|Overall Study|Exclusion criteria met at first visit|5|||
161556322|NCT02611830|583425443|FG000|OL Induction Phase|Lack of Efficacy|9|||
161556323|NCT02611830|583425444|FG001|OL Induction Phase|Lack of Efficacy|0|||
161556324|NCT02611830|583425445|FG002|OL Induction Phase|Lack of Efficacy|0|||
161556325|NCT02611830|583425446|FG003|OL Induction Phase|Lack of Efficacy|0|||
161556326|NCT02611830|583425443|FG000|OL Induction Phase|Reason not specified|3|||
161556327|NCT02611830|583425444|FG001|OL Induction Phase|Reason not specified|0|||
161556328|NCT02611830|583425445|FG002|OL Induction Phase|Reason not specified|0|||
161556329|NCT02611830|583425446|FG003|OL Induction Phase|Reason not specified|0|||
161556330|NCT02611830|583425443|FG000|Maintenance Phase|Lack of Efficacy|0|||
161556331|NCT02611830|583425444|FG001|Maintenance Phase|Lack of Efficacy|29|||
161556332|NCT02611830|583425445|FG002|Maintenance Phase|Lack of Efficacy|18|||
161556333|NCT02611830|583425446|FG003|Maintenance Phase|Lack of Efficacy|6|||
161556334|NCT02611830|583425443|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
161556335|NCT02611830|583425444|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
161556336|NCT02611830|583425445|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
161556337|NCT02611830|583425446|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
161556338|NCT02611830|583425443|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
161556339|NCT02611830|583425444|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
161556340|NCT02611830|583425445|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
161556341|NCT02611830|583425446|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
161556342|NCT02611830|583425443|FG000|Maintenance Phase|Lost to Follow-up|0|||
161556343|NCT02611830|583425444|FG001|Maintenance Phase|Lost to Follow-up|0|||
161556344|NCT02611830|583425445|FG002|Maintenance Phase|Lost to Follow-up|0|||
161556345|NCT02611830|583425446|FG003|Maintenance Phase|Lost to Follow-up|1|||
161556346|NCT02611830|583425443|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
161556347|NCT02611830|583425444|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
161556348|NCT02611830|583425445|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
161556349|NCT02611830|583425446|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
161556350|NCT02611830|583425443|FG000|Maintenance Phase|Pregnancy|0|||
161556351|NCT02611830|583425444|FG001|Maintenance Phase|Pregnancy|0|||
161556352|NCT02611830|583425445|FG002|Maintenance Phase|Pregnancy|1|||
161556353|NCT02611830|583425446|FG003|Maintenance Phase|Pregnancy|0|||
161556354|NCT02611830|583425443|FG000|Maintenance Phase|Reason not specified|0|||
161556355|NCT02611830|583425444|FG001|Maintenance Phase|Reason not specified|1|||
161556356|NCT02611830|583425445|FG002|Maintenance Phase|Reason not specified|4|||
161556357|NCT02611830|583425446|FG003|Maintenance Phase|Reason not specified|0|||
161799256|NCT01265784|584307275|FG001|Overall Study|Death|0|||
161799257|NCT01265784|584307276|FG002|Overall Study|Death|0|||
161799258|NCT01265784|584307274|FG000|Overall Study|Protocol Violation|2|||
161799259|NCT01265784|584307275|FG001|Overall Study|Protocol Violation|0|||
161799260|NCT01265784|584307276|FG002|Overall Study|Protocol Violation|0|||
161799261|NCT01265784|584307274|FG000|Overall Study|Incorrectly Randomized|0|||
161799262|NCT01265784|584307275|FG001|Overall Study|Incorrectly Randomized|0|||
161799263|NCT01265784|584307276|FG002|Overall Study|Incorrectly Randomized|1|||
161799264|NCT04333095|584307281|FG000|Overall Study|Protocol Violation|4|||
161799265|NCT04333095|584307282|FG001|Overall Study|Protocol Violation|0|||
161799266|NCT04333095|584307281|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
161799267|NCT04333095|584307282|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
161799268|NCT04333095|584307281|FG000|Overall Study|Mini Sternotomy|4|||
161799269|NCT04333095|584307282|FG001|Overall Study|Mini Sternotomy|5|||
161799270|NCT03740165|584307283|FG000|Overall Study|Death|232|||
161799271|NCT03740165|584307284|FG001|Overall Study|Death|242|||
161799272|NCT03740165|584307285|FG002|Overall Study|Death|229|||
161799273|NCT03740165|584307283|FG000|Overall Study|Lost to Follow-up|0|||
161799274|NCT03740165|584307284|FG001|Overall Study|Lost to Follow-up|0|||
161799275|NCT03740165|584307285|FG002|Overall Study|Lost to Follow-up|1|||
161799276|NCT03740165|584307283|FG000|Overall Study|Withdrawal by Subject|7|||
161799277|NCT03740165|584307284|FG001|Overall Study|Withdrawal by Subject|4|||
161799278|NCT03740165|584307285|FG002|Overall Study|Withdrawal by Subject|3|||
161799279|NCT03740165|584307283|FG000|Overall Study|Ongoing in Study|216|||
161799280|NCT03740165|584307284|FG001|Overall Study|Ongoing in Study|212|||
161556358|NCT01987830|583425457|FG000|Overall Study|Never received baseline scan|1|||
161556359|NCT02117544|583426930|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
161556360|NCT02117544|583426931|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
161799281|NCT03740165|584307285|FG002|Overall Study|Ongoing in Study|221|||
161799282|NCT03049618|584307286|FG000|Overall Study|Death|1|||
161799283|NCT03049618|584307287|FG001|Overall Study|Death|0|||
161799284|NCT03049618|584307286|FG000|Overall Study|Lack of Efficacy|1|||
161799285|NCT03049618|584307287|FG001|Overall Study|Lack of Efficacy|2|||
161799286|NCT03717064|584309198|FG000|Period 2|Adverse Event|1|||
161799287|NCT02841709|584309199|FG000|5th Intervention|Adverse Event|2|||
161556361|NCT04172987|583426932|FG000|Lead In Period|Adverse Event|1|||
161556362|NCT04172987|583426932|FG000|Lead In Period|Protocol Violation|1|||
161556363|NCT04172987|583426932|FG000|Period 1|Physician Decision|1|||
161556364|NCT04172987|583426932|FG000|Period 2|Adverse Event|5|||
161799288|NCT02841709|584309200|FG001|5th Intervention|Adverse Event|0|||
161903281|NCT03560869|584692573|FG000|Overall Study|Withdrawal by Subject|3|||
161903282|NCT03560869|584692574|FG001|Overall Study|Withdrawal by Subject|4|||
161903283|NCT03560869|584692573|FG000|Overall Study|Screening failure|4|||
161903284|NCT03560869|584692574|FG001|Overall Study|Screening failure|4|||
161903285|NCT03560869|584692573|FG000|Overall Study|Withdrawal by PI|0|||
161903286|NCT03560869|584692574|FG001|Overall Study|Withdrawal by PI|1|||
161903287|NCT02481050|584694779|FG000|Overall Study|Adverse Event|1|||
161903288|NCT02481050|584694779|FG000|Overall Study|Disease Progression|47|||
161903289|NCT02481050|584694779|FG000|Overall Study|Withdrawal by Subject|7|||
161903290|NCT02481050|584694779|FG000|Overall Study|Other|3|||
161903291|NCT01548599|584694782|FG000|Overall Study|Lost to Follow-up|0|||
161903292|NCT01548599|584694783|FG001|Overall Study|Lost to Follow-up|1|||
161903293|NCT01548599|584694782|FG000|Overall Study|Withdrawal by Subject|4|||
161903294|NCT01548599|584694783|FG001|Overall Study|Withdrawal by Subject|0|||
161903295|NCT01548599|584694782|FG000|Overall Study|Death|2|||
161903296|NCT01548599|584694783|FG001|Overall Study|Death|1|||
161903297|NCT02188160|584694784|FG000|Overall Study|Adverse Event|1|||
161903298|NCT02188160|584694785|FG001|Overall Study|Adverse Event|0|||
161903299|NCT02188160|584694784|FG000|Overall Study|Use of an excluded medication|0|||
161903300|NCT02188160|584694785|FG001|Overall Study|Use of an excluded medication|1|||
161903301|NCT01022203|584694790|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
161903302|NCT01022203|584694791|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
161903303|NCT01022203|584694790|FG000|Post Treatment Assessment|Physician Decision|2|||
161903304|NCT01022203|584694791|FG001|Post Treatment Assessment|Physician Decision|0|||
161903305|NCT01022203|584694790|FG000|Post Treatment Assessment|Adverse Event|0|||
161903306|NCT01022203|584694791|FG001|Post Treatment Assessment|Adverse Event|2|||
161903307|NCT01022203|584694790|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
161903308|NCT01022203|584694791|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
161903309|NCT03163446|584694792|FG000|Overall Study|Unable to return for Day 180 visit|2|||
161903310|NCT03163446|584694793|FG001|Overall Study|Unable to return for Day 180 visit|0|||
161903311|NCT03163446|584694792|FG000|Overall Study|Withdrawal by Subject|2|||
161903312|NCT03163446|584694793|FG001|Overall Study|Withdrawal by Subject|6|||
161903313|NCT03163446|584694792|FG000|Overall Study|Death|16|||
161903314|NCT03163446|584694793|FG001|Overall Study|Death|5|||
161903315|NCT03163446|584694792|FG000|Overall Study|Lost to Follow-up|6|||
161903316|NCT03163446|584694793|FG001|Overall Study|Lost to Follow-up|5|||
161903317|NCT03163446|584694792|FG000|Overall Study|Physician Decision|1|||
161903318|NCT03163446|584694793|FG001|Overall Study|Physician Decision|1|||
161903319|NCT03163446|584694792|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
161903320|NCT03163446|584694793|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
161903321|NCT03638128|584694794|FG000|Overall Study|Withdrawal by Subject|1|||
161903322|NCT03638128|584694795|FG001|Overall Study|Withdrawal by Subject|7|||
161903323|NCT03638128|584694796|FG002|Overall Study|Withdrawal by Subject|6|||
161903324|NCT03638128|584694794|FG000|Overall Study|Sponsor Decision|15|||
161903325|NCT03638128|584694795|FG001|Overall Study|Sponsor Decision|12|||
161903326|NCT03638128|584694796|FG002|Overall Study|Sponsor Decision|19|||
161903327|NCT03638128|584694794|FG000|Overall Study|Lost to Follow-up|0|||
161903328|NCT03638128|584694795|FG001|Overall Study|Lost to Follow-up|0|||
161903329|NCT03638128|584694796|FG002|Overall Study|Lost to Follow-up|1|||
161903330|NCT00611806|584694797|FG000|Overall Study|Withdrawal by Subject|8|||
161903331|NCT00611806|584694798|FG001|Overall Study|Withdrawal by Subject|2|||
161903332|NCT00611806|584694797|FG000|Overall Study|Adverse Event|2|||
161903333|NCT00611806|584694798|FG001|Overall Study|Adverse Event|1|||
161903334|NCT00611806|584694797|FG000|Overall Study|Lost to Follow-up|6|||
161903335|NCT00611806|584694798|FG001|Overall Study|Lost to Follow-up|0|||
161903336|NCT00903201|584694800|FG000|Overall Study|Adverse Event|1|||
161903337|NCT00903201|584694801|FG001|Overall Study|Adverse Event|4|||
161903338|NCT00903201|584694802|FG002|Overall Study|Adverse Event|0|||
161903339|NCT00903201|584694800|FG000|Overall Study|Protocol Violation|2|||
161903340|NCT00903201|584694801|FG001|Overall Study|Protocol Violation|1|||
161903341|NCT00903201|584694802|FG002|Overall Study|Protocol Violation|0|||
161903342|NCT00903201|584694800|FG000|Overall Study|Lost to Follow-up|0|||
161451266|NCT00271505|583048198|FG000|Overall Study|Screen Failure|3|||
161451267|NCT00271505|583048198|FG000|Overall Study|Adverse Event|1|||
161451268|NCT00271505|583048198|FG000|Overall Study|Death|1|||
161903343|NCT00903201|584694801|FG001|Overall Study|Lost to Follow-up|1|||
161903344|NCT00903201|584694802|FG002|Overall Study|Lost to Follow-up|0|||
161903345|NCT00903201|584694800|FG000|Overall Study|Physician Decision|1|||
161903346|NCT00903201|584694801|FG001|Overall Study|Physician Decision|0|||
161903347|NCT00903201|584694802|FG002|Overall Study|Physician Decision|1|||
161903348|NCT00903201|584694800|FG000|Overall Study|Withdrawal by Subject|1|||
161903349|NCT00903201|584694801|FG001|Overall Study|Withdrawal by Subject|0|||
161903350|NCT00903201|584694802|FG002|Overall Study|Withdrawal by Subject|1|||
161903351|NCT00945243|584694803|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
161903352|NCT00754741|584694804|FG000|Overall Study|Died or disenrolled|57|||
161903353|NCT00754741|584694805|FG001|Overall Study|Died or disenrolled|69|||
161903354|NCT00754741|584694806|FG002|Overall Study|Died or disenrolled|54|||
161451269|NCT04556383|583048199|FG000|PCP|Lack of Efficacy|28|||
161556365|NCT04172987|583426932|FG000|Period 2|Dosing Termination by Sponsor|4|||
161556366|NCT01603121|583426933|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
161556367|NCT01603121|583426934|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
161556368|NCT00738530|583426935|FG000|Overall Study|Death|220|||
161556369|NCT00738530|583426936|FG001|Overall Study|Death|224|||
161556370|NCT00738530|583426935|FG000|Overall Study|Lost to Follow-up|8|||
161556371|NCT00738530|583426936|FG001|Overall Study|Lost to Follow-up|6|||
161556372|NCT00738530|583426935|FG000|Overall Study|Withdrawal by Subject|6|||
161556373|NCT00738530|583426936|FG001|Overall Study|Withdrawal by Subject|8|||
161556374|NCT01656759|583426937|FG000|Overall Study|Protocol Violation|2|||
161556375|NCT01656759|583426938|FG001|Overall Study|Protocol Violation|3|||
161556376|NCT01628510|583426939|FG000|Overall Study|Withdrawal by Subject|0|||
161556377|NCT01628510|583426940|FG001|Overall Study|Withdrawal by Subject|4|||
161556378|NCT01628510|583426939|FG000|Overall Study|Death|3|||
161556379|NCT01628510|583426940|FG001|Overall Study|Death|1|||
161556380|NCT04179461|583426941|FG000|Overall Study|Lost to Follow-up|4|||
161556381|NCT03160079|583426947|FG000|Overall Study|Adverse Event|2|||
161556382|NCT03160079|583426948|FG001|Overall Study|Adverse Event|0|||
161556383|NCT03160079|583426947|FG000|Overall Study|Disease Progression|1|||
161556384|NCT03160079|583426948|FG001|Overall Study|Disease Progression|0|||
161556385|NCT03160079|583426947|FG000|Overall Study|Physician Decision|1|||
161556386|NCT03160079|583426948|FG001|Overall Study|Physician Decision|0|||
161556387|NCT03259373|583426960|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
161556388|NCT03259373|583426961|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
161556389|NCT03259373|583426960|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
161556390|NCT03259373|583426961|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
161556391|NCT03259373|583426960|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
161556392|NCT03259373|583426961|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
161556393|NCT03259373|583426960|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
161556394|NCT03259373|583426961|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
161799289|NCT02841709|584309201|FG002|5th Intervention|Adverse Event|0|||
161799290|NCT02841709|584309202|FG003|5th Intervention|Adverse Event|0|||
161799291|NCT02841709|584309203|FG004|5th Intervention|Adverse Event|2|||
161799292|NCT01929109|584309204|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
161799293|NCT01929109|584309205|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
161799294|NCT01929109|584309206|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
161799295|NCT01929109|584309207|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
161799296|NCT01929109|584309208|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
161799297|NCT04526210|584309213|FG000|Overall Study|Sponsor decision|7|||
161799298|NCT04526210|584309214|FG001|Overall Study|Sponsor decision|5|||
161799299|NCT04526210|584309213|FG000|Overall Study|Withdrawal by Subject|3|||
161799300|NCT04526210|584309214|FG001|Overall Study|Withdrawal by Subject|2|||
161799301|NCT01781637|584309215|FG000|Overall Study|Adverse Event|1|||
161799302|NCT01781637|584309216|FG001|Overall Study|Adverse Event|0|||
161799303|NCT01781637|584309215|FG000|Overall Study|Lack of Efficacy|2|||
161799304|NCT01781637|584309216|FG001|Overall Study|Lack of Efficacy|6|||
161799305|NCT01781637|584309215|FG000|Overall Study|Withdrawal by Subject|1|||
161799306|NCT01781637|584309216|FG001|Overall Study|Withdrawal by Subject|0|||
161799307|NCT02637232|584309217|FG000|Overall Study|Lost to Follow-up|42|||
161799308|NCT02637232|584309217|FG000|Overall Study|Adverse Event|11|||
161799309|NCT02637232|584309217|FG000|Overall Study|patient 's decision|2|||
161799310|NCT00090857|584309218|FG000|Overall Study|Lost to Follow-up|0|||
161799311|NCT00090857|584309219|FG001|Overall Study|Lost to Follow-up|1|||
161799312|NCT00090857|584309218|FG000|Overall Study|Withdrawal by Subject|2|||
161799313|NCT00090857|584309219|FG001|Overall Study|Withdrawal by Subject|0|||
161799314|NCT00090857|584309218|FG000|Overall Study|Adverse Event|2|||
161799315|NCT00090857|584309219|FG001|Overall Study|Adverse Event|2|||
161799316|NCT05097326|584309221|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
161799317|NCT05097326|584309222|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
161799318|NCT03480425|584309224|FG000|Overall Study|Force transducer technical failure|1|||
161799319|NCT01244126|584309225|FG000|Overall Study|Protocol Violation|3|||
161799320|NCT01244126|584309226|FG001|Overall Study|Protocol Violation|3|||
161556395|NCT03259373|583426960|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
161799321|NCT01244126|584309227|FG002|Overall Study|Protocol Violation|9|||
161799322|NCT04373434|584309236|FG000|Overall Study|Lost to Follow-up|37|||
161799323|NCT04373434|584309237|FG001|Overall Study|Lost to Follow-up|32|||
161799324|NCT04373434|584309236|FG000|Overall Study|Refused at 9 months|1|||
161799325|NCT04373434|584309237|FG001|Overall Study|Refused at 9 months|2|||
161799326|NCT04373434|584309236|FG000|Overall Study|Refused at 4 months|7|||
161799327|NCT04373434|584309237|FG001|Overall Study|Refused at 4 months|3|||
161799328|NCT04373434|584309236|FG000|Overall Study|Excluded|2|||
161799329|NCT04373434|584309237|FG001|Overall Study|Excluded|0|||
161556396|NCT03259373|583426961|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
161556397|NCT03259373|583426960|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
161556398|NCT03259373|583426961|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
161556399|NCT01513967|583426965|FG000|Overall Study|Pregnancy|0|||
161556400|NCT01513967|583426966|FG001|Overall Study|Pregnancy|0|||
161556401|NCT01513967|583426967|FG002|Overall Study|Pregnancy|0|||
161556402|NCT01513967|583426968|FG003|Overall Study|Pregnancy|0|||
161556403|NCT01513967|583426969|FG004|Overall Study|Pregnancy|0|||
161556404|NCT01513967|583426970|FG005|Overall Study|Pregnancy|0|||
161556405|NCT01513967|583426971|FG006|Overall Study|Pregnancy|1|||
161556406|NCT01513967|583426972|FG007|Overall Study|Pregnancy|0|||
161556407|NCT01513967|583426965|FG000|Overall Study|missed a study visit|0|||
161556408|NCT01513967|583426966|FG001|Overall Study|missed a study visit|0|||
161556409|NCT01513967|583426967|FG002|Overall Study|missed a study visit|0|||
161556410|NCT01513967|583426968|FG003|Overall Study|missed a study visit|0|||
161556411|NCT01513967|583426969|FG004|Overall Study|missed a study visit|0|||
161556412|NCT01513967|583426970|FG005|Overall Study|missed a study visit|0|||
161556413|NCT01513967|583426971|FG006|Overall Study|missed a study visit|1|||
161556414|NCT01513967|583426972|FG007|Overall Study|missed a study visit|0|||
161556415|NCT01513967|583426965|FG000|Overall Study|excluded due to positive drug screen|0|||
161556416|NCT01513967|583426966|FG001|Overall Study|excluded due to positive drug screen|0|||
161556417|NCT01513967|583426967|FG002|Overall Study|excluded due to positive drug screen|0|||
161556418|NCT01513967|583426968|FG003|Overall Study|excluded due to positive drug screen|0|||
161556419|NCT01513967|583426969|FG004|Overall Study|excluded due to positive drug screen|0|||
161556420|NCT01513967|583426970|FG005|Overall Study|excluded due to positive drug screen|0|||
161556421|NCT01513967|583426971|FG006|Overall Study|excluded due to positive drug screen|0|||
161556422|NCT01513967|583426972|FG007|Overall Study|excluded due to positive drug screen|2|||
161556423|NCT01513967|583426965|FG000|Overall Study|Physician Decision|0|||
161556424|NCT01513967|583426966|FG001|Overall Study|Physician Decision|0|||
161556425|NCT01513967|583426967|FG002|Overall Study|Physician Decision|0|||
161556426|NCT01513967|583426968|FG003|Overall Study|Physician Decision|0|||
161556427|NCT01513967|583426969|FG004|Overall Study|Physician Decision|0|||
161556428|NCT01513967|583426970|FG005|Overall Study|Physician Decision|1|||
161556429|NCT01513967|583426971|FG006|Overall Study|Physician Decision|0|||
161556430|NCT01513967|583426972|FG007|Overall Study|Physician Decision|0|||
161556431|NCT05764239|583426975|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
161556432|NCT05764239|583426975|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
161556433|NCT05764239|583426975|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
161556434|NCT05764239|583426975|FG000|DEP (Part 1)|Adverse Event|1|||
161556435|NCT05764239|583426975|FG000|DEP (Part 1)|Lost to Follow-up|1|||
161556436|NCT05764239|583426975|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
161556437|NCT05764239|583426975|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
161556438|NCT05764239|583426975|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
161556439|NCT05764239|583426975|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
161556440|NCT00057811|583426979|FG000|Overall Study|Lack of Efficacy|1|||
161556441|NCT00057811|583426980|FG001|Overall Study|Lack of Efficacy|4|||
161556442|NCT00057811|583426979|FG000|Overall Study|Physician Decision|1|||
161556443|NCT00057811|583426980|FG001|Overall Study|Physician Decision|0|||
161556444|NCT00057811|583426979|FG000|Overall Study|Withdrawal by Subject|3|||
161556445|NCT00057811|583426980|FG001|Overall Study|Withdrawal by Subject|4|||
161556446|NCT00057811|583426979|FG000|Overall Study|Ineligible|4|||
161556447|NCT00057811|583426980|FG001|Overall Study|Ineligible|2|||
161556448|NCT00057811|583426979|FG000|Overall Study|Inevaluable|1|||
161556449|NCT00057811|583426980|FG001|Overall Study|Inevaluable|2|||
161556450|NCT00556374|583426981|FG000|Overall Study|Withdrawal by Subject|235|||
161556451|NCT00556374|583426982|FG001|Overall Study|Withdrawal by Subject|205|||
161556452|NCT00556374|583426981|FG000|Overall Study|Death|158|||
161556453|NCT00556374|583426982|FG001|Overall Study|Death|127|||
161556454|NCT00556374|583426981|FG000|Overall Study|Lost to Follow-up|24|||
161556455|NCT00556374|583426982|FG001|Overall Study|Lost to Follow-up|17|||
161556456|NCT00556374|583426981|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
161556457|NCT00556374|583426982|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
161556458|NCT04131907|583426983|FG000|Overall Study|Adverse Event|2|||
161556459|NCT04131907|583426984|FG001|Overall Study|Adverse Event|0|||
161556460|NCT04131907|583426985|FG002|Overall Study|Adverse Event|0|||
161556461|NCT04131907|583426983|FG000|Overall Study|Physician Decision|4|||
161556462|NCT04131907|583426984|FG001|Overall Study|Physician Decision|22|||
161556463|NCT04131907|583426985|FG002|Overall Study|Physician Decision|0|||
161556464|NCT04131907|583426983|FG000|Overall Study|Withdrawal by Subject|2|||
161556465|NCT04131907|583426984|FG001|Overall Study|Withdrawal by Subject|0|||
161556466|NCT04131907|583426985|FG002|Overall Study|Withdrawal by Subject|1|||
161556467|NCT04131907|583426983|FG000|Overall Study|Treatment failure|2|||
161556468|NCT04131907|583426984|FG001|Overall Study|Treatment failure|0|||
161556469|NCT04131907|583426985|FG002|Overall Study|Treatment failure|1|||
161556470|NCT05294419|583426986|FG000|Overall Study|Protocol Violation|4|||
161556471|NCT05294419|583426987|FG001|Overall Study|Protocol Violation|0|||
161903355|NCT04152200|584694807|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
161903356|NCT04152200|584694808|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
161903357|NCT04969289|584694809|FG000|Overall Study|Lost to Follow-up|13|||
161903358|NCT04969289|584694810|FG001|Overall Study|Lost to Follow-up|9|||
161903359|NCT02699996|584694811|FG000|Overall Study|Withdrawal by Subject|5|||
161903360|NCT02699996|584694812|FG001|Overall Study|Withdrawal by Subject|2|||
161903361|NCT01921517|584694813|FG000|Overall Study|Lost to Follow-up|5|||
161903362|NCT01921517|584694814|FG001|Overall Study|Lost to Follow-up|0|||
161903363|NCT01921517|584694813|FG000|Overall Study|Newly diagnosed health concern|2|||
161903364|NCT01921517|584694814|FG001|Overall Study|Newly diagnosed health concern|0|||
161903365|NCT01921517|584694813|FG000|Overall Study|Physician Decision|0|||
161903366|NCT01921517|584694814|FG001|Overall Study|Physician Decision|2|||
161903367|NCT01921517|584694813|FG000|Overall Study|Withdrawal by Subject|7|||
161903368|NCT01921517|584694814|FG001|Overall Study|Withdrawal by Subject|3|||
161903369|NCT01921517|584694813|FG000|Overall Study|Subject missed final imaging|1|||
161903370|NCT01921517|584694814|FG001|Overall Study|Subject missed final imaging|4|||
161903371|NCT04069715|584694815|FG000|Overall Study|Lost to Follow-up|1|||
161903372|NCT04069715|584694816|FG001|Overall Study|Lost to Follow-up|1|||
161903373|NCT04069715|584694815|FG000|Overall Study|Physician Decision|1|||
161903374|NCT04069715|584694816|FG001|Overall Study|Physician Decision|1|||
161903375|NCT04069715|584694815|FG000|Overall Study|Withdrawal by Subject|3|||
161903376|NCT04069715|584694816|FG001|Overall Study|Withdrawal by Subject|3|||
161903377|NCT02486692|584694819|FG000|Overall Study|did not login for randomization|4|||
161903378|NCT02486692|584694820|FG001|Overall Study|did not login for randomization|7|||
161903379|NCT02063672|584694821|FG000|Overall Study|Ongoing Follow-up|27|||
161903380|NCT02063672|584694822|FG001|Overall Study|Ongoing Follow-up|14|||
161903381|NCT02063672|584694821|FG000|Overall Study|Death|5|||
161903382|NCT02063672|584694822|FG001|Overall Study|Death|3|||
161903383|NCT02063672|584694821|FG000|Overall Study|Lost to Follow-up|1|||
161903384|NCT02063672|584694822|FG001|Overall Study|Lost to Follow-up|3|||
161556472|NCT05294419|583426988|FG002|Overall Study|Protocol Violation|0|||
161556473|NCT05294419|583426986|FG000|Overall Study|Lost to Follow-up|6|||
161556474|NCT05294419|583426987|FG001|Overall Study|Lost to Follow-up|0|||
161556475|NCT05294419|583426988|FG002|Overall Study|Lost to Follow-up|0|||
161556476|NCT05294419|583426986|FG000|Overall Study|Results voided after publishing|2|||
161556477|NCT05294419|583426987|FG001|Overall Study|Results voided after publishing|0|||
161556478|NCT05294419|583426988|FG002|Overall Study|Results voided after publishing|0|||
161556479|NCT00847301|583426989|FG000|Overall Study|Adverse Event|35|||
161556480|NCT00847301|583426989|FG000|Overall Study|Switch to other anticoagulants|16|||
161556481|NCT00847301|583426989|FG000|Overall Study|Lost to Follow-up|1|||
161556482|NCT00847301|583426989|FG000|Overall Study|No prescription after hospital discharge|1|||
161556483|NCT00847301|583426989|FG000|Overall Study|Other reason not defined above|1|||
161556484|NCT00641186|583426990|FG000|Overall Study|Adverse Event|3|||
161556485|NCT00442286|583426991|FG000|Overall Study|Death|2|||
161556486|NCT00442286|583426992|FG001|Overall Study|Death|2|||
161556487|NCT00442286|583426991|FG000|Overall Study|Lost to Follow-up|1|||
161556488|NCT00442286|583426992|FG001|Overall Study|Lost to Follow-up|0|||
161556489|NCT00442286|583426991|FG000|Overall Study|Withdrawal by Subject|2|||
161556490|NCT00442286|583426992|FG001|Overall Study|Withdrawal by Subject|0|||
161556491|NCT00442286|583426991|FG000|Overall Study|System explanted|1|||
161556492|NCT00442286|583426992|FG001|Overall Study|System explanted|0|||
161556493|NCT00442286|583426991|FG000|Overall Study|Patient Injury|1|||
161556494|NCT00442286|583426992|FG001|Overall Study|Patient Injury|0|||
161556495|NCT03428815|583426995|FG000|Overall Study|Lost to Follow-up|2|||
161556496|NCT03428815|583426996|FG001|Overall Study|Lost to Follow-up|2|||
161556497|NCT03428815|583426995|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
161556498|NCT03428815|583426996|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
161556499|NCT03428815|583426995|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
161556500|NCT03428815|583426996|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
161556501|NCT05221749|583426997|FG000|Overall Study|Lost to Follow-up|2|||
161556502|NCT05221749|583426998|FG001|Overall Study|Lost to Follow-up|3|||
161556503|NCT02102464|583426999|FG000|Randomized Study|Withdrawal by Subject|0|||
161556504|NCT02102464|583427000|FG001|Randomized Study|Withdrawal by Subject|1|||
161556505|NCT02102464|583427001|FG002|Randomized Study|Withdrawal by Subject|0|||
161556506|NCT01700348|583427002|FG000|Overall Study|Withdrawal by Subject|22|||
161556507|NCT01700348|583427002|FG000|Overall Study|Lost to Follow-up|1|||
161903385|NCT02063672|584694821|FG000|Overall Study|Withdrawal by Subject|2|||
161903386|NCT02063672|584694822|FG001|Overall Study|Withdrawal by Subject|2|||
161903387|NCT01307787|584694824|FG000|Overall Study|Withdrawal by Subject|2|||
161903388|NCT01307787|584694825|FG001|Overall Study|Withdrawal by Subject|0|||
161903389|NCT02452047|584694830|FG000|Overall Study|Adverse Event|0|||
161903390|NCT02452047|584694831|FG001|Overall Study|Adverse Event|1|||
161903391|NCT02452047|584694832|FG002|Overall Study|Adverse Event|1|||
161556508|NCT02404493|583427005|FG000|Overall Study|Adverse Event|1|||
161556509|NCT02404493|583427006|FG001|Overall Study|Adverse Event|1|||
161799330|NCT00527423|584309238|FG000|Overall Study|Protocol Violation|1|||
161799331|NCT00527423|584309238|FG000|Overall Study|Adverse Event|5|||
161799332|NCT00527423|584309238|FG000|Overall Study|Physician Decision|4|||
161799333|NCT00527423|584309238|FG000|Overall Study|Withdrawal by Subject|10|||
161799334|NCT00527423|584309238|FG000|Overall Study|Lost to Follow-up|4|||
161799335|NCT00527423|584309238|FG000|Overall Study|OTHER|4|||
161799336|NCT00527423|584309238|FG000|Overall Study|Death|9|||
161799337|NCT02446132|584309239|FG000|Overall Study|Adverse Event|10|||
161799338|NCT02446132|584309240|FG001|Overall Study|Adverse Event|27|||
161799339|NCT02446132|584309241|FG002|Overall Study|Adverse Event|27|||
161799340|NCT02446132|584309239|FG000|Overall Study|Death|2|||
161799341|NCT02446132|584309240|FG001|Overall Study|Death|13|||
161799342|NCT02446132|584309241|FG002|Overall Study|Death|10|||
161799343|NCT02446132|584309239|FG000|Overall Study|Lack of Efficacy|1|||
161799344|NCT02446132|584309240|FG001|Overall Study|Lack of Efficacy|10|||
161799345|NCT02446132|584309241|FG002|Overall Study|Lack of Efficacy|6|||
161799346|NCT02446132|584309239|FG000|Overall Study|Lost to Follow-up|2|||
161799347|NCT02446132|584309240|FG001|Overall Study|Lost to Follow-up|4|||
161799348|NCT02446132|584309241|FG002|Overall Study|Lost to Follow-up|5|||
161799349|NCT02446132|584309239|FG000|Overall Study|Non-compliance With Study Drug|2|||
161799350|NCT02446132|584309240|FG001|Overall Study|Non-compliance With Study Drug|2|||
161799351|NCT02446132|584309241|FG002|Overall Study|Non-compliance With Study Drug|3|||
161799352|NCT02446132|584309239|FG000|Overall Study|Physician Decision|1|||
161799353|NCT02446132|584309240|FG001|Overall Study|Physician Decision|8|||
161799354|NCT02446132|584309241|FG002|Overall Study|Physician Decision|13|||
161799355|NCT02446132|584309239|FG000|Overall Study|Protocol Deviation|0|||
161799356|NCT02446132|584309240|FG001|Overall Study|Protocol Deviation|0|||
161799357|NCT02446132|584309241|FG002|Overall Study|Protocol Deviation|1|||
161799358|NCT02446132|584309239|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
161799359|NCT02446132|584309240|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
161799360|NCT02446132|584309241|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
161799361|NCT02446132|584309239|FG000|Overall Study|Study Terminated by Sponsor|4|||
161799362|NCT02446132|584309240|FG001|Overall Study|Study Terminated by Sponsor|35|||
161799363|NCT02446132|584309241|FG002|Overall Study|Study Terminated by Sponsor|58|||
161799364|NCT02446132|584309239|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
161799365|NCT02446132|584309240|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
161799366|NCT02446132|584309241|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
161799367|NCT02446132|584309239|FG000|Overall Study|Withdrawal by Subject|11|||
161799368|NCT02446132|584309240|FG001|Overall Study|Withdrawal by Subject|29|||
161799369|NCT02446132|584309241|FG002|Overall Study|Withdrawal by Subject|25|||
161799370|NCT02446132|584309239|FG000|Overall Study|Reason not Specified|4|||
161799371|NCT02446132|584309240|FG001|Overall Study|Reason not Specified|16|||
161799372|NCT02446132|584309241|FG002|Overall Study|Reason not Specified|10|||
161799373|NCT02446132|584309239|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
161799374|NCT02446132|584309240|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
161799375|NCT02446132|584309241|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
161799376|NCT00436007|584309242|FG000|Overall Study|Withdrawal by Subject|5|||
161799377|NCT00436007|584309243|FG001|Overall Study|Withdrawal by Subject|3|||
161799378|NCT00436007|584309244|FG002|Overall Study|Withdrawal by Subject|4|||
161799379|NCT00436007|584309242|FG000|Overall Study|Lost to Follow-up|14|||
161799380|NCT00436007|584309243|FG001|Overall Study|Lost to Follow-up|10|||
161799381|NCT00436007|584309244|FG002|Overall Study|Lost to Follow-up|13|||
161799382|NCT00436007|584309242|FG000|Overall Study|Physician Decision|0|||
161799383|NCT00436007|584309243|FG001|Overall Study|Physician Decision|0|||
161799384|NCT00436007|584309244|FG002|Overall Study|Physician Decision|2|||
161799385|NCT00436007|584309242|FG000|Overall Study|Death|0|||
161799386|NCT00436007|584309243|FG001|Overall Study|Death|1|||
161799387|NCT00436007|584309244|FG002|Overall Study|Death|3|||
161799388|NCT00436007|584309242|FG000|Overall Study|Other|0|||
161799389|NCT00436007|584309243|FG001|Overall Study|Other|0|||
161799390|NCT00436007|584309244|FG002|Overall Study|Other|1|||
161799391|NCT01439165|584309245|FG000|Overall Study|Protocol Violation|3|||
161799392|NCT01439165|584309246|FG001|Overall Study|Protocol Violation|0|||
161799393|NCT01439165|584309245|FG000|Overall Study|Lost to Follow-up|11|||
161799394|NCT01439165|584309246|FG001|Overall Study|Lost to Follow-up|1|||
161903392|NCT02452047|584694830|FG000|Overall Study|Death|1|||
161903393|NCT02452047|584694831|FG001|Overall Study|Death|3|||
161903394|NCT02452047|584694832|FG002|Overall Study|Death|1|||
161903395|NCT02452047|584694830|FG000|Overall Study|Physician Decision|1|||
161799395|NCT01439165|584309245|FG000|Overall Study|Withdrawal by Subject|7|||
161799396|NCT01439165|584309246|FG001|Overall Study|Withdrawal by Subject|1|||
161799397|NCT01089647|584309247|FG000|Overall Study|Lost to Follow-up|2|||
161799398|NCT01089647|584309248|FG001|Overall Study|Lost to Follow-up|2|||
161799399|NCT01089647|584309247|FG000|Overall Study|Withdrawal by Subject|2|||
161799400|NCT01089647|584309248|FG001|Overall Study|Withdrawal by Subject|1|||
161903396|NCT02452047|584694831|FG001|Overall Study|Physician Decision|0|||
161903397|NCT02452047|584694832|FG002|Overall Study|Physician Decision|0|||
161903398|NCT02452047|584694830|FG000|Overall Study|Lost to Follow-up|1|||
161903399|NCT02452047|584694831|FG001|Overall Study|Lost to Follow-up|1|||
161903400|NCT02452047|584694832|FG002|Overall Study|Lost to Follow-up|0|||
161903401|NCT02452047|584694830|FG000|Overall Study|Withdrawal by Subject|1|||
161903402|NCT02452047|584694831|FG001|Overall Study|Withdrawal by Subject|0|||
161903403|NCT02452047|584694832|FG002|Overall Study|Withdrawal by Subject|0|||
161903404|NCT02157519|584694845|FG000|Overall Study|Death|3|||
161903405|NCT02157519|584694846|FG001|Overall Study|Death|1|||
161903406|NCT02157519|584694845|FG000|Overall Study|Withdrawal by Subject|7|||
161903407|NCT02157519|584694846|FG001|Overall Study|Withdrawal by Subject|0|||
161903408|NCT02157519|584694845|FG000|Overall Study|Lost to Follow-up|1|||
161903409|NCT02157519|584694846|FG001|Overall Study|Lost to Follow-up|0|||
161903410|NCT01656395|584694847|FG000|Overall Study|Adverse Event|1|||
161903411|NCT01656395|584694848|FG001|Overall Study|Adverse Event|14|||
161903412|NCT01656395|584694849|FG002|Overall Study|Adverse Event|5|||
161903413|NCT01656395|584694850|FG003|Overall Study|Adverse Event|4|||
161903414|NCT01656395|584694851|FG004|Overall Study|Adverse Event|5|||
161903415|NCT01656395|584694852|FG005|Overall Study|Adverse Event|7|||
161903416|NCT01656395|584694853|FG006|Overall Study|Adverse Event|0|||
161903417|NCT01656395|584694854|FG007|Overall Study|Adverse Event|0|||
161903418|NCT01656395|584694847|FG000|Overall Study|Lack of Efficacy|1|||
161903419|NCT01656395|584694848|FG001|Overall Study|Lack of Efficacy|8|||
161903420|NCT01656395|584694849|FG002|Overall Study|Lack of Efficacy|6|||
161903421|NCT01656395|584694850|FG003|Overall Study|Lack of Efficacy|1|||
161903422|NCT01656395|584694851|FG004|Overall Study|Lack of Efficacy|1|||
161903423|NCT01656395|584694852|FG005|Overall Study|Lack of Efficacy|6|||
161903424|NCT01656395|584694853|FG006|Overall Study|Lack of Efficacy|0|||
161903425|NCT01656395|584694854|FG007|Overall Study|Lack of Efficacy|0|||
161903426|NCT01656395|584694847|FG000|Overall Study|Lost to Follow-up|1|||
161903427|NCT01656395|584694848|FG001|Overall Study|Lost to Follow-up|0|||
161903428|NCT01656395|584694849|FG002|Overall Study|Lost to Follow-up|0|||
161903429|NCT01656395|584694850|FG003|Overall Study|Lost to Follow-up|0|||
161903430|NCT01656395|584694851|FG004|Overall Study|Lost to Follow-up|0|||
161451270|NCT04556383|583048200|FG001|PCP|Lack of Efficacy|23|||
161451271|NCT04556383|583048201|FG002|PCP|Lack of Efficacy|23|||
161451272|NCT04556383|583048202|FG003|PCP|Lack of Efficacy|0|||
161451273|NCT04556383|583048199|FG000|PCP|Study terminated by sponsor|15|||
161451274|NCT04556383|583048200|FG001|PCP|Study terminated by sponsor|13|||
161451275|NCT04556383|583048201|FG002|PCP|Study terminated by sponsor|16|||
161451276|NCT04556383|583048202|FG003|PCP|Study terminated by sponsor|0|||
161451277|NCT04556383|583048199|FG000|PCP|Withdrawal by Subject|8|||
161451278|NCT04556383|583048200|FG001|PCP|Withdrawal by Subject|6|||
161451279|NCT04556383|583048201|FG002|PCP|Withdrawal by Subject|6|||
161451280|NCT04556383|583048202|FG003|PCP|Withdrawal by Subject|0|||
161451281|NCT04556383|583048199|FG000|PCP|Adverse Event|1|||
161451282|NCT04556383|583048200|FG001|PCP|Adverse Event|7|||
161451283|NCT04556383|583048201|FG002|PCP|Adverse Event|7|||
161451284|NCT04556383|583048202|FG003|PCP|Adverse Event|0|||
161451285|NCT04556383|583048199|FG000|PCP|Other, Not Specified|1|||
161451286|NCT04556383|583048200|FG001|PCP|Other, Not Specified|2|||
161451287|NCT04556383|583048201|FG002|PCP|Other, Not Specified|1|||
161451288|NCT04556383|583048202|FG003|PCP|Other, Not Specified|0|||
161451289|NCT04556383|583048199|FG000|PCP|Protocol Violation|1|||
161451290|NCT04556383|583048200|FG001|PCP|Protocol Violation|0|||
161451291|NCT04556383|583048201|FG002|PCP|Protocol Violation|1|||
161451292|NCT04556383|583048202|FG003|PCP|Protocol Violation|0|||
161451293|NCT04556383|583048199|FG000|PCP|Lost to Follow-up|1|||
161451294|NCT04556383|583048200|FG001|PCP|Lost to Follow-up|0|||
161451295|NCT04556383|583048201|FG002|PCP|Lost to Follow-up|0|||
161451296|NCT04556383|583048202|FG003|PCP|Lost to Follow-up|0|||
161451297|NCT04556383|583048199|FG000|PCP|Physician Decision|0|||
161451298|NCT04556383|583048200|FG001|PCP|Physician Decision|1|||
161451299|NCT04556383|583048201|FG002|PCP|Physician Decision|0|||
161451300|NCT04556383|583048202|FG003|PCP|Physician Decision|0|||
161451301|NCT04556383|583048199|FG000|PCP|Site terminated by sponsor|0|||
161451302|NCT04556383|583048200|FG001|PCP|Site terminated by sponsor|1|||
161451303|NCT04556383|583048201|FG002|PCP|Site terminated by sponsor|0|||
161451304|NCT04556383|583048202|FG003|PCP|Site terminated by sponsor|0|||
161451305|NCT04556383|583048199|FG000|OLE|Study terminated by sponsor|0|||
161451306|NCT04556383|583048200|FG001|OLE|Study terminated by sponsor|0|||
161451307|NCT04556383|583048201|FG002|OLE|Study terminated by sponsor|0|||
161451308|NCT04556383|583048202|FG003|OLE|Study terminated by sponsor|68|||
161451309|NCT04556383|583048199|FG000|OLE|Withdrawal by Subject|0|||
161451310|NCT04556383|583048200|FG001|OLE|Withdrawal by Subject|0|||
161451311|NCT04556383|583048201|FG002|OLE|Withdrawal by Subject|0|||
161451312|NCT04556383|583048202|FG003|OLE|Withdrawal by Subject|10|||
161451313|NCT04556383|583048199|FG000|OLE|Lack of Efficacy|0|||
161451314|NCT04556383|583048200|FG001|OLE|Lack of Efficacy|0|||
161451315|NCT04556383|583048201|FG002|OLE|Lack of Efficacy|0|||
161903431|NCT01656395|584694852|FG005|Overall Study|Lost to Follow-up|0|||
161451316|NCT04556383|583048202|FG003|OLE|Lack of Efficacy|7|||
161451317|NCT04556383|583048199|FG000|OLE|Adverse Event|0|||
161451318|NCT04556383|583048200|FG001|OLE|Adverse Event|0|||
161451319|NCT04556383|583048201|FG002|OLE|Adverse Event|0|||
161451320|NCT04556383|583048202|FG003|OLE|Adverse Event|2|||
161451321|NCT04556383|583048199|FG000|OLE|Other, Not Specified|0|||
161556510|NCT04140890|583427007|FG000|Overall Study|Withdrawal by Subject|0|||
161556511|NCT04140890|583427008|FG001|Overall Study|Withdrawal by Subject|1|||
161556512|NCT02388074|583427009|FG000|Overall Study|Lost in Transit|2|||
161556513|NCT02388074|583427009|FG000|Overall Study|Sample Not Returned|1|||
161556514|NCT01778062|583427012|FG000|Overall Study|Adverse Event|1|||
161556515|NCT01778062|583427013|FG001|Overall Study|Adverse Event|3|||
161556516|NCT01778062|583427012|FG000|Overall Study|Consent Withdrawal|1|||
161556517|NCT01778062|583427013|FG001|Overall Study|Consent Withdrawal|5|||
161556518|NCT01778062|583427012|FG000|Overall Study|major protocol deviation|4|||
161556519|NCT01778062|583427013|FG001|Overall Study|major protocol deviation|3|||
161556520|NCT03958630|583427016|FG000|Overall Study|Withdrawal by Subject|0|||
161556521|NCT03958630|583427017|FG001|Overall Study|Withdrawal by Subject|0|||
161556522|NCT03958630|583427018|FG002|Overall Study|Withdrawal by Subject|1|||
161556523|NCT03958630|583427016|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
161556524|NCT03958630|583427017|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
161556525|NCT03958630|583427018|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
161556526|NCT01824472|583427023|FG000|Overall Study|Lost to Follow-up|0|||
161799401|NCT01089647|584309247|FG000|Overall Study|Adverse Event|0|||
161799402|NCT01089647|584309248|FG001|Overall Study|Adverse Event|1|||
161799403|NCT01531205|584309249|FG000|Overall Study|Did not proceed to surgery|1|||
161799404|NCT02001558|584309252|FG000|Overall Study|Lost to Follow-up|8|||
161799405|NCT02001558|584309253|FG001|Overall Study|Lost to Follow-up|14|||
161799406|NCT01457053|584309255|FG000|Overall Study|Unable to undergo selected treatment|1|||
161799407|NCT01457053|584309256|FG001|Overall Study|Unable to undergo selected treatment|1|||
161799408|NCT00984295|584309258|FG000|Overall Study|Lost to Follow-up|31|||
161799409|NCT00984295|584309259|FG001|Overall Study|Lost to Follow-up|12|||
161799410|NCT00984295|584309260|FG002|Overall Study|Lost to Follow-up|13|||
161799411|NCT00984295|584309258|FG000|Overall Study|Protocol Violation|2|||
161799412|NCT00984295|584309259|FG001|Overall Study|Protocol Violation|1|||
161799413|NCT00984295|584309260|FG002|Overall Study|Protocol Violation|4|||
161799414|NCT00984295|584309258|FG000|Overall Study|Withdrawal by Subject|18|||
161799415|NCT00984295|584309259|FG001|Overall Study|Withdrawal by Subject|9|||
161799416|NCT00984295|584309260|FG002|Overall Study|Withdrawal by Subject|12|||
161799417|NCT00984295|584309258|FG000|Overall Study|CAE - discontinued test vaccine|0|||
161799418|NCT00984295|584309259|FG001|Overall Study|CAE - discontinued test vaccine|1|||
161799419|NCT00984295|584309260|FG002|Overall Study|CAE - discontinued test vaccine|3|||
161799420|NCT00984295|584309258|FG000|Overall Study|Missed one or more blood samplings|3|||
161799421|NCT00984295|584309259|FG001|Overall Study|Missed one or more blood samplings|7|||
161799422|NCT00984295|584309260|FG002|Overall Study|Missed one or more blood samplings|2|||
161799423|NCT00984295|584309258|FG000|Overall Study|Incomplete safety follow-up|11|||
161799424|NCT00984295|584309259|FG001|Overall Study|Incomplete safety follow-up|2|||
161799425|NCT00984295|584309260|FG002|Overall Study|Incomplete safety follow-up|3|||
161799426|NCT02364557|584309261|FG000|Overall Study|Protocol Violation|3|||
161799427|NCT02364557|584309262|FG001|Overall Study|Protocol Violation|1|||
161799428|NCT04347239|584309263|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
161799429|NCT04347239|584309264|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
161799430|NCT04347239|584309265|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
161799431|NCT04347239|584309263|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
161799432|NCT04347239|584309264|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
161799433|NCT04347239|584309265|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
161799434|NCT04582539|584309266|FG000|Overall Study|Death|1|||
161799435|NCT04582539|584309267|FG001|Overall Study|Death|1|||
161799436|NCT04582539|584309268|FG002|Overall Study|Death|0|||
161799437|NCT04582539|584309269|FG003|Overall Study|Death|1|||
161799438|NCT04582539|584309270|FG004|Overall Study|Death|0|||
161799439|NCT04582539|584309266|FG000|Overall Study|Lost to Follow-up|1|||
161799440|NCT04582539|584309267|FG001|Overall Study|Lost to Follow-up|0|||
161799441|NCT04582539|584309268|FG002|Overall Study|Lost to Follow-up|0|||
161799442|NCT04582539|584309269|FG003|Overall Study|Lost to Follow-up|0|||
161799443|NCT04582539|584309270|FG004|Overall Study|Lost to Follow-up|0|||
161799444|NCT04582539|584309266|FG000|Overall Study|Study Terminated by Sponsor|1|||
161799445|NCT04582539|584309267|FG001|Overall Study|Study Terminated by Sponsor|3|||
161799446|NCT04582539|584309268|FG002|Overall Study|Study Terminated by Sponsor|2|||
161799447|NCT04582539|584309269|FG003|Overall Study|Study Terminated by Sponsor|2|||
161799448|NCT04582539|584309270|FG004|Overall Study|Study Terminated by Sponsor|3|||
161799449|NCT04582539|584309266|FG000|Overall Study|Physician Decision|0|||
161903432|NCT01656395|584694853|FG006|Overall Study|Lost to Follow-up|0|||
161799450|NCT04582539|584309267|FG001|Overall Study|Physician Decision|1|||
161799451|NCT04582539|584309268|FG002|Overall Study|Physician Decision|0|||
161799452|NCT04582539|584309269|FG003|Overall Study|Physician Decision|0|||
161799453|NCT04582539|584309270|FG004|Overall Study|Physician Decision|0|||
161799454|NCT04582539|584309266|FG000|Overall Study|Withdrawal by Subject|1|||
161799455|NCT04582539|584309267|FG001|Overall Study|Withdrawal by Subject|0|||
161903433|NCT01656395|584694854|FG007|Overall Study|Lost to Follow-up|0|||
161556527|NCT01824472|583427024|FG001|Overall Study|Lost to Follow-up|0|||
161903434|NCT01656395|584694847|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161903435|NCT01656395|584694848|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161903436|NCT01656395|584694849|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161903437|NCT01656395|584694850|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161903438|NCT01656395|584694851|FG004|Overall Study|Non-Compliance with Study Drug|1|||
161903439|NCT01656395|584694852|FG005|Overall Study|Non-Compliance with Study Drug|1|||
161903440|NCT01656395|584694853|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161903441|NCT01656395|584694854|FG007|Overall Study|Non-Compliance with Study Drug|0|||
161903442|NCT01656395|584694847|FG000|Overall Study|Other|0|||
161903443|NCT01656395|584694848|FG001|Overall Study|Other|0|||
161903444|NCT01656395|584694849|FG002|Overall Study|Other|1|||
161903445|NCT01656395|584694850|FG003|Overall Study|Other|0|||
161903446|NCT01656395|584694851|FG004|Overall Study|Other|0|||
161903447|NCT01656395|584694852|FG005|Overall Study|Other|1|||
161903448|NCT01656395|584694853|FG006|Overall Study|Other|0|||
161903449|NCT01656395|584694854|FG007|Overall Study|Other|0|||
161903450|NCT01656395|584694847|FG000|Overall Study|Physician Decision|2|||
161903451|NCT01656395|584694848|FG001|Overall Study|Physician Decision|3|||
161903452|NCT01656395|584694849|FG002|Overall Study|Physician Decision|3|||
161903453|NCT01656395|584694850|FG003|Overall Study|Physician Decision|2|||
161903454|NCT01656395|584694851|FG004|Overall Study|Physician Decision|3|||
161903455|NCT01656395|584694852|FG005|Overall Study|Physician Decision|3|||
161903456|NCT01656395|584694853|FG006|Overall Study|Physician Decision|0|||
161903457|NCT01656395|584694854|FG007|Overall Study|Physician Decision|0|||
161903458|NCT01656395|584694847|FG000|Overall Study|Pregnancy|0|||
161903459|NCT01656395|584694848|FG001|Overall Study|Pregnancy|0|||
161903460|NCT01656395|584694849|FG002|Overall Study|Pregnancy|1|||
161903461|NCT01656395|584694850|FG003|Overall Study|Pregnancy|0|||
161903462|NCT01656395|584694851|FG004|Overall Study|Pregnancy|0|||
161903463|NCT01656395|584694852|FG005|Overall Study|Pregnancy|0|||
161903464|NCT01656395|584694853|FG006|Overall Study|Pregnancy|0|||
161451322|NCT04556383|583048200|FG001|OLE|Other, Not Specified|0|||
161451323|NCT04556383|583048201|FG002|OLE|Other, Not Specified|0|||
161451324|NCT04556383|583048202|FG003|OLE|Other, Not Specified|2|||
161451325|NCT04556383|583048199|FG000|OLE|Death|0|||
161451326|NCT04556383|583048200|FG001|OLE|Death|0|||
161451327|NCT04556383|583048201|FG002|OLE|Death|0|||
161451328|NCT04556383|583048202|FG003|OLE|Death|1|||
161451329|NCT04556383|583048199|FG000|OLE|Lost to Follow-up|0|||
161451330|NCT04556383|583048200|FG001|OLE|Lost to Follow-up|0|||
161451331|NCT04556383|583048201|FG002|OLE|Lost to Follow-up|0|||
161451332|NCT04556383|583048202|FG003|OLE|Lost to Follow-up|1|||
161451333|NCT03704636|583048203|FG000|Overall Study|Inadequate Venous Flow|3|||
161451334|NCT02720042|583048204|FG000|Overall Study|Death|3|||
161451335|NCT02720042|583048204|FG000|Overall Study|Lost to Follow-up|4|||
161451336|NCT02720042|583048204|FG000|Overall Study|Withdrawal by Subject|1|||
161451337|NCT02720042|583048204|FG000|Overall Study|Physician Decision|3|||
161451338|NCT02720042|583048204|FG000|Overall Study|Phasix Mesh explanted|1|||
161451339|NCT02720042|583048204|FG000|Overall Study|unable due to non-study-related illness|3|||
161451340|NCT00539188|583048205|FG000|Overall Study|Withdrawal by Subject|1|||
161451341|NCT00539188|583048206|FG001|Overall Study|Withdrawal by Subject|0|||
161451342|NCT00539188|583048205|FG000|Overall Study|Lost to Follow-up|2|||
161451343|NCT00539188|583048206|FG001|Overall Study|Lost to Follow-up|1|||
161451344|NCT00509145|583048207|FG000|Overall Study|Death|0|||
161451345|NCT00509145|583048208|FG001|Overall Study|Death|2|||
161451346|NCT00509145|583048207|FG000|Overall Study|Adverse Event|42|||
161451347|NCT00509145|583048208|FG001|Overall Study|Adverse Event|28|||
161451348|NCT00509145|583048207|FG000|Overall Study|Withdrawal by Subject|32|||
161451349|NCT00509145|583048208|FG001|Overall Study|Withdrawal by Subject|38|||
161451350|NCT00509145|583048207|FG000|Overall Study|Physician Decision|11|||
161451351|NCT00509145|583048208|FG001|Overall Study|Physician Decision|14|||
161451352|NCT00509145|583048207|FG000|Overall Study|Protocol Violation|1|||
161451353|NCT00509145|583048208|FG001|Overall Study|Protocol Violation|6|||
161451354|NCT00509145|583048207|FG000|Overall Study|Pregnancy|3|||
161451355|NCT00509145|583048208|FG001|Overall Study|Pregnancy|8|||
161451356|NCT00509145|583048207|FG000|Overall Study|Lost to Follow-up|6|||
161903465|NCT01656395|584694854|FG007|Overall Study|Pregnancy|0|||
161903466|NCT01656395|584694847|FG000|Overall Study|Progressive Disease|0|||
161903467|NCT01656395|584694848|FG001|Overall Study|Progressive Disease|0|||
161903468|NCT01656395|584694849|FG002|Overall Study|Progressive Disease|0|||
161903469|NCT01656395|584694850|FG003|Overall Study|Progressive Disease|0|||
161903470|NCT01656395|584694851|FG004|Overall Study|Progressive Disease|0|||
161451357|NCT00509145|583048208|FG001|Overall Study|Lost to Follow-up|5|||
161451358|NCT00509145|583048207|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
161451359|NCT00509145|583048208|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
161451360|NCT00509145|583048207|FG000|Overall Study|Other|6|||
161451361|NCT00509145|583048208|FG001|Overall Study|Other|6|||
161451362|NCT01994889|583048211|FG000|Overall Study|Adverse Event|5|||
161451363|NCT01994889|583048212|FG001|Overall Study|Adverse Event|12|||
161903471|NCT01656395|584694852|FG005|Overall Study|Progressive Disease|1|||
161903472|NCT01656395|584694853|FG006|Overall Study|Progressive Disease|0|||
161903473|NCT01656395|584694854|FG007|Overall Study|Progressive Disease|0|||
161556528|NCT01824472|583427025|FG002|Overall Study|Lost to Follow-up|1|||
161556529|NCT01824472|583427023|FG000|Overall Study|Withdrawal by Subject|1|||
161556530|NCT01824472|583427024|FG001|Overall Study|Withdrawal by Subject|5|||
161556531|NCT01824472|583427025|FG002|Overall Study|Withdrawal by Subject|3|||
161556532|NCT01824472|583427023|FG000|Overall Study|Ineligible post randomization&screening|0|||
161556533|NCT01824472|583427024|FG001|Overall Study|Ineligible post randomization&screening|2|||
161556534|NCT01824472|583427025|FG002|Overall Study|Ineligible post randomization&screening|0|||
161556535|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
161556536|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
161556537|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
161556538|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
161556539|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
161556540|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
161556541|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
161556542|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
161556543|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
161556544|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
161556545|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
161556546|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
161556547|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
161556548|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
161556549|NCT01815736|583427026|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
161556550|NCT01815736|583427027|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
161556551|NCT01815736|583427026|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
161556552|NCT01815736|583427027|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
161556553|NCT01815736|583427026|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
161556554|NCT01815736|583427027|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
161556555|NCT01815736|583427026|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
161556556|NCT01815736|583427027|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
161556557|NCT01815736|583427026|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
161556558|NCT01815736|583427027|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
161556559|NCT01815736|583427026|FG000|Extension Treatment Phase- After Week 96|Death|1|||
161556560|NCT01815736|583427027|FG001|Extension Treatment Phase- After Week 96|Death|0|||
161556561|NCT03387514|583427031|FG000|Overall Study|Withdrawal by Subject|2|||
161556562|NCT03387514|583427031|FG000|Overall Study|Physician Decision|1|||
161556563|NCT03387514|583427031|FG000|Overall Study|Lost to Follow-up|2|||
161556564|NCT03317379|583427036|FG000|Overall Study|Lost to Follow-up|0|||
161556565|NCT03317379|583427037|FG001|Overall Study|Lost to Follow-up|3|||
161799456|NCT04582539|584309268|FG002|Overall Study|Withdrawal by Subject|2|||
161799457|NCT04582539|584309269|FG003|Overall Study|Withdrawal by Subject|1|||
161799458|NCT04582539|584309270|FG004|Overall Study|Withdrawal by Subject|0|||
161799459|NCT04582539|584309266|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799460|NCT04582539|584309267|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799461|NCT04582539|584309268|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799462|NCT04582539|584309269|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
161799463|NCT04582539|584309270|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799464|NCT00788957|584309279|FG000|Part 1|Death|8|||
161799465|NCT00788957|584309280|FG001|Part 1|Death|0|||
161799466|NCT00788957|584309281|FG002|Part 1|Death|0|||
161799467|NCT00788957|584309282|FG003|Part 1|Death|0|||
161799468|NCT00788957|584309283|FG004|Part 1|Death|0|||
161799469|NCT00788957|584309284|FG005|Part 1|Death|0|||
161799470|NCT00788957|584309279|FG000|Part 1|Lost to Follow-up|1|||
161799471|NCT00788957|584309280|FG001|Part 1|Lost to Follow-up|0|||
161799472|NCT00788957|584309281|FG002|Part 1|Lost to Follow-up|0|||
161799473|NCT00788957|584309282|FG003|Part 1|Lost to Follow-up|0|||
161799474|NCT00788957|584309283|FG004|Part 1|Lost to Follow-up|0|||
161799475|NCT00788957|584309284|FG005|Part 1|Lost to Follow-up|0|||
161556566|NCT03317379|583427038|FG002|Overall Study|Lost to Follow-up|2|||
161556567|NCT03040687|583427039|FG000|Overall Study|Withdrawal by Subject|1|||
161556568|NCT03040687|583427040|FG001|Overall Study|Withdrawal by Subject|0|||
161556569|NCT03040687|583427041|FG002|Overall Study|Withdrawal by Subject|0|||
161556570|NCT02846558|583427042|FG000|Overall Study|Adverse Event|1|||
161556571|NCT02846558|583427043|FG001|Overall Study|Adverse Event|0|||
161556572|NCT02846558|583427044|FG002|Overall Study|Adverse Event|0|||
161556573|NCT02846558|583427045|FG003|Overall Study|Adverse Event|0|||
161556574|NCT02846558|583427042|FG000|Overall Study|Withdrawal by Subject|5|||
161799476|NCT00788957|584309279|FG000|Part 2|Withdrawal by Subject|0|||
161799477|NCT00788957|584309280|FG001|Part 2|Withdrawal by Subject|9|||
161799478|NCT00788957|584309281|FG002|Part 2|Withdrawal by Subject|5|||
161799479|NCT00788957|584309282|FG003|Part 2|Withdrawal by Subject|3|||
161799480|NCT00788957|584309283|FG004|Part 2|Withdrawal by Subject|0|||
161556575|NCT02846558|583427043|FG001|Overall Study|Withdrawal by Subject|4|||
161556576|NCT02846558|583427044|FG002|Overall Study|Withdrawal by Subject|2|||
161556577|NCT02846558|583427045|FG003|Overall Study|Withdrawal by Subject|2|||
161556578|NCT02846558|583427042|FG000|Overall Study|Lost to Follow-up|2|||
161556579|NCT02846558|583427043|FG001|Overall Study|Lost to Follow-up|0|||
161556580|NCT02846558|583427044|FG002|Overall Study|Lost to Follow-up|0|||
161556581|NCT02846558|583427045|FG003|Overall Study|Lost to Follow-up|0|||
161556582|NCT04445155|583427046|FG000|Overall Study|Lost to Follow-up|11|||
161556583|NCT04445155|583427047|FG001|Overall Study|Lost to Follow-up|2|||
161556584|NCT04445155|583427048|FG002|Overall Study|Lost to Follow-up|3|||
161556585|NCT04445155|583427049|FG003|Overall Study|Lost to Follow-up|0|||
161556586|NCT04445155|583427046|FG000|Overall Study|Withdrawal by Subject|8|||
161556587|NCT04445155|583427047|FG001|Overall Study|Withdrawal by Subject|0|||
161556588|NCT04445155|583427048|FG002|Overall Study|Withdrawal by Subject|0|||
161556589|NCT04445155|583427049|FG003|Overall Study|Withdrawal by Subject|0|||
161556590|NCT04445155|583427046|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
161556591|NCT04445155|583427047|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
161556592|NCT04445155|583427048|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
161556593|NCT04445155|583427049|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
161556594|NCT04445155|583427046|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
161556595|NCT04445155|583427047|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
161556596|NCT04445155|583427048|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
161556597|NCT04445155|583427049|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
161556598|NCT04157686|583427050|FG000|Overall Study|Adverse Event|1|||
161556599|NCT04157686|583427051|FG001|Overall Study|Adverse Event|0|||
161556600|NCT04157686|583427052|FG002|Overall Study|Adverse Event|1|||
161556601|NCT04157686|583427053|FG003|Overall Study|Adverse Event|0|||
161556602|NCT04157686|583427054|FG004|Overall Study|Adverse Event|1|||
161556603|NCT04157686|583427055|FG005|Overall Study|Adverse Event|0|||
161556604|NCT04157686|583427056|FG006|Overall Study|Adverse Event|0|||
161556605|NCT04157686|583427057|FG007|Overall Study|Adverse Event|0|||
161556606|NCT04157686|583427050|FG000|Overall Study|Pregnancy|0|||
161556607|NCT04157686|583427051|FG001|Overall Study|Pregnancy|1|||
161556608|NCT04157686|583427052|FG002|Overall Study|Pregnancy|3|||
161556609|NCT04157686|583427053|FG003|Overall Study|Pregnancy|0|||
161556610|NCT04157686|583427054|FG004|Overall Study|Pregnancy|0|||
161556611|NCT04157686|583427055|FG005|Overall Study|Pregnancy|0|||
161556612|NCT04157686|583427056|FG006|Overall Study|Pregnancy|3|||
161556613|NCT04157686|583427057|FG007|Overall Study|Pregnancy|0|||
161556614|NCT04157686|583427050|FG000|Overall Study|Lost to Follow-up|1|||
161556615|NCT04157686|583427051|FG001|Overall Study|Lost to Follow-up|2|||
161556616|NCT04157686|583427052|FG002|Overall Study|Lost to Follow-up|8|||
161556617|NCT04157686|583427053|FG003|Overall Study|Lost to Follow-up|6|||
161556618|NCT04157686|583427054|FG004|Overall Study|Lost to Follow-up|6|||
161556619|NCT04157686|583427055|FG005|Overall Study|Lost to Follow-up|3|||
161556620|NCT04157686|583427056|FG006|Overall Study|Lost to Follow-up|7|||
161556621|NCT04157686|583427057|FG007|Overall Study|Lost to Follow-up|9|||
161556622|NCT04157686|583427050|FG000|Overall Study|Lack of Efficacy|0|||
161556623|NCT04157686|583427051|FG001|Overall Study|Lack of Efficacy|0|||
161556624|NCT04157686|583427052|FG002|Overall Study|Lack of Efficacy|0|||
161556625|NCT04157686|583427053|FG003|Overall Study|Lack of Efficacy|0|||
161799481|NCT00788957|584309284|FG005|Part 2|Withdrawal by Subject|0|||
161799482|NCT00788957|584309279|FG000|Part 2|Death|0|||
161799483|NCT00788957|584309280|FG001|Part 2|Death|32|||
161799484|NCT00788957|584309281|FG002|Part 2|Death|35|||
161799485|NCT00788957|584309282|FG003|Part 2|Death|37|||
161799486|NCT00788957|584309283|FG004|Part 2|Death|0|||
161799487|NCT00788957|584309284|FG005|Part 2|Death|0|||
161799488|NCT00788957|584309279|FG000|Part 2|Lost to Follow-up|0|||
161799489|NCT00788957|584309280|FG001|Part 2|Lost to Follow-up|0|||
161799490|NCT00788957|584309281|FG002|Part 2|Lost to Follow-up|3|||
161799491|NCT00788957|584309282|FG003|Part 2|Lost to Follow-up|0|||
161799492|NCT00788957|584309283|FG004|Part 2|Lost to Follow-up|0|||
161799493|NCT00788957|584309284|FG005|Part 2|Lost to Follow-up|0|||
161903474|NCT01656395|584694847|FG000|Overall Study|Protocol Violation|6|||
161556626|NCT04157686|583427054|FG004|Overall Study|Lack of Efficacy|0|||
161556627|NCT04157686|583427055|FG005|Overall Study|Lack of Efficacy|2|||
161556628|NCT04157686|583427056|FG006|Overall Study|Lack of Efficacy|0|||
161556629|NCT04157686|583427057|FG007|Overall Study|Lack of Efficacy|1|||
161556630|NCT04157686|583427050|FG000|Overall Study|Withdrawal by Subject|10|||
161556631|NCT04157686|583427051|FG001|Overall Study|Withdrawal by Subject|10|||
161556632|NCT04157686|583427052|FG002|Overall Study|Withdrawal by Subject|12|||
161799494|NCT00788957|584309279|FG000|Part 2|On-study at time of data cut-off|0|||
161799495|NCT00788957|584309280|FG001|Part 2|On-study at time of data cut-off|1|||
161799496|NCT00788957|584309281|FG002|Part 2|On-study at time of data cut-off|1|||
161799497|NCT00788957|584309282|FG003|Part 2|On-study at time of data cut-off|1|||
161799498|NCT00788957|584309283|FG004|Part 2|On-study at time of data cut-off|0|||
161903475|NCT01656395|584694848|FG001|Overall Study|Protocol Violation|6|||
161799499|NCT00788957|584309284|FG005|Part 2|On-study at time of data cut-off|0|||
161799500|NCT00788957|584309279|FG000|Part 3|Withdrawal by Subject|0|||
161799501|NCT00788957|584309280|FG001|Part 3|Withdrawal by Subject|0|||
161799502|NCT00788957|584309281|FG002|Part 3|Withdrawal by Subject|0|||
161799503|NCT00788957|584309282|FG003|Part 3|Withdrawal by Subject|0|||
161799504|NCT00788957|584309283|FG004|Part 3|Withdrawal by Subject|0|||
161799505|NCT00788957|584309284|FG005|Part 3|Withdrawal by Subject|2|||
161799506|NCT00788957|584309279|FG000|Part 3|Death|0|||
161799507|NCT00788957|584309280|FG001|Part 3|Death|0|||
161799508|NCT00788957|584309281|FG002|Part 3|Death|0|||
161799509|NCT00788957|584309282|FG003|Part 3|Death|0|||
161799510|NCT00788957|584309283|FG004|Part 3|Death|8|||
161799511|NCT00788957|584309284|FG005|Part 3|Death|8|||
161799512|NCT00788957|584309279|FG000|Part 3|On-study at time of data cut-off|0|||
161799513|NCT00788957|584309280|FG001|Part 3|On-study at time of data cut-off|0|||
161799514|NCT00788957|584309281|FG002|Part 3|On-study at time of data cut-off|0|||
161799515|NCT00788957|584309282|FG003|Part 3|On-study at time of data cut-off|0|||
161799516|NCT00788957|584309283|FG004|Part 3|On-study at time of data cut-off|1|||
161799517|NCT00788957|584309284|FG005|Part 3|On-study at time of data cut-off|0|||
161799518|NCT00662129|584309285|FG000|Overall Study|Protocol Violation|1|||
161799519|NCT00662129|584309285|FG000|Overall Study|Cancel prior to beginning treatment|1|||
161799520|NCT00662129|584309285|FG000|Overall Study|Ineligible|1|||
161799521|NCT00796510|584309298|FG000|Overall Study|Death|1|||
161799522|NCT00796510|584309299|FG001|Overall Study|Death|0|||
161799523|NCT00796510|584309298|FG000|Overall Study|Study Terminated|2|||
161799524|NCT00796510|584309299|FG001|Overall Study|Study Terminated|0|||
161799525|NCT05030753|584309300|FG000|9-week|Lost to Follow-up|10|||
161799526|NCT05030753|584309301|FG001|9-week|Lost to Follow-up|7|||
161799527|NCT05030753|584309300|FG000|9-week|Withdrawal by Subject|1|||
161799528|NCT05030753|584309301|FG001|9-week|Withdrawal by Subject|0|||
161799529|NCT05030753|584309300|FG000|9-week|Excluded from analysis due to missing covariates|2|||
161799530|NCT05030753|584309301|FG001|9-week|Excluded from analysis due to missing covariates|1|||
161799531|NCT05030753|584309300|FG000|6-month post intervention|Lost to Follow-up|5|||
161799532|NCT05030753|584309301|FG001|6-month post intervention|Lost to Follow-up|4|||
161799533|NCT05030753|584309300|FG000|6-month post intervention|Withdrawal by Subject|4|||
161799534|NCT05030753|584309301|FG001|6-month post intervention|Withdrawal by Subject|0|||
161799535|NCT05030753|584309300|FG000|18-month post intervention|Lost to Follow-up|3|||
161799536|NCT05030753|584309301|FG001|18-month post intervention|Lost to Follow-up|1|||
161799537|NCT03072459|584309306|FG000|Overall Study|Device revised/removed|1|||
161799538|NCT03072459|584309306|FG000|Overall Study|Subject not able to return|1|||
161799539|NCT00329602|584309307|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
161799540|NCT00329602|584309308|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
161799541|NCT00329602|584309309|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
161799542|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
161799543|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
161799544|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
161799545|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
161799546|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
161799547|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
161799548|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
161799549|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
161799550|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
161799551|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
161799552|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
161799553|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
161799554|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
161799555|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
161799556|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
161799557|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
161799558|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
161799559|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
161799560|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
161799561|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
161799562|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
161799563|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
161903476|NCT01656395|584694849|FG002|Overall Study|Protocol Violation|9|||
161799564|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
161799565|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
161799566|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
161799567|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Death|2|||
161799568|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Death|4|||
161903477|NCT01656395|584694850|FG003|Overall Study|Protocol Violation|2|||
161799569|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
161903478|NCT01656395|584694851|FG004|Overall Study|Protocol Violation|4|||
161903479|NCT01656395|584694852|FG005|Overall Study|Protocol Violation|10|||
161903480|NCT01656395|584694853|FG006|Overall Study|Protocol Violation|0|||
161903481|NCT01656395|584694854|FG007|Overall Study|Protocol Violation|0|||
161903482|NCT01656395|584694847|FG000|Overall Study|Screen Failure|2|||
161903483|NCT01656395|584694848|FG001|Overall Study|Screen Failure|1|||
161903484|NCT01656395|584694849|FG002|Overall Study|Screen Failure|7|||
161903485|NCT01656395|584694850|FG003|Overall Study|Screen Failure|1|||
161903486|NCT01656395|584694851|FG004|Overall Study|Screen Failure|0|||
161903487|NCT01656395|584694852|FG005|Overall Study|Screen Failure|8|||
161903488|NCT01656395|584694853|FG006|Overall Study|Screen Failure|0|||
161903489|NCT01656395|584694854|FG007|Overall Study|Screen Failure|0|||
161903490|NCT01656395|584694847|FG000|Overall Study|Withdrawal by Subject|3|||
161903491|NCT01656395|584694848|FG001|Overall Study|Withdrawal by Subject|1|||
161903492|NCT01656395|584694849|FG002|Overall Study|Withdrawal by Subject|4|||
161903493|NCT01656395|584694850|FG003|Overall Study|Withdrawal by Subject|2|||
161903494|NCT01656395|584694851|FG004|Overall Study|Withdrawal by Subject|0|||
161903495|NCT01656395|584694852|FG005|Overall Study|Withdrawal by Subject|3|||
161903496|NCT01656395|584694853|FG006|Overall Study|Withdrawal by Subject|0|||
161903497|NCT01656395|584694854|FG007|Overall Study|Withdrawal by Subject|0|||
161903498|NCT00230048|584694858|FG000|Overall Study|Lost to Follow-up|13|||
161903499|NCT00230048|584694859|FG001|Overall Study|Lost to Follow-up|18|||
161903500|NCT00676403|584694860|FG000|Overall Study|Adverse Event|1|||
161903501|NCT00676403|584694861|FG001|Overall Study|Adverse Event|2|||
161903502|NCT00676403|584694862|FG002|Overall Study|Adverse Event|0|||
161903503|NCT00676403|584694863|FG003|Overall Study|Adverse Event|5|||
161556633|NCT04157686|583427053|FG003|Overall Study|Withdrawal by Subject|20|||
161556634|NCT04157686|583427054|FG004|Overall Study|Withdrawal by Subject|12|||
161556635|NCT04157686|583427055|FG005|Overall Study|Withdrawal by Subject|11|||
161556636|NCT04157686|583427056|FG006|Overall Study|Withdrawal by Subject|18|||
161556637|NCT04157686|583427057|FG007|Overall Study|Withdrawal by Subject|24|||
161799570|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
161799571|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
161799572|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
161799573|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
161799574|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
161799575|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
161799576|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
161799577|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
161799578|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
161799579|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Death|3|||
161799580|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Death|2|||
161799581|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
161799582|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
161799583|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
161799584|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
161799585|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
161799586|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
161799587|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
161799588|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
161799589|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
161799590|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
161799591|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
161799592|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
161799593|NCT02097121|584309316|FG000|Overall Study|Other, not specified|4|||
161799594|NCT02097121|584309317|FG001|Overall Study|Other, not specified|2|||
161799595|NCT02097121|584309318|FG002|Overall Study|Other, not specified|3|||
161799596|NCT02097121|584309316|FG000|Overall Study|Lack of Efficacy|2|||
161799597|NCT02097121|584309317|FG001|Overall Study|Lack of Efficacy|1|||
161799598|NCT02097121|584309318|FG002|Overall Study|Lack of Efficacy|3|||
161799599|NCT02097121|584309316|FG000|Overall Study|Withdrawal by Subject|0|||
161799600|NCT02097121|584309317|FG001|Overall Study|Withdrawal by Subject|1|||
161799601|NCT02097121|584309318|FG002|Overall Study|Withdrawal by Subject|2|||
161799602|NCT02097121|584309316|FG000|Overall Study|Adverse Event|0|||
161799603|NCT02097121|584309317|FG001|Overall Study|Adverse Event|1|||
161799604|NCT02097121|584309318|FG002|Overall Study|Adverse Event|0|||
161556638|NCT04157686|583427050|FG000|Overall Study|Physician Decision|0|||
161556639|NCT04157686|583427051|FG001|Overall Study|Physician Decision|0|||
161799605|NCT02097121|584309316|FG000|Overall Study|Lost to Follow-up|1|||
161799606|NCT02097121|584309317|FG001|Overall Study|Lost to Follow-up|1|||
161799607|NCT02097121|584309318|FG002|Overall Study|Lost to Follow-up|2|||
161903504|NCT00676403|584694864|FG004|Overall Study|Adverse Event|1|||
161903505|NCT00676403|584694865|FG005|Overall Study|Adverse Event|2|||
161903506|NCT00676403|584694860|FG000|Overall Study|Lost to Follow-up|0|||
161903507|NCT00676403|584694861|FG001|Overall Study|Lost to Follow-up|0|||
161903508|NCT00676403|584694862|FG002|Overall Study|Lost to Follow-up|0|||
161903509|NCT00676403|584694863|FG003|Overall Study|Lost to Follow-up|0|||
161799608|NCT00510510|584309319|FG000|Overall Study|Adverse Event|4|||
161799609|NCT00510510|584309320|FG001|Overall Study|Adverse Event|3|||
161799610|NCT00510510|584309321|FG002|Overall Study|Adverse Event|6|||
161799611|NCT00510510|584309319|FG000|Overall Study|Lack of Efficacy|0|||
161799612|NCT00510510|584309320|FG001|Overall Study|Lack of Efficacy|1|||
161799613|NCT00510510|584309321|FG002|Overall Study|Lack of Efficacy|1|||
161799614|NCT00510510|584309319|FG000|Overall Study|Subjects no longer requires study drug|0|||
161799615|NCT00510510|584309320|FG001|Overall Study|Subjects no longer requires study drug|0|||
161799616|NCT00510510|584309321|FG002|Overall Study|Subjects no longer requires study drug|2|||
161799617|NCT00510510|584309319|FG000|Overall Study|Withdrawal by Subject|1|||
161799618|NCT00510510|584309320|FG001|Overall Study|Withdrawal by Subject|2|||
161799619|NCT00510510|584309321|FG002|Overall Study|Withdrawal by Subject|3|||
161799620|NCT00510510|584309319|FG000|Overall Study|Lost to Follow-up|0|||
161799621|NCT00510510|584309320|FG001|Overall Study|Lost to Follow-up|0|||
161799622|NCT00510510|584309321|FG002|Overall Study|Lost to Follow-up|1|||
161799623|NCT00510510|584309319|FG000|Overall Study|Protocol Violation|0|||
161799624|NCT00510510|584309320|FG001|Overall Study|Protocol Violation|3|||
161799625|NCT00510510|584309321|FG002|Overall Study|Protocol Violation|4|||
161799626|NCT03595657|584309322|FG000|Overall Study|Adverse Event|14|||
161799627|NCT03595657|584309322|FG000|Overall Study|Death|1|||
161799628|NCT03595657|584309322|FG000|Overall Study|Lack of Efficacy|40|||
161799629|NCT03595657|584309322|FG000|Overall Study|Withdrawal by Subject|10|||
161799630|NCT03595657|584309322|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
161799631|NCT03595657|584309322|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
161799632|NCT01066052|584309323|FG000|Overall Study|Enrolled But Not Treated|3|||
161799633|NCT01066052|584309324|FG001|Overall Study|Enrolled But Not Treated|0|||
161799634|NCT01200394|584309325|FG000|Overall Study|Adverse Event|0|||
161799635|NCT01200394|584309326|FG001|Overall Study|Adverse Event|14|||
161799636|NCT01200394|584309325|FG000|Overall Study|Death|1|||
161799637|NCT01200394|584309326|FG001|Overall Study|Death|0|||
161799638|NCT01200394|584309325|FG000|Overall Study|Lost to Follow-up|0|||
161799639|NCT01200394|584309326|FG001|Overall Study|Lost to Follow-up|1|||
161799640|NCT01200394|584309325|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161799641|NCT01200394|584309326|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
161799642|NCT01200394|584309325|FG000|Overall Study|Protocol Violation|0|||
161799643|NCT01200394|584309326|FG001|Overall Study|Protocol Violation|3|||
161799644|NCT01200394|584309325|FG000|Overall Study|Withdrawal by Subject|0|||
161799645|NCT01200394|584309326|FG001|Overall Study|Withdrawal by Subject|5|||
161799646|NCT01200394|584309325|FG000|Overall Study|Other|0|||
161799647|NCT01200394|584309326|FG001|Overall Study|Other|1|||
161799648|NCT01835145|584309329|FG000|Overall Study|Ineligible prior to treatment|1|||
161799649|NCT01835145|584309330|FG001|Overall Study|Ineligible prior to treatment|0|||
161799650|NCT02729896|584309331|FG000|Overall Study|Death|0|||
161799651|NCT02729896|584309332|FG001|Overall Study|Death|2|||
161799652|NCT02729896|584309333|FG002|Overall Study|Death|13|||
161799653|NCT02729896|584309331|FG000|Overall Study|Lost to Follow-up|0|||
161799654|NCT02729896|584309332|FG001|Overall Study|Lost to Follow-up|2|||
161799655|NCT02729896|584309333|FG002|Overall Study|Lost to Follow-up|3|||
161799656|NCT02729896|584309331|FG000|Overall Study|Other|0|||
161451364|NCT01994889|583048213|FG002|Overall Study|Adverse Event|11|||
161451365|NCT01994889|583048211|FG000|Overall Study|Cardiac Device Implantation|0|||
161451366|NCT01994889|583048212|FG001|Overall Study|Cardiac Device Implantation|2|||
161451367|NCT01994889|583048213|FG002|Overall Study|Cardiac Device Implantation|0|||
161451368|NCT01994889|583048211|FG000|Overall Study|Organ Transplantation|1|||
161451369|NCT01994889|583048212|FG001|Overall Study|Organ Transplantation|5|||
161451370|NCT01994889|583048213|FG002|Overall Study|Organ Transplantation|5|||
161451371|NCT01994889|583048211|FG000|Overall Study|No longer willing to participate|8|||
161451372|NCT01994889|583048212|FG001|Overall Study|No longer willing to participate|17|||
161451373|NCT01994889|583048213|FG002|Overall Study|No longer willing to participate|37|||
161451374|NCT01994889|583048211|FG000|Overall Study|Lost to Follow-up|0|||
161451375|NCT01994889|583048212|FG001|Overall Study|Lost to Follow-up|1|||
161451376|NCT01994889|583048213|FG002|Overall Study|Lost to Follow-up|0|||
161451377|NCT01994889|583048211|FG000|Overall Study|Protocol Violation|0|||
161451378|NCT01994889|583048212|FG001|Overall Study|Protocol Violation|1|||
161556640|NCT04157686|583427052|FG002|Overall Study|Physician Decision|1|||
161799657|NCT02729896|584309332|FG001|Overall Study|Other|2|||
161799658|NCT02729896|584309333|FG002|Overall Study|Other|0|||
161799659|NCT02729896|584309331|FG000|Overall Study|Physician Decision|1|||
161799660|NCT02729896|584309332|FG001|Overall Study|Physician Decision|2|||
161799661|NCT02729896|584309333|FG002|Overall Study|Physician Decision|3|||
161799662|NCT02729896|584309331|FG000|Overall Study|Progressive Disease|0|||
161799663|NCT02729896|584309332|FG001|Overall Study|Progressive Disease|1|||
161799664|NCT02729896|584309333|FG002|Overall Study|Progressive Disease|0|||
161451379|NCT01994889|583048213|FG002|Overall Study|Protocol Violation|1|||
161799665|NCT02729896|584309331|FG000|Overall Study|Withdrawal by Subject|1|||
161799666|NCT02729896|584309332|FG001|Overall Study|Withdrawal by Subject|0|||
161799667|NCT02729896|584309333|FG002|Overall Study|Withdrawal by Subject|3|||
161799668|NCT04094870|584309334|FG000|Overall Study|Lost to Follow-up|1|||
161903510|NCT00676403|584694864|FG004|Overall Study|Lost to Follow-up|0|||
161903511|NCT00676403|584694865|FG005|Overall Study|Lost to Follow-up|1|||
161903512|NCT00676403|584694860|FG000|Overall Study|Reason Unspecified|1|||
161903513|NCT00676403|584694861|FG001|Overall Study|Reason Unspecified|0|||
161903514|NCT00676403|584694862|FG002|Overall Study|Reason Unspecified|1|||
161903515|NCT00676403|584694863|FG003|Overall Study|Reason Unspecified|0|||
161903516|NCT00676403|584694864|FG004|Overall Study|Reason Unspecified|0|||
161903517|NCT00676403|584694865|FG005|Overall Study|Reason Unspecified|1|||
161903518|NCT00676403|584694860|FG000|Overall Study|Withdrawal by Subject|0|||
161903519|NCT00676403|584694861|FG001|Overall Study|Withdrawal by Subject|0|||
161903520|NCT00676403|584694862|FG002|Overall Study|Withdrawal by Subject|0|||
161903521|NCT00676403|584694863|FG003|Overall Study|Withdrawal by Subject|0|||
161903522|NCT00676403|584694864|FG004|Overall Study|Withdrawal by Subject|0|||
161903523|NCT00676403|584694865|FG005|Overall Study|Withdrawal by Subject|1|||
161903524|NCT03225170|584694866|FG000|Overall Study|Lost to Follow-up|4|||
161903525|NCT03225170|584694867|FG001|Overall Study|Lost to Follow-up|4|||
161903526|NCT03225170|584694868|FG002|Overall Study|Lost to Follow-up|0|||
161903527|NCT03225170|584694866|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
161903528|NCT03225170|584694867|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
161903529|NCT03225170|584694868|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
161903530|NCT01272908|584694869|FG000|Initial Treatment Period|Adverse Event|1|||
161903531|NCT01272908|584694869|FG000|Initial Treatment Period|Lack of Efficacy|5|||
161903532|NCT01272908|584694869|FG000|Initial Treatment Period|Protocol Violation|1|||
161903533|NCT01272908|584694869|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161903534|NCT01272908|584694869|FG000|Re-Treatment Period|Adverse Event|2|||
161903535|NCT01272908|584694869|FG000|Re-Treatment Period|Lack of Efficacy|3|||
161903536|NCT01272908|584694869|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
161903537|NCT00971867|584694870|FG000|Overall Study|Adverse Event|4|||
161903538|NCT00971867|584694870|FG000|Overall Study|Participant Withdrew Consent|1|||
161903539|NCT00971867|584694870|FG000|Overall Study|Disease Progression|6|||
161903540|NCT04157088|584694882|FG000|Overall Study|Study terminated by sponsor|23|||
161903541|NCT04157088|584694882|FG000|Overall Study|Withdrawal by Subject|4|||
161903542|NCT04157088|584694882|FG000|Overall Study|Lost to Follow-up|2|||
161903543|NCT04157088|584694882|FG000|Overall Study|Death|1|||
161903544|NCT02421419|584694883|FG000|Overall Study|Physician Decision|0|||
161903545|NCT02421419|584694884|FG001|Overall Study|Physician Decision|0|||
161903546|NCT02421419|584694885|FG002|Overall Study|Physician Decision|1|||
161903547|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
161903548|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
161903549|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Adverse Event|57|||
161903550|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Adverse Event|49|||
161903551|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
161903552|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
161903553|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Site closure|3|||
161903554|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Site closure|2|||
161903555|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
161903556|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
161903557|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Physician Decision|48|||
161903558|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Physician Decision|38|||
161903559|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
161903560|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
161903561|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
161903562|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
161903563|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
161903564|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
161903565|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
161903566|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
161903567|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
161903568|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
161903569|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
161903570|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
161903571|NCT05067972|584694888|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
161903572|NCT05067972|584694889|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
161903573|NCT05067972|584694890|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
161903574|NCT05067972|584694891|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
161903575|NCT05067972|584694892|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
161451380|NCT01994889|583048211|FG000|Overall Study|Death|14|||
161451381|NCT01994889|583048212|FG001|Overall Study|Death|25|||
161451382|NCT01994889|583048213|FG002|Overall Study|Death|38|||
161451383|NCT01214395|583048217|FG000|Overall Study|All patients had infection|5|||
161451384|NCT00334113|583048229|FG000|Overall Study|Lost to Follow-up|2|||
161451385|NCT00334113|583048230|FG001|Overall Study|Lost to Follow-up|2|||
161451386|NCT00334113|583048229|FG000|Overall Study|Withdrawal by Subject|0|||
161556641|NCT04157686|583427053|FG003|Overall Study|Physician Decision|0|||
161556642|NCT04157686|583427054|FG004|Overall Study|Physician Decision|1|||
161556643|NCT04157686|583427055|FG005|Overall Study|Physician Decision|0|||
161556644|NCT04157686|583427056|FG006|Overall Study|Physician Decision|3|||
161556645|NCT04157686|583427057|FG007|Overall Study|Physician Decision|0|||
161556646|NCT04157686|583427050|FG000|Overall Study|Death|0|||
161799669|NCT04094870|584309335|FG001|Overall Study|Lost to Follow-up|1|||
161799670|NCT02708277|584309337|FG000|Overall Study|Lost to Follow-up|7|||
161799671|NCT02708277|584309338|FG001|Overall Study|Lost to Follow-up|4|||
161799672|NCT01592370|584309341|FG000|Overall Study|Disease Progression|62|||
161799673|NCT01592370|584309342|FG001|Overall Study|Disease Progression|16|||
161799674|NCT01592370|584309343|FG002|Overall Study|Disease Progression|52|||
161799675|NCT01592370|584309344|FG003|Overall Study|Disease Progression|3|||
161799676|NCT01592370|584309345|FG004|Overall Study|Disease Progression|3|||
161799677|NCT01592370|584309346|FG005|Overall Study|Disease Progression|31|||
161799678|NCT01592370|584309347|FG006|Overall Study|Disease Progression|14|||
161799679|NCT01592370|584309341|FG000|Overall Study|Study Drug Toxicity|14|||
161799680|NCT01592370|584309342|FG001|Overall Study|Study Drug Toxicity|3|||
161799681|NCT01592370|584309343|FG002|Overall Study|Study Drug Toxicity|0|||
161799682|NCT01592370|584309344|FG003|Overall Study|Study Drug Toxicity|0|||
161799683|NCT01592370|584309345|FG004|Overall Study|Study Drug Toxicity|0|||
161799684|NCT01592370|584309346|FG005|Overall Study|Study Drug Toxicity|0|||
161799685|NCT01592370|584309347|FG006|Overall Study|Study Drug Toxicity|1|||
161799686|NCT01592370|584309341|FG000|Overall Study|AE unrelated to study drug|4|||
161799687|NCT01592370|584309342|FG001|Overall Study|AE unrelated to study drug|3|||
161799688|NCT01592370|584309343|FG002|Overall Study|AE unrelated to study drug|0|||
161799689|NCT01592370|584309344|FG003|Overall Study|AE unrelated to study drug|0|||
161799690|NCT01592370|584309345|FG004|Overall Study|AE unrelated to study drug|0|||
161799691|NCT01592370|584309346|FG005|Overall Study|AE unrelated to study drug|0|||
161799692|NCT01592370|584309347|FG006|Overall Study|AE unrelated to study drug|1|||
161799693|NCT01592370|584309341|FG000|Overall Study|Request to discontinue study treatment|5|||
161799694|NCT01592370|584309342|FG001|Overall Study|Request to discontinue study treatment|0|||
161799695|NCT01592370|584309343|FG002|Overall Study|Request to discontinue study treatment|2|||
161799696|NCT01592370|584309344|FG003|Overall Study|Request to discontinue study treatment|0|||
161799697|NCT01592370|584309345|FG004|Overall Study|Request to discontinue study treatment|1|||
161799698|NCT01592370|584309346|FG005|Overall Study|Request to discontinue study treatment|2|||
161799699|NCT01592370|584309347|FG006|Overall Study|Request to discontinue study treatment|0|||
161799700|NCT01592370|584309341|FG000|Overall Study|Withdrew consent|1|||
161799701|NCT01592370|584309342|FG001|Overall Study|Withdrew consent|2|||
161799702|NCT01592370|584309343|FG002|Overall Study|Withdrew consent|1|||
161799703|NCT01592370|584309344|FG003|Overall Study|Withdrew consent|1|||
161799704|NCT01592370|584309345|FG004|Overall Study|Withdrew consent|0|||
161799705|NCT01592370|584309346|FG005|Overall Study|Withdrew consent|0|||
161799706|NCT01592370|584309347|FG006|Overall Study|Withdrew consent|0|||
161799707|NCT01592370|584309341|FG000|Overall Study|Maximum clinical benefit|11|||
161799708|NCT01592370|584309342|FG001|Overall Study|Maximum clinical benefit|1|||
161799709|NCT01592370|584309343|FG002|Overall Study|Maximum clinical benefit|7|||
161799710|NCT01592370|584309344|FG003|Overall Study|Maximum clinical benefit|1|||
161799711|NCT01592370|584309345|FG004|Overall Study|Maximum clinical benefit|0|||
161799712|NCT01592370|584309346|FG005|Overall Study|Maximum clinical benefit|0|||
161799713|NCT01592370|584309347|FG006|Overall Study|Maximum clinical benefit|0|||
161799714|NCT01592370|584309341|FG000|Overall Study|No longer meets study criteria|1|||
161799715|NCT01592370|584309342|FG001|Overall Study|No longer meets study criteria|0|||
161799716|NCT01592370|584309343|FG002|Overall Study|No longer meets study criteria|0|||
161799717|NCT01592370|584309344|FG003|Overall Study|No longer meets study criteria|0|||
161799718|NCT01592370|584309345|FG004|Overall Study|No longer meets study criteria|0|||
161799719|NCT01592370|584309346|FG005|Overall Study|No longer meets study criteria|0|||
161799720|NCT01592370|584309347|FG006|Overall Study|No longer meets study criteria|0|||
161799721|NCT01592370|584309341|FG000|Overall Study|Other Reasons|6|||
161799722|NCT01592370|584309342|FG001|Overall Study|Other Reasons|0|||
161799723|NCT01592370|584309343|FG002|Overall Study|Other Reasons|10|||
161556647|NCT04157686|583427051|FG001|Overall Study|Death|0|||
161556648|NCT04157686|583427052|FG002|Overall Study|Death|0|||
161556649|NCT04157686|583427053|FG003|Overall Study|Death|2|||
161556650|NCT04157686|583427054|FG004|Overall Study|Death|0|||
161799724|NCT01592370|584309344|FG003|Overall Study|Other Reasons|0|||
161799725|NCT01592370|584309345|FG004|Overall Study|Other Reasons|0|||
161799726|NCT01592370|584309346|FG005|Overall Study|Other Reasons|1|||
161799727|NCT01592370|584309347|FG006|Overall Study|Other Reasons|0|||
161799728|NCT01592370|584309341|FG000|Overall Study|Not Treated|0|||
161799729|NCT01592370|584309342|FG001|Overall Study|Not Treated|0|||
161799730|NCT01592370|584309343|FG002|Overall Study|Not Treated|0|||
161799731|NCT01592370|584309344|FG003|Overall Study|Not Treated|0|||
161799732|NCT01592370|584309345|FG004|Overall Study|Not Treated|2|||
161799733|NCT01592370|584309346|FG005|Overall Study|Not Treated|2|||
161799734|NCT01592370|584309347|FG006|Overall Study|Not Treated|0|||
161799735|NCT02742181|584309348|FG000|Overall Study|Physician Decision|1|||
161903576|NCT05067972|584694893|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
161903577|NCT05067972|584694894|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
161903578|NCT05067972|584694888|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
161903579|NCT05067972|584694889|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
161903580|NCT05067972|584694890|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
161903581|NCT05067972|584694891|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
161903582|NCT05067972|584694892|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
161903583|NCT05067972|584694893|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
161903584|NCT05067972|584694894|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
161903585|NCT05067972|584694888|FG000|Part 1: Treatment|Progressive Disease|3|||
161903586|NCT05067972|584694889|FG001|Part 1: Treatment|Progressive Disease|3|||
161903587|NCT05067972|584694890|FG002|Part 1: Treatment|Progressive Disease|4|||
161903588|NCT05067972|584694891|FG003|Part 1: Treatment|Progressive Disease|2|||
161903589|NCT05067972|584694892|FG004|Part 1: Treatment|Progressive Disease|3|||
161903590|NCT05067972|584694893|FG005|Part 1: Treatment|Progressive Disease|0|||
161903591|NCT05067972|584694894|FG006|Part 1: Treatment|Progressive Disease|2|||
161903592|NCT05067972|584694888|FG000|Part 1: Treatment|Physician Decision|0|||
161903593|NCT05067972|584694889|FG001|Part 1: Treatment|Physician Decision|0|||
161903594|NCT05067972|584694890|FG002|Part 1: Treatment|Physician Decision|0|||
161903595|NCT05067972|584694891|FG003|Part 1: Treatment|Physician Decision|1|||
161903596|NCT05067972|584694892|FG004|Part 1: Treatment|Physician Decision|0|||
161903597|NCT05067972|584694893|FG005|Part 1: Treatment|Physician Decision|0|||
161903598|NCT05067972|584694894|FG006|Part 1: Treatment|Physician Decision|0|||
161903599|NCT05067972|584694888|FG000|Part 1: Treatment|Death|0|||
161903600|NCT05067972|584694889|FG001|Part 1: Treatment|Death|0|||
161903601|NCT05067972|584694890|FG002|Part 1: Treatment|Death|0|||
161903602|NCT05067972|584694891|FG003|Part 1: Treatment|Death|2|||
161903603|NCT05067972|584694892|FG004|Part 1: Treatment|Death|0|||
161903604|NCT05067972|584694893|FG005|Part 1: Treatment|Death|0|||
161903605|NCT05067972|584694894|FG006|Part 1: Treatment|Death|0|||
161903606|NCT05067972|584694888|FG000|Part 1: Treatment|Adverse Event|0|||
161903607|NCT05067972|584694889|FG001|Part 1: Treatment|Adverse Event|0|||
161903608|NCT05067972|584694890|FG002|Part 1: Treatment|Adverse Event|0|||
161903609|NCT05067972|584694891|FG003|Part 1: Treatment|Adverse Event|0|||
161903610|NCT05067972|584694892|FG004|Part 1: Treatment|Adverse Event|0|||
161903611|NCT05067972|584694893|FG005|Part 1: Treatment|Adverse Event|2|||
161903612|NCT05067972|584694894|FG006|Part 1: Treatment|Adverse Event|1|||
161903613|NCT05067972|584694888|FG000|Part 1: Follow-up|Adverse Event|0|||
161903614|NCT05067972|584694889|FG001|Part 1: Follow-up|Adverse Event|0|||
161903615|NCT05067972|584694890|FG002|Part 1: Follow-up|Adverse Event|0|||
161903616|NCT05067972|584694891|FG003|Part 1: Follow-up|Adverse Event|0|||
161903617|NCT05067972|584694892|FG004|Part 1: Follow-up|Adverse Event|0|||
161903618|NCT05067972|584694893|FG005|Part 1: Follow-up|Adverse Event|1|||
161903619|NCT05067972|584694894|FG006|Part 1: Follow-up|Adverse Event|0|||
161903620|NCT05067972|584694888|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
161903621|NCT05067972|584694889|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
161903622|NCT05067972|584694890|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
161903623|NCT05067972|584694891|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
161903624|NCT05067972|584694892|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
161903625|NCT05067972|584694893|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
161903626|NCT05067972|584694894|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
161903627|NCT05067972|584694888|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903628|NCT05067972|584694889|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903629|NCT05067972|584694890|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903630|NCT05067972|584694891|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903631|NCT05067972|584694892|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903632|NCT05067972|584694893|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
161903633|NCT05067972|584694894|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903634|NCT05067972|584694888|FG000|Part 1: Follow-up|Physician Decision|0|||
161903635|NCT05067972|584694889|FG001|Part 1: Follow-up|Physician Decision|0|||
161903636|NCT05067972|584694890|FG002|Part 1: Follow-up|Physician Decision|0|||
161903637|NCT05067972|584694891|FG003|Part 1: Follow-up|Physician Decision|1|||
161903638|NCT05067972|584694892|FG004|Part 1: Follow-up|Physician Decision|0|||
161903639|NCT05067972|584694893|FG005|Part 1: Follow-up|Physician Decision|0|||
161903640|NCT05067972|584694894|FG006|Part 1: Follow-up|Physician Decision|0|||
161903641|NCT05067972|584694888|FG000|Part 1: Follow-up|Death|1|||
161903642|NCT05067972|584694889|FG001|Part 1: Follow-up|Death|2|||
161903643|NCT05067972|584694890|FG002|Part 1: Follow-up|Death|1|||
161903644|NCT05067972|584694891|FG003|Part 1: Follow-up|Death|0|||
161903645|NCT05067972|584694892|FG004|Part 1: Follow-up|Death|1|||
161903646|NCT05067972|584694893|FG005|Part 1: Follow-up|Death|0|||
161903647|NCT05067972|584694894|FG006|Part 1: Follow-up|Death|1|||
161903648|NCT00810199|584694902|FG000|Overall Study|Adverse Event|24|||
161903649|NCT00810199|584694903|FG001|Overall Study|Adverse Event|26|||
161903650|NCT00810199|584694902|FG000|Overall Study|Death|4|||
161903651|NCT00810199|584694903|FG001|Overall Study|Death|6|||
161903652|NCT00810199|584694902|FG000|Overall Study|Withdrew consent|9|||
161903653|NCT00810199|584694903|FG001|Overall Study|Withdrew consent|12|||
161556651|NCT04157686|583427055|FG005|Overall Study|Death|0|||
161556652|NCT04157686|583427056|FG006|Overall Study|Death|0|||
161556653|NCT04157686|583427057|FG007|Overall Study|Death|0|||
161556654|NCT04157686|583427050|FG000|Overall Study|Protocol Violation|0|||
161903654|NCT00810199|584694902|FG000|Overall Study|Insufficient therapeutic response|5|||
161903655|NCT00810199|584694903|FG001|Overall Study|Insufficient therapeutic response|14|||
161903656|NCT00810199|584694902|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
161903657|NCT00810199|584694903|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
161903658|NCT00810199|584694902|FG000|Overall Study|Administrative/Other|5|||
161903659|NCT00810199|584694903|FG001|Overall Study|Administrative/Other|6|||
161903660|NCT00810199|584694902|FG000|Overall Study|Protocol Violation|2|||
161903661|NCT00810199|584694903|FG001|Overall Study|Protocol Violation|6|||
161903662|NCT00810199|584694902|FG000|Overall Study|Failure to return|1|||
161903663|NCT00810199|584694903|FG001|Overall Study|Failure to return|4|||
161903664|NCT00810199|584694902|FG000|Overall Study|Did not receive study drug|2|||
161903665|NCT00810199|584694903|FG001|Overall Study|Did not receive study drug|1|||
161903666|NCT00101868|584694911|FG000|Overall Study|Death|10|||
161903667|NCT00101868|584694912|FG001|Overall Study|Death|10|||
161903668|NCT00101868|584694911|FG000|Overall Study|Withdrawal by Subject|8|||
161903669|NCT00101868|584694912|FG001|Overall Study|Withdrawal by Subject|9|||
161903670|NCT00101868|584694911|FG000|Overall Study|Protocol Violation|3|||
161903671|NCT00101868|584694912|FG001|Overall Study|Protocol Violation|0|||
161903672|NCT00101868|584694911|FG000|Overall Study|Lost to Follow-up|8|||
161903673|NCT00101868|584694912|FG001|Overall Study|Lost to Follow-up|13|||
161903674|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
161903675|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
161903676|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
161903677|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
161903678|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
161903679|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
161903680|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
161903681|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
161903682|NCT04001803|584694914|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
161903683|NCT04001803|584694914|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
161903684|NCT01931397|584694917|FG000|Overall Study|Physician Decision|2|||
161903685|NCT01931397|584694917|FG000|Overall Study|Withdrawal by Subject|8|||
161903686|NCT01931397|584694917|FG000|Overall Study|moved out of state|1|||
161903687|NCT02329327|584694921|FG000|Overall Study|Death|78|||
161903688|NCT02329327|584694922|FG001|Overall Study|Death|0|||
161903689|NCT02329327|584694921|FG000|Overall Study|Withdrawal by Subject|3|||
161903690|NCT02329327|584694922|FG001|Overall Study|Withdrawal by Subject|0|||
161903691|NCT02329327|584694921|FG000|Overall Study|Lost to Follow-up|4|||
161903692|NCT02329327|584694922|FG001|Overall Study|Lost to Follow-up|0|||
161903693|NCT02493517|584694923|FG000|Overall Study|Protocol Violation|1|||
161903694|NCT02493517|584694924|FG001|Overall Study|Protocol Violation|2|||
161903695|NCT02493517|584694923|FG000|Overall Study|Withdrawal by Subject|1|||
161903696|NCT02493517|584694924|FG001|Overall Study|Withdrawal by Subject|2|||
161903697|NCT02493517|584694923|FG000|Overall Study|Adverse Event|0|||
161903698|NCT02493517|584694924|FG001|Overall Study|Adverse Event|2|||
161903699|NCT02493517|584694923|FG000|Overall Study|Missed study visit|0|||
161903700|NCT02493517|584694924|FG001|Overall Study|Missed study visit|1|||
161903701|NCT01367249|584694925|FG000|Overall Study|Withdrawal by Subject|6|||
161903702|NCT01367249|584694926|FG001|Overall Study|Withdrawal by Subject|6|||
161903703|NCT01367249|584694925|FG000|Overall Study|Other|3|||
161903704|NCT01367249|584694926|FG001|Overall Study|Other|10|||
161903705|NCT03718429|584694927|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
161903706|NCT03718429|584694928|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
161903707|NCT03718429|584694929|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
161903708|NCT03718429|584694930|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
161556655|NCT04157686|583427051|FG001|Overall Study|Protocol Violation|0|||
161903709|NCT05404711|584694931|FG000|Completed Study Visit|Withdrawal by Subject|1|||
161556656|NCT04157686|583427052|FG002|Overall Study|Protocol Violation|0|||
161903710|NCT05404711|584694931|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
161556657|NCT04157686|583427053|FG003|Overall Study|Protocol Violation|0|||
161556658|NCT04157686|583427054|FG004|Overall Study|Protocol Violation|1|||
161556659|NCT04157686|583427055|FG005|Overall Study|Protocol Violation|0|||
161556660|NCT04157686|583427056|FG006|Overall Study|Protocol Violation|0|||
161556661|NCT04157686|583427057|FG007|Overall Study|Protocol Violation|0|||
161556662|NCT04157686|583427050|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
161556663|NCT04157686|583427051|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
161903711|NCT05404711|584694931|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
161903712|NCT05404711|584694931|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
161903713|NCT05404711|584694931|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
161903714|NCT05404711|584694931|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
161903715|NCT00325819|584694932|FG000|Overall Study|Study product lost in mail|2|||
161903716|NCT00325819|584694933|FG001|Overall Study|Study product lost in mail|1|||
161903717|NCT00325819|584694932|FG000|Overall Study|Did not take a dose of study product|4|||
161903718|NCT00325819|584694933|FG001|Overall Study|Did not take a dose of study product|9|||
161903719|NCT00325819|584694932|FG000|Overall Study|Lost to Follow-up|3|||
161903720|NCT00325819|584694933|FG001|Overall Study|Lost to Follow-up|3|||
161903721|NCT02346877|584694934|FG000|Overall Study|Adverse Event|1|||
161903722|NCT02346877|584694935|FG001|Overall Study|Adverse Event|0|||
161903723|NCT02346877|584694934|FG000|Overall Study|Administrative Decision|1|||
161903724|NCT02346877|584694935|FG001|Overall Study|Administrative Decision|0|||
161903725|NCT02346877|584694934|FG000|Overall Study|Sponsor Decision|12|||
161903726|NCT02346877|584694935|FG001|Overall Study|Sponsor Decision|0|||
161903727|NCT02346877|584694934|FG000|Overall Study|Missing|5|||
161903728|NCT02346877|584694935|FG001|Overall Study|Missing|0|||
161903729|NCT01683604|584694942|FG000|Overall Study|Adverse Event|2|||
161903730|NCT01683604|584694942|FG000|Overall Study|Lack of Efficacy|1|||
161903731|NCT01683604|584694942|FG000|Overall Study|Other|2|||
161903732|NCT03430856|584694943|FG000|Overall Study|Adverse Event|0|||
161903733|NCT03430856|584694944|FG001|Overall Study|Adverse Event|1|||
161903734|NCT03430856|584694945|FG002|Overall Study|Adverse Event|0|||
161903735|NCT03430856|584694943|FG000|Overall Study|Rescue criteria|1|||
161903736|NCT03430856|584694944|FG001|Overall Study|Rescue criteria|1|||
161903737|NCT03430856|584694945|FG002|Overall Study|Rescue criteria|0|||
161903738|NCT03430856|584694943|FG000|Overall Study|Voluntary withdrawal of consent|1|||
161903739|NCT03430856|584694944|FG001|Overall Study|Voluntary withdrawal of consent|1|||
161903740|NCT03430856|584694945|FG002|Overall Study|Voluntary withdrawal of consent|1|||
161903741|NCT01094288|584696876|FG000|Overall Study|Adverse Event|0|||
161903742|NCT01094288|584696877|FG001|Overall Study|Adverse Event|3|||
161903743|NCT01094288|584696878|FG002|Overall Study|Adverse Event|1|||
161903744|NCT01094288|584696879|FG003|Overall Study|Adverse Event|1|||
161903745|NCT01094288|584696880|FG004|Overall Study|Adverse Event|0|||
161903746|NCT01094288|584696881|FG005|Overall Study|Adverse Event|0|||
161903747|NCT01094288|584696882|FG006|Overall Study|Adverse Event|0|||
161903748|NCT01094288|584696883|FG007|Overall Study|Adverse Event|0|||
161903749|NCT01094288|584696876|FG000|Overall Study|Withdrawal by Subject|0|||
161903750|NCT01094288|584696877|FG001|Overall Study|Withdrawal by Subject|1|||
161903751|NCT01094288|584696878|FG002|Overall Study|Withdrawal by Subject|2|||
161903752|NCT01094288|584696879|FG003|Overall Study|Withdrawal by Subject|0|||
161903753|NCT01094288|584696880|FG004|Overall Study|Withdrawal by Subject|0|||
161903754|NCT01094288|584696881|FG005|Overall Study|Withdrawal by Subject|0|||
161903755|NCT01094288|584696882|FG006|Overall Study|Withdrawal by Subject|0|||
161903756|NCT01094288|584696883|FG007|Overall Study|Withdrawal by Subject|2|||
161903757|NCT01094288|584696876|FG000|Overall Study|Initiation of Alternative Therapy|0|||
161903758|NCT01094288|584696877|FG001|Overall Study|Initiation of Alternative Therapy|0|||
161903759|NCT01094288|584696878|FG002|Overall Study|Initiation of Alternative Therapy|1|||
161903760|NCT01094288|584696879|FG003|Overall Study|Initiation of Alternative Therapy|0|||
161903761|NCT01094288|584696880|FG004|Overall Study|Initiation of Alternative Therapy|0|||
161903762|NCT01094288|584696881|FG005|Overall Study|Initiation of Alternative Therapy|0|||
161903763|NCT01094288|584696882|FG006|Overall Study|Initiation of Alternative Therapy|0|||
161903764|NCT01094288|584696883|FG007|Overall Study|Initiation of Alternative Therapy|0|||
161903765|NCT01094288|584696876|FG000|Overall Study|Reason not Specified|2|||
161903766|NCT01094288|584696877|FG001|Overall Study|Reason not Specified|3|||
161903767|NCT01094288|584696878|FG002|Overall Study|Reason not Specified|0|||
161903768|NCT01094288|584696879|FG003|Overall Study|Reason not Specified|1|||
161903769|NCT01094288|584696880|FG004|Overall Study|Reason not Specified|0|||
161903770|NCT01094288|584696881|FG005|Overall Study|Reason not Specified|0|||
161903771|NCT01094288|584696882|FG006|Overall Study|Reason not Specified|0|||
161903772|NCT01094288|584696883|FG007|Overall Study|Reason not Specified|0|||
161903773|NCT01094288|584696876|FG000|Overall Study|Ongoing Participants|0|||
161903774|NCT01094288|584696877|FG001|Overall Study|Ongoing Participants|3|||
161903775|NCT01094288|584696878|FG002|Overall Study|Ongoing Participants|0|||
161903776|NCT01094288|584696879|FG003|Overall Study|Ongoing Participants|0|||
161903777|NCT01094288|584696880|FG004|Overall Study|Ongoing Participants|0|||
161903778|NCT01094288|584696881|FG005|Overall Study|Ongoing Participants|0|||
161903779|NCT01094288|584696882|FG006|Overall Study|Ongoing Participants|0|||
161903780|NCT01094288|584696883|FG007|Overall Study|Ongoing Participants|0|||
161903781|NCT02611882|584696886|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
161903782|NCT02611882|584696887|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
161903783|NCT02611882|584696888|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
161903784|NCT01228591|584696889|FG000|Baseline|Lack of Efficacy|1|||
161903785|NCT01228591|584696890|FG001|Baseline|Lack of Efficacy|2|||
161903786|NCT01389232|584696891|FG000|Overall Study|Had scaffold removed|15|||
161903787|NCT01389232|584696891|FG000|Overall Study|Personal reasons|2|||
161903788|NCT01389232|584696891|FG000|Overall Study|Adverse Event|1|||
161903789|NCT01389232|584696891|FG000|Overall Study|Death|1|||
161903790|NCT01317940|584696892|FG000|Overall Study|Death|1|||
161556664|NCT04157686|583427052|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
161556665|NCT04157686|583427053|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
161799736|NCT02742181|584309349|FG001|Overall Study|Physician Decision|0|||
161799737|NCT02739984|584309350|FG000|Overall Study|Sponsor Decision|1|||
161799738|NCT02739984|584309351|FG001|Overall Study|Sponsor Decision|0|||
161799739|NCT02739984|584309350|FG000|Overall Study|Withdrawal by Subject|1|||
161799740|NCT02739984|584309351|FG001|Overall Study|Withdrawal by Subject|1|||
161799741|NCT02739984|584309350|FG000|Overall Study|Death|0|||
161799742|NCT02739984|584309351|FG001|Overall Study|Death|1|||
161799743|NCT02739984|584309350|FG000|Overall Study|Lost to Follow-up|3|||
161799744|NCT02739984|584309351|FG001|Overall Study|Lost to Follow-up|0|||
161799745|NCT01048333|584309356|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799746|NCT01048333|584309357|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
161799747|NCT01048333|584309358|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799748|NCT01048333|584309359|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799749|NCT01048333|584309360|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799750|NCT01048333|584309361|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799751|NCT00996736|584309363|FG000|Overall Study|Death|1|||
161799752|NCT00996736|584309364|FG001|Overall Study|Death|1|||
161799753|NCT00996736|584309363|FG000|Overall Study|Lost to Follow-up|15|||
161799754|NCT00996736|584309364|FG001|Overall Study|Lost to Follow-up|14|||
161799755|NCT00996736|584309363|FG000|Overall Study|Visit not within 3-month window|5|||
161799756|NCT00996736|584309364|FG001|Overall Study|Visit not within 3-month window|3|||
161799757|NCT02346201|584309365|FG000|Overall Study|Adverse Event|3|||
161799758|NCT02346201|584309366|FG001|Overall Study|Adverse Event|2|||
161799759|NCT02346201|584309365|FG000|Overall Study|Lost to Follow-up|1|||
161799760|NCT02346201|584309366|FG001|Overall Study|Lost to Follow-up|0|||
161799761|NCT02346201|584309365|FG000|Overall Study|Withdrawal by Subject|6|||
161799762|NCT02346201|584309366|FG001|Overall Study|Withdrawal by Subject|3|||
161799763|NCT02346201|584309365|FG000|Overall Study|Unavailable for future follow-up|0|||
161799764|NCT02346201|584309366|FG001|Overall Study|Unavailable for future follow-up|1|||
161799765|NCT02346201|584309365|FG000|Overall Study|Physician Decision|0|||
161799766|NCT02346201|584309366|FG001|Overall Study|Physician Decision|1|||
161799767|NCT02346201|584309365|FG000|Overall Study|Missed final visit|0|||
161799768|NCT02346201|584309366|FG001|Overall Study|Missed final visit|2|||
161799769|NCT05200858|584309367|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
161799770|NCT05200858|584309368|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
161799771|NCT05200858|584309369|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
161799772|NCT05200858|584309370|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
161799773|NCT00409578|584309373|FG000|Overall Study|Adverse Event|27|||
161799774|NCT00409578|584309374|FG001|Overall Study|Adverse Event|37|||
161799775|NCT00409578|584309375|FG002|Overall Study|Adverse Event|25|||
161799776|NCT00409578|584309376|FG003|Overall Study|Adverse Event|33|||
161799777|NCT00409578|584309373|FG000|Overall Study|Abnormal laboratory value(s)|2|||
161799778|NCT00409578|584309374|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161799779|NCT00409578|584309375|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161799780|NCT00409578|584309376|FG003|Overall Study|Abnormal laboratory value(s)|4|||
161799781|NCT00409578|584309373|FG000|Overall Study|Lack of Efficacy|0|||
161799782|NCT00409578|584309374|FG001|Overall Study|Lack of Efficacy|0|||
161799783|NCT00409578|584309375|FG002|Overall Study|Lack of Efficacy|0|||
161799784|NCT00409578|584309376|FG003|Overall Study|Lack of Efficacy|2|||
161799785|NCT00409578|584309373|FG000|Overall Study|Subject no longer requires study drug|0|||
161799786|NCT00409578|584309374|FG001|Overall Study|Subject no longer requires study drug|0|||
161799787|NCT00409578|584309375|FG002|Overall Study|Subject no longer requires study drug|0|||
161799788|NCT00409578|584309376|FG003|Overall Study|Subject no longer requires study drug|1|||
161799789|NCT00409578|584309373|FG000|Overall Study|Withdrawal by Subject|8|||
161799790|NCT00409578|584309374|FG001|Overall Study|Withdrawal by Subject|15|||
161799791|NCT00409578|584309375|FG002|Overall Study|Withdrawal by Subject|16|||
161799792|NCT00409578|584309376|FG003|Overall Study|Withdrawal by Subject|17|||
161799793|NCT00409578|584309373|FG000|Overall Study|Lost to Follow-up|2|||
161903791|NCT01317940|584696893|FG001|Overall Study|Death|0|||
161799794|NCT00409578|584309374|FG001|Overall Study|Lost to Follow-up|0|||
161799795|NCT00409578|584309375|FG002|Overall Study|Lost to Follow-up|2|||
161799796|NCT00409578|584309376|FG003|Overall Study|Lost to Follow-up|2|||
161799797|NCT00409578|584309373|FG000|Overall Study|Administrative problems|8|||
161799798|NCT00409578|584309374|FG001|Overall Study|Administrative problems|9|||
161799799|NCT00409578|584309375|FG002|Overall Study|Administrative problems|2|||
161799800|NCT00409578|584309376|FG003|Overall Study|Administrative problems|4|||
161799801|NCT00409578|584309373|FG000|Overall Study|Death|2|||
161903792|NCT01317940|584696894|FG002|Overall Study|Death|1|||
161903793|NCT01317940|584696895|FG003|Overall Study|Death|0|||
161799802|NCT00409578|584309374|FG001|Overall Study|Death|4|||
161799803|NCT00409578|584309375|FG002|Overall Study|Death|4|||
161799804|NCT00409578|584309376|FG003|Overall Study|Death|2|||
161799805|NCT00409578|584309373|FG000|Overall Study|Protocol Violation|3|||
161799806|NCT00409578|584309374|FG001|Overall Study|Protocol Violation|2|||
161799807|NCT00409578|584309375|FG002|Overall Study|Protocol Violation|3|||
161903794|NCT01317940|584696896|FG004|Overall Study|Death|0|||
161903795|NCT01317940|584696897|FG005|Overall Study|Death|0|||
161903796|NCT01317940|584696892|FG000|Overall Study|Lost to Follow-up|0|||
161903797|NCT01317940|584696893|FG001|Overall Study|Lost to Follow-up|0|||
161903798|NCT01317940|584696894|FG002|Overall Study|Lost to Follow-up|1|||
161903799|NCT01317940|584696895|FG003|Overall Study|Lost to Follow-up|1|||
161903800|NCT01317940|584696896|FG004|Overall Study|Lost to Follow-up|1|||
161903801|NCT01317940|584696897|FG005|Overall Study|Lost to Follow-up|0|||
161903802|NCT01317940|584696892|FG000|Overall Study|Change in therapy plan|0|||
161903803|NCT01317940|584696893|FG001|Overall Study|Change in therapy plan|0|||
161903804|NCT01317940|584696894|FG002|Overall Study|Change in therapy plan|3|||
161903805|NCT01317940|584696895|FG003|Overall Study|Change in therapy plan|0|||
161903806|NCT01317940|584696896|FG004|Overall Study|Change in therapy plan|0|||
161903807|NCT01317940|584696897|FG005|Overall Study|Change in therapy plan|0|||
161903808|NCT02371616|584696899|FG000|Overall Study|Protocol Violation|2|||
161903809|NCT02371616|584696900|FG001|Overall Study|Protocol Violation|1|||
161903810|NCT02371616|584696899|FG000|Overall Study|Adverse Event|0|||
161903811|NCT02371616|584696900|FG001|Overall Study|Adverse Event|1|||
161903812|NCT02371616|584696899|FG000|Overall Study|Withdrawal of Consent|1|||
161903813|NCT02371616|584696900|FG001|Overall Study|Withdrawal of Consent|0|||
161903814|NCT02371616|584696899|FG000|Overall Study|Other (Not specified)|1|||
161903815|NCT02371616|584696900|FG001|Overall Study|Other (Not specified)|5|||
161903816|NCT03205150|584696903|FG000|Overall Study|Protocol deviation|1|||
161903817|NCT03205150|584696904|FG001|Overall Study|Protocol deviation|3|||
161903818|NCT03205150|584696905|FG002|Overall Study|Protocol deviation|0|||
161903819|NCT03205150|584696903|FG000|Overall Study|Patient/guardian decision|0|||
161903820|NCT03205150|584696904|FG001|Overall Study|Patient/guardian decision|3|||
161903821|NCT03205150|584696905|FG002|Overall Study|Patient/guardian decision|0|||
161903822|NCT03205150|584696903|FG000|Overall Study|Adverse Event|1|||
161903823|NCT03205150|584696904|FG001|Overall Study|Adverse Event|1|||
161903824|NCT03205150|584696905|FG002|Overall Study|Adverse Event|1|||
161903825|NCT03205150|584696903|FG000|Overall Study|Lost to Follow-up|0|||
161903826|NCT03205150|584696904|FG001|Overall Study|Lost to Follow-up|0|||
161903827|NCT03205150|584696905|FG002|Overall Study|Lost to Follow-up|1|||
161903828|NCT01095835|584696906|FG000|Overall Study|Adverse Event|8|||
161903829|NCT01095835|584696907|FG001|Overall Study|Adverse Event|6|||
161903830|NCT01095835|584696908|FG002|Overall Study|Adverse Event|6|||
161903831|NCT01095835|584696906|FG000|Overall Study|Lack of Efficacy|0|||
161903832|NCT01095835|584696907|FG001|Overall Study|Lack of Efficacy|1|||
161903833|NCT01095835|584696908|FG002|Overall Study|Lack of Efficacy|0|||
161903834|NCT01095835|584696906|FG000|Overall Study|Physician Decision|0|||
161903835|NCT01095835|584696907|FG001|Overall Study|Physician Decision|0|||
161903836|NCT01095835|584696908|FG002|Overall Study|Physician Decision|1|||
161903837|NCT01095835|584696906|FG000|Overall Study|Withdrawal by Subject|1|||
161903838|NCT01095835|584696907|FG001|Overall Study|Withdrawal by Subject|3|||
161903839|NCT01095835|584696908|FG002|Overall Study|Withdrawal by Subject|0|||
161903840|NCT01095835|584696906|FG000|Overall Study|Non study compliance|0|||
161903841|NCT01095835|584696907|FG001|Overall Study|Non study compliance|0|||
161903842|NCT01095835|584696908|FG002|Overall Study|Non study compliance|1|||
161903843|NCT01095835|584696906|FG000|Overall Study|Protocol Violation|1|||
161903844|NCT01095835|584696907|FG001|Overall Study|Protocol Violation|2|||
161903845|NCT01095835|584696908|FG002|Overall Study|Protocol Violation|0|||
161903846|NCT03028142|584696909|FG000|Overall Study|Adverse Event|1|||
161903847|NCT03028142|584696910|FG001|Overall Study|Adverse Event|1|||
161903848|NCT03028142|584696911|FG002|Overall Study|Adverse Event|0|||
161903849|NCT03028142|584696912|FG003|Overall Study|Adverse Event|0|||
161903850|NCT03028142|584696913|FG004|Overall Study|Adverse Event|0|||
161903851|NCT03028142|584696914|FG005|Overall Study|Adverse Event|1|||
161903852|NCT03028142|584696909|FG000|Overall Study|Withdrawal by Subject|0|||
161903853|NCT03028142|584696910|FG001|Overall Study|Withdrawal by Subject|0|||
161799808|NCT00409578|584309376|FG003|Overall Study|Protocol Violation|1|||
161799809|NCT00409578|584309373|FG000|Overall Study|Missing|0|||
161799810|NCT00409578|584309374|FG001|Overall Study|Missing|1|||
161799811|NCT00409578|584309375|FG002|Overall Study|Missing|0|||
161799812|NCT00409578|584309376|FG003|Overall Study|Missing|1|||
161799813|NCT02109133|584309377|FG000|Overall Study|Lost to Follow-up|1|||
161799814|NCT02109133|584309378|FG001|Overall Study|Lost to Follow-up|0|||
161799815|NCT02448771|584309379|FG000|Overall Study|Disease Progression|30|||
161799816|NCT02448771|584309379|FG000|Overall Study|Unacceptable Toxicity|1|||
161799817|NCT02448771|584309379|FG000|Overall Study|Physician Decision|3|||
161799818|NCT02448771|584309379|FG000|Overall Study|Started new therapy|2|||
161799819|NCT00770315|584309381|FG000|Overall Study|Adverse Event|11|||
161799820|NCT00770315|584309382|FG001|Overall Study|Adverse Event|17|||
161799821|NCT00770315|584309383|FG002|Overall Study|Adverse Event|16|||
161799822|NCT00770315|584309384|FG003|Overall Study|Adverse Event|6|||
161799823|NCT00770315|584309381|FG000|Overall Study|Lost to Follow-up|9|||
161799824|NCT00770315|584309382|FG001|Overall Study|Lost to Follow-up|5|||
161903854|NCT03028142|584696911|FG002|Overall Study|Withdrawal by Subject|0|||
161903855|NCT03028142|584696912|FG003|Overall Study|Withdrawal by Subject|0|||
161556666|NCT04157686|583427054|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
161556667|NCT04157686|583427055|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
161556668|NCT04157686|583427056|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
161556669|NCT04157686|583427057|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
161556670|NCT01556243|583427062|FG000|Overall Study|Ineligible|34|||
161556671|NCT01556243|583427062|FG000|Overall Study|Converted to mastectomy|14|||
161556672|NCT01556243|583427062|FG000|Overall Study|Unable to achieve negative margins|2|||
161556673|NCT01556243|583427062|FG000|Overall Study|Withdrawal by Subject|16|||
161556674|NCT01388543|583427063|FG000|Day 14|Adverse Event|1|||
161556675|NCT01388543|583427064|FG001|Day 14|Adverse Event|4|||
161556676|NCT04684914|583427065|FG000|Overall Study|Withdrawal by Subject|1|||
161556677|NCT04684914|583427066|FG001|Overall Study|Withdrawal by Subject|0|||
161556678|NCT04684914|583427065|FG000|Overall Study|Discontinued before receiving study treatment|1|||
161556679|NCT04684914|583427066|FG001|Overall Study|Discontinued before receiving study treatment|2|||
161556680|NCT03363659|583427067|FG000|Overall Study|Adverse Event|1|||
161556681|NCT03363659|583427067|FG000|Overall Study|Screen fail|1|||
161556682|NCT03363659|583427067|FG000|Overall Study|Withdrawal by Subject|1|||
161556683|NCT02353832|583427068|FG000|Overall Study|Ineligible after enrollment|1|||
161556684|NCT02353832|583427068|FG000|Overall Study|Lost to Follow-up|1|||
161556685|NCT00904150|583427069|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
161556686|NCT00904150|583427070|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
161556687|NCT00904150|583427069|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
161556688|NCT00904150|583427070|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
161556689|NCT01671748|583427071|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
161556690|NCT01671748|583427072|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
161556691|NCT01671748|583427071|FG000|4 Week run-in Phase|Adverse Event|1|||
161556692|NCT01671748|583427072|FG001|4 Week run-in Phase|Adverse Event|0|||
161556693|NCT01671748|583427071|FG000|4 Week run-in Phase|Not eligible|9|||
161556694|NCT01671748|583427072|FG001|4 Week run-in Phase|Not eligible|0|||
161556695|NCT03872388|583427075|FG000|Overall Study|Disease Progression|0|||
161556696|NCT03872388|583427076|FG001|Overall Study|Disease Progression|0|||
161556697|NCT03872388|583427077|FG002|Overall Study|Disease Progression|0|||
161556698|NCT03872388|583427078|FG003|Overall Study|Disease Progression|0|||
161556699|NCT03872388|583427079|FG004|Overall Study|Disease Progression|0|||
161556700|NCT03872388|583427080|FG005|Overall Study|Disease Progression|0|||
161556701|NCT03872388|583427081|FG006|Overall Study|Disease Progression|1|||
161556702|NCT03872388|583427082|FG007|Overall Study|Disease Progression|1|||
161556703|NCT04191135|583427083|FG000|Induction Treatment|Not Treated|2|||
161556704|NCT04191135|583427084|FG001|Induction Treatment|Not Treated|0|||
161799825|NCT00770315|584309383|FG002|Overall Study|Lost to Follow-up|10|||
161799826|NCT00770315|584309384|FG003|Overall Study|Lost to Follow-up|3|||
161799827|NCT00770315|584309381|FG000|Overall Study|Withdrawal by Subject|13|||
161799828|NCT00770315|584309382|FG001|Overall Study|Withdrawal by Subject|17|||
161799829|NCT00770315|584309383|FG002|Overall Study|Withdrawal by Subject|24|||
161799830|NCT00770315|584309384|FG003|Overall Study|Withdrawal by Subject|20|||
161799831|NCT00770315|584309381|FG000|Overall Study|Noncompliance with Protocol|7|||
161799832|NCT00770315|584309382|FG001|Overall Study|Noncompliance with Protocol|4|||
161799833|NCT00770315|584309383|FG002|Overall Study|Noncompliance with Protocol|7|||
161799834|NCT00770315|584309384|FG003|Overall Study|Noncompliance with Protocol|9|||
161799835|NCT01210001|584310895|FG000|Overall Study|Not treated|1|||
161799836|NCT01210001|584310896|FG001|Overall Study|Not treated|0|||
161799837|NCT01210001|584310897|FG002|Overall Study|Not treated|0|||
161799838|NCT01210001|584310895|FG000|Overall Study|Adverse Event|4|||
161799839|NCT01210001|584310896|FG001|Overall Study|Adverse Event|2|||
161799840|NCT01210001|584310897|FG002|Overall Study|Adverse Event|5|||
161799841|NCT01210001|584310895|FG000|Overall Study|Non compliant with protocol|2|||
161799842|NCT01210001|584310896|FG001|Overall Study|Non compliant with protocol|2|||
161799843|NCT01210001|584310897|FG002|Overall Study|Non compliant with protocol|3|||
161799844|NCT01210001|584310895|FG000|Overall Study|Lost to Follow-up|4|||
161799845|NCT01210001|584310896|FG001|Overall Study|Lost to Follow-up|3|||
161799846|NCT01210001|584310897|FG002|Overall Study|Lost to Follow-up|2|||
161799847|NCT01210001|584310895|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
161799848|NCT01210001|584310896|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
161799849|NCT01210001|584310897|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
161799850|NCT01210001|584310895|FG000|Overall Study|Other reason not defined above|2|||
161799851|NCT01210001|584310896|FG001|Overall Study|Other reason not defined above|2|||
161799852|NCT01210001|584310897|FG002|Overall Study|Other reason not defined above|1|||
161799853|NCT00788125|584310898|FG000|Overall Study|Death|6|||
161799854|NCT01374919|584310908|FG000|Overall Study|Withdrawal by Subject|2|||
161799855|NCT02999178|584310909|FG000|Overall Study|Adverse Event|85|||
161799856|NCT02999178|584310910|FG001|Overall Study|Adverse Event|62|||
161799857|NCT02999178|584310909|FG000|Overall Study|Protocol Violation|1|||
161799858|NCT02999178|584310910|FG001|Overall Study|Protocol Violation|2|||
161799859|NCT02999178|584310909|FG000|Overall Study|Lost to Follow-up|0|||
161799860|NCT02999178|584310910|FG001|Overall Study|Lost to Follow-up|2|||
161799861|NCT02999178|584310909|FG000|Overall Study|Withdrawal by Subject|21|||
161799862|NCT02999178|584310910|FG001|Overall Study|Withdrawal by Subject|21|||
161799863|NCT02999178|584310909|FG000|Overall Study|Other reason not defined above|7|||
161799864|NCT02999178|584310910|FG001|Overall Study|Other reason not defined above|13|||
161799865|NCT00630305|584310911|FG000|Overall Study|Withdrawal by Subject|1|||
161799866|NCT00630305|584310911|FG000|Overall Study|Inability to insert contact lens|1|||
161799867|NCT01085045|584310912|FG000|Part A|Withdrawal by Subject|4|||
161799868|NCT01085045|584310912|FG000|Part A|Adverse Event|6|||
161799869|NCT01085045|584310912|FG000|Part A|Protocol Violation|1|||
161799870|NCT01085045|584310912|FG000|Part A|Protocol Specified Criteria|7|||
161799871|NCT01085045|584310912|FG000|Part B|Withdrawal by Subject|2|||
161799872|NCT01085045|584310912|FG000|Part B|Protocol Specified Criteria|6|||
161799873|NCT01085045|584310912|FG000|Part B|Lost to Follow-up|1|||
161799874|NCT01085045|584310912|FG000|Part B|Adverse Event|6|||
161799875|NCT00863746|584310920|FG000|Treatment|Not treated|4|||
161799876|NCT00863746|584310921|FG001|Treatment|Not treated|2|||
161799877|NCT00863746|584310920|FG000|Treatment|Adverse Event|41|||
161799878|NCT00863746|584310921|FG001|Treatment|Adverse Event|16|||
161799879|NCT00863746|584310920|FG000|Treatment|non-compliant with study medication|4|||
161799880|NCT00863746|584310921|FG001|Treatment|non-compliant with study medication|0|||
161799881|NCT00863746|584310920|FG000|Treatment|Consent withdrawn|15|||
161799882|NCT00863746|584310921|FG001|Treatment|Consent withdrawn|14|||
161799883|NCT00863746|584310920|FG000|Treatment|Lost to Follow-up|1|||
161799884|NCT00863746|584310921|FG001|Treatment|Lost to Follow-up|0|||
161799885|NCT00863746|584310920|FG000|Treatment|Protocol Violation|5|||
161451387|NCT00334113|583048230|FG001|Overall Study|Withdrawal by Subject|1|||
161451388|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
161451389|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
161451390|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
161451391|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
161451392|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Other|2|||
161451393|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
161451394|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
161451395|NCT02509026|583048235|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
161451396|NCT02509026|583048235|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
161451397|NCT02509026|583048235|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
161451398|NCT02509026|583048235|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
161451399|NCT02509026|583048235|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
161451400|NCT02509026|583048235|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
161451401|NCT01165216|583048236|FG000|Overall Study|Adverse Event|6|||
161451402|NCT01165216|583048237|FG001|Overall Study|Adverse Event|3|||
161451403|NCT01165216|583048236|FG000|Overall Study|Withdrawal by Subject|1|||
161451404|NCT01165216|583048237|FG001|Overall Study|Withdrawal by Subject|1|||
161451405|NCT01165216|583048236|FG000|Overall Study|Disease progression|1|||
161451406|NCT01165216|583048237|FG001|Overall Study|Disease progression|3|||
161451407|NCT00243841|583048241|FG000|Overall Study|Physician Decision|0|||
161451408|NCT00243841|583048242|FG001|Overall Study|Physician Decision|0|||
161451409|NCT00243841|583048243|FG002|Overall Study|Physician Decision|1|||
161451410|NCT00243841|583048244|FG003|Overall Study|Physician Decision|0|||
161451411|NCT00243841|583048245|FG004|Overall Study|Physician Decision|0|||
161451412|NCT00243841|583048246|FG005|Overall Study|Physician Decision|2|||
161451413|NCT05601544|583048247|FG000|Phase 2 Period 1|Adverse Event|0|||
161451414|NCT05601544|583048248|FG001|Phase 2 Period 1|Adverse Event|1|||
161451415|NCT05601544|583048249|FG002|Phase 2 Period 1|Adverse Event|0|||
161451416|NCT05601544|583048250|FG003|Phase 2 Period 1|Adverse Event|0|||
161451417|NCT05601544|583048251|FG004|Phase 2 Period 1|Adverse Event|0|||
161451418|NCT05601544|583048252|FG005|Phase 2 Period 1|Adverse Event|0|||
161451419|NCT01601652|583048254|FG000|Overall Study|Death|1|||
161451420|NCT02537015|583048261|FG000|Overall Study|Adverse Event|3|||
161451421|NCT02537015|583048261|FG000|Overall Study|Withdrawal by Subject|2|||
161556705|NCT04191135|583427085|FG002|Induction Treatment|Not Treated|0|||
161556706|NCT04191135|583427083|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
161799886|NCT00863746|584310921|FG001|Treatment|Protocol Violation|3|||
161451422|NCT02537015|583048261|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161451423|NCT01808092|583048269|FG000|Overall Study|Death|39|||
161451424|NCT01808092|583048270|FG001|Overall Study|Death|29|||
161451425|NCT01808092|583048269|FG000|Overall Study|Lost to Follow-up|3|||
161451426|NCT01808092|583048270|FG001|Overall Study|Lost to Follow-up|7|||
161799887|NCT00863746|584310920|FG000|Treatment|Other|1|||
161799888|NCT00863746|584310921|FG001|Treatment|Other|0|||
161799889|NCT00863746|584310920|FG000|Survival Follow up|Death|244|||
161799890|NCT00863746|584310921|FG001|Survival Follow up|Death|271|||
161451427|NCT01808092|583048269|FG000|Overall Study|Withdrawal by Subject|9|||
161556707|NCT04191135|583427084|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
161799891|NCT00863746|584310920|FG000|Survival Follow up|Lost to Follow-up|2|||
161799892|NCT00863746|584310921|FG001|Survival Follow up|Lost to Follow-up|1|||
161799893|NCT00863746|584310920|FG000|Survival Follow up|Consent Withdrawn|7|||
161799894|NCT00863746|584310921|FG001|Survival Follow up|Consent Withdrawn|8|||
161903856|NCT03028142|584696913|FG004|Overall Study|Withdrawal by Subject|1|||
161903857|NCT03028142|584696914|FG005|Overall Study|Withdrawal by Subject|0|||
161903858|NCT00116688|584696918|FG000|Overall Study|Protocol deviation|1|||
161903859|NCT00116688|584696919|FG001|Overall Study|Protocol deviation|0|||
161903860|NCT00116688|584696918|FG000|Overall Study|Noncompliance|3|||
161903861|NCT00116688|584696919|FG001|Overall Study|Noncompliance|1|||
161903862|NCT00116688|584696918|FG000|Overall Study|Adverse Event|11|||
161903863|NCT00116688|584696919|FG001|Overall Study|Adverse Event|0|||
161903864|NCT00116688|584696918|FG000|Overall Study|Withdrawal by Subject|26|||
161903865|NCT00116688|584696919|FG001|Overall Study|Withdrawal by Subject|2|||
161903866|NCT00116688|584696918|FG000|Overall Study|Requirement for alternative therapy|11|||
161903867|NCT00116688|584696919|FG001|Overall Study|Requirement for alternative therapy|1|||
161903868|NCT00116688|584696918|FG000|Overall Study|Physician Decision|7|||
161903869|NCT00116688|584696919|FG001|Overall Study|Physician Decision|0|||
161903870|NCT00116688|584696918|FG000|Overall Study|Lost to Follow-up|3|||
161903871|NCT00116688|584696919|FG001|Overall Study|Lost to Follow-up|0|||
161903872|NCT00116688|584696918|FG000|Overall Study|Death|15|||
161903873|NCT00116688|584696919|FG001|Overall Study|Death|0|||
161903874|NCT00116688|584696918|FG000|Overall Study|Protocol-specified criteria|3|||
161903875|NCT00116688|584696919|FG001|Overall Study|Protocol-specified criteria|0|||
161903876|NCT00116688|584696918|FG000|Overall Study|Pregnancy|1|||
161903877|NCT00116688|584696919|FG001|Overall Study|Pregnancy|0|||
161903878|NCT00116688|584696918|FG000|Overall Study|Other|11|||
161903879|NCT00116688|584696919|FG001|Overall Study|Other|0|||
161903880|NCT01775670|584696924|FG000|Overall Study|Lost to Follow-up|1|||
161903881|NCT01775670|584696925|FG001|Overall Study|Lost to Follow-up|1|||
161903882|NCT01298700|584696927|FG000|Overall Study|Adverse Event|50|||
161903883|NCT01298700|584696928|FG001|Overall Study|Adverse Event|51|||
161903884|NCT01298700|584696927|FG000|Overall Study|Lack of Efficacy|9|||
161903885|NCT01298700|584696928|FG001|Overall Study|Lack of Efficacy|14|||
161903886|NCT01298700|584696927|FG000|Overall Study|Lost to Follow-up|5|||
161903887|NCT01298700|584696928|FG001|Overall Study|Lost to Follow-up|2|||
161903888|NCT01298700|584696927|FG000|Overall Study|Withdrawal by Subject|12|||
161903889|NCT01298700|584696928|FG001|Overall Study|Withdrawal by Subject|9|||
161903890|NCT01298700|584696927|FG000|Overall Study|Protocol Violation|6|||
161903891|NCT01298700|584696928|FG001|Overall Study|Protocol Violation|4|||
161903892|NCT01298700|584696927|FG000|Overall Study|Other Miscellaneous Reasons|16|||
161903893|NCT01298700|584696928|FG001|Overall Study|Other Miscellaneous Reasons|15|||
161903894|NCT01298700|584696927|FG000|Overall Study|Did not Receive Study Drug|3|||
161903895|NCT01298700|584696928|FG001|Overall Study|Did not Receive Study Drug|5|||
161903896|NCT04006145|584696931|FG000|Overall Study|Lost to Follow-up|0|||
161903897|NCT04006145|584696932|FG001|Overall Study|Lost to Follow-up|1|||
161903898|NCT04006145|584696931|FG000|Overall Study|Other|1|||
161903899|NCT04006145|584696932|FG001|Overall Study|Other|2|||
161903900|NCT01001429|584696933|FG000|Overall Study|surgery cancelled|0|||
161903901|NCT01001429|584696934|FG001|Overall Study|surgery cancelled|1|||
161903902|NCT00010257|584696937|FG000|Overall Study|Withdrawal by Subject|1|||
161903903|NCT00010257|584696938|FG001|Overall Study|Withdrawal by Subject|0|||
161903904|NCT02812186|584696939|FG000|Period 1|Post randomization screen failure|5|||
161903905|NCT02812186|584696940|FG001|Period 1|Post randomization screen failure|9|||
161903906|NCT02812186|584696939|FG000|Period 1|nonevaluable data sets|6|||
161903907|NCT02812186|584696940|FG001|Period 1|nonevaluable data sets|6|||
161903908|NCT00643760|584696943|FG000|Overall Study|Adverse Event|11|||
161903909|NCT00643760|584696944|FG001|Overall Study|Adverse Event|5|||
161903910|NCT00643760|584696945|FG002|Overall Study|Adverse Event|12|||
161903911|NCT00643760|584696946|FG003|Overall Study|Adverse Event|21|||
161903912|NCT00643760|584696947|FG004|Overall Study|Adverse Event|6|||
161903913|NCT00643760|584696943|FG000|Overall Study|Lack of Efficacy|3|||
161903914|NCT00643760|584696944|FG001|Overall Study|Lack of Efficacy|1|||
161903915|NCT00643760|584696945|FG002|Overall Study|Lack of Efficacy|0|||
161903916|NCT00643760|584696946|FG003|Overall Study|Lack of Efficacy|4|||
161903917|NCT00643760|584696947|FG004|Overall Study|Lack of Efficacy|3|||
161903918|NCT00643760|584696943|FG000|Overall Study|Protocol Violation|7|||
161903919|NCT00643760|584696944|FG001|Overall Study|Protocol Violation|6|||
161903920|NCT00643760|584696945|FG002|Overall Study|Protocol Violation|4|||
161903921|NCT00643760|584696946|FG003|Overall Study|Protocol Violation|4|||
161903922|NCT00643760|584696947|FG004|Overall Study|Protocol Violation|6|||
161903923|NCT00643760|584696943|FG000|Overall Study|Lost to Follow-up|6|||
161903924|NCT00643760|584696944|FG001|Overall Study|Lost to Follow-up|2|||
161903925|NCT00643760|584696945|FG002|Overall Study|Lost to Follow-up|1|||
161903926|NCT00643760|584696946|FG003|Overall Study|Lost to Follow-up|3|||
161903927|NCT00643760|584696947|FG004|Overall Study|Lost to Follow-up|3|||
161903928|NCT00643760|584696943|FG000|Overall Study|Investigator Discretion|0|||
161903929|NCT00643760|584696944|FG001|Overall Study|Investigator Discretion|0|||
161903930|NCT00643760|584696945|FG002|Overall Study|Investigator Discretion|0|||
161903931|NCT00643760|584696946|FG003|Overall Study|Investigator Discretion|2|||
161903932|NCT00643760|584696947|FG004|Overall Study|Investigator Discretion|0|||
161903933|NCT00643760|584696943|FG000|Overall Study|Withdrawal by Subject|3|||
161903934|NCT00643760|584696944|FG001|Overall Study|Withdrawal by Subject|1|||
161903935|NCT00643760|584696945|FG002|Overall Study|Withdrawal by Subject|2|||
161903936|NCT00643760|584696946|FG003|Overall Study|Withdrawal by Subject|4|||
161903937|NCT00643760|584696947|FG004|Overall Study|Withdrawal by Subject|1|||
161903938|NCT00789321|584696951|FG000|Overall Study|Adverse Event|0|||
161903939|NCT00789321|584696952|FG001|Overall Study|Adverse Event|1|||
161903940|NCT00104052|584696953|FG000|Overall Study|Adverse Event|1|||
161903941|NCT00104052|584696953|FG000|Overall Study|Lack of Efficacy|26|||
161903942|NCT00104052|584696953|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
161903943|NCT01162343|584696954|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
161903944|NCT01162343|584696954|FG000|Overall Study|Refused psychiatrist assessment|12|||
161903945|NCT01294423|584696959|FG000|Overall Study|Adverse Event|1|||
161903946|NCT01294423|584696960|FG001|Overall Study|Adverse Event|2|||
161903947|NCT01294423|584696961|FG002|Overall Study|Adverse Event|3|||
161903948|NCT01294423|584696959|FG000|Overall Study|Withdrawal by Subject|1|||
161903949|NCT01294423|584696960|FG001|Overall Study|Withdrawal by Subject|2|||
161903950|NCT01294423|584696961|FG002|Overall Study|Withdrawal by Subject|2|||
161903951|NCT01294423|584696959|FG000|Overall Study|subject no longer meets study criteria|2|||
161903952|NCT01294423|584696960|FG001|Overall Study|subject no longer meets study criteria|5|||
161903953|NCT01294423|584696961|FG002|Overall Study|subject no longer meets study criteria|2|||
161903954|NCT01294423|584696959|FG000|Overall Study|poor/non-compliance|1|||
161903955|NCT01294423|584696960|FG001|Overall Study|poor/non-compliance|0|||
161903956|NCT01294423|584696961|FG002|Overall Study|poor/non-compliance|1|||
161903957|NCT01241279|584696962|FG000|Overall Study|Lost to Follow-up|0|||
161903958|NCT01241279|584696963|FG001|Overall Study|Lost to Follow-up|1|||
161903959|NCT01484951|584696964|FG000|Overall Study|Adverse Event|3|||
161903960|NCT01484951|584696964|FG000|Overall Study|Personal Reasons|1|||
161903961|NCT01484951|584696964|FG000|Overall Study|Non-Compliance|1|||
161903962|NCT02026141|584696966|FG000|Overall Study|Protocol Violation|0|||
161903963|NCT02026141|584696967|FG001|Overall Study|Protocol Violation|1|||
161903964|NCT02169505|584696968|FG000|Overall Study|Withdrawal by Subject|1|||
161903965|NCT01248455|584696969|FG000|Overall Study|switched to alternate treatment|1|||
161903966|NCT02735980|584696970|FG000|Overall Study|Adverse Event|0|||
161556708|NCT04191135|583427085|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
161556709|NCT04191135|583427083|FG000|Induction Treatment|Adverse Event|25|||
161556710|NCT04191135|583427084|FG001|Induction Treatment|Adverse Event|0|||
161556711|NCT04191135|583427085|FG002|Induction Treatment|Adverse Event|0|||
161556712|NCT04191135|583427083|FG000|Induction Treatment|Clinical Progression|8|||
161556713|NCT04191135|583427084|FG001|Induction Treatment|Clinical Progression|0|||
161556714|NCT04191135|583427085|FG002|Induction Treatment|Clinical Progression|0|||
161556715|NCT04191135|583427083|FG000|Induction Treatment|Excluded Medication|1|||
161556716|NCT04191135|583427084|FG001|Induction Treatment|Excluded Medication|0|||
161556717|NCT04191135|583427085|FG002|Induction Treatment|Excluded Medication|0|||
161556718|NCT04191135|583427083|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
161556719|NCT04191135|583427084|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
161556720|NCT04191135|583427085|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
161556721|NCT04191135|583427083|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
161556722|NCT04191135|583427084|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
161556723|NCT04191135|583427085|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
161556724|NCT04191135|583427083|FG000|Induction Treatment|Physician Decision|2|||
161556725|NCT04191135|583427084|FG001|Induction Treatment|Physician Decision|0|||
161556726|NCT04191135|583427085|FG002|Induction Treatment|Physician Decision|0|||
161556727|NCT04191135|583427083|FG000|Induction Treatment|Progressive Disease|135|||
161556728|NCT04191135|583427084|FG001|Induction Treatment|Progressive Disease|0|||
161556729|NCT04191135|583427085|FG002|Induction Treatment|Progressive Disease|0|||
161556730|NCT04191135|583427083|FG000|Induction Treatment|Protocol Violation|10|||
161556731|NCT04191135|583427084|FG001|Induction Treatment|Protocol Violation|0|||
161556732|NCT04191135|583427085|FG002|Induction Treatment|Protocol Violation|0|||
161556733|NCT04191135|583427083|FG000|Induction Treatment|Withdrawal by Subject|4|||
161556734|NCT04191135|583427084|FG001|Induction Treatment|Withdrawal by Subject|0|||
161903967|NCT02735980|584696971|FG001|Overall Study|Adverse Event|4|||
161903968|NCT02735980|584696972|FG002|Overall Study|Adverse Event|1|||
161903969|NCT02735980|584696970|FG000|Overall Study|Death|5|||
161556735|NCT04191135|583427085|FG002|Induction Treatment|Withdrawal by Subject|0|||
161556736|NCT04191135|583427083|FG000|Randomized Treatment|Death|0|||
161556737|NCT04191135|583427084|FG001|Randomized Treatment|Death|50|||
161903970|NCT02735980|584696971|FG001|Overall Study|Death|4|||
161903971|NCT02735980|584696972|FG002|Overall Study|Death|0|||
161556738|NCT04191135|583427085|FG002|Randomized Treatment|Death|54|||
161903972|NCT02735980|584696970|FG000|Overall Study|Physician Decision|3|||
161903973|NCT02735980|584696971|FG001|Overall Study|Physician Decision|1|||
161556739|NCT04191135|583427083|FG000|Randomized Treatment|Lost to Follow-up|0|||
161556740|NCT04191135|583427084|FG001|Randomized Treatment|Lost to Follow-up|0|||
161556741|NCT04191135|583427085|FG002|Randomized Treatment|Lost to Follow-up|1|||
161556742|NCT04191135|583427083|FG000|Randomized Treatment|Withdrawal by Subject|0|||
161556743|NCT04191135|583427084|FG001|Randomized Treatment|Withdrawal by Subject|2|||
161799895|NCT02924038|584310922|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
161799896|NCT02924038|584310923|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
161799897|NCT02473640|584310924|FG000|Treatment Period 1|Adverse Event|1|||
161799898|NCT02395822|584310925|FG000|Overall Study|Withdrawal by Subject|1|||
161799899|NCT02395822|584310925|FG000|Overall Study|Death|1|||
161799900|NCT03292653|584310928|FG000|Overall Study|Adverse Event|0|||
161799901|NCT03292653|584310929|FG001|Overall Study|Adverse Event|0|||
161799902|NCT03292653|584310930|FG002|Overall Study|Adverse Event|1|||
161799903|NCT03292653|584310928|FG000|Overall Study|Did not Receive Treatment|1|||
161799904|NCT03292653|584310929|FG001|Overall Study|Did not Receive Treatment|0|||
161799905|NCT03292653|584310930|FG002|Overall Study|Did not Receive Treatment|0|||
161799906|NCT04720664|584310931|FG000|Overall Study|Adverse Event|2|||
161799907|NCT04720664|584310931|FG000|Overall Study|Lack of Efficacy|9|||
161799908|NCT03311646|584310938|FG000|Overall Study|Physician Decision|1|||
161799909|NCT03311646|584310938|FG000|Overall Study|Withdrawal by Subject|5|||
161799910|NCT03311646|584310938|FG000|Overall Study|Lost to Follow-up|5|||
161799911|NCT03311646|584310938|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
161799912|NCT03103100|584310941|FG000|Overall Study|Adverse Event|1|||
161799913|NCT03103100|584310942|FG001|Overall Study|Adverse Event|0|||
161799914|NCT03103100|584310943|FG002|Overall Study|Adverse Event|0|||
161799915|NCT03103100|584310941|FG000|Overall Study|Physician Decision|1|||
161799916|NCT03103100|584310942|FG001|Overall Study|Physician Decision|0|||
161799917|NCT03103100|584310943|FG002|Overall Study|Physician Decision|2|||
161799918|NCT00531206|584310944|FG000|Overall Study|Adverse Event related|5|||
161799919|NCT00531206|584310944|FG000|Overall Study|Lack of Efficacy|2|||
161799920|NCT00531206|584310944|FG000|Overall Study|Lost to Follow-up|5|||
161799921|NCT00531206|584310944|FG000|Overall Study|including non-related adverse events|8|||
161799922|NCT03331042|584310963|FG000|Overall Study|Protocol Violation|1|||
161799923|NCT03331042|584310964|FG001|Overall Study|Protocol Violation|0|||
161799924|NCT03331042|584310965|FG002|Overall Study|Protocol Violation|0|||
161799925|NCT03331042|584310966|FG003|Overall Study|Protocol Violation|0|||
161799926|NCT03331042|584310963|FG000|Overall Study|Physician Decision|0|||
161799927|NCT03331042|584310964|FG001|Overall Study|Physician Decision|0|||
161799928|NCT03331042|584310965|FG002|Overall Study|Physician Decision|1|||
161799929|NCT03331042|584310966|FG003|Overall Study|Physician Decision|0|||
161799930|NCT03331042|584310963|FG000|Overall Study|Lost to Follow-up|0|||
161799931|NCT03331042|584310964|FG001|Overall Study|Lost to Follow-up|0|||
161799932|NCT03331042|584310965|FG002|Overall Study|Lost to Follow-up|0|||
161799933|NCT03331042|584310966|FG003|Overall Study|Lost to Follow-up|1|||
161799934|NCT02720510|584310970|FG000|Overall Study|Study Terminated by the sponsor|2|||
161799935|NCT02720510|584310971|FG001|Overall Study|Study Terminated by the sponsor|0|||
161799936|NCT02720510|584310970|FG000|Overall Study|Adverse Event|0|||
161799937|NCT02720510|584310971|FG001|Overall Study|Adverse Event|1|||
161799938|NCT02720510|584310970|FG000|Overall Study|Physician Decision|1|||
161799939|NCT02720510|584310971|FG001|Overall Study|Physician Decision|2|||
161799940|NCT02460159|584310972|FG000|Overall Study|Adverse Event|4|||
161799941|NCT02460159|584310973|FG001|Overall Study|Adverse Event|1|||
161799942|NCT02460159|584310972|FG000|Overall Study|Withdrawal by Subject|2|||
161799943|NCT02460159|584310973|FG001|Overall Study|Withdrawal by Subject|0|||
161799944|NCT03499964|584310974|FG000|Overall Study|Lack of Efficacy|6|||
161799945|NCT03499964|584310975|FG001|Overall Study|Lack of Efficacy|26|||
161799946|NCT03499964|584310974|FG000|Overall Study|Adverse Event|1|||
161799947|NCT03499964|584310975|FG001|Overall Study|Adverse Event|0|||
161451428|NCT01808092|583048270|FG001|Overall Study|Withdrawal by Subject|4|||
161451429|NCT01808092|583048269|FG000|Overall Study|Other Eligibility criteria|3|||
161451430|NCT01808092|583048270|FG001|Overall Study|Other Eligibility criteria|5|||
161451431|NCT02626624|583048273|FG000|Overall Study|Adverse Event|1|||
161451432|NCT02626624|583048273|FG000|Overall Study|Lost to Follow-up|3|||
161451433|NCT02626624|583048273|FG000|Overall Study|Protocol Violation|4|||
161451434|NCT02626624|583048273|FG000|Overall Study|Death|2|||
161451435|NCT01097005|583048277|FG000|Overall Study|Case Report Form not collected|18|||
161451436|NCT01097005|583048277|FG000|Overall Study|Subjects cannot visit the hospital|1|||
161451437|NCT01097005|583048277|FG000|Overall Study|Poor medication compliance|1|||
161451438|NCT01097005|583048277|FG000|Overall Study|No examination data available|244|||
161451439|NCT01097005|583048277|FG000|Overall Study|Deviation from exclusion criteria|37|||
161451440|NCT01097005|583048277|FG000|Overall Study|Adverse Event|14|||
161668046|NCT00406653|583837482|FG006|Induction Period|Declined participation but followup done|0|||
161799948|NCT03499964|584310974|FG000|Overall Study|Death|1|||
161799949|NCT03499964|584310975|FG001|Overall Study|Death|0|||
161799950|NCT03499964|584310974|FG000|Overall Study|Withdrawal by Subject|2|||
161799951|NCT03499964|584310975|FG001|Overall Study|Withdrawal by Subject|1|||
161799952|NCT03499964|584310974|FG000|Overall Study|Lost to Follow-up|1|||
161799953|NCT03499964|584310975|FG001|Overall Study|Lost to Follow-up|0|||
161799954|NCT00084084|584310976|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
161799955|NCT00084084|584310976|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
161799956|NCT01047345|584310977|FG000|Base Study|Adverse Event|3|||
161799957|NCT01047345|584310978|FG001|Base Study|Adverse Event|0|||
161556744|NCT04191135|583427085|FG002|Randomized Treatment|Withdrawal by Subject|0|||
161556745|NCT04191135|583427083|FG000|Randomized Treatment|Ongoing in Trial|0|||
161556746|NCT04191135|583427084|FG001|Randomized Treatment|Ongoing in Trial|83|||
161556747|NCT04191135|583427085|FG002|Randomized Treatment|Ongoing in Trial|81|||
161556748|NCT02107274|583428859|FG000|Treatment vs. Placebo|Adverse Event|3|||
161556749|NCT02107274|583428860|FG001|Treatment vs. Placebo|Adverse Event|0|||
161556750|NCT02107274|583428859|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
161556751|NCT02107274|583428860|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
161556752|NCT02107274|583428859|FG000|Control Phase|Lost to Follow-up|1|||
161556753|NCT02107274|583428860|FG001|Control Phase|Lost to Follow-up|1|||
161556754|NCT02107274|583428859|FG000|Control Phase|Death|2|||
161556755|NCT02107274|583428860|FG001|Control Phase|Death|0|||
161556756|NCT02107274|583428859|FG000|Control Phase|Adverse Event|0|||
161556757|NCT02107274|583428860|FG001|Control Phase|Adverse Event|1|||
161556758|NCT05305040|583428863|FG000|Overall Study|Not Dosed|37|||
161556759|NCT05305040|583428864|FG001|Overall Study|Not Dosed|37|||
161556760|NCT05305040|583428863|FG000|Overall Study|Study Closure|34|||
161556761|NCT05305040|583428864|FG001|Overall Study|Study Closure|46|||
161556762|NCT05305040|583428863|FG000|Overall Study|Death|14|||
161556763|NCT05305040|583428864|FG001|Overall Study|Death|13|||
161556764|NCT05305040|583428863|FG000|Overall Study|Withdrawal by Subject|15|||
161556765|NCT05305040|583428864|FG001|Overall Study|Withdrawal by Subject|10|||
161556766|NCT05305040|583428863|FG000|Overall Study|Other|13|||
161556767|NCT05305040|583428864|FG001|Overall Study|Other|10|||
161556768|NCT05305040|583428863|FG000|Overall Study|Primary Malignancy Relapse|3|||
161556769|NCT05305040|583428864|FG001|Overall Study|Primary Malignancy Relapse|4|||
161556770|NCT05305040|583428863|FG000|Overall Study|Adverse Event|3|||
161556771|NCT05305040|583428864|FG001|Overall Study|Adverse Event|3|||
161556772|NCT05305040|583428863|FG000|Overall Study|Lost to Follow-up|2|||
161556773|NCT05305040|583428864|FG001|Overall Study|Lost to Follow-up|1|||
161556774|NCT05305040|583428863|FG000|Overall Study|Graft versus host disease|2|||
161556775|NCT05305040|583428864|FG001|Overall Study|Graft versus host disease|0|||
161556776|NCT05305040|583428863|FG000|Overall Study|Investigator's Decision|1|||
161556777|NCT05305040|583428864|FG001|Overall Study|Investigator's Decision|1|||
161556778|NCT05305040|583428863|FG000|Overall Study|COVID-19 Reasons|1|||
161799958|NCT01047345|584310979|FG002|Base Study|Adverse Event|0|||
161799959|NCT01047345|584310977|FG000|Base Study|Lost to Follow-up|4|||
161799960|NCT01047345|584310978|FG001|Base Study|Lost to Follow-up|1|||
161799961|NCT01047345|584310979|FG002|Base Study|Lost to Follow-up|0|||
161799962|NCT01047345|584310977|FG000|Base Study|Protocol Violation|3|||
161799963|NCT01047345|584310978|FG001|Base Study|Protocol Violation|1|||
161799964|NCT01047345|584310979|FG002|Base Study|Protocol Violation|0|||
161799965|NCT01047345|584310977|FG000|Base Study|Withdrawal by Subject|12|||
161799966|NCT01047345|584310978|FG001|Base Study|Withdrawal by Subject|4|||
161799967|NCT01047345|584310979|FG002|Base Study|Withdrawal by Subject|0|||
161799968|NCT01047345|584310977|FG000|Extension|Withdrawal by Subject|0|||
161799969|NCT01047345|584310978|FG001|Extension|Withdrawal by Subject|0|||
161799970|NCT01047345|584310979|FG002|Extension|Withdrawal by Subject|1|||
161799971|NCT01047345|584310977|FG000|Extension|Lost to Follow-up|0|||
161799972|NCT01047345|584310978|FG001|Extension|Lost to Follow-up|0|||
161799973|NCT01047345|584310979|FG002|Extension|Lost to Follow-up|5|||
161799974|NCT00712010|584310980|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
161799975|NCT00995553|584310984|FG000|Overall Study|Withdrawal by Subject|2|||
161799976|NCT00995553|584310985|FG001|Overall Study|Withdrawal by Subject|6|||
161799977|NCT00927810|584310986|FG000|Overall Study|Withdrawal by Subject|0|||
161799978|NCT00927810|584310987|FG001|Overall Study|Withdrawal by Subject|3|||
161799979|NCT00927810|584310988|FG002|Overall Study|Withdrawal by Subject|0|||
161799980|NCT00927810|584310989|FG003|Overall Study|Withdrawal by Subject|1|||
161799981|NCT00927810|584310986|FG000|Overall Study|Lost to Follow-up|0|||
161799982|NCT00927810|584310987|FG001|Overall Study|Lost to Follow-up|2|||
161799983|NCT00927810|584310988|FG002|Overall Study|Lost to Follow-up|1|||
161799984|NCT00927810|584310989|FG003|Overall Study|Lost to Follow-up|1|||
161799985|NCT00927810|584310986|FG000|Overall Study|Death|0|||
161799986|NCT00927810|584310987|FG001|Overall Study|Death|2|||
161799987|NCT00927810|584310988|FG002|Overall Study|Death|0|||
161799988|NCT00927810|584310989|FG003|Overall Study|Death|0|||
161799989|NCT00927810|584310986|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161799990|NCT00927810|584310987|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161799991|NCT00927810|584310988|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161556779|NCT05305040|583428864|FG001|Overall Study|COVID-19 Reasons|0|||
161556780|NCT02206685|583428865|FG000|Overall Study|Surgery cancelled/changed|2|||
161556781|NCT02206685|583428866|FG001|Overall Study|Surgery cancelled/changed|3|||
161556782|NCT02206685|583428865|FG000|Overall Study|Withdrawal by Subject|1|||
161799992|NCT00927810|584310989|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161556783|NCT02206685|583428866|FG001|Overall Study|Withdrawal by Subject|2|||
161556784|NCT02206685|583428865|FG000|Overall Study|Protocol Violation|2|||
161799993|NCT02465567|584310990|FG000|Overall Study|Adverse Event|118|||
161799994|NCT02465567|584310991|FG001|Overall Study|Adverse Event|113|||
161799995|NCT02465567|584310992|FG002|Overall Study|Adverse Event|147|||
161903974|NCT02735980|584696972|FG002|Overall Study|Physician Decision|0|||
161903975|NCT02735980|584696970|FG000|Overall Study|Screen failure|1|||
161903976|NCT02735980|584696971|FG001|Overall Study|Screen failure|0|||
161903977|NCT02735980|584696972|FG002|Overall Study|Screen failure|0|||
161903978|NCT02735980|584696970|FG000|Overall Study|Withdrawal by Subject|1|||
161903979|NCT02735980|584696971|FG001|Overall Study|Withdrawal by Subject|2|||
161903980|NCT02735980|584696972|FG002|Overall Study|Withdrawal by Subject|0|||
161903981|NCT00917124|584696976|FG000|Overall Study|Protocol Violation|4|||
161903982|NCT00917124|584696977|FG001|Overall Study|Protocol Violation|6|||
161903983|NCT01783743|584696978|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
161903984|NCT01783743|584696979|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
161903985|NCT01783743|584696978|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
161903986|NCT01783743|584696979|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
161903987|NCT01783743|584696978|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
161903988|NCT01783743|584696979|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
161903989|NCT00126594|584696994|FG000|Overall Study|Ineligible|2|||
161903990|NCT00126594|584696995|FG001|Overall Study|Ineligible|0|||
161903991|NCT00126594|584696994|FG000|Overall Study|Withdrawal by Subject|0|||
161903992|NCT00126594|584696995|FG001|Overall Study|Withdrawal by Subject|4|||
161903993|NCT00126594|584696994|FG000|Overall Study|Physician Decision|1|||
161903994|NCT00126594|584696995|FG001|Overall Study|Physician Decision|3|||
161903995|NCT00126594|584696994|FG000|Overall Study|Adverse Event|7|||
161903996|NCT00126594|584696995|FG001|Overall Study|Adverse Event|5|||
161903997|NCT00126594|584696994|FG000|Overall Study|Non-compliance|0|||
161903998|NCT00126594|584696995|FG001|Overall Study|Non-compliance|1|||
161903999|NCT00126594|584696994|FG000|Overall Study|Disease Progression|29|||
161904000|NCT00126594|584696995|FG001|Overall Study|Disease Progression|24|||
161904001|NCT00983372|584696996|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
161904002|NCT00983372|584696996|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
161904003|NCT00983372|584696996|FG000|Diltiazem ER Alone|Adverse Event|1|||
161904004|NCT05635045|584696997|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161904005|NCT05635045|584696998|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161904006|NCT05635045|584696999|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
161904007|NCT05635045|584697000|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161904008|NCT00673257|584697010|FG000|Overall Study|Withdrawal by Subject|4|||
161904009|NCT00673257|584697010|FG000|Overall Study|Unable to obtain specimen|1|||
161904010|NCT01585246|584697017|FG000|Overall Study|Lost to Follow-up|0|||
161904011|NCT01585246|584697018|FG001|Overall Study|Lost to Follow-up|0|||
161904012|NCT01585246|584697019|FG002|Overall Study|Lost to Follow-up|2|||
161904013|NCT01585246|584697020|FG003|Overall Study|Lost to Follow-up|1|||
161904014|NCT01585246|584697021|FG004|Overall Study|Lost to Follow-up|0|||
161904015|NCT01585246|584697017|FG000|Overall Study|Protocol Violation|0|||
161904016|NCT01585246|584697018|FG001|Overall Study|Protocol Violation|0|||
161904017|NCT01585246|584697019|FG002|Overall Study|Protocol Violation|0|||
161904018|NCT01585246|584697020|FG003|Overall Study|Protocol Violation|0|||
161904019|NCT01585246|584697021|FG004|Overall Study|Protocol Violation|1|||
161904020|NCT01585246|584697017|FG000|Overall Study|Withdrawal by Subject|0|||
161904021|NCT01585246|584697018|FG001|Overall Study|Withdrawal by Subject|0|||
161904022|NCT01585246|584697019|FG002|Overall Study|Withdrawal by Subject|1|||
161904023|NCT01585246|584697020|FG003|Overall Study|Withdrawal by Subject|2|||
161904024|NCT01585246|584697021|FG004|Overall Study|Withdrawal by Subject|1|||
161904025|NCT01585246|584697017|FG000|Overall Study|Other|0|||
161904026|NCT01585246|584697018|FG001|Overall Study|Other|1|||
161904027|NCT01585246|584697019|FG002|Overall Study|Other|1|||
161904028|NCT01585246|584697020|FG003|Overall Study|Other|1|||
161904029|NCT01585246|584697021|FG004|Overall Study|Other|0|||
161904030|NCT04396626|584697022|FG000|Overall Study|Premature termination of study|975|||
161904031|NCT02111174|584697023|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
161904032|NCT02111174|584697024|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
161904033|NCT02111174|584697023|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
161904034|NCT02111174|584697024|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
161904035|NCT02111174|584697023|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
161904036|NCT02111174|584697024|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
161904037|NCT02111174|584697023|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
161904038|NCT02111174|584697024|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
161904039|NCT04552132|584697025|FG000|Overall Study|Lost to Follow-up|4|||
161904040|NCT04552132|584697026|FG001|Overall Study|Lost to Follow-up|3|||
161904041|NCT04552132|584697025|FG000|Overall Study|Protocol Violation|1|||
161904042|NCT04552132|584697026|FG001|Overall Study|Protocol Violation|0|||
161904043|NCT01657162|584697027|FG000|Overall Study|Adverse Event|26|||
161904044|NCT01657162|584697028|FG001|Overall Study|Adverse Event|36|||
161904045|NCT01657162|584697027|FG000|Overall Study|Withdrawal by Subject|13|||
161904046|NCT01657162|584697028|FG001|Overall Study|Withdrawal by Subject|13|||
161904047|NCT01657162|584697027|FG000|Overall Study|Continuing Significant Deterioration|9|||
161904048|NCT01657162|584697028|FG001|Overall Study|Continuing Significant Deterioration|3|||
161904049|NCT01657162|584697027|FG000|Overall Study|Refusal of Treatment|4|||
161904050|NCT01657162|584697028|FG001|Overall Study|Refusal of Treatment|6|||
161904051|NCT01657162|584697027|FG000|Overall Study|Lost to Follow-up|3|||
161904052|NCT01657162|584697028|FG001|Overall Study|Lost to Follow-up|4|||
161904053|NCT01657162|584697027|FG000|Overall Study|Death|2|||
161904054|NCT01657162|584697028|FG001|Overall Study|Death|3|||
161904055|NCT01657162|584697027|FG000|Overall Study|Inability to Complete Study Procedures|1|||
161904056|NCT01657162|584697028|FG001|Overall Study|Inability to Complete Study Procedures|7|||
161904057|NCT01657162|584697027|FG000|Overall Study|Protocol Violation|1|||
161904058|NCT01657162|584697028|FG001|Overall Study|Protocol Violation|0|||
161904059|NCT01657162|584697027|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
161904060|NCT01657162|584697028|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
161904061|NCT01657162|584697027|FG000|Overall Study|Other than Specified|0|||
161904062|NCT01657162|584697028|FG001|Overall Study|Other than Specified|2|||
161904063|NCT02600923|584697031|FG000|Overall Study|Death|10|||
161904064|NCT02600923|584697031|FG000|Overall Study|Adverse Event|3|||
161904065|NCT02600923|584697031|FG000|Overall Study|Global deterioration of health status|2|||
161904066|NCT02600923|584697031|FG000|Overall Study|Insufficient clinical response|6|||
161904067|NCT02600923|584697031|FG000|Overall Study|Lost to Follow-up|1|||
161904068|NCT02600923|584697031|FG000|Overall Study|Withdrawal by Subject|5|||
161904069|NCT02600923|584697031|FG000|Overall Study|Objective progression or relapse|50|||
161904070|NCT02600923|584697031|FG000|Overall Study|Study terminated by Sponsor|53|||
161904071|NCT02600923|584697031|FG000|Overall Study|Not treated|1|||
161904072|NCT00792909|584697032|FG000|Overall Study|Withdrawal by Subject|0|||
161904073|NCT00792909|584697033|FG001|Overall Study|Withdrawal by Subject|1|||
161904074|NCT00792909|584697034|FG002|Overall Study|Withdrawal by Subject|0|||
161904075|NCT01747499|584697037|FG000|Overall Study|Steroid refractory aGvHD|1|||
161904076|NCT01747499|584697038|FG001|Overall Study|Steroid refractory aGvHD|0|||
161904077|NCT01747499|584697039|FG002|Overall Study|Steroid refractory aGvHD|0|||
161904078|NCT01747499|584697040|FG003|Overall Study|Steroid refractory aGvHD|1|||
161904079|NCT01747499|584697041|FG004|Overall Study|Steroid refractory aGvHD|4|||
161904080|NCT01747499|584697037|FG000|Overall Study|Physician Decision|0|||
161904081|NCT01747499|584697038|FG001|Overall Study|Physician Decision|1|||
161904082|NCT01747499|584697039|FG002|Overall Study|Physician Decision|0|||
161904083|NCT01747499|584697040|FG003|Overall Study|Physician Decision|0|||
161904084|NCT01747499|584697041|FG004|Overall Study|Physician Decision|2|||
161904085|NCT01747499|584697037|FG000|Overall Study|Death|0|||
161904086|NCT01747499|584697038|FG001|Overall Study|Death|0|||
161904087|NCT01747499|584697039|FG002|Overall Study|Death|0|||
161904088|NCT01747499|584697040|FG003|Overall Study|Death|1|||
161904089|NCT01747499|584697041|FG004|Overall Study|Death|1|||
161904090|NCT01747499|584697037|FG000|Overall Study|Withdrawal by Subject|0|||
161451441|NCT01097005|583048277|FG000|Overall Study|Discontinuance by complication|50|||
161451442|NCT03865316|583050601|FG000|Overall Study|Procedure Cancelled|4|||
161451443|NCT03865316|583050601|FG000|Overall Study|Equipment failure|4|||
161451444|NCT01836276|583050605|FG000|Overall Study|Lost to Follow-up|28|||
161451445|NCT01836276|583050606|FG001|Overall Study|Lost to Follow-up|51|||
161451446|NCT02208063|583050613|FG000|Overall Study|Death|3|||
161451447|NCT02208063|583050614|FG001|Overall Study|Death|5|||
161451448|NCT02208063|583050613|FG000|Overall Study|Not Specified in report|3|||
161451449|NCT02208063|583050614|FG001|Overall Study|Not Specified in report|4|||
161451450|NCT02208063|583050613|FG000|Overall Study|Withdrawal by Subject|5|||
161451451|NCT02208063|583050614|FG001|Overall Study|Withdrawal by Subject|2|||
161451452|NCT02208063|583050613|FG000|Overall Study|Lost to Follow-up|1|||
161451453|NCT02208063|583050614|FG001|Overall Study|Lost to Follow-up|0|||
161451454|NCT00913458|583050615|FG000|Phase 1|Non-Responder|54|||
161451455|NCT00913458|583050616|FG001|Phase 1|Non-Responder|0|||
161451456|NCT00913458|583050617|FG002|Phase 1|Non-Responder|0|||
161451457|NCT00913458|583050618|FG003|Phase 1|Non-Responder|0|||
161451458|NCT00913458|583050619|FG004|Phase 1|Non-Responder|0|||
161451459|NCT00913458|583050620|FG005|Phase 1|Non-Responder|0|||
161451460|NCT00913458|583050621|FG006|Phase 1|Non-Responder|0|||
161451461|NCT00913458|583050615|FG000|Phase 1|Subject Request|17|||
161904091|NCT01747499|584697038|FG001|Overall Study|Withdrawal by Subject|0|||
161904092|NCT01747499|584697039|FG002|Overall Study|Withdrawal by Subject|0|||
161904093|NCT01747499|584697040|FG003|Overall Study|Withdrawal by Subject|0|||
161904094|NCT01747499|584697041|FG004|Overall Study|Withdrawal by Subject|6|||
161904095|NCT01747499|584697037|FG000|Overall Study|Developed AML and death|0|||
161904096|NCT01747499|584697038|FG001|Overall Study|Developed AML and death|0|||
161904097|NCT01747499|584697039|FG002|Overall Study|Developed AML and death|0|||
161904098|NCT01747499|584697040|FG003|Overall Study|Developed AML and death|0|||
161904099|NCT01747499|584697041|FG004|Overall Study|Developed AML and death|1|||
161451462|NCT00913458|583050616|FG001|Phase 1|Subject Request|0|||
161904100|NCT01747499|584697037|FG000|Overall Study|Determined not to be eligible|0|||
161451463|NCT00913458|583050617|FG002|Phase 1|Subject Request|0|||
161451464|NCT00913458|583050618|FG003|Phase 1|Subject Request|0|||
161451465|NCT00913458|583050619|FG004|Phase 1|Subject Request|0|||
161451466|NCT00913458|583050620|FG005|Phase 1|Subject Request|0|||
161556785|NCT02206685|583428866|FG001|Overall Study|Protocol Violation|2|||
161556786|NCT01195675|583428867|FG000|Overall Study|Adverse Event|1|||
161556787|NCT01195675|583428867|FG000|Overall Study|Withdrawal by Subject|2|||
161556788|NCT01174550|583428868|FG000|Overall Study|Death|75|||
161556789|NCT01174550|583428869|FG001|Overall Study|Death|74|||
161556790|NCT01174550|583428868|FG000|Overall Study|Lost to Follow-up|652|||
161799996|NCT02465567|584310993|FG003|Overall Study|Adverse Event|138|||
161799997|NCT02465567|584310990|FG000|Overall Study|Lack of Efficacy|103|||
161799998|NCT02465567|584310991|FG001|Overall Study|Lack of Efficacy|102|||
161799999|NCT02465567|584310992|FG002|Overall Study|Lack of Efficacy|171|||
161800000|NCT02465567|584310993|FG003|Overall Study|Lack of Efficacy|135|||
161800001|NCT02465567|584310990|FG000|Overall Study|Withdrawal by Subject|104|||
161800002|NCT02465567|584310991|FG001|Overall Study|Withdrawal by Subject|94|||
161800003|NCT02465567|584310992|FG002|Overall Study|Withdrawal by Subject|123|||
161800004|NCT02465567|584310993|FG003|Overall Study|Withdrawal by Subject|130|||
161800005|NCT02465567|584310990|FG000|Overall Study|Physician Decision|23|||
161800006|NCT02465567|584310991|FG001|Overall Study|Physician Decision|33|||
161800007|NCT02465567|584310992|FG002|Overall Study|Physician Decision|38|||
161800008|NCT02465567|584310993|FG003|Overall Study|Physician Decision|28|||
161800009|NCT02465567|584310990|FG000|Overall Study|Major Protocol Deviation|24|||
161800010|NCT02465567|584310991|FG001|Overall Study|Major Protocol Deviation|26|||
161800011|NCT02465567|584310992|FG002|Overall Study|Major Protocol Deviation|22|||
161800012|NCT02465567|584310993|FG003|Overall Study|Major Protocol Deviation|25|||
161800013|NCT02465567|584310990|FG000|Overall Study|Lost to Follow-up|25|||
161800014|NCT02465567|584310991|FG001|Overall Study|Lost to Follow-up|21|||
161800015|NCT02465567|584310992|FG002|Overall Study|Lost to Follow-up|19|||
161800016|NCT02465567|584310993|FG003|Overall Study|Lost to Follow-up|15|||
161800017|NCT02465567|584310990|FG000|Overall Study|Protocol Specified Criteria|20|||
161800018|NCT02465567|584310991|FG001|Overall Study|Protocol Specified Criteria|10|||
161800019|NCT02465567|584310992|FG002|Overall Study|Protocol Specified Criteria|9|||
161800020|NCT02465567|584310993|FG003|Overall Study|Protocol Specified Criteria|12|||
161800021|NCT02465567|584310990|FG000|Overall Study|Administrative Reasons|12|||
161800022|NCT02465567|584310991|FG001|Overall Study|Administrative Reasons|9|||
161800023|NCT02465567|584310992|FG002|Overall Study|Administrative Reasons|11|||
161800024|NCT02465567|584310993|FG003|Overall Study|Administrative Reasons|5|||
161800025|NCT02465567|584310990|FG000|Overall Study|Randomized but not treated|1|||
161800026|NCT02465567|584310991|FG001|Overall Study|Randomized but not treated|5|||
161800027|NCT02465567|584310992|FG002|Overall Study|Randomized but not treated|4|||
161800028|NCT02465567|584310993|FG003|Overall Study|Randomized but not treated|5|||
161800029|NCT02465567|584310990|FG000|Overall Study|enrolled in >1 studies|18|||
161800030|NCT02465567|584310991|FG001|Overall Study|enrolled in >1 studies|11|||
161800031|NCT02465567|584310992|FG002|Overall Study|enrolled in >1 studies|19|||
161800032|NCT02465567|584310993|FG003|Overall Study|enrolled in >1 studies|15|||
161800033|NCT02465567|584310990|FG000|Overall Study|missing PI Signature|1|||
161800034|NCT02465567|584310991|FG001|Overall Study|missing PI Signature|0|||
161800035|NCT02465567|584310992|FG002|Overall Study|missing PI Signature|0|||
161800036|NCT02465567|584310993|FG003|Overall Study|missing PI Signature|0|||
161800037|NCT00950807|584310997|FG000|Treatment Period 1|Lack of Efficacy|1|||
161800038|NCT00950807|584310998|FG001|Treatment Period 1|Lack of Efficacy|0|||
161800039|NCT00950807|584310999|FG002|Treatment Period 1|Lack of Efficacy|0|||
161800040|NCT00950807|584311000|FG003|Treatment Period 1|Lack of Efficacy|0|||
161800041|NCT00950807|584311001|FG004|Treatment Period 1|Lack of Efficacy|0|||
161800042|NCT00950807|584311002|FG005|Treatment Period 1|Lack of Efficacy|1|||
161800043|NCT00950807|584311003|FG006|Treatment Period 1|Lack of Efficacy|0|||
161800044|NCT00950807|584311004|FG007|Treatment Period 1|Lack of Efficacy|0|||
161800045|NCT00950807|584311005|FG008|Treatment Period 1|Lack of Efficacy|0|||
161800046|NCT00950807|584311006|FG009|Treatment Period 1|Lack of Efficacy|0|||
161800047|NCT00950807|584310997|FG000|Treatment Period 1|Protocol Violation|1|||
161800048|NCT00950807|584310998|FG001|Treatment Period 1|Protocol Violation|0|||
161800049|NCT00950807|584310999|FG002|Treatment Period 1|Protocol Violation|0|||
161800050|NCT00950807|584311000|FG003|Treatment Period 1|Protocol Violation|0|||
161800051|NCT00950807|584311001|FG004|Treatment Period 1|Protocol Violation|0|||
161800052|NCT00950807|584311002|FG005|Treatment Period 1|Protocol Violation|0|||
161800053|NCT00950807|584311003|FG006|Treatment Period 1|Protocol Violation|0|||
161800054|NCT00950807|584311004|FG007|Treatment Period 1|Protocol Violation|0|||
161800055|NCT00950807|584311005|FG008|Treatment Period 1|Protocol Violation|0|||
161800056|NCT00950807|584311006|FG009|Treatment Period 1|Protocol Violation|0|||
161800057|NCT00950807|584310997|FG000|Treatment Period 1|Lost to Follow-up|0|||
161800058|NCT00950807|584310998|FG001|Treatment Period 1|Lost to Follow-up|0|||
161800059|NCT00950807|584310999|FG002|Treatment Period 1|Lost to Follow-up|1|||
161800060|NCT00950807|584311000|FG003|Treatment Period 1|Lost to Follow-up|0|||
161800061|NCT00950807|584311001|FG004|Treatment Period 1|Lost to Follow-up|0|||
161556791|NCT01174550|583428869|FG001|Overall Study|Lost to Follow-up|510|||
161556792|NCT01174550|583428868|FG000|Overall Study|Withdrawal by Subject|543|||
161800062|NCT00950807|584311002|FG005|Treatment Period 1|Lost to Follow-up|0|||
161800063|NCT00950807|584311003|FG006|Treatment Period 1|Lost to Follow-up|0|||
161556793|NCT01174550|583428869|FG001|Overall Study|Withdrawal by Subject|289|||
161800064|NCT00950807|584311004|FG007|Treatment Period 1|Lost to Follow-up|0|||
161800065|NCT00950807|584311005|FG008|Treatment Period 1|Lost to Follow-up|0|||
161800066|NCT00950807|584311006|FG009|Treatment Period 1|Lost to Follow-up|0|||
161800067|NCT00950807|584310997|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161800068|NCT00950807|584310998|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161800069|NCT00950807|584310999|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161800070|NCT00950807|584311000|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161800071|NCT00950807|584311001|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161800072|NCT00950807|584311002|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161800073|NCT00950807|584311003|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161800074|NCT00950807|584311004|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161800075|NCT00950807|584311005|FG008|Treatment Period 1|Withdrawal by Subject|1|||
161800076|NCT00950807|584311006|FG009|Treatment Period 1|Withdrawal by Subject|0|||
161800077|NCT00950807|584310997|FG000|Treatment Period 1|Adverse Event|0|||
161800078|NCT00950807|584310998|FG001|Treatment Period 1|Adverse Event|0|||
161800079|NCT00950807|584310999|FG002|Treatment Period 1|Adverse Event|0|||
161800080|NCT00950807|584311000|FG003|Treatment Period 1|Adverse Event|0|||
161800081|NCT00950807|584311001|FG004|Treatment Period 1|Adverse Event|0|||
161800082|NCT00950807|584311002|FG005|Treatment Period 1|Adverse Event|1|||
161800083|NCT00950807|584311003|FG006|Treatment Period 1|Adverse Event|0|||
161800084|NCT00950807|584311004|FG007|Treatment Period 1|Adverse Event|0|||
161800085|NCT00950807|584311005|FG008|Treatment Period 1|Adverse Event|0|||
161800086|NCT00950807|584311006|FG009|Treatment Period 1|Adverse Event|0|||
161800087|NCT00950807|584310997|FG000|Washout Period 1|Lack of Efficacy|0|||
161800088|NCT00950807|584310998|FG001|Washout Period 1|Lack of Efficacy|0|||
161800089|NCT00950807|584310999|FG002|Washout Period 1|Lack of Efficacy|0|||
161800090|NCT00950807|584311000|FG003|Washout Period 1|Lack of Efficacy|0|||
161800091|NCT00950807|584311001|FG004|Washout Period 1|Lack of Efficacy|0|||
161800092|NCT00950807|584311002|FG005|Washout Period 1|Lack of Efficacy|0|||
161800093|NCT00950807|584311003|FG006|Washout Period 1|Lack of Efficacy|1|||
161800094|NCT00950807|584311004|FG007|Washout Period 1|Lack of Efficacy|0|||
161800095|NCT00950807|584311005|FG008|Washout Period 1|Lack of Efficacy|0|||
161800096|NCT00950807|584311006|FG009|Washout Period 1|Lack of Efficacy|0|||
161800097|NCT00950807|584310997|FG000|Washout Period 1|Withdrawal by Subject|0|||
161800098|NCT00950807|584310998|FG001|Washout Period 1|Withdrawal by Subject|0|||
161800099|NCT00950807|584310999|FG002|Washout Period 1|Withdrawal by Subject|0|||
161800100|NCT00950807|584311000|FG003|Washout Period 1|Withdrawal by Subject|0|||
161800101|NCT00950807|584311001|FG004|Washout Period 1|Withdrawal by Subject|0|||
161800102|NCT00950807|584311002|FG005|Washout Period 1|Withdrawal by Subject|0|||
161800103|NCT00950807|584311003|FG006|Washout Period 1|Withdrawal by Subject|0|||
161800104|NCT00950807|584311004|FG007|Washout Period 1|Withdrawal by Subject|0|||
161800105|NCT00950807|584311005|FG008|Washout Period 1|Withdrawal by Subject|1|||
161800106|NCT00950807|584311006|FG009|Washout Period 1|Withdrawal by Subject|0|||
161800107|NCT00950807|584310997|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
161800108|NCT00950807|584310998|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800109|NCT00950807|584310999|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800110|NCT00950807|584311000|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800111|NCT00950807|584311001|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800112|NCT00950807|584311002|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800113|NCT00950807|584311003|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
161800114|NCT00950807|584311004|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
161800115|NCT00950807|584311005|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800116|NCT00950807|584311006|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800117|NCT00950807|584310997|FG000|Washout Period 1|Adverse Event|2|||
161800118|NCT00950807|584310998|FG001|Washout Period 1|Adverse Event|0|||
161800119|NCT00950807|584310999|FG002|Washout Period 1|Adverse Event|0|||
161800120|NCT00950807|584311000|FG003|Washout Period 1|Adverse Event|1|||
161800121|NCT00950807|584311001|FG004|Washout Period 1|Adverse Event|1|||
161800122|NCT00950807|584311002|FG005|Washout Period 1|Adverse Event|0|||
161800123|NCT00950807|584311003|FG006|Washout Period 1|Adverse Event|0|||
161800124|NCT00950807|584311004|FG007|Washout Period 1|Adverse Event|0|||
161800125|NCT00950807|584311005|FG008|Washout Period 1|Adverse Event|0|||
161800126|NCT00950807|584311006|FG009|Washout Period 1|Adverse Event|0|||
161800127|NCT00950807|584310997|FG000|Treatment Period 2|Lack of Efficacy|1|||
161800128|NCT00950807|584310998|FG001|Treatment Period 2|Lack of Efficacy|0|||
161800129|NCT00950807|584310999|FG002|Treatment Period 2|Lack of Efficacy|0|||
161800130|NCT00950807|584311000|FG003|Treatment Period 2|Lack of Efficacy|0|||
161800131|NCT00950807|584311001|FG004|Treatment Period 2|Lack of Efficacy|0|||
161904101|NCT01747499|584697038|FG001|Overall Study|Determined not to be eligible|0|||
161904102|NCT01747499|584697039|FG002|Overall Study|Determined not to be eligible|0|||
161800132|NCT00950807|584311002|FG005|Treatment Period 2|Lack of Efficacy|0|||
161800133|NCT00950807|584311003|FG006|Treatment Period 2|Lack of Efficacy|0|||
161800134|NCT00950807|584311004|FG007|Treatment Period 2|Lack of Efficacy|0|||
161800135|NCT00950807|584311005|FG008|Treatment Period 2|Lack of Efficacy|0|||
161800136|NCT00950807|584311006|FG009|Treatment Period 2|Lack of Efficacy|0|||
161800137|NCT00950807|584310997|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161904103|NCT01747499|584697040|FG003|Overall Study|Determined not to be eligible|0|||
161904104|NCT01747499|584697041|FG004|Overall Study|Determined not to be eligible|1|||
161904105|NCT01676701|584697042|FG000|Overall Study|Protocol Violation|1|||
161904106|NCT01676701|584697043|FG001|Overall Study|Protocol Violation|0|||
161904107|NCT01676701|584697042|FG000|Overall Study|Sponsor Decision|3|||
161904108|NCT01676701|584697043|FG001|Overall Study|Sponsor Decision|4|||
161904109|NCT00196105|584697044|FG000|Overall Study|Lost to Follow-up|4|||
161904110|NCT00196105|584697045|FG001|Overall Study|Lost to Follow-up|5|||
161904111|NCT00196105|584697046|FG002|Overall Study|Lost to Follow-up|7|||
161904112|NCT04058028|584697050|FG000|Overall Study|Withdrawal of Consent from Study|12|||
161904113|NCT04058028|584697051|FG001|Overall Study|Withdrawal of Consent from Study|8|||
161904114|NCT04058028|584697052|FG002|Overall Study|Withdrawal of Consent from Study|6|||
161904115|NCT04058028|584697053|FG003|Overall Study|Withdrawal of Consent from Study|7|||
161904116|NCT04058028|584697050|FG000|Overall Study|Decision by Sponsor|13|||
161904117|NCT04058028|584697051|FG001|Overall Study|Decision by Sponsor|4|||
161904118|NCT04058028|584697052|FG002|Overall Study|Decision by Sponsor|1|||
161904119|NCT04058028|584697053|FG003|Overall Study|Decision by Sponsor|35|||
161904120|NCT04058028|584697050|FG000|Overall Study|Lost to Follow-up|1|||
161904121|NCT04058028|584697051|FG001|Overall Study|Lost to Follow-up|1|||
161904122|NCT04058028|584697052|FG002|Overall Study|Lost to Follow-up|1|||
161904123|NCT04058028|584697053|FG003|Overall Study|Lost to Follow-up|0|||
161904124|NCT04058028|584697050|FG000|Overall Study|Death|0|||
161904125|NCT04058028|584697051|FG001|Overall Study|Death|1|||
161904126|NCT04058028|584697052|FG002|Overall Study|Death|0|||
161904127|NCT04058028|584697053|FG003|Overall Study|Death|0|||
161904128|NCT02227784|584697054|FG000|Double-Blind Phase|Adverse Event|3|||
161904129|NCT02227784|584697055|FG001|Double-Blind Phase|Adverse Event|2|||
161904130|NCT02227784|584697056|FG002|Double-Blind Phase|Adverse Event|1|||
161904131|NCT02227784|584697057|FG003|Double-Blind Phase|Adverse Event|3|||
161904132|NCT02227784|584697058|FG004|Double-Blind Phase|Adverse Event|0|||
161904133|NCT02227784|584697054|FG000|Double-Blind Phase|Physician Decision|1|||
161904134|NCT02227784|584697055|FG001|Double-Blind Phase|Physician Decision|0|||
161904135|NCT02227784|584697056|FG002|Double-Blind Phase|Physician Decision|0|||
161904136|NCT02227784|584697057|FG003|Double-Blind Phase|Physician Decision|1|||
161904137|NCT02227784|584697058|FG004|Double-Blind Phase|Physician Decision|0|||
161904138|NCT02227784|584697054|FG000|Double-Blind Phase|Protocol Violation|0|||
161904139|NCT02227784|584697055|FG001|Double-Blind Phase|Protocol Violation|0|||
161904140|NCT02227784|584697056|FG002|Double-Blind Phase|Protocol Violation|1|||
161904141|NCT02227784|584697057|FG003|Double-Blind Phase|Protocol Violation|1|||
161904142|NCT02227784|584697058|FG004|Double-Blind Phase|Protocol Violation|0|||
161904143|NCT02227784|584697054|FG000|Double-Blind Phase|Sponsor Decision|34|||
161904144|NCT02227784|584697055|FG001|Double-Blind Phase|Sponsor Decision|15|||
161904145|NCT02227784|584697056|FG002|Double-Blind Phase|Sponsor Decision|14|||
161556794|NCT01536262|583428870|FG000|Overall Study|Adverse Event|6|||
161556795|NCT01536262|583428871|FG001|Overall Study|Adverse Event|1|||
161556796|NCT01536262|583428872|FG002|Overall Study|Adverse Event|2|||
161556797|NCT01536262|583428870|FG000|Overall Study|Withdrawal by Subject|1|||
161556798|NCT01536262|583428871|FG001|Overall Study|Withdrawal by Subject|1|||
161556799|NCT01536262|583428872|FG002|Overall Study|Withdrawal by Subject|0|||
161556800|NCT01536262|583428870|FG000|Overall Study|Other than stated above|1|||
161556801|NCT01536262|583428871|FG001|Overall Study|Other than stated above|0|||
161556802|NCT01536262|583428872|FG002|Overall Study|Other than stated above|0|||
161556803|NCT01460381|583428876|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
161556804|NCT01460381|583428877|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
161556805|NCT01097655|583428878|FG000|Overall Study|Withdrawal by Subject|1|||
161556806|NCT01097655|583428878|FG000|Overall Study|Subject Documented Twice|1|||
161556807|NCT01097655|583428878|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
161556808|NCT01033643|583428879|FG000|Overall Study|Withdrew Consent|0|||
161556809|NCT01033643|583428880|FG001|Overall Study|Withdrew Consent|3|||
161556810|NCT01033643|583428881|FG002|Overall Study|Withdrew Consent|0|||
161556811|NCT01033643|583428882|FG003|Overall Study|Withdrew Consent|0|||
161556812|NCT01033643|583428883|FG004|Overall Study|Withdrew Consent|0|||
161556813|NCT01033643|583428884|FG005|Overall Study|Withdrew Consent|1|||
161556814|NCT03527277|583428885|FG000|Overall Study|Withdrawal by Subject|5|||
161556815|NCT03527277|583428886|FG001|Overall Study|Withdrawal by Subject|0|||
161556816|NCT03527277|583428885|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
161904146|NCT02227784|584697057|FG003|Double-Blind Phase|Sponsor Decision|32|||
161904147|NCT02227784|584697058|FG004|Double-Blind Phase|Sponsor Decision|0|||
161904148|NCT02227784|584697054|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161904149|NCT02227784|584697055|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
161904150|NCT02227784|584697056|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
161904151|NCT02227784|584697057|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
161904152|NCT02227784|584697058|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161556817|NCT03527277|583428886|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
161556818|NCT03527277|583428885|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
161556819|NCT03527277|583428886|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
161556820|NCT01781611|583428887|FG000|Overall Study|Adverse Event|4|||
161556821|NCT01781611|583428888|FG001|Overall Study|Adverse Event|0|||
161556822|NCT02652130|583428889|FG000|Overall Study|Death|1|||
161556823|NCT00354029|583428890|FG000|Overall Study|Protocol Violation|4|||
161556824|NCT00354029|583428891|FG001|Overall Study|Protocol Violation|2|||
161904153|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904154|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904155|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904156|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904157|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
161904158|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Death|0|||
161904159|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Death|0|||
161904160|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Death|0|||
161904161|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Death|0|||
161904162|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Death|1|||
161904163|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904164|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904165|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904166|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904167|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
161904168|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904169|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904170|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904171|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904172|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
161904173|NCT00248651|584697059|FG000|Overall Study|Withdrawal by Subject|28|||
161904174|NCT00248651|584697060|FG001|Overall Study|Withdrawal by Subject|40|||
161904175|NCT00248651|584697061|FG002|Overall Study|Withdrawal by Subject|32|||
161904176|NCT00828113|584697064|FG000|Overall Study|Withdrawal by Subject|27|||
161904177|NCT00828113|584697065|FG001|Overall Study|Withdrawal by Subject|26|||
161904178|NCT00828113|584697064|FG000|Overall Study|Lost to Follow-up|3|||
161904179|NCT00828113|584697065|FG001|Overall Study|Lost to Follow-up|5|||
161904180|NCT01365130|584697066|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
161904181|NCT05607576|584697068|FG000|Overall Study|immediate sensor error|2|||
161904182|NCT05607576|584697068|FG000|Overall Study|Physician Decision|2|||
161904183|NCT05616013|584697069|FG000|Overall Study|Adverse Event|6|||
161904184|NCT05616013|584697070|FG001|Overall Study|Adverse Event|12|||
161904185|NCT05616013|584697071|FG002|Overall Study|Adverse Event|8|||
161904186|NCT05616013|584697072|FG003|Overall Study|Adverse Event|4|||
161904187|NCT05616013|584697073|FG004|Overall Study|Adverse Event|6|||
161904188|NCT05616013|584697074|FG005|Overall Study|Adverse Event|8|||
161904189|NCT05616013|584697075|FG006|Overall Study|Adverse Event|3|||
161904190|NCT05616013|584697076|FG007|Overall Study|Adverse Event|6|||
161904191|NCT05616013|584697077|FG008|Overall Study|Adverse Event|1|||
161904192|NCT05616013|584697069|FG000|Overall Study|Lost to Follow-up|5|||
161904193|NCT05616013|584697070|FG001|Overall Study|Lost to Follow-up|4|||
161904194|NCT05616013|584697071|FG002|Overall Study|Lost to Follow-up|3|||
161904195|NCT05616013|584697072|FG003|Overall Study|Lost to Follow-up|2|||
161904196|NCT05616013|584697073|FG004|Overall Study|Lost to Follow-up|0|||
161904197|NCT05616013|584697074|FG005|Overall Study|Lost to Follow-up|5|||
161904198|NCT05616013|584697075|FG006|Overall Study|Lost to Follow-up|2|||
161904199|NCT05616013|584697076|FG007|Overall Study|Lost to Follow-up|1|||
161904200|NCT05616013|584697077|FG008|Overall Study|Lost to Follow-up|2|||
161904201|NCT05616013|584697069|FG000|Overall Study|Non-compliance with study requirements|2|||
161904202|NCT05616013|584697070|FG001|Overall Study|Non-compliance with study requirements|2|||
161904203|NCT05616013|584697071|FG002|Overall Study|Non-compliance with study requirements|2|||
161904204|NCT05616013|584697072|FG003|Overall Study|Non-compliance with study requirements|3|||
161904205|NCT05616013|584697073|FG004|Overall Study|Non-compliance with study requirements|0|||
161904206|NCT05616013|584697074|FG005|Overall Study|Non-compliance with study requirements|2|||
161904207|NCT05616013|584697075|FG006|Overall Study|Non-compliance with study requirements|1|||
161904208|NCT05616013|584697076|FG007|Overall Study|Non-compliance with study requirements|1|||
161904209|NCT05616013|584697077|FG008|Overall Study|Non-compliance with study requirements|4|||
161904210|NCT05616013|584697069|FG000|Overall Study|Withdrawal by Subject|11|||
161904211|NCT05616013|584697070|FG001|Overall Study|Withdrawal by Subject|9|||
161904212|NCT05616013|584697071|FG002|Overall Study|Withdrawal by Subject|8|||
161904213|NCT05616013|584697072|FG003|Overall Study|Withdrawal by Subject|6|||
161904214|NCT05616013|584697073|FG004|Overall Study|Withdrawal by Subject|3|||
161904215|NCT05616013|584697074|FG005|Overall Study|Withdrawal by Subject|4|||
161904216|NCT05616013|584697075|FG006|Overall Study|Withdrawal by Subject|6|||
161904217|NCT05616013|584697076|FG007|Overall Study|Withdrawal by Subject|5|||
161904218|NCT05616013|584697077|FG008|Overall Study|Withdrawal by Subject|4|||
161904219|NCT05616013|584697069|FG000|Overall Study|Physician Decision|0|||
161556825|NCT01021332|583428892|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
161800138|NCT00950807|584310998|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161800139|NCT00950807|584310999|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161800140|NCT00950807|584311000|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161800141|NCT00950807|584311001|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161800142|NCT00950807|584311002|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161800143|NCT00950807|584311003|FG006|Treatment Period 2|Withdrawal by Subject|1|||
161800144|NCT00950807|584311004|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161800145|NCT00950807|584311005|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161800146|NCT00950807|584311006|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161800147|NCT00950807|584310997|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
161800148|NCT00950807|584310998|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800149|NCT00950807|584310999|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800150|NCT00950807|584311000|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800151|NCT00950807|584311001|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800152|NCT00950807|584311002|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800153|NCT00950807|584311003|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800154|NCT00950807|584311004|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800155|NCT00950807|584311005|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800156|NCT00950807|584311006|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800157|NCT00950807|584310997|FG000|Treatment Period 2|Adverse Event|0|||
161800158|NCT00950807|584310998|FG001|Treatment Period 2|Adverse Event|1|||
161800159|NCT00950807|584310999|FG002|Treatment Period 2|Adverse Event|0|||
161800160|NCT00950807|584311000|FG003|Treatment Period 2|Adverse Event|1|||
161800161|NCT00950807|584311001|FG004|Treatment Period 2|Adverse Event|0|||
161800162|NCT00950807|584311002|FG005|Treatment Period 2|Adverse Event|1|||
161800163|NCT00950807|584311003|FG006|Treatment Period 2|Adverse Event|0|||
161800164|NCT00950807|584311004|FG007|Treatment Period 2|Adverse Event|1|||
161800165|NCT00950807|584311005|FG008|Treatment Period 2|Adverse Event|0|||
161800166|NCT00950807|584311006|FG009|Treatment Period 2|Adverse Event|0|||
161800167|NCT00950807|584310997|FG000|Washout Period 2|Lack of Efficacy|1|||
161800168|NCT00950807|584310998|FG001|Washout Period 2|Lack of Efficacy|0|||
161800169|NCT00950807|584310999|FG002|Washout Period 2|Lack of Efficacy|0|||
161800170|NCT00950807|584311000|FG003|Washout Period 2|Lack of Efficacy|0|||
161800171|NCT00950807|584311001|FG004|Washout Period 2|Lack of Efficacy|0|||
161800172|NCT00950807|584311002|FG005|Washout Period 2|Lack of Efficacy|0|||
161800173|NCT00950807|584311003|FG006|Washout Period 2|Lack of Efficacy|0|||
161800174|NCT00950807|584311004|FG007|Washout Period 2|Lack of Efficacy|0|||
161800175|NCT00950807|584311005|FG008|Washout Period 2|Lack of Efficacy|0|||
161800176|NCT00950807|584311006|FG009|Washout Period 2|Lack of Efficacy|0|||
161800177|NCT00950807|584310997|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800178|NCT00950807|584310998|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800179|NCT00950807|584310999|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800180|NCT00950807|584311000|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800181|NCT00950807|584311001|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800182|NCT00950807|584311002|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800183|NCT00950807|584311003|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800184|NCT00950807|584311004|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800185|NCT00950807|584311005|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800186|NCT00950807|584311006|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800187|NCT00950807|584310997|FG000|Washout Period 2|Adverse Event|3|||
161800188|NCT00950807|584310998|FG001|Washout Period 2|Adverse Event|0|||
161800189|NCT00950807|584310999|FG002|Washout Period 2|Adverse Event|0|||
161800190|NCT00950807|584311000|FG003|Washout Period 2|Adverse Event|1|||
161800191|NCT00950807|584311001|FG004|Washout Period 2|Adverse Event|0|||
161800192|NCT00950807|584311002|FG005|Washout Period 2|Adverse Event|0|||
161800193|NCT00950807|584311003|FG006|Washout Period 2|Adverse Event|0|||
161800194|NCT00950807|584311004|FG007|Washout Period 2|Adverse Event|0|||
161800195|NCT00950807|584311005|FG008|Washout Period 2|Adverse Event|0|||
161800196|NCT00950807|584311006|FG009|Washout Period 2|Adverse Event|0|||
161800197|NCT00950807|584310997|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161800198|NCT00950807|584310998|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161800199|NCT00950807|584310999|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161451467|NCT00913458|583050621|FG006|Phase 1|Subject Request|0|||
161800200|NCT00950807|584311000|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161800201|NCT00950807|584311001|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161800202|NCT00950807|584311002|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161800203|NCT00950807|584311003|FG006|Treatment Period 3|Withdrawal by Subject|0|||
161800204|NCT00950807|584311004|FG007|Treatment Period 3|Withdrawal by Subject|0|||
161800205|NCT00950807|584311005|FG008|Treatment Period 3|Withdrawal by Subject|0|||
161800206|NCT00950807|584311006|FG009|Treatment Period 3|Withdrawal by Subject|1|||
161800207|NCT00950807|584310997|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161800208|NCT00950807|584310998|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800209|NCT00950807|584310999|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800210|NCT00950807|584311000|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161556826|NCT01021332|583428892|FG000|Overall Study|Adverse Event|43|||
161556827|NCT01021332|583428892|FG000|Overall Study|Lack of Efficacy|19|||
161556828|NCT01021332|583428892|FG000|Overall Study|Withdrawal of Consent|23|||
161556829|NCT01021332|583428892|FG000|Overall Study|Lost to Follow-up|4|||
161556830|NCT01021332|583428892|FG000|Overall Study|Protocol Violation|9|||
161556831|NCT01021332|583428892|FG000|Overall Study|Miscellaneous|3|||
161556832|NCT00826280|583428893|FG000|Overall Study|Randomized but drug not received|1|||
161800211|NCT00950807|584311001|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800212|NCT00950807|584311002|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800213|NCT00950807|584311003|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800214|NCT00950807|584311004|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161800215|NCT00950807|584311005|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800216|NCT00950807|584311006|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800217|NCT00950807|584310997|FG000|Treatment Period 3|Adverse Event|0|||
161800218|NCT00950807|584310998|FG001|Treatment Period 3|Adverse Event|0|||
161800219|NCT00950807|584310999|FG002|Treatment Period 3|Adverse Event|0|||
161800220|NCT00950807|584311000|FG003|Treatment Period 3|Adverse Event|0|||
161800221|NCT00950807|584311001|FG004|Treatment Period 3|Adverse Event|0|||
161800222|NCT00950807|584311002|FG005|Treatment Period 3|Adverse Event|0|||
161800223|NCT00950807|584311003|FG006|Treatment Period 3|Adverse Event|1|||
161800224|NCT00950807|584311004|FG007|Treatment Period 3|Adverse Event|0|||
161800225|NCT00950807|584311005|FG008|Treatment Period 3|Adverse Event|0|||
161800226|NCT00950807|584311006|FG009|Treatment Period 3|Adverse Event|0|||
161800227|NCT00337077|584311007|FG000|Overall Study|Progressive disease|25|||
161800228|NCT00337077|584311008|FG001|Overall Study|Progressive disease|37|||
161800229|NCT00337077|584311009|FG002|Overall Study|Progressive disease|19|||
161800230|NCT00337077|584311007|FG000|Overall Study|Adverse Event|7|||
161800231|NCT00337077|584311008|FG001|Overall Study|Adverse Event|7|||
161800232|NCT00337077|584311009|FG002|Overall Study|Adverse Event|1|||
161800233|NCT00337077|584311007|FG000|Overall Study|Death|0|||
161800234|NCT00337077|584311008|FG001|Overall Study|Death|1|||
161800235|NCT00337077|584311009|FG002|Overall Study|Death|0|||
161800236|NCT00337077|584311007|FG000|Overall Study|Withdrawal by Subject|7|||
161800237|NCT00337077|584311008|FG001|Overall Study|Withdrawal by Subject|2|||
161800238|NCT00337077|584311009|FG002|Overall Study|Withdrawal by Subject|2|||
161800239|NCT00337077|584311007|FG000|Overall Study|Alternative therapy|1|||
161800240|NCT00337077|584311008|FG001|Overall Study|Alternative therapy|0|||
161800241|NCT00337077|584311009|FG002|Overall Study|Alternative therapy|0|||
161800242|NCT00337077|584311007|FG000|Overall Study|Physician Decision|1|||
161800243|NCT00337077|584311008|FG001|Overall Study|Physician Decision|4|||
161800244|NCT00337077|584311009|FG002|Overall Study|Physician Decision|2|||
161800245|NCT00337077|584311007|FG000|Overall Study|Never started treatment|1|||
161800246|NCT00337077|584311008|FG001|Overall Study|Never started treatment|1|||
161800247|NCT00337077|584311009|FG002|Overall Study|Never started treatment|0|||
161800248|NCT00337077|584311007|FG000|Overall Study|Ineligible|1|||
161800249|NCT00337077|584311008|FG001|Overall Study|Ineligible|1|||
161800250|NCT00337077|584311009|FG002|Overall Study|Ineligible|1|||
161800251|NCT01492400|584311013|FG000|Overall Study|Miscellaneous Reasons|2|||
161800252|NCT01492400|584311014|FG001|Overall Study|Miscellaneous Reasons|3|||
161800253|NCT01492400|584311013|FG000|Overall Study|Personal Reasons|0|||
161800254|NCT01492400|584311014|FG001|Overall Study|Personal Reasons|5|||
161800255|NCT01492400|584311013|FG000|Overall Study|Lost to Follow-up|3|||
161800256|NCT01492400|584311014|FG001|Overall Study|Lost to Follow-up|1|||
161800257|NCT01492400|584311013|FG000|Overall Study|Pregnancy|0|||
161800258|NCT01492400|584311014|FG001|Overall Study|Pregnancy|1|||
161800259|NCT01492400|584311013|FG000|Overall Study|Lack of Efficacy|1|||
161800260|NCT01492400|584311014|FG001|Overall Study|Lack of Efficacy|1|||
161800261|NCT01492400|584311013|FG000|Overall Study|Adverse Event|10|||
161800262|NCT01492400|584311014|FG001|Overall Study|Adverse Event|5|||
161800263|NCT00659607|584311015|FG000|Overall Study|No blood pressure recorded|147|||
161800264|NCT00659607|584311015|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
161800265|NCT00659607|584311015|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
161800266|NCT00659607|584311015|FG000|Overall Study|No recorded efficacy data|15|||
161800267|NCT00659607|584311015|FG000|Overall Study|Inconsistent BP measuring date|2|||
161800268|NCT02568384|584311021|FG000|Overall Study|Mobile devices incompatible with App|2|||
161800269|NCT03184441|584311022|FG000|Overall Study|Withdrawal by Subject|1|||
161800270|NCT00264810|584311023|FG000|Baseline|Withdrawal by Subject|10|||
161800271|NCT00264810|584311024|FG001|Baseline|Withdrawal by Subject|10|||
161800272|NCT00264810|584311023|FG000|Baseline|Physician Decision|7|||
161800273|NCT00264810|584311024|FG001|Baseline|Physician Decision|8|||
161800274|NCT00264810|584311023|FG000|Baseline|Subject Compliance Failure|3|||
161800275|NCT00264810|584311024|FG001|Baseline|Subject Compliance Failure|3|||
161800276|NCT00264810|584311023|FG000|Baseline|Insufficient Seizure Frequency|2|||
161800277|NCT00264810|584311024|FG001|Baseline|Insufficient Seizure Frequency|2|||
161556833|NCT00826280|583428894|FG001|Overall Study|Randomized but drug not received|0|||
161800278|NCT00264810|584311023|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
161800279|NCT00264810|584311024|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
161800280|NCT00264810|584311023|FG000|Baseline|Other|0|||
161904220|NCT05616013|584697070|FG001|Overall Study|Physician Decision|0|||
161904221|NCT05616013|584697071|FG002|Overall Study|Physician Decision|1|||
161904222|NCT05616013|584697072|FG003|Overall Study|Physician Decision|0|||
161904223|NCT05616013|584697073|FG004|Overall Study|Physician Decision|0|||
161904224|NCT05616013|584697074|FG005|Overall Study|Physician Decision|1|||
161904225|NCT05616013|584697075|FG006|Overall Study|Physician Decision|3|||
161904226|NCT05616013|584697076|FG007|Overall Study|Physician Decision|0|||
161904227|NCT05616013|584697077|FG008|Overall Study|Physician Decision|0|||
161904228|NCT05616013|584697069|FG000|Overall Study|Protocol Violation|0|||
161904229|NCT05616013|584697070|FG001|Overall Study|Protocol Violation|0|||
161904230|NCT05616013|584697071|FG002|Overall Study|Protocol Violation|0|||
161904231|NCT05616013|584697072|FG003|Overall Study|Protocol Violation|0|||
161904232|NCT05616013|584697073|FG004|Overall Study|Protocol Violation|0|||
161800281|NCT00264810|584311024|FG001|Baseline|Other|1|||
161800282|NCT00264810|584311023|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
161800283|NCT00264810|584311024|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
161800284|NCT00264810|584311023|FG000|Stimulation Optimization Period|Death|0|||
161800285|NCT00264810|584311024|FG001|Stimulation Optimization Period|Death|1|||
161800286|NCT00264810|584311023|FG000|Blinded Evaluation Period|Explant due to infection|1|||
161800287|NCT00264810|584311024|FG001|Blinded Evaluation Period|Explant due to infection|1|||
161800288|NCT00264810|584311023|FG000|Open Label Evaluation Period|Explant due to infection|1|||
161800289|NCT00264810|584311024|FG001|Open Label Evaluation Period|Explant due to infection|1|||
161800290|NCT00264810|584311023|FG000|Open Label Evaluation Period|Death|3|||
161800291|NCT00264810|584311024|FG001|Open Label Evaluation Period|Death|2|||
161800292|NCT00264810|584311023|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
161800293|NCT00264810|584311024|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
161800294|NCT02994056|584311025|FG000|Overall Study|Death|8|||
161800295|NCT02994056|584311025|FG000|Overall Study|Withdrew Consent|1|||
161800296|NCT02199509|584311028|FG000|Overall Study|Suicidal Ideation|0|||
161800297|NCT02199509|584311029|FG001|Overall Study|Suicidal Ideation|1|||
161800298|NCT02199509|584311028|FG000|Overall Study|Misunderstood titration schedule|1|||
161800299|NCT02199509|584311029|FG001|Overall Study|Misunderstood titration schedule|0|||
161800300|NCT01346410|584311031|FG000|Overall Study|Death|1|||
161800301|NCT00979628|584311032|FG000|Overall Study|received regimen < 24 hours|7|||
161800302|NCT00979628|584311033|FG001|Overall Study|received regimen < 24 hours|6|||
161800303|NCT00979628|584311034|FG002|Overall Study|received regimen < 24 hours|5|||
161800304|NCT00979628|584311032|FG000|Overall Study|received steroids|1|||
161800305|NCT00979628|584311033|FG001|Overall Study|received steroids|1|||
161800306|NCT00979628|584311034|FG002|Overall Study|received steroids|0|||
161800307|NCT00979628|584311032|FG000|Overall Study|transferred to ICU|1|||
161800308|NCT00979628|584311033|FG001|Overall Study|transferred to ICU|2|||
161800309|NCT00979628|584311034|FG002|Overall Study|transferred to ICU|1|||
161800310|NCT05905783|584311035|FG000|Overall Study|Lost to Follow-up|12|||
161800311|NCT05905783|584311036|FG001|Overall Study|Lost to Follow-up|18|||
161800312|NCT05905783|584311035|FG000|Overall Study|Withdrawal by Subject|29|||
161800313|NCT05905783|584311036|FG001|Overall Study|Withdrawal by Subject|37|||
161800314|NCT05905783|584311035|FG000|Overall Study|Decision by sponsor|69|||
161800315|NCT05905783|584311036|FG001|Overall Study|Decision by sponsor|65|||
161800316|NCT00911859|584311037|FG000|Treatment Period|Adverse Event|3|||
161800317|NCT00911859|584311038|FG001|Treatment Period|Adverse Event|3|||
161800318|NCT00911859|584311039|FG002|Treatment Period|Adverse Event|7|||
161800319|NCT00911859|584311037|FG000|Treatment Period|Death|1|||
161800320|NCT00911859|584311038|FG001|Treatment Period|Death|3|||
161800321|NCT00911859|584311039|FG002|Treatment Period|Death|5|||
161800322|NCT00911859|584311037|FG000|Treatment Period|Lack of Efficacy|1|||
161800323|NCT00911859|584311038|FG001|Treatment Period|Lack of Efficacy|7|||
161800324|NCT00911859|584311039|FG002|Treatment Period|Lack of Efficacy|5|||
161800325|NCT00911859|584311037|FG000|Treatment Period|Physician Decision|3|||
161800326|NCT00911859|584311038|FG001|Treatment Period|Physician Decision|3|||
161800327|NCT00911859|584311039|FG002|Treatment Period|Physician Decision|3|||
161800328|NCT00911859|584311037|FG000|Treatment Period|Withdrawal by Subject|0|||
161800329|NCT00911859|584311038|FG001|Treatment Period|Withdrawal by Subject|4|||
161800330|NCT00911859|584311039|FG002|Treatment Period|Withdrawal by Subject|5|||
161800331|NCT00911859|584311037|FG000|Treatment Period|Did not receive study treatment|0|||
161800332|NCT00911859|584311038|FG001|Treatment Period|Did not receive study treatment|1|||
161800333|NCT00911859|584311039|FG002|Treatment Period|Did not receive study treatment|0|||
161800334|NCT00911859|584311037|FG000|Maintainance Period|Lack of Efficacy|0|||
161800335|NCT00911859|584311038|FG001|Maintainance Period|Lack of Efficacy|0|||
161800336|NCT00911859|584311039|FG002|Maintainance Period|Lack of Efficacy|9|||
161800337|NCT00911859|584311037|FG000|Maintainance Period|Physician Decision|0|||
161800338|NCT00911859|584311038|FG001|Maintainance Period|Physician Decision|0|||
161800339|NCT00911859|584311039|FG002|Maintainance Period|Physician Decision|9|||
161800340|NCT00911859|584311037|FG000|Maintainance Period|Withdrawal by Subject|0|||
161904233|NCT05616013|584697074|FG005|Overall Study|Protocol Violation|0|||
161904234|NCT05616013|584697075|FG006|Overall Study|Protocol Violation|1|||
161904235|NCT05616013|584697076|FG007|Overall Study|Protocol Violation|0|||
161904236|NCT05616013|584697077|FG008|Overall Study|Protocol Violation|2|||
161556834|NCT00826280|583428895|FG002|Overall Study|Randomized but drug not received|1|||
161556835|NCT00826280|583428893|FG000|Overall Study|Adverse Event|1|||
161556836|NCT00826280|583428894|FG001|Overall Study|Adverse Event|3|||
161556837|NCT00826280|583428895|FG002|Overall Study|Adverse Event|0|||
161800341|NCT00911859|584311038|FG001|Maintainance Period|Withdrawal by Subject|0|||
161800342|NCT00911859|584311039|FG002|Maintainance Period|Withdrawal by Subject|3|||
161800343|NCT00911859|584311037|FG000|Follow-up Period|Death|5|||
161800344|NCT00911859|584311038|FG001|Follow-up Period|Death|8|||
161800345|NCT00911859|584311039|FG002|Follow-up Period|Death|10|||
161800346|NCT00911859|584311037|FG000|Follow-up Period|Lost to Follow-up|1|||
161800347|NCT00911859|584311038|FG001|Follow-up Period|Lost to Follow-up|1|||
161800348|NCT00911859|584311039|FG002|Follow-up Period|Lost to Follow-up|0|||
161800349|NCT00911859|584311037|FG000|Follow-up Period|Withdrawal by Subject|0|||
161800350|NCT00911859|584311038|FG001|Follow-up Period|Withdrawal by Subject|4|||
161800351|NCT00911859|584311039|FG002|Follow-up Period|Withdrawal by Subject|4|||
161800352|NCT00911859|584311037|FG000|Follow-up Period|Study terminated by sponsor|5|||
161800353|NCT00911859|584311038|FG001|Follow-up Period|Study terminated by sponsor|33|||
161800354|NCT00911859|584311039|FG002|Follow-up Period|Study terminated by sponsor|27|||
161800355|NCT03008460|584311044|FG000|Overall Study|Protocol deviation|0|||
161800356|NCT03008460|584311045|FG001|Overall Study|Protocol deviation|2|||
161800357|NCT03008460|584311044|FG000|Overall Study|Study drug not dispensed|0|||
161800358|NCT03008460|584311045|FG001|Overall Study|Study drug not dispensed|1|||
161800359|NCT03008460|584311044|FG000|Overall Study|Adverse Event|0|||
161800360|NCT03008460|584311045|FG001|Overall Study|Adverse Event|1|||
161800361|NCT03008460|584311044|FG000|Overall Study|Withdrawal by Subject|5|||
161800362|NCT03008460|584311045|FG001|Overall Study|Withdrawal by Subject|6|||
161800363|NCT03008460|584311044|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
161800364|NCT03008460|584311045|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
161800365|NCT03008460|584311044|FG000|Overall Study|End of study visit outside permitted time window|0|||
161800366|NCT03008460|584311045|FG001|Overall Study|End of study visit outside permitted time window|1|||
161800367|NCT03008460|584311044|FG000|Overall Study|Lost to Follow-up|1|||
161800368|NCT03008460|584311045|FG001|Overall Study|Lost to Follow-up|3|||
161800369|NCT00634179|584311049|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
161800370|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800371|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800372|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800373|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
161800374|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800375|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800376|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800377|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800378|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
161800379|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800380|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800381|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800382|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
161800383|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
161800384|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
161800385|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
161800386|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
161800387|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
161800388|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
161800389|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
161800390|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
161800391|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
161800392|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
161800393|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
161800394|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
161800395|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800396|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800397|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800398|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800399|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800400|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800401|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800402|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
161800403|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800404|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161556838|NCT00826280|583428893|FG000|Overall Study|Lost to Follow-up|0|||
161556839|NCT00826280|583428894|FG001|Overall Study|Lost to Follow-up|1|||
161556840|NCT00826280|583428895|FG002|Overall Study|Lost to Follow-up|0|||
161556841|NCT00826280|583428893|FG000|Overall Study|Sponsor discontinued subject or study|1|||
161556842|NCT00826280|583428894|FG001|Overall Study|Sponsor discontinued subject or study|0|||
161556843|NCT00826280|583428895|FG002|Overall Study|Sponsor discontinued subject or study|0|||
161556844|NCT00826280|583428893|FG000|Overall Study|Reversible ischemic defect not present|43|||
161556845|NCT00826280|583428894|FG001|Overall Study|Reversible ischemic defect not present|40|||
161556846|NCT00826280|583428895|FG002|Overall Study|Reversible ischemic defect not present|44|||
161556847|NCT00826280|583428893|FG000|Overall Study|Interpretation Failure|1|||
161556848|NCT00826280|583428894|FG001|Overall Study|Interpretation Failure|0|||
161556849|NCT00826280|583428895|FG002|Overall Study|Interpretation Failure|0|||
161556850|NCT00826280|583428893|FG000|Overall Study|Machine Failure|1|||
161556851|NCT00826280|583428894|FG001|Overall Study|Machine Failure|1|||
161556852|NCT00826280|583428895|FG002|Overall Study|Machine Failure|0|||
161556853|NCT00826280|583428893|FG000|Overall Study|One or more non-interpretable scan|0|||
161556854|NCT00826280|583428894|FG001|Overall Study|One or more non-interpretable scan|1|||
161556855|NCT00826280|583428895|FG002|Overall Study|One or more non-interpretable scan|1|||
161556856|NCT00839917|583428899|FG000|Overall Study|Lost to Follow-up|1|||
161556857|NCT00839917|583428900|FG001|Overall Study|Lost to Follow-up|0|||
161800405|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800406|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800407|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
161800408|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800409|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800410|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800411|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
161800412|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800413|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800414|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
161800415|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800416|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800417|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800418|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
161800419|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
161800420|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
161800421|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
161800422|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
161800423|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
161800424|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
161800425|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
161800426|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
161800427|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
161800428|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
161800429|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
161800430|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161800431|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
161800432|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
161800433|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161800434|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
161800435|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161800436|NCT00767325|584311056|FG000|Overall Study|Lack of Efficacy|2|||
161800437|NCT00767325|584311056|FG000|Overall Study|Adverse Event|7|||
161800438|NCT00767325|584311056|FG000|Overall Study|Lost to Follow-up|3|||
161800439|NCT00767325|584311056|FG000|Overall Study|No longer met study criteria|2|||
161800440|NCT00767325|584311056|FG000|Overall Study|Missed visit due to family reasons|1|||
161800441|NCT03538756|584311057|FG000|Long-Term Follow-up|Adverse Event|0|||
161800442|NCT03538756|584311058|FG001|Long-Term Follow-up|Adverse Event|0|||
161800443|NCT03538756|584311059|FG002|Long-Term Follow-up|Adverse Event|6|||
161800444|NCT03538756|584311057|FG000|Long-Term Follow-up|Death|0|||
161800445|NCT03538756|584311058|FG001|Long-Term Follow-up|Death|0|||
161800446|NCT03538756|584311059|FG002|Long-Term Follow-up|Death|1|||
161800447|NCT03538756|584311057|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
161800448|NCT03538756|584311058|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
161800449|NCT03538756|584311059|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
161800450|NCT03538756|584311057|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
161800451|NCT03538756|584311058|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
161556858|NCT00839917|583428899|FG000|Overall Study|Did not receive vaccine|0|||
161556859|NCT00839917|583428900|FG001|Overall Study|Did not receive vaccine|1|||
161556860|NCT04466618|583428913|FG000|Overall Study|Withdrawal by Subject|0|||
161800452|NCT03538756|584311059|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
161800453|NCT03538756|584311057|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
161800454|NCT03538756|584311058|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
161800455|NCT03538756|584311059|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
161800456|NCT00752856|584311060|FG000|Overall Study|randomized but did not do viral kinetics|0|||
161800457|NCT00752856|584311061|FG001|Overall Study|randomized but did not do viral kinetics|1|||
161800458|NCT02688608|584311062|FG000|Overall Study|Lost to Follow-up|1|||
161800459|NCT00454636|584312305|FG000|Overall Study|Adverse Event|10|||
161800460|NCT00454636|584312306|FG001|Overall Study|Adverse Event|6|||
161800461|NCT00454636|584312307|FG002|Overall Study|Adverse Event|9|||
161800462|NCT00454636|584312308|FG003|Overall Study|Adverse Event|15|||
161800463|NCT00454636|584312305|FG000|Overall Study|Disease Progression|11|||
161800464|NCT00454636|584312306|FG001|Overall Study|Disease Progression|12|||
161800465|NCT00454636|584312307|FG002|Overall Study|Disease Progression|4|||
161800466|NCT00454636|584312308|FG003|Overall Study|Disease Progression|11|||
161800467|NCT00454636|584312305|FG000|Overall Study|Protocol Violation|3|||
161800468|NCT00454636|584312306|FG001|Overall Study|Protocol Violation|2|||
161800469|NCT00454636|584312307|FG002|Overall Study|Protocol Violation|3|||
161800470|NCT00454636|584312308|FG003|Overall Study|Protocol Violation|3|||
161800471|NCT00454636|584312305|FG000|Overall Study|Death|6|||
161800472|NCT00454636|584312306|FG001|Overall Study|Death|1|||
161800473|NCT00454636|584312307|FG002|Overall Study|Death|1|||
161800474|NCT00454636|584312308|FG003|Overall Study|Death|1|||
161800475|NCT00454636|584312305|FG000|Overall Study|Patient refusal|1|||
161800476|NCT00454636|584312306|FG001|Overall Study|Patient refusal|1|||
161800477|NCT00454636|584312307|FG002|Overall Study|Patient refusal|3|||
161800478|NCT00454636|584312308|FG003|Overall Study|Patient refusal|2|||
161800479|NCT00454636|584312305|FG000|Overall Study|Lost to Follow-up|0|||
161800480|NCT00454636|584312306|FG001|Overall Study|Lost to Follow-up|1|||
161800481|NCT00454636|584312307|FG002|Overall Study|Lost to Follow-up|0|||
161800482|NCT00454636|584312308|FG003|Overall Study|Lost to Follow-up|0|||
161800483|NCT00806156|584312309|FG000|Overall Study|Death|35|||
161800484|NCT00806156|584312310|FG001|Overall Study|Death|95|||
161800485|NCT00806156|584312309|FG000|Overall Study|Did not meet eligibility criteria|1|||
161800486|NCT00806156|584312310|FG001|Overall Study|Did not meet eligibility criteria|0|||
161800487|NCT00806156|584312309|FG000|Overall Study|Study terminated by Sponsor|2|||
161800488|NCT00806156|584312310|FG001|Overall Study|Study terminated by Sponsor|40|||
161800489|NCT00806156|584312309|FG000|Overall Study|Consent withdrawn by subject|1|||
161800490|NCT00806156|584312310|FG001|Overall Study|Consent withdrawn by subject|3|||
161800491|NCT00806156|584312309|FG000|Overall Study|Lost to Follow-up|0|||
161800492|NCT00806156|584312310|FG001|Overall Study|Lost to Follow-up|1|||
161800493|NCT02674334|584312315|FG000|Overall Study|Lost to Follow-up|5|||
161800494|NCT02674334|584312316|FG001|Overall Study|Lost to Follow-up|3|||
161800495|NCT02674334|584312315|FG000|Overall Study|participant difficulty breathing|1|||
161800496|NCT02674334|584312316|FG001|Overall Study|participant difficulty breathing|0|||
161800497|NCT02674334|584312315|FG000|Overall Study|NIRS not recording|1|||
161800498|NCT02674334|584312316|FG001|Overall Study|NIRS not recording|0|||
161800499|NCT00860405|584312327|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
161800500|NCT00860405|584312328|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
161800501|NCT00864097|584312329|FG000|Overall Study|Death|0|||
161800502|NCT00864097|584312330|FG001|Overall Study|Death|1|||
161800503|NCT00864097|584312331|FG002|Overall Study|Death|0|||
161800504|NCT00864097|584312332|FG003|Overall Study|Death|0|||
161800505|NCT00864097|584312329|FG000|Overall Study|Adverse Event|6|||
161800506|NCT00864097|584312330|FG001|Overall Study|Adverse Event|8|||
161800507|NCT00864097|584312331|FG002|Overall Study|Adverse Event|11|||
161800508|NCT00864097|584312332|FG003|Overall Study|Adverse Event|9|||
161800509|NCT00864097|584312329|FG000|Overall Study|Lack of Efficacy|9|||
161800510|NCT00864097|584312330|FG001|Overall Study|Lack of Efficacy|3|||
161800511|NCT00864097|584312331|FG002|Overall Study|Lack of Efficacy|7|||
161800512|NCT00864097|584312332|FG003|Overall Study|Lack of Efficacy|2|||
161800513|NCT00864097|584312329|FG000|Overall Study|Lost to Follow-up|0|||
161800514|NCT00864097|584312330|FG001|Overall Study|Lost to Follow-up|1|||
161800515|NCT00864097|584312331|FG002|Overall Study|Lost to Follow-up|0|||
161800516|NCT00864097|584312332|FG003|Overall Study|Lost to Follow-up|1|||
161800517|NCT00864097|584312329|FG000|Overall Study|Withdrawal by Subject|15|||
161800518|NCT00864097|584312330|FG001|Overall Study|Withdrawal by Subject|11|||
161800519|NCT00864097|584312331|FG002|Overall Study|Withdrawal by Subject|11|||
161904237|NCT05616013|584697069|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
161800520|NCT00864097|584312332|FG003|Overall Study|Withdrawal by Subject|12|||
161800521|NCT00864097|584312329|FG000|Overall Study|Protocol Violation|2|||
161800522|NCT00864097|584312330|FG001|Overall Study|Protocol Violation|1|||
161800523|NCT00864097|584312331|FG002|Overall Study|Protocol Violation|0|||
161800524|NCT00864097|584312332|FG003|Overall Study|Protocol Violation|1|||
161800525|NCT00864097|584312329|FG000|Overall Study|Terminated by sponsor|105|||
161800526|NCT00864097|584312330|FG001|Overall Study|Terminated by sponsor|112|||
161800527|NCT00864097|584312331|FG002|Overall Study|Terminated by sponsor|102|||
161800528|NCT00864097|584312332|FG003|Overall Study|Terminated by sponsor|99|||
161556861|NCT04466618|583428914|FG001|Overall Study|Withdrawal by Subject|1|||
161556862|NCT02800928|583428915|FG000|Overall Study|Withdrawal by Subject|1|||
161556863|NCT02800928|583428916|FG001|Overall Study|Withdrawal by Subject|1|||
161556864|NCT02800928|583428915|FG000|Overall Study|Protocol Violation|1|||
161556865|NCT02800928|583428916|FG001|Overall Study|Protocol Violation|1|||
161556866|NCT02886728|583428924|FG000|Overall Study|Withdrew Consent|31|||
161556867|NCT02886728|583428925|FG001|Overall Study|Withdrew Consent|13|||
161556868|NCT02886728|583428926|FG002|Overall Study|Withdrew Consent|11|||
161556869|NCT02886728|583428927|FG003|Overall Study|Withdrew Consent|47|||
161556870|NCT02886728|583428924|FG000|Overall Study|Lost to Follow-up|12|||
161556871|NCT02886728|583428925|FG001|Overall Study|Lost to Follow-up|6|||
161556872|NCT02886728|583428926|FG002|Overall Study|Lost to Follow-up|13|||
161556873|NCT02886728|583428927|FG003|Overall Study|Lost to Follow-up|12|||
161556874|NCT02886728|583428924|FG000|Overall Study|Adverse Event|13|||
161556875|NCT02886728|583428925|FG001|Overall Study|Adverse Event|5|||
161556876|NCT02886728|583428926|FG002|Overall Study|Adverse Event|5|||
161556877|NCT02886728|583428927|FG003|Overall Study|Adverse Event|11|||
161556878|NCT02886728|583428924|FG000|Overall Study|Investigator's Discretion|11|||
161556879|NCT02886728|583428925|FG001|Overall Study|Investigator's Discretion|7|||
161556880|NCT02886728|583428926|FG002|Overall Study|Investigator's Discretion|5|||
161556881|NCT02886728|583428927|FG003|Overall Study|Investigator's Discretion|11|||
161556882|NCT02886728|583428924|FG000|Overall Study|Death|3|||
161556883|NCT02886728|583428925|FG001|Overall Study|Death|1|||
161556884|NCT02886728|583428926|FG002|Overall Study|Death|0|||
161556885|NCT02886728|583428927|FG003|Overall Study|Death|0|||
161556886|NCT02886728|583428924|FG000|Overall Study|Protocol Violation|0|||
161556887|NCT02886728|583428925|FG001|Overall Study|Protocol Violation|0|||
161556888|NCT02886728|583428926|FG002|Overall Study|Protocol Violation|0|||
161556889|NCT02886728|583428927|FG003|Overall Study|Protocol Violation|4|||
161556890|NCT02886728|583428924|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161556891|NCT02886728|583428925|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161556892|NCT02886728|583428926|FG002|Overall Study|Non-Compliance with Study Drug|1|||
161556893|NCT02886728|583428927|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161556894|NCT02886728|583428924|FG000|Overall Study|Pregnancy|0|||
161556895|NCT02886728|583428925|FG001|Overall Study|Pregnancy|0|||
161556896|NCT02886728|583428926|FG002|Overall Study|Pregnancy|1|||
161556897|NCT02886728|583428927|FG003|Overall Study|Pregnancy|0|||
161556898|NCT02886728|583428924|FG000|Overall Study|Randomized but Not Dosed|1|||
161556899|NCT02886728|583428925|FG001|Overall Study|Randomized but Not Dosed|0|||
161556900|NCT02886728|583428926|FG002|Overall Study|Randomized but Not Dosed|0|||
161800529|NCT00864097|584312329|FG000|Overall Study|Randomized but not treated|2|||
161800530|NCT00864097|584312330|FG001|Overall Study|Randomized but not treated|0|||
161800531|NCT00864097|584312331|FG002|Overall Study|Randomized but not treated|1|||
161800532|NCT00864097|584312332|FG003|Overall Study|Randomized but not treated|0|||
161800533|NCT00864097|584312329|FG000|Overall Study|Other|0|||
161800534|NCT00864097|584312330|FG001|Overall Study|Other|0|||
161800535|NCT00864097|584312331|FG002|Overall Study|Other|0|||
161800536|NCT00864097|584312332|FG003|Overall Study|Other|1|||
161800537|NCT00320112|584312335|FG000|Overall Study|Lost to Follow-up|3|||
161800538|NCT00320112|584312336|FG001|Overall Study|Lost to Follow-up|4|||
161800539|NCT00320112|584312335|FG000|Overall Study|Withdrawal by Subject|3|||
161800540|NCT00320112|584312336|FG001|Overall Study|Withdrawal by Subject|0|||
161800541|NCT00320112|584312335|FG000|Overall Study|Death|2|||
161800542|NCT00320112|584312336|FG001|Overall Study|Death|1|||
161800543|NCT02899338|584312337|FG000|Overall Study|Adverse Event|1|||
161800544|NCT02899338|584312338|FG001|Overall Study|Adverse Event|2|||
161800545|NCT02899338|584312337|FG000|Overall Study|Withdrawal by Subject|2|||
161800546|NCT02899338|584312338|FG001|Overall Study|Withdrawal by Subject|0|||
161800547|NCT06179108|584312339|FG000|Overall Study|Withdrawal by Subject|16|||
161904238|NCT05616013|584697070|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
161556901|NCT02886728|583428927|FG003|Overall Study|Randomized but Not Dosed|2|||
161556902|NCT00109928|583428928|FG000|Overall Study|Adverse Event|2|||
161556903|NCT00109928|583428928|FG000|Overall Study|Progression|6|||
161556904|NCT00109928|583428928|FG000|Overall Study|Death|2|||
161556905|NCT00109928|583428928|FG000|Overall Study|not protocol specified|2|||
161556906|NCT00109928|583428928|FG000|Overall Study|not eligible|1|||
161556907|NCT01364727|583428929|FG000|Overall Study|Not Eligible|2|||
161556908|NCT01676220|583428930|FG000|Overall Study|Randomized But Not Treated|4|||
161556909|NCT01676220|583428931|FG001|Overall Study|Randomized But Not Treated|1|||
161556910|NCT01676220|583428930|FG000|Overall Study|Adverse Event|10|||
161556911|NCT01676220|583428931|FG001|Overall Study|Adverse Event|8|||
161556912|NCT01676220|583428930|FG000|Overall Study|Lack of Efficacy|2|||
161556913|NCT01676220|583428931|FG001|Overall Study|Lack of Efficacy|5|||
161556914|NCT01676220|583428930|FG000|Overall Study|Protocol Violation|11|||
161800548|NCT06179108|584312340|FG001|Overall Study|Withdrawal by Subject|19|||
161800549|NCT06179108|584312341|FG002|Overall Study|Withdrawal by Subject|10|||
161556915|NCT01676220|583428931|FG001|Overall Study|Protocol Violation|12|||
161800550|NCT06179108|584312342|FG003|Overall Study|Withdrawal by Subject|11|||
161800551|NCT06179108|584312339|FG000|Overall Study|Lost to Follow-up|12|||
161800552|NCT06179108|584312340|FG001|Overall Study|Lost to Follow-up|4|||
161800553|NCT06179108|584312341|FG002|Overall Study|Lost to Follow-up|1|||
161800554|NCT06179108|584312342|FG003|Overall Study|Lost to Follow-up|9|||
161800555|NCT06179108|584312339|FG000|Overall Study|Adverse Event|2|||
161800556|NCT06179108|584312340|FG001|Overall Study|Adverse Event|3|||
161800557|NCT06179108|584312341|FG002|Overall Study|Adverse Event|3|||
161800558|NCT06179108|584312342|FG003|Overall Study|Adverse Event|2|||
161800559|NCT06179108|584312339|FG000|Overall Study|Protocol Violation|0|||
161800560|NCT06179108|584312340|FG001|Overall Study|Protocol Violation|1|||
161800561|NCT06179108|584312341|FG002|Overall Study|Protocol Violation|0|||
161800562|NCT06179108|584312342|FG003|Overall Study|Protocol Violation|1|||
161800563|NCT06179108|584312339|FG000|Overall Study|Physician Decision|1|||
161800564|NCT06179108|584312340|FG001|Overall Study|Physician Decision|1|||
161800565|NCT06179108|584312341|FG002|Overall Study|Physician Decision|0|||
161800566|NCT06179108|584312342|FG003|Overall Study|Physician Decision|0|||
161800567|NCT06179108|584312339|FG000|Overall Study|Lack of Efficacy|0|||
161800568|NCT06179108|584312340|FG001|Overall Study|Lack of Efficacy|0|||
161800569|NCT06179108|584312341|FG002|Overall Study|Lack of Efficacy|0|||
161800570|NCT06179108|584312342|FG003|Overall Study|Lack of Efficacy|1|||
161800571|NCT06179108|584312339|FG000|Overall Study|Death|0|||
161800572|NCT06179108|584312340|FG001|Overall Study|Death|0|||
161800573|NCT06179108|584312341|FG002|Overall Study|Death|0|||
161800574|NCT06179108|584312342|FG003|Overall Study|Death|1|||
161800575|NCT00814463|584312343|FG000|Overall Study|Lost to Follow-up|1|||
161800576|NCT02780687|584312346|FG000|Overall Study|Adverse Event|1|||
161800577|NCT02780687|584312347|FG001|Overall Study|Adverse Event|1|||
161800578|NCT02780687|584312346|FG000|Overall Study|Withdrawal by Subject|2|||
161800579|NCT02780687|584312347|FG001|Overall Study|Withdrawal by Subject|1|||
161800580|NCT02780687|584312346|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
161800581|NCT02780687|584312347|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
161800582|NCT02780687|584312346|FG000|Overall Study|progressive disease|29|||
161800583|NCT02780687|584312347|FG001|Overall Study|progressive disease|6|||
161800584|NCT00414765|584312349|FG000|Overall Study|Adverse Event|5|||
161800585|NCT00414765|584312350|FG001|Overall Study|Adverse Event|9|||
161800586|NCT00414765|584312349|FG000|Overall Study|Withdrawal by Subject|1|||
161800587|NCT00414765|584312350|FG001|Overall Study|Withdrawal by Subject|1|||
161800588|NCT00414765|584312349|FG000|Overall Study|Disease Progression|0|||
161800589|NCT00414765|584312350|FG001|Overall Study|Disease Progression|1|||
161800590|NCT05694013|584312352|FG000|Overall Study|Death|6|||
161800591|NCT05694013|584312353|FG001|Overall Study|Death|2|||
161800592|NCT05694013|584312352|FG000|Overall Study|Participant Decision|0|||
161800593|NCT05694013|584312353|FG001|Overall Study|Participant Decision|1|||
161800594|NCT05694013|584312352|FG000|Overall Study|Physician Decision|1|||
161800595|NCT05694013|584312353|FG001|Overall Study|Physician Decision|0|||
161800596|NCT05694013|584312352|FG000|Overall Study|Progressive Disease|0|||
161800597|NCT05694013|584312353|FG001|Overall Study|Progressive Disease|1|||
161800598|NCT05694013|584312352|FG000|Overall Study|Study Terminated by Sponsor|12|||
161800599|NCT05694013|584312353|FG001|Overall Study|Study Terminated by Sponsor|17|||
161800600|NCT05694013|584312352|FG000|Overall Study|Withdrawal by Subject|3|||
161451468|NCT00913458|583050615|FG000|Phase 1|Adverse Event|20|||
161451469|NCT00913458|583050616|FG001|Phase 1|Adverse Event|0|||
161451470|NCT00913458|583050617|FG002|Phase 1|Adverse Event|0|||
161451471|NCT00913458|583050618|FG003|Phase 1|Adverse Event|0|||
161451472|NCT00913458|583050619|FG004|Phase 1|Adverse Event|0|||
161451473|NCT00913458|583050620|FG005|Phase 1|Adverse Event|0|||
161451474|NCT00913458|583050621|FG006|Phase 1|Adverse Event|0|||
161451475|NCT00913458|583050615|FG000|Phase 1|Lost to Follow-up|2|||
161451476|NCT00913458|583050616|FG001|Phase 1|Lost to Follow-up|0|||
161451477|NCT00913458|583050617|FG002|Phase 1|Lost to Follow-up|0|||
161451478|NCT00913458|583050618|FG003|Phase 1|Lost to Follow-up|0|||
161451479|NCT00913458|583050619|FG004|Phase 1|Lost to Follow-up|0|||
161451480|NCT00913458|583050620|FG005|Phase 1|Lost to Follow-up|0|||
161451481|NCT00913458|583050621|FG006|Phase 1|Lost to Follow-up|0|||
161451482|NCT00913458|583050615|FG000|Phase 1|Protocol Violation|10|||
161451483|NCT00913458|583050616|FG001|Phase 1|Protocol Violation|0|||
161451484|NCT00913458|583050617|FG002|Phase 1|Protocol Violation|0|||
161800601|NCT05694013|584312353|FG001|Overall Study|Withdrawal by Subject|0|||
161800602|NCT01199861|584312354|FG000|Overall Study|Administrative problems|1|||
161800603|NCT01199861|584312355|FG001|Overall Study|Administrative problems|0|||
161800604|NCT01199861|584312354|FG000|Overall Study|Adverse Event|1|||
161451485|NCT00913458|583050618|FG003|Phase 1|Protocol Violation|0|||
161451486|NCT00913458|583050619|FG004|Phase 1|Protocol Violation|0|||
161800605|NCT01199861|584312355|FG001|Overall Study|Adverse Event|0|||
161800606|NCT04817891|584312356|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
161800607|NCT04817891|584312356|FG000|Overall Study|Adverse Event|1|||
161800608|NCT04817891|584312356|FG000|Overall Study|Withdrawal by Subject|1|||
161800609|NCT03982433|584312357|FG000|Overall Study|Lost to Follow-up|1|||
161800610|NCT04981912|584312358|FG000|Overall Study|Physician Decision|2|||
161800611|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161800612|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
161904239|NCT05616013|584697071|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904240|NCT05616013|584697072|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904241|NCT05616013|584697073|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904242|NCT05616013|584697074|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904243|NCT05616013|584697075|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904244|NCT05616013|584697076|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904245|NCT05616013|584697077|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904246|NCT05616013|584697069|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
161904247|NCT05616013|584697070|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904248|NCT05616013|584697071|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904249|NCT05616013|584697072|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904250|NCT05616013|584697073|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904251|NCT05616013|584697074|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904252|NCT05616013|584697075|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904253|NCT05616013|584697076|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904254|NCT05616013|584697077|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904255|NCT05616013|584697069|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
161904256|NCT05616013|584697070|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904257|NCT05616013|584697071|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904258|NCT05616013|584697072|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904259|NCT05616013|584697073|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904260|NCT05616013|584697074|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904261|NCT05616013|584697075|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904262|NCT05616013|584697076|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904263|NCT05616013|584697077|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904264|NCT05616013|584697069|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904265|NCT05616013|584697070|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
161904266|NCT05616013|584697071|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904267|NCT05616013|584697072|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904268|NCT05616013|584697073|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904269|NCT05616013|584697074|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904270|NCT05616013|584697075|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904271|NCT05616013|584697076|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904272|NCT05616013|584697077|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904273|NCT05616013|584697069|FG000|Overall Study|Participant Decision, Time Constraints|0|||
161904274|NCT05616013|584697070|FG001|Overall Study|Participant Decision, Time Constraints|1|||
161904275|NCT05616013|584697071|FG002|Overall Study|Participant Decision, Time Constraints|0|||
161904276|NCT05616013|584697072|FG003|Overall Study|Participant Decision, Time Constraints|0|||
161904277|NCT05616013|584697073|FG004|Overall Study|Participant Decision, Time Constraints|0|||
161904278|NCT05616013|584697074|FG005|Overall Study|Participant Decision, Time Constraints|0|||
161904279|NCT05616013|584697075|FG006|Overall Study|Participant Decision, Time Constraints|0|||
161904280|NCT05616013|584697076|FG007|Overall Study|Participant Decision, Time Constraints|0|||
161904281|NCT05616013|584697077|FG008|Overall Study|Participant Decision, Time Constraints|0|||
161904282|NCT05616013|584697069|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161904283|NCT05616013|584697070|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161904284|NCT05616013|584697071|FG002|Overall Study|Prohibited Concomitant Medication|1|||
161904285|NCT05616013|584697072|FG003|Overall Study|Prohibited Concomitant Medication|0|||
161904286|NCT05616013|584697073|FG004|Overall Study|Prohibited Concomitant Medication|0|||
161904287|NCT05616013|584697074|FG005|Overall Study|Prohibited Concomitant Medication|0|||
161904288|NCT05616013|584697075|FG006|Overall Study|Prohibited Concomitant Medication|0|||
161904289|NCT05616013|584697076|FG007|Overall Study|Prohibited Concomitant Medication|0|||
161904290|NCT05616013|584697077|FG008|Overall Study|Prohibited Concomitant Medication|0|||
161904291|NCT05616013|584697069|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904292|NCT05616013|584697070|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904293|NCT05616013|584697071|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
161904294|NCT05616013|584697072|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
161556916|NCT01676220|583428930|FG000|Overall Study|Received Rescue Therapy|14|||
161556917|NCT01676220|583428931|FG001|Overall Study|Received Rescue Therapy|22|||
161556918|NCT01676220|583428930|FG000|Overall Study|Personal Reason|34|||
161556919|NCT01676220|583428931|FG001|Overall Study|Personal Reason|45|||
161556920|NCT01676220|583428930|FG000|Overall Study|Lost to Follow-up|11|||
161556921|NCT01676220|583428931|FG001|Overall Study|Lost to Follow-up|18|||
161904295|NCT05616013|584697073|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904296|NCT05616013|584697074|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904297|NCT05616013|584697075|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
161451487|NCT00913458|583050620|FG005|Phase 1|Protocol Violation|0|||
161451488|NCT00913458|583050621|FG006|Phase 1|Protocol Violation|0|||
161451489|NCT00913458|583050615|FG000|Phase 1|Sponsor|2|||
161800613|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161800614|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161800615|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
161800616|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
161800617|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
161800618|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
161800619|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161800620|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
161800621|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161800622|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161800623|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
161800624|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
161800625|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
161800626|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
161800627|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161800628|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
161800629|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161800630|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161800631|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
161800632|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
161800633|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
161800634|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
161800635|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161800636|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161800637|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161800638|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
161800639|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
161800640|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
161800641|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
161800642|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
161800643|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
161800644|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
161800645|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
161800646|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
161800647|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
161800648|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
161800649|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
161800650|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
161800651|NCT02153736|584312369|FG000|Overall Study|Lost to Follow-up|1|||
161800652|NCT02153736|584312370|FG001|Overall Study|Lost to Follow-up|0|||
161800653|NCT02153736|584312369|FG000|Overall Study|Medical status change made ineligible|1|||
161800654|NCT02153736|584312370|FG001|Overall Study|Medical status change made ineligible|0|||
161800655|NCT02153736|584312369|FG000|Overall Study|Death|0|||
161800656|NCT02153736|584312370|FG001|Overall Study|Death|1|||
161800657|NCT02153736|584312369|FG000|Overall Study|Withdrawal by Subject|0|||
161800658|NCT02153736|584312370|FG001|Overall Study|Withdrawal by Subject|1|||
161800659|NCT01734772|584312371|FG000|Overall Study|Adverse Event|1|||
161800660|NCT01734772|584312372|FG001|Overall Study|Adverse Event|2|||
161800661|NCT01734772|584312371|FG000|Overall Study|Withdrawal by Subject|0|||
161800662|NCT01734772|584312372|FG001|Overall Study|Withdrawal by Subject|1|||
161800663|NCT00720122|584312379|FG000|Overall Study|Lost to Follow-up|1|||
161800664|NCT00720122|584312379|FG000|Overall Study|Physician Decision|1|||
161800665|NCT00720122|584312379|FG000|Overall Study|Withdrawal by Subject|7|||
161800666|NCT01867242|584312380|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
161800667|NCT01867242|584312381|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
161800668|NCT01867242|584312382|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
161800669|NCT03066999|584312383|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
161800670|NCT03066999|584312384|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
161800671|NCT00661999|584312385|FG000|Overall Study|Adverse Event|11|||
161800672|NCT00661999|584312386|FG001|Overall Study|Adverse Event|5|||
161800673|NCT00661999|584312387|FG002|Overall Study|Adverse Event|8|||
161556922|NCT01676220|583428930|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
161556923|NCT01676220|583428931|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
161556924|NCT01676220|583428930|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
161556925|NCT01676220|583428931|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
161556926|NCT01676220|583428930|FG000|Overall Study|Perceived Lack of Efficacy|3|||
161556927|NCT01676220|583428931|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161556928|NCT01676220|583428930|FG000|Overall Study|Non Serious Hypoglycemia|2|||
161556929|NCT01676220|583428931|FG001|Overall Study|Non Serious Hypoglycemia|0|||
161556930|NCT01676220|583428930|FG000|Overall Study|No More Need of Insulin|1|||
161556931|NCT01676220|583428931|FG001|Overall Study|No More Need of Insulin|0|||
161556932|NCT02411591|583428932|FG000|Overall Study|Adverse Event|0|||
161556933|NCT02411591|583428933|FG001|Overall Study|Adverse Event|4|||
161556934|NCT02411591|583428934|FG002|Overall Study|Adverse Event|2|||
161556935|NCT02411591|583428932|FG000|Overall Study|Withdrawal by Subject|0|||
161556936|NCT02411591|583428933|FG001|Overall Study|Withdrawal by Subject|3|||
161556937|NCT02411591|583428934|FG002|Overall Study|Withdrawal by Subject|0|||
161556938|NCT02411591|583428932|FG000|Overall Study|Physician Decision|0|||
161556939|NCT02411591|583428933|FG001|Overall Study|Physician Decision|3|||
161556940|NCT02411591|583428934|FG002|Overall Study|Physician Decision|1|||
161556941|NCT00750893|583428937|FG000|Overall Study|Adverse Event|5|||
161556942|NCT00750893|583428937|FG000|Overall Study|Withdrawal by Subject|10|||
161556943|NCT00750893|583428937|FG000|Overall Study|Lost to Follow-up|510|||
161800674|NCT00661999|584312385|FG000|Overall Study|Death|8|||
161800675|NCT00661999|584312386|FG001|Overall Study|Death|6|||
161800676|NCT00661999|584312387|FG002|Overall Study|Death|3|||
161800677|NCT00661999|584312385|FG000|Overall Study|Other Reasons|5|||
161800678|NCT00661999|584312386|FG001|Overall Study|Other Reasons|12|||
161800679|NCT00661999|584312387|FG002|Overall Study|Other Reasons|23|||
161800680|NCT00661999|584312385|FG000|Overall Study|Withdrawal by Subject|30|||
161800681|NCT00661999|584312386|FG001|Overall Study|Withdrawal by Subject|23|||
161800682|NCT00661999|584312387|FG002|Overall Study|Withdrawal by Subject|14|||
161800683|NCT00661999|584312385|FG000|Overall Study|Alternative Treatment|1|||
161800684|NCT00661999|584312386|FG001|Overall Study|Alternative Treatment|0|||
161800685|NCT00661999|584312387|FG002|Overall Study|Alternative Treatment|0|||
161800686|NCT00661999|584312385|FG000|Overall Study|Other Medical Problems|4|||
161800687|NCT00661999|584312386|FG001|Overall Study|Other Medical Problems|4|||
161800688|NCT00661999|584312387|FG002|Overall Study|Other Medical Problems|9|||
161800689|NCT01139164|584312390|FG000|Overall Study|Withdrawn prior to study start|0|||
161800690|NCT01139164|584312391|FG001|Overall Study|Withdrawn prior to study start|2|||
161800691|NCT01139164|584312392|FG002|Overall Study|Withdrawn prior to study start|0|||
161800692|NCT01790568|584312393|FG000|Overall Study|Progression prior to transplant|0|||
161800693|NCT01790568|584312394|FG001|Overall Study|Progression prior to transplant|1|||
161800694|NCT01361126|584312395|FG000|Overall Study|Sponsor decision|0|||
161800695|NCT01361126|584312396|FG001|Overall Study|Sponsor decision|2|||
161800696|NCT01658943|584312399|FG000|Overall Study|Adverse Event|6|||
161556944|NCT00750893|583428937|FG000|Overall Study|Other|17|||
161800697|NCT01658943|584312400|FG001|Overall Study|Adverse Event|13|||
161800698|NCT01658943|584312399|FG000|Overall Study|Withdrawal by Subject|9|||
161800699|NCT01658943|584312400|FG001|Overall Study|Withdrawal by Subject|2|||
161800700|NCT01658943|584312399|FG000|Overall Study|Progression/Relapse|39|||
161800701|NCT01658943|584312400|FG001|Overall Study|Progression/Relapse|40|||
161800702|NCT01658943|584312399|FG000|Overall Study|Death|4|||
161800703|NCT01658943|584312400|FG001|Overall Study|Death|2|||
161800704|NCT01658943|584312399|FG000|Overall Study|not protocol specified|4|||
161800705|NCT01658943|584312400|FG001|Overall Study|not protocol specified|1|||
161800706|NCT01658943|584312399|FG000|Overall Study|Not eligible|7|||
161800707|NCT01658943|584312400|FG001|Overall Study|Not eligible|9|||
161800708|NCT01658943|584312399|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
161800709|NCT01658943|584312400|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
161800710|NCT04272801|584312403|FG000|Overall Study|Withdrawal by Subject|4|||
161800711|NCT04272801|584312403|FG000|Overall Study|Lost to Follow-up|4|||
161800712|NCT04272801|584312403|FG000|Overall Study|Ineligible|1|||
161800713|NCT02456909|584312404|FG000|Overall Study|Did not receive allocated intervention|24|||
161800714|NCT02456909|584312405|FG001|Overall Study|Did not receive allocated intervention|26|||
161800715|NCT02456909|584312404|FG000|Overall Study|Did not complete the primary outcome|0|||
161800716|NCT02456909|584312405|FG001|Overall Study|Did not complete the primary outcome|1|||
161800717|NCT02130466|584312406|FG000|Overall Study|Death|4|||
161556945|NCT00661258|583428945|FG000|Overall Study|Death|1|||
161556946|NCT00661258|583428946|FG001|Overall Study|Death|0|||
161556947|NCT00661258|583428945|FG000|Overall Study|caught by police and in detox center|2|||
161556948|NCT00661258|583428946|FG001|Overall Study|caught by police and in detox center|1|||
161800718|NCT02130466|584312407|FG001|Overall Study|Death|1|||
161800719|NCT02130466|584312408|FG002|Overall Study|Death|1|||
161800720|NCT02130466|584312409|FG003|Overall Study|Death|3|||
161800721|NCT02130466|584312410|FG004|Overall Study|Death|2|||
161800722|NCT02130466|584312411|FG005|Overall Study|Death|30|||
161800723|NCT02130466|584312412|FG006|Overall Study|Death|45|||
161800724|NCT02130466|584312413|FG007|Overall Study|Death|2|||
161800725|NCT02130466|584312414|FG008|Overall Study|Death|3|||
161800726|NCT02130466|584312415|FG009|Overall Study|Death|4|||
161800727|NCT02130466|584312416|FG010|Overall Study|Death|5|||
161800728|NCT02130466|584312417|FG011|Overall Study|Death|3|||
161800729|NCT02130466|584312418|FG012|Overall Study|Death|11|||
161800730|NCT02130466|584312419|FG013|Overall Study|Death|7|||
161800731|NCT02130466|584312406|FG000|Overall Study|Lost to Follow-up|1|||
161800732|NCT02130466|584312407|FG001|Overall Study|Lost to Follow-up|0|||
161800733|NCT02130466|584312408|FG002|Overall Study|Lost to Follow-up|0|||
161800734|NCT02130466|584312409|FG003|Overall Study|Lost to Follow-up|0|||
161800735|NCT02130466|584312410|FG004|Overall Study|Lost to Follow-up|0|||
161800736|NCT02130466|584312411|FG005|Overall Study|Lost to Follow-up|1|||
161800737|NCT02130466|584312412|FG006|Overall Study|Lost to Follow-up|0|||
161800738|NCT02130466|584312413|FG007|Overall Study|Lost to Follow-up|0|||
161800739|NCT02130466|584312414|FG008|Overall Study|Lost to Follow-up|0|||
161800740|NCT02130466|584312415|FG009|Overall Study|Lost to Follow-up|0|||
161800741|NCT02130466|584312416|FG010|Overall Study|Lost to Follow-up|0|||
161800742|NCT02130466|584312417|FG011|Overall Study|Lost to Follow-up|0|||
161800743|NCT02130466|584312418|FG012|Overall Study|Lost to Follow-up|1|||
161800744|NCT02130466|584312419|FG013|Overall Study|Lost to Follow-up|0|||
161800745|NCT02130466|584312406|FG000|Overall Study|Physician Decision|0|||
161800746|NCT02130466|584312407|FG001|Overall Study|Physician Decision|0|||
161800747|NCT02130466|584312408|FG002|Overall Study|Physician Decision|0|||
161800748|NCT02130466|584312409|FG003|Overall Study|Physician Decision|0|||
161800749|NCT02130466|584312410|FG004|Overall Study|Physician Decision|0|||
161800750|NCT02130466|584312411|FG005|Overall Study|Physician Decision|1|||
161800751|NCT02130466|584312412|FG006|Overall Study|Physician Decision|1|||
161800752|NCT02130466|584312413|FG007|Overall Study|Physician Decision|0|||
161800753|NCT02130466|584312414|FG008|Overall Study|Physician Decision|0|||
161800754|NCT02130466|584312415|FG009|Overall Study|Physician Decision|0|||
161800755|NCT02130466|584312416|FG010|Overall Study|Physician Decision|0|||
161800756|NCT02130466|584312417|FG011|Overall Study|Physician Decision|0|||
161800757|NCT02130466|584312418|FG012|Overall Study|Physician Decision|0|||
161800758|NCT02130466|584312419|FG013|Overall Study|Physician Decision|0|||
161800759|NCT02130466|584312406|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800760|NCT02130466|584312407|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
161800761|NCT02130466|584312408|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800762|NCT02130466|584312409|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
161800763|NCT02130466|584312410|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800764|NCT02130466|584312411|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
161800765|NCT02130466|584312412|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
161800766|NCT02130466|584312413|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800767|NCT02130466|584312414|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800768|NCT02130466|584312415|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800769|NCT02130466|584312416|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800770|NCT02130466|584312417|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800771|NCT02130466|584312418|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800772|NCT02130466|584312419|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
161800773|NCT02130466|584312406|FG000|Overall Study|Withdrawal by Subject|1|||
161800774|NCT02130466|584312407|FG001|Overall Study|Withdrawal by Subject|0|||
161800775|NCT02130466|584312408|FG002|Overall Study|Withdrawal by Subject|0|||
161800776|NCT02130466|584312409|FG003|Overall Study|Withdrawal by Subject|0|||
161800777|NCT02130466|584312410|FG004|Overall Study|Withdrawal by Subject|0|||
161800778|NCT02130466|584312411|FG005|Overall Study|Withdrawal by Subject|1|||
161800779|NCT02130466|584312412|FG006|Overall Study|Withdrawal by Subject|0|||
161800780|NCT02130466|584312413|FG007|Overall Study|Withdrawal by Subject|0|||
161800781|NCT02130466|584312414|FG008|Overall Study|Withdrawal by Subject|1|||
161800782|NCT02130466|584312415|FG009|Overall Study|Withdrawal by Subject|0|||
161800783|NCT02130466|584312416|FG010|Overall Study|Withdrawal by Subject|0|||
161800784|NCT02130466|584312417|FG011|Overall Study|Withdrawal by Subject|0|||
161800785|NCT02130466|584312418|FG012|Overall Study|Withdrawal by Subject|0|||
161451490|NCT00913458|583050616|FG001|Phase 1|Sponsor|0|||
161451491|NCT00913458|583050617|FG002|Phase 1|Sponsor|0|||
161800786|NCT02130466|584312419|FG013|Overall Study|Withdrawal by Subject|0|||
161800787|NCT04529109|584312421|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161904298|NCT05616013|584697076|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
161800788|NCT04529109|584312422|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161800789|NCT01508936|584312424|FG000|Overall Study|Adverse Event|11|||
161800790|NCT01508936|584312425|FG001|Overall Study|Adverse Event|32|||
161800791|NCT01508936|584312424|FG000|Overall Study|Lack of Efficacy|0|||
161800792|NCT01508936|584312425|FG001|Overall Study|Lack of Efficacy|1|||
161800793|NCT01508936|584312424|FG000|Overall Study|Withdrawal by Subject|4|||
161800794|NCT01508936|584312425|FG001|Overall Study|Withdrawal by Subject|18|||
161800795|NCT01508936|584312424|FG000|Overall Study|Protocol Violation|2|||
161904299|NCT05616013|584697077|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904300|NCT05616013|584697069|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904301|NCT05616013|584697070|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904302|NCT05616013|584697071|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904303|NCT05616013|584697072|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
161904304|NCT05616013|584697073|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904305|NCT05616013|584697074|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904306|NCT05616013|584697075|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904307|NCT05616013|584697076|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904308|NCT05616013|584697077|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904309|NCT05616013|584697069|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904310|NCT05616013|584697070|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904311|NCT05616013|584697071|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904312|NCT05616013|584697072|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904313|NCT05616013|584697073|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904314|NCT05616013|584697074|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904315|NCT05616013|584697075|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
161904316|NCT05616013|584697076|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904317|NCT05616013|584697077|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904318|NCT05616013|584697069|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904319|NCT05616013|584697070|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904320|NCT05616013|584697071|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904321|NCT05616013|584697072|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904322|NCT05616013|584697073|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904323|NCT05616013|584697074|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904324|NCT05616013|584697075|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904325|NCT05616013|584697076|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904326|NCT05616013|584697077|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
161904327|NCT05616013|584697069|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904328|NCT05616013|584697070|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904329|NCT05616013|584697071|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904330|NCT05616013|584697072|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904331|NCT05616013|584697073|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904332|NCT05616013|584697074|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904333|NCT05616013|584697075|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904334|NCT05616013|584697076|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904335|NCT05616013|584697077|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
161904336|NCT02357459|584698619|FG000|Overall Study|Adverse Event|0|||
161904337|NCT02357459|584698620|FG001|Overall Study|Adverse Event|1|||
161904338|NCT02357459|584698621|FG002|Overall Study|Adverse Event|1|||
161904339|NCT02357459|584698619|FG000|Overall Study|Withdrawal by Subject|5|||
161904340|NCT02357459|584698620|FG001|Overall Study|Withdrawal by Subject|3|||
161904341|NCT02357459|584698621|FG002|Overall Study|Withdrawal by Subject|3|||
161904342|NCT02357459|584698619|FG000|Overall Study|Physician Decision|0|||
161904343|NCT02357459|584698620|FG001|Overall Study|Physician Decision|2|||
161904344|NCT02357459|584698621|FG002|Overall Study|Physician Decision|0|||
161904345|NCT02357459|584698619|FG000|Overall Study|Protocol Violation|1|||
161904346|NCT02357459|584698620|FG001|Overall Study|Protocol Violation|1|||
161904347|NCT02357459|584698621|FG002|Overall Study|Protocol Violation|0|||
161904348|NCT02357459|584698619|FG000|Overall Study|Lost to Follow-up|1|||
161904349|NCT02357459|584698620|FG001|Overall Study|Lost to Follow-up|3|||
161904350|NCT02357459|584698621|FG002|Overall Study|Lost to Follow-up|0|||
161904351|NCT02357459|584698619|FG000|Overall Study|Lack of Efficacy|7|||
161904352|NCT02357459|584698620|FG001|Overall Study|Lack of Efficacy|4|||
161904353|NCT02357459|584698621|FG002|Overall Study|Lack of Efficacy|4|||
161904354|NCT02357459|584698619|FG000|Overall Study|Patient Relocated|2|||
161904355|NCT02357459|584698620|FG001|Overall Study|Patient Relocated|0|||
161904356|NCT02357459|584698621|FG002|Overall Study|Patient Relocated|0|||
161904357|NCT02357459|584698619|FG000|Overall Study|Instruction from PCP|1|||
161904358|NCT02357459|584698620|FG001|Overall Study|Instruction from PCP|0|||
161904359|NCT02357459|584698621|FG002|Overall Study|Instruction from PCP|0|||
161904360|NCT02357459|584698619|FG000|Overall Study|Incarceration|0|||
161904361|NCT02357459|584698620|FG001|Overall Study|Incarceration|0|||
161904362|NCT02357459|584698621|FG002|Overall Study|Incarceration|1|||
161556949|NCT01628874|583428947|FG000|Overall Study|Physician Decision|1|||
161556950|NCT01628874|583428948|FG001|Overall Study|Physician Decision|1|||
161556951|NCT01628874|583428947|FG000|Overall Study|Age >4 months|4|||
161556952|NCT01628874|583428948|FG001|Overall Study|Age >4 months|2|||
161556953|NCT00873093|583428949|FG000|Overall Study|Adverse Event|0|||
161556954|NCT00873093|583428950|FG001|Overall Study|Adverse Event|2|||
161556955|NCT00873093|583428951|FG002|Overall Study|Adverse Event|0|||
161556956|NCT00873093|583428952|FG003|Overall Study|Adverse Event|0|||
161556957|NCT00873093|583428953|FG004|Overall Study|Adverse Event|0|||
161556958|NCT00873093|583428949|FG000|Overall Study|Death|0|||
161556959|NCT00873093|583428950|FG001|Overall Study|Death|3|||
161556960|NCT00873093|583428951|FG002|Overall Study|Death|2|||
161556961|NCT00873093|583428952|FG003|Overall Study|Death|0|||
161556962|NCT00873093|583428953|FG004|Overall Study|Death|0|||
161556963|NCT00873093|583428949|FG000|Overall Study|Physician Decision|0|||
161556964|NCT00873093|583428950|FG001|Overall Study|Physician Decision|17|||
161556965|NCT00873093|583428951|FG002|Overall Study|Physician Decision|10|||
161556966|NCT00873093|583428952|FG003|Overall Study|Physician Decision|10|||
161556967|NCT00873093|583428953|FG004|Overall Study|Physician Decision|2|||
161556968|NCT00873093|583428949|FG000|Overall Study|Withdrawal by Subject|1|||
161556969|NCT00873093|583428950|FG001|Overall Study|Withdrawal by Subject|4|||
161556970|NCT00873093|583428951|FG002|Overall Study|Withdrawal by Subject|4|||
161556971|NCT00873093|583428952|FG003|Overall Study|Withdrawal by Subject|0|||
161556972|NCT00873093|583428953|FG004|Overall Study|Withdrawal by Subject|0|||
161556973|NCT00873093|583428949|FG000|Overall Study|Ineligible|0|||
161800796|NCT01508936|584312425|FG001|Overall Study|Protocol Violation|3|||
161800797|NCT01508936|584312424|FG000|Overall Study|Lost to Follow-up|2|||
161800798|NCT01508936|584312425|FG001|Overall Study|Lost to Follow-up|9|||
161800799|NCT01508936|584312424|FG000|Overall Study|Other|0|||
161800800|NCT01508936|584312425|FG001|Overall Study|Other|5|||
161800801|NCT01508936|584312424|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
161800802|NCT01508936|584312425|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
161800803|NCT00679367|584312426|FG000|Overall Study|Adverse Event|7|||
161800804|NCT00679367|584312426|FG000|Overall Study|inability to swallow oral drugs|1|||
161800805|NCT00679367|584312426|FG000|Overall Study|Lack of Efficacy|3|||
161800806|NCT00679367|584312426|FG000|Overall Study|Withdrawal by Subject|1|||
161800807|NCT00922779|584312427|FG000|Overall Study|Adverse Event|67|||
161800808|NCT00922779|584312427|FG000|Overall Study|Pregnancy|7|||
161904363|NCT02357459|584698619|FG000|Overall Study|Pre-planned Knee surgery|0|||
161904364|NCT02357459|584698620|FG001|Overall Study|Pre-planned Knee surgery|0|||
161904365|NCT02357459|584698621|FG002|Overall Study|Pre-planned Knee surgery|2|||
161451492|NCT00913458|583050618|FG003|Phase 1|Sponsor|0|||
161451493|NCT00913458|583050619|FG004|Phase 1|Sponsor|0|||
161451494|NCT00913458|583050620|FG005|Phase 1|Sponsor|0|||
161451495|NCT00913458|583050621|FG006|Phase 1|Sponsor|0|||
161451496|NCT00913458|583050615|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
161451497|NCT00913458|583050616|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
161451498|NCT00913458|583050617|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
161451499|NCT00913458|583050618|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
161451500|NCT00913458|583050619|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
161451501|NCT00913458|583050620|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
161451502|NCT00913458|583050621|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
161451503|NCT00913458|583050615|FG000|Phase 2|Non-Responder|0|||
161451504|NCT00913458|583050616|FG001|Phase 2|Non-Responder|5|||
161451505|NCT00913458|583050617|FG002|Phase 2|Non-Responder|7|||
161451506|NCT00913458|583050618|FG003|Phase 2|Non-Responder|12|||
161451507|NCT00913458|583050619|FG004|Phase 2|Non-Responder|0|||
161451508|NCT00913458|583050620|FG005|Phase 2|Non-Responder|0|||
161451509|NCT00913458|583050621|FG006|Phase 2|Non-Responder|0|||
161451510|NCT00913458|583050615|FG000|Phase 2|Subject Request|0|||
161451511|NCT00913458|583050616|FG001|Phase 2|Subject Request|0|||
161556974|NCT00873093|583428950|FG001|Overall Study|Ineligible|1|||
161800809|NCT00922779|584312427|FG000|Overall Study|Withdrawal by Subject|308|||
161800810|NCT00922779|584312427|FG000|Overall Study|Lost to Follow-up|44|||
161800811|NCT00922779|584312427|FG000|Overall Study|Other|27|||
161800812|NCT00922779|584312427|FG000|Overall Study|Missing|1874|||
161800813|NCT01611090|584312428|FG000|Randomized Period|Lost to Follow-up|8|||
161904366|NCT02357459|584698619|FG000|Overall Study|Job Commitments|0|||
161451512|NCT00913458|583050617|FG002|Phase 2|Subject Request|1|||
161451513|NCT00913458|583050618|FG003|Phase 2|Subject Request|2|||
161451514|NCT00913458|583050619|FG004|Phase 2|Subject Request|0|||
161556975|NCT00873093|583428951|FG002|Overall Study|Ineligible|0|||
161556976|NCT00873093|583428952|FG003|Overall Study|Ineligible|1|||
161800814|NCT01611090|584312429|FG001|Randomized Period|Lost to Follow-up|3|||
161800815|NCT01611090|584312430|FG002|Randomized Period|Lost to Follow-up|0|||
161904367|NCT02357459|584698620|FG001|Overall Study|Job Commitments|0|||
161904368|NCT02357459|584698621|FG002|Overall Study|Job Commitments|1|||
161556977|NCT00873093|583428953|FG004|Overall Study|Ineligible|0|||
161556978|NCT01152554|583428955|FG000|Overall Study|Withdrawal by Subject|73|||
161556979|NCT01152554|583428956|FG001|Overall Study|Withdrawal by Subject|28|||
161556980|NCT01152554|583428955|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
161451515|NCT00913458|583050620|FG005|Phase 2|Subject Request|0|||
161800816|NCT01611090|584312428|FG000|Randomized Period|Withdrawal by Subject|22|||
161800817|NCT01611090|584312429|FG001|Randomized Period|Withdrawal by Subject|26|||
161800818|NCT01611090|584312430|FG002|Randomized Period|Withdrawal by Subject|0|||
161800819|NCT01611090|584312428|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
161800820|NCT01611090|584312429|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
161800821|NCT01611090|584312430|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
161800822|NCT01611090|584312428|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
161800823|NCT01611090|584312429|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
161800824|NCT01611090|584312430|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
161800825|NCT03968224|584312431|FG000|Overall Study|Lost to Follow-up|11|||
161800826|NCT03968224|584312432|FG001|Overall Study|Lost to Follow-up|18|||
161800827|NCT04256421|584312434|FG000|Overall Study|Death|171|||
161800828|NCT04256421|584312435|FG001|Overall Study|Death|180|||
161800829|NCT04256421|584312434|FG000|Overall Study|Lost to Follow-up|1|||
161800830|NCT04256421|584312435|FG001|Overall Study|Lost to Follow-up|1|||
161800831|NCT04256421|584312434|FG000|Overall Study|Withdrawal by Subject|9|||
161800832|NCT04256421|584312435|FG001|Overall Study|Withdrawal by Subject|10|||
161800833|NCT04256421|584312434|FG000|Overall Study|Ongoing in Study|66|||
161800834|NCT04256421|584312435|FG001|Overall Study|Ongoing in Study|52|||
161800835|NCT05771428|584314373|FG000|Overall Study|Adverse Event|0|||
161800836|NCT05771428|584314374|FG001|Overall Study|Adverse Event|1|||
161800837|NCT05771428|584314375|FG002|Overall Study|Adverse Event|1|||
161800838|NCT05771428|584314376|FG003|Overall Study|Adverse Event|1|||
161800839|NCT05771428|584314373|FG000|Overall Study|Withdrawal by Subject|3|||
161800840|NCT05771428|584314374|FG001|Overall Study|Withdrawal by Subject|2|||
161800841|NCT05771428|584314375|FG002|Overall Study|Withdrawal by Subject|1|||
161800842|NCT05771428|584314376|FG003|Overall Study|Withdrawal by Subject|4|||
161800843|NCT05771428|584314373|FG000|Overall Study|Other|0|||
161800844|NCT05771428|584314374|FG001|Overall Study|Other|1|||
161800845|NCT05771428|584314375|FG002|Overall Study|Other|2|||
161800846|NCT05771428|584314376|FG003|Overall Study|Other|1|||
161800847|NCT05771428|584314373|FG000|Overall Study|Randomized but Not Treated|0|||
161800848|NCT05771428|584314374|FG001|Overall Study|Randomized but Not Treated|0|||
161800849|NCT05771428|584314375|FG002|Overall Study|Randomized but Not Treated|1|||
161800850|NCT05771428|584314376|FG003|Overall Study|Randomized but Not Treated|0|||
161451516|NCT00913458|583050621|FG006|Phase 2|Subject Request|0|||
161451517|NCT00913458|583050615|FG000|Phase 2|Adverse Event|0|||
161451518|NCT00913458|583050616|FG001|Phase 2|Adverse Event|3|||
161451519|NCT00913458|583050617|FG002|Phase 2|Adverse Event|0|||
161451520|NCT00913458|583050618|FG003|Phase 2|Adverse Event|1|||
161451521|NCT00913458|583050619|FG004|Phase 2|Adverse Event|0|||
161451522|NCT00913458|583050620|FG005|Phase 2|Adverse Event|0|||
161451523|NCT00913458|583050621|FG006|Phase 2|Adverse Event|0|||
161451524|NCT00913458|583050615|FG000|Phase 2|Lost to Follow-up|0|||
161451525|NCT00913458|583050616|FG001|Phase 2|Lost to Follow-up|0|||
161451526|NCT00913458|583050617|FG002|Phase 2|Lost to Follow-up|0|||
161451527|NCT00913458|583050618|FG003|Phase 2|Lost to Follow-up|1|||
161451528|NCT00913458|583050619|FG004|Phase 2|Lost to Follow-up|0|||
161451529|NCT00913458|583050620|FG005|Phase 2|Lost to Follow-up|0|||
161451530|NCT00913458|583050621|FG006|Phase 2|Lost to Follow-up|0|||
161451531|NCT00913458|583050615|FG000|Phase 2|Protocol Violation|0|||
161451532|NCT00913458|583050616|FG001|Phase 2|Protocol Violation|2|||
161451533|NCT00913458|583050617|FG002|Phase 2|Protocol Violation|0|||
161451534|NCT00913458|583050618|FG003|Phase 2|Protocol Violation|0|||
161451535|NCT00913458|583050619|FG004|Phase 2|Protocol Violation|0|||
161451536|NCT00913458|583050620|FG005|Phase 2|Protocol Violation|0|||
161451537|NCT00913458|583050621|FG006|Phase 2|Protocol Violation|0|||
161451538|NCT00913458|583050615|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
161451539|NCT00913458|583050616|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
161451540|NCT00913458|583050617|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
161451541|NCT00913458|583050618|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
161800851|NCT04025229|584314377|FG000|Overall Study|Adverse Event|1|||
161451542|NCT00913458|583050619|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
161451543|NCT00913458|583050620|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
161451544|NCT00913458|583050621|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
161451545|NCT00913458|583050615|FG000|Phase 3|Adverse Event|0|||
161451546|NCT00913458|583050616|FG001|Phase 3|Adverse Event|0|||
161451547|NCT00913458|583050617|FG002|Phase 3|Adverse Event|0|||
161451548|NCT00913458|583050618|FG003|Phase 3|Adverse Event|0|||
161451549|NCT00913458|583050619|FG004|Phase 3|Adverse Event|5|||
161451550|NCT00913458|583050620|FG005|Phase 3|Adverse Event|4|||
161451551|NCT00913458|583050621|FG006|Phase 3|Adverse Event|1|||
161451552|NCT00913458|583050615|FG000|Phase 3|Lost to Follow-up|0|||
161451553|NCT00913458|583050616|FG001|Phase 3|Lost to Follow-up|0|||
161451554|NCT00913458|583050617|FG002|Phase 3|Lost to Follow-up|0|||
161800852|NCT04025229|584314378|FG001|Overall Study|Adverse Event|0|||
161800853|NCT04025229|584314377|FG000|Overall Study|Withdrawal by Subject|0|||
161800854|NCT04025229|584314378|FG001|Overall Study|Withdrawal by Subject|2|||
161800855|NCT04025229|584314377|FG000|Overall Study|Death|0|||
161800856|NCT04025229|584314378|FG001|Overall Study|Death|1|||
161800857|NCT04025229|584314377|FG000|Overall Study|Physician Decision|0|||
161800858|NCT04025229|584314378|FG001|Overall Study|Physician Decision|1|||
161800859|NCT03815942|584314379|FG000|Overall Study|Withdrawal by Subject|0|||
161800860|NCT03815942|584314380|FG001|Overall Study|Withdrawal by Subject|17|||
161800861|NCT00366899|584314381|FG000|Infant Series|Withdrawal by Subject|4|||
161800862|NCT00366899|584314382|FG001|Infant Series|Withdrawal by Subject|7|||
161800863|NCT00366899|584314381|FG000|Infant Series|Protocol Violation|2|||
161800864|NCT00366899|584314382|FG001|Infant Series|Protocol Violation|1|||
161800865|NCT00366899|584314381|FG000|Infant Series|Failed to return|1|||
161800866|NCT00366899|584314382|FG001|Infant Series|Failed to return|1|||
161800867|NCT00366899|584314381|FG000|Infant Series|Lost to Follow-up|0|||
161800868|NCT00366899|584314382|FG001|Infant Series|Lost to Follow-up|2|||
161800869|NCT00366899|584314381|FG000|Infant Series|Adverse Event|0|||
161800870|NCT00366899|584314382|FG001|Infant Series|Adverse Event|1|||
161800871|NCT00366899|584314381|FG000|Infant Series|Physician Decision|1|||
161800872|NCT00366899|584314382|FG001|Infant Series|Physician Decision|0|||
161800873|NCT00366899|584314381|FG000|Infant Series|Randomized but not consented|1|||
161800874|NCT00366899|584314382|FG001|Infant Series|Randomized but not consented|0|||
161800875|NCT00366899|584314381|FG000|After Infant Series|Lost to Follow-up|4|||
161800876|NCT00366899|584314382|FG001|After Infant Series|Lost to Follow-up|3|||
161800877|NCT00366899|584314381|FG000|After Infant Series|Withdrawal by Subject|1|||
161800878|NCT00366899|584314382|FG001|After Infant Series|Withdrawal by Subject|4|||
161800879|NCT00366899|584314381|FG000|After Infant Series|Adverse Event|1|||
161800880|NCT00366899|584314382|FG001|After Infant Series|Adverse Event|2|||
161800881|NCT00366899|584314381|FG000|After Infant Series|Protocol Violation|1|||
161800882|NCT00366899|584314382|FG001|After Infant Series|Protocol Violation|0|||
161800883|NCT00366899|584314381|FG000|Toddler Dose|Withdrawal by Subject|1|||
161800884|NCT00366899|584314382|FG001|Toddler Dose|Withdrawal by Subject|1|||
161800885|NCT00366899|584314381|FG000|Toddler Dose|Protocol Violation|1|||
161800886|NCT00366899|584314382|FG001|Toddler Dose|Protocol Violation|0|||
161800887|NCT03601637|584314383|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
161800888|NCT03601637|584314384|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
161800889|NCT03601637|584314383|FG000|Overall Study|Adverse Event|1|||
161800890|NCT03601637|584314384|FG001|Overall Study|Adverse Event|1|||
161800891|NCT03601637|584314383|FG000|Overall Study|Other|0|||
161800892|NCT03601637|584314384|FG001|Overall Study|Other|1|||
161800893|NCT02322047|584314386|FG000|Overall Study|Physician Decision|1|||
161800894|NCT02322047|584314387|FG001|Overall Study|Physician Decision|0|||
161800895|NCT02322047|584314388|FG002|Overall Study|Physician Decision|0|||
161800896|NCT02322047|584314389|FG003|Overall Study|Physician Decision|0|||
161800897|NCT02322047|584314386|FG000|Overall Study|Withdrawal by Subject|1|||
161800898|NCT02322047|584314387|FG001|Overall Study|Withdrawal by Subject|0|||
161800899|NCT02322047|584314388|FG002|Overall Study|Withdrawal by Subject|0|||
161800900|NCT02322047|584314389|FG003|Overall Study|Withdrawal by Subject|1|||
161800901|NCT02322047|584314386|FG000|Overall Study|Adverse Event|0|||
161800902|NCT02322047|584314387|FG001|Overall Study|Adverse Event|1|||
161800903|NCT02322047|584314388|FG002|Overall Study|Adverse Event|0|||
161800904|NCT02322047|584314389|FG003|Overall Study|Adverse Event|0|||
161800905|NCT02322047|584314386|FG000|Overall Study|Lost to Follow-up|0|||
161800906|NCT02322047|584314387|FG001|Overall Study|Lost to Follow-up|0|||
161800907|NCT02322047|584314388|FG002|Overall Study|Lost to Follow-up|1|||
161800908|NCT02322047|584314389|FG003|Overall Study|Lost to Follow-up|1|||
161800909|NCT00920140|584314392|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
161800910|NCT00920140|584314393|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
161800911|NCT00920140|584314394|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
161800912|NCT00920140|584314395|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
161800913|NCT00920140|584314396|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
161800914|NCT00920140|584314392|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
161800915|NCT00920140|584314393|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
161800916|NCT00920140|584314394|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161800917|NCT00920140|584314395|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161800918|NCT00920140|584314396|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161800919|NCT00920140|584314392|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800920|NCT00920140|584314393|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
161800921|NCT00920140|584314394|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800922|NCT00920140|584314395|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800923|NCT00920140|584314396|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800924|NCT00920140|584314392|FG000|Phase 2|Adverse Event|0|||
161800925|NCT00920140|584314393|FG001|Phase 2|Adverse Event|0|||
161800926|NCT00920140|584314394|FG002|Phase 2|Adverse Event|14|||
161800927|NCT00920140|584314395|FG003|Phase 2|Adverse Event|2|||
161800928|NCT00920140|584314396|FG004|Phase 2|Adverse Event|3|||
161800929|NCT00920140|584314392|FG000|Phase 2|Lack of Efficacy|0|||
161800930|NCT00920140|584314393|FG001|Phase 2|Lack of Efficacy|0|||
161800931|NCT00920140|584314394|FG002|Phase 2|Lack of Efficacy|29|||
161800932|NCT00920140|584314395|FG003|Phase 2|Lack of Efficacy|14|||
161800933|NCT00920140|584314396|FG004|Phase 2|Lack of Efficacy|5|||
161556981|NCT01152554|583428956|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
161556982|NCT01152554|583428955|FG000|Overall Study|Adverse Event|67|||
161556983|NCT01152554|583428956|FG001|Overall Study|Adverse Event|14|||
161556984|NCT01152554|583428955|FG000|Overall Study|Severe non-compliance to protocol|36|||
161556985|NCT01152554|583428956|FG001|Overall Study|Severe non-compliance to protocol|14|||
161556986|NCT01152554|583428955|FG000|Overall Study|Condition under investigation worsened|5|||
161556987|NCT01152554|583428956|FG001|Overall Study|Condition under investigation worsened|2|||
161800934|NCT00920140|584314392|FG000|Phase 2|Lost to Follow-up|0|||
161800935|NCT00920140|584314393|FG001|Phase 2|Lost to Follow-up|0|||
161800936|NCT00920140|584314394|FG002|Phase 2|Lost to Follow-up|0|||
161800937|NCT00920140|584314395|FG003|Phase 2|Lost to Follow-up|1|||
161800938|NCT00920140|584314396|FG004|Phase 2|Lost to Follow-up|0|||
161800939|NCT00920140|584314392|FG000|Phase 2|Physician Decision|0|||
161800940|NCT00920140|584314393|FG001|Phase 2|Physician Decision|0|||
161800941|NCT00920140|584314394|FG002|Phase 2|Physician Decision|3|||
161800942|NCT00920140|584314395|FG003|Phase 2|Physician Decision|3|||
161800943|NCT00920140|584314396|FG004|Phase 2|Physician Decision|2|||
161800944|NCT00920140|584314392|FG000|Phase 2|Withdrawal by Subject|0|||
161800945|NCT00920140|584314393|FG001|Phase 2|Withdrawal by Subject|0|||
161800946|NCT00920140|584314394|FG002|Phase 2|Withdrawal by Subject|4|||
161800947|NCT00920140|584314395|FG003|Phase 2|Withdrawal by Subject|2|||
161800948|NCT00920140|584314396|FG004|Phase 2|Withdrawal by Subject|1|||
161800949|NCT01400425|584314397|FG000|Overall Study|Withdrawal by Subject|10|||
161800950|NCT00720096|584314399|FG000|Overall Study|Withdrawal by Subject|0|||
161800951|NCT00720096|584314400|FG001|Overall Study|Withdrawal by Subject|2|||
161800952|NCT04557124|584314401|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
161800953|NCT04557124|584314402|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
161800954|NCT04557124|584314401|FG000|Mid-point (1 Month)|Missed testing|5|||
161800955|NCT04557124|584314402|FG001|Mid-point (1 Month)|Missed testing|4|||
161800956|NCT04557124|584314401|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
161800957|NCT04557124|584314402|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
161800958|NCT04557124|584314401|FG000|Post-testing (2 Months)|Missed testing|1|||
161800959|NCT04557124|584314402|FG001|Post-testing (2 Months)|Missed testing|5|||
161800960|NCT04557124|584314401|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
161800961|NCT04557124|584314402|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
161800962|NCT04557124|584314401|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
161800963|NCT04557124|584314402|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
161800964|NCT00001849|584314403|FG000|Overall Study|Death|4|||
161800965|NCT00001849|584314403|FG000|Overall Study|Lost to Follow-up|2|||
161800966|NCT00001849|584314403|FG000|Overall Study|Withdrawal by Subject|2|||
161800967|NCT00001849|584314403|FG000|Overall Study|tumor remained occult|6|||
161800968|NCT00442936|584314404|FG000|Overall Study|Protocol Violation|1|||
161800969|NCT00442936|584314405|FG001|Overall Study|Protocol Violation|0|||
161800970|NCT00442936|584314406|FG002|Overall Study|Protocol Violation|1|||
161800971|NCT00442936|584314407|FG003|Overall Study|Protocol Violation|1|||
161800972|NCT02428699|584314408|FG000|Washout Period 1|Screen Failure|1|||
161800973|NCT02428699|584314409|FG001|Washout Period 1|Screen Failure|2|||
161800974|NCT03127137|584314410|FG000|Overall Study|Requested sedation after consent|1|||
161800975|NCT03127137|584314411|FG001|Overall Study|Requested sedation after consent|0|||
161800976|NCT03127137|584314410|FG000|Overall Study|Malfunction in electronic data collection|1|||
161800977|NCT03127137|584314411|FG001|Overall Study|Malfunction in electronic data collection|0|||
161800978|NCT03127137|584314410|FG000|Overall Study|Post procedure testing could not be obtained|0|||
161800979|NCT03127137|584314411|FG001|Overall Study|Post procedure testing could not be obtained|1|||
161800980|NCT04424407|584314412|FG000|Overall Study|Withdrawal by Subject|2|||
161800981|NCT04424407|584314412|FG000|Overall Study|Lost to Follow-up|1|||
161800982|NCT00264797|584314413|FG000|Overall Study|Withdrawal by Subject|11|||
161800983|NCT00264797|584314414|FG001|Overall Study|Withdrawal by Subject|11|||
161800984|NCT00264797|584314413|FG000|Overall Study|Lost to Follow-up|9|||
161800985|NCT00264797|584314414|FG001|Overall Study|Lost to Follow-up|17|||
161800986|NCT00264797|584314413|FG000|Overall Study|Moved from area|3|||
161800987|NCT00264797|584314414|FG001|Overall Study|Moved from area|1|||
161556988|NCT01152554|583428955|FG000|Overall Study|Lack of Efficacy|20|||
161556989|NCT01152554|583428956|FG001|Overall Study|Lack of Efficacy|3|||
161556990|NCT01152554|583428955|FG000|Overall Study|Study-specific withdrawal criteria|17|||
161800988|NCT00264797|584314413|FG000|Overall Study|Practical Problems|2|||
161800989|NCT00264797|584314414|FG001|Overall Study|Practical Problems|3|||
161800990|NCT00264797|584314413|FG000|Overall Study|Incarceration|4|||
161800991|NCT00264797|584314414|FG001|Overall Study|Incarceration|5|||
161800992|NCT00264797|584314413|FG000|Overall Study|Pressure/advice from Outsiders|1|||
161800993|NCT00264797|584314414|FG001|Overall Study|Pressure/advice from Outsiders|1|||
161556991|NCT01152554|583428956|FG001|Overall Study|Study-specific withdrawal criteria|8|||
161556992|NCT01152554|583428955|FG000|Overall Study|Lost to Follow-up|87|||
161800994|NCT00264797|584314413|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
161800995|NCT00264797|584314414|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
161800996|NCT00264797|584314413|FG000|Overall Study|Other|3|||
161800997|NCT00264797|584314414|FG001|Overall Study|Other|4|||
161904369|NCT03246347|584698622|FG000|Overall Study|On Study|23|||
161800998|NCT03992196|584314415|FG000|Enrollment|lost to follow-up prior dosing|1|||
161800999|NCT03992196|584314416|FG001|Enrollment|lost to follow-up prior dosing|0|||
161451555|NCT00913458|583050618|FG003|Phase 3|Lost to Follow-up|0|||
161801000|NCT03992196|584314417|FG002|Enrollment|lost to follow-up prior dosing|0|||
161801001|NCT03992196|584314415|FG000|Treatment|Protocol Violation|0|||
161801002|NCT03992196|584314416|FG001|Treatment|Protocol Violation|0|||
161801003|NCT03992196|584314417|FG002|Treatment|Protocol Violation|1|||
161801004|NCT03992196|584314415|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
161801005|NCT03992196|584314416|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
161801006|NCT03992196|584314417|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
161801007|NCT03992196|584314415|FG000|Treatment|Withdrawal due to non-compliance|0|||
161801008|NCT03992196|584314416|FG001|Treatment|Withdrawal due to non-compliance|0|||
161801009|NCT03992196|584314417|FG002|Treatment|Withdrawal due to non-compliance|1|||
161801010|NCT03992196|584314415|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
161801011|NCT03992196|584314416|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
161801012|NCT03992196|584314417|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
161801013|NCT03992196|584314415|FG000|Treatment|Withdrawal by parent/guardian|0|||
161801014|NCT03992196|584314416|FG001|Treatment|Withdrawal by parent/guardian|0|||
161801015|NCT03992196|584314417|FG002|Treatment|Withdrawal by parent/guardian|2|||
161801016|NCT00755196|584314419|FG000|Overall Study|Lost to Follow-up|1|||
161801017|NCT00755196|584314419|FG000|Overall Study|Lack of Efficiency|1|||
161801018|NCT02388763|584314420|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
161801019|NCT02388763|584314421|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
161801020|NCT02388763|584314420|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
161801021|NCT02388763|584314421|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
161801022|NCT01604850|584314422|FG000|Overall Study|Enrolled but never treated|0|||
161904370|NCT00916578|584698623|FG000|Overall Study|Physician Decision|2|||
161451556|NCT00913458|583050619|FG004|Phase 3|Lost to Follow-up|2|||
161451557|NCT00913458|583050620|FG005|Phase 3|Lost to Follow-up|0|||
161451558|NCT00913458|583050621|FG006|Phase 3|Lost to Follow-up|0|||
161451559|NCT00913458|583050615|FG000|Phase 3|Non-Responder|0|||
161451560|NCT00913458|583050616|FG001|Phase 3|Non-Responder|0|||
161451561|NCT00913458|583050617|FG002|Phase 3|Non-Responder|0|||
161451562|NCT00913458|583050618|FG003|Phase 3|Non-Responder|0|||
161451563|NCT00913458|583050619|FG004|Phase 3|Non-Responder|0|||
161451564|NCT00913458|583050620|FG005|Phase 3|Non-Responder|1|||
161451565|NCT00913458|583050621|FG006|Phase 3|Non-Responder|3|||
161451566|NCT00913458|583050615|FG000|Phase 3|Withdrawal by Subject|0|||
161451567|NCT00913458|583050616|FG001|Phase 3|Withdrawal by Subject|0|||
161451568|NCT00913458|583050617|FG002|Phase 3|Withdrawal by Subject|0|||
161451569|NCT00913458|583050618|FG003|Phase 3|Withdrawal by Subject|0|||
161451570|NCT00913458|583050619|FG004|Phase 3|Withdrawal by Subject|1|||
161451571|NCT00913458|583050620|FG005|Phase 3|Withdrawal by Subject|2|||
161451572|NCT00913458|583050621|FG006|Phase 3|Withdrawal by Subject|0|||
161451573|NCT00913458|583050615|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
161451574|NCT00913458|583050616|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
161451575|NCT00913458|583050617|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
161451576|NCT00913458|583050618|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
161451577|NCT00913458|583050619|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
161451578|NCT00913458|583050620|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
161451579|NCT00913458|583050621|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
161451580|NCT02366091|583050622|FG000|Overall Study|Withdrawal by Subject|3|||
161451581|NCT02366091|583050623|FG001|Overall Study|Withdrawal by Subject|7|||
161451582|NCT02366091|583050624|FG002|Overall Study|Withdrawal by Subject|3|||
161451583|NCT02366091|583050625|FG003|Overall Study|Withdrawal by Subject|1|||
161451584|NCT02338232|583050626|FG000|Overall Study|Screen Failure|3|||
161904371|NCT00916578|584698623|FG000|Overall Study|Withdrawal by Subject|3|||
161904372|NCT00916578|584698623|FG000|Overall Study|Insurance Denial|2|||
161451585|NCT02338232|583050626|FG000|Overall Study|Withdrawal by Subject|6|||
161451586|NCT02338232|583050626|FG000|Overall Study|Adverse Event|2|||
161451587|NCT03890666|583050627|FG000|Overall Study|Withdrawal by Subject|0|||
161451588|NCT03890666|583050628|FG001|Overall Study|Withdrawal by Subject|1|||
161451589|NCT03890666|583050627|FG000|Overall Study|Protocol deviation|1|||
161451590|NCT03890666|583050628|FG001|Overall Study|Protocol deviation|4|||
161451591|NCT03890666|583050627|FG000|Overall Study|Lost to Follow-up|2|||
161451592|NCT03890666|583050628|FG001|Overall Study|Lost to Follow-up|5|||
161451593|NCT03890666|583050627|FG000|Overall Study|Other than specified|1|||
161451594|NCT03890666|583050628|FG001|Overall Study|Other than specified|8|||
161451595|NCT01105065|583050629|FG000|Overall Study|Adverse Event|5|||
161451596|NCT01105065|583050629|FG000|Overall Study|Technical Problems|1|||
161451597|NCT02122783|583050633|FG000|Overall Study|Adverse Event|0|||
161451598|NCT02122783|583050634|FG001|Overall Study|Adverse Event|1|||
161451599|NCT00322621|583050635|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
161451600|NCT00322621|583050636|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
161451601|NCT00322621|583050637|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
161556993|NCT01152554|583428956|FG001|Overall Study|Lost to Follow-up|32|||
161904373|NCT02771275|584698630|FG000|Overall Study|Reoperation|3|||
161904374|NCT02771275|584698630|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
161904375|NCT05556148|584698631|FG000|Overall Study|Early Termination|29|||
161904376|NCT05556148|584698631|FG000|Overall Study|Baseline Tasks Expired|4|||
161904377|NCT05556148|584698631|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
161904378|NCT05556148|584698631|FG000|Overall Study|No Longer Wished to Participate|1|||
161904379|NCT05556148|584698631|FG000|Overall Study|Bacterial Conjunctivitis|1|||
161904380|NCT01171898|584698632|FG000|Overall Study|Death|0|||
161904381|NCT01171898|584698633|FG001|Overall Study|Death|0|||
161904382|NCT01171898|584698634|FG002|Overall Study|Death|2|||
161904383|NCT01171898|584698635|FG003|Overall Study|Death|0|||
161904384|NCT01171898|584698632|FG000|Overall Study|Lost to Follow-up|0|||
161904385|NCT01171898|584698633|FG001|Overall Study|Lost to Follow-up|1|||
161904386|NCT01171898|584698634|FG002|Overall Study|Lost to Follow-up|1|||
161904387|NCT01171898|584698635|FG003|Overall Study|Lost to Follow-up|1|||
161904388|NCT01171898|584698632|FG000|Overall Study|Withdrawal by Subject|1|||
161904389|NCT01171898|584698633|FG001|Overall Study|Withdrawal by Subject|4|||
161904390|NCT01171898|584698634|FG002|Overall Study|Withdrawal by Subject|6|||
161904391|NCT01171898|584698635|FG003|Overall Study|Withdrawal by Subject|3|||
161904392|NCT01171898|584698632|FG000|Overall Study|Terminated by Sponsor|1|||
161904393|NCT01171898|584698633|FG001|Overall Study|Terminated by Sponsor|0|||
161904394|NCT01171898|584698634|FG002|Overall Study|Terminated by Sponsor|0|||
161904395|NCT01171898|584698635|FG003|Overall Study|Terminated by Sponsor|0|||
161904396|NCT01171898|584698632|FG000|Overall Study|Ongoing|1|||
161904397|NCT01171898|584698633|FG001|Overall Study|Ongoing|9|||
161904398|NCT01171898|584698634|FG002|Overall Study|Ongoing|3|||
161904399|NCT01171898|584698635|FG003|Overall Study|Ongoing|0|||
161904400|NCT01171898|584698632|FG000|Overall Study|Other|1|||
161904401|NCT01171898|584698633|FG001|Overall Study|Other|5|||
161904402|NCT01171898|584698634|FG002|Overall Study|Other|0|||
161904403|NCT01171898|584698635|FG003|Overall Study|Other|2|||
161904404|NCT03191799|584698636|FG000|Overall Study|Withdrawal by Subject|4|||
161904405|NCT03191799|584698636|FG000|Overall Study|Physician Decision|2|||
161904406|NCT03191799|584698636|FG000|Overall Study|Lost to Follow-up|1|||
161904407|NCT03191799|584698636|FG000|Overall Study|Death|2|||
161904408|NCT01239797|584698637|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
161904409|NCT01239797|584698638|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
161904410|NCT01239797|584698637|FG000|Randomized Participants|Participant withdrew consent|1|||
161904411|NCT01239797|584698638|FG001|Randomized Participants|Participant withdrew consent|7|||
161904412|NCT01239797|584698637|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
161904413|NCT01239797|584698638|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
161904414|NCT01239797|584698637|FG000|Treated Participants|Disease progression|185|||
161904415|NCT01239797|584698638|FG001|Treated Participants|Disease progression|185|||
161904416|NCT01239797|584698637|FG000|Treated Participants|Study drug toxicity|39|||
161904417|NCT01239797|584698638|FG001|Treated Participants|Study drug toxicity|45|||
161904418|NCT01239797|584698637|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
161904419|NCT01239797|584698638|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
161904420|NCT01239797|584698637|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
161904421|NCT01239797|584698638|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
161904422|NCT01239797|584698637|FG000|Treated Participants|Administrative reason by sponsor|13|||
161904423|NCT01239797|584698638|FG001|Treated Participants|Administrative reason by sponsor|4|||
161904424|NCT01239797|584698637|FG000|Treated Participants|Other reasons|14|||
161904425|NCT01239797|584698638|FG001|Treated Participants|Other reasons|14|||
161904426|NCT01239797|584698637|FG000|Treated Participants|Participant withdrew consent|6|||
161904427|NCT01239797|584698638|FG001|Treated Participants|Participant withdrew consent|11|||
161904428|NCT01239797|584698637|FG000|Treated Participants|Death|1|||
161904429|NCT01239797|584698638|FG001|Treated Participants|Death|1|||
161904430|NCT01239797|584698637|FG000|Treated Participants|Participant no longer meets study criteria|1|||
161904431|NCT01239797|584698638|FG001|Treated Participants|Participant no longer meets study criteria|1|||
161904432|NCT01239797|584698637|FG000|Treated Participants|Poor/non-compliance|0|||
161904433|NCT01239797|584698638|FG001|Treated Participants|Poor/non-compliance|1|||
161904434|NCT00853762|584698641|FG000|Overall Study|Premature Termination|16|||
161904435|NCT00853762|584698642|FG001|Overall Study|Premature Termination|15|||
161904436|NCT00853762|584698643|FG002|Overall Study|Premature Termination|14|||
161451602|NCT00322621|583050635|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
161451603|NCT00322621|583050636|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
161451604|NCT00322621|583050637|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
161451605|NCT00322621|583050635|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
161451606|NCT00322621|583050636|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
161904437|NCT00853762|584698644|FG003|Overall Study|Premature Termination|21|||
161904438|NCT00853762|584698641|FG000|Overall Study|Protocol Violation|0|||
161904439|NCT00853762|584698642|FG001|Overall Study|Protocol Violation|0|||
161904440|NCT00853762|584698643|FG002|Overall Study|Protocol Violation|0|||
161556994|NCT01152554|583428955|FG000|Overall Study|Other|28|||
161556995|NCT01152554|583428956|FG001|Overall Study|Other|8|||
161556996|NCT01152554|583428955|FG000|Overall Study|Death|1|||
161556997|NCT01152554|583428956|FG001|Overall Study|Death|1|||
161556998|NCT00146640|583428959|FG000|Overall Study|Adverse Event|12|||
161556999|NCT00146640|583428960|FG001|Overall Study|Adverse Event|10|||
161557000|NCT00146640|583428959|FG000|Overall Study|Medical Reasons|3|||
161557001|NCT00146640|583428960|FG001|Overall Study|Medical Reasons|0|||
161557002|NCT00146640|583428959|FG000|Overall Study|Non-Medical Reasons|8|||
161557003|NCT00146640|583428960|FG001|Overall Study|Non-Medical Reasons|4|||
161557004|NCT03486899|583428961|FG000|Overall Study|Lost to Follow-up|4|||
161557005|NCT03486899|583428962|FG001|Overall Study|Lost to Follow-up|1|||
161557006|NCT03486899|583428963|FG002|Overall Study|Lost to Follow-up|4|||
161557007|NCT03486899|583428964|FG003|Overall Study|Lost to Follow-up|3|||
161557008|NCT03486899|583428961|FG000|Overall Study|Death|1|||
161557009|NCT03486899|583428962|FG001|Overall Study|Death|0|||
161557010|NCT03486899|583428963|FG002|Overall Study|Death|0|||
161557011|NCT03486899|583428964|FG003|Overall Study|Death|1|||
161557012|NCT03486899|583428961|FG000|Overall Study|Adverse Event|0|||
161557013|NCT03486899|583428962|FG001|Overall Study|Adverse Event|2|||
161557014|NCT03486899|583428963|FG002|Overall Study|Adverse Event|0|||
161557015|NCT03486899|583428964|FG003|Overall Study|Adverse Event|2|||
161557016|NCT03486899|583428961|FG000|Overall Study|Withdrawal by Subject|3|||
161557017|NCT03486899|583428962|FG001|Overall Study|Withdrawal by Subject|7|||
161557018|NCT03486899|583428963|FG002|Overall Study|Withdrawal by Subject|4|||
161557019|NCT03486899|583428964|FG003|Overall Study|Withdrawal by Subject|3|||
161557020|NCT03486899|583428961|FG000|Overall Study|Other Reasons|0|||
161557021|NCT03486899|583428962|FG001|Overall Study|Other Reasons|1|||
161557022|NCT03486899|583428963|FG002|Overall Study|Other Reasons|0|||
161557023|NCT03486899|583428964|FG003|Overall Study|Other Reasons|1|||
161557024|NCT01439711|583428965|FG000|Overall Study|Ineligible|13|||
161557025|NCT01439711|583428965|FG000|Overall Study|Cancel|3|||
161557026|NCT01439711|583428965|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
161557027|NCT01439711|583428965|FG000|Overall Study|Adverse Event|5|||
161557028|NCT01439711|583428965|FG000|Overall Study|Withdrawal by Subject|3|||
161557029|NCT01439711|583428965|FG000|Overall Study|Progression During Active Tx|3|||
161557030|NCT01439711|583428965|FG000|Overall Study|Noncompliance|3|||
161557031|NCT01439711|583428965|FG000|Overall Study|No MRI|9|||
161557032|NCT04242875|583428966|FG000|Overall Study|Adverse Event|2|||
161557033|NCT02397460|583428967|FG000|Treatment Period 2|Adverse Event|0|||
161557034|NCT02397460|583428968|FG001|Treatment Period 2|Adverse Event|0|||
161557035|NCT02397460|583428969|FG002|Treatment Period 2|Adverse Event|0|||
161557036|NCT02397460|583428970|FG003|Treatment Period 2|Adverse Event|0|||
161557037|NCT02397460|583428971|FG004|Treatment Period 2|Adverse Event|0|||
161557038|NCT02397460|583428972|FG005|Treatment Period 2|Adverse Event|0|||
161557039|NCT02397460|583428973|FG006|Treatment Period 2|Adverse Event|0|||
161557040|NCT02397460|583428974|FG007|Treatment Period 2|Adverse Event|1|||
161557041|NCT02397460|583428967|FG000|Treatment Period 4|Adverse Event|0|||
161557042|NCT02397460|583428968|FG001|Treatment Period 4|Adverse Event|1|||
161557043|NCT02397460|583428969|FG002|Treatment Period 4|Adverse Event|0|||
161557044|NCT02397460|583428970|FG003|Treatment Period 4|Adverse Event|0|||
161557045|NCT02397460|583428971|FG004|Treatment Period 4|Adverse Event|0|||
161557046|NCT02397460|583428972|FG005|Treatment Period 4|Adverse Event|0|||
161801023|NCT01604850|584314423|FG001|Overall Study|Enrolled but never treated|1|||
161801024|NCT01604850|584314422|FG000|Overall Study|Efficacy Failure|50|||
161801025|NCT01604850|584314423|FG001|Overall Study|Efficacy Failure|29|||
161801026|NCT01604850|584314422|FG000|Overall Study|Lost to Follow-up|1|||
161801027|NCT01604850|584314423|FG001|Overall Study|Lost to Follow-up|0|||
161801028|NCT01604850|584314422|FG000|Overall Study|Subject withdrew consent|1|||
161801029|NCT01604850|584314423|FG001|Overall Study|Subject withdrew consent|0|||
161801030|NCT01703832|584314424|FG000|Overall Study|Withdrawal by Subject|1|||
161904441|NCT00853762|584698644|FG003|Overall Study|Protocol Violation|1|||
161801031|NCT01703832|584314425|FG001|Overall Study|Withdrawal by Subject|0|||
161904442|NCT00853762|584698641|FG000|Overall Study|Withdrawal by Subject|0|||
161904443|NCT00853762|584698642|FG001|Overall Study|Withdrawal by Subject|0|||
161904444|NCT00853762|584698643|FG002|Overall Study|Withdrawal by Subject|1|||
161557047|NCT02397460|583428973|FG006|Treatment Period 4|Adverse Event|0|||
161557048|NCT02397460|583428974|FG007|Treatment Period 4|Adverse Event|0|||
161557049|NCT02397460|583428967|FG000|Treatment Period 4|Physician Decision|0|||
161557050|NCT02397460|583428968|FG001|Treatment Period 4|Physician Decision|0|||
161557051|NCT02397460|583428969|FG002|Treatment Period 4|Physician Decision|0|||
161557052|NCT02397460|583428970|FG003|Treatment Period 4|Physician Decision|0|||
161557053|NCT02397460|583428971|FG004|Treatment Period 4|Physician Decision|1|||
161557054|NCT02397460|583428972|FG005|Treatment Period 4|Physician Decision|0|||
161557055|NCT02397460|583428973|FG006|Treatment Period 4|Physician Decision|0|||
161557056|NCT02397460|583428974|FG007|Treatment Period 4|Physician Decision|0|||
161557057|NCT01723826|583428978|FG000|Overall Study|Adverse Event|4|||
161557058|NCT01723826|583428979|FG001|Overall Study|Adverse Event|1|||
161557059|NCT01723826|583428980|FG002|Overall Study|Adverse Event|4|||
161557060|NCT01723826|583428981|FG003|Overall Study|Adverse Event|5|||
161904445|NCT00853762|584698644|FG003|Overall Study|Withdrawal by Subject|0|||
161904446|NCT00853762|584698641|FG000|Overall Study|Other|0|||
161904447|NCT00853762|584698642|FG001|Overall Study|Other|2|||
161904448|NCT00853762|584698643|FG002|Overall Study|Other|0|||
161904449|NCT00853762|584698644|FG003|Overall Study|Other|0|||
161904450|NCT00853762|584698641|FG000|Overall Study|Randomised but not Treated|0|||
161904451|NCT00853762|584698642|FG001|Overall Study|Randomised but not Treated|2|||
161904452|NCT00853762|584698643|FG002|Overall Study|Randomised but not Treated|2|||
161557061|NCT01723826|583428978|FG000|Overall Study|Death according to AE eCRF|2|||
161557062|NCT01723826|583428979|FG001|Overall Study|Death according to AE eCRF|3|||
161557063|NCT01723826|583428980|FG002|Overall Study|Death according to AE eCRF|3|||
161904453|NCT00853762|584698644|FG003|Overall Study|Randomised but not Treated|0|||
161904454|NCT02000921|584698645|FG000|Overall Study|Withdrawal by Subject|3|||
161904455|NCT02000921|584698646|FG001|Overall Study|Withdrawal by Subject|10|||
161904456|NCT02000921|584698647|FG002|Overall Study|Withdrawal by Subject|5|||
161904457|NCT02000921|584698645|FG000|Overall Study|Lost to Follow-up|2|||
161904458|NCT02000921|584698646|FG001|Overall Study|Lost to Follow-up|4|||
161904459|NCT02000921|584698647|FG002|Overall Study|Lost to Follow-up|5|||
161904460|NCT02000921|584698645|FG000|Overall Study|Physician Decision|0|||
161904461|NCT02000921|584698646|FG001|Overall Study|Physician Decision|2|||
161904462|NCT02000921|584698647|FG002|Overall Study|Physician Decision|0|||
161904463|NCT02631941|584698654|FG000|Overall Study|Physician Decision|0|||
161904464|NCT02631941|584698655|FG001|Overall Study|Physician Decision|1|||
161904465|NCT02631941|584698656|FG002|Overall Study|Physician Decision|0|||
161904466|NCT02631941|584698657|FG003|Overall Study|Physician Decision|0|||
161557064|NCT01723826|583428981|FG003|Overall Study|Death according to AE eCRF|7|||
161557065|NCT01723826|583428978|FG000|Overall Study|Lost to Follow-up|1|||
161557066|NCT01723826|583428979|FG001|Overall Study|Lost to Follow-up|3|||
161557067|NCT01723826|583428980|FG002|Overall Study|Lost to Follow-up|1|||
161557068|NCT01723826|583428981|FG003|Overall Study|Lost to Follow-up|1|||
161557069|NCT01723826|583428978|FG000|Overall Study|Non-compliance|0|||
161557070|NCT01723826|583428979|FG001|Overall Study|Non-compliance|1|||
161557071|NCT01723826|583428980|FG002|Overall Study|Non-compliance|3|||
161557072|NCT01723826|583428981|FG003|Overall Study|Non-compliance|3|||
161557073|NCT01723826|583428978|FG000|Overall Study|Non-compliance With Study Drug|0|||
161557074|NCT01723826|583428979|FG001|Overall Study|Non-compliance With Study Drug|1|||
161557075|NCT01723826|583428980|FG002|Overall Study|Non-compliance With Study Drug|0|||
161557076|NCT01723826|583428981|FG003|Overall Study|Non-compliance With Study Drug|0|||
161557077|NCT01723826|583428978|FG000|Overall Study|Other Reason|8|||
161557078|NCT01723826|583428979|FG001|Overall Study|Other Reason|6|||
161557079|NCT01723826|583428980|FG002|Overall Study|Other Reason|12|||
161557080|NCT01723826|583428981|FG003|Overall Study|Other Reason|14|||
161557081|NCT01723826|583428978|FG000|Overall Study|Physician Decision|1|||
161557082|NCT01723826|583428979|FG001|Overall Study|Physician Decision|3|||
161557083|NCT01723826|583428980|FG002|Overall Study|Physician Decision|4|||
161557084|NCT01723826|583428981|FG003|Overall Study|Physician Decision|11|||
161557085|NCT01723826|583428978|FG000|Overall Study|Protocol Violation|1|||
161557086|NCT01723826|583428979|FG001|Overall Study|Protocol Violation|1|||
161557087|NCT01723826|583428980|FG002|Overall Study|Protocol Violation|3|||
161557088|NCT01723826|583428981|FG003|Overall Study|Protocol Violation|1|||
161557089|NCT01723826|583428978|FG000|Overall Study|Withdrawal by Subject|10|||
161557090|NCT01723826|583428979|FG001|Overall Study|Withdrawal by Subject|17|||
161557091|NCT01723826|583428980|FG002|Overall Study|Withdrawal by Subject|27|||
161557092|NCT01723826|583428981|FG003|Overall Study|Withdrawal by Subject|48|||
161557093|NCT01767129|583428982|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161557094|NCT01767129|583428983|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161557095|NCT01473420|583428987|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
161557096|NCT01473420|583428988|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
161557097|NCT01473420|583428987|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
161557098|NCT01473420|583428988|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
161557099|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
161557100|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
161557101|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
161557102|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
161557103|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
161557104|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
161904467|NCT02631941|584698658|FG004|Overall Study|Physician Decision|0|||
161904468|NCT02631941|584698659|FG005|Overall Study|Physician Decision|0|||
161904469|NCT02631941|584698660|FG006|Overall Study|Physician Decision|0|||
161904470|NCT02631941|584698661|FG007|Overall Study|Physician Decision|0|||
161557105|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
161557106|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
161557107|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
161904471|NCT02631941|584698662|FG008|Overall Study|Physician Decision|0|||
161904472|NCT02631941|584698663|FG009|Overall Study|Physician Decision|0|||
161904473|NCT02631941|584698654|FG000|Overall Study|Adverse Event|0|||
161904474|NCT02631941|584698655|FG001|Overall Study|Adverse Event|1|||
161557108|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
161557109|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
161557110|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
161557111|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
161557112|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
161557113|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
161557114|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
161557115|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
161557116|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
161557117|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
161557118|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
161557119|NCT01473420|583428987|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
161557120|NCT01473420|583428988|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
161557121|NCT02906202|583428997|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
161557122|NCT04213846|583430732|FG000|Overall Study|Withdrawal by Subject|7|||
161557123|NCT04213846|583430733|FG001|Overall Study|Withdrawal by Subject|6|||
161557124|NCT04213846|583430732|FG000|Overall Study|Lost to Follow-up|15|||
161557125|NCT04213846|583430733|FG001|Overall Study|Lost to Follow-up|21|||
161557126|NCT04096365|583430741|FG000|Overall Study|Adverse Event|1|||
161557127|NCT01939158|583430746|FG000|Overall Study|Adverse Event|1|||
161557128|NCT01939158|583430747|FG001|Overall Study|Adverse Event|0|||
161557129|NCT01939158|583430748|FG002|Overall Study|Adverse Event|0|||
161557130|NCT01939158|583430749|FG003|Overall Study|Adverse Event|0|||
161557131|NCT01939158|583430746|FG000|Overall Study|Withdrawal by Subject|22|||
161557132|NCT01939158|583430747|FG001|Overall Study|Withdrawal by Subject|25|||
161557133|NCT01939158|583430748|FG002|Overall Study|Withdrawal by Subject|15|||
161557134|NCT01939158|583430749|FG003|Overall Study|Withdrawal by Subject|17|||
161557135|NCT01939158|583430746|FG000|Overall Study|Migrated/moved from study area|5|||
161557136|NCT01939158|583430747|FG001|Overall Study|Migrated/moved from study area|7|||
161557137|NCT01939158|583430748|FG002|Overall Study|Migrated/moved from study area|3|||
161557138|NCT01939158|583430749|FG003|Overall Study|Migrated/moved from study area|6|||
161557139|NCT01939158|583430746|FG000|Overall Study|Lost to Follow-up|18|||
161557140|NCT01939158|583430747|FG001|Overall Study|Lost to Follow-up|17|||
161557141|NCT01939158|583430748|FG002|Overall Study|Lost to Follow-up|17|||
161557142|NCT01939158|583430749|FG003|Overall Study|Lost to Follow-up|17|||
161557143|NCT01939158|583430746|FG000|Overall Study|Death|0|||
161557144|NCT01939158|583430747|FG001|Overall Study|Death|0|||
161557145|NCT01939158|583430748|FG002|Overall Study|Death|1|||
161557146|NCT01939158|583430749|FG003|Overall Study|Death|1|||
161557147|NCT01939158|583430746|FG000|Overall Study|No longer meets eligibility criteria|0|||
161557148|NCT01939158|583430747|FG001|Overall Study|No longer meets eligibility criteria|0|||
161557149|NCT01939158|583430748|FG002|Overall Study|No longer meets eligibility criteria|1|||
161557150|NCT01939158|583430749|FG003|Overall Study|No longer meets eligibility criteria|0|||
161557151|NCT01939158|583430746|FG000|Overall Study|Other|1|||
161557152|NCT01939158|583430747|FG001|Overall Study|Other|3|||
161557153|NCT01939158|583430748|FG002|Overall Study|Other|4|||
161557154|NCT01939158|583430749|FG003|Overall Study|Other|3|||
161557155|NCT05310084|583430750|FG000|Overall Study|Withdrawal by Subject|2|||
161557156|NCT05310084|583430751|FG001|Overall Study|Withdrawal by Subject|3|||
161557157|NCT05310084|583430750|FG000|Overall Study|Participant availability|0|||
161557158|NCT05310084|583430751|FG001|Overall Study|Participant availability|4|||
161557159|NCT05310084|583430750|FG000|Overall Study|Lost to Follow-up|1|||
161557160|NCT05310084|583430751|FG001|Overall Study|Lost to Follow-up|1|||
161557161|NCT05310084|583430750|FG000|Overall Study|Adverse Event|1|||
161557162|NCT05310084|583430751|FG001|Overall Study|Adverse Event|1|||
161557163|NCT05310084|583430750|FG000|Overall Study|Randomized but not vaccinated|4|||
161904475|NCT02631941|584698656|FG002|Overall Study|Adverse Event|0|||
161904476|NCT02631941|584698657|FG003|Overall Study|Adverse Event|0|||
161904477|NCT02631941|584698658|FG004|Overall Study|Adverse Event|0|||
161904478|NCT02631941|584698659|FG005|Overall Study|Adverse Event|0|||
161904479|NCT02631941|584698660|FG006|Overall Study|Adverse Event|0|||
161904480|NCT02631941|584698661|FG007|Overall Study|Adverse Event|0|||
161904481|NCT02631941|584698662|FG008|Overall Study|Adverse Event|0|||
161904482|NCT02631941|584698663|FG009|Overall Study|Adverse Event|0|||
161904483|NCT02631941|584698654|FG000|Overall Study|Withdrawal by Subject|0|||
161557164|NCT05310084|583430751|FG001|Overall Study|Randomized but not vaccinated|2|||
161557165|NCT02065245|583430753|FG000|Infusion 1|Lost to Follow-up|0|||
161557166|NCT02065245|583430754|FG001|Infusion 1|Lost to Follow-up|0|||
161557167|NCT02065245|583430755|FG002|Infusion 1|Lost to Follow-up|0|||
161557168|NCT02065245|583430756|FG003|Infusion 1|Lost to Follow-up|0|||
161557169|NCT02065245|583430757|FG004|Infusion 1|Lost to Follow-up|0|||
161557170|NCT02065245|583430758|FG005|Infusion 1|Lost to Follow-up|0|||
161557171|NCT02065245|583430759|FG006|Infusion 1|Lost to Follow-up|1|||
161904484|NCT02631941|584698655|FG001|Overall Study|Withdrawal by Subject|0|||
161904485|NCT02631941|584698656|FG002|Overall Study|Withdrawal by Subject|0|||
161557172|NCT02065245|583430753|FG000|Infusion 1|Death|0|||
161904486|NCT02631941|584698657|FG003|Overall Study|Withdrawal by Subject|0|||
161904487|NCT02631941|584698658|FG004|Overall Study|Withdrawal by Subject|1|||
161904488|NCT02631941|584698659|FG005|Overall Study|Withdrawal by Subject|0|||
161904489|NCT02631941|584698660|FG006|Overall Study|Withdrawal by Subject|0|||
161904490|NCT02631941|584698661|FG007|Overall Study|Withdrawal by Subject|1|||
161904491|NCT02631941|584698662|FG008|Overall Study|Withdrawal by Subject|0|||
161904492|NCT02631941|584698663|FG009|Overall Study|Withdrawal by Subject|0|||
161904493|NCT02631941|584698654|FG000|Overall Study|Lost to Follow-up|0|||
161904494|NCT02631941|584698655|FG001|Overall Study|Lost to Follow-up|0|||
161904495|NCT02631941|584698656|FG002|Overall Study|Lost to Follow-up|0|||
161904496|NCT02631941|584698657|FG003|Overall Study|Lost to Follow-up|0|||
161904497|NCT02631941|584698658|FG004|Overall Study|Lost to Follow-up|0|||
161904498|NCT02631941|584698659|FG005|Overall Study|Lost to Follow-up|0|||
161904499|NCT02631941|584698660|FG006|Overall Study|Lost to Follow-up|0|||
161904500|NCT02631941|584698661|FG007|Overall Study|Lost to Follow-up|0|||
161904501|NCT02631941|584698662|FG008|Overall Study|Lost to Follow-up|1|||
161904502|NCT02631941|584698663|FG009|Overall Study|Lost to Follow-up|0|||
161904503|NCT03933449|584698664|FG000|Overall Study|Adverse Event|6|||
161904504|NCT03933449|584698665|FG001|Overall Study|Adverse Event|4|||
161904505|NCT03933449|584698664|FG000|Overall Study|Death|55|||
161904506|NCT03933449|584698665|FG001|Overall Study|Death|57|||
161904507|NCT03933449|584698664|FG000|Overall Study|Sponsor Decision|1|||
161904508|NCT03933449|584698665|FG001|Overall Study|Sponsor Decision|0|||
161904509|NCT02087774|584698668|FG000|Overall Study|Were absent day of data collection|8|||
161904510|NCT02087774|584698669|FG001|Overall Study|Were absent day of data collection|20|||
161904511|NCT02204917|584698670|FG000|Overall Study|Protocol Violation|1|||
161904512|NCT02869789|584698671|FG000|Overall Study|Disease progression|184|||
161904513|NCT02869789|584698672|FG001|Overall Study|Disease progression|109|||
161904514|NCT02869789|584698673|FG002|Overall Study|Disease progression|260|||
161904515|NCT02869789|584698674|FG003|Overall Study|Disease progression|19|||
161904516|NCT02869789|584698671|FG000|Overall Study|Study drug toxicity|90|||
161904517|NCT02869789|584698672|FG001|Overall Study|Study drug toxicity|32|||
161904518|NCT02869789|584698673|FG002|Overall Study|Study drug toxicity|55|||
161904519|NCT02869789|584698674|FG003|Overall Study|Study drug toxicity|14|||
161904520|NCT02869789|584698671|FG000|Overall Study|Death|7|||
161904521|NCT02869789|584698672|FG001|Overall Study|Death|3|||
161904522|NCT02869789|584698673|FG002|Overall Study|Death|5|||
161904523|NCT02869789|584698674|FG003|Overall Study|Death|1|||
161904524|NCT02869789|584698671|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
161904525|NCT02869789|584698672|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
161904526|NCT02869789|584698673|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
161904527|NCT02869789|584698674|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
161904528|NCT02869789|584698671|FG000|Overall Study|Participant request to discontinue study treatment|10|||
161904529|NCT02869789|584698672|FG001|Overall Study|Participant request to discontinue study treatment|5|||
161904530|NCT02869789|584698673|FG002|Overall Study|Participant request to discontinue study treatment|5|||
161904531|NCT02869789|584698674|FG003|Overall Study|Participant request to discontinue study treatment|3|||
161904532|NCT02869789|584698671|FG000|Overall Study|Withdrawal by Subject|5|||
161904533|NCT02869789|584698672|FG001|Overall Study|Withdrawal by Subject|2|||
161904534|NCT02869789|584698673|FG002|Overall Study|Withdrawal by Subject|7|||
161904535|NCT02869789|584698674|FG003|Overall Study|Withdrawal by Subject|2|||
161904536|NCT02869789|584698671|FG000|Overall Study|Lost to Follow-up|0|||
161904537|NCT02869789|584698672|FG001|Overall Study|Lost to Follow-up|0|||
161904538|NCT02869789|584698673|FG002|Overall Study|Lost to Follow-up|2|||
161904539|NCT02869789|584698674|FG003|Overall Study|Lost to Follow-up|0|||
161904540|NCT02869789|584698671|FG000|Overall Study|Maximum clinical benefit|5|||
161904541|NCT02869789|584698672|FG001|Overall Study|Maximum clinical benefit|2|||
161904542|NCT02869789|584698673|FG002|Overall Study|Maximum clinical benefit|1|||
161904543|NCT02869789|584698674|FG003|Overall Study|Maximum clinical benefit|0|||
161904544|NCT02869789|584698671|FG000|Overall Study|Poor/Non-compliance|0|||
161904545|NCT02869789|584698672|FG001|Overall Study|Poor/Non-compliance|2|||
161904546|NCT02869789|584698673|FG002|Overall Study|Poor/Non-compliance|1|||
161904547|NCT02869789|584698674|FG003|Overall Study|Poor/Non-compliance|0|||
161904548|NCT02869789|584698671|FG000|Overall Study|Participant no longer meets study criteria|0|||
161904549|NCT02869789|584698672|FG001|Overall Study|Participant no longer meets study criteria|1|||
161904550|NCT02869789|584698673|FG002|Overall Study|Participant no longer meets study criteria|1|||
161904551|NCT02869789|584698674|FG003|Overall Study|Participant no longer meets study criteria|0|||
161904552|NCT02869789|584698671|FG000|Overall Study|Administrative reason by sponsor|0|||
161904553|NCT02869789|584698672|FG001|Overall Study|Administrative reason by sponsor|0|||
161904554|NCT02869789|584698673|FG002|Overall Study|Administrative reason by sponsor|1|||
161451607|NCT00322621|583050637|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
161904555|NCT02869789|584698674|FG003|Overall Study|Administrative reason by sponsor|0|||
161451608|NCT00322621|583050635|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
161451609|NCT00322621|583050636|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
161904556|NCT02869789|584698671|FG000|Overall Study|Other reasons|4|||
161904557|NCT02869789|584698672|FG001|Overall Study|Other reasons|8|||
161904558|NCT02869789|584698673|FG002|Overall Study|Other reasons|6|||
161557173|NCT02065245|583430754|FG001|Infusion 1|Death|0|||
161557174|NCT02065245|583430755|FG002|Infusion 1|Death|1|||
161557175|NCT02065245|583430756|FG003|Infusion 1|Death|0|||
161557176|NCT02065245|583430757|FG004|Infusion 1|Death|1|||
161904559|NCT02869789|584698674|FG003|Overall Study|Other reasons|0|||
161904560|NCT00297648|584698676|FG000|Overall Study|Adverse Event|13|||
161904561|NCT00297648|584698676|FG000|Overall Study|Lack of Efficacy|18|||
161904562|NCT00297648|584698676|FG000|Overall Study|Lost to Follow-up|1|||
161904563|NCT00297648|584698676|FG000|Overall Study|Withdrawal by Subject|3|||
161904564|NCT00297648|584698676|FG000|Overall Study|Other: Incompliance|1|||
161904565|NCT01529606|584698680|FG000|Overall Study|Lost to Follow-up|21|||
161904566|NCT01529606|584698681|FG001|Overall Study|Lost to Follow-up|18|||
161904567|NCT01746862|584698682|FG000|Overall Study|Withdrawal by Subject|1|||
161904568|NCT01746862|584698683|FG001|Overall Study|Withdrawal by Subject|1|||
161904569|NCT01746862|584698682|FG000|Overall Study|Protocol Violation|1|||
161904570|NCT01746862|584698683|FG001|Overall Study|Protocol Violation|0|||
161904571|NCT01746862|584698682|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
161904572|NCT01746862|584698683|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
161904573|NCT01746862|584698682|FG000|Overall Study|Entered puberty during the study|1|||
161904574|NCT01746862|584698683|FG001|Overall Study|Entered puberty during the study|0|||
161904575|NCT04742673|584698684|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
161904576|NCT04742673|584698685|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
161904577|NCT00731822|584698692|FG000|Overall Study|Adverse Event|2|||
161904578|NCT00731822|584698693|FG001|Overall Study|Adverse Event|1|||
161904579|NCT00731822|584698692|FG000|Overall Study|Protocol Violation|1|||
161904580|NCT00731822|584698693|FG001|Overall Study|Protocol Violation|0|||
161904581|NCT00731822|584698692|FG000|Overall Study|Lost to Follow-up|1|||
161904582|NCT00731822|584698693|FG001|Overall Study|Lost to Follow-up|0|||
161904583|NCT05209880|584698695|FG000|1-Month Follow-up|Spoke with Doctor|5|||
161904584|NCT05209880|584698696|FG001|1-Month Follow-up|Spoke with Doctor|5|||
161904585|NCT05209880|584698695|FG000|1-Month Follow-up|Lost to Follow-up|7|||
161904586|NCT05209880|584698696|FG001|1-Month Follow-up|Lost to Follow-up|9|||
161904587|NCT05209880|584698695|FG000|1-Month Follow-up|Discontinued|0|||
161904588|NCT05209880|584698696|FG001|1-Month Follow-up|Discontinued|1|||
161904589|NCT05209880|584698695|FG000|3-Month Follow-up|Spoke with Doctor|17|||
161904590|NCT05209880|584698696|FG001|3-Month Follow-up|Spoke with Doctor|7|||
161904591|NCT05209880|584698695|FG000|3-Month Follow-up|Lost to Follow-up|8|||
161904592|NCT05209880|584698696|FG001|3-Month Follow-up|Lost to Follow-up|10|||
161904593|NCT05209880|584698695|FG000|3-Month Follow-up|Discontinued|1|||
161904594|NCT05209880|584698696|FG001|3-Month Follow-up|Discontinued|3|||
161904595|NCT05209880|584698695|FG000|6-Month Follow-up|Spoke with Doctor|25|||
161904596|NCT05209880|584698696|FG001|6-Month Follow-up|Spoke with Doctor|14|||
161904597|NCT05209880|584698695|FG000|6-Month Follow-up|Lost to Follow-up|9|||
161904598|NCT05209880|584698696|FG001|6-Month Follow-up|Lost to Follow-up|14|||
161904599|NCT05209880|584698695|FG000|6-Month Follow-up|Discontinued|1|||
161904600|NCT05209880|584698696|FG001|6-Month Follow-up|Discontinued|3|||
161904601|NCT02127658|584698697|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
161904602|NCT02127658|584698698|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
161904603|NCT02127658|584698697|FG000|Overall Study|Withdrawal by Subject|0|||
161904604|NCT02127658|584698698|FG001|Overall Study|Withdrawal by Subject|2|||
161904605|NCT02127658|584698697|FG000|Overall Study|Physician Decision|0|||
161904606|NCT02127658|584698698|FG001|Overall Study|Physician Decision|1|||
161904607|NCT03834493|584698699|FG000|Overall Study|Participants Ongoing|311|||
161904608|NCT03834493|584698700|FG001|Overall Study|Participants Ongoing|324|||
161904609|NCT03834493|584698699|FG000|Overall Study|Withdrawal by Subject|20|||
161904610|NCT03834493|584698700|FG001|Overall Study|Withdrawal by Subject|17|||
161904611|NCT03834493|584698699|FG000|Overall Study|Physician Decision|1|||
161904612|NCT03834493|584698700|FG001|Overall Study|Physician Decision|0|||
161904613|NCT03834493|584698699|FG000|Overall Study|Death|289|||
161557177|NCT02065245|583430758|FG005|Infusion 1|Death|0|||
161904614|NCT03834493|584698700|FG001|Overall Study|Death|282|||
161904615|NCT04003103|584698701|FG000|Overall Study|Death|1|||
161904616|NCT04003103|584698702|FG001|Overall Study|Death|0|||
161904617|NCT04003103|584698703|FG002|Overall Study|Death|0|||
161904618|NCT04003103|584698701|FG000|Overall Study|Lost to Follow-up|4|||
161904619|NCT04003103|584698702|FG001|Overall Study|Lost to Follow-up|3|||
161904620|NCT04003103|584698703|FG002|Overall Study|Lost to Follow-up|2|||
161904621|NCT04003103|584698701|FG000|Overall Study|Withdrawal by Subject|10|||
161904622|NCT04003103|584698702|FG001|Overall Study|Withdrawal by Subject|1|||
161904623|NCT04003103|584698703|FG002|Overall Study|Withdrawal by Subject|1|||
161904624|NCT04003103|584698701|FG000|Overall Study|Status not recorded|0|||
161904625|NCT04003103|584698702|FG001|Overall Study|Status not recorded|2|||
161904626|NCT04003103|584698703|FG002|Overall Study|Status not recorded|0|||
161557178|NCT02065245|583430759|FG006|Infusion 1|Death|0|||
161557179|NCT02065245|583430753|FG000|Infusion 2|Death|0|||
161557180|NCT02065245|583430754|FG001|Infusion 2|Death|0|||
161557181|NCT02065245|583430755|FG002|Infusion 2|Death|0|||
161904627|NCT04073303|584698708|FG000|Overall Study|Adverse Event|0|||
161904628|NCT04073303|584698709|FG001|Overall Study|Adverse Event|2|||
161904629|NCT04073303|584698708|FG000|Overall Study|Withdrawal by Subject|16|||
161904630|NCT04073303|584698709|FG001|Overall Study|Withdrawal by Subject|36|||
161904631|NCT04073303|584698708|FG000|Overall Study|Lost to Follow-up|6|||
161904632|NCT04073303|584698709|FG001|Overall Study|Lost to Follow-up|1|||
161904633|NCT04073303|584698708|FG000|Overall Study|Protocol Deviation|0|||
161904634|NCT04073303|584698709|FG001|Overall Study|Protocol Deviation|4|||
161904635|NCT04073303|584698708|FG000|Overall Study|Other|1|||
161904636|NCT04073303|584698709|FG001|Overall Study|Other|1|||
161904637|NCT02277028|584698712|FG000|Overall Study|Lost to Follow-up|1|||
161904638|NCT02277028|584698713|FG001|Overall Study|Lost to Follow-up|0|||
161904639|NCT02277028|584698712|FG000|Overall Study|Withdrawal by Subject|0|||
161904640|NCT02277028|584698713|FG001|Overall Study|Withdrawal by Subject|1|||
161904641|NCT02718911|584698714|FG000|Overall Study|Adverse Event|0|||
161904642|NCT02718911|584698715|FG001|Overall Study|Adverse Event|0|||
161904643|NCT02718911|584698716|FG002|Overall Study|Adverse Event|0|||
161904644|NCT02718911|584698717|FG003|Overall Study|Adverse Event|0|||
161904645|NCT02718911|584698718|FG004|Overall Study|Adverse Event|0|||
161904646|NCT02718911|584698719|FG005|Overall Study|Adverse Event|0|||
161904647|NCT02718911|584698720|FG006|Overall Study|Adverse Event|0|||
161904648|NCT02718911|584698721|FG007|Overall Study|Adverse Event|0|||
161904649|NCT02718911|584698722|FG008|Overall Study|Adverse Event|0|||
161904650|NCT02718911|584698723|FG009|Overall Study|Adverse Event|2|||
161904651|NCT02718911|584698714|FG000|Overall Study|Death|2|||
161904652|NCT02718911|584698715|FG001|Overall Study|Death|3|||
161904653|NCT02718911|584698716|FG002|Overall Study|Death|1|||
161904654|NCT02718911|584698717|FG003|Overall Study|Death|0|||
161904655|NCT02718911|584698718|FG004|Overall Study|Death|1|||
161904656|NCT02718911|584698719|FG005|Overall Study|Death|3|||
161904657|NCT02718911|584698720|FG006|Overall Study|Death|1|||
161904658|NCT02718911|584698721|FG007|Overall Study|Death|1|||
161904659|NCT02718911|584698722|FG008|Overall Study|Death|4|||
161904660|NCT02718911|584698723|FG009|Overall Study|Death|3|||
161904661|NCT02718911|584698714|FG000|Overall Study|Lost to Follow-up|0|||
161904662|NCT02718911|584698715|FG001|Overall Study|Lost to Follow-up|0|||
161904663|NCT02718911|584698716|FG002|Overall Study|Lost to Follow-up|0|||
161904664|NCT02718911|584698717|FG003|Overall Study|Lost to Follow-up|0|||
161904665|NCT02718911|584698718|FG004|Overall Study|Lost to Follow-up|0|||
161904666|NCT02718911|584698719|FG005|Overall Study|Lost to Follow-up|0|||
161904667|NCT02718911|584698720|FG006|Overall Study|Lost to Follow-up|0|||
161904668|NCT02718911|584698721|FG007|Overall Study|Lost to Follow-up|0|||
161904669|NCT02718911|584698722|FG008|Overall Study|Lost to Follow-up|1|||
161904670|NCT02718911|584698723|FG009|Overall Study|Lost to Follow-up|0|||
161904671|NCT02718911|584698714|FG000|Overall Study|Physician Decision|2|||
161904672|NCT02718911|584698715|FG001|Overall Study|Physician Decision|0|||
161904673|NCT02718911|584698716|FG002|Overall Study|Physician Decision|1|||
161904674|NCT02718911|584698717|FG003|Overall Study|Physician Decision|1|||
161904675|NCT02718911|584698718|FG004|Overall Study|Physician Decision|0|||
161904676|NCT02718911|584698719|FG005|Overall Study|Physician Decision|0|||
161904677|NCT02718911|584698720|FG006|Overall Study|Physician Decision|0|||
161904678|NCT02718911|584698721|FG007|Overall Study|Physician Decision|1|||
161904679|NCT02718911|584698722|FG008|Overall Study|Physician Decision|2|||
161904680|NCT02718911|584698723|FG009|Overall Study|Physician Decision|1|||
161904681|NCT02718911|584698714|FG000|Overall Study|Withdrawal by Subject|0|||
161904682|NCT02718911|584698715|FG001|Overall Study|Withdrawal by Subject|0|||
161904683|NCT02718911|584698716|FG002|Overall Study|Withdrawal by Subject|0|||
161904684|NCT02718911|584698717|FG003|Overall Study|Withdrawal by Subject|0|||
161904685|NCT02718911|584698718|FG004|Overall Study|Withdrawal by Subject|1|||
161904686|NCT02718911|584698719|FG005|Overall Study|Withdrawal by Subject|0|||
161904687|NCT02718911|584698720|FG006|Overall Study|Withdrawal by Subject|0|||
161557182|NCT02065245|583430756|FG003|Infusion 2|Death|0|||
161557183|NCT02065245|583430757|FG004|Infusion 2|Death|0|||
161557184|NCT02065245|583430758|FG005|Infusion 2|Death|0|||
161557185|NCT02065245|583430759|FG006|Infusion 2|Death|1|||
161557186|NCT02065245|583430753|FG000|Infusion 3|Lost to Follow-up|1|||
161904688|NCT02718911|584698721|FG007|Overall Study|Withdrawal by Subject|0|||
161904689|NCT02718911|584698722|FG008|Overall Study|Withdrawal by Subject|1|||
161904690|NCT02718911|584698723|FG009|Overall Study|Withdrawal by Subject|4|||
161904691|NCT02718911|584698714|FG000|Overall Study|Reason Not Collected|0|||
161904692|NCT02718911|584698715|FG001|Overall Study|Reason Not Collected|0|||
161904693|NCT02718911|584698716|FG002|Overall Study|Reason Not Collected|1|||
161904694|NCT02718911|584698717|FG003|Overall Study|Reason Not Collected|0|||
161904695|NCT02718911|584698718|FG004|Overall Study|Reason Not Collected|0|||
161904696|NCT02718911|584698719|FG005|Overall Study|Reason Not Collected|0|||
161557187|NCT02065245|583430754|FG001|Infusion 3|Lost to Follow-up|1|||
161904697|NCT02718911|584698720|FG006|Overall Study|Reason Not Collected|2|||
161904698|NCT02718911|584698721|FG007|Overall Study|Reason Not Collected|1|||
161557188|NCT02065245|583430755|FG002|Infusion 3|Lost to Follow-up|0|||
161904699|NCT02718911|584698722|FG008|Overall Study|Reason Not Collected|4|||
161904700|NCT02718911|584698723|FG009|Overall Study|Reason Not Collected|9|||
161904701|NCT04817332|584698724|FG000|Overall Study|Lost to Follow-up|3|||
161904702|NCT04817332|584698725|FG001|Overall Study|Lost to Follow-up|3|||
161557189|NCT02065245|583430756|FG003|Infusion 3|Lost to Follow-up|0|||
161557190|NCT02065245|583430757|FG004|Infusion 3|Lost to Follow-up|0|||
161557191|NCT02065245|583430758|FG005|Infusion 3|Lost to Follow-up|0|||
161557192|NCT02065245|583430759|FG006|Infusion 3|Lost to Follow-up|0|||
161557193|NCT00924664|583430760|FG000|Overall Study|Adverse Event|23|||
161557194|NCT00924664|583430761|FG001|Overall Study|Adverse Event|39|||
161557195|NCT00924664|583430760|FG000|Overall Study|Lack of Efficacy|10|||
161557196|NCT00924664|583430761|FG001|Overall Study|Lack of Efficacy|15|||
161557197|NCT00924664|583430760|FG000|Overall Study|Lost to Follow-up|10|||
161557198|NCT00924664|583430761|FG001|Overall Study|Lost to Follow-up|12|||
161557199|NCT00924664|583430760|FG000|Overall Study|Withdrawal by Subject|47|||
161557200|NCT00924664|583430761|FG001|Overall Study|Withdrawal by Subject|71|||
161557201|NCT00924664|583430760|FG000|Overall Study|Protocol Violation|2|||
161557202|NCT00924664|583430761|FG001|Overall Study|Protocol Violation|5|||
161557203|NCT00924664|583430760|FG000|Overall Study|Pregnancy|1|||
161557204|NCT00924664|583430761|FG001|Overall Study|Pregnancy|1|||
161557205|NCT00924664|583430760|FG000|Overall Study|Death|0|||
161557206|NCT00924664|583430761|FG001|Overall Study|Death|2|||
161557207|NCT00924664|583430760|FG000|Overall Study|Study terminated by sponsor|199|||
161557208|NCT00924664|583430761|FG001|Overall Study|Study terminated by sponsor|330|||
161557209|NCT00924664|583430760|FG000|Overall Study|Other|29|||
161557210|NCT00924664|583430761|FG001|Overall Study|Other|52|||
161557211|NCT00924664|583430760|FG000|Overall Study|Randomized but not Treated|1|||
161557212|NCT00924664|583430761|FG001|Overall Study|Randomized but not Treated|0|||
161557213|NCT01598987|583430762|FG000|Baseline to Month 12|Administrative problems|2|||
161557214|NCT01598987|583430762|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
161557215|NCT01598987|583430762|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
161557216|NCT01598987|583430762|FG000|Baseline to 24 Month|Administrative problems|2|||
161557217|NCT01598987|583430762|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
161557218|NCT03531905|583430763|FG000|Overall Study|Withdrawal by Subject|3|||
161557219|NCT03531905|583430764|FG001|Overall Study|Withdrawal by Subject|3|||
161557220|NCT03531905|583430765|FG002|Overall Study|Withdrawal by Subject|2|||
161557221|NCT03531905|583430763|FG000|Overall Study|Lost to Follow-up|2|||
161557222|NCT03531905|583430764|FG001|Overall Study|Lost to Follow-up|2|||
161557223|NCT03531905|583430765|FG002|Overall Study|Lost to Follow-up|1|||
161557224|NCT03531905|583430763|FG000|Overall Study|Participant was out of town|1|||
161557225|NCT03531905|583430764|FG001|Overall Study|Participant was out of town|0|||
161557226|NCT03531905|583430765|FG002|Overall Study|Participant was out of town|0|||
161557227|NCT03531905|583430763|FG000|Overall Study|Could not speak with the participant|1|||
161557228|NCT03531905|583430764|FG001|Overall Study|Could not speak with the participant|0|||
161557229|NCT03531905|583430765|FG002|Overall Study|Could not speak with the participant|0|||
161557230|NCT01616563|583430766|FG000|Overall Study|Lost to Follow-up|40|||
161557231|NCT01333943|583430772|FG000|Overall Study|Known neuropathy|1|||
161557232|NCT01333943|583430773|FG001|Overall Study|Known neuropathy|0|||
161557233|NCT02459587|583430780|FG000|3-Month Follow-up Assessment|Death|0|||
161557234|NCT02459587|583430781|FG001|3-Month Follow-up Assessment|Death|2|||
161904703|NCT04817332|584698724|FG000|Overall Study|Protocol Violation|2|||
161904704|NCT04817332|584698725|FG001|Overall Study|Protocol Violation|0|||
161904705|NCT01867008|584698728|FG000|Overall Study|Withdrawal by Subject|1|||
161904706|NCT01158261|584698730|FG000|Overall Study|Lost to Follow-up|9|||
161904707|NCT01158261|584698730|FG000|Overall Study|Death|7|||
161904708|NCT01158261|584698730|FG000|Overall Study|Withdrawal by Subject|1|||
161904709|NCT03143101|584698731|FG000|Overall Study|Withdrawal by Subject|0|||
161904710|NCT03143101|584698732|FG001|Overall Study|Withdrawal by Subject|1|||
161904711|NCT03143101|584698733|FG002|Overall Study|Withdrawal by Subject|0|||
161904712|NCT03143101|584698731|FG000|Overall Study|Lost to Follow-up|2|||
161904713|NCT03143101|584698732|FG001|Overall Study|Lost to Follow-up|2|||
161904714|NCT03143101|584698733|FG002|Overall Study|Lost to Follow-up|0|||
161904715|NCT05227118|584698734|FG000|Overall Study|Adverse Event|0|||
161904716|NCT05227118|584698735|FG001|Overall Study|Adverse Event|0|||
161904717|NCT05227118|584698736|FG002|Overall Study|Adverse Event|1|||
161904718|NCT05227118|584698737|FG003|Overall Study|Adverse Event|0|||
161557235|NCT02459587|583430780|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
161557236|NCT02459587|583430781|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
161904719|NCT05227118|584698734|FG000|Overall Study|Withdrawal by Subject|0|||
161557237|NCT02459587|583430780|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
161904720|NCT05227118|584698735|FG001|Overall Study|Withdrawal by Subject|0|||
161904721|NCT05227118|584698736|FG002|Overall Study|Withdrawal by Subject|2|||
161557238|NCT02459587|583430781|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
161557239|NCT02459587|583430780|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
161557240|NCT02459587|583430781|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
161904722|NCT05227118|584698737|FG003|Overall Study|Withdrawal by Subject|0|||
161904723|NCT03727841|584698738|FG000|Overall Study|Physician Decision|3|||
161904724|NCT03727841|584698739|FG001|Overall Study|Physician Decision|1|||
161904725|NCT03126786|584698740|FG000|Overall Study|Adverse Event|3|||
161557241|NCT02459587|583430780|FG000|6-month Follow-up Assessment|Death|2|||
161904726|NCT03126786|584698741|FG001|Overall Study|Adverse Event|0|||
161557242|NCT02459587|583430781|FG001|6-month Follow-up Assessment|Death|1|||
161557243|NCT02459587|583430780|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
161557244|NCT02459587|583430781|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
161557245|NCT02459587|583430780|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
161557246|NCT02459587|583430781|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
161557247|NCT02459587|583430780|FG000|12-month Follow-up Assessment|Death|2|||
161557248|NCT02459587|583430781|FG001|12-month Follow-up Assessment|Death|0|||
161557249|NCT02459587|583430780|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
161557250|NCT02459587|583430781|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
161557251|NCT02459587|583430780|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
161557252|NCT02459587|583430781|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
161557253|NCT02459587|583430780|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
161557254|NCT02459587|583430781|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
161557255|NCT02028884|583430784|FG000|Double-blind Period|Adverse Event|5|||
161557256|NCT02028884|583430785|FG001|Double-blind Period|Adverse Event|3|||
161557257|NCT02028884|583430786|FG002|Double-blind Period|Adverse Event|0|||
161557258|NCT02028884|583430784|FG000|Double-blind Period|Eligibility Violation|1|||
161557259|NCT02028884|583430785|FG001|Double-blind Period|Eligibility Violation|0|||
161557260|NCT02028884|583430786|FG002|Double-blind Period|Eligibility Violation|0|||
161557261|NCT02028884|583430784|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
161557262|NCT02028884|583430785|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
161557263|NCT02028884|583430786|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
161557264|NCT02028884|583430784|FG000|Double-blind Period|Withdrawal by Subject|2|||
161557265|NCT02028884|583430785|FG001|Double-blind Period|Withdrawal by Subject|0|||
161557266|NCT02028884|583430786|FG002|Double-blind Period|Withdrawal by Subject|0|||
161557267|NCT02028884|583430784|FG000|Open-label Extension Period|Adverse Event|3|||
161557268|NCT02028884|583430785|FG001|Open-label Extension Period|Adverse Event|1|||
161557269|NCT02028884|583430786|FG002|Open-label Extension Period|Adverse Event|0|||
161557270|NCT02028884|583430784|FG000|Open-label Extension Period|Lack of Efficacy|3|||
161801032|NCT00243932|584314426|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
161801033|NCT00243932|584314427|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
161801034|NCT00243932|584314428|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
161801035|NCT01458405|584314431|FG000|Phase 1 (up to 12 Months)|Other|0|||
161801036|NCT01458405|584314432|FG001|Phase 1 (up to 12 Months)|Other|1|||
161801037|NCT01458405|584314433|FG002|Phase 1 (up to 12 Months)|Other|0|||
161801038|NCT01458405|584314434|FG003|Phase 1 (up to 12 Months)|Other|0|||
161801039|NCT01458405|584314431|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
161801040|NCT01458405|584314432|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
161801041|NCT01458405|584314433|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
161801042|NCT01458405|584314434|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
161801043|NCT01458405|584314431|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161801044|NCT01458405|584314432|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161801045|NCT01458405|584314433|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161801046|NCT01458405|584314434|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
161801047|NCT01458405|584314431|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161801048|NCT01458405|584314432|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161801049|NCT01458405|584314433|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161801050|NCT01458405|584314434|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
161801051|NCT02497781|584314438|FG000|Overall Study|Withdrawal by Subject|2|||
161801052|NCT02497781|584314439|FG001|Overall Study|Withdrawal by Subject|0|||
161801053|NCT02497781|584314438|FG000|Overall Study|Lack of Efficacy|0|||
161801054|NCT02497781|584314439|FG001|Overall Study|Lack of Efficacy|1|||
161801055|NCT02497781|584314438|FG000|Overall Study|Randomised but not treated|1|||
161801056|NCT02497781|584314439|FG001|Overall Study|Randomised but not treated|1|||
161801057|NCT02497781|584314438|FG000|Overall Study|Lost to Follow-up|1|||
161801058|NCT02497781|584314439|FG001|Overall Study|Lost to Follow-up|1|||
161801059|NCT01193608|584314440|FG000|Overall Study|Other|0|||
161801060|NCT01193608|584314441|FG001|Overall Study|Other|1|||
161801061|NCT01193608|584314442|FG002|Overall Study|Other|0|||
161801062|NCT01193608|584314443|FG003|Overall Study|Other|0|||
161801063|NCT01193608|584314444|FG004|Overall Study|Other|0|||
161801064|NCT01193608|584314445|FG005|Overall Study|Other|0|||
161801065|NCT01193608|584314440|FG000|Overall Study|Withdrawal by Subject|0|||
161557271|NCT02028884|583430785|FG001|Open-label Extension Period|Lack of Efficacy|0|||
161557272|NCT02028884|583430786|FG002|Open-label Extension Period|Lack of Efficacy|0|||
161557273|NCT02028884|583430784|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
161801066|NCT01193608|584314441|FG001|Overall Study|Withdrawal by Subject|1|||
161801067|NCT01193608|584314442|FG002|Overall Study|Withdrawal by Subject|2|||
161801068|NCT01193608|584314443|FG003|Overall Study|Withdrawal by Subject|3|||
161801069|NCT01193608|584314444|FG004|Overall Study|Withdrawal by Subject|3|||
161801070|NCT01193608|584314445|FG005|Overall Study|Withdrawal by Subject|0|||
161801071|NCT01193608|584314440|FG000|Overall Study|Lost to Follow-up|0|||
161801072|NCT01193608|584314441|FG001|Overall Study|Lost to Follow-up|0|||
161801073|NCT01193608|584314442|FG002|Overall Study|Lost to Follow-up|0|||
161557274|NCT02028884|583430785|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
161904727|NCT03126786|584698740|FG000|Overall Study|Lost to Follow-up|0|||
161904728|NCT03126786|584698741|FG001|Overall Study|Lost to Follow-up|1|||
161904729|NCT03126786|584698740|FG000|Overall Study|Withdrawal by Subject|3|||
161904730|NCT03126786|584698741|FG001|Overall Study|Withdrawal by Subject|1|||
161557275|NCT02028884|583430786|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
161557276|NCT02028884|583430784|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161557277|NCT02028884|583430785|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
161557278|NCT02028884|583430786|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161557279|NCT02028884|583430784|FG000|Open-label Extension Period|Switched to another treatment option|3|||
161557280|NCT02028884|583430785|FG001|Open-label Extension Period|Switched to another treatment option|0|||
161557281|NCT02028884|583430786|FG002|Open-label Extension Period|Switched to another treatment option|0|||
161557282|NCT02297503|583430789|FG000|Overall Study|Withdrawal by Subject|1|||
161557283|NCT02297503|583430790|FG001|Overall Study|Withdrawal by Subject|1|||
161557284|NCT02297503|583430789|FG000|Overall Study|Protocol Violation|1|||
161557285|NCT02297503|583430790|FG001|Overall Study|Protocol Violation|0|||
161557286|NCT02297503|583430789|FG000|Overall Study|Pregnancy|0|||
161557287|NCT02297503|583430790|FG001|Overall Study|Pregnancy|1|||
161557288|NCT02297503|583430789|FG000|Overall Study|Lost to Follow-up|0|||
161557289|NCT02297503|583430790|FG001|Overall Study|Lost to Follow-up|1|||
161557290|NCT02297503|583430789|FG000|Overall Study|Medical reason|0|||
161557291|NCT02297503|583430790|FG001|Overall Study|Medical reason|1|||
161557292|NCT00765362|583430791|FG000|Overall Study|Death|9|||
161557293|NCT00765362|583430791|FG000|Overall Study|Adverse Event|2|||
161557294|NCT00765362|583430791|FG000|Overall Study|Protocol Violation|18|||
161557295|NCT00765362|583430791|FG000|Overall Study|Withdrawal by Subject|13|||
161557296|NCT00765362|583430791|FG000|Overall Study|Lost to Follow-up|95|||
161557297|NCT00519779|583430794|FG000|Overall Study|Withdrawal by Subject|0|||
161557298|NCT00519779|583430795|FG001|Overall Study|Withdrawal by Subject|1|||
161557299|NCT01123161|583430796|FG000|Overall Study|Lost to Follow-up|1|||
161557300|NCT01123161|583430797|FG001|Overall Study|Lost to Follow-up|0|||
161904731|NCT01601496|584698742|FG000|Overall Study|Physician Decision|1|||
161904732|NCT01601496|584698742|FG000|Overall Study|Withdrawal by Subject|1|||
161904733|NCT01601496|584698742|FG000|Overall Study|Lost to Follow-up|6|||
161904734|NCT01601496|584698742|FG000|Overall Study|Death|4|||
161904735|NCT01601496|584698742|FG000|Overall Study|Other: patient refusal to continue|3|||
161904736|NCT03243305|584698743|FG000|Overall Study|Lost to Follow-up|250|||
161904737|NCT03243305|584698743|FG000|Overall Study|Withdrawal by Subject|170|||
161904738|NCT03243305|584698743|FG000|Overall Study|Pregnancy|104|||
161904739|NCT03243305|584698743|FG000|Overall Study|Non-Compliance with Study Drug|38|||
161904740|NCT03243305|584698743|FG000|Overall Study|Adverse Event|23|||
161904741|NCT03243305|584698743|FG000|Overall Study|No sexually active|26|||
161904742|NCT03243305|584698743|FG000|Overall Study|Physician Decision|22|||
161904743|NCT03243305|584698743|FG000|Overall Study|Protocol Violation|22|||
161904744|NCT03243305|584698743|FG000|Overall Study|Study method no longer primary method|12|||
161904745|NCT03243305|584698743|FG000|Overall Study|Study Terminated by Sponsor|1|||
161904746|NCT03243305|584698743|FG000|Overall Study|Early terminations|267|||
161904747|NCT00227539|584698744|FG000|Overall Study|Protocol Violation|1|||
161904748|NCT02689804|584698745|FG000|Overall Study|Withdrawal by Subject|2|||
161904749|NCT02689804|584698746|FG001|Overall Study|Withdrawal by Subject|0|||
161904750|NCT00570401|584698749|FG000|Overall Study|Adverse Event|2|||
161904751|NCT04391842|584698753|FG000|Overall Study|Withdrawal by Subject|2|||
161904752|NCT00992017|584698754|FG000|Overall Study|Lost to Follow-up|2|||
161904753|NCT00992017|584698754|FG000|Overall Study|Withdrawal by Subject|2|||
161904754|NCT00992017|584698754|FG000|Overall Study|Unable to get to clinic|5|||
161904755|NCT00992017|584698754|FG000|Overall Study|Not adhere to study requirements|1|||
161557301|NCT01123161|583430796|FG000|Overall Study|Withdrawal by Subject|1|||
161557302|NCT01123161|583430797|FG001|Overall Study|Withdrawal by Subject|0|||
161557303|NCT04320615|583430803|FG000|Overall Study|Withdrawal by Subject|4|||
161557304|NCT04320615|583430804|FG001|Overall Study|Withdrawal by Subject|10|||
161557305|NCT04320615|583430803|FG000|Overall Study|Physician Decision|2|||
161557306|NCT04320615|583430804|FG001|Overall Study|Physician Decision|0|||
161557307|NCT04320615|583430803|FG000|Overall Study|Other|2|||
161557308|NCT04320615|583430804|FG001|Overall Study|Other|0|||
161904756|NCT01691378|584698755|FG000|Overall Study|Withdrawal by Subject|2|||
161904757|NCT01691378|584698756|FG001|Overall Study|Withdrawal by Subject|0|||
161904758|NCT01691378|584698755|FG000|Overall Study|Lost to Follow-up|5|||
161904759|NCT01691378|584698756|FG001|Overall Study|Lost to Follow-up|2|||
161904760|NCT01107925|584698763|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
161904761|NCT01107925|584698764|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904762|NCT01107925|584698765|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161557309|NCT04320615|583430803|FG000|Overall Study|Lost to Follow-up|5|||
161557310|NCT04320615|583430804|FG001|Overall Study|Lost to Follow-up|23|||
161557311|NCT04320615|583430803|FG000|Overall Study|Death|35|||
161557312|NCT04320615|583430804|FG001|Overall Study|Death|71|||
161557313|NCT03990363|583430805|FG000|Overall Study|Withdrawal by Subject|10|||
161904763|NCT01107925|584698766|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904764|NCT01107925|584698767|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
161904765|NCT01107925|584698768|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904766|NCT01107925|584698763|FG000|Period 2|Withdrawal by Subject|0|||
161904767|NCT01107925|584698764|FG001|Period 2|Withdrawal by Subject|1|||
161904768|NCT01107925|584698765|FG002|Period 2|Withdrawal by Subject|0|||
161904769|NCT01107925|584698766|FG003|Period 2|Withdrawal by Subject|0|||
161904770|NCT01107925|584698767|FG004|Period 2|Withdrawal by Subject|0|||
161904771|NCT01107925|584698768|FG005|Period 2|Withdrawal by Subject|1|||
161904772|NCT04877990|584698769|FG000|Treatment|Other reasons|3|||
161904773|NCT04877990|584698770|FG001|Treatment|Other reasons|1|||
161557314|NCT03990363|583430806|FG001|Overall Study|Withdrawal by Subject|9|||
161557315|NCT03990363|583430807|FG002|Overall Study|Withdrawal by Subject|18|||
161557316|NCT03990363|583430808|FG003|Overall Study|Withdrawal by Subject|11|||
161557317|NCT03990363|583430809|FG004|Overall Study|Withdrawal by Subject|9|||
161557318|NCT03990363|583430805|FG000|Overall Study|Physician Decision|1|||
161557319|NCT03990363|583430806|FG001|Overall Study|Physician Decision|0|||
161557320|NCT03990363|583430807|FG002|Overall Study|Physician Decision|0|||
161557321|NCT03990363|583430808|FG003|Overall Study|Physician Decision|0|||
161557322|NCT03990363|583430809|FG004|Overall Study|Physician Decision|0|||
161557323|NCT03990363|583430805|FG000|Overall Study|Adverse Event|1|||
161557324|NCT03990363|583430806|FG001|Overall Study|Adverse Event|3|||
161557325|NCT03990363|583430807|FG002|Overall Study|Adverse Event|2|||
161557326|NCT03990363|583430808|FG003|Overall Study|Adverse Event|2|||
161557327|NCT03990363|583430809|FG004|Overall Study|Adverse Event|0|||
161557328|NCT03990363|583430805|FG000|Overall Study|Death|14|||
161557329|NCT03990363|583430806|FG001|Overall Study|Death|8|||
161557330|NCT03990363|583430807|FG002|Overall Study|Death|14|||
161557331|NCT03990363|583430808|FG003|Overall Study|Death|10|||
161557332|NCT03990363|583430809|FG004|Overall Study|Death|11|||
161904774|NCT04877990|584698769|FG000|Treatment|Administrative reasons by sponsor|17|||
161904775|NCT04877990|584698770|FG001|Treatment|Administrative reasons by sponsor|33|||
161904776|NCT04877990|584698769|FG000|Treatment|Withdrawal by Subject|2|||
161904777|NCT04877990|584698770|FG001|Treatment|Withdrawal by Subject|6|||
161904778|NCT04877990|584698769|FG000|Treatment|Adverse Event|2|||
161904779|NCT04877990|584698770|FG001|Treatment|Adverse Event|1|||
161904780|NCT04235504|584698771|FG000|Study Phase|Withdrawal by Subject|5|||
161904781|NCT04235504|584698772|FG001|Study Phase|Withdrawal by Subject|2|||
161904782|NCT04235504|584698773|FG002|Study Phase|Withdrawal by Subject|0|||
161904783|NCT04235504|584698774|FG003|Study Phase|Withdrawal by Subject|0|||
161904784|NCT04235504|584698771|FG000|Continuation Phase|Withdrawal by Subject|0|||
161904785|NCT04235504|584698772|FG001|Continuation Phase|Withdrawal by Subject|4|||
161904786|NCT04235504|584698773|FG002|Continuation Phase|Withdrawal by Subject|0|||
161904787|NCT04235504|584698774|FG003|Continuation Phase|Withdrawal by Subject|0|||
161904788|NCT04235504|584698771|FG000|Continuation Phase|Adverse Event|0|||
161904789|NCT04235504|584698772|FG001|Continuation Phase|Adverse Event|1|||
161904790|NCT04235504|584698773|FG002|Continuation Phase|Adverse Event|0|||
161904791|NCT04235504|584698774|FG003|Continuation Phase|Adverse Event|0|||
161904792|NCT04235504|584698771|FG000|Continuation Phase|Physician Decision|1|||
161904793|NCT04235504|584698772|FG001|Continuation Phase|Physician Decision|2|||
161904794|NCT04235504|584698773|FG002|Continuation Phase|Physician Decision|1|||
161904795|NCT04235504|584698774|FG003|Continuation Phase|Physician Decision|0|||
161904796|NCT04888494|584698777|FG000|Overall Study|Lost to Follow-up|2|||
161904797|NCT04888494|584698778|FG001|Overall Study|Lost to Follow-up|3|||
161904798|NCT04888494|584698777|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
161904799|NCT04888494|584698778|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
161904800|NCT00565604|584698780|FG000|Overall Study|Failure to treat|2|||
161904801|NCT00565604|584698780|FG000|Overall Study|Lost to Follow-up|2|||
161904802|NCT03652818|584701086|FG000|Overall Study|Adverse Event|1|||
161557333|NCT03990363|583430805|FG000|Overall Study|Failure to meet randomization criteria|0|||
161557334|NCT03990363|583430806|FG001|Overall Study|Failure to meet randomization criteria|1|||
161557335|NCT03990363|583430807|FG002|Overall Study|Failure to meet randomization criteria|1|||
161557336|NCT03990363|583430808|FG003|Overall Study|Failure to meet randomization criteria|0|||
161557337|NCT03990363|583430809|FG004|Overall Study|Failure to meet randomization criteria|0|||
161557338|NCT03990363|583430805|FG000|Overall Study|Lost to Follow-up|0|||
161904803|NCT03652818|584701087|FG001|Overall Study|Adverse Event|0|||
161904804|NCT03652818|584701088|FG002|Overall Study|Adverse Event|0|||
161904805|NCT03652818|584701089|FG003|Overall Study|Adverse Event|0|||
161904806|NCT03652818|584701090|FG004|Overall Study|Adverse Event|0|||
161904807|NCT03652818|584701086|FG000|Overall Study|Physician Decision|1|||
161904808|NCT03652818|584701087|FG001|Overall Study|Physician Decision|0|||
161904809|NCT03652818|584701088|FG002|Overall Study|Physician Decision|0|||
161904810|NCT03652818|584701089|FG003|Overall Study|Physician Decision|0|||
161557339|NCT03990363|583430806|FG001|Overall Study|Lost to Follow-up|0|||
161557340|NCT03990363|583430807|FG002|Overall Study|Lost to Follow-up|0|||
161904811|NCT03652818|584701090|FG004|Overall Study|Physician Decision|0|||
161557341|NCT03990363|583430808|FG003|Overall Study|Lost to Follow-up|1|||
161904812|NCT03652818|584701086|FG000|Overall Study|Lost to Follow-up|0|||
161557342|NCT03990363|583430809|FG004|Overall Study|Lost to Follow-up|2|||
161557343|NCT03990363|583430805|FG000|Overall Study|Non-compliance with study drug|2|||
161557344|NCT03990363|583430806|FG001|Overall Study|Non-compliance with study drug|1|||
161557345|NCT03990363|583430807|FG002|Overall Study|Non-compliance with study drug|2|||
161557346|NCT03990363|583430808|FG003|Overall Study|Non-compliance with study drug|0|||
161557347|NCT03990363|583430809|FG004|Overall Study|Non-compliance with study drug|0|||
161904813|NCT03652818|584701087|FG001|Overall Study|Lost to Follow-up|1|||
161904814|NCT03652818|584701088|FG002|Overall Study|Lost to Follow-up|2|||
161557348|NCT03990363|583430805|FG000|Overall Study|Study terminated by sponsor|0|||
161557349|NCT03990363|583430806|FG001|Overall Study|Study terminated by sponsor|1|||
161557350|NCT03990363|583430807|FG002|Overall Study|Study terminated by sponsor|0|||
161557351|NCT03990363|583430808|FG003|Overall Study|Study terminated by sponsor|0|||
161557352|NCT03990363|583430809|FG004|Overall Study|Study terminated by sponsor|0|||
161904815|NCT03652818|584701089|FG003|Overall Study|Lost to Follow-up|1|||
161904816|NCT03652818|584701090|FG004|Overall Study|Lost to Follow-up|1|||
161904817|NCT01699750|584701093|FG000|Overall Study|Withdrew Consent|0|||
161904818|NCT01699750|584701094|FG001|Overall Study|Withdrew Consent|1|||
161904819|NCT01699750|584701093|FG000|Overall Study|Other|0|||
161904820|NCT01699750|584701094|FG001|Overall Study|Other|2|||
161904821|NCT01868646|584701097|FG000|Overall Study|Do not meet inclusion criteria|3|||
161904822|NCT01868646|584701098|FG001|Overall Study|Do not meet inclusion criteria|5|||
161904823|NCT01831427|584701099|FG000|Overall Study|Adverse Event|0|||
161904824|NCT01831427|584701100|FG001|Overall Study|Adverse Event|1|||
161904825|NCT01831427|584701101|FG002|Overall Study|Adverse Event|0|||
161904826|NCT01831427|584701102|FG003|Overall Study|Adverse Event|0|||
161904827|NCT01831427|584701103|FG004|Overall Study|Adverse Event|0|||
161904828|NCT01831427|584701104|FG005|Overall Study|Adverse Event|1|||
161904829|NCT01831427|584701105|FG006|Overall Study|Adverse Event|0|||
161904830|NCT01831427|584701106|FG007|Overall Study|Adverse Event|1|||
161904831|NCT01831427|584701107|FG008|Overall Study|Adverse Event|0|||
161904832|NCT01831427|584701108|FG009|Overall Study|Adverse Event|0|||
161904833|NCT01831427|584701109|FG010|Overall Study|Adverse Event|2|||
161904834|NCT01831427|584701099|FG000|Overall Study|Investigator's Discretion|0|||
161904835|NCT01831427|584701100|FG001|Overall Study|Investigator's Discretion|0|||
161904836|NCT01831427|584701101|FG002|Overall Study|Investigator's Discretion|0|||
161904837|NCT01831427|584701102|FG003|Overall Study|Investigator's Discretion|1|||
161904838|NCT01831427|584701103|FG004|Overall Study|Investigator's Discretion|0|||
161904839|NCT01831427|584701104|FG005|Overall Study|Investigator's Discretion|0|||
161904840|NCT01831427|584701105|FG006|Overall Study|Investigator's Discretion|0|||
161904841|NCT01831427|584701106|FG007|Overall Study|Investigator's Discretion|0|||
161904842|NCT01831427|584701107|FG008|Overall Study|Investigator's Discretion|0|||
161904843|NCT01831427|584701108|FG009|Overall Study|Investigator's Discretion|0|||
161904844|NCT01831427|584701109|FG010|Overall Study|Investigator's Discretion|0|||
161904845|NCT01831427|584701099|FG000|Overall Study|Withdrew Consent|0|||
161904846|NCT01831427|584701100|FG001|Overall Study|Withdrew Consent|0|||
161904847|NCT01831427|584701101|FG002|Overall Study|Withdrew Consent|0|||
161557353|NCT03990363|583430805|FG000|Overall Study|Site terminated by sponsor|2|||
161557354|NCT03990363|583430806|FG001|Overall Study|Site terminated by sponsor|1|||
161557355|NCT03990363|583430807|FG002|Overall Study|Site terminated by sponsor|2|||
161557356|NCT03990363|583430808|FG003|Overall Study|Site terminated by sponsor|0|||
161557357|NCT03990363|583430809|FG004|Overall Study|Site terminated by sponsor|2|||
161557358|NCT03990363|583430805|FG000|Overall Study|Not categorized|5|||
161557359|NCT03990363|583430806|FG001|Overall Study|Not categorized|5|||
161557360|NCT03990363|583430807|FG002|Overall Study|Not categorized|3|||
161557361|NCT03990363|583430808|FG003|Overall Study|Not categorized|2|||
161557362|NCT03990363|583430809|FG004|Overall Study|Not categorized|2|||
161557363|NCT01349660|583430815|FG000|Overall Study|Still Receiving Study Treatment|0|||
161557364|NCT01349660|583430816|FG001|Overall Study|Still Receiving Study Treatment|0|||
161557365|NCT01349660|583430817|FG002|Overall Study|Still Receiving Study Treatment|1|||
161557366|NCT01349660|583430815|FG000|Overall Study|Disease Progression|2|||
161557367|NCT01349660|583430816|FG001|Overall Study|Disease Progression|4|||
161557368|NCT01349660|583430817|FG002|Overall Study|Disease Progression|50|||
161904848|NCT01831427|584701102|FG003|Overall Study|Withdrew Consent|0|||
161904849|NCT01831427|584701103|FG004|Overall Study|Withdrew Consent|0|||
161904850|NCT01831427|584701104|FG005|Overall Study|Withdrew Consent|0|||
161904851|NCT01831427|584701105|FG006|Overall Study|Withdrew Consent|2|||
161904852|NCT01831427|584701106|FG007|Overall Study|Withdrew Consent|0|||
161904853|NCT01831427|584701107|FG008|Overall Study|Withdrew Consent|0|||
161904854|NCT01831427|584701108|FG009|Overall Study|Withdrew Consent|1|||
161904855|NCT01831427|584701109|FG010|Overall Study|Withdrew Consent|1|||
161904856|NCT00536510|584701112|FG000|Overall Study|Adverse Event|27|||
161904857|NCT00536510|584701113|FG001|Overall Study|Adverse Event|4|||
161904858|NCT00536510|584701112|FG000|Overall Study|Lost to Follow-up|11|||
161904859|NCT00536510|584701113|FG001|Overall Study|Lost to Follow-up|8|||
161904860|NCT00536510|584701112|FG000|Overall Study|Protocol Violation|4|||
161557369|NCT01349660|583430815|FG000|Overall Study|Adverse Event|1|||
161904861|NCT00536510|584701113|FG001|Overall Study|Protocol Violation|5|||
161904862|NCT00536510|584701112|FG000|Overall Study|Withdrawal by Subject|16|||
161801074|NCT01193608|584314443|FG003|Overall Study|Lost to Follow-up|0|||
161801075|NCT01193608|584314444|FG004|Overall Study|Lost to Follow-up|1|||
161801076|NCT01193608|584314445|FG005|Overall Study|Lost to Follow-up|2|||
161801077|NCT01193608|584314440|FG000|Overall Study|Adverse Event|0|||
161801078|NCT01193608|584314441|FG001|Overall Study|Adverse Event|0|||
161801079|NCT01193608|584314442|FG002|Overall Study|Adverse Event|0|||
161801080|NCT01193608|584314443|FG003|Overall Study|Adverse Event|0|||
161801081|NCT01193608|584314444|FG004|Overall Study|Adverse Event|1|||
161801082|NCT01193608|584314445|FG005|Overall Study|Adverse Event|0|||
161801083|NCT01249664|584314446|FG000|Overall Study|Withdrawal by Subject|5|||
161801084|NCT01249664|584314447|FG001|Overall Study|Withdrawal by Subject|0|||
161801085|NCT01249664|584314446|FG000|Overall Study|Adverse Event|1|||
161801086|NCT01249664|584314447|FG001|Overall Study|Adverse Event|0|||
161801087|NCT01025037|584314452|FG000|Overall Study|Adverse Event|3|||
161801088|NCT01025037|584314452|FG000|Overall Study|Lost to Follow-up|7|||
161801089|NCT01025037|584314452|FG000|Overall Study|Withdrawal by Subject|1|||
161801090|NCT01370408|584314453|FG000|Overall Study|treatment failure|9|||
161801091|NCT05014412|584314457|FG000|Overall Study|Death|11|||
161801092|NCT05014412|584314458|FG001|Overall Study|Death|7|||
161801093|NCT05014412|584314459|FG002|Overall Study|Death|4|||
161801094|NCT05014412|584314460|FG003|Overall Study|Death|7|||
161801095|NCT05014412|584314457|FG000|Overall Study|Withdrawal by Subject|1|||
161801096|NCT05014412|584314458|FG001|Overall Study|Withdrawal by Subject|1|||
161801097|NCT05014412|584314459|FG002|Overall Study|Withdrawal by Subject|1|||
161801098|NCT05014412|584314460|FG003|Overall Study|Withdrawal by Subject|2|||
161801099|NCT05014412|584314457|FG000|Overall Study|Ongoing|21|||
161801100|NCT05014412|584314458|FG001|Overall Study|Ongoing|4|||
161801101|NCT05014412|584314459|FG002|Overall Study|Ongoing|6|||
161801102|NCT05014412|584314460|FG003|Overall Study|Ongoing|20|||
161801103|NCT02353169|584314461|FG000|Overall Study|QTc > 450 msec|1|||
161801104|NCT02353169|584314462|FG001|Overall Study|QTc > 450 msec|1|||
161801105|NCT02353169|584314463|FG002|Overall Study|QTc > 450 msec|1|||
161801106|NCT02353169|584314464|FG003|Overall Study|QTc > 450 msec|1|||
161801107|NCT02353169|584314461|FG000|Overall Study|OR team declined|2|||
161801108|NCT02353169|584314462|FG001|Overall Study|OR team declined|0|||
161801109|NCT02353169|584314463|FG002|Overall Study|OR team declined|0|||
161801110|NCT02353169|584314464|FG003|Overall Study|OR team declined|0|||
161801111|NCT02353169|584314461|FG000|Overall Study|Inhalational induction|0|||
161801112|NCT02353169|584314462|FG001|Overall Study|Inhalational induction|2|||
161801113|NCT02353169|584314463|FG002|Overall Study|Inhalational induction|0|||
161801114|NCT02353169|584314464|FG003|Overall Study|Inhalational induction|0|||
161801115|NCT02353169|584314461|FG000|Overall Study|ECG data error|0|||
161801116|NCT02353169|584314462|FG001|Overall Study|ECG data error|3|||
161801117|NCT02353169|584314463|FG002|Overall Study|ECG data error|2|||
161801118|NCT02353169|584314464|FG003|Overall Study|ECG data error|2|||
161801119|NCT02353169|584314461|FG000|Overall Study|Pre-op medication|0|||
161801120|NCT02353169|584314462|FG001|Overall Study|Pre-op medication|0|||
161801121|NCT02353169|584314463|FG002|Overall Study|Pre-op medication|1|||
161801122|NCT02353169|584314464|FG003|Overall Study|Pre-op medication|0|||
161801123|NCT00486837|584314465|FG000|Overall Study|Withdrawal by Subject|1|||
161801124|NCT00486837|584314466|FG001|Overall Study|Withdrawal by Subject|0|||
161801125|NCT00486837|584314465|FG000|Overall Study|Adverse Event|1|||
161801126|NCT00486837|584314466|FG001|Overall Study|Adverse Event|1|||
161801127|NCT00486837|584314465|FG000|Overall Study|Protocol Violation|4|||
161801128|NCT00486837|584314466|FG001|Overall Study|Protocol Violation|2|||
161801129|NCT00486837|584314465|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
161801130|NCT00486837|584314466|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
161801131|NCT05295953|584314467|FG000|Overall Study|Withdrawal by Subject|0|||
161801132|NCT05295953|584314468|FG001|Overall Study|Withdrawal by Subject|1|||
161801133|NCT05956665|584314472|FG000|Overall Study|Death|1|||
161801134|NCT05956665|584314472|FG000|Overall Study|Withdrawal by Subject|1|||
161801135|NCT00368277|584314475|FG000|Overall Study|Adverse Event|33|||
161801136|NCT00368277|584314476|FG001|Overall Study|Adverse Event|49|||
161801137|NCT00368277|584314475|FG000|Overall Study|Death|2|||
161801138|NCT00368277|584314476|FG001|Overall Study|Death|1|||
161904863|NCT00536510|584701113|FG001|Overall Study|Withdrawal by Subject|9|||
161801139|NCT00368277|584314475|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
161904864|NCT00536510|584701112|FG000|Overall Study|Flushing with Product|20|||
161904865|NCT00536510|584701113|FG001|Overall Study|Flushing with Product|0|||
161801140|NCT00368277|584314476|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
161801141|NCT00368277|584314475|FG000|Overall Study|Protocol deviation|7|||
161801142|NCT00368277|584314476|FG001|Overall Study|Protocol deviation|0|||
161801143|NCT00368277|584314475|FG000|Overall Study|Patient withdrew consent|32|||
161801144|NCT00368277|584314476|FG001|Overall Study|Patient withdrew consent|28|||
161801145|NCT00368277|584314475|FG000|Overall Study|Lost to Follow-up|8|||
161801146|NCT00368277|584314476|FG001|Overall Study|Lost to Follow-up|6|||
161801147|NCT00117949|584314479|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
161801148|NCT00117949|584314480|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
161801149|NCT00117949|584314481|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
161557370|NCT01349660|583430816|FG001|Overall Study|Adverse Event|1|||
161557371|NCT01349660|583430817|FG002|Overall Study|Adverse Event|12|||
161557372|NCT01349660|583430815|FG000|Overall Study|Withdrawal by Subject|2|||
161801150|NCT00117949|584314482|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
161801151|NCT00117949|584314479|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
161801152|NCT00117949|584314480|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
161801153|NCT00117949|584314481|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
161801154|NCT00117949|584314482|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
161801155|NCT00117949|584314479|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
161801156|NCT00117949|584314480|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
161801157|NCT00117949|584314481|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
161801158|NCT00117949|584314482|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
161801159|NCT00117949|584314479|FG000|Overall Study|PSA increase >=10ng/mL|0|||
161801160|NCT00117949|584314480|FG001|Overall Study|PSA increase >=10ng/mL|1|||
161801161|NCT00117949|584314481|FG002|Overall Study|PSA increase >=10ng/mL|1|||
161801162|NCT00117949|584314482|FG003|Overall Study|PSA increase >=10ng/mL|0|||
161801163|NCT00117949|584314479|FG000|Overall Study|PSA reduction <=50%|0|||
161801164|NCT00117949|584314480|FG001|Overall Study|PSA reduction <=50%|2|||
161801165|NCT00117949|584314481|FG002|Overall Study|PSA reduction <=50%|2|||
161801166|NCT00117949|584314482|FG003|Overall Study|PSA reduction <=50%|4|||
161801167|NCT00117949|584314479|FG000|Overall Study|Hepatic abnormalities|0|||
161801168|NCT00117949|584314480|FG001|Overall Study|Hepatic abnormalities|1|||
161801169|NCT00117949|584314481|FG002|Overall Study|Hepatic abnormalities|0|||
161801170|NCT00117949|584314482|FG003|Overall Study|Hepatic abnormalities|1|||
161801171|NCT05275998|584314483|FG000|Overall Study|Adverse Event|0|||
161801172|NCT05275998|584314484|FG001|Overall Study|Adverse Event|0|||
161801173|NCT05275998|584314485|FG002|Overall Study|Adverse Event|0|||
161801174|NCT05275998|584314486|FG003|Overall Study|Adverse Event|1|||
161801175|NCT05275998|584314483|FG000|Overall Study|Withdrawal by Subject|0|||
161801176|NCT05275998|584314484|FG001|Overall Study|Withdrawal by Subject|0|||
161801177|NCT05275998|584314485|FG002|Overall Study|Withdrawal by Subject|0|||
161801178|NCT05275998|584314486|FG003|Overall Study|Withdrawal by Subject|1|||
161801179|NCT05275998|584314483|FG000|Overall Study|Physician Decision|0|||
161801180|NCT05275998|584314484|FG001|Overall Study|Physician Decision|0|||
161801181|NCT05275998|584314485|FG002|Overall Study|Physician Decision|0|||
161801182|NCT05275998|584314486|FG003|Overall Study|Physician Decision|1|||
161801183|NCT05275998|584314483|FG000|Overall Study|Protocol Violation|0|||
161801184|NCT05275998|584314484|FG001|Overall Study|Protocol Violation|0|||
161801185|NCT05275998|584314485|FG002|Overall Study|Protocol Violation|1|||
161801186|NCT05275998|584314486|FG003|Overall Study|Protocol Violation|0|||
161801187|NCT01936948|584314487|FG000|Overall Study|no 30-day follow-up data|0|||
161801188|NCT01936948|584314488|FG001|Overall Study|no 30-day follow-up data|3|||
161801189|NCT01936948|584314489|FG002|Overall Study|no 30-day follow-up data|3|||
161801190|NCT01936948|584314490|FG003|Overall Study|no 30-day follow-up data|3|||
161801191|NCT01974141|584314491|FG000|Overall Study|Other Reasons|28|||
161801192|NCT01974141|584314492|FG001|Overall Study|Other Reasons|18|||
161801193|NCT01974141|584314491|FG000|Overall Study|Protocol Violation|2|||
161801194|NCT01974141|584314492|FG001|Overall Study|Protocol Violation|6|||
161801195|NCT01974141|584314491|FG000|Overall Study|Personal Reasons|21|||
161801196|NCT01974141|584314492|FG001|Overall Study|Personal Reasons|20|||
161801197|NCT01974141|584314491|FG000|Overall Study|Lost to Follow-up|38|||
161801198|NCT01974141|584314492|FG001|Overall Study|Lost to Follow-up|29|||
161801199|NCT01974141|584314491|FG000|Overall Study|Pregnancy|3|||
161801200|NCT01974141|584314492|FG001|Overall Study|Pregnancy|3|||
161801201|NCT01974141|584314491|FG000|Overall Study|Lack of Efficacy|0|||
161801202|NCT01974141|584314492|FG001|Overall Study|Lack of Efficacy|1|||
161801203|NCT01974141|584314491|FG000|Overall Study|Adverse Event|4|||
161801204|NCT01974141|584314492|FG001|Overall Study|Adverse Event|5|||
161801205|NCT00406848|584314494|FG000|Overall Study|Withdrawal by Subject|27|||
161801206|NCT00406848|584314495|FG001|Overall Study|Withdrawal by Subject|22|||
161557373|NCT01349660|583430816|FG001|Overall Study|Withdrawal by Subject|0|||
161557374|NCT01349660|583430817|FG002|Overall Study|Withdrawal by Subject|9|||
161801207|NCT00406848|584314494|FG000|Overall Study|Adverse Event|38|||
161801208|NCT00406848|584314495|FG001|Overall Study|Adverse Event|7|||
161801209|NCT00406848|584314494|FG000|Overall Study|Lack of Efficacy|9|||
161801210|NCT00406848|584314495|FG001|Overall Study|Lack of Efficacy|14|||
161801211|NCT00406848|584314494|FG000|Overall Study|Protocol Violation|10|||
161801212|NCT00406848|584314495|FG001|Overall Study|Protocol Violation|6|||
161801213|NCT00406848|584314494|FG000|Overall Study|Lost to Follow-up|6|||
161557375|NCT01349660|583430815|FG000|Overall Study|Death|1|||
161801214|NCT00406848|584314495|FG001|Overall Study|Lost to Follow-up|2|||
161801215|NCT00406848|584314494|FG000|Overall Study|Physician Decision|2|||
161801216|NCT00406848|584314495|FG001|Overall Study|Physician Decision|2|||
161801217|NCT00406848|584314494|FG000|Overall Study|Sponsor Decision|1|||
161801218|NCT00406848|584314495|FG001|Overall Study|Sponsor Decision|1|||
161557376|NCT01349660|583430816|FG001|Overall Study|Death|1|||
161801219|NCT04803357|584314496|FG000|Overall Study|Withdrawal by Subject|31|||
161904866|NCT00536510|584701112|FG000|Overall Study|Laboratory Adverse Event|2|||
161557377|NCT01349660|583430817|FG002|Overall Study|Death|0|||
161557378|NCT01349660|583430815|FG000|Overall Study|Non-Permitted Interventions|0|||
161557379|NCT01349660|583430816|FG001|Overall Study|Non-Permitted Interventions|0|||
161801220|NCT04803357|584314497|FG001|Overall Study|Withdrawal by Subject|5|||
161801221|NCT02879643|584314499|FG000|Overall Study|Adverse Event|0|||
161801222|NCT02879643|584314500|FG001|Overall Study|Adverse Event|0|||
161801223|NCT02879643|584314501|FG002|Overall Study|Adverse Event|1|||
161801224|NCT02879643|584314502|FG003|Overall Study|Adverse Event|1|||
161801225|NCT02879643|584314503|FG004|Overall Study|Adverse Event|0|||
161801226|NCT00182091|584314504|FG000|Overall Study|Withdrawal by Subject|1|||
161801227|NCT00182091|584314505|FG001|Overall Study|Withdrawal by Subject|0|||
161801228|NCT00182091|584314506|FG002|Overall Study|Withdrawal by Subject|0|||
161801229|NCT00182091|584314507|FG003|Overall Study|Withdrawal by Subject|0|||
161801230|NCT01046253|584314508|FG000|Second Intervention|Adverse Event|0|||
161801231|NCT01046253|584314509|FG001|Second Intervention|Adverse Event|1|||
161801232|NCT01046253|584314508|FG000|Second Intervention|Protocol Violation|0|||
161801233|NCT01046253|584314509|FG001|Second Intervention|Protocol Violation|1|||
161801234|NCT02339909|584314510|FG000|Overall Study|Became ineligible after randomisation|89|||
161801235|NCT02339909|584314511|FG001|Overall Study|Became ineligible after randomisation|63|||
161801236|NCT02339909|584314512|FG002|Overall Study|Became ineligible after randomisation|71|||
161801237|NCT00860028|584314513|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
161801238|NCT00860028|584314514|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
161801239|NCT02576990|584314515|FG000|Overall Study|Death|29|||
161801240|NCT02576990|584314516|FG001|Overall Study|Death|18|||
161801241|NCT02576990|584314515|FG000|Overall Study|Physician Decision|1|||
161801242|NCT02576990|584314516|FG001|Overall Study|Physician Decision|0|||
161801243|NCT02576990|584314515|FG000|Overall Study|Screen failure|2|||
161801244|NCT02576990|584314516|FG001|Overall Study|Screen failure|0|||
161801245|NCT02576990|584314515|FG000|Overall Study|Sponsor's decision|24|||
161801246|NCT02576990|584314516|FG001|Overall Study|Sponsor's decision|4|||
161801247|NCT02576990|584314515|FG000|Overall Study|Withdrawal by Subject|0|||
161801248|NCT02576990|584314516|FG001|Overall Study|Withdrawal by Subject|2|||
161801249|NCT00936390|584314517|FG000|Overall Study|Protocol Violation|21|||
161801250|NCT00936390|584314518|FG001|Overall Study|Protocol Violation|25|||
161801251|NCT02093689|584314519|FG000|Overall Study|Physician Decision|4|||
161801252|NCT02093689|584314520|FG001|Overall Study|Physician Decision|0|||
161801253|NCT02093689|584314521|FG002|Overall Study|Physician Decision|0|||
161801254|NCT00475020|584314522|FG000|Overall Study|Physician Decision|3|||
161801255|NCT00475020|584314522|FG000|Overall Study|Insurance Denial|1|||
161801256|NCT00475020|584314522|FG000|Overall Study|Donor not able to donate the last minute|1|||
161801257|NCT01575054|584314523|FG000|Overall Study|Other Reasons|5|||
161801258|NCT01575054|584314524|FG001|Overall Study|Other Reasons|3|||
161801259|NCT01575054|584314523|FG000|Overall Study|Protocol Violation|2|||
161801260|NCT01575054|584314524|FG001|Overall Study|Protocol Violation|1|||
161801261|NCT01575054|584314523|FG000|Overall Study|Personal Reasons|10|||
161801262|NCT01575054|584314524|FG001|Overall Study|Personal Reasons|11|||
161801263|NCT01575054|584314523|FG000|Overall Study|Lost to Follow-up|3|||
161801264|NCT01575054|584314524|FG001|Overall Study|Lost to Follow-up|3|||
161801265|NCT01575054|584314523|FG000|Overall Study|Adverse Event|9|||
161801266|NCT01575054|584314524|FG001|Overall Study|Adverse Event|8|||
161801267|NCT03481309|584314525|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
161801268|NCT03481309|584314526|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801269|NCT03481309|584314527|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801270|NCT03481309|584314528|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801271|NCT03481309|584314529|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801272|NCT03481309|584314530|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801273|NCT03309956|584314533|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
161801274|NCT02768298|584314534|FG000|Overall Study|Adverse Event|1|||
161801275|NCT02768298|584314535|FG001|Overall Study|Adverse Event|4|||
161801276|NCT02768298|584314534|FG000|Overall Study|Death|2|||
161801277|NCT02768298|584314535|FG001|Overall Study|Death|1|||
161801278|NCT02768298|584314534|FG000|Overall Study|Non-compliance with study treatment|0|||
161801279|NCT02768298|584314535|FG001|Overall Study|Non-compliance with study treatment|1|||
161801280|NCT02768298|584314534|FG000|Overall Study|Subject/guardian decision|1|||
161801281|NCT02768298|584314535|FG001|Overall Study|Subject/guardian decision|0|||
161801282|NCT02768298|584314534|FG000|Overall Study|Withdrawal of informed consent|0|||
161801283|NCT02768298|584314535|FG001|Overall Study|Withdrawal of informed consent|1|||
161801284|NCT03365947|584314536|FG000|Overall Study|Lost to Follow-up|0|||
161801285|NCT03365947|584314537|FG001|Overall Study|Lost to Follow-up|0|||
161801286|NCT03365947|584314538|FG002|Overall Study|Lost to Follow-up|0|||
161801287|NCT03365947|584314539|FG003|Overall Study|Lost to Follow-up|0|||
161801288|NCT03365947|584314540|FG004|Overall Study|Lost to Follow-up|0|||
161801289|NCT03365947|584314541|FG005|Overall Study|Lost to Follow-up|1|||
161801290|NCT03365947|584314542|FG006|Overall Study|Lost to Follow-up|0|||
161801291|NCT03365947|584314543|FG007|Overall Study|Lost to Follow-up|0|||
161801292|NCT03365947|584314544|FG008|Overall Study|Lost to Follow-up|0|||
161801293|NCT03365947|584314545|FG009|Overall Study|Lost to Follow-up|0|||
161557380|NCT01349660|583430817|FG002|Overall Study|Non-Permitted Interventions|2|||
161557381|NCT01349660|583430815|FG000|Overall Study|Study Compliance|0|||
161557382|NCT01349660|583430816|FG001|Overall Study|Study Compliance|0|||
161557383|NCT01349660|583430817|FG002|Overall Study|Study Compliance|1|||
161557384|NCT01349660|583430815|FG000|Overall Study|Declining Performance Status|0|||
161557385|NCT01349660|583430816|FG001|Overall Study|Declining Performance Status|0|||
161904867|NCT00536510|584701113|FG001|Overall Study|Laboratory Adverse Event|1|||
161904868|NCT00536510|584701112|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
161904869|NCT00536510|584701113|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
161904870|NCT01249417|584701114|FG000|Randomised Population|Study treatment not received|0|||
161904871|NCT01249417|584701115|FG001|Randomised Population|Study treatment not received|0|||
161904872|NCT01249417|584701116|FG002|Randomised Population|Study treatment not received|2|||
161904873|NCT01249417|584701114|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
161904874|NCT01249417|584701115|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
161904875|NCT01249417|584701116|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
161904876|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Other|0|||
161904877|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Other|0|||
161904878|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Other|1|||
161904879|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
161904880|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
161904881|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
161904882|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
161904883|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
161904884|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
161904885|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
161904886|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
161904887|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
161904888|NCT01854697|584701117|FG000|Overall Study|Adverse Event|1|||
161904889|NCT01854697|584701118|FG001|Overall Study|Adverse Event|0|||
161904890|NCT01854697|584701119|FG002|Overall Study|Adverse Event|0|||
161904891|NCT01854697|584701120|FG003|Overall Study|Adverse Event|0|||
161904892|NCT01854697|584701121|FG004|Overall Study|Adverse Event|1|||
161904893|NCT01854697|584701117|FG000|Overall Study|Lost to Follow-up|4|||
161904894|NCT01854697|584701118|FG001|Overall Study|Lost to Follow-up|1|||
161904895|NCT01854697|584701119|FG002|Overall Study|Lost to Follow-up|1|||
161904896|NCT01854697|584701120|FG003|Overall Study|Lost to Follow-up|2|||
161904897|NCT01854697|584701121|FG004|Overall Study|Lost to Follow-up|0|||
161904898|NCT01854697|584701117|FG000|Overall Study|To enter another AbbVie study|1|||
161904899|NCT01854697|584701118|FG001|Overall Study|To enter another AbbVie study|0|||
161904900|NCT01854697|584701119|FG002|Overall Study|To enter another AbbVie study|0|||
161904901|NCT01854697|584701120|FG003|Overall Study|To enter another AbbVie study|0|||
161904902|NCT01854697|584701121|FG004|Overall Study|To enter another AbbVie study|1|||
161904903|NCT01854697|584701117|FG000|Overall Study|Withdrew Consent|0|||
161904904|NCT01854697|584701118|FG001|Overall Study|Withdrew Consent|1|||
161904905|NCT01854697|584701119|FG002|Overall Study|Withdrew Consent|0|||
161904906|NCT01854697|584701120|FG003|Overall Study|Withdrew Consent|1|||
161904907|NCT01854697|584701121|FG004|Overall Study|Withdrew Consent|0|||
161904908|NCT01854697|584701117|FG000|Overall Study|Other|0|||
161904909|NCT01854697|584701118|FG001|Overall Study|Other|1|||
161904910|NCT01854697|584701119|FG002|Overall Study|Other|1|||
161904911|NCT01854697|584701120|FG003|Overall Study|Other|0|||
161904912|NCT01854697|584701121|FG004|Overall Study|Other|0|||
161904913|NCT03074695|584701122|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
161904914|NCT03074695|584701123|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
161904915|NCT03074695|584701122|FG000|Overall Study|Research staff not available|1|||
161904916|NCT03074695|584701123|FG001|Overall Study|Research staff not available|2|||
161904917|NCT03074695|584701122|FG000|Overall Study|Did not receive neuraxial block|2|||
161904918|NCT03074695|584701123|FG001|Overall Study|Did not receive neuraxial block|2|||
161904919|NCT00902577|584701124|FG000|Overall Study|Withdrawal by Subject|6|||
161904920|NCT00902577|584701124|FG000|Overall Study|FMISO production failure|2|||
161904921|NCT01232790|584701125|FG000|Randomization|Withdrawal by Subject|2|||
161904922|NCT01232790|584701126|FG001|Randomization|Withdrawal by Subject|0|||
161904923|NCT01232790|584701125|FG000|Randomization|Protocol Violation|0|||
161557386|NCT01349660|583430817|FG002|Overall Study|Declining Performance Status|1|||
161904924|NCT01232790|584701126|FG001|Randomization|Protocol Violation|1|||
161904925|NCT01232790|584701125|FG000|Randomization|Physician Decision|0|||
161904926|NCT01232790|584701126|FG001|Randomization|Physician Decision|1|||
161904927|NCT01232790|584701125|FG000|Initial Assessment|Withdrawal by Subject|0|||
161904928|NCT01232790|584701126|FG001|Initial Assessment|Withdrawal by Subject|1|||
161904929|NCT01232790|584701125|FG000|First Crossover|Withdrawal by Subject|1|||
161904930|NCT01232790|584701126|FG001|First Crossover|Withdrawal by Subject|0|||
161904931|NCT01232790|584701125|FG000|Second Crossover|Withdrawal by Subject|1|||
161904932|NCT01232790|584701126|FG001|Second Crossover|Withdrawal by Subject|2|||
161904933|NCT00468585|584701127|FG000|Overall Study|Patient not treated|1|||
161557387|NCT01563978|583430819|FG000|Overall Study|Physician Decision|1|||
161557388|NCT01563978|583430820|FG001|Overall Study|Physician Decision|0|||
161557389|NCT01563978|583430819|FG000|Overall Study|Lost to Follow-up|1|||
161557390|NCT01563978|583430820|FG001|Overall Study|Lost to Follow-up|0|||
161557391|NCT01563978|583430819|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
161557392|NCT01563978|583430820|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
161557393|NCT01563978|583430819|FG000|Overall Study|Adverse Event|1|||
161557394|NCT01563978|583430820|FG001|Overall Study|Adverse Event|2|||
161557395|NCT04630756|583430821|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
161557396|NCT04630756|583430822|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
161557397|NCT04630756|583430823|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
161557398|NCT05593211|583430825|FG000|Overall Study|Withdrawal by Subject|1|||
161557399|NCT03225846|583430826|FG000|Overall Study|Adverse Event|0|||
161557400|NCT03225846|583430827|FG001|Overall Study|Adverse Event|0|||
161557401|NCT03225846|583430828|FG002|Overall Study|Adverse Event|0|||
161557402|NCT03225846|583430829|FG003|Overall Study|Adverse Event|0|||
161557403|NCT03225846|583430830|FG004|Overall Study|Adverse Event|0|||
161557404|NCT03225846|583430831|FG005|Overall Study|Adverse Event|0|||
161557405|NCT03225846|583430832|FG006|Overall Study|Adverse Event|6|||
161557406|NCT03225846|583430826|FG000|Overall Study|Withdrawal by Subject|0|||
161557407|NCT03225846|583430827|FG001|Overall Study|Withdrawal by Subject|1|||
161557408|NCT03225846|583430828|FG002|Overall Study|Withdrawal by Subject|0|||
161557409|NCT03225846|583430829|FG003|Overall Study|Withdrawal by Subject|0|||
161557410|NCT03225846|583430830|FG004|Overall Study|Withdrawal by Subject|0|||
161557411|NCT03225846|583430831|FG005|Overall Study|Withdrawal by Subject|0|||
161557412|NCT03225846|583430832|FG006|Overall Study|Withdrawal by Subject|0|||
161557413|NCT03225846|583430826|FG000|Overall Study|Death|0|||
161557414|NCT03225846|583430827|FG001|Overall Study|Death|1|||
161557415|NCT03225846|583430828|FG002|Overall Study|Death|0|||
161557416|NCT03225846|583430829|FG003|Overall Study|Death|0|||
161557417|NCT03225846|583430830|FG004|Overall Study|Death|0|||
161557418|NCT03225846|583430831|FG005|Overall Study|Death|0|||
161557419|NCT03225846|583430832|FG006|Overall Study|Death|0|||
161557420|NCT03225846|583430826|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
161557421|NCT03225846|583430827|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
161557422|NCT03225846|583430828|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
161557423|NCT03225846|583430829|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
161557424|NCT03225846|583430830|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
161557425|NCT03225846|583430831|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
161557426|NCT03225846|583430832|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
161557427|NCT03225846|583430826|FG000|Overall Study|Patient decision|0|||
161557428|NCT03225846|583430827|FG001|Overall Study|Patient decision|0|||
161557429|NCT03225846|583430828|FG002|Overall Study|Patient decision|0|||
161557430|NCT03225846|583430829|FG003|Overall Study|Patient decision|0|||
161557431|NCT03225846|583430830|FG004|Overall Study|Patient decision|0|||
161557432|NCT03225846|583430831|FG005|Overall Study|Patient decision|0|||
161557433|NCT03225846|583430832|FG006|Overall Study|Patient decision|1|||
161557434|NCT04248465|583430833|FG000|Randomized-Controlled Period|Death|12|||
161557435|NCT04248465|583430834|FG001|Randomized-Controlled Period|Death|5|||
161557436|NCT04248465|583430833|FG000|Randomized-Controlled Period|Adverse Event|2|||
161557437|NCT04248465|583430834|FG001|Randomized-Controlled Period|Adverse Event|0|||
161557438|NCT04248465|583430833|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
161557439|NCT04248465|583430834|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
161801294|NCT03365947|584314546|FG010|Overall Study|Lost to Follow-up|0|||
161801295|NCT03365947|584314547|FG011|Overall Study|Lost to Follow-up|0|||
161801296|NCT03365947|584314548|FG012|Overall Study|Lost to Follow-up|0|||
161801297|NCT03365947|584314549|FG013|Overall Study|Lost to Follow-up|0|||
161801298|NCT03365947|584314550|FG014|Overall Study|Lost to Follow-up|0|||
161801299|NCT03365947|584314551|FG015|Overall Study|Lost to Follow-up|0|||
161801300|NCT03365947|584314552|FG016|Overall Study|Lost to Follow-up|0|||
161801301|NCT03365947|584314553|FG017|Overall Study|Lost to Follow-up|0|||
161801302|NCT03365947|584314554|FG018|Overall Study|Lost to Follow-up|0|||
161801303|NCT02518685|584314555|FG000|Overall Study|Adverse Event|29|||
161801304|NCT02518685|584314556|FG001|Overall Study|Adverse Event|1|||
161801305|NCT02518685|584314555|FG000|Overall Study|Withdrawal by Subject|10|||
161801306|NCT02518685|584314556|FG001|Overall Study|Withdrawal by Subject|3|||
161801307|NCT02518685|584314555|FG000|Overall Study|relocation, study fatigue|7|||
161801308|NCT02518685|584314556|FG001|Overall Study|relocation, study fatigue|2|||
161801309|NCT02518685|584314555|FG000|Overall Study|Pregnancy|1|||
161801310|NCT02518685|584314556|FG001|Overall Study|Pregnancy|0|||
161801311|NCT02518685|584314555|FG000|Overall Study|Physician Decision|1|||
161904934|NCT00468585|584701128|FG001|Overall Study|Patient not treated|0|||
161801312|NCT02518685|584314556|FG001|Overall Study|Physician Decision|0|||
161904935|NCT00468585|584701129|FG002|Overall Study|Patient not treated|1|||
161801313|NCT02518685|584314555|FG000|Overall Study|Lost to Follow-up|1|||
161801314|NCT02518685|584314556|FG001|Overall Study|Lost to Follow-up|4|||
161904936|NCT00468585|584701130|FG003|Overall Study|Patient not treated|0|||
161904937|NCT00468585|584701127|FG000|Overall Study|Patient found to be ineligible|0|||
161904938|NCT00468585|584701128|FG001|Overall Study|Patient found to be ineligible|0|||
161904939|NCT00468585|584701129|FG002|Overall Study|Patient found to be ineligible|1|||
161904940|NCT00468585|584701130|FG003|Overall Study|Patient found to be ineligible|0|||
161904941|NCT00468585|584701127|FG000|Overall Study|Adverse Event|0|||
161904942|NCT00468585|584701128|FG001|Overall Study|Adverse Event|0|||
161904943|NCT00468585|584701129|FG002|Overall Study|Adverse Event|1|||
161904944|NCT00468585|584701130|FG003|Overall Study|Adverse Event|0|||
161904945|NCT00468585|584701127|FG000|Overall Study|Withdrawal by Subject|0|||
161904946|NCT00468585|584701128|FG001|Overall Study|Withdrawal by Subject|0|||
161904947|NCT00468585|584701129|FG002|Overall Study|Withdrawal by Subject|2|||
161904948|NCT00468585|584701130|FG003|Overall Study|Withdrawal by Subject|1|||
161904949|NCT03769649|584701131|FG000|Overall Study|Lost to Follow-up|4|||
161904950|NCT03322293|584701132|FG000|Overall Study|Lost to Follow-up|0|||
161904951|NCT03322293|584701133|FG001|Overall Study|Lost to Follow-up|0|||
161904952|NCT03322293|584701134|FG002|Overall Study|Lost to Follow-up|1|||
161904953|NCT00083915|584701137|FG000|Overall Study|Death|6|||
161904954|NCT00083915|584701138|FG001|Overall Study|Death|3|||
161904955|NCT00083915|584701137|FG000|Overall Study|Physician Decision|11|||
161904956|NCT00083915|584701138|FG001|Overall Study|Physician Decision|6|||
161904957|NCT00083915|584701137|FG000|Overall Study|Withdrawal by Subject|8|||
161904958|NCT00083915|584701138|FG001|Overall Study|Withdrawal by Subject|3|||
161904959|NCT00083915|584701137|FG000|Overall Study|disease progression|18|||
161904960|NCT00083915|584701138|FG001|Overall Study|disease progression|23|||
161904961|NCT00083915|584701137|FG000|Overall Study|Failure to collect|3|||
161904962|NCT00083915|584701138|FG001|Overall Study|Failure to collect|0|||
161904963|NCT00083915|584701137|FG000|Overall Study|No response|3|||
161904964|NCT00083915|584701138|FG001|Overall Study|No response|1|||
161904965|NCT00083915|584701137|FG000|Overall Study|Insurance issues|1|||
161904966|NCT00083915|584701138|FG001|Overall Study|Insurance issues|1|||
161904967|NCT00719901|584701140|FG000|Overall Study|Adverse Event|5|||
161904968|NCT00719901|584701140|FG000|Overall Study|Withdrawal by Subject|1|||
161904969|NCT00719901|584701140|FG000|Overall Study|Alternate Treatment|1|||
161904970|NCT00719901|584701140|FG000|Overall Study|Disease Progression|3|||
161904971|NCT00719901|584701140|FG000|Overall Study|Availability of Study Drug|1|||
161904972|NCT04456686|584701143|FG000|Overall Study|Adverse Event|2|||
161904973|NCT04456686|584701144|FG001|Overall Study|Adverse Event|1|||
161904974|NCT04456686|584701143|FG000|Overall Study|Lack of Efficacy|3|||
161904975|NCT04456686|584701144|FG001|Overall Study|Lack of Efficacy|1|||
161904976|NCT04456686|584701143|FG000|Overall Study|Withdrew consent|3|||
161904977|NCT04456686|584701144|FG001|Overall Study|Withdrew consent|1|||
161904978|NCT04456686|584701143|FG000|Overall Study|Physician Decision|2|||
161904979|NCT04456686|584701144|FG001|Overall Study|Physician Decision|2|||
161904980|NCT04456686|584701143|FG000|Overall Study|Withdrawal by Subject|5|||
161904981|NCT04456686|584701144|FG001|Overall Study|Withdrawal by Subject|1|||
161904982|NCT04456686|584701143|FG000|Overall Study|Protocol Violation|0|||
161904983|NCT04456686|584701144|FG001|Overall Study|Protocol Violation|1|||
161904984|NCT02858401|584701147|FG000|Overall Study|Withdrew Consent|0|||
161904985|NCT02858401|584701148|FG001|Overall Study|Withdrew Consent|0|||
161904986|NCT02858401|584701149|FG002|Overall Study|Withdrew Consent|0|||
161904987|NCT02858401|584701150|FG003|Overall Study|Withdrew Consent|0|||
161904988|NCT02858401|584701151|FG004|Overall Study|Withdrew Consent|0|||
161904989|NCT02858401|584701152|FG005|Overall Study|Withdrew Consent|1|||
161904990|NCT02858401|584701153|FG006|Overall Study|Withdrew Consent|0|||
161904991|NCT02858401|584701147|FG000|Overall Study|Lost to Follow-up|0|||
161904992|NCT02858401|584701148|FG001|Overall Study|Lost to Follow-up|1|||
161904993|NCT02858401|584701149|FG002|Overall Study|Lost to Follow-up|0|||
161904994|NCT02858401|584701150|FG003|Overall Study|Lost to Follow-up|0|||
161904995|NCT02858401|584701151|FG004|Overall Study|Lost to Follow-up|0|||
161904996|NCT02858401|584701152|FG005|Overall Study|Lost to Follow-up|0|||
161904997|NCT02858401|584701153|FG006|Overall Study|Lost to Follow-up|0|||
161904998|NCT03722576|584701154|FG000|Overall Study|Withdrawal by Subject|3|||
161904999|NCT03722576|584701154|FG000|Overall Study|Adverse Event|2|||
161905000|NCT03722576|584701154|FG000|Overall Study|Physician Decision|1|||
161905001|NCT03722576|584701154|FG000|Overall Study|Lost to Follow-up|1|||
161905002|NCT02059239|584701158|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
161905003|NCT02059239|584701159|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
161905004|NCT02059239|584701158|FG000|Overall Study|Physician Decision|1|||
161905005|NCT02059239|584701159|FG001|Overall Study|Physician Decision|0|||
161905006|NCT01408706|584701161|FG000|Overall Study|Physician Decision|1|||
161905007|NCT01408706|584701162|FG001|Overall Study|Physician Decision|0|||
161905008|NCT01268267|584701163|FG000|Overall Study|Protocol Violation|1|||
161905009|NCT01222104|584701164|FG000|Overall Study|Lost to Follow-up|37|||
161905010|NCT01222104|584701164|FG000|Overall Study|Death|10|||
161905011|NCT00888654|584701166|FG000|Overall Study|Problems swallowing oral meds.|1|||
161905012|NCT00888654|584701166|FG000|Overall Study|Not enough oral meds before surgery|3|||
161905013|NCT00888654|584701166|FG000|Overall Study|Surgery aborted|2|||
161905014|NCT00888654|584701166|FG000|Overall Study|Withdrawal by Subject|1|||
161557440|NCT04248465|583430833|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
161557441|NCT04248465|583430834|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
161557442|NCT04248465|583430833|FG000|Randomized-Controlled Period|Physician Decision|1|||
161557443|NCT04248465|583430834|FG001|Randomized-Controlled Period|Physician Decision|1|||
161557444|NCT04248465|583430833|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
161557445|NCT04248465|583430834|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
161557446|NCT04248465|583430833|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
161557447|NCT04248465|583430834|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
161557448|NCT04248465|583430833|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161557449|NCT04248465|583430834|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
161557450|NCT05708846|583430835|FG000|Overall Study|Death|5|||
161557451|NCT05708846|583430835|FG000|Overall Study|Withdrawal by Subject|20|||
161557452|NCT03621982|583430836|FG000|Overall Study|Withdrawal by Subject|1|||
161557453|NCT03621982|583430837|FG001|Overall Study|Withdrawal by Subject|0|||
161557454|NCT03621982|583430838|FG002|Overall Study|Withdrawal by Subject|0|||
161557455|NCT03621982|583430839|FG003|Overall Study|Withdrawal by Subject|1|||
161557456|NCT03621982|583430840|FG004|Overall Study|Withdrawal by Subject|0|||
161557457|NCT03621982|583430841|FG005|Overall Study|Withdrawal by Subject|1|||
161557458|NCT03621982|583430842|FG006|Overall Study|Withdrawal by Subject|1|||
161557459|NCT03621982|583430843|FG007|Overall Study|Withdrawal by Subject|0|||
161557460|NCT03621982|583430844|FG008|Overall Study|Withdrawal by Subject|1|||
161557461|NCT03621982|583430845|FG009|Overall Study|Withdrawal by Subject|0|||
161557462|NCT03621982|583430846|FG010|Overall Study|Withdrawal by Subject|2|||
161557463|NCT03621982|583430847|FG011|Overall Study|Withdrawal by Subject|1|||
161557464|NCT03621982|583430848|FG012|Overall Study|Withdrawal by Subject|2|||
161557465|NCT03621982|583430849|FG013|Overall Study|Withdrawal by Subject|2|||
161557466|NCT03621982|583430836|FG000|Overall Study|Investigator/Sponsor decision|0|||
161557467|NCT03621982|583430837|FG001|Overall Study|Investigator/Sponsor decision|0|||
161557468|NCT03621982|583430838|FG002|Overall Study|Investigator/Sponsor decision|0|||
161557469|NCT03621982|583430839|FG003|Overall Study|Investigator/Sponsor decision|0|||
161557470|NCT03621982|583430840|FG004|Overall Study|Investigator/Sponsor decision|0|||
161557471|NCT03621982|583430841|FG005|Overall Study|Investigator/Sponsor decision|0|||
161557472|NCT03621982|583430842|FG006|Overall Study|Investigator/Sponsor decision|0|||
161557473|NCT03621982|583430843|FG007|Overall Study|Investigator/Sponsor decision|0|||
161557474|NCT03621982|583430844|FG008|Overall Study|Investigator/Sponsor decision|0|||
161557475|NCT03621982|583430845|FG009|Overall Study|Investigator/Sponsor decision|0|||
161557476|NCT03621982|583430846|FG010|Overall Study|Investigator/Sponsor decision|0|||
161557477|NCT03621982|583430847|FG011|Overall Study|Investigator/Sponsor decision|4|||
161557478|NCT03621982|583430848|FG012|Overall Study|Investigator/Sponsor decision|0|||
161557479|NCT03621982|583430849|FG013|Overall Study|Investigator/Sponsor decision|2|||
161557480|NCT03621982|583430836|FG000|Overall Study|Death|2|||
161557481|NCT03621982|583430837|FG001|Overall Study|Death|4|||
161557482|NCT03621982|583430838|FG002|Overall Study|Death|4|||
161557483|NCT03621982|583430839|FG003|Overall Study|Death|3|||
161557484|NCT03621982|583430840|FG004|Overall Study|Death|8|||
161557485|NCT03621982|583430841|FG005|Overall Study|Death|4|||
161557486|NCT03621982|583430842|FG006|Overall Study|Death|6|||
161557487|NCT03621982|583430843|FG007|Overall Study|Death|3|||
161557488|NCT03621982|583430844|FG008|Overall Study|Death|0|||
161557489|NCT03621982|583430845|FG009|Overall Study|Death|3|||
161557490|NCT03621982|583430846|FG010|Overall Study|Death|8|||
161557491|NCT03621982|583430847|FG011|Overall Study|Death|4|||
161557492|NCT03621982|583430848|FG012|Overall Study|Death|2|||
161557493|NCT03621982|583430849|FG013|Overall Study|Death|2|||
161557494|NCT03621982|583430836|FG000|Overall Study|Lost to Follow-up|0|||
161557495|NCT03621982|583430837|FG001|Overall Study|Lost to Follow-up|0|||
161557496|NCT03621982|583430838|FG002|Overall Study|Lost to Follow-up|1|||
161557497|NCT03621982|583430839|FG003|Overall Study|Lost to Follow-up|0|||
161557498|NCT03621982|583430840|FG004|Overall Study|Lost to Follow-up|0|||
161557499|NCT03621982|583430841|FG005|Overall Study|Lost to Follow-up|0|||
161557500|NCT03621982|583430842|FG006|Overall Study|Lost to Follow-up|1|||
161557501|NCT03621982|583430843|FG007|Overall Study|Lost to Follow-up|0|||
161557502|NCT03621982|583430844|FG008|Overall Study|Lost to Follow-up|0|||
161557503|NCT03621982|583430845|FG009|Overall Study|Lost to Follow-up|1|||
161557504|NCT03621982|583430846|FG010|Overall Study|Lost to Follow-up|0|||
161557505|NCT03621982|583430847|FG011|Overall Study|Lost to Follow-up|0|||
161557506|NCT03621982|583430848|FG012|Overall Study|Lost to Follow-up|0|||
161557507|NCT03621982|583430849|FG013|Overall Study|Lost to Follow-up|0|||
161557508|NCT00238420|583430850|FG000|Overall Study|Protocol Violation|1|||
161557509|NCT00238420|583430851|FG001|Overall Study|Protocol Violation|1|||
161557510|NCT01254890|583430854|FG000|Overall Study|Ineligible|0|||
161557511|NCT01254890|583430855|FG001|Overall Study|Ineligible|3|||
161557512|NCT01254890|583430854|FG000|Overall Study|Withdrawal by Subject|1|||
161557513|NCT01254890|583430855|FG001|Overall Study|Withdrawal by Subject|2|||
161557514|NCT01254890|583430854|FG000|Overall Study|Disease Progression|0|||
161557515|NCT01254890|583430855|FG001|Overall Study|Disease Progression|5|||
161557516|NCT02419755|583430866|FG000|Overall Study|Death|1|||
161557517|NCT02419755|583430867|FG001|Overall Study|Death|3|||
161557518|NCT02419755|583430866|FG000|Overall Study|Relapse|0|||
161557519|NCT02419755|583430867|FG001|Overall Study|Relapse|1|||
161557520|NCT02419755|583430866|FG000|Overall Study|Ineligible|1|||
161557521|NCT02419755|583430867|FG001|Overall Study|Ineligible|0|||
161557522|NCT02419755|583430866|FG000|Overall Study|Withdrawal by Subject|1|||
161557523|NCT02419755|583430867|FG001|Overall Study|Withdrawal by Subject|0|||
161557524|NCT00810641|583430870|FG000|Overall Study|Withdrawal by Subject|0|||
161557525|NCT00810641|583430871|FG001|Overall Study|Withdrawal by Subject|1|||
161557526|NCT00810641|583430872|FG002|Overall Study|Withdrawal by Subject|2|||
161557527|NCT02325713|583430875|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557528|NCT02325713|583430876|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557529|NCT02325713|583430877|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557530|NCT02325713|583430878|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557531|NCT02325713|583430879|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557532|NCT02325713|583430880|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557533|NCT02325713|583430881|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557534|NCT02325713|583430882|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557535|NCT02325713|583430883|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557536|NCT02325713|583430884|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557537|NCT02325713|583430885|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
161557538|NCT02325713|583430886|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557539|NCT02325713|583430887|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557540|NCT02325713|583430888|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557541|NCT02325713|583430889|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557542|NCT02325713|583430890|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
161557543|NCT02325713|583430875|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
161557544|NCT02325713|583430876|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557545|NCT02325713|583430877|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557546|NCT02325713|583430878|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557547|NCT02325713|583430879|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557548|NCT02325713|583430880|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557549|NCT02325713|583430881|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557550|NCT02325713|583430882|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557551|NCT02325713|583430883|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557552|NCT02325713|583430884|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557553|NCT02325713|583430885|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557554|NCT02325713|583430886|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557555|NCT02325713|583430887|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557556|NCT02325713|583430888|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557557|NCT02325713|583430889|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557558|NCT02325713|583430890|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
161557559|NCT02325713|583430875|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557560|NCT02325713|583430876|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557561|NCT02325713|583430877|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557562|NCT02325713|583430878|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557563|NCT02325713|583430879|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557564|NCT02325713|583430880|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557565|NCT02325713|583430881|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557566|NCT02325713|583430882|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557567|NCT02325713|583430883|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557568|NCT02325713|583430884|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
161801315|NCT01922349|584314557|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161801316|NCT01922349|584314558|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161801317|NCT01922349|584314559|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161801318|NCT01922349|584314560|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
161801319|NCT05109234|584314561|FG000|Overall Study|Adverse Event|2|||
161801320|NCT05109234|584314562|FG001|Overall Study|Adverse Event|2|||
161801321|NCT05109234|584314561|FG000|Overall Study|Lack of Efficacy|5|||
161801322|NCT05109234|584314562|FG001|Overall Study|Lack of Efficacy|0|||
161801323|NCT05109234|584314561|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
161801324|NCT05109234|584314562|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
161557569|NCT02325713|583430885|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557570|NCT02325713|583430886|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557571|NCT02325713|583430887|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557572|NCT02325713|583430888|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557573|NCT02325713|583430889|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161801325|NCT05109234|584314561|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
161557574|NCT02325713|583430890|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161557575|NCT01213173|583430892|FG000|Overall Study|Protocol Violation|2|||
161557576|NCT01213173|583430893|FG001|Overall Study|Protocol Violation|0|||
161557577|NCT01213173|583430892|FG000|Overall Study|Adverse Event|4|||
161557578|NCT01213173|583430893|FG001|Overall Study|Adverse Event|8|||
161557579|NCT01213173|583430892|FG000|Overall Study|Withdrawal by Subject|5|||
161557580|NCT01213173|583430893|FG001|Overall Study|Withdrawal by Subject|5|||
161557581|NCT01213173|583430892|FG000|Overall Study|Incorrect Enrollment|1|||
161557582|NCT01213173|583430893|FG001|Overall Study|Incorrect Enrollment|3|||
161557583|NCT02253316|583430894|FG000|Consolidation|Progression|4|||
161557584|NCT02253316|583430895|FG001|Consolidation|Progression|0|||
161557585|NCT02253316|583430896|FG002|Consolidation|Progression|0|||
161557586|NCT02253316|583430894|FG000|Consolidation|Non-Compliance|1|||
161557587|NCT02253316|583430895|FG001|Consolidation|Non-Compliance|0|||
161557588|NCT02253316|583430896|FG002|Consolidation|Non-Compliance|0|||
161557589|NCT02253316|583430894|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
161557590|NCT02253316|583430895|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
161557591|NCT02253316|583430896|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
161557592|NCT02253316|583430894|FG000|Consolidation|Secondary Malignancy|2|||
161557593|NCT02253316|583430895|FG001|Consolidation|Secondary Malignancy|0|||
161557594|NCT02253316|583430896|FG002|Consolidation|Secondary Malignancy|0|||
161557595|NCT02253316|583430894|FG000|Consolidation|Adverse Event|7|||
161557596|NCT02253316|583430895|FG001|Consolidation|Adverse Event|0|||
161557597|NCT02253316|583430896|FG002|Consolidation|Adverse Event|0|||
161557598|NCT02253316|583430894|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
161557599|NCT02253316|583430895|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
161557600|NCT02253316|583430896|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
161557601|NCT02253316|583430894|FG000|Maintenance|Physician Decision|0|||
161557602|NCT02253316|583430895|FG001|Maintenance|Physician Decision|7|||
161557603|NCT02253316|583430896|FG002|Maintenance|Physician Decision|16|||
161557604|NCT02253316|583430894|FG000|Maintenance|Non-Compliance|0|||
161557605|NCT02253316|583430895|FG001|Maintenance|Non-Compliance|1|||
161557606|NCT02253316|583430896|FG002|Maintenance|Non-Compliance|1|||
161557607|NCT02253316|583430894|FG000|Maintenance|Secondary Malignancy|0|||
161557608|NCT02253316|583430895|FG001|Maintenance|Secondary Malignancy|2|||
161557609|NCT02253316|583430896|FG002|Maintenance|Secondary Malignancy|6|||
161557610|NCT02253316|583430894|FG000|Maintenance|Adverse Event|0|||
161557611|NCT02253316|583430895|FG001|Maintenance|Adverse Event|8|||
161557612|NCT02253316|583430896|FG002|Maintenance|Adverse Event|12|||
161557613|NCT02253316|583430894|FG000|Maintenance|Still receiving active treatment|0|||
161557614|NCT02253316|583430895|FG001|Maintenance|Still receiving active treatment|4|||
161557615|NCT02253316|583430896|FG002|Maintenance|Still receiving active treatment|0|||
161557616|NCT02684903|583430897|FG000|Overall Study|COVID-19 shutdown of lab|4|||
161557617|NCT02684903|583430898|FG001|Overall Study|COVID-19 shutdown of lab|6|||
161557618|NCT02684903|583430897|FG000|Overall Study|Lost to Follow-up|31|||
161557619|NCT02684903|583430898|FG001|Overall Study|Lost to Follow-up|41|||
161557620|NCT06403605|583430903|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
161557621|NCT06403605|583430904|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
161557622|NCT06403605|583430903|FG000|Follow-up|Adverse Event|4|||
161557623|NCT06403605|583430904|FG001|Follow-up|Adverse Event|2|||
161557624|NCT06403605|583430903|FG000|Follow-up|Withdrawal by Subject|2|||
161557625|NCT06403605|583430904|FG001|Follow-up|Withdrawal by Subject|3|||
161557626|NCT06403605|583430903|FG000|Follow-up|Lost to Follow-up|1|||
161557627|NCT06403605|583430904|FG001|Follow-up|Lost to Follow-up|0|||
161557628|NCT06403605|583430903|FG000|Follow-up|Death|1|||
161557629|NCT06403605|583430904|FG001|Follow-up|Death|0|||
161557630|NCT06403605|583430903|FG000|Follow-up|Other reasons|0|||
161557631|NCT06403605|583430904|FG001|Follow-up|Other reasons|4|||
161557632|NCT07083843|583430905|FG000|Intervention period.|Withdrawal by Subject|1|||
161557633|NCT07083843|583430906|FG001|Intervention period.|Withdrawal by Subject|0|||
161557634|NCT07083843|583430905|FG000|Intervention period.|Death|0|||
161801326|NCT05109234|584314562|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
161557635|NCT07083843|583430906|FG001|Intervention period.|Death|1|||
161557636|NCT00394095|583432398|FG000|Screening|Withdrawal by Subject|1|||
161557637|NCT00394095|583432399|FG001|Screening|Withdrawal by Subject|0|||
161801327|NCT05109234|584314561|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
161801328|NCT05109234|584314562|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
161557638|NCT00394095|583432398|FG000|Randomized|Withdrawal by Subject|5|||
161557639|NCT00394095|583432399|FG001|Randomized|Withdrawal by Subject|1|||
161557640|NCT00394095|583432398|FG000|Randomized|Adverse Event|1|||
161557641|NCT00394095|583432399|FG001|Randomized|Adverse Event|1|||
161557642|NCT00394095|583432398|FG000|Randomized|Overdose|1|||
161557643|NCT00394095|583432399|FG001|Randomized|Overdose|0|||
161557644|NCT00394095|583432398|FG000|Randomized|Lost to Follow-up|1|||
161557645|NCT00394095|583432399|FG001|Randomized|Lost to Follow-up|2|||
161557646|NCT02401529|583432411|FG000|Overall Study|Lost to Follow-up|2|||
161557647|NCT02401529|583432412|FG001|Overall Study|Lost to Follow-up|1|||
161557648|NCT02401529|583432411|FG000|Overall Study|Physician Decision|2|||
161557649|NCT02401529|583432412|FG001|Overall Study|Physician Decision|6|||
161557650|NCT02401529|583432411|FG000|Overall Study|Protocol Violation|5|||
161557651|NCT02401529|583432412|FG001|Overall Study|Protocol Violation|0|||
161557652|NCT01036087|583432413|FG000|Overall Study|Adverse Event|2|||
161557653|NCT01036087|583432413|FG000|Overall Study|Lack of Efficacy|1|||
161557654|NCT00072475|583432416|FG000|Overall Study|Adverse Event|44|||
161557655|NCT00072475|583432416|FG000|Overall Study|Death|3|||
161557656|NCT00072475|583432416|FG000|Overall Study|Withdrawal by Subject|46|||
161557657|NCT00072475|583432416|FG000|Overall Study|Patient/Investigator Decision|4|||
161557658|NCT03303105|583432417|FG000|Overall Study|Adverse Event|0|||
161557659|NCT03303105|583432418|FG001|Overall Study|Adverse Event|2|||
161557660|NCT03303105|583432417|FG000|Overall Study|Lack of Efficacy|1|||
161557661|NCT03303105|583432418|FG001|Overall Study|Lack of Efficacy|0|||
161557662|NCT03303105|583432417|FG000|Overall Study|Protocol Violation|1|||
161557663|NCT03303105|583432418|FG001|Overall Study|Protocol Violation|0|||
161557664|NCT03303105|583432417|FG000|Overall Study|Withdrawal by Subject|0|||
161557665|NCT03303105|583432418|FG001|Overall Study|Withdrawal by Subject|2|||
161557666|NCT03566680|583432434|FG000|Overall Study|Pregnancy|1|||
161557667|NCT03566680|583432434|FG000|Overall Study|Lost to Follow-up|13|||
161557668|NCT03566680|583432434|FG000|Overall Study|Withdrawal by Subject|3|||
161557669|NCT02724020|583432436|FG000|Overall Study|Death|16|||
161557670|NCT02724020|583432437|FG001|Overall Study|Death|18|||
161557671|NCT02724020|583432438|FG002|Overall Study|Death|19|||
161557672|NCT02724020|583432436|FG000|Overall Study|Lost to Follow-up|0|||
161557673|NCT02724020|583432437|FG001|Overall Study|Lost to Follow-up|3|||
161557674|NCT02724020|583432438|FG002|Overall Study|Lost to Follow-up|0|||
161557675|NCT02724020|583432436|FG000|Overall Study|Site Terminated by Sponsor|15|||
161557676|NCT02724020|583432437|FG001|Overall Study|Site Terminated by Sponsor|8|||
161557677|NCT02724020|583432438|FG002|Overall Study|Site Terminated by Sponsor|8|||
161557678|NCT02724020|583432436|FG000|Overall Study|Withdrawal by Subject|1|||
161557679|NCT02724020|583432437|FG001|Overall Study|Withdrawal by Subject|3|||
161557680|NCT02724020|583432438|FG002|Overall Study|Withdrawal by Subject|5|||
161557681|NCT02179918|583432439|FG000|Overall Study|Death|0|||
161557682|NCT02179918|583432440|FG001|Overall Study|Death|0|||
161557683|NCT02179918|583432441|FG002|Overall Study|Death|0|||
161557684|NCT02179918|583432442|FG003|Overall Study|Death|1|||
161557685|NCT02179918|583432443|FG004|Overall Study|Death|0|||
161557686|NCT02179918|583432439|FG000|Overall Study|Lost to Follow-up|0|||
161557687|NCT02179918|583432440|FG001|Overall Study|Lost to Follow-up|0|||
161557688|NCT02179918|583432441|FG002|Overall Study|Lost to Follow-up|1|||
161557689|NCT02179918|583432442|FG003|Overall Study|Lost to Follow-up|0|||
161557690|NCT02179918|583432443|FG004|Overall Study|Lost to Follow-up|0|||
161557691|NCT02179918|583432439|FG000|Overall Study|Progressive Disease|4|||
161557692|NCT02179918|583432440|FG001|Overall Study|Progressive Disease|1|||
161557693|NCT02179918|583432441|FG002|Overall Study|Progressive Disease|1|||
161557694|NCT02179918|583432442|FG003|Overall Study|Progressive Disease|2|||
161557695|NCT02179918|583432443|FG004|Overall Study|Progressive Disease|6|||
161557696|NCT02179918|583432439|FG000|Overall Study|Other|0|||
161557697|NCT02179918|583432440|FG001|Overall Study|Other|1|||
161557698|NCT02179918|583432441|FG002|Overall Study|Other|0|||
161557699|NCT02179918|583432442|FG003|Overall Study|Other|0|||
161557700|NCT02179918|583432443|FG004|Overall Study|Other|1|||
161557701|NCT02179918|583432439|FG000|Overall Study|Subject refused further follow-up|0|||
161557702|NCT02179918|583432440|FG001|Overall Study|Subject refused further follow-up|1|||
161557703|NCT02179918|583432441|FG002|Overall Study|Subject refused further follow-up|0|||
161557704|NCT02179918|583432442|FG003|Overall Study|Subject refused further follow-up|0|||
161557705|NCT02179918|583432443|FG004|Overall Study|Subject refused further follow-up|1|||
161557706|NCT02954575|583432446|FG000|Overall Study|Withdrawal by Subject|2|||
161557707|NCT02954575|583432446|FG000|Overall Study|Adverse Event|1|||
161557708|NCT04227340|583432447|FG000|Overall Study|Withdrawal by Subject|3|||
161557709|NCT00570661|583432450|FG000|Overall Study|Disease worsening|5|||
161557710|NCT00570661|583432450|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
161557711|NCT00570661|583432450|FG000|Overall Study|Adverse Event|1|||
161557712|NCT01066156|583432451|FG000|Overall Study|ineligible|2|||
161557713|NCT01066156|583432451|FG000|Overall Study|Lost to Follow-up|7|||
161557714|NCT01066156|583432451|FG000|Overall Study|Withdrawal by Subject|1|||
161557715|NCT01734382|583432455|FG000|Part 1|Adverse Event|2|||
161557716|NCT01734382|583432456|FG001|Part 1|Adverse Event|0|||
161557717|NCT01734382|583432457|FG002|Part 1|Adverse Event|0|||
161557718|NCT01734382|583432455|FG000|Part 2|Adverse Event|0|||
161557719|NCT01734382|583432456|FG001|Part 2|Adverse Event|0|||
161557720|NCT01734382|583432457|FG002|Part 2|Adverse Event|1|||
161557721|NCT01734382|583432455|FG000|Part 2|Lack of Efficacy|0|||
161557722|NCT01734382|583432456|FG001|Part 2|Lack of Efficacy|1|||
161557723|NCT01734382|583432457|FG002|Part 2|Lack of Efficacy|1|||
161557724|NCT01734382|583432455|FG000|Part 2|Other|0|||
161557725|NCT01734382|583432456|FG001|Part 2|Other|0|||
161557726|NCT01734382|583432457|FG002|Part 2|Other|1|||
161557727|NCT01734382|583432455|FG000|Part 2|Physician Decision|0|||
161557728|NCT01734382|583432456|FG001|Part 2|Physician Decision|0|||
161557729|NCT01734382|583432457|FG002|Part 2|Physician Decision|3|||
161557730|NCT01734382|583432455|FG000|Part 2|Protocol Violation|0|||
161557731|NCT01734382|583432456|FG001|Part 2|Protocol Violation|1|||
161557732|NCT01734382|583432457|FG002|Part 2|Protocol Violation|0|||
161557733|NCT01734382|583432455|FG000|Part 2|Withdrawal by Subject|0|||
161557734|NCT01734382|583432456|FG001|Part 2|Withdrawal by Subject|0|||
161557735|NCT01734382|583432457|FG002|Part 2|Withdrawal by Subject|1|||
161557736|NCT04537949|583432458|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
161557737|NCT04537949|583432459|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
161557738|NCT04537949|583432460|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
161557739|NCT04537949|583432461|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
161557740|NCT04537949|583432462|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
161557741|NCT04537949|583432463|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
161557742|NCT04537949|583432464|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
161557743|NCT04537949|583432465|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
161557744|NCT04537949|583432458|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
161557745|NCT04537949|583432459|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
161557746|NCT04537949|583432460|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
161557747|NCT04537949|583432461|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
161557748|NCT04537949|583432462|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
161557749|NCT04537949|583432463|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
161557750|NCT04537949|583432464|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
161557751|NCT04537949|583432465|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
161557752|NCT04537949|583432458|FG000|Follow-up Phase|Lost to Follow-up|0|||
161557753|NCT04537949|583432459|FG001|Follow-up Phase|Lost to Follow-up|3|||
161557754|NCT04537949|583432460|FG002|Follow-up Phase|Lost to Follow-up|0|||
161557755|NCT04537949|583432461|FG003|Follow-up Phase|Lost to Follow-up|0|||
161557756|NCT04537949|583432462|FG004|Follow-up Phase|Lost to Follow-up|0|||
161557757|NCT04537949|583432463|FG005|Follow-up Phase|Lost to Follow-up|0|||
161557758|NCT04537949|583432464|FG006|Follow-up Phase|Lost to Follow-up|0|||
161557759|NCT04537949|583432465|FG007|Follow-up Phase|Lost to Follow-up|0|||
161557760|NCT04537949|583432458|FG000|Follow-up Phase|personal reasons|0|||
161557761|NCT04537949|583432459|FG001|Follow-up Phase|personal reasons|0|||
161557762|NCT04537949|583432460|FG002|Follow-up Phase|personal reasons|0|||
161557763|NCT04537949|583432461|FG003|Follow-up Phase|personal reasons|1|||
161557764|NCT04537949|583432462|FG004|Follow-up Phase|personal reasons|1|||
161557765|NCT04537949|583432463|FG005|Follow-up Phase|personal reasons|0|||
161557766|NCT04537949|583432464|FG006|Follow-up Phase|personal reasons|0|||
161557767|NCT04537949|583432465|FG007|Follow-up Phase|personal reasons|0|||
161557768|NCT04537949|583432458|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161557769|NCT04537949|583432459|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161557770|NCT04537949|583432460|FG002|Follow-up Phase|Withdrawal by Subject|0|||
161557771|NCT04537949|583432461|FG003|Follow-up Phase|Withdrawal by Subject|0|||
161557772|NCT04537949|583432462|FG004|Follow-up Phase|Withdrawal by Subject|1|||
161557773|NCT04537949|583432463|FG005|Follow-up Phase|Withdrawal by Subject|0|||
161557774|NCT04537949|583432464|FG006|Follow-up Phase|Withdrawal by Subject|0|||
161557775|NCT04537949|583432465|FG007|Follow-up Phase|Withdrawal by Subject|0|||
161557776|NCT04003974|583432466|FG000|Overall Study|Missing|1|||
161557777|NCT04003974|583432467|FG001|Overall Study|Missing|0|||
161557778|NCT04003974|583432466|FG000|Overall Study|Withdrawal by Subject|0|||
161557779|NCT04003974|583432467|FG001|Overall Study|Withdrawal by Subject|2|||
161557780|NCT02400307|583432468|FG000|Overall Study|Enrolled and Never Dosed|1|||
161557781|NCT02400307|583432469|FG001|Overall Study|Enrolled and Never Dosed|0|||
161557782|NCT02015663|583432473|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
161557783|NCT02015663|583432474|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
161557784|NCT02015663|583432473|FG000|Overall Study|Withdrawal by Subject|1|||
161557785|NCT02015663|583432474|FG001|Overall Study|Withdrawal by Subject|0|||
161557786|NCT02015663|583432473|FG000|Overall Study|Protocol Violation|0|||
161557787|NCT02015663|583432474|FG001|Overall Study|Protocol Violation|1|||
161557788|NCT02015663|583432473|FG000|Overall Study|Adverse Event|3|||
161557789|NCT02015663|583432474|FG001|Overall Study|Adverse Event|0|||
161557790|NCT02015663|583432473|FG000|Overall Study|Administrative problems|10|||
161557791|NCT02015663|583432474|FG001|Overall Study|Administrative problems|11|||
161557792|NCT02059161|583432476|FG000|Overall Study|Pregnancy|0|||
161557793|NCT02059161|583432477|FG001|Overall Study|Pregnancy|2|||
161557794|NCT02059161|583432476|FG000|Overall Study|Adverse Event|2|||
161557795|NCT02059161|583432477|FG001|Overall Study|Adverse Event|6|||
161557796|NCT02059161|583432476|FG000|Overall Study|Lost to Follow-up|20|||
161557797|NCT02059161|583432477|FG001|Overall Study|Lost to Follow-up|12|||
161557798|NCT02059161|583432476|FG000|Overall Study|Physician Decision|4|||
161557799|NCT02059161|583432477|FG001|Overall Study|Physician Decision|4|||
161557800|NCT02059161|583432476|FG000|Overall Study|Protocol Violation|1|||
161557801|NCT02059161|583432477|FG001|Overall Study|Protocol Violation|1|||
161557802|NCT02059161|583432476|FG000|Overall Study|Withdrawal by Subject|16|||
161557803|NCT02059161|583432477|FG001|Overall Study|Withdrawal by Subject|13|||
161557804|NCT02059161|583432476|FG000|Overall Study|Randomized in error, no study drug|0|||
161557805|NCT02059161|583432477|FG001|Overall Study|Randomized in error, no study drug|1|||
161557806|NCT02059161|583432476|FG000|Overall Study|Non-compliance with study drug|6|||
161557807|NCT02059161|583432477|FG001|Overall Study|Non-compliance with study drug|2|||
161557808|NCT03389893|583432478|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
161557809|NCT03389893|583432479|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
161557810|NCT03389893|583432480|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
161557811|NCT03389893|583432481|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
161557812|NCT03389893|583432478|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
161557813|NCT03389893|583432479|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
161557814|NCT03389893|583432480|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
161557815|NCT03389893|583432481|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
161557816|NCT03389893|583432478|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
161557817|NCT03389893|583432479|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
161557818|NCT03389893|583432480|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
161557819|NCT03389893|583432481|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
161557820|NCT03389893|583432478|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
161557821|NCT03389893|583432479|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
161557822|NCT03389893|583432480|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
161557823|NCT03389893|583432481|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
161557824|NCT01719861|583432484|FG000|Cycle 1|Death|4|||
161557825|NCT01719861|583432484|FG000|Cycle 2|Death|1|||
161557826|NCT00958009|583432485|FG000|Overall Study|Adverse Event|1|||
161557827|NCT00958009|583432485|FG000|Overall Study|Subject found device difficult to use|1|||
161557828|NCT02034435|583432498|FG000|Overall Study|Withdrawal by Subject|1|||
161557829|NCT02034435|583432499|FG001|Overall Study|Withdrawal by Subject|0|||
161557830|NCT02034435|583432500|FG002|Overall Study|Withdrawal by Subject|0|||
161557831|NCT02034435|583432501|FG003|Overall Study|Withdrawal by Subject|0|||
161557832|NCT02034435|583432498|FG000|Overall Study|Illness|0|||
161557833|NCT02034435|583432499|FG001|Overall Study|Illness|2|||
161557834|NCT02034435|583432500|FG002|Overall Study|Illness|0|||
161557835|NCT02034435|583432501|FG003|Overall Study|Illness|0|||
161557836|NCT02034435|583432498|FG000|Overall Study|Inadequate IV access|1|||
161557837|NCT02034435|583432499|FG001|Overall Study|Inadequate IV access|0|||
161557838|NCT02034435|583432500|FG002|Overall Study|Inadequate IV access|0|||
161557839|NCT02034435|583432501|FG003|Overall Study|Inadequate IV access|1|||
161557840|NCT02839681|583432504|FG000|Overall Study|Death|2|||
161557841|NCT01347645|583432508|FG000|Overall Study|Death|1|||
161557842|NCT01347645|583432509|FG001|Overall Study|Death|5|||
161557843|NCT01347645|583432510|FG002|Overall Study|Death|2|||
161557844|NCT01347645|583432511|FG003|Overall Study|Death|7|||
161557845|NCT01347645|583432512|FG004|Overall Study|Death|7|||
161557846|NCT01347645|583432508|FG000|Overall Study|Lost to Follow-up|1|||
161557847|NCT01347645|583432509|FG001|Overall Study|Lost to Follow-up|1|||
161557848|NCT01347645|583432510|FG002|Overall Study|Lost to Follow-up|0|||
161557849|NCT01347645|583432511|FG003|Overall Study|Lost to Follow-up|1|||
161557850|NCT01347645|583432512|FG004|Overall Study|Lost to Follow-up|1|||
161557851|NCT01347645|583432508|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
161557852|NCT01347645|583432509|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
161557853|NCT01347645|583432510|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
161557854|NCT01347645|583432511|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
161557855|NCT01347645|583432512|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
161557856|NCT01347645|583432508|FG000|Overall Study|Other|1|||
161557857|NCT01347645|583432509|FG001|Overall Study|Other|0|||
161557858|NCT01347645|583432510|FG002|Overall Study|Other|0|||
161557859|NCT01347645|583432511|FG003|Overall Study|Other|0|||
161557860|NCT01347645|583432512|FG004|Overall Study|Other|1|||
161557861|NCT01347645|583432508|FG000|Overall Study|Withdrawal by Subject|0|||
161557862|NCT01347645|583432509|FG001|Overall Study|Withdrawal by Subject|0|||
161557863|NCT01347645|583432510|FG002|Overall Study|Withdrawal by Subject|0|||
161557864|NCT01347645|583432511|FG003|Overall Study|Withdrawal by Subject|3|||
161801329|NCT05109234|584314561|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
161801330|NCT05109234|584314562|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
161801331|NCT00336024|584314563|FG000|Overall Study|Death|2|||
161801332|NCT00336024|584314564|FG001|Overall Study|Death|1|||
161801333|NCT00336024|584314563|FG000|Overall Study|Physician Decision|4|||
161801334|NCT00336024|584314564|FG001|Overall Study|Physician Decision|1|||
161801335|NCT00336024|584314563|FG000|Overall Study|Protocol Violation|1|||
161801336|NCT00336024|584314564|FG001|Overall Study|Protocol Violation|0|||
161801337|NCT00336024|584314563|FG000|Overall Study|Withdrawal by Subject|1|||
161801338|NCT00336024|584314564|FG001|Overall Study|Withdrawal by Subject|2|||
161557865|NCT01347645|583432512|FG004|Overall Study|Withdrawal by Subject|3|||
161557866|NCT01347645|583432508|FG000|Overall Study|Physician Decision|0|||
161801339|NCT00336024|584314563|FG000|Overall Study|Failure to fulfill consolidation|1|||
161557867|NCT01347645|583432509|FG001|Overall Study|Physician Decision|0|||
161557868|NCT01347645|583432510|FG002|Overall Study|Physician Decision|0|||
161557869|NCT01347645|583432511|FG003|Overall Study|Physician Decision|0|||
161557870|NCT01347645|583432512|FG004|Overall Study|Physician Decision|1|||
161557871|NCT01347645|583432508|FG000|Overall Study|Adverse Event|0|||
161557872|NCT01347645|583432509|FG001|Overall Study|Adverse Event|0|||
161557873|NCT01347645|583432510|FG002|Overall Study|Adverse Event|0|||
161557874|NCT01347645|583432511|FG003|Overall Study|Adverse Event|1|||
161557875|NCT01347645|583432512|FG004|Overall Study|Adverse Event|1|||
161557876|NCT00388362|583432513|FG000|Enrolled|Ineligible|1|||
161557877|NCT00388362|583432513|FG000|Enrolled|Adverse Event|9|||
161557878|NCT00388362|583432513|FG000|Enrolled|Death|1|||
161557879|NCT00388362|583432513|FG000|Enrolled|Loss insurance|1|||
161557880|NCT00388362|583432513|FG000|Enrolled|Withdrawal by Subject|1|||
161557881|NCT00388362|583432513|FG000|Remained on Study Median of 514 Days|Death|2|||
161557882|NCT01141660|583432514|FG000|Overall Study|Physician Decision|0|||
161557883|NCT01141660|583432515|FG001|Overall Study|Physician Decision|12|||
161557884|NCT00209027|583432517|FG000|Overall Study|study terminated|10|||
161557885|NCT00209027|583432518|FG001|Overall Study|study terminated|0|||
161557886|NCT04770220|583432521|FG000|Overall Study|Adverse Event|2|||
161557887|NCT04770220|583432522|FG001|Overall Study|Adverse Event|11|||
161557888|NCT04770220|583432521|FG000|Overall Study|Withdrawal by Subject|5|||
161557889|NCT04770220|583432522|FG001|Overall Study|Withdrawal by Subject|11|||
161557890|NCT04770220|583432521|FG000|Overall Study|Lost to Follow-up|4|||
161557891|NCT04770220|583432522|FG001|Overall Study|Lost to Follow-up|3|||
161557892|NCT04770220|583432521|FG000|Overall Study|not otherwise specified|2|||
161557893|NCT04770220|583432522|FG001|Overall Study|not otherwise specified|3|||
161905015|NCT00888654|584701166|FG000|Overall Study|Inelig. due to contraindication of med|1|||
161905016|NCT00888654|584701166|FG000|Overall Study|Change in surg date|1|||
161905017|NCT00888654|584701166|FG000|Overall Study|Stopped meds due to headaches|1|||
161557894|NCT04770220|583432521|FG000|Overall Study|Physician Decision|1|||
161905018|NCT01418339|584701167|FG000|Overall Study|Adverse Event|5|||
161905019|NCT01418339|584701168|FG001|Overall Study|Adverse Event|2|||
161905020|NCT01418339|584701167|FG000|Overall Study|Subject Withdrew Consent|1|||
161905021|NCT01418339|584701168|FG001|Overall Study|Subject Withdrew Consent|2|||
161905022|NCT01418339|584701167|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
161905023|NCT01418339|584701168|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
161905024|NCT02219685|584701173|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
161905025|NCT02219685|584701174|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
161557895|NCT04770220|583432522|FG001|Overall Study|Physician Decision|3|||
161557896|NCT04894903|583432524|FG000|Overall Study|Death|1|||
161557897|NCT04894903|583432525|FG001|Overall Study|Death|0|||
161557898|NCT04894903|583432524|FG000|Overall Study|Pregnancy|1|||
161557899|NCT04894903|583432525|FG001|Overall Study|Pregnancy|0|||
161557900|NCT04894903|583432524|FG000|Overall Study|Withdrawal by Subject|1|||
161557901|NCT04894903|583432525|FG001|Overall Study|Withdrawal by Subject|1|||
161557902|NCT04894903|583432524|FG000|Overall Study|moved or exited health system|1|||
161557903|NCT04894903|583432525|FG001|Overall Study|moved or exited health system|3|||
161557904|NCT01923428|583432526|FG000|Overall Study|Adverse Event|8|||
161557905|NCT01923428|583432527|FG001|Overall Study|Adverse Event|6|||
161557906|NCT01923428|583432528|FG002|Overall Study|Adverse Event|3|||
161557907|NCT01923428|583432529|FG003|Overall Study|Adverse Event|3|||
161557908|NCT01923428|583432526|FG000|Overall Study|Withdrawal by Subject|5|||
161557909|NCT01923428|583432527|FG001|Overall Study|Withdrawal by Subject|3|||
161557910|NCT01923428|583432528|FG002|Overall Study|Withdrawal by Subject|0|||
161557911|NCT01923428|583432529|FG003|Overall Study|Withdrawal by Subject|4|||
161557912|NCT01923428|583432526|FG000|Overall Study|Lost to Follow-up|2|||
161557913|NCT01923428|583432527|FG001|Overall Study|Lost to Follow-up|1|||
161557914|NCT01923428|583432528|FG002|Overall Study|Lost to Follow-up|5|||
161557915|NCT01923428|583432529|FG003|Overall Study|Lost to Follow-up|0|||
161557916|NCT01923428|583432526|FG000|Overall Study|Protocol Violation|3|||
161905026|NCT02219685|584701173|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
161557917|NCT01923428|583432527|FG001|Overall Study|Protocol Violation|0|||
161557918|NCT01923428|583432528|FG002|Overall Study|Protocol Violation|2|||
161557919|NCT01923428|583432529|FG003|Overall Study|Protocol Violation|1|||
161557920|NCT01923428|583432526|FG000|Overall Study|Non Compliance to treatment|1|||
161557921|NCT01923428|583432527|FG001|Overall Study|Non Compliance to treatment|2|||
161905027|NCT02219685|584701174|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
161905028|NCT02048722|584701175|FG000|2 Cycles of Treatment|Adverse Event|2|||
161905029|NCT02048722|584701175|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
161557922|NCT01923428|583432528|FG002|Overall Study|Non Compliance to treatment|0|||
161557923|NCT01923428|583432529|FG003|Overall Study|Non Compliance to treatment|1|||
161557924|NCT01923428|583432526|FG000|Overall Study|Lack of Efficacy|0|||
161557925|NCT01923428|583432527|FG001|Overall Study|Lack of Efficacy|0|||
161557926|NCT01923428|583432528|FG002|Overall Study|Lack of Efficacy|1|||
161557927|NCT01923428|583432529|FG003|Overall Study|Lack of Efficacy|1|||
161557928|NCT03873246|583432531|FG000|Overall Study|Adverse Event|1|||
161557929|NCT03873246|583432532|FG001|Overall Study|Adverse Event|3|||
161557930|NCT03873246|583432533|FG002|Overall Study|Adverse Event|3|||
161557931|NCT03873246|583432531|FG000|Overall Study|Lost to Follow-up|4|||
161557932|NCT03873246|583432532|FG001|Overall Study|Lost to Follow-up|4|||
161557933|NCT03873246|583432533|FG002|Overall Study|Lost to Follow-up|5|||
161557934|NCT03873246|583432531|FG000|Overall Study|Protocol Violation|0|||
161557935|NCT03873246|583432532|FG001|Overall Study|Protocol Violation|1|||
161557936|NCT03873246|583432533|FG002|Overall Study|Protocol Violation|0|||
161557937|NCT03873246|583432531|FG000|Overall Study|Withdrawal by Subject|0|||
161557938|NCT03873246|583432532|FG001|Overall Study|Withdrawal by Subject|4|||
161557939|NCT03873246|583432533|FG002|Overall Study|Withdrawal by Subject|1|||
161557940|NCT00946647|583432534|FG000|Phase 1 Part|Adverse Event|2|||
161557941|NCT00946647|583432535|FG001|Phase 1 Part|Adverse Event|5|||
161557942|NCT00946647|583432536|FG002|Phase 1 Part|Adverse Event|3|||
161557943|NCT00946647|583432537|FG003|Phase 1 Part|Adverse Event|0|||
161557944|NCT00946647|583432538|FG004|Phase 1 Part|Adverse Event|0|||
161557945|NCT00946647|583432534|FG000|Phase 1 Part|Disease progression|3|||
161557946|NCT00946647|583432535|FG001|Phase 1 Part|Disease progression|6|||
161557947|NCT00946647|583432536|FG002|Phase 1 Part|Disease progression|1|||
161557948|NCT00946647|583432537|FG003|Phase 1 Part|Disease progression|0|||
161557949|NCT00946647|583432538|FG004|Phase 1 Part|Disease progression|0|||
161557950|NCT00946647|583432534|FG000|Phase 1 Part|Withdrawal by Subject|1|||
161557951|NCT00946647|583432535|FG001|Phase 1 Part|Withdrawal by Subject|4|||
161557952|NCT00946647|583432536|FG002|Phase 1 Part|Withdrawal by Subject|3|||
161557953|NCT00946647|583432537|FG003|Phase 1 Part|Withdrawal by Subject|0|||
161557954|NCT00946647|583432538|FG004|Phase 1 Part|Withdrawal by Subject|0|||
161557955|NCT00946647|583432534|FG000|Phase 1 Part|Abnormal values|0|||
161557956|NCT00946647|583432535|FG001|Phase 1 Part|Abnormal values|2|||
161557957|NCT00946647|583432536|FG002|Phase 1 Part|Abnormal values|0|||
161557958|NCT00946647|583432537|FG003|Phase 1 Part|Abnormal values|0|||
161557959|NCT00946647|583432538|FG004|Phase 1 Part|Abnormal values|0|||
161557960|NCT00946647|583432534|FG000|Phase 1 Part|Reason missing|0|||
161557961|NCT00946647|583432535|FG001|Phase 1 Part|Reason missing|1|||
161557962|NCT00946647|583432536|FG002|Phase 1 Part|Reason missing|0|||
161557963|NCT00946647|583432537|FG003|Phase 1 Part|Reason missing|0|||
161557964|NCT00946647|583432538|FG004|Phase 1 Part|Reason missing|0|||
161557965|NCT00946647|583432534|FG000|Phase ll Part|Untreated|0|||
161557966|NCT00946647|583432535|FG001|Phase ll Part|Untreated|0|||
161557967|NCT00946647|583432536|FG002|Phase ll Part|Untreated|0|||
161557968|NCT00946647|583432537|FG003|Phase ll Part|Untreated|0|||
161557969|NCT00946647|583432538|FG004|Phase ll Part|Untreated|2|||
161557970|NCT00946647|583432534|FG000|Phase ll Part|Adverse Event|0|||
161557971|NCT00946647|583432535|FG001|Phase ll Part|Adverse Event|0|||
161557972|NCT00946647|583432536|FG002|Phase ll Part|Adverse Event|0|||
161557973|NCT00946647|583432537|FG003|Phase ll Part|Adverse Event|10|||
161557974|NCT00946647|583432538|FG004|Phase ll Part|Adverse Event|6|||
161801340|NCT00336024|584314564|FG001|Overall Study|Failure to fulfill consolidation|1|||
161801341|NCT00336024|584314563|FG000|Overall Study|Progressive Disease|4|||
161801342|NCT00336024|584314564|FG001|Overall Study|Progressive Disease|7|||
161801343|NCT00336024|584314563|FG000|Overall Study|Ineligible|7|||
161801344|NCT00336024|584314564|FG001|Overall Study|Ineligible|7|||
161801345|NCT05067504|584314566|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
161801346|NCT05067504|584314567|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
161801347|NCT05067504|584314566|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
161801348|NCT05067504|584314567|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
161801349|NCT05067504|584314566|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
161801350|NCT05067504|584314567|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
161801351|NCT03805438|584316450|FG000|Overall Study|Lack of Efficacy|1|||
161801352|NCT03805438|584316450|FG000|Overall Study|Protocol Violation|1|||
161801353|NCT00419770|584316453|FG000|Overall Study|Withdrawal by Subject|5|||
161801354|NCT00419770|584316454|FG001|Overall Study|Withdrawal by Subject|1|||
161801355|NCT02424188|584316462|FG000|Overall Study|Death|2|||
161801356|NCT02424188|584316463|FG001|Overall Study|Death|2|||
161801357|NCT02424188|584316462|FG000|Overall Study|Lost to Follow-up|1|||
161557975|NCT00946647|583432534|FG000|Phase ll Part|Withdrawal by Subject|0|||
161801358|NCT02424188|584316463|FG001|Overall Study|Lost to Follow-up|3|||
161801359|NCT02424188|584316462|FG000|Overall Study|Incarceration|1|||
161801360|NCT02424188|584316463|FG001|Overall Study|Incarceration|0|||
161557976|NCT00946647|583432535|FG001|Phase ll Part|Withdrawal by Subject|0|||
161557977|NCT00946647|583432536|FG002|Phase ll Part|Withdrawal by Subject|0|||
161557978|NCT00946647|583432537|FG003|Phase ll Part|Withdrawal by Subject|8|||
161557979|NCT00946647|583432538|FG004|Phase ll Part|Withdrawal by Subject|6|||
161557980|NCT00946647|583432534|FG000|Phase ll Part|Administrative problems|0|||
161557981|NCT00946647|583432535|FG001|Phase ll Part|Administrative problems|0|||
161557982|NCT00946647|583432536|FG002|Phase ll Part|Administrative problems|0|||
161557983|NCT00946647|583432537|FG003|Phase ll Part|Administrative problems|3|||
161557984|NCT00946647|583432538|FG004|Phase ll Part|Administrative problems|8|||
161557985|NCT00946647|583432534|FG000|Phase ll Part|Death|0|||
161557986|NCT00946647|583432535|FG001|Phase ll Part|Death|0|||
161801361|NCT01494506|584316468|FG000|Overall Study|Lack of Efficacy|77|||
161801362|NCT01494506|584316469|FG001|Overall Study|Lack of Efficacy|83|||
161905030|NCT02048722|584701175|FG000|2 Cycles of Treatment|Progressive Disease|2|||
161905031|NCT02048722|584701175|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
161905032|NCT02048722|584701175|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
161905033|NCT02048722|584701175|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
161905034|NCT00705757|584701176|FG000|Overall Study|Lack of Efficacy|5|||
161905035|NCT00705757|584701177|FG001|Overall Study|Lack of Efficacy|1|||
161905036|NCT00705757|584701178|FG002|Overall Study|Lack of Efficacy|3|||
161905037|NCT00705757|584701176|FG000|Overall Study|Lost to Follow-up|7|||
161905038|NCT00705757|584701177|FG001|Overall Study|Lost to Follow-up|6|||
161905039|NCT00705757|584701178|FG002|Overall Study|Lost to Follow-up|6|||
161905040|NCT00705757|584701176|FG000|Overall Study|Withdrawal by Subject|1|||
161905041|NCT00705757|584701177|FG001|Overall Study|Withdrawal by Subject|1|||
161905042|NCT00705757|584701178|FG002|Overall Study|Withdrawal by Subject|2|||
161557987|NCT00946647|583432536|FG002|Phase ll Part|Death|0|||
161557988|NCT00946647|583432537|FG003|Phase ll Part|Death|7|||
161557989|NCT00946647|583432538|FG004|Phase ll Part|Death|4|||
161557990|NCT00946647|583432534|FG000|Phase ll Part|Disease progression|0|||
161557991|NCT00946647|583432535|FG001|Phase ll Part|Disease progression|0|||
161557992|NCT00946647|583432536|FG002|Phase ll Part|Disease progression|0|||
161557993|NCT00946647|583432537|FG003|Phase ll Part|Disease progression|6|||
161557994|NCT00946647|583432538|FG004|Phase ll Part|Disease progression|14|||
161557995|NCT00946647|583432534|FG000|Phase ll Part|Protocol Violation|0|||
161557996|NCT00946647|583432535|FG001|Phase ll Part|Protocol Violation|0|||
161557997|NCT00946647|583432536|FG002|Phase ll Part|Protocol Violation|0|||
161557998|NCT00946647|583432537|FG003|Phase ll Part|Protocol Violation|4|||
161557999|NCT00946647|583432538|FG004|Phase ll Part|Protocol Violation|2|||
161558000|NCT00946647|583432534|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
161558001|NCT00946647|583432535|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
161558002|NCT00946647|583432536|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
161558003|NCT00946647|583432537|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
161558004|NCT00946647|583432538|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
161558005|NCT01368211|583432539|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
161558006|NCT01368211|583432540|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
161558007|NCT04988477|583432545|FG000|Overall Study|Death|1|||
161558008|NCT04988477|583432546|FG001|Overall Study|Death|0|||
161558009|NCT04988477|583432547|FG002|Overall Study|Death|0|||
161558010|NCT04988477|583432545|FG000|Overall Study|Lost to Follow-up|5|||
161558011|NCT04988477|583432546|FG001|Overall Study|Lost to Follow-up|2|||
161558012|NCT04988477|583432547|FG002|Overall Study|Lost to Follow-up|0|||
161558013|NCT04988477|583432545|FG000|Overall Study|Withdrawal by Subject|2|||
161558014|NCT04988477|583432546|FG001|Overall Study|Withdrawal by Subject|0|||
161558015|NCT04988477|583432547|FG002|Overall Study|Withdrawal by Subject|0|||
161558016|NCT04034238|583433910|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
161558017|NCT04034238|583433911|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161558018|NCT04034238|583433912|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161558019|NCT04034238|583433913|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161558020|NCT04034238|583433910|FG000|Dose Escalation Phase|Screen failures|0|||
161558021|NCT04034238|583433911|FG001|Dose Escalation Phase|Screen failures|0|||
161558022|NCT04034238|583433912|FG002|Dose Escalation Phase|Screen failures|0|||
161558023|NCT04034238|583433913|FG003|Dose Escalation Phase|Screen failures|2|||
161558024|NCT04034238|583433910|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
161558025|NCT04034238|583433911|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
161558026|NCT04034238|583433912|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
161558027|NCT04034238|583433913|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
161558028|NCT04034238|583433910|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
161558029|NCT04034238|583433911|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
161558030|NCT04034238|583433912|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
161558031|NCT04034238|583433913|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
161905043|NCT04144322|584701187|FG000|Overall Study|Lack of Efficacy|2|||
161905044|NCT04144322|584701188|FG001|Overall Study|Lack of Efficacy|2|||
161558032|NCT02153788|583433916|FG000|Overall Study|Physician Decision|2|||
161558033|NCT02153788|583433917|FG001|Overall Study|Physician Decision|1|||
161668047|NCT00406653|583837476|FG000|Induction Period|Given prohibited drug|0|||
161905045|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
161905046|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
161558034|NCT01106287|583433918|FG000|Overall Study|Adverse Event|1|||
161558035|NCT01106287|583433919|FG001|Overall Study|Adverse Event|0|||
161558036|NCT01106287|583433920|FG002|Overall Study|Adverse Event|0|||
161558037|NCT01106287|583433921|FG003|Overall Study|Adverse Event|0|||
161558038|NCT01450943|583433924|FG000|Overall Study|Screen failure, loss to follow-up|2|||
161558039|NCT01450943|583433925|FG001|Overall Study|Screen failure, loss to follow-up|7|||
161558040|NCT01450943|583433926|FG002|Overall Study|Screen failure, loss to follow-up|6|||
161558041|NCT01345292|583433927|FG000|Overall Study|Withdrawal by Subject|2|||
161558042|NCT01345292|583433928|FG001|Overall Study|Withdrawal by Subject|0|||
161558043|NCT01345292|583433929|FG002|Overall Study|Withdrawal by Subject|1|||
161558044|NCT04822298|583433933|FG000|Overall Study|Death|3|||
161558045|NCT00465361|583433936|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
161558046|NCT05406791|583433937|FG000|Overall Study|Lost to Follow-up|13|||
161558047|NCT05406791|583433938|FG001|Overall Study|Lost to Follow-up|10|||
161558048|NCT01625338|583433939|FG000|Overall Study|Enrolled but not Treated|0|||
161558049|NCT01625338|583433940|FG001|Overall Study|Enrolled but not Treated|0|||
161558050|NCT01625338|583433941|FG002|Overall Study|Enrolled but not Treated|1|||
161558051|NCT01625338|583433939|FG000|Overall Study|Efficacy Failure|27|||
161558052|NCT01625338|583433940|FG001|Overall Study|Efficacy Failure|39|||
161558053|NCT01625338|583433941|FG002|Overall Study|Efficacy Failure|31|||
161558054|NCT01625338|583433939|FG000|Overall Study|Lost to Follow-up|3|||
161558055|NCT01625338|583433940|FG001|Overall Study|Lost to Follow-up|3|||
161558056|NCT01625338|583433941|FG002|Overall Study|Lost to Follow-up|2|||
161558057|NCT01625338|583433939|FG000|Overall Study|Investigator Decision|0|||
161558058|NCT01625338|583433940|FG001|Overall Study|Investigator Decision|2|||
161558059|NCT01625338|583433941|FG002|Overall Study|Investigator Decision|1|||
161558060|NCT01625338|583433939|FG000|Overall Study|Subject Withdrew Consent|1|||
161558061|NCT01625338|583433940|FG001|Overall Study|Subject Withdrew Consent|0|||
161558062|NCT01625338|583433941|FG002|Overall Study|Subject Withdrew Consent|2|||
161558063|NCT01625338|583433939|FG000|Overall Study|Adverse Event|1|||
161558064|NCT01625338|583433940|FG001|Overall Study|Adverse Event|0|||
161558065|NCT01625338|583433941|FG002|Overall Study|Adverse Event|1|||
161558066|NCT01625338|583433939|FG000|Overall Study|Study Discontinued by Sponsor|0|||
161558067|NCT01625338|583433940|FG001|Overall Study|Study Discontinued by Sponsor|0|||
161558068|NCT01625338|583433941|FG002|Overall Study|Study Discontinued by Sponsor|1|||
161558069|NCT01789203|583433942|FG000|Overall Study|Adverse Event|2|||
161558070|NCT01789203|583433943|FG001|Overall Study|Adverse Event|2|||
161558071|NCT01789203|583433942|FG000|Overall Study|Withdrawal by Subject|1|||
161558072|NCT01789203|583433943|FG001|Overall Study|Withdrawal by Subject|0|||
161558073|NCT01789203|583433942|FG000|Overall Study|Death|1|||
161558074|NCT01789203|583433943|FG001|Overall Study|Death|0|||
161558075|NCT01789203|583433942|FG000|Overall Study|Protocol Violation|2|||
161558076|NCT01789203|583433943|FG001|Overall Study|Protocol Violation|1|||
161558077|NCT01789203|583433942|FG000|Overall Study|Other|1|||
161558078|NCT01789203|583433943|FG001|Overall Study|Other|1|||
161558079|NCT01789203|583433942|FG000|Overall Study|patient non-adherent|2|||
161558080|NCT01789203|583433943|FG001|Overall Study|patient non-adherent|0|||
161558081|NCT00515086|583433950|FG000|Overall Study|Adverse Event|1|||
161558082|NCT00515086|583433951|FG001|Overall Study|Adverse Event|1|||
161558083|NCT00515086|583433952|FG002|Overall Study|Adverse Event|2|||
161558084|NCT00515086|583433953|FG003|Overall Study|Adverse Event|3|||
161558085|NCT00515086|583433950|FG000|Overall Study|Administrative|1|||
161558086|NCT00515086|583433951|FG001|Overall Study|Administrative|1|||
161558087|NCT00515086|583433952|FG002|Overall Study|Administrative|0|||
161558088|NCT00515086|583433953|FG003|Overall Study|Administrative|0|||
161558089|NCT00515086|583433950|FG000|Overall Study|Withdrawal by Subject|1|||
161558090|NCT00515086|583433951|FG001|Overall Study|Withdrawal by Subject|0|||
161558091|NCT00515086|583433952|FG002|Overall Study|Withdrawal by Subject|0|||
161558092|NCT00515086|583433953|FG003|Overall Study|Withdrawal by Subject|1|||
161905047|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
161905048|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
161905049|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
161905050|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
161905051|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
161905052|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905053|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905054|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905055|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905056|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
161558093|NCT00515086|583433950|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
161558094|NCT00515086|583433951|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161558095|NCT00515086|583433952|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
161558096|NCT00515086|583433953|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161558097|NCT00515086|583433950|FG000|Overall Study|Lost to Follow-up|1|||
161558098|NCT00515086|583433951|FG001|Overall Study|Lost to Follow-up|0|||
161558099|NCT00515086|583433952|FG002|Overall Study|Lost to Follow-up|0|||
161558100|NCT00515086|583433953|FG003|Overall Study|Lost to Follow-up|0|||
161558101|NCT00515086|583433950|FG000|Overall Study|Study drug no longer required|0|||
161558102|NCT00515086|583433951|FG001|Overall Study|Study drug no longer required|1|||
161558103|NCT00515086|583433952|FG002|Overall Study|Study drug no longer required|0|||
161558104|NCT00515086|583433953|FG003|Overall Study|Study drug no longer required|0|||
161558105|NCT00515086|583433950|FG000|Overall Study|Death|2|||
161558106|NCT00515086|583433951|FG001|Overall Study|Death|0|||
161558107|NCT00515086|583433952|FG002|Overall Study|Death|0|||
161558108|NCT00515086|583433953|FG003|Overall Study|Death|0|||
161558109|NCT02403674|583433956|FG000|Base Study|Death|1|||
161558110|NCT02403674|583433957|FG001|Base Study|Death|4|||
161558111|NCT02403674|583433956|FG000|Base Study|Adverse Event|11|||
161558112|NCT02403674|583433957|FG001|Base Study|Adverse Event|26|||
161558113|NCT02403674|583433956|FG000|Base Study|Lack of Efficacy|31|||
161558114|NCT02403674|583433957|FG001|Base Study|Lack of Efficacy|23|||
161558115|NCT02403674|583433956|FG000|Base Study|Lost to Follow-up|6|||
161558116|NCT02403674|583433957|FG001|Base Study|Lost to Follow-up|8|||
161801363|NCT01494506|584316470|FG002|Overall Study|Lack of Efficacy|57|||
161801364|NCT01494506|584316468|FG000|Overall Study|Adverse Event|17|||
161801365|NCT01494506|584316469|FG001|Overall Study|Adverse Event|10|||
161801366|NCT01494506|584316470|FG002|Overall Study|Adverse Event|11|||
161801367|NCT01494506|584316468|FG000|Overall Study|Death|9|||
161801368|NCT01494506|584316469|FG001|Overall Study|Death|5|||
161801369|NCT01494506|584316470|FG002|Overall Study|Death|2|||
161801370|NCT01494506|584316468|FG000|Overall Study|Physician Decision|7|||
161801371|NCT01494506|584316469|FG001|Overall Study|Physician Decision|5|||
161801372|NCT01494506|584316470|FG002|Overall Study|Physician Decision|4|||
161801373|NCT01494506|584316468|FG000|Overall Study|Withdrawal by Subject|17|||
161801374|NCT01494506|584316469|FG001|Overall Study|Withdrawal by Subject|20|||
161801375|NCT01494506|584316470|FG002|Overall Study|Withdrawal by Subject|14|||
161801376|NCT01494506|584316468|FG000|Overall Study|Clinical Deterioration|21|||
161801377|NCT01494506|584316469|FG001|Overall Study|Clinical Deterioration|17|||
161801378|NCT01494506|584316470|FG002|Overall Study|Clinical Deterioration|13|||
161801379|NCT01494506|584316468|FG000|Overall Study|Sponsor Decision|0|||
161801380|NCT01494506|584316469|FG001|Overall Study|Sponsor Decision|0|||
161801381|NCT01494506|584316470|FG002|Overall Study|Sponsor Decision|1|||
161801382|NCT01494506|584316468|FG000|Overall Study|Other|0|||
161801383|NCT01494506|584316469|FG001|Overall Study|Other|3|||
161801384|NCT01494506|584316470|FG002|Overall Study|Other|1|||
161801385|NCT02777528|584316474|FG000|Overall Study|Still in study|24|||
161801386|NCT02777528|584316475|FG001|Overall Study|Still in study|10|||
161801387|NCT02777528|584316476|FG002|Overall Study|Still in study|1|||
161801388|NCT02777528|584316474|FG000|Overall Study|Study Device Explanted|1|||
161801389|NCT02777528|584316475|FG001|Overall Study|Study Device Explanted|0|||
161801390|NCT02777528|584316476|FG002|Overall Study|Study Device Explanted|0|||
161801391|NCT02777528|584316474|FG000|Overall Study|Death|14|||
161801392|NCT02777528|584316475|FG001|Overall Study|Death|7|||
161801393|NCT02777528|584316476|FG002|Overall Study|Death|1|||
161801394|NCT02777528|584316474|FG000|Overall Study|Withdrawal by Subject|2|||
161801395|NCT02777528|584316475|FG001|Overall Study|Withdrawal by Subject|2|||
161801396|NCT02777528|584316476|FG002|Overall Study|Withdrawal by Subject|1|||
161801397|NCT02777528|584316474|FG000|Overall Study|Physician Decision|2|||
161801398|NCT02777528|584316475|FG001|Overall Study|Physician Decision|1|||
161801399|NCT02777528|584316476|FG002|Overall Study|Physician Decision|0|||
161801400|NCT02777528|584316474|FG000|Overall Study|Lost to Follow-up|2|||
161801401|NCT02777528|584316475|FG001|Overall Study|Lost to Follow-up|0|||
161801402|NCT02777528|584316476|FG002|Overall Study|Lost to Follow-up|0|||
161801403|NCT02777528|584316474|FG000|Overall Study|Discontinued due to Other|1|||
161801404|NCT02777528|584316475|FG001|Overall Study|Discontinued due to Other|0|||
161801405|NCT02777528|584316476|FG002|Overall Study|Discontinued due to Other|0|||
161801406|NCT00453362|584316477|FG000|Overall Study|Adverse Event|5|||
161801407|NCT00453362|584316477|FG000|Overall Study|Death|7|||
161801408|NCT00453362|584316477|FG000|Overall Study|Physician Decision|2|||
161801409|NCT00453362|584316477|FG000|Overall Study|Withdrawal by Subject|3|||
161801410|NCT00453362|584316477|FG000|Overall Study|Progression of disease|56|||
161801411|NCT00453362|584316477|FG000|Overall Study|Screening Failure|14|||
161801412|NCT02127281|584316478|FG000|Overall Study|Lost to Follow-up|1|||
161801413|NCT02127281|584316479|FG001|Overall Study|Lost to Follow-up|0|||
161801414|NCT04885296|584316480|FG000|Period 1|Covid-19 Related|1|||
161905057|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
161801415|NCT04885296|584316481|FG001|Period 1|Covid-19 Related|0|||
161801416|NCT04885296|584316480|FG000|Period 1|Adverse Event|0|||
161801417|NCT04885296|584316481|FG001|Period 1|Adverse Event|1|||
161801418|NCT04885296|584316480|FG000|Period 1|Withdrawal by Subject|1|||
161801419|NCT04885296|584316481|FG001|Period 1|Withdrawal by Subject|1|||
161801420|NCT04885296|584316480|FG000|Period 1|Test Article No Longer Available|1|||
161801421|NCT04885296|584316481|FG001|Period 1|Test Article No Longer Available|0|||
161801422|NCT04885296|584316480|FG000|Period 1|Dispensed Study lens in Error|1|||
161905058|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161801423|NCT04885296|584316481|FG001|Period 1|Dispensed Study lens in Error|0|||
161801424|NCT04885296|584316480|FG000|Period 1|Lost to Follow-up|1|||
161801425|NCT04885296|584316481|FG001|Period 1|Lost to Follow-up|0|||
161905059|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161558117|NCT02403674|583433956|FG000|Base Study|Withdrawal by Subject|10|||
161558118|NCT02403674|583433957|FG001|Base Study|Withdrawal by Subject|17|||
161558119|NCT02403674|583433956|FG000|Base Study|Physician Decision|2|||
161801426|NCT04885296|584316480|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
161801427|NCT04885296|584316481|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
161801428|NCT00433147|584316483|FG000|Overall Study|Adverse Event|0|||
161558120|NCT02403674|583433957|FG001|Base Study|Physician Decision|2|||
161558121|NCT02403674|583433956|FG000|Base Study|Pregnancy|2|||
161558122|NCT02403674|583433957|FG001|Base Study|Pregnancy|2|||
161558123|NCT02403674|583433956|FG000|Base Study|Protocol Violation|8|||
161558124|NCT02403674|583433957|FG001|Base Study|Protocol Violation|4|||
161558125|NCT02403674|583433956|FG000|Base Study|Non-Compliance with study drug|1|||
161558126|NCT02403674|583433957|FG001|Base Study|Non-Compliance with study drug|4|||
161558127|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
161558128|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
161558129|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
161558130|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
161558131|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
161558132|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
161558133|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
161558134|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
161558135|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
161558136|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
161558137|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
161558138|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
161558139|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Death|1|||
161558140|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Death|0|||
161558141|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
161558142|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
161558143|NCT02403674|583433956|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
161558144|NCT02403674|583433957|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
161558145|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
161558146|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
161558147|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
161558148|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
161558149|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
161558150|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
161558151|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
161558152|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
161558153|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
161558154|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
161558155|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Death|2|||
161558156|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Death|2|||
161558157|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
161558158|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
161558159|NCT02403674|583433956|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
161558160|NCT02403674|583433957|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
161558161|NCT02403674|583433956|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
161558162|NCT02403674|583433957|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
161558163|NCT02403674|583433956|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
161558164|NCT02403674|583433957|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
161558165|NCT02403674|583433956|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
161558166|NCT02403674|583433957|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
161558167|NCT02403674|583433956|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
161558168|NCT02403674|583433957|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
161558169|NCT02403674|583433956|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
161558170|NCT02403674|583433957|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
161558171|NCT03487666|583433960|FG000|Overall Study|Disease progression|4|||
161558172|NCT03487666|583433961|FG001|Overall Study|Disease progression|2|||
161558173|NCT03487666|583433962|FG002|Overall Study|Disease progression|0|||
161558174|NCT03487666|583433960|FG000|Overall Study|Adverse Event|0|||
161558175|NCT03487666|583433961|FG001|Overall Study|Adverse Event|0|||
161558176|NCT03487666|583433962|FG002|Overall Study|Adverse Event|1|||
161558177|NCT03201757|583433963|FG000|Overall Study|Withdrawal by Subject|133|||
161558178|NCT03201757|583433963|FG000|Overall Study|Adverse Event|44|||
161558179|NCT03201757|583433963|FG000|Overall Study|Lost to Follow-up|37|||
161558180|NCT03201757|583433963|FG000|Overall Study|Pregnancy|2|||
161801429|NCT00433147|584316484|FG001|Overall Study|Adverse Event|1|||
161558181|NCT03201757|583433963|FG000|Overall Study|Lack of Efficacy|1|||
161558182|NCT03201757|583433963|FG000|Overall Study|Protocol Violation|20|||
161558183|NCT03201757|583433963|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
161558184|NCT03201757|583433963|FG000|Overall Study|Not Yet Determined|5|||
161558185|NCT03201757|583433963|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
161558186|NCT03201757|583433963|FG000|Overall Study|Other|20|||
161558187|NCT01254305|583433967|FG000|Overall Study|Adverse Event|6|||
161558188|NCT01254305|583433968|FG001|Overall Study|Adverse Event|3|||
161558189|NCT01254305|583433969|FG002|Overall Study|Adverse Event|2|||
161801430|NCT00433147|584316485|FG002|Overall Study|Adverse Event|0|||
161558190|NCT01254305|583433967|FG000|Overall Study|Lack of Efficacy|1|||
161558191|NCT01254305|583433968|FG001|Overall Study|Lack of Efficacy|0|||
161558192|NCT01254305|583433969|FG002|Overall Study|Lack of Efficacy|1|||
161558193|NCT01254305|583433967|FG000|Overall Study|Protocol Violation|1|||
161558194|NCT01254305|583433968|FG001|Overall Study|Protocol Violation|7|||
161558195|NCT01254305|583433969|FG002|Overall Study|Protocol Violation|3|||
161558196|NCT01254305|583433967|FG000|Overall Study|Withdrawal by Subject|4|||
161558197|NCT01254305|583433968|FG001|Overall Study|Withdrawal by Subject|2|||
161558198|NCT01254305|583433969|FG002|Overall Study|Withdrawal by Subject|4|||
161558199|NCT01254305|583433967|FG000|Overall Study|Lost to Follow-up|10|||
161558200|NCT01254305|583433968|FG001|Overall Study|Lost to Follow-up|6|||
161558201|NCT01254305|583433969|FG002|Overall Study|Lost to Follow-up|5|||
161558202|NCT01254305|583433967|FG000|Overall Study|Other Reasons|0|||
161558203|NCT01254305|583433968|FG001|Overall Study|Other Reasons|0|||
161558204|NCT01254305|583433969|FG002|Overall Study|Other Reasons|2|||
161558205|NCT03930186|583433970|FG000|Weeks 0 to 16|Adverse Event|6|||
161558206|NCT03930186|583433970|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
161558207|NCT03930186|583433970|FG000|Weeks 16 to 32|Adverse Event|1|||
161558208|NCT03930186|583433970|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
161558209|NCT03019458|583433973|FG000|Overall Study|Death|0|||
161558210|NCT03019458|583433974|FG001|Overall Study|Death|1|||
161558211|NCT00557505|583433975|FG000|Overall Study|Death|0|||
161558212|NCT00557505|583433976|FG001|Overall Study|Death|0|||
161558213|NCT00557505|583433977|FG002|Overall Study|Death|0|||
161558214|NCT00557505|583433978|FG003|Overall Study|Death|0|||
161558215|NCT00557505|583433979|FG004|Overall Study|Death|0|||
161558216|NCT00557505|583433980|FG005|Overall Study|Death|0|||
161558217|NCT00557505|583433981|FG006|Overall Study|Death|0|||
161558218|NCT00557505|583433982|FG007|Overall Study|Death|0|||
161558219|NCT00557505|583433983|FG008|Overall Study|Death|1|||
161558220|NCT00557505|583433975|FG000|Overall Study|Adverse Event|0|||
161558221|NCT00557505|583433976|FG001|Overall Study|Adverse Event|0|||
161558222|NCT00557505|583433977|FG002|Overall Study|Adverse Event|1|||
161558223|NCT00557505|583433978|FG003|Overall Study|Adverse Event|0|||
161558224|NCT00557505|583433979|FG004|Overall Study|Adverse Event|0|||
161558225|NCT00557505|583433980|FG005|Overall Study|Adverse Event|0|||
161451610|NCT00322621|583050637|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
161451611|NCT00322621|583050635|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
161451612|NCT00322621|583050636|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
161451613|NCT00322621|583050637|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
161451614|NCT00322621|583050635|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
161451615|NCT00322621|583050636|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
161451616|NCT00322621|583050637|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
161451617|NCT00322621|583050635|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
161451618|NCT00322621|583050636|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
161451619|NCT00322621|583050637|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
161905060|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161905061|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161905062|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161905063|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
161905064|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905065|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905066|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905067|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905068|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905069|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
161905070|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905071|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161558226|NCT00557505|583433981|FG006|Overall Study|Adverse Event|1|||
161558227|NCT00557505|583433982|FG007|Overall Study|Adverse Event|0|||
161905072|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905073|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905074|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905075|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Other|119|||
161905076|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Other|0|||
161905077|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Other|0|||
161905078|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Other|0|||
161558228|NCT00557505|583433983|FG008|Overall Study|Adverse Event|0|||
161558229|NCT00557505|583433975|FG000|Overall Study|Global deterioration of health|1|||
161558230|NCT00557505|583433976|FG001|Overall Study|Global deterioration of health|0|||
161558231|NCT00557505|583433977|FG002|Overall Study|Global deterioration of health|0|||
161558232|NCT00557505|583433978|FG003|Overall Study|Global deterioration of health|0|||
161558233|NCT00557505|583433979|FG004|Overall Study|Global deterioration of health|0|||
161558234|NCT00557505|583433980|FG005|Overall Study|Global deterioration of health|0|||
161451620|NCT00322621|583050635|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
161451621|NCT00322621|583050636|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
161451622|NCT00322621|583050637|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
161451623|NCT00322621|583050635|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
161451624|NCT00322621|583050636|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
161451625|NCT00322621|583050637|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
161451626|NCT00322621|583050635|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
161451627|NCT00322621|583050636|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
161451628|NCT00322621|583050637|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
161451629|NCT00322621|583050635|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
161451630|NCT00322621|583050636|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
161451631|NCT00322621|583050637|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
161451632|NCT02238067|583050640|FG000|Overall Study|Not completed survey at Month 6|45|||
161451633|NCT02213133|583050644|FG000|Overall Study|Participant discontinued study therapy|2|||
161451634|NCT02213133|583050645|FG001|Overall Study|Participant discontinued study therapy|0|||
161451635|NCT02213133|583050646|FG002|Overall Study|Participant discontinued study therapy|0|||
161451636|NCT02213133|583050644|FG000|Overall Study|Participant withdrew informed consent|2|||
161451637|NCT02213133|583050645|FG001|Overall Study|Participant withdrew informed consent|1|||
161451638|NCT02213133|583050646|FG002|Overall Study|Participant withdrew informed consent|2|||
161451639|NCT02213133|583050644|FG000|Overall Study|Disease progression|11|||
161451640|NCT02213133|583050645|FG001|Overall Study|Disease progression|2|||
161451641|NCT02213133|583050646|FG002|Overall Study|Disease progression|0|||
161451642|NCT02213133|583050644|FG000|Overall Study|Adverse Event (AE)|1|||
161451643|NCT02213133|583050645|FG001|Overall Study|Adverse Event (AE)|0|||
161451644|NCT02213133|583050646|FG002|Overall Study|Adverse Event (AE)|0|||
161451645|NCT02213133|583050644|FG000|Overall Study|Death|16|||
161451646|NCT02213133|583050645|FG001|Overall Study|Death|2|||
161451647|NCT02213133|583050646|FG002|Overall Study|Death|1|||
161451648|NCT02213133|583050644|FG000|Overall Study|Other|5|||
161451649|NCT02213133|583050645|FG001|Overall Study|Other|0|||
161451650|NCT02213133|583050646|FG002|Overall Study|Other|0|||
161451651|NCT02350764|583050647|FG000|Overall Study|Adverse Event|4|||
161451652|NCT02350764|583050647|FG000|Overall Study|Death|3|||
161451653|NCT02350764|583050647|FG000|Overall Study|Physician Decision|2|||
161451654|NCT02350764|583050647|FG000|Overall Study|Withdrawal by Subject|2|||
161451655|NCT02743611|583050648|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
161451656|NCT02743611|583050649|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
161451657|NCT02743611|583050650|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
161451658|NCT02743611|583050651|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
161451659|NCT01433289|583050652|FG000|Overall Study|Pregnancy|0|||
161451660|NCT01433289|583050653|FG001|Overall Study|Pregnancy|1|||
161451661|NCT01433289|583050654|FG002|Overall Study|Pregnancy|0|||
161451662|NCT01433289|583050655|FG003|Overall Study|Pregnancy|0|||
161451663|NCT00600119|583050656|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
161451664|NCT00600119|583050657|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
161451665|NCT00600119|583050658|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
161451666|NCT00600119|583050659|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
161801431|NCT00433147|584316486|FG003|Overall Study|Adverse Event|0|||
161801432|NCT01882647|584316487|FG000|Overall Study|Lost to Follow-up|2|||
161801433|NCT01882647|584316488|FG001|Overall Study|Lost to Follow-up|2|||
161801434|NCT01882647|584316487|FG000|Overall Study|Withdrawal by Subject|0|||
161801435|NCT01882647|584316488|FG001|Overall Study|Withdrawal by Subject|4|||
161801436|NCT01108094|584316490|FG000|Overall Study|Adverse Event|2|||
161801437|NCT01108094|584316491|FG001|Overall Study|Adverse Event|0|||
161801438|NCT01108094|584316492|FG002|Overall Study|Adverse Event|0|||
161801439|NCT01108094|584316493|FG003|Overall Study|Adverse Event|0|||
161801440|NCT01108094|584316490|FG000|Overall Study|Withdrawal by Subject|1|||
161801441|NCT01108094|584316491|FG001|Overall Study|Withdrawal by Subject|0|||
161801442|NCT01108094|584316492|FG002|Overall Study|Withdrawal by Subject|0|||
161801443|NCT01108094|584316493|FG003|Overall Study|Withdrawal by Subject|0|||
161801444|NCT05037097|584316496|FG000|Overall Study|Withdrawal by Subject|0|||
161801445|NCT05037097|584316497|FG001|Overall Study|Withdrawal by Subject|1|||
161801446|NCT05037097|584316498|FG002|Overall Study|Withdrawal by Subject|0|||
161801447|NCT05037097|584316499|FG003|Overall Study|Withdrawal by Subject|1|||
161801448|NCT05037097|584316500|FG004|Overall Study|Withdrawal by Subject|0|||
161801449|NCT05037097|584316501|FG005|Overall Study|Withdrawal by Subject|2|||
161801450|NCT05037097|584316502|FG006|Overall Study|Withdrawal by Subject|0|||
161801451|NCT05037097|584316503|FG007|Overall Study|Withdrawal by Subject|0|||
161801452|NCT05037097|584316496|FG000|Overall Study|Lost to Follow-up|0|||
161451667|NCT00600119|583050660|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
161801453|NCT05037097|584316497|FG001|Overall Study|Lost to Follow-up|1|||
161801454|NCT05037097|584316498|FG002|Overall Study|Lost to Follow-up|0|||
161801455|NCT05037097|584316499|FG003|Overall Study|Lost to Follow-up|0|||
161801456|NCT05037097|584316500|FG004|Overall Study|Lost to Follow-up|1|||
161558235|NCT00557505|583433981|FG006|Overall Study|Global deterioration of health|0|||
161558236|NCT00557505|583433982|FG007|Overall Study|Global deterioration of health|0|||
161558237|NCT00557505|583433983|FG008|Overall Study|Global deterioration of health|0|||
161558238|NCT00557505|583433975|FG000|Overall Study|Objective progression or relapse|2|||
161558239|NCT00557505|583433976|FG001|Overall Study|Objective progression or relapse|3|||
161558240|NCT00557505|583433977|FG002|Overall Study|Objective progression or relapse|3|||
161558241|NCT00557505|583433978|FG003|Overall Study|Objective progression or relapse|2|||
161558242|NCT00557505|583433979|FG004|Overall Study|Objective progression or relapse|2|||
161558243|NCT00557505|583433980|FG005|Overall Study|Objective progression or relapse|3|||
161558244|NCT00557505|583433981|FG006|Overall Study|Objective progression or relapse|2|||
161558245|NCT00557505|583433982|FG007|Overall Study|Objective progression or relapse|5|||
161558246|NCT00557505|583433983|FG008|Overall Study|Objective progression or relapse|15|||
161558247|NCT00557505|583433975|FG000|Overall Study|Withdrawal by Subject|0|||
161558248|NCT00557505|583433976|FG001|Overall Study|Withdrawal by Subject|0|||
161558249|NCT00557505|583433977|FG002|Overall Study|Withdrawal by Subject|0|||
161558250|NCT00557505|583433978|FG003|Overall Study|Withdrawal by Subject|1|||
161558251|NCT00557505|583433979|FG004|Overall Study|Withdrawal by Subject|0|||
161558252|NCT00557505|583433980|FG005|Overall Study|Withdrawal by Subject|0|||
161558253|NCT00557505|583433981|FG006|Overall Study|Withdrawal by Subject|0|||
161558254|NCT00557505|583433982|FG007|Overall Study|Withdrawal by Subject|0|||
161558255|NCT00557505|583433983|FG008|Overall Study|Withdrawal by Subject|1|||
161558256|NCT01403987|583433989|FG000|Overall Study|Residents forgot their secret PIN|18|||
161558257|NCT01403987|583433990|FG001|Overall Study|Residents forgot their secret PIN|17|||
161558258|NCT01403987|583433991|FG002|Overall Study|Residents forgot their secret PIN|18|||
161558259|NCT00751790|583433995|FG000|Overall Study|Lost to Follow-up|1|||
161558260|NCT00751790|583433995|FG000|Overall Study|Death|3|||
161668048|NCT00406653|583837477|FG001|Induction Period|Given prohibited drug|1|||
161801457|NCT05037097|584316501|FG005|Overall Study|Lost to Follow-up|1|||
161801458|NCT05037097|584316502|FG006|Overall Study|Lost to Follow-up|0|||
161801459|NCT05037097|584316503|FG007|Overall Study|Lost to Follow-up|0|||
161801460|NCT02918877|584316506|FG000|Overall Study|Withdrawal by Subject|2|||
161801461|NCT02918877|584316507|FG001|Overall Study|Withdrawal by Subject|2|||
161801462|NCT02918877|584316506|FG000|Overall Study|Surgery cancelled|1|||
161801463|NCT02918877|584316507|FG001|Overall Study|Surgery cancelled|0|||
161801464|NCT02918877|584316506|FG000|Overall Study|Physician Decision|1|||
161801465|NCT02918877|584316507|FG001|Overall Study|Physician Decision|0|||
161801466|NCT02918877|584316506|FG000|Overall Study|Received intraoperative steroids|1|||
161801467|NCT02918877|584316507|FG001|Overall Study|Received intraoperative steroids|0|||
161801468|NCT02918877|584316506|FG000|Overall Study|Unable to obtain lab samples|1|||
161801469|NCT02918877|584316507|FG001|Overall Study|Unable to obtain lab samples|0|||
161801470|NCT02918877|584316506|FG000|Overall Study|Unsafe to perform BAL|0|||
161801471|NCT02918877|584316507|FG001|Overall Study|Unsafe to perform BAL|1|||
161801472|NCT04510857|584316508|FG000|Overall Study|Withdrawal by Subject|1|||
161801473|NCT04510857|584316509|FG001|Overall Study|Withdrawal by Subject|2|||
161801474|NCT05346055|584316510|FG000|Overall Study|Withdrawal by Subject|1|||
161801475|NCT05346055|584316510|FG000|Overall Study|Protocol Violation|1|||
161801476|NCT05346055|584316510|FG000|Overall Study|Therapist decision|1|||
161801477|NCT00376220|584316513|FG000|Overall Study|Lost to Follow-up|7|||
161801478|NCT00376220|584316514|FG001|Overall Study|Lost to Follow-up|10|||
161801479|NCT00376220|584316513|FG000|Overall Study|Withdrawal by Subject|3|||
161801480|NCT00376220|584316514|FG001|Overall Study|Withdrawal by Subject|2|||
161801481|NCT02564263|584316515|FG000|Overall Study|Adverse Event|31|||
161801482|NCT02564263|584316516|FG001|Overall Study|Adverse Event|29|||
161801483|NCT02564263|584316515|FG000|Overall Study|Death|270|||
161801484|NCT02564263|584316516|FG001|Overall Study|Death|262|||
161801485|NCT02564263|584316515|FG000|Overall Study|Withdrawal by Subject|4|||
161801486|NCT02564263|584316516|FG001|Overall Study|Withdrawal by Subject|19|||
161801487|NCT02564263|584316515|FG000|Overall Study|Sponsor's decision|9|||
161905079|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Other|0|||
161905080|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Other|0|||
161905081|NCT01435759|584701192|FG000|Double-blind Phase|Adverse Event|7|||
161905082|NCT01435759|584701193|FG001|Double-blind Phase|Adverse Event|0|||
161905083|NCT01435759|584701194|FG002|Double-blind Phase|Adverse Event|1|||
161905084|NCT01435759|584701195|FG003|Double-blind Phase|Adverse Event|1|||
161801488|NCT02564263|584316516|FG001|Overall Study|Sponsor's decision|4|||
161801489|NCT02906709|584316517|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
161801490|NCT02906709|584316518|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
161801491|NCT02906709|584316517|FG000|Phase A (Week 0 to Week 16)|Death|0|||
161905085|NCT01435759|584701196|FG004|Double-blind Phase|Adverse Event|1|||
161558261|NCT00751790|583433995|FG000|Overall Study|Withdrawal by Subject|1|||
161558262|NCT04004208|583433996|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161558263|NCT04004208|583433997|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161558264|NCT04004208|583433996|FG000|Overall Study|Death|3|||
161558265|NCT04004208|583433997|FG001|Overall Study|Death|0|||
161558266|NCT04004208|583433996|FG000|Overall Study|COVID-19 pandemic|1|||
161801492|NCT02906709|584316518|FG001|Phase A (Week 0 to Week 16)|Death|1|||
161905086|NCT01435759|584701197|FG005|Double-blind Phase|Adverse Event|3|||
161558267|NCT04004208|583433997|FG001|Overall Study|COVID-19 pandemic|0|||
161558268|NCT04004208|583433996|FG000|Overall Study|Physician Decision|1|||
161558269|NCT04004208|583433997|FG001|Overall Study|Physician Decision|0|||
161558270|NCT04004208|583433996|FG000|Overall Study|Adverse Event|1|||
161558271|NCT04004208|583433997|FG001|Overall Study|Adverse Event|1|||
161558272|NCT00087490|583433999|FG000|Overall Study|Death|6|||
161558273|NCT00087490|583434000|FG001|Overall Study|Death|4|||
161558274|NCT00087490|583433999|FG000|Overall Study|Adverse Event|3|||
161558275|NCT00087490|583434000|FG001|Overall Study|Adverse Event|8|||
161558276|NCT00087490|583433999|FG000|Overall Study|Lack of Efficacy|0|||
161558277|NCT00087490|583434000|FG001|Overall Study|Lack of Efficacy|2|||
161558278|NCT00087490|583433999|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
161558279|NCT00087490|583434000|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
161558280|NCT00087490|583433999|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
161558281|NCT00087490|583434000|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
161558282|NCT00087490|583433999|FG000|Overall Study|Randomized but not treated|7|||
161558283|NCT00087490|583434000|FG001|Overall Study|Randomized but not treated|18|||
161558284|NCT01925170|583434001|FG000|Overall Study|Unverified cancer status|53|||
161558285|NCT01077024|583434004|FG000|Overall Study|Lost to Follow-up|20|||
161558286|NCT01077024|583434005|FG001|Overall Study|Lost to Follow-up|14|||
161558287|NCT01077024|583434004|FG000|Overall Study|Withdrawal by Subject|0|||
161558288|NCT01077024|583434005|FG001|Overall Study|Withdrawal by Subject|2|||
161558289|NCT01077024|583434004|FG000|Overall Study|Incarcerated|7|||
161558290|NCT01077024|583434005|FG001|Overall Study|Incarcerated|8|||
161558291|NCT01077024|583434004|FG000|Overall Study|Other|4|||
161558292|NCT01077024|583434005|FG001|Overall Study|Other|4|||
161558293|NCT00848211|583434006|FG000|Overall Study|Protocol Violation|0|||
161558294|NCT00848211|583434007|FG001|Overall Study|Protocol Violation|1|||
161558295|NCT00848211|583434008|FG002|Overall Study|Protocol Violation|1|||
161558296|NCT00848211|583434009|FG003|Overall Study|Protocol Violation|0|||
161558297|NCT00848211|583434006|FG000|Overall Study|Adverse Event|0|||
161558298|NCT00848211|583434007|FG001|Overall Study|Adverse Event|0|||
161558299|NCT00848211|583434008|FG002|Overall Study|Adverse Event|0|||
161558300|NCT00848211|583434009|FG003|Overall Study|Adverse Event|0|||
161558301|NCT00772928|583434010|FG000|Overall Study|Lost to Follow-up|9|||
161558302|NCT00772928|583434011|FG001|Overall Study|Lost to Follow-up|6|||
161558303|NCT00772928|583434010|FG000|Overall Study|Protocol Violation|10|||
161558304|NCT00772928|583434011|FG001|Overall Study|Protocol Violation|12|||
161558305|NCT00772928|583434010|FG000|Overall Study|Withdrawal by Subject|25|||
161558306|NCT00772928|583434011|FG001|Overall Study|Withdrawal by Subject|22|||
161558307|NCT00772928|583434010|FG000|Overall Study|Did not receive vaccine|0|||
161558308|NCT00772928|583434011|FG001|Overall Study|Did not receive vaccine|1|||
161558309|NCT03100838|583434012|FG000|Overall Study|Adverse Event|1|||
161558310|NCT03100838|583434013|FG001|Overall Study|Adverse Event|0|||
161558311|NCT03100838|583434014|FG002|Overall Study|Adverse Event|0|||
161558312|NCT03100838|583434015|FG003|Overall Study|Adverse Event|0|||
161905087|NCT01435759|584701192|FG000|Double-blind Phase|Protocol Violation|2|||
161905088|NCT01435759|584701193|FG001|Double-blind Phase|Protocol Violation|0|||
161905089|NCT01435759|584701194|FG002|Double-blind Phase|Protocol Violation|1|||
161905090|NCT01435759|584701195|FG003|Double-blind Phase|Protocol Violation|2|||
161905091|NCT01435759|584701196|FG004|Double-blind Phase|Protocol Violation|0|||
161905092|NCT01435759|584701197|FG005|Double-blind Phase|Protocol Violation|1|||
161905093|NCT01435759|584701192|FG000|Double-blind Phase|Withdrawal by Subject|17|||
161905094|NCT01435759|584701193|FG001|Double-blind Phase|Withdrawal by Subject|4|||
161905095|NCT01435759|584701194|FG002|Double-blind Phase|Withdrawal by Subject|3|||
161905096|NCT01435759|584701195|FG003|Double-blind Phase|Withdrawal by Subject|4|||
161905097|NCT01435759|584701196|FG004|Double-blind Phase|Withdrawal by Subject|2|||
161905098|NCT01435759|584701197|FG005|Double-blind Phase|Withdrawal by Subject|2|||
161558313|NCT03100838|583434012|FG000|Overall Study|Physician Decision|1|||
161558314|NCT03100838|583434013|FG001|Overall Study|Physician Decision|1|||
161905099|NCT01435759|584701192|FG000|Double-blind Phase|Lost to Follow-up|31|||
161905100|NCT01435759|584701193|FG001|Double-blind Phase|Lost to Follow-up|1|||
161905101|NCT01435759|584701194|FG002|Double-blind Phase|Lost to Follow-up|2|||
161905102|NCT01435759|584701195|FG003|Double-blind Phase|Lost to Follow-up|0|||
161905103|NCT01435759|584701196|FG004|Double-blind Phase|Lost to Follow-up|3|||
161558315|NCT03100838|583434014|FG002|Overall Study|Physician Decision|1|||
161558316|NCT03100838|583434015|FG003|Overall Study|Physician Decision|1|||
161558317|NCT03100838|583434012|FG000|Overall Study|Pregnancy|0|||
161558318|NCT03100838|583434013|FG001|Overall Study|Pregnancy|1|||
161558319|NCT03100838|583434014|FG002|Overall Study|Pregnancy|0|||
161558320|NCT03100838|583434015|FG003|Overall Study|Pregnancy|0|||
161558321|NCT03100838|583434012|FG000|Overall Study|Lost to Follow-up|0|||
161558322|NCT03100838|583434013|FG001|Overall Study|Lost to Follow-up|0|||
161558323|NCT03100838|583434014|FG002|Overall Study|Lost to Follow-up|1|||
161558324|NCT03100838|583434015|FG003|Overall Study|Lost to Follow-up|0|||
161558325|NCT00801242|583434016|FG000|Overall Study|Adverse Event|10|||
161558326|NCT00801242|583434016|FG000|Overall Study|Withdrawal by Subject|13|||
161558327|NCT00801242|583434016|FG000|Overall Study|Protocol Violation|5|||
161451668|NCT00600119|583050661|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
161451669|NCT00600119|583050656|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161451670|NCT00600119|583050657|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
161451671|NCT00600119|583050658|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
161451672|NCT00600119|583050659|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161451673|NCT00600119|583050660|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161451674|NCT00600119|583050661|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161451675|NCT00600119|583050656|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
161451676|NCT00600119|583050657|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
161451677|NCT00600119|583050658|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
161451678|NCT00600119|583050659|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
161451679|NCT00600119|583050660|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
161451680|NCT00600119|583050661|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
161451681|NCT00600119|583050656|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
161451682|NCT00600119|583050657|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
161451683|NCT00600119|583050658|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
161451684|NCT00600119|583050659|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
161451685|NCT00600119|583050660|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
161451686|NCT00600119|583050661|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
161451687|NCT00600119|583050656|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
161451688|NCT00600119|583050657|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
161451689|NCT00600119|583050658|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
161451690|NCT00600119|583050659|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
161451691|NCT00600119|583050660|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
161451692|NCT00600119|583050661|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
161451693|NCT00600119|583050656|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
161451694|NCT00600119|583050657|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
161451695|NCT00600119|583050658|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
161451696|NCT00600119|583050659|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
161451697|NCT00600119|583050660|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
161451698|NCT00600119|583050661|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
161451699|NCT00600119|583050656|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
161451700|NCT00600119|583050657|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161451701|NCT00600119|583050658|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161451702|NCT00600119|583050659|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
161451703|NCT00600119|583050660|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
161451704|NCT00600119|583050661|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
161451705|NCT00600119|583050656|FG000|Double-blind Treatment Period|Other|0|||
161451706|NCT00600119|583050657|FG001|Double-blind Treatment Period|Other|0|||
161451707|NCT00600119|583050658|FG002|Double-blind Treatment Period|Other|0|||
161451708|NCT00600119|583050659|FG003|Double-blind Treatment Period|Other|0|||
161451709|NCT00600119|583050660|FG004|Double-blind Treatment Period|Other|2|||
161451710|NCT00600119|583050661|FG005|Double-blind Treatment Period|Other|1|||
161451711|NCT00600119|583050656|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
161451712|NCT00600119|583050657|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
161451713|NCT00600119|583050658|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
161451714|NCT00600119|583050659|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
161451715|NCT00600119|583050660|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
161451716|NCT00600119|583050661|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
161451717|NCT00600119|583050656|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
161451718|NCT00600119|583050657|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
161451719|NCT00600119|583050658|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
161451720|NCT00600119|583050659|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
161451721|NCT00600119|583050660|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
161451722|NCT00600119|583050661|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
161451723|NCT00600119|583050656|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
161451724|NCT00600119|583050657|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
161451725|NCT00600119|583050658|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
161451726|NCT00600119|583050659|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
161451727|NCT00600119|583050660|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
161451728|NCT00600119|583050661|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
161451729|NCT00600119|583050656|FG000|Double-blind Treatment Period|Physician Decision|2|||
161451730|NCT00600119|583050657|FG001|Double-blind Treatment Period|Physician Decision|0|||
161451731|NCT00600119|583050658|FG002|Double-blind Treatment Period|Physician Decision|0|||
161905104|NCT01435759|584701197|FG005|Double-blind Phase|Lost to Follow-up|3|||
161558328|NCT00801242|583434016|FG000|Overall Study|Physician Decision|3|||
161558329|NCT00801242|583434016|FG000|Overall Study|Lost to Follow-up|1|||
161558330|NCT00801242|583434016|FG000|Overall Study|Miscellaneous reasons|20|||
161558331|NCT00184028|583434017|FG000|Overall Study|Death|1|||
161558332|NCT00184028|583434017|FG000|Overall Study|Lack of Efficacy|4|||
161558333|NCT00184028|583434017|FG000|Overall Study|Adverse Event|2|||
161558334|NCT00184028|583434017|FG000|Overall Study|Withdrawal by Subject|1|||
161558335|NCT00184028|583434017|FG000|Overall Study|Non-compliance|2|||
161558336|NCT02335268|583434018|FG000|Overall Study|Physician Decision|5|||
161558337|NCT02335268|583434019|FG001|Overall Study|Physician Decision|1|||
161558338|NCT02335268|583434018|FG000|Overall Study|Lack of Efficacy|2|||
161558339|NCT02335268|583434019|FG001|Overall Study|Lack of Efficacy|1|||
161558340|NCT02335268|583434018|FG000|Overall Study|Adverse Event|5|||
161558341|NCT02335268|583434019|FG001|Overall Study|Adverse Event|2|||
161558342|NCT02335268|583434018|FG000|Overall Study|increase blasts|2|||
161558343|NCT02335268|583434019|FG001|Overall Study|increase blasts|0|||
161558344|NCT02335268|583434018|FG000|Overall Study|Withdrawal by Subject|3|||
161558345|NCT02335268|583434019|FG001|Overall Study|Withdrawal by Subject|2|||
161558346|NCT05893797|583434020|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
161558347|NCT05893797|583434020|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
161558348|NCT05893797|583434020|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
161558349|NCT05893797|583434020|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
161558350|NCT02550873|583434021|FG000|Randomized Double Blind|Adverse Event|3|||
161558351|NCT02550873|583434022|FG001|Randomized Double Blind|Adverse Event|1|||
161558352|NCT02550873|583434023|FG002|Randomized Double Blind|Adverse Event|0|||
161558353|NCT02550873|583434021|FG000|Randomized Double Blind|Disease progression|1|||
161558354|NCT02550873|583434022|FG001|Randomized Double Blind|Disease progression|1|||
161558355|NCT02550873|583434023|FG002|Randomized Double Blind|Disease progression|0|||
161558356|NCT02550873|583434021|FG000|Open Label Extension|Study ongoing|0|||
161558357|NCT02550873|583434022|FG001|Open Label Extension|Study ongoing|0|||
161558358|NCT02550873|583434023|FG002|Open Label Extension|Study ongoing|111|||
161558359|NCT01822353|583434024|FG000|Overall Study|Adverse Event|1|||
161558360|NCT01822353|583434025|FG001|Overall Study|Adverse Event|3|||
161558361|NCT01822353|583434026|FG002|Overall Study|Adverse Event|1|||
161558362|NCT01822353|583434024|FG000|Overall Study|Pregnancy|0|||
161558363|NCT01822353|583434025|FG001|Overall Study|Pregnancy|1|||
161558364|NCT01822353|583434026|FG002|Overall Study|Pregnancy|0|||
161558365|NCT01822353|583434024|FG000|Overall Study|Withdrawal by Subject|3|||
161558366|NCT01822353|583434025|FG001|Overall Study|Withdrawal by Subject|1|||
161558367|NCT01822353|583434026|FG002|Overall Study|Withdrawal by Subject|0|||
161558368|NCT01857323|583434027|FG000|Overall Study|Adverse Event|1|||
161558369|NCT01857323|583434027|FG000|Overall Study|Withdrawal by Subject|3|||
161558370|NCT01857323|583434027|FG000|Overall Study|Non-compliance|1|||
161558371|NCT01857323|583434027|FG000|Overall Study|Protocol Violation|6|||
161558372|NCT01857323|583434027|FG000|Overall Study|Lost to Follow-up|1|||
161558373|NCT01857323|583434027|FG000|Overall Study|Other|4|||
161558374|NCT01857323|583434027|FG000|Overall Study|Did not complete 180 doses|48|||
161558375|NCT00885495|583434028|FG000|Overall Study|Adverse Event|1|||
161558376|NCT00885495|583434029|FG001|Overall Study|Adverse Event|2|||
161558377|NCT00885495|583434028|FG000|Overall Study|Protocol Violation|0|||
161558378|NCT00885495|583434029|FG001|Overall Study|Protocol Violation|1|||
161558379|NCT00885495|583434028|FG000|Overall Study|Withdrawal by Subject|1|||
161558380|NCT00885495|583434029|FG001|Overall Study|Withdrawal by Subject|0|||
161558381|NCT02107443|583434030|FG000|Overall Study|Death|42|||
161558382|NCT02107443|583434031|FG001|Overall Study|Death|30|||
161558383|NCT02107443|583434030|FG000|Overall Study|Study Protocol Violation|3|||
161558384|NCT02107443|583434031|FG001|Overall Study|Study Protocol Violation|1|||
161558385|NCT02107443|583434030|FG000|Overall Study|Registered but Not Eligible|0|||
161558386|NCT02107443|583434031|FG001|Overall Study|Registered but Not Eligible|1|||
161801493|NCT02906709|584316517|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
161801494|NCT02906709|584316518|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
161801495|NCT02906709|584316517|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
161801496|NCT02906709|584316518|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
161801497|NCT01124149|584316519|FG000|Acute Phase|Withdrawal by Subject|22|||
161558387|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
161558388|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
161558389|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
161558390|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
161558391|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Changed Mind|2|||
161558392|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Changed Mind|0|||
161558393|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
161558394|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
161558395|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
161558396|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
161558397|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
161558398|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
161905105|NCT01435759|584701192|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
161905106|NCT01435759|584701193|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905107|NCT01435759|584701194|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905108|NCT01435759|584701195|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905109|NCT01435759|584701196|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
161905110|NCT01435759|584701197|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905111|NCT01435759|584701192|FG000|Double-blind Phase|Other|8|||
161905112|NCT01435759|584701193|FG001|Double-blind Phase|Other|2|||
161905113|NCT01435759|584701194|FG002|Double-blind Phase|Other|0|||
161905114|NCT01435759|584701195|FG003|Double-blind Phase|Other|2|||
161905115|NCT01435759|584701196|FG004|Double-blind Phase|Other|0|||
161905116|NCT01435759|584701197|FG005|Double-blind Phase|Other|0|||
161905117|NCT01710020|584701198|FG000|Period 1|Protocol Violation|1|||
161905118|NCT00427908|584701199|FG000|Primary Phase|Lost to Follow-up|4|||
161905119|NCT00427908|584701200|FG001|Primary Phase|Lost to Follow-up|0|||
161905120|NCT00427908|584701201|FG002|Primary Phase|Lost to Follow-up|2|||
161905121|NCT00427908|584701202|FG003|Primary Phase|Lost to Follow-up|0|||
161905122|NCT00427908|584701199|FG000|Primary Phase|Withdrawal by Subject|1|||
161905123|NCT00427908|584701200|FG001|Primary Phase|Withdrawal by Subject|2|||
161905124|NCT00427908|584701201|FG002|Primary Phase|Withdrawal by Subject|1|||
161905125|NCT00427908|584701202|FG003|Primary Phase|Withdrawal by Subject|0|||
161905126|NCT00427908|584701199|FG000|Primary Phase|Adverse Event|0|||
161905127|NCT00427908|584701200|FG001|Primary Phase|Adverse Event|1|||
161905128|NCT00427908|584701201|FG002|Primary Phase|Adverse Event|0|||
161905129|NCT00427908|584701202|FG003|Primary Phase|Adverse Event|0|||
161905130|NCT01764841|584701203|FG000|Overall Study|Logistical Difficulties|0|||
161905131|NCT01764841|584701204|FG001|Overall Study|Logistical Difficulties|1|||
161905132|NCT01764841|584701205|FG002|Overall Study|Logistical Difficulties|0|||
161905133|NCT01764841|584701206|FG003|Overall Study|Logistical Difficulties|0|||
161905134|NCT01764841|584701203|FG000|Overall Study|Death|3|||
161451732|NCT00600119|583050659|FG003|Double-blind Treatment Period|Physician Decision|0|||
161451733|NCT00600119|583050660|FG004|Double-blind Treatment Period|Physician Decision|0|||
161451734|NCT00600119|583050661|FG005|Double-blind Treatment Period|Physician Decision|0|||
161451735|NCT00600119|583050656|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161451736|NCT00600119|583050657|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161451737|NCT00600119|583050658|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161451738|NCT00600119|583050659|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161451739|NCT00600119|583050660|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
161451740|NCT00600119|583050661|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
161451741|NCT00600119|583050656|FG000|Double-blind Treatment Period|Adverse Event|1|||
161451742|NCT00600119|583050657|FG001|Double-blind Treatment Period|Adverse Event|1|||
161451743|NCT00600119|583050658|FG002|Double-blind Treatment Period|Adverse Event|0|||
161451744|NCT00600119|583050659|FG003|Double-blind Treatment Period|Adverse Event|1|||
161451745|NCT00600119|583050660|FG004|Double-blind Treatment Period|Adverse Event|2|||
161451746|NCT00600119|583050661|FG005|Double-blind Treatment Period|Adverse Event|10|||
161451747|NCT00600119|583050656|FG000|Follow-up Period|Adverse Event|0|||
161451748|NCT00600119|583050657|FG001|Follow-up Period|Adverse Event|0|||
161451749|NCT00600119|583050658|FG002|Follow-up Period|Adverse Event|0|||
161451750|NCT00600119|583050659|FG003|Follow-up Period|Adverse Event|0|||
161451751|NCT00600119|583050660|FG004|Follow-up Period|Adverse Event|0|||
161451752|NCT00600119|583050661|FG005|Follow-up Period|Adverse Event|1|||
161451753|NCT00600119|583050656|FG000|Follow-up Period|Other|1|||
161451754|NCT00600119|583050657|FG001|Follow-up Period|Other|0|||
161451755|NCT00600119|583050658|FG002|Follow-up Period|Other|0|||
161451756|NCT00600119|583050659|FG003|Follow-up Period|Other|0|||
161451757|NCT00600119|583050660|FG004|Follow-up Period|Other|0|||
161451758|NCT00600119|583050661|FG005|Follow-up Period|Other|0|||
161451759|NCT00729469|583050662|FG000|Overall Study|Adverse Event|14|||
161451760|NCT00729469|583050663|FG001|Overall Study|Adverse Event|25|||
161451761|NCT00729469|583050662|FG000|Overall Study|Lost to Follow-up|9|||
161451762|NCT00729469|583050663|FG001|Overall Study|Lost to Follow-up|9|||
161451763|NCT00729469|583050662|FG000|Overall Study|Protocol Violation|2|||
161451764|NCT00729469|583050663|FG001|Overall Study|Protocol Violation|1|||
161451765|NCT00729469|583050662|FG000|Overall Study|Withdrawal by Subject|19|||
161451766|NCT00729469|583050663|FG001|Overall Study|Withdrawal by Subject|8|||
161451767|NCT00729469|583050662|FG000|Overall Study|Other-Not mentioned|9|||
161451768|NCT00729469|583050663|FG001|Overall Study|Other-Not mentioned|4|||
161451769|NCT00561977|583050664|FG000|Overall Study|Withdrawal by Subject|0|||
161451770|NCT00561977|583050665|FG001|Overall Study|Withdrawal by Subject|2|||
161451771|NCT00561977|583050666|FG002|Overall Study|Withdrawal by Subject|1|||
161451772|NCT00561977|583050664|FG000|Overall Study|Pregnancy|0|||
161558399|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
161905135|NCT01764841|584701204|FG001|Overall Study|Death|0|||
161905136|NCT01764841|584701205|FG002|Overall Study|Death|1|||
161905137|NCT01764841|584701206|FG003|Overall Study|Death|4|||
161905138|NCT01764841|584701203|FG000|Overall Study|No Follow Up|1|||
161451773|NCT00561977|583050665|FG001|Overall Study|Pregnancy|1|||
161451774|NCT00561977|583050666|FG002|Overall Study|Pregnancy|1|||
161801498|NCT01124149|584316519|FG000|Acute Phase|Adverse Event|21|||
161801499|NCT01124149|584316519|FG000|Acute Phase|Lack of Efficacy|17|||
161801500|NCT01124149|584316519|FG000|Acute Phase|Protocol Violation|14|||
161801501|NCT01124149|584316519|FG000|Acute Phase|Lost to Follow-up|2|||
161801502|NCT01124149|584316519|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
161801503|NCT01124149|584316519|FG000|Acute Phase|Sponsor request|1|||
161801504|NCT01124149|584316519|FG000|Acute Phase|UC symptoms not ameliorated|1|||
161801505|NCT01124149|584316519|FG000|Acute Phase|Non-compliance|1|||
161801506|NCT01124149|584316519|FG000|Acute Phase|Low hemoglobin|1|||
161801507|NCT01124149|584316519|FG000|Acute Phase|Travelling to another country|1|||
161801508|NCT01124149|584316519|FG000|Acute Phase|Sponsor decision|1|||
161801509|NCT01124149|584316519|FG000|Maintenance Phase|Lack of Efficacy|40|||
161801510|NCT01124149|584316519|FG000|Maintenance Phase|Adverse Event|24|||
161801511|NCT01124149|584316519|FG000|Maintenance Phase|Lost to Follow-up|15|||
161801512|NCT01124149|584316519|FG000|Maintenance Phase|Withdrawal by Subject|10|||
161801513|NCT01124149|584316519|FG000|Maintenance Phase|Protocol Violation|5|||
161801514|NCT01124149|584316519|FG000|Maintenance Phase|Coordinator error|1|||
161801515|NCT01124149|584316519|FG000|Maintenance Phase|Non-compliance|1|||
161801516|NCT00977106|584316520|FG000|Overall Study|Adverse Event|5|||
161801517|NCT00977106|584316521|FG001|Overall Study|Adverse Event|6|||
161801518|NCT00977106|584316520|FG000|Overall Study|Withdrawal by Subject|2|||
161801519|NCT00977106|584316521|FG001|Overall Study|Withdrawal by Subject|2|||
161801520|NCT00977106|584316520|FG000|Overall Study|Lack of Efficacy|2|||
161801521|NCT00977106|584316521|FG001|Overall Study|Lack of Efficacy|2|||
161801522|NCT00977106|584316520|FG000|Overall Study|Protocol Violation|0|||
161801523|NCT00977106|584316521|FG001|Overall Study|Protocol Violation|1|||
161801524|NCT00977106|584316520|FG000|Overall Study|Other|1|||
161801525|NCT00977106|584316521|FG001|Overall Study|Other|0|||
161801526|NCT01644500|584316522|FG000|Overall Study|Adverse Event|6|||
161801527|NCT01644500|584316523|FG001|Overall Study|Adverse Event|1|||
161801528|NCT01644500|584316524|FG002|Overall Study|Adverse Event|2|||
161801529|NCT01644500|584316522|FG000|Overall Study|Death|0|||
161801530|NCT01644500|584316523|FG001|Overall Study|Death|1|||
161801531|NCT01644500|584316524|FG002|Overall Study|Death|0|||
161801532|NCT01644500|584316522|FG000|Overall Study|Lost to Follow-up|3|||
161801533|NCT01644500|584316523|FG001|Overall Study|Lost to Follow-up|8|||
161801534|NCT01644500|584316524|FG002|Overall Study|Lost to Follow-up|0|||
161801535|NCT01644500|584316522|FG000|Overall Study|Protocol Violation|1|||
161801536|NCT01644500|584316523|FG001|Overall Study|Protocol Violation|1|||
161801537|NCT01644500|584316524|FG002|Overall Study|Protocol Violation|0|||
161801538|NCT01644500|584316522|FG000|Overall Study|Withdrawal by Subject|11|||
161801539|NCT01644500|584316523|FG001|Overall Study|Withdrawal by Subject|12|||
161801540|NCT01644500|584316524|FG002|Overall Study|Withdrawal by Subject|12|||
161801541|NCT01644500|584316522|FG000|Overall Study|Physician Decision|1|||
161801542|NCT01644500|584316523|FG001|Overall Study|Physician Decision|1|||
161801543|NCT01644500|584316524|FG002|Overall Study|Physician Decision|1|||
161801544|NCT02419313|584316525|FG000|First Intervention|Lost to Follow-up|2|||
161801545|NCT02419313|584316526|FG001|First Intervention|Lost to Follow-up|0|||
161801546|NCT02419313|584316525|FG000|Second Intervention|Lost to Follow-up|1|||
161801547|NCT02419313|584316526|FG001|Second Intervention|Lost to Follow-up|0|||
161801548|NCT00322491|584316533|FG000|Overall Study|Adverse Event|1|||
161801549|NCT00322491|584316534|FG001|Overall Study|Adverse Event|0|||
161801550|NCT00322491|584316533|FG000|Overall Study|Death|1|||
161801551|NCT00322491|584316534|FG001|Overall Study|Death|2|||
161905139|NCT01764841|584701204|FG001|Overall Study|No Follow Up|0|||
161451775|NCT00566696|583050667|FG000|Overall Study|Met Exclusion Criteria|2|||
161451776|NCT00566696|583050667|FG000|Overall Study|Muromonab not available|1|||
161451777|NCT00566696|583050667|FG000|Overall Study|Health Status Change|1|||
161451778|NCT00566696|583050667|FG000|Overall Study|Physician Decision|1|||
161451779|NCT00566696|583050667|FG000|Overall Study|Non-Patient Donors|37|||
161451780|NCT00706342|583050669|FG000|Overall Study|Adverse Event|3|||
161451781|NCT00706342|583050669|FG000|Overall Study|Not responding to treatment|2|||
161451782|NCT00706342|583050669|FG000|Overall Study|Withdrawn due to failure to respond|1|||
161451783|NCT00706342|583050669|FG000|Overall Study|Death|1|||
161801552|NCT00688064|584316535|FG000|Overall Study|Protocol Violation|0|||
161801553|NCT00688064|584316536|FG001|Overall Study|Protocol Violation|1|||
161801554|NCT00688064|584316535|FG000|Overall Study|Adverse Event|2|||
161801555|NCT00688064|584316536|FG001|Overall Study|Adverse Event|4|||
161801556|NCT00688064|584316535|FG000|Overall Study|Withdrawal by Subject|7|||
161801557|NCT00688064|584316536|FG001|Overall Study|Withdrawal by Subject|7|||
161801558|NCT00688064|584316535|FG000|Overall Study|Lost to Follow-up|10|||
161801559|NCT00688064|584316536|FG001|Overall Study|Lost to Follow-up|10|||
161801560|NCT00688064|584316535|FG000|Overall Study|Lack of Efficacy|0|||
161801561|NCT00688064|584316536|FG001|Overall Study|Lack of Efficacy|1|||
161801562|NCT00688064|584316535|FG000|Overall Study|Pregnancy|1|||
161801563|NCT00688064|584316536|FG001|Overall Study|Pregnancy|0|||
161801564|NCT00688064|584316535|FG000|Overall Study|Any other reasons|1|||
161801565|NCT00688064|584316536|FG001|Overall Study|Any other reasons|3|||
161801566|NCT00524459|584316542|FG000|Overall Study|Withdrawal by Subject|1|||
161801567|NCT00524459|584316542|FG000|Overall Study|Other|1|||
161558400|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
161558401|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Other Medical|9|||
161558402|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Other Medical|5|||
161558403|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Disease Progression|4|||
161558404|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Disease Progression|2|||
161558405|NCT02107443|583434030|FG000|Overall Study|Withdrawal: Personal Issues|0|||
161558406|NCT02107443|583434031|FG001|Overall Study|Withdrawal: Personal Issues|3|||
161558407|NCT01400893|583434032|FG000|Overall Study|Death|27|||
161558408|NCT01400893|583434033|FG001|Overall Study|Death|21|||
161558409|NCT01400893|583434032|FG000|Overall Study|Lost to Follow-up|0|||
161558410|NCT01400893|583434033|FG001|Overall Study|Lost to Follow-up|6|||
161558411|NCT00519636|583434034|FG000|Treatment Period 1|Adverse Event|1|||
161558412|NCT00519636|583434035|FG001|Treatment Period 1|Adverse Event|0|||
161558413|NCT00519636|583434036|FG002|Treatment Period 1|Adverse Event|1|||
161558414|NCT00519636|583434037|FG003|Treatment Period 1|Adverse Event|0|||
161558415|NCT00519636|583434034|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
161558416|NCT00519636|583434035|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
161558417|NCT00519636|583434036|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
161558418|NCT00519636|583434037|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
161558419|NCT00519636|583434034|FG000|Washout Period|Adverse Event|2|||
161558420|NCT00519636|583434035|FG001|Washout Period|Adverse Event|1|||
161558421|NCT00519636|583434036|FG002|Washout Period|Adverse Event|1|||
161558422|NCT00519636|583434037|FG003|Washout Period|Adverse Event|0|||
161558423|NCT00519636|583434034|FG000|Washout Period|Lost to Follow-up|1|||
161558424|NCT00519636|583434035|FG001|Washout Period|Lost to Follow-up|0|||
161558425|NCT00519636|583434036|FG002|Washout Period|Lost to Follow-up|0|||
161558426|NCT00519636|583434037|FG003|Washout Period|Lost to Follow-up|0|||
161558427|NCT00519636|583434034|FG000|Washout Period|Protocol Violation|0|||
161558428|NCT00519636|583434035|FG001|Washout Period|Protocol Violation|0|||
161558429|NCT00519636|583434036|FG002|Washout Period|Protocol Violation|1|||
161558430|NCT00519636|583434037|FG003|Washout Period|Protocol Violation|2|||
161558431|NCT00519636|583434034|FG000|Washout Period|Withdrawal by Subject|1|||
161558432|NCT00519636|583434035|FG001|Washout Period|Withdrawal by Subject|0|||
161558433|NCT00519636|583434036|FG002|Washout Period|Withdrawal by Subject|1|||
161558434|NCT00519636|583434037|FG003|Washout Period|Withdrawal by Subject|0|||
161558435|NCT00519636|583434034|FG000|Washout Period|Failed to meet continuation criteria|14|||
161558436|NCT00519636|583434035|FG001|Washout Period|Failed to meet continuation criteria|11|||
161558437|NCT00519636|583434036|FG002|Washout Period|Failed to meet continuation criteria|9|||
161558438|NCT00519636|583434037|FG003|Washout Period|Failed to meet continuation criteria|3|||
161558439|NCT00519636|583434034|FG000|Washout Period|Out of pollen area > 48 hours|1|||
161558440|NCT00519636|583434035|FG001|Washout Period|Out of pollen area > 48 hours|0|||
161558441|NCT00519636|583434036|FG002|Washout Period|Out of pollen area > 48 hours|0|||
161558442|NCT00519636|583434037|FG003|Washout Period|Out of pollen area > 48 hours|0|||
161558443|NCT00519636|583434034|FG000|Washout Period|Participating in study at another site|1|||
161558444|NCT00519636|583434035|FG001|Washout Period|Participating in study at another site|0|||
161558445|NCT00519636|583434036|FG002|Washout Period|Participating in study at another site|0|||
161558446|NCT00519636|583434037|FG003|Washout Period|Participating in study at another site|0|||
161558447|NCT00519636|583434034|FG000|Washout Period|Non-compliant|0|||
161558448|NCT00519636|583434035|FG001|Washout Period|Non-compliant|1|||
161558449|NCT00519636|583434036|FG002|Washout Period|Non-compliant|0|||
161558450|NCT00519636|583434037|FG003|Washout Period|Non-compliant|0|||
161558451|NCT00519636|583434034|FG000|Washout Period|Per doctors request|0|||
161558452|NCT00519636|583434035|FG001|Washout Period|Per doctors request|1|||
161558453|NCT00519636|583434036|FG002|Washout Period|Per doctors request|0|||
161558454|NCT00519636|583434037|FG003|Washout Period|Per doctors request|0|||
161558455|NCT00519636|583434034|FG000|Washout Period|Subject randomized in error|0|||
161558456|NCT00519636|583434035|FG001|Washout Period|Subject randomized in error|0|||
161558457|NCT00519636|583434036|FG002|Washout Period|Subject randomized in error|1|||
161558458|NCT00519636|583434037|FG003|Washout Period|Subject randomized in error|0|||
161558459|NCT00519636|583434034|FG000|Washout Period|Prohibited medications|0|||
161558460|NCT00519636|583434035|FG001|Washout Period|Prohibited medications|0|||
161558461|NCT00519636|583434036|FG002|Washout Period|Prohibited medications|1|||
161801568|NCT00728949|584316543|FG000|Overall Study|Adverse Event|8|||
161801569|NCT00728949|584316544|FG001|Overall Study|Adverse Event|0|||
161801570|NCT00728949|584316543|FG000|Overall Study|Withdrawal by Subject|2|||
161558462|NCT00519636|583434037|FG003|Washout Period|Prohibited medications|0|||
161558463|NCT00519636|583434034|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
161558464|NCT00519636|583434035|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
161558465|NCT00519636|583434036|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
161558466|NCT00519636|583434037|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
161558467|NCT00519636|583434034|FG000|Treatment Period 2|Subject randomized in error|0|||
161558468|NCT00519636|583434035|FG001|Treatment Period 2|Subject randomized in error|1|||
161558469|NCT00519636|583434036|FG002|Treatment Period 2|Subject randomized in error|0|||
161801571|NCT00728949|584316544|FG001|Overall Study|Withdrawal by Subject|2|||
161451784|NCT00706342|583050669|FG000|Overall Study|Withdrew from the study on his own.|1|||
161451785|NCT00706342|583050669|FG000|Overall Study|Investigator discretion|2|||
161451786|NCT00706342|583050669|FG000|Overall Study|Non-responder Week 12|1|||
161451787|NCT00706342|583050669|FG000|Overall Study|Ongoing|6|||
161451788|NCT00706342|583050669|FG000|Overall Study|WIthdrawal of consent|1|||
161451789|NCT00119678|583050671|FG000|Double-blind Treatment Period|Death|1|||
161451790|NCT00119678|583050672|FG001|Double-blind Treatment Period|Death|0|||
161451791|NCT00119678|583050671|FG000|Double-blind Treatment Period|Adverse Event|7|||
161451792|NCT00119678|583050672|FG001|Double-blind Treatment Period|Adverse Event|1|||
161451793|NCT00119678|583050671|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
161451794|NCT00119678|583050672|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
161451795|NCT00119678|583050671|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161451796|NCT00119678|583050672|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
161451797|NCT00119678|583050671|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
161451798|NCT00119678|583050672|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
161451799|NCT00119678|583050671|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
161451800|NCT00119678|583050672|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
161451801|NCT00119678|583050671|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
161451802|NCT00119678|583050672|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
161451803|NCT00119678|583050671|FG000|Double-blind Treatment Period|Pregnancy|0|||
161451804|NCT00119678|583050672|FG001|Double-blind Treatment Period|Pregnancy|2|||
161801572|NCT00728949|584316543|FG000|Overall Study|Abnormal Lab Results|0|||
161801573|NCT00728949|584316544|FG001|Overall Study|Abnormal Lab Results|2|||
161801574|NCT00728949|584316543|FG000|Overall Study|On treatment at cutoff date|1|||
161801575|NCT00728949|584316544|FG001|Overall Study|On treatment at cutoff date|0|||
161801576|NCT02319148|584316549|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
161801577|NCT02319148|584316550|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
161801578|NCT02319148|584316551|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
161801579|NCT02319148|584316552|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
161801580|NCT02319148|584316549|FG000|Second Intervention Period|No longer willing to participate|0|||
161801581|NCT02319148|584316550|FG001|Second Intervention Period|No longer willing to participate|1|||
161801582|NCT02319148|584316551|FG002|Second Intervention Period|No longer willing to participate|0|||
161801583|NCT02319148|584316552|FG003|Second Intervention Period|No longer willing to participate|0|||
161801584|NCT02319148|584316549|FG000|Second Intervention Period|Other|0|||
161801585|NCT02319148|584316550|FG001|Second Intervention Period|Other|0|||
161801586|NCT02319148|584316551|FG002|Second Intervention Period|Other|0|||
161801587|NCT02319148|584316552|FG003|Second Intervention Period|Other|1|||
161801588|NCT01574248|584316553|FG000|Overall Study|Withdrawal by Subject|2|||
161801589|NCT01574248|584316554|FG001|Overall Study|Withdrawal by Subject|0|||
161801590|NCT01574248|584316553|FG000|Overall Study|Missing primary endpoint data|1|||
161801591|NCT01574248|584316554|FG001|Overall Study|Missing primary endpoint data|0|||
161801592|NCT00048048|584316557|FG000|Core Treatment|Withdrawal by Subject|0|||
161801593|NCT00048048|584316558|FG001|Core Treatment|Withdrawal by Subject|0|||
161801594|NCT00048048|584316559|FG002|Core Treatment|Withdrawal by Subject|1|||
161451805|NCT00119678|583050671|FG000|Double-blind Treatment Period|Not treated|1|||
161451806|NCT00119678|583050672|FG001|Double-blind Treatment Period|Not treated|2|||
161451807|NCT00119678|583050671|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
161451808|NCT00119678|583050672|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
161451809|NCT00119678|583050671|FG000|Open-label Treatment Period|Death|1|||
161451810|NCT00119678|583050672|FG001|Open-label Treatment Period|Death|0|||
161451811|NCT00119678|583050671|FG000|Open-label Treatment Period|Adverse Event|3|||
161451812|NCT00119678|583050672|FG001|Open-label Treatment Period|Adverse Event|0|||
161451813|NCT00119678|583050671|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
161451814|NCT00119678|583050672|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
161451815|NCT00119678|583050671|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
161451816|NCT00119678|583050672|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161451817|NCT00119678|583050671|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
161451818|NCT00119678|583050672|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
161451819|NCT00119678|583050671|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
161451820|NCT00119678|583050672|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
161451821|NCT00119678|583050671|FG000|Open-label Treatment Period|Pregnancy|1|||
161451822|NCT00119678|583050672|FG001|Open-label Treatment Period|Pregnancy|0|||
161451823|NCT00119678|583050671|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
161451824|NCT00119678|583050672|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
161451825|NCT01546623|583050675|FG000|Overall Study|Adverse Event|2|||
161451826|NCT01546623|583050676|FG001|Overall Study|Adverse Event|3|||
161558470|NCT00519636|583434037|FG003|Treatment Period 2|Subject randomized in error|0|||
161558471|NCT00519636|583434034|FG000|Treatment Period 2|Per doctors request|0|||
161451827|NCT01546623|583050675|FG000|Overall Study|Major Protocol Deviation|1|||
161451828|NCT01546623|583050676|FG001|Overall Study|Major Protocol Deviation|1|||
161558472|NCT00519636|583434035|FG001|Treatment Period 2|Per doctors request|0|||
161558473|NCT00519636|583434036|FG002|Treatment Period 2|Per doctors request|1|||
161558474|NCT00519636|583434037|FG003|Treatment Period 2|Per doctors request|0|||
161558475|NCT00519636|583434034|FG000|Treatment Period 2|Subject misrandomized|0|||
161558476|NCT00519636|583434035|FG001|Treatment Period 2|Subject misrandomized|0|||
161558477|NCT00519636|583434036|FG002|Treatment Period 2|Subject misrandomized|0|||
161905140|NCT01764841|584701205|FG002|Overall Study|No Follow Up|1|||
161905141|NCT01764841|584701206|FG003|Overall Study|No Follow Up|0|||
161905142|NCT01764841|584701203|FG000|Overall Study|Protocol Violation|0|||
161905143|NCT01764841|584701204|FG001|Overall Study|Protocol Violation|1|||
161905144|NCT01764841|584701205|FG002|Overall Study|Protocol Violation|0|||
161905145|NCT01764841|584701206|FG003|Overall Study|Protocol Violation|0|||
161905146|NCT01764841|584701203|FG000|Overall Study|Withdrawal by Subject|16|||
161905147|NCT01764841|584701204|FG001|Overall Study|Withdrawal by Subject|24|||
161905148|NCT01764841|584701205|FG002|Overall Study|Withdrawal by Subject|11|||
161905149|NCT01764841|584701206|FG003|Overall Study|Withdrawal by Subject|15|||
161905150|NCT01764841|584701203|FG000|Overall Study|Lost to Follow-up|3|||
161905151|NCT01764841|584701204|FG001|Overall Study|Lost to Follow-up|0|||
161905152|NCT01764841|584701205|FG002|Overall Study|Lost to Follow-up|1|||
161905153|NCT01764841|584701206|FG003|Overall Study|Lost to Follow-up|0|||
161905154|NCT02115607|584701207|FG000|Overall Study|Withdrawal by Subject|1|||
161905155|NCT04863872|584701210|FG000|Overall Study|Withdrawal by Subject|4|||
161905156|NCT04863872|584701211|FG001|Overall Study|Withdrawal by Subject|15|||
161905157|NCT04863872|584701210|FG000|Overall Study|Death|5|||
161905158|NCT04863872|584701211|FG001|Overall Study|Death|2|||
161905159|NCT04863872|584701210|FG000|Overall Study|Lost to Follow-up|2|||
161558478|NCT00519636|583434037|FG003|Treatment Period 2|Subject misrandomized|1|||
161558479|NCT00519636|583434034|FG000|Post Study Period|Subject randomized in error|0|||
161558480|NCT00519636|583434035|FG001|Post Study Period|Subject randomized in error|0|||
161558481|NCT00519636|583434036|FG002|Post Study Period|Subject randomized in error|0|||
161558482|NCT00519636|583434037|FG003|Post Study Period|Subject randomized in error|1|||
161558483|NCT04504916|583434038|FG000|Overall Study|Study terminated|7|||
161558484|NCT04504916|583434039|FG001|Overall Study|Study terminated|8|||
161558485|NCT04504916|583434038|FG000|Overall Study|Death|54|||
161558486|NCT04504916|583434039|FG001|Overall Study|Death|18|||
161558487|NCT04504916|583434038|FG000|Overall Study|Lost to Follow-up|1|||
161558488|NCT04504916|583434039|FG001|Overall Study|Lost to Follow-up|1|||
161558489|NCT04504916|583434038|FG000|Overall Study|Withdrawal by Subject|8|||
161558490|NCT04504916|583434039|FG001|Overall Study|Withdrawal by Subject|4|||
161558491|NCT04504916|583434038|FG000|Overall Study|Did not agree to follow-up|0|||
161558492|NCT04504916|583434039|FG001|Overall Study|Did not agree to follow-up|1|||
161558493|NCT03057834|583434040|FG000|Overall Study|Withdrawal by Subject|25|||
161558494|NCT03057834|583434041|FG001|Overall Study|Withdrawal by Subject|29|||
161558495|NCT00003509|583434042|FG000|Overall Study|Not evaluable|5|||
161558496|NCT03077620|583434047|FG000|Overall Study|Unable to place lumbar catheter|1|||
161558497|NCT03077620|583434048|FG001|Overall Study|Unable to place lumbar catheter|0|||
161558498|NCT03077620|583434049|FG002|Overall Study|Unable to place lumbar catheter|1|||
161558499|NCT03077620|583434050|FG003|Overall Study|Unable to place lumbar catheter|0|||
161558500|NCT03077620|583434047|FG000|Overall Study|Withdrawal by Subject|0|||
161558501|NCT03077620|583434048|FG001|Overall Study|Withdrawal by Subject|1|||
161558502|NCT03077620|583434049|FG002|Overall Study|Withdrawal by Subject|0|||
161558503|NCT03077620|583434050|FG003|Overall Study|Withdrawal by Subject|0|||
161558504|NCT03077620|583434047|FG000|Overall Study|Physician Decision|0|||
161558505|NCT03077620|583434048|FG001|Overall Study|Physician Decision|0|||
161558506|NCT03077620|583434049|FG002|Overall Study|Physician Decision|1|||
161558507|NCT03077620|583434050|FG003|Overall Study|Physician Decision|0|||
161558508|NCT00245011|583434052|FG000|Overall Study|Lack of Efficacy|1|||
161558509|NCT00550173|583434053|FG000|Overall Study|Death|45|||
161558510|NCT00550173|583434054|FG001|Overall Study|Death|38|||
161558511|NCT00550173|583434055|FG002|Overall Study|Death|50|||
161558512|NCT00550173|583434053|FG000|Overall Study|Physician Decision|1|||
161905160|NCT04863872|584701211|FG001|Overall Study|Lost to Follow-up|1|||
161558513|NCT00550173|583434054|FG001|Overall Study|Physician Decision|2|||
161558514|NCT00550173|583434055|FG002|Overall Study|Physician Decision|2|||
161558515|NCT00550173|583434053|FG000|Overall Study|Withdrawal by Subject|9|||
161558516|NCT00550173|583434054|FG001|Overall Study|Withdrawal by Subject|12|||
161905161|NCT00549549|584701212|FG000|Overall Study|Adverse Event|5|||
161905162|NCT00549549|584701213|FG001|Overall Study|Adverse Event|3|||
161905163|NCT00549549|584701214|FG002|Overall Study|Adverse Event|1|||
161905164|NCT00549549|584701215|FG003|Overall Study|Adverse Event|9|||
161558517|NCT00550173|583434055|FG002|Overall Study|Withdrawal by Subject|17|||
161558518|NCT00550173|583434053|FG000|Overall Study|Sponsor Decision|13|||
161558519|NCT00550173|583434054|FG001|Overall Study|Sponsor Decision|7|||
161558520|NCT00550173|583434055|FG002|Overall Study|Sponsor Decision|1|||
161905165|NCT00549549|584701212|FG000|Overall Study|Lack of Efficacy|9|||
161905166|NCT00549549|584701213|FG001|Overall Study|Lack of Efficacy|6|||
161905167|NCT00549549|584701214|FG002|Overall Study|Lack of Efficacy|4|||
161905168|NCT00549549|584701215|FG003|Overall Study|Lack of Efficacy|2|||
161801595|NCT00048048|584316560|FG003|Core Treatment|Withdrawal by Subject|0|||
161801596|NCT00048048|584316561|FG004|Core Treatment|Withdrawal by Subject|0|||
161801597|NCT00048048|584316562|FG005|Core Treatment|Withdrawal by Subject|0|||
161801598|NCT00048048|584316563|FG006|Core Treatment|Withdrawal by Subject|0|||
161801599|NCT00048048|584316564|FG007|Core Treatment|Withdrawal by Subject|0|||
161451829|NCT01546623|583050675|FG000|Overall Study|High Prostate specific antigen|2|||
161451830|NCT01546623|583050676|FG001|Overall Study|High Prostate specific antigen|1|||
161451831|NCT01546623|583050675|FG000|Overall Study|Did Not Receive Study Drug|1|||
161451832|NCT01546623|583050676|FG001|Overall Study|Did Not Receive Study Drug|1|||
161451833|NCT03567343|583050677|FG000|Overall Study|Lost to Follow-up|2|||
161451834|NCT03567343|583050678|FG001|Overall Study|Lost to Follow-up|1|||
161451835|NCT03567343|583050677|FG000|Overall Study|No longer eligible|2|||
161451836|NCT03567343|583050678|FG001|Overall Study|No longer eligible|1|||
161451837|NCT03567343|583050677|FG000|Overall Study|Adverse Event|1|||
161451838|NCT03567343|583050678|FG001|Overall Study|Adverse Event|0|||
161451839|NCT03567343|583050677|FG000|Overall Study|Protocol Violation|1|||
161451840|NCT03567343|583050678|FG001|Overall Study|Protocol Violation|1|||
161451841|NCT01134705|583050679|FG000|Overall Study|Adverse Event|1|||
161451842|NCT01134705|583050680|FG001|Overall Study|Adverse Event|7|||
161451843|NCT01134705|583050679|FG000|Overall Study|Withdrawal by Subject|6|||
161451844|NCT01134705|583050680|FG001|Overall Study|Withdrawal by Subject|6|||
161451845|NCT01134705|583050679|FG000|Overall Study|Pregnancy|1|||
161451846|NCT01134705|583050680|FG001|Overall Study|Pregnancy|0|||
161451847|NCT01134705|583050679|FG000|Overall Study|Lost to Follow-up|5|||
161451848|NCT01134705|583050680|FG001|Overall Study|Lost to Follow-up|2|||
161451849|NCT01134705|583050679|FG000|Overall Study|Protocol Violation|1|||
161451850|NCT01134705|583050680|FG001|Overall Study|Protocol Violation|1|||
161451851|NCT01134705|583050679|FG000|Overall Study|Other|1|||
161451852|NCT01134705|583050680|FG001|Overall Study|Other|6|||
161451853|NCT00246740|583050681|FG000|Initial Enrollment|Death|1|||
161451854|NCT00246740|583050682|FG001|Initial Enrollment|Death|0|||
161451855|NCT00246740|583050681|FG000|Initial Enrollment|Additional surgery scheduled|0|||
161451856|NCT00246740|583050682|FG001|Initial Enrollment|Additional surgery scheduled|2|||
161451857|NCT00246740|583050681|FG000|Initial Enrollment|Surgery schedule change|4|||
161451858|NCT00246740|583050682|FG001|Initial Enrollment|Surgery schedule change|4|||
161451859|NCT00246740|583050681|FG000|Initial Enrollment|Other|1|||
161451860|NCT00246740|583050682|FG001|Initial Enrollment|Other|2|||
161451861|NCT00101452|583050683|FG000|Overall Study|Adverse Event|2|||
161451862|NCT00101452|583050684|FG001|Overall Study|Adverse Event|0|||
161451863|NCT00101452|583050685|FG002|Overall Study|Adverse Event|1|||
161451864|NCT00101452|583050683|FG000|Overall Study|Lost to Follow-up|13|||
161451865|NCT00101452|583050684|FG001|Overall Study|Lost to Follow-up|8|||
161451866|NCT00101452|583050685|FG002|Overall Study|Lost to Follow-up|14|||
161451867|NCT00101452|583050683|FG000|Overall Study|Withdrawal by Subject|10|||
161451868|NCT00101452|583050684|FG001|Overall Study|Withdrawal by Subject|14|||
161451869|NCT00101452|583050685|FG002|Overall Study|Withdrawal by Subject|9|||
161451870|NCT00101452|583050683|FG000|Overall Study|Baseline Fail|2|||
161451871|NCT00101452|583050684|FG001|Overall Study|Baseline Fail|1|||
161451872|NCT00101452|583050685|FG002|Overall Study|Baseline Fail|2|||
161451873|NCT00101452|583050683|FG000|Overall Study|Physician Decision|0|||
161451874|NCT00101452|583050684|FG001|Overall Study|Physician Decision|3|||
161451875|NCT00101452|583050685|FG002|Overall Study|Physician Decision|2|||
161451876|NCT00101452|583050683|FG000|Overall Study|Protocol Violation|2|||
161451877|NCT00101452|583050684|FG001|Overall Study|Protocol Violation|1|||
161451878|NCT00101452|583050685|FG002|Overall Study|Protocol Violation|3|||
161451879|NCT00101452|583050683|FG000|Overall Study|Other|15|||
161451880|NCT00101452|583050684|FG001|Overall Study|Other|16|||
161451881|NCT00101452|583050685|FG002|Overall Study|Other|12|||
161451882|NCT01510769|583050686|FG000|Overall Study|Adverse Event|7|||
161451883|NCT01510769|583050687|FG001|Overall Study|Adverse Event|6|||
161451884|NCT01510769|583050688|FG002|Overall Study|Adverse Event|4|||
161451885|NCT01510769|583050686|FG000|Overall Study|Gout Flare|0|||
161451886|NCT01510769|583050687|FG001|Overall Study|Gout Flare|3|||
161451887|NCT01510769|583050688|FG002|Overall Study|Gout Flare|1|||
161801600|NCT00048048|584316565|FG008|Core Treatment|Withdrawal by Subject|0|||
161801601|NCT00048048|584316566|FG009|Core Treatment|Withdrawal by Subject|0|||
161451888|NCT01510769|583050686|FG000|Overall Study|Protocol Violation|11|||
161451889|NCT01510769|583050687|FG001|Overall Study|Protocol Violation|10|||
161451890|NCT01510769|583050688|FG002|Overall Study|Protocol Violation|9|||
161451891|NCT01510769|583050686|FG000|Overall Study|Lost to Follow-up|5|||
161451892|NCT01510769|583050687|FG001|Overall Study|Lost to Follow-up|1|||
161451893|NCT01510769|583050688|FG002|Overall Study|Lost to Follow-up|5|||
161451894|NCT01510769|583050686|FG000|Overall Study|Withdrawal by Subject|3|||
161451895|NCT01510769|583050687|FG001|Overall Study|Withdrawal by Subject|4|||
161451896|NCT01510769|583050688|FG002|Overall Study|Withdrawal by Subject|3|||
161451897|NCT01510769|583050686|FG000|Overall Study|Death|1|||
161451898|NCT01510769|583050687|FG001|Overall Study|Death|1|||
161451899|NCT01510769|583050688|FG002|Overall Study|Death|0|||
161451900|NCT02674204|583050689|FG000|Overall Study|Adverse Event|1|||
161451901|NCT02674204|583050690|FG001|Overall Study|Adverse Event|0|||
161558521|NCT00550173|583434053|FG000|Overall Study|Lost to Follow-up|4|||
161558522|NCT00550173|583434054|FG001|Overall Study|Lost to Follow-up|4|||
161558523|NCT00550173|583434055|FG002|Overall Study|Lost to Follow-up|3|||
161558524|NCT00031447|583435570|FG000|Overall Study|Lost to Follow-up|0|||
161558525|NCT00031447|583435571|FG001|Overall Study|Lost to Follow-up|1|||
161558526|NCT00031447|583435570|FG000|Overall Study|Non-compliant|1|||
161558527|NCT00031447|583435571|FG001|Overall Study|Non-compliant|1|||
161558528|NCT00031447|583435570|FG000|Overall Study|Re-activation of Disease|2|||
161558529|NCT00031447|583435571|FG001|Overall Study|Re-activation of Disease|1|||
161558530|NCT00031447|583435570|FG000|Overall Study|Disruption of blinded study drug supply|7|||
161558531|NCT00031447|583435571|FG001|Overall Study|Disruption of blinded study drug supply|4|||
161558532|NCT01636362|583435575|FG000|Overall Study|Physician Decision|6|||
161558533|NCT01636362|583435575|FG000|Overall Study|Subject healed, not returning|1|||
161558534|NCT01636362|583435575|FG000|Overall Study|Withdrawal by Subject|1|||
161558535|NCT01244763|583435576|FG000|Overall Study|Adverse Event|1|||
161558536|NCT01244763|583435577|FG001|Overall Study|Adverse Event|0|||
161558537|NCT01244763|583435578|FG002|Overall Study|Adverse Event|0|||
161558538|NCT01244763|583435579|FG003|Overall Study|Adverse Event|0|||
161558539|NCT01244763|583435580|FG004|Overall Study|Adverse Event|0|||
161558540|NCT01244763|583435581|FG005|Overall Study|Adverse Event|1|||
161558541|NCT01244763|583435576|FG000|Overall Study|Death|1|||
161558542|NCT01244763|583435577|FG001|Overall Study|Death|0|||
161558543|NCT01244763|583435578|FG002|Overall Study|Death|1|||
161558544|NCT01244763|583435579|FG003|Overall Study|Death|0|||
161558545|NCT01244763|583435580|FG004|Overall Study|Death|2|||
161558546|NCT01244763|583435581|FG005|Overall Study|Death|0|||
161558547|NCT01244763|583435576|FG000|Overall Study|Physician Decision|0|||
161558548|NCT01244763|583435577|FG001|Overall Study|Physician Decision|0|||
161558549|NCT01244763|583435578|FG002|Overall Study|Physician Decision|1|||
161558550|NCT01244763|583435579|FG003|Overall Study|Physician Decision|0|||
161558551|NCT01244763|583435580|FG004|Overall Study|Physician Decision|0|||
161558552|NCT01244763|583435581|FG005|Overall Study|Physician Decision|0|||
161558553|NCT01244763|583435576|FG000|Overall Study|Withdrawal by Subject|1|||
161558554|NCT01244763|583435577|FG001|Overall Study|Withdrawal by Subject|2|||
161558555|NCT01244763|583435578|FG002|Overall Study|Withdrawal by Subject|0|||
161558556|NCT01244763|583435579|FG003|Overall Study|Withdrawal by Subject|1|||
161558557|NCT01244763|583435580|FG004|Overall Study|Withdrawal by Subject|1|||
161558558|NCT01244763|583435581|FG005|Overall Study|Withdrawal by Subject|2|||
161558559|NCT01244763|583435576|FG000|Overall Study|Lost to Follow-up|0|||
161558560|NCT01244763|583435577|FG001|Overall Study|Lost to Follow-up|1|||
161558561|NCT01244763|583435578|FG002|Overall Study|Lost to Follow-up|0|||
161558562|NCT01244763|583435579|FG003|Overall Study|Lost to Follow-up|0|||
161558563|NCT01244763|583435580|FG004|Overall Study|Lost to Follow-up|0|||
161558564|NCT01244763|583435581|FG005|Overall Study|Lost to Follow-up|0|||
161558565|NCT01244763|583435576|FG000|Overall Study|Enrolled into the Extension Study|0|||
161558566|NCT01244763|583435577|FG001|Overall Study|Enrolled into the Extension Study|0|||
161558567|NCT01244763|583435578|FG002|Overall Study|Enrolled into the Extension Study|0|||
161558568|NCT01244763|583435579|FG003|Overall Study|Enrolled into the Extension Study|0|||
161558569|NCT01244763|583435580|FG004|Overall Study|Enrolled into the Extension Study|0|||
161558570|NCT01244763|583435581|FG005|Overall Study|Enrolled into the Extension Study|1|||
161558571|NCT02271594|583435582|FG000|Overall Study|Study closed; recruiting failure|19|||
161558572|NCT02271594|583435583|FG001|Overall Study|Study closed; recruiting failure|12|||
161558573|NCT03330119|583435586|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
161558574|NCT03330119|583435587|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
161801602|NCT00048048|584316567|FG010|Core Treatment|Withdrawal by Subject|0|||
161801603|NCT00048048|584316568|FG011|Core Treatment|Withdrawal by Subject|0|||
161801604|NCT00048048|584316557|FG000|Core Treatment|Adverse Event|0|||
161801605|NCT00048048|584316558|FG001|Core Treatment|Adverse Event|0|||
161801606|NCT00048048|584316559|FG002|Core Treatment|Adverse Event|0|||
161801607|NCT00048048|584316560|FG003|Core Treatment|Adverse Event|0|||
161801608|NCT00048048|584316561|FG004|Core Treatment|Adverse Event|0|||
161801609|NCT00048048|584316562|FG005|Core Treatment|Adverse Event|0|||
161801610|NCT00048048|584316563|FG006|Core Treatment|Adverse Event|0|||
161801611|NCT00048048|584316564|FG007|Core Treatment|Adverse Event|1|||
161801612|NCT00048048|584316565|FG008|Core Treatment|Adverse Event|0|||
161558575|NCT01561079|583435588|FG000|Overall Study|Physician Decision|17|||
161558576|NCT01561079|583435588|FG000|Overall Study|Withdrawal by Subject|59|||
161558577|NCT01561079|583435588|FG000|Overall Study|Protocol Violation|2|||
161668049|NCT00406653|583837478|FG002|Induction Period|Given prohibited drug|2|||
161668050|NCT00406653|583837479|FG003|Induction Period|Given prohibited drug|0|||
161668051|NCT00406653|583837480|FG004|Induction Period|Given prohibited drug|0|||
161668052|NCT00406653|583837481|FG005|Induction Period|Given prohibited drug|0|||
161558582|NCT00550732|583435597|FG000|Overall Study|Death|4|||
161558583|NCT00550732|583435597|FG000|Overall Study|Withdrawal by Subject|2|||
161801613|NCT00048048|584316566|FG009|Core Treatment|Adverse Event|0|||
161801614|NCT00048048|584316567|FG010|Core Treatment|Adverse Event|0|||
161801615|NCT00048048|584316568|FG011|Core Treatment|Adverse Event|0|||
161558584|NCT00550732|583435597|FG000|Overall Study|Physician Decision|2|||
161558585|NCT00550732|583435597|FG000|Overall Study|Lost to Follow-up|1|||
161558586|NCT00550732|583435597|FG000|Overall Study|Palliative care|1|||
161558587|NCT00550732|583435597|FG000|Overall Study|Adverse Event|1|||
161558588|NCT01323660|583435599|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
161558589|NCT01323660|583435600|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
161558590|NCT01323660|583435601|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
161558591|NCT01323660|583435602|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
161558592|NCT01323660|583435603|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
161558593|NCT01323660|583435604|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
161558594|NCT01323660|583435599|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
161558595|NCT01323660|583435600|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
161558596|NCT01323660|583435601|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
161558597|NCT01323660|583435602|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
161558598|NCT01323660|583435603|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
161558599|NCT01323660|583435604|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
161558600|NCT01323660|583435599|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
161558601|NCT01323660|583435600|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
161558602|NCT01323660|583435601|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
161558603|NCT01323660|583435602|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
161558604|NCT01323660|583435603|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
161558605|NCT01323660|583435604|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
161558606|NCT01323660|583435599|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161558607|NCT01323660|583435600|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161558608|NCT01323660|583435601|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161558609|NCT01323660|583435602|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161558610|NCT01323660|583435603|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
161558611|NCT01323660|583435604|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161558612|NCT01323660|583435599|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161558613|NCT01323660|583435600|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161558614|NCT01323660|583435601|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161558615|NCT01323660|583435602|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161558616|NCT01323660|583435603|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161801616|NCT00048048|584316557|FG000|Extension Year 1|Early withdrawals|0|||
161801617|NCT00048048|584316558|FG001|Extension Year 1|Early withdrawals|0|||
161801618|NCT00048048|584316559|FG002|Extension Year 1|Early withdrawals|0|||
161801619|NCT00048048|584316560|FG003|Extension Year 1|Early withdrawals|0|||
161801620|NCT00048048|584316561|FG004|Extension Year 1|Early withdrawals|0|||
161801621|NCT00048048|584316562|FG005|Extension Year 1|Early withdrawals|0|||
161801622|NCT00048048|584316563|FG006|Extension Year 1|Early withdrawals|0|||
161801623|NCT00048048|584316564|FG007|Extension Year 1|Early withdrawals|0|||
161801624|NCT00048048|584316565|FG008|Extension Year 1|Early withdrawals|0|||
161801625|NCT00048048|584316566|FG009|Extension Year 1|Early withdrawals|2|||
161801626|NCT00048048|584316567|FG010|Extension Year 1|Early withdrawals|2|||
161801627|NCT00048048|584316568|FG011|Extension Year 1|Early withdrawals|4|||
161801628|NCT00048048|584316557|FG000|Extension Year 2|Early withdrawals|0|||
161801629|NCT00048048|584316558|FG001|Extension Year 2|Early withdrawals|0|||
161801630|NCT00048048|584316559|FG002|Extension Year 2|Early withdrawals|0|||
161801631|NCT00048048|584316560|FG003|Extension Year 2|Early withdrawals|0|||
161801632|NCT00048048|584316561|FG004|Extension Year 2|Early withdrawals|0|||
161801633|NCT00048048|584316562|FG005|Extension Year 2|Early withdrawals|0|||
161801634|NCT00048048|584316563|FG006|Extension Year 2|Early withdrawals|0|||
161801635|NCT00048048|584316564|FG007|Extension Year 2|Early withdrawals|0|||
161801636|NCT00048048|584316565|FG008|Extension Year 2|Early withdrawals|0|||
161801637|NCT00048048|584316566|FG009|Extension Year 2|Early withdrawals|0|||
161801638|NCT00048048|584316567|FG010|Extension Year 2|Early withdrawals|4|||
161801639|NCT00048048|584316568|FG011|Extension Year 2|Early withdrawals|2|||
161801640|NCT05518487|584316571|FG000|Overall Study|Withdrawal by Subject|3|||
161558617|NCT01323660|583435604|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161801641|NCT00543309|584316572|FG000|Overall Study|Physician Decision|0|||
161801642|NCT00543309|584316573|FG001|Overall Study|Physician Decision|1|||
161801643|NCT00543309|584316574|FG002|Overall Study|Physician Decision|0|||
161801644|NCT02194998|584316579|FG000|On-HCV Treatment|Did not pick up study medication|0|||
161801645|NCT02194998|584316580|FG001|On-HCV Treatment|Did not pick up study medication|1|||
161801646|NCT02194998|584316581|FG002|On-HCV Treatment|Did not pick up study medication|0|||
161801647|NCT02194998|584316582|FG003|On-HCV Treatment|Did not pick up study medication|0|||
161801648|NCT02194998|584316579|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
161905169|NCT00549549|584701212|FG000|Overall Study|Lost to Follow-up|1|||
161905170|NCT00549549|584701213|FG001|Overall Study|Lost to Follow-up|0|||
161801649|NCT02194998|584316580|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
161801650|NCT02194998|584316581|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
161801651|NCT02194998|584316582|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
161905171|NCT00549549|584701214|FG002|Overall Study|Lost to Follow-up|1|||
161905172|NCT00549549|584701215|FG003|Overall Study|Lost to Follow-up|2|||
161905173|NCT00549549|584701212|FG000|Overall Study|Withdrawal by Subject|0|||
161905174|NCT00549549|584701213|FG001|Overall Study|Withdrawal by Subject|4|||
161905175|NCT00549549|584701214|FG002|Overall Study|Withdrawal by Subject|1|||
161905176|NCT00549549|584701215|FG003|Overall Study|Withdrawal by Subject|0|||
161905177|NCT00549549|584701212|FG000|Overall Study|Other|9|||
161905178|NCT00549549|584701213|FG001|Overall Study|Other|9|||
161905179|NCT00549549|584701214|FG002|Overall Study|Other|9|||
161905180|NCT00549549|584701215|FG003|Overall Study|Other|11|||
161905181|NCT00549549|584701212|FG000|Overall Study|Randomized but not treated|0|||
161905182|NCT00549549|584701213|FG001|Overall Study|Randomized but not treated|0|||
161905183|NCT00549549|584701214|FG002|Overall Study|Randomized but not treated|1|||
161905184|NCT00549549|584701215|FG003|Overall Study|Randomized but not treated|1|||
161905185|NCT02155699|584701216|FG000|Overall Study|Withdrawal by Subject|0|||
161905186|NCT02155699|584701217|FG001|Overall Study|Withdrawal by Subject|3|||
161905187|NCT02155699|584701218|FG002|Overall Study|Withdrawal by Subject|6|||
161905188|NCT02155699|584701219|FG003|Overall Study|Withdrawal by Subject|1|||
161905189|NCT02155699|584701216|FG000|Overall Study|Lost to Follow-up|0|||
161905190|NCT02155699|584701217|FG001|Overall Study|Lost to Follow-up|0|||
161558618|NCT01323660|583435599|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
161558619|NCT01323660|583435600|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161558620|NCT01323660|583435601|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
161558621|NCT01323660|583435602|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
161558622|NCT01323660|583435603|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161558623|NCT01323660|583435604|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161558624|NCT01323660|583435599|FG000|Washout Period (14 Days)|Adverse Event|0|||
161558625|NCT01323660|583435600|FG001|Washout Period (14 Days)|Adverse Event|0|||
161558626|NCT01323660|583435601|FG002|Washout Period (14 Days)|Adverse Event|0|||
161558627|NCT01323660|583435602|FG003|Washout Period (14 Days)|Adverse Event|0|||
161558628|NCT01323660|583435603|FG004|Washout Period (14 Days)|Adverse Event|1|||
161558629|NCT01323660|583435604|FG005|Washout Period (14 Days)|Adverse Event|0|||
161558630|NCT01323660|583435599|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
161558631|NCT01323660|583435600|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
161558632|NCT01323660|583435601|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
161558633|NCT01323660|583435602|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
161558634|NCT01323660|583435603|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
161558635|NCT01323660|583435604|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
161558636|NCT01323660|583435599|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
161558637|NCT01323660|583435600|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161558638|NCT01323660|583435601|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161558639|NCT01323660|583435602|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
161558640|NCT01323660|583435603|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
161558641|NCT01323660|583435604|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
161558642|NCT01323660|583435599|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
161558643|NCT01323660|583435600|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161558644|NCT01323660|583435601|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
161558645|NCT01323660|583435602|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
161558646|NCT01323660|583435603|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161558647|NCT01323660|583435604|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
161558648|NCT01323660|583435599|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
161558649|NCT01323660|583435600|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
161558650|NCT01323660|583435601|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
161558651|NCT01323660|583435602|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
161558652|NCT01323660|583435603|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
161558653|NCT01323660|583435604|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
161558654|NCT01323660|583435599|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
161558655|NCT01323660|583435600|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161558656|NCT01323660|583435601|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161558657|NCT01323660|583435602|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161558658|NCT01323660|583435603|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161905191|NCT02155699|584701218|FG002|Overall Study|Lost to Follow-up|0|||
161905192|NCT02155699|584701219|FG003|Overall Study|Lost to Follow-up|3|||
161558659|NCT01323660|583435604|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
161905193|NCT02155699|584701216|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
161905194|NCT02155699|584701217|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
161905195|NCT02155699|584701218|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
161558660|NCT01323660|583435599|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161558661|NCT01323660|583435600|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161905196|NCT02155699|584701219|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
161905197|NCT05547386|584701220|FG000|Overall Study|Withdrawal by Subject|7|||
161451902|NCT02466659|583050693|FG000|Overall Study|Lost to Follow-up|5|||
161451903|NCT02466659|583050694|FG001|Overall Study|Lost to Follow-up|2|||
161451904|NCT01536392|583050695|FG000|Overall Study|Adverse Event|2|||
161451905|NCT01536392|583050696|FG001|Overall Study|Adverse Event|2|||
161451906|NCT01536392|583050695|FG000|Overall Study|Physician Decision|2|||
161451907|NCT01536392|583050696|FG001|Overall Study|Physician Decision|3|||
161451908|NCT01536392|583050695|FG000|Overall Study|Withdrawal by Subject|3|||
161451909|NCT01536392|583050696|FG001|Overall Study|Withdrawal by Subject|6|||
161451910|NCT01536392|583050695|FG000|Overall Study|Non Compliance|3|||
161801652|NCT01400113|584316583|FG000|Overall Study|Withdrawal by Subject|1|||
161801653|NCT01400113|584316584|FG001|Overall Study|Withdrawal by Subject|1|||
161801654|NCT00282256|584316585|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
161801655|NCT00282256|584316585|FG000|Extension Treatment Period|Adverse Event|2|||
161451911|NCT01536392|583050696|FG001|Overall Study|Non Compliance|4|||
161451912|NCT01536392|583050695|FG000|Overall Study|Completed therapy early|3|||
161451913|NCT01536392|583050696|FG001|Overall Study|Completed therapy early|0|||
161451914|NCT02874144|583050698|FG000|Overall Study|Lost to Follow-up|3|||
161451915|NCT02874144|583050699|FG001|Overall Study|Lost to Follow-up|5|||
161451916|NCT00486811|583050702|FG000|Overall Study|Adverse Event|28|||
161451917|NCT00486811|583050703|FG001|Overall Study|Adverse Event|60|||
161451918|NCT00486811|583050704|FG002|Overall Study|Adverse Event|135|||
161801656|NCT00762086|584316586|FG000|Overall Study|Adverse Event|2|||
161801657|NCT00762086|584316587|FG001|Overall Study|Adverse Event|0|||
161801658|NCT00762086|584316586|FG000|Overall Study|Lost to Follow-up|0|||
161801659|NCT00762086|584316587|FG001|Overall Study|Lost to Follow-up|2|||
161801660|NCT00762086|584316586|FG000|Overall Study|Non compliance|1|||
161801661|NCT00762086|584316587|FG001|Overall Study|Non compliance|0|||
161801662|NCT00762086|584316586|FG000|Overall Study|Withdrawal by Subject|2|||
161801663|NCT00762086|584316587|FG001|Overall Study|Withdrawal by Subject|2|||
161801664|NCT00762086|584316586|FG000|Overall Study|Ineligible to participate in the study|1|||
161451919|NCT00486811|583050702|FG000|Overall Study|Lack of Efficacy|34|||
161451920|NCT00486811|583050703|FG001|Overall Study|Lack of Efficacy|14|||
161451921|NCT00486811|583050704|FG002|Overall Study|Lack of Efficacy|7|||
161451922|NCT00486811|583050702|FG000|Overall Study|Lost to Follow-up|4|||
161451923|NCT00486811|583050703|FG001|Overall Study|Lost to Follow-up|6|||
161558662|NCT01323660|583435601|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161558663|NCT01323660|583435602|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161558664|NCT01323660|583435603|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
161558665|NCT01323660|583435604|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161558666|NCT00926393|583435607|FG000|Overall Study|Withdrawal by Subject|1|||
161558667|NCT00926393|583435608|FG001|Overall Study|Withdrawal by Subject|2|||
161558668|NCT00926393|583435607|FG000|Overall Study|Adverse Event|1|||
161558669|NCT00926393|583435608|FG001|Overall Study|Adverse Event|1|||
161558670|NCT00180674|583435611|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
161558671|NCT00180674|583435611|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
161558672|NCT03302910|583435612|FG000|Overall Study|Protocol Violation|1|||
161558673|NCT03302910|583435613|FG001|Overall Study|Protocol Violation|0|||
161558674|NCT01106976|583435618|FG000|Overall Study|Lost to Follow-up|8|||
161801665|NCT00762086|584316587|FG001|Overall Study|Ineligible to participate in the study|0|||
161801666|NCT03661528|584316588|FG000|Overall Study|Death|1|||
161801667|NCT03661528|584316589|FG001|Overall Study|Death|0|||
161801668|NCT03661528|584316588|FG000|Overall Study|Physician Decision|3|||
161801669|NCT03661528|584316589|FG001|Overall Study|Physician Decision|1|||
161801670|NCT03661528|584316588|FG000|Overall Study|Other than Specified|5|||
161801671|NCT03661528|584316589|FG001|Overall Study|Other than Specified|2|||
161801672|NCT03661528|584316588|FG000|Overall Study|Withdrawal by Subject|5|||
161801673|NCT03661528|584316589|FG001|Overall Study|Withdrawal by Subject|3|||
161801674|NCT03661528|584316588|FG000|Overall Study|Disease Progression|8|||
161801675|NCT03661528|584316589|FG001|Overall Study|Disease Progression|13|||
161801676|NCT03661528|584316588|FG000|Overall Study|Adverse Event|61|||
161801677|NCT03661528|584316589|FG001|Overall Study|Adverse Event|55|||
161801678|NCT03130699|584316595|FG000|Overall Study|Lost to Follow-up|34|||
161801679|NCT03130699|584316596|FG001|Overall Study|Lost to Follow-up|37|||
161801680|NCT03130699|584316597|FG002|Overall Study|Lost to Follow-up|26|||
161801681|NCT03130699|584316595|FG000|Overall Study|Withdrawal by Subject|5|||
161801682|NCT03130699|584316596|FG001|Overall Study|Withdrawal by Subject|1|||
161451924|NCT00486811|583050704|FG002|Overall Study|Lost to Follow-up|4|||
161451925|NCT00486811|583050702|FG000|Overall Study|Withdrawal by Subject|33|||
161451926|NCT00486811|583050703|FG001|Overall Study|Withdrawal by Subject|44|||
161451927|NCT00486811|583050704|FG002|Overall Study|Withdrawal by Subject|58|||
161451928|NCT00486811|583050702|FG000|Overall Study|Study drug non-compliant|5|||
161451929|NCT00486811|583050703|FG001|Overall Study|Study drug non-compliant|6|||
161558675|NCT01477749|583435619|FG000|Overall Study|Physician Decision|4|||
161801683|NCT03130699|584316597|FG002|Overall Study|Withdrawal by Subject|0|||
161801684|NCT03130699|584316595|FG000|Overall Study|Withdrawal by PI|1|||
161801685|NCT03130699|584316596|FG001|Overall Study|Withdrawal by PI|2|||
161801686|NCT03130699|584316597|FG002|Overall Study|Withdrawal by PI|5|||
161801687|NCT03130699|584316595|FG000|Overall Study|Death|0|||
161558676|NCT01094743|583435626|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
161558677|NCT02851511|583435627|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
161558678|NCT02851511|583435628|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
161558679|NCT02851511|583435629|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
161558680|NCT02851511|583435630|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
161558681|NCT02851511|583435627|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
161558682|NCT02851511|583435628|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
161558683|NCT02851511|583435629|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
161558684|NCT02851511|583435630|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
161558685|NCT02851511|583435627|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
161558686|NCT02851511|583435628|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
161558687|NCT02851511|583435629|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
161558688|NCT02851511|583435630|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
161558689|NCT02851511|583435627|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
161558690|NCT02851511|583435628|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
161558691|NCT02851511|583435629|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
161558692|NCT02851511|583435630|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
161558693|NCT02851511|583435627|FG000|Phase I|Physician Decision|0|||
161558694|NCT02851511|583435628|FG001|Phase I|Physician Decision|0|||
161558695|NCT02851511|583435629|FG002|Phase I|Physician Decision|0|||
161558696|NCT02851511|583435630|FG003|Phase I|Physician Decision|1|||
161558697|NCT02851511|583435627|FG000|Phase I|Withdrawal by Subject|2|||
161558698|NCT02851511|583435628|FG001|Phase I|Withdrawal by Subject|1|||
161558699|NCT02851511|583435629|FG002|Phase I|Withdrawal by Subject|0|||
161558700|NCT02851511|583435630|FG003|Phase I|Withdrawal by Subject|3|||
161558701|NCT02851511|583435627|FG000|Phase II|Physician Decision|18|||
161558702|NCT02851511|583435628|FG001|Phase II|Physician Decision|16|||
161558703|NCT02851511|583435629|FG002|Phase II|Physician Decision|0|||
161558704|NCT02851511|583435630|FG003|Phase II|Physician Decision|0|||
161558705|NCT02851511|583435627|FG000|Phase II|Withdrawal by Subject|18|||
161558706|NCT02851511|583435628|FG001|Phase II|Withdrawal by Subject|16|||
161558707|NCT02851511|583435629|FG002|Phase II|Withdrawal by Subject|0|||
161558708|NCT02851511|583435630|FG003|Phase II|Withdrawal by Subject|0|||
161558709|NCT02851511|583435627|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
161558710|NCT02851511|583435628|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
161558711|NCT02851511|583435629|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
161558712|NCT02851511|583435630|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
161558713|NCT02851511|583435627|FG000|Phase II|Lost to Follow-up|0|||
161558714|NCT02851511|583435628|FG001|Phase II|Lost to Follow-up|1|||
161558715|NCT02851511|583435629|FG002|Phase II|Lost to Follow-up|0|||
161558716|NCT02851511|583435630|FG003|Phase II|Lost to Follow-up|0|||
161558717|NCT04990440|583435633|FG000|Overall Study|Sponsor's Decision|0|||
161558718|NCT04990440|583435634|FG001|Overall Study|Sponsor's Decision|0|||
161558719|NCT04990440|583435635|FG002|Overall Study|Sponsor's Decision|1|||
161558720|NCT03278028|583435646|FG000|Overall Study|Lost to Follow-up|1|||
161558721|NCT03278028|583435647|FG001|Overall Study|Lost to Follow-up|0|||
161558722|NCT03278028|583435646|FG000|Overall Study|Withdrawal by Subject|3|||
161558723|NCT03278028|583435647|FG001|Overall Study|Withdrawal by Subject|1|||
161558724|NCT03278028|583435646|FG000|Overall Study|Pregnancy|0|||
161558725|NCT03278028|583435647|FG001|Overall Study|Pregnancy|1|||
161558726|NCT02118714|583435651|FG000|Overall Study|Lost to Follow-up|2|||
161558727|NCT02118714|583435651|FG000|Overall Study|Protocol Violation|1|||
161558728|NCT03023332|583435656|FG000|Overall Study|Withdrawal by Subject|10|||
161558729|NCT03023332|583435657|FG001|Overall Study|Withdrawal by Subject|5|||
161558730|NCT03023332|583435658|FG002|Overall Study|Withdrawal by Subject|4|||
161558731|NCT03023332|583435659|FG003|Overall Study|Withdrawal by Subject|7|||
161558732|NCT03023332|583435656|FG000|Overall Study|Lost to Follow-up|13|||
161558733|NCT03023332|583435657|FG001|Overall Study|Lost to Follow-up|16|||
161558734|NCT03023332|583435658|FG002|Overall Study|Lost to Follow-up|8|||
161558735|NCT03023332|583435659|FG003|Overall Study|Lost to Follow-up|13|||
161558736|NCT03023332|583435656|FG000|Overall Study|Death|1|||
161558737|NCT03023332|583435657|FG001|Overall Study|Death|0|||
161558738|NCT03023332|583435658|FG002|Overall Study|Death|0|||
161558739|NCT03023332|583435659|FG003|Overall Study|Death|0|||
161558740|NCT02412761|583435660|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161558741|NCT02412761|583435661|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161558742|NCT02412761|583435662|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161558743|NCT02412761|583435663|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161558744|NCT02412761|583435664|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161558745|NCT02412761|583435665|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161905198|NCT02573259|584701226|FG000|Overall Study|Death|1|||
161558746|NCT02013687|583435666|FG000|Overall Study|Lost to Follow-up|0|||
161558747|NCT02013687|583435667|FG001|Overall Study|Lost to Follow-up|0|||
161558748|NCT02013687|583435668|FG002|Overall Study|Lost to Follow-up|1|||
161558749|NCT02013687|583435669|FG003|Overall Study|Lost to Follow-up|0|||
161558750|NCT02013687|583435666|FG000|Overall Study|Protocol Violation|0|||
161558751|NCT02013687|583435667|FG001|Overall Study|Protocol Violation|0|||
161558752|NCT02013687|583435668|FG002|Overall Study|Protocol Violation|0|||
161558753|NCT02013687|583435669|FG003|Overall Study|Protocol Violation|1|||
161558754|NCT02013687|583435666|FG000|Overall Study|Withdrawal by Subject|0|||
161558755|NCT02013687|583435667|FG001|Overall Study|Withdrawal by Subject|0|||
161558756|NCT02013687|583435668|FG002|Overall Study|Withdrawal by Subject|0|||
161558757|NCT02013687|583435669|FG003|Overall Study|Withdrawal by Subject|1|||
161558758|NCT02013687|583435666|FG000|Overall Study|Missed visits due to patient travel|0|||
161558759|NCT02013687|583435667|FG001|Overall Study|Missed visits due to patient travel|0|||
161558760|NCT02013687|583435668|FG002|Overall Study|Missed visits due to patient travel|1|||
161558761|NCT02013687|583435669|FG003|Overall Study|Missed visits due to patient travel|0|||
161558762|NCT01782326|583435670|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
161558763|NCT01782326|583435671|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
161558764|NCT01782326|583435670|FG000|Planned Treatment Epoch|Death|29|||
161558765|NCT01782326|583435671|FG001|Planned Treatment Epoch|Death|30|||
161558766|NCT01782326|583435670|FG000|Planned Treatment Epoch|Physician Decision|18|||
161558767|NCT01782326|583435671|FG001|Planned Treatment Epoch|Physician Decision|16|||
161558768|NCT01782326|583435670|FG000|Planned Treatment Epoch|Protocol deviation|2|||
161558769|NCT01782326|583435671|FG001|Planned Treatment Epoch|Protocol deviation|3|||
161558770|NCT01782326|583435670|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
161558771|NCT01782326|583435671|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
161558772|NCT01782326|583435670|FG000|Planned Treatment Epoch|Technical problems|0|||
161558773|NCT01782326|583435671|FG001|Planned Treatment Epoch|Technical problems|4|||
161558774|NCT01782326|583435670|FG000|Double-blind Treatment|Adverse Event|129|||
161558775|NCT01782326|583435671|FG001|Double-blind Treatment|Adverse Event|145|||
161558776|NCT01782326|583435670|FG000|Double-blind Treatment|Subject/guardian decision|111|||
161558777|NCT01782326|583435671|FG001|Double-blind Treatment|Subject/guardian decision|125|||
161558778|NCT01782326|583435670|FG000|Double-blind Treatment|Lack of Efficacy|17|||
161558779|NCT01782326|583435671|FG001|Double-blind Treatment|Lack of Efficacy|22|||
161558780|NCT01782326|583435670|FG000|Double-blind Treatment|Physician Decision|13|||
161558781|NCT01782326|583435671|FG001|Double-blind Treatment|Physician Decision|16|||
161558782|NCT01782326|583435670|FG000|Double-blind Treatment|Protocol deviation|8|||
161558783|NCT01782326|583435671|FG001|Double-blind Treatment|Protocol deviation|7|||
161558784|NCT01782326|583435670|FG000|Double-blind Treatment|Technical problems|0|||
161558785|NCT01782326|583435671|FG001|Double-blind Treatment|Technical problems|5|||
161558786|NCT05968482|583435672|FG000|First Crossover Period|Withdrawal by Subject|0|||
161558787|NCT05968482|583435673|FG001|First Crossover Period|Withdrawal by Subject|0|||
161558788|NCT05968482|583435674|FG002|First Crossover Period|Withdrawal by Subject|1|||
161558789|NCT05968482|583435675|FG003|First Crossover Period|Withdrawal by Subject|0|||
161558790|NCT05968482|583435676|FG004|First Crossover Period|Withdrawal by Subject|0|||
161558791|NCT05968482|583435677|FG005|First Crossover Period|Withdrawal by Subject|0|||
161558792|NCT05968482|583435672|FG000|First Crossover Period|Adverse Event|0|||
161558793|NCT05968482|583435673|FG001|First Crossover Period|Adverse Event|0|||
161558794|NCT05968482|583435674|FG002|First Crossover Period|Adverse Event|0|||
161558795|NCT05968482|583435675|FG003|First Crossover Period|Adverse Event|0|||
161558796|NCT05968482|583435676|FG004|First Crossover Period|Adverse Event|0|||
161558797|NCT05968482|583435677|FG005|First Crossover Period|Adverse Event|1|||
161558798|NCT05968482|583435672|FG000|Second Crossover Period|Withdrawal by Subject|0|||
161558799|NCT05968482|583435673|FG001|Second Crossover Period|Withdrawal by Subject|0|||
161558800|NCT05968482|583435674|FG002|Second Crossover Period|Withdrawal by Subject|0|||
161558801|NCT05968482|583435675|FG003|Second Crossover Period|Withdrawal by Subject|0|||
161558802|NCT05968482|583435676|FG004|Second Crossover Period|Withdrawal by Subject|1|||
161558803|NCT05968482|583435677|FG005|Second Crossover Period|Withdrawal by Subject|0|||
161558804|NCT05968482|583435672|FG000|Third Crossover Period|Adverse Event|0|||
161558805|NCT05968482|583435673|FG001|Third Crossover Period|Adverse Event|0|||
161558806|NCT05968482|583435674|FG002|Third Crossover Period|Adverse Event|0|||
161558807|NCT05968482|583435675|FG003|Third Crossover Period|Adverse Event|0|||
161558808|NCT05968482|583435676|FG004|Third Crossover Period|Adverse Event|1|||
161558809|NCT05968482|583435677|FG005|Third Crossover Period|Adverse Event|0|||
161558810|NCT05968482|583435672|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
161558811|NCT05968482|583435673|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
161558812|NCT05968482|583435674|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
161558813|NCT05968482|583435675|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
161558814|NCT05968482|583435676|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
161558815|NCT05968482|583435677|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
161558816|NCT02559817|583435678|FG000|Treatment Period|Adverse Event|1|||
161905199|NCT02573259|584701227|FG001|Overall Study|Death|6|||
161558817|NCT02559817|583435679|FG001|Treatment Period|Adverse Event|0|||
161558818|NCT02559817|583435680|FG002|Treatment Period|Adverse Event|1|||
161558819|NCT02559817|583435681|FG003|Treatment Period|Adverse Event|0|||
161558820|NCT02559817|583435682|FG004|Treatment Period|Adverse Event|0|||
161558821|NCT02559817|583435678|FG000|Treatment Period|Lack of Efficacy|0|||
161558822|NCT02559817|583435679|FG001|Treatment Period|Lack of Efficacy|1|||
161558823|NCT02559817|583435680|FG002|Treatment Period|Lack of Efficacy|0|||
161558824|NCT02559817|583435681|FG003|Treatment Period|Lack of Efficacy|0|||
161558825|NCT02559817|583435682|FG004|Treatment Period|Lack of Efficacy|0|||
161558826|NCT02559817|583435678|FG000|Treatment Period|Lost to Follow-up|0|||
161558827|NCT02559817|583435679|FG001|Treatment Period|Lost to Follow-up|1|||
161558828|NCT02559817|583435680|FG002|Treatment Period|Lost to Follow-up|0|||
161558829|NCT02559817|583435681|FG003|Treatment Period|Lost to Follow-up|1|||
161558830|NCT02559817|583435682|FG004|Treatment Period|Lost to Follow-up|0|||
161558831|NCT02559817|583435678|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
161558832|NCT02559817|583435679|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
161558833|NCT02559817|583435680|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
161558834|NCT02559817|583435681|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
161558835|NCT02559817|583435682|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
161558836|NCT02559817|583435678|FG000|Treatment Period|Protocol Violation|0|||
161558837|NCT02559817|583435679|FG001|Treatment Period|Protocol Violation|0|||
161558838|NCT02559817|583435680|FG002|Treatment Period|Protocol Violation|0|||
161558839|NCT02559817|583435681|FG003|Treatment Period|Protocol Violation|1|||
161558840|NCT02559817|583435682|FG004|Treatment Period|Protocol Violation|0|||
161558841|NCT02300311|583435686|FG000|Overall Study|Other than the reason specified|1|||
161558842|NCT02300311|583435687|FG001|Overall Study|Other than the reason specified|0|||
161558843|NCT02300311|583435686|FG000|Overall Study|Refused to continue taking medication|18|||
161558844|NCT02300311|583435687|FG001|Overall Study|Refused to continue taking medication|0|||
161558845|NCT00419003|583435688|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
161558846|NCT00419003|583435689|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
161558847|NCT00419003|583435688|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
161558848|NCT00419003|583435689|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
161558849|NCT02687919|583435690|FG000|Overall Study|Withdrawal by Subject|6|||
161558850|NCT02687919|583435691|FG001|Overall Study|Withdrawal by Subject|6|||
161558851|NCT02687919|583435690|FG000|Overall Study|Protocol Violation|2|||
161558852|NCT02687919|583435691|FG001|Overall Study|Protocol Violation|0|||
161558853|NCT01653847|583435692|FG000|Overall Study|Withdrawal by Subject|1|||
161558854|NCT01653847|583435693|FG001|Overall Study|Withdrawal by Subject|0|||
161558855|NCT02554513|583435695|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
161558856|NCT02554513|583435696|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
161558857|NCT02303574|583435697|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558858|NCT02303574|583435698|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558859|NCT02303574|583435699|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
161558860|NCT02303574|583435700|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558861|NCT02303574|583435701|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558862|NCT02303574|583435702|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558863|NCT02303574|583435703|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558864|NCT02303574|583435704|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558865|NCT02303574|583435705|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558866|NCT02303574|583435706|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161558867|NCT02303574|583435697|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558868|NCT02303574|583435698|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558869|NCT02303574|583435699|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558870|NCT02303574|583435700|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558871|NCT02303574|583435701|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558872|NCT02303574|583435702|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558873|NCT02303574|583435703|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161801688|NCT03130699|584316596|FG001|Overall Study|Death|0|||
161801689|NCT03130699|584316597|FG002|Overall Study|Death|1|||
161801690|NCT04534283|584316598|FG000|Overall Study|Physician Decision|2|||
161801691|NCT04534283|584316598|FG000|Overall Study|Withdrawal by Subject|1|||
161801692|NCT04534283|584316598|FG000|Overall Study|Disease Progression|12|||
161801693|NCT04534283|584316598|FG000|Overall Study|Adverse Event|1|||
161801694|NCT05049460|584316599|FG000|Overall Study|Withdrawal by Subject|2|||
161801695|NCT05049460|584316600|FG001|Overall Study|Withdrawal by Subject|2|||
161801696|NCT05049460|584316599|FG000|Overall Study|Lost to Follow-up|2|||
161801697|NCT05049460|584316600|FG001|Overall Study|Lost to Follow-up|2|||
161558874|NCT02303574|583435704|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
161558875|NCT02303574|583435705|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558876|NCT02303574|583435706|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161558877|NCT00994279|583435711|FG000|Overall Study|Withdrawal by Subject|2|||
161801698|NCT00977470|584316601|FG000|Overall Study|Lack of Efficacy|32|||
161558878|NCT00994279|583435712|FG001|Overall Study|Withdrawal by Subject|2|||
161558879|NCT00994279|583435711|FG000|Overall Study|Toxicity|1|||
161801699|NCT00977470|584316602|FG001|Overall Study|Lack of Efficacy|30|||
161801700|NCT00977470|584316601|FG000|Overall Study|Physician Decision|2|||
161558880|NCT00994279|583435712|FG001|Overall Study|Toxicity|0|||
161558881|NCT00994279|583435711|FG000|Overall Study|Multiple reasons|1|||
161558882|NCT00994279|583435712|FG001|Overall Study|Multiple reasons|3|||
161558883|NCT01606189|583435713|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
161558884|NCT01606189|583435714|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
161558885|NCT01606189|583435715|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
161558886|NCT01606189|583435716|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
161558887|NCT01606189|583435717|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
161558888|NCT01606189|583435718|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
161558889|NCT01606189|583435713|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
161558890|NCT01606189|583435714|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
161558891|NCT01606189|583435715|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
161558892|NCT01606189|583435716|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
161558893|NCT01606189|583435717|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
161558894|NCT01606189|583435718|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
161558895|NCT00859014|583435719|FG000|Overall Study|Death|4|||
161558896|NCT00859014|583435719|FG000|Overall Study|Lost to Follow-up|1|||
161558897|NCT04796935|583435720|FG000|Overall Study|Withdrawal by Subject|0|||
161558898|NCT04796935|583435721|FG001|Overall Study|Withdrawal by Subject|1|||
161558899|NCT04796935|583435720|FG000|Overall Study|Physician Decision|0|||
161558900|NCT04796935|583435721|FG001|Overall Study|Physician Decision|1|||
161558901|NCT04796935|583435720|FG000|Overall Study|Device not available|1|||
161558902|NCT04796935|583435721|FG001|Overall Study|Device not available|0|||
161558903|NCT04796935|583435720|FG000|Overall Study|Trained provider not available|1|||
161558904|NCT04796935|583435721|FG001|Overall Study|Trained provider not available|0|||
161558905|NCT04640571|583435722|FG000|Overall Study|Withdrawal by Subject|0|||
161558906|NCT04640571|583435723|FG001|Overall Study|Withdrawal by Subject|0|||
161558907|NCT04640571|583435724|FG002|Overall Study|Withdrawal by Subject|0|||
161558908|NCT04640571|583435725|FG003|Overall Study|Withdrawal by Subject|0|||
161558909|NCT04640571|583435726|FG004|Overall Study|Withdrawal by Subject|0|||
161558910|NCT04640571|583435727|FG005|Overall Study|Withdrawal by Subject|2|||
161558911|NCT03658811|583435730|FG000|Overall Study|Lost to Follow-up|3|||
161558912|NCT04060680|583435732|FG000|Overall Study|Unsuccessful implant|17|||
161558913|NCT04060680|583435733|FG001|Overall Study|Unsuccessful implant|2|||
161558914|NCT04060680|583435732|FG000|Overall Study|Adverse Event|3|||
161558915|NCT04060680|583435733|FG001|Overall Study|Adverse Event|0|||
161558916|NCT04060680|583435732|FG000|Overall Study|Death|2|||
161558917|NCT04060680|583435733|FG001|Overall Study|Death|0|||
161558918|NCT04060680|583435732|FG000|Overall Study|Study product no longer in use|1|||
161801701|NCT00977470|584316602|FG001|Overall Study|Physician Decision|0|||
161801702|NCT00977470|584316601|FG000|Overall Study|Adverse Event|1|||
161801703|NCT00977470|584316602|FG001|Overall Study|Adverse Event|2|||
161801704|NCT00977470|584316601|FG000|Overall Study|Protocol Violation|1|||
161801705|NCT00977470|584316602|FG001|Overall Study|Protocol Violation|0|||
161801706|NCT00977470|584316601|FG000|Overall Study|Withdrawal by Subject|0|||
161801707|NCT00977470|584316602|FG001|Overall Study|Withdrawal by Subject|2|||
161801708|NCT00977470|584316601|FG000|Overall Study|Death|0|||
161801709|NCT00977470|584316602|FG001|Overall Study|Death|2|||
161801710|NCT00977470|584316601|FG000|Overall Study|clinical decline|0|||
161801711|NCT00977470|584316602|FG001|Overall Study|clinical decline|1|||
161801712|NCT00977470|584316601|FG000|Overall Study|prolonged recovery post-surgery|0|||
161801713|NCT00977470|584316602|FG001|Overall Study|prolonged recovery post-surgery|1|||
161801714|NCT00977470|584316601|FG000|Overall Study|Still on-study|2|||
161801715|NCT00977470|584316602|FG001|Overall Study|Still on-study|0|||
161801716|NCT03257462|584316603|FG000|Cohort A|Lost to Follow-up|1|||
161801717|NCT03257462|584316604|FG001|Cohort A|Lost to Follow-up|0|||
161801718|NCT03257462|584316605|FG002|Cohort A|Lost to Follow-up|0|||
161801719|NCT03257462|584316606|FG003|Cohort A|Lost to Follow-up|0|||
161801720|NCT03257462|584316603|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
161801721|NCT03257462|584316604|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
161801722|NCT03257462|584316605|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
161801723|NCT03257462|584316606|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
161801724|NCT00796822|584316607|FG000|Overall Study|Lost to Follow-up|2|||
161801725|NCT00796822|584316608|FG001|Overall Study|Lost to Follow-up|0|||
161801726|NCT00796822|584316607|FG000|Overall Study|Adverse Event|1|||
161801727|NCT00796822|584316608|FG001|Overall Study|Adverse Event|0|||
161801728|NCT06354270|584316609|FG000|Overall Study|Withdrawal by Subject|1|||
161801729|NCT06354270|584316610|FG001|Overall Study|Withdrawal by Subject|0|||
161801730|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801731|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801732|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801733|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801734|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801735|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
161558919|NCT04060680|583435733|FG001|Overall Study|Study product no longer in use|0|||
161558920|NCT04060680|583435732|FG000|Overall Study|Withdrawal by Subject|1|||
161558921|NCT04060680|583435733|FG001|Overall Study|Withdrawal by Subject|0|||
161558922|NCT03803774|583435734|FG000|Dose Escalation|Withdrawal by Subject|0|||
161558923|NCT03803774|583435735|FG001|Dose Escalation|Withdrawal by Subject|0|||
161558924|NCT03803774|583435736|FG002|Dose Escalation|Withdrawal by Subject|0|||
161558925|NCT03803774|583435737|FG003|Dose Escalation|Withdrawal by Subject|1|||
161558926|NCT03803774|583435738|FG004|Dose Escalation|Withdrawal by Subject|0|||
161558927|NCT00495469|583437902|FG000|Overall Study|Adverse Event|0|||
161558928|NCT00495469|583437903|FG001|Overall Study|Adverse Event|1|||
161558929|NCT00495469|583437904|FG002|Overall Study|Adverse Event|3|||
161558930|NCT00495469|583437905|FG003|Overall Study|Adverse Event|0|||
161558931|NCT00495469|583437906|FG004|Overall Study|Adverse Event|1|||
161558932|NCT00495469|583437907|FG005|Overall Study|Adverse Event|1|||
161558933|NCT00495469|583437908|FG006|Overall Study|Adverse Event|1|||
161558934|NCT00495469|583437902|FG000|Overall Study|Lost to Follow-up|1|||
161558935|NCT00495469|583437903|FG001|Overall Study|Lost to Follow-up|1|||
161558936|NCT00495469|583437904|FG002|Overall Study|Lost to Follow-up|3|||
161558937|NCT00495469|583437905|FG003|Overall Study|Lost to Follow-up|1|||
161558938|NCT00495469|583437906|FG004|Overall Study|Lost to Follow-up|0|||
161558939|NCT00495469|583437907|FG005|Overall Study|Lost to Follow-up|0|||
161558940|NCT00495469|583437908|FG006|Overall Study|Lost to Follow-up|0|||
161558941|NCT00495469|583437902|FG000|Overall Study|Protocol Violation|0|||
161558942|NCT00495469|583437903|FG001|Overall Study|Protocol Violation|0|||
161558943|NCT00495469|583437904|FG002|Overall Study|Protocol Violation|0|||
161558944|NCT00495469|583437905|FG003|Overall Study|Protocol Violation|0|||
161558945|NCT00495469|583437906|FG004|Overall Study|Protocol Violation|1|||
161558946|NCT00495469|583437907|FG005|Overall Study|Protocol Violation|2|||
161801736|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801737|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801738|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801739|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
161801740|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
161801741|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
161801742|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
161801743|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
161801744|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
161801745|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
161801746|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
161801747|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
161801748|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801749|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801750|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801751|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801752|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801753|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
161801754|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
161801755|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
161801756|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801757|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801758|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801759|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
161801760|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801761|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161451930|NCT00486811|583050704|FG002|Overall Study|Study drug non-compliant|3|||
161451931|NCT00486811|583050702|FG000|Overall Study|All other|18|||
161451932|NCT00486811|583050703|FG001|Overall Study|All other|11|||
161451933|NCT00486811|583050704|FG002|Overall Study|All other|7|||
161451934|NCT00852371|583050708|FG000|Overall Study|Lost to Follow-up|2|||
161451935|NCT00852371|583050709|FG001|Overall Study|Lost to Follow-up|3|||
161451936|NCT00852371|583050710|FG002|Overall Study|Lost to Follow-up|4|||
161451937|NCT00852371|583050711|FG003|Overall Study|Lost to Follow-up|2|||
161451938|NCT04525885|583050712|FG000|Overall Study|Screen Failure|1|||
161451939|NCT04525885|583050713|FG001|Overall Study|Screen Failure|0|||
161451940|NCT04525885|583050714|FG002|Overall Study|Screen Failure|0|||
161451941|NCT04525885|583050712|FG000|Overall Study|Withdrawal by Subject|14|||
161451942|NCT04525885|583050713|FG001|Overall Study|Withdrawal by Subject|6|||
161451943|NCT04525885|583050714|FG002|Overall Study|Withdrawal by Subject|20|||
161451944|NCT04525885|583050712|FG000|Overall Study|Physician Decision|1|||
161451945|NCT04525885|583050713|FG001|Overall Study|Physician Decision|0|||
161451946|NCT04525885|583050714|FG002|Overall Study|Physician Decision|1|||
161558947|NCT00495469|583437908|FG006|Overall Study|Protocol Violation|0|||
161451947|NCT03158285|583050715|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
161801762|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
161801763|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801764|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
161801765|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801766|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801767|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801768|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
161801769|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801770|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801771|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801772|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801773|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801774|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801775|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801776|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
161801777|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801778|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801779|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801780|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801781|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801782|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801783|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801784|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801785|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801786|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801787|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801788|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161801789|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801790|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801791|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801792|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801793|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801794|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801795|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801796|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801797|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
161801798|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801799|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801800|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801801|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801802|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801803|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161801804|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801805|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161801806|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801807|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801808|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801809|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801810|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801811|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
161801812|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
161801813|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161801814|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
161801815|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
161801816|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161801817|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
161801818|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
161801819|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161801820|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
161801821|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
161801822|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
161801823|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
161905200|NCT02573259|584701228|FG002|Overall Study|Death|5|||
161558948|NCT00495469|583437902|FG000|Overall Study|Withdrawal by Subject|5|||
161558949|NCT00495469|583437903|FG001|Overall Study|Withdrawal by Subject|3|||
161558950|NCT00495469|583437904|FG002|Overall Study|Withdrawal by Subject|1|||
161558951|NCT00495469|583437905|FG003|Overall Study|Withdrawal by Subject|3|||
161558952|NCT00495469|583437906|FG004|Overall Study|Withdrawal by Subject|3|||
161558953|NCT00495469|583437907|FG005|Overall Study|Withdrawal by Subject|2|||
161558954|NCT00495469|583437908|FG006|Overall Study|Withdrawal by Subject|3|||
161558955|NCT00495469|583437902|FG000|Overall Study|Lack of Efficacy|0|||
161558956|NCT00495469|583437903|FG001|Overall Study|Lack of Efficacy|0|||
161558957|NCT00495469|583437904|FG002|Overall Study|Lack of Efficacy|0|||
161558958|NCT00495469|583437905|FG003|Overall Study|Lack of Efficacy|0|||
161558959|NCT00495469|583437906|FG004|Overall Study|Lack of Efficacy|0|||
161558960|NCT00495469|583437907|FG005|Overall Study|Lack of Efficacy|0|||
161558961|NCT00495469|583437908|FG006|Overall Study|Lack of Efficacy|1|||
161558962|NCT00495469|583437902|FG000|Overall Study|Liver function test abnormality|0|||
161558963|NCT00495469|583437903|FG001|Overall Study|Liver function test abnormality|1|||
161558964|NCT00495469|583437904|FG002|Overall Study|Liver function test abnormality|0|||
161558965|NCT00495469|583437905|FG003|Overall Study|Liver function test abnormality|0|||
161558966|NCT00495469|583437906|FG004|Overall Study|Liver function test abnormality|0|||
161558967|NCT00495469|583437907|FG005|Overall Study|Liver function test abnormality|0|||
161558968|NCT00495469|583437908|FG006|Overall Study|Liver function test abnormality|0|||
161558969|NCT00495469|583437902|FG000|Overall Study|ST depression at randomisation in ECG|0|||
161558970|NCT00495469|583437903|FG001|Overall Study|ST depression at randomisation in ECG|1|||
161558971|NCT00495469|583437904|FG002|Overall Study|ST depression at randomisation in ECG|0|||
161558972|NCT00495469|583437905|FG003|Overall Study|ST depression at randomisation in ECG|0|||
161558973|NCT00495469|583437906|FG004|Overall Study|ST depression at randomisation in ECG|0|||
161558974|NCT00495469|583437907|FG005|Overall Study|ST depression at randomisation in ECG|0|||
161558975|NCT00495469|583437908|FG006|Overall Study|ST depression at randomisation in ECG|0|||
161558976|NCT00051311|583437909|FG000|Overall Study|Starting new study|0|||
161558977|NCT00051311|583437910|FG001|Overall Study|Starting new study|1|||
161558978|NCT00051311|583437909|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
161558979|NCT00051311|583437910|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
161558980|NCT00051311|583437909|FG000|Overall Study|Death of recipient|8|||
161558981|NCT00051311|583437910|FG001|Overall Study|Death of recipient|8|||
161558982|NCT00051311|583437909|FG000|Overall Study|Recipient taken off study|4|||
161558983|NCT00051311|583437910|FG001|Overall Study|Recipient taken off study|4|||
161558984|NCT04170023|583437911|FG000|LTE Period|Withdrawal by Subject|1|||
161558985|NCT04170023|583437912|FG001|LTE Period|Withdrawal by Subject|0|||
161558986|NCT04170023|583437913|FG002|LTE Period|Withdrawal by Subject|0|||
161558987|NCT04170023|583437911|FG000|LTE Period|Study Termination|11|||
161558988|NCT04170023|583437912|FG001|LTE Period|Study Termination|11|||
161558989|NCT04170023|583437913|FG002|LTE Period|Study Termination|5|||
161558990|NCT03712098|583437914|FG000|Overall Study|Lost to Follow-up|3|||
161558991|NCT03712098|583437915|FG001|Overall Study|Lost to Follow-up|7|||
161558992|NCT03712098|583437914|FG000|Overall Study|Withdrawal by Subject|9|||
161558993|NCT03712098|583437915|FG001|Overall Study|Withdrawal by Subject|4|||
161558994|NCT03712098|583437914|FG000|Overall Study|Protocol Violation|2|||
161558995|NCT03712098|583437915|FG001|Overall Study|Protocol Violation|1|||
161558996|NCT02256969|583437916|FG000|Overall Study|Screenfailed or withdrew|2|||
161558997|NCT02256969|583437917|FG001|Overall Study|Screenfailed or withdrew|1|||
161558998|NCT02256969|583437918|FG002|Overall Study|Screenfailed or withdrew|1|||
161558999|NCT00372567|583437919|FG000|Phase 3 Study|Adverse Event|5|||
161559000|NCT00372567|583437920|FG001|Phase 3 Study|Adverse Event|1|||
161559001|NCT00372567|583437921|FG002|Phase 3 Study|Adverse Event|1|||
161559002|NCT00372567|583437919|FG000|Phase 3 Study|Death|1|||
161559003|NCT00372567|583437920|FG001|Phase 3 Study|Death|1|||
161559004|NCT00372567|583437921|FG002|Phase 3 Study|Death|0|||
161559005|NCT00372567|583437919|FG000|Phase 3 Study|Protocol Violation|0|||
161905201|NCT02573259|584701229|FG003|Overall Study|Death|6|||
161905202|NCT02573259|584701230|FG004|Overall Study|Death|9|||
161905203|NCT02573259|584701231|FG005|Overall Study|Death|32|||
161559006|NCT00372567|583437920|FG001|Phase 3 Study|Protocol Violation|0|||
161559007|NCT00372567|583437921|FG002|Phase 3 Study|Protocol Violation|1|||
161559008|NCT00372567|583437919|FG000|Phase 3 Study|Objective progression or relapse|10|||
161559009|NCT00372567|583437920|FG001|Phase 3 Study|Objective progression or relapse|13|||
161559010|NCT00372567|583437921|FG002|Phase 3 Study|Objective progression or relapse|4|||
161559011|NCT00372567|583437919|FG000|Phase 3 Study|Global deterioration of health status|0|||
161559012|NCT00372567|583437920|FG001|Phase 3 Study|Global deterioration of health status|1|||
161559013|NCT00372567|583437921|FG002|Phase 3 Study|Global deterioration of health status|0|||
161559014|NCT00372567|583437919|FG000|Phase 3 Study|Other|2|||
161905204|NCT02573259|584701232|FG006|Overall Study|Death|21|||
161559015|NCT00372567|583437920|FG001|Phase 3 Study|Other|2|||
161559016|NCT00372567|583437921|FG002|Phase 3 Study|Other|1|||
161559017|NCT00372567|583437919|FG000|Phase 3 Study|study terminated by sponsor|13|||
161559018|NCT00372567|583437920|FG001|Phase 3 Study|study terminated by sponsor|8|||
161559019|NCT00372567|583437921|FG002|Phase 3 Study|study terminated by sponsor|5|||
161905205|NCT02573259|584701226|FG000|Overall Study|Lost to Follow-up|0|||
161905206|NCT02573259|584701227|FG001|Overall Study|Lost to Follow-up|0|||
161559020|NCT00953160|583437924|FG000|Overall Study|Lost to Follow-up|23|||
161559021|NCT00953160|583437924|FG000|Overall Study|Withdrawal by Subject|4|||
161559022|NCT03836664|583437929|FG000|Overall Study|Didn't complete forms and lost drug|3|||
161559023|NCT03836664|583437930|FG001|Overall Study|Didn't complete forms and lost drug|3|||
161559024|NCT01427907|583437931|FG000|Overall Study|Withdrawal by Subject|3|||
161559025|NCT01427907|583437932|FG001|Overall Study|Withdrawal by Subject|4|||
161559026|NCT00425503|583437935|FG000|Overall Study|Adverse Event|2|||
161559027|NCT00425503|583437935|FG000|Overall Study|Protocol Violation|1|||
161559028|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
161559029|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
161559030|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
161559031|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
161559032|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
161559033|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
161559034|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
161559035|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
161559036|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
161559037|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
161559038|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
161559039|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
161559040|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
161559041|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
161559042|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
161559043|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
161559044|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
161559045|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
161559046|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
161559047|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
161559048|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
161559049|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
161559050|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
161559051|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
161559052|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
161559053|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
161559054|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
161559055|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
161559056|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
161559057|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
161559058|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
161559059|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
161559060|NCT03890120|583437937|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
161559061|NCT03890120|583437938|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
161559062|NCT03890120|583437939|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
161559063|NCT03890120|583437940|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
161559064|NCT03890120|583437937|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
161559065|NCT03890120|583437938|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
161559066|NCT03890120|583437939|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
161559067|NCT03890120|583437940|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
161559068|NCT03890120|583437937|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
161559069|NCT03890120|583437938|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
161559070|NCT03890120|583437939|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
161559071|NCT03890120|583437940|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
161559072|NCT03890120|583437937|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
161559073|NCT03890120|583437938|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
161559074|NCT03890120|583437939|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
161559075|NCT03890120|583437940|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
161559076|NCT03890120|583437937|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
161801824|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
161801825|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
161559077|NCT03890120|583437938|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
161559078|NCT03890120|583437939|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
161559079|NCT03890120|583437940|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
161559080|NCT01052662|583437941|FG000|Overall Study|Lost to Follow-up|15|||
161559081|NCT01052662|583437942|FG001|Overall Study|Lost to Follow-up|13|||
161559082|NCT01052662|583437943|FG002|Overall Study|Lost to Follow-up|18|||
161559083|NCT01052662|583437941|FG000|Overall Study|Withdrawal by Subject|3|||
161559084|NCT01052662|583437942|FG001|Overall Study|Withdrawal by Subject|2|||
161559085|NCT01052662|583437943|FG002|Overall Study|Withdrawal by Subject|1|||
161559086|NCT01052662|583437941|FG000|Overall Study|Pharmacy issue|1|||
161559087|NCT01052662|583437942|FG001|Overall Study|Pharmacy issue|3|||
161559088|NCT01052662|583437943|FG002|Overall Study|Pharmacy issue|3|||
161559089|NCT01052662|583437941|FG000|Overall Study|Adverse Event|1|||
161801826|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
161801827|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
161801828|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
161801829|NCT05097989|584316611|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801830|NCT05097989|584316612|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801831|NCT05097989|584316613|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801832|NCT05097989|584316614|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801833|NCT05097989|584316615|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
161801834|NCT05097989|584316616|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801835|NCT05097989|584316617|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801836|NCT05097989|584316618|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801837|NCT05097989|584316619|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801838|NCT05097989|584316611|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
161801839|NCT05097989|584316612|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
161801840|NCT05097989|584316613|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801841|NCT05097989|584316614|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801842|NCT05097989|584316615|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801843|NCT05097989|584316616|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801844|NCT05097989|584316617|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801845|NCT05097989|584316618|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801846|NCT05097989|584316619|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801847|NCT05097989|584316611|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
161801848|NCT05097989|584316612|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
161801849|NCT05097989|584316613|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161801850|NCT05097989|584316614|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
161801851|NCT05097989|584316615|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161801852|NCT05097989|584316616|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
161801853|NCT05097989|584316617|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161801854|NCT05097989|584316618|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161801855|NCT05097989|584316619|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
161801856|NCT00918567|584316628|FG000|Overall Study|Lack of Efficacy|3|||
161801857|NCT00918567|584316629|FG001|Overall Study|Lack of Efficacy|1|||
161801858|NCT00918567|584316628|FG000|Overall Study|Withdrawal by Subject|1|||
161801859|NCT00918567|584316629|FG001|Overall Study|Withdrawal by Subject|1|||
161801860|NCT00918567|584316628|FG000|Overall Study|Adverse Event|1|||
161801861|NCT00918567|584316629|FG001|Overall Study|Adverse Event|0|||
161801862|NCT02327130|584316635|FG000|Overall Study|Discharged in less than 5 days|5|||
161801863|NCT02327130|584316635|FG000|Overall Study|Physician Decision|2|||
161801864|NCT02327130|584316635|FG000|Overall Study|Unable to provide breath sample|1|||
161801865|NCT02327130|584316635|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
161801866|NCT02327130|584316635|FG000|Overall Study|Met exclusion criteria|3|||
161801867|NCT04028843|584316636|FG000|Overall Study|Lost to Follow-up|32|||
161801868|NCT04028843|584316637|FG001|Overall Study|Lost to Follow-up|39|||
161801869|NCT04028843|584316636|FG000|Overall Study|Adverse Event|1|||
161801870|NCT04028843|584316637|FG001|Overall Study|Adverse Event|0|||
161801871|NCT04028843|584316636|FG000|Overall Study|Non-viable Pregnancy|0|||
161801872|NCT04028843|584316637|FG001|Overall Study|Non-viable Pregnancy|1|||
161801873|NCT04028843|584316636|FG000|Overall Study|Withdrawal by Subject|4|||
161801874|NCT04028843|584316637|FG001|Overall Study|Withdrawal by Subject|2|||
161801875|NCT02684344|584318054|FG000|Overall Study|Withdrawal by Subject|0|||
161801876|NCT02684344|584318055|FG001|Overall Study|Withdrawal by Subject|1|||
161801877|NCT01451762|584318056|FG000|Overall Study|Lost to Follow-up|3|||
161801878|NCT01451762|584318057|FG001|Overall Study|Lost to Follow-up|6|||
161801879|NCT01451762|584318058|FG002|Overall Study|Lost to Follow-up|6|||
161801880|NCT00525590|584318082|FG000|Overall Study|Adverse Event|3|||
161801881|NCT00525590|584318082|FG000|Overall Study|Physician Decision|3|||
161801882|NCT00525590|584318082|FG000|Overall Study|Withdrawal by Subject|16|||
161559090|NCT01052662|583437942|FG001|Overall Study|Adverse Event|1|||
161559091|NCT01052662|583437943|FG002|Overall Study|Adverse Event|0|||
161559092|NCT01052662|583437941|FG000|Overall Study|Legal Problem|2|||
161559093|NCT01052662|583437942|FG001|Overall Study|Legal Problem|0|||
161559094|NCT01052662|583437943|FG002|Overall Study|Legal Problem|0|||
161559095|NCT01052662|583437941|FG000|Overall Study|Administrative|0|||
161559096|NCT01052662|583437942|FG001|Overall Study|Administrative|3|||
161801883|NCT00525590|584318082|FG000|Overall Study|Lost to Follow-up|1|||
161559097|NCT01052662|583437943|FG002|Overall Study|Administrative|0|||
161559098|NCT00479674|583437944|FG000|Overall Study|Adverse Event|18|||
161559099|NCT00479674|583437944|FG000|Overall Study|Withdrawal by Subject|6|||
161559100|NCT00479674|583437944|FG000|Overall Study|Physician Decision|14|||
161559101|NCT00479674|583437944|FG000|Overall Study|none provided|3|||
161559102|NCT02478359|583437946|FG000|Overall Study|Disenrolled from health plan|106|||
161559103|NCT02478359|583437947|FG001|Overall Study|Disenrolled from health plan|65|||
161559104|NCT03293485|583437949|FG000|Overall Study|Death|1|||
161559105|NCT03293485|583437949|FG000|Overall Study|Screen Failure|2|||
161559106|NCT03293485|583437949|FG000|Overall Study|Withdrawal by Subject|2|||
161559107|NCT01818700|583437950|FG000|Overall Study|Adverse Event|67|||
161559108|NCT01818700|583437950|FG000|Overall Study|Lack of Efficacy|2|||
161559109|NCT01818700|583437950|FG000|Overall Study|Lost to Follow-up|5|||
161559110|NCT01818700|583437950|FG000|Overall Study|Withdrawal by Subject|27|||
161559111|NCT01818700|583437950|FG000|Overall Study|Protocol Violation|2|||
161559112|NCT01818700|583437950|FG000|Overall Study|Other|1|||
161559113|NCT01627340|583437953|FG000|Overall Study|Adverse Event|1|||
161559114|NCT01627340|583437954|FG001|Overall Study|Adverse Event|0|||
161559115|NCT01627340|583437953|FG000|Overall Study|Lost to Follow-up|8|||
161559116|NCT01627340|583437954|FG001|Overall Study|Lost to Follow-up|4|||
161559117|NCT01627340|583437953|FG000|Overall Study|Pregnancy|1|||
161559118|NCT01627340|583437954|FG001|Overall Study|Pregnancy|0|||
161559119|NCT01627340|583437953|FG000|Overall Study|Withdrawal by Subject|2|||
161559120|NCT01627340|583437954|FG001|Overall Study|Withdrawal by Subject|0|||
161559121|NCT01272011|583437955|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
161559122|NCT01272011|583437956|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
161559123|NCT01272011|583437957|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
161559124|NCT02240680|583437960|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
161559125|NCT02240680|583437961|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
161559126|NCT02240680|583437962|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
161559127|NCT02240680|583437963|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
161559128|NCT02240680|583437960|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
161559129|NCT02240680|583437961|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
161559130|NCT02240680|583437962|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
161559131|NCT02240680|583437963|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
161559132|NCT02240680|583437960|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
161559133|NCT02240680|583437961|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
161559134|NCT02240680|583437962|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
161559135|NCT02240680|583437963|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
161559136|NCT02240680|583437960|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
161559137|NCT02240680|583437961|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
161559138|NCT02240680|583437962|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
161559139|NCT02240680|583437963|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
161559140|NCT02240680|583437960|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
161559141|NCT02240680|583437961|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
161559142|NCT02240680|583437962|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
161559143|NCT02240680|583437963|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
161559144|NCT02240680|583437960|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
161559145|NCT02240680|583437961|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
161559146|NCT02240680|583437962|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
161559147|NCT02240680|583437963|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
161559148|NCT02240680|583437960|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
161559149|NCT02240680|583437961|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
161559150|NCT02240680|583437962|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
161559151|NCT02240680|583437963|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
161559152|NCT02240680|583437960|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
161559153|NCT02240680|583437961|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
161559154|NCT02240680|583437962|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
161559155|NCT02240680|583437963|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
161559156|NCT01657032|583437964|FG000|Overall Study|Lost to Follow-up|0|||
161905207|NCT02573259|584701228|FG002|Overall Study|Lost to Follow-up|0|||
161559157|NCT01657032|583437965|FG001|Overall Study|Lost to Follow-up|7|||
161559158|NCT03633903|583437966|FG000|Overall Study|Withdrawal by Subject|1|||
161559159|NCT03633903|583437967|FG001|Overall Study|Withdrawal by Subject|2|||
161559160|NCT03633903|583437966|FG000|Overall Study|Lost to Follow-up|5|||
161559161|NCT03633903|583437967|FG001|Overall Study|Lost to Follow-up|5|||
161559162|NCT01653743|583437974|FG000|Overall Study|Withdrawal by Subject|1|||
161559163|NCT01653743|583437975|FG001|Overall Study|Withdrawal by Subject|0|||
161559164|NCT01653743|583437974|FG000|Overall Study|Investigator discretion|3|||
161559165|NCT01653743|583437975|FG001|Overall Study|Investigator discretion|0|||
161559166|NCT00783718|583437984|FG000|Induction Phase|Adverse Event|4|||
161559167|NCT00783718|583437985|FG001|Induction Phase|Adverse Event|0|||
161559168|NCT00783718|583437986|FG002|Induction Phase|Adverse Event|7|||
161559169|NCT00783718|583437987|FG003|Induction Phase|Adverse Event|0|||
161559170|NCT00783718|583437988|FG004|Induction Phase|Adverse Event|0|||
161559171|NCT00783718|583437989|FG005|Induction Phase|Adverse Event|0|||
161559172|NCT00783718|583437990|FG006|Induction Phase|Adverse Event|0|||
161559173|NCT00783718|583437984|FG000|Induction Phase|Protocol Violation|1|||
161559174|NCT00783718|583437985|FG001|Induction Phase|Protocol Violation|1|||
161905208|NCT02573259|584701229|FG003|Overall Study|Lost to Follow-up|0|||
161905209|NCT02573259|584701230|FG004|Overall Study|Lost to Follow-up|0|||
161905210|NCT02573259|584701231|FG005|Overall Study|Lost to Follow-up|2|||
161905211|NCT02573259|584701232|FG006|Overall Study|Lost to Follow-up|1|||
161905212|NCT02573259|584701226|FG000|Overall Study|Participant refused further follow-up|0|||
161905213|NCT02573259|584701227|FG001|Overall Study|Participant refused further follow-up|2|||
161905214|NCT02573259|584701228|FG002|Overall Study|Participant refused further follow-up|1|||
161905215|NCT02573259|584701229|FG003|Overall Study|Participant refused further follow-up|0|||
161905216|NCT02573259|584701230|FG004|Overall Study|Participant refused further follow-up|3|||
161905217|NCT02573259|584701231|FG005|Overall Study|Participant refused further follow-up|20|||
161905218|NCT02573259|584701232|FG006|Overall Study|Participant refused further follow-up|7|||
161905219|NCT02573259|584701226|FG000|Overall Study|Other|0|||
161905220|NCT02573259|584701227|FG001|Overall Study|Other|0|||
161905221|NCT02573259|584701228|FG002|Overall Study|Other|0|||
161905222|NCT02573259|584701229|FG003|Overall Study|Other|0|||
161905223|NCT02573259|584701230|FG004|Overall Study|Other|1|||
161905224|NCT02573259|584701231|FG005|Overall Study|Other|4|||
161905225|NCT02573259|584701232|FG006|Overall Study|Other|5|||
161905226|NCT00751140|584701236|FG000|Overall Study|benign angioma excluded from analysis|1|||
161905227|NCT00808067|584701237|FG000|Overall Study|Major/minor bleed|30|||
161905228|NCT00808067|584701238|FG001|Overall Study|Major/minor bleed|44|||
161905229|NCT00808067|584701237|FG000|Overall Study|Outcome event - other|33|||
161905230|NCT00808067|584701238|FG001|Overall Study|Outcome event - other|25|||
161905231|NCT00808067|584701237|FG000|Overall Study|Adverse Event|111|||
161905232|NCT00808067|584701238|FG001|Overall Study|Adverse Event|121|||
161905233|NCT00808067|584701237|FG000|Overall Study|Hospitalization (not including surgery)|18|||
161905234|NCT00808067|584701238|FG001|Overall Study|Hospitalization (not including surgery)|17|||
161905235|NCT00808067|584701237|FG000|Overall Study|Hospitalization due to surgery|37|||
161905236|NCT00808067|584701238|FG001|Overall Study|Hospitalization due to surgery|40|||
161905237|NCT00808067|584701237|FG000|Overall Study|Reduced creatinine clearance|53|||
161905238|NCT00808067|584701238|FG001|Overall Study|Reduced creatinine clearance|55|||
161905239|NCT00808067|584701237|FG000|Overall Study|Elevated LFT results|7|||
161905240|NCT00808067|584701238|FG001|Overall Study|Elevated LFT results|3|||
161905241|NCT00808067|584701237|FG000|Overall Study|Patient refused to take study medication|65|||
161905242|NCT00808067|584701238|FG001|Overall Study|Patient refused to take study medication|76|||
161905243|NCT00808067|584701237|FG000|Overall Study|Missing|1|||
161559175|NCT00783718|583437986|FG002|Induction Phase|Protocol Violation|6|||
161905244|NCT00808067|584701238|FG001|Overall Study|Missing|0|||
161905245|NCT00808067|584701237|FG000|Overall Study|Death|1|||
161905246|NCT00808067|584701238|FG001|Overall Study|Death|1|||
161905247|NCT00808067|584701237|FG000|Overall Study|Procedure|6|||
161905248|NCT00808067|584701238|FG001|Overall Study|Procedure|7|||
161905249|NCT00808067|584701237|FG000|Overall Study|Withdrawal by Subject|21|||
161905250|NCT00808067|584701238|FG001|Overall Study|Withdrawal by Subject|25|||
161905251|NCT00808067|584701237|FG000|Overall Study|Site closed|4|||
161905252|NCT00808067|584701238|FG001|Overall Study|Site closed|3|||
161905253|NCT00808067|584701237|FG000|Overall Study|Physician Decision|47|||
161905254|NCT00808067|584701238|FG001|Overall Study|Physician Decision|38|||
161905255|NCT00808067|584701237|FG000|Overall Study|Protocol Violation|3|||
161905256|NCT00808067|584701238|FG001|Overall Study|Protocol Violation|11|||
161905257|NCT00808067|584701237|FG000|Overall Study|Patient elected|7|||
161905258|NCT00808067|584701238|FG001|Overall Study|Patient elected|9|||
161905259|NCT00808067|584701237|FG000|Overall Study|Site closed for cause|19|||
161559176|NCT00783718|583437987|FG003|Induction Phase|Protocol Violation|0|||
161559177|NCT00783718|583437988|FG004|Induction Phase|Protocol Violation|0|||
161559178|NCT00783718|583437989|FG005|Induction Phase|Protocol Violation|0|||
161559179|NCT00783718|583437990|FG006|Induction Phase|Protocol Violation|0|||
161905260|NCT00808067|584701238|FG001|Overall Study|Site closed for cause|19|||
161905261|NCT00808067|584701237|FG000|Overall Study|Other reason not defined above|5|||
161905262|NCT00808067|584701238|FG001|Overall Study|Other reason not defined above|5|||
161905263|NCT00808067|584701237|FG000|Overall Study|Excluded from analysis|13|||
161905264|NCT00808067|584701238|FG001|Overall Study|Excluded from analysis|19|||
161905265|NCT01939314|584701239|FG000|Overall Study|Withdrawal by Subject|3|||
161905266|NCT01939314|584701240|FG001|Overall Study|Withdrawal by Subject|1|||
161559180|NCT00783718|583437984|FG000|Induction Phase|Lack of Efficacy|5|||
161559181|NCT00783718|583437985|FG001|Induction Phase|Lack of Efficacy|2|||
161559182|NCT00783718|583437986|FG002|Induction Phase|Lack of Efficacy|14|||
161905267|NCT01939314|584701239|FG000|Overall Study|Protocol Violation|1|||
161905268|NCT01939314|584701240|FG001|Overall Study|Protocol Violation|0|||
161905269|NCT01939314|584701239|FG000|Overall Study|Pregnancy|0|||
161905270|NCT01939314|584701240|FG001|Overall Study|Pregnancy|1|||
161905271|NCT01939314|584701239|FG000|Overall Study|Lost to Follow-up|5|||
161559183|NCT00783718|583437987|FG003|Induction Phase|Lack of Efficacy|0|||
161559184|NCT00783718|583437988|FG004|Induction Phase|Lack of Efficacy|0|||
161559185|NCT00783718|583437989|FG005|Induction Phase|Lack of Efficacy|0|||
161559186|NCT00783718|583437990|FG006|Induction Phase|Lack of Efficacy|0|||
161559187|NCT00783718|583437984|FG000|Induction Phase|Withdrawal by Subject|3|||
161559188|NCT00783718|583437985|FG001|Induction Phase|Withdrawal by Subject|4|||
161559189|NCT00783718|583437986|FG002|Induction Phase|Withdrawal by Subject|8|||
161559190|NCT00783718|583437987|FG003|Induction Phase|Withdrawal by Subject|0|||
161559191|NCT00783718|583437988|FG004|Induction Phase|Withdrawal by Subject|0|||
161559192|NCT00783718|583437989|FG005|Induction Phase|Withdrawal by Subject|0|||
161559193|NCT00783718|583437990|FG006|Induction Phase|Withdrawal by Subject|0|||
161559194|NCT00783718|583437984|FG000|Induction Phase|Lost to Follow-up|1|||
161559195|NCT00783718|583437985|FG001|Induction Phase|Lost to Follow-up|0|||
161559196|NCT00783718|583437986|FG002|Induction Phase|Lost to Follow-up|1|||
161559197|NCT00783718|583437987|FG003|Induction Phase|Lost to Follow-up|0|||
161559198|NCT00783718|583437988|FG004|Induction Phase|Lost to Follow-up|0|||
161559199|NCT00783718|583437989|FG005|Induction Phase|Lost to Follow-up|0|||
161559200|NCT00783718|583437990|FG006|Induction Phase|Lost to Follow-up|0|||
161559201|NCT00783718|583437984|FG000|Maintenance Phase|Adverse Event|12|||
161559202|NCT00783718|583437985|FG001|Maintenance Phase|Adverse Event|0|||
161559203|NCT00783718|583437986|FG002|Maintenance Phase|Adverse Event|0|||
161559204|NCT00783718|583437987|FG003|Maintenance Phase|Adverse Event|15|||
161559205|NCT00783718|583437988|FG004|Maintenance Phase|Adverse Event|7|||
161559206|NCT00783718|583437989|FG005|Maintenance Phase|Adverse Event|6|||
161559207|NCT00783718|583437990|FG006|Maintenance Phase|Adverse Event|16|||
161559208|NCT00783718|583437984|FG000|Maintenance Phase|Protocol Violation|1|||
161559209|NCT00783718|583437985|FG001|Maintenance Phase|Protocol Violation|0|||
161559210|NCT00783718|583437986|FG002|Maintenance Phase|Protocol Violation|0|||
161559211|NCT00783718|583437987|FG003|Maintenance Phase|Protocol Violation|0|||
161559212|NCT00783718|583437988|FG004|Maintenance Phase|Protocol Violation|0|||
161559213|NCT00783718|583437989|FG005|Maintenance Phase|Protocol Violation|0|||
161559214|NCT00783718|583437990|FG006|Maintenance Phase|Protocol Violation|2|||
161559215|NCT00783718|583437984|FG000|Maintenance Phase|Lack of Efficacy|83|||
161559216|NCT00783718|583437985|FG001|Maintenance Phase|Lack of Efficacy|0|||
161559217|NCT00783718|583437986|FG002|Maintenance Phase|Lack of Efficacy|0|||
161559218|NCT00783718|583437987|FG003|Maintenance Phase|Lack of Efficacy|61|||
161559219|NCT00783718|583437988|FG004|Maintenance Phase|Lack of Efficacy|31|||
161559220|NCT00783718|583437989|FG005|Maintenance Phase|Lack of Efficacy|33|||
161559221|NCT00783718|583437990|FG006|Maintenance Phase|Lack of Efficacy|155|||
161559222|NCT00783718|583437984|FG000|Maintenance Phase|Withdrawal by Subject|6|||
161559223|NCT00783718|583437985|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161559224|NCT00783718|583437986|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161559225|NCT00783718|583437987|FG003|Maintenance Phase|Withdrawal by Subject|2|||
161559226|NCT00783718|583437988|FG004|Maintenance Phase|Withdrawal by Subject|5|||
161559227|NCT00783718|583437989|FG005|Maintenance Phase|Withdrawal by Subject|2|||
161559228|NCT00783718|583437990|FG006|Maintenance Phase|Withdrawal by Subject|20|||
161559229|NCT00783718|583437984|FG000|Maintenance Phase|Lost to Follow-up|3|||
161559230|NCT00783718|583437985|FG001|Maintenance Phase|Lost to Follow-up|0|||
161559231|NCT00783718|583437986|FG002|Maintenance Phase|Lost to Follow-up|0|||
161559232|NCT00783718|583437987|FG003|Maintenance Phase|Lost to Follow-up|0|||
161559233|NCT00783718|583437988|FG004|Maintenance Phase|Lost to Follow-up|2|||
161559234|NCT00783718|583437989|FG005|Maintenance Phase|Lost to Follow-up|0|||
161801884|NCT00525590|584318082|FG000|Overall Study|Death|9|||
161801885|NCT00525590|584318082|FG000|Overall Study|Other|13|||
161801886|NCT01345019|584318083|FG000|Blinded Treatment Phase|Death|147|||
161801887|NCT01345019|584318084|FG001|Blinded Treatment Phase|Death|137|||
161801888|NCT01345019|584318083|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
161801889|NCT01345019|584318084|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
161905272|NCT01939314|584701240|FG001|Overall Study|Lost to Follow-up|6|||
161905273|NCT00735007|584701241|FG000|Overall Study|Adverse Event|4|||
161905274|NCT00735007|584701241|FG000|Overall Study|Protocol Violation|1|||
161905275|NCT03311945|584701242|FG000|Overall Study|Adverse Event|2|||
161559235|NCT00783718|583437990|FG006|Maintenance Phase|Lost to Follow-up|2|||
161559236|NCT00577629|583437991|FG000|Treatment Period|Death|1|||
161559237|NCT00577629|583437991|FG000|Long Term Follow-Up|Death|15|||
161559238|NCT00577629|583437991|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
161559239|NCT00577629|583437991|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
161559240|NCT00577629|583437991|FG000|Long Term Follow-Up|Physician Decision|1|||
161559241|NCT02929108|583437994|FG000|Overall Study|Hospice patient death|100|||
161559242|NCT02929108|583437995|FG001|Overall Study|Hospice patient death|64|||
161905276|NCT03311945|584701242|FG000|Overall Study|Lack of Efficacy|1|||
161559243|NCT02929108|583437996|FG002|Overall Study|Hospice patient death|28|||
161559244|NCT02929108|583437997|FG003|Overall Study|Hospice patient death|46|||
161559245|NCT02929108|583437998|FG004|Overall Study|Hospice patient death|55|||
161801890|NCT01345019|584318083|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
161801891|NCT01345019|584318084|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
161559246|NCT02929108|583437999|FG005|Overall Study|Hospice patient death|28|||
161559247|NCT02929108|583438000|FG006|Overall Study|Hospice patient death|78|||
161559248|NCT01027871|583438001|FG000|Overall Study|Physician Decision|1|||
161559249|NCT01027871|583438002|FG001|Overall Study|Physician Decision|5|||
161559250|NCT01027871|583438003|FG002|Overall Study|Physician Decision|0|||
161559251|NCT01027871|583438001|FG000|Overall Study|Protocol Violation|0|||
161559252|NCT01027871|583438002|FG001|Overall Study|Protocol Violation|2|||
161559253|NCT01027871|583438003|FG002|Overall Study|Protocol Violation|2|||
161559254|NCT01027871|583438001|FG000|Overall Study|Withdrawal by Subject|1|||
161559255|NCT01027871|583438002|FG001|Overall Study|Withdrawal by Subject|2|||
161559256|NCT01027871|583438003|FG002|Overall Study|Withdrawal by Subject|2|||
161559257|NCT01027871|583438001|FG000|Overall Study|Adverse Event|0|||
161559258|NCT01027871|583438002|FG001|Overall Study|Adverse Event|2|||
161559259|NCT01027871|583438003|FG002|Overall Study|Adverse Event|2|||
161559260|NCT01027871|583438001|FG000|Overall Study|Sponsor Decision|0|||
161559261|NCT01027871|583438002|FG001|Overall Study|Sponsor Decision|2|||
161559262|NCT01027871|583438003|FG002|Overall Study|Sponsor Decision|0|||
161559263|NCT01027871|583438001|FG000|Overall Study|Discontinued Prior to Treatment|0|||
161559264|NCT01027871|583438002|FG001|Overall Study|Discontinued Prior to Treatment|0|||
161559265|NCT01027871|583438003|FG002|Overall Study|Discontinued Prior to Treatment|1|||
161559266|NCT00052962|583438004|FG000|Overall Study|Not evaluable|0|||
161559267|NCT00052962|583438005|FG001|Overall Study|Not evaluable|2|||
161559268|NCT00052962|583438004|FG000|Overall Study|Not randomized/not evaluable|1|||
161559269|NCT00052962|583438005|FG001|Overall Study|Not randomized/not evaluable|0|||
161559270|NCT01414166|583438006|FG000|Overall Study|Adverse Event|10|||
161559271|NCT01414166|583438007|FG001|Overall Study|Adverse Event|2|||
161559272|NCT01414166|583438006|FG000|Overall Study|Lost to Follow-up|4|||
161559273|NCT01414166|583438007|FG001|Overall Study|Lost to Follow-up|1|||
161559274|NCT01414166|583438006|FG000|Overall Study|Non-compliance with study drug|2|||
161559275|NCT01414166|583438007|FG001|Overall Study|Non-compliance with study drug|0|||
161559276|NCT01414166|583438006|FG000|Overall Study|Physician Decision|2|||
161559277|NCT01414166|583438007|FG001|Overall Study|Physician Decision|0|||
161559278|NCT01414166|583438006|FG000|Overall Study|Protocol Violation|2|||
161559279|NCT01414166|583438007|FG001|Overall Study|Protocol Violation|0|||
161559280|NCT01414166|583438006|FG000|Overall Study|Study terminated by Sponsor|68|||
161559281|NCT01414166|583438007|FG001|Overall Study|Study terminated by Sponsor|75|||
161559282|NCT01414166|583438006|FG000|Overall Study|Withdrawal by Subject|3|||
161559283|NCT01414166|583438007|FG001|Overall Study|Withdrawal by Subject|5|||
161559284|NCT03782727|583438008|FG000|Overall Study|Lost to Follow-up|32|||
161559285|NCT05489224|583438011|FG000|Treatment Period I|Withdrawal by Subject|6|||
161559286|NCT05489224|583438012|FG001|Treatment Period I|Withdrawal by Subject|5|||
161559287|NCT05489224|583438013|FG002|Treatment Period I|Withdrawal by Subject|0|||
161559288|NCT05489224|583438011|FG000|Treatment Period I|Adverse Event|3|||
161559289|NCT05489224|583438012|FG001|Treatment Period I|Adverse Event|11|||
161559290|NCT05489224|583438013|FG002|Treatment Period I|Adverse Event|0|||
161559291|NCT05489224|583438011|FG000|Treatment Period I|Lost to Follow-up|0|||
161559292|NCT05489224|583438012|FG001|Treatment Period I|Lost to Follow-up|1|||
161559293|NCT05489224|583438013|FG002|Treatment Period I|Lost to Follow-up|0|||
161559294|NCT05489224|583438011|FG000|Treatment Period I|Physician Decision|0|||
161559295|NCT05489224|583438012|FG001|Treatment Period I|Physician Decision|1|||
161559296|NCT05489224|583438013|FG002|Treatment Period I|Physician Decision|0|||
161559297|NCT05489224|583438011|FG000|Treatment Period II up to Week 32|Ongoing|222|||
161559298|NCT05489224|583438012|FG001|Treatment Period II up to Week 32|Ongoing|107|||
161559299|NCT05489224|583438013|FG002|Treatment Period II up to Week 32|Ongoing|107|||
161559300|NCT05489224|583438011|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
161559301|NCT05489224|583438012|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
161559302|NCT05489224|583438013|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
161559303|NCT05489224|583438011|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
161559304|NCT05489224|583438012|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
161559305|NCT05489224|583438013|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
161559306|NCT04887285|583438015|FG000|Overall Study|Lost to Follow-up|0|||
161559307|NCT04887285|583438016|FG001|Overall Study|Lost to Follow-up|2|||
161559308|NCT04887285|583438017|FG002|Overall Study|Lost to Follow-up|3|||
161559309|NCT02820051|583438021|FG000|Overall Study|Lost to Follow-up|7|||
161905277|NCT03839394|584701243|FG000|Overall Study|Lost to Follow-up|6|||
161559310|NCT02820051|583438022|FG001|Overall Study|Lost to Follow-up|4|||
161559311|NCT00832780|583438026|FG000|Overall Study|Death|16|||
161559312|NCT00832780|583438026|FG000|Overall Study|Lost to Follow-up|4|||
161559313|NCT00832780|583438026|FG000|Overall Study|no reason given|2|||
161559314|NCT00832780|583438026|FG000|Overall Study|other complicating condition|2|||
161559315|NCT00832780|583438026|FG000|Overall Study|Physician Decision|1|||
161559316|NCT05705167|583438027|FG000|Overall Study|Randomised but not Treated|0|||
161559317|NCT05705167|583438028|FG001|Overall Study|Randomised but not Treated|2|||
161559318|NCT05705167|583438029|FG002|Overall Study|Randomised but not Treated|0|||
161559319|NCT05705167|583438030|FG003|Overall Study|Randomised but not Treated|7|||
161559320|NCT05705167|583438031|FG004|Overall Study|Randomised but not Treated|0|||
161559321|NCT05705167|583438032|FG005|Overall Study|Randomised but not Treated|0|||
161801892|NCT01345019|584318083|FG000|Blinded Treatment Phase|Disease Progression|12|||
161801893|NCT01345019|584318084|FG001|Blinded Treatment Phase|Disease Progression|10|||
161801894|NCT01345019|584318083|FG000|Blinded Treatment Phase|Adverse Event|6|||
161801895|NCT01345019|584318084|FG001|Blinded Treatment Phase|Adverse Event|13|||
161801896|NCT01345019|584318083|FG000|Blinded Treatment Phase|Administrative Decision|10|||
161801897|NCT01345019|584318084|FG001|Blinded Treatment Phase|Administrative Decision|8|||
161801898|NCT01345019|584318083|FG000|Blinded Treatment Phase|Noncompliance|5|||
161801899|NCT01345019|584318084|FG001|Blinded Treatment Phase|Noncompliance|3|||
161801900|NCT01345019|584318083|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
161801901|NCT01345019|584318084|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
161801902|NCT01345019|584318083|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
161801903|NCT01345019|584318084|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
161801904|NCT01345019|584318083|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
161801905|NCT01345019|584318084|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
161801906|NCT01345019|584318083|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
161801907|NCT01345019|584318084|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
161801908|NCT01345019|584318083|FG000|Open Label Treatment Phase|Death|49|||
161801909|NCT01345019|584318084|FG001|Open Label Treatment Phase|Death|48|||
161801910|NCT01345019|584318083|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
161801911|NCT01345019|584318084|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
161801912|NCT01345019|584318083|FG000|Open Label Treatment Phase|Adverse Event|30|||
161801913|NCT01345019|584318084|FG001|Open Label Treatment Phase|Adverse Event|51|||
161801914|NCT01345019|584318083|FG000|Open Label Treatment Phase|Administrative Decision|30|||
161801915|NCT01345019|584318084|FG001|Open Label Treatment Phase|Administrative Decision|15|||
161801916|NCT01345019|584318083|FG000|Open Label Treatment Phase|Disease Progression|17|||
161801917|NCT01345019|584318084|FG001|Open Label Treatment Phase|Disease Progression|18|||
161801918|NCT01345019|584318083|FG000|Open Label Treatment Phase|Noncompliance|5|||
161801919|NCT01345019|584318084|FG001|Open Label Treatment Phase|Noncompliance|4|||
161801920|NCT01345019|584318083|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
161801921|NCT01345019|584318084|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
161801922|NCT01345019|584318083|FG000|Open Label Treatment Phase|Pregnancy|1|||
161801923|NCT01345019|584318084|FG001|Open Label Treatment Phase|Pregnancy|0|||
161801924|NCT01345019|584318083|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
161801925|NCT01345019|584318084|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
161801926|NCT01345019|584318083|FG000|Open Label Treatment Phase|Protocol Violation|0|||
161801927|NCT01345019|584318084|FG001|Open Label Treatment Phase|Protocol Violation|1|||
161801928|NCT02636907|584318085|FG000|Autoinjector Assessment Period|Adverse Event|2|||
161801929|NCT02636907|584318085|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
161801930|NCT02636907|584318085|FG000|Extension Phase|Adverse Event|2|||
161801931|NCT02636907|584318085|FG000|Extension Phase|Withdrawal by Subject|4|||
161801932|NCT02636907|584318085|FG000|Extension Phase|Physician Decision|1|||
161801933|NCT02636907|584318085|FG000|Extension Phase|Lost to Follow-up|2|||
161801934|NCT02636907|584318085|FG000|Extension Phase|Lack of Efficacy|1|||
161801935|NCT03830164|584318090|FG000|Overall Study|Adverse Event|0|||
161801936|NCT03830164|584318091|FG001|Overall Study|Adverse Event|2|||
161801937|NCT03830164|584318092|FG002|Overall Study|Adverse Event|0|||
161801938|NCT03830164|584318090|FG000|Overall Study|Lack of Efficacy|1|||
161801939|NCT03830164|584318091|FG001|Overall Study|Lack of Efficacy|5|||
161801940|NCT03830164|584318092|FG002|Overall Study|Lack of Efficacy|0|||
161801941|NCT03830164|584318090|FG000|Overall Study|Lost to Follow-up|0|||
161801942|NCT03830164|584318091|FG001|Overall Study|Lost to Follow-up|1|||
161801943|NCT03830164|584318092|FG002|Overall Study|Lost to Follow-up|0|||
161801944|NCT03830164|584318090|FG000|Overall Study|Withdrawal by Subject|1|||
161801945|NCT03830164|584318091|FG001|Overall Study|Withdrawal by Subject|0|||
161801946|NCT03830164|584318092|FG002|Overall Study|Withdrawal by Subject|0|||
161801947|NCT04099888|584318093|FG000|Overall Study|Study terminated by sponsor|9|||
161801948|NCT04099888|584318094|FG001|Overall Study|Study terminated by sponsor|11|||
161801949|NCT04099888|584318093|FG000|Overall Study|Lost to Follow-up|1|||
161801950|NCT04099888|584318094|FG001|Overall Study|Lost to Follow-up|1|||
161801951|NCT04099888|584318093|FG000|Overall Study|Withdrawal by Subject|5|||
161801952|NCT04099888|584318094|FG001|Overall Study|Withdrawal by Subject|6|||
161801953|NCT04099888|584318093|FG000|Overall Study|Death|5|||
161801954|NCT04099888|584318094|FG001|Overall Study|Death|2|||
161801955|NCT04099888|584318093|FG000|Overall Study|Other|1|||
161801956|NCT04099888|584318094|FG001|Overall Study|Other|0|||
161905278|NCT03839394|584701244|FG001|Overall Study|Lost to Follow-up|8|||
161905279|NCT03839394|584701243|FG000|Overall Study|Withdrawal by Subject|0|||
161905280|NCT03839394|584701244|FG001|Overall Study|Withdrawal by Subject|2|||
161905281|NCT01945944|584701254|FG000|Overall Study|Adverse Event|0|||
161801957|NCT00497796|584318106|FG000|Overall Study|Adverse event (not related)|9|||
161801958|NCT00497796|584318107|FG001|Overall Study|Adverse event (not related)|9|||
161801959|NCT00497796|584318106|FG000|Overall Study|Adverse event (related)|5|||
161801960|NCT00497796|584318107|FG001|Overall Study|Adverse event (related)|4|||
161905282|NCT01945944|584701255|FG001|Overall Study|Adverse Event|2|||
161801961|NCT00497796|584318106|FG000|Overall Study|CMV infection or disease treatment|30|||
161559322|NCT05705167|583438033|FG006|Overall Study|Randomised but not Treated|0|||
161559323|NCT05705167|583438027|FG000|Overall Study|Death|0|||
161559324|NCT05705167|583438028|FG001|Overall Study|Death|0|||
161559325|NCT05705167|583438029|FG002|Overall Study|Death|3|||
161559326|NCT05705167|583438030|FG003|Overall Study|Death|0|||
161559327|NCT05705167|583438031|FG004|Overall Study|Death|1|||
161559328|NCT05705167|583438032|FG005|Overall Study|Death|1|||
161559329|NCT05705167|583438033|FG006|Overall Study|Death|1|||
161559330|NCT05705167|583438027|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
161559331|NCT05705167|583438028|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
161559332|NCT05705167|583438029|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
161559333|NCT05705167|583438030|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
161559334|NCT05705167|583438031|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
161559335|NCT05705167|583438032|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
161559336|NCT05705167|583438033|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
161559337|NCT01670500|583438034|FG000|Overall Study|Withdrawal by Subject|1|||
161559338|NCT01670500|583438035|FG001|Overall Study|Withdrawal by Subject|0|||
161559339|NCT04955626|583438036|FG000|Blinded Period|Lost to Follow-up|28|||
161559340|NCT04955626|583438037|FG001|Blinded Period|Lost to Follow-up|28|||
161559341|NCT04955626|583438038|FG002|Blinded Period|Lost to Follow-up|7|||
161559342|NCT04955626|583438039|FG003|Blinded Period|Lost to Follow-up|14|||
161559343|NCT04955626|583438040|FG004|Blinded Period|Lost to Follow-up|3|||
161559344|NCT04955626|583438041|FG005|Blinded Period|Lost to Follow-up|2|||
161559345|NCT04955626|583438042|FG006|Blinded Period|Lost to Follow-up|6|||
161559346|NCT04955626|583438043|FG007|Blinded Period|Lost to Follow-up|4|||
161559347|NCT04955626|583438044|FG008|Blinded Period|Lost to Follow-up|5|||
161559348|NCT04955626|583438045|FG009|Blinded Period|Lost to Follow-up|8|||
161559349|NCT04955626|583438046|FG010|Blinded Period|Lost to Follow-up|10|||
161559350|NCT04955626|583438047|FG011|Blinded Period|Lost to Follow-up|32|||
161559351|NCT04955626|583438048|FG012|Blinded Period|Lost to Follow-up|0|||
161559352|NCT04955626|583438049|FG013|Blinded Period|Lost to Follow-up|0|||
161559353|NCT04955626|583438050|FG014|Blinded Period|Lost to Follow-up|0|||
161559354|NCT04955626|583438051|FG015|Blinded Period|Lost to Follow-up|12|||
161559355|NCT04955626|583438052|FG016|Blinded Period|Lost to Follow-up|2|||
161559356|NCT04955626|583438053|FG017|Blinded Period|Lost to Follow-up|5|||
161559357|NCT04955626|583438054|FG018|Blinded Period|Lost to Follow-up|0|||
161559358|NCT04955626|583438055|FG019|Blinded Period|Lost to Follow-up|0|||
161559359|NCT04955626|583438056|FG020|Blinded Period|Lost to Follow-up|0|||
161559360|NCT04955626|583438057|FG021|Blinded Period|Lost to Follow-up|0|||
161559361|NCT04955626|583438058|FG022|Blinded Period|Lost to Follow-up|0|||
161559362|NCT04955626|583438059|FG023|Blinded Period|Lost to Follow-up|0|||
161559363|NCT04955626|583438060|FG024|Blinded Period|Lost to Follow-up|3|||
161559364|NCT04955626|583438061|FG025|Blinded Period|Lost to Follow-up|1|||
161559365|NCT04955626|583438062|FG026|Blinded Period|Lost to Follow-up|2|||
161559366|NCT04955626|583438063|FG027|Blinded Period|Lost to Follow-up|2|||
161559367|NCT04955626|583438064|FG028|Blinded Period|Lost to Follow-up|2|||
161559368|NCT04955626|583438065|FG029|Blinded Period|Lost to Follow-up|0|||
161559369|NCT04955626|583438066|FG030|Blinded Period|Lost to Follow-up|0|||
161559370|NCT04955626|583438067|FG031|Blinded Period|Lost to Follow-up|0|||
161559371|NCT04955626|583438068|FG032|Blinded Period|Lost to Follow-up|0|||
161559372|NCT04955626|583438069|FG033|Blinded Period|Lost to Follow-up|0|||
161559373|NCT04955626|583438070|FG034|Blinded Period|Lost to Follow-up|0|||
161559374|NCT04955626|583438071|FG035|Blinded Period|Lost to Follow-up|0|||
161559375|NCT04955626|583438036|FG000|Blinded Period|Protocol Violation|5|||
161559376|NCT04955626|583438037|FG001|Blinded Period|Protocol Violation|14|||
161559377|NCT04955626|583438038|FG002|Blinded Period|Protocol Violation|0|||
161559378|NCT04955626|583438039|FG003|Blinded Period|Protocol Violation|1|||
161559379|NCT04955626|583438040|FG004|Blinded Period|Protocol Violation|2|||
161559380|NCT04955626|583438041|FG005|Blinded Period|Protocol Violation|2|||
161559381|NCT04955626|583438042|FG006|Blinded Period|Protocol Violation|0|||
161559382|NCT04955626|583438043|FG007|Blinded Period|Protocol Violation|0|||
161559383|NCT04955626|583438044|FG008|Blinded Period|Protocol Violation|0|||
161559384|NCT04955626|583438045|FG009|Blinded Period|Protocol Violation|4|||
161559385|NCT04955626|583438046|FG010|Blinded Period|Protocol Violation|6|||
161559386|NCT04955626|583438047|FG011|Blinded Period|Protocol Violation|1|||
161559387|NCT04955626|583438048|FG012|Blinded Period|Protocol Violation|0|||
161559388|NCT04955626|583438049|FG013|Blinded Period|Protocol Violation|0|||
161559389|NCT04955626|583438050|FG014|Blinded Period|Protocol Violation|2|||
161559390|NCT04955626|583438051|FG015|Blinded Period|Protocol Violation|6|||
161559391|NCT04955626|583438052|FG016|Blinded Period|Protocol Violation|4|||
161559392|NCT04955626|583438053|FG017|Blinded Period|Protocol Violation|6|||
161559393|NCT04955626|583438054|FG018|Blinded Period|Protocol Violation|0|||
161559394|NCT04955626|583438055|FG019|Blinded Period|Protocol Violation|1|||
161801962|NCT00497796|584318107|FG001|Overall Study|CMV infection or disease treatment|4|||
161801963|NCT00497796|584318106|FG000|Overall Study|Consent withdrawn|10|||
161801964|NCT00497796|584318107|FG001|Overall Study|Consent withdrawn|3|||
161559395|NCT04955626|583438056|FG020|Blinded Period|Protocol Violation|0|||
161559396|NCT04955626|583438057|FG021|Blinded Period|Protocol Violation|1|||
161559397|NCT04955626|583438058|FG022|Blinded Period|Protocol Violation|0|||
161559398|NCT04955626|583438059|FG023|Blinded Period|Protocol Violation|0|||
161905283|NCT01945944|584701254|FG000|Overall Study|Physician Decision|1|||
161905284|NCT01945944|584701255|FG001|Overall Study|Physician Decision|0|||
161905285|NCT01945944|584701254|FG000|Overall Study|Withdrawal by Subject|0|||
161905286|NCT01945944|584701255|FG001|Overall Study|Withdrawal by Subject|1|||
161905287|NCT01817075|584701256|FG000|Overall Study|Adverse Event|7|||
161905288|NCT01817075|584701257|FG001|Overall Study|Adverse Event|5|||
161905289|NCT01817075|584701256|FG000|Overall Study|Physician Decision|9|||
161905290|NCT01817075|584701257|FG001|Overall Study|Physician Decision|12|||
161905291|NCT01817075|584701256|FG000|Overall Study|Withdrawal by Subject|31|||
161905292|NCT01817075|584701257|FG001|Overall Study|Withdrawal by Subject|15|||
161905293|NCT01817075|584701256|FG000|Overall Study|Received Sorafenib after enrollment|0|||
161905294|NCT01817075|584701257|FG001|Overall Study|Received Sorafenib after enrollment|1|||
161451948|NCT03158285|583050716|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
161451949|NCT03158285|583050717|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
161451950|NCT03158285|583050715|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
161451951|NCT03158285|583050716|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
161801965|NCT00497796|584318106|FG000|Overall Study|Investigator/sponsor discretion|31|||
161801966|NCT00497796|584318107|FG001|Overall Study|Investigator/sponsor discretion|34|||
161801967|NCT00497796|584318106|FG000|Overall Study|Lost to Follow-up|0|||
161801968|NCT00497796|584318107|FG001|Overall Study|Lost to Follow-up|1|||
161801969|NCT00497796|584318106|FG000|Overall Study|Not applicable (randomized not treated)|0|||
161801970|NCT00497796|584318107|FG001|Overall Study|Not applicable (randomized not treated)|4|||
161801971|NCT01074554|584318108|FG000|Overall Study|Adverse Event|3|||
161801972|NCT01074554|584318109|FG001|Overall Study|Adverse Event|3|||
161801973|NCT01074554|584318108|FG000|Overall Study|Lost to Follow-up|0|||
161801974|NCT01074554|584318109|FG001|Overall Study|Lost to Follow-up|1|||
161801975|NCT01856309|584318111|FG000|Overall Study|Death|4|||
161801976|NCT01856309|584318112|FG001|Overall Study|Death|6|||
161801977|NCT01856309|584318113|FG002|Overall Study|Death|11|||
161801978|NCT01856309|584318114|FG003|Overall Study|Death|6|||
161801979|NCT01856309|584318111|FG000|Overall Study|Lost to Follow-up|6|||
161801980|NCT01856309|584318112|FG001|Overall Study|Lost to Follow-up|2|||
161801981|NCT01856309|584318113|FG002|Overall Study|Lost to Follow-up|4|||
161801982|NCT01856309|584318114|FG003|Overall Study|Lost to Follow-up|8|||
161801983|NCT01856309|584318111|FG000|Overall Study|Withdrawal by Subject|11|||
161801984|NCT01856309|584318112|FG001|Overall Study|Withdrawal by Subject|13|||
161801985|NCT01856309|584318113|FG002|Overall Study|Withdrawal by Subject|28|||
161801986|NCT01856309|584318114|FG003|Overall Study|Withdrawal by Subject|26|||
161801987|NCT01856309|584318111|FG000|Overall Study|Other|227|||
161801988|NCT01856309|584318112|FG001|Overall Study|Other|225|||
161801989|NCT01856309|584318113|FG002|Overall Study|Other|447|||
161801990|NCT01856309|584318114|FG003|Overall Study|Other|469|||
161801991|NCT01856309|584318111|FG000|Overall Study|Lack of Efficacy|14|||
161801992|NCT01856309|584318112|FG001|Overall Study|Lack of Efficacy|9|||
161801993|NCT01856309|584318113|FG002|Overall Study|Lack of Efficacy|40|||
161801994|NCT01856309|584318114|FG003|Overall Study|Lack of Efficacy|25|||
161801995|NCT01856309|584318111|FG000|Overall Study|Adverse Event|31|||
161801996|NCT01856309|584318112|FG001|Overall Study|Adverse Event|31|||
161801997|NCT01856309|584318113|FG002|Overall Study|Adverse Event|55|||
161801998|NCT01856309|584318114|FG003|Overall Study|Adverse Event|65|||
161801999|NCT01856309|584318111|FG000|Overall Study|Pregnancy|0|||
161802000|NCT01856309|584318112|FG001|Overall Study|Pregnancy|0|||
161802001|NCT01856309|584318113|FG002|Overall Study|Pregnancy|0|||
161802002|NCT01856309|584318114|FG003|Overall Study|Pregnancy|1|||
161802003|NCT01856309|584318111|FG000|Overall Study|Physician Decision|6|||
161802004|NCT01856309|584318112|FG001|Overall Study|Physician Decision|1|||
161802005|NCT01856309|584318113|FG002|Overall Study|Physician Decision|6|||
161802006|NCT01856309|584318114|FG003|Overall Study|Physician Decision|8|||
161802007|NCT01856309|584318111|FG000|Overall Study|Noncompliance With Study Drug|0|||
161802008|NCT01856309|584318112|FG001|Overall Study|Noncompliance With Study Drug|1|||
161802009|NCT01856309|584318113|FG002|Overall Study|Noncompliance With Study Drug|4|||
161802010|NCT01856309|584318114|FG003|Overall Study|Noncompliance With Study Drug|1|||
161802011|NCT00832377|584318115|FG000|Overall Study|Protocol Violation|1|||
161802012|NCT00220337|584318116|FG000|Overall Study|Adverse Event|70|||
161802013|NCT00220337|584318116|FG000|Overall Study|Lack of Efficacy|17|||
161905295|NCT01817075|584701256|FG000|Overall Study|Ineligible|0|||
161451952|NCT03158285|583050717|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
161802014|NCT00220337|584318116|FG000|Overall Study|Withdrawal by Subject|68|||
161905296|NCT01817075|584701257|FG001|Overall Study|Ineligible|2|||
161905297|NCT04376515|584701260|FG000|Overall Study|Found to have been vaccinated before study start|6|||
161802015|NCT00220337|584318116|FG000|Overall Study|Protocol Violation|2|||
161802016|NCT00220337|584318116|FG000|Overall Study|Lost to Follow-up|5|||
161802017|NCT00220337|584318116|FG000|Overall Study|Other|12|||
161905298|NCT04376515|584701261|FG001|Overall Study|Found to have been vaccinated before study start|6|||
161559399|NCT04955626|583438060|FG024|Blinded Period|Protocol Violation|4|||
161802018|NCT00220337|584318116|FG000|Overall Study|Unsatisfactory compliance|5|||
161802019|NCT00944697|584318117|FG000|Overall Study|Withdrawal by Subject|1|||
161802020|NCT00944697|584318118|FG001|Overall Study|Withdrawal by Subject|1|||
161905299|NCT04157517|584701262|FG000|Overall Study|Death|1|||
161905300|NCT04157517|584701263|FG001|Overall Study|Death|2|||
161905301|NCT04157517|584701264|FG002|Overall Study|Death|2|||
161905302|NCT04157517|584701265|FG003|Overall Study|Death|3|||
161905303|NCT04157517|584701266|FG004|Overall Study|Death|3|||
161905304|NCT04157517|584701267|FG005|Overall Study|Death|4|||
161905305|NCT04157517|584701268|FG006|Overall Study|Death|1|||
161905306|NCT04157517|584701269|FG007|Overall Study|Death|2|||
161905307|NCT04157517|584701270|FG008|Overall Study|Death|4|||
161905308|NCT04157517|584701271|FG009|Overall Study|Death|0|||
161451953|NCT03158285|583050715|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
161451954|NCT03158285|583050716|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
161451955|NCT03158285|583050717|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
161451956|NCT03158285|583050715|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
161451957|NCT03158285|583050716|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
161451958|NCT03158285|583050717|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
161451959|NCT03158285|583050715|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
161451960|NCT03158285|583050716|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
161451961|NCT03158285|583050717|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
161451962|NCT03158285|583050715|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
161451963|NCT03158285|583050716|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
161451964|NCT03158285|583050717|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
161451965|NCT03158285|583050715|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
161451966|NCT03158285|583050716|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
161802021|NCT00944697|584318117|FG000|Overall Study|Adverse Event|0|||
161802022|NCT00944697|584318118|FG001|Overall Study|Adverse Event|3|||
161905309|NCT04157517|584701262|FG000|Overall Study|Withdrawal by Subject|1|||
161905310|NCT04157517|584701263|FG001|Overall Study|Withdrawal by Subject|1|||
161905311|NCT04157517|584701264|FG002|Overall Study|Withdrawal by Subject|1|||
161905312|NCT04157517|584701265|FG003|Overall Study|Withdrawal by Subject|0|||
161905313|NCT04157517|584701266|FG004|Overall Study|Withdrawal by Subject|0|||
161905314|NCT04157517|584701267|FG005|Overall Study|Withdrawal by Subject|1|||
161905315|NCT04157517|584701268|FG006|Overall Study|Withdrawal by Subject|0|||
161905316|NCT04157517|584701269|FG007|Overall Study|Withdrawal by Subject|0|||
161905317|NCT04157517|584701270|FG008|Overall Study|Withdrawal by Subject|1|||
161905318|NCT04157517|584701271|FG009|Overall Study|Withdrawal by Subject|0|||
161905319|NCT04157517|584701262|FG000|Overall Study|Other|1|||
161905320|NCT04157517|584701263|FG001|Overall Study|Other|0|||
161905321|NCT04157517|584701264|FG002|Overall Study|Other|0|||
161905322|NCT04157517|584701265|FG003|Overall Study|Other|0|||
161905323|NCT04157517|584701266|FG004|Overall Study|Other|0|||
161905324|NCT04157517|584701267|FG005|Overall Study|Other|1|||
161905325|NCT04157517|584701268|FG006|Overall Study|Other|2|||
161905326|NCT04157517|584701269|FG007|Overall Study|Other|7|||
161905327|NCT04157517|584701270|FG008|Overall Study|Other|7|||
161905328|NCT04157517|584701271|FG009|Overall Study|Other|0|||
161905329|NCT03433898|584701274|FG000|Overall Study|Progressive disease|6|||
161905330|NCT03433898|584701275|FG001|Overall Study|Progressive disease|3|||
161905331|NCT03433898|584701276|FG002|Overall Study|Progressive disease|3|||
161905332|NCT03433898|584701277|FG003|Overall Study|Progressive disease|2|||
161905333|NCT03433898|584701278|FG004|Overall Study|Progressive disease|30|||
161451967|NCT03158285|583050717|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
161451968|NCT03158285|583050715|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
161451969|NCT03158285|583050716|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
161802023|NCT00944697|584318117|FG000|Overall Study|Administrative|1|||
161802024|NCT00944697|584318118|FG001|Overall Study|Administrative|1|||
161802025|NCT01273181|584318119|FG000|Phase I, Dose 1|Study termination|1|||
161802026|NCT01273181|584318120|FG001|Phase I, Dose 1|Study termination|0|||
161802027|NCT01273181|584318121|FG002|Phase I, Dose 1|Study termination|0|||
161802028|NCT01273181|584318122|FG003|Phase I, Dose 1|Study termination|0|||
161802029|NCT01273181|584318119|FG000|Phase I, Dose 2|Death during treatment|0|||
161802030|NCT01273181|584318120|FG001|Phase I, Dose 2|Death during treatment|1|||
161802031|NCT01273181|584318121|FG002|Phase I, Dose 2|Death during treatment|0|||
161802032|NCT01273181|584318122|FG003|Phase I, Dose 2|Death during treatment|0|||
161802033|NCT01273181|584318119|FG000|Phase 2, Dose 1|Study termination|0|||
161802034|NCT01273181|584318120|FG001|Phase 2, Dose 1|Study termination|0|||
161802035|NCT01273181|584318121|FG002|Phase 2, Dose 1|Study termination|1|||
161905334|NCT03433898|584701279|FG005|Overall Study|Progressive disease|29|||
161905335|NCT03433898|584701280|FG006|Overall Study|Progressive disease|17|||
161905336|NCT03433898|584701281|FG007|Overall Study|Progressive disease|30|||
161905337|NCT03433898|584701274|FG000|Overall Study|Not treated|1|||
161905338|NCT03433898|584701275|FG001|Overall Study|Not treated|0|||
161905339|NCT03433898|584701276|FG002|Overall Study|Not treated|0|||
161905340|NCT03433898|584701277|FG003|Overall Study|Not treated|0|||
161905341|NCT03433898|584701278|FG004|Overall Study|Not treated|1|||
161905342|NCT03433898|584701279|FG005|Overall Study|Not treated|0|||
161905343|NCT03433898|584701280|FG006|Overall Study|Not treated|0|||
161905344|NCT03433898|584701281|FG007|Overall Study|Not treated|0|||
161559400|NCT04955626|583438061|FG025|Blinded Period|Protocol Violation|6|||
161559401|NCT04955626|583438062|FG026|Blinded Period|Protocol Violation|5|||
161559402|NCT04955626|583438063|FG027|Blinded Period|Protocol Violation|3|||
161559403|NCT04955626|583438064|FG028|Blinded Period|Protocol Violation|4|||
161559404|NCT04955626|583438065|FG029|Blinded Period|Protocol Violation|3|||
161559405|NCT04955626|583438066|FG030|Blinded Period|Protocol Violation|0|||
161559406|NCT04955626|583438067|FG031|Blinded Period|Protocol Violation|0|||
161668053|NCT00406653|583837482|FG006|Induction Period|Given prohibited drug|0|||
161802036|NCT01273181|584318122|FG003|Phase 2, Dose 1|Study termination|0|||
161802037|NCT01273181|584318119|FG000|Phase 2, Dose 2|Death during treatment|0|||
161802038|NCT01273181|584318120|FG001|Phase 2, Dose 2|Death during treatment|0|||
161802039|NCT01273181|584318121|FG002|Phase 2, Dose 2|Death during treatment|0|||
161802040|NCT01273181|584318122|FG003|Phase 2, Dose 2|Death during treatment|1|||
161802041|NCT02458469|584318128|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802042|NCT02458469|584318129|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802043|NCT02458469|584318130|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161802044|NCT02458469|584318131|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802045|NCT02458469|584318132|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802046|NCT02458469|584318133|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802047|NCT02458469|584318128|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
161802048|NCT02458469|584318129|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
161802049|NCT02458469|584318130|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
161802050|NCT02458469|584318131|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
161802051|NCT02458469|584318132|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
161802052|NCT02458469|584318133|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
161802053|NCT02458469|584318128|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802054|NCT02458469|584318129|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802055|NCT02458469|584318130|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802056|NCT02458469|584318131|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802057|NCT02458469|584318132|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802058|NCT02458469|584318133|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
161802059|NCT00661505|584318134|FG000|Overall Study|Adverse Event|3|||
161802060|NCT00661505|584318134|FG000|Overall Study|Protocol Violation|14|||
161802061|NCT00661505|584318134|FG000|Overall Study|Withdrawal by Subject|8|||
161802062|NCT00661505|584318134|FG000|Overall Study|Lost to Follow-up|3|||
161802063|NCT00661505|584318134|FG000|Overall Study|Other|2|||
161802064|NCT02603952|584318144|FG000|Overall Study|Withdrawal by Subject|1|||
161802065|NCT02603952|584318145|FG001|Overall Study|Withdrawal by Subject|0|||
161802066|NCT02603952|584318146|FG002|Overall Study|Withdrawal by Subject|0|||
161802067|NCT02603952|584318147|FG003|Overall Study|Withdrawal by Subject|0|||
161802068|NCT02603952|584318144|FG000|Overall Study|Received oseltamivir by error|0|||
161802069|NCT02603952|584318145|FG001|Overall Study|Received oseltamivir by error|0|||
161802070|NCT02603952|584318146|FG002|Overall Study|Received oseltamivir by error|0|||
161802071|NCT02603952|584318147|FG003|Overall Study|Received oseltamivir by error|1|||
161802072|NCT03283709|584318158|FG000|Overall Study|trial terminated|0|||
161802073|NCT03283709|584318159|FG001|Overall Study|trial terminated|1|||
161802074|NCT01347710|584318163|FG000|Overall Study|Withdrawal by Subject|2|||
161802075|NCT01347710|584318163|FG000|Overall Study|Adverse Event|4|||
161802076|NCT01347710|584318163|FG000|Overall Study|Angio or SPECT not completed|18|||
161802077|NCT01347710|584318163|FG000|Overall Study|issue with vitals prior to dosing|1|||
161802078|NCT01347710|584318163|FG000|Overall Study|Lost to Follow-up|1|||
161802079|NCT01347710|584318163|FG000|Overall Study|Physician Decision|2|||
161802080|NCT01347710|584318163|FG000|Overall Study|Other|3|||
161802081|NCT04591626|584318165|FG000|Overall Study|Adverse Event|4|||
161802082|NCT04591626|584318166|FG001|Overall Study|Adverse Event|0|||
161802083|NCT04591626|584318165|FG000|Overall Study|Withdrawal by Subject|5|||
161802084|NCT04591626|584318166|FG001|Overall Study|Withdrawal by Subject|3|||
161802085|NCT04591626|584318165|FG000|Overall Study|Physician Decision|0|||
161802086|NCT04591626|584318166|FG001|Overall Study|Physician Decision|1|||
161802087|NCT04591626|584318165|FG000|Overall Study|Death|0|||
161802088|NCT04591626|584318166|FG001|Overall Study|Death|1|||
161802089|NCT04591626|584318165|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161802090|NCT04591626|584318166|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161802091|NCT01004172|584318168|FG000|Overall Study|Progressive Disease in CNS Only|16|||
161802092|NCT01004172|584318168|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
161802093|NCT01004172|584318168|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
161802094|NCT01004172|584318168|FG000|Overall Study|Adverse Event|1|||
161802095|NCT01004172|584318168|FG000|Overall Study|Physician Decision|1|||
161802096|NCT01004172|584318168|FG000|Overall Study|Symptomatic Deterioration|2|||
161802097|NCT02003183|584318172|FG000|Overall Study|Lost to Follow-up|0|||
161802098|NCT02003183|584318173|FG001|Overall Study|Lost to Follow-up|2|||
161802099|NCT00841100|584318178|FG000|Phase 1 (28 Days)|Adverse Event|1|||
161802100|NCT00841100|584318178|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
161559407|NCT04955626|583438068|FG032|Blinded Period|Protocol Violation|0|||
161559408|NCT04955626|583438069|FG033|Blinded Period|Protocol Violation|0|||
161559409|NCT04955626|583438070|FG034|Blinded Period|Protocol Violation|0|||
161559410|NCT04955626|583438071|FG035|Blinded Period|Protocol Violation|0|||
161559411|NCT04955626|583438036|FG000|Blinded Period|Death|0|||
161559412|NCT04955626|583438037|FG001|Blinded Period|Death|2|||
161451970|NCT03158285|583050717|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
161559413|NCT04955626|583438038|FG002|Blinded Period|Death|0|||
161559414|NCT04955626|583438039|FG003|Blinded Period|Death|0|||
161559415|NCT04955626|583438040|FG004|Blinded Period|Death|0|||
161802101|NCT03338972|584318179|FG000|Overall Study|Death|1|||
161451971|NCT03158285|583050715|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
161451972|NCT03158285|583050716|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
161451973|NCT03158285|583050717|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
161451974|NCT03158285|583050715|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
161451975|NCT03158285|583050716|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
161451976|NCT03158285|583050717|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
161451977|NCT03158285|583050715|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
161451978|NCT03158285|583050716|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
161451979|NCT03158285|583050717|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
161451980|NCT03158285|583050715|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
161451981|NCT03158285|583050716|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
161451982|NCT03158285|583050717|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
161451983|NCT03158285|583050715|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
161451984|NCT03158285|583050716|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
161451985|NCT03158285|583050717|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
161451986|NCT03158285|583050715|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
161451987|NCT03158285|583050716|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
161451988|NCT03158285|583050717|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
161451989|NCT03158285|583050715|FG000|Active Treatment Period: Week 52-100|Death|1|||
161451990|NCT03158285|583050716|FG001|Active Treatment Period: Week 52-100|Death|0|||
161451991|NCT03158285|583050717|FG002|Active Treatment Period: Week 52-100|Death|0|||
161451992|NCT03158285|583050715|FG000|Active Treatment Period: Week 52-100|Other|4|||
161451993|NCT03158285|583050716|FG001|Active Treatment Period: Week 52-100|Other|1|||
161451994|NCT03158285|583050717|FG002|Active Treatment Period: Week 52-100|Other|0|||
161451995|NCT02228980|583050718|FG000|Overall Study|Adverse Event|14|||
161451996|NCT02228980|583050719|FG001|Overall Study|Adverse Event|0|||
161451997|NCT02228980|583050720|FG002|Overall Study|Adverse Event|0|||
161451998|NCT02228980|583050721|FG003|Overall Study|Adverse Event|0|||
161451999|NCT02228980|583050718|FG000|Overall Study|Protocol Violation|7|||
161452000|NCT02228980|583050719|FG001|Overall Study|Protocol Violation|0|||
161452001|NCT02228980|583050720|FG002|Overall Study|Protocol Violation|0|||
161452002|NCT02228980|583050721|FG003|Overall Study|Protocol Violation|0|||
161452003|NCT02228980|583050718|FG000|Overall Study|Withdrawal by Subject|3|||
161452004|NCT02228980|583050719|FG001|Overall Study|Withdrawal by Subject|3|||
161452005|NCT02228980|583050720|FG002|Overall Study|Withdrawal by Subject|2|||
161452006|NCT02228980|583050721|FG003|Overall Study|Withdrawal by Subject|3|||
161452007|NCT02744040|583050722|FG000|Overall Study|Withdrawal by Subject|3|||
161452008|NCT02744040|583050723|FG001|Overall Study|Withdrawal by Subject|2|||
161452009|NCT02744040|583050724|FG002|Overall Study|Withdrawal by Subject|2|||
161452010|NCT02744040|583050722|FG000|Overall Study|Physician Decision|0|||
161452011|NCT02744040|583050723|FG001|Overall Study|Physician Decision|8|||
161452012|NCT02744040|583050724|FG002|Overall Study|Physician Decision|13|||
161452013|NCT02744040|583050722|FG000|Overall Study|Lost to Follow-up|3|||
161452014|NCT02744040|583050723|FG001|Overall Study|Lost to Follow-up|1|||
161452015|NCT02744040|583050724|FG002|Overall Study|Lost to Follow-up|7|||
161452016|NCT00750152|583050725|FG000|Overall Study|Adverse Event|2|||
161452017|NCT00750152|583050726|FG001|Overall Study|Adverse Event|1|||
161452018|NCT00750152|583050725|FG000|Overall Study|Lost to Follow-up|8|||
161452019|NCT00750152|583050726|FG001|Overall Study|Lost to Follow-up|13|||
161452020|NCT00750152|583050725|FG000|Overall Study|Withdrawal by Subject|3|||
161452021|NCT00750152|583050726|FG001|Overall Study|Withdrawal by Subject|3|||
161452022|NCT00750152|583050725|FG000|Overall Study|Physician Decision|1|||
161802102|NCT03338972|584318180|FG001|Overall Study|Death|1|||
161802103|NCT03338972|584318181|FG002|Overall Study|Death|0|||
161802104|NCT03338972|584318182|FG003|Overall Study|Death|0|||
161802105|NCT03338972|584318179|FG000|Overall Study|Withdrawal by Subject|1|||
161802106|NCT03338972|584318180|FG001|Overall Study|Withdrawal by Subject|0|||
161802107|NCT03338972|584318181|FG002|Overall Study|Withdrawal by Subject|0|||
161802108|NCT03338972|584318182|FG003|Overall Study|Withdrawal by Subject|0|||
161452023|NCT00750152|583050726|FG001|Overall Study|Physician Decision|1|||
161452024|NCT00750152|583050725|FG000|Overall Study|Non-compliance|0|||
161452025|NCT00750152|583050726|FG001|Overall Study|Non-compliance|1|||
161452026|NCT00750152|583050725|FG000|Overall Study|Termination by sponsor|1|||
161452027|NCT00750152|583050726|FG001|Overall Study|Termination by sponsor|0|||
161452028|NCT00750152|583050725|FG000|Overall Study|Other|7|||
161559416|NCT04955626|583438041|FG005|Blinded Period|Death|0|||
161802109|NCT01355081|584318183|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
161559417|NCT04955626|583438042|FG006|Blinded Period|Death|0|||
161559418|NCT04955626|583438043|FG007|Blinded Period|Death|2|||
161559419|NCT04955626|583438044|FG008|Blinded Period|Death|1|||
161559420|NCT04955626|583438045|FG009|Blinded Period|Death|1|||
161559421|NCT04955626|583438046|FG010|Blinded Period|Death|0|||
161559422|NCT04955626|583438047|FG011|Blinded Period|Death|2|||
161559423|NCT04955626|583438048|FG012|Blinded Period|Death|0|||
161559424|NCT04955626|583438049|FG013|Blinded Period|Death|0|||
161559425|NCT04955626|583438050|FG014|Blinded Period|Death|0|||
161559426|NCT04955626|583438051|FG015|Blinded Period|Death|0|||
161559427|NCT04955626|583438052|FG016|Blinded Period|Death|0|||
161559428|NCT04955626|583438053|FG017|Blinded Period|Death|0|||
161559429|NCT04955626|583438054|FG018|Blinded Period|Death|0|||
161559430|NCT04955626|583438055|FG019|Blinded Period|Death|0|||
161559431|NCT04955626|583438056|FG020|Blinded Period|Death|0|||
161559432|NCT04955626|583438057|FG021|Blinded Period|Death|0|||
161559433|NCT04955626|583438058|FG022|Blinded Period|Death|0|||
161559434|NCT04955626|583438059|FG023|Blinded Period|Death|1|||
161559435|NCT04955626|583438060|FG024|Blinded Period|Death|0|||
161559436|NCT04955626|583438061|FG025|Blinded Period|Death|0|||
161559437|NCT04955626|583438062|FG026|Blinded Period|Death|1|||
161559438|NCT04955626|583438063|FG027|Blinded Period|Death|1|||
161559439|NCT04955626|583438064|FG028|Blinded Period|Death|0|||
161559440|NCT04955626|583438065|FG029|Blinded Period|Death|1|||
161559441|NCT04955626|583438066|FG030|Blinded Period|Death|0|||
161559442|NCT04955626|583438067|FG031|Blinded Period|Death|0|||
161802110|NCT01355081|584318184|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161802111|NCT01355081|584318185|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161802112|NCT01355081|584318183|FG000|Overall Study|Major Protocol Deviation|0|||
161802113|NCT01355081|584318184|FG001|Overall Study|Major Protocol Deviation|1|||
161802114|NCT01355081|584318185|FG002|Overall Study|Major Protocol Deviation|0|||
161802115|NCT01355081|584318183|FG000|Overall Study|Lost to Follow-up|0|||
161802116|NCT01355081|584318184|FG001|Overall Study|Lost to Follow-up|0|||
161802117|NCT01355081|584318185|FG002|Overall Study|Lost to Follow-up|1|||
161802118|NCT01355081|584318183|FG000|Overall Study|Withdrawal of Consent|2|||
161802119|NCT01355081|584318184|FG001|Overall Study|Withdrawal of Consent|3|||
161802120|NCT01355081|584318185|FG002|Overall Study|Withdrawal of Consent|3|||
161802121|NCT01355081|584318183|FG000|Overall Study|Lack of Efficacy|2|||
161802122|NCT01355081|584318184|FG001|Overall Study|Lack of Efficacy|1|||
161802123|NCT01355081|584318185|FG002|Overall Study|Lack of Efficacy|1|||
161802124|NCT01355081|584318183|FG000|Overall Study|Non Compliance with Study Medication|0|||
161802125|NCT01355081|584318184|FG001|Overall Study|Non Compliance with Study Medication|1|||
161802126|NCT01355081|584318185|FG002|Overall Study|Non Compliance with Study Medication|0|||
161802127|NCT02719522|584318188|FG000|Overall Study|Implant Failure|4|||
161802128|NCT02719522|584318188|FG000|Overall Study|Death|2|||
161802129|NCT02719522|584318188|FG000|Overall Study|Lost to Follow-up|5|||
161802130|NCT06096168|584318189|FG000|Overall Study|Death|30|||
161802131|NCT06096168|584318189|FG000|Overall Study|Revision|2|||
161802132|NCT01868009|584318190|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
161802133|NCT01868009|584318191|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
161802134|NCT01868009|584318190|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
161802135|NCT01868009|584318191|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
161802136|NCT01868009|584318190|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
161802137|NCT01868009|584318191|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
161802138|NCT04603937|584318192|FG000|Overall Study|Adverse Event|9|||
161802139|NCT04603937|584318193|FG001|Overall Study|Adverse Event|10|||
161802140|NCT04603937|584318192|FG000|Overall Study|Withdrawal by Subject|7|||
161802141|NCT04603937|584318193|FG001|Overall Study|Withdrawal by Subject|6|||
161802142|NCT04603937|584318192|FG000|Overall Study|Lost to Follow-up|5|||
161802143|NCT04603937|584318193|FG001|Overall Study|Lost to Follow-up|6|||
161802144|NCT04603937|584318192|FG000|Overall Study|Physician Decision|0|||
161802145|NCT04603937|584318193|FG001|Overall Study|Physician Decision|1|||
161802146|NCT04603937|584318192|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
161802147|NCT04603937|584318193|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
161802148|NCT00993616|584318194|FG000|Overall Study|No tumor at entry|1|||
161802149|NCT00993616|584318194|FG000|Overall Study|Never treated|1|||
161559443|NCT04955626|583438068|FG032|Blinded Period|Death|0|||
161802150|NCT02585258|584318195|FG000|Overall Study|Adverse Event|28|||
161802151|NCT02585258|584318196|FG001|Overall Study|Adverse Event|29|||
161802152|NCT02585258|584318195|FG000|Overall Study|Death|3|||
161802153|NCT02585258|584318196|FG001|Overall Study|Death|2|||
161802154|NCT02585258|584318195|FG000|Overall Study|Lack of Efficacy|7|||
161559444|NCT04955626|583438069|FG033|Blinded Period|Death|0|||
161559445|NCT04955626|583438070|FG034|Blinded Period|Death|0|||
161559446|NCT04955626|583438071|FG035|Blinded Period|Death|0|||
161559447|NCT04955626|583438036|FG000|Blinded Period|Adverse Event|0|||
161559448|NCT04955626|583438037|FG001|Blinded Period|Adverse Event|1|||
161559449|NCT04955626|583438038|FG002|Blinded Period|Adverse Event|1|||
161559450|NCT04955626|583438039|FG003|Blinded Period|Adverse Event|1|||
161559451|NCT04955626|583438040|FG004|Blinded Period|Adverse Event|0|||
161559452|NCT04955626|583438041|FG005|Blinded Period|Adverse Event|0|||
161905345|NCT03433898|584701274|FG000|Overall Study|Death|0|||
161905346|NCT03433898|584701275|FG001|Overall Study|Death|0|||
161905347|NCT03433898|584701276|FG002|Overall Study|Death|0|||
161905348|NCT03433898|584701277|FG003|Overall Study|Death|0|||
161905349|NCT03433898|584701278|FG004|Overall Study|Death|0|||
161905350|NCT03433898|584701279|FG005|Overall Study|Death|0|||
161905351|NCT03433898|584701280|FG006|Overall Study|Death|1|||
161905352|NCT03433898|584701281|FG007|Overall Study|Death|1|||
161905353|NCT03433898|584701274|FG000|Overall Study|Withdrawal by Subject|0|||
161905354|NCT03433898|584701275|FG001|Overall Study|Withdrawal by Subject|0|||
161905355|NCT03433898|584701276|FG002|Overall Study|Withdrawal by Subject|0|||
161905356|NCT03433898|584701277|FG003|Overall Study|Withdrawal by Subject|0|||
161905357|NCT03433898|584701278|FG004|Overall Study|Withdrawal by Subject|2|||
161905358|NCT03433898|584701279|FG005|Overall Study|Withdrawal by Subject|0|||
161905359|NCT03433898|584701280|FG006|Overall Study|Withdrawal by Subject|0|||
161905360|NCT03433898|584701281|FG007|Overall Study|Withdrawal by Subject|0|||
161905361|NCT03433898|584701274|FG000|Overall Study|Adverse Event|0|||
161905362|NCT03433898|584701275|FG001|Overall Study|Adverse Event|0|||
161905363|NCT03433898|584701276|FG002|Overall Study|Adverse Event|0|||
161905364|NCT03433898|584701277|FG003|Overall Study|Adverse Event|0|||
161905365|NCT03433898|584701278|FG004|Overall Study|Adverse Event|0|||
161905366|NCT03433898|584701279|FG005|Overall Study|Adverse Event|5|||
161905367|NCT03433898|584701280|FG006|Overall Study|Adverse Event|2|||
161905368|NCT03433898|584701281|FG007|Overall Study|Adverse Event|2|||
161905369|NCT03433898|584701274|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905370|NCT03433898|584701275|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905371|NCT03433898|584701276|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905372|NCT03433898|584701277|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905373|NCT03433898|584701278|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
161905374|NCT03433898|584701279|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905375|NCT03433898|584701280|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905376|NCT03433898|584701281|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905377|NCT01395810|584701286|FG000|Overall Study|Adverse Event|0|||
161905378|NCT01395810|584701287|FG001|Overall Study|Adverse Event|1|||
161905379|NCT01395810|584701288|FG002|Overall Study|Adverse Event|0|||
161905380|NCT01395810|584701289|FG003|Overall Study|Adverse Event|0|||
161905381|NCT01395810|584701286|FG000|Overall Study|Lack of Efficacy|0|||
161905382|NCT01395810|584701287|FG001|Overall Study|Lack of Efficacy|1|||
161905383|NCT01395810|584701288|FG002|Overall Study|Lack of Efficacy|0|||
161905384|NCT01395810|584701289|FG003|Overall Study|Lack of Efficacy|0|||
161905385|NCT01395810|584701286|FG000|Overall Study|Withdrawal criteria|0|||
161905386|NCT01395810|584701287|FG001|Overall Study|Withdrawal criteria|2|||
161905387|NCT01395810|584701288|FG002|Overall Study|Withdrawal criteria|0|||
161905388|NCT01395810|584701289|FG003|Overall Study|Withdrawal criteria|0|||
161905389|NCT01395810|584701286|FG000|Overall Study|Unclassified|2|||
161905390|NCT01395810|584701287|FG001|Overall Study|Unclassified|0|||
161905391|NCT01395810|584701288|FG002|Overall Study|Unclassified|0|||
161905392|NCT01395810|584701289|FG003|Overall Study|Unclassified|0|||
161905393|NCT04579380|584703322|FG000|Overall Study|Death|9|||
161905394|NCT04579380|584703323|FG001|Overall Study|Death|22|||
161905395|NCT04579380|584703324|FG002|Overall Study|Death|22|||
161905396|NCT04579380|584703325|FG003|Overall Study|Death|17|||
161905397|NCT04579380|584703326|FG004|Overall Study|Death|6|||
161905398|NCT04579380|584703327|FG005|Overall Study|Death|21|||
161905399|NCT04579380|584703328|FG006|Overall Study|Death|10|||
161905400|NCT04579380|584703329|FG007|Overall Study|Death|11|||
161905401|NCT04579380|584703330|FG008|Overall Study|Death|25|||
161559453|NCT04955626|583438042|FG006|Blinded Period|Adverse Event|0|||
161559454|NCT04955626|583438043|FG007|Blinded Period|Adverse Event|0|||
161559455|NCT04955626|583438044|FG008|Blinded Period|Adverse Event|0|||
161559456|NCT04955626|583438045|FG009|Blinded Period|Adverse Event|1|||
161905402|NCT04579380|584703322|FG000|Overall Study|Withdrawal by Subject|0|||
161905403|NCT04579380|584703323|FG001|Overall Study|Withdrawal by Subject|3|||
161905404|NCT04579380|584703324|FG002|Overall Study|Withdrawal by Subject|4|||
161905405|NCT04579380|584703325|FG003|Overall Study|Withdrawal by Subject|0|||
161905406|NCT04579380|584703326|FG004|Overall Study|Withdrawal by Subject|1|||
161905407|NCT04579380|584703327|FG005|Overall Study|Withdrawal by Subject|2|||
161905408|NCT04579380|584703328|FG006|Overall Study|Withdrawal by Subject|0|||
161905409|NCT04579380|584703329|FG007|Overall Study|Withdrawal by Subject|1|||
161905410|NCT04579380|584703330|FG008|Overall Study|Withdrawal by Subject|2|||
161905411|NCT04579380|584703322|FG000|Overall Study|Ongoing|2|||
161905412|NCT04579380|584703323|FG001|Overall Study|Ongoing|6|||
161905413|NCT04579380|584703324|FG002|Overall Study|Ongoing|4|||
161905414|NCT04579380|584703325|FG003|Overall Study|Ongoing|8|||
161905415|NCT04579380|584703326|FG004|Overall Study|Ongoing|5|||
161905416|NCT04579380|584703327|FG005|Overall Study|Ongoing|8|||
161559457|NCT04955626|583438046|FG010|Blinded Period|Adverse Event|1|||
161559458|NCT04955626|583438047|FG011|Blinded Period|Adverse Event|0|||
161559459|NCT04955626|583438048|FG012|Blinded Period|Adverse Event|0|||
161905417|NCT04579380|584703328|FG006|Overall Study|Ongoing|3|||
161559460|NCT04955626|583438049|FG013|Blinded Period|Adverse Event|0|||
161905418|NCT04579380|584703329|FG007|Overall Study|Ongoing|19|||
161559461|NCT04955626|583438050|FG014|Blinded Period|Adverse Event|0|||
161905419|NCT04579380|584703330|FG008|Overall Study|Ongoing|6|||
161905420|NCT04113694|584703331|FG000|Overall Study|Adverse Event|2|||
161905421|NCT04113694|584703331|FG000|Overall Study|Lost to Follow-up|2|||
161905422|NCT04113694|584703331|FG000|Overall Study|Withdrawal by Subject|6|||
161905423|NCT04113694|584703331|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
161559462|NCT04955626|583438051|FG015|Blinded Period|Adverse Event|0|||
161559463|NCT04955626|583438052|FG016|Blinded Period|Adverse Event|0|||
161559464|NCT04955626|583438053|FG017|Blinded Period|Adverse Event|0|||
161905424|NCT05630196|584703334|FG000|Overall Study|Adverse Event|2|||
161905425|NCT05630196|584703335|FG001|Overall Study|Adverse Event|1|||
161905426|NCT05630196|584703334|FG000|Overall Study|Lost to Follow-up|1|||
161905427|NCT05630196|584703335|FG001|Overall Study|Lost to Follow-up|1|||
161559465|NCT04955626|583438054|FG018|Blinded Period|Adverse Event|1|||
161559466|NCT04955626|583438055|FG019|Blinded Period|Adverse Event|0|||
161559467|NCT04955626|583438056|FG020|Blinded Period|Adverse Event|0|||
161559468|NCT04955626|583438057|FG021|Blinded Period|Adverse Event|0|||
161559469|NCT04955626|583438058|FG022|Blinded Period|Adverse Event|0|||
161559470|NCT04955626|583438059|FG023|Blinded Period|Adverse Event|0|||
161559471|NCT04955626|583438060|FG024|Blinded Period|Adverse Event|0|||
161559472|NCT04955626|583438061|FG025|Blinded Period|Adverse Event|0|||
161559473|NCT04955626|583438062|FG026|Blinded Period|Adverse Event|1|||
161559474|NCT04955626|583438063|FG027|Blinded Period|Adverse Event|0|||
161559475|NCT04955626|583438064|FG028|Blinded Period|Adverse Event|0|||
161559476|NCT04955626|583438065|FG029|Blinded Period|Adverse Event|0|||
161559477|NCT04955626|583438066|FG030|Blinded Period|Adverse Event|0|||
161559478|NCT04955626|583438067|FG031|Blinded Period|Adverse Event|0|||
161559479|NCT04955626|583438068|FG032|Blinded Period|Adverse Event|0|||
161559480|NCT04955626|583438069|FG033|Blinded Period|Adverse Event|0|||
161559481|NCT04955626|583438070|FG034|Blinded Period|Adverse Event|0|||
161559482|NCT04955626|583438071|FG035|Blinded Period|Adverse Event|0|||
161559483|NCT04955626|583438036|FG000|Blinded Period|No longer meets eligibility criteria|1|||
161559484|NCT04955626|583438037|FG001|Blinded Period|No longer meets eligibility criteria|2|||
161559485|NCT04955626|583438038|FG002|Blinded Period|No longer meets eligibility criteria|0|||
161559486|NCT04955626|583438039|FG003|Blinded Period|No longer meets eligibility criteria|1|||
161559487|NCT04955626|583438040|FG004|Blinded Period|No longer meets eligibility criteria|0|||
161559488|NCT04955626|583438041|FG005|Blinded Period|No longer meets eligibility criteria|0|||
161559489|NCT04955626|583438042|FG006|Blinded Period|No longer meets eligibility criteria|0|||
161559490|NCT04955626|583438043|FG007|Blinded Period|No longer meets eligibility criteria|0|||
161559491|NCT04955626|583438044|FG008|Blinded Period|No longer meets eligibility criteria|1|||
161559492|NCT04955626|583438045|FG009|Blinded Period|No longer meets eligibility criteria|0|||
161559493|NCT04955626|583438046|FG010|Blinded Period|No longer meets eligibility criteria|1|||
161559494|NCT04955626|583438047|FG011|Blinded Period|No longer meets eligibility criteria|1|||
161905428|NCT05630196|584703334|FG000|Overall Study|Protocol Violation|2|||
161905429|NCT05630196|584703335|FG001|Overall Study|Protocol Violation|3|||
161905430|NCT05630196|584703334|FG000|Overall Study|Physician Decision|1|||
161905431|NCT05630196|584703335|FG001|Overall Study|Physician Decision|0|||
161905432|NCT05630196|584703334|FG000|Overall Study|Withdrawal by Subject|3|||
161905433|NCT05630196|584703335|FG001|Overall Study|Withdrawal by Subject|4|||
161905434|NCT03973996|584703337|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161905435|NCT03973996|584703338|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161905436|NCT03973996|584703339|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161905437|NCT03973996|584703340|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
161905438|NCT04070989|584703341|FG000|Overall Study|Death|1|||
161559495|NCT04955626|583438048|FG012|Blinded Period|No longer meets eligibility criteria|0|||
161559496|NCT04955626|583438049|FG013|Blinded Period|No longer meets eligibility criteria|0|||
161559497|NCT04955626|583438050|FG014|Blinded Period|No longer meets eligibility criteria|0|||
161559498|NCT04955626|583438051|FG015|Blinded Period|No longer meets eligibility criteria|3|||
161559499|NCT04955626|583438052|FG016|Blinded Period|No longer meets eligibility criteria|0|||
161559500|NCT04955626|583438053|FG017|Blinded Period|No longer meets eligibility criteria|2|||
161559501|NCT04955626|583438054|FG018|Blinded Period|No longer meets eligibility criteria|0|||
161559502|NCT04955626|583438055|FG019|Blinded Period|No longer meets eligibility criteria|0|||
161559503|NCT04955626|583438056|FG020|Blinded Period|No longer meets eligibility criteria|0|||
161559504|NCT04955626|583438057|FG021|Blinded Period|No longer meets eligibility criteria|0|||
161559505|NCT04955626|583438058|FG022|Blinded Period|No longer meets eligibility criteria|0|||
161559506|NCT04955626|583438059|FG023|Blinded Period|No longer meets eligibility criteria|0|||
161559507|NCT04955626|583438060|FG024|Blinded Period|No longer meets eligibility criteria|1|||
161559508|NCT04955626|583438061|FG025|Blinded Period|No longer meets eligibility criteria|0|||
161559509|NCT04955626|583438062|FG026|Blinded Period|No longer meets eligibility criteria|0|||
161559510|NCT04955626|583438063|FG027|Blinded Period|No longer meets eligibility criteria|1|||
161559511|NCT04955626|583438064|FG028|Blinded Period|No longer meets eligibility criteria|0|||
161559512|NCT04955626|583438065|FG029|Blinded Period|No longer meets eligibility criteria|0|||
161559513|NCT04955626|583438066|FG030|Blinded Period|No longer meets eligibility criteria|0|||
161559514|NCT04955626|583438067|FG031|Blinded Period|No longer meets eligibility criteria|0|||
161559515|NCT04955626|583438068|FG032|Blinded Period|No longer meets eligibility criteria|0|||
161559516|NCT04955626|583438069|FG033|Blinded Period|No longer meets eligibility criteria|0|||
161559517|NCT04955626|583438070|FG034|Blinded Period|No longer meets eligibility criteria|0|||
161559518|NCT04955626|583438071|FG035|Blinded Period|No longer meets eligibility criteria|0|||
161559519|NCT04955626|583438036|FG000|Blinded Period|Other|54|||
161559520|NCT04955626|583438037|FG001|Blinded Period|Other|3|||
161559521|NCT04955626|583438038|FG002|Blinded Period|Other|4|||
161559522|NCT04955626|583438039|FG003|Blinded Period|Other|2|||
161559523|NCT04955626|583438040|FG004|Blinded Period|Other|0|||
161559524|NCT04955626|583438041|FG005|Blinded Period|Other|0|||
161559525|NCT04955626|583438042|FG006|Blinded Period|Other|2|||
161559526|NCT04955626|583438043|FG007|Blinded Period|Other|2|||
161559527|NCT04955626|583438044|FG008|Blinded Period|Other|1|||
161559528|NCT04955626|583438045|FG009|Blinded Period|Other|0|||
161559529|NCT04955626|583438046|FG010|Blinded Period|Other|1|||
161559530|NCT04955626|583438047|FG011|Blinded Period|Other|1|||
161559531|NCT04955626|583438048|FG012|Blinded Period|Other|0|||
161559532|NCT04955626|583438049|FG013|Blinded Period|Other|0|||
161559533|NCT04955626|583438050|FG014|Blinded Period|Other|0|||
161559534|NCT04955626|583438051|FG015|Blinded Period|Other|0|||
161559535|NCT04955626|583438052|FG016|Blinded Period|Other|0|||
161559536|NCT04955626|583438053|FG017|Blinded Period|Other|1|||
161559537|NCT04955626|583438054|FG018|Blinded Period|Other|0|||
161559538|NCT04955626|583438055|FG019|Blinded Period|Other|0|||
161559539|NCT04955626|583438056|FG020|Blinded Period|Other|0|||
161559540|NCT04955626|583438057|FG021|Blinded Period|Other|0|||
161559541|NCT04955626|583438058|FG022|Blinded Period|Other|0|||
161559542|NCT04955626|583438059|FG023|Blinded Period|Other|0|||
161559543|NCT04955626|583438060|FG024|Blinded Period|Other|0|||
161559544|NCT04955626|583438061|FG025|Blinded Period|Other|0|||
161559545|NCT04955626|583438062|FG026|Blinded Period|Other|2|||
161559546|NCT04955626|583438063|FG027|Blinded Period|Other|0|||
161559547|NCT04955626|583438064|FG028|Blinded Period|Other|0|||
161559548|NCT04955626|583438065|FG029|Blinded Period|Other|0|||
161559549|NCT04955626|583438066|FG030|Blinded Period|Other|0|||
161559550|NCT04955626|583438067|FG031|Blinded Period|Other|0|||
161559551|NCT04955626|583438068|FG032|Blinded Period|Other|0|||
161559552|NCT04955626|583438069|FG033|Blinded Period|Other|0|||
161559553|NCT04955626|583438070|FG034|Blinded Period|Other|0|||
161559554|NCT04955626|583438071|FG035|Blinded Period|Other|0|||
161559555|NCT04955626|583438036|FG000|Blinded Period|Physician Decision|1|||
161559556|NCT04955626|583438037|FG001|Blinded Period|Physician Decision|1|||
161559557|NCT04955626|583438038|FG002|Blinded Period|Physician Decision|0|||
161559558|NCT04955626|583438039|FG003|Blinded Period|Physician Decision|3|||
161559559|NCT04955626|583438040|FG004|Blinded Period|Physician Decision|0|||
161559560|NCT04955626|583438041|FG005|Blinded Period|Physician Decision|0|||
161559561|NCT04955626|583438042|FG006|Blinded Period|Physician Decision|1|||
161559562|NCT04955626|583438043|FG007|Blinded Period|Physician Decision|1|||
161559563|NCT04955626|583438044|FG008|Blinded Period|Physician Decision|0|||
161559564|NCT04955626|583438045|FG009|Blinded Period|Physician Decision|0|||
161559565|NCT04955626|583438046|FG010|Blinded Period|Physician Decision|0|||
161559566|NCT04955626|583438047|FG011|Blinded Period|Physician Decision|5|||
161559567|NCT04955626|583438048|FG012|Blinded Period|Physician Decision|0|||
161559568|NCT04955626|583438049|FG013|Blinded Period|Physician Decision|0|||
161559569|NCT04955626|583438050|FG014|Blinded Period|Physician Decision|0|||
161559570|NCT04955626|583438051|FG015|Blinded Period|Physician Decision|0|||
161559571|NCT04955626|583438052|FG016|Blinded Period|Physician Decision|0|||
161559572|NCT04955626|583438053|FG017|Blinded Period|Physician Decision|0|||
161559573|NCT04955626|583438054|FG018|Blinded Period|Physician Decision|0|||
161559574|NCT04955626|583438055|FG019|Blinded Period|Physician Decision|0|||
161559575|NCT04955626|583438056|FG020|Blinded Period|Physician Decision|0|||
161802155|NCT02585258|584318196|FG001|Overall Study|Lack of Efficacy|9|||
161802156|NCT02585258|584318195|FG000|Overall Study|includes covid-related access problems|42|||
161559576|NCT04955626|583438057|FG021|Blinded Period|Physician Decision|0|||
161559577|NCT04955626|583438058|FG022|Blinded Period|Physician Decision|0|||
161559578|NCT04955626|583438059|FG023|Blinded Period|Physician Decision|0|||
161559579|NCT04955626|583438060|FG024|Blinded Period|Physician Decision|0|||
161559580|NCT04955626|583438061|FG025|Blinded Period|Physician Decision|0|||
161559581|NCT04955626|583438062|FG026|Blinded Period|Physician Decision|0|||
161559582|NCT04955626|583438063|FG027|Blinded Period|Physician Decision|0|||
161802157|NCT02585258|584318196|FG001|Overall Study|includes covid-related access problems|46|||
161559583|NCT04955626|583438064|FG028|Blinded Period|Physician Decision|0|||
161559584|NCT04955626|583438065|FG029|Blinded Period|Physician Decision|0|||
161559585|NCT04955626|583438066|FG030|Blinded Period|Physician Decision|0|||
161559586|NCT04955626|583438067|FG031|Blinded Period|Physician Decision|0|||
161559587|NCT04955626|583438068|FG032|Blinded Period|Physician Decision|0|||
161559588|NCT04955626|583438069|FG033|Blinded Period|Physician Decision|0|||
161559589|NCT04955626|583438070|FG034|Blinded Period|Physician Decision|0|||
161559590|NCT04955626|583438071|FG035|Blinded Period|Physician Decision|0|||
161452029|NCT00750152|583050726|FG001|Overall Study|Other|8|||
161452030|NCT01642615|583050727|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
161452031|NCT01642615|583050728|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
161452032|NCT01642615|583050729|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
161452033|NCT01642615|583050727|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
161452034|NCT01642615|583050728|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
161452035|NCT01642615|583050729|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
161452036|NCT01642615|583050727|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
161452037|NCT01642615|583050728|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
161452038|NCT01642615|583050729|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
161452039|NCT01642615|583050727|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
161452040|NCT01642615|583050728|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
161452041|NCT01642615|583050729|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
161452042|NCT01642615|583050727|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
161452043|NCT01642615|583050728|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
161452044|NCT01642615|583050729|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
161452045|NCT01642615|583050727|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
161452046|NCT01642615|583050728|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
161452047|NCT01642615|583050729|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
161452048|NCT01642615|583050727|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
161452049|NCT01642615|583050728|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
161452050|NCT01642615|583050729|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
161452051|NCT01642615|583050727|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
161452052|NCT01642615|583050728|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
161452053|NCT01642615|583050729|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
161452054|NCT01642615|583050727|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
161452055|NCT01642615|583050728|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
161802158|NCT02585258|584318195|FG000|Overall Study|Lost to Follow-up|5|||
161802159|NCT02585258|584318196|FG001|Overall Study|Lost to Follow-up|2|||
161802160|NCT05125952|584318197|FG000|Overall Study|Physician Decision|1|||
161802161|NCT03946449|584318198|FG000|Treatment Extension II|Rolled over to another study|0|||
161802162|NCT03946449|584318199|FG001|Treatment Extension II|Rolled over to another study|0|||
161802163|NCT03946449|584318200|FG002|Treatment Extension II|Rolled over to another study|2|||
161802164|NCT03946449|584318198|FG000|Treatment Extension II|Withdrawal by Subject|0|||
161802165|NCT03946449|584318199|FG001|Treatment Extension II|Withdrawal by Subject|0|||
161802166|NCT03946449|584318200|FG002|Treatment Extension II|Withdrawal by Subject|1|||
161802167|NCT02848326|584319603|FG000|Treatment Period|Adverse Event|5|||
161802168|NCT02848326|584319604|FG001|Treatment Period|Adverse Event|4|||
161802169|NCT02848326|584319605|FG002|Treatment Period|Adverse Event|11|||
161802170|NCT02848326|584319606|FG003|Treatment Period|Adverse Event|6|||
161802171|NCT02848326|584319607|FG004|Treatment Period|Adverse Event|5|||
161802172|NCT02848326|584319608|FG005|Treatment Period|Adverse Event|7|||
161802173|NCT02848326|584319603|FG000|Treatment Period|Withdrawal of Consent|20|||
161802174|NCT02848326|584319604|FG001|Treatment Period|Withdrawal of Consent|6|||
161802175|NCT02848326|584319605|FG002|Treatment Period|Withdrawal of Consent|9|||
161802176|NCT02848326|584319606|FG003|Treatment Period|Withdrawal of Consent|6|||
161802177|NCT02848326|584319607|FG004|Treatment Period|Withdrawal of Consent|9|||
161802178|NCT02848326|584319608|FG005|Treatment Period|Withdrawal of Consent|6|||
161802179|NCT02848326|584319603|FG000|Treatment Period|Lost to Follow-up|5|||
161802180|NCT02848326|584319604|FG001|Treatment Period|Lost to Follow-up|1|||
161802181|NCT02848326|584319605|FG002|Treatment Period|Lost to Follow-up|11|||
161802182|NCT02848326|584319606|FG003|Treatment Period|Lost to Follow-up|7|||
161802183|NCT02848326|584319607|FG004|Treatment Period|Lost to Follow-up|2|||
161802184|NCT02848326|584319608|FG005|Treatment Period|Lost to Follow-up|3|||
161802185|NCT02848326|584319603|FG000|Treatment Period|Pregnancy|0|||
161802186|NCT02848326|584319604|FG001|Treatment Period|Pregnancy|0|||
161802187|NCT02848326|584319605|FG002|Treatment Period|Pregnancy|1|||
161802188|NCT02848326|584319606|FG003|Treatment Period|Pregnancy|1|||
161802189|NCT02848326|584319607|FG004|Treatment Period|Pregnancy|0|||
161802190|NCT02848326|584319608|FG005|Treatment Period|Pregnancy|1|||
161802191|NCT02848326|584319603|FG000|Treatment Period|Protocol Violation|4|||
161802192|NCT02848326|584319604|FG001|Treatment Period|Protocol Violation|3|||
161802193|NCT02848326|584319605|FG002|Treatment Period|Protocol Violation|4|||
161802194|NCT02848326|584319606|FG003|Treatment Period|Protocol Violation|2|||
161802195|NCT02848326|584319607|FG004|Treatment Period|Protocol Violation|3|||
161802196|NCT02848326|584319608|FG005|Treatment Period|Protocol Violation|3|||
161802197|NCT02848326|584319603|FG000|Treatment Period|Non-compliance with Study Drug|4|||
161802198|NCT02848326|584319604|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161802199|NCT02848326|584319605|FG002|Treatment Period|Non-compliance with Study Drug|0|||
161802200|NCT02848326|584319606|FG003|Treatment Period|Non-compliance with Study Drug|1|||
161559591|NCT04955626|583438036|FG000|Blinded Period|Withdrawal by Subject|26|||
161559592|NCT04955626|583438037|FG001|Blinded Period|Withdrawal by Subject|62|||
161559593|NCT04955626|583438038|FG002|Blinded Period|Withdrawal by Subject|14|||
161559594|NCT04955626|583438039|FG003|Blinded Period|Withdrawal by Subject|16|||
161559595|NCT04955626|583438040|FG004|Blinded Period|Withdrawal by Subject|1|||
161559596|NCT04955626|583438041|FG005|Blinded Period|Withdrawal by Subject|2|||
161559597|NCT04955626|583438042|FG006|Blinded Period|Withdrawal by Subject|9|||
161559598|NCT04955626|583438043|FG007|Blinded Period|Withdrawal by Subject|5|||
161559599|NCT04955626|583438044|FG008|Blinded Period|Withdrawal by Subject|3|||
161559600|NCT04955626|583438045|FG009|Blinded Period|Withdrawal by Subject|15|||
161559601|NCT04955626|583438046|FG010|Blinded Period|Withdrawal by Subject|11|||
161559602|NCT04955626|583438047|FG011|Blinded Period|Withdrawal by Subject|7|||
161559603|NCT04955626|583438048|FG012|Blinded Period|Withdrawal by Subject|2|||
161559604|NCT04955626|583438049|FG013|Blinded Period|Withdrawal by Subject|0|||
161559605|NCT04955626|583438050|FG014|Blinded Period|Withdrawal by Subject|1|||
161559606|NCT04955626|583438051|FG015|Blinded Period|Withdrawal by Subject|11|||
161559607|NCT04955626|583438052|FG016|Blinded Period|Withdrawal by Subject|2|||
161559608|NCT04955626|583438053|FG017|Blinded Period|Withdrawal by Subject|5|||
161559609|NCT04955626|583438054|FG018|Blinded Period|Withdrawal by Subject|0|||
161559610|NCT04955626|583438055|FG019|Blinded Period|Withdrawal by Subject|0|||
161559611|NCT04955626|583438056|FG020|Blinded Period|Withdrawal by Subject|1|||
161559612|NCT04955626|583438057|FG021|Blinded Period|Withdrawal by Subject|0|||
161559613|NCT04955626|583438058|FG022|Blinded Period|Withdrawal by Subject|0|||
161559614|NCT04955626|583438059|FG023|Blinded Period|Withdrawal by Subject|0|||
161559615|NCT04955626|583438060|FG024|Blinded Period|Withdrawal by Subject|5|||
161559616|NCT04955626|583438061|FG025|Blinded Period|Withdrawal by Subject|1|||
161559617|NCT04955626|583438062|FG026|Blinded Period|Withdrawal by Subject|5|||
161559618|NCT04955626|583438063|FG027|Blinded Period|Withdrawal by Subject|1|||
161559619|NCT04955626|583438064|FG028|Blinded Period|Withdrawal by Subject|4|||
161559620|NCT04955626|583438065|FG029|Blinded Period|Withdrawal by Subject|2|||
161559621|NCT04955626|583438066|FG030|Blinded Period|Withdrawal by Subject|0|||
161559622|NCT04955626|583438067|FG031|Blinded Period|Withdrawal by Subject|0|||
161559623|NCT04955626|583438068|FG032|Blinded Period|Withdrawal by Subject|0|||
161559624|NCT04955626|583438069|FG033|Blinded Period|Withdrawal by Subject|0|||
161559625|NCT04955626|583438070|FG034|Blinded Period|Withdrawal by Subject|0|||
161559626|NCT04955626|583438071|FG035|Blinded Period|Withdrawal by Subject|0|||
161559627|NCT04955626|583438036|FG000|Blinded Period|Refused further study procedures|0|||
161559628|NCT04955626|583438037|FG001|Blinded Period|Refused further study procedures|0|||
161559629|NCT04955626|583438038|FG002|Blinded Period|Refused further study procedures|0|||
161559630|NCT04955626|583438039|FG003|Blinded Period|Refused further study procedures|0|||
161559631|NCT04955626|583438040|FG004|Blinded Period|Refused further study procedures|0|||
161559632|NCT04955626|583438041|FG005|Blinded Period|Refused further study procedures|0|||
161559633|NCT04955626|583438042|FG006|Blinded Period|Refused further study procedures|1|||
161559634|NCT04955626|583438043|FG007|Blinded Period|Refused further study procedures|0|||
161559635|NCT04955626|583438044|FG008|Blinded Period|Refused further study procedures|0|||
161559636|NCT04955626|583438045|FG009|Blinded Period|Refused further study procedures|0|||
161559637|NCT04955626|583438046|FG010|Blinded Period|Refused further study procedures|0|||
161559638|NCT04955626|583438047|FG011|Blinded Period|Refused further study procedures|2|||
161559639|NCT04955626|583438048|FG012|Blinded Period|Refused further study procedures|0|||
161559640|NCT04955626|583438049|FG013|Blinded Period|Refused further study procedures|0|||
161559641|NCT04955626|583438050|FG014|Blinded Period|Refused further study procedures|0|||
161559642|NCT04955626|583438051|FG015|Blinded Period|Refused further study procedures|0|||
161559643|NCT04955626|583438052|FG016|Blinded Period|Refused further study procedures|0|||
161802201|NCT02848326|584319607|FG004|Treatment Period|Non-compliance with Study Drug|0|||
161802202|NCT02848326|584319608|FG005|Treatment Period|Non-compliance with Study Drug|0|||
161802203|NCT02848326|584319603|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
161802204|NCT02848326|584319604|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
161802205|NCT02848326|584319605|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
161802206|NCT02848326|584319606|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
161802207|NCT02848326|584319607|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
161802208|NCT02848326|584319608|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
161559644|NCT04955626|583438053|FG017|Blinded Period|Refused further study procedures|0|||
161802209|NCT02848326|584319603|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
161559645|NCT04955626|583438054|FG018|Blinded Period|Refused further study procedures|0|||
161802210|NCT02848326|584319604|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161802211|NCT02848326|584319605|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
161559646|NCT04955626|583438055|FG019|Blinded Period|Refused further study procedures|0|||
161559647|NCT04955626|583438056|FG020|Blinded Period|Refused further study procedures|0|||
161559648|NCT04955626|583438057|FG021|Blinded Period|Refused further study procedures|0|||
161559649|NCT04955626|583438058|FG022|Blinded Period|Refused further study procedures|0|||
161559650|NCT04955626|583438059|FG023|Blinded Period|Refused further study procedures|0|||
161802212|NCT02848326|584319606|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
161559651|NCT04955626|583438060|FG024|Blinded Period|Refused further study procedures|0|||
161559652|NCT04955626|583438061|FG025|Blinded Period|Refused further study procedures|0|||
161559653|NCT04955626|583438062|FG026|Blinded Period|Refused further study procedures|0|||
161559654|NCT04955626|583438063|FG027|Blinded Period|Refused further study procedures|0|||
161559655|NCT04955626|583438064|FG028|Blinded Period|Refused further study procedures|0|||
161559656|NCT04955626|583438065|FG029|Blinded Period|Refused further study procedures|0|||
161559657|NCT04955626|583438066|FG030|Blinded Period|Refused further study procedures|0|||
161559658|NCT04955626|583438067|FG031|Blinded Period|Refused further study procedures|0|||
161559659|NCT04955626|583438068|FG032|Blinded Period|Refused further study procedures|0|||
161559660|NCT04955626|583438069|FG033|Blinded Period|Refused further study procedures|0|||
161559661|NCT04955626|583438070|FG034|Blinded Period|Refused further study procedures|0|||
161559662|NCT04955626|583438071|FG035|Blinded Period|Refused further study procedures|0|||
161559663|NCT04955626|583438036|FG000|Blinded Period|Participants entered open label period|4544|||
161559664|NCT04955626|583438037|FG001|Blinded Period|Participants entered open label period|4906|||
161559665|NCT04955626|583438038|FG002|Blinded Period|Participants entered open label period|0|||
161559666|NCT04955626|583438039|FG003|Blinded Period|Participants entered open label period|0|||
161559667|NCT04955626|583438040|FG004|Blinded Period|Participants entered open label period|0|||
161559668|NCT04955626|583438041|FG005|Blinded Period|Participants entered open label period|0|||
161559669|NCT04955626|583438042|FG006|Blinded Period|Participants entered open label period|0|||
161559670|NCT04955626|583438043|FG007|Blinded Period|Participants entered open label period|0|||
161559671|NCT04955626|583438044|FG008|Blinded Period|Participants entered open label period|0|||
161559672|NCT04955626|583438045|FG009|Blinded Period|Participants entered open label period|0|||
161559673|NCT04955626|583438046|FG010|Blinded Period|Participants entered open label period|0|||
161559674|NCT04955626|583438047|FG011|Blinded Period|Participants entered open label period|0|||
161559675|NCT04955626|583438048|FG012|Blinded Period|Participants entered open label period|0|||
161559676|NCT04955626|583438049|FG013|Blinded Period|Participants entered open label period|0|||
161559677|NCT04955626|583438050|FG014|Blinded Period|Participants entered open label period|0|||
161559678|NCT04955626|583438051|FG015|Blinded Period|Participants entered open label period|0|||
161559679|NCT04955626|583438052|FG016|Blinded Period|Participants entered open label period|0|||
161559680|NCT04955626|583438053|FG017|Blinded Period|Participants entered open label period|0|||
161559681|NCT04955626|583438054|FG018|Blinded Period|Participants entered open label period|0|||
161559682|NCT04955626|583438055|FG019|Blinded Period|Participants entered open label period|0|||
161559683|NCT04955626|583438056|FG020|Blinded Period|Participants entered open label period|0|||
161559684|NCT04955626|583438057|FG021|Blinded Period|Participants entered open label period|0|||
161559685|NCT04955626|583438058|FG022|Blinded Period|Participants entered open label period|0|||
161559686|NCT04955626|583438059|FG023|Blinded Period|Participants entered open label period|0|||
161559687|NCT04955626|583438060|FG024|Blinded Period|Participants entered open label period|0|||
161559688|NCT04955626|583438061|FG025|Blinded Period|Participants entered open label period|0|||
161559689|NCT04955626|583438062|FG026|Blinded Period|Participants entered open label period|0|||
161559690|NCT04955626|583438063|FG027|Blinded Period|Participants entered open label period|0|||
161559691|NCT04955626|583438064|FG028|Blinded Period|Participants entered open label period|0|||
161559692|NCT04955626|583438065|FG029|Blinded Period|Participants entered open label period|0|||
161559693|NCT04955626|583438066|FG030|Blinded Period|Participants entered open label period|0|||
161559694|NCT04955626|583438067|FG031|Blinded Period|Participants entered open label period|0|||
161559695|NCT04955626|583438068|FG032|Blinded Period|Participants entered open label period|0|||
161559696|NCT04955626|583438069|FG033|Blinded Period|Participants entered open label period|0|||
161559697|NCT04955626|583438070|FG034|Blinded Period|Participants entered open label period|0|||
161559698|NCT04955626|583438071|FG035|Blinded Period|Participants entered open label period|0|||
161559699|NCT04955626|583438036|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
161559700|NCT04955626|583438037|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
161559701|NCT04955626|583438038|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
161559702|NCT04955626|583438039|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
161559703|NCT04955626|583438040|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
161559704|NCT04955626|583438041|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
161559705|NCT04955626|583438042|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
161559706|NCT04955626|583438043|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
161802213|NCT02848326|584319607|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
161802214|NCT02848326|584319608|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
161802215|NCT04349917|584319626|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
161802216|NCT04349917|584319627|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
161802217|NCT04349917|584319626|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
161802218|NCT04349917|584319627|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
161802219|NCT00441467|584319631|FG000|Overall Study|Adverse Event|6|||
161802220|NCT00441467|584319631|FG000|Overall Study|Withdrawal by Subject|3|||
161802221|NCT00441467|584319631|FG000|Overall Study|Progressive disease|9|||
161802222|NCT01042522|584319633|FG000|Overall Study|Adverse Event|1|||
161802223|NCT01042522|584319634|FG001|Overall Study|Adverse Event|2|||
161802224|NCT01042522|584319633|FG000|Overall Study|Disease Progression|5|||
161802225|NCT01042522|584319634|FG001|Overall Study|Disease Progression|0|||
161802226|NCT01042522|584319633|FG000|Overall Study|Death|1|||
161802227|NCT01042522|584319634|FG001|Overall Study|Death|0|||
161802228|NCT01042522|584319633|FG000|Overall Study|Patient Refused|0|||
161802229|NCT01042522|584319634|FG001|Overall Study|Patient Refused|3|||
161802230|NCT01042522|584319633|FG000|Overall Study|Withdrawal by Subject|1|||
161802231|NCT01042522|584319634|FG001|Overall Study|Withdrawal by Subject|1|||
161802232|NCT00745420|584319638|FG000|Overall Study|Ineligible|1|||
161452056|NCT01642615|583050729|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
161452057|NCT00402740|583050732|FG000|Overall Study|Withdrawal by Subject|18|||
161452058|NCT00402740|583050732|FG000|Overall Study|Death|50|||
161452059|NCT00402740|583050732|FG000|Overall Study|Lost to Follow-up|6|||
161452060|NCT00402740|583050732|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
161452061|NCT00402740|583050732|FG000|Overall Study|Subject disposition unknown.|1|||
161452062|NCT00715910|583050733|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
161452063|NCT00715910|583050734|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
161452064|NCT00715910|583050735|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
161452065|NCT00715910|583050736|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
161452066|NCT00715910|583050737|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
161452067|NCT00715910|583050738|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
161452068|NCT00715910|583050733|FG000|Booster and ESFU Phase|Other|0|||
161452069|NCT00715910|583050734|FG001|Booster and ESFU Phase|Other|0|||
161452070|NCT00715910|583050735|FG002|Booster and ESFU Phase|Other|0|||
161452071|NCT00715910|583050736|FG003|Booster and ESFU Phase|Other|5|||
161452072|NCT00715910|583050737|FG004|Booster and ESFU Phase|Other|1|||
161452073|NCT00715910|583050738|FG005|Booster and ESFU Phase|Other|0|||
161452074|NCT01185353|583050739|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
161452075|NCT01185353|583050740|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
161452076|NCT01185353|583050741|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
161452077|NCT01185353|583050742|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
161452078|NCT01185353|583050743|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
161452079|NCT01185353|583050744|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
161452080|NCT01185353|583050745|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
161452081|NCT01185353|583050746|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
161452082|NCT01185353|583050747|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
161452083|NCT01185353|583050748|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
161452084|NCT01185353|583050739|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452085|NCT01185353|583050740|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452086|NCT01185353|583050741|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452087|NCT01185353|583050742|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452088|NCT01185353|583050743|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
161452089|NCT01185353|583050744|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452090|NCT01185353|583050745|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452091|NCT01185353|583050746|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452092|NCT01185353|583050747|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452093|NCT01185353|583050748|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161452094|NCT01185353|583050739|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
161452095|NCT01185353|583050740|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452096|NCT01185353|583050741|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452097|NCT01185353|583050742|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452098|NCT01185353|583050743|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
161452099|NCT01185353|583050744|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452100|NCT01185353|583050745|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452101|NCT01185353|583050746|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452102|NCT01185353|583050747|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452103|NCT01185353|583050748|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161452104|NCT01185353|583050739|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452105|NCT01185353|583050740|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452106|NCT01185353|583050741|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
161452107|NCT01185353|583050742|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452108|NCT01185353|583050743|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
161452109|NCT01185353|583050744|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452110|NCT01185353|583050745|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452111|NCT01185353|583050746|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452112|NCT01185353|583050747|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452113|NCT01185353|583050748|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161452114|NCT01185353|583050739|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452115|NCT01185353|583050740|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452116|NCT01185353|583050741|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161802233|NCT00088829|584319648|FG000|Overall Study|PI left institution and study was close|22|||
161802234|NCT01367275|584319649|FG000|Overall Study|Ineligible|1|||
161802235|NCT01367275|584319649|FG000|Overall Study|Disease Progression|2|||
161452117|NCT01185353|583050742|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452118|NCT01185353|583050743|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
161905439|NCT04070989|584703342|FG001|Overall Study|Death|0|||
161905440|NCT04070989|584703343|FG002|Overall Study|Death|0|||
161905441|NCT04070989|584703341|FG000|Overall Study|Study Terminated by Sponsor|7|||
161905442|NCT04070989|584703342|FG001|Overall Study|Study Terminated by Sponsor|8|||
161905443|NCT04070989|584703343|FG002|Overall Study|Study Terminated by Sponsor|23|||
161905444|NCT04070989|584703341|FG000|Overall Study|Withdrawal by Subject|0|||
161905445|NCT04070989|584703342|FG001|Overall Study|Withdrawal by Subject|1|||
161905446|NCT04070989|584703343|FG002|Overall Study|Withdrawal by Subject|0|||
161559707|NCT04955626|583438044|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
161559708|NCT04955626|583438045|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
161559709|NCT04955626|583438046|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
161559710|NCT04955626|583438047|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
161559711|NCT04955626|583438048|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
161559712|NCT04955626|583438049|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
161559713|NCT04955626|583438050|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
161559714|NCT04955626|583438051|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
161559715|NCT04955626|583438052|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
161559716|NCT04955626|583438053|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
161559717|NCT04955626|583438054|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
161559718|NCT04955626|583438055|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
161559719|NCT04955626|583438056|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
161559720|NCT04955626|583438057|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
161559721|NCT04955626|583438058|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
161559722|NCT04955626|583438059|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
161559723|NCT04955626|583438060|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
161559724|NCT04955626|583438061|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
161559725|NCT04955626|583438062|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
161559726|NCT04955626|583438063|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
161559727|NCT04955626|583438064|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
161559728|NCT04955626|583438065|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
161559729|NCT04955626|583438066|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
161559730|NCT04955626|583438067|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
161559731|NCT04955626|583438068|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
161559732|NCT04955626|583438069|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
161559733|NCT04955626|583438070|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
161559734|NCT04955626|583438071|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
161559735|NCT04955626|583438036|FG000|Blinded Period|Medication error|0|||
161559736|NCT04955626|583438037|FG001|Blinded Period|Medication error|0|||
161559737|NCT04955626|583438038|FG002|Blinded Period|Medication error|0|||
161559738|NCT04955626|583438039|FG003|Blinded Period|Medication error|0|||
161559739|NCT04955626|583438040|FG004|Blinded Period|Medication error|0|||
161559740|NCT04955626|583438041|FG005|Blinded Period|Medication error|0|||
161559741|NCT04955626|583438042|FG006|Blinded Period|Medication error|0|||
161559742|NCT04955626|583438043|FG007|Blinded Period|Medication error|0|||
161559743|NCT04955626|583438044|FG008|Blinded Period|Medication error|0|||
161559744|NCT04955626|583438045|FG009|Blinded Period|Medication error|0|||
161559745|NCT04955626|583438046|FG010|Blinded Period|Medication error|2|||
161559746|NCT04955626|583438047|FG011|Blinded Period|Medication error|0|||
161559747|NCT04955626|583438048|FG012|Blinded Period|Medication error|0|||
161559748|NCT04955626|583438049|FG013|Blinded Period|Medication error|0|||
161559749|NCT04955626|583438050|FG014|Blinded Period|Medication error|0|||
161559750|NCT04955626|583438051|FG015|Blinded Period|Medication error|0|||
161559751|NCT04955626|583438052|FG016|Blinded Period|Medication error|0|||
161559752|NCT04955626|583438053|FG017|Blinded Period|Medication error|0|||
161559753|NCT04955626|583438054|FG018|Blinded Period|Medication error|0|||
161559754|NCT04955626|583438055|FG019|Blinded Period|Medication error|0|||
161559755|NCT04955626|583438056|FG020|Blinded Period|Medication error|0|||
161559756|NCT04955626|583438057|FG021|Blinded Period|Medication error|0|||
161559757|NCT04955626|583438058|FG022|Blinded Period|Medication error|0|||
161559758|NCT04955626|583438059|FG023|Blinded Period|Medication error|0|||
161559759|NCT04955626|583438060|FG024|Blinded Period|Medication error|0|||
161559760|NCT04955626|583438061|FG025|Blinded Period|Medication error|0|||
161559761|NCT04955626|583438062|FG026|Blinded Period|Medication error|0|||
161559762|NCT04955626|583438063|FG027|Blinded Period|Medication error|0|||
161905447|NCT04070989|584703341|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
161905448|NCT04070989|584703342|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
161905449|NCT04070989|584703343|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
161905450|NCT04070989|584703341|FG000|Overall Study|Other|1|||
161905451|NCT04070989|584703342|FG001|Overall Study|Other|1|||
161905452|NCT04070989|584703343|FG002|Overall Study|Other|0|||
161559763|NCT04955626|583438064|FG028|Blinded Period|Medication error|4|||
161559764|NCT04955626|583438065|FG029|Blinded Period|Medication error|0|||
161559765|NCT04955626|583438066|FG030|Blinded Period|Medication error|0|||
161559766|NCT04955626|583438067|FG031|Blinded Period|Medication error|0|||
161559767|NCT04955626|583438068|FG032|Blinded Period|Medication error|0|||
161559768|NCT04955626|583438069|FG033|Blinded Period|Medication error|0|||
161559769|NCT04955626|583438070|FG034|Blinded Period|Medication error|0|||
161559770|NCT04955626|583438071|FG035|Blinded Period|Medication error|0|||
161559771|NCT04955626|583438036|FG000|Open-Label Period|Lost to Follow-up|109|||
161559772|NCT04955626|583438037|FG001|Open-Label Period|Lost to Follow-up|41|||
161559773|NCT04955626|583438038|FG002|Open-Label Period|Lost to Follow-up|0|||
161559774|NCT04955626|583438039|FG003|Open-Label Period|Lost to Follow-up|0|||
161559775|NCT04955626|583438040|FG004|Open-Label Period|Lost to Follow-up|0|||
161559776|NCT04955626|583438041|FG005|Open-Label Period|Lost to Follow-up|0|||
161559777|NCT04955626|583438042|FG006|Open-Label Period|Lost to Follow-up|0|||
161559778|NCT04955626|583438043|FG007|Open-Label Period|Lost to Follow-up|0|||
161559779|NCT04955626|583438044|FG008|Open-Label Period|Lost to Follow-up|0|||
161559780|NCT04955626|583438045|FG009|Open-Label Period|Lost to Follow-up|0|||
161559781|NCT04955626|583438046|FG010|Open-Label Period|Lost to Follow-up|0|||
161559782|NCT04955626|583438047|FG011|Open-Label Period|Lost to Follow-up|0|||
161559783|NCT04955626|583438048|FG012|Open-Label Period|Lost to Follow-up|0|||
161559784|NCT04955626|583438049|FG013|Open-Label Period|Lost to Follow-up|0|||
161559785|NCT04955626|583438050|FG014|Open-Label Period|Lost to Follow-up|0|||
161559786|NCT04955626|583438051|FG015|Open-Label Period|Lost to Follow-up|0|||
161559787|NCT04955626|583438052|FG016|Open-Label Period|Lost to Follow-up|0|||
161559788|NCT04955626|583438053|FG017|Open-Label Period|Lost to Follow-up|0|||
161559789|NCT04955626|583438054|FG018|Open-Label Period|Lost to Follow-up|0|||
161559790|NCT04955626|583438055|FG019|Open-Label Period|Lost to Follow-up|0|||
161559791|NCT04955626|583438056|FG020|Open-Label Period|Lost to Follow-up|0|||
161559792|NCT04955626|583438057|FG021|Open-Label Period|Lost to Follow-up|0|||
161559793|NCT04955626|583438058|FG022|Open-Label Period|Lost to Follow-up|0|||
161559794|NCT04955626|583438059|FG023|Open-Label Period|Lost to Follow-up|0|||
161559795|NCT04955626|583438060|FG024|Open-Label Period|Lost to Follow-up|0|||
161559796|NCT04955626|583438061|FG025|Open-Label Period|Lost to Follow-up|0|||
161559797|NCT04955626|583438062|FG026|Open-Label Period|Lost to Follow-up|0|||
161559798|NCT04955626|583438063|FG027|Open-Label Period|Lost to Follow-up|0|||
161559799|NCT04955626|583438064|FG028|Open-Label Period|Lost to Follow-up|0|||
161559800|NCT04955626|583438065|FG029|Open-Label Period|Lost to Follow-up|0|||
161559801|NCT04955626|583438066|FG030|Open-Label Period|Lost to Follow-up|0|||
161559802|NCT04955626|583438067|FG031|Open-Label Period|Lost to Follow-up|0|||
161559803|NCT04955626|583438068|FG032|Open-Label Period|Lost to Follow-up|0|||
161559804|NCT04955626|583438069|FG033|Open-Label Period|Lost to Follow-up|0|||
161559805|NCT04955626|583438070|FG034|Open-Label Period|Lost to Follow-up|0|||
161559806|NCT04955626|583438071|FG035|Open-Label Period|Lost to Follow-up|0|||
161559807|NCT04955626|583438036|FG000|Open-Label Period|Protocol Violation|377|||
161559808|NCT04955626|583438037|FG001|Open-Label Period|Protocol Violation|48|||
161559809|NCT04955626|583438038|FG002|Open-Label Period|Protocol Violation|0|||
161559810|NCT04955626|583438039|FG003|Open-Label Period|Protocol Violation|0|||
161559811|NCT04955626|583438040|FG004|Open-Label Period|Protocol Violation|0|||
161559812|NCT04955626|583438041|FG005|Open-Label Period|Protocol Violation|0|||
161559813|NCT04955626|583438042|FG006|Open-Label Period|Protocol Violation|0|||
161559814|NCT04955626|583438043|FG007|Open-Label Period|Protocol Violation|0|||
161559815|NCT04955626|583438044|FG008|Open-Label Period|Protocol Violation|0|||
161559816|NCT04955626|583438045|FG009|Open-Label Period|Protocol Violation|0|||
161559817|NCT04955626|583438046|FG010|Open-Label Period|Protocol Violation|0|||
161559818|NCT04955626|583438047|FG011|Open-Label Period|Protocol Violation|0|||
161559819|NCT04955626|583438048|FG012|Open-Label Period|Protocol Violation|0|||
161559820|NCT04955626|583438049|FG013|Open-Label Period|Protocol Violation|0|||
161559821|NCT04955626|583438050|FG014|Open-Label Period|Protocol Violation|0|||
161559822|NCT04955626|583438051|FG015|Open-Label Period|Protocol Violation|0|||
161559823|NCT04955626|583438052|FG016|Open-Label Period|Protocol Violation|0|||
161559824|NCT04955626|583438053|FG017|Open-Label Period|Protocol Violation|0|||
161559825|NCT04955626|583438054|FG018|Open-Label Period|Protocol Violation|0|||
161559826|NCT04955626|583438055|FG019|Open-Label Period|Protocol Violation|0|||
161559827|NCT04955626|583438056|FG020|Open-Label Period|Protocol Violation|0|||
161559828|NCT04955626|583438057|FG021|Open-Label Period|Protocol Violation|0|||
161802236|NCT02532764|584319650|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802237|NCT02532764|584319651|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802238|NCT02532764|584319652|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802239|NCT02532764|584319653|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161559829|NCT04955626|583438058|FG022|Open-Label Period|Protocol Violation|0|||
161559830|NCT04955626|583438059|FG023|Open-Label Period|Protocol Violation|0|||
161559831|NCT04955626|583438060|FG024|Open-Label Period|Protocol Violation|0|||
161802240|NCT02532764|584319654|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802241|NCT02532764|584319655|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161559832|NCT04955626|583438061|FG025|Open-Label Period|Protocol Violation|0|||
161559833|NCT04955626|583438062|FG026|Open-Label Period|Protocol Violation|0|||
161559834|NCT04955626|583438063|FG027|Open-Label Period|Protocol Violation|0|||
161559835|NCT04955626|583438064|FG028|Open-Label Period|Protocol Violation|0|||
161559836|NCT04955626|583438065|FG029|Open-Label Period|Protocol Violation|0|||
161559837|NCT04955626|583438066|FG030|Open-Label Period|Protocol Violation|0|||
161559838|NCT04955626|583438067|FG031|Open-Label Period|Protocol Violation|0|||
161559839|NCT04955626|583438068|FG032|Open-Label Period|Protocol Violation|0|||
161559840|NCT04955626|583438069|FG033|Open-Label Period|Protocol Violation|0|||
161559841|NCT04955626|583438070|FG034|Open-Label Period|Protocol Violation|0|||
161559842|NCT04955626|583438071|FG035|Open-Label Period|Protocol Violation|0|||
161559843|NCT04955626|583438036|FG000|Open-Label Period|Death|5|||
161559844|NCT04955626|583438037|FG001|Open-Label Period|Death|5|||
161559845|NCT04955626|583438038|FG002|Open-Label Period|Death|0|||
161559846|NCT04955626|583438039|FG003|Open-Label Period|Death|0|||
161559847|NCT04955626|583438040|FG004|Open-Label Period|Death|0|||
161559848|NCT04955626|583438041|FG005|Open-Label Period|Death|0|||
161559849|NCT04955626|583438042|FG006|Open-Label Period|Death|0|||
161559850|NCT04955626|583438043|FG007|Open-Label Period|Death|0|||
161559851|NCT04955626|583438044|FG008|Open-Label Period|Death|0|||
161559852|NCT04955626|583438045|FG009|Open-Label Period|Death|0|||
161559853|NCT04955626|583438046|FG010|Open-Label Period|Death|0|||
161559854|NCT04955626|583438047|FG011|Open-Label Period|Death|0|||
161559855|NCT04955626|583438048|FG012|Open-Label Period|Death|0|||
161559856|NCT04955626|583438049|FG013|Open-Label Period|Death|0|||
161559857|NCT04955626|583438050|FG014|Open-Label Period|Death|0|||
161559858|NCT04955626|583438051|FG015|Open-Label Period|Death|0|||
161559859|NCT04955626|583438052|FG016|Open-Label Period|Death|0|||
161559860|NCT04955626|583438053|FG017|Open-Label Period|Death|0|||
161559861|NCT04955626|583438054|FG018|Open-Label Period|Death|0|||
161559862|NCT04955626|583438055|FG019|Open-Label Period|Death|0|||
161559863|NCT04955626|583438056|FG020|Open-Label Period|Death|0|||
161559864|NCT04955626|583438057|FG021|Open-Label Period|Death|0|||
161559865|NCT04955626|583438058|FG022|Open-Label Period|Death|0|||
161559866|NCT04955626|583438059|FG023|Open-Label Period|Death|0|||
161559867|NCT04955626|583438060|FG024|Open-Label Period|Death|0|||
161559868|NCT04955626|583438061|FG025|Open-Label Period|Death|0|||
161559869|NCT04955626|583438062|FG026|Open-Label Period|Death|0|||
161559870|NCT04955626|583438063|FG027|Open-Label Period|Death|0|||
161559871|NCT04955626|583438064|FG028|Open-Label Period|Death|0|||
161559872|NCT04955626|583438065|FG029|Open-Label Period|Death|0|||
161559873|NCT04955626|583438066|FG030|Open-Label Period|Death|0|||
161559874|NCT04955626|583438067|FG031|Open-Label Period|Death|0|||
161559875|NCT04955626|583438068|FG032|Open-Label Period|Death|0|||
161559876|NCT04955626|583438069|FG033|Open-Label Period|Death|0|||
161559877|NCT04955626|583438070|FG034|Open-Label Period|Death|0|||
161559878|NCT04955626|583438071|FG035|Open-Label Period|Death|0|||
161559879|NCT04955626|583438036|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
161559880|NCT04955626|583438037|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
161559881|NCT04955626|583438038|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
161559882|NCT04955626|583438039|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
161559883|NCT04955626|583438040|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
161559884|NCT04955626|583438041|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
161559885|NCT04955626|583438042|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
161559886|NCT04955626|583438043|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
161559887|NCT04955626|583438044|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
161559888|NCT04955626|583438045|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
161559889|NCT04955626|583438046|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
161559890|NCT04955626|583438047|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
161559891|NCT04955626|583438048|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
161559892|NCT04955626|583438049|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
161559893|NCT04955626|583438050|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
161559894|NCT04955626|583438051|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
161559895|NCT04955626|583438052|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
161559896|NCT04955626|583438053|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
161559897|NCT04955626|583438054|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
161559898|NCT04955626|583438055|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
161559899|NCT04955626|583438056|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
161559900|NCT04955626|583438057|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
161559901|NCT04955626|583438058|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
161559902|NCT04955626|583438059|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
161559903|NCT04955626|583438060|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
161559904|NCT04955626|583438061|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
161905453|NCT06088784|584703344|FG000|Overall Study|Adverse Event|0|||
161559905|NCT04955626|583438062|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
161559906|NCT04955626|583438063|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
161559907|NCT04955626|583438064|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
161559908|NCT04955626|583438065|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
161559909|NCT04955626|583438066|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
161559910|NCT04955626|583438067|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
161559911|NCT04955626|583438068|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
161559912|NCT04955626|583438069|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
161559913|NCT04955626|583438070|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
161559914|NCT04955626|583438071|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
161559915|NCT04955626|583438036|FG000|Open-Label Period|Other|621|||
161559916|NCT04955626|583438037|FG001|Open-Label Period|Other|429|||
161559917|NCT04955626|583438038|FG002|Open-Label Period|Other|0|||
161559918|NCT04955626|583438039|FG003|Open-Label Period|Other|0|||
161559919|NCT04955626|583438040|FG004|Open-Label Period|Other|0|||
161559920|NCT04955626|583438041|FG005|Open-Label Period|Other|0|||
161559921|NCT04955626|583438042|FG006|Open-Label Period|Other|0|||
161559922|NCT04955626|583438043|FG007|Open-Label Period|Other|0|||
161559923|NCT04955626|583438044|FG008|Open-Label Period|Other|0|||
161559924|NCT04955626|583438045|FG009|Open-Label Period|Other|0|||
161559925|NCT04955626|583438046|FG010|Open-Label Period|Other|0|||
161559926|NCT04955626|583438047|FG011|Open-Label Period|Other|0|||
161559927|NCT04955626|583438048|FG012|Open-Label Period|Other|0|||
161559928|NCT04955626|583438049|FG013|Open-Label Period|Other|0|||
161559929|NCT04955626|583438050|FG014|Open-Label Period|Other|0|||
161559930|NCT04955626|583438051|FG015|Open-Label Period|Other|0|||
161559931|NCT04955626|583438052|FG016|Open-Label Period|Other|0|||
161559932|NCT04955626|583438053|FG017|Open-Label Period|Other|0|||
161559933|NCT04955626|583438054|FG018|Open-Label Period|Other|0|||
161559934|NCT04955626|583438055|FG019|Open-Label Period|Other|0|||
161559935|NCT04955626|583438056|FG020|Open-Label Period|Other|0|||
161559936|NCT04955626|583438057|FG021|Open-Label Period|Other|0|||
161559937|NCT04955626|583438058|FG022|Open-Label Period|Other|0|||
161559938|NCT04955626|583438059|FG023|Open-Label Period|Other|0|||
161559939|NCT04955626|583438060|FG024|Open-Label Period|Other|0|||
161559940|NCT04955626|583438061|FG025|Open-Label Period|Other|0|||
161559941|NCT04955626|583438062|FG026|Open-Label Period|Other|0|||
161559942|NCT04955626|583438063|FG027|Open-Label Period|Other|0|||
161559943|NCT04955626|583438064|FG028|Open-Label Period|Other|0|||
161559944|NCT04955626|583438065|FG029|Open-Label Period|Other|0|||
161559945|NCT04955626|583438066|FG030|Open-Label Period|Other|0|||
161559946|NCT04955626|583438067|FG031|Open-Label Period|Other|0|||
161559947|NCT04955626|583438068|FG032|Open-Label Period|Other|0|||
161559948|NCT04955626|583438069|FG033|Open-Label Period|Other|0|||
161559949|NCT04955626|583438070|FG034|Open-Label Period|Other|0|||
161559950|NCT04955626|583438071|FG035|Open-Label Period|Other|0|||
161559951|NCT04955626|583438036|FG000|Open-Label Period|Physician Decision|2|||
161559952|NCT04955626|583438037|FG001|Open-Label Period|Physician Decision|0|||
161559953|NCT04955626|583438038|FG002|Open-Label Period|Physician Decision|0|||
161559954|NCT04955626|583438039|FG003|Open-Label Period|Physician Decision|0|||
161559955|NCT04955626|583438040|FG004|Open-Label Period|Physician Decision|0|||
161559956|NCT04955626|583438041|FG005|Open-Label Period|Physician Decision|0|||
161559957|NCT04955626|583438042|FG006|Open-Label Period|Physician Decision|0|||
161559958|NCT04955626|583438043|FG007|Open-Label Period|Physician Decision|0|||
161559959|NCT04955626|583438044|FG008|Open-Label Period|Physician Decision|0|||
161559960|NCT04955626|583438045|FG009|Open-Label Period|Physician Decision|0|||
161559961|NCT04955626|583438046|FG010|Open-Label Period|Physician Decision|0|||
161802242|NCT02532764|584319656|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802243|NCT02532764|584319657|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161802244|NCT02532764|584319658|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161905454|NCT06088784|584703345|FG001|Overall Study|Adverse Event|0|||
161452119|NCT01185353|583050744|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452120|NCT01185353|583050745|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452121|NCT01185353|583050746|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452122|NCT01185353|583050747|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452123|NCT01185353|583050748|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161452124|NCT01185353|583050739|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
161452125|NCT01185353|583050740|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161452126|NCT01185353|583050741|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161559962|NCT04955626|583438047|FG011|Open-Label Period|Physician Decision|0|||
161559963|NCT04955626|583438048|FG012|Open-Label Period|Physician Decision|0|||
161559964|NCT04955626|583438049|FG013|Open-Label Period|Physician Decision|0|||
161452127|NCT01185353|583050742|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161559965|NCT04955626|583438050|FG014|Open-Label Period|Physician Decision|0|||
161559966|NCT04955626|583438051|FG015|Open-Label Period|Physician Decision|0|||
161559967|NCT04955626|583438052|FG016|Open-Label Period|Physician Decision|0|||
161559968|NCT04955626|583438053|FG017|Open-Label Period|Physician Decision|0|||
161559969|NCT04955626|583438054|FG018|Open-Label Period|Physician Decision|0|||
161559970|NCT04955626|583438055|FG019|Open-Label Period|Physician Decision|0|||
161559971|NCT04955626|583438056|FG020|Open-Label Period|Physician Decision|0|||
161559972|NCT04955626|583438057|FG021|Open-Label Period|Physician Decision|0|||
161559973|NCT04955626|583438058|FG022|Open-Label Period|Physician Decision|0|||
161559974|NCT04955626|583438059|FG023|Open-Label Period|Physician Decision|0|||
161559975|NCT04955626|583438060|FG024|Open-Label Period|Physician Decision|0|||
161559976|NCT04955626|583438061|FG025|Open-Label Period|Physician Decision|0|||
161559977|NCT04955626|583438062|FG026|Open-Label Period|Physician Decision|0|||
161559978|NCT04955626|583438063|FG027|Open-Label Period|Physician Decision|0|||
161559979|NCT04955626|583438064|FG028|Open-Label Period|Physician Decision|0|||
161559980|NCT04955626|583438065|FG029|Open-Label Period|Physician Decision|0|||
161559981|NCT04955626|583438066|FG030|Open-Label Period|Physician Decision|0|||
161559982|NCT04955626|583438067|FG031|Open-Label Period|Physician Decision|0|||
161559983|NCT04955626|583438068|FG032|Open-Label Period|Physician Decision|0|||
161559984|NCT04955626|583438069|FG033|Open-Label Period|Physician Decision|0|||
161559985|NCT04955626|583438070|FG034|Open-Label Period|Physician Decision|0|||
161559986|NCT04955626|583438071|FG035|Open-Label Period|Physician Decision|0|||
161559987|NCT04955626|583438036|FG000|Open-Label Period|Withdrawal by Subject|135|||
161559988|NCT04955626|583438037|FG001|Open-Label Period|Withdrawal by Subject|25|||
161559989|NCT04955626|583438038|FG002|Open-Label Period|Withdrawal by Subject|0|||
161559990|NCT04955626|583438039|FG003|Open-Label Period|Withdrawal by Subject|0|||
161559991|NCT04955626|583438040|FG004|Open-Label Period|Withdrawal by Subject|0|||
161559992|NCT04955626|583438041|FG005|Open-Label Period|Withdrawal by Subject|0|||
161559993|NCT04955626|583438042|FG006|Open-Label Period|Withdrawal by Subject|0|||
161559994|NCT04955626|583438043|FG007|Open-Label Period|Withdrawal by Subject|0|||
161559995|NCT04955626|583438044|FG008|Open-Label Period|Withdrawal by Subject|0|||
161559996|NCT04955626|583438045|FG009|Open-Label Period|Withdrawal by Subject|0|||
161559997|NCT04955626|583438046|FG010|Open-Label Period|Withdrawal by Subject|0|||
161559998|NCT04955626|583438047|FG011|Open-Label Period|Withdrawal by Subject|0|||
161559999|NCT04955626|583438048|FG012|Open-Label Period|Withdrawal by Subject|0|||
161560000|NCT04955626|583438049|FG013|Open-Label Period|Withdrawal by Subject|0|||
161560001|NCT04955626|583438050|FG014|Open-Label Period|Withdrawal by Subject|0|||
161560002|NCT04955626|583438051|FG015|Open-Label Period|Withdrawal by Subject|0|||
161560003|NCT04955626|583438052|FG016|Open-Label Period|Withdrawal by Subject|0|||
161560004|NCT04955626|583438053|FG017|Open-Label Period|Withdrawal by Subject|0|||
161560005|NCT04955626|583438054|FG018|Open-Label Period|Withdrawal by Subject|0|||
161560006|NCT04955626|583438055|FG019|Open-Label Period|Withdrawal by Subject|0|||
161560007|NCT04955626|583438056|FG020|Open-Label Period|Withdrawal by Subject|0|||
161560008|NCT04955626|583438057|FG021|Open-Label Period|Withdrawal by Subject|0|||
161560009|NCT04955626|583438058|FG022|Open-Label Period|Withdrawal by Subject|0|||
161560010|NCT04955626|583438059|FG023|Open-Label Period|Withdrawal by Subject|0|||
161560011|NCT04955626|583438060|FG024|Open-Label Period|Withdrawal by Subject|0|||
161560012|NCT04955626|583438061|FG025|Open-Label Period|Withdrawal by Subject|0|||
161560013|NCT04955626|583438062|FG026|Open-Label Period|Withdrawal by Subject|0|||
161560014|NCT04955626|583438063|FG027|Open-Label Period|Withdrawal by Subject|0|||
161560015|NCT04955626|583438064|FG028|Open-Label Period|Withdrawal by Subject|0|||
161560016|NCT04955626|583438065|FG029|Open-Label Period|Withdrawal by Subject|0|||
161560017|NCT04955626|583438066|FG030|Open-Label Period|Withdrawal by Subject|0|||
161560018|NCT04955626|583438067|FG031|Open-Label Period|Withdrawal by Subject|0|||
161560019|NCT04955626|583438068|FG032|Open-Label Period|Withdrawal by Subject|0|||
161560020|NCT04955626|583438069|FG033|Open-Label Period|Withdrawal by Subject|0|||
161560021|NCT04955626|583438070|FG034|Open-Label Period|Withdrawal by Subject|0|||
161560022|NCT04955626|583438071|FG035|Open-Label Period|Withdrawal by Subject|0|||
161560023|NCT04955626|583438036|FG000|Open-Label Period|Refused further study procedures|1|||
161560024|NCT04955626|583438037|FG001|Open-Label Period|Refused further study procedures|0|||
161560025|NCT04955626|583438038|FG002|Open-Label Period|Refused further study procedures|0|||
161560026|NCT04955626|583438039|FG003|Open-Label Period|Refused further study procedures|0|||
161560027|NCT04955626|583438040|FG004|Open-Label Period|Refused further study procedures|0|||
161560028|NCT04955626|583438041|FG005|Open-Label Period|Refused further study procedures|0|||
161560029|NCT04955626|583438042|FG006|Open-Label Period|Refused further study procedures|0|||
161560030|NCT04955626|583438043|FG007|Open-Label Period|Refused further study procedures|0|||
161560031|NCT04955626|583438044|FG008|Open-Label Period|Refused further study procedures|0|||
161560032|NCT04955626|583438045|FG009|Open-Label Period|Refused further study procedures|0|||
161560033|NCT04955626|583438046|FG010|Open-Label Period|Refused further study procedures|0|||
161560034|NCT04955626|583438047|FG011|Open-Label Period|Refused further study procedures|0|||
161560035|NCT04955626|583438048|FG012|Open-Label Period|Refused further study procedures|0|||
161560036|NCT04955626|583438049|FG013|Open-Label Period|Refused further study procedures|0|||
161560037|NCT04955626|583438050|FG014|Open-Label Period|Refused further study procedures|0|||
161560038|NCT04955626|583438051|FG015|Open-Label Period|Refused further study procedures|0|||
161560039|NCT04955626|583438052|FG016|Open-Label Period|Refused further study procedures|0|||
161560040|NCT04955626|583438053|FG017|Open-Label Period|Refused further study procedures|0|||
161560041|NCT04955626|583438054|FG018|Open-Label Period|Refused further study procedures|0|||
161560042|NCT04955626|583438055|FG019|Open-Label Period|Refused further study procedures|0|||
161905455|NCT06088784|584703346|FG002|Overall Study|Adverse Event|0|||
161905456|NCT06088784|584703347|FG003|Overall Study|Adverse Event|0|||
161560043|NCT04955626|583438056|FG020|Open-Label Period|Refused further study procedures|0|||
161560044|NCT04955626|583438057|FG021|Open-Label Period|Refused further study procedures|0|||
161560045|NCT04955626|583438058|FG022|Open-Label Period|Refused further study procedures|0|||
161560046|NCT04955626|583438059|FG023|Open-Label Period|Refused further study procedures|0|||
161905457|NCT06088784|584703348|FG004|Overall Study|Adverse Event|0|||
161905458|NCT06088784|584703349|FG005|Overall Study|Adverse Event|0|||
161905459|NCT06088784|584703350|FG006|Overall Study|Adverse Event|3|||
161905460|NCT06088784|584703351|FG007|Overall Study|Adverse Event|0|||
161905461|NCT06088784|584703352|FG008|Overall Study|Adverse Event|0|||
161905462|NCT06088784|584703353|FG009|Overall Study|Adverse Event|0|||
161905463|NCT06088784|584703354|FG010|Overall Study|Adverse Event|0|||
161905464|NCT06088784|584703355|FG011|Overall Study|Adverse Event|0|||
161905465|NCT06088784|584703344|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905466|NCT06088784|584703345|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905467|NCT06088784|584703346|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905468|NCT06088784|584703347|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905469|NCT06088784|584703348|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905470|NCT06088784|584703349|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905471|NCT06088784|584703350|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
161905472|NCT06088784|584703351|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905473|NCT06088784|584703352|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905474|NCT06088784|584703353|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905475|NCT06088784|584703354|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905476|NCT06088784|584703355|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905477|NCT05556616|584703358|FG000|Overall Study|Withdrawal by Subject|1|||
161905478|NCT05556616|584703359|FG001|Overall Study|Withdrawal by Subject|0|||
161905479|NCT05556616|584703360|FG002|Overall Study|Withdrawal by Subject|0|||
161452128|NCT01185353|583050743|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
161452129|NCT01185353|583050744|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161452130|NCT01185353|583050745|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161452131|NCT01185353|583050746|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161452132|NCT01185353|583050747|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161452133|NCT01185353|583050748|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161452134|NCT01185353|583050739|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452135|NCT01185353|583050740|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452136|NCT01185353|583050741|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
161452137|NCT01185353|583050742|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452138|NCT01185353|583050743|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452139|NCT01185353|583050744|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
161452140|NCT01185353|583050745|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452141|NCT01185353|583050746|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452142|NCT01185353|583050747|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452143|NCT01185353|583050748|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
161452144|NCT01185353|583050739|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452145|NCT01185353|583050740|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
161452146|NCT01185353|583050741|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452147|NCT01185353|583050742|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
161452148|NCT01185353|583050743|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452149|NCT01185353|583050744|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452150|NCT01185353|583050745|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452151|NCT01185353|583050746|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452152|NCT01185353|583050747|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452153|NCT01185353|583050748|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161452154|NCT01185353|583050739|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452155|NCT01185353|583050740|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452156|NCT01185353|583050741|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452157|NCT01185353|583050742|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
161452158|NCT01185353|583050743|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452159|NCT01185353|583050744|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452160|NCT01185353|583050745|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
161452161|NCT01185353|583050746|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452162|NCT01185353|583050747|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452163|NCT01185353|583050748|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
161452164|NCT01185353|583050739|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161452165|NCT01185353|583050740|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161560047|NCT04955626|583438060|FG024|Open-Label Period|Refused further study procedures|0|||
161905480|NCT05556616|584703361|FG003|Overall Study|Withdrawal by Subject|0|||
161905481|NCT05556616|584703362|FG004|Overall Study|Withdrawal by Subject|0|||
161905482|NCT05556616|584703363|FG005|Overall Study|Withdrawal by Subject|0|||
161905483|NCT05556616|584703364|FG006|Overall Study|Withdrawal by Subject|0|||
161452166|NCT01185353|583050741|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
161452167|NCT01185353|583050742|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
161452168|NCT01185353|583050743|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161452169|NCT01185353|583050744|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
161452170|NCT01185353|583050745|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
161905484|NCT05556616|584703358|FG000|Overall Study|Death|0|||
161560048|NCT04955626|583438061|FG025|Open-Label Period|Refused further study procedures|0|||
161560049|NCT04955626|583438062|FG026|Open-Label Period|Refused further study procedures|0|||
161560050|NCT04955626|583438063|FG027|Open-Label Period|Refused further study procedures|0|||
161560051|NCT04955626|583438064|FG028|Open-Label Period|Refused further study procedures|0|||
161560052|NCT04955626|583438065|FG029|Open-Label Period|Refused further study procedures|0|||
161560053|NCT04955626|583438066|FG030|Open-Label Period|Refused further study procedures|0|||
161560054|NCT04955626|583438067|FG031|Open-Label Period|Refused further study procedures|0|||
161560055|NCT04955626|583438068|FG032|Open-Label Period|Refused further study procedures|0|||
161560056|NCT04955626|583438069|FG033|Open-Label Period|Refused further study procedures|0|||
161802245|NCT02532764|584319659|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161802246|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
161802247|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
161802248|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
161802249|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
161802250|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
161802251|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
161802252|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
161802253|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
161802254|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
161802255|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
161802256|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
161802257|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
161802258|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
161802259|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
161802260|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
161802261|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Death|1|||
161802262|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Death|1|||
161802263|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Death|0|||
161802264|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
161802265|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
161802266|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
161802267|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
161802268|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
161802269|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
161802270|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
161802271|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
161802272|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
161802273|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
161802274|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
161802275|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
161802276|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
161802277|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
161802278|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
161802279|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
161802280|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
161802281|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
161802282|NCT00048568|584319661|FG000|Open-Label Period|Death|0|||
161802283|NCT00048568|584319662|FG001|Open-Label Period|Death|0|||
161802284|NCT00048568|584319663|FG002|Open-Label Period|Death|13|||
161802285|NCT00048568|584319661|FG000|Open-Label Period|Adverse Event|0|||
161802286|NCT00048568|584319662|FG001|Open-Label Period|Adverse Event|0|||
161802287|NCT00048568|584319663|FG002|Open-Label Period|Adverse Event|49|||
161802288|NCT00048568|584319661|FG000|Open-Label Period|Lack of Efficacy|0|||
161802289|NCT00048568|584319662|FG001|Open-Label Period|Lack of Efficacy|0|||
161802290|NCT00048568|584319663|FG002|Open-Label Period|Lack of Efficacy|32|||
161802291|NCT00048568|584319661|FG000|Open-Label Period|Withdrawal by Subject|0|||
161802292|NCT00048568|584319662|FG001|Open-Label Period|Withdrawal by Subject|0|||
161802293|NCT00048568|584319663|FG002|Open-Label Period|Withdrawal by Subject|26|||
161802294|NCT00048568|584319661|FG000|Open-Label Period|Pregnancy|0|||
161802295|NCT00048568|584319662|FG001|Open-Label Period|Pregnancy|0|||
161802296|NCT00048568|584319663|FG002|Open-Label Period|Pregnancy|5|||
161802297|NCT00048568|584319661|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
161802298|NCT00048568|584319662|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
161905485|NCT05556616|584703359|FG001|Overall Study|Death|0|||
161905486|NCT05556616|584703360|FG002|Overall Study|Death|2|||
161905487|NCT05556616|584703361|FG003|Overall Study|Death|1|||
161560057|NCT04955626|583438070|FG034|Open-Label Period|Refused further study procedures|0|||
161560058|NCT04955626|583438071|FG035|Open-Label Period|Refused further study procedures|0|||
161802299|NCT00048568|584319663|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
161802300|NCT00048568|584319661|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
161560059|NCT04955626|583438036|FG000|Open-Label Period|Adverse Event|1|||
161560060|NCT04955626|583438037|FG001|Open-Label Period|Adverse Event|0|||
161560061|NCT04955626|583438038|FG002|Open-Label Period|Adverse Event|0|||
161560062|NCT04955626|583438039|FG003|Open-Label Period|Adverse Event|0|||
161560063|NCT04955626|583438040|FG004|Open-Label Period|Adverse Event|0|||
161560064|NCT04955626|583438041|FG005|Open-Label Period|Adverse Event|0|||
161560065|NCT04955626|583438042|FG006|Open-Label Period|Adverse Event|0|||
161560066|NCT04955626|583438043|FG007|Open-Label Period|Adverse Event|0|||
161560067|NCT04955626|583438044|FG008|Open-Label Period|Adverse Event|0|||
161560068|NCT04955626|583438045|FG009|Open-Label Period|Adverse Event|0|||
161560069|NCT04955626|583438046|FG010|Open-Label Period|Adverse Event|0|||
161560070|NCT04955626|583438047|FG011|Open-Label Period|Adverse Event|0|||
161560071|NCT04955626|583438048|FG012|Open-Label Period|Adverse Event|0|||
161560072|NCT04955626|583438049|FG013|Open-Label Period|Adverse Event|0|||
161560073|NCT04955626|583438050|FG014|Open-Label Period|Adverse Event|0|||
161560074|NCT04955626|583438051|FG015|Open-Label Period|Adverse Event|0|||
161560075|NCT04955626|583438052|FG016|Open-Label Period|Adverse Event|0|||
161560076|NCT04955626|583438053|FG017|Open-Label Period|Adverse Event|0|||
161560077|NCT04955626|583438054|FG018|Open-Label Period|Adverse Event|0|||
161560078|NCT04955626|583438055|FG019|Open-Label Period|Adverse Event|0|||
161560079|NCT04955626|583438056|FG020|Open-Label Period|Adverse Event|0|||
161560080|NCT04955626|583438057|FG021|Open-Label Period|Adverse Event|0|||
161560081|NCT04955626|583438058|FG022|Open-Label Period|Adverse Event|0|||
161560082|NCT04955626|583438059|FG023|Open-Label Period|Adverse Event|0|||
161560083|NCT04955626|583438060|FG024|Open-Label Period|Adverse Event|0|||
161560084|NCT04955626|583438061|FG025|Open-Label Period|Adverse Event|0|||
161560085|NCT04955626|583438062|FG026|Open-Label Period|Adverse Event|0|||
161560086|NCT04955626|583438063|FG027|Open-Label Period|Adverse Event|0|||
161560087|NCT04955626|583438064|FG028|Open-Label Period|Adverse Event|0|||
161560088|NCT04955626|583438065|FG029|Open-Label Period|Adverse Event|0|||
161560089|NCT04955626|583438066|FG030|Open-Label Period|Adverse Event|0|||
161560090|NCT04955626|583438067|FG031|Open-Label Period|Adverse Event|0|||
161560091|NCT04955626|583438068|FG032|Open-Label Period|Adverse Event|0|||
161560092|NCT04955626|583438069|FG033|Open-Label Period|Adverse Event|0|||
161560093|NCT04955626|583438070|FG034|Open-Label Period|Adverse Event|0|||
161560094|NCT04955626|583438071|FG035|Open-Label Period|Adverse Event|0|||
161560095|NCT04955626|583438036|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
161560096|NCT04955626|583438037|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
161560097|NCT04955626|583438038|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
161560098|NCT04955626|583438039|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
161802301|NCT00048568|584319662|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
161802302|NCT00048568|584319663|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
161802303|NCT00048568|584319661|FG000|Open-Label Period|Unknown Reasons|0|||
161802304|NCT00048568|584319662|FG001|Open-Label Period|Unknown Reasons|0|||
161802305|NCT00048568|584319663|FG002|Open-Label Period|Unknown Reasons|25|||
161802306|NCT00048568|584319661|FG000|Open-Label Period|Lost to Follow-up|0|||
161802307|NCT00048568|584319662|FG001|Open-Label Period|Lost to Follow-up|0|||
161802308|NCT00048568|584319663|FG002|Open-Label Period|Lost to Follow-up|7|||
161802309|NCT01717976|584319664|FG000|Overall Study|Protocol Violation|0|||
161802310|NCT01717976|584319665|FG001|Overall Study|Protocol Violation|1|||
161802311|NCT03831048|584319666|FG000|Overall Study|Protocol Violation|9|||
161802312|NCT03831048|584319667|FG001|Overall Study|Protocol Violation|3|||
161802313|NCT03831048|584319666|FG000|Overall Study|Death|4|||
161802314|NCT03831048|584319667|FG001|Overall Study|Death|9|||
161802315|NCT03831048|584319666|FG000|Overall Study|Re-transplant|0|||
161802316|NCT03831048|584319667|FG001|Overall Study|Re-transplant|2|||
161802317|NCT03831048|584319666|FG000|Overall Study|Protocol violation and death|1|||
161802318|NCT03831048|584319667|FG001|Overall Study|Protocol violation and death|1|||
161802319|NCT01996033|584319669|FG000|Overall Study|Death|1|||
161560099|NCT04955626|583438040|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
161560100|NCT04955626|583438041|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
161560101|NCT04955626|583438042|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
161560102|NCT04955626|583438043|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
161560103|NCT04955626|583438044|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
161560104|NCT04955626|583438045|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
161560105|NCT04955626|583438046|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
161560106|NCT04955626|583438047|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
161560107|NCT04955626|583438048|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
161560108|NCT04955626|583438049|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
161905488|NCT05556616|584703362|FG004|Overall Study|Death|0|||
161560109|NCT04955626|583438050|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
161560110|NCT04955626|583438051|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
161560111|NCT04955626|583438052|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
161560112|NCT04955626|583438053|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
161802320|NCT01996033|584319669|FG000|Overall Study|Physician Decision|1|||
161802321|NCT01996033|584319669|FG000|Overall Study|Withdrawal by Subject|4|||
161802322|NCT01996033|584319669|FG000|Overall Study|Lost to Follow-up|3|||
161905489|NCT05556616|584703363|FG005|Overall Study|Death|0|||
161560113|NCT04955626|583438054|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
161560114|NCT04955626|583438055|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
161560115|NCT04955626|583438056|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
161560116|NCT04955626|583438057|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
161560117|NCT04955626|583438058|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
161560118|NCT04955626|583438059|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
161560119|NCT04955626|583438060|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
161560120|NCT04955626|583438061|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
161560121|NCT04955626|583438062|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
161560122|NCT04955626|583438063|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
161560123|NCT04955626|583438064|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
161560124|NCT04955626|583438065|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
161560125|NCT04955626|583438066|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
161560126|NCT04955626|583438067|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
161560127|NCT04955626|583438068|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
161560128|NCT04955626|583438069|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
161560129|NCT04955626|583438070|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
161560130|NCT04955626|583438071|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
161560131|NCT04955626|583438036|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560132|NCT04955626|583438037|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
161560133|NCT04955626|583438038|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560134|NCT04955626|583438039|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560135|NCT04955626|583438040|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560136|NCT04955626|583438041|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560137|NCT04955626|583438042|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560138|NCT04955626|583438043|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560139|NCT04955626|583438044|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560140|NCT04955626|583438045|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560141|NCT04955626|583438046|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560142|NCT04955626|583438047|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560143|NCT04955626|583438048|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560144|NCT04955626|583438049|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560145|NCT04955626|583438050|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560146|NCT04955626|583438051|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560147|NCT04955626|583438052|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560148|NCT04955626|583438053|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560149|NCT04955626|583438054|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560150|NCT04955626|583438055|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560151|NCT04955626|583438056|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560152|NCT04955626|583438057|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560153|NCT04955626|583438058|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560154|NCT04955626|583438059|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560155|NCT04955626|583438060|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560156|NCT04955626|583438061|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560157|NCT04955626|583438062|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560158|NCT04955626|583438063|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560159|NCT04955626|583438064|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560160|NCT04955626|583438065|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560161|NCT04955626|583438066|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560162|NCT04955626|583438067|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560163|NCT04955626|583438068|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560164|NCT04955626|583438069|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560165|NCT04955626|583438070|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161560166|NCT04955626|583438071|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161802323|NCT02731157|584319671|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
161802324|NCT04276883|584319676|FG000|Overall Study|Withdrawal by Subject|2|||
161802325|NCT04276883|584319677|FG001|Overall Study|Withdrawal by Subject|3|||
161802326|NCT04276883|584319678|FG002|Overall Study|Withdrawal by Subject|6|||
161802327|NCT04276883|584319676|FG000|Overall Study|Lost to Follow-up|1|||
161802328|NCT04276883|584319677|FG001|Overall Study|Lost to Follow-up|3|||
161560167|NCT04951479|583438074|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
161560168|NCT04209790|583438075|FG000|Overall Study|Physician Decision|1|||
161560169|NCT03706690|583438076|FG000|Overall Study|Withdrawal by Subject|8|||
161560170|NCT03706690|583438077|FG001|Overall Study|Withdrawal by Subject|8|||
161560171|NCT03706690|583438076|FG000|Overall Study|Death|143|||
161560172|NCT03706690|583438077|FG001|Overall Study|Death|75|||
161560173|NCT03706690|583438076|FG000|Overall Study|Ongoing at DCO|121|||
161560174|NCT03706690|583438077|FG001|Overall Study|Ongoing at DCO|52|||
161560175|NCT05617040|583438078|FG000|Overall Study|Adverse Event|0|||
161560176|NCT05617040|583438079|FG001|Overall Study|Adverse Event|1|||
161560177|NCT05617040|583438080|FG002|Overall Study|Adverse Event|0|||
161560178|NCT05617040|583438078|FG000|Overall Study|Death|0|||
161560179|NCT05617040|583438079|FG001|Overall Study|Death|0|||
161560180|NCT05617040|583438080|FG002|Overall Study|Death|1|||
161905490|NCT05556616|584703364|FG006|Overall Study|Death|0|||
161905491|NCT05556616|584703358|FG000|Overall Study|Study Terminated by Sponsor|0|||
161905492|NCT05556616|584703359|FG001|Overall Study|Study Terminated by Sponsor|3|||
161905493|NCT05556616|584703360|FG002|Overall Study|Study Terminated by Sponsor|0|||
161905494|NCT05556616|584703361|FG003|Overall Study|Study Terminated by Sponsor|0|||
161905495|NCT05556616|584703362|FG004|Overall Study|Study Terminated by Sponsor|0|||
161905496|NCT05556616|584703363|FG005|Overall Study|Study Terminated by Sponsor|0|||
161905497|NCT05556616|584703364|FG006|Overall Study|Study Terminated by Sponsor|0|||
161905498|NCT03256578|584703365|FG000|Overall Study|Excluded Post Randomization|66|||
161905499|NCT03256578|584703366|FG001|Overall Study|Excluded Post Randomization|56|||
161905500|NCT05428436|584703367|FG000|Period 1 - 2 washout|Adverse Event|1|||
161905501|NCT05428436|584703368|FG001|Period 1 - 2 washout|Adverse Event|0|||
161802329|NCT04276883|584319678|FG002|Overall Study|Lost to Follow-up|0|||
161802330|NCT04276883|584319676|FG000|Overall Study|Adverse Event|0|||
161802331|NCT04276883|584319677|FG001|Overall Study|Adverse Event|1|||
161802332|NCT04276883|584319678|FG002|Overall Study|Adverse Event|0|||
161802333|NCT04276883|584319676|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
161802334|NCT04276883|584319677|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
161802335|NCT04276883|584319678|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
161802336|NCT02732210|584319679|FG000|Overall Study|Site Closed|0|||
161905502|NCT05428436|584703369|FG002|Period 1 - 2 washout|Adverse Event|0|||
161905503|NCT03964207|584703370|FG000|First Treatment|Withdrawal by Subject|1|||
161905504|NCT03964207|584703371|FG001|First Treatment|Withdrawal by Subject|2|||
161905505|NCT03964207|584703370|FG000|First Treatment|Protocol Violation|1|||
161905506|NCT03964207|584703371|FG001|First Treatment|Protocol Violation|0|||
161905507|NCT03964207|584703370|FG000|First Treatment|Lost to Follow-up|1|||
161905508|NCT03964207|584703371|FG001|First Treatment|Lost to Follow-up|0|||
161905509|NCT03964207|584703370|FG000|Second Treatment|Lost to Follow-up|0|||
161560181|NCT02711826|583438081|FG000|Overall Study|Physician Decision|0|||
161560182|NCT02711826|583438082|FG001|Overall Study|Physician Decision|0|||
161560183|NCT02711826|583438083|FG002|Overall Study|Physician Decision|0|||
161560184|NCT02711826|583438084|FG003|Overall Study|Physician Decision|1|||
161560185|NCT02711826|583438085|FG004|Overall Study|Physician Decision|0|||
161560186|NCT02711826|583438081|FG000|Overall Study|Withdrawal by Subject|0|||
161560187|NCT02711826|583438082|FG001|Overall Study|Withdrawal by Subject|1|||
161560188|NCT02711826|583438083|FG002|Overall Study|Withdrawal by Subject|0|||
161560189|NCT02711826|583438084|FG003|Overall Study|Withdrawal by Subject|4|||
161560190|NCT02711826|583438085|FG004|Overall Study|Withdrawal by Subject|0|||
161560191|NCT02711826|583438081|FG000|Overall Study|Failure to manufacture cellular product|0|||
161560192|NCT02711826|583438082|FG001|Overall Study|Failure to manufacture cellular product|0|||
161560193|NCT02711826|583438083|FG002|Overall Study|Failure to manufacture cellular product|5|||
161560194|NCT02711826|583438084|FG003|Overall Study|Failure to manufacture cellular product|0|||
161560195|NCT02711826|583438085|FG004|Overall Study|Failure to manufacture cellular product|0|||
161560196|NCT02711826|583438081|FG000|Overall Study|Infusion canceled for active infection|0|||
161560197|NCT02711826|583438082|FG001|Overall Study|Infusion canceled for active infection|1|||
161560198|NCT02711826|583438083|FG002|Overall Study|Infusion canceled for active infection|0|||
161802337|NCT02732210|584319680|FG001|Overall Study|Site Closed|11|||
161802338|NCT02732210|584319679|FG000|Overall Study|Study Ended|13|||
161802339|NCT02732210|584319680|FG001|Overall Study|Study Ended|13|||
161802340|NCT02732210|584319679|FG000|Overall Study|Withdrawal by Subject|28|||
161802341|NCT02732210|584319680|FG001|Overall Study|Withdrawal by Subject|87|||
161905510|NCT03964207|584703371|FG001|Second Treatment|Lost to Follow-up|1|||
161905511|NCT03964207|584703370|FG000|Second Treatment|Adverse Event|1|||
161905512|NCT03964207|584703371|FG001|Second Treatment|Adverse Event|2|||
161905513|NCT00830219|584703372|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161905514|NCT00830219|584703373|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161905515|NCT01130272|584703374|FG000|Overall Study|Adverse Event|2|||
161560199|NCT02711826|583438084|FG003|Overall Study|Infusion canceled for active infection|0|||
161560200|NCT02711826|583438085|FG004|Overall Study|Infusion canceled for active infection|0|||
161560201|NCT02711826|583438081|FG000|Overall Study|Screen failures|0|||
161560202|NCT02711826|583438082|FG001|Overall Study|Screen failures|0|||
161560203|NCT02711826|583438083|FG002|Overall Study|Screen failures|0|||
161560204|NCT02711826|583438084|FG003|Overall Study|Screen failures|4|||
161560205|NCT02711826|583438085|FG004|Overall Study|Screen failures|0|||
161560206|NCT00729690|583438086|FG000|Overall Study|IT Catheter Malfunction|0|||
161560207|NCT00729690|583438087|FG001|Overall Study|IT Catheter Malfunction|2|||
161802342|NCT02732210|584319679|FG000|Overall Study|Lost to Follow-up|5|||
161905516|NCT01130272|584703375|FG001|Overall Study|Adverse Event|5|||
161905517|NCT01130272|584703376|FG002|Overall Study|Adverse Event|6|||
161905518|NCT01130272|584703377|FG003|Overall Study|Adverse Event|22|||
161905519|NCT01130272|584703378|FG004|Overall Study|Adverse Event|7|||
161905520|NCT01130272|584703374|FG000|Overall Study|IVRS-confirmed constipation|0|||
161905521|NCT01130272|584703375|FG001|Overall Study|IVRS-confirmed constipation|1|||
161905522|NCT01130272|584703376|FG002|Overall Study|IVRS-confirmed constipation|1|||
161905523|NCT01130272|584703377|FG003|Overall Study|IVRS-confirmed constipation|2|||
161905524|NCT01130272|584703378|FG004|Overall Study|IVRS-confirmed constipation|0|||
161905525|NCT01130272|584703374|FG000|Overall Study|Rescue medications due to diarrhea|3|||
161905526|NCT01130272|584703375|FG001|Overall Study|Rescue medications due to diarrhea|5|||
161905527|NCT01130272|584703376|FG002|Overall Study|Rescue medications due to diarrhea|8|||
161905528|NCT01130272|584703377|FG003|Overall Study|Rescue medications due to diarrhea|8|||
161905529|NCT01130272|584703378|FG004|Overall Study|Rescue medications due to diarrhea|6|||
161905530|NCT01130272|584703374|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
161905531|NCT01130272|584703375|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
161905532|NCT01130272|584703376|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
161905533|NCT01130272|584703377|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
161560208|NCT00729690|583438088|FG002|Overall Study|IT Catheter Malfunction|2|||
161560209|NCT02169219|583438089|FG000|Overall Study|Lack of Efficacy|6|||
161560210|NCT04482855|583438090|FG000|Overall Study|Lost to Follow-up|1|||
161560211|NCT04482855|583438091|FG001|Overall Study|Lost to Follow-up|0|||
161560212|NCT04482855|583438090|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
161560213|NCT04482855|583438091|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
161560214|NCT04482855|583438090|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
161560215|NCT04482855|583438091|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
161560216|NCT02507219|583438095|FG000|Overall Study|Physician Decision|1|||
161560217|NCT02507219|583438096|FG001|Overall Study|Physician Decision|0|||
161560218|NCT02507219|583438097|FG002|Overall Study|Physician Decision|0|||
161560219|NCT02507219|583438098|FG003|Overall Study|Physician Decision|0|||
161560220|NCT02507219|583438099|FG004|Overall Study|Physician Decision|0|||
161560221|NCT02507219|583438100|FG005|Overall Study|Physician Decision|0|||
161560222|NCT02507219|583438095|FG000|Overall Study|Withdrawal by Subject|0|||
161560223|NCT02507219|583438096|FG001|Overall Study|Withdrawal by Subject|0|||
161560224|NCT02507219|583438097|FG002|Overall Study|Withdrawal by Subject|0|||
161560225|NCT02507219|583438098|FG003|Overall Study|Withdrawal by Subject|0|||
161560226|NCT02507219|583438099|FG004|Overall Study|Withdrawal by Subject|1|||
161560227|NCT02507219|583438100|FG005|Overall Study|Withdrawal by Subject|0|||
161560228|NCT02886936|583438101|FG000|Overall Study|Lost to Follow-up|4|||
161560229|NCT02886936|583438102|FG001|Overall Study|Lost to Follow-up|3|||
161560230|NCT02886936|583438103|FG002|Overall Study|Lost to Follow-up|0|||
161560231|NCT04562779|583438104|FG000|Overall Study|Lost to Follow-up|7|||
161560232|NCT04562779|583438105|FG001|Overall Study|Lost to Follow-up|5|||
161560233|NCT04562779|583438106|FG002|Overall Study|Lost to Follow-up|10|||
161560234|NCT04562779|583438104|FG000|Overall Study|Protocol Violation|2|||
161560235|NCT04562779|583438105|FG001|Overall Study|Protocol Violation|2|||
161560236|NCT04562779|583438106|FG002|Overall Study|Protocol Violation|0|||
161560237|NCT02320721|583438107|FG000|Overall Study|Adverse Event|6|||
161560238|NCT02320721|583438108|FG001|Overall Study|Adverse Event|6|||
161560239|NCT02320721|583438107|FG000|Overall Study|Lack of Efficacy|2|||
161560240|NCT02320721|583438108|FG001|Overall Study|Lack of Efficacy|0|||
161560241|NCT02320721|583438107|FG000|Overall Study|Poor compliance to protocol|3|||
161560242|NCT02320721|583438108|FG001|Overall Study|Poor compliance to protocol|7|||
161560243|NCT02320721|583438107|FG000|Overall Study|Randomized but not treated|0|||
161560244|NCT02320721|583438108|FG001|Overall Study|Randomized but not treated|1|||
161560245|NCT02320721|583438107|FG000|Overall Study|Hypoglycemia|1|||
161560246|NCT02320721|583438108|FG001|Overall Study|Hypoglycemia|0|||
161560247|NCT02320721|583438107|FG000|Overall Study|Other than specified above|15|||
161560248|NCT02320721|583438108|FG001|Overall Study|Other than specified above|20|||
161560249|NCT03173248|583438109|FG000|Overall Study|Death|28|||
161560250|NCT03173248|583438110|FG001|Overall Study|Death|46|||
161905534|NCT01130272|584703378|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
161905535|NCT01130272|584703374|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161560251|NCT03173248|583438109|FG000|Overall Study|Lost to Follow-up|0|||
161560252|NCT03173248|583438110|FG001|Overall Study|Lost to Follow-up|1|||
161560253|NCT03173248|583438109|FG000|Overall Study|Withdrawal by Subject|6|||
161560254|NCT03173248|583438110|FG001|Overall Study|Withdrawal by Subject|4|||
161560255|NCT03173248|583438109|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
161560256|NCT03173248|583438110|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
161905536|NCT01130272|584703375|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161905537|NCT01130272|584703376|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161668054|NCT00406653|583837476|FG000|Induction Period|Incarcerated|0|||
161905538|NCT01130272|584703377|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
161905539|NCT01130272|584703378|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161560257|NCT01544582|583438111|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
161560258|NCT01544582|583438112|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
161560259|NCT01544582|583438113|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
161560260|NCT01544582|583438114|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
161560261|NCT01544582|583438111|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
161560262|NCT01544582|583438112|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
161560263|NCT01544582|583438113|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
161560264|NCT01544582|583438114|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
161560265|NCT01544582|583438111|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
161560266|NCT01544582|583438112|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
161560267|NCT01544582|583438113|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
161560268|NCT01544582|583438114|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
161560269|NCT01544582|583438111|FG000|Analysis Population|Physician Decision|0|||
161560270|NCT01544582|583438112|FG001|Analysis Population|Physician Decision|13|||
161560271|NCT01544582|583438113|FG002|Analysis Population|Physician Decision|10|||
161560272|NCT01544582|583438114|FG003|Analysis Population|Physician Decision|9|||
161560273|NCT01544582|583438111|FG000|Analysis Population|Safety Reason|0|||
161560274|NCT01544582|583438112|FG001|Analysis Population|Safety Reason|33|||
161560275|NCT01544582|583438113|FG002|Analysis Population|Safety Reason|31|||
161560276|NCT01544582|583438114|FG003|Analysis Population|Safety Reason|8|||
161560277|NCT01544582|583438111|FG000|Analysis Population|Effectiveness Reason|0|||
161560278|NCT01544582|583438112|FG001|Analysis Population|Effectiveness Reason|48|||
161560279|NCT01544582|583438113|FG002|Analysis Population|Effectiveness Reason|29|||
161560280|NCT01544582|583438114|FG003|Analysis Population|Effectiveness Reason|12|||
161560281|NCT01544582|583438111|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
161560282|NCT01544582|583438112|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
161560283|NCT01544582|583438113|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
161560284|NCT01544582|583438114|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
161560285|NCT01544582|583438111|FG000|Analysis Population|Lost to Follow-up|0|||
161560286|NCT01544582|583438112|FG001|Analysis Population|Lost to Follow-up|6|||
161560287|NCT01544582|583438113|FG002|Analysis Population|Lost to Follow-up|6|||
161560288|NCT01544582|583438114|FG003|Analysis Population|Lost to Follow-up|5|||
161560289|NCT01544582|583438111|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
161560290|NCT01544582|583438112|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
161560291|NCT01544582|583438113|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
161560292|NCT01544582|583438114|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
161560293|NCT01544582|583438111|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
161560294|NCT01544582|583438112|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
161560295|NCT01544582|583438113|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
161560296|NCT01544582|583438114|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
161560297|NCT01544582|583438111|FG000|Analysis Population|Intolerance|0|||
161560298|NCT01544582|583438112|FG001|Analysis Population|Intolerance|1|||
161560299|NCT01544582|583438113|FG002|Analysis Population|Intolerance|0|||
161560300|NCT01544582|583438114|FG003|Analysis Population|Intolerance|0|||
161560301|NCT01544582|583438111|FG000|Analysis Population|Liver Transplantation|0|||
161560302|NCT01544582|583438112|FG001|Analysis Population|Liver Transplantation|0|||
161560303|NCT01544582|583438113|FG002|Analysis Population|Liver Transplantation|1|||
161560304|NCT01544582|583438114|FG003|Analysis Population|Liver Transplantation|0|||
161560305|NCT01544582|583438111|FG000|Analysis Population|No Social Insurance|0|||
161560306|NCT01544582|583438112|FG001|Analysis Population|No Social Insurance|0|||
161560307|NCT01544582|583438113|FG002|Analysis Population|No Social Insurance|1|||
161560308|NCT01544582|583438114|FG003|Analysis Population|No Social Insurance|0|||
161560309|NCT01544582|583438111|FG000|Analysis Population|Poor Adherence|0|||
161560310|NCT01544582|583438112|FG001|Analysis Population|Poor Adherence|0|||
161560311|NCT01544582|583438113|FG002|Analysis Population|Poor Adherence|1|||
161560312|NCT01544582|583438114|FG003|Analysis Population|Poor Adherence|0|||
161560313|NCT01544582|583438111|FG000|Analysis Population|Poor Participant Compliance|0|||
161560314|NCT01544582|583438112|FG001|Analysis Population|Poor Participant Compliance|1|||
161560315|NCT01544582|583438113|FG002|Analysis Population|Poor Participant Compliance|0|||
161560316|NCT01544582|583438114|FG003|Analysis Population|Poor Participant Compliance|0|||
161560317|NCT01544582|583438111|FG000|Analysis Population|Programmed Surgery|0|||
161560318|NCT01544582|583438112|FG001|Analysis Population|Programmed Surgery|1|||
161560319|NCT01544582|583438113|FG002|Analysis Population|Programmed Surgery|0|||
161802343|NCT02732210|584319680|FG001|Overall Study|Lost to Follow-up|57|||
161802344|NCT02732210|584319679|FG000|Overall Study|Death|4|||
161560320|NCT01544582|583438114|FG003|Analysis Population|Programmed Surgery|0|||
161560321|NCT01544582|583438111|FG000|Analysis Population|Participant in Jail|0|||
161560322|NCT01544582|583438112|FG001|Analysis Population|Participant in Jail|0|||
161560323|NCT01544582|583438113|FG002|Analysis Population|Participant in Jail|1|||
161560324|NCT01544582|583438114|FG003|Analysis Population|Participant in Jail|0|||
161560325|NCT03015740|583438117|FG000|Overall Study|Adverse Event|1|||
161560326|NCT03015740|583438118|FG001|Overall Study|Adverse Event|0|||
161802345|NCT02732210|584319680|FG001|Overall Study|Death|15|||
161560327|NCT03015740|583438119|FG002|Overall Study|Adverse Event|0|||
161560328|NCT03015740|583438117|FG000|Overall Study|Death|3|||
161560329|NCT03015740|583438118|FG001|Overall Study|Death|5|||
161560330|NCT03015740|583438119|FG002|Overall Study|Death|0|||
161560331|NCT03015740|583438117|FG000|Overall Study|Withdrawal by Subject|2|||
161560332|NCT03015740|583438118|FG001|Overall Study|Withdrawal by Subject|0|||
161560333|NCT03015740|583438119|FG002|Overall Study|Withdrawal by Subject|0|||
161560334|NCT05194735|583440128|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
161560335|NCT05194735|583440129|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
161560336|NCT05194735|583440130|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
161560337|NCT05194735|583440128|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
161560338|NCT05194735|583440129|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
161560339|NCT05194735|583440130|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
161560340|NCT05194735|583440128|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
161560341|NCT05194735|583440129|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
161560342|NCT05194735|583440130|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
161560343|NCT05194735|583440128|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
161560344|NCT05194735|583440129|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
161560345|NCT05194735|583440130|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
161560346|NCT00731042|583440131|FG000|Second Intervention|Did not meet inclusion criteria|0|||
161560347|NCT00731042|583440132|FG001|Second Intervention|Did not meet inclusion criteria|2|||
161560348|NCT01256476|583440133|FG000|Overall Study|Adverse Event|2|||
161560349|NCT01256476|583440134|FG001|Overall Study|Adverse Event|1|||
161560350|NCT01256476|583440133|FG000|Overall Study|Withdrawal by Subject|2|||
161560351|NCT01256476|583440134|FG001|Overall Study|Withdrawal by Subject|1|||
161560352|NCT01256476|583440133|FG000|Overall Study|Lost to Follow-up|1|||
161560353|NCT01256476|583440134|FG001|Overall Study|Lost to Follow-up|2|||
161560354|NCT01256476|583440133|FG000|Overall Study|Persistent ALT or AST elevation|1|||
161560355|NCT01256476|583440134|FG001|Overall Study|Persistent ALT or AST elevation|0|||
161560356|NCT01256476|583440133|FG000|Overall Study|Physician Decision|0|||
161560357|NCT01256476|583440134|FG001|Overall Study|Physician Decision|1|||
161560358|NCT01256476|583440133|FG000|Overall Study|Subject non-compliance|0|||
161560359|NCT01256476|583440134|FG001|Overall Study|Subject non-compliance|1|||
161560360|NCT01256476|583440133|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
161560361|NCT01256476|583440134|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
161560362|NCT00231179|583440137|FG000|Overall Study|Lost to Follow-up|21|||
161560363|NCT00231179|583440138|FG001|Overall Study|Lost to Follow-up|21|||
161560364|NCT00231179|583440137|FG000|Overall Study|Withdrawal by Subject|3|||
161560365|NCT00231179|583440138|FG001|Overall Study|Withdrawal by Subject|3|||
161560366|NCT02491411|583440139|FG000|Overall Study|Physician Decision|4|||
161560367|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
161560368|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
161560369|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
161560370|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
161560371|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
161560372|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
161560373|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
161560374|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
161560375|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
161560376|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
161560377|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
161560378|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
161560379|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
161560380|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
161560381|NCT04672460|583440141|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
161560382|NCT04672460|583440142|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
161560383|NCT04672460|583440141|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
161560384|NCT04672460|583440142|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
161560385|NCT04672460|583440141|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
161560386|NCT04672460|583440142|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
161560387|NCT04672460|583440141|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
161560388|NCT04672460|583440142|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
161668055|NCT00406653|583837477|FG001|Induction Period|Incarcerated|0|||
161905540|NCT01130272|584703374|FG000|Overall Study|Protocol Violation|0|||
161905541|NCT01130272|584703375|FG001|Overall Study|Protocol Violation|0|||
161905542|NCT01130272|584703376|FG002|Overall Study|Protocol Violation|3|||
161560389|NCT04672460|583440141|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
161560390|NCT04672460|583440142|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
161560391|NCT04672460|583440141|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
161560392|NCT04672460|583440142|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
161560393|NCT04672460|583440141|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
161560394|NCT04672460|583440142|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
161560395|NCT04672460|583440141|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
161560396|NCT04672460|583440142|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
161560397|NCT04672460|583440141|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
161560398|NCT04672460|583440142|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
161560399|NCT04672460|583440141|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
161560400|NCT04672460|583440142|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
161560401|NCT00940017|583440145|FG000|Overall Study|did not meet entrance criteria|3|||
161560402|NCT00940017|583440145|FG000|Overall Study|Adverse Event|1|||
161560403|NCT00569946|583440146|FG000|Overall Study|Adverse Event|16|||
161560404|NCT00569946|583440146|FG000|Overall Study|Objective Progression or Relapse|42|||
161560405|NCT00569946|583440146|FG000|Overall Study|Global Deterioration of Health Status|1|||
161560406|NCT02949271|583440149|FG000|Overall Study|Lack of Efficacy|5|||
161560407|NCT02949271|583440150|FG001|Overall Study|Lack of Efficacy|4|||
161560408|NCT02949271|583440149|FG000|Overall Study|Lost to Follow-up|3|||
161560409|NCT02949271|583440150|FG001|Overall Study|Lost to Follow-up|6|||
161560410|NCT02949271|583440149|FG000|Overall Study|Physician Decision|5|||
161560411|NCT02949271|583440150|FG001|Overall Study|Physician Decision|5|||
161560412|NCT02949271|583440149|FG000|Overall Study|Protocol Violation|6|||
161560413|NCT02949271|583440150|FG001|Overall Study|Protocol Violation|3|||
161560414|NCT02949271|583440149|FG000|Overall Study|Withdrawal by Subject|1|||
161560415|NCT02949271|583440150|FG001|Overall Study|Withdrawal by Subject|0|||
161560416|NCT02949271|583440149|FG000|Overall Study|Delivered prior to intervention|7|||
161560417|NCT02949271|583440150|FG001|Overall Study|Delivered prior to intervention|9|||
161560418|NCT02949271|583440149|FG000|Overall Study|Outside the window for cervical dilation|2|||
161560419|NCT02949271|583440150|FG001|Overall Study|Outside the window for cervical dilation|3|||
161560420|NCT05458102|583440151|FG000|Overall Study|Withdrew consent|2|||
161560421|NCT05458102|583440152|FG001|Overall Study|Withdrew consent|0|||
161560422|NCT05458102|583440151|FG000|Overall Study|Adverse Event|1|||
161560423|NCT05458102|583440152|FG001|Overall Study|Adverse Event|0|||
161560424|NCT05458102|583440151|FG000|Overall Study|Enrolled but never treated|1|||
161560425|NCT05458102|583440152|FG001|Overall Study|Enrolled but never treated|0|||
161560426|NCT05458102|583440151|FG000|Overall Study|Protocol Violation|1|||
161560427|NCT05458102|583440152|FG001|Overall Study|Protocol Violation|0|||
161560428|NCT00852475|583440158|FG000|Overall Study|Lost to Follow-up|3|||
161560429|NCT00852475|583440159|FG001|Overall Study|Lost to Follow-up|4|||
161560430|NCT02373813|583440160|FG000|Run-In Period|Other, Not Specified|5|||
161560431|NCT02373813|583440161|FG001|Run-In Period|Other, Not Specified|0|||
161560432|NCT02373813|583440162|FG002|Run-In Period|Other, Not Specified|0|||
161560433|NCT02373813|583440163|FG003|Run-In Period|Other, Not Specified|0|||
161560434|NCT02373813|583440160|FG000|Run-In Period|Withdrawal by Subject|16|||
161560435|NCT02373813|583440161|FG001|Run-In Period|Withdrawal by Subject|0|||
161560436|NCT02373813|583440162|FG002|Run-In Period|Withdrawal by Subject|0|||
161560437|NCT02373813|583440163|FG003|Run-In Period|Withdrawal by Subject|0|||
161560438|NCT02373813|583440160|FG000|Run-In Period|Decision by Sponsor|11|||
161560439|NCT02373813|583440161|FG001|Run-In Period|Decision by Sponsor|0|||
161560440|NCT02373813|583440162|FG002|Run-In Period|Decision by Sponsor|0|||
161560441|NCT02373813|583440163|FG003|Run-In Period|Decision by Sponsor|0|||
161560442|NCT02373813|583440160|FG000|Run-In Period|Protocol Violation|75|||
161560443|NCT02373813|583440161|FG001|Run-In Period|Protocol Violation|0|||
161560444|NCT02373813|583440162|FG002|Run-In Period|Protocol Violation|0|||
161560445|NCT02373813|583440163|FG003|Run-In Period|Protocol Violation|0|||
161560446|NCT02373813|583440160|FG000|Run-In Period|Lost to Follow-up|2|||
161560447|NCT02373813|583440161|FG001|Run-In Period|Lost to Follow-up|0|||
161560448|NCT02373813|583440162|FG002|Run-In Period|Lost to Follow-up|0|||
161560449|NCT02373813|583440163|FG003|Run-In Period|Lost to Follow-up|0|||
161560450|NCT02373813|583440160|FG000|Run-In Period|Adverse Event|3|||
161560451|NCT02373813|583440161|FG001|Run-In Period|Adverse Event|0|||
161560452|NCT02373813|583440162|FG002|Run-In Period|Adverse Event|0|||
161560453|NCT02373813|583440163|FG003|Run-In Period|Adverse Event|0|||
161560454|NCT02373813|583440160|FG000|Run-In Period|Noncompliance|1|||
161560455|NCT02373813|583440161|FG001|Run-In Period|Noncompliance|0|||
161560456|NCT02373813|583440162|FG002|Run-In Period|Noncompliance|0|||
161560457|NCT02373813|583440163|FG003|Run-In Period|Noncompliance|0|||
161560458|NCT02373813|583440160|FG000|Run-In Period|Ineligibility Determined|3|||
161560459|NCT02373813|583440161|FG001|Run-In Period|Ineligibility Determined|0|||
161905543|NCT01130272|584703377|FG003|Overall Study|Protocol Violation|5|||
161560460|NCT02373813|583440162|FG002|Run-In Period|Ineligibility Determined|0|||
161560461|NCT02373813|583440163|FG003|Run-In Period|Ineligibility Determined|0|||
161560462|NCT02373813|583440160|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
161905544|NCT01130272|584703378|FG004|Overall Study|Protocol Violation|5|||
161560463|NCT02373813|583440161|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
161560464|NCT02373813|583440162|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
161560465|NCT02373813|583440163|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
161560466|NCT02373813|583440160|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161560467|NCT02373813|583440161|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
161560468|NCT02373813|583440162|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
161560469|NCT02373813|583440163|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
161560470|NCT02373813|583440160|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161560471|NCT02373813|583440161|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161560472|NCT02373813|583440162|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
161560473|NCT02373813|583440163|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
161560474|NCT02373813|583440160|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161560475|NCT02373813|583440161|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
161560476|NCT02373813|583440162|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161560477|NCT02373813|583440163|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
161560478|NCT01511536|583440164|FG000|Phase 1|Other|0|||
161560479|NCT01511536|583440165|FG001|Phase 1|Other|1|||
161560480|NCT01511536|583440166|FG002|Phase 1|Other|0|||
161560481|NCT01511536|583440164|FG000|Phase 2|Other|0|||
161560482|NCT01511536|583440165|FG001|Phase 2|Other|0|||
161560483|NCT01511536|583440166|FG002|Phase 2|Other|9|||
161560484|NCT01764386|583440170|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
161560485|NCT01764386|583440171|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
161905545|NCT01130272|584703374|FG000|Overall Study|Lost to Follow-up|4|||
161905546|NCT01130272|584703375|FG001|Overall Study|Lost to Follow-up|3|||
161905547|NCT01130272|584703376|FG002|Overall Study|Lost to Follow-up|4|||
161905548|NCT01130272|584703377|FG003|Overall Study|Lost to Follow-up|7|||
161905549|NCT01130272|584703378|FG004|Overall Study|Lost to Follow-up|6|||
161905550|NCT01130272|584703374|FG000|Overall Study|Withdrawal by Subject|4|||
161905551|NCT01130272|584703375|FG001|Overall Study|Withdrawal by Subject|11|||
161905552|NCT01130272|584703376|FG002|Overall Study|Withdrawal by Subject|10|||
161905553|NCT01130272|584703377|FG003|Overall Study|Withdrawal by Subject|9|||
161905554|NCT01130272|584703378|FG004|Overall Study|Withdrawal by Subject|8|||
161905555|NCT01130272|584703374|FG000|Overall Study|Physician Decision|1|||
161905556|NCT01130272|584703375|FG001|Overall Study|Physician Decision|1|||
161905557|NCT01130272|584703376|FG002|Overall Study|Physician Decision|0|||
161905558|NCT01130272|584703377|FG003|Overall Study|Physician Decision|1|||
161905559|NCT01130272|584703378|FG004|Overall Study|Physician Decision|2|||
161905560|NCT01130272|584703374|FG000|Overall Study|Sponsor decision|6|||
161905561|NCT01130272|584703375|FG001|Overall Study|Sponsor decision|15|||
161905562|NCT01130272|584703376|FG002|Overall Study|Sponsor decision|16|||
161905563|NCT01130272|584703377|FG003|Overall Study|Sponsor decision|13|||
161905564|NCT01130272|584703378|FG004|Overall Study|Sponsor decision|16|||
161905565|NCT01130272|584703374|FG000|Overall Study|Study arm discontinued|38|||
161905566|NCT01130272|584703375|FG001|Overall Study|Study arm discontinued|0|||
161905567|NCT01130272|584703376|FG002|Overall Study|Study arm discontinued|0|||
161905568|NCT01130272|584703377|FG003|Overall Study|Study arm discontinued|0|||
161560486|NCT01764386|583440170|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
161560487|NCT01764386|583440171|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
161560488|NCT01764386|583440170|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
161560489|NCT01764386|583440171|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
161560490|NCT01764386|583440170|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
161560491|NCT01764386|583440171|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
161560492|NCT01764386|583440170|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
161560493|NCT01764386|583440171|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
161560494|NCT01764386|583440170|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
161560495|NCT01764386|583440171|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
161560496|NCT01764386|583440170|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
161560497|NCT01764386|583440171|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
161560498|NCT01764386|583440170|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
161560499|NCT01764386|583440171|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
161560500|NCT02703532|583440173|FG000|Overall Study|Withdrawal by Subject|0|||
161560501|NCT02703532|583440174|FG001|Overall Study|Withdrawal by Subject|1|||
161560502|NCT02703532|583440175|FG002|Overall Study|Withdrawal by Subject|0|||
161560503|NCT02703532|583440176|FG003|Overall Study|Withdrawal by Subject|1|||
161905569|NCT01130272|584703378|FG004|Overall Study|Study arm discontinued|0|||
161905570|NCT00641056|584703379|FG000|Overall Study|Adverse Event|12|||
161560504|NCT02703532|583440173|FG000|Overall Study|Lost to Follow-up|2|||
161560505|NCT02703532|583440174|FG001|Overall Study|Lost to Follow-up|0|||
161905571|NCT00641056|584703380|FG001|Overall Study|Adverse Event|2|||
161905572|NCT00641056|584703379|FG000|Overall Study|Lost to Follow-up|2|||
161905573|NCT00641056|584703380|FG001|Overall Study|Lost to Follow-up|1|||
161905574|NCT00641056|584703379|FG000|Overall Study|Physician Decision|3|||
161560506|NCT02703532|583440175|FG002|Overall Study|Lost to Follow-up|2|||
161560507|NCT02703532|583440176|FG003|Overall Study|Lost to Follow-up|0|||
161560508|NCT03738241|583440177|FG000|Overall Study|Withdrawal by Subject|0|||
161560509|NCT03738241|583440178|FG001|Overall Study|Withdrawal by Subject|0|||
161560510|NCT03738241|583440179|FG002|Overall Study|Withdrawal by Subject|0|||
161560511|NCT03738241|583440180|FG003|Overall Study|Withdrawal by Subject|0|||
161560512|NCT03738241|583440181|FG004|Overall Study|Withdrawal by Subject|0|||
161560513|NCT03738241|583440182|FG005|Overall Study|Withdrawal by Subject|0|||
161560514|NCT03738241|583440183|FG006|Overall Study|Withdrawal by Subject|0|||
161560515|NCT03738241|583440184|FG007|Overall Study|Withdrawal by Subject|0|||
161560516|NCT03738241|583440185|FG008|Overall Study|Withdrawal by Subject|0|||
161560517|NCT03738241|583440186|FG009|Overall Study|Withdrawal by Subject|1|||
161560518|NCT03738241|583440177|FG000|Overall Study|Physician Decision|0|||
161560519|NCT03738241|583440178|FG001|Overall Study|Physician Decision|0|||
161560520|NCT03738241|583440179|FG002|Overall Study|Physician Decision|0|||
161560521|NCT03738241|583440180|FG003|Overall Study|Physician Decision|0|||
161560522|NCT03738241|583440181|FG004|Overall Study|Physician Decision|0|||
161560523|NCT03738241|583440182|FG005|Overall Study|Physician Decision|0|||
161560524|NCT03738241|583440183|FG006|Overall Study|Physician Decision|0|||
161560525|NCT03738241|583440184|FG007|Overall Study|Physician Decision|0|||
161560526|NCT03738241|583440185|FG008|Overall Study|Physician Decision|1|||
161560527|NCT03738241|583440186|FG009|Overall Study|Physician Decision|0|||
161560528|NCT03738241|583440177|FG000|Overall Study|Adverse Event|1|||
161560529|NCT03738241|583440178|FG001|Overall Study|Adverse Event|0|||
161560530|NCT03738241|583440179|FG002|Overall Study|Adverse Event|0|||
161560531|NCT03738241|583440180|FG003|Overall Study|Adverse Event|0|||
161560532|NCT03738241|583440181|FG004|Overall Study|Adverse Event|0|||
161560533|NCT03738241|583440182|FG005|Overall Study|Adverse Event|0|||
161560534|NCT03738241|583440183|FG006|Overall Study|Adverse Event|0|||
161560535|NCT03738241|583440184|FG007|Overall Study|Adverse Event|0|||
161560536|NCT03738241|583440185|FG008|Overall Study|Adverse Event|0|||
161560537|NCT03738241|583440186|FG009|Overall Study|Adverse Event|0|||
161560538|NCT03169361|583440187|FG000|Overall Study|Protocol Violation|32|||
161560539|NCT02263885|583440188|FG000|Overall Study|Withdrawal by Subject|7|||
161560540|NCT02263885|583440188|FG000|Overall Study|Alternative Treatment|3|||
161560541|NCT00664521|583440196|FG000|Overall Study|Adverse Event|4|||
161560542|NCT00664521|583440197|FG001|Overall Study|Adverse Event|1|||
161560543|NCT00664521|583440196|FG000|Overall Study|Lost to Follow-up|1|||
161560544|NCT00664521|583440197|FG001|Overall Study|Lost to Follow-up|0|||
161560545|NCT00664521|583440196|FG000|Overall Study|Other|1|||
161560546|NCT00664521|583440197|FG001|Overall Study|Other|0|||
161560547|NCT03239210|583440200|FG000|Overall Study|Lost to Follow-up|2|||
161560548|NCT03239210|583440201|FG001|Overall Study|Lost to Follow-up|2|||
161560549|NCT03239210|583440200|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
161560550|NCT03239210|583440201|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
161802346|NCT02732210|584319679|FG000|Overall Study|Other|35|||
161802347|NCT02732210|584319680|FG001|Overall Study|Other|103|||
161802348|NCT02732210|584319679|FG000|Overall Study|Missing|0|||
161802349|NCT02732210|584319680|FG001|Overall Study|Missing|8|||
161802350|NCT01876706|584319681|FG000|Overall Study|BPH Intervention|9|||
161802351|NCT01876706|584319681|FG000|Overall Study|Lost to Follow-up|7|||
161802352|NCT01876706|584319681|FG000|Overall Study|Withdrawals|6|||
161802353|NCT01876706|584319681|FG000|Overall Study|Death|3|||
161802354|NCT00604500|584319682|FG000|Overall Study|Adverse Event|2|||
161802355|NCT00604500|584319682|FG000|Overall Study|Protocol Violation|2|||
161802356|NCT00604500|584319682|FG000|Overall Study|Treatment Failure|1|||
161802357|NCT00604500|584319682|FG000|Overall Study|Withdrawal by Subject|4|||
161802358|NCT00604500|584319682|FG000|Overall Study|Administrative|1|||
161802359|NCT00604500|584319682|FG000|Overall Study|Did not meet protocol eligibility|1|||
161802360|NCT01448057|584319684|FG000|Overall Study|Protocol Violation|3|||
161802361|NCT01448057|584319685|FG001|Overall Study|Protocol Violation|2|||
161905575|NCT00641056|584703380|FG001|Overall Study|Physician Decision|1|||
161560551|NCT03239210|583440200|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
161560552|NCT03239210|583440201|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
161560553|NCT00278564|583440203|FG000|Overall Study|Lack of Efficacy|4|||
161560554|NCT00480441|583440204|FG000|Screening|Not Eligible|37|||
161560555|NCT00480441|583440205|FG001|Screening|Not Eligible|0|||
161560556|NCT00480441|583440206|FG002|Screening|Not Eligible|0|||
161560557|NCT00480441|583440204|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
161560558|NCT00480441|583440205|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
161560559|NCT00480441|583440206|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
161560560|NCT00480441|583440204|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
161560561|NCT00480441|583440205|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
161802362|NCT01448057|584319684|FG000|Overall Study|Lost to Follow-up|3|||
161802363|NCT01448057|584319685|FG001|Overall Study|Lost to Follow-up|0|||
161802364|NCT01448057|584319684|FG000|Overall Study|Adverse Event|0|||
161802365|NCT01448057|584319685|FG001|Overall Study|Adverse Event|2|||
161802366|NCT01448057|584319684|FG000|Overall Study|Withdrawal by Subject|2|||
161905576|NCT00641056|584703379|FG000|Overall Study|Protocol Violation|2|||
161802367|NCT01448057|584319685|FG001|Overall Study|Withdrawal by Subject|0|||
161802368|NCT03883906|584319686|FG000|Overall Study|Withdrawal by Subject|2|||
161802369|NCT03883906|584319686|FG000|Overall Study|Physician Decision|5|||
161802370|NCT02468778|584319690|FG000|Overall Study|Death|2|||
161802371|NCT02468778|584319691|FG001|Overall Study|Death|1|||
161802372|NCT02468778|584319692|FG002|Overall Study|Death|0|||
161802373|NCT02468778|584319690|FG000|Overall Study|Lost to Follow-up|1|||
161802374|NCT02468778|584319691|FG001|Overall Study|Lost to Follow-up|2|||
161802375|NCT02468778|584319692|FG002|Overall Study|Lost to Follow-up|2|||
161802376|NCT02468778|584319690|FG000|Overall Study|Withdrawal by Subject|0|||
161802377|NCT02468778|584319691|FG001|Overall Study|Withdrawal by Subject|1|||
161802378|NCT02468778|584319692|FG002|Overall Study|Withdrawal by Subject|1|||
161802379|NCT03912337|584319697|FG000|Overall Study|Withdrawal of Consent From Study|1|||
161905577|NCT00641056|584703380|FG001|Overall Study|Protocol Violation|0|||
161452171|NCT01185353|583050746|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161452172|NCT01185353|583050747|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161452173|NCT01185353|583050748|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161452174|NCT01185353|583050739|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452175|NCT01185353|583050740|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452176|NCT01185353|583050741|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452177|NCT01185353|583050742|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452178|NCT01185353|583050743|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452179|NCT01185353|583050744|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452180|NCT01185353|583050745|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
161452181|NCT01185353|583050746|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452182|NCT01185353|583050747|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452183|NCT01185353|583050748|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
161452184|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452185|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452186|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452187|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452188|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452189|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452190|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161452191|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
161452192|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
161452193|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
161452194|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452195|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452196|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452197|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452198|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452199|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452200|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
161452201|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
161452202|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
161452203|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
161452204|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452205|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452206|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452207|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452208|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452209|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452210|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
161452211|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
161452212|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
161452213|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
161452214|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452215|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452216|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452217|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452218|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452219|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452220|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161802380|NCT03912337|584319698|FG001|Overall Study|Withdrawal of Consent From Study|0|||
161452221|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452222|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
161452223|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161452224|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Death|0|||
161668056|NCT00406653|583837478|FG002|Induction Period|Incarcerated|1|||
161802381|NCT03912337|584319697|FG000|Overall Study|Lost to Follow-up|1|||
161802382|NCT03912337|584319698|FG001|Overall Study|Lost to Follow-up|1|||
161802383|NCT03561883|584319702|FG000|Overall Study|Adverse Event|10|||
161802384|NCT03561883|584319703|FG001|Overall Study|Adverse Event|13|||
161802385|NCT03561883|584319702|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161802386|NCT03561883|584319703|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161802387|NCT03561883|584319702|FG000|Overall Study|Protocol Violation|2|||
161802388|NCT03561883|584319703|FG001|Overall Study|Protocol Violation|3|||
161802389|NCT03561883|584319702|FG000|Overall Study|Withdrawal by Subject|14|||
161802390|NCT03561883|584319703|FG001|Overall Study|Withdrawal by Subject|6|||
161802391|NCT03561883|584319702|FG000|Overall Study|Lost to Follow-up|2|||
161802392|NCT03561883|584319703|FG001|Overall Study|Lost to Follow-up|6|||
161802393|NCT03561883|584319702|FG000|Overall Study|Study Terminated by Sponsor|12|||
161802394|NCT03561883|584319703|FG001|Overall Study|Study Terminated by Sponsor|11|||
161802395|NCT03561883|584319702|FG000|Overall Study|Physician Decision|1|||
161802396|NCT03561883|584319703|FG001|Overall Study|Physician Decision|0|||
161802397|NCT03561883|584319702|FG000|Overall Study|Randomized by Mistake|1|||
161452225|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Death|0|||
161452226|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Death|0|||
161452227|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Death|0|||
161452228|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Death|0|||
161452229|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Death|0|||
161452230|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Death|0|||
161452231|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Death|0|||
161452232|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Death|0|||
161452233|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Death|1|||
161452234|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452235|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452236|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452237|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452238|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452239|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452240|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452241|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452242|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161452243|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
161452244|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452245|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452246|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452247|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452248|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452249|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452250|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452251|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452252|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
161452253|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
161452254|NCT01185353|583050739|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452255|NCT01185353|583050740|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452256|NCT01185353|583050741|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452257|NCT01185353|583050742|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452258|NCT01185353|583050743|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452259|NCT01185353|583050744|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452260|NCT01185353|583050745|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452261|NCT01185353|583050746|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452262|NCT01185353|583050747|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
161452263|NCT01185353|583050748|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
161452264|NCT01185353|583050739|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452265|NCT01185353|583050740|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452266|NCT01185353|583050741|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452267|NCT01185353|583050742|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452268|NCT01185353|583050743|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452269|NCT01185353|583050744|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452270|NCT01185353|583050745|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161802398|NCT03561883|584319703|FG001|Overall Study|Randomized by Mistake|0|||
161802399|NCT03561883|584319702|FG000|Overall Study|Other, Not Specified|3|||
161802400|NCT03561883|584319703|FG001|Overall Study|Other, Not Specified|2|||
161802401|NCT03978624|584319704|FG000|Overall Study|Protocol Violation|1|||
161452271|NCT01185353|583050746|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
161452272|NCT01185353|583050747|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
161452273|NCT01185353|583050748|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
161452274|NCT01185353|583050739|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161802402|NCT03978624|584319705|FG001|Overall Study|Protocol Violation|0|||
161905578|NCT00641056|584703379|FG000|Overall Study|Entry Criteria Not Met|3|||
161560562|NCT00480441|583440206|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
161560563|NCT00480441|583440204|FG000|Baseline Functional MRI|physical contraindication|4|||
161560564|NCT00480441|583440205|FG001|Baseline Functional MRI|physical contraindication|0|||
161560565|NCT00480441|583440206|FG002|Baseline Functional MRI|physical contraindication|0|||
161560566|NCT00480441|583440204|FG000|Randomization|Lost to Follow-up|0|||
161560567|NCT00480441|583440205|FG001|Randomization|Lost to Follow-up|7|||
161560568|NCT00480441|583440206|FG002|Randomization|Lost to Follow-up|2|||
161560569|NCT01113463|583440207|FG000|Overall Study|Physician Decision|5|||
161560570|NCT01657682|583440209|FG000|Overall Study|Lost to Follow-up|1|||
161560571|NCT01657682|583440210|FG001|Overall Study|Lost to Follow-up|0|||
161560572|NCT01657682|583440211|FG002|Overall Study|Lost to Follow-up|0|||
161560573|NCT01657682|583440209|FG000|Overall Study|Withdrawal by Subject|0|||
161560574|NCT01657682|583440210|FG001|Overall Study|Withdrawal by Subject|1|||
161560575|NCT01657682|583440211|FG002|Overall Study|Withdrawal by Subject|1|||
161560576|NCT01657682|583440209|FG000|Overall Study|Adverse Event|0|||
161560577|NCT01657682|583440210|FG001|Overall Study|Adverse Event|1|||
161560578|NCT01657682|583440211|FG002|Overall Study|Adverse Event|0|||
161560579|NCT03379233|583440218|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
161560580|NCT03379233|583440219|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
161560581|NCT00965484|583440220|FG000|Overall Study|Protocol Violation|1|||
161560582|NCT00965484|583440220|FG000|Overall Study|Withdrawal by Subject|1|||
161560583|NCT02531438|583440221|FG000|Overall Study|Adverse Event|7|||
161560584|NCT02531438|583440222|FG001|Overall Study|Adverse Event|9|||
161560585|NCT02531438|583440221|FG000|Overall Study|Lost to Follow-up|0|||
161560586|NCT02531438|583440222|FG001|Overall Study|Lost to Follow-up|3|||
161560587|NCT02531438|583440221|FG000|Overall Study|Withdrawal by Subject|7|||
161560588|NCT02531438|583440222|FG001|Overall Study|Withdrawal by Subject|8|||
161560589|NCT02531438|583440221|FG000|Overall Study|Physician Decision|0|||
161560590|NCT02531438|583440222|FG001|Overall Study|Physician Decision|1|||
161560591|NCT02531438|583440221|FG000|Overall Study|Death|6|||
161560592|NCT02531438|583440222|FG001|Overall Study|Death|3|||
161560593|NCT02531438|583440221|FG000|Overall Study|Randomized, but Not Treated|4|||
161560594|NCT02531438|583440222|FG001|Overall Study|Randomized, but Not Treated|0|||
161560595|NCT02531438|583440221|FG000|Overall Study|Missed EOT/PTE Visit|5|||
161560596|NCT02531438|583440222|FG001|Overall Study|Missed EOT/PTE Visit|2|||
161560597|NCT02531438|583440221|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
161560598|NCT02531438|583440222|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
161560599|NCT01813422|583440224|FG000|Overall Study|Withdrawal by Subject|14|||
161560600|NCT01813422|583440225|FG001|Overall Study|Withdrawal by Subject|8|||
161560601|NCT01813422|583440224|FG000|Overall Study|Death|2|||
161560602|NCT01813422|583440225|FG001|Overall Study|Death|3|||
161560603|NCT01813422|583440224|FG000|Overall Study|Sponsor Decision|2|||
161560604|NCT01813422|583440225|FG001|Overall Study|Sponsor Decision|1|||
161560605|NCT01813422|583440224|FG000|Overall Study|Lost to Follow-up|2|||
161802403|NCT00958243|584319710|FG000|Overall Study|Withdrawal by Subject|0|||
161802404|NCT00958243|584319711|FG001|Overall Study|Withdrawal by Subject|1|||
161802405|NCT00958243|584319712|FG002|Overall Study|Withdrawal by Subject|3|||
161802406|NCT00958243|584319713|FG003|Overall Study|Withdrawal by Subject|1|||
161802407|NCT00958243|584319714|FG004|Overall Study|Withdrawal by Subject|1|||
161802408|NCT00958243|584319715|FG005|Overall Study|Withdrawal by Subject|5|||
161802409|NCT00958243|584319710|FG000|Overall Study|Lost to Follow-up|2|||
161802410|NCT00958243|584319711|FG001|Overall Study|Lost to Follow-up|5|||
161802411|NCT00958243|584319712|FG002|Overall Study|Lost to Follow-up|11|||
161802412|NCT00958243|584319713|FG003|Overall Study|Lost to Follow-up|2|||
161802413|NCT00958243|584319714|FG004|Overall Study|Lost to Follow-up|8|||
161802414|NCT00958243|584319715|FG005|Overall Study|Lost to Follow-up|5|||
161802415|NCT04646109|584319716|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
161802416|NCT04646109|584319717|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
161802417|NCT06176768|584319718|FG000|Overall Study|Adverse Event|1|||
161802418|NCT06176768|584319719|FG001|Overall Study|Adverse Event|0|||
161905579|NCT00641056|584703380|FG001|Overall Study|Entry Criteria Not Met|0|||
161905580|NCT00641056|584703379|FG000|Overall Study|Subject Decision|6|||
161905581|NCT00641056|584703380|FG001|Overall Study|Subject Decision|19|||
161560606|NCT01813422|583440225|FG001|Overall Study|Lost to Follow-up|4|||
161560607|NCT02015195|583440230|FG000|Overall Study|Adverse Event|0|||
161560608|NCT02015195|583440231|FG001|Overall Study|Adverse Event|0|||
161560609|NCT02015195|583440232|FG002|Overall Study|Adverse Event|0|||
161802419|NCT06176768|584319718|FG000|Overall Study|Assigned treatment by mistake|1|||
161802420|NCT06176768|584319719|FG001|Overall Study|Assigned treatment by mistake|0|||
161905582|NCT00641056|584703379|FG000|Overall Study|Sponsor Decision|1|||
161560610|NCT02015195|583440233|FG003|Overall Study|Adverse Event|1|||
161560611|NCT02015195|583440234|FG004|Overall Study|Adverse Event|0|||
161560612|NCT02015195|583440235|FG005|Overall Study|Adverse Event|0|||
161560613|NCT02015195|583440236|FG006|Overall Study|Adverse Event|0|||
161560614|NCT01318811|583440237|FG000|Overall Study|Physician Decision|1|||
161560615|NCT01318811|583440238|FG001|Overall Study|Physician Decision|1|||
161560616|NCT01318811|583440237|FG000|Overall Study|CRRT stopped for head CT|0|||
161560617|NCT01318811|583440238|FG001|Overall Study|CRRT stopped for head CT|1|||
161560618|NCT01318811|583440237|FG000|Overall Study|Death|0|||
161560619|NCT01318811|583440238|FG001|Overall Study|Death|1|||
161560620|NCT01318811|583440237|FG000|Overall Study|CRRT stopped for head MRI|0|||
161560621|NCT01318811|583440238|FG001|Overall Study|CRRT stopped for head MRI|1|||
161560622|NCT00811187|583440239|FG000|Overall Study|Unable to place device / procedure abort|3|||
161560623|NCT00811187|583440240|FG001|Overall Study|Unable to place device / procedure abort|3|||
161560624|NCT02825043|583440241|FG000|Overall Study|Lost to Follow-up|4|||
161560625|NCT00131911|583440242|FG000|Overall Study|Withdrawal by Subject|1|||
161560626|NCT00131911|583440243|FG001|Overall Study|Withdrawal by Subject|0|||
161560627|NCT00329303|583440244|FG000|Overall Study|Lack of Efficacy|1|||
161560628|NCT00329303|583440245|FG001|Overall Study|Lack of Efficacy|0|||
161560629|NCT00329303|583440244|FG000|Overall Study|Decision of the sponsor|0|||
161560630|NCT00329303|583440245|FG001|Overall Study|Decision of the sponsor|1|||
161560631|NCT00329303|583440244|FG000|Overall Study|Patient no longer available|1|||
161560632|NCT00329303|583440245|FG001|Overall Study|Patient no longer available|0|||
161560633|NCT00329303|583440244|FG000|Overall Study|Patient relocated|0|||
161560634|NCT00329303|583440245|FG001|Overall Study|Patient relocated|1|||
161560635|NCT03582137|583440251|FG000|Overall Study|Adverse Event|1|||
161560636|NCT03582137|583440252|FG001|Overall Study|Adverse Event|0|||
161560637|NCT00558753|583440253|FG000|Overall Study|Lost to Follow-up|5|||
161560638|NCT00558753|583440254|FG001|Overall Study|Lost to Follow-up|7|||
161560639|NCT03704298|583440259|FG000|Overall Study|Death|3|||
161560640|NCT03704298|583440260|FG001|Overall Study|Death|1|||
161560641|NCT03704298|583440261|FG002|Overall Study|Death|1|||
161560642|NCT03704298|583440262|FG003|Overall Study|Death|0|||
161560643|NCT03704298|583440259|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
161560644|NCT03704298|583440260|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
161560645|NCT03704298|583440261|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
161560646|NCT03704298|583440262|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
161560647|NCT03704298|583440259|FG000|Overall Study|Withdrawal by Subject|1|||
161560648|NCT03704298|583440260|FG001|Overall Study|Withdrawal by Subject|0|||
161560649|NCT03704298|583440261|FG002|Overall Study|Withdrawal by Subject|0|||
161560650|NCT03704298|583440262|FG003|Overall Study|Withdrawal by Subject|0|||
161560651|NCT03704298|583440259|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
161560652|NCT03704298|583440260|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
161560653|NCT03704298|583440261|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
161560654|NCT03704298|583440262|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
161560655|NCT00162942|583440263|FG000|Overall Study|Adverse Event|10|||
161560656|NCT00162942|583440264|FG001|Overall Study|Adverse Event|6|||
161560657|NCT00162942|583440263|FG000|Overall Study|Death|1|||
161560658|NCT00162942|583440264|FG001|Overall Study|Death|0|||
161560659|NCT00162942|583440263|FG000|Overall Study|Withdrawal by Subject|3|||
161560660|NCT00162942|583440264|FG001|Overall Study|Withdrawal by Subject|6|||
161560661|NCT00162942|583440263|FG000|Overall Study|Physician Decision|1|||
161560662|NCT00162942|583440264|FG001|Overall Study|Physician Decision|0|||
161560663|NCT00162942|583440263|FG000|Overall Study|Enter Open-Label Study|76|||
161560664|NCT00162942|583440264|FG001|Overall Study|Enter Open-Label Study|35|||
161560665|NCT00162942|583440263|FG000|Overall Study|Alternate Therapy|6|||
161560666|NCT00162942|583440264|FG001|Overall Study|Alternate Therapy|2|||
161560667|NCT00162942|583440263|FG000|Overall Study|Lack of Efficacy|1|||
161560668|NCT00162942|583440264|FG001|Overall Study|Lack of Efficacy|0|||
161560669|NCT00162942|583440263|FG000|Overall Study|Flare During Active Treatment|7|||
161560670|NCT00162942|583440264|FG001|Overall Study|Flare During Active Treatment|3|||
161560671|NCT00162942|583440263|FG000|Overall Study|2 or more consecutive treatments missed|1|||
161560672|NCT00162942|583440264|FG001|Overall Study|2 or more consecutive treatments missed|0|||
161560673|NCT01167023|583440265|FG000|Overall Study|Lost to Follow-up|0|||
161560674|NCT01167023|583440266|FG001|Overall Study|Lost to Follow-up|1|||
161560675|NCT01167023|583440267|FG002|Overall Study|Lost to Follow-up|1|||
161560676|NCT01167023|583440265|FG000|Overall Study|Screen Failure|0|||
161560677|NCT01167023|583440266|FG001|Overall Study|Screen Failure|1|||
161560678|NCT01167023|583440267|FG002|Overall Study|Screen Failure|0|||
161560679|NCT01167023|583440265|FG000|Overall Study|Sponsor Decision|0|||
161560680|NCT01167023|583440266|FG001|Overall Study|Sponsor Decision|1|||
161560681|NCT01167023|583440267|FG002|Overall Study|Sponsor Decision|0|||
161560682|NCT01167023|583440265|FG000|Overall Study|Withdrawal by Subject|0|||
161802421|NCT06176768|584319718|FG000|Overall Study|Lost to Follow-up|0|||
161802422|NCT06176768|584319719|FG001|Overall Study|Lost to Follow-up|3|||
161802423|NCT06176768|584319718|FG000|Overall Study|Physician Decision|1|||
161802424|NCT06176768|584319719|FG001|Overall Study|Physician Decision|0|||
161802425|NCT06176768|584319718|FG000|Overall Study|Protocol deviation|3|||
161802426|NCT06176768|584319719|FG001|Overall Study|Protocol deviation|1|||
161802427|NCT06176768|584319718|FG000|Overall Study|Other|1|||
161802428|NCT06176768|584319719|FG001|Overall Study|Other|0|||
161802429|NCT06176768|584319718|FG000|Overall Study|Withdrawal by Subject|6|||
161560683|NCT01167023|583440266|FG001|Overall Study|Withdrawal by Subject|0|||
161560684|NCT01167023|583440267|FG002|Overall Study|Withdrawal by Subject|1|||
161560685|NCT00410384|583440268|FG000|Overall Study|Withdrawal by Subject|28|||
161560686|NCT00410384|583440269|FG001|Overall Study|Withdrawal by Subject|17|||
161560687|NCT00410384|583440270|FG002|Overall Study|Withdrawal by Subject|20|||
161560688|NCT00410384|583440268|FG000|Overall Study|Adverse Event|23|||
161560689|NCT00410384|583440269|FG001|Overall Study|Adverse Event|18|||
161560690|NCT00410384|583440270|FG002|Overall Study|Adverse Event|23|||
161560691|NCT00410384|583440268|FG000|Overall Study|Lack of Efficacy|20|||
161560692|NCT00410384|583440269|FG001|Overall Study|Lack of Efficacy|12|||
161560693|NCT00410384|583440270|FG002|Overall Study|Lack of Efficacy|17|||
161560694|NCT00410384|583440268|FG000|Overall Study|Lack of Compliance|2|||
161560695|NCT00410384|583440269|FG001|Overall Study|Lack of Compliance|2|||
161560696|NCT00410384|583440270|FG002|Overall Study|Lack of Compliance|2|||
161560697|NCT00410384|583440268|FG000|Overall Study|Lost to Follow-up|4|||
161560698|NCT00410384|583440269|FG001|Overall Study|Lost to Follow-up|6|||
161560699|NCT00410384|583440270|FG002|Overall Study|Lost to Follow-up|6|||
161560700|NCT00410384|583440268|FG000|Overall Study|Protocol Violation|6|||
161560701|NCT00410384|583440269|FG001|Overall Study|Protocol Violation|6|||
161560702|NCT00410384|583440270|FG002|Overall Study|Protocol Violation|6|||
161560703|NCT00410384|583440268|FG000|Overall Study|Physician Decision|3|||
161560704|NCT00410384|583440269|FG001|Overall Study|Physician Decision|3|||
161560705|NCT00410384|583440270|FG002|Overall Study|Physician Decision|4|||
161560706|NCT00410384|583440268|FG000|Overall Study|Other|3|||
161560707|NCT00410384|583440269|FG001|Overall Study|Other|8|||
161560708|NCT00410384|583440270|FG002|Overall Study|Other|4|||
161560709|NCT01192295|583440271|FG000|Overall Study|Adverse Event|3|||
161560710|NCT01192295|583440272|FG001|Overall Study|Adverse Event|7|||
161560711|NCT01192295|583440271|FG000|Overall Study|Withdrawal by Subject|3|||
161560712|NCT01192295|583440272|FG001|Overall Study|Withdrawal by Subject|4|||
161560713|NCT01192295|583440271|FG000|Overall Study|Lost to Follow-up|0|||
161560714|NCT01192295|583440272|FG001|Overall Study|Lost to Follow-up|1|||
161560715|NCT01192295|583440271|FG000|Overall Study|Lack of Efficacy|0|||
161560716|NCT01192295|583440272|FG001|Overall Study|Lack of Efficacy|5|||
161560717|NCT01192295|583440271|FG000|Overall Study|Administrative|4|||
161560718|NCT01192295|583440272|FG001|Overall Study|Administrative|6|||
161560719|NCT00630539|583440273|FG000|Overall Study|Adverse Event|1|||
161560720|NCT00630539|583440274|FG001|Overall Study|Adverse Event|3|||
161560721|NCT00630539|583440275|FG002|Overall Study|Adverse Event|1|||
161560722|NCT00630539|583440276|FG003|Overall Study|Adverse Event|2|||
161560723|NCT00630539|583440273|FG000|Overall Study|Withdrawal by Subject|0|||
161560724|NCT00630539|583440274|FG001|Overall Study|Withdrawal by Subject|1|||
161560725|NCT00630539|583440275|FG002|Overall Study|Withdrawal by Subject|0|||
161560726|NCT00630539|583440276|FG003|Overall Study|Withdrawal by Subject|1|||
161560727|NCT03473756|583440289|FG000|Overall Study|Withdrawal by Subject|1|||
161560728|NCT03473756|583440290|FG001|Overall Study|Withdrawal by Subject|4|||
161560729|NCT03473756|583440289|FG000|Overall Study|Adverse Event|6|||
161560730|NCT03473756|583440290|FG001|Overall Study|Adverse Event|7|||
161560731|NCT03473756|583440289|FG000|Overall Study|Lack of Efficacy|3|||
161560732|NCT03473756|583440290|FG001|Overall Study|Lack of Efficacy|10|||
161560733|NCT03473756|583440289|FG000|Overall Study|Physician Decision|0|||
161560734|NCT03473756|583440290|FG001|Overall Study|Physician Decision|2|||
161560735|NCT03473756|583440289|FG000|Overall Study|End of study treatment|0|||
161802430|NCT06176768|584319719|FG001|Overall Study|Withdrawal by Subject|9|||
161802431|NCT01606306|584319722|FG000|Overall Study|Lack of Efficacy|2|||
161802432|NCT01606306|584319723|FG001|Overall Study|Lack of Efficacy|1|||
161802433|NCT01606306|584319724|FG002|Overall Study|Lack of Efficacy|4|||
161802434|NCT01606306|584319725|FG003|Overall Study|Lack of Efficacy|4|||
161802435|NCT01606306|584319726|FG004|Overall Study|Lack of Efficacy|1|||
161802436|NCT01606306|584319727|FG005|Overall Study|Lack of Efficacy|2|||
161802437|NCT01606306|584319722|FG000|Overall Study|Adverse Event|1|||
161802438|NCT01606306|584319723|FG001|Overall Study|Adverse Event|0|||
161802439|NCT01606306|584319724|FG002|Overall Study|Adverse Event|1|||
161802440|NCT01606306|584319725|FG003|Overall Study|Adverse Event|1|||
161802441|NCT01606306|584319726|FG004|Overall Study|Adverse Event|2|||
161802442|NCT01606306|584319727|FG005|Overall Study|Adverse Event|0|||
161802443|NCT01606306|584319722|FG000|Overall Study|Lost to Follow-up|7|||
161802444|NCT01606306|584319723|FG001|Overall Study|Lost to Follow-up|4|||
161802445|NCT01606306|584319724|FG002|Overall Study|Lost to Follow-up|5|||
161802446|NCT01606306|584319725|FG003|Overall Study|Lost to Follow-up|4|||
161560736|NCT03473756|583440290|FG001|Overall Study|End of study treatment|2|||
161560737|NCT03473756|583440289|FG000|Overall Study|Lost to Follow-up|0|||
161560738|NCT03473756|583440290|FG001|Overall Study|Lost to Follow-up|1|||
161560739|NCT03714022|583440291|FG000|Overall Study|Adverse Event|1|||
161560740|NCT03714022|583440292|FG001|Overall Study|Adverse Event|0|||
161560741|NCT03714022|583440291|FG000|Overall Study|Consent withdrawal|0|||
161560742|NCT03714022|583440292|FG001|Overall Study|Consent withdrawal|1|||
161560743|NCT03714022|583440291|FG000|Overall Study|Lost to Follow-up|3|||
161560744|NCT03714022|583440292|FG001|Overall Study|Lost to Follow-up|2|||
161802447|NCT01606306|584319726|FG004|Overall Study|Lost to Follow-up|3|||
161452275|NCT01185353|583050740|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161452276|NCT01185353|583050741|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161452277|NCT01185353|583050742|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161452278|NCT01185353|583050743|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161452279|NCT01185353|583050744|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161802448|NCT01606306|584319727|FG005|Overall Study|Lost to Follow-up|5|||
161802449|NCT01606306|584319722|FG000|Overall Study|Withdrawal by Subject|4|||
161802450|NCT01606306|584319723|FG001|Overall Study|Withdrawal by Subject|3|||
161802451|NCT01606306|584319724|FG002|Overall Study|Withdrawal by Subject|4|||
161802452|NCT01606306|584319725|FG003|Overall Study|Withdrawal by Subject|4|||
161802453|NCT01606306|584319726|FG004|Overall Study|Withdrawal by Subject|5|||
161802454|NCT01606306|584319727|FG005|Overall Study|Withdrawal by Subject|4|||
161802455|NCT01606306|584319722|FG000|Overall Study|Physician Decision|1|||
161802456|NCT01606306|584319723|FG001|Overall Study|Physician Decision|2|||
161802457|NCT01606306|584319724|FG002|Overall Study|Physician Decision|0|||
161802458|NCT01606306|584319725|FG003|Overall Study|Physician Decision|0|||
161802459|NCT01606306|584319726|FG004|Overall Study|Physician Decision|0|||
161802460|NCT01606306|584319727|FG005|Overall Study|Physician Decision|0|||
161802461|NCT00970281|584319728|FG000|Overall Study|Lack of Efficacy|1|||
161802462|NCT00970281|584319729|FG001|Overall Study|Lack of Efficacy|14|||
161802463|NCT00970281|584319728|FG000|Overall Study|Withdrawal by Subject|0|||
161802464|NCT00970281|584319729|FG001|Overall Study|Withdrawal by Subject|1|||
161802465|NCT00970281|584319728|FG000|Overall Study|Physician Decision|1|||
161802466|NCT00970281|584319729|FG001|Overall Study|Physician Decision|1|||
161802467|NCT02937701|584321354|FG000|Day 1 to Week 22|Adverse Event|11|||
161802468|NCT02937701|584321355|FG001|Day 1 to Week 22|Adverse Event|14|||
161802469|NCT02937701|584321356|FG002|Day 1 to Week 22|Adverse Event|0|||
161802470|NCT02937701|584321357|FG003|Day 1 to Week 22|Adverse Event|0|||
161802471|NCT02937701|584321358|FG004|Day 1 to Week 22|Adverse Event|0|||
161452280|NCT01185353|583050745|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
161452281|NCT01185353|583050746|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
161452282|NCT01185353|583050747|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
161452283|NCT01185353|583050748|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
161452284|NCT01185353|583050739|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452285|NCT01185353|583050740|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452286|NCT01185353|583050741|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452287|NCT01185353|583050742|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452288|NCT01185353|583050743|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452289|NCT01185353|583050744|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452290|NCT01185353|583050745|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452291|NCT01185353|583050746|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
161452292|NCT01185353|583050747|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
161452293|NCT01185353|583050748|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
161452294|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
161452295|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
161452296|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
161452297|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
161452298|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
161452299|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
161452300|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
161452301|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
161452302|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
161452303|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
161452304|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452305|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
161452306|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452307|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452308|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452309|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452310|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452311|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161452312|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
161452313|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
161452314|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
161452315|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
161452316|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
161452317|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
161452318|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
161560745|NCT02487446|583440296|FG000|Period 1|Physician Decision|0|||
161802472|NCT02937701|584321354|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
161905583|NCT00641056|584703380|FG001|Overall Study|Sponsor Decision|2|||
161905584|NCT00239720|584703381|FG000|Overall Study|Adverse Event|1|||
161905585|NCT00239720|584703382|FG001|Overall Study|Adverse Event|0|||
161905586|NCT00239720|584703381|FG000|Overall Study|Lost to Follow-up|0|||
161905587|NCT00239720|584703382|FG001|Overall Study|Lost to Follow-up|1|||
161905588|NCT01811732|584703383|FG000|Overall Study|Lost to Follow-up|24|||
161905589|NCT01811732|584703384|FG001|Overall Study|Lost to Follow-up|30|||
161905590|NCT01811732|584703383|FG000|Overall Study|Withdrawal by Subject|16|||
161905591|NCT01811732|584703384|FG001|Overall Study|Withdrawal by Subject|10|||
161905592|NCT01811732|584703383|FG000|Overall Study|Adverse Event|3|||
161905593|NCT01811732|584703384|FG001|Overall Study|Adverse Event|9|||
161452319|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
161452320|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
161452321|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|Other|0|||
161452322|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|Other|0|||
161452323|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|Other|1|||
161452324|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|Other|1|||
161452325|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|Other|0|||
161452326|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|Other|0|||
161452327|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|Other|0|||
161452328|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|Other|1|||
161452329|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|Other|0|||
161452330|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|Death|0|||
161452331|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|Death|0|||
161452332|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|Death|0|||
161452333|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|Death|0|||
161452334|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|Death|0|||
161452335|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|Death|1|||
161452336|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|Death|0|||
161452337|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|Death|0|||
161452338|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|Death|0|||
161452339|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452340|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452341|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452342|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452343|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452344|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
161452345|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
161452346|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452347|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
161452348|NCT00557856|583050749|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
161452349|NCT00557856|583050750|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452350|NCT00557856|583050751|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452351|NCT00557856|583050752|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452352|NCT00557856|583050753|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452353|NCT00557856|583050754|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452354|NCT00557856|583050755|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452355|NCT00557856|583050756|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452356|NCT00557856|583050757|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
161452357|NCT00557856|583050749|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452358|NCT00557856|583050750|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452359|NCT00557856|583050751|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452360|NCT00557856|583050752|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452361|NCT00557856|583050753|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452362|NCT00557856|583050754|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452363|NCT00557856|583050755|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452364|NCT00557856|583050756|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
161452365|NCT00557856|583050757|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
161452366|NCT00557856|583050749|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452367|NCT00557856|583050750|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452368|NCT00557856|583050751|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452369|NCT00557856|583050752|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452370|NCT00557856|583050753|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452371|NCT00557856|583050754|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452372|NCT00557856|583050755|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452373|NCT00557856|583050756|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161452374|NCT00557856|583050757|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
161452375|NCT00557856|583050749|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
161905594|NCT01811732|584703383|FG000|Overall Study|Lack of Efficacy|3|||
161452376|NCT00557856|583050750|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
161452377|NCT00557856|583050751|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
161452378|NCT00557856|583050752|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
161452379|NCT00557856|583050753|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
161452380|NCT00557856|583050754|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
161452381|NCT00557856|583050755|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
161452382|NCT00557856|583050756|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
161452383|NCT00557856|583050757|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
161452384|NCT00557856|583050749|FG000|Part 2: Exploratory Phase|Other|0|||
161452385|NCT00557856|583050750|FG001|Part 2: Exploratory Phase|Other|0|||
161452386|NCT00557856|583050751|FG002|Part 2: Exploratory Phase|Other|0|||
161452387|NCT00557856|583050752|FG003|Part 2: Exploratory Phase|Other|0|||
161452388|NCT00557856|583050753|FG004|Part 2: Exploratory Phase|Other|0|||
161452389|NCT00557856|583050754|FG005|Part 2: Exploratory Phase|Other|0|||
161452390|NCT00557856|583050755|FG006|Part 2: Exploratory Phase|Other|0|||
161452391|NCT00557856|583050756|FG007|Part 2: Exploratory Phase|Other|0|||
161452392|NCT00557856|583050757|FG008|Part 2: Exploratory Phase|Other|1|||
161452393|NCT00557856|583050749|FG000|Part 2: Exploratory Phase|Death|0|||
161452394|NCT00557856|583050750|FG001|Part 2: Exploratory Phase|Death|0|||
161452395|NCT00557856|583050751|FG002|Part 2: Exploratory Phase|Death|0|||
161452396|NCT00557856|583050752|FG003|Part 2: Exploratory Phase|Death|0|||
161452397|NCT00557856|583050753|FG004|Part 2: Exploratory Phase|Death|0|||
161452398|NCT00557856|583050754|FG005|Part 2: Exploratory Phase|Death|0|||
161452399|NCT00557856|583050755|FG006|Part 2: Exploratory Phase|Death|0|||
161452400|NCT00557856|583050756|FG007|Part 2: Exploratory Phase|Death|0|||
161452401|NCT00557856|583050757|FG008|Part 2: Exploratory Phase|Death|2|||
161452402|NCT00557856|583050749|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452403|NCT00557856|583050750|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452404|NCT00557856|583050751|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452405|NCT00557856|583050752|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452406|NCT00557856|583050753|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452407|NCT00557856|583050754|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452408|NCT00557856|583050755|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452409|NCT00557856|583050756|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
161452410|NCT00557856|583050757|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
161452411|NCT00363545|583050758|FG000|Overall Study|Serious Adverse Event|0|||
161452412|NCT00363545|583050759|FG001|Overall Study|Serious Adverse Event|1|||
161452413|NCT00363545|583050758|FG000|Overall Study|Withdrawal by Subject|12|||
161452414|NCT00363545|583050759|FG001|Overall Study|Withdrawal by Subject|15|||
161452415|NCT00363545|583050758|FG000|Overall Study|Migrated/moved from study area|3|||
161452416|NCT00363545|583050759|FG001|Overall Study|Migrated/moved from study area|6|||
161452417|NCT00363545|583050758|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
161452418|NCT00363545|583050759|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
161452419|NCT00363545|583050758|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
161452420|NCT00363545|583050759|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
161452421|NCT00363545|583050758|FG000|Overall Study|Others|1|||
161452422|NCT00363545|583050759|FG001|Overall Study|Others|0|||
161452423|NCT03425253|583050763|FG000|Overall Study|Adverse Event|2|||
161452424|NCT03425253|583050763|FG000|Overall Study|Lost to Follow-up|3|||
161452425|NCT03425253|583050763|FG000|Overall Study|Withdrew Consent|6|||
161452426|NCT03425253|583050763|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
161452427|NCT05009979|583050766|FG000|Overall Study|Withdrawal by Subject|1|||
161452428|NCT04174365|583050769|FG000|Overall Study|Lost to Follow-up|1|||
161452429|NCT04174365|583050770|FG001|Overall Study|Lost to Follow-up|2|||
161452430|NCT04174365|583050769|FG000|Overall Study|Adverse Event|2|||
161452431|NCT04174365|583050770|FG001|Overall Study|Adverse Event|1|||
161452432|NCT04174365|583050769|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
161452433|NCT04174365|583050770|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
161452434|NCT04174365|583050769|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
161452435|NCT04174365|583050770|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
161452436|NCT04174365|583050769|FG000|Overall Study|Protocol Deviation|1|||
161452437|NCT04174365|583050770|FG001|Overall Study|Protocol Deviation|0|||
161452438|NCT04174365|583050769|FG000|Overall Study|Lack of Efficacy|0|||
161452439|NCT04174365|583050770|FG001|Overall Study|Lack of Efficacy|2|||
161560746|NCT02487446|583440297|FG001|Period 1|Physician Decision|1|||
161452440|NCT04174365|583050769|FG000|Overall Study|Disease Relapse|1|||
161452441|NCT04174365|583050770|FG001|Overall Study|Disease Relapse|0|||
161560747|NCT02487446|583440296|FG000|Period 1|Lack of Efficacy|1|||
161452442|NCT04174365|583050769|FG000|Overall Study|Reason Not Specified|0|||
161452443|NCT04174365|583050770|FG001|Overall Study|Reason Not Specified|1|||
161452444|NCT04627285|583050771|FG000|Overall Study|Adverse Event|0|||
161452445|NCT04627285|583050772|FG001|Overall Study|Adverse Event|2|||
161452446|NCT04627285|583050771|FG000|Overall Study|Lost to Follow-up|1|||
161452447|NCT04627285|583050772|FG001|Overall Study|Lost to Follow-up|0|||
161802473|NCT02937701|584321355|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
161802474|NCT02937701|584321356|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
161802475|NCT02937701|584321357|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
161802476|NCT02937701|584321358|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
161802477|NCT02937701|584321354|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
161802478|NCT02937701|584321355|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
161802479|NCT02937701|584321356|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161802480|NCT02937701|584321357|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161905595|NCT01811732|584703384|FG001|Overall Study|Lack of Efficacy|1|||
161905596|NCT01811732|584703383|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
161905597|NCT01811732|584703384|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
161905598|NCT01811732|584703383|FG000|Overall Study|Physician Decision|2|||
161905599|NCT01811732|584703384|FG001|Overall Study|Physician Decision|0|||
161905600|NCT01811732|584703383|FG000|Overall Study|Death|1|||
161905601|NCT01811732|584703384|FG001|Overall Study|Death|1|||
161452448|NCT04627285|583050771|FG000|Overall Study|Withdrawal by Subject|1|||
161452449|NCT04627285|583050772|FG001|Overall Study|Withdrawal by Subject|1|||
161452450|NCT04627285|583050771|FG000|Overall Study|Sponsor decision|5|||
161452451|NCT04627285|583050772|FG001|Overall Study|Sponsor decision|0|||
161452452|NCT04627285|583050771|FG000|Overall Study|Participant left country; aunt informed the site|0|||
161452453|NCT04627285|583050772|FG001|Overall Study|Participant left country; aunt informed the site|1|||
161452454|NCT03658876|583052102|FG000|Overall Study|Protocol Violation|3|||
161452455|NCT03658876|583052103|FG001|Overall Study|Protocol Violation|2|||
161452456|NCT03658876|583052102|FG000|Overall Study|Withdrawal by Subject|2|||
161452457|NCT03658876|583052103|FG001|Overall Study|Withdrawal by Subject|0|||
161452458|NCT03658876|583052102|FG000|Overall Study|Death|0|||
161452459|NCT03658876|583052103|FG001|Overall Study|Death|1|||
161452460|NCT03658876|583052102|FG000|Overall Study|Intercurrent illness|6|||
161452461|NCT03658876|583052103|FG001|Overall Study|Intercurrent illness|4|||
161452462|NCT03658876|583052102|FG000|Overall Study|Transplantation/other operation|1|||
161452463|NCT03658876|583052103|FG001|Overall Study|Transplantation/other operation|5|||
161452464|NCT01330017|583052104|FG000|Overall Study|Adverse Event|0|||
161452465|NCT01330017|583052105|FG001|Overall Study|Adverse Event|1|||
161452466|NCT01330017|583052106|FG002|Overall Study|Adverse Event|1|||
161452467|NCT01330017|583052107|FG003|Overall Study|Adverse Event|4|||
161452468|NCT01330017|583052108|FG004|Overall Study|Adverse Event|0|||
161452469|NCT01330017|583052104|FG000|Overall Study|Withdrawal by Subject|0|||
161452470|NCT01330017|583052105|FG001|Overall Study|Withdrawal by Subject|0|||
161452471|NCT01330017|583052106|FG002|Overall Study|Withdrawal by Subject|1|||
161452472|NCT01330017|583052107|FG003|Overall Study|Withdrawal by Subject|0|||
161452473|NCT01330017|583052108|FG004|Overall Study|Withdrawal by Subject|1|||
161452474|NCT01330017|583052104|FG000|Overall Study|Lost to Follow-up|0|||
161452475|NCT01330017|583052105|FG001|Overall Study|Lost to Follow-up|0|||
161452476|NCT01330017|583052106|FG002|Overall Study|Lost to Follow-up|1|||
161452477|NCT01330017|583052107|FG003|Overall Study|Lost to Follow-up|0|||
161452478|NCT01330017|583052108|FG004|Overall Study|Lost to Follow-up|0|||
161452479|NCT01330017|583052104|FG000|Overall Study|Protocol Violation|0|||
161452480|NCT01330017|583052105|FG001|Overall Study|Protocol Violation|0|||
161452481|NCT01330017|583052106|FG002|Overall Study|Protocol Violation|0|||
161452482|NCT01330017|583052107|FG003|Overall Study|Protocol Violation|1|||
161452483|NCT01330017|583052108|FG004|Overall Study|Protocol Violation|0|||
161452484|NCT01330017|583052104|FG000|Overall Study|Unknown Reason|5|||
161452485|NCT01330017|583052105|FG001|Overall Study|Unknown Reason|3|||
161452486|NCT01330017|583052106|FG002|Overall Study|Unknown Reason|5|||
161452487|NCT01330017|583052107|FG003|Overall Study|Unknown Reason|7|||
161452488|NCT01330017|583052108|FG004|Overall Study|Unknown Reason|2|||
161452489|NCT03137069|583052112|FG000|Overall Study|Withdrawal by Subject|1|||
161452490|NCT03137069|583052113|FG001|Overall Study|Withdrawal by Subject|2|||
161452491|NCT03137069|583052114|FG002|Overall Study|Withdrawal by Subject|2|||
161452492|NCT03137069|583052115|FG003|Overall Study|Withdrawal by Subject|2|||
161452493|NCT03137069|583052116|FG004|Overall Study|Withdrawal by Subject|0|||
161452494|NCT03137069|583052117|FG005|Overall Study|Withdrawal by Subject|0|||
161452495|NCT03137069|583052112|FG000|Overall Study|Adverse Event|0|||
161802481|NCT02937701|584321358|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161802482|NCT02937701|584321354|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
161802483|NCT02937701|584321355|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
161802484|NCT02937701|584321356|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
161452496|NCT03137069|583052113|FG001|Overall Study|Adverse Event|3|||
161452497|NCT03137069|583052114|FG002|Overall Study|Adverse Event|1|||
161452498|NCT03137069|583052115|FG003|Overall Study|Adverse Event|1|||
161452499|NCT03137069|583052116|FG004|Overall Study|Adverse Event|0|||
161452500|NCT03137069|583052117|FG005|Overall Study|Adverse Event|1|||
161452501|NCT03137069|583052112|FG000|Overall Study|Protocol Violation|0|||
161452502|NCT03137069|583052113|FG001|Overall Study|Protocol Violation|1|||
161905602|NCT01811732|584703383|FG000|Overall Study|Insufficient venous access|0|||
161905603|NCT01811732|584703384|FG001|Overall Study|Insufficient venous access|1|||
161560748|NCT02487446|583440297|FG001|Period 1|Lack of Efficacy|0|||
161560749|NCT02487446|583440296|FG000|Period 1|Protocol deviation|3|||
161560750|NCT02487446|583440297|FG001|Period 1|Protocol deviation|2|||
161560751|NCT02487446|583440296|FG000|Period 1|Lost to Follow-up|2|||
161560752|NCT02487446|583440297|FG001|Period 1|Lost to Follow-up|0|||
161560753|NCT02487446|583440296|FG000|Period 1|Withdrawal by Subject|2|||
161560754|NCT02487446|583440297|FG001|Period 1|Withdrawal by Subject|0|||
161560755|NCT02487446|583440296|FG000|Period 1|Adverse Event|5|||
161560756|NCT02487446|583440297|FG001|Period 1|Adverse Event|5|||
161560757|NCT02487446|583440296|FG000|Washout|Lost to Follow-up|0|||
161560758|NCT02487446|583440297|FG001|Washout|Lost to Follow-up|2|||
161560759|NCT02487446|583440296|FG000|Washout|Withdrawal by Subject|1|||
161560760|NCT02487446|583440297|FG001|Washout|Withdrawal by Subject|4|||
161560761|NCT02487446|583440296|FG000|Washout|Adverse Event|2|||
161560762|NCT02487446|583440297|FG001|Washout|Adverse Event|2|||
161560763|NCT02487446|583440296|FG000|Period 2|Protocol deviation|0|||
161560764|NCT02487446|583440297|FG001|Period 2|Protocol deviation|1|||
161560765|NCT02487446|583440296|FG000|Period 2|Lost to Follow-up|1|||
161560766|NCT02487446|583440297|FG001|Period 2|Lost to Follow-up|1|||
161560767|NCT02487446|583440296|FG000|Period 2|Withdrawal by Subject|1|||
161560768|NCT02487446|583440297|FG001|Period 2|Withdrawal by Subject|1|||
161560769|NCT02487446|583440296|FG000|Period 2|Adverse Event|6|||
161560770|NCT02487446|583440297|FG001|Period 2|Adverse Event|2|||
161560771|NCT02234310|583440298|FG000|Overall Study|Physician Decision|1|||
161802485|NCT02937701|584321357|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
161802486|NCT02937701|584321358|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
161802487|NCT02937701|584321354|FG000|Day 1 to Week 22|Death|1|||
161802488|NCT02937701|584321355|FG001|Day 1 to Week 22|Death|1|||
161802489|NCT02937701|584321356|FG002|Day 1 to Week 22|Death|0|||
161802490|NCT02937701|584321357|FG003|Day 1 to Week 22|Death|0|||
161802491|NCT02937701|584321358|FG004|Day 1 to Week 22|Death|0|||
161802492|NCT02937701|584321354|FG000|Day 1 to Week 22|Protocol Violation|1|||
161802493|NCT02937701|584321355|FG001|Day 1 to Week 22|Protocol Violation|1|||
161802494|NCT02937701|584321356|FG002|Day 1 to Week 22|Protocol Violation|0|||
161802495|NCT02937701|584321357|FG003|Day 1 to Week 22|Protocol Violation|0|||
161802496|NCT02937701|584321358|FG004|Day 1 to Week 22|Protocol Violation|0|||
161802497|NCT02937701|584321354|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
161802498|NCT02937701|584321355|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
161802499|NCT02937701|584321356|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
161802500|NCT02937701|584321357|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
161802501|NCT02937701|584321358|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
161802502|NCT02937701|584321354|FG000|Day 1 to Week 22|Physician Decision|2|||
161802503|NCT02937701|584321355|FG001|Day 1 to Week 22|Physician Decision|0|||
161802504|NCT02937701|584321356|FG002|Day 1 to Week 22|Physician Decision|0|||
161802505|NCT02937701|584321357|FG003|Day 1 to Week 22|Physician Decision|0|||
161802506|NCT02937701|584321358|FG004|Day 1 to Week 22|Physician Decision|0|||
161802507|NCT02937701|584321354|FG000|Day 1 to Week 22|Other|1|||
161802508|NCT02937701|584321355|FG001|Day 1 to Week 22|Other|0|||
161802509|NCT02937701|584321356|FG002|Day 1 to Week 22|Other|0|||
161802510|NCT02937701|584321357|FG003|Day 1 to Week 22|Other|0|||
161802511|NCT02937701|584321358|FG004|Day 1 to Week 22|Other|0|||
161802512|NCT02937701|584321354|FG000|Week 22 to Week 50|Adverse Event|0|||
161802513|NCT02937701|584321355|FG001|Week 22 to Week 50|Adverse Event|0|||
161802514|NCT02937701|584321356|FG002|Week 22 to Week 50|Adverse Event|10|||
161802515|NCT02937701|584321357|FG003|Week 22 to Week 50|Adverse Event|3|||
161802516|NCT02937701|584321358|FG004|Week 22 to Week 50|Adverse Event|3|||
161802517|NCT02937701|584321354|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
161802518|NCT02937701|584321355|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
161802519|NCT02937701|584321356|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
161802520|NCT02937701|584321357|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
161802521|NCT02937701|584321358|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
161905604|NCT01811732|584703383|FG000|Overall Study|Protocol Violation|0|||
161905605|NCT01811732|584703384|FG001|Overall Study|Protocol Violation|1|||
161802522|NCT02937701|584321354|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
161560772|NCT02234310|583440298|FG000|Overall Study|Adverse Event|1|||
161560773|NCT02234310|583440298|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
161560774|NCT02234310|583440298|FG000|Overall Study|Withdrawal by Subject|2|||
161560775|NCT03289455|583440299|FG000|Overall Study|Death|1|||
161560776|NCT03289455|583440300|FG001|Overall Study|Death|0|||
161560777|NCT03289455|583440301|FG002|Overall Study|Death|0|||
161560778|NCT03289455|583440299|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
161560779|NCT03289455|583440300|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
161560780|NCT03289455|583440301|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
161560781|NCT03289455|583440299|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
161560782|NCT03289455|583440300|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
161560783|NCT03289455|583440301|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
161905606|NCT01811732|584703383|FG000|Overall Study|Subject incarcerated|1|||
161905607|NCT01811732|584703384|FG001|Overall Study|Subject incarcerated|2|||
161560784|NCT03289455|583440299|FG000|Overall Study|Progressive disease|3|||
161560785|NCT03289455|583440300|FG001|Overall Study|Progressive disease|4|||
161560786|NCT03289455|583440301|FG002|Overall Study|Progressive disease|5|||
161560787|NCT02624778|583441928|FG000|Overall Study|Lost to Follow-up|0|||
161560788|NCT02624778|583441929|FG001|Overall Study|Lost to Follow-up|0|||
161560789|NCT02624778|583441930|FG002|Overall Study|Lost to Follow-up|1|||
161560790|NCT02624778|583441931|FG003|Overall Study|Lost to Follow-up|0|||
161560791|NCT02624778|583441932|FG004|Overall Study|Lost to Follow-up|0|||
161560792|NCT02624778|583441933|FG005|Overall Study|Lost to Follow-up|0|||
161560793|NCT02624778|583441934|FG006|Overall Study|Lost to Follow-up|0|||
161560794|NCT02624778|583441935|FG007|Overall Study|Lost to Follow-up|0|||
161560795|NCT02624778|583441936|FG008|Overall Study|Lost to Follow-up|0|||
161560796|NCT02624778|583441928|FG000|Overall Study|Withdrawal by Subject|0|||
161560797|NCT02624778|583441929|FG001|Overall Study|Withdrawal by Subject|1|||
161560798|NCT02624778|583441930|FG002|Overall Study|Withdrawal by Subject|0|||
161560799|NCT02624778|583441931|FG003|Overall Study|Withdrawal by Subject|0|||
161560800|NCT02624778|583441932|FG004|Overall Study|Withdrawal by Subject|0|||
161560801|NCT02624778|583441933|FG005|Overall Study|Withdrawal by Subject|1|||
161560802|NCT02624778|583441934|FG006|Overall Study|Withdrawal by Subject|1|||
161560803|NCT02624778|583441935|FG007|Overall Study|Withdrawal by Subject|1|||
161560804|NCT02624778|583441936|FG008|Overall Study|Withdrawal by Subject|1|||
161560805|NCT02624778|583441928|FG000|Overall Study|Adverse Event|0|||
161560806|NCT02624778|583441929|FG001|Overall Study|Adverse Event|0|||
161560807|NCT02624778|583441930|FG002|Overall Study|Adverse Event|0|||
161560808|NCT02624778|583441931|FG003|Overall Study|Adverse Event|0|||
161560809|NCT02624778|583441932|FG004|Overall Study|Adverse Event|0|||
161802523|NCT02937701|584321355|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
161802524|NCT02937701|584321356|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
161802525|NCT02937701|584321357|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
161802526|NCT02937701|584321358|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
161802527|NCT02937701|584321354|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
161802528|NCT02937701|584321355|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
161802529|NCT02937701|584321356|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
161802530|NCT02937701|584321357|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
161802531|NCT02937701|584321358|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
161802532|NCT02937701|584321354|FG000|Week 22 to Week 50|Physician Decision|0|||
161802533|NCT02937701|584321355|FG001|Week 22 to Week 50|Physician Decision|0|||
161802534|NCT02937701|584321356|FG002|Week 22 to Week 50|Physician Decision|2|||
161802535|NCT02937701|584321357|FG003|Week 22 to Week 50|Physician Decision|0|||
161802536|NCT02937701|584321358|FG004|Week 22 to Week 50|Physician Decision|1|||
161802537|NCT02937701|584321354|FG000|Week 22 to Week 50|Other|0|||
161802538|NCT02937701|584321355|FG001|Week 22 to Week 50|Other|0|||
161802539|NCT02937701|584321356|FG002|Week 22 to Week 50|Other|0|||
161802540|NCT02937701|584321357|FG003|Week 22 to Week 50|Other|0|||
161802541|NCT02937701|584321358|FG004|Week 22 to Week 50|Other|1|||
161802542|NCT02289963|584321359|FG000|Overall Study|Adverse Event|1|||
161802543|NCT02289963|584321360|FG001|Overall Study|Adverse Event|2|||
161802544|NCT02289963|584321359|FG000|Overall Study|Poor compliance to protocol|1|||
161802545|NCT02289963|584321360|FG001|Overall Study|Poor compliance to protocol|0|||
161802546|NCT02289963|584321359|FG000|Overall Study|Withdrawal by Subject|1|||
161802547|NCT02289963|584321360|FG001|Overall Study|Withdrawal by Subject|0|||
161802548|NCT02289963|584321359|FG000|Overall Study|Last injection missed|2|||
161802549|NCT02289963|584321360|FG001|Overall Study|Last injection missed|2|||
161802550|NCT02289963|584321359|FG000|Overall Study|End treatment visit outside visit window|0|||
161802551|NCT02289963|584321360|FG001|Overall Study|End treatment visit outside visit window|4|||
161802552|NCT02289963|584321359|FG000|Overall Study|Other than specified above|0|||
161802553|NCT02289963|584321360|FG001|Overall Study|Other than specified above|2|||
161802554|NCT01507051|584321362|FG000|Overall Study|Withdrawal by Subject|1|||
161802555|NCT01507051|584321363|FG001|Overall Study|Withdrawal by Subject|3|||
161802556|NCT01507051|584321364|FG002|Overall Study|Withdrawal by Subject|1|||
161560810|NCT02624778|583441933|FG005|Overall Study|Adverse Event|0|||
161560811|NCT02624778|583441934|FG006|Overall Study|Adverse Event|0|||
161560812|NCT02624778|583441935|FG007|Overall Study|Adverse Event|0|||
161560813|NCT02624778|583441936|FG008|Overall Study|Adverse Event|2|||
161560814|NCT02624778|583441928|FG000|Overall Study|Death|0|||
161560815|NCT02624778|583441929|FG001|Overall Study|Death|0|||
161560816|NCT02624778|583441930|FG002|Overall Study|Death|0|||
161560817|NCT02624778|583441931|FG003|Overall Study|Death|0|||
161560818|NCT02624778|583441932|FG004|Overall Study|Death|0|||
161560819|NCT02624778|583441933|FG005|Overall Study|Death|0|||
161560820|NCT02624778|583441934|FG006|Overall Study|Death|1|||
161802557|NCT01507051|584321365|FG003|Overall Study|Withdrawal by Subject|6|||
161802558|NCT01507051|584321362|FG000|Overall Study|Physician Decision|0|||
161802559|NCT01507051|584321363|FG001|Overall Study|Physician Decision|0|||
161802560|NCT01507051|584321364|FG002|Overall Study|Physician Decision|0|||
161560821|NCT02624778|583441935|FG007|Overall Study|Death|0|||
161560822|NCT02624778|583441936|FG008|Overall Study|Death|0|||
161560823|NCT02624778|583441928|FG000|Overall Study|Physician Decision|0|||
161560824|NCT02624778|583441929|FG001|Overall Study|Physician Decision|0|||
161560825|NCT02624778|583441930|FG002|Overall Study|Physician Decision|0|||
161560826|NCT02624778|583441931|FG003|Overall Study|Physician Decision|0|||
161560827|NCT02624778|583441932|FG004|Overall Study|Physician Decision|0|||
161560828|NCT02624778|583441933|FG005|Overall Study|Physician Decision|0|||
161560829|NCT02624778|583441934|FG006|Overall Study|Physician Decision|0|||
161560830|NCT02624778|583441935|FG007|Overall Study|Physician Decision|3|||
161560831|NCT02624778|583441936|FG008|Overall Study|Physician Decision|3|||
161560832|NCT04091672|583441939|FG000|Overall Study|Death|6|||
161560833|NCT04091672|583441940|FG001|Overall Study|Death|6|||
161560834|NCT04091672|583441939|FG000|Overall Study|Lost to Follow-up|7|||
161560835|NCT04091672|583441940|FG001|Overall Study|Lost to Follow-up|7|||
161560836|NCT04091672|583441939|FG000|Overall Study|Withdrawal by Subject|3|||
161560837|NCT04091672|583441940|FG001|Overall Study|Withdrawal by Subject|3|||
161560838|NCT04091672|583441939|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
161560839|NCT04091672|583441940|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
161560840|NCT05296629|583441941|FG000|Overall Study|Withdrawal by Subject|3|||
161560841|NCT05296629|583441942|FG001|Overall Study|Withdrawal by Subject|10|||
161560842|NCT05296629|583441943|FG002|Overall Study|Withdrawal by Subject|4|||
161560843|NCT05296629|583441941|FG000|Overall Study|Lost to Follow-up|2|||
161560844|NCT05296629|583441942|FG001|Overall Study|Lost to Follow-up|7|||
161560845|NCT05296629|583441943|FG002|Overall Study|Lost to Follow-up|1|||
161560846|NCT05296629|583441941|FG000|Overall Study|Adverse Event|0|||
161560847|NCT05296629|583441942|FG001|Overall Study|Adverse Event|4|||
161560848|NCT05296629|583441943|FG002|Overall Study|Adverse Event|2|||
161560849|NCT05296629|583441941|FG000|Overall Study|Protocol Violation|0|||
161560850|NCT05296629|583441942|FG001|Overall Study|Protocol Violation|2|||
161560851|NCT05296629|583441943|FG002|Overall Study|Protocol Violation|0|||
161560852|NCT04610684|583441949|FG000|Study Treatment|Withdrawal by Subject|1|||
161560853|NCT04610684|583441949|FG000|Study Treatment|Disease Progression|2|||
161560854|NCT04610684|583441949|FG000|Follow up|Death|2|||
161560855|NCT04610684|583441949|FG000|Follow up|Withdrawal by Subject|1|||
161560856|NCT00359619|583441950|FG000|Overall Study|Adverse Event|0|||
161560857|NCT00359619|583441951|FG001|Overall Study|Adverse Event|0|||
161560858|NCT00359619|583441952|FG002|Overall Study|Adverse Event|1|||
161560859|NCT00359619|583441953|FG003|Overall Study|Adverse Event|0|||
161560860|NCT00359619|583441954|FG004|Overall Study|Adverse Event|0|||
161560861|NCT00359619|583441955|FG005|Overall Study|Adverse Event|0|||
161560862|NCT00359619|583441956|FG006|Overall Study|Adverse Event|1|||
161560863|NCT00359619|583441950|FG000|Overall Study|Withdrawal by Subject|3|||
161560864|NCT00359619|583441951|FG001|Overall Study|Withdrawal by Subject|1|||
161560865|NCT00359619|583441952|FG002|Overall Study|Withdrawal by Subject|4|||
161560866|NCT00359619|583441953|FG003|Overall Study|Withdrawal by Subject|2|||
161560867|NCT00359619|583441954|FG004|Overall Study|Withdrawal by Subject|2|||
161560868|NCT00359619|583441955|FG005|Overall Study|Withdrawal by Subject|0|||
161560869|NCT00359619|583441956|FG006|Overall Study|Withdrawal by Subject|3|||
161560870|NCT00359619|583441950|FG000|Overall Study|Other|1|||
161560871|NCT00359619|583441951|FG001|Overall Study|Other|0|||
161560872|NCT00359619|583441952|FG002|Overall Study|Other|0|||
161560873|NCT00359619|583441953|FG003|Overall Study|Other|0|||
161560874|NCT00359619|583441954|FG004|Overall Study|Other|0|||
161560875|NCT00359619|583441955|FG005|Overall Study|Other|0|||
161560876|NCT00359619|583441956|FG006|Overall Study|Other|0|||
161560877|NCT00359619|583441950|FG000|Overall Study|Lost to Follow-up|4|||
161560878|NCT00359619|583441951|FG001|Overall Study|Lost to Follow-up|4|||
161560879|NCT00359619|583441952|FG002|Overall Study|Lost to Follow-up|2|||
161560880|NCT00359619|583441953|FG003|Overall Study|Lost to Follow-up|1|||
161560881|NCT00359619|583441954|FG004|Overall Study|Lost to Follow-up|1|||
161560882|NCT00359619|583441955|FG005|Overall Study|Lost to Follow-up|5|||
161560883|NCT00359619|583441956|FG006|Overall Study|Lost to Follow-up|0|||
161560884|NCT00049517|583441957|FG000|Induction|Disease progression|0|||
161560885|NCT00049517|583441958|FG001|Induction|Disease progression|0|||
161560886|NCT00049517|583441959|FG002|Induction|Disease progression|0|||
161560887|NCT00049517|583441960|FG003|Induction|Disease progression|0|||
161560888|NCT00049517|583441961|FG004|Induction|Disease progression|18|||
161560889|NCT00049517|583441962|FG005|Induction|Disease progression|11|||
161560890|NCT00049517|583441957|FG000|Induction|Adverse Event|0|||
161560891|NCT00049517|583441958|FG001|Induction|Adverse Event|0|||
161560892|NCT00049517|583441959|FG002|Induction|Adverse Event|0|||
161560893|NCT00049517|583441960|FG003|Induction|Adverse Event|0|||
161560894|NCT00049517|583441961|FG004|Induction|Adverse Event|5|||
161802561|NCT01507051|584321365|FG003|Overall Study|Physician Decision|1|||
161802562|NCT01507051|584321362|FG000|Overall Study|Adverse Event|1|||
161802563|NCT01507051|584321363|FG001|Overall Study|Adverse Event|0|||
161560895|NCT00049517|583441962|FG005|Induction|Adverse Event|7|||
161802564|NCT01507051|584321364|FG002|Overall Study|Adverse Event|0|||
161560896|NCT00049517|583441957|FG000|Induction|Death|0|||
161560897|NCT00049517|583441958|FG001|Induction|Death|0|||
161560898|NCT00049517|583441959|FG002|Induction|Death|0|||
161560899|NCT00049517|583441960|FG003|Induction|Death|0|||
161560900|NCT00049517|583441961|FG004|Induction|Death|9|||
161560901|NCT00049517|583441962|FG005|Induction|Death|6|||
161560902|NCT00049517|583441957|FG000|Induction|Withdrawal by Subject|0|||
161802565|NCT01507051|584321365|FG003|Overall Study|Adverse Event|0|||
161802566|NCT01941095|584321366|FG000|Overall Study|Insufficient therapeutic response|13|||
161802567|NCT01941095|584321366|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
161802568|NCT01941095|584321366|FG000|Overall Study|Adverse Event|11|||
161452503|NCT03137069|583052114|FG002|Overall Study|Protocol Violation|0|||
161452504|NCT03137069|583052115|FG003|Overall Study|Protocol Violation|1|||
161452505|NCT03137069|583052116|FG004|Overall Study|Protocol Violation|1|||
161452506|NCT03137069|583052117|FG005|Overall Study|Protocol Violation|1|||
161452507|NCT03137069|583052112|FG000|Overall Study|Physician Decision|0|||
161452508|NCT03137069|583052113|FG001|Overall Study|Physician Decision|0|||
161452509|NCT03137069|583052114|FG002|Overall Study|Physician Decision|0|||
161452510|NCT03137069|583052115|FG003|Overall Study|Physician Decision|1|||
161452511|NCT03137069|583052116|FG004|Overall Study|Physician Decision|0|||
161452512|NCT03137069|583052117|FG005|Overall Study|Physician Decision|0|||
161452513|NCT03137069|583052112|FG000|Overall Study|Study Terminated by Sponsor|0|||
161452514|NCT03137069|583052113|FG001|Overall Study|Study Terminated by Sponsor|0|||
161452515|NCT03137069|583052114|FG002|Overall Study|Study Terminated by Sponsor|0|||
161452516|NCT03137069|583052115|FG003|Overall Study|Study Terminated by Sponsor|0|||
161452517|NCT03137069|583052116|FG004|Overall Study|Study Terminated by Sponsor|1|||
161452518|NCT03137069|583052117|FG005|Overall Study|Study Terminated by Sponsor|0|||
161452519|NCT03137069|583052112|FG000|Overall Study|Data Entry Error|0|||
161452520|NCT03137069|583052113|FG001|Overall Study|Data Entry Error|0|||
161452521|NCT03137069|583052114|FG002|Overall Study|Data Entry Error|0|||
161452522|NCT03137069|583052115|FG003|Overall Study|Data Entry Error|1|||
161452523|NCT03137069|583052116|FG004|Overall Study|Data Entry Error|0|||
161452524|NCT03137069|583052117|FG005|Overall Study|Data Entry Error|0|||
161452525|NCT02043899|583052119|FG000|Overall Study|Adverse Event|3|||
161452526|NCT02043899|583052119|FG000|Overall Study|Physician Decision|1|||
161452527|NCT02043899|583052119|FG000|Overall Study|Withdrawal by Subject|2|||
161452528|NCT02043899|583052119|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
161452529|NCT02043899|583052119|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
161452530|NCT02043899|583052119|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
161452531|NCT02043899|583052119|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
161452532|NCT02043899|583052119|FG000|Overall Study|Treatment delayed|1|||
161452533|NCT01771809|583052120|FG000|Overall Study|Adverse Event|4|||
161452534|NCT01771809|583052121|FG001|Overall Study|Adverse Event|12|||
161452535|NCT01771809|583052120|FG000|Overall Study|Protocol Violation|0|||
161452536|NCT01771809|583052121|FG001|Overall Study|Protocol Violation|1|||
161452537|NCT01771809|583052120|FG000|Overall Study|Withdrawal by Subject|34|||
161452538|NCT01771809|583052121|FG001|Overall Study|Withdrawal by Subject|42|||
161452539|NCT01771809|583052120|FG000|Overall Study|Lost to Follow-up|1|||
161802569|NCT01941095|584321366|FG000|Overall Study|Physician Decision|3|||
161802570|NCT01941095|584321366|FG000|Overall Study|Withdrawal by Subject|17|||
161452540|NCT01771809|583052121|FG001|Overall Study|Lost to Follow-up|3|||
161802571|NCT01941095|584321366|FG000|Overall Study|Lost to Follow-up|10|||
161452541|NCT01771809|583052120|FG000|Overall Study|Other (Insufficient clinical response)|22|||
161452542|NCT01771809|583052121|FG001|Overall Study|Other (Insufficient clinical response)|20|||
161560903|NCT00049517|583441958|FG001|Induction|Withdrawal by Subject|0|||
161560904|NCT00049517|583441959|FG002|Induction|Withdrawal by Subject|0|||
161560905|NCT00049517|583441960|FG003|Induction|Withdrawal by Subject|0|||
161560906|NCT00049517|583441961|FG004|Induction|Withdrawal by Subject|1|||
161560907|NCT00049517|583441962|FG005|Induction|Withdrawal by Subject|3|||
161560908|NCT00049517|583441957|FG000|Induction|Alternative therapy|0|||
161560909|NCT00049517|583441958|FG001|Induction|Alternative therapy|0|||
161560910|NCT00049517|583441959|FG002|Induction|Alternative therapy|0|||
161560911|NCT00049517|583441960|FG003|Induction|Alternative therapy|0|||
161560912|NCT00049517|583441961|FG004|Induction|Alternative therapy|2|||
161560913|NCT00049517|583441962|FG005|Induction|Alternative therapy|2|||
161560914|NCT00049517|583441957|FG000|Induction|Other complicating disease|0|||
161560915|NCT00049517|583441958|FG001|Induction|Other complicating disease|0|||
161560916|NCT00049517|583441959|FG002|Induction|Other complicating disease|0|||
161560917|NCT00049517|583441960|FG003|Induction|Other complicating disease|0|||
161560918|NCT00049517|583441961|FG004|Induction|Other complicating disease|3|||
161560919|NCT00049517|583441962|FG005|Induction|Other complicating disease|0|||
161560920|NCT00049517|583441957|FG000|Induction|Reasons not reported|0|||
161560921|NCT00049517|583441958|FG001|Induction|Reasons not reported|0|||
161560922|NCT00049517|583441959|FG002|Induction|Reasons not reported|0|||
161560923|NCT00049517|583441960|FG003|Induction|Reasons not reported|0|||
161560924|NCT00049517|583441961|FG004|Induction|Reasons not reported|22|||
161560925|NCT00049517|583441962|FG005|Induction|Reasons not reported|25|||
161560926|NCT00049517|583441957|FG000|Conditioning/Transplant|Disease progression|14|||
161560927|NCT00049517|583441958|FG001|Conditioning/Transplant|Disease progression|6|||
161560928|NCT00049517|583441959|FG002|Conditioning/Transplant|Disease progression|10|||
161560929|NCT00049517|583441960|FG003|Conditioning/Transplant|Disease progression|6|||
161560930|NCT00049517|583441961|FG004|Conditioning/Transplant|Disease progression|0|||
161560931|NCT00049517|583441962|FG005|Conditioning/Transplant|Disease progression|0|||
161560932|NCT00049517|583441957|FG000|Conditioning/Transplant|Adverse Event|2|||
161560933|NCT00049517|583441958|FG001|Conditioning/Transplant|Adverse Event|1|||
161560934|NCT00049517|583441959|FG002|Conditioning/Transplant|Adverse Event|4|||
161560935|NCT00049517|583441960|FG003|Conditioning/Transplant|Adverse Event|8|||
161560936|NCT00049517|583441961|FG004|Conditioning/Transplant|Adverse Event|0|||
161560937|NCT00049517|583441962|FG005|Conditioning/Transplant|Adverse Event|0|||
161560938|NCT00049517|583441957|FG000|Conditioning/Transplant|Death|1|||
161560939|NCT00049517|583441958|FG001|Conditioning/Transplant|Death|0|||
161560940|NCT00049517|583441959|FG002|Conditioning/Transplant|Death|0|||
161560941|NCT00049517|583441960|FG003|Conditioning/Transplant|Death|2|||
161560942|NCT00049517|583441961|FG004|Conditioning/Transplant|Death|0|||
161560943|NCT00049517|583441962|FG005|Conditioning/Transplant|Death|0|||
161560944|NCT00049517|583441957|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
161560945|NCT00049517|583441958|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
161560946|NCT00049517|583441959|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
161560947|NCT00049517|583441960|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
161560948|NCT00049517|583441961|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
161560949|NCT00049517|583441962|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
161560950|NCT00049517|583441957|FG000|Conditioning/Transplant|Alternative therapy|4|||
161560951|NCT00049517|583441958|FG001|Conditioning/Transplant|Alternative therapy|4|||
161560952|NCT00049517|583441959|FG002|Conditioning/Transplant|Alternative therapy|2|||
161560953|NCT00049517|583441960|FG003|Conditioning/Transplant|Alternative therapy|1|||
161560954|NCT00049517|583441961|FG004|Conditioning/Transplant|Alternative therapy|1|||
161560955|NCT00049517|583441962|FG005|Conditioning/Transplant|Alternative therapy|0|||
161560956|NCT00049517|583441957|FG000|Conditioning/Transplant|Other complicating disease|2|||
161560957|NCT00049517|583441958|FG001|Conditioning/Transplant|Other complicating disease|0|||
161560958|NCT00049517|583441959|FG002|Conditioning/Transplant|Other complicating disease|0|||
161560959|NCT00049517|583441960|FG003|Conditioning/Transplant|Other complicating disease|4|||
161560960|NCT00049517|583441961|FG004|Conditioning/Transplant|Other complicating disease|0|||
161560961|NCT00049517|583441962|FG005|Conditioning/Transplant|Other complicating disease|1|||
161560962|NCT00049517|583441957|FG000|Conditioning/Transplant|Reasons not reported|25|||
161802572|NCT03527745|584321367|FG000|Overall Study|Lost to Follow-up|3|||
161802573|NCT03527745|584321368|FG001|Overall Study|Lost to Follow-up|6|||
161802574|NCT03527745|584321369|FG002|Overall Study|Lost to Follow-up|7|||
161802575|NCT03527745|584321370|FG003|Overall Study|Lost to Follow-up|9|||
161802576|NCT03527745|584321371|FG004|Overall Study|Lost to Follow-up|0|||
161802577|NCT03527745|584321372|FG005|Overall Study|Lost to Follow-up|2|||
161802578|NCT03527745|584321373|FG006|Overall Study|Lost to Follow-up|3|||
161802579|NCT03527745|584321374|FG007|Overall Study|Lost to Follow-up|2|||
161560963|NCT00049517|583441958|FG001|Conditioning/Transplant|Reasons not reported|31|||
161560964|NCT00049517|583441959|FG002|Conditioning/Transplant|Reasons not reported|18|||
161560965|NCT00049517|583441960|FG003|Conditioning/Transplant|Reasons not reported|15|||
161560966|NCT00049517|583441961|FG004|Conditioning/Transplant|Reasons not reported|5|||
161802580|NCT03527745|584321375|FG008|Overall Study|Lost to Follow-up|3|||
161802581|NCT03527745|584321376|FG009|Overall Study|Lost to Follow-up|2|||
161802582|NCT03527745|584321377|FG010|Overall Study|Lost to Follow-up|1|||
161802583|NCT03527745|584321378|FG011|Overall Study|Lost to Follow-up|1|||
161802584|NCT03527745|584321379|FG012|Overall Study|Lost to Follow-up|0|||
161802585|NCT03527745|584321380|FG013|Overall Study|Lost to Follow-up|0|||
161802586|NCT03527745|584321381|FG014|Overall Study|Lost to Follow-up|0|||
161802587|NCT03527745|584321382|FG015|Overall Study|Lost to Follow-up|0|||
161802588|NCT03527745|584321383|FG016|Overall Study|Lost to Follow-up|1|||
161452543|NCT01771809|583052120|FG000|Overall Study|Death|1|||
161452544|NCT01771809|583052121|FG001|Overall Study|Death|0|||
161452545|NCT01771809|583052120|FG000|Overall Study|Other (other)|9|||
161452546|NCT01771809|583052121|FG001|Overall Study|Other (other)|5|||
161452547|NCT01106092|583052122|FG000|Overall Study|Withdrawal by Subject|0|||
161452548|NCT01106092|583052123|FG001|Overall Study|Withdrawal by Subject|0|||
161452549|NCT01106092|583052124|FG002|Overall Study|Withdrawal by Subject|0|||
161452550|NCT01106092|583052125|FG003|Overall Study|Withdrawal by Subject|1|||
161452551|NCT02434471|583052126|FG000|Overall Study|Physician Decision|9|||
161452552|NCT00369629|583052131|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
161452553|NCT00369629|583052132|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
161452554|NCT00369629|583052133|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
161452555|NCT00369629|583052134|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
161452556|NCT00369629|583052131|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
161452557|NCT00369629|583052132|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
161452558|NCT00369629|583052133|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
161452559|NCT00369629|583052134|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
161452560|NCT00369629|583052131|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
161452561|NCT00369629|583052132|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
161452562|NCT00369629|583052133|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
161452563|NCT00369629|583052134|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
161452564|NCT00369629|583052131|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
161452565|NCT00369629|583052132|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
161452566|NCT00369629|583052133|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
161452567|NCT00369629|583052134|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
161452568|NCT00369629|583052131|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
161452569|NCT00369629|583052132|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
161452570|NCT00369629|583052133|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
161452571|NCT00369629|583052134|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
161452572|NCT00369629|583052131|FG000|Completed 4 More Cycles|Progressive disease|2|||
161452573|NCT00369629|583052132|FG001|Completed 4 More Cycles|Progressive disease|1|||
161452574|NCT00369629|583052133|FG002|Completed 4 More Cycles|Progressive disease|2|||
161452575|NCT00369629|583052134|FG003|Completed 4 More Cycles|Progressive disease|0|||
161452576|NCT00369629|583052131|FG000|Follow up for 1 Year|Death|2|||
161452577|NCT00369629|583052132|FG001|Follow up for 1 Year|Death|1|||
161452578|NCT00369629|583052133|FG002|Follow up for 1 Year|Death|1|||
161452579|NCT00369629|583052134|FG003|Follow up for 1 Year|Death|0|||
161452580|NCT00369629|583052131|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
161452581|NCT00369629|583052132|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
161452582|NCT00369629|583052133|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
161452583|NCT00369629|583052134|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
161452584|NCT00369629|583052131|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
161452585|NCT00369629|583052132|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
161452586|NCT00369629|583052133|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
161452587|NCT00369629|583052134|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
161452588|NCT04839562|583052135|FG000|Overall Study|Withdrawal by Subject|0|||
161452589|NCT04839562|583052136|FG001|Overall Study|Withdrawal by Subject|1|||
161452590|NCT04839562|583052135|FG000|Overall Study|Physician Decision|0|||
161452591|NCT04839562|583052136|FG001|Overall Study|Physician Decision|1|||
161452592|NCT00877773|583052137|FG000|Overall Study|Disease Progression|44|||
161452593|NCT02907892|583052145|FG000|Overall Study|Lost to Follow-up|27|||
161452594|NCT02907892|583052146|FG001|Overall Study|Lost to Follow-up|40|||
161452595|NCT01974765|583052147|FG000|Overall Study|Withdrawal by Subject|1|||
161452596|NCT01974765|583052147|FG000|Overall Study|Death|1|||
161452597|NCT01974765|583052147|FG000|Overall Study|Adverse Event|2|||
161452598|NCT01347580|583052148|FG000|Overall Study|Withdrawal by Subject|13|||
161452599|NCT01347580|583052149|FG001|Overall Study|Withdrawal by Subject|23|||
161452600|NCT01347580|583052148|FG000|Overall Study|Death|30|||
161452601|NCT01347580|583052149|FG001|Overall Study|Death|19|||
161452602|NCT01347580|583052148|FG000|Overall Study|Protocol Violation|10|||
161452603|NCT01347580|583052149|FG001|Overall Study|Protocol Violation|7|||
161452604|NCT01347580|583052148|FG000|Overall Study|Lost to Follow-up|3|||
161452605|NCT01347580|583052149|FG001|Overall Study|Lost to Follow-up|1|||
161452606|NCT01347580|583052148|FG000|Overall Study|Had other reason|9|||
161802589|NCT03527745|584321384|FG017|Overall Study|Lost to Follow-up|0|||
161802590|NCT03527745|584321385|FG018|Overall Study|Lost to Follow-up|0|||
161802591|NCT03527745|584321386|FG019|Overall Study|Lost to Follow-up|1|||
161802592|NCT03527745|584321387|FG020|Overall Study|Lost to Follow-up|1|||
161452607|NCT01347580|583052149|FG001|Overall Study|Had other reason|6|||
161452608|NCT01964755|583052152|FG000|Overall Study|Death|2|||
161452609|NCT02870933|583052153|FG000|Overall Study|Death|2|||
161452610|NCT02870933|583052154|FG001|Overall Study|Death|1|||
161452611|NCT02870933|583052153|FG000|Overall Study|Withdrawal by Subject|0|||
161452612|NCT02870933|583052154|FG001|Overall Study|Withdrawal by Subject|1|||
161452613|NCT02168387|583052155|FG000|Overall Study|Planned exubation|6|||
161452614|NCT02168387|583052156|FG001|Overall Study|Planned exubation|3|||
161452615|NCT02168387|583052155|FG000|Overall Study|Death|1|||
161452616|NCT02168387|583052156|FG001|Overall Study|Death|0|||
161452617|NCT01659554|583052157|FG000|Overall Study|Study Termination|4|||
161452618|NCT00412373|583052158|FG000|Overall Study|Adverse Event|8|||
161452619|NCT00412373|583052159|FG001|Overall Study|Adverse Event|13|||
161452620|NCT00412373|583052158|FG000|Overall Study|Lack of Efficacy|16|||
161452621|NCT00412373|583052159|FG001|Overall Study|Lack of Efficacy|22|||
161452622|NCT00412373|583052158|FG000|Overall Study|Lost to Follow-up|7|||
161452623|NCT00412373|583052159|FG001|Overall Study|Lost to Follow-up|13|||
161452624|NCT00412373|583052158|FG000|Overall Study|Withdrawal by Subject|8|||
161452625|NCT00412373|583052159|FG001|Overall Study|Withdrawal by Subject|27|||
161452626|NCT00412373|583052158|FG000|Overall Study|Other|2|||
161452627|NCT00412373|583052159|FG001|Overall Study|Other|2|||
161452628|NCT00640224|583052160|FG000|Overall Study|Lost to Follow-up|5|||
161452629|NCT00640224|583052161|FG001|Overall Study|Lost to Follow-up|2|||
161452630|NCT00640224|583052162|FG002|Overall Study|Lost to Follow-up|0|||
161452631|NCT00640224|583052163|FG003|Overall Study|Lost to Follow-up|0|||
161452632|NCT00640224|583052160|FG000|Overall Study|Withdrawal by Subject|1|||
161452633|NCT00640224|583052161|FG001|Overall Study|Withdrawal by Subject|0|||
161452634|NCT00640224|583052162|FG002|Overall Study|Withdrawal by Subject|0|||
161452635|NCT00640224|583052163|FG003|Overall Study|Withdrawal by Subject|0|||
161452636|NCT00640224|583052160|FG000|Overall Study|Headaches|0|||
161452637|NCT00640224|583052161|FG001|Overall Study|Headaches|1|||
161452638|NCT00640224|583052162|FG002|Overall Study|Headaches|0|||
161452639|NCT00640224|583052163|FG003|Overall Study|Headaches|0|||
161452640|NCT00422513|583052164|FG000|Overall Study|Lack of Efficacy|4|||
161452641|NCT00422513|583052165|FG001|Overall Study|Lack of Efficacy|5|||
161452642|NCT00422513|583052164|FG000|Overall Study|Protocol Violation|23|||
161452643|NCT00422513|583052165|FG001|Overall Study|Protocol Violation|7|||
161452644|NCT00422513|583052164|FG000|Overall Study|Refused Treatment|4|||
161452645|NCT00422513|583052165|FG001|Overall Study|Refused Treatment|2|||
161452646|NCT00422513|583052164|FG000|Overall Study|Withdrawal by Subject|2|||
161452647|NCT00422513|583052165|FG001|Overall Study|Withdrawal by Subject|1|||
161452648|NCT00422513|583052164|FG000|Overall Study|early termination of the study|67|||
161452649|NCT00422513|583052165|FG001|Overall Study|early termination of the study|80|||
161452650|NCT00422513|583052164|FG000|Overall Study|Adverse Event|4|||
161452651|NCT00422513|583052165|FG001|Overall Study|Adverse Event|4|||
161452652|NCT00422513|583052164|FG000|Overall Study|Death|3|||
161452653|NCT00422513|583052165|FG001|Overall Study|Death|7|||
161452654|NCT03135119|583052166|FG000|Overall Study|Lost to Follow-up|2|||
161452655|NCT03135119|583052167|FG001|Overall Study|Lost to Follow-up|0|||
161452656|NCT03135119|583052166|FG000|Overall Study|Physician Decision|1|||
161452657|NCT03135119|583052167|FG001|Overall Study|Physician Decision|1|||
161452658|NCT03135119|583052166|FG000|Overall Study|COVID-19 Shutdown|2|||
161452659|NCT03135119|583052167|FG001|Overall Study|COVID-19 Shutdown|2|||
161452660|NCT01478048|583052168|FG000|Overall Study|Disease Progression|52|||
161452661|NCT01478048|583052169|FG001|Overall Study|Disease Progression|35|||
161452662|NCT01478048|583052168|FG000|Overall Study|study drug toxicity|11|||
161452663|NCT01478048|583052169|FG001|Overall Study|study drug toxicity|14|||
161452664|NCT01478048|583052168|FG000|Overall Study|Adverse Event|2|||
161452665|NCT01478048|583052169|FG001|Overall Study|Adverse Event|11|||
161452666|NCT01478048|583052168|FG000|Overall Study|subject request to discontinue treatment|3|||
161452667|NCT01478048|583052169|FG001|Overall Study|subject request to discontinue treatment|5|||
161452668|NCT01478048|583052168|FG000|Overall Study|Withdrawal by Subject|2|||
161452669|NCT01478048|583052169|FG001|Overall Study|Withdrawal by Subject|5|||
161452670|NCT01478048|583052168|FG000|Overall Study|non-specified|6|||
161452671|NCT01478048|583052169|FG001|Overall Study|non-specified|4|||
161452672|NCT01478048|583052168|FG000|Overall Study|poor/non-compliance|0|||
161452673|NCT01478048|583052169|FG001|Overall Study|poor/non-compliance|1|||
161452674|NCT01478048|583052168|FG000|Overall Study|no longer meets study criteria|1|||
161452675|NCT01478048|583052169|FG001|Overall Study|no longer meets study criteria|0|||
161452676|NCT01369329|583052171|FG000|Overall Study|Withdrawal by Subject|8|||
161452677|NCT01369329|583052172|FG001|Overall Study|Withdrawal by Subject|6|||
161452678|NCT01369329|583052173|FG002|Overall Study|Withdrawal by Subject|10|||
161452679|NCT01369329|583052171|FG000|Overall Study|Lost to Follow-up|2|||
161560967|NCT00049517|583441962|FG005|Conditioning/Transplant|Reasons not reported|5|||
161452680|NCT01369329|583052172|FG001|Overall Study|Lost to Follow-up|2|||
161452681|NCT01369329|583052173|FG002|Overall Study|Lost to Follow-up|2|||
161452682|NCT01369329|583052171|FG000|Overall Study|Other|2|||
161452683|NCT01369329|583052172|FG001|Overall Study|Other|3|||
161452684|NCT01369329|583052173|FG002|Overall Study|Other|2|||
161452685|NCT01252667|583052174|FG000|Overall Study|Transplant aborted post-conditioning|0|||
161452686|NCT01252667|583052175|FG001|Overall Study|Transplant aborted post-conditioning|0|||
161452687|NCT01252667|583052176|FG002|Overall Study|Transplant aborted post-conditioning|0|||
161452688|NCT01252667|583052177|FG003|Overall Study|Transplant aborted post-conditioning|0|||
161452689|NCT01252667|583052178|FG004|Overall Study|Transplant aborted post-conditioning|0|||
161452690|NCT01252667|583052179|FG005|Overall Study|Transplant aborted post-conditioning|1|||
161452691|NCT03032380|583052180|FG000|Overall Study|Adverse Event|0|||
161452692|NCT03032380|583052181|FG001|Overall Study|Adverse Event|1|||
161452693|NCT03032380|583052180|FG000|Overall Study|Lack of Efficacy|1|||
161452694|NCT03032380|583052181|FG001|Overall Study|Lack of Efficacy|0|||
161452695|NCT03032380|583052180|FG000|Overall Study|Withdrawal by Subject|2|||
161452696|NCT03032380|583052181|FG001|Overall Study|Withdrawal by Subject|3|||
161452697|NCT03032380|583052180|FG000|Overall Study|Recovery|0|||
161452698|NCT03032380|583052181|FG001|Overall Study|Recovery|1|||
161452699|NCT03032380|583052180|FG000|Overall Study|Death|39|||
161452700|NCT03032380|583052181|FG001|Overall Study|Death|34|||
161452701|NCT03032380|583052180|FG000|Overall Study|Other - Miscellaneous|0|||
161452702|NCT03032380|583052181|FG001|Overall Study|Other - Miscellaneous|1|||
161452703|NCT04644315|583052182|FG000|Overall Study|Subject withdrawal of consent|1|||
161452704|NCT02937584|583052183|FG000|Period 1|Adverse Event|1|||
161452705|NCT02937584|583052184|FG001|Period 1|Adverse Event|2|||
161452706|NCT02937584|583052183|FG000|Washout|Adverse Event|0|||
161452707|NCT02937584|583052184|FG001|Washout|Adverse Event|1|||
161452708|NCT01883453|583052185|FG000|Overall Study|No episode of common cold|25|||
161452709|NCT01883453|583052186|FG001|Overall Study|No episode of common cold|23|||
161452710|NCT02238080|583052187|FG000|Overall Study|Death|13|||
161452711|NCT02238080|583052187|FG000|Overall Study|Treatment interrupted|6|||
161452712|NCT02238080|583052187|FG000|Overall Study|Withdrawal by Subject|2|||
161452713|NCT02238080|583052187|FG000|Overall Study|Other|4|||
161452714|NCT00864916|583052188|FG000|Overall Study|Lost to Follow-up|4|||
161452715|NCT00864916|583052189|FG001|Overall Study|Lost to Follow-up|4|||
161452716|NCT00864916|583052188|FG000|Overall Study|Protocol Violation|1|||
161452717|NCT00864916|583052189|FG001|Overall Study|Protocol Violation|0|||
161452718|NCT00864916|583052188|FG000|Overall Study|Withdrawal by Subject|1|||
161452719|NCT00864916|583052189|FG001|Overall Study|Withdrawal by Subject|0|||
161452720|NCT01038869|583052191|FG000|Overall Study|Withdrawal by Subject|1|||
161452721|NCT01038869|583052191|FG000|Overall Study|Lost to Follow-up|6|||
161452722|NCT04136444|583052192|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
161452723|NCT04136444|583052193|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
161452724|NCT01950013|583052197|FG000|Overall Study|Withdrawal by Subject|0|||
161452725|NCT01950013|583052198|FG001|Overall Study|Withdrawal by Subject|2|||
161452726|NCT01950013|583052199|FG002|Overall Study|Withdrawal by Subject|0|||
161452727|NCT00783198|583052204|FG000|Overall Study|Adverse Event|15|||
161452728|NCT00783198|583052205|FG001|Overall Study|Adverse Event|19|||
161452729|NCT00783198|583052206|FG002|Overall Study|Adverse Event|3|||
161452730|NCT00783198|583052204|FG000|Overall Study|Lost to Follow-up|11|||
161452731|NCT00783198|583052205|FG001|Overall Study|Lost to Follow-up|1|||
161452732|NCT00783198|583052206|FG002|Overall Study|Lost to Follow-up|7|||
161452733|NCT00783198|583052204|FG000|Overall Study|Withdrawal by Subject|22|||
161452734|NCT00783198|583052205|FG001|Overall Study|Withdrawal by Subject|14|||
161452735|NCT00783198|583052206|FG002|Overall Study|Withdrawal by Subject|20|||
161452736|NCT00783198|583052204|FG000|Overall Study|Noncompliance with protocol|7|||
161452737|NCT00783198|583052205|FG001|Overall Study|Noncompliance with protocol|7|||
161452738|NCT00783198|583052206|FG002|Overall Study|Noncompliance with protocol|10|||
161452739|NCT00783198|583052204|FG000|Overall Study|Did not meet protocol eligibility|0|||
161452740|NCT00783198|583052205|FG001|Overall Study|Did not meet protocol eligibility|1|||
161452741|NCT00783198|583052206|FG002|Overall Study|Did not meet protocol eligibility|0|||
161452742|NCT00783198|583052204|FG000|Overall Study|Administrative|2|||
161452743|NCT00783198|583052205|FG001|Overall Study|Administrative|1|||
161452744|NCT00783198|583052206|FG002|Overall Study|Administrative|2|||
161452745|NCT02756806|583052207|FG000|Overall Study|Study terminated early|5|||
161452746|NCT00978757|583052212|FG000|Overall Study|Physician Decision|1|||
161452747|NCT00978757|583052213|FG001|Overall Study|Physician Decision|3|||
161452748|NCT01028300|583052214|FG000|Overall Study|Study Terminated|4|||
161452749|NCT00946153|583052217|FG000|Phase 2|Adverse Event|0|||
161452750|NCT00946153|583052218|FG001|Phase 2|Adverse Event|0|||
161452751|NCT00946153|583052219|FG002|Phase 2|Adverse Event|0|||
161452752|NCT00946153|583052220|FG003|Phase 2|Adverse Event|0|||
161452753|NCT00946153|583052221|FG004|Phase 2|Adverse Event|6|||
161452754|NCT00946153|583052217|FG000|Phase 2|Need more reduction of dose|0|||
161452755|NCT00946153|583052218|FG001|Phase 2|Need more reduction of dose|0|||
161452756|NCT00946153|583052219|FG002|Phase 2|Need more reduction of dose|0|||
161452757|NCT00946153|583052220|FG003|Phase 2|Need more reduction of dose|0|||
161452758|NCT00946153|583052221|FG004|Phase 2|Need more reduction of dose|2|||
161452759|NCT00946153|583052217|FG000|Phase 2|Physician Decision|0|||
161452760|NCT00946153|583052218|FG001|Phase 2|Physician Decision|0|||
161452761|NCT00946153|583052219|FG002|Phase 2|Physician Decision|0|||
161452762|NCT00946153|583052220|FG003|Phase 2|Physician Decision|0|||
161452763|NCT00946153|583052221|FG004|Phase 2|Physician Decision|1|||
161560968|NCT02788656|583441963|FG000|Overall Study|Withdrawal by Subject|1|||
161560969|NCT02788656|583441964|FG001|Overall Study|Withdrawal by Subject|0|||
161560970|NCT03929302|583441969|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
161560971|NCT03929302|583441970|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
161560972|NCT03929302|583441971|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
161560973|NCT03929302|583441969|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
161560974|NCT03929302|583441970|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
161560975|NCT03929302|583441971|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
161560976|NCT03929302|583441969|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
161560977|NCT03929302|583441970|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
161560978|NCT03929302|583441971|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
161560979|NCT04454567|583441973|FG000|Overall Study|Study Terminated by Sponsor|1|||
161560980|NCT04454567|583441974|FG001|Overall Study|Study Terminated by Sponsor|1|||
161560981|NCT02757885|583441975|FG000|Overall Study|Screen Failures|4|||
161560982|NCT02459964|583441976|FG000|Overall Study|Withdrawal by Subject|0|||
161560983|NCT02459964|583441977|FG001|Overall Study|Withdrawal by Subject|0|||
161560984|NCT02459964|583441978|FG002|Overall Study|Withdrawal by Subject|1|||
161560985|NCT02459964|583441976|FG000|Overall Study|Abnormal EKG changes|0|||
161560986|NCT02459964|583441977|FG001|Overall Study|Abnormal EKG changes|0|||
161560987|NCT02459964|583441978|FG002|Overall Study|Abnormal EKG changes|1|||
161560988|NCT01175707|583441979|FG000|Overall Study|Adverse Event|4|||
161560989|NCT01175707|583441980|FG001|Overall Study|Adverse Event|6|||
161560990|NCT01456780|583441981|FG000|Overall Study|Lost to Follow-up|3|||
161560991|NCT01456780|583441982|FG001|Overall Study|Lost to Follow-up|3|||
161560992|NCT01456780|583441983|FG002|Overall Study|Lost to Follow-up|0|||
161560993|NCT04531540|583441990|FG000|Overall Study|Adverse Event|1|||
161560994|NCT04531540|583441990|FG000|Overall Study|Protocol Violation|3|||
161560995|NCT04531540|583441990|FG000|Overall Study|Withdrawal by Subject|4|||
161560996|NCT04531540|583441990|FG000|Overall Study|Found to be Ineligible|1|||
161560997|NCT02688621|583441991|FG000|Overall Study|Pregnancy|1|||
161560998|NCT02688621|583441992|FG001|Overall Study|Pregnancy|3|||
161560999|NCT02688621|583441991|FG000|Overall Study|Lost to Follow-up|38|||
161561000|NCT02688621|583441992|FG001|Overall Study|Lost to Follow-up|15|||
161561001|NCT02688621|583441991|FG000|Overall Study|Withdrawal by Subject|1|||
161561002|NCT02688621|583441992|FG001|Overall Study|Withdrawal by Subject|0|||
161561003|NCT01575860|583441997|FG000|Overall Study|Withdrawal by Subject|1|||
161561004|NCT01575860|583441997|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
161561005|NCT05349864|583442002|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
161561006|NCT05349864|583442003|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
161561007|NCT00984282|583442004|FG000|Double Blind Treatment|Adverse Event|40|||
161905608|NCT01811732|584703383|FG000|Overall Study|Admitted to another facility|1|||
161905609|NCT01811732|584703384|FG001|Overall Study|Admitted to another facility|0|||
161905610|NCT01811732|584703383|FG000|Overall Study|Correct study drug not available on site|1|||
161905611|NCT01811732|584703384|FG001|Overall Study|Correct study drug not available on site|0|||
161905612|NCT01405560|584703387|FG000|Overall Study|Physician Decision|1|||
161905613|NCT00896493|584703388|FG000|Overall Study|Early disease relapse|3|||
161905614|NCT02035553|584703389|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
161905615|NCT02035553|584703390|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
161905616|NCT02035553|584703389|FG000|Overall Study|Adverse Event|10|||
161905617|NCT02035553|584703390|FG001|Overall Study|Adverse Event|6|||
161905618|NCT02035553|584703389|FG000|Overall Study|Physician Decision|3|||
161905619|NCT02035553|584703390|FG001|Overall Study|Physician Decision|2|||
161905620|NCT02035553|584703389|FG000|Overall Study|Lack of Efficacy|1|||
161905621|NCT02035553|584703390|FG001|Overall Study|Lack of Efficacy|1|||
161905622|NCT02035553|584703389|FG000|Overall Study|Withdrawal by Subject|4|||
161905623|NCT02035553|584703390|FG001|Overall Study|Withdrawal by Subject|7|||
161905624|NCT02035553|584703389|FG000|Overall Study|Non-compliance with Study Drug|0|||
161905625|NCT02035553|584703390|FG001|Overall Study|Non-compliance with Study Drug|1|||
161905626|NCT02035553|584703389|FG000|Overall Study|Lost to Follow-up|0|||
161905627|NCT02035553|584703390|FG001|Overall Study|Lost to Follow-up|1|||
161905628|NCT02035553|584703389|FG000|Overall Study|Other Reason|0|||
161905629|NCT02035553|584703390|FG001|Overall Study|Other Reason|4|||
161905630|NCT04539964|584703391|FG000|Overall Study|device malfunction|1|||
161905631|NCT04539964|584703392|FG001|Overall Study|device malfunction|0|||
161561008|NCT00984282|583442005|FG001|Double Blind Treatment|Adverse Event|6|||
161561009|NCT00984282|583442004|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
161561010|NCT00984282|583442005|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
161561011|NCT00984282|583442004|FG000|Double Blind Treatment|Physician Decision|1|||
161905632|NCT04539964|584703391|FG000|Overall Study|Withdrawal by Subject|1|||
161905633|NCT04539964|584703392|FG001|Overall Study|Withdrawal by Subject|2|||
161905634|NCT04539964|584703391|FG000|Overall Study|Adverse Event|0|||
161561012|NCT00984282|583442005|FG001|Double Blind Treatment|Physician Decision|2|||
161561013|NCT00984282|583442004|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
161905635|NCT04539964|584703392|FG001|Overall Study|Adverse Event|2|||
161452764|NCT00946153|583052217|FG000|Phase 2|14 days washout for recovery due to AE|0|||
161452765|NCT00946153|583052218|FG001|Phase 2|14 days washout for recovery due to AE|0|||
161452766|NCT00946153|583052219|FG002|Phase 2|14 days washout for recovery due to AE|0|||
161452767|NCT00946153|583052220|FG003|Phase 2|14 days washout for recovery due to AE|0|||
161452768|NCT00946153|583052221|FG004|Phase 2|14 days washout for recovery due to AE|4|||
161452769|NCT01030666|583052222|FG000|Overall Study|Lost to Follow-up|3|||
161452770|NCT01030666|583052223|FG001|Overall Study|Lost to Follow-up|2|||
161452771|NCT01144299|583052224|FG000|Overall Study|Lost to Follow-up|1|||
161452772|NCT01144299|583052225|FG001|Overall Study|Lost to Follow-up|0|||
161452773|NCT01144299|583052224|FG000|Overall Study|Withdrawal by Subject|1|||
161452774|NCT01144299|583052225|FG001|Overall Study|Withdrawal by Subject|0|||
161452775|NCT04002908|583052234|FG000|Overall Study|Death|41|||
161452776|NCT04002908|583052235|FG001|Overall Study|Death|0|||
161452777|NCT04002908|583052236|FG002|Overall Study|Death|0|||
161452778|NCT04002908|583052237|FG003|Overall Study|Death|0|||
161452779|NCT04002908|583052234|FG000|Overall Study|Withdrawal by Subject|112|||
161452780|NCT04002908|583052235|FG001|Overall Study|Withdrawal by Subject|0|||
161452781|NCT04002908|583052236|FG002|Overall Study|Withdrawal by Subject|0|||
161452782|NCT04002908|583052237|FG003|Overall Study|Withdrawal by Subject|0|||
161452783|NCT04002908|583052234|FG000|Overall Study|Lost to Follow-up|72|||
161452784|NCT04002908|583052235|FG001|Overall Study|Lost to Follow-up|0|||
161452785|NCT04002908|583052236|FG002|Overall Study|Lost to Follow-up|0|||
161452786|NCT04002908|583052237|FG003|Overall Study|Lost to Follow-up|0|||
161452787|NCT04002908|583052234|FG000|Overall Study|Infant died, so mother withdrawn|34|||
161452788|NCT04002908|583052235|FG001|Overall Study|Infant died, so mother withdrawn|0|||
161452789|NCT04002908|583052236|FG002|Overall Study|Infant died, so mother withdrawn|0|||
161452790|NCT04002908|583052237|FG003|Overall Study|Infant died, so mother withdrawn|0|||
161452791|NCT04359901|583052242|FG000|Overall Study|Withdrawal by Subject|0|||
161452792|NCT04359901|583052243|FG001|Overall Study|Withdrawal by Subject|1|||
161452793|NCT04359901|583052242|FG000|Overall Study|Death|6|||
161452794|NCT04359901|583052243|FG001|Overall Study|Death|2|||
161452795|NCT03255083|583052244|FG000|Overall Study|Clinical progression|1|||
161452796|NCT03255083|583052245|FG001|Overall Study|Clinical progression|0|||
161452797|NCT03255083|583052246|FG002|Overall Study|Clinical progression|0|||
161452798|NCT03255083|583052247|FG003|Overall Study|Clinical progression|0|||
161452799|NCT03255083|583052244|FG000|Overall Study|Adverse Event|0|||
161452800|NCT03255083|583052245|FG001|Overall Study|Adverse Event|1|||
161452801|NCT03255083|583052246|FG002|Overall Study|Adverse Event|0|||
161452802|NCT03255083|583052247|FG003|Overall Study|Adverse Event|0|||
161452803|NCT03255083|583052244|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
161452804|NCT03255083|583052245|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
161452805|NCT03255083|583052246|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
161452806|NCT03255083|583052247|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
161452807|NCT03255083|583052244|FG000|Overall Study|Withdrawal by Subject|1|||
161452808|NCT03255083|583052245|FG001|Overall Study|Withdrawal by Subject|1|||
161452809|NCT03255083|583052246|FG002|Overall Study|Withdrawal by Subject|1|||
161452810|NCT03255083|583052247|FG003|Overall Study|Withdrawal by Subject|0|||
161452811|NCT02522624|583053492|FG000|Overall Study|Technical failure|1|||
161452812|NCT02522624|583053493|FG001|Overall Study|Technical failure|0|||
161452813|NCT01350544|583053497|FG000|Overall Study|Administrative Withdrawal|0|||
161452814|NCT01350544|583053498|FG001|Overall Study|Administrative Withdrawal|1|||
161452815|NCT01350544|583053497|FG000|Overall Study|Death|1|||
161452816|NCT01350544|583053498|FG001|Overall Study|Death|2|||
161452817|NCT01350544|583053497|FG000|Overall Study|Moved out of LA County|2|||
161452818|NCT01350544|583053498|FG001|Overall Study|Moved out of LA County|2|||
161452819|NCT01350544|583053497|FG000|Overall Study|Medical Issues|1|||
161452820|NCT01350544|583053498|FG001|Overall Study|Medical Issues|1|||
161452821|NCT01350544|583053497|FG000|Overall Study|Withdrawal by Subject|0|||
161452822|NCT01350544|583053498|FG001|Overall Study|Withdrawal by Subject|1|||
161452823|NCT01350544|583053497|FG000|Overall Study|Incarceration|1|||
161452824|NCT01350544|583053498|FG001|Overall Study|Incarceration|0|||
161452825|NCT01350544|583053497|FG000|Overall Study|Lost to Follow-up|18|||
161452826|NCT01350544|583053498|FG001|Overall Study|Lost to Follow-up|15|||
161452827|NCT00910624|583053499|FG000|Treatment Phase|Adverse Event|2|||
161452828|NCT00910624|583053500|FG001|Treatment Phase|Adverse Event|6|||
161452829|NCT00910624|583053501|FG002|Treatment Phase|Adverse Event|6|||
161452830|NCT00910624|583053502|FG003|Treatment Phase|Adverse Event|0|||
161452831|NCT00910624|583053499|FG000|Treatment Phase|Treatment Failure|23|||
161452832|NCT00910624|583053500|FG001|Treatment Phase|Treatment Failure|10|||
161452833|NCT00910624|583053501|FG002|Treatment Phase|Treatment Failure|0|||
161452834|NCT00910624|583053502|FG003|Treatment Phase|Treatment Failure|0|||
161452835|NCT00910624|583053499|FG000|Treatment Phase|Lost to Follow-up|0|||
161452836|NCT00910624|583053500|FG001|Treatment Phase|Lost to Follow-up|0|||
161452837|NCT00910624|583053501|FG002|Treatment Phase|Lost to Follow-up|1|||
161452838|NCT00910624|583053502|FG003|Treatment Phase|Lost to Follow-up|0|||
161452839|NCT00910624|583053499|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
161452840|NCT00910624|583053500|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
161452841|NCT00910624|583053501|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
161452842|NCT00910624|583053502|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
161452843|NCT00910624|583053499|FG000|Treatment Phase|Withdrawal by Subject|2|||
161452844|NCT00910624|583053500|FG001|Treatment Phase|Withdrawal by Subject|1|||
161452845|NCT00910624|583053501|FG002|Treatment Phase|Withdrawal by Subject|0|||
161452846|NCT00910624|583053502|FG003|Treatment Phase|Withdrawal by Subject|0|||
161452847|NCT00910624|583053499|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
161452848|NCT00910624|583053500|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
161452849|NCT00910624|583053501|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
161452850|NCT00910624|583053502|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
161452851|NCT00910624|583053499|FG000|Follow-Up Phase|Adverse Event|0|||
161452852|NCT00910624|583053500|FG001|Follow-Up Phase|Adverse Event|0|||
161452853|NCT00910624|583053501|FG002|Follow-Up Phase|Adverse Event|1|||
161452854|NCT00910624|583053502|FG003|Follow-Up Phase|Adverse Event|0|||
161452855|NCT00910624|583053499|FG000|Follow-Up Phase|Lost to Follow-up|3|||
161452856|NCT00910624|583053500|FG001|Follow-Up Phase|Lost to Follow-up|1|||
161452857|NCT00910624|583053501|FG002|Follow-Up Phase|Lost to Follow-up|2|||
161452858|NCT00910624|583053502|FG003|Follow-Up Phase|Lost to Follow-up|0|||
161452859|NCT00910624|583053499|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
161452860|NCT00910624|583053500|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
161452861|NCT00910624|583053501|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
161452862|NCT00910624|583053502|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
161452863|NCT00910624|583053499|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
161452864|NCT00910624|583053500|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
161452865|NCT00910624|583053501|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
161452866|NCT00910624|583053502|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
161452867|NCT00910624|583053499|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
161452868|NCT00910624|583053500|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
161452869|NCT00910624|583053501|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
161452870|NCT00910624|583053502|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
161452871|NCT00910624|583053499|FG000|Follow-Up Phase|Administrative|0|||
161452872|NCT00910624|583053500|FG001|Follow-Up Phase|Administrative|1|||
161452873|NCT00910624|583053501|FG002|Follow-Up Phase|Administrative|1|||
161452874|NCT00910624|583053502|FG003|Follow-Up Phase|Administrative|0|||
161452875|NCT03699475|583053503|FG000|Overall Study|Death|1|||
161452876|NCT04618770|583053514|FG000|Overall Study|Censored from Analysis|12|||
161452877|NCT04618770|583053514|FG000|Overall Study|Early Termination|25|||
161452878|NCT00294762|583053517|FG000|Overall Study|Did not receive study treatment|3|||
161452879|NCT00294762|583053518|FG001|Overall Study|Did not receive study treatment|3|||
161452880|NCT01738646|583053519|FG000|Overall Study|Still Receiving Treatment|2|||
161452881|NCT00701662|583053521|FG000|Overall Study|Lack of Efficacy|1|||
161452882|NCT03642132|583053522|FG000|Chemotherapy Period|Adverse Event|1|||
161452883|NCT03642132|583053523|FG001|Chemotherapy Period|Adverse Event|1|||
161452884|NCT03642132|583053524|FG002|Chemotherapy Period|Adverse Event|0|||
161452885|NCT03642132|583053522|FG000|Chemotherapy Period|Physician's decision|4|||
161452886|NCT03642132|583053523|FG001|Chemotherapy Period|Physician's decision|1|||
161452887|NCT03642132|583053524|FG002|Chemotherapy Period|Physician's decision|0|||
161452888|NCT03642132|583053522|FG000|Chemotherapy Period|Progressive disease|0|||
161452889|NCT03642132|583053523|FG001|Chemotherapy Period|Progressive disease|0|||
161452890|NCT03642132|583053524|FG002|Chemotherapy Period|Progressive disease|1|||
161452891|NCT03642132|583053522|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
161452892|NCT03642132|583053523|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
161452893|NCT03642132|583053524|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
161452894|NCT03642132|583053522|FG000|Chemotherapy Period|Other|1|||
161452895|NCT03642132|583053523|FG001|Chemotherapy Period|Other|0|||
161452896|NCT03642132|583053524|FG002|Chemotherapy Period|Other|2|||
161452897|NCT03642132|583053522|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
161452898|NCT03642132|583053523|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
161452899|NCT03642132|583053524|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
161452900|NCT03642132|583053522|FG000|Maintenance Period|Adverse Event|1|||
161452901|NCT03642132|583053523|FG001|Maintenance Period|Adverse Event|2|||
161452902|NCT03642132|583053524|FG002|Maintenance Period|Adverse Event|0|||
161452903|NCT03642132|583053522|FG000|Maintenance Period|Non-compliance with study drug|0|||
161452904|NCT03642132|583053523|FG001|Maintenance Period|Non-compliance with study drug|0|||
161452905|NCT03642132|583053524|FG002|Maintenance Period|Non-compliance with study drug|1|||
161452906|NCT03642132|583053522|FG000|Maintenance Period|Physician's decision|2|||
161452907|NCT03642132|583053523|FG001|Maintenance Period|Physician's decision|2|||
161452908|NCT03642132|583053524|FG002|Maintenance Period|Physician's decision|2|||
161452909|NCT03642132|583053522|FG000|Maintenance Period|Progressive disease|9|||
161452910|NCT03642132|583053523|FG001|Maintenance Period|Progressive disease|3|||
161452911|NCT03642132|583053524|FG002|Maintenance Period|Progressive disease|6|||
161452912|NCT03642132|583053522|FG000|Maintenance Period|Other|0|||
161452913|NCT03642132|583053523|FG001|Maintenance Period|Other|0|||
161452914|NCT03642132|583053524|FG002|Maintenance Period|Other|3|||
161668057|NCT00406653|583837479|FG003|Induction Period|Incarcerated|0|||
161452915|NCT03642132|583053522|FG000|Maintenance Period|Withdrawal by Subject|1|||
161452916|NCT03642132|583053523|FG001|Maintenance Period|Withdrawal by Subject|1|||
161452917|NCT03642132|583053524|FG002|Maintenance Period|Withdrawal by Subject|2|||
161452918|NCT03642132|583053522|FG000|Follow-up Period|Other|0|||
161452919|NCT03642132|583053523|FG001|Follow-up Period|Other|0|||
161452920|NCT03642132|583053524|FG002|Follow-up Period|Other|1|||
161452921|NCT03642132|583053522|FG000|Follow-up Period|Withdrawal by Subject|1|||
161452922|NCT03642132|583053523|FG001|Follow-up Period|Withdrawal by Subject|2|||
161452923|NCT03642132|583053524|FG002|Follow-up Period|Withdrawal by Subject|0|||
161452924|NCT03642132|583053522|FG000|Follow-up Period|Study terminated by sponsor|1|||
161452925|NCT03642132|583053523|FG001|Follow-up Period|Study terminated by sponsor|0|||
161452926|NCT03642132|583053524|FG002|Follow-up Period|Study terminated by sponsor|1|||
161452927|NCT03642132|583053522|FG000|Follow-up Period|Lack of Efficacy|1|||
161452928|NCT03642132|583053523|FG001|Follow-up Period|Lack of Efficacy|0|||
161452929|NCT03642132|583053524|FG002|Follow-up Period|Lack of Efficacy|0|||
161452930|NCT03642132|583053522|FG000|Follow-up Period|Death|1|||
161452931|NCT03642132|583053523|FG001|Follow-up Period|Death|0|||
161452932|NCT03642132|583053524|FG002|Follow-up Period|Death|2|||
161452933|NCT03642132|583053522|FG000|Follow-up Period|Adverse Event|1|||
161452934|NCT03642132|583053523|FG001|Follow-up Period|Adverse Event|0|||
161452935|NCT03642132|583053524|FG002|Follow-up Period|Adverse Event|0|||
161452936|NCT04493892|583053530|FG000|Overall Study|Withdrawal by Subject|15|||
161452937|NCT02577887|583053533|FG000|Overall Study|Death|93|||
161452938|NCT02577887|583053533|FG000|Overall Study|Protocol Violation|125|||
161452939|NCT02577887|583053533|FG000|Overall Study|Withdrawal by Subject|80|||
161452940|NCT02267317|583053534|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
161452941|NCT02267317|583053535|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
161452942|NCT02267317|583053536|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
161452943|NCT02267317|583053537|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
161452944|NCT02267317|583053538|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
161452945|NCT02267317|583053539|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
161452946|NCT02267317|583053534|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
161452947|NCT02267317|583053535|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
161452948|NCT02267317|583053536|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
161452949|NCT02267317|583053537|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
161452950|NCT02267317|583053538|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
161452951|NCT02267317|583053539|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
161452952|NCT03595618|583053542|FG000|Overall Study|Adverse Event|16|||
161452953|NCT03595618|583053543|FG001|Overall Study|Adverse Event|17|||
161452954|NCT03595618|583053544|FG002|Overall Study|Adverse Event|20|||
161452955|NCT03595618|583053545|FG003|Overall Study|Adverse Event|8|||
161452956|NCT03595618|583053542|FG000|Overall Study|Withdrawal by Subject|12|||
161452957|NCT03595618|583053543|FG001|Overall Study|Withdrawal by Subject|14|||
161452958|NCT03595618|583053544|FG002|Overall Study|Withdrawal by Subject|14|||
161452959|NCT03595618|583053545|FG003|Overall Study|Withdrawal by Subject|10|||
161452960|NCT03595618|583053542|FG000|Overall Study|Lost to Follow-up|6|||
161452961|NCT03595618|583053543|FG001|Overall Study|Lost to Follow-up|4|||
161452962|NCT03595618|583053544|FG002|Overall Study|Lost to Follow-up|5|||
161452963|NCT03595618|583053545|FG003|Overall Study|Lost to Follow-up|6|||
161452964|NCT03595618|583053542|FG000|Overall Study|Protocol Violation|2|||
161452965|NCT03595618|583053543|FG001|Overall Study|Protocol Violation|0|||
161452966|NCT03595618|583053544|FG002|Overall Study|Protocol Violation|6|||
161452967|NCT03595618|583053545|FG003|Overall Study|Protocol Violation|2|||
161452968|NCT03595618|583053542|FG000|Overall Study|Physician Decision|0|||
161452969|NCT03595618|583053543|FG001|Overall Study|Physician Decision|0|||
161452970|NCT03595618|583053544|FG002|Overall Study|Physician Decision|1|||
161452971|NCT03595618|583053545|FG003|Overall Study|Physician Decision|2|||
161452972|NCT03595618|583053542|FG000|Overall Study|Miscellaneous|7|||
161452973|NCT03595618|583053543|FG001|Overall Study|Miscellaneous|5|||
161452974|NCT03595618|583053544|FG002|Overall Study|Miscellaneous|10|||
161452975|NCT03595618|583053545|FG003|Overall Study|Miscellaneous|6|||
161452976|NCT02279407|583053548|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
161452977|NCT02279407|583053549|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
161452978|NCT02279407|583053550|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
161452979|NCT02279407|583053551|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
161452980|NCT02279407|583053548|FG000|Overall Study|Withdrawal by Subject|1|||
161452981|NCT02279407|583053549|FG001|Overall Study|Withdrawal by Subject|0|||
161452982|NCT02279407|583053550|FG002|Overall Study|Withdrawal by Subject|1|||
161452983|NCT02279407|583053551|FG003|Overall Study|Withdrawal by Subject|1|||
161452984|NCT02279407|583053548|FG000|Overall Study|Adverse Event|1|||
161452985|NCT02279407|583053549|FG001|Overall Study|Adverse Event|1|||
161452986|NCT02279407|583053550|FG002|Overall Study|Adverse Event|2|||
161452987|NCT02279407|583053551|FG003|Overall Study|Adverse Event|0|||
161452988|NCT00422084|583053552|FG000|Overall Study|Adverse Event|21|||
161452989|NCT00422084|583053553|FG001|Overall Study|Adverse Event|7|||
161452990|NCT00422084|583053552|FG000|Overall Study|Withdrawal by Subject|12|||
161561014|NCT00984282|583442005|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
161561015|NCT00984282|583442004|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
161561016|NCT00984282|583442005|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
161561017|NCT00984282|583442004|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
161561018|NCT00984282|583442005|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
161561019|NCT00984282|583442004|FG000|Double Blind Treatment|Lost to Follow-up|3|||
161561020|NCT00984282|583442005|FG001|Double Blind Treatment|Lost to Follow-up|0|||
161561021|NCT00984282|583442004|FG000|Double Blind Treatment|Death|8|||
161561022|NCT00984282|583442005|FG001|Double Blind Treatment|Death|4|||
161561023|NCT00984282|583442004|FG000|Double Blind Treatment|Not treated|0|||
161561024|NCT00984282|583442005|FG001|Double Blind Treatment|Not treated|1|||
161561025|NCT00984282|583442004|FG000|Double Blind Treatment|Switched to commercial drug|6|||
161561026|NCT00984282|583442005|FG001|Double Blind Treatment|Switched to commercial drug|1|||
161561027|NCT00984282|583442004|FG000|Double Blind Treatment|protocol driven decision point|1|||
161561028|NCT00984282|583442005|FG001|Double Blind Treatment|protocol driven decision point|1|||
161561029|NCT00984282|583442004|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
161561030|NCT00984282|583442005|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
161561031|NCT00984282|583442004|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
161561032|NCT00984282|583442005|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
161561033|NCT00984282|583442004|FG000|Open-label Treatment|Adverse Event|20|||
161561034|NCT00984282|583442005|FG001|Open-label Treatment|Adverse Event|30|||
161561035|NCT00984282|583442004|FG000|Open-label Treatment|Withdrawal by Subject|6|||
161561036|NCT00984282|583442005|FG001|Open-label Treatment|Withdrawal by Subject|21|||
161561037|NCT00984282|583442004|FG000|Open-label Treatment|Death|7|||
161561038|NCT00984282|583442005|FG001|Open-label Treatment|Death|15|||
161561039|NCT00984282|583442004|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
161561040|NCT00984282|583442005|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
161561041|NCT00984282|583442004|FG000|Open-label Treatment|Lost to Follow-up|1|||
161561042|NCT00984282|583442005|FG001|Open-label Treatment|Lost to Follow-up|1|||
161561043|NCT00984282|583442004|FG000|Open-label Treatment|Patient convenience|1|||
161561044|NCT00984282|583442005|FG001|Open-label Treatment|Patient convenience|0|||
161561045|NCT00984282|583442004|FG000|Open-label Treatment|Non-compliant with study medication|1|||
161561046|NCT00984282|583442005|FG001|Open-label Treatment|Non-compliant with study medication|0|||
161561047|NCT00984282|583442004|FG000|Open-label Treatment|Target lesion removed|0|||
161561048|NCT00984282|583442005|FG001|Open-label Treatment|Target lesion removed|1|||
161802593|NCT03527745|584321388|FG021|Overall Study|Lost to Follow-up|5|||
161802594|NCT03527745|584321389|FG022|Overall Study|Lost to Follow-up|6|||
161561049|NCT00984282|583442004|FG000|Open-label Treatment|Protocol driven decision point|1|||
161802595|NCT03527745|584321390|FG023|Overall Study|Lost to Follow-up|8|||
161802596|NCT03527745|584321391|FG024|Overall Study|Lost to Follow-up|1|||
161802597|NCT03527745|584321392|FG025|Overall Study|Lost to Follow-up|3|||
161802598|NCT01475838|584321396|FG000|Randomized Phase|Randomized but Not Treated|0|||
161802599|NCT01475838|584321397|FG001|Randomized Phase|Randomized but Not Treated|5|||
161802600|NCT01475838|584321396|FG000|Randomized Phase|Adverse Event|6|||
161802601|NCT01475838|584321397|FG001|Randomized Phase|Adverse Event|1|||
161802602|NCT01475838|584321396|FG000|Randomized Phase|Pregnancy|0|||
161802603|NCT01475838|584321397|FG001|Randomized Phase|Pregnancy|1|||
161802604|NCT01475838|584321396|FG000|Randomized Phase|Investigators Discretion|1|||
161802605|NCT01475838|584321397|FG001|Randomized Phase|Investigators Discretion|2|||
161802606|NCT01475838|584321396|FG000|Randomized Phase|Withdrew Consent|10|||
161802607|NCT01475838|584321397|FG001|Randomized Phase|Withdrew Consent|14|||
161802608|NCT01475838|584321396|FG000|Randomized Phase|Lost to Follow-up|3|||
161802609|NCT01475838|584321397|FG001|Randomized Phase|Lost to Follow-up|4|||
161802610|NCT01475838|584321396|FG000|Randomized Phase|Participant Noncompliance|1|||
161802611|NCT01475838|584321397|FG001|Randomized Phase|Participant Noncompliance|5|||
161802612|NCT01475838|584321396|FG000|Randomized Phase|Protocol Violation|9|||
161802613|NCT01475838|584321397|FG001|Randomized Phase|Protocol Violation|4|||
161802614|NCT01475838|584321396|FG000|Extension Phase|Participant Noncompliance|1|||
161802615|NCT01475838|584321397|FG001|Extension Phase|Participant Noncompliance|0|||
161452991|NCT00422084|583053553|FG001|Overall Study|Withdrawal by Subject|9|||
161452992|NCT00422084|583053552|FG000|Overall Study|Lost to Follow-up|14|||
161452993|NCT00422084|583053553|FG001|Overall Study|Lost to Follow-up|9|||
161452994|NCT00422084|583053552|FG000|Overall Study|Protocol Violation|4|||
161452995|NCT00422084|583053553|FG001|Overall Study|Protocol Violation|1|||
161452996|NCT00422084|583053552|FG000|Overall Study|Lack of Efficacy|40|||
161452997|NCT00422084|583053553|FG001|Overall Study|Lack of Efficacy|42|||
161452998|NCT00422084|583053552|FG000|Overall Study|P. vivax infection|3|||
161452999|NCT00422084|583053553|FG001|Overall Study|P. vivax infection|6|||
161453000|NCT00422084|583053552|FG000|Overall Study|Cyesis|1|||
161453001|NCT00422084|583053553|FG001|Overall Study|Cyesis|0|||
161453002|NCT00422084|583053552|FG000|Overall Study|Withdrawn from study accidentally|1|||
161453003|NCT00422084|583053553|FG001|Overall Study|Withdrawn from study accidentally|0|||
161453004|NCT00422084|583053552|FG000|Overall Study|Non-compliance|1|||
161453005|NCT00422084|583053553|FG001|Overall Study|Non-compliance|0|||
161802616|NCT00560235|584321403|FG000|Phase 1|Discontinued|8|||
161802617|NCT00560235|584321404|FG001|Phase 1|Discontinued|0|||
161802618|NCT00560235|584321405|FG002|Phase 1|Discontinued|0|||
161802619|NCT00560235|584321403|FG000|Phase 1B|Discontinued|0|||
161802620|NCT00560235|584321404|FG001|Phase 1B|Discontinued|19|||
161802621|NCT00560235|584321405|FG002|Phase 1B|Discontinued|0|||
161802622|NCT00560235|584321403|FG000|Phase 2|Discontinued|0|||
161802623|NCT00560235|584321404|FG001|Phase 2|Discontinued|0|||
161802624|NCT00560235|584321405|FG002|Phase 2|Discontinued|96|||
161802625|NCT00560235|584321403|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
161802626|NCT00560235|584321404|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
161802627|NCT00560235|584321405|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
161802628|NCT04015232|584321407|FG000|Overall Study|Withdrawal by Subject|7|||
161802629|NCT04015232|584321408|FG001|Overall Study|Withdrawal by Subject|4|||
161802630|NCT04015232|584321407|FG000|Overall Study|Protocol Violation|1|||
161802631|NCT04015232|584321408|FG001|Overall Study|Protocol Violation|0|||
161802632|NCT04015232|584321407|FG000|Overall Study|Medical Grounds|3|||
161802633|NCT04015232|584321408|FG001|Overall Study|Medical Grounds|3|||
161802634|NCT00365300|584321413|FG000|Open-label Phase|Adverse Event|4|||
161802635|NCT00365300|584321414|FG001|Open-label Phase|Adverse Event|0|||
161802636|NCT00365300|584321413|FG000|Open-label Phase|Failed to Return|1|||
161802637|NCT00365300|584321414|FG001|Open-label Phase|Failed to Return|0|||
161802638|NCT00365300|584321413|FG000|Open-label Phase|Physician Decision|1|||
161802639|NCT00365300|584321414|FG001|Open-label Phase|Physician Decision|0|||
161802640|NCT00365300|584321413|FG000|Open-label Phase|Noncompliance|9|||
161802641|NCT00365300|584321414|FG001|Open-label Phase|Noncompliance|0|||
161802642|NCT00365300|584321413|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
161802643|NCT00365300|584321414|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
161802644|NCT00365300|584321413|FG000|Open-label Phase|Protocol Violation|1|||
161802645|NCT00365300|584321414|FG001|Open-label Phase|Protocol Violation|0|||
161802646|NCT00365300|584321413|FG000|Open-label Phase|Lack of Efficacy|1|||
161802647|NCT00365300|584321414|FG001|Open-label Phase|Lack of Efficacy|0|||
161802648|NCT00365300|584321413|FG000|Open-label Phase|Patient skipped open label phase|1|||
161802649|NCT00365300|584321414|FG001|Open-label Phase|Patient skipped open label phase|0|||
161802650|NCT00365300|584321413|FG000|Double-blind Phase|Failed to return|1|||
161802651|NCT00365300|584321414|FG001|Double-blind Phase|Failed to return|0|||
161802652|NCT00365300|584321413|FG000|Double-blind Phase|Noncompliance|1|||
161802653|NCT00365300|584321414|FG001|Double-blind Phase|Noncompliance|1|||
161802654|NCT00365300|584321413|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161802655|NCT00365300|584321414|FG001|Double-blind Phase|Withdrawal by Subject|1|||
161802656|NCT00365300|584321413|FG000|Double-blind Phase|Protocol Violation|3|||
161802657|NCT00365300|584321414|FG001|Double-blind Phase|Protocol Violation|1|||
161802658|NCT00365300|584321413|FG000|Double-blind Phase|Lack of Efficacy|6|||
161802659|NCT00365300|584321414|FG001|Double-blind Phase|Lack of Efficacy|6|||
161802660|NCT01991470|584321415|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
161802661|NCT01991470|584321415|FG000|Enlite 1 Period|Adverse Event|1|||
161802662|NCT01991470|584321415|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
161802663|NCT01991470|584321415|FG000|Enlite 3 Period|Lost to Follow-up|1|||
161802664|NCT01991470|584321415|FG000|Enlite 3 Period|Physician Decision|2|||
161802665|NCT01991470|584321415|FG000|Enlite 3 Period|Physician Decision|8|||
161802666|NCT01991470|584321415|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
161802667|NCT02896361|584321416|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
161802668|NCT02896361|584321417|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
161802669|NCT02896361|584321418|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
161802670|NCT02896361|584321416|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
161802671|NCT02896361|584321417|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
161802672|NCT02896361|584321418|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
161802673|NCT02143102|584321423|FG000|Overall Study|Lost to Follow-up|11|||
161802674|NCT02143102|584321424|FG001|Overall Study|Lost to Follow-up|0|||
161802675|NCT03164772|584321427|FG000|Overall Study|Death|4|||
161802676|NCT03164772|584321428|FG001|Overall Study|Death|2|||
161802677|NCT03164772|584321427|FG000|Overall Study|Adverse Event|1|||
161802678|NCT03164772|584321428|FG001|Overall Study|Adverse Event|4|||
161802679|NCT03164772|584321427|FG000|Overall Study|Progressive Disease|11|||
161802680|NCT03164772|584321428|FG001|Overall Study|Progressive Disease|21|||
161802681|NCT03164772|584321427|FG000|Overall Study|Physician Decision|2|||
161802682|NCT03164772|584321428|FG001|Overall Study|Physician Decision|0|||
161802683|NCT03164772|584321427|FG000|Overall Study|Withdrawal by Subject|0|||
161802684|NCT03164772|584321428|FG001|Overall Study|Withdrawal by Subject|4|||
161802685|NCT01029353|584321429|FG000|Overall Study|Lost to Follow-up|4|||
161802686|NCT01029353|584321430|FG001|Overall Study|Lost to Follow-up|5|||
161802687|NCT01029353|584321431|FG002|Overall Study|Lost to Follow-up|5|||
161802688|NCT01029353|584321432|FG003|Overall Study|Lost to Follow-up|4|||
161802689|NCT01029353|584321429|FG000|Overall Study|Consent Withdrawn|2|||
161802690|NCT01029353|584321430|FG001|Overall Study|Consent Withdrawn|0|||
161802691|NCT01029353|584321431|FG002|Overall Study|Consent Withdrawn|0|||
161802692|NCT01029353|584321432|FG003|Overall Study|Consent Withdrawn|0|||
161802693|NCT01029353|584321429|FG000|Overall Study|Primary Outcome Indeterminate|1|||
161905636|NCT01674725|584703393|FG000|Overall Study|Adverse Event|1|||
161905637|NCT01674725|584703394|FG001|Overall Study|Adverse Event|0|||
161905638|NCT01674725|584703393|FG000|Overall Study|Did not receive study drug|1|||
161905639|NCT01674725|584703394|FG001|Overall Study|Did not receive study drug|0|||
161905640|NCT01674725|584703393|FG000|Overall Study|Withdrawal by Subject|1|||
161905641|NCT01674725|584703394|FG001|Overall Study|Withdrawal by Subject|0|||
161905642|NCT01674725|584703393|FG000|Overall Study|Lost to Follow-up|0|||
161905643|NCT01674725|584703394|FG001|Overall Study|Lost to Follow-up|1|||
161905644|NCT03102762|584703395|FG000|Overall Study|Lost to Follow-up|1|||
161905645|NCT03102762|584703396|FG001|Overall Study|Lost to Follow-up|0|||
161905646|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
161905647|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905648|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905649|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905650|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905651|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
161905652|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905653|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905654|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905655|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905656|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
161905657|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905658|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905659|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905660|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905661|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
161905662|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161905663|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161905664|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161802694|NCT01029353|584321430|FG001|Overall Study|Primary Outcome Indeterminate|3|||
161802695|NCT01029353|584321431|FG002|Overall Study|Primary Outcome Indeterminate|2|||
161802696|NCT01029353|584321432|FG003|Overall Study|Primary Outcome Indeterminate|0|||
161802697|NCT04538170|584321435|FG000|Overall Study|Withdrawal by Subject|104|||
161802698|NCT04538170|584321436|FG001|Overall Study|Withdrawal by Subject|210|||
161802699|NCT00324168|584321441|FG000|Overall Study|Lost to Follow-up|19|||
161802700|NCT00324168|584321442|FG001|Overall Study|Lost to Follow-up|18|||
161802701|NCT00324168|584321441|FG000|Overall Study|Death|3|||
161802702|NCT00324168|584321442|FG001|Overall Study|Death|3|||
161802703|NCT00324168|584321441|FG000|Overall Study|Patient did not visit in f/u window|6|||
161802704|NCT00324168|584321442|FG001|Overall Study|Patient did not visit in f/u window|9|||
161802705|NCT01203878|584321443|FG000|Overall Study|Withdrawal by Subject|0|||
161802706|NCT01203878|584321444|FG001|Overall Study|Withdrawal by Subject|0|||
161802707|NCT01203878|584321445|FG002|Overall Study|Withdrawal by Subject|1|||
161802708|NCT01203878|584321443|FG000|Overall Study|Adverse Event|0|||
161802709|NCT01203878|584321444|FG001|Overall Study|Adverse Event|0|||
161802710|NCT01203878|584321445|FG002|Overall Study|Adverse Event|2|||
161802711|NCT00274937|584321446|FG000|Overall Study|Physician Decision|10|||
161802712|NCT00274937|584321446|FG000|Overall Study|Withdrawal by Subject|6|||
161802713|NCT00274937|584321446|FG000|Overall Study|Progressive Disease|4|||
161802714|NCT01682083|584321448|FG000|Overall Study|Lost to Follow-up|11|||
161802715|NCT01682083|584321449|FG001|Overall Study|Lost to Follow-up|18|||
161802716|NCT01682083|584321448|FG000|Overall Study|Withdrawal by Subject|31|||
161802717|NCT01682083|584321449|FG001|Overall Study|Withdrawal by Subject|40|||
161802718|NCT01682083|584321448|FG000|Overall Study|Death|60|||
161802719|NCT01682083|584321449|FG001|Overall Study|Death|93|||
161802720|NCT01682083|584321448|FG000|Overall Study|Physician Decision|5|||
161802721|NCT01682083|584321449|FG001|Overall Study|Physician Decision|4|||
161802722|NCT02932878|584321450|FG000|Overall Study|Due to Lab Results|2|||
161802723|NCT02932878|584321451|FG001|Overall Study|Due to Lab Results|1|||
161802724|NCT01918397|584321452|FG000|Overall Study|Never started treatment|2|||
161802725|NCT01918397|584321453|FG001|Overall Study|Never started treatment|1|||
161802726|NCT01918397|584321454|FG002|Overall Study|Never started treatment|0|||
161905665|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161905666|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
161905667|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161905668|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161905669|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161802727|NCT01918397|584321455|FG003|Overall Study|Never started treatment|0|||
161802728|NCT01918397|584321452|FG000|Overall Study|Adverse Event|1|||
161802729|NCT01918397|584321453|FG001|Overall Study|Adverse Event|1|||
161802730|NCT01918397|584321454|FG002|Overall Study|Adverse Event|1|||
161802731|NCT01918397|584321455|FG003|Overall Study|Adverse Event|0|||
161802732|NCT01918397|584321452|FG000|Overall Study|Lack of compliance|2|||
161905670|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161905671|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
161905672|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905673|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905674|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905675|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905676|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
161905677|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905678|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905679|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905680|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905681|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
161905682|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905683|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905684|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905685|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905686|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
161905687|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905688|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905689|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905690|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905691|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161905692|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
161905693|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161905694|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161905695|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
161905696|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
161905697|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
161905698|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
161905699|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
161905700|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
161905701|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
161802733|NCT01918397|584321453|FG001|Overall Study|Lack of compliance|2|||
161802734|NCT01918397|584321454|FG002|Overall Study|Lack of compliance|3|||
161802735|NCT01918397|584321455|FG003|Overall Study|Lack of compliance|0|||
161802736|NCT01918397|584321452|FG000|Overall Study|Pregnancy|0|||
161802737|NCT01918397|584321453|FG001|Overall Study|Pregnancy|1|||
161802738|NCT01918397|584321454|FG002|Overall Study|Pregnancy|0|||
161802739|NCT01918397|584321455|FG003|Overall Study|Pregnancy|0|||
161802740|NCT01918397|584321452|FG000|Overall Study|Rifampin susceptible|0|||
161802741|NCT01918397|584321453|FG001|Overall Study|Rifampin susceptible|0|||
161802742|NCT01918397|584321454|FG002|Overall Study|Rifampin susceptible|0|||
161802743|NCT01918397|584321455|FG003|Overall Study|Rifampin susceptible|2|||
161802744|NCT01918397|584321452|FG000|Overall Study|Treatment failure|0|||
161802745|NCT01918397|584321453|FG001|Overall Study|Treatment failure|0|||
161802746|NCT01918397|584321454|FG002|Overall Study|Treatment failure|0|||
161802747|NCT01918397|584321455|FG003|Overall Study|Treatment failure|1|||
161802748|NCT01918397|584321452|FG000|Overall Study|Withdrawal by Subject|3|||
161802749|NCT01918397|584321453|FG001|Overall Study|Withdrawal by Subject|2|||
161802750|NCT01918397|584321454|FG002|Overall Study|Withdrawal by Subject|1|||
161802751|NCT01918397|584321455|FG003|Overall Study|Withdrawal by Subject|1|||
161802752|NCT01918397|584321452|FG000|Overall Study|XDR at baseline|0|||
161802753|NCT01918397|584321453|FG001|Overall Study|XDR at baseline|0|||
161802754|NCT01918397|584321454|FG002|Overall Study|XDR at baseline|1|||
161802755|NCT01918397|584321455|FG003|Overall Study|XDR at baseline|0|||
161802756|NCT01918397|584321452|FG000|Overall Study|Lost to Follow-up|2|||
161802757|NCT01918397|584321453|FG001|Overall Study|Lost to Follow-up|1|||
161802758|NCT01918397|584321454|FG002|Overall Study|Lost to Follow-up|1|||
161802759|NCT01918397|584321455|FG003|Overall Study|Lost to Follow-up|1|||
161802760|NCT01918397|584321452|FG000|Overall Study|Increased QTc|1|||
161802761|NCT01918397|584321453|FG001|Overall Study|Increased QTc|0|||
161802762|NCT01918397|584321454|FG002|Overall Study|Increased QTc|0|||
161802763|NCT01918397|584321455|FG003|Overall Study|Increased QTc|1|||
161802764|NCT01918397|584321452|FG000|Overall Study|Death|0|||
161802765|NCT01918397|584321453|FG001|Overall Study|Death|0|||
161802766|NCT01918397|584321454|FG002|Overall Study|Death|1|||
161802767|NCT01918397|584321455|FG003|Overall Study|Death|0|||
161802768|NCT01918397|584321452|FG000|Overall Study|Involved in another investigative trial|0|||
161802769|NCT01918397|584321453|FG001|Overall Study|Involved in another investigative trial|0|||
161905702|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
161905703|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
161905704|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
161905705|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
161905706|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
161905707|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
161905708|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
161905709|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
161905710|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
161905711|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
161905712|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
161905713|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
161905714|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
161905715|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
161905716|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
161905717|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161905718|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161905719|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161905720|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
161905721|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905722|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905723|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
161905724|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905725|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905726|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
161905727|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
161905728|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
161905729|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
161905730|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
161905731|NCT01290718|584703404|FG000|Overall Study|Early termination of the study|4|||
161905732|NCT00748241|584703406|FG000|Overall Study|Implant failure|1|||
161905733|NCT00748241|584703406|FG000|Overall Study|Lost to Follow-up|5|||
161905734|NCT00748241|584703406|FG000|Overall Study|Death|2|||
161905735|NCT01240382|584703407|FG000|Overall Study|Adverse Event|2|||
161905736|NCT01240382|584703408|FG001|Overall Study|Adverse Event|1|||
161905737|NCT01240382|584703407|FG000|Overall Study|Lack of Efficacy|0|||
161905738|NCT01240382|584703408|FG001|Overall Study|Lack of Efficacy|2|||
161905739|NCT01240382|584703407|FG000|Overall Study|Fear of adverse events|0|||
161905740|NCT01240382|584703408|FG001|Overall Study|Fear of adverse events|1|||
161905741|NCT02643693|584703409|FG000|Overall Study|Physician Decision|0|||
161905742|NCT02643693|584703410|FG001|Overall Study|Physician Decision|1|||
161905743|NCT02643693|584703411|FG002|Overall Study|Physician Decision|0|||
161905744|NCT02643693|584703412|FG003|Overall Study|Physician Decision|0|||
161905745|NCT02643693|584703413|FG004|Overall Study|Physician Decision|0|||
161905746|NCT02643693|584703414|FG005|Overall Study|Physician Decision|0|||
161905747|NCT02643693|584703409|FG000|Overall Study|Withdrawal by Subject|0|||
161905748|NCT02643693|584703410|FG001|Overall Study|Withdrawal by Subject|1|||
161905749|NCT02643693|584703411|FG002|Overall Study|Withdrawal by Subject|0|||
161905750|NCT02643693|584703412|FG003|Overall Study|Withdrawal by Subject|0|||
161905751|NCT02643693|584703413|FG004|Overall Study|Withdrawal by Subject|0|||
161905752|NCT02643693|584703414|FG005|Overall Study|Withdrawal by Subject|0|||
161905753|NCT02643693|584703409|FG000|Overall Study|Protocol Adherence Issues|2|||
161905754|NCT02643693|584703410|FG001|Overall Study|Protocol Adherence Issues|0|||
161905755|NCT02643693|584703411|FG002|Overall Study|Protocol Adherence Issues|1|||
161905756|NCT02643693|584703412|FG003|Overall Study|Protocol Adherence Issues|0|||
161905757|NCT02643693|584703413|FG004|Overall Study|Protocol Adherence Issues|0|||
161905758|NCT02643693|584703414|FG005|Overall Study|Protocol Adherence Issues|1|||
161905759|NCT01319565|584703415|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
161905760|NCT01319565|584703416|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
161905761|NCT01319565|584703417|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
161905762|NCT00698815|584703419|FG000|Overall Study|Death|1|||
161905763|NCT00698815|584703420|FG001|Overall Study|Death|2|||
161905764|NCT00698815|584703421|FG002|Overall Study|Death|4|||
161905765|NCT00698815|584703419|FG000|Overall Study|Withdrawal by Subject|6|||
161905766|NCT00698815|584703420|FG001|Overall Study|Withdrawal by Subject|3|||
161905767|NCT00698815|584703421|FG002|Overall Study|Withdrawal by Subject|2|||
161905768|NCT00698815|584703419|FG000|Overall Study|MD discretion|2|||
161905769|NCT00698815|584703420|FG001|Overall Study|MD discretion|7|||
161905770|NCT00698815|584703421|FG002|Overall Study|MD discretion|2|||
161905771|NCT00698815|584703419|FG000|Overall Study|Did not receive protocol treatment|1|||
161561050|NCT00984282|583442005|FG001|Open-label Treatment|Protocol driven decision point|1|||
161561051|NCT00984282|583442004|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
161561052|NCT00984282|583442005|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
161561053|NCT00984282|583442004|FG000|Open-label Treatment|Switched to commercial drug|6|||
161561054|NCT00984282|583442005|FG001|Open-label Treatment|Switched to commercial drug|7|||
161561055|NCT00984282|583442004|FG000|Open-label Treatment|Physician Decision|1|||
161561056|NCT00984282|583442005|FG001|Open-label Treatment|Physician Decision|0|||
161561057|NCT00984282|583442004|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
161561058|NCT00984282|583442005|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
161561059|NCT00984282|583442004|FG000|Long Term Follow-up|Death|27|||
161561060|NCT00984282|583442005|FG001|Long Term Follow-up|Death|68|||
161561061|NCT00984282|583442004|FG000|Long Term Follow-up|Lost to Follow-up|3|||
161561062|NCT00984282|583442005|FG001|Long Term Follow-up|Lost to Follow-up|6|||
161561063|NCT00984282|583442004|FG000|Long Term Follow-up|Protocol driven decision point|25|||
161561064|NCT00984282|583442005|FG001|Long Term Follow-up|Protocol driven decision point|26|||
161561065|NCT00984282|583442004|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
161561066|NCT00984282|583442005|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
161561067|NCT00984282|583442004|FG000|Long Term Follow-up|Switched to commercial drug|4|||
161561068|NCT00984282|583442005|FG001|Long Term Follow-up|Switched to commercial drug|2|||
161561069|NCT00984282|583442004|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
161561070|NCT00984282|583442005|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
161561071|NCT02223793|583442006|FG000|Overall Study|Lost to Follow-up|10|||
161561072|NCT02223793|583442007|FG001|Overall Study|Lost to Follow-up|1|||
161802770|NCT01918397|584321454|FG002|Overall Study|Involved in another investigative trial|0|||
161802771|NCT01918397|584321455|FG003|Overall Study|Involved in another investigative trial|1|||
161802772|NCT03952143|584321460|FG000|Lead-In Period|Adverse Event|2|||
161802773|NCT03952143|584321461|FG001|Lead-In Period|Adverse Event|0|||
161802774|NCT03952143|584321462|FG002|Lead-In Period|Adverse Event|0|||
161802775|NCT03952143|584321460|FG000|Lead-In Period|Lack of Efficacy|2|||
161802776|NCT03952143|584321461|FG001|Lead-In Period|Lack of Efficacy|0|||
161802777|NCT03952143|584321462|FG002|Lead-In Period|Lack of Efficacy|0|||
161802778|NCT03952143|584321460|FG000|Lead-In Period|Physician Decision|5|||
161802779|NCT03952143|584321461|FG001|Lead-In Period|Physician Decision|0|||
161802780|NCT03952143|584321462|FG002|Lead-In Period|Physician Decision|0|||
161802781|NCT03952143|584321460|FG000|Lead-In Period|Protocol Violation|5|||
161802782|NCT03952143|584321461|FG001|Lead-In Period|Protocol Violation|0|||
161802783|NCT03952143|584321462|FG002|Lead-In Period|Protocol Violation|0|||
161802784|NCT03952143|584321460|FG000|Lead-In Period|Withdrawal by Subject|19|||
161802785|NCT03952143|584321461|FG001|Lead-In Period|Withdrawal by Subject|0|||
161802786|NCT03952143|584321462|FG002|Lead-In Period|Withdrawal by Subject|0|||
161802787|NCT03952143|584321460|FG000|Treatment Period|Adverse Event|0|||
161802788|NCT03952143|584321461|FG001|Treatment Period|Adverse Event|0|||
161802789|NCT03952143|584321462|FG002|Treatment Period|Adverse Event|1|||
161802790|NCT03952143|584321460|FG000|Treatment Period|Lost to Follow-up|0|||
161802791|NCT03952143|584321461|FG001|Treatment Period|Lost to Follow-up|2|||
161802792|NCT03952143|584321462|FG002|Treatment Period|Lost to Follow-up|0|||
161802793|NCT03952143|584321460|FG000|Treatment Period|Physician Decision|0|||
161802794|NCT03952143|584321461|FG001|Treatment Period|Physician Decision|0|||
161802795|NCT03952143|584321462|FG002|Treatment Period|Physician Decision|2|||
161802796|NCT03952143|584321460|FG000|Treatment Period|Protocol Violation|0|||
161802797|NCT03952143|584321461|FG001|Treatment Period|Protocol Violation|0|||
161802798|NCT03952143|584321462|FG002|Treatment Period|Protocol Violation|1|||
161802799|NCT03952143|584321460|FG000|Treatment Period|Withdrawal by Subject|0|||
161802800|NCT03952143|584321461|FG001|Treatment Period|Withdrawal by Subject|5|||
161802801|NCT03952143|584321462|FG002|Treatment Period|Withdrawal by Subject|26|||
161802802|NCT03952143|584321460|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
161802803|NCT03952143|584321461|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
161802804|NCT03952143|584321462|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
161802805|NCT03952143|584321460|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
161802806|NCT03952143|584321461|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
161802807|NCT03952143|584321462|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
161802808|NCT02152566|584321463|FG000|Overall Study|Lost to Follow-up|1|||
161802809|NCT02152566|584321463|FG000|Overall Study|Withdrawal by Subject|2|||
161802810|NCT00496964|584321464|FG000|Overall Study|Withdrawal by Subject|0|||
161802811|NCT00496964|584321465|FG001|Overall Study|Withdrawal by Subject|1|||
161802812|NCT02942264|584321466|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802813|NCT02942264|584321467|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
161802814|NCT02942264|584321468|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161561073|NCT02223793|583442008|FG002|Overall Study|Lost to Follow-up|2|||
161561074|NCT02223793|583442006|FG000|Overall Study|Withdrawal by Subject|3|||
161802815|NCT02942264|584321469|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802816|NCT02942264|584321470|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802817|NCT02942264|584321471|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161561075|NCT02223793|583442007|FG001|Overall Study|Withdrawal by Subject|2|||
161561076|NCT02223793|583442008|FG002|Overall Study|Withdrawal by Subject|3|||
161561077|NCT02223793|583442006|FG000|Overall Study|Moved/studycenter unable to participate|4|||
161561078|NCT02223793|583442007|FG001|Overall Study|Moved/studycenter unable to participate|6|||
161561079|NCT02223793|583442008|FG002|Overall Study|Moved/studycenter unable to participate|8|||
161561080|NCT02321540|583442010|FG000|Overall Study|Death|0|||
161561081|NCT02321540|583442011|FG001|Overall Study|Death|1|||
161561082|NCT02321540|583442010|FG000|Overall Study|Progression|3|||
161561083|NCT02321540|583442011|FG001|Overall Study|Progression|9|||
161561084|NCT03606460|583442013|FG000|Overall Study|Lost to Follow-up|1|||
161561085|NCT03606460|583442014|FG001|Overall Study|Lost to Follow-up|8|||
161561086|NCT00003377|583442015|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
161561087|NCT00003377|583442016|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
161561088|NCT00003377|583442017|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
161561089|NCT00003377|583442018|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
161561090|NCT00003377|583442019|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
161561091|NCT00003377|583442015|FG000|Period II|Ureteral stent complications|0|||
161561092|NCT00003377|583442016|FG001|Period II|Ureteral stent complications|0|||
161561093|NCT00003377|583442017|FG002|Period II|Ureteral stent complications|0|||
161561094|NCT00003377|583442018|FG003|Period II|Ureteral stent complications|0|||
161561095|NCT00003377|583442019|FG004|Period II|Ureteral stent complications|1|||
161561096|NCT04541186|583442023|FG000|Main Study|Adverse Event|0|||
161561097|NCT04541186|583442024|FG001|Main Study|Adverse Event|0|||
161561098|NCT04541186|583442025|FG002|Main Study|Adverse Event|4|||
161561099|NCT04541186|583442026|FG003|Main Study|Adverse Event|0|||
161561100|NCT04541186|583442027|FG004|Main Study|Adverse Event|0|||
161561101|NCT04541186|583442023|FG000|Main Study|Investigator Decision|0|||
161561102|NCT04541186|583442024|FG001|Main Study|Investigator Decision|0|||
161561103|NCT04541186|583442025|FG002|Main Study|Investigator Decision|1|||
161561104|NCT04541186|583442026|FG003|Main Study|Investigator Decision|1|||
161561105|NCT04541186|583442027|FG004|Main Study|Investigator Decision|0|||
161561106|NCT04541186|583442023|FG000|Main Study|Withdrawal by Subject|1|||
161561107|NCT04541186|583442024|FG001|Main Study|Withdrawal by Subject|1|||
161561108|NCT04541186|583442025|FG002|Main Study|Withdrawal by Subject|0|||
161561109|NCT04541186|583442026|FG003|Main Study|Withdrawal by Subject|0|||
161561110|NCT04541186|583442027|FG004|Main Study|Withdrawal by Subject|0|||
161561111|NCT04541186|583442023|FG000|Main Study|COVID-19-related Dose Interruption|0|||
161561112|NCT04541186|583442024|FG001|Main Study|COVID-19-related Dose Interruption|0|||
161561113|NCT04541186|583442025|FG002|Main Study|COVID-19-related Dose Interruption|0|||
161561114|NCT04541186|583442026|FG003|Main Study|COVID-19-related Dose Interruption|0|||
161561115|NCT04541186|583442027|FG004|Main Study|COVID-19-related Dose Interruption|1|||
161561116|NCT04541186|583442023|FG000|Main Study|Randomized in Error Not Treated|0|||
161561117|NCT04541186|583442024|FG001|Main Study|Randomized in Error Not Treated|0|||
161561118|NCT04541186|583442025|FG002|Main Study|Randomized in Error Not Treated|1|||
161561119|NCT04541186|583442026|FG003|Main Study|Randomized in Error Not Treated|0|||
161561120|NCT04541186|583442027|FG004|Main Study|Randomized in Error Not Treated|0|||
161561121|NCT04541186|583442023|FG000|Fibrate Expansion Study|Other than Specified|0|||
161561122|NCT04541186|583442024|FG001|Fibrate Expansion Study|Other than Specified|0|||
161561123|NCT04541186|583442025|FG002|Fibrate Expansion Study|Other than Specified|0|||
161561124|NCT04541186|583442026|FG003|Fibrate Expansion Study|Other than Specified|0|||
161561125|NCT04541186|583442027|FG004|Fibrate Expansion Study|Other than Specified|1|||
161561126|NCT00303303|583442030|FG000|Overall Study|Withdrawal by Subject|0|||
161561127|NCT00303303|583442031|FG001|Overall Study|Withdrawal by Subject|0|||
161561128|NCT00303303|583442032|FG002|Overall Study|Withdrawal by Subject|1|||
161561129|NCT03085017|583442033|FG000|Overall Study|Death|0|||
161561130|NCT03085017|583442034|FG001|Overall Study|Death|3|||
161561131|NCT00058058|583442035|FG000|Overall Study|Withdrawal by Subject|4|||
161561132|NCT00058058|583442035|FG000|Overall Study|Ineligible|20|||
161561133|NCT00058058|583442035|FG000|Overall Study|Claustrophobic|5|||
161561134|NCT00058058|583442035|FG000|Overall Study|technical issues|6|||
161561135|NCT00058058|583442035|FG000|Overall Study|Poor positioning, illness,pain|3|||
161802818|NCT02942264|584321472|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
161802819|NCT02942264|584321473|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802820|NCT02942264|584321474|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802821|NCT02942264|584321466|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802822|NCT02942264|584321467|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802823|NCT02942264|584321468|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802824|NCT02942264|584321469|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802825|NCT02942264|584321470|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802826|NCT02942264|584321471|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802827|NCT02942264|584321472|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802828|NCT02942264|584321473|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161561136|NCT00582790|583442036|FG000|Overall Study|Rapid progression of disease|1|||
161561137|NCT02680756|583442041|FG000|Overall Study|Adverse Event|10|||
161561138|NCT02680756|583442042|FG001|Overall Study|Adverse Event|2|||
161561139|NCT02680756|583442041|FG000|Overall Study|Lost to Follow-up|7|||
161561140|NCT02680756|583442042|FG001|Overall Study|Lost to Follow-up|6|||
161561141|NCT02680756|583442041|FG000|Overall Study|Withdrawal by Subject|5|||
161802829|NCT02942264|584321474|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
161802830|NCT01328093|584321475|FG000|Double-Blind Phase|Adverse Event|78|||
161802831|NCT01328093|584321476|FG001|Double-Blind Phase|Adverse Event|15|||
161802832|NCT01328093|584321475|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
161802833|NCT01328093|584321476|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
161802834|NCT01328093|584321475|FG000|Double-Blind Phase|Lost to Follow-up|39|||
161802835|NCT01328093|584321476|FG001|Double-Blind Phase|Lost to Follow-up|14|||
161802836|NCT01328093|584321475|FG000|Double-Blind Phase|Protocol Violation|30|||
161802837|NCT01328093|584321476|FG001|Double-Blind Phase|Protocol Violation|10|||
161802838|NCT01328093|584321475|FG000|Double-Blind Phase|Lack of Efficacy|55|||
161802839|NCT01328093|584321476|FG001|Double-Blind Phase|Lack of Efficacy|13|||
161802840|NCT01328093|584321475|FG000|Double-Blind Phase|Sponsor Decision|17|||
161802841|NCT01328093|584321476|FG001|Double-Blind Phase|Sponsor Decision|3|||
161802842|NCT01328093|584321475|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
161802843|NCT01328093|584321476|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
161802844|NCT01328093|584321475|FG000|Double-Blind Phase|Scheduling conflict|8|||
161802845|NCT01328093|584321476|FG001|Double-Blind Phase|Scheduling conflict|3|||
161802846|NCT01328093|584321475|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
161802847|NCT01328093|584321476|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
161802848|NCT01328093|584321475|FG000|Double-Blind Phase|Death|1|||
161802849|NCT01328093|584321476|FG001|Double-Blind Phase|Death|0|||
161802850|NCT01328093|584321475|FG000|Open-Label Phase|Sponsor Decision|98|||
161802851|NCT01328093|584321476|FG001|Open-Label Phase|Sponsor Decision|34|||
161802852|NCT01328093|584321475|FG000|Open-Label Phase|Protocol Violation|8|||
161802853|NCT01328093|584321476|FG001|Open-Label Phase|Protocol Violation|3|||
161802854|NCT01328093|584321475|FG000|Open-Label Phase|Lost to Follow-up|10|||
161802855|NCT01328093|584321476|FG001|Open-Label Phase|Lost to Follow-up|1|||
161802856|NCT01328093|584321475|FG000|Open-Label Phase|Adverse Event|10|||
161802857|NCT01328093|584321476|FG001|Open-Label Phase|Adverse Event|4|||
161802858|NCT01328093|584321475|FG000|Open-Label Phase|Lack of Efficacy|5|||
161802859|NCT01328093|584321476|FG001|Open-Label Phase|Lack of Efficacy|6|||
161802860|NCT01328093|584321475|FG000|Open-Label Phase|Withdrawal by Subject|4|||
161802861|NCT01328093|584321476|FG001|Open-Label Phase|Withdrawal by Subject|1|||
161802862|NCT01328093|584321475|FG000|Open-Label Phase|Scheduling conflict|2|||
161802863|NCT01328093|584321476|FG001|Open-Label Phase|Scheduling conflict|1|||
161802864|NCT01328093|584321475|FG000|Open-Label Phase|Subject is moving or has moved|2|||
161802865|NCT01328093|584321476|FG001|Open-Label Phase|Subject is moving or has moved|0|||
161802866|NCT01328093|584321475|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
161802867|NCT01328093|584321476|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
161802868|NCT01225146|584321479|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
161802869|NCT01225146|584321480|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
161802870|NCT03657160|584321481|FG000|Overall Study|Adverse Event|5|||
161802871|NCT03657160|584321482|FG001|Overall Study|Adverse Event|6|||
161802872|NCT03657160|584321481|FG000|Overall Study|Protocol Deviation|3|||
161802873|NCT03657160|584321482|FG001|Overall Study|Protocol Deviation|0|||
161802874|NCT03657160|584321481|FG000|Overall Study|Withdrawal by Subject|18|||
161802875|NCT03657160|584321482|FG001|Overall Study|Withdrawal by Subject|16|||
161802876|NCT03657160|584321481|FG000|Overall Study|Site Termination|1|||
161802877|NCT03657160|584321482|FG001|Overall Study|Site Termination|0|||
161802878|NCT03657160|584321481|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
161802879|NCT03657160|584321482|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
161802880|NCT03657160|584321481|FG000|Overall Study|Death|33|||
161802881|NCT03657160|584321482|FG001|Overall Study|Death|26|||
161802882|NCT03657160|584321481|FG000|Overall Study|Death (COVID-19-Related)|1|||
161802883|NCT03657160|584321482|FG001|Overall Study|Death (COVID-19-Related)|0|||
161802884|NCT03657160|584321481|FG000|Overall Study|Reason Not Specified|5|||
161802885|NCT03657160|584321482|FG001|Overall Study|Reason Not Specified|5|||
161802886|NCT03657160|584321481|FG000|Overall Study|Other (COVID-19-Related)|0|||
161802887|NCT03657160|584321482|FG001|Overall Study|Other (COVID-19-Related)|1|||
161802888|NCT00686959|584321485|FG000|Overall Study|Participants censored (no death events)|124|||
161802889|NCT00686959|584321486|FG001|Overall Study|Participants censored (no death events)|117|||
161802890|NCT02191891|584321488|FG000|Overall Study|Withdrawal by Subject|0|||
161802891|NCT02191891|584321489|FG001|Overall Study|Withdrawal by Subject|1|||
161802892|NCT02191891|584321490|FG002|Overall Study|Withdrawal by Subject|0|||
161802893|NCT02191891|584321491|FG003|Overall Study|Withdrawal by Subject|0|||
161802894|NCT02191891|584321492|FG004|Overall Study|Withdrawal by Subject|1|||
161802895|NCT02191891|584321488|FG000|Overall Study|Adverse Event|0|||
161802896|NCT02191891|584321489|FG001|Overall Study|Adverse Event|1|||
161802897|NCT02191891|584321490|FG002|Overall Study|Adverse Event|0|||
161802898|NCT02191891|584321491|FG003|Overall Study|Adverse Event|0|||
161802899|NCT02191891|584321492|FG004|Overall Study|Adverse Event|2|||
161802900|NCT02191891|584321488|FG000|Overall Study|Disease Progression|4|||
161668058|NCT00406653|583837480|FG004|Induction Period|Incarcerated|0|||
161905772|NCT00698815|584703420|FG001|Overall Study|Did not receive protocol treatment|2|||
161905773|NCT00698815|584703421|FG002|Overall Study|Did not receive protocol treatment|2|||
161905774|NCT03575702|584703423|FG000|Overall Study|Withdrawal by Subject|1|||
161905775|NCT03575702|584703424|FG001|Overall Study|Withdrawal by Subject|1|||
161905776|NCT03575702|584703423|FG000|Overall Study|Lost to Follow-up|1|||
161905777|NCT03575702|584703424|FG001|Overall Study|Lost to Follow-up|2|||
161905778|NCT03575702|584703423|FG000|Overall Study|Protocol Violation|0|||
161905779|NCT03575702|584703424|FG001|Overall Study|Protocol Violation|1|||
161905780|NCT03575702|584703423|FG000|Overall Study|Patient non compliance|4|||
161905781|NCT03575702|584703424|FG001|Overall Study|Patient non compliance|0|||
161905782|NCT00490035|584703429|FG000|Overall Study|AE, non-serious non-fatal|3|||
161905783|NCT00490035|584703430|FG001|Overall Study|AE, non-serious non-fatal|4|||
161905784|NCT00490035|584703431|FG002|Overall Study|AE, non-serious non-fatal|4|||
161905785|NCT00490035|584703432|FG003|Overall Study|AE, non-serious non-fatal|5|||
161905786|NCT00490035|584703429|FG000|Overall Study|Lost to Follow-up|2|||
161905787|NCT00490035|584703430|FG001|Overall Study|Lost to Follow-up|0|||
161905788|NCT00490035|584703431|FG002|Overall Study|Lost to Follow-up|1|||
161905789|NCT00490035|584703432|FG003|Overall Study|Lost to Follow-up|0|||
161905790|NCT00490035|584703429|FG000|Overall Study|Withdrawal by Subject|2|||
161905791|NCT00490035|584703430|FG001|Overall Study|Withdrawal by Subject|1|||
161905792|NCT00490035|584703431|FG002|Overall Study|Withdrawal by Subject|1|||
161905793|NCT00490035|584703432|FG003|Overall Study|Withdrawal by Subject|0|||
161905794|NCT00490035|584703429|FG000|Overall Study|Other reason|0|||
161905795|NCT00490035|584703430|FG001|Overall Study|Other reason|1|||
161905796|NCT00490035|584703431|FG002|Overall Study|Other reason|3|||
161905797|NCT00490035|584703432|FG003|Overall Study|Other reason|1|||
161905798|NCT00490035|584703429|FG000|Overall Study|AE, serious fatal|1|||
161905799|NCT00490035|584703430|FG001|Overall Study|AE, serious fatal|0|||
161905800|NCT00490035|584703431|FG002|Overall Study|AE, serious fatal|0|||
161905801|NCT00490035|584703432|FG003|Overall Study|AE, serious fatal|0|||
161905802|NCT00490035|584703429|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161905803|NCT00490035|584703430|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161905804|NCT00490035|584703431|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
161905805|NCT00490035|584703432|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161905806|NCT00490035|584703429|FG000|Overall Study|AE of unknown type|0|||
161905807|NCT00490035|584703430|FG001|Overall Study|AE of unknown type|0|||
161905808|NCT00490035|584703431|FG002|Overall Study|AE of unknown type|2|||
161905809|NCT00490035|584703432|FG003|Overall Study|AE of unknown type|0|||
161905810|NCT05559905|584703433|FG000|Overall Study|Withdrawal by Subject|1|||
161905811|NCT05559905|584703434|FG001|Overall Study|Withdrawal by Subject|0|||
161905812|NCT05559905|584703435|FG002|Overall Study|Withdrawal by Subject|0|||
161905813|NCT05559905|584703433|FG000|Overall Study|Not Reported|1|||
161905814|NCT05559905|584703434|FG001|Overall Study|Not Reported|0|||
161905815|NCT05559905|584703435|FG002|Overall Study|Not Reported|0|||
161905816|NCT05276973|584703436|FG000|Overall Study|Treated and DLT unevaluable|1|||
161905817|NCT05276973|584703437|FG001|Overall Study|Treated and DLT unevaluable|1|||
161905818|NCT05276973|584703438|FG002|Overall Study|Treated and DLT unevaluable|0|||
161905819|NCT03180736|584703439|FG000|Overall Study|Adverse Event|3|||
161905820|NCT03180736|584703440|FG001|Overall Study|Adverse Event|4|||
161905821|NCT03180736|584703439|FG000|Overall Study|Death|10|||
161905822|NCT03180736|584703440|FG001|Overall Study|Death|7|||
161905823|NCT03180736|584703439|FG000|Overall Study|Withdrawal by Subject|5|||
161905824|NCT03180736|584703440|FG001|Overall Study|Withdrawal by Subject|12|||
161905825|NCT03180736|584703439|FG000|Overall Study|Lost to Follow-up|1|||
161905826|NCT03180736|584703440|FG001|Overall Study|Lost to Follow-up|0|||
161905827|NCT03180736|584703439|FG000|Overall Study|Lack of Efficacy|66|||
161905828|NCT03180736|584703440|FG001|Overall Study|Lack of Efficacy|87|||
161905829|NCT03180736|584703439|FG000|Overall Study|Physician Decision|4|||
161905830|NCT03180736|584703440|FG001|Overall Study|Physician Decision|7|||
161905831|NCT03180736|584703439|FG000|Overall Study|randomized but not treated|2|||
161905832|NCT03180736|584703440|FG001|Overall Study|randomized but not treated|3|||
161905833|NCT03258593|584703441|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
161905834|NCT03258593|584703442|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
161905835|NCT03258593|584703443|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
161905836|NCT03258593|584703444|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
161905837|NCT03258593|584703441|FG000|Run-In Maintenance Phase|Disease progression|3|||
161905838|NCT03258593|584703442|FG001|Run-In Maintenance Phase|Disease progression|0|||
161905839|NCT03258593|584703443|FG002|Run-In Maintenance Phase|Disease progression|0|||
161905840|NCT03258593|584703444|FG003|Run-In Maintenance Phase|Disease progression|0|||
161905841|NCT03258593|584703441|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161905842|NCT03258593|584703442|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
161905843|NCT03258593|584703443|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161905844|NCT03258593|584703444|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161453006|NCT00422084|583053552|FG000|Overall Study|Re-location|0|||
161453007|NCT00422084|583053553|FG001|Overall Study|Re-location|1|||
161905845|NCT03258593|584703441|FG000|Expansion Maintenance Phase|Physician Decision|0|||
161561142|NCT02680756|583442042|FG001|Overall Study|Withdrawal by Subject|5|||
161561143|NCT02680756|583442041|FG000|Overall Study|Physician Decision|4|||
161561144|NCT02680756|583442042|FG001|Overall Study|Physician Decision|1|||
161561145|NCT02680756|583442041|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
161561146|NCT02680756|583442042|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
161561147|NCT02680756|583442041|FG000|Overall Study|Blood transfusion for any reason|0|||
161561148|NCT02680756|583442042|FG001|Overall Study|Blood transfusion for any reason|1|||
161561149|NCT02680756|583442041|FG000|Overall Study|Death|1|||
161561150|NCT02680756|583442042|FG001|Overall Study|Death|0|||
161561151|NCT02680756|583442041|FG000|Overall Study|Protocol Violation|1|||
161561152|NCT02680756|583442042|FG001|Overall Study|Protocol Violation|0|||
161561153|NCT02680756|583442041|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
161561154|NCT02680756|583442042|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
161561155|NCT02680756|583442041|FG000|Overall Study|None of above or not recorded|3|||
161561156|NCT02680756|583442042|FG001|Overall Study|None of above or not recorded|2|||
161561157|NCT02374957|583442043|FG000|Overall Study|Patient did not complete forms correctly|1|||
161561158|NCT02374957|583442044|FG001|Overall Study|Patient did not complete forms correctly|0|||
161561159|NCT00748969|583442045|FG000|Overall Study|Withdrawal by Subject|1|||
161561160|NCT00748969|583442046|FG001|Overall Study|Withdrawal by Subject|0|||
161561161|NCT00748969|583442045|FG000|Overall Study|Withdrawal by Subject|0|||
161802901|NCT02191891|584321489|FG001|Overall Study|Disease Progression|10|||
161802902|NCT02191891|584321490|FG002|Overall Study|Disease Progression|4|||
161802903|NCT02191891|584321491|FG003|Overall Study|Disease Progression|2|||
161802904|NCT02191891|584321492|FG004|Overall Study|Disease Progression|7|||
161802905|NCT01062256|584321493|FG000|Overall Study|Adverse Event|1|||
161802906|NCT01062256|584321494|FG001|Overall Study|Adverse Event|0|||
161802907|NCT01062256|584321495|FG002|Overall Study|Adverse Event|0|||
161802908|NCT01062256|584321493|FG000|Overall Study|Withdrawal by Subject|1|||
161802909|NCT01062256|584321494|FG001|Overall Study|Withdrawal by Subject|1|||
161802910|NCT01062256|584321495|FG002|Overall Study|Withdrawal by Subject|1|||
161802911|NCT01062256|584321493|FG000|Overall Study|Ineligible|1|||
161802912|NCT01062256|584321494|FG001|Overall Study|Ineligible|4|||
161802913|NCT01062256|584321495|FG002|Overall Study|Ineligible|3|||
161802914|NCT01062256|584321493|FG000|Overall Study|Administrative|0|||
161802915|NCT01062256|584321494|FG001|Overall Study|Administrative|2|||
161802916|NCT01062256|584321495|FG002|Overall Study|Administrative|0|||
161802917|NCT03099538|584321496|FG000|Overall Study|Lack of Efficacy|3|||
161802918|NCT02365207|584321508|FG000|Overall Study|Withdrawal by Subject|1|||
161802919|NCT02365207|584321508|FG000|Overall Study|Physician Decision|1|||
161802920|NCT01318499|584321511|FG000|Overall Study|Adverse Event|16|||
161802921|NCT01318499|584321512|FG001|Overall Study|Adverse Event|11|||
161802922|NCT01318499|584321513|FG002|Overall Study|Adverse Event|6|||
161802923|NCT01318499|584321511|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
161802924|NCT01318499|584321512|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
161802925|NCT01318499|584321513|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
161802926|NCT01318499|584321511|FG000|Overall Study|Noncompliance|2|||
161802927|NCT01318499|584321512|FG001|Overall Study|Noncompliance|3|||
161802928|NCT01318499|584321513|FG002|Overall Study|Noncompliance|0|||
161802929|NCT01318499|584321511|FG000|Overall Study|Treatment Failure|19|||
161802930|NCT01318499|584321512|FG001|Overall Study|Treatment Failure|19|||
161802931|NCT01318499|584321513|FG002|Overall Study|Treatment Failure|101|||
161802932|NCT01318499|584321511|FG000|Overall Study|Protocol Violation|2|||
161802933|NCT01318499|584321512|FG001|Overall Study|Protocol Violation|4|||
161802934|NCT01318499|584321513|FG002|Overall Study|Protocol Violation|2|||
161802935|NCT01318499|584321511|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
161802936|NCT01318499|584321512|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
161802937|NCT01318499|584321513|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
161802938|NCT01318499|584321511|FG000|Overall Study|Other|7|||
161802939|NCT01318499|584321512|FG001|Overall Study|Other|10|||
161802940|NCT01318499|584321513|FG002|Overall Study|Other|22|||
161802941|NCT01395030|584321514|FG000|Overall Study|Did not complete FCH PET/CT|7|||
161802942|NCT02672553|584321515|FG000|Overall Study|Death|3|||
161802943|NCT02672553|584321516|FG001|Overall Study|Death|5|||
161802944|NCT02672553|584321515|FG000|Overall Study|Valve Explant|1|||
161802945|NCT02672553|584321516|FG001|Overall Study|Valve Explant|0|||
161802946|NCT02672553|584321515|FG000|Overall Study|Conversion to Commercial Valve|3|||
161802947|NCT02672553|584321516|FG001|Overall Study|Conversion to Commercial Valve|0|||
161802948|NCT02672553|584321515|FG000|Overall Study|Withdrawal by Subject|3|||
161802949|NCT02672553|584321516|FG001|Overall Study|Withdrawal by Subject|3|||
161802950|NCT02672553|584321515|FG000|Overall Study|Intraoperative screen failure|2|||
161802951|NCT02672553|584321516|FG001|Overall Study|Intraoperative screen failure|0|||
161802952|NCT00950872|584321517|FG000|Overall Study|Withdrawal by Subject|1|||
161802953|NCT00950872|584321517|FG000|Overall Study|Did not have surgery|2|||
161802954|NCT01759290|584321518|FG000|Overall Study|Subjects withdrawn consent|5|||
161802955|NCT01759290|584321518|FG000|Overall Study|Physician Decision|2|||
161802956|NCT01759290|584321518|FG000|Overall Study|Death|17|||
161561162|NCT00748969|583442046|FG001|Overall Study|Withdrawal by Subject|1|||
161905846|NCT03258593|584703442|FG001|Expansion Maintenance Phase|Physician Decision|1|||
161905847|NCT03258593|584703443|FG002|Expansion Maintenance Phase|Physician Decision|0|||
161905848|NCT03258593|584703444|FG003|Expansion Maintenance Phase|Physician Decision|0|||
161905849|NCT05457257|584703451|FG000|Overall Study|Withdrawal by Subject|0|||
161905850|NCT05457257|584703452|FG001|Overall Study|Withdrawal by Subject|2|||
161905851|NCT05457257|584703451|FG000|Overall Study|Death|10|||
161905852|NCT05457257|584703452|FG001|Overall Study|Death|3|||
161905853|NCT05457257|584703451|FG000|Overall Study|Ongoing|19|||
161561163|NCT03532178|583442047|FG000|First Period|Withdrawal by Subject|1|||
161905854|NCT05457257|584703452|FG001|Overall Study|Ongoing|9|||
161905855|NCT02131064|584703455|FG000|Overall Study|Death|5|||
161561164|NCT03532178|583442048|FG001|First Period|Withdrawal by Subject|3|||
161561165|NCT03532178|583442047|FG000|First Period|technical issues in data collection Technical issues|0|||
161905856|NCT02131064|584703456|FG001|Overall Study|Death|6|||
161905857|NCT02131064|584703455|FG000|Overall Study|Lost to Follow-up|4|||
161905858|NCT02131064|584703456|FG001|Overall Study|Lost to Follow-up|8|||
161905859|NCT02131064|584703455|FG000|Overall Study|Withdrawal by Subject|14|||
161905860|NCT02131064|584703456|FG001|Overall Study|Withdrawal by Subject|18|||
161905861|NCT02131064|584703455|FG000|Overall Study|Other|2|||
161905862|NCT02131064|584703456|FG001|Overall Study|Other|2|||
161905863|NCT00593918|584703461|FG000|Overall Study|Withdrawal by Subject|5|||
161905864|NCT00593918|584703462|FG001|Overall Study|Withdrawal by Subject|24|||
161905865|NCT00871234|584703469|FG000|Overall Study|Adverse Event|2|||
161905866|NCT00871234|584703469|FG000|Overall Study|Lost to Follow-up|3|||
161905867|NCT04344301|584703471|FG000|Overall Study|Withdrawal by Subject|1|||
161905868|NCT04344301|584703472|FG001|Overall Study|Withdrawal by Subject|0|||
161905869|NCT04344301|584703471|FG000|Overall Study|Death|0|||
161905870|NCT04344301|584703472|FG001|Overall Study|Death|1|||
161905871|NCT00072410|584703473|FG000|Overall Study|Progressive disease|0|||
161905872|NCT00072410|584703474|FG001|Overall Study|Progressive disease|3|||
161905873|NCT03160716|584703475|FG000|Overall Study|Lost to Follow-up|1|||
161905874|NCT01628848|584703476|FG000|Overall Study|Adverse Event|9|||
161905875|NCT01628848|584703477|FG001|Overall Study|Adverse Event|7|||
161905876|NCT01628848|584703476|FG000|Overall Study|Lack of Efficacy|0|||
161905877|NCT01628848|584703477|FG001|Overall Study|Lack of Efficacy|4|||
161905878|NCT01628848|584703476|FG000|Overall Study|Withdrawal by Subject|0|||
161905879|NCT01628848|584703477|FG001|Overall Study|Withdrawal by Subject|2|||
161905880|NCT01628848|584703476|FG000|Overall Study|Physician Decision|3|||
161905881|NCT01628848|584703477|FG001|Overall Study|Physician Decision|1|||
161905882|NCT00689338|584703479|FG000|Overall Study|Death|65|||
161905883|NCT00689338|584703479|FG000|Overall Study|Adverse Event|13|||
161905884|NCT00689338|584703479|FG000|Overall Study|Insufficient Clinical Response|1|||
161905885|NCT00689338|584703479|FG000|Overall Study|Lack of Efficacy|6|||
161905886|NCT00689338|584703479|FG000|Overall Study|Other|8|||
161905887|NCT00689338|584703479|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
161905888|NCT00689338|584703479|FG000|Overall Study|Lost to Follow-up|5|||
161905889|NCT00689338|584703479|FG000|Overall Study|Withdrawal by Subject|3|||
161905890|NCT00689338|584703479|FG000|Overall Study|Protocol Violation|15|||
161905891|NCT02104895|584703482|FG000|Overall Study|Withdrawal by Subject|0|||
161905892|NCT02104895|584703483|FG001|Overall Study|Withdrawal by Subject|14|||
161905893|NCT00969228|584703484|FG000|Overall Study|Adverse Event|1|||
161905894|NCT00969228|584703485|FG001|Overall Study|Adverse Event|0|||
161905895|NCT00969228|584703484|FG000|Overall Study|Withdrawal by Subject|4|||
161905896|NCT00969228|584703485|FG001|Overall Study|Withdrawal by Subject|0|||
161905897|NCT00969228|584703484|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
161905898|NCT00969228|584703485|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
161905899|NCT02895295|584703487|FG000|Overall Study|Survey Non-response|71|||
161905900|NCT02895295|584703488|FG001|Overall Study|Survey Non-response|94|||
161905901|NCT02895295|584703489|FG002|Overall Study|Survey Non-response|92|||
161905902|NCT02532283|584703490|FG000|Overall Study|Adverse Event|0|||
161905903|NCT02532283|584703491|FG001|Overall Study|Adverse Event|1|||
161905904|NCT02532283|584703490|FG000|Overall Study|Death|1|||
161905905|NCT02532283|584703491|FG001|Overall Study|Death|0|||
161905906|NCT02532283|584703490|FG000|Overall Study|Lost to Follow-up|0|||
161905907|NCT02532283|584703491|FG001|Overall Study|Lost to Follow-up|1|||
161905908|NCT02532283|584703490|FG000|Overall Study|Withdrawal by Subject|8|||
161905909|NCT02532283|584703491|FG001|Overall Study|Withdrawal by Subject|3|||
161905910|NCT03811821|584703492|FG000|Overall Study|Adverse Event|1|||
161905911|NCT03811821|584703493|FG001|Overall Study|Adverse Event|1|||
161905912|NCT03811821|584703492|FG000|Overall Study|Withdrawal by Subject|5|||
161905913|NCT03811821|584703493|FG001|Overall Study|Withdrawal by Subject|4|||
161905914|NCT03811821|584703492|FG000|Overall Study|Lost to Follow-up|2|||
161905915|NCT03811821|584703493|FG001|Overall Study|Lost to Follow-up|2|||
161905916|NCT03811821|584703492|FG000|Overall Study|Contraindication for treatment|0|||
161905917|NCT03811821|584703493|FG001|Overall Study|Contraindication for treatment|1|||
161905918|NCT03811821|584703492|FG000|Overall Study|Tolerability|0|||
161905919|NCT03811821|584703493|FG001|Overall Study|Tolerability|3|||
161905920|NCT03811821|584703492|FG000|Overall Study|Comorbidities|0|||
161905921|NCT03811821|584703493|FG001|Overall Study|Comorbidities|2|||
161802957|NCT01759290|584321518|FG000|Overall Study|Lost to Follow-up|53|||
161802958|NCT01759290|584321518|FG000|Overall Study|Unknown reason|4|||
161802959|NCT01766778|584321522|FG000|Overall Study|Adverse Event|4|||
161802960|NCT01766778|584321523|FG001|Overall Study|Adverse Event|4|||
161802961|NCT01766778|584321522|FG000|Overall Study|Withdrawal by Subject|1|||
161802962|NCT01766778|584321523|FG001|Overall Study|Withdrawal by Subject|0|||
161802963|NCT01054599|584321524|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
161802964|NCT01054599|584321525|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
161802965|NCT01054599|584321524|FG000|Overall Study|Protocol Violation|1|||
161802966|NCT01054599|584321525|FG001|Overall Study|Protocol Violation|0|||
161802967|NCT01054599|584321524|FG000|Overall Study|Spells/seizure-like episodes|1|||
161802968|NCT01054599|584321525|FG001|Overall Study|Spells/seizure-like episodes|1|||
161802969|NCT01054599|584321524|FG000|Overall Study|Timing/scheduling difficulties|1|||
161802970|NCT01054599|584321525|FG001|Overall Study|Timing/scheduling difficulties|1|||
161802971|NCT01054599|584321524|FG000|Overall Study|Visual impairment, WTAR <80|0|||
161802972|NCT01054599|584321525|FG001|Overall Study|Visual impairment, WTAR <80|1|||
161802973|NCT01054599|584321524|FG000|Overall Study|Lost to Follow-up|0|||
161802974|NCT01054599|584321525|FG001|Overall Study|Lost to Follow-up|2|||
161802975|NCT01054599|584321524|FG000|Overall Study|Adverse Event|0|||
161802976|NCT01054599|584321525|FG001|Overall Study|Adverse Event|1|||
161802977|NCT01054599|584321524|FG000|Overall Study|Withdrawal by Subject|0|||
161802978|NCT01054599|584321525|FG001|Overall Study|Withdrawal by Subject|1|||
161802979|NCT01104662|584321526|FG000|Overall Study|Adverse Event|2|||
161802980|NCT01104662|584321527|FG001|Overall Study|Adverse Event|2|||
161802981|NCT01104662|584321528|FG002|Overall Study|Adverse Event|0|||
161802982|NCT01104662|584321529|FG003|Overall Study|Adverse Event|1|||
161802983|NCT01104662|584321530|FG004|Overall Study|Adverse Event|1|||
161802984|NCT01104662|584321531|FG005|Overall Study|Adverse Event|1|||
161802985|NCT01104662|584321532|FG006|Overall Study|Adverse Event|0|||
161905922|NCT01496976|584704745|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
161905923|NCT00870727|584704746|FG000|Overall Study|Lost to Follow-up|0|||
161905924|NCT00870727|584704747|FG001|Overall Study|Lost to Follow-up|1|||
161905925|NCT00870727|584704746|FG000|Overall Study|Lack of Efficacy|1|||
161905926|NCT00870727|584704747|FG001|Overall Study|Lack of Efficacy|3|||
161905927|NCT00870727|584704746|FG000|Overall Study|Adverse Event|0|||
161905928|NCT00870727|584704747|FG001|Overall Study|Adverse Event|1|||
161905929|NCT01774981|584704761|FG000|Overall Study|Adverse Event|0|||
161905930|NCT01774981|584704762|FG001|Overall Study|Adverse Event|0|||
161905931|NCT01774981|584704763|FG002|Overall Study|Adverse Event|0|||
161905932|NCT01774981|584704764|FG003|Overall Study|Adverse Event|0|||
161905933|NCT01774981|584704765|FG004|Overall Study|Adverse Event|0|||
161905934|NCT01774981|584704766|FG005|Overall Study|Adverse Event|1|||
161905935|NCT01774981|584704767|FG006|Overall Study|Adverse Event|0|||
161905936|NCT01774981|584704768|FG007|Overall Study|Adverse Event|0|||
161905937|NCT01774981|584704761|FG000|Overall Study|Withdrawal by Subject|0|||
161905938|NCT01774981|584704762|FG001|Overall Study|Withdrawal by Subject|0|||
161905939|NCT01774981|584704763|FG002|Overall Study|Withdrawal by Subject|0|||
161905940|NCT01774981|584704764|FG003|Overall Study|Withdrawal by Subject|0|||
161905941|NCT01774981|584704765|FG004|Overall Study|Withdrawal by Subject|0|||
161905942|NCT01774981|584704766|FG005|Overall Study|Withdrawal by Subject|0|||
161905943|NCT01774981|584704767|FG006|Overall Study|Withdrawal by Subject|0|||
161905944|NCT01774981|584704768|FG007|Overall Study|Withdrawal by Subject|1|||
161905945|NCT01774981|584704761|FG000|Overall Study|Death|0|||
161905946|NCT01774981|584704762|FG001|Overall Study|Death|0|||
161905947|NCT01774981|584704763|FG002|Overall Study|Death|0|||
161905948|NCT01774981|584704764|FG003|Overall Study|Death|0|||
161905949|NCT01774981|584704765|FG004|Overall Study|Death|1|||
161905950|NCT01774981|584704766|FG005|Overall Study|Death|0|||
161905951|NCT01774981|584704767|FG006|Overall Study|Death|0|||
161905952|NCT01774981|584704768|FG007|Overall Study|Death|0|||
161905953|NCT00001566|584704771|FG000|Overall Study|patients' choice to discontinue protocol|3|||
161905954|NCT00001566|584704771|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
161905955|NCT00001566|584704771|FG000|Overall Study|Death|13|||
161905956|NCT00001566|584704771|FG000|Overall Study|Lost to Follow-up|1|||
161905957|NCT00001566|584704771|FG000|Overall Study|unable to complete initial apheresis|1|||
161905958|NCT02915835|584704772|FG000|Overall Study|Physician Decision|1|||
161905959|NCT02915835|584704773|FG001|Overall Study|Physician Decision|0|||
161905960|NCT02915835|584704772|FG000|Overall Study|Withdrawal by Subject|0|||
161453008|NCT00422084|583053552|FG000|Overall Study|Not defined|1|||
161802986|NCT01104662|584321533|FG007|Overall Study|Adverse Event|0|||
161802987|NCT01104662|584321526|FG000|Overall Study|Clinical Failure|1|||
161905961|NCT02915835|584704773|FG001|Overall Study|Withdrawal by Subject|1|||
161453009|NCT00422084|583053553|FG001|Overall Study|Not defined|1|||
161802988|NCT01104662|584321527|FG001|Overall Study|Clinical Failure|0|||
161905962|NCT00433836|584704774|FG000|Overall Study|Adverse Event|7|||
161905963|NCT00433836|584704775|FG001|Overall Study|Adverse Event|0|||
161905964|NCT00433836|584704774|FG000|Overall Study|Lost to Follow-up|3|||
161905965|NCT00433836|584704775|FG001|Overall Study|Lost to Follow-up|0|||
161905966|NCT00433836|584704774|FG000|Overall Study|Withdrawal by Subject|2|||
161453010|NCT03774823|583053554|FG000|Overall Study|Withdrawal by Subject|1|||
161453011|NCT03774823|583053555|FG001|Overall Study|Withdrawal by Subject|1|||
161453012|NCT03996369|583053564|FG000|Overall Study|Protocol deviation|1|||
161453013|NCT03996369|583053565|FG001|Overall Study|Protocol deviation|1|||
161453014|NCT03996369|583053564|FG000|Overall Study|Physician Decision|4|||
161453015|NCT03996369|583053565|FG001|Overall Study|Physician Decision|2|||
161453016|NCT03996369|583053564|FG000|Overall Study|Participant decision|0|||
161453017|NCT03996369|583053565|FG001|Overall Study|Participant decision|1|||
161453018|NCT03996369|583053564|FG000|Overall Study|Lack of Efficacy|4|||
161453019|NCT03996369|583053565|FG001|Overall Study|Lack of Efficacy|0|||
161453020|NCT03996369|583053564|FG000|Overall Study|Adverse Event|9|||
161453021|NCT03996369|583053565|FG001|Overall Study|Adverse Event|0|||
161453022|NCT03996369|583053564|FG000|Overall Study|Withdrawal by Subject|6|||
161453023|NCT03996369|583053565|FG001|Overall Study|Withdrawal by Subject|8|||
161453024|NCT03996369|583053564|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
161453025|NCT03996369|583053565|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
161453026|NCT03996369|583053564|FG000|Overall Study|Lost to Follow-up|0|||
161453027|NCT03996369|583053565|FG001|Overall Study|Lost to Follow-up|1|||
161802989|NCT01104662|584321528|FG002|Overall Study|Clinical Failure|0|||
161802990|NCT01104662|584321529|FG003|Overall Study|Clinical Failure|0|||
161802991|NCT01104662|584321530|FG004|Overall Study|Clinical Failure|0|||
161802992|NCT01104662|584321531|FG005|Overall Study|Clinical Failure|1|||
161802993|NCT01104662|584321532|FG006|Overall Study|Clinical Failure|0|||
161802994|NCT01104662|584321533|FG007|Overall Study|Clinical Failure|0|||
161802995|NCT01104662|584321526|FG000|Overall Study|Participant left investigator's care|1|||
161802996|NCT01104662|584321527|FG001|Overall Study|Participant left investigator's care|1|||
161802997|NCT01104662|584321528|FG002|Overall Study|Participant left investigator's care|0|||
161802998|NCT01104662|584321529|FG003|Overall Study|Participant left investigator's care|0|||
161802999|NCT01104662|584321530|FG004|Overall Study|Participant left investigator's care|0|||
161803000|NCT01104662|584321531|FG005|Overall Study|Participant left investigator's care|0|||
161803001|NCT01104662|584321532|FG006|Overall Study|Participant left investigator's care|0|||
161803002|NCT01104662|584321533|FG007|Overall Study|Participant left investigator's care|0|||
161803003|NCT01104662|584321526|FG000|Overall Study|Reason not specified|3|||
161803004|NCT01104662|584321527|FG001|Overall Study|Reason not specified|3|||
161803005|NCT01104662|584321528|FG002|Overall Study|Reason not specified|0|||
161803006|NCT01104662|584321529|FG003|Overall Study|Reason not specified|0|||
161803007|NCT01104662|584321530|FG004|Overall Study|Reason not specified|0|||
161803008|NCT01104662|584321531|FG005|Overall Study|Reason not specified|1|||
161803009|NCT01104662|584321532|FG006|Overall Study|Reason not specified|0|||
161803010|NCT01104662|584321533|FG007|Overall Study|Reason not specified|0|||
161803011|NCT01104662|584321526|FG000|Overall Study|Randomized but not treated|3|||
161803012|NCT01104662|584321527|FG001|Overall Study|Randomized but not treated|4|||
161803013|NCT01104662|584321528|FG002|Overall Study|Randomized but not treated|1|||
161803014|NCT01104662|584321529|FG003|Overall Study|Randomized but not treated|0|||
161803015|NCT01104662|584321530|FG004|Overall Study|Randomized but not treated|0|||
161803016|NCT01104662|584321531|FG005|Overall Study|Randomized but not treated|1|||
161803017|NCT01104662|584321532|FG006|Overall Study|Randomized but not treated|0|||
161803018|NCT01104662|584321533|FG007|Overall Study|Randomized but not treated|0|||
161803019|NCT01478620|584321534|FG000|Overall Study|Lost to Follow-up|6|||
161803020|NCT02888171|584321540|FG000|Overall Study|Lost to Follow-up|2|||
161803021|NCT02888171|584321541|FG001|Overall Study|Lost to Follow-up|1|||
161803022|NCT02888171|584321540|FG000|Overall Study|Withdrawal by Subject|3|||
161803023|NCT02888171|584321541|FG001|Overall Study|Withdrawal by Subject|2|||
161803024|NCT02888171|584321540|FG000|Overall Study|Adverse Event|0|||
161803025|NCT02888171|584321541|FG001|Overall Study|Adverse Event|1|||
161803026|NCT04188106|584323323|FG000|Overall Study|Lost to Follow-up|5|||
161803027|NCT04188106|584323323|FG000|Overall Study|Non-Compliance|1|||
161803028|NCT01101022|584323324|FG000|Overall Study|Adverse Event|6|||
161803029|NCT01101022|584323325|FG001|Overall Study|Adverse Event|2|||
161803030|NCT01101022|584323324|FG000|Overall Study|Protocol Violation|4|||
161803031|NCT01101022|584323325|FG001|Overall Study|Protocol Violation|3|||
161803032|NCT01101022|584323324|FG000|Overall Study|Withdrawal by Subject|3|||
161803033|NCT01101022|584323325|FG001|Overall Study|Withdrawal by Subject|8|||
161803034|NCT01101022|584323324|FG000|Overall Study|Lost to Follow-up|1|||
161803035|NCT01101022|584323325|FG001|Overall Study|Lost to Follow-up|4|||
161803036|NCT01101022|584323324|FG000|Overall Study|Lack of Efficacy|0|||
161803037|NCT01101022|584323325|FG001|Overall Study|Lack of Efficacy|7|||
161803038|NCT01101022|584323324|FG000|Overall Study|Sponsor decision|1|||
161803039|NCT01101022|584323325|FG001|Overall Study|Sponsor decision|1|||
161803040|NCT01101022|584323324|FG000|Overall Study|Non-compliance|1|||
161453028|NCT01579812|583053566|FG000|Overall Study|Ineligible after treatment start|40|||
161453029|NCT01579812|583053566|FG000|Overall Study|Patient choice|3|||
161453030|NCT01579812|583053566|FG000|Overall Study|Noncompliance|3|||
161668059|NCT00406653|583837481|FG005|Induction Period|Incarcerated|0|||
161803041|NCT01101022|584323325|FG001|Overall Study|Non-compliance|0|||
161803042|NCT01101022|584323324|FG000|Overall Study|Work schedule|1|||
161803043|NCT01101022|584323325|FG001|Overall Study|Work schedule|1|||
161803044|NCT01101022|584323324|FG000|Overall Study|Vacation|0|||
161803045|NCT01101022|584323325|FG001|Overall Study|Vacation|1|||
161803046|NCT03075761|584323326|FG000|Overall Study|Lost to Follow-up|1|||
161803047|NCT03075761|584323327|FG001|Overall Study|Lost to Follow-up|6|||
161803048|NCT01139047|584323328|FG000|Overall Study|Withdrawal by Subject|1|||
161803049|NCT00420303|584323333|FG000|Overall Study|Serious Adverse Event|1|||
161803050|NCT00420303|584323334|FG001|Overall Study|Serious Adverse Event|0|||
161803051|NCT00420303|584323333|FG000|Overall Study|Lack of Efficacy|0|||
161803052|NCT00420303|584323334|FG001|Overall Study|Lack of Efficacy|3|||
161803053|NCT00420303|584323333|FG000|Overall Study|Physician Decision|0|||
161803054|NCT00420303|584323334|FG001|Overall Study|Physician Decision|1|||
161803055|NCT04455633|584323336|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
161803056|NCT04455633|584323337|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
161803057|NCT04455633|584323338|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
161803058|NCT04455633|584323336|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
161803059|NCT04455633|584323337|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
161803060|NCT04455633|584323338|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
161803061|NCT04455633|584323336|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
161803062|NCT04455633|584323337|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
161803063|NCT04455633|584323338|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
161803064|NCT04455633|584323336|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
161803065|NCT04455633|584323337|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
161803066|NCT04455633|584323338|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
161803067|NCT01648166|584323339|FG000|Overall Study|inadequate toenail samples|53|||
161803068|NCT01648166|584323340|FG001|Overall Study|inadequate toenail samples|100|||
161803069|NCT00883090|584323341|FG000|Overall Study|Sponsor's decision|1|||
161803070|NCT00883090|584323341|FG000|Overall Study|Withdrawal by Subject|1|||
161803071|NCT01087970|584323344|FG000|Overall Study|Protocol Violation|2|||
161803072|NCT00849901|584323352|FG000|Acute Treatment Phase|Adverse Event|9|||
161803073|NCT00849901|584323353|FG001|Acute Treatment Phase|Adverse Event|1|||
161803074|NCT00849901|584323354|FG002|Acute Treatment Phase|Adverse Event|3|||
161803075|NCT00849901|584323352|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
161803076|NCT00849901|584323353|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
161803077|NCT00849901|584323354|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
161803078|NCT00849901|584323352|FG000|Acute Treatment Phase|Protocol Violation|0|||
161803079|NCT00849901|584323353|FG001|Acute Treatment Phase|Protocol Violation|2|||
161803080|NCT00849901|584323354|FG002|Acute Treatment Phase|Protocol Violation|1|||
161803081|NCT00849901|584323352|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
161803082|NCT00849901|584323353|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
161803083|NCT00849901|584323354|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
161803084|NCT00849901|584323352|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
161803085|NCT00849901|584323353|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
161803086|NCT00849901|584323354|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
161803087|NCT00849901|584323352|FG000|Acute Treatment Phase|Physician Decision|1|||
161803088|NCT00849901|584323353|FG001|Acute Treatment Phase|Physician Decision|1|||
161803089|NCT00849901|584323354|FG002|Acute Treatment Phase|Physician Decision|1|||
161803090|NCT00849901|584323352|FG000|Acute Treatment Phase|Sponsor Decision|1|||
161803091|NCT00849901|584323353|FG001|Acute Treatment Phase|Sponsor Decision|0|||
161803092|NCT00849901|584323354|FG002|Acute Treatment Phase|Sponsor Decision|0|||
161803093|NCT00849901|584323352|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
161803094|NCT00849901|584323353|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
161803095|NCT00849901|584323354|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
161803096|NCT00849901|584323352|FG000|Extension Phase|Adverse Event|2|||
161803097|NCT00849901|584323353|FG001|Extension Phase|Adverse Event|8|||
161803098|NCT00849901|584323354|FG002|Extension Phase|Adverse Event|4|||
161803099|NCT00849901|584323352|FG000|Extension Phase|Lost to Follow-up|3|||
161803100|NCT00849901|584323353|FG001|Extension Phase|Lost to Follow-up|0|||
161803101|NCT00849901|584323354|FG002|Extension Phase|Lost to Follow-up|1|||
161803102|NCT00849901|584323352|FG000|Extension Phase|Protocol Violation|2|||
161803103|NCT00849901|584323353|FG001|Extension Phase|Protocol Violation|2|||
161905967|NCT00433836|584704775|FG001|Overall Study|Withdrawal by Subject|1|||
161905968|NCT00433836|584704774|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161905969|NCT00433836|584704775|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161905970|NCT00433836|584704774|FG000|Overall Study|Protocol Violation|0|||
161905971|NCT00433836|584704775|FG001|Overall Study|Protocol Violation|2|||
161905972|NCT00433836|584704774|FG000|Overall Study|Condition no longer requires study drug|0|||
161905973|NCT00433836|584704775|FG001|Overall Study|Condition no longer requires study drug|1|||
161905974|NCT00433836|584704774|FG000|Overall Study|Abnormal laboratory values|0|||
161905975|NCT00433836|584704775|FG001|Overall Study|Abnormal laboratory values|1|||
161905976|NCT00113607|584704776|FG000|Overall Study|Adverse Event|40|||
161905977|NCT00113607|584704777|FG001|Overall Study|Adverse Event|71|||
161803104|NCT00849901|584323354|FG002|Extension Phase|Protocol Violation|4|||
161803105|NCT00849901|584323352|FG000|Extension Phase|Withdrawal by Subject|7|||
161905978|NCT00113607|584704776|FG000|Overall Study|Death|8|||
161905979|NCT00113607|584704777|FG001|Overall Study|Death|8|||
161905980|NCT00113607|584704776|FG000|Overall Study|Withdrawal by Subject|50|||
161905981|NCT00113607|584704777|FG001|Overall Study|Withdrawal by Subject|58|||
161905982|NCT00113607|584704776|FG000|Overall Study|Lost to Follow-up|0|||
161905983|NCT00113607|584704777|FG001|Overall Study|Lost to Follow-up|2|||
161905984|NCT00113607|584704776|FG000|Overall Study|Disease Progression|180|||
161905985|NCT00113607|584704777|FG001|Overall Study|Disease Progression|142|||
161905986|NCT00113607|584704776|FG000|Overall Study|Complete Response (Confirmed)|14|||
161905987|NCT00113607|584704777|FG001|Overall Study|Complete Response (Confirmed)|24|||
161905988|NCT00113607|584704776|FG000|Overall Study|Other|43|||
161905989|NCT00113607|584704777|FG001|Overall Study|Other|32|||
161905990|NCT03669549|584704778|FG000|Overall Study|Adverse Event|4|||
161905991|NCT03669549|584704778|FG000|Overall Study|Withdrawal by Subject|1|||
161905992|NCT03669549|584704778|FG000|Overall Study|Study terminated by the Sponsor|1|||
161905993|NCT00909844|584704779|FG000|Overall Study|Adverse Event|1|||
161905994|NCT00909844|584704779|FG000|Overall Study|Withdrawal by Subject|1|||
161905995|NCT00909844|584704779|FG000|Overall Study|Lost to Follow-up|2|||
161905996|NCT00706004|584704780|FG000|Overall Study|Did not meet eligibility criteria|2|||
161905997|NCT02674516|584704781|FG000|Overall Study|Lost to Follow-up|3|||
161905998|NCT02674516|584704782|FG001|Overall Study|Lost to Follow-up|0|||
161905999|NCT02674516|584704781|FG000|Overall Study|Protocol Violation|0|||
161906000|NCT02674516|584704782|FG001|Overall Study|Protocol Violation|4|||
161906001|NCT02674516|584704781|FG000|Overall Study|Knowledge of study hypothesis|1|||
161906002|NCT02674516|584704782|FG001|Overall Study|Knowledge of study hypothesis|0|||
161906003|NCT01064479|584704783|FG000|Overall Study|Death|10|||
161906004|NCT01064479|584704784|FG001|Overall Study|Death|11|||
161906005|NCT01064479|584704783|FG000|Overall Study|Withdrawal by Subject|2|||
161906006|NCT01064479|584704784|FG001|Overall Study|Withdrawal by Subject|2|||
161906007|NCT01064479|584704783|FG000|Overall Study|Disease progression|1|||
161906008|NCT01064479|584704784|FG001|Overall Study|Disease progression|1|||
161906009|NCT01064479|584704783|FG000|Overall Study|Toxicity|1|||
161906010|NCT01064479|584704784|FG001|Overall Study|Toxicity|1|||
161906011|NCT01064479|584704783|FG000|Overall Study|Other|1|||
161906012|NCT01064479|584704784|FG001|Overall Study|Other|2|||
161906013|NCT05696392|584704790|FG000|Overall Study|Lost to Follow-up|3|||
161906014|NCT05696392|584704790|FG000|Overall Study|Protocol Violation|1|||
161906015|NCT05696392|584704790|FG000|Overall Study|Withdrawal by Subject|1|||
161906016|NCT04464707|584704794|FG000|Overall Study|Adverse Event|1|||
161906017|NCT04464707|584704795|FG001|Overall Study|Adverse Event|0|||
161906018|NCT04464707|584704796|FG002|Overall Study|Adverse Event|0|||
161906019|NCT04464707|584704794|FG000|Overall Study|Withdrawal by Subject|0|||
161906020|NCT04464707|584704795|FG001|Overall Study|Withdrawal by Subject|0|||
161906021|NCT04464707|584704796|FG002|Overall Study|Withdrawal by Subject|2|||
161906022|NCT04464707|584704794|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161906023|NCT04464707|584704795|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161906024|NCT04464707|584704796|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161906025|NCT04464707|584704794|FG000|Overall Study|Protocol Deviation|1|||
161906026|NCT04464707|584704795|FG001|Overall Study|Protocol Deviation|0|||
161906027|NCT04464707|584704796|FG002|Overall Study|Protocol Deviation|0|||
161906028|NCT04464707|584704794|FG000|Overall Study|Lost to Follow-up|2|||
161906029|NCT04464707|584704795|FG001|Overall Study|Lost to Follow-up|0|||
161906030|NCT04464707|584704796|FG002|Overall Study|Lost to Follow-up|1|||
161906031|NCT04831138|584704797|FG000|Overall Study|Lost to Follow-up|2|||
161906032|NCT04831138|584704798|FG001|Overall Study|Lost to Follow-up|0|||
161906033|NCT04202497|584704806|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
161906034|NCT04202497|584704807|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161906035|NCT04202497|584704808|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161906036|NCT04202497|584704809|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161906037|NCT05590377|584704812|FG000|Overall Study|Death|1|||
161906038|NCT05590377|584704813|FG001|Overall Study|Death|1|||
161906039|NCT05590377|584704814|FG002|Overall Study|Death|2|||
161906040|NCT05590377|584704815|FG003|Overall Study|Death|0|||
161906041|NCT05590377|584704816|FG004|Overall Study|Death|0|||
161906042|NCT05590377|584704812|FG000|Overall Study|Study Terminated by Sponsor|1|||
161906043|NCT05590377|584704813|FG001|Overall Study|Study Terminated by Sponsor|5|||
161906044|NCT05590377|584704814|FG002|Overall Study|Study Terminated by Sponsor|4|||
161906045|NCT05590377|584704815|FG003|Overall Study|Study Terminated by Sponsor|0|||
161906046|NCT05590377|584704816|FG004|Overall Study|Study Terminated by Sponsor|0|||
161906047|NCT05590377|584704812|FG000|Overall Study|Withdrawal by Subject|1|||
161906048|NCT05590377|584704813|FG001|Overall Study|Withdrawal by Subject|0|||
161906049|NCT05590377|584704814|FG002|Overall Study|Withdrawal by Subject|0|||
161906050|NCT05590377|584704815|FG003|Overall Study|Withdrawal by Subject|0|||
161906051|NCT05590377|584704816|FG004|Overall Study|Withdrawal by Subject|0|||
161906052|NCT03389620|584704817|FG000|Overall Study|Lost to Follow-up|5|||
161906053|NCT03389620|584704818|FG001|Overall Study|Lost to Follow-up|1|||
161906054|NCT04782180|584704825|FG000|Overall Study|Withdrawal by Subject|2|||
161906055|NCT04782180|584704825|FG000|Overall Study|Lost to Follow-up|2|||
161906056|NCT05852353|584704826|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
161906057|NCT05852353|584704826|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
161906058|NCT05852353|584704826|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
161906059|NCT05852353|584704826|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
161906060|NCT01005745|584704827|FG000|Overall Study|No TIL growth|1|||
161906061|NCT01005745|584704827|FG000|Overall Study|Disease progressed during TIL growth|3|||
161906062|NCT01005745|584704827|FG000|Overall Study|Death prior to treatment|1|||
161906063|NCT01005745|584704827|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
161906064|NCT06077773|584704828|FG000|Overall Study|Withdrawal by Subject|1|||
161906065|NCT06077773|584704829|FG001|Overall Study|Withdrawal by Subject|0|||
161906066|NCT06077773|584704830|FG002|Overall Study|Withdrawal by Subject|1|||
161906067|NCT06077773|584704828|FG000|Overall Study|Lost to Follow-up|0|||
161906068|NCT06077773|584704829|FG001|Overall Study|Lost to Follow-up|1|||
161906069|NCT06077773|584704830|FG002|Overall Study|Lost to Follow-up|0|||
161803106|NCT00849901|584323353|FG001|Extension Phase|Withdrawal by Subject|6|||
161803107|NCT00849901|584323354|FG002|Extension Phase|Withdrawal by Subject|3|||
161803108|NCT00849901|584323352|FG000|Extension Phase|Parent or Caregiver Decision|10|||
161803109|NCT00849901|584323353|FG001|Extension Phase|Parent or Caregiver Decision|4|||
161803110|NCT00849901|584323354|FG002|Extension Phase|Parent or Caregiver Decision|4|||
161803111|NCT00849901|584323352|FG000|Extension Phase|Physician Decision|1|||
161803112|NCT00849901|584323353|FG001|Extension Phase|Physician Decision|2|||
161803113|NCT00849901|584323354|FG002|Extension Phase|Physician Decision|0|||
161803114|NCT00849901|584323352|FG000|Extension Phase|Lack of Efficacy|2|||
161803115|NCT00849901|584323353|FG001|Extension Phase|Lack of Efficacy|4|||
161803116|NCT00849901|584323354|FG002|Extension Phase|Lack of Efficacy|1|||
161803117|NCT00262223|584323355|FG000|Treatment Phase|Withdrawal by Subject|3|||
161803118|NCT00262223|584323356|FG001|Treatment Phase|Withdrawal by Subject|6|||
161803119|NCT00262223|584323355|FG000|Treatment Phase|Adverse Event|1|||
161803120|NCT00262223|584323356|FG001|Treatment Phase|Adverse Event|2|||
161803121|NCT00262223|584323355|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
161803122|NCT00262223|584323356|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
161803123|NCT00262223|584323355|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
161803124|NCT00262223|584323356|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
161803125|NCT00262223|584323355|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
161803126|NCT00262223|584323356|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
161803127|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
161803128|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
161803129|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
161803130|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
161803131|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
161803132|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
161803133|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
161803134|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
161803135|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
161803136|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
161803137|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
161803138|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
161803139|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
161803140|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
161803141|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
161803142|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
161803143|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
161803144|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
161803145|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
161803146|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
161803147|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
161803148|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
161803149|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
161803150|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
161803151|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
161803152|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
161803153|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
161803154|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
161803155|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
161803156|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
161803157|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
161803158|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
161803159|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
161803160|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
161803161|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
161906070|NCT06077773|584704828|FG000|Overall Study|Adverse Event|0|||
161906071|NCT06077773|584704829|FG001|Overall Study|Adverse Event|0|||
161906072|NCT06077773|584704830|FG002|Overall Study|Adverse Event|2|||
161906073|NCT03834506|584704831|FG000|Overall Study|Death|336|||
161906074|NCT03834506|584704832|FG001|Overall Study|Death|326|||
161906075|NCT03834506|584704831|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161906076|NCT03834506|584704832|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161906077|NCT03834506|584704831|FG000|Overall Study|Withdrawal by Subject|10|||
161906078|NCT03834506|584704832|FG001|Overall Study|Withdrawal by Subject|8|||
161906079|NCT03834506|584704831|FG000|Overall Study|Sponsor decision|165|||
161906080|NCT03834506|584704832|FG001|Overall Study|Sponsor decision|178|||
161906081|NCT03834506|584704831|FG000|Overall Study|Physician Decision|3|||
161906082|NCT03834506|584704832|FG001|Overall Study|Physician Decision|1|||
161906083|NCT03834506|584704831|FG000|Overall Study|Lost to Follow-up|0|||
161906084|NCT03834506|584704832|FG001|Overall Study|Lost to Follow-up|1|||
161906085|NCT04577794|584704833|FG000|Overall Study|Adverse Event|1|||
161906086|NCT04577794|584704834|FG001|Overall Study|Adverse Event|1|||
161906087|NCT01619878|584704837|FG000|6 Week Follow-up Phase|Adverse Event|1|||
161906088|NCT01619878|584704837|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
161906089|NCT01619878|584704837|FG000|Follow-up at 12 Months of Age|Death|2|||
161906090|NCT01883895|584704838|FG000|Overall Study|Lost to Follow-up|2|||
161906091|NCT04414787|584704839|FG000|Overall Study|Patient Death|18|||
161906092|NCT04414787|584704840|FG001|Overall Study|Patient Death|18|||
161906093|NCT04414787|584704841|FG002|Overall Study|Patient Death|15|||
161906094|NCT04414787|584704842|FG003|Overall Study|Patient Death|15|||
161906095|NCT04414787|584704839|FG000|Overall Study|Patient Hospitalization|1|||
161906096|NCT04414787|584704840|FG001|Overall Study|Patient Hospitalization|1|||
161906097|NCT04414787|584704841|FG002|Overall Study|Patient Hospitalization|2|||
161906098|NCT04414787|584704842|FG003|Overall Study|Patient Hospitalization|2|||
161561166|NCT03532178|583442048|FG001|First Period|technical issues in data collection Technical issues|1|||
161561167|NCT03532178|583442047|FG000|Second Period|Withdrawal by Subject|1|||
161561168|NCT03532178|583442048|FG001|Second Period|Withdrawal by Subject|1|||
161561169|NCT03532178|583442047|FG000|Second Period|Technical issues|0|||
161906099|NCT04414787|584704839|FG000|Overall Study|Lost to Follow-up|7|||
161803162|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
161906100|NCT04414787|584704840|FG001|Overall Study|Lost to Follow-up|7|||
161906101|NCT04414787|584704841|FG002|Overall Study|Lost to Follow-up|5|||
161906102|NCT04414787|584704842|FG003|Overall Study|Lost to Follow-up|5|||
161906103|NCT04414787|584704839|FG000|Overall Study|Residence in post-acute care facility|3|||
161906104|NCT04414787|584704840|FG001|Overall Study|Residence in post-acute care facility|3|||
161906105|NCT04414787|584704841|FG002|Overall Study|Residence in post-acute care facility|5|||
161906106|NCT04414787|584704842|FG003|Overall Study|Residence in post-acute care facility|5|||
161906107|NCT05093933|584704843|FG000|Overall Study|Death|372|||
161906108|NCT05093933|584704844|FG001|Overall Study|Death|434|||
161906109|NCT05093933|584704843|FG000|Overall Study|Lost to Follow-up|13|||
161906110|NCT05093933|584704844|FG001|Overall Study|Lost to Follow-up|16|||
161906111|NCT05093933|584704843|FG000|Overall Study|Physician Decision|0|||
161906112|NCT05093933|584704844|FG001|Overall Study|Physician Decision|2|||
161803163|NCT01866319|584323360|FG000|Overall Study|Adverse Event|12|||
161803164|NCT01866319|584323361|FG001|Overall Study|Adverse Event|5|||
161803165|NCT01866319|584323362|FG002|Overall Study|Adverse Event|9|||
161803166|NCT01866319|584323360|FG000|Overall Study|Clinical progression|3|||
161803167|NCT01866319|584323361|FG001|Overall Study|Clinical progression|2|||
161803168|NCT01866319|584323362|FG002|Overall Study|Clinical progression|2|||
161803169|NCT01866319|584323360|FG000|Overall Study|Death|153|||
161803170|NCT01866319|584323361|FG001|Overall Study|Death|154|||
161803171|NCT01866319|584323362|FG002|Overall Study|Death|147|||
161803172|NCT01866319|584323360|FG000|Overall Study|Lost to Follow-up|6|||
161803173|NCT01866319|584323361|FG001|Overall Study|Lost to Follow-up|3|||
161803174|NCT01866319|584323362|FG002|Overall Study|Lost to Follow-up|8|||
161803175|NCT01866319|584323360|FG000|Overall Study|Physician Decision|1|||
161803176|NCT01866319|584323361|FG001|Overall Study|Physician Decision|0|||
161803177|NCT01866319|584323362|FG002|Overall Study|Physician Decision|1|||
161803178|NCT01866319|584323360|FG000|Overall Study|Protocol Violation|0|||
161803179|NCT01866319|584323361|FG001|Overall Study|Protocol Violation|0|||
161803180|NCT01866319|584323362|FG002|Overall Study|Protocol Violation|1|||
161803181|NCT01866319|584323360|FG000|Overall Study|Withdrawal by Subject|32|||
161803182|NCT01866319|584323361|FG001|Overall Study|Withdrawal by Subject|14|||
161803183|NCT01866319|584323362|FG002|Overall Study|Withdrawal by Subject|12|||
161803184|NCT03980483|584323363|FG000|Overall Study|Adverse Event|13|||
161803185|NCT03980483|584323364|FG001|Overall Study|Adverse Event|29|||
161803186|NCT03980483|584323365|FG002|Overall Study|Adverse Event|11|||
161803187|NCT03980483|584323366|FG003|Overall Study|Adverse Event|2|||
161803188|NCT03980483|584323367|FG004|Overall Study|Adverse Event|2|||
161803189|NCT03980483|584323368|FG005|Overall Study|Adverse Event|2|||
161803190|NCT03980483|584323363|FG000|Overall Study|Lack of Efficacy|7|||
161803191|NCT03980483|584323364|FG001|Overall Study|Lack of Efficacy|6|||
161906113|NCT05093933|584704843|FG000|Overall Study|Sponsor Decision|1|||
161906114|NCT05093933|584704844|FG001|Overall Study|Sponsor Decision|3|||
161906115|NCT05093933|584704843|FG000|Overall Study|Withdrawal by Guardian|1|||
161906116|NCT05093933|584704844|FG001|Overall Study|Withdrawal by Guardian|1|||
161906117|NCT05093933|584704843|FG000|Overall Study|Withdrawal by Subject|18|||
161906118|NCT05093933|584704844|FG001|Overall Study|Withdrawal by Subject|25|||
161906119|NCT05069259|584704848|FG000|Overall Study|Withdrawal by Subject|1|||
161906120|NCT05069259|584704848|FG000|Overall Study|Sponsor decision|1|||
161906121|NCT00922636|584706241|FG000|Overall Study|Adverse Event|3|||
161906122|NCT00922636|584706242|FG001|Overall Study|Adverse Event|3|||
161906123|NCT00922636|584706243|FG002|Overall Study|Adverse Event|2|||
161906124|NCT00922636|584706244|FG003|Overall Study|Adverse Event|3|||
161906125|NCT00922636|584706245|FG004|Overall Study|Adverse Event|2|||
161906126|NCT00922636|584706241|FG000|Overall Study|Lack of Efficacy|1|||
161906127|NCT00922636|584706242|FG001|Overall Study|Lack of Efficacy|7|||
161906128|NCT00922636|584706243|FG002|Overall Study|Lack of Efficacy|3|||
161906129|NCT00922636|584706244|FG003|Overall Study|Lack of Efficacy|2|||
161906130|NCT00922636|584706245|FG004|Overall Study|Lack of Efficacy|4|||
161906131|NCT00922636|584706241|FG000|Overall Study|Sponsor Decision|0|||
161906132|NCT00922636|584706242|FG001|Overall Study|Sponsor Decision|0|||
161906133|NCT00922636|584706243|FG002|Overall Study|Sponsor Decision|2|||
161906134|NCT00922636|584706244|FG003|Overall Study|Sponsor Decision|0|||
161906135|NCT00922636|584706245|FG004|Overall Study|Sponsor Decision|0|||
161906136|NCT00922636|584706241|FG000|Overall Study|Withdrawal by Subject|0|||
161906137|NCT00922636|584706242|FG001|Overall Study|Withdrawal by Subject|0|||
161906138|NCT00922636|584706243|FG002|Overall Study|Withdrawal by Subject|5|||
161906139|NCT00922636|584706244|FG003|Overall Study|Withdrawal by Subject|2|||
161906140|NCT00922636|584706245|FG004|Overall Study|Withdrawal by Subject|4|||
161906141|NCT00922636|584706241|FG000|Overall Study|Protocol Violation|0|||
161906142|NCT00922636|584706242|FG001|Overall Study|Protocol Violation|0|||
161906143|NCT00922636|584706243|FG002|Overall Study|Protocol Violation|2|||
161906144|NCT00922636|584706244|FG003|Overall Study|Protocol Violation|2|||
161906145|NCT00922636|584706245|FG004|Overall Study|Protocol Violation|0|||
161906146|NCT00922636|584706241|FG000|Overall Study|Entry Criteria Not Met|0|||
161906147|NCT00922636|584706242|FG001|Overall Study|Entry Criteria Not Met|0|||
161906148|NCT00922636|584706243|FG002|Overall Study|Entry Criteria Not Met|1|||
161906149|NCT00922636|584706244|FG003|Overall Study|Entry Criteria Not Met|1|||
161906150|NCT00922636|584706245|FG004|Overall Study|Entry Criteria Not Met|0|||
161906151|NCT00922636|584706241|FG000|Overall Study|Parent/Caregiver Decision|2|||
161906152|NCT00922636|584706242|FG001|Overall Study|Parent/Caregiver Decision|4|||
161906153|NCT00922636|584706243|FG002|Overall Study|Parent/Caregiver Decision|3|||
161906154|NCT00922636|584706244|FG003|Overall Study|Parent/Caregiver Decision|5|||
161906155|NCT00922636|584706245|FG004|Overall Study|Parent/Caregiver Decision|2|||
161906156|NCT00922636|584706241|FG000|Overall Study|Lost to Follow-up|1|||
161906157|NCT00922636|584706242|FG001|Overall Study|Lost to Follow-up|2|||
161906158|NCT00922636|584706243|FG002|Overall Study|Lost to Follow-up|2|||
161906159|NCT00922636|584706244|FG003|Overall Study|Lost to Follow-up|2|||
161906160|NCT00922636|584706245|FG004|Overall Study|Lost to Follow-up|4|||
161906161|NCT01117870|584706246|FG000|Overall Study|Inability to place needle|1|||
161906162|NCT01117870|584706247|FG001|Overall Study|Inability to place needle|0|||
161906163|NCT01309386|584706248|FG000|Overall Study|Other|2|||
161906164|NCT01309386|584706249|FG001|Overall Study|Other|0|||
161906165|NCT01309386|584706248|FG000|Overall Study|Withdrawal by Subject|2|||
161906166|NCT01309386|584706249|FG001|Overall Study|Withdrawal by Subject|0|||
161906167|NCT01309386|584706248|FG000|Overall Study|Progressive disease|9|||
161906168|NCT01309386|584706249|FG001|Overall Study|Progressive disease|11|||
161906169|NCT01309386|584706248|FG000|Overall Study|Physician Decision|1|||
161906170|NCT01309386|584706249|FG001|Overall Study|Physician Decision|1|||
161906171|NCT01309386|584706248|FG000|Overall Study|Lack of Efficacy|3|||
161906172|NCT01309386|584706249|FG001|Overall Study|Lack of Efficacy|1|||
161906173|NCT01309386|584706248|FG000|Overall Study|Adverse Event|5|||
161906174|NCT01309386|584706249|FG001|Overall Study|Adverse Event|8|||
161906175|NCT02456727|584706250|FG000|Overall Study|Lost to Follow-up|63|||
161906176|NCT02456727|584706251|FG001|Overall Study|Lost to Follow-up|65|||
161906177|NCT02456727|584706250|FG000|Overall Study|Death|2|||
161906178|NCT02456727|584706251|FG001|Overall Study|Death|1|||
161906179|NCT02456727|584706250|FG000|Overall Study|Withdrawal by Subject|1|||
161906180|NCT02456727|584706251|FG001|Overall Study|Withdrawal by Subject|10|||
161906181|NCT02456727|584706250|FG000|Overall Study|Never Initiated Treatment|43|||
161906182|NCT02456727|584706251|FG001|Overall Study|Never Initiated Treatment|30|||
161906183|NCT03885908|584706252|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
161906184|NCT03885908|584706253|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
161906185|NCT03885908|584706252|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
161906186|NCT03885908|584706253|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
161906187|NCT03885908|584706252|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
161906188|NCT03885908|584706253|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
161906189|NCT03885908|584706252|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
161906190|NCT03885908|584706253|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
161906191|NCT02974868|584706254|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
161906192|NCT02974868|584706255|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
161906193|NCT02974868|584706256|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
161906194|NCT02974868|584706257|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
161906195|NCT02974868|584706254|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
161906196|NCT02974868|584706255|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
161906197|NCT02974868|584706256|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
161906198|NCT02974868|584706257|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
161906199|NCT02974868|584706254|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
161906200|NCT02974868|584706255|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
161906201|NCT02974868|584706256|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
161906202|NCT02974868|584706257|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
161906203|NCT02974868|584706254|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
161906204|NCT02974868|584706255|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
161906205|NCT02974868|584706256|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
161906206|NCT02974868|584706257|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
161906207|NCT00749398|584706258|FG000|Overall Study|Lack of Efficacy|7|||
161906208|NCT00749398|584706258|FG000|Overall Study|Adverse Event|4|||
161906209|NCT00749398|584706258|FG000|Overall Study|Serious adverse event|11|||
161906210|NCT00749398|584706258|FG000|Overall Study|Withdrawal by Subject|17|||
161906211|NCT00749398|584706258|FG000|Overall Study|Lost to Follow-up|11|||
161906212|NCT00749398|584706258|FG000|Overall Study|Reason not specified|2|||
161906213|NCT00749398|584706258|FG000|Overall Study|Unknown reason|1|||
161906214|NCT01663402|584706259|FG000|Overall Study|Randomized but not treated|19|||
161906215|NCT01663402|584706260|FG001|Overall Study|Randomized but not treated|11|||
161906216|NCT01663402|584706259|FG000|Overall Study|Adverse Event|347|||
161906217|NCT01663402|584706260|FG001|Overall Study|Adverse Event|362|||
161906218|NCT01663402|584706259|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
161906219|NCT01663402|584706260|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
161906220|NCT01663402|584706259|FG000|Overall Study|Poor compliance to protocol|529|||
161906221|NCT01663402|584706260|FG001|Overall Study|Poor compliance to protocol|454|||
161906222|NCT01663402|584706259|FG000|Overall Study|Physician Decision|77|||
161906223|NCT01663402|584706260|FG001|Overall Study|Physician Decision|62|||
161906224|NCT01663402|584706259|FG000|Overall Study|Site terminated by sponsor|1|||
161906225|NCT01663402|584706260|FG001|Overall Study|Site terminated by sponsor|3|||
161906226|NCT01663402|584706259|FG000|Overall Study|Participant moved|139|||
161906227|NCT01663402|584706260|FG001|Overall Study|Participant moved|104|||
161906228|NCT01663402|584706259|FG000|Overall Study|Withdrawal by Subject|118|||
161906229|NCT01663402|584706260|FG001|Overall Study|Withdrawal by Subject|91|||
161906230|NCT01663402|584706259|FG000|Overall Study|Related to study drug administration|96|||
161906231|NCT01663402|584706260|FG001|Overall Study|Related to study drug administration|105|||
161906232|NCT01663402|584706259|FG000|Overall Study|Lost to Follow-up|17|||
161906233|NCT01663402|584706260|FG001|Overall Study|Lost to Follow-up|15|||
161906234|NCT01663402|584706259|FG000|Overall Study|Other than specified above|172|||
161906235|NCT01663402|584706260|FG001|Overall Study|Other than specified above|147|||
161906236|NCT05953363|584706263|FG000|Overall Study|Screen Failure|2|||
161906237|NCT05953363|584706263|FG000|Overall Study|Withdrawal by Subject|3|||
161906238|NCT05953363|584706263|FG000|Overall Study|Surgery cancelled|2|||
161906239|NCT05953363|584706263|FG000|Overall Study|Adverse Event|1|||
161906240|NCT01701674|584706264|FG000|Overall Study|Unable to safely complete treatment|1|||
161906241|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161906242|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
161906243|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161906244|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161906245|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Adverse Event|0|||
161906246|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Adverse Event|1|||
161906247|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
161906248|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
161906249|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
161906250|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
161906251|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
161906252|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
161906253|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Other Reasons|2|||
161906254|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Other Reasons|0|||
161906255|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Other Reasons|0|||
161906256|NCT04613518|584706269|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
161906257|NCT04613518|584706270|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
161906258|NCT04613518|584706271|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161906259|NCT04613518|584706269|FG000|Open-Label Treatment Period|Adverse Event|1|||
161906260|NCT04613518|584706270|FG001|Open-Label Treatment Period|Adverse Event|0|||
161906261|NCT04613518|584706271|FG002|Open-Label Treatment Period|Adverse Event|3|||
161906262|NCT04613518|584706269|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
161906263|NCT04613518|584706270|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
161906264|NCT04613518|584706271|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
161906265|NCT04613518|584706269|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
161906266|NCT04613518|584706270|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
161906267|NCT04613518|584706271|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
161906268|NCT04613518|584706269|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
161906269|NCT04613518|584706270|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
161906270|NCT04613518|584706271|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
161906271|NCT04613518|584706269|FG000|Open-Label Treatment Period|Other reasons|1|||
161906272|NCT04613518|584706270|FG001|Open-Label Treatment Period|Other reasons|0|||
161906273|NCT04613518|584706271|FG002|Open-Label Treatment Period|Other reasons|0|||
161906274|NCT03509467|584706272|FG000|Overall Study|Withdrawal by Subject|5|||
161906275|NCT03509467|584706273|FG001|Overall Study|Withdrawal by Subject|1|||
161906276|NCT03509467|584706274|FG002|Overall Study|Withdrawal by Subject|6|||
161906277|NCT03509467|584706275|FG003|Overall Study|Withdrawal by Subject|7|||
161906278|NCT03509467|584706276|FG004|Overall Study|Withdrawal by Subject|10|||
161906279|NCT03509467|584706277|FG005|Overall Study|Withdrawal by Subject|10|||
161906280|NCT03509467|584706278|FG006|Overall Study|Withdrawal by Subject|10|||
161906281|NCT03509467|584706279|FG007|Overall Study|Withdrawal by Subject|10|||
161906282|NCT03509467|584706272|FG000|Overall Study|Death|0|||
161906283|NCT03509467|584706273|FG001|Overall Study|Death|0|||
161803192|NCT03980483|584323365|FG002|Overall Study|Lack of Efficacy|0|||
161803193|NCT03980483|584323366|FG003|Overall Study|Lack of Efficacy|3|||
161803194|NCT03980483|584323367|FG004|Overall Study|Lack of Efficacy|1|||
161803195|NCT03980483|584323368|FG005|Overall Study|Lack of Efficacy|1|||
161803196|NCT03980483|584323363|FG000|Overall Study|Lost to Follow-up|2|||
161803197|NCT03980483|584323364|FG001|Overall Study|Lost to Follow-up|4|||
161803198|NCT03980483|584323365|FG002|Overall Study|Lost to Follow-up|2|||
161803199|NCT03980483|584323366|FG003|Overall Study|Lost to Follow-up|1|||
161803200|NCT03980483|584323367|FG004|Overall Study|Lost to Follow-up|2|||
161803201|NCT03980483|584323368|FG005|Overall Study|Lost to Follow-up|0|||
161803202|NCT03980483|584323363|FG000|Overall Study|Protocol Violation|4|||
161803203|NCT03980483|584323364|FG001|Overall Study|Protocol Violation|2|||
161803204|NCT03980483|584323365|FG002|Overall Study|Protocol Violation|1|||
161803205|NCT03980483|584323366|FG003|Overall Study|Protocol Violation|1|||
161803206|NCT03980483|584323367|FG004|Overall Study|Protocol Violation|0|||
161803207|NCT03980483|584323368|FG005|Overall Study|Protocol Violation|0|||
161803208|NCT03980483|584323363|FG000|Overall Study|Physician Decision|14|||
161803209|NCT03980483|584323364|FG001|Overall Study|Physician Decision|10|||
161803210|NCT03980483|584323365|FG002|Overall Study|Physician Decision|7|||
161803211|NCT03980483|584323366|FG003|Overall Study|Physician Decision|4|||
161803212|NCT03980483|584323367|FG004|Overall Study|Physician Decision|4|||
161803213|NCT03980483|584323368|FG005|Overall Study|Physician Decision|2|||
161803214|NCT03980483|584323363|FG000|Overall Study|Withdrawal by Subject|38|||
161803215|NCT03980483|584323364|FG001|Overall Study|Withdrawal by Subject|21|||
161803216|NCT03980483|584323365|FG002|Overall Study|Withdrawal by Subject|15|||
161803217|NCT03980483|584323366|FG003|Overall Study|Withdrawal by Subject|5|||
161803218|NCT03980483|584323367|FG004|Overall Study|Withdrawal by Subject|3|||
161803219|NCT03980483|584323368|FG005|Overall Study|Withdrawal by Subject|4|||
161803220|NCT03980483|584323363|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
161906284|NCT03509467|584706274|FG002|Overall Study|Death|2|||
161906285|NCT03509467|584706275|FG003|Overall Study|Death|2|||
161906286|NCT03509467|584706276|FG004|Overall Study|Death|1|||
161906287|NCT03509467|584706277|FG005|Overall Study|Death|0|||
161906288|NCT03509467|584706278|FG006|Overall Study|Death|1|||
161906289|NCT03509467|584706279|FG007|Overall Study|Death|0|||
161906290|NCT03509467|584706272|FG000|Overall Study|Proxy Withdrawal|0|||
161906291|NCT03509467|584706273|FG001|Overall Study|Proxy Withdrawal|0|||
161906292|NCT03509467|584706274|FG002|Overall Study|Proxy Withdrawal|0|||
161906293|NCT03509467|584706275|FG003|Overall Study|Proxy Withdrawal|0|||
161906294|NCT03509467|584706276|FG004|Overall Study|Proxy Withdrawal|0|||
161906295|NCT03509467|584706277|FG005|Overall Study|Proxy Withdrawal|0|||
161906296|NCT03509467|584706278|FG006|Overall Study|Proxy Withdrawal|0|||
161906297|NCT03509467|584706279|FG007|Overall Study|Proxy Withdrawal|1|||
161906298|NCT04275973|584706282|FG000|Overall Study|Withdrawal by Subject|2|||
161906299|NCT04275973|584706283|FG001|Overall Study|Withdrawal by Subject|1|||
161906300|NCT06110754|584706284|FG000|Overall Study|Withdrawal by Subject|0|||
161906301|NCT06110754|584706285|FG001|Overall Study|Withdrawal by Subject|0|||
161906302|NCT06110754|584706286|FG002|Overall Study|Withdrawal by Subject|1|||
161803221|NCT03980483|584323364|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161803222|NCT03980483|584323365|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161803223|NCT03980483|584323366|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161803224|NCT03980483|584323367|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161906303|NCT06110754|584706287|FG003|Overall Study|Withdrawal by Subject|0|||
161906304|NCT02499146|584706290|FG000|Overall Study|Global deterioration of health status|1|||
161906305|NCT02499146|584706290|FG000|Overall Study|Objective progression or relapse|20|||
161906306|NCT02499146|584706290|FG000|Overall Study|Other|2|||
161906307|NCT02499146|584706290|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
161906308|NCT04325828|584706291|FG000|Overall Study|Ongoing|26|||
161906309|NCT05115630|584706292|FG000|Overall Study|Due to COVID19|1|||
161906310|NCT05115630|584706292|FG000|Overall Study|Due to Bacteremia|1|||
161906311|NCT05115630|584706292|FG000|Overall Study|Due to viral infection|1|||
161906312|NCT02287038|584706295|FG000|Overall Study|Stopped attending appointments|3|||
161906313|NCT02287038|584706296|FG001|Overall Study|Stopped attending appointments|2|||
161906314|NCT02287038|584706295|FG000|Overall Study|Anxiety after starting medication|0|||
161906315|NCT02287038|584706296|FG001|Overall Study|Anxiety after starting medication|1|||
161906316|NCT02287038|584706295|FG000|Overall Study|Nausea after starting medication|1|||
161906317|NCT02287038|584706296|FG001|Overall Study|Nausea after starting medication|0|||
161906318|NCT02287038|584706295|FG000|Overall Study|Abnormal ECG after starting medication|1|||
161906319|NCT02287038|584706296|FG001|Overall Study|Abnormal ECG after starting medication|0|||
161906320|NCT05502302|584706304|FG000|Overall Study|Lost to Follow-up|6|||
161906321|NCT05502302|584706304|FG000|Overall Study|Death|2|||
161906322|NCT02998151|584706308|FG000|Overall Study|Withdrawal by Subject|3|||
161906323|NCT02998151|584706308|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
161906324|NCT02998151|584706308|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
161906325|NCT02667301|584706311|FG000|Overall Study|Adverse Event|1|||
161906326|NCT02667301|584706311|FG000|Overall Study|Lack of Efficacy|1|||
161906327|NCT00846586|584706313|FG000|Overall Study|Adverse Event|20|||
161906328|NCT00846586|584706314|FG001|Overall Study|Adverse Event|10|||
161906329|NCT00846586|584706313|FG000|Overall Study|Subject withdrew consent|8|||
161906330|NCT00846586|584706314|FG001|Overall Study|Subject withdrew consent|10|||
161906331|NCT00846586|584706313|FG000|Overall Study|Administrative problems|5|||
161906332|NCT00846586|584706314|FG001|Overall Study|Administrative problems|4|||
161906333|NCT00846586|584706313|FG000|Overall Study|Death|2|||
161906334|NCT00846586|584706314|FG001|Overall Study|Death|0|||
161906335|NCT00846586|584706313|FG000|Overall Study|Protocol deviation|2|||
161906336|NCT00846586|584706314|FG001|Overall Study|Protocol deviation|6|||
161906337|NCT00846586|584706313|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161906338|NCT00846586|584706314|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161906339|NCT00846586|584706313|FG000|Overall Study|Lost to Follow-up|1|||
161906340|NCT00846586|584706314|FG001|Overall Study|Lost to Follow-up|4|||
161906341|NCT00846586|584706313|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161906342|NCT00846586|584706314|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161906343|NCT04037358|584706317|FG000|Overall Study|Patient withdrew before intervention|1|||
161906344|NCT04037358|584706318|FG001|Overall Study|Patient withdrew before intervention|0|||
161906345|NCT05027815|584706321|FG000|Overall Study|Death|2|||
161906346|NCT05027815|584706322|FG001|Overall Study|Death|1|||
161906347|NCT04802161|584706324|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
161906348|NCT04802161|584706325|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
161906349|NCT04802161|584706326|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
161906350|NCT04802161|584706327|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
161906351|NCT04802161|584706324|FG000|Overall Study|Clinical Instability|0|||
161906352|NCT04802161|584706325|FG001|Overall Study|Clinical Instability|0|||
161906353|NCT04802161|584706326|FG002|Overall Study|Clinical Instability|1|||
161906354|NCT04802161|584706327|FG003|Overall Study|Clinical Instability|0|||
161906355|NCT04802161|584706324|FG000|Overall Study|Adverse Event|0|||
161906356|NCT04802161|584706325|FG001|Overall Study|Adverse Event|0|||
161906357|NCT04802161|584706326|FG002|Overall Study|Adverse Event|1|||
161906358|NCT04802161|584706327|FG003|Overall Study|Adverse Event|0|||
161906359|NCT04802161|584706324|FG000|Overall Study|Death|0|||
161906360|NCT04802161|584706325|FG001|Overall Study|Death|0|||
161453031|NCT01579812|583053566|FG000|Overall Study|Withdrawal by Subject|6|||
161453032|NCT00653432|583053567|FG000|Overall Study|Adverse Event|4|||
161906361|NCT04802161|584706326|FG002|Overall Study|Death|1|||
161453033|NCT00653432|583053568|FG001|Overall Study|Adverse Event|1|||
161453034|NCT00653432|583053567|FG000|Overall Study|Withdrawal by Subject|4|||
161453035|NCT00653432|583053568|FG001|Overall Study|Withdrawal by Subject|5|||
161906362|NCT04802161|584706327|FG003|Overall Study|Death|0|||
161906363|NCT00447902|584706333|FG000|Overall Study|Adverse Event|0|||
161906364|NCT00447902|584706334|FG001|Overall Study|Adverse Event|3|||
161906365|NCT00447902|584706333|FG000|Overall Study|Protocol Violation|1|||
161906366|NCT00447902|584706334|FG001|Overall Study|Protocol Violation|0|||
161906367|NCT00447902|584706333|FG000|Overall Study|Withdrawal by Subject|0|||
161906368|NCT00447902|584706334|FG001|Overall Study|Withdrawal by Subject|1|||
161906369|NCT00447902|584706333|FG000|Overall Study|included patients who discontinued|1|||
161906370|NCT00447902|584706334|FG001|Overall Study|included patients who discontinued|1|||
161453036|NCT00653432|583053567|FG000|Overall Study|Lost to Follow-up|7|||
161906371|NCT00447902|584706333|FG000|Overall Study|Lack of Efficacy|2|||
161561170|NCT03532178|583442048|FG001|Second Period|Technical issues|1|||
161561171|NCT00372528|583442051|FG000|Overall Study|Lack of Efficacy|1|||
161561172|NCT00372528|583442051|FG000|Overall Study|Adverse Event|1|||
161561173|NCT00372528|583442051|FG000|Overall Study|Study Terminated by Sponsor|18|||
161561174|NCT00372528|583442051|FG000|Overall Study|Other|1|||
161561175|NCT01417000|583442052|FG000|Overall Study|Death|59|||
161561176|NCT01417000|583442053|FG001|Overall Study|Death|28|||
161561177|NCT01417000|583442052|FG000|Overall Study|Lost to Follow-up|1|||
161561178|NCT01417000|583442053|FG001|Overall Study|Lost to Follow-up|0|||
161561179|NCT01417000|583442052|FG000|Overall Study|Study Terminated by Sponsor|1|||
161561180|NCT01417000|583442053|FG001|Overall Study|Study Terminated by Sponsor|1|||
161561181|NCT00562965|583442054|FG000|Overall Study|Withdrawal by Subject|0|||
161561182|NCT00562965|583442055|FG001|Overall Study|Withdrawal by Subject|1|||
161561183|NCT00562965|583442054|FG000|Overall Study|Death|2|||
161561184|NCT00562965|583442055|FG001|Overall Study|Death|4|||
161561185|NCT00562965|583442054|FG000|Overall Study|Lost to Follow-up|1|||
161561186|NCT00562965|583442055|FG001|Overall Study|Lost to Follow-up|0|||
161561187|NCT00562965|583442054|FG000|Overall Study|Other|0|||
161561188|NCT00562965|583442055|FG001|Overall Study|Other|1|||
161561189|NCT00761774|583442056|FG000|Overall Study|Adverse Event|17|||
161561190|NCT00761774|583442056|FG000|Overall Study|Lack of Efficacy|37|||
161561191|NCT00761774|583442056|FG000|Overall Study|Lost to Follow-up|2|||
161561192|NCT00761774|583442056|FG000|Overall Study|Withdrawal by Subject|9|||
161561193|NCT00761774|583442056|FG000|Overall Study|Non-compliance|4|||
161561194|NCT00761774|583442056|FG000|Overall Study|End of study|2|||
161561195|NCT00761774|583442056|FG000|Overall Study|Reclassification of seizures|1|||
161561196|NCT00761774|583442056|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
161561197|NCT00761774|583442056|FG000|Overall Study|Sponsor decision|1|||
161561198|NCT00761774|583442056|FG000|Overall Study|Investigator clinical judgement|1|||
161561199|NCT00761774|583442056|FG000|Overall Study|Patient moved out of study area|1|||
161561200|NCT00761774|583442056|FG000|Overall Study|Coordinator leaving site|1|||
161561201|NCT00761774|583442056|FG000|Overall Study|Subject IP non-compliance|1|||
161803225|NCT03980483|584323368|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161561202|NCT00761774|583442056|FG000|Overall Study|IP stopped by hospital physician|1|||
161561203|NCT01124617|583442057|FG000|Overall Study|Adverse Event|5|||
161561204|NCT01124617|583442058|FG001|Overall Study|Adverse Event|2|||
161561205|NCT01124617|583442057|FG000|Overall Study|Lack of Efficacy|2|||
161561206|NCT01124617|583442058|FG001|Overall Study|Lack of Efficacy|1|||
161561207|NCT01124617|583442057|FG000|Overall Study|Protocol Violation|1|||
161561208|NCT01124617|583442058|FG001|Overall Study|Protocol Violation|1|||
161561209|NCT01124617|583442057|FG000|Overall Study|Withdrawal by Subject|9|||
161561210|NCT01124617|583442058|FG001|Overall Study|Withdrawal by Subject|1|||
161561211|NCT01124617|583442057|FG000|Overall Study|Other|2|||
161561212|NCT01124617|583442058|FG001|Overall Study|Other|1|||
161561213|NCT01354938|583442060|FG000|Overall Study|Lost to Follow-up|1|||
161561214|NCT01253200|583442061|FG000|Overall Study|Death|1|||
161561215|NCT01253200|583442062|FG001|Overall Study|Death|0|||
161561216|NCT01253200|583442063|FG002|Overall Study|Death|0|||
161803226|NCT03980483|584323363|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803227|NCT03980483|584323364|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
161803228|NCT03980483|584323365|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803229|NCT03980483|584323366|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803230|NCT03980483|584323367|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803231|NCT03980483|584323368|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803232|NCT03980483|584323363|FG000|Overall Study|Other|0|||
161803233|NCT03980483|584323364|FG001|Overall Study|Other|1|||
161803234|NCT03980483|584323365|FG002|Overall Study|Other|0|||
161803235|NCT03980483|584323366|FG003|Overall Study|Other|0|||
161803236|NCT03980483|584323367|FG004|Overall Study|Other|0|||
161803237|NCT03980483|584323368|FG005|Overall Study|Other|0|||
161803238|NCT05150964|584323369|FG000|Overall Study|Lost to Follow-up|2|||
161803239|NCT00623779|584323370|FG000|Overall Study|Adverse Event|1|||
161803240|NCT00623779|584323371|FG001|Overall Study|Adverse Event|3|||
161803241|NCT00623779|584323372|FG002|Overall Study|Adverse Event|0|||
161561217|NCT01253200|583442064|FG003|Overall Study|Death|0|||
161561218|NCT01253200|583442065|FG004|Overall Study|Death|0|||
161561219|NCT01253200|583442061|FG000|Overall Study|Lost to Follow-up|1|||
161561220|NCT01253200|583442062|FG001|Overall Study|Lost to Follow-up|1|||
161561221|NCT01253200|583442063|FG002|Overall Study|Lost to Follow-up|0|||
161803242|NCT00623779|584323370|FG000|Overall Study|Criteria from CSR|2|||
161803243|NCT00623779|584323371|FG001|Overall Study|Criteria from CSR|0|||
161803244|NCT00623779|584323372|FG002|Overall Study|Criteria from CSR|1|||
161561222|NCT01253200|583442064|FG003|Overall Study|Lost to Follow-up|0|||
161561223|NCT01253200|583442065|FG004|Overall Study|Lost to Follow-up|0|||
161803245|NCT01629381|584323380|FG000|Overall Study|Withdrawal by Subject|2|||
161561224|NCT01253200|583442061|FG000|Overall Study|Withdrawal by Subject|2|||
161561225|NCT01253200|583442062|FG001|Overall Study|Withdrawal by Subject|0|||
161561226|NCT01253200|583442063|FG002|Overall Study|Withdrawal by Subject|0|||
161561227|NCT01253200|583442064|FG003|Overall Study|Withdrawal by Subject|0|||
161803246|NCT01629381|584323381|FG001|Overall Study|Withdrawal by Subject|5|||
161803247|NCT00906347|584323384|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
161803248|NCT00906347|584323385|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
161803249|NCT00906347|584323384|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
161803250|NCT00906347|584323385|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
161803251|NCT00906347|584323384|FG000|Received Study Drug|Refused study drug|1|||
161803252|NCT00906347|584323385|FG001|Received Study Drug|Refused study drug|0|||
161803253|NCT00906347|584323384|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
161803254|NCT00906347|584323385|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
161803255|NCT00680121|584323391|FG000|Overall Study|Lost to Follow-up|27|||
161803256|NCT00680121|584323392|FG001|Overall Study|Lost to Follow-up|23|||
161803257|NCT02849652|584323395|FG000|Overall Study|Lost to Follow-up|104|||
161803258|NCT02849652|584323396|FG001|Overall Study|Lost to Follow-up|35|||
161803259|NCT02849652|584323397|FG002|Overall Study|Lost to Follow-up|116|||
161803260|NCT02849652|584323398|FG003|Overall Study|Lost to Follow-up|22|||
161803261|NCT02849652|584323395|FG000|Overall Study|Withdrawal by Subject|10|||
161803262|NCT02849652|584323396|FG001|Overall Study|Withdrawal by Subject|2|||
161803263|NCT02849652|584323397|FG002|Overall Study|Withdrawal by Subject|8|||
161803264|NCT02849652|584323398|FG003|Overall Study|Withdrawal by Subject|4|||
161453037|NCT00653432|583053568|FG001|Overall Study|Lost to Follow-up|6|||
161453038|NCT00653432|583053567|FG000|Overall Study|Use/Need of Con Therapy|2|||
161803265|NCT02545998|584323399|FG000|Overall Study|Lost to Follow-up|12|||
161803266|NCT02545998|584323400|FG001|Overall Study|Lost to Follow-up|3|||
161803267|NCT02545998|584323399|FG000|Overall Study|Withdrawal by Subject|3|||
161803268|NCT02545998|584323400|FG001|Overall Study|Withdrawal by Subject|2|||
161803269|NCT00472290|584323401|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
161803270|NCT00472290|584323401|FG000|Overall Study|Protocol Specified Criteria|7|||
161803271|NCT00472290|584323401|FG000|Overall Study|Administrative Decision|37|||
161803272|NCT00472290|584323401|FG000|Overall Study|Death|3|||
161803273|NCT00472290|584323401|FG000|Overall Study|Lost to Follow-up|1|||
161803274|NCT00472290|584323401|FG000|Overall Study|Lack of Efficacy|1|||
161803275|NCT00472290|584323401|FG000|Overall Study|Disease Progression|4|||
161803276|NCT00472290|584323401|FG000|Overall Study|Withdrawal by Subject|5|||
161906372|NCT00447902|584706334|FG001|Overall Study|Lack of Efficacy|1|||
161453039|NCT00653432|583053568|FG001|Overall Study|Use/Need of Con Therapy|1|||
161453040|NCT00653432|583053567|FG000|Overall Study|Other - Reason Not Provided|5|||
161453041|NCT00653432|583053568|FG001|Overall Study|Other - Reason Not Provided|3|||
161453042|NCT01782469|583053569|FG000|Overall Study|Lost to Follow-up|1|||
161453043|NCT00357760|583053570|FG000|Overall Study|Disease progression|44|||
161453044|NCT00357760|583053571|FG001|Overall Study|Disease progression|17|||
161453045|NCT00357760|583053570|FG000|Overall Study|Adverse Event|10|||
161453046|NCT00357760|583053571|FG001|Overall Study|Adverse Event|7|||
161453047|NCT00357760|583053570|FG000|Overall Study|Death|0|||
161453048|NCT00357760|583053571|FG001|Overall Study|Death|3|||
161453049|NCT00357760|583053570|FG000|Overall Study|Alternative therapy|1|||
161453050|NCT00357760|583053571|FG001|Overall Study|Alternative therapy|0|||
161453051|NCT00357760|583053570|FG000|Overall Study|Withdrawal by Subject|0|||
161453052|NCT00357760|583053571|FG001|Overall Study|Withdrawal by Subject|2|||
161453053|NCT00357760|583053570|FG000|Overall Study|Never started treatment|2|||
161453054|NCT00357760|583053571|FG001|Overall Study|Never started treatment|1|||
161453055|NCT00357760|583053570|FG000|Overall Study|Ineligible|0|||
161453056|NCT00357760|583053571|FG001|Overall Study|Ineligible|2|||
161453057|NCT00357760|583053570|FG000|Overall Study|Physician Decision|2|||
161453058|NCT00357760|583053571|FG001|Overall Study|Physician Decision|1|||
161453059|NCT00357760|583053570|FG000|Overall Study|Protocol Violation|0|||
161453060|NCT00357760|583053571|FG001|Overall Study|Protocol Violation|1|||
161453061|NCT00357760|583053570|FG000|Overall Study|To receive hospice care|0|||
161453062|NCT00357760|583053571|FG001|Overall Study|To receive hospice care|1|||
161453063|NCT02353143|583053572|FG000|Overall Study|Withdrawal by Subject|1|||
161453064|NCT02353143|583053573|FG001|Overall Study|Withdrawal by Subject|0|||
161453065|NCT02353143|583053574|FG002|Overall Study|Withdrawal by Subject|0|||
161453066|NCT02353143|583053575|FG003|Overall Study|Withdrawal by Subject|0|||
161453067|NCT02353143|583053576|FG004|Overall Study|Withdrawal by Subject|1|||
161453068|NCT02353143|583053577|FG005|Overall Study|Withdrawal by Subject|0|||
161453069|NCT02353143|583053578|FG006|Overall Study|Withdrawal by Subject|0|||
161453070|NCT02353143|583053579|FG007|Overall Study|Withdrawal by Subject|1|||
161453071|NCT02353143|583053580|FG008|Overall Study|Withdrawal by Subject|1|||
161453072|NCT02353143|583053572|FG000|Overall Study|Lack of Efficacy|2|||
161453073|NCT02353143|583053573|FG001|Overall Study|Lack of Efficacy|1|||
161453074|NCT02353143|583053574|FG002|Overall Study|Lack of Efficacy|2|||
161453075|NCT02353143|583053575|FG003|Overall Study|Lack of Efficacy|4|||
161453076|NCT02353143|583053576|FG004|Overall Study|Lack of Efficacy|13|||
161453077|NCT02353143|583053577|FG005|Overall Study|Lack of Efficacy|2|||
161453078|NCT02353143|583053578|FG006|Overall Study|Lack of Efficacy|2|||
161453079|NCT02353143|583053579|FG007|Overall Study|Lack of Efficacy|2|||
161453080|NCT02353143|583053580|FG008|Overall Study|Lack of Efficacy|1|||
161453081|NCT02353143|583053572|FG000|Overall Study|reason not specified|1|||
161668060|NCT00406653|583837482|FG006|Induction Period|Incarcerated|0|||
161561228|NCT01253200|583442065|FG004|Overall Study|Withdrawal by Subject|0|||
161803277|NCT00472290|584323401|FG000|Overall Study|Adverse Event|6|||
161803278|NCT00472290|584323401|FG000|Overall Study|Requirement for alternative therapy|7|||
161803279|NCT00777829|584323403|FG000|Overall Study|Withdrawal by Subject|0|||
161803280|NCT00777829|584323404|FG001|Overall Study|Withdrawal by Subject|2|||
161803281|NCT00745095|584323406|FG000|Overall Study|Declined to participate|1|||
161803282|NCT00745095|584323407|FG001|Overall Study|Declined to participate|0|||
161803283|NCT00745095|584323408|FG002|Overall Study|Declined to participate|0|||
161803284|NCT00745095|584323409|FG003|Overall Study|Declined to participate|0|||
161803285|NCT00745095|584323410|FG004|Overall Study|Declined to participate|92|||
161803286|NCT00745095|584323411|FG005|Overall Study|Declined to participate|95|||
161803287|NCT00745095|584323406|FG000|Overall Study|Ineligible due to GFR criteria|0|||
161803288|NCT00745095|584323407|FG001|Overall Study|Ineligible due to GFR criteria|2|||
161803289|NCT00745095|584323408|FG002|Overall Study|Ineligible due to GFR criteria|3|||
161803290|NCT00745095|584323409|FG003|Overall Study|Ineligible due to GFR criteria|3|||
161803291|NCT00745095|584323410|FG004|Overall Study|Ineligible due to GFR criteria|30|||
161803292|NCT00745095|584323411|FG005|Overall Study|Ineligible due to GFR criteria|28|||
161803293|NCT01226797|584323416|FG000|Overall Study|Adverse Event|1|||
161803294|NCT01226797|584323417|FG001|Overall Study|Adverse Event|0|||
161561229|NCT01253200|583442061|FG000|Overall Study|Protocol Violation|1|||
161561230|NCT01253200|583442062|FG001|Overall Study|Protocol Violation|4|||
161561231|NCT01253200|583442063|FG002|Overall Study|Protocol Violation|0|||
161561232|NCT01253200|583442064|FG003|Overall Study|Protocol Violation|0|||
161803295|NCT01226797|584323416|FG000|Overall Study|No longer willing to participate|1|||
161803296|NCT01226797|584323417|FG001|Overall Study|No longer willing to participate|0|||
161803297|NCT01226797|584323416|FG000|Overall Study|Protocol Violation|0|||
161803298|NCT01226797|584323417|FG001|Overall Study|Protocol Violation|1|||
161803299|NCT00577460|584323418|FG000|Overall Study|Adverse Event|11|||
161803300|NCT00577460|584323419|FG001|Overall Study|Adverse Event|7|||
161803301|NCT00577460|584323420|FG002|Overall Study|Adverse Event|14|||
161803302|NCT00577460|584323418|FG000|Overall Study|Protocol Violation|0|||
161803303|NCT00577460|584323419|FG001|Overall Study|Protocol Violation|1|||
161803304|NCT00577460|584323420|FG002|Overall Study|Protocol Violation|1|||
161803305|NCT00577460|584323418|FG000|Overall Study|Lost to Follow-up|0|||
161803306|NCT00577460|584323419|FG001|Overall Study|Lost to Follow-up|3|||
161803307|NCT00577460|584323420|FG002|Overall Study|Lost to Follow-up|4|||
161803308|NCT00577460|584323418|FG000|Overall Study|Withdrawal by Subject|5|||
161803309|NCT00577460|584323419|FG001|Overall Study|Withdrawal by Subject|5|||
161803310|NCT00577460|584323420|FG002|Overall Study|Withdrawal by Subject|6|||
161803311|NCT00577460|584323418|FG000|Overall Study|Other|0|||
161803312|NCT00577460|584323419|FG001|Overall Study|Other|3|||
161803313|NCT00577460|584323420|FG002|Overall Study|Other|2|||
161803314|NCT00162123|584323421|FG000|Overall Study|Disease progression|27|||
161803315|NCT00162123|584323422|FG001|Overall Study|Disease progression|19|||
161803316|NCT00162123|584323423|FG002|Overall Study|Disease progression|10|||
161803317|NCT00162123|584323424|FG003|Overall Study|Disease progression|4|||
161803318|NCT00162123|584323425|FG004|Overall Study|Disease progression|8|||
161803319|NCT00162123|584323426|FG005|Overall Study|Disease progression|3|||
161803320|NCT00162123|584323427|FG006|Overall Study|Disease progression|1|||
161803321|NCT00162123|584323428|FG007|Overall Study|Disease progression|0|||
161803322|NCT00162123|584323421|FG000|Overall Study|Study drug toxicity|6|||
161803323|NCT00162123|584323422|FG001|Overall Study|Study drug toxicity|1|||
161803324|NCT00162123|584323423|FG002|Overall Study|Study drug toxicity|5|||
161803325|NCT00162123|584323424|FG003|Overall Study|Study drug toxicity|0|||
161803326|NCT00162123|584323425|FG004|Overall Study|Study drug toxicity|4|||
161803327|NCT00162123|584323426|FG005|Overall Study|Study drug toxicity|1|||
161803328|NCT00162123|584323427|FG006|Overall Study|Study drug toxicity|1|||
161803329|NCT00162123|584323428|FG007|Overall Study|Study drug toxicity|0|||
161803330|NCT00162123|584323421|FG000|Overall Study|Death|3|||
161803331|NCT00162123|584323422|FG001|Overall Study|Death|3|||
161803332|NCT00162123|584323423|FG002|Overall Study|Death|1|||
161803333|NCT00162123|584323424|FG003|Overall Study|Death|1|||
161453082|NCT02353143|583053573|FG001|Overall Study|reason not specified|2|||
161803334|NCT00162123|584323425|FG004|Overall Study|Death|1|||
161803335|NCT00162123|584323426|FG005|Overall Study|Death|1|||
161453083|NCT02353143|583053574|FG002|Overall Study|reason not specified|0|||
161453084|NCT02353143|583053575|FG003|Overall Study|reason not specified|0|||
161453085|NCT02353143|583053576|FG004|Overall Study|reason not specified|6|||
161453086|NCT02353143|583053577|FG005|Overall Study|reason not specified|1|||
161453087|NCT02353143|583053578|FG006|Overall Study|reason not specified|0|||
161453088|NCT02353143|583053579|FG007|Overall Study|reason not specified|3|||
161453089|NCT02353143|583053580|FG008|Overall Study|reason not specified|1|||
161453090|NCT02353143|583053572|FG000|Overall Study|Physician Decision|0|||
161453091|NCT02353143|583053573|FG001|Overall Study|Physician Decision|4|||
161453092|NCT02353143|583053574|FG002|Overall Study|Physician Decision|2|||
161906373|NCT01655901|584708731|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161453093|NCT02353143|583053575|FG003|Overall Study|Physician Decision|3|||
161906374|NCT01655901|584708732|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161803336|NCT00162123|584323427|FG006|Overall Study|Death|0|||
161906375|NCT01655901|584708733|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161906376|NCT01655901|584708734|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
161906377|NCT01655901|584708735|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161906378|NCT01655901|584708736|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
161906379|NCT00352118|584708737|FG000|Overall Study|Physician Decision|4|||
161906380|NCT02997163|584708738|FG000|Overall Study|Adverse Event|1|||
161906381|NCT02997163|584708739|FG001|Overall Study|Adverse Event|0|||
161906382|NCT02997163|584708740|FG002|Overall Study|Adverse Event|0|||
161906383|NCT02997163|584708741|FG003|Overall Study|Adverse Event|1|||
161906384|NCT00557466|584708745|FG000|Overall Study|Adverse Event|3|||
161906385|NCT00557466|584708746|FG001|Overall Study|Adverse Event|1|||
161906386|NCT00557466|584708747|FG002|Overall Study|Adverse Event|4|||
161906387|NCT00557466|584708748|FG003|Overall Study|Adverse Event|1|||
161906388|NCT00557466|584708749|FG004|Overall Study|Adverse Event|2|||
161906389|NCT00557466|584708750|FG005|Overall Study|Adverse Event|4|||
161906390|NCT00557466|584708745|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161453094|NCT02353143|583053576|FG004|Overall Study|Physician Decision|4|||
161453095|NCT02353143|583053577|FG005|Overall Study|Physician Decision|0|||
161453096|NCT02353143|583053578|FG006|Overall Study|Physician Decision|1|||
161453097|NCT02353143|583053579|FG007|Overall Study|Physician Decision|2|||
161453098|NCT02353143|583053580|FG008|Overall Study|Physician Decision|0|||
161453099|NCT02353143|583053572|FG000|Overall Study|Adverse Event|0|||
161453100|NCT02353143|583053573|FG001|Overall Study|Adverse Event|0|||
161453101|NCT02353143|583053574|FG002|Overall Study|Adverse Event|1|||
161453102|NCT02353143|583053575|FG003|Overall Study|Adverse Event|0|||
161453103|NCT02353143|583053576|FG004|Overall Study|Adverse Event|1|||
161453104|NCT02353143|583053577|FG005|Overall Study|Adverse Event|1|||
161453105|NCT02353143|583053578|FG006|Overall Study|Adverse Event|0|||
161453106|NCT02353143|583053579|FG007|Overall Study|Adverse Event|0|||
161453107|NCT02353143|583053580|FG008|Overall Study|Adverse Event|0|||
161453108|NCT02353143|583053572|FG000|Overall Study|patient receiving other treatment for AML|0|||
161453109|NCT02353143|583053573|FG001|Overall Study|patient receiving other treatment for AML|0|||
161453110|NCT02353143|583053574|FG002|Overall Study|patient receiving other treatment for AML|1|||
161453111|NCT02353143|583053575|FG003|Overall Study|patient receiving other treatment for AML|0|||
161453112|NCT02353143|583053576|FG004|Overall Study|patient receiving other treatment for AML|0|||
161453113|NCT02353143|583053577|FG005|Overall Study|patient receiving other treatment for AML|0|||
161453114|NCT02353143|583053578|FG006|Overall Study|patient receiving other treatment for AML|0|||
161453115|NCT02353143|583053579|FG007|Overall Study|patient receiving other treatment for AML|0|||
161453116|NCT02353143|583053580|FG008|Overall Study|patient receiving other treatment for AML|0|||
161453117|NCT02353143|583053572|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
161453118|NCT02353143|583053573|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
161453119|NCT02353143|583053574|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
161453120|NCT02353143|583053575|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
161453121|NCT02353143|583053576|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
161453122|NCT02353143|583053577|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
161453123|NCT02353143|583053578|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
161453124|NCT02353143|583053579|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
161453125|NCT02353143|583053580|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
161453126|NCT04740905|583053581|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
161453127|NCT04740905|583053582|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
161453128|NCT04740905|583053581|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
161453129|NCT04740905|583053582|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
161453130|NCT04740905|583053581|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161453131|NCT04740905|583053582|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
161453132|NCT04740905|583053581|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
161453133|NCT04740905|583053582|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
161453134|NCT04740905|583053581|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
161453135|NCT04740905|583053582|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
161453136|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
161453137|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
161561233|NCT01253200|583442065|FG004|Overall Study|Protocol Violation|5|||
161561234|NCT01253200|583442061|FG000|Overall Study|intents|10|||
161906391|NCT00557466|584708746|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161906392|NCT00557466|584708747|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161906393|NCT00557466|584708748|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161906394|NCT00557466|584708749|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161906395|NCT00557466|584708750|FG005|Overall Study|Abnormal laboratory value(s)|0|||
161906396|NCT00557466|584708745|FG000|Overall Study|Protocol deviation|0|||
161906397|NCT00557466|584708746|FG001|Overall Study|Protocol deviation|1|||
161453138|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
161453139|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
161453140|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
161453141|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
161561235|NCT01253200|583442062|FG001|Overall Study|intents|10|||
161803337|NCT00162123|584323428|FG007|Overall Study|Death|0|||
161803338|NCT00162123|584323421|FG000|Overall Study|Withdrawal by Subject|2|||
161803339|NCT00162123|584323422|FG001|Overall Study|Withdrawal by Subject|0|||
161803340|NCT00162123|584323423|FG002|Overall Study|Withdrawal by Subject|2|||
161803341|NCT00162123|584323424|FG003|Overall Study|Withdrawal by Subject|1|||
161803342|NCT00162123|584323425|FG004|Overall Study|Withdrawal by Subject|1|||
161803343|NCT00162123|584323426|FG005|Overall Study|Withdrawal by Subject|2|||
161803344|NCT00162123|584323427|FG006|Overall Study|Withdrawal by Subject|1|||
161803345|NCT00162123|584323428|FG007|Overall Study|Withdrawal by Subject|0|||
161803346|NCT00162123|584323421|FG000|Overall Study|Deterioration without progression|2|||
161803347|NCT00162123|584323422|FG001|Overall Study|Deterioration without progression|2|||
161803348|NCT00162123|584323423|FG002|Overall Study|Deterioration without progression|3|||
161803349|NCT00162123|584323424|FG003|Overall Study|Deterioration without progression|0|||
161803350|NCT00162123|584323425|FG004|Overall Study|Deterioration without progression|1|||
161803351|NCT00162123|584323426|FG005|Overall Study|Deterioration without progression|0|||
161803352|NCT00162123|584323427|FG006|Overall Study|Deterioration without progression|0|||
161803353|NCT00162123|584323428|FG007|Overall Study|Deterioration without progression|0|||
161803354|NCT00162123|584323421|FG000|Overall Study|Adverse Event|1|||
161803355|NCT00162123|584323422|FG001|Overall Study|Adverse Event|2|||
161803356|NCT00162123|584323423|FG002|Overall Study|Adverse Event|0|||
161803357|NCT00162123|584323424|FG003|Overall Study|Adverse Event|2|||
161803358|NCT00162123|584323425|FG004|Overall Study|Adverse Event|1|||
161803359|NCT00162123|584323426|FG005|Overall Study|Adverse Event|0|||
161803360|NCT00162123|584323427|FG006|Overall Study|Adverse Event|0|||
161803361|NCT00162123|584323428|FG007|Overall Study|Adverse Event|0|||
161803362|NCT00162123|584323421|FG000|Overall Study|Not specified (before treatment)|2|||
161803363|NCT00162123|584323422|FG001|Overall Study|Not specified (before treatment)|0|||
161803364|NCT00162123|584323423|FG002|Overall Study|Not specified (before treatment)|0|||
161803365|NCT00162123|584323424|FG003|Overall Study|Not specified (before treatment)|0|||
161803366|NCT00162123|584323425|FG004|Overall Study|Not specified (before treatment)|12|||
161803367|NCT00162123|584323426|FG005|Overall Study|Not specified (before treatment)|1|||
161803368|NCT00162123|584323427|FG006|Overall Study|Not specified (before treatment)|0|||
161803369|NCT00162123|584323428|FG007|Overall Study|Not specified (before treatment)|0|||
161803370|NCT00162123|584323421|FG000|Overall Study|Not specified (after start of treatment)|0|||
161803371|NCT00162123|584323422|FG001|Overall Study|Not specified (after start of treatment)|0|||
161803372|NCT00162123|584323423|FG002|Overall Study|Not specified (after start of treatment)|0|||
161803373|NCT00162123|584323424|FG003|Overall Study|Not specified (after start of treatment)|0|||
161803374|NCT00162123|584323425|FG004|Overall Study|Not specified (after start of treatment)|3|||
161803375|NCT00162123|584323426|FG005|Overall Study|Not specified (after start of treatment)|0|||
161803376|NCT00162123|584323427|FG006|Overall Study|Not specified (after start of treatment)|0|||
161803377|NCT00162123|584323428|FG007|Overall Study|Not specified (after start of treatment)|0|||
161803378|NCT00162123|584323421|FG000|Overall Study|Physician Decision|1|||
161803379|NCT00162123|584323422|FG001|Overall Study|Physician Decision|2|||
161803380|NCT00162123|584323423|FG002|Overall Study|Physician Decision|0|||
161803381|NCT00162123|584323424|FG003|Overall Study|Physician Decision|0|||
161803382|NCT00162123|584323425|FG004|Overall Study|Physician Decision|0|||
161803383|NCT00162123|584323426|FG005|Overall Study|Physician Decision|1|||
161803384|NCT00162123|584323427|FG006|Overall Study|Physician Decision|1|||
161803385|NCT00162123|584323428|FG007|Overall Study|Physician Decision|0|||
161803386|NCT00162123|584323421|FG000|Overall Study|Tumor assessment only (not treated)|0|||
161803387|NCT00162123|584323422|FG001|Overall Study|Tumor assessment only (not treated)|0|||
161803388|NCT00162123|584323423|FG002|Overall Study|Tumor assessment only (not treated)|0|||
161803389|NCT00162123|584323424|FG003|Overall Study|Tumor assessment only (not treated)|0|||
161803390|NCT00162123|584323425|FG004|Overall Study|Tumor assessment only (not treated)|0|||
161803391|NCT00162123|584323426|FG005|Overall Study|Tumor assessment only (not treated)|0|||
161803392|NCT00162123|584323427|FG006|Overall Study|Tumor assessment only (not treated)|0|||
161803393|NCT00162123|584323428|FG007|Overall Study|Tumor assessment only (not treated)|1|||
161803394|NCT00162123|584323421|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
161803395|NCT00162123|584323422|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
161803396|NCT00162123|584323423|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
161803397|NCT00162123|584323424|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
161803398|NCT00162123|584323425|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
161803399|NCT00162123|584323426|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
161803400|NCT00162123|584323427|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
161803401|NCT00162123|584323428|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
161803402|NCT02016170|584323429|FG000|Overall Study|Adverse Event|1|||
161803403|NCT02016170|584323430|FG001|Overall Study|Adverse Event|1|||
161803404|NCT02016170|584323431|FG002|Overall Study|Adverse Event|0|||
161803405|NCT02016170|584323429|FG000|Overall Study|Protocol Violation|1|||
161803406|NCT02016170|584323430|FG001|Overall Study|Protocol Violation|0|||
161803407|NCT02016170|584323431|FG002|Overall Study|Protocol Violation|0|||
161803408|NCT05214560|584323436|FG000|Overall Study|Screening Failure|1|||
161803409|NCT05214560|584323436|FG000|Overall Study|Physician Decision|4|||
161803410|NCT05214560|584323436|FG000|Overall Study|Withdrawal by Subject|1|||
161803411|NCT05214560|584323436|FG000|Overall Study|Lost to Follow-up|2|||
161803412|NCT05214560|584323436|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
161803413|NCT05214560|584323436|FG000|Overall Study|Study physician not available for the anesthesia|3|||
161803414|NCT05214560|584323436|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
161803415|NCT05214560|584323436|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
161803416|NCT05214560|584323436|FG000|Overall Study|Surgery not performed|3|||
161803417|NCT00408902|584323440|FG000|Overall Study|Lack of Efficacy|7|||
161803418|NCT00408902|584323440|FG000|Overall Study|Adverse Event|3|||
161803419|NCT00878995|584323441|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
161803420|NCT00878995|584323442|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
161803421|NCT03629249|584323443|FG000|Overall Study|Study terminated by sponsor|197|||
161803422|NCT03629249|584323444|FG001|Overall Study|Study terminated by sponsor|197|||
161803423|NCT03629249|584323445|FG002|Overall Study|Study terminated by sponsor|194|||
161803424|NCT03629249|584323443|FG000|Overall Study|Protocol deviation|0|||
161803425|NCT03629249|584323444|FG001|Overall Study|Protocol deviation|2|||
161803426|NCT03629249|584323445|FG002|Overall Study|Protocol deviation|5|||
161803427|NCT03629249|584323443|FG000|Overall Study|Subject decision|1|||
161803428|NCT03629249|584323444|FG001|Overall Study|Subject decision|1|||
161803429|NCT03629249|584323445|FG002|Overall Study|Subject decision|3|||
161803430|NCT03629249|584323443|FG000|Overall Study|Adverse Event|1|||
161803431|NCT03629249|584323444|FG001|Overall Study|Adverse Event|1|||
161803432|NCT03629249|584323445|FG002|Overall Study|Adverse Event|0|||
161803433|NCT03629249|584323443|FG000|Overall Study|Death|1|||
161803434|NCT03629249|584323444|FG001|Overall Study|Death|0|||
161803435|NCT03629249|584323445|FG002|Overall Study|Death|0|||
161803436|NCT03629249|584323443|FG000|Overall Study|Physician Decision|1|||
161803437|NCT03629249|584323444|FG001|Overall Study|Physician Decision|0|||
161803438|NCT03629249|584323445|FG002|Overall Study|Physician Decision|0|||
161803439|NCT00352690|584323446|FG000|Overall Study|Determined to be ineligible|2|||
161803440|NCT00352690|584323447|FG001|Overall Study|Determined to be ineligible|0|||
161803441|NCT03633721|584323450|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
161803442|NCT03633721|584323451|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
161803443|NCT03633721|584323452|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
161803444|NCT03633721|584323453|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
161803445|NCT01475474|584323457|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
161803446|NCT01475474|584323457|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
161803447|NCT02343120|584323458|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
161803448|NCT02343120|584323459|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
161803449|NCT02343120|584323460|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
161803450|NCT02343120|584323461|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
161803451|NCT02343120|584323462|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
161803452|NCT02343120|584323458|FG000|Part 1: Dose Escalation|Death|1|||
161803453|NCT02343120|584323459|FG001|Part 1: Dose Escalation|Death|2|||
161803454|NCT02343120|584323460|FG002|Part 1: Dose Escalation|Death|2|||
161803455|NCT02343120|584323461|FG003|Part 1: Dose Escalation|Death|2|||
161803456|NCT02343120|584323462|FG004|Part 1: Dose Escalation|Death|1|||
161803457|NCT02343120|584323458|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
161803458|NCT02343120|584323459|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803459|NCT02343120|584323460|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803460|NCT02343120|584323461|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803461|NCT02343120|584323462|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803462|NCT02343120|584323458|FG000|Part 2: Expansion|Sponsor decision|0|||
161803463|NCT02343120|584323459|FG001|Part 2: Expansion|Sponsor decision|0|||
161803464|NCT02343120|584323460|FG002|Part 2: Expansion|Sponsor decision|0|||
161803465|NCT02343120|584323461|FG003|Part 2: Expansion|Sponsor decision|165|||
161803466|NCT02343120|584323462|FG004|Part 2: Expansion|Sponsor decision|67|||
161803467|NCT02343120|584323458|FG000|Part 2: Expansion|Death|0|||
161803468|NCT02343120|584323459|FG001|Part 2: Expansion|Death|0|||
161803469|NCT02343120|584323460|FG002|Part 2: Expansion|Death|0|||
161803470|NCT02343120|584323461|FG003|Part 2: Expansion|Death|74|||
161803471|NCT02343120|584323462|FG004|Part 2: Expansion|Death|17|||
161803472|NCT02343120|584323458|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
161803473|NCT02343120|584323459|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
161803474|NCT02343120|584323460|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
161803475|NCT02343120|584323461|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
161803476|NCT02343120|584323462|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
161803477|NCT02343120|584323458|FG000|Part 2: Expansion|Lost to Follow-up|0|||
161803478|NCT02343120|584323459|FG001|Part 2: Expansion|Lost to Follow-up|0|||
161803479|NCT02343120|584323460|FG002|Part 2: Expansion|Lost to Follow-up|0|||
161803480|NCT02343120|584323461|FG003|Part 2: Expansion|Lost to Follow-up|5|||
161803481|NCT02343120|584323462|FG004|Part 2: Expansion|Lost to Follow-up|2|||
161803482|NCT02343120|584323458|FG000|Part 2: Expansion|Other|0|||
161803483|NCT02343120|584323459|FG001|Part 2: Expansion|Other|0|||
161803484|NCT02343120|584323460|FG002|Part 2: Expansion|Other|0|||
161803485|NCT02343120|584323461|FG003|Part 2: Expansion|Other|1|||
161906398|NCT00557466|584708747|FG002|Overall Study|Protocol deviation|0|||
161906399|NCT00557466|584708748|FG003|Overall Study|Protocol deviation|2|||
161906400|NCT00557466|584708749|FG004|Overall Study|Protocol deviation|0|||
161906401|NCT00557466|584708750|FG005|Overall Study|Protocol deviation|0|||
161906402|NCT00557466|584708745|FG000|Overall Study|Subject withdrew consent|0|||
161906403|NCT00557466|584708746|FG001|Overall Study|Subject withdrew consent|0|||
161906404|NCT00557466|584708747|FG002|Overall Study|Subject withdrew consent|0|||
161906405|NCT00557466|584708748|FG003|Overall Study|Subject withdrew consent|0|||
161906406|NCT00557466|584708749|FG004|Overall Study|Subject withdrew consent|1|||
161906407|NCT00557466|584708750|FG005|Overall Study|Subject withdrew consent|2|||
161906408|NCT00557466|584708745|FG000|Overall Study|Administrative problems|0|||
161906409|NCT00557466|584708746|FG001|Overall Study|Administrative problems|1|||
161906410|NCT00557466|584708747|FG002|Overall Study|Administrative problems|1|||
161906411|NCT00557466|584708748|FG003|Overall Study|Administrative problems|0|||
161906412|NCT00557466|584708749|FG004|Overall Study|Administrative problems|0|||
161906413|NCT00557466|584708750|FG005|Overall Study|Administrative problems|0|||
161906414|NCT00557466|584708745|FG000|Overall Study|Abnormal test procedure results|0|||
161906415|NCT00557466|584708746|FG001|Overall Study|Abnormal test procedure results|0|||
161906416|NCT00557466|584708747|FG002|Overall Study|Abnormal test procedure results|1|||
161906417|NCT00557466|584708748|FG003|Overall Study|Abnormal test procedure results|0|||
161906418|NCT00557466|584708749|FG004|Overall Study|Abnormal test procedure results|0|||
161906419|NCT00557466|584708750|FG005|Overall Study|Abnormal test procedure results|0|||
161906420|NCT00557466|584708745|FG000|Overall Study|Lost to Follow-up|0|||
161906421|NCT00557466|584708746|FG001|Overall Study|Lost to Follow-up|0|||
161906422|NCT00557466|584708747|FG002|Overall Study|Lost to Follow-up|0|||
161906423|NCT00557466|584708748|FG003|Overall Study|Lost to Follow-up|1|||
161906424|NCT00557466|584708749|FG004|Overall Study|Lost to Follow-up|0|||
161906425|NCT00557466|584708750|FG005|Overall Study|Lost to Follow-up|0|||
161906426|NCT01712516|584708751|FG000|Overall Study|Technical problems|0|||
161906427|NCT01712516|584708752|FG001|Overall Study|Technical problems|0|||
161906428|NCT01712516|584708753|FG002|Overall Study|Technical problems|0|||
161906429|NCT01712516|584708754|FG003|Overall Study|Technical problems|2|||
161906430|NCT01712516|584708751|FG000|Overall Study|Lost to Follow-up|0|||
161906431|NCT01712516|584708752|FG001|Overall Study|Lost to Follow-up|0|||
161906432|NCT01712516|584708753|FG002|Overall Study|Lost to Follow-up|2|||
161906433|NCT01712516|584708754|FG003|Overall Study|Lost to Follow-up|1|||
161906434|NCT01712516|584708751|FG000|Overall Study|Death|0|||
161906435|NCT01712516|584708752|FG001|Overall Study|Death|1|||
161906436|NCT01712516|584708753|FG002|Overall Study|Death|0|||
161906437|NCT01712516|584708754|FG003|Overall Study|Death|0|||
161906438|NCT01712516|584708751|FG000|Overall Study|Protocol deviation|1|||
161906439|NCT01712516|584708752|FG001|Overall Study|Protocol deviation|0|||
161906440|NCT01712516|584708753|FG002|Overall Study|Protocol deviation|1|||
161906441|NCT01712516|584708754|FG003|Overall Study|Protocol deviation|0|||
161906442|NCT01712516|584708751|FG000|Overall Study|Physician Decision|2|||
161906443|NCT01712516|584708752|FG001|Overall Study|Physician Decision|0|||
161906444|NCT01712516|584708753|FG002|Overall Study|Physician Decision|0|||
161906445|NCT01712516|584708754|FG003|Overall Study|Physician Decision|1|||
161906446|NCT01712516|584708751|FG000|Overall Study|Withdrawal by Subject|3|||
161906447|NCT01712516|584708752|FG001|Overall Study|Withdrawal by Subject|9|||
161906448|NCT01712516|584708753|FG002|Overall Study|Withdrawal by Subject|3|||
161906449|NCT01712516|584708754|FG003|Overall Study|Withdrawal by Subject|9|||
161906450|NCT01251952|584708759|FG000|Overall Study|Adverse Event|1|||
161906451|NCT00496769|584708760|FG000|Double Blind|>=1 reason assigned per patient|558|||
161803486|NCT02343120|584323462|FG004|Part 2: Expansion|Other|5|||
161803487|NCT02343120|584323458|FG000|Part 2: Expansion|Adverse Event|0|||
161803488|NCT02343120|584323459|FG001|Part 2: Expansion|Adverse Event|0|||
161803489|NCT02343120|584323460|FG002|Part 2: Expansion|Adverse Event|0|||
161803490|NCT02343120|584323461|FG003|Part 2: Expansion|Adverse Event|1|||
161803491|NCT02343120|584323462|FG004|Part 2: Expansion|Adverse Event|1|||
161803492|NCT02534493|584323468|FG000|Overall Study|Lost to Follow-up|1|||
161803493|NCT02534493|584323468|FG000|Overall Study|Withdrawal by Subject|1|||
161906452|NCT00496769|584708761|FG001|Double Blind|>=1 reason assigned per patient|649|||
161906453|NCT00496769|584708762|FG002|Double Blind|>=1 reason assigned per patient|0|||
161906454|NCT00496769|584708760|FG000|Open Label|>=1 reason assigned per patient|0|||
161906455|NCT00496769|584708761|FG001|Open Label|>=1 reason assigned per patient|0|||
161906456|NCT00496769|584708762|FG002|Open Label|>=1 reason assigned per patient|1011|||
161906457|NCT02308046|584708763|FG000|Overall Study|Negative yeast culture at Baseline|32|||
161906458|NCT02308046|584708764|FG001|Overall Study|Negative yeast culture at Baseline|33|||
161906459|NCT02308046|584708763|FG000|Overall Study|Positive for STD at Baseline|1|||
161906460|NCT02308046|584708764|FG001|Overall Study|Positive for STD at Baseline|2|||
161906461|NCT02308046|584708763|FG000|Overall Study|Lost to Follow-up|1|||
161453142|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
161803494|NCT02514174|584323470|FG000|Overall Study|Patient refused to continue medication|1|||
161803495|NCT02514174|584323470|FG000|Overall Study|Adverse Event|2|||
161803496|NCT02514174|584323470|FG000|Overall Study|Study closed by sponsor|9|||
161803497|NCT02514174|584323470|FG000|Overall Study|Progressive disease|11|||
161906462|NCT02308046|584708764|FG001|Overall Study|Lost to Follow-up|3|||
161906463|NCT02224625|584708770|FG000|Irritation|Adverse Event|6|||
161906464|NCT02224625|584708770|FG000|Sensitization|Adverse Event|55|||
161906465|NCT01181167|584708771|FG000|Overall Study|Adverse Event|11|||
161906466|NCT01181167|584708772|FG001|Overall Study|Adverse Event|21|||
161906467|NCT01181167|584708771|FG000|Overall Study|Lost to Follow-up|1|||
161906468|NCT01181167|584708772|FG001|Overall Study|Lost to Follow-up|0|||
161906469|NCT01181167|584708771|FG000|Overall Study|Physician Decision|2|||
161906470|NCT01181167|584708772|FG001|Overall Study|Physician Decision|3|||
161906471|NCT01181167|584708771|FG000|Overall Study|Protocol Violation|3|||
161906472|NCT01181167|584708772|FG001|Overall Study|Protocol Violation|0|||
161906473|NCT01181167|584708771|FG000|Overall Study|Withdrawal by Subject|6|||
161906474|NCT01181167|584708772|FG001|Overall Study|Withdrawal by Subject|8|||
161906475|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
161906476|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
161906477|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
161906478|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
161906479|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
161906480|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
161906481|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
161906482|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
161906483|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
161906484|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
161906485|NCT01573000|584708773|FG000|Crossover Phase|Lack of Efficacy|0|||
161906486|NCT01573000|584708774|FG001|Crossover Phase|Lack of Efficacy|13|||
161906487|NCT01573000|584708773|FG000|Crossover Phase|Lost to Follow-up|0|||
161906488|NCT01573000|584708774|FG001|Crossover Phase|Lost to Follow-up|2|||
161906489|NCT01573000|584708773|FG000|Crossover Phase|Death|0|||
161906490|NCT01573000|584708774|FG001|Crossover Phase|Death|3|||
161906491|NCT01573000|584708773|FG000|Long-Term Follow-Up|Death|3|||
161906492|NCT01573000|584708774|FG001|Long-Term Follow-Up|Death|0|||
161906493|NCT01573000|584708773|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
161906494|NCT01573000|584708774|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
161906495|NCT03342001|584708780|FG000|Overall Study|Adverse Event|1|||
161906496|NCT03342001|584708780|FG000|Overall Study|Lost to Follow-up|1|||
161906497|NCT01433159|584708781|FG000|Overall Study|Adverse Event|1|||
161906498|NCT01433159|584708782|FG001|Overall Study|Adverse Event|0|||
161906499|NCT01433159|584708781|FG000|Overall Study|Physician Decision|1|||
161906500|NCT01433159|584708782|FG001|Overall Study|Physician Decision|0|||
161906501|NCT01433159|584708781|FG000|Overall Study|Protocol Violation|0|||
161906502|NCT01433159|584708782|FG001|Overall Study|Protocol Violation|1|||
161906503|NCT01100853|584708783|FG000|Overall Study|Lost to Follow-up|11|||
161906504|NCT01100853|584708784|FG001|Overall Study|Lost to Follow-up|6|||
161906505|NCT01100853|584708783|FG000|Overall Study|Received <4 study injections|10|||
161906506|NCT01100853|584708784|FG001|Overall Study|Received <4 study injections|13|||
161906507|NCT01100853|584708783|FG000|Overall Study|Withdrawal by Subject|6|||
161906508|NCT01100853|584708784|FG001|Overall Study|Withdrawal by Subject|4|||
161803498|NCT02514174|584323470|FG000|Overall Study|Treatment change|1|||
161803499|NCT02514174|584323470|FG000|Overall Study|Treated off study with Afatinib.|1|||
161803500|NCT01691248|584323471|FG000|Overall Study|Protocol Violation|43|||
161803501|NCT01691248|584323472|FG001|Overall Study|Protocol Violation|27|||
161803502|NCT01691248|584323471|FG000|Overall Study|Adverse Event|24|||
161803503|NCT01691248|584323472|FG001|Overall Study|Adverse Event|22|||
161803504|NCT01691248|584323471|FG000|Overall Study|Withdrawal by Subject|20|||
161803505|NCT01691248|584323472|FG001|Overall Study|Withdrawal by Subject|18|||
161803506|NCT01691248|584323471|FG000|Overall Study|Confirmed CDAD|14|||
161803507|NCT01691248|584323472|FG001|Overall Study|Confirmed CDAD|31|||
161803508|NCT01691248|584323471|FG000|Overall Study|Lost to Follow-up|2|||
161803509|NCT01691248|584323472|FG001|Overall Study|Lost to Follow-up|5|||
161803510|NCT01691248|584323471|FG000|Overall Study|Reason not provided|4|||
161803511|NCT01691248|584323472|FG001|Overall Study|Reason not provided|4|||
161803512|NCT01691248|584323471|FG000|Overall Study|Not Treated|4|||
161803513|NCT01691248|584323472|FG001|Overall Study|Not Treated|7|||
161803514|NCT02817841|584325095|FG000|Overall Study|Lost to Follow-up|287|||
161803515|NCT02817841|584325095|FG000|Overall Study|Withdrawal by Subject|183|||
161803516|NCT02817841|584325095|FG000|Overall Study|Adverse event not related to bleeding|131|||
161803517|NCT02817841|584325095|FG000|Overall Study|Adverse event related to bleeding|51|||
161803518|NCT02817841|584325095|FG000|Overall Study|Pregnancy|32|||
161906509|NCT01384877|584708785|FG000|Treatment 2|Lost to Follow-up|2|||
161906510|NCT01384877|584708786|FG001|Treatment 2|Lost to Follow-up|2|||
161906511|NCT01930539|584708799|FG000|Overall Study|Withdrawal by Subject|2|||
161906512|NCT01930539|584708800|FG001|Overall Study|Withdrawal by Subject|2|||
161906513|NCT01548404|584708801|FG000|Overall Study|Adverse Event|3|||
161906514|NCT01548404|584708802|FG001|Overall Study|Adverse Event|1|||
161803519|NCT02817841|584325095|FG000|Overall Study|Pregnancy wish|17|||
161803520|NCT02817841|584325095|FG000|Overall Study|Other reasons|53|||
161803521|NCT02817841|584325095|FG000|Overall Study|Protocol Violation|94|||
161906515|NCT01548404|584708801|FG000|Overall Study|Physician Decision|2|||
161906516|NCT01548404|584708802|FG001|Overall Study|Physician Decision|1|||
161906517|NCT01548404|584708801|FG000|Overall Study|Inadequate response to study treatment|23|||
161906518|NCT01548404|584708802|FG001|Overall Study|Inadequate response to study treatment|7|||
161906519|NCT01548404|584708801|FG000|Overall Study|Lost to Follow-up|2|||
161906520|NCT01548404|584708802|FG001|Overall Study|Lost to Follow-up|0|||
161906521|NCT01548404|584708801|FG000|Overall Study|Withdrawal by Subject|0|||
161906522|NCT01548404|584708802|FG001|Overall Study|Withdrawal by Subject|3|||
161906523|NCT01548404|584708801|FG000|Overall Study|Other than specified above|0|||
161906524|NCT01548404|584708802|FG001|Overall Study|Other than specified above|2|||
161906525|NCT00883181|584708803|FG000|Overall Study|Hematological Adverse Event|26|||
161906526|NCT00883181|584708803|FG000|Overall Study|Non-hematological Adverse Event|55|||
161906527|NCT00883181|584708803|FG000|Overall Study|Disease Progression|94|||
161906528|NCT00883181|584708803|FG000|Overall Study|Administrative Reason|24|||
161906529|NCT00883181|584708803|FG000|Overall Study|Withdrawal by Subject|4|||
161906530|NCT00883181|584708803|FG000|Overall Study|Death|31|||
161906531|NCT00883181|584708803|FG000|Overall Study|Other|38|||
161906532|NCT00883181|584708803|FG000|Overall Study|Protocol Deviation|3|||
161906533|NCT00883181|584708803|FG000|Overall Study|Noncompliance|3|||
161906534|NCT04040439|584708804|FG000|Overall Study|Invalid registration|11|||
161906535|NCT04040439|584708804|FG000|Overall Study|No IC* on publication of study results|2|||
161906536|NCT00426270|584708805|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
161906537|NCT00426270|584708805|FG000|Overall Study|Adverse Event|5|||
161906538|NCT01450813|584708806|FG000|Overall Study|Physician Decision|1|||
161906539|NCT01450813|584708807|FG001|Overall Study|Physician Decision|1|||
161906540|NCT01450813|584708808|FG002|Overall Study|Physician Decision|0|||
161906541|NCT01450813|584708809|FG003|Overall Study|Physician Decision|3|||
161906542|NCT02062437|584708812|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
161906543|NCT02062437|584708812|FG000|Overall Study|Patient not available for the 2y visit|18|||
161906544|NCT02062437|584708812|FG000|Overall Study|Death|2|||
161906545|NCT02062437|584708812|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
161906546|NCT00752089|584708813|FG000|Overall Study|Adverse Event|1|||
161906547|NCT00752089|584708813|FG000|Overall Study|Protocol Deviation|2|||
161906548|NCT00752089|584708813|FG000|Overall Study|Could not attend visit 9|1|||
161906549|NCT00752089|584708813|FG000|Overall Study|Not capable of wearing partial denture|1|||
161803522|NCT00705536|584325096|FG000|Start Period 1|Withdrawal by Subject|0|||
161803523|NCT00705536|584325097|FG001|Start Period 1|Withdrawal by Subject|0|||
161803524|NCT00705536|584325098|FG002|Start Period 1|Withdrawal by Subject|0|||
161803525|NCT00705536|584325099|FG003|Start Period 1|Withdrawal by Subject|1|||
161803526|NCT01746017|584325102|FG000|Period 1|Withdrawal by Subject|0|||
161803527|NCT01746017|584325103|FG001|Period 1|Withdrawal by Subject|0|||
161803528|NCT01746017|584325104|FG002|Period 1|Withdrawal by Subject|0|||
161803529|NCT01746017|584325105|FG003|Period 1|Withdrawal by Subject|0|||
161803530|NCT01746017|584325106|FG004|Period 1|Withdrawal by Subject|0|||
161803531|NCT01746017|584325107|FG005|Period 1|Withdrawal by Subject|0|||
161803532|NCT01746017|584325108|FG006|Period 1|Withdrawal by Subject|1|||
161803533|NCT01746017|584325109|FG007|Period 1|Withdrawal by Subject|0|||
161803534|NCT01746017|584325110|FG008|Period 1|Withdrawal by Subject|0|||
161803535|NCT01746017|584325111|FG009|Period 1|Withdrawal by Subject|0|||
161803536|NCT01746017|584325112|FG010|Period 1|Withdrawal by Subject|0|||
161803537|NCT01746017|584325102|FG000|Period 3|Withdrawal by Subject|0|||
161803538|NCT01746017|584325103|FG001|Period 3|Withdrawal by Subject|0|||
161803539|NCT01746017|584325104|FG002|Period 3|Withdrawal by Subject|0|||
161803540|NCT01746017|584325105|FG003|Period 3|Withdrawal by Subject|0|||
161803541|NCT01746017|584325106|FG004|Period 3|Withdrawal by Subject|0|||
161803542|NCT01746017|584325107|FG005|Period 3|Withdrawal by Subject|1|||
161803543|NCT01746017|584325108|FG006|Period 3|Withdrawal by Subject|0|||
161803544|NCT01746017|584325109|FG007|Period 3|Withdrawal by Subject|0|||
161803545|NCT01746017|584325110|FG008|Period 3|Withdrawal by Subject|0|||
161803546|NCT01746017|584325111|FG009|Period 3|Withdrawal by Subject|0|||
161803547|NCT01746017|584325112|FG010|Period 3|Withdrawal by Subject|0|||
161803548|NCT02424097|584325115|FG000|Overall Study|Lost to Follow-up|1|||
161803549|NCT02424097|584325116|FG001|Overall Study|Lost to Follow-up|2|||
161803550|NCT01675622|584325117|FG000|Overall Study|Withdrawal by Subject|2|||
161906550|NCT00752089|584708813|FG000|Overall Study|Cannot continue the study|1|||
161906551|NCT00960193|584708814|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
161906552|NCT01324102|584708815|FG000|Overall Study|illness|1|||
161906553|NCT01324102|584708816|FG001|Overall Study|illness|6|||
161906554|NCT00728494|584708819|FG000|Overall Study|Adverse Event|7|||
161803551|NCT01675622|584325118|FG001|Overall Study|Withdrawal by Subject|2|||
161803552|NCT01675622|584325117|FG000|Overall Study|Adverse Event|12|||
161803553|NCT01675622|584325118|FG001|Overall Study|Adverse Event|10|||
161803554|NCT01675622|584325117|FG000|Overall Study|Protocol Violation|4|||
161803555|NCT01675622|584325118|FG001|Overall Study|Protocol Violation|1|||
161803556|NCT01675622|584325117|FG000|Overall Study|Lack of Efficacy|2|||
161803557|NCT01675622|584325118|FG001|Overall Study|Lack of Efficacy|4|||
161803558|NCT01675622|584325117|FG000|Overall Study|Lost to Follow-up|1|||
161803559|NCT01675622|584325118|FG001|Overall Study|Lost to Follow-up|3|||
161906555|NCT00728494|584708820|FG001|Overall Study|Adverse Event|0|||
161906556|NCT00728494|584708819|FG000|Overall Study|Withdrawal by Subject|0|||
161906557|NCT00728494|584708820|FG001|Overall Study|Withdrawal by Subject|2|||
161906558|NCT00728494|584708819|FG000|Overall Study|Lack of Efficacy|2|||
161906559|NCT00728494|584708820|FG001|Overall Study|Lack of Efficacy|4|||
161906560|NCT00728494|584708819|FG000|Overall Study|No data available|0|||
161906561|NCT00728494|584708820|FG001|Overall Study|No data available|1|||
161906562|NCT00386334|584708821|FG000|Double Blind Period|Adverse Event|9|||
161906563|NCT00386334|584708822|FG001|Double Blind Period|Adverse Event|14|||
161906564|NCT00386334|584708821|FG000|Double Blind Period|Protocol Violation|1|||
161906565|NCT00386334|584708822|FG001|Double Blind Period|Protocol Violation|1|||
161906566|NCT00386334|584708821|FG000|Double Blind Period|Withdrawal by Subject|9|||
161906567|NCT00386334|584708822|FG001|Double Blind Period|Withdrawal by Subject|13|||
161906568|NCT00386334|584708821|FG000|Double Blind Period|Lack of Efficacy|20|||
161906569|NCT00386334|584708822|FG001|Double Blind Period|Lack of Efficacy|11|||
161906570|NCT00386334|584708821|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
161906571|NCT00386334|584708822|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
161906572|NCT00386334|584708821|FG000|Double Blind Period|Other|3|||
161906573|NCT00386334|584708822|FG001|Double Blind Period|Other|3|||
161906574|NCT00386334|584708821|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
161906575|NCT00386334|584708822|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
161906576|NCT03238417|584708823|FG000|Overall|non-response|955|||
161906577|NCT03238417|584708824|FG001|Overall|non-response|1920|||
161906578|NCT03238417|584708823|FG000|Overall|partial completion|48|||
161906579|NCT03238417|584708824|FG001|Overall|partial completion|68|||
161906580|NCT03238417|584708823|FG000|Baseline|Partial completion|17|||
161906581|NCT03238417|584708824|FG001|Baseline|Partial completion|48|||
161906582|NCT03238417|584708823|FG000|Baseline|non-response|372|||
161906583|NCT03238417|584708824|FG001|Baseline|non-response|669|||
161906584|NCT03238417|584708823|FG000|12-month|non-response|296|||
161906585|NCT03238417|584708824|FG001|12-month|non-response|669|||
161906586|NCT03238417|584708823|FG000|12-month|partial completion|23|||
161906587|NCT03238417|584708824|FG001|12-month|partial completion|37|||
161906588|NCT03238417|584708823|FG000|24-month|non-response|287|||
161906589|NCT03238417|584708824|FG001|24-month|non-response|594|||
161906590|NCT03238417|584708823|FG000|24-month|partial completion|8|||
161906591|NCT03238417|584708824|FG001|24-month|partial completion|31|||
161906592|NCT02089347|584708825|FG000|Overall Study|Protocol Violation|1|||
161906593|NCT02089347|584708826|FG001|Overall Study|Protocol Violation|0|||
161906594|NCT00975416|584708827|FG000|Overall Study|early discharge from tx|3|||
161906595|NCT00975416|584708828|FG001|Overall Study|early discharge from tx|5|||
161906596|NCT01249131|584708829|FG000|Washout Period of 10 Days|Adverse Event|0|||
161906597|NCT01249131|584708830|FG001|Washout Period of 10 Days|Adverse Event|0|||
161906598|NCT01249131|584708831|FG002|Washout Period of 10 Days|Adverse Event|0|||
161906599|NCT01249131|584708832|FG003|Washout Period of 10 Days|Adverse Event|0|||
161906600|NCT01249131|584708833|FG004|Washout Period of 10 Days|Adverse Event|1|||
161906601|NCT01249131|584708834|FG005|Washout Period of 10 Days|Adverse Event|0|||
161906602|NCT01225549|584708835|FG000|Period 4 - Washout|Disallowed medication|0|||
161906603|NCT01225549|584708836|FG001|Period 4 - Washout|Disallowed medication|1|||
161906604|NCT01225549|584708837|FG002|Period 4 - Washout|Disallowed medication|0|||
161906605|NCT01225549|584708838|FG003|Period 4 - Washout|Disallowed medication|0|||
161906606|NCT01225549|584708839|FG004|Period 4 - Washout|Disallowed medication|0|||
161906607|NCT01225549|584708840|FG005|Period 4 - Washout|Disallowed medication|0|||
161906608|NCT01225549|584708841|FG006|Period 4 - Washout|Disallowed medication|0|||
161906609|NCT01225549|584708842|FG007|Period 4 - Washout|Disallowed medication|0|||
161906610|NCT01225549|584708843|FG008|Period 4 - Washout|Disallowed medication|0|||
161906611|NCT01225549|584708844|FG009|Period 4 - Washout|Disallowed medication|0|||
161906612|NCT01225549|584708835|FG000|Period 6 - Washout|Disallowed medication|0|||
161906613|NCT01225549|584708836|FG001|Period 6 - Washout|Disallowed medication|0|||
161906614|NCT01225549|584708837|FG002|Period 6 - Washout|Disallowed medication|0|||
161906615|NCT01225549|584708838|FG003|Period 6 - Washout|Disallowed medication|1|||
161906616|NCT01225549|584708839|FG004|Period 6 - Washout|Disallowed medication|0|||
161906617|NCT01225549|584708840|FG005|Period 6 - Washout|Disallowed medication|0|||
161906618|NCT01225549|584708841|FG006|Period 6 - Washout|Disallowed medication|0|||
161906619|NCT01225549|584708842|FG007|Period 6 - Washout|Disallowed medication|0|||
161906620|NCT01225549|584708843|FG008|Period 6 - Washout|Disallowed medication|0|||
161906621|NCT01225549|584708844|FG009|Period 6 - Washout|Disallowed medication|0|||
161906622|NCT01184872|584708845|FG000|Overall Study|Adverse Event|3|||
161906623|NCT01184872|584708846|FG001|Overall Study|Adverse Event|4|||
161906624|NCT01184872|584708845|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161906625|NCT01184872|584708846|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161906626|NCT01184872|584708845|FG000|Overall Study|Withdrawal by Subject|2|||
161906627|NCT01184872|584708846|FG001|Overall Study|Withdrawal by Subject|0|||
161906628|NCT01184872|584708845|FG000|Overall Study|Lost to Follow-up|0|||
161906629|NCT01184872|584708846|FG001|Overall Study|Lost to Follow-up|1|||
161906630|NCT01184872|584708845|FG000|Overall Study|Administrative problems|1|||
161906631|NCT01184872|584708846|FG001|Overall Study|Administrative problems|1|||
161561236|NCT01253200|583442063|FG002|Overall Study|intents|1|||
161803560|NCT01675622|584325117|FG000|Overall Study|Other|5|||
161803561|NCT01675622|584325118|FG001|Overall Study|Other|4|||
161803562|NCT04032977|584325119|FG000|Overall Study|Withdrawal by Subject|6|||
161803563|NCT04032977|584325120|FG001|Overall Study|Withdrawal by Subject|1|||
161803564|NCT04032977|584325119|FG000|Overall Study|Lost to Follow-up|2|||
161803565|NCT04032977|584325120|FG001|Overall Study|Lost to Follow-up|7|||
161803566|NCT04032977|584325119|FG000|Overall Study|Pregnancy|1|||
161803567|NCT04032977|584325120|FG001|Overall Study|Pregnancy|0|||
161803568|NCT01519661|584325122|FG000|Overall Study|Protocol deviation|6|||
161803569|NCT01519661|584325122|FG000|Overall Study|Lost to Follow-up|3|||
161803570|NCT01519661|584325122|FG000|Overall Study|Withdrawal by Subject|17|||
161803571|NCT01519661|584325122|FG000|Overall Study|Lack of Efficacy|6|||
161803572|NCT01519661|584325122|FG000|Overall Study|Adverse Event|29|||
161803573|NCT00840632|584325124|FG000|First Intervention|Withdrawal by Subject|0|||
161803574|NCT00840632|584325125|FG001|First Intervention|Withdrawal by Subject|1|||
161803575|NCT00840632|584325124|FG000|Washout|Withdrawal by Subject|1|||
161803576|NCT00840632|584325125|FG001|Washout|Withdrawal by Subject|1|||
161803577|NCT05017480|584325126|FG000|Stage 1 Study|Withdrawal by Subject|8|||
161803578|NCT05017480|584325127|FG001|Stage 1 Study|Withdrawal by Subject|6|||
161803579|NCT05017480|584325128|FG002|Stage 1 Study|Withdrawal by Subject|0|||
161803580|NCT05017480|584325129|FG003|Stage 1 Study|Withdrawal by Subject|0|||
161803581|NCT05017480|584325130|FG004|Stage 1 Study|Withdrawal by Subject|0|||
161803582|NCT05017480|584325126|FG000|Stage 1 Study|Adverse Event|1|||
161803583|NCT05017480|584325127|FG001|Stage 1 Study|Adverse Event|1|||
161803584|NCT05017480|584325128|FG002|Stage 1 Study|Adverse Event|0|||
161803585|NCT05017480|584325129|FG003|Stage 1 Study|Adverse Event|0|||
161803586|NCT05017480|584325130|FG004|Stage 1 Study|Adverse Event|0|||
161803587|NCT05017480|584325126|FG000|Stage 1 Study|Poor Compliance|1|||
161803588|NCT05017480|584325127|FG001|Stage 1 Study|Poor Compliance|1|||
161803589|NCT05017480|584325128|FG002|Stage 1 Study|Poor Compliance|0|||
161803590|NCT05017480|584325129|FG003|Stage 1 Study|Poor Compliance|0|||
161803591|NCT05017480|584325130|FG004|Stage 1 Study|Poor Compliance|0|||
161803592|NCT05017480|584325126|FG000|Stage 1 Study|Physician Decision|0|||
161803593|NCT05017480|584325127|FG001|Stage 1 Study|Physician Decision|1|||
161803594|NCT05017480|584325128|FG002|Stage 1 Study|Physician Decision|0|||
161803595|NCT05017480|584325129|FG003|Stage 1 Study|Physician Decision|0|||
161803596|NCT05017480|584325130|FG004|Stage 1 Study|Physician Decision|0|||
161803597|NCT05017480|584325126|FG000|Stage 2 Study|Withdrawal by Subject|0|||
161803598|NCT05017480|584325127|FG001|Stage 2 Study|Withdrawal by Subject|0|||
161803599|NCT05017480|584325128|FG002|Stage 2 Study|Withdrawal by Subject|6|||
161803600|NCT05017480|584325129|FG003|Stage 2 Study|Withdrawal by Subject|9|||
161803601|NCT05017480|584325130|FG004|Stage 2 Study|Withdrawal by Subject|11|||
161803602|NCT05017480|584325126|FG000|Stage 2 Study|Lost to Follow-up|0|||
161803603|NCT05017480|584325127|FG001|Stage 2 Study|Lost to Follow-up|0|||
161803604|NCT05017480|584325128|FG002|Stage 2 Study|Lost to Follow-up|0|||
161803605|NCT05017480|584325129|FG003|Stage 2 Study|Lost to Follow-up|2|||
161803606|NCT05017480|584325130|FG004|Stage 2 Study|Lost to Follow-up|1|||
161803607|NCT05017480|584325126|FG000|Stage 2 Study|Adverse Event|0|||
161803608|NCT05017480|584325127|FG001|Stage 2 Study|Adverse Event|0|||
161803609|NCT05017480|584325128|FG002|Stage 2 Study|Adverse Event|0|||
161803610|NCT05017480|584325129|FG003|Stage 2 Study|Adverse Event|1|||
161803611|NCT05017480|584325130|FG004|Stage 2 Study|Adverse Event|0|||
161803612|NCT05017480|584325126|FG000|Stage 2 Study|COVID-19|0|||
161803613|NCT05017480|584325127|FG001|Stage 2 Study|COVID-19|0|||
161803614|NCT05017480|584325128|FG002|Stage 2 Study|COVID-19|0|||
161803615|NCT05017480|584325129|FG003|Stage 2 Study|COVID-19|1|||
161803616|NCT05017480|584325130|FG004|Stage 2 Study|COVID-19|0|||
161803617|NCT05017480|584325126|FG000|Stage 2 Study|Pregnancy|0|||
161803618|NCT05017480|584325127|FG001|Stage 2 Study|Pregnancy|0|||
161803619|NCT05017480|584325128|FG002|Stage 2 Study|Pregnancy|0|||
161803620|NCT05017480|584325129|FG003|Stage 2 Study|Pregnancy|0|||
161803621|NCT05017480|584325130|FG004|Stage 2 Study|Pregnancy|1|||
161803622|NCT02311361|584325131|FG000|Overall Study|Did not receive treatment|0|||
161803623|NCT02311361|584325132|FG001|Overall Study|Did not receive treatment|1|||
161803624|NCT02311361|584325133|FG002|Overall Study|Did not receive treatment|0|||
161803625|NCT02311361|584325134|FG003|Overall Study|Did not receive treatment|1|||
161803626|NCT05628675|584325139|FG000|Overall Study|Lost to Follow-up|2|||
161803627|NCT05628675|584325139|FG000|Overall Study|Withdrawal by Subject|1|||
161803628|NCT00633594|584325142|FG000|Overall Study|Adverse Event|0|||
161803629|NCT00633594|584325143|FG001|Overall Study|Adverse Event|4|||
161803630|NCT00633594|584325144|FG002|Overall Study|Adverse Event|7|||
161803631|NCT00633594|584325142|FG000|Overall Study|Death|0|||
161803632|NCT00633594|584325143|FG001|Overall Study|Death|1|||
161803633|NCT00633594|584325144|FG002|Overall Study|Death|2|||
161803634|NCT00633594|584325142|FG000|Overall Study|Disease Progression|0|||
161803635|NCT00633594|584325143|FG001|Overall Study|Disease Progression|0|||
161803636|NCT00633594|584325144|FG002|Overall Study|Disease Progression|1|||
161803637|NCT02028715|584325145|FG000|Overall Study|Adverse Event|2|||
161803638|NCT02028715|584325146|FG001|Overall Study|Adverse Event|2|||
161803639|NCT02028715|584325145|FG000|Overall Study|Physician Decision|1|||
161906632|NCT01184872|584708845|FG000|Overall Study|Protocol deviation|1|||
161906633|NCT01184872|584708846|FG001|Overall Study|Protocol deviation|0|||
161906634|NCT03426345|584708847|FG000|Overall Study|Adverse Event|4|||
161906635|NCT03426345|584708848|FG001|Overall Study|Adverse Event|4|||
161906636|NCT03426345|584708847|FG000|Overall Study|Lack of Efficacy|1|||
161906637|NCT03426345|584708848|FG001|Overall Study|Lack of Efficacy|0|||
161906638|NCT03426345|584708847|FG000|Overall Study|Withdrawal by Subject|5|||
161906639|NCT03426345|584708848|FG001|Overall Study|Withdrawal by Subject|6|||
161906640|NCT03426345|584708847|FG000|Overall Study|Lost to Follow-up|3|||
161906641|NCT03426345|584708848|FG001|Overall Study|Lost to Follow-up|1|||
161906642|NCT03426345|584708847|FG000|Overall Study|Protocol Deviation|3|||
161906643|NCT03426345|584708848|FG001|Overall Study|Protocol Deviation|4|||
161906644|NCT03426345|584708847|FG000|Overall Study|Reason Not Specified|1|||
161906645|NCT03426345|584708848|FG001|Overall Study|Reason Not Specified|2|||
161906646|NCT03426345|584708847|FG000|Overall Study|Missing Completion Status|1|||
161906647|NCT03426345|584708848|FG001|Overall Study|Missing Completion Status|0|||
161906648|NCT00192114|584708855|FG000|Overall Study|Objective Tumor Progression|19|||
161906649|NCT00192114|584708855|FG000|Overall Study|Adverse Event|2|||
161906650|NCT00192114|584708855|FG000|Overall Study|Clinical Progression|2|||
161906651|NCT00192114|584708855|FG000|Overall Study|Death|1|||
161906652|NCT00492297|584708856|FG000|Treatment|Death|2|||
161906653|NCT00492297|584708856|FG000|Treatment|Study terminated by sponsor|3|||
161906654|NCT00492297|584708856|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
161906655|NCT00492297|584708856|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
161906656|NCT00492297|584708856|FG000|Survival Only Follow-up|Death|46|||
161906657|NCT00492297|584708856|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
161906658|NCT00492297|584708856|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
161906659|NCT01900444|584708866|FG000|Overall Study|Protocol Violation|2|||
161906660|NCT01900444|584708866|FG000|Overall Study|Lost to Follow-up|1|||
161906661|NCT00072384|584708867|FG000|Overall Study|Physician Decision|1|||
161906662|NCT00072384|584708867|FG000|Overall Study|Ineligible|8|||
161906663|NCT01825200|584708868|FG000|Overall Study|Lost to Follow-up|5|||
161906664|NCT01825200|584708869|FG001|Overall Study|Lost to Follow-up|6|||
161906665|NCT01825200|584708868|FG000|Overall Study|Withdrawal by Subject|0|||
161906666|NCT01825200|584708869|FG001|Overall Study|Withdrawal by Subject|1|||
161906667|NCT04219189|584708871|FG000|Overall Study|Withdrawal by Subject|1|||
161906668|NCT04219189|584708872|FG001|Overall Study|Withdrawal by Subject|2|||
161906669|NCT04219189|584708871|FG000|Overall Study|Protocol Violation|0|||
161906670|NCT04219189|584708872|FG001|Overall Study|Protocol Violation|1|||
161906671|NCT04219189|584708871|FG000|Overall Study|Lost to Follow-up|0|||
161906672|NCT04219189|584708872|FG001|Overall Study|Lost to Follow-up|1|||
161906673|NCT04219189|584708871|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
161906674|NCT04219189|584708872|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
161906675|NCT06058390|584708873|FG000|Overall Study|Lost to Follow-up|0|||
161906676|NCT06058390|584708874|FG001|Overall Study|Lost to Follow-up|0|||
161906677|NCT06058390|584708875|FG002|Overall Study|Lost to Follow-up|2|||
161906678|NCT06058390|584708876|FG003|Overall Study|Lost to Follow-up|1|||
161906679|NCT06058390|584708873|FG000|Overall Study|Physician Decision|0|||
161906680|NCT06058390|584708874|FG001|Overall Study|Physician Decision|0|||
161906681|NCT06058390|584708875|FG002|Overall Study|Physician Decision|0|||
161906682|NCT06058390|584708876|FG003|Overall Study|Physician Decision|1|||
161906683|NCT06058390|584708873|FG000|Overall Study|Participants did not receive any study intervention|0|||
161906684|NCT06058390|584708874|FG001|Overall Study|Participants did not receive any study intervention|0|||
161906685|NCT06058390|584708875|FG002|Overall Study|Participants did not receive any study intervention|0|||
161906686|NCT06058390|584708876|FG003|Overall Study|Participants did not receive any study intervention|1|||
161906687|NCT03585270|584708877|FG000|Overall Study|Withdrawal by Subject|2|||
161906688|NCT03585270|584708878|FG001|Overall Study|Withdrawal by Subject|6|||
161906689|NCT03585270|584708877|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
161906690|NCT03585270|584708878|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
161906691|NCT03585270|584708877|FG000|Overall Study|Adverse Event|5|||
161906692|NCT03585270|584708878|FG001|Overall Study|Adverse Event|2|||
161906693|NCT03585270|584708877|FG000|Overall Study|Lost to Follow-up|1|||
161906694|NCT03585270|584708878|FG001|Overall Study|Lost to Follow-up|4|||
161906695|NCT03585270|584708877|FG000|Overall Study|Death|5|||
161906696|NCT03585270|584708878|FG001|Overall Study|Death|3|||
161906697|NCT03585270|584708877|FG000|Overall Study|Other reasons|2|||
161906698|NCT03585270|584708878|FG001|Overall Study|Other reasons|2|||
161906699|NCT03292016|584708879|FG000|Second Washout|Adverse Event|0|||
161561237|NCT01253200|583442064|FG003|Overall Study|intents|3|||
161906700|NCT03292016|584708880|FG001|Second Washout|Adverse Event|1|||
161906701|NCT03292016|584708881|FG002|Second Washout|Adverse Event|0|||
161906702|NCT03292016|584708882|FG003|Second Washout|Adverse Event|0|||
161906703|NCT03292016|584708883|FG004|Second Washout|Adverse Event|0|||
161906704|NCT03292016|584708884|FG005|Second Washout|Adverse Event|0|||
161906705|NCT03904693|584708885|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906706|NCT03904693|584708886|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161453143|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
161453144|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
161453145|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
161453146|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
161453147|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
161803640|NCT02028715|584325146|FG001|Overall Study|Physician Decision|0|||
161803641|NCT02028715|584325145|FG000|Overall Study|Did not complete satisfaction surveys|2|||
161803642|NCT02028715|584325146|FG001|Overall Study|Did not complete satisfaction surveys|2|||
161803643|NCT01492361|584325147|FG000|Overall Study|Withdrawal by Subject|281|||
161803644|NCT01492361|584325148|FG001|Overall Study|Withdrawal by Subject|297|||
161803645|NCT01492361|584325147|FG000|Overall Study|Physician Decision|12|||
161803646|NCT01492361|584325148|FG001|Overall Study|Physician Decision|12|||
161803647|NCT01492361|584325147|FG000|Overall Study|Lost to Follow-up|6|||
161803648|NCT01492361|584325148|FG001|Overall Study|Lost to Follow-up|13|||
161803649|NCT01492361|584325147|FG000|Overall Study|Other than specified above|106|||
161803650|NCT01492361|584325148|FG001|Overall Study|Other than specified above|138|||
161803651|NCT01315249|584325154|FG000|Overall Study|Adverse Event|22|||
161803652|NCT01315249|584325155|FG001|Overall Study|Adverse Event|26|||
161803653|NCT01315249|584325154|FG000|Overall Study|Withdrawal by Subject|11|||
161803654|NCT01315249|584325155|FG001|Overall Study|Withdrawal by Subject|10|||
161803655|NCT01315249|584325154|FG000|Overall Study|Protocol Violation|8|||
161803656|NCT01315249|584325155|FG001|Overall Study|Protocol Violation|5|||
161803657|NCT01315249|584325154|FG000|Overall Study|Abnormal test results|1|||
161803658|NCT01315249|584325155|FG001|Overall Study|Abnormal test results|2|||
161803659|NCT01315249|584325154|FG000|Overall Study|Administrative problems|1|||
161803660|NCT01315249|584325155|FG001|Overall Study|Administrative problems|0|||
161803661|NCT01315249|584325154|FG000|Overall Study|inability to use device|1|||
161803662|NCT01315249|584325155|FG001|Overall Study|inability to use device|0|||
161803663|NCT01315249|584325154|FG000|Overall Study|Lack of Efficacy|0|||
161803664|NCT01315249|584325155|FG001|Overall Study|Lack of Efficacy|1|||
161803665|NCT01315249|584325154|FG000|Overall Study|Lost to Follow-up|0|||
161803666|NCT01315249|584325155|FG001|Overall Study|Lost to Follow-up|2|||
161803667|NCT01315249|584325154|FG000|Overall Study|Death|0|||
161803668|NCT01315249|584325155|FG001|Overall Study|Death|1|||
161803669|NCT03655106|584325156|FG000|Overall Study|Withdrawal by Subject|3|||
161803670|NCT03655106|584325157|FG001|Overall Study|Withdrawal by Subject|2|||
161803671|NCT03655106|584325156|FG000|Overall Study|Lost to Follow-up|2|||
161803672|NCT03655106|584325157|FG001|Overall Study|Lost to Follow-up|1|||
161803673|NCT03655106|584325156|FG000|Overall Study|Duplicate Enrollment|1|||
161803674|NCT03655106|584325157|FG001|Overall Study|Duplicate Enrollment|1|||
161803675|NCT03655106|584325156|FG000|Overall Study|Protocol Violation|3|||
161803676|NCT03655106|584325157|FG001|Overall Study|Protocol Violation|0|||
161803677|NCT03227445|584325158|FG000|Period 1 (28 Days)|Adverse Event|1|||
161803678|NCT03227445|584325159|FG001|Period 1 (28 Days)|Adverse Event|2|||
161803679|NCT03227445|584325160|FG002|Period 1 (28 Days)|Adverse Event|0|||
161803680|NCT03227445|584325161|FG003|Period 1 (28 Days)|Adverse Event|1|||
161803681|NCT03227445|584325158|FG000|Period 1 (28 Days)|Protocol Violation|1|||
161803682|NCT03227445|584325159|FG001|Period 1 (28 Days)|Protocol Violation|0|||
161803683|NCT03227445|584325160|FG002|Period 1 (28 Days)|Protocol Violation|0|||
161803684|NCT03227445|584325161|FG003|Period 1 (28 Days)|Protocol Violation|0|||
161803685|NCT03227445|584325158|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
161803686|NCT03227445|584325159|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
161803687|NCT03227445|584325160|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
161803688|NCT03227445|584325161|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
161803689|NCT03227445|584325158|FG000|Period 2 (28 Days)|Adverse Event|1|||
161803690|NCT03227445|584325159|FG001|Period 2 (28 Days)|Adverse Event|0|||
161803691|NCT03227445|584325160|FG002|Period 2 (28 Days)|Adverse Event|2|||
161803692|NCT03227445|584325161|FG003|Period 2 (28 Days)|Adverse Event|1|||
161803693|NCT03227445|584325158|FG000|Period 2 (28 Days)|Protocol Violation|0|||
161803694|NCT03227445|584325159|FG001|Period 2 (28 Days)|Protocol Violation|0|||
161803695|NCT03227445|584325160|FG002|Period 2 (28 Days)|Protocol Violation|0|||
161803696|NCT03227445|584325161|FG003|Period 2 (28 Days)|Protocol Violation|1|||
161803697|NCT03227445|584325158|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
161803698|NCT03227445|584325159|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
161803699|NCT03227445|584325160|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
161803700|NCT03227445|584325161|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
161803701|NCT01287013|584325166|FG000|Overall Study|Non-evaluable|3|||
161906707|NCT03904693|584708887|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
161803702|NCT01287013|584325167|FG001|Overall Study|Non-evaluable|5|||
161803703|NCT01287013|584325168|FG002|Overall Study|Non-evaluable|21|||
161803704|NCT00051025|584325169|FG000|Overall Study|Progressive Disease|1|||
161803705|NCT00051025|584325170|FG001|Overall Study|Progressive Disease|1|||
161803706|NCT00051025|584325169|FG000|Overall Study|Adverse Event|1|||
161803707|NCT00051025|584325170|FG001|Overall Study|Adverse Event|1|||
161803708|NCT00051025|584325169|FG000|Overall Study|Withdrawal by Subject|0|||
161803709|NCT00051025|584325170|FG001|Overall Study|Withdrawal by Subject|1|||
161803710|NCT00051025|584325169|FG000|Overall Study|Death|0|||
161906708|NCT03904693|584708888|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906709|NCT03904693|584708889|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906710|NCT03904693|584708890|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906711|NCT03904693|584708885|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906712|NCT03904693|584708886|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906713|NCT03904693|584708887|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
161906714|NCT03904693|584708888|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906715|NCT03904693|584708889|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906716|NCT03904693|584708890|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906717|NCT03904693|584708885|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906718|NCT03904693|584708886|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
161906719|NCT03904693|584708887|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
161906720|NCT03904693|584708888|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906721|NCT03904693|584708889|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906722|NCT03904693|584708890|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906723|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161906724|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161906725|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161906726|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
161906727|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
161906728|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
161906729|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906730|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906731|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906732|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906733|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906734|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
161906735|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906736|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906737|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906738|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
161906739|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906740|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906741|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906742|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906743|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906744|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
161906745|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906746|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161803711|NCT00051025|584325170|FG001|Overall Study|Death|1|||
161803712|NCT01179048|584325171|FG000|Overall Study|Withdrawn - does not allow contact|4|||
161803713|NCT01179048|584325172|FG001|Overall Study|Withdrawn - does not allow contact|8|||
161803714|NCT01179048|584325171|FG000|Overall Study|Lost to Follow-up|8|||
161803715|NCT01179048|584325172|FG001|Overall Study|Lost to Follow-up|9|||
161803716|NCT01179048|584325171|FG000|Overall Study|Alive|127|||
161803717|NCT01179048|584325172|FG001|Overall Study|Alive|142|||
161803718|NCT01900730|584325173|FG000|Overall Study|Withdrawal by Subject|1|||
161803719|NCT01900730|584325174|FG001|Overall Study|Withdrawal by Subject|0|||
161803720|NCT01900730|584325173|FG000|Overall Study|Screen Failure|1|||
161803721|NCT01900730|584325174|FG001|Overall Study|Screen Failure|0|||
161803722|NCT02109042|584325175|FG000|Overall Study|Sponsor Decision|15|||
161803723|NCT03203447|584325180|FG000|Overall Study|Withdrawal by Subject|2|||
161803724|NCT03203447|584325181|FG001|Overall Study|Withdrawal by Subject|1|||
161803725|NCT03203447|584325180|FG000|Overall Study|Lost to Follow-up|1|||
161803726|NCT03203447|584325181|FG001|Overall Study|Lost to Follow-up|10|||
161803727|NCT03203447|584325180|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
161803728|NCT03203447|584325181|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
161803729|NCT02189941|584325182|FG000|Overall Study|Non-compliance|0|||
161803730|NCT02189941|584325183|FG001|Overall Study|Non-compliance|0|||
161906747|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906748|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161561238|NCT01253200|583442065|FG004|Overall Study|intents|0|||
161561239|NCT01253200|583442061|FG000|Overall Study|Attempts|6|||
161803731|NCT02189941|584325184|FG002|Overall Study|Non-compliance|1|||
161803732|NCT00445003|584325185|FG000|Overall Study|Death|1|||
161803733|NCT00445003|584325186|FG001|Overall Study|Death|2|||
161803734|NCT00445003|584325187|FG002|Overall Study|Death|1|||
161803735|NCT00445003|584325185|FG000|Overall Study|Missed Visit|3|||
161906749|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906750|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906751|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906752|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
161906753|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906754|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906755|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906756|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906757|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
161906758|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906759|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906760|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906761|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906762|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906763|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906764|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
161906765|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161803736|NCT00445003|584325186|FG001|Overall Study|Missed Visit|5|||
161803737|NCT00445003|584325187|FG002|Overall Study|Missed Visit|1|||
161803738|NCT00445003|584325185|FG000|Overall Study|Dropped|1|||
161803739|NCT00445003|584325186|FG001|Overall Study|Dropped|3|||
161803740|NCT00445003|584325187|FG002|Overall Study|Dropped|2|||
161803741|NCT01471093|584325190|FG000|Overall Study|Adverse Event|1|||
161803742|NCT01471093|584325191|FG001|Overall Study|Adverse Event|0|||
161803743|NCT01471093|584325192|FG002|Overall Study|Adverse Event|0|||
161803744|NCT01471093|584325193|FG003|Overall Study|Adverse Event|0|||
161803745|NCT00528606|584325194|FG000|Overall Study|Withdrew consent|4|||
161803746|NCT00528606|584325195|FG001|Overall Study|Withdrew consent|3|||
161803747|NCT00528606|584325194|FG000|Overall Study|Lost to Follow-up|4|||
161803748|NCT00528606|584325195|FG001|Overall Study|Lost to Follow-up|1|||
161803749|NCT00528606|584325194|FG000|Overall Study|Adverse Event|3|||
161803750|NCT00528606|584325195|FG001|Overall Study|Adverse Event|0|||
161803751|NCT00528606|584325194|FG000|Overall Study|Other|2|||
161803752|NCT00528606|584325195|FG001|Overall Study|Other|0|||
161803753|NCT02475954|584325196|FG000|Overall Study|Withdrawal by Subject|2|||
161803754|NCT02475954|584325197|FG001|Overall Study|Withdrawal by Subject|2|||
161803755|NCT02475954|584325196|FG000|Overall Study|Lost to Follow-up|11|||
161803756|NCT02475954|584325197|FG001|Overall Study|Lost to Follow-up|9|||
161803757|NCT02475954|584325196|FG000|Overall Study|Death|1|||
161803758|NCT02475954|584325197|FG001|Overall Study|Death|1|||
161803759|NCT00880568|584325199|FG000|Overall Study|Disease progression|3|||
161803760|NCT00880568|584325200|FG001|Overall Study|Disease progression|3|||
161803761|NCT00880568|584325201|FG002|Overall Study|Disease progression|3|||
161803762|NCT00880568|584325202|FG003|Overall Study|Disease progression|1|||
161803763|NCT00880568|584325203|FG004|Overall Study|Disease progression|3|||
161803764|NCT00880568|584325204|FG005|Overall Study|Disease progression|3|||
161803765|NCT00880568|584325205|FG006|Overall Study|Disease progression|5|||
161803766|NCT00880568|584325206|FG007|Overall Study|Disease progression|0|||
161803767|NCT00880568|584325207|FG008|Overall Study|Disease progression|3|||
161906766|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906767|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906768|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906769|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906770|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
161906771|NCT01172873|584708891|FG000|Overall Study|Withdrawal by Subject|3|||
161906772|NCT01172873|584708892|FG001|Overall Study|Withdrawal by Subject|2|||
161906773|NCT05518539|584708893|FG000|Overall Study|Lost to Follow-up|6|||
161906774|NCT03589807|584708894|FG000|Overall Study|Lost to Follow-up|0|||
161906775|NCT03589807|584708895|FG001|Overall Study|Lost to Follow-up|2|||
161906776|NCT03589807|584708896|FG002|Overall Study|Lost to Follow-up|2|||
161803768|NCT00880568|584325199|FG000|Overall Study|Adverse Event|0|||
161803769|NCT00880568|584325200|FG001|Overall Study|Adverse Event|0|||
161803770|NCT00880568|584325201|FG002|Overall Study|Adverse Event|0|||
161803771|NCT00880568|584325202|FG003|Overall Study|Adverse Event|0|||
161803772|NCT00880568|584325203|FG004|Overall Study|Adverse Event|0|||
161803773|NCT00880568|584325204|FG005|Overall Study|Adverse Event|0|||
161803774|NCT00880568|584325205|FG006|Overall Study|Adverse Event|1|||
161803775|NCT00880568|584325206|FG007|Overall Study|Adverse Event|1|||
161803776|NCT00880568|584325207|FG008|Overall Study|Adverse Event|0|||
161803777|NCT00880568|584325199|FG000|Overall Study|Withdrawal by Subject|0|||
161803778|NCT00880568|584325200|FG001|Overall Study|Withdrawal by Subject|0|||
161803779|NCT00880568|584325201|FG002|Overall Study|Withdrawal by Subject|0|||
161803780|NCT00880568|584325202|FG003|Overall Study|Withdrawal by Subject|0|||
161803781|NCT00880568|584325203|FG004|Overall Study|Withdrawal by Subject|0|||
161906777|NCT03589807|584708897|FG003|Overall Study|Lost to Follow-up|3|||
161906778|NCT03589807|584708898|FG004|Overall Study|Lost to Follow-up|1|||
161906779|NCT03589807|584708899|FG005|Overall Study|Lost to Follow-up|1|||
161906780|NCT03589807|584708894|FG000|Overall Study|Withdrawal by Subject|0|||
161906781|NCT03589807|584708895|FG001|Overall Study|Withdrawal by Subject|5|||
161906782|NCT03589807|584708896|FG002|Overall Study|Withdrawal by Subject|0|||
161906783|NCT03589807|584708897|FG003|Overall Study|Withdrawal by Subject|0|||
161906784|NCT03589807|584708898|FG004|Overall Study|Withdrawal by Subject|0|||
161906785|NCT03589807|584708899|FG005|Overall Study|Withdrawal by Subject|0|||
161906786|NCT03589807|584708894|FG000|Overall Study|Protocol Violation|0|||
161906787|NCT03589807|584708895|FG001|Overall Study|Protocol Violation|0|||
161906788|NCT03589807|584708896|FG002|Overall Study|Protocol Violation|0|||
161906789|NCT03589807|584708897|FG003|Overall Study|Protocol Violation|1|||
161906790|NCT03589807|584708898|FG004|Overall Study|Protocol Violation|0|||
161906791|NCT03589807|584708899|FG005|Overall Study|Protocol Violation|0|||
161906792|NCT03589807|584708894|FG000|Overall Study|Enrolled but treatment not administered|0|||
161906793|NCT03589807|584708895|FG001|Overall Study|Enrolled but treatment not administered|0|||
161906794|NCT03589807|584708896|FG002|Overall Study|Enrolled but treatment not administered|0|||
161906795|NCT03589807|584708897|FG003|Overall Study|Enrolled but treatment not administered|0|||
161906796|NCT03589807|584708898|FG004|Overall Study|Enrolled but treatment not administered|1|||
161906797|NCT03589807|584708899|FG005|Overall Study|Enrolled but treatment not administered|0|||
161906798|NCT01211145|584708900|FG000|Overall Study|Reason not specified|3|||
161906799|NCT01211145|584708901|FG001|Overall Study|Reason not specified|2|||
161906800|NCT01211145|584708902|FG002|Overall Study|Reason not specified|2|||
161906801|NCT01211145|584708903|FG003|Overall Study|Reason not specified|1|||
161906802|NCT01211145|584708900|FG000|Overall Study|Lost to Follow-up|3|||
161906803|NCT01211145|584708901|FG001|Overall Study|Lost to Follow-up|2|||
161906804|NCT01211145|584708902|FG002|Overall Study|Lost to Follow-up|1|||
161906805|NCT01211145|584708903|FG003|Overall Study|Lost to Follow-up|2|||
161906806|NCT01211145|584708900|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161906807|NCT01211145|584708901|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161906808|NCT01211145|584708902|FG002|Overall Study|Study-specific withdrawal criteria|0|||
161906809|NCT01211145|584708903|FG003|Overall Study|Study-specific withdrawal criteria|0|||
161906810|NCT01211145|584708900|FG000|Overall Study|Severe noncompliance to protocol|1|||
161906811|NCT01211145|584708901|FG001|Overall Study|Severe noncompliance to protocol|0|||
161906812|NCT01211145|584708902|FG002|Overall Study|Severe noncompliance to protocol|0|||
161906813|NCT01211145|584708903|FG003|Overall Study|Severe noncompliance to protocol|0|||
161906814|NCT01211145|584708900|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
161906815|NCT01211145|584708901|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
161803782|NCT00880568|584325204|FG005|Overall Study|Withdrawal by Subject|0|||
161803783|NCT00880568|584325205|FG006|Overall Study|Withdrawal by Subject|0|||
161803784|NCT00880568|584325206|FG007|Overall Study|Withdrawal by Subject|1|||
161803785|NCT00880568|584325207|FG008|Overall Study|Withdrawal by Subject|0|||
161803786|NCT00620022|584325208|FG000|Treatment Period 1|Adverse Event|4|||
161803787|NCT00620022|584325209|FG001|Treatment Period 1|Adverse Event|6|||
161803788|NCT00620022|584325208|FG000|Treatment Period 1|Subject withdrew consent|1|||
161803789|NCT00620022|584325209|FG001|Treatment Period 1|Subject withdrew consent|0|||
161803790|NCT00620022|584325208|FG000|Treatment Period 2|Adverse Event|2|||
161803791|NCT00620022|584325209|FG001|Treatment Period 2|Adverse Event|2|||
161803792|NCT00760266|584325211|FG000|Overall Study|Adverse Event|13|||
161803793|NCT00760266|584325212|FG001|Overall Study|Adverse Event|7|||
161803794|NCT00760266|584325211|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161803795|NCT00760266|584325212|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161803796|NCT00760266|584325211|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161803797|NCT00760266|584325212|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161803798|NCT00760266|584325211|FG000|Overall Study|Lack of Efficacy|2|||
161803799|NCT00760266|584325212|FG001|Overall Study|Lack of Efficacy|2|||
161803800|NCT00760266|584325211|FG000|Overall Study|Protocol deviation|2|||
161803801|NCT00760266|584325212|FG001|Overall Study|Protocol deviation|4|||
161803802|NCT00760266|584325211|FG000|Overall Study|Patient withdrew consent|3|||
161803803|NCT00760266|584325212|FG001|Overall Study|Patient withdrew consent|3|||
161803804|NCT00760266|584325211|FG000|Overall Study|Lost to Follow-up|2|||
161803805|NCT00760266|584325212|FG001|Overall Study|Lost to Follow-up|1|||
161803806|NCT00760266|584325211|FG000|Overall Study|Administrative Problems|0|||
161803807|NCT00760266|584325212|FG001|Overall Study|Administrative Problems|1|||
161803808|NCT01239121|584325213|FG000|Overall Study|Withdrawal by Subject|2|||
161906816|NCT01211145|584708902|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
161803809|NCT01239121|584325214|FG001|Overall Study|Withdrawal by Subject|4|||
161906817|NCT01211145|584708903|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
161906818|NCT01211145|584708900|FG000|Overall Study|Patient decision|2|||
161906819|NCT01211145|584708901|FG001|Overall Study|Patient decision|1|||
161561240|NCT01253200|583442062|FG001|Overall Study|Attempts|4|||
161803810|NCT01239121|584325215|FG002|Overall Study|Withdrawal by Subject|0|||
161803811|NCT04006171|584325218|FG000|Overall Study|Withdrawal by Subject|8|||
161803812|NCT04006171|584325219|FG001|Overall Study|Withdrawal by Subject|7|||
161906820|NCT01211145|584708902|FG002|Overall Study|Patient decision|0|||
161906821|NCT01211145|584708903|FG003|Overall Study|Patient decision|2|||
161906822|NCT00249834|584708906|FG000|Overall Study|Ovarian stimulation failed|1|||
161906823|NCT00249834|584708907|FG001|Overall Study|Ovarian stimulation failed|0|||
161906824|NCT00249834|584708908|FG002|Overall Study|Ovarian stimulation failed|0|||
161906825|NCT00249834|584708909|FG003|Overall Study|Ovarian stimulation failed|0|||
161906826|NCT00249834|584708910|FG004|Overall Study|Ovarian stimulation failed|0|||
161906827|NCT00249834|584708911|FG005|Overall Study|Ovarian stimulation failed|0|||
161906828|NCT00249834|584708912|FG006|Overall Study|Ovarian stimulation failed|0|||
161906829|NCT00249834|584708913|FG007|Overall Study|Ovarian stimulation failed|0|||
161906830|NCT00249834|584708906|FG000|Overall Study|Failure of down-regulation|0|||
161906831|NCT00249834|584708907|FG001|Overall Study|Failure of down-regulation|0|||
161906832|NCT00249834|584708908|FG002|Overall Study|Failure of down-regulation|0|||
161906833|NCT00249834|584708909|FG003|Overall Study|Failure of down-regulation|0|||
161906834|NCT00249834|584708910|FG004|Overall Study|Failure of down-regulation|0|||
161906835|NCT00249834|584708911|FG005|Overall Study|Failure of down-regulation|0|||
161906836|NCT00249834|584708912|FG006|Overall Study|Failure of down-regulation|1|||
161906837|NCT00249834|584708913|FG007|Overall Study|Failure of down-regulation|0|||
161906838|NCT00249834|584708906|FG000|Overall Study|Protocol Violation|0|||
161906839|NCT00249834|584708907|FG001|Overall Study|Protocol Violation|19|||
161906840|NCT00249834|584708908|FG002|Overall Study|Protocol Violation|14|||
161906841|NCT00249834|584708909|FG003|Overall Study|Protocol Violation|8|||
161906842|NCT00249834|584708910|FG004|Overall Study|Protocol Violation|5|||
161803813|NCT04006171|584325218|FG000|Overall Study|missing serum samples|2|||
161803814|NCT04006171|584325219|FG001|Overall Study|missing serum samples|2|||
161803815|NCT04006171|584325218|FG000|Overall Study|insufficient sample volume|2|||
161803816|NCT04006171|584325219|FG001|Overall Study|insufficient sample volume|3|||
161803817|NCT03049488|584325220|FG000|Overall Study|Lost to Follow-up|1|||
161803818|NCT03049488|584325221|FG001|Overall Study|Lost to Follow-up|1|||
161803819|NCT03049488|584325222|FG002|Overall Study|Lost to Follow-up|0|||
161803820|NCT03049488|584325223|FG003|Overall Study|Lost to Follow-up|0|||
161803821|NCT03049488|584325224|FG004|Overall Study|Lost to Follow-up|0|||
161803822|NCT03049488|584325225|FG005|Overall Study|Lost to Follow-up|0|||
161803823|NCT03049488|584325220|FG000|Overall Study|Moved from Area|1|||
161803824|NCT03049488|584325221|FG001|Overall Study|Moved from Area|0|||
161803825|NCT03049488|584325222|FG002|Overall Study|Moved from Area|0|||
161803826|NCT03049488|584325223|FG003|Overall Study|Moved from Area|1|||
161803827|NCT03049488|584325224|FG004|Overall Study|Moved from Area|1|||
161803828|NCT03049488|584325225|FG005|Overall Study|Moved from Area|0|||
161803829|NCT03049488|584325220|FG000|Overall Study|Physician Decision|0|||
161803830|NCT03049488|584325221|FG001|Overall Study|Physician Decision|1|||
161803831|NCT03049488|584325222|FG002|Overall Study|Physician Decision|0|||
161803832|NCT03049488|584325223|FG003|Overall Study|Physician Decision|0|||
161803833|NCT03049488|584325224|FG004|Overall Study|Physician Decision|0|||
161803834|NCT03049488|584325225|FG005|Overall Study|Physician Decision|0|||
161803835|NCT03049488|584325220|FG000|Overall Study|Withdrawal by Subject|0|||
161803836|NCT03049488|584325221|FG001|Overall Study|Withdrawal by Subject|0|||
161803837|NCT03049488|584325222|FG002|Overall Study|Withdrawal by Subject|0|||
161803838|NCT03049488|584325223|FG003|Overall Study|Withdrawal by Subject|1|||
161803839|NCT03049488|584325224|FG004|Overall Study|Withdrawal by Subject|1|||
161803840|NCT03049488|584325225|FG005|Overall Study|Withdrawal by Subject|0|||
161803841|NCT00440557|584325226|FG000|Overall Study|Withdrawal by Subject|10|||
161803842|NCT00440557|584325227|FG001|Overall Study|Withdrawal by Subject|5|||
161803843|NCT00440557|584325228|FG002|Overall Study|Withdrawal by Subject|11|||
161803844|NCT00440557|584325226|FG000|Overall Study|Lost to Follow-up|1|||
161803845|NCT00440557|584325227|FG001|Overall Study|Lost to Follow-up|2|||
161803846|NCT00440557|584325228|FG002|Overall Study|Lost to Follow-up|6|||
161803847|NCT00440557|584325226|FG000|Overall Study|Adverse Event|3|||
161803848|NCT00440557|584325227|FG001|Overall Study|Adverse Event|3|||
161906843|NCT00249834|584708911|FG005|Overall Study|Protocol Violation|2|||
161906844|NCT00249834|584708912|FG006|Overall Study|Protocol Violation|0|||
161906845|NCT00249834|584708913|FG007|Overall Study|Protocol Violation|0|||
161906846|NCT02688933|584708916|FG000|Overall Study|Adverse Event|3|||
161906847|NCT02688933|584708917|FG001|Overall Study|Adverse Event|1|||
161906848|NCT02688933|584708916|FG000|Overall Study|Lack of Efficacy|2|||
161803849|NCT00440557|584325228|FG002|Overall Study|Adverse Event|5|||
161803850|NCT00440557|584325226|FG000|Overall Study|Death|2|||
161803851|NCT00440557|584325227|FG001|Overall Study|Death|6|||
161906849|NCT02688933|584708917|FG001|Overall Study|Lack of Efficacy|2|||
161906850|NCT02688933|584708916|FG000|Overall Study|Poor compliance to protocol|7|||
161906851|NCT02688933|584708917|FG001|Overall Study|Poor compliance to protocol|4|||
161803852|NCT00440557|584325228|FG002|Overall Study|Death|3|||
161803853|NCT00440557|584325226|FG000|Overall Study|Began Dialysis|4|||
161803854|NCT00440557|584325227|FG001|Overall Study|Began Dialysis|1|||
161803855|NCT00440557|584325228|FG002|Overall Study|Began Dialysis|4|||
161803856|NCT00440557|584325226|FG000|Overall Study|Principal Investigator decision|0|||
161803857|NCT00440557|584325227|FG001|Overall Study|Principal Investigator decision|3|||
161803858|NCT00440557|584325228|FG002|Overall Study|Principal Investigator decision|1|||
161906852|NCT02688933|584708916|FG000|Overall Study|Hypoglycemia|2|||
161906853|NCT02688933|584708917|FG001|Overall Study|Hypoglycemia|0|||
161906854|NCT02688933|584708916|FG000|Overall Study|Other than Specified|14|||
161906855|NCT02688933|584708917|FG001|Overall Study|Other than Specified|25|||
161906856|NCT02688933|584708916|FG000|Overall Study|Lost to Follow-up|1|||
161906857|NCT02688933|584708917|FG001|Overall Study|Lost to Follow-up|5|||
161906858|NCT01949142|584708931|FG000|Overall Study|Withdrawal of consent|1|||
161906859|NCT01949142|584708932|FG001|Overall Study|Withdrawal of consent|0|||
161906860|NCT01949142|584708931|FG000|Overall Study|Lost to Follow-up|1|||
161906861|NCT01949142|584708932|FG001|Overall Study|Lost to Follow-up|1|||
161906862|NCT01949142|584708931|FG000|Overall Study|Parent changed their mind|1|||
161906863|NCT01949142|584708932|FG001|Overall Study|Parent changed their mind|0|||
161906864|NCT02873689|584710445|FG000|Overall Study|Lack of Efficacy|1|||
161906865|NCT02873689|584710446|FG001|Overall Study|Lack of Efficacy|0|||
161906866|NCT02873689|584710445|FG000|Overall Study|Withdrawal by Subject|2|||
161906867|NCT02873689|584710446|FG001|Overall Study|Withdrawal by Subject|2|||
161906868|NCT02873689|584710445|FG000|Overall Study|Protocol Violation|1|||
161906869|NCT02873689|584710446|FG001|Overall Study|Protocol Violation|0|||
161906870|NCT02873689|584710445|FG000|Overall Study|Adverse Event|2|||
161906871|NCT02873689|584710446|FG001|Overall Study|Adverse Event|2|||
161906872|NCT02873689|584710445|FG000|Overall Study|Randomized but not Treated|1|||
161906873|NCT02873689|584710446|FG001|Overall Study|Randomized but not Treated|1|||
161906874|NCT00434252|584710450|FG000|Overall Study|Lack of Efficacy|50|||
161906875|NCT00434252|584710451|FG001|Overall Study|Lack of Efficacy|100|||
161906876|NCT00434252|584710450|FG000|Overall Study|Adverse Event|6|||
161906877|NCT00434252|584710451|FG001|Overall Study|Adverse Event|13|||
161906878|NCT00434252|584710450|FG000|Overall Study|Death|1|||
161906879|NCT00434252|584710451|FG001|Overall Study|Death|2|||
161906880|NCT00434252|584710450|FG000|Overall Study|Lost to Follow-up|0|||
161906881|NCT00434252|584710451|FG001|Overall Study|Lost to Follow-up|1|||
161906882|NCT00434252|584710450|FG000|Overall Study|Physician Decision|4|||
161906883|NCT00434252|584710451|FG001|Overall Study|Physician Decision|8|||
161906884|NCT00434252|584710450|FG000|Overall Study|Withdrawal by Subject|3|||
161906885|NCT00434252|584710451|FG001|Overall Study|Withdrawal by Subject|7|||
161906886|NCT02337764|584710452|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
161906887|NCT02337764|584710452|FG000|Overall Study|Voluntary Withdrawal|12|||
161906888|NCT02337764|584710452|FG000|Overall Study|Lack of Efficacy|2|||
161906889|NCT02990000|584710453|FG000|Overall Study|Failed to provide data beyond baseline|36|||
161906890|NCT02990000|584710454|FG001|Overall Study|Failed to provide data beyond baseline|34|||
161906891|NCT02810418|584710461|FG000|Arm A Dose Escalation|Adverse Event|2|||
161906892|NCT02810418|584710462|FG001|Arm A Dose Escalation|Adverse Event|1|||
161906893|NCT02810418|584710463|FG002|Arm A Dose Escalation|Adverse Event|0|||
161906894|NCT02810418|584710464|FG003|Arm A Dose Escalation|Adverse Event|0|||
161906895|NCT02810418|584710465|FG004|Arm A Dose Escalation|Adverse Event|0|||
161906896|NCT02810418|584710466|FG005|Arm A Dose Escalation|Adverse Event|0|||
161906897|NCT02810418|584710467|FG006|Arm A Dose Escalation|Adverse Event|0|||
161906898|NCT02810418|584710461|FG000|Dose Expansion|Adverse Event|0|||
161906899|NCT02810418|584710462|FG001|Dose Expansion|Adverse Event|1|||
161906900|NCT02810418|584710463|FG002|Dose Expansion|Adverse Event|1|||
161906901|NCT02810418|584710464|FG003|Dose Expansion|Adverse Event|0|||
161906902|NCT02810418|584710465|FG004|Dose Expansion|Adverse Event|0|||
161906903|NCT02810418|584710466|FG005|Dose Expansion|Adverse Event|0|||
161906904|NCT02810418|584710467|FG006|Dose Expansion|Adverse Event|0|||
161906905|NCT02810418|584710461|FG000|Dose Expansion|Physician Decision|0|||
161906906|NCT02810418|584710462|FG001|Dose Expansion|Physician Decision|0|||
161906907|NCT02810418|584710463|FG002|Dose Expansion|Physician Decision|2|||
161906908|NCT02810418|584710464|FG003|Dose Expansion|Physician Decision|0|||
161906909|NCT02810418|584710465|FG004|Dose Expansion|Physician Decision|0|||
161906910|NCT02810418|584710466|FG005|Dose Expansion|Physician Decision|0|||
161453148|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
161453149|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
161453150|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
161453151|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
161453152|NCT04740905|583053581|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
161906911|NCT02810418|584710467|FG006|Dose Expansion|Physician Decision|0|||
161906912|NCT02810418|584710461|FG000|Arm B Dose Escalation|Adverse Event|0|||
161906913|NCT02810418|584710462|FG001|Arm B Dose Escalation|Adverse Event|0|||
161906914|NCT02810418|584710463|FG002|Arm B Dose Escalation|Adverse Event|0|||
161906915|NCT02810418|584710464|FG003|Arm B Dose Escalation|Adverse Event|0|||
161906916|NCT02810418|584710465|FG004|Arm B Dose Escalation|Adverse Event|1|||
161906917|NCT02810418|584710466|FG005|Arm B Dose Escalation|Adverse Event|2|||
161906918|NCT02810418|584710467|FG006|Arm B Dose Escalation|Adverse Event|0|||
161906919|NCT03103503|584710468|FG000|Overall Study|Death|64|||
161906920|NCT03103503|584710468|FG000|Overall Study|Physician Decision|57|||
161906921|NCT03103503|584710468|FG000|Overall Study|Withdrawal by Subject|10|||
161906922|NCT03103503|584710468|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
161906923|NCT03103503|584710468|FG000|Overall Study|Lost to Follow-up|3|||
161906924|NCT03103503|584710468|FG000|Overall Study|Study Closure|757|||
161906925|NCT04161391|584710475|FG000|Overall Study|Adverse Event|0|||
161906926|NCT04161391|584710476|FG001|Overall Study|Adverse Event|1|||
161906927|NCT04161391|584710477|FG002|Overall Study|Adverse Event|0|||
161906928|NCT04161391|584710478|FG003|Overall Study|Adverse Event|1|||
161906929|NCT04161391|584710479|FG004|Overall Study|Adverse Event|0|||
161906930|NCT04161391|584710480|FG005|Overall Study|Adverse Event|0|||
161906931|NCT04161391|584710481|FG006|Overall Study|Adverse Event|0|||
161906932|NCT04161391|584710482|FG007|Overall Study|Adverse Event|3|||
161906933|NCT04161391|584710483|FG008|Overall Study|Adverse Event|0|||
161906934|NCT04161391|584710475|FG000|Overall Study|Death|0|||
161906935|NCT04161391|584710476|FG001|Overall Study|Death|0|||
161906936|NCT04161391|584710477|FG002|Overall Study|Death|0|||
161906937|NCT04161391|584710478|FG003|Overall Study|Death|0|||
161906938|NCT04161391|584710479|FG004|Overall Study|Death|0|||
161906939|NCT04161391|584710480|FG005|Overall Study|Death|0|||
161906940|NCT04161391|584710481|FG006|Overall Study|Death|0|||
161906941|NCT04161391|584710482|FG007|Overall Study|Death|1|||
161906942|NCT04161391|584710483|FG008|Overall Study|Death|0|||
161906943|NCT04161391|584710475|FG000|Overall Study|Physician Decision|0|||
161906944|NCT04161391|584710476|FG001|Overall Study|Physician Decision|0|||
161906945|NCT04161391|584710477|FG002|Overall Study|Physician Decision|1|||
161906946|NCT04161391|584710478|FG003|Overall Study|Physician Decision|2|||
161906947|NCT04161391|584710479|FG004|Overall Study|Physician Decision|0|||
161906948|NCT04161391|584710480|FG005|Overall Study|Physician Decision|0|||
161906949|NCT04161391|584710481|FG006|Overall Study|Physician Decision|2|||
161906950|NCT04161391|584710482|FG007|Overall Study|Physician Decision|0|||
161906951|NCT04161391|584710483|FG008|Overall Study|Physician Decision|0|||
161906952|NCT04161391|584710475|FG000|Overall Study|Progressive Disease|4|||
161906953|NCT04161391|584710476|FG001|Overall Study|Progressive Disease|3|||
161906954|NCT04161391|584710477|FG002|Overall Study|Progressive Disease|3|||
161906955|NCT04161391|584710478|FG003|Overall Study|Progressive Disease|5|||
161906956|NCT04161391|584710479|FG004|Overall Study|Progressive Disease|3|||
161906957|NCT04161391|584710480|FG005|Overall Study|Progressive Disease|3|||
161906958|NCT04161391|584710481|FG006|Overall Study|Progressive Disease|5|||
161906959|NCT04161391|584710482|FG007|Overall Study|Progressive Disease|2|||
161906960|NCT04161391|584710483|FG008|Overall Study|Progressive Disease|2|||
161906961|NCT02579629|584710489|FG000|Overall Study|Withdrawal by Subject|0|||
161906962|NCT02579629|584710490|FG001|Overall Study|Withdrawal by Subject|1|||
161906963|NCT02579629|584710491|FG002|Overall Study|Withdrawal by Subject|0|||
161906964|NCT02579629|584710489|FG000|Overall Study|Screen Failure|2|||
161906965|NCT02579629|584710490|FG001|Overall Study|Screen Failure|0|||
161906966|NCT02579629|584710491|FG002|Overall Study|Screen Failure|2|||
161906967|NCT00737048|584710492|FG000|Overall Study|Physician Decision|0|||
161906968|NCT00737048|584710493|FG001|Overall Study|Physician Decision|0|||
161906969|NCT00737048|584710494|FG002|Overall Study|Physician Decision|1|||
161906970|NCT00737048|584710492|FG000|Overall Study|Adverse Event|0|||
161906971|NCT00737048|584710493|FG001|Overall Study|Adverse Event|1|||
161906972|NCT00737048|584710494|FG002|Overall Study|Adverse Event|0|||
161906973|NCT00737048|584710492|FG000|Overall Study|Worsening of the symptoms|3|||
161906974|NCT00737048|584710493|FG001|Overall Study|Worsening of the symptoms|5|||
161906975|NCT00737048|584710494|FG002|Overall Study|Worsening of the symptoms|3|||
161453153|NCT04740905|583053582|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
161453154|NCT01534182|583053583|FG000|Overall Study|Administrative problems|1|||
161906976|NCT01739335|584710495|FG000|Overall Study|Lost to Follow-up|7|||
161906977|NCT01739335|584710496|FG001|Overall Study|Lost to Follow-up|4|||
161906978|NCT01739335|584710495|FG000|Overall Study|Ineligible patient randomized|0|||
161906979|NCT01739335|584710496|FG001|Overall Study|Ineligible patient randomized|1|||
161453155|NCT01534182|583053584|FG001|Overall Study|Administrative problems|0|||
161453156|NCT01534182|583053583|FG000|Overall Study|Withdrawal by Subject|4|||
161453157|NCT01534182|583053584|FG001|Overall Study|Withdrawal by Subject|7|||
161453158|NCT01534182|583053583|FG000|Overall Study|Adverse Event|7|||
161453159|NCT01534182|583053584|FG001|Overall Study|Adverse Event|3|||
161453160|NCT03077087|583053585|FG000|Overall Study|Physician Decision|2|||
161453161|NCT01989468|583053586|FG000|Overall Study|Adverse Event|10|||
161561241|NCT01253200|583442063|FG002|Overall Study|Attempts|1|||
161561242|NCT01253200|583442064|FG003|Overall Study|Attempts|2|||
161906980|NCT01863771|584710498|FG000|Induction Phase|Adverse Event|9|||
161906981|NCT01863771|584710499|FG001|Induction Phase|Adverse Event|0|||
161906982|NCT01863771|584710500|FG002|Induction Phase|Adverse Event|0|||
161906983|NCT01863771|584710501|FG003|Induction Phase|Adverse Event|0|||
161906984|NCT01863771|584710498|FG000|Induction Phase|Lack of Efficacy|10|||
161906985|NCT01863771|584710499|FG001|Induction Phase|Lack of Efficacy|0|||
161906986|NCT01863771|584710500|FG002|Induction Phase|Lack of Efficacy|0|||
161906987|NCT01863771|584710501|FG003|Induction Phase|Lack of Efficacy|0|||
161906988|NCT01863771|584710498|FG000|Induction Phase|Withdrawal by Subject|2|||
161906989|NCT01863771|584710499|FG001|Induction Phase|Withdrawal by Subject|0|||
161906990|NCT01863771|584710500|FG002|Induction Phase|Withdrawal by Subject|0|||
161906991|NCT01863771|584710501|FG003|Induction Phase|Withdrawal by Subject|0|||
161906992|NCT01863771|584710498|FG000|Maintenance Phase|Adverse Event|0|||
161906993|NCT01863771|584710499|FG001|Maintenance Phase|Adverse Event|0|||
161906994|NCT01863771|584710500|FG002|Maintenance Phase|Adverse Event|1|||
161906995|NCT01863771|584710501|FG003|Maintenance Phase|Adverse Event|1|||
161906996|NCT01863771|584710498|FG000|Maintenance Phase|Lack of Efficacy|0|||
161906997|NCT01863771|584710499|FG001|Maintenance Phase|Lack of Efficacy|3|||
161906998|NCT01863771|584710500|FG002|Maintenance Phase|Lack of Efficacy|7|||
161906999|NCT01863771|584710501|FG003|Maintenance Phase|Lack of Efficacy|38|||
161907000|NCT01863771|584710498|FG000|Maintenance Phase|Physician Decision|0|||
161907001|NCT01863771|584710499|FG001|Maintenance Phase|Physician Decision|0|||
161907002|NCT01863771|584710500|FG002|Maintenance Phase|Physician Decision|2|||
161907003|NCT01863771|584710501|FG003|Maintenance Phase|Physician Decision|1|||
161907004|NCT01863771|584710498|FG000|Maintenance Phase|Pregnancy|0|||
161907005|NCT01863771|584710499|FG001|Maintenance Phase|Pregnancy|1|||
161907006|NCT01863771|584710500|FG002|Maintenance Phase|Pregnancy|0|||
161907007|NCT01863771|584710501|FG003|Maintenance Phase|Pregnancy|0|||
161907008|NCT01863771|584710498|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161907009|NCT01863771|584710499|FG001|Maintenance Phase|Withdrawal by Subject|1|||
161907010|NCT01863771|584710500|FG002|Maintenance Phase|Withdrawal by Subject|2|||
161907011|NCT01863771|584710501|FG003|Maintenance Phase|Withdrawal by Subject|3|||
161907012|NCT02914834|584710507|FG000|Overall Study|Study halted due to COVID|1|||
161907013|NCT02914834|584710508|FG001|Overall Study|Study halted due to COVID|1|||
161907014|NCT02914834|584710507|FG000|Overall Study|1 subject withdrew|0|||
161907015|NCT02914834|584710508|FG001|Overall Study|1 subject withdrew|1|||
161907016|NCT01245101|584710515|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
161907017|NCT01245101|584710516|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
161907018|NCT01245101|584710515|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
161907019|NCT01245101|584710516|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
161907020|NCT01245101|584710515|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
161907021|NCT01245101|584710516|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
161907022|NCT00473083|584710519|FG000|Overall Study|Adverse Event|1|||
161907023|NCT00473083|584710520|FG001|Overall Study|Adverse Event|0|||
161907024|NCT00473083|584710521|FG002|Overall Study|Adverse Event|0|||
161907025|NCT02446691|584710522|FG000|Overall Study|Withdrawal by Subject|2|||
161907026|NCT02446691|584710522|FG000|Overall Study|Lost to Follow-up|8|||
161907027|NCT02446691|584710522|FG000|Overall Study|Protocol Violation|1|||
161907028|NCT03903172|584710525|FG000|Overall Study|screen fail|4|||
161907029|NCT03903172|584710526|FG001|Overall Study|screen fail|1|||
161907030|NCT01545388|584710527|FG000|Overall Study|Adverse Event|2|||
161907031|NCT01545388|584710528|FG001|Overall Study|Adverse Event|4|||
161907032|NCT01545388|584710529|FG002|Overall Study|Adverse Event|1|||
161907033|NCT01545388|584710527|FG000|Overall Study|Lack of Efficacy|3|||
161907034|NCT01545388|584710528|FG001|Overall Study|Lack of Efficacy|2|||
161907035|NCT01545388|584710529|FG002|Overall Study|Lack of Efficacy|5|||
161907036|NCT01545388|584710527|FG000|Overall Study|Participant moved or relocated|1|||
161907037|NCT01545388|584710528|FG001|Overall Study|Participant moved or relocated|0|||
161907038|NCT01545388|584710529|FG002|Overall Study|Participant moved or relocated|0|||
161907039|NCT01545388|584710527|FG000|Overall Study|Withdrawal by Subject|1|||
161907040|NCT01545388|584710528|FG001|Overall Study|Withdrawal by Subject|4|||
161907041|NCT01545388|584710529|FG002|Overall Study|Withdrawal by Subject|2|||
161907042|NCT01545388|584710527|FG000|Overall Study|Other|1|||
161907043|NCT01545388|584710528|FG001|Overall Study|Other|1|||
161907044|NCT01545388|584710529|FG002|Overall Study|Other|0|||
161907045|NCT01474486|584710532|FG000|Overall Study|Death|2|||
161907046|NCT01474486|584710532|FG000|Overall Study|Withdrawal by Subject|4|||
161907047|NCT01474486|584710532|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
161907048|NCT01255163|584710533|FG000|Overall Study|Withdrawal by Subject|1|||
161907049|NCT01255163|584710534|FG001|Overall Study|Withdrawal by Subject|0|||
161907050|NCT01255163|584710533|FG000|Overall Study|Lost to Follow-up|2|||
161907051|NCT01255163|584710534|FG001|Overall Study|Lost to Follow-up|0|||
161907052|NCT01255163|584710533|FG000|Overall Study|Adverse Event|0|||
161907053|NCT01255163|584710534|FG001|Overall Study|Adverse Event|2|||
161907054|NCT01255163|584710533|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
161907055|NCT01255163|584710534|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
161907056|NCT02495389|584710535|FG000|Overall Study|Withdrawal by Subject|40|||
161907057|NCT01924533|584710536|FG000|Overall Study|Death|181|||
161907058|NCT01924533|584710537|FG001|Overall Study|Death|200|||
161907059|NCT01924533|584710536|FG000|Overall Study|Lost to Follow-up|0|||
161907060|NCT01924533|584710537|FG001|Overall Study|Lost to Follow-up|1|||
161907061|NCT01924533|584710536|FG000|Overall Study|Withdrawal by Subject|7|||
161907062|NCT01924533|584710537|FG001|Overall Study|Withdrawal by Subject|3|||
161907063|NCT01924533|584710536|FG000|Overall Study|Other Eligibility criteria|1|||
161907064|NCT01924533|584710537|FG001|Overall Study|Other Eligibility criteria|1|||
161907065|NCT05817669|584710538|FG000|Overall Study|Prohibited medication used|1|||
161907066|NCT05817669|584710539|FG001|Overall Study|Prohibited medication used|2|||
161907067|NCT05817669|584710538|FG000|Overall Study|Adverse Event|1|||
161907068|NCT05817669|584710539|FG001|Overall Study|Adverse Event|0|||
161907069|NCT05817669|584710538|FG000|Overall Study|Withdrawal by Subject|1|||
161907070|NCT05817669|584710539|FG001|Overall Study|Withdrawal by Subject|2|||
161907071|NCT04233879|584710540|FG000|Overall Study|Death|2|||
161907072|NCT04233879|584710541|FG001|Overall Study|Death|0|||
161907073|NCT04233879|584710540|FG000|Overall Study|Lost to Follow-up|3|||
161907074|NCT04233879|584710541|FG001|Overall Study|Lost to Follow-up|8|||
161907075|NCT04233879|584710540|FG000|Overall Study|Physician Decision|4|||
161907076|NCT04233879|584710541|FG001|Overall Study|Physician Decision|4|||
161907077|NCT04233879|584710540|FG000|Overall Study|Withdrawal by Subject|7|||
161907078|NCT04233879|584710541|FG001|Overall Study|Withdrawal by Subject|10|||
161907079|NCT04233879|584710540|FG000|Overall Study|Other|281|||
161907080|NCT04233879|584710541|FG001|Overall Study|Other|279|||
161907081|NCT01802385|584710545|FG000|Overall Study|Death|106|||
161907082|NCT01802385|584710546|FG001|Overall Study|Death|120|||
161907083|NCT03810183|584710547|FG000|Overall Study|Study terminated by Sponsor|2|||
161907084|NCT03810183|584710548|FG001|Overall Study|Study terminated by Sponsor|1|||
161907085|NCT00323063|584710550|FG000|Overall Study|Adverse Event|1|||
161907086|NCT00323063|584710551|FG001|Overall Study|Adverse Event|0|||
161907087|NCT00323063|584710550|FG000|Overall Study|brain mets discovered prior to treatment|1|||
161907088|NCT00323063|584710551|FG001|Overall Study|brain mets discovered prior to treatment|0|||
161907089|NCT05002972|584710553|FG000|Overall Study|Withdrawal by Subject|2|||
161907090|NCT01664091|584710554|FG000|Overall Study|Death|1|||
161907091|NCT01664091|584710554|FG000|Overall Study|Disease Progression|2|||
161907092|NCT01664091|584710554|FG000|Overall Study|Lost to Follow-up|2|||
161907093|NCT01664091|584710554|FG000|Overall Study|Withdrawal by Subject|1|||
161907094|NCT02053493|584710557|FG000|Overall Study|Withdrawal by Subject|1|||
161907095|NCT02053493|584710558|FG001|Overall Study|Withdrawal by Subject|1|||
161907096|NCT01076543|584710561|FG000|Overall Study|Withdrawal by Subject|2|||
161907097|NCT01076543|584710562|FG001|Overall Study|Withdrawal by Subject|0|||
161907098|NCT01076543|584710563|FG002|Overall Study|Withdrawal by Subject|0|||
161907099|NCT01076543|584710564|FG003|Overall Study|Withdrawal by Subject|0|||
161907100|NCT01076543|584710565|FG004|Overall Study|Withdrawal by Subject|0|||
161907101|NCT01076543|584710566|FG005|Overall Study|Withdrawal by Subject|0|||
161907102|NCT00338741|584710567|FG000|Overall Study|Lost to Follow-up|2|||
161907103|NCT00338741|584710568|FG001|Overall Study|Lost to Follow-up|0|||
161907104|NCT01534273|584710569|FG000|Period 1|Physician Decision|0|||
161907105|NCT01534273|584710570|FG001|Period 1|Physician Decision|0|||
161907106|NCT01534273|584710571|FG002|Period 1|Physician Decision|0|||
161907107|NCT01534273|584710572|FG003|Period 1|Physician Decision|1|||
161907108|NCT01534273|584710573|FG004|Period 1|Physician Decision|0|||
161907109|NCT01534273|584710574|FG005|Period 1|Physician Decision|0|||
161907110|NCT01534273|584710575|FG006|Period 1|Physician Decision|0|||
161907111|NCT01619865|584710576|FG000|Overall Study|Adverse Event|1|||
161907112|NCT01619865|584710576|FG000|Overall Study|Death|2|||
161907113|NCT01619865|584710576|FG000|Overall Study|subject not able to comply|1|||
161907114|NCT03586050|584710577|FG000|Overall Study|Death|3|||
161907115|NCT03586050|584710577|FG000|Overall Study|Withdrawal by Subject|2|||
161907116|NCT01494818|584710578|FG000|Overall Study|Relocation|1|||
161907117|NCT01494818|584710579|FG001|Overall Study|Relocation|2|||
161907118|NCT01494818|584710578|FG000|Overall Study|Lost to Follow-up|1|||
161907119|NCT01494818|584710579|FG001|Overall Study|Lost to Follow-up|0|||
161907120|NCT00791999|584710580|FG000|Overall Study|Protocol planed withdrawal|14|||
161907121|NCT00791999|584710581|FG001|Overall Study|Protocol planed withdrawal|11|||
161907122|NCT00791999|584710582|FG002|Overall Study|Protocol planed withdrawal|11|||
161907123|NCT00791999|584710583|FG003|Overall Study|Protocol planed withdrawal|45|||
161907124|NCT00791999|584710580|FG000|Overall Study|Withdrawal by Subject|0|||
161453162|NCT01989468|583053587|FG001|Overall Study|Adverse Event|15|||
161453163|NCT01989468|583053588|FG002|Overall Study|Adverse Event|4|||
161453164|NCT01989468|583053589|FG003|Overall Study|Adverse Event|5|||
161453165|NCT01989468|583053590|FG004|Overall Study|Adverse Event|4|||
161453166|NCT01989468|583053586|FG000|Overall Study|Lack of Efficacy|11|||
161453167|NCT01989468|583053587|FG001|Overall Study|Lack of Efficacy|11|||
161453168|NCT01989468|583053588|FG002|Overall Study|Lack of Efficacy|7|||
161453169|NCT01989468|583053589|FG003|Overall Study|Lack of Efficacy|4|||
161453170|NCT01989468|583053590|FG004|Overall Study|Lack of Efficacy|2|||
161907125|NCT00791999|584710581|FG001|Overall Study|Withdrawal by Subject|1|||
161907126|NCT00791999|584710582|FG002|Overall Study|Withdrawal by Subject|0|||
161907127|NCT00791999|584710583|FG003|Overall Study|Withdrawal by Subject|2|||
161907128|NCT00791999|584710580|FG000|Overall Study|Protocol Violation|3|||
161907129|NCT00791999|584710581|FG001|Overall Study|Protocol Violation|0|||
161907130|NCT00791999|584710582|FG002|Overall Study|Protocol Violation|1|||
161907131|NCT00791999|584710583|FG003|Overall Study|Protocol Violation|0|||
161453171|NCT01989468|583053586|FG000|Overall Study|Lost to Follow-up|5|||
161907132|NCT00791999|584710580|FG000|Overall Study|Adverse Event|3|||
161907133|NCT00791999|584710581|FG001|Overall Study|Adverse Event|3|||
161453172|NCT01989468|583053587|FG001|Overall Study|Lost to Follow-up|2|||
161907134|NCT00791999|584710582|FG002|Overall Study|Adverse Event|7|||
161907135|NCT00791999|584710583|FG003|Overall Study|Adverse Event|3|||
161453173|NCT01989468|583053588|FG002|Overall Study|Lost to Follow-up|0|||
161907136|NCT00791999|584710580|FG000|Overall Study|Lack of Efficacy|0|||
161907137|NCT00791999|584710581|FG001|Overall Study|Lack of Efficacy|1|||
161907138|NCT00791999|584710582|FG002|Overall Study|Lack of Efficacy|0|||
161907139|NCT00791999|584710583|FG003|Overall Study|Lack of Efficacy|2|||
161907140|NCT00791999|584710580|FG000|Overall Study|Reason other than those above|1|||
161907141|NCT00791999|584710581|FG001|Overall Study|Reason other than those above|0|||
161907142|NCT00791999|584710582|FG002|Overall Study|Reason other than those above|1|||
161907143|NCT00791999|584710583|FG003|Overall Study|Reason other than those above|0|||
161907144|NCT00617357|584710586|FG000|Overall Study|Lost to Follow-up|7|||
161907145|NCT00617357|584710586|FG000|Overall Study|Death|5|||
161907146|NCT00617357|584710586|FG000|Overall Study|insurance concerns|2|||
161907147|NCT00617357|584710586|FG000|Overall Study|Withdrawal by Subject|1|||
161907148|NCT00617357|584710586|FG000|Overall Study|Physician Decision|1|||
161907149|NCT02153918|584710591|FG000|Overall Study|Refused further treatment|1|||
161907150|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907151|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161907152|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161803859|NCT00440557|584325226|FG000|Overall Study|Patient moved|1|||
161803860|NCT00440557|584325227|FG001|Overall Study|Patient moved|2|||
161803861|NCT00440557|584325228|FG002|Overall Study|Patient moved|1|||
161803862|NCT00440557|584325226|FG000|Overall Study|Principal Investigator's office closed|3|||
161803863|NCT00440557|584325227|FG001|Overall Study|Principal Investigator's office closed|6|||
161803864|NCT00440557|584325228|FG002|Overall Study|Principal Investigator's office closed|4|||
161803865|NCT00440557|584325226|FG000|Overall Study|Patient transferred to nursing home|0|||
161803866|NCT00440557|584325227|FG001|Overall Study|Patient transferred to nursing home|1|||
161803867|NCT00440557|584325228|FG002|Overall Study|Patient transferred to nursing home|0|||
161803868|NCT00440557|584325226|FG000|Overall Study|Patient had surgery|1|||
161803869|NCT00440557|584325227|FG001|Overall Study|Patient had surgery|0|||
161803870|NCT00440557|584325228|FG002|Overall Study|Patient had surgery|0|||
161803871|NCT01939197|584325229|FG000|Overall Study|Withdrawal by Subject|1|||
161803872|NCT01939197|584325230|FG001|Overall Study|Withdrawal by Subject|0|||
161803873|NCT01939197|584325231|FG002|Overall Study|Withdrawal by Subject|0|||
161803874|NCT01939197|584325232|FG003|Overall Study|Withdrawal by Subject|0|||
161803875|NCT01939197|584325233|FG004|Overall Study|Withdrawal by Subject|1|||
161803876|NCT01939197|584325234|FG005|Overall Study|Withdrawal by Subject|0|||
161803877|NCT01939197|584325235|FG006|Overall Study|Withdrawal by Subject|0|||
161803878|NCT01939197|584325229|FG000|Overall Study|Lost to Follow-up|0|||
161803879|NCT01939197|584325230|FG001|Overall Study|Lost to Follow-up|1|||
161803880|NCT01939197|584325231|FG002|Overall Study|Lost to Follow-up|0|||
161803881|NCT01939197|584325232|FG003|Overall Study|Lost to Follow-up|1|||
161803882|NCT01939197|584325233|FG004|Overall Study|Lost to Follow-up|3|||
161803883|NCT01939197|584325234|FG005|Overall Study|Lost to Follow-up|1|||
161803884|NCT01939197|584325235|FG006|Overall Study|Lost to Follow-up|2|||
161803885|NCT04977336|584325236|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
161803886|NCT04977336|584325237|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161803887|NCT04977336|584325238|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161803888|NCT04977336|584325239|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
161803889|NCT04977336|584325240|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161803890|NCT04977336|584325236|FG000|Overall Study|Lost to Follow-up|0|||
161803891|NCT04977336|584325237|FG001|Overall Study|Lost to Follow-up|0|||
161803892|NCT04977336|584325238|FG002|Overall Study|Lost to Follow-up|1|||
161803893|NCT04977336|584325239|FG003|Overall Study|Lost to Follow-up|0|||
161803894|NCT04977336|584325240|FG004|Overall Study|Lost to Follow-up|0|||
161803895|NCT02480764|584325242|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
161803896|NCT02480764|584325243|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161803897|NCT02480764|584325244|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
161803898|NCT02480764|584325242|FG000|Overall Study|Major Protocol Deviation|1|||
161803899|NCT02480764|584325243|FG001|Overall Study|Major Protocol Deviation|4|||
161803900|NCT02480764|584325244|FG002|Overall Study|Major Protocol Deviation|3|||
161803901|NCT02480764|584325242|FG000|Overall Study|Lost to Follow-up|0|||
161803902|NCT02480764|584325243|FG001|Overall Study|Lost to Follow-up|1|||
161803903|NCT02480764|584325244|FG002|Overall Study|Lost to Follow-up|2|||
161803904|NCT02480764|584325242|FG000|Overall Study|Voluntary Withdrawal|6|||
161803905|NCT02480764|584325243|FG001|Overall Study|Voluntary Withdrawal|5|||
161803906|NCT02480764|584325244|FG002|Overall Study|Voluntary Withdrawal|10|||
161803907|NCT02480764|584325242|FG000|Overall Study|Lack of Efficacy|0|||
161803908|NCT02480764|584325243|FG001|Overall Study|Lack of Efficacy|3|||
161907153|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161803909|NCT02480764|584325244|FG002|Overall Study|Lack of Efficacy|3|||
161803910|NCT02480764|584325242|FG000|Overall Study|Reason not Specified|0|||
161803911|NCT02480764|584325243|FG001|Overall Study|Reason not Specified|1|||
161803912|NCT02480764|584325244|FG002|Overall Study|Reason not Specified|0|||
161803913|NCT01030965|584325247|FG000|Overall Study|Lack of Efficacy|3|||
161453174|NCT01989468|583053589|FG003|Overall Study|Lost to Follow-up|1|||
161453175|NCT01989468|583053590|FG004|Overall Study|Lost to Follow-up|1|||
161453176|NCT01989468|583053586|FG000|Overall Study|Physician Decision|4|||
161453177|NCT01989468|583053587|FG001|Overall Study|Physician Decision|1|||
161453178|NCT01989468|583053588|FG002|Overall Study|Physician Decision|0|||
161453179|NCT01989468|583053589|FG003|Overall Study|Physician Decision|1|||
161803914|NCT01030965|584325248|FG001|Overall Study|Lack of Efficacy|2|||
161803915|NCT01030965|584325249|FG002|Overall Study|Lack of Efficacy|0|||
161803916|NCT01030965|584325250|FG003|Overall Study|Lack of Efficacy|3|||
161803917|NCT01030965|584325247|FG000|Overall Study|Protocol Violation|1|||
161803918|NCT01030965|584325248|FG001|Overall Study|Protocol Violation|1|||
161803919|NCT01030965|584325249|FG002|Overall Study|Protocol Violation|1|||
161803920|NCT01030965|584325250|FG003|Overall Study|Protocol Violation|1|||
161803921|NCT01030965|584325247|FG000|Overall Study|Adverse Event|0|||
161803922|NCT01030965|584325248|FG001|Overall Study|Adverse Event|1|||
161803923|NCT01030965|584325249|FG002|Overall Study|Adverse Event|2|||
161803924|NCT01030965|584325250|FG003|Overall Study|Adverse Event|1|||
161803925|NCT01030965|584325247|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
161803926|NCT01030965|584325248|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
161803927|NCT01030965|584325249|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
161803928|NCT01030965|584325250|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
161803929|NCT01030965|584325247|FG000|Overall Study|Withdrawal by Subject|0|||
161803930|NCT01030965|584325248|FG001|Overall Study|Withdrawal by Subject|1|||
161803931|NCT01030965|584325249|FG002|Overall Study|Withdrawal by Subject|0|||
161803932|NCT01030965|584325250|FG003|Overall Study|Withdrawal by Subject|2|||
161803933|NCT02097290|584325251|FG000|Overall Study|Death|6|||
161803934|NCT02097290|584325251|FG000|Overall Study|Total Withdrawals|3|||
161803935|NCT02097290|584325251|FG000|Overall Study|Attempt|8|||
161803936|NCT03991494|584325252|FG000|Overall Study|Progressive Disease|4|||
161803937|NCT05277389|584325253|FG000|Overall Study|Lost to Follow-up|1|||
161803938|NCT05277389|584325254|FG001|Overall Study|Lost to Follow-up|4|||
161803939|NCT00591630|584325262|FG000|Overall Study|Death|0|||
161803940|NCT00591630|584325263|FG001|Overall Study|Death|0|||
161803941|NCT00591630|584325264|FG002|Overall Study|Death|1|||
161803942|NCT00591630|584325265|FG003|Overall Study|Death|0|||
161803943|NCT01432171|584325266|FG000|Overall Study|Death|1|||
161803944|NCT01432171|584325267|FG001|Overall Study|Death|2|||
161803945|NCT01432171|584325266|FG000|Overall Study|Lost to Follow-up|6|||
161803946|NCT01432171|584325267|FG001|Overall Study|Lost to Follow-up|5|||
161803947|NCT01432171|584325266|FG000|Overall Study|Withdrawal by Subject|3|||
161803948|NCT01432171|584325267|FG001|Overall Study|Withdrawal by Subject|1|||
161803949|NCT01432171|584325266|FG000|Overall Study|Noncompliance|2|||
161803950|NCT01432171|584325267|FG001|Overall Study|Noncompliance|3|||
161803951|NCT01432171|584325266|FG000|Overall Study|Insurance denial trial coverage|1|||
161803952|NCT01432171|584325267|FG001|Overall Study|Insurance denial trial coverage|0|||
161803953|NCT01432171|584325266|FG000|Overall Study|Patient moved to palliative care|1|||
161803954|NCT01432171|584325267|FG001|Overall Study|Patient moved to palliative care|0|||
161803955|NCT02863575|584325268|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
161803956|NCT02863575|584325269|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
161453180|NCT01989468|583053590|FG004|Overall Study|Physician Decision|0|||
161453181|NCT01989468|583053586|FG000|Overall Study|Pregnancy|0|||
161453182|NCT01989468|583053587|FG001|Overall Study|Pregnancy|1|||
161453183|NCT01989468|583053588|FG002|Overall Study|Pregnancy|0|||
161453184|NCT01989468|583053589|FG003|Overall Study|Pregnancy|0|||
161453185|NCT01989468|583053590|FG004|Overall Study|Pregnancy|0|||
161453186|NCT01989468|583053586|FG000|Overall Study|Technical Problems|3|||
161453187|NCT01989468|583053587|FG001|Overall Study|Technical Problems|1|||
161803957|NCT02863575|584325270|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
161803958|NCT02863575|584325268|FG000|Overall Study|Withdrawal by Subject|0|||
161803959|NCT02863575|584325269|FG001|Overall Study|Withdrawal by Subject|1|||
161803960|NCT02863575|584325270|FG002|Overall Study|Withdrawal by Subject|1|||
161803961|NCT02863575|584325268|FG000|Overall Study|Adverse Event|0|||
161803962|NCT02863575|584325269|FG001|Overall Study|Adverse Event|1|||
161803963|NCT02863575|584325270|FG002|Overall Study|Adverse Event|0|||
161453188|NCT01989468|583053588|FG002|Overall Study|Technical Problems|3|||
161803964|NCT01248247|584326613|FG000|Overall Study|Adverse Event|2|||
161803965|NCT01248247|584326614|FG001|Overall Study|Adverse Event|4|||
161803966|NCT01248247|584326615|FG002|Overall Study|Adverse Event|4|||
161803967|NCT01248247|584326616|FG003|Overall Study|Adverse Event|2|||
161803968|NCT01248247|584326613|FG000|Overall Study|Death|0|||
161803969|NCT01248247|584326614|FG001|Overall Study|Death|1|||
161803970|NCT01248247|584326615|FG002|Overall Study|Death|4|||
161803971|NCT01248247|584326616|FG003|Overall Study|Death|7|||
161803972|NCT01248247|584326613|FG000|Overall Study|Lost to Follow-up|0|||
161803973|NCT01248247|584326614|FG001|Overall Study|Lost to Follow-up|1|||
161803974|NCT01248247|584326615|FG002|Overall Study|Lost to Follow-up|1|||
161803975|NCT01248247|584326616|FG003|Overall Study|Lost to Follow-up|0|||
161803976|NCT01248247|584326613|FG000|Overall Study|Alternative treatment|0|||
161803977|NCT01248247|584326614|FG001|Overall Study|Alternative treatment|1|||
161453189|NCT01989468|583053589|FG003|Overall Study|Technical Problems|1|||
161803978|NCT01248247|584326615|FG002|Overall Study|Alternative treatment|0|||
161803979|NCT01248247|584326616|FG003|Overall Study|Alternative treatment|0|||
161803980|NCT01248247|584326613|FG000|Overall Study|Other|2|||
161803981|NCT01248247|584326614|FG001|Overall Study|Other|8|||
161803982|NCT01248247|584326615|FG002|Overall Study|Other|8|||
161803983|NCT01248247|584326616|FG003|Overall Study|Other|5|||
161803984|NCT01248247|584326613|FG000|Overall Study|Progression|18|||
161803985|NCT01248247|584326614|FG001|Overall Study|Progression|27|||
161803986|NCT01248247|584326615|FG002|Overall Study|Progression|56|||
161803987|NCT01248247|584326616|FG003|Overall Study|Progression|44|||
161803988|NCT01248247|584326613|FG000|Overall Study|Refuse further treatment|0|||
161803989|NCT01248247|584326614|FG001|Overall Study|Refuse further treatment|0|||
161803990|NCT01248247|584326615|FG002|Overall Study|Refuse further treatment|1|||
161803991|NCT01248247|584326616|FG003|Overall Study|Refuse further treatment|2|||
161803992|NCT01248247|584326613|FG000|Overall Study|Complicating disease|0|||
161803993|NCT01248247|584326614|FG001|Overall Study|Complicating disease|0|||
161803994|NCT01248247|584326615|FG002|Overall Study|Complicating disease|1|||
161803995|NCT01248247|584326616|FG003|Overall Study|Complicating disease|1|||
161803996|NCT00549718|584326617|FG000|Overall Study|Insufficient clinical response|20|||
161803997|NCT00549718|584326618|FG001|Overall Study|Insufficient clinical response|7|||
161803998|NCT00549718|584326619|FG002|Overall Study|Insufficient clinical response|18|||
161803999|NCT00549718|584326620|FG003|Overall Study|Insufficient clinical response|32|||
161804000|NCT00549718|584326617|FG000|Overall Study|Adverse Event|6|||
161804001|NCT00549718|584326618|FG001|Overall Study|Adverse Event|8|||
161804002|NCT00549718|584326619|FG002|Overall Study|Adverse Event|7|||
161804003|NCT00549718|584326620|FG003|Overall Study|Adverse Event|3|||
161804004|NCT00549718|584326617|FG000|Overall Study|Lost to Follow-up|4|||
161804005|NCT00549718|584326618|FG001|Overall Study|Lost to Follow-up|2|||
161804006|NCT00549718|584326619|FG002|Overall Study|Lost to Follow-up|0|||
161804007|NCT00549718|584326620|FG003|Overall Study|Lost to Follow-up|6|||
161804008|NCT00549718|584326617|FG000|Overall Study|Withdrawal by Subject|9|||
161804009|NCT00549718|584326618|FG001|Overall Study|Withdrawal by Subject|18|||
161804010|NCT00549718|584326619|FG002|Overall Study|Withdrawal by Subject|12|||
161804011|NCT00549718|584326620|FG003|Overall Study|Withdrawal by Subject|13|||
161804012|NCT00549718|584326617|FG000|Overall Study|Administrative|2|||
161804013|NCT00549718|584326618|FG001|Overall Study|Administrative|2|||
161804014|NCT00549718|584326619|FG002|Overall Study|Administrative|2|||
161804015|NCT00549718|584326620|FG003|Overall Study|Administrative|1|||
161804016|NCT00397488|584326621|FG000|Overall Study|Withdrawal by Subject|3|||
161804017|NCT00397488|584326621|FG000|Overall Study|Adverse Event|3|||
161804018|NCT00397488|584326621|FG000|Overall Study|Death|1|||
161804019|NCT02880761|584326625|FG000|Overall Study|Death|6|||
161804020|NCT02880761|584326626|FG001|Overall Study|Death|8|||
161804021|NCT02880761|584326625|FG000|Overall Study|Withdrawal by Subject|3|||
161804022|NCT02880761|584326626|FG001|Overall Study|Withdrawal by Subject|6|||
161804023|NCT02880761|584326625|FG000|Overall Study|Protocol Violation|4|||
161804024|NCT02880761|584326626|FG001|Overall Study|Protocol Violation|3|||
161804025|NCT02880761|584326625|FG000|Overall Study|Lost to Follow-up|3|||
161804026|NCT02880761|584326626|FG001|Overall Study|Lost to Follow-up|4|||
161804027|NCT02943447|584326627|FG000|Blinded Study Phase|Withdrew Consent|1|||
161804028|NCT02943447|584326628|FG001|Blinded Study Phase|Withdrew Consent|2|||
161804029|NCT02943447|584326629|FG002|Blinded Study Phase|Withdrew Consent|1|||
161804030|NCT02943447|584326627|FG000|Blinded Study Phase|Adverse Event|3|||
161804031|NCT02943447|584326628|FG001|Blinded Study Phase|Adverse Event|0|||
161804032|NCT02943447|584326629|FG002|Blinded Study Phase|Adverse Event|0|||
161804033|NCT02943447|584326627|FG000|Blinded Study Phase|Investigator's discretion|1|||
161804034|NCT02943447|584326628|FG001|Blinded Study Phase|Investigator's discretion|0|||
161804035|NCT02943447|584326629|FG002|Blinded Study Phase|Investigator's discretion|0|||
161804036|NCT02943447|584326627|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
161804037|NCT02943447|584326628|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
161804038|NCT02943447|584326629|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
161804039|NCT02943447|584326627|FG000|Open-Label Extension Phase|Adverse Event|4|||
161804040|NCT02943447|584326628|FG001|Open-Label Extension Phase|Adverse Event|7|||
161804041|NCT02943447|584326629|FG002|Open-Label Extension Phase|Adverse Event|3|||
161804042|NCT02943447|584326627|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
161804043|NCT02943447|584326628|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
161804044|NCT02943447|584326629|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
161804045|NCT02943447|584326627|FG000|Open-Label Extension Phase|Withdrew consent|1|||
161804046|NCT02943447|584326628|FG001|Open-Label Extension Phase|Withdrew consent|1|||
161804047|NCT02943447|584326629|FG002|Open-Label Extension Phase|Withdrew consent|1|||
161804048|NCT02943447|584326627|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161804049|NCT02943447|584326628|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161804050|NCT02943447|584326629|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161804051|NCT02106156|584326630|FG000|Overall Study|Patient Died|19|||
161804052|NCT02106156|584326631|FG001|Overall Study|Patient Died|0|||
161804053|NCT02106156|584326632|FG002|Overall Study|Patient Died|0|||
161907154|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907155|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
161907156|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Refused|0|||
161907157|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Refused|0|||
161907158|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Refused|0|||
161907159|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Refused|0|||
161907160|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Refused|1|||
161907161|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Refused|0|||
161907162|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907163|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
161907164|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907165|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907166|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907167|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907168|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Death|0|||
161907169|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Death|0|||
161907170|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Death|0|||
161907171|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Death|0|||
161907172|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Death|1|||
161907173|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Death|0|||
161907174|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907175|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907176|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907177|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907178|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907179|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
161907180|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907181|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907182|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161907183|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907184|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907185|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907186|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
161907187|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161907188|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161907189|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
161907190|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161907191|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
161907192|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
161907193|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907194|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907195|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907196|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907197|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907198|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Death|1|||
161907199|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Death|0|||
161907200|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Death|1|||
161907201|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Death|1|||
161907202|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Death|1|||
161907203|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Death|0|||
161907204|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907205|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907206|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907207|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907208|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907209|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
161907210|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161907211|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907212|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907213|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907214|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907215|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907216|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
161907217|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
161907218|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907219|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907220|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907221|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907222|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161907223|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161907224|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161907225|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161907226|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161907227|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161907228|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907229|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907230|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907231|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
161907232|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
161907233|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907234|NCT03327324|584710592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
161907235|NCT03327324|584710593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907236|NCT03327324|584710594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907237|NCT03327324|584710595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907238|NCT03327324|584710596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907239|NCT03327324|584710597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907240|NCT03327324|584710592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
161907241|NCT03327324|584710593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907242|NCT03327324|584710594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907243|NCT03327324|584710595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907244|NCT03327324|584710596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907245|NCT03327324|584710597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907246|NCT01791985|584710598|FG000|Overall Study|Adverse Event|7|||
161907247|NCT01791985|584710598|FG000|Overall Study|Withdrawal by Subject|1|||
161907248|NCT01103323|584710599|FG000|Without/Before Drug Switch|Adverse Event|50|||
161907249|NCT01103323|584710600|FG001|Without/Before Drug Switch|Adverse Event|7|||
161907250|NCT01103323|584710599|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
161907251|NCT01103323|584710600|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
161907252|NCT01103323|584710599|FG000|Without/Before Drug Switch|Protocol Violation|2|||
161907253|NCT01103323|584710600|FG001|Without/Before Drug Switch|Protocol Violation|0|||
161907254|NCT01103323|584710599|FG000|Without/Before Drug Switch|Physician Decision|2|||
161907255|NCT01103323|584710600|FG001|Without/Before Drug Switch|Physician Decision|0|||
161907256|NCT01103323|584710599|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
161907257|NCT01103323|584710600|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
161907258|NCT01103323|584710599|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
161907259|NCT01103323|584710600|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
161907260|NCT01103323|584710599|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
161907261|NCT01103323|584710600|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
161907262|NCT01946204|584710606|FG000|Overall Study|Death|38|||
161907263|NCT01946204|584710607|FG001|Overall Study|Death|59|||
161907264|NCT01946204|584710606|FG000|Overall Study|Withdrawal by Subject|37|||
161907265|NCT01946204|584710607|FG001|Overall Study|Withdrawal by Subject|50|||
161907266|NCT01946204|584710606|FG000|Overall Study|Lost to Follow-up|3|||
161907267|NCT01946204|584710607|FG001|Overall Study|Lost to Follow-up|7|||
161907268|NCT01946204|584710606|FG000|Overall Study|Ongoing|316|||
161907269|NCT01946204|584710607|FG001|Overall Study|Ongoing|687|||
161907270|NCT01946204|584710606|FG000|Overall Study|Other|7|||
161907271|NCT01946204|584710607|FG001|Overall Study|Other|3|||
161907272|NCT03797898|584710608|FG000|Overall Study|Lost to Follow-up|60|||
161907273|NCT03797898|584710609|FG001|Overall Study|Lost to Follow-up|69|||
161804054|NCT02106156|584326630|FG000|Overall Study|Lack of Tolerability|305|||
161804055|NCT02106156|584326631|FG001|Overall Study|Lack of Tolerability|3|||
161804056|NCT02106156|584326632|FG002|Overall Study|Lack of Tolerability|0|||
161804057|NCT02106156|584326630|FG000|Overall Study|Lack of Virological Response|1044|||
161804058|NCT02106156|584326631|FG001|Overall Study|Lack of Virological Response|8|||
161804059|NCT02106156|584326632|FG002|Overall Study|Lack of Virological Response|0|||
161804060|NCT02106156|584326630|FG000|Overall Study|Concomitant Disease|74|||
161804061|NCT02106156|584326631|FG001|Overall Study|Concomitant Disease|2|||
161804062|NCT02106156|584326632|FG002|Overall Study|Concomitant Disease|0|||
161804063|NCT02106156|584326630|FG000|Overall Study|Lack of Compliance|211|||
161804064|NCT02106156|584326631|FG001|Overall Study|Lack of Compliance|7|||
161804065|NCT02106156|584326632|FG002|Overall Study|Lack of Compliance|0|||
161804066|NCT02106156|584326630|FG000|Overall Study|Patients Request|307|||
161804067|NCT02106156|584326631|FG001|Overall Study|Patients Request|9|||
161804068|NCT02106156|584326632|FG002|Overall Study|Patients Request|0|||
161804069|NCT02106156|584326630|FG000|Overall Study|Lost to Follow-up|451|||
161804070|NCT02106156|584326631|FG001|Overall Study|Lost to Follow-up|8|||
161804071|NCT02106156|584326632|FG002|Overall Study|Lost to Follow-up|0|||
161804072|NCT02106156|584326630|FG000|Overall Study|Unplanned Event|82|||
161804073|NCT02106156|584326631|FG001|Overall Study|Unplanned Event|2|||
161804074|NCT02106156|584326632|FG002|Overall Study|Unplanned Event|0|||
161804075|NCT02106156|584326630|FG000|Overall Study|Change of Laboratory Parameter|10|||
161804076|NCT02106156|584326631|FG001|Overall Study|Change of Laboratory Parameter|0|||
161804077|NCT02106156|584326632|FG002|Overall Study|Change of Laboratory Parameter|0|||
161804078|NCT02106156|584326630|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
161804079|NCT02106156|584326631|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
161804080|NCT02106156|584326632|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
161804081|NCT02106156|584326630|FG000|Overall Study|Relocation/Change of Physician|40|||
161804082|NCT02106156|584326631|FG001|Overall Study|Relocation/Change of Physician|1|||
161804083|NCT02106156|584326632|FG002|Overall Study|Relocation/Change of Physician|0|||
161804084|NCT01136382|584326635|FG000|Overall Study|Other|8|||
161804085|NCT01136382|584326636|FG001|Overall Study|Other|3|||
161804086|NCT01136382|584326635|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
161804087|NCT01136382|584326636|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
161804088|NCT01136382|584326635|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
161804089|NCT01136382|584326636|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161804090|NCT01136382|584326635|FG000|Overall Study|Withdrawal by Subject|4|||
161804091|NCT01136382|584326636|FG001|Overall Study|Withdrawal by Subject|1|||
161804092|NCT00358449|584326640|FG000|Overall Study|Adverse Event|1|||
161804093|NCT00358449|584326641|FG001|Overall Study|Adverse Event|0|||
161804094|NCT00358449|584326642|FG002|Overall Study|Adverse Event|1|||
161804095|NCT00358449|584326640|FG000|Overall Study|Lost to Follow-up|1|||
161804096|NCT00358449|584326641|FG001|Overall Study|Lost to Follow-up|0|||
161804097|NCT00358449|584326642|FG002|Overall Study|Lost to Follow-up|0|||
161804098|NCT00358449|584326640|FG000|Overall Study|Withdrawal by Subject|2|||
161804099|NCT00358449|584326641|FG001|Overall Study|Withdrawal by Subject|0|||
161804100|NCT00358449|584326642|FG002|Overall Study|Withdrawal by Subject|0|||
161804101|NCT00358449|584326640|FG000|Overall Study|Lack of Efficacy|0|||
161804102|NCT00358449|584326641|FG001|Overall Study|Lack of Efficacy|1|||
161804103|NCT00358449|584326642|FG002|Overall Study|Lack of Efficacy|0|||
161804104|NCT00358449|584326640|FG000|Overall Study|Steriod Inhaler was Increased|0|||
161804105|NCT00358449|584326641|FG001|Overall Study|Steriod Inhaler was Increased|0|||
161804106|NCT00358449|584326642|FG002|Overall Study|Steriod Inhaler was Increased|1|||
161804107|NCT01804270|584326643|FG000|Overall Study|Withdrawal by Subject|1|||
161804108|NCT01804270|584326644|FG001|Overall Study|Withdrawal by Subject|1|||
161804109|NCT02334722|584326646|FG000|Overall Study|Lost to Follow-up|4|||
161804110|NCT02334722|584326647|FG001|Overall Study|Lost to Follow-up|0|||
161804111|NCT02334722|584326646|FG000|Overall Study|6 week questionnaire not completed|2|||
161804112|NCT02334722|584326647|FG001|Overall Study|6 week questionnaire not completed|0|||
161804113|NCT02334722|584326646|FG000|Overall Study|Unable to obtain medication|1|||
161804114|NCT02334722|584326647|FG001|Overall Study|Unable to obtain medication|1|||
161804115|NCT02334722|584326646|FG000|Overall Study|Withdrawal by Subject|0|||
161804116|NCT02334722|584326647|FG001|Overall Study|Withdrawal by Subject|3|||
161804117|NCT02334722|584326646|FG000|Overall Study|Adverse Event|0|||
161804118|NCT02334722|584326647|FG001|Overall Study|Adverse Event|2|||
161804119|NCT02334722|584326646|FG000|Overall Study|Physician Decision|0|||
161804120|NCT02334722|584326647|FG001|Overall Study|Physician Decision|1|||
161804121|NCT03988803|584326648|FG000|Period 2|Prematurely discontinued from medication|2|||
161804122|NCT03988803|584326648|FG000|Period 2|Adverse Event|1|||
161804123|NCT01617668|584326649|FG000|Overall Study|Adverse Event|7|||
161804124|NCT01617668|584326650|FG001|Overall Study|Adverse Event|0|||
161804125|NCT01617668|584326651|FG002|Overall Study|Adverse Event|12|||
161804126|NCT01617668|584326652|FG003|Overall Study|Adverse Event|5|||
161804127|NCT01617668|584326649|FG000|Overall Study|Physician Decision|1|||
161804128|NCT01617668|584326650|FG001|Overall Study|Physician Decision|2|||
161804129|NCT01617668|584326651|FG002|Overall Study|Physician Decision|3|||
161804130|NCT01617668|584326652|FG003|Overall Study|Physician Decision|0|||
161907274|NCT03797898|584710608|FG000|Overall Study|Withdrawal by Subject|9|||
161907275|NCT03797898|584710609|FG001|Overall Study|Withdrawal by Subject|7|||
161907276|NCT03797898|584710608|FG000|Overall Study|Became ineligible|5|||
161907277|NCT03797898|584710609|FG001|Overall Study|Became ineligible|2|||
161907278|NCT00485069|584710610|FG000|Overall Study|Adverse Event|10|||
161907279|NCT00485069|584710611|FG001|Overall Study|Adverse Event|4|||
161907280|NCT00485069|584710610|FG000|Overall Study|Lack of Efficacy|2|||
161907281|NCT00485069|584710611|FG001|Overall Study|Lack of Efficacy|1|||
161907282|NCT00485069|584710610|FG000|Overall Study|Protocol Violation|0|||
161907283|NCT00485069|584710611|FG001|Overall Study|Protocol Violation|1|||
161907284|NCT00485069|584710610|FG000|Overall Study|Withdrawal by Subject|6|||
161907285|NCT00485069|584710611|FG001|Overall Study|Withdrawal by Subject|6|||
161907286|NCT03217591|584710612|FG000|Overall Study|Adverse Event|1|||
161907287|NCT03217591|584710613|FG001|Overall Study|Adverse Event|2|||
161907288|NCT03217591|584710614|FG002|Overall Study|Adverse Event|6|||
161804131|NCT01617668|584326649|FG000|Overall Study|Progressive Disease|4|||
161907289|NCT03217591|584710612|FG000|Overall Study|Withdrawal by Subject|0|||
161907290|NCT03217591|584710613|FG001|Overall Study|Withdrawal by Subject|1|||
161907291|NCT03217591|584710614|FG002|Overall Study|Withdrawal by Subject|3|||
161907292|NCT03217591|584710612|FG000|Overall Study|Lost to Follow-up|1|||
161804132|NCT01617668|584326650|FG001|Overall Study|Progressive Disease|4|||
161804133|NCT01617668|584326651|FG002|Overall Study|Progressive Disease|6|||
161804134|NCT01617668|584326652|FG003|Overall Study|Progressive Disease|9|||
161804135|NCT01617668|584326649|FG000|Overall Study|Subject/guardian decision|1|||
161804136|NCT01617668|584326650|FG001|Overall Study|Subject/guardian decision|3|||
161804137|NCT01617668|584326651|FG002|Overall Study|Subject/guardian decision|2|||
161804138|NCT01617668|584326652|FG003|Overall Study|Subject/guardian decision|1|||
161804139|NCT00925769|584326653|FG000|Overall Study|Major toxicity|1|||
161804140|NCT00925769|584326654|FG001|Overall Study|Major toxicity|0|||
161804141|NCT00925769|584326655|FG002|Overall Study|Major toxicity|1|||
161804142|NCT00925769|584326656|FG003|Overall Study|Major toxicity|1|||
161804143|NCT00925769|584326657|FG004|Overall Study|Major toxicity|0|||
161804144|NCT00925769|584326658|FG005|Overall Study|Major toxicity|0|||
161804145|NCT00925769|584326653|FG000|Overall Study|Disease progression|4|||
161804146|NCT00925769|584326654|FG001|Overall Study|Disease progression|5|||
161804147|NCT00925769|584326655|FG002|Overall Study|Disease progression|3|||
161804148|NCT00925769|584326656|FG003|Overall Study|Disease progression|4|||
161804149|NCT00925769|584326657|FG004|Overall Study|Disease progression|2|||
161804150|NCT00925769|584326658|FG005|Overall Study|Disease progression|3|||
161804151|NCT00925769|584326653|FG000|Overall Study|Death|0|||
161804152|NCT00925769|584326654|FG001|Overall Study|Death|0|||
161804153|NCT00925769|584326655|FG002|Overall Study|Death|1|||
161804154|NCT00925769|584326656|FG003|Overall Study|Death|0|||
161804155|NCT00925769|584326657|FG004|Overall Study|Death|0|||
161804156|NCT00925769|584326658|FG005|Overall Study|Death|0|||
161804157|NCT00925769|584326653|FG000|Overall Study|Physician Decision|1|||
161804158|NCT00925769|584326654|FG001|Overall Study|Physician Decision|0|||
161804159|NCT00925769|584326655|FG002|Overall Study|Physician Decision|0|||
161804160|NCT00925769|584326656|FG003|Overall Study|Physician Decision|0|||
161804161|NCT00925769|584326657|FG004|Overall Study|Physician Decision|0|||
161804162|NCT00925769|584326658|FG005|Overall Study|Physician Decision|0|||
161804163|NCT00925769|584326653|FG000|Overall Study|Missing documentation|0|||
161804164|NCT00925769|584326654|FG001|Overall Study|Missing documentation|1|||
161453190|NCT01989468|583053590|FG004|Overall Study|Technical Problems|0|||
161907293|NCT03217591|584710613|FG001|Overall Study|Lost to Follow-up|0|||
161907294|NCT03217591|584710614|FG002|Overall Study|Lost to Follow-up|0|||
161907295|NCT03217591|584710612|FG000|Overall Study|Protocol Violation|1|||
161907296|NCT03217591|584710613|FG001|Overall Study|Protocol Violation|0|||
161907297|NCT03217591|584710614|FG002|Overall Study|Protocol Violation|1|||
161453191|NCT01989468|583053586|FG000|Overall Study|Subject Guardian Decision|11|||
161453192|NCT01989468|583053587|FG001|Overall Study|Subject Guardian Decision|6|||
161453193|NCT01989468|583053588|FG002|Overall Study|Subject Guardian Decision|4|||
161453194|NCT01989468|583053589|FG003|Overall Study|Subject Guardian Decision|4|||
161453195|NCT01989468|583053590|FG004|Overall Study|Subject Guardian Decision|1|||
161453196|NCT01989468|583053586|FG000|Overall Study|Death|3|||
161804165|NCT00925769|584326655|FG002|Overall Study|Missing documentation|0|||
161804166|NCT00925769|584326656|FG003|Overall Study|Missing documentation|0|||
161804167|NCT00925769|584326657|FG004|Overall Study|Missing documentation|0|||
161804168|NCT00925769|584326658|FG005|Overall Study|Missing documentation|0|||
161804169|NCT00925769|584326653|FG000|Overall Study|End of study visit not done|0|||
161804170|NCT00925769|584326654|FG001|Overall Study|End of study visit not done|0|||
161804171|NCT00925769|584326655|FG002|Overall Study|End of study visit not done|1|||
161804172|NCT00925769|584326656|FG003|Overall Study|End of study visit not done|0|||
161907298|NCT00086190|584710615|FG000|Overall Study|Adverse Event|6|||
161907299|NCT00086190|584710616|FG001|Overall Study|Adverse Event|2|||
161804173|NCT00925769|584326657|FG004|Overall Study|End of study visit not done|0|||
161804174|NCT00925769|584326658|FG005|Overall Study|End of study visit not done|0|||
161804175|NCT00925769|584326653|FG000|Overall Study|Participant is unable to swallow drug|0|||
161804176|NCT00925769|584326654|FG001|Overall Study|Participant is unable to swallow drug|0|||
161907300|NCT00086190|584710617|FG002|Overall Study|Adverse Event|2|||
161907301|NCT00086190|584710615|FG000|Overall Study|Withdrawal by Subject|0|||
161907302|NCT00086190|584710616|FG001|Overall Study|Withdrawal by Subject|2|||
161907303|NCT00086190|584710617|FG002|Overall Study|Withdrawal by Subject|2|||
161907304|NCT00086190|584710615|FG000|Overall Study|Protocol Violation|1|||
161907305|NCT00086190|584710616|FG001|Overall Study|Protocol Violation|0|||
161907306|NCT00086190|584710617|FG002|Overall Study|Protocol Violation|0|||
161907307|NCT00086190|584710615|FG000|Overall Study|Moved|1|||
161907308|NCT00086190|584710616|FG001|Overall Study|Moved|0|||
161907309|NCT00086190|584710617|FG002|Overall Study|Moved|0|||
161907310|NCT00086190|584710615|FG000|Overall Study|Worsening depression|0|||
161907311|NCT00086190|584710616|FG001|Overall Study|Worsening depression|0|||
161907312|NCT00086190|584710617|FG002|Overall Study|Worsening depression|2|||
161453197|NCT01989468|583053587|FG001|Overall Study|Death|0|||
161804177|NCT00925769|584326655|FG002|Overall Study|Participant is unable to swallow drug|0|||
161804178|NCT00925769|584326656|FG003|Overall Study|Participant is unable to swallow drug|1|||
161804179|NCT00925769|584326657|FG004|Overall Study|Participant is unable to swallow drug|0|||
161804180|NCT00925769|584326658|FG005|Overall Study|Participant is unable to swallow drug|0|||
161804181|NCT00925769|584326653|FG000|Overall Study|Adverse Event|0|||
161804182|NCT00925769|584326654|FG001|Overall Study|Adverse Event|0|||
161804183|NCT00925769|584326655|FG002|Overall Study|Adverse Event|0|||
161804184|NCT00925769|584326656|FG003|Overall Study|Adverse Event|0|||
161804185|NCT00925769|584326657|FG004|Overall Study|Adverse Event|1|||
161804186|NCT00925769|584326658|FG005|Overall Study|Adverse Event|0|||
161804187|NCT01666730|584326661|FG000|Overall Study|Adverse Event|16|||
161804188|NCT01666730|584326661|FG000|Overall Study|Death|2|||
161804189|NCT01666730|584326661|FG000|Overall Study|Physician Decision|5|||
161804190|NCT01666730|584326661|FG000|Overall Study|Withdrawal by Subject|9|||
161804191|NCT01666730|584326661|FG000|Overall Study|Disease progression/relapse|18|||
161804192|NCT01434693|584326662|FG000|Overall Study|Adverse Event|1|||
161804193|NCT01434693|584326663|FG001|Overall Study|Adverse Event|0|||
161804194|NCT01434693|584326664|FG002|Overall Study|Adverse Event|0|||
161804195|NCT01434693|584326665|FG003|Overall Study|Adverse Event|0|||
161804196|NCT01434693|584326662|FG000|Overall Study|Withdrawal by Subject|1|||
161804197|NCT01434693|584326663|FG001|Overall Study|Withdrawal by Subject|0|||
161804198|NCT01434693|584326664|FG002|Overall Study|Withdrawal by Subject|1|||
161804199|NCT01434693|584326665|FG003|Overall Study|Withdrawal by Subject|1|||
161804200|NCT01434693|584326662|FG000|Overall Study|Lost to Follow-up|1|||
161804201|NCT01434693|584326663|FG001|Overall Study|Lost to Follow-up|0|||
161804202|NCT01434693|584326664|FG002|Overall Study|Lost to Follow-up|0|||
161804203|NCT01434693|584326665|FG003|Overall Study|Lost to Follow-up|0|||
161804204|NCT00912288|584326666|FG000|Overall Study|Death|0|||
161804205|NCT00912288|584326667|FG001|Overall Study|Death|1|||
161804206|NCT00912288|584326666|FG000|Overall Study|Adverse Event|1|||
161804207|NCT00912288|584326667|FG001|Overall Study|Adverse Event|1|||
161804208|NCT00912288|584326666|FG000|Overall Study|Lost to Follow-up|1|||
161804209|NCT00912288|584326667|FG001|Overall Study|Lost to Follow-up|0|||
161804210|NCT00912288|584326666|FG000|Overall Study|Protocol Violation|1|||
161804211|NCT00912288|584326667|FG001|Overall Study|Protocol Violation|0|||
161804212|NCT00912288|584326666|FG000|Overall Study|Withdrawal by Subject|3|||
161804213|NCT00912288|584326667|FG001|Overall Study|Withdrawal by Subject|3|||
161804214|NCT00912288|584326666|FG000|Overall Study|Study terminated by sponsor|34|||
161804215|NCT00912288|584326667|FG001|Overall Study|Study terminated by sponsor|35|||
161804216|NCT00912288|584326666|FG000|Overall Study|Other|1|||
161804217|NCT00912288|584326667|FG001|Overall Study|Other|0|||
161804218|NCT02087904|584326669|FG000|Overall Study|Did Not Receive Study Drug|0|||
161804219|NCT02087904|584326670|FG001|Overall Study|Did Not Receive Study Drug|0|||
161804220|NCT02087904|584326671|FG002|Overall Study|Did Not Receive Study Drug|2|||
161804221|NCT02087904|584326672|FG003|Overall Study|Did Not Receive Study Drug|1|||
161907313|NCT03902613|584710622|FG000|Overall Study|Physician Decision|1|||
161907314|NCT00350545|584712125|FG000|Overall Study|Withdrawal by Subject|2|||
161907315|NCT01190891|584712126|FG000|Overall Study|Protocol Violation|1|||
161907316|NCT01190891|584712127|FG001|Overall Study|Protocol Violation|0|||
161907317|NCT01190891|584712126|FG000|Overall Study|Withdrawal by Subject|5|||
161804222|NCT02087904|584326669|FG000|Overall Study|Adverse Event|8|||
161804223|NCT02087904|584326670|FG001|Overall Study|Adverse Event|4|||
161804224|NCT02087904|584326671|FG002|Overall Study|Adverse Event|4|||
161804225|NCT02087904|584326672|FG003|Overall Study|Adverse Event|12|||
161804226|NCT02087904|584326669|FG000|Overall Study|Lack of Efficacy|3|||
161804227|NCT02087904|584326670|FG001|Overall Study|Lack of Efficacy|6|||
161804228|NCT02087904|584326671|FG002|Overall Study|Lack of Efficacy|3|||
161804229|NCT02087904|584326672|FG003|Overall Study|Lack of Efficacy|2|||
161804230|NCT02087904|584326669|FG000|Overall Study|Other|6|||
161804231|NCT02087904|584326670|FG001|Overall Study|Other|2|||
161804232|NCT02087904|584326671|FG002|Overall Study|Other|4|||
161804233|NCT02087904|584326672|FG003|Overall Study|Other|4|||
161804234|NCT02087904|584326669|FG000|Overall Study|Withdrawal by Subject|8|||
161804235|NCT02087904|584326670|FG001|Overall Study|Withdrawal by Subject|3|||
161804236|NCT02087904|584326671|FG002|Overall Study|Withdrawal by Subject|7|||
161907318|NCT01190891|584712127|FG001|Overall Study|Withdrawal by Subject|0|||
161907319|NCT00301834|584712128|FG000|Overall Study|Death|1|||
161907320|NCT02737358|584712129|FG000|Overall Study|Withdrawal by Subject|7|||
161907321|NCT02737358|584712130|FG001|Overall Study|Withdrawal by Subject|12|||
161907322|NCT02737358|584712129|FG000|Overall Study|Lost to Follow-up|2|||
161907323|NCT02737358|584712130|FG001|Overall Study|Lost to Follow-up|3|||
161907324|NCT00744939|584712131|FG000|Overall Study|Withdrawal by Subject|9|||
161907325|NCT00744939|584712131|FG000|Overall Study|Protocol Violation|13|||
161907326|NCT00744939|584712131|FG000|Overall Study|Death|24|||
161907327|NCT00744939|584712131|FG000|Overall Study|distance|4|||
161907328|NCT00744939|584712131|FG000|Overall Study|Lost to Follow-up|12|||
161907329|NCT00744939|584712131|FG000|Overall Study|Medical history exclusionary|1|||
161907330|NCT00744939|584712131|FG000|Overall Study|Did not receive Magnevist|7|||
161907331|NCT00744939|584712131|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
161907332|NCT00744939|584712131|FG000|Overall Study|coma|1|||
161907333|NCT00744939|584712131|FG000|Overall Study|incorrect race|1|||
161907334|NCT00183430|584712132|FG000|Overall Study|Adverse Event|1|||
161907335|NCT00183430|584712133|FG001|Overall Study|Adverse Event|0|||
161907336|NCT00183430|584712132|FG000|Overall Study|Lost to Follow-up|3|||
161907337|NCT00183430|584712133|FG001|Overall Study|Lost to Follow-up|0|||
161907338|NCT00183430|584712132|FG000|Overall Study|did not meet inclusion criteria|1|||
161907339|NCT00183430|584712133|FG001|Overall Study|did not meet inclusion criteria|0|||
161907340|NCT00183430|584712132|FG000|Overall Study|Withdrawal by Subject|1|||
161907341|NCT00183430|584712133|FG001|Overall Study|Withdrawal by Subject|0|||
161907342|NCT03636256|584712142|FG000|Overall Study|Lost to Follow-up|3|||
161907343|NCT03636256|584712143|FG001|Overall Study|Lost to Follow-up|0|||
161907344|NCT03636256|584712144|FG002|Overall Study|Lost to Follow-up|2|||
161907345|NCT03636256|584712145|FG003|Overall Study|Lost to Follow-up|1|||
161907346|NCT03636256|584712146|FG004|Overall Study|Lost to Follow-up|0|||
161907347|NCT03636256|584712147|FG005|Overall Study|Lost to Follow-up|4|||
161907348|NCT03636256|584712148|FG006|Overall Study|Lost to Follow-up|2|||
161907349|NCT03636256|584712149|FG007|Overall Study|Lost to Follow-up|0|||
161907350|NCT03636256|584712150|FG008|Overall Study|Lost to Follow-up|4|||
161907351|NCT03636256|584712142|FG000|Overall Study|Withdrawal by Subject|0|||
161907352|NCT03636256|584712143|FG001|Overall Study|Withdrawal by Subject|0|||
161907353|NCT03636256|584712144|FG002|Overall Study|Withdrawal by Subject|0|||
161907354|NCT03636256|584712145|FG003|Overall Study|Withdrawal by Subject|0|||
161907355|NCT03636256|584712146|FG004|Overall Study|Withdrawal by Subject|0|||
161907356|NCT03636256|584712147|FG005|Overall Study|Withdrawal by Subject|0|||
161907357|NCT03636256|584712148|FG006|Overall Study|Withdrawal by Subject|0|||
161907358|NCT03636256|584712149|FG007|Overall Study|Withdrawal by Subject|0|||
161907359|NCT03636256|584712150|FG008|Overall Study|Withdrawal by Subject|1|||
161907360|NCT01218308|584712151|FG000|Overall Study|Adverse Event|1|||
161907361|NCT01218308|584712152|FG001|Overall Study|Adverse Event|2|||
161907362|NCT01218308|584712151|FG000|Overall Study|Protocol Violation|0|||
161907363|NCT01218308|584712152|FG001|Overall Study|Protocol Violation|2|||
161907364|NCT01218308|584712151|FG000|Overall Study|Withdrawal by Subject|61|||
161907365|NCT01218308|584712152|FG001|Overall Study|Withdrawal by Subject|64|||
161907366|NCT01218308|584712151|FG000|Overall Study|Lost to Follow-up|27|||
161907367|NCT01218308|584712152|FG001|Overall Study|Lost to Follow-up|31|||
161907368|NCT01218308|584712151|FG000|Overall Study|Other|14|||
161907369|NCT01218308|584712152|FG001|Overall Study|Other|21|||
161907370|NCT02666222|584712160|FG000|Overall Study|Death|2|||
161907371|NCT03504917|584712164|FG000|Blinded Treatment Period|Protocol Violation|1|||
161907372|NCT03504917|584712165|FG001|Blinded Treatment Period|Protocol Violation|0|||
161907373|NCT03504917|584712164|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
161907374|NCT03504917|584712165|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
161907375|NCT03504917|584712164|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
161907376|NCT03504917|584712165|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
161907377|NCT03504917|584712164|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
161907378|NCT03504917|584712165|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
161907379|NCT03504917|584712164|FG000|Blinded Treatment Period|Adverse Event|4|||
161907380|NCT03504917|584712165|FG001|Blinded Treatment Period|Adverse Event|4|||
161907381|NCT03504917|584712164|FG000|Blinded Treatment Period|Physician Decision|1|||
161907382|NCT03504917|584712165|FG001|Blinded Treatment Period|Physician Decision|0|||
161907383|NCT03504917|584712164|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
161907384|NCT03504917|584712165|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
161907385|NCT03504917|584712164|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
161907386|NCT03504917|584712165|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
161907387|NCT03504917|584712164|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
161453198|NCT01989468|583053588|FG002|Overall Study|Death|1|||
161907388|NCT03504917|584712165|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
161907389|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
161907390|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
161804237|NCT02087904|584326672|FG003|Overall Study|Withdrawal by Subject|4|||
161804238|NCT02087904|584326669|FG000|Overall Study|Lost to Follow-up|0|||
161804239|NCT02087904|584326670|FG001|Overall Study|Lost to Follow-up|4|||
161804240|NCT02087904|584326671|FG002|Overall Study|Lost to Follow-up|2|||
161804241|NCT02087904|584326672|FG003|Overall Study|Lost to Follow-up|2|||
161804242|NCT01735630|584326673|FG000|Overall Study|Adverse Event|8|||
161804243|NCT01735630|584326674|FG001|Overall Study|Adverse Event|7|||
161804244|NCT01735630|584326673|FG000|Overall Study|Lost to Follow-up|1|||
161804245|NCT01735630|584326674|FG001|Overall Study|Lost to Follow-up|0|||
161804246|NCT01735630|584326673|FG000|Overall Study|Physician Decision|0|||
161804247|NCT01735630|584326674|FG001|Overall Study|Physician Decision|1|||
161804248|NCT01735630|584326673|FG000|Overall Study|Sponsor Decision|2|||
161804249|NCT01735630|584326674|FG001|Overall Study|Sponsor Decision|1|||
161804250|NCT01735630|584326673|FG000|Overall Study|Withdrawal by Subject|7|||
161804251|NCT01735630|584326674|FG001|Overall Study|Withdrawal by Subject|9|||
161804252|NCT00891293|584326676|FG000|Overall Study|Adverse Event|2|||
161804253|NCT00891293|584326676|FG000|Overall Study|Protocol Violation|2|||
161804254|NCT00891293|584326676|FG000|Overall Study|Laboratory abnormality|4|||
161804255|NCT00891293|584326676|FG000|Overall Study|Lost to Follow-up|7|||
161804256|NCT00891293|584326676|FG000|Overall Study|Subject withdrew consent|7|||
161804257|NCT00891293|584326676|FG000|Overall Study|Sponsor termination|62|||
161804258|NCT02178722|584326677|FG000|Overall Study|Withdrawal by Subject|0|||
161804259|NCT02178722|584326678|FG001|Overall Study|Withdrawal by Subject|0|||
161804260|NCT02178722|584326679|FG002|Overall Study|Withdrawal by Subject|0|||
161804261|NCT02178722|584326680|FG003|Overall Study|Withdrawal by Subject|2|||
161804262|NCT02178722|584326681|FG004|Overall Study|Withdrawal by Subject|33|||
161804263|NCT02178722|584326677|FG000|Overall Study|Death|2|||
161804264|NCT02178722|584326678|FG001|Overall Study|Death|13|||
161804265|NCT02178722|584326679|FG002|Overall Study|Death|12|||
161804266|NCT02178722|584326680|FG003|Overall Study|Death|12|||
161804267|NCT02178722|584326681|FG004|Overall Study|Death|205|||
161804268|NCT02178722|584326677|FG000|Overall Study|Lost to Follow-up|0|||
161804269|NCT02178722|584326678|FG001|Overall Study|Lost to Follow-up|0|||
161804270|NCT02178722|584326679|FG002|Overall Study|Lost to Follow-up|0|||
161804271|NCT02178722|584326680|FG003|Overall Study|Lost to Follow-up|2|||
161804272|NCT02178722|584326681|FG004|Overall Study|Lost to Follow-up|11|||
161804273|NCT02178722|584326677|FG000|Overall Study|Study terminated by Sponsor|2|||
161804274|NCT02178722|584326678|FG001|Overall Study|Study terminated by Sponsor|7|||
161804275|NCT02178722|584326679|FG002|Overall Study|Study terminated by Sponsor|6|||
161804276|NCT02178722|584326680|FG003|Overall Study|Study terminated by Sponsor|4|||
161804277|NCT02178722|584326681|FG004|Overall Study|Study terminated by Sponsor|128|||
161804278|NCT02178722|584326677|FG000|Overall Study|Physician Decision|0|||
161907391|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
161907392|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
161907393|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
161907394|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
161907395|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
161907396|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
161804279|NCT02178722|584326678|FG001|Overall Study|Physician Decision|0|||
161804280|NCT02178722|584326679|FG002|Overall Study|Physician Decision|0|||
161804281|NCT02178722|584326680|FG003|Overall Study|Physician Decision|0|||
161804282|NCT02178722|584326681|FG004|Overall Study|Physician Decision|3|||
161804283|NCT02178722|584326677|FG000|Overall Study|Other|0|||
161804284|NCT02178722|584326678|FG001|Overall Study|Other|0|||
161907397|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
161907398|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
161907399|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
161804285|NCT02178722|584326679|FG002|Overall Study|Other|0|||
161804286|NCT02178722|584326680|FG003|Overall Study|Other|0|||
161804287|NCT02178722|584326681|FG004|Overall Study|Other|2|||
161804288|NCT01572948|584326682|FG000|Overall Study|Lost to Follow-up|1|||
161804289|NCT01572948|584326683|FG001|Overall Study|Lost to Follow-up|0|||
161804290|NCT01572948|584326682|FG000|Overall Study|unable to contact|0|||
161804291|NCT01572948|584326683|FG001|Overall Study|unable to contact|1|||
161804292|NCT02107092|584326690|FG000|Overall Study|Miscellaneous|3|||
161804293|NCT02107092|584326690|FG000|Overall Study|Subject compliance|3|||
161804294|NCT02107092|584326690|FG000|Overall Study|Hypo-or hyperkalemia|2|||
161804295|NCT02107092|584326690|FG000|Overall Study|Met ECG withdrawal criteria|3|||
161804296|NCT02107092|584326690|FG000|Overall Study|Physician Decision|3|||
161804297|NCT02107092|584326690|FG000|Overall Study|Lost to Follow-up|2|||
161804298|NCT02107092|584326690|FG000|Overall Study|Withdrawal by Subject|9|||
161804299|NCT02107092|584326690|FG000|Overall Study|Adverse Event|7|||
161804300|NCT02107092|584326690|FG000|Overall Study|Expected progression of CKD|12|||
161804301|NCT00537030|584326691|FG000|Overall Study|Physician Decision|2|||
161804302|NCT00537030|584326691|FG000|Overall Study|Withdrawal by Subject|2|||
161804303|NCT00537030|584326691|FG000|Overall Study|≥ Grade 2 allergy|7|||
161804304|NCT00537030|584326691|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
161804305|NCT00537030|584326691|FG000|Overall Study|Ineligible|2|||
161907400|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
161907401|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
161907402|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
161907403|NCT03863353|584712166|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
161907404|NCT03863353|584712167|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
161907405|NCT04079790|584712171|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
161907406|NCT04079790|584712172|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161907407|NCT04079790|584712173|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161907408|NCT04079790|584712174|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161907409|NCT04079790|584712171|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161907410|NCT04079790|584712172|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161907411|NCT04079790|584712173|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
161907412|NCT04079790|584712174|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161907413|NCT04079790|584712171|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161907414|NCT04079790|584712172|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161907415|NCT04079790|584712173|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
161907416|NCT04079790|584712174|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161907417|NCT04275336|584712178|FG000|Overall Study|First venipuncture failed|4|||
161907418|NCT04275336|584712179|FG001|Overall Study|First venipuncture failed|6|||
161907419|NCT04275336|584712180|FG002|Overall Study|First venipuncture failed|5|||
161907420|NCT04275336|584712178|FG000|Overall Study|Unscheduled venipuncture|9|||
161907421|NCT04275336|584712179|FG001|Overall Study|Unscheduled venipuncture|13|||
161907422|NCT04275336|584712180|FG002|Overall Study|Unscheduled venipuncture|7|||
161907423|NCT04275336|584712178|FG000|Overall Study|Failed specimen of saliva|4|||
161907424|NCT04275336|584712179|FG001|Overall Study|Failed specimen of saliva|3|||
161907425|NCT04275336|584712180|FG002|Overall Study|Failed specimen of saliva|4|||
161907426|NCT03055936|584712181|FG000|Overall Study|Adverse Event|0|||
161907427|NCT03055936|584712182|FG001|Overall Study|Adverse Event|1|||
161907428|NCT03055936|584712183|FG002|Overall Study|Adverse Event|1|||
161907429|NCT03055936|584712184|FG003|Overall Study|Adverse Event|1|||
161907430|NCT03055936|584712181|FG000|Overall Study|Personal reason|2|||
161907431|NCT03055936|584712182|FG001|Overall Study|Personal reason|0|||
161907432|NCT03055936|584712183|FG002|Overall Study|Personal reason|1|||
161907433|NCT03055936|584712184|FG003|Overall Study|Personal reason|0|||
161907434|NCT01909804|584712191|FG000|Overall Study|Randomized but Never Treated|0|||
161907435|NCT01909804|584712192|FG001|Overall Study|Randomized but Never Treated|0|||
161907436|NCT01909804|584712193|FG002|Overall Study|Randomized but Never Treated|0|||
161907437|NCT01909804|584712194|FG003|Overall Study|Randomized but Never Treated|0|||
161907438|NCT01909804|584712195|FG004|Overall Study|Randomized but Never Treated|0|||
161907439|NCT01909804|584712196|FG005|Overall Study|Randomized but Never Treated|0|||
161907440|NCT01909804|584712197|FG006|Overall Study|Randomized but Never Treated|1|||
161907441|NCT01909804|584712198|FG007|Overall Study|Randomized but Never Treated|0|||
161907442|NCT01909804|584712199|FG008|Overall Study|Randomized but Never Treated|0|||
161907443|NCT01909804|584712200|FG009|Overall Study|Randomized but Never Treated|0|||
161907444|NCT01909804|584712201|FG010|Overall Study|Randomized but Never Treated|0|||
161907445|NCT01909804|584712202|FG011|Overall Study|Randomized but Never Treated|1|||
161907446|NCT01909804|584712191|FG000|Overall Study|Death|0|||
161907447|NCT01909804|584712192|FG001|Overall Study|Death|0|||
161907448|NCT01909804|584712193|FG002|Overall Study|Death|0|||
161907449|NCT01909804|584712194|FG003|Overall Study|Death|0|||
161907450|NCT01909804|584712195|FG004|Overall Study|Death|0|||
161907451|NCT01909804|584712196|FG005|Overall Study|Death|0|||
161907452|NCT01909804|584712197|FG006|Overall Study|Death|0|||
161907453|NCT01909804|584712198|FG007|Overall Study|Death|0|||
161907454|NCT01909804|584712199|FG008|Overall Study|Death|0|||
161907455|NCT01909804|584712200|FG009|Overall Study|Death|0|||
161907456|NCT01909804|584712201|FG010|Overall Study|Death|1|||
161907457|NCT01909804|584712202|FG011|Overall Study|Death|0|||
161907458|NCT01909804|584712191|FG000|Overall Study|Lack of Efficacy|4|||
161907459|NCT01909804|584712192|FG001|Overall Study|Lack of Efficacy|1|||
161907460|NCT01909804|584712193|FG002|Overall Study|Lack of Efficacy|0|||
161907461|NCT01909804|584712194|FG003|Overall Study|Lack of Efficacy|0|||
161907462|NCT01909804|584712195|FG004|Overall Study|Lack of Efficacy|7|||
161907463|NCT01909804|584712196|FG005|Overall Study|Lack of Efficacy|3|||
161907464|NCT01909804|584712197|FG006|Overall Study|Lack of Efficacy|1|||
161907465|NCT01909804|584712198|FG007|Overall Study|Lack of Efficacy|1|||
161907466|NCT01909804|584712199|FG008|Overall Study|Lack of Efficacy|0|||
161907467|NCT01909804|584712200|FG009|Overall Study|Lack of Efficacy|1|||
161907468|NCT01909804|584712201|FG010|Overall Study|Lack of Efficacy|0|||
161907469|NCT01909804|584712202|FG011|Overall Study|Lack of Efficacy|1|||
161561243|NCT01253200|583442065|FG004|Overall Study|Attempts|0|||
161561244|NCT02049437|583442066|FG000|Period 1|Adverse Event|1|||
161907470|NCT01909804|584712191|FG000|Overall Study|Withdrew Consent|0|||
161907471|NCT01909804|584712192|FG001|Overall Study|Withdrew Consent|0|||
161907472|NCT01909804|584712193|FG002|Overall Study|Withdrew Consent|0|||
161804306|NCT00537030|584326691|FG000|Overall Study|Inevaluable|2|||
161804307|NCT04213326|584326693|FG000|Overall Study|Consent withdrawn|51|||
161804308|NCT04213326|584326694|FG001|Overall Study|Consent withdrawn|241|||
161804309|NCT04213326|584326693|FG000|Overall Study|Lost to Follow-up|50|||
161804310|NCT04213326|584326694|FG001|Overall Study|Lost to Follow-up|902|||
161804311|NCT04213326|584326693|FG000|Overall Study|Protocol Violation|3|||
161804312|NCT04213326|584326694|FG001|Overall Study|Protocol Violation|25|||
161804313|NCT04213326|584326693|FG000|Overall Study|Participant eligibility changed|106|||
161804314|NCT04213326|584326694|FG001|Overall Study|Participant eligibility changed|19|||
161804315|NCT04213326|584326693|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
161804316|NCT04213326|584326694|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
161804317|NCT04213326|584326693|FG000|Overall Study|Incomplete study visit|0|||
161804318|NCT04213326|584326694|FG001|Overall Study|Incomplete study visit|367|||
161804319|NCT01496183|584326695|FG000|Overall Study|Physician Decision|3|||
161804320|NCT01496183|584326696|FG001|Overall Study|Physician Decision|1|||
161804321|NCT01496183|584326695|FG000|Overall Study|Withdrawal by Subject|0|||
161804322|NCT01496183|584326696|FG001|Overall Study|Withdrawal by Subject|1|||
161804323|NCT01173692|584326699|FG000|Overall Study|Adverse Event|1|||
161804324|NCT01173692|584326700|FG001|Overall Study|Adverse Event|2|||
161804325|NCT01173692|584326699|FG000|Overall Study|Withdrawal by Subject|1|||
161804326|NCT01173692|584326700|FG001|Overall Study|Withdrawal by Subject|3|||
161804327|NCT00669864|584326703|FG000|Overall Study|Lost to Follow-up|2|||
161804328|NCT00669864|584326703|FG000|Overall Study|Protocol Violation|2|||
161804329|NCT00669864|584326703|FG000|Overall Study|Withdrawal by Subject|3|||
161804330|NCT00669864|584326703|FG000|Overall Study|Other|2|||
161804331|NCT02457832|584326714|FG000|Training|Lost to Follow-up|10|||
161804332|NCT02457832|584326715|FG001|Training|Lost to Follow-up|6|||
161804333|NCT02457832|584326716|FG002|Training|Lost to Follow-up|3|||
161804334|NCT02457832|584326714|FG000|One Month Washout|Lost to Follow-up|0|||
161804335|NCT02457832|584326715|FG001|One Month Washout|Lost to Follow-up|1|||
161804336|NCT02457832|584326716|FG002|One Month Washout|Lost to Follow-up|1|||
161804337|NCT01044732|584326717|FG000|Overall Study|Lost to Follow-up|2|||
161804338|NCT01044732|584326718|FG001|Overall Study|Lost to Follow-up|1|||
161804339|NCT01044732|584326717|FG000|Overall Study|Physician Decision|5|||
161804340|NCT01044732|584326718|FG001|Overall Study|Physician Decision|3|||
161804341|NCT01044732|584326717|FG000|Overall Study|Protocol Violation|11|||
161804342|NCT01044732|584326718|FG001|Overall Study|Protocol Violation|12|||
161804343|NCT01044732|584326717|FG000|Overall Study|Withdrawal by Subject|0|||
161804344|NCT01044732|584326718|FG001|Overall Study|Withdrawal by Subject|1|||
161804345|NCT01044732|584326717|FG000|Overall Study|Inadequate bowel preparation|11|||
161804346|NCT01044732|584326718|FG001|Overall Study|Inadequate bowel preparation|17|||
161804347|NCT01044732|584326717|FG000|Overall Study|Inability to reach cecum|5|||
161804348|NCT01044732|584326718|FG001|Overall Study|Inability to reach cecum|2|||
161804349|NCT01044732|584326717|FG000|Overall Study|Technical error or malfunction|15|||
161804350|NCT01044732|584326718|FG001|Overall Study|Technical error or malfunction|14|||
161804351|NCT03069937|584326723|FG000|Overall Study|Second primary malignancy noted|1|||
161804352|NCT03144687|584326724|FG000|Overall Study|Death|0|||
161804353|NCT03144687|584326725|FG001|Overall Study|Death|2|||
161804354|NCT03144687|584326724|FG000|Overall Study|Lost to Follow-up|0|||
161804355|NCT03144687|584326725|FG001|Overall Study|Lost to Follow-up|1|||
161804356|NCT03144687|584326724|FG000|Overall Study|Physician Decision|0|||
161804357|NCT03144687|584326725|FG001|Overall Study|Physician Decision|1|||
161804358|NCT03144687|584326724|FG000|Overall Study|Withdrawal by Subject|1|||
161804359|NCT03144687|584326725|FG001|Overall Study|Withdrawal by Subject|3|||
161804360|NCT03144687|584326724|FG000|Overall Study|Not Reported|2|||
161804361|NCT03144687|584326725|FG001|Overall Study|Not Reported|0|||
161804362|NCT00824265|584326728|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
161907473|NCT01909804|584712194|FG003|Overall Study|Withdrew Consent|0|||
161561245|NCT02049437|583442067|FG001|Period 1|Adverse Event|1|||
161561246|NCT02049437|583442066|FG000|Period 1|Adverse Event|1|||
161561247|NCT02049437|583442067|FG001|Period 1|Adverse Event|0|||
161561248|NCT01163149|583442073|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
161561249|NCT01163149|583442074|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161804363|NCT00824265|584326729|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
161804364|NCT00824265|584326728|FG000|Treatment Phase|Protocol Violation|1|||
161804365|NCT00824265|584326729|FG001|Treatment Phase|Protocol Violation|0|||
161804366|NCT00824265|584326728|FG000|Treatment Phase|Lost to Follow-up|1|||
161804367|NCT00824265|584326729|FG001|Treatment Phase|Lost to Follow-up|1|||
161804368|NCT00824265|584326728|FG000|Treatment Phase|Physician Decision|6|||
161804369|NCT00824265|584326729|FG001|Treatment Phase|Physician Decision|12|||
161804370|NCT00824265|584326728|FG000|Treatment Phase|Withdrawal by Subject|6|||
161804371|NCT00824265|584326729|FG001|Treatment Phase|Withdrawal by Subject|15|||
161804372|NCT00824265|584326728|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
161804373|NCT00824265|584326729|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
161804374|NCT00824265|584326728|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
161804375|NCT00824265|584326729|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
161804376|NCT01411332|584326732|FG000|Enrollment|Protocol Violation|0|||
161804377|NCT01411332|584326733|FG001|Enrollment|Protocol Violation|1|||
161804378|NCT01411332|584326732|FG000|Enrollment|Withdrawal by Subject|0|||
161804379|NCT01411332|584326733|FG001|Enrollment|Withdrawal by Subject|1|||
161804380|NCT01411332|584326732|FG000|Treatment|Lost to Follow-up|1|||
161804381|NCT01411332|584326733|FG001|Treatment|Lost to Follow-up|0|||
161804382|NCT02170688|584326734|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
161804383|NCT02170688|584326735|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
161804384|NCT02170688|584326736|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
161804385|NCT02170688|584326737|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
161804386|NCT02170688|584326738|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
161804387|NCT02170688|584326734|FG000|Overall Study|Full dose not received|0|||
161804388|NCT02170688|584326735|FG001|Overall Study|Full dose not received|1|||
161804389|NCT02170688|584326736|FG002|Overall Study|Full dose not received|0|||
161804390|NCT02170688|584326737|FG003|Overall Study|Full dose not received|0|||
161804391|NCT02170688|584326738|FG004|Overall Study|Full dose not received|0|||
161804392|NCT02170688|584326734|FG000|Overall Study|Physician Decision|0|||
161804393|NCT02170688|584326735|FG001|Overall Study|Physician Decision|0|||
161804394|NCT02170688|584326736|FG002|Overall Study|Physician Decision|1|||
161804395|NCT02170688|584326737|FG003|Overall Study|Physician Decision|0|||
161804396|NCT02170688|584326738|FG004|Overall Study|Physician Decision|0|||
161804397|NCT02079532|584326741|FG000|Overall Study|Adverse Event|7|||
161804398|NCT02079532|584326741|FG000|Overall Study|Additional or changed therapy|2|||
161804399|NCT02079532|584326741|FG000|Overall Study|Lack of Efficacy|9|||
161804400|NCT02079532|584326741|FG000|Overall Study|Protocol Violation|3|||
161804401|NCT02079532|584326741|FG000|Overall Study|Withdrawal by Subject|1|||
161804402|NCT02079532|584326741|FG000|Overall Study|Administrative problems|1|||
161804403|NCT02079532|584326741|FG000|Overall Study|Inclusion into ReFIRST|3|||
161804404|NCT02079532|584326741|FG000|Overall Study|Other|3|||
161804405|NCT02920996|584326742|FG000|Overall Study|Adverse Event|8|||
161804406|NCT02920996|584326743|FG001|Overall Study|Adverse Event|0|||
161804407|NCT02920996|584326742|FG000|Overall Study|Physician Decision|1|||
161804408|NCT02920996|584326743|FG001|Overall Study|Physician Decision|0|||
161804409|NCT02920996|584326742|FG000|Overall Study|Death|1|||
161804410|NCT02920996|584326743|FG001|Overall Study|Death|0|||
161804411|NCT02920996|584326742|FG000|Overall Study|Missing|1|||
161804412|NCT02920996|584326743|FG001|Overall Study|Missing|0|||
161804413|NCT02920996|584326742|FG000|Overall Study|Subject Non-Compliance|1|||
161804414|NCT02920996|584326743|FG001|Overall Study|Subject Non-Compliance|0|||
161804415|NCT01402947|584326744|FG000|First Intervention|Adverse Event|0|||
161804416|NCT01402947|584326745|FG001|First Intervention|Adverse Event|1|||
161804417|NCT01471522|584326749|FG000|Overall Study|Withdrawal by Subject|28|||
161804418|NCT01471522|584326750|FG001|Overall Study|Withdrawal by Subject|22|||
161804419|NCT01471522|584326749|FG000|Overall Study|Lost to Follow-up|36|||
161804420|NCT01471522|584326750|FG001|Overall Study|Lost to Follow-up|26|||
161804421|NCT01706926|584326752|FG000|Overall Study|Lost to Follow-up|0|||
161804422|NCT01706926|584326753|FG001|Overall Study|Lost to Follow-up|0|||
161804423|NCT01706926|584326754|FG002|Overall Study|Lost to Follow-up|1|||
161804424|NCT01706926|584326755|FG003|Overall Study|Lost to Follow-up|0|||
161804425|NCT01706926|584326752|FG000|Overall Study|Withdrawal by Subject|2|||
161804426|NCT01706926|584326753|FG001|Overall Study|Withdrawal by Subject|0|||
161804427|NCT01706926|584326754|FG002|Overall Study|Withdrawal by Subject|1|||
161804428|NCT01706926|584326755|FG003|Overall Study|Withdrawal by Subject|2|||
161804429|NCT01706926|584326752|FG000|Overall Study|Other|4|||
161804430|NCT01706926|584326753|FG001|Overall Study|Other|4|||
161804431|NCT01706926|584326754|FG002|Overall Study|Other|4|||
161804432|NCT01706926|584326755|FG003|Overall Study|Other|3|||
161804433|NCT03597256|584327962|FG000|Overall Study|Lost to Follow-up|3|||
161804434|NCT03597256|584327963|FG001|Overall Study|Lost to Follow-up|1|||
161804435|NCT03597256|584327962|FG000|Overall Study|Withdrawal by Subject|0|||
161804436|NCT03597256|584327963|FG001|Overall Study|Withdrawal by Subject|1|||
161804437|NCT03597256|584327962|FG000|Overall Study|Could not return for treatment|0|||
161804438|NCT03597256|584327963|FG001|Overall Study|Could not return for treatment|1|||
161804439|NCT03597256|584327962|FG000|Overall Study|Moved from location|0|||
161804440|NCT03597256|584327963|FG001|Overall Study|Moved from location|1|||
161804441|NCT03597256|584327962|FG000|Overall Study|Not accepted the treatment|0|||
161804442|NCT03597256|584327963|FG001|Overall Study|Not accepted the treatment|1|||
161804443|NCT01725529|584327972|FG000|Overall Study|Adverse Event|1|||
161804444|NCT01725529|584327973|FG001|Overall Study|Adverse Event|0|||
161804445|NCT01725529|584327974|FG002|Overall Study|Adverse Event|0|||
161804446|NCT01725529|584327972|FG000|Overall Study|Lost to Follow-up|2|||
161804447|NCT01725529|584327973|FG001|Overall Study|Lost to Follow-up|1|||
161804448|NCT01725529|584327974|FG002|Overall Study|Lost to Follow-up|1|||
161804449|NCT01725529|584327972|FG000|Overall Study|Protocol Violation|0|||
161804450|NCT01725529|584327973|FG001|Overall Study|Protocol Violation|1|||
161804451|NCT01725529|584327974|FG002|Overall Study|Protocol Violation|1|||
161804452|NCT01725529|584327972|FG000|Overall Study|Withdrawal by Subject|12|||
161804453|NCT01725529|584327973|FG001|Overall Study|Withdrawal by Subject|14|||
161804454|NCT01725529|584327974|FG002|Overall Study|Withdrawal by Subject|8|||
161804455|NCT02653664|584327976|FG000|Post-Treatment|Withdrawal by Subject|6|||
161804456|NCT02653664|584327977|FG001|Post-Treatment|Withdrawal by Subject|5|||
161804457|NCT02653664|584327978|FG002|Post-Treatment|Withdrawal by Subject|7|||
161804458|NCT02653664|584327976|FG000|Post-Treatment|Lost to Follow-up|8|||
161804459|NCT02653664|584327977|FG001|Post-Treatment|Lost to Follow-up|1|||
161804460|NCT02653664|584327978|FG002|Post-Treatment|Lost to Follow-up|7|||
161804461|NCT02653664|584327976|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
161804462|NCT02653664|584327977|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
161804463|NCT02653664|584327978|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
161804464|NCT02653664|584327976|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
161804465|NCT02653664|584327977|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
161804466|NCT02653664|584327978|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
161804467|NCT02653664|584327976|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804468|NCT02653664|584327977|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
161804469|NCT02653664|584327978|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804470|NCT02653664|584327976|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
161804471|NCT02653664|584327977|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
161804472|NCT02653664|584327978|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
161804473|NCT02653664|584327976|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
161804474|NCT02653664|584327977|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
161804475|NCT02653664|584327978|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
161804476|NCT02653664|584327976|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
161804477|NCT02653664|584327977|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
161804478|NCT02653664|584327978|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
161804479|NCT02653664|584327976|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804480|NCT02653664|584327977|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
161804481|NCT02653664|584327978|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804482|NCT02653664|584327976|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
161804483|NCT02653664|584327977|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
161804484|NCT02653664|584327978|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
161804485|NCT04657770|584327979|FG000|Overall Study|Withdrawal by Subject|3|||
161804486|NCT04657770|584327979|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
161804487|NCT00485472|584327980|FG000|Overall Study|Adverse Event|8|||
161804488|NCT00485472|584327981|FG001|Overall Study|Adverse Event|5|||
161804489|NCT00485472|584327980|FG000|Overall Study|Lack of Efficacy|5|||
161804490|NCT00485472|584327981|FG001|Overall Study|Lack of Efficacy|4|||
161804491|NCT00485472|584327980|FG000|Overall Study|Withdrawal by Subject|1|||
161804492|NCT00485472|584327981|FG001|Overall Study|Withdrawal by Subject|0|||
161804493|NCT00485472|584327980|FG000|Overall Study|Protocol Violation|0|||
161804494|NCT00485472|584327981|FG001|Overall Study|Protocol Violation|1|||
161804495|NCT00485472|584327980|FG000|Overall Study|Other|2|||
161804496|NCT00485472|584327981|FG001|Overall Study|Other|1|||
161804497|NCT00485472|584327980|FG000|Overall Study|Lost to Follow-up|0|||
161804498|NCT00485472|584327981|FG001|Overall Study|Lost to Follow-up|1|||
161804499|NCT00746798|584327982|FG000|Overall Study|Protocol Violation|0|||
161804500|NCT00746798|584327983|FG001|Overall Study|Protocol Violation|1|||
161804501|NCT00746798|584327984|FG002|Overall Study|Protocol Violation|0|||
161907474|NCT01909804|584712195|FG004|Overall Study|Withdrew Consent|1|||
161907475|NCT01909804|584712196|FG005|Overall Study|Withdrew Consent|1|||
161907476|NCT01909804|584712197|FG006|Overall Study|Withdrew Consent|0|||
161907477|NCT01909804|584712198|FG007|Overall Study|Withdrew Consent|0|||
161907478|NCT01909804|584712199|FG008|Overall Study|Withdrew Consent|0|||
161907479|NCT01909804|584712200|FG009|Overall Study|Withdrew Consent|0|||
161804502|NCT00746798|584327985|FG003|Overall Study|Protocol Violation|0|||
161804503|NCT00746798|584327982|FG000|Overall Study|Withdrawal by Subject|0|||
161804504|NCT00746798|584327983|FG001|Overall Study|Withdrawal by Subject|1|||
161804505|NCT00746798|584327984|FG002|Overall Study|Withdrawal by Subject|1|||
161804506|NCT00746798|584327985|FG003|Overall Study|Withdrawal by Subject|0|||
161907480|NCT01909804|584712201|FG010|Overall Study|Withdrew Consent|0|||
161907481|NCT01909804|584712202|FG011|Overall Study|Withdrew Consent|0|||
161907482|NCT01909804|584712191|FG000|Overall Study|Protocol Violation|0|||
161907483|NCT01909804|584712192|FG001|Overall Study|Protocol Violation|0|||
161907484|NCT01909804|584712193|FG002|Overall Study|Protocol Violation|0|||
161907485|NCT01909804|584712194|FG003|Overall Study|Protocol Violation|0|||
161907486|NCT01909804|584712195|FG004|Overall Study|Protocol Violation|0|||
161907487|NCT01909804|584712196|FG005|Overall Study|Protocol Violation|0|||
161453199|NCT01989468|583053589|FG003|Overall Study|Death|0|||
161453200|NCT01989468|583053590|FG004|Overall Study|Death|0|||
161453201|NCT01224782|583053593|FG000|Overall Study|Lost to Follow-up|177|||
161453202|NCT01224782|583053593|FG000|Overall Study|Withdrawal by Subject|16|||
161453203|NCT01224782|583053593|FG000|Overall Study|Death|14|||
161453204|NCT01224782|583053593|FG000|Overall Study|Improvement|13|||
161804507|NCT00746798|584327982|FG000|Overall Study|Death|0|||
161804508|NCT00746798|584327983|FG001|Overall Study|Death|0|||
161907488|NCT01909804|584712197|FG006|Overall Study|Protocol Violation|0|||
161907489|NCT01909804|584712198|FG007|Overall Study|Protocol Violation|0|||
161907490|NCT01909804|584712199|FG008|Overall Study|Protocol Violation|0|||
161907491|NCT01909804|584712200|FG009|Overall Study|Protocol Violation|0|||
161907492|NCT01909804|584712201|FG010|Overall Study|Protocol Violation|0|||
161907493|NCT01909804|584712202|FG011|Overall Study|Protocol Violation|1|||
161907494|NCT05222880|584712204|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161907495|NCT05222880|584712204|FG000|Overall Study|Withdrew Consent during Study|1|||
161907496|NCT05222880|584712204|FG000|Overall Study|COVID-19 Related|1|||
161907497|NCT05401565|584712205|FG000|Overall Study|Lost to Follow-up|1|||
161907498|NCT05401565|584712206|FG001|Overall Study|Lost to Follow-up|0|||
161907499|NCT05401565|584712205|FG000|Overall Study|Adverse Event|2|||
161907500|NCT05401565|584712206|FG001|Overall Study|Adverse Event|0|||
161907501|NCT01077323|584712209|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
161907502|NCT01077323|584712210|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
161907503|NCT01077323|584712211|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
161907504|NCT01077323|584712209|FG000|Overall Study|Dispensing of drug in baseline period|0|||
161907505|NCT01077323|584712210|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
161907506|NCT01077323|584712211|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
161907507|NCT01077323|584712209|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
161907508|NCT01077323|584712210|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
161907509|NCT01077323|584712211|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
161907510|NCT01091246|584712212|FG000|Overall Study|Lost to Follow-up|23|||
161907511|NCT01091246|584712213|FG001|Overall Study|Lost to Follow-up|11|||
161907512|NCT01091246|584712214|FG002|Overall Study|Lost to Follow-up|7|||
161907513|NCT01091246|584712212|FG000|Overall Study|Adverse Event|1|||
161907514|NCT01091246|584712213|FG001|Overall Study|Adverse Event|0|||
161907515|NCT01091246|584712214|FG002|Overall Study|Adverse Event|1|||
161907516|NCT01091246|584712212|FG000|Overall Study|Withdrawal by Subject|9|||
161907517|NCT01091246|584712213|FG001|Overall Study|Withdrawal by Subject|5|||
161907518|NCT01091246|584712214|FG002|Overall Study|Withdrawal by Subject|4|||
161907519|NCT01091246|584712212|FG000|Overall Study|Subject not dosed|2|||
161907520|NCT01091246|584712213|FG001|Overall Study|Subject not dosed|0|||
161907521|NCT01091246|584712214|FG002|Overall Study|Subject not dosed|1|||
161907522|NCT01676012|584712215|FG000|Overall Study|Adverse Event|2|||
161907523|NCT01676012|584712215|FG000|Overall Study|incomplete set of videos|1|||
161907524|NCT02155985|584712220|FG000|Overall Study|Withdrawal by Subject|0|||
161907525|NCT02155985|584712221|FG001|Overall Study|Withdrawal by Subject|0|||
161907526|NCT02155985|584712222|FG002|Overall Study|Withdrawal by Subject|1|||
161907527|NCT02155985|584712220|FG000|Overall Study|Lost to Follow-up|1|||
161907528|NCT02155985|584712221|FG001|Overall Study|Lost to Follow-up|0|||
161907529|NCT02155985|584712222|FG002|Overall Study|Lost to Follow-up|0|||
161907530|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Early discharge|5|||
161907531|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Early discharge|5|||
161907532|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
161907533|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
161907534|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
161907535|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
161907536|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
161907537|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
161907538|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
161907539|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
161907540|NCT04460326|584712227|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
161907541|NCT04460326|584712228|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
161907542|NCT03372798|584712229|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
161907543|NCT03372798|584712230|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
161907544|NCT03372798|584712229|FG000|Overall Study|Failure of imaging probe|0|||
161907545|NCT03372798|584712230|FG001|Overall Study|Failure of imaging probe|1|||
161907546|NCT04794751|584712231|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
161907547|NCT04794751|584712232|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
161907548|NCT04794751|584712231|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
161907549|NCT04794751|584712232|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
161907550|NCT04794751|584712231|FG000|Period 1|Protocol Violation|0|||
161907551|NCT04794751|584712232|FG001|Period 1|Protocol Violation|2|||
161907552|NCT04794751|584712231|FG000|Period 1|Withdrawal by Subject|0|||
161907553|NCT04794751|584712232|FG001|Period 1|Withdrawal by Subject|1|||
161907554|NCT04794751|584712231|FG000|Period 2|Withdrawal by Subject|0|||
161907555|NCT04794751|584712232|FG001|Period 2|Withdrawal by Subject|1|||
161907556|NCT04794751|584712231|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
161907557|NCT04794751|584712232|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
161907558|NCT04794751|584712231|FG000|Period 2|Protocol Violation|1|||
161907559|NCT04794751|584712232|FG001|Period 2|Protocol Violation|0|||
161907560|NCT01405898|584712233|FG000|Overall Study|Withdrawal by Subject|2|||
161907561|NCT01405898|584712234|FG001|Overall Study|Withdrawal by Subject|2|||
161907562|NCT01687218|584712235|FG000|Overall Study|Withdrawal by Subject|2|||
161907563|NCT01687218|584712236|FG001|Overall Study|Withdrawal by Subject|3|||
161907564|NCT01687218|584712237|FG002|Overall Study|Withdrawal by Subject|0|||
161907565|NCT01687218|584712238|FG003|Overall Study|Withdrawal by Subject|1|||
161907566|NCT01687218|584712239|FG004|Overall Study|Withdrawal by Subject|1|||
161907567|NCT01687218|584712240|FG005|Overall Study|Withdrawal by Subject|0|||
161907568|NCT01687218|584712235|FG000|Overall Study|Relocated, no follow-up planned|1|||
161907569|NCT01687218|584712236|FG001|Overall Study|Relocated, no follow-up planned|0|||
161907570|NCT01687218|584712237|FG002|Overall Study|Relocated, no follow-up planned|1|||
161907571|NCT01687218|584712238|FG003|Overall Study|Relocated, no follow-up planned|1|||
161907572|NCT01687218|584712239|FG004|Overall Study|Relocated, no follow-up planned|0|||
161907573|NCT01687218|584712240|FG005|Overall Study|Relocated, no follow-up planned|0|||
161907574|NCT03528551|584712245|FG000|Overall Study|Lost to Follow-up|0|||
161907575|NCT03528551|584712246|FG001|Overall Study|Lost to Follow-up|1|||
161907576|NCT03528551|584712247|FG002|Overall Study|Lost to Follow-up|0|||
161907577|NCT03528551|584712245|FG000|Overall Study|Transferred to other arm/group|2|||
161907578|NCT03528551|584712246|FG001|Overall Study|Transferred to other arm/group|3|||
161907579|NCT03528551|584712247|FG002|Overall Study|Transferred to other arm/group|0|||
161907580|NCT03528551|584712245|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161907581|NCT03528551|584712246|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161804509|NCT00746798|584327984|FG002|Overall Study|Death|2|||
161804510|NCT00746798|584327985|FG003|Overall Study|Death|0|||
161804511|NCT00746798|584327982|FG000|Overall Study|Participant unable to return for visit|1|||
161804512|NCT00746798|584327983|FG001|Overall Study|Participant unable to return for visit|0|||
161804513|NCT00746798|584327984|FG002|Overall Study|Participant unable to return for visit|0|||
161804514|NCT00746798|584327985|FG003|Overall Study|Participant unable to return for visit|0|||
161804515|NCT04915755|584327988|FG000|Overall Study|Physician Decision|3|||
161804516|NCT04915755|584327989|FG001|Overall Study|Physician Decision|2|||
161804517|NCT04915755|584327988|FG000|Overall Study|Withdrawal by Subject|1|||
161804518|NCT04915755|584327989|FG001|Overall Study|Withdrawal by Subject|1|||
161804519|NCT04915755|584327988|FG000|Overall Study|Ongoing for PACT|3|||
161804520|NCT04915755|584327989|FG001|Overall Study|Ongoing for PACT|2|||
161804521|NCT04915755|584327988|FG000|Overall Study|Other|7|||
161804522|NCT04915755|584327989|FG001|Overall Study|Other|11|||
161804523|NCT02495857|584327998|FG000|Overall Study|Adverse Event|5|||
161804524|NCT02495857|584327999|FG001|Overall Study|Adverse Event|0|||
161804525|NCT02495857|584328000|FG002|Overall Study|Adverse Event|1|||
161804526|NCT02495857|584327998|FG000|Overall Study|Withdrawal by Subject|9|||
161804527|NCT02495857|584327999|FG001|Overall Study|Withdrawal by Subject|6|||
161804528|NCT02495857|584328000|FG002|Overall Study|Withdrawal by Subject|10|||
161804529|NCT02495857|584327998|FG000|Overall Study|Physician Decision|0|||
161804530|NCT02495857|584327999|FG001|Overall Study|Physician Decision|1|||
161804531|NCT02495857|584328000|FG002|Overall Study|Physician Decision|0|||
161804532|NCT02495857|584327998|FG000|Overall Study|Protocol Violation|1|||
161804533|NCT02495857|584327999|FG001|Overall Study|Protocol Violation|1|||
161804534|NCT02495857|584328000|FG002|Overall Study|Protocol Violation|2|||
161804535|NCT02495857|584327998|FG000|Overall Study|Lost to Follow-up|4|||
161804536|NCT02495857|584327999|FG001|Overall Study|Lost to Follow-up|5|||
161804537|NCT02495857|584328000|FG002|Overall Study|Lost to Follow-up|3|||
161804538|NCT02495857|584327998|FG000|Overall Study|Other|3|||
161804539|NCT02495857|584327999|FG001|Overall Study|Other|3|||
161804540|NCT02495857|584328000|FG002|Overall Study|Other|2|||
161804541|NCT01367457|584328001|FG000|Overall Study|Death|2|||
161804542|NCT01367457|584328002|FG001|Overall Study|Death|0|||
161804543|NCT01367457|584328003|FG002|Overall Study|Death|0|||
161804544|NCT01367457|584328001|FG000|Overall Study|Investigator's decision|2|||
161804545|NCT01367457|584328002|FG001|Overall Study|Investigator's decision|0|||
161804546|NCT01367457|584328003|FG002|Overall Study|Investigator's decision|0|||
161804547|NCT01367457|584328001|FG000|Overall Study|Clinical decline (CD)|2|||
161804548|NCT01367457|584328002|FG001|Overall Study|Clinical decline (CD)|0|||
161804549|NCT01367457|584328003|FG002|Overall Study|Clinical decline (CD)|0|||
161804550|NCT01367457|584328001|FG000|Overall Study|Progression and death|8|||
161804551|NCT01367457|584328002|FG001|Overall Study|Progression and death|0|||
161804552|NCT01367457|584328003|FG002|Overall Study|Progression and death|0|||
161907582|NCT03528551|584712247|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161907583|NCT03528551|584712245|FG000|Overall Study|Protocol Violation|0|||
161907584|NCT03528551|584712246|FG001|Overall Study|Protocol Violation|3|||
161453205|NCT01224782|583053593|FG000|Overall Study|Adverse Event|12|||
161804553|NCT01367457|584328001|FG000|Overall Study|Toxicity|16|||
161804554|NCT01367457|584328002|FG001|Overall Study|Toxicity|0|||
161804555|NCT01367457|584328003|FG002|Overall Study|Toxicity|0|||
161804556|NCT01367457|584328001|FG000|Overall Study|Progression|137|||
161907585|NCT03528551|584712247|FG002|Overall Study|Protocol Violation|0|||
161907586|NCT03528551|584712245|FG000|Overall Study|Withdrawal by Subject|0|||
161804557|NCT01367457|584328002|FG001|Overall Study|Progression|0|||
161804558|NCT01367457|584328003|FG002|Overall Study|Progression|0|||
161804559|NCT01367457|584328001|FG000|Overall Study|Patient asks for rest + slow progression|1|||
161804560|NCT01367457|584328002|FG001|Overall Study|Patient asks for rest + slow progression|0|||
161907587|NCT03528551|584712246|FG001|Overall Study|Withdrawal by Subject|7|||
161907588|NCT03528551|584712247|FG002|Overall Study|Withdrawal by Subject|0|||
161907589|NCT01789047|584712250|FG000|Overall Study|Adverse Event|3|||
161907590|NCT01789047|584712251|FG001|Overall Study|Adverse Event|2|||
161907591|NCT01789047|584712250|FG000|Overall Study|Withdrawal by Subject|1|||
161907592|NCT01789047|584712251|FG001|Overall Study|Withdrawal by Subject|2|||
161907593|NCT03644017|584712252|FG000|Overall Study|Access Abandonment|5|||
161907594|NCT03644017|584712252|FG000|Overall Study|Kidney Transplant|2|||
161907595|NCT01204671|584712253|FG000|Overall Study|Adverse Event|4|||
161907596|NCT01204671|584712254|FG001|Overall Study|Adverse Event|3|||
161907597|NCT01204671|584712255|FG002|Overall Study|Adverse Event|3|||
161907598|NCT01204671|584712256|FG003|Overall Study|Adverse Event|3|||
161907599|NCT01204671|584712257|FG004|Overall Study|Adverse Event|1|||
161907600|NCT01204671|584712253|FG000|Overall Study|Withdrawal by Subject|2|||
161907601|NCT01204671|584712254|FG001|Overall Study|Withdrawal by Subject|3|||
161907602|NCT01204671|584712255|FG002|Overall Study|Withdrawal by Subject|4|||
161907603|NCT01204671|584712256|FG003|Overall Study|Withdrawal by Subject|5|||
161907604|NCT01204671|584712257|FG004|Overall Study|Withdrawal by Subject|3|||
161907605|NCT01204671|584712253|FG000|Overall Study|Lost to Follow-up|7|||
161907606|NCT01204671|584712254|FG001|Overall Study|Lost to Follow-up|8|||
161907607|NCT01204671|584712255|FG002|Overall Study|Lost to Follow-up|6|||
161453206|NCT01224782|583053593|FG000|Overall Study|Adverse Reaction|11|||
161804561|NCT01367457|584328003|FG002|Overall Study|Patient asks for rest + slow progression|0|||
161804562|NCT01367457|584328001|FG000|Overall Study|Investigator's opinion, stable disease|1|||
161804563|NCT01367457|584328002|FG001|Overall Study|Investigator's opinion, stable disease|0|||
161804564|NCT01367457|584328003|FG002|Overall Study|Investigator's opinion, stable disease|0|||
161804565|NCT01367457|584328001|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
161804566|NCT01367457|584328002|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
161804567|NCT01367457|584328003|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
161804568|NCT01367457|584328001|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
161804569|NCT01367457|584328002|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
161804570|NCT01367457|584328003|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
161804571|NCT01367457|584328001|FG000|Overall Study|low grade toxicities + stable disease|1|||
161804572|NCT01367457|584328002|FG001|Overall Study|low grade toxicities + stable disease|0|||
161804573|NCT01367457|584328003|FG002|Overall Study|low grade toxicities + stable disease|0|||
161804574|NCT01367457|584328001|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
161804575|NCT01367457|584328002|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
161804576|NCT01367457|584328003|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
161804577|NCT01367457|584328001|FG000|Overall Study|Withdrawal by Subject|1|||
161804578|NCT01367457|584328002|FG001|Overall Study|Withdrawal by Subject|0|||
161804579|NCT01367457|584328003|FG002|Overall Study|Withdrawal by Subject|0|||
161804580|NCT01367457|584328001|FG000|Overall Study|CD, associated leukaemia|1|||
161804581|NCT01367457|584328002|FG001|Overall Study|CD, associated leukaemia|0|||
161804582|NCT01367457|584328003|FG002|Overall Study|CD, associated leukaemia|0|||
161804583|NCT01367457|584328001|FG000|Overall Study|Uncontrolled pain|1|||
161804584|NCT01367457|584328002|FG001|Overall Study|Uncontrolled pain|0|||
161804585|NCT01367457|584328003|FG002|Overall Study|Uncontrolled pain|0|||
161804586|NCT01367457|584328001|FG000|Overall Study|Overall status worsens to grade 4|1|||
161804587|NCT01367457|584328002|FG001|Overall Study|Overall status worsens to grade 4|0|||
161804588|NCT01367457|584328003|FG002|Overall Study|Overall status worsens to grade 4|0|||
161804589|NCT01367457|584328001|FG000|Overall Study|Stabilisation + frequent infections|1|||
161804590|NCT01367457|584328002|FG001|Overall Study|Stabilisation + frequent infections|0|||
161804591|NCT01367457|584328003|FG002|Overall Study|Stabilisation + frequent infections|0|||
161804592|NCT01367457|584328001|FG000|Overall Study|No clinical benefit|1|||
161804593|NCT01367457|584328002|FG001|Overall Study|No clinical benefit|0|||
161804594|NCT01367457|584328003|FG002|Overall Study|No clinical benefit|0|||
161804595|NCT01367457|584328001|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
161804596|NCT01367457|584328002|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
161804597|NCT01367457|584328003|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
161804598|NCT01367457|584328001|FG000|Overall Study|Overall decline|1|||
161804599|NCT01367457|584328002|FG001|Overall Study|Overall decline|0|||
161804600|NCT01367457|584328003|FG002|Overall Study|Overall decline|0|||
161804601|NCT01367457|584328001|FG000|Overall Study|Rejection of treatment|1|||
161804602|NCT01367457|584328002|FG001|Overall Study|Rejection of treatment|0|||
161804603|NCT01367457|584328003|FG002|Overall Study|Rejection of treatment|0|||
161804604|NCT01367457|584328001|FG000|Overall Study|Lost to Follow-up|1|||
161804605|NCT01367457|584328002|FG001|Overall Study|Lost to Follow-up|0|||
161804606|NCT01367457|584328003|FG002|Overall Study|Lost to Follow-up|0|||
161804607|NCT01367457|584328001|FG000|Overall Study|Death from septic shock|1|||
161804608|NCT01367457|584328002|FG001|Overall Study|Death from septic shock|0|||
161804609|NCT01367457|584328003|FG002|Overall Study|Death from septic shock|0|||
161907608|NCT01204671|584712256|FG003|Overall Study|Lost to Follow-up|4|||
161907609|NCT01204671|584712257|FG004|Overall Study|Lost to Follow-up|0|||
161907610|NCT01204671|584712253|FG000|Overall Study|Unknown Completion Status|1|||
161804610|NCT01367457|584328001|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
161804611|NCT01367457|584328002|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
161804612|NCT01367457|584328003|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
161804613|NCT01367457|584328001|FG000|Overall Study|Patient's Wish|1|||
161804614|NCT01367457|584328002|FG001|Overall Study|Patient's Wish|0|||
161804615|NCT01367457|584328003|FG002|Overall Study|Patient's Wish|0|||
161804616|NCT01367457|584328001|FG000|Overall Study|Palliative. Overall decline|1|||
161804617|NCT01367457|584328002|FG001|Overall Study|Palliative. Overall decline|0|||
161804618|NCT01367457|584328003|FG002|Overall Study|Palliative. Overall decline|0|||
161804619|NCT01367457|584328001|FG000|Overall Study|Suspected DP/suspected active infection|1|||
161804620|NCT01367457|584328002|FG001|Overall Study|Suspected DP/suspected active infection|0|||
161804621|NCT01367457|584328003|FG002|Overall Study|Suspected DP/suspected active infection|0|||
161804622|NCT04407806|584328008|FG000|Overall Study|Withdrawal by Subject|1|||
161804623|NCT04407806|584328009|FG001|Overall Study|Withdrawal by Subject|2|||
161804624|NCT03447262|584328012|FG000|Overall Study|Adverse Event|7|||
161804625|NCT03447262|584328012|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161804626|NCT03447262|584328012|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
161804627|NCT03447262|584328012|FG000|Overall Study|Death|2|||
161804628|NCT03447262|584328012|FG000|Overall Study|Study Termination by Sponsor|455|||
161804629|NCT03447262|584328012|FG000|Overall Study|Other|4|||
161804630|NCT02058498|584328016|FG000|Overall Study|Withdrawal by Subject|4|||
161804631|NCT03478397|584328017|FG000|Overall Study|Refused to participate|31|||
161804632|NCT03478397|584328018|FG001|Overall Study|Refused to participate|7|||
161804633|NCT04605094|584328019|FG000|Overall Study|Adverse Event|2|||
161804634|NCT04605094|584328020|FG001|Overall Study|Adverse Event|2|||
161804635|NCT04605094|584328019|FG000|Overall Study|Lost to Follow-up|1|||
161804636|NCT04605094|584328020|FG001|Overall Study|Lost to Follow-up|4|||
161804637|NCT04605094|584328019|FG000|Overall Study|Physician Decision|2|||
161804638|NCT04605094|584328020|FG001|Overall Study|Physician Decision|2|||
161804639|NCT04605094|584328019|FG000|Overall Study|Study terminated by Sponsor|31|||
161804640|NCT04605094|584328020|FG001|Overall Study|Study terminated by Sponsor|33|||
161804641|NCT04605094|584328019|FG000|Overall Study|Withdrawal by Subject|22|||
161804642|NCT04605094|584328020|FG001|Overall Study|Withdrawal by Subject|19|||
161804643|NCT04605094|584328019|FG000|Overall Study|Other|1|||
161804644|NCT04605094|584328020|FG001|Overall Study|Other|1|||
161804645|NCT04206332|584328023|FG000|Part A|Lost to Follow-up|0|||
161804646|NCT04206332|584328024|FG001|Part A|Lost to Follow-up|1|||
161804647|NCT04206332|584328025|FG002|Part A|Lost to Follow-up|0|||
161804648|NCT04206332|584328026|FG003|Part A|Lost to Follow-up|0|||
161804649|NCT04206332|584328027|FG004|Part A|Lost to Follow-up|0|||
161804650|NCT04206332|584328028|FG005|Part A|Lost to Follow-up|0|||
161804651|NCT04206332|584328029|FG006|Part A|Lost to Follow-up|0|||
161804652|NCT04206332|584328030|FG007|Part A|Lost to Follow-up|0|||
161804653|NCT04206332|584328031|FG008|Part A|Lost to Follow-up|0|||
161804654|NCT04206332|584328032|FG009|Part A|Lost to Follow-up|0|||
161804655|NCT04206332|584328033|FG010|Part A|Lost to Follow-up|0|||
161804656|NCT04206332|584328034|FG011|Part A|Lost to Follow-up|0|||
161804657|NCT04206332|584328035|FG012|Part A|Lost to Follow-up|0|||
161804658|NCT04206332|584328036|FG013|Part A|Lost to Follow-up|0|||
161804659|NCT04206332|584328037|FG014|Part A|Lost to Follow-up|0|||
161804660|NCT04206332|584328038|FG015|Part A|Lost to Follow-up|0|||
161804661|NCT04206332|584328039|FG016|Part A|Lost to Follow-up|0|||
161804662|NCT04206332|584328023|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804663|NCT04206332|584328024|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804664|NCT04206332|584328025|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804665|NCT04206332|584328026|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804666|NCT04206332|584328027|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804667|NCT04206332|584328028|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
161804668|NCT04206332|584328029|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804669|NCT04206332|584328030|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804670|NCT04206332|584328031|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804671|NCT04206332|584328032|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804672|NCT04206332|584328033|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804673|NCT04206332|584328034|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804674|NCT04206332|584328035|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804675|NCT04206332|584328036|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804676|NCT04206332|584328037|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804677|NCT04206332|584328038|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804678|NCT04206332|584328039|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804679|NCT04206332|584328023|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804680|NCT04206332|584328024|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804681|NCT04206332|584328025|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804682|NCT04206332|584328026|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804683|NCT04206332|584328027|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804684|NCT04206332|584328028|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804685|NCT04206332|584328029|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804686|NCT04206332|584328030|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
161804687|NCT04206332|584328031|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804688|NCT04206332|584328032|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804689|NCT04206332|584328033|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
161804690|NCT04206332|584328034|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804691|NCT04206332|584328035|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804692|NCT04206332|584328036|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804693|NCT04206332|584328037|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804694|NCT04206332|584328038|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804695|NCT04206332|584328039|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804696|NCT04206332|584328023|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804697|NCT04206332|584328024|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804698|NCT04206332|584328025|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804699|NCT04206332|584328026|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804700|NCT04206332|584328027|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804701|NCT04206332|584328028|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804702|NCT04206332|584328029|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804703|NCT04206332|584328030|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804704|NCT04206332|584328031|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804705|NCT04206332|584328032|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804706|NCT04206332|584328033|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804707|NCT04206332|584328034|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804708|NCT04206332|584328035|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804709|NCT04206332|584328036|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804710|NCT04206332|584328037|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804711|NCT04206332|584328038|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804712|NCT04206332|584328039|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
161804713|NCT04206332|584328023|FG000|Part C|Withdrawal by Subject|0|||
161804714|NCT04206332|584328024|FG001|Part C|Withdrawal by Subject|0|||
161804715|NCT04206332|584328025|FG002|Part C|Withdrawal by Subject|0|||
161804716|NCT04206332|584328026|FG003|Part C|Withdrawal by Subject|0|||
161804717|NCT04206332|584328027|FG004|Part C|Withdrawal by Subject|0|||
161804718|NCT04206332|584328028|FG005|Part C|Withdrawal by Subject|0|||
161804719|NCT04206332|584328029|FG006|Part C|Withdrawal by Subject|0|||
161804720|NCT04206332|584328030|FG007|Part C|Withdrawal by Subject|0|||
161804721|NCT04206332|584328031|FG008|Part C|Withdrawal by Subject|0|||
161804722|NCT04206332|584328032|FG009|Part C|Withdrawal by Subject|0|||
161804723|NCT04206332|584328033|FG010|Part C|Withdrawal by Subject|0|||
161804724|NCT04206332|584328034|FG011|Part C|Withdrawal by Subject|0|||
161804725|NCT04206332|584328035|FG012|Part C|Withdrawal by Subject|0|||
161804726|NCT04206332|584328036|FG013|Part C|Withdrawal by Subject|0|||
161804727|NCT04206332|584328037|FG014|Part C|Withdrawal by Subject|2|||
161907611|NCT01204671|584712254|FG001|Overall Study|Unknown Completion Status|1|||
161907612|NCT01204671|584712255|FG002|Overall Study|Unknown Completion Status|0|||
161907613|NCT01204671|584712256|FG003|Overall Study|Unknown Completion Status|0|||
161907614|NCT01204671|584712257|FG004|Overall Study|Unknown Completion Status|0|||
161907615|NCT01204671|584712253|FG000|Overall Study|Physician Decision|0|||
161907616|NCT01204671|584712254|FG001|Overall Study|Physician Decision|0|||
161907617|NCT01204671|584712255|FG002|Overall Study|Physician Decision|0|||
161907618|NCT01204671|584712256|FG003|Overall Study|Physician Decision|1|||
161561250|NCT01163149|583442075|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
161907619|NCT01204671|584712257|FG004|Overall Study|Physician Decision|0|||
161804728|NCT04206332|584328038|FG015|Part C|Withdrawal by Subject|0|||
161804729|NCT04206332|584328039|FG016|Part C|Withdrawal by Subject|0|||
161804730|NCT01449630|584328044|FG000|Period 1|Physician Decision|1|||
161804731|NCT01449630|584328045|FG001|Period 1|Physician Decision|0|||
161804732|NCT01449630|584328046|FG002|Period 1|Physician Decision|0|||
161804733|NCT01449630|584328047|FG003|Period 1|Physician Decision|1|||
161804734|NCT01449630|584328048|FG004|Period 1|Physician Decision|0|||
161804735|NCT01449630|584328049|FG005|Period 1|Physician Decision|0|||
161804736|NCT01449630|584328050|FG006|Period 1|Physician Decision|0|||
161804737|NCT01449630|584328051|FG007|Period 1|Physician Decision|0|||
161804738|NCT01449630|584328052|FG008|Period 1|Physician Decision|0|||
161804739|NCT01449630|584328044|FG000|Period 1|Sponsor Decision|0|||
161804740|NCT01449630|584328045|FG001|Period 1|Sponsor Decision|0|||
161804741|NCT01449630|584328046|FG002|Period 1|Sponsor Decision|0|||
161804742|NCT01449630|584328047|FG003|Period 1|Sponsor Decision|0|||
161804743|NCT01449630|584328048|FG004|Period 1|Sponsor Decision|0|||
161804744|NCT01449630|584328049|FG005|Period 1|Sponsor Decision|1|||
161804745|NCT01449630|584328050|FG006|Period 1|Sponsor Decision|0|||
161804746|NCT01449630|584328051|FG007|Period 1|Sponsor Decision|0|||
161804747|NCT01449630|584328052|FG008|Period 1|Sponsor Decision|0|||
161804748|NCT01449630|584328044|FG000|Period 2|Sponsor Decision|0|||
161804749|NCT01449630|584328045|FG001|Period 2|Sponsor Decision|0|||
161804750|NCT01449630|584328046|FG002|Period 2|Sponsor Decision|0|||
161804751|NCT01449630|584328047|FG003|Period 2|Sponsor Decision|0|||
161804752|NCT01449630|584328048|FG004|Period 2|Sponsor Decision|0|||
161804753|NCT01449630|584328049|FG005|Period 2|Sponsor Decision|0|||
161804754|NCT01449630|584328050|FG006|Period 2|Sponsor Decision|1|||
161804755|NCT01449630|584328051|FG007|Period 2|Sponsor Decision|0|||
161804756|NCT01449630|584328052|FG008|Period 2|Sponsor Decision|0|||
161804757|NCT00874237|584328053|FG000|Overall Study|Physician Decision|0|||
161804758|NCT00874237|584328054|FG001|Overall Study|Physician Decision|1|||
161804759|NCT00874237|584328055|FG002|Overall Study|Physician Decision|0|||
161804760|NCT00874237|584328056|FG003|Overall Study|Physician Decision|0|||
161804761|NCT00874237|584328057|FG004|Overall Study|Physician Decision|0|||
161804762|NCT00874237|584328058|FG005|Overall Study|Physician Decision|0|||
161804763|NCT00874237|584328053|FG000|Overall Study|Withdrawal by Subject|0|||
161804764|NCT00874237|584328054|FG001|Overall Study|Withdrawal by Subject|0|||
161804765|NCT00874237|584328055|FG002|Overall Study|Withdrawal by Subject|1|||
161804766|NCT00874237|584328056|FG003|Overall Study|Withdrawal by Subject|0|||
161804767|NCT00874237|584328057|FG004|Overall Study|Withdrawal by Subject|0|||
161804768|NCT00874237|584328058|FG005|Overall Study|Withdrawal by Subject|0|||
161804769|NCT00877032|584328061|FG000|Overall Study|Did not meet entrance criteria|0|||
161804770|NCT00877032|584328062|FG001|Overall Study|Did not meet entrance criteria|0|||
161804771|NCT00877032|584328063|FG002|Overall Study|Did not meet entrance criteria|0|||
161804772|NCT00877032|584328064|FG003|Overall Study|Did not meet entrance criteria|1|||
161804773|NCT00877032|584328065|FG004|Overall Study|Did not meet entrance criteria|0|||
161804774|NCT00877032|584328066|FG005|Overall Study|Did not meet entrance criteria|0|||
161804775|NCT00877032|584328067|FG006|Overall Study|Did not meet entrance criteria|2|||
161804776|NCT01941030|584328070|FG000|Overall Study|Death|3|||
161804777|NCT01941030|584328071|FG001|Overall Study|Death|2|||
161804778|NCT01941030|584328070|FG000|Overall Study|Lost to Follow-up|6|||
161804779|NCT01941030|584328071|FG001|Overall Study|Lost to Follow-up|5|||
161804780|NCT01941030|584328070|FG000|Overall Study|Withdrawal by Subject|4|||
161804781|NCT01941030|584328071|FG001|Overall Study|Withdrawal by Subject|6|||
161804782|NCT05067647|584328072|FG000|Overall Study|Lost to Follow-up|1|||
161804783|NCT02781727|584328073|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
161804784|NCT02781727|584328074|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
161804785|NCT02781727|584328073|FG000|Treatment Period|Withdrawal by Subject|1|||
161804786|NCT02781727|584328074|FG001|Treatment Period|Withdrawal by Subject|0|||
161804787|NCT02781727|584328073|FG000|Treatment Period|Lost to Follow-up|0|||
161804788|NCT02781727|584328074|FG001|Treatment Period|Lost to Follow-up|1|||
161804789|NCT01569152|584328078|FG000|Phase IIa, Period 1|Early Escape|5|||
161804790|NCT01569152|584328079|FG001|Phase IIa, Period 1|Early Escape|22|||
161804791|NCT01569152|584328080|FG002|Phase IIa, Period 1|Early Escape|0|||
161804792|NCT01569152|584328078|FG000|Phase IIa, Period 1|Adverse Event|4|||
161804793|NCT01569152|584328079|FG001|Phase IIa, Period 1|Adverse Event|0|||
161804794|NCT01569152|584328080|FG002|Phase IIa, Period 1|Adverse Event|0|||
161804795|NCT01569152|584328078|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
161804796|NCT01569152|584328079|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
161804797|NCT01569152|584328080|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
161804798|NCT01569152|584328078|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
161804799|NCT01569152|584328079|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
161804800|NCT01569152|584328080|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
161804801|NCT01569152|584328078|FG000|Phase IIa, Period 1|Protocol Violation|0|||
161804802|NCT01569152|584328079|FG001|Phase IIa, Period 1|Protocol Violation|1|||
161804803|NCT01569152|584328080|FG002|Phase IIa, Period 1|Protocol Violation|0|||
161804804|NCT01569152|584328078|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
161804805|NCT01569152|584328079|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
161907620|NCT02700048|584712258|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
161907621|NCT02700048|584712259|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
161907622|NCT02175225|584712260|FG000|Overall Study|Withdrawal by Subject|1|||
161907623|NCT02175225|584712261|FG001|Overall Study|Withdrawal by Subject|2|||
161907624|NCT02175225|584712260|FG000|Overall Study|Lost to Follow-up|6|||
161907625|NCT02175225|584712261|FG001|Overall Study|Lost to Follow-up|7|||
161907626|NCT02175225|584712260|FG000|Overall Study|Study drug not administered|1|||
161907627|NCT02175225|584712261|FG001|Overall Study|Study drug not administered|2|||
161907628|NCT02340000|584712262|FG000|Time Period 1|Withdrawal by Subject|6|||
161907629|NCT02340000|584712263|FG001|Time Period 1|Withdrawal by Subject|8|||
161907630|NCT02340000|584712262|FG000|Time Period 1|Lost to Follow-up|6|||
161907631|NCT02340000|584712263|FG001|Time Period 1|Lost to Follow-up|7|||
161907632|NCT02340000|584712262|FG000|Time Period 2|Withdrawal by Subject|9|||
161907633|NCT02340000|584712263|FG001|Time Period 2|Withdrawal by Subject|7|||
161907634|NCT02340000|584712262|FG000|Time Period 2|Lost to Follow-up|10|||
161907635|NCT02340000|584712263|FG001|Time Period 2|Lost to Follow-up|8|||
161907636|NCT02668640|584712264|FG000|Overall Study|Lost to Follow-up|13|||
161907637|NCT02668640|584712264|FG000|Overall Study|Other, not specified|1|||
161907638|NCT00919633|584712274|FG000|Overall Study|Adverse Event|1|||
161907639|NCT00919633|584712275|FG001|Overall Study|Adverse Event|9|||
161907640|NCT00919633|584712276|FG002|Overall Study|Adverse Event|12|||
161907641|NCT00919633|584712277|FG003|Overall Study|Adverse Event|10|||
161907642|NCT00919633|584712274|FG000|Overall Study|Death|0|||
161907643|NCT00919633|584712275|FG001|Overall Study|Death|0|||
161907644|NCT00919633|584712276|FG002|Overall Study|Death|2|||
161907645|NCT00919633|584712277|FG003|Overall Study|Death|0|||
161907646|NCT00919633|584712274|FG000|Overall Study|Lack of Efficacy|17|||
161907647|NCT00919633|584712275|FG001|Overall Study|Lack of Efficacy|3|||
161907648|NCT00919633|584712276|FG002|Overall Study|Lack of Efficacy|2|||
161907649|NCT00919633|584712277|FG003|Overall Study|Lack of Efficacy|3|||
161907650|NCT00919633|584712274|FG000|Overall Study|Withdrawal by Subject|1|||
161907651|NCT00919633|584712275|FG001|Overall Study|Withdrawal by Subject|2|||
161907652|NCT00919633|584712276|FG002|Overall Study|Withdrawal by Subject|4|||
161907653|NCT00919633|584712277|FG003|Overall Study|Withdrawal by Subject|3|||
161907654|NCT00919633|584712274|FG000|Overall Study|Lost to Follow-up|3|||
161907655|NCT00919633|584712275|FG001|Overall Study|Lost to Follow-up|1|||
161907656|NCT00919633|584712276|FG002|Overall Study|Lost to Follow-up|0|||
161907657|NCT00919633|584712277|FG003|Overall Study|Lost to Follow-up|2|||
161907658|NCT00919633|584712274|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
161907659|NCT00919633|584712275|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
161907660|NCT00919633|584712276|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
161907661|NCT00919633|584712277|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
161907662|NCT00919633|584712274|FG000|Overall Study|Protocol Violation|0|||
161907663|NCT00919633|584712275|FG001|Overall Study|Protocol Violation|0|||
161907664|NCT00919633|584712276|FG002|Overall Study|Protocol Violation|0|||
161907665|NCT00919633|584712277|FG003|Overall Study|Protocol Violation|1|||
161907666|NCT00919633|584712274|FG000|Overall Study|Physician Decision|0|||
161907667|NCT00919633|584712275|FG001|Overall Study|Physician Decision|0|||
161907668|NCT00919633|584712276|FG002|Overall Study|Physician Decision|0|||
161907669|NCT00919633|584712277|FG003|Overall Study|Physician Decision|1|||
161907670|NCT00919633|584712274|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
161907671|NCT00919633|584712275|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
161907672|NCT00919633|584712276|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
161907673|NCT00919633|584712277|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
161907674|NCT00919633|584712274|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
161907675|NCT00919633|584712275|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
161907676|NCT00919633|584712276|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
161907677|NCT00919633|584712277|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
161907678|NCT01526785|584712278|FG000|Overall Study|Study Terminated by Sponsor|8|||
161907679|NCT01526785|584712278|FG000|Overall Study|Death|2|||
161907680|NCT01526785|584712278|FG000|Overall Study|Physician Decision|1|||
161907681|NCT01526785|584712278|FG000|Overall Study|Withdrawal by Subject|2|||
161907682|NCT01121263|584712281|FG000|Overall Study|Death|3|||
161907683|NCT01121263|584712282|FG001|Overall Study|Death|2|||
161907684|NCT01121263|584712281|FG000|Overall Study|Lost to Follow-up|22|||
161907685|NCT01121263|584712282|FG001|Overall Study|Lost to Follow-up|12|||
161907686|NCT01121263|584712281|FG000|Overall Study|Withdrawal by Subject|0|||
161907687|NCT01121263|584712282|FG001|Overall Study|Withdrawal by Subject|1|||
161907688|NCT00723229|584713989|FG000|First Intervention|Lost to Follow-up|7|||
161907689|NCT00723229|584713990|FG001|First Intervention|Lost to Follow-up|3|||
161907690|NCT02337491|584713991|FG000|Overall Study|Death|1|||
161907691|NCT02337491|584713992|FG001|Overall Study|Death|1|||
161907692|NCT02337491|584713991|FG000|Overall Study|Adverse Event|0|||
161907693|NCT02337491|584713992|FG001|Overall Study|Adverse Event|1|||
161907694|NCT02337491|584713991|FG000|Overall Study|Withdrawal by Subject|3|||
161907695|NCT02337491|584713992|FG001|Overall Study|Withdrawal by Subject|0|||
161907696|NCT02337491|584713991|FG000|Overall Study|Progressive Disease|44|||
161907697|NCT02337491|584713992|FG001|Overall Study|Progressive Disease|28|||
161907698|NCT02337491|584713991|FG000|Overall Study|On Treatment|2|||
161907699|NCT02337491|584713992|FG001|Overall Study|On Treatment|0|||
161907700|NCT01432951|584713993|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
161907701|NCT02900352|584713994|FG000|Overall Study|Lost to Follow-up|28|||
161907702|NCT02900352|584713995|FG001|Overall Study|Lost to Follow-up|17|||
161907703|NCT00785356|584713997|FG000|Overall Study|Study prematurely terminated|8|||
161907704|NCT03712280|584714003|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
161907705|NCT03712280|584714004|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
161907706|NCT03712280|584714005|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
161907707|NCT03712280|584714006|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
161907708|NCT03712280|584714003|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
161907709|NCT03712280|584714004|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
161907710|NCT03712280|584714005|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
161907711|NCT03712280|584714006|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
161907712|NCT03712280|584714003|FG000|Overall Study|Adverse Event|0|||
161907713|NCT03712280|584714004|FG001|Overall Study|Adverse Event|0|||
161907714|NCT03712280|584714005|FG002|Overall Study|Adverse Event|1|||
161907715|NCT03712280|584714006|FG003|Overall Study|Adverse Event|0|||
161907716|NCT00106002|584714007|FG000|Overall Study|Did not take any study drug|1|||
161907717|NCT00106002|584714007|FG000|Overall Study|Ineligible after Registration|1|||
161907718|NCT01122173|584714012|FG000|Overall Study|Lost to Follow-up|3|||
161907719|NCT01122173|584714012|FG000|Overall Study|Withdrawal by Subject|3|||
161907720|NCT01122173|584714012|FG000|Overall Study|Left study for other reasons|3|||
161907721|NCT02265510|584714013|FG000|Overall Study|Withdrawal by Subject|1|||
161907722|NCT02265510|584714014|FG001|Overall Study|Withdrawal by Subject|1|||
161907723|NCT02265510|584714015|FG002|Overall Study|Withdrawal by Subject|2|||
161907724|NCT02265510|584714016|FG003|Overall Study|Withdrawal by Subject|1|||
161907725|NCT02265510|584714017|FG004|Overall Study|Withdrawal by Subject|0|||
161907726|NCT02265510|584714018|FG005|Overall Study|Withdrawal by Subject|2|||
161907727|NCT02265510|584714019|FG006|Overall Study|Withdrawal by Subject|0|||
161907728|NCT02265510|584714020|FG007|Overall Study|Withdrawal by Subject|2|||
161907729|NCT02265510|584714021|FG008|Overall Study|Withdrawal by Subject|0|||
161907730|NCT02265510|584714022|FG009|Overall Study|Withdrawal by Subject|0|||
161907731|NCT02265510|584714023|FG010|Overall Study|Withdrawal by Subject|0|||
161907732|NCT02265510|584714024|FG011|Overall Study|Withdrawal by Subject|0|||
161907733|NCT02265510|584714025|FG012|Overall Study|Withdrawal by Subject|1|||
161907734|NCT02265510|584714026|FG013|Overall Study|Withdrawal by Subject|0|||
161907735|NCT02265510|584714013|FG000|Overall Study|Disease Progression|0|||
161907736|NCT02265510|584714014|FG001|Overall Study|Disease Progression|1|||
161907737|NCT02265510|584714015|FG002|Overall Study|Disease Progression|2|||
161907738|NCT02265510|584714016|FG003|Overall Study|Disease Progression|1|||
161907739|NCT02265510|584714017|FG004|Overall Study|Disease Progression|1|||
161907740|NCT02265510|584714018|FG005|Overall Study|Disease Progression|0|||
161907741|NCT02265510|584714019|FG006|Overall Study|Disease Progression|0|||
161907742|NCT02265510|584714020|FG007|Overall Study|Disease Progression|0|||
161907743|NCT02265510|584714021|FG008|Overall Study|Disease Progression|0|||
161907744|NCT02265510|584714022|FG009|Overall Study|Disease Progression|0|||
161907745|NCT02265510|584714023|FG010|Overall Study|Disease Progression|0|||
161907746|NCT02265510|584714024|FG011|Overall Study|Disease Progression|0|||
161907747|NCT02265510|584714025|FG012|Overall Study|Disease Progression|0|||
161907748|NCT02265510|584714026|FG013|Overall Study|Disease Progression|0|||
161907749|NCT02265510|584714013|FG000|Overall Study|Death|2|||
161907750|NCT02265510|584714014|FG001|Overall Study|Death|0|||
161907751|NCT02265510|584714015|FG002|Overall Study|Death|2|||
161907752|NCT02265510|584714016|FG003|Overall Study|Death|2|||
161907753|NCT02265510|584714017|FG004|Overall Study|Death|1|||
161907754|NCT02265510|584714018|FG005|Overall Study|Death|3|||
161907755|NCT02265510|584714019|FG006|Overall Study|Death|2|||
161907756|NCT02265510|584714020|FG007|Overall Study|Death|1|||
161907757|NCT02265510|584714021|FG008|Overall Study|Death|3|||
161907758|NCT02265510|584714022|FG009|Overall Study|Death|3|||
161907759|NCT02265510|584714023|FG010|Overall Study|Death|4|||
161907760|NCT02265510|584714024|FG011|Overall Study|Death|12|||
161907761|NCT02265510|584714025|FG012|Overall Study|Death|7|||
161907762|NCT02265510|584714026|FG013|Overall Study|Death|6|||
161907763|NCT02265510|584714013|FG000|Overall Study|Lost to Follow-up|0|||
161907764|NCT02265510|584714014|FG001|Overall Study|Lost to Follow-up|0|||
161907765|NCT02265510|584714015|FG002|Overall Study|Lost to Follow-up|0|||
161907766|NCT02265510|584714016|FG003|Overall Study|Lost to Follow-up|0|||
161907767|NCT02265510|584714017|FG004|Overall Study|Lost to Follow-up|1|||
161907768|NCT02265510|584714018|FG005|Overall Study|Lost to Follow-up|0|||
161907769|NCT02265510|584714019|FG006|Overall Study|Lost to Follow-up|0|||
161907770|NCT02265510|584714020|FG007|Overall Study|Lost to Follow-up|0|||
161907771|NCT02265510|584714021|FG008|Overall Study|Lost to Follow-up|0|||
161907772|NCT02265510|584714022|FG009|Overall Study|Lost to Follow-up|2|||
161907773|NCT02265510|584714023|FG010|Overall Study|Lost to Follow-up|0|||
161907774|NCT02265510|584714024|FG011|Overall Study|Lost to Follow-up|0|||
161907775|NCT02265510|584714025|FG012|Overall Study|Lost to Follow-up|0|||
161907776|NCT02265510|584714026|FG013|Overall Study|Lost to Follow-up|2|||
161907777|NCT02265510|584714013|FG000|Overall Study|Other|0|||
161907778|NCT02265510|584714014|FG001|Overall Study|Other|1|||
161907779|NCT02265510|584714015|FG002|Overall Study|Other|0|||
161907780|NCT02265510|584714016|FG003|Overall Study|Other|0|||
161907781|NCT02265510|584714017|FG004|Overall Study|Other|0|||
161907782|NCT02265510|584714018|FG005|Overall Study|Other|0|||
161907783|NCT02265510|584714019|FG006|Overall Study|Other|0|||
161907784|NCT02265510|584714020|FG007|Overall Study|Other|0|||
161907785|NCT02265510|584714021|FG008|Overall Study|Other|0|||
161907786|NCT02265510|584714022|FG009|Overall Study|Other|0|||
161907787|NCT02265510|584714023|FG010|Overall Study|Other|0|||
161907788|NCT02265510|584714024|FG011|Overall Study|Other|0|||
161907789|NCT02265510|584714025|FG012|Overall Study|Other|0|||
161907790|NCT02265510|584714026|FG013|Overall Study|Other|0|||
161907791|NCT02265510|584714013|FG000|Overall Study|Study Terminated by Sponsor|0|||
161907792|NCT02265510|584714014|FG001|Overall Study|Study Terminated by Sponsor|0|||
161907793|NCT02265510|584714015|FG002|Overall Study|Study Terminated by Sponsor|0|||
161907794|NCT02265510|584714016|FG003|Overall Study|Study Terminated by Sponsor|0|||
161907795|NCT02265510|584714017|FG004|Overall Study|Study Terminated by Sponsor|0|||
161907796|NCT02265510|584714018|FG005|Overall Study|Study Terminated by Sponsor|1|||
161907797|NCT02265510|584714019|FG006|Overall Study|Study Terminated by Sponsor|1|||
161907798|NCT02265510|584714020|FG007|Overall Study|Study Terminated by Sponsor|1|||
161907799|NCT02265510|584714021|FG008|Overall Study|Study Terminated by Sponsor|1|||
161907800|NCT02265510|584714022|FG009|Overall Study|Study Terminated by Sponsor|2|||
161907801|NCT02265510|584714023|FG010|Overall Study|Study Terminated by Sponsor|1|||
161907802|NCT02265510|584714024|FG011|Overall Study|Study Terminated by Sponsor|4|||
161907803|NCT02265510|584714025|FG012|Overall Study|Study Terminated by Sponsor|1|||
161907804|NCT02265510|584714026|FG013|Overall Study|Study Terminated by Sponsor|2|||
161907805|NCT02530385|584714027|FG000|Overall Study|Withdrawal by Subject|0|||
161907806|NCT02530385|584714028|FG001|Overall Study|Withdrawal by Subject|1|||
161907807|NCT00116142|584714029|FG000|Overall Study|Adverse Event|8|||
161907808|NCT00116142|584714030|FG001|Overall Study|Adverse Event|7|||
161907809|NCT00116142|584714029|FG000|Overall Study|Protocol Violation|2|||
161907810|NCT00116142|584714030|FG001|Overall Study|Protocol Violation|1|||
161907811|NCT00116142|584714029|FG000|Overall Study|Withdrawal by Subject|5|||
161907812|NCT00116142|584714030|FG001|Overall Study|Withdrawal by Subject|5|||
161907813|NCT00116142|584714029|FG000|Overall Study|Physician Decision|3|||
161907814|NCT00116142|584714030|FG001|Overall Study|Physician Decision|1|||
161907815|NCT00116142|584714029|FG000|Overall Study|Delayed Radiation Therapy|1|||
161907816|NCT00116142|584714030|FG001|Overall Study|Delayed Radiation Therapy|0|||
161907817|NCT00116142|584714029|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
161907818|NCT00116142|584714030|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
161907819|NCT00116142|584714029|FG000|Overall Study|Patient stopped due to depression|0|||
161907820|NCT00116142|584714030|FG001|Overall Study|Patient stopped due to depression|1|||
161907821|NCT00116142|584714029|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
161907822|NCT00116142|584714030|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
161907823|NCT00116142|584714029|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
161907824|NCT00116142|584714030|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
161907825|NCT00116142|584714029|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
161804806|NCT01569152|584328080|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
161804807|NCT01569152|584328078|FG000|Safety Extension, Period 3|Adverse Event|0|||
161804808|NCT01569152|584328079|FG001|Safety Extension, Period 3|Adverse Event|0|||
161804809|NCT01569152|584328080|FG002|Safety Extension, Period 3|Adverse Event|4|||
161804810|NCT01569152|584328078|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
161804811|NCT01569152|584328079|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
161804812|NCT01569152|584328080|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
161804813|NCT01569152|584328078|FG000|Safety Extension, Period 3|Physician Decision|0|||
161804814|NCT01569152|584328079|FG001|Safety Extension, Period 3|Physician Decision|0|||
161804815|NCT01569152|584328080|FG002|Safety Extension, Period 3|Physician Decision|2|||
161804816|NCT01569152|584328078|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
161804817|NCT01569152|584328079|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
161804818|NCT01569152|584328080|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
161804819|NCT00683293|584328085|FG000|Overall Study|Withdrawal by Subject|2|||
161804820|NCT00683293|584328086|FG001|Overall Study|Withdrawal by Subject|3|||
161804821|NCT00743197|584328089|FG000|Overall Study|Study terminated due to departure of PI.|1|||
161804822|NCT00743197|584328090|FG001|Overall Study|Study terminated due to departure of PI.|2|||
161804823|NCT02507375|584328091|FG000|Overall Study|Progressive Disease|4|||
161804824|NCT02507375|584328092|FG001|Overall Study|Progressive Disease|5|||
161907826|NCT00116142|584714030|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
161907827|NCT03093181|584714032|FG000|Overall Study|Withdrawal by Subject|2|||
161907828|NCT03093181|584714033|FG001|Overall Study|Withdrawal by Subject|1|||
161907829|NCT03093181|584714034|FG002|Overall Study|Withdrawal by Subject|2|||
161907830|NCT03093181|584714032|FG000|Overall Study|Other (Not specified)|1|||
161907831|NCT03093181|584714033|FG001|Overall Study|Other (Not specified)|0|||
161907832|NCT03093181|584714034|FG002|Overall Study|Other (Not specified)|0|||
161907833|NCT03093181|584714032|FG000|Overall Study|Adverse Event|0|||
161907834|NCT03093181|584714033|FG001|Overall Study|Adverse Event|1|||
161907835|NCT03093181|584714034|FG002|Overall Study|Adverse Event|0|||
161907836|NCT03093181|584714032|FG000|Overall Study|Other (Protocol violation)|0|||
161907837|NCT03093181|584714033|FG001|Overall Study|Other (Protocol violation)|0|||
161907838|NCT03093181|584714034|FG002|Overall Study|Other (Protocol violation)|1|||
161907839|NCT04076917|584714035|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
161907840|NCT04076917|584714035|FG000|Overall Study|Study closure|13|||
161907841|NCT04076917|584714035|FG000|Overall Study|Physician Decision|3|||
161907842|NCT04076917|584714035|FG000|Overall Study|Death|1|||
161907843|NCT04076917|584714035|FG000|Overall Study|Lost to Follow-up|1|||
161907844|NCT04076917|584714035|FG000|Overall Study|Withdrawal by Subject|1|||
161907845|NCT04076917|584714035|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
161907846|NCT04210986|584714036|FG000|Overall Study|Lost to Follow-up|5|||
161907847|NCT04210986|584714037|FG001|Overall Study|Lost to Follow-up|2|||
161907848|NCT04210986|584714036|FG000|Overall Study|Withdrawal by Subject|3|||
161907849|NCT04210986|584714037|FG001|Overall Study|Withdrawal by Subject|1|||
161907850|NCT04210986|584714036|FG000|Overall Study|Protocol Violation|1|||
161907851|NCT04210986|584714037|FG001|Overall Study|Protocol Violation|1|||
161907852|NCT04210986|584714036|FG000|Overall Study|Physician Decision|0|||
161907853|NCT04210986|584714037|FG001|Overall Study|Physician Decision|1|||
161907854|NCT02378662|584714038|FG000|Overall Study|Early Discontinuation|2|||
161907855|NCT02378662|584714039|FG001|Overall Study|Early Discontinuation|0|||
161907856|NCT01774591|584714040|FG000|Overall Study|Physician Decision|1|||
161907857|NCT01774591|584714041|FG001|Overall Study|Physician Decision|1|||
161907858|NCT01774591|584714040|FG000|Overall Study|Withdrawal by Subject|0|||
161907859|NCT01774591|584714041|FG001|Overall Study|Withdrawal by Subject|1|||
161907860|NCT01774591|584714040|FG000|Overall Study|Adverse Event|0|||
161907861|NCT01774591|584714041|FG001|Overall Study|Adverse Event|2|||
161907862|NCT01159574|584714042|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
161907863|NCT01159574|584714042|FG000|Treatment Phase|Adverse Event|3|||
161907864|NCT01159574|584714042|FG000|Treatment Phase|Death|6|||
161907865|NCT01159574|584714042|FG000|Treatment Phase|Physician Decision|2|||
161907866|NCT01159574|584714042|FG000|Treatment Phase|Withdrawal by Subject|7|||
161907867|NCT01159574|584714042|FG000|Treatment Phase|still on treatment|2|||
161907868|NCT01159574|584714042|FG000|Follow Up Phase|Lost to Follow-up|2|||
161907869|NCT01159574|584714042|FG000|Follow Up Phase|still being followed for overall surviva|18|||
161907870|NCT02984982|584714043|FG000|Overall Study|Adverse Event|2|||
161907871|NCT02984982|584714044|FG001|Overall Study|Adverse Event|5|||
161907872|NCT02984982|584714043|FG000|Overall Study|Poor Compliance to Protocol|4|||
161907873|NCT02984982|584714044|FG001|Overall Study|Poor Compliance to Protocol|4|||
161907874|NCT02984982|584714043|FG000|Overall Study|Withdrawal by Subject|2|||
161907875|NCT02984982|584714044|FG001|Overall Study|Withdrawal by Subject|0|||
161907876|NCT02984982|584714043|FG000|Overall Study|Randomized but not treated|0|||
161907877|NCT02984982|584714044|FG001|Overall Study|Randomized but not treated|1|||
161907878|NCT02144701|584714045|FG000|Overall Study|development of relapse, GVHD or death|9|||
161907879|NCT02144701|584714046|FG001|Overall Study|development of relapse, GVHD or death|3|||
161907880|NCT04622969|584714057|FG000|Overall Study|Withdrawal by Subject|2|||
161907881|NCT04622969|584714058|FG001|Overall Study|Withdrawal by Subject|3|||
161907882|NCT04467515|584714059|FG000|Overall Study|Lost to Follow-up|1|||
161907883|NCT04467515|584714060|FG001|Overall Study|Lost to Follow-up|0|||
161907884|NCT04467515|584714061|FG002|Overall Study|Lost to Follow-up|0|||
161907885|NCT04467515|584714059|FG000|Overall Study|Withdrawal by Subject|1|||
161907886|NCT04467515|584714060|FG001|Overall Study|Withdrawal by Subject|0|||
161907887|NCT04467515|584714061|FG002|Overall Study|Withdrawal by Subject|1|||
161907888|NCT04467515|584714059|FG000|Overall Study|Progressive Disease|0|||
161907889|NCT04467515|584714060|FG001|Overall Study|Progressive Disease|1|||
161907890|NCT04467515|584714061|FG002|Overall Study|Progressive Disease|3|||
161907891|NCT04467515|584714059|FG000|Overall Study|Death|0|||
161907892|NCT04467515|584714060|FG001|Overall Study|Death|1|||
161907893|NCT04467515|584714061|FG002|Overall Study|Death|0|||
161907894|NCT04249427|584714064|FG000|Overall Study|Adverse Event|3|||
161907895|NCT04249427|584714065|FG001|Overall Study|Adverse Event|1|||
161907896|NCT04249427|584714064|FG000|Overall Study|Lack of Efficacy|0|||
161907897|NCT04249427|584714065|FG001|Overall Study|Lack of Efficacy|1|||
161907898|NCT04249427|584714064|FG000|Overall Study|Withdrawal by Subject|1|||
161907899|NCT04249427|584714065|FG001|Overall Study|Withdrawal by Subject|2|||
161907900|NCT03886272|584714066|FG000|Period 1|Withdrawal by Subject|0|||
161907901|NCT03886272|584714067|FG001|Period 1|Withdrawal by Subject|0|||
161907902|NCT03886272|584714068|FG002|Period 1|Withdrawal by Subject|0|||
161907903|NCT03886272|584714069|FG003|Period 1|Withdrawal by Subject|0|||
161907904|NCT03886272|584714070|FG004|Period 1|Withdrawal by Subject|0|||
161907905|NCT03886272|584714071|FG005|Period 1|Withdrawal by Subject|1|||
161907906|NCT03886272|584714072|FG006|Period 1|Withdrawal by Subject|0|||
161907907|NCT02848664|584714078|FG000|Overall Study|Withdrawal by Subject|2|||
161907908|NCT02848664|584714078|FG000|Overall Study|Adverse Event|1|||
161907909|NCT02848664|584714078|FG000|Overall Study|no assistance for device training|1|||
161907910|NCT02849080|584714081|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
161907911|NCT02849080|584714082|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
161907912|NCT02849080|584714083|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
161907913|NCT02849080|584714084|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
161907914|NCT02849080|584714081|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
161907915|NCT02849080|584714082|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
161907916|NCT02849080|584714083|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
161907917|NCT02849080|584714084|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
161907918|NCT02849080|584714081|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
161907919|NCT02849080|584714082|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
161907920|NCT02849080|584714083|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
161907921|NCT02849080|584714084|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
161907922|NCT02849080|584714081|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
161907923|NCT02849080|584714082|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161907924|NCT02849080|584714083|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161907925|NCT02849080|584714084|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161907926|NCT02849080|584714081|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
161907927|NCT02849080|584714082|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
161907928|NCT02849080|584714083|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
161907929|NCT02849080|584714084|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
161907930|NCT02849080|584714081|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
161907931|NCT02849080|584714082|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161907932|NCT02849080|584714083|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161907933|NCT02849080|584714084|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161907934|NCT01819727|584714087|FG000|Overall Study|Adverse Event|8|||
161907935|NCT01819727|584714088|FG001|Overall Study|Adverse Event|9|||
161907936|NCT01819727|584714087|FG000|Overall Study|Death|1|||
161907937|NCT01819727|584714088|FG001|Overall Study|Death|0|||
161907938|NCT01819727|584714087|FG000|Overall Study|Lost to Follow-up|1|||
161907939|NCT01819727|584714088|FG001|Overall Study|Lost to Follow-up|1|||
161907940|NCT01819727|584714087|FG000|Overall Study|Physician Decision|3|||
161907941|NCT01819727|584714088|FG001|Overall Study|Physician Decision|2|||
161907942|NCT01819727|584714087|FG000|Overall Study|Pregnancy|1|||
161907943|NCT01819727|584714088|FG001|Overall Study|Pregnancy|0|||
161907944|NCT01819727|584714087|FG000|Overall Study|Protocol Violation|0|||
161907945|NCT01819727|584714088|FG001|Overall Study|Protocol Violation|2|||
161907946|NCT01819727|584714087|FG000|Overall Study|Study Terminated by Sponsor|0|||
161907947|NCT01819727|584714088|FG001|Overall Study|Study Terminated by Sponsor|1|||
161907948|NCT01819727|584714087|FG000|Overall Study|Withdrawal by Subject|6|||
161907949|NCT01819727|584714088|FG001|Overall Study|Withdrawal by Subject|11|||
161907950|NCT01819727|584714087|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
161907951|NCT01819727|584714088|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
161907952|NCT01819727|584714087|FG000|Overall Study|Quit due to lack of health benifits|0|||
161907953|NCT01819727|584714088|FG001|Overall Study|Quit due to lack of health benifits|1|||
161907954|NCT00732069|584714091|FG000|Washout After First Study Drug|Adverse Event|1|||
161907955|NCT00732069|584714092|FG001|Washout After First Study Drug|Adverse Event|0|||
161907956|NCT00732069|584714093|FG002|Washout After First Study Drug|Adverse Event|0|||
161907957|NCT00732069|584714094|FG003|Washout After First Study Drug|Adverse Event|0|||
161907958|NCT00732069|584714095|FG004|Washout After First Study Drug|Adverse Event|0|||
161907959|NCT00732069|584714096|FG005|Washout After First Study Drug|Adverse Event|0|||
161907960|NCT00402727|584714097|FG000|Overall Study|Adverse Event|10|||
161907961|NCT00402727|584714098|FG001|Overall Study|Adverse Event|6|||
161907962|NCT00402727|584714097|FG000|Overall Study|Death|1|||
161907963|NCT00402727|584714098|FG001|Overall Study|Death|0|||
161907964|NCT00402727|584714097|FG000|Overall Study|Lack of Efficacy|1|||
161907965|NCT00402727|584714098|FG001|Overall Study|Lack of Efficacy|3|||
161907966|NCT00402727|584714097|FG000|Overall Study|Lost to Follow-up|24|||
161907967|NCT00402727|584714098|FG001|Overall Study|Lost to Follow-up|11|||
161907968|NCT00402727|584714097|FG000|Overall Study|Physician Decision|1|||
161561251|NCT01163149|583442073|FG000|Extension Treatment Period|Adverse Event|0|||
161907969|NCT00402727|584714098|FG001|Overall Study|Physician Decision|1|||
161907970|NCT00402727|584714097|FG000|Overall Study|Protocol Violation|0|||
161907971|NCT00402727|584714098|FG001|Overall Study|Protocol Violation|4|||
161907972|NCT00402727|584714097|FG000|Overall Study|Withdrawal by Subject|3|||
161907973|NCT00402727|584714098|FG001|Overall Study|Withdrawal by Subject|7|||
161907974|NCT00402727|584714097|FG000|Overall Study|supply problems|2|||
161907975|NCT00402727|584714098|FG001|Overall Study|supply problems|1|||
161907976|NCT00402727|584714097|FG000|Overall Study|non-compliance|0|||
161907977|NCT00402727|584714098|FG001|Overall Study|non-compliance|1|||
161907978|NCT00577317|584714099|FG000|Overall Study|Study Terminated|0|||
161907979|NCT00577317|584714100|FG001|Overall Study|Study Terminated|2|||
161907980|NCT02283658|584714104|FG000|Overall Study|Withdrawal by Subject|1|||
161907981|NCT03608826|584714106|FG000|Overall Study|Death|3|||
161804825|NCT02507375|584328091|FG000|Overall Study|Death|0|||
161804826|NCT02507375|584328092|FG001|Overall Study|Death|1|||
161804827|NCT02507375|584328091|FG000|Overall Study|Refused treatment|0|||
161804828|NCT02507375|584328092|FG001|Overall Study|Refused treatment|1|||
161804829|NCT02507375|584328091|FG000|Overall Study|Adverse Event|0|||
161804830|NCT02507375|584328092|FG001|Overall Study|Adverse Event|1|||
161804831|NCT02158936|584328093|FG000|Overall Study|Study closed/ terminated|57|||
161804832|NCT02158936|584328094|FG001|Overall Study|Study closed/ terminated|77|||
161804833|NCT02158936|584328093|FG000|Overall Study|Azacitidine tx discontinued|53|||
161804834|NCT02158936|584328094|FG001|Overall Study|Azacitidine tx discontinued|46|||
161804835|NCT02158936|584328093|FG000|Overall Study|Adverse Event|39|||
161804836|NCT02158936|584328094|FG001|Overall Study|Adverse Event|24|||
161804837|NCT02158936|584328093|FG000|Overall Study|Withdrawal by Subject|15|||
161804838|NCT02158936|584328094|FG001|Overall Study|Withdrawal by Subject|16|||
161804839|NCT02158936|584328093|FG000|Overall Study|Physician Decision|15|||
161804840|NCT02158936|584328094|FG001|Overall Study|Physician Decision|13|||
161804841|NCT02158936|584328093|FG000|Overall Study|Lost to Follow-up|0|||
161804842|NCT02158936|584328094|FG001|Overall Study|Lost to Follow-up|1|||
161804843|NCT00522457|584328095|FG000|Overall Study|Due to disease progression|16|||
161804844|NCT00522457|584328095|FG000|Overall Study|Adverse Event|2|||
161804845|NCT01215981|584329776|FG000|Overall Study|Physician Decision|0|||
161804846|NCT01215981|584329777|FG001|Overall Study|Physician Decision|1|||
161804847|NCT01215981|584329776|FG000|Overall Study|Protocol Violation|1|||
161804848|NCT01215981|584329777|FG001|Overall Study|Protocol Violation|0|||
161804849|NCT01215981|584329776|FG000|Overall Study|Withdrawal by Subject|1|||
161804850|NCT01215981|584329777|FG001|Overall Study|Withdrawal by Subject|0|||
161804851|NCT00727571|584329783|FG000|Overall Study|Ineligibility determined|1|||
161804852|NCT00727571|584329784|FG001|Overall Study|Ineligibility determined|1|||
161804853|NCT00727571|584329785|FG002|Overall Study|Ineligibility determined|1|||
161804854|NCT00727571|584329786|FG003|Overall Study|Ineligibility determined|0|||
161804855|NCT00727571|584329783|FG000|Overall Study|Death|0|||
161804856|NCT00727571|584329784|FG001|Overall Study|Death|19|||
161804857|NCT00727571|584329785|FG002|Overall Study|Death|5|||
161804858|NCT00727571|584329786|FG003|Overall Study|Death|1|||
161804859|NCT00727571|584329783|FG000|Overall Study|Physician Decision|0|||
161804860|NCT00727571|584329784|FG001|Overall Study|Physician Decision|5|||
161804861|NCT00727571|584329785|FG002|Overall Study|Physician Decision|0|||
161804862|NCT00727571|584329786|FG003|Overall Study|Physician Decision|0|||
161804863|NCT00727571|584329783|FG000|Overall Study|Withdrawal by Subject|0|||
161804864|NCT00727571|584329784|FG001|Overall Study|Withdrawal by Subject|10|||
161804865|NCT00727571|584329785|FG002|Overall Study|Withdrawal by Subject|11|||
161804866|NCT00727571|584329786|FG003|Overall Study|Withdrawal by Subject|0|||
161804867|NCT00727571|584329783|FG000|Overall Study|Subject Non Compliance|0|||
161804868|NCT00727571|584329784|FG001|Overall Study|Subject Non Compliance|6|||
161804869|NCT00727571|584329785|FG002|Overall Study|Subject Non Compliance|0|||
161804870|NCT00727571|584329786|FG003|Overall Study|Subject Non Compliance|4|||
161804871|NCT00727571|584329783|FG000|Overall Study|Dismissed from nursing home|0|||
161804872|NCT00727571|584329784|FG001|Overall Study|Dismissed from nursing home|9|||
161804873|NCT00727571|584329785|FG002|Overall Study|Dismissed from nursing home|5|||
161804874|NCT00727571|584329786|FG003|Overall Study|Dismissed from nursing home|0|||
161804875|NCT00727571|584329783|FG000|Overall Study|Hospitalization|0|||
161804876|NCT00727571|584329784|FG001|Overall Study|Hospitalization|1|||
161804877|NCT00727571|584329785|FG002|Overall Study|Hospitalization|0|||
161804878|NCT00727571|584329786|FG003|Overall Study|Hospitalization|1|||
161804879|NCT00727571|584329783|FG000|Overall Study|AE not leading to hospitalization|0|||
161804880|NCT00727571|584329784|FG001|Overall Study|AE not leading to hospitalization|0|||
161804881|NCT00727571|584329785|FG002|Overall Study|AE not leading to hospitalization|2|||
161804882|NCT00727571|584329786|FG003|Overall Study|AE not leading to hospitalization|0|||
161804883|NCT00727571|584329783|FG000|Overall Study|Other|0|||
161804884|NCT00727571|584329784|FG001|Overall Study|Other|4|||
161804885|NCT00727571|584329785|FG002|Overall Study|Other|6|||
161804886|NCT00727571|584329786|FG003|Overall Study|Other|0|||
161453207|NCT01224782|583053593|FG000|Overall Study|Noncompliance|10|||
161804887|NCT03247556|584329787|FG000|Overall Study|Adverse Event|1|||
161804888|NCT03247556|584329788|FG001|Overall Study|Adverse Event|4|||
161804889|NCT03247556|584329789|FG002|Overall Study|Adverse Event|5|||
161804890|NCT03247556|584329787|FG000|Overall Study|Lost to Follow-up|5|||
161804891|NCT03247556|584329788|FG001|Overall Study|Lost to Follow-up|5|||
161804892|NCT03247556|584329789|FG002|Overall Study|Lost to Follow-up|4|||
161804893|NCT03247556|584329787|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
161804894|NCT03247556|584329788|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
161453208|NCT01224782|583053593|FG000|Overall Study|Other|4|||
161804895|NCT03247556|584329789|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
161804896|NCT03247556|584329787|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
161804897|NCT03247556|584329788|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
161804898|NCT03247556|584329789|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
161804899|NCT03247556|584329787|FG000|Overall Study|Protocol Violation|2|||
161804900|NCT03247556|584329788|FG001|Overall Study|Protocol Violation|0|||
161907982|NCT03608826|584714106|FG000|Overall Study|Heart Transplant|3|||
161907983|NCT03608826|584714106|FG000|Overall Study|Physician Decision|4|||
161907984|NCT00875810|584714123|FG000|Overall Study|Withdrawal by Subject|1|||
161907985|NCT00875810|584714123|FG000|Overall Study|Physician Decision|3|||
161907986|NCT00875810|584714123|FG000|Overall Study|Lost to Follow-up|39|||
161907987|NCT00875810|584714123|FG000|Overall Study|Patient enroled but not implanted|2|||
161907988|NCT00875810|584714123|FG000|Overall Study|Device explanted|1|||
161907989|NCT00887484|584714127|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
161907990|NCT00887484|584714127|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
161907991|NCT00887484|584714127|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
161907992|NCT01061606|584714128|FG000|Overall Study|Adverse Event|1|||
161907993|NCT01061606|584714128|FG000|Overall Study|Death|1|||
161907994|NCT01061606|584714128|FG000|Overall Study|Disease Progression|4|||
161907995|NCT01061606|584714128|FG000|Overall Study|alternative therapy|2|||
161907996|NCT01316224|584714129|FG000|Overall Study|Protocol Violation|3|||
161907997|NCT01316224|584714129|FG000|Overall Study|Adverse Event|3|||
161907998|NCT01316224|584714129|FG000|Overall Study|Lack of Efficacy|1|||
161907999|NCT01316224|584714129|FG000|Overall Study|Withdrawal by Subject|1|||
161908000|NCT01316224|584714129|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
161908001|NCT01316224|584714129|FG000|Overall Study|Other|1|||
161908002|NCT03106077|584714134|FG000|Overall Study|Screen Failure|94|||
161908003|NCT03106077|584714135|FG001|Overall Study|Screen Failure|0|||
161804901|NCT03247556|584329789|FG002|Overall Study|Protocol Violation|1|||
161804902|NCT03247556|584329787|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
161804903|NCT03247556|584329788|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
161804904|NCT03247556|584329789|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
161804905|NCT01710657|584329791|FG000|Overall Study|Lost to Follow-up|2|||
161804906|NCT01710657|584329792|FG001|Overall Study|Lost to Follow-up|0|||
161804907|NCT01710657|584329793|FG002|Overall Study|Lost to Follow-up|1|||
161804908|NCT01710657|584329791|FG000|Overall Study|Protocol Violation|2|||
161804909|NCT01710657|584329792|FG001|Overall Study|Protocol Violation|2|||
161804910|NCT01710657|584329793|FG002|Overall Study|Protocol Violation|0|||
161804911|NCT01710657|584329791|FG000|Overall Study|Adverse Event|14|||
161804912|NCT01710657|584329792|FG001|Overall Study|Adverse Event|8|||
161804913|NCT01710657|584329793|FG002|Overall Study|Adverse Event|28|||
161804914|NCT01710657|584329791|FG000|Overall Study|Withdrawal by Subject|0|||
161804915|NCT01710657|584329792|FG001|Overall Study|Withdrawal by Subject|1|||
161804916|NCT01710657|584329793|FG002|Overall Study|Withdrawal by Subject|2|||
161804917|NCT01710657|584329791|FG000|Overall Study|Lack of Efficacy|0|||
161804918|NCT01710657|584329792|FG001|Overall Study|Lack of Efficacy|1|||
161804919|NCT01710657|584329793|FG002|Overall Study|Lack of Efficacy|1|||
161804920|NCT02724462|584329795|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
161804921|NCT02724462|584329796|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
161804922|NCT02724462|584329795|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161804923|NCT02724462|584329796|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161804924|NCT02724462|584329795|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
161804925|NCT02724462|584329796|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
161804926|NCT02724462|584329795|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161804927|NCT02724462|584329796|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161804928|NCT02724462|584329795|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
161804929|NCT02724462|584329796|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
161804930|NCT02724462|584329795|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161804931|NCT02724462|584329796|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161804932|NCT00469417|584329797|FG000|Overall Study|Treatment failure all lesions|18|||
161804933|NCT00469417|584329798|FG001|Overall Study|Treatment failure all lesions|11|||
161804934|NCT00469417|584329797|FG000|Overall Study|Consent withdrawn|1|||
161804935|NCT00469417|584329798|FG001|Overall Study|Consent withdrawn|1|||
161804936|NCT00469417|584329797|FG000|Overall Study|Adverse Event|8|||
161804937|NCT00469417|584329798|FG001|Overall Study|Adverse Event|2|||
161804938|NCT00469417|584329797|FG000|Overall Study|Lost to Follow-up|1|||
161804939|NCT00469417|584329798|FG001|Overall Study|Lost to Follow-up|2|||
161804940|NCT00469417|584329797|FG000|Overall Study|Intercurrent disease|0|||
161804941|NCT00469417|584329798|FG001|Overall Study|Intercurrent disease|1|||
161804942|NCT00469417|584329797|FG000|Overall Study|Randomized but not treated|2|||
161804943|NCT00469417|584329798|FG001|Overall Study|Randomized but not treated|0|||
161804944|NCT05327491|584329801|FG000|Periods 1 & 2|Miscellaneous|0|||
161804945|NCT05327491|584329802|FG001|Periods 1 & 2|Miscellaneous|1|||
161804946|NCT05327491|584329803|FG002|Periods 1 & 2|Miscellaneous|0|||
161804947|NCT05327491|584329804|FG003|Periods 1 & 2|Miscellaneous|0|||
161804948|NCT05327491|584329801|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
161804949|NCT05327491|584329802|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
161804950|NCT05327491|584329803|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
161804951|NCT05327491|584329804|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
161804952|NCT02188303|584329805|FG000|Overall Study|Adverse Event|0|||
161804953|NCT02188303|584329806|FG001|Overall Study|Adverse Event|0|||
161908004|NCT01274533|584714136|FG000|Overall Study|Withdrawal by Subject|1|||
161908005|NCT01274533|584714136|FG000|Overall Study|Non-compliance|1|||
161908006|NCT01274533|584714136|FG000|Overall Study|Disease progression|2|||
161908007|NCT02563899|584714137|FG000|Overall Study|Protocol Violation|1|||
161908008|NCT02563899|584714138|FG001|Overall Study|Protocol Violation|0|||
161908009|NCT02563899|584714139|FG002|Overall Study|Protocol Violation|0|||
161908010|NCT02563899|584714140|FG003|Overall Study|Protocol Violation|0|||
161908011|NCT02563899|584714137|FG000|Overall Study|Withdrawal by Subject|0|||
161908012|NCT02563899|584714138|FG001|Overall Study|Withdrawal by Subject|0|||
161908013|NCT02563899|584714139|FG002|Overall Study|Withdrawal by Subject|1|||
161908014|NCT02563899|584714140|FG003|Overall Study|Withdrawal by Subject|0|||
161908015|NCT02008526|584714141|FG000|Overall Study|Death|0|||
161908016|NCT02008526|584714142|FG001|Overall Study|Death|2|||
161908017|NCT02008526|584714143|FG002|Overall Study|Death|1|||
161908018|NCT02008526|584714141|FG000|Overall Study|Withdrawal by Subject|3|||
161908019|NCT02008526|584714142|FG001|Overall Study|Withdrawal by Subject|3|||
161908020|NCT02008526|584714143|FG002|Overall Study|Withdrawal by Subject|2|||
161908021|NCT02008526|584714141|FG000|Overall Study|Lost to Follow-up|5|||
161908022|NCT02008526|584714142|FG001|Overall Study|Lost to Follow-up|9|||
161908023|NCT02008526|584714143|FG002|Overall Study|Lost to Follow-up|6|||
161908024|NCT01305564|584714150|FG000|Overall Study|Death|21|||
161908025|NCT01305564|584714150|FG000|Overall Study|Lost to Follow-up|12|||
161908026|NCT01305564|584714150|FG000|Overall Study|Withdrawal by Subject|1|||
161908027|NCT01305564|584714150|FG000|Overall Study|Physician Decision|3|||
161908028|NCT02322749|584714151|FG000|Period 2|Adverse Event|0|||
161908029|NCT02322749|584714152|FG001|Period 2|Adverse Event|0|||
161908030|NCT02322749|584714153|FG002|Period 2|Adverse Event|0|||
161908031|NCT02322749|584714154|FG003|Period 2|Adverse Event|1|||
161908032|NCT02322749|584714155|FG004|Period 2|Adverse Event|0|||
161908033|NCT02322749|584714156|FG005|Period 2|Adverse Event|0|||
161908034|NCT02322749|584714151|FG000|Period 2|Withdrawal by Subject|0|||
161908035|NCT02322749|584714152|FG001|Period 2|Withdrawal by Subject|0|||
161908036|NCT02322749|584714153|FG002|Period 2|Withdrawal by Subject|0|||
161908037|NCT02322749|584714154|FG003|Period 2|Withdrawal by Subject|1|||
161908038|NCT02322749|584714155|FG004|Period 2|Withdrawal by Subject|0|||
161908039|NCT02322749|584714156|FG005|Period 2|Withdrawal by Subject|0|||
161908040|NCT02322749|584714151|FG000|Period 3|Withdrawal by Subject|0|||
161908041|NCT02322749|584714152|FG001|Period 3|Withdrawal by Subject|0|||
161908042|NCT02322749|584714153|FG002|Period 3|Withdrawal by Subject|1|||
161908043|NCT02322749|584714154|FG003|Period 3|Withdrawal by Subject|0|||
161908044|NCT02322749|584714155|FG004|Period 3|Withdrawal by Subject|0|||
161908045|NCT02322749|584714156|FG005|Period 3|Withdrawal by Subject|0|||
161908046|NCT01190813|584714161|FG000|Overall Study|Lost to Follow-up|1|||
161908047|NCT01190813|584714162|FG001|Overall Study|Lost to Follow-up|2|||
161908048|NCT01190813|584714161|FG000|Overall Study|Withdrawal by Subject|2|||
161908049|NCT01190813|584714162|FG001|Overall Study|Withdrawal by Subject|1|||
161908050|NCT01190813|584714161|FG000|Overall Study|Refused study treatment after randomized|1|||
161908051|NCT01190813|584714162|FG001|Overall Study|Refused study treatment after randomized|0|||
161908052|NCT01190813|584714161|FG000|Overall Study|Adverse Event|0|||
161908053|NCT01190813|584714162|FG001|Overall Study|Adverse Event|1|||
161908054|NCT03810456|584714164|FG000|Treatment|Urgent Family Matters|3|||
161908055|NCT03810456|584714165|FG001|Treatment|Urgent Family Matters|0|||
161908056|NCT03810456|584714166|FG002|Treatment|Urgent Family Matters|0|||
161908057|NCT03810456|584714164|FG000|Treatment|Scheduling Conflicts|0|||
161908058|NCT03810456|584714165|FG001|Treatment|Scheduling Conflicts|11|||
161908059|NCT03810456|584714166|FG002|Treatment|Scheduling Conflicts|0|||
161908060|NCT03810456|584714164|FG000|Treatment|No Longer Interested|0|||
161908061|NCT03810456|584714165|FG001|Treatment|No Longer Interested|12|||
161908062|NCT03810456|584714166|FG002|Treatment|No Longer Interested|0|||
161908063|NCT03810456|584714164|FG000|Treatment|Transportation Issues|0|||
161908064|NCT03810456|584714165|FG001|Treatment|Transportation Issues|1|||
161908065|NCT03810456|584714166|FG002|Treatment|Transportation Issues|0|||
161908066|NCT03810456|584714164|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
161908067|NCT03810456|584714165|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
161908068|NCT03810456|584714166|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
161908069|NCT03810456|584714164|FG000|1 Month Follow-Up|Relocated to Different State|1|||
161908070|NCT03810456|584714165|FG001|1 Month Follow-Up|Relocated to Different State|0|||
161908071|NCT03810456|584714166|FG002|1 Month Follow-Up|Relocated to Different State|1|||
161908072|NCT03810456|584714164|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
161908073|NCT03810456|584714165|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
161908074|NCT03810456|584714166|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
161908075|NCT03810456|584714164|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
161908076|NCT03810456|584714165|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
161908077|NCT03810456|584714166|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
161908078|NCT03810456|584714164|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
161908079|NCT03810456|584714165|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
161908080|NCT03810456|584714166|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
161908081|NCT03810456|584714164|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
161908082|NCT03810456|584714165|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
161908083|NCT03810456|584714166|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
161908084|NCT03810456|584714164|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
161908085|NCT03810456|584714165|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
161908086|NCT03810456|584714166|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
161908087|NCT04265261|584714171|FG000|Overall Study|Adverse Event|2|||
161908088|NCT04265261|584714172|FG001|Overall Study|Adverse Event|0|||
161908089|NCT04265261|584714173|FG002|Overall Study|Adverse Event|0|||
161908090|NCT04265261|584714171|FG000|Overall Study|Death|1|||
161908091|NCT04265261|584714172|FG001|Overall Study|Death|0|||
161908092|NCT04265261|584714173|FG002|Overall Study|Death|0|||
161908093|NCT04265261|584714171|FG000|Overall Study|Lost to Follow-up|4|||
161908094|NCT04265261|584714172|FG001|Overall Study|Lost to Follow-up|1|||
161908095|NCT04265261|584714173|FG002|Overall Study|Lost to Follow-up|3|||
161908096|NCT04265261|584714171|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161908097|NCT04265261|584714172|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161908098|NCT04265261|584714173|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161908099|NCT04265261|584714171|FG000|Overall Study|Physician Decision|0|||
161908100|NCT04265261|584714172|FG001|Overall Study|Physician Decision|0|||
161908101|NCT04265261|584714173|FG002|Overall Study|Physician Decision|1|||
161908102|NCT04265261|584714171|FG000|Overall Study|Protocol Deviation|0|||
161908103|NCT04265261|584714172|FG001|Overall Study|Protocol Deviation|2|||
161908104|NCT04265261|584714173|FG002|Overall Study|Protocol Deviation|0|||
161908105|NCT04265261|584714171|FG000|Overall Study|Withdrawal by Subject|2|||
161908106|NCT04265261|584714172|FG001|Overall Study|Withdrawal by Subject|1|||
161908107|NCT04265261|584714173|FG002|Overall Study|Withdrawal by Subject|4|||
161908108|NCT07116759|584714174|FG000|Overall Study|Incompatibility with the RHMC device|2|||
161908109|NCT03408899|584715765|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
161908110|NCT00606008|584715766|FG000|Overall Study|Adverse Event|1|||
161908111|NCT00606008|584715766|FG000|Overall Study|Withdrawal by Subject|4|||
161908112|NCT04745351|584715767|FG000|Overall Study|Death|51|||
161908113|NCT04745351|584715768|FG001|Overall Study|Death|25|||
161908114|NCT04745351|584715767|FG000|Overall Study|Lost to Follow-up|9|||
161908115|NCT04745351|584715768|FG001|Overall Study|Lost to Follow-up|3|||
161908116|NCT04745351|584715767|FG000|Overall Study|Randomized but Never Treated|3|||
161908117|NCT04745351|584715768|FG001|Overall Study|Randomized but Never Treated|3|||
161908118|NCT04745351|584715767|FG000|Overall Study|Adverse Event|4|||
161908119|NCT04745351|584715768|FG001|Overall Study|Adverse Event|0|||
161908120|NCT04745351|584715767|FG000|Overall Study|Withdrew Consent|1|||
161908121|NCT04745351|584715768|FG001|Overall Study|Withdrew Consent|2|||
161908122|NCT04745351|584715767|FG000|Overall Study|Investigator's Discretion|2|||
161908123|NCT04745351|584715768|FG001|Overall Study|Investigator's Discretion|0|||
161908124|NCT04745351|584715767|FG000|Overall Study|Protocol Violation|1|||
161908125|NCT04745351|584715768|FG001|Overall Study|Protocol Violation|0|||
161908126|NCT02014272|584715772|FG000|Intervention Period 1|Withdrawal by Subject|1|||
161908127|NCT02014272|584715773|FG001|Intervention Period 1|Withdrawal by Subject|0|||
161908128|NCT02014272|584715772|FG000|Intervention Period 1|Adverse Event|0|||
161908129|NCT02014272|584715773|FG001|Intervention Period 1|Adverse Event|1|||
161908130|NCT03499795|584715774|FG000|Overall Study|Adverse Event|1|||
161908131|NCT03499795|584715774|FG000|Overall Study|Lost to Follow-up|1|||
161908132|NCT00630916|584715775|FG000|Overall Study|Death|110|||
161908133|NCT00630916|584715775|FG000|Overall Study|Explant|8|||
161908134|NCT00630916|584715775|FG000|Overall Study|Lost to Follow-up|5|||
161908135|NCT00630916|584715775|FG000|Overall Study|Withdrawal by Subject|30|||
161908136|NCT00630916|584715775|FG000|Overall Study|Protocol Violation|7|||
161908137|NCT00630916|584715775|FG000|Overall Study|Physician Decision|47|||
161908138|NCT00630916|584715775|FG000|Overall Study|Lack of Efficacy|3|||
161908139|NCT00324155|584715776|FG000|Enrolled and Randomized|No longer met study criteria|3|||
161908140|NCT00324155|584715777|FG001|Enrolled and Randomized|No longer met study criteria|0|||
161908141|NCT00324155|584715776|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
161908142|NCT00324155|584715777|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
161908143|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
161908144|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
161908145|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
161908146|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
161908147|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Death|8|||
161908148|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Death|15|||
161908149|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
161908150|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
161908151|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
161908152|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
161908153|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
161908154|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
161908155|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
161908156|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
161908157|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
161908158|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
161908159|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
161908160|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
161908161|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
161908162|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
161908163|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
161908164|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
161908165|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
161908166|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
161908167|NCT00324155|584715776|FG000|Follow-up Phase|On-going participants still on drug|11|||
161908168|NCT00324155|584715777|FG001|Follow-up Phase|On-going participants still on drug|6|||
161908169|NCT00390689|584715778|FG000|Overall Study|Adverse Event|2|||
161908170|NCT00390689|584715779|FG001|Overall Study|Adverse Event|5|||
161908171|NCT00390689|584715780|FG002|Overall Study|Adverse Event|2|||
161908172|NCT00390689|584715778|FG000|Overall Study|Lack of Efficacy|0|||
161908173|NCT00390689|584715779|FG001|Overall Study|Lack of Efficacy|0|||
161908174|NCT00390689|584715780|FG002|Overall Study|Lack of Efficacy|1|||
161908175|NCT00390689|584715778|FG000|Overall Study|Protocol Violation|1|||
161908176|NCT00390689|584715779|FG001|Overall Study|Protocol Violation|0|||
161908177|NCT00390689|584715780|FG002|Overall Study|Protocol Violation|0|||
161908178|NCT00390689|584715778|FG000|Overall Study|Investigator's judgement|2|||
161908179|NCT00390689|584715779|FG001|Overall Study|Investigator's judgement|0|||
161908180|NCT00390689|584715780|FG002|Overall Study|Investigator's judgement|0|||
161908181|NCT01253161|584715781|FG000|Overall Study|Adverse Event|1|||
161908182|NCT03101020|584715783|FG000|Overall Study|Lack of time to participate|1|||
161908183|NCT03101020|584715784|FG001|Overall Study|Lack of time to participate|0|||
161908184|NCT03101020|584715783|FG000|Overall Study|Ran over by a car|0|||
161908185|NCT03101020|584715784|FG001|Overall Study|Ran over by a car|1|||
161908186|NCT03101020|584715783|FG000|Overall Study|Withdrawal by Subject|0|||
161908187|NCT03101020|584715784|FG001|Overall Study|Withdrawal by Subject|2|||
161908188|NCT05412134|584715785|FG000|Overall Study|Lost to Follow-up|2|||
161908189|NCT05412134|584715786|FG001|Overall Study|Lost to Follow-up|0|||
161908190|NCT03167242|584715788|FG000|Overall Study|Patient/Guardian Decision|0|||
161908191|NCT03167242|584715789|FG001|Overall Study|Patient/Guardian Decision|1|||
161908192|NCT03167242|584715790|FG002|Overall Study|Patient/Guardian Decision|2|||
161908193|NCT03167242|584715791|FG003|Overall Study|Patient/Guardian Decision|1|||
161908194|NCT03167242|584715792|FG004|Overall Study|Patient/Guardian Decision|1|||
161908195|NCT03167242|584715793|FG005|Overall Study|Patient/Guardian Decision|1|||
161908196|NCT03167242|584715794|FG006|Overall Study|Patient/Guardian Decision|0|||
161908197|NCT03167242|584715795|FG007|Overall Study|Patient/Guardian Decision|0|||
161908198|NCT03167242|584715796|FG008|Overall Study|Patient/Guardian Decision|0|||
161908199|NCT03167242|584715797|FG009|Overall Study|Patient/Guardian Decision|0|||
161908200|NCT03167242|584715798|FG010|Overall Study|Patient/Guardian Decision|1|||
161908201|NCT03167242|584715799|FG011|Overall Study|Patient/Guardian Decision|0|||
161908202|NCT03167242|584715788|FG000|Overall Study|Lost to Follow-up|0|||
161908203|NCT03167242|584715789|FG001|Overall Study|Lost to Follow-up|0|||
161908204|NCT03167242|584715790|FG002|Overall Study|Lost to Follow-up|1|||
161908205|NCT03167242|584715791|FG003|Overall Study|Lost to Follow-up|0|||
161908206|NCT03167242|584715792|FG004|Overall Study|Lost to Follow-up|0|||
161908207|NCT03167242|584715793|FG005|Overall Study|Lost to Follow-up|1|||
161908208|NCT03167242|584715794|FG006|Overall Study|Lost to Follow-up|2|||
161908209|NCT03167242|584715795|FG007|Overall Study|Lost to Follow-up|1|||
161908210|NCT03167242|584715796|FG008|Overall Study|Lost to Follow-up|0|||
161908211|NCT03167242|584715797|FG009|Overall Study|Lost to Follow-up|0|||
161908212|NCT03167242|584715798|FG010|Overall Study|Lost to Follow-up|1|||
161908213|NCT03167242|584715799|FG011|Overall Study|Lost to Follow-up|1|||
161908214|NCT03167242|584715788|FG000|Overall Study|Reason not provided|0|||
161908215|NCT03167242|584715789|FG001|Overall Study|Reason not provided|0|||
161908216|NCT03167242|584715790|FG002|Overall Study|Reason not provided|0|||
161908217|NCT03167242|584715791|FG003|Overall Study|Reason not provided|0|||
161908218|NCT03167242|584715792|FG004|Overall Study|Reason not provided|0|||
161908219|NCT03167242|584715793|FG005|Overall Study|Reason not provided|0|||
161908220|NCT03167242|584715794|FG006|Overall Study|Reason not provided|0|||
161908221|NCT03167242|584715795|FG007|Overall Study|Reason not provided|0|||
161908222|NCT03167242|584715796|FG008|Overall Study|Reason not provided|1|||
161908223|NCT03167242|584715797|FG009|Overall Study|Reason not provided|0|||
161908224|NCT03167242|584715798|FG010|Overall Study|Reason not provided|0|||
161908225|NCT03167242|584715799|FG011|Overall Study|Reason not provided|0|||
161908226|NCT03444584|584715801|FG000|Overall Study|Withdrawal by Subject|0|||
161908227|NCT03444584|584715802|FG001|Overall Study|Withdrawal by Subject|1|||
161908228|NCT03444584|584715801|FG000|Overall Study|Other|0|||
161908229|NCT03444584|584715802|FG001|Overall Study|Other|1|||
161908230|NCT03786380|584715803|FG000|Overall Study|Adverse Event|1|||
161908231|NCT03786380|584715804|FG001|Overall Study|Adverse Event|0|||
161908232|NCT03786380|584715805|FG002|Overall Study|Adverse Event|0|||
161908233|NCT03786380|584715806|FG003|Overall Study|Adverse Event|3|||
161908234|NCT03786380|584715807|FG004|Overall Study|Adverse Event|1|||
161908235|NCT03786380|584715803|FG000|Overall Study|Lack of Efficacy|0|||
161908236|NCT03786380|584715804|FG001|Overall Study|Lack of Efficacy|0|||
161908237|NCT03786380|584715805|FG002|Overall Study|Lack of Efficacy|0|||
161908238|NCT03786380|584715806|FG003|Overall Study|Lack of Efficacy|0|||
161908239|NCT03786380|584715807|FG004|Overall Study|Lack of Efficacy|1|||
161908240|NCT03786380|584715803|FG000|Overall Study|Withdrawal by Subject|1|||
161908241|NCT03786380|584715804|FG001|Overall Study|Withdrawal by Subject|2|||
161908242|NCT03786380|584715805|FG002|Overall Study|Withdrawal by Subject|2|||
161908243|NCT03786380|584715806|FG003|Overall Study|Withdrawal by Subject|1|||
161908244|NCT03786380|584715807|FG004|Overall Study|Withdrawal by Subject|2|||
161908245|NCT03786380|584715803|FG000|Overall Study|Lost to Follow-up|3|||
161908246|NCT03786380|584715804|FG001|Overall Study|Lost to Follow-up|0|||
161908247|NCT03786380|584715805|FG002|Overall Study|Lost to Follow-up|1|||
161908248|NCT03786380|584715806|FG003|Overall Study|Lost to Follow-up|2|||
161908249|NCT03786380|584715807|FG004|Overall Study|Lost to Follow-up|0|||
161908250|NCT03786380|584715803|FG000|Overall Study|Physician Decision|0|||
161908251|NCT03786380|584715804|FG001|Overall Study|Physician Decision|0|||
161908252|NCT03786380|584715805|FG002|Overall Study|Physician Decision|1|||
161908253|NCT03786380|584715806|FG003|Overall Study|Physician Decision|0|||
161908254|NCT03786380|584715807|FG004|Overall Study|Physician Decision|0|||
161908255|NCT03786380|584715803|FG000|Overall Study|Study Terminated by the Sponsor|30|||
161908256|NCT03786380|584715804|FG001|Overall Study|Study Terminated by the Sponsor|20|||
161908257|NCT03786380|584715805|FG002|Overall Study|Study Terminated by the Sponsor|50|||
161908258|NCT03786380|584715806|FG003|Overall Study|Study Terminated by the Sponsor|57|||
161908259|NCT03786380|584715807|FG004|Overall Study|Study Terminated by the Sponsor|23|||
161908260|NCT03786380|584715803|FG000|Overall Study|Reason Not Specified|0|||
161908261|NCT03786380|584715804|FG001|Overall Study|Reason Not Specified|0|||
161908262|NCT03786380|584715805|FG002|Overall Study|Reason Not Specified|0|||
161908263|NCT03786380|584715806|FG003|Overall Study|Reason Not Specified|0|||
161908264|NCT03786380|584715807|FG004|Overall Study|Reason Not Specified|1|||
161908265|NCT01038687|584715810|FG000|Overall Study|Adverse Event|0|||
161908266|NCT01038687|584715811|FG001|Overall Study|Adverse Event|2|||
161908267|NCT01038687|584715812|FG002|Overall Study|Adverse Event|1|||
161908268|NCT02783911|584715813|FG000|Overall Study|Lost to Follow-up|3|||
161908269|NCT02783911|584715814|FG001|Overall Study|Lost to Follow-up|32|||
161908270|NCT02616783|584715815|FG000|Overall Study|Randomized but Not Treated|1|||
161908271|NCT02616783|584715816|FG001|Overall Study|Randomized but Not Treated|0|||
161908272|NCT02616783|584715815|FG000|Overall Study|Adverse Event|1|||
161908273|NCT02616783|584715816|FG001|Overall Study|Adverse Event|0|||
161908274|NCT02616783|584715815|FG000|Overall Study|Death|1|||
161908275|NCT02616783|584715816|FG001|Overall Study|Death|0|||
161908276|NCT02616783|584715815|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161908277|NCT02616783|584715816|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161908278|NCT02616783|584715815|FG000|Overall Study|Protocol Violation|1|||
161908279|NCT02616783|584715816|FG001|Overall Study|Protocol Violation|1|||
161908280|NCT02616783|584715815|FG000|Overall Study|Withdrew Consent|1|||
161908281|NCT02616783|584715816|FG001|Overall Study|Withdrew Consent|1|||
161908282|NCT00467519|584715817|FG000|Overall Study|Protocol Violation|8|||
161908283|NCT00467519|584715818|FG001|Overall Study|Protocol Violation|4|||
161908284|NCT00467519|584715817|FG000|Overall Study|Lost to Follow-up|2|||
161908285|NCT00467519|584715818|FG001|Overall Study|Lost to Follow-up|9|||
161908286|NCT00467519|584715817|FG000|Overall Study|Withdrawal by Subject|4|||
161908287|NCT00467519|584715818|FG001|Overall Study|Withdrawal by Subject|10|||
161908288|NCT00372424|584715819|FG000|Overall Study|Adverse Event|2|||
161908289|NCT00372424|584715819|FG000|Overall Study|Withdrawal by Subject|1|||
161908290|NCT00372424|584715819|FG000|Overall Study|Death|1|||
161908291|NCT00372424|584715819|FG000|Overall Study|Objective Progression or Relapse|14|||
161908292|NCT00372424|584715819|FG000|Overall Study|Other|7|||
161908293|NCT00372424|584715819|FG000|Overall Study|Enrolled, Not Treated|1|||
161908294|NCT02314728|584715830|FG000|Overall Study|Protocol Violation|1|||
161908295|NCT02314728|584715831|FG001|Overall Study|Protocol Violation|0|||
161908296|NCT02314728|584715830|FG000|Overall Study|Lost to Follow-up|0|||
161908297|NCT02314728|584715831|FG001|Overall Study|Lost to Follow-up|1|||
161908298|NCT03118934|584715833|FG000|Overall Study|Adverse Event|0|||
161908299|NCT03118934|584715834|FG001|Overall Study|Adverse Event|0|||
161908300|NCT03118934|584715835|FG002|Overall Study|Adverse Event|0|||
161908301|NCT03118934|584715836|FG003|Overall Study|Adverse Event|0|||
161453209|NCT01224782|583053593|FG000|Overall Study|Start of Dialysis|3|||
161908302|NCT03118934|584715837|FG004|Overall Study|Adverse Event|0|||
161908303|NCT03118934|584715838|FG005|Overall Study|Adverse Event|1|||
161908304|NCT03118934|584715833|FG000|Overall Study|Physician Decision|0|||
161908305|NCT03118934|584715834|FG001|Overall Study|Physician Decision|0|||
161908306|NCT03118934|584715835|FG002|Overall Study|Physician Decision|0|||
161908307|NCT03118934|584715836|FG003|Overall Study|Physician Decision|0|||
161561252|NCT01163149|583442074|FG001|Extension Treatment Period|Adverse Event|1|||
161561253|NCT01163149|583442075|FG002|Extension Treatment Period|Adverse Event|0|||
161804954|NCT02188303|584329807|FG002|Overall Study|Adverse Event|0|||
161804955|NCT02188303|584329808|FG003|Overall Study|Adverse Event|0|||
161804956|NCT02188303|584329809|FG004|Overall Study|Adverse Event|0|||
161804957|NCT02188303|584329810|FG005|Overall Study|Adverse Event|2|||
161804958|NCT02188303|584329811|FG006|Overall Study|Adverse Event|0|||
161804959|NCT02188303|584329812|FG007|Overall Study|Adverse Event|2|||
161804960|NCT02188303|584329805|FG000|Overall Study|Dose Termination Criteria Met|0|||
161804961|NCT02188303|584329806|FG001|Overall Study|Dose Termination Criteria Met|0|||
161804962|NCT02188303|584329807|FG002|Overall Study|Dose Termination Criteria Met|0|||
161804963|NCT02188303|584329808|FG003|Overall Study|Dose Termination Criteria Met|0|||
161804964|NCT02188303|584329809|FG004|Overall Study|Dose Termination Criteria Met|0|||
161804965|NCT02188303|584329810|FG005|Overall Study|Dose Termination Criteria Met|0|||
161804966|NCT02188303|584329811|FG006|Overall Study|Dose Termination Criteria Met|2|||
161804967|NCT02188303|584329812|FG007|Overall Study|Dose Termination Criteria Met|4|||
161804968|NCT05612724|584329815|FG000|Overall Study|Lost to Follow-up|4|||
161804969|NCT04000815|584329822|FG000|Overall Study|Lost to Follow-up|9|||
161804970|NCT04000815|584329823|FG001|Overall Study|Lost to Follow-up|2|||
161804971|NCT04000815|584329824|FG002|Overall Study|Lost to Follow-up|3|||
161804972|NCT04000815|584329822|FG000|Overall Study|Withdrawal by Subject|4|||
161804973|NCT04000815|584329823|FG001|Overall Study|Withdrawal by Subject|3|||
161804974|NCT04000815|584329824|FG002|Overall Study|Withdrawal by Subject|2|||
161804975|NCT04000815|584329822|FG000|Overall Study|Right ovarian cyst occured|1|||
161804976|NCT04000815|584329823|FG001|Overall Study|Right ovarian cyst occured|0|||
161804977|NCT04000815|584329824|FG002|Overall Study|Right ovarian cyst occured|0|||
161804978|NCT04000815|584329822|FG000|Overall Study|Hypertension occured on follow up|0|||
161804979|NCT04000815|584329823|FG001|Overall Study|Hypertension occured on follow up|0|||
161804980|NCT04000815|584329824|FG002|Overall Study|Hypertension occured on follow up|2|||
161804981|NCT00239577|584329825|FG000|Primary Phase|Adverse Event|0|||
161804982|NCT00239577|584329826|FG001|Primary Phase|Adverse Event|0|||
161804983|NCT00239577|584329827|FG002|Primary Phase|Adverse Event|1|||
161804984|NCT00239577|584329828|FG003|Primary Phase|Adverse Event|0|||
161804985|NCT00239577|584329825|FG000|Primary Phase|Other|5|||
161804986|NCT00239577|584329826|FG001|Primary Phase|Other|3|||
161804987|NCT00239577|584329827|FG002|Primary Phase|Other|2|||
161804988|NCT00239577|584329828|FG003|Primary Phase|Other|0|||
161804989|NCT01034358|584329831|FG000|Overall Study|Withdrawal by Subject|1|||
161804990|NCT01034358|584329831|FG000|Overall Study|Protocol Violation|1|||
161804991|NCT00377260|584329834|FG000|Overall Study|Lost to Follow-up|0|||
161804992|NCT00377260|584329835|FG001|Overall Study|Lost to Follow-up|1|||
161804993|NCT00377260|584329834|FG000|Overall Study|Withdrawal by Subject|2|||
161804994|NCT00377260|584329835|FG001|Overall Study|Withdrawal by Subject|4|||
161804995|NCT02017964|584329836|FG000|Overall Study|Patient deemed ineligible|1|||
161804996|NCT02300103|584329837|FG000|Overall Study|Lack of Efficacy|3|||
161804997|NCT02300103|584329837|FG000|Overall Study|Protocol Violation|1|||
161804998|NCT02300103|584329837|FG000|Overall Study|Withdrew Consent|2|||
161804999|NCT04091971|584329838|FG000|Overall Study|Withdrawal by Subject|1|||
161805000|NCT04091971|584329838|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
161805001|NCT04091971|584329838|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
161805002|NCT01391793|584329839|FG000|Overall Study|Ineligible|3|||
161805003|NCT01391793|584329840|FG001|Overall Study|Ineligible|0|||
161805004|NCT01391793|584329839|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
161805005|NCT01391793|584329840|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
161805006|NCT01391793|584329839|FG000|Overall Study|No DMSA|73|||
161805007|NCT01391793|584329840|FG001|Overall Study|No DMSA|57|||
161805008|NCT01015625|584329841|FG000|Overall Study|Lost to Follow-up|3|||
161805009|NCT01015625|584329842|FG001|Overall Study|Lost to Follow-up|1|||
161805010|NCT01015625|584329841|FG000|Overall Study|Withdrawal by Subject|2|||
161805011|NCT01015625|584329842|FG001|Overall Study|Withdrawal by Subject|3|||
161805012|NCT01015625|584329841|FG000|Overall Study|Physician Decision|2|||
161805013|NCT01015625|584329842|FG001|Overall Study|Physician Decision|0|||
161805014|NCT01015625|584329841|FG000|Overall Study|Death|30|||
161805015|NCT01015625|584329842|FG001|Overall Study|Death|22|||
161805016|NCT00150462|584329845|FG000|Overall Study|Disease Progression or Relapse|3|||
161805017|NCT00150462|584329846|FG001|Overall Study|Disease Progression or Relapse|1|||
161561254|NCT01163149|583442073|FG000|Extension Treatment Period|Noncompliance|0|||
161805018|NCT00150462|584329847|FG002|Overall Study|Disease Progression or Relapse|2|||
161805019|NCT00150462|584329848|FG003|Overall Study|Disease Progression or Relapse|1|||
161805020|NCT00150462|584329849|FG004|Overall Study|Disease Progression or Relapse|2|||
161805021|NCT00150462|584329850|FG005|Overall Study|Disease Progression or Relapse|2|||
161805022|NCT00150462|584329851|FG006|Overall Study|Disease Progression or Relapse|3|||
161805023|NCT00150462|584329852|FG007|Overall Study|Disease Progression or Relapse|5|||
161805024|NCT00150462|584329853|FG008|Overall Study|Disease Progression or Relapse|5|||
161805025|NCT00150462|584329854|FG009|Overall Study|Disease Progression or Relapse|3|||
161805026|NCT00150462|584329855|FG010|Overall Study|Disease Progression or Relapse|2|||
161805027|NCT00150462|584329845|FG000|Overall Study|Withdrawal by Subject|0|||
161805028|NCT00150462|584329846|FG001|Overall Study|Withdrawal by Subject|1|||
161805029|NCT00150462|584329847|FG002|Overall Study|Withdrawal by Subject|1|||
161805030|NCT00150462|584329848|FG003|Overall Study|Withdrawal by Subject|0|||
161805031|NCT00150462|584329849|FG004|Overall Study|Withdrawal by Subject|1|||
161805032|NCT00150462|584329850|FG005|Overall Study|Withdrawal by Subject|2|||
161805033|NCT00150462|584329851|FG006|Overall Study|Withdrawal by Subject|0|||
161805034|NCT00150462|584329852|FG007|Overall Study|Withdrawal by Subject|1|||
161805035|NCT00150462|584329853|FG008|Overall Study|Withdrawal by Subject|0|||
161805036|NCT00150462|584329854|FG009|Overall Study|Withdrawal by Subject|1|||
161805037|NCT00150462|584329855|FG010|Overall Study|Withdrawal by Subject|0|||
161805038|NCT00150462|584329845|FG000|Overall Study|Death|0|||
161805039|NCT00150462|584329846|FG001|Overall Study|Death|1|||
161805040|NCT00150462|584329847|FG002|Overall Study|Death|0|||
161805041|NCT00150462|584329848|FG003|Overall Study|Death|0|||
161805042|NCT00150462|584329849|FG004|Overall Study|Death|0|||
161805043|NCT00150462|584329850|FG005|Overall Study|Death|0|||
161805044|NCT00150462|584329851|FG006|Overall Study|Death|0|||
161805045|NCT00150462|584329852|FG007|Overall Study|Death|0|||
161805046|NCT00150462|584329853|FG008|Overall Study|Death|1|||
161805047|NCT00150462|584329854|FG009|Overall Study|Death|0|||
161805048|NCT00150462|584329855|FG010|Overall Study|Death|0|||
161805049|NCT00150462|584329845|FG000|Overall Study|Adverse Event|0|||
161805050|NCT00150462|584329846|FG001|Overall Study|Adverse Event|0|||
161805051|NCT00150462|584329847|FG002|Overall Study|Adverse Event|0|||
161805052|NCT00150462|584329848|FG003|Overall Study|Adverse Event|1|||
161805053|NCT00150462|584329849|FG004|Overall Study|Adverse Event|0|||
161805054|NCT00150462|584329850|FG005|Overall Study|Adverse Event|0|||
161805055|NCT00150462|584329851|FG006|Overall Study|Adverse Event|0|||
161805056|NCT00150462|584329852|FG007|Overall Study|Adverse Event|2|||
161805057|NCT00150462|584329853|FG008|Overall Study|Adverse Event|0|||
161805058|NCT00150462|584329854|FG009|Overall Study|Adverse Event|1|||
161805059|NCT00150462|584329855|FG010|Overall Study|Adverse Event|0|||
161805060|NCT00150462|584329845|FG000|Overall Study|Physician Decision|0|||
161805061|NCT00150462|584329846|FG001|Overall Study|Physician Decision|0|||
161805062|NCT00150462|584329847|FG002|Overall Study|Physician Decision|1|||
161805063|NCT00150462|584329848|FG003|Overall Study|Physician Decision|1|||
161805064|NCT00150462|584329849|FG004|Overall Study|Physician Decision|0|||
161805065|NCT00150462|584329850|FG005|Overall Study|Physician Decision|0|||
161805066|NCT00150462|584329851|FG006|Overall Study|Physician Decision|0|||
161805067|NCT00150462|584329852|FG007|Overall Study|Physician Decision|0|||
161805068|NCT00150462|584329853|FG008|Overall Study|Physician Decision|0|||
161805069|NCT00150462|584329854|FG009|Overall Study|Physician Decision|0|||
161805070|NCT00150462|584329855|FG010|Overall Study|Physician Decision|0|||
161805071|NCT00150462|584329845|FG000|Overall Study|Other|0|||
161805072|NCT00150462|584329846|FG001|Overall Study|Other|0|||
161805073|NCT00150462|584329847|FG002|Overall Study|Other|0|||
161805074|NCT00150462|584329848|FG003|Overall Study|Other|0|||
161805075|NCT00150462|584329849|FG004|Overall Study|Other|0|||
161908308|NCT03118934|584715837|FG004|Overall Study|Physician Decision|0|||
161908309|NCT03118934|584715838|FG005|Overall Study|Physician Decision|1|||
161908310|NCT03118934|584715833|FG000|Overall Study|Discontinued prior to exposure|0|||
161908311|NCT03118934|584715834|FG001|Overall Study|Discontinued prior to exposure|1|||
161908312|NCT03118934|584715835|FG002|Overall Study|Discontinued prior to exposure|1|||
161908313|NCT03118934|584715836|FG003|Overall Study|Discontinued prior to exposure|1|||
161908314|NCT03118934|584715837|FG004|Overall Study|Discontinued prior to exposure|2|||
161908315|NCT03118934|584715838|FG005|Overall Study|Discontinued prior to exposure|0|||
161908316|NCT00069264|584715841|FG000|Overall Study|Adverse Event|3|||
161908317|NCT00069264|584715841|FG000|Overall Study|Progressive Disease|23|||
161908318|NCT00069264|584715841|FG000|Overall Study|Withdrawal by Subject|3|||
161908319|NCT00069264|584715841|FG000|Overall Study|Discon Therapy|3|||
161908320|NCT03014206|584715842|FG000|Overall Study|Registration Violation|12|||
161908321|NCT02895347|584715845|FG000|Overall Study|Withdrawal by Subject|3|||
161908322|NCT02895347|584715846|FG001|Overall Study|Withdrawal by Subject|1|||
161908323|NCT01673178|584715847|FG000|Overall Study|Lost to Follow-up|0|||
161805076|NCT00150462|584329850|FG005|Overall Study|Other|0|||
161805077|NCT00150462|584329851|FG006|Overall Study|Other|0|||
161805078|NCT00150462|584329852|FG007|Overall Study|Other|0|||
161805079|NCT00150462|584329853|FG008|Overall Study|Other|0|||
161805080|NCT00150462|584329854|FG009|Overall Study|Other|1|||
161805081|NCT00150462|584329855|FG010|Overall Study|Other|1|||
161805082|NCT00569374|584329856|FG000|Overall Study|Withdrawal by Subject|4|||
161805083|NCT03107091|584329857|FG000|Overall Study|Physician Decision|1|||
161805084|NCT00105196|584329860|FG000|Overall Study|Lack of Efficacy|2|||
161805085|NCT00105196|584329861|FG001|Overall Study|Lack of Efficacy|3|||
161805086|NCT00105196|584329860|FG000|Overall Study|Adverse Event|11|||
161805087|NCT00105196|584329861|FG001|Overall Study|Adverse Event|3|||
161805088|NCT00105196|584329860|FG000|Overall Study|Withdrawal by Subject|6|||
161805089|NCT00105196|584329861|FG001|Overall Study|Withdrawal by Subject|6|||
161805090|NCT00105196|584329860|FG000|Overall Study|Lost to Follow-up|3|||
161908324|NCT01673178|584715848|FG001|Overall Study|Lost to Follow-up|1|||
161805091|NCT00105196|584329861|FG001|Overall Study|Lost to Follow-up|2|||
161805092|NCT00105196|584329860|FG000|Overall Study|Poor/noncompliance|3|||
161805093|NCT00105196|584329861|FG001|Overall Study|Poor/noncompliance|4|||
161805094|NCT00105196|584329860|FG000|Overall Study|Protocol Violation|5|||
161805095|NCT00105196|584329861|FG001|Overall Study|Protocol Violation|2|||
161805096|NCT00105196|584329860|FG000|Overall Study|pending surgery|0|||
161805097|NCT00105196|584329861|FG001|Overall Study|pending surgery|1|||
161805098|NCT00105196|584329860|FG000|Overall Study|marijuana use|0|||
161805099|NCT00105196|584329861|FG001|Overall Study|marijuana use|1|||
161805100|NCT00105196|584329860|FG000|Overall Study|Subject became unblinded|0|||
161805101|NCT00105196|584329861|FG001|Overall Study|Subject became unblinded|1|||
161805102|NCT03340727|584329862|FG000|Overall Study|Death|1|||
161805103|NCT03340727|584329863|FG001|Overall Study|Death|0|||
161805104|NCT03340727|584329862|FG000|Overall Study|Lost to Follow-up|31|||
161805105|NCT03340727|584329863|FG001|Overall Study|Lost to Follow-up|35|||
161805106|NCT03340727|584329862|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
161805107|NCT03340727|584329863|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
161805108|NCT03340727|584329862|FG000|Overall Study|Transferred to another facility|10|||
161805109|NCT03340727|584329863|FG001|Overall Study|Transferred to another facility|7|||
161805110|NCT03340727|584329862|FG000|Overall Study|Withdrawal by Subject|28|||
161805111|NCT03340727|584329863|FG001|Overall Study|Withdrawal by Subject|17|||
161805112|NCT01126736|584329864|FG000|Overall Study|Death|2|||
161805113|NCT01126736|584329865|FG001|Overall Study|Death|2|||
161805114|NCT01126736|584329866|FG002|Overall Study|Death|1|||
161805115|NCT01126736|584329867|FG003|Overall Study|Death|19|||
161805116|NCT01126736|584329868|FG004|Overall Study|Death|19|||
161805117|NCT01126736|584329864|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161805118|NCT01126736|584329865|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161805119|NCT01126736|584329866|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161805120|NCT01126736|584329867|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
161805121|NCT01126736|584329868|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
161805122|NCT01126736|584329864|FG000|Overall Study|Lost to Follow-up|0|||
161805123|NCT01126736|584329865|FG001|Overall Study|Lost to Follow-up|0|||
161805124|NCT01126736|584329866|FG002|Overall Study|Lost to Follow-up|0|||
161805125|NCT01126736|584329867|FG003|Overall Study|Lost to Follow-up|1|||
161805126|NCT01126736|584329868|FG004|Overall Study|Lost to Follow-up|1|||
161805127|NCT01126736|584329864|FG000|Overall Study|Administrative reasons|0|||
161805128|NCT01126736|584329865|FG001|Overall Study|Administrative reasons|0|||
161805129|NCT01126736|584329866|FG002|Overall Study|Administrative reasons|0|||
161805130|NCT01126736|584329867|FG003|Overall Study|Administrative reasons|0|||
161805131|NCT01126736|584329868|FG004|Overall Study|Administrative reasons|1|||
161805132|NCT01126736|584329864|FG000|Overall Study|Progressive disease|0|||
161805133|NCT01126736|584329865|FG001|Overall Study|Progressive disease|0|||
161805134|NCT01126736|584329866|FG002|Overall Study|Progressive disease|0|||
161805135|NCT01126736|584329867|FG003|Overall Study|Progressive disease|2|||
161805136|NCT01126736|584329868|FG004|Overall Study|Progressive disease|1|||
161805137|NCT01126736|584329864|FG000|Overall Study|Withdrawal by Subject|0|||
161805138|NCT01126736|584329865|FG001|Overall Study|Withdrawal by Subject|0|||
161805139|NCT01126736|584329866|FG002|Overall Study|Withdrawal by Subject|0|||
161805140|NCT01126736|584329867|FG003|Overall Study|Withdrawal by Subject|1|||
161805141|NCT01126736|584329868|FG004|Overall Study|Withdrawal by Subject|1|||
161805142|NCT01126736|584329864|FG000|Overall Study|Other|2|||
161805143|NCT01126736|584329865|FG001|Overall Study|Other|4|||
161805144|NCT01126736|584329866|FG002|Overall Study|Other|4|||
161805145|NCT01126736|584329867|FG003|Overall Study|Other|16|||
161805146|NCT01126736|584329868|FG004|Overall Study|Other|15|||
161805147|NCT00813293|584329871|FG000|Overall Study|Intercurrent illness|1|||
161805148|NCT00813293|584329872|FG001|Overall Study|Intercurrent illness|0|||
161805149|NCT00813293|584329871|FG000|Overall Study|Adverse Event|0|||
161805150|NCT00813293|584329872|FG001|Overall Study|Adverse Event|1|||
161805151|NCT02794974|584329873|FG000|Overall Study|Physician Decision|0|||
161805152|NCT02794974|584329874|FG001|Overall Study|Physician Decision|1|||
161805153|NCT00533273|584329877|FG000|Double-blind|Withdrew consent|0|||
161805154|NCT00533273|584329878|FG001|Double-blind|Withdrew consent|2|||
161805155|NCT00533273|584329877|FG000|Open-label|Withdrawal by Subject|6|||
161805156|NCT00533273|584329878|FG001|Open-label|Withdrawal by Subject|0|||
161805157|NCT01873586|584329880|FG000|Overall Study|Lost to Follow-up|3|||
161908325|NCT01673178|584715849|FG002|Overall Study|Lost to Follow-up|0|||
161805158|NCT02202850|584329881|FG000|Overall Study|Other|2|||
161805159|NCT02202850|584329882|FG001|Overall Study|Other|2|||
161805160|NCT02202850|584329881|FG000|Overall Study|Enbrel treatment discontinued|15|||
161805161|NCT02202850|584329882|FG001|Overall Study|Enbrel treatment discontinued|3|||
161805162|NCT02202850|584329881|FG000|Overall Study|Lost to Follow-up|7|||
161805163|NCT02202850|584329882|FG001|Overall Study|Lost to Follow-up|1|||
161805164|NCT00615069|584329883|FG000|Overall Study|Death|10|||
161805165|NCT00615069|584329883|FG000|Overall Study|Physician Decision|2|||
161805166|NCT00615069|584329883|FG000|Overall Study|Withdrawal by Subject|4|||
161805167|NCT00669942|584329884|FG000|Parts 2 and 3|Adverse Event|0|||
161805168|NCT00669942|584329885|FG001|Parts 2 and 3|Adverse Event|0|||
161805169|NCT00669942|584329886|FG002|Parts 2 and 3|Adverse Event|0|||
161805170|NCT00669942|584329887|FG003|Parts 2 and 3|Adverse Event|0|||
161805171|NCT00669942|584329888|FG004|Parts 2 and 3|Adverse Event|0|||
161805172|NCT00669942|584329889|FG005|Parts 2 and 3|Adverse Event|0|||
161805173|NCT00669942|584329890|FG006|Parts 2 and 3|Adverse Event|0|||
161805174|NCT00669942|584329891|FG007|Parts 2 and 3|Adverse Event|2|||
161805175|NCT00669942|584329892|FG008|Parts 2 and 3|Adverse Event|1|||
161805176|NCT00669942|584329893|FG009|Parts 2 and 3|Adverse Event|0|||
161805177|NCT00669942|584329894|FG010|Parts 2 and 3|Adverse Event|0|||
161805178|NCT00669942|584329895|FG011|Parts 2 and 3|Adverse Event|0|||
161805179|NCT00669942|584329884|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
161805180|NCT00669942|584329885|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
161805181|NCT00669942|584329886|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
161805182|NCT00669942|584329887|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
161805183|NCT00669942|584329888|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
161805184|NCT00669942|584329889|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
161805185|NCT00669942|584329890|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
161805186|NCT00669942|584329891|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
161805187|NCT00669942|584329892|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
161805188|NCT00669942|584329893|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
161805189|NCT00669942|584329894|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
161805190|NCT00669942|584329895|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
161805191|NCT00669942|584329884|FG000|Parts 2 and 3|Protocol Violation|0|||
161805192|NCT00669942|584329885|FG001|Parts 2 and 3|Protocol Violation|0|||
161805193|NCT00669942|584329886|FG002|Parts 2 and 3|Protocol Violation|0|||
161805194|NCT00669942|584329887|FG003|Parts 2 and 3|Protocol Violation|0|||
161805195|NCT00669942|584329888|FG004|Parts 2 and 3|Protocol Violation|0|||
161805196|NCT00669942|584329889|FG005|Parts 2 and 3|Protocol Violation|1|||
161805197|NCT00669942|584329890|FG006|Parts 2 and 3|Protocol Violation|0|||
161805198|NCT00669942|584329891|FG007|Parts 2 and 3|Protocol Violation|0|||
161805199|NCT00669942|584329892|FG008|Parts 2 and 3|Protocol Violation|0|||
161805200|NCT00669942|584329893|FG009|Parts 2 and 3|Protocol Violation|0|||
161805201|NCT00669942|584329894|FG010|Parts 2 and 3|Protocol Violation|0|||
161805202|NCT00669942|584329895|FG011|Parts 2 and 3|Protocol Violation|0|||
161805203|NCT03752528|584329896|FG000|Part A|Lost to Follow-up|1|||
161805204|NCT03752528|584329896|FG000|Part A|Protocol Violation|1|||
161805205|NCT03752528|584329896|FG000|Part B|Protocol Violation|1|||
161805206|NCT03752528|584329896|FG000|Part B|Study terminated by sponsor|3|||
161805207|NCT01981720|584329897|FG000|Overall Study|Adverse Event|1|||
161805208|NCT01981720|584329897|FG000|Overall Study|Withdrawal by Subject|3|||
161805209|NCT01981720|584329897|FG000|Overall Study|Pregnancy|1|||
161805210|NCT00282048|584329898|FG000|Overall Study|Lack of Efficacy|30|||
161805211|NCT00282048|584329898|FG000|Overall Study|Adverse Event|22|||
161805212|NCT00282048|584329898|FG000|Overall Study|Withdrawal by Subject|1|||
161805213|NCT00282048|584329898|FG000|Overall Study|Other|8|||
161805214|NCT00282048|584329898|FG000|Overall Study|Ongoing|1|||
161805215|NCT00259012|584329901|FG000|Overall Study|Adverse Event|0|||
161805216|NCT00259012|584329902|FG001|Overall Study|Adverse Event|1|||
161805217|NCT00259012|584329901|FG000|Overall Study|Withdrawal by Subject|1|||
161805218|NCT00259012|584329902|FG001|Overall Study|Withdrawal by Subject|0|||
161805219|NCT00259012|584329901|FG000|Overall Study|Physician Decision|0|||
161805220|NCT00259012|584329902|FG001|Overall Study|Physician Decision|1|||
161805221|NCT00259012|584329901|FG000|Overall Study|Lost to Follow-up|0|||
161805222|NCT00259012|584329902|FG001|Overall Study|Lost to Follow-up|1|||
161805223|NCT00259012|584329901|FG000|Overall Study|Protocol Violation|1|||
161805224|NCT00259012|584329902|FG001|Overall Study|Protocol Violation|1|||
161805225|NCT03522675|584329903|FG000|Overall Study|Screen fail|1|||
161805226|NCT03522675|584329903|FG000|Overall Study|Non-reactive to histamine|1|||
161805227|NCT00707161|584329904|FG000|Overall Study|Physician Decision|6|||
161805228|NCT02674477|584329905|FG000|Overall Study|Protocol Violation|8|||
161908326|NCT01673178|584715850|FG003|Overall Study|Lost to Follow-up|0|||
161805229|NCT02674477|584329906|FG001|Overall Study|Protocol Violation|2|||
161805230|NCT02336165|584329911|FG000|Overall Study|Death|3|||
161805231|NCT02336165|584329912|FG001|Overall Study|Death|0|||
161805232|NCT02336165|584329913|FG002|Overall Study|Death|0|||
161805233|NCT02336165|584329914|FG003|Overall Study|Death|0|||
161805234|NCT02336165|584329915|FG004|Overall Study|Death|1|||
161805235|NCT02336165|584329911|FG000|Overall Study|Physician Decision|2|||
161805236|NCT02336165|584329912|FG001|Overall Study|Physician Decision|2|||
161805237|NCT02336165|584329913|FG002|Overall Study|Physician Decision|1|||
161805238|NCT02336165|584329914|FG003|Overall Study|Physician Decision|1|||
161805239|NCT02336165|584329915|FG004|Overall Study|Physician Decision|0|||
161805240|NCT02336165|584329911|FG000|Overall Study|Withdrawal by Subject|0|||
161805241|NCT02336165|584329912|FG001|Overall Study|Withdrawal by Subject|0|||
161805242|NCT02336165|584329913|FG002|Overall Study|Withdrawal by Subject|1|||
161805243|NCT02336165|584329914|FG003|Overall Study|Withdrawal by Subject|0|||
161805244|NCT02336165|584329915|FG004|Overall Study|Withdrawal by Subject|1|||
161805245|NCT02336165|584329911|FG000|Overall Study|Adverse Event|4|||
161805246|NCT02336165|584329912|FG001|Overall Study|Adverse Event|1|||
161908327|NCT01673178|584715851|FG004|Overall Study|Lost to Follow-up|0|||
161908328|NCT01673178|584715847|FG000|Overall Study|Withdrawal by Subject|0|||
161908329|NCT01673178|584715848|FG001|Overall Study|Withdrawal by Subject|0|||
161908330|NCT01673178|584715849|FG002|Overall Study|Withdrawal by Subject|1|||
161908331|NCT01673178|584715850|FG003|Overall Study|Withdrawal by Subject|4|||
161908332|NCT01673178|584715851|FG004|Overall Study|Withdrawal by Subject|2|||
161908333|NCT01673178|584715847|FG000|Overall Study|Protocol Violation|1|||
161908334|NCT01673178|584715848|FG001|Overall Study|Protocol Violation|1|||
161908335|NCT01673178|584715849|FG002|Overall Study|Protocol Violation|0|||
161908336|NCT01673178|584715850|FG003|Overall Study|Protocol Violation|1|||
161908337|NCT01673178|584715851|FG004|Overall Study|Protocol Violation|0|||
161908338|NCT01673178|584715847|FG000|Overall Study|Adverse Event|1|||
161908339|NCT01673178|584715848|FG001|Overall Study|Adverse Event|0|||
161908340|NCT01673178|584715849|FG002|Overall Study|Adverse Event|0|||
161908341|NCT01673178|584715850|FG003|Overall Study|Adverse Event|2|||
161908342|NCT01673178|584715851|FG004|Overall Study|Adverse Event|0|||
161908343|NCT01673178|584715847|FG000|Overall Study|Other|1|||
161908344|NCT01673178|584715848|FG001|Overall Study|Other|0|||
161908345|NCT01673178|584715849|FG002|Overall Study|Other|2|||
161908346|NCT01673178|584715850|FG003|Overall Study|Other|1|||
161908347|NCT01673178|584715851|FG004|Overall Study|Other|0|||
161908348|NCT03177148|584715852|FG000|Overall Study|Lost to Follow-up|50|||
161908349|NCT03177148|584715853|FG001|Overall Study|Lost to Follow-up|1|||
161908350|NCT03177148|584715852|FG000|Overall Study|Death|1|||
161908351|NCT03177148|584715853|FG001|Overall Study|Death|0|||
161908352|NCT02557399|584715854|FG000|Overall Study|Adverse Event|6|||
161908353|NCT02557399|584715855|FG001|Overall Study|Adverse Event|5|||
161908354|NCT02557399|584715854|FG000|Overall Study|Protocol Violation|0|||
161908355|NCT02557399|584715855|FG001|Overall Study|Protocol Violation|1|||
161908356|NCT02557399|584715854|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161908357|NCT02557399|584715855|FG001|Overall Study|Protocol-defined stopping criteria|1|||
161908358|NCT02557399|584715854|FG000|Overall Study|Withdrawal by Subject|1|||
161908359|NCT02557399|584715855|FG001|Overall Study|Withdrawal by Subject|1|||
161908360|NCT03139552|584715859|FG000|Overall Study|unable to attend tasting due to schedule|3|||
161908361|NCT00780975|584715866|FG000|Overall Study|Progressive disease|3|||
161908362|NCT00780975|584715866|FG000|Overall Study|Toxicity|5|||
161908363|NCT03122171|584715867|FG000|Overall Study|Withdrawal by Subject|1|||
161908364|NCT03044314|584715868|FG000|Overall Study|Physician Decision|2|||
161908365|NCT03044314|584715868|FG000|Overall Study|Withdrawal by Subject|1|||
161908366|NCT03044314|584715868|FG000|Overall Study|Connector tubing not available|1|||
161908367|NCT00264147|584715869|FG000|Treatment I Period|Adverse Event|3|||
161908368|NCT00264147|584715870|FG001|Treatment I Period|Adverse Event|6|||
161908369|NCT00264147|584715871|FG002|Treatment I Period|Adverse Event|3|||
161908370|NCT00264147|584715872|FG003|Treatment I Period|Adverse Event|5|||
161908371|NCT00264147|584715873|FG004|Treatment I Period|Adverse Event|7|||
161908372|NCT00264147|584715874|FG005|Treatment I Period|Adverse Event|0|||
161908373|NCT00264147|584715869|FG000|Treatment I Period|Laboratory Adverse Event|0|||
161908374|NCT00264147|584715870|FG001|Treatment I Period|Laboratory Adverse Event|0|||
161908375|NCT00264147|584715871|FG002|Treatment I Period|Laboratory Adverse Event|0|||
161908376|NCT00264147|584715872|FG003|Treatment I Period|Laboratory Adverse Event|1|||
161908377|NCT00264147|584715873|FG004|Treatment I Period|Laboratory Adverse Event|0|||
161908378|NCT00264147|584715874|FG005|Treatment I Period|Laboratory Adverse Event|0|||
161908379|NCT00264147|584715869|FG000|Treatment I Period|Lack of Efficacy|6|||
161908380|NCT00264147|584715870|FG001|Treatment I Period|Lack of Efficacy|2|||
161908381|NCT00264147|584715871|FG002|Treatment I Period|Lack of Efficacy|8|||
161908382|NCT00264147|584715872|FG003|Treatment I Period|Lack of Efficacy|0|||
161908383|NCT00264147|584715873|FG004|Treatment I Period|Lack of Efficacy|1|||
161908384|NCT00264147|584715874|FG005|Treatment I Period|Lack of Efficacy|0|||
161908385|NCT00264147|584715869|FG000|Treatment I Period|Lost to Follow-up|1|||
161908386|NCT00264147|584715870|FG001|Treatment I Period|Lost to Follow-up|0|||
161908387|NCT00264147|584715871|FG002|Treatment I Period|Lost to Follow-up|0|||
161908388|NCT00264147|584715872|FG003|Treatment I Period|Lost to Follow-up|1|||
161908389|NCT00264147|584715873|FG004|Treatment I Period|Lost to Follow-up|1|||
161908390|NCT00264147|584715874|FG005|Treatment I Period|Lost to Follow-up|0|||
161908391|NCT00264147|584715869|FG000|Treatment I Period|Protocol Violation|2|||
161908392|NCT00264147|584715870|FG001|Treatment I Period|Protocol Violation|2|||
161908393|NCT00264147|584715871|FG002|Treatment I Period|Protocol Violation|0|||
161908394|NCT00264147|584715872|FG003|Treatment I Period|Protocol Violation|0|||
161908395|NCT00264147|584715873|FG004|Treatment I Period|Protocol Violation|0|||
161908396|NCT00264147|584715874|FG005|Treatment I Period|Protocol Violation|0|||
161908397|NCT00264147|584715869|FG000|Treatment I Period|Withdrawal by Subject|2|||
161908398|NCT00264147|584715870|FG001|Treatment I Period|Withdrawal by Subject|0|||
161908399|NCT00264147|584715871|FG002|Treatment I Period|Withdrawal by Subject|0|||
161908400|NCT00264147|584715872|FG003|Treatment I Period|Withdrawal by Subject|2|||
161908401|NCT00264147|584715873|FG004|Treatment I Period|Withdrawal by Subject|2|||
161908402|NCT00264147|584715874|FG005|Treatment I Period|Withdrawal by Subject|0|||
161908403|NCT00264147|584715869|FG000|Treatment I Period|Patient out of town for an extended time|0|||
161908404|NCT00264147|584715870|FG001|Treatment I Period|Patient out of town for an extended time|1|||
161908405|NCT00264147|584715871|FG002|Treatment I Period|Patient out of town for an extended time|0|||
161908406|NCT00264147|584715872|FG003|Treatment I Period|Patient out of town for an extended time|0|||
161908407|NCT00264147|584715873|FG004|Treatment I Period|Patient out of town for an extended time|0|||
161908408|NCT00264147|584715874|FG005|Treatment I Period|Patient out of town for an extended time|0|||
161908409|NCT00264147|584715869|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908410|NCT00264147|584715870|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908411|NCT00264147|584715871|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
161908412|NCT00264147|584715872|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908413|NCT00264147|584715873|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908414|NCT00264147|584715874|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908415|NCT00264147|584715869|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
161908416|NCT00264147|584715870|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
161908417|NCT00264147|584715871|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
161908418|NCT00264147|584715872|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
161908419|NCT00264147|584715873|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
161908420|NCT00264147|584715874|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
161908421|NCT00264147|584715869|FG000|Treatment II Period|Adverse Event|0|||
161908422|NCT00264147|584715870|FG001|Treatment II Period|Adverse Event|0|||
161908423|NCT00264147|584715871|FG002|Treatment II Period|Adverse Event|0|||
161908424|NCT00264147|584715872|FG003|Treatment II Period|Adverse Event|0|||
161908425|NCT00264147|584715873|FG004|Treatment II Period|Adverse Event|9|||
161908426|NCT00264147|584715874|FG005|Treatment II Period|Adverse Event|9|||
161908427|NCT00264147|584715869|FG000|Treatment II Period|Laboratory Adverse Event|0|||
161908428|NCT00264147|584715870|FG001|Treatment II Period|Laboratory Adverse Event|0|||
161908429|NCT00264147|584715871|FG002|Treatment II Period|Laboratory Adverse Event|0|||
161908430|NCT00264147|584715872|FG003|Treatment II Period|Laboratory Adverse Event|0|||
161908431|NCT00264147|584715873|FG004|Treatment II Period|Laboratory Adverse Event|0|||
161908432|NCT00264147|584715874|FG005|Treatment II Period|Laboratory Adverse Event|1|||
161908433|NCT00264147|584715869|FG000|Treatment II Period|Lack of Efficacy|0|||
161908434|NCT00264147|584715870|FG001|Treatment II Period|Lack of Efficacy|0|||
161908435|NCT00264147|584715871|FG002|Treatment II Period|Lack of Efficacy|0|||
161908436|NCT00264147|584715872|FG003|Treatment II Period|Lack of Efficacy|0|||
161908437|NCT00264147|584715873|FG004|Treatment II Period|Lack of Efficacy|20|||
161908438|NCT00264147|584715874|FG005|Treatment II Period|Lack of Efficacy|19|||
161908439|NCT00264147|584715869|FG000|Treatment II Period|Lost to Follow-up|0|||
161908440|NCT00264147|584715870|FG001|Treatment II Period|Lost to Follow-up|0|||
161908441|NCT00264147|584715871|FG002|Treatment II Period|Lost to Follow-up|0|||
161908442|NCT00264147|584715872|FG003|Treatment II Period|Lost to Follow-up|0|||
161908443|NCT00264147|584715873|FG004|Treatment II Period|Lost to Follow-up|1|||
161908444|NCT00264147|584715874|FG005|Treatment II Period|Lost to Follow-up|1|||
161908445|NCT00264147|584715869|FG000|Treatment II Period|Withdrawal by Subject|0|||
161908446|NCT00264147|584715870|FG001|Treatment II Period|Withdrawal by Subject|0|||
161908447|NCT00264147|584715871|FG002|Treatment II Period|Withdrawal by Subject|0|||
161908448|NCT00264147|584715872|FG003|Treatment II Period|Withdrawal by Subject|0|||
161908449|NCT00264147|584715873|FG004|Treatment II Period|Withdrawal by Subject|3|||
161908450|NCT00264147|584715874|FG005|Treatment II Period|Withdrawal by Subject|2|||
161908451|NCT00264147|584715869|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908452|NCT00264147|584715870|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908453|NCT00264147|584715871|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908454|NCT00264147|584715872|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908455|NCT00264147|584715873|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908456|NCT00264147|584715874|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
161908457|NCT03234465|584715875|FG000|Overall Study|Adverse Event|4|||
161908458|NCT03234465|584715876|FG001|Overall Study|Adverse Event|2|||
161908459|NCT03234465|584715875|FG000|Overall Study|Death|0|||
161908460|NCT03234465|584715876|FG001|Overall Study|Death|1|||
161908461|NCT03234465|584715875|FG000|Overall Study|Lost to Follow-up|1|||
161908462|NCT03234465|584715876|FG001|Overall Study|Lost to Follow-up|1|||
161908463|NCT03234465|584715875|FG000|Overall Study|Withdrawal by Subject|12|||
161908464|NCT03234465|584715876|FG001|Overall Study|Withdrawal by Subject|27|||
161908465|NCT03234465|584715875|FG000|Overall Study|Symptomatic deterioration|0|||
161908466|NCT03234465|584715876|FG001|Overall Study|Symptomatic deterioration|1|||
161908467|NCT03234465|584715875|FG000|Overall Study|Non-compliance|2|||
161908468|NCT03234465|584715876|FG001|Overall Study|Non-compliance|0|||
161908469|NCT03234465|584715875|FG000|Overall Study|Other|14|||
161908470|NCT03234465|584715876|FG001|Overall Study|Other|8|||
161908471|NCT00449163|584715877|FG000|Overall Study|Physician Decision|3|||
161908472|NCT00606307|584715880|FG000|Overall Study|Adverse Event|2|||
161908473|NCT00606307|584715880|FG000|Overall Study|Withdrawal by Subject|2|||
161908474|NCT00606307|584715880|FG000|Overall Study|Disease progression|6|||
161908475|NCT00606307|584715880|FG000|Overall Study|QTc prolongation|1|||
161908476|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
161908477|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
161908478|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
161908479|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
161908480|NCT03669588|584715895|FG000|Overall Study|Adverse Event|1|||
161908481|NCT03669588|584715896|FG001|Overall Study|Adverse Event|0|||
161908482|NCT03669588|584715895|FG000|Overall Study|Physician Decision|0|||
161908483|NCT03669588|584715896|FG001|Overall Study|Physician Decision|1|||
161908484|NCT03669588|584715895|FG000|Overall Study|Protocol Violation|1|||
161908485|NCT03669588|584715896|FG001|Overall Study|Protocol Violation|0|||
161908486|NCT03669588|584715895|FG000|Overall Study|Sponsor Decision|1|||
161908487|NCT03669588|584715896|FG001|Overall Study|Sponsor Decision|1|||
161908488|NCT03669588|584715895|FG000|Overall Study|Withdrawal by Subject|1|||
161908489|NCT03669588|584715896|FG001|Overall Study|Withdrawal by Subject|4|||
161908490|NCT03669588|584715895|FG000|Overall Study|Rescue Therapy Needed|0|||
161908491|NCT03669588|584715896|FG001|Overall Study|Rescue Therapy Needed|1|||
161908492|NCT00369343|584715906|FG000|Double-blind Phase|Adverse Event|19|||
161908493|NCT00369343|584715907|FG001|Double-blind Phase|Adverse Event|4|||
161908494|NCT00369343|584715906|FG000|Double-blind Phase|Failed to return|2|||
161908495|NCT00369343|584715907|FG001|Double-blind Phase|Failed to return|0|||
161908496|NCT00369343|584715906|FG000|Double-blind Phase|Lost to Follow-up|9|||
161908497|NCT00369343|584715907|FG001|Double-blind Phase|Lost to Follow-up|2|||
161908498|NCT00369343|584715906|FG000|Double-blind Phase|Protocol Violation|2|||
161908499|NCT00369343|584715907|FG001|Double-blind Phase|Protocol Violation|0|||
161908500|NCT00369343|584715906|FG000|Double-blind Phase|Withdrawal by Subject|8|||
161908501|NCT00369343|584715907|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161805247|NCT02336165|584329913|FG002|Overall Study|Adverse Event|2|||
161805248|NCT02336165|584329914|FG003|Overall Study|Adverse Event|4|||
161805249|NCT02336165|584329915|FG004|Overall Study|Adverse Event|1|||
161805250|NCT02336165|584329911|FG000|Overall Study|Progressive disease|23|||
161805251|NCT02336165|584329912|FG001|Overall Study|Progressive disease|22|||
161805252|NCT02336165|584329913|FG002|Overall Study|Progressive disease|27|||
161805253|NCT02336165|584329914|FG003|Overall Study|Progressive disease|24|||
161805254|NCT02336165|584329915|FG004|Overall Study|Progressive disease|19|||
161805255|NCT02336165|584329911|FG000|Overall Study|Non-compliance|1|||
161805256|NCT02336165|584329912|FG001|Overall Study|Non-compliance|0|||
161805257|NCT02336165|584329913|FG002|Overall Study|Non-compliance|0|||
161805258|NCT02336165|584329914|FG003|Overall Study|Non-compliance|1|||
161805259|NCT02336165|584329915|FG004|Overall Study|Non-compliance|0|||
161805260|NCT02336165|584329911|FG000|Overall Study|Other|1|||
161805261|NCT02336165|584329912|FG001|Overall Study|Other|0|||
161805262|NCT02336165|584329913|FG002|Overall Study|Other|0|||
161805263|NCT02336165|584329914|FG003|Overall Study|Other|1|||
161805264|NCT02336165|584329915|FG004|Overall Study|Other|0|||
161805265|NCT00450190|584329916|FG000|Overall Study|Withdrawal by Subject|2|||
161805266|NCT03002077|584329919|FG000|Overall Study|Non-compliance with Study Drug|4|||
161805267|NCT03002077|584329919|FG000|Overall Study|Non-compliance w/Background ADT|1|||
161805268|NCT03002077|584329919|FG000|Overall Study|Study Terminated by Sponsor|257|||
161805269|NCT03002077|584329919|FG000|Overall Study|Site Terminated by Sponsor|5|||
161805270|NCT03002077|584329919|FG000|Overall Study|Miscellaneous Reasons|10|||
161805271|NCT03002077|584329919|FG000|Overall Study|Adverse Event|23|||
161805272|NCT03002077|584329919|FG000|Overall Study|Lack of Efficacy|20|||
161805273|NCT03002077|584329919|FG000|Overall Study|Withdrawal by Subject|72|||
161805274|NCT03002077|584329919|FG000|Overall Study|Lost to Follow-up|21|||
161805275|NCT03002077|584329919|FG000|Overall Study|Pregnancy|4|||
161805276|NCT03002077|584329919|FG000|Overall Study|Protocol Violation|21|||
161805277|NCT00834756|584329922|FG000|First Intervention|Adverse Event|1|||
161805278|NCT00834756|584329923|FG001|First Intervention|Adverse Event|0|||
161805279|NCT00834756|584329922|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161805280|NCT00834756|584329923|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
161805281|NCT04625114|584329935|FG000|Overall Study|Adverse Event|3|||
161805282|NCT04625114|584329936|FG001|Overall Study|Adverse Event|1|||
161805283|NCT04625114|584329935|FG000|Overall Study|Withdrawal by Subject|2|||
161908502|NCT00369343|584715906|FG000|Double-blind Phase|Lack of Efficacy|0|||
161908503|NCT00369343|584715907|FG001|Double-blind Phase|Lack of Efficacy|4|||
161805284|NCT04625114|584329936|FG001|Overall Study|Withdrawal by Subject|0|||
161908504|NCT00369343|584715906|FG000|Double-blind Phase|Protocol deviation|4|||
161805285|NCT00986245|584329937|FG000|First Intervention|Poor compliance|8|||
161805286|NCT00986245|584329938|FG001|First Intervention|Poor compliance|4|||
161908505|NCT00369343|584715907|FG001|Double-blind Phase|Protocol deviation|0|||
161908506|NCT00369343|584715906|FG000|Open-label Phase|Adverse Event|19|||
161908507|NCT00369343|584715907|FG001|Open-label Phase|Adverse Event|7|||
161805287|NCT00986245|584329937|FG000|First Intervention|Lack of Efficacy|1|||
161805288|NCT00986245|584329938|FG001|First Intervention|Lack of Efficacy|2|||
161805289|NCT00986245|584329937|FG000|First Intervention|Withdrawal by Subject|0|||
161805290|NCT00986245|584329938|FG001|First Intervention|Withdrawal by Subject|1|||
161908508|NCT00369343|584715906|FG000|Open-label Phase|Failed to return|4|||
161805291|NCT00986245|584329937|FG000|First Intervention|Protocol Violation|0|||
161805292|NCT00986245|584329938|FG001|First Intervention|Protocol Violation|1|||
161805293|NCT00986245|584329937|FG000|First Intervention|Out of indication|1|||
161805294|NCT00986245|584329938|FG001|First Intervention|Out of indication|0|||
161805295|NCT00986245|584329937|FG000|Second Intervention|Poor compliance|1|||
161805296|NCT00986245|584329938|FG001|Second Intervention|Poor compliance|0|||
161805297|NCT00986245|584329937|FG000|Second Intervention|Lost to Follow-up|1|||
161805298|NCT00986245|584329938|FG001|Second Intervention|Lost to Follow-up|0|||
161805299|NCT00986245|584329937|FG000|Second Intervention|Protocol Violation|0|||
161805300|NCT00986245|584329938|FG001|Second Intervention|Protocol Violation|1|||
161805301|NCT00854308|584329942|FG000|Overall Study|Disease progression|42|||
161805302|NCT00854308|584329943|FG001|Overall Study|Disease progression|50|||
161805303|NCT00854308|584329942|FG000|Overall Study|Adverse Event|8|||
161805304|NCT00854308|584329943|FG001|Overall Study|Adverse Event|3|||
161805305|NCT00854308|584329942|FG000|Overall Study|Death|2|||
161805306|NCT00854308|584329943|FG001|Overall Study|Death|5|||
161805307|NCT00854308|584329942|FG000|Overall Study|Physician Decision|6|||
161805308|NCT00854308|584329943|FG001|Overall Study|Physician Decision|6|||
161805309|NCT00854308|584329942|FG000|Overall Study|Withdrawal by Subject|4|||
161805310|NCT00854308|584329943|FG001|Overall Study|Withdrawal by Subject|2|||
161805311|NCT00854308|584329942|FG000|Overall Study|Sponsor's decision to terminate study|0|||
161805312|NCT00854308|584329943|FG001|Overall Study|Sponsor's decision to terminate study|1|||
161805313|NCT01390844|584329944|FG000|Treatment Phase|Adverse Event|12|||
161805314|NCT01390844|584329945|FG001|Treatment Phase|Adverse Event|2|||
161805315|NCT01390844|584329946|FG002|Treatment Phase|Adverse Event|3|||
161805316|NCT01390844|584329947|FG003|Treatment Phase|Adverse Event|2|||
161805317|NCT01390844|584329944|FG000|Treatment Phase|Treatment Failure|23|||
161805318|NCT01390844|584329945|FG001|Treatment Phase|Treatment Failure|25|||
161805319|NCT01390844|584329946|FG002|Treatment Phase|Treatment Failure|10|||
161805320|NCT01390844|584329947|FG003|Treatment Phase|Treatment Failure|13|||
161805321|NCT01390844|584329944|FG000|Treatment Phase|Non-Medical Reasons|5|||
161805322|NCT01390844|584329945|FG001|Treatment Phase|Non-Medical Reasons|1|||
161805323|NCT01390844|584329946|FG002|Treatment Phase|Non-Medical Reasons|8|||
161805324|NCT01390844|584329947|FG003|Treatment Phase|Non-Medical Reasons|1|||
161805325|NCT01390844|584329944|FG000|Treatment Phase|Non-GCP Compliant|0|||
161805326|NCT01390844|584329945|FG001|Treatment Phase|Non-GCP Compliant|0|||
161805327|NCT01390844|584329946|FG002|Treatment Phase|Non-GCP Compliant|10|||
161805328|NCT01390844|584329947|FG003|Treatment Phase|Non-GCP Compliant|3|||
161805329|NCT01390844|584329944|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
161805330|NCT01390844|584329945|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
161805331|NCT01390844|584329946|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
161805332|NCT01390844|584329947|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
161805333|NCT03048500|584329950|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
161805334|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
161805335|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Death|1|||
161805336|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
161805337|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
161805338|NCT03048500|584329950|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
161805339|NCT03048500|584329950|FG000|Follow up for 3 Years|Death|12|||
161805340|NCT01479439|584329951|FG000|Overall Study|Adverse Event|1|||
161805341|NCT01479439|584329952|FG001|Overall Study|Adverse Event|0|||
161805342|NCT01479439|584329953|FG002|Overall Study|Adverse Event|0|||
161805343|NCT01479439|584329951|FG000|Overall Study|Lost to Follow-up|0|||
161805344|NCT01479439|584329952|FG001|Overall Study|Lost to Follow-up|1|||
161805345|NCT01479439|584329953|FG002|Overall Study|Lost to Follow-up|0|||
161805346|NCT01479439|584329951|FG000|Overall Study|Protocol Violation|0|||
161805347|NCT01479439|584329952|FG001|Overall Study|Protocol Violation|0|||
161805348|NCT01479439|584329953|FG002|Overall Study|Protocol Violation|2|||
161805349|NCT02079766|584329956|FG000|Overall Study|Physician Decision|1|||
161805350|NCT02079766|584329957|FG001|Overall Study|Physician Decision|0|||
161805351|NCT02079766|584329956|FG000|Overall Study|Withdrawal by Subject|1|||
161805352|NCT02079766|584329957|FG001|Overall Study|Withdrawal by Subject|0|||
161805353|NCT03018249|584329964|FG000|Overall Study|Withdrawal by Subject|2|||
161805354|NCT03018249|584329965|FG001|Overall Study|Withdrawal by Subject|2|||
161805355|NCT03544138|584329966|FG000|Overall Study|Lost to Follow-up|29|||
161805356|NCT00096447|584331657|FG000|Overall Study|Never treated|1|||
161805357|NCT01838941|584331658|FG000|Overall Study|Adverse Event|1|||
161805358|NCT01838941|584331658|FG000|Overall Study|Withdrawal by Subject|1|||
161805359|NCT00829530|584331664|FG000|First Intervention|Adverse Event|0|||
161805360|NCT00829530|584331665|FG001|First Intervention|Adverse Event|1|||
161908509|NCT00369343|584715907|FG001|Open-label Phase|Failed to return|0|||
161805361|NCT00829530|584331664|FG000|First Intervention|Intolerance to Venopuncture|0|||
161805362|NCT00829530|584331665|FG001|First Intervention|Intolerance to Venopuncture|1|||
161805363|NCT00829530|584331664|FG000|Second Intervention|Intolerance to Venopuncture|1|||
161805364|NCT00829530|584331665|FG001|Second Intervention|Intolerance to Venopuncture|0|||
161805365|NCT04466111|584331666|FG000|Prior to Trial Phase|Physician Decision|1|||
161805366|NCT03553823|584331675|FG000|Overall Study|Physician Decision|0|||
161805367|NCT03553823|584331676|FG001|Overall Study|Physician Decision|1|||
161908510|NCT00369343|584715906|FG000|Open-label Phase|Physician Decision|2|||
161805368|NCT00893464|584331677|FG000|Overall Study|Did not complete therapy/experience PD|0|||
161805369|NCT00893464|584331678|FG001|Overall Study|Did not complete therapy/experience PD|0|||
161908511|NCT00369343|584715907|FG001|Open-label Phase|Physician Decision|0|||
161908512|NCT00369343|584715906|FG000|Open-label Phase|Lost to Follow-up|5|||
161908513|NCT00369343|584715907|FG001|Open-label Phase|Lost to Follow-up|3|||
161908514|NCT00369343|584715906|FG000|Open-label Phase|inadvertently reported study completers|3|||
161908515|NCT00369343|584715907|FG001|Open-label Phase|inadvertently reported study completers|2|||
161908516|NCT00369343|584715906|FG000|Open-label Phase|Protocol Violation|1|||
161908517|NCT00369343|584715907|FG001|Open-label Phase|Protocol Violation|3|||
161908518|NCT00369343|584715906|FG000|Open-label Phase|Withdrawal by Subject|15|||
161908519|NCT00369343|584715907|FG001|Open-label Phase|Withdrawal by Subject|6|||
161908520|NCT00369343|584715906|FG000|Open-label Phase|Lack of Efficacy|4|||
161908521|NCT00369343|584715907|FG001|Open-label Phase|Lack of Efficacy|3|||
161908522|NCT00369343|584715906|FG000|Open-label Phase|Lack of continuance tolerability|3|||
161908523|NCT00369343|584715907|FG001|Open-label Phase|Lack of continuance tolerability|4|||
161908524|NCT00369343|584715906|FG000|Open-label Phase|did not take study drug|1|||
161908525|NCT00369343|584715907|FG001|Open-label Phase|did not take study drug|2|||
161908526|NCT00073918|584715908|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
161908527|NCT00073918|584715908|FG000|Overall Study|Rapid disease progression|2|||
161908528|NCT00073918|584715908|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
161908529|NCT02033759|584715911|FG000|Overall Study|Withdrawal by Subject|2|||
161908530|NCT02033759|584715912|FG001|Overall Study|Withdrawal by Subject|1|||
161908531|NCT02033759|584715911|FG000|Overall Study|Protocol Violation|1|||
161908532|NCT02033759|584715912|FG001|Overall Study|Protocol Violation|1|||
161908533|NCT04821830|584715918|FG000|Overall Study|Withdrawal by Subject|1|||
161908534|NCT04821830|584715919|FG001|Overall Study|Withdrawal by Subject|0|||
161908535|NCT00490919|584715920|FG000|Open-label Run-in Period|Adverse Event|239|||
161908536|NCT00490919|584715921|FG001|Open-label Run-in Period|Adverse Event|0|||
161805370|NCT00893464|584331679|FG002|Overall Study|Did not complete therapy/experience PD|0|||
161805371|NCT00893464|584331680|FG003|Overall Study|Did not complete therapy/experience PD|0|||
161805372|NCT00893464|584331681|FG004|Overall Study|Did not complete therapy/experience PD|0|||
161805373|NCT00893464|584331682|FG005|Overall Study|Did not complete therapy/experience PD|0|||
161805374|NCT00893464|584331683|FG006|Overall Study|Did not complete therapy/experience PD|2|||
161805375|NCT00893464|584331684|FG007|Overall Study|Did not complete therapy/experience PD|2|||
161805376|NCT03450070|584331685|FG000|Overall Study|Withdrawal by Subject|8|||
161805377|NCT02910037|584331688|FG000|Overall Study|Withdrawal by Subject|4|||
161805378|NCT02910037|584331688|FG000|Overall Study|Lost to Follow-up|6|||
161805379|NCT01035060|584331689|FG000|Overall Study|Lost to Follow-up|0|||
161805380|NCT01035060|584331690|FG001|Overall Study|Lost to Follow-up|7|||
161805381|NCT01035060|584331689|FG000|Overall Study|Did not quality after 2nd screening|14|||
161805382|NCT01035060|584331690|FG001|Overall Study|Did not quality after 2nd screening|1|||
161805383|NCT01035060|584331689|FG000|Overall Study|Withdrawal by Subject|8|||
161805384|NCT01035060|584331690|FG001|Overall Study|Withdrawal by Subject|6|||
161805385|NCT01035060|584331689|FG000|Overall Study|Physician Decision|2|||
161805386|NCT01035060|584331690|FG001|Overall Study|Physician Decision|0|||
161805387|NCT00454909|584331691|FG000|Overall Study|Withdrawal by Subject|1|||
161805388|NCT00454909|584331692|FG001|Overall Study|Withdrawal by Subject|0|||
161805389|NCT00454909|584331693|FG002|Overall Study|Withdrawal by Subject|0|||
161805390|NCT00454909|584331691|FG000|Overall Study|Migrated/moved from study area|0|||
161805391|NCT00454909|584331692|FG001|Overall Study|Migrated/moved from study area|0|||
161805392|NCT00454909|584331693|FG002|Overall Study|Migrated/moved from study area|1|||
161805393|NCT00454909|584331691|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
161805394|NCT00454909|584331692|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
161805395|NCT00454909|584331693|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
161805396|NCT00454909|584331691|FG000|Overall Study|Others|1|||
161805397|NCT00454909|584331692|FG001|Overall Study|Others|0|||
161805398|NCT00454909|584331693|FG002|Overall Study|Others|0|||
161805399|NCT02549092|584331694|FG000|Treatment Period|Adverse Event|2|||
161805400|NCT02549092|584331695|FG001|Treatment Period|Adverse Event|2|||
161805401|NCT02549092|584331694|FG000|Treatment Period|Withdrawal by Subject|1|||
161805402|NCT02549092|584331695|FG001|Treatment Period|Withdrawal by Subject|3|||
161805403|NCT02549092|584331694|FG000|Treatment Period|Lack of Efficacy|0|||
161805404|NCT02549092|584331695|FG001|Treatment Period|Lack of Efficacy|2|||
161805405|NCT02549092|584331694|FG000|Extension/Transition Period|Adverse Event|1|||
161805406|NCT02549092|584331695|FG001|Extension/Transition Period|Adverse Event|1|||
161805407|NCT02549092|584331694|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
161908537|NCT00490919|584715922|FG002|Open-label Run-in Period|Adverse Event|0|||
161805408|NCT02549092|584331695|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
161908538|NCT00490919|584715920|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
161908539|NCT00490919|584715921|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161908540|NCT00490919|584715922|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161908541|NCT00490919|584715920|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
161908542|NCT00490919|584715921|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161908543|NCT00490919|584715922|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161908544|NCT00490919|584715920|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
161908545|NCT00490919|584715921|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161908546|NCT00490919|584715922|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161908547|NCT00490919|584715920|FG000|Open-label Run-in Period|Administrative|40|||
161908548|NCT00490919|584715921|FG001|Open-label Run-in Period|Administrative|0|||
161908549|NCT00490919|584715922|FG002|Open-label Run-in Period|Administrative|0|||
161908550|NCT00490919|584715920|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
161908551|NCT00490919|584715921|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
161908552|NCT00490919|584715922|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
161908553|NCT00490919|584715920|FG000|Double-blind Phase|Adverse Event|0|||
161908554|NCT00490919|584715921|FG001|Double-blind Phase|Adverse Event|40|||
161908555|NCT00490919|584715922|FG002|Double-blind Phase|Adverse Event|20|||
161908556|NCT00490919|584715920|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161908557|NCT00490919|584715921|FG001|Double-blind Phase|Withdrawal by Subject|10|||
161908558|NCT00490919|584715922|FG002|Double-blind Phase|Withdrawal by Subject|11|||
161908559|NCT00490919|584715920|FG000|Double-blind Phase|Lost to Follow-up|0|||
161908560|NCT00490919|584715921|FG001|Double-blind Phase|Lost to Follow-up|8|||
161908561|NCT00490919|584715922|FG002|Double-blind Phase|Lost to Follow-up|11|||
161908562|NCT00490919|584715920|FG000|Double-blind Phase|Lack of Efficacy|0|||
161908563|NCT00490919|584715921|FG001|Double-blind Phase|Lack of Efficacy|22|||
161908564|NCT00490919|584715922|FG002|Double-blind Phase|Lack of Efficacy|36|||
161908565|NCT00490919|584715920|FG000|Double-blind Phase|Administrative|0|||
161908566|NCT00490919|584715921|FG001|Double-blind Phase|Administrative|6|||
161908567|NCT00490919|584715922|FG002|Double-blind Phase|Administrative|6|||
161908568|NCT04350827|584715923|FG000|Overall Study|Lost to Follow-up|1|||
161908569|NCT04350827|584715924|FG001|Overall Study|Lost to Follow-up|2|||
161908570|NCT02034006|584717724|FG000|Overall Study|Withdrawal by Subject|7|||
161908571|NCT02034006|584717724|FG000|Overall Study|Lost to Follow-up|5|||
161908572|NCT02034006|584717724|FG000|Overall Study|Death|1|||
161908573|NCT02034006|584717724|FG000|Overall Study|Pregnancy|1|||
161908574|NCT00161213|584717727|FG000|Overall Study|Withdrawal by Subject|1|||
161908575|NCT00161213|584717727|FG000|Overall Study|Evaluable for toxicity but not response|1|||
161908576|NCT01926028|584717728|FG000|Overall Study|Lost to Follow-up|7|||
161908577|NCT01926028|584717729|FG001|Overall Study|Lost to Follow-up|6|||
161908578|NCT01926028|584717730|FG002|Overall Study|Lost to Follow-up|0|||
161908579|NCT01926028|584717728|FG000|Overall Study|Physician Decision|1|||
161908580|NCT01926028|584717729|FG001|Overall Study|Physician Decision|5|||
161908581|NCT01926028|584717730|FG002|Overall Study|Physician Decision|0|||
161561255|NCT01163149|583442074|FG001|Extension Treatment Period|Noncompliance|0|||
161805409|NCT02549092|584331694|FG000|Extension/Transition Period|Other, Not Specified|4|||
161805410|NCT02549092|584331695|FG001|Extension/Transition Period|Other, Not Specified|2|||
161908582|NCT01926028|584717728|FG000|Overall Study|Withdrawal by Subject|9|||
161908583|NCT01926028|584717729|FG001|Overall Study|Withdrawal by Subject|9|||
161908584|NCT01926028|584717730|FG002|Overall Study|Withdrawal by Subject|2|||
161805411|NCT00910663|584331698|FG000|Period 1|Withdrawal by Subject|0|||
161805412|NCT00910663|584331699|FG001|Period 1|Withdrawal by Subject|1|||
161805413|NCT01772537|584331700|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
161805414|NCT01772537|584331701|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
161805415|NCT01772537|584331702|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
161805416|NCT01536574|584331706|FG000|Overall Study|Adverse Event|4|||
161805417|NCT01536574|584331707|FG001|Overall Study|Adverse Event|5|||
161805418|NCT01536574|584331706|FG000|Overall Study|Withdrawal by Subject|1|||
161805419|NCT01536574|584331707|FG001|Overall Study|Withdrawal by Subject|2|||
161805420|NCT01536574|584331706|FG000|Overall Study|Lack of Efficacy|1|||
161805421|NCT01536574|584331707|FG001|Overall Study|Lack of Efficacy|0|||
161805422|NCT01376167|584331708|FG000|Overall Study|Lost to Follow-up|2|||
161805423|NCT01376167|584331709|FG001|Overall Study|Lost to Follow-up|4|||
161805424|NCT01376167|584331710|FG002|Overall Study|Lost to Follow-up|2|||
161805425|NCT01376167|584331708|FG000|Overall Study|Physician Decision|1|||
161805426|NCT01376167|584331709|FG001|Overall Study|Physician Decision|1|||
161805427|NCT01376167|584331710|FG002|Overall Study|Physician Decision|0|||
161805428|NCT01376167|584331708|FG000|Overall Study|Withdrawal by Subject|1|||
161805429|NCT01376167|584331709|FG001|Overall Study|Withdrawal by Subject|5|||
161908585|NCT01926028|584717728|FG000|Overall Study|Non compliance or other reasons|4|||
161908586|NCT01926028|584717729|FG001|Overall Study|Non compliance or other reasons|2|||
161805430|NCT01376167|584331710|FG002|Overall Study|Withdrawal by Subject|4|||
161805431|NCT02193165|584331713|FG000|4 Week Product Use|Lost to Follow-up|1|||
161805432|NCT02193165|584331714|FG001|4 Week Product Use|Lost to Follow-up|1|||
161805433|NCT02193165|584331715|FG002|4 Week Product Use|Lost to Follow-up|1|||
161908587|NCT01926028|584717730|FG002|Overall Study|Non compliance or other reasons|0|||
161908588|NCT02351934|584717731|FG000|Allocation|POD weight<pre-op weight|3|||
161908589|NCT02351934|584717732|FG001|Allocation|POD weight<pre-op weight|0|||
161908590|NCT02351934|584717731|FG000|Allocation|Hypotension preventing administration|2|||
161908591|NCT02351934|584717732|FG001|Allocation|Hypotension preventing administration|0|||
161908592|NCT02351934|584717731|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
161805434|NCT02193165|584331713|FG000|6 Week Product Use|Lost to Follow-up|0|||
161805435|NCT02193165|584331714|FG001|6 Week Product Use|Lost to Follow-up|1|||
161805436|NCT02193165|584331715|FG002|6 Week Product Use|Lost to Follow-up|0|||
161805437|NCT01546545|584331717|FG000|Overall Study|Withdrawal by Subject|1|||
161805438|NCT01214850|584331718|FG000|Overall Study|Withdrawal by Subject|38|||
161805439|NCT01214850|584331719|FG001|Overall Study|Withdrawal by Subject|31|||
161805440|NCT01214850|584331720|FG002|Overall Study|Withdrawal by Subject|28|||
161805441|NCT01214850|584331718|FG000|Overall Study|Lost to Follow-up|124|||
161805442|NCT01214850|584331719|FG001|Overall Study|Lost to Follow-up|98|||
161805443|NCT01214850|584331720|FG002|Overall Study|Lost to Follow-up|123|||
161805444|NCT01214850|584331718|FG000|Overall Study|Protocol Violation|5|||
161805445|NCT01214850|584331719|FG001|Overall Study|Protocol Violation|5|||
161805446|NCT01214850|584331720|FG002|Overall Study|Protocol Violation|6|||
161805447|NCT01214850|584331718|FG000|Overall Study|Adverse event or death|11|||
161805448|NCT01214850|584331719|FG001|Overall Study|Adverse event or death|8|||
161805449|NCT01214850|584331720|FG002|Overall Study|Adverse event or death|3|||
161805450|NCT01214850|584331718|FG000|Overall Study|Inappropriate enrollment|2|||
161805451|NCT01214850|584331719|FG001|Overall Study|Inappropriate enrollment|1|||
161805452|NCT01214850|584331720|FG002|Overall Study|Inappropriate enrollment|0|||
161805453|NCT01214850|584331718|FG000|Overall Study|Administrative reason|1|||
161805454|NCT01214850|584331719|FG001|Overall Study|Administrative reason|0|||
161805455|NCT01214850|584331720|FG002|Overall Study|Administrative reason|0|||
161805456|NCT01214850|584331718|FG000|Overall Study|Unable to classify|2|||
161805457|NCT01214850|584331719|FG001|Overall Study|Unable to classify|1|||
161805458|NCT01214850|584331720|FG002|Overall Study|Unable to classify|1|||
161805459|NCT00610363|584331725|FG000|Overall Study|Non-compliance with protocol|0|||
161805460|NCT00610363|584331726|FG001|Overall Study|Non-compliance with protocol|1|||
161805461|NCT00610363|584331725|FG000|Overall Study|Adverse Event|3|||
161805462|NCT00610363|584331726|FG001|Overall Study|Adverse Event|1|||
161805463|NCT00610363|584331725|FG000|Overall Study|Lack of Efficacy|2|||
161805464|NCT00610363|584331726|FG001|Overall Study|Lack of Efficacy|0|||
161805465|NCT00610363|584331725|FG000|Overall Study|Lost to Follow-up|4|||
161805466|NCT00610363|584331726|FG001|Overall Study|Lost to Follow-up|0|||
161805467|NCT00610363|584331725|FG000|Overall Study|Withdrawal by Subject|1|||
161805468|NCT00610363|584331726|FG001|Overall Study|Withdrawal by Subject|0|||
161805469|NCT00610363|584331725|FG000|Overall Study|Other than specified above|1|||
161805470|NCT00610363|584331726|FG001|Overall Study|Other than specified above|1|||
161805471|NCT03361228|584331736|FG000|Overall Study|Other|1|||
161805472|NCT03361228|584331737|FG001|Overall Study|Other|1|||
161805473|NCT03361228|584331736|FG000|Overall Study|Death|3|||
161805474|NCT03361228|584331737|FG001|Overall Study|Death|0|||
161805475|NCT01722877|584331739|FG000|Overall Study|Death|1|||
161805476|NCT01722877|584331739|FG000|Overall Study|Lost to Follow-up|1|||
161805477|NCT03693430|584331740|FG000|Overall Study|Lost to Follow-up|3|||
161805478|NCT03693430|584331741|FG001|Overall Study|Lost to Follow-up|14|||
161805479|NCT03693430|584331740|FG000|Overall Study|Death|1|||
161805480|NCT03693430|584331741|FG001|Overall Study|Death|0|||
161805481|NCT03693430|584331740|FG000|Overall Study|Withdrawal by Subject|0|||
161805482|NCT03693430|584331741|FG001|Overall Study|Withdrawal by Subject|4|||
161805483|NCT00585689|584331743|FG000|Overall Study|Received different ABI-007 schedule|3|||
161805484|NCT00585689|584331743|FG000|Overall Study|Adverse Event|1|||
161805485|NCT00585689|584331743|FG000|Overall Study|Patient Declined Surgery|1|||
161805486|NCT00585689|584331743|FG000|Overall Study|Patient had unresectable disease|1|||
161805487|NCT00585689|584331743|FG000|Overall Study|Death|1|||
161805488|NCT02930005|584331744|FG000|Overall Study|Lost to Follow-up|1|||
161805489|NCT02930005|584331745|FG001|Overall Study|Lost to Follow-up|5|||
161805490|NCT02373098|584331746|FG000|Overall Study|Lost to Follow-up|1|||
161805491|NCT02373098|584331747|FG001|Overall Study|Lost to Follow-up|0|||
161805492|NCT02373098|584331746|FG000|Overall Study|Protocol Violation|3|||
161805493|NCT02373098|584331747|FG001|Overall Study|Protocol Violation|0|||
161805494|NCT02373098|584331746|FG000|Overall Study|Withdrawal by Subject|5|||
161805495|NCT02373098|584331747|FG001|Overall Study|Withdrawal by Subject|0|||
161805496|NCT02373098|584331746|FG000|Overall Study|Adverse Event|3|||
161805497|NCT02373098|584331747|FG001|Overall Study|Adverse Event|0|||
161805498|NCT00304083|584331755|FG000|Overall Study|Withdrawal by Subject|4|||
161805499|NCT00304083|584331756|FG001|Overall Study|Withdrawal by Subject|2|||
161805500|NCT00304083|584331755|FG000|Overall Study|Physician Decision|8|||
161908593|NCT02351934|584717732|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
161805501|NCT00304083|584331756|FG001|Overall Study|Physician Decision|3|||
161908594|NCT02351934|584717731|FG000|Follow-Up|POD weight<pre-op weight|3|||
161908595|NCT02351934|584717732|FG001|Follow-Up|POD weight<pre-op weight|0|||
161805502|NCT00304083|584331755|FG000|Overall Study|Disease Progression|5|||
161805503|NCT00304083|584331756|FG001|Overall Study|Disease Progression|1|||
161805504|NCT00304083|584331755|FG000|Overall Study|Other|5|||
161805505|NCT00304083|584331756|FG001|Overall Study|Other|2|||
161805506|NCT03966365|584331757|FG000|Overall Study|Protocol Violation|1|||
161805507|NCT03966365|584331758|FG001|Overall Study|Protocol Violation|0|||
161805508|NCT01378975|584331759|FG000|Overall Study|Death|77|||
161805509|NCT01378975|584331760|FG001|Overall Study|Death|46|||
161908596|NCT02351934|584717731|FG000|Follow-Up|Acute Kidney Injury|1|||
161908597|NCT02351934|584717732|FG001|Follow-Up|Acute Kidney Injury|0|||
161908598|NCT02351934|584717731|FG000|Follow-Up|Early dismissal|3|||
161908599|NCT02351934|584717732|FG001|Follow-Up|Early dismissal|0|||
161908600|NCT02351934|584717731|FG000|Follow-Up|Hypotension|3|||
161908601|NCT02351934|584717732|FG001|Follow-Up|Hypotension|0|||
161908602|NCT02351934|584717731|FG000|Follow-Up|No documentation|2|||
161908603|NCT02351934|584717732|FG001|Follow-Up|No documentation|0|||
161908604|NCT02351934|584717731|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
161908605|NCT02351934|584717732|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
161908606|NCT02351934|584717731|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
161908607|NCT02351934|584717732|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
161908608|NCT04635839|584717733|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
161908609|NCT04635839|584717734|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
161908610|NCT02870868|584717735|FG000|Overall Study|Withdrawal by Subject|2|||
161908611|NCT02870868|584717736|FG001|Overall Study|Withdrawal by Subject|1|||
161908612|NCT00499122|584717737|FG000|Overall Study|Withdrawal by Subject|2|||
161908613|NCT00288912|584717738|FG000|Overall Study|Developed exclusion criterion|4|||
161908614|NCT00288912|584717739|FG001|Overall Study|Developed exclusion criterion|6|||
161908615|NCT00288912|584717740|FG002|Overall Study|Developed exclusion criterion|7|||
161908616|NCT00288912|584717738|FG000|Overall Study|Lost to Follow-up|9|||
161908617|NCT00288912|584717739|FG001|Overall Study|Lost to Follow-up|6|||
161908618|NCT00288912|584717740|FG002|Overall Study|Lost to Follow-up|9|||
161908619|NCT00288912|584717738|FG000|Overall Study|Withdrawal by Subject|4|||
161908620|NCT00288912|584717739|FG001|Overall Study|Withdrawal by Subject|5|||
161908621|NCT00288912|584717740|FG002|Overall Study|Withdrawal by Subject|12|||
161908622|NCT03312738|584717741|FG000|Overall Study|Progressive disease|58|||
161908623|NCT03312738|584717742|FG001|Overall Study|Progressive disease|67|||
161908624|NCT03312738|584717741|FG000|Overall Study|Patient/guardian decision|13|||
161908625|NCT03312738|584717742|FG001|Overall Study|Patient/guardian decision|5|||
161908626|NCT03312738|584717741|FG000|Overall Study|Adverse Event|5|||
161908627|NCT03312738|584717742|FG001|Overall Study|Adverse Event|3|||
161908628|NCT03312738|584717741|FG000|Overall Study|Protocol deviation|2|||
161908629|NCT03312738|584717742|FG001|Overall Study|Protocol deviation|0|||
161908630|NCT03312738|584717741|FG000|Overall Study|Technical problems|0|||
161908631|NCT03312738|584717742|FG001|Overall Study|Technical problems|1|||
161908632|NCT03312738|584717741|FG000|Overall Study|Physician Decision|2|||
161453210|NCT01224782|583053593|FG000|Overall Study|Change of Treatment|1|||
161453211|NCT01224782|583053593|FG000|Overall Study|Financial Reasons|1|||
161453212|NCT01224782|583053593|FG000|Overall Study|Deterioration|1|||
161453213|NCT01224782|583053593|FG000|Overall Study|Transplantation|1|||
161453214|NCT01960907|583053594|FG000|Overall Study|Death|4|||
161453215|NCT01960907|583053595|FG001|Overall Study|Death|3|||
161453216|NCT01960907|583053594|FG000|Overall Study|Withdrawal by Subject|32|||
161453217|NCT01960907|583053595|FG001|Overall Study|Withdrawal by Subject|42|||
161561256|NCT01163149|583442075|FG002|Extension Treatment Period|Noncompliance|1|||
161561257|NCT01700530|583442076|FG000|Overall Study|Withdrawal by Subject|0|||
161561258|NCT01700530|583442077|FG001|Overall Study|Withdrawal by Subject|3|||
161561259|NCT01700530|583442078|FG002|Overall Study|Withdrawal by Subject|1|||
161561260|NCT00578227|583442080|FG000|Overall Study|Lost to Follow-up|0|||
161561261|NCT00578227|583442081|FG001|Overall Study|Lost to Follow-up|1|||
161561262|NCT00578227|583442082|FG002|Overall Study|Lost to Follow-up|1|||
161561263|NCT00578227|583442080|FG000|Overall Study|Withdrawal by Subject|5|||
161561264|NCT00578227|583442081|FG001|Overall Study|Withdrawal by Subject|1|||
161561265|NCT00578227|583442082|FG002|Overall Study|Withdrawal by Subject|3|||
161561266|NCT00916006|583442086|FG000|Overall Study|Adverse Event|1|||
161561267|NCT00916006|583442087|FG001|Overall Study|Adverse Event|1|||
161561268|NCT00916006|583442086|FG000|Overall Study|Withdrawal by Subject|2|||
161561269|NCT00916006|583442087|FG001|Overall Study|Withdrawal by Subject|5|||
161561270|NCT00916006|583442086|FG000|Overall Study|Protocol Violation|0|||
161561271|NCT00916006|583442087|FG001|Overall Study|Protocol Violation|1|||
161561272|NCT04736056|583442089|FG000|Overall Study|Death|0|||
161561273|NCT04736056|583442090|FG001|Overall Study|Death|0|||
161561274|NCT04736056|583442091|FG002|Overall Study|Death|0|||
161561275|NCT04736056|583442092|FG003|Overall Study|Death|1|||
161908633|NCT03312738|584717742|FG001|Overall Study|Physician Decision|3|||
161908634|NCT02466399|584717751|FG000|Overall Study|Adverse Event|1|||
161908635|NCT02466399|584717752|FG001|Overall Study|Adverse Event|0|||
161908636|NCT02466399|584717751|FG000|Overall Study|Early exit due to family emergency|1|||
161908637|NCT02466399|584717752|FG001|Overall Study|Early exit due to family emergency|0|||
161908638|NCT04539275|584717753|FG000|Overall Study|Death|2|||
161908639|NCT04539275|584717754|FG001|Overall Study|Death|4|||
161453218|NCT00977080|583053598|FG000|Overall Study|Adverse Event|2|||
161561276|NCT04736056|583442089|FG000|Overall Study|Lost to Follow-up|1|||
161561277|NCT04736056|583442090|FG001|Overall Study|Lost to Follow-up|0|||
161908640|NCT04539275|584717753|FG000|Overall Study|Lost to Follow-up|1|||
161908641|NCT04539275|584717754|FG001|Overall Study|Lost to Follow-up|1|||
161908642|NCT04539275|584717753|FG000|Overall Study|Withdrawal by Subject|3|||
161908643|NCT04539275|584717754|FG001|Overall Study|Withdrawal by Subject|0|||
161908644|NCT00607893|584717759|FG000|Overall Study|Lost to Follow-up|4|||
161908645|NCT00607893|584717760|FG001|Overall Study|Lost to Follow-up|0|||
161908646|NCT00607893|584717759|FG000|Overall Study|withdrew due to loss of interest|0|||
161908647|NCT00607893|584717760|FG001|Overall Study|withdrew due to loss of interest|1|||
161908648|NCT00607893|584717759|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
161908649|NCT00607893|584717760|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
161908650|NCT00607893|584717759|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
161908651|NCT00607893|584717760|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
161908652|NCT00607893|584717759|FG000|Overall Study|Declined to be treated|1|||
161908653|NCT00607893|584717760|FG001|Overall Study|Declined to be treated|0|||
161908654|NCT00607893|584717759|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
161908655|NCT00607893|584717760|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
161908656|NCT02669849|584717761|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161908657|NCT02669849|584717762|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161908658|NCT02669849|584717763|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161908659|NCT02669849|584717761|FG000|Overall Study|Lost to Follow-up|1|||
161908660|NCT02669849|584717762|FG001|Overall Study|Lost to Follow-up|0|||
161908661|NCT02669849|584717763|FG002|Overall Study|Lost to Follow-up|3|||
161908662|NCT02669849|584717761|FG000|Overall Study|Death|1|||
161908663|NCT02669849|584717762|FG001|Overall Study|Death|1|||
161908664|NCT02669849|584717763|FG002|Overall Study|Death|2|||
161908665|NCT02669849|584717761|FG000|Overall Study|Study terminated by sponsor|16|||
161908666|NCT02669849|584717762|FG001|Overall Study|Study terminated by sponsor|1|||
161908667|NCT02669849|584717763|FG002|Overall Study|Study terminated by sponsor|14|||
161908668|NCT02669849|584717761|FG000|Overall Study|Other|0|||
161908669|NCT02669849|584717762|FG001|Overall Study|Other|0|||
161908670|NCT02669849|584717763|FG002|Overall Study|Other|2|||
161908671|NCT01799941|584717764|FG000|Overall Study|Adverse Event|34|||
161908672|NCT01799941|584717764|FG000|Overall Study|Withdrawal by Subject|21|||
161908673|NCT01799941|584717764|FG000|Overall Study|Death|2|||
161908674|NCT01799941|584717764|FG000|Overall Study|Investigator Decision|4|||
161908675|NCT01799941|584717764|FG000|Overall Study|Lack of Efficacy|3|||
161908676|NCT01799941|584717764|FG000|Overall Study|Lost to Follow-up|17|||
161908677|NCT01799941|584717764|FG000|Overall Study|Other|15|||
161908678|NCT00547339|584717765|FG000|Overall Study|Physician Decision|0|||
161908679|NCT00547339|584717766|FG001|Overall Study|Physician Decision|0|||
161908680|NCT00547339|584717767|FG002|Overall Study|Physician Decision|1|||
161908681|NCT00547339|584717768|FG003|Overall Study|Physician Decision|0|||
161908682|NCT02426684|584717769|FG000|Overall Study|Physician Decision|1|||
161453219|NCT00977080|583053599|FG001|Overall Study|Adverse Event|7|||
161453220|NCT00977080|583053600|FG002|Overall Study|Adverse Event|7|||
161453221|NCT00977080|583053601|FG003|Overall Study|Adverse Event|7|||
161453222|NCT00977080|583053598|FG000|Overall Study|Withdrawal by Subject|1|||
161453223|NCT00977080|583053599|FG001|Overall Study|Withdrawal by Subject|5|||
161453224|NCT00977080|583053600|FG002|Overall Study|Withdrawal by Subject|1|||
161453225|NCT00977080|583053601|FG003|Overall Study|Withdrawal by Subject|5|||
161453226|NCT00977080|583053598|FG000|Overall Study|Protocol Violation|7|||
161453227|NCT00977080|583053599|FG001|Overall Study|Protocol Violation|3|||
161453228|NCT00977080|583053600|FG002|Overall Study|Protocol Violation|4|||
161453229|NCT00977080|583053601|FG003|Overall Study|Protocol Violation|3|||
161453230|NCT00977080|583053598|FG000|Overall Study|Noncompliance|0|||
161453231|NCT00977080|583053599|FG001|Overall Study|Noncompliance|2|||
161453232|NCT00977080|583053600|FG002|Overall Study|Noncompliance|1|||
161453233|NCT00977080|583053601|FG003|Overall Study|Noncompliance|0|||
161453234|NCT00977080|583053598|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
161453235|NCT00977080|583053599|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
161453236|NCT00977080|583053600|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
161453237|NCT00977080|583053601|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
161453238|NCT00977080|583053598|FG000|Overall Study|Required kidney transplantation|1|||
161453239|NCT00977080|583053599|FG001|Overall Study|Required kidney transplantation|3|||
161453240|NCT00977080|583053600|FG002|Overall Study|Required kidney transplantation|3|||
161453241|NCT00977080|583053601|FG003|Overall Study|Required kidney transplantation|1|||
161453242|NCT00977080|583053598|FG000|Overall Study|Travel for family reasons|1|||
161453243|NCT00977080|583053599|FG001|Overall Study|Travel for family reasons|0|||
161453244|NCT00977080|583053600|FG002|Overall Study|Travel for family reasons|0|||
161453245|NCT00977080|583053601|FG003|Overall Study|Travel for family reasons|0|||
161908683|NCT03736967|584717770|FG000|Overall Study|Withdrawal by Subject|26|||
161908684|NCT03736967|584717771|FG001|Overall Study|Withdrawal by Subject|25|||
161908685|NCT03736967|584717772|FG002|Overall Study|Withdrawal by Subject|23|||
161908686|NCT03736967|584717773|FG003|Overall Study|Withdrawal by Subject|26|||
161908687|NCT03736967|584717770|FG000|Overall Study|Lost to Follow-up|3|||
161908688|NCT03736967|584717771|FG001|Overall Study|Lost to Follow-up|2|||
161908689|NCT03736967|584717772|FG002|Overall Study|Lost to Follow-up|1|||
161908690|NCT03736967|584717773|FG003|Overall Study|Lost to Follow-up|1|||
161908691|NCT03736967|584717770|FG000|Overall Study|Physician Decision|1|||
161908692|NCT03736967|584717771|FG001|Overall Study|Physician Decision|0|||
161908693|NCT03736967|584717772|FG002|Overall Study|Physician Decision|0|||
161908694|NCT03736967|584717773|FG003|Overall Study|Physician Decision|1|||
161908695|NCT03736967|584717770|FG000|Overall Study|Adverse Event|0|||
161908696|NCT03736967|584717771|FG001|Overall Study|Adverse Event|1|||
161908697|NCT03736967|584717772|FG002|Overall Study|Adverse Event|0|||
161908698|NCT03736967|584717773|FG003|Overall Study|Adverse Event|1|||
161908699|NCT03736967|584717770|FG000|Overall Study|Death|0|||
161908700|NCT03736967|584717771|FG001|Overall Study|Death|0|||
161908701|NCT03736967|584717772|FG002|Overall Study|Death|0|||
161908702|NCT03736967|584717773|FG003|Overall Study|Death|1|||
161908703|NCT03736967|584717770|FG000|Overall Study|Randomized but never treated|1|||
161908704|NCT03736967|584717771|FG001|Overall Study|Randomized but never treated|0|||
161908705|NCT03736967|584717772|FG002|Overall Study|Randomized but never treated|0|||
161908706|NCT03736967|584717773|FG003|Overall Study|Randomized but never treated|0|||
161908707|NCT02369653|584717774|FG000|Overall Study|Lost to Follow-up|0|||
161908708|NCT02369653|584717775|FG001|Overall Study|Lost to Follow-up|1|||
161908709|NCT02369653|584717774|FG000|Overall Study|Administrative reason by sponsor|0|||
161908710|NCT02369653|584717775|FG001|Overall Study|Administrative reason by sponsor|1|||
161908711|NCT02369653|584717774|FG000|Overall Study|Death|1|||
161908712|NCT02369653|584717775|FG001|Overall Study|Death|2|||
161908713|NCT02369653|584717774|FG000|Overall Study|Participant withdrew consent|13|||
161908714|NCT02369653|584717775|FG001|Overall Study|Participant withdrew consent|3|||
161908715|NCT03587636|584717776|FG000|Overall Study|Lost to Follow-up|2|||
161908716|NCT03587636|584717777|FG001|Overall Study|Lost to Follow-up|5|||
161908717|NCT01587885|584717778|FG000|Treatment Period 1|Failure to Return|0|||
161908718|NCT01587885|584717779|FG001|Treatment Period 1|Failure to Return|1|||
161908719|NCT01587885|584717778|FG000|Treatment Period 1|Protocol Violation|0|||
161908720|NCT01587885|584717779|FG001|Treatment Period 1|Protocol Violation|2|||
161908721|NCT01458587|584717780|FG000|Overall Study|Withdrawal by Subject|1|||
161908722|NCT01458587|584717781|FG001|Overall Study|Withdrawal by Subject|0|||
161908723|NCT01603602|584717782|FG000|Overall Study|Adverse Event|1|||
161908724|NCT01603602|584717783|FG001|Overall Study|Adverse Event|0|||
161908725|NCT01603602|584717784|FG002|Overall Study|Adverse Event|0|||
161908726|NCT01603602|584717782|FG000|Overall Study|Personal Reasons|1|||
161908727|NCT01603602|584717783|FG001|Overall Study|Personal Reasons|0|||
161908728|NCT01603602|584717784|FG002|Overall Study|Personal Reasons|1|||
161908729|NCT04748718|584717788|FG000|Overall Study|Lost to Follow-up|50|||
161908730|NCT00316004|584717789|FG000|Overall Study|Subject was not given study fluid.|14|||
161908731|NCT00316004|584717790|FG001|Overall Study|Subject was not given study fluid.|14|||
161908732|NCT00316004|584717791|FG002|Overall Study|Subject was not given study fluid.|21|||
161908733|NCT01118299|584717792|FG000|Overall Study|Death|7|||
161908734|NCT01118299|584717793|FG001|Overall Study|Death|5|||
161908735|NCT01118299|584717792|FG000|Overall Study|Withdrawal by Subject|8|||
161908736|NCT01118299|584717793|FG001|Overall Study|Withdrawal by Subject|8|||
161908737|NCT01118299|584717792|FG000|Overall Study|Lost to Follow-up|2|||
161908738|NCT01118299|584717793|FG001|Overall Study|Lost to Follow-up|1|||
161908739|NCT01118299|584717792|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
161908740|NCT01118299|584717793|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
161908741|NCT01935089|584717795|FG000|Overall Study|Adverse Event|2|||
161908742|NCT01935089|584717795|FG000|Overall Study|Withdrawal by Subject|1|||
161908743|NCT02932943|584717796|FG000|Overall Study|Lost to Follow-up|0|||
161908744|NCT02932943|584717797|FG001|Overall Study|Lost to Follow-up|2|||
161908745|NCT02932943|584717796|FG000|Overall Study|Adverse Event|2|||
161908746|NCT02932943|584717797|FG001|Overall Study|Adverse Event|2|||
161908747|NCT02932943|584717796|FG000|Overall Study|Withdrawal by Subject|3|||
161908748|NCT02932943|584717797|FG001|Overall Study|Withdrawal by Subject|3|||
161908749|NCT02665117|584717800|FG000|Overall Study|Physician Decision|1|||
161908750|NCT02665117|584717801|FG001|Overall Study|Physician Decision|0|||
161908751|NCT00977197|584717802|FG000|Overall Study|Withdrawal by Subject|3|||
161908752|NCT00977197|584717803|FG001|Overall Study|Withdrawal by Subject|4|||
161908753|NCT00977197|584717802|FG000|Overall Study|Adverse Event|3|||
161908754|NCT00977197|584717803|FG001|Overall Study|Adverse Event|1|||
161453246|NCT01765218|583053604|FG000|Overall Study|Protocol Violation|1|||
161453247|NCT01765218|583053605|FG001|Overall Study|Protocol Violation|2|||
161908755|NCT00977197|584717802|FG000|Overall Study|Lack of Efficacy|1|||
161908756|NCT00977197|584717803|FG001|Overall Study|Lack of Efficacy|0|||
161908757|NCT00977197|584717802|FG000|Overall Study|Lost to Follow-up|1|||
161908758|NCT00977197|584717803|FG001|Overall Study|Lost to Follow-up|3|||
161908759|NCT00977197|584717802|FG000|Overall Study|Nonadherence|1|||
161908760|NCT00977197|584717803|FG001|Overall Study|Nonadherence|1|||
161908761|NCT05379920|584717804|FG000|Overall Study|Lost to Follow-up|0|||
161908762|NCT05379920|584717805|FG001|Overall Study|Lost to Follow-up|5|||
161908763|NCT05379920|584717806|FG002|Overall Study|Lost to Follow-up|0|||
161908764|NCT05379920|584717807|FG003|Overall Study|Lost to Follow-up|0|||
161908765|NCT03530293|584717810|FG000|Pre-randomization|Adverse Event|12|||
161908766|NCT03530293|584717811|FG001|Pre-randomization|Adverse Event|0|||
161908767|NCT03530293|584717812|FG002|Pre-randomization|Adverse Event|0|||
161908768|NCT03530293|584717810|FG000|Pre-randomization|Protocol Violation|2|||
161908769|NCT03530293|584717811|FG001|Pre-randomization|Protocol Violation|0|||
161805510|NCT01378975|584331759|FG000|Overall Study|Investigator Request|1|||
161805511|NCT01378975|584331760|FG001|Overall Study|Investigator Request|0|||
161805512|NCT01378975|584331759|FG000|Overall Study|Lost to Follow-up|4|||
161805513|NCT01378975|584331760|FG001|Overall Study|Lost to Follow-up|1|||
161805514|NCT01378975|584331759|FG000|Overall Study|Withdrew Consent|4|||
161805515|NCT01378975|584331760|FG001|Overall Study|Withdrew Consent|3|||
161805516|NCT03929393|584331763|FG000|Overall Study|Death|1|||
161805517|NCT03929393|584331764|FG001|Overall Study|Death|0|||
161805518|NCT03929393|584331763|FG000|Overall Study|Time Commitment|2|||
161805519|NCT03929393|584331764|FG001|Overall Study|Time Commitment|5|||
161805520|NCT03929393|584331763|FG000|Overall Study|Motor Vehicle Accident|0|||
161805521|NCT03929393|584331764|FG001|Overall Study|Motor Vehicle Accident|1|||
161805522|NCT03929393|584331763|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
161805523|NCT03929393|584331764|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
161805524|NCT03929393|584331763|FG000|Overall Study|Other|1|||
161805525|NCT03929393|584331764|FG001|Overall Study|Other|3|||
161805526|NCT00694551|584331777|FG000|Overall Study|Disease Progression|1|||
161805527|NCT00694551|584331778|FG001|Overall Study|Disease Progression|0|||
161805528|NCT00694551|584331779|FG002|Overall Study|Disease Progression|1|||
161805529|NCT01937390|584331783|FG000|Overall Study|Death|2|||
161805530|NCT01937390|584331783|FG000|Overall Study|Lost to Follow-up|7|||
161805531|NCT01937390|584331783|FG000|Overall Study|Withdrawal by Subject|5|||
161805532|NCT01937390|584331783|FG000|Overall Study|Fail to return|21|||
161805533|NCT02216071|584331784|FG000|Overall Study|Withdrawal by Subject|7|||
161805534|NCT02216071|584331785|FG001|Overall Study|Withdrawal by Subject|2|||
161805535|NCT02216071|584331784|FG000|Overall Study|Lost to Follow-up|3|||
161805536|NCT02216071|584331785|FG001|Overall Study|Lost to Follow-up|3|||
161805537|NCT02216071|584331784|FG000|Overall Study|Protocol Violation|3|||
161805538|NCT02216071|584331785|FG001|Overall Study|Protocol Violation|5|||
161805539|NCT02216071|584331784|FG000|Overall Study|Other|2|||
161805540|NCT02216071|584331785|FG001|Overall Study|Other|2|||
161805541|NCT01706536|584331786|FG000|Overall Study|Withdrawal by Subject|1|||
161805542|NCT01706536|584331787|FG001|Overall Study|Withdrawal by Subject|0|||
161805543|NCT01706536|584331788|FG002|Overall Study|Withdrawal by Subject|1|||
161805544|NCT01706536|584331789|FG003|Overall Study|Withdrawal by Subject|0|||
161805545|NCT01706536|584331790|FG004|Overall Study|Withdrawal by Subject|0|||
161805546|NCT01706536|584331786|FG000|Overall Study|Adverse Event|2|||
161805547|NCT01706536|584331787|FG001|Overall Study|Adverse Event|3|||
161805548|NCT01706536|584331788|FG002|Overall Study|Adverse Event|4|||
161805549|NCT01706536|584331789|FG003|Overall Study|Adverse Event|3|||
161805550|NCT01706536|584331790|FG004|Overall Study|Adverse Event|2|||
161805551|NCT01706536|584331786|FG000|Overall Study|Lack of Efficacy|1|||
161805552|NCT01706536|584331787|FG001|Overall Study|Lack of Efficacy|0|||
161805553|NCT01706536|584331788|FG002|Overall Study|Lack of Efficacy|0|||
161805554|NCT01706536|584331789|FG003|Overall Study|Lack of Efficacy|1|||
161805555|NCT01706536|584331790|FG004|Overall Study|Lack of Efficacy|0|||
161805556|NCT01706536|584331786|FG000|Overall Study|non compliance|0|||
161805557|NCT01706536|584331787|FG001|Overall Study|non compliance|1|||
161805558|NCT01706536|584331788|FG002|Overall Study|non compliance|0|||
161805559|NCT01706536|584331789|FG003|Overall Study|non compliance|0|||
161805560|NCT01706536|584331790|FG004|Overall Study|non compliance|0|||
161805561|NCT04753437|584331791|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161805562|NCT04753437|584331792|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161805563|NCT04753437|584331791|FG000|Overall Study|Liver Function Test Abnormalities|2|||
161805564|NCT04753437|584331792|FG001|Overall Study|Liver Function Test Abnormalities|4|||
161805565|NCT00385684|584331795|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
161805566|NCT00385684|584331796|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
161805567|NCT00385684|584331795|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
161805568|NCT00385684|584331796|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
161805569|NCT00385684|584331795|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
161805570|NCT00385684|584331796|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
161805571|NCT00463606|584331797|FG000|Overall Study|Adverse Event|21|||
161805572|NCT00463606|584331798|FG001|Overall Study|Adverse Event|18|||
161805573|NCT00463606|584331799|FG002|Overall Study|Adverse Event|11|||
161805574|NCT00463606|584331797|FG000|Overall Study|Withdrawal by Subject|11|||
161805575|NCT00463606|584331798|FG001|Overall Study|Withdrawal by Subject|11|||
161805576|NCT00463606|584331799|FG002|Overall Study|Withdrawal by Subject|5|||
161805577|NCT00463606|584331797|FG000|Overall Study|Lost to Follow-up|2|||
161805578|NCT00463606|584331798|FG001|Overall Study|Lost to Follow-up|2|||
161805579|NCT00463606|584331799|FG002|Overall Study|Lost to Follow-up|3|||
161805580|NCT00463606|584331797|FG000|Overall Study|Subject noncompliance|1|||
161805581|NCT00463606|584331798|FG001|Overall Study|Subject noncompliance|1|||
161805582|NCT00463606|584331799|FG002|Overall Study|Subject noncompliance|0|||
161805583|NCT00463606|584331797|FG000|Overall Study|Subject moved out of town|1|||
161805584|NCT00463606|584331798|FG001|Overall Study|Subject moved out of town|0|||
161805585|NCT00463606|584331799|FG002|Overall Study|Subject moved out of town|0|||
161805586|NCT00463606|584331797|FG000|Overall Study|Physician Decision|0|||
161805587|NCT00463606|584331798|FG001|Overall Study|Physician Decision|1|||
161908770|NCT03530293|584717812|FG002|Pre-randomization|Protocol Violation|0|||
161908771|NCT03530293|584717810|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
161908772|NCT03530293|584717811|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
161908773|NCT03530293|584717812|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
161908774|NCT03530293|584717810|FG000|Pre-randomization|Withdrawal by Subject|5|||
161908775|NCT03530293|584717811|FG001|Pre-randomization|Withdrawal by Subject|0|||
161908776|NCT03530293|584717812|FG002|Pre-randomization|Withdrawal by Subject|0|||
161908777|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
161908778|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
161908779|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
161908780|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
161908781|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
161908782|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
161908783|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
161908784|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
161908785|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
161908786|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
161908787|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
161908788|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
161908789|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
161908790|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
161908791|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
161908792|NCT03482024|584717814|FG000|Overall Study|Physician Decision|1|||
161908793|NCT03482024|584717815|FG001|Overall Study|Physician Decision|0|||
161908794|NCT03482024|584717816|FG002|Overall Study|Physician Decision|0|||
161908795|NCT03482024|584717817|FG003|Overall Study|Physician Decision|0|||
161908796|NCT03482024|584717818|FG004|Overall Study|Physician Decision|0|||
161908797|NCT02295644|584717819|FG000|Overall Study|Did not meet inclusion criterion|0|||
161908798|NCT02295644|584717820|FG001|Overall Study|Did not meet inclusion criterion|0|||
161908799|NCT02295644|584717821|FG002|Overall Study|Did not meet inclusion criterion|1|||
161908800|NCT02295644|584717822|FG003|Overall Study|Did not meet inclusion criterion|2|||
161908801|NCT02147626|584717823|FG000|Overall Study|Lost to Follow-up|4|||
161908802|NCT02147626|584717824|FG001|Overall Study|Lost to Follow-up|4|||
161908803|NCT02147626|584717823|FG000|Overall Study|Pregnancy|1|||
161908804|NCT02147626|584717824|FG001|Overall Study|Pregnancy|2|||
161908805|NCT02147626|584717823|FG000|Overall Study|Withdrawal by Subject|0|||
161908806|NCT02147626|584717824|FG001|Overall Study|Withdrawal by Subject|1|||
161908807|NCT00423046|584717825|FG000|Overall Study|Other|340|||
161908808|NCT00423046|584717826|FG001|Overall Study|Other|345|||
161908809|NCT05214118|584717827|FG000|Overall Study|Lost to Follow-up|0|||
161908810|NCT05214118|584717828|FG001|Overall Study|Lost to Follow-up|2|||
161908811|NCT05214118|584717827|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
161908812|NCT05214118|584717828|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
161908813|NCT05214118|584717827|FG000|Overall Study|moved|1|||
161908814|NCT05214118|584717828|FG001|Overall Study|moved|0|||
161908815|NCT03080935|584717829|FG000|Overall Study|Death|34|||
161908816|NCT03080935|584717830|FG001|Overall Study|Death|50|||
161908817|NCT03080935|584717829|FG000|Overall Study|Lost to Follow-up|5|||
161908818|NCT03080935|584717830|FG001|Overall Study|Lost to Follow-up|4|||
161908819|NCT03080935|584717829|FG000|Overall Study|Withdrawal by Subject|11|||
161908820|NCT03080935|584717830|FG001|Overall Study|Withdrawal by Subject|15|||
161908821|NCT01614470|584717831|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
161908822|NCT01614470|584717832|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161908823|NCT01614470|584717833|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161908824|NCT01614470|584717831|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
161908825|NCT01614470|584717832|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
161908826|NCT01614470|584717833|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
161908827|NCT02175121|584717834|FG000|Overall Study|Lack of Efficacy|1|||
161908828|NCT02175121|584717835|FG001|Overall Study|Lack of Efficacy|0|||
161908829|NCT02175121|584717836|FG002|Overall Study|Lack of Efficacy|0|||
161908830|NCT02175121|584717837|FG003|Overall Study|Lack of Efficacy|0|||
161908831|NCT02175121|584717838|FG004|Overall Study|Lack of Efficacy|0|||
161908832|NCT02175121|584717834|FG000|Overall Study|Lost to Follow-up|0|||
161908833|NCT02175121|584717835|FG001|Overall Study|Lost to Follow-up|1|||
161908834|NCT02175121|584717836|FG002|Overall Study|Lost to Follow-up|0|||
161908835|NCT02175121|584717837|FG003|Overall Study|Lost to Follow-up|1|||
161908836|NCT02175121|584717838|FG004|Overall Study|Lost to Follow-up|0|||
161908837|NCT02175121|584717834|FG000|Overall Study|Personal emergency|0|||
161908838|NCT02175121|584717835|FG001|Overall Study|Personal emergency|0|||
161908839|NCT02175121|584717836|FG002|Overall Study|Personal emergency|0|||
161908840|NCT02175121|584717837|FG003|Overall Study|Personal emergency|0|||
161908841|NCT02175121|584717838|FG004|Overall Study|Personal emergency|1|||
161908842|NCT02175121|584717834|FG000|Overall Study|Schedule conflict|0|||
161908843|NCT02175121|584717835|FG001|Overall Study|Schedule conflict|0|||
161908844|NCT02175121|584717836|FG002|Overall Study|Schedule conflict|1|||
161908845|NCT02175121|584717837|FG003|Overall Study|Schedule conflict|0|||
161908846|NCT02175121|584717838|FG004|Overall Study|Schedule conflict|0|||
161908847|NCT02175121|584717834|FG000|Overall Study|Time issues|0|||
161908848|NCT02175121|584717835|FG001|Overall Study|Time issues|0|||
161908849|NCT02175121|584717836|FG002|Overall Study|Time issues|1|||
161908850|NCT02175121|584717837|FG003|Overall Study|Time issues|0|||
161908851|NCT02175121|584717838|FG004|Overall Study|Time issues|0|||
161908852|NCT02949947|584717844|FG000|Overall Study|Non Compliance|0|||
161908853|NCT02949947|584717845|FG001|Overall Study|Non Compliance|1|||
161908854|NCT02949947|584717844|FG000|Overall Study|Insurance change|1|||
161908855|NCT02949947|584717845|FG001|Overall Study|Insurance change|0|||
161908856|NCT00794664|584717846|FG000|Treatment Period|Withdrawal by Subject|0|||
161908857|NCT00794664|584717847|FG001|Treatment Period|Withdrawal by Subject|2|||
161908858|NCT00794664|584717846|FG000|Treatment Period|Protocol non-compliance|0|||
161908859|NCT00794664|584717847|FG001|Treatment Period|Protocol non-compliance|1|||
161908860|NCT00794664|584717846|FG000|Treatment Period|Other|0|||
161908861|NCT00794664|584717847|FG001|Treatment Period|Other|1|||
161908862|NCT00794664|584717846|FG000|Treatment Period|Adverse Event|1|||
161908863|NCT00794664|584717847|FG001|Treatment Period|Adverse Event|8|||
161908864|NCT00794664|584717846|FG000|Follow-up Period|Other|1|||
161908865|NCT00794664|584717847|FG001|Follow-up Period|Other|2|||
161908866|NCT00794664|584717846|FG000|Follow-up Period|Withdrawal by Subject|0|||
161908867|NCT00794664|584717847|FG001|Follow-up Period|Withdrawal by Subject|2|||
161908868|NCT00794664|584717846|FG000|Follow-up Period|Protocol non-compliance|0|||
161908869|NCT00794664|584717847|FG001|Follow-up Period|Protocol non-compliance|1|||
161908870|NCT01973218|584717848|FG000|Overall Study|Adverse Event|1|||
161908871|NCT01973218|584717849|FG001|Overall Study|Adverse Event|0|||
161908872|NCT01973218|584717848|FG000|Overall Study|Withdrawal by Subject|1|||
161908873|NCT01973218|584717849|FG001|Overall Study|Withdrawal by Subject|0|||
161908874|NCT00720499|584717850|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
161908875|NCT00720499|584717851|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161908876|NCT00720499|584717850|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
161908877|NCT00720499|584717851|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
161908878|NCT00720499|584717850|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
161908879|NCT00720499|584717851|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
161908880|NCT02247466|584717852|FG000|Overall Study|Procedure changed to open surgery|0|||
161908881|NCT02247466|584717853|FG001|Overall Study|Procedure changed to open surgery|3|||
161908882|NCT00492726|584717854|FG000|Overall Study|Adverse Event|10|||
161908883|NCT00492726|584717855|FG001|Overall Study|Adverse Event|6|||
161908884|NCT00492726|584717854|FG000|Overall Study|Death|7|||
161908885|NCT00492726|584717855|FG001|Overall Study|Death|2|||
161908886|NCT00492726|584717854|FG000|Overall Study|Lack of Efficacy|0|||
161908887|NCT00492726|584717855|FG001|Overall Study|Lack of Efficacy|2|||
161908888|NCT00492726|584717854|FG000|Overall Study|Lost to Follow-up|27|||
161908889|NCT00492726|584717855|FG001|Overall Study|Lost to Follow-up|19|||
161908890|NCT00492726|584717854|FG000|Overall Study|Physician Decision|0|||
161908891|NCT00492726|584717855|FG001|Overall Study|Physician Decision|1|||
161908892|NCT00492726|584717854|FG000|Overall Study|Withdrawal by Subject|6|||
161908893|NCT00492726|584717855|FG001|Overall Study|Withdrawal by Subject|3|||
161908894|NCT00492726|584717854|FG000|Overall Study|Non compliant with study medication|0|||
161908895|NCT00492726|584717855|FG001|Overall Study|Non compliant with study medication|3|||
161908896|NCT04386902|584717856|FG000|Overall Study|Withdrawal by Subject|5|||
161908897|NCT04386902|584717856|FG000|Overall Study|Technical problems in the recording|5|||
161908898|NCT01100502|584717857|FG000|Overall Study|Withdrawal by Subject|18|||
161908899|NCT01100502|584717858|FG001|Overall Study|Withdrawal by Subject|25|||
161908900|NCT01100502|584717857|FG000|Overall Study|Lost to Follow-up|13|||
161908901|NCT01100502|584717858|FG001|Overall Study|Lost to Follow-up|28|||
161908902|NCT01100502|584717857|FG000|Overall Study|Site request to end participation in study|0|||
161908903|NCT01100502|584717858|FG001|Overall Study|Site request to end participation in study|1|||
161908904|NCT01100502|584717857|FG000|Overall Study|Death|45|||
161908905|NCT01100502|584717858|FG001|Overall Study|Death|40|||
161908906|NCT04356937|584717866|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
161908907|NCT04356937|584717867|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
161908908|NCT00807365|584717868|FG000|Overall Study|Study Terminated|5|||
161908909|NCT00960804|584717869|FG000|Overall Study|Adverse Event|1|||
161908910|NCT00960804|584717870|FG001|Overall Study|Adverse Event|0|||
161908911|NCT00960804|584717871|FG002|Overall Study|Adverse Event|0|||
161908912|NCT00960804|584717869|FG000|Overall Study|Withdrawal by Subject|1|||
161908913|NCT00960804|584717870|FG001|Overall Study|Withdrawal by Subject|0|||
161908914|NCT00960804|584717871|FG002|Overall Study|Withdrawal by Subject|0|||
161908915|NCT00960804|584717869|FG000|Overall Study|Study terminated by the sponsor|5|||
161908916|NCT00960804|584717870|FG001|Overall Study|Study terminated by the sponsor|4|||
161908917|NCT00960804|584717871|FG002|Overall Study|Study terminated by the sponsor|10|||
161908918|NCT02007720|584717873|FG000|Overall Study|Withdrawal by Subject|9|||
161908919|NCT02007720|584717874|FG001|Overall Study|Withdrawal by Subject|11|||
161908920|NCT02007720|584717873|FG000|Overall Study|study terminated by sponsor|58|||
161908921|NCT02007720|584717874|FG001|Overall Study|study terminated by sponsor|54|||
161908922|NCT02007720|584717873|FG000|Overall Study|technical problem|4|||
161908923|NCT02007720|584717874|FG001|Overall Study|technical problem|2|||
161908924|NCT02007720|584717873|FG000|Overall Study|patient followd less than 165 days|11|||
161908925|NCT02007720|584717874|FG001|Overall Study|patient followd less than 165 days|5|||
161908926|NCT02100124|584717877|FG000|Overall Study|Lost to Follow-up|5|||
161908927|NCT02100124|584717878|FG001|Overall Study|Lost to Follow-up|11|||
161908928|NCT02100124|584717879|FG002|Overall Study|Lost to Follow-up|3|||
161908929|NCT02100124|584717877|FG000|Overall Study|Withdrawal by Subject|1|||
161908930|NCT02100124|584717878|FG001|Overall Study|Withdrawal by Subject|0|||
161908931|NCT02100124|584717879|FG002|Overall Study|Withdrawal by Subject|0|||
161908932|NCT00750269|584719206|FG000|Overall Study|Protocol Violation|0|||
161908933|NCT00750269|584719207|FG001|Overall Study|Protocol Violation|1|||
161908934|NCT00750269|584719208|FG002|Overall Study|Protocol Violation|1|||
161908935|NCT00750269|584719209|FG003|Overall Study|Protocol Violation|2|||
161908936|NCT00750269|584719210|FG004|Overall Study|Protocol Violation|4|||
161908937|NCT00750269|584719206|FG000|Overall Study|Withdrawal by Subject|0|||
161908938|NCT00750269|584719207|FG001|Overall Study|Withdrawal by Subject|0|||
161908939|NCT00750269|584719208|FG002|Overall Study|Withdrawal by Subject|2|||
161908940|NCT00750269|584719209|FG003|Overall Study|Withdrawal by Subject|2|||
161908941|NCT00750269|584719210|FG004|Overall Study|Withdrawal by Subject|2|||
161908942|NCT00750269|584719206|FG000|Overall Study|Physician Decision|0|||
161908943|NCT00750269|584719207|FG001|Overall Study|Physician Decision|0|||
161908944|NCT00750269|584719208|FG002|Overall Study|Physician Decision|0|||
161908945|NCT00750269|584719209|FG003|Overall Study|Physician Decision|0|||
161908946|NCT00750269|584719210|FG004|Overall Study|Physician Decision|2|||
161908947|NCT00750269|584719206|FG000|Overall Study|Patient too large for positioning|0|||
161908948|NCT00750269|584719207|FG001|Overall Study|Patient too large for positioning|0|||
161908949|NCT00750269|584719208|FG002|Overall Study|Patient too large for positioning|1|||
161908950|NCT00750269|584719209|FG003|Overall Study|Patient too large for positioning|0|||
161908951|NCT00750269|584719210|FG004|Overall Study|Patient too large for positioning|0|||
161908952|NCT00750269|584719206|FG000|Overall Study|Site error|0|||
161908953|NCT00750269|584719207|FG001|Overall Study|Site error|0|||
161908954|NCT00750269|584719208|FG002|Overall Study|Site error|0|||
161908955|NCT00750269|584719209|FG003|Overall Study|Site error|1|||
161908956|NCT00750269|584719210|FG004|Overall Study|Site error|0|||
161908957|NCT00750269|584719206|FG000|Overall Study|SBRT plan could not be drawn|0|||
161908958|NCT00750269|584719207|FG001|Overall Study|SBRT plan could not be drawn|0|||
161908959|NCT00750269|584719208|FG002|Overall Study|SBRT plan could not be drawn|0|||
161908960|NCT00750269|584719209|FG003|Overall Study|SBRT plan could not be drawn|0|||
161908961|NCT00750269|584719210|FG004|Overall Study|SBRT plan could not be drawn|1|||
161908962|NCT00750269|584719206|FG000|Overall Study|Fiducials could not be placed|0|||
161908963|NCT00750269|584719207|FG001|Overall Study|Fiducials could not be placed|0|||
161908964|NCT00750269|584719208|FG002|Overall Study|Fiducials could not be placed|0|||
161908965|NCT00750269|584719209|FG003|Overall Study|Fiducials could not be placed|0|||
161908966|NCT00750269|584719210|FG004|Overall Study|Fiducials could not be placed|1|||
161908967|NCT01898078|584719211|FG000|Overall Study|Progressive Disease|1|||
161908968|NCT01898078|584719212|FG001|Overall Study|Progressive Disease|5|||
161908969|NCT01898078|584719211|FG000|Overall Study|Adverse Event|2|||
161908970|NCT01898078|584719212|FG001|Overall Study|Adverse Event|1|||
161908971|NCT01898078|584719211|FG000|Overall Study|Withdrawal by Subject|1|||
161908972|NCT01898078|584719212|FG001|Overall Study|Withdrawal by Subject|1|||
161908973|NCT01898078|584719211|FG000|Overall Study|Symptomatic Deterioration|2|||
161908974|NCT01898078|584719212|FG001|Overall Study|Symptomatic Deterioration|0|||
161908975|NCT01898078|584719211|FG000|Overall Study|Reason not Specified|0|||
161908976|NCT01898078|584719212|FG001|Overall Study|Reason not Specified|1|||
161908977|NCT03630393|584719219|FG000|Overall Study|Death|1|||
161908978|NCT03630393|584719220|FG001|Overall Study|Death|0|||
161908979|NCT00900562|584719229|FG000|Overall Study|Progressive disease|9|||
161908980|NCT00900562|584719230|FG001|Overall Study|Progressive disease|5|||
161908981|NCT00900562|584719229|FG000|Overall Study|Toxicity|1|||
161908982|NCT00900562|584719230|FG001|Overall Study|Toxicity|0|||
161908983|NCT00900562|584719229|FG000|Overall Study|Death|1|||
161908984|NCT00900562|584719230|FG001|Overall Study|Death|1|||
161908985|NCT00900562|584719229|FG000|Overall Study|Withdrawal by Subject|0|||
161908986|NCT00900562|584719230|FG001|Overall Study|Withdrawal by Subject|1|||
161908987|NCT00900562|584719229|FG000|Overall Study|Unrelated adverse event|1|||
161908988|NCT00900562|584719230|FG001|Overall Study|Unrelated adverse event|0|||
161908989|NCT01483118|584719242|FG000|Overall Study|Lost to Follow-up|12|||
161908990|NCT01483118|584719243|FG001|Overall Study|Lost to Follow-up|16|||
161908991|NCT01079780|584719245|FG000|Overall Study|Disease progression|43|||
161908992|NCT01079780|584719246|FG001|Overall Study|Disease progression|7|||
161908993|NCT01079780|584719247|FG002|Overall Study|Disease progression|31|||
161908994|NCT01079780|584719245|FG000|Overall Study|Adverse Event|13|||
161908995|NCT01079780|584719246|FG001|Overall Study|Adverse Event|5|||
161908996|NCT01079780|584719247|FG002|Overall Study|Adverse Event|7|||
161908997|NCT01079780|584719245|FG000|Overall Study|Death|2|||
161908998|NCT01079780|584719246|FG001|Overall Study|Death|0|||
161908999|NCT01079780|584719247|FG002|Overall Study|Death|2|||
161909000|NCT01079780|584719245|FG000|Overall Study|Withdrawal by Subject|6|||
161909001|NCT01079780|584719246|FG001|Overall Study|Withdrawal by Subject|4|||
161909002|NCT01079780|584719247|FG002|Overall Study|Withdrawal by Subject|4|||
161909003|NCT01079780|584719245|FG000|Overall Study|Alternative therapy|2|||
161909004|NCT01079780|584719246|FG001|Overall Study|Alternative therapy|0|||
161909005|NCT01079780|584719247|FG002|Overall Study|Alternative therapy|2|||
161909006|NCT01079780|584719245|FG000|Overall Study|Physician Decision|1|||
161909007|NCT01079780|584719246|FG001|Overall Study|Physician Decision|0|||
161909008|NCT01079780|584719247|FG002|Overall Study|Physician Decision|1|||
161909009|NCT01079780|584719245|FG000|Overall Study|Error made in lesion measurement|1|||
161909010|NCT01079780|584719246|FG001|Overall Study|Error made in lesion measurement|0|||
161909011|NCT01079780|584719247|FG002|Overall Study|Error made in lesion measurement|0|||
161909012|NCT01079780|584719245|FG000|Overall Study|Patient had surgery|1|||
161909013|NCT01079780|584719246|FG001|Overall Study|Patient had surgery|0|||
161909014|NCT01079780|584719247|FG002|Overall Study|Patient had surgery|0|||
161909015|NCT01079780|584719245|FG000|Overall Study|Treatment cycle delay|0|||
161909016|NCT01079780|584719246|FG001|Overall Study|Treatment cycle delay|0|||
161909017|NCT01079780|584719247|FG002|Overall Study|Treatment cycle delay|1|||
161909018|NCT01079780|584719245|FG000|Overall Study|Never started treatment|1|||
161909019|NCT01079780|584719246|FG001|Overall Study|Never started treatment|0|||
161909020|NCT01079780|584719247|FG002|Overall Study|Never started treatment|2|||
161909021|NCT01178294|584719248|FG000|Overall Study|Adverse Event|4|||
161909022|NCT01178294|584719248|FG000|Overall Study|Lost to Follow-up|2|||
161909023|NCT01178294|584719248|FG000|Overall Study|Lack of Efficacy|1|||
161909024|NCT01178294|584719248|FG000|Overall Study|Death|1|||
161909025|NCT01178294|584719248|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
161909026|NCT01178294|584719248|FG000|Overall Study|Subject status is terminal|1|||
161909027|NCT01178294|584719248|FG000|Overall Study|Completion status could not be verified|1|||
161909028|NCT02783066|584719249|FG000|Overall Study|Withdrawal by Subject|13|||
161909029|NCT00551369|584719250|FG000|Overall Study|Protocol Violation|5|||
161909030|NCT00551369|584719250|FG000|Overall Study|Withdrawal by Subject|1|||
161909031|NCT00551369|584719250|FG000|Overall Study|Not treated per protocol and re|1|||
161909032|NCT01663623|584719253|FG000|Overall Study|Adverse Event|3|||
161909033|NCT01663623|584719254|FG001|Overall Study|Adverse Event|7|||
161909034|NCT01663623|584719253|FG000|Overall Study|Lack of Efficacy|5|||
161909035|NCT01663623|584719254|FG001|Overall Study|Lack of Efficacy|6|||
161909036|NCT01663623|584719253|FG000|Overall Study|Protocol Violation|0|||
161909037|NCT01663623|584719254|FG001|Overall Study|Protocol Violation|1|||
161909038|NCT01663623|584719253|FG000|Overall Study|Other-Study closed/terminated|1|||
161909039|NCT01663623|584719254|FG001|Overall Study|Other-Study closed/terminated|1|||
161909040|NCT01663623|584719253|FG000|Overall Study|Physician Decision|1|||
161909041|NCT01663623|584719254|FG001|Overall Study|Physician Decision|4|||
161909042|NCT01663623|584719253|FG000|Overall Study|Withdrawal by Subject|2|||
161909043|NCT01663623|584719254|FG001|Overall Study|Withdrawal by Subject|1|||
161909044|NCT02251275|584719255|FG000|Overall Study|Adverse Event|23|||
161909045|NCT02251275|584719256|FG001|Overall Study|Adverse Event|60|||
161909046|NCT02251275|584719257|FG002|Overall Study|Adverse Event|28|||
161909047|NCT02251275|584719258|FG003|Overall Study|Adverse Event|0|||
161909048|NCT02251275|584719259|FG004|Overall Study|Adverse Event|0|||
161909049|NCT02251275|584719255|FG000|Overall Study|Lost to Follow-up|5|||
161909050|NCT02251275|584719256|FG001|Overall Study|Lost to Follow-up|6|||
161909051|NCT02251275|584719257|FG002|Overall Study|Lost to Follow-up|4|||
161909052|NCT02251275|584719258|FG003|Overall Study|Lost to Follow-up|0|||
161909053|NCT02251275|584719259|FG004|Overall Study|Lost to Follow-up|0|||
161909054|NCT02251275|584719255|FG000|Overall Study|Physician Decision|19|||
161909055|NCT02251275|584719256|FG001|Overall Study|Physician Decision|30|||
161909056|NCT02251275|584719257|FG002|Overall Study|Physician Decision|26|||
161909057|NCT02251275|584719258|FG003|Overall Study|Physician Decision|0|||
161909058|NCT02251275|584719259|FG004|Overall Study|Physician Decision|1|||
161909059|NCT02251275|584719255|FG000|Overall Study|Protocol Deviation|0|||
161909060|NCT02251275|584719256|FG001|Overall Study|Protocol Deviation|0|||
161909061|NCT02251275|584719257|FG002|Overall Study|Protocol Deviation|1|||
161909062|NCT02251275|584719258|FG003|Overall Study|Protocol Deviation|0|||
161909063|NCT02251275|584719259|FG004|Overall Study|Protocol Deviation|0|||
161909064|NCT02251275|584719255|FG000|Overall Study|Withdrawal by Subject|25|||
161909065|NCT02251275|584719256|FG001|Overall Study|Withdrawal by Subject|51|||
161909066|NCT02251275|584719257|FG002|Overall Study|Withdrawal by Subject|35|||
161909067|NCT02251275|584719258|FG003|Overall Study|Withdrawal by Subject|1|||
161909068|NCT02251275|584719259|FG004|Overall Study|Withdrawal by Subject|0|||
161909069|NCT01004614|584719263|FG000|Washout|Withdrawal by Subject|0|||
161909070|NCT01004614|584719264|FG001|Washout|Withdrawal by Subject|1|||
161909071|NCT01004614|584719265|FG002|Washout|Withdrawal by Subject|0|||
161909072|NCT01004614|584719266|FG003|Washout|Withdrawal by Subject|0|||
161909073|NCT01569022|584719268|FG000|First Intervention|Lost to Follow-up|2|||
161909074|NCT01569022|584719269|FG001|First Intervention|Lost to Follow-up|1|||
161909075|NCT01569022|584719268|FG000|Second Intervention|Lost to Follow-up|2|||
161909076|NCT01569022|584719269|FG001|Second Intervention|Lost to Follow-up|2|||
161909077|NCT02111083|584719274|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
161909078|NCT02111083|584719275|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
161909079|NCT00644059|584719276|FG000|Overall Study|Lost to Follow-up|37|||
161909080|NCT00644059|584719277|FG001|Overall Study|Lost to Follow-up|34|||
161909081|NCT00644059|584719278|FG002|Overall Study|Lost to Follow-up|16|||
161909082|NCT00644059|584719276|FG000|Overall Study|Withdrawal by Subject|52|||
161909083|NCT00644059|584719277|FG001|Overall Study|Withdrawal by Subject|60|||
161909084|NCT00644059|584719278|FG002|Overall Study|Withdrawal by Subject|30|||
161909085|NCT00644059|584719276|FG000|Overall Study|Adverse Event|8|||
161909086|NCT00644059|584719277|FG001|Overall Study|Adverse Event|5|||
161909087|NCT00644059|584719278|FG002|Overall Study|Adverse Event|1|||
161909088|NCT00644059|584719276|FG000|Overall Study|Inappropriate Enrollment|1|||
161909089|NCT00644059|584719277|FG001|Overall Study|Inappropriate Enrollment|3|||
161909090|NCT00644059|584719278|FG002|Overall Study|Inappropriate Enrollment|0|||
161909091|NCT00644059|584719276|FG000|Overall Study|Protocol Deviation/violation|20|||
161909092|NCT00644059|584719277|FG001|Overall Study|Protocol Deviation/violation|19|||
161909093|NCT00644059|584719278|FG002|Overall Study|Protocol Deviation/violation|15|||
161909094|NCT00644059|584719276|FG000|Overall Study|Unable to classify|6|||
161909095|NCT00644059|584719277|FG001|Overall Study|Unable to classify|2|||
161909096|NCT00644059|584719278|FG002|Overall Study|Unable to classify|3|||
161909097|NCT01302899|584719279|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
161909098|NCT01302899|584719280|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
161909099|NCT01302899|584719279|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
161909100|NCT01302899|584719280|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
161909101|NCT02834975|584719281|FG000|Overall Study|Physician Decision|2|||
161909102|NCT02834975|584719281|FG000|Overall Study|Adverse Event|1|||
161909103|NCT02834975|584719281|FG000|Overall Study|Withdrawal by Subject|1|||
161909104|NCT02834975|584719281|FG000|Overall Study|Lack of Efficacy|1|||
161909105|NCT02497469|584719283|FG000|Overall Study|Randomized but not Treated|0|||
161909106|NCT02497469|584719284|FG001|Overall Study|Randomized but not Treated|2|||
161909107|NCT02497469|584719283|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
161909108|NCT02497469|584719284|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
161909109|NCT02497469|584719283|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
161909110|NCT02497469|584719284|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
161909111|NCT02497469|584719283|FG000|Overall Study|Significant Protocol Deviation|4|||
161909112|NCT02497469|584719284|FG001|Overall Study|Significant Protocol Deviation|5|||
161909113|NCT02497469|584719283|FG000|Overall Study|Lost to Follow-up|14|||
161909114|NCT02497469|584719284|FG001|Overall Study|Lost to Follow-up|4|||
161909115|NCT02497469|584719283|FG000|Overall Study|Voluntary Withdrawal|39|||
161909116|NCT02497469|584719284|FG001|Overall Study|Voluntary Withdrawal|41|||
161909117|NCT02497469|584719283|FG000|Overall Study|Pregnancy|1|||
161909118|NCT02497469|584719284|FG001|Overall Study|Pregnancy|1|||
161909119|NCT02497469|584719283|FG000|Overall Study|Lack of Efficacy|86|||
161909120|NCT02497469|584719284|FG001|Overall Study|Lack of Efficacy|40|||
161909121|NCT02497469|584719283|FG000|Overall Study|Reason not Specified|6|||
161909122|NCT02497469|584719284|FG001|Overall Study|Reason not Specified|6|||
161909123|NCT03558516|584719285|FG000|Overall Study|Protocol Violation|2|||
161909124|NCT03558516|584719286|FG001|Overall Study|Protocol Violation|2|||
161909125|NCT02714153|584719287|FG000|Overall Study|Death|1|||
161909126|NCT02737722|584719290|FG000|Overall Study|Physician Decision|0|||
161909127|NCT02737722|584719291|FG001|Overall Study|Physician Decision|0|||
161909128|NCT02737722|584719292|FG002|Overall Study|Physician Decision|1|||
161909129|NCT02737722|584719293|FG003|Overall Study|Physician Decision|0|||
161909130|NCT01603277|584719294|FG000|Overall Study|Adverse Event|1|||
161909131|NCT01603277|584719295|FG001|Overall Study|Adverse Event|2|||
161909132|NCT01603277|584719294|FG000|Overall Study|Physician Decision|0|||
161909133|NCT01603277|584719295|FG001|Overall Study|Physician Decision|1|||
161909134|NCT01603277|584719294|FG000|Overall Study|Protocol Violation|6|||
161909135|NCT01603277|584719295|FG001|Overall Study|Protocol Violation|10|||
161909136|NCT01603277|584719294|FG000|Overall Study|Withdrawal by Subject|5|||
161909137|NCT01603277|584719295|FG001|Overall Study|Withdrawal by Subject|4|||
161909138|NCT01603277|584719294|FG000|Overall Study|Non-Compliance|2|||
161909139|NCT01603277|584719295|FG001|Overall Study|Non-Compliance|1|||
161909140|NCT02785939|584719301|FG000|Overall Study|Progression|25|||
161909141|NCT02785939|584719302|FG001|Overall Study|Progression|8|||
161909142|NCT02785939|584719301|FG000|Overall Study|Adverse Event|3|||
161909143|NCT02785939|584719302|FG001|Overall Study|Adverse Event|1|||
161453248|NCT00313781|583053606|FG000|Before Crossover|Death|22|||
161909144|NCT02785939|584719301|FG000|Overall Study|Death|1|||
161909145|NCT02785939|584719302|FG001|Overall Study|Death|0|||
161909146|NCT02785939|584719301|FG000|Overall Study|Refusal|1|||
161909147|NCT02785939|584719302|FG001|Overall Study|Refusal|0|||
161909148|NCT02785939|584719301|FG000|Overall Study|Deteriorating health|1|||
161909149|NCT02785939|584719302|FG001|Overall Study|Deteriorating health|0|||
161909150|NCT02785939|584719301|FG000|Overall Study|Not protocol specified|0|||
161909151|NCT02785939|584719302|FG001|Overall Study|Not protocol specified|1|||
161909152|NCT04465422|584719303|FG000|Overall Study|Lost to Follow-up|0|||
161561278|NCT04736056|583442091|FG002|Overall Study|Lost to Follow-up|1|||
161561279|NCT04736056|583442092|FG003|Overall Study|Lost to Follow-up|1|||
161561280|NCT04736056|583442089|FG000|Overall Study|Withdrawal by Subject|2|||
161561281|NCT04736056|583442090|FG001|Overall Study|Withdrawal by Subject|0|||
161561282|NCT04736056|583442091|FG002|Overall Study|Withdrawal by Subject|0|||
161805588|NCT00463606|584331799|FG002|Overall Study|Physician Decision|0|||
161805589|NCT00463606|584331797|FG000|Overall Study|Sponsor request|0|||
161805590|NCT00463606|584331798|FG001|Overall Study|Sponsor request|1|||
161805591|NCT00463606|584331799|FG002|Overall Study|Sponsor request|0|||
161805592|NCT00463606|584331797|FG000|Overall Study|Exclusion criteria violation|2|||
161805593|NCT00463606|584331798|FG001|Overall Study|Exclusion criteria violation|0|||
161805594|NCT00463606|584331799|FG002|Overall Study|Exclusion criteria violation|0|||
161805595|NCT00463606|584331797|FG000|Overall Study|Coordinator error|1|||
161805596|NCT00463606|584331798|FG001|Overall Study|Coordinator error|0|||
161805597|NCT00463606|584331799|FG002|Overall Study|Coordinator error|0|||
161805598|NCT00463606|584331797|FG000|Overall Study|Patient randomized in error|1|||
161805599|NCT00463606|584331798|FG001|Overall Study|Patient randomized in error|0|||
161805600|NCT00463606|584331799|FG002|Overall Study|Patient randomized in error|0|||
161805601|NCT00463606|584331797|FG000|Overall Study|Participation in another ABT-335 trial|1|||
161805602|NCT00463606|584331798|FG001|Overall Study|Participation in another ABT-335 trial|0|||
161805603|NCT00463606|584331799|FG002|Overall Study|Participation in another ABT-335 trial|0|||
161805604|NCT00463606|584331797|FG000|Overall Study|Protocol Violation|0|||
161805605|NCT00463606|584331798|FG001|Overall Study|Protocol Violation|0|||
161805606|NCT00463606|584331799|FG002|Overall Study|Protocol Violation|1|||
161805607|NCT02682602|584331801|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
161805608|NCT02682602|584331802|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
161805609|NCT02682602|584331801|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
161805610|NCT02682602|584331802|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
161805611|NCT03567174|584331803|FG000|Overall Study|Death|24|||
161805612|NCT03567174|584331804|FG001|Overall Study|Death|31|||
161805613|NCT03567174|584331803|FG000|Overall Study|Lost to Follow-up|165|||
161805614|NCT03567174|584331804|FG001|Overall Study|Lost to Follow-up|174|||
161805615|NCT02140060|584331805|FG000|Overall Study|Adverse Event|0|||
161805616|NCT02140060|584331806|FG001|Overall Study|Adverse Event|0|||
161805617|NCT02140060|584331807|FG002|Overall Study|Adverse Event|0|||
161805618|NCT02140060|584331808|FG003|Overall Study|Adverse Event|1|||
161805619|NCT02140060|584331809|FG004|Overall Study|Adverse Event|1|||
161805620|NCT02140060|584331810|FG005|Overall Study|Adverse Event|1|||
161805621|NCT02140060|584331805|FG000|Overall Study|Lack of Efficacy|0|||
161805622|NCT02140060|584331806|FG001|Overall Study|Lack of Efficacy|0|||
161805623|NCT02140060|584331807|FG002|Overall Study|Lack of Efficacy|0|||
161805624|NCT02140060|584331808|FG003|Overall Study|Lack of Efficacy|1|||
161805625|NCT02140060|584331809|FG004|Overall Study|Lack of Efficacy|0|||
161805626|NCT02140060|584331810|FG005|Overall Study|Lack of Efficacy|0|||
161805627|NCT01066143|584333804|FG000|Overall Study|ineligible for the study|8|||
161805628|NCT05376319|584333805|FG000|Overall Study|Funding termination|2|||
161805629|NCT05376319|584333806|FG001|Overall Study|Funding termination|4|||
161805630|NCT01340495|584333807|FG000|Overall Study|Withdrawal by Subject|1|||
161805631|NCT03497897|584333808|FG000|Overall Study|Adverse Event|1|||
161805632|NCT03497897|584333809|FG001|Overall Study|Adverse Event|1|||
161805633|NCT03497897|584333810|FG002|Overall Study|Adverse Event|1|||
161805634|NCT03497897|584333808|FG000|Overall Study|Lost to Follow-up|2|||
161805635|NCT03497897|584333809|FG001|Overall Study|Lost to Follow-up|0|||
161805636|NCT03497897|584333810|FG002|Overall Study|Lost to Follow-up|2|||
161805637|NCT03497897|584333808|FG000|Overall Study|Physician Decision|1|||
161805638|NCT03497897|584333809|FG001|Overall Study|Physician Decision|0|||
161805639|NCT03497897|584333810|FG002|Overall Study|Physician Decision|0|||
161805640|NCT03497897|584333808|FG000|Overall Study|Subject/Guardian Decision|2|||
161805641|NCT03497897|584333809|FG001|Overall Study|Subject/Guardian Decision|1|||
161805642|NCT03497897|584333810|FG002|Overall Study|Subject/Guardian Decision|3|||
161805643|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805644|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805645|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
161805646|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805647|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805648|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805649|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805650|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
161805651|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805652|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805653|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805654|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805655|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161909153|NCT04465422|584719304|FG001|Overall Study|Lost to Follow-up|2|||
161909154|NCT01787552|584719305|FG000|Overall Study|Withdrawal by Subject|2|||
161909155|NCT01787552|584719306|FG001|Overall Study|Withdrawal by Subject|0|||
161909156|NCT01787552|584719307|FG002|Overall Study|Withdrawal by Subject|0|||
161909157|NCT01787552|584719308|FG003|Overall Study|Withdrawal by Subject|4|||
161909158|NCT01787552|584719305|FG000|Overall Study|Physician Decision|2|||
161909159|NCT01787552|584719306|FG001|Overall Study|Physician Decision|2|||
161909160|NCT01787552|584719307|FG002|Overall Study|Physician Decision|1|||
161909161|NCT01787552|584719308|FG003|Overall Study|Physician Decision|2|||
161909162|NCT01787552|584719305|FG000|Overall Study|Death|0|||
161909163|NCT01787552|584719306|FG001|Overall Study|Death|0|||
161909164|NCT01787552|584719307|FG002|Overall Study|Death|0|||
161909165|NCT01787552|584719308|FG003|Overall Study|Death|1|||
161909166|NCT01787552|584719305|FG000|Overall Study|Adverse Event|2|||
161909167|NCT01787552|584719306|FG001|Overall Study|Adverse Event|5|||
161909168|NCT01787552|584719307|FG002|Overall Study|Adverse Event|2|||
161909169|NCT01787552|584719308|FG003|Overall Study|Adverse Event|16|||
161909170|NCT01787552|584719305|FG000|Overall Study|Study terminated by Sponsor|0|||
161909171|NCT01787552|584719306|FG001|Overall Study|Study terminated by Sponsor|0|||
161909172|NCT01787552|584719307|FG002|Overall Study|Study terminated by Sponsor|1|||
161909173|NCT01787552|584719308|FG003|Overall Study|Study terminated by Sponsor|3|||
161909174|NCT01787552|584719305|FG000|Overall Study|Progressive Disease|2|||
161909175|NCT01787552|584719306|FG001|Overall Study|Progressive Disease|2|||
161909176|NCT01787552|584719307|FG002|Overall Study|Progressive Disease|1|||
161909177|NCT01787552|584719308|FG003|Overall Study|Progressive Disease|1|||
161909178|NCT01604785|584719313|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
161909179|NCT01604785|584719314|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
161909180|NCT00931632|584719317|FG000|Overall Study|Withdrawal by Subject|2|||
161909181|NCT00931632|584719318|FG001|Overall Study|Withdrawal by Subject|3|||
161909182|NCT00931632|584719317|FG000|Overall Study|Adverse Event|19|||
161909183|NCT00931632|584719318|FG001|Overall Study|Adverse Event|15|||
161909184|NCT01419314|584719319|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
161909185|NCT01419314|584719320|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
161909186|NCT01419314|584719319|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
161909187|NCT01419314|584719320|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
161909188|NCT01419314|584719319|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
161909189|NCT01419314|584719320|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
161909190|NCT01118052|584719325|FG000|Overall Study|Never treated|2|||
161909191|NCT00843492|584719326|FG000|Overall Study|Adverse Event|0|||
161909192|NCT00843492|584719327|FG001|Overall Study|Adverse Event|3|||
161909193|NCT00843492|584719326|FG000|Overall Study|Lost to Follow-up|4|||
161909194|NCT00843492|584719327|FG001|Overall Study|Lost to Follow-up|4|||
161909195|NCT00843492|584719326|FG000|Overall Study|Withdrawal by Subject|0|||
161909196|NCT00843492|584719327|FG001|Overall Study|Withdrawal by Subject|4|||
161909197|NCT00843492|584719326|FG000|Overall Study|Immobilization Stopped|1|||
161909198|NCT00843492|584719327|FG001|Overall Study|Immobilization Stopped|0|||
161909199|NCT00843492|584719326|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
161909200|NCT00843492|584719327|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
161909201|NCT00843492|584719326|FG000|Overall Study|Orthopedic Surgery|0|||
161909202|NCT00843492|584719327|FG001|Overall Study|Orthopedic Surgery|2|||
161909203|NCT00843492|584719326|FG000|Overall Study|Visit Not Performed|1|||
161909204|NCT00843492|584719327|FG001|Overall Study|Visit Not Performed|0|||
161909205|NCT00843492|584719326|FG000|Overall Study|Deep-vein Thrombosis|1|||
161909206|NCT00843492|584719327|FG001|Overall Study|Deep-vein Thrombosis|0|||
161909207|NCT01677741|584719328|FG000|Overall Study|Death|0|||
161909208|NCT01677741|584719329|FG001|Overall Study|Death|0|||
161909209|NCT01677741|584719330|FG002|Overall Study|Death|0|||
161909210|NCT01677741|584719331|FG003|Overall Study|Death|1|||
161909211|NCT01677741|584719332|FG004|Overall Study|Death|0|||
161453249|NCT00313781|583053607|FG001|Before Crossover|Death|8|||
161453250|NCT00313781|583053608|FG002|Before Crossover|Death|0|||
161453251|NCT00313781|583053606|FG000|Before Crossover|Lost to Follow-up|0|||
161453252|NCT00313781|583053607|FG001|Before Crossover|Lost to Follow-up|3|||
161453253|NCT00313781|583053608|FG002|Before Crossover|Lost to Follow-up|0|||
161453254|NCT00313781|583053606|FG000|Before Crossover|Withdrawal by Subject|3|||
161453255|NCT00313781|583053607|FG001|Before Crossover|Withdrawal by Subject|1|||
161453256|NCT00313781|583053608|FG002|Before Crossover|Withdrawal by Subject|0|||
161453257|NCT00313781|583053606|FG000|Before Crossover|Other|45|||
161453258|NCT00313781|583053607|FG001|Before Crossover|Other|30|||
161453259|NCT00313781|583053608|FG002|Before Crossover|Other|0|||
161909212|NCT01677741|584719333|FG005|Overall Study|Death|1|||
161909213|NCT01677741|584719334|FG006|Overall Study|Death|0|||
161909214|NCT01677741|584719335|FG007|Overall Study|Death|0|||
161909215|NCT01677741|584719328|FG000|Overall Study|Withdrawal by Subject|2|||
161909216|NCT01677741|584719329|FG001|Overall Study|Withdrawal by Subject|7|||
161909217|NCT01677741|584719330|FG002|Overall Study|Withdrawal by Subject|5|||
161909218|NCT01677741|584719331|FG003|Overall Study|Withdrawal by Subject|4|||
161909219|NCT01677741|584719332|FG004|Overall Study|Withdrawal by Subject|11|||
161909220|NCT01677741|584719333|FG005|Overall Study|Withdrawal by Subject|20|||
161909221|NCT01677741|584719334|FG006|Overall Study|Withdrawal by Subject|4|||
161909222|NCT01677741|584719335|FG007|Overall Study|Withdrawal by Subject|2|||
161909223|NCT01677741|584719328|FG000|Overall Study|Enrolled in a rollover study|0|||
161909224|NCT01677741|584719329|FG001|Overall Study|Enrolled in a rollover study|3|||
161909225|NCT01677741|584719330|FG002|Overall Study|Enrolled in a rollover study|2|||
161909226|NCT01677741|584719331|FG003|Overall Study|Enrolled in a rollover study|1|||
161909227|NCT01677741|584719332|FG004|Overall Study|Enrolled in a rollover study|6|||
161909228|NCT01677741|584719333|FG005|Overall Study|Enrolled in a rollover study|6|||
161909229|NCT01677741|584719334|FG006|Overall Study|Enrolled in a rollover study|7|||
161909230|NCT01677741|584719335|FG007|Overall Study|Enrolled in a rollover study|0|||
161909231|NCT01677741|584719328|FG000|Overall Study|Progressive disease|1|||
161909232|NCT01677741|584719329|FG001|Overall Study|Progressive disease|0|||
161909233|NCT01677741|584719330|FG002|Overall Study|Progressive disease|1|||
161909234|NCT01677741|584719331|FG003|Overall Study|Progressive disease|0|||
161909235|NCT01677741|584719332|FG004|Overall Study|Progressive disease|0|||
161909236|NCT01677741|584719333|FG005|Overall Study|Progressive disease|1|||
161909237|NCT01677741|584719334|FG006|Overall Study|Progressive disease|0|||
161909238|NCT01677741|584719335|FG007|Overall Study|Progressive disease|0|||
161909239|NCT00721799|584719338|FG000|Overall Study|Withdrawal by Subject|7|||
161909240|NCT00721799|584719338|FG000|Overall Study|withdraw by subject after scan 1|1|||
161909241|NCT01441973|584719339|FG000|Overall Study|Disease progression|8|||
161909242|NCT01441973|584719340|FG001|Overall Study|Disease progression|6|||
161909243|NCT01441973|584719339|FG000|Overall Study|Adverse event unrelated to study drug|3|||
161909244|NCT01441973|584719340|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161909245|NCT01441973|584719339|FG000|Overall Study|Participant request to discontinue|1|||
161909246|NCT01441973|584719340|FG001|Overall Study|Participant request to discontinue|1|||
161909247|NCT01441973|584719339|FG000|Overall Study|Poor compliance/noncompliance|0|||
161909248|NCT01441973|584719340|FG001|Overall Study|Poor compliance/noncompliance|1|||
161909249|NCT01441973|584719339|FG000|Overall Study|Administrative reason by sponsor|3|||
161909250|NCT01441973|584719340|FG001|Overall Study|Administrative reason by sponsor|5|||
161909251|NCT01441973|584719339|FG000|Overall Study|Participant withdrew consent|0|||
161909252|NCT01441973|584719340|FG001|Overall Study|Participant withdrew consent|1|||
161909253|NCT00941928|584721346|FG000|Overall Study|Withdrawal by Subject|1|||
161909254|NCT00941928|584721346|FG000|Overall Study|Disease Progression|1|||
161909255|NCT02300610|584721347|FG000|Overall Study|Withdrawal by Subject|1|||
161909256|NCT02300610|584721348|FG001|Overall Study|Withdrawal by Subject|0|||
161909257|NCT02300610|584721349|FG002|Overall Study|Withdrawal by Subject|1|||
161909258|NCT00095979|584721350|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
161909259|NCT02051296|584721357|FG000|Overall Study|Lost to Follow-up|1|||
161909260|NCT02051296|584721358|FG001|Overall Study|Lost to Follow-up|2|||
161909261|NCT02051296|584721357|FG000|Overall Study|withdraw prior to treatment|7|||
161909262|NCT02051296|584721358|FG001|Overall Study|withdraw prior to treatment|7|||
161909263|NCT02133508|584721359|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
161909264|NCT02133508|584721359|FG000|Overall Study|Death|12|||
161909265|NCT02133508|584721359|FG000|Overall Study|Lost to Follow-up|2|||
161909266|NCT02152007|584721360|FG000|Overall Study|Withdrawal by Subject|1|||
161909267|NCT03363906|584721369|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
161909268|NCT03363906|584721370|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
161909269|NCT03363906|584721369|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
161909270|NCT03363906|584721370|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
161909271|NCT03363906|584721369|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
161909272|NCT03363906|584721370|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
161909273|NCT03363906|584721369|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
161909274|NCT03363906|584721370|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
161909275|NCT00676143|584721371|FG000|Overall Study|Adverse Event|34|||
161909276|NCT00676143|584721372|FG001|Overall Study|Adverse Event|60|||
161909277|NCT00676143|584721371|FG000|Overall Study|Death|4|||
161909278|NCT00676143|584721372|FG001|Overall Study|Death|4|||
161909279|NCT00676143|584721371|FG000|Overall Study|Lack of Efficacy|0|||
161909280|NCT00676143|584721372|FG001|Overall Study|Lack of Efficacy|6|||
161909281|NCT00676143|584721371|FG000|Overall Study|Lost to Follow-up|0|||
161909282|NCT00676143|584721372|FG001|Overall Study|Lost to Follow-up|13|||
161909283|NCT00676143|584721371|FG000|Overall Study|Physician Decision|5|||
161909284|NCT00676143|584721372|FG001|Overall Study|Physician Decision|8|||
161909285|NCT00676143|584721371|FG000|Overall Study|Protocol Violation|4|||
161909286|NCT00676143|584721372|FG001|Overall Study|Protocol Violation|8|||
161909287|NCT00676143|584721371|FG000|Overall Study|Withdrawal by Subject|24|||
161909288|NCT00676143|584721372|FG001|Overall Study|Withdrawal by Subject|42|||
161909289|NCT00676143|584721371|FG000|Overall Study|Discontinuation of study by sponsor|65|||
161909290|NCT00676143|584721372|FG001|Overall Study|Discontinuation of study by sponsor|88|||
161909291|NCT00676143|584721371|FG000|Overall Study|Failed to return|2|||
161909292|NCT00676143|584721372|FG001|Overall Study|Failed to return|1|||
161909293|NCT00676143|584721371|FG000|Overall Study|Loss of caregiver|5|||
161453260|NCT00313781|583053606|FG000|Before Crossover|Crossover|0|||
161909294|NCT00676143|584721372|FG001|Overall Study|Loss of caregiver|3|||
161909295|NCT00676143|584721371|FG000|Overall Study|Other|11|||
161909296|NCT00676143|584721372|FG001|Overall Study|Other|20|||
161909297|NCT00676143|584721371|FG000|Overall Study|Participant participation unknown|1|||
161909298|NCT00676143|584721372|FG001|Overall Study|Participant participation unknown|4|||
161909299|NCT00676143|584721371|FG000|Overall Study|Vasogenic edema recurrence|1|||
161909300|NCT00676143|584721372|FG001|Overall Study|Vasogenic edema recurrence|3|||
161909301|NCT00929669|584721373|FG000|Overall Study|elevated glucose levels|1|||
161909302|NCT00472420|584721374|FG000|Induction Treatment Period|Physician Decision|9|||
161909303|NCT00472420|584721374|FG000|Induction Treatment Period|Adverse Event|3|||
161909304|NCT00472420|584721374|FG000|Induction Treatment Period|Non-compliance|1|||
161909305|NCT00472420|584721374|FG000|Induction Treatment Period|Death|3|||
161909306|NCT00472420|584721374|FG000|Follow-up Period|Death|5|||
161909307|NCT00472420|584721374|FG000|Follow-up Period|Physician Decision|9|||
161909308|NCT00472420|584721374|FG000|Follow-up Period|Lost to Follow-up|2|||
161909309|NCT00472420|584721374|FG000|Follow-up Period|Protocol Violation|1|||
161909310|NCT00686972|584721376|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
161909311|NCT01901185|584721377|FG000|Overall Study|Withdrawal by Subject|2|||
161909312|NCT02065557|584721380|FG000|Induction Period|Withdrawal by Subject|2|||
161909313|NCT02065557|584721381|FG001|Induction Period|Withdrawal by Subject|1|||
161909314|NCT02065557|584721382|FG002|Induction Period|Withdrawal by Subject|0|||
161909315|NCT02065557|584721383|FG003|Induction Period|Withdrawal by Subject|0|||
161909316|NCT02065557|584721384|FG004|Induction Period|Withdrawal by Subject|0|||
161909317|NCT02065557|584721385|FG005|Induction Period|Withdrawal by Subject|0|||
161561283|NCT04736056|583442092|FG003|Overall Study|Withdrawal by Subject|0|||
161561284|NCT04736056|583442089|FG000|Overall Study|Physician Decision|1|||
161561285|NCT04736056|583442090|FG001|Overall Study|Physician Decision|0|||
161909318|NCT02065557|584721380|FG000|Induction Period|Lack of Efficacy|2|||
161909319|NCT02065557|584721381|FG001|Induction Period|Lack of Efficacy|1|||
161909320|NCT02065557|584721382|FG002|Induction Period|Lack of Efficacy|1|||
161909321|NCT02065557|584721383|FG003|Induction Period|Lack of Efficacy|0|||
161909322|NCT02065557|584721384|FG004|Induction Period|Lack of Efficacy|0|||
161909323|NCT02065557|584721385|FG005|Induction Period|Lack of Efficacy|0|||
161909324|NCT02065557|584721380|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161909325|NCT02065557|584721381|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161909326|NCT02065557|584721382|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161909327|NCT02065557|584721383|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161909328|NCT02065557|584721384|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161909329|NCT02065557|584721385|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161909330|NCT02065557|584721380|FG000|Induction Period|Non-Responder at Week 8|4|||
161909331|NCT02065557|584721381|FG001|Induction Period|Non-Responder at Week 8|4|||
161909332|NCT02065557|584721382|FG002|Induction Period|Non-Responder at Week 8|0|||
161909333|NCT02065557|584721383|FG003|Induction Period|Non-Responder at Week 8|0|||
161909334|NCT02065557|584721384|FG004|Induction Period|Non-Responder at Week 8|0|||
161909335|NCT02065557|584721385|FG005|Induction Period|Non-Responder at Week 8|0|||
161909336|NCT02065557|584721380|FG000|Induction Period|Adverse Event|1|||
161909337|NCT02065557|584721381|FG001|Induction Period|Adverse Event|1|||
161909338|NCT02065557|584721382|FG002|Induction Period|Adverse Event|0|||
161909339|NCT02065557|584721383|FG003|Induction Period|Adverse Event|0|||
161909340|NCT02065557|584721384|FG004|Induction Period|Adverse Event|0|||
161909341|NCT02065557|584721385|FG005|Induction Period|Adverse Event|0|||
161909342|NCT02065557|584721380|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909343|NCT02065557|584721381|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909344|NCT02065557|584721382|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909345|NCT02065557|584721383|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
161909346|NCT02065557|584721384|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
161909347|NCT02065557|584721385|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909348|NCT02065557|584721380|FG000|Maintenance Period|Withdrawal by Subject|0|||
161561286|NCT04736056|583442091|FG002|Overall Study|Physician Decision|1|||
161561287|NCT04736056|583442092|FG003|Overall Study|Physician Decision|0|||
161561288|NCT04529538|583442093|FG000|Overall Study|Lost to Follow-up|3|||
161561289|NCT04529538|583442094|FG001|Overall Study|Lost to Follow-up|2|||
161561290|NCT04529538|583442095|FG002|Overall Study|Lost to Follow-up|1|||
161909349|NCT02065557|584721381|FG001|Maintenance Period|Withdrawal by Subject|0|||
161909350|NCT02065557|584721382|FG002|Maintenance Period|Withdrawal by Subject|0|||
161909351|NCT02065557|584721383|FG003|Maintenance Period|Withdrawal by Subject|0|||
161909352|NCT02065557|584721384|FG004|Maintenance Period|Withdrawal by Subject|2|||
161909353|NCT02065557|584721385|FG005|Maintenance Period|Withdrawal by Subject|1|||
161909354|NCT02065557|584721380|FG000|Maintenance Period|Lack of Efficacy|0|||
161909355|NCT02065557|584721381|FG001|Maintenance Period|Lack of Efficacy|0|||
161909356|NCT02065557|584721382|FG002|Maintenance Period|Lack of Efficacy|0|||
161909357|NCT02065557|584721383|FG003|Maintenance Period|Lack of Efficacy|0|||
161909358|NCT02065557|584721384|FG004|Maintenance Period|Lack of Efficacy|5|||
161909359|NCT02065557|584721385|FG005|Maintenance Period|Lack of Efficacy|2|||
161909360|NCT02065557|584721380|FG000|Maintenance Period|Subject Non-Compliance|0|||
161805656|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805657|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805658|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805659|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
161805660|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805661|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805662|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805663|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805664|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805665|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805666|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
161805667|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805668|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805669|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805670|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805671|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
161805672|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805673|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
161805674|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805675|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805676|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805677|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805678|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805679|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805680|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805681|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161805682|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805683|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161805684|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161805685|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805686|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805687|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805688|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805689|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805690|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
161805691|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805692|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Other|0|||
161805693|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Other|0|||
161805694|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Other|0|||
161805695|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Other|0|||
161805696|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Other|1|||
161805697|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Other|4|||
161805698|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Other|0|||
161805699|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Adverse Event|0|||
161805700|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Adverse Event|0|||
161805701|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Adverse Event|0|||
161805702|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Adverse Event|0|||
161805703|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Adverse Event|1|||
161805704|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Adverse Event|0|||
161805705|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Adverse Event|1|||
161805706|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805707|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805708|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805709|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805710|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805711|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805712|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
161805713|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805714|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805715|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805716|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805717|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161561291|NCT04529538|583442096|FG003|Overall Study|Lost to Follow-up|0|||
161805718|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805719|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
161805720|NCT00667862|584333819|FG000|Overall Study|Adverse Event|9|||
161805721|NCT00667862|584333819|FG000|Overall Study|Death|1|||
161805722|NCT00667862|584333819|FG000|Overall Study|Disease Progression|22|||
161805723|NCT00667862|584333819|FG000|Overall Study|Withdrawal by Subject|3|||
161453261|NCT00313781|583053607|FG001|Before Crossover|Crossover|37|||
161453262|NCT00313781|583053608|FG002|Before Crossover|Crossover|0|||
161453263|NCT00313781|583053606|FG000|Before Crossover|Randomized, not treated|5|||
161453264|NCT00313781|583053607|FG001|Before Crossover|Randomized, not treated|0|||
161453265|NCT00313781|583053608|FG002|Before Crossover|Randomized, not treated|0|||
161453266|NCT00313781|583053606|FG000|After Crossover|Death|0|||
161805724|NCT00667095|584333823|FG000|Overall Study|Withdrawal by Subject|0|||
161805725|NCT00667095|584333824|FG001|Overall Study|Withdrawal by Subject|1|||
161805726|NCT01520909|584333825|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
161805727|NCT01520909|584333826|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
161805728|NCT01520909|584333827|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
161805729|NCT01520909|584333825|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
161805730|NCT01520909|584333826|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
161805731|NCT01520909|584333827|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
161805732|NCT01520909|584333825|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
161805733|NCT01520909|584333826|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
161805734|NCT01520909|584333827|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
161805735|NCT01520909|584333825|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
161805736|NCT01520909|584333826|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
161805737|NCT01520909|584333827|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
161805738|NCT01435265|584333829|FG000|Overall Study|Lost to Follow-up|0|||
161805739|NCT01435265|584333830|FG001|Overall Study|Lost to Follow-up|1|||
161805740|NCT01149473|584333831|FG000|First Intervention|Adverse Event|1|||
161805741|NCT01149473|584333832|FG001|First Intervention|Adverse Event|1|||
161805742|NCT01149473|584333831|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161805743|NCT01149473|584333832|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161805744|NCT02128997|584333833|FG000|Overall Study|Lost to Follow-up|6|||
161805745|NCT02128997|584333834|FG001|Overall Study|Lost to Follow-up|11|||
161805746|NCT00856388|584333844|FG000|Overall Study|Other|1|||
161805747|NCT05038293|584333845|FG000|Overall Study|device was not operating properly for one subject.|1|||
161805748|NCT05038293|584333846|FG001|Overall Study|device was not operating properly for one subject.|0|||
161805749|NCT05038293|584333845|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
161805750|NCT05038293|584333846|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
161805751|NCT01171989|584333848|FG000|Overall Study|Lost to Follow-up|0|||
161805752|NCT01171989|584333849|FG001|Overall Study|Lost to Follow-up|0|||
161805753|NCT01171989|584333850|FG002|Overall Study|Lost to Follow-up|1|||
161805754|NCT00418184|584333851|FG000|Double-blind Phase|Withdrawal by Subject|22|||
161805755|NCT00418184|584333852|FG001|Double-blind Phase|Withdrawal by Subject|9|||
161805756|NCT00418184|584333851|FG000|Double-blind Phase|Adverse Event|2|||
161805757|NCT00418184|584333852|FG001|Double-blind Phase|Adverse Event|1|||
161805758|NCT00418184|584333851|FG000|Double-blind Phase|Poor compliance|3|||
161805759|NCT00418184|584333852|FG001|Double-blind Phase|Poor compliance|1|||
161805760|NCT00620074|584333854|FG000|Overall Study|Adverse Event|1|||
161805761|NCT01247701|584333856|FG000|Overall Study|Death|2|||
161805762|NCT01247701|584333856|FG000|Overall Study|Relapsed|8|||
161805763|NCT04166630|584333857|FG000|Overall Study|Withdrawal by Subject|0|||
161805764|NCT04166630|584333858|FG001|Overall Study|Withdrawal by Subject|1|||
161805765|NCT02822235|584333859|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
161805766|NCT02822235|584333860|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
161805767|NCT02822235|584333859|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
161805768|NCT02822235|584333860|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
161805769|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
161805770|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
161805771|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
161805772|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
161805773|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
161805774|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
161453267|NCT00313781|583053607|FG001|After Crossover|Death|0|||
161453268|NCT00313781|583053608|FG002|After Crossover|Death|6|||
161805775|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
161805776|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
161453269|NCT00313781|583053606|FG000|After Crossover|Withdrawal by Subject|0|||
161805777|NCT01038856|584333863|FG000|Overall Study|Adverse Event|2|||
161805778|NCT04638153|584333864|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161453270|NCT00313781|583053607|FG001|After Crossover|Withdrawal by Subject|0|||
161805779|NCT04638153|584333865|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161805780|NCT04638153|584333866|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161805781|NCT04638153|584333864|FG000|Overall Study|Study terminated by sponsor|4|||
161805782|NCT04638153|584333865|FG001|Overall Study|Study terminated by sponsor|2|||
161805783|NCT04638153|584333866|FG002|Overall Study|Study terminated by sponsor|14|||
161805784|NCT01440283|584333867|FG000|Overall Study|Death|3|||
161805785|NCT01440283|584333867|FG000|Overall Study|Withdrawal by Subject|4|||
161805786|NCT01440283|584333867|FG000|Overall Study|Physician Decision|3|||
161805787|NCT01196052|584333868|FG000|Overall Study|Adverse Event|9|||
161805788|NCT01196052|584333868|FG000|Overall Study|Lost to Follow-up|1|||
161805789|NCT01196052|584333868|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
161805790|NCT01196052|584333868|FG000|Overall Study|Reason not Specified|5|||
161805791|NCT01196052|584333868|FG000|Overall Study|Withdrawal by Subject|6|||
161805792|NCT01389102|584333869|FG000|Overall Study|Adverse Event|1|||
161805793|NCT01389102|584333870|FG001|Overall Study|Adverse Event|3|||
161805794|NCT01389102|584333871|FG002|Overall Study|Adverse Event|2|||
161805795|NCT01389102|584333872|FG003|Overall Study|Adverse Event|2|||
161805796|NCT01389102|584333873|FG004|Overall Study|Adverse Event|2|||
161805797|NCT01389102|584333874|FG005|Overall Study|Adverse Event|2|||
161805798|NCT01389102|584333869|FG000|Overall Study|Hurricane Katrina|4|||
161805799|NCT01389102|584333870|FG001|Overall Study|Hurricane Katrina|2|||
161805800|NCT01389102|584333871|FG002|Overall Study|Hurricane Katrina|3|||
161805801|NCT01389102|584333872|FG003|Overall Study|Hurricane Katrina|0|||
161805802|NCT01389102|584333873|FG004|Overall Study|Hurricane Katrina|3|||
161805803|NCT01389102|584333874|FG005|Overall Study|Hurricane Katrina|1|||
161805804|NCT01389102|584333869|FG000|Overall Study|Lost to Follow-up|4|||
161805805|NCT01389102|584333870|FG001|Overall Study|Lost to Follow-up|1|||
161805806|NCT01389102|584333871|FG002|Overall Study|Lost to Follow-up|1|||
161805807|NCT01389102|584333872|FG003|Overall Study|Lost to Follow-up|2|||
161805808|NCT01389102|584333873|FG004|Overall Study|Lost to Follow-up|4|||
161805809|NCT01389102|584333874|FG005|Overall Study|Lost to Follow-up|1|||
161805810|NCT01389102|584333869|FG000|Overall Study|Protocol Violation|0|||
161805811|NCT01389102|584333870|FG001|Overall Study|Protocol Violation|0|||
161805812|NCT01389102|584333871|FG002|Overall Study|Protocol Violation|3|||
161805813|NCT01389102|584333872|FG003|Overall Study|Protocol Violation|0|||
161805814|NCT01389102|584333873|FG004|Overall Study|Protocol Violation|1|||
161805815|NCT01389102|584333874|FG005|Overall Study|Protocol Violation|1|||
161805816|NCT01389102|584333869|FG000|Overall Study|Withdrawal by Subject|7|||
161805817|NCT01389102|584333870|FG001|Overall Study|Withdrawal by Subject|4|||
161805818|NCT01389102|584333871|FG002|Overall Study|Withdrawal by Subject|9|||
161805819|NCT01389102|584333872|FG003|Overall Study|Withdrawal by Subject|2|||
161805820|NCT01389102|584333873|FG004|Overall Study|Withdrawal by Subject|3|||
161805821|NCT01389102|584333874|FG005|Overall Study|Withdrawal by Subject|3|||
161805822|NCT01389102|584333869|FG000|Overall Study|Subject Traveling Out of Country|0|||
161805823|NCT01389102|584333870|FG001|Overall Study|Subject Traveling Out of Country|0|||
161805824|NCT01389102|584333871|FG002|Overall Study|Subject Traveling Out of Country|0|||
161805825|NCT01389102|584333872|FG003|Overall Study|Subject Traveling Out of Country|1|||
161805826|NCT01389102|584333873|FG004|Overall Study|Subject Traveling Out of Country|0|||
161805827|NCT01389102|584333874|FG005|Overall Study|Subject Traveling Out of Country|0|||
161805828|NCT01389102|584333869|FG000|Overall Study|Subject Moved|2|||
161805829|NCT01389102|584333870|FG001|Overall Study|Subject Moved|0|||
161805830|NCT01389102|584333871|FG002|Overall Study|Subject Moved|1|||
161805831|NCT01389102|584333872|FG003|Overall Study|Subject Moved|0|||
161805832|NCT01389102|584333873|FG004|Overall Study|Subject Moved|0|||
161805833|NCT01389102|584333874|FG005|Overall Study|Subject Moved|0|||
161805834|NCT01389102|584333869|FG000|Overall Study|Unavailable due to husband's illness|0|||
161805835|NCT01389102|584333870|FG001|Overall Study|Unavailable due to husband's illness|1|||
161805836|NCT01389102|584333871|FG002|Overall Study|Unavailable due to husband's illness|0|||
161805837|NCT01389102|584333872|FG003|Overall Study|Unavailable due to husband's illness|0|||
161805838|NCT01389102|584333873|FG004|Overall Study|Unavailable due to husband's illness|0|||
161805839|NCT01389102|584333874|FG005|Overall Study|Unavailable due to husband's illness|0|||
161805840|NCT01389102|584333869|FG000|Overall Study|Investigator Judgement|0|||
161805841|NCT01389102|584333870|FG001|Overall Study|Investigator Judgement|1|||
161805842|NCT01389102|584333871|FG002|Overall Study|Investigator Judgement|0|||
161805843|NCT01389102|584333872|FG003|Overall Study|Investigator Judgement|0|||
161805844|NCT01389102|584333873|FG004|Overall Study|Investigator Judgement|0|||
161805845|NCT01389102|584333874|FG005|Overall Study|Investigator Judgement|0|||
161805846|NCT00050778|584333875|FG000|Overall Study|Adverse Event|13|||
161805847|NCT00050778|584333876|FG001|Overall Study|Adverse Event|3|||
161805848|NCT00050778|584333877|FG002|Overall Study|Adverse Event|2|||
161805849|NCT00050778|584333875|FG000|Overall Study|Death|0|||
161805850|NCT00050778|584333876|FG001|Overall Study|Death|1|||
161805851|NCT00050778|584333877|FG002|Overall Study|Death|1|||
161805852|NCT00050778|584333875|FG000|Overall Study|Lack of Efficacy|16|||
161805853|NCT00050778|584333876|FG001|Overall Study|Lack of Efficacy|2|||
161805854|NCT00050778|584333877|FG002|Overall Study|Lack of Efficacy|2|||
161805855|NCT00050778|584333875|FG000|Overall Study|Lost to Follow-up|0|||
161909361|NCT02065557|584721381|FG001|Maintenance Period|Subject Non-Compliance|0|||
161909362|NCT02065557|584721382|FG002|Maintenance Period|Subject Non-Compliance|0|||
161909363|NCT02065557|584721383|FG003|Maintenance Period|Subject Non-Compliance|0|||
161909364|NCT02065557|584721384|FG004|Maintenance Period|Subject Non-Compliance|0|||
161909365|NCT02065557|584721385|FG005|Maintenance Period|Subject Non-Compliance|1|||
161909366|NCT01462942|584721389|FG000|Overall Study|Adverse Event|7|||
161561292|NCT04529538|583442097|FG004|Overall Study|Lost to Follow-up|1|||
161805856|NCT00050778|584333876|FG001|Overall Study|Lost to Follow-up|2|||
161909367|NCT01462942|584721390|FG001|Overall Study|Adverse Event|12|||
161909368|NCT01462942|584721391|FG002|Overall Study|Adverse Event|10|||
161909369|NCT01462942|584721392|FG003|Overall Study|Adverse Event|11|||
161909370|NCT01462942|584721393|FG004|Overall Study|Adverse Event|11|||
161909371|NCT01462942|584721389|FG000|Overall Study|Other, including COPD exacerbation|3|||
161909372|NCT01462942|584721390|FG001|Overall Study|Other, including COPD exacerbation|5|||
161909373|NCT01462942|584721391|FG002|Overall Study|Other, including COPD exacerbation|2|||
161909374|NCT01462942|584721392|FG003|Overall Study|Other, including COPD exacerbation|8|||
161909375|NCT01462942|584721393|FG004|Overall Study|Other, including COPD exacerbation|5|||
161909376|NCT01462942|584721389|FG000|Overall Study|Withdrawal by Subject|14|||
161909377|NCT01462942|584721390|FG001|Overall Study|Withdrawal by Subject|10|||
161805857|NCT00050778|584333877|FG002|Overall Study|Lost to Follow-up|4|||
161805858|NCT00050778|584333875|FG000|Overall Study|Physician Decision|3|||
161805859|NCT00050778|584333876|FG001|Overall Study|Physician Decision|0|||
161805860|NCT00050778|584333877|FG002|Overall Study|Physician Decision|2|||
161805861|NCT00050778|584333875|FG000|Overall Study|Protocol Violation|2|||
161805862|NCT00050778|584333876|FG001|Overall Study|Protocol Violation|0|||
161805863|NCT00050778|584333877|FG002|Overall Study|Protocol Violation|1|||
161805864|NCT00050778|584333875|FG000|Overall Study|Withdrawal by Subject|6|||
161805865|NCT00050778|584333876|FG001|Overall Study|Withdrawal by Subject|8|||
161805866|NCT00050778|584333877|FG002|Overall Study|Withdrawal by Subject|4|||
161805867|NCT00050778|584333875|FG000|Overall Study|Randomized but not treated|4|||
161805868|NCT00050778|584333876|FG001|Overall Study|Randomized but not treated|5|||
161805869|NCT00050778|584333877|FG002|Overall Study|Randomized but not treated|2|||
161805870|NCT00050778|584333875|FG000|Overall Study|Familial and personal reasons|1|||
161805871|NCT00050778|584333876|FG001|Overall Study|Familial and personal reasons|0|||
161805872|NCT00050778|584333877|FG002|Overall Study|Familial and personal reasons|0|||
161805873|NCT01661686|584333879|FG000|Overall Study|Lost to Follow-up|2|||
161805874|NCT01661686|584333880|FG001|Overall Study|Lost to Follow-up|1|||
161805875|NCT01661686|584333879|FG000|Overall Study|did not receive allocated intervention|0|||
161805876|NCT01661686|584333880|FG001|Overall Study|did not receive allocated intervention|1|||
161805877|NCT01720264|584333885|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
161805878|NCT01720264|584333885|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
161805879|NCT01720264|584333885|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
161805880|NCT04869787|584333886|FG000|Screening|Physician Decision|1|||
161805881|NCT04869787|584333886|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
161805882|NCT02914600|584333887|FG000|Overall Study|Adverse Event|298|||
161805883|NCT02914600|584333888|FG001|Overall Study|Adverse Event|35|||
161805884|NCT02914600|584333889|FG002|Overall Study|Adverse Event|25|||
161805885|NCT02914600|584333887|FG000|Overall Study|Sponsors decision|287|||
161805886|NCT02914600|584333888|FG001|Overall Study|Sponsors decision|41|||
161805887|NCT02914600|584333889|FG002|Overall Study|Sponsors decision|12|||
161805888|NCT02914600|584333887|FG000|Overall Study|Withdrawal by Subject|158|||
161805889|NCT02914600|584333888|FG001|Overall Study|Withdrawal by Subject|20|||
161805890|NCT02914600|584333889|FG002|Overall Study|Withdrawal by Subject|18|||
161805891|NCT02914600|584333887|FG000|Overall Study|Investigators discretion|169|||
161805892|NCT02914600|584333888|FG001|Overall Study|Investigators discretion|14|||
161805893|NCT02914600|584333889|FG002|Overall Study|Investigators discretion|13|||
161805894|NCT02914600|584333887|FG000|Overall Study|Lost to Follow-up|10|||
161805895|NCT02914600|584333888|FG001|Overall Study|Lost to Follow-up|4|||
161805896|NCT02914600|584333889|FG002|Overall Study|Lost to Follow-up|0|||
161805897|NCT02914600|584333887|FG000|Overall Study|Pregnancy|8|||
161805898|NCT02914600|584333888|FG001|Overall Study|Pregnancy|0|||
161805899|NCT02914600|584333889|FG002|Overall Study|Pregnancy|0|||
161805900|NCT02914600|584333887|FG000|Overall Study|Protocol Violation|5|||
161805901|NCT02914600|584333888|FG001|Overall Study|Protocol Violation|3|||
161805902|NCT02914600|584333889|FG002|Overall Study|Protocol Violation|0|||
161805903|NCT02914600|584333887|FG000|Overall Study|Non-compliance with study drug|6|||
161805904|NCT02914600|584333888|FG001|Overall Study|Non-compliance with study drug|1|||
161909378|NCT01462942|584721391|FG002|Overall Study|Withdrawal by Subject|14|||
161909379|NCT01462942|584721392|FG003|Overall Study|Withdrawal by Subject|16|||
161909380|NCT01462942|584721393|FG004|Overall Study|Withdrawal by Subject|19|||
161805905|NCT02914600|584333889|FG002|Overall Study|Non-compliance with study drug|0|||
161805906|NCT02914600|584333887|FG000|Overall Study|Death|3|||
161805907|NCT02914600|584333888|FG001|Overall Study|Death|1|||
161805908|NCT02914600|584333889|FG002|Overall Study|Death|1|||
161909381|NCT01462942|584721389|FG000|Overall Study|Lack of Efficacy|6|||
161909382|NCT01462942|584721390|FG001|Overall Study|Lack of Efficacy|0|||
161909383|NCT01462942|584721391|FG002|Overall Study|Lack of Efficacy|4|||
161909384|NCT01462942|584721392|FG003|Overall Study|Lack of Efficacy|5|||
161909385|NCT01462942|584721393|FG004|Overall Study|Lack of Efficacy|3|||
161909386|NCT01462942|584721389|FG000|Overall Study|Lost to Follow-up|0|||
161909387|NCT01462942|584721390|FG001|Overall Study|Lost to Follow-up|1|||
161909388|NCT01462942|584721391|FG002|Overall Study|Lost to Follow-up|1|||
161909389|NCT01462942|584721392|FG003|Overall Study|Lost to Follow-up|1|||
161909390|NCT01462942|584721393|FG004|Overall Study|Lost to Follow-up|1|||
161909391|NCT01462942|584721389|FG000|Overall Study|Protocol Violation|4|||
161909392|NCT01462942|584721390|FG001|Overall Study|Protocol Violation|6|||
161909393|NCT01462942|584721391|FG002|Overall Study|Protocol Violation|9|||
161561293|NCT04529538|583442098|FG005|Overall Study|Lost to Follow-up|1|||
161561294|NCT04529538|583442099|FG006|Overall Study|Lost to Follow-up|2|||
161561295|NCT04529538|583442100|FG007|Overall Study|Lost to Follow-up|0|||
161561296|NCT04529538|583442093|FG000|Overall Study|Not eligible at enrollment|0|||
161561297|NCT04529538|583442094|FG001|Overall Study|Not eligible at enrollment|1|||
161561298|NCT04529538|583442095|FG002|Overall Study|Not eligible at enrollment|2|||
161561299|NCT04529538|583442096|FG003|Overall Study|Not eligible at enrollment|1|||
161561300|NCT04529538|583442097|FG004|Overall Study|Not eligible at enrollment|0|||
161909394|NCT01462942|584721392|FG003|Overall Study|Protocol Violation|9|||
161909395|NCT01462942|584721393|FG004|Overall Study|Protocol Violation|6|||
161909396|NCT01026493|584721394|FG000|Overall Study|Protocol Violation|0|||
161909397|NCT01026493|584721395|FG001|Overall Study|Protocol Violation|1|||
161909398|NCT01026493|584721396|FG002|Overall Study|Protocol Violation|0|||
161909399|NCT01026493|584721397|FG003|Overall Study|Protocol Violation|0|||
161909400|NCT01026493|584721398|FG004|Overall Study|Protocol Violation|2|||
161909401|NCT01026493|584721399|FG005|Overall Study|Protocol Violation|3|||
161909402|NCT01026493|584721400|FG006|Overall Study|Protocol Violation|4|||
161909403|NCT01026493|584721401|FG007|Overall Study|Protocol Violation|1|||
161909404|NCT02662569|584721402|FG000|Overall Study|Withdrawal by Subject|6|||
161909405|NCT02662569|584721403|FG001|Overall Study|Withdrawal by Subject|1|||
161909406|NCT02662569|584721404|FG002|Overall Study|Withdrawal by Subject|6|||
161909407|NCT02662569|584721405|FG003|Overall Study|Withdrawal by Subject|4|||
161909408|NCT02662569|584721402|FG000|Overall Study|Lost to Follow-up|1|||
161909409|NCT02662569|584721403|FG001|Overall Study|Lost to Follow-up|0|||
161909410|NCT02662569|584721404|FG002|Overall Study|Lost to Follow-up|0|||
161909411|NCT02662569|584721405|FG003|Overall Study|Lost to Follow-up|0|||
161909412|NCT03154086|584721406|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909413|NCT03154086|584721407|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909414|NCT03154086|584721408|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909415|NCT03154086|584721409|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
161909416|NCT03154086|584721410|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909417|NCT03154086|584721411|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909418|NCT03154086|584721412|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909419|NCT03154086|584721413|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909420|NCT03154086|584721414|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909421|NCT03154086|584721415|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909422|NCT03154086|584721416|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909423|NCT03154086|584721417|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909424|NCT03154086|584721418|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909425|NCT03154086|584721419|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909426|NCT03154086|584721420|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909427|NCT03154086|584721406|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909428|NCT03154086|584721407|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
161909429|NCT03154086|584721408|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909430|NCT03154086|584721409|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909431|NCT03154086|584721410|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909432|NCT03154086|584721411|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909433|NCT03154086|584721412|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909434|NCT03154086|584721413|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909435|NCT03154086|584721414|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909436|NCT03154086|584721415|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909437|NCT03154086|584721416|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909438|NCT03154086|584721417|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909439|NCT03154086|584721418|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909440|NCT03154086|584721419|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909441|NCT03154086|584721420|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909442|NCT03154086|584721406|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909443|NCT03154086|584721407|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909444|NCT03154086|584721408|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
161909445|NCT03154086|584721409|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909446|NCT03154086|584721410|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909447|NCT03154086|584721411|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161805909|NCT02914600|584333887|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
161805910|NCT02914600|584333888|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
161561301|NCT04529538|583442098|FG005|Overall Study|Not eligible at enrollment|0|||
161561302|NCT04529538|583442099|FG006|Overall Study|Not eligible at enrollment|0|||
161561303|NCT04529538|583442100|FG007|Overall Study|Not eligible at enrollment|1|||
161561304|NCT04529538|583442093|FG000|Overall Study|Withdrawal by Subject|0|||
161561305|NCT04529538|583442094|FG001|Overall Study|Withdrawal by Subject|1|||
161561306|NCT04529538|583442095|FG002|Overall Study|Withdrawal by Subject|1|||
161561307|NCT04529538|583442096|FG003|Overall Study|Withdrawal by Subject|2|||
161805911|NCT02914600|584333889|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
161805912|NCT02914600|584333887|FG000|Overall Study|Enrolled but not treated|1|||
161805913|NCT02914600|584333888|FG001|Overall Study|Enrolled but not treated|0|||
161805914|NCT02914600|584333889|FG002|Overall Study|Enrolled but not treated|0|||
161805915|NCT02996682|584333890|FG000|Overall Study|Death|0|||
161805916|NCT02996682|584333891|FG001|Overall Study|Death|3|||
161805917|NCT02457520|584333892|FG000|Active Treatment Phase|Adverse Event|10|||
161805918|NCT02457520|584333892|FG000|Active Treatment Phase|Lost to Follow-up|8|||
161805919|NCT02457520|584333892|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
161805920|NCT02457520|584333892|FG000|Active Treatment Phase|other|4|||
161805921|NCT02457520|584333892|FG000|Active Treatment Phase|Physician Decision|1|||
161805922|NCT02457520|584333892|FG000|Active Treatment Phase|Protocol Violation|1|||
161805923|NCT02457520|584333892|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
161805924|NCT02457520|584333892|FG000|Post-treatment Period|Other: Retreatment Required|7|||
161805925|NCT02457520|584333892|FG000|Post-treatment Period|Lost to Follow-up|23|||
161805926|NCT02457520|584333892|FG000|Post-treatment Period|Other|3|||
161805927|NCT02457520|584333892|FG000|Post-treatment Period|Physician Decision|1|||
161805928|NCT02457520|584333892|FG000|Post-treatment Period|Withdrawal by Subject|14|||
161805929|NCT02511782|584333895|FG000|Overall Study|Withdrawal by Subject|1|||
161805930|NCT02511782|584333896|FG001|Overall Study|Withdrawal by Subject|0|||
161805931|NCT02511782|584333897|FG002|Overall Study|Withdrawal by Subject|0|||
161805932|NCT00579670|584333898|FG000|Overall Study|Death|1|||
161805933|NCT00579670|584333899|FG001|Overall Study|Death|0|||
161805934|NCT00579670|584333900|FG002|Overall Study|Death|0|||
161805935|NCT00579670|584333901|FG003|Overall Study|Death|0|||
161805936|NCT00579670|584333902|FG004|Overall Study|Death|0|||
161805937|NCT00579670|584333898|FG000|Overall Study|Adverse Event|1|||
161805938|NCT00579670|584333899|FG001|Overall Study|Adverse Event|0|||
161805939|NCT00579670|584333900|FG002|Overall Study|Adverse Event|1|||
161805940|NCT00579670|584333901|FG003|Overall Study|Adverse Event|2|||
161805941|NCT00579670|584333902|FG004|Overall Study|Adverse Event|0|||
161805942|NCT00579670|584333898|FG000|Overall Study|Lack of Efficacy|0|||
161805943|NCT00579670|584333899|FG001|Overall Study|Lack of Efficacy|0|||
161805944|NCT00579670|584333900|FG002|Overall Study|Lack of Efficacy|1|||
161805945|NCT00579670|584333901|FG003|Overall Study|Lack of Efficacy|14|||
161805946|NCT00579670|584333902|FG004|Overall Study|Lack of Efficacy|0|||
161805947|NCT00579670|584333898|FG000|Overall Study|Lost to Follow-up|0|||
161805948|NCT00579670|584333899|FG001|Overall Study|Lost to Follow-up|1|||
161805949|NCT00579670|584333900|FG002|Overall Study|Lost to Follow-up|0|||
161805950|NCT00579670|584333901|FG003|Overall Study|Lost to Follow-up|4|||
161805951|NCT00579670|584333902|FG004|Overall Study|Lost to Follow-up|0|||
161805952|NCT00579670|584333898|FG000|Overall Study|Other|0|||
161805953|NCT00579670|584333899|FG001|Overall Study|Other|0|||
161805954|NCT00579670|584333900|FG002|Overall Study|Other|1|||
161805955|NCT00579670|584333901|FG003|Overall Study|Other|2|||
161805956|NCT00579670|584333902|FG004|Overall Study|Other|0|||
161805957|NCT00579670|584333898|FG000|Overall Study|Withdrawal by Subject|0|||
161805958|NCT00579670|584333899|FG001|Overall Study|Withdrawal by Subject|0|||
161805959|NCT00579670|584333900|FG002|Overall Study|Withdrawal by Subject|1|||
161805960|NCT00579670|584333901|FG003|Overall Study|Withdrawal by Subject|0|||
161805961|NCT00579670|584333902|FG004|Overall Study|Withdrawal by Subject|0|||
161805962|NCT00112463|584333903|FG000|Overall Study|Physician Decision|1|||
161805963|NCT00112463|584333903|FG000|Overall Study|Progression|30|||
161805964|NCT00112463|584333903|FG000|Overall Study|Second Primary|1|||
161805965|NCT00112463|584333903|FG000|Overall Study|Toxicity|3|||
161805966|NCT00112463|584333903|FG000|Overall Study|Withdrawal by Subject|2|||
161805967|NCT00112463|584333903|FG000|Overall Study|Never started treatment|2|||
161909448|NCT03154086|584721412|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161561308|NCT04529538|583442097|FG004|Overall Study|Withdrawal by Subject|0|||
161805968|NCT00678639|584333904|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
161805969|NCT00678639|584333905|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
161805970|NCT00870870|584333909|FG000|Overall Study|Withdrawal by Subject|0|||
161805971|NCT00870870|584333910|FG001|Overall Study|Withdrawal by Subject|1|||
161909449|NCT03154086|584721413|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909450|NCT03154086|584721414|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909451|NCT03154086|584721415|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909452|NCT03154086|584721416|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909453|NCT03154086|584721417|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909454|NCT03154086|584721418|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909455|NCT03154086|584721419|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909456|NCT03154086|584721420|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909457|NCT03154086|584721406|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
161909458|NCT03154086|584721407|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909459|NCT03154086|584721408|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909460|NCT03154086|584721409|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909461|NCT03154086|584721410|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909462|NCT03154086|584721411|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909463|NCT03154086|584721412|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909464|NCT03154086|584721413|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909465|NCT03154086|584721414|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909466|NCT03154086|584721415|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909467|NCT03154086|584721416|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909468|NCT03154086|584721417|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909469|NCT03154086|584721418|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909470|NCT03154086|584721419|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909471|NCT03154086|584721420|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909472|NCT03154086|584721406|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909473|NCT03154086|584721407|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909474|NCT03154086|584721408|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909475|NCT03154086|584721409|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909476|NCT03154086|584721410|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909477|NCT03154086|584721411|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909478|NCT03154086|584721412|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909479|NCT03154086|584721413|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909480|NCT03154086|584721414|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
161909481|NCT03154086|584721415|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909482|NCT03154086|584721416|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909483|NCT03154086|584721417|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909484|NCT03154086|584721418|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909485|NCT03154086|584721419|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909486|NCT03154086|584721420|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909487|NCT03154086|584721406|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909488|NCT03154086|584721407|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909489|NCT03154086|584721408|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909490|NCT03154086|584721409|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909491|NCT03154086|584721410|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909492|NCT03154086|584721411|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909493|NCT03154086|584721412|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909494|NCT03154086|584721413|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
161909495|NCT03154086|584721414|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909496|NCT03154086|584721415|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909497|NCT03154086|584721416|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909498|NCT03154086|584721417|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909499|NCT03154086|584721418|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909500|NCT03154086|584721419|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909501|NCT03154086|584721420|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909502|NCT03154086|584721406|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
161909503|NCT03154086|584721407|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
161909504|NCT03154086|584721408|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
161909505|NCT03154086|584721409|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
161909506|NCT03154086|584721410|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
161909507|NCT03154086|584721411|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
161909508|NCT03154086|584721412|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
161909509|NCT03154086|584721413|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
161909510|NCT03154086|584721414|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
161909511|NCT03154086|584721415|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
161909512|NCT03154086|584721416|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
161909513|NCT03154086|584721417|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
161453271|NCT00313781|583053608|FG002|After Crossover|Withdrawal by Subject|3|||
161909514|NCT03154086|584721418|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
161909515|NCT03154086|584721419|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
161909516|NCT03154086|584721420|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
161909517|NCT01701245|584721425|FG000|Overall Study|Protocol Violation|1|||
161909518|NCT01701245|584721426|FG001|Overall Study|Protocol Violation|3|||
161909519|NCT01701245|584721425|FG000|Overall Study|Did not complete the open label period|11|||
161909520|NCT01701245|584721426|FG001|Overall Study|Did not complete the open label period|12|||
161909521|NCT01299584|584721451|FG000|Overall Study|Protocol Violation|9|||
161909522|NCT00572832|584721452|FG000|Overall Study|Lost to Follow-up|0|||
161909523|NCT00572832|584721453|FG001|Overall Study|Lost to Follow-up|11|||
161909524|NCT00572832|584721452|FG000|Overall Study|Pregnancy|0|||
161909525|NCT00572832|584721453|FG001|Overall Study|Pregnancy|1|||
161909526|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
161909527|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909528|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909529|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909530|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909531|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909532|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909533|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
161909534|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909535|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909536|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909537|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909538|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909539|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909540|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909541|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
161909542|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909543|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909544|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161453272|NCT00313781|583053606|FG000|After Crossover|Other|0|||
161805972|NCT00870870|584333911|FG002|Overall Study|Withdrawal by Subject|1|||
161805973|NCT00870870|584333912|FG003|Overall Study|Withdrawal by Subject|3|||
161453273|NCT00313781|583053607|FG001|After Crossover|Other|0|||
161805974|NCT00870870|584333909|FG000|Overall Study|Adverse Event|0|||
161805975|NCT00870870|584333910|FG001|Overall Study|Adverse Event|0|||
161805976|NCT00870870|584333911|FG002|Overall Study|Adverse Event|2|||
161805977|NCT00870870|584333912|FG003|Overall Study|Adverse Event|2|||
161805978|NCT03639311|584333916|FG000|Maintenance Phase|Lost to Follow-up|1|||
161805979|NCT03639311|584333917|FG001|Maintenance Phase|Lost to Follow-up|0|||
161805980|NCT03639311|584333918|FG002|Maintenance Phase|Lost to Follow-up|0|||
161805981|NCT03639311|584333916|FG000|Maintenance Phase|Adverse Event|1|||
161805982|NCT03639311|584333917|FG001|Maintenance Phase|Adverse Event|0|||
161805983|NCT03639311|584333918|FG002|Maintenance Phase|Adverse Event|0|||
161805984|NCT03639311|584333916|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
161805985|NCT03639311|584333917|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
161805986|NCT03639311|584333918|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
161805987|NCT03639311|584333916|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
161805988|NCT03639311|584333917|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
161805989|NCT03639311|584333918|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
161805990|NCT03639311|584333916|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
161805991|NCT03639311|584333917|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161805992|NCT03639311|584333918|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161805993|NCT03639311|584333916|FG000|Maintenance Phase|Lack of Efficacy|1|||
161805994|NCT03639311|584333917|FG001|Maintenance Phase|Lack of Efficacy|0|||
161805995|NCT03639311|584333918|FG002|Maintenance Phase|Lack of Efficacy|0|||
161805996|NCT00822926|584333919|FG000|Second Injection Visit|Lost to Follow-up|1|||
161805997|NCT00822926|584333920|FG001|Second Injection Visit|Lost to Follow-up|0|||
161805998|NCT00822926|584333919|FG000|Second Injection Visit|Withdrawal by Subject|0|||
161805999|NCT00822926|584333920|FG001|Second Injection Visit|Withdrawal by Subject|1|||
161806000|NCT00855738|584333921|FG000|Overall Study|Lost to Follow-up|2|||
161806001|NCT00855738|584333921|FG000|Overall Study|Adverse Event|1|||
161909545|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909546|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909547|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161806002|NCT00855738|584333921|FG000|Overall Study|Subject Defaulted|1|||
161806003|NCT00855738|584333921|FG000|Overall Study|Death|1|||
161806004|NCT03135834|584333922|FG000|Stage 1|Adverse Event|1|||
161806005|NCT03135834|584333923|FG001|Stage 1|Adverse Event|2|||
161453274|NCT00313781|583053608|FG002|After Crossover|Other|18|||
161806006|NCT03135834|584333924|FG002|Stage 1|Adverse Event|2|||
161806007|NCT03135834|584333925|FG003|Stage 1|Adverse Event|1|||
161806008|NCT03135834|584333922|FG000|Stage 1|Death|1|||
161806009|NCT03135834|584333923|FG001|Stage 1|Death|0|||
161806010|NCT03135834|584333924|FG002|Stage 1|Death|0|||
161806011|NCT03135834|584333925|FG003|Stage 1|Death|0|||
161806012|NCT03135834|584333922|FG000|Stage 1|Lost to Follow-up|17|||
161806013|NCT03135834|584333923|FG001|Stage 1|Lost to Follow-up|24|||
161806014|NCT03135834|584333924|FG002|Stage 1|Lost to Follow-up|21|||
161806015|NCT03135834|584333925|FG003|Stage 1|Lost to Follow-up|38|||
161806016|NCT03135834|584333922|FG000|Stage 1|No longer met eligibility criteria|1|||
161806017|NCT03135834|584333923|FG001|Stage 1|No longer met eligibility criteria|6|||
161806018|NCT03135834|584333924|FG002|Stage 1|No longer met eligibility criteria|2|||
161806019|NCT03135834|584333925|FG003|Stage 1|No longer met eligibility criteria|5|||
161806020|NCT03135834|584333922|FG000|Stage 1|Other|0|||
161806021|NCT03135834|584333923|FG001|Stage 1|Other|2|||
161806022|NCT03135834|584333924|FG002|Stage 1|Other|1|||
161806023|NCT03135834|584333925|FG003|Stage 1|Other|0|||
161806024|NCT03135834|584333922|FG000|Stage 1|Physician Decision|0|||
161806025|NCT03135834|584333923|FG001|Stage 1|Physician Decision|1|||
161806026|NCT03135834|584333924|FG002|Stage 1|Physician Decision|0|||
161806027|NCT03135834|584333925|FG003|Stage 1|Physician Decision|0|||
161806028|NCT03135834|584333922|FG000|Stage 1|Pregnancy|0|||
161806029|NCT03135834|584333923|FG001|Stage 1|Pregnancy|4|||
161806030|NCT03135834|584333924|FG002|Stage 1|Pregnancy|2|||
161806031|NCT03135834|584333925|FG003|Stage 1|Pregnancy|4|||
161806032|NCT03135834|584333922|FG000|Stage 1|Protocol Violation|1|||
161806033|NCT03135834|584333923|FG001|Stage 1|Protocol Violation|1|||
161806034|NCT03135834|584333924|FG002|Stage 1|Protocol Violation|2|||
161806035|NCT03135834|584333925|FG003|Stage 1|Protocol Violation|1|||
161806036|NCT03135834|584333922|FG000|Stage 1|Withdrawal by parent/guardian|2|||
161806037|NCT03135834|584333923|FG001|Stage 1|Withdrawal by parent/guardian|10|||
161806038|NCT03135834|584333924|FG002|Stage 1|Withdrawal by parent/guardian|2|||
161806039|NCT03135834|584333925|FG003|Stage 1|Withdrawal by parent/guardian|1|||
161806040|NCT03135834|584333922|FG000|Stage 1|Withdrawal by Subject|16|||
161806041|NCT03135834|584333923|FG001|Stage 1|Withdrawal by Subject|22|||
161806042|NCT03135834|584333924|FG002|Stage 1|Withdrawal by Subject|7|||
161806043|NCT03135834|584333925|FG003|Stage 1|Withdrawal by Subject|10|||
161806044|NCT03135834|584333922|FG000|Stage 1|Randomized but not Vaccinated|0|||
161806045|NCT03135834|584333923|FG001|Stage 1|Randomized but not Vaccinated|3|||
161806046|NCT03135834|584333924|FG002|Stage 1|Randomized but not Vaccinated|1|||
161806047|NCT03135834|584333925|FG003|Stage 1|Randomized but not Vaccinated|6|||
161806048|NCT03135834|584333922|FG000|Stage 2|Lost to Follow-up|0|||
161806049|NCT03135834|584333923|FG001|Stage 2|Lost to Follow-up|1|||
161806050|NCT03135834|584333924|FG002|Stage 2|Lost to Follow-up|0|||
161806051|NCT03135834|584333925|FG003|Stage 2|Lost to Follow-up|0|||
161806052|NCT03135834|584333922|FG000|Stage 2|Withdrawal by Subject|0|||
161806053|NCT03135834|584333923|FG001|Stage 2|Withdrawal by Subject|1|||
161806054|NCT03135834|584333924|FG002|Stage 2|Withdrawal by Subject|0|||
161806055|NCT03135834|584333925|FG003|Stage 2|Withdrawal by Subject|0|||
161806056|NCT03135834|584333922|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
161806057|NCT03135834|584333923|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
161806058|NCT03135834|584333924|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
161806059|NCT03135834|584333925|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
161806060|NCT03135834|584333922|FG000|Stage 2|Did not receive Booster Vaccination|1|||
161806061|NCT03135834|584333923|FG001|Stage 2|Did not receive Booster Vaccination|1|||
161806062|NCT03135834|584333924|FG002|Stage 2|Did not receive Booster Vaccination|0|||
161806063|NCT03135834|584333925|FG003|Stage 2|Did not receive Booster Vaccination|0|||
161806064|NCT00319735|584333926|FG000|Overall Study|Death|2|||
161806065|NCT02421952|584333935|FG000|Overall Study|Diary Not Returned|93|||
161806066|NCT02421952|584333935|FG000|Overall Study|Failed seriation task|13|||
161806067|NCT02421952|584333935|FG000|Overall Study|Subject uncooperative for baseline test|2|||
161806068|NCT02421952|584333935|FG000|Overall Study|Surgery cancelled|1|||
161806069|NCT03262012|584333946|FG000|Overall Study|Withdrawal by Subject|15|||
161806070|NCT03262012|584333947|FG001|Overall Study|Withdrawal by Subject|13|||
161806071|NCT03262012|584333948|FG002|Overall Study|Withdrawal by Subject|8|||
161806072|NCT03262012|584333949|FG003|Overall Study|Withdrawal by Subject|7|||
161806073|NCT03262012|584333946|FG000|Overall Study|Adverse Event|10|||
161806074|NCT03262012|584333947|FG001|Overall Study|Adverse Event|12|||
161806075|NCT03262012|584333948|FG002|Overall Study|Adverse Event|4|||
161806076|NCT03262012|584333949|FG003|Overall Study|Adverse Event|6|||
161806077|NCT03262012|584333946|FG000|Overall Study|Physician Decision|2|||
161806078|NCT03262012|584333947|FG001|Overall Study|Physician Decision|5|||
161806079|NCT03262012|584333948|FG002|Overall Study|Physician Decision|1|||
161806080|NCT03262012|584333949|FG003|Overall Study|Physician Decision|0|||
161806081|NCT03262012|584333946|FG000|Overall Study|Lack of Efficacy|0|||
161806082|NCT03262012|584333947|FG001|Overall Study|Lack of Efficacy|5|||
161806083|NCT03262012|584333948|FG002|Overall Study|Lack of Efficacy|1|||
161806084|NCT03262012|584333949|FG003|Overall Study|Lack of Efficacy|2|||
161806085|NCT03262012|584333946|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
161909548|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161561309|NCT04529538|583442098|FG005|Overall Study|Withdrawal by Subject|2|||
161561310|NCT04529538|583442099|FG006|Overall Study|Withdrawal by Subject|3|||
161561311|NCT04529538|583442100|FG007|Overall Study|Withdrawal by Subject|0|||
161561312|NCT04529538|583442093|FG000|Overall Study|Other|0|||
161806086|NCT03262012|584333947|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
161806087|NCT03262012|584333948|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
161806088|NCT03262012|584333949|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
161806089|NCT00154102|584333952|FG000|Overall Study|investigational study phase ongoing|7|||
161806090|NCT00154102|584333953|FG001|Overall Study|investigational study phase ongoing|2|||
161806091|NCT02865122|584333954|FG000|Overall Study|Adverse Event|1|||
161806092|NCT02865122|584333955|FG001|Overall Study|Adverse Event|0|||
161806093|NCT02865122|584333956|FG002|Overall Study|Adverse Event|0|||
161806094|NCT02422264|584335831|FG000|Overall Study|Serious Adverse Event|1|||
161806095|NCT02422264|584335832|FG001|Overall Study|Serious Adverse Event|0|||
161806096|NCT02422264|584335831|FG000|Overall Study|Withdrawal by Subject|1|||
161806097|NCT02422264|584335832|FG001|Overall Study|Withdrawal by Subject|2|||
161806098|NCT02422264|584335831|FG000|Overall Study|Migrated/moved from study area|3|||
161806099|NCT02422264|584335832|FG001|Overall Study|Migrated/moved from study area|1|||
161806100|NCT02422264|584335831|FG000|Overall Study|Subject vaccinated outside of the study|0|||
161806101|NCT02422264|584335832|FG001|Overall Study|Subject vaccinated outside of the study|1|||
161806102|NCT03021018|584335833|FG000|Overall Study|Adverse Event|1|||
161806103|NCT03021018|584335834|FG001|Overall Study|Adverse Event|0|||
161806104|NCT03021018|584335835|FG002|Overall Study|Adverse Event|0|||
161806105|NCT03021018|584335833|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
161806106|NCT03021018|584335834|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
161806107|NCT03021018|584335835|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
161806108|NCT04123548|584335838|FG000|Overall Study|Withdrawal by Subject|1|||
161806109|NCT04123548|584335838|FG000|Overall Study|Lost to Follow-up|8|||
161806110|NCT04123548|584335838|FG000|Overall Study|Death|4|||
161806111|NCT04123548|584335838|FG000|Overall Study|Reason Not Specified|1|||
161806112|NCT04112823|584335841|FG000|Overall Study|Lost to Follow-up|2|||
161806113|NCT04112823|584335842|FG001|Overall Study|Lost to Follow-up|3|||
161806114|NCT03603314|584335845|FG000|Overall Study|Lost to Follow-up|0|||
161806115|NCT03603314|584335846|FG001|Overall Study|Lost to Follow-up|3|||
161806116|NCT03603314|584335847|FG002|Overall Study|Lost to Follow-up|0|||
161806117|NCT03603314|584335845|FG000|Overall Study|Protocol Violation|0|||
161806118|NCT03603314|584335846|FG001|Overall Study|Protocol Violation|1|||
161806119|NCT03603314|584335847|FG002|Overall Study|Protocol Violation|0|||
161806120|NCT03603314|584335845|FG000|Overall Study|Adverse Event|2|||
161806121|NCT03603314|584335846|FG001|Overall Study|Adverse Event|0|||
161806122|NCT03603314|584335847|FG002|Overall Study|Adverse Event|0|||
161806123|NCT03603314|584335845|FG000|Overall Study|Physician Decision|1|||
161806124|NCT03603314|584335846|FG001|Overall Study|Physician Decision|1|||
161806125|NCT03603314|584335847|FG002|Overall Study|Physician Decision|0|||
161806126|NCT03603314|584335845|FG000|Overall Study|Withdrawal by Subject|4|||
161806127|NCT03603314|584335846|FG001|Overall Study|Withdrawal by Subject|5|||
161806128|NCT03603314|584335847|FG002|Overall Study|Withdrawal by Subject|3|||
161806129|NCT03603314|584335845|FG000|Overall Study|Other|0|||
161806130|NCT03603314|584335846|FG001|Overall Study|Other|1|||
161806131|NCT03603314|584335847|FG002|Overall Study|Other|0|||
161806132|NCT00436553|584335848|FG000|Overall Study|Adverse Event|4|||
161806133|NCT00436553|584335849|FG001|Overall Study|Adverse Event|3|||
161806134|NCT00436553|584335850|FG002|Overall Study|Adverse Event|4|||
161806135|NCT00436553|584335848|FG000|Overall Study|Death|3|||
161806136|NCT00436553|584335849|FG001|Overall Study|Death|1|||
161806137|NCT00436553|584335850|FG002|Overall Study|Death|3|||
161806138|NCT00436553|584335848|FG000|Overall Study|Lost to Follow-up|0|||
161806139|NCT00436553|584335849|FG001|Overall Study|Lost to Follow-up|2|||
161806140|NCT00436553|584335850|FG002|Overall Study|Lost to Follow-up|0|||
161806141|NCT00436553|584335848|FG000|Overall Study|Protocol Violation|1|||
161806142|NCT00436553|584335849|FG001|Overall Study|Protocol Violation|0|||
161806143|NCT00436553|584335850|FG002|Overall Study|Protocol Violation|0|||
161806144|NCT00436553|584335848|FG000|Overall Study|Withdrawal by Subject|5|||
161806145|NCT00436553|584335849|FG001|Overall Study|Withdrawal by Subject|6|||
161806146|NCT00436553|584335850|FG002|Overall Study|Withdrawal by Subject|3|||
161806147|NCT00625443|584335859|FG000|Overall Study|Adverse Event|1|||
161909549|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
161909550|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161561313|NCT04529538|583442094|FG001|Overall Study|Other|1|||
161561314|NCT04529538|583442095|FG002|Overall Study|Other|0|||
161561315|NCT04529538|583442096|FG003|Overall Study|Other|0|||
161806148|NCT00625443|584335860|FG001|Overall Study|Adverse Event|4|||
161806149|NCT00625443|584335861|FG002|Overall Study|Adverse Event|0|||
161806150|NCT00625443|584335859|FG000|Overall Study|Non-compliance with protocol|0|||
161806151|NCT00625443|584335860|FG001|Overall Study|Non-compliance with protocol|1|||
161806152|NCT00625443|584335861|FG002|Overall Study|Non-compliance with protocol|0|||
161806153|NCT00625443|584335859|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
161561316|NCT04529538|583442097|FG004|Overall Study|Other|0|||
161561317|NCT04529538|583442098|FG005|Overall Study|Other|0|||
161561318|NCT04529538|583442099|FG006|Overall Study|Other|0|||
161561319|NCT04529538|583442100|FG007|Overall Study|Other|0|||
161561320|NCT04529538|583442093|FG000|Overall Study|Adverse Event|0|||
161561321|NCT04529538|583442094|FG001|Overall Study|Adverse Event|0|||
161806154|NCT00625443|584335860|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
161806155|NCT00625443|584335861|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
161806156|NCT00625443|584335859|FG000|Overall Study|Withdrawal by Subject|0|||
161806157|NCT00625443|584335860|FG001|Overall Study|Withdrawal by Subject|1|||
161806158|NCT00625443|584335861|FG002|Overall Study|Withdrawal by Subject|2|||
161806159|NCT00625443|584335859|FG000|Overall Study|Physician Decision|0|||
161806160|NCT00625443|584335860|FG001|Overall Study|Physician Decision|4|||
161806161|NCT00625443|584335861|FG002|Overall Study|Physician Decision|2|||
161806162|NCT00625443|584335859|FG000|Overall Study|Other|0|||
161806163|NCT00625443|584335860|FG001|Overall Study|Other|1|||
161806164|NCT00625443|584335861|FG002|Overall Study|Other|1|||
161806165|NCT02015390|584335862|FG000|Overall Study|Lost to Follow-up|1|||
161806166|NCT02015390|584335863|FG001|Overall Study|Lost to Follow-up|0|||
161806167|NCT02015390|584335862|FG000|Overall Study|Adverse Event|0|||
161806168|NCT02015390|584335863|FG001|Overall Study|Adverse Event|3|||
161806169|NCT02015390|584335862|FG000|Overall Study|Physician Decision|0|||
161806170|NCT02015390|584335863|FG001|Overall Study|Physician Decision|1|||
161806171|NCT00064753|584335866|FG000|Overall Study|Death|251|||
161806172|NCT00064753|584335867|FG001|Overall Study|Death|242|||
161806173|NCT00064753|584335866|FG000|Overall Study|Withdrawal by Subject|198|||
161806174|NCT00064753|584335867|FG001|Overall Study|Withdrawal by Subject|171|||
161806175|NCT00064753|584335866|FG000|Overall Study|Lost to Follow-up|225|||
161806176|NCT00064753|584335867|FG001|Overall Study|Lost to Follow-up|235|||
161806177|NCT02193880|584335868|FG000|Overall Study|patients did not collect enough HPC|3|||
161806178|NCT03136380|584335869|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806179|NCT03136380|584335870|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
161806180|NCT03136380|584335871|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806181|NCT03136380|584335872|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806182|NCT03136380|584335873|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806183|NCT02728102|584335877|FG000|Overall Study|Death|3|||
161806184|NCT02728102|584335878|FG001|Overall Study|Death|0|||
161806185|NCT02728102|584335879|FG002|Overall Study|Death|1|||
161806186|NCT02728102|584335877|FG000|Overall Study|Withdrawal by Subject|0|||
161806187|NCT02728102|584335878|FG001|Overall Study|Withdrawal by Subject|2|||
161806188|NCT02728102|584335879|FG002|Overall Study|Withdrawal by Subject|3|||
161806189|NCT02728102|584335877|FG000|Overall Study|Physician Decision|1|||
161806190|NCT02728102|584335878|FG001|Overall Study|Physician Decision|1|||
161806191|NCT02728102|584335879|FG002|Overall Study|Physician Decision|0|||
161806192|NCT02728102|584335877|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
161806193|NCT02728102|584335878|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
161806194|NCT02728102|584335879|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
161806195|NCT02728102|584335877|FG000|Overall Study|Covid|0|||
161806196|NCT02728102|584335878|FG001|Overall Study|Covid|0|||
161806197|NCT02728102|584335879|FG002|Overall Study|Covid|1|||
161806198|NCT02419937|584335884|FG000|Overall Study|Lost to Follow-up|1|||
161806199|NCT02419937|584335885|FG001|Overall Study|Lost to Follow-up|0|||
161806200|NCT00553280|584335886|FG000|Overall Study|Adverse Event|19|||
161806201|NCT00553280|584335886|FG000|Overall Study|Lack of Efficacy|3|||
161806202|NCT00553280|584335886|FG000|Overall Study|Withdrawal by Subject|3|||
161806203|NCT00553280|584335886|FG000|Overall Study|Physician Decision|1|||
161806204|NCT01182415|584335887|FG000|Overall Study|Lost to Follow-up|1|||
161806205|NCT01544127|584335888|FG000|Overall Study|Lost to Follow-up|4|||
161806206|NCT01544127|584335889|FG001|Overall Study|Lost to Follow-up|2|||
161806207|NCT01544127|584335890|FG002|Overall Study|Lost to Follow-up|9|||
161806208|NCT01544127|584335888|FG000|Overall Study|Withdrawal by Subject|2|||
161806209|NCT01544127|584335889|FG001|Overall Study|Withdrawal by Subject|2|||
161806210|NCT01544127|584335890|FG002|Overall Study|Withdrawal by Subject|1|||
161806211|NCT01544127|584335888|FG000|Overall Study|Discharged out of catchment area|1|||
161806212|NCT01544127|584335889|FG001|Overall Study|Discharged out of catchment area|1|||
161806213|NCT01544127|584335890|FG002|Overall Study|Discharged out of catchment area|1|||
161806214|NCT01544127|584335888|FG000|Overall Study|Death|1|||
161806215|NCT01544127|584335889|FG001|Overall Study|Death|0|||
161806216|NCT01544127|584335890|FG002|Overall Study|Death|0|||
161806217|NCT01544127|584335888|FG000|Overall Study|Jail or Prison|1|||
161561322|NCT04529538|583442095|FG002|Overall Study|Adverse Event|0|||
161561323|NCT04529538|583442096|FG003|Overall Study|Adverse Event|1|||
161561324|NCT04529538|583442097|FG004|Overall Study|Adverse Event|0|||
161806218|NCT01544127|584335889|FG001|Overall Study|Jail or Prison|1|||
161806219|NCT01544127|584335890|FG002|Overall Study|Jail or Prison|2|||
161561325|NCT04529538|583442098|FG005|Overall Study|Adverse Event|0|||
161806220|NCT01544127|584335888|FG000|Overall Study|Became Psychotic|1|||
161561326|NCT04529538|583442099|FG006|Overall Study|Adverse Event|0|||
161561327|NCT04529538|583442100|FG007|Overall Study|Adverse Event|0|||
161561328|NCT04529538|583442093|FG000|Overall Study|Protocol Deviation|0|||
161561329|NCT04529538|583442094|FG001|Overall Study|Protocol Deviation|0|||
161561330|NCT04529538|583442095|FG002|Overall Study|Protocol Deviation|0|||
161806221|NCT01544127|584335889|FG001|Overall Study|Became Psychotic|0|||
161806222|NCT01544127|584335890|FG002|Overall Study|Became Psychotic|0|||
161806223|NCT01544127|584335888|FG000|Overall Study|Researcher withdrew|1|||
161806224|NCT01544127|584335889|FG001|Overall Study|Researcher withdrew|0|||
161806225|NCT01544127|584335890|FG002|Overall Study|Researcher withdrew|0|||
161806226|NCT01544127|584335888|FG000|Overall Study|Went active duty|0|||
161806227|NCT01544127|584335889|FG001|Overall Study|Went active duty|0|||
161806228|NCT01544127|584335890|FG002|Overall Study|Went active duty|1|||
161806229|NCT01256684|584335893|FG000|Overall Study|Adverse Event|1|||
161806230|NCT01256684|584335894|FG001|Overall Study|Adverse Event|4|||
161806231|NCT01256684|584335895|FG002|Overall Study|Adverse Event|2|||
161806232|NCT01256684|584335893|FG000|Overall Study|Withdrawal by Subject|4|||
161806233|NCT01256684|584335894|FG001|Overall Study|Withdrawal by Subject|0|||
161806234|NCT01256684|584335895|FG002|Overall Study|Withdrawal by Subject|2|||
161806235|NCT01256684|584335893|FG000|Overall Study|Physician Decision|0|||
161806236|NCT01256684|584335894|FG001|Overall Study|Physician Decision|1|||
161806237|NCT01256684|584335895|FG002|Overall Study|Physician Decision|0|||
161806238|NCT01256684|584335893|FG000|Overall Study|Lack of Efficacy|0|||
161806239|NCT01256684|584335894|FG001|Overall Study|Lack of Efficacy|1|||
161806240|NCT01256684|584335895|FG002|Overall Study|Lack of Efficacy|1|||
161806241|NCT01256684|584335893|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
161806242|NCT01256684|584335894|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
161806243|NCT01256684|584335895|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
161806244|NCT02587962|584335899|FG000|Overall Study|Adverse Event|0|||
161806245|NCT02587962|584335900|FG001|Overall Study|Adverse Event|0|||
161806246|NCT02587962|584335901|FG002|Overall Study|Adverse Event|1|||
161806247|NCT02587962|584335902|FG003|Overall Study|Adverse Event|0|||
161806248|NCT02587962|584335903|FG004|Overall Study|Adverse Event|0|||
161806249|NCT02587962|584335899|FG000|Overall Study|Withdrawal by Subject|0|||
161806250|NCT02587962|584335900|FG001|Overall Study|Withdrawal by Subject|0|||
161806251|NCT02587962|584335901|FG002|Overall Study|Withdrawal by Subject|1|||
161806252|NCT02587962|584335902|FG003|Overall Study|Withdrawal by Subject|1|||
161806253|NCT02587962|584335903|FG004|Overall Study|Withdrawal by Subject|4|||
161806254|NCT02587962|584335899|FG000|Overall Study|Radiological progression|2|||
161806255|NCT02587962|584335900|FG001|Overall Study|Radiological progression|2|||
161806256|NCT02587962|584335901|FG002|Overall Study|Radiological progression|2|||
161806257|NCT02587962|584335902|FG003|Overall Study|Radiological progression|5|||
161806258|NCT02587962|584335903|FG004|Overall Study|Radiological progression|10|||
161806259|NCT02587962|584335899|FG000|Overall Study|Clinical progression|0|||
161806260|NCT02587962|584335900|FG001|Overall Study|Clinical progression|1|||
161806261|NCT02587962|584335901|FG002|Overall Study|Clinical progression|2|||
161806262|NCT02587962|584335902|FG003|Overall Study|Clinical progression|0|||
161806263|NCT02587962|584335903|FG004|Overall Study|Clinical progression|1|||
161806264|NCT00184600|584335904|FG000|Overall Study|Adverse Event|9|||
161806265|NCT00184600|584335905|FG001|Overall Study|Adverse Event|0|||
161806266|NCT00184600|584335906|FG002|Overall Study|Adverse Event|5|||
161806267|NCT00184600|584335904|FG000|Overall Study|Death|3|||
161806268|NCT00184600|584335905|FG001|Overall Study|Death|9|||
161806269|NCT00184600|584335906|FG002|Overall Study|Death|7|||
161806270|NCT00184600|584335904|FG000|Overall Study|Lack of Efficacy|3|||
161806271|NCT00184600|584335905|FG001|Overall Study|Lack of Efficacy|1|||
161806272|NCT00184600|584335906|FG002|Overall Study|Lack of Efficacy|3|||
161806273|NCT00184600|584335904|FG000|Overall Study|Lost to Follow-up|4|||
161806274|NCT00184600|584335905|FG001|Overall Study|Lost to Follow-up|6|||
161806275|NCT00184600|584335906|FG002|Overall Study|Lost to Follow-up|1|||
161806276|NCT00184600|584335904|FG000|Overall Study|Protocol Violation|2|||
161806277|NCT00184600|584335905|FG001|Overall Study|Protocol Violation|2|||
161806278|NCT00184600|584335906|FG002|Overall Study|Protocol Violation|3|||
161806279|NCT00184600|584335904|FG000|Overall Study|Withdrawal by Subject|20|||
161806280|NCT00184600|584335905|FG001|Overall Study|Withdrawal by Subject|28|||
161806281|NCT00184600|584335906|FG002|Overall Study|Withdrawal by Subject|12|||
161806282|NCT00184600|584335904|FG000|Overall Study|Unclassified|4|||
161806283|NCT00184600|584335905|FG001|Overall Study|Unclassified|5|||
161806284|NCT00184600|584335906|FG002|Overall Study|Unclassified|3|||
161806285|NCT00696020|584335909|FG000|Overall Study|Adverse Event|3|||
161806286|NCT00696020|584335910|FG001|Overall Study|Adverse Event|1|||
161561331|NCT04529538|583442096|FG003|Overall Study|Protocol Deviation|1|||
161806287|NCT00696020|584335911|FG002|Overall Study|Adverse Event|2|||
161806288|NCT00696020|584335912|FG003|Overall Study|Adverse Event|1|||
161806289|NCT00696020|584335909|FG000|Overall Study|Lack of Efficacy|1|||
161806290|NCT00696020|584335910|FG001|Overall Study|Lack of Efficacy|0|||
161806291|NCT00696020|584335911|FG002|Overall Study|Lack of Efficacy|0|||
161806292|NCT00696020|584335912|FG003|Overall Study|Lack of Efficacy|0|||
161909551|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161909552|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161909553|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161909554|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909555|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909556|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
161909557|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909558|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909559|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909560|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909561|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909562|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909563|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
161909564|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909565|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909566|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909567|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909568|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909569|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909570|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909571|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
161909572|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909573|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161561332|NCT04529538|583442097|FG004|Overall Study|Protocol Deviation|0|||
161561333|NCT04529538|583442098|FG005|Overall Study|Protocol Deviation|0|||
161561334|NCT04529538|583442099|FG006|Overall Study|Protocol Deviation|0|||
161561335|NCT04529538|583442100|FG007|Overall Study|Protocol Deviation|0|||
161561336|NCT04529538|583442093|FG000|Overall Study|Physician Decision|0|||
161561337|NCT04529538|583442094|FG001|Overall Study|Physician Decision|0|||
161561338|NCT04529538|583442095|FG002|Overall Study|Physician Decision|0|||
161561339|NCT04529538|583442096|FG003|Overall Study|Physician Decision|0|||
161909574|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909575|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909576|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909577|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909578|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
161909579|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909580|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909581|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909582|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909583|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161561340|NCT04529538|583442097|FG004|Overall Study|Physician Decision|0|||
161561341|NCT04529538|583442098|FG005|Overall Study|Physician Decision|1|||
161561342|NCT04529538|583442099|FG006|Overall Study|Physician Decision|0|||
161561343|NCT04529538|583442100|FG007|Overall Study|Physician Decision|1|||
161561344|NCT02223182|583442102|FG000|Double-Blind Period|Adverse Event|0|||
161561345|NCT02223182|583442103|FG001|Double-Blind Period|Adverse Event|2|||
161561346|NCT02223182|583442104|FG002|Double-Blind Period|Adverse Event|1|||
161909584|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909585|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909586|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
161909587|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909588|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909589|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909590|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909591|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909592|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909593|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
161909594|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909595|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909596|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161561347|NCT02223182|583442105|FG003|Double-Blind Period|Adverse Event|0|||
161561348|NCT02223182|583442102|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161909597|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909598|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161561349|NCT02223182|583442103|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161561350|NCT02223182|583442104|FG002|Double-Blind Period|Withdrawal by Subject|1|||
161909599|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909600|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
161909601|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909602|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909603|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909604|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909605|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909606|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909607|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
161806293|NCT00696020|584335909|FG000|Overall Study|Protocol Violation|0|||
161909608|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909609|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909610|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909611|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909612|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909613|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909614|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909615|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
161909616|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909617|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909618|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909619|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909620|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909621|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909622|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
161909623|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909624|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909625|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161806294|NCT00696020|584335910|FG001|Overall Study|Protocol Violation|0|||
161806295|NCT00696020|584335911|FG002|Overall Study|Protocol Violation|0|||
161806296|NCT00696020|584335912|FG003|Overall Study|Protocol Violation|1|||
161806297|NCT00696020|584335909|FG000|Overall Study|Withdrawal by Subject|0|||
161806298|NCT00696020|584335910|FG001|Overall Study|Withdrawal by Subject|1|||
161806299|NCT00696020|584335911|FG002|Overall Study|Withdrawal by Subject|0|||
161806300|NCT00696020|584335912|FG003|Overall Study|Withdrawal by Subject|1|||
161806301|NCT00696020|584335909|FG000|Overall Study|Other not stated above|0|||
161806302|NCT00696020|584335910|FG001|Overall Study|Other not stated above|0|||
161806303|NCT00696020|584335911|FG002|Overall Study|Other not stated above|1|||
161806304|NCT00696020|584335912|FG003|Overall Study|Other not stated above|1|||
161806305|NCT00624065|584335913|FG000|Overall Study|Adverse Event|5|||
161806306|NCT00624065|584335914|FG001|Overall Study|Adverse Event|6|||
161806307|NCT00624065|584335913|FG000|Overall Study|Lost to Follow-up|4|||
161806308|NCT00624065|584335914|FG001|Overall Study|Lost to Follow-up|1|||
161806309|NCT00624065|584335913|FG000|Overall Study|Consent withdrawn|6|||
161806310|NCT00624065|584335914|FG001|Overall Study|Consent withdrawn|5|||
161806311|NCT00624065|584335913|FG000|Overall Study|Lack of Efficacy|0|||
161806312|NCT00624065|584335914|FG001|Overall Study|Lack of Efficacy|3|||
161806313|NCT00624065|584335913|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
161806314|NCT00624065|584335914|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
161806315|NCT01387022|584335915|FG000|Overall Study|Death|1|||
161806316|NCT01387022|584335916|FG001|Overall Study|Death|1|||
161806317|NCT01387022|584335915|FG000|Overall Study|Lost to Follow-up|0|||
161806318|NCT01387022|584335916|FG001|Overall Study|Lost to Follow-up|3|||
161806319|NCT02076022|584335917|FG000|Overall Study|Withdrawal by Subject|2|||
161806320|NCT02076022|584335918|FG001|Overall Study|Withdrawal by Subject|0|||
161806321|NCT01536405|584335921|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
161806322|NCT01536405|584335922|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
161806323|NCT01536405|584335921|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
161806324|NCT01536405|584335922|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
161806325|NCT01536405|584335921|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
161806326|NCT01536405|584335922|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
161806327|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
161806328|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
161806329|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
161806330|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
161806331|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
161806332|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
161909626|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909627|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909628|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161561351|NCT02223182|583442105|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161561352|NCT02223182|583442102|FG000|Double-Blind Period|Lost to Follow-up|0|||
161561353|NCT02223182|583442103|FG001|Double-Blind Period|Lost to Follow-up|1|||
161561354|NCT02223182|583442104|FG002|Double-Blind Period|Lost to Follow-up|0|||
161561355|NCT02223182|583442105|FG003|Double-Blind Period|Lost to Follow-up|0|||
161561356|NCT02223182|583442102|FG000|Double-Blind Period|Non Compliance|0|||
161561357|NCT02223182|583442103|FG001|Double-Blind Period|Non Compliance|0|||
161561358|NCT02223182|583442104|FG002|Double-Blind Period|Non Compliance|0|||
161806333|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
161806334|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
161806335|NCT01536405|584335921|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
161806336|NCT01536405|584335922|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
161806337|NCT01536405|584335921|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
161806338|NCT01536405|584335922|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
161806339|NCT01536405|584335921|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
161806340|NCT01536405|584335922|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
161806341|NCT01536405|584335921|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
161806342|NCT01536405|584335922|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
161806343|NCT01536405|584335921|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
161806344|NCT01536405|584335922|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
161806345|NCT01536405|584335921|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
161806346|NCT01536405|584335922|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
161806347|NCT03687736|584335926|FG000|Overall Study|Lost to Follow-up|7|||
161806348|NCT03687736|584335926|FG000|Overall Study|Withdrawal by Subject|3|||
161806349|NCT01844375|584335927|FG000|Overall Study|Protocol Violation|1|||
161806350|NCT01844375|584335928|FG001|Overall Study|Protocol Violation|1|||
161806351|NCT03627091|584335929|FG000|Overall Study|Adverse Event|0|||
161806352|NCT03627091|584335930|FG001|Overall Study|Adverse Event|0|||
161806353|NCT03627091|584335931|FG002|Overall Study|Adverse Event|2|||
161806354|NCT03627091|584335929|FG000|Overall Study|Withdrawal by Subject|2|||
161806355|NCT03627091|584335930|FG001|Overall Study|Withdrawal by Subject|0|||
161806356|NCT03627091|584335931|FG002|Overall Study|Withdrawal by Subject|2|||
161806357|NCT03627091|584335929|FG000|Overall Study|Physician Decision|2|||
161806358|NCT03627091|584335930|FG001|Overall Study|Physician Decision|0|||
161806359|NCT03627091|584335931|FG002|Overall Study|Physician Decision|0|||
161806360|NCT03627091|584335929|FG000|Overall Study|Site terminated by sponsor|0|||
161806361|NCT03627091|584335930|FG001|Overall Study|Site terminated by sponsor|1|||
161806362|NCT03627091|584335931|FG002|Overall Study|Site terminated by sponsor|0|||
161806363|NCT03627091|584335929|FG000|Overall Study|Disease relapse|7|||
161806364|NCT03627091|584335930|FG001|Overall Study|Disease relapse|5|||
161806365|NCT03627091|584335931|FG002|Overall Study|Disease relapse|1|||
161806366|NCT03627091|584335929|FG000|Overall Study|Other|1|||
161806367|NCT03627091|584335930|FG001|Overall Study|Other|0|||
161806368|NCT03627091|584335931|FG002|Overall Study|Other|0|||
161806369|NCT02514122|584335932|FG000|Overall Study|Withdrawal by Subject|2|||
161806370|NCT02514122|584335933|FG001|Overall Study|Withdrawal by Subject|0|||
161806371|NCT01472341|584335937|FG000|Overall Study|Started insulin therapy|55|||
161806372|NCT01472341|584335937|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
161806373|NCT01472341|584335937|FG000|Overall Study|Withdrawal by Subject|39|||
161806374|NCT01472341|584335937|FG000|Overall Study|Lost to Follow-up|52|||
161806375|NCT01472341|584335937|FG000|Overall Study|Laboratory parameters unavailable|25|||
161806376|NCT01472341|584335937|FG000|Overall Study|Death|9|||
161806377|NCT00296647|584335941|FG000|Overall Study|Death|4|||
161806378|NCT00296647|584335942|FG001|Overall Study|Death|1|||
161806379|NCT00296647|584335943|FG002|Overall Study|Death|2|||
161806380|NCT00296647|584335944|FG003|Overall Study|Death|1|||
161806381|NCT00296647|584335945|FG004|Overall Study|Death|1|||
161806382|NCT00296647|584335941|FG000|Overall Study|Withdrawal by Subject|28|||
161806383|NCT00296647|584335942|FG001|Overall Study|Withdrawal by Subject|27|||
161806384|NCT00296647|584335943|FG002|Overall Study|Withdrawal by Subject|32|||
161806385|NCT00296647|584335944|FG003|Overall Study|Withdrawal by Subject|16|||
161806386|NCT00296647|584335945|FG004|Overall Study|Withdrawal by Subject|19|||
161806387|NCT05615935|584335948|FG000|Overall Study|Lost to Follow-up|1|||
161806388|NCT05615935|584335949|FG001|Overall Study|Lost to Follow-up|1|||
161806389|NCT01863745|584335950|FG000|Overall Study|Disease Progression|9|||
161806390|NCT01863745|584335950|FG000|Overall Study|Adverse Event|2|||
161806391|NCT01863745|584335950|FG000|Overall Study|Death|1|||
161806392|NCT01863745|584335950|FG000|Overall Study|Withdrawal by Subject|1|||
161806393|NCT00735904|584335951|FG000|Overall Study|Adverse Event|3|||
161806394|NCT00735904|584335951|FG000|Overall Study|Death|20|||
161806395|NCT00735904|584335951|FG000|Overall Study|Protocol Violation|1|||
161806396|NCT00735904|584335951|FG000|Overall Study|Withdrawal by Subject|1|||
161806397|NCT00735904|584335951|FG000|Overall Study|Study Terminated by Sponsor|5|||
161806398|NCT00735904|584335951|FG000|Overall Study|Other|8|||
161806399|NCT01171963|584335954|FG000|Overall Study|Adverse Event|10|||
161806400|NCT01171963|584335955|FG001|Overall Study|Adverse Event|15|||
161806401|NCT01171963|584335954|FG000|Overall Study|Lost to Follow-up|23|||
161561359|NCT02223182|583442105|FG003|Double-Blind Period|Non Compliance|1|||
161561360|NCT02223182|583442102|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
161806402|NCT01171963|584335955|FG001|Overall Study|Lost to Follow-up|24|||
161806403|NCT01171963|584335954|FG000|Overall Study|Other - diarrhoea|1|||
161806404|NCT01171963|584335955|FG001|Overall Study|Other - diarrhoea|0|||
161806405|NCT01171963|584335954|FG000|Overall Study|Withdrawal by Subject|114|||
161806406|NCT01171963|584335955|FG001|Overall Study|Withdrawal by Subject|129|||
161806407|NCT05093205|584335956|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
161806408|NCT05093205|584335957|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
161806409|NCT05093205|584335958|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
161806410|NCT05093205|584335959|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
161806411|NCT05093205|584335960|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
161806412|NCT05093205|584335961|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
161806413|NCT05093205|584335962|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
161806414|NCT05093205|584335963|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
161806415|NCT05093205|584335964|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
161806416|NCT05093205|584335965|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
161806417|NCT05093205|584335966|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
161806418|NCT05093205|584335967|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
161806419|NCT05093205|584335968|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
161806420|NCT05093205|584335956|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806421|NCT05093205|584335957|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806422|NCT05093205|584335958|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
161806423|NCT05093205|584335959|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806424|NCT05093205|584335960|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806425|NCT05093205|584335961|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806426|NCT05093205|584335962|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806427|NCT05093205|584335963|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806428|NCT05093205|584335964|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806429|NCT05093205|584335965|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806430|NCT05093205|584335966|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806431|NCT05093205|584335967|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806432|NCT05093205|584335968|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806433|NCT05093205|584335956|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
161806434|NCT05093205|584335957|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
161806435|NCT05093205|584335958|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
161806436|NCT05093205|584335959|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
161806437|NCT05093205|584335960|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
161806438|NCT05093205|584335961|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
161806439|NCT05093205|584335962|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
161806440|NCT05093205|584335963|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
161806441|NCT05093205|584335964|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
161806442|NCT05093205|584335965|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
161806443|NCT05093205|584335966|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
161806444|NCT05093205|584335967|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
161806445|NCT05093205|584335968|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
161806446|NCT05093205|584335956|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
161806447|NCT05093205|584335957|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
161806448|NCT05093205|584335958|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
161806449|NCT05093205|584335959|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
161806450|NCT05093205|584335960|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
161806451|NCT05093205|584335961|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
161806452|NCT05093205|584335962|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
161806453|NCT05093205|584335963|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
161806454|NCT05093205|584335964|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
161806455|NCT05093205|584335965|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
161806456|NCT05093205|584335966|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
161806457|NCT05093205|584335967|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
161806458|NCT05093205|584335968|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
161806459|NCT05093205|584335956|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
161806460|NCT05093205|584335957|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
161806461|NCT05093205|584335958|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
161806462|NCT05093205|584335959|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
161806463|NCT05093205|584335960|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
161806464|NCT05093205|584335961|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
161806465|NCT05093205|584335962|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
161806466|NCT05093205|584335963|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
161806467|NCT05093205|584335964|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
161806468|NCT05093205|584335965|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
161806469|NCT05093205|584335966|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
161909629|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909630|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
161909631|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909632|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909633|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909634|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909635|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909636|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909637|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
161909638|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909639|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909640|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161806470|NCT05093205|584335967|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
161806471|NCT05093205|584335968|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
161806472|NCT05093205|584335956|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
161806473|NCT05093205|584335957|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
161806474|NCT05093205|584335958|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
161806475|NCT05093205|584335959|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
161806476|NCT05093205|584335960|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
161806477|NCT05093205|584335961|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
161806478|NCT05093205|584335962|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
161806479|NCT05093205|584335963|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
161806480|NCT05093205|584335964|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
161806481|NCT05093205|584335965|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
161806482|NCT05093205|584335966|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
161806483|NCT05093205|584335967|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
161806484|NCT05093205|584335968|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
161806485|NCT05093205|584335956|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
161806486|NCT05093205|584335957|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
161806487|NCT05093205|584335958|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
161806488|NCT05093205|584335959|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
161806489|NCT05093205|584335960|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
161806490|NCT05093205|584335961|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
161806491|NCT05093205|584335962|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
161806492|NCT05093205|584335963|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
161806493|NCT05093205|584335964|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
161806494|NCT05093205|584335965|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
161806495|NCT05093205|584335966|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
161806496|NCT05093205|584335967|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
161806497|NCT05093205|584335968|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
161806498|NCT05093205|584335956|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
161806499|NCT05093205|584335957|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
161806500|NCT05093205|584335958|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
161806501|NCT05093205|584335959|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
161806502|NCT05093205|584335960|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
161806503|NCT05093205|584335961|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
161806504|NCT05093205|584335962|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
161806505|NCT05093205|584335963|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
161806506|NCT05093205|584335964|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
161806507|NCT05093205|584335965|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
161806508|NCT05093205|584335966|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
161806509|NCT05093205|584335967|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
161806510|NCT05093205|584335968|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
161806511|NCT05093205|584335956|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806512|NCT05093205|584335957|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806513|NCT05093205|584335958|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806514|NCT05093205|584335959|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806515|NCT05093205|584335960|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806516|NCT05093205|584335961|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806517|NCT05093205|584335962|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806518|NCT05093205|584335963|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806519|NCT05093205|584335964|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806520|NCT05093205|584335965|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
161806521|NCT05093205|584335966|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806522|NCT05093205|584335967|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806523|NCT05093205|584335968|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806524|NCT05093205|584335956|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
161806525|NCT05093205|584335957|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
161806526|NCT05093205|584335958|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
161806527|NCT05093205|584335959|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
161909641|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909642|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909643|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909644|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
161909645|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909646|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909647|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909648|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909649|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909650|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909651|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
161909652|NCT01776554|584721472|FG000|Overall Study|Adverse Event|1|||
161909653|NCT01776554|584721473|FG001|Overall Study|Adverse Event|0|||
161909654|NCT01776554|584721472|FG000|Overall Study|Withdrawal by Subject|3|||
161909655|NCT01776554|584721473|FG001|Overall Study|Withdrawal by Subject|8|||
161909656|NCT01776554|584721472|FG000|Overall Study|Lost to Follow-up|6|||
161909657|NCT01776554|584721473|FG001|Overall Study|Lost to Follow-up|9|||
161909658|NCT01776554|584721472|FG000|Overall Study|Administrative Reason|2|||
161909659|NCT01776554|584721473|FG001|Overall Study|Administrative Reason|5|||
161909660|NCT01776554|584721472|FG000|Overall Study|Protocol Violation|1|||
161909661|NCT01776554|584721473|FG001|Overall Study|Protocol Violation|0|||
161909662|NCT01776554|584721472|FG000|Overall Study|Unclassified|4|||
161909663|NCT01776554|584721473|FG001|Overall Study|Unclassified|1|||
161909664|NCT01041859|584721474|FG000|Open-Label Titration|Adverse Event|69|||
161909665|NCT01041859|584721475|FG001|Open-Label Titration|Adverse Event|0|||
161909666|NCT01041859|584721476|FG002|Open-Label Titration|Adverse Event|0|||
161909667|NCT01041859|584721474|FG000|Open-Label Titration|Lack of Efficacy|3|||
161909668|NCT01041859|584721475|FG001|Open-Label Titration|Lack of Efficacy|0|||
161909669|NCT01041859|584721476|FG002|Open-Label Titration|Lack of Efficacy|0|||
161909670|NCT01041859|584721474|FG000|Open-Label Titration|Lost to Follow-up|1|||
161909671|NCT01041859|584721475|FG001|Open-Label Titration|Lost to Follow-up|0|||
161909672|NCT01041859|584721476|FG002|Open-Label Titration|Lost to Follow-up|0|||
161909673|NCT01041859|584721474|FG000|Open-Label Titration|Physician Decision|1|||
161909674|NCT01041859|584721475|FG001|Open-Label Titration|Physician Decision|0|||
161909675|NCT01041859|584721476|FG002|Open-Label Titration|Physician Decision|0|||
161909676|NCT01041859|584721474|FG000|Open-Label Titration|Protocol Violation|1|||
161909677|NCT01041859|584721475|FG001|Open-Label Titration|Protocol Violation|0|||
161909678|NCT01041859|584721476|FG002|Open-Label Titration|Protocol Violation|0|||
161909679|NCT01041859|584721474|FG000|Open-Label Titration|Other|7|||
161909680|NCT01041859|584721475|FG001|Open-Label Titration|Other|0|||
161909681|NCT01041859|584721476|FG002|Open-Label Titration|Other|0|||
161909682|NCT01041859|584721474|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
161909683|NCT01041859|584721475|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
161909684|NCT01041859|584721476|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
161909685|NCT01041859|584721474|FG000|Open-Label Titration|Withdrawal by Subject|11|||
161909686|NCT01041859|584721475|FG001|Open-Label Titration|Withdrawal by Subject|0|||
161909687|NCT01041859|584721476|FG002|Open-Label Titration|Withdrawal by Subject|0|||
161909688|NCT01041859|584721474|FG000|Double-Blind Maintenance|Adverse Event|0|||
161909689|NCT01041859|584721475|FG001|Double-Blind Maintenance|Adverse Event|23|||
161909690|NCT01041859|584721476|FG002|Double-Blind Maintenance|Adverse Event|13|||
161909691|NCT01041859|584721474|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
161909692|NCT01041859|584721475|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
161909693|NCT01041859|584721476|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
161909694|NCT01041859|584721474|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
161909695|NCT01041859|584721475|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
161909696|NCT01041859|584721476|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
161909697|NCT01041859|584721474|FG000|Double-Blind Maintenance|Physician Decision|0|||
161806528|NCT05093205|584335960|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
161806529|NCT05093205|584335961|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
161806530|NCT05093205|584335962|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
161806531|NCT05093205|584335963|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
161806532|NCT05093205|584335964|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
161806533|NCT05093205|584335965|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
161806534|NCT05093205|584335966|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
161806535|NCT05093205|584335967|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
161806536|NCT05093205|584335968|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
161806537|NCT05093205|584335956|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806538|NCT05093205|584335957|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806539|NCT05093205|584335958|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806540|NCT05093205|584335959|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806541|NCT05093205|584335960|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806542|NCT05093205|584335961|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161909698|NCT01041859|584721475|FG001|Double-Blind Maintenance|Physician Decision|2|||
161909699|NCT01041859|584721476|FG002|Double-Blind Maintenance|Physician Decision|1|||
161909700|NCT01041859|584721474|FG000|Double-Blind Maintenance|Protocol Violation|0|||
161909701|NCT01041859|584721475|FG001|Double-Blind Maintenance|Protocol Violation|1|||
161909702|NCT01041859|584721476|FG002|Double-Blind Maintenance|Protocol Violation|3|||
161909703|NCT01041859|584721474|FG000|Double-Blind Maintenance|Other|0|||
161909704|NCT01041859|584721475|FG001|Double-Blind Maintenance|Other|6|||
161909705|NCT01041859|584721476|FG002|Double-Blind Maintenance|Other|2|||
161909706|NCT01041859|584721474|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
161909707|NCT01041859|584721475|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
161909708|NCT01041859|584721476|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
161909709|NCT01041859|584721474|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
161909710|NCT01041859|584721475|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
161909711|NCT01041859|584721476|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
161909712|NCT02027025|584721477|FG000|Overall Study|Adverse Event|0|||
161909713|NCT02027025|584721478|FG001|Overall Study|Adverse Event|1|||
161909714|NCT02027025|584721479|FG002|Overall Study|Adverse Event|1|||
161909715|NCT02027025|584721477|FG000|Overall Study|Protocol Violation|1|||
161909716|NCT02027025|584721478|FG001|Overall Study|Protocol Violation|0|||
161909717|NCT02027025|584721479|FG002|Overall Study|Protocol Violation|0|||
161909718|NCT02027025|584721477|FG000|Overall Study|Lost to Follow-up|0|||
161909719|NCT02027025|584721478|FG001|Overall Study|Lost to Follow-up|2|||
161909720|NCT02027025|584721479|FG002|Overall Study|Lost to Follow-up|0|||
161909721|NCT02027025|584721477|FG000|Overall Study|Withdrawal by Subject|0|||
161909722|NCT02027025|584721478|FG001|Overall Study|Withdrawal by Subject|1|||
161909723|NCT02027025|584721479|FG002|Overall Study|Withdrawal by Subject|0|||
161909724|NCT02027025|584721477|FG000|Overall Study|Sponsor's decision|0|||
161909725|NCT02027025|584721478|FG001|Overall Study|Sponsor's decision|1|||
161909726|NCT02027025|584721479|FG002|Overall Study|Sponsor's decision|0|||
161909727|NCT04798027|584721480|FG000|Overall Study|Protocol Violation|0|||
161909728|NCT04798027|584721481|FG001|Overall Study|Protocol Violation|0|||
161909729|NCT04798027|584721482|FG002|Overall Study|Protocol Violation|0|||
161909730|NCT04798027|584721483|FG003|Overall Study|Protocol Violation|0|||
161909731|NCT04798027|584721484|FG004|Overall Study|Protocol Violation|1|||
161909732|NCT04798027|584721485|FG005|Overall Study|Protocol Violation|0|||
161909733|NCT04798027|584721486|FG006|Overall Study|Protocol Violation|0|||
161909734|NCT04798027|584721487|FG007|Overall Study|Protocol Violation|1|||
161909735|NCT04798027|584721488|FG008|Overall Study|Protocol Violation|0|||
161909736|NCT04798027|584721480|FG000|Overall Study|Withdrawal by Subject|1|||
161909737|NCT04798027|584721481|FG001|Overall Study|Withdrawal by Subject|0|||
161909738|NCT04798027|584721482|FG002|Overall Study|Withdrawal by Subject|1|||
161909739|NCT04798027|584721483|FG003|Overall Study|Withdrawal by Subject|1|||
161909740|NCT04798027|584721484|FG004|Overall Study|Withdrawal by Subject|1|||
161909741|NCT04798027|584721485|FG005|Overall Study|Withdrawal by Subject|1|||
161909742|NCT04798027|584721486|FG006|Overall Study|Withdrawal by Subject|3|||
161909743|NCT04798027|584721487|FG007|Overall Study|Withdrawal by Subject|2|||
161909744|NCT04798027|584721488|FG008|Overall Study|Withdrawal by Subject|2|||
161909745|NCT04798027|584721480|FG000|Overall Study|Lost to Follow-up|1|||
161909746|NCT04798027|584721481|FG001|Overall Study|Lost to Follow-up|3|||
161909747|NCT04798027|584721482|FG002|Overall Study|Lost to Follow-up|0|||
161909748|NCT04798027|584721483|FG003|Overall Study|Lost to Follow-up|0|||
161909749|NCT04798027|584721484|FG004|Overall Study|Lost to Follow-up|0|||
161909750|NCT04798027|584721485|FG005|Overall Study|Lost to Follow-up|1|||
161909751|NCT04798027|584721486|FG006|Overall Study|Lost to Follow-up|0|||
161909752|NCT04798027|584721487|FG007|Overall Study|Lost to Follow-up|0|||
161909753|NCT04798027|584721488|FG008|Overall Study|Lost to Follow-up|1|||
161909754|NCT04798027|584721480|FG000|Overall Study|Withdrawal by Sponsor|8|||
161909755|NCT04798027|584721481|FG001|Overall Study|Withdrawal by Sponsor|22|||
161909756|NCT04798027|584721482|FG002|Overall Study|Withdrawal by Sponsor|9|||
161909757|NCT04798027|584721483|FG003|Overall Study|Withdrawal by Sponsor|26|||
161909758|NCT04798027|584721484|FG004|Overall Study|Withdrawal by Sponsor|24|||
161909759|NCT04798027|584721485|FG005|Overall Study|Withdrawal by Sponsor|11|||
161909760|NCT04798027|584721486|FG006|Overall Study|Withdrawal by Sponsor|25|||
161909761|NCT04798027|584721487|FG007|Overall Study|Withdrawal by Sponsor|26|||
161909762|NCT04798027|584721488|FG008|Overall Study|Withdrawal by Sponsor|11|||
161909763|NCT00828711|584721491|FG000|Overall Study|Lost to Follow-up|1|||
161909764|NCT00828711|584721492|FG001|Overall Study|Lost to Follow-up|0|||
161909765|NCT00828711|584721493|FG002|Overall Study|Lost to Follow-up|0|||
161909766|NCT01618968|584721494|FG000|Overall Study|Adverse Event|1|||
161909767|NCT01618968|584721495|FG001|Overall Study|Adverse Event|0|||
161909768|NCT01618968|584721496|FG002|Overall Study|Adverse Event|0|||
161909769|NCT01618968|584721497|FG003|Overall Study|Adverse Event|0|||
161909770|NCT01618968|584721494|FG000|Overall Study|Death|0|||
161909771|NCT01618968|584721495|FG001|Overall Study|Death|0|||
161909772|NCT01618968|584721496|FG002|Overall Study|Death|0|||
161909773|NCT01618968|584721497|FG003|Overall Study|Death|1|||
161909774|NCT02230891|584721500|FG000|Baseline|Did not meet inclusion|0|||
161909775|NCT02230891|584721501|FG001|Baseline|Did not meet inclusion|1|||
161909776|NCT02230891|584721502|FG002|Baseline|Did not meet inclusion|1|||
161909777|NCT02230891|584721500|FG000|2 Week|Withdrawal by Subject|2|||
161909778|NCT02230891|584721501|FG001|2 Week|Withdrawal by Subject|2|||
161909779|NCT02230891|584721502|FG002|2 Week|Withdrawal by Subject|0|||
161909780|NCT02230891|584721500|FG000|2 Week|Consent withdrawn|1|||
161909781|NCT02230891|584721501|FG001|2 Week|Consent withdrawn|0|||
161909782|NCT02230891|584721502|FG002|2 Week|Consent withdrawn|0|||
161909783|NCT02230891|584721500|FG000|6 Month|Withdrawal by Subject|1|||
161909784|NCT02230891|584721501|FG001|6 Month|Withdrawal by Subject|1|||
161909785|NCT02230891|584721502|FG002|6 Month|Withdrawal by Subject|1|||
161909786|NCT02230891|584721500|FG000|6 Month|Physician Decision|0|||
161909787|NCT02230891|584721501|FG001|6 Month|Physician Decision|2|||
161909788|NCT02230891|584721502|FG002|6 Month|Physician Decision|0|||
161909789|NCT02230891|584721500|FG000|12 Month|Death|1|||
161909790|NCT02230891|584721501|FG001|12 Month|Death|0|||
161909791|NCT02230891|584721502|FG002|12 Month|Death|0|||
161909792|NCT02230891|584721500|FG000|12 Month|Lost to Follow-up|0|||
161909793|NCT02230891|584721501|FG001|12 Month|Lost to Follow-up|1|||
161909794|NCT02230891|584721502|FG002|12 Month|Lost to Follow-up|0|||
161909795|NCT02230891|584721500|FG000|12 Month|Withdrawal by Subject|0|||
161909796|NCT02230891|584721501|FG001|12 Month|Withdrawal by Subject|2|||
161909797|NCT02230891|584721502|FG002|12 Month|Withdrawal by Subject|0|||
161909798|NCT02230891|584721500|FG000|18 Month End of Study|Death|0|||
161909799|NCT02230891|584721501|FG001|18 Month End of Study|Death|0|||
161909800|NCT02230891|584721502|FG002|18 Month End of Study|Death|1|||
161909801|NCT02230891|584721500|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
161909802|NCT02230891|584721501|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
161909803|NCT02230891|584721502|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
161909804|NCT03087058|584721504|FG000|Overall Study|Withdrawal by Subject|2|||
161909805|NCT03087058|584721505|FG001|Overall Study|Withdrawal by Subject|0|||
161909806|NCT03087058|584721506|FG002|Overall Study|Withdrawal by Subject|0|||
161909807|NCT05158140|584721510|FG000|Overall Study|Death|0|||
161909808|NCT05158140|584721511|FG001|Overall Study|Death|0|||
161909809|NCT05158140|584721512|FG002|Overall Study|Death|0|||
161909810|NCT05158140|584721513|FG003|Overall Study|Death|1|||
161909811|NCT05158140|584721510|FG000|Overall Study|Lost to Follow-up|3|||
161909812|NCT05158140|584721511|FG001|Overall Study|Lost to Follow-up|6|||
161909813|NCT05158140|584721512|FG002|Overall Study|Lost to Follow-up|4|||
161909814|NCT05158140|584721513|FG003|Overall Study|Lost to Follow-up|3|||
161909815|NCT05158140|584721510|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161909816|NCT05158140|584721511|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161909817|NCT05158140|584721512|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
161909818|NCT05158140|584721513|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161909819|NCT05158140|584721510|FG000|Overall Study|Withdrawal by Subject|3|||
161909820|NCT05158140|584721511|FG001|Overall Study|Withdrawal by Subject|7|||
161909821|NCT05158140|584721512|FG002|Overall Study|Withdrawal by Subject|3|||
161909822|NCT05158140|584721513|FG003|Overall Study|Withdrawal by Subject|7|||
161909823|NCT00617279|584721514|FG000|Overall Study|Study terminated by Sponsor|10|||
161909824|NCT00617279|584721515|FG001|Overall Study|Study terminated by Sponsor|15|||
161909825|NCT00617279|584721514|FG000|Overall Study|Graft abandonment|2|||
161909826|NCT00617279|584721515|FG001|Overall Study|Graft abandonment|0|||
161909827|NCT00617279|584721514|FG000|Overall Study|Lost to Follow-up|1|||
161909828|NCT00617279|584721515|FG001|Overall Study|Lost to Follow-up|0|||
161909829|NCT00617279|584721514|FG000|Overall Study|Death|1|||
161909830|NCT00617279|584721515|FG001|Overall Study|Death|2|||
161909831|NCT01814007|584721517|FG000|Overall Study|Withdrawal by Subject|1|||
161909832|NCT01324947|584721519|FG000|Overall Study|Adverse Event|7|||
161909833|NCT01324947|584721519|FG000|Overall Study|Death|10|||
161909834|NCT01324947|584721519|FG000|Overall Study|Other|3|||
161909835|NCT01324947|584721519|FG000|Overall Study|Progressive Disease|50|||
161909836|NCT01324947|584721519|FG000|Overall Study|Withdrawal by Subject|3|||
161909837|NCT01324947|584721519|FG000|Overall Study|1 discontinued before starting drug|1|||
161909838|NCT01274351|584721520|FG000|Overall Study|Lost to Follow-up|1|||
161909839|NCT01274351|584721520|FG000|Overall Study|patient not compliant with the protocol|1|||
161909840|NCT01274351|584721520|FG000|Overall Study|Pregnancy|1|||
161909841|NCT01274351|584721520|FG000|Overall Study|Death|2|||
161909842|NCT01274351|584721520|FG000|Overall Study|Withdrawal by Subject|3|||
161909843|NCT01274351|584721520|FG000|Overall Study|Adverse Event|8|||
161909844|NCT01274351|584721520|FG000|Overall Study|progression of disease|3|||
161909845|NCT01274351|584721520|FG000|Overall Study|hospitalization|1|||
161909846|NCT01296412|584721521|FG000|Overall Study|Adverse Event|8|||
161909847|NCT01296412|584721522|FG001|Overall Study|Adverse Event|29|||
161909848|NCT01296412|584721521|FG000|Overall Study|Lack of Efficacy|1|||
161909849|NCT01296412|584721522|FG001|Overall Study|Lack of Efficacy|0|||
161909850|NCT01296412|584721521|FG000|Overall Study|Lost to Follow-up|10|||
161909851|NCT01296412|584721522|FG001|Overall Study|Lost to Follow-up|7|||
161909852|NCT01296412|584721521|FG000|Overall Study|Non-compliance with study drug|1|||
161909853|NCT01296412|584721522|FG001|Overall Study|Non-compliance with study drug|2|||
161909854|NCT01296412|584721521|FG000|Overall Study|Other reason not specified|20|||
161909855|NCT01296412|584721522|FG001|Overall Study|Other reason not specified|15|||
161909856|NCT01296412|584721521|FG000|Overall Study|Physician Decision|1|||
161909857|NCT01296412|584721522|FG001|Overall Study|Physician Decision|3|||
161909858|NCT01296412|584721521|FG000|Overall Study|Pregnancy|0|||
161909859|NCT01296412|584721522|FG001|Overall Study|Pregnancy|1|||
161909860|NCT01296412|584721521|FG000|Overall Study|Withdrawal by Subject|10|||
161909861|NCT01296412|584721522|FG001|Overall Study|Withdrawal by Subject|13|||
161909862|NCT02160626|584721523|FG000|Overall Study|Adverse Event|1|||
161909863|NCT02160626|584721524|FG001|Overall Study|Adverse Event|0|||
161909864|NCT02160626|584721525|FG002|Overall Study|Adverse Event|0|||
161909865|NCT02160626|584721523|FG000|Overall Study|Schedule not conducive to study visits|0|||
161909866|NCT02160626|584721524|FG001|Overall Study|Schedule not conducive to study visits|0|||
161909867|NCT02160626|584721525|FG002|Overall Study|Schedule not conducive to study visits|1|||
161909868|NCT02160626|584721523|FG000|Overall Study|Withdrawal by Subject|0|||
161909869|NCT02160626|584721524|FG001|Overall Study|Withdrawal by Subject|1|||
161909870|NCT02160626|584721525|FG002|Overall Study|Withdrawal by Subject|0|||
161909871|NCT03861039|584723410|FG000|Overall Study|Adverse Event|2|||
161909872|NCT03861039|584723411|FG001|Overall Study|Adverse Event|5|||
161909873|NCT03861039|584723412|FG002|Overall Study|Adverse Event|11|||
161909874|NCT03861039|584723410|FG000|Overall Study|Withdrawal by Subject|1|||
161909875|NCT03861039|584723411|FG001|Overall Study|Withdrawal by Subject|3|||
161909876|NCT03861039|584723412|FG002|Overall Study|Withdrawal by Subject|4|||
161909877|NCT01113749|584723413|FG000|Overall Study|Lost to Follow-up|1|||
161909878|NCT01113749|584723414|FG001|Overall Study|Lost to Follow-up|2|||
161909879|NCT03427892|584723415|FG000|Overall Study|Lost to Follow-up|2|||
161909880|NCT03255187|584723416|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
161909881|NCT03255187|584723417|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
161909882|NCT03255187|584723416|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
161909883|NCT03255187|584723417|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
161909884|NCT02934178|584723418|FG000|Received Vaccination 2|Death|0|||
161909885|NCT02934178|584723419|FG001|Received Vaccination 2|Death|1|||
161909886|NCT02934178|584723418|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
161909887|NCT02934178|584723419|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
161909888|NCT00720278|584723423|FG000|Overall Study|Adverse Event|5|||
161909889|NCT00720278|584723424|FG001|Overall Study|Adverse Event|3|||
161909890|NCT00720278|584723425|FG002|Overall Study|Adverse Event|4|||
161909891|NCT00720278|584723423|FG000|Overall Study|Withdrawal by Subject|0|||
161909892|NCT00720278|584723424|FG001|Overall Study|Withdrawal by Subject|1|||
161909893|NCT00720278|584723425|FG002|Overall Study|Withdrawal by Subject|0|||
161909894|NCT00720278|584723423|FG000|Overall Study|Lost to Follow-up|0|||
161909895|NCT00720278|584723424|FG001|Overall Study|Lost to Follow-up|0|||
161909896|NCT00720278|584723425|FG002|Overall Study|Lost to Follow-up|1|||
161909897|NCT00720278|584723423|FG000|Overall Study|Non-compliance|1|||
161909898|NCT00720278|584723424|FG001|Overall Study|Non-compliance|0|||
161909899|NCT00720278|584723425|FG002|Overall Study|Non-compliance|0|||
161909900|NCT00720278|584723423|FG000|Overall Study|eligibility criteria violation|1|||
161909901|NCT00720278|584723424|FG001|Overall Study|eligibility criteria violation|0|||
161909902|NCT00720278|584723425|FG002|Overall Study|eligibility criteria violation|1|||
161909903|NCT01075048|584723427|FG000|Overall Study|Death|4|||
161909904|NCT01075048|584723428|FG001|Overall Study|Death|17|||
161909905|NCT01075048|584723429|FG002|Overall Study|Death|12|||
161909906|NCT01075048|584723427|FG000|Overall Study|Start of other or new therapy|4|||
161909907|NCT01075048|584723428|FG001|Overall Study|Start of other or new therapy|36|||
161909908|NCT01075048|584723429|FG002|Overall Study|Start of other or new therapy|46|||
161909909|NCT01075048|584723427|FG000|Overall Study|Withdrawal by Subject|1|||
161909910|NCT01075048|584723428|FG001|Overall Study|Withdrawal by Subject|6|||
161909911|NCT01075048|584723429|FG002|Overall Study|Withdrawal by Subject|3|||
161909912|NCT01075048|584723427|FG000|Overall Study|Lost to Follow-up|0|||
161909913|NCT01075048|584723428|FG001|Overall Study|Lost to Follow-up|1|||
161909914|NCT01075048|584723429|FG002|Overall Study|Lost to Follow-up|1|||
161909915|NCT03944616|584723430|FG000|Overall Study|Lost to Follow-up|0|||
161909916|NCT03944616|584723431|FG001|Overall Study|Lost to Follow-up|2|||
161909917|NCT00408499|584723433|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909918|NCT00408499|584723434|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909919|NCT00408499|584723435|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
161909920|NCT00408499|584723436|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909921|NCT00408499|584723437|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909922|NCT00408499|584723433|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
161909923|NCT00408499|584723434|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
161909924|NCT00408499|584723435|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161909925|NCT00408499|584723436|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161909926|NCT00408499|584723437|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161909927|NCT00408499|584723433|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
161909928|NCT00408499|584723434|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
161909929|NCT00408499|584723435|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161909930|NCT00408499|584723436|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161909931|NCT00408499|584723437|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161909932|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Adverse Event|0|||
161909933|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Adverse Event|0|||
161909934|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Adverse Event|0|||
161909935|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Adverse Event|0|||
161909936|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Adverse Event|9|||
161909937|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Death|0|||
161909938|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Death|0|||
161909939|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Death|0|||
161909940|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Death|0|||
161909941|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Death|2|||
161909942|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Physician Decision|0|||
161909943|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Physician Decision|0|||
161909944|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Physician Decision|0|||
161909945|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Physician Decision|0|||
161909946|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Physician Decision|1|||
161909947|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909948|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909949|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909950|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909951|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
161909952|NCT00408499|584723433|FG000|Phase II- MTD Expansion|treatment delay|0|||
161909953|NCT00408499|584723434|FG001|Phase II- MTD Expansion|treatment delay|0|||
161909954|NCT00408499|584723435|FG002|Phase II- MTD Expansion|treatment delay|0|||
161909955|NCT00408499|584723436|FG003|Phase II- MTD Expansion|treatment delay|0|||
161909956|NCT00408499|584723437|FG004|Phase II- MTD Expansion|treatment delay|3|||
161909957|NCT00997334|584723440|FG000|Overall Study|still on therapy|12|||
161909958|NCT00997334|584723440|FG000|Overall Study|Adverse Event|3|||
161909959|NCT00997334|584723440|FG000|Overall Study|Patient non-compliance|1|||
161909960|NCT00997334|584723440|FG000|Overall Study|Withdrawal by Subject|3|||
161909961|NCT00997334|584723440|FG000|Overall Study|Death|2|||
161909962|NCT00997334|584723440|FG000|Overall Study|Urgent Palliative Care|2|||
161909963|NCT00997334|584723440|FG000|Overall Study|No lesion amenable|1|||
161561361|NCT02223182|583442103|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
161909964|NCT00997334|584723440|FG000|Overall Study|Ineligible|1|||
161909965|NCT01586195|584723444|FG000|Overall Study|Death|11|||
161909966|NCT01586195|584723444|FG000|Overall Study|Withdrawal of Consent|5|||
161909967|NCT01586195|584723444|FG000|Overall Study|Started new anti-melanoma therapy|1|||
161909968|NCT01586195|584723444|FG000|Overall Study|Reason not specified|9|||
161909969|NCT01855958|584723445|FG000|Overall Study|Withdrawal by Subject|1|||
161909970|NCT01855958|584723446|FG001|Overall Study|Withdrawal by Subject|0|||
161909971|NCT01287936|584723447|FG000|Overall Study|Lost to Follow-up|0|||
161909972|NCT01287936|584723448|FG001|Overall Study|Lost to Follow-up|1|||
161909973|NCT01287936|584723449|FG002|Overall Study|Lost to Follow-up|1|||
161909974|NCT00296244|584723450|FG000|Overall Study|Underwent retransplant|0|||
161909975|NCT00296244|584723451|FG001|Overall Study|Underwent retransplant|1|||
161909976|NCT00266708|584723457|FG000|Overall Study|No renal function|1|||
161909977|NCT00266708|584723458|FG001|Overall Study|No renal function|1|||
161909978|NCT00266708|584723457|FG000|Overall Study|Refused biopsy|3|||
161909979|NCT00266708|584723458|FG001|Overall Study|Refused biopsy|6|||
161909980|NCT00266708|584723457|FG000|Overall Study|Asthma|0|||
161909981|NCT00266708|584723458|FG001|Overall Study|Asthma|2|||
161909982|NCT00703534|584723459|FG000|Overall Study|Adverse Event|14|||
161909983|NCT00703534|584723460|FG001|Overall Study|Adverse Event|3|||
161909984|NCT00703534|584723459|FG000|Overall Study|Withdrawal by Subject|8|||
161909985|NCT00703534|584723460|FG001|Overall Study|Withdrawal by Subject|7|||
161909986|NCT00703534|584723459|FG000|Overall Study|Incorrect Enrollment|6|||
161909987|NCT00703534|584723460|FG001|Overall Study|Incorrect Enrollment|6|||
161909988|NCT00703534|584723459|FG000|Overall Study|Lost to Follow-up|1|||
161909989|NCT00703534|584723460|FG001|Overall Study|Lost to Follow-up|4|||
161909990|NCT00703534|584723459|FG000|Overall Study|Severe Non Compliance|1|||
161909991|NCT00703534|584723460|FG001|Overall Study|Severe Non Compliance|5|||
161909992|NCT02791269|584723461|FG000|Overall Study|Lost to Follow-up|0|||
161909993|NCT02791269|584723462|FG001|Overall Study|Lost to Follow-up|1|||
161909994|NCT00427934|584723463|FG000|Overall Study|Adverse Event|1|||
161909995|NCT00427934|584723464|FG001|Overall Study|Adverse Event|0|||
161909996|NCT00427934|584723465|FG002|Overall Study|Adverse Event|5|||
161909997|NCT00427934|584723466|FG003|Overall Study|Adverse Event|4|||
161909998|NCT00427934|584723463|FG000|Overall Study|Lack of Efficacy|0|||
161909999|NCT00427934|584723464|FG001|Overall Study|Lack of Efficacy|0|||
161910000|NCT00427934|584723465|FG002|Overall Study|Lack of Efficacy|5|||
161910001|NCT00427934|584723466|FG003|Overall Study|Lack of Efficacy|2|||
161910002|NCT00427934|584723463|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
161910003|NCT00427934|584723464|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
161910004|NCT00427934|584723465|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
161910005|NCT00427934|584723466|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
161910006|NCT00427934|584723463|FG000|Overall Study|Other|0|||
161910007|NCT00427934|584723464|FG001|Overall Study|Other|0|||
161910008|NCT00427934|584723465|FG002|Overall Study|Other|11|||
161910009|NCT00427934|584723466|FG003|Overall Study|Other|5|||
161910010|NCT00427934|584723463|FG000|Overall Study|Withdrawal by Subject|0|||
161910011|NCT00427934|584723464|FG001|Overall Study|Withdrawal by Subject|0|||
161910012|NCT00427934|584723465|FG002|Overall Study|Withdrawal by Subject|1|||
161910013|NCT00427934|584723466|FG003|Overall Study|Withdrawal by Subject|3|||
161910014|NCT02683109|584723467|FG000|Overall Study|Adverse Event|1|||
161453275|NCT01590758|583053609|FG000|Overall Study|Withdrawal by Subject|0|||
161453276|NCT01590758|583053610|FG001|Overall Study|Withdrawal by Subject|3|||
161453277|NCT01590758|583053609|FG000|Overall Study|Physician Decision|1|||
161453278|NCT01590758|583053610|FG001|Overall Study|Physician Decision|2|||
161453279|NCT01590758|583053609|FG000|Overall Study|Lost to Follow-up|4|||
161453280|NCT01590758|583053610|FG001|Overall Study|Lost to Follow-up|2|||
161453281|NCT02929498|583053611|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
161453282|NCT02929498|583053612|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
161453283|NCT02929498|583053613|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
161453284|NCT02929498|583053611|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
161453285|NCT02929498|583053612|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
161910015|NCT02683109|584723468|FG001|Overall Study|Adverse Event|0|||
161910016|NCT00368251|584723469|FG000|Overall Study|SAE, non-fatal|1|||
161910017|NCT00368251|584723470|FG001|Overall Study|SAE, non-fatal|0|||
161910018|NCT00368251|584723471|FG002|Overall Study|SAE, non-fatal|0|||
161910019|NCT00368251|584723469|FG000|Overall Study|AE, non-serious non-fatal|0|||
161910020|NCT00368251|584723470|FG001|Overall Study|AE, non-serious non-fatal|0|||
161910021|NCT00368251|584723471|FG002|Overall Study|AE, non-serious non-fatal|1|||
161910022|NCT03617588|584723472|FG000|Overall Study|Withdrawal by Subject|1|||
161910023|NCT03617588|584723473|FG001|Overall Study|Withdrawal by Subject|0|||
161910024|NCT03098979|584723478|FG000|Overall Study|Adverse Event|1|||
161910025|NCT03098979|584723479|FG001|Overall Study|Adverse Event|0|||
161910026|NCT03098979|584723480|FG002|Overall Study|Adverse Event|1|||
161910027|NCT03098979|584723481|FG003|Overall Study|Adverse Event|4|||
161910028|NCT03098979|584723482|FG004|Overall Study|Adverse Event|6|||
161910029|NCT03098979|584723483|FG005|Overall Study|Adverse Event|1|||
161910030|NCT03098979|584723478|FG000|Overall Study|Withdrawal by Subject|2|||
161910031|NCT03098979|584723479|FG001|Overall Study|Withdrawal by Subject|1|||
161910032|NCT03098979|584723480|FG002|Overall Study|Withdrawal by Subject|1|||
161910033|NCT03098979|584723481|FG003|Overall Study|Withdrawal by Subject|1|||
161910034|NCT03098979|584723482|FG004|Overall Study|Withdrawal by Subject|2|||
161910035|NCT03098979|584723483|FG005|Overall Study|Withdrawal by Subject|1|||
161910036|NCT03098979|584723478|FG000|Overall Study|Death|1|||
161910037|NCT03098979|584723479|FG001|Overall Study|Death|0|||
161910038|NCT03098979|584723480|FG002|Overall Study|Death|2|||
161910039|NCT03098979|584723481|FG003|Overall Study|Death|0|||
161910040|NCT03098979|584723482|FG004|Overall Study|Death|1|||
161910041|NCT03098979|584723483|FG005|Overall Study|Death|0|||
161910042|NCT03098979|584723478|FG000|Overall Study|Physician Decision|2|||
161910043|NCT03098979|584723479|FG001|Overall Study|Physician Decision|1|||
161910044|NCT03098979|584723480|FG002|Overall Study|Physician Decision|0|||
161910045|NCT03098979|584723481|FG003|Overall Study|Physician Decision|0|||
161910046|NCT03098979|584723482|FG004|Overall Study|Physician Decision|0|||
161910047|NCT03098979|584723483|FG005|Overall Study|Physician Decision|0|||
161910048|NCT03098979|584723478|FG000|Overall Study|Non-compliance|0|||
161910049|NCT03098979|584723479|FG001|Overall Study|Non-compliance|0|||
161910050|NCT03098979|584723480|FG002|Overall Study|Non-compliance|0|||
161910051|NCT03098979|584723481|FG003|Overall Study|Non-compliance|0|||
161910052|NCT03098979|584723482|FG004|Overall Study|Non-compliance|0|||
161910053|NCT03098979|584723483|FG005|Overall Study|Non-compliance|1|||
161910054|NCT03098979|584723478|FG000|Overall Study|Protocol Violation|0|||
161910055|NCT03098979|584723479|FG001|Overall Study|Protocol Violation|0|||
161910056|NCT03098979|584723480|FG002|Overall Study|Protocol Violation|0|||
161910057|NCT03098979|584723481|FG003|Overall Study|Protocol Violation|0|||
161910058|NCT03098979|584723482|FG004|Overall Study|Protocol Violation|0|||
161910059|NCT03098979|584723483|FG005|Overall Study|Protocol Violation|1|||
161910060|NCT04459338|584723486|FG000|Overall Study|Loss of IV during study|1|||
161910061|NCT04459338|584723487|FG001|Overall Study|Loss of IV during study|0|||
161910062|NCT03157089|584723488|FG000|Overall Study|Treated only with pembrolizumab|1|||
161910063|NCT03157089|584723489|FG001|Overall Study|Treated only with pembrolizumab|0|||
161910064|NCT03157089|584723488|FG000|Overall Study|Adverse Event|5|||
161910065|NCT03157089|584723489|FG001|Overall Study|Adverse Event|4|||
161910066|NCT03157089|584723488|FG000|Overall Study|Progressive disease|6|||
161910067|NCT03157089|584723489|FG001|Overall Study|Progressive disease|8|||
161910068|NCT00784875|584723490|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
161910069|NCT00784875|584723491|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
161910070|NCT00784875|584723492|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
161910071|NCT00784875|584723493|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
161910072|NCT00784875|584723490|FG000|Period A - Baseline|Adverse Event|0|||
161910073|NCT00784875|584723491|FG001|Period A - Baseline|Adverse Event|0|||
161910074|NCT00784875|584723492|FG002|Period A - Baseline|Adverse Event|0|||
161910075|NCT00784875|584723493|FG003|Period A - Baseline|Adverse Event|8|||
161910076|NCT00784875|584723490|FG000|Period A - Baseline|Protocol Violation|0|||
161910077|NCT00784875|584723491|FG001|Period A - Baseline|Protocol Violation|0|||
161910078|NCT00784875|584723492|FG002|Period A - Baseline|Protocol Violation|0|||
161910079|NCT00784875|584723493|FG003|Period A - Baseline|Protocol Violation|25|||
161910080|NCT00784875|584723490|FG000|Period A - Baseline|Withdrawal by Subject|0|||
161910081|NCT00784875|584723491|FG001|Period A - Baseline|Withdrawal by Subject|0|||
161910082|NCT00784875|584723492|FG002|Period A - Baseline|Withdrawal by Subject|0|||
161453286|NCT02929498|583053613|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
161453287|NCT01011309|583053618|FG000|Overall Study|Adverse Event|2|||
161910083|NCT00784875|584723493|FG003|Period A - Baseline|Withdrawal by Subject|27|||
161910084|NCT00784875|584723490|FG000|Period A - Baseline|Physician Decision|0|||
161910085|NCT00784875|584723491|FG001|Period A - Baseline|Physician Decision|0|||
161910086|NCT00784875|584723492|FG002|Period A - Baseline|Physician Decision|0|||
161910087|NCT00784875|584723493|FG003|Period A - Baseline|Physician Decision|2|||
161910088|NCT00784875|584723490|FG000|Period A - Baseline|Sponsor Decision|0|||
161910089|NCT00784875|584723491|FG001|Period A - Baseline|Sponsor Decision|0|||
161910090|NCT00784875|584723492|FG002|Period A - Baseline|Sponsor Decision|0|||
161910091|NCT00784875|584723493|FG003|Period A - Baseline|Sponsor Decision|113|||
161910092|NCT00784875|584723490|FG000|Period A - Baseline|Lost to Follow-up|0|||
161910093|NCT00784875|584723491|FG001|Period A - Baseline|Lost to Follow-up|0|||
161910094|NCT00784875|584723492|FG002|Period A - Baseline|Lost to Follow-up|0|||
161910095|NCT00784875|584723493|FG003|Period A - Baseline|Lost to Follow-up|2|||
161910096|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
161561362|NCT02223182|583442104|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
161561363|NCT02223182|583442105|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
161561364|NCT02223182|583442102|FG000|Open-Label 500 Period|Adverse Event|1|||
161561365|NCT02223182|583442103|FG001|Open-Label 500 Period|Adverse Event|0|||
161561366|NCT02223182|583442104|FG002|Open-Label 500 Period|Adverse Event|2|||
161561367|NCT02223182|583442105|FG003|Open-Label 500 Period|Adverse Event|1|||
161561368|NCT02223182|583442102|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
161561369|NCT02223182|583442103|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
161561370|NCT02223182|583442104|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
161561371|NCT02223182|583442105|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
161561372|NCT02223182|583442102|FG000|Open-Label 500 Period|Physician Decision|0|||
161561373|NCT02223182|583442103|FG001|Open-Label 500 Period|Physician Decision|0|||
161561374|NCT02223182|583442104|FG002|Open-Label 500 Period|Physician Decision|0|||
161561375|NCT02223182|583442105|FG003|Open-Label 500 Period|Physician Decision|1|||
161561376|NCT02223182|583442102|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
161561377|NCT02223182|583442103|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
161561378|NCT02223182|583442104|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
161561379|NCT02223182|583442105|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
161561380|NCT02223182|583442102|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
161561381|NCT02223182|583442103|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
161561382|NCT02223182|583442104|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
161561383|NCT02223182|583442105|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
161561384|NCT02223182|583442102|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
161561385|NCT02223182|583442103|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
161561386|NCT02223182|583442104|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
161561387|NCT02223182|583442105|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
161561388|NCT02223182|583442102|FG000|Open-Label 300 Period|Non Compliance|0|||
161561389|NCT02223182|583442103|FG001|Open-Label 300 Period|Non Compliance|2|||
161561390|NCT02223182|583442104|FG002|Open-Label 300 Period|Non Compliance|1|||
161561391|NCT02223182|583442105|FG003|Open-Label 300 Period|Non Compliance|0|||
161561392|NCT04956692|583442112|FG000|Overall Study|Death|115|||
161561393|NCT04956692|583442113|FG001|Overall Study|Death|47|||
161561394|NCT04956692|583442112|FG000|Overall Study|Lost to Follow-up|0|||
161561395|NCT04956692|583442113|FG001|Overall Study|Lost to Follow-up|1|||
161561396|NCT04956692|583442112|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161561397|NCT04956692|583442113|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161561398|NCT04956692|583442112|FG000|Overall Study|Withdrawal by Subject|5|||
161561399|NCT04956692|583442113|FG001|Overall Study|Withdrawal by Subject|2|||
161561400|NCT04956692|583442112|FG000|Overall Study|Ongoing in Study|236|||
161561401|NCT04956692|583442113|FG001|Overall Study|Ongoing in Study|123|||
161561402|NCT02099539|583442118|FG000|Overall Study|Progressive Disease|3|||
161561403|NCT02099539|583442119|FG001|Overall Study|Progressive Disease|2|||
161561404|NCT02099539|583442120|FG002|Overall Study|Progressive Disease|2|||
161561405|NCT02099539|583442121|FG003|Overall Study|Progressive Disease|1|||
161561406|NCT02099539|583442122|FG004|Overall Study|Progressive Disease|4|||
161561407|NCT02099539|583442123|FG005|Overall Study|Progressive Disease|2|||
161561408|NCT02099539|583442124|FG006|Overall Study|Progressive Disease|0|||
161561409|NCT02099539|583442118|FG000|Overall Study|Adverse Event|0|||
161561410|NCT02099539|583442119|FG001|Overall Study|Adverse Event|0|||
161561411|NCT02099539|583442120|FG002|Overall Study|Adverse Event|1|||
161561412|NCT02099539|583442121|FG003|Overall Study|Adverse Event|1|||
161561413|NCT02099539|583442122|FG004|Overall Study|Adverse Event|0|||
161561414|NCT02099539|583442123|FG005|Overall Study|Adverse Event|0|||
161561415|NCT02099539|583442124|FG006|Overall Study|Adverse Event|0|||
161561416|NCT02099539|583442118|FG000|Overall Study|Physician Decision|0|||
161561417|NCT02099539|583442119|FG001|Overall Study|Physician Decision|0|||
161561418|NCT02099539|583442120|FG002|Overall Study|Physician Decision|0|||
161806543|NCT05093205|584335962|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806544|NCT05093205|584335963|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806545|NCT05093205|584335964|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806546|NCT05093205|584335965|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806547|NCT05093205|584335966|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
161806548|NCT05093205|584335967|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806549|NCT05093205|584335968|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806550|NCT05093205|584335956|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806551|NCT05093205|584335957|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806552|NCT05093205|584335958|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161561419|NCT02099539|583442121|FG003|Overall Study|Physician Decision|0|||
161806553|NCT05093205|584335959|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806554|NCT05093205|584335960|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806555|NCT05093205|584335961|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806556|NCT05093205|584335962|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161561420|NCT02099539|583442122|FG004|Overall Study|Physician Decision|0|||
161561421|NCT02099539|583442123|FG005|Overall Study|Physician Decision|1|||
161561422|NCT02099539|583442124|FG006|Overall Study|Physician Decision|0|||
161561423|NCT01211665|583444175|FG000|Overall Study|Withdrawal by Subject|1|||
161561424|NCT01211665|583444176|FG001|Overall Study|Withdrawal by Subject|0|||
161561425|NCT01211665|583444175|FG000|Overall Study|Death|1|||
161561426|NCT01211665|583444176|FG001|Overall Study|Death|0|||
161561427|NCT00498186|583444179|FG000|Overall Study|Protocol Violation|10|||
161561428|NCT00498186|583444179|FG000|Overall Study|Lack of Efficacy|31|||
161561429|NCT00498186|583444179|FG000|Overall Study|Adverse Event|89|||
161561430|NCT00498186|583444179|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
161561431|NCT00498186|583444179|FG000|Overall Study|Withdrawal by Subject|18|||
161561432|NCT00498186|583444179|FG000|Overall Study|Lost to Follow-up|3|||
161561433|NCT00498186|583444179|FG000|Overall Study|Other|10|||
161561434|NCT03302156|583444180|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
161561435|NCT03302156|583444181|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
161561436|NCT03302156|583444182|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
161561437|NCT03635112|583444184|FG000|Overall Study|Adverse Event|5|||
161561438|NCT03635112|583444185|FG001|Overall Study|Adverse Event|9|||
161561439|NCT03635112|583444186|FG002|Overall Study|Adverse Event|14|||
161561440|NCT03635112|583444184|FG000|Overall Study|Lost to Follow-up|1|||
161561441|NCT03635112|583444185|FG001|Overall Study|Lost to Follow-up|0|||
161561442|NCT03635112|583444186|FG002|Overall Study|Lost to Follow-up|1|||
161561443|NCT03635112|583444184|FG000|Overall Study|Physician Decision|5|||
161561444|NCT03635112|583444185|FG001|Overall Study|Physician Decision|7|||
161561445|NCT03635112|583444186|FG002|Overall Study|Physician Decision|5|||
161561446|NCT03635112|583444184|FG000|Overall Study|Protocol Violation|0|||
161561447|NCT03635112|583444185|FG001|Overall Study|Protocol Violation|0|||
161561448|NCT03635112|583444186|FG002|Overall Study|Protocol Violation|1|||
161561449|NCT03635112|583444184|FG000|Overall Study|Study Terminated by Sponsor|11|||
161561450|NCT03635112|583444185|FG001|Overall Study|Study Terminated by Sponsor|17|||
161561451|NCT03635112|583444186|FG002|Overall Study|Study Terminated by Sponsor|21|||
161561452|NCT03635112|583444184|FG000|Overall Study|Withdrawal by Subject|4|||
161561453|NCT03635112|583444185|FG001|Overall Study|Withdrawal by Subject|9|||
161561454|NCT03635112|583444186|FG002|Overall Study|Withdrawal by Subject|7|||
161806557|NCT05093205|584335963|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806558|NCT05093205|584335964|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806559|NCT05093205|584335965|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806560|NCT05093205|584335966|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806561|NCT05093205|584335967|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
161806562|NCT05093205|584335968|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806563|NCT05093205|584335956|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
161806564|NCT05093205|584335957|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
161806565|NCT05093205|584335958|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
161806566|NCT05093205|584335959|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
161806567|NCT05093205|584335960|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
161806568|NCT05093205|584335961|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
161806569|NCT05093205|584335962|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
161806570|NCT05093205|584335963|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
161806571|NCT05093205|584335964|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
161806572|NCT05093205|584335965|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
161806573|NCT05093205|584335966|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
161806574|NCT05093205|584335967|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
161806575|NCT05093205|584335968|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
161806576|NCT05093205|584335956|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806577|NCT05093205|584335957|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806578|NCT05093205|584335958|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806579|NCT05093205|584335959|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806580|NCT05093205|584335960|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806581|NCT05093205|584335961|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806582|NCT05093205|584335962|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806583|NCT05093205|584335963|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806584|NCT05093205|584335964|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806585|NCT05093205|584335965|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806586|NCT05093205|584335966|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806587|NCT05093205|584335967|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
161806588|NCT05093205|584335968|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806589|NCT00268905|584335978|FG000|Overall Study|Adverse Event|3|||
161806590|NCT00268905|584335979|FG001|Overall Study|Adverse Event|0|||
161806591|NCT00268905|584335980|FG002|Overall Study|Adverse Event|4|||
161806592|NCT00268905|584335978|FG000|Overall Study|Lost to Follow-up|0|||
161806593|NCT00268905|584335979|FG001|Overall Study|Lost to Follow-up|1|||
161806594|NCT00268905|584335980|FG002|Overall Study|Lost to Follow-up|0|||
161806595|NCT00268905|584335978|FG000|Overall Study|Withdrawal by Subject|0|||
161806596|NCT00268905|584335979|FG001|Overall Study|Withdrawal by Subject|0|||
161806597|NCT00268905|584335980|FG002|Overall Study|Withdrawal by Subject|3|||
161806598|NCT00268905|584335978|FG000|Overall Study|Progressive Disease|28|||
161806599|NCT00268905|584335979|FG001|Overall Study|Progressive Disease|4|||
161910097|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
161910098|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
161910099|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
161910100|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
161910101|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
161910102|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
161910103|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
161910104|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
161910105|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
161910106|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
161910107|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
161910108|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161910109|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
161910110|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161910111|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161910112|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
161910113|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
161910114|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
161910115|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
161910116|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
161910117|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
161910118|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
161910119|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
161910120|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
161910121|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
161910122|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
161910123|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
161561455|NCT03635112|583444184|FG000|Overall Study|Miscellaneous|0|||
161910124|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161910125|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161910126|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
161910127|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161910128|NCT00784875|584723490|FG000|Period C|Adverse Event|1|||
161910129|NCT00784875|584723491|FG001|Period C|Adverse Event|0|||
161910130|NCT00784875|584723492|FG002|Period C|Adverse Event|4|||
161910131|NCT00784875|584723493|FG003|Period C|Adverse Event|2|||
161910132|NCT00784875|584723490|FG000|Period C|Protocol Violation|0|||
161910133|NCT00784875|584723491|FG001|Period C|Protocol Violation|0|||
161910134|NCT00784875|584723492|FG002|Period C|Protocol Violation|1|||
161910135|NCT00784875|584723493|FG003|Period C|Protocol Violation|2|||
161910136|NCT00784875|584723490|FG000|Period C|Lack of Efficacy|0|||
161561456|NCT03635112|583444185|FG001|Overall Study|Miscellaneous|0|||
161561457|NCT03635112|583444186|FG002|Overall Study|Miscellaneous|1|||
161561458|NCT03283553|583444191|FG000|Patient Participant Flow|Death|5|||
161561459|NCT03283553|583444192|FG001|Patient Participant Flow|Death|10|||
161561460|NCT03283553|583444191|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
161561461|NCT03283553|583444192|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
161561462|NCT03283553|583444191|FG000|Patient Participant Flow|Lost to Follow-up|1|||
161561463|NCT03283553|583444192|FG001|Patient Participant Flow|Lost to Follow-up|1|||
161561464|NCT03283553|583444191|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
161561465|NCT03283553|583444192|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
161561466|NCT03283553|583444191|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
161561467|NCT03283553|583444192|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
161561468|NCT03283553|583444191|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
161561469|NCT03283553|583444192|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
161561470|NCT03686683|583444193|FG000|Overall Study|Withdrawal by Subject|52|||
161561471|NCT03686683|583444194|FG001|Overall Study|Withdrawal by Subject|32|||
161561472|NCT03686683|583444193|FG000|Overall Study|Lost to Follow-up|23|||
161561473|NCT03686683|583444194|FG001|Overall Study|Lost to Follow-up|19|||
161561474|NCT03686683|583444193|FG000|Overall Study|Adverse Event|1|||
161561475|NCT03686683|583444194|FG001|Overall Study|Adverse Event|0|||
161561476|NCT03686683|583444193|FG000|Overall Study|Death|10|||
161561477|NCT03686683|583444194|FG001|Overall Study|Death|5|||
161561478|NCT03686683|583444193|FG000|Overall Study|Progressive Disease|1|||
161561479|NCT03686683|583444194|FG001|Overall Study|Progressive Disease|1|||
161910137|NCT00784875|584723491|FG001|Period C|Lack of Efficacy|0|||
161910138|NCT00784875|584723492|FG002|Period C|Lack of Efficacy|1|||
161910139|NCT00784875|584723493|FG003|Period C|Lack of Efficacy|0|||
161910140|NCT00784875|584723490|FG000|Period C|Withdrawal by Subject|1|||
161910141|NCT00784875|584723491|FG001|Period C|Withdrawal by Subject|1|||
161910142|NCT00784875|584723492|FG002|Period C|Withdrawal by Subject|2|||
161910143|NCT00784875|584723493|FG003|Period C|Withdrawal by Subject|0|||
161910144|NCT00784875|584723490|FG000|Period C|Physician Decision|0|||
161910145|NCT00784875|584723491|FG001|Period C|Physician Decision|0|||
161453288|NCT01011309|583053619|FG001|Overall Study|Adverse Event|1|||
161453289|NCT01011309|583053620|FG002|Overall Study|Adverse Event|2|||
161453290|NCT01011309|583053618|FG000|Overall Study|Lack of Efficacy|0|||
161453291|NCT01011309|583053619|FG001|Overall Study|Lack of Efficacy|1|||
161453292|NCT01011309|583053620|FG002|Overall Study|Lack of Efficacy|0|||
161453293|NCT01011309|583053618|FG000|Overall Study|Protocol Violation|0|||
161453294|NCT01011309|583053619|FG001|Overall Study|Protocol Violation|1|||
161453295|NCT01011309|583053620|FG002|Overall Study|Protocol Violation|3|||
161453296|NCT00530504|583053623|FG000|Overall Study|Death|54|||
161453297|NCT00530504|583053623|FG000|Overall Study|Lost to Follow-up|26|||
161453298|NCT00530504|583053623|FG000|Overall Study|Withdrawal by Subject|39|||
161453299|NCT00530504|583053623|FG000|Overall Study|Exited study due to other reasons|33|||
161453300|NCT00006289|583053624|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
161453301|NCT00006289|583053625|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
161453302|NCT00006289|583053624|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
161453303|NCT00006289|583053625|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
161453304|NCT00576420|583055305|FG000|Overall Study|Death|0|||
161453305|NCT00576420|583055306|FG001|Overall Study|Death|0|||
161453306|NCT00576420|583055307|FG002|Overall Study|Death|1|||
161453307|NCT02616146|583055308|FG000|Overall Study|Adverse Event|64|||
161453308|NCT02616146|583055309|FG001|Overall Study|Adverse Event|24|||
161453309|NCT02616146|583055308|FG000|Overall Study|Lost to Follow-up|23|||
161453310|NCT02616146|583055309|FG001|Overall Study|Lost to Follow-up|13|||
161453311|NCT02616146|583055308|FG000|Overall Study|Non-compliance with study protocol|2|||
161453312|NCT02616146|583055309|FG001|Overall Study|Non-compliance with study protocol|0|||
161453313|NCT02616146|583055308|FG000|Overall Study|Non-compliance with study drug|4|||
161453314|NCT02616146|583055309|FG001|Overall Study|Non-compliance with study drug|2|||
161453315|NCT02616146|583055308|FG000|Overall Study|Pregnancy|2|||
161453316|NCT02616146|583055309|FG001|Overall Study|Pregnancy|2|||
161453317|NCT02616146|583055308|FG000|Overall Study|Pregnancy wish|3|||
161453318|NCT02616146|583055309|FG001|Overall Study|Pregnancy wish|0|||
161453319|NCT02616146|583055308|FG000|Overall Study|Protocol Violation|6|||
161453320|NCT02616146|583055309|FG001|Overall Study|Protocol Violation|3|||
161453321|NCT02616146|583055308|FG000|Overall Study|Study terminated by sponsor|1372|||
161453322|NCT02616146|583055309|FG001|Overall Study|Study terminated by sponsor|432|||
161453323|NCT02616146|583055308|FG000|Overall Study|Participant moved|4|||
161453324|NCT02616146|583055309|FG001|Overall Study|Participant moved|3|||
161453325|NCT02616146|583055308|FG000|Overall Study|Withdrawal by Subject|30|||
161453326|NCT02616146|583055309|FG001|Overall Study|Withdrawal by Subject|24|||
161453327|NCT02616146|583055308|FG000|Overall Study|Physician Decision|2|||
161453328|NCT02616146|583055309|FG001|Overall Study|Physician Decision|1|||
161453329|NCT01221272|583055310|FG000|Period 1|Adverse Event|2|||
161453330|NCT01221272|583055311|FG001|Period 1|Adverse Event|0|||
161453331|NCT01221272|583055310|FG000|Period 1|Consent Withdrawal|0|||
161453332|NCT01221272|583055311|FG001|Period 1|Consent Withdrawal|1|||
161453333|NCT01221272|583055310|FG000|Period 1|Significant Dosing Noncompliance|0|||
161453334|NCT01221272|583055311|FG001|Period 1|Significant Dosing Noncompliance|1|||
161453335|NCT01221272|583055310|FG000|Period 2|Adverse Event|0|||
161453336|NCT01221272|583055311|FG001|Period 2|Adverse Event|2|||
161453337|NCT01340872|583055312|FG000|Double-blind Phase|Adverse Event|6|||
161453338|NCT01340872|583055313|FG001|Double-blind Phase|Adverse Event|4|||
161453339|NCT01340872|583055314|FG002|Double-blind Phase|Adverse Event|0|||
161453340|NCT01340872|583055315|FG003|Double-blind Phase|Adverse Event|0|||
161453341|NCT01340872|583055312|FG000|Double-blind Phase|Withdrawal by Subject|3|||
161453342|NCT01340872|583055313|FG001|Double-blind Phase|Withdrawal by Subject|5|||
161453343|NCT01340872|583055314|FG002|Double-blind Phase|Withdrawal by Subject|0|||
161453344|NCT01340872|583055315|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161453345|NCT01340872|583055312|FG000|Double-blind Phase|Lost to Follow-up|0|||
161453346|NCT01340872|583055313|FG001|Double-blind Phase|Lost to Follow-up|1|||
161453347|NCT01340872|583055314|FG002|Double-blind Phase|Lost to Follow-up|0|||
161453348|NCT01340872|583055315|FG003|Double-blind Phase|Lost to Follow-up|0|||
161453349|NCT01340872|583055312|FG000|Double-blind Phase|Protocol Violation|0|||
161453350|NCT01340872|583055313|FG001|Double-blind Phase|Protocol Violation|1|||
161453351|NCT01340872|583055314|FG002|Double-blind Phase|Protocol Violation|0|||
161453352|NCT01340872|583055315|FG003|Double-blind Phase|Protocol Violation|0|||
161453353|NCT01340872|583055312|FG000|Open-label Phase|Physician Decision|0|||
161453354|NCT01340872|583055313|FG001|Open-label Phase|Physician Decision|0|||
161453355|NCT01340872|583055314|FG002|Open-label Phase|Physician Decision|2|||
161453356|NCT01340872|583055315|FG003|Open-label Phase|Physician Decision|1|||
161453357|NCT01340872|583055312|FG000|Open-label Phase|Pregnancy|0|||
161453358|NCT01340872|583055313|FG001|Open-label Phase|Pregnancy|0|||
161453359|NCT01340872|583055314|FG002|Open-label Phase|Pregnancy|1|||
161453360|NCT01340872|583055315|FG003|Open-label Phase|Pregnancy|0|||
161453361|NCT01340872|583055312|FG000|Open-label Phase|Adverse Event|0|||
161453362|NCT01340872|583055313|FG001|Open-label Phase|Adverse Event|0|||
161453363|NCT01340872|583055314|FG002|Open-label Phase|Adverse Event|8|||
161453364|NCT01340872|583055315|FG003|Open-label Phase|Adverse Event|4|||
161453365|NCT01340872|583055312|FG000|Open-label Phase|Withdrawal by Subject|0|||
161453366|NCT01340872|583055313|FG001|Open-label Phase|Withdrawal by Subject|0|||
161453367|NCT01340872|583055314|FG002|Open-label Phase|Withdrawal by Subject|1|||
161453368|NCT01340872|583055315|FG003|Open-label Phase|Withdrawal by Subject|6|||
161453369|NCT01340872|583055312|FG000|Open-label Phase|Worsening of IBD|0|||
161453370|NCT01340872|583055313|FG001|Open-label Phase|Worsening of IBD|0|||
161453371|NCT01340872|583055314|FG002|Open-label Phase|Worsening of IBD|1|||
161453372|NCT01340872|583055315|FG003|Open-label Phase|Worsening of IBD|0|||
161453373|NCT03039621|583055320|FG000|Overall Study|Violation of inclusion criteria|3|||
161453374|NCT03039621|583055321|FG001|Overall Study|Violation of inclusion criteria|2|||
161453375|NCT03039621|583055320|FG000|Overall Study|Non-compliance with protocol requirement|4|||
161453376|NCT03039621|583055321|FG001|Overall Study|Non-compliance with protocol requirement|5|||
161453377|NCT03039621|583055320|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
161453378|NCT03039621|583055321|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
161453379|NCT03039621|583055320|FG000|Overall Study|Violation of non-inclusion criteria|1|||
161453380|NCT03039621|583055321|FG001|Overall Study|Violation of non-inclusion criteria|2|||
161453381|NCT03254108|583055322|FG000|Overall Study|Adverse Event|0|||
161453382|NCT03254108|583055323|FG001|Overall Study|Adverse Event|2|||
161453383|NCT03254108|583055324|FG002|Overall Study|Adverse Event|0|||
161453384|NCT03254108|583055325|FG003|Overall Study|Adverse Event|1|||
161453385|NCT03254108|583055326|FG004|Overall Study|Adverse Event|1|||
161453386|NCT03254108|583055322|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
161453387|NCT03254108|583055323|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
161453388|NCT03254108|583055324|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
161453389|NCT03254108|583055325|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
161453390|NCT03254108|583055326|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
161453391|NCT00362180|583055327|FG000|Treated Period|Withdrawal by Subject|1|||
161453392|NCT00362180|583055328|FG001|Treated Period|Withdrawal by Subject|0|||
161453393|NCT00362180|583055329|FG002|Treated Period|Withdrawal by Subject|0|||
161453394|NCT00362180|583055330|FG003|Treated Period|Withdrawal by Subject|0|||
161453395|NCT00362180|583055331|FG004|Treated Period|Withdrawal by Subject|0|||
161453396|NCT00362180|583055332|FG005|Treated Period|Withdrawal by Subject|0|||
161453397|NCT00362180|583055333|FG006|Treated Period|Withdrawal by Subject|0|||
161453398|NCT00362180|583055334|FG007|Treated Period|Withdrawal by Subject|0|||
161453399|NCT00362180|583055335|FG008|Treated Period|Withdrawal by Subject|0|||
161453400|NCT00362180|583055327|FG000|Treated Period|Adverse Event|0|||
161453401|NCT00362180|583055328|FG001|Treated Period|Adverse Event|0|||
161453402|NCT00362180|583055329|FG002|Treated Period|Adverse Event|0|||
161453403|NCT00362180|583055330|FG003|Treated Period|Adverse Event|0|||
161453404|NCT00362180|583055331|FG004|Treated Period|Adverse Event|0|||
161453405|NCT00362180|583055332|FG005|Treated Period|Adverse Event|1|||
161453406|NCT00362180|583055333|FG006|Treated Period|Adverse Event|0|||
161453407|NCT00362180|583055334|FG007|Treated Period|Adverse Event|1|||
161453408|NCT00362180|583055335|FG008|Treated Period|Adverse Event|0|||
161453409|NCT02600871|583055338|FG000|Overall Study|Lost to Follow-up|13|||
161453410|NCT02600871|583055339|FG001|Overall Study|Lost to Follow-up|10|||
161453411|NCT01246466|583055343|FG000|Overall Study|Death|1|||
161453412|NCT01246466|583055343|FG000|Overall Study|Withdrawal by Subject|1|||
161453413|NCT01142089|583055344|FG000|Overall Study|Physician Decision|1|||
161453414|NCT01142089|583055345|FG001|Overall Study|Physician Decision|0|||
161453415|NCT01142089|583055344|FG000|Overall Study|Withdrawal by Subject|1|||
161453416|NCT01142089|583055345|FG001|Overall Study|Withdrawal by Subject|2|||
161453417|NCT01142089|583055344|FG000|Overall Study|Use of prohibited medications|0|||
161453418|NCT01142089|583055345|FG001|Overall Study|Use of prohibited medications|1|||
161453419|NCT01142089|583055344|FG000|Overall Study|Noncompliance with study procedures|2|||
161453420|NCT01142089|583055345|FG001|Overall Study|Noncompliance with study procedures|1|||
161453421|NCT01142089|583055344|FG000|Overall Study|Patient required rescue medication|8|||
161453422|NCT01142089|583055345|FG001|Overall Study|Patient required rescue medication|17|||
161453423|NCT00348933|583055348|FG000|Overall Study|Withdrawal by Subject|10|||
161453424|NCT00348933|583055348|FG000|Overall Study|Lost to Follow-up|6|||
161453425|NCT00348933|583055348|FG000|Overall Study|Protocol Violation|2|||
161453426|NCT00348933|583055348|FG000|Overall Study|Adverse Event|7|||
161453427|NCT01489111|583055349|FG000|Overall Study|Withdrawal criterion|1|||
161453428|NCT00003472|583055352|FG000|Overall Study|Not evaluable|3|||
161453429|NCT00874939|583055353|FG000|Overall Study|Study terminated|4|||
161453430|NCT01444092|583055354|FG000|Overall Study|Adverse Event|8|||
161453431|NCT01444092|583055354|FG000|Overall Study|Protocol Violation|1|||
161453432|NCT01444092|583055354|FG000|Overall Study|Withdrawal by Subject|1|||
161453433|NCT01444092|583055354|FG000|Overall Study|Other Eligibility criteria|7|||
161453434|NCT00603590|583055355|FG000|Overall Study|Did not attend study clinic|39|||
161453435|NCT00603590|583055356|FG001|Overall Study|Did not attend study clinic|30|||
161453436|NCT00603590|583055355|FG000|Overall Study|Refused blood test|5|||
161453437|NCT00603590|583055356|FG001|Overall Study|Refused blood test|1|||
161453438|NCT00603590|583055355|FG000|Overall Study|Patient discontinued study drug|22|||
161453439|NCT00603590|583055356|FG001|Overall Study|Patient discontinued study drug|15|||
161453440|NCT00603590|583055355|FG000|Overall Study|Adverse Event|2|||
161453441|NCT00603590|583055356|FG001|Overall Study|Adverse Event|0|||
161453442|NCT00603590|583055355|FG000|Overall Study|Lost to Follow-up|8|||
161453443|NCT00603590|583055356|FG001|Overall Study|Lost to Follow-up|4|||
161453444|NCT00603590|583055355|FG000|Overall Study|Cardiovascular event|0|||
161453445|NCT00603590|583055356|FG001|Overall Study|Cardiovascular event|1|||
161453446|NCT03005873|583055360|FG000|Overall Study|Prohibited medication use post radnomization|1|||
161453447|NCT03005873|583055361|FG001|Overall Study|Prohibited medication use post radnomization|1|||
161453448|NCT03005873|583055362|FG002|Overall Study|Prohibited medication use post radnomization|1|||
161453449|NCT03005873|583055360|FG000|Overall Study|Withdrew consent|0|||
161453450|NCT03005873|583055361|FG001|Overall Study|Withdrew consent|1|||
161453451|NCT03005873|583055362|FG002|Overall Study|Withdrew consent|2|||
161453452|NCT03005873|583055360|FG000|Overall Study|Lost to Follow-up|0|||
161453453|NCT03005873|583055361|FG001|Overall Study|Lost to Follow-up|1|||
161453454|NCT03005873|583055362|FG002|Overall Study|Lost to Follow-up|0|||
161453455|NCT03005873|583055360|FG000|Overall Study|Ineligible post randomization|0|||
161453456|NCT03005873|583055361|FG001|Overall Study|Ineligible post randomization|0|||
161453457|NCT03005873|583055362|FG002|Overall Study|Ineligible post randomization|1|||
161453458|NCT04585009|583055363|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
161453459|NCT04585009|583055364|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453460|NCT04585009|583055365|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453461|NCT04585009|583055366|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453462|NCT04585009|583055367|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453463|NCT04585009|583055368|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453464|NCT04585009|583055369|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453465|NCT04585009|583055370|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453466|NCT04585009|583055371|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453467|NCT04585009|583055372|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453468|NCT04585009|583055373|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453469|NCT04585009|583055374|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161453470|NCT04585009|583055363|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
161453471|NCT04585009|583055364|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453472|NCT04585009|583055365|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453473|NCT04585009|583055366|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453474|NCT04585009|583055367|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453475|NCT04585009|583055368|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453476|NCT04585009|583055369|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453477|NCT04585009|583055370|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453478|NCT04585009|583055371|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453479|NCT04585009|583055372|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453480|NCT04585009|583055373|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453481|NCT04585009|583055374|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
161453482|NCT04585009|583055363|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453483|NCT04585009|583055364|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453484|NCT04585009|583055365|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453485|NCT04585009|583055366|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453486|NCT04585009|583055367|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453487|NCT04585009|583055368|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453488|NCT04585009|583055369|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453489|NCT04585009|583055370|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
161453490|NCT04585009|583055371|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453491|NCT04585009|583055372|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453492|NCT04585009|583055373|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453493|NCT04585009|583055374|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
161453494|NCT04585009|583055363|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453495|NCT04585009|583055364|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453496|NCT04585009|583055365|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453497|NCT04585009|583055366|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453498|NCT04585009|583055367|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
161453499|NCT04585009|583055368|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453500|NCT04585009|583055369|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453501|NCT04585009|583055370|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161910146|NCT00784875|584723492|FG002|Period C|Physician Decision|1|||
161910147|NCT00784875|584723493|FG003|Period C|Physician Decision|1|||
161910148|NCT00784875|584723490|FG000|Period C|Sponsor Decision|5|||
161910149|NCT00784875|584723491|FG001|Period C|Sponsor Decision|5|||
161910150|NCT00784875|584723492|FG002|Period C|Sponsor Decision|4|||
161910151|NCT00784875|584723493|FG003|Period C|Sponsor Decision|2|||
161910152|NCT00784875|584723490|FG000|Period D|Adverse Event|0|||
161910153|NCT00784875|584723491|FG001|Period D|Adverse Event|2|||
161910154|NCT00784875|584723492|FG002|Period D|Adverse Event|2|||
161910155|NCT00784875|584723493|FG003|Period D|Adverse Event|0|||
161910156|NCT00784875|584723490|FG000|Period D|Protocol Violation|1|||
161910157|NCT00784875|584723491|FG001|Period D|Protocol Violation|0|||
161910158|NCT00784875|584723492|FG002|Period D|Protocol Violation|0|||
161910159|NCT00784875|584723493|FG003|Period D|Protocol Violation|0|||
161910160|NCT00784875|584723490|FG000|Period D|Withdrawal by Subject|2|||
161910161|NCT00784875|584723491|FG001|Period D|Withdrawal by Subject|0|||
161910162|NCT00784875|584723492|FG002|Period D|Withdrawal by Subject|2|||
161910163|NCT00784875|584723493|FG003|Period D|Withdrawal by Subject|0|||
161910164|NCT00784875|584723490|FG000|Period D|Physician Decision|0|||
161910165|NCT00784875|584723491|FG001|Period D|Physician Decision|1|||
161910166|NCT00784875|584723492|FG002|Period D|Physician Decision|0|||
161910167|NCT00784875|584723493|FG003|Period D|Physician Decision|0|||
161910168|NCT00784875|584723490|FG000|Period D|Sponsor Decision|1|||
161910169|NCT00784875|584723491|FG001|Period D|Sponsor Decision|1|||
161910170|NCT00784875|584723492|FG002|Period D|Sponsor Decision|1|||
161910171|NCT00784875|584723493|FG003|Period D|Sponsor Decision|0|||
161910172|NCT00784875|584723490|FG000|Period D|Lost to Follow-up|1|||
161910173|NCT00784875|584723491|FG001|Period D|Lost to Follow-up|0|||
161910174|NCT00784875|584723492|FG002|Period D|Lost to Follow-up|1|||
161910175|NCT00784875|584723493|FG003|Period D|Lost to Follow-up|1|||
161910176|NCT00958074|584723494|FG000|Overall Study|Withdrawal by Subject|0|||
161910177|NCT00958074|584723495|FG001|Overall Study|Withdrawal by Subject|1|||
161910178|NCT01829347|584723500|FG000|VTI-210|Death|5|||
161910179|NCT01829347|584723501|FG001|VTI-210|Death|3|||
161910180|NCT01829347|584723500|FG000|VTI-210|Withdrawal by Subject|1|||
161910181|NCT01829347|584723501|FG001|VTI-210|Withdrawal by Subject|0|||
161910182|NCT01829347|584723500|FG000|VTI-210E|Death|2|||
161910183|NCT01829347|584723501|FG001|VTI-210E|Death|1|||
161910184|NCT01829347|584723500|FG000|VTI-210E|Study terminated prematurely|1|||
161910185|NCT01829347|584723501|FG001|VTI-210E|Study terminated prematurely|5|||
161910186|NCT02515227|584723502|FG000|Overall Study|Adverse Event|0|||
161910187|NCT02515227|584723503|FG001|Overall Study|Adverse Event|2|||
161910188|NCT02515227|584723502|FG000|Overall Study|Progressive disease|2|||
161910189|NCT02515227|584723503|FG001|Overall Study|Progressive disease|9|||
161910190|NCT03451071|584723510|FG000|First Vaccine|Withdrawal by Subject|1|||
161910191|NCT03451071|584723510|FG000|Second Vaccine|Lost to Follow-up|19|||
161910192|NCT03451071|584723510|FG000|Third Vaccine|Lost to Follow-up|22|||
161910193|NCT03451071|584723510|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
161910194|NCT00250588|584723511|FG000|Overall Study|Withdrawal by Subject|3|||
161806600|NCT00268905|584335980|FG002|Overall Study|Progressive Disease|3|||
161806601|NCT00268905|584335978|FG000|Overall Study|Physician Decision|3|||
161806602|NCT00268905|584335979|FG001|Overall Study|Physician Decision|0|||
161806603|NCT00268905|584335980|FG002|Overall Study|Physician Decision|1|||
161806604|NCT00268905|584335978|FG000|Overall Study|Clinical Progression|9|||
161806605|NCT00268905|584335979|FG001|Overall Study|Clinical Progression|4|||
161806606|NCT00268905|584335980|FG002|Overall Study|Clinical Progression|1|||
161806607|NCT04510285|584335981|FG000|Overall Study|Death|1|||
161806608|NCT00048581|584335982|FG000|Double-Blind Period|Adverse Event|9|||
161806609|NCT00048581|584335983|FG001|Double-Blind Period|Adverse Event|5|||
161910195|NCT00250588|584723512|FG001|Overall Study|Withdrawal by Subject|6|||
161910196|NCT00250588|584723513|FG002|Overall Study|Withdrawal by Subject|0|||
161910197|NCT00250588|584723511|FG000|Overall Study|Lost to Follow-up|6|||
161910198|NCT00250588|584723512|FG001|Overall Study|Lost to Follow-up|13|||
161910199|NCT00250588|584723513|FG002|Overall Study|Lost to Follow-up|13|||
161910200|NCT00706797|584723514|FG000|Overall Study|Lack of Efficacy|3|||
161910201|NCT00706797|584723515|FG001|Overall Study|Lack of Efficacy|0|||
161910202|NCT00706797|584723514|FG000|Overall Study|Adverse Event|0|||
161910203|NCT00706797|584723515|FG001|Overall Study|Adverse Event|3|||
161910204|NCT00706797|584723514|FG000|Overall Study|Withdrawal by Subject|8|||
161910205|NCT00706797|584723515|FG001|Overall Study|Withdrawal by Subject|1|||
161910206|NCT00706797|584723514|FG000|Overall Study|Death|1|||
161910207|NCT00706797|584723515|FG001|Overall Study|Death|0|||
161910208|NCT00706797|584723514|FG000|Overall Study|Discontinuation of study by sponsor|52|||
161910209|NCT00706797|584723515|FG001|Overall Study|Discontinuation of study by sponsor|63|||
161910210|NCT00706797|584723514|FG000|Overall Study|Protocol Violation|3|||
161806610|NCT00048581|584335984|FG002|Double-Blind Period|Adverse Event|0|||
161910211|NCT00706797|584723515|FG001|Overall Study|Protocol Violation|2|||
161910212|NCT00706797|584723514|FG000|Overall Study|Lost to Follow-up|1|||
161910213|NCT00706797|584723515|FG001|Overall Study|Lost to Follow-up|2|||
161910214|NCT00706797|584723514|FG000|Overall Study|Other|1|||
161910215|NCT00706797|584723515|FG001|Overall Study|Other|0|||
161910216|NCT01670292|584723518|FG000|Overall Study|Lost to Follow-up|14|||
161910217|NCT03555149|584723522|FG000|Overall Study|Death|18|||
161910218|NCT03555149|584723523|FG001|Overall Study|Death|15|||
161910219|NCT03555149|584723524|FG002|Overall Study|Death|15|||
161910220|NCT03555149|584723525|FG003|Overall Study|Death|4|||
161561480|NCT03686683|583444193|FG000|Overall Study|Noncompliance|1|||
161561481|NCT03686683|583444194|FG001|Overall Study|Noncompliance|0|||
161561482|NCT03686683|583444193|FG000|Overall Study|Physician Decision|1|||
161561483|NCT03686683|583444194|FG001|Overall Study|Physician Decision|1|||
161561484|NCT03686683|583444193|FG000|Overall Study|Screen fail post-randomization|1|||
161561485|NCT03686683|583444194|FG001|Overall Study|Screen fail post-randomization|0|||
161561486|NCT03686683|583444193|FG000|Overall Study|Protocol Violation|3|||
161561487|NCT03686683|583444194|FG001|Overall Study|Protocol Violation|0|||
161561488|NCT03686683|583444193|FG000|Overall Study|No data available|1|||
161561489|NCT03686683|583444194|FG001|Overall Study|No data available|0|||
161910221|NCT03555149|584723526|FG004|Overall Study|Death|4|||
161910222|NCT03555149|584723527|FG005|Overall Study|Death|11|||
161910223|NCT03555149|584723528|FG006|Overall Study|Death|12|||
161910224|NCT03555149|584723529|FG007|Overall Study|Death|1|||
161910225|NCT03555149|584723522|FG000|Overall Study|Lost to Follow-up|1|||
161910226|NCT03555149|584723523|FG001|Overall Study|Lost to Follow-up|0|||
161910227|NCT03555149|584723524|FG002|Overall Study|Lost to Follow-up|0|||
161910228|NCT03555149|584723525|FG003|Overall Study|Lost to Follow-up|0|||
161910229|NCT03555149|584723526|FG004|Overall Study|Lost to Follow-up|0|||
161910230|NCT03555149|584723527|FG005|Overall Study|Lost to Follow-up|1|||
161910231|NCT03555149|584723528|FG006|Overall Study|Lost to Follow-up|0|||
161910232|NCT03555149|584723529|FG007|Overall Study|Lost to Follow-up|0|||
161910233|NCT03555149|584723522|FG000|Overall Study|Physician Decision|1|||
161910234|NCT03555149|584723523|FG001|Overall Study|Physician Decision|0|||
161910235|NCT03555149|584723524|FG002|Overall Study|Physician Decision|0|||
161910236|NCT03555149|584723525|FG003|Overall Study|Physician Decision|0|||
161910237|NCT03555149|584723526|FG004|Overall Study|Physician Decision|0|||
161910238|NCT03555149|584723527|FG005|Overall Study|Physician Decision|0|||
161910239|NCT03555149|584723528|FG006|Overall Study|Physician Decision|0|||
161910240|NCT03555149|584723529|FG007|Overall Study|Physician Decision|0|||
161910241|NCT03555149|584723522|FG000|Overall Study|Study Terminated By Sponsor|1|||
161910242|NCT03555149|584723523|FG001|Overall Study|Study Terminated By Sponsor|0|||
161910243|NCT03555149|584723524|FG002|Overall Study|Study Terminated By Sponsor|0|||
161910244|NCT03555149|584723525|FG003|Overall Study|Study Terminated By Sponsor|0|||
161910245|NCT03555149|584723526|FG004|Overall Study|Study Terminated By Sponsor|0|||
161910246|NCT03555149|584723527|FG005|Overall Study|Study Terminated By Sponsor|2|||
161910247|NCT03555149|584723528|FG006|Overall Study|Study Terminated By Sponsor|3|||
161910248|NCT03555149|584723529|FG007|Overall Study|Study Terminated By Sponsor|1|||
161910249|NCT03555149|584723522|FG000|Overall Study|Withdrawal by Subject|3|||
161910250|NCT03555149|584723523|FG001|Overall Study|Withdrawal by Subject|0|||
161910251|NCT03555149|584723524|FG002|Overall Study|Withdrawal by Subject|0|||
161910252|NCT03555149|584723525|FG003|Overall Study|Withdrawal by Subject|2|||
161910253|NCT03555149|584723526|FG004|Overall Study|Withdrawal by Subject|0|||
161910254|NCT03555149|584723527|FG005|Overall Study|Withdrawal by Subject|1|||
161910255|NCT03555149|584723528|FG006|Overall Study|Withdrawal by Subject|0|||
161910256|NCT03555149|584723529|FG007|Overall Study|Withdrawal by Subject|0|||
161910257|NCT01692119|584723535|FG000|Overall Study|Protocol Violation|3|||
161910258|NCT01692119|584723536|FG001|Overall Study|Protocol Violation|1|||
161910259|NCT01692119|584723535|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
161910260|NCT01692119|584723536|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
161910261|NCT04656652|584723537|FG000|Overall Study|Lost to Follow-up|2|||
161910262|NCT04656652|584723538|FG001|Overall Study|Lost to Follow-up|2|||
161910263|NCT04656652|584723537|FG000|Overall Study|Death|213|||
161910264|NCT04656652|584723538|FG001|Overall Study|Death|212|||
161561490|NCT01770860|583444195|FG000|Overall Study|Withdrawal by Subject|4|||
161561491|NCT01770860|583444195|FG000|Overall Study|Lost to Follow-up|1|||
161561492|NCT01770860|583444195|FG000|Overall Study|Administrative decision made by the PI|1|||
161910265|NCT04656652|584723537|FG000|Overall Study|Other|1|||
161910266|NCT04656652|584723538|FG001|Overall Study|Other|0|||
161910267|NCT04656652|584723537|FG000|Overall Study|Withdrawal by Subject|15|||
161910268|NCT04656652|584723538|FG001|Overall Study|Withdrawal by Subject|29|||
161561493|NCT05124899|583444196|FG000|Overall Study|Lost to Follow-up|3|||
161561494|NCT03432533|583444201|FG000|Overall Study|Lost to Follow-up|1|||
161561495|NCT03432533|583444202|FG001|Overall Study|Lost to Follow-up|2|||
161561496|NCT03432533|583444201|FG000|Overall Study|Withdrawal by Subject|14|||
161910269|NCT02722967|584723539|FG000|Overall Study|Adverse Event|1|||
161910270|NCT02722967|584723540|FG001|Overall Study|Adverse Event|0|||
161910271|NCT02722967|584723541|FG002|Overall Study|Adverse Event|0|||
161910272|NCT02722967|584723539|FG000|Overall Study|Lost to Follow-up|0|||
161910273|NCT02722967|584723540|FG001|Overall Study|Lost to Follow-up|1|||
161910274|NCT02722967|584723541|FG002|Overall Study|Lost to Follow-up|0|||
161910275|NCT02722967|584723539|FG000|Overall Study|Non-compliance with patch wearing|2|||
161910276|NCT02722967|584723540|FG001|Overall Study|Non-compliance with patch wearing|1|||
161910277|NCT02722967|584723541|FG002|Overall Study|Non-compliance with patch wearing|1|||
161561497|NCT03432533|583444202|FG001|Overall Study|Withdrawal by Subject|9|||
161806611|NCT00048581|584335982|FG000|Double-Blind Period|Lack of Efficacy|14|||
161806612|NCT00048581|584335983|FG001|Double-Blind Period|Lack of Efficacy|27|||
161806613|NCT00048581|584335984|FG002|Double-Blind Period|Lack of Efficacy|0|||
161806614|NCT00048581|584335982|FG000|Double-Blind Period|Lost to Follow-up|5|||
161806615|NCT00048581|584335983|FG001|Double-Blind Period|Lost to Follow-up|0|||
161806616|NCT00048581|584335984|FG002|Double-Blind Period|Lost to Follow-up|0|||
161806617|NCT00048581|584335982|FG000|Double-Blind Period|Withdrawal by Subject|5|||
161806618|NCT00048581|584335983|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161806619|NCT00048581|584335984|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161806620|NCT00048581|584335982|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
161806621|NCT00048581|584335983|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
161806622|NCT00048581|584335984|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
161806623|NCT00048581|584335982|FG000|Double-Blind Period|Investigator Decision|1|||
161806624|NCT00048581|584335983|FG001|Double-Blind Period|Investigator Decision|0|||
161806625|NCT00048581|584335984|FG002|Double-Blind Period|Investigator Decision|0|||
161806626|NCT00048581|584335982|FG000|Open-Label Period|Death|0|||
161806627|NCT00048581|584335983|FG001|Open-Label Period|Death|0|||
161806628|NCT00048581|584335984|FG002|Open-Label Period|Death|4|||
161806629|NCT00048581|584335982|FG000|Open-Label Period|Adverse Event|0|||
161806630|NCT00048581|584335983|FG001|Open-Label Period|Adverse Event|0|||
161806631|NCT00048581|584335984|FG002|Open-Label Period|Adverse Event|37|||
161806632|NCT00048581|584335982|FG000|Open-Label Period|Lack of Efficacy|0|||
161806633|NCT00048581|584335983|FG001|Open-Label Period|Lack of Efficacy|0|||
161806634|NCT00048581|584335984|FG002|Open-Label Period|Lack of Efficacy|69|||
161806635|NCT00048581|584335982|FG000|Open-Label Period|Lost to Follow-up|0|||
161806636|NCT00048581|584335983|FG001|Open-Label Period|Lost to Follow-up|0|||
161806637|NCT00048581|584335984|FG002|Open-Label Period|Lost to Follow-up|14|||
161806638|NCT00048581|584335982|FG000|Open-Label Period|Withdrawal by Subject|0|||
161806639|NCT00048581|584335983|FG001|Open-Label Period|Withdrawal by Subject|0|||
161806640|NCT00048581|584335984|FG002|Open-Label Period|Withdrawal by Subject|20|||
161806641|NCT00048581|584335982|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
161806642|NCT00048581|584335983|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
161806643|NCT00048581|584335984|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
161806644|NCT00048581|584335982|FG000|Open-Label Period|Poor/Non-compliance|0|||
161806645|NCT00048581|584335983|FG001|Open-Label Period|Poor/Non-compliance|0|||
161806646|NCT00048581|584335984|FG002|Open-Label Period|Poor/Non-compliance|5|||
161806647|NCT00048581|584335982|FG000|Open-Label Period|Pregnancy|0|||
161806648|NCT00048581|584335983|FG001|Open-Label Period|Pregnancy|0|||
161806649|NCT00048581|584335984|FG002|Open-Label Period|Pregnancy|7|||
161806650|NCT00048581|584335982|FG000|Open-Label Period|Study Site Closure|0|||
161806651|NCT00048581|584335983|FG001|Open-Label Period|Study Site Closure|0|||
161806652|NCT00048581|584335984|FG002|Open-Label Period|Study Site Closure|2|||
161806653|NCT00048581|584335982|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
161806654|NCT00048581|584335983|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
161806655|NCT00048581|584335984|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
161806656|NCT00048581|584335982|FG000|Open-Label Period|Problem With Transportation To Site|0|||
161806657|NCT00048581|584335983|FG001|Open-Label Period|Problem With Transportation To Site|0|||
161806658|NCT00048581|584335984|FG002|Open-Label Period|Problem With Transportation To Site|1|||
161806659|NCT00048581|584335982|FG000|Open-Label Period|Primary Investigator Retired|0|||
161806660|NCT00048581|584335983|FG001|Open-Label Period|Primary Investigator Retired|0|||
161806661|NCT00048581|584335984|FG002|Open-Label Period|Primary Investigator Retired|2|||
161561498|NCT01648283|583444203|FG000|Overall Study|Withdrawal by Subject|14|||
161561499|NCT01605136|583444216|FG000|Study Period|Withdrawal by Subject|2|||
161561500|NCT01605136|583444217|FG001|Study Period|Withdrawal by Subject|0|||
161561501|NCT01605136|583444216|FG000|Study Period|Physician Decision|1|||
161561502|NCT01605136|583444217|FG001|Study Period|Physician Decision|1|||
161561503|NCT01605136|583444216|FG000|Study Period|Lost to Follow-up|0|||
161561504|NCT01605136|583444217|FG001|Study Period|Lost to Follow-up|2|||
161561505|NCT01605136|583444216|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
161561506|NCT01605136|583444217|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
161561507|NCT01072929|583444218|FG000|Overall Study|Adverse Event|8|||
161561508|NCT01072929|583444219|FG001|Overall Study|Adverse Event|11|||
161561509|NCT01072929|583444220|FG002|Overall Study|Adverse Event|2|||
161561510|NCT01072929|583444218|FG000|Overall Study|Lack of Efficacy|7|||
161561511|NCT01072929|583444219|FG001|Overall Study|Lack of Efficacy|4|||
161806662|NCT00048581|584335982|FG000|Open-Label Period|Study Ended By Sponsor|0|||
161806663|NCT00048581|584335983|FG001|Open-Label Period|Study Ended By Sponsor|0|||
161806664|NCT00048581|584335984|FG002|Open-Label Period|Study Ended By Sponsor|1|||
161806665|NCT01406795|584335985|FG000|Overall Study|Withdrawal by Subject|1|||
161806666|NCT03897088|584335988|FG000|Overall Study|Withdrawal by Subject|12|||
161806667|NCT03897088|584335989|FG001|Overall Study|Withdrawal by Subject|12|||
161806668|NCT03897088|584335988|FG000|Overall Study|Lost to Follow-up|7|||
161561512|NCT01072929|583444220|FG002|Overall Study|Lack of Efficacy|0|||
161806669|NCT03897088|584335989|FG001|Overall Study|Lost to Follow-up|15|||
161806670|NCT03897088|584335988|FG000|Overall Study|Sponsor Decision|1|||
161806671|NCT03897088|584335989|FG001|Overall Study|Sponsor Decision|2|||
161806672|NCT03897088|584335988|FG000|Overall Study|COVID-19|2|||
161806673|NCT03897088|584335989|FG001|Overall Study|COVID-19|0|||
161806674|NCT03897088|584335988|FG000|Overall Study|Other|3|||
161806675|NCT03897088|584335989|FG001|Overall Study|Other|0|||
161806676|NCT03897088|584335988|FG000|Overall Study|Non-compliance with Study Drug|1|||
161910278|NCT02722967|584723539|FG000|Overall Study|Withdrawal by Subject|1|||
161910279|NCT02722967|584723540|FG001|Overall Study|Withdrawal by Subject|0|||
161910280|NCT02722967|584723541|FG002|Overall Study|Withdrawal by Subject|1|||
161910281|NCT02722967|584723539|FG000|Overall Study|Physician Decision|1|||
161910282|NCT02722967|584723540|FG001|Overall Study|Physician Decision|0|||
161910283|NCT02722967|584723541|FG002|Overall Study|Physician Decision|0|||
161910284|NCT02722967|584723539|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
161910285|NCT02722967|584723540|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
161910286|NCT02722967|584723541|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
161910287|NCT04142242|584723542|FG000|Stage I|Non-compliance with the protocol|1|||
161910288|NCT04142242|584723543|FG001|Stage I|Non-compliance with the protocol|0|||
161910289|NCT04142242|584723544|FG002|Stage I|Non-compliance with the protocol|0|||
161910290|NCT04142242|584723545|FG003|Stage I|Non-compliance with the protocol|0|||
161910291|NCT04142242|584723546|FG004|Stage I|Non-compliance with the protocol|0|||
161910292|NCT04142242|584723547|FG005|Stage I|Non-compliance with the protocol|1|||
161561513|NCT01072929|583444218|FG000|Overall Study|Withdrawal by Subject|7|||
161561514|NCT01072929|583444219|FG001|Overall Study|Withdrawal by Subject|15|||
161561515|NCT01072929|583444220|FG002|Overall Study|Withdrawal by Subject|3|||
161561516|NCT01072929|583444218|FG000|Overall Study|Protocol Violation|13|||
161561517|NCT01072929|583444219|FG001|Overall Study|Protocol Violation|11|||
161561518|NCT01072929|583444220|FG002|Overall Study|Protocol Violation|2|||
161561519|NCT01072929|583444218|FG000|Overall Study|Lost to Follow-up|8|||
161561520|NCT01072929|583444219|FG001|Overall Study|Lost to Follow-up|4|||
161561521|NCT01072929|583444220|FG002|Overall Study|Lost to Follow-up|1|||
161561522|NCT01072929|583444218|FG000|Overall Study|Noncompliance with study medication|0|||
161561523|NCT01072929|583444219|FG001|Overall Study|Noncompliance with study medication|3|||
161561524|NCT01072929|583444220|FG002|Overall Study|Noncompliance with study medication|0|||
161561525|NCT01072929|583444218|FG000|Overall Study|Noncompliance with study procedures|1|||
161561526|NCT01072929|583444219|FG001|Overall Study|Noncompliance with study procedures|0|||
161561527|NCT01072929|583444220|FG002|Overall Study|Noncompliance with study procedures|1|||
161561528|NCT01072929|583444218|FG000|Overall Study|Other|0|||
161561529|NCT01072929|583444219|FG001|Overall Study|Other|3|||
161561530|NCT01072929|583444220|FG002|Overall Study|Other|0|||
161561531|NCT04833855|583444221|FG000|Overall Study|Decision by sponsor|0|||
161561532|NCT04833855|583444222|FG001|Overall Study|Decision by sponsor|1|||
161561533|NCT04833855|583444223|FG002|Overall Study|Decision by sponsor|0|||
161561534|NCT04833855|583444224|FG003|Overall Study|Decision by sponsor|0|||
161561535|NCT04833855|583444221|FG000|Overall Study|Withdrawal by Subject|4|||
161561536|NCT04833855|583444222|FG001|Overall Study|Withdrawal by Subject|1|||
161561537|NCT04833855|583444223|FG002|Overall Study|Withdrawal by Subject|3|||
161561538|NCT04833855|583444224|FG003|Overall Study|Withdrawal by Subject|1|||
161561539|NCT04833855|583444221|FG000|Overall Study|Lost to Follow-up|1|||
161561540|NCT04833855|583444222|FG001|Overall Study|Lost to Follow-up|0|||
161561541|NCT04833855|583444223|FG002|Overall Study|Lost to Follow-up|2|||
161561542|NCT04833855|583444224|FG003|Overall Study|Lost to Follow-up|2|||
161561543|NCT04833855|583444221|FG000|Overall Study|Protocol specified criteria|0|||
161561544|NCT04833855|583444222|FG001|Overall Study|Protocol specified criteria|0|||
161561545|NCT04833855|583444223|FG002|Overall Study|Protocol specified criteria|2|||
161561546|NCT04833855|583444224|FG003|Overall Study|Protocol specified criteria|1|||
161561547|NCT02806336|583444225|FG000|Overall Study|Physician Decision|1|||
161561548|NCT02806336|583444226|FG001|Overall Study|Physician Decision|0|||
161561549|NCT02806336|583444225|FG000|Overall Study|Withdrawal by Subject|2|||
161561550|NCT02806336|583444226|FG001|Overall Study|Withdrawal by Subject|4|||
161561551|NCT02806336|583444225|FG000|Overall Study|COVID-19 research shut down|3|||
161561552|NCT02806336|583444226|FG001|Overall Study|COVID-19 research shut down|4|||
161561553|NCT02806336|583444225|FG000|Overall Study|Lack of Efficacy|0|||
161561554|NCT02806336|583444226|FG001|Overall Study|Lack of Efficacy|1|||
161561555|NCT03682536|583444227|FG000|Randomization|Withdrawal by Subject|0|||
161561556|NCT03682536|583444228|FG001|Randomization|Withdrawal by Subject|2|||
161561557|NCT03682536|583444227|FG000|Treatment|Other Reasons|8|||
161910293|NCT04142242|584723542|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910294|NCT04142242|584723543|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
161910295|NCT04142242|584723544|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161561558|NCT03682536|583444228|FG001|Treatment|Other Reasons|7|||
161561559|NCT03682536|583444227|FG000|Treatment|Physician Decision|5|||
161561560|NCT03682536|583444228|FG001|Treatment|Physician Decision|5|||
161561561|NCT03682536|583444227|FG000|Treatment|Protocol Violation|1|||
161561562|NCT03682536|583444228|FG001|Treatment|Protocol Violation|0|||
161561563|NCT03682536|583444227|FG000|Treatment|Study Terminated by Sponsor|1|||
161561564|NCT03682536|583444228|FG001|Treatment|Study Terminated by Sponsor|2|||
161561565|NCT03682536|583444227|FG000|Treatment|Lost to Follow-up|0|||
161561566|NCT03682536|583444228|FG001|Treatment|Lost to Follow-up|1|||
161561567|NCT03682536|583444227|FG000|Treatment|Withdrawal by Subject|16|||
161561568|NCT03682536|583444228|FG001|Treatment|Withdrawal by Subject|18|||
161561569|NCT03682536|583444227|FG000|Treatment|Lack of Efficacy|41|||
161561570|NCT03682536|583444228|FG001|Treatment|Lack of Efficacy|68|||
161561571|NCT03682536|583444227|FG000|Treatment|Disease Progression|9|||
161561572|NCT03682536|583444228|FG001|Treatment|Disease Progression|7|||
161561573|NCT03682536|583444227|FG000|Treatment|Adverse Event|9|||
161561574|NCT03682536|583444228|FG001|Treatment|Adverse Event|5|||
161561575|NCT03682536|583444227|FG000|Treatment|Death|14|||
161561576|NCT03682536|583444228|FG001|Treatment|Death|13|||
161561577|NCT04824131|583444229|FG000|CAB LA Oral Phase|Adverse Event|1|||
161561578|NCT04824131|583444229|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
161561579|NCT04824131|583444229|FG000|Step 3|Withdrawal by Subject|2|||
161561580|NCT03008122|583444235|FG000|Overall Study|Physician Decision|3|||
161561581|NCT03008122|583444236|FG001|Overall Study|Physician Decision|2|||
161561582|NCT03008122|583444237|FG002|Overall Study|Physician Decision|0|||
161561583|NCT03008122|583444235|FG000|Overall Study|Withdrawal by Subject|1|||
161561584|NCT03008122|583444236|FG001|Overall Study|Withdrawal by Subject|3|||
161561585|NCT03008122|583444237|FG002|Overall Study|Withdrawal by Subject|0|||
161561586|NCT03008122|583444235|FG000|Overall Study|Lost to Follow-up|4|||
161910296|NCT04142242|584723545|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910297|NCT04142242|584723546|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910298|NCT04142242|584723547|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910299|NCT04142242|584723542|FG000|Stage II|Non-compliance with the protocol|0|||
161910300|NCT04142242|584723543|FG001|Stage II|Non-compliance with the protocol|0|||
161910301|NCT04142242|584723544|FG002|Stage II|Non-compliance with the protocol|0|||
161910302|NCT04142242|584723545|FG003|Stage II|Non-compliance with the protocol|2|||
161910303|NCT04142242|584723546|FG004|Stage II|Non-compliance with the protocol|0|||
161910304|NCT04142242|584723547|FG005|Stage II|Non-compliance with the protocol|0|||
161910305|NCT04142242|584723542|FG000|Stage II|Lost to Follow-up|0|||
161910306|NCT04142242|584723543|FG001|Stage II|Lost to Follow-up|0|||
161910307|NCT04142242|584723544|FG002|Stage II|Lost to Follow-up|1|||
161910308|NCT04142242|584723545|FG003|Stage II|Lost to Follow-up|2|||
161910309|NCT04142242|584723546|FG004|Stage II|Lost to Follow-up|0|||
161910310|NCT04142242|584723547|FG005|Stage II|Lost to Follow-up|0|||
161910311|NCT04142242|584723542|FG000|Stage II|Withdrawal by Subject|0|||
161910312|NCT04142242|584723543|FG001|Stage II|Withdrawal by Subject|0|||
161910313|NCT04142242|584723544|FG002|Stage II|Withdrawal by Subject|5|||
161561587|NCT03008122|583444236|FG001|Overall Study|Lost to Follow-up|8|||
161561588|NCT03008122|583444237|FG002|Overall Study|Lost to Follow-up|3|||
161561589|NCT03008122|583444235|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161561590|NCT03008122|583444236|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161561591|NCT03008122|583444237|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161561592|NCT03008122|583444235|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
161561593|NCT03008122|583444236|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
161561594|NCT03008122|583444237|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
161561595|NCT03008122|583444235|FG000|Overall Study|Death|0|||
161561596|NCT03008122|583444236|FG001|Overall Study|Death|0|||
161561597|NCT03008122|583444237|FG002|Overall Study|Death|1|||
161561598|NCT04159896|583444238|FG000|Overall Study|Lack of Efficacy|7|||
161561599|NCT04159896|583444238|FG000|Overall Study|Withdrawal by Subject|1|||
161910314|NCT04142242|584723545|FG003|Stage II|Withdrawal by Subject|9|||
161910315|NCT04142242|584723546|FG004|Stage II|Withdrawal by Subject|0|||
161910316|NCT04142242|584723547|FG005|Stage II|Withdrawal by Subject|0|||
161910317|NCT00846053|584723550|FG000|Overall Study|Physician Decision|3|||
161910318|NCT00846053|584723551|FG001|Overall Study|Physician Decision|0|||
161910319|NCT03883386|584723559|FG000|First Assignment|Lost to Follow-up|1|||
161561600|NCT04159896|583444238|FG000|Overall Study|Adverse Event|1|||
161561601|NCT04159896|583444238|FG000|Overall Study|A transient ischaemic attack|1|||
161561602|NCT01222247|583444239|FG000|Overall Study|Lost to Follow-up|2|||
161561603|NCT01222247|583444240|FG001|Overall Study|Lost to Follow-up|2|||
161561604|NCT02338609|583444241|FG000|Overall Study|Physician Decision|1|||
161910320|NCT03883386|584723560|FG001|First Assignment|Lost to Follow-up|0|||
161910321|NCT03883386|584723559|FG000|First Assignment|Withdrawal by Subject|1|||
161910322|NCT03883386|584723560|FG001|First Assignment|Withdrawal by Subject|1|||
161910323|NCT01326871|584723561|FG000|Overall Study|Major surgery|0|||
161910324|NCT01326871|584723562|FG001|Overall Study|Major surgery|1|||
161910325|NCT01326871|584723563|FG002|Overall Study|Major surgery|0|||
161910326|NCT01326871|584723561|FG000|Overall Study|SAE and death|0|||
161561605|NCT02338609|583444241|FG000|Overall Study|Death|1|||
161910327|NCT01326871|584723562|FG001|Overall Study|SAE and death|2|||
161910328|NCT01326871|584723563|FG002|Overall Study|SAE and death|0|||
161561606|NCT02084082|583444242|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
161561607|NCT02084082|583444243|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
161561608|NCT02084082|583444244|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
161561609|NCT02084082|583444245|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
161561610|NCT02084082|583444242|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161561611|NCT02084082|583444243|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161561612|NCT02084082|583444244|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161910329|NCT01326871|584723561|FG000|Overall Study|Physician decision and decreased performance status|0|||
161910330|NCT01326871|584723562|FG001|Overall Study|Physician decision and decreased performance status|1|||
161561613|NCT02084082|583444245|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
161561614|NCT01449721|583444250|FG000|Overall Study|Physician Decision|0|||
161561615|NCT01449721|583444251|FG001|Overall Study|Physician Decision|1|||
161561616|NCT01449721|583444250|FG000|Overall Study|Physician Decision|0|||
161561617|NCT01449721|583444251|FG001|Overall Study|Physician Decision|1|||
161561618|NCT02148718|583444252|FG000|Overall Study|Protocol Violation|26|||
161561619|NCT02148718|583444252|FG000|Overall Study|Discontinued Study Prematurely|5|||
161561620|NCT01822821|583444257|FG000|Overall Study|Eligible surgery cancelled|1|||
161561621|NCT01822821|583444258|FG001|Overall Study|Eligible surgery cancelled|1|||
161561622|NCT01822821|583444257|FG000|Overall Study|Other reasons|1|||
161561623|NCT01822821|583444258|FG001|Overall Study|Other reasons|0|||
161561624|NCT00333788|583444261|FG000|Overall Study|Adverse Event|44|||
161561625|NCT00333788|583444261|FG000|Overall Study|Lack of Efficacy|80|||
161561626|NCT00333788|583444261|FG000|Overall Study|Lost to Follow-up|2|||
161561627|NCT00333788|583444261|FG000|Overall Study|Withdrawal by Subject|24|||
161561628|NCT00333788|583444261|FG000|Overall Study|Other: Non-compliance|2|||
161561629|NCT00333788|583444261|FG000|Overall Study|Other: Moved|2|||
161561630|NCT00333788|583444261|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
161561631|NCT00333788|583444261|FG000|Overall Study|Other: Investigator decision|1|||
161561632|NCT00333788|583444261|FG000|Overall Study|Other: Quality of life concern|1|||
161561633|NCT00333788|583444261|FG000|Overall Study|Other: Sponsor decision|1|||
161561634|NCT00333788|583444261|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
161561635|NCT00333788|583444261|FG000|Overall Study|Other: Medical monitor decision|1|||
161561636|NCT00333788|583444261|FG000|Overall Study|Other: Physician decision|1|||
161561637|NCT00333788|583444261|FG000|Overall Study|Other: Signed consent for another study|1|||
161561638|NCT00114959|583444262|FG000|Overall Study|Lack of Efficacy|6|||
161561639|NCT00114959|583444262|FG000|Overall Study|Physician Decision|1|||
161561640|NCT00114959|583444262|FG000|Overall Study|Death|1|||
161561641|NCT02322775|583444269|FG000|Overall Study|Adverse Event|1|||
161561642|NCT02322775|583444270|FG001|Overall Study|Adverse Event|0|||
161561643|NCT02322775|583444269|FG000|Overall Study|Lost to Follow-up|0|||
161561644|NCT02322775|583444270|FG001|Overall Study|Lost to Follow-up|1|||
161561645|NCT02322775|583444269|FG000|Overall Study|Protocol Violation|1|||
161561646|NCT02322775|583444270|FG001|Overall Study|Protocol Violation|0|||
161561647|NCT02322775|583444269|FG000|Overall Study|Withdrawal by Subject|3|||
161910331|NCT01326871|584723563|FG002|Overall Study|Physician decision and decreased performance status|0|||
161910332|NCT01326871|584723561|FG000|Overall Study|Disease progression|0|||
161910333|NCT01326871|584723562|FG001|Overall Study|Disease progression|11|||
161910334|NCT01326871|584723563|FG002|Overall Study|Disease progression|5|||
161910335|NCT01326871|584723561|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
161910336|NCT01326871|584723562|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
161910337|NCT01326871|584723563|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
161910338|NCT01326871|584723561|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
161910339|NCT01326871|584723562|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
161910340|NCT01326871|584723563|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
161910341|NCT01326871|584723561|FG000|Overall Study|Withdrawal by Subject|0|||
161910342|NCT01326871|584723562|FG001|Overall Study|Withdrawal by Subject|1|||
161910343|NCT01326871|584723563|FG002|Overall Study|Withdrawal by Subject|0|||
161910344|NCT01326871|584723561|FG000|Overall Study|DLT|0|||
161910345|NCT01326871|584723562|FG001|Overall Study|DLT|2|||
161910346|NCT01326871|584723563|FG002|Overall Study|DLT|0|||
161910347|NCT01326871|584723561|FG000|Overall Study|SAE, disease progression and subject decision|0|||
161910348|NCT01326871|584723562|FG001|Overall Study|SAE, disease progression and subject decision|1|||
161910349|NCT01326871|584723563|FG002|Overall Study|SAE, disease progression and subject decision|0|||
161910350|NCT01326871|584723561|FG000|Overall Study|Death|0|||
161910351|NCT01326871|584723562|FG001|Overall Study|Death|1|||
161910352|NCT01326871|584723563|FG002|Overall Study|Death|0|||
161910353|NCT01326871|584723561|FG000|Overall Study|Other|0|||
161910354|NCT01326871|584723562|FG001|Overall Study|Other|3|||
161910355|NCT01326871|584723563|FG002|Overall Study|Other|0|||
161910356|NCT01326871|584723561|FG000|Overall Study|SAE and disease progression|0|||
161561648|NCT02322775|583444270|FG001|Overall Study|Withdrawal by Subject|4|||
161561649|NCT02322775|583444269|FG000|Overall Study|Not willing to perform all FU visits|0|||
161561650|NCT02322775|583444270|FG001|Overall Study|Not willing to perform all FU visits|1|||
161561651|NCT04739423|583444271|FG000|Overall Study|Protocol Violation|0|||
161561652|NCT04739423|583444272|FG001|Overall Study|Protocol Violation|1|||
161561653|NCT04739423|583444273|FG002|Overall Study|Protocol Violation|0|||
161561654|NCT04739423|583444274|FG003|Overall Study|Protocol Violation|0|||
161561655|NCT04739423|583444275|FG004|Overall Study|Protocol Violation|0|||
161561656|NCT04739423|583444276|FG005|Overall Study|Protocol Violation|0|||
161910357|NCT01326871|584723562|FG001|Overall Study|SAE and disease progression|0|||
161910358|NCT01326871|584723563|FG002|Overall Study|SAE and disease progression|1|||
161561657|NCT04739423|583444271|FG000|Overall Study|Adverse Event|0|||
161561658|NCT04739423|583444272|FG001|Overall Study|Adverse Event|0|||
161561659|NCT04739423|583444273|FG002|Overall Study|Adverse Event|1|||
161561660|NCT04739423|583444274|FG003|Overall Study|Adverse Event|0|||
161561661|NCT04739423|583444275|FG004|Overall Study|Adverse Event|1|||
161561662|NCT04739423|583444276|FG005|Overall Study|Adverse Event|0|||
161561663|NCT04739423|583444271|FG000|Overall Study|Withdrawal by Subject|0|||
161561664|NCT04739423|583444272|FG001|Overall Study|Withdrawal by Subject|0|||
161561665|NCT04739423|583444273|FG002|Overall Study|Withdrawal by Subject|0|||
161561666|NCT04739423|583444274|FG003|Overall Study|Withdrawal by Subject|0|||
161561667|NCT04739423|583444275|FG004|Overall Study|Withdrawal by Subject|0|||
161806677|NCT03897088|584335989|FG001|Overall Study|Non-compliance with Study Drug|1|||
161806678|NCT03897088|584335988|FG000|Overall Study|Pregnancy|0|||
161806679|NCT03897088|584335989|FG001|Overall Study|Pregnancy|1|||
161806680|NCT04320849|584336000|FG000|Overall Study|Withdrawal by Subject|4|||
161806681|NCT04320849|584336000|FG000|Overall Study|Imaging data unavailable|2|||
161806682|NCT04320849|584336000|FG000|Overall Study|Incomplete imaging|2|||
161806683|NCT00119379|584336003|FG000|Overall Study|Adverse Event|4|||
161806684|NCT00119379|584336004|FG001|Overall Study|Adverse Event|1|||
161806685|NCT01469546|584336005|FG000|Received 5 mg Dose|Adverse Event|13|||
161806686|NCT01469546|584336005|FG000|Received 5 mg Dose|Death|2|||
161806687|NCT01469546|584336005|FG000|Received 5 mg Dose|Protocol Violation|2|||
161806688|NCT01469546|584336005|FG000|Received 5 mg Dose|Progressive Disease|3|||
161806689|NCT01469546|584336005|FG000|Received 5 mg Dose|Physician Decision|3|||
161806690|NCT02801877|584336006|FG000|Overall Study|Lost to Follow-up|1|||
161806691|NCT02801877|584336007|FG001|Overall Study|Lost to Follow-up|1|||
161806692|NCT02801877|584336008|FG002|Overall Study|Lost to Follow-up|2|||
161806693|NCT02801877|584336009|FG003|Overall Study|Lost to Follow-up|0|||
161806694|NCT02801877|584336006|FG000|Overall Study|Never Started Treatment|2|||
161806695|NCT02801877|584336007|FG001|Overall Study|Never Started Treatment|0|||
161806696|NCT02801877|584336008|FG002|Overall Study|Never Started Treatment|4|||
161806697|NCT02801877|584336009|FG003|Overall Study|Never Started Treatment|0|||
161806698|NCT04934722|584337680|FG000|Overall Study|Death|4|||
161806699|NCT04934722|584337681|FG001|Overall Study|Death|3|||
161806700|NCT04934722|584337680|FG000|Overall Study|Participants Ongoing|88|||
161806701|NCT04934722|584337681|FG001|Overall Study|Participants Ongoing|91|||
161806702|NCT06358820|584337682|FG000|Overall Study|Adverse Event|11|||
161806703|NCT06358820|584337682|FG000|Overall Study|kidney transplantation|3|||
161806704|NCT06358820|584337682|FG000|Overall Study|patient voluntary withdrawal|6|||
161806705|NCT06358820|584337682|FG000|Overall Study|Physician Decision|1|||
161806706|NCT01294787|584337683|FG000|Period 1|Adverse Event|0|||
161806707|NCT01294787|584337684|FG001|Period 1|Adverse Event|0|||
161806708|NCT01294787|584337685|FG002|Period 1|Adverse Event|0|||
161806709|NCT01294787|584337686|FG003|Period 1|Adverse Event|0|||
161806710|NCT01294787|584337687|FG004|Period 1|Adverse Event|1|||
161806711|NCT01294787|584337688|FG005|Period 1|Adverse Event|0|||
161806712|NCT01294787|584337683|FG000|Period 1|Withdrawal by Subject|0|||
161806713|NCT01294787|584337684|FG001|Period 1|Withdrawal by Subject|0|||
161806714|NCT01294787|584337685|FG002|Period 1|Withdrawal by Subject|0|||
161806715|NCT01294787|584337686|FG003|Period 1|Withdrawal by Subject|1|||
161806716|NCT01294787|584337687|FG004|Period 1|Withdrawal by Subject|1|||
161806717|NCT01294787|584337688|FG005|Period 1|Withdrawal by Subject|1|||
161806718|NCT01294787|584337683|FG000|Period 1|Administrative problem|0|||
161806719|NCT01294787|584337684|FG001|Period 1|Administrative problem|0|||
161806720|NCT01294787|584337685|FG002|Period 1|Administrative problem|1|||
161806721|NCT01294787|584337686|FG003|Period 1|Administrative problem|0|||
161806722|NCT01294787|584337687|FG004|Period 1|Administrative problem|0|||
161806723|NCT01294787|584337688|FG005|Period 1|Administrative problem|1|||
161806724|NCT01294787|584337683|FG000|Period 2|Adverse Event|0|||
161806725|NCT01294787|584337684|FG001|Period 2|Adverse Event|3|||
161806726|NCT01294787|584337685|FG002|Period 2|Adverse Event|0|||
161806727|NCT01294787|584337686|FG003|Period 2|Adverse Event|1|||
161806728|NCT01294787|584337687|FG004|Period 2|Adverse Event|0|||
161806729|NCT01294787|584337688|FG005|Period 2|Adverse Event|0|||
161806730|NCT01294787|584337683|FG000|Period 2|No longer needs study drug|0|||
161806731|NCT01294787|584337684|FG001|Period 2|No longer needs study drug|0|||
161806732|NCT01294787|584337685|FG002|Period 2|No longer needs study drug|0|||
161806733|NCT01294787|584337686|FG003|Period 2|No longer needs study drug|1|||
161561668|NCT04739423|583444276|FG005|Overall Study|Withdrawal by Subject|1|||
161806734|NCT01294787|584337687|FG004|Period 2|No longer needs study drug|0|||
161806735|NCT01294787|584337688|FG005|Period 2|No longer needs study drug|0|||
161806736|NCT01294787|584337683|FG000|Period 3|Adverse Event|0|||
161806737|NCT01294787|584337684|FG001|Period 3|Adverse Event|0|||
161806738|NCT01294787|584337685|FG002|Period 3|Adverse Event|0|||
161806739|NCT01294787|584337686|FG003|Period 3|Adverse Event|0|||
161806740|NCT01294787|584337687|FG004|Period 3|Adverse Event|1|||
161806741|NCT01294787|584337688|FG005|Period 3|Adverse Event|0|||
161806742|NCT01124175|584337689|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161806743|NCT01124175|584337690|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
161806744|NCT00942968|584337691|FG000|Overall Study|Adverse Event|60|||
161806745|NCT00942968|584337691|FG000|Overall Study|Death|76|||
161806746|NCT00942968|584337691|FG000|Overall Study|Protocol Violation|9|||
161561669|NCT01007552|583444280|FG000|Overall Study|Withdrawal by Subject|1|||
161561670|NCT03212365|583444296|FG000|Overall Study|Discharged prior to Xa level|12|||
161561671|NCT03212365|583444297|FG001|Overall Study|Discharged prior to Xa level|8|||
161561672|NCT03212365|583444296|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
161561673|NCT03212365|583444297|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
161561674|NCT03212365|583444296|FG000|Overall Study|Refused study medication|3|||
161561675|NCT03212365|583444297|FG001|Overall Study|Refused study medication|0|||
161561676|NCT03212365|583444296|FG000|Overall Study|Initiated heparin infusion on floor|1|||
161561677|NCT03212365|583444297|FG001|Overall Study|Initiated heparin infusion on floor|1|||
161561678|NCT03212365|583444296|FG000|Overall Study|Unexpected return to OR|1|||
161561679|NCT03212365|583444297|FG001|Overall Study|Unexpected return to OR|1|||
161561680|NCT03212365|583444296|FG000|Overall Study|Medication distribution error|1|||
161561681|NCT03212365|583444297|FG001|Overall Study|Medication distribution error|0|||
161561682|NCT03212365|583444296|FG000|Overall Study|Required epidural placement|1|||
161561683|NCT03212365|583444297|FG001|Overall Study|Required epidural placement|0|||
161561684|NCT03212365|583444296|FG000|Overall Study|Withdrawal by Subject|0|||
161561685|NCT03212365|583444297|FG001|Overall Study|Withdrawal by Subject|1|||
161561686|NCT03212365|583444296|FG000|Overall Study|developed acute renal failure|0|||
161561687|NCT03212365|583444297|FG001|Overall Study|developed acute renal failure|1|||
161561688|NCT00333138|583444298|FG000|Core Study (6 Months)|Adverse Event|4|||
161561689|NCT00333138|583444299|FG001|Core Study (6 Months)|Adverse Event|5|||
161910359|NCT01326871|584723561|FG000|Overall Study|SAE and physician decision|0|||
161910360|NCT01326871|584723562|FG001|Overall Study|SAE and physician decision|0|||
161561690|NCT00333138|583444300|FG002|Core Study (6 Months)|Adverse Event|8|||
161561691|NCT00333138|583444298|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
161561692|NCT00333138|583444299|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
161561693|NCT00333138|583444300|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
161561694|NCT00333138|583444298|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
161561695|NCT00333138|583444299|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
161561696|NCT00333138|583444300|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
161561697|NCT00333138|583444298|FG000|Core Study (6 Months)|Protocol Violation|1|||
161561698|NCT00333138|583444299|FG001|Core Study (6 Months)|Protocol Violation|0|||
161561699|NCT00333138|583444300|FG002|Core Study (6 Months)|Protocol Violation|1|||
161561700|NCT00333138|583444298|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
161561701|NCT00333138|583444299|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
161561702|NCT00333138|583444300|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
161561703|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
161561704|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
161561705|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
161561706|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
161561707|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
161561708|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
161561709|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
161561710|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
161561711|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
161561712|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
161561713|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
161561714|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
161561715|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
161561716|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
161561717|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
161561718|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
161561719|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
161561720|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
161910361|NCT01326871|584723563|FG002|Overall Study|SAE and physician decision|1|||
161910362|NCT01326871|584723561|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
161910363|NCT01326871|584723562|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
161453502|NCT04585009|583055371|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453503|NCT04585009|583055372|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453504|NCT04585009|583055373|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453505|NCT04585009|583055374|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
161453506|NCT04585009|583055363|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453507|NCT04585009|583055364|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453508|NCT04585009|583055365|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453509|NCT04585009|583055366|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161910364|NCT01326871|584723563|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
161453510|NCT04585009|583055367|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453511|NCT04585009|583055368|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453512|NCT04585009|583055369|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453513|NCT04585009|583055370|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161806747|NCT00942968|584337691|FG000|Overall Study|Lost to Follow-up|4|||
161806748|NCT00942968|584337691|FG000|Overall Study|Withdrawal by Subject|44|||
161453514|NCT04585009|583055371|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453515|NCT04585009|583055372|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
161453516|NCT04585009|583055373|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453517|NCT04585009|583055374|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
161453518|NCT04585009|583055363|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161806749|NCT00942968|584337691|FG000|Overall Study|Sponsor request|5|||
161806750|NCT00942968|584337691|FG000|Overall Study|Physician Decision|11|||
161806751|NCT00942968|584337691|FG000|Overall Study|Progression of disease|12|||
161806752|NCT00942968|584337691|FG000|Overall Study|Inferior vena cava filter placement|4|||
161806753|NCT00942968|584337691|FG000|Overall Study|Pulmonary embolism (PE)|1|||
161910365|NCT01326871|584723561|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
161453519|NCT04585009|583055364|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453520|NCT04585009|583055365|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453521|NCT04585009|583055366|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453522|NCT04585009|583055367|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453523|NCT04585009|583055368|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453524|NCT04585009|583055369|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453525|NCT04585009|583055370|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453526|NCT04585009|583055371|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453527|NCT04585009|583055372|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453528|NCT04585009|583055373|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161453529|NCT04585009|583055374|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
161453530|NCT05338671|583055376|FG000|Overall Study|Lost to Follow-up|2|||
161453531|NCT05338671|583055377|FG001|Overall Study|Lost to Follow-up|2|||
161453532|NCT05338671|583055376|FG000|Overall Study|Root canal completed in a single visit|1|||
161453533|NCT05338671|583055377|FG001|Overall Study|Root canal completed in a single visit|0|||
161453534|NCT03859973|583055378|FG000|Overall Study|Other reason than listed|3|||
161453535|NCT03859973|583055379|FG001|Overall Study|Other reason than listed|2|||
161453536|NCT03859973|583055378|FG000|Overall Study|COVID-19 related, not due to AE|3|||
161453537|NCT03859973|583055379|FG001|Overall Study|COVID-19 related, not due to AE|4|||
161453538|NCT03859973|583055378|FG000|Overall Study|Withdrawal by Subject|8|||
161453539|NCT03859973|583055379|FG001|Overall Study|Withdrawal by Subject|9|||
161453540|NCT03859973|583055378|FG000|Overall Study|Lost to Follow-up|2|||
161453541|NCT03859973|583055379|FG001|Overall Study|Lost to Follow-up|3|||
161453542|NCT03859973|583055378|FG000|Overall Study|Protocol Violation|1|||
161453543|NCT03859973|583055379|FG001|Overall Study|Protocol Violation|3|||
161453544|NCT03859973|583055378|FG000|Overall Study|Adverse Event|3|||
161453545|NCT03859973|583055379|FG001|Overall Study|Adverse Event|5|||
161453546|NCT02855541|583055380|FG000|Overall Study|Change in health status|2|||
161453547|NCT02855541|583055380|FG000|Overall Study|Withdrawal by Subject|2|||
161453548|NCT03085914|583055381|FG000|Overall Study|Death|6|||
161453549|NCT03085914|583055382|FG001|Overall Study|Death|6|||
161453550|NCT03085914|583055383|FG002|Overall Study|Death|4|||
161453551|NCT03085914|583055384|FG003|Overall Study|Death|1|||
161453552|NCT03085914|583055385|FG004|Overall Study|Death|5|||
161453553|NCT03085914|583055386|FG005|Overall Study|Death|2|||
161453554|NCT03085914|583055387|FG006|Overall Study|Death|2|||
161453555|NCT03085914|583055381|FG000|Overall Study|Withdrawal by Subject|1|||
161453556|NCT03085914|583055382|FG001|Overall Study|Withdrawal by Subject|1|||
161453557|NCT03085914|583055383|FG002|Overall Study|Withdrawal by Subject|2|||
161453558|NCT03085914|583055384|FG003|Overall Study|Withdrawal by Subject|2|||
161453559|NCT03085914|583055385|FG004|Overall Study|Withdrawal by Subject|2|||
161453560|NCT03085914|583055386|FG005|Overall Study|Withdrawal by Subject|0|||
161453561|NCT03085914|583055387|FG006|Overall Study|Withdrawal by Subject|1|||
161453562|NCT03085914|583055381|FG000|Overall Study|Lost to Follow-up|0|||
161453563|NCT03085914|583055382|FG001|Overall Study|Lost to Follow-up|0|||
161453564|NCT03085914|583055383|FG002|Overall Study|Lost to Follow-up|1|||
161453565|NCT03085914|583055384|FG003|Overall Study|Lost to Follow-up|0|||
161453566|NCT03085914|583055385|FG004|Overall Study|Lost to Follow-up|0|||
161453567|NCT03085914|583055386|FG005|Overall Study|Lost to Follow-up|1|||
161453568|NCT03085914|583055387|FG006|Overall Study|Lost to Follow-up|1|||
161453569|NCT03085914|583055381|FG000|Overall Study|Reason was not specified,|2|||
161453570|NCT03085914|583055382|FG001|Overall Study|Reason was not specified,|2|||
161453571|NCT03085914|583055383|FG002|Overall Study|Reason was not specified,|2|||
161453572|NCT03085914|583055384|FG003|Overall Study|Reason was not specified,|3|||
161453573|NCT03085914|583055385|FG004|Overall Study|Reason was not specified,|3|||
161453574|NCT03085914|583055386|FG005|Overall Study|Reason was not specified,|3|||
161806754|NCT00942968|584337691|FG000|Overall Study|Participant required pancreatic biopsy|1|||
161561721|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
161561722|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
161561723|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
161561724|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
161561725|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
161561726|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
161561727|NCT00333138|583444298|FG000|Extension Study (Month6 to End of Study)|Death|0|||
161561728|NCT00333138|583444299|FG001|Extension Study (Month6 to End of Study)|Death|1|||
161561729|NCT00333138|583444300|FG002|Extension Study (Month6 to End of Study)|Death|0|||
161561730|NCT03005288|583444301|FG000|Overall Study|Withdrawal by Subject|7|||
161561731|NCT03005288|583444302|FG001|Overall Study|Withdrawal by Subject|5|||
161561732|NCT03005288|583444301|FG000|Overall Study|Lost to Follow-up|0|||
161561733|NCT03005288|583444302|FG001|Overall Study|Lost to Follow-up|1|||
161910366|NCT01326871|584723562|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
161910367|NCT01326871|584723563|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
161910368|NCT01326871|584723561|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
161910369|NCT01326871|584723562|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
161910370|NCT01326871|584723563|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
161910371|NCT01326871|584723561|FG000|Overall Study|Physician Decision|0|||
161910372|NCT01326871|584723562|FG001|Overall Study|Physician Decision|0|||
161910373|NCT01326871|584723563|FG002|Overall Study|Physician Decision|1|||
161910374|NCT01326871|584723561|FG000|Overall Study|SAE|0|||
161910375|NCT01326871|584723562|FG001|Overall Study|SAE|0|||
161910376|NCT01326871|584723563|FG002|Overall Study|SAE|1|||
161910377|NCT01326871|584723561|FG000|Overall Study|Disease progression and death|0|||
161910378|NCT01326871|584723562|FG001|Overall Study|Disease progression and death|0|||
161910379|NCT01326871|584723563|FG002|Overall Study|Disease progression and death|1|||
161910380|NCT01326871|584723561|FG000|Overall Study|Subject decision|0|||
161910381|NCT01326871|584723562|FG001|Overall Study|Subject decision|0|||
161910382|NCT01326871|584723563|FG002|Overall Study|Subject decision|1|||
161910383|NCT00251758|584723564|FG000|Overall Study|Adverse Event|7|||
161910384|NCT00251758|584723565|FG001|Overall Study|Adverse Event|9|||
161910385|NCT00251758|584723566|FG002|Overall Study|Adverse Event|11|||
161910386|NCT00251758|584723564|FG000|Overall Study|Lost to Follow-up|4|||
161910387|NCT00251758|584723565|FG001|Overall Study|Lost to Follow-up|2|||
161910388|NCT00251758|584723566|FG002|Overall Study|Lost to Follow-up|5|||
161910389|NCT00251758|584723564|FG000|Overall Study|Withdrawal by Subject|13|||
161910390|NCT00251758|584723565|FG001|Overall Study|Withdrawal by Subject|7|||
161910391|NCT00251758|584723566|FG002|Overall Study|Withdrawal by Subject|3|||
161910392|NCT00251758|584723564|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161910393|NCT00251758|584723565|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
161910394|NCT00251758|584723566|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
161910395|NCT00251758|584723564|FG000|Overall Study|Lack of Efficacy|3|||
161910396|NCT00251758|584723565|FG001|Overall Study|Lack of Efficacy|0|||
161910397|NCT00251758|584723566|FG002|Overall Study|Lack of Efficacy|0|||
161910398|NCT00251758|584723564|FG000|Overall Study|Noncompliant|0|||
161910399|NCT00251758|584723565|FG001|Overall Study|Noncompliant|2|||
161910400|NCT00251758|584723566|FG002|Overall Study|Noncompliant|2|||
161910401|NCT00251758|584723564|FG000|Overall Study|Pregnancy|0|||
161910402|NCT00251758|584723565|FG001|Overall Study|Pregnancy|1|||
161910403|NCT00251758|584723566|FG002|Overall Study|Pregnancy|0|||
161910404|NCT00251758|584723564|FG000|Overall Study|Per Subject Request|0|||
161910405|NCT00251758|584723565|FG001|Overall Study|Per Subject Request|0|||
161910406|NCT00251758|584723566|FG002|Overall Study|Per Subject Request|1|||
161910407|NCT00251758|584723564|FG000|Overall Study|Per Investigator Request|1|||
161910408|NCT00251758|584723565|FG001|Overall Study|Per Investigator Request|0|||
161910409|NCT00251758|584723566|FG002|Overall Study|Per Investigator Request|0|||
161910410|NCT01387269|584723568|FG000|Overall Study|Death|38|||
161910411|NCT01387269|584723569|FG001|Overall Study|Death|20|||
161561734|NCT03005288|583444301|FG000|Overall Study|Adverse Event|5|||
161561735|NCT03005288|583444302|FG001|Overall Study|Adverse Event|0|||
161561736|NCT03005288|583444301|FG000|Overall Study|Protocol deviation|0|||
161910412|NCT01387269|584723568|FG000|Overall Study|Other|8|||
161910413|NCT01387269|584723569|FG001|Overall Study|Other|7|||
161561737|NCT03005288|583444302|FG001|Overall Study|Protocol deviation|1|||
161561738|NCT03005288|583444301|FG000|Overall Study|Physician Decision|0|||
161561739|NCT03005288|583444302|FG001|Overall Study|Physician Decision|1|||
161561740|NCT04011033|583444303|FG000|Overall Study|Physician Decision|2|||
161910414|NCT01387269|584723568|FG000|Overall Study|Unrelated AE|12|||
161910415|NCT01387269|584723569|FG001|Overall Study|Unrelated AE|3|||
161561741|NCT04011033|583444304|FG001|Overall Study|Physician Decision|3|||
161910416|NCT01387269|584723568|FG000|Overall Study|Withdrawal by patient|32|||
161910417|NCT01387269|584723569|FG001|Overall Study|Withdrawal by patient|10|||
161910418|NCT01387269|584723568|FG000|Overall Study|Study drug-related AE|1|||
161910419|NCT01387269|584723569|FG001|Overall Study|Study drug-related AE|0|||
161910420|NCT01387269|584723568|FG000|Overall Study|Lost to Follow-up|1|||
161910421|NCT01387269|584723569|FG001|Overall Study|Lost to Follow-up|0|||
161910422|NCT01200329|584723572|FG000|Overall Study|Lack of financial coverage|2|||
161910423|NCT01200329|584723572|FG000|Overall Study|Progressive disease|1|||
161910424|NCT03642990|584723577|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
161910425|NCT03642990|584723577|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
161910426|NCT01265498|584723582|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
161910427|NCT01265498|584723583|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
161910428|NCT04158219|584723589|FG000|Overall Study|Lost to Follow-up|1|||
161910429|NCT04239924|584723596|FG000|Overall Study|Lost to Follow-up|2|||
161910430|NCT04194814|584723597|FG000|Overall Study|Physician Decision|3|||
161910431|NCT04194814|584723598|FG001|Overall Study|Physician Decision|0|||
161910432|NCT04194814|584723597|FG000|Overall Study|Withdrawal by Subject|0|||
161910433|NCT04194814|584723598|FG001|Overall Study|Withdrawal by Subject|2|||
161910434|NCT00959751|584725543|FG000|Overall Study|Lost to Follow-up|2|||
161910435|NCT00959751|584725544|FG001|Overall Study|Lost to Follow-up|3|||
161910436|NCT00959751|584725543|FG000|Overall Study|Consent Withdrawn|0|||
161910437|NCT00959751|584725544|FG001|Overall Study|Consent Withdrawn|1|||
161910438|NCT00959751|584725543|FG000|Overall Study|Non-compliance to Study Procedures|0|||
161910439|NCT00959751|584725544|FG001|Overall Study|Non-compliance to Study Procedures|1|||
161910440|NCT00959751|584725543|FG000|Overall Study|No migraine headache without aura|7|||
161910441|NCT00959751|584725544|FG001|Overall Study|No migraine headache without aura|7|||
161910442|NCT03737994|584725545|FG000|Overall Study|Withdrawal by Subject|0|||
161910443|NCT03737994|584725546|FG001|Overall Study|Withdrawal by Subject|0|||
161910444|NCT03737994|584725547|FG002|Overall Study|Withdrawal by Subject|0|||
161910445|NCT03737994|584725548|FG003|Overall Study|Withdrawal by Subject|0|||
161910446|NCT03737994|584725549|FG004|Overall Study|Withdrawal by Subject|0|||
161910447|NCT03737994|584725550|FG005|Overall Study|Withdrawal by Subject|0|||
161910448|NCT03737994|584725551|FG006|Overall Study|Withdrawal by Subject|1|||
161806755|NCT00942968|584337691|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
161806756|NCT01948258|584337692|FG000|Overall Study|Pregnancy|41|||
161806757|NCT01948258|584337692|FG000|Overall Study|Did not complete by cut-off date|35|||
161806758|NCT01948258|584337692|FG000|Overall Study|Lost to Follow-up|27|||
161806759|NCT01948258|584337692|FG000|Overall Study|Withdrawal by SPD|8|||
161806760|NCT01948258|584337692|FG000|Overall Study|Withdrawal by Subject|6|||
161806761|NCT01948258|584337692|FG000|Overall Study|Health Care Professional|43|||
161806762|NCT01948258|584337692|FG000|Overall Study|Removed from statistical analysis|2|||
161806763|NCT00520130|584337699|FG000|Overall Study|Disease progression on study|4|||
161806764|NCT00520130|584337700|FG001|Overall Study|Disease progression on study|0|||
161806765|NCT00520130|584337699|FG000|Overall Study|Physician Decision|1|||
161806766|NCT00520130|584337700|FG001|Overall Study|Physician Decision|1|||
161806767|NCT01045096|584337703|FG000|Overall Study|Withdrawal by Subject|2|||
161806768|NCT01045096|584337704|FG001|Overall Study|Withdrawal by Subject|0|||
161806769|NCT01045096|584337705|FG002|Overall Study|Withdrawal by Subject|0|||
161806770|NCT01045096|584337703|FG000|Overall Study|Other|1|||
161806771|NCT01045096|584337704|FG001|Overall Study|Other|0|||
161806772|NCT01045096|584337705|FG002|Overall Study|Other|0|||
161806773|NCT01900691|584337706|FG000|Overall Study|Death|7|||
161806774|NCT01900691|584337706|FG000|Overall Study|Lost to Follow-up|4|||
161806775|NCT01900691|584337706|FG000|Overall Study|Study Device Not Placed|3|||
161806776|NCT01900691|584337706|FG000|Overall Study|Non study stent placed|2|||
161806777|NCT01900691|584337706|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
161806778|NCT01900691|584337706|FG000|Overall Study|Complete stent migration through digestive tract|1|||
161806779|NCT01954394|584337707|FG000|Overall Study|Enrolled but not treated|1|||
161806780|NCT01954394|584337708|FG001|Overall Study|Enrolled but not treated|0|||
161806781|NCT01954394|584337707|FG000|Overall Study|Adverse Event|10|||
161806782|NCT01954394|584337708|FG001|Overall Study|Adverse Event|23|||
161806783|NCT01954394|584337707|FG000|Overall Study|Poor compliance to protocol|7|||
161806784|NCT01954394|584337708|FG001|Overall Study|Poor compliance to protocol|7|||
161806785|NCT01954394|584337707|FG000|Overall Study|Participant Moved|0|||
161806786|NCT01954394|584337708|FG001|Overall Study|Participant Moved|4|||
161806787|NCT01954394|584337707|FG000|Overall Study|Related to Study Drug administration|2|||
161806788|NCT01954394|584337708|FG001|Overall Study|Related to Study Drug administration|2|||
161806789|NCT01954394|584337707|FG000|Overall Study|Other than specified above|10|||
161806790|NCT01954394|584337708|FG001|Overall Study|Other than specified above|21|||
161806791|NCT00909610|584337709|FG000|Period: First Intervention|Adverse Event|0|||
161910449|NCT00761319|584725552|FG000|Overall Study|Protocol Violation|21|||
161910450|NCT00761319|584725553|FG001|Overall Study|Protocol Violation|14|||
161910451|NCT00761319|584725552|FG000|Overall Study|Adverse Event|11|||
161910452|NCT00761319|584725553|FG001|Overall Study|Adverse Event|7|||
161910453|NCT00761319|584725552|FG000|Overall Study|Withdrawal by Subject|8|||
161910454|NCT00761319|584725553|FG001|Overall Study|Withdrawal by Subject|7|||
161806792|NCT00909610|584337710|FG001|Period: First Intervention|Adverse Event|1|||
161806793|NCT00909610|584337709|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
161806794|NCT00909610|584337710|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
161806795|NCT00909610|584337709|FG000|Period: Second Intervention|Adverse Event|1|||
161561742|NCT04011033|583444303|FG000|Overall Study|Withdrawal by Subject|1|||
161561743|NCT04011033|583444304|FG001|Overall Study|Withdrawal by Subject|0|||
161561744|NCT01823341|583444305|FG000|Overall Study|Failed run-in|7|||
161561745|NCT01823341|583444305|FG000|Overall Study|Withdrawal by Subject|7|||
161561746|NCT01823341|583444305|FG000|Overall Study|Adverse Event|1|||
161561747|NCT01342887|583444306|FG000|Overall Study|Death|2|||
161561748|NCT00663962|583444307|FG000|Overall Study|somnolence|1|||
161561749|NCT00663962|583444308|FG001|Overall Study|somnolence|0|||
161561750|NCT02698436|583444320|FG000|Overall Study|Adverse Event|1|||
161453575|NCT03085914|583055387|FG006|Overall Study|Reason was not specified,|6|||
161561751|NCT02698436|583444321|FG001|Overall Study|Adverse Event|0|||
161561752|NCT02698436|583444320|FG000|Overall Study|Withdrawal by Subject|3|||
161561753|NCT02698436|583444321|FG001|Overall Study|Withdrawal by Subject|3|||
161561754|NCT02698436|583444320|FG000|Overall Study|Lost to Follow-up|2|||
161561755|NCT02698436|583444321|FG001|Overall Study|Lost to Follow-up|4|||
161561756|NCT02698436|583444320|FG000|Overall Study|Non-compliance with study regimen|1|||
161561757|NCT02698436|583444321|FG001|Overall Study|Non-compliance with study regimen|0|||
161561758|NCT00665561|583444326|FG000|Overall Study|Death recorded on subject summary pages|75|||
161561759|NCT00665561|583444327|FG001|Overall Study|Death recorded on subject summary pages|75|||
161561760|NCT00665561|583444326|FG000|Overall Study|Does not meet entrance criteria|19|||
161910455|NCT00761319|584725552|FG000|Overall Study|Noncompliance|4|||
161910456|NCT00761319|584725553|FG001|Overall Study|Noncompliance|3|||
161910457|NCT00761319|584725552|FG000|Overall Study|Lost to Follow-up|1|||
161910458|NCT00761319|584725553|FG001|Overall Study|Lost to Follow-up|1|||
161910459|NCT00761319|584725552|FG000|Overall Study|Nonspecified|2|||
161910460|NCT00761319|584725553|FG001|Overall Study|Nonspecified|2|||
161910461|NCT00761319|584725552|FG000|Overall Study|Missing|1|||
161910462|NCT00761319|584725553|FG001|Overall Study|Missing|0|||
161910463|NCT01373164|584725554|FG000|Overall Study|Lost to Follow-up|0|||
161910464|NCT01373164|584725555|FG001|Overall Study|Lost to Follow-up|0|||
161910465|NCT01373164|584725556|FG002|Overall Study|Lost to Follow-up|1|||
161910466|NCT01373164|584725557|FG003|Overall Study|Lost to Follow-up|2|||
161910467|NCT01373164|584725558|FG004|Overall Study|Lost to Follow-up|0|||
161910468|NCT01373164|584725554|FG000|Overall Study|Withdrawal by Subject|0|||
161910469|NCT01373164|584725555|FG001|Overall Study|Withdrawal by Subject|1|||
161910470|NCT01373164|584725556|FG002|Overall Study|Withdrawal by Subject|0|||
161910471|NCT01373164|584725557|FG003|Overall Study|Withdrawal by Subject|10|||
161910472|NCT01373164|584725558|FG004|Overall Study|Withdrawal by Subject|2|||
161453576|NCT03085914|583055381|FG000|Overall Study|Progressive Disease|0|||
161453577|NCT03085914|583055382|FG001|Overall Study|Progressive Disease|0|||
161453578|NCT03085914|583055383|FG002|Overall Study|Progressive Disease|2|||
161453579|NCT03085914|583055384|FG003|Overall Study|Progressive Disease|2|||
161453580|NCT03085914|583055385|FG004|Overall Study|Progressive Disease|1|||
161453581|NCT03085914|583055386|FG005|Overall Study|Progressive Disease|1|||
161453582|NCT03085914|583055387|FG006|Overall Study|Progressive Disease|1|||
161453583|NCT03085914|583055381|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161453584|NCT03085914|583055382|FG001|Overall Study|Study Terminated by the Sponsor|0|||
161453585|NCT03085914|583055383|FG002|Overall Study|Study Terminated by the Sponsor|0|||
161453586|NCT03085914|583055384|FG003|Overall Study|Study Terminated by the Sponsor|1|||
161453587|NCT03085914|583055385|FG004|Overall Study|Study Terminated by the Sponsor|2|||
161453588|NCT03085914|583055386|FG005|Overall Study|Study Terminated by the Sponsor|1|||
161453589|NCT03085914|583055387|FG006|Overall Study|Study Terminated by the Sponsor|0|||
161453590|NCT03874429|583055391|FG000|Overall Study|Adverse Event|2|||
161453591|NCT03874429|583055392|FG001|Overall Study|Adverse Event|2|||
161453592|NCT03874429|583055391|FG000|Overall Study|Lack of Efficacy|0|||
161453593|NCT03874429|583055392|FG001|Overall Study|Lack of Efficacy|1|||
161453594|NCT03874429|583055391|FG000|Overall Study|Covid-19 pandemic|4|||
161453595|NCT03874429|583055392|FG001|Overall Study|Covid-19 pandemic|2|||
161453596|NCT01561898|583055393|FG000|Overall Study|Withdrawal by Subject|0|||
161453597|NCT01561898|583055394|FG001|Overall Study|Withdrawal by Subject|8|||
161453598|NCT01561898|583055395|FG002|Overall Study|Withdrawal by Subject|12|||
161453599|NCT01561898|583055396|FG003|Overall Study|Withdrawal by Subject|5|||
161453600|NCT01561898|583055393|FG000|Overall Study|Lack of Efficacy|0|||
161453601|NCT01561898|583055394|FG001|Overall Study|Lack of Efficacy|8|||
161453602|NCT01561898|583055395|FG002|Overall Study|Lack of Efficacy|10|||
161910473|NCT01125930|584725563|FG000|Overall Study|Adverse Event|0|||
161910474|NCT01125930|584725564|FG001|Overall Study|Adverse Event|1|||
161910475|NCT01125930|584725563|FG000|Overall Study|Withdrawal by Subject|1|||
161910476|NCT01125930|584725564|FG001|Overall Study|Withdrawal by Subject|6|||
161453603|NCT01561898|583055396|FG003|Overall Study|Lack of Efficacy|5|||
161453604|NCT01561898|583055393|FG000|Overall Study|Worsening of complications|0|||
161453605|NCT01561898|583055394|FG001|Overall Study|Worsening of complications|1|||
161453606|NCT01561898|583055395|FG002|Overall Study|Worsening of complications|0|||
161453607|NCT01561898|583055396|FG003|Overall Study|Worsening of complications|0|||
161453608|NCT01561898|583055393|FG000|Overall Study|Lost to Follow-up|0|||
161561761|NCT00665561|583444327|FG001|Overall Study|Does not meet entrance criteria|21|||
161910477|NCT01125930|584725563|FG000|Overall Study|Protocol Violation|0|||
161910478|NCT01125930|584725564|FG001|Overall Study|Protocol Violation|1|||
161910479|NCT01125930|584725563|FG000|Overall Study|Lost to Follow-up|0|||
161910480|NCT01125930|584725564|FG001|Overall Study|Lost to Follow-up|2|||
161910481|NCT01715831|584725569|FG000|Overall Study|Adverse Event|1|||
161910482|NCT03261401|584725570|FG000|Overall Study|Withdrawal by Subject|0|||
161910483|NCT03261401|584725571|FG001|Overall Study|Withdrawal by Subject|0|||
161910484|NCT03261401|584725572|FG002|Overall Study|Withdrawal by Subject|0|||
161910485|NCT03261401|584725573|FG003|Overall Study|Withdrawal by Subject|0|||
161910486|NCT03261401|584725574|FG004|Overall Study|Withdrawal by Subject|0|||
161910487|NCT03261401|584725575|FG005|Overall Study|Withdrawal by Subject|1|||
161910488|NCT03261401|584725576|FG006|Overall Study|Withdrawal by Subject|0|||
161910489|NCT03261401|584725577|FG007|Overall Study|Withdrawal by Subject|0|||
161910490|NCT03261401|584725578|FG008|Overall Study|Withdrawal by Subject|0|||
161910491|NCT03261401|584725579|FG009|Overall Study|Withdrawal by Subject|0|||
161910492|NCT03261401|584725580|FG010|Overall Study|Withdrawal by Subject|0|||
161910493|NCT03261401|584725581|FG011|Overall Study|Withdrawal by Subject|0|||
161910494|NCT03261401|584725582|FG012|Overall Study|Withdrawal by Subject|0|||
161910495|NCT03261401|584725570|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
161910496|NCT03261401|584725571|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
161910497|NCT03261401|584725572|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
161910498|NCT03261401|584725573|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
161910499|NCT03261401|584725574|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
161910500|NCT03261401|584725575|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
161910501|NCT03261401|584725576|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
161910502|NCT03261401|584725577|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
161910503|NCT03261401|584725578|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
161910504|NCT03261401|584725579|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
161910505|NCT03261401|584725580|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
161910506|NCT03261401|584725581|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
161453609|NCT01561898|583055394|FG001|Overall Study|Lost to Follow-up|0|||
161453610|NCT01561898|583055395|FG002|Overall Study|Lost to Follow-up|1|||
161453611|NCT01561898|583055396|FG003|Overall Study|Lost to Follow-up|0|||
161453612|NCT01561898|583055393|FG000|Overall Study|Adverse Event|1|||
161453613|NCT01561898|583055394|FG001|Overall Study|Adverse Event|19|||
161453614|NCT01561898|583055395|FG002|Overall Study|Adverse Event|14|||
161453615|NCT01561898|583055396|FG003|Overall Study|Adverse Event|9|||
161453616|NCT01561898|583055393|FG000|Overall Study|Physician Decision|1|||
161453617|NCT01561898|583055394|FG001|Overall Study|Physician Decision|5|||
161453618|NCT01561898|583055395|FG002|Overall Study|Physician Decision|7|||
161453619|NCT01561898|583055396|FG003|Overall Study|Physician Decision|1|||
161453620|NCT00331552|583055397|FG000|Period 3: Phase II|Neurological Symptoms|1|||
161453621|NCT00331552|583055398|FG001|Period 3: Phase II|Neurological Symptoms|0|||
161453622|NCT00331552|583055397|FG000|Period 3: Phase II|Severe Nausea|1|||
161453623|NCT00331552|583055398|FG001|Period 3: Phase II|Severe Nausea|0|||
161453624|NCT01445548|583055399|FG000|Overall Study|Adverse Event|1|||
161453625|NCT03560518|583055400|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
161453626|NCT03560518|583055401|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
161453627|NCT03560518|583055402|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
161453628|NCT03560518|583055400|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
161453629|NCT03560518|583055401|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
161453630|NCT03560518|583055402|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
161453631|NCT03560518|583055400|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161453632|NCT03560518|583055401|FG001|Double Blind Treatment Period|Protocol Violation|2|||
161453633|NCT03560518|583055402|FG002|Double Blind Treatment Period|Protocol Violation|0|||
161453634|NCT03560518|583055400|FG000|Double Blind Treatment Period|Pregnancy|0|||
161453635|NCT03560518|583055401|FG001|Double Blind Treatment Period|Pregnancy|2|||
161453636|NCT03560518|583055402|FG002|Double Blind Treatment Period|Pregnancy|0|||
161453637|NCT03560518|583055400|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
161453638|NCT03560518|583055401|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
161453639|NCT03560518|583055402|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
161453640|NCT03560518|583055400|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
161453641|NCT03560518|583055401|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
161453642|NCT03560518|583055402|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
161453643|NCT03560518|583055400|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
161910507|NCT03261401|584725582|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
161453644|NCT03560518|583055401|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
161453645|NCT03560518|583055402|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
161910508|NCT01516216|584725583|FG000|Overall Study|Adverse Event|2|||
161453646|NCT03560518|583055400|FG000|Double Blind Treatment Period|Adverse Event|0|||
161453647|NCT03560518|583055401|FG001|Double Blind Treatment Period|Adverse Event|3|||
161453648|NCT03560518|583055402|FG002|Double Blind Treatment Period|Adverse Event|1|||
161453649|NCT00159822|583055403|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
161561762|NCT00665561|583444326|FG000|Overall Study|Lost to Follow-up|203|||
161910509|NCT01516216|584725584|FG001|Overall Study|Adverse Event|4|||
161910510|NCT01516216|584725583|FG000|Overall Study|Disease Progression|38|||
161561763|NCT00665561|583444327|FG001|Overall Study|Lost to Follow-up|264|||
161910511|NCT01516216|584725584|FG001|Overall Study|Disease Progression|34|||
161910512|NCT01516216|584725583|FG000|Overall Study|Withdrawal by Subject|9|||
161910513|NCT01516216|584725584|FG001|Overall Study|Withdrawal by Subject|11|||
161910514|NCT01516216|584725583|FG000|Overall Study|Potentially Curative Resection|6|||
161910515|NCT01516216|584725584|FG001|Overall Study|Potentially Curative Resection|12|||
161910516|NCT01516216|584725583|FG000|Overall Study|Nonadherence|2|||
161910517|NCT01516216|584725584|FG001|Overall Study|Nonadherence|3|||
161910518|NCT01516216|584725583|FG000|Overall Study|Physician Decision|6|||
161910519|NCT01516216|584725584|FG001|Overall Study|Physician Decision|3|||
161910520|NCT01516216|584725583|FG000|Overall Study|Prolonged Treatment Delay|5|||
161910521|NCT01516216|584725584|FG001|Overall Study|Prolonged Treatment Delay|1|||
161910522|NCT01516216|584725583|FG000|Overall Study|Intercurrent Illness|1|||
161910523|NCT01516216|584725584|FG001|Overall Study|Intercurrent Illness|0|||
161910524|NCT01516216|584725583|FG000|Overall Study|Death|1|||
161910525|NCT01516216|584725584|FG001|Overall Study|Death|1|||
161910526|NCT01715298|584725585|FG000|Overall Study|Lost to Follow-up|0|||
161910527|NCT01715298|584725586|FG001|Overall Study|Lost to Follow-up|2|||
161910528|NCT01715298|584725585|FG000|Overall Study|Patient/guardian decision|7|||
161910529|NCT01715298|584725586|FG001|Overall Study|Patient/guardian decision|9|||
161910530|NCT02419807|584725587|FG000|Overall Study|Withdrawal by Subject|4|||
161910531|NCT02419807|584725587|FG000|Overall Study|Physician Decision|1|||
161910532|NCT02419807|584725587|FG000|Overall Study|Protocol Violation|5|||
161910533|NCT01006629|584725590|FG000|Overall Study|Adverse Event|1|||
161910534|NCT01006629|584725590|FG000|Overall Study|Parent refused to continue participation|1|||
161910535|NCT01006629|584725590|FG000|Overall Study|Parent unable to perform site visit|4|||
161910536|NCT01499511|584725591|FG000|Overall Study|Death|1|||
161910537|NCT01499511|584725592|FG001|Overall Study|Death|0|||
161561764|NCT00665561|583444326|FG000|Overall Study|Withdrawal by Subject|74|||
161561765|NCT00665561|583444327|FG001|Overall Study|Withdrawal by Subject|65|||
161561766|NCT00665561|583444326|FG000|Overall Study|Other|123|||
161561767|NCT00665561|583444327|FG001|Overall Study|Other|108|||
161561768|NCT00665561|583444326|FG000|Overall Study|Site closed|8|||
161561769|NCT00665561|583444327|FG001|Overall Study|Site closed|0|||
161561770|NCT00665561|583444326|FG000|Overall Study|Withdrawn due to pregnancy|0|||
161910538|NCT00998946|584725594|FG000|Overall Study|Lost to Follow-up|1|||
161910539|NCT00998946|584725594|FG000|Overall Study|Withdrawal by Subject|1|||
161910540|NCT00998946|584725594|FG000|Overall Study|Death|2|||
161910541|NCT00998946|584725594|FG000|Overall Study|Reason Unspecified|3|||
161910542|NCT00998946|584725594|FG000|Overall Study|Enrolled but not Dosed|2|||
161910543|NCT01065818|584725596|FG000|Overall Study|Withdrawal by Subject|1|||
161910544|NCT01065818|584725596|FG000|Overall Study|Not a candidate for surgery|1|||
161910545|NCT00853385|584725597|FG000|Overall Study|Death|0|||
161910546|NCT00853385|584725598|FG001|Overall Study|Death|0|||
161910547|NCT00853385|584725599|FG002|Overall Study|Death|0|||
161910548|NCT00853385|584725600|FG003|Overall Study|Death|0|||
161910549|NCT00853385|584725601|FG004|Overall Study|Death|1|||
161910550|NCT00853385|584725597|FG000|Overall Study|Adverse Event|24|||
161910551|NCT00853385|584725598|FG001|Overall Study|Adverse Event|24|||
161910552|NCT00853385|584725599|FG002|Overall Study|Adverse Event|2|||
161910553|NCT00853385|584725600|FG003|Overall Study|Adverse Event|5|||
161910554|NCT00853385|584725601|FG004|Overall Study|Adverse Event|22|||
161910555|NCT00853385|584725597|FG000|Overall Study|Lack of Efficacy|6|||
161910556|NCT00853385|584725598|FG001|Overall Study|Lack of Efficacy|7|||
161910557|NCT00853385|584725599|FG002|Overall Study|Lack of Efficacy|3|||
161910558|NCT00853385|584725600|FG003|Overall Study|Lack of Efficacy|3|||
161910559|NCT00853385|584725601|FG004|Overall Study|Lack of Efficacy|6|||
161910560|NCT00853385|584725597|FG000|Overall Study|Lost to Follow-up|2|||
161561771|NCT00665561|583444327|FG001|Overall Study|Withdrawn due to pregnancy|1|||
161561772|NCT03253653|583444328|FG000|Overall Study|Withdrawal by Subject|4|||
161561773|NCT03253653|583444329|FG001|Overall Study|Withdrawal by Subject|1|||
161910561|NCT00853385|584725598|FG001|Overall Study|Lost to Follow-up|1|||
161910562|NCT00853385|584725599|FG002|Overall Study|Lost to Follow-up|0|||
161561774|NCT03253653|583444328|FG000|Overall Study|Protocol Violation|0|||
161910563|NCT00853385|584725600|FG003|Overall Study|Lost to Follow-up|0|||
161910564|NCT00853385|584725601|FG004|Overall Study|Lost to Follow-up|0|||
161910565|NCT00853385|584725597|FG000|Overall Study|Withdrawal by Subject|4|||
161910566|NCT00853385|584725598|FG001|Overall Study|Withdrawal by Subject|2|||
161910567|NCT00853385|584725599|FG002|Overall Study|Withdrawal by Subject|0|||
161910568|NCT00853385|584725600|FG003|Overall Study|Withdrawal by Subject|1|||
161910569|NCT00853385|584725601|FG004|Overall Study|Withdrawal by Subject|1|||
161910570|NCT00853385|584725597|FG000|Overall Study|Other|18|||
161561775|NCT03253653|583444329|FG001|Overall Study|Protocol Violation|5|||
161910571|NCT00853385|584725598|FG001|Overall Study|Other|9|||
161910572|NCT00853385|584725599|FG002|Overall Study|Other|4|||
161910573|NCT00853385|584725600|FG003|Overall Study|Other|4|||
161806796|NCT00909610|584337710|FG001|Period: Second Intervention|Adverse Event|0|||
161806797|NCT00328926|584337714|FG000|Overall Study|Pregnancy|2|||
161806798|NCT00328926|584337715|FG001|Overall Study|Pregnancy|1|||
161806799|NCT00328926|584337716|FG002|Overall Study|Pregnancy|0|||
161806800|NCT00328926|584337714|FG000|Overall Study|Lost to Follow-up|0|||
161806801|NCT00328926|584337715|FG001|Overall Study|Lost to Follow-up|1|||
161806802|NCT00328926|584337716|FG002|Overall Study|Lost to Follow-up|0|||
161806803|NCT00328926|584337714|FG000|Overall Study|Death|0|||
161806804|NCT00328926|584337715|FG001|Overall Study|Death|0|||
161806805|NCT00328926|584337716|FG002|Overall Study|Death|1|||
161806806|NCT00328926|584337714|FG000|Overall Study|In vitro fertilization treatment|0|||
161806807|NCT00328926|584337715|FG001|Overall Study|In vitro fertilization treatment|0|||
161806808|NCT00328926|584337716|FG002|Overall Study|In vitro fertilization treatment|1|||
161806809|NCT00328926|584337714|FG000|Overall Study|Lack of ovarian response|0|||
161806810|NCT00328926|584337715|FG001|Overall Study|Lack of ovarian response|1|||
161806811|NCT00328926|584337716|FG002|Overall Study|Lack of ovarian response|0|||
161806812|NCT02269657|584337719|FG000|Overall Study|Protocol Violation|3|||
161806813|NCT00834249|584337724|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161806814|NCT00834249|584337725|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161806815|NCT00834249|584337724|FG000|Second Intervention|Adverse Event|1|||
161806816|NCT00834249|584337725|FG001|Second Intervention|Adverse Event|0|||
161806817|NCT00851877|584337726|FG000|Phase I-1|Death|1|||
161806818|NCT00851877|584337727|FG001|Phase I-1|Death|0|||
161806819|NCT00851877|584337728|FG002|Phase I-1|Death|0|||
161806820|NCT00851877|584337726|FG000|Phase II|Withdrawal by Subject|0|||
161910574|NCT00853385|584725601|FG004|Overall Study|Other|12|||
161453650|NCT00159822|583055403|FG000|Voriconazole Treatment Period|Adverse Event|9|||
161806821|NCT00851877|584337727|FG001|Phase II|Withdrawal by Subject|0|||
161806822|NCT00851877|584337728|FG002|Phase II|Withdrawal by Subject|3|||
161806823|NCT00834743|584337729|FG000|Second Intervention|Withdrawal by Subject|1|||
161806824|NCT00834743|584337730|FG001|Second Intervention|Withdrawal by Subject|0|||
161806825|NCT00627016|584337731|FG000|Overall Study|Adverse Event|1|||
161806826|NCT00627016|584337732|FG001|Overall Study|Adverse Event|1|||
161806827|NCT00627016|584337731|FG000|Overall Study|Protocol Violation|0|||
161806828|NCT00627016|584337732|FG001|Overall Study|Protocol Violation|2|||
161806829|NCT00627016|584337731|FG000|Overall Study|Lost to Follow-up|0|||
161806830|NCT00627016|584337732|FG001|Overall Study|Lost to Follow-up|1|||
161806831|NCT00627016|584337731|FG000|Overall Study|Withdrawal by Subject|2|||
161806832|NCT00627016|584337732|FG001|Overall Study|Withdrawal by Subject|1|||
161806833|NCT00627016|584337731|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161806834|NCT00627016|584337732|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
161806835|NCT00627016|584337731|FG000|Overall Study|Lack of Efficacy|1|||
161806836|NCT00627016|584337732|FG001|Overall Study|Lack of Efficacy|0|||
161806837|NCT00627016|584337731|FG000|Overall Study|Placed on Excluded Drugs|1|||
161806838|NCT00627016|584337732|FG001|Overall Study|Placed on Excluded Drugs|0|||
161806839|NCT00627016|584337731|FG000|Overall Study|Pregnancy|1|||
161806840|NCT00627016|584337732|FG001|Overall Study|Pregnancy|0|||
161806841|NCT01534663|584337733|FG000|Overall Study|Lost to Follow-up|0|||
161910575|NCT00915525|584725602|FG000|Overall Study|Protocol Violation|9|||
161453651|NCT00159822|583055403|FG000|Voriconazole Treatment Period|Death|4|||
161453652|NCT00159822|583055403|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
161453653|NCT00159822|583055403|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
161453654|NCT00159822|583055403|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
161453655|NCT00159822|583055403|FG000|Post-treatment Follow-up Period|Death|1|||
161453656|NCT00159822|583055403|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
161453657|NCT00159822|583055403|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
161453658|NCT01215916|583055405|FG000|Overall Study|Progressive Disease|0|||
161453659|NCT01215916|583055406|FG001|Overall Study|Progressive Disease|2|||
161453660|NCT01215916|583055407|FG002|Overall Study|Progressive Disease|1|||
161453661|NCT01215916|583055408|FG003|Overall Study|Progressive Disease|2|||
161453662|NCT01215916|583055409|FG004|Overall Study|Progressive Disease|5|||
161453663|NCT01215916|583055410|FG005|Overall Study|Progressive Disease|4|||
161453664|NCT01215916|583055411|FG006|Overall Study|Progressive Disease|5|||
161453665|NCT01215916|583055412|FG007|Overall Study|Progressive Disease|3|||
161453666|NCT01215916|583055413|FG008|Overall Study|Progressive Disease|1|||
161453667|NCT01215916|583055405|FG000|Overall Study|Adverse Event|1|||
161453668|NCT01215916|583055406|FG001|Overall Study|Adverse Event|1|||
161453669|NCT01215916|583055407|FG002|Overall Study|Adverse Event|0|||
161561776|NCT04978363|583446097|FG000|Overall Study|Other medical issues unrelated to the study|0|||
161806842|NCT01534663|584337734|FG001|Overall Study|Lost to Follow-up|2|||
161806843|NCT01534663|584337733|FG000|Overall Study|Adverse Event|2|||
161806844|NCT01534663|584337734|FG001|Overall Study|Adverse Event|1|||
161453670|NCT01215916|583055408|FG003|Overall Study|Adverse Event|1|||
161453671|NCT01215916|583055409|FG004|Overall Study|Adverse Event|0|||
161453672|NCT01215916|583055410|FG005|Overall Study|Adverse Event|0|||
161806845|NCT01693523|584337735|FG000|Overall Study|Adverse Event|2|||
161806846|NCT01693523|584337736|FG001|Overall Study|Adverse Event|1|||
161806847|NCT01693523|584337737|FG002|Overall Study|Adverse Event|0|||
161910576|NCT00915525|584725603|FG001|Overall Study|Protocol Violation|4|||
161910577|NCT00915525|584725602|FG000|Overall Study|Withdrawal by Subject|59|||
161910578|NCT00915525|584725603|FG001|Overall Study|Withdrawal by Subject|21|||
161910579|NCT00915525|584725602|FG000|Overall Study|Lost to Follow-up|27|||
161806848|NCT01693523|584337735|FG000|Overall Study|Death|0|||
161806849|NCT01693523|584337736|FG001|Overall Study|Death|1|||
161806850|NCT01693523|584337737|FG002|Overall Study|Death|1|||
161806851|NCT01693523|584337735|FG000|Overall Study|Lost to Follow-up|0|||
161806852|NCT01693523|584337736|FG001|Overall Study|Lost to Follow-up|0|||
161806853|NCT01693523|584337737|FG002|Overall Study|Lost to Follow-up|4|||
161806854|NCT01693523|584337735|FG000|Overall Study|Physician Decision|0|||
161806855|NCT01693523|584337736|FG001|Overall Study|Physician Decision|0|||
161806856|NCT01693523|584337737|FG002|Overall Study|Physician Decision|1|||
161806857|NCT01693523|584337735|FG000|Overall Study|Withdrawal by Subject|1|||
161806858|NCT01693523|584337736|FG001|Overall Study|Withdrawal by Subject|2|||
161806859|NCT01693523|584337737|FG002|Overall Study|Withdrawal by Subject|2|||
161806860|NCT01693523|584337735|FG000|Overall Study|Lack of compliance study medication|1|||
161806861|NCT01693523|584337736|FG001|Overall Study|Lack of compliance study medication|2|||
161806862|NCT01693523|584337737|FG002|Overall Study|Lack of compliance study medication|0|||
161806863|NCT01693523|584337735|FG000|Overall Study|Chemotherapy was held|1|||
161806864|NCT01693523|584337736|FG001|Overall Study|Chemotherapy was held|2|||
161806865|NCT01693523|584337737|FG002|Overall Study|Chemotherapy was held|0|||
161806866|NCT03025880|584337738|FG000|Overall Study|Adverse Event|1|||
161806867|NCT03025880|584337739|FG001|Overall Study|Adverse Event|0|||
161806868|NCT03025880|584337738|FG000|Overall Study|Death|1|||
161806869|NCT03025880|584337739|FG001|Overall Study|Death|1|||
161806870|NCT03025880|584337738|FG000|Overall Study|Withdrawal by Subject|0|||
161806871|NCT03025880|584337739|FG001|Overall Study|Withdrawal by Subject|1|||
161806872|NCT03025880|584337738|FG000|Overall Study|Physician Decision|0|||
161806873|NCT03025880|584337739|FG001|Overall Study|Physician Decision|1|||
161806874|NCT03025880|584337738|FG000|Overall Study|Progressive Disease|12|||
161806875|NCT03025880|584337739|FG001|Overall Study|Progressive Disease|19|||
161806876|NCT00086996|584337741|FG000|Overall Study|Adverse Event|29|||
161806877|NCT00086996|584337741|FG000|Overall Study|Death|4|||
161910580|NCT00915525|584725603|FG001|Overall Study|Lost to Follow-up|16|||
161561777|NCT04978363|583446098|FG001|Overall Study|Other medical issues unrelated to the study|0|||
161561778|NCT04978363|583446099|FG002|Overall Study|Other medical issues unrelated to the study|0|||
161561779|NCT04978363|583446100|FG003|Overall Study|Other medical issues unrelated to the study|0|||
161561780|NCT04978363|583446101|FG004|Overall Study|Other medical issues unrelated to the study|1|||
161561781|NCT04978363|583446102|FG005|Overall Study|Other medical issues unrelated to the study|0|||
161561782|NCT04978363|583446103|FG006|Overall Study|Other medical issues unrelated to the study|0|||
161561783|NCT04978363|583446104|FG007|Overall Study|Other medical issues unrelated to the study|0|||
161561784|NCT04978363|583446105|FG008|Overall Study|Other medical issues unrelated to the study|0|||
161561785|NCT04978363|583446106|FG009|Overall Study|Other medical issues unrelated to the study|0|||
161561786|NCT04978363|583446107|FG010|Overall Study|Other medical issues unrelated to the study|0|||
161561787|NCT04978363|583446097|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
161561788|NCT04978363|583446098|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
161561789|NCT04978363|583446099|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
161561790|NCT04978363|583446100|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
161561791|NCT04978363|583446101|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
161561792|NCT04978363|583446102|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
161561793|NCT04978363|583446103|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
161561794|NCT04978363|583446104|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
161561795|NCT04978363|583446105|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
161561796|NCT04978363|583446106|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
161806878|NCT00086996|584337741|FG000|Overall Study|progression/relapse|7|||
161806879|NCT00086996|584337741|FG000|Overall Study|Withdrawal by Subject|13|||
161806880|NCT00086996|584337741|FG000|Overall Study|Other|6|||
161806881|NCT00086996|584337741|FG000|Overall Study|not eligible|5|||
161910581|NCT00915525|584725602|FG000|Overall Study|Pregnancy|2|||
161453673|NCT01215916|583055411|FG006|Overall Study|Adverse Event|3|||
161453674|NCT01215916|583055412|FG007|Overall Study|Adverse Event|0|||
161453675|NCT01215916|583055413|FG008|Overall Study|Adverse Event|0|||
161453676|NCT01215916|583055405|FG000|Overall Study|Withdrawal by Subject|0|||
161453677|NCT01215916|583055406|FG001|Overall Study|Withdrawal by Subject|1|||
161453678|NCT01215916|583055407|FG002|Overall Study|Withdrawal by Subject|1|||
161453679|NCT01215916|583055408|FG003|Overall Study|Withdrawal by Subject|2|||
161453680|NCT01215916|583055409|FG004|Overall Study|Withdrawal by Subject|0|||
161453681|NCT01215916|583055410|FG005|Overall Study|Withdrawal by Subject|0|||
161453682|NCT01215916|583055411|FG006|Overall Study|Withdrawal by Subject|1|||
161453683|NCT01215916|583055412|FG007|Overall Study|Withdrawal by Subject|0|||
161453684|NCT01215916|583055413|FG008|Overall Study|Withdrawal by Subject|0|||
161453685|NCT01215916|583055405|FG000|Overall Study|Death|0|||
161806882|NCT01422538|584337742|FG000|Overall Study|Lost to Follow-up|0|||
161910582|NCT00915525|584725603|FG001|Overall Study|Pregnancy|0|||
161561797|NCT04978363|583446107|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
161561798|NCT04978363|583446097|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561799|NCT04978363|583446098|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
161561800|NCT04978363|583446099|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561801|NCT04978363|583446100|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561802|NCT04978363|583446101|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561803|NCT04978363|583446102|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561804|NCT04978363|583446103|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561805|NCT04978363|583446104|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561806|NCT04978363|583446105|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561807|NCT04978363|583446106|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561808|NCT04978363|583446107|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
161561809|NCT01251614|583446108|FG000|Overall Study|Adverse Event|1|||
161561810|NCT01251614|583446109|FG001|Overall Study|Adverse Event|0|||
161561811|NCT01251614|583446110|FG002|Overall Study|Adverse Event|1|||
161561812|NCT01251614|583446108|FG000|Overall Study|Lack of Efficacy|1|||
161561813|NCT01251614|583446109|FG001|Overall Study|Lack of Efficacy|9|||
161561814|NCT01251614|583446110|FG002|Overall Study|Lack of Efficacy|4|||
161561815|NCT01251614|583446108|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
161561816|NCT01251614|583446109|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
161561817|NCT01251614|583446110|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
161561818|NCT01251614|583446108|FG000|Overall Study|Pregnancy|0|||
161561819|NCT01251614|583446109|FG001|Overall Study|Pregnancy|0|||
161561820|NCT01251614|583446110|FG002|Overall Study|Pregnancy|2|||
161561821|NCT01251614|583446108|FG000|Overall Study|Loss of Disease Control|0|||
161561822|NCT01251614|583446109|FG001|Overall Study|Loss of Disease Control|1|||
161561823|NCT01251614|583446110|FG002|Overall Study|Loss of Disease Control|0|||
161561824|NCT01251614|583446108|FG000|Overall Study|Withdrawal by Subject|0|||
161561825|NCT01251614|583446109|FG001|Overall Study|Withdrawal by Subject|2|||
161561826|NCT01251614|583446110|FG002|Overall Study|Withdrawal by Subject|1|||
161561827|NCT01251614|583446108|FG000|Overall Study|Lost to Follow-up|0|||
161561828|NCT01251614|583446109|FG001|Overall Study|Lost to Follow-up|1|||
161561829|NCT01251614|583446110|FG002|Overall Study|Lost to Follow-up|0|||
161561830|NCT01876043|583446112|FG000|Overall Study|Death|1|||
161561831|NCT01876043|583446112|FG000|Overall Study|Withdrawal by Subject|1|||
161561832|NCT00079937|583446113|FG000|Overall Study|Adverse Event|2|||
161561833|NCT00079937|583446114|FG001|Overall Study|Adverse Event|1|||
161561834|NCT00079937|583446113|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161561835|NCT00079937|583446114|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161561836|NCT00079937|583446113|FG000|Overall Study|Subject no longer requires study drug|3|||
161561837|NCT00079937|583446114|FG001|Overall Study|Subject no longer requires study drug|0|||
161561838|NCT00079937|583446113|FG000|Overall Study|Protocol Violation|8|||
161561839|NCT00079937|583446114|FG001|Overall Study|Protocol Violation|6|||
161561840|NCT00079937|583446113|FG000|Overall Study|Withdrawal by Subject|21|||
161910583|NCT00915525|584725602|FG000|Overall Study|Lack of Efficacy|15|||
161453686|NCT01215916|583055406|FG001|Overall Study|Death|1|||
161453687|NCT01215916|583055407|FG002|Overall Study|Death|0|||
161453688|NCT01215916|583055408|FG003|Overall Study|Death|0|||
161453689|NCT01215916|583055409|FG004|Overall Study|Death|1|||
161453690|NCT01215916|583055410|FG005|Overall Study|Death|0|||
161453691|NCT01215916|583055411|FG006|Overall Study|Death|0|||
161453692|NCT01215916|583055412|FG007|Overall Study|Death|0|||
161453693|NCT01215916|583055413|FG008|Overall Study|Death|1|||
161453694|NCT01215916|583055405|FG000|Overall Study|Physician Decision|0|||
161453695|NCT01215916|583055406|FG001|Overall Study|Physician Decision|0|||
161453696|NCT01215916|583055407|FG002|Overall Study|Physician Decision|1|||
161453697|NCT01215916|583055408|FG003|Overall Study|Physician Decision|1|||
161453698|NCT01215916|583055409|FG004|Overall Study|Physician Decision|0|||
161453699|NCT01215916|583055410|FG005|Overall Study|Physician Decision|0|||
161453700|NCT01215916|583055411|FG006|Overall Study|Physician Decision|0|||
161453701|NCT01215916|583055412|FG007|Overall Study|Physician Decision|0|||
161453702|NCT01215916|583055413|FG008|Overall Study|Physician Decision|0|||
161453703|NCT01185301|583055414|FG000|Overall Study|Adverse Event|3|||
161453704|NCT01185301|583055415|FG001|Overall Study|Adverse Event|0|||
161453705|NCT01185301|583055416|FG002|Overall Study|Adverse Event|2|||
161453706|NCT01185301|583055417|FG003|Overall Study|Adverse Event|3|||
161453707|NCT01185301|583055414|FG000|Overall Study|Withdrawal by Subject|7|||
161453708|NCT01185301|583055415|FG001|Overall Study|Withdrawal by Subject|5|||
161453709|NCT01185301|583055416|FG002|Overall Study|Withdrawal by Subject|2|||
161561841|NCT00079937|583446114|FG001|Overall Study|Withdrawal by Subject|7|||
161453710|NCT01185301|583055417|FG003|Overall Study|Withdrawal by Subject|3|||
161453711|NCT01185301|583055414|FG000|Overall Study|Lost to Follow-up|2|||
161453712|NCT01185301|583055415|FG001|Overall Study|Lost to Follow-up|0|||
161453713|NCT01185301|583055416|FG002|Overall Study|Lost to Follow-up|0|||
161453714|NCT01185301|583055417|FG003|Overall Study|Lost to Follow-up|1|||
161910584|NCT00915525|584725603|FG001|Overall Study|Lack of Efficacy|32|||
161910585|NCT00915525|584725602|FG000|Overall Study|Adverse Event|29|||
161910586|NCT00915525|584725603|FG001|Overall Study|Adverse Event|13|||
161910587|NCT00915525|584725602|FG000|Overall Study|Missing|12|||
161910588|NCT00915525|584725603|FG001|Overall Study|Missing|1|||
161910589|NCT00915525|584725602|FG000|Overall Study|Other Reason|35|||
161910590|NCT00915525|584725603|FG001|Overall Study|Other Reason|12|||
161910591|NCT00915525|584725602|FG000|Overall Study|Site Closed|27|||
161910592|NCT00915525|584725603|FG001|Overall Study|Site Closed|9|||
161910593|NCT00915525|584725602|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
161910594|NCT00915525|584725603|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
161910595|NCT00915525|584725602|FG000|Overall Study|Study Burden|28|||
161910596|NCT00915525|584725603|FG001|Overall Study|Study Burden|12|||
161910597|NCT00915525|584725602|FG000|Overall Study|Non-Compliance|3|||
161910598|NCT00915525|584725603|FG001|Overall Study|Non-Compliance|1|||
161910599|NCT00915525|584725602|FG000|Overall Study|Patient Moved|15|||
161910600|NCT00915525|584725603|FG001|Overall Study|Patient Moved|9|||
161910601|NCT00577408|584725604|FG000|Overall Study|Stopped attending study visits|9|||
161910602|NCT00577408|584725605|FG001|Overall Study|Stopped attending study visits|11|||
161910603|NCT00577408|584725604|FG000|Overall Study|Continued opioid use|3|||
161910604|NCT00577408|584725605|FG001|Overall Study|Continued opioid use|2|||
161910605|NCT00577408|584725604|FG000|Overall Study|Non-compliance with study meds|0|||
161910606|NCT00577408|584725605|FG001|Overall Study|Non-compliance with study meds|3|||
161910607|NCT00577408|584725604|FG000|Overall Study|Refused Oral Naltrexone|0|||
161910608|NCT00577408|584725605|FG001|Overall Study|Refused Oral Naltrexone|1|||
161910609|NCT00577408|584725604|FG000|Overall Study|Moved out of state|0|||
161910610|NCT00577408|584725605|FG001|Overall Study|Moved out of state|1|||
161910611|NCT00577408|584725604|FG000|Overall Study|Scheduling Issues|0|||
161910612|NCT00577408|584725605|FG001|Overall Study|Scheduling Issues|3|||
161910613|NCT00577408|584725604|FG000|Overall Study|Death|0|||
161910614|NCT00577408|584725605|FG001|Overall Study|Death|1|||
161910615|NCT00577408|584725604|FG000|Overall Study|Psychiatric hospitalization|0|||
161910616|NCT00577408|584725605|FG001|Overall Study|Psychiatric hospitalization|1|||
161910617|NCT03435055|584725606|FG000|Screening|Physician Decision|2|||
161910618|NCT03435055|584725606|FG000|Received Intervention|Did not complete nitrous administration|3|||
161910619|NCT02732639|584725612|FG000|Overall Study|Lost to Follow-up|1|||
161910620|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
161910621|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161910622|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161910623|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161910624|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
161910625|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161910626|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161453715|NCT01185301|583055414|FG000|Overall Study|Other Reason|3|||
161453716|NCT01185301|583055415|FG001|Overall Study|Other Reason|2|||
161453717|NCT01185301|583055416|FG002|Overall Study|Other Reason|2|||
161453718|NCT01185301|583055417|FG003|Overall Study|Other Reason|2|||
161453719|NCT02683746|583055418|FG000|Overall Study|Adverse Event|3|||
161453720|NCT02683746|583055419|FG001|Overall Study|Adverse Event|2|||
161453721|NCT02683746|583055418|FG000|Overall Study|Lost to Follow-up|5|||
161453722|NCT02683746|583055419|FG001|Overall Study|Lost to Follow-up|6|||
161453723|NCT02683746|583055418|FG000|Overall Study|Withdrawal by Subject|6|||
161453724|NCT02683746|583055419|FG001|Overall Study|Withdrawal by Subject|5|||
161453725|NCT02683746|583055418|FG000|Overall Study|Physician Decision|2|||
161453726|NCT02683746|583055419|FG001|Overall Study|Physician Decision|1|||
161453727|NCT03726996|583055423|FG000|Overall Study|Parent's decision|2|||
161453728|NCT03726996|583055423|FG000|Overall Study|Study early termination|2|||
161453729|NCT03531632|583055428|FG000|Overall Study|Adverse Event|0|||
161453730|NCT03531632|583055429|FG001|Overall Study|Adverse Event|0|||
161453731|NCT03531632|583055430|FG002|Overall Study|Adverse Event|1|||
161453732|NCT03531632|583055428|FG000|Overall Study|Death|4|||
161453733|NCT03531632|583055429|FG001|Overall Study|Death|0|||
161453734|NCT03531632|583055430|FG002|Overall Study|Death|14|||
161453735|NCT03531632|583055428|FG000|Overall Study|Study Terminated|1|||
161910627|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161910628|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
161910629|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
161910630|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
161453736|NCT03531632|583055429|FG001|Overall Study|Study Terminated|3|||
161453737|NCT03531632|583055430|FG002|Overall Study|Study Terminated|11|||
161453738|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
161453739|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
161453740|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Adverse Event|7|||
161910631|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
161910632|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
161910633|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161561842|NCT00079937|583446113|FG000|Overall Study|Lost to Follow-up|12|||
161561843|NCT00079937|583446114|FG001|Overall Study|Lost to Follow-up|5|||
161561844|NCT00079937|583446113|FG000|Overall Study|Administrative problems|22|||
161561845|NCT00079937|583446114|FG001|Overall Study|Administrative problems|11|||
161561846|NCT02857283|583446115|FG000|First Exposure|Withdrawal by Subject|1|||
161561847|NCT02857283|583446116|FG001|First Exposure|Withdrawal by Subject|0|||
161561848|NCT00093795|583446117|FG000|Overall Study|No follow up data|20|||
161561849|NCT00093795|583446118|FG001|Overall Study|No follow up data|16|||
161561850|NCT00093795|583446119|FG002|Overall Study|No follow up data|17|||
161561851|NCT00613301|583446120|FG000|Overall Study|Adverse Event|49|||
161561852|NCT00613301|583446120|FG000|Overall Study|Lost to Follow-up|88|||
161561853|NCT00613301|583446120|FG000|Overall Study|Withdrawal by Subject|5|||
161561854|NCT00613301|583446120|FG000|Overall Study|Death|6|||
161561855|NCT00613301|583446120|FG000|Overall Study|Lack of Efficacy|13|||
161561856|NCT00613301|583446120|FG000|Overall Study|Physician Decision|2|||
161561857|NCT00613301|583446120|FG000|Overall Study|No data was collected|53|||
161561858|NCT00613301|583446120|FG000|Overall Study|Irregularly enrolled patients|12|||
161561859|NCT01684046|583446123|FG000|Period 1, First 30 Days|Adverse Event|0|||
161806883|NCT01422538|584337743|FG001|Overall Study|Lost to Follow-up|1|||
161806884|NCT01422538|584337744|FG002|Overall Study|Lost to Follow-up|1|||
161806885|NCT01422538|584337742|FG000|Overall Study|Missed visit|0|||
161806886|NCT01422538|584337743|FG001|Overall Study|Missed visit|1|||
161806887|NCT01422538|584337744|FG002|Overall Study|Missed visit|1|||
161806888|NCT00312663|584337745|FG000|Immunization Phase|Adverse Event|0|||
161806889|NCT00312663|584337746|FG001|Immunization Phase|Adverse Event|1|||
161806890|NCT00312663|584337747|FG002|Immunization Phase|Adverse Event|0|||
161806891|NCT00286754|584337748|FG000|Overall Study|Adverse Event|2|||
161806892|NCT00286754|584337749|FG001|Overall Study|Adverse Event|2|||
161806893|NCT00286754|584337750|FG002|Overall Study|Adverse Event|3|||
161806894|NCT00286754|584337748|FG000|Overall Study|Withdrawal by Subject|6|||
161806895|NCT00286754|584337749|FG001|Overall Study|Withdrawal by Subject|2|||
161806896|NCT00286754|584337750|FG002|Overall Study|Withdrawal by Subject|0|||
161806897|NCT00286754|584337748|FG000|Overall Study|Lost to Follow-up|12|||
161806898|NCT00286754|584337749|FG001|Overall Study|Lost to Follow-up|14|||
161806899|NCT00286754|584337750|FG002|Overall Study|Lost to Follow-up|6|||
161806900|NCT00286754|584337748|FG000|Overall Study|Moved out of state|0|||
161806901|NCT00286754|584337749|FG001|Overall Study|Moved out of state|0|||
161806902|NCT00286754|584337750|FG002|Overall Study|Moved out of state|1|||
161806903|NCT02661295|584337751|FG000|Overall Study|Death|1|||
161806904|NCT02661295|584337751|FG000|Overall Study|Transferred Out|1|||
161806905|NCT02661295|584337751|FG000|Overall Study|Kidney Transplant|1|||
161806906|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to side effects|8|||
161806907|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to access type|1|||
161806908|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to allergies|1|||
161806909|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to non-compliance|1|||
161806910|NCT02661295|584337751|FG000|Overall Study|Withdrawal by Subject|3|||
161806911|NCT02661295|584337751|FG000|Overall Study|Failed screening|2|||
161806912|NCT00301366|584337752|FG000|Overall Study|Adverse Event|1|||
161806913|NCT01313273|584337753|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
161806914|NCT01313273|584337754|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
161806915|NCT01313273|584337753|FG000|Overall Study|Withdrawal by Subject|1|||
161806916|NCT01313273|584337754|FG001|Overall Study|Withdrawal by Subject|0|||
161806917|NCT01313273|584337753|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
161806918|NCT01313273|584337754|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
161806919|NCT02726581|584337755|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161806920|NCT02726581|584337756|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
161806921|NCT02726581|584337757|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161806922|NCT02726581|584337755|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
161806923|NCT02726581|584337756|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
161806924|NCT02726581|584337757|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
161806925|NCT02726581|584337755|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161806926|NCT02726581|584337756|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161806927|NCT02726581|584337757|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161806928|NCT02726581|584337755|FG000|Treatment Period|Disease progression|47|||
161806929|NCT02726581|584337756|FG001|Treatment Period|Disease progression|50|||
161806930|NCT02726581|584337757|FG002|Treatment Period|Disease progression|16|||
161806931|NCT02726581|584337755|FG000|Treatment Period|Other reasons|9|||
161561860|NCT01684046|583446124|FG001|Period 1, First 30 Days|Adverse Event|2|||
161561861|NCT00762463|583446125|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
161561862|NCT00762463|583446126|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
161806932|NCT02726581|584337756|FG001|Treatment Period|Other reasons|8|||
161806933|NCT02726581|584337757|FG002|Treatment Period|Other reasons|2|||
161806934|NCT02726581|584337755|FG000|Treatment Period|Study drug toxicity|6|||
161806935|NCT02726581|584337756|FG001|Treatment Period|Study drug toxicity|3|||
161806936|NCT02726581|584337757|FG002|Treatment Period|Study drug toxicity|2|||
161561863|NCT00762463|583446127|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
161561864|NCT00762463|583446128|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
161561865|NCT00762463|583446125|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
161561866|NCT00762463|583446126|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
161561867|NCT00762463|583446127|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
161561868|NCT00762463|583446128|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
161561869|NCT00762463|583446125|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
161561870|NCT00762463|583446126|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
161561871|NCT00762463|583446127|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
161561872|NCT00762463|583446128|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
161561873|NCT00762463|583446125|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
161561874|NCT00762463|583446126|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
161561875|NCT00762463|583446127|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
161561876|NCT00762463|583446128|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
161561877|NCT00762463|583446125|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
161561878|NCT00762463|583446126|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
161561879|NCT00762463|583446127|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
161561880|NCT00762463|583446128|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
161561881|NCT00762463|583446125|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
161561882|NCT00762463|583446126|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
161561883|NCT00762463|583446127|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
161561884|NCT00762463|583446128|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
161561885|NCT00762463|583446125|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
161561886|NCT00762463|583446126|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
161561887|NCT00762463|583446127|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
161561888|NCT00762463|583446128|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
161561889|NCT00762463|583446125|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
161561890|NCT00762463|583446126|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
161561891|NCT00762463|583446127|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
161561892|NCT00762463|583446128|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
161561893|NCT00531479|583446129|FG000|Overall Study|Death|68|||
161561894|NCT00531479|583446130|FG001|Overall Study|Death|71|||
161561895|NCT00531479|583446129|FG000|Overall Study|Lost to Follow-up|0|||
161561896|NCT00531479|583446130|FG001|Overall Study|Lost to Follow-up|2|||
161561897|NCT00531479|583446129|FG000|Overall Study|Other|0|||
161561898|NCT00531479|583446130|FG001|Overall Study|Other|1|||
161561899|NCT00531479|583446129|FG000|Overall Study|Withdrawal by Subject|6|||
161561900|NCT00531479|583446130|FG001|Overall Study|Withdrawal by Subject|6|||
161561901|NCT00531479|583446129|FG000|Overall Study|Did not receive treatment|2|||
161561902|NCT00531479|583446130|FG001|Overall Study|Did not receive treatment|3|||
161561903|NCT00797862|583446131|FG000|Overall Study|Adverse Event|86|||
161561904|NCT00797862|583446132|FG001|Overall Study|Adverse Event|44|||
161561905|NCT00797862|583446133|FG002|Overall Study|Adverse Event|58|||
161561906|NCT00797862|583446131|FG000|Overall Study|Abnormal Test Procedure Result|0|||
161561907|NCT00797862|583446132|FG001|Overall Study|Abnormal Test Procedure Result|1|||
161561908|NCT00797862|583446133|FG002|Overall Study|Abnormal Test Procedure Result|1|||
161561909|NCT00797862|583446131|FG000|Overall Study|Lack of Efficacy|1|||
161561910|NCT00797862|583446132|FG001|Overall Study|Lack of Efficacy|7|||
161561911|NCT00797862|583446133|FG002|Overall Study|Lack of Efficacy|6|||
161561912|NCT00797862|583446131|FG000|Overall Study|No longer required study medication|1|||
161561913|NCT00797862|583446132|FG001|Overall Study|No longer required study medication|0|||
161561914|NCT00797862|583446133|FG002|Overall Study|No longer required study medication|0|||
161561915|NCT00797862|583446131|FG000|Overall Study|Withdrawal by Subject|14|||
161561916|NCT00797862|583446132|FG001|Overall Study|Withdrawal by Subject|7|||
161561917|NCT00797862|583446133|FG002|Overall Study|Withdrawal by Subject|7|||
161561918|NCT00797862|583446131|FG000|Overall Study|Lost to Follow-up|11|||
161561919|NCT00797862|583446132|FG001|Overall Study|Lost to Follow-up|0|||
161561920|NCT00797862|583446133|FG002|Overall Study|Lost to Follow-up|5|||
161561921|NCT00797862|583446131|FG000|Overall Study|Administrative Problem|4|||
161561922|NCT00797862|583446132|FG001|Overall Study|Administrative Problem|0|||
161561923|NCT00797862|583446133|FG002|Overall Study|Administrative Problem|0|||
161561924|NCT00797862|583446131|FG000|Overall Study|Protocol Violation|4|||
161561925|NCT00797862|583446132|FG001|Overall Study|Protocol Violation|6|||
161561926|NCT00797862|583446133|FG002|Overall Study|Protocol Violation|8|||
161561927|NCT00797862|583446131|FG000|Overall Study|Mis-randomized|3|||
161561928|NCT00797862|583446132|FG001|Overall Study|Mis-randomized|3|||
161561929|NCT00797862|583446133|FG002|Overall Study|Mis-randomized|1|||
161561930|NCT05074498|583446138|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
161561931|NCT05074498|583446139|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
161561932|NCT05074498|583446140|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
161910634|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161453741|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Adverse Event|6|||
161453742|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
161453743|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
161910635|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161453744|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Physician Decision|4|||
161453745|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Physician Decision|4|||
161453746|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
161453747|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
161453748|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
161453749|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
161453750|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
161453751|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
161453752|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Non-compliance|1|||
161453753|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Non-compliance|0|||
161453754|NCT00470834|583055431|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
161453755|NCT00470834|583055432|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
161453756|NCT00470834|583055431|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
161453757|NCT00470834|583055432|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
161453758|NCT00470834|583055431|FG000|Extension Period (24 Months)|Adverse Event|3|||
161453759|NCT00470834|583055432|FG001|Extension Period (24 Months)|Adverse Event|4|||
161453760|NCT00470834|583055431|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
161453761|NCT00470834|583055432|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
161561933|NCT05074498|583446141|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
161561934|NCT05074498|583446142|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
161910636|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
161910637|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
161910638|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
161910639|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
161910640|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
161910641|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161910642|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161910643|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161910644|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
161910645|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161910646|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161910647|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161910648|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
161910649|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161910650|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161910651|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161910652|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161910653|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
161910654|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161910655|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161910656|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161910657|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
161910658|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161910659|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161910660|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
161910661|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
161910662|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
161910663|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
161910664|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161910665|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
161910666|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161910667|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161910668|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
161910669|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
161910670|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
161910671|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
161910672|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161910673|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
161910674|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161910675|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161910676|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161453762|NCT00470834|583055431|FG000|Extension Period (24 Months)|Physician Decision|4|||
161561935|NCT05074498|583446143|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
161561936|NCT05074498|583446138|FG000|Part 1 (Upto Day 104)|Other|1|||
161561937|NCT05074498|583446139|FG001|Part 1 (Upto Day 104)|Other|0|||
161561938|NCT05074498|583446140|FG002|Part 1 (Upto Day 104)|Other|0|||
161561939|NCT05074498|583446141|FG003|Part 1 (Upto Day 104)|Other|0|||
161561940|NCT05074498|583446142|FG004|Part 1 (Upto Day 104)|Other|0|||
161561941|NCT05074498|583446143|FG005|Part 1 (Upto Day 104)|Other|0|||
161561942|NCT05074498|583446138|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
161561943|NCT05074498|583446139|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
161561944|NCT05074498|583446140|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
161561945|NCT05074498|583446141|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
161453763|NCT00470834|583055432|FG001|Extension Period (24 Months)|Physician Decision|3|||
161453764|NCT00470834|583055431|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
161453765|NCT00470834|583055432|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
161453766|NCT00470834|583055431|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
161453767|NCT00470834|583055432|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
161453768|NCT00470834|583055431|FG000|Extension Period (24 Months)|Non-compliance|0|||
161453769|NCT00470834|583055432|FG001|Extension Period (24 Months)|Non-compliance|1|||
161561946|NCT05074498|583446142|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
161561947|NCT05074498|583446143|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
161561948|NCT05074498|583446138|FG000|Part 2 (Upto Day 104)|Death|0|||
161561949|NCT05074498|583446139|FG001|Part 2 (Upto Day 104)|Death|0|||
161561950|NCT05074498|583446140|FG002|Part 2 (Upto Day 104)|Death|0|||
161561951|NCT05074498|583446141|FG003|Part 2 (Upto Day 104)|Death|0|||
161561952|NCT05074498|583446142|FG004|Part 2 (Upto Day 104)|Death|1|||
161561953|NCT05074498|583446143|FG005|Part 2 (Upto Day 104)|Death|0|||
161561954|NCT05074498|583446138|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
161561955|NCT05074498|583446139|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
161561956|NCT05074498|583446140|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
161561957|NCT05074498|583446141|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
161561958|NCT05074498|583446142|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
161561959|NCT05074498|583446143|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
161561960|NCT05074498|583446138|FG000|Part 2 (Upto Day 104)|Other|0|||
161561961|NCT05074498|583446139|FG001|Part 2 (Upto Day 104)|Other|0|||
161561962|NCT05074498|583446140|FG002|Part 2 (Upto Day 104)|Other|0|||
161561963|NCT05074498|583446141|FG003|Part 2 (Upto Day 104)|Other|0|||
161561964|NCT05074498|583446142|FG004|Part 2 (Upto Day 104)|Other|1|||
161561965|NCT05074498|583446143|FG005|Part 2 (Upto Day 104)|Other|0|||
161561966|NCT01306331|583446145|FG000|Overall Study|Adverse Event|28|||
161561967|NCT01306331|583446146|FG001|Overall Study|Adverse Event|25|||
161561968|NCT01306331|583446145|FG000|Overall Study|Lost to Follow-up|321|||
161561969|NCT01306331|583446146|FG001|Overall Study|Lost to Follow-up|323|||
161561970|NCT01306331|583446145|FG000|Overall Study|Physician Decision|26|||
161561971|NCT01306331|583446146|FG001|Overall Study|Physician Decision|22|||
161561972|NCT01306331|583446145|FG000|Overall Study|Pregnancy|136|||
161561973|NCT01306331|583446146|FG001|Overall Study|Pregnancy|151|||
161561974|NCT01306331|583446145|FG000|Overall Study|Protocol Violation|154|||
161561975|NCT01306331|583446146|FG001|Overall Study|Protocol Violation|124|||
161561976|NCT01306331|583446145|FG000|Overall Study|Withdrawal by Subject|163|||
161561977|NCT01306331|583446146|FG001|Overall Study|Withdrawal by Subject|152|||
161561978|NCT01306331|583446145|FG000|Overall Study|Not sexually active|29|||
161561979|NCT01306331|583446146|FG001|Overall Study|Not sexually active|28|||
161561980|NCT01306331|583446145|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
161561981|NCT01306331|583446146|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
161561982|NCT01306331|583446145|FG000|Overall Study|Other|34|||
161561983|NCT01306331|583446146|FG001|Overall Study|Other|32|||
161561984|NCT00172185|583446153|FG000|Overall Study|Adverse Event|0|||
161806937|NCT02726581|584337755|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
161806938|NCT02726581|584337756|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
161806939|NCT02726581|584337757|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
161806940|NCT02726581|584337755|FG000|Treatment Period|Participant withdrew consent|3|||
161806941|NCT02726581|584337756|FG001|Treatment Period|Participant withdrew consent|1|||
161806942|NCT02726581|584337757|FG002|Treatment Period|Participant withdrew consent|1|||
161806943|NCT02726581|584337755|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
161561985|NCT00172185|583446154|FG001|Overall Study|Adverse Event|1|||
161561986|NCT00172185|583446155|FG002|Overall Study|Adverse Event|3|||
161561987|NCT00172185|583446156|FG003|Overall Study|Adverse Event|4|||
161561988|NCT00172185|583446153|FG000|Overall Study|Physician Decision|0|||
161561989|NCT00172185|583446154|FG001|Overall Study|Physician Decision|0|||
161561990|NCT00172185|583446155|FG002|Overall Study|Physician Decision|1|||
161561991|NCT00172185|583446156|FG003|Overall Study|Physician Decision|0|||
161561992|NCT00172185|583446153|FG000|Overall Study|SPONSOR Decision|0|||
161561993|NCT00172185|583446154|FG001|Overall Study|SPONSOR Decision|1|||
161561994|NCT00172185|583446155|FG002|Overall Study|SPONSOR Decision|0|||
161561995|NCT00172185|583446156|FG003|Overall Study|SPONSOR Decision|0|||
161561996|NCT00172185|583446153|FG000|Overall Study|Withdrawal by Subject|0|||
161561997|NCT00172185|583446154|FG001|Overall Study|Withdrawal by Subject|0|||
161561998|NCT00172185|583446155|FG002|Overall Study|Withdrawal by Subject|1|||
161561999|NCT00172185|583446156|FG003|Overall Study|Withdrawal by Subject|0|||
161562000|NCT01677936|583446157|FG000|Overall Study|Lost to Follow-up|4|||
161562001|NCT01677936|583446158|FG001|Overall Study|Lost to Follow-up|1|||
161562002|NCT01677936|583446157|FG000|Overall Study|Protocol Violation|3|||
161562003|NCT01677936|583446158|FG001|Overall Study|Protocol Violation|0|||
161562004|NCT01677936|583446157|FG000|Overall Study|Adverse Event|1|||
161562005|NCT01677936|583446158|FG001|Overall Study|Adverse Event|0|||
161562006|NCT01677936|583446157|FG000|Overall Study|Lost to Follow-up|1|||
161562007|NCT01677936|583446158|FG001|Overall Study|Lost to Follow-up|0|||
161562008|NCT01677936|583446157|FG000|Overall Study|Protocol Violation|0|||
161562009|NCT01677936|583446158|FG001|Overall Study|Protocol Violation|4|||
161562010|NCT02790606|583446161|FG000|Overall Study|Death|27|||
161562011|NCT02790606|583446161|FG000|Overall Study|Lost to Follow-up|4|||
161562012|NCT02790606|583446161|FG000|Overall Study|Physician Decision|3|||
161562013|NCT02790606|583446161|FG000|Overall Study|Withdrawal by Subject|1|||
161562014|NCT02735915|583446162|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
161562015|NCT02735915|583446162|FG000|Overall Study|Withdrawal following SAE|2|||
161562016|NCT02735915|583446162|FG000|Overall Study|Withdrawal by Subject|1|||
161562017|NCT05328973|583446163|FG000|Overall Study|Withdrawal by Subject|0|||
161562018|NCT05328973|583446164|FG001|Overall Study|Withdrawal by Subject|1|||
161562019|NCT00409708|583446170|FG000|Treatment|Abnormal test procedure result(s)|1|||
161562020|NCT00409708|583446171|FG001|Treatment|Abnormal test procedure result(s)|0|||
161562021|NCT00409708|583446170|FG000|Treatment|Lack of Efficacy|0|||
161562022|NCT00409708|583446171|FG001|Treatment|Lack of Efficacy|1|||
161562023|NCT00409708|583446170|FG000|Treatment|Protocol Violation|6|||
161562024|NCT00409708|583446171|FG001|Treatment|Protocol Violation|2|||
161562025|NCT00409708|583446170|FG000|Treatment|Withdrawal by Subject|3|||
161562026|NCT00409708|583446171|FG001|Treatment|Withdrawal by Subject|8|||
161562027|NCT00409708|583446170|FG000|Treatment|Lost to Follow-up|0|||
161562028|NCT00409708|583446171|FG001|Treatment|Lost to Follow-up|6|||
161562029|NCT00409708|583446170|FG000|Treatment|Administrative problems|5|||
161562030|NCT00409708|583446171|FG001|Treatment|Administrative problems|0|||
161562031|NCT00409708|583446170|FG000|Washout|Lack of Efficacy|9|||
161562032|NCT00409708|583446171|FG001|Washout|Lack of Efficacy|1|||
161562033|NCT00409708|583446170|FG000|Washout|Protocol Violation|0|||
161562034|NCT00409708|583446171|FG001|Washout|Protocol Violation|1|||
161562035|NCT00409708|583446170|FG000|Washout|Withdrawal by Subject|11|||
161562036|NCT00409708|583446171|FG001|Washout|Withdrawal by Subject|5|||
161562037|NCT00409708|583446170|FG000|Washout|Lost to Follow-up|1|||
161562038|NCT00409708|583446171|FG001|Washout|Lost to Follow-up|3|||
161562039|NCT00946114|583446172|FG000|Overall Study|Death|5|||
161562040|NCT00946114|583446173|FG001|Overall Study|Death|2|||
161562041|NCT00946114|583446172|FG000|Overall Study|Other|1|||
161562042|NCT00946114|583446173|FG001|Overall Study|Other|0|||
161562043|NCT00946114|583446172|FG000|Overall Study|Withdrawal by Subject|2|||
161562044|NCT00946114|583446173|FG001|Overall Study|Withdrawal by Subject|0|||
161562045|NCT00723294|583446174|FG000|Overall Study|Lobular histology|2|||
161562046|NCT00723294|583446174|FG000|Overall Study|>25% intraductal component|1|||
161562047|NCT00723294|583446174|FG000|Overall Study|No MRI tumor enhancement|1|||
161562048|NCT00723294|583446174|FG000|Overall Study|1.0-Tesla MRI|1|||
161562049|NCT00723294|583446174|FG000|Overall Study|No cryoabalation|2|||
161562050|NCT00723294|583446174|FG000|Overall Study|Did not undergo surgery|1|||
161562051|NCT00723294|583446174|FG000|Overall Study|Treated prior to registration|1|||
161562052|NCT00723294|583446174|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
161562053|NCT00723294|583446174|FG000|Overall Study|Benign lesion|1|||
161562054|NCT00723294|583446174|FG000|Overall Study|Withdrawal by Subject|1|||
161562055|NCT00723294|583446174|FG000|Overall Study|No treatment due to probe failure|1|||
161562056|NCT00088465|583446175|FG000|Overall Study|Withdrawal by Subject|290|||
161562057|NCT00088465|583446175|FG000|Overall Study|Adverse Event|77|||
161562058|NCT00088465|583446175|FG000|Overall Study|Lost to Follow-up|57|||
161562059|NCT00088465|583446175|FG000|Overall Study|Physician Decision|45|||
161562060|NCT00088465|583446175|FG000|Overall Study|Sponsor Decision|37|||
161562061|NCT00088465|583446175|FG000|Overall Study|Lack of Efficacy|27|||
161562062|NCT00088465|583446175|FG000|Overall Study|Protocol Violation|17|||
161562063|NCT00088465|583446175|FG000|Overall Study|Death|11|||
161562064|NCT04565249|583446176|FG000|Overall Study|Death|0|||
161562065|NCT04565249|583446177|FG001|Overall Study|Death|0|||
161562066|NCT04565249|583446178|FG002|Overall Study|Death|0|||
161910677|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
161562067|NCT04565249|583446179|FG003|Overall Study|Death|1|||
161562068|NCT02390557|583446180|FG000|Wave 2|Survey non-respondent|72|||
161562069|NCT02390557|583446181|FG001|Wave 2|Survey non-respondent|41|||
161562070|NCT02390557|583446182|FG002|Wave 2|Survey non-respondent|23|||
161562071|NCT04337489|583446183|FG000|Overall Study|Withdrawal by Subject|1|||
161562072|NCT03255941|583446184|FG000|Overall Study|Not eligible or refused injection|37|||
161562073|NCT03255941|583446185|FG001|Overall Study|Not eligible or refused injection|44|||
161562074|NCT03255941|583446186|FG002|Overall Study|Not eligible or refused injection|5|||
161562075|NCT03255941|583446187|FG003|Overall Study|Not eligible or refused injection|6|||
161562076|NCT03255941|583446184|FG000|Overall Study|Did not complete exit interview|1|||
161562077|NCT03255941|583446185|FG001|Overall Study|Did not complete exit interview|2|||
161562078|NCT03255941|583446186|FG002|Overall Study|Did not complete exit interview|0|||
161562079|NCT03255941|583446187|FG003|Overall Study|Did not complete exit interview|0|||
161562080|NCT00335153|583446199|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
161562081|NCT00335153|583446199|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
161562082|NCT00335153|583446199|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
161562083|NCT00335153|583446199|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
161562084|NCT00335153|583446199|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
161562085|NCT00335153|583446199|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
161562086|NCT00335153|583446199|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
161562087|NCT00335153|583446199|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
161562088|NCT00335153|583446199|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
161562089|NCT00335153|583446199|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
161562090|NCT01528709|583446200|FG000|Overall Study|Death|2|||
161562091|NCT01528709|583446201|FG001|Overall Study|Death|0|||
161562092|NCT01528709|583446200|FG000|Overall Study|Withdrawal by Subject|10|||
161562093|NCT01528709|583446201|FG001|Overall Study|Withdrawal by Subject|15|||
161562094|NCT01528709|583446200|FG000|Overall Study|allergy|1|||
161562095|NCT01528709|583446201|FG001|Overall Study|allergy|0|||
161562096|NCT00945477|583446202|FG000|Overall Study|Adverse Event|3|||
161562097|NCT00945477|583446202|FG000|Overall Study|Lack of Efficacy|2|||
161562098|NCT00945477|583446202|FG000|Overall Study|Withdrawal by Subject|1|||
161562099|NCT00797225|583446203|FG000|Weeks 1 to 12|Adverse Event|0|||
161562100|NCT00797225|583446204|FG001|Weeks 1 to 12|Adverse Event|0|||
161562101|NCT00797225|583446205|FG002|Weeks 1 to 12|Adverse Event|1|||
161562102|NCT00797225|583446206|FG003|Weeks 1 to 12|Adverse Event|0|||
161562103|NCT00797225|583446207|FG004|Weeks 1 to 12|Adverse Event|0|||
161562104|NCT00797225|583446208|FG005|Weeks 1 to 12|Adverse Event|0|||
161562105|NCT00797225|583446209|FG006|Weeks 1 to 12|Adverse Event|0|||
161562106|NCT00797225|583446210|FG007|Weeks 1 to 12|Adverse Event|0|||
161562107|NCT00797225|583446203|FG000|Weeks 1 to 12|Non-compliance|0|||
161562108|NCT00797225|583446204|FG001|Weeks 1 to 12|Non-compliance|1|||
161562109|NCT00797225|583446205|FG002|Weeks 1 to 12|Non-compliance|0|||
161562110|NCT00797225|583446206|FG003|Weeks 1 to 12|Non-compliance|0|||
161562111|NCT00797225|583446207|FG004|Weeks 1 to 12|Non-compliance|0|||
161562112|NCT00797225|583446208|FG005|Weeks 1 to 12|Non-compliance|0|||
161562113|NCT00797225|583446209|FG006|Weeks 1 to 12|Non-compliance|0|||
161562114|NCT00797225|583446210|FG007|Weeks 1 to 12|Non-compliance|0|||
161562115|NCT00797225|583446203|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
161562116|NCT00797225|583446204|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
161562117|NCT00797225|583446205|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
161562118|NCT00797225|583446206|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
161562119|NCT00797225|583446207|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
161562120|NCT00797225|583446208|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
161562121|NCT00797225|583446209|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
161562122|NCT00797225|583446210|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
161562123|NCT00797225|583446203|FG000|Weeks 1 to 12|Sponsor Decision|1|||
161562124|NCT00797225|583446204|FG001|Weeks 1 to 12|Sponsor Decision|0|||
161562125|NCT00797225|583446205|FG002|Weeks 1 to 12|Sponsor Decision|0|||
161562126|NCT00797225|583446206|FG003|Weeks 1 to 12|Sponsor Decision|0|||
161562127|NCT00797225|583446207|FG004|Weeks 1 to 12|Sponsor Decision|0|||
161562128|NCT00797225|583446208|FG005|Weeks 1 to 12|Sponsor Decision|0|||
161562129|NCT00797225|583446209|FG006|Weeks 1 to 12|Sponsor Decision|0|||
161562130|NCT00797225|583446210|FG007|Weeks 1 to 12|Sponsor Decision|0|||
161562131|NCT00797225|583446203|FG000|Weeks 13 to 24|Non-compliance|0|||
161562132|NCT00797225|583446204|FG001|Weeks 13 to 24|Non-compliance|2|||
161562133|NCT00797225|583446205|FG002|Weeks 13 to 24|Non-compliance|0|||
161562134|NCT00797225|583446206|FG003|Weeks 13 to 24|Non-compliance|0|||
161562135|NCT00797225|583446207|FG004|Weeks 13 to 24|Non-compliance|0|||
161562136|NCT00797225|583446208|FG005|Weeks 13 to 24|Non-compliance|0|||
161562137|NCT00797225|583446209|FG006|Weeks 13 to 24|Non-compliance|0|||
161562138|NCT00797225|583446210|FG007|Weeks 13 to 24|Non-compliance|0|||
161562139|NCT00797225|583446203|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
161562140|NCT00797225|583446204|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
161562141|NCT00797225|583446205|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
161562142|NCT00797225|583446206|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
161562143|NCT00797225|583446207|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
161562144|NCT00797225|583446208|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
161562145|NCT00797225|583446209|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
161562146|NCT00797225|583446210|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
161562147|NCT00797225|583446203|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
161562148|NCT00797225|583446204|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
161562149|NCT00797225|583446205|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
161562150|NCT00797225|583446206|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
161562151|NCT00797225|583446207|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
161562152|NCT00797225|583446208|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
161562153|NCT00797225|583446209|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
161562154|NCT00797225|583446210|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
161562155|NCT00797225|583446203|FG000|Weeks 13 to 24|Adverse Event|0|||
161562156|NCT00797225|583446204|FG001|Weeks 13 to 24|Adverse Event|1|||
161562157|NCT00797225|583446205|FG002|Weeks 13 to 24|Adverse Event|0|||
161562158|NCT00797225|583446206|FG003|Weeks 13 to 24|Adverse Event|0|||
161562159|NCT00797225|583446207|FG004|Weeks 13 to 24|Adverse Event|0|||
161562160|NCT00797225|583446208|FG005|Weeks 13 to 24|Adverse Event|0|||
161562161|NCT00797225|583446209|FG006|Weeks 13 to 24|Adverse Event|1|||
161562162|NCT00797225|583446210|FG007|Weeks 13 to 24|Adverse Event|0|||
161562163|NCT00797225|583446203|FG000|Weeks 13 to 24|Sponsor Decision|0|||
161562164|NCT00797225|583446204|FG001|Weeks 13 to 24|Sponsor Decision|0|||
161562165|NCT00797225|583446205|FG002|Weeks 13 to 24|Sponsor Decision|0|||
161562166|NCT00797225|583446206|FG003|Weeks 13 to 24|Sponsor Decision|0|||
161562167|NCT00797225|583446207|FG004|Weeks 13 to 24|Sponsor Decision|0|||
161562168|NCT00797225|583446208|FG005|Weeks 13 to 24|Sponsor Decision|0|||
161562169|NCT00797225|583446209|FG006|Weeks 13 to 24|Sponsor Decision|1|||
161562170|NCT00797225|583446210|FG007|Weeks 13 to 24|Sponsor Decision|0|||
161562171|NCT00097370|583446212|FG000|Stage 1|Adverse Event|3|||
161562172|NCT00097370|583446212|FG000|Stage 1|Withdrawal by Subject|1|||
161562173|NCT00097370|583446212|FG000|Stage 1|Lack of Efficacy|2|||
161562174|NCT00097370|583446212|FG000|Stage 2|Adverse Event|5|||
161562175|NCT00097370|583446212|FG000|Stage 2|Withdrawal by Subject|1|||
161562176|NCT00097370|583446212|FG000|Stage 2|Lack of Efficacy|3|||
161562177|NCT00097370|583446212|FG000|Stage 2|Pregnancy|1|||
161562178|NCT00097370|583446212|FG000|Stage 2|Sponsor Terminated Study|2|||
161562179|NCT00097370|583446212|FG000|Stage 2|Lost to Follow-up|1|||
161562180|NCT00097370|583446212|FG000|Stage 3|Adverse Event|2|||
161562181|NCT00097370|583446212|FG000|Stage 3|Withdrawal by Subject|3|||
161562182|NCT00097370|583446212|FG000|Stage 3|Lack of Efficacy|1|||
161562183|NCT00097370|583446212|FG000|Stage 3|Sponsor Terminated Study|52|||
161562184|NCT00097370|583446212|FG000|Stage 3|Lost to Follow-up|1|||
161562185|NCT00062868|583446214|FG000|Dose Level 1|Death|2|||
161562186|NCT00062868|583446215|FG001|Dose Level 1|Death|0|||
161562187|NCT00062868|583446216|FG002|Dose Level 1|Death|0|||
161562188|NCT00062868|583446217|FG003|Dose Level 1|Death|2|||
161562189|NCT00062868|583446218|FG004|Dose Level 1|Death|0|||
161562190|NCT00062868|583446219|FG005|Dose Level 1|Death|0|||
161562191|NCT00062868|583446220|FG006|Dose Level 1|Death|3|||
161562192|NCT00062868|583446221|FG007|Dose Level 1|Death|0|||
161562193|NCT00062868|583446222|FG008|Dose Level 1|Death|0|||
161562194|NCT00062868|583446223|FG009|Dose Level 1|Death|0|||
161562195|NCT00062868|583446224|FG010|Dose Level 1|Death|0|||
161562196|NCT00062868|583446225|FG011|Dose Level 1|Death|0|||
161562197|NCT00062868|583446226|FG012|Dose Level 1|Death|0|||
161562198|NCT00062868|583446227|FG013|Dose Level 1|Death|0|||
161562199|NCT00062868|583446228|FG014|Dose Level 1|Death|0|||
161562200|NCT00062868|583446229|FG015|Dose Level 1|Death|0|||
161562201|NCT00062868|583446230|FG016|Dose Level 1|Death|0|||
161562202|NCT00062868|583446231|FG017|Dose Level 1|Death|0|||
161562203|NCT00062868|583446232|FG018|Dose Level 1|Death|7|||
161562204|NCT00062868|583446233|FG019|Dose Level 1|Death|0|||
161562205|NCT00062868|583446234|FG020|Dose Level 1|Death|1|||
161562206|NCT00062868|583446214|FG000|Dose Level 1|Lost to Follow-up|0|||
161562207|NCT00062868|583446215|FG001|Dose Level 1|Lost to Follow-up|0|||
161562208|NCT00062868|583446216|FG002|Dose Level 1|Lost to Follow-up|0|||
161562209|NCT00062868|583446217|FG003|Dose Level 1|Lost to Follow-up|0|||
161562210|NCT00062868|583446218|FG004|Dose Level 1|Lost to Follow-up|0|||
161562211|NCT00062868|583446219|FG005|Dose Level 1|Lost to Follow-up|0|||
161562212|NCT00062868|583446220|FG006|Dose Level 1|Lost to Follow-up|0|||
161562213|NCT00062868|583446221|FG007|Dose Level 1|Lost to Follow-up|0|||
161562214|NCT00062868|583446222|FG008|Dose Level 1|Lost to Follow-up|0|||
161562215|NCT00062868|583446223|FG009|Dose Level 1|Lost to Follow-up|0|||
161562216|NCT00062868|583446224|FG010|Dose Level 1|Lost to Follow-up|0|||
161562217|NCT00062868|583446225|FG011|Dose Level 1|Lost to Follow-up|0|||
161562218|NCT00062868|583446226|FG012|Dose Level 1|Lost to Follow-up|1|||
161562219|NCT00062868|583446227|FG013|Dose Level 1|Lost to Follow-up|0|||
161562220|NCT00062868|583446228|FG014|Dose Level 1|Lost to Follow-up|0|||
161562221|NCT00062868|583446229|FG015|Dose Level 1|Lost to Follow-up|0|||
161562222|NCT00062868|583446230|FG016|Dose Level 1|Lost to Follow-up|0|||
161562223|NCT00062868|583446231|FG017|Dose Level 1|Lost to Follow-up|0|||
161562224|NCT00062868|583446232|FG018|Dose Level 1|Lost to Follow-up|2|||
161562225|NCT00062868|583446233|FG019|Dose Level 1|Lost to Follow-up|0|||
161562226|NCT00062868|583446234|FG020|Dose Level 1|Lost to Follow-up|1|||
161562227|NCT00062868|583446214|FG000|Dose Level 2|Death|0|||
161562228|NCT00062868|583446215|FG001|Dose Level 2|Death|3|||
161562229|NCT00062868|583446216|FG002|Dose Level 2|Death|0|||
161562230|NCT00062868|583446217|FG003|Dose Level 2|Death|0|||
161562231|NCT00062868|583446218|FG004|Dose Level 2|Death|2|||
161562232|NCT00062868|583446219|FG005|Dose Level 2|Death|0|||
161562233|NCT00062868|583446220|FG006|Dose Level 2|Death|0|||
161562234|NCT00062868|583446221|FG007|Dose Level 2|Death|0|||
161562235|NCT00062868|583446222|FG008|Dose Level 2|Death|0|||
161562236|NCT00062868|583446223|FG009|Dose Level 2|Death|0|||
161562237|NCT00062868|583446224|FG010|Dose Level 2|Death|1|||
161453770|NCT00470834|583055431|FG000|Extension Period (24 Months)|Disease Progression|0|||
161453771|NCT00470834|583055432|FG001|Extension Period (24 Months)|Disease Progression|1|||
161453772|NCT00065429|583055433|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
161453773|NCT00065429|583055434|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
161453774|NCT00065429|583055435|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
161453775|NCT00065429|583055436|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
161453776|NCT00065429|583055437|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
161453777|NCT00065429|583055438|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
161453778|NCT00065429|583055439|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
161453779|NCT00065429|583055433|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
161453780|NCT00065429|583055434|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
161453781|NCT00065429|583055435|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
161453782|NCT00065429|583055436|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
161453783|NCT00065429|583055437|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
161453784|NCT00065429|583055438|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
161453785|NCT00065429|583055439|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
161453786|NCT00065429|583055433|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
161453787|NCT00065429|583055434|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
161453788|NCT00065429|583055435|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
161453789|NCT00065429|583055436|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
161453790|NCT00065429|583055437|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
161453791|NCT00065429|583055438|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
161453792|NCT00065429|583055439|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
161453793|NCT00065429|583055433|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
161453794|NCT00065429|583055434|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
161453795|NCT00065429|583055435|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
161453796|NCT00065429|583055436|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
161453797|NCT00065429|583055437|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
161453798|NCT00065429|583055438|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
161453799|NCT00065429|583055439|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
161453800|NCT00065429|583055433|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
161453801|NCT00065429|583055434|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
161453802|NCT00065429|583055435|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
161453803|NCT00065429|583055436|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
161453804|NCT00065429|583055437|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
161453805|NCT00065429|583055438|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
161453806|NCT00065429|583055439|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
161453807|NCT00065429|583055433|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161453808|NCT00065429|583055434|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161453809|NCT00065429|583055435|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161453810|NCT00065429|583055436|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161453811|NCT00065429|583055437|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
161453812|NCT00065429|583055438|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161453813|NCT00065429|583055439|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161453814|NCT00065429|583055433|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161453815|NCT00065429|583055434|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161453816|NCT00065429|583055435|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161453817|NCT00065429|583055436|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161453818|NCT00065429|583055437|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
161453819|NCT00065429|583055438|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161453820|NCT00065429|583055439|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161453821|NCT01616693|583055441|FG000|Evaluated for Safety|Physician Decision|1|||
161453822|NCT01616693|583055442|FG001|Evaluated for Safety|Physician Decision|0|||
161453823|NCT01616693|583055443|FG002|Evaluated for Safety|Physician Decision|1|||
161453824|NCT01616693|583055444|FG003|Evaluated for Safety|Physician Decision|0|||
161453825|NCT01616693|583055441|FG000|Received Both Vaccines|Adverse Event|2|||
161453826|NCT01616693|583055442|FG001|Received Both Vaccines|Adverse Event|0|||
161453827|NCT01616693|583055443|FG002|Received Both Vaccines|Adverse Event|0|||
161453828|NCT01616693|583055444|FG003|Received Both Vaccines|Adverse Event|0|||
161453829|NCT01616693|583055441|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
161453830|NCT01616693|583055442|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
161453831|NCT01616693|583055443|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
161453832|NCT01616693|583055444|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
161453833|NCT01616693|583055441|FG000|Received Both Vaccines|Lost to Follow-up|4|||
161453834|NCT01616693|583055442|FG001|Received Both Vaccines|Lost to Follow-up|3|||
161453835|NCT01616693|583055443|FG002|Received Both Vaccines|Lost to Follow-up|4|||
161453836|NCT01616693|583055444|FG003|Received Both Vaccines|Lost to Follow-up|4|||
161453837|NCT01616693|583055441|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
161453838|NCT01616693|583055442|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
161453839|NCT01616693|583055443|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
161562238|NCT00062868|583446225|FG011|Dose Level 2|Death|0|||
161562239|NCT00062868|583446226|FG012|Dose Level 2|Death|0|||
161562240|NCT00062868|583446227|FG013|Dose Level 2|Death|0|||
161562241|NCT00062868|583446228|FG014|Dose Level 2|Death|0|||
161562242|NCT00062868|583446229|FG015|Dose Level 2|Death|0|||
161562243|NCT00062868|583446230|FG016|Dose Level 2|Death|2|||
161562244|NCT00062868|583446231|FG017|Dose Level 2|Death|0|||
161562245|NCT00062868|583446232|FG018|Dose Level 2|Death|0|||
161562246|NCT00062868|583446233|FG019|Dose Level 2|Death|0|||
161562247|NCT00062868|583446234|FG020|Dose Level 2|Death|0|||
161562248|NCT00062868|583446214|FG000|Dose Level 2|Lost to Follow-up|0|||
161562249|NCT00062868|583446215|FG001|Dose Level 2|Lost to Follow-up|0|||
161562250|NCT00062868|583446216|FG002|Dose Level 2|Lost to Follow-up|0|||
161562251|NCT00062868|583446217|FG003|Dose Level 2|Lost to Follow-up|0|||
161562252|NCT00062868|583446218|FG004|Dose Level 2|Lost to Follow-up|0|||
161562253|NCT00062868|583446219|FG005|Dose Level 2|Lost to Follow-up|0|||
161562254|NCT00062868|583446220|FG006|Dose Level 2|Lost to Follow-up|0|||
161562255|NCT00062868|583446221|FG007|Dose Level 2|Lost to Follow-up|0|||
161562256|NCT00062868|583446222|FG008|Dose Level 2|Lost to Follow-up|0|||
161562257|NCT00062868|583446223|FG009|Dose Level 2|Lost to Follow-up|0|||
161562258|NCT00062868|583446224|FG010|Dose Level 2|Lost to Follow-up|0|||
161562259|NCT00062868|583446225|FG011|Dose Level 2|Lost to Follow-up|0|||
161562260|NCT00062868|583446226|FG012|Dose Level 2|Lost to Follow-up|0|||
161562261|NCT00062868|583446227|FG013|Dose Level 2|Lost to Follow-up|1|||
161562262|NCT00062868|583446228|FG014|Dose Level 2|Lost to Follow-up|0|||
161562263|NCT00062868|583446229|FG015|Dose Level 2|Lost to Follow-up|0|||
161562264|NCT00062868|583446230|FG016|Dose Level 2|Lost to Follow-up|1|||
161562265|NCT00062868|583446231|FG017|Dose Level 2|Lost to Follow-up|0|||
161562266|NCT00062868|583446232|FG018|Dose Level 2|Lost to Follow-up|0|||
161562267|NCT00062868|583446233|FG019|Dose Level 2|Lost to Follow-up|0|||
161562268|NCT00062868|583446234|FG020|Dose Level 2|Lost to Follow-up|0|||
161562269|NCT00062868|583446214|FG000|Dose Level 3|Death|0|||
161562270|NCT00062868|583446215|FG001|Dose Level 3|Death|0|||
161562271|NCT00062868|583446216|FG002|Dose Level 3|Death|0|||
161562272|NCT00062868|583446217|FG003|Dose Level 3|Death|0|||
161562273|NCT00062868|583446218|FG004|Dose Level 3|Death|0|||
161562274|NCT00062868|583446219|FG005|Dose Level 3|Death|0|||
161562275|NCT00062868|583446220|FG006|Dose Level 3|Death|0|||
161562276|NCT00062868|583446221|FG007|Dose Level 3|Death|0|||
161562277|NCT00062868|583446222|FG008|Dose Level 3|Death|0|||
161562278|NCT00062868|583446223|FG009|Dose Level 3|Death|0|||
161562279|NCT00062868|583446224|FG010|Dose Level 3|Death|0|||
161562280|NCT00062868|583446225|FG011|Dose Level 3|Death|1|||
161562281|NCT00062868|583446226|FG012|Dose Level 3|Death|0|||
161562282|NCT00062868|583446227|FG013|Dose Level 3|Death|0|||
161562283|NCT00062868|583446228|FG014|Dose Level 3|Death|0|||
161562284|NCT00062868|583446229|FG015|Dose Level 3|Death|0|||
161562285|NCT00062868|583446230|FG016|Dose Level 3|Death|0|||
161562286|NCT00062868|583446231|FG017|Dose Level 3|Death|1|||
161562287|NCT00062868|583446232|FG018|Dose Level 3|Death|0|||
161562288|NCT00062868|583446233|FG019|Dose Level 3|Death|0|||
161562289|NCT00062868|583446234|FG020|Dose Level 3|Death|0|||
161562290|NCT00062868|583446214|FG000|Dose Level 3|Lost to Follow-up|0|||
161562291|NCT00062868|583446215|FG001|Dose Level 3|Lost to Follow-up|0|||
161806944|NCT02726581|584337756|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
161806945|NCT02726581|584337757|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
161806946|NCT02726581|584337755|FG000|Treatment Period|Maximum clinical benefit|0|||
161806947|NCT02726581|584337756|FG001|Treatment Period|Maximum clinical benefit|2|||
161806948|NCT02726581|584337757|FG002|Treatment Period|Maximum clinical benefit|0|||
161806949|NCT02726581|584337755|FG000|Treatment Period|Death|1|||
161806950|NCT02726581|584337756|FG001|Treatment Period|Death|0|||
161806951|NCT02726581|584337757|FG002|Treatment Period|Death|0|||
161806952|NCT02726581|584337755|FG000|Treatment Period|Poor/non-compliance|1|||
161806953|NCT02726581|584337756|FG001|Treatment Period|Poor/non-compliance|0|||
161806954|NCT02726581|584337757|FG002|Treatment Period|Poor/non-compliance|0|||
161806955|NCT02726581|584337755|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161806956|NCT02726581|584337756|FG001|Treatment Period|Participant no longer meets study criteria|1|||
161806957|NCT02726581|584337757|FG002|Treatment Period|Participant no longer meets study criteria|0|||
161806958|NCT03496623|584337759|FG000|Run-In Period (2 Weeks)|Death|1|||
161562292|NCT00062868|583446216|FG002|Dose Level 3|Lost to Follow-up|0|||
161562293|NCT00062868|583446217|FG003|Dose Level 3|Lost to Follow-up|0|||
161562294|NCT00062868|583446218|FG004|Dose Level 3|Lost to Follow-up|0|||
161562295|NCT00062868|583446219|FG005|Dose Level 3|Lost to Follow-up|0|||
161562296|NCT00062868|583446220|FG006|Dose Level 3|Lost to Follow-up|0|||
161806959|NCT03496623|584337760|FG001|Run-In Period (2 Weeks)|Death|0|||
161562297|NCT00062868|583446221|FG007|Dose Level 3|Lost to Follow-up|0|||
161562298|NCT00062868|583446222|FG008|Dose Level 3|Lost to Follow-up|0|||
161562299|NCT00062868|583446223|FG009|Dose Level 3|Lost to Follow-up|0|||
161562300|NCT00062868|583446224|FG010|Dose Level 3|Lost to Follow-up|0|||
161562301|NCT00062868|583446225|FG011|Dose Level 3|Lost to Follow-up|0|||
161806960|NCT03496623|584337761|FG002|Run-In Period (2 Weeks)|Death|0|||
161806961|NCT03496623|584337762|FG003|Run-In Period (2 Weeks)|Death|0|||
161806962|NCT03496623|584337763|FG004|Run-In Period (2 Weeks)|Death|0|||
161562302|NCT00062868|583446226|FG012|Dose Level 3|Lost to Follow-up|0|||
161562303|NCT00062868|583446227|FG013|Dose Level 3|Lost to Follow-up|0|||
161562304|NCT00062868|583446228|FG014|Dose Level 3|Lost to Follow-up|1|||
161562305|NCT00062868|583446229|FG015|Dose Level 3|Lost to Follow-up|0|||
161562306|NCT00062868|583446230|FG016|Dose Level 3|Lost to Follow-up|0|||
161562307|NCT00062868|583446231|FG017|Dose Level 3|Lost to Follow-up|0|||
161562308|NCT00062868|583446232|FG018|Dose Level 3|Lost to Follow-up|0|||
161562309|NCT00062868|583446233|FG019|Dose Level 3|Lost to Follow-up|0|||
161562310|NCT00062868|583446234|FG020|Dose Level 3|Lost to Follow-up|0|||
161562311|NCT00062868|583446214|FG000|Dose Level 3|Withdrew|0|||
161562312|NCT00062868|583446215|FG001|Dose Level 3|Withdrew|0|||
161562313|NCT00062868|583446216|FG002|Dose Level 3|Withdrew|2|||
161562314|NCT00062868|583446217|FG003|Dose Level 3|Withdrew|0|||
161562315|NCT00062868|583446218|FG004|Dose Level 3|Withdrew|0|||
161562316|NCT00062868|583446219|FG005|Dose Level 3|Withdrew|0|||
161562317|NCT00062868|583446220|FG006|Dose Level 3|Withdrew|0|||
161562318|NCT00062868|583446221|FG007|Dose Level 3|Withdrew|0|||
161562319|NCT00062868|583446222|FG008|Dose Level 3|Withdrew|0|||
161562320|NCT00062868|583446223|FG009|Dose Level 3|Withdrew|0|||
161562321|NCT00062868|583446224|FG010|Dose Level 3|Withdrew|0|||
161562322|NCT00062868|583446225|FG011|Dose Level 3|Withdrew|0|||
161562323|NCT00062868|583446226|FG012|Dose Level 3|Withdrew|0|||
161562324|NCT00062868|583446227|FG013|Dose Level 3|Withdrew|0|||
161562325|NCT00062868|583446228|FG014|Dose Level 3|Withdrew|0|||
161562326|NCT00062868|583446229|FG015|Dose Level 3|Withdrew|0|||
161562327|NCT00062868|583446230|FG016|Dose Level 3|Withdrew|0|||
161562328|NCT00062868|583446231|FG017|Dose Level 3|Withdrew|0|||
161562329|NCT00062868|583446232|FG018|Dose Level 3|Withdrew|0|||
161562330|NCT00062868|583446233|FG019|Dose Level 3|Withdrew|0|||
161562331|NCT00062868|583446234|FG020|Dose Level 3|Withdrew|0|||
161562332|NCT03824236|583446235|FG000|Overall Study|Lost to Follow-up|0|||
161562333|NCT03824236|583446236|FG001|Overall Study|Lost to Follow-up|0|||
161562334|NCT03824236|583446237|FG002|Overall Study|Lost to Follow-up|1|||
161562335|NCT01641861|583446238|FG000|Overall Study|Lost to Follow-up|21|||
161562336|NCT01641861|583446239|FG001|Overall Study|Lost to Follow-up|16|||
161562337|NCT01641861|583446238|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
161562338|NCT01641861|583446239|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
161562339|NCT01641861|583446238|FG000|Overall Study|Died due to drowning|0|||
161562340|NCT01641861|583446239|FG001|Overall Study|Died due to drowning|1|||
161562341|NCT04949399|583446240|FG000|Overall Study|Lost to Follow-up|11|||
161562342|NCT04949399|583446241|FG001|Overall Study|Lost to Follow-up|6|||
161562343|NCT04949399|583446240|FG000|Overall Study|Withdrawal by Subject|2|||
161562344|NCT04949399|583446241|FG001|Overall Study|Withdrawal by Subject|3|||
161562345|NCT01515319|583446242|FG000|Overall Study|Withdrawal by Subject|0|||
161562346|NCT01515319|583446243|FG001|Overall Study|Withdrawal by Subject|0|||
161562347|NCT01515319|583446244|FG002|Overall Study|Withdrawal by Subject|0|||
161562348|NCT01515319|583446245|FG003|Overall Study|Withdrawal by Subject|0|||
161562349|NCT01515319|583446246|FG004|Overall Study|Withdrawal by Subject|0|||
161562350|NCT01515319|583446247|FG005|Overall Study|Withdrawal by Subject|0|||
161562351|NCT01515319|583446248|FG006|Overall Study|Withdrawal by Subject|1|||
161562352|NCT01515319|583446249|FG007|Overall Study|Withdrawal by Subject|0|||
161562353|NCT01515319|583446250|FG008|Overall Study|Withdrawal by Subject|0|||
161562354|NCT01515319|583446251|FG009|Overall Study|Withdrawal by Subject|0|||
161562355|NCT01515319|583446242|FG000|Overall Study|Adverse Event|0|||
161562356|NCT01515319|583446243|FG001|Overall Study|Adverse Event|0|||
161806963|NCT03496623|584337759|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
161806964|NCT03496623|584337760|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806965|NCT03496623|584337761|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806966|NCT03496623|584337762|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806967|NCT03496623|584337763|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806968|NCT03496623|584337759|FG000|Period 1 (12 Weeks)|Death|0|||
161806969|NCT03496623|584337760|FG001|Period 1 (12 Weeks)|Death|3|||
161806970|NCT03496623|584337761|FG002|Period 1 (12 Weeks)|Death|0|||
161806971|NCT03496623|584337762|FG003|Period 1 (12 Weeks)|Death|0|||
161562357|NCT01515319|583446244|FG002|Overall Study|Adverse Event|0|||
161562358|NCT01515319|583446245|FG003|Overall Study|Adverse Event|0|||
161562359|NCT01515319|583446246|FG004|Overall Study|Adverse Event|0|||
161562360|NCT01515319|583446247|FG005|Overall Study|Adverse Event|0|||
161562361|NCT01515319|583446248|FG006|Overall Study|Adverse Event|0|||
161562362|NCT01515319|583446249|FG007|Overall Study|Adverse Event|0|||
161806972|NCT03496623|584337763|FG004|Period 1 (12 Weeks)|Death|0|||
161806973|NCT03496623|584337759|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161562363|NCT01515319|583446250|FG008|Overall Study|Adverse Event|3|||
161562364|NCT01515319|583446251|FG009|Overall Study|Adverse Event|0|||
161562365|NCT01515319|583446242|FG000|Overall Study|Protocol Violation|0|||
161562366|NCT01515319|583446243|FG001|Overall Study|Protocol Violation|0|||
161562367|NCT01515319|583446244|FG002|Overall Study|Protocol Violation|0|||
161562368|NCT01515319|583446245|FG003|Overall Study|Protocol Violation|0|||
161562369|NCT01515319|583446246|FG004|Overall Study|Protocol Violation|0|||
161562370|NCT01515319|583446247|FG005|Overall Study|Protocol Violation|0|||
161910678|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161910679|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161910680|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161910681|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
161910682|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161910683|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161910684|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
161910685|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
161910686|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
161562371|NCT01515319|583446248|FG006|Overall Study|Protocol Violation|0|||
161562372|NCT01515319|583446249|FG007|Overall Study|Protocol Violation|0|||
161562373|NCT01515319|583446250|FG008|Overall Study|Protocol Violation|2|||
161562374|NCT01515319|583446251|FG009|Overall Study|Protocol Violation|0|||
161562375|NCT04880161|583446252|FG000|Overall Study|Withdrawal by Subject|1|||
161562376|NCT04880161|583446253|FG001|Overall Study|Withdrawal by Subject|0|||
161562377|NCT04880161|583446252|FG000|Overall Study|Lack of Compliance|1|||
161562378|NCT04880161|583446253|FG001|Overall Study|Lack of Compliance|1|||
161562379|NCT04880161|583446252|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
161562380|NCT04880161|583446253|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
161562381|NCT04880161|583446252|FG000|Overall Study|Screen Failure|0|||
161562382|NCT04880161|583446253|FG001|Overall Study|Screen Failure|1|||
161562383|NCT01354106|583446254|FG000|Overall Study|Withdrawal by Subject|2|||
161562384|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Adverse Event|5|||
161562385|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Adverse Event|13|||
161562386|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Adverse Event|0|||
161562387|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
161562388|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
161562389|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
161562390|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
161562391|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
161562392|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
161562393|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
161562394|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
161562395|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
161562396|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
161562397|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
161562398|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
161562399|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
161562400|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
161562401|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
161562402|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Physician Decision|2|||
161562403|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Physician Decision|3|||
161562404|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Physician Decision|0|||
161562405|NCT01449929|583446255|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
161562406|NCT01449929|583446256|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
161562407|NCT01449929|583446257|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
161562408|NCT01449929|583446255|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
161562409|NCT01449929|583446256|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
161562410|NCT01449929|583446257|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
161562411|NCT01449929|583446255|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
161562412|NCT01449929|583446256|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
161562413|NCT01449929|583446257|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
161562414|NCT01449929|583446255|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
161562415|NCT01449929|583446256|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
161562416|NCT01449929|583446257|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
161562417|NCT00901485|583446258|FG000|Overall Study|Lack of Efficacy|0|||
161562418|NCT00901485|583446259|FG001|Overall Study|Lack of Efficacy|2|||
161562419|NCT00901485|583446258|FG000|Overall Study|Withdrawal by Subject|1|||
161562420|NCT00901485|583446259|FG001|Overall Study|Withdrawal by Subject|2|||
161562421|NCT01871285|583446260|FG000|First Intervention (1 Day)|Adverse Event|1|||
161562422|NCT01871285|583446261|FG001|First Intervention (1 Day)|Adverse Event|0|||
161562423|NCT01871285|583446262|FG002|First Intervention (1 Day)|Adverse Event|0|||
161562424|NCT01871285|583446263|FG003|First Intervention (1 Day)|Adverse Event|0|||
161562425|NCT01871285|583446260|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
161562426|NCT01871285|583446261|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
161910687|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
161562427|NCT01871285|583446262|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
161562428|NCT01871285|583446263|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
161562429|NCT05397470|583446264|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
161562430|NCT05397470|583446265|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
161562431|NCT05397470|583446266|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
161562432|NCT05397470|583446264|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
161562433|NCT05397470|583446265|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
161562434|NCT05397470|583446266|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
161562435|NCT05397470|583446264|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
161562436|NCT05397470|583446265|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
161562437|NCT05397470|583446266|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
161562438|NCT05397470|583446264|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
161562439|NCT05397470|583446265|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
161562440|NCT05397470|583446266|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
161562441|NCT05397470|583446264|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
161562442|NCT05397470|583446265|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
161562443|NCT05397470|583446266|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
161562444|NCT05397470|583446264|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
161562445|NCT05397470|583446265|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
161562446|NCT05397470|583446266|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
161562447|NCT05397470|583446264|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
161562448|NCT05397470|583446265|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
161562449|NCT05397470|583446266|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
161562450|NCT01919619|583446267|FG000|Overall Study|Physician Decision|1|||
161562451|NCT01919619|583446268|FG001|Overall Study|Physician Decision|1|||
161562452|NCT00587288|583448268|FG000|Overall Study|Adverse Event|0|||
161562453|NCT00587288|583448269|FG001|Overall Study|Adverse Event|1|||
161562454|NCT00587288|583448268|FG000|Overall Study|Lack of Efficacy|2|||
161562455|NCT00587288|583448269|FG001|Overall Study|Lack of Efficacy|8|||
161562456|NCT00587288|583448268|FG000|Overall Study|Protocol Violation|1|||
161562457|NCT00587288|583448269|FG001|Overall Study|Protocol Violation|0|||
161562458|NCT01257503|583448273|FG000|Overall Study|Lost to Follow-up|7|||
161562459|NCT01257503|583448274|FG001|Overall Study|Lost to Follow-up|10|||
161562460|NCT01257503|583448273|FG000|Overall Study|Over 5 years old at enrollment|0|||
161562461|NCT01257503|583448274|FG001|Overall Study|Over 5 years old at enrollment|1|||
161562462|NCT01257503|583448273|FG000|Overall Study|strep culture positive at enrollment|1|||
161562463|NCT01257503|583448274|FG001|Overall Study|strep culture positive at enrollment|0|||
161562464|NCT02333630|583448275|FG000|Overall Study|Lost to Follow-up|5|||
161562465|NCT02333630|583448276|FG001|Overall Study|Lost to Follow-up|2|||
161562466|NCT00315055|583448277|FG000|Overall Study|Protocol Violation|2|||
161562467|NCT00315055|583448278|FG001|Overall Study|Protocol Violation|4|||
161562468|NCT00315055|583448277|FG000|Overall Study|Lost to Follow-up|1|||
161562469|NCT00315055|583448278|FG001|Overall Study|Lost to Follow-up|1|||
161562470|NCT02359435|583448279|FG000|Overall Study|Lost to Follow-up|4|||
161562471|NCT02359435|583448280|FG001|Overall Study|Lost to Follow-up|4|||
161562472|NCT02347943|583448282|FG000|Overall Study|Study was cancelled|140|||
161562473|NCT02347943|583448283|FG001|Overall Study|Study was cancelled|67|||
161562474|NCT02347943|583448284|FG002|Overall Study|Study was cancelled|45|||
161562475|NCT03681691|583448291|FG000|Overall Study|COVID|1|||
161562476|NCT03681691|583448292|FG001|Overall Study|COVID|0|||
161562477|NCT03681691|583448291|FG000|Overall Study|prolonged bleeding|1|||
161562478|NCT03681691|583448292|FG001|Overall Study|prolonged bleeding|0|||
161562479|NCT03681691|583448291|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
161562480|NCT03681691|583448292|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
161562481|NCT03613129|583448293|FG000|Pre-treatment Assessment|Protocol Violation|2|||
161562482|NCT03613129|583448294|FG001|Pre-treatment Assessment|Protocol Violation|0|||
161562483|NCT03613129|583448295|FG002|Pre-treatment Assessment|Protocol Violation|0|||
161806974|NCT03496623|584337760|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161806975|NCT03496623|584337761|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161806976|NCT03496623|584337762|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
161806977|NCT03496623|584337763|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
161806978|NCT03496623|584337759|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161562484|NCT03613129|583448296|FG003|Pre-treatment Assessment|Protocol Violation|0|||
161562485|NCT03613129|583448297|FG004|Pre-treatment Assessment|Protocol Violation|0|||
161562486|NCT03613129|583448293|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
161562487|NCT03613129|583448294|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
161562488|NCT03613129|583448295|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
161562489|NCT03613129|583448296|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
161562490|NCT03613129|583448297|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
161562491|NCT02334306|583448298|FG000|Double-blind Period|Adverse Event|0|||
161562492|NCT02334306|583448299|FG001|Double-blind Period|Adverse Event|1|||
161562493|NCT02334306|583448298|FG000|Double-blind Period|Withdrawal by Subject|1|||
161806979|NCT03496623|584337760|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161806980|NCT03496623|584337761|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161562494|NCT02334306|583448299|FG001|Double-blind Period|Withdrawal by Subject|1|||
161562495|NCT01687270|583448300|FG000|Overall Study|Lack of Efficacy|11|||
161562496|NCT01687270|583448300|FG000|Overall Study|Lost to Follow-up|1|||
161562497|NCT02534896|583448301|FG000|Overall Study|Adverse Event|2|||
161562498|NCT02534896|583448302|FG001|Overall Study|Adverse Event|1|||
161562499|NCT02534896|583448303|FG002|Overall Study|Adverse Event|1|||
161562500|NCT02534896|583448301|FG000|Overall Study|Insufficient therapeutic response|2|||
161562501|NCT02534896|583448302|FG001|Overall Study|Insufficient therapeutic response|0|||
161562502|NCT02534896|583448303|FG002|Overall Study|Insufficient therapeutic response|0|||
161562503|NCT00711646|583448304|FG000|Overall Study|Adverse Event|6|||
161562504|NCT00711646|583448305|FG001|Overall Study|Adverse Event|1|||
161562505|NCT00711646|583448304|FG000|Overall Study|Withdrawal by Subject|4|||
161562506|NCT00711646|583448305|FG001|Overall Study|Withdrawal by Subject|0|||
161562507|NCT00711646|583448304|FG000|Overall Study|Protocol Violation|0|||
161562508|NCT00711646|583448305|FG001|Overall Study|Protocol Violation|1|||
161562509|NCT00711646|583448304|FG000|Overall Study|Lost to Follow-up|1|||
161562510|NCT00711646|583448305|FG001|Overall Study|Lost to Follow-up|0|||
161562511|NCT00711646|583448304|FG000|Overall Study|administrative decision|0|||
161562512|NCT00711646|583448305|FG001|Overall Study|administrative decision|1|||
161562513|NCT00711646|583448304|FG000|Overall Study|patient non-compliance|1|||
161562514|NCT00711646|583448305|FG001|Overall Study|patient non-compliance|0|||
161562515|NCT03441360|583448306|FG000|Overall Study|Radiological disease progression|5|||
161562516|NCT03441360|583448307|FG001|Overall Study|Radiological disease progression|6|||
161562517|NCT03441360|583448308|FG002|Overall Study|Radiological disease progression|4|||
161562518|NCT03441360|583448306|FG000|Overall Study|Clinical disease progression|2|||
161562519|NCT03441360|583448307|FG001|Overall Study|Clinical disease progression|2|||
161562520|NCT03441360|583448308|FG002|Overall Study|Clinical disease progression|0|||
161562521|NCT03441360|583448306|FG000|Overall Study|Adverse Event|1|||
161562522|NCT03441360|583448307|FG001|Overall Study|Adverse Event|0|||
161562523|NCT03441360|583448308|FG002|Overall Study|Adverse Event|1|||
161562524|NCT00269399|583448309|FG000|Overall Study|Lack of Efficacy|27|||
161562525|NCT00269399|583448310|FG001|Overall Study|Lack of Efficacy|10|||
161562526|NCT00269399|583448309|FG000|Overall Study|Adverse Event|10|||
161562527|NCT00269399|583448310|FG001|Overall Study|Adverse Event|4|||
161562528|NCT00269399|583448309|FG000|Overall Study|Withdrawal by Subject|2|||
161562529|NCT00269399|583448310|FG001|Overall Study|Withdrawal by Subject|5|||
161562530|NCT00269399|583448309|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
161562531|NCT00269399|583448310|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
161562532|NCT00269399|583448309|FG000|Overall Study|Other|0|||
161562533|NCT00269399|583448310|FG001|Overall Study|Other|4|||
161562534|NCT00269399|583448309|FG000|Overall Study|Development of exclusion criteria|0|||
161562535|NCT00269399|583448310|FG001|Overall Study|Development of exclusion criteria|1|||
161562536|NCT01360840|583448313|FG000|Overall Study|Ongoing at data cut-off|10|||
161562537|NCT01360840|583448314|FG001|Overall Study|Ongoing at data cut-off|10|||
161562538|NCT01360840|583448315|FG002|Overall Study|Ongoing at data cut-off|9|||
161562539|NCT00920686|583448319|FG000|Overall Study|Lost to Follow-up|2|||
161562540|NCT00920686|583448320|FG001|Overall Study|Lost to Follow-up|3|||
161562541|NCT00920686|583448321|FG002|Overall Study|Lost to Follow-up|1|||
161562542|NCT00920686|583448319|FG000|Overall Study|Study drug dosing criteria not met|17|||
161562543|NCT00920686|583448320|FG001|Overall Study|Study drug dosing criteria not met|19|||
161562544|NCT00920686|583448321|FG002|Overall Study|Study drug dosing criteria not met|12|||
161562545|NCT03006341|583448322|FG000|Overall Study|Not linked in the EMR|25069|||
161562546|NCT03006341|583448323|FG001|Overall Study|Not linked in the EMR|67505|||
161562547|NCT03006341|583448324|FG002|Overall Study|Not linked in the EMR|30993|||
161562548|NCT03006341|583448325|FG003|Overall Study|Not linked in the EMR|10685|||
161562549|NCT02950545|583448326|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
161562550|NCT02950545|583448327|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
161910688|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
161910689|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
161910690|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
161562551|NCT02950545|583448328|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
161562552|NCT02950545|583448329|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
161562553|NCT02950545|583448330|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
161562554|NCT02950545|583448331|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
161562555|NCT02950545|583448326|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
161562556|NCT02950545|583448327|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
161562557|NCT02950545|583448328|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
161562558|NCT02950545|583448329|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
161562559|NCT02950545|583448330|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
161562560|NCT02950545|583448331|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
161562561|NCT02950545|583448326|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
161562562|NCT02950545|583448327|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
161562563|NCT02950545|583448328|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
161562564|NCT02950545|583448329|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
161562565|NCT02950545|583448330|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
161562566|NCT02950545|583448331|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
161562567|NCT02950545|583448326|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
161562568|NCT02950545|583448327|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
161562569|NCT02950545|583448328|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
161562570|NCT02950545|583448329|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
161562571|NCT02950545|583448330|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
161562572|NCT02950545|583448331|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
161562573|NCT02950545|583448326|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
161562574|NCT02950545|583448327|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
161562575|NCT02950545|583448328|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
161562576|NCT02950545|583448329|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
161562577|NCT02950545|583448330|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
161562578|NCT02950545|583448331|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
161562579|NCT04296942|583448332|FG000|Overall Study|Study closure by sponsor|1|||
161562580|NCT04296942|583448333|FG001|Overall Study|Study closure by sponsor|0|||
161562581|NCT04296942|583448334|FG002|Overall Study|Study closure by sponsor|0|||
161562582|NCT01579578|583448335|FG000|Overall Study|Death|4|||
161562583|NCT01579578|583448336|FG001|Overall Study|Death|1|||
161562584|NCT01579578|583448335|FG000|Overall Study|Lost to Follow-up|1|||
161562585|NCT01579578|583448336|FG001|Overall Study|Lost to Follow-up|1|||
161562586|NCT01579578|583448335|FG000|Overall Study|Withdrawal by Subject|2|||
161562587|NCT01579578|583448336|FG001|Overall Study|Withdrawal by Subject|1|||
161562588|NCT01579578|583448335|FG000|Overall Study|Eligibility criteria|3|||
161562589|NCT01579578|583448336|FG001|Overall Study|Eligibility criteria|9|||
161562590|NCT01579578|583448335|FG000|Overall Study|Ongoing|3|||
161562591|NCT01579578|583448336|FG001|Overall Study|Ongoing|0|||
161562592|NCT01004263|583448339|FG000|Overall Study|Adverse Event|15|||
161562593|NCT01004263|583448339|FG000|Overall Study|Withdrawal by Subject|58|||
161562594|NCT01004263|583448339|FG000|Overall Study|Protocol Violation|10|||
161562595|NCT01004263|583448339|FG000|Overall Study|Lost to Follow-up|64|||
161562596|NCT01004263|583448339|FG000|Overall Study|Lack of Efficacy|13|||
161562597|NCT01004263|583448339|FG000|Overall Study|Pregnancy|2|||
161562598|NCT01004263|583448339|FG000|Overall Study|Physician Decision|15|||
161562599|NCT01004263|583448339|FG000|Overall Study|Lack of Qualifying Event|2|||
161562600|NCT01237678|583448340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
161562601|NCT01237678|583448341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
161562602|NCT01237678|583448342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
161562603|NCT01237678|583448340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
161562604|NCT01237678|583448341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
161562605|NCT01237678|583448342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
161562606|NCT01237678|583448340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
161562607|NCT01237678|583448341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
161562608|NCT01237678|583448342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
161562609|NCT01237678|583448340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
161562610|NCT01237678|583448341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
161562611|NCT01237678|583448342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
161562612|NCT01237678|583448340|FG000|Phase II|Adverse Event|0|||
161562613|NCT01237678|583448341|FG001|Phase II|Adverse Event|39|||
161562614|NCT01237678|583448342|FG002|Phase II|Adverse Event|9|||
161562615|NCT01237678|583448340|FG000|Phase II|Death|0|||
161562616|NCT01237678|583448341|FG001|Phase II|Death|0|||
161562617|NCT01237678|583448342|FG002|Phase II|Death|2|||
161562618|NCT01237678|583448340|FG000|Phase II|Lack of Efficacy|0|||
161562619|NCT01237678|583448341|FG001|Phase II|Lack of Efficacy|25|||
161562620|NCT01237678|583448342|FG002|Phase II|Lack of Efficacy|3|||
161562621|NCT01237678|583448340|FG000|Phase II|Withdrawal by Subject|0|||
161562622|NCT01237678|583448341|FG001|Phase II|Withdrawal by Subject|1|||
161562623|NCT01237678|583448342|FG002|Phase II|Withdrawal by Subject|5|||
161562624|NCT01237678|583448340|FG000|Phase II|Completed Cycles 4-6|0|||
161562625|NCT01237678|583448341|FG001|Phase II|Completed Cycles 4-6|11|||
161562626|NCT01237678|583448342|FG002|Phase II|Completed Cycles 4-6|21|||
161562627|NCT01237678|583448340|FG000|Phase II|Sponsor Decision/Study Closed|0|||
161562628|NCT01237678|583448341|FG001|Phase II|Sponsor Decision/Study Closed|18|||
161562629|NCT01237678|583448342|FG002|Phase II|Sponsor Decision/Study Closed|7|||
161562630|NCT01237678|583448340|FG000|Phase II|Randomized but were not treated|0|||
161806981|NCT03496623|584337762|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161806982|NCT03496623|584337763|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161806983|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161806984|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
161562631|NCT01237678|583448341|FG001|Phase II|Randomized but were not treated|4|||
161562632|NCT01237678|583448342|FG002|Phase II|Randomized but were not treated|3|||
161562633|NCT03398356|583448347|FG000|Before Treatment|Lost to Follow-up|1|||
161562634|NCT03398356|583448348|FG001|Before Treatment|Lost to Follow-up|2|||
161562635|NCT03398356|583448349|FG002|Before Treatment|Lost to Follow-up|0|||
161562636|NCT03398356|583448347|FG000|Before Treatment|drug intolerance|2|||
161562637|NCT03398356|583448348|FG001|Before Treatment|drug intolerance|1|||
161562638|NCT03398356|583448349|FG002|Before Treatment|drug intolerance|0|||
161562639|NCT03398356|583448347|FG000|Before Treatment|Withdrawal by Subject|0|||
161562640|NCT03398356|583448348|FG001|Before Treatment|Withdrawal by Subject|5|||
161562641|NCT03398356|583448349|FG002|Before Treatment|Withdrawal by Subject|0|||
161562642|NCT03398356|583448347|FG000|Before Treatment|Physician Decision|0|||
161562643|NCT03398356|583448348|FG001|Before Treatment|Physician Decision|0|||
161562644|NCT03398356|583448349|FG002|Before Treatment|Physician Decision|11|||
161562645|NCT03398356|583448347|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
161562646|NCT03398356|583448348|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
161562647|NCT03398356|583448349|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
161562648|NCT01982760|583448350|FG000|Overall Study|Physician Decision|1|||
161562649|NCT01982760|583448351|FG001|Overall Study|Physician Decision|0|||
161562650|NCT00821236|583448352|FG000|Overall Study|Lost to Follow-up|3|||
161562651|NCT00530777|583448353|FG000|Overall Study|Lost to Follow-up|0|||
161562652|NCT00530777|583448354|FG001|Overall Study|Lost to Follow-up|1|||
161562653|NCT00530777|583448353|FG000|Overall Study|Death|1|||
161562654|NCT00530777|583448354|FG001|Overall Study|Death|2|||
161562655|NCT00530777|583448353|FG000|Overall Study|Physician Decision|1|||
161562656|NCT00530777|583448354|FG001|Overall Study|Physician Decision|0|||
161562657|NCT00530777|583448353|FG000|Overall Study|Withdrawal by Subject|0|||
161562658|NCT00530777|583448354|FG001|Overall Study|Withdrawal by Subject|1|||
161562659|NCT00530777|583448353|FG000|Overall Study|Unable to adhere to visit schedule|5|||
161562660|NCT00530777|583448354|FG001|Overall Study|Unable to adhere to visit schedule|1|||
161562661|NCT01582243|583448356|FG000|Overall Study|Withdrawal by Subject|1|||
161562662|NCT01582243|583448356|FG000|Overall Study|Adverse Event|1|||
161562663|NCT01582243|583448356|FG000|Overall Study|Lost to Follow-up|1|||
161562664|NCT02954055|583448358|FG000|Overall Study|Did not initiate therapy|6|||
161562665|NCT02954055|583448359|FG001|Overall Study|Did not initiate therapy|1|||
161562666|NCT02096003|583448360|FG000|Overall Study|Protocol Violation|0|||
161562667|NCT02096003|583448361|FG001|Overall Study|Protocol Violation|2|||
161562668|NCT02096003|583448360|FG000|Overall Study|additional surgery|2|||
161562669|NCT02096003|583448361|FG001|Overall Study|additional surgery|1|||
161562670|NCT01763047|583448362|FG000|Period 1|Test Article Not Available|4|||
161562671|NCT01763047|583448363|FG001|Period 1|Test Article Not Available|1|||
161562672|NCT01763047|583448362|FG000|Period 1|Protocol Violation|4|||
161562673|NCT01763047|583448363|FG001|Period 1|Protocol Violation|4|||
161562674|NCT01763047|583448362|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
161562675|NCT01763047|583448363|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
161562676|NCT01763047|583448362|FG000|Period 1|Adverse Event|0|||
161562677|NCT01763047|583448363|FG001|Period 1|Adverse Event|1|||
161562678|NCT01763047|583448362|FG000|Period 1|Unsatisfactory Visual Response|0|||
161562679|NCT01763047|583448363|FG001|Period 1|Unsatisfactory Visual Response|3|||
161562680|NCT01763047|583448362|FG000|Period 1|Lens Power Not Available|0|||
161562681|NCT01763047|583448363|FG001|Period 1|Lens Power Not Available|1|||
161562682|NCT01763047|583448362|FG000|Period 1|Study Site office Closed|0|||
161562683|NCT01763047|583448363|FG001|Period 1|Study Site office Closed|1|||
161562684|NCT01763047|583448362|FG000|Period 2|Lens Discomfort|1|||
161562685|NCT01763047|583448363|FG001|Period 2|Lens Discomfort|0|||
161562686|NCT01763047|583448362|FG000|Period 2|No longer meets Eligibility Criteria|1|||
161562687|NCT01763047|583448363|FG001|Period 2|No longer meets Eligibility Criteria|0|||
161562688|NCT01763047|583448362|FG000|Period 2|Study Site office Closed|1|||
161562689|NCT01763047|583448363|FG001|Period 2|Study Site office Closed|1|||
161562690|NCT01763047|583448362|FG000|Period 2|Unsatisfactory Visual Response|1|||
161562691|NCT01763047|583448363|FG001|Period 2|Unsatisfactory Visual Response|1|||
161562692|NCT01763047|583448362|FG000|Period 2|Protocol Violation|0|||
161562693|NCT01763047|583448363|FG001|Period 2|Protocol Violation|2|||
161562694|NCT01763047|583448362|FG000|Period 2|Unsatisfactory lens Fitting|0|||
161562695|NCT01763047|583448363|FG001|Period 2|Unsatisfactory lens Fitting|1|||
161562696|NCT01008748|583448366|FG000|Overall Study|Lost to Follow-up|80|||
161562697|NCT01008748|583448366|FG000|Overall Study|Other|1|||
161562698|NCT01767909|583448367|FG000|Overall Study|Withdrawal by Subject|4|||
161562699|NCT01767909|583448368|FG001|Overall Study|Withdrawal by Subject|7|||
161562700|NCT01767909|583448367|FG000|Overall Study|Adverse Event|3|||
161562701|NCT01767909|583448368|FG001|Overall Study|Adverse Event|1|||
161562702|NCT01767909|583448367|FG000|Overall Study|Withdrawal by Study Partner|3|||
161562703|NCT01767909|583448368|FG001|Overall Study|Withdrawal by Study Partner|1|||
161562704|NCT01767909|583448367|FG000|Overall Study|Non-Compliance|2|||
161562705|NCT01767909|583448368|FG001|Overall Study|Non-Compliance|0|||
161562706|NCT01767909|583448367|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161562707|NCT01767909|583448368|FG001|Overall Study|Perceived Lack of Efficacy|0|||
161562708|NCT01767909|583448367|FG000|Overall Study|Investigator Recommendation|0|||
161562709|NCT01767909|583448368|FG001|Overall Study|Investigator Recommendation|1|||
161562710|NCT01767909|583448367|FG000|Overall Study|Lost to Follow-up|0|||
161562711|NCT01767909|583448368|FG001|Overall Study|Lost to Follow-up|1|||
161562712|NCT01767909|583448367|FG000|Overall Study|LP uncessessful|0|||
161562713|NCT01767909|583448368|FG001|Overall Study|LP uncessessful|1|||
161806985|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
161806986|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161806987|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161806988|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161806989|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161806990|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
161806991|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161806992|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161453840|NCT01616693|583055444|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
161453841|NCT00441116|583055448|FG000|Overall Study|Adverse Event|1|||
161453842|NCT00441116|583055449|FG001|Overall Study|Adverse Event|1|||
161453843|NCT00441116|583055448|FG000|Overall Study|Withdrawal by Subject|1|||
161453844|NCT00441116|583055449|FG001|Overall Study|Withdrawal by Subject|0|||
161453845|NCT00441116|583055448|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
161453846|NCT00441116|583055449|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
161453847|NCT02925338|583055450|FG000|Overall Study|Death|0|||
161453848|NCT02925338|583055451|FG001|Overall Study|Death|2|||
161453849|NCT02925338|583055452|FG002|Overall Study|Death|1|||
161453850|NCT02925338|583055453|FG003|Overall Study|Death|0|||
161453851|NCT02925338|583055454|FG004|Overall Study|Death|0|||
161453852|NCT02925338|583055450|FG000|Overall Study|Lost to Follow-up|30|||
161453853|NCT02925338|583055451|FG001|Overall Study|Lost to Follow-up|10|||
161453854|NCT02925338|583055452|FG002|Overall Study|Lost to Follow-up|1|||
161453855|NCT02925338|583055453|FG003|Overall Study|Lost to Follow-up|16|||
161453856|NCT02925338|583055454|FG004|Overall Study|Lost to Follow-up|3|||
161453857|NCT02925338|583055450|FG000|Overall Study|Withdrawal by Subject|3|||
161453858|NCT02925338|583055451|FG001|Overall Study|Withdrawal by Subject|0|||
161453859|NCT02925338|583055452|FG002|Overall Study|Withdrawal by Subject|3|||
161453860|NCT02925338|583055453|FG003|Overall Study|Withdrawal by Subject|2|||
161453861|NCT02925338|583055454|FG004|Overall Study|Withdrawal by Subject|2|||
161453862|NCT02925338|583055450|FG000|Overall Study|Missing|38|||
161453863|NCT02925338|583055451|FG001|Overall Study|Missing|27|||
161453864|NCT02925338|583055452|FG002|Overall Study|Missing|0|||
161453865|NCT02925338|583055453|FG003|Overall Study|Missing|3|||
161453866|NCT02925338|583055454|FG004|Overall Study|Missing|2|||
161453867|NCT02925338|583055450|FG000|Overall Study|Participant's Decision|11|||
161453868|NCT02925338|583055451|FG001|Overall Study|Participant's Decision|7|||
161453869|NCT02925338|583055452|FG002|Overall Study|Participant's Decision|3|||
161453870|NCT02925338|583055453|FG003|Overall Study|Participant's Decision|8|||
161453871|NCT02925338|583055454|FG004|Overall Study|Participant's Decision|1|||
161453872|NCT02925338|583055450|FG000|Overall Study|Treatment Discontinuation|144|||
161453873|NCT02925338|583055451|FG001|Overall Study|Treatment Discontinuation|65|||
161453874|NCT02925338|583055452|FG002|Overall Study|Treatment Discontinuation|56|||
161453875|NCT02925338|583055453|FG003|Overall Study|Treatment Discontinuation|131|||
161453876|NCT02925338|583055454|FG004|Overall Study|Treatment Discontinuation|22|||
161453877|NCT00636363|583055457|FG000|Overall Study|Conjunctivitis|0|||
161453878|NCT00636363|583055458|FG001|Overall Study|Conjunctivitis|0|||
161453879|NCT00636363|583055459|FG002|Overall Study|Conjunctivitis|1|||
161453880|NCT00636363|583055457|FG000|Overall Study|Adverse Event|0|||
161453881|NCT00636363|583055458|FG001|Overall Study|Adverse Event|0|||
161453882|NCT00636363|583055459|FG002|Overall Study|Adverse Event|1|||
161453883|NCT00636363|583055457|FG000|Overall Study|Positive slit lamp finding|0|||
161453884|NCT00636363|583055458|FG001|Overall Study|Positive slit lamp finding|2|||
161453885|NCT00636363|583055459|FG002|Overall Study|Positive slit lamp finding|1|||
161453886|NCT00636363|583055457|FG000|Overall Study|Study related symptoms/complaints|8|||
161453887|NCT00636363|583055458|FG001|Overall Study|Study related symptoms/complaints|7|||
161453888|NCT00636363|583055459|FG002|Overall Study|Study related symptoms/complaints|4|||
161453889|NCT00636363|583055457|FG000|Overall Study|Met ineligibility criteria|0|||
161453890|NCT00636363|583055458|FG001|Overall Study|Met ineligibility criteria|0|||
161453891|NCT00636363|583055459|FG002|Overall Study|Met ineligibility criteria|3|||
161453892|NCT00636363|583055457|FG000|Overall Study|Missed > 1 visit|0|||
161453893|NCT00636363|583055458|FG001|Overall Study|Missed > 1 visit|1|||
161453894|NCT00636363|583055459|FG002|Overall Study|Missed > 1 visit|3|||
161453895|NCT00636363|583055457|FG000|Overall Study|Lack of motivation|1|||
161453896|NCT00636363|583055458|FG001|Overall Study|Lack of motivation|0|||
161453897|NCT00636363|583055459|FG002|Overall Study|Lack of motivation|1|||
161453898|NCT00636363|583055457|FG000|Overall Study|Protocol Violation|0|||
161453899|NCT00636363|583055458|FG001|Overall Study|Protocol Violation|3|||
161453900|NCT00636363|583055459|FG002|Overall Study|Protocol Violation|0|||
161453901|NCT00636363|583055457|FG000|Overall Study|Lost to Follow-up|3|||
161453902|NCT00636363|583055458|FG001|Overall Study|Lost to Follow-up|4|||
161453903|NCT00636363|583055459|FG002|Overall Study|Lost to Follow-up|2|||
161453904|NCT00636363|583055457|FG000|Overall Study|Withdrawal by Subject|1|||
161453905|NCT00636363|583055458|FG001|Overall Study|Withdrawal by Subject|3|||
161806993|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161453906|NCT00636363|583055459|FG002|Overall Study|Withdrawal by Subject|2|||
161453907|NCT03148691|583055462|FG000|Overall Study|Protocol Violation|1|||
161453908|NCT03148691|583055463|FG001|Overall Study|Protocol Violation|2|||
161562714|NCT03251378|583448369|FG000|Overall Study|Death|3|||
161562715|NCT03251378|583448370|FG001|Overall Study|Death|2|||
161562716|NCT03251378|583448371|FG002|Overall Study|Death|3|||
161562717|NCT03251378|583448372|FG003|Overall Study|Death|30|||
161562718|NCT03251378|583448373|FG004|Overall Study|Death|24|||
161562719|NCT03251378|583448374|FG005|Overall Study|Death|12|||
161562720|NCT03251378|583448375|FG006|Overall Study|Death|12|||
161562721|NCT03251378|583448369|FG000|Overall Study|Lost to Follow-up|0|||
161562722|NCT03251378|583448370|FG001|Overall Study|Lost to Follow-up|0|||
161562723|NCT03251378|583448371|FG002|Overall Study|Lost to Follow-up|1|||
161562724|NCT03251378|583448372|FG003|Overall Study|Lost to Follow-up|3|||
161562725|NCT03251378|583448373|FG004|Overall Study|Lost to Follow-up|0|||
161562726|NCT03251378|583448374|FG005|Overall Study|Lost to Follow-up|0|||
161562727|NCT03251378|583448375|FG006|Overall Study|Lost to Follow-up|0|||
161562728|NCT03251378|583448369|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
161562729|NCT03251378|583448370|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
161562730|NCT03251378|583448371|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
161562731|NCT03251378|583448372|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
161562732|NCT03251378|583448373|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
161562733|NCT03251378|583448374|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
161562734|NCT03251378|583448375|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
161562735|NCT03251378|583448369|FG000|Overall Study|Progressive disease|2|||
161562736|NCT03251378|583448370|FG001|Overall Study|Progressive disease|0|||
161562737|NCT03251378|583448371|FG002|Overall Study|Progressive disease|0|||
161562738|NCT03251378|583448372|FG003|Overall Study|Progressive disease|1|||
161562739|NCT03251378|583448373|FG004|Overall Study|Progressive disease|0|||
161562740|NCT03251378|583448374|FG005|Overall Study|Progressive disease|0|||
161562741|NCT03251378|583448375|FG006|Overall Study|Progressive disease|0|||
161562742|NCT03251378|583448369|FG000|Overall Study|Physician Decision|0|||
161562743|NCT03251378|583448370|FG001|Overall Study|Physician Decision|2|||
161562744|NCT03251378|583448371|FG002|Overall Study|Physician Decision|0|||
161562745|NCT03251378|583448372|FG003|Overall Study|Physician Decision|0|||
161562746|NCT03251378|583448373|FG004|Overall Study|Physician Decision|0|||
161562747|NCT03251378|583448374|FG005|Overall Study|Physician Decision|0|||
161562748|NCT03251378|583448375|FG006|Overall Study|Physician Decision|0|||
161562749|NCT03251378|583448369|FG000|Overall Study|Other|2|||
161562750|NCT03251378|583448370|FG001|Overall Study|Other|3|||
161562751|NCT03251378|583448371|FG002|Overall Study|Other|2|||
161562752|NCT03251378|583448372|FG003|Overall Study|Other|0|||
161562753|NCT03251378|583448373|FG004|Overall Study|Other|1|||
161562754|NCT03251378|583448374|FG005|Overall Study|Other|1|||
161562755|NCT03251378|583448375|FG006|Overall Study|Other|1|||
161562756|NCT03251378|583448369|FG000|Overall Study|Other|0|||
161562757|NCT03251378|583448370|FG001|Overall Study|Other|0|||
161562758|NCT03251378|583448371|FG002|Overall Study|Other|0|||
161562759|NCT03251378|583448372|FG003|Overall Study|Other|4|||
161562760|NCT03251378|583448373|FG004|Overall Study|Other|13|||
161562761|NCT03251378|583448374|FG005|Overall Study|Other|0|||
161562762|NCT03251378|583448375|FG006|Overall Study|Other|0|||
161562763|NCT05780047|583448376|FG000|Overall Study|Did not submit baseline urine test kit|226|||
161806994|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806995|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
161806996|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806997|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806998|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161806999|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
161807000|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161807001|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161807002|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161807003|NCT02543203|584337764|FG000|Overall Study|Unpalatable Fragrance|2|||
161807004|NCT02543203|584337765|FG001|Overall Study|Unpalatable Fragrance|2|||
161807005|NCT02543203|584337764|FG000|Overall Study|Lost to Follow-up|1|||
161807006|NCT02543203|584337765|FG001|Overall Study|Lost to Follow-up|0|||
161807007|NCT02543203|584337764|FG000|Overall Study|Increased Irritability|1|||
161807008|NCT02543203|584337765|FG001|Overall Study|Increased Irritability|0|||
161807009|NCT02543203|584337764|FG000|Overall Study|Family|1|||
161562764|NCT05780047|583448376|FG000|Overall Study|Lost to Follow-up|34|||
161562765|NCT05780047|583448376|FG000|Overall Study|Did not submit second urine test kit|124|||
161562766|NCT00764868|583448386|FG000|Overall Study|Adverse Event|18|||
161562767|NCT00764868|583448386|FG000|Overall Study|Withdrawal by Subject|31|||
161562768|NCT00764868|583448386|FG000|Overall Study|Non-compliance|16|||
161562769|NCT00764868|583448386|FG000|Overall Study|Lost to Follow-up|25|||
161562770|NCT00764868|583448386|FG000|Overall Study|Lack of Efficacy|5|||
161562771|NCT00764868|583448386|FG000|Overall Study|Subject moved|7|||
161562772|NCT00764868|583448386|FG000|Overall Study|Pregnancy|3|||
161562773|NCT00764868|583448386|FG000|Overall Study|Prohibited medication|1|||
161807010|NCT02543203|584337765|FG001|Overall Study|Family|2|||
161562774|NCT00764868|583448386|FG000|Overall Study|Out of town|1|||
161562775|NCT00764868|583448386|FG000|Overall Study|Misuse and compliance of study drug|1|||
161562776|NCT00764868|583448386|FG000|Overall Study|Subject sent to boarding school|1|||
161562777|NCT00764868|583448386|FG000|Overall Study|Met an exclusion criteria|1|||
161562778|NCT00764868|583448386|FG000|Overall Study|Positive drug screen|2|||
161562779|NCT00764868|583448386|FG000|Overall Study|Sponsor requested withdrawal|1|||
161562780|NCT00783692|583448387|FG000|Induction Phase|Adverse Event|7|||
161562781|NCT00783692|583448388|FG001|Induction Phase|Adverse Event|9|||
161807011|NCT02543203|584337764|FG000|Overall Study|Negative Behavior|1|||
161807012|NCT02543203|584337765|FG001|Overall Study|Negative Behavior|0|||
161807013|NCT02543203|584337764|FG000|Overall Study|Withdrawal by Subject|0|||
161807014|NCT02543203|584337765|FG001|Overall Study|Withdrawal by Subject|1|||
161807015|NCT04786184|584337766|FG000|Overall Study|Adverse Event|4|||
161807016|NCT04786184|584337767|FG001|Overall Study|Adverse Event|0|||
161807017|NCT04786184|584337766|FG000|Overall Study|Withdrawal by Subject|3|||
161807018|NCT04786184|584337767|FG001|Overall Study|Withdrawal by Subject|1|||
161807019|NCT04786184|584337766|FG000|Overall Study|Lost to Follow-up|4|||
161807020|NCT04786184|584337767|FG001|Overall Study|Lost to Follow-up|2|||
161807021|NCT00565448|584337768|FG000|Overall Study|Adverse Event|1|||
161807022|NCT00565448|584337769|FG001|Overall Study|Adverse Event|2|||
161807023|NCT00565448|584337768|FG000|Overall Study|Disease progression|1|||
161807024|NCT00565448|584337769|FG001|Overall Study|Disease progression|0|||
161807025|NCT00565448|584337768|FG000|Overall Study|Withdrawal by Subject|1|||
161807026|NCT00565448|584337769|FG001|Overall Study|Withdrawal by Subject|0|||
161807027|NCT00193609|584337770|FG000|Overall Study|Lack of Efficacy|2|||
161807028|NCT00193609|584337770|FG000|Overall Study|Adverse Event|2|||
161807029|NCT00302952|584337771|FG000|Overall Study|Physician Decision|1|||
161807030|NCT00302952|584337772|FG001|Overall Study|Physician Decision|1|||
161807031|NCT00302952|584337771|FG000|Overall Study|Withdrawal by Subject|2|||
161807032|NCT00302952|584337772|FG001|Overall Study|Withdrawal by Subject|3|||
161807033|NCT00302952|584337771|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
161807034|NCT00302952|584337772|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
161807035|NCT02979353|584337773|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
161807036|NCT02979353|584337774|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
161807037|NCT02979353|584337773|FG000|Overall Study|Withdrawal by Subject|16|||
161807038|NCT02979353|584337774|FG001|Overall Study|Withdrawal by Subject|12|||
161807039|NCT02979353|584337773|FG000|Overall Study|Death|10|||
161807040|NCT02979353|584337774|FG001|Overall Study|Death|11|||
161807041|NCT02979353|584337773|FG000|Overall Study|Transfer to Hospice Care|19|||
161807042|NCT02979353|584337774|FG001|Overall Study|Transfer to Hospice Care|14|||
161807043|NCT02979353|584337773|FG000|Overall Study|Lost to Follow-up|1|||
161807044|NCT02979353|584337774|FG001|Overall Study|Lost to Follow-up|5|||
161807045|NCT00857623|584337775|FG000|Overall Study|Adverse Event|5|||
161807046|NCT00857623|584337776|FG001|Overall Study|Adverse Event|2|||
161807047|NCT00857623|584337775|FG000|Overall Study|Study-specific discontinuation criteria|5|||
161807048|NCT00857623|584337776|FG001|Overall Study|Study-specific discontinuation criteria|3|||
161807049|NCT00857623|584337775|FG000|Overall Study|Withdrawal by Subject|2|||
161807050|NCT00857623|584337776|FG001|Overall Study|Withdrawal by Subject|1|||
161807051|NCT00857623|584337775|FG000|Overall Study|Lack of Efficacy|1|||
161807052|NCT00857623|584337776|FG001|Overall Study|Lack of Efficacy|1|||
161807053|NCT00857623|584337775|FG000|Overall Study|Severe non-compliance to protocol|1|||
161807054|NCT00857623|584337776|FG001|Overall Study|Severe non-compliance to protocol|1|||
161807055|NCT00857623|584337775|FG000|Overall Study|Intake of prohibited medication|0|||
161807056|NCT00857623|584337776|FG001|Overall Study|Intake of prohibited medication|1|||
161807057|NCT00857623|584337775|FG000|Overall Study|Positive for HEP C|0|||
161807058|NCT00857623|584337776|FG001|Overall Study|Positive for HEP C|1|||
161807059|NCT04185909|584337777|FG000|Overall Study|Lost to Follow-up|1|||
161807060|NCT02193178|584337778|FG000|Overall Study|Lost to Follow-up|1|||
161807061|NCT02193178|584337778|FG000|Overall Study|Dry eyes|1|||
161807062|NCT03435081|584337779|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
161807063|NCT03435081|584337780|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
161807064|NCT03435081|584337781|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
161807065|NCT03435081|584337779|FG000|Week 0 to Week 16|Adverse Event|2|||
161562782|NCT00783692|583448389|FG002|Induction Phase|Adverse Event|24|||
161562783|NCT00783692|583448390|FG003|Induction Phase|Adverse Event|0|||
161562784|NCT00783692|583448391|FG004|Induction Phase|Adverse Event|0|||
161562785|NCT00783692|583448392|FG005|Induction Phase|Adverse Event|0|||
161562786|NCT00783692|583448393|FG006|Induction Phase|Adverse Event|0|||
161807066|NCT03435081|584337780|FG001|Week 0 to Week 16|Adverse Event|2|||
161807067|NCT03435081|584337781|FG002|Week 0 to Week 16|Adverse Event|2|||
161807068|NCT03435081|584337779|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
161807069|NCT03435081|584337780|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
161807070|NCT03435081|584337781|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
161807071|NCT03435081|584337779|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
161807072|NCT03435081|584337780|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
161807073|NCT03435081|584337781|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
161807074|NCT03435081|584337779|FG000|Week 0 to Week 16|Pregnancy|1|||
161807075|NCT03435081|584337780|FG001|Week 0 to Week 16|Pregnancy|0|||
161807076|NCT03435081|584337781|FG002|Week 0 to Week 16|Pregnancy|0|||
161807077|NCT03435081|584337779|FG000|Week 0 to Week 16|Non-compliance|1|||
161807078|NCT03435081|584337780|FG001|Week 0 to Week 16|Non-compliance|0|||
161807079|NCT03435081|584337781|FG002|Week 0 to Week 16|Non-compliance|2|||
161807080|NCT03435081|584337779|FG000|Week 0 to Week 16|Inadequate Response|0|||
161807081|NCT03435081|584337780|FG001|Week 0 to Week 16|Inadequate Response|1|||
161807082|NCT03435081|584337781|FG002|Week 0 to Week 16|Inadequate Response|0|||
161807083|NCT03435081|584337779|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
161807084|NCT03435081|584337780|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
161807085|NCT03435081|584337781|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
161807086|NCT03435081|584337779|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
161807087|NCT03435081|584337780|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
161807088|NCT03435081|584337781|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
161807089|NCT03435081|584337779|FG000|Week 16 to Week 104|Adverse Event|1|||
161807090|NCT03435081|584337780|FG001|Week 16 to Week 104|Adverse Event|0|||
161807091|NCT03435081|584337781|FG002|Week 16 to Week 104|Adverse Event|2|||
161807092|NCT03435081|584337779|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
161807093|NCT03435081|584337780|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
161807094|NCT03435081|584337781|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
161807095|NCT03435081|584337779|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
161807096|NCT03435081|584337780|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
161807097|NCT03435081|584337781|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
161807098|NCT03435081|584337779|FG000|Week 16 to Week 104|Non--Compliance|0|||
161807099|NCT03435081|584337780|FG001|Week 16 to Week 104|Non--Compliance|0|||
161807100|NCT03435081|584337781|FG002|Week 16 to Week 104|Non--Compliance|1|||
161807101|NCT02601560|584337782|FG000|Overall Study|Other|0|||
161807102|NCT02601560|584337783|FG001|Overall Study|Other|0|||
161807103|NCT02601560|584337784|FG002|Overall Study|Other|0|||
161807104|NCT02601560|584337785|FG003|Overall Study|Other|0|||
161807105|NCT02601560|584337786|FG004|Overall Study|Other|0|||
161807106|NCT02601560|584337787|FG005|Overall Study|Other|0|||
161807107|NCT02601560|584337788|FG006|Overall Study|Other|1|||
161807108|NCT02601560|584337789|FG007|Overall Study|Other|0|||
161807109|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
161807110|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
161807111|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
161807112|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
161807113|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
161807114|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
161807115|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
161807116|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
161807117|NCT00420238|584337790|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
161807118|NCT00420238|584337791|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
161453909|NCT03148691|583055464|FG002|Overall Study|Protocol Violation|7|||
161453910|NCT03148691|583055462|FG000|Overall Study|Lost to Follow-up|0|||
161453911|NCT03148691|583055463|FG001|Overall Study|Lost to Follow-up|0|||
161453912|NCT03148691|583055464|FG002|Overall Study|Lost to Follow-up|1|||
161453913|NCT03148691|583055462|FG000|Overall Study|Other|1|||
161453914|NCT03148691|583055463|FG001|Overall Study|Other|0|||
161453915|NCT03148691|583055464|FG002|Overall Study|Other|0|||
161453916|NCT03148691|583055462|FG000|Overall Study|Withdrawal by Subject|1|||
161453917|NCT03148691|583055463|FG001|Overall Study|Withdrawal by Subject|0|||
161453918|NCT03148691|583055464|FG002|Overall Study|Withdrawal by Subject|0|||
161453919|NCT00096356|583055465|FG000|Overall Study|Adverse Event|11|||
161453920|NCT00096356|583055466|FG001|Overall Study|Adverse Event|9|||
161453921|NCT00096356|583055465|FG000|Overall Study|Physician Decision|5|||
161453922|NCT00096356|583055466|FG001|Overall Study|Physician Decision|3|||
161453923|NCT00096356|583055465|FG000|Overall Study|Withdrawal by Subject|17|||
161453924|NCT00096356|583055466|FG001|Overall Study|Withdrawal by Subject|23|||
161453925|NCT00096356|583055465|FG000|Overall Study|Lack of Efficacy|1|||
161453926|NCT00096356|583055466|FG001|Overall Study|Lack of Efficacy|0|||
161453927|NCT00096356|583055465|FG000|Overall Study|multiple reasons|10|||
161453928|NCT00096356|583055466|FG001|Overall Study|multiple reasons|18|||
161453929|NCT01008423|583055467|FG000|Overall Study|Adverse Event|13|||
161453930|NCT01008423|583055468|FG001|Overall Study|Adverse Event|6|||
161453931|NCT01008423|583055467|FG000|Overall Study|Withdrawal by Subject|4|||
161453932|NCT01008423|583055468|FG001|Overall Study|Withdrawal by Subject|7|||
161453933|NCT01008423|583055467|FG000|Overall Study|Lost to Follow-up|0|||
161453934|NCT01008423|583055468|FG001|Overall Study|Lost to Follow-up|2|||
161453935|NCT01008423|583055467|FG000|Overall Study|Low Cortisol|0|||
161453936|NCT01008423|583055468|FG001|Overall Study|Low Cortisol|1|||
161453937|NCT01008423|583055467|FG000|Overall Study|Lack of Efficacy|0|||
161807119|NCT00420238|584337790|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
161807120|NCT00420238|584337791|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
161807121|NCT00626548|584337792|FG000|Overall Study|Adverse Event|164|||
161562787|NCT00783692|583448387|FG000|Induction Phase|Protocol Violation|0|||
161562788|NCT00783692|583448388|FG001|Induction Phase|Protocol Violation|0|||
161562789|NCT00783692|583448389|FG002|Induction Phase|Protocol Violation|1|||
161562790|NCT00783692|583448390|FG003|Induction Phase|Protocol Violation|0|||
161562791|NCT00783692|583448391|FG004|Induction Phase|Protocol Violation|0|||
161562792|NCT00783692|583448392|FG005|Induction Phase|Protocol Violation|0|||
161562793|NCT00783692|583448393|FG006|Induction Phase|Protocol Violation|0|||
161562794|NCT00783692|583448387|FG000|Induction Phase|Lack of Efficacy|1|||
161562795|NCT00783692|583448388|FG001|Induction Phase|Lack of Efficacy|3|||
161562796|NCT00783692|583448389|FG002|Induction Phase|Lack of Efficacy|28|||
161562797|NCT00783692|583448390|FG003|Induction Phase|Lack of Efficacy|0|||
161562798|NCT00783692|583448391|FG004|Induction Phase|Lack of Efficacy|0|||
161562799|NCT00783692|583448392|FG005|Induction Phase|Lack of Efficacy|0|||
161562800|NCT00783692|583448393|FG006|Induction Phase|Lack of Efficacy|0|||
161562801|NCT00783692|583448387|FG000|Induction Phase|Withdrawal by Subject|3|||
161562802|NCT00783692|583448388|FG001|Induction Phase|Withdrawal by Subject|9|||
161562803|NCT00783692|583448389|FG002|Induction Phase|Withdrawal by Subject|16|||
161562804|NCT00783692|583448390|FG003|Induction Phase|Withdrawal by Subject|0|||
161562805|NCT00783692|583448391|FG004|Induction Phase|Withdrawal by Subject|0|||
161562806|NCT00783692|583448392|FG005|Induction Phase|Withdrawal by Subject|0|||
161562807|NCT00783692|583448393|FG006|Induction Phase|Withdrawal by Subject|0|||
161562808|NCT00783692|583448387|FG000|Induction Phase|Lost to Follow-up|0|||
161562809|NCT00783692|583448388|FG001|Induction Phase|Lost to Follow-up|0|||
161562810|NCT00783692|583448389|FG002|Induction Phase|Lost to Follow-up|3|||
161562811|NCT00783692|583448390|FG003|Induction Phase|Lost to Follow-up|0|||
161562812|NCT00783692|583448391|FG004|Induction Phase|Lost to Follow-up|0|||
161562813|NCT00783692|583448392|FG005|Induction Phase|Lost to Follow-up|0|||
161562814|NCT00783692|583448393|FG006|Induction Phase|Lost to Follow-up|0|||
161562815|NCT00783692|583448387|FG000|Induction Phase|Other|0|||
161562816|NCT00783692|583448388|FG001|Induction Phase|Other|0|||
161562817|NCT00783692|583448389|FG002|Induction Phase|Other|2|||
161562818|NCT00783692|583448390|FG003|Induction Phase|Other|0|||
161562819|NCT00783692|583448391|FG004|Induction Phase|Other|0|||
161562820|NCT00783692|583448392|FG005|Induction Phase|Other|0|||
161562821|NCT00783692|583448393|FG006|Induction Phase|Other|0|||
161562822|NCT00783692|583448387|FG000|Maintenance Phase|Adverse Event|7|||
161562823|NCT00783692|583448388|FG001|Maintenance Phase|Adverse Event|0|||
161562824|NCT00783692|583448389|FG002|Maintenance Phase|Adverse Event|0|||
161807122|NCT00626548|584337793|FG001|Overall Study|Adverse Event|44|||
161807123|NCT00626548|584337792|FG000|Overall Study|Withdrawal by Subject|42|||
161807124|NCT00626548|584337793|FG001|Overall Study|Withdrawal by Subject|46|||
161807125|NCT00626548|584337792|FG000|Overall Study|Protocol Violation|4|||
161807126|NCT00626548|584337793|FG001|Overall Study|Protocol Violation|11|||
161807127|NCT00626548|584337792|FG000|Overall Study|Lost to Follow-up|2|||
161807128|NCT00626548|584337793|FG001|Overall Study|Lost to Follow-up|2|||
161807129|NCT00626548|584337792|FG000|Overall Study|Other termination reason|493|||
161807130|NCT00626548|584337793|FG001|Overall Study|Other termination reason|613|||
161807131|NCT03555305|584337794|FG000|Period 1|Physician Decision|0|||
161807132|NCT03555305|584337795|FG001|Period 1|Physician Decision|1|||
161807133|NCT03555305|584337794|FG000|Period 1|Adverse Event|0|||
161807134|NCT03555305|584337795|FG001|Period 1|Adverse Event|1|||
161807135|NCT03125200|584337796|FG000|Overall Study|Study Termination|0|||
161807136|NCT03125200|584337797|FG001|Overall Study|Study Termination|0|||
161807137|NCT03125200|584337798|FG002|Overall Study|Study Termination|0|||
161807138|NCT03125200|584337799|FG003|Overall Study|Study Termination|1|||
161453938|NCT01008423|583055468|FG001|Overall Study|Lack of Efficacy|5|||
161453939|NCT01008423|583055467|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
161453940|NCT01008423|583055468|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
161453941|NCT01008423|583055467|FG000|Overall Study|Personal Conflict|1|||
161453942|NCT01008423|583055468|FG001|Overall Study|Personal Conflict|0|||
161453943|NCT01008423|583055467|FG000|Overall Study|Other|0|||
161453944|NCT01008423|583055468|FG001|Overall Study|Other|1|||
161453945|NCT01181986|583055472|FG000|Phase 1|Lost to Follow-up|0|||
161453946|NCT01181986|583055473|FG001|Phase 1|Lost to Follow-up|1|||
161453947|NCT01181986|583055474|FG002|Phase 1|Lost to Follow-up|1|||
161453948|NCT01181986|583055472|FG000|Phase 1|Adverse Event|0|||
161453949|NCT01181986|583055473|FG001|Phase 1|Adverse Event|0|||
161453950|NCT01181986|583055474|FG002|Phase 1|Adverse Event|1|||
161453951|NCT01181986|583055472|FG000|Phase 1|Protocol Violation|1|||
161453952|NCT01181986|583055473|FG001|Phase 1|Protocol Violation|0|||
161453953|NCT01181986|583055474|FG002|Phase 1|Protocol Violation|0|||
161453954|NCT01181986|583055472|FG000|Phase 2|Adverse Event|0|||
161562825|NCT00783692|583448390|FG003|Maintenance Phase|Adverse Event|15|||
161562826|NCT00783692|583448391|FG004|Maintenance Phase|Adverse Event|12|||
161562827|NCT00783692|583448392|FG005|Maintenance Phase|Adverse Event|9|||
161562828|NCT00783692|583448393|FG006|Maintenance Phase|Adverse Event|38|||
161562829|NCT00783692|583448387|FG000|Maintenance Phase|Protocol Violation|0|||
161807139|NCT03125200|584337800|FG004|Overall Study|Study Termination|1|||
161807140|NCT03125200|584337801|FG005|Overall Study|Study Termination|2|||
161807141|NCT03125200|584337802|FG006|Overall Study|Study Termination|1|||
161807142|NCT03125200|584337796|FG000|Overall Study|Clinical Progression|0|||
161562830|NCT00783692|583448388|FG001|Maintenance Phase|Protocol Violation|0|||
161562831|NCT00783692|583448389|FG002|Maintenance Phase|Protocol Violation|0|||
161562832|NCT00783692|583448390|FG003|Maintenance Phase|Protocol Violation|1|||
161562833|NCT00783692|583448391|FG004|Maintenance Phase|Protocol Violation|2|||
161562834|NCT00783692|583448392|FG005|Maintenance Phase|Protocol Violation|3|||
161562835|NCT00783692|583448393|FG006|Maintenance Phase|Protocol Violation|4|||
161562836|NCT00783692|583448387|FG000|Maintenance Phase|Lack of Efficacy|79|||
161453955|NCT01181986|583055473|FG001|Phase 2|Adverse Event|3|||
161453956|NCT01181986|583055474|FG002|Phase 2|Adverse Event|0|||
161453957|NCT01181986|583055472|FG000|Phase 2|Medical condition|0|||
161453958|NCT01181986|583055473|FG001|Phase 2|Medical condition|1|||
161453959|NCT01181986|583055474|FG002|Phase 2|Medical condition|0|||
161453960|NCT00831493|583055475|FG000|Overall Study|Intractable nausea and vomiting|1|||
161453961|NCT00835731|583055476|FG000|Overall Study|Withdrawal by Subject|1|||
161453962|NCT00835731|583055477|FG001|Overall Study|Withdrawal by Subject|0|||
161453963|NCT00835731|583055476|FG000|Overall Study|Physician Decision|1|||
161562837|NCT00783692|583448388|FG001|Maintenance Phase|Lack of Efficacy|0|||
161562838|NCT00783692|583448389|FG002|Maintenance Phase|Lack of Efficacy|0|||
161562839|NCT00783692|583448390|FG003|Maintenance Phase|Lack of Efficacy|64|||
161562840|NCT00783692|583448391|FG004|Maintenance Phase|Lack of Efficacy|58|||
161562841|NCT00783692|583448392|FG005|Maintenance Phase|Lack of Efficacy|48|||
161562842|NCT00783692|583448393|FG006|Maintenance Phase|Lack of Efficacy|177|||
161562843|NCT00783692|583448387|FG000|Maintenance Phase|Withdrawal by Subject|7|||
161562844|NCT00783692|583448388|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161562845|NCT00783692|583448389|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161562846|NCT00783692|583448390|FG003|Maintenance Phase|Withdrawal by Subject|7|||
161562847|NCT00783692|583448391|FG004|Maintenance Phase|Withdrawal by Subject|6|||
161562848|NCT00783692|583448392|FG005|Maintenance Phase|Withdrawal by Subject|9|||
161562849|NCT00783692|583448393|FG006|Maintenance Phase|Withdrawal by Subject|24|||
161562850|NCT00783692|583448387|FG000|Maintenance Phase|Lost to Follow-up|2|||
161562851|NCT00783692|583448388|FG001|Maintenance Phase|Lost to Follow-up|0|||
161562852|NCT00783692|583448389|FG002|Maintenance Phase|Lost to Follow-up|0|||
161562853|NCT00783692|583448390|FG003|Maintenance Phase|Lost to Follow-up|1|||
161562854|NCT00783692|583448391|FG004|Maintenance Phase|Lost to Follow-up|3|||
161562855|NCT00783692|583448392|FG005|Maintenance Phase|Lost to Follow-up|2|||
161562856|NCT00783692|583448393|FG006|Maintenance Phase|Lost to Follow-up|5|||
161562857|NCT00783692|583448387|FG000|Maintenance Phase|Other|0|||
161562858|NCT00783692|583448388|FG001|Maintenance Phase|Other|0|||
161562859|NCT00783692|583448389|FG002|Maintenance Phase|Other|0|||
161562860|NCT00783692|583448390|FG003|Maintenance Phase|Other|1|||
161562861|NCT00783692|583448391|FG004|Maintenance Phase|Other|0|||
161562862|NCT00783692|583448392|FG005|Maintenance Phase|Other|1|||
161562863|NCT00783692|583448393|FG006|Maintenance Phase|Other|1|||
161562864|NCT04438785|583448401|FG000|Overall Study|change of weight, give up intervention|2|||
161562865|NCT04438785|583448402|FG001|Overall Study|change of weight, give up intervention|10|||
161562866|NCT04831775|583448403|FG000|Overall Study|Lost to Follow-up|11|||
161562867|NCT04831775|583448404|FG001|Overall Study|Lost to Follow-up|13|||
161562868|NCT02027935|583448405|FG000|Overall Study|Death|1|||
161562869|NCT02027935|583448405|FG000|Overall Study|Lack of Efficacy|5|||
161562870|NCT02027935|583448405|FG000|Overall Study|Study Closure|1|||
161562871|NCT03115346|583448406|FG000|Overall Study|Did not have AAA surgery|28|||
161562872|NCT03115346|583448407|FG001|Overall Study|Did not have AAA surgery|15|||
161562873|NCT03115346|583448406|FG000|Overall Study|Death|3|||
161562874|NCT03115346|583448407|FG001|Overall Study|Death|1|||
161562875|NCT03115346|583448406|FG000|Overall Study|Withdrawal by Subject|0|||
161562876|NCT03115346|583448407|FG001|Overall Study|Withdrawal by Subject|3|||
161562877|NCT03115346|583448406|FG000|Overall Study|Lost to Follow-up|0|||
161562878|NCT03115346|583448407|FG001|Overall Study|Lost to Follow-up|3|||
161562879|NCT00689104|583448408|FG000|Overall Study|Eligibility criterion not met|5|||
161562880|NCT00689104|583448409|FG001|Overall Study|Eligibility criterion not met|8|||
161562881|NCT00689104|583448410|FG002|Overall Study|Eligibility criterion not met|0|||
161562882|NCT00689104|583448411|FG003|Overall Study|Eligibility criterion not met|4|||
161562883|NCT00689104|583448408|FG000|Overall Study|Adverse Event|13|||
161562884|NCT00689104|583448409|FG001|Overall Study|Adverse Event|25|||
161562885|NCT00689104|583448410|FG002|Overall Study|Adverse Event|16|||
161562886|NCT00689104|583448411|FG003|Overall Study|Adverse Event|24|||
161562887|NCT00689104|583448408|FG000|Overall Study|Lack of Efficacy|5|||
161562888|NCT00689104|583448409|FG001|Overall Study|Lack of Efficacy|6|||
161562889|NCT00689104|583448410|FG002|Overall Study|Lack of Efficacy|2|||
161562890|NCT00689104|583448411|FG003|Overall Study|Lack of Efficacy|3|||
161562891|NCT00689104|583448408|FG000|Overall Study|Withdrawal by Subject|12|||
161562892|NCT00689104|583448409|FG001|Overall Study|Withdrawal by Subject|11|||
161562893|NCT00689104|583448410|FG002|Overall Study|Withdrawal by Subject|18|||
161562894|NCT00689104|583448411|FG003|Overall Study|Withdrawal by Subject|11|||
161453964|NCT00835731|583055477|FG001|Overall Study|Physician Decision|1|||
161453965|NCT00348881|583055478|FG000|Overall Study|Lost to Follow-up|12|||
161562895|NCT00689104|583448408|FG000|Overall Study|Lost to Follow-up|4|||
161562896|NCT00689104|583448409|FG001|Overall Study|Lost to Follow-up|3|||
161807143|NCT03125200|584337797|FG001|Overall Study|Clinical Progression|0|||
161807144|NCT03125200|584337798|FG002|Overall Study|Clinical Progression|0|||
161807145|NCT03125200|584337799|FG003|Overall Study|Clinical Progression|1|||
161807146|NCT03125200|584337800|FG004|Overall Study|Clinical Progression|0|||
161807147|NCT03125200|584337801|FG005|Overall Study|Clinical Progression|1|||
161807148|NCT03125200|584337802|FG006|Overall Study|Clinical Progression|0|||
161807149|NCT03125200|584337796|FG000|Overall Study|Progressive Disease|2|||
161807150|NCT03125200|584337797|FG001|Overall Study|Progressive Disease|1|||
161807151|NCT03125200|584337798|FG002|Overall Study|Progressive Disease|2|||
161807152|NCT03125200|584337799|FG003|Overall Study|Progressive Disease|1|||
161910691|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
161910692|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
161910693|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
161910694|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
161453966|NCT00348881|583055479|FG001|Overall Study|Lost to Follow-up|6|||
161807153|NCT03125200|584337800|FG004|Overall Study|Progressive Disease|2|||
161807154|NCT03125200|584337801|FG005|Overall Study|Progressive Disease|0|||
161807155|NCT03125200|584337802|FG006|Overall Study|Progressive Disease|1|||
161807156|NCT03125200|584337796|FG000|Overall Study|Lack of Efficacy|0|||
161807157|NCT03125200|584337797|FG001|Overall Study|Lack of Efficacy|0|||
161807158|NCT03125200|584337798|FG002|Overall Study|Lack of Efficacy|0|||
161807159|NCT03125200|584337799|FG003|Overall Study|Lack of Efficacy|1|||
161807160|NCT03125200|584337800|FG004|Overall Study|Lack of Efficacy|0|||
161807161|NCT03125200|584337801|FG005|Overall Study|Lack of Efficacy|0|||
161807162|NCT03125200|584337802|FG006|Overall Study|Lack of Efficacy|0|||
161807163|NCT03125200|584337796|FG000|Overall Study|Toxicity|0|||
161807164|NCT03125200|584337797|FG001|Overall Study|Toxicity|0|||
161807165|NCT03125200|584337798|FG002|Overall Study|Toxicity|0|||
161807166|NCT03125200|584337799|FG003|Overall Study|Toxicity|1|||
161807167|NCT03125200|584337800|FG004|Overall Study|Toxicity|0|||
161807168|NCT03125200|584337801|FG005|Overall Study|Toxicity|0|||
161807169|NCT03125200|584337802|FG006|Overall Study|Toxicity|0|||
161807170|NCT03125200|584337796|FG000|Overall Study|Consent Withdrawn by Subject|0|||
161807171|NCT03125200|584337797|FG001|Overall Study|Consent Withdrawn by Subject|1|||
161807172|NCT03125200|584337798|FG002|Overall Study|Consent Withdrawn by Subject|0|||
161807173|NCT03125200|584337799|FG003|Overall Study|Consent Withdrawn by Subject|0|||
161807174|NCT03125200|584337800|FG004|Overall Study|Consent Withdrawn by Subject|1|||
161807175|NCT03125200|584337801|FG005|Overall Study|Consent Withdrawn by Subject|0|||
161807176|NCT03125200|584337802|FG006|Overall Study|Consent Withdrawn by Subject|1|||
161807177|NCT01811953|584339650|FG000|Overall Study|Adverse Event|0|||
161807178|NCT01811953|584339651|FG001|Overall Study|Adverse Event|0|||
161807179|NCT01811953|584339652|FG002|Overall Study|Adverse Event|0|||
161807180|NCT01811953|584339653|FG003|Overall Study|Adverse Event|1|||
161453967|NCT00348881|583055478|FG000|Overall Study|Withdrawal by Subject|3|||
161453968|NCT00348881|583055479|FG001|Overall Study|Withdrawal by Subject|4|||
161453969|NCT00348881|583055478|FG000|Overall Study|Adverse Event|2|||
161453970|NCT00348881|583055479|FG001|Overall Study|Adverse Event|0|||
161453971|NCT00348881|583055478|FG000|Overall Study|Serious Adverse Event|0|||
161453972|NCT00348881|583055479|FG001|Overall Study|Serious Adverse Event|2|||
161453973|NCT05092360|583055485|FG000|Overall Study|Withdrawal by Subject|21|||
161453974|NCT05092360|583055486|FG001|Overall Study|Withdrawal by Subject|4|||
161453975|NCT05092360|583055487|FG002|Overall Study|Withdrawal by Subject|9|||
161453976|NCT05092360|583055488|FG003|Overall Study|Withdrawal by Subject|26|||
161453977|NCT05092360|583055485|FG000|Overall Study|Death|97|||
161453978|NCT05092360|583055486|FG001|Overall Study|Death|14|||
161453979|NCT05092360|583055487|FG002|Overall Study|Death|31|||
161453980|NCT05092360|583055488|FG003|Overall Study|Death|101|||
161453981|NCT05092360|583055485|FG000|Overall Study|Lost to Follow-up|1|||
161453982|NCT05092360|583055486|FG001|Overall Study|Lost to Follow-up|2|||
161453983|NCT05092360|583055487|FG002|Overall Study|Lost to Follow-up|2|||
161453984|NCT05092360|583055488|FG003|Overall Study|Lost to Follow-up|2|||
161807181|NCT01811953|584339654|FG004|Overall Study|Adverse Event|0|||
161807182|NCT01811953|584339655|FG005|Overall Study|Adverse Event|1|||
161807183|NCT01811953|584339650|FG000|Overall Study|Protocol Violation|0|||
161807184|NCT01811953|584339651|FG001|Overall Study|Protocol Violation|0|||
161807185|NCT01811953|584339652|FG002|Overall Study|Protocol Violation|0|||
161807186|NCT01811953|584339653|FG003|Overall Study|Protocol Violation|0|||
161807187|NCT01811953|584339654|FG004|Overall Study|Protocol Violation|1|||
161453985|NCT05092360|583055485|FG000|Overall Study|Study terminated by sponsor|65|||
161453986|NCT05092360|583055486|FG001|Overall Study|Study terminated by sponsor|7|||
161807188|NCT01811953|584339655|FG005|Overall Study|Protocol Violation|0|||
161807189|NCT03785548|584339656|FG000|Overall Study|age > 80|1|||
161807190|NCT03785548|584339657|FG001|Overall Study|age > 80|0|||
161807191|NCT03785548|584339656|FG000|Overall Study|no Postop queries|1|||
161807192|NCT03785548|584339657|FG001|Overall Study|no Postop queries|0|||
161807193|NCT00396279|584339660|FG000|Overall Study|Ongoing in study|26|||
161807194|NCT00396279|584339660|FG000|Overall Study|Disease progression|2|||
161807195|NCT00396279|584339660|FG000|Overall Study|Withdrawal by Subject|1|||
161562897|NCT00689104|583448410|FG002|Overall Study|Lost to Follow-up|2|||
161562898|NCT00689104|583448411|FG003|Overall Study|Lost to Follow-up|5|||
161562899|NCT00689104|583448408|FG000|Overall Study|Protocol Violation|2|||
161562900|NCT00689104|583448409|FG001|Overall Study|Protocol Violation|3|||
161562901|NCT00689104|583448410|FG002|Overall Study|Protocol Violation|5|||
161562902|NCT00689104|583448411|FG003|Overall Study|Protocol Violation|3|||
161562903|NCT00689104|583448408|FG000|Overall Study|Randomized but never received study drug|2|||
161562904|NCT00689104|583448409|FG001|Overall Study|Randomized but never received study drug|1|||
161562905|NCT00689104|583448410|FG002|Overall Study|Randomized but never received study drug|1|||
161562906|NCT00689104|583448411|FG003|Overall Study|Randomized but never received study drug|0|||
161562907|NCT00689104|583448408|FG000|Overall Study|Physician Decision|1|||
161562908|NCT00689104|583448409|FG001|Overall Study|Physician Decision|0|||
161562909|NCT00689104|583448410|FG002|Overall Study|Physician Decision|0|||
161562910|NCT00689104|583448411|FG003|Overall Study|Physician Decision|0|||
161807196|NCT00396279|584339660|FG000|Overall Study|Physician Decision|1|||
161807197|NCT01882257|584339669|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
161562911|NCT00689104|583448408|FG000|Overall Study|Non-compliance with study procedures|0|||
161562912|NCT00689104|583448409|FG001|Overall Study|Non-compliance with study procedures|0|||
161562913|NCT00689104|583448410|FG002|Overall Study|Non-compliance with study procedures|1|||
161562914|NCT00689104|583448411|FG003|Overall Study|Non-compliance with study procedures|0|||
161562915|NCT01737268|583448412|FG000|Overall Study|Adverse Event|6|||
161562916|NCT01737268|583448412|FG000|Overall Study|Worsening of Target Disease|2|||
161562917|NCT01737268|583448412|FG000|Overall Study|In consideration of the patient's safety|1|||
161562918|NCT04873817|583448413|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
161562919|NCT04873817|583448413|FG000|Overall Study|Lost to Follow-up|4|||
161562920|NCT04873817|583448413|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
161562921|NCT04873817|583448413|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
161562922|NCT04873817|583448413|FG000|Overall Study|Other Reasons|3|||
161562923|NCT02696226|583448421|FG000|Overall Study|Study terminated - lack of enrollment|1|||
161562924|NCT02696226|583448422|FG001|Overall Study|Study terminated - lack of enrollment|0|||
161562925|NCT02696226|583448423|FG002|Overall Study|Study terminated - lack of enrollment|2|||
161562926|NCT02696226|583448424|FG003|Overall Study|Study terminated - lack of enrollment|0|||
161562927|NCT01394991|583448427|FG000|Overall Study|Adverse Event|0|||
161562928|NCT01394991|583448428|FG001|Overall Study|Adverse Event|4|||
161562929|NCT01394991|583448427|FG000|Overall Study|Lack of Efficacy|5|||
161562930|NCT01394991|583448428|FG001|Overall Study|Lack of Efficacy|7|||
161562931|NCT01394991|583448427|FG000|Overall Study|Lost to Follow-up|6|||
161562932|NCT01394991|583448428|FG001|Overall Study|Lost to Follow-up|8|||
161562933|NCT01394991|583448427|FG000|Overall Study|Physician Decision|1|||
161562934|NCT01394991|583448428|FG001|Overall Study|Physician Decision|3|||
161562935|NCT01394991|583448427|FG000|Overall Study|Protocol Violation|1|||
161562936|NCT01394991|583448428|FG001|Overall Study|Protocol Violation|1|||
161562937|NCT01394991|583448427|FG000|Overall Study|Withdrawal by Subject|20|||
161562938|NCT01394991|583448428|FG001|Overall Study|Withdrawal by Subject|17|||
161562939|NCT01394991|583448427|FG000|Overall Study|Chemotherapy Termination|10|||
161562940|NCT01394991|583448428|FG001|Overall Study|Chemotherapy Termination|15|||
161562941|NCT01394991|583448427|FG000|Overall Study|Disease Progression|7|||
161562942|NCT01394991|583448428|FG001|Overall Study|Disease Progression|7|||
161562943|NCT01394991|583448427|FG000|Overall Study|Prematurely Termination of Trial|9|||
161562944|NCT01394991|583448428|FG001|Overall Study|Prematurely Termination of Trial|10|||
161562945|NCT02337361|583448429|FG000|3-month Follow-up|Lost to Follow-up|19|||
161807198|NCT01882257|584339670|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
161562946|NCT02337361|583448430|FG001|3-month Follow-up|Lost to Follow-up|14|||
161562947|NCT02337361|583448429|FG000|6-month Follow-up|Lost to Follow-up|2|||
161562948|NCT02337361|583448430|FG001|6-month Follow-up|Lost to Follow-up|4|||
161562949|NCT03073005|583448431|FG000|Overall Study|Death|6|||
161562950|NCT03073005|583448432|FG001|Overall Study|Death|0|||
161562951|NCT03073005|583448433|FG002|Overall Study|Death|7|||
161562952|NCT03073005|583448434|FG003|Overall Study|Death|0|||
161562953|NCT03073005|583448431|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
161562954|NCT03073005|583448432|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
161562955|NCT03073005|583448433|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
161562956|NCT03073005|583448434|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
161562957|NCT03073005|583448431|FG000|Overall Study|Lost to Follow-up|2|||
161562958|NCT03073005|583448432|FG001|Overall Study|Lost to Follow-up|2|||
161562959|NCT03073005|583448433|FG002|Overall Study|Lost to Follow-up|1|||
161562960|NCT03073005|583448434|FG003|Overall Study|Lost to Follow-up|2|||
161562961|NCT03073005|583448431|FG000|Overall Study|Withdrawal by Subject|0|||
161562962|NCT03073005|583448432|FG001|Overall Study|Withdrawal by Subject|4|||
161807199|NCT01882257|584339671|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
161562963|NCT03073005|583448433|FG002|Overall Study|Withdrawal by Subject|4|||
161562964|NCT03073005|583448434|FG003|Overall Study|Withdrawal by Subject|4|||
161562965|NCT01734811|583448442|FG000|Overall Study|Lost to Follow-up|2|||
161562966|NCT01734811|583448443|FG001|Overall Study|Lost to Follow-up|3|||
161807200|NCT01882257|584339669|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
161453987|NCT05092360|583055487|FG002|Overall Study|Study terminated by sponsor|13|||
161453988|NCT05092360|583055488|FG003|Overall Study|Study terminated by sponsor|61|||
161453989|NCT01675167|583055489|FG000|Open-label Titration Phase|Adverse Event|81|||
161453990|NCT01675167|583055490|FG001|Open-label Titration Phase|Adverse Event|0|||
161453991|NCT01675167|583055491|FG002|Open-label Titration Phase|Adverse Event|0|||
161453992|NCT01675167|583055489|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
161453993|NCT01675167|583055490|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
161453994|NCT01675167|583055491|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
161453995|NCT01675167|583055489|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
161453996|NCT01675167|583055490|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
161453997|NCT01675167|583055491|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
161453998|NCT01675167|583055489|FG000|Open-label Titration Phase|Protocol Violation|43|||
161453999|NCT01675167|583055490|FG001|Open-label Titration Phase|Protocol Violation|0|||
161454000|NCT01675167|583055491|FG002|Open-label Titration Phase|Protocol Violation|0|||
161454001|NCT01675167|583055489|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
161454002|NCT01675167|583055490|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
161454003|NCT01675167|583055491|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
161454004|NCT01675167|583055489|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
161454005|NCT01675167|583055490|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
161454006|NCT01675167|583055491|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
161454007|NCT01675167|583055489|FG000|Open-label Titration Phase|Other|55|||
161454008|NCT01675167|583055490|FG001|Open-label Titration Phase|Other|0|||
161454009|NCT01675167|583055491|FG002|Open-label Titration Phase|Other|0|||
161454010|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
161454011|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
161454012|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
161454013|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161454014|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
161454015|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
161454016|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161454017|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Adverse Event|5|||
161454018|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Adverse Event|13|||
161454019|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
161454020|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
161454021|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
161454022|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161454023|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161454024|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
161454025|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
161454026|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
161454027|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
161454028|NCT01675167|583055489|FG000|Double-blind Treatment Phase|Other|0|||
161454029|NCT01675167|583055490|FG001|Double-blind Treatment Phase|Other|7|||
161454030|NCT01675167|583055491|FG002|Double-blind Treatment Phase|Other|5|||
161454031|NCT04531462|583056503|FG000|Overall Study|Withdrawal by Subject|3|||
161454032|NCT04531462|583056504|FG001|Overall Study|Withdrawal by Subject|1|||
161454033|NCT04531462|583056503|FG000|Overall Study|Adverse Event|3|||
161454034|NCT04531462|583056504|FG001|Overall Study|Adverse Event|3|||
161454035|NCT00504582|583056505|FG000|Overall Study|Lost to Follow-up|1|||
161454036|NCT00504582|583056506|FG001|Overall Study|Lost to Follow-up|0|||
161454037|NCT00504582|583056507|FG002|Overall Study|Lost to Follow-up|0|||
161454038|NCT01264081|583056510|FG000|Participants Screened|Screening failures|30|||
161454039|NCT01264081|583056510|FG000|Started Treatment|Withdrawal by Subject|1|||
161454040|NCT01264081|583056510|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
161454041|NCT02716896|583056511|FG000|Overall Study|Physician Decision|0|||
161454042|NCT02716896|583056512|FG001|Overall Study|Physician Decision|1|||
161454043|NCT01727700|583056513|FG000|Overall Study|Adverse Event|0|||
161454044|NCT01727700|583056514|FG001|Overall Study|Adverse Event|7|||
161454045|NCT01727700|583056515|FG002|Overall Study|Adverse Event|1|||
161454046|NCT01727700|583056513|FG000|Overall Study|Particpant withdrew consent|0|||
161454047|NCT01727700|583056514|FG001|Overall Study|Particpant withdrew consent|3|||
161454048|NCT01727700|583056515|FG002|Overall Study|Particpant withdrew consent|1|||
161454049|NCT01727700|583056513|FG000|Overall Study|Protocol Violation|2|||
161454050|NCT01727700|583056514|FG001|Overall Study|Protocol Violation|0|||
161454051|NCT01727700|583056515|FG002|Overall Study|Protocol Violation|0|||
161454052|NCT04391049|583056519|FG000|Overall Study|Protocol Violation|1|||
161454053|NCT01242813|583056520|FG000|Overall Study|Lost to Follow-up|2|||
161454054|NCT00958438|583056522|FG000|Overall Study|Protocol Violation|3|||
161454055|NCT00958438|583056523|FG001|Overall Study|Protocol Violation|2|||
161454056|NCT00958438|583056524|FG002|Overall Study|Protocol Violation|2|||
161454057|NCT00958438|583056522|FG000|Overall Study|Withdrawal by Subject|4|||
161454058|NCT00958438|583056523|FG001|Overall Study|Withdrawal by Subject|2|||
161454059|NCT00958438|583056524|FG002|Overall Study|Withdrawal by Subject|1|||
161454060|NCT00958438|583056522|FG000|Overall Study|Adverse Event|0|||
161454061|NCT00958438|583056523|FG001|Overall Study|Adverse Event|3|||
161454062|NCT00958438|583056524|FG002|Overall Study|Adverse Event|0|||
161454063|NCT00958438|583056522|FG000|Overall Study|Physician Decision|1|||
161454064|NCT00958438|583056523|FG001|Overall Study|Physician Decision|0|||
161454065|NCT00958438|583056524|FG002|Overall Study|Physician Decision|1|||
161454066|NCT00958438|583056522|FG000|Overall Study|Other than specified above|2|||
161454067|NCT00958438|583056523|FG001|Overall Study|Other than specified above|3|||
161454068|NCT00958438|583056524|FG002|Overall Study|Other than specified above|2|||
161454069|NCT02788279|583056525|FG000|Overall Study|Death|62|||
161454070|NCT02788279|583056526|FG001|Overall Study|Death|136|||
161454071|NCT02788279|583056527|FG002|Overall Study|Death|72|||
161454072|NCT02788279|583056525|FG000|Overall Study|Withdrawal by Subject|10|||
161454073|NCT02788279|583056526|FG001|Overall Study|Withdrawal by Subject|15|||
161454074|NCT02788279|583056527|FG002|Overall Study|Withdrawal by Subject|5|||
161454075|NCT02788279|583056525|FG000|Overall Study|Lost to Follow-up|0|||
161454076|NCT02788279|583056526|FG001|Overall Study|Lost to Follow-up|3|||
161454077|NCT02788279|583056527|FG002|Overall Study|Lost to Follow-up|2|||
161454078|NCT02788279|583056525|FG000|Overall Study|Sponsor decision|18|||
161454079|NCT02788279|583056526|FG001|Overall Study|Sponsor decision|29|||
161454080|NCT02788279|583056527|FG002|Overall Study|Sponsor decision|11|||
161454081|NCT00329849|583056529|FG000|Overall Study|Withdrawal by Subject|6|||
161454082|NCT00329849|583056530|FG001|Overall Study|Withdrawal by Subject|4|||
161454083|NCT01133990|583056535|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
161454084|NCT01133990|583056536|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161454085|NCT01133990|583056537|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161454086|NCT01133990|583056538|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161454087|NCT01133990|583056539|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161454088|NCT01133990|583056540|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161454089|NCT01133990|583056535|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
161454090|NCT01133990|583056536|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
161454091|NCT01133990|583056537|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
161454092|NCT01133990|583056538|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
161454093|NCT01133990|583056539|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
161454094|NCT01133990|583056540|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
161454095|NCT01133990|583056535|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
161454096|NCT01133990|583056536|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161454097|NCT01133990|583056537|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161454098|NCT01133990|583056538|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161454099|NCT01133990|583056539|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161454100|NCT01133990|583056540|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161454101|NCT01133990|583056535|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
161454102|NCT01133990|583056536|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
161454103|NCT01133990|583056537|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
161454104|NCT01133990|583056538|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
161454105|NCT01133990|583056539|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
161454106|NCT01133990|583056540|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
161454107|NCT05277337|583056541|FG000|Overall Study|Lost to Follow-up|2|||
161454108|NCT05277337|583056542|FG001|Overall Study|Lost to Follow-up|0|||
161454109|NCT05277337|583056541|FG000|Overall Study|Withdrawal by Subject|1|||
161454110|NCT05277337|583056542|FG001|Overall Study|Withdrawal by Subject|0|||
161454111|NCT04987944|583056547|FG000|Overall Study|Adverse Event|0|||
161454112|NCT04987944|583056548|FG001|Overall Study|Adverse Event|1|||
161454113|NCT04987944|583056547|FG000|Overall Study|Withdrawal by Subject|0|||
161454114|NCT04987944|583056548|FG001|Overall Study|Withdrawal by Subject|1|||
161454115|NCT02946931|583056558|FG000|Overall Study|Did not require collection of CRFs|588|||
161454116|NCT02946931|583056558|FG000|Overall Study|Other than listed|37|||
161454117|NCT02946931|583056558|FG000|Overall Study|Discharge from hospital|118|||
161454118|NCT02946931|583056558|FG000|Overall Study|Adverse Event|81|||
161454119|NCT02946931|583056558|FG000|Overall Study|CRFs not valid|1|||
161454120|NCT02946931|583056558|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
161454121|NCT00869778|583056559|FG000|Overall Study|Adverse Event|2|||
161454122|NCT00869778|583056560|FG001|Overall Study|Adverse Event|0|||
161454123|NCT00869778|583056561|FG002|Overall Study|Adverse Event|0|||
161454124|NCT00869778|583056559|FG000|Overall Study|Withdrawal by Subject|3|||
161454125|NCT00869778|583056560|FG001|Overall Study|Withdrawal by Subject|4|||
161454126|NCT00869778|583056561|FG002|Overall Study|Withdrawal by Subject|5|||
161454127|NCT00869778|583056559|FG000|Overall Study|Pregnancy|1|||
161454128|NCT00869778|583056560|FG001|Overall Study|Pregnancy|0|||
161454129|NCT00869778|583056561|FG002|Overall Study|Pregnancy|0|||
161454130|NCT00869778|583056559|FG000|Overall Study|Protocol Violation|5|||
161807201|NCT01882257|584339670|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
161562967|NCT01734811|583448442|FG000|Overall Study|Withdrawal by Subject|2|||
161562968|NCT01734811|583448443|FG001|Overall Study|Withdrawal by Subject|0|||
161562969|NCT02427646|583448444|FG000|Overall Study|Lack of Efficacy|2|||
161562970|NCT02427646|583448445|FG001|Overall Study|Lack of Efficacy|3|||
161562971|NCT02427646|583448444|FG000|Overall Study|Physician Decision|1|||
161562972|NCT02427646|583448445|FG001|Overall Study|Physician Decision|4|||
161562973|NCT02427646|583448444|FG000|Overall Study|Protocol Violation|3|||
161562974|NCT02427646|583448445|FG001|Overall Study|Protocol Violation|3|||
161562975|NCT02427646|583448444|FG000|Overall Study|Bothersome hand weakness|2|||
161562976|NCT02427646|583448445|FG001|Overall Study|Bothersome hand weakness|4|||
161562977|NCT01101542|583448448|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
161562978|NCT01101542|583448448|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
161562979|NCT01101542|583448448|FG000|Year 4 Surveillance Period|Other|287|||
161562980|NCT01101542|583448448|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
161562981|NCT01101542|583448448|FG000|Year 5 Surveillance Period|Pregnancy|1|||
161562982|NCT01101542|583448448|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
161562983|NCT01101542|583448448|FG000|Year 6 Surveillance Period|Pregnancy|1|||
161562984|NCT01101542|583448448|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
161562985|NCT00701311|583448449|FG000|Overall Study|Lack of Efficacy|3|||
161562986|NCT00701311|583448449|FG000|Overall Study|Adverse Event|3|||
161562987|NCT00701311|583448449|FG000|Overall Study|Withdrawal by Subject|2|||
161562988|NCT04580407|583448450|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
161562989|NCT00814489|583448453|FG000|Overall Study|Other|2|||
161562990|NCT00814489|583448454|FG001|Overall Study|Other|0|||
161562991|NCT00814489|583448455|FG002|Overall Study|Other|1|||
161562992|NCT01712685|583448481|FG000|Overall Study|pt declined to participate before trmt|1|||
161562993|NCT02268396|583450153|FG000|Overall Study|Adverse Event|3|||
161562994|NCT02268396|583450153|FG000|Overall Study|Administrative|2|||
161562995|NCT02268396|583450153|FG000|Overall Study|Withdrawal by Subject|1|||
161562996|NCT02268396|583450153|FG000|Overall Study|Lost to Follow-up|2|||
161562997|NCT02268396|583450153|FG000|Overall Study|Protocol-Specified Criteria|2|||
161562998|NCT02268396|583450153|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
161562999|NCT01311648|583450154|FG000|Main Study|Protocol Violation|0|||
161563000|NCT01311648|583450155|FG001|Main Study|Protocol Violation|1|||
161563001|NCT01311648|583450154|FG000|Main Study|Adverse Event|0|||
161563002|NCT01311648|583450155|FG001|Main Study|Adverse Event|1|||
161563003|NCT01311648|583450154|FG000|Main Study|Inhibitor management|0|||
161563004|NCT01311648|583450155|FG001|Main Study|Inhibitor management|17|||
161563005|NCT01311648|583450154|FG000|Main Study|Withdrawal by Subject|0|||
161563006|NCT01311648|583450155|FG001|Main Study|Withdrawal by Subject|2|||
161563007|NCT01311648|583450154|FG000|Extension Study|Physician Decision|0|||
161563008|NCT01311648|583450155|FG001|Extension Study|Physician Decision|1|||
161563009|NCT01311648|583450154|FG000|Extension Study|ITI therapy with marketed product|0|||
161563010|NCT01311648|583450155|FG001|Extension Study|ITI therapy with marketed product|1|||
161563011|NCT01311648|583450154|FG000|Extension Study|Incorrect visit planning|0|||
161563012|NCT01311648|583450155|FG001|Extension Study|Incorrect visit planning|1|||
161563013|NCT01311648|583450154|FG000|Extension Study|Family's decision|0|||
161807202|NCT01882257|584339671|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
161807203|NCT00830206|584339672|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161807204|NCT00830206|584339673|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
161807205|NCT00905346|584339675|FG000|Period 1|Withdrawal by Subject|1|||
161807206|NCT00905346|584339676|FG001|Period 1|Withdrawal by Subject|0|||
161807207|NCT03351335|584339677|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
161807208|NCT03351335|584339678|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
161807209|NCT03351335|584339679|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
161807210|NCT04089735|584339684|FG000|Overall Study|Adverse Event|1|||
161807211|NCT04089735|584339685|FG001|Overall Study|Adverse Event|0|||
161807212|NCT04089735|584339686|FG002|Overall Study|Adverse Event|1|||
161807213|NCT04089735|584339687|FG003|Overall Study|Adverse Event|1|||
161910695|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
161910696|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
161563014|NCT01311648|583450155|FG001|Extension Study|Family's decision|1|||
161563015|NCT01311648|583450154|FG000|Extension Study|Failure of ITI therapy|0|||
161563016|NCT01311648|583450155|FG001|Extension Study|Failure of ITI therapy|3|||
161563017|NCT01311648|583450154|FG000|Extension Study|Long travel|0|||
161563018|NCT01311648|583450155|FG001|Extension Study|Long travel|1|||
161563019|NCT01311648|583450154|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
161563020|NCT01311648|583450155|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
161563021|NCT01311648|583450154|FG000|Extension Study|Withdrawal by Subject|0|||
161563022|NCT01311648|583450155|FG001|Extension Study|Withdrawal by Subject|1|||
161563023|NCT01311648|583450154|FG000|Extension Study|Inhibitor management|0|||
161807214|NCT04089735|584339688|FG004|Overall Study|Adverse Event|0|||
161807215|NCT04089735|584339689|FG005|Overall Study|Adverse Event|0|||
161807216|NCT04089735|584339684|FG000|Overall Study|Physician Decision|0|||
161807217|NCT04089735|584339685|FG001|Overall Study|Physician Decision|3|||
161454131|NCT00869778|583056560|FG001|Overall Study|Protocol Violation|3|||
161454132|NCT00869778|583056561|FG002|Overall Study|Protocol Violation|5|||
161454133|NCT00869778|583056559|FG000|Overall Study|Unblinding|1|||
161454134|NCT00869778|583056560|FG001|Overall Study|Unblinding|0|||
161454135|NCT00869778|583056561|FG002|Overall Study|Unblinding|0|||
161454136|NCT03339297|583056562|FG000|Overall Study|Relapse of Hematologic Disease|1|||
161454137|NCT03339297|583056563|FG001|Overall Study|Relapse of Hematologic Disease|0|||
161454138|NCT03339297|583056562|FG000|Overall Study|Death|10|||
161454139|NCT03339297|583056563|FG001|Overall Study|Death|7|||
161454140|NCT03339297|583056562|FG000|Overall Study|Hepatic Candidosis|1|||
161454141|NCT03339297|583056563|FG001|Overall Study|Hepatic Candidosis|0|||
161454142|NCT03339297|583056562|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
161454143|NCT03339297|583056563|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
161454144|NCT03339297|583056562|FG000|Overall Study|Consent Withdrawn by Participant|3|||
161454145|NCT03339297|583056563|FG001|Overall Study|Consent Withdrawn by Participant|3|||
161454146|NCT03339297|583056562|FG000|Overall Study|Disease Relapse|2|||
161454147|NCT03339297|583056563|FG001|Overall Study|Disease Relapse|0|||
161454148|NCT03339297|583056562|FG000|Overall Study|Physician Decision|1|||
161454149|NCT03339297|583056563|FG001|Overall Study|Physician Decision|1|||
161454150|NCT03339297|583056562|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
161454151|NCT03339297|583056563|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
161454152|NCT03339297|583056562|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
161454153|NCT03339297|583056563|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
161454154|NCT03339297|583056562|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
161454155|NCT03339297|583056563|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
161454156|NCT03339297|583056562|FG000|Overall Study|Adverse Event, Non-fatal|1|||
161454157|NCT03339297|583056563|FG001|Overall Study|Adverse Event, Non-fatal|0|||
161454158|NCT03339297|583056562|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
161454159|NCT03339297|583056563|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
161454160|NCT03339297|583056562|FG000|Overall Study|Patient Was Not Eligible|1|||
161454161|NCT03339297|583056563|FG001|Overall Study|Patient Was Not Eligible|0|||
161454162|NCT03051620|583056566|FG000|Overall Study|Lost to Follow-up|6|||
161454163|NCT03051620|583056566|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
161454164|NCT00393510|583056567|FG000|Overall Study|Physician Decision|3|||
161454165|NCT00393510|583056568|FG001|Overall Study|Physician Decision|9|||
161454166|NCT02412488|583056569|FG000|Overall Study|Lost to Follow-up|10|||
161454167|NCT02412488|583056569|FG000|Overall Study|Withdrawal by Subject|5|||
161454168|NCT02412488|583056569|FG000|Overall Study|Physician Decision|1|||
161454169|NCT02412488|583056569|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
161454170|NCT02412488|583056569|FG000|Overall Study|Reveal LINQ explant|1|||
161454171|NCT00674154|583056570|FG000|Overall Study|Withdrawal by Subject|3|||
161454172|NCT00674154|583056571|FG001|Overall Study|Withdrawal by Subject|1|||
161454173|NCT00674154|583056570|FG000|Overall Study|Did not want parathyroidectomy|0|||
161454174|NCT00674154|583056571|FG001|Overall Study|Did not want parathyroidectomy|2|||
161454175|NCT00816023|583056572|FG000|Overall Study|Lost to Follow-up|1|||
161454176|NCT00816023|583056573|FG001|Overall Study|Lost to Follow-up|1|||
161454177|NCT00816023|583056574|FG002|Overall Study|Lost to Follow-up|0|||
161454178|NCT00816023|583056575|FG003|Overall Study|Lost to Follow-up|0|||
161454179|NCT00816023|583056572|FG000|Overall Study|Withdrawal by Subject|1|||
161454180|NCT00816023|583056573|FG001|Overall Study|Withdrawal by Subject|0|||
161454181|NCT00816023|583056574|FG002|Overall Study|Withdrawal by Subject|0|||
161454182|NCT00816023|583056575|FG003|Overall Study|Withdrawal by Subject|0|||
161454183|NCT00816023|583056572|FG000|Overall Study|Physician Decision|0|||
161454184|NCT00816023|583056573|FG001|Overall Study|Physician Decision|0|||
161454185|NCT00816023|583056574|FG002|Overall Study|Physician Decision|1|||
161454186|NCT00816023|583056575|FG003|Overall Study|Physician Decision|0|||
161454187|NCT00816023|583056572|FG000|Overall Study|assessments complete prior to window|1|||
161454188|NCT00816023|583056573|FG001|Overall Study|assessments complete prior to window|1|||
161454189|NCT00816023|583056574|FG002|Overall Study|assessments complete prior to window|2|||
161454190|NCT00816023|583056575|FG003|Overall Study|assessments complete prior to window|1|||
161454191|NCT00816023|583056572|FG000|Overall Study|Randomized Not Treated|6|||
161454192|NCT00816023|583056573|FG001|Overall Study|Randomized Not Treated|4|||
161454193|NCT00816023|583056574|FG002|Overall Study|Randomized Not Treated|6|||
161454194|NCT00816023|583056575|FG003|Overall Study|Randomized Not Treated|11|||
161454195|NCT03554486|583056576|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
161454196|NCT03554486|583056577|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
161454197|NCT03554486|583056578|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
161454198|NCT03554486|583056576|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
161454199|NCT03554486|583056577|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
161454200|NCT03554486|583056578|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
161454201|NCT03554486|583056576|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161454202|NCT03554486|583056577|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161454203|NCT03554486|583056578|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161454204|NCT03288142|583056579|FG000|Overall Study|Lost to Follow-up|22|||
161563024|NCT01311648|583450155|FG001|Extension Study|Inhibitor management|2|||
161563025|NCT01645111|583450156|FG000|Overall Study|Did not require Clevidipine|15|||
161563026|NCT01304706|583450159|FG000|Overall Study|Adverse Event|2|||
161563027|NCT01304706|583450159|FG000|Overall Study|Lack of Efficacy|1|||
161563028|NCT01304706|583450159|FG000|Overall Study|Death|3|||
161563029|NCT01304706|583450159|FG000|Overall Study|Withdrawal by Subject|3|||
161563030|NCT01304706|583450159|FG000|Overall Study|Lost to Follow-up|7|||
161563031|NCT01304706|583450159|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
161563032|NCT05526911|583450160|FG000|Overall Study|Adverse Event|2|||
161563033|NCT05025449|583450161|FG000|Overall Study|Withdrawal by Subject|1|||
161563034|NCT05025449|583450161|FG000|Overall Study|Patient emergently taken to operating room|1|||
161563035|NCT01419717|583450162|FG000|Overall Study|Protocol-specified Criteria|62|||
161563036|NCT01419717|583450162|FG000|Overall Study|Adverse Event|19|||
161563037|NCT01419717|583450162|FG000|Overall Study|Death|17|||
161563038|NCT01419717|583450162|FG000|Overall Study|Withdrawal by Subject|10|||
161563039|NCT01419717|583450162|FG000|Overall Study|Disease Progression|9|||
161563040|NCT01419717|583450162|FG000|Overall Study|Other|4|||
161563041|NCT01419717|583450162|FG000|Overall Study|Lost to Follow-up|2|||
161563042|NCT01419717|583450162|FG000|Overall Study|Administrative Decision|1|||
161563043|NCT01419717|583450162|FG000|Overall Study|Noncompliance|1|||
161563044|NCT01240356|583450164|FG000|Overall Study|Withdrawal by Subject|2|||
161563045|NCT01240356|583450165|FG001|Overall Study|Withdrawal by Subject|0|||
161563046|NCT01240356|583450164|FG000|Overall Study|MRI contraindication|1|||
161563047|NCT01240356|583450165|FG001|Overall Study|MRI contraindication|0|||
161563048|NCT04048135|583450166|FG000|Overall Study|Withdrawal by Subject|1|||
161563049|NCT04048135|583450167|FG001|Overall Study|Withdrawal by Subject|1|||
161563050|NCT04048135|583450168|FG002|Overall Study|Withdrawal by Subject|1|||
161563051|NCT04048135|583450169|FG003|Overall Study|Withdrawal by Subject|2|||
161563052|NCT04048135|583450170|FG004|Overall Study|Withdrawal by Subject|0|||
161563053|NCT04048135|583450171|FG005|Overall Study|Withdrawal by Subject|0|||
161563054|NCT04048135|583450172|FG006|Overall Study|Withdrawal by Subject|1|||
161563055|NCT04048135|583450173|FG007|Overall Study|Withdrawal by Subject|1|||
161563056|NCT04048135|583450166|FG000|Overall Study|Adverse Event|0|||
161563057|NCT04048135|583450167|FG001|Overall Study|Adverse Event|0|||
161563058|NCT04048135|583450168|FG002|Overall Study|Adverse Event|0|||
161563059|NCT04048135|583450169|FG003|Overall Study|Adverse Event|1|||
161563060|NCT04048135|583450170|FG004|Overall Study|Adverse Event|1|||
161563061|NCT04048135|583450171|FG005|Overall Study|Adverse Event|0|||
161563062|NCT04048135|583450172|FG006|Overall Study|Adverse Event|0|||
161563063|NCT04048135|583450173|FG007|Overall Study|Adverse Event|0|||
161563064|NCT04048135|583450166|FG000|Overall Study|Protocol Violation|0|||
161563065|NCT04048135|583450167|FG001|Overall Study|Protocol Violation|0|||
161563066|NCT04048135|583450168|FG002|Overall Study|Protocol Violation|0|||
161563067|NCT04048135|583450169|FG003|Overall Study|Protocol Violation|0|||
161563068|NCT04048135|583450170|FG004|Overall Study|Protocol Violation|0|||
161563069|NCT04048135|583450171|FG005|Overall Study|Protocol Violation|1|||
161563070|NCT04048135|583450172|FG006|Overall Study|Protocol Violation|0|||
161563071|NCT04048135|583450173|FG007|Overall Study|Protocol Violation|0|||
161563072|NCT00448864|583450174|FG000|Overall Study|Death|1|||
161563073|NCT00448864|583450175|FG001|Overall Study|Death|0|||
161563074|NCT00448864|583450176|FG002|Overall Study|Death|0|||
161563075|NCT00448864|583450174|FG000|Overall Study|Lost to Follow-up|3|||
161563076|NCT00448864|583450175|FG001|Overall Study|Lost to Follow-up|1|||
161563077|NCT00448864|583450176|FG002|Overall Study|Lost to Follow-up|0|||
161563078|NCT00448864|583450174|FG000|Overall Study|Physician Decision|1|||
161563079|NCT00448864|583450175|FG001|Overall Study|Physician Decision|0|||
161563080|NCT00448864|583450176|FG002|Overall Study|Physician Decision|1|||
161563081|NCT00448864|583450174|FG000|Overall Study|Withdrawal by Subject|0|||
161563082|NCT00448864|583450175|FG001|Overall Study|Withdrawal by Subject|2|||
161563083|NCT00448864|583450176|FG002|Overall Study|Withdrawal by Subject|0|||
161563084|NCT00448864|583450174|FG000|Overall Study|Protocol Violation|0|||
161563085|NCT00448864|583450175|FG001|Overall Study|Protocol Violation|2|||
161563086|NCT00448864|583450176|FG002|Overall Study|Protocol Violation|0|||
161563087|NCT01474538|583450178|FG000|Treatment Period 1|Death|1|||
161563088|NCT01474538|583450179|FG001|Treatment Period 1|Death|0|||
161563089|NCT01474538|583450178|FG000|Treatment Period 1|Physician Decision|1|||
161563090|NCT01474538|583450179|FG001|Treatment Period 1|Physician Decision|0|||
161563091|NCT01474538|583450178|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161563092|NCT01474538|583450179|FG001|Treatment Period 1|Withdrawal by Subject|3|||
161563093|NCT01474538|583450178|FG000|Treatment Period 1|Protocol Violation|0|||
161563094|NCT01474538|583450179|FG001|Treatment Period 1|Protocol Violation|1|||
161563095|NCT01474538|583450178|FG000|Treatment Period 2|Death|1|||
161563096|NCT01474538|583450179|FG001|Treatment Period 2|Death|0|||
161563097|NCT01474538|583450178|FG000|Treatment Period 2|Adverse Event|1|||
161563098|NCT01474538|583450179|FG001|Treatment Period 2|Adverse Event|1|||
161563099|NCT01474538|583450178|FG000|Treatment Period 2|Withdrawal by Subject|2|||
161563100|NCT01474538|583450179|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161563101|NCT01474538|583450178|FG000|Treatment Period 2|Sponsor decision|1|||
161563102|NCT01474538|583450179|FG001|Treatment Period 2|Sponsor decision|0|||
161563103|NCT01474538|583450178|FG000|Treatment Period 2|Physician Decision|0|||
161563104|NCT01474538|583450179|FG001|Treatment Period 2|Physician Decision|1|||
161563105|NCT01474538|583450178|FG000|Treatment Period 2|Protocol Violation|1|||
161563106|NCT01474538|583450179|FG001|Treatment Period 2|Protocol Violation|0|||
161563107|NCT00367237|583450180|FG000|Overall Study|Adverse Event|7|||
161563108|NCT00367237|583450181|FG001|Overall Study|Adverse Event|2|||
161563109|NCT00367237|583450180|FG000|Overall Study|Lost to Follow-up|1|||
161563110|NCT00367237|583450181|FG001|Overall Study|Lost to Follow-up|0|||
161563111|NCT00367237|583450180|FG000|Overall Study|Withdrawal by Subject|0|||
161563112|NCT00367237|583450181|FG001|Overall Study|Withdrawal by Subject|4|||
161563113|NCT00367237|583450180|FG000|Overall Study|Protocol Violation|2|||
161563114|NCT00367237|583450181|FG001|Overall Study|Protocol Violation|5|||
161563115|NCT02501629|583450182|FG000|Overall Study|Death|0|||
161563116|NCT02501629|583450183|FG001|Overall Study|Death|1|||
161563117|NCT02501629|583450182|FG000|Overall Study|Withdrawn from study by sponsor|1|||
161563118|NCT02501629|583450183|FG001|Overall Study|Withdrawn from study by sponsor|0|||
161563119|NCT02501629|583450182|FG000|Overall Study|Early termination by sponsor|1|||
161563120|NCT02501629|583450183|FG001|Overall Study|Early termination by sponsor|0|||
161563121|NCT02501629|583450182|FG000|Overall Study|Withdrawal by Subject|3|||
161563122|NCT02501629|583450183|FG001|Overall Study|Withdrawal by Subject|5|||
161563123|NCT02501629|583450182|FG000|Overall Study|Subject did not return to site|0|||
161563124|NCT02501629|583450183|FG001|Overall Study|Subject did not return to site|1|||
161563125|NCT00868231|583450184|FG000|Treatment Period 1|Adverse Event|0|||
161563126|NCT00868231|583450185|FG001|Treatment Period 1|Adverse Event|0|||
161563127|NCT00868231|583450186|FG002|Treatment Period 1|Adverse Event|0|||
161563128|NCT00868231|583450187|FG003|Treatment Period 1|Adverse Event|0|||
161563129|NCT00868231|583450188|FG004|Treatment Period 1|Adverse Event|1|||
161563130|NCT00868231|583450189|FG005|Treatment Period 1|Adverse Event|0|||
161563131|NCT00868231|583450184|FG000|Treatment Period 2|Adverse Event|1|||
161563132|NCT00868231|583450185|FG001|Treatment Period 2|Adverse Event|0|||
161563133|NCT00868231|583450186|FG002|Treatment Period 2|Adverse Event|0|||
161563134|NCT00868231|583450187|FG003|Treatment Period 2|Adverse Event|0|||
161563135|NCT00868231|583450188|FG004|Treatment Period 2|Adverse Event|0|||
161563136|NCT00868231|583450189|FG005|Treatment Period 2|Adverse Event|0|||
161563137|NCT00868231|583450184|FG000|Treatment Period 3|Adverse Event|0|||
161563138|NCT00868231|583450185|FG001|Treatment Period 3|Adverse Event|0|||
161563139|NCT00868231|583450186|FG002|Treatment Period 3|Adverse Event|1|||
161563140|NCT00868231|583450187|FG003|Treatment Period 3|Adverse Event|0|||
161563141|NCT00868231|583450188|FG004|Treatment Period 3|Adverse Event|0|||
161563142|NCT00868231|583450189|FG005|Treatment Period 3|Adverse Event|0|||
161563143|NCT03120676|583450190|FG000|Overall Study|Not treated|1|||
161563144|NCT00886613|583450195|FG000|Overall Study|Protocol deviation (Part B)|1|||
161563145|NCT00886613|583450196|FG001|Overall Study|Protocol deviation (Part B)|0|||
161563146|NCT00886613|583450197|FG002|Overall Study|Protocol deviation (Part B)|0|||
161563147|NCT00886613|583450195|FG000|Overall Study|Lost to follow-up (Part B)|1|||
161563148|NCT00886613|583450196|FG001|Overall Study|Lost to follow-up (Part B)|0|||
161807218|NCT04089735|584339686|FG002|Overall Study|Physician Decision|0|||
161807219|NCT04089735|584339687|FG003|Overall Study|Physician Decision|0|||
161807220|NCT04089735|584339688|FG004|Overall Study|Physician Decision|0|||
161807221|NCT04089735|584339689|FG005|Overall Study|Physician Decision|0|||
161807222|NCT04089735|584339684|FG000|Overall Study|Withdrawal by Subject|0|||
161807223|NCT04089735|584339685|FG001|Overall Study|Withdrawal by Subject|0|||
161807224|NCT04089735|584339686|FG002|Overall Study|Withdrawal by Subject|1|||
161807225|NCT04089735|584339687|FG003|Overall Study|Withdrawal by Subject|0|||
161807226|NCT04089735|584339688|FG004|Overall Study|Withdrawal by Subject|0|||
161807227|NCT04089735|584339689|FG005|Overall Study|Withdrawal by Subject|0|||
161807228|NCT04089735|584339684|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
161807229|NCT04089735|584339685|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
161807230|NCT04089735|584339686|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
161807231|NCT04089735|584339687|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
161807232|NCT04089735|584339688|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
161910697|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
161563149|NCT00886613|583450197|FG002|Overall Study|Lost to follow-up (Part B)|1|||
161563150|NCT00886613|583450195|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
161563151|NCT00886613|583450196|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
161563152|NCT00886613|583450197|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
161563153|NCT01124162|583450198|FG000|First Intervention|Adverse Event|2|||
161563154|NCT01124162|583450199|FG001|First Intervention|Adverse Event|0|||
161563155|NCT01124162|583450198|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161563156|NCT01124162|583450199|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161563157|NCT00465985|583450200|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
161563158|NCT00465985|583450201|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
161563159|NCT00465985|583450200|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
161563160|NCT00465985|583450201|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
161563161|NCT00465985|583450200|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
161807233|NCT04089735|584339689|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
161807234|NCT02736721|584339694|FG000|Overall Study|Adverse Event|8|||
161807235|NCT02736721|584339694|FG000|Overall Study|Lost to Follow-up|3|||
161807236|NCT02736721|584339694|FG000|Overall Study|Other|5|||
161807237|NCT02956460|584339695|FG000|Lens 1|Lost to Follow-up|1|||
161807238|NCT02956460|584339696|FG001|Lens 1|Lost to Follow-up|0|||
161807239|NCT00829673|584339697|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161807240|NCT00829673|584339698|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161807241|NCT00272779|584339699|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
161807242|NCT00272779|584339700|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
161807243|NCT00272779|584339699|FG000|Baseline Through Week 48|Death before Week 48|4|||
161807244|NCT00272779|584339700|FG001|Baseline Through Week 48|Death before Week 48|4|||
161807245|NCT00272779|584339699|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
161807246|NCT00272779|584339700|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
161807247|NCT00272779|584339699|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
161807248|NCT00272779|584339700|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
161807249|NCT00272779|584339699|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
161807250|NCT00272779|584339700|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
161807251|NCT00272779|584339699|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
161807252|NCT00272779|584339700|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
161807253|NCT00272779|584339699|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
161807254|NCT00272779|584339700|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
161807255|NCT00272779|584339699|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
161807256|NCT00272779|584339700|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
161807257|NCT00272779|584339699|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
161807258|NCT00272779|584339700|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
161807259|NCT00272779|584339699|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
161807260|NCT00272779|584339700|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
161807261|NCT00272779|584339699|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
161807262|NCT00272779|584339700|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
161807263|NCT00272779|584339699|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
161807264|NCT00272779|584339700|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
161807265|NCT00272779|584339699|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
161807266|NCT00272779|584339700|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
161807267|NCT00272779|584339699|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
161807268|NCT00272779|584339700|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
161807269|NCT00272779|584339699|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
161807270|NCT00272779|584339700|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
161807271|NCT00272779|584339699|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
161807272|NCT00272779|584339700|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
161807273|NCT00272779|584339699|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
161807274|NCT00272779|584339700|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
161807275|NCT00272779|584339699|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
161807276|NCT00272779|584339700|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
161807277|NCT00272779|584339699|FG000|Baseline Through Week 48|Continuing treatment|385|||
161807278|NCT00272779|584339700|FG001|Baseline Through Week 48|Continuing treatment|368|||
161807279|NCT00272779|584339699|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
161807280|NCT00272779|584339700|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
161807281|NCT00272779|584339699|FG000|Baseline Through Week 48|Never treated|2|||
161807282|NCT00272779|584339700|FG001|Baseline Through Week 48|Never treated|3|||
161807283|NCT00272779|584339699|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
161807284|NCT00272779|584339700|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
161807285|NCT00272779|584339699|FG000|Baseline Through Week 96|Death before Week 96|6|||
161807286|NCT00272779|584339700|FG001|Baseline Through Week 96|Death before Week 96|5|||
161807287|NCT00272779|584339699|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
161807288|NCT00272779|584339700|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
161807289|NCT00272779|584339699|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
161807290|NCT00272779|584339700|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
161807291|NCT00272779|584339699|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
161910698|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
161910699|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
161807292|NCT00272779|584339700|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
161807293|NCT00272779|584339699|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
161807294|NCT00272779|584339700|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
161807295|NCT00272779|584339699|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
161807296|NCT00272779|584339700|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
161454205|NCT03288142|583056580|FG001|Overall Study|Lost to Follow-up|15|||
161454206|NCT02034409|583056581|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
161454207|NCT02034409|583056582|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
161454208|NCT02034409|583056581|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
161454209|NCT02034409|583056582|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
161454210|NCT02034409|583056581|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
161454211|NCT02034409|583056582|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
161454212|NCT02034409|583056581|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
161454213|NCT02034409|583056582|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
161454214|NCT02034409|583056581|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
161454215|NCT02034409|583056582|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
161454216|NCT02034409|583056581|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
161454217|NCT02034409|583056582|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
161454218|NCT02270944|583056586|FG000|Overall Study|Lost to Follow-up|9|||
161454219|NCT02270944|583056587|FG001|Overall Study|Lost to Follow-up|4|||
161454220|NCT02270944|583056586|FG000|Overall Study|Withdrawal by Subject|2|||
161454221|NCT02270944|583056587|FG001|Overall Study|Withdrawal by Subject|1|||
161454222|NCT02342418|583056588|FG000|Overall Study|Adverse Event|0|||
161454223|NCT02342418|583056589|FG001|Overall Study|Adverse Event|1|||
161454224|NCT01699867|583056590|FG000|Overall Study|Screening Failure|3|||
161454225|NCT04255394|583056591|FG000|Overall Study|Death|35|||
161454226|NCT04255394|583056592|FG001|Overall Study|Death|25|||
161454227|NCT04255394|583056591|FG000|Overall Study|Device removed|2|||
161454228|NCT04255394|583056592|FG001|Overall Study|Device removed|10|||
161454229|NCT04255394|583056591|FG000|Overall Study|Withdrawal by Subject|9|||
161454230|NCT04255394|583056592|FG001|Overall Study|Withdrawal by Subject|8|||
161454231|NCT04255394|583056591|FG000|Overall Study|Screen Failure/Not treated|12|||
161454232|NCT04255394|583056592|FG001|Overall Study|Screen Failure/Not treated|8|||
161454233|NCT04255394|583056591|FG000|Overall Study|Lost to Follow-up|123|||
161454234|NCT04255394|583056592|FG001|Overall Study|Lost to Follow-up|265|||
161454235|NCT04255394|583056591|FG000|Overall Study|Adverse Event|1|||
161454236|NCT04255394|583056592|FG001|Overall Study|Adverse Event|3|||
161454237|NCT01525225|583056601|FG000|Enrollment|No longer met study criteria|1|||
161454238|NCT01525225|583056601|FG000|Enrollment|Other|1|||
161454239|NCT01379508|583056602|FG000|Treatment to Week 104|Adverse Event|2|||
161454240|NCT01379508|583056603|FG001|Treatment to Week 104|Adverse Event|0|||
161454241|NCT01379508|583056604|FG002|Treatment to Week 104|Adverse Event|5|||
161454242|NCT01379508|583056605|FG003|Treatment to Week 104|Adverse Event|0|||
161454243|NCT01379508|583056602|FG000|Treatment to Week 104|Abnormal lab value|1|||
161454244|NCT01379508|583056603|FG001|Treatment to Week 104|Abnormal lab value|0|||
161454245|NCT01379508|583056604|FG002|Treatment to Week 104|Abnormal lab value|0|||
161454246|NCT01379508|583056605|FG003|Treatment to Week 104|Abnormal lab value|0|||
161454247|NCT01379508|583056602|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
161454248|NCT01379508|583056603|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
161454249|NCT01379508|583056604|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
161454250|NCT01379508|583056605|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
161454251|NCT01379508|583056602|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
161454252|NCT01379508|583056603|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
161454253|NCT01379508|583056604|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
161454254|NCT01379508|583056605|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
161454255|NCT01379508|583056602|FG000|Treatment to Week 104|Lost to Follow-up|5|||
161454256|NCT01379508|583056603|FG001|Treatment to Week 104|Lost to Follow-up|0|||
161454257|NCT01379508|583056604|FG002|Treatment to Week 104|Lost to Follow-up|3|||
161454258|NCT01379508|583056605|FG003|Treatment to Week 104|Lost to Follow-up|0|||
161454259|NCT01379508|583056602|FG000|Treatment to Week 104|Administrative problems|3|||
161454260|NCT01379508|583056603|FG001|Treatment to Week 104|Administrative problems|1|||
161454261|NCT01379508|583056604|FG002|Treatment to Week 104|Administrative problems|0|||
161454262|NCT01379508|583056605|FG003|Treatment to Week 104|Administrative problems|0|||
161454263|NCT01379508|583056602|FG000|Treatment to Week 104|Protocol Violation|1|||
161454264|NCT01379508|583056603|FG001|Treatment to Week 104|Protocol Violation|1|||
161454265|NCT01379508|583056604|FG002|Treatment to Week 104|Protocol Violation|1|||
161454266|NCT01379508|583056605|FG003|Treatment to Week 104|Protocol Violation|0|||
161454267|NCT01379508|583056602|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
161454268|NCT01379508|583056603|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
161454269|NCT01379508|583056604|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
161454270|NCT01379508|583056605|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
161454271|NCT01379508|583056602|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
161454272|NCT01379508|583056603|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
161454273|NCT01379508|583056604|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
161910700|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161910701|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161910702|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
161910703|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161454274|NCT01379508|583056605|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
161454275|NCT01379508|583056602|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
161454276|NCT01379508|583056603|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
161454277|NCT01379508|583056604|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
161454278|NCT01379508|583056605|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
161454279|NCT01379508|583056602|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
161454280|NCT01379508|583056603|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
161454281|NCT01379508|583056604|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
161454282|NCT01379508|583056605|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
161454283|NCT01182844|583056606|FG000|Overall Study|Withdrawal by Subject|0|||
161454284|NCT01182844|583056607|FG001|Overall Study|Withdrawal by Subject|2|||
161454285|NCT03952039|583056610|FG000|Overall Study|Adverse Event|22|||
161454286|NCT03952039|583056611|FG001|Overall Study|Adverse Event|8|||
161454287|NCT03952039|583056610|FG000|Overall Study|Withdrawal by Participant|17|||
161454288|NCT03952039|583056611|FG001|Overall Study|Withdrawal by Participant|12|||
161454289|NCT03952039|583056610|FG000|Overall Study|Death|13|||
161454290|NCT03952039|583056611|FG001|Overall Study|Death|6|||
161454291|NCT03952039|583056610|FG000|Overall Study|Lack of Efficacy|12|||
161454292|NCT03952039|583056611|FG001|Overall Study|Lack of Efficacy|2|||
161454293|NCT03952039|583056610|FG000|Overall Study|Physician Decision|9|||
161454294|NCT03952039|583056611|FG001|Overall Study|Physician Decision|3|||
161454295|NCT03952039|583056610|FG000|Overall Study|Progressive Disease|6|||
161454296|NCT03952039|583056611|FG001|Overall Study|Progressive Disease|4|||
161454297|NCT03952039|583056610|FG000|Overall Study|Other Reasons|12|||
161454298|NCT03952039|583056611|FG001|Overall Study|Other Reasons|4|||
161454299|NCT02055365|583058924|FG000|Overall Study|Prematurely Withdrawn|1|||
161454300|NCT03603509|583058928|FG000|Overall Study|Lost to Follow-up|3|||
161454301|NCT03603509|583058929|FG001|Overall Study|Lost to Follow-up|4|||
161454302|NCT02656680|583058932|FG000|Overall Study|Lost to Follow-up|0|||
161454303|NCT02656680|583058933|FG001|Overall Study|Lost to Follow-up|1|||
161454304|NCT02656680|583058934|FG002|Overall Study|Lost to Follow-up|7|||
161454305|NCT01258998|583058935|FG000|Overall Study|Ineligible|1|||
161454306|NCT01143389|583058936|FG000|Overall Study|Lost to Follow-up|26|||
161454307|NCT01143389|583058937|FG001|Overall Study|Lost to Follow-up|25|||
161454308|NCT04966910|583058940|FG000|Baseline|Participant did not complete measure|0|||
161454309|NCT04966910|583058941|FG001|Baseline|Participant did not complete measure|0|||
161454310|NCT04966910|583058942|FG002|Baseline|Participant did not complete measure|1|||
161454311|NCT04966910|583058943|FG003|Baseline|Participant did not complete measure|0|||
161454312|NCT04966910|583058940|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
161454313|NCT04966910|583058941|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
161454314|NCT04966910|583058942|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
161454315|NCT04966910|583058943|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
161454316|NCT04966910|583058940|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
161454317|NCT04966910|583058941|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
161454318|NCT04966910|583058942|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
161454319|NCT04966910|583058943|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
161454320|NCT04966910|583058940|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
161454321|NCT04966910|583058941|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
161454322|NCT04966910|583058942|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
161454323|NCT04966910|583058943|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
161454324|NCT00002931|583058944|FG000|Overall Study|rapidly progressing disease during|2|||
161454325|NCT01757691|583058945|FG000|Overall Study|Administrative problems|2|||
161454326|NCT01757691|583058946|FG001|Overall Study|Administrative problems|0|||
161454327|NCT02054481|583058950|FG000|Overall Study|Adverse Event|1|||
161454328|NCT02054481|583058951|FG001|Overall Study|Adverse Event|1|||
161454329|NCT02054481|583058952|FG002|Overall Study|Adverse Event|0|||
161454330|NCT02054481|583058953|FG003|Overall Study|Adverse Event|1|||
161454331|NCT02054481|583058950|FG000|Overall Study|Lost to Follow-up|1|||
161454332|NCT02054481|583058951|FG001|Overall Study|Lost to Follow-up|0|||
161454333|NCT02054481|583058952|FG002|Overall Study|Lost to Follow-up|0|||
161454334|NCT02054481|583058953|FG003|Overall Study|Lost to Follow-up|0|||
161454335|NCT02054481|583058950|FG000|Overall Study|Other reason|2|||
161454336|NCT02054481|583058951|FG001|Overall Study|Other reason|1|||
161454337|NCT02054481|583058952|FG002|Overall Study|Other reason|2|||
161454338|NCT02054481|583058953|FG003|Overall Study|Other reason|0|||
161454339|NCT01012219|583058954|FG000|Period 1|Withdrawal by Subject|1|||
161454340|NCT01012219|583058954|FG000|Period 2|Withdrawal by Subject|1|||
161454341|NCT01909791|583058955|FG000|Overall Study|Death|9|||
161454342|NCT01909791|583058956|FG001|Overall Study|Death|8|||
161454343|NCT01909791|583058957|FG002|Overall Study|Death|4|||
161563162|NCT00465985|583450201|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
161563163|NCT00465985|583450200|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
161563164|NCT00465985|583450201|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
161563165|NCT03439124|583450202|FG000|Overall Study|Adverse Event|2|||
161563166|NCT03439124|583450203|FG001|Overall Study|Adverse Event|0|||
161563167|NCT03439124|583450202|FG000|Overall Study|Lost to Follow-up|1|||
161563168|NCT03439124|583450203|FG001|Overall Study|Lost to Follow-up|0|||
161563169|NCT03439124|583450202|FG000|Overall Study|Other reasons|1|||
161563170|NCT03439124|583450203|FG001|Overall Study|Other reasons|0|||
161563171|NCT04353037|583450204|FG000|Overall Study|Lost to Follow-up|0|||
161563172|NCT04353037|583450205|FG001|Overall Study|Lost to Follow-up|1|||
161563173|NCT04353037|583450206|FG002|Overall Study|Lost to Follow-up|2|||
161563174|NCT04353037|583450207|FG003|Overall Study|Lost to Follow-up|3|||
161563175|NCT04353037|583450204|FG000|Overall Study|Withdrawal by Subject|0|||
161563176|NCT04353037|583450205|FG001|Overall Study|Withdrawal by Subject|2|||
161563177|NCT04353037|583450206|FG002|Overall Study|Withdrawal by Subject|3|||
161563178|NCT04353037|583450207|FG003|Overall Study|Withdrawal by Subject|5|||
161563179|NCT04353037|583450204|FG000|Overall Study|Adverse Event|0|||
161563180|NCT04353037|583450205|FG001|Overall Study|Adverse Event|0|||
161563181|NCT04353037|583450206|FG002|Overall Study|Adverse Event|2|||
161563182|NCT04353037|583450207|FG003|Overall Study|Adverse Event|0|||
161563183|NCT04353037|583450204|FG000|Overall Study|Exposure Change|0|||
161563184|NCT04353037|583450205|FG001|Overall Study|Exposure Change|0|||
161563185|NCT04353037|583450206|FG002|Overall Study|Exposure Change|0|||
161563186|NCT04353037|583450207|FG003|Overall Study|Exposure Change|2|||
161563187|NCT00463151|583450209|FG000|Overall Study|Adverse Event|0|||
161563188|NCT00463151|583450210|FG001|Overall Study|Adverse Event|0|||
161563189|NCT00463151|583450211|FG002|Overall Study|Adverse Event|1|||
161563190|NCT00463151|583450212|FG003|Overall Study|Adverse Event|0|||
161563191|NCT00463151|583450209|FG000|Overall Study|Lack of Efficacy|2|||
161563192|NCT00463151|583450210|FG001|Overall Study|Lack of Efficacy|5|||
161563193|NCT00463151|583450211|FG002|Overall Study|Lack of Efficacy|2|||
161563194|NCT00463151|583450212|FG003|Overall Study|Lack of Efficacy|5|||
161563195|NCT00463151|583450209|FG000|Overall Study|Protocol Violation|0|||
161563196|NCT00463151|583450210|FG001|Overall Study|Protocol Violation|0|||
161563197|NCT00463151|583450211|FG002|Overall Study|Protocol Violation|0|||
161563198|NCT00463151|583450212|FG003|Overall Study|Protocol Violation|1|||
161563199|NCT00463151|583450209|FG000|Overall Study|Withdrawal by Subject|0|||
161563200|NCT00463151|583450210|FG001|Overall Study|Withdrawal by Subject|0|||
161563201|NCT00463151|583450211|FG002|Overall Study|Withdrawal by Subject|0|||
161563202|NCT00463151|583450212|FG003|Overall Study|Withdrawal by Subject|1|||
161563203|NCT05349084|583450213|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
161563204|NCT00688688|583450214|FG000|Overall Study|Eligibility criterion not met|7|||
161563205|NCT00688688|583450215|FG001|Overall Study|Eligibility criterion not met|7|||
161563206|NCT00688688|583450216|FG002|Overall Study|Eligibility criterion not met|10|||
161563207|NCT00688688|583450214|FG000|Overall Study|Adverse Event|52|||
161563208|NCT00688688|583450215|FG001|Overall Study|Adverse Event|51|||
161563209|NCT00688688|583450216|FG002|Overall Study|Adverse Event|50|||
161563210|NCT00688688|583450214|FG000|Overall Study|Lack of Efficacy|34|||
161563211|NCT00688688|583450215|FG001|Overall Study|Lack of Efficacy|25|||
161563212|NCT00688688|583450216|FG002|Overall Study|Lack of Efficacy|45|||
161563213|NCT00688688|583450214|FG000|Overall Study|Withdrawal by Subject|66|||
161563214|NCT00688688|583450215|FG001|Overall Study|Withdrawal by Subject|75|||
161563215|NCT00688688|583450216|FG002|Overall Study|Withdrawal by Subject|65|||
161563216|NCT00688688|583450214|FG000|Overall Study|Lost to Follow-up|14|||
161563217|NCT00688688|583450215|FG001|Overall Study|Lost to Follow-up|7|||
161563218|NCT00688688|583450216|FG002|Overall Study|Lost to Follow-up|7|||
161563219|NCT00688688|583450214|FG000|Overall Study|Protocol Violation|6|||
161563220|NCT00688688|583450215|FG001|Overall Study|Protocol Violation|9|||
161563221|NCT00688688|583450216|FG002|Overall Study|Protocol Violation|11|||
161563222|NCT00688688|583450214|FG000|Overall Study|Randomized but never received study drug|1|||
161563223|NCT00688688|583450215|FG001|Overall Study|Randomized but never received study drug|0|||
161563224|NCT00688688|583450216|FG002|Overall Study|Randomized but never received study drug|0|||
161563225|NCT00688688|583450214|FG000|Overall Study|Non-compliance with study procedures|5|||
161563226|NCT00688688|583450215|FG001|Overall Study|Non-compliance with study procedures|3|||
161563227|NCT00688688|583450216|FG002|Overall Study|Non-compliance with study procedures|4|||
161563228|NCT00688688|583450214|FG000|Overall Study|Taking exclusionary medications|1|||
161563229|NCT00688688|583450215|FG001|Overall Study|Taking exclusionary medications|0|||
161563230|NCT00688688|583450216|FG002|Overall Study|Taking exclusionary medications|0|||
161563231|NCT00688688|583450214|FG000|Overall Study|Site closure|0|||
161563232|NCT00688688|583450215|FG001|Overall Study|Site closure|1|||
161563233|NCT00688688|583450216|FG002|Overall Study|Site closure|0|||
161563234|NCT00688688|583450214|FG000|Overall Study|Violation of exclusion criterion|0|||
161563235|NCT00688688|583450215|FG001|Overall Study|Violation of exclusion criterion|1|||
161563236|NCT00688688|583450216|FG002|Overall Study|Violation of exclusion criterion|0|||
161563237|NCT01941316|583450227|FG000|Overall Study|Adverse Event|0|||
161563238|NCT01941316|583450228|FG001|Overall Study|Adverse Event|1|||
161563239|NCT01941316|583450229|FG002|Overall Study|Adverse Event|0|||
161563240|NCT01941316|583450230|FG003|Overall Study|Adverse Event|7|||
161563241|NCT01941316|583450227|FG000|Overall Study|Progressive Disease|3|||
161563242|NCT01941316|583450228|FG001|Overall Study|Progressive Disease|6|||
161563243|NCT01941316|583450229|FG002|Overall Study|Progressive Disease|2|||
161563244|NCT01941316|583450230|FG003|Overall Study|Progressive Disease|29|||
161563245|NCT01941316|583450227|FG000|Overall Study|Withdrawal by Subject|0|||
161563246|NCT01941316|583450228|FG001|Overall Study|Withdrawal by Subject|2|||
161563247|NCT01941316|583450229|FG002|Overall Study|Withdrawal by Subject|1|||
161563248|NCT01941316|583450230|FG003|Overall Study|Withdrawal by Subject|8|||
161563249|NCT01941316|583450227|FG000|Overall Study|Death|0|||
161563250|NCT01941316|583450228|FG001|Overall Study|Death|0|||
161563251|NCT01941316|583450229|FG002|Overall Study|Death|0|||
161563252|NCT01941316|583450230|FG003|Overall Study|Death|3|||
161563253|NCT01941316|583450227|FG000|Overall Study|Physician Decision|0|||
161563254|NCT01941316|583450228|FG001|Overall Study|Physician Decision|0|||
161563255|NCT01941316|583450229|FG002|Overall Study|Physician Decision|0|||
161563256|NCT01941316|583450230|FG003|Overall Study|Physician Decision|3|||
161563257|NCT01941316|583450227|FG000|Overall Study|Protocol Violation|0|||
161563258|NCT01941316|583450228|FG001|Overall Study|Protocol Violation|0|||
161563259|NCT01941316|583450229|FG002|Overall Study|Protocol Violation|0|||
161563260|NCT01941316|583450230|FG003|Overall Study|Protocol Violation|3|||
161563261|NCT01941316|583450227|FG000|Overall Study|Intercurrent illness|0|||
161563262|NCT01941316|583450228|FG001|Overall Study|Intercurrent illness|0|||
161563263|NCT01941316|583450229|FG002|Overall Study|Intercurrent illness|0|||
161563264|NCT01941316|583450230|FG003|Overall Study|Intercurrent illness|1|||
161563265|NCT01941316|583450227|FG000|Overall Study|Other, not specified|0|||
161563266|NCT01941316|583450228|FG001|Overall Study|Other, not specified|0|||
161563267|NCT01941316|583450229|FG002|Overall Study|Other, not specified|0|||
161563268|NCT01941316|583450230|FG003|Overall Study|Other, not specified|1|||
161563269|NCT02775435|583450231|FG000|Overall Study|Adverse Event|32|||
161563270|NCT02775435|583450232|FG001|Overall Study|Adverse Event|27|||
161563271|NCT02775435|583450231|FG000|Overall Study|Lost to Follow-up|2|||
161563272|NCT02775435|583450232|FG001|Overall Study|Lost to Follow-up|2|||
161563273|NCT02775435|583450231|FG000|Overall Study|Sponsor decision|44|||
161563274|NCT02775435|583450232|FG001|Overall Study|Sponsor decision|19|||
161563275|NCT02775435|583450231|FG000|Overall Study|Withdrawal by Subject|4|||
161563276|NCT02775435|583450232|FG001|Overall Study|Withdrawal by Subject|9|||
161563277|NCT02775435|583450231|FG000|Overall Study|Death|196|||
161563278|NCT02775435|583450232|FG001|Overall Study|Death|224|||
161563279|NCT00320489|583450233|FG000|Overall Study|Adverse Event|26|||
161563280|NCT00320489|583450234|FG001|Overall Study|Adverse Event|25|||
161563281|NCT00320489|583450233|FG000|Overall Study|Clinical Relapse|26|||
161563282|NCT00320489|583450234|FG001|Overall Study|Clinical Relapse|20|||
161563283|NCT00320489|583450233|FG000|Overall Study|Death|0|||
161563284|NCT00320489|583450234|FG001|Overall Study|Death|2|||
161563285|NCT00320489|583450233|FG000|Overall Study|Entry Criteria Exclusion|2|||
161563286|NCT00320489|583450234|FG001|Overall Study|Entry Criteria Exclusion|4|||
161563287|NCT00320489|583450233|FG000|Overall Study|Lack of Efficacy|16|||
161563288|NCT00320489|583450234|FG001|Overall Study|Lack of Efficacy|7|||
161563289|NCT00320489|583450233|FG000|Overall Study|Lost to Follow-up|21|||
161563290|NCT00320489|583450234|FG001|Overall Study|Lost to Follow-up|22|||
161563291|NCT00320489|583450233|FG000|Overall Study|Physician Decision|8|||
161563292|NCT00320489|583450234|FG001|Overall Study|Physician Decision|8|||
161563293|NCT00320489|583450233|FG000|Overall Study|Protocol Violation|4|||
161563294|NCT00320489|583450234|FG001|Overall Study|Protocol Violation|4|||
161563295|NCT00320489|583450233|FG000|Overall Study|Sponsor Decision|3|||
161563296|NCT00320489|583450234|FG001|Overall Study|Sponsor Decision|3|||
161563297|NCT00320489|583450233|FG000|Overall Study|Withdrawal by Subject|39|||
161563298|NCT00320489|583450234|FG001|Overall Study|Withdrawal by Subject|41|||
161563299|NCT02282527|583450235|FG000|Overall Study|Lost to Follow-up|0|||
161563300|NCT02282527|583450236|FG001|Overall Study|Lost to Follow-up|1|||
161563301|NCT02282527|583450235|FG000|Overall Study|Lack of home health aid|1|||
161563302|NCT02282527|583450236|FG001|Overall Study|Lack of home health aid|0|||
161563303|NCT00941031|583450237|FG000|Induction Period|Lack of Efficacy|2|||
161563304|NCT00941031|583450238|FG001|Induction Period|Lack of Efficacy|1|||
161563305|NCT00941031|583450239|FG002|Induction Period|Lack of Efficacy|0|||
161563306|NCT00941031|583450240|FG003|Induction Period|Lack of Efficacy|5|||
161563307|NCT00941031|583450241|FG004|Induction Period|Lack of Efficacy|0|||
161563308|NCT00941031|583450242|FG005|Induction Period|Lack of Efficacy|0|||
161563309|NCT00941031|583450243|FG006|Induction Period|Lack of Efficacy|0|||
161563310|NCT00941031|583450237|FG000|Induction Period|Withdrawal by Subject|1|||
161563311|NCT00941031|583450238|FG001|Induction Period|Withdrawal by Subject|2|||
161563312|NCT00941031|583450239|FG002|Induction Period|Withdrawal by Subject|2|||
161563313|NCT00941031|583450240|FG003|Induction Period|Withdrawal by Subject|2|||
161563314|NCT00941031|583450241|FG004|Induction Period|Withdrawal by Subject|0|||
161563315|NCT00941031|583450242|FG005|Induction Period|Withdrawal by Subject|0|||
161563316|NCT00941031|583450243|FG006|Induction Period|Withdrawal by Subject|0|||
161807297|NCT00272779|584339699|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
161807298|NCT00272779|584339700|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
161807299|NCT00272779|584339699|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
161807300|NCT00272779|584339700|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
161807301|NCT00272779|584339699|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
161807302|NCT00272779|584339700|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
161807303|NCT00272779|584339699|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
161807304|NCT00272779|584339700|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
161807305|NCT00272779|584339699|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
161807306|NCT00272779|584339700|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
161807307|NCT00272779|584339699|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
161807308|NCT00272779|584339700|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
161807309|NCT00272779|584339699|FG000|Baseline Through Week 96|Never treated|2|||
161454344|NCT01909791|583058955|FG000|Overall Study|Withdrawal by Subject|5|||
161454345|NCT01909791|583058956|FG001|Overall Study|Withdrawal by Subject|9|||
161454346|NCT01909791|583058957|FG002|Overall Study|Withdrawal by Subject|13|||
161454347|NCT01909791|583058955|FG000|Overall Study|Lost to Follow-up|5|||
161454348|NCT01909791|583058956|FG001|Overall Study|Lost to Follow-up|11|||
161454349|NCT01909791|583058957|FG002|Overall Study|Lost to Follow-up|10|||
161454350|NCT01909791|583058955|FG000|Overall Study|Missed Visit|2|||
161454351|NCT01909791|583058956|FG001|Overall Study|Missed Visit|0|||
161454352|NCT01909791|583058957|FG002|Overall Study|Missed Visit|1|||
161454353|NCT01328366|583058960|FG000|Overall Study|Death|1|||
161454354|NCT01328366|583058960|FG000|Overall Study|Withdrawal by Subject|2|||
161454355|NCT01328366|583058960|FG000|Overall Study|Lost to Follow-up|7|||
161454356|NCT01713933|583058961|FG000|Overall Study|Lost to Follow-up|2|||
161454357|NCT01713933|583058961|FG000|Overall Study|Withdrawal by Subject|3|||
161454358|NCT01713933|583058961|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
161454359|NCT00528970|583058962|FG000|Overall Study|Adverse Event|6|||
161454360|NCT00528970|583058963|FG001|Overall Study|Adverse Event|8|||
161454361|NCT00528970|583058964|FG002|Overall Study|Adverse Event|5|||
161454362|NCT00528970|583058962|FG000|Overall Study|Lost to Follow-up|0|||
161454363|NCT00528970|583058963|FG001|Overall Study|Lost to Follow-up|0|||
161454364|NCT00528970|583058964|FG002|Overall Study|Lost to Follow-up|1|||
161454365|NCT00528970|583058962|FG000|Overall Study|Other than specified|2|||
161454366|NCT00528970|583058963|FG001|Overall Study|Other than specified|3|||
161454367|NCT00528970|583058964|FG002|Overall Study|Other than specified|3|||
161454368|NCT00528970|583058962|FG000|Overall Study|Protocol Violation|2|||
161454369|NCT00528970|583058963|FG001|Overall Study|Protocol Violation|1|||
161454370|NCT00528970|583058964|FG002|Overall Study|Protocol Violation|4|||
161454371|NCT00528970|583058962|FG000|Overall Study|Lack of Efficacy|0|||
161454372|NCT00528970|583058963|FG001|Overall Study|Lack of Efficacy|0|||
161454373|NCT00528970|583058964|FG002|Overall Study|Lack of Efficacy|1|||
161454374|NCT00528970|583058962|FG000|Overall Study|Withdrawal by Subject|4|||
161454375|NCT00528970|583058963|FG001|Overall Study|Withdrawal by Subject|3|||
161454376|NCT00528970|583058964|FG002|Overall Study|Withdrawal by Subject|5|||
161454377|NCT00528970|583058962|FG000|Overall Study|Randomized but not treated|0|||
161454378|NCT00528970|583058963|FG001|Overall Study|Randomized but not treated|0|||
161454379|NCT00528970|583058964|FG002|Overall Study|Randomized but not treated|1|||
161454380|NCT02882152|583058965|FG000|Overall Study|Lost to Follow-up|1|||
161454381|NCT02882152|583058966|FG001|Overall Study|Lost to Follow-up|0|||
161454382|NCT01009840|583058967|FG000|Overall Study|Lost to Follow-up|1|||
161454383|NCT01009840|583058967|FG000|Overall Study|Adverse Event|4|||
161454384|NCT01009840|583058967|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
161454385|NCT01009840|583058967|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
161454386|NCT01009840|583058967|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
161454387|NCT01104376|583058972|FG000|Overall Study|Withdrawal by Subject|15|||
161454388|NCT01104376|583058972|FG000|Overall Study|Consented but excluded after labs|13|||
161454389|NCT00797966|583058973|FG000|Phase A|Lost to Follow-up|0|||
161454390|NCT00797966|583058974|FG001|Phase A|Lost to Follow-up|0|||
161454391|NCT00797966|583058975|FG002|Phase A|Lost to Follow-up|0|||
161454392|NCT00797966|583058976|FG003|Phase A|Lost to Follow-up|0|||
161454393|NCT00797966|583058977|FG004|Phase A|Lost to Follow-up|33|||
161454394|NCT00797966|583058978|FG005|Phase A|Lost to Follow-up|0|||
161454395|NCT00797966|583058973|FG000|Phase A|Adverse Event|0|||
161454396|NCT00797966|583058974|FG001|Phase A|Adverse Event|0|||
161454397|NCT00797966|583058975|FG002|Phase A|Adverse Event|0|||
161454398|NCT00797966|583058976|FG003|Phase A|Adverse Event|0|||
161454399|NCT00797966|583058977|FG004|Phase A|Adverse Event|46|||
161454400|NCT00797966|583058978|FG005|Phase A|Adverse Event|0|||
161454401|NCT00797966|583058973|FG000|Phase A|Met withdrawal criteria|0|||
161454402|NCT00797966|583058974|FG001|Phase A|Met withdrawal criteria|0|||
161454403|NCT00797966|583058975|FG002|Phase A|Met withdrawal criteria|0|||
161454404|NCT00797966|583058976|FG003|Phase A|Met withdrawal criteria|0|||
161454405|NCT00797966|583058977|FG004|Phase A|Met withdrawal criteria|4|||
161454406|NCT00797966|583058978|FG005|Phase A|Met withdrawal criteria|0|||
161454407|NCT00797966|583058973|FG000|Phase A|Physician Decision|0|||
161910704|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
161910705|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
161454408|NCT00797966|583058974|FG001|Phase A|Physician Decision|0|||
161454409|NCT00797966|583058975|FG002|Phase A|Physician Decision|0|||
161454410|NCT00797966|583058976|FG003|Phase A|Physician Decision|0|||
161454411|NCT00797966|583058977|FG004|Phase A|Physician Decision|13|||
161454412|NCT00797966|583058978|FG005|Phase A|Physician Decision|0|||
161454413|NCT00797966|583058973|FG000|Phase A|Withdrawal by Subject|0|||
161454414|NCT00797966|583058974|FG001|Phase A|Withdrawal by Subject|0|||
161454415|NCT00797966|583058975|FG002|Phase A|Withdrawal by Subject|0|||
161454416|NCT00797966|583058976|FG003|Phase A|Withdrawal by Subject|0|||
161454417|NCT00797966|583058977|FG004|Phase A|Withdrawal by Subject|33|||
161454418|NCT00797966|583058978|FG005|Phase A|Withdrawal by Subject|0|||
161454419|NCT00797966|583058973|FG000|Phase A|Protocol deviation|0|||
161454420|NCT00797966|583058974|FG001|Phase A|Protocol deviation|0|||
161454421|NCT00797966|583058975|FG002|Phase A|Protocol deviation|0|||
161454422|NCT00797966|583058976|FG003|Phase A|Protocol deviation|0|||
161454423|NCT00797966|583058977|FG004|Phase A|Protocol deviation|56|||
161454424|NCT00797966|583058978|FG005|Phase A|Protocol deviation|0|||
161454425|NCT00797966|583058973|FG000|Phase B|Lost to Follow-up|0|||
161454426|NCT00797966|583058974|FG001|Phase B|Lost to Follow-up|1|||
161454427|NCT00797966|583058975|FG002|Phase B|Lost to Follow-up|3|||
161454428|NCT00797966|583058976|FG003|Phase B|Lost to Follow-up|0|||
161454429|NCT00797966|583058977|FG004|Phase B|Lost to Follow-up|0|||
161454430|NCT00797966|583058978|FG005|Phase B|Lost to Follow-up|0|||
161454431|NCT00797966|583058973|FG000|Phase B|Adverse Event|2|||
161454432|NCT00797966|583058974|FG001|Phase B|Adverse Event|1|||
161454433|NCT00797966|583058975|FG002|Phase B|Adverse Event|3|||
161454434|NCT00797966|583058976|FG003|Phase B|Adverse Event|1|||
161454435|NCT00797966|583058977|FG004|Phase B|Adverse Event|0|||
161454436|NCT00797966|583058978|FG005|Phase B|Adverse Event|0|||
161454437|NCT00797966|583058973|FG000|Phase B|Met Withdrawal Criteria|3|||
161454438|NCT00797966|583058974|FG001|Phase B|Met Withdrawal Criteria|3|||
161454439|NCT00797966|583058975|FG002|Phase B|Met Withdrawal Criteria|6|||
161454440|NCT00797966|583058976|FG003|Phase B|Met Withdrawal Criteria|1|||
161454441|NCT00797966|583058977|FG004|Phase B|Met Withdrawal Criteria|0|||
161454442|NCT00797966|583058978|FG005|Phase B|Met Withdrawal Criteria|0|||
161454443|NCT00797966|583058973|FG000|Phase B|Physician Decision|1|||
161454444|NCT00797966|583058974|FG001|Phase B|Physician Decision|0|||
161454445|NCT00797966|583058975|FG002|Phase B|Physician Decision|3|||
161454446|NCT00797966|583058976|FG003|Phase B|Physician Decision|1|||
161454447|NCT00797966|583058977|FG004|Phase B|Physician Decision|0|||
161454448|NCT00797966|583058978|FG005|Phase B|Physician Decision|0|||
161454449|NCT00797966|583058973|FG000|Phase B|Withdrawal by Subject|1|||
161454450|NCT00797966|583058974|FG001|Phase B|Withdrawal by Subject|4|||
161454451|NCT00797966|583058975|FG002|Phase B|Withdrawal by Subject|3|||
161454452|NCT00797966|583058976|FG003|Phase B|Withdrawal by Subject|3|||
161454453|NCT00797966|583058977|FG004|Phase B|Withdrawal by Subject|0|||
161454454|NCT00797966|583058978|FG005|Phase B|Withdrawal by Subject|0|||
161454455|NCT00797966|583058973|FG000|Phase B|Protocol Deviation|4|||
161454456|NCT00797966|583058974|FG001|Phase B|Protocol Deviation|8|||
161454457|NCT00797966|583058975|FG002|Phase B|Protocol Deviation|2|||
161454458|NCT00797966|583058976|FG003|Phase B|Protocol Deviation|6|||
161454459|NCT00797966|583058977|FG004|Phase B|Protocol Deviation|0|||
161454460|NCT00797966|583058978|FG005|Phase B|Protocol Deviation|0|||
161454461|NCT00797966|583058973|FG000|Phase B|Lack of Efficacy|0|||
161454462|NCT00797966|583058974|FG001|Phase B|Lack of Efficacy|1|||
161454463|NCT00797966|583058975|FG002|Phase B|Lack of Efficacy|1|||
161454464|NCT00797966|583058976|FG003|Phase B|Lack of Efficacy|4|||
161454465|NCT00797966|583058977|FG004|Phase B|Lack of Efficacy|0|||
161454466|NCT00797966|583058978|FG005|Phase B|Lack of Efficacy|0|||
161454467|NCT00797966|583058973|FG000|Phase A+|Lost to Follow-up|0|||
161454468|NCT00797966|583058974|FG001|Phase A+|Lost to Follow-up|0|||
161454469|NCT00797966|583058975|FG002|Phase A+|Lost to Follow-up|0|||
161454470|NCT00797966|583058976|FG003|Phase A+|Lost to Follow-up|0|||
161454471|NCT00797966|583058977|FG004|Phase A+|Lost to Follow-up|0|||
161454472|NCT00797966|583058978|FG005|Phase A+|Lost to Follow-up|9|||
161454473|NCT00797966|583058973|FG000|Phase A+|Met withdrawal criteria|0|||
161910706|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
161454474|NCT00797966|583058974|FG001|Phase A+|Met withdrawal criteria|0|||
161454475|NCT00797966|583058975|FG002|Phase A+|Met withdrawal criteria|0|||
161454476|NCT00797966|583058976|FG003|Phase A+|Met withdrawal criteria|0|||
161454477|NCT00797966|583058977|FG004|Phase A+|Met withdrawal criteria|0|||
161454478|NCT00797966|583058978|FG005|Phase A+|Met withdrawal criteria|5|||
161454479|NCT00797966|583058973|FG000|Phase A+|Withdrawal by Subject|0|||
161454480|NCT00797966|583058974|FG001|Phase A+|Withdrawal by Subject|0|||
161454481|NCT00797966|583058975|FG002|Phase A+|Withdrawal by Subject|0|||
161454482|NCT00797966|583058976|FG003|Phase A+|Withdrawal by Subject|0|||
161454483|NCT00797966|583058977|FG004|Phase A+|Withdrawal by Subject|0|||
161454484|NCT00797966|583058978|FG005|Phase A+|Withdrawal by Subject|6|||
161454485|NCT00797966|583058973|FG000|Phase A+|Adverse Event|0|||
161454486|NCT00797966|583058974|FG001|Phase A+|Adverse Event|0|||
161563317|NCT00941031|583450237|FG000|Induction Period|Adminstative Problems|1|||
161563318|NCT00941031|583450238|FG001|Induction Period|Adminstative Problems|1|||
161563319|NCT00941031|583450239|FG002|Induction Period|Adminstative Problems|1|||
161563320|NCT00941031|583450240|FG003|Induction Period|Adminstative Problems|0|||
161563321|NCT00941031|583450241|FG004|Induction Period|Adminstative Problems|0|||
161563322|NCT00941031|583450242|FG005|Induction Period|Adminstative Problems|0|||
161563323|NCT00941031|583450243|FG006|Induction Period|Adminstative Problems|0|||
161563324|NCT00941031|583450237|FG000|Induction Period|Adverse Event|1|||
161563325|NCT00941031|583450238|FG001|Induction Period|Adverse Event|0|||
161563326|NCT00941031|583450239|FG002|Induction Period|Adverse Event|3|||
161563327|NCT00941031|583450240|FG003|Induction Period|Adverse Event|2|||
161563328|NCT00941031|583450241|FG004|Induction Period|Adverse Event|0|||
161563329|NCT00941031|583450242|FG005|Induction Period|Adverse Event|0|||
161563330|NCT00941031|583450243|FG006|Induction Period|Adverse Event|0|||
161563331|NCT00941031|583450237|FG000|Maintenance Period|Withdrawal by Subject|0|||
161563332|NCT00941031|583450238|FG001|Maintenance Period|Withdrawal by Subject|0|||
161563333|NCT00941031|583450239|FG002|Maintenance Period|Withdrawal by Subject|0|||
161563334|NCT00941031|583450240|FG003|Maintenance Period|Withdrawal by Subject|0|||
161563335|NCT00941031|583450241|FG004|Maintenance Period|Withdrawal by Subject|6|||
161563336|NCT00941031|583450242|FG005|Maintenance Period|Withdrawal by Subject|2|||
161563337|NCT00941031|583450243|FG006|Maintenance Period|Withdrawal by Subject|13|||
161563338|NCT00941031|583450237|FG000|Maintenance Period|Administrative Problems|0|||
161563339|NCT00941031|583450238|FG001|Maintenance Period|Administrative Problems|0|||
161563340|NCT00941031|583450239|FG002|Maintenance Period|Administrative Problems|0|||
161563341|NCT00941031|583450240|FG003|Maintenance Period|Administrative Problems|0|||
161563342|NCT00941031|583450241|FG004|Maintenance Period|Administrative Problems|1|||
161563343|NCT00941031|583450242|FG005|Maintenance Period|Administrative Problems|0|||
161563344|NCT00941031|583450243|FG006|Maintenance Period|Administrative Problems|1|||
161563345|NCT00941031|583450237|FG000|Maintenance Period|Protocol Violation|0|||
161563346|NCT00941031|583450238|FG001|Maintenance Period|Protocol Violation|0|||
161563347|NCT00941031|583450239|FG002|Maintenance Period|Protocol Violation|0|||
161563348|NCT00941031|583450240|FG003|Maintenance Period|Protocol Violation|0|||
161563349|NCT00941031|583450241|FG004|Maintenance Period|Protocol Violation|0|||
161563350|NCT00941031|583450242|FG005|Maintenance Period|Protocol Violation|0|||
161563351|NCT00941031|583450243|FG006|Maintenance Period|Protocol Violation|1|||
161563352|NCT00941031|583450237|FG000|Maintenance Period|Adverse Event|0|||
161563353|NCT00941031|583450238|FG001|Maintenance Period|Adverse Event|0|||
161563354|NCT00941031|583450239|FG002|Maintenance Period|Adverse Event|0|||
161563355|NCT00941031|583450240|FG003|Maintenance Period|Adverse Event|0|||
161563356|NCT00941031|583450241|FG004|Maintenance Period|Adverse Event|0|||
161563357|NCT00941031|583450242|FG005|Maintenance Period|Adverse Event|2|||
161563358|NCT00941031|583450243|FG006|Maintenance Period|Adverse Event|8|||
161563359|NCT00941031|583450237|FG000|Maintenance Period|Lost to Follow-up|0|||
161563360|NCT00941031|583450238|FG001|Maintenance Period|Lost to Follow-up|0|||
161563361|NCT00941031|583450239|FG002|Maintenance Period|Lost to Follow-up|0|||
161563362|NCT00941031|583450240|FG003|Maintenance Period|Lost to Follow-up|0|||
161563363|NCT00941031|583450241|FG004|Maintenance Period|Lost to Follow-up|2|||
161563364|NCT00941031|583450242|FG005|Maintenance Period|Lost to Follow-up|2|||
161563365|NCT00941031|583450243|FG006|Maintenance Period|Lost to Follow-up|7|||
161563366|NCT00941031|583450237|FG000|Maintenance Period|Lack of Efficacy|0|||
161563367|NCT00941031|583450238|FG001|Maintenance Period|Lack of Efficacy|0|||
161563368|NCT00941031|583450239|FG002|Maintenance Period|Lack of Efficacy|0|||
161563369|NCT00941031|583450240|FG003|Maintenance Period|Lack of Efficacy|0|||
161563370|NCT00941031|583450241|FG004|Maintenance Period|Lack of Efficacy|0|||
161563371|NCT00941031|583450242|FG005|Maintenance Period|Lack of Efficacy|0|||
161563372|NCT00941031|583450243|FG006|Maintenance Period|Lack of Efficacy|13|||
161563373|NCT01872611|583450244|FG000|Overall Study|Adverse Event|3|||
161563374|NCT01872611|583450245|FG001|Overall Study|Adverse Event|1|||
161563375|NCT01872611|583450244|FG000|Overall Study|Adverse Event, prior to treatment|0|||
161563376|NCT01872611|583450245|FG001|Overall Study|Adverse Event, prior to treatment|1|||
161563377|NCT01872611|583450244|FG000|Overall Study|Death|0|||
161563378|NCT01872611|583450245|FG001|Overall Study|Death|1|||
161563379|NCT01872611|583450244|FG000|Overall Study|Death, prior to treatment|0|||
161563380|NCT01872611|583450245|FG001|Overall Study|Death, prior to treatment|1|||
161563381|NCT01872611|583450244|FG000|Overall Study|Lost to Follow-up|8|||
161563382|NCT01872611|583450245|FG001|Overall Study|Lost to Follow-up|1|||
161563383|NCT01872611|583450244|FG000|Overall Study|Physician Decision|1|||
161563384|NCT01872611|583450245|FG001|Overall Study|Physician Decision|0|||
161563385|NCT01872611|583450244|FG000|Overall Study|Withdrawal by Subject|6|||
161563386|NCT01872611|583450245|FG001|Overall Study|Withdrawal by Subject|1|||
161563387|NCT01872611|583450244|FG000|Overall Study|Reason not provided|6|||
161563388|NCT01872611|583450245|FG001|Overall Study|Reason not provided|6|||
161563389|NCT04555044|583450248|FG000|Overall Study|Adverse Event|0|||
161563390|NCT04555044|583450249|FG001|Overall Study|Adverse Event|1|||
161563391|NCT04088188|583450252|FG000|Overall Study|Withdrawal by Subject|2|||
161563392|NCT04088188|583450253|FG001|Overall Study|Withdrawal by Subject|0|||
161563393|NCT04088188|583450252|FG000|Overall Study|Adverse Event|2|||
161807310|NCT00272779|584339700|FG001|Baseline Through Week 96|Never treated|3|||
161807311|NCT00272779|584339699|FG000|Baseline Through Week 96|Continuing on treatment|61|||
161807312|NCT00272779|584339700|FG001|Baseline Through Week 96|Continuing on treatment|38|||
161454487|NCT00797966|583058975|FG002|Phase A+|Adverse Event|0|||
161454488|NCT00797966|583058976|FG003|Phase A+|Adverse Event|0|||
161454489|NCT00797966|583058977|FG004|Phase A+|Adverse Event|0|||
161454490|NCT00797966|583058978|FG005|Phase A+|Adverse Event|4|||
161454491|NCT00797966|583058973|FG000|Phase A+|Protocol deviation|0|||
161454492|NCT00797966|583058974|FG001|Phase A+|Protocol deviation|0|||
161454493|NCT00797966|583058975|FG002|Phase A+|Protocol deviation|0|||
161454494|NCT00797966|583058976|FG003|Phase A+|Protocol deviation|0|||
161454495|NCT00797966|583058977|FG004|Phase A+|Protocol deviation|0|||
161454496|NCT00797966|583058978|FG005|Phase A+|Protocol deviation|4|||
161454497|NCT01002820|583058982|FG000|Overall Study|Adverse Event|1|||
161454498|NCT01002820|583058982|FG000|Overall Study|Withdrawal by Subject|2|||
161454499|NCT01002820|583058982|FG000|Overall Study|Lack of Efficacy|1|||
161454500|NCT01673347|583058983|FG000|Overall Study|failure of allograft|7|||
161454501|NCT01430754|583058986|FG000|Run-In Phase|Circadian Period Ineligible|24|||
161454502|NCT01430754|583058987|FG001|Run-In Phase|Circadian Period Ineligible|0|||
161454503|NCT01430754|583058986|FG000|Run-In Phase|Protocol Violation|6|||
161454504|NCT01430754|583058987|FG001|Run-In Phase|Protocol Violation|0|||
161454505|NCT01430754|583058986|FG000|Run-In Phase|Adverse Event|2|||
161454506|NCT01430754|583058987|FG001|Run-In Phase|Adverse Event|0|||
161454507|NCT01430754|583058986|FG000|Run-In Phase|Other|2|||
161454508|NCT01430754|583058987|FG001|Run-In Phase|Other|0|||
161454509|NCT01430754|583058986|FG000|Run-In Phase|Withdrawal by Subject|2|||
161454510|NCT01430754|583058987|FG001|Run-In Phase|Withdrawal by Subject|0|||
161454511|NCT01430754|583058986|FG000|Run-In Phase|Lost to Follow-up|1|||
161454512|NCT01430754|583058987|FG001|Run-In Phase|Lost to Follow-up|0|||
161454513|NCT00895011|583058988|FG000|Overall Study|Withdrawal by Subject|14|||
161454514|NCT00895011|583058989|FG001|Overall Study|Withdrawal by Subject|7|||
161454515|NCT00895011|583058990|FG002|Overall Study|Withdrawal by Subject|2|||
161454516|NCT00895011|583058988|FG000|Overall Study|Lost to Follow-up|5|||
161454517|NCT00895011|583058989|FG001|Overall Study|Lost to Follow-up|4|||
161454518|NCT00895011|583058990|FG002|Overall Study|Lost to Follow-up|1|||
161454519|NCT00895011|583058988|FG000|Overall Study|Protocol Violation|3|||
161454520|NCT00895011|583058989|FG001|Overall Study|Protocol Violation|1|||
161454521|NCT00895011|583058990|FG002|Overall Study|Protocol Violation|3|||
161454522|NCT00895011|583058988|FG000|Overall Study|Adverse Event|1|||
161454523|NCT00895011|583058989|FG001|Overall Study|Adverse Event|2|||
161454524|NCT00895011|583058990|FG002|Overall Study|Adverse Event|2|||
161454525|NCT00895011|583058988|FG000|Overall Study|schedule conflict|1|||
161454526|NCT00895011|583058989|FG001|Overall Study|schedule conflict|0|||
161454527|NCT00895011|583058990|FG002|Overall Study|schedule conflict|0|||
161454528|NCT02661178|583058997|FG000|Part 1|Protocol Violation|1|||
161454529|NCT02661178|583058998|FG001|Part 1|Protocol Violation|0|||
161454530|NCT02661178|583058999|FG002|Part 1|Protocol Violation|0|||
161454531|NCT02661178|583059000|FG003|Part 1|Protocol Violation|0|||
161454532|NCT02661178|583059001|FG004|Part 1|Protocol Violation|0|||
161454533|NCT02661178|583059002|FG005|Part 1|Protocol Violation|0|||
161454534|NCT02661178|583059003|FG006|Part 1|Protocol Violation|0|||
161454535|NCT02661178|583059004|FG007|Part 1|Protocol Violation|0|||
161454536|NCT02661178|583059005|FG008|Part 1|Protocol Violation|0|||
161454537|NCT02661178|583059006|FG009|Part 1|Protocol Violation|0|||
161454538|NCT02661178|583059007|FG010|Part 1|Protocol Violation|0|||
161454539|NCT02661178|583059008|FG011|Part 1|Protocol Violation|0|||
161454540|NCT02661178|583059009|FG012|Part 1|Protocol Violation|0|||
161454541|NCT02661178|583059010|FG013|Part 1|Protocol Violation|0|||
161454542|NCT02661178|583059011|FG014|Part 1|Protocol Violation|0|||
161454543|NCT02278471|583059012|FG000|Overall Study|Lost to Follow-up|6|||
161454544|NCT02278471|583059013|FG001|Overall Study|Lost to Follow-up|15|||
161454545|NCT02278471|583059012|FG000|Overall Study|Death|2|||
161454546|NCT02278471|583059013|FG001|Overall Study|Death|2|||
161454547|NCT02278471|583059012|FG000|Overall Study|Withdrawal by Subject|0|||
161454548|NCT02278471|583059013|FG001|Overall Study|Withdrawal by Subject|3|||
161454549|NCT00275821|583059014|FG000|Overall Study|Adverse Event|4|||
161807313|NCT02440711|584339701|FG000|Second Intervention|Lost to Follow-up|1|||
161454550|NCT00275821|583059015|FG001|Overall Study|Adverse Event|12|||
161454551|NCT00275821|583059016|FG002|Overall Study|Adverse Event|5|||
161454552|NCT00275821|583059014|FG000|Overall Study|Administrative problems|3|||
161454553|NCT00275821|583059015|FG001|Overall Study|Administrative problems|4|||
161454554|NCT00275821|583059016|FG002|Overall Study|Administrative problems|4|||
161454555|NCT00275821|583059014|FG000|Overall Study|Withdrawal by Subject|0|||
161454556|NCT00275821|583059015|FG001|Overall Study|Withdrawal by Subject|2|||
161454557|NCT00275821|583059016|FG002|Overall Study|Withdrawal by Subject|1|||
161454558|NCT00275821|583059014|FG000|Overall Study|Lost to Follow-up|0|||
161454559|NCT00275821|583059015|FG001|Overall Study|Lost to Follow-up|1|||
161454560|NCT00275821|583059016|FG002|Overall Study|Lost to Follow-up|1|||
161454561|NCT00275821|583059014|FG000|Overall Study|Death|0|||
161454562|NCT00275821|583059015|FG001|Overall Study|Death|2|||
161454563|NCT00275821|583059016|FG002|Overall Study|Death|1|||
161563394|NCT04088188|583450253|FG001|Overall Study|Adverse Event|0|||
161563395|NCT03686384|583450254|FG000|Overall Study|Lack of Efficacy|4|||
161563396|NCT03686384|583450255|FG001|Overall Study|Lack of Efficacy|13|||
161563397|NCT03686384|583450254|FG000|Overall Study|Lost to Follow-up|3|||
161563398|NCT03686384|583450255|FG001|Overall Study|Lost to Follow-up|0|||
161563399|NCT03686384|583450254|FG000|Overall Study|Physician Decision|0|||
161563400|NCT03686384|583450255|FG001|Overall Study|Physician Decision|1|||
161563401|NCT03686384|583450254|FG000|Overall Study|Took prohibited medication|0|||
161563402|NCT03686384|583450255|FG001|Overall Study|Took prohibited medication|1|||
161563403|NCT02696785|583450265|FG000|Blinded Treatment Period|Adverse Event|0|||
161563404|NCT02696785|583450266|FG001|Blinded Treatment Period|Adverse Event|1|||
161563405|NCT02696785|583450267|FG002|Blinded Treatment Period|Adverse Event|3|||
161563406|NCT02696785|583450268|FG003|Blinded Treatment Period|Adverse Event|0|||
161563407|NCT02696785|583450265|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
161563408|NCT02696785|583450266|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
161563409|NCT02696785|583450267|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
161563410|NCT02696785|583450268|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
161563411|NCT02696785|583450265|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
161563412|NCT02696785|583450266|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
161563413|NCT02696785|583450267|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
161563414|NCT02696785|583450268|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
161563415|NCT02696785|583450265|FG000|Blinded Treatment Period|Screen Failure|1|||
161563416|NCT02696785|583450266|FG001|Blinded Treatment Period|Screen Failure|0|||
161563417|NCT02696785|583450267|FG002|Blinded Treatment Period|Screen Failure|0|||
161563418|NCT02696785|583450268|FG003|Blinded Treatment Period|Screen Failure|0|||
161563419|NCT02696785|583450265|FG000|Washout Period|Withdrawal by Subject|0|||
161563420|NCT02696785|583450266|FG001|Washout Period|Withdrawal by Subject|1|||
161563421|NCT02696785|583450267|FG002|Washout Period|Withdrawal by Subject|0|||
161563422|NCT02696785|583450268|FG003|Washout Period|Withdrawal by Subject|0|||
161563423|NCT02696785|583450265|FG000|Washout Period|Lack of Efficacy|0|||
161563424|NCT02696785|583450266|FG001|Washout Period|Lack of Efficacy|1|||
161563425|NCT02696785|583450267|FG002|Washout Period|Lack of Efficacy|0|||
161563426|NCT02696785|583450268|FG003|Washout Period|Lack of Efficacy|0|||
161563427|NCT02696785|583450265|FG000|Extended Treatment Period|Adverse Event|2|||
161563428|NCT02696785|583450266|FG001|Extended Treatment Period|Adverse Event|3|||
161563429|NCT02696785|583450267|FG002|Extended Treatment Period|Adverse Event|2|||
161563430|NCT02696785|583450268|FG003|Extended Treatment Period|Adverse Event|1|||
161563431|NCT02696785|583450265|FG000|Extended Treatment Period|Lack of Efficacy|0|||
161563432|NCT02696785|583450266|FG001|Extended Treatment Period|Lack of Efficacy|1|||
161563433|NCT02696785|583450267|FG002|Extended Treatment Period|Lack of Efficacy|0|||
161563434|NCT02696785|583450268|FG003|Extended Treatment Period|Lack of Efficacy|0|||
161563435|NCT02696785|583450265|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
161563436|NCT02696785|583450266|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
161563437|NCT02696785|583450267|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
161563438|NCT02696785|583450268|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
161563439|NCT02696785|583450265|FG000|Follow-up Period|Adverse Event|0|||
161563440|NCT02696785|583450266|FG001|Follow-up Period|Adverse Event|0|||
161563441|NCT02696785|583450267|FG002|Follow-up Period|Adverse Event|8|||
161563442|NCT02696785|583450268|FG003|Follow-up Period|Adverse Event|2|||
161563443|NCT02696785|583450265|FG000|Follow-up Period|Lost to Follow-up|0|||
161563444|NCT02696785|583450266|FG001|Follow-up Period|Lost to Follow-up|0|||
161563445|NCT02696785|583450267|FG002|Follow-up Period|Lost to Follow-up|0|||
161563446|NCT02696785|583450268|FG003|Follow-up Period|Lost to Follow-up|1|||
161563447|NCT02696785|583450265|FG000|Follow-up Period|Lack of Efficacy|0|||
161563448|NCT02696785|583450266|FG001|Follow-up Period|Lack of Efficacy|0|||
161563449|NCT02696785|583450267|FG002|Follow-up Period|Lack of Efficacy|0|||
161563450|NCT02696785|583450268|FG003|Follow-up Period|Lack of Efficacy|1|||
161563451|NCT02696785|583450265|FG000|Follow-up Period|Withdrawal by Subject|1|||
161563452|NCT02696785|583450266|FG001|Follow-up Period|Withdrawal by Subject|0|||
161563453|NCT02696785|583450267|FG002|Follow-up Period|Withdrawal by Subject|5|||
161563454|NCT02696785|583450268|FG003|Follow-up Period|Withdrawal by Subject|4|||
161563455|NCT04863898|583450272|FG000|Overall Study|Away from study clinic during intervention training period|2|||
161563456|NCT04863898|583450272|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
161563457|NCT04863898|583450272|FG000|Overall Study|Lost to Follow-up|3|||
161563458|NCT04863898|583450272|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
161563459|NCT04863898|583450272|FG000|Overall Study|No longer employed at clinic|3|||
161563460|NCT00614744|583450273|FG000|Overall Study|Lost to Follow-up|5|||
161563461|NCT00614744|583450274|FG001|Overall Study|Lost to Follow-up|4|||
161563462|NCT00614744|583450273|FG000|Overall Study|Incomplete for Behavior Issues|0|||
161563463|NCT00614744|583450274|FG001|Overall Study|Incomplete for Behavior Issues|2|||
161563464|NCT00877851|583450275|FG000|Overall Study|Lost to Follow-up|5|||
161563465|NCT00877851|583450276|FG001|Overall Study|Lost to Follow-up|5|||
161563466|NCT00877851|583450275|FG000|Overall Study|computer problem|3|||
161563467|NCT00877851|583450276|FG001|Overall Study|computer problem|0|||
161563468|NCT00877851|583450275|FG000|Overall Study|no longer interested in participating|1|||
161563469|NCT00877851|583450276|FG001|Overall Study|no longer interested in participating|0|||
161563470|NCT02431533|583450277|FG000|Overall Study|Withdrawal by Subject|1|||
161563471|NCT02431533|583450278|FG001|Overall Study|Withdrawal by Subject|3|||
161563472|NCT02431533|583450277|FG000|Overall Study|Developed Exclusionary criteria|1|||
161563473|NCT02431533|583450278|FG001|Overall Study|Developed Exclusionary criteria|0|||
161563474|NCT02320253|583450279|FG000|Overall Study|Withdrawal by Subject|3|||
161563475|NCT02320253|583450280|FG001|Overall Study|Withdrawal by Subject|0|||
161563476|NCT02320253|583450281|FG002|Overall Study|Withdrawal by Subject|0|||
161563477|NCT02320253|583450279|FG000|Overall Study|Lost to Follow-up|2|||
161563478|NCT02320253|583450280|FG001|Overall Study|Lost to Follow-up|2|||
161563479|NCT02320253|583450281|FG002|Overall Study|Lost to Follow-up|1|||
161563480|NCT02320253|583450279|FG000|Overall Study|Death|1|||
161563481|NCT02320253|583450280|FG001|Overall Study|Death|0|||
161563482|NCT02320253|583450281|FG002|Overall Study|Death|1|||
161563483|NCT01516892|583450282|FG000|Overall Study|Adverse Event|25|||
161563484|NCT01516892|583450282|FG000|Overall Study|Lack of Efficacy|35|||
161563485|NCT01516892|583450282|FG000|Overall Study|Pregnancy|5|||
161563486|NCT01516892|583450282|FG000|Overall Study|Lost to Follow-up|82|||
161563487|NCT01516892|583450282|FG000|Overall Study|Subject Withdrew Consent|92|||
161563488|NCT01516892|583450282|FG000|Overall Study|Protocol Violation|60|||
161563489|NCT01516892|583450282|FG000|Overall Study|Other Miscellaneous Reasons|43|||
161563490|NCT01516892|583450282|FG000|Overall Study|Missing|1|||
161563491|NCT02956967|583450283|FG000|Overall Study|Adverse Event|3|||
161563492|NCT02956967|583450283|FG000|Overall Study|Reason non-related to neutropenia|10|||
161563493|NCT02956967|583450283|FG000|Overall Study|Lost to Follow-up|5|||
161563494|NCT02956967|583450283|FG000|Overall Study|Missing|1|||
161563495|NCT02956967|583450283|FG000|Overall Study|Termination of Nivestim administration|29|||
161563496|NCT00819234|583450284|FG000|Overall Study|Withdrawal by Subject|8|||
161563497|NCT00819234|583450285|FG001|Overall Study|Withdrawal by Subject|13|||
161563498|NCT00819234|583450286|FG002|Overall Study|Withdrawal by Subject|6|||
161563499|NCT00819234|583450287|FG003|Overall Study|Withdrawal by Subject|3|||
161563500|NCT00819234|583450288|FG004|Overall Study|Withdrawal by Subject|0|||
161563501|NCT00819234|583450289|FG005|Overall Study|Withdrawal by Subject|4|||
161563502|NCT00819234|583450290|FG006|Overall Study|Withdrawal by Subject|4|||
161563503|NCT00819234|583450291|FG007|Overall Study|Withdrawal by Subject|8|||
161563504|NCT00819234|583450292|FG008|Overall Study|Withdrawal by Subject|5|||
161563505|NCT00819234|583450293|FG009|Overall Study|Withdrawal by Subject|3|||
161563506|NCT00819234|583450284|FG000|Overall Study|Adverse Event|0|||
161563507|NCT00819234|583450285|FG001|Overall Study|Adverse Event|0|||
161563508|NCT00819234|583450286|FG002|Overall Study|Adverse Event|1|||
161563509|NCT00819234|583450287|FG003|Overall Study|Adverse Event|0|||
161563510|NCT00819234|583450288|FG004|Overall Study|Adverse Event|0|||
161563511|NCT00819234|583450289|FG005|Overall Study|Adverse Event|2|||
161563512|NCT00819234|583450290|FG006|Overall Study|Adverse Event|0|||
161563513|NCT00819234|583450291|FG007|Overall Study|Adverse Event|0|||
161563514|NCT00819234|583450292|FG008|Overall Study|Adverse Event|0|||
161563515|NCT00819234|583450293|FG009|Overall Study|Adverse Event|0|||
161563516|NCT00819234|583450284|FG000|Overall Study|Physician Decision|0|||
161563517|NCT00819234|583450285|FG001|Overall Study|Physician Decision|0|||
161563518|NCT00819234|583450286|FG002|Overall Study|Physician Decision|0|||
161563519|NCT00819234|583450287|FG003|Overall Study|Physician Decision|1|||
161563520|NCT00819234|583450288|FG004|Overall Study|Physician Decision|0|||
161563521|NCT00819234|583450289|FG005|Overall Study|Physician Decision|0|||
161563522|NCT00819234|583450290|FG006|Overall Study|Physician Decision|0|||
161563523|NCT00819234|583450291|FG007|Overall Study|Physician Decision|0|||
161563524|NCT00819234|583450292|FG008|Overall Study|Physician Decision|0|||
161563525|NCT00819234|583450293|FG009|Overall Study|Physician Decision|2|||
161563526|NCT00819234|583450284|FG000|Overall Study|Protocol Violation|0|||
161563527|NCT00819234|583450285|FG001|Overall Study|Protocol Violation|0|||
161807314|NCT02440711|584339702|FG001|Second Intervention|Lost to Follow-up|0|||
161807315|NCT04129346|584339703|FG000|Overall Study|Death|1|||
161807316|NCT04129346|584339704|FG001|Overall Study|Death|0|||
161807317|NCT05755282|584339705|FG000|Overall Study|Protocol Violation|0|||
161807318|NCT05755282|584339706|FG001|Overall Study|Protocol Violation|1|||
161563528|NCT00819234|583450286|FG002|Overall Study|Protocol Violation|1|||
161563529|NCT00819234|583450287|FG003|Overall Study|Protocol Violation|0|||
161807319|NCT00573066|584339707|FG000|Overall Study|Exclusion criteria|18|||
161807320|NCT00573066|584339707|FG000|Overall Study|IV malfunction|1|||
161563530|NCT00819234|583450288|FG004|Overall Study|Protocol Violation|0|||
161807321|NCT00573066|584339707|FG000|Overall Study|Postoperative bleeding|1|||
161807322|NCT04088760|584339709|FG000|Overall Study|Physician Decision|1|||
161563531|NCT00819234|583450289|FG005|Overall Study|Protocol Violation|0|||
161563532|NCT00819234|583450290|FG006|Overall Study|Protocol Violation|0|||
161563533|NCT00819234|583450291|FG007|Overall Study|Protocol Violation|0|||
161563534|NCT00819234|583450292|FG008|Overall Study|Protocol Violation|0|||
161563535|NCT00819234|583450293|FG009|Overall Study|Protocol Violation|0|||
161563536|NCT00819234|583450284|FG000|Overall Study|Lost to Follow-up|2|||
161563537|NCT00819234|583450285|FG001|Overall Study|Lost to Follow-up|2|||
161563538|NCT00819234|583450286|FG002|Overall Study|Lost to Follow-up|0|||
161563539|NCT00819234|583450287|FG003|Overall Study|Lost to Follow-up|2|||
161563540|NCT00819234|583450288|FG004|Overall Study|Lost to Follow-up|1|||
161563541|NCT00819234|583450289|FG005|Overall Study|Lost to Follow-up|1|||
161563542|NCT00819234|583450290|FG006|Overall Study|Lost to Follow-up|1|||
161563543|NCT00819234|583450291|FG007|Overall Study|Lost to Follow-up|1|||
161563544|NCT00819234|583450292|FG008|Overall Study|Lost to Follow-up|1|||
161563545|NCT00819234|583450293|FG009|Overall Study|Lost to Follow-up|2|||
161563546|NCT01096056|583450294|FG000|Overall Study|Lost to Follow-up|0|||
161563547|NCT01096056|583450295|FG001|Overall Study|Lost to Follow-up|1|||
161563548|NCT00924560|583450296|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
161563549|NCT00924560|583450297|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
161563550|NCT00924560|583450298|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
161563551|NCT00924560|583450296|FG000|Overall Study|Non Compliance with the Protocol|20|||
161563552|NCT00924560|583450297|FG001|Overall Study|Non Compliance with the Protocol|15|||
161563553|NCT00924560|583450298|FG002|Overall Study|Non Compliance with the Protocol|4|||
161563554|NCT00924560|583450296|FG000|Overall Study|Physician Decision|2|||
161563555|NCT00924560|583450297|FG001|Overall Study|Physician Decision|3|||
161563556|NCT00924560|583450298|FG002|Overall Study|Physician Decision|4|||
161563557|NCT00924560|583450296|FG000|Overall Study|Withdrawal by Subject|50|||
161563558|NCT00924560|583450297|FG001|Overall Study|Withdrawal by Subject|44|||
161563559|NCT00924560|583450298|FG002|Overall Study|Withdrawal by Subject|18|||
161563560|NCT00924560|583450296|FG000|Overall Study|Adverse Event|39|||
161563561|NCT00924560|583450297|FG001|Overall Study|Adverse Event|33|||
161563562|NCT00924560|583450298|FG002|Overall Study|Adverse Event|0|||
161563563|NCT00924560|583450296|FG000|Overall Study|Pregnancy|5|||
161563564|NCT00924560|583450297|FG001|Overall Study|Pregnancy|7|||
161563565|NCT00924560|583450298|FG002|Overall Study|Pregnancy|1|||
161563566|NCT00924560|583450296|FG000|Overall Study|Lost to Follow-up|78|||
161563567|NCT00924560|583450297|FG001|Overall Study|Lost to Follow-up|94|||
161563568|NCT00924560|583450298|FG002|Overall Study|Lost to Follow-up|45|||
161563569|NCT00924560|583450296|FG000|Overall Study|Miscellaneous Reasons|13|||
161563570|NCT00924560|583450297|FG001|Overall Study|Miscellaneous Reasons|10|||
161563571|NCT00924560|583450298|FG002|Overall Study|Miscellaneous Reasons|10|||
161563572|NCT03590743|583450301|FG000|Overall Study|Withdrawal by Subject|0|||
161563573|NCT03590743|583450302|FG001|Overall Study|Withdrawal by Subject|1|||
161563574|NCT01190176|583450303|FG000|Overall Study|Withdrawal by Subject|1|||
161563575|NCT01190176|583450303|FG000|Overall Study|Lost to Follow-up|1|||
161563576|NCT01221181|583450304|FG000|Overall Study|Lost to Follow-up|1|||
161563577|NCT01290094|583450305|FG000|Overall Study|Withdrawal by Subject|1|||
161563578|NCT01290094|583450305|FG000|Overall Study|Lost to Follow-up|5|||
161563579|NCT02738840|583452386|FG000|Overall Study|MRI Scan not Performed|5|||
161563580|NCT02738840|583452386|FG000|Overall Study|Lost to Follow-up|1|||
161563581|NCT02738840|583452386|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
161563582|NCT02738840|583452386|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
161563583|NCT00256308|583452394|FG000|Overall Study|Death|2|||
161563584|NCT02466516|583452397|FG000|Overall Study|Adverse Event|1|||
161563585|NCT02466516|583452398|FG001|Overall Study|Adverse Event|1|||
161563586|NCT02466516|583452399|FG002|Overall Study|Adverse Event|0|||
161563587|NCT02466516|583452400|FG003|Overall Study|Adverse Event|0|||
161563588|NCT02466516|583452401|FG004|Overall Study|Adverse Event|0|||
161563589|NCT02466516|583452397|FG000|Overall Study|Withdrew Consent|1|||
161563590|NCT02466516|583452398|FG001|Overall Study|Withdrew Consent|0|||
161563591|NCT02466516|583452399|FG002|Overall Study|Withdrew Consent|0|||
161563592|NCT02466516|583452400|FG003|Overall Study|Withdrew Consent|0|||
161563593|NCT02466516|583452401|FG004|Overall Study|Withdrew Consent|0|||
161563594|NCT02466516|583452397|FG000|Overall Study|Lost to Follow-up|2|||
161563595|NCT02466516|583452398|FG001|Overall Study|Lost to Follow-up|0|||
161563596|NCT02466516|583452399|FG002|Overall Study|Lost to Follow-up|1|||
161563597|NCT02466516|583452400|FG003|Overall Study|Lost to Follow-up|0|||
161563598|NCT02466516|583452401|FG004|Overall Study|Lost to Follow-up|0|||
161563599|NCT04358549|583452402|FG000|Overall Study|Adverse Event|0|||
161563600|NCT04358549|583452403|FG001|Overall Study|Adverse Event|1|||
161563601|NCT04358549|583452402|FG000|Overall Study|Death|1|||
161563602|NCT04358549|583452403|FG001|Overall Study|Death|0|||
161563603|NCT04358549|583452402|FG000|Overall Study|Lost to Follow-up|2|||
161563604|NCT04358549|583452403|FG001|Overall Study|Lost to Follow-up|1|||
161563605|NCT04358549|583452402|FG000|Overall Study|Withdrawal by Subject|6|||
161563606|NCT04358549|583452403|FG001|Overall Study|Withdrawal by Subject|6|||
161563607|NCT04358549|583452402|FG000|Overall Study|Start remdesivir|1|||
161563608|NCT04358549|583452403|FG001|Overall Study|Start remdesivir|0|||
161563609|NCT01062126|583452405|FG000|Overall Study|Death|209|||
161563610|NCT01062126|583452405|FG000|Overall Study|All Withdrawals|324|||
161563611|NCT00646451|583452406|FG000|Overall Study|Adverse Event|3|||
161563612|NCT00646451|583452407|FG001|Overall Study|Adverse Event|0|||
161563613|NCT00646451|583452406|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
161563614|NCT00646451|583452407|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
161563615|NCT04867902|583452408|FG000|Overall Study|Lost to Follow-up|1|||
161563616|NCT04867902|583452408|FG000|Overall Study|Withdrawal by Subject|2|||
161563617|NCT04867902|583452408|FG000|Overall Study|Protocol Violation|1|||
161563618|NCT01390857|583452411|FG000|Overall Study|Protocol Violation|2|||
161563619|NCT01390857|583452411|FG000|Overall Study|Lost to Follow-up|1|||
161563620|NCT01390857|583452411|FG000|Overall Study|No Visit after the First Visit|7|||
161563621|NCT00672256|583452419|FG000|Overall Study|PI dropped, bad data|44|||
161563622|NCT02072226|583452423|FG000|Overall Study|Lost to Follow-up|11|||
161563623|NCT02072226|583452424|FG001|Overall Study|Lost to Follow-up|7|||
161563624|NCT02072226|583452423|FG000|Overall Study|Patient Non-compliance|2|||
161563625|NCT02072226|583452424|FG001|Overall Study|Patient Non-compliance|3|||
161563626|NCT02072226|583452423|FG000|Overall Study|Death|1|||
161563627|NCT02072226|583452424|FG001|Overall Study|Death|0|||
161563628|NCT02072226|583452423|FG000|Overall Study|Patient Withdrawal of Consent|1|||
161563629|NCT02072226|583452424|FG001|Overall Study|Patient Withdrawal of Consent|0|||
161563630|NCT03255018|583452425|FG000|Overall Study|Death on study|0|||
161563631|NCT03255018|583452426|FG001|Overall Study|Death on study|5|||
161563632|NCT03255018|583452425|FG000|Overall Study|Withdrawal by Subject|0|||
161563633|NCT03255018|583452426|FG001|Overall Study|Withdrawal by Subject|2|||
161563634|NCT01720043|583452428|FG000|Overall Study|Withdrawal by Subject|1|||
161563635|NCT01688973|583452429|FG000|Overall Study|Ineligible|2|||
161563636|NCT01688973|583452430|FG001|Overall Study|Ineligible|3|||
161563637|NCT03710564|583452434|FG000|Overall Study|Study Terminated by Sponsor|104|||
161563638|NCT03710564|583452435|FG001|Overall Study|Study Terminated by Sponsor|55|||
161563639|NCT03710564|583452434|FG000|Overall Study|Withdrawal by Subject|57|||
161563640|NCT03710564|583452435|FG001|Overall Study|Withdrawal by Subject|25|||
161563641|NCT03710564|583452434|FG000|Overall Study|Death|10|||
161563642|NCT03710564|583452435|FG001|Overall Study|Death|4|||
161563643|NCT03710564|583452434|FG000|Overall Study|Lost to Follow-up|5|||
161563644|NCT03710564|583452435|FG001|Overall Study|Lost to Follow-up|4|||
161563645|NCT03710564|583452434|FG000|Overall Study|Protocol Violation|3|||
161563646|NCT03710564|583452435|FG001|Overall Study|Protocol Violation|2|||
161563647|NCT03710564|583452434|FG000|Overall Study|Adverse Event|3|||
161563648|NCT03710564|583452435|FG001|Overall Study|Adverse Event|0|||
161563649|NCT03710564|583452434|FG000|Overall Study|Physician Decision|2|||
161563650|NCT03710564|583452435|FG001|Overall Study|Physician Decision|3|||
161563651|NCT00972543|583452436|FG000|Overall Study|Adverse Event|1|||
161563652|NCT00972543|583452437|FG001|Overall Study|Adverse Event|0|||
161563653|NCT00972543|583452436|FG000|Overall Study|Early study termination by sponsor|4|||
161563654|NCT00972543|583452437|FG001|Overall Study|Early study termination by sponsor|1|||
161563655|NCT00293462|583452438|FG000|Overall Study|Withdrawal by Subject|4|||
161563656|NCT00293462|583452439|FG001|Overall Study|Withdrawal by Subject|3|||
161563657|NCT00293462|583452440|FG002|Overall Study|Withdrawal by Subject|8|||
161563658|NCT00293462|583452438|FG000|Overall Study|Death|1|||
161563659|NCT00293462|583452439|FG001|Overall Study|Death|0|||
161563660|NCT00293462|583452440|FG002|Overall Study|Death|0|||
161563661|NCT00293462|583452438|FG000|Overall Study|Lost to Follow-up|0|||
161563662|NCT00293462|583452439|FG001|Overall Study|Lost to Follow-up|1|||
161563663|NCT00293462|583452440|FG002|Overall Study|Lost to Follow-up|0|||
161563664|NCT00293462|583452438|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
161563665|NCT00293462|583452439|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
161563666|NCT00293462|583452440|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
161563667|NCT00293462|583452438|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
161563668|NCT00293462|583452439|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
161563669|NCT00293462|583452440|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
161563670|NCT00293462|583452438|FG000|Overall Study|Refuse Radiation Treatment|1|||
161563671|NCT00293462|583452439|FG001|Overall Study|Refuse Radiation Treatment|0|||
161563672|NCT00293462|583452440|FG002|Overall Study|Refuse Radiation Treatment|0|||
161563673|NCT00293462|583452438|FG000|Overall Study|No Show|0|||
161563674|NCT00293462|583452439|FG001|Overall Study|No Show|0|||
161563675|NCT00293462|583452440|FG002|Overall Study|No Show|1|||
161563676|NCT00293462|583452438|FG000|Overall Study|Went back to his home country|0|||
161563677|NCT00293462|583452439|FG001|Overall Study|Went back to his home country|0|||
161563678|NCT00293462|583452440|FG002|Overall Study|Went back to his home country|1|||
161563679|NCT00293462|583452438|FG000|Overall Study|Blood clot after chemotherapy|0|||
161563680|NCT00293462|583452439|FG001|Overall Study|Blood clot after chemotherapy|0|||
161563681|NCT00293462|583452440|FG002|Overall Study|Blood clot after chemotherapy|1|||
161563682|NCT00293462|583452438|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
161563683|NCT00293462|583452439|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
161563684|NCT00293462|583452440|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
161563685|NCT00293462|583452438|FG000|Overall Study|Possible Tracheostomy leakage|0|||
161563686|NCT00293462|583452439|FG001|Overall Study|Possible Tracheostomy leakage|1|||
161563687|NCT00293462|583452440|FG002|Overall Study|Possible Tracheostomy leakage|0|||
161563688|NCT00293462|583452438|FG000|Overall Study|Low radiation dose in oral cavity|0|||
161563689|NCT00293462|583452439|FG001|Overall Study|Low radiation dose in oral cavity|1|||
161563690|NCT00293462|583452440|FG002|Overall Study|Low radiation dose in oral cavity|0|||
161563691|NCT00293462|583452438|FG000|Overall Study|Physician Decision|0|||
161563692|NCT00293462|583452439|FG001|Overall Study|Physician Decision|1|||
161563693|NCT00293462|583452440|FG002|Overall Study|Physician Decision|0|||
161563694|NCT00372060|583452441|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
161563695|NCT00372060|583452442|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
161563696|NCT00372060|583452441|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
161563697|NCT00372060|583452442|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
161563698|NCT00372060|583452441|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
161563699|NCT00372060|583452442|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
161563700|NCT00372060|583452441|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
161563701|NCT00372060|583452442|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
161563702|NCT00372060|583452441|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
161563703|NCT00372060|583452442|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
161563704|NCT00372060|583452441|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
161563705|NCT00372060|583452442|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
161563706|NCT00647348|583452443|FG000|Overall Study|Lost to Follow-up|3|||
161563707|NCT00647348|583452444|FG001|Overall Study|Lost to Follow-up|6|||
161563708|NCT03382821|583452448|FG000|Overall Study|Did not receive allocated intervention.|0|||
161563709|NCT03382821|583452449|FG001|Overall Study|Did not receive allocated intervention.|3|||
161563710|NCT00282438|583452450|FG000|Overall Study|Lack of Efficacy|1|||
161563711|NCT00282438|583452451|FG001|Overall Study|Lack of Efficacy|0|||
161563712|NCT00282438|583452450|FG000|Overall Study|Death|0|||
161563713|NCT00282438|583452451|FG001|Overall Study|Death|1|||
161563714|NCT01119703|583452460|FG000|Overall Study|Adverse Event|0|||
161563715|NCT01119703|583452461|FG001|Overall Study|Adverse Event|1|||
161563716|NCT01511250|583452462|FG000|Overall Study|Withdrawal of Consent|1|||
161563717|NCT01511250|583452463|FG001|Overall Study|Withdrawal of Consent|0|||
161563718|NCT01511250|583452464|FG002|Overall Study|Withdrawal of Consent|0|||
161563719|NCT01511250|583452465|FG003|Overall Study|Withdrawal of Consent|0|||
161563720|NCT01511250|583452466|FG004|Overall Study|Withdrawal of Consent|0|||
161563721|NCT01511250|583452467|FG005|Overall Study|Withdrawal of Consent|0|||
161563722|NCT01511250|583452468|FG006|Overall Study|Withdrawal of Consent|0|||
161563723|NCT01511250|583452469|FG007|Overall Study|Withdrawal of Consent|1|||
161563724|NCT01511250|583452470|FG008|Overall Study|Withdrawal of Consent|1|||
161563725|NCT01511250|583452471|FG009|Overall Study|Withdrawal of Consent|0|||
161563726|NCT01511250|583452462|FG000|Overall Study|Sponsor/Investigator Decision|1|||
161563727|NCT01511250|583452463|FG001|Overall Study|Sponsor/Investigator Decision|0|||
161563728|NCT01511250|583452464|FG002|Overall Study|Sponsor/Investigator Decision|0|||
161563729|NCT01511250|583452465|FG003|Overall Study|Sponsor/Investigator Decision|0|||
161563730|NCT01511250|583452466|FG004|Overall Study|Sponsor/Investigator Decision|0|||
161563731|NCT01511250|583452467|FG005|Overall Study|Sponsor/Investigator Decision|0|||
161563732|NCT01511250|583452468|FG006|Overall Study|Sponsor/Investigator Decision|0|||
161563733|NCT01511250|583452469|FG007|Overall Study|Sponsor/Investigator Decision|0|||
161563734|NCT01511250|583452470|FG008|Overall Study|Sponsor/Investigator Decision|0|||
161563735|NCT01511250|583452471|FG009|Overall Study|Sponsor/Investigator Decision|0|||
161563736|NCT01511250|583452462|FG000|Overall Study|Lost to Follow-up|7|||
161563737|NCT01511250|583452463|FG001|Overall Study|Lost to Follow-up|3|||
161563738|NCT01511250|583452464|FG002|Overall Study|Lost to Follow-up|3|||
161563739|NCT01511250|583452465|FG003|Overall Study|Lost to Follow-up|3|||
161563740|NCT01511250|583452466|FG004|Overall Study|Lost to Follow-up|0|||
161563741|NCT01511250|583452467|FG005|Overall Study|Lost to Follow-up|0|||
161563742|NCT01511250|583452468|FG006|Overall Study|Lost to Follow-up|2|||
161563743|NCT01511250|583452469|FG007|Overall Study|Lost to Follow-up|3|||
161563744|NCT01511250|583452470|FG008|Overall Study|Lost to Follow-up|13|||
161563745|NCT01511250|583452471|FG009|Overall Study|Lost to Follow-up|5|||
161563746|NCT01511250|583452462|FG000|Overall Study|Protocol Violation|0|||
161563747|NCT01511250|583452463|FG001|Overall Study|Protocol Violation|2|||
161563748|NCT01511250|583452464|FG002|Overall Study|Protocol Violation|1|||
161563749|NCT01511250|583452465|FG003|Overall Study|Protocol Violation|0|||
161563750|NCT01511250|583452466|FG004|Overall Study|Protocol Violation|0|||
161563751|NCT01511250|583452467|FG005|Overall Study|Protocol Violation|0|||
161563752|NCT01511250|583452468|FG006|Overall Study|Protocol Violation|0|||
161563753|NCT01511250|583452469|FG007|Overall Study|Protocol Violation|0|||
161563754|NCT01511250|583452470|FG008|Overall Study|Protocol Violation|0|||
161563755|NCT01511250|583452471|FG009|Overall Study|Protocol Violation|0|||
161563756|NCT04668144|583452472|FG000|Overall Study|Protocol Violation|0|||
161563757|NCT04668144|583452473|FG001|Overall Study|Protocol Violation|1|||
161563758|NCT04668144|583452474|FG002|Overall Study|Protocol Violation|2|||
161563759|NCT02095158|583452475|FG000|Overall Study|Adverse Event|14|||
161563760|NCT02095158|583452475|FG000|Overall Study|Lack of Efficacy|3|||
161563761|NCT02095158|583452475|FG000|Overall Study|Pregnancy|1|||
161563762|NCT02095158|583452475|FG000|Overall Study|Lost to Follow-up|20|||
161563763|NCT02095158|583452475|FG000|Overall Study|Personal Reasons|35|||
161563764|NCT02095158|583452475|FG000|Overall Study|Protocol Violation|1|||
161563765|NCT02095158|583452475|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161563766|NCT03441984|583452476|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563767|NCT03441984|583452477|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563768|NCT03441984|583452478|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
161563769|NCT03441984|583452479|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563770|NCT03441984|583452480|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563771|NCT03441984|583452481|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563772|NCT03441984|583452482|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563773|NCT03441984|583452483|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563774|NCT03441984|583452484|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563775|NCT03441984|583452485|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563776|NCT03441984|583452486|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563777|NCT03441984|583452487|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161563778|NCT00631917|583452488|FG000|Overall Study|Adverse Event|34|||
161563779|NCT00631917|583452489|FG001|Overall Study|Adverse Event|45|||
161563780|NCT00631917|583452488|FG000|Overall Study|Abnormal laboratory value(s)|2|||
161563781|NCT00631917|583452489|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161563782|NCT00631917|583452488|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161563783|NCT00631917|583452489|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161563784|NCT00631917|583452488|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
161563785|NCT00631917|583452489|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
161563786|NCT00631917|583452488|FG000|Overall Study|No longer required study drug|0|||
161563787|NCT00631917|583452489|FG001|Overall Study|No longer required study drug|1|||
161563788|NCT00631917|583452488|FG000|Overall Study|Protocol deviation|6|||
161563789|NCT00631917|583452489|FG001|Overall Study|Protocol deviation|5|||
161563790|NCT00631917|583452488|FG000|Overall Study|Subject withdrew consent|25|||
161563791|NCT00631917|583452489|FG001|Overall Study|Subject withdrew consent|33|||
161563792|NCT00631917|583452488|FG000|Overall Study|Lost to Follow-up|7|||
161563793|NCT00631917|583452489|FG001|Overall Study|Lost to Follow-up|7|||
161563794|NCT00631917|583452488|FG000|Overall Study|Administrative problems|2|||
161563795|NCT00631917|583452489|FG001|Overall Study|Administrative problems|0|||
161563796|NCT00631917|583452488|FG000|Overall Study|Death|1|||
161563797|NCT00631917|583452489|FG001|Overall Study|Death|0|||
161563798|NCT03285711|583452490|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
161563799|NCT03285711|583452491|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
161563800|NCT03285711|583452492|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
161563801|NCT03285711|583452493|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
161563802|NCT03285711|583452490|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
161563803|NCT03285711|583452491|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
161563804|NCT03285711|583452492|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
161563805|NCT03285711|583452493|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
161563806|NCT03285711|583452490|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
161563807|NCT03285711|583452491|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
161563808|NCT03285711|583452492|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
161563809|NCT03285711|583452493|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
161563810|NCT03285711|583452490|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
161563811|NCT03285711|583452491|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
161563812|NCT03285711|583452492|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
161563813|NCT03285711|583452493|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
161563814|NCT00770211|583452496|FG000|Overall Study|Lost to Follow-up|1|||
161563815|NCT00770211|583452497|FG001|Overall Study|Lost to Follow-up|0|||
161563816|NCT00770211|583452496|FG000|Overall Study|Withdrawal by Subject|0|||
161563817|NCT00770211|583452497|FG001|Overall Study|Withdrawal by Subject|2|||
161563818|NCT00318656|583452498|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
161563819|NCT00318656|583452499|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
161563820|NCT00318656|583452498|FG000|Overall Study|Did not receive any treatment|0|||
161563821|NCT00318656|583452499|FG001|Overall Study|Did not receive any treatment|1|||
161563822|NCT01446003|583452501|FG000|Period 1|Protocol Violation|2|||
161563823|NCT01446003|583452502|FG001|Period 1|Protocol Violation|0|||
161563824|NCT01446003|583452501|FG000|Period 2|Adverse Event|1|||
161563825|NCT01446003|583452502|FG001|Period 2|Adverse Event|0|||
161807323|NCT01185548|584339710|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
161807324|NCT02770820|584339712|FG000|Overall Study|Death|1|||
161807325|NCT02770820|584339712|FG000|Overall Study|Physician Decision|2|||
161807326|NCT00376623|584339713|FG000|Overall Study|Progressive disease|35|||
161807327|NCT00376623|584339714|FG001|Overall Study|Progressive disease|22|||
161807328|NCT00376623|584339715|FG002|Overall Study|Progressive disease|17|||
161807329|NCT00376623|584339713|FG000|Overall Study|Lost to Follow-up|0|||
161807330|NCT00376623|584339714|FG001|Overall Study|Lost to Follow-up|1|||
161807331|NCT00376623|584339715|FG002|Overall Study|Lost to Follow-up|0|||
161807332|NCT00376623|584339713|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
161807333|NCT00376623|584339714|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
161807334|NCT00376623|584339715|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
161910707|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
161910708|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
161910709|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
161563826|NCT01740557|583452503|FG000|Overall Study|Ineligible|1|||
161910710|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
161910711|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
161910712|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
161910713|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
161910714|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
161910715|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
161910716|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
161910717|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
161910718|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
161910719|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
161910720|NCT00827567|584725617|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
161910721|NCT01200355|584725621|FG000|Overall Study|Death|7|||
161910722|NCT01200355|584725622|FG001|Overall Study|Death|2|||
161910723|NCT03502798|584725623|FG000|Overall Study|equipment failure|0|||
161910724|NCT03502798|584725624|FG001|Overall Study|equipment failure|7|||
161910725|NCT00485303|584725625|FG000|Overall Study|Adverse Event|5|||
161563827|NCT01740557|583452503|FG000|Overall Study|Screen failure|1|||
161563828|NCT00490555|583452504|FG000|Overall Study|noncompliant with drug administration|0|||
161563829|NCT00490555|583452505|FG001|Overall Study|noncompliant with drug administration|0|||
161563830|NCT00490555|583452506|FG002|Overall Study|noncompliant with drug administration|2|||
161563831|NCT00490555|583452507|FG003|Overall Study|noncompliant with drug administration|0|||
161563832|NCT01007149|583452508|FG000|Overall Study|Administrative problems|0|||
161563833|NCT01007149|583452509|FG001|Overall Study|Administrative problems|1|||
161563834|NCT03568162|583452513|FG000|Overall Study|Adverse Event|0|||
161563835|NCT03568162|583452514|FG001|Overall Study|Adverse Event|1|||
161563836|NCT03568162|583452515|FG002|Overall Study|Adverse Event|2|||
161563837|NCT03568162|583452516|FG003|Overall Study|Adverse Event|0|||
161563838|NCT03568162|583452517|FG004|Overall Study|Adverse Event|0|||
161563839|NCT03568162|583452518|FG005|Overall Study|Adverse Event|1|||
161563840|NCT03568162|583452513|FG000|Overall Study|Death|0|||
161563841|NCT03568162|583452514|FG001|Overall Study|Death|0|||
161563842|NCT03568162|583452515|FG002|Overall Study|Death|0|||
161563843|NCT03568162|583452516|FG003|Overall Study|Death|0|||
161563844|NCT03568162|583452517|FG004|Overall Study|Death|1|||
161563845|NCT03568162|583452518|FG005|Overall Study|Death|0|||
161563846|NCT03568162|583452513|FG000|Overall Study|Lost to Follow-up|3|||
161563847|NCT03568162|583452514|FG001|Overall Study|Lost to Follow-up|2|||
161563848|NCT03568162|583452515|FG002|Overall Study|Lost to Follow-up|4|||
161563849|NCT03568162|583452516|FG003|Overall Study|Lost to Follow-up|2|||
161563850|NCT03568162|583452517|FG004|Overall Study|Lost to Follow-up|3|||
161563851|NCT03568162|583452518|FG005|Overall Study|Lost to Follow-up|2|||
161563852|NCT03568162|583452513|FG000|Overall Study|Physician Decision|0|||
161563853|NCT03568162|583452514|FG001|Overall Study|Physician Decision|1|||
161563854|NCT03568162|583452515|FG002|Overall Study|Physician Decision|1|||
161563855|NCT03568162|583452516|FG003|Overall Study|Physician Decision|0|||
161563856|NCT03568162|583452517|FG004|Overall Study|Physician Decision|1|||
161910726|NCT00485303|584725625|FG000|Overall Study|Progressive Disease|44|||
161910727|NCT00485303|584725625|FG000|Overall Study|Other|3|||
161910728|NCT00485303|584725625|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
161910729|NCT00485303|584725625|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
161910730|NCT00296335|584725632|FG000|Overall Study|Recurrence|3|||
161910731|NCT00296335|584725633|FG001|Overall Study|Recurrence|51|||
161910732|NCT00296335|584725632|FG000|Overall Study|Adverse Event|17|||
161910733|NCT00296335|584725633|FG001|Overall Study|Adverse Event|27|||
161910734|NCT00296335|584725632|FG000|Overall Study|Lost to Follow-up|7|||
161910735|NCT00296335|584725633|FG001|Overall Study|Lost to Follow-up|33|||
161910736|NCT00296335|584725632|FG000|Overall Study|Physician Decision|3|||
161563857|NCT03568162|583452518|FG005|Overall Study|Physician Decision|0|||
161563858|NCT03568162|583452513|FG000|Overall Study|Pregnancy|0|||
161563859|NCT03568162|583452514|FG001|Overall Study|Pregnancy|0|||
161563860|NCT03568162|583452515|FG002|Overall Study|Pregnancy|0|||
161563861|NCT03568162|583452516|FG003|Overall Study|Pregnancy|1|||
161563862|NCT03568162|583452517|FG004|Overall Study|Pregnancy|0|||
161563863|NCT03568162|583452518|FG005|Overall Study|Pregnancy|0|||
161563864|NCT03568162|583452513|FG000|Overall Study|Protocol Violation|1|||
161563865|NCT03568162|583452514|FG001|Overall Study|Protocol Violation|0|||
161563866|NCT03568162|583452515|FG002|Overall Study|Protocol Violation|1|||
161563867|NCT03568162|583452516|FG003|Overall Study|Protocol Violation|1|||
161563868|NCT03568162|583452517|FG004|Overall Study|Protocol Violation|1|||
161563869|NCT03568162|583452518|FG005|Overall Study|Protocol Violation|1|||
161910737|NCT00296335|584725633|FG001|Overall Study|Physician Decision|11|||
161910738|NCT01027845|584725634|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
161910739|NCT01027845|584725635|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
161910740|NCT01027845|584725636|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
161910741|NCT01027845|584725637|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
161910742|NCT01027845|584725634|FG000|Primary Vaccination Phase|Adverse Event|1|||
161910743|NCT01027845|584725635|FG001|Primary Vaccination Phase|Adverse Event|0|||
161910744|NCT01027845|584725636|FG002|Primary Vaccination Phase|Adverse Event|0|||
161910745|NCT01027845|584725637|FG003|Primary Vaccination Phase|Adverse Event|0|||
161910746|NCT01027845|584725634|FG000|Primary Vaccination Phase|Protocol Violation|1|||
161910747|NCT01027845|584725635|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161910748|NCT01027845|584725636|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161910749|NCT01027845|584725637|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161910750|NCT01027845|584725634|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
161910751|NCT01027845|584725635|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
161910752|NCT01027845|584725636|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
161910753|NCT01027845|584725637|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
161910754|NCT01027845|584725634|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
161910755|NCT01027845|584725635|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161910756|NCT01027845|584725636|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
161910757|NCT01027845|584725637|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
161910758|NCT01027845|584725634|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
161910759|NCT01027845|584725635|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
161910760|NCT01027845|584725636|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
161910761|NCT01027845|584725637|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
161910762|NCT00368550|584725638|FG000|Overall Study|Adverse Event|7|||
161910763|NCT00368550|584725639|FG001|Overall Study|Adverse Event|4|||
161910764|NCT00368550|584725638|FG000|Overall Study|Lack of Efficacy|4|||
161910765|NCT00368550|584725639|FG001|Overall Study|Lack of Efficacy|9|||
161910766|NCT00368550|584725638|FG000|Overall Study|Withdrawal by Subject|17|||
161910767|NCT00368550|584725639|FG001|Overall Study|Withdrawal by Subject|10|||
161910768|NCT00087178|584725640|FG000|Overall Study|No follow up data|5|||
161910769|NCT00087178|584725641|FG001|Overall Study|No follow up data|15|||
161910770|NCT00087178|584725640|FG000|Overall Study|No clinical assessment|1|||
161910771|NCT00087178|584725641|FG001|Overall Study|No clinical assessment|2|||
161910772|NCT00087178|584725640|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
161910773|NCT00087178|584725641|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
161910774|NCT03895086|584725642|FG000|Overall Study|Early termination study|1|||
161910775|NCT03895086|584725643|FG001|Overall Study|Early termination study|0|||
161910776|NCT00062166|584725644|FG000|Overall Study|Withdrawal by Subject|6|||
161910777|NCT06494761|584725648|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
161910778|NCT06494761|584725648|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
161910779|NCT04865289|584725649|FG000|Overall Study|Death|34|||
161910780|NCT04865289|584725650|FG001|Overall Study|Death|25|||
161910781|NCT04865289|584725649|FG000|Overall Study|Physician Decision|27|||
161910782|NCT04865289|584725650|FG001|Overall Study|Physician Decision|27|||
161910783|NCT04865289|584725649|FG000|Overall Study|Sponsor Decision|11|||
161910784|NCT04865289|584725650|FG001|Overall Study|Sponsor Decision|1|||
161910785|NCT04865289|584725649|FG000|Overall Study|Withdrawal by Subject|2|||
161910786|NCT04865289|584725650|FG001|Overall Study|Withdrawal by Subject|3|||
161910787|NCT03104374|584725651|FG000|Period 1|Adverse Event|7|||
161910788|NCT03104374|584725652|FG001|Period 1|Adverse Event|7|||
161910789|NCT03104374|584725653|FG002|Period 1|Adverse Event|12|||
161910790|NCT03104374|584725654|FG003|Period 1|Adverse Event|14|||
161910791|NCT03104374|584725651|FG000|Period 1|Withdrawal by Subject|18|||
161807335|NCT00376623|584339713|FG000|Overall Study|Not treated with BI 2536|1|||
161807336|NCT00376623|584339714|FG001|Overall Study|Not treated with BI 2536|0|||
161807337|NCT00376623|584339715|FG002|Overall Study|Not treated with BI 2536|0|||
161807338|NCT00376623|584339713|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
161807339|NCT00376623|584339714|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807340|NCT00376623|584339715|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807341|NCT00376623|584339713|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
161807342|NCT00376623|584339714|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
161807343|NCT00376623|584339715|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
161807344|NCT00376623|584339713|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
161807345|NCT00376623|584339714|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
161910792|NCT03104374|584725652|FG001|Period 1|Withdrawal by Subject|9|||
161910793|NCT03104374|584725653|FG002|Period 1|Withdrawal by Subject|10|||
161910794|NCT03104374|584725654|FG003|Period 1|Withdrawal by Subject|17|||
161910795|NCT03104374|584725651|FG000|Period 1|Lost to Follow-up|4|||
161454564|NCT00275821|583059014|FG000|Overall Study|Lack of Efficacy|2|||
161910796|NCT03104374|584725652|FG001|Period 1|Lost to Follow-up|4|||
161910797|NCT03104374|584725653|FG002|Period 1|Lost to Follow-up|6|||
161910798|NCT03104374|584725654|FG003|Period 1|Lost to Follow-up|8|||
161910799|NCT03104374|584725651|FG000|Period 1|Lack of Efficacy|6|||
161910800|NCT03104374|584725652|FG001|Period 1|Lack of Efficacy|7|||
161910801|NCT03104374|584725653|FG002|Period 1|Lack of Efficacy|12|||
161910802|NCT03104374|584725654|FG003|Period 1|Lack of Efficacy|6|||
161910803|NCT03104374|584725651|FG000|Period 1|Other|2|||
161910804|NCT03104374|584725652|FG001|Period 1|Other|2|||
161910805|NCT03104374|584725653|FG002|Period 1|Other|4|||
161910806|NCT03104374|584725654|FG003|Period 1|Other|7|||
161910807|NCT03104374|584725651|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161454565|NCT00275821|583059015|FG001|Overall Study|Lack of Efficacy|1|||
161454566|NCT00275821|583059016|FG002|Overall Study|Lack of Efficacy|0|||
161454567|NCT00275821|583059014|FG000|Overall Study|Protocol Violation|5|||
161454568|NCT00275821|583059015|FG001|Overall Study|Protocol Violation|1|||
161454569|NCT00275821|583059016|FG002|Overall Study|Protocol Violation|0|||
161454570|NCT00409175|583059017|FG000|Overall Study|Adverse Event|4|||
161454571|NCT00409175|583059018|FG001|Overall Study|Adverse Event|3|||
161454572|NCT00409175|583059017|FG000|Overall Study|Withdrawal by Subject|1|||
161454573|NCT00409175|583059018|FG001|Overall Study|Withdrawal by Subject|2|||
161454574|NCT00409175|583059017|FG000|Overall Study|Negative genotype|0|||
161454575|NCT00409175|583059018|FG001|Overall Study|Negative genotype|1|||
161454576|NCT00409175|583059017|FG000|Overall Study|Liver transplantation|13|||
161454577|NCT00409175|583059018|FG001|Overall Study|Liver transplantation|13|||
161454578|NCT01328444|583059021|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
161454579|NCT01328444|583059022|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
161454580|NCT01328444|583059023|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
161454581|NCT01328444|583059024|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
161454582|NCT01328444|583059025|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
161454583|NCT01328444|583059026|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
161454584|NCT01328444|583059021|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
161454585|NCT01328444|583059022|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
161454586|NCT01328444|583059023|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
161454587|NCT01328444|583059024|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
161454588|NCT01328444|583059025|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
161454589|NCT01328444|583059026|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
161454590|NCT01328444|583059021|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
161454591|NCT01328444|583059022|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
161454592|NCT01328444|583059023|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
161454593|NCT01328444|583059024|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
161454594|NCT01328444|583059025|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
161454595|NCT01328444|583059026|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
161454596|NCT01328444|583059021|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
161454597|NCT01328444|583059022|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
161454598|NCT01328444|583059023|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
161454599|NCT01328444|583059024|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
161454600|NCT01328444|583059025|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
161454601|NCT01328444|583059026|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
161454602|NCT01328444|583059021|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
161454603|NCT01328444|583059022|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161454604|NCT01328444|583059023|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161454605|NCT01328444|583059024|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161454606|NCT01328444|583059025|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161454607|NCT01328444|583059026|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161454608|NCT01328444|583059021|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161454609|NCT01328444|583059022|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
161454610|NCT01328444|583059023|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
161454611|NCT01328444|583059024|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
161454612|NCT01328444|583059025|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
161454613|NCT01328444|583059026|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161454614|NCT01328444|583059021|FG000|Washout Period (14 Days)|Adverse Event|1|||
161454615|NCT01328444|583059022|FG001|Washout Period (14 Days)|Adverse Event|1|||
161454616|NCT01328444|583059023|FG002|Washout Period (14 Days)|Adverse Event|0|||
161454617|NCT01328444|583059024|FG003|Washout Period (14 Days)|Adverse Event|1|||
161454618|NCT01328444|583059025|FG004|Washout Period (14 Days)|Adverse Event|1|||
161454619|NCT01328444|583059026|FG005|Washout Period (14 Days)|Adverse Event|2|||
161454620|NCT01328444|583059021|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
161910808|NCT03104374|584725652|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161910809|NCT03104374|584725653|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161563870|NCT03568162|583452513|FG000|Overall Study|Withdrawal by Subject|15|||
161563871|NCT03568162|583452514|FG001|Overall Study|Withdrawal by Subject|15|||
161563872|NCT03568162|583452515|FG002|Overall Study|Withdrawal by Subject|26|||
161563873|NCT03568162|583452516|FG003|Overall Study|Withdrawal by Subject|22|||
161563874|NCT03568162|583452517|FG004|Overall Study|Withdrawal by Subject|6|||
161563875|NCT03568162|583452518|FG005|Overall Study|Withdrawal by Subject|9|||
161563876|NCT03568162|583452513|FG000|Overall Study|Others|3|||
161563877|NCT03568162|583452514|FG001|Overall Study|Others|4|||
161563878|NCT03568162|583452515|FG002|Overall Study|Others|1|||
161563879|NCT03568162|583452516|FG003|Overall Study|Others|4|||
161563880|NCT03568162|583452517|FG004|Overall Study|Others|2|||
161563881|NCT03568162|583452518|FG005|Overall Study|Others|1|||
161563882|NCT00337818|583452519|FG000|Overall Study|Lost to Follow-up|289|||
161563883|NCT00337818|583452520|FG001|Overall Study|Lost to Follow-up|91|||
161563884|NCT00337818|583452521|FG002|Overall Study|Lost to Follow-up|107|||
161563885|NCT00938340|583452523|FG000|Overall Study|Withdrawal by Subject|3|||
161563886|NCT00938340|583452523|FG000|Overall Study|Protocol Violation|1|||
161563887|NCT00938340|583452523|FG000|Overall Study|Adverse Event|1|||
161563888|NCT05174065|583452525|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161563889|NCT05174065|583452526|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
161563890|NCT05174065|583452527|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
161563891|NCT05174065|583452525|FG000|Placebo-controlled Period|Other|0|||
161563892|NCT05174065|583452526|FG001|Placebo-controlled Period|Other|1|||
161563893|NCT05174065|583452527|FG002|Placebo-controlled Period|Other|0|||
161563894|NCT05174065|583452525|FG000|Placebo-controlled Period|Adverse Event|1|||
161563895|NCT05174065|583452526|FG001|Placebo-controlled Period|Adverse Event|1|||
161563896|NCT05174065|583452527|FG002|Placebo-controlled Period|Adverse Event|0|||
161563897|NCT05174065|583452525|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
161563898|NCT05174065|583452526|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
161563899|NCT05174065|583452527|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
161563900|NCT05174065|583452525|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
161563901|NCT05174065|583452526|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
161563902|NCT05174065|583452527|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
161563903|NCT05174065|583452525|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
161563904|NCT05174065|583452526|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
161563905|NCT05174065|583452527|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
161563906|NCT00209274|583452530|FG000|Overall Study|Missed visit|3|||
161563907|NCT00209274|583452531|FG001|Overall Study|Missed visit|2|||
161563908|NCT00209274|583452530|FG000|Overall Study|Death|32|||
161563909|NCT00209274|583452531|FG001|Overall Study|Death|15|||
161563910|NCT00209274|583452530|FG000|Overall Study|Withdrawal by Subject|30|||
161563911|NCT00209274|583452531|FG001|Overall Study|Withdrawal by Subject|15|||
161563912|NCT00209274|583452530|FG000|Overall Study|Randomized not treated (RNT)|6|||
161563913|NCT00209274|583452531|FG001|Overall Study|Randomized not treated (RNT)|15|||
161563914|NCT02753530|583452533|FG000|Overall Study|Adverse Event|7|||
161563915|NCT02753530|583452534|FG001|Overall Study|Adverse Event|1|||
161563916|NCT02753530|583452533|FG000|Overall Study|Death|0|||
161563917|NCT02753530|583452534|FG001|Overall Study|Death|1|||
161563918|NCT02753530|583452533|FG000|Overall Study|Physician Decision|0|||
161563919|NCT02753530|583452534|FG001|Overall Study|Physician Decision|1|||
161563920|NCT02753530|583452533|FG000|Overall Study|Protocol Violation|1|||
161563921|NCT02753530|583452534|FG001|Overall Study|Protocol Violation|0|||
161563922|NCT02753530|583452533|FG000|Overall Study|Withdrawal by Subject|4|||
161563923|NCT02753530|583452534|FG001|Overall Study|Withdrawal by Subject|3|||
161563924|NCT02909101|583452535|FG000|Overall Study|Lost to Follow-up|1|||
161563925|NCT02909101|583452536|FG001|Overall Study|Lost to Follow-up|1|||
161563926|NCT01959880|583452537|FG000|Overall Study|Withdrawal by Subject|11|||
161563927|NCT01959880|583452538|FG001|Overall Study|Withdrawal by Subject|13|||
161563928|NCT01959880|583452539|FG002|Overall Study|Withdrawal by Subject|8|||
161563929|NCT01959880|583452540|FG003|Overall Study|Withdrawal by Subject|7|||
161563930|NCT01959880|583452537|FG000|Overall Study|Death|1|||
161563931|NCT01959880|583452538|FG001|Overall Study|Death|10|||
161563932|NCT01959880|583452539|FG002|Overall Study|Death|1|||
161563933|NCT01959880|583452540|FG003|Overall Study|Death|2|||
161563934|NCT01959880|583452537|FG000|Overall Study|Lost to Follow-up|95|||
161563935|NCT01959880|583452538|FG001|Overall Study|Lost to Follow-up|18|||
161563936|NCT01959880|583452539|FG002|Overall Study|Lost to Follow-up|15|||
161563937|NCT01959880|583452540|FG003|Overall Study|Lost to Follow-up|8|||
161563938|NCT01959880|583452537|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
161563939|NCT01959880|583452538|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
161563940|NCT01959880|583452539|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
161563941|NCT01959880|583452540|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
161563942|NCT01959880|583452537|FG000|Overall Study|Study completed early-FDA approved|1003|||
161563943|NCT01959880|583452538|FG001|Overall Study|Study completed early-FDA approved|311|||
161563944|NCT01959880|583452539|FG002|Overall Study|Study completed early-FDA approved|179|||
161563945|NCT01959880|583452540|FG003|Overall Study|Study completed early-FDA approved|152|||
161563946|NCT01537133|583454478|FG000|Overall Study|Withdrawal by Subject|2|||
161563947|NCT01537133|583454479|FG001|Overall Study|Withdrawal by Subject|0|||
161563948|NCT01537133|583454480|FG002|Overall Study|Withdrawal by Subject|0|||
161563949|NCT01537133|583454481|FG003|Overall Study|Withdrawal by Subject|0|||
161563950|NCT01537133|583454478|FG000|Overall Study|Lost to Follow-up|1|||
161563951|NCT01537133|583454479|FG001|Overall Study|Lost to Follow-up|0|||
161563952|NCT01537133|583454480|FG002|Overall Study|Lost to Follow-up|0|||
161563953|NCT01537133|583454481|FG003|Overall Study|Lost to Follow-up|0|||
161563954|NCT03712930|583454482|FG000|Overall Study|Death|7|||
161563955|NCT03712930|583454482|FG000|Overall Study|Physician Decision|1|||
161563956|NCT03712930|583454482|FG000|Overall Study|Study Terminated by Sponsor|3|||
161563957|NCT03712930|583454482|FG000|Overall Study|Progressive Disease|2|||
161563958|NCT03837028|583454485|FG000|Overall Study|Lost to Follow-up|4|||
161563959|NCT03837028|583454486|FG001|Overall Study|Lost to Follow-up|0|||
161563960|NCT03837028|583454487|FG002|Overall Study|Lost to Follow-up|2|||
161563961|NCT03837028|583454488|FG003|Overall Study|Lost to Follow-up|0|||
161563962|NCT03837028|583454485|FG000|Overall Study|Withdrawal by Subject|12|||
161563963|NCT03837028|583454486|FG001|Overall Study|Withdrawal by Subject|11|||
161563964|NCT03837028|583454487|FG002|Overall Study|Withdrawal by Subject|11|||
161563965|NCT03837028|583454488|FG003|Overall Study|Withdrawal by Subject|7|||
161563966|NCT03784963|583454489|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
161563967|NCT03784963|583454490|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
161563968|NCT03784963|583454491|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
161563969|NCT03784963|583454492|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
161563970|NCT00157014|583454493|FG000|Overall Study|Death|4|||
161563971|NCT00157014|583454494|FG001|Overall Study|Death|2|||
161563972|NCT00157014|583454495|FG002|Overall Study|Death|1|||
161563973|NCT00157014|583454496|FG003|Overall Study|Death|1|||
161563974|NCT00157014|583454493|FG000|Overall Study|Physician Decision|0|||
161563975|NCT00157014|583454494|FG001|Overall Study|Physician Decision|1|||
161563976|NCT00157014|583454495|FG002|Overall Study|Physician Decision|0|||
161563977|NCT00157014|583454496|FG003|Overall Study|Physician Decision|0|||
161563978|NCT00157014|583454493|FG000|Overall Study|Medications withdrawn on family request|0|||
161563979|NCT00157014|583454494|FG001|Overall Study|Medications withdrawn on family request|1|||
161563980|NCT00157014|583454495|FG002|Overall Study|Medications withdrawn on family request|0|||
161563981|NCT00157014|583454496|FG003|Overall Study|Medications withdrawn on family request|0|||
161563982|NCT00157014|583454493|FG000|Overall Study|Patient withdrawn by investigator|1|||
161563983|NCT00157014|583454494|FG001|Overall Study|Patient withdrawn by investigator|0|||
161563984|NCT00157014|583454495|FG002|Overall Study|Patient withdrawn by investigator|0|||
161563985|NCT00157014|583454496|FG003|Overall Study|Patient withdrawn by investigator|0|||
161563986|NCT00157014|583454493|FG000|Overall Study|Patient unable to return in nursing home|1|||
161563987|NCT00157014|583454494|FG001|Overall Study|Patient unable to return in nursing home|0|||
161563988|NCT00157014|583454495|FG002|Overall Study|Patient unable to return in nursing home|0|||
161563989|NCT00157014|583454496|FG003|Overall Study|Patient unable to return in nursing home|0|||
161563990|NCT00157014|583454493|FG000|Overall Study|Patient would not receive transplant|0|||
161563991|NCT00157014|583454494|FG001|Overall Study|Patient would not receive transplant|1|||
161563992|NCT00157014|583454495|FG002|Overall Study|Patient would not receive transplant|0|||
161563993|NCT00157014|583454496|FG003|Overall Study|Patient would not receive transplant|0|||
161563994|NCT00157014|583454493|FG000|Overall Study|Withdrawal by Subject|1|||
161563995|NCT00157014|583454494|FG001|Overall Study|Withdrawal by Subject|0|||
161563996|NCT00157014|583454495|FG002|Overall Study|Withdrawal by Subject|0|||
161563997|NCT00157014|583454496|FG003|Overall Study|Withdrawal by Subject|0|||
161563998|NCT01362491|583454497|FG000|Overall Study|Ineligible|1|||
161563999|NCT01362491|583454498|FG001|Overall Study|Ineligible|0|||
161564000|NCT01362491|583454499|FG002|Overall Study|Ineligible|0|||
161564001|NCT05355116|583454500|FG000|Overall Study|Withdrawal by Subject|2|||
161564002|NCT00349908|583454501|FG000|Overall Study|Withdrawal by Subject|0|||
161564003|NCT00349908|583454502|FG001|Overall Study|Withdrawal by Subject|4|||
161564004|NCT01289119|583454506|FG000|Overall Study|Adverse Event|2|||
161564005|NCT01289119|583454507|FG001|Overall Study|Adverse Event|1|||
161564006|NCT01289119|583454508|FG002|Overall Study|Adverse Event|0|||
161564007|NCT01289119|583454509|FG003|Overall Study|Adverse Event|2|||
161564008|NCT01289119|583454510|FG004|Overall Study|Adverse Event|1|||
161564009|NCT01289119|583454511|FG005|Overall Study|Adverse Event|0|||
161564010|NCT01289119|583454506|FG000|Overall Study|Major Protocol Deviation|2|||
161564011|NCT01289119|583454507|FG001|Overall Study|Major Protocol Deviation|1|||
161564012|NCT01289119|583454508|FG002|Overall Study|Major Protocol Deviation|3|||
161564013|NCT01289119|583454509|FG003|Overall Study|Major Protocol Deviation|0|||
161564014|NCT01289119|583454510|FG004|Overall Study|Major Protocol Deviation|2|||
161564015|NCT01289119|583454511|FG005|Overall Study|Major Protocol Deviation|1|||
161564016|NCT01289119|583454506|FG000|Overall Study|Lost to Follow-up|0|||
161564017|NCT01289119|583454507|FG001|Overall Study|Lost to Follow-up|3|||
161564018|NCT01289119|583454508|FG002|Overall Study|Lost to Follow-up|0|||
161564019|NCT01289119|583454509|FG003|Overall Study|Lost to Follow-up|0|||
161564020|NCT01289119|583454510|FG004|Overall Study|Lost to Follow-up|0|||
161564021|NCT01289119|583454511|FG005|Overall Study|Lost to Follow-up|1|||
161564022|NCT01289119|583454506|FG000|Overall Study|Withdrawal by Subject|4|||
161564023|NCT01289119|583454507|FG001|Overall Study|Withdrawal by Subject|2|||
161564024|NCT01289119|583454508|FG002|Overall Study|Withdrawal by Subject|4|||
161564025|NCT01289119|583454509|FG003|Overall Study|Withdrawal by Subject|3|||
161564026|NCT01289119|583454510|FG004|Overall Study|Withdrawal by Subject|1|||
161564027|NCT01289119|583454511|FG005|Overall Study|Withdrawal by Subject|1|||
161564028|NCT01289119|583454506|FG000|Overall Study|Pregnancy|0|||
161564029|NCT01289119|583454507|FG001|Overall Study|Pregnancy|1|||
161564030|NCT01289119|583454508|FG002|Overall Study|Pregnancy|0|||
161564031|NCT01289119|583454509|FG003|Overall Study|Pregnancy|0|||
161564032|NCT01289119|583454510|FG004|Overall Study|Pregnancy|0|||
161564033|NCT01289119|583454511|FG005|Overall Study|Pregnancy|0|||
161564034|NCT01289119|583454506|FG000|Overall Study|Lack of Efficacy|0|||
161564035|NCT01289119|583454507|FG001|Overall Study|Lack of Efficacy|1|||
161564036|NCT01289119|583454508|FG002|Overall Study|Lack of Efficacy|1|||
161564037|NCT01289119|583454509|FG003|Overall Study|Lack of Efficacy|1|||
161564038|NCT01289119|583454510|FG004|Overall Study|Lack of Efficacy|1|||
161564039|NCT01289119|583454511|FG005|Overall Study|Lack of Efficacy|1|||
161564040|NCT01289119|583454506|FG000|Overall Study|Other|1|||
161564041|NCT01289119|583454507|FG001|Overall Study|Other|0|||
161564042|NCT01289119|583454508|FG002|Overall Study|Other|1|||
161564043|NCT01289119|583454509|FG003|Overall Study|Other|0|||
161564044|NCT01289119|583454510|FG004|Overall Study|Other|0|||
161564045|NCT01289119|583454511|FG005|Overall Study|Other|0|||
161564046|NCT01704846|583454512|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161564047|NCT01704846|583454513|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161564048|NCT00530335|583454516|FG000|Overall Study|Adverse Event|3|||
161564049|NCT00530335|583454516|FG000|Overall Study|Protocol Violation|1|||
161564050|NCT00530335|583454516|FG000|Overall Study|Withdrawal by Subject|1|||
161564051|NCT00530335|583454516|FG000|Overall Study|Physician Decision|1|||
161564052|NCT01244984|583454518|FG000|Overall Study|Adverse Event|2|||
161564053|NCT01244984|583454519|FG001|Overall Study|Adverse Event|11|||
161564054|NCT01244984|583454520|FG002|Overall Study|Adverse Event|2|||
161564055|NCT01244984|583454518|FG000|Overall Study|Protocol Violation|1|||
161564056|NCT01244984|583454519|FG001|Overall Study|Protocol Violation|0|||
161564057|NCT01244984|583454520|FG002|Overall Study|Protocol Violation|0|||
161564058|NCT01244984|583454518|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
161564059|NCT01244984|583454519|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
161564060|NCT01244984|583454520|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
161564061|NCT01244984|583454518|FG000|Overall Study|Withdrawal by Subject|1|||
161564062|NCT01244984|583454519|FG001|Overall Study|Withdrawal by Subject|2|||
161564063|NCT01244984|583454520|FG002|Overall Study|Withdrawal by Subject|2|||
161564064|NCT04577183|583454521|FG000|Overall Study|Death|1|||
161564065|NCT04577183|583454521|FG000|Overall Study|Withdrawal by Subject|3|||
161564066|NCT04577183|583454521|FG000|Overall Study|Early termination|2|||
161564067|NCT01168401|583454522|FG000|Overall Study|Lost to Follow-up|1|||
161564068|NCT01168401|583454523|FG001|Overall Study|Lost to Follow-up|1|||
161564069|NCT01168401|583454524|FG002|Overall Study|Lost to Follow-up|2|||
161564070|NCT01168401|583454525|FG003|Overall Study|Lost to Follow-up|1|||
161564071|NCT01168401|583454526|FG004|Overall Study|Lost to Follow-up|0|||
161564072|NCT01168401|583454527|FG005|Overall Study|Lost to Follow-up|0|||
161564073|NCT01168401|583454528|FG006|Overall Study|Lost to Follow-up|0|||
161564074|NCT01168401|583454529|FG007|Overall Study|Lost to Follow-up|0|||
161564075|NCT01168401|583454530|FG008|Overall Study|Lost to Follow-up|0|||
161564076|NCT01168401|583454531|FG009|Overall Study|Lost to Follow-up|0|||
161564077|NCT01168401|583454532|FG010|Overall Study|Lost to Follow-up|0|||
161564078|NCT01168401|583454522|FG000|Overall Study|Withdrawal by Subject|0|||
161564079|NCT01168401|583454523|FG001|Overall Study|Withdrawal by Subject|0|||
161564080|NCT01168401|583454524|FG002|Overall Study|Withdrawal by Subject|0|||
161564081|NCT01168401|583454525|FG003|Overall Study|Withdrawal by Subject|1|||
161564082|NCT01168401|583454526|FG004|Overall Study|Withdrawal by Subject|0|||
161564083|NCT01168401|583454527|FG005|Overall Study|Withdrawal by Subject|0|||
161564084|NCT01168401|583454528|FG006|Overall Study|Withdrawal by Subject|0|||
161564085|NCT01168401|583454529|FG007|Overall Study|Withdrawal by Subject|0|||
161564086|NCT01168401|583454530|FG008|Overall Study|Withdrawal by Subject|0|||
161564087|NCT01168401|583454531|FG009|Overall Study|Withdrawal by Subject|0|||
161564088|NCT01168401|583454532|FG010|Overall Study|Withdrawal by Subject|0|||
161564089|NCT01801930|583454537|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
161564090|NCT01801930|583454538|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
161564091|NCT01801930|583454539|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
161564092|NCT01801930|583454540|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
161564093|NCT01801930|583454537|FG000|Overall Study|DLT occurs|0|||
161564094|NCT01801930|583454538|FG001|Overall Study|DLT occurs|1|||
161564095|NCT01801930|583454539|FG002|Overall Study|DLT occurs|0|||
161564096|NCT01801930|583454540|FG003|Overall Study|DLT occurs|0|||
161564097|NCT03396835|583454553|FG000|Overall Study|Withdrawn prior to completion|1|||
161564098|NCT03396835|583454553|FG000|Overall Study|Did not meet criteria for data analysis|1|||
161564099|NCT03467724|583454554|FG000|Overall Study|Lost to Follow-up|5|||
161564100|NCT03467724|583454554|FG000|Overall Study|Withdrawal by Subject|1|||
161564101|NCT03467724|583454554|FG000|Overall Study|Protocol Violation|1|||
161564102|NCT03467724|583454554|FG000|Overall Study|Adverse Event|1|||
161564103|NCT01451814|583454555|FG000|Overall Study|Withdrawal by Subject|1|||
161564104|NCT01451814|583454556|FG001|Overall Study|Withdrawal by Subject|1|||
161564105|NCT01451814|583454555|FG000|Overall Study|Lost to Follow-up|5|||
161564106|NCT01451814|583454556|FG001|Overall Study|Lost to Follow-up|4|||
161564107|NCT02049866|583454557|FG000|Overall Study|Withdrawal by Subject|1|||
161564108|NCT03101592|583454560|FG000|Overall Study|participant files could not be located|111|||
161564109|NCT03101592|583454561|FG001|Overall Study|participant files could not be located|170|||
161564110|NCT03101592|583454562|FG002|Overall Study|participant files could not be located|118|||
161910810|NCT03104374|584725654|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
161910811|NCT03104374|584725651|FG000|Period 2|Adverse Event|4|||
161910812|NCT03104374|584725652|FG001|Period 2|Adverse Event|7|||
161910813|NCT03104374|584725653|FG002|Period 2|Adverse Event|10|||
161910814|NCT03104374|584725654|FG003|Period 2|Adverse Event|10|||
161910815|NCT03104374|584725651|FG000|Period 2|Withdrawal by Subject|3|||
161910816|NCT03104374|584725652|FG001|Period 2|Withdrawal by Subject|7|||
161910817|NCT03104374|584725653|FG002|Period 2|Withdrawal by Subject|13|||
161910818|NCT03104374|584725654|FG003|Period 2|Withdrawal by Subject|16|||
161910819|NCT03104374|584725651|FG000|Period 2|Lost to Follow-up|2|||
161910820|NCT03104374|584725652|FG001|Period 2|Lost to Follow-up|2|||
161910821|NCT03104374|584725653|FG002|Period 2|Lost to Follow-up|3|||
161910822|NCT03104374|584725654|FG003|Period 2|Lost to Follow-up|5|||
161910823|NCT03104374|584725651|FG000|Period 2|Lack of Efficacy|2|||
161910824|NCT03104374|584725652|FG001|Period 2|Lack of Efficacy|4|||
161910825|NCT03104374|584725653|FG002|Period 2|Lack of Efficacy|7|||
161910826|NCT03104374|584725654|FG003|Period 2|Lack of Efficacy|4|||
161910827|NCT03104374|584725651|FG000|Period 2|COVID-19 Infection|0|||
161910828|NCT03104374|584725652|FG001|Period 2|COVID-19 Infection|0|||
161910829|NCT03104374|584725653|FG002|Period 2|COVID-19 Infection|1|||
161910830|NCT03104374|584725654|FG003|Period 2|COVID-19 Infection|0|||
161910831|NCT03104374|584725651|FG000|Period 2|Other|3|||
161910832|NCT03104374|584725652|FG001|Period 2|Other|2|||
161910833|NCT03104374|584725653|FG002|Period 2|Other|2|||
161910834|NCT03104374|584725654|FG003|Period 2|Other|4|||
161910835|NCT03210714|584725655|FG000|Overall Study|Adverse Event|6|||
161910836|NCT03210714|584725655|FG000|Overall Study|Physician Decision|1|||
161910837|NCT03210714|584725655|FG000|Overall Study|Progressive disease|11|||
161910838|NCT03210714|584725655|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
161910839|NCT00803179|584725656|FG000|Overall Study|Lost to Follow-up|3|||
161910840|NCT04158648|584725657|FG000|Overall Study|Ongoing in the Study|69|||
161910841|NCT04158648|584725657|FG000|Overall Study|Withdrawal by Subject|4|||
161910842|NCT04609514|584725658|FG000|Overall Study|Lost to Follow-up|5|||
161910843|NCT04609514|584725659|FG001|Overall Study|Lost to Follow-up|4|||
161910844|NCT04609514|584725658|FG000|Overall Study|Withdrawal by PI|0|||
161910845|NCT04609514|584725659|FG001|Overall Study|Withdrawal by PI|2|||
161910846|NCT00885118|584725660|FG000|Overall Study|Adverse Event|1|||
161910847|NCT00885118|584725661|FG001|Overall Study|Adverse Event|0|||
161910848|NCT00885118|584725662|FG002|Overall Study|Adverse Event|0|||
161910849|NCT00885118|584725663|FG003|Overall Study|Adverse Event|0|||
161910850|NCT00885118|584725664|FG004|Overall Study|Adverse Event|0|||
161910851|NCT00885118|584725660|FG000|Overall Study|Withdrawal by Subject|0|||
161910852|NCT00885118|584725661|FG001|Overall Study|Withdrawal by Subject|0|||
161910853|NCT00885118|584725662|FG002|Overall Study|Withdrawal by Subject|0|||
161910854|NCT00885118|584725663|FG003|Overall Study|Withdrawal by Subject|0|||
161910855|NCT00885118|584725664|FG004|Overall Study|Withdrawal by Subject|1|||
161910856|NCT00885118|584725660|FG000|Overall Study|Other reason not defined above|0|||
161910857|NCT00885118|584725661|FG001|Overall Study|Other reason not defined above|0|||
161910858|NCT00885118|584725662|FG002|Overall Study|Other reason not defined above|1|||
161910859|NCT00885118|584725663|FG003|Overall Study|Other reason not defined above|0|||
161910860|NCT00885118|584725664|FG004|Overall Study|Other reason not defined above|0|||
161910861|NCT00921024|584725679|FG000|Overall Study|Lost to Follow-up|2|||
161910862|NCT00921024|584725680|FG001|Overall Study|Lost to Follow-up|0|||
161910863|NCT00921024|584725679|FG000|Overall Study|Received concomittant therapy|2|||
161910864|NCT00921024|584725680|FG001|Overall Study|Received concomittant therapy|0|||
161564111|NCT02397889|583454565|FG000|Overall Study|Physician Decision|1|||
161910865|NCT00921024|584725679|FG000|Overall Study|Withdrawal by Subject|0|||
161910866|NCT00921024|584725680|FG001|Overall Study|Withdrawal by Subject|3|||
161910867|NCT02097823|584725681|FG000|Overall Study|Withdrawal by Subject|1|||
161910868|NCT02097823|584725682|FG001|Overall Study|Withdrawal by Subject|1|||
161910869|NCT05399680|584727086|FG000|Overall Study|Lost to Follow-up|1|||
161910870|NCT05399680|584727087|FG001|Overall Study|Lost to Follow-up|0|||
161910871|NCT05399680|584727086|FG000|Overall Study|Death|0|||
161564112|NCT02397889|583454566|FG001|Overall Study|Physician Decision|0|||
161564113|NCT02219490|583454570|FG000|Overall Study|Adverse Event|24|||
161564114|NCT02219490|583454570|FG000|Overall Study|Withdrew consent|96|||
161564115|NCT02219490|583454570|FG000|Overall Study|Lost to Follow-up|126|||
161564116|NCT02219490|583454570|FG000|Overall Study|COVID-19 infection|2|||
161564117|NCT02219490|583454570|FG000|Overall Study|COVID-19 logistical restrictions|33|||
161564118|NCT02219490|583454570|FG000|Overall Study|Other, not specified|57|||
161564119|NCT01928940|583454574|FG000|Overall Study|Adverse Event|0|||
161564120|NCT01928940|583454575|FG001|Overall Study|Adverse Event|1|||
161564121|NCT01352507|583454578|FG000|Treatment Period 1|Adverse Event|3|||
161564122|NCT01352507|583454579|FG001|Treatment Period 1|Adverse Event|0|||
161564123|NCT01352507|583454578|FG000|Treatment Period 1|Lost to Follow-up|3|||
161564124|NCT01352507|583454579|FG001|Treatment Period 1|Lost to Follow-up|4|||
161564125|NCT01352507|583454578|FG000|Treatment Period 1|Withdrawal by Subject|7|||
161564126|NCT01352507|583454579|FG001|Treatment Period 1|Withdrawal by Subject|5|||
161564127|NCT01352507|583454578|FG000|Treatment Period 1|Physician Decision|1|||
161564128|NCT01352507|583454579|FG001|Treatment Period 1|Physician Decision|0|||
161564129|NCT01352507|583454578|FG000|Washout Period|Withdrawal by Subject|0|||
161564130|NCT01352507|583454579|FG001|Washout Period|Withdrawal by Subject|1|||
161564131|NCT01352507|583454578|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
161564132|NCT01352507|583454579|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
161564133|NCT01352507|583454578|FG000|Treatment Period 2|Withdrawal by Subject|4|||
161564134|NCT01352507|583454579|FG001|Treatment Period 2|Withdrawal by Subject|3|||
161564135|NCT01352507|583454578|FG000|Treatment Period 2|Lack of Efficacy|1|||
161564136|NCT01352507|583454579|FG001|Treatment Period 2|Lack of Efficacy|0|||
161564137|NCT03178201|583454580|FG000|Overall Study|Off study|5|||
161564138|NCT04639947|583454585|FG000|Overall Study|Screen fail|1|||
161564139|NCT01018511|583454586|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
161564140|NCT01018511|583454587|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
161564141|NCT01018511|583454588|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
161564142|NCT01018511|583454589|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
161564143|NCT01018511|583454586|FG000|Overall Study|Adverse Event|5|||
161564144|NCT01018511|583454587|FG001|Overall Study|Adverse Event|9|||
161564145|NCT01018511|583454588|FG002|Overall Study|Adverse Event|13|||
161564146|NCT01018511|583454589|FG003|Overall Study|Adverse Event|10|||
161564147|NCT01018511|583454586|FG000|Overall Study|Lack of Efficacy|4|||
161564148|NCT01018511|583454587|FG001|Overall Study|Lack of Efficacy|1|||
161564149|NCT01018511|583454588|FG002|Overall Study|Lack of Efficacy|1|||
161564150|NCT01018511|583454589|FG003|Overall Study|Lack of Efficacy|2|||
161564151|NCT01018511|583454586|FG000|Overall Study|Withdrawal by Subject|6|||
161564152|NCT01018511|583454587|FG001|Overall Study|Withdrawal by Subject|5|||
161564153|NCT01018511|583454588|FG002|Overall Study|Withdrawal by Subject|11|||
161564154|NCT01018511|583454589|FG003|Overall Study|Withdrawal by Subject|9|||
161564155|NCT01018511|583454586|FG000|Overall Study|Lost to Follow-up|0|||
161564156|NCT01018511|583454587|FG001|Overall Study|Lost to Follow-up|0|||
161564157|NCT01018511|583454588|FG002|Overall Study|Lost to Follow-up|1|||
161564158|NCT01018511|583454589|FG003|Overall Study|Lost to Follow-up|0|||
161564159|NCT01018511|583454586|FG000|Overall Study|Protocol Violation|5|||
161564160|NCT01018511|583454587|FG001|Overall Study|Protocol Violation|8|||
161564161|NCT01018511|583454588|FG002|Overall Study|Protocol Violation|7|||
161564162|NCT01018511|583454589|FG003|Overall Study|Protocol Violation|9|||
161564163|NCT01018511|583454586|FG000|Overall Study|Miscellaneous|0|||
161564164|NCT01018511|583454587|FG001|Overall Study|Miscellaneous|2|||
161564165|NCT01018511|583454588|FG002|Overall Study|Miscellaneous|0|||
161564166|NCT01018511|583454589|FG003|Overall Study|Miscellaneous|0|||
161564167|NCT03424239|583454590|FG000|Overall Study|Withdrawal by Subject|2|||
161564168|NCT00604786|583454598|FG000|Overall Study|Lost to Follow-up|2|||
161564169|NCT00604786|583454599|FG001|Overall Study|Lost to Follow-up|0|||
161564170|NCT03697460|583454600|FG000|Overall Study|Withdrawal by Subject|3|||
161564171|NCT03369951|583454601|FG000|Overall Study|Withdrawal by Subject|3|||
161564172|NCT03369951|583454601|FG000|Overall Study|Death|1|||
161564173|NCT03369951|583454601|FG000|Overall Study|Lost to Follow-up|1|||
161564174|NCT03369951|583454601|FG000|Overall Study|Protocol Violation|1|||
161807346|NCT00376623|584339715|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807347|NCT00376623|584339713|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
161807348|NCT00376623|584339714|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
161807349|NCT00376623|584339715|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
161807350|NCT00376623|584339713|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161564175|NCT03677375|583454602|FG000|Overall Study|Incomplete procedure|8|||
161564176|NCT03677375|583454602|FG000|Overall Study|Adverse Event|3|||
161564177|NCT03677375|583454602|FG000|Overall Study|Physician Decision|1|||
161564178|NCT00725010|583454608|FG000|Overall Study|Toxicity|9|||
161564179|NCT00725010|583454608|FG000|Overall Study|Tumor Progression|7|||
161564180|NCT00725010|583454608|FG000|Overall Study|Withdrawal by Subject|2|||
161564181|NCT00725010|583454608|FG000|Overall Study|Death|1|||
161564182|NCT00725010|583454608|FG000|Overall Study|Lost to Follow-up|1|||
161564183|NCT00725010|583454608|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
161564184|NCT00725010|583454608|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
161564185|NCT00725010|583454608|FG000|Overall Study|No further documentation|1|||
161564186|NCT00725010|583454608|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
161564187|NCT02414828|583454609|FG000|Overall Study|Lost to Follow-up|0|||
161564188|NCT02414828|583454610|FG001|Overall Study|Lost to Follow-up|1|||
161564189|NCT02414828|583454611|FG002|Overall Study|Lost to Follow-up|1|||
161564190|NCT02414828|583454612|FG003|Overall Study|Lost to Follow-up|2|||
161564191|NCT00430677|583454614|FG000|Short-term Period|Death|1|||
161564192|NCT00430677|583454615|FG001|Short-term Period|Death|1|||
161564193|NCT00430677|583454616|FG002|Short-term Period|Death|5|||
161564194|NCT00430677|583454614|FG000|Short-term Period|Adverse Event|15|||
161564195|NCT00430677|583454615|FG001|Short-term Period|Adverse Event|13|||
161564196|NCT00430677|583454616|FG002|Short-term Period|Adverse Event|9|||
161564197|NCT00430677|583454614|FG000|Short-term Period|Lack of Efficacy|5|||
161564198|NCT00430677|583454615|FG001|Short-term Period|Lack of Efficacy|6|||
161564199|NCT00430677|583454616|FG002|Short-term Period|Lack of Efficacy|4|||
161564200|NCT00430677|583454614|FG000|Short-term Period|Withdrawal by Subject|1|||
161564201|NCT00430677|583454615|FG001|Short-term Period|Withdrawal by Subject|1|||
161564202|NCT00430677|583454616|FG002|Short-term Period|Withdrawal by Subject|2|||
161564203|NCT00430677|583454614|FG000|Short-term Period|Participant no longer met study criteria|1|||
161564204|NCT00430677|583454615|FG001|Short-term Period|Participant no longer met study criteria|1|||
161564205|NCT00430677|583454616|FG002|Short-term Period|Participant no longer met study criteria|2|||
161564206|NCT00430677|583454614|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
161564207|NCT00430677|583454615|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
161564208|NCT00430677|583454616|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
161564209|NCT00430677|583454614|FG000|Short-term Period|Pregnancy|0|||
161564210|NCT00430677|583454615|FG001|Short-term Period|Pregnancy|2|||
161564211|NCT00430677|583454616|FG002|Short-term Period|Pregnancy|0|||
161564212|NCT00430677|583454614|FG000|Long-term Extension Period|Death|1|||
161564213|NCT00430677|583454615|FG001|Long-term Extension Period|Death|0|||
161564214|NCT00430677|583454616|FG002|Long-term Extension Period|Death|0|||
161564215|NCT00430677|583454614|FG000|Long-term Extension Period|Adverse Event|3|||
161564216|NCT00430677|583454615|FG001|Long-term Extension Period|Adverse Event|2|||
161564217|NCT00430677|583454616|FG002|Long-term Extension Period|Adverse Event|5|||
161564218|NCT00430677|583454614|FG000|Long-term Extension Period|Lack of Efficacy|5|||
161564219|NCT00430677|583454615|FG001|Long-term Extension Period|Lack of Efficacy|3|||
161564220|NCT00430677|583454616|FG002|Long-term Extension Period|Lack of Efficacy|8|||
161564221|NCT00430677|583454614|FG000|Long-term Extension Period|Lost to Follow-up|1|||
161564222|NCT00430677|583454615|FG001|Long-term Extension Period|Lost to Follow-up|1|||
161564223|NCT00430677|583454616|FG002|Long-term Extension Period|Lost to Follow-up|1|||
161564224|NCT00430677|583454614|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
161564225|NCT00430677|583454615|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
161564226|NCT00430677|583454616|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
161564227|NCT00430677|583454614|FG000|Long-term Extension Period|Pregnancy|1|||
161564228|NCT00430677|583454615|FG001|Long-term Extension Period|Pregnancy|1|||
161564229|NCT00430677|583454616|FG002|Long-term Extension Period|Pregnancy|0|||
161564230|NCT00430677|583454614|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
161564231|NCT00430677|583454615|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
161564232|NCT00430677|583454616|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
161564233|NCT00430677|583454614|FG000|Long-term Extension Period|Other|2|||
161564234|NCT00430677|583454615|FG001|Long-term Extension Period|Other|1|||
161564235|NCT00430677|583454616|FG002|Long-term Extension Period|Other|1|||
161564236|NCT00430677|583454614|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
161564237|NCT00430677|583454615|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
161564238|NCT00430677|583454616|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
161564239|NCT01555762|583454617|FG000|Overall Study|No information on Bevacizumab intake|11|||
161564240|NCT01555762|583454617|FG000|Overall Study|Missing start date of infusion|8|||
161564241|NCT01555762|583454617|FG000|Overall Study|75 years old or more ticked No|1|||
161564242|NCT01555762|583454617|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
161564243|NCT01555762|583454617|FG000|Overall Study|Death linked to progression of disease|165|||
161564244|NCT01555762|583454617|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
161564245|NCT01555762|583454617|FG000|Overall Study|Investigator's decision|10|||
161564246|NCT01555762|583454617|FG000|Overall Study|Participant not wishing to continue|5|||
161564247|NCT01555762|583454617|FG000|Overall Study|Missing data|1|||
161564248|NCT01555762|583454617|FG000|Overall Study|Death linked to an adverse event|14|||
161564249|NCT00299702|583454626|FG000|Overall Study|Death|1|||
161564250|NCT00299702|583454627|FG001|Overall Study|Death|0|||
161564251|NCT00299702|583454626|FG000|Overall Study|Adverse Event|0|||
161564252|NCT00299702|583454627|FG001|Overall Study|Adverse Event|4|||
161564253|NCT00299702|583454626|FG000|Overall Study|Lost to Follow-up|18|||
161564254|NCT00299702|583454627|FG001|Overall Study|Lost to Follow-up|10|||
161564255|NCT00299702|583454626|FG000|Overall Study|Withdrawal by Subject|25|||
161910872|NCT05399680|584727087|FG001|Overall Study|Death|1|||
161807351|NCT00376623|584339714|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807352|NCT00376623|584339715|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
161807353|NCT00376623|584339713|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
161807354|NCT00376623|584339714|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
161807355|NCT00376623|584339715|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
161807356|NCT00376623|584339713|FG000|Overall Study|Increase of tumour markers|0|||
161807357|NCT00376623|584339714|FG001|Overall Study|Increase of tumour markers|1|||
161807358|NCT00376623|584339715|FG002|Overall Study|Increase of tumour markers|0|||
161807359|NCT00376623|584339713|FG000|Overall Study|Bone metastasis|1|||
161564256|NCT00299702|583454627|FG001|Overall Study|Withdrawal by Subject|23|||
161564257|NCT00299702|583454626|FG000|Overall Study|Pregnancy|0|||
161564258|NCT00299702|583454627|FG001|Overall Study|Pregnancy|1|||
161564259|NCT00299702|583454626|FG000|Overall Study|Insufficient Response|4|||
161564260|NCT00299702|583454627|FG001|Overall Study|Insufficient Response|3|||
161564261|NCT00299702|583454626|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
161564262|NCT00299702|583454627|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
161564263|NCT00670540|583454628|FG000|Overall Study|ineligible|17|||
161564264|NCT00670540|583454628|FG000|Overall Study|not living in France|348|||
161564265|NCT00670540|583454628|FG000|Overall Study|refused to participate|189|||
161564266|NCT00670540|583454628|FG000|Overall Study|controls randomised for no follow up|2770|||
161564267|NCT00670540|583454628|FG000|Overall Study|missing information inclusion criteria|1|||
161564268|NCT01866917|583454629|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
161564269|NCT01866917|583454630|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
161564270|NCT03537651|583456244|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
161564271|NCT03537651|583456244|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
161564272|NCT03537651|583456244|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
161564273|NCT03537651|583456244|FG000|Part A (Up to 96 Weeks)|Other|1|||
161564274|NCT03537651|583456244|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
161807360|NCT00376623|584339714|FG001|Overall Study|Bone metastasis|0|||
161807361|NCT00376623|584339715|FG002|Overall Study|Bone metastasis|0|||
161807362|NCT02331394|584339718|FG000|Overall Study|Disease progression|1|||
161807363|NCT02098876|584339726|FG000|Overall Study|Withdrawal by Subject|5|||
161807364|NCT02098876|584339727|FG001|Overall Study|Withdrawal by Subject|5|||
161807365|NCT03195491|584339728|FG000|Overall Study|Study drug toxicity|25|||
161807366|NCT03195491|584339729|FG001|Overall Study|Study drug toxicity|3|||
161807367|NCT03195491|584339728|FG000|Overall Study|Maximum clinical benefit|5|||
161807368|NCT03195491|584339729|FG001|Overall Study|Maximum clinical benefit|0|||
161807369|NCT03195491|584339728|FG000|Overall Study|Lost to Follow-up|1|||
161807370|NCT03195491|584339729|FG001|Overall Study|Lost to Follow-up|0|||
161807371|NCT03195491|584339728|FG000|Overall Study|Death|3|||
161807372|NCT03195491|584339729|FG001|Overall Study|Death|0|||
161807373|NCT03195491|584339728|FG000|Overall Study|Adverse event unrelated to study drug|19|||
161807374|NCT03195491|584339729|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161807375|NCT03195491|584339728|FG000|Overall Study|Disease progression|266|||
161807376|NCT03195491|584339729|FG001|Overall Study|Disease progression|8|||
161807377|NCT03195491|584339728|FG000|Overall Study|Other reasons|10|||
161807378|NCT03195491|584339729|FG001|Overall Study|Other reasons|0|||
161807379|NCT03195491|584339728|FG000|Overall Study|Participant withdrew consent|8|||
161807380|NCT03195491|584339729|FG001|Overall Study|Participant withdrew consent|1|||
161807381|NCT03195491|584339728|FG000|Overall Study|Participant no longer meets study criteria|0|||
161807382|NCT03195491|584339729|FG001|Overall Study|Participant no longer meets study criteria|1|||
161807383|NCT03195491|584339728|FG000|Overall Study|Participant request to discontinue study treatment|10|||
161807384|NCT03195491|584339729|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161807385|NCT01061866|584339732|FG000|Overall Study|Adverse Event|2|||
161807386|NCT01270503|584339733|FG000|Overall Study|Lost to Follow-up|1|||
161807387|NCT02459951|584339734|FG000|Overall Study|Unable to meet holding requirement|1|||
161807388|NCT02255097|584339735|FG000|Overall Study|Death|151|||
161807389|NCT02255097|584339735|FG000|Overall Study|Lost to Follow-up|5|||
161807390|NCT02255097|584339735|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
161910873|NCT02659865|584727088|FG000|Period 1|Withdrawal by Subject|1|||
161807391|NCT02255097|584339735|FG000|Overall Study|Withdrawal by Subject|7|||
161807392|NCT02255097|584339735|FG000|Overall Study|Allocated but not treated|1|||
161807393|NCT04239872|584339736|FG000|Overall Study|Lost to Follow-up|0|||
161807394|NCT04239872|584339737|FG001|Overall Study|Lost to Follow-up|1|||
161807395|NCT03956862|584339742|FG000|Overall Study|Lost to Follow-up|1|||
161807396|NCT03956862|584339743|FG001|Overall Study|Lost to Follow-up|1|||
161807397|NCT03956862|584339742|FG000|Overall Study|Withdrawal by Subject|1|||
161807398|NCT03956862|584339743|FG001|Overall Study|Withdrawal by Subject|1|||
161807399|NCT01498120|584339744|FG000|Overall Study|Lost to Follow-up|1|||
161807400|NCT01498120|584339744|FG000|Overall Study|Withdrawal by Subject|5|||
161807401|NCT01498120|584339744|FG000|Overall Study|AE, non-serious non-fatal|3|||
161807402|NCT01498120|584339744|FG000|Overall Study|Other|4|||
161910874|NCT02659865|584727089|FG001|Period 1|Withdrawal by Subject|0|||
161910875|NCT02659865|584727090|FG002|Period 1|Withdrawal by Subject|0|||
161910876|NCT02659865|584727091|FG003|Period 1|Withdrawal by Subject|0|||
161910877|NCT02659865|584727092|FG004|Period 1|Withdrawal by Subject|0|||
161910878|NCT02659865|584727088|FG000|Period 1|Adverse Event|0|||
161910879|NCT02659865|584727089|FG001|Period 1|Adverse Event|0|||
161910880|NCT02659865|584727090|FG002|Period 1|Adverse Event|0|||
161910881|NCT02659865|584727091|FG003|Period 1|Adverse Event|0|||
161910882|NCT02659865|584727092|FG004|Period 1|Adverse Event|1|||
161910883|NCT02325414|584727093|FG000|Overall Study|Withdrawal by Subject|3|||
161910884|NCT02325414|584727094|FG001|Overall Study|Withdrawal by Subject|1|||
161910885|NCT02325414|584727093|FG000|Overall Study|Lost to Follow-up|5|||
161910886|NCT02325414|584727094|FG001|Overall Study|Lost to Follow-up|5|||
161910887|NCT02775851|584727095|FG000|Overall Study|Adverse Event|1|||
161910888|NCT02775851|584727096|FG001|Overall Study|Adverse Event|10|||
161910889|NCT02775851|584727095|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
161910890|NCT02775851|584727096|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
161910891|NCT02775851|584727095|FG000|Overall Study|Progression/Relapse|0|||
161910892|NCT02775851|584727096|FG001|Overall Study|Progression/Relapse|4|||
161910893|NCT02775851|584727095|FG000|Overall Study|Other - Not Protocol Specified|0|||
161910894|NCT02775851|584727096|FG001|Overall Study|Other - Not Protocol Specified|7|||
161910895|NCT02775851|584727095|FG000|Overall Study|Withdrawal by Subject|1|||
161910896|NCT02775851|584727096|FG001|Overall Study|Withdrawal by Subject|0|||
161910897|NCT03055013|584727097|FG000|Overall Study|Adverse Event|78|||
161910898|NCT03055013|584727098|FG001|Overall Study|Adverse Event|0|||
161910899|NCT03055013|584727097|FG000|Overall Study|Death|6|||
161910900|NCT03055013|584727098|FG001|Overall Study|Death|0|||
161910901|NCT03055013|584727097|FG000|Overall Study|Disease relapse|33|||
161910902|NCT03055013|584727098|FG001|Overall Study|Disease relapse|0|||
161910903|NCT03055013|584727097|FG000|Overall Study|Withdrawal by Subject|28|||
161910904|NCT03055013|584727098|FG001|Overall Study|Withdrawal by Subject|0|||
161910905|NCT03055013|584727097|FG000|Overall Study|Other complicating disease|5|||
161910906|NCT03055013|584727098|FG001|Overall Study|Other complicating disease|0|||
161910907|NCT03055013|584727097|FG000|Overall Study|Physician Decision|1|||
161910908|NCT03055013|584727098|FG001|Overall Study|Physician Decision|0|||
161910909|NCT03055013|584727097|FG000|Overall Study|Benign mass/non-RCC|4|||
161910910|NCT03055013|584727098|FG001|Overall Study|Benign mass/non-RCC|0|||
161910911|NCT03055013|584727097|FG000|Overall Study|Enrolled in another trial|1|||
161910912|NCT03055013|584727098|FG001|Overall Study|Enrolled in another trial|0|||
161910913|NCT03055013|584727097|FG000|Overall Study|Non-protocol therapy|1|||
161910914|NCT03055013|584727098|FG001|Overall Study|Non-protocol therapy|0|||
161910915|NCT03055013|584727097|FG000|Overall Study|Incompliance|1|||
161454621|NCT01328444|583059022|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
161454622|NCT01328444|583059023|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
161454623|NCT01328444|583059024|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
161454624|NCT01328444|583059025|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
161454625|NCT01328444|583059026|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
161454626|NCT01328444|583059021|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
161454627|NCT01328444|583059022|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
161454628|NCT01328444|583059023|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
161454629|NCT01328444|583059024|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
161454630|NCT01328444|583059025|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
161454631|NCT01328444|583059026|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
161454632|NCT01328444|583059021|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
161454633|NCT01328444|583059022|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161454634|NCT01328444|583059023|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
161454635|NCT01328444|583059024|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
161454636|NCT01328444|583059025|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
161454637|NCT01328444|583059026|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161454638|NCT01328444|583059021|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
161454639|NCT01328444|583059022|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161454640|NCT01328444|583059023|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161454641|NCT01328444|583059024|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
161454642|NCT01328444|583059025|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
161454643|NCT01328444|583059026|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
161910916|NCT03055013|584727098|FG001|Overall Study|Incompliance|0|||
161910917|NCT03055013|584727097|FG000|Overall Study|Insurance issues|1|||
161454644|NCT01328444|583059021|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
161454645|NCT01328444|583059022|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
161454646|NCT01328444|583059023|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
161910918|NCT03055013|584727098|FG001|Overall Study|Insurance issues|0|||
161910919|NCT03055013|584727097|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
161454647|NCT01328444|583059024|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
161910920|NCT03055013|584727098|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
161910921|NCT03055013|584727097|FG000|Overall Study|Did not receive nivolumab|10|||
161910922|NCT03055013|584727098|FG001|Overall Study|Did not receive nivolumab|0|||
161910923|NCT03055013|584727097|FG000|Overall Study|Did not receive surgery|0|||
161910924|NCT03055013|584727098|FG001|Overall Study|Did not receive surgery|28|||
161910925|NCT03817528|584727105|FG000|Overall Study|Withdrawal by Subject|1|||
161910926|NCT03817528|584727105|FG000|Overall Study|Adverse Event|2|||
161910927|NCT02765035|584727110|FG000|First Intervention (90 Days)|Adverse Event|1|||
161910928|NCT02765035|584727111|FG001|First Intervention (90 Days)|Adverse Event|1|||
161910929|NCT02765035|584727110|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
161910930|NCT02765035|584727111|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
161910931|NCT00671749|584727113|FG000|Overall Study|Adverse Event|2|||
161910932|NCT00671749|584727113|FG000|Overall Study|Withdrawal by Subject|4|||
161910933|NCT00671749|584727113|FG000|Overall Study|Protocol Violation|1|||
161910934|NCT00671749|584727113|FG000|Overall Study|Lost to Follow-up|1|||
161910935|NCT01259245|584727119|FG000|Overall Study|Withdrawal by Subject|27|||
161910936|NCT01259245|584727120|FG001|Overall Study|Withdrawal by Subject|24|||
161910937|NCT01259245|584727119|FG000|Overall Study|Death|1|||
161910938|NCT01259245|584727120|FG001|Overall Study|Death|2|||
161910939|NCT03937778|584727121|FG000|Overall Study|Withdrawal by Subject|1|||
161910940|NCT03937778|584727121|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
161564275|NCT03537651|583456244|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161564276|NCT03537651|583456244|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
161564277|NCT03537651|583456244|FG000|Part B (Up to 192 Weeks)|Other|1|||
161564278|NCT00197236|583456245|FG000|Overall Study|Adverse Event|1|||
161564279|NCT00197236|583456246|FG001|Overall Study|Adverse Event|0|||
161564280|NCT00197236|583456247|FG002|Overall Study|Adverse Event|1|||
161564281|NCT00197236|583456245|FG000|Overall Study|Lost to Follow-up|5|||
161564282|NCT00197236|583456246|FG001|Overall Study|Lost to Follow-up|14|||
161564283|NCT00197236|583456247|FG002|Overall Study|Lost to Follow-up|6|||
161564284|NCT00197236|583456245|FG000|Overall Study|Protocol Violation|0|||
161564285|NCT00197236|583456246|FG001|Overall Study|Protocol Violation|0|||
161564286|NCT00197236|583456247|FG002|Overall Study|Protocol Violation|1|||
161564287|NCT00197236|583456245|FG000|Overall Study|Withdrawal by Subject|7|||
161564288|NCT00197236|583456246|FG001|Overall Study|Withdrawal by Subject|3|||
161564289|NCT00197236|583456247|FG002|Overall Study|Withdrawal by Subject|11|||
161564290|NCT00197236|583456245|FG000|Overall Study|Study drug/medication expiration|1|||
161564291|NCT00197236|583456246|FG001|Overall Study|Study drug/medication expiration|0|||
161807403|NCT02294604|584339745|FG000|Overall Study|Did not provide samples for culture|0|||
161807404|NCT02294604|584339746|FG001|Overall Study|Did not provide samples for culture|1|||
161807405|NCT02294604|584339747|FG002|Overall Study|Did not provide samples for culture|0|||
161807406|NCT02294604|584339745|FG000|Overall Study|Culture contamination|1|||
161807407|NCT02294604|584339746|FG001|Overall Study|Culture contamination|2|||
161807408|NCT02294604|584339747|FG002|Overall Study|Culture contamination|0|||
161807409|NCT01118312|584339748|FG000|Overall Study|Lost to Follow-up|33|||
161807410|NCT01118312|584339749|FG001|Overall Study|Lost to Follow-up|32|||
161807411|NCT01118312|584339748|FG000|Overall Study|Withdrawal by Subject|1|||
161807412|NCT01118312|584339749|FG001|Overall Study|Withdrawal by Subject|3|||
161807413|NCT03965091|584339750|FG000|Overall Study|Adverse Event|0|||
161807414|NCT03965091|584339751|FG001|Overall Study|Adverse Event|2|||
161807415|NCT03965091|584339752|FG002|Overall Study|Adverse Event|3|||
161807416|NCT03965091|584339750|FG000|Overall Study|Withdrawal by Subject|11|||
161807417|NCT03965091|584339751|FG001|Overall Study|Withdrawal by Subject|3|||
161807418|NCT03965091|584339752|FG002|Overall Study|Withdrawal by Subject|5|||
161807419|NCT03965091|584339750|FG000|Overall Study|Non-compliance with study drug|0|||
161807420|NCT03965091|584339751|FG001|Overall Study|Non-compliance with study drug|0|||
161807421|NCT03965091|584339752|FG002|Overall Study|Non-compliance with study drug|1|||
161807422|NCT03965091|584339750|FG000|Overall Study|Lost to Follow-up|1|||
161807423|NCT03965091|584339751|FG001|Overall Study|Lost to Follow-up|1|||
161807424|NCT03965091|584339752|FG002|Overall Study|Lost to Follow-up|1|||
161807425|NCT03965091|584339750|FG000|Overall Study|Lack of Efficacy|2|||
161807426|NCT03965091|584339751|FG001|Overall Study|Lack of Efficacy|0|||
161807427|NCT03965091|584339752|FG002|Overall Study|Lack of Efficacy|0|||
161807428|NCT03965091|584339750|FG000|Overall Study|Other than specified|9|||
161807429|NCT03965091|584339751|FG001|Overall Study|Other than specified|11|||
161807430|NCT03965091|584339752|FG002|Overall Study|Other than specified|8|||
161807431|NCT04060147|584339754|FG000|Overall Study|Withdrew consent|1|||
161807432|NCT01534520|584339755|FG000|Overall Study|Adverse Event|0|||
161807433|NCT01534520|584339756|FG001|Overall Study|Adverse Event|1|||
161807434|NCT03204539|584339759|FG000|Overall Study|Loss of funding|0|||
161807435|NCT03204539|584339760|FG001|Overall Study|Loss of funding|1|||
161807436|NCT00550537|584339763|FG000|Overall Study|Death|18|||
161807437|NCT00550537|584339763|FG000|Overall Study|Adverse Event|20|||
161807438|NCT00550537|584339763|FG000|Overall Study|Disease progression before|46|||
161807439|NCT00550537|584339763|FG000|Overall Study|Withdrawal by Subject|7|||
161910941|NCT01281306|584727123|FG000|Overall Study|Lack of Efficacy|0|||
161910942|NCT01281306|584727124|FG001|Overall Study|Lack of Efficacy|1|||
161910943|NCT01281306|584727125|FG002|Overall Study|Lack of Efficacy|3|||
161564292|NCT00197236|583456247|FG002|Overall Study|Study drug/medication expiration|3|||
161564293|NCT00197236|583456245|FG000|Overall Study|Returned out of specified time window|0|||
161564294|NCT00197236|583456246|FG001|Overall Study|Returned out of specified time window|0|||
161564295|NCT00197236|583456247|FG002|Overall Study|Returned out of specified time window|1|||
161564296|NCT02524288|583456248|FG000|Overall Study|Adverse Event|115|||
161564297|NCT02524288|583456248|FG000|Overall Study|Lost to Follow-up|216|||
161564298|NCT02524288|583456248|FG000|Overall Study|Non-Compliance With Protocol|32|||
161564299|NCT02524288|583456248|FG000|Overall Study|Non-Compliance With Study Drug|14|||
161564300|NCT02524288|583456248|FG000|Overall Study|Pregnancy Wish|6|||
161564301|NCT02524288|583456248|FG000|Overall Study|Protocol Violation|6|||
161564302|NCT02524288|583456248|FG000|Overall Study|Screen Failure|2|||
161564303|NCT02524288|583456248|FG000|Overall Study|Site Discontinued Study Participation|1|||
161564304|NCT02524288|583456248|FG000|Overall Study|Study Terminated By Sponsor|1417|||
161910944|NCT01281306|584727126|FG003|Overall Study|Lack of Efficacy|0|||
161910945|NCT01281306|584727127|FG004|Overall Study|Lack of Efficacy|2|||
161910946|NCT01281306|584727128|FG005|Overall Study|Lack of Efficacy|0|||
161910947|NCT01281306|584727129|FG006|Overall Study|Lack of Efficacy|1|||
161910948|NCT01281306|584727123|FG000|Overall Study|Withdrawal by Subject|1|||
161910949|NCT01281306|584727124|FG001|Overall Study|Withdrawal by Subject|0|||
161910950|NCT01281306|584727125|FG002|Overall Study|Withdrawal by Subject|2|||
161910951|NCT01281306|584727126|FG003|Overall Study|Withdrawal by Subject|4|||
161910952|NCT01281306|584727127|FG004|Overall Study|Withdrawal by Subject|1|||
161564305|NCT02524288|583456248|FG000|Overall Study|Subject Moved|32|||
161910953|NCT01281306|584727128|FG005|Overall Study|Withdrawal by Subject|3|||
161910954|NCT01281306|584727129|FG006|Overall Study|Withdrawal by Subject|1|||
161910955|NCT01281306|584727123|FG000|Overall Study|Protocol deviation|0|||
161910956|NCT01281306|584727124|FG001|Overall Study|Protocol deviation|1|||
161910957|NCT01281306|584727125|FG002|Overall Study|Protocol deviation|1|||
161910958|NCT01281306|584727126|FG003|Overall Study|Protocol deviation|1|||
161910959|NCT01281306|584727127|FG004|Overall Study|Protocol deviation|1|||
161910960|NCT01281306|584727128|FG005|Overall Study|Protocol deviation|0|||
161910961|NCT01281306|584727129|FG006|Overall Study|Protocol deviation|0|||
161910962|NCT01281306|584727123|FG000|Overall Study|Condition no longer requires study drug|1|||
161910963|NCT01281306|584727124|FG001|Overall Study|Condition no longer requires study drug|0|||
161910964|NCT01281306|584727125|FG002|Overall Study|Condition no longer requires study drug|0|||
161910965|NCT01281306|584727126|FG003|Overall Study|Condition no longer requires study drug|0|||
161910966|NCT01281306|584727127|FG004|Overall Study|Condition no longer requires study drug|0|||
161910967|NCT01281306|584727128|FG005|Overall Study|Condition no longer requires study drug|1|||
161910968|NCT01281306|584727129|FG006|Overall Study|Condition no longer requires study drug|1|||
161910969|NCT01281306|584727123|FG000|Overall Study|Lost to Follow-up|1|||
161910970|NCT01281306|584727124|FG001|Overall Study|Lost to Follow-up|0|||
161910971|NCT01281306|584727125|FG002|Overall Study|Lost to Follow-up|0|||
161910972|NCT01281306|584727126|FG003|Overall Study|Lost to Follow-up|2|||
161910973|NCT01281306|584727127|FG004|Overall Study|Lost to Follow-up|0|||
161910974|NCT01281306|584727128|FG005|Overall Study|Lost to Follow-up|0|||
161910975|NCT01281306|584727129|FG006|Overall Study|Lost to Follow-up|1|||
161910976|NCT01281306|584727123|FG000|Overall Study|Death|1|||
161910977|NCT01281306|584727124|FG001|Overall Study|Death|0|||
161910978|NCT01281306|584727125|FG002|Overall Study|Death|0|||
161910979|NCT01281306|584727126|FG003|Overall Study|Death|0|||
161910980|NCT01281306|584727127|FG004|Overall Study|Death|0|||
161910981|NCT01281306|584727128|FG005|Overall Study|Death|0|||
161910982|NCT01281306|584727129|FG006|Overall Study|Death|0|||
161910983|NCT01281306|584727123|FG000|Overall Study|Adverse Event|3|||
161910984|NCT01281306|584727124|FG001|Overall Study|Adverse Event|2|||
161910985|NCT01281306|584727125|FG002|Overall Study|Adverse Event|2|||
161910986|NCT01281306|584727126|FG003|Overall Study|Adverse Event|3|||
161564306|NCT02524288|583456248|FG000|Overall Study|Withdrawal by Subject|76|||
161564307|NCT02524288|583456248|FG000|Overall Study|Pregnancy|22|||
161564308|NCT02524288|583456248|FG000|Overall Study|Physician Decision|2|||
161564309|NCT01835899|583456250|FG000|Overall Study|Adverse Event|0|||
161564310|NCT01835899|583456251|FG001|Overall Study|Adverse Event|0|||
161564311|NCT01835899|583456252|FG002|Overall Study|Adverse Event|1|||
161910987|NCT01281306|584727127|FG004|Overall Study|Adverse Event|5|||
161910988|NCT01281306|584727128|FG005|Overall Study|Adverse Event|3|||
161910989|NCT01281306|584727129|FG006|Overall Study|Adverse Event|3|||
161910990|NCT01281306|584727123|FG000|Overall Study|Randomized in error|1|||
161910991|NCT01281306|584727124|FG001|Overall Study|Randomized in error|0|||
161564312|NCT01835899|583456250|FG000|Overall Study|Other than stated above|0|||
161564313|NCT01835899|583456251|FG001|Overall Study|Other than stated above|1|||
161564314|NCT01835899|583456252|FG002|Overall Study|Other than stated above|0|||
161564315|NCT02616263|583456253|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
161564316|NCT02616263|583456254|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
161910992|NCT01281306|584727125|FG002|Overall Study|Randomized in error|0|||
161910993|NCT01281306|584727126|FG003|Overall Study|Randomized in error|1|||
161910994|NCT01281306|584727127|FG004|Overall Study|Randomized in error|0|||
161564317|NCT02616263|583456253|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
161910995|NCT01281306|584727128|FG005|Overall Study|Randomized in error|0|||
161910996|NCT01281306|584727129|FG006|Overall Study|Randomized in error|0|||
161910997|NCT01401322|584727130|FG000|Overall Study|Withdrawal by Subject|1|||
161910998|NCT01401322|584727130|FG000|Overall Study|Physician Decision|1|||
161910999|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911000|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
161911001|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911002|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911003|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911004|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
161911005|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
161454648|NCT01328444|583059025|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
161454649|NCT01328444|583059026|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
161454650|NCT01328444|583059021|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
161454651|NCT01328444|583059022|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
161454652|NCT01328444|583059023|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
161454653|NCT01328444|583059024|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
161454654|NCT01328444|583059025|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
161454655|NCT01328444|583059026|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
161454656|NCT01328444|583059021|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161454657|NCT01328444|583059022|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161454658|NCT01328444|583059023|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
161454659|NCT01328444|583059024|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
161454660|NCT01328444|583059025|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
161454661|NCT01328444|583059026|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
161454662|NCT01328444|583059021|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161454663|NCT01328444|583059022|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161454664|NCT01328444|583059023|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161454665|NCT01328444|583059024|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161454666|NCT01328444|583059025|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161454667|NCT01328444|583059026|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161454668|NCT03241368|583059031|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
161454669|NCT03241368|583059031|FG000|Overall Study|Lost to Follow-up|1|||
161454670|NCT03241368|583059031|FG000|Overall Study|Physician Decision|6|||
161454671|NCT03241368|583059031|FG000|Overall Study|Withdrawal by Subject|6|||
161454672|NCT03241368|583059031|FG000|Overall Study|Protocol Violation|1|||
161454673|NCT03316911|583059032|FG000|Overall Study|Lost to Follow-up|33|||
161454674|NCT03316911|583059033|FG001|Overall Study|Lost to Follow-up|29|||
161454675|NCT01119937|583059034|FG000|Overall Study|Adverse Event|11|||
161454676|NCT01119937|583059035|FG001|Overall Study|Adverse Event|5|||
161454677|NCT01119937|583059034|FG000|Overall Study|Protocol deviation|3|||
161454678|NCT01119937|583059035|FG001|Overall Study|Protocol deviation|1|||
161454679|NCT01119937|583059034|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161454680|NCT01119937|583059035|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161454681|NCT01119937|583059034|FG000|Overall Study|Withdrawal by Subject|2|||
161454682|NCT01119937|583059035|FG001|Overall Study|Withdrawal by Subject|1|||
161454683|NCT01270802|583059036|FG000|Overall Study|Withdrawal by Subject|1|||
161454684|NCT01270802|583059037|FG001|Overall Study|Withdrawal by Subject|0|||
161454685|NCT01270802|583059036|FG000|Overall Study|Adverse Event|1|||
161454686|NCT01270802|583059037|FG001|Overall Study|Adverse Event|0|||
161454687|NCT01270802|583059036|FG000|Overall Study|Lost to Follow-up|0|||
161454688|NCT01270802|583059037|FG001|Overall Study|Lost to Follow-up|1|||
161454689|NCT01566214|583059038|FG000|Overall Study|Lost to Follow-up|3|||
161454690|NCT01566214|583059039|FG001|Overall Study|Lost to Follow-up|0|||
161454691|NCT04620798|583059040|FG000|Overall Study|Lost to Follow-up|126|||
161454692|NCT04620798|583059041|FG001|Overall Study|Lost to Follow-up|138|||
161454693|NCT03222492|583059049|FG000|Overall Study|Withdrawal by Subject|0|||
161454694|NCT03222492|583059050|FG001|Overall Study|Withdrawal by Subject|0|||
161454695|NCT03222492|583059051|FG002|Overall Study|Withdrawal by Subject|1|||
161454696|NCT03222492|583059052|FG003|Overall Study|Withdrawal by Subject|0|||
161454697|NCT03222492|583059049|FG000|Overall Study|COVID-19 related|0|||
161454698|NCT03222492|583059050|FG001|Overall Study|COVID-19 related|0|||
161454699|NCT03222492|583059051|FG002|Overall Study|COVID-19 related|1|||
161454700|NCT03222492|583059052|FG003|Overall Study|COVID-19 related|0|||
161454701|NCT02486627|583059055|FG000|Overall Study|Death|1|||
161454702|NCT02486627|583059056|FG001|Overall Study|Death|0|||
161454703|NCT02486627|583059055|FG000|Overall Study|Other Unspecified|0|||
161454704|NCT02486627|583059056|FG001|Overall Study|Other Unspecified|2|||
161454705|NCT02486627|583059055|FG000|Overall Study|Consent Withdrawn by Participant|4|||
161454706|NCT02486627|583059056|FG001|Overall Study|Consent Withdrawn by Participant|3|||
161454707|NCT02486627|583059055|FG000|Overall Study|Significant Participant Noncompliance|1|||
161454708|NCT02486627|583059056|FG001|Overall Study|Significant Participant Noncompliance|1|||
161454709|NCT02486627|583059055|FG000|Overall Study|Lost to Follow-up|1|||
161454710|NCT02486627|583059056|FG001|Overall Study|Lost to Follow-up|3|||
161911006|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161564318|NCT02616263|583456254|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
161564319|NCT02616263|583456253|FG000|6 Month to 1.5 Year|Death|1|||
161564320|NCT02616263|583456254|FG001|6 Month to 1.5 Year|Death|0|||
161564321|NCT02616263|583456253|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
161564322|NCT02616263|583456254|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
161564323|NCT02616263|583456253|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
161564324|NCT02616263|583456254|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
161564325|NCT02616263|583456253|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
161564326|NCT02616263|583456254|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
161564327|NCT02939183|583456260|FG000|Overall Study|Death|0|||
161564328|NCT02939183|583456261|FG001|Overall Study|Death|0|||
161564329|NCT02939183|583456262|FG002|Overall Study|Death|1|||
161564330|NCT02939183|583456263|FG003|Overall Study|Death|0|||
161564331|NCT02939183|583456264|FG004|Overall Study|Death|0|||
161564332|NCT02939183|583456265|FG005|Overall Study|Death|2|||
161564333|NCT02939183|583456266|FG006|Overall Study|Death|1|||
161564334|NCT02939183|583456267|FG007|Overall Study|Death|0|||
161564335|NCT02939183|583456268|FG008|Overall Study|Death|0|||
161564336|NCT02939183|583456260|FG000|Overall Study|Sponsor decision|0|||
161564337|NCT02939183|583456261|FG001|Overall Study|Sponsor decision|1|||
161564338|NCT02939183|583456262|FG002|Overall Study|Sponsor decision|0|||
161564339|NCT02939183|583456263|FG003|Overall Study|Sponsor decision|1|||
161564340|NCT02939183|583456264|FG004|Overall Study|Sponsor decision|2|||
161564341|NCT02939183|583456265|FG005|Overall Study|Sponsor decision|0|||
161564342|NCT02939183|583456266|FG006|Overall Study|Sponsor decision|3|||
161564343|NCT02939183|583456267|FG007|Overall Study|Sponsor decision|1|||
161911007|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161911008|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161911009|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
161911010|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
161911011|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161911012|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161911013|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161911014|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
161911015|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
161911016|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161911017|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161911018|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161911019|NCT03466346|584727133|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
161911020|NCT03466346|584727134|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
161911021|NCT03466346|584727135|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
161911022|NCT03466346|584727136|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
161911023|NCT03466346|584727137|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
161911024|NCT03466346|584727133|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161911025|NCT03466346|584727134|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161911026|NCT03466346|584727135|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161911027|NCT03466346|584727136|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
161911028|NCT03466346|584727137|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
161911029|NCT03466346|584727133|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
161911030|NCT03466346|584727134|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
161911031|NCT03466346|584727135|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
161911032|NCT03466346|584727136|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
161911033|NCT03466346|584727137|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
161911034|NCT02410629|584727139|FG000|Overall Study|Family cannot commit to the study|2|||
161911035|NCT02410629|584727140|FG001|Overall Study|Family cannot commit to the study|1|||
161911036|NCT02410629|584727139|FG000|Overall Study|Subject returned to work|1|||
161911037|NCT02410629|584727140|FG001|Overall Study|Subject returned to work|0|||
161911038|NCT02410629|584727139|FG000|Overall Study|Subject moved back to home country|0|||
161911039|NCT02410629|584727140|FG001|Overall Study|Subject moved back to home country|1|||
161911040|NCT02410629|584727139|FG000|Overall Study|Subject underwent heart surgery|0|||
161911041|NCT02410629|584727140|FG001|Overall Study|Subject underwent heart surgery|1|||
161911042|NCT01192815|584727141|FG000|Overall Study|Withdrawal by Subject|1|||
161564344|NCT02939183|583456268|FG008|Overall Study|Sponsor decision|4|||
161564345|NCT02939183|583456260|FG000|Overall Study|Withdrawal by Subject|0|||
161564346|NCT02939183|583456261|FG001|Overall Study|Withdrawal by Subject|2|||
161564347|NCT02939183|583456262|FG002|Overall Study|Withdrawal by Subject|0|||
161564348|NCT02939183|583456263|FG003|Overall Study|Withdrawal by Subject|1|||
161564349|NCT02939183|583456264|FG004|Overall Study|Withdrawal by Subject|0|||
161564350|NCT02939183|583456265|FG005|Overall Study|Withdrawal by Subject|0|||
161564351|NCT02939183|583456266|FG006|Overall Study|Withdrawal by Subject|2|||
161564352|NCT02939183|583456267|FG007|Overall Study|Withdrawal by Subject|2|||
161564353|NCT02939183|583456268|FG008|Overall Study|Withdrawal by Subject|2|||
161564354|NCT02939183|583456260|FG000|Overall Study|Not treated due to adverse event|0|||
161564355|NCT02939183|583456261|FG001|Overall Study|Not treated due to adverse event|0|||
161564356|NCT02939183|583456262|FG002|Overall Study|Not treated due to adverse event|0|||
161564357|NCT02939183|583456263|FG003|Overall Study|Not treated due to adverse event|1|||
161564358|NCT02939183|583456264|FG004|Overall Study|Not treated due to adverse event|0|||
161564359|NCT02939183|583456265|FG005|Overall Study|Not treated due to adverse event|0|||
161911043|NCT01192815|584727141|FG000|Overall Study|Lack of Efficacy|1|||
161911044|NCT03451045|584727142|FG000|Overall Study|Lack of Efficacy|3|||
161911045|NCT03451045|584727143|FG001|Overall Study|Lack of Efficacy|2|||
161911046|NCT03451045|584727144|FG002|Overall Study|Lack of Efficacy|2|||
161911047|NCT03451045|584727142|FG000|Overall Study|Physician Decision|1|||
161911048|NCT03451045|584727143|FG001|Overall Study|Physician Decision|1|||
161911049|NCT03451045|584727144|FG002|Overall Study|Physician Decision|1|||
161911050|NCT03451045|584727142|FG000|Overall Study|Withdrawal by Subject|4|||
161911051|NCT03451045|584727143|FG001|Overall Study|Withdrawal by Subject|0|||
161911052|NCT03451045|584727144|FG002|Overall Study|Withdrawal by Subject|5|||
161911053|NCT03451045|584727142|FG000|Overall Study|Pregnancy|0|||
161911054|NCT03451045|584727143|FG001|Overall Study|Pregnancy|0|||
161911055|NCT03451045|584727144|FG002|Overall Study|Pregnancy|2|||
161911056|NCT03451045|584727142|FG000|Overall Study|Adverse Event|7|||
161564360|NCT02939183|583456266|FG006|Overall Study|Not treated due to adverse event|1|||
161564361|NCT02939183|583456267|FG007|Overall Study|Not treated due to adverse event|0|||
161564362|NCT02939183|583456268|FG008|Overall Study|Not treated due to adverse event|0|||
161564363|NCT05015478|583456269|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
161564364|NCT05015478|583456270|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
161564365|NCT05015478|583456271|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
161564366|NCT05015478|583456272|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
161564367|NCT04939428|583456273|FG000|Overall Study|Death|0|||
161564368|NCT04939428|583456274|FG001|Overall Study|Death|1|||
161564369|NCT04939428|583456275|FG002|Overall Study|Death|0|||
161564370|NCT04939428|583456273|FG000|Overall Study|Lost to Follow-up|0|||
161564371|NCT04939428|583456274|FG001|Overall Study|Lost to Follow-up|5|||
161564372|NCT04939428|583456275|FG002|Overall Study|Lost to Follow-up|0|||
161564373|NCT04939428|583456273|FG000|Overall Study|Physician Decision|1|||
161564374|NCT04939428|583456274|FG001|Overall Study|Physician Decision|0|||
161564375|NCT04939428|583456275|FG002|Overall Study|Physician Decision|0|||
161564376|NCT04939428|583456273|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161564377|NCT04939428|583456274|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161564378|NCT04939428|583456275|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161564379|NCT04939428|583456273|FG000|Overall Study|Withdrawal by Subject|10|||
161564380|NCT04939428|583456274|FG001|Overall Study|Withdrawal by Subject|11|||
161564381|NCT04939428|583456275|FG002|Overall Study|Withdrawal by Subject|0|||
161564382|NCT04939428|583456273|FG000|Overall Study|Unkown|6|||
161564383|NCT04939428|583456274|FG001|Overall Study|Unkown|3|||
161564384|NCT04939428|583456275|FG002|Overall Study|Unkown|0|||
161564385|NCT04939428|583456273|FG000|Overall Study|Discotinued per protocol|0|||
161564386|NCT04939428|583456274|FG001|Overall Study|Discotinued per protocol|0|||
161564387|NCT04939428|583456275|FG002|Overall Study|Discotinued per protocol|902|||
161564388|NCT04319094|583456278|FG000|Baseline|Lost to Follow-up|4|||
161564389|NCT04319094|583456279|FG001|Baseline|Lost to Follow-up|5|||
161564390|NCT04319094|583456278|FG000|Baseline|Protocol Violation|0|||
161564391|NCT04319094|583456279|FG001|Baseline|Protocol Violation|3|||
161564392|NCT04319094|583456278|FG000|Baseline|Withdrawal by Subject|2|||
161564393|NCT04319094|583456279|FG001|Baseline|Withdrawal by Subject|1|||
161564394|NCT04319094|583456278|FG000|Post-Intervention|Death|0|||
161564395|NCT04319094|583456279|FG001|Post-Intervention|Death|1|||
161564396|NCT04319094|583456278|FG000|Post-Intervention|Lost to Follow-up|4|||
161564397|NCT04319094|583456279|FG001|Post-Intervention|Lost to Follow-up|4|||
161564398|NCT04319094|583456278|FG000|Post-Intervention|Withdrawal by Subject|8|||
161564399|NCT04319094|583456279|FG001|Post-Intervention|Withdrawal by Subject|5|||
161564400|NCT04319094|583456278|FG000|Post-Intervention|Incomplete Data Collection|1|||
161564401|NCT04319094|583456279|FG001|Post-Intervention|Incomplete Data Collection|3|||
161564402|NCT04319094|583456278|FG000|3-month|Death|1|||
161564403|NCT04319094|583456279|FG001|3-month|Death|0|||
161564404|NCT04319094|583456278|FG000|3-month|Lost to Follow-up|2|||
161911057|NCT03451045|584727143|FG001|Overall Study|Adverse Event|1|||
161564405|NCT04319094|583456279|FG001|3-month|Lost to Follow-up|2|||
161564406|NCT04319094|583456278|FG000|3-month|Withdrawal by Subject|0|||
161564407|NCT04319094|583456279|FG001|3-month|Withdrawal by Subject|3|||
161564408|NCT04319094|583456278|FG000|3-month|Incomplete data collection|9|||
161564409|NCT04319094|583456279|FG001|3-month|Incomplete data collection|7|||
161911058|NCT03451045|584727144|FG002|Overall Study|Adverse Event|3|||
161911059|NCT03451045|584727142|FG000|Overall Study|Non-compliance with study|2|||
161911060|NCT03451045|584727143|FG001|Overall Study|Non-compliance with study|0|||
161911061|NCT03451045|584727144|FG002|Overall Study|Non-compliance with study|1|||
161911062|NCT03451045|584727142|FG000|Overall Study|any other reason|10|||
161911063|NCT03451045|584727143|FG001|Overall Study|any other reason|2|||
161911064|NCT03451045|584727144|FG002|Overall Study|any other reason|13|||
161911065|NCT00863707|584727145|FG000|Overall Study|Randomized, but drug not received|4|||
161564410|NCT04319094|583456278|FG000|6-month|Lost to Follow-up|1|||
161564411|NCT04319094|583456279|FG001|6-month|Lost to Follow-up|1|||
161564412|NCT04319094|583456278|FG000|6-month|Withdrawal by Subject|0|||
161564413|NCT04319094|583456279|FG001|6-month|Withdrawal by Subject|3|||
161564414|NCT04319094|583456278|FG000|6-month|Incomplete data collection|14|||
161564415|NCT04319094|583456279|FG001|6-month|Incomplete data collection|9|||
161564416|NCT04319094|583456278|FG000|9-month|Lost to Follow-up|8|||
161564417|NCT04319094|583456279|FG001|9-month|Lost to Follow-up|4|||
161564418|NCT04319094|583456278|FG000|9-month|Withdrawal by Subject|0|||
161564419|NCT04319094|583456279|FG001|9-month|Withdrawal by Subject|1|||
161564420|NCT04319094|583456278|FG000|9-month|Incomplete data collection|8|||
161807440|NCT00550537|584339763|FG000|Overall Study|Change in treatment plan|4|||
161807441|NCT00550537|584339763|FG000|Overall Study|Other complicating ilness|3|||
161807442|NCT00550537|584339763|FG000|Overall Study|Declining performance status|2|||
161807443|NCT00550537|584339763|FG000|Overall Study|Treated closer to home|4|||
161807444|NCT02008565|584339764|FG000|Overall Study|Protocol Violation|1|||
161807445|NCT02008565|584339765|FG001|Overall Study|Protocol Violation|1|||
161807446|NCT02008565|584339766|FG002|Overall Study|Protocol Violation|2|||
161807447|NCT02008565|584339767|FG003|Overall Study|Protocol Violation|0|||
161807448|NCT00617305|584339768|FG000|Overall Study|Adverse Event|4|||
161807449|NCT00617305|584339769|FG001|Overall Study|Adverse Event|0|||
161807450|NCT00617305|584339770|FG002|Overall Study|Adverse Event|0|||
161807451|NCT00617305|584339768|FG000|Overall Study|Death|1|||
161807452|NCT00617305|584339769|FG001|Overall Study|Death|0|||
161807453|NCT00617305|584339770|FG002|Overall Study|Death|0|||
161807454|NCT00617305|584339768|FG000|Overall Study|Physician Decision|1|||
161807455|NCT00617305|584339769|FG001|Overall Study|Physician Decision|0|||
161807456|NCT00617305|584339770|FG002|Overall Study|Physician Decision|0|||
161807457|NCT00617305|584339768|FG000|Overall Study|Protocol Violation|1|||
161807458|NCT00617305|584339769|FG001|Overall Study|Protocol Violation|0|||
161807459|NCT00617305|584339770|FG002|Overall Study|Protocol Violation|1|||
161807460|NCT00617305|584339768|FG000|Overall Study|Withdrawal by Subject|1|||
161807461|NCT00617305|584339769|FG001|Overall Study|Withdrawal by Subject|0|||
161807462|NCT00617305|584339770|FG002|Overall Study|Withdrawal by Subject|0|||
161807463|NCT00537979|584339772|FG000|Overall Study|Adverse Event|2|||
161807464|NCT00537979|584339773|FG001|Overall Study|Adverse Event|2|||
161807465|NCT00537979|584339772|FG000|Overall Study|Withdrawal by Subject|1|||
161807466|NCT00537979|584339773|FG001|Overall Study|Withdrawal by Subject|4|||
161807467|NCT00537979|584339772|FG000|Overall Study|Lost to Follow-up|1|||
161807468|NCT00537979|584339773|FG001|Overall Study|Lost to Follow-up|4|||
161911066|NCT00863707|584727146|FG001|Overall Study|Randomized, but drug not received|3|||
161911067|NCT01142336|584727147|FG000|Overall Study|Adverse Event|1|||
161911068|NCT01142336|584727148|FG001|Overall Study|Adverse Event|1|||
161911069|NCT01142336|584727147|FG000|Overall Study|Lost to Follow-up|0|||
161911070|NCT01142336|584727148|FG001|Overall Study|Lost to Follow-up|1|||
161911071|NCT00830128|584727149|FG000|Overall Study|Adverse Event|5|||
161911072|NCT00830128|584727149|FG000|Overall Study|Lack of Efficacy|7|||
161911073|NCT00830128|584727149|FG000|Overall Study|Protocol Violation|1|||
161911074|NCT00830128|584727149|FG000|Overall Study|Withdrawal by Subject|2|||
161911075|NCT00830128|584727149|FG000|Overall Study|Family obligation|1|||
161911076|NCT00830128|584727149|FG000|Overall Study|Relocation|1|||
161911077|NCT00830128|584727149|FG000|Overall Study|Work obligation|1|||
161911078|NCT00830128|584727149|FG000|Overall Study|Operating a vehicle|1|||
161911079|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
161911080|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
161911081|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
161911082|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
161911083|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
161911084|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
161911085|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
161911086|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
161911087|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
161911088|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
161911089|NCT03025035|584727152|FG000|Overall Study|Death|2|||
161807469|NCT00537979|584339772|FG000|Overall Study|Lack of Efficacy|0|||
161807470|NCT00537979|584339773|FG001|Overall Study|Lack of Efficacy|1|||
161807471|NCT00537979|584339772|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
161564421|NCT04319094|583456279|FG001|9-month|Incomplete data collection|5|||
161564422|NCT04319094|583456278|FG000|12-month|Lost to Follow-up|11|||
161564423|NCT04319094|583456279|FG001|12-month|Lost to Follow-up|8|||
161807472|NCT00537979|584339773|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
161807473|NCT00537979|584339772|FG000|Overall Study|Death|0|||
161807474|NCT00537979|584339773|FG001|Overall Study|Death|3|||
161807475|NCT00537979|584339772|FG000|Overall Study|Kidney transplant|0|||
161807476|NCT00537979|584339773|FG001|Overall Study|Kidney transplant|3|||
161807477|NCT00537979|584339772|FG000|Overall Study|Heart failure|0|||
161807478|NCT00537979|584339773|FG001|Overall Study|Heart failure|1|||
161807479|NCT04384978|584339777|FG000|Overall Study|Withdrawal by Subject|4|||
161807480|NCT04384978|584339778|FG001|Overall Study|Withdrawal by Subject|0|||
161807481|NCT00385593|584339779|FG000|Overall Study|Adverse Event|3|||
161807482|NCT00385593|584339780|FG001|Overall Study|Adverse Event|2|||
161807483|NCT00385593|584339779|FG000|Overall Study|Withdrawal by Subject|17|||
161807484|NCT00385593|584339780|FG001|Overall Study|Withdrawal by Subject|7|||
161807485|NCT00385593|584339779|FG000|Overall Study|Lost to Follow-up|12|||
161807486|NCT00385593|584339780|FG001|Overall Study|Lost to Follow-up|8|||
161807487|NCT00385593|584339779|FG000|Overall Study|Protocol Violation|7|||
161807488|NCT00385593|584339780|FG001|Overall Study|Protocol Violation|4|||
161807489|NCT00385593|584339779|FG000|Overall Study|Several reasons|17|||
161807490|NCT00385593|584339780|FG001|Overall Study|Several reasons|15|||
161807491|NCT00385593|584339779|FG000|Overall Study|Incorrect inclusion|2|||
161807492|NCT00385593|584339780|FG001|Overall Study|Incorrect inclusion|0|||
161807493|NCT00385593|584339779|FG000|Overall Study|Incorrect randomization|0|||
161807494|NCT00385593|584339780|FG001|Overall Study|Incorrect randomization|1|||
161807495|NCT01223365|584339801|FG000|Open-label Titration Period|Enrolled but not treated|1|||
161807496|NCT01223365|584339801|FG000|Open-label Titration Period|Adverse Event|23|||
161807497|NCT01223365|584339801|FG000|Open-label Titration Period|Lack of Efficacy|3|||
161807498|NCT01223365|584339801|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
161807499|NCT01223365|584339801|FG000|Open-label Titration Period|Protocol Violation|1|||
161807500|NCT01223365|584339801|FG000|Open-label Titration Period|Lost to Follow-up|2|||
161807501|NCT01223365|584339801|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
161807502|NCT01223365|584339801|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
161807503|NCT01223365|584339801|FG000|Open-label Titration Period|Starting physical therapy|1|||
161807504|NCT01223365|584339801|FG000|Open-label Treatment Period|Adverse Event|39|||
161807505|NCT01223365|584339801|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
161807506|NCT01223365|584339801|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
161807507|NCT01223365|584339801|FG000|Open-label Treatment Period|Protocol Violation|15|||
161807508|NCT01223365|584339801|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
161807509|NCT01223365|584339801|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
161807510|NCT01223365|584339801|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
161807511|NCT01223365|584339801|FG000|Open-label Treatment Period|Moved out of area|2|||
161807512|NCT01223365|584339801|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
161807513|NCT01223365|584339801|FG000|Open-label Treatment Period|"Out of window"|1|||
161807514|NCT01223365|584339801|FG000|Open-label Treatment Period|Starting physical therapy|1|||
161807515|NCT01223365|584339801|FG000|Open-label Treatment Period|Physician Decision|2|||
161807516|NCT03041025|584339802|FG000|Overall Study|Adverse Event|0|||
161807517|NCT03041025|584339803|FG001|Overall Study|Adverse Event|0|||
161807518|NCT03041025|584339804|FG002|Overall Study|Adverse Event|1|||
161807519|NCT03041025|584339802|FG000|Overall Study|Lost to Follow-up|1|||
161807520|NCT03041025|584339803|FG001|Overall Study|Lost to Follow-up|0|||
161807521|NCT03041025|584339804|FG002|Overall Study|Lost to Follow-up|0|||
161807522|NCT03041025|584339802|FG000|Overall Study|Withdrawal by Subject|0|||
161807523|NCT03041025|584339803|FG001|Overall Study|Withdrawal by Subject|0|||
161807524|NCT03041025|584339804|FG002|Overall Study|Withdrawal by Subject|1|||
161807525|NCT02963259|584339805|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
161807526|NCT02963259|584339805|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
161807527|NCT02963259|584339805|FG000|Overall Study|Death|1|||
161807528|NCT02963259|584339805|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
161807529|NCT02131129|584339806|FG000|Overall Study|Withdrawal by Subject|1|||
161807530|NCT02131129|584339807|FG001|Overall Study|Withdrawal by Subject|0|||
161807531|NCT03880266|584339808|FG000|Overall Study|Withdrawal by Subject|0|||
161807532|NCT03880266|584339809|FG001|Overall Study|Withdrawal by Subject|1|||
161807533|NCT03880266|584339810|FG002|Overall Study|Withdrawal by Subject|1|||
161807534|NCT03880266|584339811|FG003|Overall Study|Withdrawal by Subject|0|||
161807535|NCT03880266|584339812|FG004|Overall Study|Withdrawal by Subject|0|||
161807536|NCT03880266|584339813|FG005|Overall Study|Withdrawal by Subject|0|||
161807537|NCT03880266|584339814|FG006|Overall Study|Withdrawal by Subject|0|||
161807538|NCT03880266|584339815|FG007|Overall Study|Withdrawal by Subject|0|||
161807539|NCT01511939|584341133|FG000|Overall Study|Withdrawal by Subject|2|||
161807540|NCT01511939|584341134|FG001|Overall Study|Withdrawal by Subject|1|||
161807541|NCT01511939|584341135|FG002|Overall Study|Withdrawal by Subject|0|||
161807542|NCT01993030|584341138|FG000|Overall Study|Adverse Event|0|||
161807543|NCT01993030|584341139|FG001|Overall Study|Adverse Event|4|||
161807544|NCT00829790|584341145|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
161564424|NCT00654238|583456283|FG000|Overall Study|Screen Failures|4|||
161564425|NCT03905135|583456285|FG000|Dose Escalation|Adverse Event|1|||
161564426|NCT03905135|583456286|FG001|Dose Escalation|Adverse Event|1|||
161564427|NCT03905135|583456285|FG000|Dose Escalation|Progressive disease|3|||
161564428|NCT03905135|583456286|FG001|Dose Escalation|Progressive disease|1|||
161564429|NCT03905135|583456285|FG000|Dose Escalation|Intercurrent illness|1|||
161564430|NCT03905135|583456286|FG001|Dose Escalation|Intercurrent illness|0|||
161564431|NCT04523181|583456287|FG000|Overall Study|Withdrawal by Subject|4|||
161564432|NCT04523181|583456288|FG001|Overall Study|Withdrawal by Subject|5|||
161564433|NCT04523181|583456287|FG000|Overall Study|Lost to Follow-up|2|||
161564434|NCT04523181|583456288|FG001|Overall Study|Lost to Follow-up|3|||
161564435|NCT04523181|583456287|FG000|Overall Study|Physician Decision|1|||
161564436|NCT04523181|583456288|FG001|Overall Study|Physician Decision|0|||
161564437|NCT04523181|583456287|FG000|Overall Study|Transferred to external facility.|1|||
161564438|NCT04523181|583456288|FG001|Overall Study|Transferred to external facility.|1|||
161564439|NCT02042443|583456291|FG000|Overall Study|Adverse Event|2|||
161564440|NCT02042443|583456292|FG001|Overall Study|Adverse Event|1|||
161564441|NCT02042443|583456291|FG000|Overall Study|Withdrawal by Subject|0|||
161564442|NCT02042443|583456292|FG001|Overall Study|Withdrawal by Subject|1|||
161564443|NCT02042443|583456291|FG000|Overall Study|Progression|21|||
161564444|NCT02042443|583456292|FG001|Overall Study|Progression|17|||
161564445|NCT02042443|583456291|FG000|Overall Study|not protocol specified|1|||
161564446|NCT02042443|583456292|FG001|Overall Study|not protocol specified|1|||
161564447|NCT02042443|583456291|FG000|Overall Study|Not eligible/not analyzable|3|||
161564448|NCT02042443|583456292|FG001|Overall Study|Not eligible/not analyzable|6|||
161564449|NCT01649427|583456293|FG000|Overall Study|Adverse Event|1|||
161564450|NCT01649427|583456294|FG001|Overall Study|Adverse Event|1|||
161564451|NCT01649427|583456293|FG000|Overall Study|Withdrawal by Subject|8|||
161564452|NCT01649427|583456294|FG001|Overall Study|Withdrawal by Subject|7|||
161564453|NCT01649427|583456293|FG000|Overall Study|Lost to Follow-up|0|||
161564454|NCT01649427|583456294|FG001|Overall Study|Lost to Follow-up|1|||
161564455|NCT01649427|583456293|FG000|Overall Study|Graft loss|0|||
161564456|NCT01649427|583456294|FG001|Overall Study|Graft loss|1|||
161564457|NCT01649427|583456293|FG000|Overall Study|Surgical problems during nephrectomy|2|||
161564458|NCT01649427|583456294|FG001|Overall Study|Surgical problems during nephrectomy|2|||
161564459|NCT02138916|583456297|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
161564460|NCT02138916|583456298|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
161564461|NCT02138916|583456299|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
161564462|NCT02138916|583456297|FG000|Overall Study|Death|14|||
161564463|NCT02138916|583456298|FG001|Overall Study|Death|11|||
161564464|NCT02138916|583456299|FG002|Overall Study|Death|12|||
161564465|NCT02138916|583456297|FG000|Overall Study|Withdrawal by Subject|27|||
161564466|NCT02138916|583456298|FG001|Overall Study|Withdrawal by Subject|31|||
161564467|NCT02138916|583456299|FG002|Overall Study|Withdrawal by Subject|32|||
161564468|NCT02138916|583456297|FG000|Overall Study|Study specific withdrawal criteria|0|||
161564469|NCT02138916|583456298|FG001|Overall Study|Study specific withdrawal criteria|0|||
161564470|NCT02138916|583456299|FG002|Overall Study|Study specific withdrawal criteria|1|||
161564471|NCT02138916|583456297|FG000|Overall Study|incorrect enrolment|1|||
161564472|NCT02138916|583456298|FG001|Overall Study|incorrect enrolment|1|||
161564473|NCT02138916|583456299|FG002|Overall Study|incorrect enrolment|0|||
161564474|NCT02138916|583456297|FG000|Overall Study|Severe non-compliance|1|||
161564475|NCT02138916|583456298|FG001|Overall Study|Severe non-compliance|2|||
161564476|NCT02138916|583456299|FG002|Overall Study|Severe non-compliance|1|||
161564477|NCT02138916|583456297|FG000|Overall Study|Lost to Follow-up|4|||
161564478|NCT02138916|583456298|FG001|Overall Study|Lost to Follow-up|2|||
161564479|NCT02138916|583456299|FG002|Overall Study|Lost to Follow-up|3|||
161564480|NCT02138916|583456297|FG000|Overall Study|Adverse Event|4|||
161564481|NCT02138916|583456298|FG001|Overall Study|Adverse Event|4|||
161564482|NCT02138916|583456299|FG002|Overall Study|Adverse Event|3|||
161564483|NCT01913340|583456300|FG000|Overall Study|Death|2|||
161564484|NCT01913340|583456301|FG001|Overall Study|Death|5|||
161564485|NCT01913340|583456300|FG000|Overall Study|Lost to Follow-up|1|||
161564486|NCT01913340|583456301|FG001|Overall Study|Lost to Follow-up|1|||
161564487|NCT05750745|583456303|FG000|Overall Study|Adverse Event|1|||
161564488|NCT05750745|583456304|FG001|Overall Study|Adverse Event|0|||
161564489|NCT05750745|583456305|FG002|Overall Study|Adverse Event|0|||
161564490|NCT05750745|583456303|FG000|Overall Study|Protocol Violation|1|||
161564491|NCT05750745|583456304|FG001|Overall Study|Protocol Violation|0|||
161564492|NCT05750745|583456305|FG002|Overall Study|Protocol Violation|0|||
161564493|NCT05750745|583456303|FG000|Overall Study|Withdrawal by Subject|0|||
161564494|NCT05750745|583456304|FG001|Overall Study|Withdrawal by Subject|1|||
161564495|NCT05750745|583456305|FG002|Overall Study|Withdrawal by Subject|0|||
161564496|NCT05096884|583456307|FG000|Overall Study|Excluded based on negative tilt table test|4|||
161564497|NCT02482233|583456308|FG000|Overall Study|Lost to Follow-up|1|||
161564498|NCT02482233|583456309|FG001|Overall Study|Lost to Follow-up|1|||
161564499|NCT04888585|583456310|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
161564500|NCT04888585|583456311|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
161564501|NCT04888585|583456312|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
161564502|NCT04888585|583456313|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
161564503|NCT04888585|583456314|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
161564504|NCT04888585|583456315|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
161564505|NCT04888585|583456316|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
161564506|NCT04888585|583456317|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
161564507|NCT04888585|583456318|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
161564508|NCT04888585|583456319|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
161564509|NCT04888585|583456320|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
161564510|NCT04888585|583456310|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564511|NCT04888585|583456311|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
161564512|NCT04888585|583456312|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
161564513|NCT04888585|583456313|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
161564514|NCT04888585|583456314|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
161564515|NCT04888585|583456315|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564516|NCT04888585|583456316|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564517|NCT04888585|583456317|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564518|NCT04888585|583456318|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564519|NCT04888585|583456319|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564520|NCT04888585|583456320|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161564521|NCT04888585|583456310|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564522|NCT04888585|583456311|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564523|NCT04888585|583456312|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
161564524|NCT04888585|583456313|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564525|NCT04888585|583456314|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
161564526|NCT04888585|583456315|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564527|NCT04888585|583456316|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564528|NCT04888585|583456317|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564529|NCT04888585|583456318|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564530|NCT04888585|583456319|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564531|NCT04888585|583456320|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161564532|NCT04888585|583456310|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564533|NCT04888585|583456311|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564534|NCT04888585|583456312|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564535|NCT04888585|583456313|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564536|NCT04888585|583456314|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564537|NCT04888585|583456315|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564538|NCT04888585|583456316|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564539|NCT04888585|583456317|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
161564540|NCT04888585|583456318|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564541|NCT04888585|583456319|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
161564542|NCT04888585|583456320|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
161564543|NCT04888585|583456310|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
161564544|NCT04888585|583456311|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
161564545|NCT04888585|583456312|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
161564546|NCT04888585|583456313|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
161564547|NCT04888585|583456314|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
161564548|NCT04888585|583456315|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
161564549|NCT04888585|583456316|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
161564550|NCT04888585|583456317|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
161564551|NCT04888585|583456318|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
161564552|NCT04888585|583456319|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
161564553|NCT04888585|583456320|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
161564554|NCT04888585|583456310|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161564555|NCT04888585|583456311|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161564556|NCT04888585|583456312|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161564557|NCT04888585|583456313|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161564558|NCT04888585|583456314|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161564559|NCT04888585|583456315|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
161564560|NCT04888585|583456316|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
161564561|NCT04888585|583456317|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
161564562|NCT04888585|583456318|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
161564563|NCT04888585|583456319|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
161564564|NCT04888585|583456320|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
161564565|NCT04888585|583456310|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
161564566|NCT04888585|583456311|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
161564567|NCT04888585|583456312|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
161564568|NCT04888585|583456313|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
161564569|NCT04888585|583456314|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
161564570|NCT04888585|583456315|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
161564571|NCT04888585|583456316|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
161564572|NCT04888585|583456317|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
161564573|NCT04888585|583456318|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
161564574|NCT04888585|583456319|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
161564575|NCT04888585|583456320|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
161564576|NCT04888585|583456310|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564577|NCT04888585|583456311|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564578|NCT04888585|583456312|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564579|NCT04888585|583456313|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564580|NCT04888585|583456314|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564581|NCT04888585|583456315|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564582|NCT04888585|583456316|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
161564583|NCT04888585|583456317|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
161564584|NCT04888585|583456318|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
161564585|NCT04888585|583456319|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
161564586|NCT04888585|583456320|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161564587|NCT04927975|583456321|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
161564588|NCT04927975|583456322|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
161564589|NCT04927975|583456323|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
161564590|NCT04927975|583456324|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
161564591|NCT04927975|583456325|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
161564592|NCT04927975|583456326|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
161564593|NCT04927975|583456321|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
161564594|NCT04927975|583456322|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
161564595|NCT04927975|583456323|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
161564596|NCT04927975|583456324|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
161564597|NCT04927975|583456325|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
161564598|NCT04927975|583456326|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
161564599|NCT04927975|583456321|FG000|Period 1 (Baseline-Week 24)|Death|0|||
161564600|NCT04927975|583456322|FG001|Period 1 (Baseline-Week 24)|Death|0|||
161564601|NCT04927975|583456323|FG002|Period 1 (Baseline-Week 24)|Death|0|||
161564602|NCT04927975|583456324|FG003|Period 1 (Baseline-Week 24)|Death|0|||
161564603|NCT04927975|583456325|FG004|Period 1 (Baseline-Week 24)|Death|0|||
161564604|NCT04927975|583456326|FG005|Period 1 (Baseline-Week 24)|Death|1|||
161564605|NCT04927975|583456321|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
161564606|NCT04927975|583456322|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
161564607|NCT04927975|583456323|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
161564608|NCT04927975|583456324|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
161564609|NCT04927975|583456325|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
161564610|NCT04927975|583456326|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
161564611|NCT04927975|583456321|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
161564612|NCT04927975|583456322|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
161564613|NCT04927975|583456323|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
161564614|NCT04927975|583456324|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
161564615|NCT04927975|583456325|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
161564616|NCT04927975|583456326|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
161564617|NCT03822351|583456327|FG000|Overall Study|Death|27|||
161564618|NCT03822351|583456328|FG001|Overall Study|Death|23|||
161564619|NCT03822351|583456329|FG002|Overall Study|Death|24|||
161564620|NCT03822351|583456327|FG000|Overall Study|Lost to Follow-up|6|||
161564621|NCT03822351|583456328|FG001|Overall Study|Lost to Follow-up|2|||
161564622|NCT03822351|583456329|FG002|Overall Study|Lost to Follow-up|1|||
161564623|NCT03822351|583456327|FG000|Overall Study|Withdrawal by Subject|10|||
161564624|NCT03822351|583456328|FG001|Overall Study|Withdrawal by Subject|4|||
161564625|NCT03822351|583456329|FG002|Overall Study|Withdrawal by Subject|6|||
161564626|NCT03822351|583456327|FG000|Overall Study|Progressive Disease|2|||
161564627|NCT03822351|583456328|FG001|Overall Study|Progressive Disease|1|||
161564628|NCT03822351|583456329|FG002|Overall Study|Progressive Disease|0|||
161564629|NCT03822351|583456327|FG000|Overall Study|Not Treated|1|||
161564630|NCT03822351|583456328|FG001|Overall Study|Not Treated|1|||
161564631|NCT03822351|583456329|FG002|Overall Study|Not Treated|1|||
161564632|NCT00768066|583456332|FG000|Overall Study|Did not receive study product injection.|3|||
161564633|NCT00768066|583456333|FG001|Overall Study|Did not receive study product injection.|3|||
161564634|NCT00768066|583456334|FG002|Overall Study|Did not receive study product injection.|0|||
161564635|NCT05550337|583456335|FG000|Overall Study|Lack of Efficacy|0|||
161564636|NCT05550337|583456336|FG001|Overall Study|Lack of Efficacy|0|||
161564637|NCT05550337|583456337|FG002|Overall Study|Lack of Efficacy|1|||
161564638|NCT05550337|583456335|FG000|Overall Study|Adverse Event|1|||
161564639|NCT05550337|583456336|FG001|Overall Study|Adverse Event|5|||
161564640|NCT05550337|583456337|FG002|Overall Study|Adverse Event|0|||
161564641|NCT05550337|583456335|FG000|Overall Study|Withdrawal by Subject|8|||
161564642|NCT05550337|583456336|FG001|Overall Study|Withdrawal by Subject|14|||
161564643|NCT05550337|583456337|FG002|Overall Study|Withdrawal by Subject|10|||
161564644|NCT05550337|583456335|FG000|Overall Study|Pregnancy|0|||
161564645|NCT05550337|583456336|FG001|Overall Study|Pregnancy|0|||
161564646|NCT05550337|583456337|FG002|Overall Study|Pregnancy|1|||
161564647|NCT05550337|583456335|FG000|Overall Study|Protocol Violation|1|||
161564648|NCT05550337|583456336|FG001|Overall Study|Protocol Violation|3|||
161564649|NCT05550337|583456337|FG002|Overall Study|Protocol Violation|4|||
161564650|NCT05550337|583456335|FG000|Overall Study|Physician Decision|2|||
161564651|NCT05550337|583456336|FG001|Overall Study|Physician Decision|1|||
161564652|NCT05550337|583456337|FG002|Overall Study|Physician Decision|1|||
161564653|NCT05550337|583456335|FG000|Overall Study|Lost to Follow-up|16|||
161564654|NCT05550337|583456336|FG001|Overall Study|Lost to Follow-up|11|||
161564655|NCT05550337|583456337|FG002|Overall Study|Lost to Follow-up|11|||
161564656|NCT02189863|583456338|FG000|First 2 Weeks|Motion Sickness|4|||
161564657|NCT02189863|583456339|FG001|First 2 Weeks|Motion Sickness|2|||
161564658|NCT02926937|583456346|FG000|Overall Study|Adverse Event|0|||
161911090|NCT03025035|584727152|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
161911091|NCT01123655|584727155|FG000|Overall Study|Medication for RA had to be changed|1|||
161911092|NCT01123655|584727156|FG001|Overall Study|Medication for RA had to be changed|0|||
161911093|NCT01123655|584727157|FG002|Overall Study|Medication for RA had to be changed|0|||
161911094|NCT01123655|584727155|FG000|Overall Study|new illness|0|||
161911095|NCT01123655|584727156|FG001|Overall Study|new illness|1|||
161911096|NCT01123655|584727157|FG002|Overall Study|new illness|0|||
161911097|NCT01123655|584727155|FG000|Overall Study|began prohibitive drug|0|||
161911098|NCT01123655|584727156|FG001|Overall Study|began prohibitive drug|0|||
161911099|NCT01123655|584727157|FG002|Overall Study|began prohibitive drug|1|||
161911100|NCT05063448|584727162|FG000|Overall Study|Withdrawal by Subject|1|||
161911101|NCT02475369|584727166|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
161911102|NCT02475369|584727167|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
161911103|NCT03329885|584727173|FG000|Overall Study|Sponsor discontinued the study early|0|||
161911104|NCT03329885|584727174|FG001|Overall Study|Sponsor discontinued the study early|0|||
161911105|NCT03329885|584727175|FG002|Overall Study|Sponsor discontinued the study early|0|||
161911106|NCT03329885|584727176|FG003|Overall Study|Sponsor discontinued the study early|0|||
161911107|NCT03329885|584727177|FG004|Overall Study|Sponsor discontinued the study early|0|||
161911108|NCT03329885|584727178|FG005|Overall Study|Sponsor discontinued the study early|0|||
161911109|NCT03329885|584727179|FG006|Overall Study|Sponsor discontinued the study early|1|||
161911110|NCT03329885|584727180|FG007|Overall Study|Sponsor discontinued the study early|1|||
161911111|NCT03329885|584727181|FG008|Overall Study|Sponsor discontinued the study early|0|||
161911112|NCT01991795|584727182|FG000|Overall Study|Lost to Follow-up|6|||
161911113|NCT01991795|584727183|FG001|Overall Study|Lost to Follow-up|4|||
161911114|NCT01991795|584727182|FG000|Overall Study|Withdrawal by Subject|117|||
161911115|NCT01991795|584727183|FG001|Overall Study|Withdrawal by Subject|94|||
161911116|NCT01991795|584727182|FG000|Overall Study|Site prematurely closed by sponsor|26|||
161911117|NCT01991795|584727183|FG001|Overall Study|Site prematurely closed by sponsor|25|||
161911118|NCT01981616|584727185|FG000|Overall Study|Adverse Event|0|||
161911119|NCT01981616|584727186|FG001|Overall Study|Adverse Event|1|||
161911120|NCT01981616|584727185|FG000|Overall Study|Protocol Violation|1|||
161911121|NCT01981616|584727186|FG001|Overall Study|Protocol Violation|0|||
161911122|NCT03641508|584727187|FG000|First Injection|Lost to Follow-up|2|||
161911123|NCT03641508|584727188|FG001|First Injection|Lost to Follow-up|0|||
161911124|NCT02404545|584727189|FG000|Overall Study|Sponsor Termination|6|||
161807545|NCT00829790|584341146|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
161807546|NCT04247282|584341150|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
161807547|NCT04247282|584341151|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
161807548|NCT04247282|584341152|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
161807549|NCT04247282|584341153|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
161807550|NCT04247282|584341150|FG000|Overall Study|Refused further treatment|0|||
161911125|NCT02404545|584727190|FG001|Overall Study|Sponsor Termination|6|||
161564659|NCT02926937|583456347|FG001|Overall Study|Adverse Event|1|||
161564660|NCT02926937|583456348|FG002|Overall Study|Adverse Event|1|||
161564661|NCT02926937|583456346|FG000|Overall Study|Poor Compliance to Protocol|1|||
161564662|NCT02926937|583456347|FG001|Overall Study|Poor Compliance to Protocol|0|||
161807551|NCT04247282|584341151|FG001|Overall Study|Refused further treatment|1|||
161807552|NCT04247282|584341152|FG002|Overall Study|Refused further treatment|0|||
161807553|NCT04247282|584341153|FG003|Overall Study|Refused further treatment|0|||
161911126|NCT00094445|584727191|FG000|Overall Study|Withdrawal by Subject|3|||
161564663|NCT02926937|583456348|FG002|Overall Study|Poor Compliance to Protocol|0|||
161564664|NCT02926937|583456346|FG000|Overall Study|Lost to Follow-up|4|||
161911127|NCT00094445|584727191|FG000|Overall Study|Lost to Follow-up|1|||
161911128|NCT00094445|584727191|FG000|Overall Study|Progressive Disease|2|||
161911129|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
161564665|NCT02926937|583456347|FG001|Overall Study|Lost to Follow-up|5|||
161564666|NCT02926937|583456348|FG002|Overall Study|Lost to Follow-up|0|||
161564667|NCT02926937|583456346|FG000|Overall Study|At the Participant's own Request|11|||
161564668|NCT02926937|583456347|FG001|Overall Study|At the Participant's own Request|5|||
161564669|NCT02926937|583456348|FG002|Overall Study|At the Participant's own Request|8|||
161564670|NCT02926937|583456346|FG000|Overall Study|Reason not Specified|3|||
161911130|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
161911131|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
161911132|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
161911133|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
161911134|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
161911135|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
161911136|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161911137|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161911138|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161911139|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
161911140|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
161911141|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161911142|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161911143|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161911144|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
161911145|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
161911146|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161911147|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161911148|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161911149|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
161911150|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
161911151|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161911152|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161911153|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161911154|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
161911155|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
161911156|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161911157|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161911158|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161564671|NCT02926937|583456347|FG001|Overall Study|Reason not Specified|4|||
161564672|NCT02926937|583456348|FG002|Overall Study|Reason not Specified|2|||
161911159|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
161911160|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
161911161|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161911162|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161911163|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161911164|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
161911165|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
161564673|NCT01559090|583456349|FG000|Stage I|Withdrawal by Subject|2|||
161564674|NCT01559090|583456350|FG001|Stage I|Withdrawal by Subject|2|||
161564675|NCT01559090|583456351|FG002|Stage I|Withdrawal by Subject|3|||
161564676|NCT01559090|583456349|FG000|Stage II|Withdrawal by Subject|1|||
161564677|NCT01559090|583456350|FG001|Stage II|Withdrawal by Subject|0|||
161564678|NCT01559090|583456351|FG002|Stage II|Withdrawal by Subject|0|||
161564679|NCT03499600|583456355|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
161564680|NCT03499600|583456356|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
161564681|NCT00561574|583456357|FG000|Overall Study|Adverse Event|21|||
161564682|NCT00561574|583456358|FG001|Overall Study|Adverse Event|24|||
161564683|NCT00561574|583456357|FG000|Overall Study|Lack of Efficacy|11|||
161564684|NCT00561574|583456358|FG001|Overall Study|Lack of Efficacy|21|||
161564685|NCT00561574|583456357|FG000|Overall Study|Withdrawal by Subject|4|||
161564686|NCT00561574|583456358|FG001|Overall Study|Withdrawal by Subject|4|||
161564687|NCT00561574|583456357|FG000|Overall Study|Reason Unrelated to Trial|6|||
161564688|NCT00561574|583456358|FG001|Overall Study|Reason Unrelated to Trial|2|||
161564689|NCT00561574|583456357|FG000|Overall Study|Lost to Follow-up|1|||
161564690|NCT00561574|583456358|FG001|Overall Study|Lost to Follow-up|0|||
161564691|NCT00561574|583456357|FG000|Overall Study|Other|5|||
161564692|NCT00561574|583456358|FG001|Overall Study|Other|7|||
161564693|NCT03971357|583456359|FG000|Overall Study|Lack of Efficacy|0|||
161564694|NCT03971357|583456360|FG001|Overall Study|Lack of Efficacy|1|||
161564695|NCT01729871|583456361|FG000|Overall Study|Adverse Event|7|||
161564696|NCT01729871|583456362|FG001|Overall Study|Adverse Event|7|||
161564697|NCT01729871|583456361|FG000|Overall Study|Death|0|||
161564698|NCT01729871|583456362|FG001|Overall Study|Death|1|||
161564699|NCT01729871|583456361|FG000|Overall Study|Lack of Efficacy|0|||
161564700|NCT01729871|583456362|FG001|Overall Study|Lack of Efficacy|1|||
161564701|NCT01729871|583456361|FG000|Overall Study|Physician Decision|0|||
161564702|NCT01729871|583456362|FG001|Overall Study|Physician Decision|2|||
161564703|NCT01729871|583456361|FG000|Overall Study|Protocol Violation|1|||
161564704|NCT01729871|583456362|FG001|Overall Study|Protocol Violation|0|||
161564705|NCT01729871|583456361|FG000|Overall Study|Withdrawal by Subject|0|||
161564706|NCT01729871|583456362|FG001|Overall Study|Withdrawal by Subject|3|||
161564707|NCT01729871|583456361|FG000|Overall Study|Other|4|||
161564708|NCT01729871|583456362|FG001|Overall Study|Other|9|||
161564709|NCT00445692|583456363|FG000|Overall Study|Adverse Event|11|||
161564710|NCT00445692|583456363|FG000|Overall Study|Lack of Efficacy|5|||
161564711|NCT01143077|583456365|FG000|Overall Study|Lack of Efficacy|0|||
161564712|NCT01143077|583456366|FG001|Overall Study|Lack of Efficacy|2|||
161564713|NCT01143077|583456367|FG002|Overall Study|Lack of Efficacy|1|||
161564714|NCT01143077|583456365|FG000|Overall Study|Adverse Event|5|||
161564715|NCT01143077|583456366|FG001|Overall Study|Adverse Event|6|||
161564716|NCT01143077|583456367|FG002|Overall Study|Adverse Event|5|||
161564717|NCT01143077|583456365|FG000|Overall Study|Lost to Follow-up|2|||
161564718|NCT01143077|583456366|FG001|Overall Study|Lost to Follow-up|3|||
161564719|NCT01143077|583456367|FG002|Overall Study|Lost to Follow-up|4|||
161564720|NCT01143077|583456365|FG000|Overall Study|Protocol Violation|2|||
161564721|NCT01143077|583456366|FG001|Overall Study|Protocol Violation|0|||
161564722|NCT01143077|583456367|FG002|Overall Study|Protocol Violation|0|||
161564723|NCT01143077|583456365|FG000|Overall Study|Withdrawal by Subject|4|||
161454711|NCT02112045|583059060|FG000|Overall Study|Withdrawal by Subject|1|||
161454712|NCT02112045|583059061|FG001|Overall Study|Withdrawal by Subject|0|||
161454713|NCT00627445|583059062|FG000|Overall Study|Adverse Event|3|||
161454714|NCT00627445|583059063|FG001|Overall Study|Adverse Event|3|||
161911166|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161911167|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161911168|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161911169|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
161911170|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161911171|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161454715|NCT00627445|583059062|FG000|Overall Study|Lack of Efficacy|0|||
161454716|NCT00627445|583059063|FG001|Overall Study|Lack of Efficacy|1|||
161454717|NCT00627445|583059062|FG000|Overall Study|Other|6|||
161454718|NCT00627445|583059063|FG001|Overall Study|Other|8|||
161564724|NCT01143077|583456366|FG001|Overall Study|Withdrawal by Subject|3|||
161564725|NCT01143077|583456367|FG002|Overall Study|Withdrawal by Subject|3|||
161454719|NCT00796523|583059064|FG000|Overall Study|Lost to Follow-up|9|||
161454720|NCT00796523|583059065|FG001|Overall Study|Lost to Follow-up|7|||
161454721|NCT02431260|583059070|FG000|Overall Study|Subject Decision|0|||
161454722|NCT02431260|583059071|FG001|Overall Study|Subject Decision|1|||
161454723|NCT02431260|583059072|FG002|Overall Study|Subject Decision|1|||
161454724|NCT02431260|583059073|FG003|Overall Study|Subject Decision|0|||
161454725|NCT02431260|583059074|FG004|Overall Study|Subject Decision|0|||
161454726|NCT02431260|583059075|FG005|Overall Study|Subject Decision|0|||
161454727|NCT02431260|583059076|FG006|Overall Study|Subject Decision|0|||
161454728|NCT02431260|583059077|FG007|Overall Study|Subject Decision|0|||
161454729|NCT02431260|583059078|FG008|Overall Study|Subject Decision|1|||
161454730|NCT02431260|583059079|FG009|Overall Study|Subject Decision|1|||
161454731|NCT02431260|583059080|FG010|Overall Study|Subject Decision|0|||
161564726|NCT01143077|583456365|FG000|Overall Study|Non-compliance with study drug|0|||
161564727|NCT01143077|583456366|FG001|Overall Study|Non-compliance with study drug|1|||
161564728|NCT01143077|583456367|FG002|Overall Study|Non-compliance with study drug|1|||
161564729|NCT01143077|583456365|FG000|Overall Study|Administrative|1|||
161454732|NCT02431260|583059081|FG011|Overall Study|Subject Decision|1|||
161454733|NCT02431260|583059082|FG012|Overall Study|Subject Decision|0|||
161564730|NCT01143077|583456366|FG001|Overall Study|Administrative|0|||
161564731|NCT01143077|583456367|FG002|Overall Study|Administrative|0|||
161564732|NCT01143077|583456365|FG000|Overall Study|Principal Investigator Decision|2|||
161564733|NCT01143077|583456366|FG001|Overall Study|Principal Investigator Decision|0|||
161564734|NCT01143077|583456367|FG002|Overall Study|Principal Investigator Decision|1|||
161564735|NCT00630864|583456373|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
161564736|NCT00630864|583456373|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
161564737|NCT02931396|583456376|FG000|Overall Study|Lost to Follow-up|3|||
161454734|NCT02431260|583059083|FG013|Overall Study|Subject Decision|0|||
161454735|NCT02431260|583059070|FG000|Overall Study|Death|4|||
161564738|NCT02931396|583456377|FG001|Overall Study|Lost to Follow-up|0|||
161564739|NCT02931396|583456376|FG000|Overall Study|Withdrawal by Subject|2|||
161454736|NCT02431260|583059071|FG001|Overall Study|Death|4|||
161454737|NCT02431260|583059072|FG002|Overall Study|Death|3|||
161454738|NCT02431260|583059073|FG003|Overall Study|Death|4|||
161454739|NCT02431260|583059074|FG004|Overall Study|Death|2|||
161454740|NCT02431260|583059075|FG005|Overall Study|Death|2|||
161454741|NCT02431260|583059076|FG006|Overall Study|Death|3|||
161454742|NCT02431260|583059077|FG007|Overall Study|Death|1|||
161454743|NCT02431260|583059078|FG008|Overall Study|Death|6|||
161454744|NCT02431260|583059079|FG009|Overall Study|Death|6|||
161454745|NCT02431260|583059080|FG010|Overall Study|Death|3|||
161454746|NCT02431260|583059081|FG011|Overall Study|Death|2|||
161454747|NCT02431260|583059082|FG012|Overall Study|Death|5|||
161454748|NCT02431260|583059083|FG013|Overall Study|Death|1|||
161454749|NCT02431260|583059070|FG000|Overall Study|Lost to Follow-up|0|||
161454750|NCT02431260|583059071|FG001|Overall Study|Lost to Follow-up|0|||
161454751|NCT02431260|583059072|FG002|Overall Study|Lost to Follow-up|0|||
161454752|NCT02431260|583059073|FG003|Overall Study|Lost to Follow-up|0|||
161454753|NCT02431260|583059074|FG004|Overall Study|Lost to Follow-up|0|||
161454754|NCT02431260|583059075|FG005|Overall Study|Lost to Follow-up|1|||
161454755|NCT02431260|583059076|FG006|Overall Study|Lost to Follow-up|0|||
161454756|NCT02431260|583059077|FG007|Overall Study|Lost to Follow-up|0|||
161454757|NCT02431260|583059078|FG008|Overall Study|Lost to Follow-up|0|||
161454758|NCT02431260|583059079|FG009|Overall Study|Lost to Follow-up|0|||
161454759|NCT02431260|583059080|FG010|Overall Study|Lost to Follow-up|0|||
161454760|NCT02431260|583059081|FG011|Overall Study|Lost to Follow-up|0|||
161454761|NCT02431260|583059082|FG012|Overall Study|Lost to Follow-up|0|||
161454762|NCT02431260|583059083|FG013|Overall Study|Lost to Follow-up|0|||
161454763|NCT02431260|583059070|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161454764|NCT02431260|583059071|FG001|Overall Study|Study Terminated by the Sponsor|0|||
161454765|NCT02431260|583059072|FG002|Overall Study|Study Terminated by the Sponsor|2|||
161454766|NCT02431260|583059073|FG003|Overall Study|Study Terminated by the Sponsor|1|||
161454767|NCT02431260|583059074|FG004|Overall Study|Study Terminated by the Sponsor|1|||
161454768|NCT02431260|583059075|FG005|Overall Study|Study Terminated by the Sponsor|0|||
161454769|NCT02431260|583059076|FG006|Overall Study|Study Terminated by the Sponsor|1|||
161454770|NCT02431260|583059077|FG007|Overall Study|Study Terminated by the Sponsor|2|||
161454771|NCT02431260|583059078|FG008|Overall Study|Study Terminated by the Sponsor|1|||
161454772|NCT02431260|583059079|FG009|Overall Study|Study Terminated by the Sponsor|1|||
161454773|NCT02431260|583059080|FG010|Overall Study|Study Terminated by the Sponsor|1|||
161454774|NCT02431260|583059081|FG011|Overall Study|Study Terminated by the Sponsor|0|||
161454775|NCT02431260|583059082|FG012|Overall Study|Study Terminated by the Sponsor|4|||
161454776|NCT02431260|583059083|FG013|Overall Study|Study Terminated by the Sponsor|0|||
161454777|NCT02431260|583059070|FG000|Overall Study|Physician Decision|0|||
161454778|NCT02431260|583059071|FG001|Overall Study|Physician Decision|0|||
161454779|NCT02431260|583059072|FG002|Overall Study|Physician Decision|0|||
161454780|NCT02431260|583059073|FG003|Overall Study|Physician Decision|0|||
161454781|NCT02431260|583059074|FG004|Overall Study|Physician Decision|0|||
161454782|NCT02431260|583059075|FG005|Overall Study|Physician Decision|1|||
161454783|NCT02431260|583059076|FG006|Overall Study|Physician Decision|0|||
161454784|NCT02431260|583059077|FG007|Overall Study|Physician Decision|0|||
161454785|NCT02431260|583059078|FG008|Overall Study|Physician Decision|0|||
161454786|NCT02431260|583059079|FG009|Overall Study|Physician Decision|0|||
161454787|NCT02431260|583059080|FG010|Overall Study|Physician Decision|0|||
161454788|NCT02431260|583059081|FG011|Overall Study|Physician Decision|0|||
161454789|NCT02431260|583059082|FG012|Overall Study|Physician Decision|0|||
161454790|NCT02431260|583059083|FG013|Overall Study|Physician Decision|0|||
161454791|NCT02431260|583059070|FG000|Overall Study|Other Unspecified|0|||
161454792|NCT02431260|583059071|FG001|Overall Study|Other Unspecified|0|||
161454793|NCT02431260|583059072|FG002|Overall Study|Other Unspecified|0|||
161454794|NCT02431260|583059073|FG003|Overall Study|Other Unspecified|0|||
161564740|NCT02931396|583456377|FG001|Overall Study|Withdrawal by Subject|0|||
161564741|NCT00681811|583456380|FG000|Overall Study|Adverse Event|1|||
161564742|NCT00681811|583456381|FG001|Overall Study|Adverse Event|1|||
161564743|NCT00681811|583456380|FG000|Overall Study|Withdrawal by Subject|2|||
161564744|NCT00681811|583456381|FG001|Overall Study|Withdrawal by Subject|2|||
161564745|NCT00681811|583456380|FG000|Overall Study|Non-compliance|0|||
161564746|NCT00681811|583456381|FG001|Overall Study|Non-compliance|1|||
161564747|NCT01140347|583456388|FG000|Overall Study|Lost to Follow-up|5|||
161564748|NCT01140347|583456389|FG001|Overall Study|Lost to Follow-up|6|||
161564749|NCT01140347|583456388|FG000|Overall Study|Withdrawal by Subject|13|||
161564750|NCT01140347|583456389|FG001|Overall Study|Withdrawal by Subject|8|||
161564751|NCT00828919|583456390|FG000|Overall Study|Death|0|||
161564752|NCT00828919|583456391|FG001|Overall Study|Death|1|||
161564753|NCT00828919|583456392|FG002|Overall Study|Death|2|||
161564754|NCT00828919|583456393|FG003|Overall Study|Death|0|||
161564755|NCT00828919|583456394|FG004|Overall Study|Death|0|||
161564756|NCT00828919|583456390|FG000|Overall Study|Adverse Event|2|||
161564757|NCT00828919|583456391|FG001|Overall Study|Adverse Event|2|||
161564758|NCT00828919|583456392|FG002|Overall Study|Adverse Event|2|||
161564759|NCT00828919|583456393|FG003|Overall Study|Adverse Event|1|||
161564760|NCT00828919|583456394|FG004|Overall Study|Adverse Event|3|||
161564761|NCT00828919|583456390|FG000|Overall Study|Objective progression or relapse|4|||
161564762|NCT00828919|583456391|FG001|Overall Study|Objective progression or relapse|4|||
161564763|NCT00828919|583456392|FG002|Overall Study|Objective progression or relapse|11|||
161564764|NCT00828919|583456393|FG003|Overall Study|Objective progression or relapse|0|||
161564765|NCT00828919|583456394|FG004|Overall Study|Objective progression or relapse|5|||
161564766|NCT00828919|583456390|FG000|Overall Study|No longer willing to participate in study|0|||
161564767|NCT00828919|583456391|FG001|Overall Study|No longer willing to participate in study|0|||
161564768|NCT00828919|583456392|FG002|Overall Study|No longer willing to participate in study|2|||
161564769|NCT00828919|583456393|FG003|Overall Study|No longer willing to participate in study|0|||
161564770|NCT00828919|583456394|FG004|Overall Study|No longer willing to participate in study|0|||
161564771|NCT00828919|583456390|FG000|Overall Study|Insufficient Clinical Response|0|||
161564772|NCT00828919|583456391|FG001|Overall Study|Insufficient Clinical Response|1|||
161564773|NCT00828919|583456392|FG002|Overall Study|Insufficient Clinical Response|2|||
161564774|NCT00828919|583456393|FG003|Overall Study|Insufficient Clinical Response|0|||
161564775|NCT00828919|583456394|FG004|Overall Study|Insufficient Clinical Response|0|||
161564776|NCT00828919|583456390|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
161564777|NCT00828919|583456391|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
161564778|NCT00828919|583456392|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
161564779|NCT00828919|583456393|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
161564780|NCT00828919|583456394|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
161807554|NCT01263704|584341154|FG000|Overall Study|Progressive disease|18|||
161807555|NCT01263704|584341154|FG000|Overall Study|Adverse Event|3|||
161807556|NCT01263704|584341154|FG000|Overall Study|Death|2|||
161807557|NCT01263704|584341154|FG000|Overall Study|Patient withdrew consent|2|||
161807558|NCT01263704|584341154|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161807559|NCT01263704|584341154|FG000|Overall Study|Lost to Follow-up|1|||
161807560|NCT01263704|584341154|FG000|Overall Study|Colon metastases|1|||
161807561|NCT01263704|584341154|FG000|Overall Study|Principal Investigator (PI) decision|1|||
161807562|NCT00102440|584341155|FG000|Overall Study|Lost to Follow-up|25|||
161807563|NCT00102440|584341156|FG001|Overall Study|Lost to Follow-up|18|||
161807564|NCT00102440|584341157|FG002|Overall Study|Lost to Follow-up|21|||
161807565|NCT00102440|584341155|FG000|Overall Study|Adverse Event|16|||
161807566|NCT00102440|584341156|FG001|Overall Study|Adverse Event|23|||
161807567|NCT00102440|584341157|FG002|Overall Study|Adverse Event|8|||
161807568|NCT00102440|584341155|FG000|Overall Study|Gout Flare|10|||
161807569|NCT00102440|584341156|FG001|Overall Study|Gout Flare|28|||
161807570|NCT00102440|584341157|FG002|Overall Study|Gout Flare|9|||
161807571|NCT00102440|584341155|FG000|Overall Study|Personal Reason(s)|19|||
161807572|NCT00102440|584341156|FG001|Overall Study|Personal Reason(s)|13|||
161807573|NCT00102440|584341157|FG002|Overall Study|Personal Reason(s)|13|||
161807574|NCT00102440|584341155|FG000|Overall Study|Other|11|||
161807575|NCT00102440|584341156|FG001|Overall Study|Other|14|||
161807576|NCT00102440|584341157|FG002|Overall Study|Other|14|||
161807577|NCT00102440|584341155|FG000|Overall Study|Protocol Violation|7|||
161807578|NCT00102440|584341156|FG001|Overall Study|Protocol Violation|2|||
161807579|NCT00102440|584341157|FG002|Overall Study|Protocol Violation|1|||
161807580|NCT01792635|584341159|FG000|Part B|Adverse Event|0|||
161807581|NCT01792635|584341160|FG001|Part B|Adverse Event|0|||
161807582|NCT01792635|584341161|FG002|Part B|Adverse Event|1|||
161807583|NCT01792635|584341159|FG000|Part B|Study terminated|0|||
161807584|NCT01792635|584341160|FG001|Part B|Study terminated|4|||
161807585|NCT01792635|584341161|FG002|Part B|Study terminated|3|||
161807586|NCT01010542|584341162|FG000|Overall Study|Adverse Event|0|||
161807587|NCT01010542|584341163|FG001|Overall Study|Adverse Event|1|||
161807588|NCT01010542|584341164|FG002|Overall Study|Adverse Event|0|||
161564781|NCT00828919|583456390|FG000|Overall Study|Other|1|||
161564782|NCT00828919|583456391|FG001|Overall Study|Other|0|||
161564783|NCT00828919|583456392|FG002|Overall Study|Other|1|||
161564784|NCT00828919|583456393|FG003|Overall Study|Other|1|||
161564785|NCT00828919|583456394|FG004|Overall Study|Other|0|||
161564786|NCT00828919|583456390|FG000|Overall Study|Lost to Follow-up|0|||
161911172|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161911173|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161911174|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
161911175|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
161911176|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
161911177|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
161911178|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
161911179|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
161911180|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
161911181|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
161911182|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
161911183|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
161911184|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
161911185|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911186|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911187|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911188|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911189|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
161911190|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911191|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911192|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911193|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911194|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911195|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
161911196|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911197|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911198|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161564787|NCT00828919|583456391|FG001|Overall Study|Lost to Follow-up|1|||
161564788|NCT00828919|583456392|FG002|Overall Study|Lost to Follow-up|0|||
161564789|NCT00828919|583456393|FG003|Overall Study|Lost to Follow-up|0|||
161564790|NCT00828919|583456394|FG004|Overall Study|Lost to Follow-up|0|||
161564791|NCT01562743|583456395|FG000|Overall Study|Adverse Event|29|||
161564792|NCT01562743|583456395|FG000|Overall Study|Lack of Efficacy|3|||
161911199|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
161911200|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
161911201|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
161911202|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
161911203|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
161911204|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911205|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
161911206|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911207|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911208|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911209|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
161911210|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911211|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911212|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911213|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911214|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911215|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
161911216|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911217|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911218|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911219|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
161564793|NCT01562743|583456395|FG000|Overall Study|Withdrawal by Subject|13|||
161564794|NCT01562743|583456395|FG000|Overall Study|Protocol Violation|1|||
161564795|NCT01562743|583456395|FG000|Overall Study|Discontinuation criteria|2|||
161564796|NCT01562743|583456395|FG000|Overall Study|Lost to Follow-up|2|||
161564797|NCT01562743|583456395|FG000|Overall Study|Physician Decision|2|||
161564798|NCT05567159|583456396|FG000|Overall Study|Adverse Event|4|||
161564799|NCT05567159|583456396|FG000|Overall Study|Physician Decision|3|||
161564800|NCT05567159|583456396|FG000|Overall Study|Protocol deviation|1|||
161564801|NCT04155424|583456398|FG000|Overall Study|Other than specified|3|||
161564802|NCT04155424|583456398|FG000|Overall Study|Withdrawal by Subject|1|||
161564803|NCT04155424|583456398|FG000|Overall Study|Adverse Event|1|||
161564804|NCT00662909|583456399|FG000|Overall Study|Adverse Event|17|||
161564805|NCT00662909|583456400|FG001|Overall Study|Adverse Event|18|||
161564806|NCT00662909|583456401|FG002|Overall Study|Adverse Event|19|||
161564807|NCT00662909|583456399|FG000|Overall Study|Lack of Efficacy|9|||
161564808|NCT00662909|583456400|FG001|Overall Study|Lack of Efficacy|1|||
161564809|NCT00662909|583456401|FG002|Overall Study|Lack of Efficacy|5|||
161564810|NCT00662909|583456399|FG000|Overall Study|Withdrawal by Subject|29|||
161564811|NCT00662909|583456400|FG001|Overall Study|Withdrawal by Subject|22|||
161564812|NCT00662909|583456401|FG002|Overall Study|Withdrawal by Subject|16|||
161564813|NCT00662909|583456399|FG000|Overall Study|Lost to Follow-up|2|||
161564814|NCT00662909|583456400|FG001|Overall Study|Lost to Follow-up|9|||
161564815|NCT00662909|583456401|FG002|Overall Study|Lost to Follow-up|3|||
161564816|NCT00662909|583456399|FG000|Overall Study|Protocol Violation|7|||
161564817|NCT00662909|583456400|FG001|Overall Study|Protocol Violation|4|||
161564818|NCT00662909|583456401|FG002|Overall Study|Protocol Violation|5|||
161564819|NCT00662909|583456399|FG000|Overall Study|Randomized- never received study drug|1|||
161564820|NCT00662909|583456400|FG001|Overall Study|Randomized- never received study drug|0|||
161564821|NCT00662909|583456401|FG002|Overall Study|Randomized- never received study drug|0|||
161564822|NCT00662909|583456399|FG000|Overall Study|Non-compliance with study procedures|3|||
161564823|NCT00662909|583456400|FG001|Overall Study|Non-compliance with study procedures|3|||
161564824|NCT00662909|583456401|FG002|Overall Study|Non-compliance with study procedures|2|||
161564825|NCT00662909|583456399|FG000|Overall Study|Physician Decision|1|||
161564826|NCT00662909|583456400|FG001|Overall Study|Physician Decision|1|||
161564827|NCT00662909|583456401|FG002|Overall Study|Physician Decision|2|||
161564828|NCT00662909|583456399|FG000|Overall Study|Eligibility criterion not met|0|||
161564829|NCT00662909|583456400|FG001|Overall Study|Eligibility criterion not met|1|||
161564830|NCT00662909|583456401|FG002|Overall Study|Eligibility criterion not met|1|||
161564831|NCT00817635|583458721|FG000|Overall Study|Adverse Event|1|||
161564832|NCT00817635|583458722|FG001|Overall Study|Adverse Event|0|||
161564833|NCT00817635|583458723|FG002|Overall Study|Adverse Event|0|||
161564834|NCT00817635|583458724|FG003|Overall Study|Adverse Event|1|||
161564835|NCT00817635|583458725|FG004|Overall Study|Adverse Event|1|||
161564836|NCT00817635|583458721|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161564837|NCT00817635|583458722|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
161564838|NCT00817635|583458723|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161564839|NCT00817635|583458724|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
161564840|NCT00817635|583458725|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
161564841|NCT00817635|583458721|FG000|Overall Study|Withdrawal by Subject|2|||
161564842|NCT00817635|583458722|FG001|Overall Study|Withdrawal by Subject|1|||
161564843|NCT00817635|583458723|FG002|Overall Study|Withdrawal by Subject|0|||
161564844|NCT00817635|583458724|FG003|Overall Study|Withdrawal by Subject|1|||
161564845|NCT00817635|583458725|FG004|Overall Study|Withdrawal by Subject|2|||
161564846|NCT00817635|583458721|FG000|Overall Study|Lost to Follow-up|0|||
161564847|NCT00817635|583458722|FG001|Overall Study|Lost to Follow-up|1|||
161564848|NCT00817635|583458723|FG002|Overall Study|Lost to Follow-up|0|||
161564849|NCT00817635|583458724|FG003|Overall Study|Lost to Follow-up|1|||
161911220|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161564850|NCT00817635|583458725|FG004|Overall Study|Lost to Follow-up|0|||
161564851|NCT00817635|583458721|FG000|Overall Study|Administrative Problems|0|||
161564852|NCT00817635|583458722|FG001|Overall Study|Administrative Problems|0|||
161564853|NCT00817635|583458723|FG002|Overall Study|Administrative Problems|0|||
161564854|NCT00817635|583458724|FG003|Overall Study|Administrative Problems|0|||
161564855|NCT00817635|583458725|FG004|Overall Study|Administrative Problems|1|||
161564856|NCT00817635|583458721|FG000|Overall Study|Protocol Violation|5|||
161564857|NCT00817635|583458722|FG001|Overall Study|Protocol Violation|1|||
161564858|NCT00817635|583458723|FG002|Overall Study|Protocol Violation|3|||
161564859|NCT00817635|583458724|FG003|Overall Study|Protocol Violation|2|||
161564860|NCT00817635|583458725|FG004|Overall Study|Protocol Violation|3|||
161564861|NCT01259102|583458726|FG000|Overall Study|Adverse Event|1|||
161564862|NCT01259102|583458727|FG001|Overall Study|Adverse Event|0|||
161564863|NCT01259102|583458728|FG002|Overall Study|Adverse Event|1|||
161564864|NCT01259102|583458729|FG003|Overall Study|Adverse Event|1|||
161564865|NCT01259102|583458730|FG004|Overall Study|Adverse Event|0|||
161564866|NCT01259102|583458726|FG000|Overall Study|Other|0|||
161564867|NCT01259102|583458727|FG001|Overall Study|Other|0|||
161564868|NCT01259102|583458728|FG002|Overall Study|Other|1|||
161564869|NCT01259102|583458729|FG003|Overall Study|Other|1|||
161564870|NCT01259102|583458730|FG004|Overall Study|Other|1|||
161564871|NCT00918957|583458732|FG000|Overall Study|Adverse Event|2|||
161564872|NCT00918957|583458733|FG001|Overall Study|Adverse Event|0|||
161564873|NCT00918957|583458732|FG000|Overall Study|Withdrawal by Subject|1|||
161564874|NCT00918957|583458733|FG001|Overall Study|Withdrawal by Subject|0|||
161564875|NCT03107611|583458734|FG000|Overall Study|Adverse Event|1|||
161564876|NCT03107611|583458735|FG001|Overall Study|Adverse Event|0|||
161564877|NCT03107611|583458736|FG002|Overall Study|Adverse Event|2|||
161564878|NCT03107611|583458734|FG000|Overall Study|Lost to Follow-up|3|||
161564879|NCT03107611|583458735|FG001|Overall Study|Lost to Follow-up|3|||
161564880|NCT03107611|583458736|FG002|Overall Study|Lost to Follow-up|3|||
161564881|NCT03107611|583458734|FG000|Overall Study|Protocol Violation|0|||
161564882|NCT03107611|583458735|FG001|Overall Study|Protocol Violation|0|||
161564883|NCT03107611|583458736|FG002|Overall Study|Protocol Violation|1|||
161807589|NCT01010542|584341162|FG000|Overall Study|Lost to Follow-up|0|||
161807590|NCT01010542|584341163|FG001|Overall Study|Lost to Follow-up|1|||
161807591|NCT01010542|584341164|FG002|Overall Study|Lost to Follow-up|0|||
161807592|NCT01010542|584341162|FG000|Overall Study|Withdrawal by Subject|0|||
161807593|NCT01010542|584341163|FG001|Overall Study|Withdrawal by Subject|3|||
161807594|NCT01010542|584341164|FG002|Overall Study|Withdrawal by Subject|2|||
161807595|NCT01401647|584341176|FG000|Overall Study|Withdrawal by Subject|1|||
161807596|NCT01401647|584341177|FG001|Overall Study|Withdrawal by Subject|5|||
161807597|NCT01401647|584341178|FG002|Overall Study|Withdrawal by Subject|2|||
161807598|NCT01401647|584341176|FG000|Overall Study|Lost to Follow-up|3|||
161807599|NCT01401647|584341177|FG001|Overall Study|Lost to Follow-up|3|||
161807600|NCT01401647|584341178|FG002|Overall Study|Lost to Follow-up|1|||
161807601|NCT00473330|584341182|FG000|Core Study|Adverse Event|4|||
161807602|NCT00473330|584341183|FG001|Core Study|Adverse Event|4|||
161807603|NCT00473330|584341184|FG002|Core Study|Adverse Event|1|||
161807604|NCT00473330|584341182|FG000|Core Study|Death|6|||
161807605|NCT00473330|584341183|FG001|Core Study|Death|4|||
161807606|NCT00473330|584341184|FG002|Core Study|Death|4|||
161807607|NCT00473330|584341182|FG000|Core Study|Lost to Follow-up|5|||
161807608|NCT00473330|584341183|FG001|Core Study|Lost to Follow-up|5|||
161807609|NCT00473330|584341184|FG002|Core Study|Lost to Follow-up|10|||
161807610|NCT00473330|584341182|FG000|Core Study|Physician Decision|2|||
161807611|NCT00473330|584341183|FG001|Core Study|Physician Decision|1|||
161807612|NCT00473330|584341184|FG002|Core Study|Physician Decision|3|||
161807613|NCT00473330|584341182|FG000|Core Study|Subject Non-compliance|1|||
161807614|NCT00473330|584341183|FG001|Core Study|Subject Non-compliance|2|||
161807615|NCT00473330|584341184|FG002|Core Study|Subject Non-compliance|1|||
161807616|NCT00473330|584341182|FG000|Core Study|Subject Required Other Therapy|0|||
161807617|NCT00473330|584341183|FG001|Core Study|Subject Required Other Therapy|1|||
161807618|NCT00473330|584341184|FG002|Core Study|Subject Required Other Therapy|3|||
161807619|NCT00473330|584341182|FG000|Core Study|Subject's Decision|9|||
161807620|NCT00473330|584341183|FG001|Core Study|Subject's Decision|8|||
161807621|NCT00473330|584341184|FG002|Core Study|Subject's Decision|19|||
161807622|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
161807623|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
161807624|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
161807625|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Death|2|||
161807626|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Death|0|||
161807627|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Death|0|||
161807628|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
161807629|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
161807630|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
161807631|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
161807632|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
161807633|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
161807634|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
161807635|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
161807636|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
161807637|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
161807638|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
161807639|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
161807640|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
161807641|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
161807642|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
161807643|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
161807644|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
161807645|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
161807646|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
161807647|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
161807648|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
161564884|NCT03107611|583458734|FG000|Overall Study|Withdrawal by Subject|1|||
161564885|NCT03107611|583458735|FG001|Overall Study|Withdrawal by Subject|0|||
161564886|NCT03107611|583458736|FG002|Overall Study|Withdrawal by Subject|1|||
161564887|NCT03107611|583458734|FG000|Overall Study|Worsening signs/symptoms|2|||
161564888|NCT03107611|583458735|FG001|Overall Study|Worsening signs/symptoms|1|||
161564889|NCT03107611|583458736|FG002|Overall Study|Worsening signs/symptoms|2|||
161564890|NCT01720446|583458739|FG000|Overall Study|Lost to Follow-up|12|||
161564891|NCT01720446|583458740|FG001|Overall Study|Lost to Follow-up|6|||
161564892|NCT01720446|583458741|FG002|Overall Study|Lost to Follow-up|16|||
161564893|NCT01720446|583458742|FG003|Overall Study|Lost to Follow-up|16|||
161564894|NCT01720446|583458739|FG000|Overall Study|Withdrawal by Subject|2|||
161564895|NCT01720446|583458740|FG001|Overall Study|Withdrawal by Subject|5|||
161564896|NCT01720446|583458741|FG002|Overall Study|Withdrawal by Subject|4|||
161564897|NCT01720446|583458742|FG003|Overall Study|Withdrawal by Subject|4|||
161564898|NCT01020838|583458743|FG000|Overall Study|Death|90|||
161564899|NCT01020838|583458743|FG000|Overall Study|Adverse Event|1|||
161564900|NCT01020838|583458743|FG000|Overall Study|Withdrawal by Subject|9|||
161564901|NCT01020838|583458743|FG000|Overall Study|Lost to Follow-up|6|||
161564902|NCT01020838|583458743|FG000|Overall Study|Most common: Study ended by sponsor|77|||
161564903|NCT04176458|583458744|FG000|Overall Study|Covid 19|4|||
161564904|NCT00891618|583458745|FG000|Overall Study|Withdrawal by Subject|1|||
161564905|NCT02145182|583458746|FG000|Overall Study|Adverse Event|4|||
161564906|NCT02145182|583458747|FG001|Overall Study|Adverse Event|1|||
161564907|NCT02145182|583458746|FG000|Overall Study|Death|7|||
161564908|NCT02145182|583458747|FG001|Overall Study|Death|7|||
161564909|NCT02145182|583458746|FG000|Overall Study|Lost to Follow-up|2|||
161564910|NCT02145182|583458747|FG001|Overall Study|Lost to Follow-up|2|||
161564911|NCT02145182|583458746|FG000|Overall Study|Pre-transplant Withdrawal|0|||
161564912|NCT02145182|583458747|FG001|Overall Study|Pre-transplant Withdrawal|2|||
161564913|NCT02145182|583458746|FG000|Overall Study|Withdrawal by Subject|5|||
161564914|NCT02145182|583458747|FG001|Overall Study|Withdrawal by Subject|4|||
161564915|NCT03999554|583458749|FG000|Overall Study|Lost to Follow-up|4|||
161564916|NCT03999554|583458750|FG001|Overall Study|Lost to Follow-up|5|||
161564917|NCT03999554|583458751|FG002|Overall Study|Lost to Follow-up|4|||
161564918|NCT03999554|583458752|FG003|Overall Study|Lost to Follow-up|5|||
161564919|NCT03999554|583458753|FG004|Overall Study|Lost to Follow-up|8|||
161564920|NCT03999554|583458749|FG000|Overall Study|Protocol Violation|0|||
161564921|NCT03999554|583458750|FG001|Overall Study|Protocol Violation|0|||
161564922|NCT03999554|583458751|FG002|Overall Study|Protocol Violation|5|||
161564923|NCT03999554|583458752|FG003|Overall Study|Protocol Violation|0|||
161564924|NCT03999554|583458753|FG004|Overall Study|Protocol Violation|0|||
161454795|NCT02431260|583059074|FG004|Overall Study|Other Unspecified|0|||
161454796|NCT02431260|583059075|FG005|Overall Study|Other Unspecified|0|||
161454797|NCT02431260|583059076|FG006|Overall Study|Other Unspecified|0|||
161454798|NCT02431260|583059077|FG007|Overall Study|Other Unspecified|0|||
161454799|NCT02431260|583059078|FG008|Overall Study|Other Unspecified|0|||
161454800|NCT02431260|583059079|FG009|Overall Study|Other Unspecified|0|||
161454801|NCT02431260|583059080|FG010|Overall Study|Other Unspecified|0|||
161454802|NCT02431260|583059081|FG011|Overall Study|Other Unspecified|1|||
161454803|NCT02431260|583059082|FG012|Overall Study|Other Unspecified|1|||
161454804|NCT02431260|583059083|FG013|Overall Study|Other Unspecified|0|||
161454805|NCT00321646|583059084|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
161454806|NCT00321646|583059084|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
161454807|NCT00321646|583059084|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
161454808|NCT01375075|583059091|FG000|Overall Study|Adverse Event|0|||
161454809|NCT01375075|583059092|FG001|Overall Study|Adverse Event|0|||
161454810|NCT01375075|583059093|FG002|Overall Study|Adverse Event|3|||
161454811|NCT01375075|583059094|FG003|Overall Study|Adverse Event|1|||
161454812|NCT01375075|583059095|FG004|Overall Study|Adverse Event|0|||
161454813|NCT01375075|583059096|FG005|Overall Study|Adverse Event|1|||
161454814|NCT01375075|583059091|FG000|Overall Study|Entry Criterion Not Met|1|||
161454815|NCT01375075|583059092|FG001|Overall Study|Entry Criterion Not Met|0|||
161454816|NCT01375075|583059093|FG002|Overall Study|Entry Criterion Not Met|0|||
161454817|NCT01375075|583059094|FG003|Overall Study|Entry Criterion Not Met|0|||
161454818|NCT01375075|583059095|FG004|Overall Study|Entry Criterion Not Met|0|||
161454819|NCT01375075|583059096|FG005|Overall Study|Entry Criterion Not Met|1|||
161564925|NCT03999554|583458749|FG000|Overall Study|Pregnancy|0|||
161564926|NCT03999554|583458750|FG001|Overall Study|Pregnancy|0|||
161564927|NCT03999554|583458751|FG002|Overall Study|Pregnancy|1|||
161564928|NCT03999554|583458752|FG003|Overall Study|Pregnancy|0|||
161911221|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161911222|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161564929|NCT03999554|583458753|FG004|Overall Study|Pregnancy|0|||
161454820|NCT01375075|583059091|FG000|Overall Study|Withdrawal by Subject|0|||
161454821|NCT01375075|583059092|FG001|Overall Study|Withdrawal by Subject|1|||
161454822|NCT01375075|583059093|FG002|Overall Study|Withdrawal by Subject|0|||
161564930|NCT03999554|583458749|FG000|Overall Study|Withdrawal by Subject|2|||
161454823|NCT01375075|583059094|FG003|Overall Study|Withdrawal by Subject|0|||
161564931|NCT03999554|583458750|FG001|Overall Study|Withdrawal by Subject|2|||
161564932|NCT03999554|583458751|FG002|Overall Study|Withdrawal by Subject|2|||
161564933|NCT03999554|583458752|FG003|Overall Study|Withdrawal by Subject|1|||
161564934|NCT03999554|583458753|FG004|Overall Study|Withdrawal by Subject|1|||
161564935|NCT03999554|583458749|FG000|Overall Study|failure to comply with protocol requirements|0|||
161564936|NCT03999554|583458750|FG001|Overall Study|failure to comply with protocol requirements|0|||
161564937|NCT03999554|583458751|FG002|Overall Study|failure to comply with protocol requirements|0|||
161564938|NCT03999554|583458752|FG003|Overall Study|failure to comply with protocol requirements|1|||
161564939|NCT03999554|583458753|FG004|Overall Study|failure to comply with protocol requirements|0|||
161564940|NCT02082158|583458754|FG000|Overall Study|Withdrawal by Subject|0|||
161564941|NCT02082158|583458755|FG001|Overall Study|Withdrawal by Subject|0|||
161564942|NCT02082158|583458756|FG002|Overall Study|Withdrawal by Subject|0|||
161564943|NCT02082158|583458757|FG003|Overall Study|Withdrawal by Subject|0|||
161564944|NCT02082158|583458758|FG004|Overall Study|Withdrawal by Subject|1|||
161564945|NCT02082158|583458759|FG005|Overall Study|Withdrawal by Subject|0|||
161807649|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Death|2|||
161807650|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Death|2|||
161807651|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Death|1|||
161807652|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
161807653|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
161807654|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
161807655|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
161807656|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
161807657|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
161807658|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
161807659|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
161807660|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
161807661|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
161807662|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
161807663|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
161807664|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
161807665|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
161807666|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
161807667|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
161807668|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
161807669|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
161807670|NCT01975948|584341186|FG000|Overall Study|Withdrawal by Subject|17|||
161807671|NCT01975948|584341187|FG001|Overall Study|Withdrawal by Subject|21|||
161807672|NCT01975948|584341188|FG002|Overall Study|Withdrawal by Subject|7|||
161807673|NCT01975948|584341189|FG003|Overall Study|Withdrawal by Subject|6|||
161807674|NCT01675765|584341190|FG000|Overall Study|Progressive disease|4|||
161807675|NCT01675765|584341191|FG001|Overall Study|Progressive disease|4|||
161807676|NCT01675765|584341190|FG000|Overall Study|Adverse Event|1|||
161807677|NCT01675765|584341191|FG001|Overall Study|Adverse Event|2|||
161807678|NCT01675765|584341190|FG000|Overall Study|Withdrawal by Subject|2|||
161807679|NCT01675765|584341191|FG001|Overall Study|Withdrawal by Subject|0|||
161807680|NCT01675765|584341190|FG000|Overall Study|Death|1|||
161807681|NCT01675765|584341191|FG001|Overall Study|Death|0|||
161807682|NCT01675765|584341190|FG000|Overall Study|Clinical progression|3|||
161807683|NCT01675765|584341191|FG001|Overall Study|Clinical progression|2|||
161807684|NCT00336479|584341193|FG000|Overall Study|Adverse Event|8|||
161807685|NCT00336479|584341194|FG001|Overall Study|Adverse Event|11|||
161807686|NCT00336479|584341195|FG002|Overall Study|Adverse Event|18|||
161807687|NCT00336479|584341196|FG003|Overall Study|Adverse Event|4|||
161807688|NCT00336479|584341193|FG000|Overall Study|Noncompliant|1|||
161807689|NCT00336479|584341194|FG001|Overall Study|Noncompliant|7|||
161807690|NCT00336479|584341195|FG002|Overall Study|Noncompliant|3|||
161807691|NCT00336479|584341196|FG003|Overall Study|Noncompliant|0|||
161807692|NCT00336479|584341193|FG000|Overall Study|Physician Decision|2|||
161807693|NCT00336479|584341194|FG001|Overall Study|Physician Decision|3|||
161807694|NCT00336479|584341195|FG002|Overall Study|Physician Decision|1|||
161807695|NCT00336479|584341196|FG003|Overall Study|Physician Decision|0|||
161807696|NCT00336479|584341193|FG000|Overall Study|Lost to Follow-up|3|||
161807697|NCT00336479|584341194|FG001|Overall Study|Lost to Follow-up|2|||
161807698|NCT00336479|584341195|FG002|Overall Study|Lost to Follow-up|0|||
161807699|NCT00336479|584341196|FG003|Overall Study|Lost to Follow-up|0|||
161807700|NCT00336479|584341193|FG000|Overall Study|Withdrawal by Subject|3|||
161807701|NCT00336479|584341194|FG001|Overall Study|Withdrawal by Subject|2|||
161807702|NCT00336479|584341195|FG002|Overall Study|Withdrawal by Subject|3|||
161807703|NCT00336479|584341196|FG003|Overall Study|Withdrawal by Subject|0|||
161807704|NCT00336479|584341193|FG000|Overall Study|Other|0|||
161807705|NCT00336479|584341194|FG001|Overall Study|Other|0|||
161911223|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161911224|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911225|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
161911226|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911227|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911228|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911229|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
161911230|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911231|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911232|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911233|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911234|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
161911235|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911236|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911237|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911238|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911239|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
161911240|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
161911241|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
161911242|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
161911243|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
161911244|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
161911245|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
161911246|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
161911247|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
161911248|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
161911249|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
161911250|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
161911251|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
161911252|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
161911253|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
161911254|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161911255|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161911256|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
161911257|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161911258|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
161911259|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161911260|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161911261|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
161911262|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
161911263|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
161911264|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161911265|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161911266|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161911267|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
161911268|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
161911269|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911270|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911271|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
161911272|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911273|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911274|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
161911275|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
161807706|NCT00336479|584341195|FG002|Overall Study|Other|1|||
161807707|NCT00336479|584341196|FG003|Overall Study|Other|0|||
161807708|NCT00336479|584341193|FG000|Overall Study|Virologic Stopping Rule|20|||
161807709|NCT00336479|584341194|FG001|Overall Study|Virologic Stopping Rule|0|||
161807710|NCT00336479|584341195|FG002|Overall Study|Virologic Stopping Rule|0|||
161807711|NCT00336479|584341196|FG003|Overall Study|Virologic Stopping Rule|0|||
161807712|NCT00846495|584341197|FG000|Overall Study|Lost to Follow-up|1|||
161807713|NCT00846495|584341198|FG001|Overall Study|Lost to Follow-up|0|||
161911276|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
161911277|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
161807714|NCT00846495|584341197|FG000|Overall Study|Adverse Event|5|||
161807715|NCT00846495|584341198|FG001|Overall Study|Adverse Event|1|||
161807716|NCT00846495|584341197|FG000|Overall Study|Lack of Efficacy|1|||
161911278|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
161911279|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161911280|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161911281|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161911282|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
161911283|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
161911284|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911285|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911286|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911287|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911288|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
161911289|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
161911290|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
161911291|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
161911292|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
161911293|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
161911294|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911295|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911296|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911297|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911298|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
161911299|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911300|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911301|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
161911302|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911303|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911304|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161911305|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161911306|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161911307|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
161911308|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
161911309|NCT02078817|584727197|FG000|Overall Study|Withdrawal by Subject|1|||
161911310|NCT00855218|584727198|FG000|Overall Study|Adverse Event|43|||
161911311|NCT00855218|584727199|FG001|Overall Study|Adverse Event|27|||
161911312|NCT00855218|584727198|FG000|Overall Study|Withdrawal by Subject|10|||
161911313|NCT00855218|584727199|FG001|Overall Study|Withdrawal by Subject|6|||
161911314|NCT00855218|584727198|FG000|Overall Study|Physician Decision|18|||
161911315|NCT00855218|584727199|FG001|Overall Study|Physician Decision|11|||
161911316|NCT00855218|584727198|FG000|Overall Study|Lost to Follow-up|0|||
161911317|NCT00855218|584727199|FG001|Overall Study|Lost to Follow-up|1|||
161911318|NCT00855218|584727198|FG000|Overall Study|Protocol Violation|5|||
161911319|NCT00855218|584727199|FG001|Overall Study|Protocol Violation|9|||
161911320|NCT00855218|584727198|FG000|Overall Study|non-compliant with study drug|3|||
161911321|NCT00855218|584727199|FG001|Overall Study|non-compliant with study drug|1|||
161911322|NCT00855218|584727198|FG000|Overall Study|patient convenience|2|||
161911323|NCT00855218|584727199|FG001|Overall Study|patient convenience|0|||
161911324|NCT00855218|584727198|FG000|Overall Study|technical problems|2|||
161911325|NCT00855218|584727199|FG001|Overall Study|technical problems|1|||
161911326|NCT00855218|584727198|FG000|Overall Study|Still treated with study medication|0|||
161911327|NCT00855218|584727199|FG001|Overall Study|Still treated with study medication|1|||
161911328|NCT00855218|584727198|FG000|Overall Study|Untreatable disease progression|54|||
161911329|NCT00855218|584727199|FG001|Overall Study|Untreatable disease progression|67|||
161911330|NCT00855218|584727198|FG000|Overall Study|Second malignancy|0|||
161911331|NCT00855218|584727199|FG001|Overall Study|Second malignancy|1|||
161911332|NCT00855218|584727198|FG000|Overall Study|Progression measurement proven|7|||
161911333|NCT00855218|584727199|FG001|Overall Study|Progression measurement proven|15|||
161911334|NCT00855218|584727198|FG000|Overall Study|Clinical endpoint reached|10|||
161454824|NCT01375075|583059095|FG004|Overall Study|Withdrawal by Subject|0|||
161454825|NCT01375075|583059096|FG005|Overall Study|Withdrawal by Subject|1|||
161454826|NCT00384111|583059097|FG000|Overall Study|Disease Progression|3|||
161454827|NCT00384111|583059097|FG000|Overall Study|Adverse Event|1|||
161454828|NCT00384111|583059097|FG000|Overall Study|Investigator Decision|3|||
161454829|NCT00384111|583059097|FG000|Overall Study|Study Terminated by the Sponsor|19|||
161454830|NCT00821509|583059098|FG000|Overall Study|Withdrawal by Subject|12|||
161454831|NCT00821509|583059099|FG001|Overall Study|Withdrawal by Subject|11|||
161454832|NCT00821509|583059100|FG002|Overall Study|Withdrawal by Subject|34|||
161454833|NCT01551420|583059101|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
161454834|NCT01551420|583059102|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
161564946|NCT02082158|583458754|FG000|Overall Study|Failed Fit-testing|8|||
161564947|NCT02082158|583458755|FG001|Overall Study|Failed Fit-testing|8|||
161564948|NCT02082158|583458756|FG002|Overall Study|Failed Fit-testing|14|||
161564949|NCT02082158|583458757|FG003|Overall Study|Failed Fit-testing|4|||
161564950|NCT02082158|583458758|FG004|Overall Study|Failed Fit-testing|3|||
161564951|NCT02082158|583458759|FG005|Overall Study|Failed Fit-testing|7|||
161564952|NCT01466881|583458762|FG000|Overall Study|Ineligible|5|||
161564953|NCT01466881|583458762|FG000|Overall Study|Adverse Event|6|||
161564954|NCT01466881|583458762|FG000|Overall Study|Progression/relapse|20|||
161564955|NCT01466881|583458762|FG000|Overall Study|Death|4|||
161564956|NCT01466881|583458762|FG000|Overall Study|Other reason not protocol specified|5|||
161564957|NCT00742274|583458763|FG000|Overall Study|Death|1|||
161564958|NCT00742274|583458764|FG001|Overall Study|Death|0|||
161564959|NCT00742274|583458763|FG000|Overall Study|Withdrawal by Subject|1|||
161564960|NCT00742274|583458764|FG001|Overall Study|Withdrawal by Subject|2|||
161564961|NCT00742274|583458763|FG000|Overall Study|Removed for medical reasons|1|||
161564962|NCT00742274|583458764|FG001|Overall Study|Removed for medical reasons|1|||
161564963|NCT01101165|583458765|FG000|Period 1|Adverse Event|1|||
161564964|NCT01101165|583458766|FG001|Period 1|Adverse Event|2|||
161564965|NCT01101165|583458765|FG000|Period 1|Withdrawal by Subject|0|||
161564966|NCT01101165|583458766|FG001|Period 1|Withdrawal by Subject|2|||
161564967|NCT01101165|583458765|FG000|Period 1|Positive Drug Screen|0|||
161564968|NCT01101165|583458766|FG001|Period 1|Positive Drug Screen|1|||
161564969|NCT01101165|583458765|FG000|Period 1|Lost to Follow-up|1|||
161564970|NCT01101165|583458766|FG001|Period 1|Lost to Follow-up|0|||
161564971|NCT01101165|583458765|FG000|Period 2|Withdrawal by Subject|3|||
161564972|NCT01101165|583458766|FG001|Period 2|Withdrawal by Subject|1|||
161564973|NCT01101165|583458765|FG000|Period 2|Adverse Event|1|||
161564974|NCT01101165|583458766|FG001|Period 2|Adverse Event|0|||
161564975|NCT00619151|583458768|FG000|Overall Study|Study terminated prior to followup|1|||
161564976|NCT00619151|583458769|FG001|Overall Study|Study terminated prior to followup|0|||
161564977|NCT03124108|583458773|FG000|Overall Study|Adverse Event|0|||
161564978|NCT03124108|583458774|FG001|Overall Study|Adverse Event|1|||
161564979|NCT03124108|583458775|FG002|Overall Study|Adverse Event|0|||
161564980|NCT01670019|583458783|FG000|Overall Study|Adverse Event|3|||
161564981|NCT01670019|583458784|FG001|Overall Study|Adverse Event|0|||
161564982|NCT01670019|583458783|FG000|Overall Study|Withdrawal by Subject|6|||
161564983|NCT01670019|583458784|FG001|Overall Study|Withdrawal by Subject|0|||
161564984|NCT05487703|583458785|FG000|Overall Study|Other|19|||
161564985|NCT05487703|583458785|FG000|Overall Study|Participant not well|5|||
161564986|NCT05487703|583458785|FG000|Overall Study|Insurance Reasons|6|||
161564987|NCT05487703|583458785|FG000|Overall Study|Physician Decision|19|||
161564988|NCT05487703|583458785|FG000|Overall Study|Lack of Efficacy|60|||
161564989|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
161564990|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
161564991|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
161564992|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Death|3|||
161564993|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Death|0|||
161564994|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Death|0|||
161564995|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
161564996|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
161564997|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
161564998|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
161564999|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
161565000|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
161565001|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
161565002|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
161565003|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
161565004|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
161565005|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
161565006|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
161565007|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
161565008|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
161565009|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
161565010|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Other|1|||
161565011|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Other|0|||
161565012|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Other|0|||
161565013|NCT02403323|583458786|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
161565014|NCT02403323|583458787|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
161565015|NCT02403323|583458788|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
161565016|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
161565017|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
161565018|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
161565019|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
161565020|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
161911335|NCT00855218|584727199|FG001|Overall Study|Clinical endpoint reached|13|||
161911336|NCT00769561|584727201|FG000|Overall Study|Withdrawal by Subject|2|||
161454835|NCT01551420|583059101|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
161454836|NCT01551420|583059102|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
161454837|NCT01551420|583059101|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
161454838|NCT01551420|583059102|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
161911337|NCT00769561|584727202|FG001|Overall Study|Withdrawal by Subject|2|||
161911338|NCT00769561|584727201|FG000|Overall Study|Lost to Follow-up|1|||
161911339|NCT00769561|584727202|FG001|Overall Study|Lost to Follow-up|3|||
161911340|NCT03824561|584727205|FG000|Overall Study|Protocol Violation|19|||
161911341|NCT01773928|584727206|FG000|Overall Study|Adverse Event|0|||
161911342|NCT01773928|584727207|FG001|Overall Study|Adverse Event|0|||
161911343|NCT01773928|584727208|FG002|Overall Study|Adverse Event|0|||
161911344|NCT01773928|584727209|FG003|Overall Study|Adverse Event|0|||
161911345|NCT01773928|584727210|FG004|Overall Study|Adverse Event|0|||
161911346|NCT01773928|584727211|FG005|Overall Study|Adverse Event|0|||
161911347|NCT01773928|584727212|FG006|Overall Study|Adverse Event|0|||
161911348|NCT01773928|584727213|FG007|Overall Study|Adverse Event|1|||
161911349|NCT01773928|584727214|FG008|Overall Study|Adverse Event|0|||
161911350|NCT01773928|584727206|FG000|Overall Study|Physician Decision|0|||
161911351|NCT01773928|584727207|FG001|Overall Study|Physician Decision|0|||
161911352|NCT01773928|584727208|FG002|Overall Study|Physician Decision|0|||
161911353|NCT01773928|584727209|FG003|Overall Study|Physician Decision|1|||
161911354|NCT01773928|584727210|FG004|Overall Study|Physician Decision|0|||
161911355|NCT01773928|584727211|FG005|Overall Study|Physician Decision|0|||
161911356|NCT01773928|584727212|FG006|Overall Study|Physician Decision|0|||
161911357|NCT01773928|584727213|FG007|Overall Study|Physician Decision|0|||
161911358|NCT01773928|584727214|FG008|Overall Study|Physician Decision|0|||
161911359|NCT01773928|584727206|FG000|Overall Study|Withdrawal by Subject|5|||
161911360|NCT01773928|584727207|FG001|Overall Study|Withdrawal by Subject|4|||
161911361|NCT01773928|584727208|FG002|Overall Study|Withdrawal by Subject|4|||
161911362|NCT01773928|584727209|FG003|Overall Study|Withdrawal by Subject|4|||
161911363|NCT01773928|584727210|FG004|Overall Study|Withdrawal by Subject|7|||
161911364|NCT01773928|584727211|FG005|Overall Study|Withdrawal by Subject|1|||
161911365|NCT01773928|584727212|FG006|Overall Study|Withdrawal by Subject|0|||
161911366|NCT01773928|584727213|FG007|Overall Study|Withdrawal by Subject|0|||
161911367|NCT01773928|584727214|FG008|Overall Study|Withdrawal by Subject|1|||
161911368|NCT01773928|584727206|FG000|Overall Study|Lost to Follow-up|0|||
161911369|NCT01773928|584727207|FG001|Overall Study|Lost to Follow-up|0|||
161911370|NCT01773928|584727208|FG002|Overall Study|Lost to Follow-up|0|||
161911371|NCT01773928|584727209|FG003|Overall Study|Lost to Follow-up|0|||
161911372|NCT01773928|584727210|FG004|Overall Study|Lost to Follow-up|0|||
161911373|NCT01773928|584727211|FG005|Overall Study|Lost to Follow-up|1|||
161911374|NCT01773928|584727212|FG006|Overall Study|Lost to Follow-up|0|||
161911375|NCT01773928|584727213|FG007|Overall Study|Lost to Follow-up|0|||
161454839|NCT01551420|583059101|FG000|Screened for Part B Eligibility|Declined participation|8|||
161454840|NCT01551420|583059102|FG001|Screened for Part B Eligibility|Declined participation|1|||
161454841|NCT01551420|583059101|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
161454842|NCT01551420|583059102|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
161454843|NCT01551420|583059101|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
161454844|NCT01551420|583059102|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
161454845|NCT01551420|583059101|FG000|Home Use (Part B)|Withdrawal by staff|0|||
161454846|NCT01551420|583059102|FG001|Home Use (Part B)|Withdrawal by staff|1|||
161454847|NCT03612856|583059103|FG000|Pre-dose Period|Physician Decision|0|||
161454848|NCT03612856|583059104|FG001|Pre-dose Period|Physician Decision|1|||
161454849|NCT03612856|583059105|FG002|Pre-dose Period|Physician Decision|1|||
161454850|NCT03612856|583059103|FG000|Pre-dose Period|Withdrawal by Subject|0|||
161454851|NCT03612856|583059104|FG001|Pre-dose Period|Withdrawal by Subject|1|||
161454852|NCT03612856|583059105|FG002|Pre-dose Period|Withdrawal by Subject|0|||
161454853|NCT01576159|583059106|FG000|Overall Study|Withdrawal by Subject|0|||
161454854|NCT01576159|583059107|FG001|Overall Study|Withdrawal by Subject|1|||
161454855|NCT01576159|583059108|FG002|Overall Study|Withdrawal by Subject|0|||
161454856|NCT01576159|583059109|FG003|Overall Study|Withdrawal by Subject|0|||
161454857|NCT01576159|583059106|FG000|Overall Study|Physician Decision|0|||
161454858|NCT01576159|583059107|FG001|Overall Study|Physician Decision|0|||
161454859|NCT01576159|583059108|FG002|Overall Study|Physician Decision|1|||
161454860|NCT01576159|583059109|FG003|Overall Study|Physician Decision|0|||
161454861|NCT01576159|583059106|FG000|Overall Study|Lost to Follow-up|0|||
161911376|NCT01773928|584727214|FG008|Overall Study|Lost to Follow-up|0|||
161911377|NCT01773928|584727206|FG000|Overall Study|Subject misrepresented age|0|||
161911378|NCT01773928|584727207|FG001|Overall Study|Subject misrepresented age|1|||
161911379|NCT01773928|584727208|FG002|Overall Study|Subject misrepresented age|0|||
161911380|NCT01773928|584727209|FG003|Overall Study|Subject misrepresented age|0|||
161911381|NCT01773928|584727210|FG004|Overall Study|Subject misrepresented age|0|||
161911382|NCT01773928|584727211|FG005|Overall Study|Subject misrepresented age|0|||
161911383|NCT01773928|584727212|FG006|Overall Study|Subject misrepresented age|0|||
161911384|NCT01773928|584727213|FG007|Overall Study|Subject misrepresented age|0|||
161565021|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
161565022|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
161565023|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
161565024|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
161565025|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
161565026|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
161565027|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
161565028|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
161565029|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
161565030|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
161565031|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
161911385|NCT01773928|584727214|FG008|Overall Study|Subject misrepresented age|0|||
161911386|NCT01773928|584727206|FG000|Overall Study|Subject met exclusion criteria|0|||
161911387|NCT01773928|584727207|FG001|Overall Study|Subject met exclusion criteria|0|||
161911388|NCT01773928|584727208|FG002|Overall Study|Subject met exclusion criteria|0|||
161911389|NCT01773928|584727209|FG003|Overall Study|Subject met exclusion criteria|0|||
161911390|NCT01773928|584727210|FG004|Overall Study|Subject met exclusion criteria|0|||
161911391|NCT01773928|584727211|FG005|Overall Study|Subject met exclusion criteria|0|||
161911392|NCT01773928|584727212|FG006|Overall Study|Subject met exclusion criteria|0|||
161911393|NCT01773928|584727213|FG007|Overall Study|Subject met exclusion criteria|0|||
161911394|NCT01773928|584727214|FG008|Overall Study|Subject met exclusion criteria|1|||
161911395|NCT01773928|584727206|FG000|Overall Study|Randomized, had to leave, never returned|0|||
161911396|NCT01773928|584727207|FG001|Overall Study|Randomized, had to leave, never returned|0|||
161911397|NCT01773928|584727208|FG002|Overall Study|Randomized, had to leave, never returned|0|||
161911398|NCT01773928|584727209|FG003|Overall Study|Randomized, had to leave, never returned|1|||
161911399|NCT01773928|584727210|FG004|Overall Study|Randomized, had to leave, never returned|0|||
161911400|NCT01773928|584727211|FG005|Overall Study|Randomized, had to leave, never returned|0|||
161911401|NCT01773928|584727212|FG006|Overall Study|Randomized, had to leave, never returned|0|||
161911402|NCT01773928|584727213|FG007|Overall Study|Randomized, had to leave, never returned|0|||
161911403|NCT01773928|584727214|FG008|Overall Study|Randomized, had to leave, never returned|0|||
161911404|NCT01773928|584727206|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
161911405|NCT01773928|584727207|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
161911406|NCT01773928|584727208|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
161911407|NCT01773928|584727209|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
161911408|NCT01773928|584727210|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
161911409|NCT01773928|584727211|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
161911410|NCT01773928|584727212|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
161911411|NCT01773928|584727213|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
161911412|NCT01773928|584727214|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
161911413|NCT02370511|584727215|FG000|Overall Study|Death|10|||
161911414|NCT02370511|584727216|FG001|Overall Study|Death|7|||
161911415|NCT02370511|584727217|FG002|Overall Study|Death|1|||
161911416|NCT02370511|584727215|FG000|Overall Study|Withdrawal by Subject|2|||
161911417|NCT02370511|584727216|FG001|Overall Study|Withdrawal by Subject|0|||
161911418|NCT02370511|584727217|FG002|Overall Study|Withdrawal by Subject|0|||
161911419|NCT02370511|584727215|FG000|Overall Study|Lost to Follow-up|0|||
161911420|NCT02370511|584727216|FG001|Overall Study|Lost to Follow-up|4|||
161911421|NCT02370511|584727217|FG002|Overall Study|Lost to Follow-up|0|||
161911422|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
161911423|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161911424|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161911425|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161911426|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
161911427|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161911428|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161454862|NCT01576159|583059107|FG001|Overall Study|Lost to Follow-up|0|||
161454863|NCT01576159|583059108|FG002|Overall Study|Lost to Follow-up|0|||
161454864|NCT01576159|583059109|FG003|Overall Study|Lost to Follow-up|1|||
161454865|NCT01576159|583059106|FG000|Overall Study|Protocol Violation|1|||
161454866|NCT01576159|583059107|FG001|Overall Study|Protocol Violation|0|||
161454867|NCT01576159|583059108|FG002|Overall Study|Protocol Violation|0|||
161454868|NCT01576159|583059109|FG003|Overall Study|Protocol Violation|0|||
161454869|NCT04463069|583059110|FG000|Overall Study|Withdrawal by Subject|2|||
161454870|NCT04463069|583059111|FG001|Overall Study|Withdrawal by Subject|10|||
161454871|NCT04463069|583059110|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
161454872|NCT04463069|583059111|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
161454873|NCT00311584|583059113|FG000|Overall Study|Death|1|||
161454874|NCT00311584|583059114|FG001|Overall Study|Death|0|||
161454875|NCT00311584|583059113|FG000|Overall Study|Lack of Efficacy|12|||
161454876|NCT00311584|583059114|FG001|Overall Study|Lack of Efficacy|15|||
161911429|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161911430|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
161911431|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161911432|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161911433|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161911434|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
161911435|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
161911436|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
161911437|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
161911438|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
161911439|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161911440|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161911441|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161911442|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
161911443|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161911444|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161911445|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161911446|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161911447|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
161454877|NCT00311584|583059113|FG000|Overall Study|Physician Decision|4|||
161454878|NCT00311584|583059114|FG001|Overall Study|Physician Decision|5|||
161454879|NCT00311584|583059113|FG000|Overall Study|Withdrawal by Subject|1|||
161454880|NCT00311584|583059114|FG001|Overall Study|Withdrawal by Subject|1|||
161454881|NCT00311584|583059113|FG000|Overall Study|ineligible|2|||
161454882|NCT00311584|583059114|FG001|Overall Study|ineligible|2|||
161454883|NCT03073733|583059121|FG000|Overall Study|Lost to Follow-up|1|||
161454884|NCT03073733|583059122|FG001|Overall Study|Lost to Follow-up|0|||
161454885|NCT03073733|583059123|FG002|Overall Study|Lost to Follow-up|0|||
161454886|NCT03073733|583059121|FG000|Overall Study|Physician Decision|0|||
161454887|NCT03073733|583059122|FG001|Overall Study|Physician Decision|1|||
161454888|NCT03073733|583059123|FG002|Overall Study|Physician Decision|0|||
161454889|NCT03073733|583059121|FG000|Overall Study|Withdrawal by Subject|0|||
161454890|NCT03073733|583059122|FG001|Overall Study|Withdrawal by Subject|0|||
161454891|NCT03073733|583059123|FG002|Overall Study|Withdrawal by Subject|1|||
161454892|NCT01454778|583059124|FG000|Overall Study|Lost to Follow-up|2|||
161454893|NCT01454778|583059124|FG000|Overall Study|Death|1|||
161454894|NCT01227629|583059126|FG000|Overall Study|Adverse Event|2|||
161454895|NCT01227629|583059127|FG001|Overall Study|Adverse Event|2|||
161454896|NCT01227629|583059128|FG002|Overall Study|Adverse Event|1|||
161454897|NCT01227629|583059129|FG003|Overall Study|Adverse Event|6|||
161454898|NCT01227629|583059130|FG004|Overall Study|Adverse Event|1|||
161454899|NCT01227629|583059131|FG005|Overall Study|Adverse Event|1|||
161454900|NCT01227629|583059132|FG006|Overall Study|Adverse Event|6|||
161454901|NCT01227629|583059133|FG007|Overall Study|Adverse Event|6|||
161454902|NCT01227629|583059134|FG008|Overall Study|Adverse Event|4|||
161454903|NCT01227629|583059135|FG009|Overall Study|Adverse Event|0|||
161454904|NCT01227629|583059126|FG000|Overall Study|Protocol Violation|0|||
161454905|NCT01227629|583059127|FG001|Overall Study|Protocol Violation|0|||
161454906|NCT01227629|583059128|FG002|Overall Study|Protocol Violation|0|||
161454907|NCT01227629|583059129|FG003|Overall Study|Protocol Violation|1|||
161454908|NCT01227629|583059130|FG004|Overall Study|Protocol Violation|0|||
161454909|NCT01227629|583059131|FG005|Overall Study|Protocol Violation|0|||
161454910|NCT01227629|583059132|FG006|Overall Study|Protocol Violation|0|||
161454911|NCT01227629|583059133|FG007|Overall Study|Protocol Violation|0|||
161454912|NCT01227629|583059134|FG008|Overall Study|Protocol Violation|0|||
161454913|NCT01227629|583059135|FG009|Overall Study|Protocol Violation|0|||
161454914|NCT01227629|583059126|FG000|Overall Study|Lost to Follow-up|0|||
161454915|NCT01227629|583059127|FG001|Overall Study|Lost to Follow-up|0|||
161454916|NCT01227629|583059128|FG002|Overall Study|Lost to Follow-up|0|||
161454917|NCT01227629|583059129|FG003|Overall Study|Lost to Follow-up|0|||
161454918|NCT01227629|583059130|FG004|Overall Study|Lost to Follow-up|1|||
161454919|NCT01227629|583059131|FG005|Overall Study|Lost to Follow-up|0|||
161454920|NCT01227629|583059132|FG006|Overall Study|Lost to Follow-up|0|||
161454921|NCT01227629|583059133|FG007|Overall Study|Lost to Follow-up|0|||
161454922|NCT01227629|583059134|FG008|Overall Study|Lost to Follow-up|0|||
161454923|NCT01227629|583059135|FG009|Overall Study|Lost to Follow-up|0|||
161454924|NCT01227629|583059126|FG000|Overall Study|Withdrawal by Subject|0|||
161454925|NCT01227629|583059127|FG001|Overall Study|Withdrawal by Subject|0|||
161454926|NCT01227629|583059128|FG002|Overall Study|Withdrawal by Subject|0|||
161454927|NCT01227629|583059129|FG003|Overall Study|Withdrawal by Subject|0|||
161454928|NCT01227629|583059130|FG004|Overall Study|Withdrawal by Subject|0|||
161454929|NCT01227629|583059131|FG005|Overall Study|Withdrawal by Subject|0|||
161454930|NCT01227629|583059132|FG006|Overall Study|Withdrawal by Subject|2|||
161454931|NCT01227629|583059133|FG007|Overall Study|Withdrawal by Subject|0|||
161454932|NCT01227629|583059134|FG008|Overall Study|Withdrawal by Subject|0|||
161454933|NCT01227629|583059135|FG009|Overall Study|Withdrawal by Subject|1|||
161565032|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
161565033|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
161565034|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
161565035|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
161565036|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
161565037|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
161565038|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
161565039|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
161565040|NCT02403323|583458786|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
161565041|NCT02403323|583458787|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
161565042|NCT02403323|583458788|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
161565043|NCT03885596|583458792|FG000|Overall Study|Withdrawal by Subject|2|||
161565044|NCT03885596|583458793|FG001|Overall Study|Withdrawal by Subject|1|||
161565045|NCT03885596|583458794|FG002|Overall Study|Withdrawal by Subject|0|||
161565046|NCT03885596|583458795|FG003|Overall Study|Withdrawal by Subject|0|||
161565047|NCT00746330|583458796|FG000|Period 1|Abnormal test procedure result|0|||
161565048|NCT00746330|583458797|FG001|Period 1|Abnormal test procedure result|0|||
161565049|NCT00746330|583458798|FG002|Period 1|Abnormal test procedure result|1|||
161565050|NCT00746330|583458799|FG003|Period 1|Abnormal test procedure result|0|||
161565051|NCT01076335|583458800|FG000|Overall Study|Withdrawal by Subject|3|||
161565052|NCT01076335|583458800|FG000|Overall Study|Withdrawal without treatment|1|||
161565053|NCT00517933|583458802|FG000|Period 1|Death|2|||
161565054|NCT00517933|583458803|FG001|Period 1|Death|1|||
161565055|NCT00517933|583458802|FG000|Period 1|Adverse Event|4|||
161565056|NCT00517933|583458803|FG001|Period 1|Adverse Event|4|||
161565057|NCT00517933|583458802|FG000|Period 1|Lost to Follow-up|2|||
161565058|NCT00517933|583458803|FG001|Period 1|Lost to Follow-up|0|||
161565059|NCT00517933|583458802|FG000|Period 1|Underwent lung transplant|0|||
161565060|NCT00517933|583458803|FG001|Period 1|Underwent lung transplant|1|||
161565061|NCT00517933|583458802|FG000|Period 2|Death|2|||
161565062|NCT00517933|583458803|FG001|Period 2|Death|4|||
161565063|NCT00517933|583458802|FG000|Period 2|Adverse Event|2|||
161565064|NCT00517933|583458803|FG001|Period 2|Adverse Event|4|||
161565065|NCT00517933|583458802|FG000|Period 2|Physician Decision|1|||
161565066|NCT00517933|583458803|FG001|Period 2|Physician Decision|0|||
161565067|NCT00517933|583458802|FG000|Period 2|Withdrawal by Subject|1|||
161565068|NCT00517933|583458803|FG001|Period 2|Withdrawal by Subject|3|||
161565069|NCT00517933|583458802|FG000|Period 2|Underwent lung transplant|0|||
161565070|NCT00517933|583458803|FG001|Period 2|Underwent lung transplant|2|||
161565071|NCT00235495|583458804|FG000|Overall Study|Death|52|||
161565072|NCT00235495|583458805|FG001|Overall Study|Death|42|||
161565073|NCT00235495|583458804|FG000|Overall Study|Withdrawal by Subject|5|||
161565074|NCT00235495|583458805|FG001|Overall Study|Withdrawal by Subject|3|||
161565075|NCT00235495|583458804|FG000|Overall Study|Lost to Follow-up|11|||
161565076|NCT00235495|583458805|FG001|Overall Study|Lost to Follow-up|13|||
161565077|NCT00235495|583458804|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
161565078|NCT00235495|583458805|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
161565079|NCT01268566|583458810|FG000|Overall Study|Lost to Follow-up|1|||
161565080|NCT01268566|583458810|FG000|Overall Study|Withdrawal by Subject|12|||
161565081|NCT01268566|583458810|FG000|Overall Study|Death|30|||
161565082|NCT02784704|583458817|FG000|Overall Study|Adverse Event|4|||
161565083|NCT02784704|583458818|FG001|Overall Study|Adverse Event|2|||
161565084|NCT02784704|583458817|FG000|Overall Study|Lost to Follow-up|6|||
161565085|NCT02784704|583458818|FG001|Overall Study|Lost to Follow-up|4|||
161565086|NCT02784704|583458817|FG000|Overall Study|Withdrawal by Subject|1|||
161565087|NCT02784704|583458818|FG001|Overall Study|Withdrawal by Subject|3|||
161565088|NCT02784704|583458817|FG000|Overall Study|Subject Non Compliance|2|||
161565089|NCT02784704|583458818|FG001|Overall Study|Subject Non Compliance|0|||
161565090|NCT00603538|583458819|FG000|Overall Study|Adverse Event|0|||
161565091|NCT00603538|583458820|FG001|Overall Study|Adverse Event|4|||
161565092|NCT00603538|583458821|FG002|Overall Study|Adverse Event|2|||
161565093|NCT00603538|583458819|FG000|Overall Study|Objective progression or relapse|3|||
161565094|NCT00603538|583458820|FG001|Overall Study|Objective progression or relapse|0|||
161565095|NCT00603538|583458821|FG002|Overall Study|Objective progression or relapse|0|||
161565096|NCT04794179|583458823|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
161565097|NCT04794179|583458824|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
161565098|NCT03781804|583458836|FG000|Overall Study|Adverse Event|2|||
161565099|NCT03781804|583458837|FG001|Overall Study|Adverse Event|2|||
161807717|NCT00846495|584341198|FG001|Overall Study|Lack of Efficacy|2|||
161807718|NCT00846495|584341197|FG000|Overall Study|Physician Decision|1|||
161807719|NCT00846495|584341198|FG001|Overall Study|Physician Decision|0|||
161807720|NCT01079988|584341199|FG000|Overall Study|Lost to Follow-up|0|||
161565100|NCT03781804|583458838|FG002|Overall Study|Adverse Event|3|||
161565101|NCT03781804|583458836|FG000|Overall Study|Lost to Follow-up|1|||
161565102|NCT03781804|583458837|FG001|Overall Study|Lost to Follow-up|1|||
161807721|NCT01079988|584341200|FG001|Overall Study|Lost to Follow-up|0|||
161565103|NCT03781804|583458838|FG002|Overall Study|Lost to Follow-up|2|||
161565104|NCT03781804|583458836|FG000|Overall Study|Lack of Efficacy|4|||
161565105|NCT03781804|583458837|FG001|Overall Study|Lack of Efficacy|2|||
161565106|NCT03781804|583458838|FG002|Overall Study|Lack of Efficacy|9|||
161565107|NCT03781804|583458836|FG000|Overall Study|Protocol Violation|0|||
161565108|NCT03781804|583458837|FG001|Overall Study|Protocol Violation|0|||
161565109|NCT03781804|583458838|FG002|Overall Study|Protocol Violation|1|||
161565110|NCT03781804|583458836|FG000|Overall Study|Withdrawal by Subject|0|||
161565111|NCT03781804|583458837|FG001|Overall Study|Withdrawal by Subject|1|||
161565112|NCT03781804|583458838|FG002|Overall Study|Withdrawal by Subject|1|||
161565113|NCT03781804|583458836|FG000|Overall Study|Reason not provided|2|||
161565114|NCT03781804|583458837|FG001|Overall Study|Reason not provided|2|||
161565115|NCT03781804|583458838|FG002|Overall Study|Reason not provided|0|||
161565116|NCT03717194|583458839|FG000|Overall Study|Withdrawal by Subject|2|||
161565117|NCT03717194|583458840|FG001|Overall Study|Withdrawal by Subject|4|||
161565118|NCT03717194|583458839|FG000|Overall Study|Adverse Event|1|||
161565119|NCT03717194|583458840|FG001|Overall Study|Adverse Event|1|||
161565120|NCT04678830|583458841|FG000|Overall Study|Lack of Efficacy|2|||
161565121|NCT04678830|583458842|FG001|Overall Study|Lack of Efficacy|0|||
161565122|NCT04678830|583458841|FG000|Overall Study|Withdrawal by Subject|0|||
161565123|NCT04678830|583458842|FG001|Overall Study|Withdrawal by Subject|1|||
161565124|NCT01836458|583458845|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161565125|NCT01836458|583458846|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161565126|NCT01836458|583458847|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
161565127|NCT01836458|583458848|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
161565128|NCT00429793|583458849|FG000|Overall Study|Improper pre-protocol treatment|3|||
161565129|NCT00429793|583458849|FG000|Overall Study|Required test not done|1|||
161565130|NCT00429793|583458849|FG000|Overall Study|Never treated|1|||
161565131|NCT00429793|583458849|FG000|Overall Study|Non-measurable|1|||
161565132|NCT00813488|583458850|FG000|Titration Period 1|Adverse Event|6|||
161565133|NCT00813488|583458851|FG001|Titration Period 1|Adverse Event|1|||
161565134|NCT00813488|583458850|FG000|Titration Period 1|Lack of Efficacy|9|||
161565135|NCT00813488|583458851|FG001|Titration Period 1|Lack of Efficacy|7|||
161565136|NCT00813488|583458850|FG000|Titration Period 1|Withdrawal by Subject|2|||
161565137|NCT00813488|583458851|FG001|Titration Period 1|Withdrawal by Subject|2|||
161565138|NCT00813488|583458850|FG000|Titration Period 1|Protocol Violation|4|||
161565139|NCT00813488|583458851|FG001|Titration Period 1|Protocol Violation|3|||
161565140|NCT00813488|583458850|FG000|Titration Period 1|Non-compliance to study medication|4|||
161565141|NCT00813488|583458851|FG001|Titration Period 1|Non-compliance to study medication|1|||
161565142|NCT00813488|583458850|FG000|Titration Period 1|Non-compliance to study procedures|2|||
161565143|NCT00813488|583458851|FG001|Titration Period 1|Non-compliance to study procedures|2|||
161565144|NCT00813488|583458850|FG000|Titration Period 1|Technical Difficulties|0|||
161565145|NCT00813488|583458851|FG001|Titration Period 1|Technical Difficulties|1|||
161565146|NCT00813488|583458850|FG000|Titration Period 2|Adverse Event|2|||
161565147|NCT00813488|583458851|FG001|Titration Period 2|Adverse Event|3|||
161565148|NCT00813488|583458850|FG000|Titration Period 2|Lack of Efficacy|8|||
161565149|NCT00813488|583458851|FG001|Titration Period 2|Lack of Efficacy|4|||
161565150|NCT00813488|583458850|FG000|Titration Period 2|Protocol Violation|3|||
161565151|NCT00813488|583458851|FG001|Titration Period 2|Protocol Violation|2|||
161565152|NCT00813488|583458850|FG000|Titration Period 2|Lost to Follow-up|1|||
161565153|NCT00813488|583458851|FG001|Titration Period 2|Lost to Follow-up|0|||
161565154|NCT00813488|583458850|FG000|Titration Period 2|Non-compliance with study procedures|2|||
161565155|NCT00813488|583458851|FG001|Titration Period 2|Non-compliance with study procedures|1|||
161565156|NCT00813488|583458850|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
161565157|NCT00813488|583458851|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
161565158|NCT00813488|583458850|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
161565159|NCT00813488|583458851|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
161565160|NCT00813488|583458850|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
161565161|NCT00813488|583458851|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
161565162|NCT00813488|583458850|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
161807722|NCT01079988|584341201|FG002|Overall Study|Lost to Follow-up|0|||
161565163|NCT00813488|583458851|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
161565164|NCT00813488|583458850|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
161565165|NCT00813488|583458851|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
161565166|NCT00813488|583458850|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
161565167|NCT00813488|583458851|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
161565168|NCT00813488|583458850|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
161565169|NCT00813488|583458851|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
161565170|NCT00813488|583458850|FG000|Double-blind Treatment Period 2|Other|1|||
161565171|NCT00813488|583458851|FG001|Double-blind Treatment Period 2|Other|0|||
161565172|NCT00813488|583458850|FG000|Open-label Extension|Adverse Event|1|||
161565173|NCT00813488|583458851|FG001|Open-label Extension|Adverse Event|2|||
161565174|NCT00813488|583458850|FG000|Open-label Extension|Lack of Efficacy|3|||
161565175|NCT00813488|583458851|FG001|Open-label Extension|Lack of Efficacy|0|||
161911448|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161911449|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161911450|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161454934|NCT01227629|583059126|FG000|Overall Study|Other|0|||
161454935|NCT01227629|583059127|FG001|Overall Study|Other|0|||
161454936|NCT01227629|583059128|FG002|Overall Study|Other|0|||
161454937|NCT01227629|583059129|FG003|Overall Study|Other|1|||
161454938|NCT01227629|583059130|FG004|Overall Study|Other|0|||
161454939|NCT01227629|583059131|FG005|Overall Study|Other|0|||
161454940|NCT01227629|583059132|FG006|Overall Study|Other|0|||
161454941|NCT01227629|583059133|FG007|Overall Study|Other|0|||
161454942|NCT01227629|583059134|FG008|Overall Study|Other|2|||
161454943|NCT01227629|583059135|FG009|Overall Study|Other|1|||
161454944|NCT00129311|583059136|FG000|Overall Study|Withdrawal by Subject|12|||
161454945|NCT00129311|583059137|FG001|Overall Study|Withdrawal by Subject|19|||
161454946|NCT02446171|583061216|FG000|Overall Study|Withdrawal by Subject|0|||
161454947|NCT02446171|583061217|FG001|Overall Study|Withdrawal by Subject|0|||
161454948|NCT02446171|583061218|FG002|Overall Study|Withdrawal by Subject|2|||
161454949|NCT02446171|583061219|FG003|Overall Study|Withdrawal by Subject|0|||
161454950|NCT02320903|583061222|FG000|Overall Study|Withdrawal by Subject|0|||
161454951|NCT02320903|583061223|FG001|Overall Study|Withdrawal by Subject|9|||
161454952|NCT02320903|583061224|FG002|Overall Study|Withdrawal by Subject|9|||
161454953|NCT02320903|583061222|FG000|Overall Study|Exited therapy; no longer eligible|8|||
161454954|NCT02320903|583061223|FG001|Overall Study|Exited therapy; no longer eligible|2|||
161454955|NCT02320903|583061224|FG002|Overall Study|Exited therapy; no longer eligible|2|||
161454956|NCT02320903|583061222|FG000|Overall Study|Lost to Follow-up|0|||
161454957|NCT02320903|583061223|FG001|Overall Study|Lost to Follow-up|5|||
161454958|NCT02320903|583061224|FG002|Overall Study|Lost to Follow-up|5|||
161454959|NCT00773383|583061225|FG000|Overall Study|Adverse Event|4|||
161454960|NCT00773383|583061225|FG000|Overall Study|Death|1|||
161454961|NCT00773383|583061225|FG000|Overall Study|Progression of Disease|23|||
161454962|NCT00773383|583061225|FG000|Overall Study|Other|2|||
161454963|NCT00773383|583061225|FG000|Overall Study|No study dose received|1|||
161454964|NCT03811093|583061243|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
161454965|NCT03811093|583061244|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
161454966|NCT03811093|583061243|FG000|Overall Study|Unable to measure body fat percentage|2|||
161454967|NCT03811093|583061244|FG001|Overall Study|Unable to measure body fat percentage|0|||
161454968|NCT00464490|583061246|FG000|Overall Study|Physician Decision|11|||
161454969|NCT00464490|583061247|FG001|Overall Study|Physician Decision|11|||
161454970|NCT03188042|583061250|FG000|Overall Study|Withdrawal by Subject|1|||
161454971|NCT03188042|583061251|FG001|Overall Study|Withdrawal by Subject|1|||
161454972|NCT00039871|583061259|FG000|Overall Study|Adverse Event|165|||
161454973|NCT00039871|583061259|FG000|Overall Study|Lost to Follow-up|18|||
161454974|NCT00039871|583061259|FG000|Overall Study|Protocol Violation|24|||
161454975|NCT00039871|583061259|FG000|Overall Study|Withdrawal by Subject|97|||
161454976|NCT00039871|583061259|FG000|Overall Study|Did not meet eligibility criteria|11|||
161454977|NCT00039871|583061259|FG000|Overall Study|Administrative|1|||
161454978|NCT00039871|583061259|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
161454979|NCT00039871|583061259|FG000|Overall Study|Never entered follow-up|7|||
161454980|NCT02446743|583061260|FG000|Overall Study|Withdrawal by Subject|1|||
161454981|NCT02446743|583061261|FG001|Overall Study|Withdrawal by Subject|1|||
161454982|NCT02446743|583061260|FG000|Overall Study|Lost to Follow-up|1|||
161454983|NCT02446743|583061261|FG001|Overall Study|Lost to Follow-up|0|||
161454984|NCT02446743|583061260|FG000|Overall Study|Adverse Event|1|||
161454985|NCT02446743|583061261|FG001|Overall Study|Adverse Event|1|||
161454986|NCT02446743|583061260|FG000|Overall Study|Other|2|||
161454987|NCT02446743|583061261|FG001|Overall Study|Other|3|||
161454988|NCT02478398|583061262|FG000|Overall Study|Adverse Event|20|||
161454989|NCT02478398|583061263|FG001|Overall Study|Adverse Event|5|||
161454990|NCT02478398|583061262|FG000|Overall Study|Lost to Follow-up|5|||
161454991|NCT02478398|583061263|FG001|Overall Study|Lost to Follow-up|4|||
161454992|NCT02478398|583061262|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161454993|NCT02478398|583061263|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161454994|NCT02478398|583061262|FG000|Overall Study|Protocol Violation|3|||
161454995|NCT02478398|583061263|FG001|Overall Study|Protocol Violation|1|||
161454996|NCT02478398|583061262|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
161454997|NCT02478398|583061263|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
161454998|NCT02478398|583061262|FG000|Overall Study|Withdrawal By Participant|10|||
161454999|NCT02478398|583061263|FG001|Overall Study|Withdrawal By Participant|4|||
161455000|NCT01475071|583061267|FG000|Overall Study|Physician Decision|1|||
161455001|NCT01475071|583061267|FG000|Overall Study|Withdrawal by Subject|6|||
161455002|NCT01475071|583061267|FG000|Overall Study|Lost to Follow-up|1|||
161455003|NCT01205581|583061271|FG000|Overall Study|Withdrawal by Subject|1|||
161911451|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
161455004|NCT01205581|583061272|FG001|Overall Study|Withdrawal by Subject|0|||
161455005|NCT01205581|583061273|FG002|Overall Study|Withdrawal by Subject|0|||
161455006|NCT01205581|583061274|FG003|Overall Study|Withdrawal by Subject|0|||
161565176|NCT00813488|583458850|FG000|Open-label Extension|Withdrawal by Subject|0|||
161565177|NCT00813488|583458851|FG001|Open-label Extension|Withdrawal by Subject|2|||
161565178|NCT00813488|583458850|FG000|Open-label Extension|Protocol Violation|1|||
161565179|NCT00813488|583458851|FG001|Open-label Extension|Protocol Violation|2|||
161565180|NCT00813488|583458850|FG000|Open-label Extension|Non-compliance study medication|4|||
161565181|NCT00813488|583458851|FG001|Open-label Extension|Non-compliance study medication|0|||
161565182|NCT00813488|583458850|FG000|Open-label Extension|Non-compliance study procedures|2|||
161565183|NCT00813488|583458851|FG001|Open-label Extension|Non-compliance study procedures|1|||
161565184|NCT00813488|583458850|FG000|Open-label Extension|Other|1|||
161565185|NCT00813488|583458851|FG001|Open-label Extension|Other|0|||
161565186|NCT01333514|583458854|FG000|Overall Study|Withdrawal by Subject|1|||
161565187|NCT01333514|583458855|FG001|Overall Study|Withdrawal by Subject|0|||
161565188|NCT00836810|583458856|FG000|Overall Study|New diagnosis|1|||
161565189|NCT00836810|583458857|FG001|Overall Study|New diagnosis|0|||
161565190|NCT00819910|583458858|FG000|Overall Study|Adverse Event|0|||
161565191|NCT00819910|583458859|FG001|Overall Study|Adverse Event|0|||
161565192|NCT00819910|583458860|FG002|Overall Study|Adverse Event|2|||
161565193|NCT00819910|583458861|FG003|Overall Study|Adverse Event|1|||
161565194|NCT00819910|583458858|FG000|Overall Study|Withdrawal by Subject|1|||
161565195|NCT00819910|583458859|FG001|Overall Study|Withdrawal by Subject|1|||
161565196|NCT00819910|583458860|FG002|Overall Study|Withdrawal by Subject|1|||
161565197|NCT00819910|583458861|FG003|Overall Study|Withdrawal by Subject|0|||
161565198|NCT00819910|583458858|FG000|Overall Study|Lost to Follow-up|1|||
161565199|NCT00819910|583458859|FG001|Overall Study|Lost to Follow-up|0|||
161565200|NCT00819910|583458860|FG002|Overall Study|Lost to Follow-up|0|||
161565201|NCT00819910|583458861|FG003|Overall Study|Lost to Follow-up|0|||
161565202|NCT00871429|583458863|FG000|Overall Study|Lost to Follow-up|6|||
161565203|NCT00871429|583458863|FG000|Overall Study|Withdrawal by Subject|17|||
161565204|NCT00871429|583458863|FG000|Overall Study|Questionnaire not completed|1|||
161565205|NCT03102242|583458864|FG000|Overall Study|Adverse Event|2|||
161565206|NCT00389519|583458865|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
161565207|NCT00389519|583458866|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
161565208|NCT00389519|583458867|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
161565209|NCT00389519|583458868|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
161565210|NCT00389519|583458865|FG000|Placebo Run-In|Withdrawal by Subject|19|||
161565211|NCT00389519|583458866|FG001|Placebo Run-In|Withdrawal by Subject|0|||
161565212|NCT00389519|583458867|FG002|Placebo Run-In|Withdrawal by Subject|0|||
161565213|NCT00389519|583458868|FG003|Placebo Run-In|Withdrawal by Subject|0|||
161565214|NCT00389519|583458865|FG000|Placebo Run-In|Reason not specified|40|||
161565215|NCT00389519|583458866|FG001|Placebo Run-In|Reason not specified|0|||
161565216|NCT00389519|583458867|FG002|Placebo Run-In|Reason not specified|0|||
161565217|NCT00389519|583458868|FG003|Placebo Run-In|Reason not specified|0|||
161565218|NCT00389519|583458865|FG000|Randomized|Did not receive study drug|2|||
161565219|NCT00389519|583458866|FG001|Randomized|Did not receive study drug|0|||
161565220|NCT00389519|583458867|FG002|Randomized|Did not receive study drug|0|||
161911452|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161911453|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161911454|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
161911455|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
161911456|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
161911457|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
161911458|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161911459|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
161911460|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161911461|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161911462|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161565221|NCT00389519|583458868|FG003|Randomized|Did not receive study drug|0|||
161565222|NCT00389519|583458865|FG000|Treated|Adverse Event|1|||
161565223|NCT00389519|583458866|FG001|Treated|Adverse Event|0|||
161565224|NCT00389519|583458867|FG002|Treated|Adverse Event|0|||
161565225|NCT00389519|583458868|FG003|Treated|Adverse Event|2|||
161565226|NCT00389519|583458865|FG000|Treated|Reason not specified|1|||
161565227|NCT00389519|583458866|FG001|Treated|Reason not specified|1|||
161911463|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
161911464|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161911465|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161911466|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
161911467|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
161565228|NCT00389519|583458867|FG002|Treated|Reason not specified|0|||
161565229|NCT00389519|583458868|FG003|Treated|Reason not specified|2|||
161565230|NCT03425539|583458871|FG000|Overall Study|Randomized but not treated|0|||
161565231|NCT03425539|583458872|FG001|Overall Study|Randomized but not treated|1|||
161565232|NCT03425539|583458871|FG000|Overall Study|Adverse Event|2|||
161565233|NCT03425539|583458872|FG001|Overall Study|Adverse Event|2|||
161565234|NCT03425539|583458871|FG000|Overall Study|Withdrawal by Subject|3|||
161565235|NCT03425539|583458872|FG001|Overall Study|Withdrawal by Subject|0|||
161565236|NCT03425539|583458871|FG000|Overall Study|Lost to Follow-up|0|||
161565237|NCT03425539|583458872|FG001|Overall Study|Lost to Follow-up|1|||
161565238|NCT01772719|583458873|FG000|Overall Study|Withdrawal by Subject|3|||
161565239|NCT01772719|583458873|FG000|Overall Study|Adverse Event|2|||
161565240|NCT01772719|583458873|FG000|Overall Study|Protocol Violation|1|||
161565241|NCT01772719|583458873|FG000|Overall Study|Lost to Follow-up|1|||
161565242|NCT02040844|583458874|FG000|Overall Study|Adverse Event|0|||
161565243|NCT02040844|583458875|FG001|Overall Study|Adverse Event|0|||
161565244|NCT02040844|583458876|FG002|Overall Study|Adverse Event|1|||
161565245|NCT02040844|583458874|FG000|Overall Study|Withdrawal by Subject|16|||
161565246|NCT02040844|583458875|FG001|Overall Study|Withdrawal by Subject|22|||
161565247|NCT02040844|583458876|FG002|Overall Study|Withdrawal by Subject|25|||
161565248|NCT02040844|583458874|FG000|Overall Study|Lost to Follow-up|12|||
161565249|NCT02040844|583458875|FG001|Overall Study|Lost to Follow-up|9|||
161565250|NCT02040844|583458876|FG002|Overall Study|Lost to Follow-up|13|||
161565251|NCT02040844|583458874|FG000|Overall Study|Missing|13|||
161565252|NCT02040844|583458875|FG001|Overall Study|Missing|3|||
161565253|NCT02040844|583458876|FG002|Overall Study|Missing|2|||
161565254|NCT02040844|583458874|FG000|Overall Study|Non-specified|8|||
161565255|NCT02040844|583458875|FG001|Overall Study|Non-specified|2|||
161565256|NCT02040844|583458876|FG002|Overall Study|Non-specified|5|||
161565257|NCT02040844|583458874|FG000|Overall Study|Concomitant medication|1|||
161565258|NCT02040844|583458875|FG001|Overall Study|Concomitant medication|3|||
161565259|NCT02040844|583458876|FG002|Overall Study|Concomitant medication|1|||
161565260|NCT00946192|583458877|FG000|Overall Study|Lost to Follow-up|6|||
161565261|NCT00946192|583458878|FG001|Overall Study|Lost to Follow-up|11|||
161565262|NCT00946192|583458879|FG002|Overall Study|Lost to Follow-up|9|||
161565263|NCT00946192|583458877|FG000|Overall Study|Withdrawal by Subject|10|||
161565264|NCT00946192|583458878|FG001|Overall Study|Withdrawal by Subject|7|||
161565265|NCT00946192|583458879|FG002|Overall Study|Withdrawal by Subject|3|||
161565266|NCT00946192|583458877|FG000|Overall Study|Did not start medication|2|||
161565267|NCT00946192|583458878|FG001|Overall Study|Did not start medication|0|||
161565268|NCT00946192|583458879|FG002|Overall Study|Did not start medication|0|||
161565269|NCT00477412|583458880|FG000|Overall Study|Death|0|||
161565270|NCT00477412|583458881|FG001|Overall Study|Death|0|||
161565271|NCT00477412|583458882|FG002|Overall Study|Death|0|||
161565272|NCT00477412|583458883|FG003|Overall Study|Death|4|||
161565273|NCT00477412|583458880|FG000|Overall Study|Lost to Follow-up|0|||
161565274|NCT00477412|583458881|FG001|Overall Study|Lost to Follow-up|0|||
161565275|NCT00477412|583458882|FG002|Overall Study|Lost to Follow-up|0|||
161565276|NCT00477412|583458883|FG003|Overall Study|Lost to Follow-up|1|||
161565277|NCT00477412|583458880|FG000|Overall Study|Withdrawal by Subject|0|||
161565278|NCT00477412|583458881|FG001|Overall Study|Withdrawal by Subject|0|||
161565279|NCT00477412|583458882|FG002|Overall Study|Withdrawal by Subject|0|||
161565280|NCT00477412|583458883|FG003|Overall Study|Withdrawal by Subject|2|||
161565281|NCT00477412|583458880|FG000|Overall Study|Second Malignancy|0|||
161565282|NCT00477412|583458881|FG001|Overall Study|Second Malignancy|0|||
161565283|NCT00477412|583458882|FG002|Overall Study|Second Malignancy|0|||
161565284|NCT00477412|583458883|FG003|Overall Study|Second Malignancy|1|||
161565285|NCT00477412|583458880|FG000|Overall Study|Adverse Event|1|||
161565286|NCT00477412|583458881|FG001|Overall Study|Adverse Event|0|||
161565287|NCT00477412|583458882|FG002|Overall Study|Adverse Event|1|||
161565288|NCT00477412|583458883|FG003|Overall Study|Adverse Event|0|||
161565289|NCT01080131|583458884|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
161565290|NCT01080131|583458885|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
161565291|NCT01080131|583458884|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
161565292|NCT01080131|583458885|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
161565293|NCT01080131|583458884|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
161565294|NCT01080131|583458885|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
161565295|NCT01080131|583458884|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
161565296|NCT01080131|583458885|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
161807723|NCT01079988|584341202|FG003|Overall Study|Lost to Follow-up|1|||
161565297|NCT01080131|583458884|FG000|Core Study (0- 12 Weeks)|Death|1|||
161565298|NCT01080131|583458885|FG001|Core Study (0- 12 Weeks)|Death|0|||
161565299|NCT01080131|583458884|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
161565300|NCT01080131|583458885|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
161565301|NCT01080131|583458884|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
161565302|NCT01080131|583458885|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
161565303|NCT01080131|583458884|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
161565304|NCT01080131|583458885|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
161565305|NCT01080131|583458884|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
161565306|NCT01080131|583458885|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
161807724|NCT01079988|584341203|FG004|Overall Study|Lost to Follow-up|0|||
161565307|NCT01080131|583458884|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
161565308|NCT01080131|583458885|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
161565309|NCT01080131|583458884|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
161565310|NCT01080131|583458885|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
161565311|NCT01080131|583458884|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
161565312|NCT01080131|583458885|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
161565313|NCT01080131|583458884|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
161565314|NCT01080131|583458885|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
161565315|NCT02014558|583458886|FG000|Overall Study|Never Received Study Drug|0|||
161565316|NCT02014558|583458887|FG001|Overall Study|Never Received Study Drug|0|||
161565317|NCT02014558|583458888|FG002|Overall Study|Never Received Study Drug|0|||
161565318|NCT02014558|583458889|FG003|Overall Study|Never Received Study Drug|0|||
161565319|NCT02014558|583458890|FG004|Overall Study|Never Received Study Drug|1|||
161565320|NCT02014558|583458891|FG005|Overall Study|Never Received Study Drug|0|||
161565321|NCT02014558|583458892|FG006|Overall Study|Never Received Study Drug|1|||
161565322|NCT02014558|583458893|FG007|Overall Study|Never Received Study Drug|0|||
161565323|NCT02014558|583458894|FG008|Overall Study|Never Received Study Drug|2|||
161565324|NCT02014558|583458895|FG009|Overall Study|Never Received Study Drug|0|||
161565325|NCT02014558|583458896|FG010|Overall Study|Never Received Study Drug|2|||
161565326|NCT02014558|583458897|FG011|Overall Study|Never Received Study Drug|2|||
161565327|NCT02014558|583458898|FG012|Overall Study|Never Received Study Drug|0|||
161565328|NCT02014558|583458886|FG000|Overall Study|Adverse Event|0|||
161565329|NCT02014558|583458887|FG001|Overall Study|Adverse Event|0|||
161565330|NCT02014558|583458888|FG002|Overall Study|Adverse Event|0|||
161565331|NCT02014558|583458889|FG003|Overall Study|Adverse Event|0|||
161565332|NCT02014558|583458890|FG004|Overall Study|Adverse Event|1|||
161565333|NCT02014558|583458891|FG005|Overall Study|Adverse Event|0|||
161565334|NCT02014558|583458892|FG006|Overall Study|Adverse Event|0|||
161565335|NCT02014558|583458893|FG007|Overall Study|Adverse Event|0|||
161565336|NCT02014558|583458894|FG008|Overall Study|Adverse Event|2|||
161565337|NCT02014558|583458895|FG009|Overall Study|Adverse Event|2|||
161565338|NCT02014558|583458896|FG010|Overall Study|Adverse Event|5|||
161565339|NCT02014558|583458897|FG011|Overall Study|Adverse Event|21|||
161565340|NCT02014558|583458898|FG012|Overall Study|Adverse Event|3|||
161565341|NCT02014558|583458886|FG000|Overall Study|Death|1|||
161565342|NCT02014558|583458887|FG001|Overall Study|Death|0|||
161565343|NCT02014558|583458888|FG002|Overall Study|Death|0|||
161565344|NCT02014558|583458889|FG003|Overall Study|Death|0|||
161565345|NCT02014558|583458890|FG004|Overall Study|Death|0|||
161565346|NCT02014558|583458891|FG005|Overall Study|Death|0|||
161565347|NCT02014558|583458892|FG006|Overall Study|Death|1|||
161565348|NCT02014558|583458893|FG007|Overall Study|Death|1|||
161565349|NCT02014558|583458894|FG008|Overall Study|Death|2|||
161565350|NCT02014558|583458895|FG009|Overall Study|Death|5|||
161565351|NCT02014558|583458896|FG010|Overall Study|Death|5|||
161565352|NCT02014558|583458897|FG011|Overall Study|Death|19|||
161565353|NCT02014558|583458898|FG012|Overall Study|Death|2|||
161565354|NCT02014558|583458886|FG000|Overall Study|Lack of Efficacy|1|||
161565355|NCT02014558|583458887|FG001|Overall Study|Lack of Efficacy|2|||
161565356|NCT02014558|583458888|FG002|Overall Study|Lack of Efficacy|1|||
161565357|NCT02014558|583458889|FG003|Overall Study|Lack of Efficacy|1|||
161565358|NCT02014558|583458890|FG004|Overall Study|Lack of Efficacy|0|||
161565359|NCT02014558|583458891|FG005|Overall Study|Lack of Efficacy|0|||
161565360|NCT02014558|583458892|FG006|Overall Study|Lack of Efficacy|1|||
161565361|NCT02014558|583458893|FG007|Overall Study|Lack of Efficacy|3|||
161565362|NCT02014558|583458894|FG008|Overall Study|Lack of Efficacy|3|||
161565363|NCT02014558|583458895|FG009|Overall Study|Lack of Efficacy|3|||
161565364|NCT02014558|583458896|FG010|Overall Study|Lack of Efficacy|16|||
161565365|NCT02014558|583458897|FG011|Overall Study|Lack of Efficacy|8|||
161565366|NCT02014558|583458898|FG012|Overall Study|Lack of Efficacy|5|||
161565367|NCT02014558|583458886|FG000|Overall Study|Lost to Follow-up|0|||
161565368|NCT02014558|583458887|FG001|Overall Study|Lost to Follow-up|0|||
161565369|NCT02014558|583458888|FG002|Overall Study|Lost to Follow-up|0|||
161565370|NCT02014558|583458889|FG003|Overall Study|Lost to Follow-up|0|||
161807725|NCT01079988|584341199|FG000|Overall Study|Lack of Efficacy|1|||
161807726|NCT01079988|584341200|FG001|Overall Study|Lack of Efficacy|0|||
161807727|NCT01079988|584341201|FG002|Overall Study|Lack of Efficacy|0|||
161807728|NCT01079988|584341202|FG003|Overall Study|Lack of Efficacy|0|||
161807729|NCT01079988|584341203|FG004|Overall Study|Lack of Efficacy|0|||
161807730|NCT01079988|584341199|FG000|Overall Study|Other|0|||
161807731|NCT01079988|584341200|FG001|Overall Study|Other|0|||
161807732|NCT01079988|584341201|FG002|Overall Study|Other|0|||
161807733|NCT01079988|584341202|FG003|Overall Study|Other|2|||
161807734|NCT01079988|584341203|FG004|Overall Study|Other|1|||
161807735|NCT01265056|584341204|FG000|Initial Study Period|Withdrawal by Subject|1|||
161565371|NCT02014558|583458890|FG004|Overall Study|Lost to Follow-up|0|||
161565372|NCT02014558|583458891|FG005|Overall Study|Lost to Follow-up|0|||
161565373|NCT02014558|583458892|FG006|Overall Study|Lost to Follow-up|0|||
161807736|NCT01265056|584341205|FG001|Initial Study Period|Withdrawal by Subject|1|||
161807737|NCT01265056|584341204|FG000|Initial Study Period|Withdrawal by Subject|1|||
161807738|NCT01265056|584341205|FG001|Initial Study Period|Withdrawal by Subject|1|||
161807739|NCT01265056|584341204|FG000|Follow up|Lost to Follow-up|7|||
161807740|NCT01265056|584341205|FG001|Follow up|Lost to Follow-up|3|||
161807741|NCT02711852|584341210|FG000|Overall Study|Death|5|||
161807742|NCT02711852|584341210|FG000|Overall Study|Lost to Follow-up|1|||
161807743|NCT02711852|584341210|FG000|Overall Study|Completed follow-up|3|||
161807744|NCT02711852|584341210|FG000|Overall Study|Withdrawal by Subject|1|||
161807745|NCT01417078|584341214|FG000|Overall Study|Withdrawal by Subject|1|||
161807746|NCT01059903|584341215|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
161807747|NCT01059903|584341216|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
161911468|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
161911469|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
161911470|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
161911471|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
161911472|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
161911473|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
161911474|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
161911475|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
161455007|NCT01205581|583061275|FG004|Overall Study|Withdrawal by Subject|0|||
161911476|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
161911477|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
161911478|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
161911479|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
161911480|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
161911481|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
161911482|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
161807748|NCT00858845|584341217|FG000|Overall Study|Patient underwent heart transplant.|0|||
161807749|NCT00858845|584341218|FG001|Overall Study|Patient underwent heart transplant.|1|||
161807750|NCT03031847|584341219|FG000|Overall Study|Death|1|||
161807751|NCT03031847|584341220|FG001|Overall Study|Death|1|||
161807752|NCT03031847|584341221|FG002|Overall Study|Death|2|||
161807753|NCT03031847|584341222|FG003|Overall Study|Death|3|||
161807754|NCT03031847|584341219|FG000|Overall Study|Lost to Follow-up|1|||
161807755|NCT03031847|584341220|FG001|Overall Study|Lost to Follow-up|1|||
161807756|NCT03031847|584341221|FG002|Overall Study|Lost to Follow-up|2|||
161807757|NCT03031847|584341222|FG003|Overall Study|Lost to Follow-up|3|||
161911483|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
161455008|NCT01205581|583061276|FG005|Overall Study|Withdrawal by Subject|0|||
161455009|NCT00770146|583061291|FG000|Treatment Period|Withdrawal by Subject|6|||
161455010|NCT00770146|583061292|FG001|Treatment Period|Withdrawal by Subject|13|||
161455011|NCT00770146|583061291|FG000|Treatment Period|Adverse Event|2|||
161455012|NCT00770146|583061292|FG001|Treatment Period|Adverse Event|26|||
161455013|NCT00770146|583061291|FG000|Treatment Period|Other|1|||
161455014|NCT00770146|583061292|FG001|Treatment Period|Other|5|||
161455015|NCT00770146|583061291|FG000|Treatment Period|Protocol non-compliance|0|||
161455016|NCT00770146|583061292|FG001|Treatment Period|Protocol non-compliance|1|||
161455017|NCT00770146|583061291|FG000|Follow-up Period|Withdrawal by Subject|7|||
161455018|NCT00770146|583061292|FG001|Follow-up Period|Withdrawal by Subject|13|||
161455019|NCT00770146|583061291|FG000|Follow-up Period|Adverse Event|0|||
161455020|NCT00770146|583061292|FG001|Follow-up Period|Adverse Event|2|||
161455021|NCT00770146|583061291|FG000|Follow-up Period|Other|4|||
161455022|NCT00770146|583061292|FG001|Follow-up Period|Other|5|||
161455023|NCT01525901|583061294|FG000|Period 2: 12 Weeks|Adverse Event|0|||
161455024|NCT01525901|583061295|FG001|Period 2: 12 Weeks|Adverse Event|1|||
161455025|NCT01525901|583061296|FG002|Period 2: 12 Weeks|Adverse Event|0|||
161455026|NCT01525901|583061297|FG003|Period 2: 12 Weeks|Adverse Event|0|||
161455027|NCT04449029|583061299|FG000|Overall Study|Adverse Event|0|||
161455028|NCT04449029|583061300|FG001|Overall Study|Adverse Event|1|||
161455029|NCT04449029|583061301|FG002|Overall Study|Adverse Event|1|||
161455030|NCT04449029|583061302|FG003|Overall Study|Adverse Event|0|||
161455031|NCT04449029|583061303|FG004|Overall Study|Adverse Event|1|||
161455032|NCT04449029|583061304|FG005|Overall Study|Adverse Event|0|||
161455033|NCT04449029|583061305|FG006|Overall Study|Adverse Event|1|||
161455034|NCT04449029|583061306|FG007|Overall Study|Adverse Event|0|||
161455035|NCT04449029|583061299|FG000|Overall Study|Lost to Follow-up|0|||
161455036|NCT04449029|583061300|FG001|Overall Study|Lost to Follow-up|1|||
161455037|NCT04449029|583061301|FG002|Overall Study|Lost to Follow-up|0|||
161455038|NCT04449029|583061302|FG003|Overall Study|Lost to Follow-up|0|||
161807758|NCT02100228|584341225|FG000|Overall Study|Other|19|||
161807759|NCT02100228|584341226|FG001|Overall Study|Other|19|||
161807760|NCT02100228|584341225|FG000|Overall Study|Administrative reason|0|||
161807761|NCT02100228|584341226|FG001|Overall Study|Administrative reason|1|||
161455039|NCT04449029|583061303|FG004|Overall Study|Lost to Follow-up|0|||
161455040|NCT04449029|583061304|FG005|Overall Study|Lost to Follow-up|0|||
161455041|NCT04449029|583061305|FG006|Overall Study|Lost to Follow-up|0|||
161911484|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
161911485|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
161911486|NCT03092752|584727222|FG000|Overall Study|Aged <40 years|14209|||
161911487|NCT03092752|584727222|FG000|Overall Study|At least one claim with T2DM|61299|||
161911488|NCT03092752|584727222|FG000|Overall Study|Having no claim of study drugs|29282|||
161911489|NCT03092752|584727222|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
161911490|NCT03092752|584727222|FG000|Overall Study|<6 month history|245900|||
161911491|NCT03882918|584727224|FG000|Overall Study|Study terminated by sponsor|98|||
161911492|NCT03882918|584727224|FG000|Overall Study|Protocol Violation|1|||
161911493|NCT03882918|584727224|FG000|Overall Study|Other|9|||
161911494|NCT03882918|584727224|FG000|Overall Study|Lack of Efficacy|14|||
161911495|NCT03882918|584727224|FG000|Overall Study|Adverse Event|13|||
161911496|NCT03882918|584727224|FG000|Overall Study|Withdrawal by Subject|5|||
161911497|NCT06996301|584727225|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
161911498|NCT06996301|584727226|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
161911499|NCT06996301|584727225|FG000|Overall Study|Patients with discordant diagnostic results|107|||
161911500|NCT06996301|584727226|FG001|Overall Study|Patients with discordant diagnostic results|90|||
161911501|NCT06996301|584727225|FG000|Overall Study|Lost to Follow-up|31|||
161911502|NCT06996301|584727226|FG001|Overall Study|Lost to Follow-up|56|||
161911503|NCT06996301|584727225|FG000|Overall Study|Withdrawal by Subject|12|||
161565374|NCT02014558|583458893|FG007|Overall Study|Lost to Follow-up|0|||
161565375|NCT02014558|583458894|FG008|Overall Study|Lost to Follow-up|0|||
161565376|NCT02014558|583458895|FG009|Overall Study|Lost to Follow-up|0|||
161565377|NCT02014558|583458896|FG010|Overall Study|Lost to Follow-up|1|||
161565378|NCT02014558|583458897|FG011|Overall Study|Lost to Follow-up|0|||
161565379|NCT02014558|583458898|FG012|Overall Study|Lost to Follow-up|0|||
161565380|NCT02014558|583458886|FG000|Overall Study|Progressive Disease|1|||
161565381|NCT02014558|583458887|FG001|Overall Study|Progressive Disease|0|||
161565382|NCT02014558|583458888|FG002|Overall Study|Progressive Disease|1|||
161565383|NCT02014558|583458889|FG003|Overall Study|Progressive Disease|1|||
161565384|NCT02014558|583458890|FG004|Overall Study|Progressive Disease|1|||
161565385|NCT02014558|583458891|FG005|Overall Study|Progressive Disease|2|||
161565386|NCT02014558|583458892|FG006|Overall Study|Progressive Disease|1|||
161565387|NCT02014558|583458893|FG007|Overall Study|Progressive Disease|6|||
161565388|NCT02014558|583458894|FG008|Overall Study|Progressive Disease|5|||
161565389|NCT02014558|583458895|FG009|Overall Study|Progressive Disease|6|||
161565390|NCT02014558|583458896|FG010|Overall Study|Progressive Disease|22|||
161565391|NCT02014558|583458897|FG011|Overall Study|Progressive Disease|31|||
161565392|NCT02014558|583458898|FG012|Overall Study|Progressive Disease|6|||
161565393|NCT02014558|583458886|FG000|Overall Study|Withdrawal by Subject|0|||
161565394|NCT02014558|583458887|FG001|Overall Study|Withdrawal by Subject|0|||
161565395|NCT02014558|583458888|FG002|Overall Study|Withdrawal by Subject|0|||
161565396|NCT02014558|583458889|FG003|Overall Study|Withdrawal by Subject|0|||
161565397|NCT02014558|583458890|FG004|Overall Study|Withdrawal by Subject|1|||
161565398|NCT02014558|583458891|FG005|Overall Study|Withdrawal by Subject|0|||
161565399|NCT02014558|583458892|FG006|Overall Study|Withdrawal by Subject|0|||
161565400|NCT02014558|583458893|FG007|Overall Study|Withdrawal by Subject|0|||
161565401|NCT02014558|583458894|FG008|Overall Study|Withdrawal by Subject|0|||
161565402|NCT02014558|583458895|FG009|Overall Study|Withdrawal by Subject|2|||
161565403|NCT02014558|583458896|FG010|Overall Study|Withdrawal by Subject|6|||
161565404|NCT02014558|583458897|FG011|Overall Study|Withdrawal by Subject|10|||
161565405|NCT02014558|583458898|FG012|Overall Study|Withdrawal by Subject|0|||
161565406|NCT02014558|583458886|FG000|Overall Study|Miscellaneous|2|||
161565407|NCT02014558|583458887|FG001|Overall Study|Miscellaneous|1|||
161565408|NCT02014558|583458888|FG002|Overall Study|Miscellaneous|1|||
161565409|NCT02014558|583458889|FG003|Overall Study|Miscellaneous|1|||
161565410|NCT02014558|583458890|FG004|Overall Study|Miscellaneous|0|||
161565411|NCT02014558|583458891|FG005|Overall Study|Miscellaneous|1|||
161565412|NCT02014558|583458892|FG006|Overall Study|Miscellaneous|0|||
161565413|NCT02014558|583458893|FG007|Overall Study|Miscellaneous|1|||
161565414|NCT02014558|583458894|FG008|Overall Study|Miscellaneous|1|||
161565415|NCT02014558|583458895|FG009|Overall Study|Miscellaneous|3|||
161565416|NCT02014558|583458896|FG010|Overall Study|Miscellaneous|12|||
161565417|NCT02014558|583458897|FG011|Overall Study|Miscellaneous|11|||
161565418|NCT02014558|583458898|FG012|Overall Study|Miscellaneous|1|||
161565419|NCT01560949|583458899|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
161565420|NCT01560949|583458899|FG000|Surgery Phase|Physician Decision|3|||
161565421|NCT05460663|583458900|FG000|Overall Study|Withdrawal by Subject|2|||
161565422|NCT05460663|583458901|FG001|Overall Study|Withdrawal by Subject|5|||
161911504|NCT06996301|584727226|FG001|Overall Study|Withdrawal by Subject|7|||
161911505|NCT04030598|584727227|FG000|Overall Study|Voluntary Withdrawal|0|||
161911506|NCT04030598|584727228|FG001|Overall Study|Voluntary Withdrawal|1|||
161911507|NCT04030598|584727229|FG002|Overall Study|Voluntary Withdrawal|0|||
161565423|NCT01091454|583460209|FG000|Overall Study|Ineligible|1|||
161565424|NCT01510912|583460210|FG000|Overall Study|Adverse Event|99|||
161565425|NCT01510912|583460210|FG000|Overall Study|Lack of Efficacy|12|||
161455042|NCT04449029|583061306|FG007|Overall Study|Lost to Follow-up|0|||
161455043|NCT04449029|583061299|FG000|Overall Study|Protocol Violation|0|||
161455044|NCT04449029|583061300|FG001|Overall Study|Protocol Violation|1|||
161455045|NCT04449029|583061301|FG002|Overall Study|Protocol Violation|0|||
161455046|NCT04449029|583061302|FG003|Overall Study|Protocol Violation|0|||
161455047|NCT04449029|583061303|FG004|Overall Study|Protocol Violation|0|||
161455048|NCT04449029|583061304|FG005|Overall Study|Protocol Violation|0|||
161455049|NCT04449029|583061305|FG006|Overall Study|Protocol Violation|0|||
161455050|NCT04449029|583061306|FG007|Overall Study|Protocol Violation|0|||
161455051|NCT04449029|583061299|FG000|Overall Study|Physician Decision|0|||
161455052|NCT04449029|583061300|FG001|Overall Study|Physician Decision|0|||
161455053|NCT04449029|583061301|FG002|Overall Study|Physician Decision|0|||
161455054|NCT04449029|583061302|FG003|Overall Study|Physician Decision|0|||
161455055|NCT04449029|583061303|FG004|Overall Study|Physician Decision|0|||
161455056|NCT04449029|583061304|FG005|Overall Study|Physician Decision|1|||
161455057|NCT04449029|583061305|FG006|Overall Study|Physician Decision|0|||
161455058|NCT04449029|583061306|FG007|Overall Study|Physician Decision|0|||
161807762|NCT02100228|584341225|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
161807763|NCT02100228|584341226|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
161807764|NCT02100228|584341225|FG000|Overall Study|Non-compliance|0|||
161807765|NCT02100228|584341226|FG001|Overall Study|Non-compliance|3|||
161807766|NCT02100228|584341225|FG000|Overall Study|Lost to Follow-up|0|||
161807767|NCT02100228|584341226|FG001|Overall Study|Lost to Follow-up|1|||
161807768|NCT02100228|584341225|FG000|Overall Study|Withdrawal by Subject|27|||
161807769|NCT02100228|584341226|FG001|Overall Study|Withdrawal by Subject|37|||
161807770|NCT02100228|584341225|FG000|Overall Study|Adverse Event|16|||
161807771|NCT02100228|584341226|FG001|Overall Study|Adverse Event|12|||
161807772|NCT02100228|584341225|FG000|Overall Study|Death|1|||
161911508|NCT01419535|584727230|FG000|Overall Study|could not maintain iv line|1|||
161455059|NCT04449029|583061299|FG000|Overall Study|Withdrawal by Subject|3|||
161807773|NCT02100228|584341226|FG001|Overall Study|Death|1|||
161911509|NCT01419535|584727231|FG001|Overall Study|could not maintain iv line|1|||
161911510|NCT01419535|584727230|FG000|Overall Study|Withdrawal by Subject|0|||
161911511|NCT01419535|584727231|FG001|Overall Study|Withdrawal by Subject|1|||
161911512|NCT03675308|584728604|FG000|Overall Study|Adverse Event|3|||
161911513|NCT03675308|584728605|FG001|Overall Study|Adverse Event|2|||
161911514|NCT03675308|584728604|FG000|Overall Study|Withdrawal by Subject|6|||
161911515|NCT03675308|584728605|FG001|Overall Study|Withdrawal by Subject|4|||
161911516|NCT03675308|584728604|FG000|Overall Study|Lost to Follow-up|3|||
161911517|NCT03675308|584728605|FG001|Overall Study|Lost to Follow-up|0|||
161911518|NCT03675308|584728604|FG000|Overall Study|Lack of Efficacy|1|||
161911519|NCT03675308|584728605|FG001|Overall Study|Lack of Efficacy|1|||
161911520|NCT03675308|584728604|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
161911521|NCT03675308|584728605|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
161911522|NCT03675308|584728604|FG000|Overall Study|Other|0|||
161911523|NCT03675308|584728605|FG001|Overall Study|Other|1|||
161911524|NCT05722522|584728606|FG000|Overall Study|Adverse Event|0|||
161911525|NCT05722522|584728607|FG001|Overall Study|Adverse Event|1|||
161911526|NCT06125964|584728610|FG000|Overall Study|Lost to Follow-up|0|||
161911527|NCT06125964|584728611|FG001|Overall Study|Lost to Follow-up|1|||
161911528|NCT06125964|584728612|FG002|Overall Study|Lost to Follow-up|0|||
161911529|NCT06125964|584728613|FG003|Overall Study|Lost to Follow-up|0|||
161911530|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
161911531|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
161911532|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
161911533|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Death|1|||
161911534|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Death|1|||
161911535|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Death|0|||
161911536|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
161911537|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
161911538|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
161911539|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
161911540|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
161911541|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
161911542|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
161911543|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
161911544|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
161911545|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
161911546|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
161565426|NCT01510912|583460210|FG000|Overall Study|Non-compliance with trial drug|23|||
161565427|NCT01510912|583460210|FG000|Overall Study|Withdrawal by Subject|49|||
161565428|NCT01510912|583460210|FG000|Overall Study|Physician Decision|1|||
161565429|NCT01510912|583460210|FG000|Overall Study|Protocol Violation|27|||
161565430|NCT01510912|583460210|FG000|Overall Study|Lost to Follow-up|26|||
161565431|NCT01510912|583460210|FG000|Overall Study|Other, including joint replacement|5|||
161565432|NCT03179787|583460211|FG000|Overall Study|Lost to Follow-up|15|||
161565433|NCT03179787|583460211|FG000|Overall Study|Case report failures|2|||
161565434|NCT03179787|583460211|FG000|Overall Study|Treatment not administered|1|||
161565435|NCT03181958|583460212|FG000|Overall Study|Lost to Follow-up|17|||
161565436|NCT03181958|583460213|FG001|Overall Study|Lost to Follow-up|21|||
161565437|NCT03181958|583460214|FG002|Overall Study|Lost to Follow-up|15|||
161565438|NCT02030028|583460215|FG000|Overall Study|Withdrawal by Subject|4|||
161565439|NCT02030028|583460215|FG000|Overall Study|lack of transportation|1|||
161911547|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
161565440|NCT00661778|583460216|FG000|Overall Study|Disease Progression|23|||
161565441|NCT00661778|583460216|FG000|Overall Study|Adverse Event|18|||
161565442|NCT00661778|583460216|FG000|Overall Study|Reason not Specified|6|||
161565443|NCT00661778|583460216|FG000|Overall Study|Protocol Violation|2|||
161565444|NCT00661778|583460216|FG000|Overall Study|Withdrawal of Consent|1|||
161565445|NCT02236559|583460223|FG000|Overall Study|Met Exclusion|3|||
161565446|NCT02236559|583460224|FG001|Overall Study|Met Exclusion|6|||
161565447|NCT02236559|583460223|FG000|Overall Study|Did not Meet Inclusion|3|||
161565448|NCT02236559|583460224|FG001|Overall Study|Did not Meet Inclusion|3|||
161565449|NCT02236559|583460223|FG000|Overall Study|Subject Did Not Consent|4|||
161565450|NCT02236559|583460224|FG001|Overall Study|Subject Did Not Consent|2|||
161565451|NCT02236559|583460223|FG000|Overall Study|Physician Decision|1|||
161565452|NCT02236559|583460224|FG001|Overall Study|Physician Decision|1|||
161565453|NCT02236559|583460223|FG000|Overall Study|Withdrawal by Subject|1|||
161565454|NCT02236559|583460224|FG001|Overall Study|Withdrawal by Subject|0|||
161565455|NCT02263508|583460225|FG000|Overall Study|Withdrawal by Subject|1|||
161565456|NCT02263508|583460226|FG001|Overall Study|Withdrawal by Subject|23|||
161565457|NCT02263508|583460227|FG002|Overall Study|Withdrawal by Subject|17|||
161565458|NCT02263508|583460225|FG000|Overall Study|Sponsor Decision|12|||
161565459|NCT02263508|583460226|FG001|Overall Study|Sponsor Decision|165|||
161565460|NCT02263508|583460227|FG002|Overall Study|Sponsor Decision|182|||
161565461|NCT02263508|583460225|FG000|Overall Study|Lost to Follow-up|2|||
161565462|NCT02263508|583460226|FG001|Overall Study|Lost to Follow-up|7|||
161565463|NCT02263508|583460227|FG002|Overall Study|Lost to Follow-up|7|||
161565464|NCT02263508|583460225|FG000|Overall Study|Death|6|||
161565465|NCT02263508|583460226|FG001|Overall Study|Death|151|||
161565466|NCT02263508|583460227|FG002|Overall Study|Death|140|||
161565467|NCT04148937|583460228|FG000|Overall Study|Withdrawal by Subject|0|||
161565468|NCT04148937|583460229|FG001|Overall Study|Withdrawal by Subject|0|||
161565469|NCT04148937|583460230|FG002|Overall Study|Withdrawal by Subject|0|||
161565470|NCT04148937|583460231|FG003|Overall Study|Withdrawal by Subject|1|||
161565471|NCT04148937|583460232|FG004|Overall Study|Withdrawal by Subject|0|||
161565472|NCT04148937|583460233|FG005|Overall Study|Withdrawal by Subject|1|||
161565473|NCT04148937|583460234|FG006|Overall Study|Withdrawal by Subject|1|||
161565474|NCT04148937|583460235|FG007|Overall Study|Withdrawal by Subject|0|||
161565475|NCT04148937|583460228|FG000|Overall Study|Lost to Follow-up|0|||
161565476|NCT04148937|583460229|FG001|Overall Study|Lost to Follow-up|0|||
161565477|NCT04148937|583460230|FG002|Overall Study|Lost to Follow-up|1|||
161565478|NCT04148937|583460231|FG003|Overall Study|Lost to Follow-up|0|||
161565479|NCT04148937|583460232|FG004|Overall Study|Lost to Follow-up|0|||
161565480|NCT04148937|583460233|FG005|Overall Study|Lost to Follow-up|2|||
161565481|NCT04148937|583460234|FG006|Overall Study|Lost to Follow-up|0|||
161565482|NCT04148937|583460235|FG007|Overall Study|Lost to Follow-up|0|||
161565483|NCT01149681|583460236|FG000|Overall Study|Withdrawal by Subject|7|||
161911548|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
161911549|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
161565484|NCT01149681|583460236|FG000|Overall Study|Progressive disease|1|||
161565485|NCT01149681|583460236|FG000|Overall Study|Physician Decision|2|||
161565486|NCT01149681|583460236|FG000|Overall Study|adverse events nonrelated study drug|2|||
161565487|NCT00686517|583460237|FG000|Treatment|Serious Adverse Event|1|||
161565488|NCT00686517|583460238|FG001|Treatment|Serious Adverse Event|2|||
161565489|NCT00686517|583460239|FG002|Treatment|Serious Adverse Event|1|||
161565490|NCT00686517|583460237|FG000|Treatment|Adverse Event|2|||
161565491|NCT00686517|583460238|FG001|Treatment|Adverse Event|0|||
161565492|NCT00686517|583460239|FG002|Treatment|Adverse Event|0|||
161565493|NCT00686517|583460237|FG000|Treatment|Poor Protocol Compliance|1|||
161565494|NCT00686517|583460238|FG001|Treatment|Poor Protocol Compliance|0|||
161565495|NCT00686517|583460239|FG002|Treatment|Poor Protocol Compliance|0|||
161565496|NCT00686517|583460237|FG000|Treatment|Protocol Violation|2|||
161565497|NCT00686517|583460238|FG001|Treatment|Protocol Violation|1|||
161565498|NCT00686517|583460239|FG002|Treatment|Protocol Violation|0|||
161565499|NCT01803646|583460240|FG000|Overall Study|Protocol Violation|1|||
161565500|NCT01803646|583460241|FG001|Overall Study|Protocol Violation|0|||
161565501|NCT01803646|583460240|FG000|Overall Study|Adverse Event|1|||
161565502|NCT01803646|583460241|FG001|Overall Study|Adverse Event|1|||
161565503|NCT01803646|583460240|FG000|Overall Study|Withdrawal by Subject|9|||
161565504|NCT01803646|583460241|FG001|Overall Study|Withdrawal by Subject|6|||
161565505|NCT01803646|583460240|FG000|Overall Study|Randomization error|1|||
161565506|NCT01803646|583460241|FG001|Overall Study|Randomization error|2|||
161565507|NCT01803646|583460240|FG000|Overall Study|Lost to Follow-up|5|||
161565508|NCT01803646|583460241|FG001|Overall Study|Lost to Follow-up|1|||
161565509|NCT01167426|583460242|FG000|Overall Study|Lost to Follow-up|6|||
161565510|NCT01167426|583460242|FG000|Overall Study|Protocol Violation|1|||
161565511|NCT01167426|583460242|FG000|Overall Study|Withdrawal by Subject|2|||
161565512|NCT01167426|583460242|FG000|Overall Study|Sponsor Decision|1|||
161565513|NCT02993471|583460243|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
161565514|NCT02993471|583460243|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
161565515|NCT01908634|583460245|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
161565516|NCT01908634|583460245|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
161565517|NCT01876511|583460246|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
161565518|NCT01876511|583460247|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
161565519|NCT01876511|583460248|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
161565520|NCT01876511|583460246|FG000|Overall Study|Death (unrelated)|3|||
161565521|NCT01876511|583460247|FG001|Overall Study|Death (unrelated)|0|||
161565522|NCT01876511|583460248|FG002|Overall Study|Death (unrelated)|2|||
161565523|NCT01876511|583460246|FG000|Overall Study|Drug-related Toxicity|5|||
161565524|NCT01876511|583460247|FG001|Overall Study|Drug-related Toxicity|1|||
161565525|NCT01876511|583460248|FG002|Overall Study|Drug-related Toxicity|6|||
161911550|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
161455060|NCT04449029|583061300|FG001|Overall Study|Withdrawal by Subject|0|||
161455061|NCT04449029|583061301|FG002|Overall Study|Withdrawal by Subject|1|||
161455062|NCT04449029|583061302|FG003|Overall Study|Withdrawal by Subject|1|||
161455063|NCT04449029|583061303|FG004|Overall Study|Withdrawal by Subject|5|||
161455064|NCT04449029|583061304|FG005|Overall Study|Withdrawal by Subject|1|||
161455065|NCT04449029|583061305|FG006|Overall Study|Withdrawal by Subject|4|||
161455066|NCT04449029|583061306|FG007|Overall Study|Withdrawal by Subject|0|||
161455067|NCT01073462|583061307|FG000|Overall Study|Death|14|||
161455068|NCT01073462|583061307|FG000|Overall Study|Kidney transplant|10|||
161455069|NCT01073462|583061307|FG000|Overall Study|Low parathyroid hormone levels|8|||
161455070|NCT01073462|583061307|FG000|Overall Study|Serious adverse event|2|||
161455071|NCT01073462|583061307|FG000|Overall Study|Lost to Follow-up|7|||
161455072|NCT01238588|583061313|FG000|Overall Study|Withdrawal by Subject|1|||
161455073|NCT01238588|583061313|FG000|Overall Study|Physician Decision|2|||
161455074|NCT00247611|583061314|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
161455075|NCT00247611|583061315|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
161455076|NCT00247611|583061314|FG000|Baselined|Completed baseline only|9|||
161455077|NCT00247611|583061315|FG001|Baselined|Completed baseline only|8|||
161455078|NCT05395091|583061316|FG000|Baseline to Month 12|Adverse Event|7|||
161455079|NCT05395091|583061317|FG001|Baseline to Month 12|Adverse Event|2|||
161455080|NCT05395091|583061318|FG002|Baseline to Month 12|Adverse Event|0|||
161455081|NCT05395091|583061316|FG000|Baseline to Month 12|Death|3|||
161455082|NCT05395091|583061317|FG001|Baseline to Month 12|Death|1|||
161455083|NCT05395091|583061318|FG002|Baseline to Month 12|Death|0|||
161455084|NCT05395091|583061316|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
161455085|NCT05395091|583061317|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
161455086|NCT05395091|583061318|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
161455087|NCT05395091|583061316|FG000|Baseline to Month 12|Protocol Violation|2|||
161455088|NCT05395091|583061317|FG001|Baseline to Month 12|Protocol Violation|3|||
161455089|NCT05395091|583061318|FG002|Baseline to Month 12|Protocol Violation|0|||
161455090|NCT05395091|583061316|FG000|Baseline to Month 12|Physician Decision|1|||
161455091|NCT05395091|583061317|FG001|Baseline to Month 12|Physician Decision|0|||
161455092|NCT05395091|583061318|FG002|Baseline to Month 12|Physician Decision|0|||
161455093|NCT05395091|583061316|FG000|Month 12 to Month 18|Death|1|||
161455094|NCT05395091|583061317|FG001|Month 12 to Month 18|Death|0|||
161455095|NCT05395091|583061318|FG002|Month 12 to Month 18|Death|0|||
161565526|NCT01876511|583460246|FG000|Overall Study|Patient Decision|3|||
161565527|NCT01876511|583460247|FG001|Overall Study|Patient Decision|0|||
161565528|NCT01876511|583460248|FG002|Overall Study|Patient Decision|6|||
161565529|NCT01876511|583460246|FG000|Overall Study|Physician Decision|1|||
161455096|NCT05395091|583061316|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
161455097|NCT05395091|583061317|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
161455098|NCT05395091|583061318|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
161565530|NCT01876511|583460247|FG001|Overall Study|Physician Decision|0|||
161565531|NCT01876511|583460248|FG002|Overall Study|Physician Decision|1|||
161911551|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
161911552|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
161911553|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
161911554|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
161455099|NCT05395091|583061316|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
161455100|NCT05395091|583061317|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
161455101|NCT05395091|583061318|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
161455102|NCT05395091|583061316|FG000|Month 12 to Month 18|Other reasons|0|||
161455103|NCT05395091|583061317|FG001|Month 12 to Month 18|Other reasons|0|||
161455104|NCT05395091|583061318|FG002|Month 12 to Month 18|Other reasons|1|||
161455105|NCT01509053|583061320|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
161455106|NCT01509053|583061320|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
161455107|NCT01509053|583061320|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
161455108|NCT01509053|583061320|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
161455109|NCT01509053|583061320|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
161455110|NCT01509053|583061320|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
161455111|NCT01915303|583061326|FG000|Core Phase|Adverse Event|7|||
161455112|NCT01915303|583061326|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
161455113|NCT01915303|583061326|FG000|Core Phase|Death|2|||
161455114|NCT01915303|583061326|FG000|Core Phase|Protocol Violation|2|||
161455115|NCT01915303|583061326|FG000|Core Phase|Abnormal lab value|1|||
161455116|NCT01915303|583061326|FG000|Core Phase|Withdrawal by Subject|1|||
161455117|NCT01915303|583061326|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
161455118|NCT01915303|583061326|FG000|Extension Phase|Withdrawal by Subject|4|||
161455119|NCT01915303|583061326|FG000|Extension Phase|Adverse Event|3|||
161455120|NCT01915303|583061326|FG000|Extension Phase|Death|1|||
161455121|NCT01915303|583061326|FG000|Extension Phase|Protocol Violation|1|||
161455122|NCT02509117|583061328|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455123|NCT02509117|583061329|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
161455124|NCT02509117|583061330|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455125|NCT02509117|583061331|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455126|NCT02509117|583061332|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455127|NCT02509117|583061333|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455128|NCT02509117|583061334|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455129|NCT02509117|583061335|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455130|NCT02509117|583061336|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455131|NCT02509117|583061337|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161455132|NCT02509117|583061328|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455133|NCT02509117|583061329|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455134|NCT02509117|583061330|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455135|NCT02509117|583061331|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455136|NCT02509117|583061332|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455137|NCT02509117|583061333|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455138|NCT02509117|583061334|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455139|NCT02509117|583061335|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161807774|NCT00214422|584341227|FG000|Overall Study|Physician Decision|2|||
161807775|NCT00214422|584341228|FG001|Overall Study|Physician Decision|0|||
161807776|NCT00214422|584341229|FG002|Overall Study|Physician Decision|0|||
161807777|NCT00214422|584341227|FG000|Overall Study|Developed esophageal ca|1|||
161807778|NCT00214422|584341228|FG001|Overall Study|Developed esophageal ca|0|||
161807779|NCT00214422|584341229|FG002|Overall Study|Developed esophageal ca|0|||
161807780|NCT00214422|584341227|FG000|Overall Study|Pt taken off study|1|||
161807781|NCT00214422|584341228|FG001|Overall Study|Pt taken off study|1|||
161807782|NCT00214422|584341229|FG002|Overall Study|Pt taken off study|0|||
161807783|NCT00214422|584341227|FG000|Overall Study|Disease progression on study|1|||
161807784|NCT00214422|584341228|FG001|Overall Study|Disease progression on study|0|||
161807785|NCT00214422|584341229|FG002|Overall Study|Disease progression on study|0|||
161807786|NCT00214422|584341227|FG000|Overall Study|Unable to make a radiation treatment|0|||
161807787|NCT00214422|584341228|FG001|Overall Study|Unable to make a radiation treatment|0|||
161807788|NCT00214422|584341229|FG002|Overall Study|Unable to make a radiation treatment|1|||
161807789|NCT02612337|584341230|FG000|Overall Study|Lack of Efficacy|1|||
161807790|NCT02612337|584341231|FG001|Overall Study|Lack of Efficacy|0|||
161807791|NCT02612337|584341230|FG000|Overall Study|Withdrawal by Subject|2|||
161807792|NCT02612337|584341231|FG001|Overall Study|Withdrawal by Subject|2|||
161807793|NCT02612337|584341230|FG000|Overall Study|Did not receive study drug|0|||
161807794|NCT02612337|584341231|FG001|Overall Study|Did not receive study drug|1|||
161807795|NCT00854100|584341238|FG000|Overall Study|Inability to complete the study visits|0|||
161807796|NCT00854100|584341239|FG001|Overall Study|Inability to complete the study visits|0|||
161455140|NCT02509117|583061336|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161455141|NCT02509117|583061337|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
161455142|NCT02509117|583061328|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455143|NCT02509117|583061329|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455144|NCT02509117|583061330|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455145|NCT02509117|583061331|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455146|NCT02509117|583061332|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455147|NCT02509117|583061333|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455148|NCT02509117|583061334|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455149|NCT02509117|583061335|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455150|NCT02509117|583061336|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161455151|NCT02509117|583061337|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
161455152|NCT00832624|583061338|FG000|Overall Study|Study Terminated|10|||
161455153|NCT00548184|583061341|FG000|Overall Study|Adverse Event|3|||
161455154|NCT00548184|583061341|FG000|Overall Study|took other drug|1|||
161455155|NCT00548184|583061341|FG000|Overall Study|Found Her2 negative|1|||
161455156|NCT00280748|583061348|FG000|Overall Study|Decline in performance|3|||
161455157|NCT00280748|583061348|FG000|Overall Study|Extra-cranial disease progression|1|||
161455158|NCT01433250|583061349|FG000|Overall Study|Protocol Violation|0|||
161455159|NCT01433250|583061350|FG001|Overall Study|Protocol Violation|1|||
161455160|NCT01433250|583061349|FG000|Overall Study|Withdrawal by Subject|3|||
161455161|NCT01433250|583061350|FG001|Overall Study|Withdrawal by Subject|2|||
161455162|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
161455163|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
161455164|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
161455165|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
161455166|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
161455167|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
161455168|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
161455169|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
161455170|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
161455171|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
161455172|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
161455173|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
161455174|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
161455175|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
161455176|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
161455177|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
161455178|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
161455179|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
161455180|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
161455181|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
161455182|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
161455183|NCT01227824|583061355|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
161455184|NCT01227824|583061356|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
161455185|NCT01227824|583061357|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
161455186|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
161455187|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
161455188|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
161455189|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
161455190|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
161455191|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
161455192|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
161455193|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
161455194|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
161455195|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
161455196|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
161455197|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
161455198|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
161455199|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
161455200|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
161565532|NCT05790408|583460249|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
161565533|NCT04044664|583460263|FG000|Stage 1|Adverse Event|3|||
161911555|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
161911556|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
161911557|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
161911558|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
161911559|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
161911560|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Other|10|||
161911561|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Other|4|||
161911562|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Other|0|||
161911563|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
161455201|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
161455202|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
161455203|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
161455204|NCT01227824|583061355|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
161455205|NCT01227824|583061356|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
161455206|NCT01227824|583061357|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
161455207|NCT02576145|583061358|FG000|Overall Study|Adverse Event|1|||
161455208|NCT02576145|583061359|FG001|Overall Study|Adverse Event|0|||
161455209|NCT02576145|583061358|FG000|Overall Study|Withdrawal by Subject|1|||
161455210|NCT02576145|583061359|FG001|Overall Study|Withdrawal by Subject|0|||
161455211|NCT02576145|583061358|FG000|Overall Study|Acute rejection|1|||
161455212|NCT02576145|583061359|FG001|Overall Study|Acute rejection|0|||
161455213|NCT02576145|583061358|FG000|Overall Study|Tetanus Titers Decreased|0|||
161455214|NCT02576145|583061359|FG001|Overall Study|Tetanus Titers Decreased|1|||
161455215|NCT00336583|583062634|FG000|Overall Study|Lost to Follow-up|1|||
161455216|NCT00336583|583062634|FG000|Overall Study|Death|1|||
161455217|NCT02276027|583062637|FG000|Overall Study|Death|1|||
161455218|NCT02276027|583062638|FG001|Overall Study|Death|0|||
161455219|NCT02276027|583062639|FG002|Overall Study|Death|0|||
161455220|NCT02276027|583062640|FG003|Overall Study|Death|2|||
161455221|NCT02276027|583062637|FG000|Overall Study|Physician Decision|0|||
161455222|NCT02276027|583062638|FG001|Overall Study|Physician Decision|0|||
161455223|NCT02276027|583062639|FG002|Overall Study|Physician Decision|0|||
161455224|NCT02276027|583062640|FG003|Overall Study|Physician Decision|1|||
161455225|NCT02276027|583062637|FG000|Overall Study|Progressive disease|1|||
161455226|NCT02276027|583062638|FG001|Overall Study|Progressive disease|13|||
161455227|NCT02276027|583062639|FG002|Overall Study|Progressive disease|12|||
161455228|NCT02276027|583062640|FG003|Overall Study|Progressive disease|14|||
161455229|NCT02276027|583062637|FG000|Overall Study|Subject/guardian decision|0|||
161455230|NCT02276027|583062638|FG001|Overall Study|Subject/guardian decision|1|||
161455231|NCT02276027|583062639|FG002|Overall Study|Subject/guardian decision|0|||
161455232|NCT02276027|583062640|FG003|Overall Study|Subject/guardian decision|3|||
161455233|NCT02276027|583062637|FG000|Overall Study|Adverse Event|0|||
161455234|NCT02276027|583062638|FG001|Overall Study|Adverse Event|2|||
161455235|NCT02276027|583062639|FG002|Overall Study|Adverse Event|8|||
161455236|NCT02276027|583062640|FG003|Overall Study|Adverse Event|2|||
161455237|NCT03224598|583062641|FG000|Overall Study|Lost to Follow-up|0|||
161455238|NCT03224598|583062642|FG001|Overall Study|Lost to Follow-up|2|||
161455239|NCT03224598|583062643|FG002|Overall Study|Lost to Follow-up|0|||
161455240|NCT03224598|583062641|FG000|Overall Study|Other|0|||
161455241|NCT03224598|583062642|FG001|Overall Study|Other|1|||
161455242|NCT03224598|583062643|FG002|Overall Study|Other|0|||
161455243|NCT03328182|583062646|FG000|Overall Study|Withdrawal by Subject|1|||
161455244|NCT03328182|583062646|FG000|Overall Study|Protocol Violation|2|||
161455245|NCT03328182|583062646|FG000|Overall Study|No Product Evaluated|1|||
161455246|NCT00003830|583062647|FG000|Overall Study|No follow up data|3|||
161455247|NCT00003830|583062648|FG001|Overall Study|No follow up data|0|||
161455248|NCT00003830|583062647|FG000|Overall Study|Sentinel node positive patients|829|||
161455249|NCT00003830|583062648|FG001|Overall Study|Sentinel node positive patients|793|||
161455250|NCT01095094|583062649|FG000|Overall Study|Withdrawal by Subject|1|||
161455251|NCT01095094|583062649|FG000|Overall Study|Death|1|||
161455252|NCT01095094|583062649|FG000|Overall Study|Physician Decision|1|||
161455253|NCT05347147|583062650|FG000|Overall Study|Lost to Follow-up|0|||
161455254|NCT05347147|583062651|FG001|Overall Study|Lost to Follow-up|1|||
161455255|NCT05347147|583062650|FG000|Overall Study|Sponsor request|3|||
161455256|NCT05347147|583062651|FG001|Overall Study|Sponsor request|3|||
161455257|NCT05347147|583062650|FG000|Overall Study|Study termination|2|||
161455258|NCT05347147|583062651|FG001|Overall Study|Study termination|1|||
161455259|NCT00137839|583062653|FG000|Overall Study|Adverse Event|7|||
161455260|NCT00137839|583062653|FG000|Overall Study|Physician Decision|7|||
161455261|NCT00137839|583062653|FG000|Overall Study|Death|8|||
161455262|NCT00137839|583062653|FG000|Overall Study|Disease Progression|60|||
161455263|NCT00137839|583062653|FG000|Overall Study|Not Start Treatment|1|||
161455264|NCT00137839|583062653|FG000|Overall Study|Prolonged Treatment Delay|1|||
161455265|NCT03739242|583062654|FG000|Overall Study|Withdrawal by Subject|1|||
161455266|NCT03739242|583062655|FG001|Overall Study|Withdrawal by Subject|1|||
161455267|NCT03739242|583062654|FG000|Overall Study|Protocol Violation|0|||
161455268|NCT03739242|583062655|FG001|Overall Study|Protocol Violation|1|||
161455269|NCT01122394|583062656|FG000|Overall Study|Withdrawal by Subject|1|||
161455270|NCT01122394|583062657|FG001|Overall Study|Withdrawal by Subject|1|||
161455271|NCT01122394|583062656|FG000|Overall Study|Lost to Follow-up|2|||
161455272|NCT01122394|583062657|FG001|Overall Study|Lost to Follow-up|2|||
161455273|NCT01122394|583062656|FG000|Overall Study|Adverse Event|0|||
161565534|NCT04044664|583460264|FG001|Stage 1|Adverse Event|3|||
161565535|NCT04044664|583460265|FG002|Stage 1|Adverse Event|1|||
161565536|NCT04044664|583460263|FG000|Stage 1|Lost to Follow-up|3|||
161565537|NCT04044664|583460264|FG001|Stage 1|Lost to Follow-up|2|||
161565538|NCT04044664|583460265|FG002|Stage 1|Lost to Follow-up|2|||
161565539|NCT04044664|583460263|FG000|Stage 1|Withdrawal by Subject|9|||
161565540|NCT04044664|583460264|FG001|Stage 1|Withdrawal by Subject|1|||
161565541|NCT04044664|583460265|FG002|Stage 1|Withdrawal by Subject|0|||
161565542|NCT04044664|583460263|FG000|Stage 1|noncompliance, personal reason|2|||
161565543|NCT04044664|583460264|FG001|Stage 1|noncompliance, personal reason|0|||
161565544|NCT04044664|583460265|FG002|Stage 1|noncompliance, personal reason|0|||
161565545|NCT04044664|583460263|FG000|Stage 1|randomization error|0|||
161565546|NCT04044664|583460264|FG001|Stage 1|randomization error|1|||
161565547|NCT04044664|583460265|FG002|Stage 1|randomization error|0|||
161565548|NCT04044664|583460263|FG000|Stage 2|Adverse Event|2|||
161565549|NCT04044664|583460264|FG001|Stage 2|Adverse Event|0|||
161565550|NCT04044664|583460265|FG002|Stage 2|Adverse Event|0|||
161565551|NCT04044664|583460263|FG000|Stage 2|Lost to Follow-up|3|||
161565552|NCT04044664|583460264|FG001|Stage 2|Lost to Follow-up|2|||
161565553|NCT04044664|583460265|FG002|Stage 2|Lost to Follow-up|1|||
161565554|NCT04044664|583460263|FG000|Stage 2|Withdrawal by Subject|3|||
161565555|NCT04044664|583460264|FG001|Stage 2|Withdrawal by Subject|0|||
161565556|NCT04044664|583460265|FG002|Stage 2|Withdrawal by Subject|0|||
161911564|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
161455274|NCT01122394|583062657|FG001|Overall Study|Adverse Event|1|||
161455275|NCT03086967|583062658|FG000|Overall Study|Screen Failure|2|||
161455276|NCT03086967|583062659|FG001|Overall Study|Screen Failure|2|||
161455277|NCT03361176|583062660|FG000|Overall Study|Lost to Follow-up|1|||
161455278|NCT03361176|583062661|FG001|Overall Study|Lost to Follow-up|2|||
161455279|NCT03361176|583062660|FG000|Overall Study|Adverse Event|0|||
161455280|NCT03361176|583062661|FG001|Overall Study|Adverse Event|2|||
161455281|NCT03361176|583062660|FG000|Overall Study|Withdrawal by Subject|0|||
161455282|NCT03361176|583062661|FG001|Overall Study|Withdrawal by Subject|1|||
161455283|NCT02230527|583062665|FG000|Overall Study|Withdrawal by Subject|1|||
161455284|NCT02230527|583062666|FG001|Overall Study|Withdrawal by Subject|1|||
161455285|NCT02230527|583062665|FG000|Overall Study|Death|1|||
161455286|NCT02230527|583062666|FG001|Overall Study|Death|0|||
161455287|NCT02230527|583062665|FG000|Overall Study|Lost to Follow-up|2|||
161455288|NCT02230527|583062666|FG001|Overall Study|Lost to Follow-up|1|||
161455289|NCT02230527|583062665|FG000|Overall Study|Other|1|||
161455290|NCT02230527|583062666|FG001|Overall Study|Other|0|||
161455291|NCT01752036|583062667|FG000|Overall Study|Death|2|||
161455292|NCT01011478|583062668|FG000|Overall Study|No follow up data|12|||
161455293|NCT01011478|583062669|FG001|Overall Study|No follow up data|7|||
161455294|NCT01437995|583062673|FG000|Overall Study|Lost to Follow-up|11|||
161455295|NCT01437995|583062674|FG001|Overall Study|Lost to Follow-up|18|||
161455296|NCT01437995|583062675|FG002|Overall Study|Lost to Follow-up|20|||
161455297|NCT04456673|583062676|FG000|Overall Study|Adverse Event|7|||
161455298|NCT04456673|583062677|FG001|Overall Study|Adverse Event|14|||
161455299|NCT04456673|583062676|FG000|Overall Study|Poor compliance to protocol|1|||
161455300|NCT04456673|583062677|FG001|Overall Study|Poor compliance to protocol|0|||
161455301|NCT04456673|583062676|FG000|Overall Study|Withdrawal by Subject|31|||
161455302|NCT04456673|583062677|FG001|Overall Study|Withdrawal by Subject|23|||
161455303|NCT04456673|583062676|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
161455304|NCT04456673|583062677|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
161455305|NCT02160002|583062678|FG000|Overall Study|Withdrawal by Subject|2|||
161455306|NCT02160002|583062679|FG001|Overall Study|Withdrawal by Subject|1|||
161455307|NCT04395001|583062681|FG000|Overall Study|Lost to Follow-up|8|||
161455308|NCT04395001|583062682|FG001|Overall Study|Lost to Follow-up|9|||
161455309|NCT04395001|583062683|FG002|Overall Study|Lost to Follow-up|5|||
161455310|NCT04395001|583062681|FG000|Overall Study|Withdrawal by Subject|3|||
161455311|NCT04395001|583062682|FG001|Overall Study|Withdrawal by Subject|1|||
161455312|NCT04395001|583062683|FG002|Overall Study|Withdrawal by Subject|3|||
161455313|NCT04395001|583062681|FG000|Overall Study|missed appointment|7|||
161455314|NCT04395001|583062682|FG001|Overall Study|missed appointment|4|||
161565557|NCT04044664|583460263|FG000|Stage 2|protocol deviation|1|||
161455315|NCT04395001|583062683|FG002|Overall Study|missed appointment|1|||
161455316|NCT04418661|583062684|FG000|Overall Study|Adverse Event|0|||
161565558|NCT04044664|583460264|FG001|Stage 2|protocol deviation|0|||
161565559|NCT04044664|583460265|FG002|Stage 2|protocol deviation|0|||
161565560|NCT00001575|583460269|FG000|Overall Study|Screening failures-Ph I portion|22|||
161565561|NCT00001575|583460269|FG000|Overall Study|Withdrawn/deaths|23|||
161565562|NCT00831792|583460272|FG000|Overall Study|Not Eligible|3|||
161565563|NCT00831792|583460272|FG000|Overall Study|Adverse Event|1|||
161565564|NCT00831792|583460272|FG000|Overall Study|Death|1|||
161565565|NCT00831792|583460272|FG000|Overall Study|Lack of Efficacy|1|||
161565566|NCT03736785|583460274|FG000|Overall Study|Adverse Event|1|||
161565567|NCT03736785|583460275|FG001|Overall Study|Adverse Event|1|||
161565568|NCT03736785|583460276|FG002|Overall Study|Adverse Event|1|||
161565569|NCT03736785|583460274|FG000|Overall Study|Death|1|||
161565570|NCT03736785|583460275|FG001|Overall Study|Death|0|||
161565571|NCT03736785|583460276|FG002|Overall Study|Death|1|||
161565572|NCT03736785|583460274|FG000|Overall Study|Lost to Follow-up|0|||
161565573|NCT03736785|583460275|FG001|Overall Study|Lost to Follow-up|2|||
161565574|NCT03736785|583460276|FG002|Overall Study|Lost to Follow-up|3|||
161565575|NCT03736785|583460274|FG000|Overall Study|Non compliance with study drug|1|||
161565576|NCT03736785|583460275|FG001|Overall Study|Non compliance with study drug|1|||
161565577|NCT03736785|583460276|FG002|Overall Study|Non compliance with study drug|0|||
161565578|NCT03736785|583460274|FG000|Overall Study|Physician Decision|0|||
161565579|NCT03736785|583460275|FG001|Overall Study|Physician Decision|1|||
161565580|NCT03736785|583460276|FG002|Overall Study|Physician Decision|1|||
161565581|NCT03736785|583460274|FG000|Overall Study|Protocol Violation|1|||
161565582|NCT03736785|583460275|FG001|Overall Study|Protocol Violation|4|||
161565583|NCT03736785|583460276|FG002|Overall Study|Protocol Violation|3|||
161565584|NCT03736785|583460274|FG000|Overall Study|Sponsor Decision|1|||
161565585|NCT03736785|583460275|FG001|Overall Study|Sponsor Decision|0|||
161565586|NCT03736785|583460276|FG002|Overall Study|Sponsor Decision|0|||
161565587|NCT03736785|583460274|FG000|Overall Study|Unknown/Missing data|3|||
161565588|NCT03736785|583460275|FG001|Overall Study|Unknown/Missing data|2|||
161565589|NCT03736785|583460276|FG002|Overall Study|Unknown/Missing data|1|||
161565590|NCT03736785|583460274|FG000|Overall Study|Withdrawal by Subject|9|||
161565591|NCT03736785|583460275|FG001|Overall Study|Withdrawal by Subject|6|||
161565592|NCT03736785|583460276|FG002|Overall Study|Withdrawal by Subject|4|||
161565593|NCT02974010|583460277|FG000|Overall Study|Lost to Follow-up|3|||
161565594|NCT02974010|583460278|FG001|Overall Study|Lost to Follow-up|1|||
161565595|NCT02974010|583460279|FG002|Overall Study|Lost to Follow-up|0|||
161565596|NCT02974010|583460280|FG003|Overall Study|Lost to Follow-up|0|||
161565597|NCT02974010|583460277|FG000|Overall Study|Withdrawal by Subject|2|||
161565598|NCT02974010|583460278|FG001|Overall Study|Withdrawal by Subject|1|||
161565599|NCT02974010|583460279|FG002|Overall Study|Withdrawal by Subject|0|||
161565600|NCT02974010|583460280|FG003|Overall Study|Withdrawal by Subject|0|||
161565601|NCT02974010|583460277|FG000|Overall Study|Adverse Event|0|||
161565602|NCT02974010|583460278|FG001|Overall Study|Adverse Event|1|||
161565603|NCT02974010|583460279|FG002|Overall Study|Adverse Event|0|||
161565604|NCT02974010|583460280|FG003|Overall Study|Adverse Event|0|||
161565605|NCT02974010|583460277|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
161565606|NCT02974010|583460278|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
161565607|NCT02974010|583460279|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
161565608|NCT02974010|583460280|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
161565609|NCT02974010|583460277|FG000|Overall Study|Lack of Efficacy|0|||
161565610|NCT02974010|583460278|FG001|Overall Study|Lack of Efficacy|0|||
161565611|NCT02974010|583460279|FG002|Overall Study|Lack of Efficacy|1|||
161565612|NCT02974010|583460280|FG003|Overall Study|Lack of Efficacy|0|||
161807797|NCT00854100|584341240|FG002|Overall Study|Inability to complete the study visits|1|||
161807798|NCT00854100|584341238|FG000|Overall Study|Lost to Follow-up|2|||
161807799|NCT00854100|584341239|FG001|Overall Study|Lost to Follow-up|0|||
161807800|NCT00854100|584341240|FG002|Overall Study|Lost to Follow-up|3|||
161807801|NCT00854100|584341238|FG000|Overall Study|Withdrawal by Subject|3|||
161807802|NCT00854100|584341239|FG001|Overall Study|Withdrawal by Subject|1|||
161807803|NCT00854100|584341240|FG002|Overall Study|Withdrawal by Subject|2|||
161807804|NCT00854100|584341238|FG000|Overall Study|Protocol Violation|2|||
161807805|NCT00854100|584341239|FG001|Overall Study|Protocol Violation|4|||
161807806|NCT00854100|584341240|FG002|Overall Study|Protocol Violation|3|||
161807807|NCT00854100|584341238|FG000|Overall Study|Adverse Event|2|||
161807808|NCT00854100|584341239|FG001|Overall Study|Adverse Event|1|||
161807809|NCT00854100|584341240|FG002|Overall Study|Adverse Event|2|||
161807810|NCT02242201|584341244|FG000|Overall Study|preoperative identified neuropathy|2|||
161807811|NCT02242201|584341245|FG001|Overall Study|preoperative identified neuropathy|0|||
161565613|NCT03256344|583460283|FG000|Overall Study|Death|6|||
161807812|NCT02242201|584341246|FG002|Overall Study|preoperative identified neuropathy|0|||
161807813|NCT02242201|584341244|FG000|Overall Study|planned post-op anticoagulation|1|||
161911565|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
161911566|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
161807814|NCT02242201|584341245|FG001|Overall Study|planned post-op anticoagulation|0|||
161807815|NCT02242201|584341246|FG002|Overall Study|planned post-op anticoagulation|0|||
161565614|NCT03256344|583460284|FG001|Overall Study|Death|22|||
161565615|NCT03256344|583460283|FG000|Overall Study|Withdrawal by Subject|3|||
161565616|NCT03256344|583460284|FG001|Overall Study|Withdrawal by Subject|3|||
161565617|NCT03256344|583460283|FG000|Overall Study|Sponsor Decision|1|||
161565618|NCT03256344|583460284|FG001|Overall Study|Sponsor Decision|0|||
161565619|NCT00880906|583460285|FG000|Overall Study|Lost to Follow-up|0|||
161807816|NCT02242201|584341244|FG000|Overall Study|changed surgical procedure|1|||
161807817|NCT02242201|584341245|FG001|Overall Study|changed surgical procedure|0|||
161807818|NCT02242201|584341246|FG002|Overall Study|changed surgical procedure|0|||
161807819|NCT02242201|584341244|FG000|Overall Study|postponed surgery|0|||
161807820|NCT02242201|584341245|FG001|Overall Study|postponed surgery|0|||
161807821|NCT02242201|584341246|FG002|Overall Study|postponed surgery|1|||
161807822|NCT02242201|584341244|FG000|Overall Study|preoperative opioid consumption|0|||
161807823|NCT02242201|584341245|FG001|Overall Study|preoperative opioid consumption|1|||
161807824|NCT02242201|584341246|FG002|Overall Study|preoperative opioid consumption|0|||
161807825|NCT00389064|584341247|FG000|Overall Study|Adverse Event|11|||
161807826|NCT00389064|584341248|FG001|Overall Study|Adverse Event|3|||
161807827|NCT00389064|584341247|FG000|Overall Study|Lack of Efficacy|3|||
161807828|NCT00389064|584341248|FG001|Overall Study|Lack of Efficacy|14|||
161807829|NCT00389064|584341247|FG000|Overall Study|Withdrawal by Subject|17|||
161807830|NCT00389064|584341248|FG001|Overall Study|Withdrawal by Subject|27|||
161807831|NCT00389064|584341247|FG000|Overall Study|Physician Decision|2|||
161807832|NCT00389064|584341248|FG001|Overall Study|Physician Decision|2|||
161807833|NCT00389064|584341247|FG000|Overall Study|Lost to Follow-up|1|||
161807834|NCT00389064|584341248|FG001|Overall Study|Lost to Follow-up|2|||
161807835|NCT00389064|584341247|FG000|Overall Study|Protocol Violation|2|||
161807836|NCT00389064|584341248|FG001|Overall Study|Protocol Violation|0|||
161807837|NCT00389064|584341247|FG000|Overall Study|Multiple Reasons|9|||
161807838|NCT00389064|584341248|FG001|Overall Study|Multiple Reasons|11|||
161807839|NCT01697696|584341251|FG000|Overall Study|Study terminated by sponsor|0|||
161807840|NCT01697696|584341252|FG001|Overall Study|Study terminated by sponsor|3|||
161807841|NCT01697696|584341251|FG000|Overall Study|Protocol deviation|1|||
161807842|NCT01697696|584341252|FG001|Overall Study|Protocol deviation|0|||
161807843|NCT01697696|584341251|FG000|Overall Study|Physician Decision|1|||
161807844|NCT01697696|584341252|FG001|Overall Study|Physician Decision|0|||
161807845|NCT01697696|584341251|FG000|Overall Study|Death|4|||
161807846|NCT01697696|584341252|FG001|Overall Study|Death|2|||
161807847|NCT01697696|584341251|FG000|Overall Study|Lost to Follow-up|10|||
161807848|NCT01697696|584341252|FG001|Overall Study|Lost to Follow-up|7|||
161807849|NCT01697696|584341251|FG000|Overall Study|Subject/guardian decision|31|||
161807850|NCT01697696|584341252|FG001|Overall Study|Subject/guardian decision|35|||
161807851|NCT03616106|584341253|FG000|Overall Study|Removed by PI|6|||
161807852|NCT03616106|584341254|FG001|Overall Study|Removed by PI|0|||
161807853|NCT03616106|584341253|FG000|Overall Study|Withdrawal by Subject|1|||
161807854|NCT03616106|584341254|FG001|Overall Study|Withdrawal by Subject|1|||
161807855|NCT03616106|584341253|FG000|Overall Study|Lost to Follow-up|7|||
161807856|NCT03616106|584341254|FG001|Overall Study|Lost to Follow-up|0|||
161807857|NCT01880593|584341255|FG000|Overall Study|Adverse Event|1|||
161807858|NCT01880593|584341256|FG001|Overall Study|Adverse Event|0|||
161807859|NCT01880593|584341255|FG000|Overall Study|Lack of Efficacy|1|||
161807860|NCT01880593|584341256|FG001|Overall Study|Lack of Efficacy|5|||
161807861|NCT01880593|584341255|FG000|Overall Study|Withdrawal by Subject|6|||
161807862|NCT01880593|584341256|FG001|Overall Study|Withdrawal by Subject|1|||
161807863|NCT05275205|584341261|FG000|Overall Study|Adverse Event|1|||
161807864|NCT05275205|584341262|FG001|Overall Study|Adverse Event|2|||
161807865|NCT05275205|584341261|FG000|Overall Study|Physician Decision|1|||
161807866|NCT05275205|584341262|FG001|Overall Study|Physician Decision|1|||
161807867|NCT05275205|584341261|FG000|Overall Study|Withdrawal by Subject|2|||
161807868|NCT05275205|584341262|FG001|Overall Study|Withdrawal by Subject|3|||
161807869|NCT05275205|584341261|FG000|Overall Study|Death|1|||
161807870|NCT05275205|584341262|FG001|Overall Study|Death|0|||
161807871|NCT05275205|584341261|FG000|Overall Study|Patient unable to attend visits|1|||
161807872|NCT05275205|584341262|FG001|Overall Study|Patient unable to attend visits|0|||
161807873|NCT03243630|584341264|FG000|Overall Study|Protocol Violation|1|||
161807874|NCT03243630|584341264|FG000|Overall Study|Physician Decision|1|||
161807875|NCT00939003|584341265|FG000|Double-blind Treatment Period|Adverse Event|1|||
161807876|NCT00939003|584341266|FG001|Double-blind Treatment Period|Adverse Event|1|||
161807877|NCT00939003|584341265|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161807878|NCT00939003|584341266|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161807879|NCT00939003|584341265|FG000|Double-blind Treatment Period|Pregnancy|0|||
161807880|NCT00939003|584341266|FG001|Double-blind Treatment Period|Pregnancy|1|||
161565620|NCT00880906|583460286|FG001|Overall Study|Lost to Follow-up|1|||
161807881|NCT00939003|584341265|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
161807882|NCT00939003|584341266|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
161807883|NCT00939003|584341265|FG000|Open-label Treatment Period|Adverse Event|4|||
161807884|NCT00939003|584341266|FG001|Open-label Treatment Period|Adverse Event|8|||
161807885|NCT00939003|584341265|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
161807886|NCT00939003|584341266|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
161807887|NCT00939003|584341265|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
161807888|NCT00939003|584341266|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
161807889|NCT00939003|584341265|FG000|Open-label Treatment Period|Pregnancy|1|||
161455317|NCT04418661|583062685|FG001|Overall Study|Adverse Event|1|||
161455318|NCT04418661|583062686|FG002|Overall Study|Adverse Event|5|||
161455319|NCT04418661|583062687|FG003|Overall Study|Adverse Event|3|||
161455320|NCT04418661|583062688|FG004|Overall Study|Adverse Event|0|||
161455321|NCT04418661|583062689|FG005|Overall Study|Adverse Event|2|||
161455322|NCT04418661|583062684|FG000|Overall Study|Progressive disease|4|||
161455323|NCT04418661|583062685|FG001|Overall Study|Progressive disease|11|||
161455324|NCT04418661|583062686|FG002|Overall Study|Progressive disease|6|||
161455325|NCT04418661|583062687|FG003|Overall Study|Progressive disease|11|||
161455326|NCT04418661|583062688|FG004|Overall Study|Progressive disease|1|||
161455327|NCT04418661|583062689|FG005|Overall Study|Progressive disease|12|||
161455328|NCT04418661|583062684|FG000|Overall Study|Withdrawal by Subject|0|||
161455329|NCT04418661|583062685|FG001|Overall Study|Withdrawal by Subject|1|||
161455330|NCT04418661|583062686|FG002|Overall Study|Withdrawal by Subject|0|||
161455331|NCT04418661|583062687|FG003|Overall Study|Withdrawal by Subject|1|||
161455332|NCT04418661|583062688|FG004|Overall Study|Withdrawal by Subject|0|||
161455333|NCT04418661|583062689|FG005|Overall Study|Withdrawal by Subject|0|||
161455334|NCT04418661|583062684|FG000|Overall Study|Other|0|||
161455335|NCT04418661|583062685|FG001|Overall Study|Other|0|||
161455336|NCT04418661|583062686|FG002|Overall Study|Other|1|||
161455337|NCT04418661|583062687|FG003|Overall Study|Other|3|||
161455338|NCT04418661|583062688|FG004|Overall Study|Other|0|||
161455339|NCT04418661|583062689|FG005|Overall Study|Other|1|||
161455340|NCT03337490|583062690|FG000|Overall Study|Withdrawal by Subject|1|||
161455341|NCT03337490|583062691|FG001|Overall Study|Withdrawal by Subject|0|||
161455342|NCT03337490|583062692|FG002|Overall Study|Withdrawal by Subject|0|||
161455343|NCT03337490|583062690|FG000|Overall Study|Lack of Efficacy|10|||
161455344|NCT03337490|583062691|FG001|Overall Study|Lack of Efficacy|12|||
161455345|NCT03337490|583062692|FG002|Overall Study|Lack of Efficacy|35|||
161455346|NCT03337490|583062690|FG000|Overall Study|Physician Decision|0|||
161455347|NCT03337490|583062691|FG001|Overall Study|Physician Decision|1|||
161455348|NCT03337490|583062692|FG002|Overall Study|Physician Decision|0|||
161455349|NCT03337490|583062690|FG000|Overall Study|Lost to Follow-up|0|||
161455350|NCT03337490|583062691|FG001|Overall Study|Lost to Follow-up|1|||
161455351|NCT03337490|583062692|FG002|Overall Study|Lost to Follow-up|0|||
161455352|NCT01689532|583062693|FG000|Overall Study|Adverse Event|9|||
161455353|NCT01689532|583062694|FG001|Overall Study|Adverse Event|5|||
161455354|NCT01689532|583062693|FG000|Overall Study|Lack of Efficacy|2|||
161455355|NCT01689532|583062694|FG001|Overall Study|Lack of Efficacy|2|||
161455356|NCT01689532|583062693|FG000|Overall Study|Withdrawal by Subject|1|||
161455357|NCT01689532|583062694|FG001|Overall Study|Withdrawal by Subject|2|||
161455358|NCT01689532|583062693|FG000|Overall Study|Physician Decision|2|||
161455359|NCT01689532|583062694|FG001|Overall Study|Physician Decision|0|||
161455360|NCT01363349|583062695|FG000|Overall Study|Adverse Event|6|||
161455361|NCT01363349|583062696|FG001|Overall Study|Adverse Event|7|||
161455362|NCT01363349|583062695|FG000|Overall Study|Lack of Efficacy|3|||
161565621|NCT00880906|583460285|FG000|Overall Study|Did not meet criteria following patholog|12|||
161565622|NCT00880906|583460286|FG001|Overall Study|Did not meet criteria following patholog|6|||
161565623|NCT01664104|583460287|FG000|Overall Study|Adverse Event|6|||
161565624|NCT01664104|583460287|FG000|Overall Study|Lack of Efficacy|2|||
161565625|NCT01664104|583460287|FG000|Overall Study|Withdrawal by Subject|1|||
161807890|NCT00939003|584341266|FG001|Open-label Treatment Period|Pregnancy|1|||
161807891|NCT00939003|584341265|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
161807892|NCT00939003|584341266|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
161807893|NCT00939003|584341265|FG000|Open-label Treatment Period|Site Closure|3|||
161807894|NCT00939003|584341266|FG001|Open-label Treatment Period|Site Closure|4|||
161807895|NCT02186821|584341268|FG000|Overall Study|Adverse Event|9|||
161807896|NCT02186821|584341268|FG000|Overall Study|Death|2|||
161807897|NCT02186821|584341268|FG000|Overall Study|Disease progression|32|||
161807898|NCT02186821|584341268|FG000|Overall Study|Protocol Violation|1|||
161565626|NCT01664104|583460287|FG000|Overall Study|Lost to Follow-up|4|||
161565627|NCT01664104|583460287|FG000|Overall Study|Other|1|||
161565628|NCT01664104|583460287|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
161565629|NCT03586167|583460289|FG000|Overall Study|Other|1|||
161807899|NCT02186821|584341268|FG000|Overall Study|Physician Decision|1|||
161807900|NCT02186821|584341268|FG000|Overall Study|Study terminated by sponsor|2|||
161455363|NCT01363349|583062696|FG001|Overall Study|Lack of Efficacy|10|||
161455364|NCT01363349|583062695|FG000|Overall Study|Non compliance/Protocol deviations|2|||
161455365|NCT01363349|583062696|FG001|Overall Study|Non compliance/Protocol deviations|2|||
161455366|NCT01363349|583062695|FG000|Overall Study|Withdrawal by Subject|14|||
161455367|NCT01363349|583062696|FG001|Overall Study|Withdrawal by Subject|6|||
161455368|NCT01363349|583062695|FG000|Overall Study|Lost to Follow-up|5|||
161455369|NCT01363349|583062696|FG001|Overall Study|Lost to Follow-up|6|||
161455370|NCT01363349|583062695|FG000|Overall Study|Not reported|36|||
161455371|NCT01363349|583062696|FG001|Overall Study|Not reported|37|||
161565630|NCT03586167|583460290|FG001|Overall Study|Other|0|||
161455372|NCT01363349|583062695|FG000|Overall Study|missing|1|||
161455373|NCT01363349|583062696|FG001|Overall Study|missing|2|||
161455374|NCT00917644|583062697|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
161911567|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
161911568|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
161565631|NCT04163458|583460293|FG000|Overall Study|Protocol Deviation|7|||
161565632|NCT04163458|583460294|FG001|Overall Study|Protocol Deviation|13|||
161565633|NCT04163458|583460293|FG000|Overall Study|Adverse Event|5|||
161565634|NCT04163458|583460294|FG001|Overall Study|Adverse Event|8|||
161565635|NCT04163458|583460293|FG000|Overall Study|Due to COVID-19 pandemic|4|||
161565636|NCT04163458|583460294|FG001|Overall Study|Due to COVID-19 pandemic|2|||
161565637|NCT04163458|583460293|FG000|Overall Study|Participant withdrew consent|2|||
161565638|NCT04163458|583460294|FG001|Overall Study|Participant withdrew consent|3|||
161565639|NCT04163458|583460293|FG000|Overall Study|Randomization failure|2|||
161565640|NCT04163458|583460294|FG001|Overall Study|Randomization failure|2|||
161565641|NCT04163458|583460293|FG000|Overall Study|Other|4|||
161565642|NCT04163458|583460294|FG001|Overall Study|Other|2|||
161565643|NCT03852433|583460300|FG000|Overall Study|Withdrawal of consent|5|||
161565644|NCT03852433|583460301|FG001|Overall Study|Withdrawal of consent|8|||
161565645|NCT03852433|583460302|FG002|Overall Study|Withdrawal of consent|1|||
161565646|NCT03852433|583460303|FG003|Overall Study|Withdrawal of consent|1|||
161565647|NCT03852433|583460300|FG000|Overall Study|Adverse Event|1|||
161565648|NCT03852433|583460301|FG001|Overall Study|Adverse Event|1|||
161565649|NCT03852433|583460302|FG002|Overall Study|Adverse Event|1|||
161565650|NCT03852433|583460303|FG003|Overall Study|Adverse Event|1|||
161565651|NCT03852433|583460300|FG000|Overall Study|Lost to Follow-up|0|||
161565652|NCT03852433|583460301|FG001|Overall Study|Lost to Follow-up|1|||
161565653|NCT03852433|583460302|FG002|Overall Study|Lost to Follow-up|0|||
161565654|NCT03852433|583460303|FG003|Overall Study|Lost to Follow-up|1|||
161565655|NCT03852433|583460300|FG000|Overall Study|Pregnancy|0|||
161565656|NCT03852433|583460301|FG001|Overall Study|Pregnancy|1|||
161565657|NCT03852433|583460302|FG002|Overall Study|Pregnancy|1|||
161565658|NCT03852433|583460303|FG003|Overall Study|Pregnancy|0|||
161565659|NCT03852433|583460300|FG000|Overall Study|Protocol Violation|0|||
161565660|NCT03852433|583460301|FG001|Overall Study|Protocol Violation|0|||
161565661|NCT03852433|583460302|FG002|Overall Study|Protocol Violation|1|||
161565662|NCT03852433|583460303|FG003|Overall Study|Protocol Violation|1|||
161565663|NCT03852433|583460300|FG000|Overall Study|Death|0|||
161565664|NCT03852433|583460301|FG001|Overall Study|Death|0|||
161565665|NCT03852433|583460302|FG002|Overall Study|Death|1|||
161565666|NCT03852433|583460303|FG003|Overall Study|Death|0|||
161565667|NCT03852433|583460300|FG000|Overall Study|Lack of Efficacy|0|||
161565668|NCT03852433|583460301|FG001|Overall Study|Lack of Efficacy|1|||
161565669|NCT03852433|583460302|FG002|Overall Study|Lack of Efficacy|0|||
161565670|NCT03852433|583460303|FG003|Overall Study|Lack of Efficacy|0|||
161565671|NCT03852433|583460300|FG000|Overall Study|Non-compliance with study drug|0|||
161565672|NCT03852433|583460301|FG001|Overall Study|Non-compliance with study drug|0|||
161565673|NCT03852433|583460302|FG002|Overall Study|Non-compliance with study drug|0|||
161565674|NCT03852433|583460303|FG003|Overall Study|Non-compliance with study drug|1|||
161565675|NCT03852433|583460300|FG000|Overall Study|Physician Decision|1|||
161565676|NCT03852433|583460301|FG001|Overall Study|Physician Decision|0|||
161565677|NCT03852433|583460302|FG002|Overall Study|Physician Decision|0|||
161565678|NCT03852433|583460303|FG003|Overall Study|Physician Decision|0|||
161565679|NCT03852433|583460300|FG000|Overall Study|Randomized but never treated|1|||
161565680|NCT03852433|583460301|FG001|Overall Study|Randomized but never treated|0|||
161565681|NCT03852433|583460302|FG002|Overall Study|Randomized but never treated|0|||
161565682|NCT03852433|583460303|FG003|Overall Study|Randomized but never treated|0|||
161565683|NCT05273801|583460318|FG000|Overall Study|Physician Decision|1|||
161565684|NCT04159506|583460319|FG000|Overall Study|Lost to Follow-up|2|||
161565685|NCT04159506|583460320|FG001|Overall Study|Lost to Follow-up|5|||
161565686|NCT02449044|583460321|FG000|Overall Study|Lost to Follow-up|2|||
161911569|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
161911570|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
161911571|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
161911572|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
161911573|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
161911574|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
161911575|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
161911576|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
161911577|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
161911578|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
161565687|NCT02449044|583460321|FG000|Overall Study|Withdrawal by Subject|13|||
161565688|NCT02449044|583460321|FG000|Overall Study|Adverse Event|30|||
161565689|NCT02449044|583460321|FG000|Overall Study|Met Withdrawal Criteria|7|||
161565690|NCT02449044|583460321|FG000|Overall Study|Physician Decision|9|||
161565691|NCT02449044|583460321|FG000|Overall Study|Sponsor Discontinued Trial|3|||
161565692|NCT04257058|583462116|FG000|Overall Study|Lost to Follow-up|31|||
161565693|NCT03227757|583462117|FG000|Overall Study|Death|25|||
161565694|NCT03227757|583462117|FG000|Overall Study|Withdrawal|10|||
161565695|NCT03227757|583462117|FG000|Overall Study|Missed visits|1|||
161565696|NCT03227757|583462117|FG000|Overall Study|Lost to Follow-up|2|||
161565697|NCT01144468|583462120|FG000|Overall Study|Lost to Follow-up|4|||
161565698|NCT01144468|583462121|FG001|Overall Study|Lost to Follow-up|7|||
161565699|NCT01144468|583462120|FG000|Overall Study|Adverse Event|3|||
161565700|NCT01144468|583462121|FG001|Overall Study|Adverse Event|2|||
161565701|NCT01144468|583462120|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
161565702|NCT01144468|583462121|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
161565703|NCT02960659|583462122|FG000|Overall Study|Withdrawal by Subject|1|||
161565704|NCT02960659|583462123|FG001|Overall Study|Withdrawal by Subject|0|||
161565705|NCT02960659|583462122|FG000|Overall Study|Poor compliance|0|||
161565706|NCT02960659|583462123|FG001|Overall Study|Poor compliance|1|||
161565707|NCT04199728|583462129|FG000|Overall Study|Adverse Event|1|||
161565708|NCT04199728|583462130|FG001|Overall Study|Adverse Event|0|||
161565709|NCT04199728|583462129|FG000|Overall Study|Withdrawal by Subject|8|||
161565710|NCT04199728|583462130|FG001|Overall Study|Withdrawal by Subject|3|||
161565711|NCT04199728|583462129|FG000|Overall Study|Screen fail after consent|0|||
161565712|NCT04199728|583462130|FG001|Overall Study|Screen fail after consent|1|||
161565713|NCT04199728|583462129|FG000|Overall Study|Early withdraw criteria met|0|||
161565714|NCT04199728|583462130|FG001|Overall Study|Early withdraw criteria met|1|||
161565715|NCT04199728|583462129|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
161565716|NCT04199728|583462130|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
161565717|NCT01875250|583462133|FG000|Overall Study|Adverse Event|2|||
161565718|NCT01875250|583462134|FG001|Overall Study|Adverse Event|0|||
161565719|NCT04057196|583462141|FG000|Overall Study|Withdrawal by Subject|3|||
161565720|NCT04057196|583462141|FG000|Overall Study|Death|3|||
161565721|NCT03068468|583462142|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
161565722|NCT03068468|583462143|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
161565723|NCT03068468|583462144|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
161565724|NCT03068468|583462145|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
161565725|NCT03068468|583462142|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
161565726|NCT03068468|583462143|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
161565727|NCT03068468|583462144|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
161565728|NCT03068468|583462145|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
161455375|NCT00917644|583062698|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
161455376|NCT00917644|583062697|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
161455377|NCT00917644|583062698|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
161565729|NCT03068468|583462142|FG000|Placebo-Controlled Period|Adverse Event|16|||
161565730|NCT03068468|583462143|FG001|Placebo-Controlled Period|Adverse Event|21|||
161565731|NCT03068468|583462144|FG002|Placebo-Controlled Period|Adverse Event|0|||
161565732|NCT03068468|583462145|FG003|Placebo-Controlled Period|Adverse Event|0|||
161565733|NCT03068468|583462142|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
161565734|NCT03068468|583462143|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
161565735|NCT03068468|583462144|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
161455378|NCT00917644|583062697|FG000|Period 2: Second Intervention|family emergency|1|||
161455379|NCT00917644|583062698|FG001|Period 2: Second Intervention|family emergency|0|||
161455380|NCT02108262|583062709|FG000|Overall Study|Non-compliance|0|||
161455381|NCT02108262|583062710|FG001|Overall Study|Non-compliance|2|||
161455382|NCT02108262|583062711|FG002|Overall Study|Non-compliance|1|||
161455383|NCT02108262|583062712|FG003|Overall Study|Non-compliance|1|||
161455384|NCT02108262|583062709|FG000|Overall Study|Randomized by error/screen failure|0|||
161455385|NCT02108262|583062710|FG001|Overall Study|Randomized by error/screen failure|0|||
161455386|NCT02108262|583062711|FG002|Overall Study|Randomized by error/screen failure|1|||
161455387|NCT02108262|583062712|FG003|Overall Study|Randomized by error/screen failure|0|||
161455388|NCT02108262|583062709|FG000|Overall Study|Distance to center|0|||
161455389|NCT02108262|583062710|FG001|Overall Study|Distance to center|1|||
161455390|NCT02108262|583062711|FG002|Overall Study|Distance to center|1|||
161455391|NCT02108262|583062712|FG003|Overall Study|Distance to center|0|||
161455392|NCT02108262|583062709|FG000|Overall Study|Adverse Event|0|||
161455393|NCT02108262|583062710|FG001|Overall Study|Adverse Event|11|||
161455394|NCT02108262|583062711|FG002|Overall Study|Adverse Event|6|||
161455395|NCT02108262|583062712|FG003|Overall Study|Adverse Event|12|||
161455396|NCT02108262|583062709|FG000|Overall Study|Death|0|||
161455397|NCT02108262|583062710|FG001|Overall Study|Death|2|||
161455398|NCT02108262|583062711|FG002|Overall Study|Death|2|||
161455399|NCT02108262|583062712|FG003|Overall Study|Death|1|||
161455400|NCT02108262|583062709|FG000|Overall Study|Lost to Follow-up|0|||
161455401|NCT02108262|583062710|FG001|Overall Study|Lost to Follow-up|0|||
161455402|NCT02108262|583062711|FG002|Overall Study|Lost to Follow-up|1|||
161455403|NCT02108262|583062712|FG003|Overall Study|Lost to Follow-up|0|||
161455404|NCT02108262|583062709|FG000|Overall Study|Physician Decision|0|||
161455405|NCT02108262|583062710|FG001|Overall Study|Physician Decision|0|||
161455406|NCT02108262|583062711|FG002|Overall Study|Physician Decision|2|||
161455407|NCT02108262|583062712|FG003|Overall Study|Physician Decision|0|||
161565736|NCT03068468|583462145|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
161565737|NCT03068468|583462142|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161455408|NCT02108262|583062709|FG000|Overall Study|Withdrawal by Subject|0|||
161455409|NCT02108262|583062710|FG001|Overall Study|Withdrawal by Subject|7|||
161455410|NCT02108262|583062711|FG002|Overall Study|Withdrawal by Subject|3|||
161455411|NCT02108262|583062712|FG003|Overall Study|Withdrawal by Subject|4|||
161455412|NCT02108262|583062709|FG000|Overall Study|Due to key hepatic values|0|||
161455413|NCT02108262|583062710|FG001|Overall Study|Due to key hepatic values|1|||
161455414|NCT02108262|583062711|FG002|Overall Study|Due to key hepatic values|0|||
161455415|NCT02108262|583062712|FG003|Overall Study|Due to key hepatic values|0|||
161455416|NCT02108262|583062709|FG000|Overall Study|Unable to contact patient|0|||
161455417|NCT02108262|583062710|FG001|Overall Study|Unable to contact patient|3|||
161455418|NCT02108262|583062711|FG002|Overall Study|Unable to contact patient|1|||
161455419|NCT02108262|583062712|FG003|Overall Study|Unable to contact patient|2|||
161455420|NCT02108262|583062709|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
161455421|NCT02108262|583062710|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
161455422|NCT02108262|583062711|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
161455423|NCT02108262|583062712|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
161455424|NCT02108262|583062709|FG000|Overall Study|Patient did not want another infusion|0|||
161455425|NCT02108262|583062710|FG001|Overall Study|Patient did not want another infusion|3|||
161911579|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
161565738|NCT03068468|583462143|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
161565739|NCT03068468|583462144|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161565740|NCT03068468|583462145|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161565741|NCT03068468|583462142|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
161565742|NCT03068468|583462143|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
161565743|NCT03068468|583462144|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
161565744|NCT03068468|583462145|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
161565745|NCT03068468|583462142|FG000|Placebo-Controlled Period|Death|0|||
161565746|NCT03068468|583462143|FG001|Placebo-Controlled Period|Death|1|||
161565747|NCT03068468|583462144|FG002|Placebo-Controlled Period|Death|0|||
161565748|NCT03068468|583462145|FG003|Placebo-Controlled Period|Death|0|||
161565749|NCT03068468|583462142|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
161565750|NCT03068468|583462143|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
161565751|NCT03068468|583462144|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
161565752|NCT03068468|583462145|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
161565753|NCT03068468|583462142|FG000|Open-Label Extension Period|Adverse Event|0|||
161565754|NCT03068468|583462143|FG001|Open-Label Extension Period|Adverse Event|0|||
161565755|NCT03068468|583462144|FG002|Open-Label Extension Period|Adverse Event|13|||
161565756|NCT03068468|583462145|FG003|Open-Label Extension Period|Adverse Event|17|||
161565757|NCT03068468|583462142|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
161565758|NCT03068468|583462143|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
161565759|NCT03068468|583462144|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
161565760|NCT03068468|583462145|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
161565761|NCT03068468|583462142|FG000|Open-Label Extension Period|Death|0|||
161565762|NCT03068468|583462143|FG001|Open-Label Extension Period|Death|0|||
161565763|NCT03068468|583462144|FG002|Open-Label Extension Period|Death|0|||
161565764|NCT03068468|583462145|FG003|Open-Label Extension Period|Death|1|||
161565765|NCT03068468|583462142|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
161565766|NCT03068468|583462143|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
161565767|NCT03068468|583462144|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
161565768|NCT03068468|583462145|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
161565769|NCT03068468|583462142|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
161565770|NCT03068468|583462143|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
161565771|NCT03068468|583462144|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
161565772|NCT03068468|583462145|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
161565773|NCT03068468|583462142|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
161565774|NCT03068468|583462143|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
161565775|NCT03068468|583462144|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
161565776|NCT03068468|583462145|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
161565777|NCT03068468|583462142|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
161565778|NCT03068468|583462143|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
161911580|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
161911581|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Other|2|||
161455426|NCT02108262|583062711|FG002|Overall Study|Patient did not want another infusion|3|||
161455427|NCT02108262|583062712|FG003|Overall Study|Patient did not want another infusion|2|||
161455428|NCT02108262|583062709|FG000|Overall Study|Vacation|0|||
161455429|NCT02108262|583062710|FG001|Overall Study|Vacation|1|||
161455430|NCT02108262|583062711|FG002|Overall Study|Vacation|0|||
161455431|NCT02108262|583062712|FG003|Overall Study|Vacation|0|||
161455432|NCT02108262|583062709|FG000|Overall Study|Patient decision|0|||
161565779|NCT03068468|583462144|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
161565780|NCT03068468|583462145|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
161455433|NCT02108262|583062710|FG001|Overall Study|Patient decision|7|||
161455434|NCT02108262|583062711|FG002|Overall Study|Patient decision|9|||
161455435|NCT02108262|583062712|FG003|Overall Study|Patient decision|14|||
161455436|NCT02108262|583062709|FG000|Overall Study|Missed IV due to pharmacy error|0|||
161455437|NCT02108262|583062710|FG001|Overall Study|Missed IV due to pharmacy error|0|||
161455438|NCT02108262|583062711|FG002|Overall Study|Missed IV due to pharmacy error|1|||
161455439|NCT02108262|583062712|FG003|Overall Study|Missed IV due to pharmacy error|0|||
161455440|NCT00392379|583062717|FG000|Overall Study|Withdrawal by Subject|17|||
161455441|NCT00392379|583062718|FG001|Overall Study|Withdrawal by Subject|28|||
161455442|NCT00392379|583062717|FG000|Overall Study|Lost to Follow-up|4|||
161455443|NCT00392379|583062718|FG001|Overall Study|Lost to Follow-up|9|||
161455444|NCT00392379|583062717|FG000|Overall Study|Adverse Event|1|||
161455445|NCT00392379|583062718|FG001|Overall Study|Adverse Event|1|||
161455446|NCT01700387|583062724|FG000|Overall Study|Withdrawal by Subject|1|||
161455447|NCT01700387|583062725|FG001|Overall Study|Withdrawal by Subject|2|||
161455448|NCT01700387|583062724|FG000|Overall Study|Adverse Event|1|||
161455449|NCT01700387|583062725|FG001|Overall Study|Adverse Event|1|||
161455450|NCT01700387|583062724|FG000|Overall Study|Lost to Follow-up|2|||
161455451|NCT01700387|583062725|FG001|Overall Study|Lost to Follow-up|1|||
161455452|NCT02730793|583062728|FG000|Overall Study|Physician Decision|0|||
161455453|NCT02730793|583062729|FG001|Overall Study|Physician Decision|1|||
161455454|NCT02730793|583062728|FG000|Overall Study|Withdrawal by Subject|0|||
161455455|NCT02730793|583062729|FG001|Overall Study|Withdrawal by Subject|1|||
161455456|NCT02365233|583062730|FG000|Overall Study|IRB withheld the data|1|||
161455457|NCT02365233|583062731|FG001|Overall Study|IRB withheld the data|2|||
161455458|NCT02365233|583062732|FG002|Overall Study|IRB withheld the data|2|||
161455459|NCT00934843|583062733|FG000|Overall Study|Protocol Violation|0|||
161455460|NCT00934843|583062734|FG001|Overall Study|Protocol Violation|1|||
161455461|NCT00160667|583062735|FG000|Overall Study|Adverse Event|3|||
161455462|NCT00160667|583062736|FG001|Overall Study|Adverse Event|1|||
161455463|NCT00160667|583062737|FG002|Overall Study|Adverse Event|4|||
161455464|NCT00160667|583062735|FG000|Overall Study|Withdrawal by Subject|2|||
161455465|NCT00160667|583062736|FG001|Overall Study|Withdrawal by Subject|0|||
161455466|NCT00160667|583062737|FG002|Overall Study|Withdrawal by Subject|1|||
161455467|NCT00160667|583062735|FG000|Overall Study|Lack of Efficacy|0|||
161455468|NCT00160667|583062736|FG001|Overall Study|Lack of Efficacy|1|||
161455469|NCT00160667|583062737|FG002|Overall Study|Lack of Efficacy|0|||
161455470|NCT00160667|583062735|FG000|Overall Study|Protocol Violation|0|||
161455471|NCT00160667|583062736|FG001|Overall Study|Protocol Violation|1|||
161455472|NCT00160667|583062737|FG002|Overall Study|Protocol Violation|0|||
161455473|NCT00160667|583062735|FG000|Overall Study|Patient decision|0|||
161455474|NCT00160667|583062736|FG001|Overall Study|Patient decision|0|||
161455475|NCT00160667|583062737|FG002|Overall Study|Patient decision|1|||
161455476|NCT00995566|583062745|FG000|Overall Study|Adverse Event|2|||
161455477|NCT00995566|583062745|FG000|Overall Study|Early study termination|52|||
161455478|NCT00545129|583062746|FG000|Overall Study|Lack of Efficacy|2|||
161455479|NCT00545129|583062747|FG001|Overall Study|Lack of Efficacy|5|||
161455480|NCT00545129|583062746|FG000|Overall Study|Death|2|||
161455481|NCT00545129|583062747|FG001|Overall Study|Death|1|||
161455482|NCT00545129|583062746|FG000|Overall Study|Adverse Event|1|||
161455483|NCT00545129|583062747|FG001|Overall Study|Adverse Event|1|||
161455484|NCT00545129|583062746|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
161455485|NCT00545129|583062747|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
161455486|NCT00545129|583062746|FG000|Overall Study|Other|3|||
161455487|NCT00545129|583062747|FG001|Overall Study|Other|3|||
161455488|NCT03678870|583062748|FG000|Overall Study|prescribed non- protocol medications|10|||
161455489|NCT03678870|583062749|FG001|Overall Study|prescribed non- protocol medications|6|||
161455490|NCT03678870|583062748|FG000|Overall Study|Lost to Follow-up|3|||
161455491|NCT03678870|583062749|FG001|Overall Study|Lost to Follow-up|2|||
161455492|NCT03104816|583062751|FG000|Overall Study|Lack of Efficacy|0|||
161455493|NCT03104816|583062752|FG001|Overall Study|Lack of Efficacy|2|||
161455494|NCT03104816|583062753|FG002|Overall Study|Lack of Efficacy|0|||
161455495|NCT03104816|583062751|FG000|Overall Study|Protocol Violation|2|||
161455496|NCT03104816|583062752|FG001|Overall Study|Protocol Violation|0|||
161455497|NCT03104816|583062753|FG002|Overall Study|Protocol Violation|2|||
161455498|NCT01426789|583062754|FG000|Part 1|Protocol deviation|0|||
161455499|NCT01426789|583062755|FG001|Part 1|Protocol deviation|1|||
161455500|NCT01426789|583062756|FG002|Part 1|Protocol deviation|0|||
161455501|NCT01426789|583062757|FG003|Part 1|Protocol deviation|0|||
161455502|NCT01426789|583062758|FG004|Part 1|Protocol deviation|0|||
161455503|NCT01426789|583062759|FG005|Part 1|Protocol deviation|0|||
161455504|NCT01426789|583062754|FG000|Part 1|Lost to Follow-up|1|||
161455505|NCT01426789|583062755|FG001|Part 1|Lost to Follow-up|2|||
161455506|NCT01426789|583062756|FG002|Part 1|Lost to Follow-up|0|||
161455507|NCT01426789|583062757|FG003|Part 1|Lost to Follow-up|0|||
161455508|NCT01426789|583062758|FG004|Part 1|Lost to Follow-up|0|||
161455509|NCT01426789|583062759|FG005|Part 1|Lost to Follow-up|0|||
161455510|NCT01426789|583062754|FG000|Part 1|Lack of Efficacy|2|||
161455511|NCT01426789|583062755|FG001|Part 1|Lack of Efficacy|1|||
161455512|NCT01426789|583062756|FG002|Part 1|Lack of Efficacy|0|||
161455513|NCT01426789|583062757|FG003|Part 1|Lack of Efficacy|0|||
161455514|NCT01426789|583062758|FG004|Part 1|Lack of Efficacy|0|||
161455515|NCT01426789|583062759|FG005|Part 1|Lack of Efficacy|0|||
161455516|NCT01426789|583062754|FG000|Part 1|Adverse Event|3|||
161455517|NCT01426789|583062755|FG001|Part 1|Adverse Event|0|||
161455518|NCT01426789|583062756|FG002|Part 1|Adverse Event|0|||
161455519|NCT01426789|583062757|FG003|Part 1|Adverse Event|0|||
161455520|NCT01426789|583062758|FG004|Part 1|Adverse Event|0|||
161455521|NCT01426789|583062759|FG005|Part 1|Adverse Event|0|||
161455522|NCT01426789|583062754|FG000|Part 2|Protocol deviation|0|||
161455523|NCT01426789|583062755|FG001|Part 2|Protocol deviation|0|||
161455524|NCT01426789|583062756|FG002|Part 2|Protocol deviation|1|||
161455525|NCT01426789|583062757|FG003|Part 2|Protocol deviation|0|||
161455526|NCT01426789|583062758|FG004|Part 2|Protocol deviation|0|||
161455527|NCT01426789|583062759|FG005|Part 2|Protocol deviation|0|||
161455528|NCT01426789|583062754|FG000|Part 2|Death|0|||
161455529|NCT01426789|583062755|FG001|Part 2|Death|0|||
161455530|NCT01426789|583062756|FG002|Part 2|Death|1|||
161455531|NCT01426789|583062757|FG003|Part 2|Death|0|||
161455532|NCT01426789|583062758|FG004|Part 2|Death|1|||
161455533|NCT01426789|583062759|FG005|Part 2|Death|0|||
161455534|NCT01426789|583062754|FG000|Part 2|Administrative problems|0|||
161455535|NCT01426789|583062755|FG001|Part 2|Administrative problems|0|||
161455536|NCT01426789|583062756|FG002|Part 2|Administrative problems|2|||
161455537|NCT01426789|583062757|FG003|Part 2|Administrative problems|0|||
161455538|NCT01426789|583062758|FG004|Part 2|Administrative problems|1|||
161565781|NCT03068468|583462142|FG000|Open-Label Extension Period|Reason not Specified|0|||
161565782|NCT03068468|583462143|FG001|Open-Label Extension Period|Reason not Specified|0|||
161565783|NCT03068468|583462144|FG002|Open-Label Extension Period|Reason not Specified|1|||
161565784|NCT03068468|583462145|FG003|Open-Label Extension Period|Reason not Specified|4|||
161565785|NCT03895034|583462147|FG000|Overall Study|Lost to Follow-up|2|||
161565786|NCT01118377|583462148|FG000|Overall Study|Did Not Receive Study Medication|1|||
161565787|NCT01118377|583462148|FG000|Overall Study|Death|38|||
161565788|NCT01118377|583462148|FG000|Overall Study|Failure to Return|3|||
161565789|NCT03140176|583462156|FG000|Overall Study|Reason missing|23|||
161565790|NCT03140176|583462156|FG000|Overall Study|Death|33|||
161565791|NCT03140176|583462156|FG000|Overall Study|Disease progression|1|||
161565792|NCT03140176|583462156|FG000|Overall Study|Physician Decision|1|||
161565793|NCT03140176|583462156|FG000|Overall Study|Withdrawal by Subject|1|||
161565794|NCT03140176|583462156|FG000|Overall Study|Lost to Follow-up|15|||
161565795|NCT00739102|583462157|FG000|Overall Study|Death|5|||
161565796|NCT00739102|583462157|FG000|Overall Study|Withdrawal by Subject|10|||
161565797|NCT01331824|583462161|FG000|Overall Study|Adverse Event|2|||
161565798|NCT01331824|583462161|FG000|Overall Study|Death|1|||
161565799|NCT01331824|583462161|FG000|Overall Study|Disease Progression|9|||
161565800|NCT01331824|583462161|FG000|Overall Study|Withdrawal by Subject|1|||
161565801|NCT01268891|583462175|FG000|Overall Study|Adverse Event|3|||
161565802|NCT01268891|583462176|FG001|Overall Study|Adverse Event|7|||
161565803|NCT01268891|583462175|FG000|Overall Study|Lack of Efficacy|1|||
161565804|NCT01268891|583462176|FG001|Overall Study|Lack of Efficacy|0|||
161565805|NCT01268891|583462175|FG000|Overall Study|Withdrawal of Consent|3|||
161565806|NCT01268891|583462176|FG001|Overall Study|Withdrawal of Consent|1|||
161565807|NCT01268891|583462175|FG000|Overall Study|Administrative or other reason(s)|1|||
161565808|NCT01268891|583462176|FG001|Overall Study|Administrative or other reason(s)|0|||
161565809|NCT00991276|583462177|FG000|First Intervention Period|Adverse Event|0|||
161565810|NCT00991276|583462178|FG001|First Intervention Period|Adverse Event|1|||
161565811|NCT00991276|583462179|FG002|First Intervention Period|Adverse Event|0|||
161565812|NCT00991276|583462180|FG003|First Intervention Period|Adverse Event|1|||
161565813|NCT00991276|583462181|FG004|First Intervention Period|Adverse Event|0|||
161565814|NCT00991276|583462182|FG005|First Intervention Period|Adverse Event|0|||
161565815|NCT00991276|583462177|FG000|First Intervention Period|Protocol Violation|0|||
161565816|NCT00991276|583462178|FG001|First Intervention Period|Protocol Violation|0|||
161565817|NCT00991276|583462179|FG002|First Intervention Period|Protocol Violation|0|||
161565818|NCT00991276|583462180|FG003|First Intervention Period|Protocol Violation|0|||
161565819|NCT00991276|583462181|FG004|First Intervention Period|Protocol Violation|2|||
161565820|NCT00991276|583462182|FG005|First Intervention Period|Protocol Violation|0|||
161565821|NCT00991276|583462177|FG000|First Intervention Period|Insufficient clinical response|0|||
161565822|NCT00991276|583462178|FG001|First Intervention Period|Insufficient clinical response|0|||
161455539|NCT01426789|583062759|FG005|Part 2|Administrative problems|0|||
161455540|NCT01426789|583062754|FG000|Part 2|Lost to Follow-up|0|||
161455541|NCT01426789|583062755|FG001|Part 2|Lost to Follow-up|0|||
161455542|NCT01426789|583062756|FG002|Part 2|Lost to Follow-up|4|||
161455543|NCT01426789|583062757|FG003|Part 2|Lost to Follow-up|0|||
161455544|NCT01426789|583062758|FG004|Part 2|Lost to Follow-up|1|||
161455545|NCT01426789|583062759|FG005|Part 2|Lost to Follow-up|0|||
161455546|NCT01426789|583062754|FG000|Part 2|Withdrawal by Subject|0|||
161455547|NCT01426789|583062755|FG001|Part 2|Withdrawal by Subject|0|||
161565823|NCT00991276|583462179|FG002|First Intervention Period|Insufficient clinical response|0|||
161565824|NCT00991276|583462180|FG003|First Intervention Period|Insufficient clinical response|0|||
161565825|NCT00991276|583462181|FG004|First Intervention Period|Insufficient clinical response|1|||
161565826|NCT00991276|583462182|FG005|First Intervention Period|Insufficient clinical response|0|||
161565827|NCT00991276|583462177|FG000|First Intervention Period|Other|0|||
161565828|NCT00991276|583462178|FG001|First Intervention Period|Other|0|||
161565829|NCT00991276|583462179|FG002|First Intervention Period|Other|0|||
161565830|NCT00991276|583462180|FG003|First Intervention Period|Other|1|||
161565831|NCT00991276|583462181|FG004|First Intervention Period|Other|1|||
161565832|NCT00991276|583462182|FG005|First Intervention Period|Other|0|||
161565833|NCT00991276|583462177|FG000|First Intervention Period|Withdrawal by Subject|0|||
161565834|NCT00991276|583462178|FG001|First Intervention Period|Withdrawal by Subject|1|||
161565835|NCT00991276|583462179|FG002|First Intervention Period|Withdrawal by Subject|0|||
161565836|NCT00991276|583462180|FG003|First Intervention Period|Withdrawal by Subject|1|||
161565837|NCT00991276|583462181|FG004|First Intervention Period|Withdrawal by Subject|0|||
161565838|NCT00991276|583462182|FG005|First Intervention Period|Withdrawal by Subject|1|||
161565839|NCT00991276|583462177|FG000|First Intervention Period|Lost to Follow-up|0|||
161565840|NCT00991276|583462178|FG001|First Intervention Period|Lost to Follow-up|1|||
161565841|NCT00991276|583462179|FG002|First Intervention Period|Lost to Follow-up|0|||
161565842|NCT00991276|583462180|FG003|First Intervention Period|Lost to Follow-up|1|||
161565843|NCT00991276|583462181|FG004|First Intervention Period|Lost to Follow-up|0|||
161565844|NCT00991276|583462182|FG005|First Intervention Period|Lost to Follow-up|0|||
161565845|NCT00991276|583462177|FG000|Second Intervention Period|Adverse Event|0|||
161565846|NCT00991276|583462178|FG001|Second Intervention Period|Adverse Event|2|||
161565847|NCT00991276|583462179|FG002|Second Intervention Period|Adverse Event|0|||
161565848|NCT00991276|583462180|FG003|Second Intervention Period|Adverse Event|1|||
161565849|NCT00991276|583462181|FG004|Second Intervention Period|Adverse Event|1|||
161565850|NCT00991276|583462182|FG005|Second Intervention Period|Adverse Event|0|||
161565851|NCT00991276|583462177|FG000|Second Intervention Period|Protocol Violation|1|||
161565852|NCT00991276|583462178|FG001|Second Intervention Period|Protocol Violation|0|||
161565853|NCT00991276|583462179|FG002|Second Intervention Period|Protocol Violation|0|||
161565854|NCT00991276|583462180|FG003|Second Intervention Period|Protocol Violation|0|||
161565855|NCT00991276|583462181|FG004|Second Intervention Period|Protocol Violation|0|||
161565856|NCT00991276|583462182|FG005|Second Intervention Period|Protocol Violation|0|||
161565857|NCT00991276|583462177|FG000|Second Intervention Period|Other|0|||
161565858|NCT00991276|583462178|FG001|Second Intervention Period|Other|0|||
161565859|NCT00991276|583462179|FG002|Second Intervention Period|Other|0|||
161565860|NCT00991276|583462180|FG003|Second Intervention Period|Other|1|||
161565861|NCT00991276|583462181|FG004|Second Intervention Period|Other|0|||
161565862|NCT00991276|583462182|FG005|Second Intervention Period|Other|1|||
161565863|NCT00991276|583462177|FG000|Third Intervention Period|Protocol Violation|1|||
161565864|NCT00991276|583462178|FG001|Third Intervention Period|Protocol Violation|0|||
161565865|NCT00991276|583462179|FG002|Third Intervention Period|Protocol Violation|0|||
161565866|NCT00991276|583462180|FG003|Third Intervention Period|Protocol Violation|0|||
161565867|NCT00991276|583462181|FG004|Third Intervention Period|Protocol Violation|0|||
161565868|NCT00991276|583462182|FG005|Third Intervention Period|Protocol Violation|0|||
161565869|NCT00991276|583462177|FG000|Third Intervention Period|Other|0|||
161565870|NCT00991276|583462178|FG001|Third Intervention Period|Other|0|||
161565871|NCT00991276|583462179|FG002|Third Intervention Period|Other|0|||
161565872|NCT00991276|583462180|FG003|Third Intervention Period|Other|0|||
161565873|NCT00991276|583462181|FG004|Third Intervention Period|Other|0|||
161565874|NCT00991276|583462182|FG005|Third Intervention Period|Other|1|||
161565875|NCT00991276|583462177|FG000|Third Intervention Period|Adverse Event|0|||
161565876|NCT00991276|583462178|FG001|Third Intervention Period|Adverse Event|0|||
161565877|NCT00991276|583462179|FG002|Third Intervention Period|Adverse Event|1|||
161565878|NCT00991276|583462180|FG003|Third Intervention Period|Adverse Event|0|||
161565879|NCT00991276|583462181|FG004|Third Intervention Period|Adverse Event|0|||
161565880|NCT00991276|583462182|FG005|Third Intervention Period|Adverse Event|0|||
161565881|NCT00991276|583462177|FG000|Third Intervention Period|Withdrawal by Subject|0|||
161565882|NCT00991276|583462178|FG001|Third Intervention Period|Withdrawal by Subject|0|||
161565883|NCT00991276|583462179|FG002|Third Intervention Period|Withdrawal by Subject|0|||
161565884|NCT00991276|583462180|FG003|Third Intervention Period|Withdrawal by Subject|1|||
161565885|NCT00991276|583462181|FG004|Third Intervention Period|Withdrawal by Subject|0|||
161565886|NCT00991276|583462182|FG005|Third Intervention Period|Withdrawal by Subject|0|||
161565887|NCT02001623|583462183|FG000|Overall Study|Disease Progression|2|||
161565888|NCT02001623|583462184|FG001|Overall Study|Disease Progression|2|||
161565889|NCT02001623|583462185|FG002|Overall Study|Disease Progression|3|||
161565890|NCT02001623|583462186|FG003|Overall Study|Disease Progression|2|||
161565891|NCT02001623|583462187|FG004|Overall Study|Disease Progression|3|||
161565892|NCT02001623|583462188|FG005|Overall Study|Disease Progression|2|||
161565893|NCT02001623|583462189|FG006|Overall Study|Disease Progression|3|||
161807901|NCT05472038|584342689|FG000|Overall Study|Adverse Event|0|||
161807902|NCT05472038|584342690|FG001|Overall Study|Adverse Event|0|||
161565894|NCT02001623|583462190|FG007|Overall Study|Disease Progression|3|||
161565895|NCT02001623|583462191|FG008|Overall Study|Disease Progression|7|||
161565896|NCT02001623|583462192|FG009|Overall Study|Disease Progression|40|||
161565897|NCT02001623|583462193|FG010|Overall Study|Disease Progression|5|||
161565898|NCT02001623|583462194|FG011|Overall Study|Disease Progression|9|||
161455548|NCT01426789|583062756|FG002|Part 2|Withdrawal by Subject|0|||
161455549|NCT01426789|583062757|FG003|Part 2|Withdrawal by Subject|1|||
161455550|NCT01426789|583062758|FG004|Part 2|Withdrawal by Subject|2|||
161455551|NCT01426789|583062759|FG005|Part 2|Withdrawal by Subject|0|||
161455552|NCT01426789|583062754|FG000|Part 2|Lack of Efficacy|0|||
161455553|NCT01426789|583062755|FG001|Part 2|Lack of Efficacy|0|||
161455554|NCT01426789|583062756|FG002|Part 2|Lack of Efficacy|5|||
161455555|NCT01426789|583062757|FG003|Part 2|Lack of Efficacy|0|||
161455556|NCT01426789|583062758|FG004|Part 2|Lack of Efficacy|2|||
161455557|NCT01426789|583062759|FG005|Part 2|Lack of Efficacy|0|||
161455558|NCT01426789|583062754|FG000|Part 2|Adverse Event|0|||
161455559|NCT01426789|583062755|FG001|Part 2|Adverse Event|0|||
161455560|NCT01426789|583062756|FG002|Part 2|Adverse Event|2|||
161455561|NCT01426789|583062757|FG003|Part 2|Adverse Event|0|||
161455562|NCT01426789|583062758|FG004|Part 2|Adverse Event|1|||
161455563|NCT01426789|583062759|FG005|Part 2|Adverse Event|0|||
161455564|NCT00883688|583064831|FG000|Overall Study|Ineligible|2|||
161455565|NCT03860935|583064838|FG000|Overall Study|Withdrawal of Consent|15|||
161455566|NCT03860935|583064839|FG001|Overall Study|Withdrawal of Consent|6|||
161455567|NCT03860935|583064838|FG000|Overall Study|Death|75|||
161455568|NCT03860935|583064839|FG001|Overall Study|Death|51|||
161455569|NCT04461600|583064843|FG000|Overall Study|Death|6|||
161565899|NCT02001623|583462195|FG012|Overall Study|Disease Progression|9|||
161565900|NCT02001623|583462196|FG013|Overall Study|Disease Progression|20|||
161565901|NCT02001623|583462197|FG014|Overall Study|Disease Progression|9|||
161565902|NCT02001623|583462183|FG000|Overall Study|Physician Decision|0|||
161807903|NCT05472038|584342691|FG002|Overall Study|Adverse Event|1|||
161807904|NCT05472038|584342692|FG003|Overall Study|Adverse Event|0|||
161807905|NCT05472038|584342693|FG004|Overall Study|Adverse Event|0|||
161807906|NCT05472038|584342694|FG005|Overall Study|Adverse Event|0|||
161807907|NCT05472038|584342695|FG006|Overall Study|Adverse Event|0|||
161807908|NCT05472038|584342696|FG007|Overall Study|Adverse Event|0|||
161807909|NCT05472038|584342697|FG008|Overall Study|Adverse Event|0|||
161807910|NCT05472038|584342698|FG009|Overall Study|Adverse Event|0|||
161807911|NCT05472038|584342699|FG010|Overall Study|Adverse Event|0|||
161807912|NCT05472038|584342700|FG011|Overall Study|Adverse Event|0|||
161807913|NCT05472038|584342689|FG000|Overall Study|Death|0|||
161807914|NCT05472038|584342690|FG001|Overall Study|Death|0|||
161807915|NCT05472038|584342691|FG002|Overall Study|Death|0|||
161807916|NCT05472038|584342692|FG003|Overall Study|Death|0|||
161807917|NCT05472038|584342693|FG004|Overall Study|Death|0|||
161807918|NCT05472038|584342694|FG005|Overall Study|Death|1|||
161807919|NCT05472038|584342695|FG006|Overall Study|Death|0|||
161807920|NCT05472038|584342696|FG007|Overall Study|Death|0|||
161807921|NCT05472038|584342697|FG008|Overall Study|Death|0|||
161807922|NCT05472038|584342698|FG009|Overall Study|Death|0|||
161807923|NCT05472038|584342699|FG010|Overall Study|Death|0|||
161807924|NCT05472038|584342700|FG011|Overall Study|Death|0|||
161807925|NCT05472038|584342689|FG000|Overall Study|Lost to Follow-up|1|||
161807926|NCT05472038|584342690|FG001|Overall Study|Lost to Follow-up|3|||
161807927|NCT05472038|584342691|FG002|Overall Study|Lost to Follow-up|3|||
161807928|NCT05472038|584342692|FG003|Overall Study|Lost to Follow-up|9|||
161807929|NCT05472038|584342693|FG004|Overall Study|Lost to Follow-up|2|||
161807930|NCT05472038|584342694|FG005|Overall Study|Lost to Follow-up|2|||
161807931|NCT05472038|584342695|FG006|Overall Study|Lost to Follow-up|1|||
161807932|NCT05472038|584342696|FG007|Overall Study|Lost to Follow-up|0|||
161807933|NCT05472038|584342697|FG008|Overall Study|Lost to Follow-up|1|||
161807934|NCT05472038|584342698|FG009|Overall Study|Lost to Follow-up|0|||
161807935|NCT05472038|584342699|FG010|Overall Study|Lost to Follow-up|2|||
161807936|NCT05472038|584342700|FG011|Overall Study|Lost to Follow-up|1|||
161807937|NCT05472038|584342689|FG000|Overall Study|Physician Decision|0|||
161807938|NCT05472038|584342690|FG001|Overall Study|Physician Decision|0|||
161807939|NCT05472038|584342691|FG002|Overall Study|Physician Decision|0|||
161807940|NCT05472038|584342692|FG003|Overall Study|Physician Decision|0|||
161807941|NCT05472038|584342693|FG004|Overall Study|Physician Decision|1|||
161455570|NCT04461600|583064844|FG001|Overall Study|Death|5|||
161455571|NCT04461600|583064843|FG000|Overall Study|Withdrawal by Subject|0|||
161455572|NCT04461600|583064844|FG001|Overall Study|Withdrawal by Subject|1|||
161455573|NCT00704522|583064845|FG000|Overall Study|Lack of Efficacy|65|||
161455574|NCT00704522|583064846|FG001|Overall Study|Lack of Efficacy|17|||
161455575|NCT00704522|583064845|FG000|Overall Study|Failure to appear again at hospital|56|||
161807942|NCT05472038|584342694|FG005|Overall Study|Physician Decision|0|||
161807943|NCT05472038|584342695|FG006|Overall Study|Physician Decision|0|||
161807944|NCT05472038|584342696|FG007|Overall Study|Physician Decision|0|||
161807945|NCT05472038|584342697|FG008|Overall Study|Physician Decision|0|||
161807946|NCT05472038|584342698|FG009|Overall Study|Physician Decision|0|||
161455576|NCT00704522|583064846|FG001|Overall Study|Failure to appear again at hospital|10|||
161807947|NCT05472038|584342699|FG010|Overall Study|Physician Decision|0|||
161455577|NCT00704522|583064845|FG000|Overall Study|Withdrawal by Subject|17|||
161565903|NCT02001623|583462184|FG001|Overall Study|Physician Decision|0|||
161807948|NCT05472038|584342700|FG011|Overall Study|Physician Decision|0|||
161807949|NCT05472038|584342689|FG000|Overall Study|Withdrawal by Subject|1|||
161807950|NCT05472038|584342690|FG001|Overall Study|Withdrawal by Subject|3|||
161455578|NCT00704522|583064846|FG001|Overall Study|Withdrawal by Subject|8|||
161455579|NCT00704522|583064845|FG000|Overall Study|Adverse Event|9|||
161455580|NCT00704522|583064846|FG001|Overall Study|Adverse Event|1|||
161455581|NCT00704522|583064845|FG000|Overall Study|Undefined causes|9|||
161455582|NCT00704522|583064846|FG001|Overall Study|Undefined causes|7|||
161455583|NCT00704522|583064845|FG000|Overall Study|No information on therapy end|27|||
161455584|NCT00704522|583064846|FG001|Overall Study|No information on therapy end|2|||
161455585|NCT04896229|583064847|FG000|Overall Study|Lost to Follow-up|113|||
161455586|NCT04896229|583064848|FG001|Overall Study|Lost to Follow-up|113|||
161455587|NCT00635024|583064849|FG000|Overall Study|Adverse Event|1|||
161455588|NCT01958489|583064850|FG000|Period 2|Adverse Event|0|||
161455589|NCT01958489|583064851|FG001|Period 2|Adverse Event|1|||
161455590|NCT00992589|583064852|FG000|Open-Label Phase|Adverse Event|4|||
161455591|NCT00992589|583064853|FG001|Open-Label Phase|Adverse Event|0|||
161455592|NCT00992589|583064854|FG002|Open-Label Phase|Adverse Event|0|||
161455593|NCT00992589|583064855|FG003|Open-Label Phase|Adverse Event|0|||
161455594|NCT00992589|583064852|FG000|Open-Label Phase|Withdrawal by Subject|20|||
161455595|NCT00992589|583064853|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161455596|NCT00992589|583064854|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161455597|NCT00992589|583064855|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161455598|NCT00992589|583064852|FG000|Open-Label Phase|Lost to Follow-up|1|||
161455599|NCT00992589|583064853|FG001|Open-Label Phase|Lost to Follow-up|0|||
161455600|NCT00992589|583064854|FG002|Open-Label Phase|Lost to Follow-up|0|||
161455601|NCT00992589|583064855|FG003|Open-Label Phase|Lost to Follow-up|0|||
161455602|NCT00992589|583064852|FG000|Open-Label Phase|Protocol Violation|3|||
161455603|NCT00992589|583064853|FG001|Open-Label Phase|Protocol Violation|0|||
161455604|NCT00992589|583064854|FG002|Open-Label Phase|Protocol Violation|0|||
161455605|NCT00992589|583064855|FG003|Open-Label Phase|Protocol Violation|0|||
161455606|NCT00992589|583064852|FG000|Open-Label Phase|Physician Decision|4|||
161455607|NCT00992589|583064853|FG001|Open-Label Phase|Physician Decision|0|||
161455608|NCT00992589|583064854|FG002|Open-Label Phase|Physician Decision|0|||
161455609|NCT00992589|583064855|FG003|Open-Label Phase|Physician Decision|0|||
161455610|NCT00992589|583064852|FG000|Open-Label Phase|Other|45|||
161455611|NCT00992589|583064853|FG001|Open-Label Phase|Other|0|||
161455612|NCT00992589|583064854|FG002|Open-Label Phase|Other|0|||
161455613|NCT00992589|583064855|FG003|Open-Label Phase|Other|0|||
161455614|NCT00992589|583064852|FG000|Double-Blind Phase|Adverse Event|0|||
161455615|NCT00992589|583064853|FG001|Double-Blind Phase|Adverse Event|6|||
161455616|NCT00992589|583064854|FG002|Double-Blind Phase|Adverse Event|2|||
161455617|NCT00992589|583064855|FG003|Double-Blind Phase|Adverse Event|3|||
161455618|NCT00992589|583064852|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161455619|NCT00992589|583064853|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161455620|NCT00992589|583064854|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
161455621|NCT00992589|583064855|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
161455622|NCT00992589|583064852|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161455623|NCT00992589|583064853|FG001|Double-Blind Phase|Lost to Follow-up|0|||
161455624|NCT00992589|583064854|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161455625|NCT00992589|583064855|FG003|Double-Blind Phase|Lost to Follow-up|2|||
161455626|NCT00992589|583064852|FG000|Double-Blind Phase|Other|0|||
161455627|NCT00992589|583064853|FG001|Double-Blind Phase|Other|1|||
161455628|NCT00992589|583064854|FG002|Double-Blind Phase|Other|6|||
161455629|NCT00992589|583064855|FG003|Double-Blind Phase|Other|3|||
161455630|NCT00045942|583064856|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
161455631|NCT00045942|583064857|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455632|NCT00045942|583064858|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161807951|NCT05472038|584342691|FG002|Overall Study|Withdrawal by Subject|1|||
161807952|NCT05472038|584342692|FG003|Overall Study|Withdrawal by Subject|6|||
161807953|NCT05472038|584342693|FG004|Overall Study|Withdrawal by Subject|1|||
161807954|NCT05472038|584342694|FG005|Overall Study|Withdrawal by Subject|3|||
161807955|NCT05472038|584342695|FG006|Overall Study|Withdrawal by Subject|0|||
161807956|NCT05472038|584342696|FG007|Overall Study|Withdrawal by Subject|2|||
161807957|NCT05472038|584342697|FG008|Overall Study|Withdrawal by Subject|3|||
161807958|NCT05472038|584342698|FG009|Overall Study|Withdrawal by Subject|1|||
161807959|NCT05472038|584342699|FG010|Overall Study|Withdrawal by Subject|2|||
161807960|NCT05472038|584342700|FG011|Overall Study|Withdrawal by Subject|2|||
161455633|NCT00045942|583064859|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455634|NCT00045942|583064860|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455635|NCT00045942|583064861|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455636|NCT00045942|583064862|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455637|NCT00045942|583064863|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455638|NCT00045942|583064864|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161455639|NCT00045942|583064856|FG000|PKC412A2104 (Core)|Adverse Event|5|||
161455640|NCT00045942|583064857|FG001|PKC412A2104 (Core)|Adverse Event|0|||
161455641|NCT00045942|583064858|FG002|PKC412A2104 (Core)|Adverse Event|0|||
161807961|NCT05472038|584342689|FG000|Overall Study|Protocol Violation|0|||
161455642|NCT00045942|583064859|FG003|PKC412A2104 (Core)|Adverse Event|0|||
161455643|NCT00045942|583064860|FG004|PKC412A2104 (Core)|Adverse Event|0|||
161455644|NCT00045942|583064861|FG005|PKC412A2104 (Core)|Adverse Event|0|||
161455645|NCT00045942|583064862|FG006|PKC412A2104 (Core)|Adverse Event|0|||
161455646|NCT00045942|583064863|FG007|PKC412A2104 (Core)|Adverse Event|0|||
161455647|NCT00045942|583064864|FG008|PKC412A2104 (Core)|Adverse Event|0|||
161455648|NCT00045942|583064856|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
161455649|NCT00045942|583064857|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455650|NCT00045942|583064858|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455651|NCT00045942|583064859|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455652|NCT00045942|583064860|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
161911582|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Other|3|||
161911583|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Other|0|||
161911584|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
161911585|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
161911586|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
161455653|NCT00045942|583064861|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455654|NCT00045942|583064862|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455655|NCT00045942|583064863|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455656|NCT00045942|583064864|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
161455657|NCT00045942|583064856|FG000|PKC412A2104 (Core)|Death|1|||
161455658|NCT00045942|583064857|FG001|PKC412A2104 (Core)|Death|0|||
161455659|NCT00045942|583064858|FG002|PKC412A2104 (Core)|Death|0|||
161455660|NCT00045942|583064859|FG003|PKC412A2104 (Core)|Death|0|||
161455661|NCT00045942|583064860|FG004|PKC412A2104 (Core)|Death|0|||
161455662|NCT00045942|583064861|FG005|PKC412A2104 (Core)|Death|0|||
161455663|NCT00045942|583064862|FG006|PKC412A2104 (Core)|Death|0|||
161455664|NCT00045942|583064863|FG007|PKC412A2104 (Core)|Death|0|||
161455665|NCT00045942|583064864|FG008|PKC412A2104 (Core)|Death|0|||
161455666|NCT00045942|583064856|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
161455667|NCT00045942|583064857|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
161455668|NCT00045942|583064858|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
161455669|NCT00045942|583064859|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
161455670|NCT00045942|583064860|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
161455671|NCT00045942|583064861|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
161455672|NCT00045942|583064862|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
161455673|NCT00045942|583064863|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
161455674|NCT00045942|583064864|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
161455675|NCT00045942|583064856|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
161455676|NCT00045942|583064857|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
161455677|NCT00045942|583064858|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
161455678|NCT00045942|583064859|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
161455679|NCT00045942|583064860|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
161455680|NCT00045942|583064861|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
161455681|NCT00045942|583064862|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
161455682|NCT00045942|583064863|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
161455683|NCT00045942|583064864|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
161455684|NCT00045942|583064856|FG000|PKC412A2104E1|Lack of Efficacy|0|||
161455685|NCT00045942|583064857|FG001|PKC412A2104E1|Lack of Efficacy|11|||
161455686|NCT00045942|583064858|FG002|PKC412A2104E1|Lack of Efficacy|11|||
161455687|NCT00045942|583064859|FG003|PKC412A2104E1|Lack of Efficacy|23|||
161455688|NCT00045942|583064860|FG004|PKC412A2104E1|Lack of Efficacy|17|||
161455689|NCT00045942|583064861|FG005|PKC412A2104E1|Lack of Efficacy|0|||
161455690|NCT00045942|583064862|FG006|PKC412A2104E1|Lack of Efficacy|0|||
161455691|NCT00045942|583064863|FG007|PKC412A2104E1|Lack of Efficacy|0|||
161455692|NCT00045942|583064864|FG008|PKC412A2104E1|Lack of Efficacy|0|||
161455693|NCT00045942|583064856|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
161455694|NCT00045942|583064857|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
161455695|NCT00045942|583064858|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
161455696|NCT00045942|583064859|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
161455697|NCT00045942|583064860|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
161455698|NCT00045942|583064861|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
161455699|NCT00045942|583064862|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
161455700|NCT00045942|583064863|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
161455701|NCT00045942|583064864|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
161455702|NCT00045942|583064856|FG000|PKC412A2104E1|Adverse Event|0|||
161455703|NCT00045942|583064857|FG001|PKC412A2104E1|Adverse Event|1|||
161455704|NCT00045942|583064858|FG002|PKC412A2104E1|Adverse Event|1|||
161455705|NCT00045942|583064859|FG003|PKC412A2104E1|Adverse Event|3|||
161455706|NCT00045942|583064860|FG004|PKC412A2104E1|Adverse Event|6|||
161455707|NCT00045942|583064861|FG005|PKC412A2104E1|Adverse Event|0|||
161455708|NCT00045942|583064862|FG006|PKC412A2104E1|Adverse Event|0|||
161455709|NCT00045942|583064863|FG007|PKC412A2104E1|Adverse Event|0|||
161455710|NCT00045942|583064864|FG008|PKC412A2104E1|Adverse Event|0|||
161455711|NCT00045942|583064856|FG000|PKC412A2104E1|Death|0|||
161455712|NCT00045942|583064857|FG001|PKC412A2104E1|Death|4|||
161455713|NCT00045942|583064858|FG002|PKC412A2104E1|Death|1|||
161455714|NCT00045942|583064859|FG003|PKC412A2104E1|Death|1|||
161455715|NCT00045942|583064860|FG004|PKC412A2104E1|Death|1|||
161455716|NCT00045942|583064861|FG005|PKC412A2104E1|Death|0|||
161565904|NCT02001623|583462185|FG002|Overall Study|Physician Decision|0|||
161807962|NCT05472038|584342690|FG001|Overall Study|Protocol Violation|0|||
161807963|NCT05472038|584342691|FG002|Overall Study|Protocol Violation|0|||
161807964|NCT05472038|584342692|FG003|Overall Study|Protocol Violation|0|||
161807965|NCT05472038|584342693|FG004|Overall Study|Protocol Violation|0|||
161807966|NCT05472038|584342694|FG005|Overall Study|Protocol Violation|0|||
161807967|NCT05472038|584342695|FG006|Overall Study|Protocol Violation|0|||
161807968|NCT05472038|584342696|FG007|Overall Study|Protocol Violation|1|||
161807969|NCT05472038|584342697|FG008|Overall Study|Protocol Violation|1|||
161807970|NCT05472038|584342698|FG009|Overall Study|Protocol Violation|1|||
161807971|NCT05472038|584342699|FG010|Overall Study|Protocol Violation|1|||
161807972|NCT05472038|584342700|FG011|Overall Study|Protocol Violation|1|||
161807973|NCT05472038|584342689|FG000|Overall Study|Not vaccinated|0|||
161807974|NCT05472038|584342690|FG001|Overall Study|Not vaccinated|0|||
161807975|NCT05472038|584342691|FG002|Overall Study|Not vaccinated|0|||
161807976|NCT05472038|584342692|FG003|Overall Study|Not vaccinated|1|||
161807977|NCT05472038|584342693|FG004|Overall Study|Not vaccinated|0|||
161807978|NCT05472038|584342694|FG005|Overall Study|Not vaccinated|0|||
161807979|NCT05472038|584342695|FG006|Overall Study|Not vaccinated|0|||
161807980|NCT05472038|584342696|FG007|Overall Study|Not vaccinated|0|||
161807981|NCT05472038|584342697|FG008|Overall Study|Not vaccinated|0|||
161807982|NCT05472038|584342698|FG009|Overall Study|Not vaccinated|0|||
161807983|NCT05472038|584342699|FG010|Overall Study|Not vaccinated|0|||
161807984|NCT05472038|584342700|FG011|Overall Study|Not vaccinated|0|||
161807985|NCT03235739|584342701|FG000|Overall Study|Withdrawal by Subject|2|||
161807986|NCT03235739|584342702|FG001|Overall Study|Withdrawal by Subject|2|||
161807987|NCT03235739|584342701|FG000|Overall Study|Physician Decision|0|||
161807988|NCT03235739|584342702|FG001|Overall Study|Physician Decision|1|||
161807989|NCT00070291|584342705|FG000|Step 1|Withdrawal by Subject|1|||
161807990|NCT00070291|584342705|FG000|Step 1|Adverse Event|1|||
161807991|NCT00070291|584342705|FG000|Step 2|Adverse Event|1|||
161807992|NCT02096211|584342706|FG000|Overall Study|Death|2|||
161807993|NCT02096211|584342706|FG000|Overall Study|Withdrawal by Subject|8|||
161807994|NCT02096211|584342706|FG000|Overall Study|Revision of implant|7|||
161807995|NCT02096211|584342706|FG000|Overall Study|Lost to Follow-up|43|||
161807996|NCT01591785|584342710|FG000|Overall Study|worsening condition|1|||
161807997|NCT01591785|584342711|FG001|Overall Study|worsening condition|2|||
161807998|NCT01591785|584342710|FG000|Overall Study|Protocol Violation|2|||
161807999|NCT01591785|584342711|FG001|Overall Study|Protocol Violation|0|||
161808000|NCT01591785|584342710|FG000|Overall Study|Lost to Follow-up|1|||
161808001|NCT01591785|584342711|FG001|Overall Study|Lost to Follow-up|0|||
161808002|NCT01049334|584342712|FG000|Overall Study|Withdrawal by Subject|5|||
161808003|NCT01049334|584342713|FG001|Overall Study|Withdrawal by Subject|3|||
161808004|NCT01049334|584342712|FG000|Overall Study|Adverse Event|2|||
161808005|NCT01049334|584342713|FG001|Overall Study|Adverse Event|3|||
161808006|NCT01049334|584342712|FG000|Overall Study|Physician Decision|2|||
161808007|NCT01049334|584342713|FG001|Overall Study|Physician Decision|0|||
161808008|NCT01049334|584342712|FG000|Overall Study|Protocol Violation|0|||
161808009|NCT01049334|584342713|FG001|Overall Study|Protocol Violation|1|||
161808010|NCT02883452|584342714|FG000|Overall Study|Withdrawal by Subject|1|||
161808011|NCT02883452|584342715|FG001|Overall Study|Withdrawal by Subject|1|||
161808012|NCT02883452|584342716|FG002|Overall Study|Withdrawal by Subject|3|||
161565905|NCT02001623|583462186|FG003|Overall Study|Physician Decision|0|||
161565906|NCT02001623|583462187|FG004|Overall Study|Physician Decision|0|||
161565907|NCT02001623|583462188|FG005|Overall Study|Physician Decision|0|||
161565908|NCT02001623|583462189|FG006|Overall Study|Physician Decision|0|||
161565909|NCT02001623|583462190|FG007|Overall Study|Physician Decision|0|||
161565910|NCT02001623|583462191|FG008|Overall Study|Physician Decision|3|||
161565911|NCT02001623|583462192|FG009|Overall Study|Physician Decision|2|||
161565912|NCT02001623|583462193|FG010|Overall Study|Physician Decision|3|||
161565913|NCT02001623|583462194|FG011|Overall Study|Physician Decision|3|||
161565914|NCT02001623|583462195|FG012|Overall Study|Physician Decision|1|||
161565915|NCT02001623|583462196|FG013|Overall Study|Physician Decision|2|||
161565916|NCT02001623|583462197|FG014|Overall Study|Physician Decision|1|||
161565917|NCT02001623|583462183|FG000|Overall Study|Death|0|||
161565918|NCT02001623|583462184|FG001|Overall Study|Death|1|||
161565919|NCT02001623|583462185|FG002|Overall Study|Death|0|||
161565920|NCT02001623|583462186|FG003|Overall Study|Death|0|||
161565921|NCT02001623|583462187|FG004|Overall Study|Death|0|||
161565922|NCT02001623|583462188|FG005|Overall Study|Death|0|||
161808013|NCT02883452|584342717|FG003|Overall Study|Withdrawal by Subject|0|||
161808014|NCT02883452|584342718|FG004|Overall Study|Withdrawal by Subject|2|||
161808015|NCT02883452|584342719|FG005|Overall Study|Withdrawal by Subject|5|||
161808016|NCT02883452|584342714|FG000|Overall Study|Disease progression|1|||
161808017|NCT02883452|584342715|FG001|Overall Study|Disease progression|0|||
161808018|NCT02883452|584342716|FG002|Overall Study|Disease progression|0|||
161808019|NCT02883452|584342717|FG003|Overall Study|Disease progression|1|||
161808020|NCT02883452|584342718|FG004|Overall Study|Disease progression|4|||
161808021|NCT02883452|584342719|FG005|Overall Study|Disease progression|5|||
161565923|NCT02001623|583462189|FG006|Overall Study|Death|0|||
161808022|NCT02883452|584342714|FG000|Overall Study|Adverse Event|2|||
161455717|NCT00045942|583064862|FG006|PKC412A2104E1|Death|0|||
161455718|NCT00045942|583064863|FG007|PKC412A2104E1|Death|0|||
161455719|NCT00045942|583064864|FG008|PKC412A2104E1|Death|0|||
161455720|NCT00045942|583064856|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455721|NCT00045942|583064857|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455722|NCT00045942|583064858|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
161455723|NCT00045942|583064859|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
161565924|NCT02001623|583462190|FG007|Overall Study|Death|0|||
161565925|NCT02001623|583462191|FG008|Overall Study|Death|0|||
161565926|NCT02001623|583462192|FG009|Overall Study|Death|0|||
161565927|NCT02001623|583462193|FG010|Overall Study|Death|0|||
161565928|NCT02001623|583462194|FG011|Overall Study|Death|0|||
161565929|NCT02001623|583462195|FG012|Overall Study|Death|0|||
161565930|NCT02001623|583462196|FG013|Overall Study|Death|0|||
161565931|NCT02001623|583462197|FG014|Overall Study|Death|0|||
161565932|NCT02001623|583462183|FG000|Overall Study|Adverse Event|0|||
161565933|NCT02001623|583462184|FG001|Overall Study|Adverse Event|0|||
161565934|NCT02001623|583462185|FG002|Overall Study|Adverse Event|0|||
161565935|NCT02001623|583462186|FG003|Overall Study|Adverse Event|0|||
161565936|NCT02001623|583462187|FG004|Overall Study|Adverse Event|0|||
161455724|NCT00045942|583064860|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455725|NCT00045942|583064861|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455726|NCT00045942|583064862|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455727|NCT00045942|583064863|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455728|NCT00045942|583064864|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
161455729|NCT00045942|583064856|FG000|PKC412A2104E2|Lost to Follow-up|0|||
161455730|NCT00045942|583064857|FG001|PKC412A2104E2|Lost to Follow-up|0|||
161455731|NCT00045942|583064858|FG002|PKC412A2104E2|Lost to Follow-up|0|||
161455732|NCT00045942|583064859|FG003|PKC412A2104E2|Lost to Follow-up|0|||
161455733|NCT00045942|583064860|FG004|PKC412A2104E2|Lost to Follow-up|0|||
161455734|NCT00045942|583064861|FG005|PKC412A2104E2|Lost to Follow-up|0|||
161455735|NCT00045942|583064862|FG006|PKC412A2104E2|Lost to Follow-up|0|||
161455736|NCT00045942|583064863|FG007|PKC412A2104E2|Lost to Follow-up|3|||
161455737|NCT00045942|583064864|FG008|PKC412A2104E2|Lost to Follow-up|0|||
161455738|NCT00045942|583064856|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
161455739|NCT00045942|583064857|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
161455740|NCT00045942|583064858|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
161455741|NCT00045942|583064859|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
161455742|NCT00045942|583064860|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
161455743|NCT00045942|583064861|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
161455744|NCT00045942|583064862|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
161565937|NCT02001623|583462188|FG005|Overall Study|Adverse Event|1|||
161565938|NCT02001623|583462189|FG006|Overall Study|Adverse Event|0|||
161808023|NCT02883452|584342715|FG001|Overall Study|Adverse Event|1|||
161808024|NCT02883452|584342716|FG002|Overall Study|Adverse Event|1|||
161808025|NCT02883452|584342717|FG003|Overall Study|Adverse Event|1|||
161808026|NCT02883452|584342718|FG004|Overall Study|Adverse Event|1|||
161808027|NCT02883452|584342719|FG005|Overall Study|Adverse Event|3|||
161808028|NCT02883452|584342714|FG000|Overall Study|Physician Decision|0|||
161808029|NCT02883452|584342715|FG001|Overall Study|Physician Decision|0|||
161808030|NCT02883452|584342716|FG002|Overall Study|Physician Decision|0|||
161808031|NCT02883452|584342717|FG003|Overall Study|Physician Decision|0|||
161808032|NCT02883452|584342718|FG004|Overall Study|Physician Decision|4|||
161808033|NCT02883452|584342719|FG005|Overall Study|Physician Decision|1|||
161808034|NCT02883452|584342714|FG000|Overall Study|Death|1|||
161808035|NCT02883452|584342715|FG001|Overall Study|Death|0|||
161808036|NCT02883452|584342716|FG002|Overall Study|Death|1|||
161808037|NCT02883452|584342717|FG003|Overall Study|Death|0|||
161808038|NCT02883452|584342718|FG004|Overall Study|Death|0|||
161808039|NCT02883452|584342719|FG005|Overall Study|Death|0|||
161808040|NCT02883452|584342714|FG000|Overall Study|Other|0|||
161455745|NCT00045942|583064863|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
161455746|NCT00045942|583064864|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
161455747|NCT00045942|583064856|FG000|PKC412A2104E2|Lack of Efficacy|0|||
161455748|NCT00045942|583064857|FG001|PKC412A2104E2|Lack of Efficacy|0|||
161455749|NCT00045942|583064858|FG002|PKC412A2104E2|Lack of Efficacy|0|||
161455750|NCT00045942|583064859|FG003|PKC412A2104E2|Lack of Efficacy|0|||
161455751|NCT00045942|583064860|FG004|PKC412A2104E2|Lack of Efficacy|0|||
161455752|NCT00045942|583064861|FG005|PKC412A2104E2|Lack of Efficacy|3|||
161455753|NCT00045942|583064862|FG006|PKC412A2104E2|Lack of Efficacy|2|||
161565939|NCT02001623|583462190|FG007|Overall Study|Adverse Event|3|||
161565940|NCT02001623|583462191|FG008|Overall Study|Adverse Event|4|||
161565941|NCT02001623|583462192|FG009|Overall Study|Adverse Event|6|||
161565942|NCT02001623|583462193|FG010|Overall Study|Adverse Event|4|||
161808041|NCT02883452|584342715|FG001|Overall Study|Other|0|||
161808042|NCT02883452|584342716|FG002|Overall Study|Other|0|||
161808043|NCT02883452|584342717|FG003|Overall Study|Other|0|||
161808044|NCT02883452|584342718|FG004|Overall Study|Other|0|||
161808045|NCT02883452|584342719|FG005|Overall Study|Other|1|||
161808046|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
161808047|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
161808048|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Death|2|||
161808049|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Death|1|||
161808050|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
161808051|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
161808052|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
161808053|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
161808054|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Other|8|||
161808055|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Other|13|||
161808056|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
161911587|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Ongoing|86|||
161911588|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Ongoing|96|||
161911589|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Ongoing|0|||
161911590|NCT04006457|584728614|FG000|Main Study Observation Period|Adverse Event|1|||
161911591|NCT04006457|584728615|FG001|Main Study Observation Period|Adverse Event|1|||
161911592|NCT04006457|584728616|FG002|Main Study Observation Period|Adverse Event|0|||
161911593|NCT04006457|584728614|FG000|Main Study Observation Period|Lost to Follow-up|0|||
161911594|NCT04006457|584728615|FG001|Main Study Observation Period|Lost to Follow-up|1|||
161911595|NCT04006457|584728616|FG002|Main Study Observation Period|Lost to Follow-up|0|||
161911596|NCT04006457|584728614|FG000|Main Study Observation Period|Pregnancy|1|||
161911597|NCT04006457|584728615|FG001|Main Study Observation Period|Pregnancy|0|||
161911598|NCT04006457|584728616|FG002|Main Study Observation Period|Pregnancy|0|||
161911599|NCT04006457|584728614|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
161911600|NCT04006457|584728615|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
161911601|NCT04006457|584728616|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
161455754|NCT00045942|583064863|FG007|PKC412A2104E2|Lack of Efficacy|2|||
161455755|NCT00045942|583064864|FG008|PKC412A2104E2|Lack of Efficacy|6|||
161455756|NCT00045942|583064856|FG000|PKC412A2104E2|Adverse Event|0|||
161455757|NCT00045942|583064857|FG001|PKC412A2104E2|Adverse Event|0|||
161455758|NCT00045942|583064858|FG002|PKC412A2104E2|Adverse Event|0|||
161455759|NCT00045942|583064859|FG003|PKC412A2104E2|Adverse Event|0|||
161455760|NCT00045942|583064860|FG004|PKC412A2104E2|Adverse Event|0|||
161455761|NCT00045942|583064861|FG005|PKC412A2104E2|Adverse Event|4|||
161455762|NCT00045942|583064862|FG006|PKC412A2104E2|Adverse Event|3|||
161455763|NCT00045942|583064863|FG007|PKC412A2104E2|Adverse Event|1|||
161455764|NCT00045942|583064864|FG008|PKC412A2104E2|Adverse Event|0|||
161455765|NCT00045942|583064856|FG000|PKC412A2104E2|Death|0|||
161455766|NCT00045942|583064857|FG001|PKC412A2104E2|Death|0|||
161455767|NCT00045942|583064858|FG002|PKC412A2104E2|Death|0|||
161455768|NCT00045942|583064859|FG003|PKC412A2104E2|Death|0|||
161455769|NCT00045942|583064860|FG004|PKC412A2104E2|Death|0|||
161455770|NCT00045942|583064861|FG005|PKC412A2104E2|Death|1|||
161455771|NCT00045942|583064862|FG006|PKC412A2104E2|Death|2|||
161455772|NCT00045942|583064863|FG007|PKC412A2104E2|Death|0|||
161455773|NCT00045942|583064864|FG008|PKC412A2104E2|Death|0|||
161455774|NCT05508074|583064865|FG000|Overall Study|Death|2|||
161455775|NCT05508074|583064866|FG001|Overall Study|Death|5|||
161455776|NCT05508074|583064865|FG000|Overall Study|Withdrawal by Subject|1|||
161455777|NCT05508074|583064866|FG001|Overall Study|Withdrawal by Subject|2|||
161455778|NCT05508074|583064865|FG000|Overall Study|Adverse Event|0|||
161455779|NCT05508074|583064866|FG001|Overall Study|Adverse Event|1|||
161455780|NCT05508074|583064865|FG000|Overall Study|Physician Decision|0|||
161455781|NCT05508074|583064866|FG001|Overall Study|Physician Decision|1|||
161455782|NCT05508074|583064865|FG000|Overall Study|wrongly randomized|0|||
161455783|NCT05508074|583064866|FG001|Overall Study|wrongly randomized|1|||
161455784|NCT05508074|583064865|FG000|Overall Study|non-compliance|0|||
161455785|NCT05508074|583064866|FG001|Overall Study|non-compliance|1|||
161455786|NCT02142387|583064867|FG000|Overall Study|<19 years old|49|||
161455787|NCT02142387|583064868|FG001|Overall Study|<19 years old|326|||
161455788|NCT02142387|583064867|FG000|Overall Study|non-cardiac etiology|504|||
161455789|NCT02142387|583064868|FG001|Overall Study|non-cardiac etiology|3431|||
161455790|NCT02142387|583064867|FG000|Overall Study|CPR not performed|74|||
161455791|NCT02142387|583064868|FG001|Overall Study|CPR not performed|473|||
161455792|NCT02142387|583064867|FG000|Overall Study|witnessed by paramedic|139|||
161455793|NCT02142387|583064868|FG001|Overall Study|witnessed by paramedic|917|||
161455794|NCT02142387|583064867|FG000|Overall Study|incomplete data|1|||
161455795|NCT02142387|583064868|FG001|Overall Study|incomplete data|9|||
161455796|NCT02142387|583064867|FG000|Overall Study|occurred not at home|298|||
161455797|NCT02142387|583064868|FG001|Overall Study|occurred not at home|2474|||
161455798|NCT01101308|583064869|FG000|Period 1|Adverse Event|2|||
161455799|NCT01101308|583064870|FG001|Period 1|Adverse Event|1|||
161455800|NCT01101308|583064869|FG000|Period 1|Positive for cotinine|1|||
161455801|NCT01101308|583064870|FG001|Period 1|Positive for cotinine|0|||
161455802|NCT02984943|583064871|FG000|Overall Study|Withdrawal by Subject|3|||
161455803|NCT02984943|583064871|FG000|Overall Study|Physician Decision|1|||
161455804|NCT02282345|583064874|FG000|Overall Study|Progression|0|||
161455805|NCT02282345|583064875|FG001|Overall Study|Progression|1|||
161808057|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
161808058|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
161455806|NCT02296138|583064876|FG000|Overall Study|Adverse Event|348|||
161455807|NCT02296138|583064877|FG001|Overall Study|Adverse Event|259|||
161455808|NCT02296138|583064876|FG000|Overall Study|Lack of Efficacy|59|||
161455809|NCT02296138|583064877|FG001|Overall Study|Lack of Efficacy|37|||
161455810|NCT02296138|583064876|FG000|Overall Study|Protocol Violation|35|||
161455811|NCT02296138|583064877|FG001|Overall Study|Protocol Violation|36|||
161455812|NCT02296138|583064876|FG000|Overall Study|Lost to Follow-up|9|||
161455813|NCT02296138|583064877|FG001|Overall Study|Lost to Follow-up|12|||
161455814|NCT02296138|583064876|FG000|Overall Study|Withdrawal by Subject|184|||
161455815|NCT02296138|583064877|FG001|Overall Study|Withdrawal by Subject|131|||
161455816|NCT02296138|583064876|FG000|Overall Study|Not Treated|1|||
161455817|NCT02296138|583064877|FG001|Overall Study|Not Treated|1|||
161455818|NCT02296138|583064876|FG000|Overall Study|Patients with data irregularities|10|||
161455819|NCT02296138|583064877|FG001|Overall Study|Patients with data irregularities|11|||
161455820|NCT02296138|583064876|FG000|Overall Study|Other than specified|15|||
161455821|NCT02296138|583064877|FG001|Overall Study|Other than specified|13|||
161455822|NCT00711516|583064878|FG000|Overall Study|Adverse Event|1|||
161455823|NCT00711516|583064879|FG001|Overall Study|Adverse Event|1|||
161455824|NCT00711516|583064878|FG000|Overall Study|Withdrawal by Subject|0|||
161455825|NCT00711516|583064879|FG001|Overall Study|Withdrawal by Subject|1|||
161455826|NCT00711516|583064878|FG000|Overall Study|Protocol Violation|0|||
161455827|NCT00711516|583064879|FG001|Overall Study|Protocol Violation|1|||
161565943|NCT02001623|583462194|FG011|Overall Study|Adverse Event|0|||
161565944|NCT02001623|583462195|FG012|Overall Study|Adverse Event|3|||
161565945|NCT02001623|583462196|FG013|Overall Study|Adverse Event|5|||
161565946|NCT02001623|583462197|FG014|Overall Study|Adverse Event|6|||
161565947|NCT02001623|583462183|FG000|Overall Study|Other - Miscellaneous|0|||
161565948|NCT02001623|583462184|FG001|Overall Study|Other - Miscellaneous|0|||
161565949|NCT02001623|583462185|FG002|Overall Study|Other - Miscellaneous|0|||
161565950|NCT02001623|583462186|FG003|Overall Study|Other - Miscellaneous|0|||
161565951|NCT02001623|583462187|FG004|Overall Study|Other - Miscellaneous|0|||
161565952|NCT02001623|583462188|FG005|Overall Study|Other - Miscellaneous|0|||
161565953|NCT02001623|583462189|FG006|Overall Study|Other - Miscellaneous|0|||
161565954|NCT02001623|583462190|FG007|Overall Study|Other - Miscellaneous|0|||
161565955|NCT02001623|583462191|FG008|Overall Study|Other - Miscellaneous|0|||
161565956|NCT02001623|583462192|FG009|Overall Study|Other - Miscellaneous|1|||
161455828|NCT04575597|583064880|FG000|Overall Study|Death|0|||
161455829|NCT04575597|583064881|FG001|Overall Study|Death|0|||
161455830|NCT04575597|583064882|FG002|Overall Study|Death|0|||
161455831|NCT04575597|583064883|FG003|Overall Study|Death|1|||
161455832|NCT04575597|583064884|FG004|Overall Study|Death|3|||
161455833|NCT04575597|583064885|FG005|Overall Study|Death|14|||
161455834|NCT04575597|583064880|FG000|Overall Study|Lost to Follow-up|2|||
161455835|NCT04575597|583064881|FG001|Overall Study|Lost to Follow-up|1|||
161455836|NCT04575597|583064882|FG002|Overall Study|Lost to Follow-up|1|||
161455837|NCT04575597|583064883|FG003|Overall Study|Lost to Follow-up|2|||
161455838|NCT04575597|583064884|FG004|Overall Study|Lost to Follow-up|10|||
161455839|NCT04575597|583064885|FG005|Overall Study|Lost to Follow-up|8|||
161455840|NCT04575597|583064880|FG000|Overall Study|Withdrawal by Subject|2|||
161455841|NCT04575597|583064881|FG001|Overall Study|Withdrawal by Subject|2|||
161455842|NCT04575597|583064882|FG002|Overall Study|Withdrawal by Subject|4|||
161455843|NCT04575597|583064883|FG003|Overall Study|Withdrawal by Subject|2|||
161455844|NCT04575597|583064884|FG004|Overall Study|Withdrawal by Subject|25|||
161455845|NCT04575597|583064885|FG005|Overall Study|Withdrawal by Subject|28|||
161455846|NCT04575597|583064880|FG000|Overall Study|Not Recorded|0|||
161565957|NCT02001623|583462193|FG010|Overall Study|Other - Miscellaneous|0|||
161565958|NCT02001623|583462194|FG011|Overall Study|Other - Miscellaneous|0|||
161565959|NCT02001623|583462195|FG012|Overall Study|Other - Miscellaneous|0|||
161455847|NCT04575597|583064881|FG001|Overall Study|Not Recorded|0|||
161455848|NCT04575597|583064882|FG002|Overall Study|Not Recorded|0|||
161455849|NCT04575597|583064883|FG003|Overall Study|Not Recorded|0|||
161455850|NCT04575597|583064884|FG004|Overall Study|Not Recorded|0|||
161455851|NCT04575597|583064885|FG005|Overall Study|Not Recorded|2|||
161455852|NCT04575597|583064880|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161565960|NCT02001623|583462196|FG013|Overall Study|Other - Miscellaneous|1|||
161455853|NCT04575597|583064881|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161565961|NCT02001623|583462197|FG014|Overall Study|Other - Miscellaneous|0|||
161565962|NCT02001623|583462183|FG000|Overall Study|Withdrawal by Subject|1|||
161565963|NCT02001623|583462184|FG001|Overall Study|Withdrawal by Subject|0|||
161565964|NCT02001623|583462185|FG002|Overall Study|Withdrawal by Subject|0|||
161565965|NCT02001623|583462186|FG003|Overall Study|Withdrawal by Subject|0|||
161565966|NCT02001623|583462187|FG004|Overall Study|Withdrawal by Subject|0|||
161455854|NCT04575597|583064882|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161455855|NCT04575597|583064883|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161455856|NCT04575597|583064884|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
161455857|NCT04575597|583064885|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161455858|NCT02095132|583064892|FG000|Overall Study|Adverse Event|0|||
161911602|NCT04006457|584728614|FG000|Main Study Observation Period|Other|8|||
161911603|NCT04006457|584728615|FG001|Main Study Observation Period|Other|16|||
161911604|NCT04006457|584728616|FG002|Main Study Observation Period|Other|0|||
161565967|NCT02001623|583462188|FG005|Overall Study|Withdrawal by Subject|0|||
161911605|NCT04006457|584728614|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
161911606|NCT04006457|584728615|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
161911607|NCT04006457|584728616|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
161911608|NCT04006457|584728614|FG000|Main Study Observation Period|Ongoing|2|||
161911609|NCT04006457|584728615|FG001|Main Study Observation Period|Ongoing|1|||
161911610|NCT04006457|584728616|FG002|Main Study Observation Period|Ongoing|0|||
161565968|NCT02001623|583462189|FG006|Overall Study|Withdrawal by Subject|0|||
161565969|NCT02001623|583462190|FG007|Overall Study|Withdrawal by Subject|0|||
161565970|NCT02001623|583462191|FG008|Overall Study|Withdrawal by Subject|1|||
161565971|NCT02001623|583462192|FG009|Overall Study|Withdrawal by Subject|3|||
161565972|NCT02001623|583462193|FG010|Overall Study|Withdrawal by Subject|2|||
161565973|NCT02001623|583462194|FG011|Overall Study|Withdrawal by Subject|2|||
161808059|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
161911611|NCT04006457|584728614|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
161911612|NCT04006457|584728615|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
161911613|NCT04006457|584728616|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
161911614|NCT03370172|584728617|FG000|Overall Study|Withdrawal by Subject|0|||
161565974|NCT02001623|583462195|FG012|Overall Study|Withdrawal by Subject|1|||
161565975|NCT02001623|583462196|FG013|Overall Study|Withdrawal by Subject|5|||
161808060|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
161808061|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
161808062|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Death|3|||
161808063|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Death|13|||
161808064|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
161808065|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
161808066|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Other|14|||
161808067|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Other|31|||
161808068|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
161808069|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
161808070|NCT02378935|584342733|FG000|Overall Study|Lack of Efficacy|10|||
161808071|NCT02378935|584342734|FG001|Overall Study|Lack of Efficacy|0|||
161808072|NCT02378935|584342735|FG002|Overall Study|Lack of Efficacy|2|||
161808073|NCT02378935|584342736|FG003|Overall Study|Lack of Efficacy|6|||
161808074|NCT02378935|584342737|FG004|Overall Study|Lack of Efficacy|0|||
161808075|NCT02378935|584342738|FG005|Overall Study|Lack of Efficacy|0|||
161808076|NCT02378935|584342739|FG006|Overall Study|Lack of Efficacy|0|||
161808077|NCT02378935|584342733|FG000|Overall Study|Death|0|||
161808078|NCT02378935|584342734|FG001|Overall Study|Death|0|||
161808079|NCT02378935|584342735|FG002|Overall Study|Death|1|||
161808080|NCT02378935|584342736|FG003|Overall Study|Death|0|||
161808081|NCT02378935|584342737|FG004|Overall Study|Death|0|||
161808082|NCT02378935|584342738|FG005|Overall Study|Death|0|||
161808083|NCT02378935|584342739|FG006|Overall Study|Death|0|||
161808084|NCT03450057|584342744|FG000|Overall Study|Death|17|||
161808085|NCT03450057|584342744|FG000|Overall Study|ICF withdrawal|4|||
161808086|NCT03450057|584342744|FG000|Overall Study|Lost to Follow-up|2|||
161808087|NCT03214952|584342747|FG000|Overall Study|Protocol Deviation|45|||
161808088|NCT03214952|584342747|FG000|Overall Study|Case Report Forms Uncollected|13|||
161808089|NCT03935880|584342748|FG000|Overall Study|Lost to Follow-up|0|||
161808090|NCT03935880|584342749|FG001|Overall Study|Lost to Follow-up|1|||
161808091|NCT02476994|584342750|FG000|Overall Study|Based on feedback from FDA|1|||
161808092|NCT02476994|584342751|FG001|Overall Study|Based on feedback from FDA|0|||
161808093|NCT02246166|584342752|FG000|Overall Study|Protocol Violation|1|||
161808094|NCT02246166|584342753|FG001|Overall Study|Protocol Violation|0|||
161808095|NCT03769896|584342754|FG000|Open-label Phase|Lack of Efficacy|5|||
161808096|NCT03769896|584342755|FG001|Open-label Phase|Lack of Efficacy|0|||
161808097|NCT03769896|584342754|FG000|Open-label Phase|Adverse Event|3|||
161808098|NCT03769896|584342755|FG001|Open-label Phase|Adverse Event|0|||
161808099|NCT03769896|584342754|FG000|Open-label Phase|Withdrawal by Subject|1|||
161808100|NCT03769896|584342755|FG001|Open-label Phase|Withdrawal by Subject|0|||
161808101|NCT01015703|584342756|FG000|Overall Study|Withdrawal by Subject|0|||
161808102|NCT01015703|584342757|FG001|Overall Study|Withdrawal by Subject|1|||
161808103|NCT01015703|584342758|FG002|Overall Study|Withdrawal by Subject|0|||
161808104|NCT01015703|584342759|FG003|Overall Study|Withdrawal by Subject|0|||
161808105|NCT01015703|584342760|FG004|Overall Study|Withdrawal by Subject|0|||
161808106|NCT01015703|584342756|FG000|Overall Study|Adverse Event|1|||
161808107|NCT01015703|584342757|FG001|Overall Study|Adverse Event|0|||
161808108|NCT01015703|584342758|FG002|Overall Study|Adverse Event|0|||
161808109|NCT01015703|584342759|FG003|Overall Study|Adverse Event|0|||
161808110|NCT01015703|584342760|FG004|Overall Study|Adverse Event|0|||
161808111|NCT01015703|584342756|FG000|Overall Study|Protocol Violation|1|||
161808112|NCT01015703|584342757|FG001|Overall Study|Protocol Violation|0|||
161565976|NCT02001623|583462197|FG014|Overall Study|Withdrawal by Subject|2|||
161565977|NCT02001623|583462183|FG000|Overall Study|Lost to Follow-up|0|||
161565978|NCT02001623|583462184|FG001|Overall Study|Lost to Follow-up|0|||
161565979|NCT02001623|583462185|FG002|Overall Study|Lost to Follow-up|0|||
161565980|NCT02001623|583462186|FG003|Overall Study|Lost to Follow-up|0|||
161565981|NCT02001623|583462187|FG004|Overall Study|Lost to Follow-up|0|||
161565982|NCT02001623|583462188|FG005|Overall Study|Lost to Follow-up|0|||
161565983|NCT02001623|583462189|FG006|Overall Study|Lost to Follow-up|0|||
161565984|NCT02001623|583462190|FG007|Overall Study|Lost to Follow-up|0|||
161565985|NCT02001623|583462191|FG008|Overall Study|Lost to Follow-up|0|||
161565986|NCT02001623|583462192|FG009|Overall Study|Lost to Follow-up|1|||
161565987|NCT02001623|583462193|FG010|Overall Study|Lost to Follow-up|0|||
161565988|NCT02001623|583462194|FG011|Overall Study|Lost to Follow-up|0|||
161565989|NCT02001623|583462195|FG012|Overall Study|Lost to Follow-up|0|||
161565990|NCT02001623|583462196|FG013|Overall Study|Lost to Follow-up|0|||
161565991|NCT02001623|583462197|FG014|Overall Study|Lost to Follow-up|0|||
161565992|NCT02001623|583462183|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
161565993|NCT02001623|583462184|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
161565994|NCT02001623|583462185|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
161565995|NCT02001623|583462186|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
161565996|NCT02001623|583462187|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
161565997|NCT02001623|583462188|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
161565998|NCT02001623|583462189|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
161565999|NCT02001623|583462190|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
161566000|NCT02001623|583462191|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
161566001|NCT02001623|583462192|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
161566002|NCT02001623|583462193|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
161566003|NCT02001623|583462194|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
161566004|NCT02001623|583462195|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
161566005|NCT02001623|583462196|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
161566006|NCT02001623|583462197|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
161566007|NCT02001623|583462183|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
161566008|NCT02001623|583462184|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
161566009|NCT02001623|583462185|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
161566010|NCT02001623|583462186|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
161566011|NCT02001623|583462187|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
161566012|NCT02001623|583462188|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
161566013|NCT02001623|583462189|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
161566014|NCT02001623|583462190|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
161566015|NCT02001623|583462191|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
161566016|NCT02001623|583462192|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
161566017|NCT02001623|583462193|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
161566018|NCT02001623|583462194|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
161566019|NCT02001623|583462195|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
161566020|NCT02001623|583462196|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
161566021|NCT02001623|583462197|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
161566022|NCT01063036|583462200|FG000|Participants Treated With Study Drug|Adverse Event|1|||
161566023|NCT01063036|583462200|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
161566024|NCT01063036|583462200|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
161566025|NCT01063036|583462200|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
161566026|NCT01063036|583462200|FG000|Participants Treated With Study Drug|Pregnancy|1|||
161566027|NCT01063036|583462200|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
161566028|NCT01063036|583462200|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
161566029|NCT01063036|583462200|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
161566030|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
161566031|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
161566032|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
161566033|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
161566034|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Adverse Event|198|||
161566035|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Adverse Event|0|||
161566036|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Adverse Event|0|||
161566037|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Adverse Event|0|||
161566038|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Death|62|||
161566039|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Death|0|||
161566040|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Death|0|||
161566041|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Death|0|||
161566042|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
161566043|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
161566044|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
161566045|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
161566046|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Complicating disease|13|||
161566047|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Complicating disease|0|||
161455859|NCT02095132|583064893|FG001|Overall Study|Adverse Event|0|||
161455860|NCT02095132|583064894|FG002|Overall Study|Adverse Event|0|||
161455861|NCT02095132|583064895|FG003|Overall Study|Adverse Event|0|||
161455862|NCT02095132|583064896|FG004|Overall Study|Adverse Event|1|||
161455863|NCT02095132|583064897|FG005|Overall Study|Adverse Event|0|||
161455864|NCT02095132|583064898|FG006|Overall Study|Adverse Event|1|||
161455865|NCT02095132|583064899|FG007|Overall Study|Adverse Event|0|||
161455866|NCT02095132|583064900|FG008|Overall Study|Adverse Event|0|||
161455867|NCT02095132|583064892|FG000|Overall Study|Death|0|||
161455868|NCT02095132|583064893|FG001|Overall Study|Death|0|||
161455869|NCT02095132|583064894|FG002|Overall Study|Death|0|||
161455870|NCT02095132|583064895|FG003|Overall Study|Death|0|||
161455871|NCT02095132|583064896|FG004|Overall Study|Death|0|||
161455872|NCT02095132|583064897|FG005|Overall Study|Death|0|||
161455873|NCT02095132|583064898|FG006|Overall Study|Death|1|||
161455874|NCT02095132|583064899|FG007|Overall Study|Death|0|||
161455875|NCT02095132|583064900|FG008|Overall Study|Death|0|||
161566048|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Complicating disease|0|||
161911615|NCT03370172|584728618|FG001|Overall Study|Withdrawal by Subject|1|||
161911616|NCT05918055|584728619|FG000|Phase I - Dose Level 1|Ineligible|0|||
161911617|NCT05918055|584728620|FG001|Phase I - Dose Level 1|Ineligible|0|||
161911618|NCT05918055|584728621|FG002|Phase I - Dose Level 1|Ineligible|1|||
161911619|NCT05918055|584728619|FG000|Phase I - Dose Level -1|Physician Decision|1|||
161911620|NCT05918055|584728620|FG001|Phase I - Dose Level -1|Physician Decision|0|||
161911621|NCT05918055|584728621|FG002|Phase I - Dose Level -1|Physician Decision|0|||
161911622|NCT02194465|584728622|FG000|Overall Study|Adverse Event|6|||
161911623|NCT02194465|584728623|FG001|Overall Study|Adverse Event|1|||
161911624|NCT02194465|584728624|FG002|Overall Study|Adverse Event|4|||
161911625|NCT02194465|584728625|FG003|Overall Study|Adverse Event|4|||
161911626|NCT02194465|584728626|FG004|Overall Study|Adverse Event|4|||
161911627|NCT02194465|584728627|FG005|Overall Study|Adverse Event|2|||
161911628|NCT02194465|584728628|FG006|Overall Study|Adverse Event|0|||
161911629|NCT02194465|584728622|FG000|Overall Study|Lost to Follow-up|0|||
161808113|NCT01015703|584342758|FG002|Overall Study|Protocol Violation|0|||
161808114|NCT01015703|584342759|FG003|Overall Study|Protocol Violation|0|||
161808115|NCT01015703|584342760|FG004|Overall Study|Protocol Violation|0|||
161808116|NCT03122535|584342761|FG000|Overall Study|Lost to Follow-up|68|||
161808117|NCT03122535|584342762|FG001|Overall Study|Lost to Follow-up|68|||
161808118|NCT03122535|584342761|FG000|Overall Study|Physician Decision|3|||
161808119|NCT03122535|584342762|FG001|Overall Study|Physician Decision|3|||
161808120|NCT03122535|584342761|FG000|Overall Study|Withdrawal by Subject|2|||
161808121|NCT03122535|584342762|FG001|Overall Study|Withdrawal by Subject|2|||
161808122|NCT00857454|584342765|FG000|Overall Study|Withdrawal by Subject|2|||
161808123|NCT00857454|584342765|FG000|Overall Study|Lost to Follow-up|1|||
161566049|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Complicating disease|0|||
161566050|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
161566051|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
161566052|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
161566053|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
161566054|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
161566055|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
161566056|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
161566057|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
161566058|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Non-compliance|4|||
161566059|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Non-compliance|0|||
161566060|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Non-compliance|0|||
161566061|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Non-compliance|0|||
161566062|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Pain|4|||
161566063|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Pain|0|||
161566064|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Pain|0|||
161566065|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Pain|0|||
161566066|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
161566067|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
161566068|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
161566069|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
161566070|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Hospice care|1|||
161566071|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Hospice care|0|||
161808124|NCT00857454|584342765|FG000|Overall Study|Adverse Event|2|||
161808125|NCT00857454|584342765|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
161911630|NCT02194465|584728623|FG001|Overall Study|Lost to Follow-up|0|||
161911631|NCT02194465|584728624|FG002|Overall Study|Lost to Follow-up|0|||
161911632|NCT02194465|584728625|FG003|Overall Study|Lost to Follow-up|1|||
161455876|NCT02095132|583064892|FG000|Overall Study|Lack of Efficacy|3|||
161455877|NCT02095132|583064893|FG001|Overall Study|Lack of Efficacy|5|||
161455878|NCT02095132|583064894|FG002|Overall Study|Lack of Efficacy|2|||
161455879|NCT02095132|583064895|FG003|Overall Study|Lack of Efficacy|8|||
161455880|NCT02095132|583064896|FG004|Overall Study|Lack of Efficacy|3|||
161911633|NCT02194465|584728626|FG004|Overall Study|Lost to Follow-up|0|||
161911634|NCT02194465|584728627|FG005|Overall Study|Lost to Follow-up|1|||
161455881|NCT02095132|583064897|FG005|Overall Study|Lack of Efficacy|6|||
161455882|NCT02095132|583064898|FG006|Overall Study|Lack of Efficacy|10|||
161455883|NCT02095132|583064899|FG007|Overall Study|Lack of Efficacy|9|||
161455884|NCT02095132|583064900|FG008|Overall Study|Lack of Efficacy|8|||
161455885|NCT02095132|583064892|FG000|Overall Study|Physician Decision|1|||
161455886|NCT02095132|583064893|FG001|Overall Study|Physician Decision|0|||
161455887|NCT02095132|583064894|FG002|Overall Study|Physician Decision|0|||
161455888|NCT02095132|583064895|FG003|Overall Study|Physician Decision|0|||
161455889|NCT02095132|583064896|FG004|Overall Study|Physician Decision|0|||
161455890|NCT02095132|583064897|FG005|Overall Study|Physician Decision|0|||
161455891|NCT02095132|583064898|FG006|Overall Study|Physician Decision|1|||
161455892|NCT02095132|583064899|FG007|Overall Study|Physician Decision|0|||
161455893|NCT02095132|583064900|FG008|Overall Study|Physician Decision|2|||
161455894|NCT02095132|583064892|FG000|Overall Study|Withdrawal by Subject|0|||
161455895|NCT02095132|583064893|FG001|Overall Study|Withdrawal by Subject|0|||
161455896|NCT02095132|583064894|FG002|Overall Study|Withdrawal by Subject|2|||
161455897|NCT02095132|583064895|FG003|Overall Study|Withdrawal by Subject|2|||
161455898|NCT02095132|583064896|FG004|Overall Study|Withdrawal by Subject|3|||
161455899|NCT02095132|583064897|FG005|Overall Study|Withdrawal by Subject|0|||
161455900|NCT02095132|583064898|FG006|Overall Study|Withdrawal by Subject|5|||
161455901|NCT02095132|583064899|FG007|Overall Study|Withdrawal by Subject|0|||
161455902|NCT02095132|583064900|FG008|Overall Study|Withdrawal by Subject|0|||
161455903|NCT04905498|583064901|FG000|Overall Study|Lost to Follow-up|0|||
161455904|NCT04905498|583064902|FG001|Overall Study|Lost to Follow-up|2|||
161455905|NCT04905498|583064901|FG000|Overall Study|COVID lockdown|1|||
161455906|NCT04905498|583064902|FG001|Overall Study|COVID lockdown|0|||
161455907|NCT01029405|583064903|FG000|Overall Study|Withdrawal by Subject|0|||
161455908|NCT01029405|583064904|FG001|Overall Study|Withdrawal by Subject|1|||
161455909|NCT01029405|583064905|FG002|Overall Study|Withdrawal by Subject|2|||
161455910|NCT01029405|583064906|FG003|Overall Study|Withdrawal by Subject|0|||
161455911|NCT01029405|583064903|FG000|Overall Study|Protocol Violation|0|||
161455912|NCT01029405|583064904|FG001|Overall Study|Protocol Violation|0|||
161455913|NCT01029405|583064905|FG002|Overall Study|Protocol Violation|0|||
161455914|NCT01029405|583064906|FG003|Overall Study|Protocol Violation|1|||
161455915|NCT01029405|583064903|FG000|Overall Study|Adverse Event|0|||
161455916|NCT01029405|583064904|FG001|Overall Study|Adverse Event|0|||
161455917|NCT01029405|583064905|FG002|Overall Study|Adverse Event|1|||
161455918|NCT01029405|583064906|FG003|Overall Study|Adverse Event|1|||
161455919|NCT01029405|583064903|FG000|Overall Study|Lost to Follow-up|2|||
161455920|NCT01029405|583064904|FG001|Overall Study|Lost to Follow-up|1|||
161455921|NCT01029405|583064905|FG002|Overall Study|Lost to Follow-up|1|||
161455922|NCT01029405|583064906|FG003|Overall Study|Lost to Follow-up|2|||
161455923|NCT01029405|583064903|FG000|Overall Study|Other|0|||
161455924|NCT01029405|583064904|FG001|Overall Study|Other|1|||
161455925|NCT01029405|583064905|FG002|Overall Study|Other|0|||
161455926|NCT01029405|583064906|FG003|Overall Study|Other|1|||
161455927|NCT02692651|583064907|FG000|Study Treatment|Death|7|||
161455928|NCT02692651|583064908|FG001|Study Treatment|Death|3|||
161455929|NCT02692651|583064907|FG000|Study Treatment|comfort care|1|||
161455930|NCT02692651|583064908|FG001|Study Treatment|comfort care|1|||
161455931|NCT02692651|583064907|FG000|Study Treatment|Protocol violation per treating team preference|8|||
161455932|NCT02692651|583064908|FG001|Study Treatment|Protocol violation per treating team preference|6|||
161455933|NCT02692651|583064907|FG000|Post Study Treatment Follow-up|Death|4|||
161455934|NCT02692651|583064908|FG001|Post Study Treatment Follow-up|Death|4|||
161455935|NCT03490981|583064909|FG000|Overall Study|Lost to Follow-up|1|||
161455936|NCT03490981|583064910|FG001|Overall Study|Lost to Follow-up|2|||
161455937|NCT02480712|583064911|FG000|Overall Study|Enrolled but Never Treated|1|||
161455938|NCT02480712|583064911|FG000|Overall Study|Lost to Follow-up|5|||
161455939|NCT02480712|583064911|FG000|Overall Study|Withdrew Consent|3|||
161455940|NCT02480712|583064911|FG000|Overall Study|Death|1|||
161455941|NCT02480712|583064911|FG000|Overall Study|Lack of Efficacy|1|||
161455942|NCT01860846|583064918|FG000|Overall Study|Lost to Follow-up|33|||
161455943|NCT00466687|583064919|FG000|Overall Study|Adverse Event|1|||
161455944|NCT00466687|583064919|FG000|Overall Study|Other complicating illness|3|||
161455945|NCT00466687|583064919|FG000|Overall Study|Withdrawal by Subject|1|||
161455946|NCT00466687|583064919|FG000|Overall Study|Disease progression|29|||
161455947|NCT02586506|583064920|FG000|Overall Study|Protocol Violation|6|||
161455948|NCT02586506|583064920|FG000|Overall Study|Lost to Follow-up|1|||
161455949|NCT02586506|583064920|FG000|Overall Study|Other Reason|2|||
161455950|NCT05027971|583064930|FG000|Overall Study|Physician Decision|7|||
161455951|NCT05027971|583064931|FG001|Overall Study|Physician Decision|3|||
161455952|NCT05027971|583064930|FG000|Overall Study|Lost to Follow-up|1|||
161455953|NCT05027971|583064931|FG001|Overall Study|Lost to Follow-up|1|||
161455954|NCT05027971|583064930|FG000|Overall Study|Withdrawal by Subject|0|||
161455955|NCT05027971|583064931|FG001|Overall Study|Withdrawal by Subject|2|||
161455956|NCT05027971|583064930|FG000|Overall Study|Non-study fiber used.|0|||
161455957|NCT05027971|583064931|FG001|Overall Study|Non-study fiber used.|1|||
161455958|NCT05027971|583064930|FG000|Overall Study|Protocol Violation|0|||
161455959|NCT05027971|583064931|FG001|Overall Study|Protocol Violation|2|||
161455960|NCT02025556|583064932|FG000|Overall Study|Adverse Event|0|||
161455961|NCT02025556|583064933|FG001|Overall Study|Adverse Event|4|||
161455962|NCT02025556|583064934|FG002|Overall Study|Adverse Event|2|||
161455963|NCT02025556|583064932|FG000|Overall Study|Lack of Efficacy|2|||
161455964|NCT02025556|583064933|FG001|Overall Study|Lack of Efficacy|1|||
161455965|NCT02025556|583064934|FG002|Overall Study|Lack of Efficacy|0|||
161455966|NCT02025556|583064932|FG000|Overall Study|Protocol Violation|2|||
161455967|NCT02025556|583064933|FG001|Overall Study|Protocol Violation|1|||
161455968|NCT02025556|583064934|FG002|Overall Study|Protocol Violation|0|||
161455969|NCT02025556|583064932|FG000|Overall Study|Withdrawal by Subject|0|||
161455970|NCT02025556|583064933|FG001|Overall Study|Withdrawal by Subject|3|||
161455971|NCT02025556|583064934|FG002|Overall Study|Withdrawal by Subject|6|||
161455972|NCT02025556|583064932|FG000|Overall Study|Lost to Follow-up|2|||
161455973|NCT02025556|583064933|FG001|Overall Study|Lost to Follow-up|4|||
161455974|NCT02025556|583064934|FG002|Overall Study|Lost to Follow-up|0|||
161455975|NCT02025556|583064932|FG000|Overall Study|Reason not reported|0|||
161455976|NCT02025556|583064933|FG001|Overall Study|Reason not reported|0|||
161455977|NCT02025556|583064934|FG002|Overall Study|Reason not reported|1|||
161455978|NCT00796991|583064937|FG000|Overall Study|Adverse Event|0|||
161455979|NCT00796991|583064938|FG001|Overall Study|Adverse Event|0|||
161455980|NCT00796991|583064939|FG002|Overall Study|Adverse Event|1|||
161455981|NCT00796991|583064937|FG000|Overall Study|Death|2|||
161455982|NCT00796991|583064938|FG001|Overall Study|Death|0|||
161455983|NCT00796991|583064939|FG002|Overall Study|Death|0|||
161455984|NCT00796991|583064937|FG000|Overall Study|Disease Progression|10|||
161455985|NCT00796991|583064938|FG001|Overall Study|Disease Progression|9|||
161455986|NCT00796991|583064939|FG002|Overall Study|Disease Progression|7|||
161455987|NCT00796991|583064937|FG000|Overall Study|Study Drug Toxicity|3|||
161455988|NCT00796991|583064938|FG001|Overall Study|Study Drug Toxicity|3|||
161808126|NCT00857454|584342765|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
161808127|NCT00857454|584342765|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
161808128|NCT00984022|584342766|FG000|Overall Study|Lost to Follow-up|10|||
161808129|NCT00984022|584342767|FG001|Overall Study|Lost to Follow-up|14|||
161455989|NCT00796991|583064939|FG002|Overall Study|Study Drug Toxicity|5|||
161455990|NCT00796991|583064937|FG000|Overall Study|Withdrawal by Subject|0|||
161455991|NCT00796991|583064938|FG001|Overall Study|Withdrawal by Subject|0|||
161455992|NCT00796991|583064939|FG002|Overall Study|Withdrawal by Subject|1|||
161455993|NCT00171834|583064941|FG000|Overall Study|Adverse Event|2|||
161455994|NCT00171834|583064942|FG001|Overall Study|Adverse Event|1|||
161455995|NCT00171834|583064943|FG002|Overall Study|Adverse Event|3|||
161808130|NCT00573443|584342768|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161808131|NCT00573443|584342769|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161808132|NCT00573443|584342770|FG002|Double-Blind Phase|Lost to Follow-up|2|||
161808133|NCT00573443|584342768|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
161808134|NCT00573443|584342769|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
161808135|NCT00573443|584342770|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
161808136|NCT00573443|584342768|FG000|Double-Blind Phase|Adverse Event|1|||
161808137|NCT00573443|584342769|FG001|Double-Blind Phase|Adverse Event|5|||
161808138|NCT00573443|584342770|FG002|Double-Blind Phase|Adverse Event|0|||
161808139|NCT00573443|584342768|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
161808140|NCT00573443|584342769|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
161455996|NCT00171834|583064944|FG003|Overall Study|Adverse Event|2|||
161455997|NCT00171834|583064945|FG004|Overall Study|Adverse Event|2|||
161455998|NCT00171834|583064946|FG005|Overall Study|Adverse Event|15|||
161455999|NCT00171834|583064947|FG006|Overall Study|Adverse Event|1|||
161456000|NCT00171834|583064941|FG000|Overall Study|Withdrawal by Subject|0|||
161456001|NCT00171834|583064942|FG001|Overall Study|Withdrawal by Subject|2|||
161456002|NCT00171834|583064943|FG002|Overall Study|Withdrawal by Subject|0|||
161456003|NCT00171834|583064944|FG003|Overall Study|Withdrawal by Subject|1|||
161456004|NCT00171834|583064945|FG004|Overall Study|Withdrawal by Subject|1|||
161456005|NCT00171834|583064946|FG005|Overall Study|Withdrawal by Subject|1|||
161456006|NCT00171834|583064947|FG006|Overall Study|Withdrawal by Subject|0|||
161456007|NCT00171834|583064941|FG000|Overall Study|Death from study indication|0|||
161456008|NCT00171834|583064942|FG001|Overall Study|Death from study indication|1|||
161456009|NCT00171834|583064943|FG002|Overall Study|Death from study indication|0|||
161456010|NCT00171834|583064944|FG003|Overall Study|Death from study indication|0|||
161456011|NCT00171834|583064945|FG004|Overall Study|Death from study indication|1|||
161456012|NCT00171834|583064946|FG005|Overall Study|Death from study indication|0|||
161456013|NCT00171834|583064947|FG006|Overall Study|Death from study indication|0|||
161456014|NCT00171834|583064941|FG000|Overall Study|Disease Progression|4|||
161566072|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Hospice care|0|||
161456015|NCT00171834|583064942|FG001|Overall Study|Disease Progression|8|||
161456016|NCT00171834|583064943|FG002|Overall Study|Disease Progression|8|||
161456017|NCT00171834|583064944|FG003|Overall Study|Disease Progression|9|||
161456018|NCT00171834|583064945|FG004|Overall Study|Disease Progression|2|||
161456019|NCT00171834|583064946|FG005|Overall Study|Disease Progression|18|||
161808141|NCT00573443|584342770|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
161456020|NCT00171834|583064947|FG006|Overall Study|Disease Progression|3|||
161456021|NCT00171834|583064941|FG000|Overall Study|Treatment Duration Completed|0|||
161456022|NCT00171834|583064942|FG001|Overall Study|Treatment Duration Completed|0|||
161456023|NCT00171834|583064943|FG002|Overall Study|Treatment Duration Completed|1|||
161456024|NCT00171834|583064944|FG003|Overall Study|Treatment Duration Completed|0|||
161456025|NCT00171834|583064945|FG004|Overall Study|Treatment Duration Completed|2|||
161456026|NCT00171834|583064946|FG005|Overall Study|Treatment Duration Completed|1|||
161456027|NCT00171834|583064947|FG006|Overall Study|Treatment Duration Completed|0|||
161456028|NCT00834080|583064948|FG000|Overall Study|Adverse Event|7|||
161456029|NCT00834080|583064948|FG000|Overall Study|Lost to Follow-up|7|||
161456030|NCT00834080|583064948|FG000|Overall Study|Withdrawal by Subject|5|||
161456031|NCT00834080|583064948|FG000|Overall Study|Other - Pregnancy|1|||
161456032|NCT00834080|583064948|FG000|Overall Study|Other - False positive tests of the UDS|1|||
161456033|NCT00834080|583064948|FG000|Overall Study|Physician Decision|1|||
161456034|NCT00834080|583064948|FG000|Overall Study|Subject Relocated|1|||
161456035|NCT04345367|583064950|FG000|Overall Study|Other|3|||
161456036|NCT04345367|583064951|FG001|Overall Study|Other|4|||
161456037|NCT04345367|583064950|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
161456038|NCT04345367|583064951|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
161456039|NCT04345367|583064950|FG000|Overall Study|Withdrawal by Subject|11|||
161456040|NCT04345367|583064951|FG001|Overall Study|Withdrawal by Subject|11|||
161456041|NCT04345367|583064950|FG000|Overall Study|Protocol Violation|4|||
161456042|NCT04345367|583064951|FG001|Overall Study|Protocol Violation|3|||
161456043|NCT04345367|583064950|FG000|Overall Study|Lost to Follow-up|2|||
161456044|NCT04345367|583064951|FG001|Overall Study|Lost to Follow-up|4|||
161456045|NCT04345367|583064950|FG000|Overall Study|Lack of Efficacy|2|||
161456046|NCT04345367|583064951|FG001|Overall Study|Lack of Efficacy|0|||
161456047|NCT04345367|583064950|FG000|Overall Study|Death|2|||
161456048|NCT04345367|583064951|FG001|Overall Study|Death|0|||
161456049|NCT04345367|583064950|FG000|Overall Study|Adverse Event|10|||
161456050|NCT04345367|583064951|FG001|Overall Study|Adverse Event|9|||
161456051|NCT00439738|583064954|FG000|Overall Study|Withdrawal by Subject|16|||
161456052|NCT00439738|583064955|FG001|Overall Study|Withdrawal by Subject|13|||
161456053|NCT00439738|583064954|FG000|Overall Study|Adverse Event|6|||
161456054|NCT00439738|583064955|FG001|Overall Study|Adverse Event|4|||
161456055|NCT00439738|583064954|FG000|Overall Study|Lost to Follow-up|5|||
161456056|NCT00439738|583064955|FG001|Overall Study|Lost to Follow-up|6|||
161456057|NCT00439738|583064954|FG000|Overall Study|Protocol Violation|6|||
161456058|NCT00439738|583064955|FG001|Overall Study|Protocol Violation|3|||
161456059|NCT00439738|583064954|FG000|Overall Study|Lack of Efficacy|2|||
161456060|NCT00439738|583064955|FG001|Overall Study|Lack of Efficacy|2|||
161456061|NCT00439738|583064954|FG000|Overall Study|Abnormal Lab Values|1|||
161456062|NCT00439738|583064955|FG001|Overall Study|Abnormal Lab Values|0|||
161456063|NCT00781885|583064958|FG000|Overall Study|Physician Decision|1|||
161456064|NCT01755026|583064959|FG000|Overall Study|Adverse Event|1|||
161456065|NCT01755026|583064960|FG001|Overall Study|Adverse Event|0|||
161456066|NCT01755026|583064959|FG000|Overall Study|Withdrawal by Subject|1|||
161456067|NCT01755026|583064960|FG001|Overall Study|Withdrawal by Subject|1|||
161456068|NCT03836001|583064961|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
161456069|NCT03836001|583064962|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
161456070|NCT03836001|583064963|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
161456071|NCT03836001|583064961|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
161456072|NCT03836001|583064962|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
161456073|NCT03836001|583064963|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
161456074|NCT03836001|583064961|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
161456075|NCT03836001|583064962|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
161456076|NCT03836001|583064963|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
161456077|NCT03836001|583064961|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
161456078|NCT03836001|583064962|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
161456079|NCT03836001|583064963|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
161456080|NCT01284491|583064964|FG000|Overall Study|Study termination|13|||
161456081|NCT01978938|583064965|FG000|Overall Study|Lost to Follow-up|12|||
161456082|NCT01978938|583064966|FG001|Overall Study|Lost to Follow-up|6|||
161456083|NCT01978938|583064965|FG000|Overall Study|Withdrawal by Subject|8|||
161456084|NCT01978938|583064966|FG001|Overall Study|Withdrawal by Subject|4|||
161456085|NCT01978938|583064965|FG000|Overall Study|Adverse Event, non-fatal|2|||
161456086|NCT01978938|583064966|FG001|Overall Study|Adverse Event, non-fatal|1|||
161456087|NCT01978938|583064965|FG000|Overall Study|Participant noncompliance|1|||
161456088|NCT01978938|583064966|FG001|Overall Study|Participant noncompliance|1|||
161456089|NCT01978938|583064965|FG000|Overall Study|Did not meet inclusion criteria|0|||
161456090|NCT01978938|583064966|FG001|Overall Study|Did not meet inclusion criteria|1|||
161456091|NCT01978938|583064965|FG000|Overall Study|Previously scheduled procedure|0|||
161456092|NCT01978938|583064966|FG001|Overall Study|Previously scheduled procedure|1|||
161456093|NCT02694757|583064967|FG000|Overall Study|Lack of Efficacy|3|||
161456094|NCT02650921|583064968|FG000|Overall Study|Withdrawal by Subject|4|||
161456095|NCT02650921|583064968|FG000|Overall Study|Lost to Follow-up|2|||
161456096|NCT02650921|583064968|FG000|Overall Study|Adverse Event|1|||
161456097|NCT02650921|583064968|FG000|Overall Study|Due to Medical Condition|1|||
161456098|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
161456099|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
161456100|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
161456101|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
161456102|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
161456103|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
161808142|NCT00573443|584342768|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
161808143|NCT00573443|584342769|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
161808144|NCT00573443|584342770|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
161808145|NCT00573443|584342768|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161808146|NCT00573443|584342769|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161808147|NCT00573443|584342770|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
161808148|NCT00573443|584342768|FG000|Double-Blind Phase|Protocol Violation|0|||
161808149|NCT00573443|584342769|FG001|Double-Blind Phase|Protocol Violation|2|||
161456104|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
161456105|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
161456106|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
161456107|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
161808150|NCT00573443|584342770|FG002|Double-Blind Phase|Protocol Violation|1|||
161808151|NCT00573443|584342768|FG000|Double-Blind Phase|Other|0|||
161808152|NCT00573443|584342769|FG001|Double-Blind Phase|Other|2|||
161808153|NCT00573443|584342770|FG002|Double-Blind Phase|Other|3|||
161808154|NCT00573443|584342768|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
161456108|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
161456109|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
161456110|NCT01087788|583064969|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
161456111|NCT01087788|583064970|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
161456112|NCT01087788|583064971|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
161456113|NCT01087788|583064969|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
161456114|NCT01087788|583064970|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
161456115|NCT01087788|583064971|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
161456116|NCT01087788|583064969|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
161456117|NCT01087788|583064970|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
161456118|NCT01087788|583064971|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
161456119|NCT01087788|583064969|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
161456120|NCT01087788|583064970|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
161456121|NCT01087788|583064971|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
161456122|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
161456123|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
161456124|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
161456125|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
161456126|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
161456127|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
161456128|NCT01087788|583064969|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
161456129|NCT01087788|583064970|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
161456130|NCT01087788|583064971|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
161456131|NCT01087788|583064969|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
161456132|NCT01087788|583064970|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
161456133|NCT01087788|583064971|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
161456134|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
161456135|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
161456136|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
161456137|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
161456138|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
161456139|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
161456140|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
161456141|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
161456142|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
161456143|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
161456144|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
161456145|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
161456146|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
161456147|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
161456148|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
161456149|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
161808155|NCT00573443|584342769|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161566073|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Hospice care|0|||
161566074|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Physician Decision|1|||
161566075|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Physician Decision|0|||
161566076|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Physician Decision|0|||
161566077|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Physician Decision|0|||
161566078|NCT01107626|583462201|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
161566079|NCT01107626|583462202|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
161566080|NCT01107626|583462203|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
161566081|NCT01107626|583462204|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
161566082|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
161566083|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
161566084|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
161566085|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
161566086|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
161566087|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
161808156|NCT00573443|584342770|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161808157|NCT00573443|584342768|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
161808158|NCT00573443|584342769|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
161808159|NCT00573443|584342770|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
161808160|NCT00573443|584342768|FG000|Open-Label Extension Phase|Adverse Event|3|||
161808161|NCT00573443|584342769|FG001|Open-Label Extension Phase|Adverse Event|0|||
161808162|NCT00573443|584342770|FG002|Open-Label Extension Phase|Adverse Event|0|||
161808163|NCT00573443|584342768|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
161808164|NCT00573443|584342769|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
161808165|NCT00573443|584342770|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
161808166|NCT00573443|584342768|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
161808167|NCT00573443|584342769|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
161808168|NCT00573443|584342770|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
161808169|NCT00573443|584342768|FG000|Open-Label Extension Phase|Protocol Violation|2|||
161808170|NCT00573443|584342769|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161808171|NCT00573443|584342770|FG002|Open-Label Extension Phase|Protocol Violation|0|||
161808172|NCT00573443|584342768|FG000|Open-Label Extension Phase|Other|2|||
161808173|NCT00573443|584342769|FG001|Open-Label Extension Phase|Other|0|||
161808174|NCT00573443|584342770|FG002|Open-Label Extension Phase|Other|0|||
161808175|NCT04567186|584342774|FG000|Period 1|COVID-19 related|1|||
161808176|NCT04567186|584342775|FG001|Period 1|COVID-19 related|0|||
161808177|NCT04567186|584342774|FG000|Period 1|Protocol Violation|0|||
161808178|NCT04567186|584342775|FG001|Period 1|Protocol Violation|1|||
161808179|NCT04567186|584342774|FG000|Period 1|Adverse Event|0|||
161808180|NCT04567186|584342775|FG001|Period 1|Adverse Event|2|||
161808181|NCT04567186|584342774|FG000|Period 2|COVID-19 Related|0|||
161808182|NCT04567186|584342775|FG001|Period 2|COVID-19 Related|1|||
161808183|NCT04567186|584342774|FG000|Period 2|Protocol Violation|0|||
161808184|NCT04567186|584342775|FG001|Period 2|Protocol Violation|1|||
161808185|NCT04567186|584342774|FG000|Period 2|Lost to Follow-up|0|||
161808186|NCT04567186|584342775|FG001|Period 2|Lost to Follow-up|1|||
161808187|NCT04567186|584342774|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
161808188|NCT04567186|584342775|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
161808189|NCT02924883|584342776|FG000|Overall Study|Death|39|||
161808190|NCT02924883|584342777|FG001|Overall Study|Death|20|||
161808191|NCT02924883|584342776|FG000|Overall Study|Lost to Follow-up|1|||
161808192|NCT02924883|584342777|FG001|Overall Study|Lost to Follow-up|0|||
161808193|NCT02924883|584342776|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
161808194|NCT02924883|584342777|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
161808195|NCT02924883|584342776|FG000|Overall Study|Protocol Violation|1|||
161808196|NCT02924883|584342777|FG001|Overall Study|Protocol Violation|0|||
161808197|NCT02924883|584342776|FG000|Overall Study|Withdrawal by Subject|22|||
161808198|NCT02924883|584342777|FG001|Overall Study|Withdrawal by Subject|16|||
161808199|NCT02924883|584342776|FG000|Overall Study|Progressive Disease|1|||
161808200|NCT02924883|584342777|FG001|Overall Study|Progressive Disease|0|||
161808201|NCT02924883|584342776|FG000|Overall Study|Study Terminated by Sponsor|69|||
161808202|NCT02924883|584342777|FG001|Overall Study|Study Terminated by Sponsor|32|||
161808203|NCT00004562|584342778|FG000|Overall Study|Lost to Follow-up|102|||
161808204|NCT00004562|584342779|FG001|Overall Study|Lost to Follow-up|91|||
161911635|NCT02194465|584728628|FG006|Overall Study|Lost to Follow-up|0|||
161911636|NCT02194465|584728622|FG000|Overall Study|Physician Decision|1|||
161566088|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
161566089|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
161566090|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Death|0|||
161808205|NCT02865850|584342780|FG000|Overall Study|Death|15|||
161808206|NCT02865850|584342781|FG001|Overall Study|Death|19|||
161808207|NCT02865850|584342780|FG000|Overall Study|Withdrawal by Subject|3|||
161808208|NCT02865850|584342781|FG001|Overall Study|Withdrawal by Subject|2|||
161808209|NCT02865850|584342780|FG000|Overall Study|Lost to Follow-up|3|||
161808210|NCT02865850|584342781|FG001|Overall Study|Lost to Follow-up|2|||
161456150|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
161456151|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
161456152|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
161456153|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
161456154|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
161456155|NCT01087788|583064969|FG000|24-weeks Dose-blind Period|Patient moved|0|||
161456156|NCT01087788|583064970|FG001|24-weeks Dose-blind Period|Patient moved|0|||
161456157|NCT01087788|583064971|FG002|24-weeks Dose-blind Period|Patient moved|1|||
161456158|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
161456159|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
161456160|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
161456161|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
161456162|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
161566091|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Death|8|||
161566092|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Death|2|||
161566093|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Death|13|||
161566094|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
161566095|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
161566096|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
161566097|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
161566098|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
161566099|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
161566100|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
161566101|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
161566102|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
161566103|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
161566104|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
161566105|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
161566106|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
161566107|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
161566108|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
161566109|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
161566110|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
161566111|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
161566112|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
161456163|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
161456164|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
161456165|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
161808211|NCT00552669|584342782|FG000|Overall Study|Death|3|||
161808212|NCT00552669|584342783|FG001|Overall Study|Death|7|||
161808213|NCT00252720|584342787|FG000|Overall Study|Withdrawal by Subject|95|||
161808214|NCT00252720|584342788|FG001|Overall Study|Withdrawal by Subject|97|||
161456166|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
161456167|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
161456168|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
161456169|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
161456170|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
161456171|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
161456172|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
161456173|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
161456174|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
161456175|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
161456176|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
161456177|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
161456178|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
161456179|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
161456180|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
161456181|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
161456182|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
161456183|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
161456184|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
161456185|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
161566113|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
161456186|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
161456187|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
161456188|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
161566114|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
161566115|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
161808215|NCT00252720|584342787|FG000|Overall Study|Death|7|||
161566116|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
161566117|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
161566118|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
161566119|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
161566120|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
161566121|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
161566122|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
161566123|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
161566124|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
161566125|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
161566126|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
161566127|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
161566128|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
161566129|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
161566130|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
161566131|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
161566132|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
161566133|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
161566134|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Pain|0|||
161566135|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Pain|0|||
161566136|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Pain|0|||
161566137|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Pain|1|||
161566138|NCT01107626|583462201|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
161566139|NCT01107626|583462202|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
161566140|NCT01107626|583462203|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
161566141|NCT01107626|583462204|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
161566142|NCT02715258|583462205|FG000|Overall Study|Withdrawal by Subject|6|||
161566143|NCT02715258|583462206|FG001|Overall Study|Withdrawal by Subject|1|||
161566144|NCT02715258|583462205|FG000|Overall Study|Lost to Follow-up|7|||
161566145|NCT02715258|583462206|FG001|Overall Study|Lost to Follow-up|1|||
161566146|NCT02715258|583462205|FG000|Overall Study|Terminated by Sponsor|0|||
161566147|NCT02715258|583462206|FG001|Overall Study|Terminated by Sponsor|1|||
161566148|NCT02715258|583462205|FG000|Overall Study|Death|0|||
161566149|NCT02715258|583462206|FG001|Overall Study|Death|1|||
161566150|NCT02715258|583462205|FG000|Overall Study|Subject non-compliant|1|||
161566151|NCT02715258|583462206|FG001|Overall Study|Subject non-compliant|1|||
161566152|NCT02715258|583462205|FG000|Overall Study|GCP violation|2|||
161566153|NCT02715258|583462206|FG001|Overall Study|GCP violation|1|||
161566154|NCT01117480|583462217|FG000|Overall Study|Protocol Violation|8|||
161566155|NCT01117480|583462217|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
161566156|NCT01280591|583462218|FG000|Overall Study|Withdrawal by Subject|0|||
161566157|NCT01280591|583462219|FG001|Overall Study|Withdrawal by Subject|0|||
161566158|NCT01280591|583462220|FG002|Overall Study|Withdrawal by Subject|0|||
161566159|NCT01280591|583462221|FG003|Overall Study|Withdrawal by Subject|2|||
161566160|NCT01280591|583462218|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
161566161|NCT01280591|583462219|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
161566162|NCT01280591|583462220|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
161566163|NCT01280591|583462221|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
161566164|NCT02955069|583462222|FG000|Overall Study|Adverse Event|7|||
161566165|NCT02955069|583462223|FG001|Overall Study|Adverse Event|2|||
161566166|NCT02955069|583462222|FG000|Overall Study|Death|7|||
161566167|NCT02955069|583462223|FG001|Overall Study|Death|3|||
161566168|NCT02955069|583462222|FG000|Overall Study|Physician Decision|10|||
161566169|NCT02955069|583462223|FG001|Overall Study|Physician Decision|2|||
161566170|NCT02955069|583462222|FG000|Overall Study|Progressive disease|64|||
161566171|NCT02955069|583462223|FG001|Overall Study|Progressive disease|13|||
161566172|NCT02955069|583462222|FG000|Overall Study|Study terminated by sponsor|4|||
161566173|NCT02955069|583462223|FG001|Overall Study|Study terminated by sponsor|0|||
161566174|NCT02955069|583462222|FG000|Overall Study|Subject/Guardian decision|3|||
161566175|NCT02955069|583462223|FG001|Overall Study|Subject/Guardian decision|1|||
161566176|NCT03721016|583462224|FG000|Overall Study|Adverse Event|0|||
161566177|NCT03721016|583462225|FG001|Overall Study|Adverse Event|1|||
161566178|NCT03721016|583462226|FG002|Overall Study|Adverse Event|1|||
161566179|NCT03721016|583462224|FG000|Overall Study|Withdrawal by Subject|8|||
161566180|NCT03721016|583462225|FG001|Overall Study|Withdrawal by Subject|16|||
161566181|NCT03721016|583462226|FG002|Overall Study|Withdrawal by Subject|13|||
161566182|NCT03721016|583462224|FG000|Overall Study|Lost to Follow-up|4|||
161566183|NCT03721016|583462225|FG001|Overall Study|Lost to Follow-up|6|||
161566184|NCT03721016|583462226|FG002|Overall Study|Lost to Follow-up|5|||
161566185|NCT03721016|583462224|FG000|Overall Study|Physician Decision|0|||
161566186|NCT03721016|583462225|FG001|Overall Study|Physician Decision|1|||
161566187|NCT03721016|583462226|FG002|Overall Study|Physician Decision|2|||
161566188|NCT03721016|583462224|FG000|Overall Study|Protocol Violation|0|||
161566189|NCT03721016|583462225|FG001|Overall Study|Protocol Violation|1|||
161566190|NCT03721016|583462226|FG002|Overall Study|Protocol Violation|0|||
161566191|NCT03721016|583462224|FG000|Overall Study|Site terminated by sponsor|3|||
161566192|NCT03721016|583462225|FG001|Overall Study|Site terminated by sponsor|7|||
161566193|NCT03721016|583462226|FG002|Overall Study|Site terminated by sponsor|6|||
161566194|NCT03721016|583462224|FG000|Overall Study|Subject exited early due to COVID-19|1|||
161566195|NCT03721016|583462225|FG001|Overall Study|Subject exited early due to COVID-19|0|||
161566196|NCT03721016|583462226|FG002|Overall Study|Subject exited early due to COVID-19|0|||
161566197|NCT03357341|583462227|FG000|Overall Study|Withdrawal by Subject|3|||
161566198|NCT03357341|583462228|FG001|Overall Study|Withdrawal by Subject|6|||
161566199|NCT03357341|583462227|FG000|Overall Study|Lost to Follow-up|4|||
161566200|NCT03357341|583462228|FG001|Overall Study|Lost to Follow-up|5|||
161566201|NCT03357341|583462227|FG000|Overall Study|Death|0|||
161566202|NCT03357341|583462228|FG001|Overall Study|Death|1|||
161808216|NCT00252720|584342788|FG001|Overall Study|Death|8|||
161808217|NCT00252720|584342787|FG000|Overall Study|Moving|23|||
161808218|NCT00252720|584342788|FG001|Overall Study|Moving|42|||
161808219|NCT00252720|584342787|FG000|Overall Study|Mainly patients lost to follow-up|7|||
161808220|NCT00252720|584342788|FG001|Overall Study|Mainly patients lost to follow-up|18|||
161808221|NCT02481830|584342791|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
161808222|NCT02481830|584342792|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
161808223|NCT02481830|584342791|FG000|Pre-treatment|Withdrawal by Subject|0|||
161808224|NCT02481830|584342792|FG001|Pre-treatment|Withdrawal by Subject|10|||
161808225|NCT02481830|584342791|FG000|Pre-treatment|Disease Progression|1|||
161808226|NCT02481830|584342792|FG001|Pre-treatment|Disease Progression|1|||
161808227|NCT02481830|584342791|FG000|Pre-treatment|Other reasons|0|||
161808228|NCT02481830|584342792|FG001|Pre-treatment|Other reasons|1|||
161808229|NCT02481830|584342791|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
161808230|NCT02481830|584342792|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
161808231|NCT02481830|584342791|FG000|Treatment|Disease Progression|233|||
161808232|NCT02481830|584342792|FG001|Treatment|Disease Progression|171|||
161808233|NCT02481830|584342791|FG000|Treatment|Study drug toxicity|18|||
161808234|NCT02481830|584342792|FG001|Treatment|Study drug toxicity|38|||
161808235|NCT02481830|584342791|FG000|Treatment|Death|1|||
161808236|NCT02481830|584342792|FG001|Treatment|Death|1|||
161808237|NCT02481830|584342791|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
161808238|NCT02481830|584342792|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
161808239|NCT02481830|584342791|FG000|Treatment|Participants request to discontinue Study treatment|6|||
161808240|NCT02481830|584342792|FG001|Treatment|Participants request to discontinue Study treatment|34|||
161808241|NCT02481830|584342791|FG000|Treatment|Withdrawal by Subject|2|||
161808242|NCT02481830|584342792|FG001|Treatment|Withdrawal by Subject|3|||
161808243|NCT02481830|584342791|FG000|Treatment|Lost to Follow-up|1|||
161808244|NCT02481830|584342792|FG001|Treatment|Lost to Follow-up|0|||
161808245|NCT02481830|584342791|FG000|Treatment|Maximum Clinical Benefit|0|||
161808246|NCT02481830|584342792|FG001|Treatment|Maximum Clinical Benefit|5|||
161808247|NCT02481830|584342791|FG000|Treatment|Administrative reason by sponsor|1|||
161808248|NCT02481830|584342792|FG001|Treatment|Administrative reason by sponsor|1|||
161808249|NCT02481830|584342791|FG000|Treatment|Other reasons|6|||
161808250|NCT02481830|584342792|FG001|Treatment|Other reasons|1|||
161808251|NCT00772941|584342793|FG000|Overall Study|CRFs not available|195|||
161808252|NCT00772941|584342793|FG000|Overall Study|Study not completed|16|||
161808253|NCT00772941|584342793|FG000|Overall Study|Missed Visits|374|||
161808254|NCT00772941|584342793|FG000|Overall Study|Poor Compliance|7|||
161808255|NCT00772941|584342793|FG000|Overall Study|GPSP Violation|90|||
161808256|NCT04627038|584342794|FG000|Overall Study|Adverse Event|36|||
161808257|NCT04627038|584342795|FG001|Overall Study|Adverse Event|8|||
161808258|NCT04627038|584342794|FG000|Overall Study|Lost to Follow-up|1|||
161808259|NCT04627038|584342795|FG001|Overall Study|Lost to Follow-up|0|||
161808260|NCT04627038|584342794|FG000|Overall Study|Physician Decision|0|||
161808261|NCT04627038|584342795|FG001|Overall Study|Physician Decision|1|||
161808262|NCT04627038|584342794|FG000|Overall Study|Protocol Violation|3|||
161808263|NCT04627038|584342795|FG001|Overall Study|Protocol Violation|1|||
161808264|NCT04627038|584342794|FG000|Overall Study|Withdrawal by Subject|13|||
161808265|NCT04627038|584342795|FG001|Overall Study|Withdrawal by Subject|3|||
161808266|NCT04627038|584342794|FG000|Overall Study|Non-compliance with study drug|0|||
161808267|NCT04627038|584342795|FG001|Overall Study|Non-compliance with study drug|1|||
161808268|NCT04627038|584342794|FG000|Overall Study|Prohibited Concomitant Medication|1|||
161808269|NCT04627038|584342795|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161808270|NCT02714062|584342801|FG000|Overall Study|Adverse Event|0|||
161808271|NCT02714062|584342802|FG001|Overall Study|Adverse Event|0|||
161808272|NCT02714062|584342803|FG002|Overall Study|Adverse Event|2|||
161808273|NCT02714062|584342801|FG000|Overall Study|Withdrawal by Subject|1|||
161808274|NCT02714062|584342802|FG001|Overall Study|Withdrawal by Subject|0|||
161911637|NCT02194465|584728623|FG001|Overall Study|Physician Decision|0|||
161566203|NCT01072357|583462231|FG000|Overall Study|Lost to Follow-up|0|||
161566204|NCT01072357|583462232|FG001|Overall Study|Lost to Follow-up|1|||
161808275|NCT02714062|584342803|FG002|Overall Study|Withdrawal by Subject|1|||
161808276|NCT02714062|584342801|FG000|Overall Study|Protocol Violation|0|||
161808277|NCT02714062|584342802|FG001|Overall Study|Protocol Violation|1|||
161566205|NCT02131324|583462233|FG000|Overall Study|Withdrawal by Subject|1|||
161566206|NCT02131324|583462234|FG001|Overall Study|Withdrawal by Subject|2|||
161566207|NCT02131324|583462233|FG000|Overall Study|Lost to Follow-up|1|||
161566208|NCT02131324|583462234|FG001|Overall Study|Lost to Follow-up|1|||
161566209|NCT01048788|583462235|FG000|Overall Study|Adverse Event|5|||
161566210|NCT01048788|583462236|FG001|Overall Study|Adverse Event|1|||
161566211|NCT01048788|583462237|FG002|Overall Study|Adverse Event|1|||
161566212|NCT01048788|583462235|FG000|Overall Study|Lack of Efficacy|0|||
161566213|NCT01048788|583462236|FG001|Overall Study|Lack of Efficacy|0|||
161566214|NCT01048788|583462237|FG002|Overall Study|Lack of Efficacy|1|||
161566215|NCT01048788|583462235|FG000|Overall Study|Withdrawal by Subject|0|||
161566216|NCT01048788|583462236|FG001|Overall Study|Withdrawal by Subject|1|||
161566217|NCT01048788|583462237|FG002|Overall Study|Withdrawal by Subject|0|||
161566218|NCT01233050|583462238|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
161566219|NCT01233050|583462239|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
161566220|NCT04582877|583462244|FG000|Overall Study|Did not use device measurement|5|||
161566221|NCT04582877|583462244|FG000|Overall Study|No fractional flow reserve test results|2|||
161566222|NCT04582877|583462244|FG000|Overall Study|Protocol Violation|1|||
161566223|NCT00957229|583462246|FG000|Study Start|Adverse Event|0|||
161566224|NCT00957229|583462247|FG001|Study Start|Adverse Event|3|||
161566225|NCT00957229|583462246|FG000|Study Start|Disease Progression|1|||
161566226|NCT00957229|583462247|FG001|Study Start|Disease Progression|0|||
161566227|NCT00957229|583462246|FG000|Reallocated to or Continued Vismodegib|Death|1|||
161566228|NCT00957229|583462247|FG001|Reallocated to or Continued Vismodegib|Death|1|||
161566229|NCT00957229|583462246|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
161566230|NCT00957229|583462247|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
161566231|NCT03095508|583462249|FG000|Overall Study|Adverse Event|0|||
161566232|NCT03095508|583462250|FG001|Overall Study|Adverse Event|1|||
161566233|NCT00335556|583462251|FG000|Overall Study|Death|0|||
161566234|NCT00335556|583462252|FG001|Overall Study|Death|5|||
161566235|NCT00335556|583462253|FG002|Overall Study|Death|0|||
161566236|NCT00335556|583462254|FG003|Overall Study|Death|0|||
161566237|NCT00335556|583462255|FG004|Overall Study|Death|1|||
161566238|NCT00335556|583462256|FG005|Overall Study|Death|0|||
161566239|NCT00335556|583462251|FG000|Overall Study|Lack of Efficacy|0|||
161566240|NCT00335556|583462252|FG001|Overall Study|Lack of Efficacy|19|||
161566241|NCT00335556|583462253|FG002|Overall Study|Lack of Efficacy|3|||
161566242|NCT00335556|583462254|FG003|Overall Study|Lack of Efficacy|3|||
161566243|NCT00335556|583462255|FG004|Overall Study|Lack of Efficacy|0|||
161566244|NCT00335556|583462256|FG005|Overall Study|Lack of Efficacy|1|||
161566245|NCT00335556|583462251|FG000|Overall Study|Physician Decision|0|||
161566246|NCT00335556|583462252|FG001|Overall Study|Physician Decision|6|||
161566247|NCT00335556|583462253|FG002|Overall Study|Physician Decision|2|||
161566248|NCT00335556|583462254|FG003|Overall Study|Physician Decision|1|||
161566249|NCT00335556|583462255|FG004|Overall Study|Physician Decision|0|||
161566250|NCT00335556|583462256|FG005|Overall Study|Physician Decision|0|||
161566251|NCT00335556|583462251|FG000|Overall Study|Ineligible|2|||
161566252|NCT00335556|583462252|FG001|Overall Study|Ineligible|0|||
161566253|NCT00335556|583462253|FG002|Overall Study|Ineligible|0|||
161566254|NCT00335556|583462254|FG003|Overall Study|Ineligible|0|||
161566255|NCT00335556|583462255|FG004|Overall Study|Ineligible|0|||
161566256|NCT00335556|583462256|FG005|Overall Study|Ineligible|0|||
161566257|NCT00335556|583462251|FG000|Overall Study|Refusal of further protocol therapy|0|||
161566258|NCT00335556|583462252|FG001|Overall Study|Refusal of further protocol therapy|4|||
161566259|NCT00335556|583462253|FG002|Overall Study|Refusal of further protocol therapy|0|||
161566260|NCT00335556|583462254|FG003|Overall Study|Refusal of further protocol therapy|1|||
161566261|NCT00335556|583462255|FG004|Overall Study|Refusal of further protocol therapy|0|||
161566262|NCT00335556|583462256|FG005|Overall Study|Refusal of further protocol therapy|0|||
161566263|NCT01878890|583462264|FG000|Overall Study|Protocol Violation|0|||
161911638|NCT02194465|584728624|FG002|Overall Study|Physician Decision|0|||
161911639|NCT02194465|584728625|FG003|Overall Study|Physician Decision|0|||
161566264|NCT01878890|583462265|FG001|Overall Study|Protocol Violation|1|||
161566265|NCT01878890|583462266|FG002|Overall Study|Protocol Violation|0|||
161911640|NCT02194465|584728626|FG004|Overall Study|Physician Decision|0|||
161911641|NCT02194465|584728627|FG005|Overall Study|Physician Decision|0|||
161566266|NCT01878890|583462267|FG003|Overall Study|Protocol Violation|0|||
161566267|NCT01710514|583462272|FG000|Overall Study|Adverse Event|6|||
161566268|NCT01710514|583462273|FG001|Overall Study|Adverse Event|7|||
161566269|NCT01710514|583462272|FG000|Overall Study|Withdrawal by Subject|1|||
161566270|NCT01710514|583462273|FG001|Overall Study|Withdrawal by Subject|0|||
161566271|NCT03404843|583462274|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
161566272|NCT03404843|583462275|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
161566273|NCT00567164|583462276|FG000|Overall Study|Withdrawal by Subject|171|||
161566274|NCT00567164|583462277|FG001|Overall Study|Withdrawal by Subject|21|||
161566275|NCT00567164|583462278|FG002|Overall Study|Withdrawal by Subject|17|||
161566276|NCT00567164|583462276|FG000|Overall Study|Protocol Violation|23|||
161566277|NCT00567164|583462277|FG001|Overall Study|Protocol Violation|4|||
161566278|NCT00567164|583462278|FG002|Overall Study|Protocol Violation|2|||
161566279|NCT00567164|583462276|FG000|Overall Study|Adverse Event|92|||
161456189|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
161456190|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
161456191|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
161456192|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
161456193|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
161456194|NCT01087788|583064969|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
161456195|NCT01087788|583064970|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
161456196|NCT01087788|583064971|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
161456197|NCT00783302|583064972|FG000|Overall Study|Lost to Follow-up|17|||
161456198|NCT00783302|583064972|FG000|Overall Study|Technical Problems|11|||
161456199|NCT00783302|583064972|FG000|Overall Study|Protocol Violation|3|||
161456200|NCT00783302|583064972|FG000|Overall Study|Physician Decision|1|||
161456201|NCT00783302|583064972|FG000|Overall Study|Withdrawal by Subject|3|||
161456202|NCT01806662|583064973|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
161456203|NCT01806662|583064974|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
161456204|NCT01806662|583064973|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
161456205|NCT01806662|583064974|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
161456206|NCT01806662|583064973|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
161456207|NCT01806662|583064974|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
161456208|NCT01806662|583064973|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
161456209|NCT01806662|583064974|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
161456210|NCT00043550|583064975|FG000|Overall Study|Withdrawal by Subject|22|||
161808278|NCT02714062|584342803|FG002|Overall Study|Protocol Violation|0|||
161808279|NCT02682784|584342804|FG000|Overall Study|Withdrawal by Subject|0|||
161808280|NCT02682784|584342805|FG001|Overall Study|Withdrawal by Subject|2|||
161808281|NCT02682784|584342806|FG002|Overall Study|Withdrawal by Subject|1|||
161808282|NCT02682784|584342807|FG003|Overall Study|Withdrawal by Subject|2|||
161808283|NCT02682784|584342804|FG000|Overall Study|Physician Decision|1|||
161808284|NCT02682784|584342805|FG001|Overall Study|Physician Decision|0|||
161808285|NCT02682784|584342806|FG002|Overall Study|Physician Decision|1|||
161808286|NCT02682784|584342807|FG003|Overall Study|Physician Decision|1|||
161808287|NCT01702987|584342808|FG000|Overall Study|Withdrawal by Subject|1|||
161808288|NCT01702987|584342809|FG001|Overall Study|Withdrawal by Subject|0|||
161808289|NCT00467363|584342810|FG000|Overall Study|Lost to Follow-up|80|||
161808290|NCT00467363|584342811|FG001|Overall Study|Lost to Follow-up|70|||
161808291|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
161808292|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
161808293|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
161808294|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Death|1|||
161808295|NCT03181594|584342812|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
161808296|NCT03181594|584342812|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
161808297|NCT02017223|584342813|FG000|Overall Study|Algorithm problems|2|||
161808298|NCT00365846|584342815|FG000|Overall Study|Lost to Follow-up|1|||
161808299|NCT00904215|584342816|FG000|Overall Study|Adverse Event|25|||
161808300|NCT00904215|584342816|FG000|Overall Study|Protocol Violation|10|||
161808301|NCT00904215|584342816|FG000|Overall Study|Lost to Follow-up|63|||
161808302|NCT00904215|584342816|FG000|Overall Study|Withdrawal by Subject|9|||
161808303|NCT00904215|584342816|FG000|Overall Study|Other|28|||
161808304|NCT01185821|584342822|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161808305|NCT01185821|584342823|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161808306|NCT01185821|584342824|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161808307|NCT01185821|584342825|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161808308|NCT01185821|584342826|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161808309|NCT01185821|584342822|FG000|Overall Study|Protocol Violation|0|||
161808310|NCT01185821|584342823|FG001|Overall Study|Protocol Violation|0|||
161808311|NCT01185821|584342824|FG002|Overall Study|Protocol Violation|0|||
161808312|NCT01185821|584342825|FG003|Overall Study|Protocol Violation|1|||
161808313|NCT01185821|584342826|FG004|Overall Study|Protocol Violation|1|||
161808314|NCT01185821|584342822|FG000|Overall Study|Abnormal test procedure result|0|||
161808315|NCT01185821|584342823|FG001|Overall Study|Abnormal test procedure result|0|||
161808316|NCT01185821|584342824|FG002|Overall Study|Abnormal test procedure result|0|||
161808317|NCT01185821|584342825|FG003|Overall Study|Abnormal test procedure result|0|||
161808318|NCT01185821|584342826|FG004|Overall Study|Abnormal test procedure result|1|||
161808319|NCT01185821|584342822|FG000|Overall Study|Death|0|||
161808320|NCT01185821|584342823|FG001|Overall Study|Death|1|||
161808321|NCT01185821|584342824|FG002|Overall Study|Death|0|||
161808322|NCT01185821|584342825|FG003|Overall Study|Death|0|||
161808323|NCT01185821|584342826|FG004|Overall Study|Death|0|||
161808324|NCT01185821|584342822|FG000|Overall Study|Condition no longer required study drug|0|||
161808325|NCT01185821|584342823|FG001|Overall Study|Condition no longer required study drug|0|||
161456211|NCT00043550|583064976|FG001|Overall Study|Withdrawal by Subject|12|||
161456212|NCT00043550|583064977|FG002|Overall Study|Withdrawal by Subject|20|||
161456213|NCT01917656|583064978|FG000|Overall Study|Adverse Event|11|||
161456214|NCT01917656|583064979|FG001|Overall Study|Adverse Event|0|||
161456215|NCT01917656|583064978|FG000|Overall Study|Withdrawal criteria|8|||
161456216|NCT01917656|583064979|FG001|Overall Study|Withdrawal criteria|14|||
161456217|NCT01917656|583064978|FG000|Overall Study|Unclassified|0|||
161456218|NCT01917656|583064979|FG001|Overall Study|Unclassified|3|||
161456219|NCT01917656|583064978|FG000|Overall Study|Withdrawal by Subject|4|||
161456220|NCT01917656|583064979|FG001|Overall Study|Withdrawal by Subject|3|||
161456221|NCT01917656|583064978|FG000|Overall Study|Lost to Follow-up|3|||
161456222|NCT01917656|583064979|FG001|Overall Study|Lost to Follow-up|4|||
161456223|NCT02285062|583064980|FG000|Pre-Treatment Period|Protocol Violation|0|||
161566280|NCT00567164|583462277|FG001|Overall Study|Adverse Event|13|||
161566281|NCT00567164|583462278|FG002|Overall Study|Adverse Event|9|||
161566282|NCT00567164|583462276|FG000|Overall Study|Death|0|||
161566283|NCT00567164|583462277|FG001|Overall Study|Death|0|||
161566284|NCT00567164|583462278|FG002|Overall Study|Death|1|||
161566285|NCT00567164|583462276|FG000|Overall Study|Lost to Follow-up|202|||
161566286|NCT00567164|583462277|FG001|Overall Study|Lost to Follow-up|23|||
161566287|NCT00567164|583462278|FG002|Overall Study|Lost to Follow-up|21|||
161808326|NCT01185821|584342824|FG002|Overall Study|Condition no longer required study drug|0|||
161808327|NCT01185821|584342825|FG003|Overall Study|Condition no longer required study drug|0|||
161808328|NCT01185821|584342826|FG004|Overall Study|Condition no longer required study drug|1|||
161808329|NCT01185821|584342822|FG000|Overall Study|Adverse Event|2|||
161808330|NCT01185821|584342823|FG001|Overall Study|Adverse Event|3|||
161808331|NCT01185821|584342824|FG002|Overall Study|Adverse Event|1|||
161808332|NCT01185821|584342825|FG003|Overall Study|Adverse Event|2|||
161808333|NCT01185821|584342826|FG004|Overall Study|Adverse Event|5|||
161808334|NCT01185821|584342822|FG000|Overall Study|Lack of Efficacy|0|||
161808335|NCT01185821|584342823|FG001|Overall Study|Lack of Efficacy|0|||
161808336|NCT01185821|584342824|FG002|Overall Study|Lack of Efficacy|3|||
161808337|NCT01185821|584342825|FG003|Overall Study|Lack of Efficacy|0|||
161808338|NCT01185821|584342826|FG004|Overall Study|Lack of Efficacy|9|||
161808339|NCT01185821|584342822|FG000|Overall Study|Withdrawal by Subject|3|||
161808340|NCT01185821|584342823|FG001|Overall Study|Withdrawal by Subject|2|||
161808341|NCT01185821|584342824|FG002|Overall Study|Withdrawal by Subject|2|||
161808342|NCT01185821|584342825|FG003|Overall Study|Withdrawal by Subject|1|||
161808343|NCT01185821|584342826|FG004|Overall Study|Withdrawal by Subject|3|||
161808344|NCT01185821|584342822|FG000|Overall Study|Lost to Follow-up|1|||
161808345|NCT01185821|584342823|FG001|Overall Study|Lost to Follow-up|1|||
161808346|NCT01185821|584342824|FG002|Overall Study|Lost to Follow-up|2|||
161808347|NCT01185821|584342825|FG003|Overall Study|Lost to Follow-up|1|||
161808348|NCT01185821|584342826|FG004|Overall Study|Lost to Follow-up|2|||
161808349|NCT01185821|584342822|FG000|Overall Study|Administrative problems|0|||
161808350|NCT01185821|584342823|FG001|Overall Study|Administrative problems|0|||
161808351|NCT01185821|584342824|FG002|Overall Study|Administrative problems|1|||
161808352|NCT01185821|584342825|FG003|Overall Study|Administrative problems|1|||
161808353|NCT01185821|584342826|FG004|Overall Study|Administrative problems|2|||
161808354|NCT03707912|584342829|FG000|Overall Study|Violation of inclusion criteria|1|||
161808355|NCT03707912|584342830|FG001|Overall Study|Violation of inclusion criteria|0|||
161808356|NCT01313780|584342838|FG000|Overall Study|Lack of Efficacy|4|||
161808357|NCT01313780|584342839|FG001|Overall Study|Lack of Efficacy|2|||
161808358|NCT01313780|584342838|FG000|Overall Study|Adverse Event|6|||
161808359|NCT01313780|584342839|FG001|Overall Study|Adverse Event|11|||
161808360|NCT01313780|584342838|FG000|Overall Study|Withdrawal by Subject|2|||
161808361|NCT01313780|584342839|FG001|Overall Study|Withdrawal by Subject|8|||
161808362|NCT01313780|584342838|FG000|Overall Study|Protocol Violation|10|||
161808363|NCT01313780|584342839|FG001|Overall Study|Protocol Violation|4|||
161808364|NCT01313780|584342838|FG000|Overall Study|missing data|3|||
161456224|NCT02285062|583064981|FG001|Pre-Treatment Period|Protocol Violation|2|||
161456225|NCT02285062|583064980|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161808365|NCT01313780|584342839|FG001|Overall Study|missing data|3|||
161456226|NCT02285062|583064981|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161456227|NCT02015221|583064982|FG000|Overall Study|Withdrawal by Subject|8|||
161566288|NCT00567164|583462276|FG000|Overall Study|Pregnancy|20|||
161566289|NCT00567164|583462277|FG001|Overall Study|Pregnancy|4|||
161566290|NCT00567164|583462278|FG002|Overall Study|Pregnancy|6|||
161566291|NCT00567164|583462276|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
161566292|NCT00567164|583462277|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
161566293|NCT00567164|583462278|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
161566294|NCT00567164|583462276|FG000|Overall Study|Missing|1|||
161566295|NCT00567164|583462277|FG001|Overall Study|Missing|0|||
161566296|NCT00567164|583462278|FG002|Overall Study|Missing|0|||
161566297|NCT03381274|583462285|FG000|Overall Study|Death|2|||
161566298|NCT03381274|583462286|FG001|Overall Study|Death|9|||
161566299|NCT03381274|583462287|FG002|Overall Study|Death|3|||
161566300|NCT03381274|583462288|FG003|Overall Study|Death|2|||
161566301|NCT03381274|583462289|FG004|Overall Study|Death|3|||
161566302|NCT03381274|583462285|FG000|Overall Study|Lost to Follow-up|0|||
161566303|NCT03381274|583462286|FG001|Overall Study|Lost to Follow-up|0|||
161566304|NCT03381274|583462287|FG002|Overall Study|Lost to Follow-up|0|||
161566305|NCT03381274|583462288|FG003|Overall Study|Lost to Follow-up|1|||
161566306|NCT03381274|583462289|FG004|Overall Study|Lost to Follow-up|0|||
161566307|NCT03381274|583462285|FG000|Overall Study|Withdrawal by Subject|2|||
161566308|NCT03381274|583462286|FG001|Overall Study|Withdrawal by Subject|1|||
161566309|NCT03381274|583462287|FG002|Overall Study|Withdrawal by Subject|3|||
161566310|NCT03381274|583462288|FG003|Overall Study|Withdrawal by Subject|1|||
161566311|NCT03381274|583462289|FG004|Overall Study|Withdrawal by Subject|0|||
161566312|NCT03381274|583462285|FG000|Overall Study|Other|1|||
161566313|NCT03381274|583462286|FG001|Overall Study|Other|11|||
161566314|NCT03381274|583462287|FG002|Overall Study|Other|0|||
161566315|NCT03381274|583462288|FG003|Overall Study|Other|2|||
161566316|NCT03381274|583462289|FG004|Overall Study|Other|2|||
161566317|NCT00751036|583462290|FG000|Overall Study|Disease Progression|28|||
161566318|NCT00751036|583462291|FG001|Overall Study|Disease Progression|29|||
161566319|NCT00751036|583462290|FG000|Overall Study|Adverse Event|6|||
161566320|NCT00751036|583462291|FG001|Overall Study|Adverse Event|4|||
161566321|NCT00751036|583462290|FG000|Overall Study|Administrative Problems|3|||
161566322|NCT00751036|583462291|FG001|Overall Study|Administrative Problems|4|||
161566323|NCT00751036|583462290|FG000|Overall Study|Withdrawal by Subject|5|||
161566324|NCT00751036|583462291|FG001|Overall Study|Withdrawal by Subject|2|||
161566325|NCT00751036|583462290|FG000|Overall Study|Death|3|||
161566326|NCT00751036|583462291|FG001|Overall Study|Death|3|||
161566327|NCT00751036|583462290|FG000|Overall Study|Lost to Follow-up|0|||
161566328|NCT00751036|583462291|FG001|Overall Study|Lost to Follow-up|1|||
161566329|NCT00751036|583462290|FG000|Overall Study|Protocol Violation|1|||
161566330|NCT00751036|583462291|FG001|Overall Study|Protocol Violation|0|||
161566331|NCT00751036|583462290|FG000|Overall Study|Missing end of Treatment Page|2|||
161566332|NCT00751036|583462291|FG001|Overall Study|Missing end of Treatment Page|3|||
161566333|NCT05570006|583464400|FG000|Overall Study|Lost to Follow-up|2|||
161808366|NCT00467896|584344173|FG000|Overall Study|Consent Withdrawal|18|||
161808367|NCT00467896|584344173|FG000|Overall Study|Adverse Event|7|||
161808368|NCT00467896|584344173|FG000|Overall Study|Serious Adverse Event|13|||
161808369|NCT00467896|584344173|FG000|Overall Study|Non-compliance|3|||
161808370|NCT00467896|584344173|FG000|Overall Study|Changed therapy|2|||
161808371|NCT00467896|584344173|FG000|Overall Study|Patient received transplant|2|||
161808372|NCT00467896|584344173|FG000|Overall Study|Patient had atrial septostomy|1|||
161808373|NCT00467896|584344173|FG000|Overall Study|Patient weaned off iloprost|1|||
161808374|NCT00467896|584344173|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
161808375|NCT00467896|584344173|FG000|Overall Study|Started intravenous prostacyclin|1|||
161808376|NCT00467896|584344173|FG000|Overall Study|Started inhaled Remodulin|1|||
161808377|NCT00467896|584344173|FG000|Overall Study|Patient had no improvement|1|||
161808378|NCT02847650|584344174|FG000|Overall Study|Adverse Event|2|||
161808379|NCT02847650|584344175|FG001|Overall Study|Adverse Event|4|||
161911642|NCT02194465|584728628|FG006|Overall Study|Physician Decision|0|||
161566334|NCT05570006|583464400|FG000|Overall Study|Withdrawal by Subject|5|||
161566335|NCT05570006|583464400|FG000|Overall Study|Other than Specified|5|||
161566336|NCT00149630|583464405|FG000|Overall Study|Incarceration|2|||
161566337|NCT00149630|583464406|FG001|Overall Study|Incarceration|0|||
161566338|NCT00149630|583464405|FG000|Overall Study|Treatment Programs|4|||
161566339|NCT00149630|583464406|FG001|Overall Study|Treatment Programs|5|||
161566340|NCT00149630|583464405|FG000|Overall Study|Adverse Event|2|||
161566341|NCT00149630|583464406|FG001|Overall Study|Adverse Event|0|||
161808380|NCT02847650|584344174|FG000|Overall Study|Lost to Follow-up|1|||
161808381|NCT02847650|584344175|FG001|Overall Study|Lost to Follow-up|0|||
161911643|NCT02194465|584728622|FG000|Overall Study|Protocol Violation|1|||
161911644|NCT02194465|584728623|FG001|Overall Study|Protocol Violation|1|||
161566342|NCT00109967|583464415|FG000|Overall Study|Cancel Prior to Treatment|2|||
161566343|NCT00109967|583464416|FG001|Overall Study|Cancel Prior to Treatment|0|||
161566344|NCT00109967|583464415|FG000|Overall Study|Adverse Event|12|||
161566345|NCT00109967|583464416|FG001|Overall Study|Adverse Event|1|||
161566346|NCT00109967|583464415|FG000|Overall Study|Withdrawal by Subject|5|||
161566347|NCT00109967|583464416|FG001|Overall Study|Withdrawal by Subject|0|||
161566348|NCT00109967|583464415|FG000|Overall Study|Physician Decision|1|||
161566349|NCT00109967|583464416|FG001|Overall Study|Physician Decision|3|||
161566350|NCT00109967|583464415|FG000|Overall Study|Death|0|||
161566351|NCT00109967|583464416|FG001|Overall Study|Death|2|||
161566352|NCT01977612|583464423|FG000|Overall Study|Lost to Follow-up|1|||
161566353|NCT01977612|583464424|FG001|Overall Study|Lost to Follow-up|1|||
161566354|NCT04381494|583464425|FG000|Overall Study|Early termination of trial|19|||
161566355|NCT04381494|583464425|FG000|Overall Study|Investigator's discretion|1|||
161566356|NCT04381494|583464425|FG000|Overall Study|Withdrawal by Subject|9|||
161566357|NCT04381494|583464425|FG000|Overall Study|NSCLC disease progression|4|||
161566358|NCT04381494|583464425|FG000|Overall Study|Device-Related Adverse Event|2|||
161566359|NCT04310579|583464427|FG000|Overall Study|Adverse Event|0|||
161566360|NCT04310579|583464428|FG001|Overall Study|Adverse Event|0|||
161566361|NCT04310579|583464429|FG002|Overall Study|Adverse Event|0|||
161566362|NCT04310579|583464430|FG003|Overall Study|Adverse Event|0|||
161566363|NCT04310579|583464431|FG004|Overall Study|Adverse Event|0|||
161566364|NCT04310579|583464432|FG005|Overall Study|Adverse Event|0|||
161566365|NCT04310579|583464433|FG006|Overall Study|Adverse Event|2|||
161566366|NCT04310579|583464434|FG007|Overall Study|Adverse Event|0|||
161566367|NCT04310579|583464435|FG008|Overall Study|Adverse Event|1|||
161566368|NCT04310579|583464436|FG009|Overall Study|Adverse Event|1|||
161566369|NCT04310579|583464437|FG010|Overall Study|Adverse Event|0|||
161566370|NCT04310579|583464427|FG000|Overall Study|Withdrawal by Subject|0|||
161566371|NCT04310579|583464428|FG001|Overall Study|Withdrawal by Subject|0|||
161566372|NCT04310579|583464429|FG002|Overall Study|Withdrawal by Subject|0|||
161566373|NCT04310579|583464430|FG003|Overall Study|Withdrawal by Subject|0|||
161566374|NCT04310579|583464431|FG004|Overall Study|Withdrawal by Subject|0|||
161566375|NCT04310579|583464432|FG005|Overall Study|Withdrawal by Subject|1|||
161566376|NCT04310579|583464433|FG006|Overall Study|Withdrawal by Subject|0|||
161566377|NCT04310579|583464434|FG007|Overall Study|Withdrawal by Subject|0|||
161566378|NCT04310579|583464435|FG008|Overall Study|Withdrawal by Subject|0|||
161566379|NCT04310579|583464436|FG009|Overall Study|Withdrawal by Subject|0|||
161566380|NCT04310579|583464437|FG010|Overall Study|Withdrawal by Subject|0|||
161566381|NCT04310579|583464427|FG000|Overall Study|Positive COVID-19 test|0|||
161566382|NCT04310579|583464428|FG001|Overall Study|Positive COVID-19 test|0|||
161566383|NCT04310579|583464429|FG002|Overall Study|Positive COVID-19 test|0|||
161566384|NCT04310579|583464430|FG003|Overall Study|Positive COVID-19 test|0|||
161566385|NCT04310579|583464431|FG004|Overall Study|Positive COVID-19 test|0|||
161566386|NCT04310579|583464432|FG005|Overall Study|Positive COVID-19 test|0|||
161566387|NCT04310579|583464433|FG006|Overall Study|Positive COVID-19 test|0|||
161566388|NCT04310579|583464434|FG007|Overall Study|Positive COVID-19 test|0|||
161911645|NCT02194465|584728624|FG002|Overall Study|Protocol Violation|2|||
161566389|NCT04310579|583464435|FG008|Overall Study|Positive COVID-19 test|0|||
161566390|NCT04310579|583464436|FG009|Overall Study|Positive COVID-19 test|0|||
161566391|NCT04310579|583464437|FG010|Overall Study|Positive COVID-19 test|1|||
161566392|NCT00943605|583464438|FG000|Overall Study|Study termination|30|||
161566393|NCT00943605|583464439|FG001|Overall Study|Study termination|30|||
161566394|NCT02232178|583464440|FG000|Overall Study|Lost to Follow-up|0|||
161566395|NCT02232178|583464441|FG001|Overall Study|Lost to Follow-up|1|||
161566396|NCT02232178|583464442|FG002|Overall Study|Lost to Follow-up|0|||
161566397|NCT02232178|583464440|FG000|Overall Study|ineligibility|0|||
161566398|NCT02232178|583464441|FG001|Overall Study|ineligibility|0|||
161566399|NCT02232178|583464442|FG002|Overall Study|ineligibility|1|||
161566400|NCT02232178|583464440|FG000|Overall Study|surgical complication|1|||
161566401|NCT02232178|583464441|FG001|Overall Study|surgical complication|0|||
161566402|NCT02232178|583464442|FG002|Overall Study|surgical complication|0|||
161566403|NCT01956669|583464445|FG000|Overall Study|Disease Progression|12|||
161566404|NCT01956669|583464446|FG001|Overall Study|Disease Progression|7|||
161566405|NCT01956669|583464447|FG002|Overall Study|Disease Progression|7|||
161566406|NCT01956669|583464448|FG003|Overall Study|Disease Progression|8|||
161566407|NCT01956669|583464449|FG004|Overall Study|Disease Progression|4|||
161566408|NCT01956669|583464450|FG005|Overall Study|Disease Progression|3|||
161566409|NCT01956669|583464451|FG006|Overall Study|Disease Progression|5|||
161911646|NCT02194465|584728625|FG003|Overall Study|Protocol Violation|1|||
161566410|NCT01956669|583464445|FG000|Overall Study|Adverse Event|0|||
161566411|NCT01956669|583464446|FG001|Overall Study|Adverse Event|2|||
161566412|NCT01956669|583464447|FG002|Overall Study|Adverse Event|2|||
161566413|NCT01956669|583464448|FG003|Overall Study|Adverse Event|1|||
161566414|NCT01956669|583464449|FG004|Overall Study|Adverse Event|0|||
161566415|NCT01956669|583464450|FG005|Overall Study|Adverse Event|0|||
161566416|NCT01956669|583464451|FG006|Overall Study|Adverse Event|0|||
161566417|NCT01956669|583464445|FG000|Overall Study|Physician Decision|0|||
161566418|NCT01956669|583464446|FG001|Overall Study|Physician Decision|2|||
161566419|NCT01956669|583464447|FG002|Overall Study|Physician Decision|0|||
161911647|NCT02194465|584728626|FG004|Overall Study|Protocol Violation|1|||
161911648|NCT02194465|584728627|FG005|Overall Study|Protocol Violation|0|||
161911649|NCT02194465|584728628|FG006|Overall Study|Protocol Violation|0|||
161566420|NCT01956669|583464448|FG003|Overall Study|Physician Decision|0|||
161566421|NCT01956669|583464449|FG004|Overall Study|Physician Decision|0|||
161566422|NCT01956669|583464450|FG005|Overall Study|Physician Decision|1|||
161566423|NCT01956669|583464451|FG006|Overall Study|Physician Decision|0|||
161566424|NCT01956669|583464445|FG000|Overall Study|Withdrawal by Subject|0|||
161911650|NCT02194465|584728622|FG000|Overall Study|Withdrawal by Subject|1|||
161566425|NCT01956669|583464446|FG001|Overall Study|Withdrawal by Subject|0|||
161566426|NCT01956669|583464447|FG002|Overall Study|Withdrawal by Subject|1|||
161566427|NCT01956669|583464448|FG003|Overall Study|Withdrawal by Subject|1|||
161566428|NCT01956669|583464449|FG004|Overall Study|Withdrawal by Subject|0|||
161566429|NCT01956669|583464450|FG005|Overall Study|Withdrawal by Subject|0|||
161566430|NCT01956669|583464451|FG006|Overall Study|Withdrawal by Subject|1|||
161566431|NCT01570751|583464452|FG000|Period A (16 Weeks)|Protocol Violation|1|||
161566432|NCT01570751|583464453|FG001|Period A (16 Weeks)|Protocol Violation|1|||
161566433|NCT01570751|583464452|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
161566434|NCT01570751|583464453|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
161566435|NCT01570751|583464452|FG000|Period A (16 Weeks)|Unclassified|2|||
161566436|NCT01570751|583464453|FG001|Period A (16 Weeks)|Unclassified|3|||
161566437|NCT01570751|583464452|FG000|Period B (16 Weeks)|Adverse Event|1|||
161566438|NCT01570751|583464453|FG001|Period B (16 Weeks)|Adverse Event|0|||
161566439|NCT01570751|583464452|FG000|Period B (16 Weeks)|Protocol Violation|0|||
161566440|NCT01570751|583464453|FG001|Period B (16 Weeks)|Protocol Violation|1|||
161566441|NCT01131494|583464458|FG000|Overall Study|Withdrawal by Subject|2|||
161566442|NCT05419557|583464460|FG000|Overall Study|Lost to Follow-up|11|||
161566443|NCT05419557|583464461|FG001|Overall Study|Lost to Follow-up|4|||
161566444|NCT01196988|583464462|FG000|Overall Study|Adverse Event|1|||
161566445|NCT01196988|583464463|FG001|Overall Study|Adverse Event|2|||
161566446|NCT01196988|583464464|FG002|Overall Study|Adverse Event|0|||
161566447|NCT01196988|583464465|FG003|Overall Study|Adverse Event|0|||
161566448|NCT01196988|583464462|FG000|Overall Study|Withdrawal by Subject|5|||
161566449|NCT01196988|583464463|FG001|Overall Study|Withdrawal by Subject|1|||
161566450|NCT01196988|583464464|FG002|Overall Study|Withdrawal by Subject|4|||
161566451|NCT01196988|583464465|FG003|Overall Study|Withdrawal by Subject|0|||
161566452|NCT01196988|583464462|FG000|Overall Study|Lost to Follow-up|16|||
161566453|NCT01196988|583464463|FG001|Overall Study|Lost to Follow-up|29|||
161566454|NCT01196988|583464464|FG002|Overall Study|Lost to Follow-up|21|||
161566455|NCT01196988|583464465|FG003|Overall Study|Lost to Follow-up|1|||
161566456|NCT01196988|583464462|FG000|Overall Study|Other|2|||
161566457|NCT01196988|583464463|FG001|Overall Study|Other|0|||
161566458|NCT01196988|583464464|FG002|Overall Study|Other|0|||
161566459|NCT01196988|583464465|FG003|Overall Study|Other|0|||
161566460|NCT02281318|583464467|FG000|Overall Study|Adverse Event|2|||
161566461|NCT02281318|583464468|FG001|Overall Study|Adverse Event|2|||
161566462|NCT02281318|583464467|FG000|Overall Study|Lack of Efficacy|2|||
161566463|NCT02281318|583464468|FG001|Overall Study|Lack of Efficacy|0|||
161566464|NCT02281318|583464467|FG000|Overall Study|Lost to Follow-up|2|||
161566465|NCT02281318|583464468|FG001|Overall Study|Lost to Follow-up|1|||
161566466|NCT02281318|583464467|FG000|Overall Study|Physician Decision|2|||
161566467|NCT02281318|583464468|FG001|Overall Study|Physician Decision|0|||
161566468|NCT02281318|583464467|FG000|Overall Study|Withdrawal by Subject|6|||
161566469|NCT02281318|583464468|FG001|Overall Study|Withdrawal by Subject|2|||
161566470|NCT05257798|583464469|FG000|Follow-up Phase|Lost to Follow-up|1|||
161566471|NCT05257798|583464470|FG001|Follow-up Phase|Lost to Follow-up|0|||
161566472|NCT00703911|583464471|FG000|Overall Study|Death|1|||
161566473|NCT00703911|583464471|FG000|Overall Study|Physician Decision|6|||
161566474|NCT00703911|583464471|FG000|Overall Study|Lost to Follow-up|1|||
161566475|NCT00703911|583464471|FG000|Overall Study|Withdrawal by Subject|2|||
161566476|NCT01064817|583464472|FG000|Study Completion|Physician Decision|1|||
161566477|NCT01064817|583464473|FG001|Study Completion|Physician Decision|0|||
161566478|NCT01064817|583464472|FG000|Study Completion|Withdrawal by Subject|1|||
161566479|NCT01064817|583464473|FG001|Study Completion|Withdrawal by Subject|0|||
161566480|NCT03102710|583464474|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
161566481|NCT03102710|583464475|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
161566482|NCT03102710|583464476|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
161566483|NCT03102710|583464474|FG000|Overall Study|Technical issues during final MRI scan|0|||
161566484|NCT03102710|583464475|FG001|Overall Study|Technical issues during final MRI scan|1|||
161566485|NCT03102710|583464476|FG002|Overall Study|Technical issues during final MRI scan|0|||
161566486|NCT03102710|583464474|FG000|Overall Study|Nausea during MRI scan|0|||
161566487|NCT03102710|583464475|FG001|Overall Study|Nausea during MRI scan|1|||
161566488|NCT03102710|583464476|FG002|Overall Study|Nausea during MRI scan|0|||
161566489|NCT03102710|583464474|FG000|Overall Study|Subject unable to attend final session|0|||
161566490|NCT03102710|583464475|FG001|Overall Study|Subject unable to attend final session|1|||
161911651|NCT02194465|584728623|FG001|Overall Study|Withdrawal by Subject|3|||
161566491|NCT03102710|583464476|FG002|Overall Study|Subject unable to attend final session|0|||
161566492|NCT01368406|583464477|FG000|Overall Study|Lost to Follow-up|8|||
161566493|NCT01368406|583464478|FG001|Overall Study|Lost to Follow-up|4|||
161566494|NCT01368406|583464477|FG000|Overall Study|Withdrawal by Subject|8|||
161566495|NCT01368406|583464478|FG001|Overall Study|Withdrawal by Subject|4|||
161566496|NCT01368406|583464477|FG000|Overall Study|relapse of the disease|3|||
161566497|NCT01368406|583464478|FG001|Overall Study|relapse of the disease|2|||
161911652|NCT02194465|584728624|FG002|Overall Study|Withdrawal by Subject|1|||
161566498|NCT01368406|583464477|FG000|Overall Study|started working|2|||
161566499|NCT01368406|583464478|FG001|Overall Study|started working|3|||
161566500|NCT04012853|583464479|FG000|Overall Study|Withdrawal by Subject|1|||
161566501|NCT04012853|583464480|FG001|Overall Study|Withdrawal by Subject|1|||
161566502|NCT04012853|583464479|FG000|Overall Study|Protocol Violation|1|||
161566503|NCT04012853|583464480|FG001|Overall Study|Protocol Violation|0|||
161566504|NCT04012853|583464479|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
161566505|NCT04012853|583464480|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
161566506|NCT04304534|583464481|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
161566507|NCT04304534|583464482|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
161566508|NCT04304534|583464483|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
161566509|NCT04304534|583464484|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
161808382|NCT02847650|584344174|FG000|Overall Study|Protocol Violation|0|||
161808383|NCT02847650|584344175|FG001|Overall Study|Protocol Violation|1|||
161808384|NCT02847650|584344174|FG000|Overall Study|Withdrawal by Subject|1|||
161808385|NCT02847650|584344175|FG001|Overall Study|Withdrawal by Subject|1|||
161808386|NCT03818581|584344178|FG000|Overall Study|Adverse Event|1|||
161808387|NCT03818581|584344179|FG001|Overall Study|Adverse Event|0|||
161808388|NCT03818581|584344180|FG002|Overall Study|Adverse Event|0|||
161808389|NCT03818581|584344181|FG003|Overall Study|Adverse Event|0|||
161808390|NCT03818581|584344182|FG004|Overall Study|Adverse Event|0|||
161808391|NCT03818581|584344178|FG000|Overall Study|Covid-19|2|||
161808392|NCT03818581|584344179|FG001|Overall Study|Covid-19|0|||
161808393|NCT03818581|584344180|FG002|Overall Study|Covid-19|0|||
161808394|NCT03818581|584344181|FG003|Overall Study|Covid-19|0|||
161808395|NCT03818581|584344182|FG004|Overall Study|Covid-19|1|||
161808396|NCT03818581|584344178|FG000|Overall Study|Withdrawal by Subject|0|||
161808397|NCT03818581|584344179|FG001|Overall Study|Withdrawal by Subject|0|||
161808398|NCT03818581|584344180|FG002|Overall Study|Withdrawal by Subject|0|||
161808399|NCT03818581|584344181|FG003|Overall Study|Withdrawal by Subject|0|||
161808400|NCT03818581|584344182|FG004|Overall Study|Withdrawal by Subject|1|||
161808401|NCT03818581|584344178|FG000|Overall Study|No longer met study criteria|0|||
161808402|NCT03818581|584344179|FG001|Overall Study|No longer met study criteria|0|||
161808403|NCT03818581|584344180|FG002|Overall Study|No longer met study criteria|0|||
161808404|NCT03818581|584344181|FG003|Overall Study|No longer met study criteria|0|||
161808405|NCT03818581|584344182|FG004|Overall Study|No longer met study criteria|1|||
161808406|NCT01466166|584344186|FG000|Overall Study|Death|1|||
161808407|NCT01466166|584344186|FG000|Overall Study|Lost to Follow-up|7|||
161808408|NCT01466166|584344186|FG000|Overall Study|Infusion Reaction (IR)|27|||
161808409|NCT01466166|584344186|FG000|Overall Study|Adverse Event (Other than IR)|11|||
161808410|NCT01466166|584344186|FG000|Overall Study|Elevated Serum Uric Acid|78|||
161808411|NCT01466166|584344186|FG000|Overall Study|Withdrawal by Subject|13|||
161808412|NCT01466166|584344186|FG000|Overall Study|Sponsor Decision|4|||
161808413|NCT01466166|584344186|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
161808414|NCT01466166|584344186|FG000|Overall Study|Other|20|||
161808415|NCT02262377|584344187|FG000|Overall Study|Lost to Follow-up|5|||
161808416|NCT02262377|584344188|FG001|Overall Study|Lost to Follow-up|6|||
161808417|NCT02262377|584344187|FG000|Overall Study|Found ineligible after enrollment|3|||
161808418|NCT02262377|584344188|FG001|Overall Study|Found ineligible after enrollment|0|||
161808419|NCT02262377|584344187|FG000|Overall Study|Withdrawal by Subject|4|||
161808420|NCT02262377|584344188|FG001|Overall Study|Withdrawal by Subject|0|||
161808421|NCT00371839|584344189|FG000|Overall Study|Death|4|||
161808422|NCT00371839|584344190|FG001|Overall Study|Death|0|||
161808423|NCT00371839|584344191|FG002|Overall Study|Death|0|||
161808424|NCT00371839|584344189|FG000|Overall Study|Withdrawal by Subject|7|||
161808425|NCT00371839|584344190|FG001|Overall Study|Withdrawal by Subject|4|||
161808426|NCT00371839|584344191|FG002|Overall Study|Withdrawal by Subject|0|||
161808427|NCT00371839|584344189|FG000|Overall Study|Lost to Follow-up|6|||
161808428|NCT00371839|584344190|FG001|Overall Study|Lost to Follow-up|3|||
161808429|NCT00371839|584344191|FG002|Overall Study|Lost to Follow-up|2|||
161808430|NCT02533258|584344193|FG000|Overall Study|Adverse Event|1|||
161808431|NCT02533258|584344193|FG000|Overall Study|Death|2|||
161808432|NCT02533258|584344193|FG000|Overall Study|Other|1|||
161808433|NCT02533258|584344193|FG000|Overall Study|Economic factor|1|||
161808434|NCT02533258|584344193|FG000|Overall Study|Progression of pleural effusion|1|||
161808435|NCT02533258|584344193|FG000|Overall Study|Lack of Efficacy|2|||
161808436|NCT02563561|584344194|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
161566510|NCT04304534|583464481|FG000|Overall Study|Non-Compliance with study drug|0|||
161566511|NCT04304534|583464482|FG001|Overall Study|Non-Compliance with study drug|1|||
161808437|NCT02563561|584344195|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
161808438|NCT02563561|584344196|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
161808439|NCT02563561|584344194|FG000|Overall Study|Withdrew of Consent|1|||
161808440|NCT02563561|584344195|FG001|Overall Study|Withdrew of Consent|1|||
161808441|NCT02563561|584344196|FG002|Overall Study|Withdrew of Consent|2|||
161808442|NCT02563561|584344194|FG000|Overall Study|Lost to Follow-up|1|||
161808443|NCT02563561|584344195|FG001|Overall Study|Lost to Follow-up|1|||
161808444|NCT02563561|584344196|FG002|Overall Study|Lost to Follow-up|0|||
161808445|NCT02563561|584344194|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
161808446|NCT02563561|584344195|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
161808447|NCT02563561|584344196|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
161808448|NCT02563561|584344194|FG000|Overall Study|Investigator Decision|3|||
161808449|NCT02563561|584344195|FG001|Overall Study|Investigator Decision|4|||
161808450|NCT02563561|584344196|FG002|Overall Study|Investigator Decision|2|||
161808451|NCT02563561|584344194|FG000|Overall Study|Sponsor Decision|5|||
161808452|NCT02563561|584344195|FG001|Overall Study|Sponsor Decision|2|||
161808453|NCT02563561|584344196|FG002|Overall Study|Sponsor Decision|4|||
161808454|NCT02563561|584344194|FG000|Overall Study|Other|1|||
161808455|NCT02563561|584344195|FG001|Overall Study|Other|5|||
161808456|NCT02563561|584344196|FG002|Overall Study|Other|2|||
161808457|NCT02646124|584344197|FG000|Overall Study|Lost to Follow-up|0|||
161808458|NCT02646124|584344198|FG001|Overall Study|Lost to Follow-up|2|||
161808459|NCT03154047|584344199|FG000|Overall Study|Death|1|||
161808460|NCT03154047|584344199|FG000|Overall Study|Study terminated by sponsor|76|||
161808461|NCT03154047|584344199|FG000|Overall Study|Withdrawal by Subject|3|||
161808462|NCT00365365|584344200|FG000|Overall Study|Randomized but not treated|0|||
161808463|NCT00365365|584344201|FG001|Overall Study|Randomized but not treated|2|||
161808464|NCT00365365|584344202|FG002|Overall Study|Randomized but not treated|0|||
161808465|NCT00365365|584344200|FG000|Overall Study|Poor compliance to protocol|0|||
161808466|NCT00365365|584344201|FG001|Overall Study|Poor compliance to protocol|1|||
161808467|NCT00365365|584344202|FG002|Overall Study|Poor compliance to protocol|0|||
161808468|NCT00365365|584344200|FG000|Overall Study|Lost to Follow-up|3|||
161808469|NCT00365365|584344201|FG001|Overall Study|Lost to Follow-up|3|||
161808470|NCT00365365|584344202|FG002|Overall Study|Lost to Follow-up|3|||
161808471|NCT00365365|584344200|FG000|Overall Study|Death|1|||
161808472|NCT00365365|584344201|FG001|Overall Study|Death|3|||
161808473|NCT00365365|584344202|FG002|Overall Study|Death|0|||
161808474|NCT00365365|584344200|FG000|Overall Study|Subject's request|11|||
161808475|NCT00365365|584344201|FG001|Overall Study|Subject's request|13|||
161808476|NCT00365365|584344202|FG002|Overall Study|Subject's request|1|||
161808477|NCT00365365|584344200|FG000|Overall Study|Disease progression/relapse|9|||
161808478|NCT00365365|584344201|FG001|Overall Study|Disease progression/relapse|6|||
161808479|NCT00365365|584344202|FG002|Overall Study|Disease progression/relapse|7|||
161808480|NCT00365365|584344200|FG000|Overall Study|Adverse Event|6|||
161808481|NCT00365365|584344201|FG001|Overall Study|Adverse Event|6|||
161808482|NCT00365365|584344202|FG002|Overall Study|Adverse Event|3|||
161808483|NCT00365365|584344200|FG000|Overall Study|Moved|2|||
161808484|NCT00365365|584344201|FG001|Overall Study|Moved|0|||
161808485|NCT00365365|584344202|FG002|Overall Study|Moved|0|||
161808486|NCT00365365|584344200|FG000|Overall Study|New cancer|1|||
161808487|NCT00365365|584344201|FG001|Overall Study|New cancer|0|||
161808488|NCT00365365|584344202|FG002|Overall Study|New cancer|0|||
161808489|NCT00365365|584344200|FG000|Overall Study|Withdrew consent|1|||
161808490|NCT00365365|584344201|FG001|Overall Study|Withdrew consent|1|||
161808491|NCT00365365|584344202|FG002|Overall Study|Withdrew consent|0|||
161808492|NCT00365365|584344200|FG000|Overall Study|Second malignancy|0|||
161808493|NCT00365365|584344201|FG001|Overall Study|Second malignancy|1|||
161808494|NCT00365365|584344202|FG002|Overall Study|Second malignancy|0|||
161808495|NCT00365365|584344200|FG000|Overall Study|Patient/physician decision|0|||
161808496|NCT00365365|584344201|FG001|Overall Study|Patient/physician decision|0|||
161808497|NCT00365365|584344202|FG002|Overall Study|Patient/physician decision|1|||
161808498|NCT00838630|584344203|FG000|First Intervention|Adverse Event|1|||
161808499|NCT00838630|584344204|FG001|First Intervention|Adverse Event|0|||
161808500|NCT00838630|584344203|FG000|Washout: 7 Days|Protocol Violation|1|||
161808501|NCT00838630|584344204|FG001|Washout: 7 Days|Protocol Violation|0|||
161808502|NCT04263649|584344211|FG000|Overall Study|Adverse Event|53|||
161808503|NCT04263649|584344211|FG000|Overall Study|Lost to Follow-up|3|||
161808504|NCT04263649|584344211|FG000|Overall Study|Death|29|||
161808505|NCT04263649|584344211|FG000|Overall Study|Device deficiency|19|||
161808506|NCT04263649|584344211|FG000|Overall Study|other reasons|11|||
161808507|NCT02057458|584344212|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
161808508|NCT02057458|584344213|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
161808509|NCT02057458|584344214|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
161808510|NCT02057458|584344212|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
161808511|NCT02057458|584344213|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
161808512|NCT02057458|584344214|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
161808513|NCT02057458|584344212|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
161808514|NCT02057458|584344213|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
161808515|NCT02057458|584344214|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
161808516|NCT05169710|584344215|FG000|Overall Study|Adverse Event|1|||
161808517|NCT05169710|584344216|FG001|Overall Study|Adverse Event|2|||
161808518|NCT05169710|584344217|FG002|Overall Study|Adverse Event|2|||
161808519|NCT05169710|584344215|FG000|Overall Study|Lost to Follow-up|0|||
161808520|NCT05169710|584344216|FG001|Overall Study|Lost to Follow-up|0|||
161808521|NCT05169710|584344217|FG002|Overall Study|Lost to Follow-up|1|||
161808522|NCT05169710|584344215|FG000|Overall Study|Withdrawal by Subject|2|||
161808523|NCT05169710|584344216|FG001|Overall Study|Withdrawal by Subject|1|||
161566512|NCT04304534|583464483|FG002|Overall Study|Non-Compliance with study drug|1|||
161566513|NCT04304534|583464484|FG003|Overall Study|Non-Compliance with study drug|1|||
161566514|NCT04304534|583464481|FG000|Overall Study|Lost to Follow-up|0|||
161566515|NCT04304534|583464482|FG001|Overall Study|Lost to Follow-up|1|||
161566516|NCT04304534|583464483|FG002|Overall Study|Lost to Follow-up|2|||
161566517|NCT04304534|583464484|FG003|Overall Study|Lost to Follow-up|3|||
161566518|NCT04304534|583464481|FG000|Overall Study|Unspecific|4|||
161566519|NCT04304534|583464482|FG001|Overall Study|Unspecific|2|||
161566520|NCT04304534|583464483|FG002|Overall Study|Unspecific|2|||
161566521|NCT04304534|583464484|FG003|Overall Study|Unspecific|2|||
161566522|NCT04304534|583464481|FG000|Overall Study|Technical Problems|2|||
161566523|NCT04304534|583464482|FG001|Overall Study|Technical Problems|2|||
161566524|NCT04304534|583464483|FG002|Overall Study|Technical Problems|3|||
161566525|NCT04304534|583464484|FG003|Overall Study|Technical Problems|4|||
161566526|NCT04304534|583464481|FG000|Overall Study|Death|7|||
161566527|NCT04304534|583464482|FG001|Overall Study|Death|2|||
161566528|NCT04304534|583464483|FG002|Overall Study|Death|4|||
161566529|NCT04304534|583464484|FG003|Overall Study|Death|3|||
161566530|NCT04304534|583464481|FG000|Overall Study|Withdrawal by Subject|7|||
161566531|NCT04304534|583464482|FG001|Overall Study|Withdrawal by Subject|2|||
161566532|NCT04304534|583464483|FG002|Overall Study|Withdrawal by Subject|7|||
161566533|NCT04304534|583464484|FG003|Overall Study|Withdrawal by Subject|4|||
161566534|NCT04304534|583464481|FG000|Overall Study|Physician Decision|4|||
161566535|NCT04304534|583464482|FG001|Overall Study|Physician Decision|9|||
161566536|NCT04304534|583464483|FG002|Overall Study|Physician Decision|9|||
161566537|NCT04304534|583464484|FG003|Overall Study|Physician Decision|5|||
161566538|NCT04304534|583464481|FG000|Overall Study|Subject Decision|34|||
161566539|NCT04304534|583464482|FG001|Overall Study|Subject Decision|25|||
161566540|NCT04304534|583464483|FG002|Overall Study|Subject Decision|25|||
161566541|NCT04304534|583464484|FG003|Overall Study|Subject Decision|26|||
161566542|NCT04304534|583464481|FG000|Overall Study|Adverse Event|35|||
161566543|NCT04304534|583464482|FG001|Overall Study|Adverse Event|40|||
161566544|NCT04304534|583464483|FG002|Overall Study|Adverse Event|39|||
161566545|NCT04304534|583464484|FG003|Overall Study|Adverse Event|44|||
161566546|NCT01313182|583464485|FG000|Overall Study|Protocol Violation|66|||
161566547|NCT01313182|583464486|FG001|Overall Study|Protocol Violation|92|||
161566548|NCT01695317|583464487|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
161566549|NCT01695317|583464488|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
161566550|NCT01695317|583464487|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
161566551|NCT01695317|583464488|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
161566552|NCT00003656|583464489|FG000|Overall Study|Adverse Event|0|||
161566553|NCT00003656|583464490|FG001|Overall Study|Adverse Event|1|||
161566554|NCT00464672|583464491|FG000|Overall Study|withdrawal of consent|0|||
161566555|NCT00464672|583464492|FG001|Overall Study|withdrawal of consent|0|||
161566556|NCT00464672|583464493|FG002|Overall Study|withdrawal of consent|0|||
161566557|NCT00464672|583464494|FG003|Overall Study|withdrawal of consent|1|||
161566558|NCT00464672|583464495|FG004|Overall Study|withdrawal of consent|9|||
161566559|NCT00464672|583464496|FG005|Overall Study|withdrawal of consent|4|||
161566560|NCT00464672|583464491|FG000|Overall Study|Lost to Follow-up|25|||
161566561|NCT00464672|583464492|FG001|Overall Study|Lost to Follow-up|10|||
161566562|NCT00464672|583464493|FG002|Overall Study|Lost to Follow-up|0|||
161808524|NCT05169710|584344217|FG002|Overall Study|Withdrawal by Subject|0|||
161808525|NCT05169710|584344215|FG000|Overall Study|Other Study Discontinuation Reason|0|||
161808526|NCT05169710|584344216|FG001|Overall Study|Other Study Discontinuation Reason|2|||
161808527|NCT05169710|584344217|FG002|Overall Study|Other Study Discontinuation Reason|0|||
161808528|NCT00723710|584344225|FG000|Overall Study|Disease progression|48|||
161808529|NCT00723710|584344225|FG000|Overall Study|Adverse Event|88|||
161808530|NCT00723710|584344225|FG000|Overall Study|Withdrawal by Subject|36|||
161808531|NCT00723710|584344225|FG000|Overall Study|Physician Decision|2|||
161911653|NCT02194465|584728625|FG003|Overall Study|Withdrawal by Subject|2|||
161566563|NCT00464672|583464494|FG003|Overall Study|Lost to Follow-up|0|||
161566564|NCT00464672|583464495|FG004|Overall Study|Lost to Follow-up|1|||
161566565|NCT00464672|583464496|FG005|Overall Study|Lost to Follow-up|0|||
161566566|NCT03055767|583464497|FG000|Open-Label Period|Lost to Follow-up|0|||
161808532|NCT00468286|584344226|FG000|Overall Study|Adverse Event|1|||
161808533|NCT00468286|584344227|FG001|Overall Study|Adverse Event|6|||
161566567|NCT03055767|583464498|FG001|Open-Label Period|Lost to Follow-up|0|||
161566568|NCT03055767|583464499|FG002|Open-Label Period|Lost to Follow-up|2|||
161566569|NCT03055767|583464500|FG003|Open-Label Period|Lost to Follow-up|0|||
161566570|NCT03055767|583464497|FG000|Open-Label Period|Withdrawal by Subject|0|||
161566571|NCT03055767|583464498|FG001|Open-Label Period|Withdrawal by Subject|0|||
161566572|NCT03055767|583464499|FG002|Open-Label Period|Withdrawal by Subject|0|||
161566573|NCT03055767|583464500|FG003|Open-Label Period|Withdrawal by Subject|1|||
161566574|NCT02759731|583464503|FG000|Overall Study|Did not complete treatment.|8|||
161566575|NCT00763282|583464508|FG000|Overall Study|Withdrawal by Subject|6|||
161566576|NCT00763282|583464509|FG001|Overall Study|Withdrawal by Subject|5|||
161566577|NCT00763282|583464508|FG000|Overall Study|Death|4|||
161566578|NCT00763282|583464509|FG001|Overall Study|Death|3|||
161566579|NCT00763282|583464508|FG000|Overall Study|Lost to Follow-up|22|||
161566580|NCT00763282|583464509|FG001|Overall Study|Lost to Follow-up|26|||
161566581|NCT00606580|583464510|FG000|Overall Study|Lost to Follow-up|1|||
161566582|NCT00606580|583464511|FG001|Overall Study|Lost to Follow-up|1|||
161566583|NCT00606580|583464512|FG002|Overall Study|Lost to Follow-up|4|||
161566584|NCT00606580|583464510|FG000|Overall Study|Clinical failures|1|||
161566585|NCT00606580|583464511|FG001|Overall Study|Clinical failures|0|||
161566586|NCT00606580|583464512|FG002|Overall Study|Clinical failures|12|||
161566587|NCT00606580|583464510|FG000|Overall Study|Withdrawal by investigator|0|||
161566588|NCT00606580|583464511|FG001|Overall Study|Withdrawal by investigator|1|||
161566589|NCT00606580|583464512|FG002|Overall Study|Withdrawal by investigator|6|||
161566590|NCT00606580|583464510|FG000|Overall Study|Withdrawal by Subject|0|||
161566591|NCT00606580|583464511|FG001|Overall Study|Withdrawal by Subject|1|||
161566592|NCT00606580|583464512|FG002|Overall Study|Withdrawal by Subject|0|||
161566593|NCT04580303|583464513|FG000|Overall Study|Adverse Event|0|||
161566594|NCT04580303|583464514|FG001|Overall Study|Adverse Event|1|||
161566595|NCT04580303|583464515|FG002|Overall Study|Adverse Event|0|||
161566596|NCT04580303|583464516|FG003|Overall Study|Adverse Event|0|||
161566597|NCT04580303|583464513|FG000|Overall Study|Withdrawal by Subject|0|||
161566598|NCT04580303|583464514|FG001|Overall Study|Withdrawal by Subject|0|||
161566599|NCT04580303|583464515|FG002|Overall Study|Withdrawal by Subject|1|||
161566600|NCT04580303|583464516|FG003|Overall Study|Withdrawal by Subject|0|||
161566601|NCT01833065|583464517|FG000|Overall Study|Adverse Event|6|||
161566602|NCT01833065|583464518|FG001|Overall Study|Adverse Event|1|||
161566603|NCT01833065|583464519|FG002|Overall Study|Adverse Event|0|||
161566604|NCT01833065|583464520|FG003|Overall Study|Adverse Event|2|||
161566605|NCT01833065|583464521|FG004|Overall Study|Adverse Event|3|||
161566606|NCT01833065|583464517|FG000|Overall Study|Protocol Violation|1|||
161566607|NCT01833065|583464518|FG001|Overall Study|Protocol Violation|0|||
161566608|NCT01833065|583464519|FG002|Overall Study|Protocol Violation|0|||
161566609|NCT01833065|583464520|FG003|Overall Study|Protocol Violation|0|||
161566610|NCT01833065|583464521|FG004|Overall Study|Protocol Violation|2|||
161566611|NCT01833065|583464517|FG000|Overall Study|Lost to Follow-up|1|||
161566612|NCT01833065|583464518|FG001|Overall Study|Lost to Follow-up|0|||
161566613|NCT01833065|583464519|FG002|Overall Study|Lost to Follow-up|0|||
161566614|NCT01833065|583464520|FG003|Overall Study|Lost to Follow-up|0|||
161566615|NCT01833065|583464521|FG004|Overall Study|Lost to Follow-up|3|||
161566616|NCT01833065|583464517|FG000|Overall Study|Withdrawal by Subject|6|||
161566617|NCT01833065|583464518|FG001|Overall Study|Withdrawal by Subject|2|||
161566618|NCT01833065|583464519|FG002|Overall Study|Withdrawal by Subject|4|||
161566619|NCT01833065|583464520|FG003|Overall Study|Withdrawal by Subject|3|||
161566620|NCT01833065|583464521|FG004|Overall Study|Withdrawal by Subject|11|||
161566621|NCT01833065|583464517|FG000|Overall Study|Subject's substantial non-compliance|0|||
161566622|NCT01833065|583464518|FG001|Overall Study|Subject's substantial non-compliance|1|||
161566623|NCT01833065|583464519|FG002|Overall Study|Subject's substantial non-compliance|0|||
161566624|NCT01833065|583464520|FG003|Overall Study|Subject's substantial non-compliance|0|||
161566625|NCT01833065|583464521|FG004|Overall Study|Subject's substantial non-compliance|0|||
161566626|NCT01833065|583464517|FG000|Overall Study|Trial terminated by sponsor|8|||
161566627|NCT01833065|583464518|FG001|Overall Study|Trial terminated by sponsor|8|||
161566628|NCT01833065|583464519|FG002|Overall Study|Trial terminated by sponsor|7|||
161566629|NCT01833065|583464520|FG003|Overall Study|Trial terminated by sponsor|3|||
161566630|NCT01833065|583464521|FG004|Overall Study|Trial terminated by sponsor|13|||
161566631|NCT01833065|583464517|FG000|Overall Study|Others|2|||
161566632|NCT01833065|583464518|FG001|Overall Study|Others|1|||
161566633|NCT01833065|583464519|FG002|Overall Study|Others|1|||
161566634|NCT01833065|583464520|FG003|Overall Study|Others|1|||
161566635|NCT01833065|583464521|FG004|Overall Study|Others|4|||
161566636|NCT00601640|583464523|FG000|Overall Study|Withdrawal by Subject|3|||
161566637|NCT00601640|583464524|FG001|Overall Study|Withdrawal by Subject|0|||
161566638|NCT00601640|583464525|FG002|Overall Study|Withdrawal by Subject|7|||
161566639|NCT00601640|583464523|FG000|Overall Study|Death|1|||
161566640|NCT00601640|583464524|FG001|Overall Study|Death|0|||
161566641|NCT00601640|583464525|FG002|Overall Study|Death|0|||
161566642|NCT00601640|583464523|FG000|Overall Study|Adverse Event|0|||
161566643|NCT00601640|583464524|FG001|Overall Study|Adverse Event|4|||
161566644|NCT00601640|583464525|FG002|Overall Study|Adverse Event|2|||
161566645|NCT00601640|583464523|FG000|Overall Study|intercurrent illness|1|||
161566646|NCT00601640|583464524|FG001|Overall Study|intercurrent illness|0|||
161566647|NCT00601640|583464525|FG002|Overall Study|intercurrent illness|0|||
161566648|NCT00601640|583464523|FG000|Overall Study|change in eligibility status|0|||
161566649|NCT00601640|583464524|FG001|Overall Study|change in eligibility status|1|||
161566650|NCT00601640|583464525|FG002|Overall Study|change in eligibility status|1|||
161566651|NCT00015457|583464528|FG000|First Intervention|Adverse Event|0|||
161566652|NCT00015457|583464529|FG001|First Intervention|Adverse Event|2|||
161566653|NCT00015457|583464528|FG000|First Intervention|Lack of Efficacy|0|||
161566654|NCT00015457|583464529|FG001|First Intervention|Lack of Efficacy|1|||
161566655|NCT00015457|583464528|FG000|Second Intervention|Withdrawal by Subject|1|||
161566656|NCT00015457|583464529|FG001|Second Intervention|Withdrawal by Subject|0|||
161566657|NCT01456936|583464530|FG000|Overall Study|Other reason|41|||
161566658|NCT01456936|583464531|FG001|Overall Study|Other reason|30|||
161566659|NCT01456936|583464532|FG002|Overall Study|Other reason|36|||
161566660|NCT01456936|583464533|FG003|Overall Study|Other reason|33|||
161566661|NCT01456936|583464530|FG000|Overall Study|No longer meets eligibility criteria|4|||
161566662|NCT01456936|583464531|FG001|Overall Study|No longer meets eligibility criteria|8|||
161566663|NCT01456936|583464532|FG002|Overall Study|No longer meets eligibility criteria|6|||
161566664|NCT01456936|583464533|FG003|Overall Study|No longer meets eligibility criteria|5|||
161566665|NCT01456936|583464530|FG000|Overall Study|Protocol Violation|4|||
161566666|NCT01456936|583464531|FG001|Overall Study|Protocol Violation|2|||
161566667|NCT01456936|583464532|FG002|Overall Study|Protocol Violation|5|||
161566668|NCT01456936|583464533|FG003|Overall Study|Protocol Violation|5|||
161566669|NCT01456936|583464530|FG000|Overall Study|Pregnancy|1|||
161566670|NCT01456936|583464531|FG001|Overall Study|Pregnancy|0|||
161566671|NCT01456936|583464532|FG002|Overall Study|Pregnancy|0|||
161566672|NCT01456936|583464533|FG003|Overall Study|Pregnancy|1|||
161566673|NCT01456936|583464530|FG000|Overall Study|Insufficient clinical response|4|||
161566674|NCT01456936|583464531|FG001|Overall Study|Insufficient clinical response|4|||
161566675|NCT01456936|583464532|FG002|Overall Study|Insufficient clinical response|14|||
161566676|NCT01456936|583464533|FG003|Overall Study|Insufficient clinical response|13|||
161566677|NCT01456936|583464530|FG000|Overall Study|No longer willing to participate|195|||
161566678|NCT01456936|583464531|FG001|Overall Study|No longer willing to participate|218|||
161566679|NCT01456936|583464532|FG002|Overall Study|No longer willing to participate|224|||
161566680|NCT01456936|583464533|FG003|Overall Study|No longer willing to participate|248|||
161566681|NCT01456936|583464530|FG000|Overall Study|Lost to Follow-up|135|||
161566682|NCT01456936|583464531|FG001|Overall Study|Lost to Follow-up|126|||
161566683|NCT01456936|583464532|FG002|Overall Study|Lost to Follow-up|144|||
161566684|NCT01456936|583464533|FG003|Overall Study|Lost to Follow-up|127|||
161566685|NCT01456936|583464530|FG000|Overall Study|Medication error|0|||
161566686|NCT01456936|583464531|FG001|Overall Study|Medication error|1|||
161566687|NCT01456936|583464532|FG002|Overall Study|Medication error|0|||
161566688|NCT01456936|583464533|FG003|Overall Study|Medication error|1|||
161566689|NCT01456936|583464530|FG000|Overall Study|Adverse event (study drug)|25|||
161566690|NCT01456936|583464531|FG001|Overall Study|Adverse event (study drug)|21|||
161566691|NCT01456936|583464532|FG002|Overall Study|Adverse event (study drug)|26|||
161566692|NCT01456936|583464533|FG003|Overall Study|Adverse event (study drug)|17|||
161566693|NCT01456936|583464530|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
161566694|NCT01456936|583464531|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
161566695|NCT01456936|583464532|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
161566696|NCT01456936|583464533|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
161566697|NCT01456936|583464530|FG000|Overall Study|Death|0|||
161566698|NCT01456936|583464531|FG001|Overall Study|Death|3|||
161566699|NCT01456936|583464532|FG002|Overall Study|Death|1|||
161566700|NCT01456936|583464533|FG003|Overall Study|Death|3|||
161566701|NCT01456936|583464530|FG000|Overall Study|Randomized but not treated|21|||
161566702|NCT01456936|583464531|FG001|Overall Study|Randomized but not treated|28|||
161566703|NCT01456936|583464532|FG002|Overall Study|Randomized but not treated|16|||
161566704|NCT01456936|583464533|FG003|Overall Study|Randomized but not treated|21|||
161566705|NCT00543725|583464534|FG000|Overall Study|Adverse Event|18|||
161566706|NCT00543725|583464535|FG001|Overall Study|Adverse Event|27|||
161566707|NCT00543725|583464534|FG000|Overall Study|Sponsor's Decision|0|||
161808534|NCT00468286|584344226|FG000|Overall Study|Protocol Violation|2|||
161808535|NCT00468286|584344227|FG001|Overall Study|Protocol Violation|2|||
161808536|NCT00468286|584344226|FG000|Overall Study|Withdrawal by Subject|4|||
161808537|NCT00468286|584344227|FG001|Overall Study|Withdrawal by Subject|3|||
161808538|NCT00468286|584344226|FG000|Overall Study|Physician Decision|0|||
161808539|NCT00468286|584344227|FG001|Overall Study|Physician Decision|1|||
161808540|NCT02196675|584344229|FG000|Overall Study|Withdrawal by Subject|1|||
161808541|NCT02196675|584344230|FG001|Overall Study|Withdrawal by Subject|0|||
161808542|NCT02196675|584344231|FG002|Overall Study|Withdrawal by Subject|0|||
161808543|NCT02196675|584344229|FG000|Overall Study|Intra-operative surgical exclusion|1|||
161808544|NCT02196675|584344230|FG001|Overall Study|Intra-operative surgical exclusion|1|||
161808545|NCT02196675|584344231|FG002|Overall Study|Intra-operative surgical exclusion|0|||
161808546|NCT02196675|584344229|FG000|Overall Study|Protocol Violation|0|||
161808547|NCT02196675|584344230|FG001|Overall Study|Protocol Violation|1|||
161808548|NCT02196675|584344231|FG002|Overall Study|Protocol Violation|0|||
161808549|NCT02196675|584344229|FG000|Overall Study|Death|0|||
161808550|NCT02196675|584344230|FG001|Overall Study|Death|0|||
161808551|NCT02196675|584344231|FG002|Overall Study|Death|1|||
161808552|NCT03459807|584344232|FG000|Overall Study|Withdrawal due to transplant|0|||
161808553|NCT03459807|584344233|FG001|Overall Study|Withdrawal due to transplant|1|||
161808554|NCT02392000|584344238|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
161566708|NCT00543725|583464535|FG001|Overall Study|Sponsor's Decision|1|||
161566709|NCT00543725|583464534|FG000|Overall Study|Subject Non-Compliant|4|||
161566710|NCT00543725|583464535|FG001|Overall Study|Subject Non-Compliant|4|||
161566711|NCT00543725|583464534|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161566712|NCT00543725|583464535|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
161566713|NCT00543725|583464534|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
161566714|NCT00543725|583464535|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
161566715|NCT00543725|583464534|FG000|Overall Study|Protocol Violation|0|||
161566716|NCT00543725|583464535|FG001|Overall Study|Protocol Violation|1|||
161566717|NCT00543725|583464534|FG000|Overall Study|Withdrawal by Subject|4|||
161566718|NCT00543725|583464535|FG001|Overall Study|Withdrawal by Subject|13|||
161566719|NCT00543725|583464534|FG000|Overall Study|Lost to Follow-up|15|||
161566720|NCT00543725|583464535|FG001|Overall Study|Lost to Follow-up|11|||
161566721|NCT00543725|583464534|FG000|Overall Study|Other|3|||
161566722|NCT00543725|583464535|FG001|Overall Study|Other|3|||
161566723|NCT00906698|583464536|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
161566724|NCT00906698|583464537|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
161566725|NCT00906698|583464538|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
161566726|NCT00906698|583464539|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
161566727|NCT00906698|583464540|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
161566728|NCT00906698|583464541|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
161566729|NCT00906698|583464536|FG000|Overall Study|Adverse Event|0|||
161566730|NCT00906698|583464537|FG001|Overall Study|Adverse Event|0|||
161566731|NCT00906698|583464538|FG002|Overall Study|Adverse Event|2|||
161566732|NCT00906698|583464539|FG003|Overall Study|Adverse Event|0|||
161566733|NCT00906698|583464540|FG004|Overall Study|Adverse Event|4|||
161566734|NCT00906698|583464541|FG005|Overall Study|Adverse Event|1|||
161566735|NCT00906698|583464536|FG000|Overall Study|Disease progression|3|||
161566736|NCT00906698|583464537|FG001|Overall Study|Disease progression|12|||
161566737|NCT00906698|583464538|FG002|Overall Study|Disease progression|4|||
161566738|NCT00906698|583464539|FG003|Overall Study|Disease progression|4|||
161566739|NCT00906698|583464540|FG004|Overall Study|Disease progression|12|||
161566740|NCT00906698|583464541|FG005|Overall Study|Disease progression|4|||
161566741|NCT00906698|583464536|FG000|Overall Study|Withdrawal by Subject|0|||
161566742|NCT00906698|583464537|FG001|Overall Study|Withdrawal by Subject|0|||
161566743|NCT00906698|583464538|FG002|Overall Study|Withdrawal by Subject|0|||
161566744|NCT00906698|583464539|FG003|Overall Study|Withdrawal by Subject|0|||
161566745|NCT00906698|583464540|FG004|Overall Study|Withdrawal by Subject|1|||
161566746|NCT00906698|583464541|FG005|Overall Study|Withdrawal by Subject|0|||
161566747|NCT00906698|583464536|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
161566748|NCT00906698|583464537|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
161566749|NCT00906698|583464538|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
161566750|NCT00906698|583464539|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
161566751|NCT00906698|583464540|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
161566752|NCT00906698|583464541|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
161566753|NCT01250002|583464542|FG000|Overall Study|Change to open surgical procedure|4|||
161566754|NCT01250002|583464543|FG001|Overall Study|Change to open surgical procedure|3|||
161566755|NCT02317705|583464544|FG000|Overall Study|Withdrawal by Subject|3|||
161566756|NCT02317705|583464544|FG000|Overall Study|Physician Decision|1|||
161566757|NCT02317705|583464544|FG000|Overall Study|Drug not usable|1|||
161566758|NCT01674569|583464545|FG000|Overall Study|Adverse Event|0|||
161566759|NCT01674569|583464546|FG001|Overall Study|Adverse Event|2|||
161566760|NCT01674569|583464547|FG002|Overall Study|Adverse Event|0|||
161566761|NCT01674569|583464548|FG003|Overall Study|Adverse Event|1|||
161566762|NCT01674569|583464549|FG004|Overall Study|Adverse Event|2|||
161566763|NCT01674569|583464550|FG005|Overall Study|Adverse Event|2|||
161566764|NCT01674569|583464545|FG000|Overall Study|Protocol Violation|0|||
161566765|NCT01674569|583464546|FG001|Overall Study|Protocol Violation|1|||
161566766|NCT01674569|583464547|FG002|Overall Study|Protocol Violation|1|||
161566767|NCT01674569|583464548|FG003|Overall Study|Protocol Violation|0|||
161566768|NCT01674569|583464549|FG004|Overall Study|Protocol Violation|0|||
161566769|NCT01674569|583464550|FG005|Overall Study|Protocol Violation|0|||
161566770|NCT01674569|583464545|FG000|Overall Study|Withdrawal by Subject|0|||
161566771|NCT01674569|583464546|FG001|Overall Study|Withdrawal by Subject|0|||
161566772|NCT01674569|583464547|FG002|Overall Study|Withdrawal by Subject|1|||
161566773|NCT01674569|583464548|FG003|Overall Study|Withdrawal by Subject|0|||
161566774|NCT01674569|583464549|FG004|Overall Study|Withdrawal by Subject|0|||
161566775|NCT01674569|583464550|FG005|Overall Study|Withdrawal by Subject|0|||
161566776|NCT01599325|583464551|FG000|Primary Parent Phase|Adverse Event|5|||
161566777|NCT01599325|583464551|FG000|Primary Parent Phase|Disease Progression|7|||
161566778|NCT01599325|583464551|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
161566779|NCT01599325|583464551|FG000|Primary Parent Phase|Death|13|||
161566780|NCT01599325|583464551|FG000|Primary Parent Phase|Protocol Violation|1|||
161566781|NCT01599325|583464551|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
161566782|NCT01599325|583464551|FG000|Primary Parent Phase|Other|2|||
161566783|NCT01599325|583464551|FG000|Extension Phase|Study Closure|1|||
161566784|NCT01599325|583464551|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
161566785|NCT01599325|583464551|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
161566786|NCT01599325|583464551|FG000|Extension Phase|Disease Progression|1|||
161566787|NCT01599325|583464551|FG000|Extension Phase|Withdrawal by Subject|8|||
161566788|NCT02365298|583464554|FG000|Period 2|incorrect Rx dispensed|1|||
161566789|NCT02365298|583464555|FG001|Period 2|incorrect Rx dispensed|0|||
161566790|NCT02365298|583464554|FG000|Period 2|Discontinued at request of Sponsor|1|||
161566791|NCT02365298|583464555|FG001|Period 2|Discontinued at request of Sponsor|0|||
161566792|NCT02365298|583464554|FG000|Period 2|Test Article longer available|0|||
161566793|NCT02365298|583464555|FG001|Period 2|Test Article longer available|1|||
161566794|NCT02365298|583464554|FG000|Period 2|Protocol Violation|0|||
161566795|NCT02365298|583464555|FG001|Period 2|Protocol Violation|1|||
161566796|NCT02846415|583464556|FG000|Overall Study|Lost to Follow-up|2|||
161566797|NCT02846415|583464557|FG001|Overall Study|Lost to Follow-up|0|||
161566798|NCT02846415|583464556|FG000|Overall Study|Withdrawal by Subject|1|||
161566799|NCT02846415|583464557|FG001|Overall Study|Withdrawal by Subject|1|||
161566800|NCT02595398|583464558|FG000|Overall Study|Non-compliance|1|||
161566801|NCT02595398|583464559|FG001|Overall Study|Non-compliance|0|||
161566802|NCT02595398|583464558|FG000|Overall Study|Withdrawal by Subject|2|||
161566803|NCT02595398|583464559|FG001|Overall Study|Withdrawal by Subject|1|||
161566804|NCT02595398|583464558|FG000|Overall Study|Lost to Follow-up|1|||
161566805|NCT02595398|583464559|FG001|Overall Study|Lost to Follow-up|0|||
161566806|NCT00502593|583464560|FG000|Overall Study|Withdrawn unspecified reason|1|||
161566807|NCT00502593|583464561|FG001|Overall Study|Withdrawn unspecified reason|1|||
161566808|NCT00502593|583464562|FG002|Overall Study|Withdrawn unspecified reason|3|||
161566809|NCT00502593|583464563|FG003|Overall Study|Withdrawn unspecified reason|1|||
161566810|NCT00502593|583464564|FG004|Overall Study|Withdrawn unspecified reason|2|||
161566811|NCT00502593|583464565|FG005|Overall Study|Withdrawn unspecified reason|0|||
161911654|NCT02194465|584728626|FG004|Overall Study|Withdrawal by Subject|2|||
161911655|NCT02194465|584728627|FG005|Overall Study|Withdrawal by Subject|1|||
161911656|NCT02194465|584728628|FG006|Overall Study|Withdrawal by Subject|2|||
161911657|NCT02194465|584728622|FG000|Overall Study|Discontinued follow-up period|0|||
161911658|NCT02194465|584728623|FG001|Overall Study|Discontinued follow-up period|2|||
161911659|NCT02194465|584728624|FG002|Overall Study|Discontinued follow-up period|1|||
161911660|NCT02194465|584728625|FG003|Overall Study|Discontinued follow-up period|0|||
161911661|NCT02194465|584728626|FG004|Overall Study|Discontinued follow-up period|2|||
161566812|NCT00502593|583464566|FG006|Overall Study|Withdrawn unspecified reason|2|||
161566813|NCT00502593|583464567|FG007|Overall Study|Withdrawn unspecified reason|0|||
161566814|NCT00502593|583464568|FG008|Overall Study|Withdrawn unspecified reason|0|||
161566815|NCT00502593|583464569|FG009|Overall Study|Withdrawn unspecified reason|0|||
161566816|NCT00502593|583464570|FG010|Overall Study|Withdrawn unspecified reason|0|||
161566817|NCT00502593|583464571|FG011|Overall Study|Withdrawn unspecified reason|0|||
161566818|NCT00502593|583464560|FG000|Overall Study|Withdrawal by Subject|0|||
161566819|NCT00502593|583464561|FG001|Overall Study|Withdrawal by Subject|0|||
161566820|NCT00502593|583464562|FG002|Overall Study|Withdrawal by Subject|6|||
161566821|NCT00502593|583464563|FG003|Overall Study|Withdrawal by Subject|2|||
161566822|NCT00502593|583464564|FG004|Overall Study|Withdrawal by Subject|2|||
161566823|NCT00502593|583464565|FG005|Overall Study|Withdrawal by Subject|0|||
161566824|NCT00502593|583464566|FG006|Overall Study|Withdrawal by Subject|3|||
161566825|NCT00502593|583464567|FG007|Overall Study|Withdrawal by Subject|0|||
161566826|NCT00502593|583464568|FG008|Overall Study|Withdrawal by Subject|3|||
161566827|NCT00502593|583464569|FG009|Overall Study|Withdrawal by Subject|0|||
161566828|NCT00502593|583464570|FG010|Overall Study|Withdrawal by Subject|1|||
161566829|NCT00502593|583464571|FG011|Overall Study|Withdrawal by Subject|0|||
161566830|NCT00502593|583464560|FG000|Overall Study|Lost to Follow-up|2|||
161911662|NCT02194465|584728627|FG005|Overall Study|Discontinued follow-up period|0|||
161911663|NCT02194465|584728628|FG006|Overall Study|Discontinued follow-up period|0|||
161911664|NCT00420745|584728629|FG000|Overall Study|Adverse Event|2|||
161911665|NCT00420745|584728630|FG001|Overall Study|Adverse Event|2|||
161911666|NCT00420745|584728629|FG000|Overall Study|Lost to Follow-up|10|||
161911667|NCT00420745|584728630|FG001|Overall Study|Lost to Follow-up|2|||
161911668|NCT00420745|584728629|FG000|Overall Study|Protocol Violation|1|||
161911669|NCT00420745|584728630|FG001|Overall Study|Protocol Violation|0|||
161911670|NCT00420745|584728629|FG000|Overall Study|Physician Decision|1|||
161911671|NCT00420745|584728630|FG001|Overall Study|Physician Decision|1|||
161566831|NCT00502593|583464561|FG001|Overall Study|Lost to Follow-up|1|||
161566832|NCT00502593|583464562|FG002|Overall Study|Lost to Follow-up|1|||
161566833|NCT00502593|583464563|FG003|Overall Study|Lost to Follow-up|1|||
161566834|NCT00502593|583464564|FG004|Overall Study|Lost to Follow-up|0|||
161566835|NCT00502593|583464565|FG005|Overall Study|Lost to Follow-up|0|||
161566836|NCT00502593|583464566|FG006|Overall Study|Lost to Follow-up|0|||
161566837|NCT00502593|583464567|FG007|Overall Study|Lost to Follow-up|0|||
161566838|NCT00502593|583464568|FG008|Overall Study|Lost to Follow-up|3|||
161911672|NCT00420745|584728629|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
161566839|NCT00502593|583464569|FG009|Overall Study|Lost to Follow-up|0|||
161566840|NCT00502593|583464570|FG010|Overall Study|Lost to Follow-up|1|||
161566841|NCT00502593|583464571|FG011|Overall Study|Lost to Follow-up|0|||
161911673|NCT00420745|584728630|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
161911674|NCT00420745|584728629|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
161911675|NCT00420745|584728630|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
161911676|NCT02058095|584728632|FG000|Overall Study|Adverse Event|1|||
161911677|NCT02058095|584728633|FG001|Overall Study|Adverse Event|0|||
161911678|NCT00726453|584728634|FG000|Primary Enrollment Group|Death|18|||
161911679|NCT00726453|584728635|FG001|Primary Enrollment Group|Death|0|||
161911680|NCT00726453|584728634|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
161911681|NCT00726453|584728635|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
161911682|NCT00726453|584728634|FG000|38 mm Length Group|Death|0|||
161911683|NCT00726453|584728635|FG001|38 mm Length Group|Death|3|||
161911684|NCT01588509|584728639|FG000|Overall Study|Lost to Follow-up|1|||
161911685|NCT01588509|584728640|FG001|Overall Study|Lost to Follow-up|0|||
161911686|NCT01983930|584728641|FG000|Overall Study|Withdrawal by Subject|9|||
161911687|NCT01983930|584728642|FG001|Overall Study|Withdrawal by Subject|8|||
161911688|NCT01983930|584728641|FG000|Overall Study|Adverse Event|0|||
161911689|NCT01983930|584728642|FG001|Overall Study|Adverse Event|1|||
161911690|NCT01454284|584728643|FG000|Overall Study|Adverse Event|20|||
161911691|NCT01454284|584728644|FG001|Overall Study|Adverse Event|7|||
161911692|NCT01454284|584728643|FG000|Overall Study|Death|0|||
161911693|NCT01454284|584728644|FG001|Overall Study|Death|3|||
161911694|NCT01454284|584728643|FG000|Overall Study|Lost to Follow-up|13|||
161911695|NCT01454284|584728644|FG001|Overall Study|Lost to Follow-up|8|||
161911696|NCT01454284|584728643|FG000|Overall Study|Protocol Violation|9|||
161911697|NCT01454284|584728644|FG001|Overall Study|Protocol Violation|6|||
161911698|NCT01454284|584728643|FG000|Overall Study|Withdrawal by Subject|58|||
161911699|NCT01454284|584728644|FG001|Overall Study|Withdrawal by Subject|36|||
161911700|NCT01454284|584728643|FG000|Overall Study|Physician Decision|16|||
161911701|NCT01454284|584728644|FG001|Overall Study|Physician Decision|11|||
161911702|NCT01454284|584728643|FG000|Overall Study|Sponsor Decision|0|||
161911703|NCT01454284|584728644|FG001|Overall Study|Sponsor Decision|2|||
161911704|NCT02842866|584728647|FG000|Overall Study|Serious Adverse Event|0|||
161911705|NCT02842866|584728648|FG001|Overall Study|Serious Adverse Event|1|||
161911706|NCT02842866|584728647|FG000|Overall Study|Protocol Violation|4|||
161911707|NCT02842866|584728648|FG001|Overall Study|Protocol Violation|2|||
161911708|NCT02842866|584728647|FG000|Overall Study|Lost to Follow-up|2|||
161911709|NCT02842866|584728648|FG001|Overall Study|Lost to Follow-up|0|||
161911710|NCT02842866|584728647|FG000|Overall Study|Withdrawal by Subject|1|||
161911711|NCT02842866|584728648|FG001|Overall Study|Withdrawal by Subject|0|||
161911712|NCT01432327|584728649|FG000|Posttest 3 Months|depression|3|||
161911713|NCT01432327|584728650|FG001|Posttest 3 Months|depression|0|||
161911714|NCT01432327|584728651|FG002|Posttest 3 Months|depression|0|||
161911715|NCT01432327|584728652|FG003|Posttest 3 Months|depression|0|||
161911716|NCT01432327|584728649|FG000|Posttest 3 Months|Lost to Follow-up|1|||
161911717|NCT01432327|584728650|FG001|Posttest 3 Months|Lost to Follow-up|0|||
161911718|NCT01432327|584728651|FG002|Posttest 3 Months|Lost to Follow-up|2|||
161911719|NCT01432327|584728652|FG003|Posttest 3 Months|Lost to Follow-up|1|||
161911720|NCT01432327|584728649|FG000|Posttest 3 Months|Allergic reaction|0|||
161911721|NCT01432327|584728650|FG001|Posttest 3 Months|Allergic reaction|2|||
161911722|NCT01432327|584728651|FG002|Posttest 3 Months|Allergic reaction|0|||
161911723|NCT01432327|584728652|FG003|Posttest 3 Months|Allergic reaction|0|||
161911724|NCT01432327|584728649|FG000|Posttest 6 Months|Lost to Follow-up|0|||
161911725|NCT01432327|584728650|FG001|Posttest 6 Months|Lost to Follow-up|0|||
161911726|NCT01432327|584728651|FG002|Posttest 6 Months|Lost to Follow-up|3|||
161911727|NCT01432327|584728652|FG003|Posttest 6 Months|Lost to Follow-up|2|||
161911728|NCT01432327|584728649|FG000|Posttest 6 Months|Allergic reaction|0|||
161911729|NCT01432327|584728650|FG001|Posttest 6 Months|Allergic reaction|0|||
161911730|NCT01432327|584728651|FG002|Posttest 6 Months|Allergic reaction|1|||
161911731|NCT01432327|584728652|FG003|Posttest 6 Months|Allergic reaction|0|||
161911732|NCT01432327|584728649|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
161911733|NCT01432327|584728650|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
161911734|NCT01432327|584728651|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
161911735|NCT01432327|584728652|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
161911736|NCT01432327|584728649|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
161911737|NCT01432327|584728650|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
161911738|NCT01432327|584728651|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
161911739|NCT01432327|584728652|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
161911740|NCT01432327|584728649|FG000|Posttest 1 Year|Lost to Follow-up|0|||
161911741|NCT01432327|584728650|FG001|Posttest 1 Year|Lost to Follow-up|0|||
161911742|NCT01432327|584728651|FG002|Posttest 1 Year|Lost to Follow-up|4|||
161911743|NCT01432327|584728652|FG003|Posttest 1 Year|Lost to Follow-up|2|||
161911744|NCT01432327|584728649|FG000|Posttest 1 Year|Allergic reaction|0|||
161911745|NCT01432327|584728650|FG001|Posttest 1 Year|Allergic reaction|0|||
161911746|NCT01432327|584728651|FG002|Posttest 1 Year|Allergic reaction|1|||
161911747|NCT01432327|584728652|FG003|Posttest 1 Year|Allergic reaction|1|||
161911748|NCT03248037|584728653|FG000|Overall Study|Withdrawal by Subject|6|||
161911749|NCT03248037|584728654|FG001|Overall Study|Withdrawal by Subject|9|||
161566842|NCT02081391|583464572|FG000|12-hour Treatment|Withdrawal by Subject|3|||
161566843|NCT02081391|583464573|FG001|12-hour Treatment|Withdrawal by Subject|2|||
161566844|NCT02081391|583464574|FG002|12-hour Treatment|Withdrawal by Subject|0|||
161566845|NCT02081391|583464575|FG003|12-hour Treatment|Withdrawal by Subject|0|||
161566846|NCT02081391|583464572|FG000|12-hour Treatment|Physician Decision|4|||
161566847|NCT02081391|583464573|FG001|12-hour Treatment|Physician Decision|1|||
161566848|NCT02081391|583464574|FG002|12-hour Treatment|Physician Decision|0|||
161566849|NCT02081391|583464575|FG003|12-hour Treatment|Physician Decision|0|||
161566850|NCT02081391|583464572|FG000|12-hour Treatment|Lack of Efficacy|3|||
161566851|NCT02081391|583464573|FG001|12-hour Treatment|Lack of Efficacy|0|||
161566852|NCT02081391|583464574|FG002|12-hour Treatment|Lack of Efficacy|0|||
161566853|NCT02081391|583464575|FG003|12-hour Treatment|Lack of Efficacy|0|||
161566854|NCT02081391|583464572|FG000|12-hour Treatment|Adverse Event|4|||
161566855|NCT02081391|583464573|FG001|12-hour Treatment|Adverse Event|2|||
161566856|NCT02081391|583464574|FG002|12-hour Treatment|Adverse Event|0|||
161566857|NCT02081391|583464575|FG003|12-hour Treatment|Adverse Event|0|||
161566858|NCT02081391|583464572|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
161566859|NCT02081391|583464573|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
161566860|NCT02081391|583464574|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
161566861|NCT02081391|583464575|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
161566862|NCT02081391|583464572|FG000|12-hour Treatment|Further reasons|2|||
161566863|NCT02081391|583464573|FG001|12-hour Treatment|Further reasons|1|||
161566864|NCT02081391|583464574|FG002|12-hour Treatment|Further reasons|0|||
161566865|NCT02081391|583464575|FG003|12-hour Treatment|Further reasons|0|||
161566866|NCT02081391|583464572|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
161566867|NCT02081391|583464573|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
161566868|NCT02081391|583464574|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
161566869|NCT02081391|583464575|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
161566870|NCT02081391|583464572|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
161566871|NCT02081391|583464573|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
161566872|NCT02081391|583464574|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
161566873|NCT02081391|583464575|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
161566874|NCT02081391|583464572|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
161566875|NCT02081391|583464573|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
161566876|NCT02081391|583464574|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
161566877|NCT02081391|583464575|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
161566878|NCT02081391|583464572|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
161566879|NCT02081391|583464573|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
161566880|NCT02081391|583464574|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
161566881|NCT02081391|583464575|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
161566882|NCT02081391|583464572|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
161566883|NCT02081391|583464573|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
161566884|NCT02081391|583464574|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
161566885|NCT02081391|583464575|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
161566886|NCT02081391|583464572|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
161566887|NCT02081391|583464573|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
161566888|NCT02081391|583464574|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
161566889|NCT02081391|583464575|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
161566890|NCT01458275|583464576|FG000|Overall Study|Adverse Event|3|||
161566891|NCT01458275|583464577|FG001|Overall Study|Adverse Event|4|||
161566892|NCT01458275|583464578|FG002|Overall Study|Adverse Event|1|||
161566893|NCT01458275|583464576|FG000|Overall Study|Lost to Follow-up|3|||
161808555|NCT02392000|584344238|FG000|Overall Study|Withdrawal by Subject|1|||
161808556|NCT02392000|584344238|FG000|Overall Study|Lost to Follow-up|8|||
161808557|NCT00833937|584344239|FG000|Washout|Withdrawal by Subject|1|||
161808558|NCT00833937|584344240|FG001|Washout|Withdrawal by Subject|0|||
161808559|NCT00576056|584344243|FG000|Overall Study|Adverse Event|1|||
161808560|NCT00576056|584344243|FG000|Overall Study|Death|1|||
161808561|NCT00576056|584344243|FG000|Overall Study|Lack of Efficacy|1|||
161911750|NCT03248037|584728653|FG000|Overall Study|Adverse Event|15|||
161808562|NCT00576056|584344243|FG000|Overall Study|Withdrawal by Subject|2|||
161808563|NCT00576056|584344243|FG000|Overall Study|did not meet eligibility criteria|8|||
161911751|NCT03248037|584728654|FG001|Overall Study|Adverse Event|0|||
161808564|NCT00576056|584344243|FG000|Overall Study|Physician Decision|1|||
161911752|NCT02897349|584728658|FG000|Overall Study|Lost to Follow-up|2|||
161911753|NCT02897349|584728659|FG001|Overall Study|Lost to Follow-up|2|||
161566894|NCT01458275|583464577|FG001|Overall Study|Lost to Follow-up|2|||
161566895|NCT01458275|583464578|FG002|Overall Study|Lost to Follow-up|5|||
161566896|NCT01458275|583464576|FG000|Overall Study|Protocol Violation|5|||
161566897|NCT01458275|583464577|FG001|Overall Study|Protocol Violation|5|||
161566898|NCT01458275|583464578|FG002|Overall Study|Protocol Violation|2|||
161566899|NCT01458275|583464576|FG000|Overall Study|Withdrawal by Subject|3|||
161911754|NCT02897349|584728658|FG000|Overall Study|Adverse Event|3|||
161911755|NCT02897349|584728659|FG001|Overall Study|Adverse Event|3|||
161911756|NCT02897349|584728658|FG000|Overall Study|Other than listed above|0|||
161911757|NCT02897349|584728659|FG001|Overall Study|Other than listed above|1|||
161911758|NCT01218802|584728686|FG000|Overall Study|Lost to Follow-up|5|||
161911759|NCT01218802|584728687|FG001|Overall Study|Lost to Follow-up|6|||
161911760|NCT01218802|584728686|FG000|Overall Study|Withdrawal by Subject|3|||
161911761|NCT01218802|584728687|FG001|Overall Study|Withdrawal by Subject|10|||
161911762|NCT01218802|584728686|FG000|Overall Study|Adverse Event|0|||
161911763|NCT01218802|584728687|FG001|Overall Study|Adverse Event|2|||
161911764|NCT01218802|584728686|FG000|Overall Study|Incarcerated|2|||
161911765|NCT01218802|584728687|FG001|Overall Study|Incarcerated|0|||
161911766|NCT00471497|584728689|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
161911767|NCT00471497|584728690|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
161911768|NCT00471497|584728691|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
161911769|NCT00471497|584728689|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
161911770|NCT00471497|584728690|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
161911771|NCT00471497|584728691|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
161911772|NCT00471497|584728689|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
161911773|NCT00471497|584728690|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
161911774|NCT00471497|584728691|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
161911775|NCT00471497|584728689|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
161911776|NCT00471497|584728690|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
161911777|NCT00471497|584728691|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
161911778|NCT00471497|584728689|FG000|Core Treatment Phase|Lost to Follow-up|6|||
161911779|NCT00471497|584728690|FG001|Core Treatment Phase|Lost to Follow-up|6|||
161911780|NCT00471497|584728691|FG002|Core Treatment Phase|Lost to Follow-up|3|||
161911781|NCT00471497|584728689|FG000|Core Treatment Phase|Death|3|||
161911782|NCT00471497|584728690|FG001|Core Treatment Phase|Death|9|||
161911783|NCT00471497|584728691|FG002|Core Treatment Phase|Death|3|||
161911784|NCT00471497|584728689|FG000|Core Treatment Phase|Disease Progression|10|||
161911785|NCT00471497|584728690|FG001|Core Treatment Phase|Disease Progression|2|||
161911786|NCT00471497|584728691|FG002|Core Treatment Phase|Disease Progression|4|||
161911787|NCT00471497|584728689|FG000|Core Treatment Phase|Protocol Violation|6|||
161911788|NCT00471497|584728690|FG001|Core Treatment Phase|Protocol Violation|15|||
161911789|NCT00471497|584728691|FG002|Core Treatment Phase|Protocol Violation|11|||
161911790|NCT00471497|584728689|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
161911791|NCT00471497|584728690|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
161566900|NCT01458275|583464577|FG001|Overall Study|Withdrawal by Subject|2|||
161566901|NCT01458275|583464578|FG002|Overall Study|Withdrawal by Subject|1|||
161566902|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
161911792|NCT00471497|584728691|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
161911793|NCT00471497|584728689|FG000|Core Treatment Phase|Administrative problems|14|||
161911794|NCT00471497|584728690|FG001|Core Treatment Phase|Administrative problems|14|||
161911795|NCT00471497|584728691|FG002|Core Treatment Phase|Administrative problems|12|||
161911796|NCT00471497|584728689|FG000|Core Treatment Phase|Adverse Event|43|||
161911797|NCT00471497|584728690|FG001|Core Treatment Phase|Adverse Event|53|||
161911798|NCT00471497|584728691|FG002|Core Treatment Phase|Adverse Event|89|||
161911799|NCT00471497|584728689|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
161911800|NCT00471497|584728690|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
161911801|NCT00471497|584728691|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
161911802|NCT00471497|584728689|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
161911803|NCT00471497|584728690|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
161911804|NCT00471497|584728691|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
161911805|NCT00471497|584728689|FG000|Extension Phase|Adverse Event|9|||
161911806|NCT00471497|584728690|FG001|Extension Phase|Adverse Event|5|||
161911807|NCT00471497|584728691|FG002|Extension Phase|Adverse Event|1|||
161911808|NCT00471497|584728689|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
161911809|NCT00471497|584728690|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
161911810|NCT00471497|584728691|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161911811|NCT00471497|584728689|FG000|Extension Phase|Withdrawal by Subject|3|||
161911812|NCT00471497|584728690|FG001|Extension Phase|Withdrawal by Subject|1|||
161911813|NCT00471497|584728691|FG002|Extension Phase|Withdrawal by Subject|0|||
161911814|NCT00471497|584728689|FG000|Extension Phase|Lost to Follow-up|2|||
161911815|NCT00471497|584728690|FG001|Extension Phase|Lost to Follow-up|0|||
161566903|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
161566904|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
161911816|NCT00471497|584728691|FG002|Extension Phase|Lost to Follow-up|0|||
161911817|NCT00471497|584728689|FG000|Extension Phase|Death|1|||
161911818|NCT00471497|584728690|FG001|Extension Phase|Death|0|||
161911819|NCT00471497|584728691|FG002|Extension Phase|Death|0|||
161911820|NCT00471497|584728689|FG000|Extension Phase|Disease progression|2|||
161911821|NCT00471497|584728690|FG001|Extension Phase|Disease progression|0|||
161566905|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
161566906|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
161566907|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
161566908|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
161566909|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
161566910|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
161566911|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
161566912|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
161566913|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
161566914|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
161566915|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
161566916|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
161566917|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
161566918|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
161566919|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
161566920|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
161566921|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
161566922|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
161566923|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161566924|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161566925|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161566926|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161566927|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161566928|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161566929|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
161566930|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
161566931|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
161566932|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161808565|NCT03197883|584344244|FG000|Overall Study|Adverse Event|1|||
161808566|NCT03197883|584344245|FG001|Overall Study|Adverse Event|1|||
161808567|NCT03197883|584344244|FG000|Overall Study|Lost to Follow-up|1|||
161808568|NCT03197883|584344245|FG001|Overall Study|Lost to Follow-up|0|||
161808569|NCT03197883|584344244|FG000|Overall Study|Protocol Violation|1|||
161808570|NCT03197883|584344245|FG001|Overall Study|Protocol Violation|0|||
161808571|NCT03197883|584344244|FG000|Overall Study|Other (Not Specified)|0|||
161808572|NCT03197883|584344245|FG001|Overall Study|Other (Not Specified)|5|||
161808573|NCT01353664|584344246|FG000|Overall Study|Other|3|||
161808574|NCT01353664|584344246|FG000|Overall Study|Disease Progression|16|||
161808575|NCT03273153|584344247|FG000|Overall Study|Adverse Event|1|||
161808576|NCT03273153|584344248|FG001|Overall Study|Adverse Event|2|||
161808577|NCT03273153|584344247|FG000|Overall Study|Missing|0|||
161808578|NCT03273153|584344248|FG001|Overall Study|Missing|2|||
161808579|NCT03273153|584344247|FG000|Overall Study|Other|3|||
161808580|NCT03273153|584344248|FG001|Overall Study|Other|2|||
161808581|NCT03273153|584344247|FG000|Overall Study|Symptomatic Deterioration|0|||
161808582|NCT03273153|584344248|FG001|Overall Study|Symptomatic Deterioration|1|||
161808583|NCT03273153|584344247|FG000|Overall Study|Progressive Disease|6|||
161808584|NCT03273153|584344248|FG001|Overall Study|Progressive Disease|5|||
161808585|NCT03273153|584344247|FG000|Overall Study|Physician Decision|1|||
161808586|NCT03273153|584344248|FG001|Overall Study|Physician Decision|3|||
161808587|NCT03273153|584344247|FG000|Overall Study|Study Terminated by Sponsor|112|||
161808588|NCT03273153|584344248|FG001|Overall Study|Study Terminated by Sponsor|102|||
161808589|NCT03273153|584344247|FG000|Overall Study|Withdrawal by Subject|26|||
161808590|NCT03273153|584344248|FG001|Overall Study|Withdrawal by Subject|25|||
161808591|NCT03273153|584344247|FG000|Overall Study|Protocol Deviation|3|||
161808592|NCT03273153|584344248|FG001|Overall Study|Protocol Deviation|0|||
161808593|NCT03273153|584344247|FG000|Overall Study|Lost to Follow-up|6|||
161808594|NCT03273153|584344248|FG001|Overall Study|Lost to Follow-up|11|||
161808595|NCT03273153|584344247|FG000|Overall Study|Death|66|||
161808596|NCT03273153|584344248|FG001|Overall Study|Death|69|||
161808597|NCT00838539|584344249|FG000|Overall Study|Disease Progression|2|||
161808598|NCT00838539|584344250|FG001|Overall Study|Disease Progression|4|||
161808599|NCT00838539|584344251|FG002|Overall Study|Disease Progression|3|||
161808600|NCT00838539|584344252|FG003|Overall Study|Disease Progression|2|||
161808601|NCT00838539|584344253|FG004|Overall Study|Disease Progression|4|||
161911822|NCT00471497|584728691|FG002|Extension Phase|Disease progression|0|||
161566933|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161808602|NCT00838539|584344254|FG005|Overall Study|Disease Progression|2|||
161808603|NCT00838539|584344255|FG006|Overall Study|Disease Progression|3|||
161808604|NCT00838539|584344256|FG007|Overall Study|Disease Progression|4|||
161911823|NCT00471497|584728689|FG000|Extension Phase|Protocol Violation|2|||
161911824|NCT00471497|584728690|FG001|Extension Phase|Protocol Violation|2|||
161566934|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161566935|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161566936|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161808605|NCT00838539|584344257|FG008|Overall Study|Disease Progression|4|||
161911825|NCT00471497|584728691|FG002|Extension Phase|Protocol Violation|0|||
161911826|NCT04004000|584728692|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
161911827|NCT02121210|584728693|FG000|Overall Study|Adverse Event|5|||
161911828|NCT02121210|584728694|FG001|Overall Study|Adverse Event|7|||
161911829|NCT02121210|584728693|FG000|Overall Study|Lack of Efficacy|2|||
161911830|NCT02121210|584728694|FG001|Overall Study|Lack of Efficacy|0|||
161911831|NCT02121210|584728693|FG000|Overall Study|Other than specified above|0|||
161911832|NCT02121210|584728694|FG001|Overall Study|Other than specified above|2|||
161911833|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
161911834|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
161911835|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911836|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911837|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911838|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911839|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911840|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911841|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911842|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911843|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
161911844|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
161911845|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911846|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911847|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911848|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911849|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911850|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911851|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911852|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911853|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
161911854|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911855|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911856|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911857|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911858|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911859|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911860|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911861|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911862|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911863|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
161911864|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
161911865|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911866|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911867|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911868|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911869|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911870|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911871|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911872|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911873|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
161911874|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
161911875|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911876|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911877|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911878|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911879|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911880|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161566937|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161566938|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
161566939|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
161911881|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911882|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911883|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
161911884|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
161911885|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161808606|NCT00838539|584344258|FG009|Overall Study|Disease Progression|5|||
161808607|NCT00838539|584344259|FG010|Overall Study|Disease Progression|1|||
161808608|NCT00838539|584344260|FG011|Overall Study|Disease Progression|4|||
161808609|NCT00838539|584344249|FG000|Overall Study|Adverse Event|1|||
161808610|NCT00838539|584344250|FG001|Overall Study|Adverse Event|1|||
161808611|NCT00838539|584344251|FG002|Overall Study|Adverse Event|1|||
161808612|NCT00838539|584344252|FG003|Overall Study|Adverse Event|1|||
161808613|NCT00838539|584344253|FG004|Overall Study|Adverse Event|2|||
161808614|NCT00838539|584344254|FG005|Overall Study|Adverse Event|1|||
161808615|NCT00838539|584344255|FG006|Overall Study|Adverse Event|0|||
161808616|NCT00838539|584344256|FG007|Overall Study|Adverse Event|2|||
161808617|NCT00838539|584344257|FG008|Overall Study|Adverse Event|0|||
161808618|NCT00838539|584344258|FG009|Overall Study|Adverse Event|1|||
161808619|NCT00838539|584344259|FG010|Overall Study|Adverse Event|2|||
161808620|NCT00838539|584344260|FG011|Overall Study|Adverse Event|0|||
161808621|NCT00838539|584344249|FG000|Overall Study|Withdrawal by Subject|0|||
161808622|NCT00838539|584344250|FG001|Overall Study|Withdrawal by Subject|1|||
161808623|NCT00838539|584344251|FG002|Overall Study|Withdrawal by Subject|0|||
161808624|NCT00838539|584344252|FG003|Overall Study|Withdrawal by Subject|0|||
161808625|NCT00838539|584344253|FG004|Overall Study|Withdrawal by Subject|0|||
161808626|NCT00838539|584344254|FG005|Overall Study|Withdrawal by Subject|0|||
161808627|NCT00838539|584344255|FG006|Overall Study|Withdrawal by Subject|0|||
161808628|NCT00838539|584344256|FG007|Overall Study|Withdrawal by Subject|0|||
161808629|NCT00838539|584344257|FG008|Overall Study|Withdrawal by Subject|0|||
161808630|NCT00838539|584344258|FG009|Overall Study|Withdrawal by Subject|1|||
161808631|NCT00838539|584344259|FG010|Overall Study|Withdrawal by Subject|2|||
161808632|NCT00838539|584344260|FG011|Overall Study|Withdrawal by Subject|0|||
161911886|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161456228|NCT02015221|583064983|FG001|Overall Study|Withdrawal by Subject|6|||
161456229|NCT02015221|583064982|FG000|Overall Study|Lost to Follow-up|1|||
161456230|NCT02015221|583064983|FG001|Overall Study|Lost to Follow-up|0|||
161456231|NCT01306929|583064984|FG000|Overall Study|Withdrawal by Subject|23|||
161456232|NCT01306929|583064984|FG000|Overall Study|Adverse Event|21|||
161456233|NCT01306929|583064984|FG000|Overall Study|Physician Decision|13|||
161456234|NCT01306929|583064984|FG000|Overall Study|Death|8|||
161456235|NCT01306929|583064984|FG000|Overall Study|Withdrawal by parent/guardian|5|||
161456236|NCT01306929|583064984|FG000|Overall Study|Protocol Violation|3|||
161456237|NCT01306929|583064984|FG000|Overall Study|Non-compliance with study drug|2|||
161456238|NCT01306929|583064984|FG000|Overall Study|Lost to Follow-up|2|||
161456239|NCT01306929|583064984|FG000|Overall Study|Various|17|||
161456240|NCT00483756|583064987|FG000|Overall Study|Death|2|||
161456241|NCT00483756|583064988|FG001|Overall Study|Death|0|||
161456242|NCT00483756|583064989|FG002|Overall Study|Death|1|||
161456243|NCT00483756|583064987|FG000|Overall Study|Adverse Event|19|||
161456244|NCT00483756|583064988|FG001|Overall Study|Adverse Event|38|||
161456245|NCT00483756|583064989|FG002|Overall Study|Adverse Event|40|||
161456246|NCT00483756|583064987|FG000|Overall Study|Lack of Efficacy|1|||
161456247|NCT00483756|583064988|FG001|Overall Study|Lack of Efficacy|0|||
161456248|NCT00483756|583064989|FG002|Overall Study|Lack of Efficacy|0|||
161456249|NCT00483756|583064987|FG000|Overall Study|Lost to Follow-up|3|||
161456250|NCT00483756|583064988|FG001|Overall Study|Lost to Follow-up|1|||
161456251|NCT00483756|583064989|FG002|Overall Study|Lost to Follow-up|0|||
161456252|NCT00483756|583064987|FG000|Overall Study|Withdrawal by Subject|5|||
161456253|NCT00483756|583064988|FG001|Overall Study|Withdrawal by Subject|3|||
161456254|NCT00483756|583064989|FG002|Overall Study|Withdrawal by Subject|4|||
161456255|NCT00483756|583064987|FG000|Overall Study|Other|2|||
161456256|NCT00483756|583064988|FG001|Overall Study|Other|4|||
161456257|NCT00483756|583064989|FG002|Overall Study|Other|3|||
161456258|NCT00483756|583064987|FG000|Overall Study|Randomized, Not Treated|1|||
161456259|NCT00483756|583064988|FG001|Overall Study|Randomized, Not Treated|4|||
161456260|NCT00483756|583064989|FG002|Overall Study|Randomized, Not Treated|4|||
161456261|NCT01829243|583064990|FG000|First Intervention|Screen Failure|4|||
161456262|NCT01829243|583064991|FG001|First Intervention|Screen Failure|2|||
161456263|NCT02282293|583064996|FG000|Overall Study|Lost to Follow-up|2|||
161456264|NCT02282293|583064997|FG001|Overall Study|Lost to Follow-up|2|||
161456265|NCT02282293|583064996|FG000|Overall Study|Unable to comply with study procedures|1|||
161456266|NCT02282293|583064997|FG001|Overall Study|Unable to comply with study procedures|0|||
161456267|NCT02282293|583064996|FG000|Overall Study|Moved out of study area|0|||
161456268|NCT02282293|583064997|FG001|Overall Study|Moved out of study area|1|||
161456269|NCT00608569|583064998|FG000|Overall Study|Death|4|||
161456270|NCT00608569|583064999|FG001|Overall Study|Death|3|||
161456271|NCT00608569|583064998|FG000|Overall Study|Lost to Follow-up|4|||
161456272|NCT00608569|583064999|FG001|Overall Study|Lost to Follow-up|5|||
161456273|NCT00608569|583064998|FG000|Overall Study|Withdrawal by Subject|1|||
161456274|NCT00608569|583064999|FG001|Overall Study|Withdrawal by Subject|0|||
161456275|NCT00608569|583064998|FG000|Overall Study|Adverse Event|1|||
161456276|NCT00608569|583064999|FG001|Overall Study|Adverse Event|0|||
161456277|NCT00608569|583064998|FG000|Overall Study|Unable to adhere with study requirements|0|||
161911887|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161456278|NCT00608569|583064999|FG001|Overall Study|Unable to adhere with study requirements|1|||
161808633|NCT00838539|584344249|FG000|Overall Study|Death|0|||
161808634|NCT00838539|584344250|FG001|Overall Study|Death|0|||
161808635|NCT00838539|584344251|FG002|Overall Study|Death|0|||
161808636|NCT00838539|584344252|FG003|Overall Study|Death|0|||
161808637|NCT00838539|584344253|FG004|Overall Study|Death|0|||
161808638|NCT00838539|584344254|FG005|Overall Study|Death|0|||
161808639|NCT00838539|584344255|FG006|Overall Study|Death|1|||
161808640|NCT00838539|584344256|FG007|Overall Study|Death|0|||
161808641|NCT00838539|584344257|FG008|Overall Study|Death|0|||
161808642|NCT00838539|584344258|FG009|Overall Study|Death|0|||
161808643|NCT00838539|584344259|FG010|Overall Study|Death|0|||
161808644|NCT00838539|584344260|FG011|Overall Study|Death|0|||
161808645|NCT00838539|584344249|FG000|Overall Study|Physician Decision|0|||
161808646|NCT00838539|584344250|FG001|Overall Study|Physician Decision|0|||
161808647|NCT00838539|584344251|FG002|Overall Study|Physician Decision|0|||
161808648|NCT00838539|584344252|FG003|Overall Study|Physician Decision|0|||
161808649|NCT00838539|584344253|FG004|Overall Study|Physician Decision|0|||
161808650|NCT00838539|584344254|FG005|Overall Study|Physician Decision|0|||
161808651|NCT00838539|584344255|FG006|Overall Study|Physician Decision|0|||
161808652|NCT00838539|584344256|FG007|Overall Study|Physician Decision|0|||
161808653|NCT00838539|584344257|FG008|Overall Study|Physician Decision|1|||
161808654|NCT00838539|584344258|FG009|Overall Study|Physician Decision|0|||
161808655|NCT00838539|584344259|FG010|Overall Study|Physician Decision|0|||
161808656|NCT00838539|584344260|FG011|Overall Study|Physician Decision|0|||
161808657|NCT00838539|584344249|FG000|Overall Study|Clinical Progression|0|||
161808658|NCT00838539|584344250|FG001|Overall Study|Clinical Progression|0|||
161808659|NCT00838539|584344251|FG002|Overall Study|Clinical Progression|0|||
161808660|NCT00838539|584344252|FG003|Overall Study|Clinical Progression|0|||
161808661|NCT00838539|584344253|FG004|Overall Study|Clinical Progression|0|||
161808662|NCT00838539|584344254|FG005|Overall Study|Clinical Progression|0|||
161808663|NCT00838539|584344255|FG006|Overall Study|Clinical Progression|1|||
161808664|NCT00838539|584344256|FG007|Overall Study|Clinical Progression|0|||
161808665|NCT00838539|584344257|FG008|Overall Study|Clinical Progression|0|||
161808666|NCT00838539|584344258|FG009|Overall Study|Clinical Progression|0|||
161808667|NCT00838539|584344259|FG010|Overall Study|Clinical Progression|0|||
161808668|NCT00838539|584344260|FG011|Overall Study|Clinical Progression|0|||
161808669|NCT00838539|584344249|FG000|Overall Study|Symptomatic Deterioration|0|||
161808670|NCT00838539|584344250|FG001|Overall Study|Symptomatic Deterioration|0|||
161808671|NCT00838539|584344251|FG002|Overall Study|Symptomatic Deterioration|1|||
161808672|NCT00838539|584344252|FG003|Overall Study|Symptomatic Deterioration|1|||
161808673|NCT00838539|584344253|FG004|Overall Study|Symptomatic Deterioration|0|||
161808674|NCT00838539|584344254|FG005|Overall Study|Symptomatic Deterioration|1|||
161808675|NCT00838539|584344255|FG006|Overall Study|Symptomatic Deterioration|0|||
161808676|NCT00838539|584344256|FG007|Overall Study|Symptomatic Deterioration|0|||
161808677|NCT00838539|584344257|FG008|Overall Study|Symptomatic Deterioration|0|||
161808678|NCT00838539|584344258|FG009|Overall Study|Symptomatic Deterioration|1|||
161456279|NCT03011892|583065000|FG000|Double Blind (DB) Period|Adverse Event|0|||
161456280|NCT03011892|583065001|FG001|Double Blind (DB) Period|Adverse Event|1|||
161456281|NCT03011892|583065002|FG002|Double Blind (DB) Period|Adverse Event|1|||
161456282|NCT03011892|583065003|FG003|Double Blind (DB) Period|Adverse Event|0|||
161456283|NCT03011892|583065004|FG004|Double Blind (DB) Period|Adverse Event|0|||
161456284|NCT03011892|583065005|FG005|Double Blind (DB) Period|Adverse Event|0|||
161456285|NCT03011892|583065006|FG006|Double Blind (DB) Period|Adverse Event|0|||
161456286|NCT03011892|583065007|FG007|Double Blind (DB) Period|Adverse Event|0|||
161456287|NCT03011892|583065008|FG008|Double Blind (DB) Period|Adverse Event|0|||
161456288|NCT03011892|583065009|FG009|Double Blind (DB) Period|Adverse Event|0|||
161456289|NCT03011892|583065010|FG010|Double Blind (DB) Period|Adverse Event|0|||
161456290|NCT03011892|583065011|FG011|Double Blind (DB) Period|Adverse Event|0|||
161456291|NCT03011892|583065000|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
161456292|NCT03011892|583065001|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
161456293|NCT03011892|583065002|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
161456294|NCT03011892|583065003|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
161456295|NCT03011892|583065004|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
161808679|NCT00838539|584344259|FG010|Overall Study|Symptomatic Deterioration|0|||
161808680|NCT00838539|584344260|FG011|Overall Study|Symptomatic Deterioration|0|||
161808681|NCT01908205|584344261|FG000|Overall Study|Lost to Follow-up|2|||
161808682|NCT01908205|584344262|FG001|Overall Study|Lost to Follow-up|0|||
161808683|NCT01908205|584344261|FG000|Overall Study|Withdrawal by Subject|3|||
161808684|NCT01908205|584344262|FG001|Overall Study|Withdrawal by Subject|1|||
161808685|NCT05323396|584344263|FG000|Overall Study|Lost to Follow-up|1|||
161808686|NCT05323396|584344264|FG001|Overall Study|Lost to Follow-up|35|||
161456296|NCT03011892|583065005|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
161456297|NCT03011892|583065006|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
161456298|NCT03011892|583065007|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
161808687|NCT05323396|584344263|FG000|Overall Study|Pregnancy|1|||
161808688|NCT05323396|584344264|FG001|Overall Study|Pregnancy|0|||
161808689|NCT03420300|584344266|FG000|Overall Study|Death|2|||
161911888|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911889|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911890|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911891|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911892|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911893|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
161911894|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
161911895|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911896|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911897|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911898|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911899|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911900|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911901|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911902|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911903|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911904|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911905|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
161911906|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
161911907|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911908|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911909|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911910|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911911|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911912|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911913|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911914|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911915|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
161911916|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
161911917|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911918|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911919|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911920|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911921|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161566940|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
161566941|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161566942|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161566943|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161566944|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
161566945|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161566946|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161566947|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
161566948|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566949|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566950|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566951|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566952|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566953|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566954|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566955|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161566956|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566957|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
161566958|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566959|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566960|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566961|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566962|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566963|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161566964|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161911922|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911923|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911924|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911925|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
161566965|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566966|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566967|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
161911926|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911927|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911928|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911929|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911930|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911931|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911932|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911933|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911934|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911935|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
161911936|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
161911937|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911938|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911939|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911940|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911941|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911942|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911943|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161566968|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566969|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566970|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566971|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566972|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566973|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161566974|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
161566975|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566976|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566977|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566978|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566979|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566980|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161911944|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911945|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
161911946|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
161911947|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911948|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911949|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911950|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911951|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911952|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911953|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
161911954|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
161911955|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
161911956|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
161911957|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
161911958|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
161911959|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
161911960|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
161911961|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
161911962|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
161911963|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911964|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911965|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911966|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911967|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
161911968|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
161911969|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911970|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
161911971|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911972|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911973|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911974|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911975|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161566981|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566982|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
161566983|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
161566984|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566985|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566986|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566987|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566988|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566989|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566990|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566991|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161566992|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
161566993|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161566994|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161566995|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161566996|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161566997|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161566998|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161566999|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161567000|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
161567001|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567002|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
161567003|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
161567004|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567005|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567006|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567007|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567008|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567009|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161567010|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
161567011|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
161567012|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567013|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567014|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567015|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567016|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567017|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567018|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161567019|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567020|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
161567021|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567022|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567023|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567024|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567025|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567026|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567027|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
161567028|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567029|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
161567030|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567031|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567032|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567033|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567034|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567035|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161808690|NCT04149964|584344274|FG000|Overall Study|Lost to Follow-up|19|||
161808691|NCT04149964|584344275|FG001|Overall Study|Lost to Follow-up|18|||
161808692|NCT01424644|584344276|FG000|Overall Study|Adverse Event|2|||
161808693|NCT01424644|584344277|FG001|Overall Study|Adverse Event|0|||
161808694|NCT01424644|584344276|FG000|Overall Study|Withdrawal by Subject|9|||
161808695|NCT01424644|584344277|FG001|Overall Study|Withdrawal by Subject|12|||
161808696|NCT01424644|584344276|FG000|Overall Study|Lost to Follow-up|16|||
161808697|NCT01424644|584344277|FG001|Overall Study|Lost to Follow-up|12|||
161808698|NCT01424644|584344276|FG000|Overall Study|Protocol Violation|4|||
161808699|NCT01424644|584344277|FG001|Overall Study|Protocol Violation|3|||
161808700|NCT01424644|584344276|FG000|Overall Study|Administrative Reason|1|||
161808701|NCT01424644|584344277|FG001|Overall Study|Administrative Reason|0|||
161808702|NCT01424644|584344276|FG000|Overall Study|Unable to Classify|1|||
161567036|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161567037|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567038|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567039|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
161567040|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567041|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567042|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567043|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567044|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567045|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
161567046|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567047|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567048|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
161567049|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567050|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161808703|NCT01424644|584344277|FG001|Overall Study|Unable to Classify|0|||
161808704|NCT05593965|584344278|FG000|1st Intervention (1 Day)|Technical error|1|||
161808705|NCT05593965|584344279|FG001|1st Intervention (1 Day)|Technical error|0|||
161808706|NCT02066922|584344282|FG000|Overall Study|Adverse Event|1|||
161808707|NCT00440297|584344283|FG000|Overall Study|Adverse Event|8|||
161808708|NCT00440297|584344284|FG001|Overall Study|Adverse Event|5|||
161808709|NCT00440297|584344283|FG000|Overall Study|Lost to Follow-up|1|||
161808710|NCT00440297|584344284|FG001|Overall Study|Lost to Follow-up|0|||
161808711|NCT00440297|584344283|FG000|Overall Study|Physician Decision|1|||
161808712|NCT00440297|584344284|FG001|Overall Study|Physician Decision|0|||
161808713|NCT00440297|584344283|FG000|Overall Study|Protocol Violation|11|||
161808714|NCT00440297|584344284|FG001|Overall Study|Protocol Violation|7|||
161808715|NCT00440297|584344283|FG000|Overall Study|Withdrawal by Subject|1|||
161808716|NCT00440297|584344284|FG001|Overall Study|Withdrawal by Subject|6|||
161808717|NCT00440297|584344283|FG000|Overall Study|Randomized by mistake|1|||
161808718|NCT00440297|584344284|FG001|Overall Study|Randomized by mistake|0|||
161808719|NCT02445339|584344285|FG000|Overall Study|Physician Decision|1|||
161808720|NCT02445339|584344286|FG001|Overall Study|Physician Decision|0|||
161808721|NCT02445339|584344285|FG000|Overall Study|Lost to Follow-up|11|||
161808722|NCT02445339|584344286|FG001|Overall Study|Lost to Follow-up|15|||
161808723|NCT02024932|584344287|FG000|Overall Study|Adverse Event|2|||
161808724|NCT02024932|584344288|FG001|Overall Study|Adverse Event|3|||
161808725|NCT02024932|584344289|FG002|Overall Study|Adverse Event|0|||
161808726|NCT02024932|584344290|FG003|Overall Study|Adverse Event|0|||
161808727|NCT02024932|584344291|FG004|Overall Study|Adverse Event|2|||
161808728|NCT02024932|584344292|FG005|Overall Study|Adverse Event|0|||
161808729|NCT02024932|584344287|FG000|Overall Study|Abnormal laboratory value|0|||
161808730|NCT02024932|584344288|FG001|Overall Study|Abnormal laboratory value|0|||
161808731|NCT02024932|584344289|FG002|Overall Study|Abnormal laboratory value|0|||
161808732|NCT02024932|584344290|FG003|Overall Study|Abnormal laboratory value|2|||
161808733|NCT02024932|584344291|FG004|Overall Study|Abnormal laboratory value|0|||
161808734|NCT02024932|584344292|FG005|Overall Study|Abnormal laboratory value|0|||
161808735|NCT03206177|584344293|FG000|Overall Study|Withdrawal by Subject|1|||
161808736|NCT03020641|584344294|FG000|Overall Study|Lost to Follow-up|0|||
161808737|NCT03020641|584344295|FG001|Overall Study|Lost to Follow-up|1|||
161808738|NCT03020641|584344294|FG000|Overall Study|Converted to open surgery|2|||
161808739|NCT03020641|584344295|FG001|Overall Study|Converted to open surgery|1|||
161808740|NCT03020641|584344294|FG000|Overall Study|for surgery not performed|0|||
161808741|NCT03020641|584344295|FG001|Overall Study|for surgery not performed|1|||
161808742|NCT00727961|584344296|FG000|Overall Study|Lost to Follow-up|1|||
161808743|NCT00727961|584344296|FG000|Overall Study|Adverse Event|4|||
161808744|NCT00727961|584344296|FG000|Overall Study|Patient's refusal|2|||
161808745|NCT00727961|584344296|FG000|Overall Study|Progression|30|||
161808746|NCT03238781|584344297|FG000|Overall Study|Adverse Event|1|||
161808747|NCT03238781|584344298|FG001|Overall Study|Adverse Event|1|||
161808748|NCT03238781|584344299|FG002|Overall Study|Adverse Event|2|||
161808749|NCT03238781|584344297|FG000|Overall Study|Lost to Follow-up|2|||
161808750|NCT03238781|584344298|FG001|Overall Study|Lost to Follow-up|1|||
161808751|NCT03238781|584344299|FG002|Overall Study|Lost to Follow-up|2|||
161808752|NCT03238781|584344297|FG000|Overall Study|Withdrawal by Subject|23|||
161808753|NCT03238781|584344298|FG001|Overall Study|Withdrawal by Subject|14|||
161808754|NCT03238781|584344299|FG002|Overall Study|Withdrawal by Subject|16|||
161808755|NCT03238781|584344297|FG000|Overall Study|Decision by sponsor|0|||
161808756|NCT03238781|584344298|FG001|Overall Study|Decision by sponsor|1|||
161808757|NCT03238781|584344299|FG002|Overall Study|Decision by sponsor|0|||
161808758|NCT03161405|584344300|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
161808759|NCT01577381|584344301|FG000|Overall Study|Discontinued|2|||
161567051|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567052|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567053|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567054|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
161567055|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567056|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567057|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
161567058|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567059|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567060|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567061|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567062|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567063|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
161567064|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567065|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567066|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567067|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567068|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567069|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567070|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
161567071|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567072|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
161567073|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
161567074|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
161567075|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567076|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567077|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567078|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567079|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567080|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567081|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
161567082|NCT03598790|583465858|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567083|NCT03598790|583465859|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567084|NCT03598790|583465860|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
161567085|NCT03598790|583465861|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567086|NCT03598790|583465862|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567087|NCT03598790|583465863|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567088|NCT03598790|583465864|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567089|NCT03598790|583465865|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567090|NCT03598790|583465866|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
161567091|NCT03598790|583465858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161567092|NCT03598790|583465859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161567093|NCT03598790|583465860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161567094|NCT03598790|583465861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
161567095|NCT03598790|583465862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
161567096|NCT03598790|583465863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
161567097|NCT03598790|583465864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161567098|NCT03598790|583465865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161567099|NCT03598790|583465866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161567100|NCT03598790|583465858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567101|NCT03598790|583465859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161808760|NCT01577381|584344302|FG001|Overall Study|Discontinued|1|||
161808761|NCT01577381|584344303|FG002|Overall Study|Discontinued|2|||
161808762|NCT01577381|584344304|FG003|Overall Study|Discontinued|2|||
161808763|NCT01577381|584344301|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
161808764|NCT01577381|584344302|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
161808765|NCT01577381|584344303|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
161808766|NCT01577381|584344304|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
161808767|NCT01421277|584344305|FG000|Overall Study|Lack of qualifying event|0|||
161567102|NCT03598790|583465860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567103|NCT03598790|583465861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
161567104|NCT03598790|583465862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567105|NCT03598790|583465863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567106|NCT03598790|583465864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567107|NCT03598790|583465865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567108|NCT03598790|583465866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
161567109|NCT03598790|583465858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567110|NCT03598790|583465859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567111|NCT03598790|583465860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567112|NCT03598790|583465861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
161567113|NCT03598790|583465862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567114|NCT03598790|583465863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567115|NCT03598790|583465864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567116|NCT03598790|583465865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567117|NCT03598790|583465866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161567118|NCT03598790|583465858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567119|NCT03598790|583465859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567120|NCT03598790|583465860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567121|NCT03598790|583465861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
161567122|NCT03598790|583465862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
161567123|NCT03598790|583465863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567124|NCT03598790|583465864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567125|NCT03598790|583465865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567126|NCT03598790|583465866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161567127|NCT03598790|583465858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567128|NCT03598790|583465859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567129|NCT03598790|583465860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567130|NCT03598790|583465861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
161567131|NCT03598790|583465862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567132|NCT03598790|583465863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567133|NCT03598790|583465864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567134|NCT03598790|583465865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567135|NCT03598790|583465866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
161567136|NCT03410992|583465868|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567137|NCT03410992|583465869|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
161567138|NCT03410992|583465870|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567139|NCT03410992|583465871|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567140|NCT03410992|583465872|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567141|NCT03410992|583465873|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567142|NCT03410992|583465874|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567143|NCT03410992|583465875|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567144|NCT03410992|583465876|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567145|NCT03410992|583465877|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567146|NCT03410992|583465878|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161567147|NCT03410992|583465868|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
161567148|NCT03410992|583465869|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
161567149|NCT03410992|583465870|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567150|NCT03410992|583465871|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567151|NCT03410992|583465872|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567152|NCT03410992|583465873|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567153|NCT03410992|583465874|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567154|NCT03410992|583465875|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567155|NCT03410992|583465876|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567156|NCT03410992|583465877|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161808768|NCT01421277|584344306|FG001|Overall Study|Lack of qualifying event|61|||
161808769|NCT01421277|584344305|FG000|Overall Study|Incomplete baseline data|0|||
161808770|NCT01421277|584344306|FG001|Overall Study|Incomplete baseline data|31|||
161808771|NCT02039908|584344307|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
161808772|NCT02039908|584344308|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
161808773|NCT02039908|584344309|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
161808774|NCT02039908|584344310|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
161808775|NCT02039908|584344307|FG000|Phase 1-Summer|Protocol Violation|6|||
161808776|NCT02039908|584344308|FG001|Phase 1-Summer|Protocol Violation|0|||
161808777|NCT02039908|584344309|FG002|Phase 1-Summer|Protocol Violation|0|||
161911976|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161567157|NCT03410992|583465878|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
161567158|NCT03410992|583465868|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
161567159|NCT03410992|583465869|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
161808778|NCT02039908|584344310|FG003|Phase 1-Summer|Protocol Violation|0|||
161808779|NCT02039908|584344307|FG000|Phase 2-School Year|Lost to Follow-up|0|||
161808780|NCT02039908|584344308|FG001|Phase 2-School Year|Lost to Follow-up|0|||
161808781|NCT02039908|584344309|FG002|Phase 2-School Year|Lost to Follow-up|1|||
161808782|NCT02039908|584344310|FG003|Phase 2-School Year|Lost to Follow-up|3|||
161808783|NCT02039908|584344307|FG000|Phase 2-School Year|Protocol Violation|0|||
161808784|NCT02039908|584344308|FG001|Phase 2-School Year|Protocol Violation|0|||
161808785|NCT02039908|584344309|FG002|Phase 2-School Year|Protocol Violation|3|||
161808786|NCT02039908|584344310|FG003|Phase 2-School Year|Protocol Violation|0|||
161808787|NCT02039908|584344307|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
161808788|NCT02039908|584344308|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
161808789|NCT02039908|584344309|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
161808790|NCT02039908|584344310|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
161808791|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
161808792|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
161808793|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
161808794|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
161808795|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808796|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808797|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808798|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808799|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808800|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808801|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808802|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808803|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808804|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808805|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808806|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808807|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808808|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808809|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808810|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808811|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808812|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
161808813|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
161808814|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
161808815|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
161808816|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808817|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808818|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808819|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808820|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808821|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808822|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808823|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808824|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808825|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808826|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808827|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808828|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808829|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808830|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808831|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808832|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808833|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
161808834|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
161808835|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
161808836|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
161911977|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
161911978|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161808837|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808838|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161911979|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
161567160|NCT03410992|583465870|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567161|NCT03410992|583465871|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567162|NCT03410992|583465872|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567163|NCT03410992|583465873|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567164|NCT03410992|583465874|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567165|NCT03410992|583465875|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567166|NCT03410992|583465876|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567167|NCT03410992|583465877|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567168|NCT03410992|583465878|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161567169|NCT03410992|583465868|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
161567170|NCT03410992|583465869|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567171|NCT03410992|583465870|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567172|NCT03410992|583465871|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567173|NCT03410992|583465872|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567174|NCT03410992|583465873|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567175|NCT03410992|583465874|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567176|NCT03410992|583465875|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567177|NCT03410992|583465876|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567178|NCT03410992|583465877|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567179|NCT03410992|583465878|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161567180|NCT03410992|583465868|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
161567181|NCT03410992|583465869|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
161567182|NCT03410992|583465870|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567183|NCT03410992|583465871|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567184|NCT03410992|583465872|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567185|NCT03410992|583465873|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567186|NCT03410992|583465874|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567187|NCT03410992|583465875|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567188|NCT03410992|583465876|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567189|NCT03410992|583465877|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567190|NCT03410992|583465878|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161567191|NCT03410992|583465868|FG000|Week 16 Assessment|Incorrect escapers|0|||
161567192|NCT03410992|583465869|FG001|Week 16 Assessment|Incorrect escapers|6|||
161567193|NCT03410992|583465870|FG002|Week 16 Assessment|Incorrect escapers|0|||
161567194|NCT03410992|583465871|FG003|Week 16 Assessment|Incorrect escapers|0|||
161567195|NCT03410992|583465872|FG004|Week 16 Assessment|Incorrect escapers|0|||
161567196|NCT03410992|583465873|FG005|Week 16 Assessment|Incorrect escapers|0|||
161567197|NCT03410992|583465874|FG006|Week 16 Assessment|Incorrect escapers|0|||
161567198|NCT03410992|583465875|FG007|Week 16 Assessment|Incorrect escapers|0|||
161567199|NCT03410992|583465876|FG008|Week 16 Assessment|Incorrect escapers|0|||
161567200|NCT03410992|583465877|FG009|Week 16 Assessment|Incorrect escapers|0|||
161567201|NCT03410992|583465878|FG010|Week 16 Assessment|Incorrect escapers|0|||
161567202|NCT03410992|583465868|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567203|NCT03410992|583465869|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567204|NCT03410992|583465870|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567205|NCT03410992|583465871|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
161567206|NCT03410992|583465872|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
161567207|NCT03410992|583465873|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567208|NCT03410992|583465874|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567209|NCT03410992|583465875|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567210|NCT03410992|583465876|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567211|NCT03410992|583465877|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567212|NCT03410992|583465878|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
161567213|NCT03410992|583465868|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567214|NCT03410992|583465869|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567215|NCT03410992|583465870|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567216|NCT03410992|583465871|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
161567217|NCT03410992|583465872|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
161567218|NCT03410992|583465873|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
161567219|NCT03410992|583465874|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567220|NCT03410992|583465875|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567221|NCT03410992|583465876|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567222|NCT03410992|583465877|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567223|NCT03410992|583465878|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
161567224|NCT03410992|583465868|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567225|NCT03410992|583465869|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567226|NCT03410992|583465870|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567227|NCT03410992|583465871|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567228|NCT03410992|583465872|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567229|NCT03410992|583465873|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
161911980|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
161911981|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911982|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911983|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911984|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911985|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911986|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911987|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161911988|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161911989|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161911990|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
161911991|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911992|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911993|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911994|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911995|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911996|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911997|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
161911998|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911999|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912000|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912001|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912002|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912003|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912004|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912005|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912006|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912007|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
161912008|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912009|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
161912010|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
161912011|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912012|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912013|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912014|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912015|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912016|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912017|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912018|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912019|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912020|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
161912021|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912022|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912023|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912024|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912025|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912026|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912027|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912028|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
161912029|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912030|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912031|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912032|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912033|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912034|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912035|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912036|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912037|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912038|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912039|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161567230|NCT03410992|583465874|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161912040|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912041|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
161912042|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
161567231|NCT03410992|583465875|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567232|NCT03410992|583465876|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567233|NCT03410992|583465877|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567234|NCT03410992|583465878|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
161567235|NCT03410992|583465868|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567236|NCT03410992|583465869|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567237|NCT03410992|583465870|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567238|NCT03410992|583465871|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
161567239|NCT03410992|583465872|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
161567240|NCT03410992|583465873|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
161567241|NCT03410992|583465874|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567242|NCT03410992|583465875|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567243|NCT03410992|583465876|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567244|NCT03410992|583465877|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567245|NCT03410992|583465878|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
161567246|NCT03410992|583465868|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567247|NCT03410992|583465869|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567248|NCT03410992|583465870|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567249|NCT03410992|583465871|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567250|NCT03410992|583465872|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567251|NCT03410992|583465873|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567252|NCT03410992|583465874|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567253|NCT03410992|583465875|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
161567254|NCT03410992|583465876|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567255|NCT03410992|583465877|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567256|NCT03410992|583465878|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
161567257|NCT03410992|583465868|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567258|NCT03410992|583465869|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567259|NCT03410992|583465870|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567260|NCT03410992|583465871|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567261|NCT03410992|583465872|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567262|NCT03410992|583465873|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567263|NCT03410992|583465874|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567264|NCT03410992|583465875|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567265|NCT03410992|583465876|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
161567266|NCT03410992|583465877|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567267|NCT03410992|583465878|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161567268|NCT05298111|583465882|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
161567269|NCT05298111|583465883|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
161567270|NCT04988295|583465886|FG000|Overall Study|Withdrawal by Subject|9|||
161567271|NCT04988295|583465887|FG001|Overall Study|Withdrawal by Subject|29|||
161567272|NCT04988295|583465888|FG002|Overall Study|Withdrawal by Subject|6|||
161567273|NCT04988295|583465889|FG003|Overall Study|Withdrawal by Subject|0|||
161567274|NCT04988295|583465886|FG000|Overall Study|Lost to Follow-up|1|||
161567275|NCT04988295|583465887|FG001|Overall Study|Lost to Follow-up|0|||
161567276|NCT04988295|583465888|FG002|Overall Study|Lost to Follow-up|0|||
161567277|NCT04988295|583465889|FG003|Overall Study|Lost to Follow-up|0|||
161912043|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912044|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912045|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912046|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912047|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912048|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912049|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161567278|NCT04988295|583465886|FG000|Overall Study|Study participation ongoing|186|||
161912050|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161567279|NCT04988295|583465887|FG001|Overall Study|Study participation ongoing|169|||
161567280|NCT04988295|583465888|FG002|Overall Study|Study participation ongoing|99|||
161567281|NCT04988295|583465889|FG003|Overall Study|Study participation ongoing|119|||
161912051|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
161567282|NCT04083976|583465894|FG000|Overall Study|Lost to Follow-up|3|||
161567283|NCT04083976|583465895|FG001|Overall Study|Lost to Follow-up|0|||
161912052|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
161567284|NCT04083976|583465896|FG002|Overall Study|Lost to Follow-up|0|||
161912053|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912054|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912055|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912056|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912057|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912058|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912059|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912060|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912061|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
161912062|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
161912063|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912064|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912065|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912066|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912067|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912068|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912069|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912070|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912071|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
161912072|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
161912073|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912074|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912075|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912076|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912077|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912078|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912079|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912080|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912081|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
161912082|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
161912083|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912084|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912085|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912086|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912087|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912088|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912089|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912090|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912091|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
161912092|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912093|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912094|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912095|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912096|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912097|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912098|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912099|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912100|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912101|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
161912102|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912103|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161456299|NCT03011892|583065008|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
161456300|NCT03011892|583065009|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
161456301|NCT03011892|583065010|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
161456302|NCT03011892|583065011|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
161456303|NCT03011892|583065000|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
161456304|NCT03011892|583065001|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
161456305|NCT03011892|583065002|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
161456306|NCT03011892|583065003|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
161456307|NCT03011892|583065004|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
161456308|NCT03011892|583065005|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
161456309|NCT03011892|583065006|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
161456310|NCT03011892|583065007|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
161456311|NCT03011892|583065008|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
161456312|NCT03011892|583065009|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
161912104|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912105|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912106|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912107|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912108|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912109|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912110|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912111|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
161912112|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
161912113|NCT05117060|584728719|FG000|Overall Study|Adverse Event|3|||
161912114|NCT05117060|584728720|FG001|Overall Study|Adverse Event|5|||
161912115|NCT05117060|584728721|FG002|Overall Study|Adverse Event|6|||
161912116|NCT05117060|584728722|FG003|Overall Study|Adverse Event|1|||
161912117|NCT05117060|584728719|FG000|Overall Study|Lost to Follow-up|0|||
161912118|NCT05117060|584728720|FG001|Overall Study|Lost to Follow-up|0|||
161912119|NCT05117060|584728721|FG002|Overall Study|Lost to Follow-up|0|||
161912120|NCT05117060|584728722|FG003|Overall Study|Lost to Follow-up|1|||
161912121|NCT05117060|584728719|FG000|Overall Study|Lack of Efficacy|4|||
161912122|NCT05117060|584728720|FG001|Overall Study|Lack of Efficacy|5|||
161912123|NCT05117060|584728721|FG002|Overall Study|Lack of Efficacy|2|||
161912124|NCT05117060|584728722|FG003|Overall Study|Lack of Efficacy|6|||
161912125|NCT05117060|584728719|FG000|Overall Study|Withdrawal by Subject|8|||
161912126|NCT05117060|584728720|FG001|Overall Study|Withdrawal by Subject|5|||
161912127|NCT05117060|584728721|FG002|Overall Study|Withdrawal by Subject|5|||
161912128|NCT05117060|584728722|FG003|Overall Study|Withdrawal by Subject|6|||
161912129|NCT05117060|584728719|FG000|Overall Study|Other|2|||
161912130|NCT05117060|584728720|FG001|Overall Study|Other|1|||
161912131|NCT05117060|584728721|FG002|Overall Study|Other|3|||
161912132|NCT05117060|584728722|FG003|Overall Study|Other|1|||
161912133|NCT03141359|584728723|FG000|Overall Study|Death|32|||
161912134|NCT03141359|584728723|FG000|Overall Study|Still On Study (in follow up)|29|||
161912135|NCT05079321|584728724|FG000|Overall Study|Withdrawal by Subject|2|||
161912136|NCT05079321|584728725|FG001|Overall Study|Withdrawal by Subject|2|||
161912137|NCT05079321|584728724|FG000|Overall Study|Lost to Follow-up|0|||
161912138|NCT05079321|584728725|FG001|Overall Study|Lost to Follow-up|1|||
161912139|NCT01081626|584728726|FG000|Overall Study|Dosing error|1|||
161912140|NCT01081626|584728727|FG001|Overall Study|Dosing error|1|||
161912141|NCT01081626|584728726|FG000|Overall Study|Missing Estradiol|25|||
161912142|NCT01081626|584728727|FG001|Overall Study|Missing Estradiol|28|||
161912143|NCT01081626|584728726|FG000|Overall Study|Low antral follicle count|1|||
161912144|NCT01081626|584728727|FG001|Overall Study|Low antral follicle count|0|||
161912145|NCT01081626|584728726|FG000|Overall Study|Overstimulation|0|||
161912146|NCT01081626|584728727|FG001|Overall Study|Overstimulation|1|||
161912147|NCT01081626|584728726|FG000|Overall Study|Lost to Follow-up|0|||
161912148|NCT01081626|584728727|FG001|Overall Study|Lost to Follow-up|1|||
161912149|NCT01081626|584728726|FG000|Overall Study|Other|33|||
161912150|NCT01081626|584728727|FG001|Overall Study|Other|30|||
161912151|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Other than specified|2|||
161912152|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Other than specified|4|||
161912153|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
161912154|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
161912155|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Pregnancy|0|||
161912156|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Pregnancy|2|||
161912157|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Physician Decision|1|||
161912158|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Physician Decision|1|||
161912159|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
161912160|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
161912161|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Adverse Event|2|||
161912162|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Adverse Event|1|||
161912163|NCT05965752|584728733|FG000|Overall Study|Adverse Event|0|||
161912164|NCT05965752|584728734|FG001|Overall Study|Adverse Event|1|||
161912165|NCT05965752|584728735|FG002|Overall Study|Adverse Event|0|||
161912166|NCT05965752|584728736|FG003|Overall Study|Adverse Event|1|||
161912167|NCT05965752|584728737|FG004|Overall Study|Adverse Event|3|||
161912168|NCT05965752|584728733|FG000|Overall Study|Lost to Follow-up|2|||
161912169|NCT05965752|584728734|FG001|Overall Study|Lost to Follow-up|0|||
161912170|NCT05965752|584728735|FG002|Overall Study|Lost to Follow-up|1|||
161912171|NCT05965752|584728736|FG003|Overall Study|Lost to Follow-up|1|||
161912172|NCT05965752|584728737|FG004|Overall Study|Lost to Follow-up|1|||
161912173|NCT05965752|584728733|FG000|Overall Study|Withdrawal by Subject|2|||
161912174|NCT05965752|584728734|FG001|Overall Study|Withdrawal by Subject|2|||
161912175|NCT05965752|584728735|FG002|Overall Study|Withdrawal by Subject|1|||
161912176|NCT05965752|584728736|FG003|Overall Study|Withdrawal by Subject|5|||
161912177|NCT05965752|584728737|FG004|Overall Study|Withdrawal by Subject|0|||
161456313|NCT03011892|583065010|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
161456314|NCT03011892|583065011|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
161456315|NCT03011892|583065000|FG000|Double Blind (DB) Period|Other|1|||
161808839|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808840|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808841|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808842|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808843|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808844|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808845|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808846|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808847|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808848|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808849|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808850|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808851|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808852|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808853|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808854|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
161808855|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
161808856|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
161808857|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808858|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808859|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161456316|NCT03011892|583065001|FG001|Double Blind (DB) Period|Other|1|||
161456317|NCT03011892|583065002|FG002|Double Blind (DB) Period|Other|1|||
161456318|NCT03011892|583065003|FG003|Double Blind (DB) Period|Other|0|||
161456319|NCT03011892|583065004|FG004|Double Blind (DB) Period|Other|1|||
161456320|NCT03011892|583065005|FG005|Double Blind (DB) Period|Other|0|||
161456321|NCT03011892|583065006|FG006|Double Blind (DB) Period|Other|0|||
161456322|NCT03011892|583065007|FG007|Double Blind (DB) Period|Other|0|||
161456323|NCT03011892|583065008|FG008|Double Blind (DB) Period|Other|0|||
161456324|NCT03011892|583065009|FG009|Double Blind (DB) Period|Other|0|||
161456325|NCT03011892|583065010|FG010|Double Blind (DB) Period|Other|0|||
161456326|NCT03011892|583065011|FG011|Double Blind (DB) Period|Other|0|||
161456327|NCT03011892|583065000|FG000|Double Blind (DB) Period|Physician Decision|1|||
161456328|NCT03011892|583065001|FG001|Double Blind (DB) Period|Physician Decision|0|||
161456329|NCT03011892|583065002|FG002|Double Blind (DB) Period|Physician Decision|1|||
161456330|NCT03011892|583065003|FG003|Double Blind (DB) Period|Physician Decision|0|||
161456331|NCT03011892|583065004|FG004|Double Blind (DB) Period|Physician Decision|0|||
161456332|NCT03011892|583065005|FG005|Double Blind (DB) Period|Physician Decision|0|||
161456333|NCT03011892|583065006|FG006|Double Blind (DB) Period|Physician Decision|0|||
161456334|NCT03011892|583065007|FG007|Double Blind (DB) Period|Physician Decision|0|||
161456335|NCT03011892|583065008|FG008|Double Blind (DB) Period|Physician Decision|0|||
161456336|NCT03011892|583065009|FG009|Double Blind (DB) Period|Physician Decision|0|||
161456337|NCT03011892|583065010|FG010|Double Blind (DB) Period|Physician Decision|0|||
161456338|NCT03011892|583065011|FG011|Double Blind (DB) Period|Physician Decision|0|||
161456339|NCT03011892|583065000|FG000|Double Blind (DB) Period|Pregnancy|0|||
161456340|NCT03011892|583065001|FG001|Double Blind (DB) Period|Pregnancy|0|||
161456341|NCT03011892|583065002|FG002|Double Blind (DB) Period|Pregnancy|0|||
161456342|NCT03011892|583065003|FG003|Double Blind (DB) Period|Pregnancy|0|||
161456343|NCT03011892|583065004|FG004|Double Blind (DB) Period|Pregnancy|1|||
161456344|NCT03011892|583065005|FG005|Double Blind (DB) Period|Pregnancy|0|||
161456345|NCT03011892|583065006|FG006|Double Blind (DB) Period|Pregnancy|0|||
161456346|NCT03011892|583065007|FG007|Double Blind (DB) Period|Pregnancy|0|||
161456347|NCT03011892|583065008|FG008|Double Blind (DB) Period|Pregnancy|0|||
161456348|NCT03011892|583065009|FG009|Double Blind (DB) Period|Pregnancy|0|||
161456349|NCT03011892|583065010|FG010|Double Blind (DB) Period|Pregnancy|0|||
161456350|NCT03011892|583065011|FG011|Double Blind (DB) Period|Pregnancy|0|||
161456351|NCT03011892|583065000|FG000|Double Blind (DB) Period|Protocol Violation|1|||
161456352|NCT03011892|583065001|FG001|Double Blind (DB) Period|Protocol Violation|0|||
161456353|NCT03011892|583065002|FG002|Double Blind (DB) Period|Protocol Violation|0|||
161456354|NCT03011892|583065003|FG003|Double Blind (DB) Period|Protocol Violation|0|||
161456355|NCT03011892|583065004|FG004|Double Blind (DB) Period|Protocol Violation|0|||
161456356|NCT03011892|583065005|FG005|Double Blind (DB) Period|Protocol Violation|0|||
161456357|NCT03011892|583065006|FG006|Double Blind (DB) Period|Protocol Violation|0|||
161456358|NCT03011892|583065007|FG007|Double Blind (DB) Period|Protocol Violation|0|||
161456359|NCT03011892|583065008|FG008|Double Blind (DB) Period|Protocol Violation|0|||
161456360|NCT03011892|583065009|FG009|Double Blind (DB) Period|Protocol Violation|0|||
161456361|NCT03011892|583065010|FG010|Double Blind (DB) Period|Protocol Violation|0|||
161456362|NCT03011892|583065011|FG011|Double Blind (DB) Period|Protocol Violation|0|||
161456363|NCT03011892|583065000|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
161567285|NCT04083976|583465897|FG003|Overall Study|Lost to Follow-up|1|||
161912178|NCT05965752|584728733|FG000|Overall Study|Disease Relapse|1|||
161912179|NCT05965752|584728734|FG001|Overall Study|Disease Relapse|0|||
161456364|NCT03011892|583065001|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
161912180|NCT05965752|584728735|FG002|Overall Study|Disease Relapse|1|||
161456365|NCT03011892|583065002|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
161456366|NCT03011892|583065003|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
161456367|NCT03011892|583065004|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
161456368|NCT03011892|583065005|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
161456369|NCT03011892|583065006|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
161456370|NCT03011892|583065007|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
161456371|NCT03011892|583065008|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
161456372|NCT03011892|583065009|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
161456373|NCT03011892|583065010|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
161456374|NCT03011892|583065011|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
161456375|NCT03011892|583065000|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
161456376|NCT03011892|583065001|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
161456377|NCT03011892|583065002|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
161456378|NCT03011892|583065003|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
161456379|NCT03011892|583065004|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
161456380|NCT03011892|583065005|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
161456381|NCT03011892|583065006|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
161456382|NCT03011892|583065007|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
161456383|NCT03011892|583065008|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
161456384|NCT03011892|583065009|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
161456385|NCT03011892|583065010|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
161456386|NCT03011892|583065011|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
161456387|NCT03011892|583065000|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
161456388|NCT03011892|583065001|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
161456389|NCT03011892|583065002|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
161456390|NCT03011892|583065003|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
161456391|NCT03011892|583065004|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
161456392|NCT03011892|583065005|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
161456393|NCT03011892|583065006|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
161456394|NCT03011892|583065007|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
161456395|NCT03011892|583065008|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
161456396|NCT03011892|583065009|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
161456397|NCT03011892|583065010|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
161456398|NCT03011892|583065011|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
161456399|NCT03011892|583065000|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
161456400|NCT03011892|583065001|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
161456401|NCT03011892|583065002|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
161456402|NCT03011892|583065003|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
161456403|NCT03011892|583065004|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
161456404|NCT03011892|583065005|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
161456405|NCT03011892|583065006|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
161456406|NCT03011892|583065007|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
161456407|NCT03011892|583065008|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
161456408|NCT03011892|583065009|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
161456409|NCT03011892|583065010|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
161456410|NCT03011892|583065011|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
161456411|NCT03011892|583065000|FG000|Open Label (OL) Period|Reason not specified|0|||
161456412|NCT03011892|583065001|FG001|Open Label (OL) Period|Reason not specified|0|||
161456413|NCT03011892|583065002|FG002|Open Label (OL) Period|Reason not specified|0|||
161456414|NCT03011892|583065003|FG003|Open Label (OL) Period|Reason not specified|0|||
161456415|NCT03011892|583065004|FG004|Open Label (OL) Period|Reason not specified|0|||
161456416|NCT03011892|583065005|FG005|Open Label (OL) Period|Reason not specified|0|||
161456417|NCT03011892|583065006|FG006|Open Label (OL) Period|Reason not specified|0|||
161456418|NCT03011892|583065007|FG007|Open Label (OL) Period|Reason not specified|1|||
161456419|NCT03011892|583065008|FG008|Open Label (OL) Period|Reason not specified|0|||
161456420|NCT03011892|583065009|FG009|Open Label (OL) Period|Reason not specified|0|||
161456421|NCT03011892|583065010|FG010|Open Label (OL) Period|Reason not specified|0|||
161456422|NCT03011892|583065011|FG011|Open Label (OL) Period|Reason not specified|0|||
161456423|NCT02312687|583065026|FG000|Overall Study|Other, Not Specified|1|||
161456424|NCT00906971|583065027|FG000|Overall Study|Withdrawal by Subject|8|||
161456425|NCT00906971|583065028|FG001|Overall Study|Withdrawal by Subject|2|||
161456426|NCT00906971|583065027|FG000|Overall Study|Lost to Follow-up|0|||
161456427|NCT00906971|583065028|FG001|Overall Study|Lost to Follow-up|1|||
161456428|NCT01007253|583065035|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
161456429|NCT01007253|583065036|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
161456430|NCT01007253|583065037|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
161456431|NCT01007253|583065038|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
161567286|NCT04083976|583465894|FG000|Overall Study|Withdrawal by Subject|16|||
161567287|NCT04083976|583465895|FG001|Overall Study|Withdrawal by Subject|1|||
161567288|NCT04083976|583465896|FG002|Overall Study|Withdrawal by Subject|9|||
161567289|NCT04083976|583465897|FG003|Overall Study|Withdrawal by Subject|0|||
161567290|NCT04083976|583465894|FG000|Overall Study|Sponsor Decision|14|||
161567291|NCT04083976|583465895|FG001|Overall Study|Sponsor Decision|0|||
161567292|NCT04083976|583465896|FG002|Overall Study|Sponsor Decision|0|||
161567293|NCT04083976|583465897|FG003|Overall Study|Sponsor Decision|7|||
161567294|NCT04083976|583465894|FG000|Overall Study|Other|1|||
161567295|NCT04083976|583465895|FG001|Overall Study|Other|0|||
161567296|NCT04083976|583465896|FG002|Overall Study|Other|1|||
161567297|NCT04083976|583465897|FG003|Overall Study|Other|0|||
161567298|NCT00930813|583465899|FG000|Overall Study|Death|4|||
161567299|NCT00930813|583465900|FG001|Overall Study|Death|5|||
161567300|NCT00930813|583465899|FG000|Overall Study|Withdrawal by Subject|2|||
161567301|NCT00930813|583465900|FG001|Overall Study|Withdrawal by Subject|5|||
161567302|NCT00930813|583465899|FG000|Overall Study|Lost to Follow-up|2|||
161567303|NCT00930813|583465900|FG001|Overall Study|Lost to Follow-up|4|||
161567304|NCT01693614|583465901|FG000|Overall Study|Adverse Event|7|||
161567305|NCT01693614|583465902|FG001|Overall Study|Adverse Event|11|||
161567306|NCT01693614|583465903|FG002|Overall Study|Adverse Event|5|||
161567307|NCT01693614|583465901|FG000|Overall Study|Disease progression|11|||
161567308|NCT01693614|583465902|FG001|Overall Study|Disease progression|8|||
161567309|NCT01693614|583465903|FG002|Overall Study|Disease progression|7|||
161567310|NCT01693614|583465901|FG000|Overall Study|Protocol Violation|5|||
161567311|NCT01693614|583465902|FG001|Overall Study|Protocol Violation|2|||
161567312|NCT01693614|583465903|FG002|Overall Study|Protocol Violation|1|||
161567313|NCT01693614|583465901|FG000|Overall Study|Death|1|||
161567314|NCT01693614|583465902|FG001|Overall Study|Death|0|||
161567315|NCT01693614|583465903|FG002|Overall Study|Death|0|||
161567316|NCT01693614|583465901|FG000|Overall Study|Physician Decision|1|||
161567317|NCT01693614|583465902|FG001|Overall Study|Physician Decision|1|||
161567318|NCT01693614|583465903|FG002|Overall Study|Physician Decision|4|||
161567319|NCT01693614|583465901|FG000|Overall Study|Withdrawal by subject/guardian|0|||
161567320|NCT01693614|583465902|FG001|Overall Study|Withdrawal by subject/guardian|0|||
161567321|NCT01693614|583465903|FG002|Overall Study|Withdrawal by subject/guardian|2|||
161567322|NCT01693614|583465901|FG000|Overall Study|Withdrawal by Subject|1|||
161567323|NCT01693614|583465902|FG001|Overall Study|Withdrawal by Subject|0|||
161567324|NCT01693614|583465903|FG002|Overall Study|Withdrawal by Subject|5|||
161567325|NCT04618471|583465904|FG000|Overall Study|Screen Failure|62|||
161567326|NCT04618471|583465904|FG000|Overall Study|Withdrawal by Subject|6|||
161567327|NCT04618471|583465904|FG000|Overall Study|Physician Decision|2|||
161567328|NCT04618471|583465904|FG000|Overall Study|Lost to Follow-up|1|||
161567329|NCT04618471|583465904|FG000|Overall Study|Various other reasons|2|||
161567330|NCT04618471|583465904|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
161567331|NCT00588666|583465905|FG000|Overall Study|Adverse Event|4|||
161567332|NCT02299635|583465908|FG000|Overall Study|Adverse Event|2|||
161567333|NCT02299635|583465908|FG000|Overall Study|Death|1|||
161567334|NCT02299635|583465908|FG000|Overall Study|Global deterioration of health status|1|||
161567335|NCT02299635|583465908|FG000|Overall Study|Objective progression or relapse|10|||
161567336|NCT02299635|583465908|FG000|Overall Study|Withdrawal by Subject|2|||
161567337|NCT02299635|583465908|FG000|Overall Study|Other|3|||
161567338|NCT00927823|583465909|FG000|Continuous Dosing Period|Death|0|||
161567339|NCT00927823|583465910|FG001|Continuous Dosing Period|Death|0|||
161567340|NCT00927823|583465911|FG002|Continuous Dosing Period|Death|6|||
161567341|NCT00927823|583465912|FG003|Continuous Dosing Period|Death|0|||
161567342|NCT00927823|583465909|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
161567343|NCT00927823|583465910|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
161567344|NCT00927823|583465911|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
161567345|NCT00927823|583465912|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
161567346|NCT00927823|583465909|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
161567347|NCT00927823|583465910|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
161567348|NCT00927823|583465911|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
161567349|NCT00927823|583465912|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
161912181|NCT05965752|584728736|FG003|Overall Study|Disease Relapse|0|||
161567350|NCT00927823|583465909|FG000|Continuous Dosing Period|Other|1|||
161567351|NCT00927823|583465910|FG001|Continuous Dosing Period|Other|2|||
161567352|NCT00927823|583465911|FG002|Continuous Dosing Period|Other|9|||
161912182|NCT05965752|584728737|FG004|Overall Study|Disease Relapse|0|||
161912183|NCT05965752|584728733|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161567353|NCT00927823|583465912|FG003|Continuous Dosing Period|Other|3|||
161567354|NCT00828672|583465913|FG000|Study Treatment|Lost to Follow-up|1|||
161567355|NCT00828672|583465914|FG001|Study Treatment|Lost to Follow-up|0|||
161567356|NCT00828672|583465913|FG000|Study Treatment|Adverse Event|0|||
161567357|NCT00828672|583465914|FG001|Study Treatment|Adverse Event|1|||
161567358|NCT00828672|583465913|FG000|Study Treatment|Complete response, no surgery|1|||
161567359|NCT00828672|583465914|FG001|Study Treatment|Complete response, no surgery|1|||
161567360|NCT00828672|583465913|FG000|Post-surgery (<30 Days)|No central review materials|0|||
161456432|NCT02677324|583066684|FG000|Overall Study|Disease Progression|6|||
161456433|NCT02677324|583066684|FG000|Overall Study|Inability to Swallow pills|1|||
161456434|NCT02677324|583066684|FG000|Overall Study|Non-compliance|1|||
161456435|NCT02677324|583066684|FG000|Overall Study|Lack of Efficacy|1|||
161456436|NCT02677324|583066684|FG000|Overall Study|Medical insurance coverage|1|||
161456437|NCT02677324|583066684|FG000|Overall Study|Adverse Event|1|||
161456438|NCT02677324|583066684|FG000|Overall Study|IgM Myeloma diagnosis|1|||
161456439|NCT01895361|583066685|FG000|Overall Study|Adverse Event|1|||
161456440|NCT01895361|583066686|FG001|Overall Study|Adverse Event|1|||
161456441|NCT01895361|583066687|FG002|Overall Study|Adverse Event|3|||
161456442|NCT01895361|583066685|FG000|Overall Study|Death|2|||
161456443|NCT01895361|583066686|FG001|Overall Study|Death|1|||
161456444|NCT01895361|583066687|FG002|Overall Study|Death|2|||
161456445|NCT01895361|583066685|FG000|Overall Study|Lost to Follow-up|4|||
161456446|NCT01895361|583066686|FG001|Overall Study|Lost to Follow-up|4|||
161456447|NCT01895361|583066687|FG002|Overall Study|Lost to Follow-up|6|||
161456448|NCT01895361|583066685|FG000|Overall Study|Non-compliance with study|1|||
161456449|NCT01895361|583066686|FG001|Overall Study|Non-compliance with study|3|||
161456450|NCT01895361|583066687|FG002|Overall Study|Non-compliance with study|1|||
161456451|NCT01895361|583066685|FG000|Overall Study|Physician Decision|2|||
161456452|NCT01895361|583066686|FG001|Overall Study|Physician Decision|2|||
161456453|NCT01895361|583066687|FG002|Overall Study|Physician Decision|2|||
161456454|NCT01895361|583066685|FG000|Overall Study|Withdrawal by Subject|7|||
161456455|NCT01895361|583066686|FG001|Overall Study|Withdrawal by Subject|6|||
161456456|NCT01895361|583066687|FG002|Overall Study|Withdrawal by Subject|6|||
161456457|NCT01895361|583066685|FG000|Overall Study|Lack of Efficacy|0|||
161456458|NCT01895361|583066686|FG001|Overall Study|Lack of Efficacy|1|||
161456459|NCT01895361|583066687|FG002|Overall Study|Lack of Efficacy|0|||
161456460|NCT01895361|583066685|FG000|Overall Study|Reasons different from categories above|7|||
161456461|NCT01895361|583066686|FG001|Overall Study|Reasons different from categories above|3|||
161456462|NCT01895361|583066687|FG002|Overall Study|Reasons different from categories above|4|||
161456463|NCT01268579|583066688|FG000|Overall Study|Adverse Event|1|||
161456464|NCT01268579|583066688|FG000|Overall Study|Withdrawal by Subject|2|||
161456465|NCT03312751|583066689|FG000|Overall Study|Death|7|||
161456466|NCT03312751|583066690|FG001|Overall Study|Death|9|||
161456467|NCT03312751|583066689|FG000|Overall Study|Study discontinuation due to other reason|0|||
161456468|NCT03312751|583066690|FG001|Overall Study|Study discontinuation due to other reason|1|||
161456469|NCT05463198|583066691|FG000|Overall Study|Withdrawal by Subject|19|||
161456470|NCT05463198|583066691|FG000|Overall Study|Procedure Notes Missing|18|||
161456471|NCT02239120|583066694|FG000|Overall Study|Death|56|||
161456472|NCT02239120|583066695|FG001|Overall Study|Death|58|||
161456473|NCT02239120|583066694|FG000|Overall Study|Lost to Follow-up|19|||
161456474|NCT02239120|583066695|FG001|Overall Study|Lost to Follow-up|14|||
161456475|NCT00046891|583066701|FG000|Overall Study|Cancels|5|||
161456476|NCT00046891|583066702|FG001|Overall Study|Cancels|9|||
161456477|NCT00046891|583066701|FG000|Overall Study|Ineligible|1|||
161456478|NCT00046891|583066702|FG001|Overall Study|Ineligible|1|||
161456479|NCT00046891|583066701|FG000|Overall Study|Withdrawal by Subject|18|||
161456480|NCT00046891|583066702|FG001|Overall Study|Withdrawal by Subject|15|||
161456481|NCT00046891|583066701|FG000|Overall Study|Adverse Event|5|||
161456482|NCT00046891|583066702|FG001|Overall Study|Adverse Event|5|||
161456483|NCT00420641|583066705|FG000|Overall Study|Adverse Event|3|||
161456484|NCT00420641|583066706|FG001|Overall Study|Adverse Event|25|||
161456485|NCT00420641|583066707|FG002|Overall Study|Adverse Event|10|||
161456486|NCT00420641|583066705|FG000|Overall Study|Lost to Follow-up|2|||
161456487|NCT00420641|583066706|FG001|Overall Study|Lost to Follow-up|4|||
161456488|NCT00420641|583066707|FG002|Overall Study|Lost to Follow-up|2|||
161456489|NCT00420641|583066705|FG000|Overall Study|Protocol Violation|8|||
161456490|NCT00420641|583066706|FG001|Overall Study|Protocol Violation|8|||
161456491|NCT00420641|583066707|FG002|Overall Study|Protocol Violation|7|||
161456492|NCT00420641|583066705|FG000|Overall Study|Withdrawal by Subject|15|||
161456493|NCT00420641|583066706|FG001|Overall Study|Withdrawal by Subject|21|||
161456494|NCT00420641|583066707|FG002|Overall Study|Withdrawal by Subject|14|||
161456495|NCT00420641|583066705|FG000|Overall Study|Lack of Efficacy|6|||
161456496|NCT00420641|583066706|FG001|Overall Study|Lack of Efficacy|5|||
161456497|NCT00420641|583066707|FG002|Overall Study|Lack of Efficacy|4|||
161456498|NCT00420641|583066705|FG000|Overall Study|Non-compliance|7|||
161456499|NCT00420641|583066706|FG001|Overall Study|Non-compliance|5|||
161456500|NCT00420641|583066707|FG002|Overall Study|Non-compliance|4|||
161456501|NCT00420641|583066705|FG000|Overall Study|Other|4|||
161456502|NCT00420641|583066706|FG001|Overall Study|Other|4|||
161456503|NCT00420641|583066707|FG002|Overall Study|Other|3|||
161456504|NCT02815280|583066719|FG000|Double-Blind Phase|Adverse Event|1|||
161456505|NCT02815280|583066720|FG001|Double-Blind Phase|Adverse Event|1|||
161456506|NCT02815280|583066719|FG000|Double-Blind Phase|Lost to Follow-up|10|||
161456507|NCT02815280|583066720|FG001|Double-Blind Phase|Lost to Follow-up|9|||
161456508|NCT02815280|583066719|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
161567361|NCT00828672|583465914|FG001|Post-surgery (<30 Days)|No central review materials|1|||
161567362|NCT04889118|583465915|FG000|Overall Study|Death|49|||
161567363|NCT04889118|583465916|FG001|Overall Study|Death|47|||
161567364|NCT04889118|583465915|FG000|Overall Study|Sponsor Decision|15|||
161567365|NCT04889118|583465916|FG001|Overall Study|Sponsor Decision|20|||
161567366|NCT01744691|583465917|FG000|Overall Study|Progressive Disease|18|||
161567367|NCT01744691|583465917|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
161567368|NCT01744691|583465917|FG000|Overall Study|Withdrawal of consent for treatment|3|||
161567369|NCT01744691|583465917|FG000|Overall Study|Physician Decision|4|||
161567370|NCT02701361|583465918|FG000|Overall Study|Lost to Follow-up|5|||
161567371|NCT02701361|583465919|FG001|Overall Study|Lost to Follow-up|2|||
161567372|NCT02701361|583465920|FG002|Overall Study|Lost to Follow-up|1|||
161567373|NCT02701361|583465918|FG000|Overall Study|Withdrawal by Subject|4|||
161567374|NCT02701361|583465919|FG001|Overall Study|Withdrawal by Subject|0|||
161567375|NCT02701361|583465920|FG002|Overall Study|Withdrawal by Subject|0|||
161567376|NCT02701361|583465918|FG000|Overall Study|timed out in rehab center|0|||
161567377|NCT02701361|583465919|FG001|Overall Study|timed out in rehab center|1|||
161567378|NCT02701361|583465920|FG002|Overall Study|timed out in rehab center|0|||
161567379|NCT02701361|583465918|FG000|Overall Study|incarceration|0|||
161567380|NCT02701361|583465919|FG001|Overall Study|incarceration|0|||
161567381|NCT02701361|583465920|FG002|Overall Study|incarceration|1|||
161567382|NCT00404079|583465927|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
161567383|NCT00404079|583465928|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
161567384|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Other|4|||
161567385|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Other|0|||
161567386|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
161567387|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
161567388|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
161567389|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
161567390|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
161567391|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
161567392|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
161567393|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
161567394|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
161567395|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
161567396|NCT00853827|583465929|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
161567397|NCT00853827|583465930|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
161567398|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
161567399|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
161567400|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
161567401|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
161567402|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
161567403|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
161567404|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
161567405|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
161567406|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
161567407|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
161567408|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
161567409|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
161567410|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
161567411|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
161567412|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
161567413|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
161808860|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808861|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808862|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808863|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808864|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808865|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808866|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808867|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161912184|NCT05965752|584728734|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161912185|NCT05965752|584728735|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161912186|NCT05965752|584728736|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
161912187|NCT05965752|584728737|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161912188|NCT05965752|584728733|FG000|Overall Study|Unable to Return for Study Visits|0|||
161567414|NCT00853827|583465929|FG000|Double Blind Period (103 Weeks)|Death|1|||
161567415|NCT00853827|583465930|FG001|Double Blind Period (103 Weeks)|Death|6|||
161567416|NCT00580801|583465941|FG000|Overall Study|Physician Decision|1|||
161567417|NCT00580801|583465942|FG001|Overall Study|Physician Decision|0|||
161567418|NCT00580801|583465943|FG002|Overall Study|Physician Decision|0|||
161567419|NCT00580801|583465941|FG000|Overall Study|Adverse Event|2|||
161567420|NCT00580801|583465942|FG001|Overall Study|Adverse Event|0|||
161567421|NCT00580801|583465943|FG002|Overall Study|Adverse Event|0|||
161567422|NCT00580801|583465941|FG000|Overall Study|Lost to Follow-up|2|||
161567423|NCT00580801|583465942|FG001|Overall Study|Lost to Follow-up|0|||
161567424|NCT00580801|583465943|FG002|Overall Study|Lost to Follow-up|0|||
161567425|NCT00580801|583465941|FG000|Overall Study|Reached a virologic endpoint|0|||
161567426|NCT00580801|583465942|FG001|Overall Study|Reached a virologic endpoint|1|||
161567427|NCT00580801|583465943|FG002|Overall Study|Reached a virologic endpoint|2|||
161567428|NCT00580801|583465941|FG000|Overall Study|Participant non-compliant|0|||
161567429|NCT00580801|583465942|FG001|Overall Study|Participant non-compliant|0|||
161567430|NCT00580801|583465943|FG002|Overall Study|Participant non-compliant|1|||
161567431|NCT00580801|583465941|FG000|Overall Study|Travel|1|||
161567432|NCT00580801|583465942|FG001|Overall Study|Travel|0|||
161567433|NCT00580801|583465943|FG002|Overall Study|Travel|0|||
161567434|NCT05576051|583465944|FG000|Overall Study|Lack of Efficacy|543|||
161567435|NCT05576051|583465945|FG001|Overall Study|Lack of Efficacy|343|||
161567436|NCT05576051|583465946|FG002|Overall Study|Lack of Efficacy|108|||
161567437|NCT05576051|583465947|FG003|Overall Study|Lack of Efficacy|72|||
161567438|NCT05576051|583465948|FG004|Overall Study|Lack of Efficacy|28|||
161567439|NCT05576051|583465949|FG005|Overall Study|Lack of Efficacy|50|||
161567440|NCT05576051|583465944|FG000|Overall Study|Safety|78|||
161567441|NCT05576051|583465945|FG001|Overall Study|Safety|74|||
161567442|NCT05576051|583465946|FG002|Overall Study|Safety|16|||
161567443|NCT05576051|583465947|FG003|Overall Study|Safety|14|||
161567444|NCT05576051|583465948|FG004|Overall Study|Safety|4|||
161567445|NCT05576051|583465949|FG005|Overall Study|Safety|5|||
161567446|NCT05576051|583465944|FG000|Overall Study|Efficacy + Safety|10|||
161567447|NCT05576051|583465945|FG001|Overall Study|Efficacy + Safety|7|||
161567448|NCT05576051|583465946|FG002|Overall Study|Efficacy + Safety|3|||
161567449|NCT05576051|583465947|FG003|Overall Study|Efficacy + Safety|0|||
161567450|NCT05576051|583465948|FG004|Overall Study|Efficacy + Safety|0|||
161567451|NCT05576051|583465949|FG005|Overall Study|Efficacy + Safety|0|||
161567452|NCT05576051|583465944|FG000|Overall Study|Other|231|||
161567453|NCT05576051|583465945|FG001|Overall Study|Other|127|||
161567454|NCT05576051|583465946|FG002|Overall Study|Other|35|||
161567455|NCT05576051|583465947|FG003|Overall Study|Other|14|||
161567456|NCT05576051|583465948|FG004|Overall Study|Other|6|||
161567457|NCT05576051|583465949|FG005|Overall Study|Other|0|||
161567458|NCT04154943|583465950|FG000|Overall Study|Study Ongoing|68|||
161567459|NCT04154943|583465950|FG000|Overall Study|Lost to Follow-up|1|||
161567460|NCT04154943|583465950|FG000|Overall Study|Decision by the Investigator|1|||
161808868|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808869|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808870|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808871|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808872|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808873|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808874|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808875|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
161808876|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808877|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808878|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
161808879|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161456509|NCT02815280|583066720|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
161456510|NCT02815280|583066719|FG000|Double-Blind Phase|Protocol Violation|2|||
161456511|NCT02815280|583066720|FG001|Double-Blind Phase|Protocol Violation|2|||
161456512|NCT02815280|583066719|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
161456513|NCT02815280|583066720|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
161456514|NCT02815280|583066719|FG000|Open-Label Phase|Adverse Event|2|||
161456515|NCT02815280|583066720|FG001|Open-Label Phase|Adverse Event|3|||
161456516|NCT02815280|583066719|FG000|Open-Label Phase|Lost to Follow-up|18|||
161456517|NCT02815280|583066720|FG001|Open-Label Phase|Lost to Follow-up|9|||
161456518|NCT02815280|583066719|FG000|Open-Label Phase|Withdrawal by Subject|33|||
161456519|NCT02815280|583066720|FG001|Open-Label Phase|Withdrawal by Subject|18|||
161456520|NCT02815280|583066719|FG000|Open-Label Phase|Protocol Violation|3|||
161456521|NCT02815280|583066720|FG001|Open-Label Phase|Protocol Violation|0|||
161456522|NCT02815280|583066719|FG000|Open-Label Phase|Administrative|26|||
161456523|NCT02815280|583066720|FG001|Open-Label Phase|Administrative|12|||
161456524|NCT02815280|583066719|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
161456525|NCT02815280|583066720|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
161456526|NCT01944839|583066736|FG000|Overall Study|Physician Decision|2|||
161567461|NCT04154943|583465950|FG000|Overall Study|Death|5|||
161567462|NCT04154943|583465950|FG000|Overall Study|Withdrawal by Subject|4|||
161456527|NCT01944839|583066737|FG001|Overall Study|Physician Decision|2|||
161456528|NCT01944839|583066736|FG000|Overall Study|Protocol Violation|0|||
161456529|NCT01944839|583066737|FG001|Overall Study|Protocol Violation|1|||
161456530|NCT01944839|583066736|FG000|Overall Study|Adverse Event|10|||
161456531|NCT01944839|583066737|FG001|Overall Study|Adverse Event|5|||
161456532|NCT01944839|583066736|FG000|Overall Study|Withdrawal by Subject|9|||
161456533|NCT01944839|583066737|FG001|Overall Study|Withdrawal by Subject|17|||
161456534|NCT01944839|583066736|FG000|Overall Study|Lost to Follow-up|1|||
161808880|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808881|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808882|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808883|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808884|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161456535|NCT01944839|583066737|FG001|Overall Study|Lost to Follow-up|0|||
161456536|NCT01944839|583066736|FG000|Overall Study|Subject non-compliance|0|||
161456537|NCT01944839|583066737|FG001|Overall Study|Subject non-compliance|3|||
161456538|NCT00609362|583066738|FG000|Overall Study|Withdrawal by Subject|2|||
161456539|NCT00609362|583066739|FG001|Overall Study|Withdrawal by Subject|1|||
161456540|NCT00609362|583066738|FG000|Overall Study|Adverse Event|1|||
161456541|NCT00609362|583066739|FG001|Overall Study|Adverse Event|0|||
161456542|NCT05093790|583066740|FG000|Overall Study|Failure to meet continuation criteria|0|||
161456543|NCT05093790|583066741|FG001|Overall Study|Failure to meet continuation criteria|0|||
161456544|NCT05093790|583066742|FG002|Overall Study|Failure to meet continuation criteria|1|||
161456545|NCT05093790|583066743|FG003|Overall Study|Failure to meet continuation criteria|0|||
161456546|NCT05093790|583066740|FG000|Overall Study|Adverse Event|1|||
161456547|NCT05093790|583066741|FG001|Overall Study|Adverse Event|0|||
161456548|NCT05093790|583066742|FG002|Overall Study|Adverse Event|0|||
161456549|NCT05093790|583066743|FG003|Overall Study|Adverse Event|0|||
161456550|NCT02582684|583066744|FG000|Overall Study|Unable to contact subject/parent|4|||
161456551|NCT02582684|583066744|FG000|Overall Study|Subject not able to get to clinic|10|||
161456552|NCT02582684|583066744|FG000|Overall Study|Subject withdrew consent|1|||
161456553|NCT02582684|583066744|FG000|Overall Study|Found to be ineligible after enrollment|2|||
161456554|NCT01587898|583066752|FG000|Overall Study|Adverse Event|1|||
161456555|NCT01587898|583066753|FG001|Overall Study|Adverse Event|1|||
161456556|NCT01587898|583066754|FG002|Overall Study|Adverse Event|0|||
161456557|NCT01587898|583066755|FG003|Overall Study|Adverse Event|0|||
161456558|NCT01587898|583066752|FG000|Overall Study|Protocol Violation|0|||
161456559|NCT01587898|583066753|FG001|Overall Study|Protocol Violation|2|||
161456560|NCT01587898|583066754|FG002|Overall Study|Protocol Violation|1|||
161456561|NCT01587898|583066755|FG003|Overall Study|Protocol Violation|1|||
161456562|NCT01587898|583066752|FG000|Overall Study|Lost to Follow-up|0|||
161456563|NCT01587898|583066753|FG001|Overall Study|Lost to Follow-up|0|||
161456564|NCT01587898|583066754|FG002|Overall Study|Lost to Follow-up|0|||
161456565|NCT01587898|583066755|FG003|Overall Study|Lost to Follow-up|1|||
161456566|NCT01587898|583066752|FG000|Overall Study|Withdrawal by Subject|2|||
161456567|NCT01587898|583066753|FG001|Overall Study|Withdrawal by Subject|1|||
161456568|NCT01587898|583066754|FG002|Overall Study|Withdrawal by Subject|0|||
161456569|NCT01587898|583066755|FG003|Overall Study|Withdrawal by Subject|0|||
161456570|NCT01587898|583066752|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
161456571|NCT01587898|583066753|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
161456572|NCT01587898|583066754|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
161456573|NCT01587898|583066755|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
161456574|NCT02720094|583066756|FG000|Overall Study|Ongoing|2210|||
161456575|NCT02720094|583066757|FG001|Overall Study|Ongoing|2203|||
161456576|NCT02720094|583066756|FG000|Overall Study|Scheduled exit visit/end of study|2|||
161456577|NCT02720094|583066757|FG001|Overall Study|Scheduled exit visit/end of study|1|||
161456578|NCT02720094|583066756|FG000|Overall Study|Death|4|||
161456579|NCT02720094|583066757|FG001|Overall Study|Death|7|||
161456580|NCT02720094|583066756|FG000|Overall Study|Withdrawal by Subject|55|||
161456581|NCT02720094|583066757|FG001|Overall Study|Withdrawal by Subject|56|||
161456582|NCT02720094|583066756|FG000|Overall Study|Lost to Follow-up|2|||
161456583|NCT02720094|583066757|FG001|Overall Study|Lost to Follow-up|7|||
161456584|NCT02720094|583066756|FG000|Overall Study|Physician Decision|1|||
161456585|NCT02720094|583066757|FG001|Overall Study|Physician Decision|3|||
161456586|NCT02720094|583066756|FG000|Overall Study|Inappropriate enrollment|1|||
161456587|NCT02720094|583066757|FG001|Overall Study|Inappropriate enrollment|3|||
161456588|NCT02720094|583066756|FG000|Overall Study|Relocation|1|||
161456589|NCT02720094|583066757|FG001|Overall Study|Relocation|1|||
161456590|NCT02437110|583066760|FG000|Screening|Lost to Follow-up|3|||
161456591|NCT02437110|583066760|FG000|Screening|Physician Decision|1|||
161456592|NCT02437110|583066760|FG000|ART|Adverse Event|3|||
161456593|NCT02437110|583066760|FG000|ART|Protocol Violation|3|||
161456594|NCT02437110|583066760|FG000|ART|Withdrawal by Subject|4|||
161456595|NCT02437110|583066760|FG000|ART|Lost to follow-up prior to start of intervention|1|||
161912189|NCT05965752|584728734|FG001|Overall Study|Unable to Return for Study Visits|1|||
161567463|NCT00544440|583465951|FG000|Overall Study|Other|1|||
161567464|NCT00544440|583465951|FG000|Overall Study|Adverse Event|1|||
161567465|NCT00544440|583465951|FG000|Overall Study|Withdrawal by Subject|2|||
161567466|NCT00544440|583465951|FG000|Overall Study|Subject Non-compliance|1|||
161567467|NCT00544440|583465951|FG000|Overall Study|Progressive Disease|47|||
161567468|NCT00544440|583465951|FG000|Overall Study|Other|5|||
161567469|NCT03601507|583465952|FG000|Overall Study|Adverse Event|1|||
161808885|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808886|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808887|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808888|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808889|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808890|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808891|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808892|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808893|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808894|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808895|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808896|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
161808897|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
161808898|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
161808899|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808900|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808901|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808902|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808903|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808904|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808905|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808906|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808907|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808908|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808909|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808910|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808911|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808912|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808913|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808914|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808915|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808916|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808917|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808918|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808919|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808920|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808921|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808922|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
161808923|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
161808924|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808925|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808926|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808927|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808928|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808929|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808930|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808931|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808932|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808933|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808934|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808935|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808936|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808937|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808938|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808939|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161567470|NCT02107014|583465955|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
161567471|NCT00591838|583465956|FG000|Overall Study|Withdrawal by Subject|0|||
161912190|NCT05965752|584728735|FG002|Overall Study|Unable to Return for Study Visits|0|||
161912191|NCT05965752|584728736|FG003|Overall Study|Unable to Return for Study Visits|3|||
161912192|NCT05965752|584728737|FG004|Overall Study|Unable to Return for Study Visits|1|||
161912193|NCT05965752|584728733|FG000|Overall Study|Early Termination|0|||
161567472|NCT00591838|583465957|FG001|Overall Study|Withdrawal by Subject|0|||
161567473|NCT00591838|583465958|FG002|Overall Study|Withdrawal by Subject|0|||
161567474|NCT00591838|583465959|FG003|Overall Study|Withdrawal by Subject|1|||
161567475|NCT00591838|583465960|FG004|Overall Study|Withdrawal by Subject|0|||
161567476|NCT00586339|583465961|FG000|Overall Study|Withdrawal by Subject|1|||
161567477|NCT00586339|583465962|FG001|Overall Study|Withdrawal by Subject|3|||
161567478|NCT00586339|583465963|FG002|Overall Study|Withdrawal by Subject|1|||
161567479|NCT00586339|583465961|FG000|Overall Study|Migrated/moved from study area|3|||
161567480|NCT00586339|583465962|FG001|Overall Study|Migrated/moved from study area|2|||
161567481|NCT00586339|583465963|FG002|Overall Study|Migrated/moved from study area|4|||
161567482|NCT00586339|583465961|FG000|Overall Study|Lost to Follow-up|3|||
161567483|NCT00586339|583465962|FG001|Overall Study|Lost to Follow-up|2|||
161567484|NCT00586339|583465963|FG002|Overall Study|Lost to Follow-up|1|||
161567485|NCT00559949|583465964|FG000|Overall Study|Progressive Disease during cycle 1|1|||
161567486|NCT00559949|583465964|FG000|Overall Study|Adverse Event|1|||
161567487|NCT00559949|583465964|FG000|Overall Study|Withdrawal by Subject|4|||
161567488|NCT00559949|583465964|FG000|Overall Study|No disease evaluation per protocol|1|||
161567489|NCT02512042|583465965|FG000|Overall Study|Adverse Event|0|||
161567490|NCT02512042|583465966|FG001|Overall Study|Adverse Event|4|||
161567491|NCT02512042|583465965|FG000|Overall Study|Withdrawal by Subject|6|||
161567492|NCT02512042|583465966|FG001|Overall Study|Withdrawal by Subject|6|||
161567493|NCT02512042|583465965|FG000|Overall Study|Non-compliance with study drug|1|||
161567494|NCT02512042|583465966|FG001|Overall Study|Non-compliance with study drug|2|||
161567495|NCT02512042|583465965|FG000|Overall Study|Lost to Follow-up|5|||
161567496|NCT02512042|583465966|FG001|Overall Study|Lost to Follow-up|2|||
161567497|NCT02512042|583465965|FG000|Overall Study|Other|11|||
161567498|NCT02512042|583465966|FG001|Overall Study|Other|11|||
161567499|NCT01467700|583465968|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
161567500|NCT01467700|583465969|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161567501|NCT01467700|583465970|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
161567502|NCT01467700|583465971|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
161567503|NCT01467700|583465968|FG000|Overall Study|Major Protocol Deviation|3|||
161567504|NCT01467700|583465969|FG001|Overall Study|Major Protocol Deviation|3|||
161567505|NCT01467700|583465970|FG002|Overall Study|Major Protocol Deviation|2|||
161567506|NCT01467700|583465971|FG003|Overall Study|Major Protocol Deviation|3|||
161567507|NCT01467700|583465968|FG000|Overall Study|Lost to Follow-up|6|||
161567508|NCT01467700|583465969|FG001|Overall Study|Lost to Follow-up|5|||
161567509|NCT01467700|583465970|FG002|Overall Study|Lost to Follow-up|2|||
161567510|NCT01467700|583465971|FG003|Overall Study|Lost to Follow-up|3|||
161567511|NCT01467700|583465968|FG000|Overall Study|Voluntary Withdrawal|5|||
161567512|NCT01467700|583465969|FG001|Overall Study|Voluntary Withdrawal|7|||
161567513|NCT01467700|583465970|FG002|Overall Study|Voluntary Withdrawal|6|||
161567514|NCT01467700|583465971|FG003|Overall Study|Voluntary Withdrawal|2|||
161567515|NCT01467700|583465968|FG000|Overall Study|Study Termination|6|||
161567516|NCT01467700|583465969|FG001|Overall Study|Study Termination|5|||
161567517|NCT01467700|583465970|FG002|Overall Study|Study Termination|10|||
161567518|NCT01467700|583465971|FG003|Overall Study|Study Termination|7|||
161567519|NCT01467700|583465968|FG000|Overall Study|Pregnancy|0|||
161567520|NCT01467700|583465969|FG001|Overall Study|Pregnancy|1|||
161567521|NCT01467700|583465970|FG002|Overall Study|Pregnancy|1|||
161567522|NCT01467700|583465971|FG003|Overall Study|Pregnancy|0|||
161567523|NCT01467700|583465968|FG000|Overall Study|Lack of Efficacy|2|||
161567524|NCT01467700|583465969|FG001|Overall Study|Lack of Efficacy|0|||
161567525|NCT01467700|583465970|FG002|Overall Study|Lack of Efficacy|2|||
161567526|NCT01467700|583465971|FG003|Overall Study|Lack of Efficacy|1|||
161567527|NCT01467700|583465968|FG000|Overall Study|Reason not Specified|1|||
161567528|NCT01467700|583465969|FG001|Overall Study|Reason not Specified|3|||
161567529|NCT01467700|583465970|FG002|Overall Study|Reason not Specified|2|||
161567530|NCT01467700|583465971|FG003|Overall Study|Reason not Specified|8|||
161567531|NCT00121199|583465972|FG000|Overall Study|Adverse Event|11|||
161567532|NCT00121199|583465972|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161567533|NCT00121199|583465972|FG000|Overall Study|Progression/Relapse|1|||
161567534|NCT00121199|583465972|FG000|Overall Study|Death|3|||
161567535|NCT00121199|583465972|FG000|Overall Study|Other - Not Protocol Specified|3|||
161567536|NCT00121199|583465972|FG000|Overall Study|Ineligible|9|||
161912194|NCT05965752|584728734|FG001|Overall Study|Early Termination|0|||
161912195|NCT05965752|584728735|FG002|Overall Study|Early Termination|1|||
161912196|NCT05965752|584728736|FG003|Overall Study|Early Termination|0|||
161567537|NCT03168438|583465973|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
161567538|NCT03168438|583465974|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
161567539|NCT04109118|583465977|FG000|Overall Study|Lost to Follow-up|3|||
161567540|NCT03235349|583465980|FG000|Overall Study|Adverse Event|1|||
161567541|NCT03235349|583465980|FG000|Overall Study|Other|1|||
161567542|NCT03394027|583465981|FG000|Overall Study|Ineligible|3|||
161567543|NCT03394027|583465982|FG001|Overall Study|Ineligible|1|||
161567544|NCT03394027|583465983|FG002|Overall Study|Ineligible|3|||
161567545|NCT03394027|583465981|FG000|Overall Study|Participant declined to participate before treatment started|0|||
161567546|NCT03394027|583465982|FG001|Overall Study|Participant declined to participate before treatment started|0|||
161567547|NCT03394027|583465983|FG002|Overall Study|Participant declined to participate before treatment started|1|||
161567548|NCT02824432|583465988|FG000|Overall Study|Major Protocol Deviation|1|||
161567549|NCT02824432|583465989|FG001|Overall Study|Major Protocol Deviation|0|||
161567550|NCT01348087|583465990|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
161567551|NCT01348087|583465990|FG000|Overall Study|Administrative problems|79|||
161567552|NCT01348087|583465990|FG000|Overall Study|protocol deviation|1|||
161912197|NCT05965752|584728737|FG004|Overall Study|Early Termination|0|||
161912198|NCT05965752|584728733|FG000|Overall Study|Reported Unwanted Symptoms|0|||
161912199|NCT05965752|584728734|FG001|Overall Study|Reported Unwanted Symptoms|0|||
161912200|NCT05965752|584728735|FG002|Overall Study|Reported Unwanted Symptoms|0|||
161567553|NCT01348087|583465990|FG000|Overall Study|Lost to Follow-up|1|||
161567554|NCT01348087|583465990|FG000|Overall Study|Subject withdrew consent|7|||
161567555|NCT01348087|583465990|FG000|Overall Study|Adverse Event|25|||
161567556|NCT05663866|583465993|FG000|Overall Study|Adverse Event|0|||
161567557|NCT05663866|583465994|FG001|Overall Study|Adverse Event|0|||
161567558|NCT05663866|583465995|FG002|Overall Study|Adverse Event|1|||
161567559|NCT05663866|583465996|FG003|Overall Study|Adverse Event|0|||
161567560|NCT05663866|583465993|FG000|Overall Study|Physician Decision|0|||
161567561|NCT05663866|583465994|FG001|Overall Study|Physician Decision|0|||
161567562|NCT05663866|583465995|FG002|Overall Study|Physician Decision|0|||
161567563|NCT05663866|583465996|FG003|Overall Study|Physician Decision|1|||
161567564|NCT05663866|583465993|FG000|Overall Study|Withdrawal by Subject|0|||
161567565|NCT05663866|583465994|FG001|Overall Study|Withdrawal by Subject|2|||
161567566|NCT05663866|583465995|FG002|Overall Study|Withdrawal by Subject|1|||
161567567|NCT05663866|583465996|FG003|Overall Study|Withdrawal by Subject|2|||
161567568|NCT05663866|583465993|FG000|Overall Study|Progressive disease|4|||
161567569|NCT05663866|583465994|FG001|Overall Study|Progressive disease|8|||
161567570|NCT05663866|583465995|FG002|Overall Study|Progressive disease|5|||
161567571|NCT05663866|583465996|FG003|Overall Study|Progressive disease|2|||
161567572|NCT05663866|583465993|FG000|Overall Study|Other|1|||
161567573|NCT05663866|583465994|FG001|Overall Study|Other|0|||
161567574|NCT05663866|583465995|FG002|Overall Study|Other|0|||
161567575|NCT05663866|583465996|FG003|Overall Study|Other|0|||
161567576|NCT05663866|583465993|FG000|Overall Study|Ongoing|1|||
161567577|NCT05663866|583465994|FG001|Overall Study|Ongoing|27|||
161567578|NCT05663866|583465995|FG002|Overall Study|Ongoing|6|||
161567579|NCT05663866|583465996|FG003|Overall Study|Ongoing|1|||
161567580|NCT05803720|583465997|FG000|Overall Study|Lost to Follow-up|3|||
161567581|NCT05803720|583465998|FG001|Overall Study|Lost to Follow-up|4|||
161567582|NCT05803720|583465997|FG000|Overall Study|Family leave/emergency|1|||
161567583|NCT05803720|583465998|FG001|Overall Study|Family leave/emergency|1|||
161567584|NCT06688370|583465999|FG000|Overall Study|Discontinued the treatment|1|||
161567585|NCT06688370|583465999|FG000|Overall Study|Prohibited treatment taken|4|||
161567586|NCT04018066|583467567|FG000|Overall Study|participants started taking medications during the study period|3|||
161567587|NCT04018066|583467567|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
161567588|NCT03568318|583467568|FG000|Overall Study|Adverse Event|3|||
161567589|NCT03568318|583467569|FG001|Overall Study|Adverse Event|1|||
161567590|NCT03568318|583467570|FG002|Overall Study|Adverse Event|1|||
161567591|NCT03568318|583467571|FG003|Overall Study|Adverse Event|0|||
161567592|NCT03568318|583467572|FG004|Overall Study|Adverse Event|1|||
161567593|NCT03568318|583467573|FG005|Overall Study|Adverse Event|0|||
161567594|NCT03568318|583467568|FG000|Overall Study|Withdrawal by Subject|6|||
161567595|NCT03568318|583467569|FG001|Overall Study|Withdrawal by Subject|5|||
161567596|NCT03568318|583467570|FG002|Overall Study|Withdrawal by Subject|2|||
161567597|NCT03568318|583467571|FG003|Overall Study|Withdrawal by Subject|1|||
161567598|NCT03568318|583467572|FG004|Overall Study|Withdrawal by Subject|0|||
161912201|NCT05965752|584728736|FG003|Overall Study|Reported Unwanted Symptoms|0|||
161567599|NCT03568318|583467573|FG005|Overall Study|Withdrawal by Subject|0|||
161567600|NCT03568318|583467568|FG000|Overall Study|Lost to Follow-up|3|||
161567601|NCT03568318|583467569|FG001|Overall Study|Lost to Follow-up|2|||
161567602|NCT03568318|583467570|FG002|Overall Study|Lost to Follow-up|2|||
161567603|NCT03568318|583467571|FG003|Overall Study|Lost to Follow-up|2|||
161567604|NCT03568318|583467572|FG004|Overall Study|Lost to Follow-up|1|||
161567605|NCT03568318|583467573|FG005|Overall Study|Lost to Follow-up|0|||
161567606|NCT03568318|583467568|FG000|Overall Study|Other|3|||
161567607|NCT03568318|583467569|FG001|Overall Study|Other|1|||
161567608|NCT03568318|583467570|FG002|Overall Study|Other|3|||
161567609|NCT03568318|583467571|FG003|Overall Study|Other|0|||
161567610|NCT03568318|583467572|FG004|Overall Study|Other|0|||
161567611|NCT03568318|583467573|FG005|Overall Study|Other|0|||
161567612|NCT03568318|583467568|FG000|Overall Study|Ongoing at Time of Analysis|5|||
161912202|NCT05965752|584728737|FG004|Overall Study|Reported Unwanted Symptoms|1|||
161912203|NCT05965752|584728733|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912204|NCT05965752|584728734|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912205|NCT05965752|584728735|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912206|NCT05965752|584728736|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912207|NCT05965752|584728737|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
161912208|NCT02074514|584728739|FG000|Overall Study|Lack of Efficacy|3|||
161912209|NCT02074514|584728740|FG001|Overall Study|Lack of Efficacy|2|||
161912210|NCT02074514|584728739|FG000|Overall Study|Lost to Follow-up|0|||
161912211|NCT02074514|584728740|FG001|Overall Study|Lost to Follow-up|1|||
161912212|NCT02074514|584728739|FG000|Overall Study|Withdrew Consent|0|||
161912213|NCT02074514|584728740|FG001|Overall Study|Withdrew Consent|1|||
161912214|NCT00666237|584728743|FG000|Overall Study|Death|5|||
161912215|NCT00666237|584728744|FG001|Overall Study|Death|5|||
161912216|NCT00666237|584728743|FG000|Overall Study|Lost to Follow-up|29|||
161912217|NCT00666237|584728744|FG001|Overall Study|Lost to Follow-up|25|||
161912218|NCT02839707|584728746|FG000|Phase I|Not eligible for analysis|9|||
161912219|NCT02839707|584728747|FG001|Phase I|Not eligible for analysis|0|||
161912220|NCT02839707|584728748|FG002|Phase I|Not eligible for analysis|0|||
161912221|NCT02839707|584728746|FG000|Phase II|Not treated according to protocol|4|||
161912222|NCT02839707|584728747|FG001|Phase II|Not treated according to protocol|0|||
161912223|NCT02839707|584728748|FG002|Phase II|Not treated according to protocol|2|||
161912224|NCT02839707|584728746|FG000|Phase III|Not treated according to protocol|0|||
161912225|NCT02839707|584728747|FG001|Phase III|Not treated according to protocol|0|||
161912226|NCT02839707|584728748|FG002|Phase III|Not treated according to protocol|4|||
161912227|NCT00109343|584730049|FG000|Overall Study|Adverse Event|1|||
161912228|NCT00109343|584730050|FG001|Overall Study|Adverse Event|0|||
161912229|NCT00109343|584730051|FG002|Overall Study|Adverse Event|2|||
161912230|NCT00109343|584730049|FG000|Overall Study|Lack of Efficacy|1|||
161912231|NCT00109343|584730050|FG001|Overall Study|Lack of Efficacy|0|||
161912232|NCT00109343|584730051|FG002|Overall Study|Lack of Efficacy|0|||
161912233|NCT00109343|584730049|FG000|Overall Study|Lost to Follow-up|35|||
161912234|NCT00109343|584730050|FG001|Overall Study|Lost to Follow-up|20|||
161912235|NCT00109343|584730051|FG002|Overall Study|Lost to Follow-up|14|||
161912236|NCT00109343|584730049|FG000|Overall Study|Protocol Violation|1|||
161912237|NCT00109343|584730050|FG001|Overall Study|Protocol Violation|2|||
161912238|NCT00109343|584730051|FG002|Overall Study|Protocol Violation|2|||
161912239|NCT00109343|584730049|FG000|Overall Study|Withdrawal by Subject|15|||
161567613|NCT03568318|583467569|FG001|Overall Study|Ongoing at Time of Analysis|3|||
161567614|NCT03568318|583467570|FG002|Overall Study|Ongoing at Time of Analysis|2|||
161567615|NCT03568318|583467571|FG003|Overall Study|Ongoing at Time of Analysis|1|||
161567616|NCT03568318|583467572|FG004|Overall Study|Ongoing at Time of Analysis|0|||
161567617|NCT03568318|583467573|FG005|Overall Study|Ongoing at Time of Analysis|0|||
161567618|NCT01249092|583467575|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
161567619|NCT01249092|583467575|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
161567620|NCT03518112|583467576|FG000|Overall Study|Withdrawal by Subject|1|||
161567621|NCT05197049|583467582|FG000|Overall Study|Death|0|||
161567622|NCT05197049|583467583|FG001|Overall Study|Death|1|||
161567623|NCT05197049|583467584|FG002|Overall Study|Death|0|||
161567624|NCT05197049|583467582|FG000|Overall Study|Lost to Follow-up|3|||
161567625|NCT05197049|583467583|FG001|Overall Study|Lost to Follow-up|1|||
161567626|NCT05197049|583467584|FG002|Overall Study|Lost to Follow-up|0|||
161567627|NCT05197049|583467582|FG000|Overall Study|Withdrawal by Subject|15|||
161567628|NCT05197049|583467583|FG001|Overall Study|Withdrawal by Subject|3|||
161567629|NCT05197049|583467584|FG002|Overall Study|Withdrawal by Subject|1|||
161567630|NCT05197049|583467582|FG000|Overall Study|GCP non-compliance|1|||
161567631|NCT05197049|583467583|FG001|Overall Study|GCP non-compliance|2|||
161567632|NCT05197049|583467584|FG002|Overall Study|GCP non-compliance|0|||
161567633|NCT05650333|583467586|FG000|Treatment Period (7 Days)|Adverse Event|1|||
161567634|NCT01460342|583467587|FG000|Overall Study|Adverse Event|5|||
161567635|NCT01460342|583467588|FG001|Overall Study|Adverse Event|4|||
161912240|NCT00109343|584730050|FG001|Overall Study|Withdrawal by Subject|11|||
161912241|NCT00109343|584730051|FG002|Overall Study|Withdrawal by Subject|10|||
161912242|NCT00109343|584730049|FG000|Overall Study|Subject Moved|6|||
161912243|NCT00109343|584730050|FG001|Overall Study|Subject Moved|2|||
161912244|NCT00109343|584730051|FG002|Overall Study|Subject Moved|1|||
161912245|NCT00109343|584730049|FG000|Overall Study|Other|5|||
161567636|NCT01460342|583467587|FG000|Overall Study|Lost to Follow-up|1|||
161567637|NCT01460342|583467588|FG001|Overall Study|Lost to Follow-up|2|||
161912246|NCT00109343|584730050|FG001|Overall Study|Other|2|||
161912247|NCT00109343|584730051|FG002|Overall Study|Other|1|||
161912248|NCT01721798|584730054|FG000|Overall Study|Death|0|||
161912249|NCT01721798|584730055|FG001|Overall Study|Death|0|||
161912250|NCT01721798|584730056|FG002|Overall Study|Death|1|||
161567638|NCT01460342|583467587|FG000|Overall Study|Protocol Violation|0|||
161567639|NCT01460342|583467588|FG001|Overall Study|Protocol Violation|1|||
161567640|NCT01460342|583467587|FG000|Overall Study|Withdrawal by Subject|3|||
161567641|NCT01460342|583467588|FG001|Overall Study|Withdrawal by Subject|4|||
161912251|NCT01721798|584730057|FG003|Overall Study|Death|1|||
161912252|NCT01721798|584730054|FG000|Overall Study|Lost to Follow-up|2|||
161456596|NCT02437110|583066760|FG000|ART|Physician decision prior to start of intervention|2|||
161456597|NCT02437110|583066760|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
161456598|NCT02437110|583066760|FG000|Post-ART|Lost to Follow-up|3|||
161456599|NCT02437110|583066760|FG000|Post-ART|Protocol Violation|4|||
161456600|NCT02437110|583066760|FG000|Post-ART|Withdrawal by Subject|3|||
161456601|NCT03735238|583066761|FG000|Overall Study|Did not want to participate in research|3|||
161456602|NCT03735238|583066761|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
161456603|NCT01261780|583066762|FG000|Overall Study|Withdrawal by Subject|1|||
161456604|NCT01261780|583066763|FG001|Overall Study|Withdrawal by Subject|0|||
161456605|NCT01261780|583066762|FG000|Overall Study|Event not related to subject|1|||
161456606|NCT01261780|583066763|FG001|Overall Study|Event not related to subject|2|||
161456607|NCT01239732|583066764|FG000|Overall Study|Termination of study per protocol|667|||
161456608|NCT01239732|583066764|FG000|Overall Study|Death|226|||
161456609|NCT01239732|583066764|FG000|Overall Study|Withdrawal by Subject|87|||
161456610|NCT01239732|583066764|FG000|Overall Study|Adverse Event|6|||
161456611|NCT01239732|583066764|FG000|Overall Study|Protocol Violation|3|||
161456612|NCT01239732|583066764|FG000|Overall Study|Participant non compliance|5|||
161456613|NCT01239732|583066764|FG000|Overall Study|Study termination by sponsor|2|||
161456614|NCT01239732|583066764|FG000|Overall Study|Investigator's decision|4|||
161456615|NCT01239732|583066764|FG000|Overall Study|Treatment failure|2|||
161456616|NCT01239732|583066764|FG000|Overall Study|Other|19|||
161456617|NCT02395302|583066765|FG000|Overall Study|Screen Failure|3|||
161456618|NCT02395302|583066765|FG000|Overall Study|Run In Failure|7|||
161456619|NCT02395302|583066765|FG000|Overall Study|Withdrawal by Subject|2|||
161456620|NCT02395302|583066765|FG000|Overall Study|Physician Decision|2|||
161456621|NCT01870076|583066771|FG000|Overall Study|Withdrawal by Subject|1|||
161456622|NCT01870076|583066772|FG001|Overall Study|Withdrawal by Subject|0|||
161456623|NCT01870076|583066773|FG002|Overall Study|Withdrawal by Subject|1|||
161456624|NCT01870076|583066774|FG003|Overall Study|Withdrawal by Subject|0|||
161456625|NCT03041129|583066775|FG000|Overall Study|Withdrawal by Subject|2|||
161456626|NCT03041129|583066776|FG001|Overall Study|Withdrawal by Subject|0|||
161456627|NCT03041129|583066777|FG002|Overall Study|Withdrawal by Subject|0|||
161456628|NCT03041129|583066778|FG003|Overall Study|Withdrawal by Subject|0|||
161456629|NCT00436501|583066781|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
161456630|NCT00436501|583066782|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
161456631|NCT00436501|583066781|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
161456632|NCT00436501|583066782|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
161456633|NCT00169442|583066794|FG000|Overall Study|Withdrawal by Subject|0|||
161456634|NCT00169442|583066795|FG001|Overall Study|Withdrawal by Subject|0|||
161456635|NCT00169442|583066796|FG002|Overall Study|Withdrawal by Subject|1|||
161456636|NCT00169442|583066797|FG003|Overall Study|Withdrawal by Subject|0|||
161456637|NCT00169442|583066798|FG004|Overall Study|Withdrawal by Subject|0|||
161456638|NCT00169442|583066799|FG005|Overall Study|Withdrawal by Subject|0|||
161456639|NCT00169442|583066794|FG000|Overall Study|Migrated/moved from study area|0|||
161456640|NCT00169442|583066795|FG001|Overall Study|Migrated/moved from study area|0|||
161456641|NCT00169442|583066796|FG002|Overall Study|Migrated/moved from study area|0|||
161456642|NCT00169442|583066797|FG003|Overall Study|Migrated/moved from study area|0|||
161456643|NCT00169442|583066798|FG004|Overall Study|Migrated/moved from study area|0|||
161456644|NCT00169442|583066799|FG005|Overall Study|Migrated/moved from study area|2|||
161456645|NCT00169442|583066794|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161456646|NCT00169442|583066795|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161456647|NCT00169442|583066796|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161456648|NCT00169442|583066797|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161456649|NCT00169442|583066798|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
161456650|NCT00169442|583066799|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161456651|NCT00169442|583066794|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
161456652|NCT00169442|583066795|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
161456653|NCT00169442|583066796|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
161456654|NCT00169442|583066797|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
161456655|NCT00169442|583066798|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
161456656|NCT00169442|583066799|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
161456657|NCT01159431|583066804|FG000|Overall Study|Adverse Event|1|||
161456658|NCT01159431|583066805|FG001|Overall Study|Adverse Event|2|||
161456659|NCT01159431|583066804|FG000|Overall Study|non-compliance|1|||
161456660|NCT01159431|583066805|FG001|Overall Study|non-compliance|1|||
161456661|NCT01159431|583066804|FG000|Overall Study|Lack of Efficacy|0|||
161456662|NCT01159431|583066805|FG001|Overall Study|Lack of Efficacy|3|||
161456663|NCT03353740|583066808|FG000|Overall Study|Images for these participants not viable|52|||
161456664|NCT02232880|583066810|FG000|Overall Study|study stopped prior to randomization|1|||
161456665|NCT03976648|583066813|FG000|Overall Study|Adverse Event|0|||
161456666|NCT03976648|583066814|FG001|Overall Study|Adverse Event|2|||
161456667|NCT03976648|583066813|FG000|Overall Study|Study terminated by sponsor|21|||
161567642|NCT01460342|583467587|FG000|Overall Study|Physician Decision|1|||
161567643|NCT01460342|583467588|FG001|Overall Study|Physician Decision|3|||
161567644|NCT01460342|583467587|FG000|Overall Study|Lack of Efficacy|1|||
161567645|NCT01460342|583467588|FG001|Overall Study|Lack of Efficacy|0|||
161567646|NCT03761784|583467589|FG000|Overall Study|Adverse Event|4|||
161567647|NCT03761784|583467590|FG001|Overall Study|Adverse Event|0|||
161567648|NCT03761784|583467589|FG000|Overall Study|Lost to Follow-up|10|||
161567649|NCT03761784|583467590|FG001|Overall Study|Lost to Follow-up|7|||
161567650|NCT03761784|583467589|FG000|Overall Study|Pregnancy|1|||
161567651|NCT03761784|583467590|FG001|Overall Study|Pregnancy|0|||
161567652|NCT03761784|583467589|FG000|Overall Study|Protocol Violation|2|||
161567653|NCT03761784|583467590|FG001|Overall Study|Protocol Violation|0|||
161567654|NCT03761784|583467589|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
161567655|NCT03761784|583467590|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
161567656|NCT03761784|583467589|FG000|Overall Study|Withdrawal by Subject|9|||
161567657|NCT03761784|583467590|FG001|Overall Study|Withdrawal by Subject|4|||
161567658|NCT03761784|583467589|FG000|Overall Study|Physician Decision|1|||
161567659|NCT03761784|583467590|FG001|Overall Study|Physician Decision|0|||
161567660|NCT03761784|583467589|FG000|Overall Study|Other Than Specified|1|||
161567661|NCT03761784|583467590|FG001|Overall Study|Other Than Specified|0|||
161567662|NCT01549652|583467591|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
161567663|NCT01549652|583467592|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
161567664|NCT01549652|583467593|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
161567665|NCT01549652|583467594|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
161567666|NCT01549652|583467591|FG000|Overall Study|Study Drug Titration Failure|5|||
161567667|NCT01549652|583467592|FG001|Overall Study|Study Drug Titration Failure|6|||
161567668|NCT01549652|583467593|FG002|Overall Study|Study Drug Titration Failure|0|||
161567669|NCT01549652|583467594|FG003|Overall Study|Study Drug Titration Failure|0|||
161567670|NCT01549652|583467591|FG000|Overall Study|Withdrawal Effect|0|||
161567671|NCT01549652|583467592|FG001|Overall Study|Withdrawal Effect|2|||
161567672|NCT01549652|583467593|FG002|Overall Study|Withdrawal Effect|0|||
161567673|NCT01549652|583467594|FG003|Overall Study|Withdrawal Effect|0|||
161567674|NCT01549652|583467591|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
161567675|NCT01549652|583467592|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
161567676|NCT01549652|583467593|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
161567677|NCT01549652|583467594|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
161567678|NCT01549652|583467591|FG000|Overall Study|Problem with Infusion|1|||
161567679|NCT01549652|583467592|FG001|Overall Study|Problem with Infusion|0|||
161567680|NCT01549652|583467593|FG002|Overall Study|Problem with Infusion|0|||
161567681|NCT01549652|583467594|FG003|Overall Study|Problem with Infusion|0|||
161567682|NCT01549652|583467591|FG000|Overall Study|Titration Non-Compliance|1|||
161567683|NCT01549652|583467592|FG001|Overall Study|Titration Non-Compliance|3|||
161567684|NCT01549652|583467593|FG002|Overall Study|Titration Non-Compliance|4|||
161567685|NCT01549652|583467594|FG003|Overall Study|Titration Non-Compliance|5|||
161567686|NCT01549652|583467591|FG000|Overall Study|Titration Side Effects|0|||
161567687|NCT01549652|583467592|FG001|Overall Study|Titration Side Effects|0|||
161567688|NCT01549652|583467593|FG002|Overall Study|Titration Side Effects|6|||
161567689|NCT01549652|583467594|FG003|Overall Study|Titration Side Effects|3|||
161567690|NCT01549652|583467591|FG000|Overall Study|Withdrawal by Subject|0|||
161567691|NCT01549652|583467592|FG001|Overall Study|Withdrawal by Subject|0|||
161567692|NCT01549652|583467593|FG002|Overall Study|Withdrawal by Subject|5|||
161567693|NCT01549652|583467594|FG003|Overall Study|Withdrawal by Subject|3|||
161567694|NCT01194258|583467597|FG000|Titration Period|Withdrawal by Subject|6|||
161567695|NCT01194258|583467598|FG001|Titration Period|Withdrawal by Subject|0|||
161567696|NCT01194258|583467599|FG002|Titration Period|Withdrawal by Subject|0|||
161567697|NCT01194258|583467600|FG003|Titration Period|Withdrawal by Subject|0|||
161567698|NCT01194258|583467601|FG004|Titration Period|Withdrawal by Subject|0|||
161567699|NCT01194258|583467597|FG000|Titration Period|Lost to Follow-up|2|||
161567700|NCT01194258|583467598|FG001|Titration Period|Lost to Follow-up|0|||
161567701|NCT01194258|583467599|FG002|Titration Period|Lost to Follow-up|0|||
161567702|NCT01194258|583467600|FG003|Titration Period|Lost to Follow-up|0|||
161567703|NCT01194258|583467601|FG004|Titration Period|Lost to Follow-up|0|||
161567704|NCT01194258|583467597|FG000|Titration Period|Titration failure|3|||
161567705|NCT01194258|583467598|FG001|Titration Period|Titration failure|0|||
161567706|NCT01194258|583467599|FG002|Titration Period|Titration failure|0|||
161567707|NCT01194258|583467600|FG003|Titration Period|Titration failure|0|||
161567708|NCT01194258|583467601|FG004|Titration Period|Titration failure|0|||
161567709|NCT01194258|583467597|FG000|Period 1 (12 Weeks)|Death|0|||
161567710|NCT01194258|583467598|FG001|Period 1 (12 Weeks)|Death|0|||
161567711|NCT01194258|583467599|FG002|Period 1 (12 Weeks)|Death|0|||
161567712|NCT01194258|583467600|FG003|Period 1 (12 Weeks)|Death|0|||
161567713|NCT01194258|583467601|FG004|Period 1 (12 Weeks)|Death|1|||
161567714|NCT01194258|583467597|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161567715|NCT01194258|583467598|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161567716|NCT01194258|583467599|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161567717|NCT01194258|583467600|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161456668|NCT03976648|583066814|FG001|Overall Study|Study terminated by sponsor|8|||
161456669|NCT03645434|583066815|FG000|Period 1|Adverse Event|0|||
161456670|NCT03645434|583066816|FG001|Period 1|Adverse Event|0|||
161456671|NCT03645434|583066817|FG002|Period 1|Adverse Event|0|||
161456672|NCT03645434|583066818|FG003|Period 1|Adverse Event|1|||
161456673|NCT03645434|583066819|FG004|Period 1|Adverse Event|0|||
161456674|NCT03645434|583066820|FG005|Period 1|Adverse Event|0|||
161456675|NCT03645434|583066815|FG000|Period 1|COPD exacerbation|0|||
161456676|NCT03645434|583066816|FG001|Period 1|COPD exacerbation|0|||
161456677|NCT03645434|583066817|FG002|Period 1|COPD exacerbation|0|||
161456678|NCT03645434|583066818|FG003|Period 1|COPD exacerbation|0|||
161456679|NCT03645434|583066819|FG004|Period 1|COPD exacerbation|1|||
161456680|NCT03645434|583066820|FG005|Period 1|COPD exacerbation|0|||
161456681|NCT00881868|583066821|FG000|Overall Study|Adverse Event|0|||
161456682|NCT00881868|583066822|FG001|Overall Study|Adverse Event|1|||
161456683|NCT00881868|583066821|FG000|Overall Study|Lost to Follow-up|2|||
161456684|NCT00881868|583066822|FG001|Overall Study|Lost to Follow-up|1|||
161456685|NCT00881868|583066821|FG000|Overall Study|Physician Decision|4|||
161456686|NCT00881868|583066822|FG001|Overall Study|Physician Decision|0|||
161456687|NCT00881868|583066821|FG000|Overall Study|Protocol Violation|2|||
161456688|NCT00881868|583066822|FG001|Overall Study|Protocol Violation|0|||
161456689|NCT02880956|583066825|FG000|Overall Study|Adverse Event|3|||
161456690|NCT02880956|583066826|FG001|Overall Study|Adverse Event|6|||
161456691|NCT02880956|583066827|FG002|Overall Study|Adverse Event|5|||
161456692|NCT02880956|583066828|FG003|Overall Study|Adverse Event|4|||
161456693|NCT02880956|583066825|FG000|Overall Study|Withdrawal by Subject|9|||
161456694|NCT02880956|583066826|FG001|Overall Study|Withdrawal by Subject|4|||
161456695|NCT02880956|583066827|FG002|Overall Study|Withdrawal by Subject|6|||
161456696|NCT02880956|583066828|FG003|Overall Study|Withdrawal by Subject|11|||
161456697|NCT02880956|583066825|FG000|Overall Study|Lost to Follow-up|0|||
161456698|NCT02880956|583066826|FG001|Overall Study|Lost to Follow-up|1|||
161456699|NCT02880956|583066827|FG002|Overall Study|Lost to Follow-up|0|||
161456700|NCT02880956|583066828|FG003|Overall Study|Lost to Follow-up|0|||
161456701|NCT02880956|583066825|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161456702|NCT02880956|583066826|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
161456703|NCT02880956|583066827|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
161456704|NCT02880956|583066828|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
161456705|NCT02880956|583066825|FG000|Overall Study|Other, Not Specified|4|||
161456706|NCT02880956|583066826|FG001|Overall Study|Other, Not Specified|2|||
161456707|NCT02880956|583066827|FG002|Overall Study|Other, Not Specified|0|||
161456708|NCT02880956|583066828|FG003|Overall Study|Other, Not Specified|3|||
161456709|NCT02081859|583066829|FG000|Overall Study|No fertilization|2|||
161456710|NCT02081859|583066830|FG001|Overall Study|No fertilization|2|||
161456711|NCT02081859|583066829|FG000|Overall Study|No sperm|1|||
161456712|NCT02081859|583066830|FG001|Overall Study|No sperm|0|||
161456713|NCT02081859|583066829|FG000|Overall Study|Unanticipated freeze all cycle|2|||
161456714|NCT02081859|583066830|FG001|Overall Study|Unanticipated freeze all cycle|6|||
161456715|NCT02081859|583066829|FG000|Overall Study|< 4 embryos|27|||
161456716|NCT02081859|583066830|FG001|Overall Study|< 4 embryos|23|||
161456717|NCT02081859|583066829|FG000|Overall Study|Other reasons|2|||
161456718|NCT02081859|583066830|FG001|Overall Study|Other reasons|0|||
161456719|NCT00884377|583068795|FG000|Overall Study|Withdrawal by Subject|1|||
161456720|NCT00884377|583068796|FG001|Overall Study|Withdrawal by Subject|0|||
161456721|NCT00884377|583068795|FG000|Overall Study|Could not confirm diagnosis|1|||
161456722|NCT00884377|583068796|FG001|Overall Study|Could not confirm diagnosis|0|||
161456723|NCT00884377|583068795|FG000|Overall Study|Physician Decision|0|||
161456724|NCT00884377|583068796|FG001|Overall Study|Physician Decision|1|||
161456725|NCT00282464|583068799|FG000|Overall Study|Adverse Event|26|||
161456726|NCT00282464|583068800|FG001|Overall Study|Adverse Event|20|||
161456727|NCT00282464|583068799|FG000|Overall Study|Lack of Efficacy|8|||
161456728|NCT00282464|583068800|FG001|Overall Study|Lack of Efficacy|8|||
161456729|NCT00282464|583068799|FG000|Overall Study|Lost to Follow-up|10|||
161456730|NCT00282464|583068800|FG001|Overall Study|Lost to Follow-up|10|||
161456731|NCT00282464|583068799|FG000|Overall Study|Withdrawal by Subject|24|||
161456732|NCT00282464|583068800|FG001|Overall Study|Withdrawal by Subject|10|||
161456733|NCT00282464|583068799|FG000|Overall Study|laboratory abnormality|1|||
161456734|NCT00282464|583068800|FG001|Overall Study|laboratory abnormality|2|||
161456735|NCT00282464|583068799|FG000|Overall Study|Protocol Violation|0|||
161456736|NCT00282464|583068800|FG001|Overall Study|Protocol Violation|7|||
161456737|NCT00282464|583068799|FG000|Overall Study|Patient moved|1|||
161456738|NCT00282464|583068800|FG001|Overall Study|Patient moved|0|||
161456739|NCT00282464|583068799|FG000|Overall Study|patient non-compliant|3|||
161456740|NCT00282464|583068800|FG001|Overall Study|patient non-compliant|0|||
161456741|NCT00282464|583068799|FG000|Overall Study|patient no show|0|||
161456742|NCT00282464|583068800|FG001|Overall Study|patient no show|1|||
161456743|NCT00282464|583068799|FG000|Overall Study|patient incarcerated|0|||
161456744|NCT00282464|583068800|FG001|Overall Study|patient incarcerated|1|||
161456745|NCT00282464|583068799|FG000|Overall Study|family crisis|0|||
161456746|NCT00282464|583068800|FG001|Overall Study|family crisis|1|||
161456747|NCT00282464|583068799|FG000|Overall Study|dispensed wrong kit|0|||
161567718|NCT01194258|583467601|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
161567719|NCT01194258|583467597|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
161567720|NCT01194258|583467598|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
161567721|NCT01194258|583467599|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
161567722|NCT01194258|583467600|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
161567723|NCT01194258|583467601|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
161567724|NCT01194258|583467597|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161567725|NCT01194258|583467598|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161567726|NCT01194258|583467599|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161567727|NCT01194258|583467600|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161567728|NCT01194258|583467601|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161567729|NCT02873754|583467603|FG000|Overall Study|Lost to Follow-up|5|||
161567730|NCT02873754|583467603|FG000|Overall Study|Couldn't complete study procedures|1|||
161567731|NCT01981850|583467604|FG000|Main Phase Stage 1|Death|2|||
161567732|NCT01981850|583467605|FG001|Main Phase Stage 1|Death|0|||
161567733|NCT01981850|583467606|FG002|Main Phase Stage 1|Death|0|||
161567734|NCT01981850|583467607|FG003|Main Phase Stage 1|Death|0|||
161567735|NCT01981850|583467608|FG004|Main Phase Stage 1|Death|0|||
161567736|NCT01981850|583467609|FG005|Main Phase Stage 1|Death|0|||
161567737|NCT01981850|583467610|FG006|Main Phase Stage 1|Death|0|||
161567738|NCT01981850|583467611|FG007|Main Phase Stage 1|Death|0|||
161567739|NCT01981850|583467612|FG008|Main Phase Stage 1|Death|0|||
161567740|NCT01981850|583467613|FG009|Main Phase Stage 1|Death|0|||
161567741|NCT01981850|583467604|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
161567742|NCT01981850|583467605|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567743|NCT01981850|583467606|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161456748|NCT00282464|583068800|FG001|Overall Study|dispensed wrong kit|1|||
161456749|NCT00282464|583068799|FG000|Overall Study|dropped due to missed visits|0|||
161456750|NCT00282464|583068800|FG001|Overall Study|dropped due to missed visits|1|||
161456751|NCT00475423|583068801|FG000|Overall Study|Protocol Violation|5|||
161456752|NCT00475423|583068801|FG000|Overall Study|Adverse Event|4|||
161456753|NCT00475423|583068801|FG000|Overall Study|Withdrawal by Subject|6|||
161456754|NCT00475423|583068801|FG000|Overall Study|Lack of Efficacy|8|||
161456755|NCT00475423|583068801|FG000|Overall Study|Death|1|||
161456756|NCT00475423|583068801|FG000|Overall Study|Reason not specified|1|||
161456757|NCT00475423|583068801|FG000|Overall Study|Lost to Follow-up|7|||
161456758|NCT01214174|583068802|FG000|Overall Study|Withdrawal by Subject|0|||
161456759|NCT01214174|583068803|FG001|Overall Study|Withdrawal by Subject|0|||
161456760|NCT01214174|583068804|FG002|Overall Study|Withdrawal by Subject|1|||
161456761|NCT00548405|583068805|FG000|Overall Study|Adverse Event|6|||
161456762|NCT00548405|583068806|FG001|Overall Study|Adverse Event|2|||
161456763|NCT00548405|583068807|FG002|Overall Study|Adverse Event|0|||
161456764|NCT00548405|583068805|FG000|Overall Study|Lack of Efficacy|6|||
161456765|NCT00548405|583068806|FG001|Overall Study|Lack of Efficacy|0|||
161456766|NCT00548405|583068807|FG002|Overall Study|Lack of Efficacy|0|||
161456767|NCT00548405|583068805|FG000|Overall Study|Physician Decision|3|||
161456768|NCT00548405|583068806|FG001|Overall Study|Physician Decision|4|||
161456769|NCT00548405|583068807|FG002|Overall Study|Physician Decision|1|||
161456770|NCT00548405|583068805|FG000|Overall Study|Pregnancy|1|||
161456771|NCT00548405|583068806|FG001|Overall Study|Pregnancy|0|||
161456772|NCT00548405|583068807|FG002|Overall Study|Pregnancy|0|||
161456773|NCT00548405|583068805|FG000|Overall Study|Protocol Violation|1|||
161456774|NCT00548405|583068806|FG001|Overall Study|Protocol Violation|0|||
161456775|NCT00548405|583068807|FG002|Overall Study|Protocol Violation|0|||
161456776|NCT00548405|583068805|FG000|Overall Study|Withdrawal by Subject|36|||
161456777|NCT00548405|583068806|FG001|Overall Study|Withdrawal by Subject|12|||
161456778|NCT00548405|583068807|FG002|Overall Study|Withdrawal by Subject|5|||
161456779|NCT00548405|583068805|FG000|Overall Study|Lost to Follow-up|1|||
161456780|NCT00548405|583068806|FG001|Overall Study|Lost to Follow-up|1|||
161456781|NCT00548405|583068807|FG002|Overall Study|Lost to Follow-up|2|||
161456782|NCT00548405|583068805|FG000|Overall Study|Death|0|||
161456783|NCT00548405|583068806|FG001|Overall Study|Death|1|||
161456784|NCT00548405|583068807|FG002|Overall Study|Death|1|||
161567744|NCT01981850|583467607|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161456785|NCT00548405|583068805|FG000|Overall Study|Sponsor decision|1|||
161456786|NCT00548405|583068806|FG001|Overall Study|Sponsor decision|0|||
161456787|NCT00548405|583068807|FG002|Overall Study|Sponsor decision|0|||
161456788|NCT00548405|583068805|FG000|Overall Study|Randomized but not treated|1|||
161456789|NCT00548405|583068806|FG001|Overall Study|Randomized but not treated|0|||
161456790|NCT00548405|583068807|FG002|Overall Study|Randomized but not treated|0|||
161456791|NCT01624870|583068808|FG000|Overall Study|Death|19|||
161456792|NCT01624870|583068808|FG000|Overall Study|Withdrawal by Subject|1|||
161456793|NCT01624870|583068808|FG000|Overall Study|CoreValve not implanted|6|||
161456794|NCT01624870|583068808|FG000|Overall Study|Lost to follow up|1|||
161567745|NCT01981850|583467608|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567746|NCT01981850|583467609|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567747|NCT01981850|583467610|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567748|NCT01981850|583467611|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567749|NCT01981850|583467612|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567750|NCT01981850|583467613|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
161567751|NCT01981850|583467604|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
161567752|NCT01981850|583467605|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
161567753|NCT01981850|583467606|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
161567754|NCT01981850|583467607|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
161567755|NCT01981850|583467608|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
161567756|NCT01981850|583467609|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
161567757|NCT01981850|583467610|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
161567758|NCT01981850|583467611|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
161567759|NCT01981850|583467612|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
161567760|NCT01981850|583467613|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
161567761|NCT01981850|583467604|FG000|Main Phase Stage 1|Various reasons|0|||
161567762|NCT01981850|583467605|FG001|Main Phase Stage 1|Various reasons|0|||
161567763|NCT01981850|583467606|FG002|Main Phase Stage 1|Various reasons|2|||
161567764|NCT01981850|583467607|FG003|Main Phase Stage 1|Various reasons|0|||
161567765|NCT01981850|583467608|FG004|Main Phase Stage 1|Various reasons|0|||
161567766|NCT01981850|583467609|FG005|Main Phase Stage 1|Various reasons|0|||
161567767|NCT01981850|583467610|FG006|Main Phase Stage 1|Various reasons|0|||
161567768|NCT01981850|583467611|FG007|Main Phase Stage 1|Various reasons|0|||
161567769|NCT01981850|583467612|FG008|Main Phase Stage 1|Various reasons|0|||
161567770|NCT01981850|583467613|FG009|Main Phase Stage 1|Various reasons|0|||
161567771|NCT01981850|583467604|FG000|Main Phase Stage 2|Adverse Event|0|||
161567772|NCT01981850|583467605|FG001|Main Phase Stage 2|Adverse Event|0|||
161567773|NCT01981850|583467606|FG002|Main Phase Stage 2|Adverse Event|0|||
161567774|NCT01981850|583467607|FG003|Main Phase Stage 2|Adverse Event|0|||
161567775|NCT01981850|583467608|FG004|Main Phase Stage 2|Adverse Event|6|||
161567776|NCT01981850|583467609|FG005|Main Phase Stage 2|Adverse Event|5|||
161567777|NCT01981850|583467610|FG006|Main Phase Stage 2|Adverse Event|7|||
161567778|NCT01981850|583467611|FG007|Main Phase Stage 2|Adverse Event|0|||
161567779|NCT01981850|583467612|FG008|Main Phase Stage 2|Adverse Event|0|||
161567780|NCT01981850|583467613|FG009|Main Phase Stage 2|Adverse Event|0|||
161567781|NCT01981850|583467604|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567782|NCT01981850|583467605|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567783|NCT01981850|583467606|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567784|NCT01981850|583467607|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567785|NCT01981850|583467608|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
161567786|NCT01981850|583467609|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
161567787|NCT01981850|583467610|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
161567788|NCT01981850|583467611|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567789|NCT01981850|583467612|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567790|NCT01981850|583467613|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
161567791|NCT01981850|583467604|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
161567792|NCT01981850|583467605|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
161567793|NCT01981850|583467606|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
161567794|NCT01981850|583467607|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
161567795|NCT01981850|583467608|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
161567796|NCT01981850|583467609|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
161567797|NCT01981850|583467610|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
161567798|NCT01981850|583467611|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
161567799|NCT01981850|583467612|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
161567800|NCT01981850|583467613|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
161567801|NCT01981850|583467604|FG000|Main Phase Stage 2|Various reasons|0|||
161567802|NCT01981850|583467605|FG001|Main Phase Stage 2|Various reasons|0|||
161567803|NCT01981850|583467606|FG002|Main Phase Stage 2|Various reasons|0|||
161567804|NCT01981850|583467607|FG003|Main Phase Stage 2|Various reasons|0|||
161567805|NCT01981850|583467608|FG004|Main Phase Stage 2|Various reasons|2|||
161567806|NCT01981850|583467609|FG005|Main Phase Stage 2|Various reasons|0|||
161567807|NCT01981850|583467610|FG006|Main Phase Stage 2|Various reasons|1|||
161567808|NCT01981850|583467611|FG007|Main Phase Stage 2|Various reasons|0|||
161567809|NCT01981850|583467612|FG008|Main Phase Stage 2|Various reasons|0|||
161567810|NCT01981850|583467613|FG009|Main Phase Stage 2|Various reasons|0|||
161567811|NCT01981850|583467604|FG000|Main Phase Stage 2|Progressive Disease|0|||
161567812|NCT01981850|583467605|FG001|Main Phase Stage 2|Progressive Disease|0|||
161567813|NCT01981850|583467606|FG002|Main Phase Stage 2|Progressive Disease|0|||
161567814|NCT01981850|583467607|FG003|Main Phase Stage 2|Progressive Disease|0|||
161567815|NCT01981850|583467608|FG004|Main Phase Stage 2|Progressive Disease|0|||
161567816|NCT01981850|583467609|FG005|Main Phase Stage 2|Progressive Disease|6|||
161567817|NCT01981850|583467610|FG006|Main Phase Stage 2|Progressive Disease|6|||
161567818|NCT01981850|583467611|FG007|Main Phase Stage 2|Progressive Disease|0|||
161567819|NCT01981850|583467612|FG008|Main Phase Stage 2|Progressive Disease|0|||
161567820|NCT01981850|583467613|FG009|Main Phase Stage 2|Progressive Disease|0|||
161567821|NCT01981850|583467604|FG000|Open Label Extension (OLE)|Adverse Event|0|||
161567822|NCT01981850|583467605|FG001|Open Label Extension (OLE)|Adverse Event|0|||
161567823|NCT01981850|583467606|FG002|Open Label Extension (OLE)|Adverse Event|0|||
161567824|NCT01981850|583467607|FG003|Open Label Extension (OLE)|Adverse Event|0|||
161567825|NCT01981850|583467608|FG004|Open Label Extension (OLE)|Adverse Event|0|||
161567826|NCT01981850|583467609|FG005|Open Label Extension (OLE)|Adverse Event|0|||
161567827|NCT01981850|583467610|FG006|Open Label Extension (OLE)|Adverse Event|0|||
161567828|NCT01981850|583467611|FG007|Open Label Extension (OLE)|Adverse Event|2|||
161567829|NCT01981850|583467612|FG008|Open Label Extension (OLE)|Adverse Event|1|||
161567830|NCT01981850|583467613|FG009|Open Label Extension (OLE)|Adverse Event|8|||
161567831|NCT01981850|583467604|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567832|NCT01981850|583467605|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567833|NCT01981850|583467606|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567834|NCT01981850|583467607|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567835|NCT01981850|583467608|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567836|NCT01981850|583467609|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567837|NCT01981850|583467610|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
161567838|NCT01981850|583467611|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
161567839|NCT01981850|583467612|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
161567840|NCT01981850|583467613|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
161567841|NCT01981850|583467604|FG000|Open Label Extension (OLE)|Various reasons|0|||
161567842|NCT01981850|583467605|FG001|Open Label Extension (OLE)|Various reasons|0|||
161567843|NCT01981850|583467606|FG002|Open Label Extension (OLE)|Various reasons|0|||
161567844|NCT01981850|583467607|FG003|Open Label Extension (OLE)|Various reasons|0|||
161567845|NCT01981850|583467608|FG004|Open Label Extension (OLE)|Various reasons|0|||
161567846|NCT01981850|583467609|FG005|Open Label Extension (OLE)|Various reasons|0|||
161567847|NCT01981850|583467610|FG006|Open Label Extension (OLE)|Various reasons|0|||
161567848|NCT01981850|583467611|FG007|Open Label Extension (OLE)|Various reasons|3|||
161567849|NCT01981850|583467612|FG008|Open Label Extension (OLE)|Various reasons|1|||
161567850|NCT01981850|583467613|FG009|Open Label Extension (OLE)|Various reasons|3|||
161567851|NCT01981850|583467604|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
161567852|NCT01981850|583467605|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
161567853|NCT01981850|583467606|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
161567854|NCT01981850|583467607|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
161567855|NCT01981850|583467608|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
161567856|NCT01981850|583467609|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
161567857|NCT01981850|583467610|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
161567858|NCT01981850|583467611|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
161567859|NCT01981850|583467612|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
161567860|NCT01981850|583467613|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
161567861|NCT01981850|583467604|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567862|NCT01981850|583467605|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567863|NCT01981850|583467606|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567864|NCT01981850|583467607|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567865|NCT01981850|583467608|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567866|NCT01981850|583467609|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567867|NCT01981850|583467610|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567868|NCT01981850|583467611|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567869|NCT01981850|583467612|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
161567870|NCT01981850|583467613|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
161567871|NCT01981850|583467604|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567872|NCT01981850|583467605|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567873|NCT01981850|583467606|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567874|NCT01981850|583467607|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567875|NCT01981850|583467608|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567876|NCT01981850|583467609|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567877|NCT01981850|583467610|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567878|NCT01981850|583467611|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567879|NCT01981850|583467612|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
161567880|NCT01981850|583467613|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
161567881|NCT02059980|583467618|FG000|Overall Study|Lost to Follow-up|2|||
161567882|NCT02059980|583467619|FG001|Overall Study|Lost to Follow-up|1|||
161567883|NCT01321606|583467620|FG000|Overall Study|Lost to Follow-up|0|||
161567884|NCT01321606|583467621|FG001|Overall Study|Lost to Follow-up|0|||
161567885|NCT01321606|583467622|FG002|Overall Study|Lost to Follow-up|0|||
161808940|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808941|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808942|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
161567886|NCT01321606|583467623|FG003|Overall Study|Lost to Follow-up|1|||
161567887|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
161567888|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
161567889|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
161567890|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
161567891|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
161567892|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
161567893|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
161567894|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
161567895|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
161567896|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
161567897|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
161567898|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
161567899|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
161567900|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
161567901|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
161567902|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
161567903|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
161567904|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
161567905|NCT03412747|583467624|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
161567906|NCT03412747|583467625|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
161567907|NCT03412747|583467626|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
161567908|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
161808943|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
161808944|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
161808945|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
161456795|NCT01878149|583068809|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
161456796|NCT01878149|583068810|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
161456797|NCT04672252|583068811|FG000|Overall Study|Protocol Violation|1|||
161456798|NCT04672252|583068812|FG001|Overall Study|Protocol Violation|0|||
161456799|NCT06390839|583068814|FG000|Overall Study|Ineligible|2|||
161456800|NCT06390839|583068814|FG000|Overall Study|Never start protocol therapy|3|||
161456801|NCT06390839|583068814|FG000|Overall Study|Adverse Event|1|||
161456802|NCT06390839|583068814|FG000|Overall Study|Alternative therapy|2|||
161456803|NCT06390839|583068814|FG000|Overall Study|Death|3|||
161456804|NCT06390839|583068814|FG000|Overall Study|Disease progression|28|||
161456805|NCT06390839|583068814|FG000|Overall Study|Withdrawal by Subject|2|||
161456806|NCT06390839|583068814|FG000|Overall Study|Complicating disease|1|||
161456807|NCT06390839|583068814|FG000|Overall Study|Noncompliance|1|||
161456808|NCT00502203|583068817|FG000|Overall Study|Inevaluable|1|||
161456809|NCT01431638|583068820|FG000|Overall Study|Adverse Event|1|||
161456810|NCT01431638|583068821|FG001|Overall Study|Adverse Event|3|||
161456811|NCT01431638|583068822|FG002|Overall Study|Adverse Event|1|||
161456812|NCT01431638|583068820|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161456813|NCT01431638|583068821|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161456814|NCT01431638|583068822|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
161456815|NCT01431638|583068820|FG000|Overall Study|Participants condition no longer requires study drug|0|||
161456816|NCT01431638|583068821|FG001|Overall Study|Participants condition no longer requires study drug|1|||
161456817|NCT01431638|583068822|FG002|Overall Study|Participants condition no longer requires study drug|0|||
161456818|NCT01431638|583068820|FG000|Overall Study|Participant withdrew consent|14|||
161456819|NCT01431638|583068821|FG001|Overall Study|Participant withdrew consent|5|||
161456820|NCT01431638|583068822|FG002|Overall Study|Participant withdrew consent|8|||
161456821|NCT01431638|583068820|FG000|Overall Study|Lost to Follow-up|7|||
161456822|NCT01431638|583068821|FG001|Overall Study|Lost to Follow-up|9|||
161456823|NCT01431638|583068822|FG002|Overall Study|Lost to Follow-up|7|||
161456824|NCT01431638|583068820|FG000|Overall Study|Administrative problems|1|||
161456825|NCT01431638|583068821|FG001|Overall Study|Administrative problems|4|||
161456826|NCT01431638|583068822|FG002|Overall Study|Administrative problems|6|||
161456827|NCT01431638|583068820|FG000|Overall Study|Death|1|||
161456828|NCT01431638|583068821|FG001|Overall Study|Death|0|||
161456829|NCT01431638|583068822|FG002|Overall Study|Death|0|||
161456830|NCT01431638|583068820|FG000|Overall Study|Protocol deviation|1|||
161456831|NCT01431638|583068821|FG001|Overall Study|Protocol deviation|1|||
161456832|NCT01431638|583068822|FG002|Overall Study|Protocol deviation|4|||
161456833|NCT01431638|583068820|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
161456834|NCT01431638|583068821|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
161456835|NCT01431638|583068822|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
161456836|NCT01381562|583068823|FG000|Overall Study|Adverse Event|0|||
161456837|NCT01381562|583068824|FG001|Overall Study|Adverse Event|1|||
161456838|NCT01381562|583068825|FG002|Overall Study|Adverse Event|0|||
161456839|NCT02660138|583068827|FG000|Overall Study|Adverse Event|0|||
161456840|NCT02660138|583068828|FG001|Overall Study|Adverse Event|3|||
161456841|NCT02660138|583068829|FG002|Overall Study|Adverse Event|2|||
161456842|NCT02660138|583068827|FG000|Overall Study|Lack of Efficacy|1|||
161456843|NCT02660138|583068828|FG001|Overall Study|Lack of Efficacy|2|||
161456844|NCT02660138|583068829|FG002|Overall Study|Lack of Efficacy|1|||
161456845|NCT02660138|583068827|FG000|Overall Study|Withdrawal by Subject|7|||
161456846|NCT02660138|583068828|FG001|Overall Study|Withdrawal by Subject|6|||
161456847|NCT02660138|583068829|FG002|Overall Study|Withdrawal by Subject|6|||
161456848|NCT02660138|583068827|FG000|Overall Study|Lost to Follow-up|4|||
161456849|NCT02660138|583068828|FG001|Overall Study|Lost to Follow-up|4|||
161456850|NCT02660138|583068829|FG002|Overall Study|Lost to Follow-up|1|||
161456851|NCT02660138|583068827|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
161456852|NCT02660138|583068828|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
161456853|NCT02660138|583068829|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
161456854|NCT02660138|583068827|FG000|Overall Study|Other|1|||
161456855|NCT02660138|583068828|FG001|Overall Study|Other|1|||
161456856|NCT02660138|583068829|FG002|Overall Study|Other|0|||
161456857|NCT02660138|583068827|FG000|Overall Study|Not treated|0|||
161456858|NCT02660138|583068828|FG001|Overall Study|Not treated|1|||
161456859|NCT02660138|583068829|FG002|Overall Study|Not treated|0|||
161456860|NCT00308581|583068833|FG000|Induction Phase|Adverse Event|0|||
161456861|NCT00308581|583068834|FG001|Induction Phase|Adverse Event|0|||
161456862|NCT00308581|583068835|FG002|Induction Phase|Adverse Event|37|||
161456863|NCT00308581|583068833|FG000|Induction Phase|Lack of Efficacy|0|||
161456864|NCT00308581|583068834|FG001|Induction Phase|Lack of Efficacy|0|||
161456865|NCT00308581|583068835|FG002|Induction Phase|Lack of Efficacy|121|||
161456866|NCT00308581|583068833|FG000|Induction Phase|Withdrawal by Subject|0|||
161456867|NCT00308581|583068834|FG001|Induction Phase|Withdrawal by Subject|0|||
161456868|NCT00308581|583068835|FG002|Induction Phase|Withdrawal by Subject|5|||
161456869|NCT00308581|583068833|FG000|Induction Phase|Unknown reason|0|||
161456870|NCT00308581|583068834|FG001|Induction Phase|Unknown reason|0|||
161456871|NCT00308581|583068835|FG002|Induction Phase|Unknown reason|3|||
161567909|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
161567910|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
161567911|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
161567912|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
161567913|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
161567914|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
161567915|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
161567916|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
161567917|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
161567918|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
161567919|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
161567920|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
161567921|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
161567922|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
161567923|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
161567924|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
161567925|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
161567926|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
161567927|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
161567928|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
161567929|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
161567930|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
161567931|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
161567932|NCT03412747|583467624|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
161567933|NCT03412747|583467625|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
161567934|NCT03412747|583467626|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
161567935|NCT04982575|583467631|FG000|Overall Study|Withdrawal by Subject|2|||
161567936|NCT04982575|583467632|FG001|Overall Study|Withdrawal by Subject|0|||
161567937|NCT04982575|583467633|FG002|Overall Study|Withdrawal by Subject|2|||
161567938|NCT03038022|583467636|FG000|Overall Study|Withdrawal by Subject|2|||
161567939|NCT03038022|583467637|FG001|Overall Study|Withdrawal by Subject|0|||
161567940|NCT03038022|583467636|FG000|Overall Study|Adverse Event|4|||
161567941|NCT03038022|583467637|FG001|Overall Study|Adverse Event|2|||
161567942|NCT01467427|583467638|FG000|Overall Study|Withdrawal by Subject|1|||
161567943|NCT01467427|583467639|FG001|Overall Study|Withdrawal by Subject|0|||
161567944|NCT01467427|583467638|FG000|Overall Study|Not continuing in extension phase|0|||
161567945|NCT01467427|583467639|FG001|Overall Study|Not continuing in extension phase|2|||
161567946|NCT01467427|583467638|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
161567947|NCT01467427|583467639|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
161567948|NCT01467427|583467638|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
161567949|NCT01467427|583467639|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
161567950|NCT01467427|583467638|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
161567951|NCT01467427|583467639|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
161567952|NCT01467427|583467638|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
161567953|NCT01467427|583467639|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
161567954|NCT04269200|583467640|FG000|Global Cohort|Death|72|||
161567955|NCT04269200|583467641|FG001|Global Cohort|Death|54|||
161567956|NCT04269200|583467642|FG002|Global Cohort|Death|49|||
161567957|NCT04269200|583467640|FG000|Global Cohort|Lost to Follow-up|0|||
161567958|NCT04269200|583467641|FG001|Global Cohort|Lost to Follow-up|0|||
161567959|NCT04269200|583467642|FG002|Global Cohort|Lost to Follow-up|2|||
161567960|NCT04269200|583467640|FG000|Global Cohort|Withdrawal by Subject|22|||
161567961|NCT04269200|583467641|FG001|Global Cohort|Withdrawal by Subject|25|||
161567962|NCT04269200|583467642|FG002|Global Cohort|Withdrawal by Subject|18|||
161567963|NCT04269200|583467640|FG000|China Cohort|Death|12|||
161567964|NCT04269200|583467641|FG001|China Cohort|Death|11|||
161567965|NCT04269200|583467642|FG002|China Cohort|Death|13|||
161567966|NCT04269200|583467640|FG000|China Cohort|Lost to Follow-up|0|||
161567967|NCT04269200|583467641|FG001|China Cohort|Lost to Follow-up|1|||
161567968|NCT04269200|583467642|FG002|China Cohort|Lost to Follow-up|1|||
161567969|NCT04269200|583467640|FG000|China Cohort|Withdrawal by Subject|2|||
161567970|NCT04269200|583467641|FG001|China Cohort|Withdrawal by Subject|2|||
161567971|NCT04269200|583467642|FG002|China Cohort|Withdrawal by Subject|4|||
161567972|NCT04181827|583467643|FG000|Overall Study|Ongoing|124|||
161567973|NCT04181827|583467644|FG001|Overall Study|Ongoing|157|||
161567974|NCT04181827|583467643|FG000|Overall Study|Death|82|||
161567975|NCT04181827|583467644|FG001|Overall Study|Death|50|||
161567976|NCT04181827|583467643|FG000|Overall Study|Lost to Follow-up|0|||
161567977|NCT04181827|583467644|FG001|Overall Study|Lost to Follow-up|1|||
161567978|NCT04181827|583467643|FG000|Overall Study|Withdrawal by Subject|5|||
161567979|NCT04181827|583467644|FG001|Overall Study|Withdrawal by Subject|0|||
161567980|NCT03887936|583467645|FG000|Overall Study|Relocation|2|||
161567981|NCT03887936|583467646|FG001|Overall Study|Relocation|2|||
161567982|NCT03887936|583467645|FG000|Overall Study|Physician Decision|0|||
161567983|NCT03887936|583467646|FG001|Overall Study|Physician Decision|1|||
161567984|NCT03887936|583467645|FG000|Overall Study|Withdrawal by Subject|0|||
161567985|NCT03887936|583467646|FG001|Overall Study|Withdrawal by Subject|1|||
161567986|NCT00539591|583467647|FG000|Overall Study|Toxicity|3|||
161567987|NCT00539591|583467648|FG001|Overall Study|Toxicity|0|||
161567988|NCT00539591|583467649|FG002|Overall Study|Toxicity|0|||
161567989|NCT00539591|583467647|FG000|Overall Study|Disease progression|2|||
161567990|NCT00539591|583467648|FG001|Overall Study|Disease progression|2|||
161567991|NCT00539591|583467649|FG002|Overall Study|Disease progression|3|||
161567992|NCT06269367|583467650|FG000|Phase I|Unable to perform study procedures|0|||
161567993|NCT06269367|583467651|FG001|Phase I|Unable to perform study procedures|1|||
161567994|NCT06269367|583467650|FG000|Phase I|Could not continue study for personal reasons.|1|||
161567995|NCT06269367|583467651|FG001|Phase I|Could not continue study for personal reasons.|0|||
161567996|NCT04305912|583467656|FG000|First Intervention|COVID-19 Suspension|2|||
161567997|NCT04305912|583467657|FG001|First Intervention|COVID-19 Suspension|0|||
161567998|NCT04305912|583467656|FG000|First Intervention|Withdrawal by Subject|0|||
161567999|NCT04305912|583467657|FG001|First Intervention|Withdrawal by Subject|1|||
161568000|NCT04305912|583467656|FG000|Second Intervention|Adverse Event|0|||
161568001|NCT04305912|583467657|FG001|Second Intervention|Adverse Event|1|||
161568002|NCT00117988|583467661|FG000|Overall Study|Death|3|||
161568003|NCT00117988|583467661|FG000|Overall Study|Adverse Event|1|||
161568004|NCT05824351|583467662|FG000|Overall Study|Adverse Event|6|||
161568005|NCT02137850|583467663|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
161568006|NCT02137850|583467664|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
161568007|NCT02137850|583467665|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
161568008|NCT02137850|583467663|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
161568009|NCT02137850|583467664|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
161568010|NCT02137850|583467665|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
161568011|NCT02137850|583467663|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
161568012|NCT02137850|583467664|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
161568013|NCT02137850|583467665|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
161568014|NCT02137850|583467663|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
161568015|NCT02137850|583467664|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
161568016|NCT02137850|583467665|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
161568017|NCT02137850|583467663|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
161568018|NCT02137850|583467664|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
161568019|NCT02137850|583467665|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
161568020|NCT02137850|583467663|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
161568021|NCT02137850|583467664|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
161568022|NCT02137850|583467665|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
161568023|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
161568024|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
161568025|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
161568026|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
161568027|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
161568028|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
161568029|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
161568030|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
161568031|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
161568032|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
161568033|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
161568034|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
161568035|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Other|0|||
161568036|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Other|1|||
161568037|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Other|0|||
161568038|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
161568039|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
161568040|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
161568041|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Early site closure|0|||
161568042|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Early site closure|2|||
161568043|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Early site closure|0|||
161568044|NCT02137850|583467663|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
161568045|NCT02137850|583467664|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
161568046|NCT02137850|583467665|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
161568047|NCT02137850|583467663|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
161568048|NCT02137850|583467664|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
161568049|NCT02137850|583467665|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
161568050|NCT02137850|583467663|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
161568051|NCT02137850|583467664|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
161568052|NCT02137850|583467665|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
161456872|NCT00308581|583068833|FG000|Randomized Maintenance Phase|Adverse Event|10|||
161456873|NCT00308581|583068834|FG001|Randomized Maintenance Phase|Adverse Event|17|||
161456874|NCT00308581|583068835|FG002|Randomized Maintenance Phase|Adverse Event|0|||
161456875|NCT00308581|583068833|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
161456876|NCT00308581|583068834|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
161456877|NCT00308581|583068835|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
161456878|NCT00308581|583068833|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
161456879|NCT00308581|583068834|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
161456880|NCT00308581|583068835|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
161456881|NCT00308581|583068833|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
161456882|NCT00308581|583068834|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
161456883|NCT00308581|583068835|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
161456884|NCT00308581|583068833|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
161456885|NCT00308581|583068834|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
161456886|NCT00308581|583068835|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
161456887|NCT00308581|583068833|FG000|Randomized Maintenance Phase|Unknown reason|3|||
161456888|NCT00308581|583068834|FG001|Randomized Maintenance Phase|Unknown reason|0|||
161456889|NCT00308581|583068835|FG002|Randomized Maintenance Phase|Unknown reason|0|||
161456890|NCT00899353|583068838|FG000|Overall Study|Adverse Event|2|||
161456891|NCT00899353|583068838|FG000|Overall Study|Lost to Follow-up|1|||
161456892|NCT00899353|583068838|FG000|Overall Study|Withdrawal by Subject|2|||
161456893|NCT00095147|583068847|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
161456894|NCT00095147|583068848|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
161456895|NCT00095147|583068849|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
161456896|NCT00095147|583068850|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
161456897|NCT00095147|583068851|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
161456898|NCT00095147|583068847|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
161456899|NCT00095147|583068848|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
161456900|NCT00095147|583068849|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
161456901|NCT00095147|583068850|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
161456902|NCT00095147|583068851|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
161456903|NCT00095147|583068847|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
161456904|NCT00095147|583068848|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
161456905|NCT00095147|583068849|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
161456906|NCT00095147|583068850|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
161456907|NCT00095147|583068851|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
161456908|NCT00095147|583068847|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
161456909|NCT00095147|583068848|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
161456910|NCT00095147|583068849|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
161456911|NCT00095147|583068850|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
161456912|NCT00095147|583068851|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
161456913|NCT00095147|583068847|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
161456914|NCT00095147|583068848|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
161456915|NCT00095147|583068849|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
161456916|NCT00095147|583068850|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
161456917|NCT00095147|583068851|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
161568053|NCT02137850|583467663|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
161568054|NCT02137850|583467664|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
161568055|NCT02137850|583467665|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
161568056|NCT02137850|583467663|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
161568057|NCT02137850|583467664|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
161568058|NCT02137850|583467665|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
161568059|NCT02137850|583467663|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
161568060|NCT02137850|583467664|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
161568061|NCT02137850|583467665|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
161568062|NCT02137850|583467663|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
161568063|NCT02137850|583467664|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
161568064|NCT02137850|583467665|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
161568065|NCT02137850|583467663|FG000|Extension Phase: Prophylaxis|Other|0|||
161568066|NCT02137850|583467664|FG001|Extension Phase: Prophylaxis|Other|1|||
161568067|NCT02137850|583467665|FG002|Extension Phase: Prophylaxis|Other|0|||
161568068|NCT02137850|583467663|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
161568069|NCT02137850|583467664|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
161568070|NCT02137850|583467665|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
161568071|NCT02912260|583467666|FG000|Main Study|Lost to Follow-up|5|||
161568072|NCT02912260|583467667|FG001|Main Study|Lost to Follow-up|4|||
161568073|NCT02912260|583467666|FG000|Main Study|Withdrawal by Subject|2|||
161568074|NCT02912260|583467667|FG001|Main Study|Withdrawal by Subject|2|||
161568075|NCT02912260|583467666|FG000|Main Study|Adverse Event|3|||
161568076|NCT02912260|583467667|FG001|Main Study|Adverse Event|0|||
161568077|NCT02912260|583467666|FG000|Main Study|Physician Decision|0|||
161568078|NCT02912260|583467667|FG001|Main Study|Physician Decision|1|||
161568079|NCT02912260|583467666|FG000|Extension Study|Withdrawal by Subject|1|||
161568080|NCT02912260|583467667|FG001|Extension Study|Withdrawal by Subject|1|||
161568081|NCT03563053|583467669|FG000|Overall Study|Withdrawal by Subject|17|||
161568082|NCT03563053|583467669|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
161568083|NCT03563053|583467669|FG000|Overall Study|Adverse Event|3|||
161568084|NCT03563053|583467669|FG000|Overall Study|Physician Decision|1|||
161568085|NCT03563053|583467669|FG000|Overall Study|study terminated by sponsor|71|||
161568086|NCT00124982|583467670|FG000|Short-term Period|Death|1|||
161568087|NCT00124982|583467671|FG001|Short-term Period|Death|1|||
161568088|NCT00124982|583467672|FG002|Short-term Period|Death|0|||
161568089|NCT00124982|583467670|FG000|Short-term Period|Adverse Event|17|||
161568090|NCT00124982|583467671|FG001|Short-term Period|Adverse Event|22|||
161568091|NCT00124982|583467672|FG002|Short-term Period|Adverse Event|0|||
161568092|NCT00124982|583467670|FG000|Short-term Period|Lack of Efficacy|32|||
161568093|NCT00124982|583467671|FG001|Short-term Period|Lack of Efficacy|73|||
161568094|NCT00124982|583467672|FG002|Short-term Period|Lack of Efficacy|0|||
161568095|NCT00124982|583467670|FG000|Short-term Period|Lost to Follow-up|8|||
161568096|NCT00124982|583467671|FG001|Short-term Period|Lost to Follow-up|5|||
161912253|NCT01721798|584730055|FG001|Overall Study|Lost to Follow-up|2|||
161568097|NCT00124982|583467672|FG002|Short-term Period|Lost to Follow-up|0|||
161568098|NCT00124982|583467670|FG000|Short-term Period|Withdrawal of Consent|7|||
161568099|NCT00124982|583467671|FG001|Short-term Period|Withdrawal of Consent|9|||
161568100|NCT00124982|583467672|FG002|Short-term Period|Withdrawal of Consent|0|||
161568101|NCT00124982|583467670|FG000|Short-term Period|Poor/Non-compliance|3|||
161568102|NCT00124982|583467671|FG001|Short-term Period|Poor/Non-compliance|1|||
161568103|NCT00124982|583467672|FG002|Short-term Period|Poor/Non-compliance|0|||
161568104|NCT00124982|583467670|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
161568105|NCT00124982|583467671|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
161568106|NCT00124982|583467672|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
161568107|NCT00124982|583467670|FG000|Short-term Period|Participant Decision|1|||
161568108|NCT00124982|583467671|FG001|Short-term Period|Participant Decision|0|||
161568109|NCT00124982|583467672|FG002|Short-term Period|Participant Decision|0|||
161568110|NCT00124982|583467670|FG000|Short-term Period|Participant Chose Own Doctor|0|||
161568111|NCT00124982|583467671|FG001|Short-term Period|Participant Chose Own Doctor|1|||
161912254|NCT01721798|584730056|FG002|Overall Study|Lost to Follow-up|9|||
161912255|NCT01721798|584730057|FG003|Overall Study|Lost to Follow-up|9|||
161912256|NCT01721798|584730054|FG000|Overall Study|Pregnancy|0|||
161912257|NCT01721798|584730055|FG001|Overall Study|Pregnancy|0|||
161912258|NCT01721798|584730056|FG002|Overall Study|Pregnancy|1|||
161568112|NCT00124982|583467672|FG002|Short-term Period|Participant Chose Own Doctor|0|||
161568113|NCT00124982|583467670|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
161568114|NCT00124982|583467671|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
161568115|NCT00124982|583467672|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
161568116|NCT00124982|583467670|FG000|Short-term Period|Participant Had Lymphopenia|1|||
161568117|NCT00124982|583467671|FG001|Short-term Period|Participant Had Lymphopenia|0|||
161568118|NCT00124982|583467672|FG002|Short-term Period|Participant Had Lymphopenia|0|||
161568119|NCT00124982|583467670|FG000|Long-term Period|Death|0|||
161568120|NCT00124982|583467671|FG001|Long-term Period|Death|0|||
161912259|NCT01721798|584730057|FG003|Overall Study|Pregnancy|1|||
161568121|NCT00124982|583467672|FG002|Long-term Period|Death|1|||
161568122|NCT00124982|583467670|FG000|Long-term Period|Adverse Event|0|||
161568123|NCT00124982|583467671|FG001|Long-term Period|Adverse Event|0|||
161568124|NCT00124982|583467672|FG002|Long-term Period|Adverse Event|17|||
161568125|NCT00124982|583467670|FG000|Long-term Period|Lack of Efficacy|0|||
161568126|NCT00124982|583467671|FG001|Long-term Period|Lack of Efficacy|0|||
161456918|NCT00095147|583068847|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
161456919|NCT00095147|583068848|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
161456920|NCT00095147|583068849|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
161456921|NCT00095147|583068850|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
161456922|NCT00095147|583068851|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
161568127|NCT00124982|583467672|FG002|Long-term Period|Lack of Efficacy|46|||
161568128|NCT00124982|583467670|FG000|Long-term Period|Lost to Follow-up|0|||
161568129|NCT00124982|583467671|FG001|Long-term Period|Lost to Follow-up|0|||
161568130|NCT00124982|583467672|FG002|Long-term Period|Lost to Follow-up|4|||
161568131|NCT00124982|583467670|FG000|Long-term Period|Withdrawal by Subject|0|||
161568132|NCT00124982|583467671|FG001|Long-term Period|Withdrawal by Subject|0|||
161568133|NCT00124982|583467672|FG002|Long-term Period|Withdrawal by Subject|16|||
161568134|NCT00124982|583467670|FG000|Long-term Period|Pregnancy|0|||
161568135|NCT00124982|583467671|FG001|Long-term Period|Pregnancy|0|||
161568136|NCT00124982|583467672|FG002|Long-term Period|Pregnancy|1|||
161568137|NCT00124982|583467670|FG000|Long-term Period|Poor/Non-compliance|0|||
161568138|NCT00124982|583467671|FG001|Long-term Period|Poor/Non-compliance|0|||
161568139|NCT00124982|583467672|FG002|Long-term Period|Poor/Non-compliance|2|||
161568140|NCT00124982|583467670|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
161568141|NCT00124982|583467671|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
161568142|NCT00124982|583467672|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
161568143|NCT00124982|583467670|FG000|Long-term Period|Neurologist Recommendation|0|||
161568144|NCT00124982|583467671|FG001|Long-term Period|Neurologist Recommendation|0|||
161568145|NCT00124982|583467672|FG002|Long-term Period|Neurologist Recommendation|1|||
161568146|NCT01137292|583467673|FG000|Overall Study|Death|30|||
161568147|NCT01137292|583467673|FG000|Overall Study|Adverse Event|3|||
161568148|NCT01137292|583467673|FG000|Overall Study|Lack of Efficacy|13|||
161568149|NCT01137292|583467673|FG000|Overall Study|Lost to Follow-up|1|||
161568150|NCT01137292|583467673|FG000|Overall Study|Other|7|||
161568151|NCT01311713|583467674|FG000|Overall Study|Death|0|||
161568152|NCT01311713|583467675|FG001|Overall Study|Death|0|||
161568153|NCT01311713|583467676|FG002|Overall Study|Death|1|||
161808946|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808947|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
161808948|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808949|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808950|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161456923|NCT00095147|583068847|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
161456924|NCT00095147|583068848|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
161456925|NCT00095147|583068849|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
161456926|NCT00095147|583068850|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
161456927|NCT00095147|583068851|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
161456928|NCT00095147|583068847|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
161456929|NCT00095147|583068848|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
161456930|NCT00095147|583068849|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
161456931|NCT00095147|583068850|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
161456932|NCT00095147|583068851|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
161456933|NCT00095147|583068847|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
161456934|NCT00095147|583068848|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
161456935|NCT00095147|583068849|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
161456936|NCT00095147|583068850|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
161568154|NCT01311713|583467677|FG003|Overall Study|Death|1|||
161568155|NCT01311713|583467678|FG004|Overall Study|Death|0|||
161808951|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808952|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808953|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808954|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808955|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808956|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808957|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808958|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808959|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808960|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808961|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808962|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161568156|NCT01311713|583467679|FG005|Overall Study|Death|1|||
161568157|NCT01311713|583467680|FG006|Overall Study|Death|0|||
161912260|NCT01721798|584730054|FG000|Overall Study|Withdrawal by Subject|1|||
161912261|NCT01721798|584730055|FG001|Overall Study|Withdrawal by Subject|0|||
161912262|NCT01721798|584730056|FG002|Overall Study|Withdrawal by Subject|2|||
161912263|NCT01721798|584730057|FG003|Overall Study|Withdrawal by Subject|1|||
161912264|NCT01721798|584730054|FG000|Overall Study|Not eligible for 24 month visit|1|||
161912265|NCT01721798|584730055|FG001|Overall Study|Not eligible for 24 month visit|0|||
161912266|NCT01721798|584730056|FG002|Overall Study|Not eligible for 24 month visit|8|||
161912267|NCT01721798|584730057|FG003|Overall Study|Not eligible for 24 month visit|7|||
161912268|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
161912269|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
161912270|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
161912271|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
161912272|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
161912273|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
161912274|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
161912275|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
161912276|NCT01408641|584730059|FG000|Overall Study|Physician Decision|1|||
161912277|NCT01408641|584730060|FG001|Overall Study|Physician Decision|0|||
161912278|NCT01316614|584730061|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
161912279|NCT01316614|584730061|FG000|Overall Study|Cytology slides not available for review|4|||
161912280|NCT01316614|584730061|FG000|Overall Study|Cystic lesion|5|||
161912281|NCT01316614|584730061|FG000|Overall Study|Inadequate number of passes|2|||
161912282|NCT01316614|584730061|FG000|Overall Study|Medically unstable|1|||
161912283|NCT00076570|584730062|FG000|Overall Study|Drug intolerance|8|||
161912284|NCT00076570|584730063|FG001|Overall Study|Drug intolerance|8|||
161912285|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
161912286|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
161912287|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
161912288|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
161912289|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
161912290|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
161912291|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
161912292|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
161912293|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
161912294|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
161912295|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
161912296|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
161912297|NCT03979313|584730064|FG000|All Subjects|Any Other Reason|16|||
161912298|NCT03979313|584730065|FG001|All Subjects|Any Other Reason|23|||
161912299|NCT03979313|584730064|FG000|All Subjects|Covid-19|1|||
161912300|NCT03979313|584730065|FG001|All Subjects|Covid-19|3|||
161912301|NCT03979313|584730064|FG000|All Subjects|Withdrawal by Subject|35|||
161912302|NCT03979313|584730065|FG001|All Subjects|Withdrawal by Subject|44|||
161912303|NCT03979313|584730064|FG000|All Subjects|Death|0|||
161912304|NCT03979313|584730065|FG001|All Subjects|Death|5|||
161912305|NCT03979313|584730064|FG000|All Subjects|Lost to Follow-up|28|||
161912306|NCT03979313|584730065|FG001|All Subjects|Lost to Follow-up|61|||
161912307|NCT00089648|584730066|FG000|Overall Study|Adverse Event|7|||
161912308|NCT00089648|584730066|FG000|Overall Study|Withdrawal by Subject|1|||
161912309|NCT00089648|584730066|FG000|Overall Study|Lack of Efficacy|33|||
161912310|NCT00423605|584730067|FG000|Overall Study|Adverse Event|129|||
161912311|NCT00423605|584730067|FG000|Overall Study|Withdrawal by Subject|36|||
161912312|NCT00423605|584730067|FG000|Overall Study|Lost to Follow-up|15|||
161912313|NCT00423605|584730067|FG000|Overall Study|Lack of Efficacy|38|||
161912314|NCT00423605|584730067|FG000|Overall Study|Sponsor Decision|3|||
161912315|NCT00423605|584730067|FG000|Overall Study|Physician Decision|8|||
161808963|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808964|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
161808965|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808966|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808967|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
161808968|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808969|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
161808970|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
161808971|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
161808972|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808973|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161912316|NCT00423605|584730067|FG000|Overall Study|Protocol Violation|7|||
161912317|NCT00423605|584730067|FG000|Overall Study|Not one of the pre-specified options|5|||
161912318|NCT03183908|584730068|FG000|Overall Study|Missing Symptom Diary Data|0|||
161912319|NCT03183908|584730069|FG001|Overall Study|Missing Symptom Diary Data|2|||
161912320|NCT00393367|584730070|FG000|Overall Study|Protocol Violation|2|||
161912321|NCT00393367|584730071|FG001|Overall Study|Protocol Violation|5|||
161912322|NCT00393367|584730070|FG000|Overall Study|Withdrawal by Subject|0|||
161912323|NCT00393367|584730071|FG001|Overall Study|Withdrawal by Subject|2|||
161912324|NCT01712178|584730072|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
161912325|NCT01712178|584730073|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
161912326|NCT01712178|584730072|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
161912327|NCT01712178|584730073|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
161912328|NCT01712178|584730072|FG000|Overall Study|Lost to Follow-up|0|||
161912329|NCT01712178|584730073|FG001|Overall Study|Lost to Follow-up|1|||
161912330|NCT00856180|584730074|FG000|Overall Study|Adverse Event|4|||
161912331|NCT00856180|584730074|FG000|Overall Study|Progressive Disease|16|||
161912332|NCT05001620|584730077|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
161912333|NCT05001620|584730078|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
161912334|NCT00819039|584730079|FG000|Overall Study|Physician Decision|1|||
161912335|NCT00819039|584730080|FG001|Overall Study|Physician Decision|0|||
161912336|NCT00819039|584730081|FG002|Overall Study|Physician Decision|1|||
161912337|NCT00819039|584730079|FG000|Overall Study|Protocol Violation|1|||
161912338|NCT00819039|584730080|FG001|Overall Study|Protocol Violation|0|||
161912339|NCT00819039|584730081|FG002|Overall Study|Protocol Violation|0|||
161912340|NCT04796415|584730082|FG000|Overall Study|not interested|12|||
161912341|NCT04796415|584730082|FG000|Overall Study|health issue|8|||
161912342|NCT04796415|584730082|FG000|Overall Study|Other|4|||
161912343|NCT04796415|584730082|FG000|Overall Study|discharged from home health service|3|||
161912344|NCT04796415|584730082|FG000|Overall Study|re-hospitalization|2|||
161912345|NCT04796415|584730082|FG000|Overall Study|moving to nursing home|1|||
161912346|NCT04796415|584730082|FG000|Overall Study|lost contact|1|||
161912347|NCT00486044|584730086|FG000|Overall Study|Withdrawal by Subject|2|||
161912348|NCT00486044|584730087|FG001|Overall Study|Withdrawal by Subject|1|||
161912349|NCT00486044|584730086|FG000|Overall Study|Adverse Event|0|||
161912350|NCT00486044|584730087|FG001|Overall Study|Adverse Event|1|||
161912351|NCT00486044|584730086|FG000|Overall Study|Lost to Follow-up|0|||
161912352|NCT00486044|584730087|FG001|Overall Study|Lost to Follow-up|1|||
161912353|NCT02701634|584730088|FG000|Overall Study|Adverse Event|2|||
161912354|NCT02701634|584730089|FG001|Overall Study|Adverse Event|3|||
161912355|NCT02701634|584730088|FG000|Overall Study|Death|1|||
161912356|NCT02701634|584730089|FG001|Overall Study|Death|0|||
161912357|NCT02701634|584730088|FG000|Overall Study|Investigator's Discretion|7|||
161912358|NCT02701634|584730089|FG001|Overall Study|Investigator's Discretion|4|||
161912359|NCT02701634|584730088|FG000|Overall Study|Study terminated by Sponsor|15|||
161912360|NCT02701634|584730089|FG001|Overall Study|Study terminated by Sponsor|17|||
161912361|NCT02701634|584730088|FG000|Overall Study|Withdrew Consent|6|||
161912362|NCT02701634|584730089|FG001|Overall Study|Withdrew Consent|7|||
161912363|NCT02701634|584730088|FG000|Overall Study|Randomized but not treated|1|||
161912364|NCT02701634|584730089|FG001|Overall Study|Randomized but not treated|0|||
161912365|NCT01206764|584730090|FG000|Overall Study|Adverse Event|20|||
161912366|NCT01206764|584730090|FG000|Overall Study|Abnormal laboratory value|2|||
161912367|NCT01206764|584730090|FG000|Overall Study|Abnormal test procedure result|1|||
161912368|NCT01206764|584730090|FG000|Overall Study|Patient withdrew consent|5|||
161912369|NCT01206764|584730090|FG000|Overall Study|Lost to Follow-up|6|||
161912370|NCT01206764|584730090|FG000|Overall Study|Death|11|||
161912371|NCT01206764|584730090|FG000|Overall Study|New cancer therapy|2|||
161912372|NCT01206764|584730090|FG000|Overall Study|Disease progression|88|||
161912373|NCT01206764|584730090|FG000|Overall Study|Protocol deviation|3|||
161912374|NCT04494646|584730091|FG000|Overall Study|Adverse Event|0|||
161912375|NCT04494646|584730092|FG001|Overall Study|Adverse Event|1|||
161912376|NCT04494646|584730091|FG000|Overall Study|Withdrawal by Subject|0|||
161912377|NCT04494646|584730092|FG001|Overall Study|Withdrawal by Subject|1|||
161912378|NCT00537277|584730095|FG000|Overall Study|Adverse Event|1|||
161912379|NCT00537277|584730095|FG000|Overall Study|Lack of Efficacy|2|||
161912380|NCT00537277|584730095|FG000|Overall Study|Lost to Follow-up|12|||
161912381|NCT00537277|584730095|FG000|Overall Study|Protocol Violation|11|||
161912382|NCT00537277|584730095|FG000|Overall Study|Unclassified|4|||
161912383|NCT00537277|584730095|FG000|Overall Study|Inability to tolerate trial medication|4|||
161912384|NCT00537277|584730095|FG000|Overall Study|Non-compliance with trial procedures|15|||
161912385|NCT05282823|584730096|FG000|Overall Study|Withdrawal by Subject|9|||
161912386|NCT05282823|584730096|FG000|Overall Study|Adverse Event|1|||
161912387|NCT05282823|584730096|FG000|Overall Study|did not meet protocol criteria|2|||
161912388|NCT05282823|584730096|FG000|Overall Study|Withdrawal by Subject|7|||
161912389|NCT00997893|584730097|FG000|Overall Study|Adverse Event|1|||
161912390|NCT00997893|584730098|FG001|Overall Study|Adverse Event|0|||
161912391|NCT00997893|584730099|FG002|Overall Study|Adverse Event|0|||
161912392|NCT00997893|584730097|FG000|Overall Study|Unable to meet study timelines|1|||
161912393|NCT00997893|584730098|FG001|Overall Study|Unable to meet study timelines|0|||
161912394|NCT00997893|584730099|FG002|Overall Study|Unable to meet study timelines|0|||
161912395|NCT00997893|584730097|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
161912396|NCT00997893|584730098|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
161912397|NCT00997893|584730099|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
161912398|NCT03620162|584730100|FG000|Overall Study|Physician Decision|4|||
161912399|NCT03620162|584730101|FG001|Overall Study|Physician Decision|0|||
161912400|NCT03620162|584730102|FG002|Overall Study|Physician Decision|1|||
161912401|NCT03620162|584730103|FG003|Overall Study|Physician Decision|0|||
161912402|NCT03620162|584730104|FG004|Overall Study|Physician Decision|2|||
161912403|NCT03620162|584730100|FG000|Overall Study|Lost to Follow-up|2|||
161912404|NCT03620162|584730101|FG001|Overall Study|Lost to Follow-up|6|||
161912405|NCT03620162|584730102|FG002|Overall Study|Lost to Follow-up|7|||
161912406|NCT03620162|584730103|FG003|Overall Study|Lost to Follow-up|3|||
161912407|NCT03620162|584730104|FG004|Overall Study|Lost to Follow-up|2|||
161912408|NCT03620162|584730100|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
161912409|NCT03620162|584730101|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
161912410|NCT03620162|584730102|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
161912411|NCT03620162|584730103|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
161912412|NCT03620162|584730104|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
161912413|NCT04009837|584730107|FG000|Overall Study|Withdrawal by Subject|5|||
161912414|NCT04009837|584730108|FG001|Overall Study|Withdrawal by Subject|4|||
161912415|NCT04009837|584730107|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
161912416|NCT04009837|584730108|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
161912417|NCT05569174|584730109|FG000|Overall Study|Adverse Event|0|||
161912418|NCT05569174|584730110|FG001|Overall Study|Adverse Event|1|||
161912419|NCT05569174|584730109|FG000|Overall Study|Lack of compliance|0|||
161912420|NCT05569174|584730110|FG001|Overall Study|Lack of compliance|1|||
161912421|NCT05569174|584730109|FG000|Overall Study|Withdrawal of consent|0|||
161912422|NCT05569174|584730110|FG001|Overall Study|Withdrawal of consent|1|||
161912423|NCT05569174|584730109|FG000|Overall Study|Participant wish|0|||
161912424|NCT05569174|584730110|FG001|Overall Study|Participant wish|1|||
161912425|NCT05569174|584730109|FG000|Overall Study|Lost to Follow-up|0|||
161912426|NCT05569174|584730110|FG001|Overall Study|Lost to Follow-up|1|||
161912427|NCT00112957|584730111|FG000|Overall Study|Progressive disease|18|||
161912428|NCT00112957|584730111|FG000|Overall Study|Physician Decision|1|||
161912429|NCT05352815|584730114|FG000|Overall Study|Withdrawal by Subject|28|||
161912430|NCT05352815|584730115|FG001|Overall Study|Withdrawal by Subject|24|||
161912431|NCT05352815|584730114|FG000|Overall Study|Lost to Follow-up|4|||
161912432|NCT05352815|584730115|FG001|Overall Study|Lost to Follow-up|7|||
161912433|NCT05352815|584730114|FG000|Overall Study|Death|2|||
161912434|NCT05352815|584730115|FG001|Overall Study|Death|3|||
161912435|NCT05352815|584730114|FG000|Overall Study|Site closure|1|||
161912436|NCT05352815|584730115|FG001|Overall Study|Site closure|0|||
161912437|NCT00961415|584730118|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
161912438|NCT00961415|584730119|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
161912439|NCT00961415|584730120|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
161912440|NCT00961415|584730118|FG000|Induction Treatment Phase|Death|77|||
161912441|NCT00961415|584730119|FG001|Induction Treatment Phase|Death|0|||
161912442|NCT00961415|584730120|FG002|Induction Treatment Phase|Death|0|||
161912443|NCT00961415|584730118|FG000|Induction Treatment Phase|Protocol Violation|1|||
161912444|NCT00961415|584730119|FG001|Induction Treatment Phase|Protocol Violation|0|||
161912445|NCT00961415|584730120|FG002|Induction Treatment Phase|Protocol Violation|0|||
161912446|NCT00961415|584730118|FG000|Induction Treatment Phase|Physician Decision|2|||
161912447|NCT00961415|584730119|FG001|Induction Treatment Phase|Physician Decision|0|||
161912448|NCT00961415|584730120|FG002|Induction Treatment Phase|Physician Decision|0|||
161912449|NCT00961415|584730118|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
161912450|NCT00961415|584730119|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
161912451|NCT00961415|584730120|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
161912452|NCT00961415|584730118|FG000|Induction Treatment Phase|Other Reason|5|||
161912453|NCT00961415|584730119|FG001|Induction Treatment Phase|Other Reason|0|||
161912454|NCT00961415|584730120|FG002|Induction Treatment Phase|Other Reason|0|||
161912455|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Death|0|||
161912456|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Death|42|||
161912457|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Death|34|||
161912458|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Investigators decision|0|||
161912459|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Investigators decision|2|||
161912460|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Investigators decision|0|||
161912461|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161912462|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
161912463|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
161912464|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Other reason|0|||
161912465|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Other reason|1|||
161912466|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Other reason|3|||
161912467|NCT00226655|584730121|FG000|Overall Study|Death|13|||
161912468|NCT00226655|584730121|FG000|Overall Study|Withdrawal by Subject|15|||
161912469|NCT00226655|584730121|FG000|Overall Study|Adverse Event|35|||
161912470|NCT00226655|584730121|FG000|Overall Study|Physician Decision|6|||
161912471|NCT00226655|584730121|FG000|Overall Study|Clinical deterioration|10|||
161912472|NCT02309359|584730122|FG000|Overall Study|Adverse Event|4|||
161912473|NCT02309359|584730123|FG001|Overall Study|Adverse Event|5|||
161912474|NCT02309359|584730124|FG002|Overall Study|Adverse Event|5|||
161912475|NCT02309359|584730125|FG003|Overall Study|Adverse Event|4|||
161912476|NCT02309359|584730126|FG004|Overall Study|Adverse Event|4|||
161912477|NCT02309359|584730122|FG000|Overall Study|Death|1|||
161912478|NCT02309359|584730123|FG001|Overall Study|Death|0|||
161912479|NCT02309359|584730124|FG002|Overall Study|Death|0|||
161912480|NCT02309359|584730125|FG003|Overall Study|Death|0|||
161912481|NCT02309359|584730126|FG004|Overall Study|Death|0|||
161912482|NCT02309359|584730122|FG000|Overall Study|Withdrawal by Subject|2|||
161912483|NCT02309359|584730123|FG001|Overall Study|Withdrawal by Subject|2|||
161912484|NCT02309359|584730124|FG002|Overall Study|Withdrawal by Subject|4|||
161912485|NCT02309359|584730125|FG003|Overall Study|Withdrawal by Subject|4|||
161912486|NCT02309359|584730126|FG004|Overall Study|Withdrawal by Subject|0|||
161912487|NCT02309359|584730122|FG000|Overall Study|Lack of Efficacy|3|||
161912488|NCT02309359|584730123|FG001|Overall Study|Lack of Efficacy|1|||
161912489|NCT02309359|584730124|FG002|Overall Study|Lack of Efficacy|0|||
161912490|NCT02309359|584730125|FG003|Overall Study|Lack of Efficacy|0|||
161912491|NCT02309359|584730126|FG004|Overall Study|Lack of Efficacy|3|||
161912492|NCT02309359|584730122|FG000|Overall Study|Lost to Follow-up|0|||
161912493|NCT02309359|584730123|FG001|Overall Study|Lost to Follow-up|0|||
161912494|NCT02309359|584730124|FG002|Overall Study|Lost to Follow-up|0|||
161912495|NCT02309359|584730125|FG003|Overall Study|Lost to Follow-up|1|||
161912496|NCT02309359|584730126|FG004|Overall Study|Lost to Follow-up|0|||
161568158|NCT01311713|583467674|FG000|Overall Study|Adverse Event|0|||
161568159|NCT01311713|583467675|FG001|Overall Study|Adverse Event|1|||
161568160|NCT01311713|583467676|FG002|Overall Study|Adverse Event|0|||
161912497|NCT02309359|584730122|FG000|Overall Study|Other|2|||
161912498|NCT02309359|584730123|FG001|Overall Study|Other|0|||
161912499|NCT02309359|584730124|FG002|Overall Study|Other|2|||
161912500|NCT02309359|584730125|FG003|Overall Study|Other|3|||
161912501|NCT02309359|584730126|FG004|Overall Study|Other|2|||
161912502|NCT05144945|584730128|FG000|Overall Study|Withdrawal by Subject|1|||
161912503|NCT05144945|584730129|FG001|Overall Study|Withdrawal by Subject|0|||
161912504|NCT06129149|584730131|FG000|Overall Study|Death|1|||
161912505|NCT04649359|584730132|FG000|Overall Study|Withdrawal by Subject|7|||
161912506|NCT04649359|584730133|FG001|Overall Study|Withdrawal by Subject|7|||
161912507|NCT04649359|584730132|FG000|Overall Study|Death|41|||
161912508|NCT04649359|584730133|FG001|Overall Study|Death|26|||
161912509|NCT04649359|584730132|FG000|Overall Study|Ongoing in the study|75|||
161912510|NCT04649359|584730133|FG001|Overall Study|Ongoing in the study|31|||
161912511|NCT03307174|584730134|FG000|Overall Study|Unplanned ICU Administrion|5|||
161912512|NCT03307174|584730135|FG001|Overall Study|Unplanned ICU Administrion|3|||
161912513|NCT03307174|584730134|FG000|Overall Study|Aborted Surgery|1|||
161912514|NCT03307174|584730135|FG001|Overall Study|Aborted Surgery|2|||
161912515|NCT03307174|584730134|FG000|Overall Study|Hypotension|6|||
161912516|NCT03307174|584730135|FG001|Overall Study|Hypotension|0|||
161912517|NCT03307174|584730134|FG000|Overall Study|Nonfunctional epidural|1|||
161912518|NCT03307174|584730135|FG001|Overall Study|Nonfunctional epidural|1|||
161912519|NCT03307174|584730134|FG000|Overall Study|Planned epidural removal|1|||
161912520|NCT03307174|584730135|FG001|Overall Study|Planned epidural removal|0|||
161912521|NCT03307174|584730134|FG000|Overall Study|Intrathecal catheter placement|0|||
161912522|NCT03307174|584730135|FG001|Overall Study|Intrathecal catheter placement|1|||
161912523|NCT05911841|584730136|FG000|Induction Period|Study Terminated by Sponsor|2|||
161912524|NCT05911841|584730137|FG001|Induction Period|Study Terminated by Sponsor|0|||
161912525|NCT05911841|584730138|FG002|Induction Period|Study Terminated by Sponsor|14|||
161912526|NCT05911841|584730139|FG003|Induction Period|Study Terminated by Sponsor|6|||
161912527|NCT05911841|584730140|FG004|Induction Period|Study Terminated by Sponsor|0|||
161912528|NCT05911841|584730141|FG005|Induction Period|Study Terminated by Sponsor|0|||
161912529|NCT05911841|584730142|FG006|Induction Period|Study Terminated by Sponsor|0|||
161912530|NCT05911841|584730143|FG007|Induction Period|Study Terminated by Sponsor|0|||
161568161|NCT01311713|583467677|FG003|Overall Study|Adverse Event|2|||
161568162|NCT01311713|583467678|FG004|Overall Study|Adverse Event|0|||
161568163|NCT01311713|583467679|FG005|Overall Study|Adverse Event|0|||
161912531|NCT05911841|584730144|FG008|Induction Period|Study Terminated by Sponsor|0|||
161568164|NCT01311713|583467680|FG006|Overall Study|Adverse Event|2|||
161568165|NCT01311713|583467674|FG000|Overall Study|Withdrawal by Subject|0|||
161912532|NCT05911841|584730145|FG009|Induction Period|Study Terminated by Sponsor|0|||
161912533|NCT05911841|584730136|FG000|Induction Period|Withdrawal by Subject|4|||
161912534|NCT05911841|584730137|FG001|Induction Period|Withdrawal by Subject|3|||
161912535|NCT05911841|584730138|FG002|Induction Period|Withdrawal by Subject|4|||
161912536|NCT05911841|584730139|FG003|Induction Period|Withdrawal by Subject|6|||
161912537|NCT05911841|584730140|FG004|Induction Period|Withdrawal by Subject|0|||
161912538|NCT05911841|584730141|FG005|Induction Period|Withdrawal by Subject|0|||
161912539|NCT05911841|584730142|FG006|Induction Period|Withdrawal by Subject|0|||
161912540|NCT05911841|584730143|FG007|Induction Period|Withdrawal by Subject|0|||
161912541|NCT05911841|584730144|FG008|Induction Period|Withdrawal by Subject|0|||
161912542|NCT05911841|584730145|FG009|Induction Period|Withdrawal by Subject|0|||
161912543|NCT05911841|584730136|FG000|Induction Period|Lack of Efficacy|3|||
161912544|NCT05911841|584730137|FG001|Induction Period|Lack of Efficacy|0|||
161912545|NCT05911841|584730138|FG002|Induction Period|Lack of Efficacy|3|||
161912546|NCT05911841|584730139|FG003|Induction Period|Lack of Efficacy|3|||
161912547|NCT05911841|584730140|FG004|Induction Period|Lack of Efficacy|0|||
161912548|NCT05911841|584730141|FG005|Induction Period|Lack of Efficacy|0|||
161912549|NCT05911841|584730142|FG006|Induction Period|Lack of Efficacy|0|||
161912550|NCT05911841|584730143|FG007|Induction Period|Lack of Efficacy|0|||
161912551|NCT05911841|584730144|FG008|Induction Period|Lack of Efficacy|0|||
161912552|NCT05911841|584730145|FG009|Induction Period|Lack of Efficacy|0|||
161912553|NCT05911841|584730136|FG000|Induction Period|Adverse Event|3|||
161912554|NCT05911841|584730137|FG001|Induction Period|Adverse Event|1|||
161912555|NCT05911841|584730138|FG002|Induction Period|Adverse Event|2|||
161912556|NCT05911841|584730139|FG003|Induction Period|Adverse Event|0|||
161912557|NCT05911841|584730140|FG004|Induction Period|Adverse Event|0|||
161912558|NCT05911841|584730141|FG005|Induction Period|Adverse Event|0|||
161912559|NCT05911841|584730142|FG006|Induction Period|Adverse Event|0|||
161912560|NCT05911841|584730143|FG007|Induction Period|Adverse Event|0|||
161912561|NCT05911841|584730144|FG008|Induction Period|Adverse Event|0|||
161912562|NCT05911841|584730145|FG009|Induction Period|Adverse Event|0|||
161912563|NCT05911841|584730136|FG000|Induction Period|Assigned Treatment by Mistake|0|||
161912564|NCT05911841|584730137|FG001|Induction Period|Assigned Treatment by Mistake|1|||
161912565|NCT05911841|584730138|FG002|Induction Period|Assigned Treatment by Mistake|0|||
161912566|NCT05911841|584730139|FG003|Induction Period|Assigned Treatment by Mistake|1|||
161912567|NCT05911841|584730140|FG004|Induction Period|Assigned Treatment by Mistake|0|||
161912568|NCT05911841|584730141|FG005|Induction Period|Assigned Treatment by Mistake|0|||
161912569|NCT05911841|584730142|FG006|Induction Period|Assigned Treatment by Mistake|0|||
161912570|NCT05911841|584730143|FG007|Induction Period|Assigned Treatment by Mistake|0|||
161912571|NCT05911841|584730144|FG008|Induction Period|Assigned Treatment by Mistake|0|||
161912572|NCT05911841|584730145|FG009|Induction Period|Assigned Treatment by Mistake|0|||
161912573|NCT05911841|584730136|FG000|Induction Period|Lost to Follow-up|0|||
161912574|NCT05911841|584730137|FG001|Induction Period|Lost to Follow-up|0|||
161912575|NCT05911841|584730138|FG002|Induction Period|Lost to Follow-up|1|||
161912576|NCT05911841|584730139|FG003|Induction Period|Lost to Follow-up|1|||
161912577|NCT05911841|584730140|FG004|Induction Period|Lost to Follow-up|0|||
161912578|NCT05911841|584730141|FG005|Induction Period|Lost to Follow-up|0|||
161912579|NCT05911841|584730142|FG006|Induction Period|Lost to Follow-up|0|||
161912580|NCT05911841|584730143|FG007|Induction Period|Lost to Follow-up|0|||
161912581|NCT05911841|584730144|FG008|Induction Period|Lost to Follow-up|0|||
161912582|NCT05911841|584730145|FG009|Induction Period|Lost to Follow-up|0|||
161912583|NCT05911841|584730136|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
161912584|NCT05911841|584730137|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
161912585|NCT05911841|584730138|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
161912586|NCT05911841|584730139|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
161912587|NCT05911841|584730140|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
161912588|NCT05911841|584730141|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
161912589|NCT05911841|584730142|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
161912590|NCT05911841|584730143|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
161912591|NCT05911841|584730144|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
161912592|NCT05911841|584730145|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
161912593|NCT05911841|584730136|FG000|Maintenance Period|Lack of Efficacy|0|||
161912594|NCT05911841|584730137|FG001|Maintenance Period|Lack of Efficacy|0|||
161912595|NCT05911841|584730138|FG002|Maintenance Period|Lack of Efficacy|0|||
161912596|NCT05911841|584730139|FG003|Maintenance Period|Lack of Efficacy|0|||
161912597|NCT05911841|584730140|FG004|Maintenance Period|Lack of Efficacy|1|||
161912598|NCT05911841|584730141|FG005|Maintenance Period|Lack of Efficacy|0|||
161912599|NCT05911841|584730142|FG006|Maintenance Period|Lack of Efficacy|1|||
161912600|NCT05911841|584730143|FG007|Maintenance Period|Lack of Efficacy|0|||
161912601|NCT05911841|584730144|FG008|Maintenance Period|Lack of Efficacy|0|||
161912602|NCT05911841|584730145|FG009|Maintenance Period|Lack of Efficacy|0|||
161912603|NCT05911841|584730136|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
161912604|NCT05911841|584730137|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
161912605|NCT05911841|584730138|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
161912606|NCT05911841|584730139|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
161912607|NCT05911841|584730140|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
161912608|NCT05911841|584730141|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
161912609|NCT05911841|584730142|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
161912610|NCT05911841|584730143|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
161912611|NCT05911841|584730144|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
161912612|NCT05911841|584730145|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
161912613|NCT05911841|584730136|FG000|Maintenance Period|Withdrawal by Subject|0|||
161912614|NCT05911841|584730137|FG001|Maintenance Period|Withdrawal by Subject|0|||
161912615|NCT05911841|584730138|FG002|Maintenance Period|Withdrawal by Subject|0|||
161912616|NCT05911841|584730139|FG003|Maintenance Period|Withdrawal by Subject|0|||
161912617|NCT05911841|584730140|FG004|Maintenance Period|Withdrawal by Subject|0|||
161912618|NCT05911841|584730141|FG005|Maintenance Period|Withdrawal by Subject|1|||
161912619|NCT05911841|584730142|FG006|Maintenance Period|Withdrawal by Subject|0|||
161912620|NCT05911841|584730143|FG007|Maintenance Period|Withdrawal by Subject|1|||
161912621|NCT05911841|584730144|FG008|Maintenance Period|Withdrawal by Subject|0|||
161912622|NCT05911841|584730145|FG009|Maintenance Period|Withdrawal by Subject|0|||
161912623|NCT05911841|584730136|FG000|Maintenance Period|Adverse Event|0|||
161912624|NCT05911841|584730137|FG001|Maintenance Period|Adverse Event|0|||
161912625|NCT05911841|584730138|FG002|Maintenance Period|Adverse Event|0|||
161912626|NCT05911841|584730139|FG003|Maintenance Period|Adverse Event|0|||
161912627|NCT05911841|584730140|FG004|Maintenance Period|Adverse Event|0|||
161912628|NCT05911841|584730141|FG005|Maintenance Period|Adverse Event|0|||
161912629|NCT05911841|584730142|FG006|Maintenance Period|Adverse Event|0|||
161912630|NCT05911841|584730143|FG007|Maintenance Period|Adverse Event|1|||
161912631|NCT05911841|584730144|FG008|Maintenance Period|Adverse Event|0|||
161912632|NCT05911841|584730145|FG009|Maintenance Period|Adverse Event|0|||
161912633|NCT05911841|584730136|FG000|Escape Period|Adverse Event|0|||
161912634|NCT05911841|584730137|FG001|Escape Period|Adverse Event|0|||
161912635|NCT05911841|584730138|FG002|Escape Period|Adverse Event|0|||
161912636|NCT05911841|584730139|FG003|Escape Period|Adverse Event|0|||
161912637|NCT05911841|584730140|FG004|Escape Period|Adverse Event|0|||
161912638|NCT05911841|584730141|FG005|Escape Period|Adverse Event|0|||
161912639|NCT05911841|584730142|FG006|Escape Period|Adverse Event|0|||
161912640|NCT05911841|584730143|FG007|Escape Period|Adverse Event|0|||
161912641|NCT05911841|584730144|FG008|Escape Period|Adverse Event|0|||
161912642|NCT05911841|584730145|FG009|Escape Period|Adverse Event|1|||
161912643|NCT05911841|584730136|FG000|Escape Period|Lack of Efficacy|0|||
161912644|NCT05911841|584730137|FG001|Escape Period|Lack of Efficacy|0|||
161912645|NCT05911841|584730138|FG002|Escape Period|Lack of Efficacy|0|||
161912646|NCT05911841|584730139|FG003|Escape Period|Lack of Efficacy|0|||
161912647|NCT05911841|584730140|FG004|Escape Period|Lack of Efficacy|0|||
161912648|NCT05911841|584730141|FG005|Escape Period|Lack of Efficacy|0|||
161912649|NCT05911841|584730142|FG006|Escape Period|Lack of Efficacy|0|||
161912650|NCT05911841|584730143|FG007|Escape Period|Lack of Efficacy|0|||
161912651|NCT05911841|584730144|FG008|Escape Period|Lack of Efficacy|0|||
161912652|NCT05911841|584730145|FG009|Escape Period|Lack of Efficacy|31|||
161912653|NCT05911841|584730136|FG000|Escape Period|Lost to Follow-up|0|||
161912654|NCT05911841|584730137|FG001|Escape Period|Lost to Follow-up|0|||
161912655|NCT05911841|584730138|FG002|Escape Period|Lost to Follow-up|0|||
161912656|NCT05911841|584730139|FG003|Escape Period|Lost to Follow-up|0|||
161912657|NCT05911841|584730140|FG004|Escape Period|Lost to Follow-up|0|||
161912658|NCT05911841|584730141|FG005|Escape Period|Lost to Follow-up|0|||
161912659|NCT05911841|584730142|FG006|Escape Period|Lost to Follow-up|0|||
161912660|NCT05911841|584730143|FG007|Escape Period|Lost to Follow-up|0|||
161912661|NCT05911841|584730144|FG008|Escape Period|Lost to Follow-up|0|||
161912662|NCT05911841|584730145|FG009|Escape Period|Lost to Follow-up|1|||
161912663|NCT05911841|584730136|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912664|NCT05911841|584730137|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912665|NCT05911841|584730138|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912666|NCT05911841|584730139|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912667|NCT05911841|584730140|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912668|NCT05911841|584730141|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912669|NCT05911841|584730142|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912670|NCT05911841|584730143|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912671|NCT05911841|584730144|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912672|NCT05911841|584730145|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
161912673|NCT05911841|584730136|FG000|Escape Period|Site Terminated by Sponsor|0|||
161912674|NCT05911841|584730137|FG001|Escape Period|Site Terminated by Sponsor|0|||
161912675|NCT05911841|584730138|FG002|Escape Period|Site Terminated by Sponsor|0|||
161912676|NCT05911841|584730139|FG003|Escape Period|Site Terminated by Sponsor|0|||
161912677|NCT05911841|584730140|FG004|Escape Period|Site Terminated by Sponsor|0|||
161912678|NCT05911841|584730141|FG005|Escape Period|Site Terminated by Sponsor|0|||
161912679|NCT05911841|584730142|FG006|Escape Period|Site Terminated by Sponsor|0|||
161912680|NCT05911841|584730143|FG007|Escape Period|Site Terminated by Sponsor|0|||
161912681|NCT05911841|584730144|FG008|Escape Period|Site Terminated by Sponsor|0|||
161912682|NCT05911841|584730145|FG009|Escape Period|Site Terminated by Sponsor|1|||
161912683|NCT05911841|584730136|FG000|Escape Period|Study Terminated by Sponsor|0|||
161568166|NCT01311713|583467675|FG001|Overall Study|Withdrawal by Subject|1|||
161912684|NCT05911841|584730137|FG001|Escape Period|Study Terminated by Sponsor|0|||
161912685|NCT05911841|584730138|FG002|Escape Period|Study Terminated by Sponsor|0|||
161912686|NCT05911841|584730139|FG003|Escape Period|Study Terminated by Sponsor|0|||
161912687|NCT05911841|584730140|FG004|Escape Period|Study Terminated by Sponsor|0|||
161912688|NCT05911841|584730141|FG005|Escape Period|Study Terminated by Sponsor|0|||
161912689|NCT05911841|584730142|FG006|Escape Period|Study Terminated by Sponsor|0|||
161912690|NCT05911841|584730143|FG007|Escape Period|Study Terminated by Sponsor|0|||
161912691|NCT05911841|584730144|FG008|Escape Period|Study Terminated by Sponsor|0|||
161912692|NCT05911841|584730145|FG009|Escape Period|Study Terminated by Sponsor|34|||
161912693|NCT05911841|584730136|FG000|Escape Period|Withdrawal by Subject|0|||
161912694|NCT05911841|584730137|FG001|Escape Period|Withdrawal by Subject|0|||
161912695|NCT05911841|584730138|FG002|Escape Period|Withdrawal by Subject|0|||
161912696|NCT05911841|584730139|FG003|Escape Period|Withdrawal by Subject|0|||
161912697|NCT05911841|584730140|FG004|Escape Period|Withdrawal by Subject|0|||
161912698|NCT05911841|584730141|FG005|Escape Period|Withdrawal by Subject|0|||
161912699|NCT05911841|584730142|FG006|Escape Period|Withdrawal by Subject|0|||
161912700|NCT05911841|584730143|FG007|Escape Period|Withdrawal by Subject|0|||
161912701|NCT05911841|584730144|FG008|Escape Period|Withdrawal by Subject|0|||
161912702|NCT05911841|584730145|FG009|Escape Period|Withdrawal by Subject|10|||
161912703|NCT05595369|584730146|FG000|Overall Study|Adverse Event|2|||
161912704|NCT05595369|584730147|FG001|Overall Study|Adverse Event|0|||
161912705|NCT05595369|584730148|FG002|Overall Study|Adverse Event|0|||
161912706|NCT05595369|584730146|FG000|Overall Study|Lost to Follow-up|11|||
161912707|NCT05595369|584730147|FG001|Overall Study|Lost to Follow-up|10|||
161912708|NCT05595369|584730148|FG002|Overall Study|Lost to Follow-up|10|||
161912709|NCT05595369|584730146|FG000|Overall Study|Physician Decision|1|||
161912710|NCT05595369|584730147|FG001|Overall Study|Physician Decision|0|||
161912711|NCT05595369|584730148|FG002|Overall Study|Physician Decision|0|||
161912712|NCT05595369|584730146|FG000|Overall Study|Withdrawal by Subject|5|||
161912713|NCT05595369|584730147|FG001|Overall Study|Withdrawal by Subject|7|||
161912714|NCT05595369|584730148|FG002|Overall Study|Withdrawal by Subject|6|||
161912715|NCT05595369|584730146|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161912716|NCT05595369|584730147|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
161912717|NCT05595369|584730148|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
161912718|NCT05595369|584730146|FG000|Overall Study|Study Drug Non-compliance|0|||
161912719|NCT05595369|584730147|FG001|Overall Study|Study Drug Non-compliance|1|||
161912720|NCT05595369|584730148|FG002|Overall Study|Study Drug Non-compliance|0|||
161912721|NCT05595369|584730146|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
161912722|NCT05595369|584730147|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
161912723|NCT05595369|584730148|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
161912724|NCT02391337|584730149|FG000|6 Months Follow-up|Death|5|||
161912725|NCT02391337|584730150|FG001|6 Months Follow-up|Death|4|||
161912726|NCT02391337|584730149|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
161912727|NCT02391337|584730150|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
161912728|NCT02391337|584730149|FG000|12 Months Follow-up|Death|2|||
161912729|NCT02391337|584730150|FG001|12 Months Follow-up|Death|0|||
161912730|NCT02391337|584730149|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
161912731|NCT02391337|584730150|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
161912732|NCT02391337|584730149|FG000|12 Months Follow-up|Lost to Follow-up|0|||
161912733|NCT02391337|584730150|FG001|12 Months Follow-up|Lost to Follow-up|2|||
161912734|NCT00465517|584730152|FG000|Overall Study|Adverse Event|7|||
161912735|NCT00465517|584730153|FG001|Overall Study|Adverse Event|3|||
161912736|NCT00465517|584730152|FG000|Overall Study|Lost to Follow-up|1|||
161912737|NCT00465517|584730153|FG001|Overall Study|Lost to Follow-up|0|||
161912738|NCT00465517|584730152|FG000|Overall Study|Withdrawal by Subject|4|||
161912739|NCT00465517|584730153|FG001|Overall Study|Withdrawal by Subject|1|||
161912740|NCT03191552|584730156|FG000|Overall Study|Lost to Follow-up|1|||
161912741|NCT03191552|584730157|FG001|Overall Study|Lost to Follow-up|0|||
161912742|NCT03191552|584730158|FG002|Overall Study|Lost to Follow-up|0|||
161912743|NCT03191552|584730156|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
161912744|NCT03191552|584730157|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
161912745|NCT03191552|584730158|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
161912746|NCT01499810|584730159|FG000|Overall Study|Lost to Follow-up|10|||
161912747|NCT01499810|584730159|FG000|Overall Study|Protocol Violation|1|||
161912748|NCT01499810|584730159|FG000|Overall Study|Withdrawal by Subject|1|||
161912749|NCT01884597|584730160|FG000|Overall Study|Adverse Event|0|||
161912750|NCT01884597|584730161|FG001|Overall Study|Adverse Event|0|||
161912751|NCT01884597|584730162|FG002|Overall Study|Adverse Event|1|||
161912752|NCT01884597|584730160|FG000|Overall Study|Lack of Efficacy|1|||
161912753|NCT01884597|584730161|FG001|Overall Study|Lack of Efficacy|0|||
161912754|NCT01884597|584730162|FG002|Overall Study|Lack of Efficacy|0|||
161912755|NCT01884597|584730160|FG000|Overall Study|Death|0|||
161912756|NCT01884597|584730161|FG001|Overall Study|Death|1|||
161912757|NCT01884597|584730162|FG002|Overall Study|Death|0|||
161912758|NCT02634710|584730163|FG000|Overall Study|Death|4|||
161912759|NCT04530630|584731813|FG000|Overall Study|Physician Decision|1|||
161912760|NCT03834961|584731816|FG000|Overall Study|Lack of Efficacy|1|||
161912761|NCT03834961|584731817|FG001|Overall Study|Lack of Efficacy|1|||
161912762|NCT03834961|584731818|FG002|Overall Study|Lack of Efficacy|0|||
161912763|NCT03834961|584731816|FG000|Overall Study|Physician Decision|0|||
161912764|NCT03834961|584731817|FG001|Overall Study|Physician Decision|1|||
161912765|NCT03834961|584731818|FG002|Overall Study|Physician Decision|0|||
161456937|NCT00095147|583068851|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
161456938|NCT00095147|583068847|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
161456939|NCT00095147|583068848|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
161456940|NCT00095147|583068849|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
161456941|NCT00095147|583068850|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
161456942|NCT00095147|583068851|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
161456943|NCT00095147|583068847|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
161456944|NCT00095147|583068848|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
161456945|NCT00095147|583068849|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
161456946|NCT00095147|583068850|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
161456947|NCT00095147|583068851|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
161456948|NCT00095147|583068847|FG000|Long-term Extension Period|Death|0|||
161456949|NCT00095147|583068848|FG001|Long-term Extension Period|Death|0|||
161456950|NCT00095147|583068849|FG002|Long-term Extension Period|Death|0|||
161456951|NCT00095147|583068850|FG003|Long-term Extension Period|Death|0|||
161456952|NCT00095147|583068851|FG004|Long-term Extension Period|Death|3|||
161456953|NCT00095147|583068847|FG000|Long-term Extension Period|Adverse Event|0|||
161456954|NCT00095147|583068848|FG001|Long-term Extension Period|Adverse Event|0|||
161456955|NCT00095147|583068849|FG002|Long-term Extension Period|Adverse Event|0|||
161456956|NCT00095147|583068850|FG003|Long-term Extension Period|Adverse Event|0|||
161912766|NCT05507437|584731821|FG000|Overall Study|Withdrawal by Subject|1|||
161912767|NCT05507437|584731822|FG001|Overall Study|Withdrawal by Subject|1|||
161912768|NCT05507437|584731821|FG000|Overall Study|Death|3|||
161912769|NCT05507437|584731822|FG001|Overall Study|Death|0|||
161912770|NCT06583096|584731823|FG000|Overall Study|Lost to Follow-up|4|||
161912771|NCT06583096|584731824|FG001|Overall Study|Lost to Follow-up|10|||
161912772|NCT06583096|584731823|FG000|Overall Study|Withdrawal by Subject|0|||
161912773|NCT06583096|584731824|FG001|Overall Study|Withdrawal by Subject|2|||
161912774|NCT05172609|584731825|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
161912775|NCT05172609|584731826|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
161912776|NCT05172609|584731825|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
161912777|NCT05172609|584731826|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
161912778|NCT05172609|584731825|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
161912779|NCT05172609|584731826|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
161912780|NCT05610605|584731829|FG000|6-month Assessment|Death|1|||
161912781|NCT05610605|584731830|FG001|6-month Assessment|Death|1|||
161912782|NCT05610605|584731829|FG000|6-month Assessment|Lost to Follow-up|20|||
161912783|NCT05610605|584731830|FG001|6-month Assessment|Lost to Follow-up|0|||
161912784|NCT05610605|584731829|FG000|6-month Assessment|Institutionalized|1|||
161912785|NCT05610605|584731830|FG001|6-month Assessment|Institutionalized|2|||
161912786|NCT05610605|584731829|FG000|12-month Assessment|Death|2|||
161912787|NCT05610605|584731830|FG001|12-month Assessment|Death|1|||
161912788|NCT05610605|584731829|FG000|12-month Assessment|Lost to Follow-up|1|||
161912789|NCT05610605|584731830|FG001|12-month Assessment|Lost to Follow-up|4|||
161912790|NCT05610605|584731829|FG000|12-month Assessment|Institutionalized|2|||
161912791|NCT05610605|584731830|FG001|12-month Assessment|Institutionalized|1|||
161912792|NCT00753519|584731831|FG000|Overall Study|Withdrawal by Subject|0|||
161912793|NCT00753519|584731832|FG001|Overall Study|Withdrawal by Subject|2|||
161912794|NCT00042289|584731833|FG000|Overall Study|Lost to Follow-up|3|||
161912795|NCT00042289|584731834|FG001|Overall Study|Lost to Follow-up|0|||
161912796|NCT00042289|584731835|FG002|Overall Study|Lost to Follow-up|0|||
161912797|NCT00042289|584731836|FG003|Overall Study|Lost to Follow-up|1|||
161912798|NCT00042289|584731837|FG004|Overall Study|Lost to Follow-up|3|||
161912799|NCT00042289|584731838|FG005|Overall Study|Lost to Follow-up|3|||
161912800|NCT00042289|584731839|FG006|Overall Study|Lost to Follow-up|6|||
161912801|NCT00042289|584731840|FG007|Overall Study|Lost to Follow-up|1|||
161912802|NCT00042289|584731841|FG008|Overall Study|Lost to Follow-up|1|||
161912803|NCT00042289|584731842|FG009|Overall Study|Lost to Follow-up|0|||
161912804|NCT00042289|584731843|FG010|Overall Study|Lost to Follow-up|0|||
161912805|NCT00042289|584731844|FG011|Overall Study|Lost to Follow-up|0|||
161456957|NCT00095147|583068851|FG004|Long-term Extension Period|Adverse Event|11|||
161456958|NCT00095147|583068847|FG000|Long-term Extension Period|Lack of Efficacy|0|||
161912806|NCT00042289|584731845|FG012|Overall Study|Lost to Follow-up|0|||
161912807|NCT00042289|584731846|FG013|Overall Study|Lost to Follow-up|0|||
161912808|NCT00042289|584731847|FG014|Overall Study|Lost to Follow-up|0|||
161912809|NCT00042289|584731848|FG015|Overall Study|Lost to Follow-up|1|||
161912810|NCT00042289|584731849|FG016|Overall Study|Lost to Follow-up|1|||
161912811|NCT00042289|584731850|FG017|Overall Study|Lost to Follow-up|0|||
161912812|NCT00042289|584731851|FG018|Overall Study|Lost to Follow-up|3|||
161912813|NCT00042289|584731852|FG019|Overall Study|Lost to Follow-up|2|||
161912814|NCT00042289|584731853|FG020|Overall Study|Lost to Follow-up|0|||
161912815|NCT00042289|584731854|FG021|Overall Study|Lost to Follow-up|0|||
161912816|NCT00042289|584731855|FG022|Overall Study|Lost to Follow-up|0|||
161912817|NCT00042289|584731856|FG023|Overall Study|Lost to Follow-up|0|||
161912818|NCT00042289|584731857|FG024|Overall Study|Lost to Follow-up|0|||
161912819|NCT00042289|584731858|FG025|Overall Study|Lost to Follow-up|0|||
161912820|NCT00042289|584731859|FG026|Overall Study|Lost to Follow-up|2|||
161912821|NCT00042289|584731860|FG027|Overall Study|Lost to Follow-up|2|||
161912822|NCT00042289|584731861|FG028|Overall Study|Lost to Follow-up|2|||
161912823|NCT00042289|584731862|FG029|Overall Study|Lost to Follow-up|0|||
161912824|NCT00042289|584731863|FG030|Overall Study|Lost to Follow-up|0|||
161912825|NCT00042289|584731864|FG031|Overall Study|Lost to Follow-up|2|||
161912826|NCT00042289|584731865|FG032|Overall Study|Lost to Follow-up|1|||
161912827|NCT00042289|584731866|FG033|Overall Study|Lost to Follow-up|1|||
161912828|NCT00042289|584731867|FG034|Overall Study|Lost to Follow-up|1|||
161912829|NCT00042289|584731868|FG035|Overall Study|Lost to Follow-up|2|||
161912830|NCT00042289|584731869|FG036|Overall Study|Lost to Follow-up|1|||
161912831|NCT00042289|584731870|FG037|Overall Study|Lost to Follow-up|1|||
161912832|NCT00042289|584731871|FG038|Overall Study|Lost to Follow-up|0|||
161912833|NCT00042289|584731872|FG039|Overall Study|Lost to Follow-up|5|||
161912834|NCT00042289|584731873|FG040|Overall Study|Lost to Follow-up|0|||
161912835|NCT00042289|584731874|FG041|Overall Study|Lost to Follow-up|2|||
161912836|NCT00042289|584731875|FG042|Overall Study|Lost to Follow-up|2|||
161912837|NCT00042289|584731876|FG043|Overall Study|Lost to Follow-up|0|||
161912838|NCT00042289|584731877|FG044|Overall Study|Lost to Follow-up|0|||
161912839|NCT00042289|584731878|FG045|Overall Study|Lost to Follow-up|1|||
161912840|NCT00042289|584731879|FG046|Overall Study|Lost to Follow-up|0|||
161912841|NCT00042289|584731833|FG000|Overall Study|Other reason|0|||
161912842|NCT00042289|584731834|FG001|Overall Study|Other reason|0|||
161912843|NCT00042289|584731835|FG002|Overall Study|Other reason|0|||
161912844|NCT00042289|584731836|FG003|Overall Study|Other reason|2|||
161912845|NCT00042289|584731837|FG004|Overall Study|Other reason|0|||
161912846|NCT00042289|584731838|FG005|Overall Study|Other reason|0|||
161912847|NCT00042289|584731839|FG006|Overall Study|Other reason|0|||
161912848|NCT00042289|584731840|FG007|Overall Study|Other reason|0|||
161912849|NCT00042289|584731841|FG008|Overall Study|Other reason|0|||
161912850|NCT00042289|584731842|FG009|Overall Study|Other reason|0|||
161912851|NCT00042289|584731843|FG010|Overall Study|Other reason|0|||
161912852|NCT00042289|584731844|FG011|Overall Study|Other reason|0|||
161912853|NCT00042289|584731845|FG012|Overall Study|Other reason|0|||
161912854|NCT00042289|584731846|FG013|Overall Study|Other reason|0|||
161912855|NCT00042289|584731847|FG014|Overall Study|Other reason|0|||
161912856|NCT00042289|584731848|FG015|Overall Study|Other reason|0|||
161912857|NCT00042289|584731849|FG016|Overall Study|Other reason|0|||
161912858|NCT00042289|584731850|FG017|Overall Study|Other reason|0|||
161912859|NCT00042289|584731851|FG018|Overall Study|Other reason|1|||
161912860|NCT00042289|584731852|FG019|Overall Study|Other reason|0|||
161912861|NCT00042289|584731853|FG020|Overall Study|Other reason|0|||
161912862|NCT00042289|584731854|FG021|Overall Study|Other reason|0|||
161912863|NCT00042289|584731855|FG022|Overall Study|Other reason|0|||
161912864|NCT00042289|584731856|FG023|Overall Study|Other reason|1|||
161912865|NCT00042289|584731857|FG024|Overall Study|Other reason|0|||
161912866|NCT00042289|584731858|FG025|Overall Study|Other reason|0|||
161912867|NCT00042289|584731859|FG026|Overall Study|Other reason|1|||
161912868|NCT00042289|584731860|FG027|Overall Study|Other reason|0|||
161912869|NCT00042289|584731861|FG028|Overall Study|Other reason|3|||
161912870|NCT00042289|584731862|FG029|Overall Study|Other reason|0|||
161912871|NCT00042289|584731863|FG030|Overall Study|Other reason|0|||
161912872|NCT00042289|584731864|FG031|Overall Study|Other reason|1|||
161912873|NCT00042289|584731865|FG032|Overall Study|Other reason|0|||
161912874|NCT00042289|584731866|FG033|Overall Study|Other reason|1|||
161912875|NCT00042289|584731867|FG034|Overall Study|Other reason|0|||
161912876|NCT00042289|584731868|FG035|Overall Study|Other reason|2|||
161912877|NCT00042289|584731869|FG036|Overall Study|Other reason|0|||
161912878|NCT00042289|584731870|FG037|Overall Study|Other reason|0|||
161568167|NCT01311713|583467676|FG002|Overall Study|Withdrawal by Subject|1|||
161568168|NCT01311713|583467677|FG003|Overall Study|Withdrawal by Subject|0|||
161912879|NCT00042289|584731871|FG038|Overall Study|Other reason|0|||
161912880|NCT00042289|584731872|FG039|Overall Study|Other reason|0|||
161912881|NCT00042289|584731873|FG040|Overall Study|Other reason|0|||
161912882|NCT00042289|584731874|FG041|Overall Study|Other reason|0|||
161912883|NCT00042289|584731875|FG042|Overall Study|Other reason|0|||
161912884|NCT00042289|584731876|FG043|Overall Study|Other reason|1|||
161912885|NCT00042289|584731877|FG044|Overall Study|Other reason|0|||
161912886|NCT00042289|584731878|FG045|Overall Study|Other reason|0|||
161912887|NCT00042289|584731879|FG046|Overall Study|Other reason|0|||
161912888|NCT00042289|584731833|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161912889|NCT00042289|584731834|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161912890|NCT00042289|584731835|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161912891|NCT00042289|584731836|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161912892|NCT00042289|584731837|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161912893|NCT00042289|584731838|FG005|Overall Study|Severe debilitation, unable to continue|0|||
161456959|NCT00095147|583068848|FG001|Long-term Extension Period|Lack of Efficacy|0|||
161456960|NCT00095147|583068849|FG002|Long-term Extension Period|Lack of Efficacy|0|||
161456961|NCT00095147|583068850|FG003|Long-term Extension Period|Lack of Efficacy|0|||
161456962|NCT00095147|583068851|FG004|Long-term Extension Period|Lack of Efficacy|9|||
161456963|NCT00095147|583068847|FG000|Long-term Extension Period|Lost to Follow-up|0|||
161456964|NCT00095147|583068848|FG001|Long-term Extension Period|Lost to Follow-up|0|||
161456965|NCT00095147|583068849|FG002|Long-term Extension Period|Lost to Follow-up|0|||
161456966|NCT00095147|583068850|FG003|Long-term Extension Period|Lost to Follow-up|0|||
161456967|NCT00095147|583068851|FG004|Long-term Extension Period|Lost to Follow-up|6|||
161456968|NCT00095147|583068847|FG000|Long-term Extension Period|Withdrawal of consent|0|||
161912894|NCT00042289|584731839|FG006|Overall Study|Severe debilitation, unable to continue|0|||
161912895|NCT00042289|584731840|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161912896|NCT00042289|584731841|FG008|Overall Study|Severe debilitation, unable to continue|0|||
161912897|NCT00042289|584731842|FG009|Overall Study|Severe debilitation, unable to continue|0|||
161912898|NCT00042289|584731843|FG010|Overall Study|Severe debilitation, unable to continue|0|||
161912899|NCT00042289|584731844|FG011|Overall Study|Severe debilitation, unable to continue|0|||
161912900|NCT00042289|584731845|FG012|Overall Study|Severe debilitation, unable to continue|0|||
161912901|NCT00042289|584731846|FG013|Overall Study|Severe debilitation, unable to continue|0|||
161912902|NCT00042289|584731847|FG014|Overall Study|Severe debilitation, unable to continue|0|||
161912903|NCT00042289|584731848|FG015|Overall Study|Severe debilitation, unable to continue|0|||
161912904|NCT00042289|584731849|FG016|Overall Study|Severe debilitation, unable to continue|0|||
161912905|NCT00042289|584731850|FG017|Overall Study|Severe debilitation, unable to continue|0|||
161912906|NCT00042289|584731851|FG018|Overall Study|Severe debilitation, unable to continue|0|||
161912907|NCT00042289|584731852|FG019|Overall Study|Severe debilitation, unable to continue|0|||
161912908|NCT00042289|584731853|FG020|Overall Study|Severe debilitation, unable to continue|0|||
161912909|NCT00042289|584731854|FG021|Overall Study|Severe debilitation, unable to continue|1|||
161912910|NCT00042289|584731855|FG022|Overall Study|Severe debilitation, unable to continue|0|||
161912911|NCT00042289|584731856|FG023|Overall Study|Severe debilitation, unable to continue|1|||
161912912|NCT00042289|584731857|FG024|Overall Study|Severe debilitation, unable to continue|0|||
161912913|NCT00042289|584731858|FG025|Overall Study|Severe debilitation, unable to continue|0|||
161912914|NCT00042289|584731859|FG026|Overall Study|Severe debilitation, unable to continue|0|||
161912915|NCT00042289|584731860|FG027|Overall Study|Severe debilitation, unable to continue|1|||
161912916|NCT00042289|584731861|FG028|Overall Study|Severe debilitation, unable to continue|0|||
161912917|NCT00042289|584731862|FG029|Overall Study|Severe debilitation, unable to continue|0|||
161912918|NCT00042289|584731863|FG030|Overall Study|Severe debilitation, unable to continue|0|||
161912919|NCT00042289|584731864|FG031|Overall Study|Severe debilitation, unable to continue|1|||
161912920|NCT00042289|584731865|FG032|Overall Study|Severe debilitation, unable to continue|1|||
161912921|NCT00042289|584731866|FG033|Overall Study|Severe debilitation, unable to continue|0|||
161912922|NCT00042289|584731867|FG034|Overall Study|Severe debilitation, unable to continue|0|||
161912923|NCT00042289|584731868|FG035|Overall Study|Severe debilitation, unable to continue|0|||
161912924|NCT00042289|584731869|FG036|Overall Study|Severe debilitation, unable to continue|0|||
161912925|NCT00042289|584731870|FG037|Overall Study|Severe debilitation, unable to continue|0|||
161912926|NCT00042289|584731871|FG038|Overall Study|Severe debilitation, unable to continue|0|||
161912927|NCT00042289|584731872|FG039|Overall Study|Severe debilitation, unable to continue|0|||
161912928|NCT00042289|584731873|FG040|Overall Study|Severe debilitation, unable to continue|0|||
161912929|NCT00042289|584731874|FG041|Overall Study|Severe debilitation, unable to continue|0|||
161912930|NCT00042289|584731875|FG042|Overall Study|Severe debilitation, unable to continue|0|||
161912931|NCT00042289|584731876|FG043|Overall Study|Severe debilitation, unable to continue|0|||
161912932|NCT00042289|584731877|FG044|Overall Study|Severe debilitation, unable to continue|0|||
161912933|NCT00042289|584731878|FG045|Overall Study|Severe debilitation, unable to continue|0|||
161912934|NCT00042289|584731879|FG046|Overall Study|Severe debilitation, unable to continue|0|||
161912935|NCT00042289|584731833|FG000|Overall Study|Site closed|0|||
161912936|NCT00042289|584731834|FG001|Overall Study|Site closed|0|||
161912937|NCT00042289|584731835|FG002|Overall Study|Site closed|0|||
161912938|NCT00042289|584731836|FG003|Overall Study|Site closed|0|||
161912939|NCT00042289|584731837|FG004|Overall Study|Site closed|0|||
161912940|NCT00042289|584731838|FG005|Overall Study|Site closed|0|||
161912941|NCT00042289|584731839|FG006|Overall Study|Site closed|0|||
161912942|NCT00042289|584731840|FG007|Overall Study|Site closed|0|||
161912943|NCT00042289|584731841|FG008|Overall Study|Site closed|0|||
161912944|NCT00042289|584731842|FG009|Overall Study|Site closed|0|||
161912945|NCT00042289|584731843|FG010|Overall Study|Site closed|0|||
161912946|NCT00042289|584731844|FG011|Overall Study|Site closed|0|||
161912947|NCT00042289|584731845|FG012|Overall Study|Site closed|0|||
161912948|NCT00042289|584731846|FG013|Overall Study|Site closed|0|||
161912949|NCT00042289|584731847|FG014|Overall Study|Site closed|0|||
161808974|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808975|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808976|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808977|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808978|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808979|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808980|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808981|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808982|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808983|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808984|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
161808985|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
161912950|NCT00042289|584731848|FG015|Overall Study|Site closed|0|||
161912951|NCT00042289|584731849|FG016|Overall Study|Site closed|0|||
161912952|NCT00042289|584731850|FG017|Overall Study|Site closed|0|||
161912953|NCT00042289|584731851|FG018|Overall Study|Site closed|0|||
161912954|NCT00042289|584731852|FG019|Overall Study|Site closed|0|||
161912955|NCT00042289|584731853|FG020|Overall Study|Site closed|0|||
161912956|NCT00042289|584731854|FG021|Overall Study|Site closed|0|||
161912957|NCT00042289|584731855|FG022|Overall Study|Site closed|0|||
161912958|NCT00042289|584731856|FG023|Overall Study|Site closed|0|||
161912959|NCT00042289|584731857|FG024|Overall Study|Site closed|0|||
161912960|NCT00042289|584731858|FG025|Overall Study|Site closed|0|||
161912961|NCT00042289|584731859|FG026|Overall Study|Site closed|0|||
161912962|NCT00042289|584731860|FG027|Overall Study|Site closed|0|||
161912963|NCT00042289|584731861|FG028|Overall Study|Site closed|0|||
161912964|NCT00042289|584731862|FG029|Overall Study|Site closed|0|||
161912965|NCT00042289|584731863|FG030|Overall Study|Site closed|0|||
161912966|NCT00042289|584731864|FG031|Overall Study|Site closed|3|||
161912967|NCT00042289|584731865|FG032|Overall Study|Site closed|0|||
161912968|NCT00042289|584731866|FG033|Overall Study|Site closed|0|||
161912969|NCT00042289|584731867|FG034|Overall Study|Site closed|0|||
161912970|NCT00042289|584731868|FG035|Overall Study|Site closed|0|||
161912971|NCT00042289|584731869|FG036|Overall Study|Site closed|1|||
161912972|NCT00042289|584731870|FG037|Overall Study|Site closed|0|||
161912973|NCT00042289|584731871|FG038|Overall Study|Site closed|0|||
161912974|NCT00042289|584731872|FG039|Overall Study|Site closed|0|||
161912975|NCT00042289|584731873|FG040|Overall Study|Site closed|0|||
161912976|NCT00042289|584731874|FG041|Overall Study|Site closed|0|||
161912977|NCT00042289|584731875|FG042|Overall Study|Site closed|1|||
161912978|NCT00042289|584731876|FG043|Overall Study|Site closed|0|||
161912979|NCT00042289|584731877|FG044|Overall Study|Site closed|0|||
161912980|NCT00042289|584731878|FG045|Overall Study|Site closed|0|||
161912981|NCT00042289|584731879|FG046|Overall Study|Site closed|0|||
161912982|NCT00042289|584731833|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
161456969|NCT00095147|583068848|FG001|Long-term Extension Period|Withdrawal of consent|0|||
161456970|NCT00095147|583068849|FG002|Long-term Extension Period|Withdrawal of consent|0|||
161456971|NCT00095147|583068850|FG003|Long-term Extension Period|Withdrawal of consent|0|||
161456972|NCT00095147|583068851|FG004|Long-term Extension Period|Withdrawal of consent|12|||
161456973|NCT00095147|583068847|FG000|Long-term Extension Period|Pregnancy|0|||
161456974|NCT00095147|583068848|FG001|Long-term Extension Period|Pregnancy|0|||
161456975|NCT00095147|583068849|FG002|Long-term Extension Period|Pregnancy|0|||
161456976|NCT00095147|583068850|FG003|Long-term Extension Period|Pregnancy|0|||
161456977|NCT00095147|583068851|FG004|Long-term Extension Period|Pregnancy|1|||
161456978|NCT00095147|583068847|FG000|Long-term Extension Period|No longer meets study criteria|0|||
161456979|NCT00095147|583068848|FG001|Long-term Extension Period|No longer meets study criteria|0|||
161456980|NCT00095147|583068849|FG002|Long-term Extension Period|No longer meets study criteria|0|||
161456981|NCT00095147|583068850|FG003|Long-term Extension Period|No longer meets study criteria|0|||
161456982|NCT00095147|583068851|FG004|Long-term Extension Period|No longer meets study criteria|1|||
161456983|NCT00095147|583068847|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
161456984|NCT00095147|583068848|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
161456985|NCT00095147|583068849|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
161456986|NCT00095147|583068850|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
161456987|NCT00095147|583068851|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
161456988|NCT00095147|583068847|FG000|Long-term Extension Period|Leaving country|0|||
161456989|NCT00095147|583068848|FG001|Long-term Extension Period|Leaving country|0|||
161456990|NCT00095147|583068849|FG002|Long-term Extension Period|Leaving country|0|||
161456991|NCT00095147|583068850|FG003|Long-term Extension Period|Leaving country|0|||
161456992|NCT00095147|583068851|FG004|Long-term Extension Period|Leaving country|1|||
161456993|NCT04604132|583068852|FG000|Overall Study|Adverse Event|2|||
161456994|NCT04604132|583068853|FG001|Overall Study|Adverse Event|0|||
161456995|NCT04604132|583068854|FG002|Overall Study|Adverse Event|0|||
161456996|NCT04604132|583068855|FG003|Overall Study|Adverse Event|1|||
161456997|NCT04604132|583068856|FG004|Overall Study|Adverse Event|2|||
161456998|NCT04604132|583068852|FG000|Overall Study|Study terminated by sponsor|0|||
161456999|NCT04604132|583068853|FG001|Overall Study|Study terminated by sponsor|0|||
161457000|NCT04604132|583068854|FG002|Overall Study|Study terminated by sponsor|0|||
161457001|NCT04604132|583068855|FG003|Overall Study|Study terminated by sponsor|0|||
161457002|NCT04604132|583068856|FG004|Overall Study|Study terminated by sponsor|1|||
161457003|NCT04604132|583068852|FG000|Overall Study|Progressive disease: Clinical progression|0|||
161457004|NCT04604132|583068853|FG001|Overall Study|Progressive disease: Clinical progression|0|||
161457005|NCT04604132|583068854|FG002|Overall Study|Progressive disease: Clinical progression|1|||
161457006|NCT04604132|583068855|FG003|Overall Study|Progressive disease: Clinical progression|0|||
161457007|NCT04604132|583068856|FG004|Overall Study|Progressive disease: Clinical progression|0|||
161457008|NCT04604132|583068852|FG000|Overall Study|Progressive disease: Radiological progression|8|||
161457009|NCT04604132|583068853|FG001|Overall Study|Progressive disease: Radiological progression|7|||
161457010|NCT04604132|583068854|FG002|Overall Study|Progressive disease: Radiological progression|10|||
161912983|NCT00042289|584731834|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
161912984|NCT00042289|584731835|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
161912985|NCT00042289|584731836|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
161912986|NCT00042289|584731837|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
161912987|NCT00042289|584731838|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
161912988|NCT00042289|584731839|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
161912989|NCT00042289|584731840|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
161912990|NCT00042289|584731841|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
161912991|NCT00042289|584731842|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
161912992|NCT00042289|584731843|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
161912993|NCT00042289|584731844|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
161912994|NCT00042289|584731845|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
161912995|NCT00042289|584731846|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
161912996|NCT00042289|584731847|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
161912997|NCT00042289|584731848|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
161912998|NCT00042289|584731849|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
161912999|NCT00042289|584731850|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
161913000|NCT00042289|584731851|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
161913001|NCT00042289|584731852|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
161913002|NCT00042289|584731853|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
161913003|NCT00042289|584731854|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
161913004|NCT00042289|584731855|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
161913005|NCT00042289|584731856|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
161913006|NCT00042289|584731857|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
161568169|NCT01311713|583467678|FG004|Overall Study|Withdrawal by Subject|0|||
161568170|NCT01311713|583467679|FG005|Overall Study|Withdrawal by Subject|1|||
161568171|NCT01311713|583467680|FG006|Overall Study|Withdrawal by Subject|2|||
161568172|NCT01311713|583467674|FG000|Overall Study|Disease progression|3|||
161568173|NCT01311713|583467675|FG001|Overall Study|Disease progression|4|||
161568174|NCT01311713|583467676|FG002|Overall Study|Disease progression|3|||
161568175|NCT01311713|583467677|FG003|Overall Study|Disease progression|2|||
161568176|NCT01311713|583467678|FG004|Overall Study|Disease progression|4|||
161568177|NCT01311713|583467679|FG005|Overall Study|Disease progression|4|||
161568178|NCT01311713|583467680|FG006|Overall Study|Disease progression|5|||
161568179|NCT01311713|583467674|FG000|Overall Study|Lost to Follow-up|0|||
161568180|NCT01311713|583467675|FG001|Overall Study|Lost to Follow-up|0|||
161568181|NCT01311713|583467676|FG002|Overall Study|Lost to Follow-up|1|||
161568182|NCT01311713|583467677|FG003|Overall Study|Lost to Follow-up|0|||
161568183|NCT01311713|583467678|FG004|Overall Study|Lost to Follow-up|0|||
161568184|NCT01311713|583467679|FG005|Overall Study|Lost to Follow-up|0|||
161568185|NCT01311713|583467680|FG006|Overall Study|Lost to Follow-up|0|||
161568186|NCT01311713|583467674|FG000|Overall Study|Stopped taking study medication|0|||
161568187|NCT01311713|583467675|FG001|Overall Study|Stopped taking study medication|0|||
161568188|NCT01311713|583467676|FG002|Overall Study|Stopped taking study medication|0|||
161568189|NCT01311713|583467677|FG003|Overall Study|Stopped taking study medication|1|||
161568190|NCT01311713|583467678|FG004|Overall Study|Stopped taking study medication|1|||
161568191|NCT01311713|583467679|FG005|Overall Study|Stopped taking study medication|0|||
161568192|NCT01311713|583467680|FG006|Overall Study|Stopped taking study medication|0|||
161568193|NCT01311713|583467674|FG000|Overall Study|Enrolled but not treated|0|||
161568194|NCT01311713|583467675|FG001|Overall Study|Enrolled but not treated|0|||
161568195|NCT01311713|583467676|FG002|Overall Study|Enrolled but not treated|1|||
161568196|NCT01311713|583467677|FG003|Overall Study|Enrolled but not treated|0|||
161568197|NCT01311713|583467678|FG004|Overall Study|Enrolled but not treated|0|||
161568198|NCT01311713|583467679|FG005|Overall Study|Enrolled but not treated|0|||
161568199|NCT01311713|583467680|FG006|Overall Study|Enrolled but not treated|0|||
161568200|NCT01311713|583467674|FG000|Overall Study|Other than specified|0|||
161808986|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
161808987|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
161808988|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
161808989|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
161808990|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
161808991|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
161808992|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
161808993|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808994|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808995|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808996|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808997|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808998|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808999|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161809000|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161809001|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809002|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809003|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809004|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809005|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
161809006|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
161809007|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
161809008|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809009|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
161809010|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
161809011|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
161809012|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
161809013|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
161809014|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809015|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809016|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809017|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809018|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161913007|NCT00042289|584731858|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
161809019|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161913008|NCT00042289|584731859|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
161568201|NCT01311713|583467675|FG001|Overall Study|Other than specified|1|||
161809020|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161457011|NCT04604132|583068855|FG003|Overall Study|Progressive disease: Radiological progression|4|||
161457012|NCT04604132|583068856|FG004|Overall Study|Progressive disease: Radiological progression|3|||
161457013|NCT04604132|583068852|FG000|Overall Study|Death|3|||
161457014|NCT04604132|583068853|FG001|Overall Study|Death|1|||
161457015|NCT04604132|583068854|FG002|Overall Study|Death|2|||
161457016|NCT04604132|583068855|FG003|Overall Study|Death|1|||
161457017|NCT04604132|583068856|FG004|Overall Study|Death|0|||
161457018|NCT00952380|583068857|FG000|Overall Study|Other|0|||
161457019|NCT00952380|583068858|FG001|Overall Study|Other|0|||
161457020|NCT00952380|583068859|FG002|Overall Study|Other|0|||
161457021|NCT00952380|583068860|FG003|Overall Study|Other|0|||
161457022|NCT00952380|583068861|FG004|Overall Study|Other|1|||
161457023|NCT00952380|583068857|FG000|Overall Study|Withdrawal by Subject|0|||
161457024|NCT00952380|583068858|FG001|Overall Study|Withdrawal by Subject|0|||
161457025|NCT00952380|583068859|FG002|Overall Study|Withdrawal by Subject|1|||
161457026|NCT00952380|583068860|FG003|Overall Study|Withdrawal by Subject|0|||
161457027|NCT00952380|583068861|FG004|Overall Study|Withdrawal by Subject|2|||
161457028|NCT00952380|583068857|FG000|Overall Study|Adverse Event|0|||
161457029|NCT00952380|583068858|FG001|Overall Study|Adverse Event|1|||
161457030|NCT00952380|583068859|FG002|Overall Study|Adverse Event|0|||
161457031|NCT00952380|583068860|FG003|Overall Study|Adverse Event|0|||
161457032|NCT00952380|583068861|FG004|Overall Study|Adverse Event|3|||
161457033|NCT00952380|583068857|FG000|Overall Study|Physician Decision|0|||
161457034|NCT00952380|583068858|FG001|Overall Study|Physician Decision|0|||
161457035|NCT00952380|583068859|FG002|Overall Study|Physician Decision|1|||
161457036|NCT00952380|583068860|FG003|Overall Study|Physician Decision|2|||
161457037|NCT00952380|583068861|FG004|Overall Study|Physician Decision|0|||
161457038|NCT00952380|583068857|FG000|Overall Study|Non-compliant to protocol|0|||
161457039|NCT00952380|583068858|FG001|Overall Study|Non-compliant to protocol|0|||
161457040|NCT00952380|583068859|FG002|Overall Study|Non-compliant to protocol|0|||
161457041|NCT00952380|583068860|FG003|Overall Study|Non-compliant to protocol|1|||
161457042|NCT00952380|583068861|FG004|Overall Study|Non-compliant to protocol|0|||
161457043|NCT03400956|583068862|FG000|Treatment Period 1|Adverse Event|0|||
161457044|NCT03400956|583068863|FG001|Treatment Period 1|Adverse Event|1|||
161457045|NCT03400956|583068864|FG002|Treatment Period 1|Adverse Event|0|||
161457046|NCT03400956|583068862|FG000|Treatment Period 1|Lost to Follow-up|0|||
161457047|NCT03400956|583068863|FG001|Treatment Period 1|Lost to Follow-up|0|||
161457048|NCT03400956|583068864|FG002|Treatment Period 1|Lost to Follow-up|1|||
161457049|NCT03400956|583068862|FG000|Treatment Period 1|Protocol Violation|0|||
161457050|NCT03400956|583068863|FG001|Treatment Period 1|Protocol Violation|2|||
161457051|NCT03400956|583068864|FG002|Treatment Period 1|Protocol Violation|0|||
161457052|NCT03400956|583068862|FG000|Treatment Period 1|Study terminated by sponsor|3|||
161457053|NCT03400956|583068863|FG001|Treatment Period 1|Study terminated by sponsor|1|||
161457054|NCT03400956|583068864|FG002|Treatment Period 1|Study terminated by sponsor|1|||
161457055|NCT03400956|583068862|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161457056|NCT03400956|583068863|FG001|Treatment Period 1|Withdrawal by Subject|2|||
161457057|NCT03400956|583068864|FG002|Treatment Period 1|Withdrawal by Subject|4|||
161457058|NCT03400956|583068862|FG000|Treatment Period 1|Other|1|||
161457059|NCT03400956|583068863|FG001|Treatment Period 1|Other|2|||
161457060|NCT03400956|583068864|FG002|Treatment Period 1|Other|3|||
161457061|NCT03400956|583068862|FG000|Post-treatment Period 1|Adverse Event|0|||
161457062|NCT03400956|583068863|FG001|Post-treatment Period 1|Adverse Event|0|||
161457063|NCT03400956|583068864|FG002|Post-treatment Period 1|Adverse Event|1|||
161457064|NCT03400956|583068862|FG000|Post-treatment Period 1|Physician Decision|2|||
161457065|NCT03400956|583068863|FG001|Post-treatment Period 1|Physician Decision|3|||
161457066|NCT03400956|583068864|FG002|Post-treatment Period 1|Physician Decision|0|||
161457067|NCT03400956|583068862|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
161457068|NCT03400956|583068863|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
161457069|NCT03400956|583068864|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
161457070|NCT03400956|583068862|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
161457071|NCT03400956|583068863|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
161457072|NCT03400956|583068864|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
161457073|NCT03400956|583068862|FG000|Post-treatment Period 1|Other|4|||
161457074|NCT03400956|583068863|FG001|Post-treatment Period 1|Other|3|||
161457075|NCT03400956|583068864|FG002|Post-treatment Period 1|Other|4|||
161457076|NCT03400956|583068862|FG000|Treatment Period 2|Adverse Event|2|||
161457077|NCT03400956|583068863|FG001|Treatment Period 2|Adverse Event|1|||
161457078|NCT03400956|583068864|FG002|Treatment Period 2|Adverse Event|1|||
161568202|NCT01311713|583467676|FG002|Overall Study|Other than specified|2|||
161457079|NCT03400956|583068862|FG000|Treatment Period 2|Lost to Follow-up|1|||
161568203|NCT01311713|583467677|FG003|Overall Study|Other than specified|0|||
161568204|NCT01311713|583467678|FG004|Overall Study|Other than specified|0|||
161568205|NCT01311713|583467679|FG005|Overall Study|Other than specified|0|||
161568206|NCT01311713|583467680|FG006|Overall Study|Other than specified|0|||
161568207|NCT00980538|583467683|FG000|Overall Study|Lost to Follow-up|20|||
161568208|NCT00980538|583467683|FG000|Overall Study|Sponsor's Decision|4|||
161568209|NCT00980538|583467683|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
161568210|NCT00980538|583467683|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
161568211|NCT00980538|583467683|FG000|Overall Study|Switch to Commercially Available Medication|25|||
161568212|NCT00980538|583467683|FG000|Overall Study|Participant Non-Compliant|9|||
161568213|NCT00980538|583467683|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
161568214|NCT00980538|583467683|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
161568215|NCT00980538|583467683|FG000|Overall Study|Other|60|||
161568216|NCT00980538|583467683|FG000|Overall Study|Other|1|||
161568217|NCT03878446|583467684|FG000|Overall Study|Withdrawn by parent or guardian|1|||
161568218|NCT03878446|583467685|FG001|Overall Study|Withdrawn by parent or guardian|0|||
161568219|NCT03878446|583467686|FG002|Overall Study|Withdrawn by parent or guardian|0|||
161568220|NCT03878446|583467687|FG003|Overall Study|Withdrawn by parent or guardian|0|||
161568221|NCT03878446|583467688|FG004|Overall Study|Withdrawn by parent or guardian|0|||
161568222|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
161568223|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
161568224|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
161568225|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
161568226|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
161568227|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
161568228|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Death|1|||
161568229|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Death|1|||
161568230|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Death|1|||
161568231|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Death|0|||
161568232|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Death|0|||
161568233|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Death|0|||
161568234|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
161568235|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
161568236|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
161568237|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
161568238|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
161568239|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
161568240|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
161568241|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
161568242|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
161568243|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
161568244|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
161568245|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
161568246|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
161568247|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
161568248|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
161568249|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
161568250|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
161568251|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
161568252|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
161568253|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
161568254|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
161568255|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
161568256|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
161568257|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
161568258|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
161568259|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
161568260|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
161568261|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
161568262|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
161568263|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
161568264|NCT03370133|583467689|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
161568265|NCT03370133|583467690|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
161568266|NCT03370133|583467691|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
161568267|NCT03370133|583467692|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
161568268|NCT03370133|583467693|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
161568269|NCT03370133|583467694|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
161568270|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
161809021|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161568271|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
161568272|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
161568273|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
161568274|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
161568275|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
161568276|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
161568277|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
161568278|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
161568279|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
161568280|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
161568281|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
161568282|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
161568283|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
161568284|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
161568285|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
161568286|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
161568287|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
161568288|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
161568289|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
161568290|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
161568291|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
161568292|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
161568293|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
161568294|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
161568295|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
161568296|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
161568297|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
161568298|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
161568299|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
161568300|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
161568301|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
161568302|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
161568303|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
161568304|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
161568305|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
161568306|NCT03370133|583467689|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
161568307|NCT03370133|583467690|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
161809022|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161457080|NCT03400956|583068863|FG001|Treatment Period 2|Lost to Follow-up|1|||
161457081|NCT03400956|583068864|FG002|Treatment Period 2|Lost to Follow-up|0|||
161457082|NCT03400956|583068862|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161457083|NCT03400956|583068863|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161457084|NCT03400956|583068864|FG002|Treatment Period 2|Withdrawal by Subject|3|||
161457085|NCT03400956|583068862|FG000|Treatment Period 2|Other|1|||
161457086|NCT03400956|583068863|FG001|Treatment Period 2|Other|1|||
161457087|NCT03400956|583068864|FG002|Treatment Period 2|Other|0|||
161457088|NCT03400956|583068862|FG000|Follow-up Period|Withdrawal by Subject|0|||
161457089|NCT03400956|583068863|FG001|Follow-up Period|Withdrawal by Subject|0|||
161457090|NCT03400956|583068864|FG002|Follow-up Period|Withdrawal by Subject|1|||
161457091|NCT03400956|583068862|FG000|Follow-up Period|Other|0|||
161457092|NCT03400956|583068863|FG001|Follow-up Period|Other|0|||
161457093|NCT03400956|583068864|FG002|Follow-up Period|Other|1|||
161457094|NCT02048241|583068866|FG000|Overall Study|Withdrawal by Subject|0|||
161457095|NCT02048241|583068867|FG001|Overall Study|Withdrawal by Subject|1|||
161457096|NCT00534313|583068868|FG000|Short-term Period|Adverse Event|1|||
161457097|NCT00534313|583068869|FG001|Short-term Period|Adverse Event|2|||
161457098|NCT00534313|583068870|FG002|Short-term Period|Adverse Event|1|||
161457099|NCT00534313|583068871|FG003|Short-term Period|Adverse Event|3|||
161457100|NCT00534313|583068868|FG000|Short-term Period|Lack of Efficacy|3|||
161457101|NCT00534313|583068869|FG001|Short-term Period|Lack of Efficacy|4|||
161457102|NCT00534313|583068870|FG002|Short-term Period|Lack of Efficacy|0|||
161457103|NCT00534313|583068871|FG003|Short-term Period|Lack of Efficacy|3|||
161457104|NCT00534313|583068868|FG000|Short-term Period|Participant not meeting study criteria|0|||
161457105|NCT00534313|583068869|FG001|Short-term Period|Participant not meeting study criteria|0|||
161457106|NCT00534313|583068870|FG002|Short-term Period|Participant not meeting study criteria|0|||
161568308|NCT03370133|583467691|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
161568309|NCT03370133|583467692|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
161568310|NCT03370133|583467693|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
161568311|NCT03370133|583467694|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
161568312|NCT02501811|583467695|FG000|Overall Study|Death|1|||
161568313|NCT02501811|583467696|FG001|Overall Study|Death|3|||
161568314|NCT02501811|583467697|FG002|Overall Study|Death|2|||
161568315|NCT02501811|583467698|FG003|Overall Study|Death|3|||
161568316|NCT02501811|583467695|FG000|Overall Study|Withdrawal by Subject|3|||
161568317|NCT02501811|583467696|FG001|Overall Study|Withdrawal by Subject|3|||
161568318|NCT02501811|583467697|FG002|Overall Study|Withdrawal by Subject|2|||
161568319|NCT02501811|583467698|FG003|Overall Study|Withdrawal by Subject|3|||
161568320|NCT02501811|583467695|FG000|Overall Study|Lost to Follow-up|0|||
161568321|NCT02501811|583467696|FG001|Overall Study|Lost to Follow-up|0|||
161568322|NCT02501811|583467697|FG002|Overall Study|Lost to Follow-up|2|||
161568323|NCT02501811|583467698|FG003|Overall Study|Lost to Follow-up|1|||
161568324|NCT04804605|583469246|FG000|Overall Study|Withdrawal by Subject|46|||
161568325|NCT04804605|583469247|FG001|Overall Study|Withdrawal by Subject|26|||
161568326|NCT04804605|583469248|FG002|Overall Study|Withdrawal by Subject|37|||
161809023|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809024|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161457107|NCT00534313|583068871|FG003|Short-term Period|Participant not meeting study criteria|1|||
161457108|NCT00534313|583068868|FG000|Short-term Period|Participant withdrew consent|2|||
161457109|NCT00534313|583068869|FG001|Short-term Period|Participant withdrew consent|0|||
161457110|NCT00534313|583068870|FG002|Short-term Period|Participant withdrew consent|0|||
161457111|NCT00534313|583068871|FG003|Short-term Period|Participant withdrew consent|2|||
161457112|NCT00534313|583068868|FG000|Short-term Period|Pregnancy|0|||
161457113|NCT00534313|583068869|FG001|Short-term Period|Pregnancy|0|||
161457114|NCT00534313|583068870|FG002|Short-term Period|Pregnancy|1|||
161457115|NCT00534313|583068871|FG003|Short-term Period|Pregnancy|0|||
161457116|NCT00534313|583068868|FG000|Long-term Period|Adverse Event|2|||
161457117|NCT00534313|583068869|FG001|Long-term Period|Adverse Event|1|||
161457118|NCT00534313|583068870|FG002|Long-term Period|Adverse Event|0|||
161457119|NCT00534313|583068871|FG003|Long-term Period|Adverse Event|1|||
161457120|NCT00534313|583068868|FG000|Long-term Period|Lack of Efficacy|14|||
161457121|NCT00534313|583068869|FG001|Long-term Period|Lack of Efficacy|10|||
161457122|NCT00534313|583068870|FG002|Long-term Period|Lack of Efficacy|14|||
161457123|NCT00534313|583068871|FG003|Long-term Period|Lack of Efficacy|12|||
161457124|NCT00534313|583068868|FG000|Long-term Period|Lost to Follow-up|1|||
161457125|NCT00534313|583068869|FG001|Long-term Period|Lost to Follow-up|2|||
161457126|NCT00534313|583068870|FG002|Long-term Period|Lost to Follow-up|0|||
161457127|NCT00534313|583068871|FG003|Long-term Period|Lost to Follow-up|0|||
161457128|NCT00534313|583068868|FG000|Long-term Period|Withdrawal by Subject|2|||
161457129|NCT00534313|583068869|FG001|Long-term Period|Withdrawal by Subject|2|||
161457130|NCT00534313|583068870|FG002|Long-term Period|Withdrawal by Subject|0|||
161457131|NCT00534313|583068871|FG003|Long-term Period|Withdrawal by Subject|0|||
161457132|NCT00534313|583068868|FG000|Long-term Period|No longer meets study criteria|0|||
161457133|NCT00534313|583068869|FG001|Long-term Period|No longer meets study criteria|1|||
161457134|NCT00534313|583068870|FG002|Long-term Period|No longer meets study criteria|0|||
161457135|NCT00534313|583068871|FG003|Long-term Period|No longer meets study criteria|0|||
161457136|NCT00534313|583068868|FG000|Long-term Period|Poor compliance/noncompliance|0|||
161457137|NCT00534313|583068869|FG001|Long-term Period|Poor compliance/noncompliance|1|||
161457138|NCT00534313|583068870|FG002|Long-term Period|Poor compliance/noncompliance|1|||
161457139|NCT00534313|583068871|FG003|Long-term Period|Poor compliance/noncompliance|0|||
161457140|NCT00534313|583068868|FG000|Long-term Period|Administrative reason by sponsor|17|||
161457141|NCT00534313|583068869|FG001|Long-term Period|Administrative reason by sponsor|15|||
161568327|NCT04804605|583469249|FG003|Overall Study|Withdrawal by Subject|21|||
161809025|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809026|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161568328|NCT04804605|583469246|FG000|Overall Study|Lost to Follow-up|47|||
161568329|NCT04804605|583469247|FG001|Overall Study|Lost to Follow-up|21|||
161568330|NCT04804605|583469248|FG002|Overall Study|Lost to Follow-up|30|||
161568331|NCT04804605|583469249|FG003|Overall Study|Lost to Follow-up|17|||
161568332|NCT04804605|583469246|FG000|Overall Study|Lack of Efficacy|28|||
161568333|NCT04804605|583469247|FG001|Overall Study|Lack of Efficacy|11|||
161568334|NCT04804605|583469248|FG002|Overall Study|Lack of Efficacy|37|||
161568335|NCT04804605|583469249|FG003|Overall Study|Lack of Efficacy|8|||
161568336|NCT04804605|583469246|FG000|Overall Study|Adverse Event|10|||
161568337|NCT04804605|583469247|FG001|Overall Study|Adverse Event|10|||
161568338|NCT04804605|583469248|FG002|Overall Study|Adverse Event|10|||
161568339|NCT04804605|583469249|FG003|Overall Study|Adverse Event|7|||
161568340|NCT04804605|583469246|FG000|Overall Study|Non-compliance|8|||
161568341|NCT04804605|583469247|FG001|Overall Study|Non-compliance|3|||
161568342|NCT04804605|583469248|FG002|Overall Study|Non-compliance|5|||
161568343|NCT04804605|583469249|FG003|Overall Study|Non-compliance|1|||
161568344|NCT04804605|583469246|FG000|Overall Study|Physician Decision|3|||
161568345|NCT04804605|583469247|FG001|Overall Study|Physician Decision|0|||
161568346|NCT04804605|583469248|FG002|Overall Study|Physician Decision|5|||
161568347|NCT04804605|583469249|FG003|Overall Study|Physician Decision|0|||
161568348|NCT04804605|583469246|FG000|Overall Study|Protocol Violation|1|||
161568349|NCT04804605|583469247|FG001|Overall Study|Protocol Violation|0|||
161568350|NCT04804605|583469248|FG002|Overall Study|Protocol Violation|0|||
161568351|NCT04804605|583469249|FG003|Overall Study|Protocol Violation|1|||
161568352|NCT04804605|583469246|FG000|Overall Study|Miscellaneous|7|||
161568353|NCT04804605|583469247|FG001|Overall Study|Miscellaneous|3|||
161568354|NCT04804605|583469248|FG002|Overall Study|Miscellaneous|4|||
161568355|NCT04804605|583469249|FG003|Overall Study|Miscellaneous|2|||
161568356|NCT00567879|583469252|FG000|Overall Study|Adverse Event|2|||
161568357|NCT00567879|583469253|FG001|Overall Study|Adverse Event|0|||
161568358|NCT00567879|583469254|FG002|Overall Study|Adverse Event|1|||
161568359|NCT00567879|583469255|FG003|Overall Study|Adverse Event|0|||
161568360|NCT00567879|583469256|FG004|Overall Study|Adverse Event|1|||
161568361|NCT00567879|583469257|FG005|Overall Study|Adverse Event|0|||
161568362|NCT00567879|583469252|FG000|Overall Study|Abnormal test procedure(s)|0|||
161568363|NCT00567879|583469253|FG001|Overall Study|Abnormal test procedure(s)|0|||
161568364|NCT00567879|583469254|FG002|Overall Study|Abnormal test procedure(s)|1|||
161568365|NCT00567879|583469255|FG003|Overall Study|Abnormal test procedure(s)|0|||
161568366|NCT00567879|583469256|FG004|Overall Study|Abnormal test procedure(s)|0|||
161568367|NCT00567879|583469257|FG005|Overall Study|Abnormal test procedure(s)|0|||
161568368|NCT00567879|583469252|FG000|Overall Study|Withdrawal by Subject|0|||
161568369|NCT00567879|583469253|FG001|Overall Study|Withdrawal by Subject|0|||
161568370|NCT00567879|583469254|FG002|Overall Study|Withdrawal by Subject|3|||
161568371|NCT00567879|583469255|FG003|Overall Study|Withdrawal by Subject|1|||
161568372|NCT00567879|583469256|FG004|Overall Study|Withdrawal by Subject|0|||
161568373|NCT00567879|583469257|FG005|Overall Study|Withdrawal by Subject|0|||
161568374|NCT00567879|583469252|FG000|Overall Study|New cancer therapy|0|||
161568375|NCT00567879|583469253|FG001|Overall Study|New cancer therapy|0|||
161568376|NCT00567879|583469254|FG002|Overall Study|New cancer therapy|1|||
161568377|NCT00567879|583469255|FG003|Overall Study|New cancer therapy|0|||
161568378|NCT00567879|583469256|FG004|Overall Study|New cancer therapy|0|||
161568379|NCT00567879|583469257|FG005|Overall Study|New cancer therapy|0|||
161568380|NCT00567879|583469252|FG000|Overall Study|Disease progression|5|||
161568381|NCT00567879|583469253|FG001|Overall Study|Disease progression|7|||
161568382|NCT00567879|583469254|FG002|Overall Study|Disease progression|15|||
161568383|NCT00567879|583469255|FG003|Overall Study|Disease progression|5|||
161568384|NCT00567879|583469256|FG004|Overall Study|Disease progression|11|||
161568385|NCT00567879|583469257|FG005|Overall Study|Disease progression|3|||
161568386|NCT00151996|583469260|FG000|Overall Study|Adverse Event|3|||
161568387|NCT00151996|583469261|FG001|Overall Study|Adverse Event|2|||
161568388|NCT00151996|583469260|FG000|Overall Study|Withdrawal by Subject|1|||
161568389|NCT00151996|583469261|FG001|Overall Study|Withdrawal by Subject|1|||
161568390|NCT00151996|583469260|FG000|Overall Study|Protocol Violation|1|||
161568391|NCT00151996|583469261|FG001|Overall Study|Protocol Violation|2|||
161568392|NCT00151996|583469260|FG000|Overall Study|Sponsor's decision|0|||
161568393|NCT00151996|583469261|FG001|Overall Study|Sponsor's decision|2|||
161568394|NCT01546155|583469262|FG000|Overall Study|could not tolerate long scan duration|3|||
161568395|NCT02930343|583469263|FG000|Overall Study|Lost to Follow-up|9|||
161568396|NCT02930343|583469264|FG001|Overall Study|Lost to Follow-up|7|||
161568397|NCT00420316|583469270|FG000|Overall Study|Withdrawal by Subject|0|||
161568398|NCT00420316|583469271|FG001|Overall Study|Withdrawal by Subject|1|||
161568399|NCT00420316|583469270|FG000|Overall Study|Lost to Follow-up|12|||
161568400|NCT00420316|583469271|FG001|Overall Study|Lost to Follow-up|8|||
161568401|NCT03546907|583469272|FG000|Overall Study|Lack of Efficacy|1|||
161568402|NCT03546907|583469273|FG001|Overall Study|Lack of Efficacy|1|||
161568403|NCT03546907|583469272|FG000|Overall Study|Withdrawal by Subject|8|||
161568404|NCT03546907|583469273|FG001|Overall Study|Withdrawal by Subject|9|||
161568405|NCT03546907|583469272|FG000|Overall Study|Adverse events (AEs)|7|||
161568406|NCT03546907|583469273|FG001|Overall Study|Adverse events (AEs)|10|||
161568407|NCT03546907|583469272|FG000|Overall Study|Other-unspecified|1|||
161568408|NCT03546907|583469273|FG001|Overall Study|Other-unspecified|1|||
161568409|NCT03720210|583469274|FG000|Overall Study|Lost to Follow-up|1|||
161568410|NCT04033432|583469275|FG000|Overall Study|Progressive Disease|8|||
161568411|NCT04033432|583469275|FG000|Overall Study|Adverse Event|4|||
161568412|NCT04033432|583469275|FG000|Overall Study|Death|1|||
161568413|NCT02274493|583469281|FG000|Overall Study|Withdrawal by Subject|1|||
161568414|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568415|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
161568416|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568417|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568418|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568419|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568420|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568421|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568422|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568423|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568424|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568425|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568426|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
161568427|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Death|0|||
161568428|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Death|0|||
161568429|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Death|0|||
161568430|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Death|1|||
161568431|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Death|0|||
161568432|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Death|0|||
161568433|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Death|0|||
161568434|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Death|0|||
161568435|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Death|0|||
161568436|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Death|0|||
161568437|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Death|0|||
161568438|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Death|0|||
161809027|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809028|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161568439|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Death|0|||
161568440|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568441|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
161568442|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
161568443|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
161568444|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
161568445|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568446|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568447|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568448|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568449|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568450|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568451|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568452|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161568453|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568454|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
161568455|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568456|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568457|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568458|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568459|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568460|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568461|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568462|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568463|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568464|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568465|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161568466|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568467|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568468|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
161568469|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568470|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568471|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568472|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568473|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568474|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568475|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568476|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568477|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568478|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161568479|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
161568480|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
161568481|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
161568482|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
161568483|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
161568484|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568485|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568486|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568487|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568488|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568489|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568490|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568491|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161568492|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568493|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568494|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568495|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568496|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
161568497|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568498|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568499|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568500|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568501|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568502|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568503|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568504|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161568505|NCT04936035|583469286|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
161809029|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809030|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
161568506|NCT04936035|583469287|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568507|NCT04936035|583469288|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568508|NCT04936035|583469289|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568509|NCT04936035|583469290|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568510|NCT04936035|583469291|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568511|NCT04936035|583469292|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568512|NCT04936035|583469293|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568513|NCT04936035|583469294|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568514|NCT04936035|583469295|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568515|NCT04936035|583469296|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568516|NCT04936035|583469297|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568517|NCT04936035|583469298|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
161568518|NCT04936035|583469286|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568519|NCT04936035|583469287|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568520|NCT04936035|583469288|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568521|NCT04936035|583469289|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568522|NCT04936035|583469290|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568523|NCT04936035|583469291|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
161568524|NCT04936035|583469292|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
161568525|NCT04936035|583469293|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568526|NCT04936035|583469294|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
161568527|NCT04936035|583469295|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
161568528|NCT04936035|583469296|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
161568529|NCT04936035|583469297|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
161568530|NCT04936035|583469298|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
161568531|NCT04936035|583469286|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568532|NCT04936035|583469287|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568533|NCT04936035|583469288|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568534|NCT04936035|583469289|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568535|NCT04936035|583469290|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568536|NCT04936035|583469291|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
161809031|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161809032|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
161809033|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809034|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161809035|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809036|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809037|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809038|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809039|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809040|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809041|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809042|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809043|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809044|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809045|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809046|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809047|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
161809048|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
161809049|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161809050|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809051|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161809052|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161809053|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161809054|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161809055|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161809056|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809057|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809058|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809059|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809060|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809061|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809062|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809063|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161913009|NCT00042289|584731860|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
161568537|NCT04936035|583469292|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
161568538|NCT04936035|583469293|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568539|NCT04936035|583469294|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
161568540|NCT04936035|583469295|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
161568541|NCT04936035|583469296|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
161568542|NCT04936035|583469297|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
161568543|NCT04936035|583469298|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
161568544|NCT04936035|583469286|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568545|NCT04936035|583469287|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568546|NCT04936035|583469288|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568547|NCT04936035|583469289|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568548|NCT04936035|583469290|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568549|NCT04936035|583469291|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568550|NCT04936035|583469292|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568551|NCT04936035|583469293|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568552|NCT04936035|583469294|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568553|NCT04936035|583469295|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
161568554|NCT04936035|583469296|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568555|NCT04936035|583469297|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
161809064|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161568556|NCT04936035|583469298|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
161568557|NCT04936035|583469286|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568558|NCT04936035|583469287|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568559|NCT04936035|583469288|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568560|NCT04936035|583469289|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568561|NCT04936035|583469290|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568562|NCT04936035|583469291|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
161568563|NCT04936035|583469292|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568564|NCT04936035|583469293|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
161568565|NCT04936035|583469294|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568566|NCT04936035|583469295|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568567|NCT04936035|583469296|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568568|NCT04936035|583469297|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568569|NCT04936035|583469298|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
161568570|NCT04936035|583469286|FG000|Post-6-Month DB Period (30months)|Death|0|||
161568571|NCT04936035|583469287|FG001|Post-6-Month DB Period (30months)|Death|0|||
161568572|NCT04936035|583469288|FG002|Post-6-Month DB Period (30months)|Death|0|||
161568573|NCT04936035|583469289|FG003|Post-6-Month DB Period (30months)|Death|0|||
161568574|NCT04936035|583469290|FG004|Post-6-Month DB Period (30months)|Death|0|||
161568575|NCT04936035|583469291|FG005|Post-6-Month DB Period (30months)|Death|0|||
161568576|NCT04936035|583469292|FG006|Post-6-Month DB Period (30months)|Death|0|||
161568577|NCT04936035|583469293|FG007|Post-6-Month DB Period (30months)|Death|0|||
161568578|NCT04936035|583469294|FG008|Post-6-Month DB Period (30months)|Death|0|||
161568579|NCT04936035|583469295|FG009|Post-6-Month DB Period (30months)|Death|1|||
161568580|NCT04936035|583469296|FG010|Post-6-Month DB Period (30months)|Death|0|||
161568581|NCT04936035|583469297|FG011|Post-6-Month DB Period (30months)|Death|0|||
161568582|NCT04936035|583469298|FG012|Post-6-Month DB Period (30months)|Death|0|||
161568583|NCT04936035|583469286|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568584|NCT04936035|583469287|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568585|NCT04936035|583469288|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568586|NCT04936035|583469289|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568587|NCT04936035|583469290|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568588|NCT04936035|583469291|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
161568589|NCT04936035|583469292|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568590|NCT04936035|583469293|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568591|NCT04936035|583469294|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568592|NCT04936035|583469295|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
161568593|NCT04936035|583469296|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
161568594|NCT04936035|583469297|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568595|NCT04936035|583469298|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161568596|NCT05827926|583469301|FG000|Overall Study|Lost to Follow-up|1|||
161568597|NCT05827926|583469302|FG001|Overall Study|Lost to Follow-up|0|||
161568598|NCT05827926|583469303|FG002|Overall Study|Lost to Follow-up|0|||
161568599|NCT05827926|583469304|FG003|Overall Study|Lost to Follow-up|0|||
161568600|NCT05827926|583469305|FG004|Overall Study|Lost to Follow-up|0|||
161568601|NCT05827926|583469306|FG005|Overall Study|Lost to Follow-up|1|||
161809065|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809066|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809067|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161457142|NCT00534313|583068870|FG002|Long-term Period|Administrative reason by sponsor|26|||
161457143|NCT00534313|583068871|FG003|Long-term Period|Administrative reason by sponsor|18|||
161457144|NCT00534313|583068868|FG000|Long-term Period|Other|1|||
161457145|NCT00534313|583068869|FG001|Long-term Period|Other|2|||
161457146|NCT00534313|583068870|FG002|Long-term Period|Other|2|||
161457147|NCT00534313|583068871|FG003|Long-term Period|Other|2|||
161457148|NCT00402233|583068872|FG000|Overall Study|Adverse Event|1|||
161457149|NCT00402233|583068873|FG001|Overall Study|Adverse Event|7|||
161457150|NCT00402233|583068874|FG002|Overall Study|Adverse Event|9|||
161457151|NCT00402233|583068875|FG003|Overall Study|Adverse Event|9|||
161457152|NCT00402233|583068872|FG000|Overall Study|Protocol Violation|0|||
161457153|NCT00402233|583068873|FG001|Overall Study|Protocol Violation|1|||
161457154|NCT00402233|583068874|FG002|Overall Study|Protocol Violation|0|||
161457155|NCT00402233|583068875|FG003|Overall Study|Protocol Violation|0|||
161457156|NCT00402233|583068872|FG000|Overall Study|Withdrawal by Subject|2|||
161457157|NCT00402233|583068873|FG001|Overall Study|Withdrawal by Subject|1|||
161457158|NCT00402233|583068874|FG002|Overall Study|Withdrawal by Subject|2|||
161457159|NCT00402233|583068875|FG003|Overall Study|Withdrawal by Subject|2|||
161457160|NCT00402233|583068872|FG000|Overall Study|Worsening of disease under study|2|||
161457161|NCT00402233|583068873|FG001|Overall Study|Worsening of disease under study|0|||
161457162|NCT00402233|583068874|FG002|Overall Study|Worsening of disease under study|0|||
161457163|NCT00402233|583068875|FG003|Overall Study|Worsening of disease under study|0|||
161457164|NCT00402233|583068872|FG000|Overall Study|Worsening of other pre-existing disease|0|||
161457165|NCT00402233|583068873|FG001|Overall Study|Worsening of other pre-existing disease|1|||
161457166|NCT00402233|583068874|FG002|Overall Study|Worsening of other pre-existing disease|0|||
161457167|NCT00402233|583068875|FG003|Overall Study|Worsening of other pre-existing disease|0|||
161457168|NCT03007888|583068876|FG000|First Intervention (14 Days)|Adverse Event|1|||
161457169|NCT03007888|583068877|FG001|First Intervention (14 Days)|Adverse Event|0|||
161457170|NCT00927940|583068878|FG000|Overall Study|Death|1|||
161457171|NCT04658940|583068880|FG000|Overall Study|Withdrawal by Subject|1|||
161457172|NCT00827931|583068882|FG000|Overall Study|Death|3|||
161457173|NCT00827931|583068883|FG001|Overall Study|Death|5|||
161457174|NCT00827931|583068882|FG000|Overall Study|Adverse Event|1|||
161457175|NCT00827931|583068883|FG001|Overall Study|Adverse Event|0|||
161457176|NCT00827931|583068882|FG000|Overall Study|Lost to Follow-up|1|||
161457177|NCT00827931|583068883|FG001|Overall Study|Lost to Follow-up|0|||
161457178|NCT00827931|583068882|FG000|Overall Study|Withdrawal by Subject|0|||
161457179|NCT00827931|583068883|FG001|Overall Study|Withdrawal by Subject|1|||
161457180|NCT00827931|583068882|FG000|Overall Study|Other|1|||
161457181|NCT00827931|583068883|FG001|Overall Study|Other|0|||
161457182|NCT03579602|583068884|FG000|Overall Study|Subject unable to receive study drug|0|||
161457183|NCT03579602|583068885|FG001|Overall Study|Subject unable to receive study drug|2|||
161457184|NCT03579602|583068884|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
161457185|NCT03579602|583068885|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
161457186|NCT00492063|583068886|FG000|Overall Study|Death|0|||
161457187|NCT00492063|583068887|FG001|Overall Study|Death|0|||
161457188|NCT00492063|583068888|FG002|Overall Study|Death|1|||
161457189|NCT00492063|583068889|FG003|Overall Study|Death|2|||
161457190|NCT00492063|583068886|FG000|Overall Study|Withdrawal by Subject|4|||
161457191|NCT00492063|583068887|FG001|Overall Study|Withdrawal by Subject|3|||
161457192|NCT00492063|583068888|FG002|Overall Study|Withdrawal by Subject|5|||
161457193|NCT00492063|583068889|FG003|Overall Study|Withdrawal by Subject|4|||
161457194|NCT00492063|583068886|FG000|Overall Study|Lost to Follow-up|6|||
161457195|NCT00492063|583068887|FG001|Overall Study|Lost to Follow-up|11|||
161457196|NCT00492063|583068888|FG002|Overall Study|Lost to Follow-up|5|||
161457197|NCT00492063|583068889|FG003|Overall Study|Lost to Follow-up|3|||
161457198|NCT00492063|583068886|FG000|Overall Study|Protocol Violation|0|||
161457199|NCT00492063|583068887|FG001|Overall Study|Protocol Violation|0|||
161457200|NCT00492063|583068888|FG002|Overall Study|Protocol Violation|0|||
161457201|NCT00492063|583068889|FG003|Overall Study|Protocol Violation|1|||
161457202|NCT00495040|583068895|FG000|Overall Study|Withdrawal by Subject|3|||
161457203|NCT01894568|583068896|FG000|Overall Study|Adverse Event|2|||
161457204|NCT01894568|583068897|FG001|Overall Study|Adverse Event|3|||
161457205|NCT01894568|583068896|FG000|Overall Study|Protocol required discontinuation|2|||
161457206|NCT01894568|583068897|FG001|Overall Study|Protocol required discontinuation|1|||
161457207|NCT01894568|583068896|FG000|Overall Study|Withdrawal by Subject|5|||
161457208|NCT01894568|583068897|FG001|Overall Study|Withdrawal by Subject|5|||
161457209|NCT01894568|583068896|FG000|Overall Study|Physician Decision|1|||
161457210|NCT01894568|583068897|FG001|Overall Study|Physician Decision|0|||
161457211|NCT01894568|583068896|FG000|Overall Study|Lost to Follow-up|0|||
161457212|NCT01894568|583068897|FG001|Overall Study|Lost to Follow-up|1|||
161457213|NCT00807573|583068898|FG000|Overall Study|Withdrawal by Subject|1|||
161457214|NCT00807573|583068898|FG000|Overall Study|Adverse Event|1|||
161457215|NCT01089361|583068901|FG000|Overall Study|Death|1|||
161457216|NCT01089361|583068902|FG001|Overall Study|Death|0|||
161457217|NCT01514370|583068903|FG000|Overall Study|Protocol Violation|2|||
161457218|NCT01514370|583068904|FG001|Overall Study|Protocol Violation|3|||
161809068|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809069|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809070|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161457219|NCT01514370|583068903|FG000|Overall Study|Lost to Follow-up|0|||
161809071|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809072|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809073|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809074|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809075|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809076|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809077|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809078|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809079|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809080|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809081|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809082|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809083|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809084|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809085|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809086|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809087|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809088|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809089|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809090|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809091|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809092|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809093|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809094|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809095|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
161809096|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809097|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809098|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809099|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809100|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809101|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809102|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809103|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809104|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809105|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809106|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161457220|NCT01514370|583068904|FG001|Overall Study|Lost to Follow-up|2|||
161457221|NCT01514370|583068903|FG000|Overall Study|Withdrawal by Subject|2|||
161457222|NCT01514370|583068904|FG001|Overall Study|Withdrawal by Subject|1|||
161457223|NCT01514370|583068903|FG000|Overall Study|Adverse Event|1|||
161457224|NCT01514370|583068904|FG001|Overall Study|Adverse Event|3|||
161457225|NCT01514370|583068903|FG000|Overall Study|Other|6|||
161457226|NCT01514370|583068904|FG001|Overall Study|Other|7|||
161457227|NCT04054947|583068905|FG000|Overall Study|Withdrawal by Subject|1|||
161457228|NCT04054947|583068906|FG001|Overall Study|Withdrawal by Subject|0|||
161457229|NCT04054947|583068905|FG000|Overall Study|Lost to Follow-up|2|||
161457230|NCT04054947|583068906|FG001|Overall Study|Lost to Follow-up|5|||
161457231|NCT01606878|583068907|FG000|Overall Study|Adverse Event|1|||
161457232|NCT01606878|583068908|FG001|Overall Study|Adverse Event|1|||
161457233|NCT01606878|583068909|FG002|Overall Study|Adverse Event|0|||
161457234|NCT01606878|583068910|FG003|Overall Study|Adverse Event|0|||
161457235|NCT01606878|583068911|FG004|Overall Study|Adverse Event|0|||
161457236|NCT01606878|583068912|FG005|Overall Study|Adverse Event|0|||
161457237|NCT01606878|583068913|FG006|Overall Study|Adverse Event|1|||
161457238|NCT01606878|583068914|FG007|Overall Study|Adverse Event|0|||
161457239|NCT01606878|583068915|FG008|Overall Study|Adverse Event|1|||
161457240|NCT01606878|583068916|FG009|Overall Study|Adverse Event|3|||
161457241|NCT01606878|583068917|FG010|Overall Study|Adverse Event|0|||
161457242|NCT01606878|583068907|FG000|Overall Study|Lack of Efficacy|1|||
161457243|NCT01606878|583068908|FG001|Overall Study|Lack of Efficacy|1|||
161457244|NCT01606878|583068909|FG002|Overall Study|Lack of Efficacy|1|||
161457245|NCT01606878|583068910|FG003|Overall Study|Lack of Efficacy|2|||
161457246|NCT01606878|583068911|FG004|Overall Study|Lack of Efficacy|1|||
161457247|NCT01606878|583068912|FG005|Overall Study|Lack of Efficacy|2|||
161457248|NCT01606878|583068913|FG006|Overall Study|Lack of Efficacy|1|||
161457249|NCT01606878|583068914|FG007|Overall Study|Lack of Efficacy|2|||
161457250|NCT01606878|583068915|FG008|Overall Study|Lack of Efficacy|2|||
161457251|NCT01606878|583068916|FG009|Overall Study|Lack of Efficacy|0|||
161457252|NCT01606878|583068917|FG010|Overall Study|Lack of Efficacy|1|||
161457253|NCT01606878|583068907|FG000|Overall Study|Physician Decision|1|||
161457254|NCT01606878|583068908|FG001|Overall Study|Physician Decision|0|||
161457255|NCT01606878|583068909|FG002|Overall Study|Physician Decision|2|||
161457256|NCT01606878|583068910|FG003|Overall Study|Physician Decision|1|||
161457257|NCT01606878|583068911|FG004|Overall Study|Physician Decision|1|||
161457258|NCT01606878|583068912|FG005|Overall Study|Physician Decision|1|||
161457259|NCT01606878|583068913|FG006|Overall Study|Physician Decision|2|||
161457260|NCT01606878|583068914|FG007|Overall Study|Physician Decision|0|||
161457261|NCT01606878|583068915|FG008|Overall Study|Physician Decision|1|||
161457262|NCT01606878|583068916|FG009|Overall Study|Physician Decision|0|||
161457263|NCT01606878|583068917|FG010|Overall Study|Physician Decision|0|||
161457264|NCT01606878|583068907|FG000|Overall Study|Withdrawal by Subject|3|||
161457265|NCT01606878|583068908|FG001|Overall Study|Withdrawal by Subject|2|||
161457266|NCT01606878|583068909|FG002|Overall Study|Withdrawal by Subject|2|||
161457267|NCT01606878|583068910|FG003|Overall Study|Withdrawal by Subject|0|||
161457268|NCT01606878|583068911|FG004|Overall Study|Withdrawal by Subject|1|||
161457269|NCT01606878|583068912|FG005|Overall Study|Withdrawal by Subject|1|||
161457270|NCT01606878|583068913|FG006|Overall Study|Withdrawal by Subject|2|||
161457271|NCT01606878|583068914|FG007|Overall Study|Withdrawal by Subject|1|||
161457272|NCT01606878|583068915|FG008|Overall Study|Withdrawal by Subject|2|||
161457273|NCT01606878|583068916|FG009|Overall Study|Withdrawal by Subject|0|||
161457274|NCT01606878|583068917|FG010|Overall Study|Withdrawal by Subject|2|||
161457275|NCT03720652|583068918|FG000|Overall Study|Withdrawal by Subject|2|||
161457276|NCT03720652|583068919|FG001|Overall Study|Withdrawal by Subject|7|||
161457277|NCT03720652|583068918|FG000|Overall Study|Lost to Follow-up|0|||
161457278|NCT03720652|583068919|FG001|Overall Study|Lost to Follow-up|4|||
161457279|NCT00604214|583068922|FG000|Baseline to Day 28|Death|223|||
161457280|NCT00604214|583068923|FG001|Baseline to Day 28|Death|202|||
161457281|NCT00604214|583068922|FG000|Baseline to Day 28|Lost to Follow-up|2|||
161457282|NCT00604214|583068923|FG001|Baseline to Day 28|Lost to Follow-up|4|||
161457283|NCT00604214|583068922|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
161457284|NCT00604214|583068923|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
161457285|NCT00604214|583068922|FG000|Day 29 to Day 90|Death|64|||
161457286|NCT00604214|583068923|FG001|Day 29 to Day 90|Death|67|||
161457287|NCT00604214|583068922|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
161457288|NCT00604214|583068923|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
161457289|NCT00604214|583068922|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
161457290|NCT00604214|583068923|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
161457291|NCT00604214|583068922|FG000|Day 91 to Day 180|Death|19|||
161457292|NCT00604214|583068923|FG001|Day 91 to Day 180|Death|23|||
161457293|NCT00604214|583068922|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
161457294|NCT00604214|583068923|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
161457295|NCT00604214|583068922|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
161457296|NCT00604214|583068923|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
161457297|NCT00534599|583068924|FG000|Overall Study|Adverse Event|25|||
161457298|NCT00534599|583068925|FG001|Overall Study|Adverse Event|4|||
161457299|NCT00534599|583068924|FG000|Overall Study|Incorrect enrollment|2|||
161457300|NCT00534599|583068925|FG001|Overall Study|Incorrect enrollment|1|||
161457301|NCT00534599|583068924|FG000|Overall Study|Mis-randomization|2|||
161457302|NCT00534599|583068925|FG001|Overall Study|Mis-randomization|2|||
161457303|NCT00534599|583068924|FG000|Overall Study|Developed study-specific d/c criteria|5|||
161457304|NCT00534599|583068925|FG001|Overall Study|Developed study-specific d/c criteria|0|||
161457305|NCT00534599|583068924|FG000|Overall Study|Lack of Efficacy|0|||
161457306|NCT00534599|583068925|FG001|Overall Study|Lack of Efficacy|1|||
161457307|NCT00534599|583068924|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
161457308|NCT00534599|583068925|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
161457309|NCT00534599|583068924|FG000|Overall Study|Protocol Violation|1|||
161457310|NCT00534599|583068925|FG001|Overall Study|Protocol Violation|3|||
161457311|NCT00534599|583068924|FG000|Overall Study|Lost to Follow-up|11|||
161457312|NCT00534599|583068925|FG001|Overall Study|Lost to Follow-up|14|||
161457313|NCT00534599|583068924|FG000|Overall Study|Withdrawal by Subject|4|||
161457314|NCT00534599|583068925|FG001|Overall Study|Withdrawal by Subject|6|||
161457315|NCT00534599|583068924|FG000|Overall Study|Other|7|||
161457316|NCT00534599|583068925|FG001|Overall Study|Other|0|||
161457317|NCT01155167|583068930|FG000|Overall Study|Insufficient ultrasound data|2|||
161457318|NCT01155167|583068931|FG001|Overall Study|Insufficient ultrasound data|0|||
161457319|NCT01155167|583068930|FG000|Overall Study|Access site changed to femoral artery|1|||
161457320|NCT01155167|583068931|FG001|Overall Study|Access site changed to femoral artery|0|||
161457321|NCT01981551|583068932|FG000|Overall Study|Refused further treatment|8|||
161568602|NCT05827926|583469307|FG006|Overall Study|Lost to Follow-up|0|||
161568603|NCT05827926|583469308|FG007|Overall Study|Lost to Follow-up|0|||
161568604|NCT05827926|583469309|FG008|Overall Study|Lost to Follow-up|0|||
161568605|NCT05827926|583469310|FG009|Overall Study|Lost to Follow-up|0|||
161568606|NCT05827926|583469311|FG010|Overall Study|Lost to Follow-up|0|||
161568607|NCT05827926|583469312|FG011|Overall Study|Lost to Follow-up|0|||
161568608|NCT05827926|583469313|FG012|Overall Study|Lost to Follow-up|1|||
161568609|NCT05827926|583469314|FG013|Overall Study|Lost to Follow-up|1|||
161568610|NCT05827926|583469315|FG014|Overall Study|Lost to Follow-up|0|||
161568611|NCT05827926|583469316|FG015|Overall Study|Lost to Follow-up|1|||
161568612|NCT05827926|583469317|FG016|Overall Study|Lost to Follow-up|2|||
161568613|NCT05827926|583469318|FG017|Overall Study|Lost to Follow-up|0|||
161568614|NCT05827926|583469319|FG018|Overall Study|Lost to Follow-up|0|||
161568615|NCT05827926|583469320|FG019|Overall Study|Lost to Follow-up|0|||
161568616|NCT05827926|583469321|FG020|Overall Study|Lost to Follow-up|1|||
161568617|NCT05827926|583469322|FG021|Overall Study|Lost to Follow-up|2|||
161568618|NCT05827926|583469323|FG022|Overall Study|Lost to Follow-up|1|||
161568619|NCT05827926|583469324|FG023|Overall Study|Lost to Follow-up|1|||
161568620|NCT05827926|583469325|FG024|Overall Study|Lost to Follow-up|2|||
161568621|NCT05827926|583469326|FG025|Overall Study|Lost to Follow-up|1|||
161568622|NCT05827926|583469327|FG026|Overall Study|Lost to Follow-up|4|||
161568623|NCT05827926|583469328|FG027|Overall Study|Lost to Follow-up|1|||
161568624|NCT05827926|583469329|FG028|Overall Study|Lost to Follow-up|2|||
161568625|NCT05827926|583469330|FG029|Overall Study|Lost to Follow-up|1|||
161568626|NCT05827926|583469331|FG030|Overall Study|Lost to Follow-up|5|||
161568627|NCT05827926|583469332|FG031|Overall Study|Lost to Follow-up|0|||
161568628|NCT05827926|583469333|FG032|Overall Study|Lost to Follow-up|3|||
161568629|NCT05827926|583469334|FG033|Overall Study|Lost to Follow-up|2|||
161568630|NCT05827926|583469335|FG034|Overall Study|Lost to Follow-up|1|||
161568631|NCT05827926|583469336|FG035|Overall Study|Lost to Follow-up|3|||
161568632|NCT05827926|583469337|FG036|Overall Study|Lost to Follow-up|4|||
161568633|NCT05827926|583469301|FG000|Overall Study|Withdrawal by Subject|1|||
161568634|NCT05827926|583469302|FG001|Overall Study|Withdrawal by Subject|0|||
161568635|NCT05827926|583469303|FG002|Overall Study|Withdrawal by Subject|1|||
161568636|NCT05827926|583469304|FG003|Overall Study|Withdrawal by Subject|1|||
161568637|NCT05827926|583469305|FG004|Overall Study|Withdrawal by Subject|0|||
161568638|NCT05827926|583469306|FG005|Overall Study|Withdrawal by Subject|0|||
161568639|NCT05827926|583469307|FG006|Overall Study|Withdrawal by Subject|0|||
161568640|NCT05827926|583469308|FG007|Overall Study|Withdrawal by Subject|0|||
161457322|NCT01981551|583068932|FG000|Overall Study|Adverse Event|1|||
161457323|NCT00167778|583068933|FG000|Overall Study|Withdrawal by Subject|1|||
161457324|NCT02654717|583068934|FG000|Overall Study|Adverse Event|2|||
161457325|NCT02654717|583068935|FG001|Overall Study|Adverse Event|2|||
161457326|NCT02654717|583068934|FG000|Overall Study|Protocol Violation|1|||
161457327|NCT02654717|583068935|FG001|Overall Study|Protocol Violation|2|||
161457328|NCT02654717|583068934|FG000|Overall Study|Withdrawal by Subject|0|||
161457329|NCT02654717|583068935|FG001|Overall Study|Withdrawal by Subject|1|||
161457330|NCT02654717|583068934|FG000|Overall Study|Non-permitted medication|3|||
161457331|NCT02654717|583068935|FG001|Overall Study|Non-permitted medication|0|||
161457332|NCT01451437|583068936|FG000|Overall Study|Adverse Event|0|||
161457333|NCT01451437|583068937|FG001|Overall Study|Adverse Event|0|||
161457334|NCT01451437|583068938|FG002|Overall Study|Adverse Event|0|||
161457335|NCT01451437|583068939|FG003|Overall Study|Adverse Event|0|||
161457336|NCT01451437|583068940|FG004|Overall Study|Adverse Event|0|||
161457337|NCT01451437|583068941|FG005|Overall Study|Adverse Event|1|||
161457338|NCT01451437|583068942|FG006|Overall Study|Adverse Event|1|||
161457339|NCT01451437|583068943|FG007|Overall Study|Adverse Event|2|||
161457340|NCT01451437|583068944|FG008|Overall Study|Adverse Event|1|||
161457341|NCT01451437|583068936|FG000|Overall Study|Physician Decision|1|||
161457342|NCT01451437|583068937|FG001|Overall Study|Physician Decision|1|||
161457343|NCT01451437|583068938|FG002|Overall Study|Physician Decision|2|||
161457344|NCT01451437|583068939|FG003|Overall Study|Physician Decision|0|||
161457345|NCT01451437|583068940|FG004|Overall Study|Physician Decision|0|||
161457346|NCT01451437|583068941|FG005|Overall Study|Physician Decision|0|||
161457347|NCT01451437|583068942|FG006|Overall Study|Physician Decision|0|||
161457348|NCT01451437|583068943|FG007|Overall Study|Physician Decision|0|||
161457349|NCT01451437|583068944|FG008|Overall Study|Physician Decision|0|||
161457350|NCT01451437|583068936|FG000|Overall Study|Disease Progression|0|||
161457351|NCT01451437|583068937|FG001|Overall Study|Disease Progression|0|||
161457352|NCT01451437|583068938|FG002|Overall Study|Disease Progression|1|||
161457353|NCT01451437|583068939|FG003|Overall Study|Disease Progression|1|||
161457354|NCT01451437|583068940|FG004|Overall Study|Disease Progression|3|||
161457355|NCT01451437|583068941|FG005|Overall Study|Disease Progression|2|||
161457356|NCT01451437|583068942|FG006|Overall Study|Disease Progression|3|||
161457357|NCT01451437|583068943|FG007|Overall Study|Disease Progression|1|||
161457358|NCT01451437|583068944|FG008|Overall Study|Disease Progression|3|||
161457359|NCT01451437|583068936|FG000|Overall Study|Protocol Violation|0|||
161457360|NCT01451437|583068937|FG001|Overall Study|Protocol Violation|0|||
161457361|NCT01451437|583068938|FG002|Overall Study|Protocol Violation|0|||
161457362|NCT01451437|583068939|FG003|Overall Study|Protocol Violation|0|||
161457363|NCT01451437|583068940|FG004|Overall Study|Protocol Violation|0|||
161457364|NCT01451437|583068941|FG005|Overall Study|Protocol Violation|0|||
161457365|NCT01451437|583068942|FG006|Overall Study|Protocol Violation|1|||
161457366|NCT01451437|583068943|FG007|Overall Study|Protocol Violation|0|||
161457367|NCT01451437|583068944|FG008|Overall Study|Protocol Violation|0|||
161457368|NCT01451437|583068936|FG000|Overall Study|Withdrawal by Subject|0|||
161457369|NCT01451437|583068937|FG001|Overall Study|Withdrawal by Subject|0|||
161457370|NCT01451437|583068938|FG002|Overall Study|Withdrawal by Subject|0|||
161457371|NCT01451437|583068939|FG003|Overall Study|Withdrawal by Subject|0|||
161457372|NCT01451437|583068940|FG004|Overall Study|Withdrawal by Subject|1|||
161457373|NCT01451437|583068941|FG005|Overall Study|Withdrawal by Subject|0|||
161457374|NCT01451437|583068942|FG006|Overall Study|Withdrawal by Subject|1|||
161457375|NCT01451437|583068943|FG007|Overall Study|Withdrawal by Subject|0|||
161457376|NCT01451437|583068944|FG008|Overall Study|Withdrawal by Subject|0|||
161457377|NCT00853970|583068947|FG000|Overall Study|Withdrawal by Subject|2|||
161457378|NCT00853970|583068948|FG001|Overall Study|Withdrawal by Subject|1|||
161457379|NCT00853970|583068947|FG000|Overall Study|Cancelled surgery|4|||
161457380|NCT00853970|583068948|FG001|Overall Study|Cancelled surgery|2|||
161457381|NCT00706849|583070161|FG000|Treatment Period|Adverse Event|0|||
161457382|NCT00706849|583070162|FG001|Treatment Period|Adverse Event|9|||
161913010|NCT00042289|584731861|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
161913011|NCT00042289|584731862|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
161913012|NCT00042289|584731863|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
161913013|NCT00042289|584731864|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
161913014|NCT00042289|584731865|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
161913015|NCT00042289|584731866|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
161913016|NCT00042289|584731867|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
161913017|NCT00042289|584731868|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
161913018|NCT00042289|584731869|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
161913019|NCT00042289|584731870|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
161913020|NCT00042289|584731871|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
161913021|NCT00042289|584731872|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
161913022|NCT00042289|584731873|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
161913023|NCT00042289|584731874|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
161913024|NCT00042289|584731875|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
161913025|NCT00042289|584731876|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
161913026|NCT00042289|584731877|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
161913027|NCT00042289|584731878|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
161913028|NCT00042289|584731879|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
161913029|NCT00042289|584731833|FG000|Overall Study|Protocol Violation|0|||
161913030|NCT00042289|584731834|FG001|Overall Study|Protocol Violation|0|||
161913031|NCT00042289|584731835|FG002|Overall Study|Protocol Violation|0|||
161913032|NCT00042289|584731836|FG003|Overall Study|Protocol Violation|0|||
161913033|NCT00042289|584731837|FG004|Overall Study|Protocol Violation|0|||
161913034|NCT00042289|584731838|FG005|Overall Study|Protocol Violation|1|||
161913035|NCT00042289|584731839|FG006|Overall Study|Protocol Violation|0|||
161913036|NCT00042289|584731840|FG007|Overall Study|Protocol Violation|1|||
161913037|NCT00042289|584731841|FG008|Overall Study|Protocol Violation|0|||
161913038|NCT00042289|584731842|FG009|Overall Study|Protocol Violation|0|||
161913039|NCT00042289|584731843|FG010|Overall Study|Protocol Violation|0|||
161913040|NCT00042289|584731844|FG011|Overall Study|Protocol Violation|0|||
161913041|NCT00042289|584731845|FG012|Overall Study|Protocol Violation|0|||
161913042|NCT00042289|584731846|FG013|Overall Study|Protocol Violation|0|||
161913043|NCT00042289|584731847|FG014|Overall Study|Protocol Violation|0|||
161913044|NCT00042289|584731848|FG015|Overall Study|Protocol Violation|0|||
161913045|NCT00042289|584731849|FG016|Overall Study|Protocol Violation|0|||
161913046|NCT00042289|584731850|FG017|Overall Study|Protocol Violation|0|||
161913047|NCT00042289|584731851|FG018|Overall Study|Protocol Violation|0|||
161913048|NCT00042289|584731852|FG019|Overall Study|Protocol Violation|0|||
161913049|NCT00042289|584731853|FG020|Overall Study|Protocol Violation|0|||
161913050|NCT00042289|584731854|FG021|Overall Study|Protocol Violation|0|||
161913051|NCT00042289|584731855|FG022|Overall Study|Protocol Violation|0|||
161913052|NCT00042289|584731856|FG023|Overall Study|Protocol Violation|1|||
161913053|NCT00042289|584731857|FG024|Overall Study|Protocol Violation|1|||
161457383|NCT00706849|583070161|FG000|Treatment Period|Other|0|||
161457384|NCT00706849|583070162|FG001|Treatment Period|Other|1|||
161457385|NCT00706849|583070161|FG000|Follow-up Period|Withdrawal by Subject|0|||
161457386|NCT00706849|583070162|FG001|Follow-up Period|Withdrawal by Subject|2|||
161457387|NCT00706849|583070161|FG000|Follow-up Period|Protocol non-compliance|0|||
161457388|NCT00706849|583070162|FG001|Follow-up Period|Protocol non-compliance|1|||
161457389|NCT01611454|583070164|FG000|Overall Study|Lack of Efficacy|18|||
161457390|NCT01611454|583070165|FG001|Overall Study|Lack of Efficacy|10|||
161457391|NCT01275339|583070168|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
161457392|NCT01275339|583070169|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
161457393|NCT01275339|583070170|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
161457394|NCT01275339|583070171|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
161457395|NCT01275339|583070168|FG000|Overall Study|Withdrawal by Subject|0|||
161457396|NCT01275339|583070169|FG001|Overall Study|Withdrawal by Subject|0|||
161568641|NCT05827926|583469309|FG008|Overall Study|Withdrawal by Subject|0|||
161568642|NCT05827926|583469310|FG009|Overall Study|Withdrawal by Subject|0|||
161568643|NCT05827926|583469311|FG010|Overall Study|Withdrawal by Subject|0|||
161568644|NCT05827926|583469312|FG011|Overall Study|Withdrawal by Subject|0|||
161568645|NCT05827926|583469313|FG012|Overall Study|Withdrawal by Subject|1|||
161568646|NCT05827926|583469314|FG013|Overall Study|Withdrawal by Subject|1|||
161568647|NCT05827926|583469315|FG014|Overall Study|Withdrawal by Subject|1|||
161568648|NCT05827926|583469316|FG015|Overall Study|Withdrawal by Subject|2|||
161568649|NCT05827926|583469317|FG016|Overall Study|Withdrawal by Subject|1|||
161568650|NCT05827926|583469318|FG017|Overall Study|Withdrawal by Subject|1|||
161568651|NCT05827926|583469319|FG018|Overall Study|Withdrawal by Subject|0|||
161568652|NCT05827926|583469320|FG019|Overall Study|Withdrawal by Subject|0|||
161568653|NCT05827926|583469321|FG020|Overall Study|Withdrawal by Subject|1|||
161568654|NCT05827926|583469322|FG021|Overall Study|Withdrawal by Subject|0|||
161568655|NCT05827926|583469323|FG022|Overall Study|Withdrawal by Subject|0|||
161568656|NCT05827926|583469324|FG023|Overall Study|Withdrawal by Subject|2|||
161568657|NCT05827926|583469325|FG024|Overall Study|Withdrawal by Subject|1|||
161568658|NCT05827926|583469326|FG025|Overall Study|Withdrawal by Subject|0|||
161568659|NCT05827926|583469327|FG026|Overall Study|Withdrawal by Subject|0|||
161568660|NCT05827926|583469328|FG027|Overall Study|Withdrawal by Subject|1|||
161568661|NCT05827926|583469329|FG028|Overall Study|Withdrawal by Subject|0|||
161568662|NCT05827926|583469330|FG029|Overall Study|Withdrawal by Subject|0|||
161568663|NCT05827926|583469331|FG030|Overall Study|Withdrawal by Subject|0|||
161568664|NCT05827926|583469332|FG031|Overall Study|Withdrawal by Subject|2|||
161568665|NCT05827926|583469333|FG032|Overall Study|Withdrawal by Subject|0|||
161568666|NCT05827926|583469334|FG033|Overall Study|Withdrawal by Subject|0|||
161568667|NCT05827926|583469335|FG034|Overall Study|Withdrawal by Subject|0|||
161568668|NCT05827926|583469336|FG035|Overall Study|Withdrawal by Subject|0|||
161568669|NCT05827926|583469337|FG036|Overall Study|Withdrawal by Subject|1|||
161568670|NCT05827926|583469301|FG000|Overall Study|Other Than Specified|0|||
161568671|NCT05827926|583469302|FG001|Overall Study|Other Than Specified|0|||
161568672|NCT05827926|583469303|FG002|Overall Study|Other Than Specified|0|||
161568673|NCT05827926|583469304|FG003|Overall Study|Other Than Specified|1|||
161568674|NCT05827926|583469305|FG004|Overall Study|Other Than Specified|0|||
161568675|NCT05827926|583469306|FG005|Overall Study|Other Than Specified|0|||
161568676|NCT05827926|583469307|FG006|Overall Study|Other Than Specified|1|||
161568677|NCT05827926|583469308|FG007|Overall Study|Other Than Specified|0|||
161568678|NCT05827926|583469309|FG008|Overall Study|Other Than Specified|0|||
161568679|NCT05827926|583469310|FG009|Overall Study|Other Than Specified|0|||
161568680|NCT05827926|583469311|FG010|Overall Study|Other Than Specified|0|||
161568681|NCT05827926|583469312|FG011|Overall Study|Other Than Specified|0|||
161568682|NCT05827926|583469313|FG012|Overall Study|Other Than Specified|0|||
161568683|NCT05827926|583469314|FG013|Overall Study|Other Than Specified|1|||
161568684|NCT05827926|583469315|FG014|Overall Study|Other Than Specified|0|||
161568685|NCT05827926|583469316|FG015|Overall Study|Other Than Specified|1|||
161568686|NCT05827926|583469317|FG016|Overall Study|Other Than Specified|0|||
161568687|NCT05827926|583469318|FG017|Overall Study|Other Than Specified|0|||
161568688|NCT05827926|583469319|FG018|Overall Study|Other Than Specified|0|||
161568689|NCT05827926|583469320|FG019|Overall Study|Other Than Specified|0|||
161568690|NCT05827926|583469321|FG020|Overall Study|Other Than Specified|0|||
161913054|NCT00042289|584731858|FG025|Overall Study|Protocol Violation|0|||
161913055|NCT00042289|584731859|FG026|Overall Study|Protocol Violation|2|||
161913056|NCT00042289|584731860|FG027|Overall Study|Protocol Violation|0|||
161913057|NCT00042289|584731861|FG028|Overall Study|Protocol Violation|0|||
161913058|NCT00042289|584731862|FG029|Overall Study|Protocol Violation|0|||
161913059|NCT00042289|584731863|FG030|Overall Study|Protocol Violation|1|||
161913060|NCT00042289|584731864|FG031|Overall Study|Protocol Violation|0|||
161913061|NCT00042289|584731865|FG032|Overall Study|Protocol Violation|0|||
161913062|NCT00042289|584731866|FG033|Overall Study|Protocol Violation|0|||
161913063|NCT00042289|584731867|FG034|Overall Study|Protocol Violation|0|||
161913064|NCT00042289|584731868|FG035|Overall Study|Protocol Violation|0|||
161913065|NCT00042289|584731869|FG036|Overall Study|Protocol Violation|0|||
161913066|NCT00042289|584731870|FG037|Overall Study|Protocol Violation|0|||
161913067|NCT00042289|584731871|FG038|Overall Study|Protocol Violation|0|||
161913068|NCT00042289|584731872|FG039|Overall Study|Protocol Violation|0|||
161913069|NCT00042289|584731873|FG040|Overall Study|Protocol Violation|0|||
161913070|NCT00042289|584731874|FG041|Overall Study|Protocol Violation|1|||
161913071|NCT00042289|584731875|FG042|Overall Study|Protocol Violation|1|||
161913072|NCT00042289|584731876|FG043|Overall Study|Protocol Violation|1|||
161913073|NCT00042289|584731877|FG044|Overall Study|Protocol Violation|0|||
161913074|NCT00042289|584731878|FG045|Overall Study|Protocol Violation|0|||
161913075|NCT00042289|584731879|FG046|Overall Study|Protocol Violation|0|||
161913076|NCT00042289|584731833|FG000|Overall Study|Withdrawal by Subject|4|||
161913077|NCT00042289|584731834|FG001|Overall Study|Withdrawal by Subject|1|||
161913078|NCT00042289|584731835|FG002|Overall Study|Withdrawal by Subject|0|||
161913079|NCT00042289|584731836|FG003|Overall Study|Withdrawal by Subject|2|||
161913080|NCT00042289|584731837|FG004|Overall Study|Withdrawal by Subject|0|||
161913081|NCT00042289|584731838|FG005|Overall Study|Withdrawal by Subject|2|||
161913082|NCT00042289|584731839|FG006|Overall Study|Withdrawal by Subject|0|||
161913083|NCT00042289|584731840|FG007|Overall Study|Withdrawal by Subject|0|||
161913084|NCT00042289|584731841|FG008|Overall Study|Withdrawal by Subject|0|||
161913085|NCT00042289|584731842|FG009|Overall Study|Withdrawal by Subject|1|||
161913086|NCT00042289|584731843|FG010|Overall Study|Withdrawal by Subject|0|||
161913087|NCT00042289|584731844|FG011|Overall Study|Withdrawal by Subject|0|||
161913088|NCT00042289|584731845|FG012|Overall Study|Withdrawal by Subject|2|||
161913089|NCT00042289|584731846|FG013|Overall Study|Withdrawal by Subject|0|||
161913090|NCT00042289|584731847|FG014|Overall Study|Withdrawal by Subject|0|||
161913091|NCT00042289|584731848|FG015|Overall Study|Withdrawal by Subject|0|||
161913092|NCT00042289|584731849|FG016|Overall Study|Withdrawal by Subject|0|||
161913093|NCT00042289|584731850|FG017|Overall Study|Withdrawal by Subject|0|||
161913094|NCT00042289|584731851|FG018|Overall Study|Withdrawal by Subject|0|||
161913095|NCT00042289|584731852|FG019|Overall Study|Withdrawal by Subject|0|||
161913096|NCT00042289|584731853|FG020|Overall Study|Withdrawal by Subject|0|||
161913097|NCT00042289|584731854|FG021|Overall Study|Withdrawal by Subject|1|||
161913098|NCT00042289|584731855|FG022|Overall Study|Withdrawal by Subject|1|||
161913099|NCT00042289|584731856|FG023|Overall Study|Withdrawal by Subject|1|||
161913100|NCT00042289|584731857|FG024|Overall Study|Withdrawal by Subject|0|||
161913101|NCT00042289|584731858|FG025|Overall Study|Withdrawal by Subject|0|||
161913102|NCT00042289|584731859|FG026|Overall Study|Withdrawal by Subject|1|||
161913103|NCT00042289|584731860|FG027|Overall Study|Withdrawal by Subject|0|||
161913104|NCT00042289|584731861|FG028|Overall Study|Withdrawal by Subject|2|||
161913105|NCT00042289|584731862|FG029|Overall Study|Withdrawal by Subject|0|||
161913106|NCT00042289|584731863|FG030|Overall Study|Withdrawal by Subject|0|||
161913107|NCT00042289|584731864|FG031|Overall Study|Withdrawal by Subject|1|||
161913108|NCT00042289|584731865|FG032|Overall Study|Withdrawal by Subject|2|||
161913109|NCT00042289|584731866|FG033|Overall Study|Withdrawal by Subject|1|||
161913110|NCT00042289|584731867|FG034|Overall Study|Withdrawal by Subject|0|||
161913111|NCT00042289|584731868|FG035|Overall Study|Withdrawal by Subject|0|||
161913112|NCT00042289|584731869|FG036|Overall Study|Withdrawal by Subject|0|||
161913113|NCT00042289|584731870|FG037|Overall Study|Withdrawal by Subject|1|||
161913114|NCT00042289|584731871|FG038|Overall Study|Withdrawal by Subject|0|||
161913115|NCT00042289|584731872|FG039|Overall Study|Withdrawal by Subject|0|||
161913116|NCT00042289|584731873|FG040|Overall Study|Withdrawal by Subject|0|||
161913117|NCT00042289|584731874|FG041|Overall Study|Withdrawal by Subject|0|||
161457397|NCT01275339|583070170|FG002|Overall Study|Withdrawal by Subject|1|||
161457398|NCT01275339|583070171|FG003|Overall Study|Withdrawal by Subject|0|||
161457399|NCT03718299|583070172|FG000|Overall Study|Adverse Event|1|||
161457400|NCT03718299|583070172|FG000|Overall Study|Withdrawal by Subject|6|||
161457401|NCT03718299|583070172|FG000|Overall Study|Physician Decision|2|||
161457402|NCT03718299|583070172|FG000|Overall Study|Lost to Follow-up|1|||
161457403|NCT04389970|583070174|FG000|Overall Study|Lost to Follow-up|1|||
161457404|NCT03123185|583070175|FG000|Overall Study|Withdrawal by Subject|0|||
161457405|NCT03123185|583070176|FG001|Overall Study|Withdrawal by Subject|0|||
161457406|NCT03123185|583070177|FG002|Overall Study|Withdrawal by Subject|0|||
161457407|NCT03123185|583070178|FG003|Overall Study|Withdrawal by Subject|0|||
161568691|NCT05827926|583469322|FG021|Overall Study|Other Than Specified|1|||
161913118|NCT00042289|584731875|FG042|Overall Study|Withdrawal by Subject|1|||
161568692|NCT05827926|583469323|FG022|Overall Study|Other Than Specified|1|||
161568693|NCT05827926|583469324|FG023|Overall Study|Other Than Specified|0|||
161568694|NCT05827926|583469325|FG024|Overall Study|Other Than Specified|0|||
161568695|NCT05827926|583469326|FG025|Overall Study|Other Than Specified|1|||
161568696|NCT05827926|583469327|FG026|Overall Study|Other Than Specified|0|||
161568697|NCT05827926|583469328|FG027|Overall Study|Other Than Specified|0|||
161568698|NCT05827926|583469329|FG028|Overall Study|Other Than Specified|0|||
161568699|NCT05827926|583469330|FG029|Overall Study|Other Than Specified|0|||
161568700|NCT05827926|583469331|FG030|Overall Study|Other Than Specified|0|||
161568701|NCT05827926|583469332|FG031|Overall Study|Other Than Specified|1|||
161568702|NCT05827926|583469333|FG032|Overall Study|Other Than Specified|0|||
161568703|NCT05827926|583469334|FG033|Overall Study|Other Than Specified|0|||
161568704|NCT05827926|583469335|FG034|Overall Study|Other Than Specified|0|||
161568705|NCT05827926|583469336|FG035|Overall Study|Other Than Specified|0|||
161568706|NCT05827926|583469337|FG036|Overall Study|Other Than Specified|0|||
161568707|NCT05827926|583469301|FG000|Overall Study|Physician Decision|0|||
161568708|NCT05827926|583469302|FG001|Overall Study|Physician Decision|0|||
161568709|NCT05827926|583469303|FG002|Overall Study|Physician Decision|0|||
161568710|NCT05827926|583469304|FG003|Overall Study|Physician Decision|0|||
161568711|NCT05827926|583469305|FG004|Overall Study|Physician Decision|0|||
161568712|NCT05827926|583469306|FG005|Overall Study|Physician Decision|0|||
161568713|NCT05827926|583469307|FG006|Overall Study|Physician Decision|0|||
161568714|NCT05827926|583469308|FG007|Overall Study|Physician Decision|0|||
161568715|NCT05827926|583469309|FG008|Overall Study|Physician Decision|0|||
161568716|NCT05827926|583469310|FG009|Overall Study|Physician Decision|0|||
161568717|NCT05827926|583469311|FG010|Overall Study|Physician Decision|0|||
161568718|NCT05827926|583469312|FG011|Overall Study|Physician Decision|0|||
161568719|NCT05827926|583469313|FG012|Overall Study|Physician Decision|0|||
161568720|NCT05827926|583469314|FG013|Overall Study|Physician Decision|0|||
161568721|NCT05827926|583469315|FG014|Overall Study|Physician Decision|0|||
161568722|NCT05827926|583469316|FG015|Overall Study|Physician Decision|0|||
161568723|NCT05827926|583469317|FG016|Overall Study|Physician Decision|0|||
161568724|NCT05827926|583469318|FG017|Overall Study|Physician Decision|0|||
161568725|NCT05827926|583469319|FG018|Overall Study|Physician Decision|1|||
161568726|NCT05827926|583469320|FG019|Overall Study|Physician Decision|0|||
161568727|NCT05827926|583469321|FG020|Overall Study|Physician Decision|0|||
161568728|NCT05827926|583469322|FG021|Overall Study|Physician Decision|0|||
161568729|NCT05827926|583469323|FG022|Overall Study|Physician Decision|0|||
161568730|NCT05827926|583469324|FG023|Overall Study|Physician Decision|0|||
161568731|NCT05827926|583469325|FG024|Overall Study|Physician Decision|0|||
161568732|NCT05827926|583469326|FG025|Overall Study|Physician Decision|0|||
161568733|NCT05827926|583469327|FG026|Overall Study|Physician Decision|0|||
161568734|NCT05827926|583469328|FG027|Overall Study|Physician Decision|0|||
161568735|NCT05827926|583469329|FG028|Overall Study|Physician Decision|0|||
161568736|NCT05827926|583469330|FG029|Overall Study|Physician Decision|0|||
161568737|NCT05827926|583469331|FG030|Overall Study|Physician Decision|0|||
161568738|NCT05827926|583469332|FG031|Overall Study|Physician Decision|0|||
161568739|NCT05827926|583469333|FG032|Overall Study|Physician Decision|0|||
161568740|NCT05827926|583469334|FG033|Overall Study|Physician Decision|0|||
161568741|NCT05827926|583469335|FG034|Overall Study|Physician Decision|0|||
161568742|NCT05827926|583469336|FG035|Overall Study|Physician Decision|0|||
161568743|NCT05827926|583469337|FG036|Overall Study|Physician Decision|0|||
161568744|NCT04588480|583469345|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
161568745|NCT04588480|583469346|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
161568746|NCT04588480|583469347|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
161568747|NCT04588480|583469345|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
161568748|NCT04588480|583469346|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
161568749|NCT04588480|583469347|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
161568750|NCT01242085|583469348|FG000|Overall Study|Withdrawal by Subject|4|||
161568751|NCT01242085|583469349|FG001|Overall Study|Withdrawal by Subject|2|||
161568752|NCT01242085|583469350|FG002|Overall Study|Withdrawal by Subject|0|||
161568753|NCT01242085|583469348|FG000|Overall Study|medically unable to have surgery|4|||
161568754|NCT01242085|583469349|FG001|Overall Study|medically unable to have surgery|5|||
161568755|NCT01242085|583469350|FG002|Overall Study|medically unable to have surgery|0|||
161568756|NCT01178762|583469351|FG000|Overall Study|Lost to Follow-up|15|||
161568757|NCT02322216|583469354|FG000|Overall Study|Adverse Event|1|||
161568758|NCT02322216|583469355|FG001|Overall Study|Adverse Event|0|||
161568759|NCT02322216|583469354|FG000|Overall Study|Withdrawal by Subject|1|||
161568760|NCT02322216|583469355|FG001|Overall Study|Withdrawal by Subject|4|||
161568761|NCT02430532|583469357|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
161568762|NCT02430532|583469358|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
161568763|NCT02430532|583469357|FG000|Overall Study|Consent Withdrawn|0|||
161568764|NCT02430532|583469358|FG001|Overall Study|Consent Withdrawn|2|||
161568765|NCT02430532|583469357|FG000|Overall Study|Adverse Event|0|||
161568766|NCT02430532|583469358|FG001|Overall Study|Adverse Event|1|||
161568767|NCT01190150|583469359|FG000|First Treatment|Withdrawal by Subject|1|||
161568768|NCT01190150|583469360|FG001|First Treatment|Withdrawal by Subject|0|||
161568769|NCT01190150|583469359|FG000|Washout|Withdrawal by Subject|0|||
161568770|NCT01190150|583469360|FG001|Washout|Withdrawal by Subject|1|||
161568771|NCT01190150|583469359|FG000|Washout|Difficulty in adherence|0|||
161568772|NCT01190150|583469360|FG001|Washout|Difficulty in adherence|1|||
161568773|NCT00608907|583469362|FG000|Overall Study|Adverse Event|6|||
161568774|NCT00608907|583469363|FG001|Overall Study|Adverse Event|0|||
161568775|NCT00608907|583469364|FG002|Overall Study|Adverse Event|1|||
161568776|NCT00608907|583469362|FG000|Overall Study|Death|1|||
161568777|NCT00608907|583469363|FG001|Overall Study|Death|0|||
161568778|NCT00608907|583469364|FG002|Overall Study|Death|0|||
161568779|NCT00608907|583469362|FG000|Overall Study|Withdrawal by Subject|4|||
161568780|NCT00608907|583469363|FG001|Overall Study|Withdrawal by Subject|0|||
161568781|NCT00608907|583469364|FG002|Overall Study|Withdrawal by Subject|0|||
161568782|NCT00608907|583469362|FG000|Overall Study|Progressive Disease|1|||
161568783|NCT00608907|583469363|FG001|Overall Study|Progressive Disease|0|||
161568784|NCT00608907|583469364|FG002|Overall Study|Progressive Disease|0|||
161568785|NCT02982213|583469367|FG000|Overall Study|Did not complete follow up questionnaire|5|||
161568786|NCT02982213|583469368|FG001|Overall Study|Did not complete follow up questionnaire|1|||
161568787|NCT03247543|583469369|FG000|Overall Study|Adverse Event|3|||
161568788|NCT03247543|583469370|FG001|Overall Study|Adverse Event|6|||
161568789|NCT03247543|583469371|FG002|Overall Study|Adverse Event|4|||
161568790|NCT03247543|583469369|FG000|Overall Study|Lost to Follow-up|10|||
161568791|NCT03247543|583469370|FG001|Overall Study|Lost to Follow-up|7|||
161568792|NCT03247543|583469371|FG002|Overall Study|Lost to Follow-up|8|||
161568793|NCT03247543|583469369|FG000|Overall Study|Consent withdrawn by caregiver|2|||
161568794|NCT03247543|583469370|FG001|Overall Study|Consent withdrawn by caregiver|2|||
161568795|NCT03247543|583469371|FG002|Overall Study|Consent withdrawn by caregiver|9|||
161568796|NCT03247543|583469369|FG000|Overall Study|Withdrawal by Subject|0|||
161568797|NCT03247543|583469370|FG001|Overall Study|Withdrawal by Subject|0|||
161568798|NCT03247543|583469371|FG002|Overall Study|Withdrawal by Subject|1|||
161568799|NCT03247543|583469369|FG000|Overall Study|Failure to Follow study procedures|1|||
161568800|NCT03247543|583469370|FG001|Overall Study|Failure to Follow study procedures|3|||
161568801|NCT03247543|583469371|FG002|Overall Study|Failure to Follow study procedures|1|||
161568802|NCT03247543|583469369|FG000|Overall Study|Lack of Efficacy|1|||
161568803|NCT03247543|583469370|FG001|Overall Study|Lack of Efficacy|0|||
161568804|NCT03247543|583469371|FG002|Overall Study|Lack of Efficacy|0|||
161568805|NCT03247543|583469369|FG000|Overall Study|Non-compliance with study visits|0|||
161568806|NCT03247543|583469370|FG001|Overall Study|Non-compliance with study visits|1|||
161568807|NCT03247543|583469371|FG002|Overall Study|Non-compliance with study visits|0|||
161568808|NCT01253226|583469377|FG000|Overall Study|Adverse Event|0|||
161809107|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809108|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161568809|NCT01253226|583469378|FG001|Overall Study|Adverse Event|0|||
161568810|NCT01253226|583469379|FG002|Overall Study|Adverse Event|1|||
161568811|NCT01253226|583469380|FG003|Overall Study|Adverse Event|0|||
161568812|NCT01253226|583469381|FG004|Overall Study|Adverse Event|0|||
161568813|NCT01253226|583469377|FG000|Overall Study|Death|0|||
161568814|NCT01253226|583469378|FG001|Overall Study|Death|1|||
161568815|NCT01253226|583469379|FG002|Overall Study|Death|0|||
161568816|NCT01253226|583469380|FG003|Overall Study|Death|0|||
161568817|NCT01253226|583469381|FG004|Overall Study|Death|0|||
161809109|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161568818|NCT01253226|583469377|FG000|Overall Study|Physician Decision|0|||
161568819|NCT01253226|583469378|FG001|Overall Study|Physician Decision|0|||
161568820|NCT01253226|583469379|FG002|Overall Study|Physician Decision|0|||
161568821|NCT01253226|583469380|FG003|Overall Study|Physician Decision|0|||
161568822|NCT01253226|583469381|FG004|Overall Study|Physician Decision|2|||
161568823|NCT01253226|583469377|FG000|Overall Study|Withdrawal by Subject|0|||
161568824|NCT01253226|583469378|FG001|Overall Study|Withdrawal by Subject|0|||
161568825|NCT01253226|583469379|FG002|Overall Study|Withdrawal by Subject|0|||
161568826|NCT01253226|583469380|FG003|Overall Study|Withdrawal by Subject|1|||
161568827|NCT01253226|583469381|FG004|Overall Study|Withdrawal by Subject|0|||
161668061|NCT00406653|583837476|FG000|Induction Period|Patient relocated|0|||
161668062|NCT00406653|583837477|FG001|Induction Period|Patient relocated|0|||
161668063|NCT00406653|583837478|FG002|Induction Period|Patient relocated|1|||
161668064|NCT00406653|583837479|FG003|Induction Period|Patient relocated|0|||
161668065|NCT00406653|583837480|FG004|Induction Period|Patient relocated|0|||
161668066|NCT00406653|583837481|FG005|Induction Period|Patient relocated|0|||
161568834|NCT04075266|583469384|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
161568835|NCT04075266|583469385|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
161568836|NCT04075266|583469384|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
161568837|NCT04075266|583469385|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
161568838|NCT01582945|583469386|FG000|Overall Study|Intolerable side-effects|1|||
161568839|NCT01582945|583469386|FG000|Overall Study|Scheduling conflicts|1|||
161568840|NCT01726023|583469387|FG000|Overall Study|Death|1|||
161568841|NCT01726023|583469388|FG001|Overall Study|Death|1|||
161568842|NCT01726023|583469387|FG000|Overall Study|Lost to Follow-up|5|||
161568843|NCT01726023|583469388|FG001|Overall Study|Lost to Follow-up|10|||
161568844|NCT01726023|583469387|FG000|Overall Study|Other Eligibility criteria|7|||
161568845|NCT01726023|583469388|FG001|Overall Study|Other Eligibility criteria|7|||
161568846|NCT01726023|583469387|FG000|Overall Study|Withdrawal by Subject|16|||
161568847|NCT01726023|583469388|FG001|Overall Study|Withdrawal by Subject|8|||
161568848|NCT03643211|583469391|FG000|Overall Study|Contract violation/deficiency|12|||
161568849|NCT03643211|583469391|FG000|Overall Study|Invalid registration|3|||
161568850|NCT03643211|583469391|FG000|Overall Study|No treatment information|2|||
161568851|NCT03643211|583469391|FG000|Overall Study|No adverse event information - No revisit|4|||
161568852|NCT04858425|583469392|FG000|Overall Study|Adverse Event|2|||
161568853|NCT04858425|583469393|FG001|Overall Study|Adverse Event|2|||
161568854|NCT04858425|583469392|FG000|Overall Study|Withdrawal by Subject|3|||
161568855|NCT04858425|583469393|FG001|Overall Study|Withdrawal by Subject|1|||
161568856|NCT04858425|583469392|FG000|Overall Study|Lost to Follow-up|4|||
161568857|NCT04858425|583469393|FG001|Overall Study|Lost to Follow-up|2|||
161568858|NCT04858425|583469392|FG000|Overall Study|Lost to Follow-up|1|||
161568859|NCT04858425|583469393|FG001|Overall Study|Lost to Follow-up|0|||
161568860|NCT03473743|583469394|FG000|Overall Study|Withdrawal by Subject|0|||
161568861|NCT03473743|583469395|FG001|Overall Study|Withdrawal by Subject|0|||
161568862|NCT03473743|583469396|FG002|Overall Study|Withdrawal by Subject|0|||
161568863|NCT03473743|583469397|FG003|Overall Study|Withdrawal by Subject|0|||
161568864|NCT03473743|583469398|FG004|Overall Study|Withdrawal by Subject|0|||
161568865|NCT03473743|583469399|FG005|Overall Study|Withdrawal by Subject|0|||
161568866|NCT03473743|583469400|FG006|Overall Study|Withdrawal by Subject|0|||
161568867|NCT03473743|583469401|FG007|Overall Study|Withdrawal by Subject|3|||
161568868|NCT03473743|583469394|FG000|Overall Study|Other|0|||
161568869|NCT03473743|583469395|FG001|Overall Study|Other|0|||
161568870|NCT03473743|583469396|FG002|Overall Study|Other|0|||
161568871|NCT03473743|583469397|FG003|Overall Study|Other|1|||
161568872|NCT03473743|583469398|FG004|Overall Study|Other|0|||
161568873|NCT03473743|583469399|FG005|Overall Study|Other|0|||
161568874|NCT03473743|583469400|FG006|Overall Study|Other|0|||
161568875|NCT03473743|583469401|FG007|Overall Study|Other|0|||
161568876|NCT03473743|583469394|FG000|Overall Study|Ongoing|0|||
161568877|NCT03473743|583469395|FG001|Overall Study|Ongoing|0|||
161568878|NCT03473743|583469396|FG002|Overall Study|Ongoing|6|||
161568879|NCT03473743|583469397|FG003|Overall Study|Ongoing|8|||
161568880|NCT03473743|583469398|FG004|Overall Study|Ongoing|1|||
161568881|NCT03473743|583469399|FG005|Overall Study|Ongoing|1|||
161568882|NCT03473743|583469400|FG006|Overall Study|Ongoing|22|||
161568883|NCT03473743|583469401|FG007|Overall Study|Ongoing|24|||
161568884|NCT03473743|583469394|FG000|Overall Study|Randomized but not treated|0|||
161568885|NCT03473743|583469395|FG001|Overall Study|Randomized but not treated|0|||
161568886|NCT03473743|583469396|FG002|Overall Study|Randomized but not treated|0|||
161568887|NCT03473743|583469397|FG003|Overall Study|Randomized but not treated|0|||
161568888|NCT03473743|583469398|FG004|Overall Study|Randomized but not treated|0|||
161568889|NCT03473743|583469399|FG005|Overall Study|Randomized but not treated|0|||
161568890|NCT03473743|583469400|FG006|Overall Study|Randomized but not treated|1|||
161568891|NCT03473743|583469401|FG007|Overall Study|Randomized but not treated|1|||
161568892|NCT02864992|583469402|FG000|Overall Study|still on treatment|15|||
161568893|NCT02864992|583469403|FG001|Overall Study|still on treatment|1|||
161568894|NCT02864992|583469404|FG002|Overall Study|still on treatment|33|||
161568895|NCT04536077|583469406|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
161568896|NCT04536077|583469407|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
161568897|NCT04536077|583469406|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
161568898|NCT04536077|583469407|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
161568899|NCT04948333|583469408|FG000|Overall Study|Adverse Event|6|||
161568900|NCT04948333|583469409|FG001|Overall Study|Adverse Event|4|||
161568901|NCT04948333|583469410|FG002|Overall Study|Adverse Event|0|||
161568902|NCT04948333|583469411|FG003|Overall Study|Adverse Event|2|||
161568903|NCT04948333|583469408|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161568904|NCT04948333|583469409|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161568905|NCT04948333|583469410|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161568906|NCT04948333|583469411|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161568907|NCT04948333|583469408|FG000|Overall Study|Progressive Disease|1|||
161568908|NCT04948333|583469409|FG001|Overall Study|Progressive Disease|5|||
161568909|NCT04948333|583469410|FG002|Overall Study|Progressive Disease|0|||
161568910|NCT04948333|583469411|FG003|Overall Study|Progressive Disease|0|||
161568911|NCT04948333|583469408|FG000|Overall Study|Physician Decision|2|||
161568912|NCT04948333|583469409|FG001|Overall Study|Physician Decision|2|||
161568913|NCT04948333|583469410|FG002|Overall Study|Physician Decision|0|||
161568914|NCT04948333|583469411|FG003|Overall Study|Physician Decision|0|||
161568915|NCT04948333|583469408|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
161568916|NCT04948333|583469409|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
161568917|NCT04948333|583469410|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
161568918|NCT04948333|583469411|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
161568919|NCT04948333|583469408|FG000|Overall Study|Withdrawal by Subject|2|||
161568920|NCT04948333|583469409|FG001|Overall Study|Withdrawal by Subject|0|||
161568921|NCT04948333|583469410|FG002|Overall Study|Withdrawal by Subject|0|||
161568922|NCT04948333|583469411|FG003|Overall Study|Withdrawal by Subject|1|||
161568923|NCT04948333|583469408|FG000|Overall Study|Protocol Violation|0|||
161568924|NCT04948333|583469409|FG001|Overall Study|Protocol Violation|1|||
161568925|NCT04948333|583469410|FG002|Overall Study|Protocol Violation|0|||
161568926|NCT04948333|583469411|FG003|Overall Study|Protocol Violation|0|||
161568927|NCT04948333|583469408|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
161568928|NCT04948333|583469409|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
161568929|NCT04948333|583469410|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
161568930|NCT04948333|583469411|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
161568931|NCT03805295|583469415|FG000|Overall Study|Lost to Follow-up|17|||
161568932|NCT03805295|583469416|FG001|Overall Study|Lost to Follow-up|43|||
161568933|NCT04925752|583469417|FG000|Overall Study|Still on Study|1826|||
161568934|NCT04925752|583469418|FG001|Overall Study|Still on Study|926|||
161568935|NCT04925752|583469417|FG000|Overall Study|Withdrew Consent|128|||
161568936|NCT04925752|583469418|FG001|Overall Study|Withdrew Consent|59|||
161568937|NCT04925752|583469417|FG000|Overall Study|Lost to Follow-up|73|||
161568938|NCT04925752|583469418|FG001|Overall Study|Lost to Follow-up|47|||
161568939|NCT04925752|583469417|FG000|Overall Study|Randomized but Never Treated|12|||
161568940|NCT04925752|583469418|FG001|Overall Study|Randomized but Never Treated|9|||
161568941|NCT04925752|583469417|FG000|Overall Study|Hiv-1 Infection|6|||
161568942|NCT04925752|583469418|FG001|Overall Study|Hiv-1 Infection|7|||
161568943|NCT04925752|583469417|FG000|Overall Study|Investigator's discretion|8|||
161568944|NCT04925752|583469418|FG001|Overall Study|Investigator's discretion|5|||
161568945|NCT04925752|583469417|FG000|Overall Study|Non-compliance with Study Drug|8|||
161568946|NCT04925752|583469418|FG001|Overall Study|Non-compliance with Study Drug|5|||
161568947|NCT04925752|583469417|FG000|Overall Study|Adverse Event|5|||
161568948|NCT04925752|583469418|FG001|Overall Study|Adverse Event|2|||
161568949|NCT04925752|583469417|FG000|Overall Study|Death|4|||
161568950|NCT04925752|583469418|FG001|Overall Study|Death|2|||
161568951|NCT04925752|583469417|FG000|Overall Study|Protocol Violation|1|||
161568952|NCT04925752|583469418|FG001|Overall Study|Protocol Violation|3|||
161568953|NCT04925752|583469417|FG000|Overall Study|Withdrew Assent|1|||
161568954|NCT04925752|583469418|FG001|Overall Study|Withdrew Assent|0|||
161568955|NCT03331250|583469419|FG000|Overall Study|Withdrawal by Subject|1|||
161568956|NCT01155869|583469425|FG000|Overall Study|Lost to Follow-up|3|||
161568957|NCT01155869|583469426|FG001|Overall Study|Lost to Follow-up|1|||
161568958|NCT04540835|583469429|FG000|Week 1|Lost to Follow-up|1|||
161568959|NCT04540835|583469429|FG000|Week 6|Pregnancy|1|||
161568960|NCT04540835|583469429|FG000|Week 6|Lack of Efficacy|1|||
161568961|NCT01227278|583470486|FG000|Overall Study|Withdrawal by Subject|4|||
161568962|NCT01227278|583470487|FG001|Overall Study|Withdrawal by Subject|4|||
161568963|NCT01227278|583470486|FG000|Overall Study|Death|0|||
161568964|NCT01227278|583470487|FG001|Overall Study|Death|2|||
161568965|NCT01227278|583470486|FG000|Overall Study|Other|1|||
161568966|NCT01227278|583470487|FG001|Overall Study|Other|2|||
161568967|NCT01281813|583470502|FG000|Overall Study|Adverse Event|0|||
161568968|NCT01281813|583470503|FG001|Overall Study|Adverse Event|0|||
161568969|NCT01281813|583470504|FG002|Overall Study|Adverse Event|10|||
161568970|NCT01281813|583470502|FG000|Overall Study|Lost to Follow-up|0|||
161568971|NCT01281813|583470503|FG001|Overall Study|Lost to Follow-up|0|||
161568972|NCT01281813|583470504|FG002|Overall Study|Lost to Follow-up|31|||
161568973|NCT01281813|583470502|FG000|Overall Study|Withdrawal by Subject|0|||
161568974|NCT01281813|583470503|FG001|Overall Study|Withdrawal by Subject|0|||
161568975|NCT01281813|583470504|FG002|Overall Study|Withdrawal by Subject|13|||
161568976|NCT01281813|583470502|FG000|Overall Study|Subject Non-Compliant|0|||
161568977|NCT01281813|583470503|FG001|Overall Study|Subject Non-Compliant|0|||
161568978|NCT01281813|583470504|FG002|Overall Study|Subject Non-Compliant|6|||
161568979|NCT01281813|583470502|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
161568980|NCT01281813|583470503|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
161568981|NCT01281813|583470504|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
161568982|NCT01281813|583470502|FG000|Overall Study|Sponsor's Decision|4|||
161568983|NCT01281813|583470503|FG001|Overall Study|Sponsor's Decision|3|||
161568984|NCT01281813|583470504|FG002|Overall Study|Sponsor's Decision|7|||
161568985|NCT01281813|583470502|FG000|Overall Study|Switched to Commercially Available Medication|0|||
161568986|NCT01281813|583470503|FG001|Overall Study|Switched to Commercially Available Medication|0|||
161568987|NCT01281813|583470504|FG002|Overall Study|Switched to Commercially Available Medication|26|||
161568988|NCT01281813|583470502|FG000|Overall Study|Other|0|||
161568989|NCT01281813|583470503|FG001|Overall Study|Other|1|||
161568990|NCT01281813|583470504|FG002|Overall Study|Other|39|||
161568991|NCT00558363|583470505|FG000|Overall Study|Physician Decision|18|||
161568992|NCT00558363|583470506|FG001|Overall Study|Physician Decision|4|||
161568993|NCT00558363|583470505|FG000|Overall Study|Withdrawal by Subject|11|||
161568994|NCT00558363|583470506|FG001|Overall Study|Withdrawal by Subject|4|||
161568995|NCT00558363|583470505|FG000|Overall Study|Adverse Event|5|||
161568996|NCT00558363|583470506|FG001|Overall Study|Adverse Event|5|||
161568997|NCT00558363|583470505|FG000|Overall Study|Lack of Efficacy|2|||
161568998|NCT00558363|583470506|FG001|Overall Study|Lack of Efficacy|2|||
161568999|NCT00558363|583470505|FG000|Overall Study|Protocol Violation|2|||
161569000|NCT00558363|583470506|FG001|Overall Study|Protocol Violation|1|||
161569001|NCT00558363|583470505|FG000|Overall Study|Lost to Follow-up|0|||
161569002|NCT00558363|583470506|FG001|Overall Study|Lost to Follow-up|1|||
161569003|NCT00558363|583470505|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
161569004|NCT00558363|583470506|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
161569005|NCT00558363|583470505|FG000|Overall Study|Randomized in Error|1|||
161569006|NCT00558363|583470506|FG001|Overall Study|Randomized in Error|2|||
161569007|NCT00558363|583470505|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
161569008|NCT00558363|583470506|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
161569009|NCT00868192|583470507|FG000|Overall Study|Ineligible|4|||
161569010|NCT00843193|583470509|FG000|Overall Study|Adverse Event|2|||
161569011|NCT00843193|583470510|FG001|Overall Study|Adverse Event|4|||
161569012|NCT00843193|583470509|FG000|Overall Study|Lack of Efficacy|1|||
161569013|NCT00843193|583470510|FG001|Overall Study|Lack of Efficacy|1|||
161569014|NCT00843193|583470509|FG000|Overall Study|Protocol Violation|1|||
161569015|NCT00843193|583470510|FG001|Overall Study|Protocol Violation|2|||
161569016|NCT00843193|583470509|FG000|Overall Study|Lost to Follow-up|1|||
161569017|NCT00843193|583470510|FG001|Overall Study|Lost to Follow-up|0|||
161569018|NCT00843193|583470509|FG000|Overall Study|Physician Decision|0|||
161569019|NCT00843193|583470510|FG001|Overall Study|Physician Decision|1|||
161569020|NCT00843193|583470509|FG000|Overall Study|Withdrawal by Subject|3|||
161569021|NCT00843193|583470510|FG001|Overall Study|Withdrawal by Subject|3|||
161569022|NCT04511650|583470511|FG000|Overall Study|Lost to Follow-up|1|||
161569023|NCT04511650|583470512|FG001|Overall Study|Lost to Follow-up|0|||
161569024|NCT04511650|583470513|FG002|Overall Study|Lost to Follow-up|0|||
161569025|NCT04511650|583470511|FG000|Overall Study|Withdrawal by Subject|1|||
161569026|NCT04511650|583470512|FG001|Overall Study|Withdrawal by Subject|0|||
161569027|NCT04511650|583470513|FG002|Overall Study|Withdrawal by Subject|0|||
161569028|NCT04511650|583470511|FG000|Overall Study|reason not provided|0|||
161569029|NCT04511650|583470512|FG001|Overall Study|reason not provided|0|||
161569030|NCT04511650|583470513|FG002|Overall Study|reason not provided|1|||
161569031|NCT04511650|583470511|FG000|Overall Study|Death|1|||
161569032|NCT04511650|583470512|FG001|Overall Study|Death|1|||
161569033|NCT04511650|583470513|FG002|Overall Study|Death|1|||
161569034|NCT03523962|583470519|FG000|Closed Fractures|Death|86|||
161569035|NCT03523962|583470520|FG001|Closed Fractures|Death|71|||
161569036|NCT03523962|583470521|FG002|Closed Fractures|Death|0|||
161569037|NCT03523962|583470522|FG003|Closed Fractures|Death|0|||
161569038|NCT03523962|583470519|FG000|Closed Fractures|Lost to Follow-up|62|||
161569039|NCT03523962|583470520|FG001|Closed Fractures|Lost to Follow-up|36|||
161569040|NCT03523962|583470521|FG002|Closed Fractures|Lost to Follow-up|0|||
161569041|NCT03523962|583470522|FG003|Closed Fractures|Lost to Follow-up|0|||
161569042|NCT03523962|583470519|FG000|Closed Fractures|Withdrawal by Subject|19|||
161569043|NCT03523962|583470520|FG001|Closed Fractures|Withdrawal by Subject|29|||
161569044|NCT03523962|583470521|FG002|Closed Fractures|Withdrawal by Subject|0|||
161569045|NCT03523962|583470522|FG003|Closed Fractures|Withdrawal by Subject|0|||
161569046|NCT03523962|583470519|FG000|Closed Fractures|Incarceration|1|||
161569047|NCT03523962|583470520|FG001|Closed Fractures|Incarceration|4|||
161569048|NCT03523962|583470521|FG002|Closed Fractures|Incarceration|0|||
161569049|NCT03523962|583470522|FG003|Closed Fractures|Incarceration|0|||
161569050|NCT03523962|583470519|FG000|Open Fractures|Death|0|||
161569051|NCT03523962|583470520|FG001|Open Fractures|Death|0|||
161569052|NCT03523962|583470521|FG002|Open Fractures|Death|11|||
161569053|NCT03523962|583470522|FG003|Open Fractures|Death|6|||
161569054|NCT03523962|583470519|FG000|Open Fractures|Lost to Follow-up|0|||
161569055|NCT03523962|583470520|FG001|Open Fractures|Lost to Follow-up|0|||
161569056|NCT03523962|583470521|FG002|Open Fractures|Lost to Follow-up|15|||
161569057|NCT03523962|583470522|FG003|Open Fractures|Lost to Follow-up|8|||
161569058|NCT03523962|583470519|FG000|Open Fractures|Withdrawal by Subject|0|||
161569059|NCT03523962|583470520|FG001|Open Fractures|Withdrawal by Subject|0|||
161569060|NCT03523962|583470521|FG002|Open Fractures|Withdrawal by Subject|6|||
161569061|NCT03523962|583470522|FG003|Open Fractures|Withdrawal by Subject|2|||
161569062|NCT03523962|583470519|FG000|Open Fractures|Incarceration|0|||
161569063|NCT03523962|583470520|FG001|Open Fractures|Incarceration|0|||
161569064|NCT03523962|583470521|FG002|Open Fractures|Incarceration|1|||
161569065|NCT03523962|583470522|FG003|Open Fractures|Incarceration|0|||
161569066|NCT00835380|583470523|FG000|Overall Study|Withdrawal by Subject|2|||
161569067|NCT01081145|583470524|FG000|Open-Label Phase|Lack of Efficacy|56|||
161569068|NCT01081145|583470525|FG001|Open-Label Phase|Lack of Efficacy|0|||
161569069|NCT01081145|583470524|FG000|Open-Label Phase|Response criteria not met|46|||
161569070|NCT01081145|583470525|FG001|Open-Label Phase|Response criteria not met|0|||
161569071|NCT01081145|583470524|FG000|Open-Label Phase|Adverse Event|42|||
161569072|NCT01081145|583470525|FG001|Open-Label Phase|Adverse Event|0|||
161569073|NCT01081145|583470524|FG000|Open-Label Phase|Withdrawal by Subject|41|||
161569074|NCT01081145|583470525|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161569075|NCT01081145|583470524|FG000|Open-Label Phase|Other|12|||
161569076|NCT01081145|583470525|FG001|Open-Label Phase|Other|0|||
161569077|NCT01081145|583470524|FG000|Open-Label Phase|Lost to Follow-up|11|||
161569078|NCT01081145|583470525|FG001|Open-Label Phase|Lost to Follow-up|0|||
161569079|NCT01081145|583470524|FG000|Open-Label Phase|Protocol Violation|4|||
161569080|NCT01081145|583470525|FG001|Open-Label Phase|Protocol Violation|0|||
161569081|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
161569082|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
161569083|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
161569084|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
161569085|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
161569086|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
161569087|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
161569088|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
161569089|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
161569090|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
161569091|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
161569092|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
161569093|NCT01081145|583470524|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
161569094|NCT01081145|583470525|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
161569095|NCT03593070|583470526|FG000|Overall Study|administrative withdrawal|1|||
161569096|NCT03593070|583470527|FG001|Overall Study|administrative withdrawal|1|||
161569097|NCT00881335|583470528|FG000|Overall Study|Lost to Follow-up|3|||
161569098|NCT00881335|583470529|FG001|Overall Study|Lost to Follow-up|2|||
161569099|NCT04538664|583470530|FG000|Overall Study|Withdrawal by Subject|5|||
161569100|NCT04538664|583470531|FG001|Overall Study|Withdrawal by Subject|9|||
161569101|NCT04538664|583470530|FG000|Overall Study|Lost to Follow-up|2|||
161569102|NCT04538664|583470531|FG001|Overall Study|Lost to Follow-up|1|||
161569103|NCT04538664|583470530|FG000|Overall Study|Ongoing|106|||
161569104|NCT04538664|583470531|FG001|Overall Study|Ongoing|115|||
161569105|NCT03681678|583470534|FG000|Overall Study|Lost to Follow-up|20|||
161569106|NCT00828945|583470537|FG000|Overall Study|Death|4|||
161569107|NCT00828945|583470537|FG000|Overall Study|Participant was missing|1|||
161569108|NCT00828945|583470537|FG000|Overall Study|Other|36|||
161569109|NCT03431350|583470540|FG000|Overall Study|ONGOING|0|||
161569110|NCT03431350|583470541|FG001|Overall Study|ONGOING|0|||
161569111|NCT03431350|583470542|FG002|Overall Study|ONGOING|2|||
161569112|NCT03431350|583470543|FG003|Overall Study|ONGOING|0|||
161569113|NCT03431350|583470544|FG004|Overall Study|ONGOING|1|||
161569114|NCT03431350|583470545|FG005|Overall Study|ONGOING|3|||
161569115|NCT03431350|583470546|FG006|Overall Study|ONGOING|0|||
161569116|NCT03431350|583470547|FG007|Overall Study|ONGOING|1|||
161569117|NCT03431350|583470548|FG008|Overall Study|ONGOING|3|||
161569118|NCT03431350|583470549|FG009|Overall Study|ONGOING|4|||
161569119|NCT03431350|583470550|FG010|Overall Study|ONGOING|2|||
161569120|NCT03431350|583470551|FG011|Overall Study|ONGOING|1|||
161569121|NCT03431350|583470540|FG000|Overall Study|Death|6|||
161569122|NCT03431350|583470541|FG001|Overall Study|Death|5|||
161569123|NCT03431350|583470542|FG002|Overall Study|Death|18|||
161569124|NCT03431350|583470543|FG003|Overall Study|Death|7|||
161569125|NCT03431350|583470544|FG004|Overall Study|Death|4|||
161569126|NCT03431350|583470545|FG005|Overall Study|Death|3|||
161569127|NCT03431350|583470546|FG006|Overall Study|Death|2|||
161569128|NCT03431350|583470547|FG007|Overall Study|Death|0|||
161569129|NCT03431350|583470548|FG008|Overall Study|Death|0|||
161569130|NCT03431350|583470549|FG009|Overall Study|Death|0|||
161569131|NCT03431350|583470550|FG010|Overall Study|Death|4|||
161569132|NCT03431350|583470551|FG011|Overall Study|Death|0|||
161569133|NCT03431350|583470540|FG000|Overall Study|Lost to Follow-up|0|||
161569134|NCT03431350|583470541|FG001|Overall Study|Lost to Follow-up|1|||
161569135|NCT03431350|583470542|FG002|Overall Study|Lost to Follow-up|0|||
161569136|NCT03431350|583470543|FG003|Overall Study|Lost to Follow-up|0|||
161569137|NCT03431350|583470544|FG004|Overall Study|Lost to Follow-up|0|||
161569138|NCT03431350|583470545|FG005|Overall Study|Lost to Follow-up|0|||
161569139|NCT03431350|583470546|FG006|Overall Study|Lost to Follow-up|0|||
161569140|NCT03431350|583470547|FG007|Overall Study|Lost to Follow-up|0|||
161569141|NCT03431350|583470548|FG008|Overall Study|Lost to Follow-up|0|||
161569142|NCT03431350|583470549|FG009|Overall Study|Lost to Follow-up|0|||
161569143|NCT03431350|583470550|FG010|Overall Study|Lost to Follow-up|0|||
161569144|NCT03431350|583470551|FG011|Overall Study|Lost to Follow-up|0|||
161569145|NCT03431350|583470540|FG000|Overall Study|Withdrawal by Subject|0|||
161569146|NCT03431350|583470541|FG001|Overall Study|Withdrawal by Subject|0|||
161569147|NCT03431350|583470542|FG002|Overall Study|Withdrawal by Subject|0|||
161569148|NCT03431350|583470543|FG003|Overall Study|Withdrawal by Subject|1|||
161569149|NCT03431350|583470544|FG004|Overall Study|Withdrawal by Subject|1|||
161569150|NCT03431350|583470545|FG005|Overall Study|Withdrawal by Subject|1|||
161569151|NCT03431350|583470546|FG006|Overall Study|Withdrawal by Subject|0|||
161569152|NCT03431350|583470547|FG007|Overall Study|Withdrawal by Subject|0|||
161569153|NCT03431350|583470548|FG008|Overall Study|Withdrawal by Subject|0|||
161569154|NCT03431350|583470549|FG009|Overall Study|Withdrawal by Subject|2|||
161569155|NCT03431350|583470550|FG010|Overall Study|Withdrawal by Subject|0|||
161569156|NCT03431350|583470551|FG011|Overall Study|Withdrawal by Subject|1|||
161569157|NCT03431350|583470540|FG000|Overall Study|Other|0|||
161569158|NCT03431350|583470541|FG001|Overall Study|Other|0|||
161569159|NCT03431350|583470542|FG002|Overall Study|Other|1|||
161569160|NCT03431350|583470543|FG003|Overall Study|Other|3|||
161569161|NCT03431350|583470544|FG004|Overall Study|Other|2|||
161569162|NCT03431350|583470545|FG005|Overall Study|Other|2|||
161569163|NCT03431350|583470546|FG006|Overall Study|Other|4|||
161569164|NCT03431350|583470547|FG007|Overall Study|Other|0|||
161569165|NCT03431350|583470548|FG008|Overall Study|Other|14|||
161569166|NCT03431350|583470549|FG009|Overall Study|Other|11|||
161569167|NCT03431350|583470550|FG010|Overall Study|Other|11|||
161569168|NCT03431350|583470551|FG011|Overall Study|Other|15|||
161569169|NCT02141074|583470554|FG000|Pre-prophylaxis|Adverse Event|3|||
161569170|NCT02141074|583470555|FG001|Pre-prophylaxis|Adverse Event|0|||
161569171|NCT02141074|583470554|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
161569172|NCT02141074|583470555|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
161569173|NCT02141074|583470554|FG000|Prophylaxis|Adverse Event|0|||
161569174|NCT02141074|583470555|FG001|Prophylaxis|Adverse Event|4|||
161569175|NCT02141074|583470554|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
161569176|NCT02141074|583470555|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
161569177|NCT02141074|583470554|FG000|Prophylaxis|Withdrawal by Subject|0|||
161569178|NCT02141074|583470555|FG001|Prophylaxis|Withdrawal by Subject|1|||
161569179|NCT03722446|583470556|FG000|Overall Study|Protocol Violation|15|||
161569180|NCT03722446|583470557|FG001|Overall Study|Protocol Violation|2|||
161569181|NCT04487080|583470564|FG000|Overall Study|Withdrawal by Subject|19|||
161569182|NCT04487080|583470565|FG001|Overall Study|Withdrawal by Subject|18|||
161569183|NCT04487080|583470566|FG002|Overall Study|Withdrawal by Subject|13|||
161569184|NCT04487080|583470564|FG000|Overall Study|Lost to Follow-up|3|||
161569185|NCT04487080|583470565|FG001|Overall Study|Lost to Follow-up|1|||
161569186|NCT04487080|583470566|FG002|Overall Study|Lost to Follow-up|0|||
161569187|NCT04487080|583470564|FG000|Overall Study|Ongoing|313|||
161569188|NCT04487080|583470565|FG001|Overall Study|Ongoing|297|||
161569189|NCT04487080|583470566|FG002|Overall Study|Ongoing|149|||
161569190|NCT04133363|583470567|FG000|Overall Study|Lost to Follow-up|2|||
161569191|NCT04133363|583470568|FG001|Overall Study|Lost to Follow-up|1|||
161569192|NCT04133363|583470569|FG002|Overall Study|Lost to Follow-up|4|||
161569193|NCT01838200|583470570|FG000|Overall Study|Adverse Event|0|||
161569194|NCT01838200|583470571|FG001|Overall Study|Adverse Event|2|||
161569195|NCT01838200|583470570|FG000|Overall Study|Progressive disease|3|||
161569196|NCT01838200|583470571|FG001|Overall Study|Progressive disease|0|||
161569197|NCT03105336|583470572|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
161569198|NCT03105336|583470573|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
161569199|NCT03105336|583470572|FG000|Overall Study|Death|40|||
161569200|NCT03105336|583470573|FG001|Overall Study|Death|8|||
161569201|NCT03105336|583470572|FG000|Overall Study|Lost to Follow-up|13|||
161569202|NCT03105336|583470573|FG001|Overall Study|Lost to Follow-up|2|||
161569203|NCT03105336|583470572|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
161569204|NCT03105336|583470573|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
161569205|NCT03105336|583470572|FG000|Overall Study|Reason Not Specified|3|||
161569206|NCT03105336|583470573|FG001|Overall Study|Reason Not Specified|3|||
161569207|NCT03105336|583470572|FG000|Overall Study|Investigator Decision|3|||
161569208|NCT03105336|583470573|FG001|Overall Study|Investigator Decision|0|||
161569209|NCT03451851|583470574|FG000|PCP: Week 0 -16|Adverse Event|1|||
161569210|NCT03451851|583470575|FG001|PCP: Week 0 -16|Adverse Event|0|||
161569211|NCT03451851|583470576|FG002|PCP: Week 0 -16|Adverse Event|0|||
161569212|NCT03451851|583470577|FG003|PCP: Week 0 -16|Adverse Event|0|||
161569213|NCT03451851|583470578|FG004|PCP: Week 0 -16|Adverse Event|0|||
161569214|NCT03451851|583470579|FG005|PCP: Week 0 -16|Adverse Event|0|||
161569215|NCT03451851|583470580|FG006|PCP: Week 0 -16|Adverse Event|1|||
161569216|NCT03451851|583470581|FG007|PCP: Week 0 -16|Adverse Event|0|||
161569217|NCT03451851|583470574|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569218|NCT03451851|583470575|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569219|NCT03451851|583470576|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
161569220|NCT03451851|583470577|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569221|NCT03451851|583470578|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569222|NCT03451851|583470579|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569223|NCT03451851|583470580|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569224|NCT03451851|583470581|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
161569225|NCT03451851|583470574|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569226|NCT03451851|583470575|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569227|NCT03451851|583470576|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
161569228|NCT03451851|583470577|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569229|NCT03451851|583470578|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569230|NCT03451851|583470579|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569231|NCT03451851|583470580|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569232|NCT03451851|583470581|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
161569233|NCT03451851|583470574|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161569234|NCT03451851|583470575|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161569235|NCT03451851|583470576|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161569236|NCT03451851|583470577|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161569237|NCT03451851|583470578|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
161569238|NCT03451851|583470579|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
161569239|NCT03451851|583470580|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161569240|NCT03451851|583470581|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161569241|NCT03451851|583470574|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569242|NCT03451851|583470575|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569243|NCT03451851|583470576|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569244|NCT03451851|583470577|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569245|NCT03451851|583470578|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
161569246|NCT03451851|583470579|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569247|NCT03451851|583470580|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569248|NCT03451851|583470581|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161569249|NCT03451851|583470574|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569250|NCT03451851|583470575|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569251|NCT03451851|583470576|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569252|NCT03451851|583470577|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569253|NCT03451851|583470578|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
161569254|NCT03451851|583470579|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569255|NCT03451851|583470580|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569256|NCT03451851|583470581|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161569257|NCT03354390|583470585|FG000|Level 1|Death|2|||
161569258|NCT03354390|583470586|FG001|Level 1|Death|0|||
161569259|NCT03354390|583470587|FG002|Level 1|Death|0|||
161569260|NCT03354390|583470588|FG003|Level 1|Death|0|||
161569261|NCT03354390|583470585|FG000|Level 1|Physician Decision|1|||
161569262|NCT03354390|583470586|FG001|Level 1|Physician Decision|0|||
161569263|NCT03354390|583470587|FG002|Level 1|Physician Decision|0|||
161569264|NCT03354390|583470588|FG003|Level 1|Physician Decision|0|||
161569265|NCT03354390|583470585|FG000|Level 2|Physician Decision|0|||
161569266|NCT03354390|583470586|FG001|Level 2|Physician Decision|2|||
161569267|NCT03354390|583470587|FG002|Level 2|Physician Decision|0|||
161569268|NCT03354390|583470588|FG003|Level 2|Physician Decision|0|||
161569269|NCT03354390|583470585|FG000|Level 2|Lack of Efficacy|0|||
161569270|NCT03354390|583470586|FG001|Level 2|Lack of Efficacy|1|||
161569271|NCT03354390|583470587|FG002|Level 2|Lack of Efficacy|0|||
161569272|NCT03354390|583470588|FG003|Level 2|Lack of Efficacy|0|||
161569273|NCT03354390|583470585|FG000|Level 2|Lost to Follow-up|0|||
161569274|NCT03354390|583470586|FG001|Level 2|Lost to Follow-up|1|||
161569275|NCT03354390|583470587|FG002|Level 2|Lost to Follow-up|0|||
161569276|NCT03354390|583470588|FG003|Level 2|Lost to Follow-up|0|||
161569277|NCT03354390|583470585|FG000|Level 3|Death|0|||
161569278|NCT03354390|583470586|FG001|Level 3|Death|0|||
161569279|NCT03354390|583470587|FG002|Level 3|Death|1|||
161569280|NCT03354390|583470588|FG003|Level 3|Death|0|||
161569281|NCT03354390|583470585|FG000|Level 3|Physician Decision|0|||
161569282|NCT03354390|583470586|FG001|Level 3|Physician Decision|0|||
161569283|NCT03354390|583470587|FG002|Level 3|Physician Decision|2|||
161569284|NCT03354390|583470588|FG003|Level 3|Physician Decision|0|||
161569285|NCT03354390|583470585|FG000|Level 4|Death|0|||
161569286|NCT03354390|583470586|FG001|Level 4|Death|0|||
161569287|NCT03354390|583470587|FG002|Level 4|Death|0|||
161569288|NCT03354390|583470588|FG003|Level 4|Death|3|||
161569289|NCT03944512|583470592|FG000|Overall Study|Death|0|||
161569290|NCT03944512|583470593|FG001|Overall Study|Death|0|||
161569291|NCT03944512|583470594|FG002|Overall Study|Death|1|||
161569292|NCT03944512|583470595|FG003|Overall Study|Death|2|||
161569293|NCT03944512|583470592|FG000|Overall Study|Lost to Follow-up|0|||
161569294|NCT03944512|583470593|FG001|Overall Study|Lost to Follow-up|0|||
161569295|NCT03944512|583470594|FG002|Overall Study|Lost to Follow-up|4|||
161569296|NCT03944512|583470595|FG003|Overall Study|Lost to Follow-up|4|||
161569297|NCT03944512|583470592|FG000|Overall Study|refused follow-up|0|||
161569298|NCT03944512|583470593|FG001|Overall Study|refused follow-up|0|||
161569299|NCT03944512|583470594|FG002|Overall Study|refused follow-up|2|||
161569300|NCT03944512|583470595|FG003|Overall Study|refused follow-up|2|||
161569301|NCT01090024|583471748|FG000|Period 1|Met exclusion criteria|0|||
161569302|NCT01090024|583471749|FG001|Period 1|Met exclusion criteria|0|||
161569303|NCT01090024|583471750|FG002|Period 1|Met exclusion criteria|0|||
161569304|NCT01090024|583471751|FG003|Period 1|Met exclusion criteria|0|||
161569305|NCT01090024|583471752|FG004|Period 1|Met exclusion criteria|0|||
161569306|NCT01090024|583471753|FG005|Period 1|Met exclusion criteria|0|||
161569307|NCT01090024|583471754|FG006|Period 1|Met exclusion criteria|0|||
161569308|NCT01090024|583471755|FG007|Period 1|Met exclusion criteria|0|||
161569309|NCT01090024|583471756|FG008|Period 1|Met exclusion criteria|0|||
161569310|NCT01090024|583471757|FG009|Period 1|Met exclusion criteria|0|||
161569311|NCT01090024|583471758|FG010|Period 1|Met exclusion criteria|0|||
161569312|NCT01090024|583471759|FG011|Period 1|Met exclusion criteria|0|||
161569313|NCT01090024|583471760|FG012|Period 1|Met exclusion criteria|0|||
161569314|NCT01090024|583471761|FG013|Period 1|Met exclusion criteria|0|||
161569315|NCT01090024|583471762|FG014|Period 1|Met exclusion criteria|1|||
161569316|NCT01090024|583471763|FG015|Period 1|Met exclusion criteria|0|||
161569317|NCT01090024|583471764|FG016|Period 1|Met exclusion criteria|0|||
161569318|NCT01090024|583471765|FG017|Period 1|Met exclusion criteria|0|||
161569319|NCT01090024|583471748|FG000|Period 1|Adverse Event|0|||
161569320|NCT01090024|583471749|FG001|Period 1|Adverse Event|0|||
161569321|NCT01090024|583471750|FG002|Period 1|Adverse Event|0|||
161569322|NCT01090024|583471751|FG003|Period 1|Adverse Event|0|||
161569323|NCT01090024|583471752|FG004|Period 1|Adverse Event|0|||
161569324|NCT01090024|583471753|FG005|Period 1|Adverse Event|0|||
161569325|NCT01090024|583471754|FG006|Period 1|Adverse Event|0|||
161569326|NCT01090024|583471755|FG007|Period 1|Adverse Event|0|||
161569327|NCT01090024|583471756|FG008|Period 1|Adverse Event|0|||
161569328|NCT01090024|583471757|FG009|Period 1|Adverse Event|1|||
161569329|NCT01090024|583471758|FG010|Period 1|Adverse Event|0|||
161569330|NCT01090024|583471759|FG011|Period 1|Adverse Event|1|||
161569331|NCT01090024|583471760|FG012|Period 1|Adverse Event|0|||
161569332|NCT01090024|583471761|FG013|Period 1|Adverse Event|0|||
161569333|NCT01090024|583471762|FG014|Period 1|Adverse Event|0|||
161569334|NCT01090024|583471763|FG015|Period 1|Adverse Event|0|||
161569335|NCT01090024|583471764|FG016|Period 1|Adverse Event|0|||
161569336|NCT01090024|583471765|FG017|Period 1|Adverse Event|1|||
161569337|NCT01090024|583471748|FG000|Period 1|Withdrawal by Subject|0|||
161569338|NCT01090024|583471749|FG001|Period 1|Withdrawal by Subject|0|||
161569339|NCT01090024|583471750|FG002|Period 1|Withdrawal by Subject|0|||
161569340|NCT01090024|583471751|FG003|Period 1|Withdrawal by Subject|1|||
161569341|NCT01090024|583471752|FG004|Period 1|Withdrawal by Subject|0|||
161569342|NCT01090024|583471753|FG005|Period 1|Withdrawal by Subject|0|||
161569343|NCT01090024|583471754|FG006|Period 1|Withdrawal by Subject|0|||
161569344|NCT01090024|583471755|FG007|Period 1|Withdrawal by Subject|0|||
161569345|NCT01090024|583471756|FG008|Period 1|Withdrawal by Subject|0|||
161569346|NCT01090024|583471757|FG009|Period 1|Withdrawal by Subject|0|||
161569347|NCT01090024|583471758|FG010|Period 1|Withdrawal by Subject|0|||
161569348|NCT01090024|583471759|FG011|Period 1|Withdrawal by Subject|0|||
161569349|NCT01090024|583471760|FG012|Period 1|Withdrawal by Subject|0|||
161569350|NCT01090024|583471761|FG013|Period 1|Withdrawal by Subject|0|||
161569351|NCT01090024|583471762|FG014|Period 1|Withdrawal by Subject|0|||
161569352|NCT01090024|583471763|FG015|Period 1|Withdrawal by Subject|0|||
161569353|NCT01090024|583471764|FG016|Period 1|Withdrawal by Subject|0|||
161569354|NCT01090024|583471765|FG017|Period 1|Withdrawal by Subject|0|||
161569355|NCT01090024|583471748|FG000|Period 1|Lost to Follow-up|0|||
161569356|NCT01090024|583471749|FG001|Period 1|Lost to Follow-up|1|||
161569357|NCT01090024|583471750|FG002|Period 1|Lost to Follow-up|0|||
161569358|NCT01090024|583471751|FG003|Period 1|Lost to Follow-up|0|||
161569359|NCT01090024|583471752|FG004|Period 1|Lost to Follow-up|0|||
161569360|NCT01090024|583471753|FG005|Period 1|Lost to Follow-up|0|||
161569361|NCT01090024|583471754|FG006|Period 1|Lost to Follow-up|0|||
161569362|NCT01090024|583471755|FG007|Period 1|Lost to Follow-up|0|||
161569363|NCT01090024|583471756|FG008|Period 1|Lost to Follow-up|0|||
161569364|NCT01090024|583471757|FG009|Period 1|Lost to Follow-up|0|||
161569365|NCT01090024|583471758|FG010|Period 1|Lost to Follow-up|0|||
161569366|NCT01090024|583471759|FG011|Period 1|Lost to Follow-up|0|||
161569367|NCT01090024|583471760|FG012|Period 1|Lost to Follow-up|0|||
161569368|NCT01090024|583471761|FG013|Period 1|Lost to Follow-up|0|||
161569369|NCT01090024|583471762|FG014|Period 1|Lost to Follow-up|0|||
161569370|NCT01090024|583471763|FG015|Period 1|Lost to Follow-up|0|||
161569371|NCT01090024|583471764|FG016|Period 1|Lost to Follow-up|0|||
161569372|NCT01090024|583471765|FG017|Period 1|Lost to Follow-up|0|||
161569373|NCT01090024|583471748|FG000|Period 2|Lost to Follow-up|0|||
161569374|NCT01090024|583471749|FG001|Period 2|Lost to Follow-up|0|||
161569375|NCT01090024|583471750|FG002|Period 2|Lost to Follow-up|0|||
161569376|NCT01090024|583471751|FG003|Period 2|Lost to Follow-up|1|||
161569377|NCT01090024|583471752|FG004|Period 2|Lost to Follow-up|0|||
161569378|NCT01090024|583471753|FG005|Period 2|Lost to Follow-up|0|||
161569379|NCT01090024|583471754|FG006|Period 2|Lost to Follow-up|0|||
161569380|NCT01090024|583471755|FG007|Period 2|Lost to Follow-up|0|||
161569381|NCT01090024|583471756|FG008|Period 2|Lost to Follow-up|0|||
161569382|NCT01090024|583471757|FG009|Period 2|Lost to Follow-up|0|||
161569383|NCT01090024|583471758|FG010|Period 2|Lost to Follow-up|0|||
161569384|NCT01090024|583471759|FG011|Period 2|Lost to Follow-up|0|||
161569385|NCT01090024|583471760|FG012|Period 2|Lost to Follow-up|0|||
161569386|NCT01090024|583471761|FG013|Period 2|Lost to Follow-up|0|||
161569387|NCT01090024|583471762|FG014|Period 2|Lost to Follow-up|0|||
161569388|NCT01090024|583471763|FG015|Period 2|Lost to Follow-up|0|||
161569389|NCT01090024|583471764|FG016|Period 2|Lost to Follow-up|0|||
161569390|NCT01090024|583471765|FG017|Period 2|Lost to Follow-up|0|||
161569391|NCT01090024|583471748|FG000|Period 2|Adverse Event|1|||
161569392|NCT01090024|583471749|FG001|Period 2|Adverse Event|0|||
161569393|NCT01090024|583471750|FG002|Period 2|Adverse Event|0|||
161569394|NCT01090024|583471751|FG003|Period 2|Adverse Event|0|||
161569395|NCT01090024|583471752|FG004|Period 2|Adverse Event|0|||
161569396|NCT01090024|583471753|FG005|Period 2|Adverse Event|0|||
161569397|NCT01090024|583471754|FG006|Period 2|Adverse Event|0|||
161569398|NCT01090024|583471755|FG007|Period 2|Adverse Event|0|||
161569399|NCT01090024|583471756|FG008|Period 2|Adverse Event|0|||
161569400|NCT01090024|583471757|FG009|Period 2|Adverse Event|0|||
161569401|NCT01090024|583471758|FG010|Period 2|Adverse Event|0|||
161569402|NCT01090024|583471759|FG011|Period 2|Adverse Event|0|||
161569403|NCT01090024|583471760|FG012|Period 2|Adverse Event|0|||
161569404|NCT01090024|583471761|FG013|Period 2|Adverse Event|0|||
161569405|NCT01090024|583471762|FG014|Period 2|Adverse Event|0|||
161569406|NCT01090024|583471763|FG015|Period 2|Adverse Event|0|||
161569407|NCT01090024|583471764|FG016|Period 2|Adverse Event|0|||
161569408|NCT01090024|583471765|FG017|Period 2|Adverse Event|0|||
161569409|NCT01090024|583471748|FG000|Period 3|Withdrawal by Subject|0|||
161569410|NCT01090024|583471749|FG001|Period 3|Withdrawal by Subject|0|||
161913119|NCT00042289|584731876|FG043|Overall Study|Withdrawal by Subject|0|||
161913120|NCT00042289|584731877|FG044|Overall Study|Withdrawal by Subject|0|||
161913121|NCT00042289|584731878|FG045|Overall Study|Withdrawal by Subject|0|||
161913122|NCT00042289|584731879|FG046|Overall Study|Withdrawal by Subject|0|||
161913123|NCT00548327|584731884|FG000|Overall Study|Adverse Event|0|||
161913124|NCT00548327|584731885|FG001|Overall Study|Adverse Event|1|||
161913125|NCT01673386|584731886|FG000|Overall Study|Study terminated by sponsor|16|||
161913126|NCT01673386|584731887|FG001|Overall Study|Study terminated by sponsor|22|||
161913127|NCT01673386|584731886|FG000|Overall Study|Adverse Event|5|||
161913128|NCT01673386|584731887|FG001|Overall Study|Adverse Event|2|||
161913129|NCT01673386|584731886|FG000|Overall Study|Progressive disease|4|||
161913130|NCT01673386|584731887|FG001|Overall Study|Progressive disease|1|||
161913131|NCT01673386|584731886|FG000|Overall Study|Withdrawal by Subject|0|||
161913132|NCT01673386|584731887|FG001|Overall Study|Withdrawal by Subject|2|||
161913133|NCT00274456|584731888|FG000|Overall Study|Still on treatment|2|||
161913134|NCT00274456|584731889|FG001|Overall Study|Still on treatment|3|||
161913135|NCT00274456|584731890|FG002|Overall Study|Still on treatment|5|||
161913136|NCT00274456|584731891|FG003|Overall Study|Still on treatment|1|||
161913137|NCT00274456|584731888|FG000|Overall Study|Unacceptable toxicity|10|||
161913138|NCT00274456|584731889|FG001|Overall Study|Unacceptable toxicity|5|||
161913139|NCT00274456|584731890|FG002|Overall Study|Unacceptable toxicity|12|||
161913140|NCT00274456|584731891|FG003|Overall Study|Unacceptable toxicity|16|||
161913141|NCT00274456|584731888|FG000|Overall Study|Adverse Event|0|||
161913142|NCT00274456|584731889|FG001|Overall Study|Adverse Event|1|||
161913143|NCT00274456|584731890|FG002|Overall Study|Adverse Event|2|||
161913144|NCT00274456|584731891|FG003|Overall Study|Adverse Event|2|||
161913145|NCT00274456|584731888|FG000|Overall Study|Physician Decision|7|||
161913146|NCT00274456|584731889|FG001|Overall Study|Physician Decision|5|||
161569411|NCT01090024|583471750|FG002|Period 3|Withdrawal by Subject|0|||
161569412|NCT01090024|583471751|FG003|Period 3|Withdrawal by Subject|0|||
161569413|NCT01090024|583471752|FG004|Period 3|Withdrawal by Subject|0|||
161569414|NCT01090024|583471753|FG005|Period 3|Withdrawal by Subject|0|||
161569415|NCT01090024|583471754|FG006|Period 3|Withdrawal by Subject|0|||
161569416|NCT01090024|583471755|FG007|Period 3|Withdrawal by Subject|0|||
161569417|NCT01090024|583471756|FG008|Period 3|Withdrawal by Subject|0|||
161809110|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809111|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809112|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161913147|NCT00274456|584731890|FG002|Overall Study|Physician Decision|6|||
161569418|NCT01090024|583471757|FG009|Period 3|Withdrawal by Subject|0|||
161569419|NCT01090024|583471758|FG010|Period 3|Withdrawal by Subject|0|||
161913148|NCT00274456|584731891|FG003|Overall Study|Physician Decision|13|||
161913149|NCT00274456|584731888|FG000|Overall Study|Lost to Follow-up|0|||
161913150|NCT00274456|584731889|FG001|Overall Study|Lost to Follow-up|0|||
161913151|NCT00274456|584731890|FG002|Overall Study|Lost to Follow-up|1|||
161913152|NCT00274456|584731891|FG003|Overall Study|Lost to Follow-up|0|||
161913153|NCT00274456|584731888|FG000|Overall Study|Withdrawal by Subject|18|||
161913154|NCT00274456|584731889|FG001|Overall Study|Withdrawal by Subject|13|||
161913155|NCT00274456|584731890|FG002|Overall Study|Withdrawal by Subject|9|||
161913156|NCT00274456|584731891|FG003|Overall Study|Withdrawal by Subject|13|||
161913157|NCT04460885|584731896|FG000|Overall Study|Withdrawal by Subject|6|||
161913158|NCT04460885|584731897|FG001|Overall Study|Withdrawal by Subject|8|||
161913159|NCT04460885|584731896|FG000|Overall Study|Site closure|1|||
161913160|NCT04460885|584731897|FG001|Overall Study|Site closure|0|||
161913161|NCT04460885|584731896|FG000|Overall Study|Death|5|||
161913162|NCT04460885|584731897|FG001|Overall Study|Death|4|||
161913163|NCT04460885|584731896|FG000|Overall Study|Physician Decision|2|||
161913164|NCT04460885|584731897|FG001|Overall Study|Physician Decision|1|||
161569420|NCT01090024|583471759|FG011|Period 3|Withdrawal by Subject|0|||
161569421|NCT01090024|583471760|FG012|Period 3|Withdrawal by Subject|0|||
161569422|NCT01090024|583471761|FG013|Period 3|Withdrawal by Subject|0|||
161569423|NCT01090024|583471762|FG014|Period 3|Withdrawal by Subject|0|||
161569424|NCT01090024|583471763|FG015|Period 3|Withdrawal by Subject|1|||
161569425|NCT01090024|583471764|FG016|Period 3|Withdrawal by Subject|0|||
161569426|NCT01090024|583471765|FG017|Period 3|Withdrawal by Subject|0|||
161569427|NCT01090024|583471748|FG000|Period 3|Protocol Violation|0|||
161569428|NCT01090024|583471749|FG001|Period 3|Protocol Violation|0|||
161569429|NCT01090024|583471750|FG002|Period 3|Protocol Violation|0|||
161569430|NCT01090024|583471751|FG003|Period 3|Protocol Violation|0|||
161569431|NCT01090024|583471752|FG004|Period 3|Protocol Violation|0|||
161569432|NCT01090024|583471753|FG005|Period 3|Protocol Violation|0|||
161569433|NCT01090024|583471754|FG006|Period 3|Protocol Violation|0|||
161569434|NCT01090024|583471755|FG007|Period 3|Protocol Violation|0|||
161569435|NCT01090024|583471756|FG008|Period 3|Protocol Violation|1|||
161569436|NCT01090024|583471757|FG009|Period 3|Protocol Violation|0|||
161569437|NCT01090024|583471758|FG010|Period 3|Protocol Violation|0|||
161569438|NCT01090024|583471759|FG011|Period 3|Protocol Violation|0|||
161569439|NCT01090024|583471760|FG012|Period 3|Protocol Violation|0|||
161569440|NCT01090024|583471761|FG013|Period 3|Protocol Violation|0|||
161569441|NCT01090024|583471762|FG014|Period 3|Protocol Violation|0|||
161569442|NCT01090024|583471763|FG015|Period 3|Protocol Violation|0|||
161569443|NCT01090024|583471764|FG016|Period 3|Protocol Violation|0|||
161569444|NCT01090024|583471765|FG017|Period 3|Protocol Violation|0|||
161569445|NCT01090024|583471748|FG000|Period 3|Adverse Event|0|||
161569446|NCT01090024|583471749|FG001|Period 3|Adverse Event|0|||
161569447|NCT01090024|583471750|FG002|Period 3|Adverse Event|0|||
161569448|NCT01090024|583471751|FG003|Period 3|Adverse Event|0|||
161569449|NCT01090024|583471752|FG004|Period 3|Adverse Event|0|||
161569450|NCT01090024|583471753|FG005|Period 3|Adverse Event|1|||
161569451|NCT01090024|583471754|FG006|Period 3|Adverse Event|0|||
161569452|NCT01090024|583471755|FG007|Period 3|Adverse Event|0|||
161569453|NCT01090024|583471756|FG008|Period 3|Adverse Event|0|||
161569454|NCT01090024|583471757|FG009|Period 3|Adverse Event|0|||
161569455|NCT01090024|583471758|FG010|Period 3|Adverse Event|0|||
161569456|NCT01090024|583471759|FG011|Period 3|Adverse Event|0|||
161569457|NCT01090024|583471760|FG012|Period 3|Adverse Event|0|||
161569458|NCT01090024|583471761|FG013|Period 3|Adverse Event|0|||
161569459|NCT01090024|583471762|FG014|Period 3|Adverse Event|0|||
161569460|NCT01090024|583471763|FG015|Period 3|Adverse Event|0|||
161809113|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809114|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809115|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809116|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809117|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809118|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809119|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
161809120|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
161809121|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
161809122|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809123|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809124|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809125|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809126|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809127|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809128|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809129|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809130|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809131|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809132|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161569461|NCT01090024|583471764|FG016|Period 3|Adverse Event|0|||
161569462|NCT01090024|583471765|FG017|Period 3|Adverse Event|0|||
161569463|NCT00470626|583471767|FG000|Overall Study|Lost to Follow-up|10|||
161569464|NCT00470626|583471767|FG000|Overall Study|Withdrawal by Subject|7|||
161569465|NCT00777556|583471768|FG000|Overall Study|Inappropriate self-selection|34|||
161569466|NCT00777556|583471768|FG000|Overall Study|Dispensed but did not use product|12|||
161569467|NCT00777556|583471768|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
161569468|NCT02380742|583471769|FG000|Overall Study|Withdrawal by Subject|1|||
161569469|NCT02380742|583471770|FG001|Overall Study|Withdrawal by Subject|0|||
161569470|NCT02689349|583471771|FG000|Overall Study|Not implanted|4|||
161569471|NCT02689349|583471772|FG001|Overall Study|Not implanted|0|||
161569472|NCT02689349|583471771|FG000|Overall Study|Withdrawal by Subject|9|||
161569473|NCT02689349|583471772|FG001|Overall Study|Withdrawal by Subject|0|||
161569474|NCT01185522|583471773|FG000|Overall Study|Lack of Efficacy|28|||
161569475|NCT01185522|583471773|FG000|Overall Study|Lost to Follow-up|19|||
161913165|NCT04460885|584731896|FG000|Overall Study|Lost to Follow-up|4|||
161457408|NCT03123185|583070179|FG004|Overall Study|Withdrawal by Subject|0|||
161457409|NCT03123185|583070180|FG005|Overall Study|Withdrawal by Subject|0|||
161457410|NCT03123185|583070181|FG006|Overall Study|Withdrawal by Subject|0|||
161457411|NCT03123185|583070182|FG007|Overall Study|Withdrawal by Subject|0|||
161457412|NCT03123185|583070183|FG008|Overall Study|Withdrawal by Subject|0|||
161457413|NCT03123185|583070184|FG009|Overall Study|Withdrawal by Subject|0|||
161457414|NCT03123185|583070185|FG010|Overall Study|Withdrawal by Subject|0|||
161457415|NCT03123185|583070186|FG011|Overall Study|Withdrawal by Subject|0|||
161457416|NCT03123185|583070187|FG012|Overall Study|Withdrawal by Subject|1|||
161457417|NCT03123185|583070188|FG013|Overall Study|Withdrawal by Subject|0|||
161457418|NCT00713310|583070193|FG000|Overall Study|Adverse Event|5|||
161457419|NCT00713310|583070194|FG001|Overall Study|Adverse Event|2|||
161457420|NCT00713310|583070193|FG000|Overall Study|Lack of Efficacy|0|||
161457421|NCT00713310|583070194|FG001|Overall Study|Lack of Efficacy|2|||
161457422|NCT00713310|583070193|FG000|Overall Study|Withdrawal by Subject|0|||
161457423|NCT00713310|583070194|FG001|Overall Study|Withdrawal by Subject|2|||
161457424|NCT00329901|583070195|FG000|Overall Study|Withdrawal by Subject|4|||
161457425|NCT00329901|583070196|FG001|Overall Study|Withdrawal by Subject|3|||
161457426|NCT00329901|583070197|FG002|Overall Study|Withdrawal by Subject|2|||
161457427|NCT00329901|583070195|FG000|Overall Study|Lost to Follow-up|2|||
161457428|NCT00329901|583070196|FG001|Overall Study|Lost to Follow-up|0|||
161457429|NCT00329901|583070197|FG002|Overall Study|Lost to Follow-up|1|||
161457430|NCT00329901|583070195|FG000|Overall Study|Protocol Violation|1|||
161457431|NCT00329901|583070196|FG001|Overall Study|Protocol Violation|0|||
161457432|NCT00329901|583070197|FG002|Overall Study|Protocol Violation|1|||
161457433|NCT00329901|583070195|FG000|Overall Study|Unable to classify|2|||
161457434|NCT00329901|583070196|FG001|Overall Study|Unable to classify|2|||
161457435|NCT00329901|583070197|FG002|Overall Study|Unable to classify|0|||
161457436|NCT05028361|583070198|FG000|Overall Study|Withdrawal by Subject|1|||
161457437|NCT05028361|583070199|FG001|Overall Study|Withdrawal by Subject|0|||
161457438|NCT01993836|583070200|FG000|Overall Study|Surgery Cancelled|3|||
161457439|NCT01993836|583070201|FG001|Overall Study|Surgery Cancelled|0|||
161457440|NCT01993836|583070202|FG002|Overall Study|Surgery Cancelled|0|||
161457441|NCT01993836|583070200|FG000|Overall Study|Physician Decision|2|||
161457442|NCT01993836|583070201|FG001|Overall Study|Physician Decision|1|||
161457443|NCT01993836|583070202|FG002|Overall Study|Physician Decision|0|||
161457444|NCT01993836|583070200|FG000|Overall Study|Death|0|||
161457445|NCT01993836|583070201|FG001|Overall Study|Death|2|||
161457446|NCT01993836|583070202|FG002|Overall Study|Death|0|||
161457447|NCT01993836|583070200|FG000|Overall Study|Withdrawal by Subject|12|||
161457448|NCT01993836|583070201|FG001|Overall Study|Withdrawal by Subject|10|||
161457449|NCT01993836|583070202|FG002|Overall Study|Withdrawal by Subject|5|||
161457450|NCT02195687|583070203|FG000|Overall Study|Personal Reasons|1|||
161457451|NCT02195687|583070204|FG001|Overall Study|Personal Reasons|1|||
161457452|NCT02195687|583070203|FG000|Overall Study|Lost to Follow-up|4|||
161457453|NCT02195687|583070204|FG001|Overall Study|Lost to Follow-up|1|||
161457454|NCT00686634|583070205|FG000|Overall Study|Protocol Violation|6|||
161457455|NCT00779259|583070206|FG000|Quinine Alone|Adverse Event|2|||
161457456|NCT04369924|583070210|FG000|Overall Study|Lost to Follow-up|302|||
161457457|NCT04369924|583070211|FG001|Overall Study|Lost to Follow-up|339|||
161457458|NCT01653132|583070214|FG000|First Intervention|Protocol Violation|1|||
161457459|NCT01653132|583070215|FG001|First Intervention|Protocol Violation|0|||
161457460|NCT03828370|583070216|FG000|3 Month Follow-up|Lost to Follow-up|4|||
161457461|NCT03828370|583070217|FG001|3 Month Follow-up|Lost to Follow-up|12|||
161457462|NCT03828370|583070216|FG000|9 Month Follow up|Lost to Follow-up|12|||
161457463|NCT03828370|583070217|FG001|9 Month Follow up|Lost to Follow-up|20|||
161457464|NCT01209832|583070221|FG000|Period 1|Sponsor Decision and was not dosed|1|||
161457465|NCT01209832|583070221|FG000|Period 2|Sponsor Decision|1|||
161457466|NCT00761150|583070222|FG000|Open-label Period|Adverse Event|36|||
161457467|NCT00761150|583070223|FG001|Open-label Period|Adverse Event|0|||
161457468|NCT00761150|583070224|FG002|Open-label Period|Adverse Event|0|||
161457469|NCT00761150|583070222|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
161457470|NCT00761150|583070223|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
161457471|NCT00761150|583070224|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
161457472|NCT00761150|583070222|FG000|Open-label Period|Lost to Follow-up|7|||
161457473|NCT00761150|583070223|FG001|Open-label Period|Lost to Follow-up|0|||
161457474|NCT00761150|583070224|FG002|Open-label Period|Lost to Follow-up|0|||
161457475|NCT00761150|583070222|FG000|Open-label Period|Lack of Efficacy|4|||
161457476|NCT00761150|583070223|FG001|Open-label Period|Lack of Efficacy|0|||
161457477|NCT00761150|583070224|FG002|Open-label Period|Lack of Efficacy|0|||
161457478|NCT00761150|583070222|FG000|Open-label Period|Withdrawal by Subject|5|||
161457479|NCT00761150|583070223|FG001|Open-label Period|Withdrawal by Subject|0|||
161457480|NCT00761150|583070224|FG002|Open-label Period|Withdrawal by Subject|0|||
161457481|NCT00761150|583070222|FG000|Open-label Period|Noncompliance|2|||
161457482|NCT00761150|583070223|FG001|Open-label Period|Noncompliance|0|||
161457483|NCT00761150|583070224|FG002|Open-label Period|Noncompliance|0|||
161457484|NCT00761150|583070222|FG000|Open-label Period|Other|5|||
161569476|NCT01185522|583471773|FG000|Overall Study|Withdrawal by Subject|10|||
161569477|NCT01185522|583471773|FG000|Overall Study|Poor tolerance|39|||
161569478|NCT01185522|583471773|FG000|Overall Study|Other reasons|12|||
161569479|NCT01729819|583471774|FG000|Overall Study|Adverse Event|2|||
161569480|NCT01729819|583471775|FG001|Overall Study|Adverse Event|4|||
161569481|NCT01729819|583471774|FG000|Overall Study|Lack of Efficacy|1|||
161569482|NCT01729819|583471775|FG001|Overall Study|Lack of Efficacy|0|||
161569483|NCT01729819|583471774|FG000|Overall Study|Lost to Follow-up|2|||
161569484|NCT01729819|583471775|FG001|Overall Study|Lost to Follow-up|0|||
161569485|NCT01729819|583471774|FG000|Overall Study|Other reason|1|||
161569486|NCT01729819|583471775|FG001|Overall Study|Other reason|0|||
161569487|NCT01729819|583471774|FG000|Overall Study|Protocol Violation|0|||
161569488|NCT01729819|583471775|FG001|Overall Study|Protocol Violation|1|||
161569489|NCT01729819|583471774|FG000|Overall Study|Withdrawal by Subject|0|||
161569490|NCT01729819|583471775|FG001|Overall Study|Withdrawal by Subject|2|||
161569491|NCT01025843|583471776|FG000|Washout 4|Withdrawal by Subject|0|||
161569492|NCT01025843|583471777|FG001|Washout 4|Withdrawal by Subject|0|||
161569493|NCT01025843|583471778|FG002|Washout 4|Withdrawal by Subject|1|||
161569494|NCT01025843|583471779|FG003|Washout 4|Withdrawal by Subject|1|||
161569495|NCT01025843|583471780|FG004|Washout 4|Withdrawal by Subject|0|||
161569496|NCT01025843|583471781|FG005|Washout 4|Withdrawal by Subject|0|||
161569497|NCT01025843|583471782|FG006|Washout 4|Withdrawal by Subject|0|||
161569498|NCT01025843|583471783|FG007|Washout 4|Withdrawal by Subject|0|||
161569499|NCT01025843|583471784|FG008|Washout 4|Withdrawal by Subject|0|||
161569500|NCT01025843|583471785|FG009|Washout 4|Withdrawal by Subject|0|||
161569501|NCT01649791|583471786|FG000|Overall Study|Disease Progression|2|||
161569502|NCT01649791|583471786|FG000|Overall Study|Adverse Event|1|||
161569503|NCT00771667|583471789|FG000|Induction Phase|Adverse Event|5|||
161569504|NCT00771667|583471790|FG001|Induction Phase|Adverse Event|2|||
161569505|NCT00771667|583471791|FG002|Induction Phase|Adverse Event|4|||
161569506|NCT00771667|583471792|FG003|Induction Phase|Adverse Event|1|||
161569507|NCT00771667|583471793|FG004|Induction Phase|Adverse Event|0|||
161569508|NCT00771667|583471794|FG005|Induction Phase|Adverse Event|0|||
161569509|NCT00771667|583471795|FG006|Induction Phase|Adverse Event|0|||
161569510|NCT00771667|583471796|FG007|Induction Phase|Adverse Event|0|||
161569511|NCT00771667|583471797|FG008|Induction Phase|Adverse Event|0|||
161569512|NCT00771667|583471798|FG009|Induction Phase|Adverse Event|0|||
161569513|NCT00771667|583471789|FG000|Induction Phase|Lack of Efficacy|9|||
161569514|NCT00771667|583471790|FG001|Induction Phase|Lack of Efficacy|2|||
161569515|NCT00771667|583471791|FG002|Induction Phase|Lack of Efficacy|4|||
161569516|NCT00771667|583471792|FG003|Induction Phase|Lack of Efficacy|3|||
161569517|NCT00771667|583471793|FG004|Induction Phase|Lack of Efficacy|0|||
161569518|NCT00771667|583471794|FG005|Induction Phase|Lack of Efficacy|0|||
161569519|NCT00771667|583471795|FG006|Induction Phase|Lack of Efficacy|0|||
161569520|NCT00771667|583471796|FG007|Induction Phase|Lack of Efficacy|0|||
161569521|NCT00771667|583471797|FG008|Induction Phase|Lack of Efficacy|0|||
161569522|NCT00771667|583471798|FG009|Induction Phase|Lack of Efficacy|0|||
161569523|NCT00771667|583471789|FG000|Induction Phase|Lost to Follow-up|1|||
161569524|NCT00771667|583471790|FG001|Induction Phase|Lost to Follow-up|0|||
161569525|NCT00771667|583471791|FG002|Induction Phase|Lost to Follow-up|1|||
161569526|NCT00771667|583471792|FG003|Induction Phase|Lost to Follow-up|0|||
161569527|NCT00771667|583471793|FG004|Induction Phase|Lost to Follow-up|0|||
161569528|NCT00771667|583471794|FG005|Induction Phase|Lost to Follow-up|0|||
161569529|NCT00771667|583471795|FG006|Induction Phase|Lost to Follow-up|0|||
161569530|NCT00771667|583471796|FG007|Induction Phase|Lost to Follow-up|0|||
161569531|NCT00771667|583471797|FG008|Induction Phase|Lost to Follow-up|0|||
161569532|NCT00771667|583471798|FG009|Induction Phase|Lost to Follow-up|0|||
161569533|NCT00771667|583471789|FG000|Induction Phase|Other|4|||
161569534|NCT00771667|583471790|FG001|Induction Phase|Other|6|||
161569535|NCT00771667|583471791|FG002|Induction Phase|Other|3|||
161569536|NCT00771667|583471792|FG003|Induction Phase|Other|4|||
161569537|NCT00771667|583471793|FG004|Induction Phase|Other|0|||
161569538|NCT00771667|583471794|FG005|Induction Phase|Other|0|||
161569539|NCT00771667|583471795|FG006|Induction Phase|Other|0|||
161569540|NCT00771667|583471796|FG007|Induction Phase|Other|0|||
161569541|NCT00771667|583471797|FG008|Induction Phase|Other|0|||
161569542|NCT00771667|583471798|FG009|Induction Phase|Other|0|||
161569543|NCT00771667|583471789|FG000|Maintenance Phase|Adverse Event|0|||
161569544|NCT00771667|583471790|FG001|Maintenance Phase|Adverse Event|0|||
161569545|NCT00771667|583471791|FG002|Maintenance Phase|Adverse Event|0|||
161569546|NCT00771667|583471792|FG003|Maintenance Phase|Adverse Event|0|||
161569547|NCT00771667|583471793|FG004|Maintenance Phase|Adverse Event|1|||
161913166|NCT04460885|584731897|FG001|Overall Study|Lost to Follow-up|4|||
161569548|NCT00771667|583471794|FG005|Maintenance Phase|Adverse Event|3|||
161569549|NCT00771667|583471795|FG006|Maintenance Phase|Adverse Event|5|||
161569550|NCT00771667|583471796|FG007|Maintenance Phase|Adverse Event|1|||
161569551|NCT00771667|583471797|FG008|Maintenance Phase|Adverse Event|8|||
161569552|NCT00771667|583471798|FG009|Maintenance Phase|Adverse Event|7|||
161569553|NCT00771667|583471789|FG000|Maintenance Phase|Lack of Efficacy|0|||
161569554|NCT00771667|583471790|FG001|Maintenance Phase|Lack of Efficacy|0|||
161569555|NCT00771667|583471791|FG002|Maintenance Phase|Lack of Efficacy|0|||
161913167|NCT02592824|584731902|FG000|Overall Study|Protocol Violation|5|||
161569556|NCT00771667|583471792|FG003|Maintenance Phase|Lack of Efficacy|0|||
161569557|NCT00771667|583471793|FG004|Maintenance Phase|Lack of Efficacy|1|||
161569558|NCT00771667|583471794|FG005|Maintenance Phase|Lack of Efficacy|3|||
161569559|NCT00771667|583471795|FG006|Maintenance Phase|Lack of Efficacy|3|||
161569560|NCT00771667|583471796|FG007|Maintenance Phase|Lack of Efficacy|2|||
161569561|NCT00771667|583471797|FG008|Maintenance Phase|Lack of Efficacy|11|||
161569562|NCT00771667|583471798|FG009|Maintenance Phase|Lack of Efficacy|7|||
161569563|NCT00771667|583471789|FG000|Maintenance Phase|Other|0|||
161569564|NCT00771667|583471790|FG001|Maintenance Phase|Other|0|||
161569565|NCT00771667|583471791|FG002|Maintenance Phase|Other|0|||
161569566|NCT00771667|583471792|FG003|Maintenance Phase|Other|0|||
161569567|NCT00771667|583471793|FG004|Maintenance Phase|Other|0|||
161569568|NCT00771667|583471794|FG005|Maintenance Phase|Other|1|||
161569569|NCT00771667|583471795|FG006|Maintenance Phase|Other|2|||
161569570|NCT00771667|583471796|FG007|Maintenance Phase|Other|2|||
161569571|NCT00771667|583471797|FG008|Maintenance Phase|Other|3|||
161569572|NCT00771667|583471798|FG009|Maintenance Phase|Other|3|||
161569573|NCT01897233|583471799|FG000|Part B (24 Weeks)|Adverse Event|1|||
161569574|NCT01897233|583471799|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
161569575|NCT01897233|583471799|FG000|Part B (24 Weeks)|Physician Decision|1|||
161569576|NCT00364286|583471800|FG000|Overall Study|Withdrawal by Subject|1|||
161569577|NCT00364286|583471800|FG000|Overall Study|Adverse Event|2|||
161569578|NCT00628862|583471805|FG000|Overall Study|Adverse Event|6|||
161569579|NCT00628862|583471806|FG001|Overall Study|Adverse Event|8|||
161569580|NCT00628862|583471807|FG002|Overall Study|Adverse Event|10|||
161569581|NCT00628862|583471805|FG000|Overall Study|Withdrawal by Subject|4|||
161569582|NCT00628862|583471806|FG001|Overall Study|Withdrawal by Subject|6|||
161569583|NCT00628862|583471807|FG002|Overall Study|Withdrawal by Subject|11|||
161569584|NCT00628862|583471805|FG000|Overall Study|Lost to Follow-up|0|||
161569585|NCT00628862|583471806|FG001|Overall Study|Lost to Follow-up|2|||
161569586|NCT00628862|583471807|FG002|Overall Study|Lost to Follow-up|1|||
161569587|NCT00628862|583471805|FG000|Overall Study|Protocol Violation|1|||
161569588|NCT00628862|583471806|FG001|Overall Study|Protocol Violation|0|||
161569589|NCT00628862|583471807|FG002|Overall Study|Protocol Violation|0|||
161569590|NCT00628862|583471805|FG000|Overall Study|COPD Exacerbation|0|||
161569591|NCT00628862|583471806|FG001|Overall Study|COPD Exacerbation|1|||
161569592|NCT00628862|583471807|FG002|Overall Study|COPD Exacerbation|0|||
161569593|NCT02814643|583471808|FG000|Overall Study|Lost to Follow-up|0|||
161569594|NCT02814643|583471809|FG001|Overall Study|Lost to Follow-up|1|||
161569595|NCT02814643|583471808|FG000|Overall Study|Withdrawal by Subject|1|||
161569596|NCT02814643|583471809|FG001|Overall Study|Withdrawal by Subject|2|||
161569597|NCT03673124|583471813|FG000|Overall Study|Eligible with no protocol therapy|2|||
161569598|NCT02174562|583471814|FG000|Overall Study|Withdrawal by Subject|7|||
161569599|NCT02174562|583471815|FG001|Overall Study|Withdrawal by Subject|2|||
161569600|NCT02174562|583471814|FG000|Overall Study|Death|2|||
161569601|NCT02174562|583471815|FG001|Overall Study|Death|0|||
161569602|NCT02174562|583471814|FG000|Overall Study|Lost to Follow-up|0|||
161569603|NCT02174562|583471815|FG001|Overall Study|Lost to Follow-up|3|||
161569604|NCT00798096|583471817|FG000|Overall Study|Ongoing|2|||
161569605|NCT00975806|583471818|FG000|Overall Study|Adverse Event|2|||
161569606|NCT00975806|583471819|FG001|Overall Study|Adverse Event|1|||
161569607|NCT00975806|583471820|FG002|Overall Study|Adverse Event|2|||
161569608|NCT00975806|583471818|FG000|Overall Study|Disease Progression|1|||
161569609|NCT00975806|583471819|FG001|Overall Study|Disease Progression|5|||
161569610|NCT00975806|583471820|FG002|Overall Study|Disease Progression|1|||
161569611|NCT00975806|583471818|FG000|Overall Study|Withdrawal by Subject|1|||
161569612|NCT00975806|583471819|FG001|Overall Study|Withdrawal by Subject|0|||
161569613|NCT00975806|583471820|FG002|Overall Study|Withdrawal by Subject|0|||
161569614|NCT00975806|583471818|FG000|Overall Study|Death|0|||
161569615|NCT00975806|583471819|FG001|Overall Study|Death|1|||
161569616|NCT00975806|583471820|FG002|Overall Study|Death|0|||
161569617|NCT00975806|583471818|FG000|Overall Study|Physician decision and disease related|1|||
161569618|NCT00975806|583471819|FG001|Overall Study|Physician decision and disease related|0|||
161809133|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809134|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161569619|NCT00975806|583471820|FG002|Overall Study|Physician decision and disease related|1|||
161569620|NCT00771849|583471825|FG000|Overall Study|Lost to Follow-up|1|||
161809135|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809136|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161913168|NCT02592824|584731903|FG001|Overall Study|Protocol Violation|3|||
161569621|NCT00771849|583471826|FG001|Overall Study|Lost to Follow-up|2|||
161569622|NCT00771849|583471825|FG000|Overall Study|Withdrawal by Subject|1|||
161569623|NCT00771849|583471826|FG001|Overall Study|Withdrawal by Subject|1|||
161569624|NCT00771849|583471825|FG000|Overall Study|Not vaccinated|0|||
161569625|NCT00771849|583471826|FG001|Overall Study|Not vaccinated|1|||
161569626|NCT00290732|583471827|FG000|Overall Study|Inability to instill drug intraductally.|0|||
161569627|NCT00290732|583471828|FG001|Overall Study|Inability to instill drug intraductally.|1|||
161569628|NCT00290732|583471829|FG002|Overall Study|Inability to instill drug intraductally.|1|||
161569629|NCT00290732|583471830|FG003|Overall Study|Inability to instill drug intraductally.|0|||
161569630|NCT00290732|583471831|FG004|Overall Study|Inability to instill drug intraductally.|0|||
161569631|NCT02736799|583471835|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
161569632|NCT02736799|583471836|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
161569633|NCT02736799|583471837|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
161569634|NCT02736799|583471838|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
161569635|NCT01833832|583471839|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
161569636|NCT00197015|583471840|FG000|Overall Study|Adverse Event|3|||
161569637|NCT00197015|583471841|FG001|Overall Study|Adverse Event|0|||
161569638|NCT00197015|583471842|FG002|Overall Study|Adverse Event|1|||
161569639|NCT00197015|583471840|FG000|Overall Study|Protocol Violation|0|||
161569640|NCT00197015|583471841|FG001|Overall Study|Protocol Violation|3|||
161569641|NCT00197015|583471842|FG002|Overall Study|Protocol Violation|3|||
161569642|NCT00197015|583471840|FG000|Overall Study|Withdrawal by Subject|17|||
161569643|NCT00197015|583471841|FG001|Overall Study|Withdrawal by Subject|37|||
161569644|NCT00197015|583471842|FG002|Overall Study|Withdrawal by Subject|34|||
161569645|NCT00197015|583471840|FG000|Overall Study|Lost to Follow-up|28|||
161569646|NCT00197015|583471841|FG001|Overall Study|Lost to Follow-up|46|||
161569647|NCT00197015|583471842|FG002|Overall Study|Lost to Follow-up|37|||
161569648|NCT00197015|583471840|FG000|Overall Study|Other|2|||
161569649|NCT00197015|583471841|FG001|Overall Study|Other|3|||
161569650|NCT00197015|583471842|FG002|Overall Study|Other|2|||
161569651|NCT02596035|583471843|FG000|Overall Study|Disease Progression|64|||
161569652|NCT02596035|583471844|FG001|Overall Study|Disease Progression|32|||
161569653|NCT02596035|583471845|FG002|Overall Study|Disease Progression|1|||
161569654|NCT02596035|583471843|FG000|Overall Study|study drug toxicity|12|||
161569655|NCT02596035|583471844|FG001|Overall Study|study drug toxicity|3|||
161569656|NCT02596035|583471845|FG002|Overall Study|study drug toxicity|0|||
161569657|NCT02596035|583471843|FG000|Overall Study|AE unrelated to study drug|5|||
161569658|NCT02596035|583471844|FG001|Overall Study|AE unrelated to study drug|2|||
161569659|NCT02596035|583471845|FG002|Overall Study|AE unrelated to study drug|0|||
161569660|NCT02596035|583471843|FG000|Overall Study|participant request to discontinue study treatment|2|||
161569661|NCT02596035|583471844|FG001|Overall Study|participant request to discontinue study treatment|0|||
161569662|NCT02596035|583471845|FG002|Overall Study|participant request to discontinue study treatment|0|||
161569663|NCT02596035|583471843|FG000|Overall Study|participant withdrew consent|2|||
161569664|NCT02596035|583471844|FG001|Overall Study|participant withdrew consent|2|||
161569665|NCT02596035|583471845|FG002|Overall Study|participant withdrew consent|0|||
161569666|NCT02596035|583471843|FG000|Overall Study|Poor/Non Comlpiance|0|||
161569667|NCT02596035|583471844|FG001|Overall Study|Poor/Non Comlpiance|1|||
161569668|NCT02596035|583471845|FG002|Overall Study|Poor/Non Comlpiance|0|||
161569669|NCT02596035|583471843|FG000|Overall Study|participant no longer meets study criteria|1|||
161569670|NCT02596035|583471844|FG001|Overall Study|participant no longer meets study criteria|0|||
161569671|NCT02596035|583471845|FG002|Overall Study|participant no longer meets study criteria|0|||
161569672|NCT02596035|583471843|FG000|Overall Study|other reasons|11|||
161569673|NCT02596035|583471844|FG001|Overall Study|other reasons|4|||
161569674|NCT02596035|583471845|FG002|Overall Study|other reasons|0|||
161569675|NCT03536884|583471847|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
161569676|NCT03536884|583471848|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
161569677|NCT03536884|583471849|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569678|NCT03536884|583471850|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569679|NCT03536884|583471851|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569680|NCT03536884|583471852|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569681|NCT03536884|583471853|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569682|NCT03536884|583471854|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569683|NCT03536884|583471855|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569684|NCT03536884|583471856|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569685|NCT03536884|583471857|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569686|NCT03536884|583471858|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161569687|NCT03536884|583471847|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569688|NCT03536884|583471848|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
161569689|NCT03536884|583471849|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569690|NCT03536884|583471850|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569691|NCT03536884|583471851|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569692|NCT03536884|583471852|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569693|NCT03536884|583471853|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569694|NCT03536884|583471854|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161913169|NCT02592824|584731902|FG000|Overall Study|Lost to Follow-up|2|||
161913170|NCT02592824|584731903|FG001|Overall Study|Lost to Follow-up|1|||
161913171|NCT01704261|584731904|FG000|Overall Study|Withdrawal by Subject|12|||
161913172|NCT01704261|584731905|FG001|Overall Study|Withdrawal by Subject|15|||
161913173|NCT01704261|584731904|FG000|Overall Study|Lost to Follow-up|1|||
161569695|NCT03536884|583471855|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569696|NCT03536884|583471856|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569697|NCT03536884|583471857|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569698|NCT03536884|583471858|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
161569699|NCT03536884|583471847|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
161569700|NCT03536884|583471848|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
161569701|NCT03536884|583471849|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569702|NCT03536884|583471850|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569703|NCT03536884|583471851|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569704|NCT03536884|583471852|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569705|NCT03536884|583471853|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569706|NCT03536884|583471854|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569707|NCT03536884|583471855|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569708|NCT03536884|583471856|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569709|NCT03536884|583471857|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569710|NCT03536884|583471858|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
161569711|NCT03536884|583471847|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569712|NCT03536884|583471848|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
161569713|NCT03536884|583471849|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569714|NCT03536884|583471850|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569715|NCT03536884|583471851|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569716|NCT03536884|583471852|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569717|NCT03536884|583471853|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569718|NCT03536884|583471854|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569719|NCT03536884|583471855|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569720|NCT03536884|583471856|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569721|NCT03536884|583471857|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569722|NCT03536884|583471858|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161569723|NCT03536884|583471847|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569724|NCT03536884|583471848|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
161569725|NCT03536884|583471849|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569726|NCT03536884|583471850|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569727|NCT03536884|583471851|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569728|NCT03536884|583471852|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569729|NCT03536884|583471853|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569730|NCT03536884|583471854|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569731|NCT03536884|583471855|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569732|NCT03536884|583471856|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569733|NCT03536884|583471857|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569734|NCT03536884|583471858|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161569735|NCT03536884|583471847|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569736|NCT03536884|583471848|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
161569737|NCT03536884|583471849|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569738|NCT03536884|583471850|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569739|NCT03536884|583471851|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569740|NCT03536884|583471852|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569741|NCT03536884|583471853|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569742|NCT03536884|583471854|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569743|NCT03536884|583471855|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569744|NCT03536884|583471856|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569745|NCT03536884|583471857|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569746|NCT03536884|583471858|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
161569747|NCT03536884|583471847|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569748|NCT03536884|583471848|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569749|NCT03536884|583471849|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
161569750|NCT03536884|583471850|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569751|NCT03536884|583471851|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
161569752|NCT03536884|583471852|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569753|NCT03536884|583471853|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569754|NCT03536884|583471854|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569755|NCT03536884|583471855|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569756|NCT03536884|583471856|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569757|NCT03536884|583471857|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569758|NCT03536884|583471858|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
161569759|NCT03536884|583471847|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569760|NCT03536884|583471848|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569761|NCT03536884|583471849|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
161569762|NCT03536884|583471850|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
161569763|NCT03536884|583471851|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
161569764|NCT03536884|583471852|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569765|NCT03536884|583471853|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569766|NCT03536884|583471854|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569767|NCT03536884|583471855|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569768|NCT03536884|583471856|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569769|NCT03536884|583471857|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569770|NCT03536884|583471858|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161569771|NCT03536884|583471847|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569772|NCT03536884|583471848|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569773|NCT03536884|583471849|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569774|NCT03536884|583471850|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
161569775|NCT03536884|583471851|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
161569776|NCT03536884|583471852|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569777|NCT03536884|583471853|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569778|NCT03536884|583471854|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569779|NCT03536884|583471855|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569780|NCT03536884|583471856|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569781|NCT03536884|583471857|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569782|NCT03536884|583471858|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161569783|NCT03536884|583471847|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569784|NCT03536884|583471848|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569785|NCT03536884|583471849|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
161569786|NCT03536884|583471850|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
161913174|NCT01704261|584731905|FG001|Overall Study|Lost to Follow-up|0|||
161913175|NCT02855268|584731906|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
161913176|NCT02855268|584731907|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
161913177|NCT02855268|584731906|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
161913178|NCT02855268|584731907|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
161913179|NCT02855268|584731906|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
161913180|NCT02855268|584731907|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
161913181|NCT02855268|584731906|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
161913182|NCT02855268|584731907|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
161913183|NCT02855268|584731906|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
161913184|NCT02855268|584731907|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
161913185|NCT02855268|584731906|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
161913186|NCT02855268|584731907|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
161913187|NCT03704064|584731910|FG000|Overall Study|Lost to Follow-up|8|||
161913188|NCT03704064|584731911|FG001|Overall Study|Lost to Follow-up|4|||
161913189|NCT03704064|584731910|FG000|Overall Study|Withdrawal by Subject|1|||
161913190|NCT03704064|584731911|FG001|Overall Study|Withdrawal by Subject|1|||
161913191|NCT03704064|584731910|FG000|Overall Study|No longer available for study visits|0|||
161913192|NCT03704064|584731911|FG001|Overall Study|No longer available for study visits|1|||
161913193|NCT03704064|584731910|FG000|Overall Study|Censoring event|1|||
161569787|NCT03536884|583471851|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
161569788|NCT03536884|583471852|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569789|NCT03536884|583471853|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569790|NCT03536884|583471854|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569791|NCT03536884|583471855|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569792|NCT03536884|583471856|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569793|NCT03536884|583471857|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569794|NCT03536884|583471858|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
161569795|NCT03536884|583471847|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569796|NCT03536884|583471848|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569797|NCT03536884|583471849|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
161569798|NCT03536884|583471850|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
161913194|NCT03704064|584731911|FG001|Overall Study|Censoring event|0|||
161913195|NCT01286129|584731912|FG000|Overall Study|Withdrawal by Subject|4|||
161913196|NCT01286129|584731913|FG001|Overall Study|Withdrawal by Subject|1|||
161569799|NCT03536884|583471851|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
161569800|NCT03536884|583471852|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569801|NCT03536884|583471853|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569802|NCT03536884|583471854|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569803|NCT03536884|583471855|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569804|NCT03536884|583471856|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569805|NCT03536884|583471857|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569806|NCT03536884|583471858|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
161569807|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569808|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569809|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569810|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569811|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569812|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
161569813|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
161569814|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
161569815|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
161569816|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569817|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569818|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
161569819|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569820|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569821|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569822|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569823|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569824|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
161569825|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
161569826|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
161569827|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
161569828|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569829|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569830|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161569831|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569832|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569833|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569834|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569835|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569836|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
161569837|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569838|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
161569839|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569840|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569841|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569842|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161569843|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569844|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569845|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569846|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569847|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569848|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
161569849|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569850|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
161569851|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
161569852|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569853|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569854|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
161569855|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569856|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161809137|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809138|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809139|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809140|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
161457485|NCT00761150|583070223|FG001|Open-label Period|Other|0|||
161457486|NCT00761150|583070224|FG002|Open-label Period|Other|0|||
161457487|NCT00761150|583070222|FG000|Double-blind Period|Lack of Efficacy|0|||
161457488|NCT00761150|583070223|FG001|Double-blind Period|Lack of Efficacy|2|||
161457489|NCT00761150|583070224|FG002|Double-blind Period|Lack of Efficacy|19|||
161457490|NCT00761150|583070222|FG000|Double-blind Period|Adverse Event|0|||
161457491|NCT00761150|583070223|FG001|Double-blind Period|Adverse Event|3|||
161457492|NCT00761150|583070224|FG002|Double-blind Period|Adverse Event|3|||
161457493|NCT00761150|583070222|FG000|Double-blind Period|Withdrawal by Subject|0|||
161457494|NCT00761150|583070223|FG001|Double-blind Period|Withdrawal by Subject|3|||
161457495|NCT00761150|583070224|FG002|Double-blind Period|Withdrawal by Subject|2|||
161569857|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569858|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569859|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569860|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
161569861|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
161569862|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
161569863|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
161569864|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569865|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569866|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161569867|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569868|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569869|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569870|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569871|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569872|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
161569873|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569874|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569875|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569876|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569877|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569878|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161569879|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569880|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569881|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569882|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569883|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569884|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569885|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
161569886|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569887|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569888|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569889|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569890|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161569891|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569892|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569893|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569894|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569895|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569896|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569897|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
161569898|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569899|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569900|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569901|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569902|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161569903|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569904|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569905|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569906|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569907|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569908|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
161569909|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569910|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569911|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569912|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569913|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569914|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
161569915|NCT03536884|583471847|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569916|NCT03536884|583471848|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569917|NCT03536884|583471849|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569918|NCT03536884|583471850|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161809141|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
161569919|NCT03536884|583471851|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569920|NCT03536884|583471852|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569921|NCT03536884|583471853|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569922|NCT03536884|583471854|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569923|NCT03536884|583471855|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
161569924|NCT03536884|583471856|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569925|NCT03536884|583471857|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569926|NCT03536884|583471858|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
161569927|NCT03536884|583471847|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569928|NCT03536884|583471848|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569929|NCT03536884|583471849|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569930|NCT03536884|583471850|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569931|NCT03536884|583471851|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569932|NCT03536884|583471852|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569933|NCT03536884|583471853|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569934|NCT03536884|583471854|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569935|NCT03536884|583471855|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
161569936|NCT03536884|583471856|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
161569937|NCT03536884|583471857|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
161569938|NCT03536884|583471858|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
161569939|NCT03536884|583471847|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569940|NCT03536884|583471848|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569941|NCT03536884|583471849|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569942|NCT03536884|583471850|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569943|NCT03536884|583471851|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569944|NCT03536884|583471852|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569945|NCT03536884|583471853|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569946|NCT03536884|583471854|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569947|NCT03536884|583471855|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
161569948|NCT03536884|583471856|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
161569949|NCT03536884|583471857|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
161569950|NCT03536884|583471858|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
161569951|NCT03536884|583471847|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569952|NCT03536884|583471848|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569953|NCT03536884|583471849|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569954|NCT03536884|583471850|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569955|NCT03536884|583471851|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569956|NCT03536884|583471852|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569957|NCT03536884|583471853|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569958|NCT03536884|583471854|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569959|NCT03536884|583471855|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569960|NCT03536884|583471856|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569961|NCT03536884|583471857|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
161569962|NCT03536884|583471858|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161569963|NCT03536884|583471847|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569964|NCT03536884|583471848|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569965|NCT03536884|583471849|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569966|NCT03536884|583471850|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569967|NCT03536884|583471851|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569968|NCT03536884|583471852|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569969|NCT03536884|583471853|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569970|NCT03536884|583471854|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569971|NCT03536884|583471855|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569972|NCT03536884|583471856|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569973|NCT03536884|583471857|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
161569974|NCT03536884|583471858|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
161569975|NCT03536884|583471847|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569976|NCT03536884|583471848|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569977|NCT03536884|583471849|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569978|NCT03536884|583471850|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161809142|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
161809143|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161569979|NCT03536884|583471851|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569980|NCT03536884|583471852|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569981|NCT03536884|583471853|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569982|NCT03536884|583471854|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569983|NCT03536884|583471855|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569984|NCT03536884|583471856|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569985|NCT03536884|583471857|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161569986|NCT03536884|583471858|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
161569987|NCT03395353|583471859|FG000|Overall Study|Adverse Event|20|||
161569988|NCT03395353|583471859|FG000|Overall Study|Protocol Violation|1|||
161569989|NCT03395353|583471859|FG000|Overall Study|Lack of Efficacy|3|||
161569990|NCT03395353|583471859|FG000|Overall Study|Withdrawal by Subject|24|||
161569991|NCT03395353|583471859|FG000|Overall Study|Discontinued visit|1|||
161569992|NCT03395353|583471859|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
161569993|NCT03395353|583471859|FG000|Overall Study|Physician Decision|4|||
161569994|NCT03395353|583471859|FG000|Overall Study|Early termination of overall study|33|||
161569995|NCT03301220|583471860|FG000|Overall Study|Death|26|||
161569996|NCT03301220|583471861|FG001|Overall Study|Death|15|||
161569997|NCT03301220|583471860|FG000|Overall Study|Withdrawal by Subject|23|||
161569998|NCT03301220|583471861|FG001|Overall Study|Withdrawal by Subject|12|||
161569999|NCT03301220|583471860|FG000|Overall Study|Lost to Follow-up|1|||
161570000|NCT03301220|583471861|FG001|Overall Study|Lost to Follow-up|1|||
161570001|NCT03301220|583471860|FG000|Overall Study|Randomized in error|1|||
161570002|NCT03301220|583471861|FG001|Overall Study|Randomized in error|1|||
161570003|NCT03301220|583471860|FG000|Overall Study|Randomized but not treated|0|||
161570004|NCT03301220|583471861|FG001|Overall Study|Randomized but not treated|1|||
161570005|NCT03301220|583471860|FG000|Overall Study|Ongoing followup|145|||
161570006|NCT03301220|583471861|FG001|Overall Study|Ongoing followup|163|||
161570007|NCT03301220|583471860|FG000|Overall Study|Principal Investigator and participant decision|0|||
161570008|NCT03301220|583471861|FG001|Overall Study|Principal Investigator and participant decision|1|||
161570009|NCT02685033|583471862|FG000|Overall Study|Withdrawal of Consent|0|||
161570010|NCT02685033|583471863|FG001|Overall Study|Withdrawal of Consent|1|||
161570011|NCT02685033|583471862|FG000|Overall Study|Lost to Follow-up|2|||
161570012|NCT02685033|583471863|FG001|Overall Study|Lost to Follow-up|1|||
161570013|NCT02685033|583471862|FG000|Overall Study|Adverse Event|1|||
161570014|NCT02685033|583471863|FG001|Overall Study|Adverse Event|0|||
161570015|NCT04845620|583471868|FG000|Overall Study|Withdrawal by Subject|11|||
161570016|NCT04845620|583471869|FG001|Overall Study|Withdrawal by Subject|10|||
161570017|NCT04845620|583471868|FG000|Overall Study|Adverse Event|5|||
161570018|NCT04845620|583471869|FG001|Overall Study|Adverse Event|4|||
161570019|NCT04845620|583471868|FG000|Overall Study|Lost to Follow-up|5|||
161570020|NCT04845620|583471869|FG001|Overall Study|Lost to Follow-up|4|||
161570021|NCT04845620|583471868|FG000|Overall Study|Lack of Efficacy|4|||
161570022|NCT04845620|583471869|FG001|Overall Study|Lack of Efficacy|4|||
161570023|NCT04845620|583471868|FG000|Overall Study|Physician Decision|2|||
161570024|NCT04845620|583471869|FG001|Overall Study|Physician Decision|1|||
161570025|NCT00708097|583471870|FG000|Period 1|Protocol Violation|0|||
161570026|NCT00708097|583471871|FG001|Period 1|Protocol Violation|1|||
161570027|NCT00708097|583471872|FG002|Period 1|Protocol Violation|0|||
161570028|NCT00708097|583471873|FG003|Period 1|Protocol Violation|2|||
161570029|NCT00708097|583471874|FG004|Period 1|Protocol Violation|0|||
161570030|NCT00708097|583471870|FG000|Period 1|Other Reason|0|||
161570031|NCT00708097|583471871|FG001|Period 1|Other Reason|0|||
161570032|NCT00708097|583471872|FG002|Period 1|Other Reason|0|||
161570033|NCT00708097|583471873|FG003|Period 1|Other Reason|0|||
161570034|NCT00708097|583471874|FG004|Period 1|Other Reason|1|||
161570035|NCT00708097|583471870|FG000|Period 2|Protocol Violation|0|||
161570036|NCT00708097|583471871|FG001|Period 2|Protocol Violation|1|||
161570037|NCT00708097|583471872|FG002|Period 2|Protocol Violation|1|||
161570038|NCT00708097|583471873|FG003|Period 2|Protocol Violation|1|||
161570039|NCT00708097|583471874|FG004|Period 2|Protocol Violation|0|||
161570040|NCT00603447|583471875|FG000|Overall Study|Adverse Event|0|||
161570041|NCT00603447|583471876|FG001|Overall Study|Adverse Event|1|||
161570042|NCT00603447|583471877|FG002|Overall Study|Adverse Event|1|||
161570043|NCT00603447|583471878|FG003|Overall Study|Adverse Event|2|||
161570044|NCT00603447|583471879|FG004|Overall Study|Adverse Event|1|||
161570045|NCT00603447|583471880|FG005|Overall Study|Adverse Event|2|||
161570046|NCT00603447|583471881|FG006|Overall Study|Adverse Event|10|||
161570047|NCT00603447|583471875|FG000|Overall Study|Other|0|||
161570048|NCT00603447|583471876|FG001|Overall Study|Other|0|||
161570049|NCT00603447|583471877|FG002|Overall Study|Other|1|||
161570050|NCT00603447|583471878|FG003|Overall Study|Other|0|||
161570051|NCT00603447|583471879|FG004|Overall Study|Other|3|||
161570052|NCT00603447|583471880|FG005|Overall Study|Other|0|||
161570053|NCT00603447|583471881|FG006|Overall Study|Other|13|||
161570054|NCT00603447|583471875|FG000|Overall Study|Withdrew Consent|0|||
161570055|NCT00603447|583471876|FG001|Overall Study|Withdrew Consent|2|||
161570056|NCT00603447|583471877|FG002|Overall Study|Withdrew Consent|0|||
161570057|NCT00603447|583471878|FG003|Overall Study|Withdrew Consent|0|||
161570058|NCT00603447|583471879|FG004|Overall Study|Withdrew Consent|1|||
161570059|NCT00603447|583471880|FG005|Overall Study|Withdrew Consent|0|||
161570060|NCT00603447|583471881|FG006|Overall Study|Withdrew Consent|1|||
161570061|NCT03425643|583471882|FG000|Overall Study|Withdrawal by Subject|10|||
161570062|NCT03425643|583471883|FG001|Overall Study|Withdrawal by Subject|12|||
161570063|NCT03425643|583471882|FG000|Overall Study|Lost to Follow-up|2|||
161570064|NCT03425643|583471883|FG001|Overall Study|Lost to Follow-up|0|||
161570065|NCT03425643|583471882|FG000|Overall Study|Death|109|||
161570066|NCT03425643|583471883|FG001|Overall Study|Death|141|||
161570067|NCT03425643|583471882|FG000|Overall Study|Ongoing in study|276|||
161570068|NCT03425643|583471883|FG001|Overall Study|Ongoing in study|247|||
161570069|NCT07214922|583471884|FG000|Overall Study|Adverse Event|0|||
161570070|NCT07214922|583471885|FG001|Overall Study|Adverse Event|0|||
161570071|NCT07214922|583471886|FG002|Overall Study|Adverse Event|1|||
161570072|NCT07214922|583471887|FG003|Overall Study|Adverse Event|0|||
161570073|NCT07214922|583471884|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
161570074|NCT07214922|583471885|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
161570075|NCT07214922|583471886|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
161570076|NCT07214922|583471887|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
161570077|NCT00726596|583473642|FG000|Overall Study|Adverse Event|2|||
161570078|NCT00726596|583473643|FG001|Overall Study|Adverse Event|1|||
161570079|NCT00726596|583473642|FG000|Overall Study|Withdrawal by Subject|3|||
161570080|NCT00726596|583473643|FG001|Overall Study|Withdrawal by Subject|3|||
161570081|NCT00482729|583473644|FG000|Overall Study|Adverse Event|29|||
161570082|NCT00482729|583473645|FG001|Overall Study|Adverse Event|33|||
161570083|NCT00482729|583473644|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
161570084|NCT00482729|583473645|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
161570085|NCT00482729|583473644|FG000|Overall Study|Hyperglycemia Criteria|7|||
161570086|NCT00482729|583473645|FG001|Overall Study|Hyperglycemia Criteria|5|||
161570087|NCT00482729|583473644|FG000|Overall Study|Lack of Efficacy|4|||
161570088|NCT00482729|583473645|FG001|Overall Study|Lack of Efficacy|16|||
161570089|NCT00482729|583473644|FG000|Overall Study|Lost to Follow-up|86|||
161570090|NCT00482729|583473645|FG001|Overall Study|Lost to Follow-up|66|||
161570091|NCT00482729|583473644|FG000|Overall Study|Physician Decision|10|||
161570092|NCT00482729|583473645|FG001|Overall Study|Physician Decision|7|||
161570093|NCT00482729|583473644|FG000|Overall Study|Pregnancy|4|||
161570094|NCT00482729|583473645|FG001|Overall Study|Pregnancy|2|||
161570095|NCT00482729|583473644|FG000|Overall Study|Protocol Violation|10|||
161570096|NCT00482729|583473645|FG001|Overall Study|Protocol Violation|18|||
161570097|NCT00482729|583473644|FG000|Overall Study|Withdrawal by Subject|67|||
161570098|NCT00482729|583473645|FG001|Overall Study|Withdrawal by Subject|69|||
161570099|NCT00486759|583473658|FG000|Treatment|Adverse event/intercurrent illness|86|||
161570100|NCT00486759|583473659|FG001|Treatment|Adverse event/intercurrent illness|39|||
161570101|NCT00486759|583473658|FG000|Treatment|Insufficient therapeutic response|37|||
161570102|NCT00486759|583473659|FG001|Treatment|Insufficient therapeutic response|39|||
161570103|NCT00486759|583473658|FG000|Treatment|Death|17|||
161570104|NCT00486759|583473659|FG001|Treatment|Death|10|||
161570105|NCT00486759|583473658|FG000|Treatment|Withdrew consent|15|||
161570106|NCT00486759|583473659|FG001|Treatment|Withdrew consent|12|||
161570107|NCT00486759|583473658|FG000|Treatment|Administrative/reason not specified|17|||
161570108|NCT00486759|583473659|FG001|Treatment|Administrative/reason not specified|21|||
161570109|NCT00486759|583473658|FG000|Treatment|Refused treatment|10|||
161570110|NCT00486759|583473659|FG001|Treatment|Refused treatment|7|||
161570111|NCT00486759|583473658|FG000|Treatment|Violation of selection criteria at entry|3|||
161570112|NCT00486759|583473659|FG001|Treatment|Violation of selection criteria at entry|3|||
161570113|NCT00486759|583473658|FG000|Treatment|Other protocol violation|1|||
161570114|NCT00486759|583473659|FG001|Treatment|Other protocol violation|5|||
161570115|NCT00486759|583473658|FG000|Treatment|Failure to return|1|||
161570116|NCT00486759|583473659|FG001|Treatment|Failure to return|1|||
161570117|NCT00486759|583473658|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
161570118|NCT00486759|583473659|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
161809144|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161570119|NCT00486759|583473658|FG000|Safety Follow-up|Death|40|||
161570120|NCT00486759|583473659|FG001|Safety Follow-up|Death|29|||
161570121|NCT00486759|583473658|FG000|Safety Follow-up|Withdrew consent|32|||
161570122|NCT00486759|583473659|FG001|Safety Follow-up|Withdrew consent|23|||
161570123|NCT00486759|583473658|FG000|Safety Follow-up|Failure to return|9|||
161570124|NCT00486759|583473659|FG001|Safety Follow-up|Failure to return|6|||
161570125|NCT00486759|583473658|FG000|Safety Follow-up|Administrative/not specified|8|||
161570126|NCT00486759|583473659|FG001|Safety Follow-up|Administrative/not specified|6|||
161570127|NCT00486759|583473658|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
161570128|NCT00486759|583473659|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
161570129|NCT00486759|583473658|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
161457496|NCT00761150|583070222|FG000|Double-blind Period|Lost to Follow-up|0|||
161457497|NCT00761150|583070223|FG001|Double-blind Period|Lost to Follow-up|2|||
161457498|NCT00761150|583070224|FG002|Double-blind Period|Lost to Follow-up|1|||
161457499|NCT00761150|583070222|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
161457500|NCT00761150|583070223|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
161809145|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161457501|NCT00761150|583070224|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
161457502|NCT00761150|583070222|FG000|Double-blind Period|Noncompliance|0|||
161457503|NCT00761150|583070223|FG001|Double-blind Period|Noncompliance|1|||
161457504|NCT00761150|583070224|FG002|Double-blind Period|Noncompliance|0|||
161457505|NCT00761150|583070222|FG000|Double-blind Period|Other|0|||
161457506|NCT00761150|583070223|FG001|Double-blind Period|Other|3|||
161457507|NCT00761150|583070224|FG002|Double-blind Period|Other|3|||
161457508|NCT01925989|583070225|FG000|Period 1|Sponsor Decision|1|||
161457509|NCT01925989|583070226|FG001|Period 1|Sponsor Decision|1|||
161457510|NCT01925989|583070227|FG002|Period 1|Sponsor Decision|0|||
161457511|NCT01925989|583070225|FG000|Period 1|Withdrawal by Subject|0|||
161457512|NCT01925989|583070226|FG001|Period 1|Withdrawal by Subject|1|||
161457513|NCT01925989|583070227|FG002|Period 1|Withdrawal by Subject|0|||
161457514|NCT02536404|583070232|FG000|Overall Study|Adverse Event|5|||
161457515|NCT02536404|583070233|FG001|Overall Study|Adverse Event|0|||
161457516|NCT02536404|583070232|FG000|Overall Study|Withdrawal by Subject|4|||
161457517|NCT02536404|583070233|FG001|Overall Study|Withdrawal by Subject|1|||
161457518|NCT02536404|583070232|FG000|Overall Study|Physician Decision|10|||
161457519|NCT02536404|583070233|FG001|Overall Study|Physician Decision|0|||
161457520|NCT02536404|583070232|FG000|Overall Study|Sponsor decision|1|||
161457521|NCT02536404|583070233|FG001|Overall Study|Sponsor decision|0|||
161457522|NCT02514473|583070234|FG000|Overall Study|Adverse Event|0|||
161457523|NCT02514473|583070235|FG001|Overall Study|Adverse Event|2|||
161457524|NCT02514473|583070234|FG000|Overall Study|Withdrawal by Subject|2|||
161457525|NCT02514473|583070235|FG001|Overall Study|Withdrawal by Subject|1|||
161457526|NCT02514473|583070234|FG000|Overall Study|Lost to Follow-up|0|||
161457527|NCT02514473|583070235|FG001|Overall Study|Lost to Follow-up|1|||
161457528|NCT02514473|583070234|FG000|Overall Study|Other|1|||
161457529|NCT02514473|583070235|FG001|Overall Study|Other|1|||
161457530|NCT04381988|583070236|FG000|Overall Study|The study was terminated|4|||
161457531|NCT04381988|583070237|FG001|Overall Study|The study was terminated|0|||
161457532|NCT02106923|583070238|FG000|Overall Study|Protocol Violation|0|||
161457533|NCT02106923|583070239|FG001|Overall Study|Protocol Violation|0|||
161457534|NCT02106923|583070240|FG002|Overall Study|Protocol Violation|0|||
161457535|NCT02106923|583070241|FG003|Overall Study|Protocol Violation|0|||
161457536|NCT02106923|583070242|FG004|Overall Study|Protocol Violation|0|||
161457537|NCT02106923|583070243|FG005|Overall Study|Protocol Violation|1|||
161457538|NCT03485495|583070244|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
161457539|NCT03485495|583070245|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
161457540|NCT03901456|583070246|FG000|Overall Study|Withdrawal by Subject|0|||
161457541|NCT03901456|583070247|FG001|Overall Study|Withdrawal by Subject|0|||
161457542|NCT03901456|583070248|FG002|Overall Study|Withdrawal by Subject|1|||
161457543|NCT03901456|583070246|FG000|Overall Study|Lost to Follow-up|0|||
161457544|NCT03901456|583070247|FG001|Overall Study|Lost to Follow-up|1|||
161457545|NCT03901456|583070248|FG002|Overall Study|Lost to Follow-up|0|||
161457546|NCT05318183|583070250|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161457547|NCT05318183|583070251|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
161457548|NCT05318183|583070250|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
161457549|NCT05318183|583070251|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161457550|NCT05318183|583070250|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
161457551|NCT05318183|583070251|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
161457552|NCT05318183|583070250|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161457553|NCT05318183|583070251|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
161457554|NCT06400251|583070252|FG000|Overall Study|Never Start Protocol Therapy|1|||
161457555|NCT06400251|583070252|FG000|Overall Study|Ineligible|2|||
161457556|NCT06400251|583070252|FG000|Overall Study|Mutation Status Not Confirmed|3|||
161457557|NCT06400251|583070252|FG000|Overall Study|Disease Progression|25|||
161457558|NCT06400251|583070252|FG000|Overall Study|Adverse Event|1|||
161457559|NCT06400251|583070252|FG000|Overall Study|Complicating Disease|1|||
161457560|NCT06400251|583070252|FG000|Overall Study|Physician Decision|2|||
161457561|NCT04098224|583070253|FG000|Overall Study|Adverse Event|1|||
161457562|NCT04098224|583070254|FG001|Overall Study|Adverse Event|0|||
161457563|NCT04098224|583070253|FG000|Overall Study|Physician Decision|1|||
161457564|NCT04098224|583070254|FG001|Overall Study|Physician Decision|0|||
161457565|NCT04098224|583070253|FG000|Overall Study|Patient not required enteral feeding|1|||
161457566|NCT04098224|583070254|FG001|Overall Study|Patient not required enteral feeding|0|||
161457567|NCT04098224|583070253|FG000|Overall Study|Patient failure nasogastric tube|1|||
161457568|NCT04098224|583070254|FG001|Overall Study|Patient failure nasogastric tube|0|||
161457569|NCT04098224|583070253|FG000|Overall Study|Patient early extubation|1|||
161457570|NCT04098224|583070254|FG001|Overall Study|Patient early extubation|3|||
161570130|NCT00486759|583473659|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
161570131|NCT00954707|583473660|FG000|Overall Study|Death|34|||
161570132|NCT00954707|583473660|FG000|Overall Study|Withdrawal by Subject|100|||
161570133|NCT00954707|583473660|FG000|Overall Study|Lost to Follow-up|33|||
161570134|NCT02987543|583473661|FG000|Overall Study|Ongoing study at data cut off|49|||
161570135|NCT02987543|583473662|FG001|Overall Study|Ongoing study at data cut off|21|||
161570136|NCT02987543|583473663|FG002|Overall Study|Ongoing study at data cut off|19|||
161570137|NCT02987543|583473664|FG003|Overall Study|Ongoing study at data cut off|12|||
161570138|NCT02987543|583473661|FG000|Overall Study|Death|88|||
161570139|NCT02987543|583473662|FG001|Overall Study|Death|54|||
161570140|NCT02987543|583473663|FG002|Overall Study|Death|67|||
161570141|NCT02987543|583473664|FG003|Overall Study|Death|28|||
161570142|NCT02987543|583473661|FG000|Overall Study|Lost to Follow-up|3|||
161570143|NCT02987543|583473662|FG001|Overall Study|Lost to Follow-up|0|||
161570144|NCT02987543|583473663|FG002|Overall Study|Lost to Follow-up|1|||
161570145|NCT02987543|583473664|FG003|Overall Study|Lost to Follow-up|0|||
161570146|NCT02987543|583473661|FG000|Overall Study|Screen failure|0|||
161570147|NCT02987543|583473662|FG001|Overall Study|Screen failure|0|||
161570148|NCT02987543|583473663|FG002|Overall Study|Screen failure|0|||
161570149|NCT02987543|583473664|FG003|Overall Study|Screen failure|1|||
161570150|NCT02987543|583473661|FG000|Overall Study|Withdrawal by Subject|21|||
161570151|NCT02987543|583473662|FG001|Overall Study|Withdrawal by Subject|7|||
161570152|NCT02987543|583473663|FG002|Overall Study|Withdrawal by Subject|7|||
161570153|NCT02987543|583473664|FG003|Overall Study|Withdrawal by Subject|6|||
161570154|NCT02987543|583473661|FG000|Overall Study|Study terminated by sponsor|1|||
161570155|NCT02987543|583473662|FG001|Overall Study|Study terminated by sponsor|0|||
161570156|NCT02987543|583473663|FG002|Overall Study|Study terminated by sponsor|0|||
161570157|NCT02987543|583473664|FG003|Overall Study|Study terminated by sponsor|0|||
161570158|NCT02987543|583473661|FG000|Overall Study|Investigator decision|0|||
161570159|NCT02987543|583473662|FG001|Overall Study|Investigator decision|1|||
161570160|NCT02987543|583473663|FG002|Overall Study|Investigator decision|0|||
161570161|NCT02987543|583473664|FG003|Overall Study|Investigator decision|0|||
161570162|NCT02987543|583473661|FG000|Overall Study|Disease progression|0|||
161570163|NCT02987543|583473662|FG001|Overall Study|Disease progression|0|||
161570164|NCT02987543|583473663|FG002|Overall Study|Disease progression|0|||
161570165|NCT02987543|583473664|FG003|Overall Study|Disease progression|1|||
161570166|NCT03646669|583473665|FG000|Overall Study|Withdrawal by Subject|5|||
161570167|NCT03646669|583473666|FG001|Overall Study|Withdrawal by Subject|0|||
161570168|NCT00377455|583473667|FG000|Overall Study|Withdrawal by Subject|1|||
161570169|NCT00309452|583473668|FG000|Overall Study|Withdrawal by Subject|3|||
161570170|NCT00309452|583473669|FG001|Overall Study|Withdrawal by Subject|0|||
161570171|NCT02962674|583473671|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
161570172|NCT03265210|583473674|FG000|Overall Study|Withdrawal by Subject|7|||
161570173|NCT03265210|583473675|FG001|Overall Study|Withdrawal by Subject|9|||
161570174|NCT03265210|583473674|FG000|Overall Study|Lost to Follow-up|2|||
161570175|NCT03265210|583473675|FG001|Overall Study|Lost to Follow-up|0|||
161570176|NCT03265210|583473674|FG000|Overall Study|Physician Decision|2|||
161570177|NCT03265210|583473675|FG001|Overall Study|Physician Decision|0|||
161570178|NCT03265210|583473674|FG000|Overall Study|Adverse Event|1|||
161570179|NCT03265210|583473675|FG001|Overall Study|Adverse Event|0|||
161570180|NCT01883492|583473676|FG000|Overall Study|Lost to Follow-up|3|||
161570181|NCT01883492|583473677|FG001|Overall Study|Lost to Follow-up|4|||
161570182|NCT01883492|583473676|FG000|Overall Study|Surgery on contra-lateral hip|0|||
161570183|NCT01883492|583473677|FG001|Overall Study|Surgery on contra-lateral hip|1|||
161570184|NCT01883492|583473676|FG000|Overall Study|Poor X-ray quality|7|||
161570185|NCT01883492|583473677|FG001|Overall Study|Poor X-ray quality|4|||
161570186|NCT01883492|583473676|FG000|Overall Study|Withdrawal by Subject|1|||
161570187|NCT01883492|583473677|FG001|Overall Study|Withdrawal by Subject|0|||
161570188|NCT01883492|583473676|FG000|Overall Study|inappropriate implant used|1|||
161570189|NCT01883492|583473677|FG001|Overall Study|inappropriate implant used|1|||
161570190|NCT01883492|583473676|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
161570191|NCT01883492|583473677|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
161570192|NCT02488980|583473683|FG000|Overall Study|Protocol Violation|2|||
161570193|NCT02488980|583473684|FG001|Overall Study|Protocol Violation|2|||
161570194|NCT02488980|583473685|FG002|Overall Study|Protocol Violation|2|||
161570195|NCT02614560|583473689|FG000|Overall Study|Death|6|||
161570196|NCT02614560|583473690|FG001|Overall Study|Death|2|||
161570197|NCT02192606|583473691|FG000|Overall Study|surgery type was changed|1|||
161570198|NCT02192606|583473692|FG001|Overall Study|surgery type was changed|1|||
161570199|NCT02192606|583473691|FG000|Overall Study|Physician Decision|1|||
161570200|NCT02192606|583473692|FG001|Overall Study|Physician Decision|2|||
161570201|NCT02192606|583473691|FG000|Overall Study|3D equipment rep unable to join|0|||
161570202|NCT02192606|583473692|FG001|Overall Study|3D equipment rep unable to join|1|||
161570203|NCT00738699|583473693|FG000|Overall Study|Withdrawal by Subject|5|||
161570204|NCT00738699|583473694|FG001|Overall Study|Withdrawal by Subject|0|||
161570205|NCT00738699|583473693|FG000|Overall Study|Lost to Follow-up|1|||
161570206|NCT00738699|583473694|FG001|Overall Study|Lost to Follow-up|0|||
161570207|NCT00738699|583473693|FG000|Overall Study|Death|144|||
161570208|NCT00738699|583473694|FG001|Overall Study|Death|68|||
161570209|NCT00738699|583473693|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
161570210|NCT00738699|583473694|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
161570211|NCT00738699|583473693|FG000|Overall Study|Other|2|||
161570212|NCT00738699|583473694|FG001|Overall Study|Other|0|||
161570213|NCT00549848|583473695|FG000|Overall Study|Death|1|||
161570214|NCT00549848|583473696|FG001|Overall Study|Death|4|||
161570215|NCT00549848|583473697|FG002|Overall Study|Death|13|||
161570216|NCT00549848|583473695|FG000|Overall Study|Physician Decision|0|||
161570217|NCT00549848|583473696|FG001|Overall Study|Physician Decision|0|||
161570218|NCT00549848|583473697|FG002|Overall Study|Physician Decision|4|||
161570219|NCT00549848|583473695|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
161570220|NCT00549848|583473696|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
161570221|NCT00549848|583473697|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
161570222|NCT00549848|583473695|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
161570223|NCT00549848|583473696|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
161570224|NCT00549848|583473697|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
161570225|NCT00549848|583473695|FG000|Overall Study|Participant/Family Withdraw|2|||
161570226|NCT00549848|583473696|FG001|Overall Study|Participant/Family Withdraw|3|||
161570227|NCT00549848|583473697|FG002|Overall Study|Participant/Family Withdraw|5|||
161570228|NCT00549848|583473695|FG000|Overall Study|Second Malignancy|1|||
161570229|NCT00549848|583473696|FG001|Overall Study|Second Malignancy|0|||
161570230|NCT00549848|583473697|FG002|Overall Study|Second Malignancy|0|||
161570231|NCT00549848|583473695|FG000|Overall Study|Transplant|3|||
161570232|NCT00549848|583473696|FG001|Overall Study|Transplant|3|||
161570233|NCT00549848|583473697|FG002|Overall Study|Transplant|18|||
161570234|NCT00549848|583473695|FG000|Overall Study|Unacceptable Toxicity|1|||
161570235|NCT00549848|583473696|FG001|Overall Study|Unacceptable Toxicity|6|||
161570236|NCT00549848|583473697|FG002|Overall Study|Unacceptable Toxicity|6|||
161570237|NCT05193318|583473698|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
161570238|NCT05193318|583473698|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
161570239|NCT03670602|583473699|FG000|Overall Study|Lost to Follow-up|1|||
161570240|NCT03670602|583473700|FG001|Overall Study|Lost to Follow-up|0|||
161570241|NCT03670602|583473699|FG000|Overall Study|Withdrawal by Subject|0|||
161570242|NCT03670602|583473700|FG001|Overall Study|Withdrawal by Subject|3|||
161570243|NCT03201809|583473701|FG000|Overall Study|Lost to Follow-up|2|||
161570244|NCT03201809|583473702|FG001|Overall Study|Lost to Follow-up|0|||
161570245|NCT00957658|583473703|FG000|Overall Study|Death|1|||
161570246|NCT00957658|583473703|FG000|Overall Study|Lost to Follow-up|4|||
161570247|NCT00957658|583473703|FG000|Overall Study|Withdrawal by Subject|12|||
161570248|NCT00957658|583473703|FG000|Overall Study|Revision|1|||
161570249|NCT00957658|583473703|FG000|Overall Study|Incomplete 2 yr data|28|||
161570250|NCT00957658|583473703|FG000|Overall Study|Site termination|10|||
161570251|NCT00957658|583473703|FG000|Overall Study|unwilling/unable to return|2|||
161570252|NCT00957658|583473703|FG000|Overall Study|surgery cancelled|2|||
161570253|NCT00957658|583473703|FG000|Overall Study|Protocol Violation|5|||
161570254|NCT03383887|583473704|FG000|Overall Study|Lost to Follow-up|0|||
161570255|NCT03383887|583473705|FG001|Overall Study|Lost to Follow-up|1|||
161570256|NCT00246012|583473712|FG000|Overall Study|Adverse Event|0|||
161570257|NCT00246012|583473713|FG001|Overall Study|Adverse Event|0|||
161570258|NCT00246012|583473714|FG002|Overall Study|Adverse Event|0|||
161570259|NCT00246012|583473715|FG003|Overall Study|Adverse Event|0|||
161570260|NCT00246012|583473716|FG004|Overall Study|Adverse Event|0|||
161570261|NCT00246012|583473717|FG005|Overall Study|Adverse Event|1|||
161570262|NCT00246012|583473718|FG006|Overall Study|Adverse Event|0|||
161570263|NCT00246012|583473719|FG007|Overall Study|Adverse Event|0|||
161570264|NCT00246012|583473720|FG008|Overall Study|Adverse Event|2|||
161913197|NCT01286129|584731912|FG000|Overall Study|Could not comply with study requirements|4|||
161570265|NCT00246012|583473712|FG000|Overall Study|Withdrawal by Subject|0|||
161570266|NCT00246012|583473713|FG001|Overall Study|Withdrawal by Subject|0|||
161570267|NCT00246012|583473714|FG002|Overall Study|Withdrawal by Subject|0|||
161570268|NCT00246012|583473715|FG003|Overall Study|Withdrawal by Subject|0|||
161570269|NCT00246012|583473716|FG004|Overall Study|Withdrawal by Subject|0|||
161570270|NCT00246012|583473717|FG005|Overall Study|Withdrawal by Subject|1|||
161570271|NCT00246012|583473718|FG006|Overall Study|Withdrawal by Subject|0|||
161570272|NCT00246012|583473719|FG007|Overall Study|Withdrawal by Subject|0|||
161913198|NCT01286129|584731913|FG001|Overall Study|Could not comply with study requirements|4|||
161913199|NCT00111761|584731914|FG000|Part 1|Physician Decision|0|||
161570273|NCT00246012|583473720|FG008|Overall Study|Withdrawal by Subject|0|||
161570274|NCT00246012|583473712|FG000|Overall Study|Disease progression|3|||
161570275|NCT00246012|583473713|FG001|Overall Study|Disease progression|1|||
161570276|NCT00246012|583473714|FG002|Overall Study|Disease progression|2|||
161570277|NCT00246012|583473715|FG003|Overall Study|Disease progression|3|||
161570278|NCT00246012|583473716|FG004|Overall Study|Disease progression|3|||
161570279|NCT00246012|583473717|FG005|Overall Study|Disease progression|25|||
161570280|NCT00246012|583473718|FG006|Overall Study|Disease progression|30|||
161570281|NCT00246012|583473719|FG007|Overall Study|Disease progression|27|||
161570282|NCT00246012|583473720|FG008|Overall Study|Disease progression|26|||
161570283|NCT00246012|583473712|FG000|Overall Study|Other|0|||
161570284|NCT00246012|583473713|FG001|Overall Study|Other|0|||
161570285|NCT00246012|583473714|FG002|Overall Study|Other|0|||
161570286|NCT00246012|583473715|FG003|Overall Study|Other|0|||
161570287|NCT00246012|583473716|FG004|Overall Study|Other|0|||
161570288|NCT00246012|583473717|FG005|Overall Study|Other|0|||
161570289|NCT00246012|583473718|FG006|Overall Study|Other|0|||
161570290|NCT00246012|583473719|FG007|Overall Study|Other|1|||
161570291|NCT00246012|583473720|FG008|Overall Study|Other|0|||
161570292|NCT00246012|583473712|FG000|Overall Study|Randomly assigned but not treated|0|||
161570293|NCT00246012|583473713|FG001|Overall Study|Randomly assigned but not treated|0|||
161570294|NCT00246012|583473714|FG002|Overall Study|Randomly assigned but not treated|0|||
161570295|NCT00246012|583473715|FG003|Overall Study|Randomly assigned but not treated|0|||
161809146|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161570296|NCT00246012|583473716|FG004|Overall Study|Randomly assigned but not treated|0|||
161570297|NCT00246012|583473717|FG005|Overall Study|Randomly assigned but not treated|1|||
161570298|NCT00246012|583473718|FG006|Overall Study|Randomly assigned but not treated|1|||
161570299|NCT00246012|583473719|FG007|Overall Study|Randomly assigned but not treated|0|||
161570300|NCT00246012|583473720|FG008|Overall Study|Randomly assigned but not treated|0|||
161570301|NCT02377362|583473721|FG000|Part A Second Treatment|Protocol Violation|0|||
161570302|NCT02377362|583473722|FG001|Part A Second Treatment|Protocol Violation|0|||
161570303|NCT02377362|583473723|FG002|Part A Second Treatment|Protocol Violation|0|||
161570304|NCT02377362|583473724|FG003|Part A Second Treatment|Protocol Violation|0|||
161570305|NCT02377362|583473725|FG004|Part A Second Treatment|Protocol Violation|1|||
161570306|NCT02377362|583473726|FG005|Part A Second Treatment|Protocol Violation|0|||
161570307|NCT02377362|583473727|FG006|Part A Second Treatment|Protocol Violation|0|||
161570308|NCT02377362|583473728|FG007|Part A Second Treatment|Protocol Violation|0|||
161570309|NCT02377362|583473729|FG008|Part A Second Treatment|Protocol Violation|0|||
161570310|NCT02377362|583473730|FG009|Part A Second Treatment|Protocol Violation|0|||
161570311|NCT02377362|583473731|FG010|Part A Second Treatment|Protocol Violation|0|||
161570312|NCT02377362|583473732|FG011|Part A Second Treatment|Protocol Violation|0|||
161570313|NCT02377362|583473733|FG012|Part A Second Treatment|Protocol Violation|0|||
161570314|NCT02377362|583473721|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570315|NCT02377362|583473722|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570316|NCT02377362|583473723|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570317|NCT02377362|583473724|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
161570318|NCT02377362|583473725|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
161570319|NCT02377362|583473726|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
161570320|NCT02377362|583473727|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570321|NCT02377362|583473728|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570322|NCT02377362|583473729|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570323|NCT02377362|583473730|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570324|NCT02377362|583473731|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570325|NCT02377362|583473732|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570326|NCT02377362|583473733|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
161570327|NCT02377362|583473721|FG000|Part B Overall|Protocol Violation|0|||
161570328|NCT02377362|583473722|FG001|Part B Overall|Protocol Violation|0|||
161570329|NCT02377362|583473723|FG002|Part B Overall|Protocol Violation|0|||
161570330|NCT02377362|583473724|FG003|Part B Overall|Protocol Violation|0|||
161570331|NCT02377362|583473725|FG004|Part B Overall|Protocol Violation|0|||
161570332|NCT02377362|583473726|FG005|Part B Overall|Protocol Violation|0|||
161570333|NCT02377362|583473727|FG006|Part B Overall|Protocol Violation|0|||
161570334|NCT02377362|583473728|FG007|Part B Overall|Protocol Violation|0|||
161570335|NCT02377362|583473729|FG008|Part B Overall|Protocol Violation|0|||
161570336|NCT02377362|583473730|FG009|Part B Overall|Protocol Violation|1|||
161570337|NCT02377362|583473731|FG010|Part B Overall|Protocol Violation|0|||
161570338|NCT02377362|583473732|FG011|Part B Overall|Protocol Violation|0|||
161570339|NCT02377362|583473733|FG012|Part B Overall|Protocol Violation|0|||
161570340|NCT02377362|583473721|FG000|Part B Overall|Adverse Event|0|||
161570341|NCT02377362|583473722|FG001|Part B Overall|Adverse Event|0|||
161570342|NCT02377362|583473723|FG002|Part B Overall|Adverse Event|0|||
161570343|NCT02377362|583473724|FG003|Part B Overall|Adverse Event|0|||
161570344|NCT02377362|583473725|FG004|Part B Overall|Adverse Event|0|||
161570345|NCT02377362|583473726|FG005|Part B Overall|Adverse Event|0|||
161809147|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161570346|NCT02377362|583473727|FG006|Part B Overall|Adverse Event|1|||
161570347|NCT02377362|583473728|FG007|Part B Overall|Adverse Event|1|||
161570348|NCT02377362|583473729|FG008|Part B Overall|Adverse Event|0|||
161570349|NCT02377362|583473730|FG009|Part B Overall|Adverse Event|0|||
161913200|NCT00111761|584731915|FG001|Part 1|Physician Decision|1|||
161570350|NCT02377362|583473731|FG010|Part B Overall|Adverse Event|0|||
161570351|NCT02377362|583473732|FG011|Part B Overall|Adverse Event|0|||
161570352|NCT02377362|583473733|FG012|Part B Overall|Adverse Event|0|||
161570353|NCT02377362|583473721|FG000|Part B Overall|Withdrawal by Subject|0|||
161570354|NCT02377362|583473722|FG001|Part B Overall|Withdrawal by Subject|0|||
161570355|NCT02377362|583473723|FG002|Part B Overall|Withdrawal by Subject|0|||
161570356|NCT02377362|583473724|FG003|Part B Overall|Withdrawal by Subject|0|||
161570357|NCT02377362|583473725|FG004|Part B Overall|Withdrawal by Subject|0|||
161570358|NCT02377362|583473726|FG005|Part B Overall|Withdrawal by Subject|0|||
161570359|NCT02377362|583473727|FG006|Part B Overall|Withdrawal by Subject|1|||
161570360|NCT02377362|583473728|FG007|Part B Overall|Withdrawal by Subject|0|||
161570361|NCT02377362|583473729|FG008|Part B Overall|Withdrawal by Subject|0|||
161570362|NCT02377362|583473730|FG009|Part B Overall|Withdrawal by Subject|0|||
161570363|NCT02377362|583473731|FG010|Part B Overall|Withdrawal by Subject|0|||
161570364|NCT02377362|583473732|FG011|Part B Overall|Withdrawal by Subject|1|||
161570365|NCT02377362|583473733|FG012|Part B Overall|Withdrawal by Subject|0|||
161570366|NCT01651949|583473736|FG000|Overall Study|Unknown status|4|||
161570367|NCT01651949|583473737|FG001|Overall Study|Unknown status|4|||
161570368|NCT01651949|583473738|FG002|Overall Study|Unknown status|0|||
161570369|NCT01651949|583473736|FG000|Overall Study|Lost to Follow-up|30|||
161570370|NCT01651949|583473737|FG001|Overall Study|Lost to Follow-up|56|||
161570371|NCT01651949|583473738|FG002|Overall Study|Lost to Follow-up|20|||
161570372|NCT01651949|583473736|FG000|Overall Study|Protocol Violation|0|||
161570373|NCT01651949|583473737|FG001|Overall Study|Protocol Violation|2|||
161570374|NCT01651949|583473738|FG002|Overall Study|Protocol Violation|1|||
161570375|NCT01651949|583473736|FG000|Overall Study|Physician Decision|0|||
161570376|NCT01651949|583473737|FG001|Overall Study|Physician Decision|2|||
161570377|NCT01651949|583473738|FG002|Overall Study|Physician Decision|0|||
161570378|NCT01651949|583473736|FG000|Overall Study|Adverse Event|0|||
161570379|NCT01651949|583473737|FG001|Overall Study|Adverse Event|2|||
161570380|NCT01651949|583473738|FG002|Overall Study|Adverse Event|1|||
161570381|NCT01651949|583473736|FG000|Overall Study|Screen failure|2|||
161570382|NCT01651949|583473737|FG001|Overall Study|Screen failure|2|||
161570383|NCT01651949|583473738|FG002|Overall Study|Screen failure|0|||
161570384|NCT01651949|583473736|FG000|Overall Study|Withdrawal by Subject|17|||
161570385|NCT01651949|583473737|FG001|Overall Study|Withdrawal by Subject|18|||
161570386|NCT01651949|583473738|FG002|Overall Study|Withdrawal by Subject|9|||
161570387|NCT01806714|583473739|FG000|Overall Study|No functioning phone number|200|||
161570388|NCT01806714|583473740|FG001|Overall Study|No functioning phone number|170|||
161570389|NCT02155829|583473741|FG000|Overall Study|Adverse Event|1|||
161570390|NCT02155829|583473742|FG001|Overall Study|Adverse Event|0|||
161570391|NCT02155829|583473741|FG000|Overall Study|Withdrawal by Subject|3|||
161570392|NCT02155829|583473742|FG001|Overall Study|Withdrawal by Subject|3|||
161570393|NCT02155829|583473741|FG000|Overall Study|Protocol Violation|2|||
161570394|NCT02155829|583473742|FG001|Overall Study|Protocol Violation|0|||
161570395|NCT01585038|583473743|FG000|Overall Study|Adverse Event|2|||
161570396|NCT01585038|583473744|FG001|Overall Study|Adverse Event|2|||
161570397|NCT00678795|583473745|FG000|Overall Study|Adverse Event|7|||
161570398|NCT00678795|583473746|FG001|Overall Study|Adverse Event|3|||
161570399|NCT00678795|583473745|FG000|Overall Study|Withdrawal by Subject|3|||
161570400|NCT00678795|583473746|FG001|Overall Study|Withdrawal by Subject|0|||
161570401|NCT00678795|583473745|FG000|Overall Study|Protocol Violation|0|||
161570402|NCT00678795|583473746|FG001|Overall Study|Protocol Violation|1|||
161570403|NCT00678795|583473745|FG000|Overall Study|Lost to Follow-up|0|||
161570404|NCT00678795|583473746|FG001|Overall Study|Lost to Follow-up|1|||
161570405|NCT00678795|583473745|FG000|Overall Study|Lack of Efficacy|1|||
161570406|NCT00678795|583473746|FG001|Overall Study|Lack of Efficacy|1|||
161570407|NCT04107805|583473747|FG000|Overall Study|Adverse Event|0|||
161570408|NCT04107805|583473748|FG001|Overall Study|Adverse Event|0|||
161570409|NCT04107805|583473749|FG002|Overall Study|Adverse Event|0|||
161570410|NCT04107805|583473750|FG003|Overall Study|Adverse Event|1|||
161570411|NCT04107805|583473751|FG004|Overall Study|Adverse Event|0|||
161570412|NCT04107805|583473752|FG005|Overall Study|Adverse Event|1|||
161570413|NCT04107805|583473753|FG006|Overall Study|Adverse Event|0|||
161570414|NCT04107805|583473754|FG007|Overall Study|Adverse Event|0|||
161570415|NCT04107805|583473755|FG008|Overall Study|Adverse Event|1|||
161570416|NCT02750709|583473758|FG000|Treatment Period 1|Adverse Event|0|||
161570417|NCT02750709|583473759|FG001|Treatment Period 1|Adverse Event|0|||
161570418|NCT02750709|583473760|FG002|Treatment Period 1|Adverse Event|0|||
161570419|NCT02750709|583473761|FG003|Treatment Period 1|Adverse Event|0|||
161570420|NCT02750709|583473762|FG004|Treatment Period 1|Adverse Event|0|||
161570421|NCT02750709|583473763|FG005|Treatment Period 1|Adverse Event|1|||
161570422|NCT01120275|583473765|FG000|Overall Study|Adverse Event|3|||
161570423|NCT01120275|583473765|FG000|Overall Study|Progression|27|||
161570424|NCT01120275|583473765|FG000|Overall Study|Ineligible|3|||
161570425|NCT01120275|583473765|FG000|Overall Study|Withdrawal by Subject|1|||
161570426|NCT01120275|583473765|FG000|Overall Study|Refusal|1|||
161570427|NCT01120275|583473765|FG000|Overall Study|Not specific|1|||
161570428|NCT01191086|583473767|FG000|Overall Study|Adverse Event|20|||
161570429|NCT01191086|583473767|FG000|Overall Study|Lack of Efficacy|10|||
161570430|NCT01191086|583473767|FG000|Overall Study|Lost to Follow-up|4|||
161570431|NCT01191086|583473767|FG000|Overall Study|Physician Decision|2|||
161570432|NCT01191086|583473767|FG000|Overall Study|Withdrawal by Subject|24|||
161457571|NCT02217527|583070255|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
161457572|NCT02217527|583070256|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
161457573|NCT02217527|583070255|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
161457574|NCT02217527|583070256|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
161457575|NCT01203852|583070260|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
161457576|NCT01203852|583070260|FG000|Washout 2 Weeks|Physician Decision|46|||
161457577|NCT01738477|583070263|FG000|Overall Study|Lost to Follow-up|1|||
161457578|NCT01738477|583070264|FG001|Overall Study|Lost to Follow-up|4|||
161457579|NCT03709576|583070267|FG000|Overall Study|progression prior to enrollment|1|||
161457580|NCT00890045|583070275|FG000|Overall Study|Death|0|||
161457581|NCT00890045|583070276|FG001|Overall Study|Death|1|||
161457582|NCT00890045|583070275|FG000|Overall Study|Did not receive HeRO Graft|0|||
161457583|NCT00890045|583070276|FG001|Overall Study|Did not receive HeRO Graft|2|||
161457584|NCT00890045|583070275|FG000|Overall Study|Lost to Follow-up|5|||
161457585|NCT00890045|583070276|FG001|Overall Study|Lost to Follow-up|7|||
161457586|NCT00510653|583070277|FG000|Overall Study|Withdrawal by Subject|8|||
161457587|NCT00510653|583070277|FG000|Overall Study|Monetary|3|||
161457588|NCT01947855|583070280|FG000|Overall Study|Withdrawal by Subject|1|||
161457589|NCT01947855|583070281|FG001|Overall Study|Withdrawal by Subject|0|||
161457590|NCT01947855|583070282|FG002|Overall Study|Withdrawal by Subject|0|||
161457591|NCT00710762|583070283|FG000|Overall Study|Progressive disease|27|||
161457592|NCT00710762|583070284|FG001|Overall Study|Progressive disease|30|||
161457593|NCT00710762|583070283|FG000|Overall Study|Adverse Event other disease worsening|2|||
161457594|NCT00710762|583070284|FG001|Overall Study|Adverse Event other disease worsening|1|||
161457595|NCT00710762|583070283|FG000|Overall Study|Other Adverse Event|7|||
161457596|NCT00710762|583070284|FG001|Overall Study|Other Adverse Event|7|||
161457597|NCT00710762|583070283|FG000|Overall Study|Lost to Follow-up|1|||
161457598|NCT00710762|583070284|FG001|Overall Study|Lost to Follow-up|0|||
161457599|NCT00710762|583070283|FG000|Overall Study|Reason other than listed above|2|||
161457600|NCT00710762|583070284|FG001|Overall Study|Reason other than listed above|2|||
161457601|NCT01892384|583070288|FG000|Overall Study|Withdrawal by Subject|1|||
161457602|NCT01892384|583070289|FG001|Overall Study|Withdrawal by Subject|1|||
161457603|NCT01892384|583070290|FG002|Overall Study|Withdrawal by Subject|0|||
161457604|NCT01892384|583070291|FG003|Overall Study|Withdrawal by Subject|0|||
161457605|NCT01700439|583070292|FG000|Overall Study|Lost to Follow-up|47|||
161457606|NCT01700439|583070292|FG000|Overall Study|Withdrawal by Subject|183|||
161457607|NCT01700439|583070292|FG000|Overall Study|Death|186|||
161457608|NCT00592774|583070293|FG000|Overall Study|Adverse Event|5|||
161457609|NCT00592774|583070294|FG001|Overall Study|Adverse Event|19|||
161457610|NCT00592774|583070295|FG002|Overall Study|Adverse Event|2|||
161457611|NCT00592774|583070296|FG003|Overall Study|Adverse Event|14|||
161457612|NCT00592774|583070297|FG004|Overall Study|Adverse Event|8|||
161457613|NCT00592774|583070293|FG000|Overall Study|Protocol Violation|0|||
161457614|NCT00592774|583070294|FG001|Overall Study|Protocol Violation|1|||
161457615|NCT00592774|583070295|FG002|Overall Study|Protocol Violation|0|||
161457616|NCT00592774|583070296|FG003|Overall Study|Protocol Violation|0|||
161457617|NCT00592774|583070297|FG004|Overall Study|Protocol Violation|1|||
161457618|NCT00592774|583070293|FG000|Overall Study|Withdrawal by Subject|3|||
161457619|NCT00592774|583070294|FG001|Overall Study|Withdrawal by Subject|7|||
161457620|NCT00592774|583070295|FG002|Overall Study|Withdrawal by Subject|0|||
161457621|NCT00592774|583070296|FG003|Overall Study|Withdrawal by Subject|0|||
161457622|NCT00592774|583070297|FG004|Overall Study|Withdrawal by Subject|0|||
161457623|NCT00592774|583070293|FG000|Overall Study|Lack of Efficacy|3|||
161457624|NCT00592774|583070294|FG001|Overall Study|Lack of Efficacy|3|||
161457625|NCT00592774|583070295|FG002|Overall Study|Lack of Efficacy|0|||
161457626|NCT00592774|583070296|FG003|Overall Study|Lack of Efficacy|0|||
161457627|NCT00592774|583070297|FG004|Overall Study|Lack of Efficacy|2|||
161457628|NCT00592774|583070293|FG000|Overall Study|Physician Decision|0|||
161457629|NCT00592774|583070294|FG001|Overall Study|Physician Decision|1|||
161457630|NCT00592774|583070295|FG002|Overall Study|Physician Decision|1|||
161457631|NCT00592774|583070296|FG003|Overall Study|Physician Decision|0|||
161457632|NCT00592774|583070297|FG004|Overall Study|Physician Decision|1|||
161457633|NCT00592774|583070293|FG000|Overall Study|Other|0|||
161457634|NCT00592774|583070294|FG001|Overall Study|Other|1|||
161457635|NCT00592774|583070295|FG002|Overall Study|Other|1|||
161457636|NCT00592774|583070296|FG003|Overall Study|Other|0|||
161457637|NCT00592774|583070297|FG004|Overall Study|Other|2|||
161457638|NCT00621621|583070298|FG000|Overall Study|Subjects were exited at EP study|30|||
161457639|NCT00621621|583070299|FG001|Overall Study|Subjects were exited at EP study|0|||
161457640|NCT00053898|583070303|FG000|Overall Study|No follow-up data from any source|9|||
161457641|NCT00053898|583070304|FG001|Overall Study|No follow-up data from any source|12|||
161457642|NCT00053898|583070303|FG000|Overall Study|Follow-up from telephone contact only|5|||
161457643|NCT00053898|583070304|FG001|Overall Study|Follow-up from telephone contact only|1|||
161457644|NCT03985878|583070308|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
161457645|NCT03985878|583070308|FG000|Overall Study|Study Terminated by Sponsor|12|||
161457646|NCT03985878|583070308|FG000|Overall Study|Withdrawal by Subject|1|||
161457647|NCT02889562|583070309|FG000|Overall Study|Physician Decision|0|||
161457648|NCT02889562|583070310|FG001|Overall Study|Physician Decision|1|||
161457649|NCT02889562|583070309|FG000|Overall Study|Withdrawal by Subject|0|||
161457650|NCT02889562|583070310|FG001|Overall Study|Withdrawal by Subject|1|||
161457651|NCT00960570|583070316|FG000|21 Day Washout Period|Adverse Event|1|||
161457652|NCT00960570|583070316|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
161457653|NCT00960570|583070316|FG000|1 Day Period Between Dosing|Adverse Event|2|||
161457654|NCT00960570|583070316|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
161457655|NCT04085367|583071502|FG000|Overall Study|Adverse Event|1|||
161457656|NCT04085367|583071503|FG001|Overall Study|Adverse Event|1|||
161457657|NCT04085367|583071502|FG000|Overall Study|Withdrawal by Subject|13|||
161457658|NCT04085367|583071503|FG001|Overall Study|Withdrawal by Subject|4|||
161457659|NCT04085367|583071502|FG000|Overall Study|Lost to Follow-up|3|||
161457660|NCT04085367|583071503|FG001|Overall Study|Lost to Follow-up|1|||
161457661|NCT04085367|583071502|FG000|Overall Study|Other unspecified|2|||
161457662|NCT04085367|583071503|FG001|Overall Study|Other unspecified|1|||
161457663|NCT04085367|583071502|FG000|Overall Study|Status Unknown|1|||
161457664|NCT04085367|583071503|FG001|Overall Study|Status Unknown|1|||
161457665|NCT00130442|583071507|FG000|Overall Study|Withdrawal by Subject|0|||
161457666|NCT00130442|583071508|FG001|Overall Study|Withdrawal by Subject|1|||
161457667|NCT00130442|583071507|FG000|Overall Study|did not meet criteria|1|||
161457668|NCT00130442|583071508|FG001|Overall Study|did not meet criteria|1|||
161457669|NCT00814333|583071509|FG000|Enrollment|Lost to Follow-up|1|||
161457670|NCT00814333|583071510|FG001|Enrollment|Lost to Follow-up|0|||
161457671|NCT01527357|583071511|FG000|Overall Study|Death|8|||
161457672|NCT01527357|583071512|FG001|Overall Study|Death|2|||
161457673|NCT01527357|583071511|FG000|Overall Study|Lost to Follow-up|6|||
161457674|NCT01527357|583071512|FG001|Overall Study|Lost to Follow-up|4|||
161457675|NCT01527357|583071511|FG000|Overall Study|Withdrew Consent|1|||
161457676|NCT01527357|583071512|FG001|Overall Study|Withdrew Consent|1|||
161457677|NCT01527357|583071511|FG000|Overall Study|Non-compliance|0|||
161457678|NCT01527357|583071512|FG001|Overall Study|Non-compliance|1|||
161457679|NCT01527357|583071511|FG000|Overall Study|No Day 29 Visit|0|||
161457680|NCT01527357|583071512|FG001|Overall Study|No Day 29 Visit|1|||
161457681|NCT01527357|583071511|FG000|Overall Study|Did Not Receive Treatment|2|||
161457682|NCT01527357|583071512|FG001|Overall Study|Did Not Receive Treatment|0|||
161457683|NCT02233946|583071513|FG000|Baseline|Withdrawal by Subject|2|||
161457684|NCT02233946|583071514|FG001|Baseline|Withdrawal by Subject|0|||
161457685|NCT02233946|583071513|FG000|3-months Follow-up|Lost to Follow-up|53|||
161457686|NCT02233946|583071514|FG001|3-months Follow-up|Lost to Follow-up|29|||
161457687|NCT02233946|583071513|FG000|6-months Follow-up|Lost to Follow-up|21|||
161457688|NCT02233946|583071514|FG001|6-months Follow-up|Lost to Follow-up|2|||
161457689|NCT02233946|583071513|FG000|9-month Follow-up|Lost to Follow-up|20|||
161457690|NCT02233946|583071514|FG001|9-month Follow-up|Lost to Follow-up|11|||
161457691|NCT02233946|583071513|FG000|12-month Follow-up|Lost to Follow-up|28|||
161457692|NCT02233946|583071514|FG001|12-month Follow-up|Lost to Follow-up|11|||
161457693|NCT00910247|583071515|FG000|Overall Study|Adverse Event|15|||
161457694|NCT00910247|583071515|FG000|Overall Study|Death|2|||
161457695|NCT00910247|583071515|FG000|Overall Study|Lost to Follow-up|10|||
161457696|NCT00910247|583071515|FG000|Overall Study|Physician Decision|3|||
161457697|NCT00910247|583071515|FG000|Overall Study|Protocol Violation|10|||
161457698|NCT00910247|583071515|FG000|Overall Study|Withdrawal by Subject|25|||
161457699|NCT00910247|583071515|FG000|Overall Study|Not collected|4|||
161457700|NCT01879579|583071516|FG000|Overall Study|Phone incompatible with texting platform|3|||
161457701|NCT01879579|583071517|FG001|Overall Study|Phone incompatible with texting platform|0|||
161457702|NCT01879579|583071516|FG000|Overall Study|Did not enroll in texting platform|1|||
161457703|NCT01879579|583071517|FG001|Overall Study|Did not enroll in texting platform|0|||
161457704|NCT01879579|583071516|FG000|Overall Study|Did not initiate insulin treatment|1|||
161457705|NCT01879579|583071517|FG001|Overall Study|Did not initiate insulin treatment|0|||
161457706|NCT01879579|583071516|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
161457707|NCT01879579|583071517|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
161457708|NCT01879579|583071516|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
161457709|NCT01879579|583071517|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
161457710|NCT02927067|583071518|FG000|Overall Study|Withdrawn Consent|20|||
161457711|NCT02927067|583071519|FG001|Overall Study|Withdrawn Consent|12|||
161457712|NCT02927067|583071518|FG000|Overall Study|Death|18|||
161457713|NCT02927067|583071519|FG001|Overall Study|Death|31|||
161457714|NCT02927067|583071518|FG000|Overall Study|Adverse Event|13|||
161457715|NCT02927067|583071519|FG001|Overall Study|Adverse Event|10|||
161457716|NCT02927067|583071518|FG000|Overall Study|Noncompliance|5|||
161457717|NCT02927067|583071519|FG001|Overall Study|Noncompliance|2|||
161457718|NCT02927067|583071518|FG000|Overall Study|Reason not Specified|4|||
161457719|NCT02927067|583071519|FG001|Overall Study|Reason not Specified|6|||
161457720|NCT02292784|583071522|FG000|Overall Study|Lost to Follow-up|1|||
161457721|NCT02292784|583071523|FG001|Overall Study|Lost to Follow-up|17|||
161457722|NCT02292784|583071524|FG002|Overall Study|Lost to Follow-up|18|||
161570433|NCT01191086|583473767|FG000|Overall Study|Discontinuation criterion met|1|||
161570434|NCT01191086|583473767|FG000|Overall Study|Other|1|||
161570435|NCT01156116|583473768|FG000|Overall Study|Withdrawal by Subject|3|||
161570436|NCT01156116|583473769|FG001|Overall Study|Withdrawal by Subject|1|||
161570437|NCT01156116|583473768|FG000|Overall Study|CPAP intolerance|2|||
161570438|NCT01156116|583473769|FG001|Overall Study|CPAP intolerance|0|||
161570439|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
161570440|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
161570441|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
161570442|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
161570443|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
161570444|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
161570445|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
161570446|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
161570447|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
161570448|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
161570449|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
161570450|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
161570451|NCT02057718|583473770|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
161570452|NCT02057718|583473771|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
161570453|NCT02057718|583473770|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
161570454|NCT02057718|583473771|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
161570455|NCT02057718|583473770|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
161570456|NCT02057718|583473771|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
161570457|NCT02057718|583473770|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
161570458|NCT02057718|583473771|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
161570459|NCT02057718|583473770|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
161570460|NCT02057718|583473771|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
161570461|NCT00906035|583473780|FG000|Overall Study|Withdrawal by Subject|2|||
161570462|NCT00906035|583473781|FG001|Overall Study|Withdrawal by Subject|3|||
161570463|NCT00906035|583473782|FG002|Overall Study|Withdrawal by Subject|0|||
161570464|NCT00130637|583473783|FG000|Overall Study|Adverse Event|2|||
161570465|NCT00130637|583473783|FG000|Overall Study|Withdrawal by Subject|1|||
161570466|NCT00139737|583473784|FG000|Overall Study|Withdrawal by Subject|190|||
161570467|NCT00139737|583473784|FG000|Overall Study|Adverse Event|58|||
161570468|NCT00139737|583473784|FG000|Overall Study|Lack of Efficacy|40|||
161570469|NCT00139737|583473784|FG000|Overall Study|Lost to Follow-up|8|||
161570470|NCT00139737|583473784|FG000|Overall Study|Death|3|||
161570471|NCT00139737|583473784|FG000|Overall Study|Laboratory Abnormality|2|||
161570472|NCT00139737|583473784|FG000|Overall Study|Protocol Violation|18|||
161570473|NCT00139737|583473784|FG000|Overall Study|Withdrew During Screening Phase|8|||
161570474|NCT00139737|583473784|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161570475|NCT00139737|583473784|FG000|Overall Study|Screened, Not Treated|13|||
161570476|NCT00217672|583473786|FG000|Allocation|Ineligible|2|||
161570477|NCT00217672|583473787|FG001|Allocation|Ineligible|0|||
161570478|NCT00217672|583473786|FG000|Treatment|disease progression|33|||
161570479|NCT00217672|583473787|FG001|Treatment|disease progression|4|||
161570480|NCT00217672|583473786|FG000|Treatment|Adverse Event|18|||
161570481|NCT00217672|583473787|FG001|Treatment|Adverse Event|2|||
161570482|NCT00217672|583473786|FG000|Treatment|reqd treatment not permitted by protocol|6|||
161570483|NCT00217672|583473787|FG001|Treatment|reqd treatment not permitted by protocol|0|||
161570484|NCT00217672|583473786|FG000|Treatment|Physician Decision|6|||
161570485|NCT00217672|583473787|FG001|Treatment|Physician Decision|0|||
161570486|NCT00217672|583473786|FG000|Treatment|insurance issues|1|||
161570487|NCT00217672|583473787|FG001|Treatment|insurance issues|1|||
161570488|NCT00217672|583473786|FG000|Treatment|Death|2|||
161570489|NCT00217672|583473787|FG001|Treatment|Death|0|||
161570490|NCT00217672|583473786|FG000|Treatment|secondary malignancy|1|||
161570491|NCT00217672|583473787|FG001|Treatment|secondary malignancy|0|||
161570492|NCT00217672|583473786|FG000|Follow-up|Withdrawal by Subject|4|||
161570493|NCT00217672|583473787|FG001|Follow-up|Withdrawal by Subject|0|||
161570494|NCT00217672|583473786|FG000|Follow-up|Lost to Follow-up|1|||
161570495|NCT00217672|583473787|FG001|Follow-up|Lost to Follow-up|0|||
161570496|NCT01972152|583473791|FG000|First Treatment Visit|Lost to Follow-up|0|||
161570497|NCT01972152|583473792|FG001|First Treatment Visit|Lost to Follow-up|1|||
161570498|NCT01972152|583473793|FG002|First Treatment Visit|Lost to Follow-up|0|||
161570499|NCT01972152|583473794|FG003|First Treatment Visit|Lost to Follow-up|0|||
161570500|NCT01972152|583473795|FG004|First Treatment Visit|Lost to Follow-up|0|||
161570501|NCT01972152|583473796|FG005|First Treatment Visit|Lost to Follow-up|0|||
161570502|NCT01972152|583473791|FG000|Second Treatment Visit|Protocol Violation|0|||
161570503|NCT01972152|583473792|FG001|Second Treatment Visit|Protocol Violation|1|||
161570504|NCT01972152|583473793|FG002|Second Treatment Visit|Protocol Violation|0|||
161570505|NCT01972152|583473794|FG003|Second Treatment Visit|Protocol Violation|0|||
161570506|NCT01972152|583473795|FG004|Second Treatment Visit|Protocol Violation|0|||
161570507|NCT01972152|583473796|FG005|Second Treatment Visit|Protocol Violation|0|||
161570508|NCT04379713|583473799|FG000|Overall Study|Adverse Event|2|||
161570509|NCT04379713|583473800|FG001|Overall Study|Adverse Event|0|||
161570510|NCT04379713|583473799|FG000|Overall Study|Physician Decision|2|||
161570511|NCT04379713|583473800|FG001|Overall Study|Physician Decision|1|||
161570512|NCT04379713|583473799|FG000|Overall Study|Protocol Violation|11|||
161570513|NCT04379713|583473800|FG001|Overall Study|Protocol Violation|6|||
161570514|NCT04379713|583473799|FG000|Overall Study|No longer met eligibility criteria|14|||
161570515|NCT04379713|583473800|FG001|Overall Study|No longer met eligibility criteria|11|||
161570516|NCT04379713|583473799|FG000|Overall Study|Withdrawal by parent/guardian|36|||
161570517|NCT04379713|583473800|FG001|Overall Study|Withdrawal by parent/guardian|15|||
161570518|NCT04379713|583473799|FG000|Overall Study|Lost to Follow-up|31|||
161570519|NCT04379713|583473800|FG001|Overall Study|Lost to Follow-up|21|||
161570520|NCT04567888|583473801|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
161570521|NCT04567888|583473802|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
161570522|NCT04567888|583473801|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
161570523|NCT04567888|583473802|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
161570524|NCT04567888|583473801|FG000|Overall Study|Reported Unusual Birth Year|2|||
161570525|NCT04567888|583473802|FG001|Overall Study|Reported Unusual Birth Year|3|||
161570526|NCT04567888|583473801|FG000|Overall Study|Duplicate Responses|0|||
161570527|NCT04567888|583473802|FG001|Overall Study|Duplicate Responses|1|||
161570528|NCT01157182|583473803|FG000|Washout of 28 Days|Adverse Event|2|||
161570529|NCT01157182|583473804|FG001|Washout of 28 Days|Adverse Event|0|||
161570530|NCT00878722|583473805|FG000|Overall Study|Progressive disease|3|||
161570531|NCT00878722|583473806|FG001|Overall Study|Progressive disease|3|||
161570532|NCT00878722|583473807|FG002|Overall Study|Progressive disease|3|||
161570533|NCT00878722|583473808|FG003|Overall Study|Progressive disease|7|||
161570534|NCT00878722|583473809|FG004|Overall Study|Progressive disease|7|||
161570535|NCT00878722|583473810|FG005|Overall Study|Progressive disease|1|||
161570536|NCT00878722|583473811|FG006|Overall Study|Progressive disease|4|||
161570537|NCT00878722|583473812|FG007|Overall Study|Progressive disease|3|||
161570538|NCT00878722|583473805|FG000|Overall Study|Death|0|||
161570539|NCT00878722|583473806|FG001|Overall Study|Death|0|||
161570540|NCT00878722|583473807|FG002|Overall Study|Death|0|||
161570541|NCT00878722|583473808|FG003|Overall Study|Death|1|||
161570542|NCT00878722|583473809|FG004|Overall Study|Death|0|||
161570543|NCT00878722|583473810|FG005|Overall Study|Death|1|||
161570544|NCT00878722|583473811|FG006|Overall Study|Death|0|||
161570545|NCT00878722|583473812|FG007|Overall Study|Death|2|||
161570546|NCT00878722|583473805|FG000|Overall Study|Adverse Event|0|||
161570547|NCT00878722|583473806|FG001|Overall Study|Adverse Event|0|||
161570548|NCT00878722|583473807|FG002|Overall Study|Adverse Event|0|||
161570549|NCT00878722|583473808|FG003|Overall Study|Adverse Event|0|||
161570550|NCT00878722|583473809|FG004|Overall Study|Adverse Event|0|||
161570551|NCT00878722|583473810|FG005|Overall Study|Adverse Event|0|||
161570552|NCT00878722|583473811|FG006|Overall Study|Adverse Event|2|||
161570553|NCT00878722|583473812|FG007|Overall Study|Adverse Event|0|||
161570554|NCT00878722|583473805|FG000|Overall Study|Withdrawal by Subject|0|||
161570555|NCT00878722|583473806|FG001|Overall Study|Withdrawal by Subject|0|||
161570556|NCT00878722|583473807|FG002|Overall Study|Withdrawal by Subject|0|||
161570557|NCT00878722|583473808|FG003|Overall Study|Withdrawal by Subject|0|||
161570558|NCT00878722|583473809|FG004|Overall Study|Withdrawal by Subject|0|||
161570559|NCT00878722|583473810|FG005|Overall Study|Withdrawal by Subject|0|||
161570560|NCT00878722|583473811|FG006|Overall Study|Withdrawal by Subject|0|||
161570561|NCT00878722|583473812|FG007|Overall Study|Withdrawal by Subject|2|||
161570562|NCT00878722|583473805|FG000|Overall Study|Relapse|0|||
161570563|NCT00878722|583473806|FG001|Overall Study|Relapse|0|||
161570564|NCT00878722|583473807|FG002|Overall Study|Relapse|0|||
161570565|NCT00878722|583473808|FG003|Overall Study|Relapse|1|||
161570566|NCT00878722|583473809|FG004|Overall Study|Relapse|0|||
161570567|NCT00878722|583473810|FG005|Overall Study|Relapse|0|||
161570568|NCT00878722|583473811|FG006|Overall Study|Relapse|0|||
161570569|NCT00878722|583473812|FG007|Overall Study|Relapse|0|||
161570570|NCT00383188|583473813|FG000|Overall Study|Adverse Event|4|||
161570571|NCT00383188|583473814|FG001|Overall Study|Adverse Event|7|||
161809148|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161570572|NCT00383188|583473815|FG002|Overall Study|Adverse Event|9|||
161570573|NCT00383188|583473816|FG003|Overall Study|Adverse Event|8|||
161570574|NCT00383188|583473817|FG004|Overall Study|Adverse Event|8|||
161570575|NCT00383188|583473813|FG000|Overall Study|Lack of Efficacy|9|||
161570576|NCT00383188|583473814|FG001|Overall Study|Lack of Efficacy|3|||
161570577|NCT00383188|583473815|FG002|Overall Study|Lack of Efficacy|3|||
161570578|NCT00383188|583473816|FG003|Overall Study|Lack of Efficacy|2|||
161570579|NCT00383188|583473817|FG004|Overall Study|Lack of Efficacy|6|||
161570580|NCT00383188|583473813|FG000|Overall Study|Other|3|||
161570581|NCT00383188|583473814|FG001|Overall Study|Other|1|||
161570582|NCT00383188|583473815|FG002|Overall Study|Other|0|||
161570583|NCT00383188|583473816|FG003|Overall Study|Other|2|||
161570584|NCT00383188|583473817|FG004|Overall Study|Other|6|||
161457723|NCT02292784|583071522|FG000|Overall Study|Withdrawal by Subject|0|||
161457724|NCT02292784|583071523|FG001|Overall Study|Withdrawal by Subject|3|||
161457725|NCT02292784|583071524|FG002|Overall Study|Withdrawal by Subject|3|||
161457726|NCT02519855|583071525|FG000|Overall Study|Adverse Event|0|||
161457727|NCT02519855|583071526|FG001|Overall Study|Adverse Event|1|||
161457728|NCT02519855|583071525|FG000|Overall Study|Lost to Follow-up|3|||
161457729|NCT02519855|583071526|FG001|Overall Study|Lost to Follow-up|3|||
161457730|NCT02919969|583071527|FG000|Overall Study|Lack of Efficacy|22|||
161457731|NCT02919969|583071527|FG000|Overall Study|Death|4|||
161457732|NCT02919969|583071527|FG000|Overall Study|Physician Decision|3|||
161457733|NCT02919969|583071527|FG000|Overall Study|Withdrawal by Subject|2|||
161457734|NCT03621475|583071528|FG000|Overall Study|No longer required restraints at initiation|0|||
161457735|NCT03621475|583071529|FG001|Overall Study|No longer required restraints at initiation|1|||
161457736|NCT01842633|583071530|FG000|Overall Study|Screen Failure|1|||
161457737|NCT01842633|583071531|FG001|Overall Study|Screen Failure|0|||
161457738|NCT01842633|583071532|FG002|Overall Study|Screen Failure|0|||
161457739|NCT01842633|583071530|FG000|Overall Study|Adverse Event|1|||
161457740|NCT01842633|583071531|FG001|Overall Study|Adverse Event|1|||
161457741|NCT01842633|583071532|FG002|Overall Study|Adverse Event|0|||
161457742|NCT01842633|583071530|FG000|Overall Study|Withdrawal by Subject|0|||
161457743|NCT01842633|583071531|FG001|Overall Study|Withdrawal by Subject|1|||
161457744|NCT01842633|583071532|FG002|Overall Study|Withdrawal by Subject|0|||
161457745|NCT01842633|583071530|FG000|Overall Study|Technical issues|1|||
161457746|NCT01842633|583071531|FG001|Overall Study|Technical issues|0|||
161457747|NCT01842633|583071532|FG002|Overall Study|Technical issues|0|||
161457748|NCT02093351|583071536|FG000|Part A|Adverse Event|0|||
161457749|NCT02093351|583071537|FG001|Part A|Adverse Event|1|||
161457750|NCT02093351|583071538|FG002|Part A|Adverse Event|1|||
161457751|NCT02093351|583071539|FG003|Part A|Adverse Event|0|||
161457752|NCT02093351|583071536|FG000|Part A|Condition under investigation worsened|2|||
161457753|NCT02093351|583071537|FG001|Part A|Condition under investigation worsened|0|||
161457754|NCT02093351|583071538|FG002|Part A|Condition under investigation worsened|2|||
161457755|NCT02093351|583071539|FG003|Part A|Condition under investigation worsened|0|||
161457756|NCT02093351|583071536|FG000|Part A|Death|0|||
161457757|NCT02093351|583071537|FG001|Part A|Death|1|||
161457758|NCT02093351|583071538|FG002|Part A|Death|0|||
161457759|NCT02093351|583071539|FG003|Part A|Death|0|||
161457760|NCT02093351|583071536|FG000|Part B|Patient decision|0|||
161457761|NCT02093351|583071537|FG001|Part B|Patient decision|0|||
161457762|NCT02093351|583071538|FG002|Part B|Patient decision|0|||
161457763|NCT02093351|583071539|FG003|Part B|Patient decision|3|||
161457764|NCT02093351|583071536|FG000|Part B|Disease progression|0|||
161457765|NCT02093351|583071537|FG001|Part B|Disease progression|0|||
161457766|NCT02093351|583071538|FG002|Part B|Disease progression|0|||
161457767|NCT02093351|583071539|FG003|Part B|Disease progression|4|||
161457768|NCT02093351|583071536|FG000|Part B|Complete response|0|||
161457769|NCT02093351|583071537|FG001|Part B|Complete response|0|||
161457770|NCT02093351|583071538|FG002|Part B|Complete response|0|||
161457771|NCT02093351|583071539|FG003|Part B|Complete response|1|||
161457772|NCT02093351|583071536|FG000|Part B|Adverse event + disease progression|0|||
161457773|NCT02093351|583071537|FG001|Part B|Adverse event + disease progression|0|||
161457774|NCT02093351|583071538|FG002|Part B|Adverse event + disease progression|0|||
161457775|NCT02093351|583071539|FG003|Part B|Adverse event + disease progression|1|||
161457776|NCT02093351|583071536|FG000|Part B|Lack of therapeutic response|0|||
161457777|NCT02093351|583071537|FG001|Part B|Lack of therapeutic response|0|||
161457778|NCT02093351|583071538|FG002|Part B|Lack of therapeutic response|0|||
161457779|NCT02093351|583071539|FG003|Part B|Lack of therapeutic response|12|||
161457780|NCT02093351|583071536|FG000|Part B|Condition under investigation worsened|0|||
161457781|NCT02093351|583071537|FG001|Part B|Condition under investigation worsened|0|||
161457782|NCT02093351|583071538|FG002|Part B|Condition under investigation worsened|0|||
161457783|NCT02093351|583071539|FG003|Part B|Condition under investigation worsened|39|||
161457784|NCT02093351|583071536|FG000|Part B|Adverse Event|0|||
161457785|NCT02093351|583071537|FG001|Part B|Adverse Event|0|||
161457786|NCT02093351|583071538|FG002|Part B|Adverse Event|0|||
161457787|NCT02093351|583071539|FG003|Part B|Adverse Event|2|||
161457788|NCT02093351|583071536|FG000|Part B|Death|0|||
161457789|NCT02093351|583071537|FG001|Part B|Death|0|||
161457790|NCT02093351|583071538|FG002|Part B|Death|0|||
161457791|NCT02093351|583071539|FG003|Part B|Death|1|||
161457792|NCT03565367|583071540|FG000|Overall Study|No scan due to technical issues|4|||
161457793|NCT03565367|583071541|FG001|Overall Study|No scan due to technical issues|0|||
161457794|NCT01099709|583071544|FG000|Period 1|Withdrawal by Subject|0|||
161457795|NCT01099709|583071545|FG001|Period 1|Withdrawal by Subject|1|||
161457796|NCT01099709|583071544|FG000|Period 1|Positive cotinine test|0|||
161457797|NCT01099709|583071545|FG001|Period 1|Positive cotinine test|1|||
161457798|NCT01099709|583071544|FG000|Period 1|Adverse Event|1|||
161457799|NCT01099709|583071545|FG001|Period 1|Adverse Event|0|||
161457800|NCT00923364|583071547|FG000|Overall Study|Death|3|||
161457801|NCT00923364|583071548|FG001|Overall Study|Death|0|||
161457802|NCT00923364|583071547|FG000|Overall Study|Did not go to transplant|1|||
161570585|NCT00383188|583473813|FG000|Overall Study|No longer willing to participate|1|||
161570586|NCT00383188|583473814|FG001|Overall Study|No longer willing to participate|0|||
161570587|NCT00383188|583473815|FG002|Overall Study|No longer willing to participate|1|||
161570588|NCT00383188|583473816|FG003|Overall Study|No longer willing to participate|0|||
161570589|NCT00383188|583473817|FG004|Overall Study|No longer willing to participate|2|||
161570590|NCT00383188|583473813|FG000|Overall Study|Lost to Follow-up|0|||
161570591|NCT00383188|583473814|FG001|Overall Study|Lost to Follow-up|0|||
161570592|NCT00383188|583473815|FG002|Overall Study|Lost to Follow-up|0|||
161570593|NCT00383188|583473816|FG003|Overall Study|Lost to Follow-up|0|||
161570594|NCT00383188|583473817|FG004|Overall Study|Lost to Follow-up|1|||
161570595|NCT00554801|583473821|FG000|Overall Study|left area before completion|5|||
161570596|NCT00554801|583473822|FG001|Overall Study|left area before completion|0|||
161570597|NCT00554801|583473821|FG000|Overall Study|Withdrawal by Subject|14|||
161570598|NCT00554801|583473822|FG001|Overall Study|Withdrawal by Subject|0|||
161570599|NCT00604721|583473823|FG000|Overall Study|Physician Decision|1|||
161570600|NCT00604721|583473823|FG000|Overall Study|Withdrawal by Subject|1|||
161570601|NCT00038103|583473824|FG000|Overall Study|Adverse Event|5|||
161570602|NCT00038103|583473825|FG001|Overall Study|Adverse Event|6|||
161570603|NCT00038103|583473824|FG000|Overall Study|Lack of Efficacy|48|||
161570604|NCT00038103|583473825|FG001|Overall Study|Lack of Efficacy|41|||
161570605|NCT00038103|583473824|FG000|Overall Study|Withdrawal by Subject|0|||
161570606|NCT00038103|583473825|FG001|Overall Study|Withdrawal by Subject|3|||
161570607|NCT00038103|583473824|FG000|Overall Study|Lost to Follow-up|0|||
161570608|NCT00038103|583473825|FG001|Overall Study|Lost to Follow-up|3|||
161570609|NCT00038103|583473824|FG000|Overall Study|Protocol Violation|0|||
161570610|NCT00038103|583473825|FG001|Overall Study|Protocol Violation|2|||
161570611|NCT00038103|583473824|FG000|Overall Study|Sponsor Decision|0|||
161570612|NCT00038103|583473825|FG001|Overall Study|Sponsor Decision|1|||
161570613|NCT00038103|583473824|FG000|Overall Study|Randomized/never treated|2|||
161570614|NCT00038103|583473825|FG001|Overall Study|Randomized/never treated|0|||
161570615|NCT01144182|583473826|FG000|Overall Study|Death|5|||
161570616|NCT01144182|583473827|FG001|Overall Study|Death|6|||
161570617|NCT01144182|583473826|FG000|Overall Study|Withdrawal by Subject|3|||
161570618|NCT01144182|583473827|FG001|Overall Study|Withdrawal by Subject|6|||
161570619|NCT01144182|583473826|FG000|Overall Study|Lost to Follow-up|9|||
161570620|NCT01144182|583473827|FG001|Overall Study|Lost to Follow-up|9|||
161570621|NCT01751724|583473835|FG000|Overall Study|extubated bef.start assigned treatment|1|||
161570622|NCT01751724|583473836|FG001|Overall Study|extubated bef.start assigned treatment|0|||
161570623|NCT01751724|583473835|FG000|Overall Study|withdrawn by parent|0|||
161570624|NCT01751724|583473836|FG001|Overall Study|withdrawn by parent|2|||
161570625|NCT00798265|583473839|FG000|Overall Study|Lost to Follow-up|1|||
161570626|NCT00798265|583473840|FG001|Overall Study|Lost to Follow-up|10|||
161570627|NCT00798265|583473839|FG000|Overall Study|Study closing|7|||
161570628|NCT00798265|583473840|FG001|Overall Study|Study closing|6|||
161570629|NCT00798265|583473839|FG000|Overall Study|Withdrawal by Subject|0|||
161570630|NCT00798265|583473840|FG001|Overall Study|Withdrawal by Subject|1|||
161570631|NCT00798265|583473839|FG000|Overall Study|Screen failure|0|||
161570632|NCT00798265|583473840|FG001|Overall Study|Screen failure|1|||
161570633|NCT00589667|583475215|FG000|Overall Study|Adverse Event|2|||
161570634|NCT00589667|583475215|FG000|Overall Study|Withdrawal by Subject|1|||
161570635|NCT03538041|583475218|FG000|12-Week Treatment Period|Adverse Event|1|||
161570636|NCT03538041|583475219|FG001|12-Week Treatment Period|Adverse Event|1|||
161570637|NCT03538041|583475218|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
161570638|NCT03538041|583475219|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
161570639|NCT03538041|583475218|FG000|Treatment Extension Period|Adverse Event|4|||
161570640|NCT03538041|583475219|FG001|Treatment Extension Period|Adverse Event|1|||
161570641|NCT03538041|583475218|FG000|Treatment Extension Period|Physician Decision|1|||
161570642|NCT03538041|583475219|FG001|Treatment Extension Period|Physician Decision|1|||
161570643|NCT03538041|583475218|FG000|Treatment Extension Period|Lack of Efficacy|1|||
161570644|NCT03538041|583475219|FG001|Treatment Extension Period|Lack of Efficacy|4|||
161570645|NCT03538041|583475218|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
161570646|NCT03538041|583475219|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
161570647|NCT03538041|583475218|FG000|Treatment Extension Period|Death|0|||
161570648|NCT03538041|583475219|FG001|Treatment Extension Period|Death|1|||
161570649|NCT00964366|583475236|FG000|Overall Study|Did not qualify at Day 1|1|||
161570650|NCT00964366|583475237|FG001|Overall Study|Did not qualify at Day 1|0|||
161570651|NCT00964366|583475236|FG000|Overall Study|Withdrawal by Subject|0|||
161570652|NCT00964366|583475237|FG001|Overall Study|Withdrawal by Subject|1|||
161570653|NCT02046616|583475239|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
161570654|NCT02046616|583475239|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
161570655|NCT02046616|583475239|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
161570656|NCT02046616|583475239|FG000|24-Week Treatment Period|Physician Decision|3|||
161570657|NCT02046616|583475239|FG000|24-Week Treatment Period|Other|1|||
161570658|NCT02046616|583475239|FG000|8-Week FU Period|Lost to Follow-up|1|||
161570659|NCT02957539|583475242|FG000|Baseline to Week 16|Lost to Follow-up|8|||
161570660|NCT02957539|583475243|FG001|Baseline to Week 16|Lost to Follow-up|10|||
161570661|NCT02957539|583475244|FG002|Baseline to Week 16|Lost to Follow-up|16|||
161570662|NCT02957539|583475242|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
161570663|NCT02957539|583475243|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
161570664|NCT02957539|583475244|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
161570665|NCT02957539|583475242|FG000|Week 16 to 32|Withdrawal by Subject|3|||
161570666|NCT02957539|583475243|FG001|Week 16 to 32|Withdrawal by Subject|3|||
161570667|NCT02957539|583475244|FG002|Week 16 to 32|Withdrawal by Subject|1|||
161570668|NCT02957539|583475242|FG000|Week 16 to 32|Lost to Follow-up|8|||
161570669|NCT02957539|583475243|FG001|Week 16 to 32|Lost to Follow-up|7|||
161570670|NCT02957539|583475244|FG002|Week 16 to 32|Lost to Follow-up|5|||
161570671|NCT02957539|583475242|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
161570672|NCT02957539|583475243|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
161570673|NCT02957539|583475244|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
161570674|NCT02957539|583475242|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
161570675|NCT02957539|583475243|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
161570676|NCT02957539|583475244|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
161570677|NCT03058991|583475254|FG000|Overall Study|Lost to Follow-up|17|||
161570678|NCT03058991|583475255|FG001|Overall Study|Lost to Follow-up|12|||
161570679|NCT03058991|583475256|FG002|Overall Study|Lost to Follow-up|12|||
161570680|NCT03058991|583475254|FG000|Overall Study|Withdrawal by Subject|1|||
161570681|NCT03058991|583475255|FG001|Overall Study|Withdrawal by Subject|0|||
161570682|NCT03058991|583475256|FG002|Overall Study|Withdrawal by Subject|0|||
161570683|NCT01689519|583475259|FG000|Intent to Treat|Death|157|||
161570684|NCT01689519|583475260|FG001|Intent to Treat|Death|167|||
161570685|NCT01689519|583475259|FG000|Intent to Treat|Lost to Follow-up|4|||
161570686|NCT01689519|583475260|FG001|Intent to Treat|Lost to Follow-up|8|||
161570687|NCT01689519|583475259|FG000|Intent to Treat|Other|2|||
161570688|NCT01689519|583475260|FG001|Intent to Treat|Other|4|||
161570689|NCT01689519|583475259|FG000|Intent to Treat|Physician Decision|4|||
161570690|NCT01689519|583475260|FG001|Intent to Treat|Physician Decision|1|||
161570691|NCT01689519|583475259|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
161570692|NCT01689519|583475260|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
161570693|NCT01689519|583475259|FG000|Intent to Treat|Withdrawal by Subject|21|||
161570694|NCT01689519|583475260|FG001|Intent to Treat|Withdrawal by Subject|20|||
161570695|NCT01689519|583475259|FG000|Safety Population|Death|158|||
161570696|NCT01689519|583475260|FG001|Safety Population|Death|165|||
161570697|NCT01689519|583475259|FG000|Safety Population|Lost to Follow-up|4|||
161570698|NCT01689519|583475260|FG001|Safety Population|Lost to Follow-up|8|||
161570699|NCT01689519|583475259|FG000|Safety Population|Other|2|||
161570700|NCT01689519|583475260|FG001|Safety Population|Other|4|||
161570701|NCT01689519|583475259|FG000|Safety Population|Physician Decision|4|||
161570702|NCT01689519|583475260|FG001|Safety Population|Physician Decision|1|||
161570703|NCT01689519|583475259|FG000|Safety Population|Study Terminated By Sponsor|60|||
161570704|NCT01689519|583475260|FG001|Safety Population|Study Terminated By Sponsor|47|||
161570705|NCT01689519|583475259|FG000|Safety Population|Withdrawal by Subject|20|||
161570706|NCT01689519|583475260|FG001|Safety Population|Withdrawal by Subject|20|||
161570707|NCT03525119|583475261|FG000|Overall Study|Adverse Event|0|||
161570708|NCT03525119|583475262|FG001|Overall Study|Adverse Event|1|||
161570709|NCT03525119|583475263|FG002|Overall Study|Adverse Event|0|||
161570710|NCT03525119|583475261|FG000|Overall Study|Lost to Follow-up|32|||
161570711|NCT03525119|583475262|FG001|Overall Study|Lost to Follow-up|33|||
161570712|NCT03525119|583475263|FG002|Overall Study|Lost to Follow-up|37|||
161570713|NCT03525119|583475261|FG000|Overall Study|Withdrawal by Subject|5|||
161570714|NCT03525119|583475262|FG001|Overall Study|Withdrawal by Subject|4|||
161570715|NCT03525119|583475263|FG002|Overall Study|Withdrawal by Subject|2|||
161570716|NCT03525119|583475261|FG000|Overall Study|Reason not Specified|2|||
161570717|NCT03525119|583475262|FG001|Overall Study|Reason not Specified|1|||
161570718|NCT03525119|583475263|FG002|Overall Study|Reason not Specified|2|||
161570719|NCT03525119|583475261|FG000|Overall Study|Randomized but not Vaccinated|1|||
161570720|NCT03525119|583475262|FG001|Overall Study|Randomized but not Vaccinated|0|||
161570721|NCT03525119|583475263|FG002|Overall Study|Randomized but not Vaccinated|2|||
161570722|NCT03781336|583475264|FG000|Overall Study|Withdrawal by Subject|2|||
161570723|NCT03781336|583475265|FG001|Overall Study|Withdrawal by Subject|2|||
161570724|NCT01959412|583475266|FG000|Overall Study|Protocol deviation|1|||
161570725|NCT01959412|583475267|FG001|Overall Study|Protocol deviation|1|||
161570726|NCT01959412|583475268|FG002|Overall Study|Protocol deviation|0|||
161570727|NCT01959412|583475269|FG003|Overall Study|Protocol deviation|1|||
161570728|NCT01959412|583475270|FG004|Overall Study|Protocol deviation|3|||
161570729|NCT01959412|583475271|FG005|Overall Study|Protocol deviation|0|||
161570730|NCT01959412|583475266|FG000|Overall Study|Adverse Event|0|||
161570731|NCT01959412|583475267|FG001|Overall Study|Adverse Event|0|||
161570732|NCT01959412|583475268|FG002|Overall Study|Adverse Event|0|||
161809149|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809150|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809151|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809152|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161913201|NCT00111761|584731914|FG000|Part 1|Death|0|||
161570733|NCT01959412|583475269|FG003|Overall Study|Adverse Event|1|||
161570734|NCT01959412|583475270|FG004|Overall Study|Adverse Event|0|||
161570735|NCT01959412|583475271|FG005|Overall Study|Adverse Event|0|||
161570736|NCT00158054|583475273|FG000|Overall Study|Refused to continue|3|||
161570737|NCT00158054|583475274|FG001|Overall Study|Refused to continue|0|||
161570738|NCT00158054|583475273|FG000|Overall Study|Unavailable for follow up|7|||
161570739|NCT00158054|583475274|FG001|Overall Study|Unavailable for follow up|3|||
161570740|NCT00509769|583475275|FG000|Overall Study|Progressive disease|77|||
161570741|NCT00509769|583475275|FG000|Overall Study|Adverse Event|4|||
161570742|NCT00509769|583475275|FG000|Overall Study|Patient's decision|1|||
161570743|NCT00509769|583475275|FG000|Overall Study|Physician Decision|8|||
161570744|NCT00509769|583475275|FG000|Overall Study|Use of prohibited therapies during study|1|||
161570745|NCT00414648|583475276|FG000|Overall Study|Adverse Event|5|||
161570746|NCT00414648|583475277|FG001|Overall Study|Adverse Event|5|||
161570747|NCT00414648|583475276|FG000|Overall Study|Death|0|||
161570748|NCT00414648|583475277|FG001|Overall Study|Death|1|||
161570749|NCT00414648|583475276|FG000|Overall Study|Lack of Efficacy|0|||
161570750|NCT00414648|583475277|FG001|Overall Study|Lack of Efficacy|2|||
161570751|NCT00414648|583475276|FG000|Overall Study|Withdrawal by Subject|0|||
161570752|NCT00414648|583475277|FG001|Overall Study|Withdrawal by Subject|1|||
161570753|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
161570754|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
161570755|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
161570756|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
161570757|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
161570758|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
161570759|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
161570760|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
161570761|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
161570762|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
161570763|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
161570764|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
161570765|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Death|7|||
161570766|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Death|4|||
161570767|NCT00410124|583475278|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
161570768|NCT00410124|583475279|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
161570769|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
161570770|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
161570771|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
161570772|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
161570773|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
161570774|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
161570775|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
161570776|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
161570777|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
161570778|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
161570779|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
161570780|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
161570781|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
161570782|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
161570783|NCT00410124|583475278|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
161570784|NCT00410124|583475279|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
161570785|NCT00319436|583475280|FG000|Overall Study|Withdrawal by Subject|6|||
161570786|NCT00319436|583475281|FG001|Overall Study|Withdrawal by Subject|7|||
161570787|NCT01839877|583475284|FG000|Overall Study|Protocol Violation|1|||
161570788|NCT02781584|583475291|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
161570789|NCT02781584|583475292|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
161570790|NCT02781584|583475293|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
161570791|NCT02781584|583475294|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
161570792|NCT02781584|583475295|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
161570793|NCT02781584|583475296|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
161570794|NCT02781584|583475297|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
161570795|NCT02781584|583475298|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
161570796|NCT02781584|583475299|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
161570797|NCT02781584|583475300|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
161570798|NCT02781584|583475301|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
161570799|NCT02781584|583475302|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
161570800|NCT02781584|583475303|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
161570801|NCT02781584|583475291|FG000|Pre-treatment Phase|Adverse Event|0|||
161570802|NCT02781584|583475292|FG001|Pre-treatment Phase|Adverse Event|0|||
161570803|NCT02781584|583475293|FG002|Pre-treatment Phase|Adverse Event|0|||
161570804|NCT02781584|583475294|FG003|Pre-treatment Phase|Adverse Event|0|||
161570805|NCT02781584|583475295|FG004|Pre-treatment Phase|Adverse Event|0|||
161570806|NCT02781584|583475296|FG005|Pre-treatment Phase|Adverse Event|0|||
161570807|NCT02781584|583475297|FG006|Pre-treatment Phase|Adverse Event|0|||
161570808|NCT02781584|583475298|FG007|Pre-treatment Phase|Adverse Event|0|||
161570809|NCT02781584|583475299|FG008|Pre-treatment Phase|Adverse Event|0|||
161570810|NCT02781584|583475300|FG009|Pre-treatment Phase|Adverse Event|0|||
161570811|NCT02781584|583475301|FG010|Pre-treatment Phase|Adverse Event|0|||
161570812|NCT02781584|583475302|FG011|Pre-treatment Phase|Adverse Event|1|||
161570813|NCT02781584|583475303|FG012|Pre-treatment Phase|Adverse Event|0|||
161570814|NCT02781584|583475291|FG000|Treatment Phase|Withdrew Consent|0|||
161570815|NCT02781584|583475292|FG001|Treatment Phase|Withdrew Consent|0|||
161570816|NCT02781584|583475293|FG002|Treatment Phase|Withdrew Consent|0|||
161570817|NCT02781584|583475294|FG003|Treatment Phase|Withdrew Consent|0|||
161570818|NCT02781584|583475295|FG004|Treatment Phase|Withdrew Consent|0|||
161570819|NCT02781584|583475296|FG005|Treatment Phase|Withdrew Consent|1|||
161570820|NCT02781584|583475297|FG006|Treatment Phase|Withdrew Consent|0|||
161570821|NCT02781584|583475298|FG007|Treatment Phase|Withdrew Consent|0|||
161570822|NCT02781584|583475299|FG008|Treatment Phase|Withdrew Consent|0|||
161570823|NCT02781584|583475300|FG009|Treatment Phase|Withdrew Consent|0|||
161570824|NCT02781584|583475301|FG010|Treatment Phase|Withdrew Consent|1|||
161570825|NCT02781584|583475302|FG011|Treatment Phase|Withdrew Consent|2|||
161570826|NCT02781584|583475303|FG012|Treatment Phase|Withdrew Consent|0|||
161570827|NCT02781584|583475291|FG000|Treatment Phase|Adverse Event|0|||
161570828|NCT02781584|583475292|FG001|Treatment Phase|Adverse Event|0|||
161570829|NCT02781584|583475293|FG002|Treatment Phase|Adverse Event|0|||
161570830|NCT02781584|583475294|FG003|Treatment Phase|Adverse Event|0|||
161570831|NCT02781584|583475295|FG004|Treatment Phase|Adverse Event|0|||
161570832|NCT02781584|583475296|FG005|Treatment Phase|Adverse Event|0|||
161570833|NCT02781584|583475297|FG006|Treatment Phase|Adverse Event|0|||
161570834|NCT02781584|583475298|FG007|Treatment Phase|Adverse Event|1|||
161570835|NCT02781584|583475299|FG008|Treatment Phase|Adverse Event|0|||
161570836|NCT02781584|583475300|FG009|Treatment Phase|Adverse Event|0|||
161570837|NCT02781584|583475301|FG010|Treatment Phase|Adverse Event|0|||
161570838|NCT02781584|583475302|FG011|Treatment Phase|Adverse Event|0|||
161570839|NCT02781584|583475303|FG012|Treatment Phase|Adverse Event|0|||
161570840|NCT02104765|583475310|FG000|Overall Study|Lost to Follow-up|0|||
161570841|NCT02104765|583475311|FG001|Overall Study|Lost to Follow-up|0|||
161570842|NCT02104765|583475312|FG002|Overall Study|Lost to Follow-up|1|||
161570843|NCT02104765|583475313|FG003|Overall Study|Lost to Follow-up|0|||
161570844|NCT02104765|583475314|FG004|Overall Study|Lost to Follow-up|0|||
161570845|NCT02104765|583475315|FG005|Overall Study|Lost to Follow-up|0|||
161570846|NCT02104765|583475316|FG006|Overall Study|Lost to Follow-up|0|||
161570847|NCT02104765|583475310|FG000|Overall Study|Withdrawal by Subject|0|||
161570848|NCT02104765|583475311|FG001|Overall Study|Withdrawal by Subject|0|||
161570849|NCT02104765|583475312|FG002|Overall Study|Withdrawal by Subject|0|||
161570850|NCT02104765|583475313|FG003|Overall Study|Withdrawal by Subject|1|||
161570851|NCT02104765|583475314|FG004|Overall Study|Withdrawal by Subject|1|||
161570852|NCT02104765|583475315|FG005|Overall Study|Withdrawal by Subject|0|||
161570853|NCT02104765|583475316|FG006|Overall Study|Withdrawal by Subject|1|||
161570854|NCT04771273|583475317|FG000|Dose Escalation Period|Not treated with trial medication|0|||
161570855|NCT04771273|583475318|FG001|Dose Escalation Period|Not treated with trial medication|1|||
161570856|NCT04771273|583475319|FG002|Dose Escalation Period|Not treated with trial medication|1|||
161570857|NCT04771273|583475320|FG003|Dose Escalation Period|Not treated with trial medication|0|||
161570858|NCT04771273|583475317|FG000|Dose Escalation Period|Other reasons than listed|2|||
161570859|NCT04771273|583475318|FG001|Dose Escalation Period|Other reasons than listed|0|||
161570860|NCT04771273|583475319|FG002|Dose Escalation Period|Other reasons than listed|2|||
161570861|NCT04771273|583475320|FG003|Dose Escalation Period|Other reasons than listed|1|||
161570862|NCT04771273|583475317|FG000|Dose Escalation Period|Protocol Violation|0|||
161570863|NCT04771273|583475318|FG001|Dose Escalation Period|Protocol Violation|0|||
161570864|NCT04771273|583475319|FG002|Dose Escalation Period|Protocol Violation|3|||
161570865|NCT04771273|583475320|FG003|Dose Escalation Period|Protocol Violation|1|||
161570866|NCT04771273|583475317|FG000|Dose Escalation Period|Burden of study procedures|1|||
161570867|NCT04771273|583475318|FG001|Dose Escalation Period|Burden of study procedures|0|||
161570868|NCT04771273|583475319|FG002|Dose Escalation Period|Burden of study procedures|0|||
161570869|NCT04771273|583475320|FG003|Dose Escalation Period|Burden of study procedures|0|||
161570870|NCT04771273|583475317|FG000|Dose Escalation Period|Change of residence|0|||
161570871|NCT04771273|583475318|FG001|Dose Escalation Period|Change of residence|0|||
161570872|NCT04771273|583475319|FG002|Dose Escalation Period|Change of residence|0|||
161570873|NCT04771273|583475320|FG003|Dose Escalation Period|Change of residence|1|||
161570874|NCT04771273|583475317|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
161570875|NCT04771273|583475318|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
161570876|NCT04771273|583475319|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
161570877|NCT04771273|583475320|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
161570878|NCT04771273|583475317|FG000|Dose Escalation Period|Adverse Event|8|||
161913202|NCT00111761|584731915|FG001|Part 1|Death|2|||
161913203|NCT00111761|584731914|FG000|Part 1|Other|0|||
161913204|NCT00111761|584731915|FG001|Part 1|Other|1|||
161913205|NCT00111761|584731914|FG000|Part 1|Withdrawal by Subject|0|||
161913206|NCT00111761|584731915|FG001|Part 1|Withdrawal by Subject|1|||
161913207|NCT00111761|584731914|FG000|Part 2|Adverse Event|1|||
161913208|NCT00111761|584731915|FG001|Part 2|Adverse Event|0|||
161913209|NCT00111761|584731914|FG000|Part 2|Physician Decision|1|||
161913210|NCT00111761|584731915|FG001|Part 2|Physician Decision|0|||
161913211|NCT00111761|584731914|FG000|Part 2|Death|1|||
161913212|NCT00111761|584731915|FG001|Part 2|Death|0|||
161913213|NCT00111761|584731914|FG000|Part 2|Disease progression|3|||
161913214|NCT00111761|584731915|FG001|Part 2|Disease progression|0|||
161913215|NCT00111761|584731914|FG000|Part 2|Protocol-specified criteria|1|||
161913216|NCT00111761|584731915|FG001|Part 2|Protocol-specified criteria|0|||
161913217|NCT00111761|584731914|FG000|Part 2|Other|1|||
161913218|NCT00111761|584731915|FG001|Part 2|Other|0|||
161913219|NCT00726609|584731918|FG000|Overall Study|Adverse Event|10|||
161913220|NCT00726609|584731918|FG000|Overall Study|Withdrawal by Subject|2|||
161913221|NCT00726609|584731918|FG000|Overall Study|Lack of Efficacy|25|||
161913222|NCT00726609|584731918|FG000|Overall Study|Other|16|||
161913223|NCT00726609|584731918|FG000|Overall Study|Missing|42|||
161913224|NCT00726609|584731918|FG000|Overall Study|Other|3|||
161913225|NCT02029417|584731921|FG000|Overall Study|Death|1|||
161913226|NCT02029417|584731921|FG000|Overall Study|Adverse Event|1|||
161913227|NCT00071981|584731922|FG000|Overall Study|Lack of Efficacy|37|||
161913228|NCT00071981|584731923|FG001|Overall Study|Lack of Efficacy|29|||
161913229|NCT00071981|584731924|FG002|Overall Study|Lack of Efficacy|30|||
161913230|NCT00071981|584731925|FG003|Overall Study|Lack of Efficacy|43|||
161913231|NCT00071981|584731922|FG000|Overall Study|Adverse Event|4|||
161913232|NCT00071981|584731923|FG001|Overall Study|Adverse Event|4|||
161913233|NCT00071981|584731924|FG002|Overall Study|Adverse Event|3|||
161913234|NCT00071981|584731925|FG003|Overall Study|Adverse Event|1|||
161913235|NCT00071981|584731922|FG000|Overall Study|Death|0|||
161913236|NCT00071981|584731923|FG001|Overall Study|Death|0|||
161913237|NCT00071981|584731924|FG002|Overall Study|Death|1|||
161913238|NCT00071981|584731925|FG003|Overall Study|Death|1|||
161913239|NCT00071981|584731922|FG000|Overall Study|Withdrawal by Subject|3|||
161913240|NCT00071981|584731923|FG001|Overall Study|Withdrawal by Subject|1|||
161913241|NCT00071981|584731924|FG002|Overall Study|Withdrawal by Subject|0|||
161913242|NCT00071981|584731925|FG003|Overall Study|Withdrawal by Subject|0|||
161913243|NCT00071981|584731922|FG000|Overall Study|No protocol therapy|2|||
161913244|NCT00071981|584731923|FG001|Overall Study|No protocol therapy|5|||
161913245|NCT00071981|584731924|FG002|Overall Study|No protocol therapy|1|||
161913246|NCT00071981|584731925|FG003|Overall Study|No protocol therapy|0|||
161913247|NCT00071981|584731922|FG000|Overall Study|others (not specified in the study)|0|||
161570879|NCT04771273|583475318|FG001|Dose Escalation Period|Adverse Event|9|||
161570880|NCT04771273|583475319|FG002|Dose Escalation Period|Adverse Event|12|||
161570881|NCT04771273|583475320|FG003|Dose Escalation Period|Adverse Event|2|||
161913248|NCT00071981|584731923|FG001|Overall Study|others (not specified in the study)|2|||
161913249|NCT00071981|584731924|FG002|Overall Study|others (not specified in the study)|2|||
161913250|NCT00071981|584731925|FG003|Overall Study|others (not specified in the study)|0|||
161913251|NCT04458922|584731926|FG000|Overall Study|Withdrawal by Subject|1|||
161913252|NCT04458922|584731927|FG001|Overall Study|Withdrawal by Subject|0|||
161913253|NCT04458922|584731928|FG002|Overall Study|Withdrawal by Subject|2|||
161913254|NCT04458922|584731926|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
161913255|NCT04458922|584731927|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
161913256|NCT04458922|584731928|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
161913257|NCT04458922|584731926|FG000|Overall Study|Adverse Event|1|||
161913258|NCT04458922|584731927|FG001|Overall Study|Adverse Event|0|||
161913259|NCT04458922|584731928|FG002|Overall Study|Adverse Event|0|||
161913260|NCT04458922|584731926|FG000|Overall Study|Started new study|0|||
161913261|NCT04458922|584731927|FG001|Overall Study|Started new study|0|||
161570882|NCT04771273|583475317|FG000|Maintenance Period|Other than listed|4|||
161570883|NCT04771273|583475318|FG001|Maintenance Period|Other than listed|2|||
161913262|NCT04458922|584731928|FG002|Overall Study|Started new study|1|||
161913263|NCT04458922|584731926|FG000|Overall Study|Progressive disease|6|||
161570884|NCT04771273|583475319|FG002|Maintenance Period|Other than listed|0|||
161570885|NCT04771273|583475320|FG003|Maintenance Period|Other than listed|3|||
161570886|NCT04771273|583475317|FG000|Maintenance Period|Burden of study procedures|1|||
161913264|NCT04458922|584731927|FG001|Overall Study|Progressive disease|8|||
161913265|NCT04458922|584731928|FG002|Overall Study|Progressive disease|2|||
161913266|NCT04458922|584731926|FG000|Overall Study|Death|1|||
161913267|NCT04458922|584731927|FG001|Overall Study|Death|0|||
161913268|NCT04458922|584731928|FG002|Overall Study|Death|2|||
161913269|NCT04458922|584731926|FG000|Overall Study|Participant started chemotherapy|0|||
161913270|NCT04458922|584731927|FG001|Overall Study|Participant started chemotherapy|1|||
161913271|NCT04458922|584731928|FG002|Overall Study|Participant started chemotherapy|0|||
161913272|NCT00465179|584731931|FG000|Overall Study|Adverse Event|4|||
161913273|NCT00465179|584731931|FG000|Overall Study|Withdrawal by Subject|2|||
161913274|NCT00465179|584731931|FG000|Overall Study|Progression of Disease|47|||
161913275|NCT00833755|584731934|FG000|Overall Study|Physician Decision|4|||
161913276|NCT00833755|584731935|FG001|Overall Study|Physician Decision|4|||
161913277|NCT00833755|584731936|FG002|Overall Study|Physician Decision|2|||
161913278|NCT00833755|584731937|FG003|Overall Study|Physician Decision|6|||
161913279|NCT00833755|584731934|FG000|Overall Study|Subject had scheduling issues|0|||
161913280|NCT00833755|584731935|FG001|Overall Study|Subject had scheduling issues|1|||
161913281|NCT00833755|584731936|FG002|Overall Study|Subject had scheduling issues|0|||
161913282|NCT00833755|584731937|FG003|Overall Study|Subject had scheduling issues|0|||
161570887|NCT04771273|583475318|FG001|Maintenance Period|Burden of study procedures|0|||
161570888|NCT04771273|583475319|FG002|Maintenance Period|Burden of study procedures|0|||
161913283|NCT04108468|584731938|FG000|Overall Study|Physician Decision|0|||
161913284|NCT04108468|584731939|FG001|Overall Study|Physician Decision|1|||
161913285|NCT04108468|584731938|FG000|Overall Study|Lost to Follow-up|0|||
161913286|NCT04108468|584731939|FG001|Overall Study|Lost to Follow-up|1|||
161913287|NCT04108468|584731938|FG000|Overall Study|Non-compliance|1|||
161913288|NCT04108468|584731939|FG001|Overall Study|Non-compliance|1|||
161913289|NCT04108468|584731938|FG000|Overall Study|Unable to attend final visit|2|||
161913290|NCT04108468|584731939|FG001|Overall Study|Unable to attend final visit|0|||
161913291|NCT04108468|584731938|FG000|Overall Study|Missed study medication|0|||
161913292|NCT04108468|584731939|FG001|Overall Study|Missed study medication|1|||
161913293|NCT06121609|584731941|FG000|Overall Study|Lack of Efficacy|0|||
161913294|NCT06121609|584731942|FG001|Overall Study|Lack of Efficacy|0|||
161913295|NCT06121609|584731943|FG002|Overall Study|Lack of Efficacy|45|||
161913296|NCT02867592|584731945|FG000|Overall Study|Adverse Event|3|||
161913297|NCT02867592|584731946|FG001|Overall Study|Adverse Event|0|||
161913298|NCT02867592|584731947|FG002|Overall Study|Adverse Event|2|||
161570889|NCT04771273|583475320|FG003|Maintenance Period|Burden of study procedures|0|||
161570890|NCT04771273|583475317|FG000|Maintenance Period|Change of residence|0|||
161570891|NCT04771273|583475318|FG001|Maintenance Period|Change of residence|1|||
161570892|NCT04771273|583475319|FG002|Maintenance Period|Change of residence|3|||
161570893|NCT04771273|583475320|FG003|Maintenance Period|Change of residence|0|||
161570894|NCT04771273|583475317|FG000|Maintenance Period|Perceived lack of efficacy|0|||
161570895|NCT04771273|583475318|FG001|Maintenance Period|Perceived lack of efficacy|0|||
161570896|NCT04771273|583475319|FG002|Maintenance Period|Perceived lack of efficacy|0|||
161570897|NCT04771273|583475320|FG003|Maintenance Period|Perceived lack of efficacy|1|||
161809153|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161913299|NCT02867592|584731948|FG003|Overall Study|Adverse Event|1|||
161570898|NCT04771273|583475317|FG000|Maintenance Period|Adverse Event|4|||
161570899|NCT04771273|583475318|FG001|Maintenance Period|Adverse Event|5|||
161809154|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809155|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809156|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809157|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809158|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809159|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809160|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809161|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809162|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
161809163|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
161809164|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809165|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809166|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809167|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809168|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809169|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809170|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809171|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809172|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809173|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809174|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809175|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809176|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161570900|NCT04771273|583475319|FG002|Maintenance Period|Adverse Event|5|||
161570901|NCT04771273|583475320|FG003|Maintenance Period|Adverse Event|0|||
161570902|NCT05196737|583475321|FG000|Non-intervention Week|Lost to Follow-up|2|||
161809177|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809178|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161913300|NCT02867592|584731949|FG004|Overall Study|Adverse Event|1|||
161913301|NCT02867592|584731950|FG005|Overall Study|Adverse Event|5|||
161913302|NCT02867592|584731945|FG000|Overall Study|Death|0|||
161809179|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809180|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809181|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809182|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809183|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
161809184|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
161809185|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809186|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809187|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809188|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809189|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809190|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809191|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809192|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809193|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809194|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809195|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809196|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809197|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809198|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809199|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809200|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809201|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809202|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809203|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
161809204|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
161809205|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
161809206|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809207|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809208|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809209|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809210|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809211|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809212|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809213|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809214|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809215|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809216|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809217|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809218|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809219|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809220|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809221|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809222|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809223|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809224|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809225|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
161809226|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
161809227|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809228|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809229|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809230|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809231|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809232|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809233|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809234|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809235|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809236|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809237|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809238|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809239|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809240|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809241|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161913303|NCT02867592|584731946|FG001|Overall Study|Death|0|||
161913304|NCT02867592|584731947|FG002|Overall Study|Death|0|||
161457803|NCT00923364|583071548|FG001|Overall Study|Did not go to transplant|0|||
161457804|NCT01397825|583071552|FG000|Overall Study|Progressive Disease|10|||
161457805|NCT01397825|583071553|FG001|Overall Study|Progressive Disease|3|||
161457806|NCT01397825|583071554|FG002|Overall Study|Progressive Disease|11|||
161457807|NCT01397825|583071555|FG003|Overall Study|Progressive Disease|1|||
161457808|NCT01397825|583071556|FG004|Overall Study|Progressive Disease|0|||
161457809|NCT01397825|583071552|FG000|Overall Study|Symptomatic Deterioration|2|||
161457810|NCT01397825|583071553|FG001|Overall Study|Symptomatic Deterioration|0|||
161457811|NCT01397825|583071554|FG002|Overall Study|Symptomatic Deterioration|4|||
161457812|NCT01397825|583071555|FG003|Overall Study|Symptomatic Deterioration|0|||
161457813|NCT01397825|583071556|FG004|Overall Study|Symptomatic Deterioration|0|||
161457814|NCT01397825|583071552|FG000|Overall Study|Adverse Event|0|||
161457815|NCT01397825|583071553|FG001|Overall Study|Adverse Event|1|||
161457816|NCT01397825|583071554|FG002|Overall Study|Adverse Event|5|||
161457817|NCT01397825|583071555|FG003|Overall Study|Adverse Event|1|||
161570903|NCT05196737|583475321|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
161570904|NCT00462943|583475322|FG000|Overall Study|Failure to achieve a response|5|||
161570905|NCT00462943|583475323|FG001|Overall Study|Failure to achieve a response|5|||
161570906|NCT00462943|583475324|FG002|Overall Study|Failure to achieve a response|1|||
161570907|NCT00462943|583475322|FG000|Overall Study|Adverse Event|6|||
161570908|NCT00462943|583475323|FG001|Overall Study|Adverse Event|4|||
161570909|NCT00462943|583475324|FG002|Overall Study|Adverse Event|1|||
161570910|NCT00462943|583475322|FG000|Overall Study|Protocol Violation|1|||
161570911|NCT00462943|583475323|FG001|Overall Study|Protocol Violation|0|||
161570912|NCT00462943|583475324|FG002|Overall Study|Protocol Violation|0|||
161570913|NCT00462943|583475322|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
161570914|NCT00462943|583475323|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
161570915|NCT00462943|583475324|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
161570916|NCT00462943|583475322|FG000|Overall Study|Disease Progression|15|||
161570917|NCT00462943|583475323|FG001|Overall Study|Disease Progression|15|||
161570918|NCT00462943|583475324|FG002|Overall Study|Disease Progression|9|||
161570919|NCT00462943|583475322|FG000|Overall Study|Death|5|||
161570920|NCT00462943|583475323|FG001|Overall Study|Death|2|||
161570921|NCT00462943|583475324|FG002|Overall Study|Death|7|||
161570922|NCT00462943|583475322|FG000|Overall Study|Stem Cell Transplant|1|||
161570923|NCT00462943|583475323|FG001|Overall Study|Stem Cell Transplant|1|||
161570924|NCT00462943|583475324|FG002|Overall Study|Stem Cell Transplant|0|||
161570925|NCT00462943|583475322|FG000|Overall Study|Bone Marrow Transplant|1|||
161570926|NCT00462943|583475323|FG001|Overall Study|Bone Marrow Transplant|0|||
161570927|NCT00462943|583475324|FG002|Overall Study|Bone Marrow Transplant|0|||
161570928|NCT00462943|583475322|FG000|Overall Study|Required Lymphocyte Infusion|1|||
161570929|NCT00462943|583475323|FG001|Overall Study|Required Lymphocyte Infusion|0|||
161570930|NCT00462943|583475324|FG002|Overall Study|Required Lymphocyte Infusion|0|||
161570931|NCT00462943|583475322|FG000|Overall Study|Transplant - not specified|1|||
161570932|NCT00462943|583475323|FG001|Overall Study|Transplant - not specified|0|||
161570933|NCT00462943|583475324|FG002|Overall Study|Transplant - not specified|1|||
161570934|NCT00462943|583475322|FG000|Overall Study|Physician Decision|1|||
161570935|NCT00462943|583475323|FG001|Overall Study|Physician Decision|0|||
161570936|NCT00462943|583475324|FG002|Overall Study|Physician Decision|0|||
161570937|NCT00462943|583475322|FG000|Overall Study|Withdrawal by Subject|0|||
161570938|NCT00462943|583475323|FG001|Overall Study|Withdrawal by Subject|1|||
161570939|NCT00462943|583475324|FG002|Overall Study|Withdrawal by Subject|0|||
161570940|NCT00995709|583475325|FG000|Overall Study|Adverse Event|4|||
161570941|NCT00995709|583475326|FG001|Overall Study|Adverse Event|2|||
161570942|NCT00995709|583475327|FG002|Overall Study|Adverse Event|0|||
161570943|NCT00995709|583475325|FG000|Overall Study|Lack of Efficacy|0|||
161570944|NCT00995709|583475326|FG001|Overall Study|Lack of Efficacy|1|||
161570945|NCT00995709|583475327|FG002|Overall Study|Lack of Efficacy|4|||
161570946|NCT00995709|583475325|FG000|Overall Study|Withdrawal by Subject|0|||
161570947|NCT00995709|583475326|FG001|Overall Study|Withdrawal by Subject|4|||
161570948|NCT00995709|583475327|FG002|Overall Study|Withdrawal by Subject|1|||
161570949|NCT00995709|583475325|FG000|Overall Study|Lost to Follow-up|1|||
161570950|NCT00995709|583475326|FG001|Overall Study|Lost to Follow-up|0|||
161570951|NCT00995709|583475327|FG002|Overall Study|Lost to Follow-up|0|||
161809242|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809243|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161570952|NCT00995709|583475325|FG000|Overall Study|Death|0|||
161809244|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809245|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161570953|NCT00995709|583475326|FG001|Overall Study|Death|1|||
161570954|NCT00995709|583475327|FG002|Overall Study|Death|0|||
161570955|NCT00995709|583475325|FG000|Overall Study|Protocol Violation|2|||
161913305|NCT02867592|584731948|FG003|Overall Study|Death|1|||
161457818|NCT01397825|583071556|FG004|Overall Study|Adverse Event|0|||
161457819|NCT01397825|583071552|FG000|Overall Study|Withdrawal by Subject|1|||
161457820|NCT01397825|583071553|FG001|Overall Study|Withdrawal by Subject|0|||
161457821|NCT01397825|583071554|FG002|Overall Study|Withdrawal by Subject|5|||
161457822|NCT01397825|583071555|FG003|Overall Study|Withdrawal by Subject|1|||
161457823|NCT01397825|583071556|FG004|Overall Study|Withdrawal by Subject|0|||
161457824|NCT01931670|583071557|FG000|Treatment Period|Exclusionary Medication Received|1|||
161809246|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
161457825|NCT01931670|583071558|FG001|Treatment Period|Exclusionary Medication Received|1|||
161457826|NCT01931670|583071559|FG002|Treatment Period|Exclusionary Medication Received|1|||
161457827|NCT01931670|583071557|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
161457828|NCT01931670|583071558|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
161457829|NCT01931670|583071559|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
161457830|NCT01931670|583071557|FG000|Treatment Period|Subject Noncompliant|4|||
161457831|NCT01931670|583071558|FG001|Treatment Period|Subject Noncompliant|9|||
161457832|NCT01931670|583071559|FG002|Treatment Period|Subject Noncompliant|5|||
161457833|NCT01931670|583071557|FG000|Treatment Period|Adverse Event|19|||
161457834|NCT01931670|583071558|FG001|Treatment Period|Adverse Event|8|||
161457835|NCT01931670|583071559|FG002|Treatment Period|Adverse Event|21|||
161457836|NCT01931670|583071557|FG000|Treatment Period|Lack of Efficacy|11|||
161457837|NCT01931670|583071558|FG001|Treatment Period|Lack of Efficacy|2|||
161457838|NCT01931670|583071559|FG002|Treatment Period|Lack of Efficacy|2|||
161457839|NCT01931670|583071557|FG000|Treatment Period|Pregnancy|7|||
161457840|NCT01931670|583071558|FG001|Treatment Period|Pregnancy|2|||
161457841|NCT01931670|583071559|FG002|Treatment Period|Pregnancy|0|||
161457842|NCT01931670|583071557|FG000|Treatment Period|Other|8|||
161457843|NCT01931670|583071558|FG001|Treatment Period|Other|7|||
161457844|NCT01931670|583071559|FG002|Treatment Period|Other|2|||
161457845|NCT01931670|583071557|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
161457846|NCT01931670|583071558|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
161457847|NCT01931670|583071559|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
161457848|NCT01931670|583071557|FG000|Treatment Period|Lost to Follow-up|19|||
161457849|NCT01931670|583071558|FG001|Treatment Period|Lost to Follow-up|5|||
161457850|NCT01931670|583071559|FG002|Treatment Period|Lost to Follow-up|7|||
161457851|NCT01931670|583071557|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
161457852|NCT01931670|583071558|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
161457853|NCT01931670|583071559|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
161457854|NCT01931670|583071557|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
161457855|NCT01931670|583071558|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
161457856|NCT01931670|583071559|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
161457857|NCT01931670|583071557|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
161457858|NCT01931670|583071558|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
161457859|NCT01931670|583071559|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
161457860|NCT01931670|583071557|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
161457861|NCT01931670|583071558|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
161457862|NCT01931670|583071559|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
161457863|NCT01931670|583071557|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
161457864|NCT01931670|583071558|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
161457865|NCT01931670|583071559|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
161457866|NCT01931670|583071557|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
161457867|NCT01931670|583071558|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
161457868|NCT01931670|583071559|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
161457869|NCT00976508|583071563|FG000|Overall Study|Death|7|||
161457870|NCT00976508|583071564|FG001|Overall Study|Death|1|||
161457871|NCT00976508|583071563|FG000|Overall Study|Lost to Follow-up|1|||
161457872|NCT00976508|583071564|FG001|Overall Study|Lost to Follow-up|0|||
161457873|NCT00976508|583071563|FG000|Overall Study|Withdrawal by Subject|1|||
161457874|NCT00976508|583071564|FG001|Overall Study|Withdrawal by Subject|0|||
161457875|NCT00976508|583071563|FG000|Overall Study|Disease Progression|4|||
161457876|NCT00976508|583071564|FG001|Overall Study|Disease Progression|4|||
161457877|NCT00976508|583071563|FG000|Overall Study|Subject Enrolled in Hospice|1|||
161457878|NCT00976508|583071564|FG001|Overall Study|Subject Enrolled in Hospice|0|||
161457879|NCT00976508|583071563|FG000|Overall Study|Terminated by the Sponsor|0|||
161457880|NCT00976508|583071564|FG001|Overall Study|Terminated by the Sponsor|1|||
161457881|NCT04352127|583071565|FG000|Overall Study|Unable to obtain readings|4|||
161457882|NCT04352127|583071566|FG001|Overall Study|Unable to obtain readings|1|||
161457883|NCT03023046|583071569|FG000|Overall Study|Withdrawal by Subject|1|||
161457884|NCT00640835|583071575|FG000|Overall Study|Adverse Event|5|||
161457885|NCT00640835|583071576|FG001|Overall Study|Adverse Event|3|||
161457886|NCT00640835|583071575|FG000|Overall Study|Withdrawal by Subject|12|||
161457887|NCT00640835|583071576|FG001|Overall Study|Withdrawal by Subject|14|||
161570956|NCT00995709|583475326|FG001|Overall Study|Protocol Violation|1|||
161570957|NCT00995709|583475327|FG002|Overall Study|Protocol Violation|0|||
161570958|NCT02698241|583475328|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
161570959|NCT02698241|583475328|FG000|Overall Study|Screening not met|7|||
161570960|NCT02698241|583475328|FG000|Overall Study|Withdrawal by Subject|7|||
161570961|NCT02698241|583475328|FG000|Overall Study|Physician Decision|2|||
161570962|NCT02698241|583475328|FG000|Overall Study|Subject underwent system modification|2|||
161570963|NCT02698241|583475328|FG000|Overall Study|Lost to Follow-up|3|||
161570964|NCT02698241|583475328|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
161570965|NCT02698241|583475328|FG000|Overall Study|geographic and licensing issue|1|||
161570966|NCT02698241|583475328|FG000|Overall Study|Death|2|||
161570967|NCT01543685|583475331|FG000|Overall Study|Lack of Efficacy|1|||
161570968|NCT01543685|583475332|FG001|Overall Study|Lack of Efficacy|2|||
161809247|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
161809248|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809249|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809250|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809251|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809252|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809253|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809254|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809255|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809256|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809257|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809258|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809259|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809260|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809261|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809262|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809263|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809264|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809265|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809266|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809267|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
161809268|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
161809269|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809270|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809271|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809272|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809273|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809274|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809275|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809276|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809277|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809278|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809279|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809280|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809281|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809282|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809283|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809284|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809285|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809286|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809287|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809288|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
161809289|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
161809290|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809291|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809292|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809293|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809294|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809295|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809296|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809297|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809298|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809299|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161570969|NCT01543685|583475333|FG002|Overall Study|Lack of Efficacy|2|||
161570970|NCT01543685|583475334|FG003|Overall Study|Lack of Efficacy|0|||
161570971|NCT01543685|583475335|FG004|Overall Study|Lack of Efficacy|2|||
161570972|NCT01543685|583475331|FG000|Overall Study|Adverse Event|2|||
161570973|NCT01543685|583475332|FG001|Overall Study|Adverse Event|1|||
161570974|NCT01543685|583475333|FG002|Overall Study|Adverse Event|0|||
161570975|NCT01543685|583475334|FG003|Overall Study|Adverse Event|0|||
161570976|NCT01543685|583475335|FG004|Overall Study|Adverse Event|2|||
161570977|NCT04776213|583475336|FG000|Overall Study|Other|1|||
161570978|NCT04776213|583475336|FG000|Overall Study|Withdrawal by Subject|7|||
161570979|NCT04776213|583475336|FG000|Overall Study|Protocol Violation|1|||
161570980|NCT04776213|583475336|FG000|Overall Study|Lost to Follow-up|2|||
161570981|NCT01838551|583475340|FG000|Overall Study|Adverse Event|16|||
161570982|NCT01838551|583475340|FG000|Overall Study|Death|1|||
161570983|NCT01838551|583475340|FG000|Overall Study|Lack of Efficacy|10|||
161570984|NCT01838551|583475340|FG000|Overall Study|Physician Decision|4|||
161570985|NCT01838551|583475340|FG000|Overall Study|Withdrawal by Subject|10|||
161570986|NCT01838551|583475340|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
161570987|NCT00906282|583475341|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
161570988|NCT00906282|583475341|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
161570989|NCT00906282|583475341|FG000|Preoperative Chemotherapy|Progressive disease|6|||
161570990|NCT00906282|583475341|FG000|Preoperative Chemotherapy|Toxicity|1|||
161570991|NCT03254394|583475346|FG000|Overall Study|Withdrawal by Subject|0|||
161570992|NCT03254394|583475347|FG001|Overall Study|Withdrawal by Subject|2|||
161570993|NCT02163915|583475348|FG000|Overall Study|Withdrawal by Subject|2|||
161570994|NCT02163915|583475349|FG001|Overall Study|Withdrawal by Subject|0|||
161570995|NCT02163915|583475350|FG002|Overall Study|Withdrawal by Subject|2|||
161570996|NCT02163915|583475351|FG003|Overall Study|Withdrawal by Subject|2|||
161570997|NCT02163915|583475352|FG004|Overall Study|Withdrawal by Subject|2|||
161570998|NCT02163915|583475348|FG000|Overall Study|Study termination|1|||
161570999|NCT02163915|583475349|FG001|Overall Study|Study termination|0|||
161571000|NCT02163915|583475350|FG002|Overall Study|Study termination|0|||
161571001|NCT02163915|583475351|FG003|Overall Study|Study termination|0|||
161571002|NCT02163915|583475352|FG004|Overall Study|Study termination|2|||
161571003|NCT02163915|583475348|FG000|Overall Study|Physician Decision|0|||
161571004|NCT02163915|583475349|FG001|Overall Study|Physician Decision|0|||
161571005|NCT02163915|583475350|FG002|Overall Study|Physician Decision|0|||
161571006|NCT02163915|583475351|FG003|Overall Study|Physician Decision|1|||
161571007|NCT02163915|583475352|FG004|Overall Study|Physician Decision|0|||
161571008|NCT02013037|583475355|FG000|Overall Study|Death|6|||
161571009|NCT02013037|583475355|FG000|Overall Study|Withdrawal by Subject|1|||
161571010|NCT02013037|583475355|FG000|Overall Study|Awaiting Transplantation|7|||
161571011|NCT02013037|583475355|FG000|Overall Study|Transplanted without DSA|2|||
161571012|NCT02465359|583475356|FG000|Overall Study|Lack of Efficacy|1|||
161809300|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809301|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809302|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809303|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809304|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809305|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809306|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809307|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809308|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
161809309|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809310|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809311|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809312|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809313|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809314|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809315|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809316|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809317|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809318|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809319|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161571013|NCT02465359|583475356|FG000|Overall Study|Withdrawal by Subject|1|||
161571014|NCT02465359|583475356|FG000|Overall Study|Adverse Event|1|||
161571015|NCT02812966|583475359|FG000|Overall Study|Death|1|||
161571016|NCT02812966|583475360|FG001|Overall Study|Death|0|||
161571017|NCT01066923|583475361|FG000|Overall Study|Withdrawal by Subject|3|||
161571018|NCT01066923|583475362|FG001|Overall Study|Withdrawal by Subject|3|||
161571019|NCT01066923|583475363|FG002|Overall Study|Withdrawal by Subject|8|||
161571020|NCT01066923|583475364|FG003|Overall Study|Withdrawal by Subject|8|||
161571021|NCT01049503|583477574|FG000|Overall Study|Lost to Follow-up|11|||
161457888|NCT00640835|583071575|FG000|Overall Study|Physician Decision|10|||
161457889|NCT00640835|583071576|FG001|Overall Study|Physician Decision|14|||
161457890|NCT00640835|583071575|FG000|Overall Study|Sponsor's Decision|11|||
161457891|NCT00640835|583071576|FG001|Overall Study|Sponsor's Decision|7|||
161457892|NCT00640835|583071575|FG000|Overall Study|Protocol Violation|2|||
161457893|NCT00640835|583071576|FG001|Overall Study|Protocol Violation|2|||
161457894|NCT00640835|583071575|FG000|Overall Study|Lost to Follow-up|17|||
161457895|NCT00640835|583071576|FG001|Overall Study|Lost to Follow-up|13|||
161457896|NCT00640835|583071575|FG000|Overall Study|Other Reason|19|||
161457897|NCT00640835|583071576|FG001|Overall Study|Other Reason|4|||
161457898|NCT05954143|583071581|FG000|Overall Study|Progressive Disease|1|||
161457899|NCT05954143|583071582|FG001|Overall Study|Progressive Disease|0|||
161457900|NCT05954143|583071581|FG000|Overall Study|Physician Decision|1|||
161457901|NCT05954143|583071582|FG001|Overall Study|Physician Decision|0|||
161457902|NCT05954143|583071581|FG000|Overall Study|Study Terminated by Sponsor|2|||
161457903|NCT05954143|583071582|FG001|Overall Study|Study Terminated by Sponsor|4|||
161457904|NCT05954143|583071581|FG000|Overall Study|Death|1|||
161457905|NCT05954143|583071582|FG001|Overall Study|Death|0|||
161457906|NCT05954143|583071581|FG000|Overall Study|Withdrawal by Subject|0|||
161457907|NCT05954143|583071582|FG001|Overall Study|Withdrawal by Subject|1|||
161457908|NCT05954143|583071581|FG000|Overall Study|Other|1|||
161457909|NCT05954143|583071582|FG001|Overall Study|Other|0|||
161457910|NCT02496676|583071584|FG000|Phase 1 - Period 1|Adverse Event|0|||
161457911|NCT02496676|583071585|FG001|Phase 1 - Period 1|Adverse Event|1|||
161457912|NCT02496676|583071584|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
161457913|NCT02496676|583071585|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
161457914|NCT05442775|583071586|FG000|Overall Study|Trial terminated|61|||
161457915|NCT05442775|583071586|FG000|Overall Study|Lack of Efficacy|4|||
161457916|NCT05442775|583071586|FG000|Overall Study|Withdrawal by Subject|4|||
161457917|NCT05442775|583071586|FG000|Overall Study|Death|1|||
161457918|NCT05442775|583071586|FG000|Overall Study|Participant removed at Sponsor request|1|||
161457919|NCT03459690|583071588|FG000|Overall Study|Lost to Follow-up|0|||
161457920|NCT03459690|583071589|FG001|Overall Study|Lost to Follow-up|1|||
161457921|NCT03459690|583071588|FG000|Overall Study|Withdrawal by Subject|1|||
161457922|NCT03459690|583071589|FG001|Overall Study|Withdrawal by Subject|1|||
161457923|NCT02963831|583071590|FG000|Overall Study|Progressive Disease|3|||
161457924|NCT02963831|583071591|FG001|Overall Study|Progressive Disease|3|||
161457925|NCT02963831|583071592|FG002|Overall Study|Progressive Disease|16|||
161457926|NCT02963831|583071593|FG003|Overall Study|Progressive Disease|27|||
161457927|NCT02963831|583071590|FG000|Overall Study|Withdrawal by Subject|1|||
161457928|NCT02963831|583071591|FG001|Overall Study|Withdrawal by Subject|0|||
161457929|NCT02963831|583071592|FG002|Overall Study|Withdrawal by Subject|2|||
161457930|NCT02963831|583071593|FG003|Overall Study|Withdrawal by Subject|4|||
161571022|NCT01049503|583477575|FG001|Overall Study|Lost to Follow-up|12|||
161571023|NCT01049503|583477576|FG002|Overall Study|Lost to Follow-up|24|||
161913306|NCT02867592|584731949|FG004|Overall Study|Death|0|||
161913307|NCT02867592|584731950|FG005|Overall Study|Death|1|||
161913308|NCT02867592|584731945|FG000|Overall Study|Lack of Efficacy|8|||
161913309|NCT02867592|584731946|FG001|Overall Study|Lack of Efficacy|10|||
161913310|NCT02867592|584731947|FG002|Overall Study|Lack of Efficacy|8|||
161913311|NCT02867592|584731948|FG003|Overall Study|Lack of Efficacy|8|||
161913312|NCT02867592|584731949|FG004|Overall Study|Lack of Efficacy|12|||
161913313|NCT02867592|584731950|FG005|Overall Study|Lack of Efficacy|17|||
161913314|NCT02867592|584731945|FG000|Overall Study|Physician Decision|1|||
161913315|NCT02867592|584731946|FG001|Overall Study|Physician Decision|2|||
161913316|NCT02867592|584731947|FG002|Overall Study|Physician Decision|2|||
161913317|NCT02867592|584731948|FG003|Overall Study|Physician Decision|0|||
161913318|NCT02867592|584731949|FG004|Overall Study|Physician Decision|5|||
161913319|NCT02867592|584731950|FG005|Overall Study|Physician Decision|1|||
161913320|NCT02867592|584731945|FG000|Overall Study|Protocol Violation|0|||
161913321|NCT02867592|584731946|FG001|Overall Study|Protocol Violation|0|||
161913322|NCT02867592|584731947|FG002|Overall Study|Protocol Violation|0|||
161913323|NCT02867592|584731948|FG003|Overall Study|Protocol Violation|0|||
161913324|NCT02867592|584731949|FG004|Overall Study|Protocol Violation|1|||
161913325|NCT02867592|584731950|FG005|Overall Study|Protocol Violation|1|||
161913326|NCT02867592|584731945|FG000|Overall Study|Withdrawal by Subject|0|||
161913327|NCT02867592|584731946|FG001|Overall Study|Withdrawal by Subject|1|||
161571024|NCT01049503|583477577|FG003|Overall Study|Lost to Follow-up|26|||
161913328|NCT02867592|584731947|FG002|Overall Study|Withdrawal by Subject|0|||
161457931|NCT02963831|583071590|FG000|Overall Study|Adverse Event|0|||
161457932|NCT02963831|583071591|FG001|Overall Study|Adverse Event|1|||
161457933|NCT02963831|583071592|FG002|Overall Study|Adverse Event|1|||
161457934|NCT02963831|583071593|FG003|Overall Study|Adverse Event|2|||
161457935|NCT02963831|583071590|FG000|Overall Study|Death|0|||
161457936|NCT02963831|583071591|FG001|Overall Study|Death|0|||
161457937|NCT02963831|583071592|FG002|Overall Study|Death|0|||
161457938|NCT02963831|583071593|FG003|Overall Study|Death|2|||
161457939|NCT01966432|583071595|FG000|Overall Study|Lost to Follow-up|3|||
161457940|NCT01966432|583071596|FG001|Overall Study|Lost to Follow-up|2|||
161913329|NCT02867592|584731948|FG003|Overall Study|Withdrawal by Subject|1|||
161913330|NCT02867592|584731949|FG004|Overall Study|Withdrawal by Subject|3|||
161457941|NCT01966432|583071597|FG002|Overall Study|Lost to Follow-up|5|||
161457942|NCT01966432|583071595|FG000|Overall Study|Withdrawal by Subject|1|||
161457943|NCT01966432|583071596|FG001|Overall Study|Withdrawal by Subject|3|||
161457944|NCT01966432|583071597|FG002|Overall Study|Withdrawal by Subject|0|||
161457945|NCT01966432|583071595|FG000|Overall Study|Subject Incarcerated|0|||
161457946|NCT01966432|583071596|FG001|Overall Study|Subject Incarcerated|0|||
161457947|NCT01966432|583071597|FG002|Overall Study|Subject Incarcerated|1|||
161457948|NCT01966432|583071595|FG000|Overall Study|SBIRT program ended|1|||
161457949|NCT01966432|583071596|FG001|Overall Study|SBIRT program ended|8|||
161457950|NCT01966432|583071597|FG002|Overall Study|SBIRT program ended|20|||
161457951|NCT03915860|583071598|FG000|Overall Study|Adverse Event|3|||
161457952|NCT03915860|583071598|FG000|Overall Study|Withdrawal by Subject|6|||
161457953|NCT03915860|583071598|FG000|Overall Study|Lost to Follow-up|2|||
161457954|NCT03915860|583071598|FG000|Overall Study|Other than specified|3|||
161457955|NCT01107379|583071602|FG000|Overall Study|Withdrawal by Subject|18|||
161457956|NCT01107379|583071602|FG000|Overall Study|Lost to Follow-up|3|||
161457957|NCT04559529|583071603|FG000|First Intervention (1 Day)|Adverse Event|0|||
161457958|NCT04559529|583071604|FG001|First Intervention (1 Day)|Adverse Event|0|||
161457959|NCT04559529|583071605|FG002|First Intervention (1 Day)|Adverse Event|0|||
161457960|NCT04559529|583071606|FG003|First Intervention (1 Day)|Adverse Event|1|||
161457961|NCT04559529|583071603|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
161457962|NCT04559529|583071604|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
161457963|NCT04559529|583071605|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
161457964|NCT04559529|583071606|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
161457965|NCT04559529|583071603|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
161457966|NCT04559529|583071604|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
161457967|NCT04559529|583071605|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
161457968|NCT04559529|583071606|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
161457969|NCT01009281|583071607|FG000|Overall Study|Administrative problems|7|||
161457970|NCT00924170|583071608|FG000|Overall Study|Refused further treatment|0|||
161457971|NCT00924170|583071609|FG001|Overall Study|Refused further treatment|1|||
161457972|NCT00924170|583071608|FG000|Overall Study|Physician Decision|0|||
161457973|NCT00924170|583071609|FG001|Overall Study|Physician Decision|1|||
161457974|NCT00924170|583071608|FG000|Overall Study|Progressive disease|3|||
161457975|NCT00924170|583071609|FG001|Overall Study|Progressive disease|6|||
161457976|NCT00924170|583071608|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
161457977|NCT00924170|583071609|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
161809320|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809321|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809322|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809323|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809324|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809325|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809326|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809327|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809328|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809329|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809330|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809331|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809332|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
161809333|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
161809334|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
161809335|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
161809336|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
161809337|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809338|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809339|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809340|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809341|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809342|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809343|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809344|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809345|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161913331|NCT02867592|584731950|FG005|Overall Study|Withdrawal by Subject|3|||
161913332|NCT02867592|584731945|FG000|Overall Study|Ineligible|1|||
161913333|NCT02867592|584731946|FG001|Overall Study|Ineligible|1|||
161913334|NCT02867592|584731947|FG002|Overall Study|Ineligible|0|||
161457978|NCT00924170|583071608|FG000|Overall Study|Death|1|||
161457979|NCT00924170|583071609|FG001|Overall Study|Death|0|||
161457980|NCT00899392|583071612|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
161913335|NCT02867592|584731948|FG003|Overall Study|Ineligible|0|||
161913336|NCT02867592|584731949|FG004|Overall Study|Ineligible|2|||
161913337|NCT02867592|584731950|FG005|Overall Study|Ineligible|0|||
161913338|NCT02867592|584731945|FG000|Overall Study|No Treatment|1|||
161913339|NCT02867592|584731946|FG001|Overall Study|No Treatment|0|||
161913340|NCT02867592|584731947|FG002|Overall Study|No Treatment|0|||
161913341|NCT02867592|584731948|FG003|Overall Study|No Treatment|0|||
161913342|NCT02867592|584731949|FG004|Overall Study|No Treatment|0|||
161913343|NCT02867592|584731950|FG005|Overall Study|No Treatment|0|||
161913344|NCT02867592|584731945|FG000|Overall Study|Still on Therapy|0|||
161913345|NCT02867592|584731946|FG001|Overall Study|Still on Therapy|0|||
161913346|NCT02867592|584731947|FG002|Overall Study|Still on Therapy|0|||
161913347|NCT02867592|584731948|FG003|Overall Study|Still on Therapy|0|||
161913348|NCT02867592|584731949|FG004|Overall Study|Still on Therapy|1|||
161913349|NCT02867592|584731950|FG005|Overall Study|Still on Therapy|0|||
161913350|NCT02867592|584731945|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913351|NCT02867592|584731946|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913352|NCT02867592|584731947|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913353|NCT02867592|584731948|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913354|NCT02867592|584731949|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913355|NCT02867592|584731950|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
161913356|NCT02867592|584731945|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
161913357|NCT02867592|584731946|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161913358|NCT02867592|584731947|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
161913359|NCT02867592|584731948|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
161913360|NCT02867592|584731949|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161913361|NCT02867592|584731950|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161913362|NCT00909870|584731951|FG000|Overall Study|Adverse Event|13|||
161913363|NCT00909870|584731952|FG001|Overall Study|Adverse Event|7|||
161913364|NCT00909870|584731951|FG000|Overall Study|Protocol Violation|1|||
161913365|NCT00909870|584731952|FG001|Overall Study|Protocol Violation|2|||
161913366|NCT00909870|584731951|FG000|Overall Study|Withdrawal by Subject|5|||
161913367|NCT00909870|584731952|FG001|Overall Study|Withdrawal by Subject|8|||
161913368|NCT00909870|584731951|FG000|Overall Study|Lost to Follow-up|3|||
161913369|NCT00909870|584731952|FG001|Overall Study|Lost to Follow-up|3|||
161913370|NCT00909870|584731951|FG000|Overall Study|Physician Decision|0|||
161913371|NCT00909870|584731952|FG001|Overall Study|Physician Decision|2|||
161913372|NCT00909870|584731951|FG000|Overall Study|Other|1|||
161913373|NCT00909870|584731952|FG001|Overall Study|Other|5|||
161913374|NCT00848497|584731953|FG000|Overall Study|Screen failure|2|||
161913375|NCT00848497|584731954|FG001|Overall Study|Screen failure|0|||
161913376|NCT00848497|584731953|FG000|Overall Study|Withdrawal by Subject|0|||
161913377|NCT00848497|584731954|FG001|Overall Study|Withdrawal by Subject|1|||
161913378|NCT01420536|584731963|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
161913379|NCT01420536|584731964|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
161913380|NCT04711005|584731967|FG000|Overall Study|Withdrawal by Subject|0|||
161913381|NCT04711005|584731968|FG001|Overall Study|Withdrawal by Subject|0|||
161913382|NCT04711005|584731969|FG002|Overall Study|Withdrawal by Subject|0|||
161913383|NCT04711005|584731970|FG003|Overall Study|Withdrawal by Subject|0|||
161913384|NCT04711005|584731971|FG004|Overall Study|Withdrawal by Subject|0|||
161913385|NCT04711005|584731972|FG005|Overall Study|Withdrawal by Subject|0|||
161913386|NCT04711005|584731973|FG006|Overall Study|Withdrawal by Subject|0|||
161913387|NCT04711005|584731974|FG007|Overall Study|Withdrawal by Subject|1|||
161913388|NCT04711005|584731975|FG008|Overall Study|Withdrawal by Subject|0|||
161913389|NCT04711005|584731976|FG009|Overall Study|Withdrawal by Subject|0|||
161913390|NCT04711005|584731967|FG000|Overall Study|Physician Decision|0|||
161913391|NCT04711005|584731968|FG001|Overall Study|Physician Decision|0|||
161913392|NCT04711005|584731969|FG002|Overall Study|Physician Decision|0|||
161913393|NCT04711005|584731970|FG003|Overall Study|Physician Decision|0|||
161913394|NCT04711005|584731971|FG004|Overall Study|Physician Decision|0|||
161913395|NCT04711005|584731972|FG005|Overall Study|Physician Decision|0|||
161913396|NCT04711005|584731973|FG006|Overall Study|Physician Decision|0|||
161913397|NCT04711005|584731974|FG007|Overall Study|Physician Decision|2|||
161457981|NCT00899392|583071613|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
161457982|NCT02520089|583071616|FG000|Overall Study|Lost to Follow-up|3|||
161457983|NCT02520089|583071617|FG001|Overall Study|Lost to Follow-up|4|||
161457984|NCT00622739|583073365|FG000|Overall Study|Physician Decision|1|||
161457985|NCT00622739|583073366|FG001|Overall Study|Physician Decision|0|||
161457986|NCT00622739|583073365|FG000|Overall Study|Adverse Event|1|||
161913398|NCT04711005|584731975|FG008|Overall Study|Physician Decision|1|||
161913399|NCT04711005|584731976|FG009|Overall Study|Physician Decision|0|||
161913400|NCT00764790|584731977|FG000|Overall Study|Protocol Violation|0|||
161913401|NCT00764790|584731978|FG001|Overall Study|Protocol Violation|0|||
161913402|NCT00764790|584731979|FG002|Overall Study|Protocol Violation|1|||
161913403|NCT00764790|584731977|FG000|Overall Study|Withdrawal by Subject|10|||
161913404|NCT00764790|584731978|FG001|Overall Study|Withdrawal by Subject|12|||
161913405|NCT00764790|584731979|FG002|Overall Study|Withdrawal by Subject|6|||
161913406|NCT00764790|584731977|FG000|Overall Study|Lost to Follow-up|28|||
161913407|NCT00764790|584731978|FG001|Overall Study|Lost to Follow-up|29|||
161457987|NCT00622739|583073366|FG001|Overall Study|Adverse Event|2|||
161457988|NCT00622739|583073365|FG000|Overall Study|Lack of Efficacy|0|||
161457989|NCT00622739|583073366|FG001|Overall Study|Lack of Efficacy|2|||
161457990|NCT00622739|583073365|FG000|Overall Study|Withdrawal by Subject|0|||
161457991|NCT00622739|583073366|FG001|Overall Study|Withdrawal by Subject|1|||
161457992|NCT00622739|583073365|FG000|Overall Study|Lost to Follow-up|0|||
161457993|NCT00622739|583073366|FG001|Overall Study|Lost to Follow-up|1|||
161457994|NCT00134784|583073367|FG000|Overall Study|Withdrawal by Subject|2|||
161457995|NCT00134784|583073368|FG001|Overall Study|Withdrawal by Subject|2|||
161457996|NCT00134784|583073369|FG002|Overall Study|Withdrawal by Subject|2|||
161457997|NCT00134784|583073370|FG003|Overall Study|Withdrawal by Subject|1|||
161457998|NCT00625742|583073371|FG000|Overall Study|Disease Progression|2|||
161457999|NCT00625742|583073371|FG000|Overall Study|Withdrawal by Subject|1|||
161458000|NCT00625742|583073371|FG000|Overall Study|Adverse Event|4|||
161458001|NCT00625742|583073371|FG000|Overall Study|Lost to Follow-up|4|||
161458002|NCT00625742|583073371|FG000|Overall Study|Ineligible|1|||
161458003|NCT03384693|583073372|FG000|Overall Study|Adverse Event|3|||
161458004|NCT03387150|583073373|FG000|Overall Study|Withdrawal by Subject|3|||
161458005|NCT03387150|583073374|FG001|Overall Study|Withdrawal by Subject|0|||
161458006|NCT03387150|583073375|FG002|Overall Study|Withdrawal by Subject|3|||
161458007|NCT03387150|583073376|FG003|Overall Study|Withdrawal by Subject|4|||
161458008|NCT03387150|583073377|FG004|Overall Study|Withdrawal by Subject|1|||
161458009|NCT03387150|583073378|FG005|Overall Study|Withdrawal by Subject|2|||
161458010|NCT03387150|583073379|FG006|Overall Study|Withdrawal by Subject|0|||
161458011|NCT03387150|583073373|FG000|Overall Study|Lost to Follow-up|3|||
161458012|NCT03387150|583073374|FG001|Overall Study|Lost to Follow-up|2|||
161458013|NCT03387150|583073375|FG002|Overall Study|Lost to Follow-up|2|||
161458014|NCT03387150|583073376|FG003|Overall Study|Lost to Follow-up|3|||
161458015|NCT03387150|583073377|FG004|Overall Study|Lost to Follow-up|3|||
161458016|NCT03387150|583073378|FG005|Overall Study|Lost to Follow-up|3|||
161458017|NCT03387150|583073379|FG006|Overall Study|Lost to Follow-up|0|||
161458018|NCT03387150|583073373|FG000|Overall Study|Participant unable to adhere to visit|0|||
161458019|NCT03387150|583073374|FG001|Overall Study|Participant unable to adhere to visit|1|||
161458020|NCT03387150|583073375|FG002|Overall Study|Participant unable to adhere to visit|0|||
161458021|NCT03387150|583073376|FG003|Overall Study|Participant unable to adhere to visit|0|||
161458022|NCT03387150|583073377|FG004|Overall Study|Participant unable to adhere to visit|2|||
161458023|NCT03387150|583073378|FG005|Overall Study|Participant unable to adhere to visit|2|||
161458024|NCT03387150|583073379|FG006|Overall Study|Participant unable to adhere to visit|0|||
161458025|NCT04006119|583073380|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
161458026|NCT04006119|583073380|FG000|End of Treatment Veledimex|Adverse Event|2|||
161458027|NCT04006119|583073380|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
161458028|NCT04006119|583073380|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
161458029|NCT04006119|583073380|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
161458030|NCT04006119|583073380|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
161458031|NCT00920907|583073385|FG000|Induction Period|Adverse Event|0|||
161458032|NCT00920907|583073386|FG001|Induction Period|Adverse Event|2|||
161458033|NCT00920907|583073385|FG000|Induction Period|Death|1|||
161458034|NCT00920907|583073386|FG001|Induction Period|Death|1|||
161458035|NCT00920907|583073385|FG000|Induction Period|Disease Progression|12|||
161458036|NCT00920907|583073386|FG001|Induction Period|Disease Progression|11|||
161458037|NCT00920907|583073385|FG000|Induction Period|Study Drug Toxicity|8|||
161458038|NCT00920907|583073386|FG001|Induction Period|Study Drug Toxicity|6|||
161458039|NCT00920907|583073385|FG000|Induction Period|No longer meets study criteria|0|||
161458040|NCT00920907|583073386|FG001|Induction Period|No longer meets study criteria|1|||
161458041|NCT00920907|583073385|FG000|Induction Period|Withdrawal by Subject|1|||
161458042|NCT00920907|583073386|FG001|Induction Period|Withdrawal by Subject|1|||
161458043|NCT00920907|583073385|FG000|Maintenance Period|Disease Progression|3|||
161458044|NCT00920907|583073386|FG001|Maintenance Period|Disease Progression|7|||
161458045|NCT00920907|583073385|FG000|Maintenance Period|Administrative (study closure)|7|||
161458046|NCT00920907|583073386|FG001|Maintenance Period|Administrative (study closure)|2|||
161458047|NCT00920907|583073385|FG000|Maintenance Period|Study Drug Toxicity|0|||
161458048|NCT00920907|583073386|FG001|Maintenance Period|Study Drug Toxicity|2|||
161458049|NCT00920907|583073385|FG000|Maintenance Period|Death|1|||
161458050|NCT00920907|583073386|FG001|Maintenance Period|Death|1|||
161458051|NCT00920907|583073385|FG000|Maintenance Period|Withdrawal by Subject|1|||
161458052|NCT00920907|583073386|FG001|Maintenance Period|Withdrawal by Subject|0|||
161458053|NCT00920907|583073385|FG000|Maintenance Period|Adverse Event|0|||
161571025|NCT01049503|583477578|FG004|Overall Study|Lost to Follow-up|27|||
161913408|NCT00764790|584731979|FG002|Overall Study|Lost to Follow-up|23|||
161458054|NCT00920907|583073386|FG001|Maintenance Period|Adverse Event|1|||
161458055|NCT02616601|583073387|FG000|Overall Study|Withdrawal by Subject|4|||
161458056|NCT02616601|583073388|FG001|Overall Study|Withdrawal by Subject|4|||
161809346|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809347|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809348|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809349|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809350|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809351|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809352|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809353|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809354|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
161809355|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
161809356|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
161809357|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
161809358|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809359|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809360|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809361|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809362|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809363|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809364|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809365|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809366|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809367|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809368|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809369|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809370|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809371|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809372|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809373|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809374|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
161809375|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809376|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809377|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
161809378|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
161809379|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809380|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809381|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809382|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809383|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809384|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809385|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809386|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809387|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809388|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809389|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809390|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809391|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809392|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809393|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809394|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809395|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809396|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809397|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
161809398|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
161809399|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
161458057|NCT02616601|583073389|FG002|Overall Study|Withdrawal by Subject|3|||
161458058|NCT02616601|583073387|FG000|Overall Study|Adverse Event|2|||
161458059|NCT02616601|583073388|FG001|Overall Study|Adverse Event|0|||
161458060|NCT02616601|583073389|FG002|Overall Study|Adverse Event|2|||
161458061|NCT02616601|583073387|FG000|Overall Study|Death|1|||
161458062|NCT02616601|583073388|FG001|Overall Study|Death|0|||
161458063|NCT02616601|583073389|FG002|Overall Study|Death|0|||
161458064|NCT02616601|583073387|FG000|Overall Study|Lost to Follow-up|1|||
161458065|NCT02616601|583073388|FG001|Overall Study|Lost to Follow-up|0|||
161458066|NCT02616601|583073389|FG002|Overall Study|Lost to Follow-up|1|||
161458067|NCT02616601|583073387|FG000|Overall Study|Non-Compliance with Test Article|1|||
161913409|NCT04935879|584731980|FG000|Overall Study|Adverse Event|2|||
161913410|NCT04935879|584731981|FG001|Overall Study|Adverse Event|1|||
161913411|NCT04935879|584731980|FG000|Overall Study|Lost to Follow-up|1|||
161913412|NCT04935879|584731981|FG001|Overall Study|Lost to Follow-up|1|||
161913413|NCT04935879|584731980|FG000|Overall Study|Pregnancy|2|||
161913414|NCT04935879|584731981|FG001|Overall Study|Pregnancy|3|||
161913415|NCT04935879|584731980|FG000|Overall Study|Withdrawal by Subject|8|||
161913416|NCT04935879|584731981|FG001|Overall Study|Withdrawal by Subject|6|||
161913417|NCT04935879|584731980|FG000|Overall Study|Other|3|||
161913418|NCT04935879|584731981|FG001|Overall Study|Other|3|||
161913419|NCT03054428|584731982|FG000|Overall Study|Physician Decision|0|||
161913420|NCT03054428|584731983|FG001|Overall Study|Physician Decision|1|||
161913421|NCT03054428|584731984|FG002|Overall Study|Physician Decision|1|||
161913422|NCT03054428|584731982|FG000|Overall Study|Lack of Efficacy|3|||
161913423|NCT03054428|584731983|FG001|Overall Study|Lack of Efficacy|1|||
161913424|NCT03054428|584731984|FG002|Overall Study|Lack of Efficacy|0|||
161913425|NCT03054428|584731982|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
161913426|NCT03054428|584731983|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
161913427|NCT03054428|584731984|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
161913428|NCT03054428|584731982|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
161913429|NCT03054428|584731983|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
161913430|NCT03054428|584731984|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
161913431|NCT03054428|584731982|FG000|Overall Study|Transitioned to OLE study|76|||
161913432|NCT03054428|584731983|FG001|Overall Study|Transitioned to OLE study|76|||
161913433|NCT03054428|584731984|FG002|Overall Study|Transitioned to OLE study|73|||
161913434|NCT03054428|584731982|FG000|Overall Study|Withdrawal by Subject|3|||
161913435|NCT03054428|584731983|FG001|Overall Study|Withdrawal by Subject|2|||
161913436|NCT03054428|584731984|FG002|Overall Study|Withdrawal by Subject|3|||
161913437|NCT03054428|584731982|FG000|Overall Study|Lost to Follow-up|0|||
161913438|NCT03054428|584731983|FG001|Overall Study|Lost to Follow-up|0|||
161913439|NCT03054428|584731984|FG002|Overall Study|Lost to Follow-up|1|||
161913440|NCT01652690|584731985|FG000|Overall Study|Withdrawal by Subject|16|||
161913441|NCT01652690|584731986|FG001|Overall Study|Withdrawal by Subject|4|||
161913442|NCT01652690|584731985|FG000|Overall Study|Other|8|||
161809400|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809401|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809402|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809403|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809404|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809405|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809406|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809407|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809408|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809409|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809410|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809411|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809412|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809413|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809414|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809415|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809416|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
161809417|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809418|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809419|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
161809420|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
161913443|NCT01652690|584731986|FG001|Overall Study|Other|9|||
161458068|NCT02616601|583073388|FG001|Overall Study|Non-Compliance with Test Article|0|||
161913444|NCT01652690|584731985|FG000|Overall Study|Lost to Follow-up|6|||
161913445|NCT01652690|584731986|FG001|Overall Study|Lost to Follow-up|6|||
161913446|NCT01652690|584731985|FG000|Overall Study|Death|5|||
161913447|NCT01652690|584731986|FG001|Overall Study|Death|2|||
161913448|NCT03225287|584731989|FG000|Overall Study|Adverse Event|0|||
161571026|NCT01049503|583477579|FG005|Overall Study|Lost to Follow-up|8|||
161571027|NCT02577523|583477582|FG000|Overall Study|Adverse Event|1|||
161809421|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809422|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809423|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809424|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809425|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809426|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809427|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809428|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809429|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809430|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809431|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809432|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809433|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809434|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809435|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809436|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809437|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
161809438|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809439|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809440|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
161809441|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
161809442|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809443|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809444|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809445|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809446|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809447|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809448|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809449|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809450|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809451|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809452|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809453|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809454|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809455|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809456|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809457|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809458|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
161809459|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809460|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809461|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
161809462|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809463|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809464|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809465|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809466|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809467|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809468|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809469|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809470|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809471|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809472|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809473|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809474|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809475|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809476|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809477|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809478|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809479|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
161571028|NCT02577523|583477583|FG001|Overall Study|Adverse Event|1|||
161571029|NCT02577523|583477582|FG000|Overall Study|Lack of Efficacy|1|||
161571030|NCT02577523|583477583|FG001|Overall Study|Lack of Efficacy|1|||
161571031|NCT02577523|583477582|FG000|Overall Study|Withdrawal by Subject|1|||
161571032|NCT02577523|583477583|FG001|Overall Study|Withdrawal by Subject|0|||
161571033|NCT00970307|583477584|FG000|Overall Study|Serious Adverse Event|1|||
161571034|NCT00970307|583477585|FG001|Overall Study|Serious Adverse Event|0|||
161571035|NCT00970307|583477586|FG002|Overall Study|Serious Adverse Event|0|||
161571036|NCT00970307|583477584|FG000|Overall Study|Withdrawal by Subject|2|||
161571037|NCT00970307|583477585|FG001|Overall Study|Withdrawal by Subject|3|||
161571038|NCT00970307|583477586|FG002|Overall Study|Withdrawal by Subject|2|||
161571039|NCT05174013|583477595|FG000|Overall Study|Lost to Follow-up|0|||
161571040|NCT05174013|583477596|FG001|Overall Study|Lost to Follow-up|0|||
161571041|NCT05174013|583477597|FG002|Overall Study|Lost to Follow-up|0|||
161571042|NCT05174013|583477598|FG003|Overall Study|Lost to Follow-up|1|||
161571043|NCT05174013|583477599|FG004|Overall Study|Lost to Follow-up|0|||
161571044|NCT05174013|583477600|FG005|Overall Study|Lost to Follow-up|0|||
161809480|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161571045|NCT05174013|583477595|FG000|Overall Study|Withdrawal by Subject|0|||
161571046|NCT05174013|583477596|FG001|Overall Study|Withdrawal by Subject|0|||
161809481|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809482|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
161809483|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809484|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809485|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809486|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809487|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809488|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809489|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809490|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809491|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809492|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809493|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809494|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809495|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809496|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809497|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809498|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809499|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809500|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809501|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809502|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809503|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
161809504|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809505|NCT00731783|584344332|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
161809506|NCT00731783|584344333|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
161809507|NCT00731783|584344332|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
161809508|NCT00731783|584344333|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
161809509|NCT00731783|584344332|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
161809510|NCT00731783|584344333|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
161809511|NCT00731783|584344332|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
161809512|NCT00731783|584344333|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
161809513|NCT04115293|584345684|FG000|Overall Study|Adverse Event|0|||
161809514|NCT04115293|584345685|FG001|Overall Study|Adverse Event|2|||
161809515|NCT04115293|584345684|FG000|Overall Study|Withdrawal by Subject|2|||
161809516|NCT04115293|584345685|FG001|Overall Study|Withdrawal by Subject|1|||
161809517|NCT04115293|584345684|FG000|Overall Study|Physician Decision|1|||
161809518|NCT04115293|584345685|FG001|Overall Study|Physician Decision|0|||
161809519|NCT04115293|584345684|FG000|Overall Study|Death|1|||
161809520|NCT04115293|584345685|FG001|Overall Study|Death|1|||
161809521|NCT02674152|584345686|FG000|Overall Study|Personal Reasons|1|||
161809522|NCT02674152|584345687|FG001|Overall Study|Personal Reasons|0|||
161809523|NCT02674152|584345688|FG002|Overall Study|Personal Reasons|0|||
161809524|NCT02674152|584345689|FG003|Overall Study|Personal Reasons|1|||
161571047|NCT05174013|583477597|FG002|Overall Study|Withdrawal by Subject|1|||
161809525|NCT02674152|584345690|FG004|Overall Study|Personal Reasons|1|||
161809526|NCT02674152|584345686|FG000|Overall Study|Other adverse event or clinical progression|0|||
161913449|NCT03225287|584731990|FG001|Overall Study|Adverse Event|0|||
161913450|NCT03225287|584731991|FG002|Overall Study|Adverse Event|1|||
161913451|NCT03225287|584731989|FG000|Overall Study|Protocol non-compliance|0|||
161571048|NCT05174013|583477598|FG003|Overall Study|Withdrawal by Subject|0|||
161571049|NCT05174013|583477599|FG004|Overall Study|Withdrawal by Subject|0|||
161571050|NCT05174013|583477600|FG005|Overall Study|Withdrawal by Subject|0|||
161458069|NCT02616601|583073389|FG002|Overall Study|Non-Compliance with Test Article|1|||
161458070|NCT00371761|583073390|FG000|Overall Study|Adverse Event|1|||
161458071|NCT00371761|583073391|FG001|Overall Study|Adverse Event|1|||
161458072|NCT00371761|583073390|FG000|Overall Study|Withdrawal by Subject|1|||
161458073|NCT00371761|583073391|FG001|Overall Study|Withdrawal by Subject|3|||
161458074|NCT00371761|583073390|FG000|Overall Study|Investigator Judgment|2|||
161458075|NCT00371761|583073391|FG001|Overall Study|Investigator Judgment|3|||
161458076|NCT00371761|583073390|FG000|Overall Study|Study termination|4|||
161458077|NCT00371761|583073391|FG001|Overall Study|Study termination|3|||
161458078|NCT00718081|583073392|FG000|Overall Study|Adverse Event|0|||
161458079|NCT00718081|583073393|FG001|Overall Study|Adverse Event|1|||
161458080|NCT00718081|583073394|FG002|Overall Study|Adverse Event|0|||
161458081|NCT00718081|583073392|FG000|Overall Study|Lack of Efficacy|7|||
161458082|NCT00718081|583073393|FG001|Overall Study|Lack of Efficacy|3|||
161458083|NCT00718081|583073394|FG002|Overall Study|Lack of Efficacy|21|||
161458084|NCT00470158|583073395|FG000|Overall Study|Death|0|||
161458085|NCT00470158|583073396|FG001|Overall Study|Death|0|||
161458086|NCT00470158|583073397|FG002|Overall Study|Death|0|||
161458087|NCT00470158|583073398|FG003|Overall Study|Death|0|||
161458088|NCT00470158|583073399|FG004|Overall Study|Death|2|||
161458089|NCT00470158|583073395|FG000|Overall Study|Lost to Follow-up|7|||
161458090|NCT00470158|583073396|FG001|Overall Study|Lost to Follow-up|8|||
161458091|NCT00470158|583073397|FG002|Overall Study|Lost to Follow-up|8|||
161458092|NCT00470158|583073398|FG003|Overall Study|Lost to Follow-up|5|||
161458093|NCT00470158|583073399|FG004|Overall Study|Lost to Follow-up|4|||
161458094|NCT00470158|583073395|FG000|Overall Study|Protocol Violation|1|||
161458095|NCT00470158|583073396|FG001|Overall Study|Protocol Violation|0|||
161458096|NCT00470158|583073397|FG002|Overall Study|Protocol Violation|0|||
161458097|NCT00470158|583073398|FG003|Overall Study|Protocol Violation|0|||
161458098|NCT00470158|583073399|FG004|Overall Study|Protocol Violation|0|||
161458099|NCT00880685|583073400|FG000|Memantine 10mg|Lost to Follow-up|2|||
161458100|NCT00880685|583073400|FG000|Memantine 20mg|Withdrawal by Subject|1|||
161458101|NCT01249118|583073401|FG000|First Washout Period|Physician Decision|0|||
161458102|NCT01249118|583073402|FG001|First Washout Period|Physician Decision|1|||
161458103|NCT01249118|583073403|FG002|First Washout Period|Physician Decision|0|||
161458104|NCT04179890|583073404|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
161458105|NCT04179890|583073405|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
161458106|NCT04179890|583073404|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
161458107|NCT04179890|583073405|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
161458108|NCT04179890|583073404|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
161458109|NCT04179890|583073405|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
161458110|NCT04179890|583073404|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
161458111|NCT04179890|583073405|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
161458112|NCT04179890|583073404|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
161458113|NCT04179890|583073405|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
161458114|NCT04179890|583073404|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
161458115|NCT04179890|583073405|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
161458116|NCT04179890|583073404|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
161458117|NCT04179890|583073405|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
161458118|NCT04179890|583073404|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
161458119|NCT04179890|583073405|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
161571051|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
161571052|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
161809527|NCT02674152|584345687|FG001|Overall Study|Other adverse event or clinical progression|1|||
161809528|NCT02674152|584345688|FG002|Overall Study|Other adverse event or clinical progression|0|||
161809529|NCT02674152|584345689|FG003|Overall Study|Other adverse event or clinical progression|3|||
161809530|NCT02674152|584345690|FG004|Overall Study|Other adverse event or clinical progression|0|||
161809531|NCT02674152|584345686|FG000|Overall Study|Dose-limiting toxicity|0|||
161809532|NCT02674152|584345687|FG001|Overall Study|Dose-limiting toxicity|0|||
161458120|NCT04179890|583073404|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
161458121|NCT04179890|583073405|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
161458122|NCT00997438|583073407|FG000|Overall Study|Blood draw difficulty|2|||
161458123|NCT00997438|583073408|FG001|Overall Study|Blood draw difficulty|0|||
161458124|NCT00997438|583073409|FG002|Overall Study|Blood draw difficulty|1|||
161458125|NCT00997438|583073407|FG000|Overall Study|Withdrawal by Subject|1|||
161458126|NCT00997438|583073408|FG001|Overall Study|Withdrawal by Subject|1|||
161458127|NCT00997438|583073409|FG002|Overall Study|Withdrawal by Subject|0|||
161809533|NCT02674152|584345688|FG002|Overall Study|Dose-limiting toxicity|0|||
161458128|NCT00997438|583073407|FG000|Overall Study|Exclusion criteria at visit 1|2|||
161458129|NCT00997438|583073408|FG001|Overall Study|Exclusion criteria at visit 1|2|||
161458130|NCT00997438|583073409|FG002|Overall Study|Exclusion criteria at visit 1|3|||
161458131|NCT01236118|583073410|FG000|Overall Study|Adverse Event|2|||
161458132|NCT01236118|583073411|FG001|Overall Study|Adverse Event|0|||
161458133|NCT01236118|583073412|FG002|Overall Study|Adverse Event|2|||
161458134|NCT01236118|583073410|FG000|Overall Study|Physician Decision|0|||
161458135|NCT01236118|583073411|FG001|Overall Study|Physician Decision|1|||
161458136|NCT01236118|583073412|FG002|Overall Study|Physician Decision|0|||
161458137|NCT01236118|583073410|FG000|Overall Study|Withdrawal by Subject|0|||
161458138|NCT01236118|583073411|FG001|Overall Study|Withdrawal by Subject|0|||
161458139|NCT01236118|583073412|FG002|Overall Study|Withdrawal by Subject|1|||
161458140|NCT04535167|583073413|FG000|Treatment|Adverse Event|0|||
161458141|NCT04535167|583073414|FG001|Treatment|Adverse Event|0|||
161458142|NCT04535167|583073415|FG002|Treatment|Adverse Event|0|||
161458143|NCT04535167|583073416|FG003|Treatment|Adverse Event|0|||
161458144|NCT04535167|583073417|FG004|Treatment|Adverse Event|0|||
161458145|NCT04535167|583073418|FG005|Treatment|Adverse Event|0|||
161458146|NCT04535167|583073419|FG006|Treatment|Adverse Event|1|||
161458147|NCT04535167|583073413|FG000|Follow-Up|Death|0|||
161458148|NCT04535167|583073414|FG001|Follow-Up|Death|0|||
161458149|NCT04535167|583073415|FG002|Follow-Up|Death|0|||
161458150|NCT04535167|583073416|FG003|Follow-Up|Death|0|||
161458151|NCT04535167|583073417|FG004|Follow-Up|Death|0|||
161458152|NCT04535167|583073418|FG005|Follow-Up|Death|0|||
161458153|NCT04535167|583073419|FG006|Follow-Up|Death|1|||
161458154|NCT04535167|583073413|FG000|Follow-Up|Lost to Follow-up|0|||
161458155|NCT04535167|583073414|FG001|Follow-Up|Lost to Follow-up|0|||
161458156|NCT04535167|583073415|FG002|Follow-Up|Lost to Follow-up|0|||
161458157|NCT04535167|583073416|FG003|Follow-Up|Lost to Follow-up|1|||
161458158|NCT04535167|583073417|FG004|Follow-Up|Lost to Follow-up|0|||
161458159|NCT04535167|583073418|FG005|Follow-Up|Lost to Follow-up|0|||
161458160|NCT04535167|583073419|FG006|Follow-Up|Lost to Follow-up|0|||
161458161|NCT00978432|583073420|FG000|Overall Study|Withdrawal by Subject|0|||
161458162|NCT00978432|583073421|FG001|Overall Study|Withdrawal by Subject|0|||
161458163|NCT00978432|583073422|FG002|Overall Study|Withdrawal by Subject|1|||
161458164|NCT00978432|583073420|FG000|Overall Study|Lack of Efficacy|1|||
161458165|NCT00978432|583073421|FG001|Overall Study|Lack of Efficacy|1|||
161458166|NCT00978432|583073422|FG002|Overall Study|Lack of Efficacy|3|||
161458167|NCT00978432|583073420|FG000|Overall Study|Adverse Event|2|||
161458168|NCT00978432|583073421|FG001|Overall Study|Adverse Event|0|||
161458169|NCT00978432|583073422|FG002|Overall Study|Adverse Event|1|||
161458170|NCT02579928|583073423|FG000|Overall Study|Withdrawal by Subject|1|||
161458171|NCT02579928|583073424|FG001|Overall Study|Withdrawal by Subject|0|||
161458172|NCT04300751|583073427|FG000|Overall Study|Withdrawal by Subject|1|||
161458173|NCT04656275|583073433|FG000|Overall Study|Study terminated by sponsor|2|||
161458174|NCT04656275|583073434|FG001|Overall Study|Study terminated by sponsor|4|||
161458175|NCT00924781|583073436|FG000|Overall Study|Study terminated by sponsor|12|||
161458176|NCT00924781|583073437|FG001|Overall Study|Study terminated by sponsor|10|||
161458177|NCT01155479|583073442|FG000|Part I|Adverse Event|13|||
161458178|NCT01155479|583073443|FG001|Part I|Adverse Event|8|||
161458179|NCT01155479|583073444|FG002|Part I|Adverse Event|18|||
161458180|NCT01155479|583073445|FG003|Part I|Adverse Event|7|||
161458181|NCT01155479|583073446|FG004|Part I|Adverse Event|6|||
161458182|NCT01155479|583073442|FG000|Part I|Administrative|2|||
161458183|NCT01155479|583073443|FG001|Part I|Administrative|2|||
161458184|NCT01155479|583073444|FG002|Part I|Administrative|2|||
161458185|NCT01155479|583073445|FG003|Part I|Administrative|0|||
161458186|NCT01155479|583073446|FG004|Part I|Administrative|0|||
161571053|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
161571054|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
161571055|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
161571056|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
161571057|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
161571058|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
161571059|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
161571060|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
161571061|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
161571062|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
161571063|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
161458187|NCT01155479|583073442|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
161458188|NCT01155479|583073443|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
161458189|NCT01155479|583073444|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
161458190|NCT01155479|583073445|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
161458191|NCT01155479|583073446|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
161458192|NCT01155479|583073442|FG000|Part I|Withdrawal by Subject|11|||
161458193|NCT01155479|583073443|FG001|Part I|Withdrawal by Subject|13|||
161458194|NCT01155479|583073444|FG002|Part I|Withdrawal by Subject|8|||
161458195|NCT01155479|583073445|FG003|Part I|Withdrawal by Subject|8|||
161458196|NCT01155479|583073446|FG004|Part I|Withdrawal by Subject|9|||
161458197|NCT01155479|583073442|FG000|Part I|Lost to Follow-up|0|||
161458198|NCT01155479|583073443|FG001|Part I|Lost to Follow-up|0|||
161458199|NCT01155479|583073444|FG002|Part I|Lost to Follow-up|1|||
161458200|NCT01155479|583073445|FG003|Part I|Lost to Follow-up|1|||
161458201|NCT01155479|583073446|FG004|Part I|Lost to Follow-up|0|||
161458202|NCT01155479|583073442|FG000|Part I|Treatment Failure|3|||
161458203|NCT01155479|583073443|FG001|Part I|Treatment Failure|0|||
161458204|NCT01155479|583073444|FG002|Part I|Treatment Failure|3|||
161458205|NCT01155479|583073445|FG003|Part I|Treatment Failure|1|||
161458206|NCT01155479|583073446|FG004|Part I|Treatment Failure|2|||
161458207|NCT01155479|583073442|FG000|Part I|Did Not Receive Treatment|4|||
161458208|NCT01155479|583073443|FG001|Part I|Did Not Receive Treatment|2|||
161458209|NCT01155479|583073444|FG002|Part I|Did Not Receive Treatment|2|||
161458210|NCT01155479|583073445|FG003|Part I|Did Not Receive Treatment|6|||
161458211|NCT01155479|583073446|FG004|Part I|Did Not Receive Treatment|1|||
161458212|NCT01155479|583073442|FG000|Part I|Non-Compliance with Protocol|2|||
161458213|NCT01155479|583073443|FG001|Part I|Non-Compliance with Protocol|1|||
161458214|NCT01155479|583073444|FG002|Part I|Non-Compliance with Protocol|3|||
161458215|NCT01155479|583073445|FG003|Part I|Non-Compliance with Protocol|3|||
161458216|NCT01155479|583073446|FG004|Part I|Non-Compliance with Protocol|2|||
161458217|NCT01155479|583073442|FG000|Part II|Adverse Event|7|||
161458218|NCT01155479|583073443|FG001|Part II|Adverse Event|6|||
161458219|NCT01155479|583073444|FG002|Part II|Adverse Event|8|||
161458220|NCT01155479|583073445|FG003|Part II|Adverse Event|3|||
161458221|NCT01155479|583073446|FG004|Part II|Adverse Event|4|||
161458222|NCT01155479|583073442|FG000|Part II|Administrative|43|||
161458223|NCT01155479|583073443|FG001|Part II|Administrative|49|||
161458224|NCT01155479|583073444|FG002|Part II|Administrative|36|||
161458225|NCT01155479|583073445|FG003|Part II|Administrative|38|||
161458226|NCT01155479|583073446|FG004|Part II|Administrative|46|||
161458227|NCT01155479|583073442|FG000|Part II|Withdrawal by Subject|8|||
161458228|NCT01155479|583073443|FG001|Part II|Withdrawal by Subject|4|||
161458229|NCT01155479|583073444|FG002|Part II|Withdrawal by Subject|12|||
161458230|NCT01155479|583073445|FG003|Part II|Withdrawal by Subject|7|||
161458231|NCT01155479|583073446|FG004|Part II|Withdrawal by Subject|3|||
161458232|NCT01155479|583073442|FG000|Part II|Lost to Follow-up|1|||
161458233|NCT01155479|583073443|FG001|Part II|Lost to Follow-up|0|||
161458234|NCT01155479|583073444|FG002|Part II|Lost to Follow-up|0|||
161458235|NCT01155479|583073445|FG003|Part II|Lost to Follow-up|0|||
161458236|NCT01155479|583073446|FG004|Part II|Lost to Follow-up|1|||
161458237|NCT01155479|583073442|FG000|Part II|Treatment Failure|0|||
161458238|NCT01155479|583073443|FG001|Part II|Treatment Failure|1|||
161458239|NCT01155479|583073444|FG002|Part II|Treatment Failure|2|||
161458240|NCT01155479|583073445|FG003|Part II|Treatment Failure|0|||
161458241|NCT01155479|583073446|FG004|Part II|Treatment Failure|1|||
161458242|NCT01155479|583073442|FG000|Part II|Non-Compliance with Protocol|0|||
161458243|NCT01155479|583073443|FG001|Part II|Non-Compliance with Protocol|1|||
161458244|NCT01155479|583073444|FG002|Part II|Non-Compliance with Protocol|0|||
161458245|NCT01155479|583073445|FG003|Part II|Non-Compliance with Protocol|2|||
161458246|NCT01155479|583073446|FG004|Part II|Non-Compliance with Protocol|0|||
161458247|NCT01857310|583073447|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
161458248|NCT01857310|583073448|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
161458249|NCT02360605|583073449|FG000|Overall Study|Withdrawal by Subject|4|||
161458250|NCT02360605|583073450|FG001|Overall Study|Withdrawal by Subject|9|||
161458251|NCT02360605|583073449|FG000|Overall Study|Lost to Follow-up|7|||
161913452|NCT03225287|584731990|FG001|Overall Study|Protocol non-compliance|0|||
161913453|NCT03225287|584731991|FG002|Overall Study|Protocol non-compliance|1|||
161913454|NCT03225287|584731989|FG000|Overall Study|Subject withdraws consent|3|||
161913455|NCT03225287|584731990|FG001|Overall Study|Subject withdraws consent|0|||
161913456|NCT03225287|584731991|FG002|Overall Study|Subject withdraws consent|0|||
161913457|NCT03225287|584731989|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
161913458|NCT03225287|584731990|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
161913459|NCT03225287|584731991|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
161913460|NCT03225287|584731989|FG000|Overall Study|Trial drug not effective|0|||
161913461|NCT03225287|584731990|FG001|Overall Study|Trial drug not effective|1|||
161913462|NCT03225287|584731991|FG002|Overall Study|Trial drug not effective|0|||
161458252|NCT02360605|583073450|FG001|Overall Study|Lost to Follow-up|8|||
161458253|NCT02360605|583073449|FG000|Overall Study|Death|0|||
161458254|NCT02360605|583073450|FG001|Overall Study|Death|1|||
161458255|NCT00290407|583073451|FG000|Overall Study|Physician Decision|2|||
161458256|NCT00868517|583073460|FG000|Overall Study|Withdrawal by Subject|3|||
161458257|NCT00868517|583073461|FG001|Overall Study|Withdrawal by Subject|3|||
161458258|NCT00868517|583073462|FG002|Overall Study|Withdrawal by Subject|2|||
161458259|NCT00868517|583073460|FG000|Overall Study|Protocol Violation|1|||
161458260|NCT00868517|583073461|FG001|Overall Study|Protocol Violation|1|||
161458261|NCT00868517|583073462|FG002|Overall Study|Protocol Violation|0|||
161458262|NCT01721577|583073463|FG000|Overall Study|Lack of Efficacy|1|||
161458263|NCT01721577|583073464|FG001|Overall Study|Lack of Efficacy|0|||
161458264|NCT01721577|583073463|FG000|Overall Study|Death|1|||
161913463|NCT03225287|584731989|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
161458265|NCT01721577|583073464|FG001|Overall Study|Death|0|||
161458266|NCT01721577|583073463|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
161458267|NCT01721577|583073464|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
161458268|NCT01721577|583073463|FG000|Overall Study|Adverse Event|0|||
161458269|NCT01721577|583073464|FG001|Overall Study|Adverse Event|2|||
161458270|NCT01055496|583073465|FG000|Overall Study|Withdrawal by Subject|2|||
161458271|NCT01055496|583073466|FG001|Overall Study|Withdrawal by Subject|4|||
161458272|NCT01055496|583073465|FG000|Overall Study|Death|13|||
161458273|NCT01055496|583073466|FG001|Overall Study|Death|23|||
161458274|NCT01055496|583073465|FG000|Overall Study|Lost to Follow-up|0|||
161458275|NCT01055496|583073466|FG001|Overall Study|Lost to Follow-up|2|||
161458276|NCT01055496|583073465|FG000|Overall Study|Other - Unspecified|0|||
161458277|NCT01055496|583073466|FG001|Overall Study|Other - Unspecified|1|||
161458278|NCT00584740|583073467|FG000|Overall Study|Adverse Event|1|||
161458279|NCT00584740|583073468|FG001|Overall Study|Adverse Event|1|||
161458280|NCT00584740|583073467|FG000|Overall Study|Lack of Efficacy|8|||
161458281|NCT00584740|583073468|FG001|Overall Study|Lack of Efficacy|2|||
161458282|NCT00584740|583073467|FG000|Overall Study|Withdrawal by Subject|3|||
161458283|NCT00584740|583073468|FG001|Overall Study|Withdrawal by Subject|2|||
161458284|NCT00584740|583073467|FG000|Overall Study|Lost to Follow-up|0|||
161458285|NCT00584740|583073468|FG001|Overall Study|Lost to Follow-up|1|||
161458286|NCT02158364|583073469|FG000|Overall Study|Case report forms uncollected|10|||
161458287|NCT02158364|583073469|FG000|Overall Study|Protocol Deviation|50|||
161458288|NCT00732940|583073473|FG000|Overall Study|Withdrawal by Subject|1|||
161458289|NCT00732940|583073474|FG001|Overall Study|Withdrawal by Subject|2|||
161458290|NCT00732940|583073473|FG000|Overall Study|Adverse Event|0|||
161458291|NCT00732940|583073474|FG001|Overall Study|Adverse Event|1|||
161458292|NCT00732940|583073473|FG000|Overall Study|Lost to Follow-up|1|||
161458293|NCT00732940|583073474|FG001|Overall Study|Lost to Follow-up|0|||
161458294|NCT01642732|583073475|FG000|Overall Study|Withdrawal by Subject|1|||
161458295|NCT01589770|583073478|FG000|Overall Study|EGFR <60ml/min|6|||
161458296|NCT01589770|583073479|FG001|Overall Study|EGFR <60ml/min|4|||
161458297|NCT01589770|583073478|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
161458298|NCT01589770|583073479|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
161458299|NCT01077375|583073485|FG000|Overall Study|Adverse Event|2|||
161458300|NCT01077375|583073486|FG001|Overall Study|Adverse Event|15|||
161458301|NCT01077375|583073485|FG000|Overall Study|Lack of Efficacy|6|||
161458302|NCT01077375|583073486|FG001|Overall Study|Lack of Efficacy|8|||
161458303|NCT01077375|583073485|FG000|Overall Study|Withdrawal by Subject|0|||
161458304|NCT01077375|583073486|FG001|Overall Study|Withdrawal by Subject|6|||
161458305|NCT01077375|583073485|FG000|Overall Study|Lost to Follow-up|2|||
161458306|NCT01077375|583073486|FG001|Overall Study|Lost to Follow-up|5|||
161458307|NCT01077375|583073485|FG000|Overall Study|Other Reason|0|||
161458308|NCT01077375|583073486|FG001|Overall Study|Other Reason|1|||
161458309|NCT03021564|583073490|FG000|Overall Study|Death|84|||
161458310|NCT03021564|583073491|FG001|Overall Study|Death|466|||
161458311|NCT03021564|583073490|FG000|Overall Study|Lost to Follow-up|0|||
161458312|NCT03021564|583073491|FG001|Overall Study|Lost to Follow-up|2|||
161458313|NCT00969280|583073492|FG000|Overall Study|Protocol Violation|2|||
161809534|NCT02674152|584345689|FG003|Overall Study|Dose-limiting toxicity|0|||
161809535|NCT02674152|584345690|FG004|Overall Study|Dose-limiting toxicity|1|||
161809536|NCT02674152|584345686|FG000|Overall Study|Progressive Disease|2|||
161809537|NCT02674152|584345687|FG001|Overall Study|Progressive Disease|1|||
161809538|NCT02674152|584345688|FG002|Overall Study|Progressive Disease|1|||
161809539|NCT02674152|584345689|FG003|Overall Study|Progressive Disease|13|||
161809540|NCT02674152|584345690|FG004|Overall Study|Progressive Disease|2|||
161809541|NCT02674152|584345686|FG000|Overall Study|Adverse Event|0|||
161809542|NCT02674152|584345687|FG001|Overall Study|Adverse Event|0|||
161809543|NCT02674152|584345688|FG002|Overall Study|Adverse Event|1|||
161809544|NCT02674152|584345689|FG003|Overall Study|Adverse Event|0|||
161809545|NCT02674152|584345690|FG004|Overall Study|Adverse Event|1|||
161809546|NCT02571907|584345691|FG000|Overall Study|Death|4|||
161458314|NCT00969280|583073493|FG001|Overall Study|Protocol Violation|1|||
161458315|NCT00969280|583073492|FG000|Overall Study|Withdrawal by Subject|0|||
161458316|NCT00969280|583073493|FG001|Overall Study|Withdrawal by Subject|1|||
161458317|NCT00969280|583073492|FG000|Overall Study|infection of influenza A(H1N1)|0|||
161458318|NCT00969280|583073493|FG001|Overall Study|infection of influenza A(H1N1)|1|||
161458319|NCT00821327|583073494|FG000|Overall Study|Adverse Event|13|||
161809547|NCT02571907|584345691|FG000|Overall Study|Lost to Follow-up|3|||
161809548|NCT02571907|584345691|FG000|Overall Study|Withdrawal by Subject|3|||
161458320|NCT00821327|583073494|FG000|Overall Study|Patient Request|1|||
161458321|NCT00821327|583073494|FG000|Overall Study|Investigator Request|2|||
161458322|NCT00821327|583073494|FG000|Overall Study|Sponsor Request|1|||
161458323|NCT00821327|583073494|FG000|Overall Study|Disease Progression|13|||
161458324|NCT00821327|583073494|FG000|Overall Study|Other/Unknown|5|||
161809549|NCT03772522|584345692|FG000|Pre-intervention|Withdrawal by Subject|3|||
161809550|NCT03772522|584345693|FG001|Pre-intervention|Withdrawal by Subject|4|||
161458325|NCT00217464|583073495|FG000|Overall Study|Progression|15|||
161458326|NCT00217464|583073495|FG000|Overall Study|Other|2|||
161458327|NCT00459979|583073496|FG000|Overall Study|Withdrawal by Subject|1|||
161458328|NCT00459979|583073496|FG000|Overall Study|Protocol Violation|1|||
161458329|NCT00278915|583073497|FG000|Overall Study|Disease progression|1|||
161458330|NCT05214573|583073498|FG000|Overall Study|Physician Decision|5924|||
161458331|NCT05214573|583073499|FG001|Overall Study|Physician Decision|0|||
161458332|NCT00814801|583073500|FG000|Overall Study|Adverse Event|15|||
161458333|NCT00814801|583073501|FG001|Overall Study|Adverse Event|16|||
161458334|NCT00814801|583073502|FG002|Overall Study|Adverse Event|19|||
161458335|NCT00814801|583073500|FG000|Overall Study|Withdrawal by Subject|9|||
161458336|NCT00814801|583073501|FG001|Overall Study|Withdrawal by Subject|11|||
161458337|NCT00814801|583073502|FG002|Overall Study|Withdrawal by Subject|14|||
161458338|NCT00814801|583073500|FG000|Overall Study|Inappropriate as a subject|1|||
161458339|NCT00814801|583073501|FG001|Overall Study|Inappropriate as a subject|1|||
161458340|NCT00814801|583073502|FG002|Overall Study|Inappropriate as a subject|1|||
161458341|NCT00814801|583073500|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
161458342|NCT00814801|583073501|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
161458343|NCT00814801|583073502|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
161458344|NCT00814801|583073500|FG000|Overall Study|Missing or change of caregiver|6|||
161458345|NCT00814801|583073501|FG001|Overall Study|Missing or change of caregiver|2|||
161458346|NCT00814801|583073502|FG002|Overall Study|Missing or change of caregiver|4|||
161458347|NCT00814801|583073500|FG000|Overall Study|Non-compliance|0|||
161458348|NCT00814801|583073501|FG001|Overall Study|Non-compliance|1|||
161458349|NCT00814801|583073502|FG002|Overall Study|Non-compliance|1|||
161458350|NCT00814801|583073500|FG000|Overall Study|Other|2|||
161458351|NCT00814801|583073501|FG001|Overall Study|Other|6|||
161458352|NCT00814801|583073502|FG002|Overall Study|Other|4|||
161458353|NCT01037088|583073505|FG000|Overall Study|Withdrawal by Subject|3|||
161458354|NCT02216812|583073506|FG000|Overall Study|Lost to Follow-up|10|||
161458355|NCT02216812|583073507|FG001|Overall Study|Lost to Follow-up|5|||
161458356|NCT00527488|583073508|FG000|Overall Study|Withdrawn prior to dosing|0|||
161458357|NCT00527488|583073509|FG001|Overall Study|Withdrawn prior to dosing|1|||
161458358|NCT00527488|583073510|FG002|Overall Study|Withdrawn prior to dosing|1|||
161458359|NCT00527488|583073511|FG003|Overall Study|Withdrawn prior to dosing|0|||
161458360|NCT03036800|583073512|FG000|Overall Study|Protocol Violation|1|||
161458361|NCT03036800|583073513|FG001|Overall Study|Protocol Violation|0|||
161458362|NCT03036800|583073512|FG000|Overall Study|Non-compliance|1|||
161458363|NCT03036800|583073513|FG001|Overall Study|Non-compliance|0|||
161458364|NCT03036800|583073512|FG000|Overall Study|Lost to Follow-up|1|||
161458365|NCT03036800|583073513|FG001|Overall Study|Lost to Follow-up|0|||
161458366|NCT03036800|583073512|FG000|Overall Study|Death|1|||
161458367|NCT03036800|583073513|FG001|Overall Study|Death|0|||
161458368|NCT03036800|583073512|FG000|Overall Study|Tolerance|5|||
161458369|NCT03036800|583073513|FG001|Overall Study|Tolerance|0|||
161458370|NCT03036800|583073512|FG000|Overall Study|Unknown/no reason given|50|||
161458371|NCT03036800|583073513|FG001|Overall Study|Unknown/no reason given|39|||
161458372|NCT01986933|583073514|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
161458373|NCT01986933|583073515|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
161458374|NCT01986933|583073516|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
161458375|NCT01986933|583073517|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
161458376|NCT01986933|583073518|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
161458377|NCT01986933|583073514|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
161458378|NCT01986933|583073515|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
161458379|NCT01986933|583073516|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
161458380|NCT01986933|583073517|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
161458381|NCT01986933|583073518|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
161458382|NCT01986933|583073514|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
161458383|NCT01986933|583073515|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
161458384|NCT01986933|583073516|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
161458385|NCT01986933|583073517|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
161458386|NCT01986933|583073518|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
161458387|NCT01986933|583073514|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
161458388|NCT01986933|583073515|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
161458389|NCT01986933|583073516|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
161458390|NCT01986933|583073517|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
161458391|NCT01986933|583073518|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
161458392|NCT01986933|583073514|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161913464|NCT03225287|584731990|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
161913465|NCT03225287|584731991|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
161458393|NCT01986933|583073515|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161458394|NCT01986933|583073516|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161458395|NCT01986933|583073517|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161458396|NCT01986933|583073518|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
161458397|NCT01986933|583073514|FG000|Active-to-active (Part B)|Adverse Event|0|||
161458398|NCT01986933|583073515|FG001|Active-to-active (Part B)|Adverse Event|2|||
161458399|NCT01986933|583073516|FG002|Active-to-active (Part B)|Adverse Event|0|||
161458400|NCT01986933|583073517|FG003|Active-to-active (Part B)|Adverse Event|1|||
161458401|NCT01986933|583073518|FG004|Active-to-active (Part B)|Adverse Event|3|||
161458402|NCT01986933|583073514|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
161458403|NCT01986933|583073515|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
161458404|NCT01986933|583073516|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
161458405|NCT01986933|583073517|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
161458406|NCT01986933|583073518|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
161458407|NCT01986933|583073514|FG000|Active-to-active (Part B)|Pregnancy|0|||
161458408|NCT01986933|583073515|FG001|Active-to-active (Part B)|Pregnancy|0|||
161458409|NCT01986933|583073516|FG002|Active-to-active (Part B)|Pregnancy|0|||
161458410|NCT01986933|583073517|FG003|Active-to-active (Part B)|Pregnancy|0|||
161458411|NCT01986933|583073518|FG004|Active-to-active (Part B)|Pregnancy|1|||
161458412|NCT01986933|583073514|FG000|Active-to-active (Part B)|Physician Decision|0|||
161458413|NCT01986933|583073515|FG001|Active-to-active (Part B)|Physician Decision|0|||
161458414|NCT01986933|583073516|FG002|Active-to-active (Part B)|Physician Decision|1|||
161458415|NCT01986933|583073517|FG003|Active-to-active (Part B)|Physician Decision|1|||
161458416|NCT01986933|583073518|FG004|Active-to-active (Part B)|Physician Decision|0|||
161458417|NCT01986933|583073514|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
161458418|NCT01986933|583073515|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
161458419|NCT01986933|583073516|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
161458420|NCT01986933|583073517|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
161458421|NCT01986933|583073518|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
161458422|NCT01986933|583073514|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
161458423|NCT01986933|583073515|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
161458424|NCT01986933|583073516|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
161458425|NCT01986933|583073517|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
161458426|NCT01986933|583073518|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
161458427|NCT01986933|583073514|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
161458428|NCT01986933|583073515|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
161458429|NCT01986933|583073516|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
161458430|NCT01986933|583073517|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
161458431|NCT01986933|583073518|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
161458432|NCT01986933|583073514|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
161458433|NCT01986933|583073515|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
161458434|NCT01986933|583073516|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
161458435|NCT01986933|583073517|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
161458436|NCT01986933|583073518|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
161458437|NCT01986933|583073514|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
161458438|NCT01986933|583073515|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
161458439|NCT01986933|583073516|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
161458440|NCT01986933|583073517|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
161458441|NCT01986933|583073518|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
161458442|NCT01986933|583073514|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
161458443|NCT01986933|583073515|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
161458444|NCT01986933|583073516|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
161458445|NCT01986933|583073517|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
161458446|NCT01986933|583073518|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
161458447|NCT01986933|583073514|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
161458448|NCT01986933|583073515|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
161458449|NCT01986933|583073516|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
161458450|NCT01986933|583073517|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
161458451|NCT01986933|583073518|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
161458452|NCT01986933|583073514|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
161458453|NCT01986933|583073515|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
161458454|NCT01986933|583073516|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
161458455|NCT01986933|583073517|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
161458456|NCT01986933|583073518|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
161458457|NCT01077154|583073519|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
161809551|NCT03772522|584345692|FG000|Intervention|Withdrawal by Subject|1|||
161809552|NCT03772522|584345693|FG001|Intervention|Withdrawal by Subject|0|||
161809553|NCT03772522|584345692|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
161809554|NCT03772522|584345693|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
161809555|NCT00218257|584345694|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
161809556|NCT00218257|584345695|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
161809557|NCT00579345|584345696|FG000|Overall Study|Withdrawal by Subject|2|||
161809558|NCT00579345|584345697|FG001|Overall Study|Withdrawal by Subject|0|||
161809559|NCT00579345|584345698|FG002|Overall Study|Withdrawal by Subject|0|||
161809560|NCT00579345|584345699|FG003|Overall Study|Withdrawal by Subject|0|||
161809561|NCT00579345|584345700|FG004|Overall Study|Withdrawal by Subject|0|||
161809562|NCT00579345|584345701|FG005|Overall Study|Withdrawal by Subject|0|||
161809563|NCT00579345|584345702|FG006|Overall Study|Withdrawal by Subject|0|||
161809564|NCT00579345|584345703|FG007|Overall Study|Withdrawal by Subject|1|||
161809565|NCT00579345|584345696|FG000|Overall Study|Lost to Follow-up|1|||
161458458|NCT01077154|583073520|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
161458459|NCT01077154|583073519|FG000|Overall Study|Withdrawal by Subject|369|||
161458460|NCT01077154|583073520|FG001|Overall Study|Withdrawal by Subject|385|||
161458461|NCT01077154|583073519|FG000|Overall Study|Death|215|||
161458462|NCT01077154|583073520|FG001|Overall Study|Death|214|||
161458463|NCT01077154|583073519|FG000|Overall Study|Lost to Follow-up|43|||
161458464|NCT01077154|583073520|FG001|Overall Study|Lost to Follow-up|35|||
161458465|NCT01077154|583073519|FG000|Overall Study|Noncompliance|22|||
161458466|NCT01077154|583073520|FG001|Overall Study|Noncompliance|20|||
161458467|NCT01077154|583073519|FG000|Overall Study|Disease Progression|18|||
161458468|NCT01077154|583073520|FG001|Overall Study|Disease Progression|20|||
161458469|NCT01077154|583073519|FG000|Overall Study|Ineligibility Determined|10|||
161458470|NCT01077154|583073520|FG001|Overall Study|Ineligibility Determined|14|||
161458471|NCT01077154|583073519|FG000|Overall Study|Other|14|||
161458472|NCT01077154|583073520|FG001|Overall Study|Other|11|||
161458473|NCT01077154|583073519|FG000|Overall Study|Adverse Event|9|||
161458474|NCT01077154|583073520|FG001|Overall Study|Adverse Event|9|||
161458475|NCT01077154|583073519|FG000|Overall Study|Administrative Decision|1|||
161458476|NCT01077154|583073520|FG001|Overall Study|Administrative Decision|6|||
161458477|NCT01077154|583073519|FG000|Overall Study|Protocol Deviation|1|||
161458478|NCT01077154|583073520|FG001|Overall Study|Protocol Deviation|0|||
161458479|NCT04030026|583073521|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
161458480|NCT04030026|583073522|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
161458481|NCT04030026|583073521|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
161458482|NCT04030026|583073522|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
161458483|NCT04030026|583073521|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
161458484|NCT04030026|583073522|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
161458485|NCT04030026|583073521|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
161458486|NCT04030026|583073522|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
161458487|NCT04030026|583073521|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
161458488|NCT04030026|583073522|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
161458489|NCT04030026|583073521|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
161458490|NCT04030026|583073522|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
161458491|NCT04030026|583073521|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
161458492|NCT04030026|583073522|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
161458493|NCT02545543|583073523|FG000|Overall Study|Lost to Follow-up|67|||
161458494|NCT02545543|583073524|FG001|Overall Study|Lost to Follow-up|25|||
161458495|NCT02545543|583073523|FG000|Overall Study|Physician Decision|3|||
161458496|NCT02545543|583073524|FG001|Overall Study|Physician Decision|0|||
161458497|NCT02545543|583073523|FG000|Overall Study|Withdrawal by Subject|9|||
161458498|NCT02545543|583073524|FG001|Overall Study|Withdrawal by Subject|8|||
161458499|NCT02545543|583073523|FG000|Overall Study|Noncomplaince|1|||
161458500|NCT02545543|583073524|FG001|Overall Study|Noncomplaince|0|||
161458501|NCT02545543|583073523|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
161458502|NCT02545543|583073524|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
161458503|NCT00811642|583073529|FG000|Overall Study|Adverse Event|3|||
161458504|NCT00811642|583073529|FG000|Overall Study|Protocol Violation|1|||
161458505|NCT00811642|583073529|FG000|Overall Study|Death|2|||
161458506|NCT00811642|583073529|FG000|Overall Study|Withdrawal by Subject|7|||
161458507|NCT00811642|583073529|FG000|Overall Study|Cumulative use of antifungal agent|2|||
161458508|NCT00815516|583074733|FG000|Overall Study|Death|3|||
161458509|NCT00815516|583074734|FG001|Overall Study|Death|1|||
161458510|NCT00815516|583074733|FG000|Overall Study|Physician Decision|1|||
161458511|NCT00815516|583074734|FG001|Overall Study|Physician Decision|0|||
161458512|NCT01992159|583074741|FG000|Overall Study|Withdrawal by Subject|4|||
161458513|NCT01992159|583074742|FG001|Overall Study|Withdrawal by Subject|7|||
161913466|NCT03225287|584731989|FG000|Overall Study|Stem cell transplantation|0|||
161913467|NCT03225287|584731990|FG001|Overall Study|Stem cell transplantation|1|||
161913468|NCT03225287|584731991|FG002|Overall Study|Stem cell transplantation|0|||
161913469|NCT06070610|584731994|FG000|Washout period|Adverse Event|1|||
161458514|NCT01992159|583074743|FG002|Overall Study|Withdrawal by Subject|0|||
161458515|NCT01992159|583074744|FG003|Overall Study|Withdrawal by Subject|3|||
161458516|NCT01992159|583074741|FG000|Overall Study|Adverse Event|0|||
161458517|NCT01992159|583074742|FG001|Overall Study|Adverse Event|1|||
161458518|NCT01992159|583074743|FG002|Overall Study|Adverse Event|0|||
161458519|NCT01992159|583074744|FG003|Overall Study|Adverse Event|1|||
161458520|NCT01992159|583074741|FG000|Overall Study|Death|0|||
161458521|NCT01992159|583074742|FG001|Overall Study|Death|0|||
161458522|NCT01992159|583074743|FG002|Overall Study|Death|1|||
161458523|NCT01992159|583074744|FG003|Overall Study|Death|0|||
161913470|NCT06070610|584731994|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
161458524|NCT00095238|583074745|FG000|Overall Study|Lack of Efficacy|9|||
161458525|NCT00095238|583074746|FG001|Overall Study|Lack of Efficacy|9|||
161458526|NCT00095238|583074745|FG000|Overall Study|Adverse Event|331|||
161458527|NCT00095238|583074746|FG001|Overall Study|Adverse Event|287|||
161458528|NCT00095238|583074745|FG000|Overall Study|Subject Withdrew Consent|208|||
161458529|NCT00095238|583074746|FG001|Overall Study|Subject Withdrew Consent|223|||
161458530|NCT00095238|583074745|FG000|Overall Study|Death|154|||
161913471|NCT00834041|584731995|FG000|Overall Study|Withdrawal by Subject|1|||
161458531|NCT00095238|583074746|FG001|Overall Study|Death|170|||
161458532|NCT00095238|583074745|FG000|Overall Study|Lost to Follow-up|19|||
161458533|NCT00095238|583074746|FG001|Overall Study|Lost to Follow-up|24|||
161458534|NCT00095238|583074745|FG000|Overall Study|Noncompliance|44|||
161458535|NCT00095238|583074746|FG001|Overall Study|Noncompliance|45|||
161458536|NCT00095238|583074745|FG000|Overall Study|No longer met study criteria|4|||
161458537|NCT00095238|583074746|FG001|Overall Study|No longer met study criteria|5|||
161458538|NCT00095238|583074745|FG000|Overall Study|Study terminated by sponsor|0|||
161458539|NCT00095238|583074746|FG001|Overall Study|Study terminated by sponsor|1|||
161458540|NCT00095238|583074745|FG000|Overall Study|Missing|1|||
161458541|NCT00095238|583074746|FG001|Overall Study|Missing|0|||
161571064|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
161809566|NCT00579345|584345697|FG001|Overall Study|Lost to Follow-up|0|||
161458542|NCT00095238|583074745|FG000|Overall Study|Other Reasons|87|||
161571065|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
161571066|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
161571067|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
161571068|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
161571069|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
161571070|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
161571071|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
161571072|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
161571073|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
161571074|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
161571075|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
161571076|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
161571077|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
161571078|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
161571079|NCT00241644|583477601|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
161571080|NCT00241644|583477602|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
161571081|NCT00241644|583477603|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
161571082|NCT00241644|583477604|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
161571083|NCT00241644|583477601|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
161571084|NCT00241644|583477602|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
161571085|NCT00241644|583477603|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
161571086|NCT00241644|583477604|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
161571087|NCT00241644|583477601|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
161571088|NCT00241644|583477602|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
161571089|NCT00241644|583477603|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
161571090|NCT00241644|583477604|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
161571091|NCT00241644|583477601|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
161571092|NCT00241644|583477602|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
161571093|NCT00241644|583477603|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
161571094|NCT00241644|583477604|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
161571095|NCT00241644|583477601|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
161571096|NCT00241644|583477602|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
161571097|NCT00241644|583477603|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
161571098|NCT00241644|583477604|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
161571099|NCT00241644|583477601|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
161571100|NCT00241644|583477602|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
161571101|NCT00241644|583477603|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
161571102|NCT00241644|583477604|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
161571103|NCT00864682|583477606|FG000|Overall Study|Protocol Violation|2|||
161571104|NCT00864682|583477607|FG001|Overall Study|Protocol Violation|1|||
161571105|NCT00864682|583477608|FG002|Overall Study|Protocol Violation|2|||
161571106|NCT00094809|583477612|FG000|Overall Study|Protocol deviation|2|||
161571107|NCT00094809|583477613|FG001|Overall Study|Protocol deviation|2|||
161571108|NCT00094809|583477612|FG000|Overall Study|Noncompliance|1|||
161571109|NCT00094809|583477613|FG001|Overall Study|Noncompliance|0|||
161571110|NCT00094809|583477612|FG000|Overall Study|Adverse Event|3|||
161571111|NCT00094809|583477613|FG001|Overall Study|Adverse Event|1|||
161571112|NCT00094809|583477612|FG000|Overall Study|Withdrawal by Subject|8|||
161571113|NCT00094809|583477613|FG001|Overall Study|Withdrawal by Subject|9|||
161571114|NCT00094809|583477612|FG000|Overall Study|Disease progression|3|||
161571115|NCT00094809|583477613|FG001|Overall Study|Disease progression|3|||
161571116|NCT00094809|583477612|FG000|Overall Study|Physician Decision|3|||
161571117|NCT00094809|583477613|FG001|Overall Study|Physician Decision|5|||
161571118|NCT00094809|583477612|FG000|Overall Study|Lost to Follow-up|6|||
161571119|NCT00094809|583477613|FG001|Overall Study|Lost to Follow-up|6|||
161571120|NCT00094809|583477612|FG000|Overall Study|Death|19|||
161571121|NCT00094809|583477613|FG001|Overall Study|Death|25|||
161809567|NCT00579345|584345698|FG002|Overall Study|Lost to Follow-up|0|||
161809568|NCT00579345|584345699|FG003|Overall Study|Lost to Follow-up|0|||
161809569|NCT00579345|584345700|FG004|Overall Study|Lost to Follow-up|0|||
161809570|NCT00579345|584345701|FG005|Overall Study|Lost to Follow-up|0|||
161809571|NCT00579345|584345702|FG006|Overall Study|Lost to Follow-up|0|||
161809572|NCT00579345|584345703|FG007|Overall Study|Lost to Follow-up|0|||
161809573|NCT00579345|584345696|FG000|Overall Study|Adverse Event|0|||
161809574|NCT00579345|584345697|FG001|Overall Study|Adverse Event|0|||
161913472|NCT00834041|584731996|FG001|Overall Study|Withdrawal by Subject|0|||
161913473|NCT00834041|584731995|FG000|Overall Study|Lost to Follow-up|0|||
161913474|NCT00834041|584731996|FG001|Overall Study|Lost to Follow-up|1|||
161571122|NCT00094809|583477612|FG000|Overall Study|Protocol-specified criteria|1|||
161571123|NCT00094809|583477613|FG001|Overall Study|Protocol-specified criteria|1|||
161571124|NCT00094809|583477612|FG000|Overall Study|Other|2|||
161571125|NCT00094809|583477613|FG001|Overall Study|Other|4|||
161571126|NCT00094809|583477612|FG000|Overall Study|Informed consent signed after treatment|1|||
161571127|NCT00094809|583477613|FG001|Overall Study|Informed consent signed after treatment|0|||
161809575|NCT00579345|584345698|FG002|Overall Study|Adverse Event|1|||
161571128|NCT00094809|583477612|FG000|Overall Study|Study drug not received|2|||
161571129|NCT00094809|583477613|FG001|Overall Study|Study drug not received|8|||
161571130|NCT00094809|583477612|FG000|Overall Study|Other|1|||
161571131|NCT00094809|583477613|FG001|Overall Study|Other|1|||
161913475|NCT01288430|584733559|FG000|Part 1|Progressive disease|2|||
161913476|NCT01288430|584733560|FG001|Part 1|Progressive disease|1|||
161913477|NCT01288430|584733561|FG002|Part 1|Progressive disease|1|||
161913478|NCT01288430|584733562|FG003|Part 1|Progressive disease|6|||
161913479|NCT01288430|584733563|FG004|Part 1|Progressive disease|2|||
161913480|NCT01288430|584733564|FG005|Part 1|Progressive disease|4|||
161913481|NCT01288430|584733565|FG006|Part 1|Progressive disease|2|||
161913482|NCT01288430|584733566|FG007|Part 1|Progressive disease|0|||
161913483|NCT01288430|584733567|FG008|Part 1|Progressive disease|0|||
161913484|NCT01288430|584733568|FG009|Part 1|Progressive disease|0|||
161913485|NCT01288430|584733559|FG000|Part 1|Clinical disease progression|0|||
161913486|NCT01288430|584733560|FG001|Part 1|Clinical disease progression|0|||
161913487|NCT01288430|584733561|FG002|Part 1|Clinical disease progression|1|||
161913488|NCT01288430|584733562|FG003|Part 1|Clinical disease progression|0|||
161913489|NCT01288430|584733563|FG004|Part 1|Clinical disease progression|0|||
161913490|NCT01288430|584733564|FG005|Part 1|Clinical disease progression|2|||
161913491|NCT01288430|584733565|FG006|Part 1|Clinical disease progression|2|||
161913492|NCT01288430|584733566|FG007|Part 1|Clinical disease progression|0|||
161913493|NCT01288430|584733567|FG008|Part 1|Clinical disease progression|0|||
161913494|NCT01288430|584733568|FG009|Part 1|Clinical disease progression|0|||
161913495|NCT01288430|584733559|FG000|Part 1|Death due to disease progression|0|||
161913496|NCT01288430|584733560|FG001|Part 1|Death due to disease progression|0|||
161913497|NCT01288430|584733561|FG002|Part 1|Death due to disease progression|0|||
161913498|NCT01288430|584733562|FG003|Part 1|Death due to disease progression|0|||
161913499|NCT01288430|584733563|FG004|Part 1|Death due to disease progression|1|||
161913500|NCT01288430|584733564|FG005|Part 1|Death due to disease progression|0|||
161913501|NCT01288430|584733565|FG006|Part 1|Death due to disease progression|0|||
161913502|NCT01288430|584733566|FG007|Part 1|Death due to disease progression|0|||
161913503|NCT01288430|584733567|FG008|Part 1|Death due to disease progression|0|||
161913504|NCT01288430|584733568|FG009|Part 1|Death due to disease progression|0|||
161913505|NCT01288430|584733559|FG000|Part 1|Adverse Event|0|||
161913506|NCT01288430|584733560|FG001|Part 1|Adverse Event|0|||
161913507|NCT01288430|584733561|FG002|Part 1|Adverse Event|3|||
161913508|NCT01288430|584733562|FG003|Part 1|Adverse Event|1|||
161913509|NCT01288430|584733563|FG004|Part 1|Adverse Event|0|||
161913510|NCT01288430|584733564|FG005|Part 1|Adverse Event|0|||
161913511|NCT01288430|584733565|FG006|Part 1|Adverse Event|2|||
161913512|NCT01288430|584733566|FG007|Part 1|Adverse Event|0|||
161913513|NCT01288430|584733567|FG008|Part 1|Adverse Event|0|||
161913514|NCT01288430|584733568|FG009|Part 1|Adverse Event|0|||
161458543|NCT00095238|583074746|FG001|Overall Study|Other Reasons|88|||
161458544|NCT03754972|583074747|FG000|Overall Study|Protocol Violation|25|||
161458545|NCT02311582|583074748|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
161458546|NCT02311582|583074749|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
161458547|NCT02311582|583074750|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
161458548|NCT02311582|583074751|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
161458549|NCT02311582|583074752|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
161458550|NCT03404960|583074754|FG000|Overall Study|Adverse Event|0|||
161458551|NCT03404960|583074755|FG001|Overall Study|Adverse Event|2|||
161458552|NCT03404960|583074754|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
161458553|NCT03404960|583074755|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
161458554|NCT03404960|583074754|FG000|Overall Study|Bowel obstruction|0|||
161458555|NCT03404960|583074755|FG001|Overall Study|Bowel obstruction|1|||
161458556|NCT03404960|583074754|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
161458557|NCT03404960|583074755|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
161458558|NCT06460493|583074758|FG000|Overall Study|Withdrawal by Subject|2|||
161458559|NCT04972630|583074761|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
161458560|NCT04972630|583074762|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
161458561|NCT04972630|583074763|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
161458562|NCT00075270|583074768|FG000|Overall Study|Withdrawal by Subject|28|||
161458563|NCT00075270|583074769|FG001|Overall Study|Withdrawal by Subject|21|||
161458564|NCT00075270|583074768|FG000|Overall Study|Lost to Follow-up|25|||
161913515|NCT01288430|584733559|FG000|Part 1|Other|0|||
161913516|NCT01288430|584733560|FG001|Part 1|Other|2|||
161913517|NCT01288430|584733561|FG002|Part 1|Other|0|||
161913518|NCT01288430|584733562|FG003|Part 1|Other|0|||
161913519|NCT01288430|584733563|FG004|Part 1|Other|0|||
161913520|NCT01288430|584733564|FG005|Part 1|Other|0|||
161913521|NCT01288430|584733565|FG006|Part 1|Other|1|||
161913522|NCT01288430|584733566|FG007|Part 1|Other|0|||
161913523|NCT01288430|584733567|FG008|Part 1|Other|0|||
161913524|NCT01288430|584733568|FG009|Part 1|Other|0|||
161913525|NCT01288430|584733559|FG000|Part 2|Progressive disease|0|||
161458565|NCT00075270|583074769|FG001|Overall Study|Lost to Follow-up|28|||
161458566|NCT00075270|583074768|FG000|Overall Study|Protocol Violation|0|||
161458567|NCT00075270|583074769|FG001|Overall Study|Protocol Violation|2|||
161458568|NCT00075270|583074768|FG000|Overall Study|Death|198|||
161458569|NCT00075270|583074769|FG001|Overall Study|Death|215|||
161458570|NCT00075270|583074768|FG000|Overall Study|Other/Unknown|9|||
161458571|NCT00075270|583074769|FG001|Overall Study|Other/Unknown|5|||
161458572|NCT00075270|583074768|FG000|Overall Study|Missing|26|||
161458573|NCT00075270|583074769|FG001|Overall Study|Missing|13|||
161458574|NCT00246571|583074770|FG000|Overall Study|Adverse Event|7|||
161458575|NCT00246571|583074771|FG001|Overall Study|Adverse Event|0|||
161571132|NCT04889664|583477614|FG000|Screen|Lost to Follow-up|1|||
161458576|NCT00246571|583074770|FG000|Overall Study|Protocol Violation|0|||
161458577|NCT00246571|583074771|FG001|Overall Study|Protocol Violation|1|||
161458578|NCT00246571|583074770|FG000|Overall Study|Withdrawal by Subject|2|||
161458579|NCT00246571|583074771|FG001|Overall Study|Withdrawal by Subject|3|||
161458580|NCT00246571|583074770|FG000|Overall Study|Lack of Efficacy|84|||
161458581|NCT00246571|583074771|FG001|Overall Study|Lack of Efficacy|21|||
161458582|NCT00246571|583074770|FG000|Overall Study|Death|17|||
161458583|NCT00246571|583074771|FG001|Overall Study|Death|3|||
161458584|NCT00246571|583074770|FG000|Overall Study|Sponsor|0|||
161458585|NCT00246571|583074771|FG001|Overall Study|Sponsor|1|||
161458586|NCT00246571|583074770|FG000|Overall Study|Did not meet entrance criteria|2|||
161458587|NCT00246571|583074771|FG001|Overall Study|Did not meet entrance criteria|1|||
161458588|NCT00246571|583074770|FG000|Overall Study|Laboratory abnormalities|1|||
161458589|NCT00246571|583074771|FG001|Overall Study|Laboratory abnormalities|0|||
161458590|NCT00246571|583074770|FG000|Overall Study|Crossover participants|0|||
161458591|NCT00246571|583074771|FG001|Overall Study|Crossover participants|74|||
161458592|NCT00775203|583074772|FG000|Overall Study|Adverse Event|25|||
161458593|NCT00775203|583074773|FG001|Overall Study|Adverse Event|6|||
161458594|NCT00775203|583074772|FG000|Overall Study|Lack of Efficacy|8|||
161458595|NCT00775203|583074773|FG001|Overall Study|Lack of Efficacy|9|||
161458596|NCT00775203|583074772|FG000|Overall Study|Withdrawal by Subject|11|||
161458597|NCT00775203|583074773|FG001|Overall Study|Withdrawal by Subject|9|||
161458598|NCT00775203|583074772|FG000|Overall Study|Lost to Follow-up|11|||
161458599|NCT00775203|583074773|FG001|Overall Study|Lost to Follow-up|15|||
161458600|NCT00775203|583074772|FG000|Overall Study|Administrative reason|2|||
161458601|NCT00775203|583074773|FG001|Overall Study|Administrative reason|0|||
161458602|NCT00775203|583074772|FG000|Overall Study|Noncompliance|4|||
161458603|NCT00775203|583074773|FG001|Overall Study|Noncompliance|2|||
161458604|NCT00775203|583074772|FG000|Overall Study|Protocol Violation|0|||
161458605|NCT00775203|583074773|FG001|Overall Study|Protocol Violation|1|||
161458606|NCT00775203|583074772|FG000|Overall Study|Entered other study|1|||
161458607|NCT00775203|583074773|FG001|Overall Study|Entered other study|0|||
161458608|NCT00775203|583074772|FG000|Overall Study|Physician Decision|0|||
161458609|NCT00775203|583074773|FG001|Overall Study|Physician Decision|1|||
161458610|NCT02987660|583074774|FG000|Overall Study|Study terminated by sponsor|10|||
161458611|NCT02987660|583074775|FG001|Overall Study|Study terminated by sponsor|10|||
161458612|NCT03422627|583074776|FG000|Overall Study|Protocol-specified Criteria|1|||
161458613|NCT03422627|583074777|FG001|Overall Study|Protocol-specified Criteria|1|||
161458614|NCT03422627|583074778|FG002|Overall Study|Protocol-specified Criteria|0|||
161458615|NCT03422627|583074779|FG003|Overall Study|Protocol-specified Criteria|0|||
161458616|NCT03422627|583074780|FG004|Overall Study|Protocol-specified Criteria|2|||
161571133|NCT04889664|583477614|FG000|Screen|Failed to meet screening criteria|1|||
161571134|NCT04889664|583477614|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
161571135|NCT02469064|583477616|FG000|Overall Study|Request not to receive intervention.|1|||
161458617|NCT03422627|583074776|FG000|Overall Study|Requirement for Alternative Therapy|1|||
161458618|NCT03422627|583074777|FG001|Overall Study|Requirement for Alternative Therapy|1|||
161458619|NCT03422627|583074778|FG002|Overall Study|Requirement for Alternative Therapy|2|||
161458620|NCT03422627|583074779|FG003|Overall Study|Requirement for Alternative Therapy|0|||
161458621|NCT03422627|583074780|FG004|Overall Study|Requirement for Alternative Therapy|0|||
161458622|NCT03422627|583074776|FG000|Overall Study|Disease Progression|1|||
161458623|NCT03422627|583074777|FG001|Overall Study|Disease Progression|0|||
161458624|NCT03422627|583074778|FG002|Overall Study|Disease Progression|1|||
161458625|NCT03422627|583074779|FG003|Overall Study|Disease Progression|2|||
161458626|NCT03422627|583074780|FG004|Overall Study|Disease Progression|0|||
161458627|NCT03422627|583074776|FG000|Overall Study|Adverse Event|2|||
161458628|NCT03422627|583074777|FG001|Overall Study|Adverse Event|1|||
161458629|NCT03422627|583074778|FG002|Overall Study|Adverse Event|0|||
161458630|NCT03422627|583074779|FG003|Overall Study|Adverse Event|0|||
161458631|NCT03422627|583074780|FG004|Overall Study|Adverse Event|2|||
161458632|NCT03422627|583074776|FG000|Overall Study|Ineligibility Determined|0|||
161458633|NCT03422627|583074777|FG001|Overall Study|Ineligibility Determined|1|||
161458634|NCT03422627|583074778|FG002|Overall Study|Ineligibility Determined|0|||
161458635|NCT03422627|583074779|FG003|Overall Study|Ineligibility Determined|0|||
161458636|NCT03422627|583074780|FG004|Overall Study|Ineligibility Determined|0|||
161458637|NCT03422627|583074776|FG000|Overall Study|Death|0|||
161458638|NCT03422627|583074777|FG001|Overall Study|Death|1|||
161458639|NCT03422627|583074778|FG002|Overall Study|Death|1|||
161458640|NCT03422627|583074779|FG003|Overall Study|Death|0|||
161458641|NCT03422627|583074780|FG004|Overall Study|Death|0|||
161458642|NCT03422627|583074776|FG000|Overall Study|Withdrawal by Subject|0|||
161458643|NCT03422627|583074777|FG001|Overall Study|Withdrawal by Subject|0|||
161458644|NCT03422627|583074778|FG002|Overall Study|Withdrawal by Subject|0|||
161458645|NCT03422627|583074779|FG003|Overall Study|Withdrawal by Subject|1|||
161458646|NCT03422627|583074780|FG004|Overall Study|Withdrawal by Subject|0|||
161458647|NCT05247398|583074781|FG000|Overall Study|Withdrawal by Subject|1|||
161458648|NCT04251156|583074782|FG000|Overall Study|Lost to Follow-up|1|||
161458649|NCT04251156|583074783|FG001|Overall Study|Lost to Follow-up|1|||
161458650|NCT04251156|583074782|FG000|Overall Study|Withdrawal by Subject|4|||
161458651|NCT04251156|583074783|FG001|Overall Study|Withdrawal by Subject|4|||
161458652|NCT05171816|583074784|FG000|Overall Study|Death|18|||
161458653|NCT05171816|583074785|FG001|Overall Study|Death|16|||
161458654|NCT02937571|583074786|FG000|Overall Study|Adverse Event|0|||
161458655|NCT02937571|583074787|FG001|Overall Study|Adverse Event|0|||
161458656|NCT02937571|583074788|FG002|Overall Study|Adverse Event|4|||
161458657|NCT02937571|583074786|FG000|Overall Study|Withdrawal by Subject|0|||
161458658|NCT02937571|583074787|FG001|Overall Study|Withdrawal by Subject|0|||
161458659|NCT02937571|583074788|FG002|Overall Study|Withdrawal by Subject|3|||
161458660|NCT04214288|583074789|FG000|Overall Study|Ongoing in the study|41|||
161458661|NCT04214288|583074790|FG001|Overall Study|Ongoing in the study|51|||
161458662|NCT04214288|583074791|FG002|Overall Study|Ongoing in the study|12|||
161458663|NCT04214288|583074792|FG003|Overall Study|Ongoing in the study|39|||
161458664|NCT04214288|583074789|FG000|Overall Study|Adverse Event|1|||
161458665|NCT04214288|583074790|FG001|Overall Study|Adverse Event|0|||
161458666|NCT04214288|583074791|FG002|Overall Study|Adverse Event|0|||
161458667|NCT04214288|583074792|FG003|Overall Study|Adverse Event|0|||
161458668|NCT04214288|583074789|FG000|Overall Study|Death|22|||
161571136|NCT02469064|583477617|FG001|Overall Study|Request not to receive intervention.|3|||
161571137|NCT02506257|583477618|FG000|Overall Study|Adverse Event|0|||
161571138|NCT02506257|583477619|FG001|Overall Study|Adverse Event|2|||
161458669|NCT04214288|583074790|FG001|Overall Study|Death|13|||
161458670|NCT04214288|583074791|FG002|Overall Study|Death|7|||
161458671|NCT04214288|583074792|FG003|Overall Study|Death|19|||
161458672|NCT04214288|583074789|FG000|Overall Study|Lost to Follow-up|1|||
161458673|NCT04214288|583074790|FG001|Overall Study|Lost to Follow-up|2|||
161458674|NCT04214288|583074791|FG002|Overall Study|Lost to Follow-up|1|||
161458675|NCT04214288|583074792|FG003|Overall Study|Lost to Follow-up|0|||
161458676|NCT04214288|583074789|FG000|Overall Study|Other|1|||
161458677|NCT04214288|583074790|FG001|Overall Study|Other|2|||
161458678|NCT04214288|583074791|FG002|Overall Study|Other|0|||
161458679|NCT04214288|583074792|FG003|Overall Study|Other|6|||
161458680|NCT04214288|583074789|FG000|Overall Study|Protocol Violation|0|||
161458681|NCT04214288|583074790|FG001|Overall Study|Protocol Violation|1|||
161458682|NCT04214288|583074791|FG002|Overall Study|Protocol Violation|0|||
161458683|NCT04214288|583074792|FG003|Overall Study|Protocol Violation|0|||
161458684|NCT04214288|583074789|FG000|Overall Study|Withdrawal by Subject|8|||
161458685|NCT04214288|583074790|FG001|Overall Study|Withdrawal by Subject|4|||
161458686|NCT04214288|583074791|FG002|Overall Study|Withdrawal by Subject|0|||
161458687|NCT04214288|583074792|FG003|Overall Study|Withdrawal by Subject|9|||
161458688|NCT02455557|583074793|FG000|Overall Study|Withdrawal by Subject|2|||
161458689|NCT01129024|583074794|FG000|Overall Study|Physician Decision|5|||
161458690|NCT01129024|583074794|FG000|Overall Study|Study Terminated by Sponsor|8|||
161458691|NCT01129024|583074794|FG000|Overall Study|Withdrawal by Subject|2|||
161458692|NCT01129024|583074794|FG000|Overall Study|Lack of Efficacy|3|||
161458693|NCT01129024|583074794|FG000|Overall Study|Needed a Platelet Transfusion|1|||
161458694|NCT04902326|583074795|FG000|Overall Study|Withdrawal by Subject|1|||
161458695|NCT04902326|583074796|FG001|Overall Study|Withdrawal by Subject|3|||
161458696|NCT04902326|583074797|FG002|Overall Study|Withdrawal by Subject|0|||
161458697|NCT04902326|583074798|FG003|Overall Study|Withdrawal by Subject|1|||
161458698|NCT04902326|583074795|FG000|Overall Study|Lost to Follow-up|14|||
161458699|NCT04902326|583074796|FG001|Overall Study|Lost to Follow-up|14|||
161458700|NCT04902326|583074797|FG002|Overall Study|Lost to Follow-up|14|||
161458701|NCT04902326|583074798|FG003|Overall Study|Lost to Follow-up|6|||
161458702|NCT04761627|583074804|FG000|Run-in Period|Death|1|||
161458703|NCT04761627|583074805|FG001|Run-in Period|Death|0|||
161458704|NCT04761627|583074806|FG002|Run-in Period|Death|0|||
161458705|NCT04761627|583074804|FG000|Run-in Period|Required alternative therapy|2|||
161458706|NCT04761627|583074805|FG001|Run-in Period|Required alternative therapy|0|||
161458707|NCT04761627|583074806|FG002|Run-in Period|Required alternative therapy|0|||
161458708|NCT04761627|583074804|FG000|Run-in Period|Lost to Follow-up|2|||
161458709|NCT04761627|583074805|FG001|Run-in Period|Lost to Follow-up|0|||
161458710|NCT04761627|583074806|FG002|Run-in Period|Lost to Follow-up|0|||
161458711|NCT04761627|583074804|FG000|Run-in Period|Protocol Violation|3|||
161458712|NCT04761627|583074805|FG001|Run-in Period|Protocol Violation|0|||
161458713|NCT04761627|583074806|FG002|Run-in Period|Protocol Violation|0|||
161571139|NCT02506257|583477620|FG002|Overall Study|Adverse Event|3|||
161458714|NCT04761627|583074804|FG000|Run-in Period|Abnormal liver function|1|||
161458715|NCT04761627|583074805|FG001|Run-in Period|Abnormal liver function|0|||
161458716|NCT04761627|583074806|FG002|Run-in Period|Abnormal liver function|0|||
161458717|NCT04761627|583074804|FG000|Run-in Period|Adverse Event|6|||
161458718|NCT04761627|583074805|FG001|Run-in Period|Adverse Event|0|||
161458719|NCT04761627|583074806|FG002|Run-in Period|Adverse Event|0|||
161458720|NCT04761627|583074804|FG000|Run-in Period|Withdrawal by Subject|7|||
161458721|NCT04761627|583074805|FG001|Run-in Period|Withdrawal by Subject|0|||
161458722|NCT04761627|583074806|FG002|Run-in Period|Withdrawal by Subject|0|||
161458723|NCT04761627|583074804|FG000|Run-in Period|Did not meet PASI 50|15|||
161458724|NCT04761627|583074805|FG001|Run-in Period|Did not meet PASI 50|0|||
161458725|NCT04761627|583074806|FG002|Run-in Period|Did not meet PASI 50|0|||
161458726|NCT04761627|583074804|FG000|Run-in Period|Study site closure|2|||
161458727|NCT04761627|583074805|FG001|Run-in Period|Study site closure|0|||
161458728|NCT04761627|583074806|FG002|Run-in Period|Study site closure|0|||
161458729|NCT04761627|583074804|FG000|Run-in Period|Pregnancy|2|||
161458730|NCT04761627|583074805|FG001|Run-in Period|Pregnancy|0|||
161458731|NCT04761627|583074806|FG002|Run-in Period|Pregnancy|0|||
161458732|NCT04761627|583074804|FG000|Post-randomization Period|Military service|0|||
161458733|NCT04761627|583074805|FG001|Post-randomization Period|Military service|1|||
161458734|NCT04761627|583074806|FG002|Post-randomization Period|Military service|0|||
161458735|NCT04761627|583074804|FG000|Post-randomization Period|Adverse Event|0|||
161458736|NCT04761627|583074805|FG001|Post-randomization Period|Adverse Event|4|||
161458737|NCT04761627|583074806|FG002|Post-randomization Period|Adverse Event|2|||
161458738|NCT04761627|583074804|FG000|Post-randomization Period|Lost to Follow-up|0|||
161458739|NCT04761627|583074805|FG001|Post-randomization Period|Lost to Follow-up|6|||
161458740|NCT04761627|583074806|FG002|Post-randomization Period|Lost to Follow-up|6|||
161458741|NCT04761627|583074804|FG000|Post-randomization Period|Withdrawal by Subject|0|||
161458742|NCT04761627|583074805|FG001|Post-randomization Period|Withdrawal by Subject|7|||
161458743|NCT04761627|583074806|FG002|Post-randomization Period|Withdrawal by Subject|6|||
161458744|NCT04761627|583074804|FG000|Post-randomization Period|Pregnancy|0|||
161458745|NCT04761627|583074805|FG001|Post-randomization Period|Pregnancy|0|||
161458746|NCT04761627|583074806|FG002|Post-randomization Period|Pregnancy|1|||
161458747|NCT04761627|583074804|FG000|Post-randomization Period|Study site closure|0|||
161458748|NCT04761627|583074805|FG001|Post-randomization Period|Study site closure|0|||
161458749|NCT04761627|583074806|FG002|Post-randomization Period|Study site closure|1|||
161458750|NCT04761627|583074804|FG000|Post-randomization Period|Family planning|0|||
161458751|NCT04761627|583074805|FG001|Post-randomization Period|Family planning|1|||
161458752|NCT04761627|583074806|FG002|Post-randomization Period|Family planning|0|||
161458753|NCT01120067|583074813|FG000|Overall Study|Lost to Follow-up|3|||
161458754|NCT01120067|583074814|FG001|Overall Study|Lost to Follow-up|1|||
161458755|NCT01120067|583074813|FG000|Overall Study|fail to engage >3 sessions|2|||
161458756|NCT01120067|583074814|FG001|Overall Study|fail to engage >3 sessions|0|||
161458757|NCT03761797|583074815|FG000|Overall Study|Changing hospital|11|||
161458758|NCT03761797|583074815|FG000|Overall Study|Improvement/remission|6|||
161458759|NCT03761797|583074815|FG000|Overall Study|Withdrawal by Subject|19|||
161809576|NCT00579345|584345699|FG003|Overall Study|Adverse Event|0|||
161809577|NCT00579345|584345700|FG004|Overall Study|Adverse Event|0|||
161809578|NCT00579345|584345701|FG005|Overall Study|Adverse Event|0|||
161809579|NCT00579345|584345702|FG006|Overall Study|Adverse Event|0|||
161809580|NCT00579345|584345703|FG007|Overall Study|Adverse Event|0|||
161809581|NCT00579345|584345696|FG000|Overall Study|Protocol Violation|1|||
161809582|NCT00579345|584345697|FG001|Overall Study|Protocol Violation|0|||
161809583|NCT00579345|584345698|FG002|Overall Study|Protocol Violation|0|||
161809584|NCT00579345|584345699|FG003|Overall Study|Protocol Violation|0|||
161809585|NCT00579345|584345700|FG004|Overall Study|Protocol Violation|0|||
161809586|NCT00579345|584345701|FG005|Overall Study|Protocol Violation|0|||
161809587|NCT00579345|584345702|FG006|Overall Study|Protocol Violation|0|||
161809588|NCT00579345|584345703|FG007|Overall Study|Protocol Violation|1|||
161809589|NCT00579345|584345696|FG000|Overall Study|Death|1|||
161809590|NCT00579345|584345697|FG001|Overall Study|Death|1|||
161809591|NCT00579345|584345698|FG002|Overall Study|Death|1|||
161809592|NCT00579345|584345699|FG003|Overall Study|Death|1|||
161809593|NCT00579345|584345700|FG004|Overall Study|Death|0|||
161809594|NCT00579345|584345701|FG005|Overall Study|Death|0|||
161913526|NCT01288430|584733560|FG001|Part 2|Progressive disease|0|||
161458760|NCT03761797|583074815|FG000|Overall Study|Lost to Follow-up|33|||
161458761|NCT03761797|583074815|FG000|Overall Study|Adverse Event|37|||
161458762|NCT03761797|583074815|FG000|Overall Study|Case report form (CRF) not collected|5|||
161458763|NCT03761797|583074815|FG000|Overall Study|No patient visit after entry|13|||
161458764|NCT03761797|583074815|FG000|Overall Study|Switch to other diabetes medication|10|||
161809595|NCT00579345|584345702|FG006|Overall Study|Death|0|||
161809596|NCT00579345|584345703|FG007|Overall Study|Death|0|||
161809597|NCT03255733|584345707|FG000|Overall Study|Lost to Follow-up|4|||
161809598|NCT00905840|584345716|FG000|Overall Study|Lost to Follow-up|11|||
161809599|NCT00905840|584345716|FG000|Overall Study|Death|3|||
161809600|NCT00905840|584345716|FG000|Overall Study|Withdrawal by Subject|1|||
161809601|NCT00905840|584345716|FG000|Overall Study|Adverse Event|1|||
161458765|NCT03761797|583074815|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
161458766|NCT03761797|583074815|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
161458767|NCT03761797|583074815|FG000|Overall Study|Insufficient effectives|2|||
161458768|NCT03761797|583074815|FG000|Overall Study|Excessive alcohol intake|1|||
161458769|NCT02207946|583074818|FG000|Overall Study|Lost to Follow-up|1|||
161458770|NCT02207946|583074819|FG001|Overall Study|Lost to Follow-up|0|||
161458771|NCT02207946|583074818|FG000|Overall Study|Adverse Event|0|||
161458772|NCT02207946|583074819|FG001|Overall Study|Adverse Event|1|||
161458773|NCT02829944|583074823|FG000|Overall Study|Physician Decision|0|||
161458774|NCT02829944|583074824|FG001|Overall Study|Physician Decision|1|||
161458775|NCT02829944|583074823|FG000|Overall Study|Screen Failure|2|||
161458776|NCT02829944|583074824|FG001|Overall Study|Screen Failure|2|||
161458777|NCT02829944|583074823|FG000|Overall Study|Inadequate Neuraxial Block|1|||
161458778|NCT02829944|583074824|FG001|Overall Study|Inadequate Neuraxial Block|1|||
161458779|NCT02829944|583074823|FG000|Overall Study|Withdrawal by Subject|2|||
161458780|NCT02829944|583074824|FG001|Overall Study|Withdrawal by Subject|1|||
161458781|NCT02829944|583074823|FG000|Overall Study|Catheter Displacement|1|||
161458782|NCT02829944|583074824|FG001|Overall Study|Catheter Displacement|0|||
161458783|NCT02829944|583074823|FG000|Overall Study|Catheter broke|0|||
161458784|NCT02829944|583074824|FG001|Overall Study|Catheter broke|1|||
161458785|NCT02829944|583074823|FG000|Overall Study|Staff unavailable|0|||
161458786|NCT02829944|583074824|FG001|Overall Study|Staff unavailable|1|||
161458787|NCT04675151|583074825|FG000|Overall Study|Protocol Violation|1|||
161458788|NCT04675151|583074826|FG001|Overall Study|Protocol Violation|0|||
161458789|NCT04675151|583074827|FG002|Overall Study|Protocol Violation|0|||
161458790|NCT04675151|583074828|FG003|Overall Study|Protocol Violation|1|||
161458791|NCT01730937|583074829|FG000|Overall Study|Protocol Violation|5|||
161458792|NCT01730937|583074830|FG001|Overall Study|Protocol Violation|11|||
161458793|NCT03947684|583074831|FG000|Overall Study|Lost to Follow-up|13|||
161458794|NCT03947684|583074832|FG001|Overall Study|Lost to Follow-up|5|||
161458795|NCT03947684|583074833|FG002|Overall Study|Lost to Follow-up|1|||
161458796|NCT03947684|583074831|FG000|Overall Study|Withdrawal by Subject|11|||
161458797|NCT03947684|583074832|FG001|Overall Study|Withdrawal by Subject|4|||
161458798|NCT03947684|583074833|FG002|Overall Study|Withdrawal by Subject|0|||
161458799|NCT03947684|583074831|FG000|Overall Study|Physician Decision|1|||
161458800|NCT03947684|583074832|FG001|Overall Study|Physician Decision|0|||
161458801|NCT03947684|583074833|FG002|Overall Study|Physician Decision|0|||
161458802|NCT03947684|583074831|FG000|Overall Study|Lack of adherence to study protocol|2|||
161458803|NCT03947684|583074832|FG001|Overall Study|Lack of adherence to study protocol|0|||
161458804|NCT03947684|583074833|FG002|Overall Study|Lack of adherence to study protocol|0|||
161458805|NCT01395784|583074839|FG000|Overall Study|Lost to Follow-up|7|||
161458806|NCT01395784|583074839|FG000|Overall Study|Withdrawal by Subject|3|||
161458807|NCT01395784|583074839|FG000|Overall Study|Physician Decision|5|||
161458808|NCT05772702|583074840|FG000|Overall Study|Adverse Event|1|||
161458809|NCT04285580|583076432|FG000|Overall Study|Protocol Violation|0|||
161458810|NCT04285580|583076433|FG001|Overall Study|Protocol Violation|1|||
161458811|NCT00562627|583076434|FG000|Overall Study|Protocol Violation|1|||
161458812|NCT00562627|583076435|FG001|Overall Study|Protocol Violation|1|||
161458813|NCT00562627|583076436|FG002|Overall Study|Protocol Violation|1|||
161458814|NCT04078178|583076438|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
161458815|NCT04078178|583076439|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
161458816|NCT04078178|583076438|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
161458817|NCT04078178|583076439|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
161458818|NCT04078178|583076438|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
161458819|NCT04078178|583076439|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
161458820|NCT04078178|583076438|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
161458821|NCT04078178|583076439|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
161458822|NCT04078178|583076438|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
161458823|NCT04078178|583076439|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
161458824|NCT05710185|583076440|FG000|Overall Study|Adverse Event|1|||
161458825|NCT05710185|583076440|FG000|Overall Study|Lack of Efficacy|1|||
161458826|NCT02316548|583076443|FG000|Overall Study|Protocol Violation|0|||
161458827|NCT02316548|583076444|FG001|Overall Study|Protocol Violation|1|||
161458828|NCT05313009|583076445|FG000|Overall Study|Death|1|||
161458829|NCT05313009|583076446|FG001|Overall Study|Death|0|||
161458830|NCT03269552|583076447|FG000|Overall Study|Adverse Event|2|||
161458831|NCT03468543|583076448|FG000|Overall Study|Protocol stopping rules met|3|||
161458832|NCT03675321|583076450|FG000|Overall Study|Lack of Efficacy|2|||
161458833|NCT03675321|583076451|FG001|Overall Study|Lack of Efficacy|2|||
161458834|NCT03675321|583076450|FG000|Overall Study|Withdrawal by Subject|1|||
161458835|NCT03675321|583076451|FG001|Overall Study|Withdrawal by Subject|3|||
161458836|NCT00807027|583076452|FG000|Overall Study|Withdrawal by Subject|13|||
161458837|NCT00807027|583076453|FG001|Overall Study|Withdrawal by Subject|14|||
161458838|NCT00807027|583076452|FG000|Overall Study|Protocol Violation|1|||
161458839|NCT00807027|583076453|FG001|Overall Study|Protocol Violation|1|||
161458840|NCT00807027|583076452|FG000|Overall Study|Adverse Event|2|||
161458841|NCT00807027|583076453|FG001|Overall Study|Adverse Event|2|||
161458842|NCT02278341|583076454|FG000|Overall Study|Randomized but never received study drug|1|||
161458843|NCT02278341|583076455|FG001|Overall Study|Randomized but never received study drug|1|||
161458844|NCT02278341|583076454|FG000|Overall Study|Adverse Event|3|||
161458845|NCT02278341|583076455|FG001|Overall Study|Adverse Event|0|||
161458846|NCT02278341|583076454|FG000|Overall Study|Death|68|||
161458847|NCT02278341|583076455|FG001|Overall Study|Death|56|||
161458848|NCT02278341|583076454|FG000|Overall Study|Withdrawal by Subject|30|||
161458849|NCT02278341|583076455|FG001|Overall Study|Withdrawal by Subject|19|||
161458850|NCT02278341|583076454|FG000|Overall Study|Lost to Follow-up|0|||
161458851|NCT02278341|583076455|FG001|Overall Study|Lost to Follow-up|1|||
161458852|NCT02278341|583076454|FG000|Overall Study|Physician Decision|1|||
161458853|NCT02278341|583076455|FG001|Overall Study|Physician Decision|1|||
161458854|NCT02278341|583076454|FG000|Overall Study|Miscellaneous|15|||
161458855|NCT02278341|583076455|FG001|Overall Study|Miscellaneous|14|||
161458856|NCT00934648|583076460|FG000|Overall Study|Failure to return|8|||
161458857|NCT00934648|583076460|FG000|Overall Study|Withdrawal by Subject|1|||
161458858|NCT02361580|583076462|FG000|Overall Study|Lost to Follow-up|6|||
161458859|NCT02361580|583076463|FG001|Overall Study|Lost to Follow-up|3|||
161458860|NCT02047318|583076464|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
161458861|NCT02047318|583076464|FG000|Core Study Period|Adverse Event|1|||
161458862|NCT02047318|583076464|FG000|Core Study Period|Withdrawal by caregiver|3|||
161458863|NCT02047318|583076464|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
161458864|NCT01487577|583076465|FG000|Overall Study|Became ineligible after signing consent|1|||
161458865|NCT01479985|583076466|FG000|Overall Study|Tablet malfunction, no data saved|1|||
161458866|NCT01479985|583076467|FG001|Overall Study|Tablet malfunction, no data saved|1|||
161458867|NCT01479985|583076466|FG000|Overall Study|No decisional conflict scale responses|0|||
161458868|NCT01479985|583076467|FG001|Overall Study|No decisional conflict scale responses|2|||
161458869|NCT01479985|583076466|FG000|Overall Study|No post-visit survey|5|||
161458870|NCT01479985|583076467|FG001|Overall Study|No post-visit survey|3|||
161458871|NCT00708201|583076468|FG000|Overall Study|Adverse Event|4|||
161458872|NCT00708201|583076469|FG001|Overall Study|Adverse Event|4|||
161458873|NCT00708201|583076468|FG000|Overall Study|Withdrawal by Subject|1|||
161458874|NCT00708201|583076469|FG001|Overall Study|Withdrawal by Subject|1|||
161458875|NCT00708201|583076468|FG000|Overall Study|Lost to Follow-up|2|||
161458876|NCT00708201|583076469|FG001|Overall Study|Lost to Follow-up|0|||
161458877|NCT00708201|583076468|FG000|Overall Study|Protocol Violation|0|||
161458878|NCT00708201|583076469|FG001|Overall Study|Protocol Violation|1|||
161458879|NCT00761748|583076470|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
161458880|NCT00761748|583076471|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
161458881|NCT00761748|583076470|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
161458882|NCT00761748|583076471|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
161458883|NCT02554279|583076472|FG000|Overall Study|Adverse Event|2|||
161458884|NCT02554279|583076473|FG001|Overall Study|Adverse Event|5|||
161458885|NCT02554279|583076472|FG000|Overall Study|Lost to Follow-up|3|||
161458886|NCT02554279|583076473|FG001|Overall Study|Lost to Follow-up|2|||
161458887|NCT02554279|583076472|FG000|Overall Study|Withdrawal by Subject|6|||
161458888|NCT02554279|583076473|FG001|Overall Study|Withdrawal by Subject|4|||
161458889|NCT02554279|583076472|FG000|Overall Study|Protocol Violation|2|||
161458890|NCT02554279|583076473|FG001|Overall Study|Protocol Violation|1|||
161458891|NCT02554279|583076472|FG000|Overall Study|Other reason|19|||
161458892|NCT02554279|583076473|FG001|Overall Study|Other reason|6|||
161458893|NCT00812487|583076474|FG000|Overall Study|Lost to Follow-up|2|||
161458894|NCT00812487|583076475|FG001|Overall Study|Lost to Follow-up|0|||
161458895|NCT00812487|583076474|FG000|Overall Study|Withdrawal by Subject|3|||
161458896|NCT00812487|583076475|FG001|Overall Study|Withdrawal by Subject|2|||
161458897|NCT00812487|583076474|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
161458898|NCT00812487|583076475|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
161458899|NCT00812487|583076474|FG000|Overall Study|Protocol Violation|0|||
161458900|NCT00812487|583076475|FG001|Overall Study|Protocol Violation|1|||
161458901|NCT00998764|583076476|FG000|Overall Study|Lack of Efficacy|3|||
161458902|NCT00998764|583076477|FG001|Overall Study|Lack of Efficacy|6|||
161458903|NCT00998764|583076476|FG000|Overall Study|Adverse Event|17|||
161458904|NCT00998764|583076477|FG001|Overall Study|Adverse Event|12|||
161458905|NCT00998764|583076476|FG000|Overall Study|Withdrawal by Subject|19|||
161458906|NCT00998764|583076477|FG001|Overall Study|Withdrawal by Subject|25|||
161458907|NCT00998764|583076476|FG000|Overall Study|Physician Decision|3|||
161458908|NCT00998764|583076477|FG001|Overall Study|Physician Decision|3|||
161458909|NCT00998764|583076476|FG000|Overall Study|Death|3|||
161458910|NCT00998764|583076477|FG001|Overall Study|Death|1|||
161458911|NCT00998764|583076476|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
161458912|NCT00998764|583076477|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
161458913|NCT00998764|583076476|FG000|Overall Study|Protocol Violation|0|||
161458914|NCT00998764|583076477|FG001|Overall Study|Protocol Violation|1|||
161458915|NCT00998764|583076476|FG000|Overall Study|Failed to Return|1|||
161458916|NCT00998764|583076477|FG001|Overall Study|Failed to Return|1|||
161458917|NCT00998764|583076476|FG000|Overall Study|Lost to Follow-up|1|||
161458918|NCT00998764|583076477|FG001|Overall Study|Lost to Follow-up|1|||
161458919|NCT00998764|583076476|FG000|Overall Study|Loss of Caregiver|0|||
161458920|NCT00998764|583076477|FG001|Overall Study|Loss of Caregiver|3|||
161458921|NCT00998764|583076476|FG000|Overall Study|Other|4|||
161458922|NCT00998764|583076477|FG001|Overall Study|Other|4|||
161458923|NCT00998764|583076476|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
161458924|NCT00998764|583076477|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
161458925|NCT01634178|583076482|FG000|Treatment Period 1|Adverse Event|0|||
161458926|NCT01634178|583076483|FG001|Treatment Period 1|Adverse Event|1|||
161458927|NCT01634178|583076482|FG000|Treatment Period 2|Adverse Event|1|||
161458928|NCT01634178|583076483|FG001|Treatment Period 2|Adverse Event|0|||
161458929|NCT01933789|583076484|FG000|Overall Study|Death|0|||
161458930|NCT01933789|583076485|FG001|Overall Study|Death|0|||
161458931|NCT01933789|583076486|FG002|Overall Study|Death|0|||
161458932|NCT01933789|583076487|FG003|Overall Study|Death|0|||
161809602|NCT00448019|584345717|FG000|Overall Study|Withdrawal by Subject|3|||
161809603|NCT00448019|584345717|FG000|Overall Study|Disease progression|1|||
161809604|NCT00448019|584345717|FG000|Overall Study|Death|2|||
161809605|NCT00448019|584345717|FG000|Overall Study|Insurance Issues|1|||
161809606|NCT03020615|584345718|FG000|Overall Study|Physician Decision|3|||
161809607|NCT03020615|584345719|FG001|Overall Study|Physician Decision|1|||
161809608|NCT03020615|584345720|FG002|Overall Study|Physician Decision|2|||
161809609|NCT03020615|584345718|FG000|Overall Study|Parent/guardian/patient choice|3|||
161809610|NCT03020615|584345719|FG001|Overall Study|Parent/guardian/patient choice|0|||
161809611|NCT03020615|584345720|FG002|Overall Study|Parent/guardian/patient choice|4|||
161809612|NCT03020615|584345718|FG000|Overall Study|Screen failure|0|||
161809613|NCT03020615|584345719|FG001|Overall Study|Screen failure|0|||
161809614|NCT03020615|584345720|FG002|Overall Study|Screen failure|1|||
161809615|NCT03020615|584345718|FG000|Overall Study|Death|1|||
161458933|NCT01933789|583076488|FG004|Overall Study|Death|21|||
161458934|NCT01933789|583076489|FG005|Overall Study|Death|32|||
161458935|NCT01933789|583076490|FG006|Overall Study|Death|0|||
161458936|NCT01933789|583076491|FG007|Overall Study|Death|0|||
161458937|NCT01933789|583076492|FG008|Overall Study|Death|0|||
161458938|NCT01933789|583076484|FG000|Overall Study|Lost to Follow-up|0|||
161809616|NCT03020615|584345719|FG001|Overall Study|Death|0|||
161809617|NCT03020615|584345720|FG002|Overall Study|Death|0|||
161458939|NCT01933789|583076485|FG001|Overall Study|Lost to Follow-up|0|||
161458940|NCT01933789|583076486|FG002|Overall Study|Lost to Follow-up|0|||
161458941|NCT01933789|583076487|FG003|Overall Study|Lost to Follow-up|1|||
161458942|NCT01933789|583076488|FG004|Overall Study|Lost to Follow-up|8|||
161809618|NCT03020615|584345718|FG000|Overall Study|Lost to Follow-up|0|||
161458943|NCT01933789|583076489|FG005|Overall Study|Lost to Follow-up|9|||
161458944|NCT01933789|583076490|FG006|Overall Study|Lost to Follow-up|1|||
161809619|NCT03020615|584345719|FG001|Overall Study|Lost to Follow-up|1|||
161809620|NCT03020615|584345720|FG002|Overall Study|Lost to Follow-up|0|||
161458945|NCT01933789|583076491|FG007|Overall Study|Lost to Follow-up|4|||
161458946|NCT01933789|583076492|FG008|Overall Study|Lost to Follow-up|0|||
161458947|NCT01933789|583076484|FG000|Overall Study|Withdrawal by Subject|2|||
161458948|NCT01933789|583076485|FG001|Overall Study|Withdrawal by Subject|1|||
161809621|NCT02760368|584345721|FG000|Overall Study|Withdrawal by Subject|8|||
161809622|NCT02760368|584345722|FG001|Overall Study|Withdrawal by Subject|12|||
161809623|NCT02760368|584345723|FG002|Overall Study|Withdrawal by Subject|9|||
161809624|NCT02760368|584345721|FG000|Overall Study|Screen Failure|0|||
161809625|NCT02760368|584345722|FG001|Overall Study|Screen Failure|0|||
161809626|NCT02760368|584345723|FG002|Overall Study|Screen Failure|1|||
161809627|NCT02760368|584345721|FG000|Overall Study|Death|0|||
161809628|NCT02760368|584345722|FG001|Overall Study|Death|1|||
161809629|NCT02760368|584345723|FG002|Overall Study|Death|0|||
161809630|NCT02760368|584345721|FG000|Overall Study|Withdrawal by Sponsor|0|||
161809631|NCT02760368|584345722|FG001|Overall Study|Withdrawal by Sponsor|0|||
161809632|NCT02760368|584345723|FG002|Overall Study|Withdrawal by Sponsor|1|||
161809633|NCT00794963|584345724|FG000|Overall Study|Withdrawal by Subject|1|||
161809634|NCT00794963|584345725|FG001|Overall Study|Withdrawal by Subject|4|||
161809635|NCT01037114|584345726|FG000|Year 20|Others|1|||
161809636|NCT01602419|584345727|FG000|Overall Study|Not treated with Wilate|9|||
161809637|NCT01602419|584345727|FG000|Overall Study|Adverse Drug Reaction|4|||
161809638|NCT01602419|584345727|FG000|Overall Study|Insurance issues|3|||
161809639|NCT01602419|584345727|FG000|Overall Study|Changed treatment centre|1|||
161809640|NCT01602419|584345727|FG000|Overall Study|Treatment centre closed|1|||
161809641|NCT01602419|584345727|FG000|Overall Study|Withdrawal by Subject|5|||
161809642|NCT01602419|584345727|FG000|Overall Study|Lost to Follow-up|6|||
161809643|NCT03620747|584345733|FG000|Overall Study|Participant decision|7|||
161809644|NCT03620747|584345733|FG000|Overall Study|Adverse Event|6|||
161809645|NCT03620747|584345733|FG000|Overall Study|Lack of Efficacy|1|||
161809646|NCT03620747|584345733|FG000|Overall Study|Poor compliance to protocol|2|||
161458949|NCT01933789|583076486|FG002|Overall Study|Withdrawal by Subject|0|||
161458950|NCT01933789|583076487|FG003|Overall Study|Withdrawal by Subject|0|||
161458951|NCT01933789|583076488|FG004|Overall Study|Withdrawal by Subject|17|||
161458952|NCT01933789|583076489|FG005|Overall Study|Withdrawal by Subject|16|||
161571140|NCT02506257|583477621|FG003|Overall Study|Adverse Event|0|||
161571141|NCT02506257|583477618|FG000|Overall Study|Protocol Violation|0|||
161571142|NCT02506257|583477619|FG001|Overall Study|Protocol Violation|0|||
161571143|NCT02506257|583477620|FG002|Overall Study|Protocol Violation|1|||
161458953|NCT01933789|583076490|FG006|Overall Study|Withdrawal by Subject|1|||
161458954|NCT01933789|583076491|FG007|Overall Study|Withdrawal by Subject|4|||
161458955|NCT01933789|583076492|FG008|Overall Study|Withdrawal by Subject|0|||
161458956|NCT01933789|583076484|FG000|Overall Study|Became Ineligible|4|||
161458957|NCT01933789|583076485|FG001|Overall Study|Became Ineligible|0|||
161458958|NCT01933789|583076486|FG002|Overall Study|Became Ineligible|0|||
161458959|NCT01933789|583076487|FG003|Overall Study|Became Ineligible|0|||
161458960|NCT01933789|583076488|FG004|Overall Study|Became Ineligible|13|||
161458961|NCT01933789|583076489|FG005|Overall Study|Became Ineligible|10|||
161458962|NCT01933789|583076490|FG006|Overall Study|Became Ineligible|13|||
161458963|NCT01933789|583076491|FG007|Overall Study|Became Ineligible|6|||
161458964|NCT01933789|583076492|FG008|Overall Study|Became Ineligible|0|||
161458965|NCT02915874|583076494|FG000|Overall Study|Lost to Follow-up|5|||
161458966|NCT02915874|583076495|FG001|Overall Study|Lost to Follow-up|4|||
161458967|NCT02915874|583076494|FG000|Overall Study|Withdrawal by Subject|1|||
161458968|NCT02915874|583076495|FG001|Overall Study|Withdrawal by Subject|1|||
161458969|NCT02915874|583076494|FG000|Overall Study|Started New Anxiety Medication|0|||
161458970|NCT02915874|583076495|FG001|Overall Study|Started New Anxiety Medication|1|||
161458971|NCT01903252|583076496|FG000|Double-Blind Induction|Adverse Event|20|||
161458972|NCT01903252|583076497|FG001|Double-Blind Induction|Adverse Event|18|||
161458973|NCT01903252|583076498|FG002|Double-Blind Induction|Adverse Event|0|||
161458974|NCT01903252|583076499|FG003|Double-Blind Induction|Adverse Event|0|||
161458975|NCT01903252|583076500|FG004|Double-Blind Induction|Adverse Event|0|||
161458976|NCT01903252|583076501|FG005|Double-Blind Induction|Adverse Event|0|||
161458977|NCT01903252|583076496|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
161458978|NCT01903252|583076497|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
161458979|NCT01903252|583076498|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
161458980|NCT01903252|583076499|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
161458981|NCT01903252|583076500|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
161458982|NCT01903252|583076501|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
161458983|NCT01903252|583076496|FG000|Double-Blind Induction|Physician Decision|2|||
161458984|NCT01903252|583076497|FG001|Double-Blind Induction|Physician Decision|3|||
161458985|NCT01903252|583076498|FG002|Double-Blind Induction|Physician Decision|0|||
161458986|NCT01903252|583076499|FG003|Double-Blind Induction|Physician Decision|0|||
161458987|NCT01903252|583076500|FG004|Double-Blind Induction|Physician Decision|0|||
161458988|NCT01903252|583076501|FG005|Double-Blind Induction|Physician Decision|0|||
161458989|NCT01903252|583076496|FG000|Double-Blind Induction|non-compliance,|7|||
161458990|NCT01903252|583076497|FG001|Double-Blind Induction|non-compliance,|7|||
161458991|NCT01903252|583076498|FG002|Double-Blind Induction|non-compliance,|0|||
161458992|NCT01903252|583076499|FG003|Double-Blind Induction|non-compliance,|0|||
161458993|NCT01903252|583076500|FG004|Double-Blind Induction|non-compliance,|0|||
161458994|NCT01903252|583076501|FG005|Double-Blind Induction|non-compliance,|0|||
161458995|NCT01903252|583076496|FG000|Extended Induction, Open-Label|Adverse Event|0|||
161458996|NCT01903252|583076497|FG001|Extended Induction, Open-Label|Adverse Event|0|||
161458997|NCT01903252|583076498|FG002|Extended Induction, Open-Label|Adverse Event|17|||
161458998|NCT01903252|583076499|FG003|Extended Induction, Open-Label|Adverse Event|0|||
161458999|NCT01903252|583076500|FG004|Extended Induction, Open-Label|Adverse Event|0|||
161459000|NCT01903252|583076501|FG005|Extended Induction, Open-Label|Adverse Event|0|||
161809647|NCT03620747|584345733|FG000|Overall Study|Other-unspecified|3|||
161809648|NCT01745120|584345736|FG000|Overall Study|Investigator decision|1|||
161809649|NCT01745120|584345737|FG001|Overall Study|Investigator decision|0|||
161809650|NCT00850174|584345745|FG000|Washout: One Week|Withdrawal by Subject|0|||
161809651|NCT00850174|584345746|FG001|Washout: One Week|Withdrawal by Subject|2|||
161809652|NCT00850174|584345745|FG000|Second Intervention|Withdrawal by Subject|1|||
161809653|NCT00850174|584345746|FG001|Second Intervention|Withdrawal by Subject|0|||
161809654|NCT00635492|584345747|FG000|Overall Study|Death|12|||
161809655|NCT00635492|584345748|FG001|Overall Study|Death|40|||
161809656|NCT00635492|584345747|FG000|Overall Study|Lost to Follow-up|151|||
161459001|NCT01903252|583076496|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
161459002|NCT01903252|583076497|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
161459003|NCT01903252|583076498|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
161459004|NCT01903252|583076499|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
161459005|NCT01903252|583076500|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
161571144|NCT02506257|583477621|FG003|Overall Study|Protocol Violation|0|||
161571145|NCT01563354|583477623|FG000|Core Phase|Adverse Event|5|||
161459006|NCT01903252|583076501|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
161571146|NCT01563354|583477624|FG001|Core Phase|Adverse Event|15|||
161459007|NCT01903252|583076496|FG000|Extended Induction, Open-Label|Physician Decision|0|||
161459008|NCT01903252|583076497|FG001|Extended Induction, Open-Label|Physician Decision|0|||
161459009|NCT01903252|583076498|FG002|Extended Induction, Open-Label|Physician Decision|1|||
161459010|NCT01903252|583076499|FG003|Extended Induction, Open-Label|Physician Decision|0|||
161459011|NCT01903252|583076500|FG004|Extended Induction, Open-Label|Physician Decision|0|||
161459012|NCT01903252|583076501|FG005|Extended Induction, Open-Label|Physician Decision|0|||
161459013|NCT01903252|583076496|FG000|Maintenance, Open-Label|Adverse Event|0|||
161459014|NCT01903252|583076497|FG001|Maintenance, Open-Label|Adverse Event|0|||
161459015|NCT01903252|583076498|FG002|Maintenance, Open-Label|Adverse Event|0|||
161459016|NCT01903252|583076499|FG003|Maintenance, Open-Label|Adverse Event|3|||
161459017|NCT01903252|583076500|FG004|Maintenance, Open-Label|Adverse Event|9|||
161459018|NCT01903252|583076501|FG005|Maintenance, Open-Label|Adverse Event|14|||
161459019|NCT01903252|583076496|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
161459020|NCT01903252|583076497|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
161459021|NCT01903252|583076498|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
161459022|NCT01903252|583076499|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
161459023|NCT01903252|583076500|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
161459024|NCT01903252|583076501|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
161459025|NCT01903252|583076496|FG000|Maintenance, Open-Label|Other|0|||
161459026|NCT01903252|583076497|FG001|Maintenance, Open-Label|Other|0|||
161459027|NCT01903252|583076498|FG002|Maintenance, Open-Label|Other|0|||
161459028|NCT01903252|583076499|FG003|Maintenance, Open-Label|Other|2|||
161459029|NCT01903252|583076500|FG004|Maintenance, Open-Label|Other|6|||
161459030|NCT01903252|583076501|FG005|Maintenance, Open-Label|Other|2|||
161459031|NCT03562767|583076502|FG000|Overall Study|Physician Decision|2|||
161459032|NCT03562767|583076503|FG001|Overall Study|Physician Decision|0|||
161459033|NCT03562767|583076504|FG002|Overall Study|Physician Decision|0|||
161459034|NCT03562767|583076502|FG000|Overall Study|Logistic Reason|1|||
161459035|NCT03562767|583076503|FG001|Overall Study|Logistic Reason|3|||
161459036|NCT03562767|583076504|FG002|Overall Study|Logistic Reason|0|||
161459037|NCT02518464|583076507|FG000|Overall Study|Adverse Event|2|||
161459038|NCT00266877|583076508|FG000|Overall Study|Death|1|||
161459039|NCT00266877|583076509|FG001|Overall Study|Death|1|||
161459040|NCT00266877|583076510|FG002|Overall Study|Death|1|||
161459041|NCT00266877|583076508|FG000|Overall Study|Adverse Event|6|||
161459042|NCT00266877|583076509|FG001|Overall Study|Adverse Event|4|||
161459043|NCT00266877|583076510|FG002|Overall Study|Adverse Event|1|||
161459044|NCT00266877|583076508|FG000|Overall Study|Physician Decision|2|||
161459045|NCT00266877|583076509|FG001|Overall Study|Physician Decision|1|||
161459046|NCT00266877|583076510|FG002|Overall Study|Physician Decision|1|||
161459047|NCT00266877|583076508|FG000|Overall Study|Withdrawal by Subject|3|||
161459048|NCT00266877|583076509|FG001|Overall Study|Withdrawal by Subject|1|||
161459049|NCT00266877|583076510|FG002|Overall Study|Withdrawal by Subject|1|||
161459050|NCT00266877|583076508|FG000|Overall Study|Disease Progression|72|||
161459051|NCT00266877|583076509|FG001|Overall Study|Disease Progression|37|||
161459052|NCT00266877|583076510|FG002|Overall Study|Disease Progression|23|||
161459053|NCT00266877|583076508|FG000|Overall Study|Symptomatic Deterioration|6|||
161459054|NCT00266877|583076509|FG001|Overall Study|Symptomatic Deterioration|3|||
161459055|NCT00266877|583076510|FG002|Overall Study|Symptomatic Deterioration|1|||
161459056|NCT00266877|583076508|FG000|Overall Study|Hospitalization|1|||
161459057|NCT00266877|583076509|FG001|Overall Study|Hospitalization|0|||
161459058|NCT00266877|583076510|FG002|Overall Study|Hospitalization|0|||
161459059|NCT00266877|583076508|FG000|Overall Study|Concomitant Radiotherapy|0|||
161459060|NCT00266877|583076509|FG001|Overall Study|Concomitant Radiotherapy|1|||
161459061|NCT00266877|583076510|FG002|Overall Study|Concomitant Radiotherapy|0|||
161459062|NCT01924429|583076514|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
161459063|NCT01924429|583076515|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
161459064|NCT01150474|583076516|FG000|Overall Study|Withdrawal by Subject|5|||
161459065|NCT01150474|583076517|FG001|Overall Study|Withdrawal by Subject|2|||
161459066|NCT01150474|583076516|FG000|Overall Study|Cancer found|1|||
161459067|NCT01150474|583076517|FG001|Overall Study|Cancer found|0|||
161459068|NCT01150474|583076516|FG000|Overall Study|Multiple Studies|0|||
161459069|NCT01150474|583076517|FG001|Overall Study|Multiple Studies|1|||
161459070|NCT01150474|583076516|FG000|Overall Study|Rectotomy|1|||
161459071|NCT01150474|583076517|FG001|Overall Study|Rectotomy|0|||
161459072|NCT01150474|583076516|FG000|Overall Study|Drug did not arrive in time|1|||
161459073|NCT01150474|583076517|FG001|Overall Study|Drug did not arrive in time|0|||
161459074|NCT01150474|583076516|FG000|Overall Study|Drug not administered|1|||
161459075|NCT01150474|583076517|FG001|Overall Study|Drug not administered|0|||
161459076|NCT01150474|583076516|FG000|Overall Study|Surgery Changed|1|||
161459077|NCT01150474|583076517|FG001|Overall Study|Surgery Changed|0|||
161459078|NCT04231981|583076518|FG000|Overall Study|Adverse Event|1|||
161459079|NCT04231981|583076518|FG000|Overall Study|Death|16|||
161459080|NCT04231981|583076518|FG000|Overall Study|Lost to Follow-up|1|||
161459081|NCT02581943|583076519|FG000|Overall Study|Death|5|||
161459082|NCT02581943|583076520|FG001|Overall Study|Death|2|||
161459083|NCT02581943|583076519|FG000|Overall Study|Disease Progression|12|||
161459084|NCT02581943|583076520|FG001|Overall Study|Disease Progression|15|||
161459085|NCT02581943|583076519|FG000|Overall Study|Withdrawal by Subject|1|||
161459086|NCT02581943|583076520|FG001|Overall Study|Withdrawal by Subject|2|||
161459087|NCT01470989|583076521|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
161459088|NCT01470989|583076522|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
161459089|NCT01470989|583076521|FG000|Overall Study|Adverse Event|2|||
161459090|NCT01470989|583076522|FG001|Overall Study|Adverse Event|5|||
161459091|NCT01470989|583076521|FG000|Overall Study|Abnormal laboratory value|1|||
161459092|NCT01470989|583076522|FG001|Overall Study|Abnormal laboratory value|1|||
161459093|NCT01470989|583076521|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161459094|NCT01470989|583076522|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161459095|NCT01470989|583076521|FG000|Overall Study|Withdrawal by Subject|19|||
161809657|NCT00635492|584345748|FG001|Overall Study|Lost to Follow-up|172|||
161809658|NCT00635492|584345747|FG000|Overall Study|Physician Decision|32|||
161809659|NCT00635492|584345748|FG001|Overall Study|Physician Decision|22|||
161809660|NCT00635492|584345747|FG000|Overall Study|Sponsor decision|2|||
161809661|NCT00635492|584345748|FG001|Overall Study|Sponsor decision|3|||
161809662|NCT00635492|584345747|FG000|Overall Study|Withdrawal by Subject|82|||
161809663|NCT00635492|584345748|FG001|Overall Study|Withdrawal by Subject|45|||
161809664|NCT04533594|584345753|FG000|Overall Study|Death|26|||
161809665|NCT01200810|584345756|FG000|Overall Study|Physician Decision|1|||
161809666|NCT01200810|584345757|FG001|Overall Study|Physician Decision|0|||
161809667|NCT01200810|584345756|FG000|Overall Study|Withdrawal by Subject|1|||
161809668|NCT01200810|584345757|FG001|Overall Study|Withdrawal by Subject|2|||
161809669|NCT01200810|584345756|FG000|Overall Study|Sponsor stopped making study drug|3|||
161809670|NCT01200810|584345757|FG001|Overall Study|Sponsor stopped making study drug|3|||
161809671|NCT03500341|584345761|FG000|Overall Study|Withdrawn prior to Completion|2|||
161809672|NCT00640562|584345764|FG000|Overall Study|Adverse Event|8|||
161809673|NCT00640562|584345765|FG001|Overall Study|Adverse Event|5|||
161809674|NCT00640562|584345764|FG000|Overall Study|Lack of Efficacy|1|||
161809675|NCT00640562|584345765|FG001|Overall Study|Lack of Efficacy|4|||
161809676|NCT00640562|584345764|FG000|Overall Study|Protocol Violation|2|||
161809677|NCT00640562|584345765|FG001|Overall Study|Protocol Violation|4|||
161809678|NCT00640562|584345764|FG000|Overall Study|Withdrawal by Subject|6|||
161809679|NCT00640562|584345765|FG001|Overall Study|Withdrawal by Subject|10|||
161809680|NCT00640562|584345764|FG000|Overall Study|Known risperidone intolerance|0|||
161809681|NCT00640562|584345765|FG001|Overall Study|Known risperidone intolerance|1|||
161459096|NCT01470989|583076522|FG001|Overall Study|Withdrawal by Subject|17|||
161459097|NCT01470989|583076521|FG000|Overall Study|Lost to Follow-up|18|||
161459098|NCT01470989|583076522|FG001|Overall Study|Lost to Follow-up|13|||
161459099|NCT01470989|583076521|FG000|Overall Study|Administrative problems|2|||
161459100|NCT01470989|583076522|FG001|Overall Study|Administrative problems|4|||
161459101|NCT01470989|583076521|FG000|Overall Study|Death|2|||
161459102|NCT01470989|583076522|FG001|Overall Study|Death|2|||
161459103|NCT01470989|583076521|FG000|Overall Study|Protocol deviation|1|||
161459104|NCT01470989|583076522|FG001|Overall Study|Protocol deviation|2|||
161459105|NCT01233687|583076523|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
161459106|NCT01233687|583076523|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
161459107|NCT01233687|583076523|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
161459108|NCT02197234|583076526|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
161459109|NCT02197234|583076526|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
161459110|NCT02197234|583076526|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
161459111|NCT02197234|583076526|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
161459112|NCT02197234|583076526|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
161459113|NCT02197234|583076526|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
161459114|NCT03783702|583076527|FG000|Overall Study|Lost to Follow-up|6|||
161459115|NCT03783702|583076528|FG001|Overall Study|Lost to Follow-up|8|||
161459116|NCT03783702|583076527|FG000|Overall Study|Protocol Violation|1|||
161459117|NCT03783702|583076528|FG001|Overall Study|Protocol Violation|3|||
161459118|NCT02119676|583076529|FG000|Overall Study|Adverse Event|9|||
161459119|NCT02119676|583076530|FG001|Overall Study|Adverse Event|17|||
161459120|NCT02119676|583076531|FG002|Overall Study|Adverse Event|10|||
161459121|NCT02119676|583076532|FG003|Overall Study|Adverse Event|10|||
161459122|NCT02119676|583076529|FG000|Overall Study|Disease progression|53|||
161913527|NCT01288430|584733561|FG002|Part 2|Progressive disease|0|||
161913528|NCT01288430|584733562|FG003|Part 2|Progressive disease|0|||
161913529|NCT01288430|584733563|FG004|Part 2|Progressive disease|0|||
161913530|NCT01288430|584733564|FG005|Part 2|Progressive disease|0|||
161913531|NCT01288430|584733565|FG006|Part 2|Progressive disease|0|||
161913532|NCT01288430|584733566|FG007|Part 2|Progressive disease|8|||
161913533|NCT01288430|584733567|FG008|Part 2|Progressive disease|7|||
161913534|NCT01288430|584733568|FG009|Part 2|Progressive disease|2|||
161913535|NCT01288430|584733559|FG000|Part 2|Clinical disease progression|0|||
161913536|NCT01288430|584733560|FG001|Part 2|Clinical disease progression|0|||
161913537|NCT01288430|584733561|FG002|Part 2|Clinical disease progression|0|||
161913538|NCT01288430|584733562|FG003|Part 2|Clinical disease progression|0|||
161913539|NCT01288430|584733563|FG004|Part 2|Clinical disease progression|0|||
161913540|NCT01288430|584733564|FG005|Part 2|Clinical disease progression|0|||
161913541|NCT01288430|584733565|FG006|Part 2|Clinical disease progression|0|||
161913542|NCT01288430|584733566|FG007|Part 2|Clinical disease progression|2|||
161913543|NCT01288430|584733567|FG008|Part 2|Clinical disease progression|0|||
161913544|NCT01288430|584733568|FG009|Part 2|Clinical disease progression|0|||
161913545|NCT01288430|584733559|FG000|Part 2|Withdrawal by Subject|0|||
161913546|NCT01288430|584733560|FG001|Part 2|Withdrawal by Subject|0|||
161913547|NCT01288430|584733561|FG002|Part 2|Withdrawal by Subject|0|||
161913548|NCT01288430|584733562|FG003|Part 2|Withdrawal by Subject|0|||
161913549|NCT01288430|584733563|FG004|Part 2|Withdrawal by Subject|0|||
161913550|NCT01288430|584733564|FG005|Part 2|Withdrawal by Subject|0|||
161913551|NCT01288430|584733565|FG006|Part 2|Withdrawal by Subject|0|||
161913552|NCT01288430|584733566|FG007|Part 2|Withdrawal by Subject|1|||
161913553|NCT01288430|584733567|FG008|Part 2|Withdrawal by Subject|4|||
161913554|NCT01288430|584733568|FG009|Part 2|Withdrawal by Subject|0|||
161913555|NCT01288430|584733559|FG000|Part 2|Adverse Event|0|||
161913556|NCT01288430|584733560|FG001|Part 2|Adverse Event|0|||
161913557|NCT01288430|584733561|FG002|Part 2|Adverse Event|0|||
161913558|NCT01288430|584733562|FG003|Part 2|Adverse Event|0|||
161913559|NCT01288430|584733563|FG004|Part 2|Adverse Event|0|||
161913560|NCT01288430|584733564|FG005|Part 2|Adverse Event|0|||
161913561|NCT01288430|584733565|FG006|Part 2|Adverse Event|0|||
161913562|NCT01288430|584733566|FG007|Part 2|Adverse Event|1|||
161913563|NCT01288430|584733567|FG008|Part 2|Adverse Event|1|||
161913564|NCT01288430|584733568|FG009|Part 2|Adverse Event|0|||
161913565|NCT01288430|584733559|FG000|Part 2|Other|0|||
161913566|NCT01288430|584733560|FG001|Part 2|Other|0|||
161913567|NCT01288430|584733561|FG002|Part 2|Other|0|||
161913568|NCT01288430|584733562|FG003|Part 2|Other|0|||
161913569|NCT01288430|584733563|FG004|Part 2|Other|0|||
161459123|NCT02119676|583076530|FG001|Overall Study|Disease progression|55|||
161459124|NCT02119676|583076531|FG002|Overall Study|Disease progression|68|||
161571147|NCT01563354|583477625|FG002|Core Phase|Adverse Event|13|||
161913570|NCT01288430|584733564|FG005|Part 2|Other|0|||
161913571|NCT01288430|584733565|FG006|Part 2|Other|0|||
161913572|NCT01288430|584733566|FG007|Part 2|Other|0|||
161913573|NCT01288430|584733567|FG008|Part 2|Other|0|||
161913574|NCT01288430|584733568|FG009|Part 2|Other|1|||
161459125|NCT02119676|583076532|FG003|Overall Study|Disease progression|73|||
161913585|NCT00788671|584733573|FG000|Overall Study|Death|2|||
161913586|NCT00788671|584733573|FG000|Overall Study|Unable to biopsy|1|||
161913587|NCT00788671|584733573|FG000|Overall Study|Withdrawal by Subject|4|||
161913588|NCT00788671|584733573|FG000|Overall Study|IUD expulsed|1|||
161913589|NCT00788671|584733573|FG000|Overall Study|Lost to follow up|2|||
161913590|NCT04780659|584733574|FG000|Overall Study|Adverse event, serious fatal|3|||
161913591|NCT04780659|584733575|FG001|Overall Study|Adverse event, serious fatal|0|||
161459126|NCT02119676|583076529|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
161459127|NCT02119676|583076530|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
161459128|NCT02119676|583076531|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
161459129|NCT02119676|583076532|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
161459130|NCT02119676|583076529|FG000|Overall Study|Physician Decision|4|||
161459131|NCT02119676|583076530|FG001|Overall Study|Physician Decision|2|||
161459132|NCT02119676|583076531|FG002|Overall Study|Physician Decision|3|||
161459133|NCT02119676|583076532|FG003|Overall Study|Physician Decision|2|||
161459134|NCT02119676|583076529|FG000|Overall Study|Death|9|||
161459135|NCT02119676|583076530|FG001|Overall Study|Death|3|||
161459136|NCT02119676|583076531|FG002|Overall Study|Death|2|||
161459137|NCT02119676|583076532|FG003|Overall Study|Death|1|||
161459138|NCT02119676|583076529|FG000|Overall Study|Noncompliance|0|||
161459139|NCT02119676|583076530|FG001|Overall Study|Noncompliance|1|||
161459140|NCT02119676|583076531|FG002|Overall Study|Noncompliance|0|||
161459141|NCT02119676|583076532|FG003|Overall Study|Noncompliance|0|||
161459142|NCT02119676|583076529|FG000|Overall Study|Lost to Follow-up|0|||
161459143|NCT02119676|583076530|FG001|Overall Study|Lost to Follow-up|0|||
161459144|NCT02119676|583076531|FG002|Overall Study|Lost to Follow-up|1|||
161459145|NCT02119676|583076532|FG003|Overall Study|Lost to Follow-up|0|||
161459146|NCT02119676|583076529|FG000|Overall Study|Protocol deviation|0|||
161459147|NCT02119676|583076530|FG001|Overall Study|Protocol deviation|0|||
161459148|NCT02119676|583076531|FG002|Overall Study|Protocol deviation|1|||
161459149|NCT02119676|583076532|FG003|Overall Study|Protocol deviation|0|||
161459150|NCT02119676|583076529|FG000|Overall Study|Other, unspecified|2|||
161459151|NCT02119676|583076530|FG001|Overall Study|Other, unspecified|1|||
161459152|NCT02119676|583076531|FG002|Overall Study|Other, unspecified|3|||
161459153|NCT02119676|583076532|FG003|Overall Study|Other, unspecified|4|||
161459154|NCT02119676|583076529|FG000|Overall Study|Did not receive study med|2|||
161459155|NCT02119676|583076530|FG001|Overall Study|Did not receive study med|2|||
161459156|NCT02119676|583076531|FG002|Overall Study|Did not receive study med|4|||
161459157|NCT02119676|583076532|FG003|Overall Study|Did not receive study med|5|||
161459158|NCT00219544|583076533|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
161459159|NCT00219544|583076534|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
161459160|NCT00219544|583076533|FG000|Single Blind Treatment Period|Adverse Event|9|||
161459161|NCT00219544|583076534|FG001|Single Blind Treatment Period|Adverse Event|0|||
161459162|NCT00219544|583076533|FG000|Single Blind Treatment Period|Protocol Violation|4|||
161459163|NCT00219544|583076534|FG001|Single Blind Treatment Period|Protocol Violation|0|||
161459164|NCT00219544|583076533|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
161459165|NCT00219544|583076534|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
161459166|NCT00219544|583076533|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
161459167|NCT00219544|583076534|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
161459168|NCT00219544|583076533|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
161459169|NCT00219544|583076534|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
161459170|NCT00989573|583076535|FG000|Overall Study|Adverse Event|8|||
161459171|NCT00989573|583076536|FG001|Overall Study|Adverse Event|12|||
161459172|NCT00989573|583076537|FG002|Overall Study|Adverse Event|4|||
161459173|NCT00989573|583076535|FG000|Overall Study|Physician Decision|0|||
161459174|NCT00989573|583076536|FG001|Overall Study|Physician Decision|2|||
161459175|NCT00989573|583076537|FG002|Overall Study|Physician Decision|0|||
161459176|NCT00989573|583076535|FG000|Overall Study|Protocol Violation|1|||
161459177|NCT00989573|583076536|FG001|Overall Study|Protocol Violation|1|||
161459178|NCT00989573|583076537|FG002|Overall Study|Protocol Violation|1|||
161459179|NCT00989573|583076535|FG000|Overall Study|Withdrawal by Subject|4|||
161459180|NCT00989573|583076536|FG001|Overall Study|Withdrawal by Subject|7|||
161459181|NCT00989573|583076537|FG002|Overall Study|Withdrawal by Subject|3|||
161459182|NCT01445886|583076539|FG000|Overall Study|Lost to Follow-up|2|||
161459183|NCT01445886|583076539|FG000|Overall Study|Protocol Violation|3|||
161809682|NCT00640562|584345764|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
161459184|NCT03473548|583076540|FG000|Overall Study|Did not attempt HST testing|3|||
161809683|NCT00640562|584345765|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
161809684|NCT00640562|584345764|FG000|Overall Study|Low study drug dose|0|||
161809685|NCT00640562|584345765|FG001|Overall Study|Low study drug dose|1|||
161459185|NCT03473548|583076541|FG001|Overall Study|Did not attempt HST testing|0|||
161459186|NCT05856760|583076552|FG000|Overall Study|Adverse Event|2|||
161459187|NCT05856760|583076552|FG000|Overall Study|Physician Decision|1|||
161459188|NCT05856760|583076552|FG000|Overall Study|Protocol Violation|1|||
161809686|NCT00640562|584345764|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
161459189|NCT05856760|583076552|FG000|Overall Study|Withdrawal by Subject|3|||
161459190|NCT04035486|583076553|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
161459191|NCT04035486|583076554|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
161459192|NCT04035486|583076555|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
161459193|NCT04035486|583076556|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
161459194|NCT04035486|583076553|FG000|Overall Study|Death|6|||
161809687|NCT00640562|584345765|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
161459195|NCT04035486|583076554|FG001|Overall Study|Death|3|||
161459196|NCT04035486|583076555|FG002|Overall Study|Death|70|||
161459197|NCT04035486|583076556|FG003|Overall Study|Death|77|||
161459198|NCT04035486|583076553|FG000|Overall Study|Screen Failure|0|||
161459199|NCT04035486|583076554|FG001|Overall Study|Screen Failure|0|||
161459200|NCT04035486|583076555|FG002|Overall Study|Screen Failure|1|||
161459201|NCT04035486|583076556|FG003|Overall Study|Screen Failure|1|||
161459202|NCT04035486|583076553|FG000|Overall Study|Withdrawal by Subject|1|||
161459203|NCT04035486|583076554|FG001|Overall Study|Withdrawal by Subject|1|||
161459204|NCT04035486|583076555|FG002|Overall Study|Withdrawal by Subject|11|||
161459205|NCT04035486|583076556|FG003|Overall Study|Withdrawal by Subject|9|||
161459206|NCT03875235|583076559|FG000|Overall Study|Ongoing study treatment|63|||
161459207|NCT03875235|583076560|FG001|Overall Study|Ongoing study treatment|20|||
161459208|NCT03875235|583076559|FG000|Overall Study|Off treatment|77|||
161459209|NCT03875235|583076560|FG001|Overall Study|Off treatment|91|||
161459210|NCT03875235|583076559|FG000|Overall Study|Withdrawal by Subject|3|||
161459211|NCT03875235|583076560|FG001|Overall Study|Withdrawal by Subject|10|||
161459212|NCT03875235|583076559|FG000|Overall Study|Death|198|||
161459213|NCT03875235|583076560|FG001|Overall Study|Death|223|||
161459214|NCT04268823|583076572|FG000|Overall Study|Adverse Event|1|||
161459215|NCT04268823|583076573|FG001|Overall Study|Adverse Event|0|||
161459216|NCT04268823|583076572|FG000|Overall Study|Participant Decision|1|||
161459217|NCT04268823|583076573|FG001|Overall Study|Participant Decision|0|||
161809688|NCT02699866|584345766|FG000|Overall Study|Withdrawal by Subject|3|||
161459218|NCT01107418|583077772|FG000|Overall Study|Disease Progression|45|||
161459219|NCT01107418|583077772|FG000|Overall Study|Adverse Event|3|||
161459220|NCT01107418|583077772|FG000|Overall Study|Withdrawal by Subject|1|||
161459221|NCT01107418|583077772|FG000|Overall Study|Study Closing|1|||
161459222|NCT01107418|583077772|FG000|Overall Study|Started Other Therapy|1|||
161459223|NCT01107418|583077772|FG000|Overall Study|Entered Extension Study|1|||
161459224|NCT02186301|583077775|FG000|Overall Study|Progressive Disease|7|||
161571148|NCT01563354|583477623|FG000|Core Phase|Withdrawal by Subject|1|||
161571149|NCT01563354|583477624|FG001|Core Phase|Withdrawal by Subject|0|||
161459225|NCT02186301|583077776|FG001|Overall Study|Progressive Disease|22|||
161571150|NCT01563354|583477625|FG002|Core Phase|Withdrawal by Subject|3|||
161571151|NCT01563354|583477623|FG000|Core Phase|Lost to Follow-up|1|||
161571152|NCT01563354|583477624|FG001|Core Phase|Lost to Follow-up|0|||
161571153|NCT01563354|583477625|FG002|Core Phase|Lost to Follow-up|0|||
161571154|NCT01563354|583477623|FG000|Core Phase|Death|1|||
161571155|NCT01563354|583477624|FG001|Core Phase|Death|5|||
161571156|NCT01563354|583477625|FG002|Core Phase|Death|2|||
161571157|NCT01563354|583477623|FG000|Core Phase|Diseasse progression|18|||
161571158|NCT01563354|583477624|FG001|Core Phase|Diseasse progression|7|||
161571159|NCT01563354|583477625|FG002|Core Phase|Diseasse progression|8|||
161571160|NCT01563354|583477623|FG000|Core Phase|Protocol deviation|2|||
161571161|NCT01563354|583477624|FG001|Core Phase|Protocol deviation|0|||
161571162|NCT01563354|583477625|FG002|Core Phase|Protocol deviation|0|||
161571163|NCT01563354|583477623|FG000|Core Phase|PI decision - did not enter extension|0|||
161571164|NCT01563354|583477624|FG001|Core Phase|PI decision - did not enter extension|1|||
161571165|NCT01563354|583477625|FG002|Core Phase|PI decision - did not enter extension|0|||
161571166|NCT01563354|583477623|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
161571167|NCT01563354|583477624|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
161571168|NCT01563354|583477625|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
161571169|NCT01563354|583477623|FG000|Extension Phase|Adverse Event|0|||
161571170|NCT01563354|583477624|FG001|Extension Phase|Adverse Event|3|||
161571171|NCT01563354|583477625|FG002|Extension Phase|Adverse Event|2|||
161571172|NCT01563354|583477623|FG000|Extension Phase|Withdrawal by Subject|0|||
161571173|NCT01563354|583477624|FG001|Extension Phase|Withdrawal by Subject|1|||
161571174|NCT01563354|583477625|FG002|Extension Phase|Withdrawal by Subject|0|||
161571175|NCT01563354|583477623|FG000|Extension Phase|Administration problems|3|||
161571176|NCT01563354|583477624|FG001|Extension Phase|Administration problems|2|||
161571177|NCT01563354|583477625|FG002|Extension Phase|Administration problems|3|||
161571178|NCT01563354|583477623|FG000|Extension Phase|Disease progression|9|||
161571179|NCT01563354|583477624|FG001|Extension Phase|Disease progression|8|||
161571180|NCT01563354|583477625|FG002|Extension Phase|Disease progression|10|||
161571181|NCT01050569|583477631|FG000|Overall Study|Lost to Follow-up|20|||
161571182|NCT01050569|583477632|FG001|Overall Study|Lost to Follow-up|14|||
161571183|NCT01050569|583477633|FG002|Overall Study|Lost to Follow-up|16|||
161571184|NCT01050569|583477631|FG000|Overall Study|Withdrawal by Subject|9|||
161571185|NCT01050569|583477632|FG001|Overall Study|Withdrawal by Subject|3|||
161571186|NCT01050569|583477633|FG002|Overall Study|Withdrawal by Subject|11|||
161571187|NCT01050569|583477631|FG000|Overall Study|Lack of Efficacy|5|||
161571188|NCT01050569|583477632|FG001|Overall Study|Lack of Efficacy|4|||
161571189|NCT01050569|583477633|FG002|Overall Study|Lack of Efficacy|3|||
161571190|NCT01050569|583477631|FG000|Overall Study|Adverse Event|1|||
161571191|NCT01050569|583477632|FG001|Overall Study|Adverse Event|0|||
161571192|NCT01050569|583477633|FG002|Overall Study|Adverse Event|0|||
161571193|NCT01050569|583477631|FG000|Overall Study|Physician Decision|3|||
161571194|NCT01050569|583477632|FG001|Overall Study|Physician Decision|3|||
161809689|NCT02699866|584345766|FG000|Overall Study|Physician Decision|2|||
161809690|NCT02699866|584345766|FG000|Overall Study|Adverse Event|3|||
161809691|NCT02937870|584345767|FG000|Overall Study|Adverse Event|1|||
161809692|NCT02937870|584345767|FG000|Overall Study|Protocol Deviation|2|||
161809693|NCT00244764|584345768|FG000|Overall Study|Adverse Event|37|||
161809694|NCT00244764|584345768|FG000|Overall Study|Lost to Follow-up|23|||
161809695|NCT00244764|584345768|FG000|Overall Study|Withdrawal by Subject|12|||
161459226|NCT02186301|583077777|FG002|Overall Study|Progressive Disease|27|||
161459227|NCT02186301|583077775|FG000|Overall Study|Adverse Event|5|||
161459228|NCT02186301|583077776|FG001|Overall Study|Adverse Event|5|||
161459229|NCT02186301|583077777|FG002|Overall Study|Adverse Event|5|||
161571195|NCT01050569|583477633|FG002|Overall Study|Physician Decision|3|||
161571196|NCT05046132|583477634|FG000|Overall Study|Adverse Event|4|||
161809696|NCT00244764|584345768|FG000|Overall Study|Disease Progression|13|||
161913592|NCT04780659|584733574|FG000|Overall Study|Withdrawal by Subject|3|||
161571197|NCT05046132|583477635|FG001|Overall Study|Adverse Event|0|||
161571198|NCT05046132|583477636|FG002|Overall Study|Adverse Event|0|||
161571199|NCT05046132|583477634|FG000|Overall Study|Withdrawal by Subject|3|||
161809697|NCT00244764|584345768|FG000|Overall Study|Protocol Violation|2|||
161571200|NCT05046132|583477635|FG001|Overall Study|Withdrawal by Subject|0|||
161571201|NCT05046132|583477636|FG002|Overall Study|Withdrawal by Subject|0|||
161809698|NCT00244764|584345768|FG000|Overall Study|Death|1|||
161459230|NCT02186301|583077775|FG000|Overall Study|Death|1|||
161459231|NCT02186301|583077776|FG001|Overall Study|Death|0|||
161459232|NCT02186301|583077777|FG002|Overall Study|Death|0|||
161571202|NCT05046132|583477634|FG000|Overall Study|Positive Covid19 Result.|0|||
161571203|NCT05046132|583477635|FG001|Overall Study|Positive Covid19 Result.|1|||
161571204|NCT05046132|583477636|FG002|Overall Study|Positive Covid19 Result.|0|||
161571205|NCT01186848|583477637|FG000|Overall Study|Lost to Follow-up|4|||
161809699|NCT00244764|584345768|FG000|Overall Study|Off Study Medication for >21 Days|1|||
161459233|NCT02186301|583077775|FG000|Overall Study|Withdrawal by Subject|5|||
161459234|NCT02186301|583077776|FG001|Overall Study|Withdrawal by Subject|1|||
161459235|NCT02186301|583077777|FG002|Overall Study|Withdrawal by Subject|3|||
161459236|NCT02186301|583077775|FG000|Overall Study|Physician Decision|1|||
161459237|NCT02186301|583077776|FG001|Overall Study|Physician Decision|0|||
161459238|NCT02186301|583077777|FG002|Overall Study|Physician Decision|1|||
161459239|NCT02186301|583077775|FG000|Overall Study|Study Terminated by Sponsor|1|||
161459240|NCT02186301|583077776|FG001|Overall Study|Study Terminated by Sponsor|0|||
161459241|NCT02186301|583077777|FG002|Overall Study|Study Terminated by Sponsor|11|||
161459242|NCT02186301|583077775|FG000|Overall Study|Protocol Deviation|0|||
161459243|NCT02186301|583077776|FG001|Overall Study|Protocol Deviation|2|||
161459244|NCT02186301|583077777|FG002|Overall Study|Protocol Deviation|0|||
161459245|NCT02186301|583077775|FG000|Overall Study|Missing|0|||
161459246|NCT02186301|583077776|FG001|Overall Study|Missing|0|||
161459247|NCT02186301|583077777|FG002|Overall Study|Missing|2|||
161459248|NCT02186301|583077775|FG000|Overall Study|Other|0|||
161459249|NCT02186301|583077776|FG001|Overall Study|Other|0|||
161459250|NCT02186301|583077777|FG002|Overall Study|Other|1|||
161459251|NCT01343823|583077778|FG000|Overall Study|Study Terminated|1|||
161459252|NCT01343823|583077779|FG001|Overall Study|Study Terminated|0|||
161459253|NCT01343823|583077780|FG002|Overall Study|Study Terminated|0|||
161459254|NCT01343823|583077781|FG003|Overall Study|Study Terminated|1|||
161459255|NCT01343823|583077778|FG000|Overall Study|Withdrawal by Subject|1|||
161459256|NCT01343823|583077779|FG001|Overall Study|Withdrawal by Subject|0|||
161459257|NCT01343823|583077780|FG002|Overall Study|Withdrawal by Subject|0|||
161459258|NCT01343823|583077781|FG003|Overall Study|Withdrawal by Subject|0|||
161459259|NCT01117792|583077786|FG000|Overall Study|Death|1|||
161459260|NCT01117792|583077786|FG000|Overall Study|Adverse Event|3|||
161913593|NCT04780659|584733575|FG001|Overall Study|Withdrawal by Subject|0|||
161913594|NCT04780659|584733574|FG000|Overall Study|Physician Decision|1|||
161459261|NCT05867342|583077787|FG000|Overall Study|Investigator Decision|3|||
161459262|NCT05867342|583077788|FG001|Overall Study|Investigator Decision|3|||
161459263|NCT00723203|583077789|FG000|Overall Study|Withdrawal by Subject|3|||
161459264|NCT00274924|583077790|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
161459265|NCT00274924|583077791|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
161459266|NCT00274924|583077792|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
161459267|NCT00274924|583077790|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
161459268|NCT00274924|583077791|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
161459269|NCT00274924|583077792|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
161459270|NCT00274924|583077790|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
161459271|NCT00274924|583077791|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
161459272|NCT00274924|583077792|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
161459273|NCT00274924|583077790|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
161459274|NCT00274924|583077791|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
161459275|NCT00274924|583077792|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
161459276|NCT00274924|583077790|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
161459277|NCT00274924|583077791|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
161459278|NCT00274924|583077792|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
161459279|NCT00274924|583077790|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
161459280|NCT00274924|583077791|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
161571206|NCT01186848|583477637|FG000|Overall Study|Withdrawal by Subject|2|||
161913595|NCT04780659|584733575|FG001|Overall Study|Physician Decision|0|||
161913596|NCT04780659|584733574|FG000|Overall Study|Died in original disease|2|||
161913597|NCT04780659|584733575|FG001|Overall Study|Died in original disease|0|||
161459281|NCT00274924|583077792|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
161459282|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
161459283|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
161459284|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
161459285|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
161459286|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
161459287|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
161459288|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
161459289|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
161459290|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
161459291|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
161459292|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
161459293|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
161459294|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
161459295|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
161459296|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
161459297|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
161571207|NCT01186848|583477637|FG000|Overall Study|Adverse Event|2|||
161913598|NCT04780659|584733574|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
161459298|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
161459299|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
161459300|NCT00274924|583077790|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
161459301|NCT00274924|583077791|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
161459302|NCT00274924|583077792|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
161459303|NCT01903525|583077795|FG000|Overall Study|Lost to Follow-up|5|||
161459304|NCT01903525|583077796|FG001|Overall Study|Lost to Follow-up|9|||
161459305|NCT01903525|583077795|FG000|Overall Study|Adverse Event|0|||
161459306|NCT01903525|583077796|FG001|Overall Study|Adverse Event|1|||
161459307|NCT01673282|583077798|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
161459308|NCT01673282|583077799|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
161459309|NCT01673282|583077798|FG000|Overall Study|Lack of Efficacy|9|||
161459310|NCT01673282|583077799|FG001|Overall Study|Lack of Efficacy|2|||
161459311|NCT01673282|583077798|FG000|Overall Study|Lost to Follow-up|11|||
161459312|NCT01673282|583077799|FG001|Overall Study|Lost to Follow-up|10|||
161459313|NCT01673282|583077798|FG000|Overall Study|Withdrawal by Subject|3|||
161459314|NCT01673282|583077799|FG001|Overall Study|Withdrawal by Subject|3|||
161459315|NCT01673282|583077798|FG000|Overall Study|Other|1|||
161459316|NCT01673282|583077799|FG001|Overall Study|Other|6|||
161459317|NCT04365257|583077800|FG000|Overall Study|Physician Decision|1|||
161459318|NCT04365257|583077801|FG001|Overall Study|Physician Decision|0|||
161459319|NCT04365257|583077800|FG000|Overall Study|Patient Noncompliance|1|||
161459320|NCT04365257|583077801|FG001|Overall Study|Patient Noncompliance|0|||
161459321|NCT04365257|583077800|FG000|Overall Study|Withdrawal by Subject|0|||
161459322|NCT04365257|583077801|FG001|Overall Study|Withdrawal by Subject|1|||
161459323|NCT02129777|583077806|FG000|Double-Blind Period|Adverse Event|0|||
161459324|NCT02129777|583077807|FG001|Double-Blind Period|Adverse Event|0|||
161459325|NCT02129777|583077808|FG002|Double-Blind Period|Adverse Event|0|||
161459326|NCT02129777|583077809|FG003|Double-Blind Period|Adverse Event|0|||
161459327|NCT02129777|583077810|FG004|Double-Blind Period|Adverse Event|1|||
161459328|NCT02129777|583077811|FG005|Double-Blind Period|Adverse Event|0|||
161459329|NCT02129777|583077812|FG006|Double-Blind Period|Adverse Event|0|||
161459330|NCT02129777|583077806|FG000|Double-Blind Period|Lost to Follow-up|1|||
161459331|NCT02129777|583077807|FG001|Double-Blind Period|Lost to Follow-up|1|||
161459332|NCT02129777|583077808|FG002|Double-Blind Period|Lost to Follow-up|1|||
161459333|NCT02129777|583077809|FG003|Double-Blind Period|Lost to Follow-up|2|||
161459334|NCT02129777|583077810|FG004|Double-Blind Period|Lost to Follow-up|0|||
161459335|NCT02129777|583077811|FG005|Double-Blind Period|Lost to Follow-up|0|||
161459336|NCT02129777|583077812|FG006|Double-Blind Period|Lost to Follow-up|0|||
161459337|NCT02129777|583077806|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161459338|NCT02129777|583077807|FG001|Double-Blind Period|Withdrawal by Subject|4|||
161459339|NCT02129777|583077808|FG002|Double-Blind Period|Withdrawal by Subject|3|||
161459340|NCT02129777|583077809|FG003|Double-Blind Period|Withdrawal by Subject|2|||
161459341|NCT02129777|583077810|FG004|Double-Blind Period|Withdrawal by Subject|3|||
161459342|NCT02129777|583077811|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161459343|NCT02129777|583077812|FG006|Double-Blind Period|Withdrawal by Subject|0|||
161459344|NCT02129777|583077806|FG000|Double-Blind Period|Pregnancy|0|||
161459345|NCT02129777|583077807|FG001|Double-Blind Period|Pregnancy|0|||
161459346|NCT02129777|583077808|FG002|Double-Blind Period|Pregnancy|0|||
161459347|NCT02129777|583077809|FG003|Double-Blind Period|Pregnancy|0|||
161459348|NCT02129777|583077810|FG004|Double-Blind Period|Pregnancy|1|||
161459349|NCT02129777|583077811|FG005|Double-Blind Period|Pregnancy|0|||
161459350|NCT02129777|583077812|FG006|Double-Blind Period|Pregnancy|0|||
161459351|NCT02129777|583077806|FG000|Double-Blind Period|Lack of Efficacy|3|||
161459352|NCT02129777|583077807|FG001|Double-Blind Period|Lack of Efficacy|1|||
161809700|NCT00244764|584345768|FG000|Overall Study|Declining Performance Status|1|||
161809701|NCT00244764|584345768|FG000|Overall Study|Participant was Hospitalized until Death|1|||
161809702|NCT00244764|584345768|FG000|Overall Study|Primary Investigator Discretion|2|||
161809703|NCT00244764|584345768|FG000|Overall Study|Sponsor Terminated Study|2|||
161809704|NCT00244764|584345768|FG000|Overall Study|Developed Secondary Malignancy|1|||
161809705|NCT01294917|584345769|FG000|Overall Study|Relocation|5|||
161809706|NCT01294917|584345769|FG000|Overall Study|Inconvenience|1|||
161459353|NCT02129777|583077808|FG002|Double-Blind Period|Lack of Efficacy|0|||
161459354|NCT02129777|583077809|FG003|Double-Blind Period|Lack of Efficacy|3|||
161459355|NCT02129777|583077810|FG004|Double-Blind Period|Lack of Efficacy|2|||
161459356|NCT02129777|583077811|FG005|Double-Blind Period|Lack of Efficacy|0|||
161459357|NCT02129777|583077812|FG006|Double-Blind Period|Lack of Efficacy|0|||
161459358|NCT02129777|583077806|FG000|Double-Blind Period|Other|1|||
161459359|NCT02129777|583077807|FG001|Double-Blind Period|Other|2|||
161459360|NCT02129777|583077808|FG002|Double-Blind Period|Other|0|||
161459361|NCT02129777|583077809|FG003|Double-Blind Period|Other|0|||
161459362|NCT02129777|583077810|FG004|Double-Blind Period|Other|0|||
161459363|NCT02129777|583077811|FG005|Double-Blind Period|Other|0|||
161459364|NCT02129777|583077812|FG006|Double-Blind Period|Other|0|||
161459365|NCT02129777|583077806|FG000|Open-Label Period|Lack of Efficacy|0|||
161459366|NCT02129777|583077807|FG001|Open-Label Period|Lack of Efficacy|0|||
161459367|NCT02129777|583077808|FG002|Open-Label Period|Lack of Efficacy|0|||
161571208|NCT00770965|583477647|FG000|Safety Set|Withdrawal by Subject|0|||
161571209|NCT00770965|583477648|FG001|Safety Set|Withdrawal by Subject|0|||
161571210|NCT00770965|583477649|FG002|Safety Set|Withdrawal by Subject|0|||
161809707|NCT03017885|584345770|FG000|Overall Study|Adverse Event|2|||
161809708|NCT03017885|584345771|FG001|Overall Study|Adverse Event|0|||
161809709|NCT03017885|584345772|FG002|Overall Study|Adverse Event|0|||
161809710|NCT03017885|584345773|FG003|Overall Study|Adverse Event|0|||
161809711|NCT03017885|584345774|FG004|Overall Study|Adverse Event|0|||
161809712|NCT03017885|584345775|FG005|Overall Study|Adverse Event|0|||
161809713|NCT03017885|584345770|FG000|Overall Study|Progression of disease|4|||
161809714|NCT03017885|584345771|FG001|Overall Study|Progression of disease|3|||
161913599|NCT04780659|584733575|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
161913600|NCT03729362|584733576|FG000|Overall Study|Withdrawal by Subject|2|||
161571211|NCT00770965|583477650|FG003|Safety Set|Withdrawal by Subject|1|||
161913601|NCT03729362|584733577|FG001|Overall Study|Withdrawal by Subject|0|||
161913602|NCT03729362|584733576|FG000|Overall Study|Physician Decision|1|||
161913603|NCT03729362|584733577|FG001|Overall Study|Physician Decision|0|||
161913604|NCT03729362|584733576|FG000|Overall Study|COVID-19 Pandemic|1|||
161913605|NCT03729362|584733577|FG001|Overall Study|COVID-19 Pandemic|0|||
161913606|NCT03729362|584733576|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
161913607|NCT03729362|584733577|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
161913608|NCT03729362|584733576|FG000|Overall Study|Adverse Event|0|||
161913609|NCT03729362|584733577|FG001|Overall Study|Adverse Event|1|||
161913610|NCT03729362|584733576|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
161913611|NCT03729362|584733577|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
161913612|NCT03405870|584733578|FG000|Overall Study|Withdrawal|1|||
161913613|NCT03405870|584733579|FG001|Overall Study|Withdrawal|0|||
161913614|NCT03405870|584733580|FG002|Overall Study|Withdrawal|1|||
161913615|NCT03405870|584733581|FG003|Overall Study|Withdrawal|0|||
161913616|NCT03405870|584733582|FG004|Overall Study|Withdrawal|0|||
161913617|NCT03405870|584733583|FG005|Overall Study|Withdrawal|0|||
161913618|NCT03405870|584733584|FG006|Overall Study|Withdrawal|1|||
161913619|NCT03405870|584733585|FG007|Overall Study|Withdrawal|0|||
161913620|NCT02807259|584733588|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
161913621|NCT02807259|584733589|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
161913622|NCT02807259|584733588|FG000|Midline (3 Months)|migration, refusal, not available|30|||
161913623|NCT02807259|584733589|FG001|Midline (3 Months)|migration, refusal, not available|34|||
161913624|NCT02807259|584733588|FG000|Endline (3 Months)|migration, refusal, not available|35|||
161913625|NCT02807259|584733589|FG001|Endline (3 Months)|migration, refusal, not available|87|||
161913626|NCT01171534|584733590|FG000|Overall Study|Lost to Follow-up|0|||
161913627|NCT01171534|584733591|FG001|Overall Study|Lost to Follow-up|2|||
161913628|NCT01171534|584733590|FG000|Overall Study|screen failure|0|||
161913629|NCT01171534|584733591|FG001|Overall Study|screen failure|1|||
161913630|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
161913631|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
161913632|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
161913633|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
161913634|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
161913635|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
161913636|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
161913637|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
161913638|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
161913639|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
161913640|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
161913641|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
161913642|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
161913643|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
161913644|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
161913645|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
161913646|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161913647|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
161913648|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161913649|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
161913650|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
161913651|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
161913652|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
161913653|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
161913654|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
161913655|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
161571212|NCT00770965|583477647|FG000|Safety Set|Protocol deviation|0|||
161809715|NCT03017885|584345772|FG002|Overall Study|Progression of disease|4|||
161809716|NCT03017885|584345773|FG003|Overall Study|Progression of disease|0|||
161459368|NCT02129777|583077809|FG003|Open-Label Period|Lack of Efficacy|0|||
161459369|NCT02129777|583077810|FG004|Open-Label Period|Lack of Efficacy|0|||
161459370|NCT02129777|583077811|FG005|Open-Label Period|Lack of Efficacy|0|||
161459371|NCT02129777|583077812|FG006|Open-Label Period|Lack of Efficacy|5|||
161459372|NCT02129777|583077806|FG000|Open-Label Period|Lost to Follow-up|0|||
161459373|NCT02129777|583077807|FG001|Open-Label Period|Lost to Follow-up|0|||
161459374|NCT02129777|583077808|FG002|Open-Label Period|Lost to Follow-up|0|||
161459375|NCT02129777|583077809|FG003|Open-Label Period|Lost to Follow-up|0|||
161459376|NCT02129777|583077810|FG004|Open-Label Period|Lost to Follow-up|0|||
161459377|NCT02129777|583077811|FG005|Open-Label Period|Lost to Follow-up|1|||
161459378|NCT02129777|583077812|FG006|Open-Label Period|Lost to Follow-up|1|||
161459379|NCT02129777|583077806|FG000|Open-Label Period|Withdrawal by Subject|0|||
161459380|NCT02129777|583077807|FG001|Open-Label Period|Withdrawal by Subject|0|||
161459381|NCT02129777|583077808|FG002|Open-Label Period|Withdrawal by Subject|0|||
161459382|NCT02129777|583077809|FG003|Open-Label Period|Withdrawal by Subject|0|||
161459383|NCT02129777|583077810|FG004|Open-Label Period|Withdrawal by Subject|0|||
161459384|NCT02129777|583077811|FG005|Open-Label Period|Withdrawal by Subject|1|||
161459385|NCT02129777|583077812|FG006|Open-Label Period|Withdrawal by Subject|3|||
161459386|NCT02129777|583077806|FG000|Open-Label Period|Study Termination|0|||
161459387|NCT02129777|583077807|FG001|Open-Label Period|Study Termination|0|||
161459388|NCT02129777|583077808|FG002|Open-Label Period|Study Termination|0|||
161459389|NCT02129777|583077809|FG003|Open-Label Period|Study Termination|0|||
161459390|NCT02129777|583077810|FG004|Open-Label Period|Study Termination|0|||
161459391|NCT02129777|583077811|FG005|Open-Label Period|Study Termination|10|||
161459392|NCT02129777|583077812|FG006|Open-Label Period|Study Termination|39|||
161459393|NCT01609478|583077820|FG000|Overall Study|Adverse Event|3|||
161459394|NCT01609478|583077821|FG001|Overall Study|Adverse Event|1|||
161459395|NCT01609478|583077822|FG002|Overall Study|Adverse Event|5|||
161459396|NCT01609478|583077820|FG000|Overall Study|Protocol Deviation|0|||
161459397|NCT01609478|583077821|FG001|Overall Study|Protocol Deviation|1|||
161459398|NCT01609478|583077822|FG002|Overall Study|Protocol Deviation|1|||
161459399|NCT01609478|583077820|FG000|Overall Study|Non-Compliance with study treatment|1|||
161459400|NCT01609478|583077821|FG001|Overall Study|Non-Compliance with study treatment|0|||
161459401|NCT01609478|583077822|FG002|Overall Study|Non-Compliance with study treatment|0|||
161459402|NCT01609478|583077820|FG000|Overall Study|Physician Decision|1|||
161459403|NCT01609478|583077821|FG001|Overall Study|Physician Decision|0|||
161459404|NCT01609478|583077822|FG002|Overall Study|Physician Decision|1|||
161459405|NCT01609478|583077820|FG000|Overall Study|Withdrawal by Subject|2|||
161459406|NCT01609478|583077821|FG001|Overall Study|Withdrawal by Subject|0|||
161459407|NCT01609478|583077822|FG002|Overall Study|Withdrawal by Subject|2|||
161459408|NCT04973137|583077823|FG000|Double Blind Phase|Adverse Event|4|||
161459409|NCT04973137|583077824|FG001|Double Blind Phase|Adverse Event|0|||
161459410|NCT04973137|583077823|FG000|Double Blind Phase|Death|25|||
161459411|NCT04973137|583077824|FG001|Double Blind Phase|Death|15|||
161459412|NCT04973137|583077823|FG000|Double Blind Phase|Physician Decision|5|||
161459413|NCT04973137|583077824|FG001|Double Blind Phase|Physician Decision|1|||
161459414|NCT04973137|583077823|FG000|Double Blind Phase|Withdrawal by Subject|6|||
161459415|NCT04973137|583077824|FG001|Double Blind Phase|Withdrawal by Subject|1|||
161459416|NCT04973137|583077823|FG000|Double Blind Phase|Other|2|||
161459417|NCT04973137|583077824|FG001|Double Blind Phase|Other|2|||
161459418|NCT04973137|583077823|FG000|Open Label Extension Phase|Death|3|||
161459419|NCT04973137|583077824|FG001|Open Label Extension Phase|Death|0|||
161459420|NCT04973137|583077823|FG000|Open Label Extension Phase|Physician Decision|0|||
161459421|NCT04973137|583077824|FG001|Open Label Extension Phase|Physician Decision|1|||
161459422|NCT04973137|583077823|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
161459423|NCT04973137|583077824|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
161459424|NCT04973137|583077823|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
161459425|NCT04973137|583077824|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
161459426|NCT04973137|583077823|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
161459427|NCT04973137|583077824|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
161459428|NCT05040971|583077825|FG000|Overall Study|Withdrawal by Subject|0|||
161459429|NCT05040971|583077826|FG001|Overall Study|Withdrawal by Subject|2|||
161459430|NCT05040971|583077825|FG000|Overall Study|Lost to Follow-up|8|||
161459431|NCT05040971|583077826|FG001|Overall Study|Lost to Follow-up|3|||
161459432|NCT05040971|583077825|FG000|Overall Study|Death|2|||
161459433|NCT05040971|583077826|FG001|Overall Study|Death|0|||
161459434|NCT04391569|583077829|FG000|Overall Study|Death|15|||
161459435|NCT04391569|583077830|FG001|Overall Study|Death|10|||
161459436|NCT04391569|583077829|FG000|Overall Study|Withdrawal by Subject|1|||
161459437|NCT04391569|583077830|FG001|Overall Study|Withdrawal by Subject|0|||
161459438|NCT04391569|583077829|FG000|Overall Study|Lost to Follow-up|3|||
161459439|NCT04391569|583077830|FG001|Overall Study|Lost to Follow-up|2|||
161459440|NCT04391569|583077829|FG000|Overall Study|Lack of Efficacy|0|||
161459441|NCT04391569|583077830|FG001|Overall Study|Lack of Efficacy|1|||
161459442|NCT04391569|583077829|FG000|Overall Study|Participant discharged to hospice facility|0|||
161459443|NCT04391569|583077830|FG001|Overall Study|Participant discharged to hospice facility|1|||
161913656|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161571213|NCT00770965|583477648|FG001|Safety Set|Protocol deviation|0|||
161571214|NCT00770965|583477649|FG002|Safety Set|Protocol deviation|1|||
161913657|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161913658|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
161913659|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
161913660|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
161913661|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
161913662|NCT04588259|584733594|FG000|Run-in period|Run-in failure|0|||
161913663|NCT04588259|584733595|FG001|Run-in period|Run-in failure|23|||
161913664|NCT04588259|584733594|FG000|Run-in period|Withdrawn before randomisation|0|||
161913665|NCT04588259|584733595|FG001|Run-in period|Withdrawn before randomisation|8|||
161571215|NCT00770965|583477650|FG003|Safety Set|Protocol deviation|0|||
161571216|NCT00770965|583477647|FG000|Excluded Set|Administrative problems|14|||
161571217|NCT00770965|583477648|FG001|Excluded Set|Administrative problems|12|||
161571218|NCT00770965|583477649|FG002|Excluded Set|Administrative problems|12|||
161571219|NCT00770965|583477650|FG003|Excluded Set|Administrative problems|10|||
161571220|NCT00770965|583477647|FG000|Excluded Set|Withdrawal by Subject|1|||
161571221|NCT00770965|583477648|FG001|Excluded Set|Withdrawal by Subject|1|||
161571222|NCT00770965|583477649|FG002|Excluded Set|Withdrawal by Subject|2|||
161571223|NCT00770965|583477650|FG003|Excluded Set|Withdrawal by Subject|3|||
161571224|NCT02371746|583477651|FG000|Overall Study|Consent withdrawn|0|||
161571225|NCT02371746|583477652|FG001|Overall Study|Consent withdrawn|0|||
161571226|NCT02371746|583477653|FG002|Overall Study|Consent withdrawn|0|||
161571227|NCT02371746|583477654|FG003|Overall Study|Consent withdrawn|0|||
161571228|NCT02371746|583477655|FG004|Overall Study|Consent withdrawn|0|||
161571229|NCT02371746|583477656|FG005|Overall Study|Consent withdrawn|0|||
161571230|NCT02371746|583477657|FG006|Overall Study|Consent withdrawn|1|||
161571231|NCT00612586|583477658|FG000|Overall Study|Adverse Event|6|||
161571232|NCT00612586|583477659|FG001|Overall Study|Adverse Event|2|||
161571233|NCT00612586|583477658|FG000|Overall Study|Death|1|||
161571234|NCT00612586|583477659|FG001|Overall Study|Death|0|||
161571235|NCT00612586|583477658|FG000|Overall Study|Entry Criteria Not Met|0|||
161571236|NCT00612586|583477659|FG001|Overall Study|Entry Criteria Not Met|2|||
161571237|NCT00612586|583477658|FG000|Overall Study|Withdrawal by Subject|7|||
161571238|NCT00612586|583477659|FG001|Overall Study|Withdrawal by Subject|9|||
161571239|NCT00612586|583477658|FG000|Overall Study|Physician Decision|1|||
161571240|NCT00612586|583477659|FG001|Overall Study|Physician Decision|2|||
161571241|NCT00612586|583477658|FG000|Overall Study|Sponsor Decision|1|||
161571242|NCT00612586|583477659|FG001|Overall Study|Sponsor Decision|1|||
161571243|NCT00612586|583477658|FG000|Overall Study|Progressive Disease|26|||
161571244|NCT00612586|583477659|FG001|Overall Study|Progressive Disease|24|||
161571245|NCT00612586|583477658|FG000|Overall Study|Randomized and Not Treated|1|||
161571246|NCT00612586|583477659|FG001|Overall Study|Randomized and Not Treated|1|||
161571247|NCT02613364|583477660|FG000|Overall Study|Other|19|||
161571248|NCT02613364|583477661|FG001|Overall Study|Other|29|||
161571249|NCT02613364|583477662|FG002|Overall Study|Other|17|||
161571250|NCT02613364|583477660|FG000|Overall Study|Too time consuming|21|||
161571251|NCT02613364|583477661|FG001|Overall Study|Too time consuming|26|||
161571252|NCT02613364|583477662|FG002|Overall Study|Too time consuming|26|||
161571253|NCT02613364|583477660|FG000|Overall Study|Withdrawal by Subject|13|||
161571254|NCT02613364|583477661|FG001|Overall Study|Withdrawal by Subject|18|||
161571255|NCT02613364|583477662|FG002|Overall Study|Withdrawal by Subject|17|||
161571256|NCT02613364|583477660|FG000|Overall Study|Medical|12|||
161571257|NCT02613364|583477661|FG001|Overall Study|Medical|13|||
161571258|NCT02613364|583477662|FG002|Overall Study|Medical|9|||
161571259|NCT02613364|583477660|FG000|Overall Study|Disliked Study Procedure|1|||
161571260|NCT02613364|583477661|FG001|Overall Study|Disliked Study Procedure|1|||
161571261|NCT02613364|583477662|FG002|Overall Study|Disliked Study Procedure|4|||
161571262|NCT02613364|583477660|FG000|Overall Study|Disliked Intervention|0|||
161571263|NCT02613364|583477661|FG001|Overall Study|Disliked Intervention|3|||
161571264|NCT02613364|583477662|FG002|Overall Study|Disliked Intervention|3|||
161571265|NCT01909336|583477663|FG000|Overall Study|Lost to Follow-up|4|||
161571266|NCT01909336|583477664|FG001|Overall Study|Lost to Follow-up|2|||
161571267|NCT01909336|583477665|FG002|Overall Study|Lost to Follow-up|2|||
161571268|NCT01909336|583477663|FG000|Overall Study|Physician Decision|0|||
161913666|NCT04588259|584733594|FG000|Treatment period|Withdrawal by Subject|6|||
161913667|NCT04588259|584733595|FG001|Treatment period|Withdrawal by Subject|6|||
161913668|NCT02100631|584733602|FG000|Overall Study|Withdrawal by Subject|1|||
161913669|NCT02100631|584733603|FG001|Overall Study|Withdrawal by Subject|0|||
161913670|NCT02100631|584733604|FG002|Overall Study|Withdrawal by Subject|0|||
161913671|NCT02100631|584733602|FG000|Overall Study|Lost to Follow-up|3|||
161913672|NCT02100631|584733603|FG001|Overall Study|Lost to Follow-up|4|||
161913673|NCT02100631|584733604|FG002|Overall Study|Lost to Follow-up|0|||
161913674|NCT02100631|584733602|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
161913675|NCT02100631|584733603|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
161913676|NCT02100631|584733604|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
161913677|NCT04476043|584733605|FG000|Overall Study|Withdrawal by Subject|1|||
161913678|NCT04476043|584733606|FG001|Overall Study|Withdrawal by Subject|3|||
161913679|NCT04476043|584733607|FG002|Overall Study|Withdrawal by Subject|4|||
161913680|NCT04476043|584733608|FG003|Overall Study|Withdrawal by Subject|1|||
161913681|NCT04476043|584733605|FG000|Overall Study|Lost to Follow-up|1|||
161913682|NCT04476043|584733606|FG001|Overall Study|Lost to Follow-up|1|||
161913683|NCT04476043|584733607|FG002|Overall Study|Lost to Follow-up|2|||
161913684|NCT04476043|584733608|FG003|Overall Study|Lost to Follow-up|1|||
161913685|NCT04476043|584733605|FG000|Overall Study|Adverse Event|2|||
161913686|NCT04476043|584733606|FG001|Overall Study|Adverse Event|0|||
161913687|NCT04476043|584733607|FG002|Overall Study|Adverse Event|1|||
161913688|NCT04476043|584733608|FG003|Overall Study|Adverse Event|0|||
161913689|NCT04476043|584733605|FG000|Overall Study|Protocol Violation|0|||
161913690|NCT04476043|584733606|FG001|Overall Study|Protocol Violation|1|||
161913691|NCT04476043|584733607|FG002|Overall Study|Protocol Violation|0|||
161809717|NCT03017885|584345774|FG004|Overall Study|Progression of disease|0|||
161809718|NCT03017885|584345775|FG005|Overall Study|Progression of disease|0|||
161809719|NCT03017885|584345770|FG000|Overall Study|Other than listed|1|||
161809720|NCT03017885|584345771|FG001|Overall Study|Other than listed|2|||
161809721|NCT03017885|584345772|FG002|Overall Study|Other than listed|1|||
161809722|NCT03017885|584345773|FG003|Overall Study|Other than listed|0|||
161809723|NCT03017885|584345774|FG004|Overall Study|Other than listed|0|||
161809724|NCT03017885|584345775|FG005|Overall Study|Other than listed|0|||
161809725|NCT03017885|584345770|FG000|Overall Study|Lost to Follow-up|2|||
161809726|NCT03017885|584345771|FG001|Overall Study|Lost to Follow-up|0|||
161809727|NCT03017885|584345772|FG002|Overall Study|Lost to Follow-up|3|||
161809728|NCT03017885|584345773|FG003|Overall Study|Lost to Follow-up|0|||
161809729|NCT03017885|584345774|FG004|Overall Study|Lost to Follow-up|0|||
161809730|NCT03017885|584345775|FG005|Overall Study|Lost to Follow-up|0|||
161809731|NCT03017885|584345770|FG000|Overall Study|Change to other anti-cancer therapy|0|||
161809732|NCT03017885|584345771|FG001|Overall Study|Change to other anti-cancer therapy|0|||
161809733|NCT03017885|584345772|FG002|Overall Study|Change to other anti-cancer therapy|1|||
161809734|NCT03017885|584345773|FG003|Overall Study|Change to other anti-cancer therapy|0|||
161809735|NCT03017885|584345774|FG004|Overall Study|Change to other anti-cancer therapy|0|||
161809736|NCT03017885|584345775|FG005|Overall Study|Change to other anti-cancer therapy|0|||
161809737|NCT01208337|584345783|FG000|Overall Study|Death|3|||
161809738|NCT00836056|584345789|FG000|First Intervention|Adverse Event|1|||
161809739|NCT00836056|584345790|FG001|First Intervention|Adverse Event|0|||
161809740|NCT01001208|584345794|FG000|Overall Study|Adverse Event|10|||
161809741|NCT01001208|584345795|FG001|Overall Study|Adverse Event|5|||
161809742|NCT01001208|584345794|FG000|Overall Study|Lost to Follow-up|5|||
161809743|NCT01001208|584345795|FG001|Overall Study|Lost to Follow-up|9|||
161809744|NCT01001208|584345794|FG000|Overall Study|Physician Decision|1|||
161809745|NCT01001208|584345795|FG001|Overall Study|Physician Decision|0|||
161809746|NCT01001208|584345794|FG000|Overall Study|Withdrawal by Subject|4|||
161809747|NCT01001208|584345795|FG001|Overall Study|Withdrawal by Subject|5|||
161809748|NCT01001208|584345794|FG000|Overall Study|Ineligibility Determined|4|||
161809749|NCT01001208|584345795|FG001|Overall Study|Ineligibility Determined|2|||
161809750|NCT01001208|584345794|FG000|Overall Study|Noncompliance|4|||
161809751|NCT01001208|584345795|FG001|Overall Study|Noncompliance|7|||
161913692|NCT04476043|584733608|FG003|Overall Study|Protocol Violation|0|||
161913693|NCT00336544|584733609|FG000|Overall Study|Lack of Efficacy|8|||
161809752|NCT01001208|584345794|FG000|Overall Study|Disease Progression|0|||
161571269|NCT01909336|583477664|FG001|Overall Study|Physician Decision|1|||
161809753|NCT01001208|584345795|FG001|Overall Study|Disease Progression|3|||
161809754|NCT01001208|584345794|FG000|Overall Study|Other|0|||
161809755|NCT01001208|584345795|FG001|Overall Study|Other|2|||
161809756|NCT01864174|584345796|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
161809757|NCT01864174|584345797|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
161571270|NCT01909336|583477665|FG002|Overall Study|Physician Decision|1|||
161571271|NCT01235949|583477666|FG000|Primary Phase|Migrated/moved from study area|1|||
161459444|NCT04391569|583077829|FG000|Overall Study|Participant family decision|1|||
161459445|NCT04391569|583077830|FG001|Overall Study|Participant family decision|0|||
161459446|NCT04391569|583077829|FG000|Overall Study|Participant discharged prematurely|1|||
161459447|NCT04391569|583077830|FG001|Overall Study|Participant discharged prematurely|0|||
161459448|NCT00938886|583077861|FG000|Overall Study|Death|0|||
161459449|NCT00938886|583077862|FG001|Overall Study|Death|1|||
161459450|NCT00938886|583077861|FG000|Overall Study|Withdrawal by Subject|4|||
161459451|NCT00938886|583077862|FG001|Overall Study|Withdrawal by Subject|7|||
161459452|NCT00938886|583077861|FG000|Overall Study|Lost to Follow-up|3|||
161459453|NCT00938886|583077862|FG001|Overall Study|Lost to Follow-up|2|||
161459454|NCT03044574|583077863|FG000|Overall Study|Lost to Follow-up|37|||
161459455|NCT03044574|583077864|FG001|Overall Study|Lost to Follow-up|45|||
161459456|NCT00645788|583077865|FG000|Overall Study|Did not receive study drug|1|||
161459457|NCT00645788|583077866|FG001|Overall Study|Did not receive study drug|1|||
161459458|NCT00645788|583077867|FG002|Overall Study|Did not receive study drug|0|||
161459459|NCT00645788|583077868|FG003|Overall Study|Did not receive study drug|0|||
161459460|NCT00645788|583077865|FG000|Overall Study|Adverse Event|4|||
161459461|NCT00645788|583077866|FG001|Overall Study|Adverse Event|9|||
161459462|NCT00645788|583077867|FG002|Overall Study|Adverse Event|5|||
161459463|NCT00645788|583077868|FG003|Overall Study|Adverse Event|3|||
161459464|NCT00645788|583077865|FG000|Overall Study|Lost to Follow-up|1|||
161459465|NCT00645788|583077866|FG001|Overall Study|Lost to Follow-up|0|||
161459466|NCT00645788|583077867|FG002|Overall Study|Lost to Follow-up|0|||
161459467|NCT00645788|583077868|FG003|Overall Study|Lost to Follow-up|0|||
161459468|NCT00645788|583077865|FG000|Overall Study|Protocol Violation|1|||
161459469|NCT00645788|583077866|FG001|Overall Study|Protocol Violation|0|||
161459470|NCT00645788|583077867|FG002|Overall Study|Protocol Violation|2|||
161459471|NCT00645788|583077868|FG003|Overall Study|Protocol Violation|0|||
161459472|NCT00645788|583077865|FG000|Overall Study|Withdrawal by Subject|0|||
161459473|NCT00645788|583077866|FG001|Overall Study|Withdrawal by Subject|1|||
161459474|NCT00645788|583077867|FG002|Overall Study|Withdrawal by Subject|0|||
161459475|NCT00645788|583077868|FG003|Overall Study|Withdrawal by Subject|2|||
161459476|NCT00645788|583077865|FG000|Overall Study|Pulmonary exacerbation|13|||
161459477|NCT00645788|583077866|FG001|Overall Study|Pulmonary exacerbation|16|||
161459478|NCT00645788|583077867|FG002|Overall Study|Pulmonary exacerbation|11|||
161459479|NCT00645788|583077868|FG003|Overall Study|Pulmonary exacerbation|9|||
161459480|NCT04090411|583077871|FG000|Induction Period|Adverse Event|3|||
161459481|NCT04090411|583077872|FG001|Induction Period|Adverse Event|1|||
161459482|NCT04090411|583077873|FG002|Induction Period|Adverse Event|1|||
161459483|NCT04090411|583077874|FG003|Induction Period|Adverse Event|1|||
161459484|NCT04090411|583077875|FG004|Induction Period|Adverse Event|0|||
161459485|NCT04090411|583077876|FG005|Induction Period|Adverse Event|0|||
161459486|NCT04090411|583077877|FG006|Induction Period|Adverse Event|0|||
161459487|NCT04090411|583077878|FG007|Induction Period|Adverse Event|0|||
161459488|NCT04090411|583077879|FG008|Induction Period|Adverse Event|0|||
161459489|NCT04090411|583077880|FG009|Induction Period|Adverse Event|0|||
161459490|NCT04090411|583077881|FG010|Induction Period|Adverse Event|0|||
161459491|NCT04090411|583077882|FG011|Induction Period|Adverse Event|0|||
161459492|NCT04090411|583077883|FG012|Induction Period|Adverse Event|0|||
161459493|NCT04090411|583077871|FG000|Induction Period|Lack of Efficacy|0|||
161459494|NCT04090411|583077872|FG001|Induction Period|Lack of Efficacy|0|||
161459495|NCT04090411|583077873|FG002|Induction Period|Lack of Efficacy|1|||
161459496|NCT04090411|583077874|FG003|Induction Period|Lack of Efficacy|1|||
161459497|NCT04090411|583077875|FG004|Induction Period|Lack of Efficacy|0|||
161459498|NCT04090411|583077876|FG005|Induction Period|Lack of Efficacy|0|||
161459499|NCT04090411|583077877|FG006|Induction Period|Lack of Efficacy|0|||
161459500|NCT04090411|583077878|FG007|Induction Period|Lack of Efficacy|0|||
161459501|NCT04090411|583077879|FG008|Induction Period|Lack of Efficacy|0|||
161459502|NCT04090411|583077880|FG009|Induction Period|Lack of Efficacy|0|||
161459503|NCT04090411|583077881|FG010|Induction Period|Lack of Efficacy|0|||
161809758|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
161809759|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
161809760|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
161809761|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
161809762|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
161809763|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
161809764|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Death|1|||
161809765|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Death|0|||
161459504|NCT04090411|583077882|FG011|Induction Period|Lack of Efficacy|0|||
161459505|NCT04090411|583077883|FG012|Induction Period|Lack of Efficacy|0|||
161459506|NCT04090411|583077871|FG000|Induction Period|Physician Decision|0|||
161459507|NCT04090411|583077872|FG001|Induction Period|Physician Decision|0|||
161459508|NCT04090411|583077873|FG002|Induction Period|Physician Decision|1|||
161459509|NCT04090411|583077874|FG003|Induction Period|Physician Decision|0|||
161459510|NCT04090411|583077875|FG004|Induction Period|Physician Decision|0|||
161459511|NCT04090411|583077876|FG005|Induction Period|Physician Decision|0|||
161459512|NCT04090411|583077877|FG006|Induction Period|Physician Decision|0|||
161459513|NCT04090411|583077878|FG007|Induction Period|Physician Decision|0|||
161459514|NCT04090411|583077879|FG008|Induction Period|Physician Decision|0|||
161459515|NCT04090411|583077880|FG009|Induction Period|Physician Decision|0|||
161459516|NCT04090411|583077881|FG010|Induction Period|Physician Decision|0|||
161459517|NCT04090411|583077882|FG011|Induction Period|Physician Decision|0|||
161459518|NCT04090411|583077883|FG012|Induction Period|Physician Decision|0|||
161459519|NCT04090411|583077871|FG000|Induction Period|Protocol Violation|0|||
161459520|NCT04090411|583077872|FG001|Induction Period|Protocol Violation|0|||
161459521|NCT04090411|583077873|FG002|Induction Period|Protocol Violation|0|||
161459522|NCT04090411|583077874|FG003|Induction Period|Protocol Violation|1|||
161459523|NCT04090411|583077875|FG004|Induction Period|Protocol Violation|0|||
161459524|NCT04090411|583077876|FG005|Induction Period|Protocol Violation|0|||
161459525|NCT04090411|583077877|FG006|Induction Period|Protocol Violation|0|||
161459526|NCT04090411|583077878|FG007|Induction Period|Protocol Violation|0|||
161459527|NCT04090411|583077879|FG008|Induction Period|Protocol Violation|0|||
161459528|NCT04090411|583077880|FG009|Induction Period|Protocol Violation|0|||
161459529|NCT04090411|583077881|FG010|Induction Period|Protocol Violation|0|||
161459530|NCT04090411|583077882|FG011|Induction Period|Protocol Violation|0|||
161459531|NCT04090411|583077883|FG012|Induction Period|Protocol Violation|0|||
161459532|NCT04090411|583077871|FG000|Induction Period|Withdrawal by Subject|2|||
161459533|NCT04090411|583077872|FG001|Induction Period|Withdrawal by Subject|0|||
161459534|NCT04090411|583077873|FG002|Induction Period|Withdrawal by Subject|1|||
161459535|NCT04090411|583077874|FG003|Induction Period|Withdrawal by Subject|5|||
161459536|NCT04090411|583077875|FG004|Induction Period|Withdrawal by Subject|0|||
161459537|NCT04090411|583077876|FG005|Induction Period|Withdrawal by Subject|0|||
161459538|NCT04090411|583077877|FG006|Induction Period|Withdrawal by Subject|0|||
161459539|NCT04090411|583077878|FG007|Induction Period|Withdrawal by Subject|0|||
161459540|NCT04090411|583077879|FG008|Induction Period|Withdrawal by Subject|0|||
161459541|NCT04090411|583077880|FG009|Induction Period|Withdrawal by Subject|0|||
161459542|NCT04090411|583077881|FG010|Induction Period|Withdrawal by Subject|0|||
161459543|NCT04090411|583077882|FG011|Induction Period|Withdrawal by Subject|0|||
161459544|NCT04090411|583077883|FG012|Induction Period|Withdrawal by Subject|0|||
161459545|NCT04090411|583077871|FG000|Chronic Period|Adverse Event|0|||
161459546|NCT04090411|583077872|FG001|Chronic Period|Adverse Event|0|||
161459547|NCT04090411|583077873|FG002|Chronic Period|Adverse Event|0|||
161459548|NCT04090411|583077874|FG003|Chronic Period|Adverse Event|0|||
161459549|NCT04090411|583077875|FG004|Chronic Period|Adverse Event|0|||
161459550|NCT04090411|583077876|FG005|Chronic Period|Adverse Event|1|||
161459551|NCT04090411|583077877|FG006|Chronic Period|Adverse Event|0|||
161459552|NCT04090411|583077878|FG007|Chronic Period|Adverse Event|3|||
161459553|NCT04090411|583077879|FG008|Chronic Period|Adverse Event|0|||
161459554|NCT04090411|583077880|FG009|Chronic Period|Adverse Event|0|||
161459555|NCT04090411|583077881|FG010|Chronic Period|Adverse Event|5|||
161459556|NCT04090411|583077882|FG011|Chronic Period|Adverse Event|1|||
161459557|NCT04090411|583077883|FG012|Chronic Period|Adverse Event|1|||
161459558|NCT04090411|583077871|FG000|Chronic Period|Lack of Efficacy|0|||
161459559|NCT04090411|583077872|FG001|Chronic Period|Lack of Efficacy|0|||
161459560|NCT04090411|583077873|FG002|Chronic Period|Lack of Efficacy|0|||
161459561|NCT04090411|583077874|FG003|Chronic Period|Lack of Efficacy|0|||
161459562|NCT04090411|583077875|FG004|Chronic Period|Lack of Efficacy|0|||
161459563|NCT04090411|583077876|FG005|Chronic Period|Lack of Efficacy|0|||
161459564|NCT04090411|583077877|FG006|Chronic Period|Lack of Efficacy|1|||
161459565|NCT04090411|583077878|FG007|Chronic Period|Lack of Efficacy|4|||
161459566|NCT04090411|583077879|FG008|Chronic Period|Lack of Efficacy|2|||
161459567|NCT04090411|583077880|FG009|Chronic Period|Lack of Efficacy|2|||
161459568|NCT04090411|583077881|FG010|Chronic Period|Lack of Efficacy|2|||
161459569|NCT04090411|583077882|FG011|Chronic Period|Lack of Efficacy|1|||
161459570|NCT04090411|583077883|FG012|Chronic Period|Lack of Efficacy|2|||
161459571|NCT04090411|583077871|FG000|Chronic Period|Relocation|0|||
161459572|NCT04090411|583077872|FG001|Chronic Period|Relocation|0|||
161459573|NCT04090411|583077873|FG002|Chronic Period|Relocation|0|||
161809766|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
161809767|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
161459574|NCT04090411|583077874|FG003|Chronic Period|Relocation|0|||
161459575|NCT04090411|583077875|FG004|Chronic Period|Relocation|0|||
161459576|NCT04090411|583077876|FG005|Chronic Period|Relocation|0|||
161459577|NCT04090411|583077877|FG006|Chronic Period|Relocation|0|||
161459578|NCT04090411|583077878|FG007|Chronic Period|Relocation|1|||
161459579|NCT04090411|583077879|FG008|Chronic Period|Relocation|0|||
161459580|NCT04090411|583077880|FG009|Chronic Period|Relocation|0|||
161459581|NCT04090411|583077881|FG010|Chronic Period|Relocation|0|||
161809768|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
161459582|NCT04090411|583077882|FG011|Chronic Period|Relocation|0|||
161809769|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
161459583|NCT04090411|583077883|FG012|Chronic Period|Relocation|0|||
161459584|NCT04090411|583077871|FG000|Chronic Period|Physician Decision|0|||
161459585|NCT04090411|583077872|FG001|Chronic Period|Physician Decision|0|||
161459586|NCT04090411|583077873|FG002|Chronic Period|Physician Decision|0|||
161459587|NCT04090411|583077874|FG003|Chronic Period|Physician Decision|0|||
161459588|NCT04090411|583077875|FG004|Chronic Period|Physician Decision|1|||
161459589|NCT04090411|583077876|FG005|Chronic Period|Physician Decision|0|||
161459590|NCT04090411|583077877|FG006|Chronic Period|Physician Decision|0|||
161459591|NCT04090411|583077878|FG007|Chronic Period|Physician Decision|1|||
161459592|NCT04090411|583077879|FG008|Chronic Period|Physician Decision|0|||
161459593|NCT04090411|583077880|FG009|Chronic Period|Physician Decision|0|||
161459594|NCT04090411|583077881|FG010|Chronic Period|Physician Decision|0|||
161459595|NCT04090411|583077882|FG011|Chronic Period|Physician Decision|1|||
161459596|NCT04090411|583077883|FG012|Chronic Period|Physician Decision|1|||
161459597|NCT04090411|583077871|FG000|Chronic Period|Protocol Violation|0|||
161459598|NCT04090411|583077872|FG001|Chronic Period|Protocol Violation|0|||
161459599|NCT04090411|583077873|FG002|Chronic Period|Protocol Violation|0|||
161459600|NCT04090411|583077874|FG003|Chronic Period|Protocol Violation|0|||
161459601|NCT04090411|583077875|FG004|Chronic Period|Protocol Violation|0|||
161459602|NCT04090411|583077876|FG005|Chronic Period|Protocol Violation|0|||
161459603|NCT04090411|583077877|FG006|Chronic Period|Protocol Violation|0|||
161459604|NCT04090411|583077878|FG007|Chronic Period|Protocol Violation|0|||
161459605|NCT04090411|583077879|FG008|Chronic Period|Protocol Violation|0|||
161459606|NCT04090411|583077880|FG009|Chronic Period|Protocol Violation|0|||
161459607|NCT04090411|583077881|FG010|Chronic Period|Protocol Violation|0|||
161459608|NCT04090411|583077882|FG011|Chronic Period|Protocol Violation|0|||
161459609|NCT04090411|583077883|FG012|Chronic Period|Protocol Violation|1|||
161459610|NCT04090411|583077871|FG000|Chronic Period|Withdrawal by Subject|0|||
161459611|NCT04090411|583077872|FG001|Chronic Period|Withdrawal by Subject|0|||
161459612|NCT04090411|583077873|FG002|Chronic Period|Withdrawal by Subject|0|||
161459613|NCT04090411|583077874|FG003|Chronic Period|Withdrawal by Subject|0|||
161459614|NCT04090411|583077875|FG004|Chronic Period|Withdrawal by Subject|0|||
161459615|NCT04090411|583077876|FG005|Chronic Period|Withdrawal by Subject|1|||
161459616|NCT04090411|583077877|FG006|Chronic Period|Withdrawal by Subject|1|||
161459617|NCT04090411|583077878|FG007|Chronic Period|Withdrawal by Subject|3|||
161459618|NCT04090411|583077879|FG008|Chronic Period|Withdrawal by Subject|3|||
161459619|NCT04090411|583077880|FG009|Chronic Period|Withdrawal by Subject|3|||
161459620|NCT04090411|583077881|FG010|Chronic Period|Withdrawal by Subject|1|||
161459621|NCT04090411|583077882|FG011|Chronic Period|Withdrawal by Subject|3|||
161459622|NCT04090411|583077883|FG012|Chronic Period|Withdrawal by Subject|0|||
161459623|NCT03764033|583077886|FG000|Treatment Phase|Withdrawal by Subject|8|||
161459624|NCT03764033|583077887|FG001|Treatment Phase|Withdrawal by Subject|3|||
161459625|NCT03764033|583077886|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
161459626|NCT03764033|583077887|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
161459627|NCT03764033|583077886|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
161459628|NCT03764033|583077887|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
161459629|NCT01006603|583077888|FG000|Overall Study|Withdrawal by Subject|17|||
161459630|NCT01006603|583077889|FG001|Overall Study|Withdrawal by Subject|19|||
161459631|NCT01006603|583077888|FG000|Overall Study|Lost to Follow-up|0|||
161459632|NCT01006603|583077889|FG001|Overall Study|Lost to Follow-up|1|||
161459633|NCT01006603|583077888|FG000|Overall Study|Safety reason|1|||
161459634|NCT01006603|583077889|FG001|Overall Study|Safety reason|1|||
161459635|NCT01006603|583077888|FG000|Overall Study|Protocol Violation|1|||
161459636|NCT01006603|583077889|FG001|Overall Study|Protocol Violation|3|||
161459637|NCT01006603|583077888|FG000|Overall Study|Incorrect enrolment|0|||
161459638|NCT01006603|583077889|FG001|Overall Study|Incorrect enrolment|2|||
161459639|NCT01006603|583077888|FG000|Overall Study|Adverse Event|15|||
161459640|NCT01006603|583077889|FG001|Overall Study|Adverse Event|7|||
161459641|NCT01006603|583077888|FG000|Overall Study|Death|1|||
161459642|NCT01006603|583077889|FG001|Overall Study|Death|1|||
161571272|NCT01235949|583477667|FG001|Primary Phase|Migrated/moved from study area|1|||
161571273|NCT01235949|583477668|FG002|Primary Phase|Migrated/moved from study area|0|||
161571274|NCT01235949|583477669|FG003|Primary Phase|Migrated/moved from study area|0|||
161459643|NCT01006603|583077888|FG000|Overall Study|Study specific discontinuation criteria|33|||
161459644|NCT01006603|583077889|FG001|Overall Study|Study specific discontinuation criteria|34|||
161459645|NCT01006603|583077888|FG000|Overall Study|Other|3|||
161459646|NCT01006603|583077889|FG001|Overall Study|Other|7|||
161459647|NCT02477696|583077894|FG000|Overall Study|Death|89|||
161809770|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Other|6|||
161809771|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Other|10|||
161459648|NCT02477696|583077895|FG001|Overall Study|Death|106|||
161459649|NCT02477696|583077894|FG000|Overall Study|Lost to Follow-up|7|||
161459650|NCT02477696|583077895|FG001|Overall Study|Lost to Follow-up|5|||
161459651|NCT02477696|583077894|FG000|Overall Study|Withdrawal by Subject|37|||
161459652|NCT02477696|583077895|FG001|Overall Study|Withdrawal by Subject|34|||
161459653|NCT02477696|583077894|FG000|Overall Study|Physician Decision|7|||
161459654|NCT02477696|583077895|FG001|Overall Study|Physician Decision|9|||
161459655|NCT02477696|583077894|FG000|Overall Study|Study terminated by sponsor|103|||
161459656|NCT02477696|583077895|FG001|Overall Study|Study terminated by sponsor|99|||
161459657|NCT02477696|583077894|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
161571275|NCT01235949|583477670|FG004|Primary Phase|Migrated/moved from study area|1|||
161571276|NCT01235949|583477671|FG005|Primary Phase|Migrated/moved from study area|2|||
161459658|NCT02477696|583077895|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
161459659|NCT02477696|583077894|FG000|Overall Study|Missing/Unknown|2|||
161459660|NCT02477696|583077895|FG001|Overall Study|Missing/Unknown|0|||
161459661|NCT03505671|583078956|FG000|Overall Study|Withdrawal by Subject|2|||
161459662|NCT03505671|583078957|FG001|Overall Study|Withdrawal by Subject|1|||
161459663|NCT03505671|583078956|FG000|Overall Study|Lost to Follow-up|1|||
161459664|NCT03505671|583078957|FG001|Overall Study|Lost to Follow-up|0|||
161459665|NCT02038829|583078958|FG000|Washout Period 1|Death|0|||
161459666|NCT02038829|583078959|FG001|Washout Period 1|Death|0|||
161459667|NCT02038829|583078960|FG002|Washout Period 1|Death|0|||
161459668|NCT02038829|583078961|FG003|Washout Period 1|Death|0|||
161459669|NCT02038829|583078962|FG004|Washout Period 1|Death|1|||
161459670|NCT02038829|583078963|FG005|Washout Period 1|Death|0|||
161459671|NCT02038829|583078964|FG006|Washout Period 1|Death|0|||
161459672|NCT02038829|583078965|FG007|Washout Period 1|Death|0|||
161459673|NCT02038829|583078966|FG008|Washout Period 1|Death|0|||
161459674|NCT02038829|583078967|FG009|Washout Period 1|Death|0|||
161459675|NCT02038829|583078968|FG010|Washout Period 1|Death|0|||
161459676|NCT02038829|583078969|FG011|Washout Period 1|Death|0|||
161459677|NCT02038829|583078958|FG000|Treatment Period 2|Adverse Event|0|||
161459678|NCT02038829|583078959|FG001|Treatment Period 2|Adverse Event|0|||
161459679|NCT02038829|583078960|FG002|Treatment Period 2|Adverse Event|0|||
161459680|NCT02038829|583078961|FG003|Treatment Period 2|Adverse Event|0|||
161459681|NCT02038829|583078962|FG004|Treatment Period 2|Adverse Event|0|||
161459682|NCT02038829|583078963|FG005|Treatment Period 2|Adverse Event|0|||
161459683|NCT02038829|583078964|FG006|Treatment Period 2|Adverse Event|0|||
161459684|NCT02038829|583078965|FG007|Treatment Period 2|Adverse Event|0|||
161459685|NCT02038829|583078966|FG008|Treatment Period 2|Adverse Event|0|||
161459686|NCT02038829|583078967|FG009|Treatment Period 2|Adverse Event|0|||
161459687|NCT02038829|583078968|FG010|Treatment Period 2|Adverse Event|1|||
161459688|NCT02038829|583078969|FG011|Treatment Period 2|Adverse Event|0|||
161459689|NCT02038829|583078958|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161459690|NCT02038829|583078959|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161459691|NCT02038829|583078960|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161459692|NCT02038829|583078961|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161459693|NCT02038829|583078962|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161459694|NCT02038829|583078963|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161459695|NCT02038829|583078964|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161459696|NCT02038829|583078965|FG007|Treatment Period 2|Withdrawal by Subject|0|||
161459697|NCT02038829|583078966|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161459698|NCT02038829|583078967|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161459699|NCT02038829|583078968|FG010|Treatment Period 2|Withdrawal by Subject|0|||
161459700|NCT02038829|583078969|FG011|Treatment Period 2|Withdrawal by Subject|0|||
161459701|NCT02038829|583078958|FG000|Washout Period 2|Adverse Event|0|||
161459702|NCT02038829|583078959|FG001|Washout Period 2|Adverse Event|0|||
161459703|NCT02038829|583078960|FG002|Washout Period 2|Adverse Event|0|||
161459704|NCT02038829|583078961|FG003|Washout Period 2|Adverse Event|0|||
161459705|NCT02038829|583078962|FG004|Washout Period 2|Adverse Event|0|||
161459706|NCT02038829|583078963|FG005|Washout Period 2|Adverse Event|0|||
161459707|NCT02038829|583078964|FG006|Washout Period 2|Adverse Event|0|||
161459708|NCT02038829|583078965|FG007|Washout Period 2|Adverse Event|0|||
161459709|NCT02038829|583078966|FG008|Washout Period 2|Adverse Event|1|||
161459710|NCT02038829|583078967|FG009|Washout Period 2|Adverse Event|0|||
161571277|NCT01235949|583477672|FG006|Primary Phase|Migrated/moved from study area|0|||
161459711|NCT02038829|583078968|FG010|Washout Period 2|Adverse Event|0|||
161459712|NCT02038829|583078969|FG011|Washout Period 2|Adverse Event|0|||
161459713|NCT02038829|583078958|FG000|Washout Period 2|Withdrawal by Subject|0|||
161459714|NCT02038829|583078959|FG001|Washout Period 2|Withdrawal by Subject|0|||
161459715|NCT02038829|583078960|FG002|Washout Period 2|Withdrawal by Subject|0|||
161459716|NCT02038829|583078961|FG003|Washout Period 2|Withdrawal by Subject|0|||
161459717|NCT02038829|583078962|FG004|Washout Period 2|Withdrawal by Subject|0|||
161459718|NCT02038829|583078963|FG005|Washout Period 2|Withdrawal by Subject|1|||
161459719|NCT02038829|583078964|FG006|Washout Period 2|Withdrawal by Subject|0|||
161459720|NCT02038829|583078965|FG007|Washout Period 2|Withdrawal by Subject|0|||
161459721|NCT02038829|583078966|FG008|Washout Period 2|Withdrawal by Subject|0|||
161571278|NCT01235949|583477673|FG007|Primary Phase|Migrated/moved from study area|0|||
161571279|NCT01235949|583477674|FG008|Primary Phase|Migrated/moved from study area|0|||
161571280|NCT01235949|583477675|FG009|Primary Phase|Migrated/moved from study area|0|||
161459722|NCT02038829|583078967|FG009|Washout Period 2|Withdrawal by Subject|0|||
161459723|NCT02038829|583078968|FG010|Washout Period 2|Withdrawal by Subject|0|||
161459724|NCT02038829|583078969|FG011|Washout Period 2|Withdrawal by Subject|0|||
161459725|NCT02038829|583078958|FG000|Treatment Period 4|Adverse Event|0|||
161459726|NCT02038829|583078959|FG001|Treatment Period 4|Adverse Event|1|||
161459727|NCT02038829|583078960|FG002|Treatment Period 4|Adverse Event|0|||
161459728|NCT02038829|583078961|FG003|Treatment Period 4|Adverse Event|0|||
161459729|NCT02038829|583078962|FG004|Treatment Period 4|Adverse Event|0|||
161459730|NCT02038829|583078963|FG005|Treatment Period 4|Adverse Event|0|||
161459731|NCT02038829|583078964|FG006|Treatment Period 4|Adverse Event|0|||
161459732|NCT02038829|583078965|FG007|Treatment Period 4|Adverse Event|0|||
161459733|NCT02038829|583078966|FG008|Treatment Period 4|Adverse Event|0|||
161459734|NCT02038829|583078967|FG009|Treatment Period 4|Adverse Event|0|||
161459735|NCT02038829|583078968|FG010|Treatment Period 4|Adverse Event|0|||
161459736|NCT02038829|583078969|FG011|Treatment Period 4|Adverse Event|0|||
161459737|NCT02038829|583078958|FG000|Washout Period 4|Adverse Event|0|||
161459738|NCT02038829|583078959|FG001|Washout Period 4|Adverse Event|0|||
161459739|NCT02038829|583078960|FG002|Washout Period 4|Adverse Event|0|||
161459740|NCT02038829|583078961|FG003|Washout Period 4|Adverse Event|0|||
161459741|NCT02038829|583078962|FG004|Washout Period 4|Adverse Event|0|||
161459742|NCT02038829|583078963|FG005|Washout Period 4|Adverse Event|0|||
161459743|NCT02038829|583078964|FG006|Washout Period 4|Adverse Event|1|||
161459744|NCT02038829|583078965|FG007|Washout Period 4|Adverse Event|0|||
161459745|NCT02038829|583078966|FG008|Washout Period 4|Adverse Event|0|||
161459746|NCT02038829|583078967|FG009|Washout Period 4|Adverse Event|0|||
161459747|NCT02038829|583078968|FG010|Washout Period 4|Adverse Event|0|||
161459748|NCT02038829|583078969|FG011|Washout Period 4|Adverse Event|0|||
161459749|NCT02038829|583078958|FG000|Treatment Period 6|Adverse Event|0|||
161459750|NCT02038829|583078959|FG001|Treatment Period 6|Adverse Event|0|||
161459751|NCT02038829|583078960|FG002|Treatment Period 6|Adverse Event|1|||
161459752|NCT02038829|583078961|FG003|Treatment Period 6|Adverse Event|0|||
161459753|NCT02038829|583078962|FG004|Treatment Period 6|Adverse Event|0|||
161459754|NCT02038829|583078963|FG005|Treatment Period 6|Adverse Event|0|||
161459755|NCT02038829|583078964|FG006|Treatment Period 6|Adverse Event|0|||
161459756|NCT02038829|583078965|FG007|Treatment Period 6|Adverse Event|0|||
161459757|NCT02038829|583078966|FG008|Treatment Period 6|Adverse Event|0|||
161459758|NCT02038829|583078967|FG009|Treatment Period 6|Adverse Event|0|||
161459759|NCT02038829|583078968|FG010|Treatment Period 6|Adverse Event|0|||
161459760|NCT02038829|583078969|FG011|Treatment Period 6|Adverse Event|0|||
161459761|NCT00749580|583078970|FG000|Overall Study|Lost to Follow-up|4|||
161459762|NCT00749580|583078971|FG001|Overall Study|Lost to Follow-up|8|||
161459763|NCT00749580|583078970|FG000|Overall Study|Adverse Event|0|||
161459764|NCT00749580|583078971|FG001|Overall Study|Adverse Event|1|||
161459765|NCT05128929|583078973|FG000|Overall Study|Adverse Event|0|||
161459766|NCT05128929|583078974|FG001|Overall Study|Adverse Event|1|||
161459767|NCT03553836|583078975|FG000|Overall Study|Ongoing in Study|460|||
161459768|NCT03553836|583078976|FG001|Overall Study|Ongoing in Study|459|||
161459769|NCT03553836|583078975|FG000|Overall Study|Withdrawal by Subject|9|||
161459770|NCT03553836|583078976|FG001|Overall Study|Withdrawal by Subject|10|||
161459771|NCT03553836|583078975|FG000|Overall Study|Lost to Follow-up|1|||
161571281|NCT01235949|583477676|FG010|Primary Phase|Migrated/moved from study area|0|||
161571282|NCT01235949|583477677|FG011|Primary Phase|Migrated/moved from study area|0|||
161571283|NCT01235949|583477678|FG012|Primary Phase|Migrated/moved from study area|0|||
161571284|NCT01235949|583477679|FG013|Primary Phase|Migrated/moved from study area|0|||
161571285|NCT01235949|583477680|FG014|Primary Phase|Migrated/moved from study area|0|||
161571286|NCT01235949|583477681|FG015|Primary Phase|Migrated/moved from study area|0|||
161571287|NCT01235949|583477682|FG016|Primary Phase|Migrated/moved from study area|0|||
161571288|NCT01235949|583477683|FG017|Primary Phase|Migrated/moved from study area|0|||
161571289|NCT01235949|583477666|FG000|Primary Phase|Adverse Event|0|||
161571290|NCT01235949|583477667|FG001|Primary Phase|Adverse Event|0|||
161571291|NCT01235949|583477668|FG002|Primary Phase|Adverse Event|0|||
161571292|NCT01235949|583477669|FG003|Primary Phase|Adverse Event|1|||
161571293|NCT01235949|583477670|FG004|Primary Phase|Adverse Event|0|||
161459772|NCT03553836|583078976|FG001|Overall Study|Lost to Follow-up|3|||
161459773|NCT03553836|583078975|FG000|Overall Study|Death|17|||
161459774|NCT03553836|583078976|FG001|Overall Study|Death|17|||
161459775|NCT05660850|583078977|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
161459776|NCT05660850|583078978|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
161459777|NCT05660850|583078979|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
161459778|NCT05660850|583078980|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
161459779|NCT02604017|583078981|FG000|Overall Study|Withdrew Consent|0|||
161459780|NCT02604017|583078982|FG001|Overall Study|Withdrew Consent|2|||
161459781|NCT02604017|583078981|FG000|Overall Study|Lost to Follow-up|5|||
161459782|NCT02604017|583078982|FG001|Overall Study|Lost to Follow-up|6|||
161459783|NCT02604017|583078981|FG000|Overall Study|Other|1|||
161571294|NCT01235949|583477671|FG005|Primary Phase|Adverse Event|0|||
161459784|NCT02604017|583078982|FG001|Overall Study|Other|0|||
161459785|NCT01653782|583078988|FG000|Overall Study|Withdrawal by Subject|9|||
161459786|NCT01653782|583078989|FG001|Overall Study|Withdrawal by Subject|15|||
161459787|NCT01653782|583078990|FG002|Overall Study|Withdrawal by Subject|4|||
161459788|NCT01653782|583078988|FG000|Overall Study|Lost to Follow-up|7|||
161459789|NCT01653782|583078989|FG001|Overall Study|Lost to Follow-up|3|||
161459790|NCT01653782|583078990|FG002|Overall Study|Lost to Follow-up|2|||
161459791|NCT01315236|583078994|FG000|Double-blind Phase|Death|1|||
161459792|NCT01315236|583078995|FG001|Double-blind Phase|Death|0|||
161459793|NCT01315236|583078994|FG000|Double-blind Phase|Adverse Event|1|||
161459794|NCT01315236|583078995|FG001|Double-blind Phase|Adverse Event|0|||
161459795|NCT01315236|583078994|FG000|Double-blind Phase|Withdrawal of Consent|1|||
161459796|NCT01315236|583078995|FG001|Double-blind Phase|Withdrawal of Consent|0|||
161459797|NCT01315236|583078994|FG000|Double-blind Phase|Lost to Follow-up|1|||
161459798|NCT01315236|583078995|FG001|Double-blind Phase|Lost to Follow-up|0|||
161459799|NCT01315236|583078994|FG000|Open-label Phase|Death|1|||
161459800|NCT01315236|583078995|FG001|Open-label Phase|Death|0|||
161459801|NCT01315236|583078994|FG000|Open-label Phase|Adverse Event|0|||
161459802|NCT01315236|583078995|FG001|Open-label Phase|Adverse Event|1|||
161459803|NCT01315236|583078994|FG000|Open-label Phase|Other|0|||
161459804|NCT01315236|583078995|FG001|Open-label Phase|Other|1|||
161459805|NCT01315236|583078994|FG000|12-Month Follow-up Period|Death|0|||
161459806|NCT01315236|583078995|FG001|12-Month Follow-up Period|Death|1|||
161459807|NCT01315236|583078994|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
161459808|NCT01315236|583078995|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
161459809|NCT02497976|583078998|FG000|Overall Study|Withdrawal by Subject|2|||
161459810|NCT02497976|583078999|FG001|Overall Study|Withdrawal by Subject|0|||
161459811|NCT02497976|583078998|FG000|Overall Study|Moved out of area|0|||
161459812|NCT02497976|583078999|FG001|Overall Study|Moved out of area|1|||
161459813|NCT00058539|583079003|FG000|Overall Study|Disease progression|24|||
161459814|NCT00058539|583079003|FG000|Overall Study|Adverse Event|3|||
161459815|NCT00058539|583079003|FG000|Overall Study|Withdrawal by Subject|5|||
161459816|NCT00058539|583079003|FG000|Overall Study|Physician Decision|9|||
161459817|NCT00058539|583079003|FG000|Overall Study|Death|1|||
161459818|NCT02483533|583079004|FG000|Overall Study|Lack of Efficacy|50|||
161459819|NCT02483533|583079005|FG001|Overall Study|Lack of Efficacy|50|||
161459820|NCT01323920|583079006|FG000|Overall Study|Death|5|||
161459821|NCT01323920|583079006|FG000|Overall Study|Withdrawal by Subject|1|||
161459822|NCT00768469|583079007|FG000|Overall Study|Adverse Event|0|||
161459823|NCT00768469|583079008|FG001|Overall Study|Adverse Event|2|||
161459824|NCT00768469|583079007|FG000|Overall Study|Disease Progression|3|||
161459825|NCT00768469|583079008|FG001|Overall Study|Disease Progression|4|||
161459826|NCT00768469|583079007|FG000|Overall Study|Withdrawal by Subject|0|||
161459827|NCT00768469|583079008|FG001|Overall Study|Withdrawal by Subject|1|||
161459828|NCT01293799|583079012|FG000|Overall Study|Kidney transplantation|109|||
161459829|NCT01293799|583079013|FG001|Overall Study|Kidney transplantation|96|||
161459830|NCT01293799|583079012|FG000|Overall Study|Transfer to hemodialysis|70|||
161459831|NCT01293799|583079013|FG001|Overall Study|Transfer to hemodialysis|90|||
161459832|NCT01293799|583079012|FG000|Overall Study|Death|27|||
161459833|NCT01293799|583079013|FG001|Overall Study|Death|29|||
161459834|NCT01293799|583079012|FG000|Overall Study|Transfer to assisted PD|24|||
161459835|NCT01293799|583079013|FG001|Overall Study|Transfer to assisted PD|18|||
161459836|NCT01293799|583079012|FG000|Overall Study|Withdrawal by Subject|26|||
161459837|NCT01293799|583079013|FG001|Overall Study|Withdrawal by Subject|0|||
161459838|NCT01293799|583079012|FG000|Overall Study|Investigator decision|5|||
161459839|NCT01293799|583079013|FG001|Overall Study|Investigator decision|2|||
161459840|NCT01293799|583079012|FG000|Overall Study|Kidney function improved|6|||
161459841|NCT01293799|583079013|FG001|Overall Study|Kidney function improved|7|||
161459842|NCT01293799|583079012|FG000|Overall Study|Other causes|6|||
161459843|NCT01293799|583079013|FG001|Overall Study|Other causes|3|||
161459844|NCT02283177|583079016|FG000|Overall Study|Withdrawal by Subject|1|||
161459845|NCT02283177|583079017|FG001|Overall Study|Withdrawal by Subject|1|||
161571295|NCT01235949|583477672|FG006|Primary Phase|Adverse Event|0|||
161571296|NCT01235949|583477673|FG007|Primary Phase|Adverse Event|0|||
161913694|NCT00336544|584733610|FG001|Overall Study|Lack of Efficacy|5|||
161459846|NCT02635646|583079019|FG000|Overall Study|Lost to Follow-up|24|||
161459847|NCT02635646|583079020|FG001|Overall Study|Lost to Follow-up|25|||
161459848|NCT02635646|583079019|FG000|Overall Study|Pregnancy|1|||
161459849|NCT02635646|583079020|FG001|Overall Study|Pregnancy|1|||
161459850|NCT00327470|583079029|FG000|Overall Study|Randomized, but not treated|0|||
161459851|NCT00327470|583079030|FG001|Overall Study|Randomized, but not treated|2|||
161459852|NCT00327470|583079029|FG000|Overall Study|Adverse Event|9|||
161459853|NCT00327470|583079030|FG001|Overall Study|Adverse Event|14|||
161571297|NCT01235949|583477674|FG008|Primary Phase|Adverse Event|0|||
161571298|NCT01235949|583477675|FG009|Primary Phase|Adverse Event|0|||
161459854|NCT00327470|583079029|FG000|Overall Study|Lack of Efficacy|7|||
161459855|NCT00327470|583079030|FG001|Overall Study|Lack of Efficacy|19|||
161459856|NCT00327470|583079029|FG000|Overall Study|Other|5|||
161459857|NCT00327470|583079030|FG001|Overall Study|Other|9|||
161459858|NCT00327470|583079029|FG000|Overall Study|Lost to Follow-up|1|||
161459859|NCT00327470|583079030|FG001|Overall Study|Lost to Follow-up|3|||
161459860|NCT00327470|583079029|FG000|Overall Study|Withdrawal by Subject|6|||
161571299|NCT01235949|583477676|FG010|Primary Phase|Adverse Event|0|||
161571300|NCT01235949|583477677|FG011|Primary Phase|Adverse Event|0|||
161913695|NCT00336544|584733609|FG000|Overall Study|Adverse Event|4|||
161913696|NCT00336544|584733610|FG001|Overall Study|Adverse Event|9|||
161459861|NCT00327470|583079030|FG001|Overall Study|Withdrawal by Subject|12|||
161459862|NCT00327470|583079029|FG000|Overall Study|Death|1|||
161459863|NCT00327470|583079030|FG001|Overall Study|Death|4|||
161459864|NCT00745615|583079037|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
161459865|NCT00745615|583079038|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
161459866|NCT00745615|583079039|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
161459867|NCT00745615|583079040|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
161459868|NCT00745615|583079041|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
161459869|NCT00745615|583079042|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
161459870|NCT00745615|583079037|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
161459871|NCT00745615|583079038|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
161459872|NCT00745615|583079039|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
161459873|NCT00745615|583079040|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
161459874|NCT00745615|583079041|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
161459875|NCT00745615|583079042|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
161459876|NCT00745615|583079037|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
161459877|NCT00745615|583079038|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
161459878|NCT00745615|583079039|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
161459879|NCT00745615|583079040|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
161459880|NCT00745615|583079041|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
161459881|NCT00745615|583079042|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
161459882|NCT00745615|583079037|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161459883|NCT00745615|583079038|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
161459884|NCT00745615|583079039|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161459885|NCT00745615|583079040|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161459886|NCT00745615|583079041|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161459887|NCT00745615|583079042|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161459888|NCT00745615|583079037|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
161459889|NCT00745615|583079038|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
161459890|NCT00745615|583079039|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
161459891|NCT00745615|583079040|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
161459892|NCT00745615|583079041|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
161459893|NCT00745615|583079042|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
161459894|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
161459895|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
161571301|NCT01235949|583477678|FG012|Primary Phase|Adverse Event|0|||
161571302|NCT01235949|583477679|FG013|Primary Phase|Adverse Event|0|||
161571303|NCT01235949|583477680|FG014|Primary Phase|Adverse Event|0|||
161571304|NCT01235949|583477681|FG015|Primary Phase|Adverse Event|0|||
161571305|NCT01235949|583477682|FG016|Primary Phase|Adverse Event|0|||
161571306|NCT01235949|583477683|FG017|Primary Phase|Adverse Event|0|||
161571307|NCT01235949|583477666|FG000|Primary Phase|Withdrawal by Subject|3|||
161571308|NCT01235949|583477667|FG001|Primary Phase|Withdrawal by Subject|2|||
161571309|NCT01235949|583477668|FG002|Primary Phase|Withdrawal by Subject|2|||
161571310|NCT01235949|583477669|FG003|Primary Phase|Withdrawal by Subject|0|||
161571311|NCT01235949|583477670|FG004|Primary Phase|Withdrawal by Subject|0|||
161571312|NCT01235949|583477671|FG005|Primary Phase|Withdrawal by Subject|3|||
161571313|NCT01235949|583477672|FG006|Primary Phase|Withdrawal by Subject|0|||
161571314|NCT01235949|583477673|FG007|Primary Phase|Withdrawal by Subject|0|||
161571315|NCT01235949|583477674|FG008|Primary Phase|Withdrawal by Subject|0|||
161571316|NCT01235949|583477675|FG009|Primary Phase|Withdrawal by Subject|0|||
161571317|NCT01235949|583477676|FG010|Primary Phase|Withdrawal by Subject|0|||
161571318|NCT01235949|583477677|FG011|Primary Phase|Withdrawal by Subject|0|||
161571319|NCT01235949|583477678|FG012|Primary Phase|Withdrawal by Subject|0|||
161571320|NCT01235949|583477679|FG013|Primary Phase|Withdrawal by Subject|0|||
161571321|NCT01235949|583477680|FG014|Primary Phase|Withdrawal by Subject|0|||
161809772|NCT01864174|584345796|FG000|Off Treatment Follow-Up|Other|2|||
161809773|NCT01864174|584345797|FG001|Off Treatment Follow-Up|Other|0|||
161809774|NCT01864174|584345796|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
161809775|NCT01864174|584345797|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
161809776|NCT02648347|584345798|FG000|Overall Study|Death|174|||
161809777|NCT02648347|584345799|FG001|Overall Study|Death|167|||
161809778|NCT02648347|584345798|FG000|Overall Study|Withdrawal by Subject|16|||
161459896|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
161459897|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
161459898|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
161571322|NCT01235949|583477681|FG015|Primary Phase|Withdrawal by Subject|0|||
161571323|NCT01235949|583477682|FG016|Primary Phase|Withdrawal by Subject|0|||
161571324|NCT01235949|583477683|FG017|Primary Phase|Withdrawal by Subject|0|||
161571325|NCT01235949|583477666|FG000|Primary Phase|Lost to Follow-up|0|||
161571326|NCT01235949|583477667|FG001|Primary Phase|Lost to Follow-up|0|||
161809779|NCT02648347|584345799|FG001|Overall Study|Withdrawal by Subject|9|||
161459899|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
161459900|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
161459901|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
161459902|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
161459903|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
161459904|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
161459905|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
161459906|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
161459907|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
161459908|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
161459909|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
161459910|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
161459911|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
161459912|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
161459913|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
161459914|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
161459915|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
161459916|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
161459917|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
161459918|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
161459919|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
161459920|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
161459921|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
161459922|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
161459923|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
161459924|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
161459925|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
161459926|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
161459927|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
161459928|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
161459929|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
161459930|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
161459931|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
161459932|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
161459933|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
161459934|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
161459935|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
161459936|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
161459937|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
161459938|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
161459939|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
161459940|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
161459941|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
161459942|NCT00745615|583079037|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
161459943|NCT00745615|583079038|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
161459944|NCT00745615|583079039|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
161459945|NCT00745615|583079040|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
161459946|NCT00745615|583079041|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
161459947|NCT00745615|583079042|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
161459948|NCT00570232|583079043|FG000|Overall Study|Adverse Event|10|||
161459949|NCT00570232|583079043|FG000|Overall Study|discontinued due to medical condition|3|||
161459950|NCT00570232|583079043|FG000|Overall Study|discontinued due to recurrence|8|||
161459951|NCT00570232|583079043|FG000|Overall Study|discontinued due to noncompliance|2|||
161459952|NCT01076075|583079044|FG000|Overall Study|Adverse Event|3|||
161459953|NCT01076075|583079045|FG001|Overall Study|Adverse Event|9|||
161459954|NCT01076075|583079044|FG000|Overall Study|Lack of Efficacy|5|||
161459955|NCT01076075|583079045|FG001|Overall Study|Lack of Efficacy|4|||
161459956|NCT01076075|583079044|FG000|Overall Study|Lost to Follow-up|6|||
161459957|NCT01076075|583079045|FG001|Overall Study|Lost to Follow-up|5|||
161459958|NCT01076075|583079044|FG000|Overall Study|other|19|||
161571327|NCT01235949|583477668|FG002|Primary Phase|Lost to Follow-up|1|||
161809780|NCT02648347|584345798|FG000|Overall Study|Lost to Follow-up|18|||
161809781|NCT02648347|584345799|FG001|Overall Study|Lost to Follow-up|21|||
161459959|NCT01076075|583079045|FG001|Overall Study|other|9|||
161459960|NCT01076075|583079044|FG000|Overall Study|Protocol Violation|0|||
161459961|NCT01076075|583079045|FG001|Overall Study|Protocol Violation|1|||
161459962|NCT01076075|583079044|FG000|Overall Study|Withdrawal by Subject|8|||
161459963|NCT01076075|583079045|FG001|Overall Study|Withdrawal by Subject|19|||
161459964|NCT01163032|583079050|FG000|Randomization Phase|Withdrawal by Subject|2|||
161459965|NCT01163032|583079051|FG001|Randomization Phase|Withdrawal by Subject|3|||
161459966|NCT01163032|583079052|FG002|Randomization Phase|Withdrawal by Subject|0|||
161459967|NCT01163032|583079050|FG000|Randomization Phase|Adverse Event|3|||
161459968|NCT01163032|583079051|FG001|Randomization Phase|Adverse Event|3|||
161459969|NCT01163032|583079052|FG002|Randomization Phase|Adverse Event|0|||
161459970|NCT01163032|583079050|FG000|Randomization Phase|Protocol Violation|0|||
161459971|NCT01163032|583079051|FG001|Randomization Phase|Protocol Violation|1|||
161459972|NCT01163032|583079052|FG002|Randomization Phase|Protocol Violation|0|||
161459973|NCT01163032|583079050|FG000|Randomization Phase|Various*|5|||
161459974|NCT01163032|583079051|FG001|Randomization Phase|Various*|4|||
161459975|NCT01163032|583079052|FG002|Randomization Phase|Various*|0|||
161459976|NCT01163032|583079050|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
161459977|NCT01163032|583079051|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
161459978|NCT01163032|583079052|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
161459979|NCT01163032|583079050|FG000|Open Label Extension Phase|Adverse Event|0|||
161459980|NCT01163032|583079051|FG001|Open Label Extension Phase|Adverse Event|0|||
161571328|NCT01235949|583477669|FG003|Primary Phase|Lost to Follow-up|1|||
161571329|NCT01235949|583477670|FG004|Primary Phase|Lost to Follow-up|0|||
161571330|NCT01235949|583477671|FG005|Primary Phase|Lost to Follow-up|2|||
161571331|NCT01235949|583477672|FG006|Primary Phase|Lost to Follow-up|0|||
161571332|NCT01235949|583477673|FG007|Primary Phase|Lost to Follow-up|0|||
161571333|NCT01235949|583477674|FG008|Primary Phase|Lost to Follow-up|0|||
161571334|NCT01235949|583477675|FG009|Primary Phase|Lost to Follow-up|0|||
161571335|NCT01235949|583477676|FG010|Primary Phase|Lost to Follow-up|0|||
161571336|NCT01235949|583477677|FG011|Primary Phase|Lost to Follow-up|0|||
161571337|NCT01235949|583477678|FG012|Primary Phase|Lost to Follow-up|0|||
161571338|NCT01235949|583477679|FG013|Primary Phase|Lost to Follow-up|0|||
161571339|NCT01235949|583477680|FG014|Primary Phase|Lost to Follow-up|0|||
161571340|NCT01235949|583477681|FG015|Primary Phase|Lost to Follow-up|0|||
161571341|NCT01235949|583477682|FG016|Primary Phase|Lost to Follow-up|0|||
161571342|NCT01235949|583477683|FG017|Primary Phase|Lost to Follow-up|0|||
161571343|NCT01235949|583477666|FG000|Booster Phase|Migrated/moved from study area|0|||
161571344|NCT01235949|583477667|FG001|Booster Phase|Migrated/moved from study area|0|||
161571345|NCT01235949|583477668|FG002|Booster Phase|Migrated/moved from study area|0|||
161571346|NCT01235949|583477669|FG003|Booster Phase|Migrated/moved from study area|0|||
161571347|NCT01235949|583477670|FG004|Booster Phase|Migrated/moved from study area|0|||
161571348|NCT01235949|583477671|FG005|Booster Phase|Migrated/moved from study area|0|||
161571349|NCT01235949|583477672|FG006|Booster Phase|Migrated/moved from study area|0|||
161571350|NCT01235949|583477673|FG007|Booster Phase|Migrated/moved from study area|0|||
161571351|NCT01235949|583477674|FG008|Booster Phase|Migrated/moved from study area|0|||
161571352|NCT01235949|583477675|FG009|Booster Phase|Migrated/moved from study area|0|||
161571353|NCT01235949|583477676|FG010|Booster Phase|Migrated/moved from study area|0|||
161571354|NCT01235949|583477677|FG011|Booster Phase|Migrated/moved from study area|1|||
161571355|NCT01235949|583477678|FG012|Booster Phase|Migrated/moved from study area|1|||
161571356|NCT01235949|583477679|FG013|Booster Phase|Migrated/moved from study area|0|||
161571357|NCT01235949|583477680|FG014|Booster Phase|Migrated/moved from study area|0|||
161571358|NCT01235949|583477681|FG015|Booster Phase|Migrated/moved from study area|0|||
161571359|NCT01235949|583477682|FG016|Booster Phase|Migrated/moved from study area|0|||
161571360|NCT01235949|583477683|FG017|Booster Phase|Migrated/moved from study area|1|||
161571361|NCT01235949|583477666|FG000|Booster Phase|Adverse Event|0|||
161571362|NCT01235949|583477667|FG001|Booster Phase|Adverse Event|0|||
161809782|NCT02648347|584345798|FG000|Overall Study|Missing|1|||
161459981|NCT01163032|583079052|FG002|Open Label Extension Phase|Adverse Event|3|||
161459982|NCT01163032|583079050|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
161571363|NCT01235949|583477668|FG002|Booster Phase|Adverse Event|0|||
161571364|NCT01235949|583477669|FG003|Booster Phase|Adverse Event|0|||
161571365|NCT01235949|583477670|FG004|Booster Phase|Adverse Event|0|||
161571366|NCT01235949|583477671|FG005|Booster Phase|Adverse Event|0|||
161571367|NCT01235949|583477672|FG006|Booster Phase|Adverse Event|0|||
161809783|NCT02648347|584345799|FG001|Overall Study|Missing|0|||
161809784|NCT03546842|584345801|FG000|Overall Study|Protocol Violation|1|||
161809785|NCT03546842|584345801|FG000|Overall Study|Withdrawal by Subject|2|||
161809786|NCT01723397|584345802|FG000|Study Period 1|Protocol Violation|0|||
161809787|NCT01723397|584345803|FG001|Study Period 1|Protocol Violation|1|||
161459983|NCT01163032|583079051|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
161459984|NCT01163032|583079052|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
161459985|NCT01163032|583079050|FG000|Open Label Extension Phase|Protocol Violation|0|||
161459986|NCT01163032|583079051|FG001|Open Label Extension Phase|Protocol Violation|0|||
161571368|NCT01235949|583477673|FG007|Booster Phase|Adverse Event|0|||
161571369|NCT01235949|583477674|FG008|Booster Phase|Adverse Event|0|||
161571370|NCT01235949|583477675|FG009|Booster Phase|Adverse Event|0|||
161571371|NCT01235949|583477676|FG010|Booster Phase|Adverse Event|0|||
161571372|NCT01235949|583477677|FG011|Booster Phase|Adverse Event|0|||
161571373|NCT01235949|583477678|FG012|Booster Phase|Adverse Event|0|||
161809788|NCT01723397|584345802|FG000|Study Period 2|Protocol Violation|0|||
161459987|NCT01163032|583079052|FG002|Open Label Extension Phase|Protocol Violation|1|||
161459988|NCT01163032|583079050|FG000|Open Label Extension Phase|Study Termination|0|||
161459989|NCT01163032|583079051|FG001|Open Label Extension Phase|Study Termination|0|||
161459990|NCT01163032|583079052|FG002|Open Label Extension Phase|Study Termination|7|||
161459991|NCT01163032|583079050|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
161459992|NCT01163032|583079051|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
161459993|NCT01163032|583079052|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
161459994|NCT02751931|583079054|FG000|Overall Study|Adverse Event|3|||
161459995|NCT02751931|583079055|FG001|Overall Study|Adverse Event|0|||
161459996|NCT02751931|583079054|FG000|Overall Study|Other: Miscelleneous|10|||
161459997|NCT02751931|583079055|FG001|Overall Study|Other: Miscelleneous|8|||
161459998|NCT03326206|583079061|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
161459999|NCT03326206|583079062|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
161460000|NCT03326206|583079061|FG000|Overall Study - 24 months|Death|8|||
161460001|NCT03326206|583079062|FG001|Overall Study - 24 months|Death|92|||
161460002|NCT03326206|583079061|FG000|Overall Study - 24 months|Observational data not available|43|||
161460003|NCT03326206|583079062|FG001|Overall Study - 24 months|Observational data not available|2879|||
161460004|NCT03326206|583079061|FG000|12 months|Unable to match cases with controls|17|||
161460005|NCT03326206|583079062|FG001|12 months|Unable to match cases with controls|22721|||
161460006|NCT03326206|583079061|FG000|12 months|Death|2|||
161460007|NCT03326206|583079062|FG001|12 months|Death|50|||
161460008|NCT03326206|583079061|FG000|12 months|Observational data not available|49|||
161460009|NCT03326206|583079062|FG001|12 months|Observational data not available|2921|||
161460010|NCT01958827|583079070|FG000|Overall Study|Adverse Event|3|||
161460011|NCT01958827|583079070|FG000|Overall Study|Lack of Efficacy|6|||
161460012|NCT01958827|583079070|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
161460013|NCT04594369|583079072|FG000|Overall Study|Adverse Event|10|||
161460014|NCT04594369|583079073|FG001|Overall Study|Adverse Event|10|||
161460015|NCT04594369|583079074|FG002|Overall Study|Adverse Event|9|||
161460016|NCT04594369|583079072|FG000|Overall Study|Death|2|||
161460017|NCT04594369|583079073|FG001|Overall Study|Death|4|||
161460018|NCT04594369|583079074|FG002|Overall Study|Death|8|||
161460019|NCT04594369|583079072|FG000|Overall Study|Lost to Follow-up|10|||
161460020|NCT04594369|583079073|FG001|Overall Study|Lost to Follow-up|2|||
161460021|NCT04594369|583079074|FG002|Overall Study|Lost to Follow-up|4|||
161460022|NCT04594369|583079072|FG000|Overall Study|Physician Decision|2|||
161460023|NCT04594369|583079073|FG001|Overall Study|Physician Decision|2|||
161460024|NCT04594369|583079074|FG002|Overall Study|Physician Decision|3|||
161460025|NCT04594369|583079072|FG000|Overall Study|Protocol deviation|1|||
161460026|NCT04594369|583079073|FG001|Overall Study|Protocol deviation|3|||
161460027|NCT04594369|583079074|FG002|Overall Study|Protocol deviation|2|||
161571374|NCT01235949|583477679|FG013|Booster Phase|Adverse Event|0|||
161571375|NCT01235949|583477680|FG014|Booster Phase|Adverse Event|0|||
161571376|NCT01235949|583477681|FG015|Booster Phase|Adverse Event|1|||
161571377|NCT01235949|583477682|FG016|Booster Phase|Adverse Event|0|||
161571378|NCT01235949|583477683|FG017|Booster Phase|Adverse Event|0|||
161571379|NCT01235949|583477666|FG000|Booster Phase|Withdrawal by Subject|0|||
161571380|NCT01235949|583477667|FG001|Booster Phase|Withdrawal by Subject|0|||
161571381|NCT01235949|583477668|FG002|Booster Phase|Withdrawal by Subject|0|||
161571382|NCT01235949|583477669|FG003|Booster Phase|Withdrawal by Subject|0|||
161571383|NCT01235949|583477670|FG004|Booster Phase|Withdrawal by Subject|0|||
161571384|NCT01235949|583477671|FG005|Booster Phase|Withdrawal by Subject|0|||
161571385|NCT01235949|583477672|FG006|Booster Phase|Withdrawal by Subject|0|||
161571386|NCT01235949|583477673|FG007|Booster Phase|Withdrawal by Subject|1|||
161571387|NCT01235949|583477674|FG008|Booster Phase|Withdrawal by Subject|1|||
161571388|NCT01235949|583477675|FG009|Booster Phase|Withdrawal by Subject|0|||
161571389|NCT01235949|583477676|FG010|Booster Phase|Withdrawal by Subject|1|||
161571390|NCT01235949|583477677|FG011|Booster Phase|Withdrawal by Subject|1|||
161571391|NCT01235949|583477678|FG012|Booster Phase|Withdrawal by Subject|2|||
161571392|NCT01235949|583477679|FG013|Booster Phase|Withdrawal by Subject|0|||
161571393|NCT01235949|583477680|FG014|Booster Phase|Withdrawal by Subject|2|||
161809789|NCT01723397|584345803|FG001|Study Period 2|Protocol Violation|1|||
161809790|NCT02739997|584345804|FG000|Overall Study|Death|1|||
161809791|NCT02739997|584345804|FG000|Overall Study|Withdrawal by Subject|1|||
161460028|NCT04594369|583079072|FG000|Overall Study|Withdrawal by Subject|40|||
161460029|NCT04594369|583079073|FG001|Overall Study|Withdrawal by Subject|32|||
161809792|NCT02158663|584345809|FG000|Overall Study|Withdrawal by Subject|5|||
161571394|NCT01235949|583477681|FG015|Booster Phase|Withdrawal by Subject|0|||
161571395|NCT01235949|583477682|FG016|Booster Phase|Withdrawal by Subject|0|||
161571396|NCT01235949|583477683|FG017|Booster Phase|Withdrawal by Subject|0|||
161571397|NCT01235949|583477666|FG000|Booster Phase|Lost to Follow-up|0|||
161571398|NCT01235949|583477667|FG001|Booster Phase|Lost to Follow-up|0|||
161571399|NCT01235949|583477668|FG002|Booster Phase|Lost to Follow-up|0|||
161571400|NCT01235949|583477669|FG003|Booster Phase|Lost to Follow-up|0|||
161571401|NCT01235949|583477670|FG004|Booster Phase|Lost to Follow-up|0|||
161571402|NCT01235949|583477671|FG005|Booster Phase|Lost to Follow-up|0|||
161460030|NCT04594369|583079074|FG002|Overall Study|Withdrawal by Subject|37|||
161460031|NCT04594369|583079072|FG000|Overall Study|Reason not specified|60|||
161460032|NCT04594369|583079073|FG001|Overall Study|Reason not specified|56|||
161460033|NCT04594369|583079074|FG002|Overall Study|Reason not specified|43|||
161460034|NCT01163318|583079075|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
161460035|NCT01163318|583079075|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
161460036|NCT01163318|583079075|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
161460037|NCT01163318|583079075|FG000|Overall Study|Participants Without Case Report Form|7|||
161460038|NCT01163318|583079075|FG000|Overall Study|Multiple Reasons Per Participant|224|||
161460039|NCT03587727|583079076|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
161460040|NCT03587727|583079076|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
161460041|NCT02003365|583080035|FG000|Overall Study|Lost to Follow-up|0|||
161460042|NCT02003365|583080036|FG001|Overall Study|Lost to Follow-up|0|||
161460043|NCT02003365|583080037|FG002|Overall Study|Lost to Follow-up|1|||
161460044|NCT02582255|583080042|FG000|Overall Study|Protocol Violation|0|||
161460045|NCT02582255|583080043|FG001|Overall Study|Protocol Violation|3|||
161460046|NCT01709578|583080044|FG000|Overall Study|Rescued and entered in long term safety|63|||
161460047|NCT01709578|583080045|FG001|Overall Study|Rescued and entered in long term safety|25|||
161460048|NCT01709578|583080046|FG002|Overall Study|Rescued and entered in long term safety|26|||
161460049|NCT01709578|583080044|FG000|Overall Study|Adverse Event|9|||
161460050|NCT01709578|583080045|FG001|Overall Study|Adverse Event|18|||
161460051|NCT01709578|583080046|FG002|Overall Study|Adverse Event|17|||
161460052|NCT01709578|583080044|FG000|Overall Study|Lack of Efficacy|5|||
161460053|NCT01709578|583080045|FG001|Overall Study|Lack of Efficacy|4|||
161460054|NCT01709578|583080046|FG002|Overall Study|Lack of Efficacy|2|||
161460055|NCT01709578|583080044|FG000|Overall Study|Poor compliance to protocol|1|||
161460056|NCT01709578|583080045|FG001|Overall Study|Poor compliance to protocol|2|||
161460057|NCT01709578|583080046|FG002|Overall Study|Poor compliance to protocol|1|||
161460058|NCT01709578|583080044|FG000|Overall Study|Other, not related to safety or efficacy|2|||
161460059|NCT01709578|583080045|FG001|Overall Study|Other, not related to safety or efficacy|7|||
161460060|NCT01709578|583080046|FG002|Overall Study|Other, not related to safety or efficacy|5|||
161460061|NCT04050371|583080047|FG000|Overall Study|Withdrawal by Subject|1|||
161460062|NCT04050371|583080048|FG001|Overall Study|Withdrawal by Subject|0|||
161460063|NCT00597701|583080049|FG000|Overall Study|Withdrawal by Subject|5|||
161460064|NCT00597701|583080050|FG001|Overall Study|Withdrawal by Subject|5|||
161460065|NCT00597701|583080049|FG000|Overall Study|Death|0|||
161460066|NCT00597701|583080050|FG001|Overall Study|Death|1|||
161460067|NCT00597701|583080049|FG000|Overall Study|Physician Decision|2|||
161460068|NCT00597701|583080050|FG001|Overall Study|Physician Decision|0|||
161460069|NCT00597701|583080049|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
161460070|NCT00597701|583080050|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
161809793|NCT02158663|584345810|FG001|Overall Study|Withdrawal by Subject|4|||
161809794|NCT01302548|584345811|FG000|Overall Study|Lost to Follow-up|2|||
161460071|NCT04617795|583080055|FG000|Main Study|Lost to Follow-up|1|||
161460072|NCT04617795|583080056|FG001|Main Study|Lost to Follow-up|0|||
161460073|NCT00472459|583080057|FG000|Overall Study|Adverse Event|13|||
161460074|NCT00472459|583080058|FG001|Overall Study|Adverse Event|13|||
161460075|NCT00472459|583080057|FG000|Overall Study|Withdrawal by Subject|5|||
161809795|NCT01302548|584345812|FG001|Overall Study|Lost to Follow-up|1|||
161809796|NCT02409355|584345813|FG000|Overall Study|Withdrawal by Subject|1|||
161809797|NCT02409355|584345814|FG001|Overall Study|Withdrawal by Subject|0|||
161809798|NCT02409355|584345813|FG000|Overall Study|Death|1|||
161809799|NCT02409355|584345814|FG001|Overall Study|Death|1|||
161809800|NCT02409355|584345813|FG000|Overall Study|Study terminated by Sponsor|2|||
161809801|NCT02409355|584345814|FG001|Overall Study|Study terminated by Sponsor|3|||
161809802|NCT01237054|584345815|FG000|Overall Study|imaging 10C0096|1|||
161809803|NCT02089997|584345829|FG000|Overall Study|Case report forms uncollected|99|||
161809804|NCT02089997|584345829|FG000|Overall Study|Protocol Violation|147|||
161809805|NCT00095212|584345830|FG000|Overall Study|Withdrawal by Subject|1|||
161809806|NCT00095212|584345831|FG001|Overall Study|Withdrawal by Subject|3|||
161809807|NCT03681470|584345832|FG000|Overall Study|Lack of Efficacy|3|||
161809808|NCT03681470|584345832|FG000|Overall Study|Lost to Follow-up|1|||
161809809|NCT03681470|584345832|FG000|Overall Study|Protocol Violation|3|||
161809810|NCT03681470|584345832|FG000|Overall Study|Withdrawal by Subject|1|||
161809811|NCT03500692|584345837|FG000|Overall Study|Death|163|||
161460076|NCT00472459|583080058|FG001|Overall Study|Withdrawal by Subject|5|||
161460077|NCT00472459|583080057|FG000|Overall Study|Protocol Violation|3|||
161460078|NCT00472459|583080058|FG001|Overall Study|Protocol Violation|3|||
161460079|NCT00472459|583080057|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
161460080|NCT00472459|583080058|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
161460081|NCT00472459|583080057|FG000|Overall Study|Lost to Follow-up|1|||
161460082|NCT00472459|583080058|FG001|Overall Study|Lost to Follow-up|1|||
161809812|NCT03500692|584345837|FG000|Overall Study|Lost to Follow-up|75|||
161809813|NCT03500692|584345837|FG000|Overall Study|Termination Reasons|3|||
161809814|NCT02305758|584345838|FG000|Overall Study|Death|27|||
161571403|NCT01235949|583477672|FG006|Booster Phase|Lost to Follow-up|0|||
161571404|NCT01235949|583477673|FG007|Booster Phase|Lost to Follow-up|0|||
161571405|NCT01235949|583477674|FG008|Booster Phase|Lost to Follow-up|1|||
161571406|NCT01235949|583477675|FG009|Booster Phase|Lost to Follow-up|1|||
161571407|NCT01235949|583477676|FG010|Booster Phase|Lost to Follow-up|1|||
161571408|NCT01235949|583477677|FG011|Booster Phase|Lost to Follow-up|1|||
161571409|NCT01235949|583477678|FG012|Booster Phase|Lost to Follow-up|0|||
161571410|NCT01235949|583477679|FG013|Booster Phase|Lost to Follow-up|0|||
161571411|NCT01235949|583477680|FG014|Booster Phase|Lost to Follow-up|0|||
161571412|NCT01235949|583477681|FG015|Booster Phase|Lost to Follow-up|0|||
161571413|NCT01235949|583477682|FG016|Booster Phase|Lost to Follow-up|0|||
161571414|NCT01235949|583477683|FG017|Booster Phase|Lost to Follow-up|1|||
161571415|NCT00754936|583477684|FG000|Overall Study|Lost to Follow-up|3|||
161571416|NCT00754936|583477684|FG000|Overall Study|Physician Decision|1|||
161571417|NCT00754936|583477684|FG000|Overall Study|Withdrawal by Subject|2|||
161571418|NCT00754936|583477684|FG000|Overall Study|Side Effects|3|||
161571419|NCT00754936|583477684|FG000|Overall Study|Inter-current medical events|3|||
161571420|NCT00436644|583477685|FG000|Overall Study|Adverse Event|2|||
161571421|NCT00436644|583477685|FG000|Overall Study|Death|1|||
161571422|NCT00619645|583477686|FG000|Overall Study|Adverse Event|1|||
161571423|NCT04364269|583477691|FG000|Overall Study|Adverse Event|1|||
161571424|NCT04364269|583477692|FG001|Overall Study|Adverse Event|0|||
161571425|NCT04364269|583477693|FG002|Overall Study|Adverse Event|0|||
161571426|NCT04364269|583477691|FG000|Overall Study|Withdrawal by Subject|0|||
161571427|NCT04364269|583477692|FG001|Overall Study|Withdrawal by Subject|1|||
161571428|NCT04364269|583477693|FG002|Overall Study|Withdrawal by Subject|0|||
161571429|NCT01490580|583477694|FG000|Overall Study|Parents withdrew consent|0|||
161571430|NCT01490580|583477695|FG001|Overall Study|Parents withdrew consent|2|||
161571431|NCT02026258|583477698|FG000|Randomized|Did not start treatment|2|||
161571432|NCT02026258|583477699|FG001|Randomized|Did not start treatment|1|||
161571433|NCT02026258|583477698|FG000|Randomized|Change in treatment plan|1|||
161571434|NCT02026258|583477699|FG001|Randomized|Change in treatment plan|0|||
161571435|NCT02026258|583477698|FG000|Randomized|Presence of periodontal disease|1|||
161571436|NCT02026258|583477699|FG001|Randomized|Presence of periodontal disease|1|||
161571437|NCT02026258|583477698|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
161571438|NCT02026258|583477699|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
161571439|NCT02026258|583477698|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
161571440|NCT02026258|583477699|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
161571441|NCT02534350|583477700|FG000|Overall Study|Randomized But Not Treated|1|||
161571442|NCT02534350|583477701|FG001|Overall Study|Randomized But Not Treated|0|||
161571443|NCT02534350|583477700|FG000|Overall Study|Protocol Violation|1|||
161571444|NCT02534350|583477701|FG001|Overall Study|Protocol Violation|0|||
161571445|NCT02534350|583477700|FG000|Overall Study|Withdrew Consent|2|||
161571446|NCT02534350|583477701|FG001|Overall Study|Withdrew Consent|0|||
161571447|NCT00972504|583477702|FG000|Overall Study|Adverse Event|2|||
161571448|NCT00972504|583477702|FG000|Overall Study|Investigator discretion|1|||
161571449|NCT00716144|583477703|FG000|Overall Study|Withdrawal by Subject|4|||
161571450|NCT00716144|583477704|FG001|Overall Study|Withdrawal by Subject|2|||
161571451|NCT00716144|583477705|FG002|Overall Study|Withdrawal by Subject|6|||
161571452|NCT00716144|583477706|FG003|Overall Study|Withdrawal by Subject|6|||
161571453|NCT00716144|583477703|FG000|Overall Study|Lost to Follow-up|2|||
161571454|NCT00716144|583477704|FG001|Overall Study|Lost to Follow-up|2|||
161571455|NCT00716144|583477705|FG002|Overall Study|Lost to Follow-up|1|||
161571456|NCT00716144|583477706|FG003|Overall Study|Lost to Follow-up|2|||
161571457|NCT00716144|583477703|FG000|Overall Study|Adverse Event|0|||
161571458|NCT00716144|583477704|FG001|Overall Study|Adverse Event|0|||
161571459|NCT00716144|583477705|FG002|Overall Study|Adverse Event|0|||
161571460|NCT00716144|583477706|FG003|Overall Study|Adverse Event|2|||
161913697|NCT00336544|584733609|FG000|Overall Study|Withdrawal by Subject|4|||
161913698|NCT00336544|584733610|FG001|Overall Study|Withdrawal by Subject|3|||
161913699|NCT00336544|584733609|FG000|Overall Study|Other|3|||
161913700|NCT00336544|584733610|FG001|Overall Study|Other|5|||
161571461|NCT00716144|583477703|FG000|Overall Study|Non-compliance|1|||
161571462|NCT00716144|583477704|FG001|Overall Study|Non-compliance|0|||
161913701|NCT00715208|584733611|FG000|Overall Study|Withdrawal by Subject|1|||
161913702|NCT00715208|584733612|FG001|Overall Study|Withdrawal by Subject|1|||
161571463|NCT00716144|583477705|FG002|Overall Study|Non-compliance|0|||
161571464|NCT00716144|583477706|FG003|Overall Study|Non-compliance|0|||
161571465|NCT00716144|583477703|FG000|Overall Study|Protocol Violation|2|||
161571466|NCT00716144|583477704|FG001|Overall Study|Protocol Violation|0|||
161571467|NCT00716144|583477705|FG002|Overall Study|Protocol Violation|1|||
161571468|NCT00716144|583477706|FG003|Overall Study|Protocol Violation|0|||
161571469|NCT00716144|583477703|FG000|Overall Study|Physician Decision|0|||
161571470|NCT00716144|583477704|FG001|Overall Study|Physician Decision|1|||
161571471|NCT00716144|583477705|FG002|Overall Study|Physician Decision|2|||
161571472|NCT00716144|583477706|FG003|Overall Study|Physician Decision|2|||
161571473|NCT00716144|583477703|FG000|Overall Study|Intercurrent illness|0|||
161913703|NCT00715208|584733611|FG000|Overall Study|Adverse Event|0|||
161571474|NCT00716144|583477704|FG001|Overall Study|Intercurrent illness|0|||
161571475|NCT00716144|583477705|FG002|Overall Study|Intercurrent illness|1|||
161571476|NCT00716144|583477706|FG003|Overall Study|Intercurrent illness|0|||
161571477|NCT00716144|583477703|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
161571478|NCT00716144|583477704|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
161571479|NCT00716144|583477705|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
161571480|NCT00716144|583477706|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
161571481|NCT00716144|583477703|FG000|Overall Study|Adverse event: left foot pain|0|||
161571482|NCT00716144|583477704|FG001|Overall Study|Adverse event: left foot pain|1|||
161571483|NCT00716144|583477705|FG002|Overall Study|Adverse event: left foot pain|0|||
161571484|NCT00716144|583477706|FG003|Overall Study|Adverse event: left foot pain|0|||
161571485|NCT00716144|583477703|FG000|Overall Study|Clinical Depression|0|||
161571486|NCT00716144|583477704|FG001|Overall Study|Clinical Depression|1|||
161571487|NCT00716144|583477705|FG002|Overall Study|Clinical Depression|0|||
161571488|NCT00716144|583477706|FG003|Overall Study|Clinical Depression|0|||
161571489|NCT00880048|583477707|FG000|Overall Study|Adverse Event|2|||
161571490|NCT00880048|583477708|FG001|Overall Study|Adverse Event|3|||
161571491|NCT00880048|583477709|FG002|Overall Study|Adverse Event|5|||
161571492|NCT00880048|583477707|FG000|Overall Study|Lack of Efficacy|1|||
161571493|NCT00880048|583477708|FG001|Overall Study|Lack of Efficacy|2|||
161571494|NCT00880048|583477709|FG002|Overall Study|Lack of Efficacy|2|||
161571495|NCT00880048|583477707|FG000|Overall Study|Protocol Violation|4|||
161571496|NCT00880048|583477708|FG001|Overall Study|Protocol Violation|6|||
161571497|NCT00880048|583477709|FG002|Overall Study|Protocol Violation|5|||
161571498|NCT00880048|583477707|FG000|Overall Study|Lost to Follow-up|6|||
161571499|NCT00880048|583477708|FG001|Overall Study|Lost to Follow-up|6|||
161571500|NCT00880048|583477709|FG002|Overall Study|Lost to Follow-up|5|||
161571501|NCT00880048|583477707|FG000|Overall Study|Physician Decision|1|||
161571502|NCT00880048|583477708|FG001|Overall Study|Physician Decision|1|||
161571503|NCT00880048|583477709|FG002|Overall Study|Physician Decision|7|||
161571504|NCT00880048|583477707|FG000|Overall Study|Withdrawal by Subject|5|||
161571505|NCT00880048|583477708|FG001|Overall Study|Withdrawal by Subject|8|||
161571506|NCT00880048|583477709|FG002|Overall Study|Withdrawal by Subject|5|||
161571507|NCT00880048|583477707|FG000|Overall Study|Study closed/terminated|9|||
161571508|NCT00880048|583477708|FG001|Overall Study|Study closed/terminated|7|||
161571509|NCT00880048|583477709|FG002|Overall Study|Study closed/terminated|6|||
161571510|NCT01104415|583477715|FG000|Core Phase|Consent withdrawn by subjects|1|||
161571511|NCT01104415|583477716|FG001|Core Phase|Consent withdrawn by subjects|0|||
161571512|NCT01104415|583477715|FG000|Extension Period|Progressive disease|0|||
161571513|NCT01104415|583477716|FG001|Extension Period|Progressive disease|4|||
161571514|NCT01104415|583477715|FG000|Extension Period|Death|0|||
161571515|NCT01104415|583477716|FG001|Extension Period|Death|1|||
161571516|NCT01104415|583477715|FG000|Extension Period|Physician Decision|0|||
161571517|NCT01104415|583477716|FG001|Extension Period|Physician Decision|1|||
161571518|NCT01104415|583477715|FG000|Extension Period|Transition to Study LX1606.302|0|||
161571519|NCT01104415|583477716|FG001|Extension Period|Transition to Study LX1606.302|4|||
161571520|NCT01104415|583477715|FG000|Extension Period|Heart surgery/feeling miserable|0|||
161571521|NCT01104415|583477716|FG001|Extension Period|Heart surgery/feeling miserable|1|||
161571522|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
161571523|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
161571524|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
161571525|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
161571526|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
161571527|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
161571528|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
161571529|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
161571530|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
161571531|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
161571532|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
161571533|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
161571534|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
161571535|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
161571536|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
161571537|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
161571538|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
161571539|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
161571540|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
161571541|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
161571542|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
161571543|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
161571544|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
161571545|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
161571546|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
161571547|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
161571548|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
161571549|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
161571550|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
161571551|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
161571552|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
161571553|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
161571554|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
161571555|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571556|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
161571557|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
161571558|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
161571559|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571560|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571561|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571562|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571563|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571564|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571565|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161571566|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571567|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571568|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571569|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571570|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
161571571|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571572|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571573|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571574|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571575|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571576|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161571577|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
161571578|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571579|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571580|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571581|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571582|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571583|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571584|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571585|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571586|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571587|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161571588|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
161571589|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
161913704|NCT00715208|584733612|FG001|Overall Study|Adverse Event|6|||
161913705|NCT00715208|584733611|FG000|Overall Study|Lack of Efficacy|0|||
161913706|NCT00715208|584733612|FG001|Overall Study|Lack of Efficacy|2|||
161913707|NCT00576758|584733613|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
161913708|NCT00576758|584733614|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
161913709|NCT00576758|584733613|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
161913710|NCT00576758|584733614|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
161913711|NCT00576758|584733613|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
161913712|NCT00576758|584733614|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
161913713|NCT00576758|584733613|FG000|Induction Treatment Period|Death|1|||
161913714|NCT00576758|584733614|FG001|Induction Treatment Period|Death|0|||
161913715|NCT00576758|584733613|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
161913716|NCT00576758|584733614|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
161913717|NCT00576758|584733613|FG000|Induction Treatment Period|Withdrew consent|1|||
161913718|NCT00576758|584733614|FG001|Induction Treatment Period|Withdrew consent|0|||
161913719|NCT00576758|584733613|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
161913720|NCT00576758|584733614|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
161913721|NCT00576758|584733613|FG000|Extension Treatment Period|Death|1|||
161913722|NCT00576758|584733614|FG001|Extension Treatment Period|Death|1|||
161913723|NCT00576758|584733613|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
161913724|NCT00576758|584733614|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
161913725|NCT00576758|584733613|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
161913726|NCT00576758|584733614|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
161571590|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
161571591|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
161571592|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
161571593|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
161571594|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
161571595|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
161571596|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
161571597|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
161571598|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
161571599|NCT02914522|583477721|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571600|NCT02914522|583477722|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
161571601|NCT02914522|583477723|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571602|NCT02914522|583477724|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571603|NCT02914522|583477725|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
161571604|NCT02914522|583477726|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
161571605|NCT02914522|583477727|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571606|NCT02914522|583477728|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571607|NCT02914522|583477729|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571608|NCT02914522|583477730|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571609|NCT02914522|583477731|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161571610|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161571611|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161571612|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161571613|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161571614|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161571615|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161571616|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
161571617|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
161571618|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
161571619|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
161571620|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
161571621|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161571622|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161571623|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161571624|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161571625|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161571626|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161571627|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
161571628|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
161571629|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
161571630|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
161571631|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
161571632|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571633|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571634|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571635|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571636|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571637|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571638|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
161571639|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
161571640|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
161571641|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161571642|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
161571643|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
161571644|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
161571645|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
161571646|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
161571647|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
161571648|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
161571649|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
161571650|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
161571651|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
161571652|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
161571653|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
161809815|NCT02305758|584345839|FG001|Overall Study|Death|27|||
161571654|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
161571655|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
161571656|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
161571657|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
161571658|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
161571659|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
161571660|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
161571661|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
161571662|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
161571663|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
161571664|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
161571665|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571666|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571667|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571668|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571669|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571670|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571671|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571672|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
161571673|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
161571674|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571675|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
161571676|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571677|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571678|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571679|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571680|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571681|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571682|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571683|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571684|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
161571685|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
161571686|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
161571687|NCT02914522|583477721|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571688|NCT02914522|583477722|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571689|NCT02914522|583477723|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571690|NCT02914522|583477724|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571691|NCT02914522|583477725|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571692|NCT02914522|583477726|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571693|NCT02914522|583477727|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571694|NCT02914522|583477728|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571695|NCT02914522|583477729|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571696|NCT02914522|583477730|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
161571697|NCT02914522|583477731|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161571698|NCT00639002|583477732|FG000|Overall Study|Death|1|||
161571699|NCT00639002|583477732|FG000|Overall Study|Adverse Event|1|||
161571700|NCT00639002|583477732|FG000|Overall Study|Protocol Violation|1|||
161571701|NCT00639002|583477732|FG000|Overall Study|Disease progression|3|||
161571702|NCT00639002|583477732|FG000|Overall Study|Physician Decision|6|||
161571703|NCT00639002|583477732|FG000|Overall Study|Lack of Efficacy|1|||
161571704|NCT00597519|583477736|FG000|Overall Study|Death|1|||
161571705|NCT03098030|583477737|FG000|Overall Study|Death|10|||
161571706|NCT03098030|583477738|FG001|Overall Study|Death|156|||
161571707|NCT03098030|583477739|FG002|Overall Study|Death|156|||
161571708|NCT03098030|583477740|FG003|Overall Study|Death|82|||
161571709|NCT03098030|583477737|FG000|Overall Study|Withdrawal by Subject|0|||
161571710|NCT03098030|583477738|FG001|Overall Study|Withdrawal by Subject|7|||
161571711|NCT03098030|583477739|FG002|Overall Study|Withdrawal by Subject|8|||
161571712|NCT03098030|583477740|FG003|Overall Study|Withdrawal by Subject|2|||
161571713|NCT03098030|583477737|FG000|Overall Study|Lost to Follow-up|0|||
161571714|NCT03098030|583477738|FG001|Overall Study|Lost to Follow-up|0|||
161571715|NCT03098030|583477739|FG002|Overall Study|Lost to Follow-up|2|||
161571716|NCT03098030|583477740|FG003|Overall Study|Lost to Follow-up|1|||
161571717|NCT03368001|583477742|FG000|Allocation|Lost to Pretest|16|||
161571718|NCT03368001|583477743|FG001|Allocation|Lost to Pretest|25|||
161571719|NCT03368001|583477742|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
161571720|NCT03368001|583477743|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
161571721|NCT03368001|583477742|FG000|Posttest|Lost to Posttest|7|||
161571722|NCT03368001|583477743|FG001|Posttest|Lost to Posttest|11|||
161571723|NCT03368001|583477742|FG000|Posttest|Discontinued Intervention|6|||
161571724|NCT03368001|583477743|FG001|Posttest|Discontinued Intervention|19|||
161571725|NCT03368001|583477742|FG000|Follow-up|Lost to Follow-up|6|||
161571726|NCT03368001|583477743|FG001|Follow-up|Lost to Follow-up|3|||
161571727|NCT03612804|583477744|FG000|Overall Study|Death|0|||
161571728|NCT03612804|583477745|FG001|Overall Study|Death|7|||
161571729|NCT03612804|583477746|FG002|Overall Study|Death|0|||
161571730|NCT03612804|583477747|FG003|Overall Study|Death|8|||
161571731|NCT03612804|583477744|FG000|Overall Study|Medication copay coverage issues|0|||
161571732|NCT03612804|583477745|FG001|Overall Study|Medication copay coverage issues|0|||
161571733|NCT03612804|583477746|FG002|Overall Study|Medication copay coverage issues|0|||
161571734|NCT03612804|583477747|FG003|Overall Study|Medication copay coverage issues|17|||
161571735|NCT03612804|583477744|FG000|Overall Study|Not current smoker at time of screening|0|||
161571736|NCT03612804|583477745|FG001|Overall Study|Not current smoker at time of screening|1|||
161913727|NCT00576758|584733613|FG000|Extension Treatment Period|Administrative/Other|3|||
161913728|NCT00576758|584733614|FG001|Extension Treatment Period|Administrative/Other|1|||
161913729|NCT00576758|584733613|FG000|Follow-up Period|Administrative/Other|6|||
161913730|NCT00576758|584733614|FG001|Follow-up Period|Administrative/Other|8|||
161913731|NCT00576758|584733613|FG000|Follow-up Period|Death|3|||
161913732|NCT00576758|584733614|FG001|Follow-up Period|Death|3|||
161913733|NCT00576758|584733613|FG000|Follow-up Period|Insufficient therapeutic response|16|||
161913734|NCT00576758|584733614|FG001|Follow-up Period|Insufficient therapeutic response|5|||
161913735|NCT00576758|584733613|FG000|Follow-up Period|Withdrew consent|2|||
161913736|NCT00576758|584733614|FG001|Follow-up Period|Withdrew consent|1|||
161913737|NCT03427411|584733615|FG000|Overall Study|Screen failure - platelets too low|0|||
161913738|NCT03427411|584733616|FG001|Overall Study|Screen failure - platelets too low|1|||
161913739|NCT00903968|584733617|FG000|Overall Study|Adverse Event|0|||
161913740|NCT00903968|584733618|FG001|Overall Study|Adverse Event|0|||
161913741|NCT00903968|584733619|FG002|Overall Study|Adverse Event|0|||
161913742|NCT00903968|584733620|FG003|Overall Study|Adverse Event|0|||
161913743|NCT00903968|584733621|FG004|Overall Study|Adverse Event|0|||
161913744|NCT00903968|584733622|FG005|Overall Study|Adverse Event|0|||
161913745|NCT00903968|584733623|FG006|Overall Study|Adverse Event|1|||
161913746|NCT00903968|584733624|FG007|Overall Study|Adverse Event|8|||
161913747|NCT00903968|584733617|FG000|Overall Study|DLT|0|||
161913748|NCT00903968|584733618|FG001|Overall Study|DLT|0|||
161913749|NCT00903968|584733619|FG002|Overall Study|DLT|0|||
161913750|NCT00903968|584733620|FG003|Overall Study|DLT|0|||
161913751|NCT00903968|584733621|FG004|Overall Study|DLT|0|||
161913752|NCT00903968|584733622|FG005|Overall Study|DLT|0|||
161913753|NCT00903968|584733623|FG006|Overall Study|DLT|2|||
161913754|NCT00903968|584733624|FG007|Overall Study|DLT|0|||
161913755|NCT00903968|584733617|FG000|Overall Study|Withdrawal by Subject|1|||
161913756|NCT00903968|584733618|FG001|Overall Study|Withdrawal by Subject|0|||
161913757|NCT00903968|584733619|FG002|Overall Study|Withdrawal by Subject|1|||
161913758|NCT00903968|584733620|FG003|Overall Study|Withdrawal by Subject|0|||
161913759|NCT00903968|584733621|FG004|Overall Study|Withdrawal by Subject|1|||
161913760|NCT00903968|584733622|FG005|Overall Study|Withdrawal by Subject|1|||
161913761|NCT00903968|584733623|FG006|Overall Study|Withdrawal by Subject|0|||
161913762|NCT00903968|584733624|FG007|Overall Study|Withdrawal by Subject|4|||
161913763|NCT00903968|584733617|FG000|Overall Study|Non-Compliance|0|||
161913764|NCT00903968|584733618|FG001|Overall Study|Non-Compliance|0|||
161913765|NCT00903968|584733619|FG002|Overall Study|Non-Compliance|0|||
161913766|NCT00903968|584733620|FG003|Overall Study|Non-Compliance|0|||
161913767|NCT00903968|584733621|FG004|Overall Study|Non-Compliance|0|||
161913768|NCT00903968|584733622|FG005|Overall Study|Non-Compliance|1|||
161913769|NCT00903968|584733623|FG006|Overall Study|Non-Compliance|0|||
161913770|NCT00903968|584733624|FG007|Overall Study|Non-Compliance|0|||
161913771|NCT00903968|584733617|FG000|Overall Study|Physician Decision|0|||
161913772|NCT00903968|584733618|FG001|Overall Study|Physician Decision|0|||
161913773|NCT00903968|584733619|FG002|Overall Study|Physician Decision|0|||
161913774|NCT00903968|584733620|FG003|Overall Study|Physician Decision|0|||
161913775|NCT00903968|584733621|FG004|Overall Study|Physician Decision|0|||
161913776|NCT00903968|584733622|FG005|Overall Study|Physician Decision|1|||
161913777|NCT00903968|584733623|FG006|Overall Study|Physician Decision|0|||
161913778|NCT00903968|584733624|FG007|Overall Study|Physician Decision|0|||
161913779|NCT00903968|584733617|FG000|Overall Study|Progressive Disease|2|||
161913780|NCT00903968|584733618|FG001|Overall Study|Progressive Disease|3|||
161913781|NCT00903968|584733619|FG002|Overall Study|Progressive Disease|2|||
161913782|NCT00903968|584733620|FG003|Overall Study|Progressive Disease|3|||
161913783|NCT00903968|584733621|FG004|Overall Study|Progressive Disease|3|||
161913784|NCT00903968|584733622|FG005|Overall Study|Progressive Disease|3|||
161913785|NCT00903968|584733623|FG006|Overall Study|Progressive Disease|0|||
161913786|NCT00903968|584733624|FG007|Overall Study|Progressive Disease|18|||
161913787|NCT00903968|584733617|FG000|Overall Study|Lack of Efficacy|0|||
161913788|NCT00903968|584733618|FG001|Overall Study|Lack of Efficacy|0|||
161913789|NCT00903968|584733619|FG002|Overall Study|Lack of Efficacy|0|||
161913790|NCT00903968|584733620|FG003|Overall Study|Lack of Efficacy|0|||
161913791|NCT00903968|584733621|FG004|Overall Study|Lack of Efficacy|0|||
161913792|NCT00903968|584733622|FG005|Overall Study|Lack of Efficacy|0|||
161913793|NCT00903968|584733623|FG006|Overall Study|Lack of Efficacy|0|||
161913794|NCT00903968|584733624|FG007|Overall Study|Lack of Efficacy|3|||
161913795|NCT01294046|584733625|FG000|Overall Study|Infection and surgical explant|1|||
161913796|NCT01294046|584733625|FG000|Overall Study|Eligibility criteria expanded|1|||
161913797|NCT01294046|584733625|FG000|Overall Study|Stimulation response inadqequate|1|||
161913798|NCT03738696|584733631|FG000|Overall Study|Withdrawal by Subject|0|||
161913799|NCT03738696|584733632|FG001|Overall Study|Withdrawal by Subject|1|||
161913800|NCT03738696|584733631|FG000|Overall Study|Lost to Follow-up|8|||
161913801|NCT03738696|584733632|FG001|Overall Study|Lost to Follow-up|14|||
161913802|NCT02690727|584733635|FG000|Overall Study|Adverse Event|2|||
161913803|NCT02690727|584733636|FG001|Overall Study|Adverse Event|2|||
161913804|NCT04757636|584733637|FG000|Overall Study|Adverse Event|25|||
161913805|NCT04757636|584733638|FG001|Overall Study|Adverse Event|8|||
161913806|NCT04757636|584733639|FG002|Overall Study|Adverse Event|11|||
161913807|NCT04757636|584733637|FG000|Overall Study|Death|9|||
161913808|NCT04757636|584733638|FG001|Overall Study|Death|12|||
161913809|NCT04757636|584733639|FG002|Overall Study|Death|6|||
161913810|NCT04757636|584733637|FG000|Overall Study|Lack of Efficacy|2|||
161913811|NCT04757636|584733638|FG001|Overall Study|Lack of Efficacy|0|||
161913812|NCT04757636|584733639|FG002|Overall Study|Lack of Efficacy|0|||
161913813|NCT04757636|584733637|FG000|Overall Study|Lost to Follow-up|1|||
161913814|NCT04757636|584733638|FG001|Overall Study|Lost to Follow-up|6|||
161913815|NCT04757636|584733639|FG002|Overall Study|Lost to Follow-up|7|||
161913816|NCT04757636|584733637|FG000|Overall Study|Physician Decision|1|||
161913817|NCT04757636|584733638|FG001|Overall Study|Physician Decision|3|||
161913818|NCT04757636|584733639|FG002|Overall Study|Physician Decision|4|||
161913819|NCT04757636|584733637|FG000|Overall Study|Withdrawal by Subject|20|||
161913820|NCT04757636|584733638|FG001|Overall Study|Withdrawal by Subject|23|||
161913821|NCT04757636|584733639|FG002|Overall Study|Withdrawal by Subject|18|||
161913822|NCT04757636|584733637|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
161913823|NCT04757636|584733638|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
161913824|NCT04757636|584733639|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
161913825|NCT04757636|584733637|FG000|Overall Study|Study Terminated by Sponsor|103|||
161913826|NCT04757636|584733638|FG001|Overall Study|Study Terminated by Sponsor|104|||
161571737|NCT03612804|583477746|FG002|Overall Study|Not current smoker at time of screening|0|||
161571738|NCT03612804|583477747|FG003|Overall Study|Not current smoker at time of screening|3|||
161571739|NCT03612804|583477744|FG000|Overall Study|Non-veteran status|0|||
161571740|NCT03612804|583477745|FG001|Overall Study|Non-veteran status|1|||
161571741|NCT03612804|583477746|FG002|Overall Study|Non-veteran status|0|||
161571742|NCT03612804|583477747|FG003|Overall Study|Non-veteran status|0|||
161571743|NCT03612804|583477744|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
161571744|NCT03612804|583477745|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
161571745|NCT03612804|583477746|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
161571746|NCT03612804|583477747|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
161571747|NCT03612804|583477744|FG000|Overall Study|Provider retired from VA|0|||
161571748|NCT03612804|583477745|FG001|Overall Study|Provider retired from VA|0|||
161571749|NCT03612804|583477746|FG002|Overall Study|Provider retired from VA|2|||
161571750|NCT03612804|583477747|FG003|Overall Study|Provider retired from VA|0|||
161571751|NCT03612804|583477744|FG000|Overall Study|Withdrawal by Subject|0|||
161571752|NCT03612804|583477745|FG001|Overall Study|Withdrawal by Subject|0|||
161571753|NCT03612804|583477746|FG002|Overall Study|Withdrawal by Subject|7|||
161571754|NCT03612804|583477747|FG003|Overall Study|Withdrawal by Subject|0|||
161571755|NCT03612804|583477744|FG000|Overall Study|Provider involved with study activities|1|||
161571756|NCT03612804|583477745|FG001|Overall Study|Provider involved with study activities|0|||
161571757|NCT03612804|583477746|FG002|Overall Study|Provider involved with study activities|0|||
161571758|NCT03612804|583477747|FG003|Overall Study|Provider involved with study activities|0|||
161571759|NCT05484726|583477748|FG000|Overall Study|Protocol Violation|3|||
161571760|NCT05484726|583477749|FG001|Overall Study|Protocol Violation|3|||
161571761|NCT05484726|583477748|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
161571762|NCT05484726|583477749|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
161571763|NCT05484726|583477748|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
161571764|NCT05484726|583477749|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
161571765|NCT05484726|583477748|FG000|Overall Study|continued need of mechanical ventilation|2|||
161571766|NCT05484726|583477749|FG001|Overall Study|continued need of mechanical ventilation|3|||
161571767|NCT05484726|583477748|FG000|Overall Study|Withdrawal by Subject|2|||
161571768|NCT05484726|583477749|FG001|Overall Study|Withdrawal by Subject|3|||
161571769|NCT05484726|583477748|FG000|Overall Study|IVH (G III & IV)|2|||
161571770|NCT05484726|583477749|FG001|Overall Study|IVH (G III & IV)|1|||
161571771|NCT05484726|583477748|FG000|Overall Study|NEC (stage II & III)|2|||
161571772|NCT05484726|583477749|FG001|Overall Study|NEC (stage II & III)|3|||
161571773|NCT04550039|583477757|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
161571774|NCT04550039|583477758|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
161571775|NCT04550039|583477757|FG000|Overall Study|patient self-withdrew from study|0|||
161571776|NCT04550039|583477758|FG001|Overall Study|patient self-withdrew from study|1|||
161571777|NCT04391309|583477759|FG000|Overall Study|Death|1|||
161571778|NCT04391309|583477760|FG001|Overall Study|Death|1|||
161571779|NCT04391309|583477759|FG000|Overall Study|Lost to Follow-up|3|||
161571780|NCT04391309|583477760|FG001|Overall Study|Lost to Follow-up|2|||
161571781|NCT04391309|583477759|FG000|Overall Study|Withdrawal by Subject|2|||
161571782|NCT04391309|583477760|FG001|Overall Study|Withdrawal by Subject|2|||
161571783|NCT05826431|583477761|FG000|Overall Study|Withdrawal by Subject|1|||
161571784|NCT00768651|583477762|FG000|Overall Study|Withdrawal by Subject|1|||
161571785|NCT02357784|583477763|FG000|Overall Study|Withdrawal by Subject|1|||
161571786|NCT01697319|583477765|FG000|Primary Phase|Withdrawal by Subject|1|||
161571787|NCT01697319|583477765|FG000|Extension Phase|Terminated by Sponsor|15|||
161571788|NCT04248829|583477769|FG000|Overall Study|Disease progression|44|||
161571789|NCT04248829|583477770|FG001|Overall Study|Disease progression|109|||
161571790|NCT04248829|583477769|FG000|Overall Study|Adverse Event|19|||
161571791|NCT04248829|583477770|FG001|Overall Study|Adverse Event|18|||
161571792|NCT04248829|583477769|FG000|Overall Study|Withdrawal by Subject|11|||
161571793|NCT04248829|583477770|FG001|Overall Study|Withdrawal by Subject|2|||
161571794|NCT04248829|583477769|FG000|Overall Study|Lost to Follow-up|0|||
161571795|NCT04248829|583477770|FG001|Overall Study|Lost to Follow-up|1|||
161571796|NCT04248829|583477769|FG000|Overall Study|Death|12|||
161571797|NCT04248829|583477770|FG001|Overall Study|Death|14|||
161809816|NCT02305758|584345838|FG000|Overall Study|Withdrew consent|9|||
161571798|NCT04248829|583477769|FG000|Overall Study|Physician Decision|2|||
161809817|NCT02305758|584345839|FG001|Overall Study|Withdrew consent|2|||
161809818|NCT02305758|584345838|FG000|Overall Study|Lost to Follow-up|6|||
161571799|NCT04248829|583477770|FG001|Overall Study|Physician Decision|4|||
161571800|NCT04248829|583477769|FG000|Overall Study|Any reason not specifically recorded|0|||
161571801|NCT04248829|583477770|FG001|Overall Study|Any reason not specifically recorded|2|||
161571802|NCT02299336|583477771|FG000|Overall Study|Withdrawal by Subject|11|||
161571803|NCT02299336|583477771|FG000|Overall Study|Adverse Event|1|||
161571804|NCT02299336|583477771|FG000|Overall Study|Death|1|||
161571805|NCT02299336|583477771|FG000|Overall Study|Lost to Follow-up|1|||
161571806|NCT01304147|583477772|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
161809819|NCT02305758|584345839|FG001|Overall Study|Lost to Follow-up|1|||
161913827|NCT04757636|584733639|FG002|Overall Study|Study Terminated by Sponsor|114|||
161913828|NCT04757636|584733637|FG000|Overall Study|Sponsor Decision|0|||
161913829|NCT04757636|584733638|FG001|Overall Study|Sponsor Decision|0|||
161913830|NCT04757636|584733639|FG002|Overall Study|Sponsor Decision|1|||
161913831|NCT04757636|584733637|FG000|Overall Study|Randomized in Error|0|||
161913832|NCT04757636|584733638|FG001|Overall Study|Randomized in Error|0|||
161913833|NCT04757636|584733639|FG002|Overall Study|Randomized in Error|2|||
161913834|NCT00091819|584733640|FG000|Overall Study|Adverse Event|1|||
161913835|NCT00091819|584733641|FG001|Overall Study|Adverse Event|1|||
161913836|NCT00091819|584733640|FG000|Overall Study|Death|4|||
161913837|NCT00091819|584733641|FG001|Overall Study|Death|5|||
161913838|NCT00091819|584733640|FG000|Overall Study|Lost to Follow-up|26|||
161913839|NCT00091819|584733641|FG001|Overall Study|Lost to Follow-up|23|||
161913840|NCT00091819|584733640|FG000|Overall Study|Withdrawal by Subject|5|||
161913841|NCT00091819|584733641|FG001|Overall Study|Withdrawal by Subject|8|||
161913842|NCT00091819|584733640|FG000|Overall Study|Protocol Violation|1|||
161913843|NCT00091819|584733641|FG001|Overall Study|Protocol Violation|2|||
161913844|NCT00091819|584733640|FG000|Overall Study|Other|2|||
161913845|NCT00091819|584733641|FG001|Overall Study|Other|3|||
161913846|NCT00091819|584733640|FG000|Overall Study|Never received study treatment|3|||
161913847|NCT00091819|584733641|FG001|Overall Study|Never received study treatment|4|||
161913848|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
161913849|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
161913850|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
161913851|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
161913852|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
161913853|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
161913854|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
161913855|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
161913856|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
161913857|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
161913858|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Death|3|||
161913859|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Death|1|||
161913860|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
161913861|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
161913862|NCT01056276|584733642|FG000|Maintenance Therapy|Toxicity|0|||
161913863|NCT01056276|584733643|FG001|Maintenance Therapy|Toxicity|2|||
161913864|NCT01056276|584733642|FG000|Maintenance Therapy|Progressive Disease|0|||
161913865|NCT01056276|584733643|FG001|Maintenance Therapy|Progressive Disease|9|||
161913866|NCT01056276|584733642|FG000|Maintenance Therapy|Physician Decision|0|||
161913867|NCT01056276|584733643|FG001|Maintenance Therapy|Physician Decision|1|||
161913868|NCT01056276|584733642|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
161913869|NCT01056276|584733643|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
161913870|NCT01056276|584733642|FG000|Maintenance Therapy|Intercurrent Illness|0|||
161913871|NCT01056276|584733643|FG001|Maintenance Therapy|Intercurrent Illness|1|||
161913872|NCT01056276|584733642|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
161913873|NCT01056276|584733643|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
161913874|NCT01859741|584733644|FG000|Overall Study|Death|3|||
161913875|NCT01859741|584733645|FG001|Overall Study|Death|2|||
161913876|NCT01859741|584733646|FG002|Overall Study|Death|4|||
161913877|NCT01859741|584733647|FG003|Overall Study|Death|3|||
161913878|NCT01859741|584733648|FG004|Overall Study|Death|5|||
161913879|NCT01859741|584733649|FG005|Overall Study|Death|4|||
161913880|NCT01859741|584733650|FG006|Overall Study|Death|51|||
161913881|NCT01859741|584733651|FG007|Overall Study|Death|51|||
161913882|NCT01859741|584733644|FG000|Overall Study|Lost to Follow-up|0|||
161913883|NCT01859741|584733645|FG001|Overall Study|Lost to Follow-up|0|||
161913884|NCT01859741|584733646|FG002|Overall Study|Lost to Follow-up|0|||
161913885|NCT01859741|584733647|FG003|Overall Study|Lost to Follow-up|0|||
161913886|NCT01859741|584733648|FG004|Overall Study|Lost to Follow-up|0|||
161913887|NCT01859741|584733649|FG005|Overall Study|Lost to Follow-up|1|||
161913888|NCT01859741|584733650|FG006|Overall Study|Lost to Follow-up|0|||
161913889|NCT01859741|584733651|FG007|Overall Study|Lost to Follow-up|4|||
161913890|NCT01859741|584733644|FG000|Overall Study|Withdrawal by Subject|0|||
161913891|NCT01859741|584733645|FG001|Overall Study|Withdrawal by Subject|1|||
161913892|NCT01859741|584733646|FG002|Overall Study|Withdrawal by Subject|2|||
161913893|NCT01859741|584733647|FG003|Overall Study|Withdrawal by Subject|0|||
161913894|NCT01859741|584733648|FG004|Overall Study|Withdrawal by Subject|0|||
161913895|NCT01859741|584733649|FG005|Overall Study|Withdrawal by Subject|1|||
161913896|NCT01859741|584733650|FG006|Overall Study|Withdrawal by Subject|1|||
161913897|NCT01859741|584733651|FG007|Overall Study|Withdrawal by Subject|1|||
161913898|NCT01859741|584733644|FG000|Overall Study|Study Terminated by Sponsor|0|||
161913899|NCT01859741|584733645|FG001|Overall Study|Study Terminated by Sponsor|0|||
161913900|NCT01859741|584733646|FG002|Overall Study|Study Terminated by Sponsor|0|||
161913901|NCT01859741|584733647|FG003|Overall Study|Study Terminated by Sponsor|0|||
161913902|NCT01859741|584733648|FG004|Overall Study|Study Terminated by Sponsor|1|||
161913903|NCT01859741|584733649|FG005|Overall Study|Study Terminated by Sponsor|0|||
161913904|NCT01859741|584733650|FG006|Overall Study|Study Terminated by Sponsor|16|||
161913905|NCT01859741|584733651|FG007|Overall Study|Study Terminated by Sponsor|14|||
161913906|NCT01859741|584733644|FG000|Overall Study|Other|0|||
161913907|NCT01859741|584733645|FG001|Overall Study|Other|0|||
161913908|NCT01859741|584733646|FG002|Overall Study|Other|0|||
161913909|NCT01859741|584733647|FG003|Overall Study|Other|0|||
161913910|NCT01859741|584733648|FG004|Overall Study|Other|0|||
161913911|NCT01859741|584733649|FG005|Overall Study|Other|0|||
161913912|NCT01859741|584733650|FG006|Overall Study|Other|2|||
161913913|NCT01859741|584733651|FG007|Overall Study|Other|0|||
161460083|NCT04850313|583080059|FG000|Overall Study|Withdrawal by Subject|0|||
161460084|NCT04850313|583080060|FG001|Overall Study|Withdrawal by Subject|1|||
161460085|NCT04393298|583080067|FG000|Overall Study|Adverse Event|0|||
161460086|NCT04393298|583080068|FG001|Overall Study|Adverse Event|0|||
161460087|NCT04393298|583080069|FG002|Overall Study|Adverse Event|0|||
161460088|NCT04393298|583080070|FG003|Overall Study|Adverse Event|0|||
161460089|NCT04393298|583080071|FG004|Overall Study|Adverse Event|1|||
161460090|NCT04393298|583080072|FG005|Overall Study|Adverse Event|0|||
161460091|NCT04393298|583080073|FG006|Overall Study|Adverse Event|0|||
161460092|NCT04393298|583080074|FG007|Overall Study|Adverse Event|0|||
161460093|NCT04393298|583080075|FG008|Overall Study|Adverse Event|2|||
161460094|NCT04393298|583080076|FG009|Overall Study|Adverse Event|0|||
161460095|NCT04393298|583080077|FG010|Overall Study|Adverse Event|0|||
161460096|NCT04393298|583080078|FG011|Overall Study|Adverse Event|0|||
161460097|NCT04393298|583080079|FG012|Overall Study|Adverse Event|1|||
161460098|NCT04393298|583080080|FG013|Overall Study|Adverse Event|1|||
161460099|NCT04393298|583080081|FG014|Overall Study|Adverse Event|0|||
161460100|NCT04393298|583080067|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460101|NCT04393298|583080068|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460102|NCT04393298|583080069|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
161460103|NCT04393298|583080070|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460104|NCT04393298|583080071|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460105|NCT04393298|583080072|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460106|NCT04393298|583080073|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460107|NCT04393298|583080074|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460108|NCT04393298|583080075|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460109|NCT04393298|583080076|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460110|NCT04393298|583080077|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460111|NCT04393298|583080078|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460112|NCT04393298|583080079|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460113|NCT04393298|583080080|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161460114|NCT04393298|583080081|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
161460115|NCT04393298|583080067|FG000|Overall Study|Lack of Efficacy|0|||
161460116|NCT04393298|583080068|FG001|Overall Study|Lack of Efficacy|0|||
161460117|NCT04393298|583080069|FG002|Overall Study|Lack of Efficacy|0|||
161460118|NCT04393298|583080070|FG003|Overall Study|Lack of Efficacy|0|||
161460119|NCT04393298|583080071|FG004|Overall Study|Lack of Efficacy|0|||
161460120|NCT04393298|583080072|FG005|Overall Study|Lack of Efficacy|0|||
161460121|NCT04393298|583080073|FG006|Overall Study|Lack of Efficacy|0|||
161460122|NCT04393298|583080074|FG007|Overall Study|Lack of Efficacy|0|||
161460123|NCT04393298|583080075|FG008|Overall Study|Lack of Efficacy|0|||
161460124|NCT04393298|583080076|FG009|Overall Study|Lack of Efficacy|0|||
161460125|NCT04393298|583080077|FG010|Overall Study|Lack of Efficacy|0|||
161460126|NCT04393298|583080078|FG011|Overall Study|Lack of Efficacy|0|||
161460127|NCT04393298|583080079|FG012|Overall Study|Lack of Efficacy|0|||
161460128|NCT04393298|583080080|FG013|Overall Study|Lack of Efficacy|0|||
161460129|NCT04393298|583080081|FG014|Overall Study|Lack of Efficacy|1|||
161460130|NCT04393298|583080067|FG000|Overall Study|Progression|1|||
161460131|NCT04393298|583080068|FG001|Overall Study|Progression|0|||
161460132|NCT04393298|583080069|FG002|Overall Study|Progression|0|||
161460133|NCT04393298|583080070|FG003|Overall Study|Progression|0|||
161460134|NCT04393298|583080071|FG004|Overall Study|Progression|0|||
161460135|NCT04393298|583080072|FG005|Overall Study|Progression|0|||
161460136|NCT04393298|583080073|FG006|Overall Study|Progression|0|||
161460137|NCT04393298|583080074|FG007|Overall Study|Progression|0|||
161460138|NCT04393298|583080075|FG008|Overall Study|Progression|0|||
161460139|NCT04393298|583080076|FG009|Overall Study|Progression|0|||
161460140|NCT04393298|583080077|FG010|Overall Study|Progression|1|||
161460141|NCT04393298|583080078|FG011|Overall Study|Progression|1|||
161460142|NCT04393298|583080079|FG012|Overall Study|Progression|0|||
161460143|NCT04393298|583080080|FG013|Overall Study|Progression|0|||
161460144|NCT04393298|583080081|FG014|Overall Study|Progression|0|||
161460145|NCT04393298|583080067|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
161913914|NCT02606253|584733652|FG000|Overall Study|Adverse Event|2|||
161913915|NCT02606253|584733653|FG001|Overall Study|Adverse Event|0|||
161571807|NCT01304147|583477773|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
161571808|NCT05233085|583477774|FG000|Overall Study|Adverse Event|1|||
161571809|NCT05233085|583477775|FG001|Overall Study|Adverse Event|0|||
161571810|NCT05233085|583477776|FG002|Overall Study|Adverse Event|0|||
161571811|NCT05233085|583477777|FG003|Overall Study|Adverse Event|0|||
161571812|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161571813|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
161571814|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
161571815|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161571816|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161571817|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161571818|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161571819|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161571820|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161571821|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161571822|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
161571823|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
161571824|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161571825|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161571826|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161571827|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161571828|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161571829|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161571830|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
161571831|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
161571832|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
161571833|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161571834|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161571835|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161571836|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161571837|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161571838|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161571839|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
161571840|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571841|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
161571842|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571843|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571844|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571845|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571846|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571847|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161571848|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161571849|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161571850|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
161571851|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161571852|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161571853|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161571854|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161571855|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161571856|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161571857|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161571858|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161571859|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161571860|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161571861|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161571862|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161571863|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161809820|NCT02305758|584345838|FG000|Overall Study|Study Terminated by Sponsor|21|||
161809821|NCT02305758|584345839|FG001|Overall Study|Study Terminated by Sponsor|34|||
161809822|NCT02305758|584345838|FG000|Overall Study|Other, not specified|2|||
161809823|NCT02305758|584345839|FG001|Overall Study|Other, not specified|1|||
161809824|NCT02032888|584345841|FG000|Treatment Period|Poor compliance/noncompliance|1|||
161571864|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161571865|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161809825|NCT02032888|584345842|FG001|Treatment Period|Poor compliance/noncompliance|1|||
161809826|NCT02032888|584345843|FG002|Treatment Period|Poor compliance/noncompliance|0|||
161571866|NCT01212757|583477778|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
161571867|NCT01212757|583477779|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
161571868|NCT01212757|583477780|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161571869|NCT01212757|583477781|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161571870|NCT01212757|583477782|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161571871|NCT01212757|583477783|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161571872|NCT01212757|583477784|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161460146|NCT04393298|583080068|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460147|NCT04393298|583080069|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460148|NCT04393298|583080070|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460149|NCT04393298|583080071|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460150|NCT04393298|583080072|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460151|NCT04393298|583080073|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460152|NCT04393298|583080074|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460153|NCT04393298|583080075|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460154|NCT04393298|583080076|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460155|NCT04393298|583080077|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460156|NCT04393298|583080078|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460157|NCT04393298|583080079|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460158|NCT04393298|583080080|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460159|NCT04393298|583080081|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
161460160|NCT04393298|583080067|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460161|NCT04393298|583080068|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
161460162|NCT04393298|583080069|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460163|NCT04393298|583080070|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460164|NCT04393298|583080071|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460165|NCT04393298|583080072|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460166|NCT04393298|583080073|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460167|NCT04393298|583080074|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460168|NCT04393298|583080075|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460169|NCT04393298|583080076|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460170|NCT04393298|583080077|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460171|NCT04393298|583080078|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460172|NCT04393298|583080079|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460173|NCT04393298|583080080|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460174|NCT04393298|583080081|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
161460175|NCT04393298|583080067|FG000|Overall Study|Clinical Progression|0|||
161460176|NCT04393298|583080068|FG001|Overall Study|Clinical Progression|2|||
161460177|NCT04393298|583080069|FG002|Overall Study|Clinical Progression|0|||
161460178|NCT04393298|583080070|FG003|Overall Study|Clinical Progression|0|||
161460179|NCT04393298|583080071|FG004|Overall Study|Clinical Progression|0|||
161460180|NCT04393298|583080072|FG005|Overall Study|Clinical Progression|0|||
161460181|NCT04393298|583080073|FG006|Overall Study|Clinical Progression|0|||
161460182|NCT04393298|583080074|FG007|Overall Study|Clinical Progression|0|||
161460183|NCT04393298|583080075|FG008|Overall Study|Clinical Progression|0|||
161460184|NCT04393298|583080076|FG009|Overall Study|Clinical Progression|0|||
161809827|NCT02032888|584345841|FG000|Treatment Period|Other|1|||
161460185|NCT04393298|583080077|FG010|Overall Study|Clinical Progression|0|||
161460186|NCT04393298|583080078|FG011|Overall Study|Clinical Progression|0|||
161460187|NCT04393298|583080079|FG012|Overall Study|Clinical Progression|0|||
161809828|NCT02032888|584345842|FG001|Treatment Period|Other|1|||
161809829|NCT02032888|584345843|FG002|Treatment Period|Other|0|||
161809830|NCT02032888|584345841|FG000|Follow-up Period|Lost to Follow-up|1|||
161809831|NCT02032888|584345842|FG001|Follow-up Period|Lost to Follow-up|1|||
161809832|NCT02032888|584345843|FG002|Follow-up Period|Lost to Follow-up|0|||
161809833|NCT02032888|584345841|FG000|Follow-up Period|Death|1|||
161809834|NCT02032888|584345842|FG001|Follow-up Period|Death|1|||
161809835|NCT02032888|584345843|FG002|Follow-up Period|Death|0|||
161809836|NCT02032888|584345841|FG000|Follow-up Period|Other|1|||
161809837|NCT02032888|584345842|FG001|Follow-up Period|Other|0|||
161809838|NCT02032888|584345843|FG002|Follow-up Period|Other|0|||
161809839|NCT02272777|584345844|FG000|Overall Study|Adverse Event|0|||
161809840|NCT02272777|584345845|FG001|Overall Study|Adverse Event|1|||
161809841|NCT02272777|584345844|FG000|Overall Study|Withdrawal by Subject|0|||
161809842|NCT02272777|584345845|FG001|Overall Study|Withdrawal by Subject|3|||
161809843|NCT02272777|584345844|FG000|Overall Study|Lost to Follow-up|2|||
161809844|NCT02272777|584345845|FG001|Overall Study|Lost to Follow-up|0|||
161809845|NCT02272777|584345844|FG000|Overall Study|Other|2|||
161809846|NCT02272777|584345845|FG001|Overall Study|Other|0|||
161809847|NCT00837486|584345846|FG000|Blinded-treatment Phase|Physician Decision|1|||
161809848|NCT00837486|584345847|FG001|Blinded-treatment Phase|Physician Decision|0|||
161809849|NCT00837486|584345846|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
161809850|NCT00837486|584345847|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
161809851|NCT00837486|584345846|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
161809852|NCT00837486|584345847|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
161809853|NCT00837486|584345846|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
161809854|NCT00837486|584345847|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
161809855|NCT03071575|584347660|FG000|Overall Study|Death|0|||
161460188|NCT04393298|583080080|FG013|Overall Study|Clinical Progression|0|||
161460189|NCT04393298|583080081|FG014|Overall Study|Clinical Progression|0|||
161460190|NCT04393298|583080067|FG000|Overall Study|Disease Progression|0|||
161460191|NCT04393298|583080068|FG001|Overall Study|Disease Progression|1|||
161460192|NCT04393298|583080069|FG002|Overall Study|Disease Progression|0|||
161460193|NCT04393298|583080070|FG003|Overall Study|Disease Progression|0|||
161809856|NCT03071575|584347661|FG001|Overall Study|Death|1|||
161809857|NCT03071575|584347660|FG000|Overall Study|Lost to Follow-up|5|||
161809858|NCT03071575|584347661|FG001|Overall Study|Lost to Follow-up|11|||
161809859|NCT03071575|584347660|FG000|Overall Study|Withdrawal by Subject|4|||
161809860|NCT03071575|584347661|FG001|Overall Study|Withdrawal by Subject|2|||
161809861|NCT02267187|584347671|FG000|Overall Study|Physician Decision|2|||
161809862|NCT02267187|584347671|FG000|Overall Study|Screen fail|3|||
161809863|NCT00712959|584347676|FG000|Overall Study|Protocol Violation|3|||
161809864|NCT00712959|584347677|FG001|Overall Study|Protocol Violation|1|||
161809865|NCT00712959|584347676|FG000|Overall Study|Lost to Follow-up|13|||
161809866|NCT00712959|584347677|FG001|Overall Study|Lost to Follow-up|2|||
161809867|NCT00712959|584347676|FG000|Overall Study|Withdrawal by Subject|3|||
161809868|NCT00712959|584347677|FG001|Overall Study|Withdrawal by Subject|0|||
161809869|NCT00834067|584347678|FG000|Washout of 21 Days|Protocol Violation|0|||
161809870|NCT00834067|584347679|FG001|Washout of 21 Days|Protocol Violation|1|||
161809871|NCT01796171|584347680|FG000|Enrolled|Death|0|||
161809872|NCT01796171|584347681|FG001|Enrolled|Death|0|||
161809873|NCT01796171|584347682|FG002|Enrolled|Death|0|||
161809874|NCT01796171|584347683|FG003|Enrolled|Death|0|||
161809875|NCT01796171|584347684|FG004|Enrolled|Death|0|||
161809876|NCT01796171|584347685|FG005|Enrolled|Death|0|||
161809877|NCT01796171|584347686|FG006|Enrolled|Death|0|||
161809878|NCT01796171|584347687|FG007|Enrolled|Death|0|||
161809879|NCT01796171|584347688|FG008|Enrolled|Death|0|||
161809880|NCT01796171|584347689|FG009|Enrolled|Death|0|||
161809881|NCT01796171|584347690|FG010|Enrolled|Death|0|||
161809882|NCT01796171|584347691|FG011|Enrolled|Death|0|||
161809883|NCT01796171|584347692|FG012|Enrolled|Death|0|||
161809884|NCT01796171|584347693|FG013|Enrolled|Death|0|||
161809885|NCT01796171|584347694|FG014|Enrolled|Death|1|||
161809886|NCT01796171|584347680|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
161809887|NCT01796171|584347681|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
161809888|NCT01796171|584347682|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
161809889|NCT01796171|584347683|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
161809890|NCT01796171|584347684|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
161809891|NCT01796171|584347685|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
161809892|NCT01796171|584347686|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
161809893|NCT01796171|584347687|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
161809894|NCT01796171|584347688|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
161809895|NCT01796171|584347689|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
161809896|NCT01796171|584347690|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
161809897|NCT01796171|584347691|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
161809898|NCT01796171|584347692|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
161809899|NCT01796171|584347693|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
161809900|NCT01796171|584347694|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
161809901|NCT01796171|584347680|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809902|NCT01796171|584347681|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809903|NCT01796171|584347682|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809904|NCT01796171|584347683|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809905|NCT01796171|584347684|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161460194|NCT04393298|583080071|FG004|Overall Study|Disease Progression|0|||
161460195|NCT04393298|583080072|FG005|Overall Study|Disease Progression|3|||
161460196|NCT04393298|583080073|FG006|Overall Study|Disease Progression|2|||
161460197|NCT04393298|583080074|FG007|Overall Study|Disease Progression|1|||
161460198|NCT04393298|583080075|FG008|Overall Study|Disease Progression|2|||
161460199|NCT04393298|583080076|FG009|Overall Study|Disease Progression|1|||
161460200|NCT04393298|583080077|FG010|Overall Study|Disease Progression|0|||
161460201|NCT04393298|583080078|FG011|Overall Study|Disease Progression|3|||
161460202|NCT04393298|583080079|FG012|Overall Study|Disease Progression|0|||
161460203|NCT04393298|583080080|FG013|Overall Study|Disease Progression|0|||
161460204|NCT04393298|583080081|FG014|Overall Study|Disease Progression|1|||
161460205|NCT04393298|583080067|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460206|NCT04393298|583080068|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460207|NCT04393298|583080069|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
161460208|NCT04393298|583080070|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460209|NCT04393298|583080071|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460210|NCT04393298|583080072|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161809906|NCT01796171|584347685|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809907|NCT01796171|584347686|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809908|NCT01796171|584347687|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809909|NCT01796171|584347688|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809910|NCT01796171|584347689|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161571873|NCT01212757|583477785|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161571874|NCT01212757|583477786|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161571875|NCT01212757|583477778|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161571876|NCT01212757|583477779|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
161571877|NCT01212757|583477780|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
161571878|NCT01212757|583477781|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
161571879|NCT01212757|583477782|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161571880|NCT01212757|583477783|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
161571881|NCT01212757|583477784|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161571882|NCT01212757|583477785|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161571883|NCT01212757|583477786|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161571884|NCT01212757|583477778|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
161571885|NCT01212757|583477779|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
161571886|NCT01212757|583477780|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
161571887|NCT01212757|583477781|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
161571888|NCT01212757|583477782|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
161571889|NCT01212757|583477783|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
161571890|NCT01212757|583477784|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
161571891|NCT01212757|583477785|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
161571892|NCT01212757|583477786|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
161571893|NCT01212757|583477778|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571894|NCT01212757|583477779|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571895|NCT01212757|583477780|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
161571896|NCT01212757|583477781|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571897|NCT01212757|583477782|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571898|NCT01212757|583477783|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571899|NCT01212757|583477784|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571900|NCT01212757|583477785|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571901|NCT01212757|583477786|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161571902|NCT01212757|583477778|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161571903|NCT01212757|583477779|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
161571904|NCT01212757|583477780|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
161571905|NCT01212757|583477781|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
161571906|NCT01212757|583477782|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
161571907|NCT01212757|583477783|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
161571908|NCT01212757|583477784|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161571909|NCT01212757|583477785|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161571910|NCT01212757|583477786|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161571911|NCT01212757|583477778|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571912|NCT01212757|583477779|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
161571913|NCT01212757|583477780|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571914|NCT01212757|583477781|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571915|NCT01212757|583477782|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
161571916|NCT01212757|583477783|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571917|NCT01212757|583477784|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571918|NCT01212757|583477785|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571919|NCT01212757|583477786|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161571920|NCT01212757|583477778|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161571921|NCT01212757|583477779|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
161571922|NCT01212757|583477780|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
161571923|NCT01212757|583477781|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161913916|NCT02606253|584733654|FG002|Overall Study|Adverse Event|0|||
161913917|NCT02606253|584733652|FG000|Overall Study|Protocol Violation|2|||
161913918|NCT02606253|584733653|FG001|Overall Study|Protocol Violation|1|||
161913919|NCT02606253|584733654|FG002|Overall Study|Protocol Violation|0|||
161913920|NCT02606253|584733652|FG000|Overall Study|Physician Decision|1|||
161913921|NCT02606253|584733653|FG001|Overall Study|Physician Decision|1|||
161913922|NCT02606253|584733654|FG002|Overall Study|Physician Decision|0|||
161913923|NCT00701363|584733655|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
161913924|NCT00701363|584733656|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161913925|NCT00701363|584733657|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161913926|NCT00701363|584733658|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161913927|NCT00701363|584733655|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
161571924|NCT01212757|583477782|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161571925|NCT01212757|583477783|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161571926|NCT01212757|583477784|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161460211|NCT04393298|583080073|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161571927|NCT01212757|583477785|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161571928|NCT01212757|583477786|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
161571929|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571930|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571931|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571932|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571933|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571934|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571935|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571936|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
161571937|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
161571938|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
161913928|NCT00701363|584733656|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
161913929|NCT00701363|584733657|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
161913930|NCT00701363|584733658|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
161913931|NCT00701363|584733655|FG000|Treatment Phase 1|Adverse Event|7|||
161913932|NCT00701363|584733656|FG001|Treatment Phase 1|Adverse Event|0|||
161913933|NCT00701363|584733657|FG002|Treatment Phase 1|Adverse Event|0|||
161913934|NCT00701363|584733658|FG003|Treatment Phase 1|Adverse Event|0|||
161913935|NCT00701363|584733655|FG000|Treatment Phase 1|Protocol Violation|1|||
161913936|NCT00701363|584733656|FG001|Treatment Phase 1|Protocol Violation|0|||
161913937|NCT00701363|584733657|FG002|Treatment Phase 1|Protocol Violation|0|||
161913938|NCT00701363|584733658|FG003|Treatment Phase 1|Protocol Violation|0|||
161913939|NCT00701363|584733655|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
161913940|NCT00701363|584733656|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
161913941|NCT00701363|584733657|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
161913942|NCT00701363|584733658|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
161913943|NCT00701363|584733655|FG000|Treatment Phase 1|Lack of Efficacy|1|||
161913944|NCT00701363|584733656|FG001|Treatment Phase 1|Lack of Efficacy|0|||
161913945|NCT00701363|584733657|FG002|Treatment Phase 1|Lack of Efficacy|0|||
161913946|NCT00701363|584733658|FG003|Treatment Phase 1|Lack of Efficacy|0|||
161913947|NCT00701363|584733655|FG000|Treatment Phase 2|Adverse Event|0|||
161913948|NCT00701363|584733656|FG001|Treatment Phase 2|Adverse Event|0|||
161913949|NCT00701363|584733657|FG002|Treatment Phase 2|Adverse Event|1|||
161913950|NCT00701363|584733658|FG003|Treatment Phase 2|Adverse Event|0|||
161913951|NCT00701363|584733655|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
161913952|NCT00701363|584733656|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
161913953|NCT00701363|584733657|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
161913954|NCT00701363|584733658|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
161913955|NCT03426878|584733659|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
161913956|NCT03426878|584733659|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
161913957|NCT03426878|584733659|FG000|Overall Study|Declined to receive results|3|||
161913958|NCT03426878|584733659|FG000|Overall Study|Received negative results by mailed letter|65|||
161913959|NCT03426878|584733659|FG000|Overall Study|Lost to Follow-up|177|||
161913960|NCT00746551|584733666|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
161913961|NCT00746551|584733667|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
161913962|NCT00746551|584733666|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
161913963|NCT00746551|584733667|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
161913964|NCT00746551|584733666|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
161913965|NCT00746551|584733667|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
161913966|NCT00262925|584733670|FG000|Overall Study|Lack of Efficacy|3|||
161913967|NCT00262925|584733670|FG000|Overall Study|Adverse Event|4|||
161913968|NCT00262925|584733670|FG000|Overall Study|Death|2|||
161913969|NCT00262925|584733670|FG000|Overall Study|alternative therapy|1|||
161913970|NCT00262925|584733670|FG000|Overall Study|Other|1|||
161913971|NCT04682301|584733672|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
161913972|NCT04682301|584733672|FG000|Overall Study|Death|2|||
161913973|NCT00560404|584733673|FG000|Overall Study|Adverse Event|2|||
161913974|NCT00560404|584733674|FG001|Overall Study|Adverse Event|3|||
161913975|NCT00560404|584733673|FG000|Overall Study|Death|3|||
161913976|NCT00560404|584733674|FG001|Overall Study|Death|3|||
161913977|NCT00560404|584733673|FG000|Overall Study|Protocol Violation|12|||
161913978|NCT00560404|584733674|FG001|Overall Study|Protocol Violation|7|||
161460212|NCT04393298|583080074|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460213|NCT04393298|583080075|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460214|NCT04393298|583080076|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460215|NCT04393298|583080077|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460216|NCT04393298|583080078|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460217|NCT04393298|583080079|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161571939|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
161571940|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
161571941|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
161571942|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
161571943|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
161571944|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
161571945|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
161571946|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
161571947|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
161809911|NCT01796171|584347690|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809912|NCT01796171|584347691|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809913|NCT01796171|584347692|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809914|NCT01796171|584347693|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
161809915|NCT01796171|584347694|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809916|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Progressive disease|0|||
161809917|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Progressive disease|1|||
161809918|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Progressive disease|0|||
161809919|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Progressive disease|0|||
161809920|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Progressive disease|0|||
161809921|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Progressive disease|0|||
161809922|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Progressive disease|0|||
161809923|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Progressive disease|0|||
161809924|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Progressive disease|0|||
161809925|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Progressive disease|0|||
161809926|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Progressive disease|0|||
161809927|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Progressive disease|0|||
161809928|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Progressive disease|0|||
161809929|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Progressive disease|0|||
161809930|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Progressive disease|0|||
161809931|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809932|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809933|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809934|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809935|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161460218|NCT04393298|583080080|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161809936|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809937|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809938|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809939|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161809940|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809941|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161460219|NCT04393298|583080081|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161460220|NCT04393298|583080067|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460221|NCT04393298|583080068|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460222|NCT04393298|583080069|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
161460223|NCT04393298|583080070|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460224|NCT04393298|583080071|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460225|NCT04393298|583080072|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460226|NCT04393298|583080073|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460227|NCT04393298|583080074|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460228|NCT04393298|583080075|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460229|NCT04393298|583080076|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460230|NCT04393298|583080077|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460231|NCT04393298|583080078|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460232|NCT04393298|583080079|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460233|NCT04393298|583080080|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460234|NCT04393298|583080081|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
161460235|NCT04393298|583080067|FG000|Overall Study|Progressive Disease (PD)|0|||
161460236|NCT04393298|583080068|FG001|Overall Study|Progressive Disease (PD)|0|||
161460237|NCT04393298|583080069|FG002|Overall Study|Progressive Disease (PD)|0|||
161460238|NCT04393298|583080070|FG003|Overall Study|Progressive Disease (PD)|3|||
161460239|NCT04393298|583080071|FG004|Overall Study|Progressive Disease (PD)|0|||
161460240|NCT04393298|583080072|FG005|Overall Study|Progressive Disease (PD)|0|||
161460241|NCT04393298|583080073|FG006|Overall Study|Progressive Disease (PD)|0|||
161460242|NCT04393298|583080074|FG007|Overall Study|Progressive Disease (PD)|0|||
161571948|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
161571949|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
161571950|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
161571951|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
161571952|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
161571953|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
161571954|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
161571955|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
161571956|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161571957|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
161571958|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
161571959|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161571960|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161571961|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161571962|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161571963|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
161571964|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
161571965|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571966|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571967|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
161571968|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571969|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571970|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571971|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571972|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571973|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
161571974|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
161571975|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
161571976|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
161571977|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
161571978|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
161571979|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
161571980|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
161571981|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
161571982|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
161571983|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
161571984|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
161571985|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
161571986|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
161571987|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
161571988|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
161571989|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
161571990|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
161571991|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
161571992|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161571993|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161571994|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
161571995|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161571996|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161571997|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161571998|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161571999|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161572000|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
161572001|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161572002|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
161572003|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
161572004|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161572005|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161572006|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161572007|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161572008|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
161572009|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
161572010|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572011|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572012|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572013|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572014|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161460243|NCT04393298|583080075|FG008|Overall Study|Progressive Disease (PD)|0|||
161460244|NCT04393298|583080076|FG009|Overall Study|Progressive Disease (PD)|0|||
161460245|NCT04393298|583080077|FG010|Overall Study|Progressive Disease (PD)|0|||
161460246|NCT04393298|583080078|FG011|Overall Study|Progressive Disease (PD)|0|||
161460247|NCT04393298|583080079|FG012|Overall Study|Progressive Disease (PD)|0|||
161460248|NCT04393298|583080080|FG013|Overall Study|Progressive Disease (PD)|0|||
161460249|NCT04393298|583080081|FG014|Overall Study|Progressive Disease (PD)|0|||
161460250|NCT04393298|583080067|FG000|Overall Study|Started a New Cancer Treatment|0|||
161460251|NCT04393298|583080068|FG001|Overall Study|Started a New Cancer Treatment|0|||
161460252|NCT04393298|583080069|FG002|Overall Study|Started a New Cancer Treatment|0|||
161460253|NCT04393298|583080070|FG003|Overall Study|Started a New Cancer Treatment|0|||
161460254|NCT04393298|583080071|FG004|Overall Study|Started a New Cancer Treatment|1|||
161460255|NCT04393298|583080072|FG005|Overall Study|Started a New Cancer Treatment|0|||
161460256|NCT04393298|583080073|FG006|Overall Study|Started a New Cancer Treatment|0|||
161460257|NCT04393298|583080074|FG007|Overall Study|Started a New Cancer Treatment|0|||
161460258|NCT04393298|583080075|FG008|Overall Study|Started a New Cancer Treatment|0|||
161460259|NCT04393298|583080076|FG009|Overall Study|Started a New Cancer Treatment|0|||
161460260|NCT04393298|583080077|FG010|Overall Study|Started a New Cancer Treatment|0|||
161460261|NCT04393298|583080078|FG011|Overall Study|Started a New Cancer Treatment|0|||
161460262|NCT04393298|583080079|FG012|Overall Study|Started a New Cancer Treatment|0|||
161460263|NCT04393298|583080080|FG013|Overall Study|Started a New Cancer Treatment|0|||
161460264|NCT04393298|583080081|FG014|Overall Study|Started a New Cancer Treatment|0|||
161460265|NCT04393298|583080067|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460266|NCT04393298|583080068|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460267|NCT04393298|583080069|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460268|NCT04393298|583080070|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460269|NCT04393298|583080071|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
161460270|NCT04393298|583080072|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460271|NCT04393298|583080073|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460272|NCT04393298|583080074|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460273|NCT04393298|583080075|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460274|NCT04393298|583080076|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460275|NCT04393298|583080077|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460276|NCT04393298|583080078|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460277|NCT04393298|583080079|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460278|NCT04393298|583080080|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460279|NCT04393298|583080081|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
161460280|NCT04393298|583080067|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460281|NCT04393298|583080068|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460282|NCT04393298|583080069|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460283|NCT04393298|583080070|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460284|NCT04393298|583080071|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460285|NCT04393298|583080072|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
161460286|NCT04393298|583080073|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460287|NCT04393298|583080074|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460288|NCT04393298|583080075|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460289|NCT04393298|583080076|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460290|NCT04393298|583080077|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460291|NCT04393298|583080078|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460292|NCT04393298|583080079|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460293|NCT04393298|583080080|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460294|NCT04393298|583080081|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161460295|NCT04393298|583080067|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460296|NCT04393298|583080068|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460297|NCT04393298|583080069|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460298|NCT04393298|583080070|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460299|NCT04393298|583080071|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460300|NCT04393298|583080072|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
161460301|NCT04393298|583080073|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161572015|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572016|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572017|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
161572018|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
161572019|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161913979|NCT00560404|584733673|FG000|Overall Study|Administrative Reasons|1|||
161460302|NCT04393298|583080074|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460303|NCT04393298|583080075|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460304|NCT04393298|583080076|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460305|NCT04393298|583080077|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460306|NCT04393298|583080078|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460307|NCT04393298|583080079|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460308|NCT04393298|583080080|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
161460309|NCT04393298|583080081|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
161460310|NCT04393298|583080067|FG000|Overall Study|Death|0|||
161460311|NCT04393298|583080068|FG001|Overall Study|Death|0|||
161460312|NCT04393298|583080069|FG002|Overall Study|Death|0|||
161460313|NCT04393298|583080070|FG003|Overall Study|Death|0|||
161460314|NCT04393298|583080071|FG004|Overall Study|Death|0|||
161460315|NCT04393298|583080072|FG005|Overall Study|Death|1|||
161460316|NCT04393298|583080073|FG006|Overall Study|Death|1|||
161460317|NCT04393298|583080074|FG007|Overall Study|Death|0|||
161460318|NCT04393298|583080075|FG008|Overall Study|Death|1|||
161460319|NCT04393298|583080076|FG009|Overall Study|Death|1|||
161460320|NCT04393298|583080077|FG010|Overall Study|Death|0|||
161460321|NCT04393298|583080078|FG011|Overall Study|Death|1|||
161460322|NCT04393298|583080079|FG012|Overall Study|Death|1|||
161460323|NCT04393298|583080080|FG013|Overall Study|Death|0|||
161460324|NCT04393298|583080081|FG014|Overall Study|Death|1|||
161460325|NCT04393298|583080067|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460326|NCT04393298|583080068|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460327|NCT04393298|583080069|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460328|NCT04393298|583080070|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460329|NCT04393298|583080071|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460330|NCT04393298|583080072|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
161460331|NCT04393298|583080073|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460332|NCT04393298|583080074|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460333|NCT04393298|583080075|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460334|NCT04393298|583080076|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460335|NCT04393298|583080077|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460336|NCT04393298|583080078|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460337|NCT04393298|583080079|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460338|NCT04393298|583080080|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460339|NCT04393298|583080081|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161460340|NCT04393298|583080067|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
161460341|NCT04393298|583080068|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
161460342|NCT04393298|583080069|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
161460343|NCT04393298|583080070|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
161460344|NCT04393298|583080071|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
161460345|NCT04393298|583080072|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
161460346|NCT04393298|583080073|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
161460347|NCT04393298|583080074|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
161460348|NCT04393298|583080075|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
161460349|NCT04393298|583080076|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
161460350|NCT04393298|583080077|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
161460351|NCT04393298|583080078|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
161460352|NCT04393298|583080079|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
161460353|NCT04393298|583080080|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
161460354|NCT04393298|583080081|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
161460355|NCT04393298|583080067|FG000|Overall Study|Patient Passed Away|0|||
161460356|NCT04393298|583080068|FG001|Overall Study|Patient Passed Away|0|||
161460357|NCT04393298|583080069|FG002|Overall Study|Patient Passed Away|0|||
161460358|NCT04393298|583080070|FG003|Overall Study|Patient Passed Away|0|||
161460359|NCT04393298|583080071|FG004|Overall Study|Patient Passed Away|0|||
161460360|NCT04393298|583080072|FG005|Overall Study|Patient Passed Away|0|||
161460361|NCT04393298|583080073|FG006|Overall Study|Patient Passed Away|0|||
161460362|NCT04393298|583080074|FG007|Overall Study|Patient Passed Away|1|||
161460363|NCT04393298|583080075|FG008|Overall Study|Patient Passed Away|0|||
161460364|NCT04393298|583080076|FG009|Overall Study|Patient Passed Away|0|||
161460365|NCT04393298|583080077|FG010|Overall Study|Patient Passed Away|0|||
161460366|NCT04393298|583080078|FG011|Overall Study|Patient Passed Away|0|||
161460367|NCT04393298|583080079|FG012|Overall Study|Patient Passed Away|0|||
161572020|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
161572021|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161460368|NCT04393298|583080080|FG013|Overall Study|Patient Passed Away|0|||
161460369|NCT04393298|583080081|FG014|Overall Study|Patient Passed Away|0|||
161460370|NCT04393298|583080067|FG000|Overall Study|Patient Deceased|0|||
161460371|NCT04393298|583080068|FG001|Overall Study|Patient Deceased|0|||
161460372|NCT04393298|583080069|FG002|Overall Study|Patient Deceased|0|||
161460373|NCT04393298|583080070|FG003|Overall Study|Patient Deceased|0|||
161460374|NCT04393298|583080071|FG004|Overall Study|Patient Deceased|0|||
161460375|NCT04393298|583080072|FG005|Overall Study|Patient Deceased|0|||
161460376|NCT04393298|583080073|FG006|Overall Study|Patient Deceased|0|||
161460377|NCT04393298|583080074|FG007|Overall Study|Patient Deceased|1|||
161460378|NCT04393298|583080075|FG008|Overall Study|Patient Deceased|0|||
161460379|NCT04393298|583080076|FG009|Overall Study|Patient Deceased|0|||
161460380|NCT04393298|583080077|FG010|Overall Study|Patient Deceased|0|||
161460381|NCT04393298|583080078|FG011|Overall Study|Patient Deceased|0|||
161460382|NCT04393298|583080079|FG012|Overall Study|Patient Deceased|0|||
161460383|NCT04393298|583080080|FG013|Overall Study|Patient Deceased|0|||
161460384|NCT04393298|583080081|FG014|Overall Study|Patient Deceased|0|||
161460385|NCT04393298|583080067|FG000|Overall Study|Patient Discharged to Hospice|0|||
161460386|NCT04393298|583080068|FG001|Overall Study|Patient Discharged to Hospice|0|||
161460387|NCT04393298|583080069|FG002|Overall Study|Patient Discharged to Hospice|0|||
161460388|NCT04393298|583080070|FG003|Overall Study|Patient Discharged to Hospice|0|||
161460389|NCT04393298|583080071|FG004|Overall Study|Patient Discharged to Hospice|0|||
161460390|NCT04393298|583080072|FG005|Overall Study|Patient Discharged to Hospice|0|||
161460391|NCT04393298|583080073|FG006|Overall Study|Patient Discharged to Hospice|0|||
161460392|NCT04393298|583080074|FG007|Overall Study|Patient Discharged to Hospice|0|||
161460393|NCT04393298|583080075|FG008|Overall Study|Patient Discharged to Hospice|1|||
161460394|NCT04393298|583080076|FG009|Overall Study|Patient Discharged to Hospice|0|||
161460395|NCT04393298|583080077|FG010|Overall Study|Patient Discharged to Hospice|0|||
161460396|NCT04393298|583080078|FG011|Overall Study|Patient Discharged to Hospice|0|||
161460397|NCT04393298|583080079|FG012|Overall Study|Patient Discharged to Hospice|0|||
161460398|NCT04393298|583080080|FG013|Overall Study|Patient Discharged to Hospice|0|||
161460399|NCT04393298|583080081|FG014|Overall Study|Patient Discharged to Hospice|0|||
161572022|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161572023|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161572024|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161572025|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161572026|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161572027|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161572028|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572029|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572030|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
161572031|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572032|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572033|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572034|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572035|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
161572036|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
161572037|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572038|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
161572039|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572040|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572041|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572042|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572043|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572044|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
161572045|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
161572046|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
161913980|NCT00560404|584733674|FG001|Overall Study|Administrative Reasons|1|||
161913981|NCT00560404|584733673|FG000|Overall Study|Withdrew Consent|4|||
161913982|NCT00560404|584733674|FG001|Overall Study|Withdrew Consent|0|||
161460400|NCT04393298|583080067|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460401|NCT04393298|583080068|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161572047|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
161460402|NCT04393298|583080069|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460403|NCT04393298|583080070|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460404|NCT04393298|583080071|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161572048|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
161572049|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
161572050|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
161913983|NCT00560404|584733673|FG000|Overall Study|Failure to return|1|||
161460405|NCT04393298|583080072|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460406|NCT04393298|583080073|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460407|NCT04393298|583080074|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460408|NCT04393298|583080075|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161572051|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
161572052|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
161913984|NCT00560404|584733674|FG001|Overall Study|Failure to return|2|||
161460409|NCT04393298|583080076|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
161460410|NCT04393298|583080077|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460411|NCT04393298|583080078|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460412|NCT04393298|583080079|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460413|NCT04393298|583080080|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460414|NCT04393298|583080081|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
161460415|NCT04393298|583080067|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
161460416|NCT04393298|583080068|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
161460417|NCT04393298|583080069|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
161460418|NCT04393298|583080070|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
161460419|NCT04393298|583080071|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
161460420|NCT04393298|583080072|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
161460421|NCT04393298|583080073|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
161460422|NCT04393298|583080074|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
161460423|NCT04393298|583080075|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
161460424|NCT04393298|583080076|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
161460425|NCT04393298|583080077|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
161460426|NCT04393298|583080078|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
161460427|NCT04393298|583080079|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
161460428|NCT04393298|583080080|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
161460429|NCT04393298|583080081|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
161460430|NCT04950608|583080089|FG000|Overall Study|Withdrawal by Subject|2|||
161460431|NCT04950608|583080089|FG000|Overall Study|Physician Decision|3|||
161460432|NCT01282203|583080093|FG000|Overall Study|Adverse Event|1|||
161460433|NCT03977454|583080094|FG000|Overall Study|immediate postoperative revision|2|||
161460434|NCT03977454|583080095|FG001|Overall Study|immediate postoperative revision|2|||
161460435|NCT04193410|583080098|FG000|Overall Study|Lost to Follow-up|7|||
161460436|NCT04193410|583080099|FG001|Overall Study|Lost to Follow-up|6|||
161460437|NCT01101191|583080104|FG000|Period 1|Withdrawal by Subject|1|||
161460438|NCT01101191|583080105|FG001|Period 1|Withdrawal by Subject|0|||
161460439|NCT01101191|583080104|FG000|Period 1|Adverse Event|1|||
161460440|NCT01101191|583080105|FG001|Period 1|Adverse Event|2|||
161460441|NCT01146860|583080106|FG000|Overall Study|Withdrawal by Subject|0|||
161460442|NCT01146860|583080107|FG001|Overall Study|Withdrawal by Subject|1|||
161460443|NCT04779216|583080108|FG000|Overall Study|Lost to Follow-up|1|||
161460444|NCT04779216|583080109|FG001|Overall Study|Lost to Follow-up|0|||
161460445|NCT04779216|583080108|FG000|Overall Study|Withdrawal by Subject|1|||
161460446|NCT04779216|583080109|FG001|Overall Study|Withdrawal by Subject|0|||
161460447|NCT02674854|583080114|FG000|Overall Study|Adverse Event|17|||
161460448|NCT02674854|583080115|FG001|Overall Study|Adverse Event|15|||
161460449|NCT02674854|583080116|FG002|Overall Study|Adverse Event|5|||
161460450|NCT02674854|583080114|FG000|Overall Study|Withdrawal by Subject|1|||
161460451|NCT02674854|583080115|FG001|Overall Study|Withdrawal by Subject|5|||
161460452|NCT02674854|583080116|FG002|Overall Study|Withdrawal by Subject|4|||
161460453|NCT02674854|583080114|FG000|Overall Study|No-compliant subject|1|||
161460454|NCT02674854|583080115|FG001|Overall Study|No-compliant subject|0|||
161460455|NCT02674854|583080116|FG002|Overall Study|No-compliant subject|1|||
161460456|NCT02674854|583080114|FG000|Overall Study|Lost to Follow-up|1|||
161460457|NCT02674854|583080115|FG001|Overall Study|Lost to Follow-up|0|||
161460458|NCT02674854|583080116|FG002|Overall Study|Lost to Follow-up|2|||
161460459|NCT02674854|583080114|FG000|Overall Study|Lack of Efficacy|0|||
161460460|NCT02674854|583080115|FG001|Overall Study|Lack of Efficacy|3|||
161460461|NCT02674854|583080116|FG002|Overall Study|Lack of Efficacy|0|||
161460462|NCT02674854|583080114|FG000|Overall Study|Disallowed Concurrent Medication|2|||
161460463|NCT02674854|583080115|FG001|Overall Study|Disallowed Concurrent Medication|2|||
161460464|NCT02674854|583080116|FG002|Overall Study|Disallowed Concurrent Medication|0|||
161460465|NCT02674854|583080114|FG000|Overall Study|Protocol Violation|1|||
161460466|NCT02674854|583080115|FG001|Overall Study|Protocol Violation|1|||
161460467|NCT02674854|583080116|FG002|Overall Study|Protocol Violation|2|||
161460468|NCT02674854|583080114|FG000|Overall Study|Death|0|||
161460469|NCT02674854|583080115|FG001|Overall Study|Death|1|||
161460470|NCT02674854|583080116|FG002|Overall Study|Death|0|||
161460471|NCT02674854|583080114|FG000|Overall Study|Subject missed V6.2|1|||
161460472|NCT02674854|583080115|FG001|Overall Study|Subject missed V6.2|0|||
161460473|NCT02674854|583080116|FG002|Overall Study|Subject missed V6.2|0|||
161460474|NCT00879879|583080117|FG000|Overall Study|Death|1|||
161460475|NCT00879879|583080117|FG000|Overall Study|Withdrawal by Subject|1|||
161460476|NCT00879879|583080117|FG000|Overall Study|Physician Decision|1|||
161460477|NCT00378079|583080119|FG000|Overall Study|Lost to Follow-up|6|||
161460478|NCT00378079|583080120|FG001|Overall Study|Lost to Follow-up|1|||
161460479|NCT00378079|583080121|FG002|Overall Study|Lost to Follow-up|0|||
161460480|NCT02274038|583080122|FG000|Overall Study|Death|1|||
161460481|NCT05458648|583080130|FG000|Overall Study|Physician Decision|1|||
161460482|NCT05458648|583080130|FG000|Overall Study|Patient presented in atrial flutter|1|||
161460483|NCT05217927|583080134|FG000|DBT Phase|Adverse Event|7|||
161460484|NCT05217927|583080135|FG001|DBT Phase|Adverse Event|2|||
161460485|NCT05217927|583080136|FG002|DBT Phase|Adverse Event|5|||
161460486|NCT05217927|583080134|FG000|DBT Phase|Lack of Efficacy|1|||
161460487|NCT05217927|583080135|FG001|DBT Phase|Lack of Efficacy|0|||
161460488|NCT05217927|583080136|FG002|DBT Phase|Lack of Efficacy|0|||
161460489|NCT05217927|583080134|FG000|DBT Phase|Lost to Follow-up|0|||
161460490|NCT05217927|583080135|FG001|DBT Phase|Lost to Follow-up|2|||
161460491|NCT05217927|583080136|FG002|DBT Phase|Lost to Follow-up|0|||
161460492|NCT05217927|583080134|FG000|DBT Phase|Non-compliance|1|||
161460493|NCT05217927|583080135|FG001|DBT Phase|Non-compliance|0|||
161460494|NCT05217927|583080136|FG002|DBT Phase|Non-compliance|0|||
161460495|NCT05217927|583080134|FG000|DBT Phase|Pregnancy|0|||
161460496|NCT05217927|583080135|FG001|DBT Phase|Pregnancy|0|||
161460497|NCT05217927|583080136|FG002|DBT Phase|Pregnancy|1|||
161460498|NCT05217927|583080134|FG000|DBT Phase|Protocol Violation|0|||
161460499|NCT05217927|583080135|FG001|DBT Phase|Protocol Violation|2|||
161460500|NCT05217927|583080136|FG002|DBT Phase|Protocol Violation|1|||
161460501|NCT05217927|583080134|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
161460502|NCT05217927|583080135|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
161460503|NCT05217927|583080136|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
161460504|NCT05217927|583080134|FG000|DBT Phase|Withdrawal of consent|8|||
161460505|NCT05217927|583080135|FG001|DBT Phase|Withdrawal of consent|5|||
161460506|NCT05217927|583080136|FG002|DBT Phase|Withdrawal of consent|7|||
161460507|NCT05217927|583080134|FG000|DBT Phase|Other|7|||
161460508|NCT05217927|583080135|FG001|DBT Phase|Other|3|||
161460509|NCT05217927|583080136|FG002|DBT Phase|Other|4|||
161460510|NCT05217927|583080134|FG000|DBT Phase|Randomized, not treated|2|||
161460511|NCT05217927|583080135|FG001|DBT Phase|Randomized, not treated|3|||
161460512|NCT05217927|583080136|FG002|DBT Phase|Randomized, not treated|2|||
161460513|NCT05217927|583080134|FG000|OLE Phase|Adverse Event|4|||
161460514|NCT05217927|583080135|FG001|OLE Phase|Adverse Event|1|||
161460515|NCT05217927|583080136|FG002|OLE Phase|Adverse Event|1|||
161460516|NCT05217927|583080134|FG000|OLE Phase|Extension phase eligibility failure|1|||
161460517|NCT05217927|583080135|FG001|OLE Phase|Extension phase eligibility failure|0|||
161460518|NCT05217927|583080136|FG002|OLE Phase|Extension phase eligibility failure|0|||
161460519|NCT05217927|583080134|FG000|OLE Phase|Lost to Follow-up|1|||
161460520|NCT05217927|583080135|FG001|OLE Phase|Lost to Follow-up|2|||
161460521|NCT05217927|583080136|FG002|OLE Phase|Lost to Follow-up|1|||
161460522|NCT05217927|583080134|FG000|OLE Phase|Non-compliance|0|||
161460523|NCT05217927|583080135|FG001|OLE Phase|Non-compliance|0|||
161460524|NCT05217927|583080136|FG002|OLE Phase|Non-compliance|1|||
161460525|NCT05217927|583080134|FG000|OLE Phase|Other|3|||
161460526|NCT05217927|583080135|FG001|OLE Phase|Other|5|||
161460527|NCT05217927|583080136|FG002|OLE Phase|Other|4|||
161460528|NCT05217927|583080134|FG000|OLE Phase|Withdrawal of consent|3|||
161460529|NCT05217927|583080135|FG001|OLE Phase|Withdrawal of consent|1|||
161460530|NCT05217927|583080136|FG002|OLE Phase|Withdrawal of consent|5|||
161460531|NCT00076024|583081012|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
161460532|NCT00076024|583081013|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
161460533|NCT00076024|583081014|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
161460534|NCT00076024|583081015|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
161460535|NCT00076024|583081012|FG000|Phase 1, Lead-in|Adverse Event|1|||
161460536|NCT00076024|583081013|FG001|Phase 1, Lead-in|Adverse Event|0|||
161460537|NCT00076024|583081014|FG002|Phase 1, Lead-in|Adverse Event|0|||
161460538|NCT00076024|583081015|FG003|Phase 1, Lead-in|Adverse Event|0|||
161460539|NCT00076024|583081012|FG000|Phase 1, Lead-in|Clinical progression|1|||
161460540|NCT00076024|583081013|FG001|Phase 1, Lead-in|Clinical progression|0|||
161460541|NCT00076024|583081014|FG002|Phase 1, Lead-in|Clinical progression|0|||
161460542|NCT00076024|583081015|FG003|Phase 1, Lead-in|Clinical progression|0|||
161460543|NCT00076024|583081012|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
161460544|NCT00076024|583081013|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
161460545|NCT00076024|583081014|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
161460546|NCT00076024|583081015|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
161460547|NCT00076024|583081012|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
161460548|NCT00076024|583081013|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
161460549|NCT00076024|583081014|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
161460550|NCT00076024|583081015|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
161460551|NCT00076024|583081012|FG000|Phase 2, Double-blind|Adverse Event|0|||
161460552|NCT00076024|583081013|FG001|Phase 2, Double-blind|Adverse Event|25|||
161460553|NCT00076024|583081014|FG002|Phase 2, Double-blind|Adverse Event|6|||
161460554|NCT00076024|583081015|FG003|Phase 2, Double-blind|Adverse Event|0|||
161460555|NCT00076024|583081012|FG000|Phase 2, Double-blind|Un-specified|0|||
161460556|NCT00076024|583081013|FG001|Phase 2, Double-blind|Un-specified|14|||
161460557|NCT00076024|583081014|FG002|Phase 2, Double-blind|Un-specified|6|||
161460558|NCT00076024|583081015|FG003|Phase 2, Double-blind|Un-specified|0|||
161460559|NCT00076024|583081012|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
161460560|NCT00076024|583081013|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
161460561|NCT00076024|583081014|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
161460562|NCT00076024|583081015|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
161460563|NCT00076024|583081012|FG000|Phase 2, Open-label|Adverse Event|0|||
161460564|NCT00076024|583081013|FG001|Phase 2, Open-label|Adverse Event|0|||
161460565|NCT00076024|583081014|FG002|Phase 2, Open-label|Adverse Event|0|||
161460566|NCT00076024|583081015|FG003|Phase 2, Open-label|Adverse Event|2|||
161460567|NCT00076024|583081012|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
161460568|NCT00076024|583081013|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
161460569|NCT00076024|583081014|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
161460570|NCT00076024|583081015|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
161460571|NCT00076024|583081012|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
161460572|NCT00076024|583081013|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
161460573|NCT00076024|583081014|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
161460574|NCT00076024|583081015|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
161460575|NCT00076024|583081012|FG000|Phase 2, Open-label|Other|0|||
161460576|NCT00076024|583081013|FG001|Phase 2, Open-label|Other|0|||
161460577|NCT00076024|583081014|FG002|Phase 2, Open-label|Other|0|||
161460578|NCT00076024|583081015|FG003|Phase 2, Open-label|Other|2|||
161460579|NCT01362595|583081016|FG000|Overall Study|Screen failure|10|||
161460580|NCT01362595|583081016|FG000|Overall Study|Withdrawal by Subject|2|||
161460581|NCT00959374|583081017|FG000|Overall Study|Withdrawal by Subject|2|||
161460582|NCT00959374|583081017|FG000|Overall Study|Lost to Follow-up|14|||
161460583|NCT00959374|583081017|FG000|Overall Study|Death|1|||
161460584|NCT00959374|583081017|FG000|Overall Study|Protocol Violation|1|||
161460585|NCT00959374|583081017|FG000|Overall Study|Implant Removed/Not Replaced|4|||
161460586|NCT00959374|583081017|FG000|Overall Study|Physician Decision|1|||
161460587|NCT03350984|583081018|FG000|Overall Study|Death|1|||
161460588|NCT03350984|583081019|FG001|Overall Study|Death|0|||
161460589|NCT03350984|583081018|FG000|Overall Study|Lost to Follow-up|5|||
161460590|NCT03350984|583081019|FG001|Overall Study|Lost to Follow-up|6|||
161460591|NCT03350984|583081018|FG000|Overall Study|Protocol Violation|1|||
161460592|NCT03350984|583081019|FG001|Overall Study|Protocol Violation|2|||
161460593|NCT03350984|583081018|FG000|Overall Study|Physician Decision|1|||
161460594|NCT03350984|583081019|FG001|Overall Study|Physician Decision|0|||
161460595|NCT02284178|583081021|FG000|Overall Study|Met exclusion criteria|49|||
161460596|NCT02284178|583081022|FG001|Overall Study|Met exclusion criteria|54|||
161460597|NCT01741012|583081023|FG000|Overall Study|Lost to Follow-up|1|||
161460598|NCT01741012|583081023|FG000|Overall Study|Withdrawal by Subject|2|||
161460599|NCT04123665|583081024|FG000|Overall Study|Withdrawal by Subject|7|||
161460600|NCT04123665|583081025|FG001|Overall Study|Withdrawal by Subject|0|||
161460601|NCT04123665|583081024|FG000|Overall Study|Lost to Follow-up|1|||
161460602|NCT04123665|583081025|FG001|Overall Study|Lost to Follow-up|0|||
161460603|NCT00958789|583081029|FG000|Overall Study|Death|5|||
161460604|NCT00958789|583081029|FG000|Overall Study|Lost to Follow-up|14|||
161460605|NCT00958789|583081029|FG000|Overall Study|Withdrawal by Subject|17|||
161460606|NCT00958789|583081029|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
161460607|NCT00958789|583081029|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
161460608|NCT00958789|583081029|FG000|Overall Study|Subject terminated|2|||
161460609|NCT00958789|583081029|FG000|Overall Study|Revision|7|||
161460610|NCT00478881|583081032|FG000|Overall Study|Adverse Event|31|||
161460611|NCT00478881|583081033|FG001|Overall Study|Adverse Event|12|||
161460612|NCT00478881|583081032|FG000|Overall Study|Lack of Efficacy|0|||
161460613|NCT00478881|583081033|FG001|Overall Study|Lack of Efficacy|3|||
161460614|NCT00478881|583081032|FG000|Overall Study|Lost to Follow-up|0|||
161460615|NCT00478881|583081033|FG001|Overall Study|Lost to Follow-up|1|||
161460616|NCT00478881|583081032|FG000|Overall Study|Protocol Violation|2|||
161460617|NCT00478881|583081033|FG001|Overall Study|Protocol Violation|2|||
161460618|NCT00478881|583081032|FG000|Overall Study|Withdrawal by Subject|6|||
161460619|NCT00478881|583081033|FG001|Overall Study|Withdrawal by Subject|2|||
161460620|NCT00478881|583081032|FG000|Overall Study|Non-Compliance with Study Medication|0|||
161460621|NCT00478881|583081033|FG001|Overall Study|Non-Compliance with Study Medication|2|||
161460622|NCT03707184|583081036|FG000|Overall Study|Withdrawal by Subject|2|||
161460623|NCT04104438|583081037|FG000|Overall Study|Death|2|||
161460624|NCT04104438|583081038|FG001|Overall Study|Death|1|||
161460625|NCT04104438|583081039|FG002|Overall Study|Death|2|||
161460626|NCT04104438|583081037|FG000|Overall Study|Adverse Event|0|||
161460627|NCT04104438|583081038|FG001|Overall Study|Adverse Event|3|||
161809942|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161460628|NCT04104438|583081039|FG002|Overall Study|Adverse Event|0|||
161460629|NCT04104438|583081037|FG000|Overall Study|Withdrawal by Subject|0|||
161460630|NCT04104438|583081038|FG001|Overall Study|Withdrawal by Subject|1|||
161460631|NCT04104438|583081039|FG002|Overall Study|Withdrawal by Subject|0|||
161460632|NCT04104438|583081037|FG000|Overall Study|Disenrolled due to noncompliance|0|||
161460633|NCT04104438|583081038|FG001|Overall Study|Disenrolled due to noncompliance|1|||
161460634|NCT04104438|583081039|FG002|Overall Study|Disenrolled due to noncompliance|0|||
161460635|NCT04104438|583081037|FG000|Overall Study|stopped due to possible operation|0|||
161460636|NCT04104438|583081038|FG001|Overall Study|stopped due to possible operation|1|||
161460637|NCT04104438|583081039|FG002|Overall Study|stopped due to possible operation|0|||
161460638|NCT04104438|583081037|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
161460639|NCT04104438|583081038|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
161460640|NCT04104438|583081039|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
161460641|NCT00930982|583081042|FG000|Overall Study|Adverse Event|19|||
161460642|NCT00930982|583081043|FG001|Overall Study|Adverse Event|23|||
161460643|NCT00930982|583081042|FG000|Overall Study|Protocol Violation|1|||
161460644|NCT00930982|583081043|FG001|Overall Study|Protocol Violation|5|||
161460645|NCT00930982|583081042|FG000|Overall Study|Withdrawal by Subject|1|||
161460646|NCT00930982|583081043|FG001|Overall Study|Withdrawal by Subject|1|||
161460647|NCT00518973|583081044|FG000|Overall Study|Withdrawal by Subject|3|||
161460648|NCT00518973|583081045|FG001|Overall Study|Withdrawal by Subject|2|||
161460649|NCT00582816|583081046|FG000|Overall Study|Engraftment Failure|3|||
161460650|NCT01001299|583081047|FG000|Overall Study|Insufficient Therapeutic Response|20|||
161460651|NCT01001299|583081047|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
161460652|NCT01001299|583081047|FG000|Overall Study|Death|1|||
161460653|NCT01001299|583081047|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
161460654|NCT01001299|583081047|FG000|Overall Study|Withdrew Consent|1|||
161460655|NCT01565499|583081048|FG000|Overall Study|Physician Decision|1|||
161460656|NCT01565499|583081048|FG000|Overall Study|Adverse Event|5|||
161460657|NCT01565499|583081048|FG000|Overall Study|Withdrawal by Subject|2|||
161460658|NCT01923168|583081049|FG000|Overall Study|Protocol Violation|1|||
161460659|NCT01923168|583081050|FG001|Overall Study|Protocol Violation|1|||
161460660|NCT01923168|583081051|FG002|Overall Study|Protocol Violation|0|||
161460661|NCT01923168|583081049|FG000|Overall Study|Subject/guardian decision|14|||
161460662|NCT01923168|583081050|FG001|Overall Study|Subject/guardian decision|14|||
161460663|NCT01923168|583081051|FG002|Overall Study|Subject/guardian decision|4|||
161460664|NCT01923168|583081049|FG000|Overall Study|Adverse Event|12|||
161460665|NCT01923168|583081050|FG001|Overall Study|Adverse Event|12|||
161460666|NCT01923168|583081051|FG002|Overall Study|Adverse Event|0|||
161460667|NCT01923168|583081049|FG000|Overall Study|Physician Decision|6|||
161460668|NCT01923168|583081050|FG001|Overall Study|Physician Decision|9|||
161460669|NCT01923168|583081051|FG002|Overall Study|Physician Decision|5|||
161460670|NCT01923168|583081049|FG000|Overall Study|Progressive disease|4|||
161460671|NCT01923168|583081050|FG001|Overall Study|Progressive disease|3|||
161460672|NCT01923168|583081051|FG002|Overall Study|Progressive disease|7|||
161460673|NCT01923168|583081049|FG000|Overall Study|Death|0|||
161460674|NCT01923168|583081050|FG001|Overall Study|Death|0|||
161460675|NCT01923168|583081051|FG002|Overall Study|Death|1|||
161460676|NCT00476047|583081052|FG000|Overall Study|Lost to Follow-up|1|||
161460677|NCT02241889|583081057|FG000|Overall Study|device issues|0|||
161460678|NCT02241889|583081058|FG001|Overall Study|device issues|0|||
161460679|NCT02241889|583081059|FG002|Overall Study|device issues|1|||
161460680|NCT02241889|583081060|FG003|Overall Study|device issues|0|||
161460681|NCT02241889|583081061|FG004|Overall Study|device issues|0|||
161460682|NCT02241889|583081062|FG005|Overall Study|device issues|0|||
161460683|NCT02241889|583081057|FG000|Overall Study|Withdrawal by Subject|0|||
161460684|NCT02241889|583081058|FG001|Overall Study|Withdrawal by Subject|0|||
161460685|NCT02241889|583081059|FG002|Overall Study|Withdrawal by Subject|0|||
161460686|NCT02241889|583081060|FG003|Overall Study|Withdrawal by Subject|0|||
161460687|NCT02241889|583081061|FG004|Overall Study|Withdrawal by Subject|0|||
161460688|NCT02241889|583081062|FG005|Overall Study|Withdrawal by Subject|1|||
161460689|NCT00773838|583081063|FG000|Overall Study|Adverse Event|29|||
161460690|NCT00773838|583081063|FG000|Overall Study|Lost to Follow-up|1|||
161460691|NCT00773838|583081063|FG000|Overall Study|Physician Decision|8|||
161460692|NCT00773838|583081063|FG000|Overall Study|Progressive Disease|82|||
161460693|NCT00773838|583081063|FG000|Overall Study|Protocol Violation|2|||
161460694|NCT00773838|583081063|FG000|Overall Study|Withdrawal by Subject|21|||
161460695|NCT00459056|583081067|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
161460696|NCT00459056|583081068|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
161460697|NCT02522871|583081069|FG000|Overall Study|Protocol Violation|1|||
161460698|NCT02522871|583081070|FG001|Overall Study|Protocol Violation|4|||
161460699|NCT02522871|583081069|FG000|Overall Study|Treated without randomization|1|||
161460700|NCT02522871|583081070|FG001|Overall Study|Treated without randomization|0|||
161460701|NCT02522871|583081069|FG000|Overall Study|Death|9|||
161460702|NCT02522871|583081070|FG001|Overall Study|Death|9|||
161460703|NCT02522871|583081069|FG000|Overall Study|Died in operating room prior to transplant|0|||
161460704|NCT02522871|583081070|FG001|Overall Study|Died in operating room prior to transplant|1|||
161460705|NCT01658813|583081071|FG000|Overall Study|Disease progression|3|||
161460706|NCT02398227|583081072|FG000|Overall Study|Lost to Follow-up|21|||
161460707|NCT02398227|583081073|FG001|Overall Study|Lost to Follow-up|12|||
161460708|NCT02398227|583081072|FG000|Overall Study|Withdrawal by Subject|5|||
161460709|NCT02398227|583081073|FG001|Overall Study|Withdrawal by Subject|6|||
161460710|NCT02398227|583081072|FG000|Overall Study|Removed from treatment and dropped out|1|||
161460711|NCT02398227|583081073|FG001|Overall Study|Removed from treatment and dropped out|0|||
161460712|NCT01715129|583081074|FG000|Overall Study|Adverse Event, fatal|1|||
161460713|NCT01715129|583081074|FG000|Overall Study|Lack of Efficacy|3|||
161460714|NCT01715129|583081074|FG000|Overall Study|Protocol Violation|1|||
161460715|NCT01715129|583081074|FG000|Overall Study|Consent Withdrawn|2|||
161460716|NCT01715129|583081074|FG000|Overall Study|Lost to Follow-up|1|||
161460717|NCT01715129|583081074|FG000|Overall Study|Other|1|||
161460718|NCT02793622|583081075|FG000|Overall Study|Lost to Follow-up|31|||
161460719|NCT02793622|583081076|FG001|Overall Study|Lost to Follow-up|19|||
161460720|NCT02793622|583081075|FG000|Overall Study|Withdrawal by Subject|21|||
161460721|NCT02793622|583081076|FG001|Overall Study|Withdrawal by Subject|17|||
161460722|NCT02793622|583081075|FG000|Overall Study|Adverse Event|0|||
161460723|NCT02793622|583081076|FG001|Overall Study|Adverse Event|1|||
161460724|NCT02793622|583081075|FG000|Overall Study|Protocol Violation|1|||
161460725|NCT02793622|583081076|FG001|Overall Study|Protocol Violation|5|||
161460726|NCT03149848|583081077|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
161460727|NCT03149848|583081077|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
161460728|NCT04738318|583081079|FG000|Overall Study|Protocol Violation|1|||
161460729|NCT04738318|583081080|FG001|Overall Study|Protocol Violation|0|||
161460730|NCT00586664|583081081|FG000|Overall Study|Withdrawal by Subject|3|||
161460731|NCT00586664|583081082|FG001|Overall Study|Withdrawal by Subject|7|||
161460732|NCT00586664|583081083|FG002|Overall Study|Withdrawal by Subject|1|||
161460733|NCT00586664|583081081|FG000|Overall Study|Exclusion criteria met|2|||
161460734|NCT00586664|583081082|FG001|Overall Study|Exclusion criteria met|0|||
161460735|NCT00586664|583081083|FG002|Overall Study|Exclusion criteria met|0|||
161460736|NCT01602666|583081084|FG000|Induction Chemotherapy|Death|2|||
161460737|NCT01602666|583081085|FG001|Induction Chemotherapy|Death|1|||
161460738|NCT01602666|583081084|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
161460739|NCT01602666|583081085|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
161460740|NCT01602666|583081084|FG000|Induction Chemotherapy|Physician Decision|12|||
161460741|NCT01602666|583081085|FG001|Induction Chemotherapy|Physician Decision|5|||
161460742|NCT01602666|583081084|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
161460743|NCT01602666|583081085|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
161460744|NCT01602666|583081084|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
161460745|NCT01602666|583081085|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
161460746|NCT01602666|583081084|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
161460747|NCT01602666|583081085|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
161460748|NCT01602666|583081084|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
161460749|NCT01602666|583081085|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
161460750|NCT01602666|583081084|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
161460751|NCT01602666|583081085|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
161460752|NCT01602666|583081084|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
161460753|NCT01602666|583081085|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
161460754|NCT01602666|583081084|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
161460755|NCT01602666|583081085|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
161460756|NCT01602666|583081084|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
161460757|NCT01602666|583081085|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
161460758|NCT03610555|583081086|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
161460759|NCT03610555|583081087|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
161460760|NCT03610555|583081088|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
161460761|NCT03610555|583081089|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
161460762|NCT01892722|583081090|FG000|Overall Study|Protocol deviation|0|||
161460763|NCT01892722|583081091|FG001|Overall Study|Protocol deviation|1|||
161460764|NCT01892722|583081090|FG000|Overall Study|Administrative problems|0|||
161460765|NCT01892722|583081091|FG001|Overall Study|Administrative problems|1|||
161460766|NCT01892722|583081090|FG000|Overall Study|Patient/guardian decision|0|||
161460767|NCT01892722|583081091|FG001|Overall Study|Patient/guardian decision|2|||
161460768|NCT01892722|583081090|FG000|Overall Study|Physician Decision|1|||
161460769|NCT01892722|583081091|FG001|Overall Study|Physician Decision|2|||
161460770|NCT01892722|583081090|FG000|Overall Study|Adverse Event|3|||
161460771|NCT01892722|583081091|FG001|Overall Study|Adverse Event|2|||
161460772|NCT01892722|583081090|FG000|Overall Study|Lack of Efficacy|0|||
161460773|NCT01892722|583081091|FG001|Overall Study|Lack of Efficacy|7|||
161460774|NCT01892722|583081090|FG000|Overall Study|Withdrawal by Subject|3|||
161460775|NCT01892722|583081091|FG001|Overall Study|Withdrawal by Subject|5|||
161460776|NCT02275910|583081092|FG000|Overall Study|Subject Choice|0|||
161460777|NCT02275910|583081093|FG001|Overall Study|Subject Choice|0|||
161460778|NCT02275910|583081094|FG002|Overall Study|Subject Choice|0|||
161460779|NCT02275910|583081095|FG003|Overall Study|Subject Choice|0|||
161460780|NCT02275910|583081096|FG004|Overall Study|Subject Choice|0|||
161572053|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
161460781|NCT02275910|583081097|FG005|Overall Study|Subject Choice|0|||
161572054|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
161460782|NCT02275910|583081098|FG006|Overall Study|Subject Choice|0|||
161460783|NCT02275910|583081099|FG007|Overall Study|Subject Choice|0|||
161460784|NCT02275910|583081100|FG008|Overall Study|Subject Choice|1|||
161460785|NCT02275910|583081101|FG009|Overall Study|Subject Choice|0|||
161460786|NCT02275910|583081102|FG010|Overall Study|Subject Choice|0|||
161460787|NCT02275910|583081103|FG011|Overall Study|Subject Choice|0|||
161460788|NCT02275910|583081092|FG000|Overall Study|Radiological Disease Progression|0|||
161460789|NCT02275910|583081093|FG001|Overall Study|Radiological Disease Progression|0|||
161460790|NCT02275910|583081094|FG002|Overall Study|Radiological Disease Progression|0|||
161460791|NCT02275910|583081095|FG003|Overall Study|Radiological Disease Progression|0|||
161460792|NCT02275910|583081096|FG004|Overall Study|Radiological Disease Progression|0|||
161460793|NCT02275910|583081097|FG005|Overall Study|Radiological Disease Progression|0|||
161460794|NCT02275910|583081098|FG006|Overall Study|Radiological Disease Progression|1|||
161460795|NCT02275910|583081099|FG007|Overall Study|Radiological Disease Progression|1|||
161460796|NCT02275910|583081100|FG008|Overall Study|Radiological Disease Progression|0|||
161460797|NCT02275910|583081101|FG009|Overall Study|Radiological Disease Progression|1|||
161460798|NCT02275910|583081102|FG010|Overall Study|Radiological Disease Progression|0|||
161460799|NCT02275910|583081103|FG011|Overall Study|Radiological Disease Progression|0|||
161460800|NCT01155219|583082346|FG000|Overall Study|Adverse Event|3|||
161460801|NCT01155219|583082347|FG001|Overall Study|Adverse Event|1|||
161460802|NCT01155219|583082346|FG000|Overall Study|non-medical reason|1|||
161460803|NCT01155219|583082347|FG001|Overall Study|non-medical reason|2|||
161460804|NCT03052764|583082348|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161460805|NCT03052764|583082349|FG001|Double-Blind Treatment Period|Adverse Event|0|||
161460806|NCT03052764|583082348|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161460807|NCT03052764|583082349|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
161460808|NCT03052764|583082348|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
161460809|NCT03052764|583082349|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
161460810|NCT03052764|583082348|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
161460811|NCT03052764|583082349|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161460812|NCT03052764|583082348|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
161460813|NCT03052764|583082349|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
161460814|NCT01314911|583082350|FG000|Overall Study|Lost to Follow-up|3|||
161460815|NCT01314911|583082351|FG001|Overall Study|Lost to Follow-up|2|||
161460816|NCT01314911|583082350|FG000|Overall Study|Withdrawal by Subject|1|||
161460817|NCT01314911|583082351|FG001|Overall Study|Withdrawal by Subject|3|||
161460818|NCT01314911|583082350|FG000|Overall Study|Received Non-randomized Study Drug|0|||
161460819|NCT01314911|583082351|FG001|Overall Study|Received Non-randomized Study Drug|1|||
161460820|NCT01314911|583082350|FG000|Overall Study|Never Started Treatment|1|||
161460821|NCT01314911|583082351|FG001|Overall Study|Never Started Treatment|0|||
161460822|NCT03150485|583082355|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
161460823|NCT03150485|583082356|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
161460824|NCT03150485|583082357|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
161460825|NCT03150485|583082358|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
161460826|NCT03150485|583082359|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
161460827|NCT03150485|583082360|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
161460828|NCT01394718|583082362|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
161460829|NCT01394718|583082363|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
161460830|NCT01695005|583082364|FG000|Overall Study|Lost to Follow-up|0|||
161460831|NCT01695005|583082365|FG001|Overall Study|Lost to Follow-up|1|||
161460832|NCT01695005|583082366|FG002|Overall Study|Lost to Follow-up|1|||
161460833|NCT01695005|583082367|FG003|Overall Study|Lost to Follow-up|0|||
161460834|NCT01695005|583082368|FG004|Overall Study|Lost to Follow-up|0|||
161460835|NCT01695005|583082369|FG005|Overall Study|Lost to Follow-up|1|||
161460836|NCT01695005|583082370|FG006|Overall Study|Lost to Follow-up|1|||
161460837|NCT01695005|583082371|FG007|Overall Study|Lost to Follow-up|1|||
161460838|NCT01695005|583082372|FG008|Overall Study|Lost to Follow-up|3|||
161460839|NCT01695005|583082373|FG009|Overall Study|Lost to Follow-up|3|||
161460840|NCT01695005|583082374|FG010|Overall Study|Lost to Follow-up|8|||
161460841|NCT01695005|583082375|FG011|Overall Study|Lost to Follow-up|5|||
161460842|NCT01695005|583082376|FG012|Overall Study|Lost to Follow-up|2|||
161460843|NCT01695005|583082377|FG013|Overall Study|Lost to Follow-up|5|||
161460844|NCT01695005|583082378|FG014|Overall Study|Lost to Follow-up|0|||
161460845|NCT01695005|583082379|FG015|Overall Study|Lost to Follow-up|4|||
161460846|NCT01695005|583082380|FG016|Overall Study|Lost to Follow-up|0|||
161460847|NCT01695005|583082381|FG017|Overall Study|Lost to Follow-up|0|||
161460848|NCT01695005|583082382|FG018|Overall Study|Lost to Follow-up|0|||
161460849|NCT01695005|583082383|FG019|Overall Study|Lost to Follow-up|1|||
161460850|NCT01695005|583082384|FG020|Overall Study|Lost to Follow-up|1|||
161809943|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161460851|NCT01695005|583082385|FG021|Overall Study|Lost to Follow-up|0|||
161460852|NCT01695005|583082386|FG022|Overall Study|Lost to Follow-up|2|||
161460853|NCT01695005|583082387|FG023|Overall Study|Lost to Follow-up|4|||
161460854|NCT01695005|583082388|FG024|Overall Study|Lost to Follow-up|2|||
161460855|NCT01695005|583082389|FG025|Overall Study|Lost to Follow-up|0|||
161460856|NCT01695005|583082390|FG026|Overall Study|Lost to Follow-up|0|||
161460857|NCT01695005|583082391|FG027|Overall Study|Lost to Follow-up|0|||
161460858|NCT01695005|583082392|FG028|Overall Study|Lost to Follow-up|1|||
161460859|NCT01695005|583082364|FG000|Overall Study|Withdrawal by Subject|0|||
161460860|NCT01695005|583082365|FG001|Overall Study|Withdrawal by Subject|0|||
161460861|NCT01695005|583082366|FG002|Overall Study|Withdrawal by Subject|0|||
161460862|NCT01695005|583082367|FG003|Overall Study|Withdrawal by Subject|2|||
161460863|NCT01695005|583082368|FG004|Overall Study|Withdrawal by Subject|0|||
161460864|NCT01695005|583082369|FG005|Overall Study|Withdrawal by Subject|1|||
161460865|NCT01695005|583082370|FG006|Overall Study|Withdrawal by Subject|0|||
161460866|NCT01695005|583082371|FG007|Overall Study|Withdrawal by Subject|1|||
161460867|NCT01695005|583082372|FG008|Overall Study|Withdrawal by Subject|0|||
161460868|NCT01695005|583082373|FG009|Overall Study|Withdrawal by Subject|1|||
161460869|NCT01695005|583082374|FG010|Overall Study|Withdrawal by Subject|2|||
161460870|NCT01695005|583082375|FG011|Overall Study|Withdrawal by Subject|1|||
161460871|NCT01695005|583082376|FG012|Overall Study|Withdrawal by Subject|1|||
161460872|NCT01695005|583082377|FG013|Overall Study|Withdrawal by Subject|0|||
161460873|NCT01695005|583082378|FG014|Overall Study|Withdrawal by Subject|0|||
161460874|NCT01695005|583082379|FG015|Overall Study|Withdrawal by Subject|0|||
161460875|NCT01695005|583082380|FG016|Overall Study|Withdrawal by Subject|0|||
161460876|NCT01695005|583082381|FG017|Overall Study|Withdrawal by Subject|0|||
161460877|NCT01695005|583082382|FG018|Overall Study|Withdrawal by Subject|2|||
161460878|NCT01695005|583082383|FG019|Overall Study|Withdrawal by Subject|0|||
161460879|NCT01695005|583082384|FG020|Overall Study|Withdrawal by Subject|1|||
161460880|NCT01695005|583082385|FG021|Overall Study|Withdrawal by Subject|0|||
161460881|NCT01695005|583082386|FG022|Overall Study|Withdrawal by Subject|0|||
161460882|NCT01695005|583082387|FG023|Overall Study|Withdrawal by Subject|0|||
161460883|NCT01695005|583082388|FG024|Overall Study|Withdrawal by Subject|1|||
161460884|NCT01695005|583082389|FG025|Overall Study|Withdrawal by Subject|0|||
161460885|NCT01695005|583082390|FG026|Overall Study|Withdrawal by Subject|0|||
161460886|NCT01695005|583082391|FG027|Overall Study|Withdrawal by Subject|1|||
161460887|NCT01695005|583082392|FG028|Overall Study|Withdrawal by Subject|0|||
161460888|NCT04478123|583082393|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
161460889|NCT04478123|583082393|FG000|Overall Study|NE|1|||
161460890|NCT02395016|583082394|FG000|Overall Study|Adverse Event|4|||
161460891|NCT02395016|583082395|FG001|Overall Study|Adverse Event|3|||
161460892|NCT02395016|583082394|FG000|Overall Study|Withdrawal by Subject|9|||
161460893|NCT02395016|583082395|FG001|Overall Study|Withdrawal by Subject|6|||
161460894|NCT02395016|583082394|FG000|Overall Study|Protocol Violation|2|||
161460895|NCT02395016|583082395|FG001|Overall Study|Protocol Violation|3|||
161460896|NCT01547780|583082396|FG000|Baseline PET Scan|Physician Decision|1|||
161460897|NCT01547780|583082397|FG001|Baseline PET Scan|Physician Decision|0|||
161460898|NCT01547780|583082398|FG002|Baseline PET Scan|Physician Decision|1|||
161460899|NCT01547780|583082399|FG003|Baseline PET Scan|Physician Decision|0|||
161460900|NCT01547780|583082396|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
161460901|NCT01547780|583082397|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
161460902|NCT01547780|583082398|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
161460903|NCT01547780|583082399|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
161460904|NCT00814879|583082401|FG000|By Week 24|Cancer Diagnosis|1|||
161460905|NCT00814879|583082402|FG001|By Week 24|Cancer Diagnosis|0|||
161460906|NCT00814879|583082401|FG000|By Week 24|Incarceration|0|||
161460907|NCT00814879|583082402|FG001|By Week 24|Incarceration|1|||
161460908|NCT00814879|583082401|FG000|By Week 48|Lost to Follow-up|2|||
161460909|NCT00814879|583082402|FG001|By Week 48|Lost to Follow-up|2|||
161460910|NCT00814879|583082401|FG000|By Week 48|Death|0|||
161460911|NCT00814879|583082402|FG001|By Week 48|Death|1|||
161460912|NCT00588952|583082403|FG000|Overall Study|Adverse Event|0|||
161460913|NCT00588952|583082404|FG001|Overall Study|Adverse Event|2|||
161460914|NCT00588952|583082403|FG000|Overall Study|Withdrawal by Subject|3|||
161460915|NCT00588952|583082404|FG001|Overall Study|Withdrawal by Subject|5|||
161460916|NCT01461057|583082405|FG000|Overall Study|Death|10|||
161460917|NCT01461057|583082406|FG001|Overall Study|Death|9|||
161460918|NCT01461057|583082405|FG000|Overall Study|Withdrawal by Subject|2|||
161460919|NCT01461057|583082406|FG001|Overall Study|Withdrawal by Subject|3|||
161460920|NCT01461057|583082405|FG000|Overall Study|Physician Decision|0|||
161460921|NCT01461057|583082406|FG001|Overall Study|Physician Decision|2|||
161460922|NCT01461057|583082405|FG000|Overall Study|Adverse Event|0|||
161460923|NCT01461057|583082406|FG001|Overall Study|Adverse Event|1|||
161460924|NCT01461057|583082405|FG000|Overall Study|Progression of Disease|1|||
161460925|NCT01461057|583082406|FG001|Overall Study|Progression of Disease|0|||
161572055|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
161460926|NCT01461057|583082405|FG000|Overall Study|Study Terminated by Sponsor|2|||
161460927|NCT01461057|583082406|FG001|Overall Study|Study Terminated by Sponsor|0|||
161809944|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161460928|NCT01288976|583082407|FG000|Overall Study|Withdrawal by Subject|58|||
161460929|NCT01288976|583082408|FG001|Overall Study|Withdrawal by Subject|12|||
161460930|NCT01288976|583082409|FG002|Overall Study|Withdrawal by Subject|9|||
161460931|NCT01288976|583082407|FG000|Overall Study|Death|98|||
161460932|NCT01288976|583082408|FG001|Overall Study|Death|6|||
161460933|NCT01288976|583082409|FG002|Overall Study|Death|4|||
161460934|NCT01288976|583082407|FG000|Overall Study|Data unavailable|22|||
161460935|NCT01288976|583082408|FG001|Overall Study|Data unavailable|9|||
161460936|NCT01288976|583082409|FG002|Overall Study|Data unavailable|7|||
161460937|NCT03560739|583082411|FG000|Overall Study|Adverse Event|0|||
161460938|NCT03560739|583082412|FG001|Overall Study|Adverse Event|1|||
161460939|NCT03560739|583082413|FG002|Overall Study|Adverse Event|0|||
161460940|NCT03560739|583082414|FG003|Overall Study|Adverse Event|0|||
161460941|NCT02448680|583082415|FG000|Overall Study|Physician Decision|1|||
161460942|NCT02448680|583082416|FG001|Overall Study|Physician Decision|1|||
161460943|NCT02448680|583082415|FG000|Overall Study|Withdrawal by Subject|0|||
161460944|NCT02448680|583082416|FG001|Overall Study|Withdrawal by Subject|2|||
161460945|NCT01739400|583082417|FG000|Overall Study|Physician Decision|3|||
161460946|NCT01739400|583082418|FG001|Overall Study|Physician Decision|0|||
161460947|NCT01739400|583082417|FG000|Overall Study|Lost to Follow-up|2|||
161460948|NCT01739400|583082418|FG001|Overall Study|Lost to Follow-up|0|||
161460949|NCT01739400|583082417|FG000|Overall Study|Death|5|||
161460950|NCT01739400|583082418|FG001|Overall Study|Death|2|||
161460951|NCT01739400|583082417|FG000|Overall Study|Withdrawal by Subject|7|||
161460952|NCT01739400|583082418|FG001|Overall Study|Withdrawal by Subject|7|||
161460953|NCT01736657|583082419|FG000|Overall Study|insufficient vascular access|1|||
161460954|NCT00642473|583082428|FG000|Overall Study|Withdrawal by Subject|0|||
161460955|NCT00642473|583082429|FG001|Overall Study|Withdrawal by Subject|5|||
161460956|NCT00642473|583082428|FG000|Overall Study|Progression or death|2|||
161460957|NCT00642473|583082429|FG001|Overall Study|Progression or death|4|||
161460958|NCT00642473|583082428|FG000|Overall Study|Other|2|||
161460959|NCT00642473|583082429|FG001|Overall Study|Other|2|||
161460960|NCT04533880|583082430|FG000|Overall Study|Lost to Follow-up|0|||
161460961|NCT04533880|583082431|FG001|Overall Study|Lost to Follow-up|1|||
161460962|NCT04533880|583082432|FG002|Overall Study|Lost to Follow-up|1|||
161460963|NCT01711879|583082435|FG000|Overall Study|Death|1|||
161460964|NCT01711879|583082436|FG001|Overall Study|Death|0|||
161460965|NCT01466179|583082437|FG000|Overall Study|Ongoing in core study|2|||
161460966|NCT01466179|583082437|FG000|Overall Study|Physician Decision|46|||
161460967|NCT01466179|583082437|FG000|Overall Study|Progressive disease|43|||
161460968|NCT01466179|583082437|FG000|Overall Study|Adverse Event|32|||
161460969|NCT01466179|583082437|FG000|Overall Study|Disease relapse|23|||
161460970|NCT01466179|583082437|FG000|Overall Study|Lack of Efficacy|14|||
161460971|NCT01466179|583082437|FG000|Overall Study|Death|7|||
161460972|NCT01466179|583082437|FG000|Overall Study|Withdrawal by Subject|7|||
161460973|NCT01466179|583082437|FG000|Overall Study|Protocol Violation|2|||
161460974|NCT01466179|583082437|FG000|Overall Study|Other|3|||
161460975|NCT03410823|583082438|FG000|Overall Study|Death|1|||
161460976|NCT03410823|583082438|FG000|Overall Study|Withdrawal by Subject|2|||
161460977|NCT03410823|583082438|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
161460978|NCT04704154|583082439|FG000|Overall Study|Adverse Event|3|||
161460979|NCT04704154|583082440|FG001|Overall Study|Adverse Event|2|||
161460980|NCT04704154|583082441|FG002|Overall Study|Adverse Event|4|||
161460981|NCT04704154|583082442|FG003|Overall Study|Adverse Event|2|||
161460982|NCT04704154|583082443|FG004|Overall Study|Adverse Event|3|||
161460983|NCT04704154|583082444|FG005|Overall Study|Adverse Event|0|||
161460984|NCT04704154|583082439|FG000|Overall Study|Death|3|||
161460985|NCT04704154|583082440|FG001|Overall Study|Death|0|||
161460986|NCT04704154|583082441|FG002|Overall Study|Death|0|||
161460987|NCT04704154|583082442|FG003|Overall Study|Death|0|||
161460988|NCT04704154|583082443|FG004|Overall Study|Death|3|||
161460989|NCT04704154|583082444|FG005|Overall Study|Death|0|||
161460990|NCT04704154|583082439|FG000|Overall Study|Physician Decision|1|||
161460991|NCT04704154|583082440|FG001|Overall Study|Physician Decision|0|||
161460992|NCT04704154|583082441|FG002|Overall Study|Physician Decision|1|||
161460993|NCT04704154|583082442|FG003|Overall Study|Physician Decision|0|||
161460994|NCT04704154|583082443|FG004|Overall Study|Physician Decision|2|||
161460995|NCT04704154|583082444|FG005|Overall Study|Physician Decision|0|||
161460996|NCT04704154|583082439|FG000|Overall Study|Participant Decision|1|||
161460997|NCT04704154|583082440|FG001|Overall Study|Participant Decision|1|||
161460998|NCT04704154|583082441|FG002|Overall Study|Participant Decision|0|||
161460999|NCT04704154|583082442|FG003|Overall Study|Participant Decision|0|||
161461000|NCT04704154|583082443|FG004|Overall Study|Participant Decision|0|||
161461001|NCT04704154|583082444|FG005|Overall Study|Participant Decision|0|||
161461002|NCT04704154|583082439|FG000|Overall Study|Progressive Disease|19|||
161461003|NCT04704154|583082440|FG001|Overall Study|Progressive Disease|17|||
161461004|NCT04704154|583082441|FG002|Overall Study|Progressive Disease|20|||
161461005|NCT04704154|583082442|FG003|Overall Study|Progressive Disease|18|||
161461006|NCT04704154|583082443|FG004|Overall Study|Progressive Disease|36|||
161461007|NCT04704154|583082444|FG005|Overall Study|Progressive Disease|30|||
161461008|NCT04704154|583082439|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
161461009|NCT04704154|583082440|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
161461010|NCT04704154|583082441|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
161461011|NCT04704154|583082442|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
161572056|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
161572057|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
161572058|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
161572059|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
161572060|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
161572061|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
161572062|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
161572063|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
161572064|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161572065|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161572066|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
161572067|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161572068|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161572069|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161572070|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161572071|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
161572072|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
161572073|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
161572074|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
161572075|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
161572076|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
161572077|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
161572078|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
161572079|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
161572080|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
161572081|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
161572082|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572083|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572084|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572085|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572086|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572087|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572088|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572089|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
161572090|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
161572091|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161572092|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
161572093|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
161572094|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161572095|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161572096|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161572097|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161572098|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161572099|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161572100|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161572101|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
161572102|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
161572103|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161572104|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161572105|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161572106|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161572107|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
161572108|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161572109|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
161572110|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
161572111|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
161572112|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
161572113|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
161572114|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
161572115|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
161572116|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
161572117|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
161572118|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161572119|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
161572120|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161572121|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161572122|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161572123|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161461012|NCT04704154|583082443|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
161461013|NCT04704154|583082444|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
161461014|NCT04704154|583082439|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
161461015|NCT04704154|583082440|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
161461016|NCT04704154|583082441|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
161461017|NCT04704154|583082442|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
161461018|NCT04704154|583082443|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
161461019|NCT04704154|583082444|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
161461020|NCT03220438|583082445|FG000|Overall Study|Lost to Follow-up|0|||
161461021|NCT03220438|583082446|FG001|Overall Study|Lost to Follow-up|0|||
161461022|NCT03220438|583082447|FG002|Overall Study|Lost to Follow-up|1|||
161461023|NCT03220438|583082448|FG003|Overall Study|Lost to Follow-up|0|||
161461024|NCT04062123|583082449|FG000|Overall Study|Withdrawal by Subject|0|||
161461025|NCT04062123|583082450|FG001|Overall Study|Withdrawal by Subject|1|||
161461026|NCT04062123|583082451|FG002|Overall Study|Withdrawal by Subject|0|||
161461027|NCT04190680|583082452|FG000|Overall Study|Not meeting criteria for data analysis|1|||
161461028|NCT04190680|583082453|FG001|Overall Study|Not meeting criteria for data analysis|15|||
161461029|NCT04190680|583082452|FG000|Overall Study|Administrative error|0|||
161461030|NCT04190680|583082453|FG001|Overall Study|Administrative error|18|||
161461031|NCT03780400|583082454|FG000|Overall Study|Lost to Follow-up|5|||
161461032|NCT03780400|583082454|FG000|Overall Study|Withdrawal by Subject|2|||
161461033|NCT01850602|583082455|FG000|Overall Study|Adverse Event|7|||
161461034|NCT01850602|583082456|FG001|Overall Study|Adverse Event|10|||
161461035|NCT01850602|583082455|FG000|Overall Study|Physician Decision|2|||
161461036|NCT01850602|583082456|FG001|Overall Study|Physician Decision|1|||
161461037|NCT01850602|583082455|FG000|Overall Study|Withdrawal by Subject|2|||
161461038|NCT01850602|583082456|FG001|Overall Study|Withdrawal by Subject|4|||
161461039|NCT01850602|583082455|FG000|Overall Study|Decrease in serum calcium|2|||
161461040|NCT01850602|583082456|FG001|Overall Study|Decrease in serum calcium|3|||
161461041|NCT01850602|583082455|FG000|Overall Study|Increase in serum ferritin|1|||
161461042|NCT01850602|583082456|FG001|Overall Study|Increase in serum ferritin|0|||
161461043|NCT00740051|583082459|FG000|Overall Study|Lack of Efficacy|2|||
161461044|NCT00740051|583082460|FG001|Overall Study|Lack of Efficacy|5|||
161461045|NCT00740051|583082459|FG000|Overall Study|Adverse Event|1|||
161461046|NCT00740051|583082460|FG001|Overall Study|Adverse Event|4|||
161461047|NCT00740051|583082459|FG000|Overall Study|Protocol Violation|2|||
161461048|NCT00740051|583082460|FG001|Overall Study|Protocol Violation|6|||
161461049|NCT00740051|583082459|FG000|Overall Study|Lost to Follow-up|3|||
161461050|NCT00740051|583082460|FG001|Overall Study|Lost to Follow-up|8|||
161461051|NCT00740051|583082459|FG000|Overall Study|Withdrawal by Subject|6|||
161461052|NCT00740051|583082460|FG001|Overall Study|Withdrawal by Subject|8|||
161461053|NCT00740051|583082459|FG000|Overall Study|Other reason (not specified)|4|||
161461054|NCT00740051|583082460|FG001|Overall Study|Other reason (not specified)|1|||
161461055|NCT03452527|583082461|FG000|Overall Study|Withdrawal by Subject|1|||
161461056|NCT03452527|583082462|FG001|Overall Study|Withdrawal by Subject|1|||
161461057|NCT03452527|583082461|FG000|Overall Study|Study Terminated|2|||
161461058|NCT03452527|583082462|FG001|Overall Study|Study Terminated|3|||
161461059|NCT01585584|583082465|FG000|Overall Study|Lack of Efficacy|1|||
161461060|NCT01585584|583082465|FG000|Overall Study|Withdrawal by Subject|1|||
161461061|NCT01585584|583082465|FG000|Overall Study|Physician Decision|2|||
161461062|NCT04369053|583083920|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
161461063|NCT04369053|583083920|FG000|Overall Study|Withdrawal by Subject|773|||
161461064|NCT04369053|583083920|FG000|Overall Study|Lost to Follow-up|182|||
161461065|NCT04369053|583083920|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
161461066|NCT00096954|583083923|FG000|Overall Study|Adverse Event|3|||
161461067|NCT00096954|583083924|FG001|Overall Study|Adverse Event|1|||
161461068|NCT00096954|583083923|FG000|Overall Study|Withdrawal by Subject|9|||
161461069|NCT00096954|583083924|FG001|Overall Study|Withdrawal by Subject|8|||
161461070|NCT00096954|583083923|FG000|Overall Study|Physician Decision|1|||
161461071|NCT00096954|583083924|FG001|Overall Study|Physician Decision|1|||
161461072|NCT00096954|583083923|FG000|Overall Study|Sponsors Decision|1|||
161461073|NCT00096954|583083924|FG001|Overall Study|Sponsors Decision|1|||
161461074|NCT00096954|583083923|FG000|Overall Study|Pregnancy|1|||
161461075|NCT00096954|583083924|FG001|Overall Study|Pregnancy|1|||
161461076|NCT00096954|583083923|FG000|Overall Study|Initiation of immunotherapy|1|||
161461077|NCT00096954|583083924|FG001|Overall Study|Initiation of immunotherapy|0|||
161572124|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161572125|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161572126|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
161461078|NCT00096954|583083923|FG000|Overall Study|Non-compliance|0|||
161461079|NCT00096954|583083924|FG001|Overall Study|Non-compliance|3|||
161572127|NCT01212757|583477778|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161461080|NCT00096954|583083923|FG000|Overall Study|Lost to Follow-up|8|||
161461081|NCT00096954|583083924|FG001|Overall Study|Lost to Follow-up|5|||
161809945|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809946|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Physician Decision|0|||
161809947|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Physician Decision|0|||
161809948|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Physician Decision|0|||
161461082|NCT01483690|583083925|FG000|Overall Study|Adverse Event|1|||
161461083|NCT01483690|583083926|FG001|Overall Study|Adverse Event|2|||
161461084|NCT01483690|583083925|FG000|Overall Study|clinical deterioration|1|||
161461085|NCT01483690|583083926|FG001|Overall Study|clinical deterioration|0|||
161461086|NCT01483690|583083925|FG000|Overall Study|Physician Decision|0|||
161461087|NCT01483690|583083926|FG001|Overall Study|Physician Decision|2|||
161461088|NCT01483690|583083925|FG000|Overall Study|exclusionary procedure|0|||
161461089|NCT01483690|583083926|FG001|Overall Study|exclusionary procedure|1|||
161461090|NCT02239224|583083927|FG000|Overall Study|Administrative|0|||
161461091|NCT02239224|583083928|FG001|Overall Study|Administrative|0|||
161461092|NCT02239224|583083929|FG002|Overall Study|Administrative|3|||
161461093|NCT02239224|583083930|FG003|Overall Study|Administrative|1|||
161461094|NCT03183778|583083931|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
161461095|NCT03228420|583083940|FG000|Overall Study|Lost to Follow-up|5|||
161461096|NCT03228420|583083941|FG001|Overall Study|Lost to Follow-up|3|||
161461097|NCT03228420|583083940|FG000|Overall Study|Withdrawal by Subject|10|||
161461098|NCT03228420|583083941|FG001|Overall Study|Withdrawal by Subject|0|||
161461099|NCT03228420|583083940|FG000|Overall Study|Adverse Event|5|||
161461100|NCT03228420|583083941|FG001|Overall Study|Adverse Event|2|||
161461101|NCT01083173|583083942|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
161461102|NCT01083173|583083943|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
161461103|NCT01083173|583083942|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
161461104|NCT01083173|583083943|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
161461105|NCT01083173|583083942|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
161461106|NCT01083173|583083943|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
161461107|NCT01083173|583083942|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
161461108|NCT01083173|583083943|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
161461109|NCT01083173|583083942|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
161461110|NCT01083173|583083943|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
161461111|NCT01083173|583083942|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
161461112|NCT01083173|583083943|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
161461113|NCT01083173|583083942|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
161461114|NCT01083173|583083943|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
161461115|NCT01083173|583083942|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
161461116|NCT01083173|583083943|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
161461117|NCT01083173|583083942|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
161461118|NCT01083173|583083943|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
161461119|NCT01083173|583083942|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
161461120|NCT01083173|583083943|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
161461121|NCT01083173|583083942|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
161461122|NCT01083173|583083943|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
161461123|NCT04626310|583083945|FG000|Overall Study|4-miss from treatment|6|||
161461124|NCT04626310|583083946|FG001|Overall Study|4-miss from treatment|5|||
161461125|NCT04626310|583083947|FG002|Overall Study|4-miss from treatment|5|||
161461126|NCT04626310|583083945|FG000|Overall Study|Withdrawal by Subject|1|||
161461127|NCT04626310|583083946|FG001|Overall Study|Withdrawal by Subject|0|||
161461128|NCT04626310|583083947|FG002|Overall Study|Withdrawal by Subject|3|||
161461129|NCT02011893|583083948|FG000|Enrollment to Randomization|Adverse Event|2|||
161461130|NCT02011893|583083949|FG001|Enrollment to Randomization|Adverse Event|0|||
161461131|NCT02011893|583083950|FG002|Enrollment to Randomization|Adverse Event|0|||
161461132|NCT02011893|583083948|FG000|Enrollment to Randomization|Physician Decision|10|||
161461133|NCT02011893|583083949|FG001|Enrollment to Randomization|Physician Decision|0|||
161461134|NCT02011893|583083950|FG002|Enrollment to Randomization|Physician Decision|0|||
161461135|NCT02011893|583083948|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
161461136|NCT02011893|583083949|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
161461137|NCT02011893|583083950|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
161461138|NCT02011893|583083948|FG000|Enrollment to Randomization|Screening Failure|29|||
161461139|NCT02011893|583083949|FG001|Enrollment to Randomization|Screening Failure|0|||
161461140|NCT02011893|583083950|FG002|Enrollment to Randomization|Screening Failure|0|||
161461141|NCT02011893|583083948|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
161461142|NCT02011893|583083949|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
161461143|NCT02011893|583083950|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
161461144|NCT02011893|583083948|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
161461145|NCT02011893|583083949|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
161461146|NCT02011893|583083950|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
161461147|NCT02011893|583083948|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
161461148|NCT02011893|583083949|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
161461149|NCT02011893|583083950|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
161461150|NCT02011893|583083948|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
161461151|NCT02011893|583083949|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
161461152|NCT02011893|583083950|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
161461153|NCT02011893|583083948|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
161572128|NCT01212757|583477779|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
161572129|NCT01212757|583477780|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
161572130|NCT01212757|583477781|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161572131|NCT01212757|583477782|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161572132|NCT01212757|583477783|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161572133|NCT01212757|583477784|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161572134|NCT01212757|583477785|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161572135|NCT01212757|583477786|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
161572136|NCT00487578|583479751|FG000|Overall Study|Adverse Event|1|||
161572137|NCT00487578|583479752|FG001|Overall Study|Adverse Event|2|||
161572138|NCT00487578|583479751|FG000|Overall Study|Lack of Efficacy|0|||
161572139|NCT00487578|583479752|FG001|Overall Study|Lack of Efficacy|1|||
161572140|NCT00487578|583479751|FG000|Overall Study|Lost to Follow-up|0|||
161572141|NCT00487578|583479752|FG001|Overall Study|Lost to Follow-up|1|||
161572142|NCT02525796|583479753|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
161572143|NCT02525796|583479754|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
161572144|NCT02525796|583479755|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
161572145|NCT02525796|583479753|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
161572146|NCT02525796|583479754|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
161572147|NCT02525796|583479755|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
161572148|NCT02525796|583479753|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
161572149|NCT02525796|583479754|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
161572150|NCT02525796|583479755|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
161572151|NCT02525796|583479753|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
161572152|NCT02525796|583479754|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
161572153|NCT02525796|583479755|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
161572154|NCT02525796|583479753|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
161572155|NCT02525796|583479754|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
161572156|NCT02525796|583479755|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
161572157|NCT00726999|583479758|FG000|Overall Study|Physician Decision|0|||
161572158|NCT00726999|583479759|FG001|Overall Study|Physician Decision|1|||
161572159|NCT00726999|583479758|FG000|Overall Study|Withdrawal by Subject|2|||
161572160|NCT00726999|583479759|FG001|Overall Study|Withdrawal by Subject|0|||
161572161|NCT00726999|583479758|FG000|Overall Study|Protocol Violation|1|||
161572162|NCT00726999|583479759|FG001|Overall Study|Protocol Violation|0|||
161572163|NCT01198275|583479760|FG000|Overall Study|Adverse Event|2|||
161572164|NCT01198275|583479761|FG001|Overall Study|Adverse Event|3|||
161572165|NCT01198275|583479760|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
161572166|NCT01198275|583479761|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
161572167|NCT00391846|583479762|FG000|Overall Study|Adverse Event|4|||
161572168|NCT00391846|583479763|FG001|Overall Study|Adverse Event|1|||
161572169|NCT00391846|583479762|FG000|Overall Study|Did not meet the required elig. crit|2|||
161572170|NCT00391846|583479763|FG001|Overall Study|Did not meet the required elig. crit|2|||
161572171|NCT00391846|583479762|FG000|Overall Study|Withdrawal by Subject|2|||
161572172|NCT00391846|583479763|FG001|Overall Study|Withdrawal by Subject|3|||
161572173|NCT00391846|583479762|FG000|Overall Study|Developed study specific DC criteria|0|||
161572174|NCT00391846|583479763|FG001|Overall Study|Developed study specific DC criteria|1|||
161572175|NCT02477670|583479767|FG000|Stage 1|Adverse Event|2|||
161572176|NCT02477670|583479768|FG001|Stage 1|Adverse Event|7|||
161572177|NCT02477670|583479769|FG002|Stage 1|Adverse Event|0|||
161572178|NCT02477670|583479770|FG003|Stage 1|Adverse Event|0|||
161572179|NCT02477670|583479771|FG004|Stage 1|Adverse Event|0|||
161461154|NCT02011893|583083949|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
161572180|NCT02477670|583479772|FG005|Stage 1|Adverse Event|0|||
161461155|NCT02011893|583083950|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
161572181|NCT02477670|583479773|FG006|Stage 1|Adverse Event|0|||
161572182|NCT02477670|583479767|FG000|Stage 1|Lost to Follow-up|0|||
161572183|NCT02477670|583479768|FG001|Stage 1|Lost to Follow-up|2|||
161572184|NCT02477670|583479769|FG002|Stage 1|Lost to Follow-up|0|||
161572185|NCT02477670|583479770|FG003|Stage 1|Lost to Follow-up|0|||
161572186|NCT02477670|583479771|FG004|Stage 1|Lost to Follow-up|0|||
161572187|NCT02477670|583479772|FG005|Stage 1|Lost to Follow-up|0|||
161572188|NCT02477670|583479773|FG006|Stage 1|Lost to Follow-up|0|||
161572189|NCT02477670|583479767|FG000|Stage 1|Withdrawal by Subject|1|||
161461156|NCT00991952|583083951|FG000|Overall Study|Adverse Event|0|||
161461157|NCT00991952|583083952|FG001|Overall Study|Adverse Event|1|||
161461158|NCT03116347|583083954|FG000|Overall Study|Withdrawal by Subject|1|||
161461159|NCT03116347|583083955|FG001|Overall Study|Withdrawal by Subject|2|||
161461160|NCT01255787|583083956|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
161461161|NCT01255787|583083957|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
161461162|NCT01255787|583083958|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
161461163|NCT01255787|583083959|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
161461164|NCT01255787|583083956|FG000|Overall Study|Major Protocol Deviation|1|||
161461165|NCT01255787|583083957|FG001|Overall Study|Major Protocol Deviation|1|||
161461166|NCT01255787|583083958|FG002|Overall Study|Major Protocol Deviation|0|||
161461167|NCT01255787|583083959|FG003|Overall Study|Major Protocol Deviation|4|||
161461168|NCT01255787|583083956|FG000|Overall Study|Lost to Follow-up|1|||
161461169|NCT01255787|583083957|FG001|Overall Study|Lost to Follow-up|2|||
161461170|NCT01255787|583083958|FG002|Overall Study|Lost to Follow-up|4|||
161461171|NCT01255787|583083959|FG003|Overall Study|Lost to Follow-up|2|||
161461172|NCT01255787|583083956|FG000|Overall Study|Withdrawal of Consent|3|||
161461173|NCT01255787|583083957|FG001|Overall Study|Withdrawal of Consent|9|||
161461174|NCT01255787|583083958|FG002|Overall Study|Withdrawal of Consent|3|||
161461175|NCT01255787|583083959|FG003|Overall Study|Withdrawal of Consent|4|||
161461176|NCT01255787|583083956|FG000|Overall Study|Pregnancy|0|||
161461177|NCT01255787|583083957|FG001|Overall Study|Pregnancy|0|||
161461178|NCT01255787|583083958|FG002|Overall Study|Pregnancy|0|||
161461179|NCT01255787|583083959|FG003|Overall Study|Pregnancy|1|||
161461180|NCT01255787|583083956|FG000|Overall Study|Lack of Efficacy|2|||
161461181|NCT01255787|583083957|FG001|Overall Study|Lack of Efficacy|2|||
161461182|NCT01255787|583083958|FG002|Overall Study|Lack of Efficacy|2|||
161461183|NCT01255787|583083959|FG003|Overall Study|Lack of Efficacy|2|||
161461184|NCT01255787|583083956|FG000|Overall Study|Noncompliance with Study Drug|3|||
161461185|NCT01255787|583083957|FG001|Overall Study|Noncompliance with Study Drug|1|||
161461186|NCT01255787|583083958|FG002|Overall Study|Noncompliance with Study Drug|0|||
161461187|NCT01255787|583083959|FG003|Overall Study|Noncompliance with Study Drug|0|||
161461188|NCT04966741|583083960|FG000|Overall Study|Lost to Follow-up|1|||
161461189|NCT04966741|583083961|FG001|Overall Study|Lost to Follow-up|0|||
161461190|NCT05101317|583083964|FG000|Week1-13|Adverse Event|0|||
161461191|NCT05101317|583083965|FG001|Week1-13|Adverse Event|1|||
161461192|NCT05101317|583083966|FG002|Week1-13|Adverse Event|0|||
161461193|NCT05101317|583083967|FG003|Week1-13|Adverse Event|0|||
161461194|NCT05101317|583083964|FG000|Week1-13|Withdrawal by Subject|0|||
161461195|NCT05101317|583083965|FG001|Week1-13|Withdrawal by Subject|2|||
161461196|NCT05101317|583083966|FG002|Week1-13|Withdrawal by Subject|0|||
161461197|NCT05101317|583083967|FG003|Week1-13|Withdrawal by Subject|0|||
161461198|NCT05101317|583083964|FG000|Week1-13|Early Withdrawl|0|||
161461199|NCT05101317|583083965|FG001|Week1-13|Early Withdrawl|0|||
161461200|NCT05101317|583083966|FG002|Week1-13|Early Withdrawl|0|||
161461201|NCT05101317|583083967|FG003|Week1-13|Early Withdrawl|1|||
161461202|NCT05101317|583083964|FG000|Week 13-25|Lost to Follow-up|0|||
161461203|NCT05101317|583083965|FG001|Week 13-25|Lost to Follow-up|0|||
161461204|NCT05101317|583083966|FG002|Week 13-25|Lost to Follow-up|1|||
161461205|NCT05101317|583083967|FG003|Week 13-25|Lost to Follow-up|0|||
161461206|NCT05101317|583083964|FG000|Week 13-25|Withdrawal by Subject|1|||
161461207|NCT05101317|583083965|FG001|Week 13-25|Withdrawal by Subject|1|||
161461208|NCT05101317|583083966|FG002|Week 13-25|Withdrawal by Subject|0|||
161461209|NCT05101317|583083967|FG003|Week 13-25|Withdrawal by Subject|0|||
161461210|NCT05101317|583083964|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
161461211|NCT05101317|583083965|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
161461212|NCT05101317|583083966|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
161461213|NCT05101317|583083967|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
161461214|NCT05764265|583083968|FG000|Overall Study|Adverse Event|1|||
161461215|NCT05764265|583083969|FG001|Overall Study|Adverse Event|0|||
161461216|NCT05764265|583083968|FG000|Overall Study|Physician Decision|1|||
161461217|NCT05764265|583083969|FG001|Overall Study|Physician Decision|8|||
161461218|NCT05764265|583083968|FG000|Overall Study|Study Terminated By Sponsor|20|||
161461219|NCT05764265|583083969|FG001|Overall Study|Study Terminated By Sponsor|0|||
161461220|NCT05764265|583083968|FG000|Overall Study|Participant Decision|1|||
161461221|NCT05764265|583083969|FG001|Overall Study|Participant Decision|0|||
161461222|NCT00509262|583083970|FG000|Overall Study|Adverse Event|16|||
161461223|NCT00509262|583083971|FG001|Overall Study|Adverse Event|18|||
161461224|NCT00509262|583083970|FG000|Overall Study|Other|2|||
161461225|NCT00509262|583083971|FG001|Overall Study|Other|2|||
161461226|NCT00509262|583083970|FG000|Overall Study|Lack of Efficacy|1|||
161461227|NCT00509262|583083971|FG001|Overall Study|Lack of Efficacy|0|||
161461228|NCT00509262|583083970|FG000|Overall Study|Lost to Follow-up|1|||
161461229|NCT00509262|583083971|FG001|Overall Study|Lost to Follow-up|6|||
161461230|NCT00509262|583083970|FG000|Overall Study|Physician Decision|1|||
161461231|NCT00509262|583083971|FG001|Overall Study|Physician Decision|3|||
161461232|NCT00509262|583083970|FG000|Overall Study|Protocol Violation|2|||
161461233|NCT00509262|583083971|FG001|Overall Study|Protocol Violation|2|||
161572190|NCT02477670|583479768|FG001|Stage 1|Withdrawal by Subject|2|||
161572191|NCT02477670|583479769|FG002|Stage 1|Withdrawal by Subject|0|||
161572192|NCT02477670|583479770|FG003|Stage 1|Withdrawal by Subject|0|||
161572193|NCT02477670|583479771|FG004|Stage 1|Withdrawal by Subject|0|||
161572194|NCT02477670|583479772|FG005|Stage 1|Withdrawal by Subject|0|||
161572195|NCT02477670|583479773|FG006|Stage 1|Withdrawal by Subject|0|||
161572196|NCT02477670|583479767|FG000|Stage 1|Non-compliance with Study Drug|1|||
161572197|NCT02477670|583479768|FG001|Stage 1|Non-compliance with Study Drug|2|||
161809949|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Physician Decision|0|||
161809950|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Physician Decision|0|||
161461234|NCT00509262|583083970|FG000|Overall Study|Withdrawal by Subject|24|||
161461235|NCT00509262|583083971|FG001|Overall Study|Withdrawal by Subject|11|||
161461236|NCT00725842|583083972|FG000|Overall Study|Lost to Follow-up|19|||
161461237|NCT00725842|583083972|FG000|Overall Study|Death|1|||
161461238|NCT00725842|583083972|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
161461239|NCT00725842|583083972|FG000|Overall Study|Consent date prior to study start date|5|||
161461240|NCT00725842|583083972|FG000|Overall Study|Inclusion criterion not met|1|||
161461241|NCT00725842|583083972|FG000|Overall Study|No Visit 1 data|1|||
161461242|NCT01853618|583083973|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
161461243|NCT01853618|583083974|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
161461244|NCT01853618|583083975|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
161461245|NCT01853618|583083976|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
161461246|NCT01853618|583083977|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
161461247|NCT01853618|583083973|FG000|Overall Study|Progressive disease|1|||
161461248|NCT01853618|583083974|FG001|Overall Study|Progressive disease|1|||
161461249|NCT01853618|583083975|FG002|Overall Study|Progressive disease|1|||
161461250|NCT01853618|583083976|FG003|Overall Study|Progressive disease|1|||
161461251|NCT01853618|583083977|FG004|Overall Study|Progressive disease|2|||
161461252|NCT01853618|583083973|FG000|Overall Study|Physician Decision|0|||
161461253|NCT01853618|583083974|FG001|Overall Study|Physician Decision|1|||
161461254|NCT01853618|583083975|FG002|Overall Study|Physician Decision|1|||
161461255|NCT01853618|583083976|FG003|Overall Study|Physician Decision|0|||
161461256|NCT01853618|583083977|FG004|Overall Study|Physician Decision|0|||
161461257|NCT01853618|583083973|FG000|Overall Study|Refused further treatment|0|||
161461258|NCT01853618|583083974|FG001|Overall Study|Refused further treatment|0|||
161461259|NCT01853618|583083975|FG002|Overall Study|Refused further treatment|0|||
161461260|NCT01853618|583083976|FG003|Overall Study|Refused further treatment|0|||
161461261|NCT01853618|583083977|FG004|Overall Study|Refused further treatment|1|||
161461262|NCT02009384|583083985|FG000|Overall Study|Death|2|||
161461263|NCT01092832|583083986|FG000|Overall Study|Other|1|||
161461264|NCT01092832|583083987|FG001|Overall Study|Other|0|||
161461265|NCT01075191|583083988|FG000|Overall Study|Death|1|||
161461266|NCT01075191|583083988|FG000|Overall Study|Intensification|3|||
161461267|NCT01075191|583083988|FG000|Overall Study|Co-morbidities|1|||
161461268|NCT01075191|583083988|FG000|Overall Study|Adverse Event|4|||
161461269|NCT01075191|583083988|FG000|Overall Study|Noncompliance|3|||
161461270|NCT01075191|583083988|FG000|Overall Study|Therapy Break|3|||
161809951|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Physician Decision|0|||
161809952|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Physician Decision|0|||
161809953|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Physician Decision|0|||
161809954|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Physician Decision|0|||
161461271|NCT01075191|583083988|FG000|Overall Study|Patient's Wish|2|||
161461272|NCT01075191|583083988|FG000|Overall Study|Unknown Reasons|1|||
161461273|NCT04777331|583083989|FG000|DBT Period|Death|2|||
161461274|NCT04777331|583083990|FG001|DBT Period|Death|1|||
161461275|NCT04777331|583083991|FG002|DBT Period|Death|0|||
161461276|NCT04777331|583083989|FG000|DBT Period|Reason not Specified|1|||
161461277|NCT04777331|583083990|FG001|DBT Period|Reason not Specified|1|||
161461278|NCT04777331|583083991|FG002|DBT Period|Reason not Specified|0|||
161461279|NCT04777331|583083989|FG000|DBT Period|Physician Decision|4|||
161461280|NCT04777331|583083990|FG001|DBT Period|Physician Decision|0|||
161461281|NCT04777331|583083991|FG002|DBT Period|Physician Decision|0|||
161461282|NCT04777331|583083989|FG000|DBT Period|Withdrawal by Subject|12|||
161461283|NCT04777331|583083990|FG001|DBT Period|Withdrawal by Subject|11|||
161461284|NCT04777331|583083991|FG002|DBT Period|Withdrawal by Subject|0|||
161461285|NCT04777331|583083989|FG000|DBT Period|Randomized but not Treated|1|||
161572198|NCT02477670|583479769|FG002|Stage 1|Non-compliance with Study Drug|0|||
161809955|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Physician Decision|0|||
161809956|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Physician Decision|5|||
161461286|NCT04777331|583083990|FG001|DBT Period|Randomized but not Treated|3|||
161461287|NCT04777331|583083991|FG002|DBT Period|Randomized but not Treated|0|||
161461288|NCT04777331|583083989|FG000|OLE Period|Ongoing in OLE|0|||
161461289|NCT04777331|583083990|FG001|OLE Period|Ongoing in OLE|0|||
161461290|NCT04777331|583083991|FG002|OLE Period|Ongoing in OLE|534|||
161461291|NCT01401959|583083992|FG000|Enrolled|Withdrawal by Subject|1|||
161461292|NCT01401959|583083993|FG001|Enrolled|Withdrawal by Subject|0|||
161461293|NCT01401959|583083994|FG002|Enrolled|Withdrawal by Subject|0|||
161461294|NCT01401959|583083992|FG000|Treated|Disease Progression|2|||
161572199|NCT02477670|583479770|FG003|Stage 1|Non-compliance with Study Drug|0|||
161572200|NCT02477670|583479771|FG004|Stage 1|Non-compliance with Study Drug|0|||
161572201|NCT02477670|583479772|FG005|Stage 1|Non-compliance with Study Drug|0|||
161572202|NCT02477670|583479773|FG006|Stage 1|Non-compliance with Study Drug|0|||
161572203|NCT02477670|583479767|FG000|Stage 2|Adverse Event|0|||
161572204|NCT02477670|583479768|FG001|Stage 2|Adverse Event|0|||
161572205|NCT02477670|583479769|FG002|Stage 2|Adverse Event|1|||
161572206|NCT02477670|583479770|FG003|Stage 2|Adverse Event|0|||
161572207|NCT02477670|583479771|FG004|Stage 2|Adverse Event|0|||
161572208|NCT02477670|583479772|FG005|Stage 2|Adverse Event|0|||
161572209|NCT02477670|583479773|FG006|Stage 2|Adverse Event|0|||
161572210|NCT02477670|583479767|FG000|Stage 2|Antipsychotic Medication Changed|0|||
161572211|NCT02477670|583479768|FG001|Stage 2|Antipsychotic Medication Changed|0|||
161572212|NCT02477670|583479769|FG002|Stage 2|Antipsychotic Medication Changed|1|||
161572213|NCT02477670|583479770|FG003|Stage 2|Antipsychotic Medication Changed|0|||
161572214|NCT02477670|583479771|FG004|Stage 2|Antipsychotic Medication Changed|0|||
161572215|NCT02477670|583479772|FG005|Stage 2|Antipsychotic Medication Changed|0|||
161572216|NCT02477670|583479773|FG006|Stage 2|Antipsychotic Medication Changed|0|||
161572217|NCT02477670|583479767|FG000|Stage 2|Withdrawal by Subject|0|||
161572218|NCT02477670|583479768|FG001|Stage 2|Withdrawal by Subject|0|||
161572219|NCT02477670|583479769|FG002|Stage 2|Withdrawal by Subject|0|||
161572220|NCT02477670|583479770|FG003|Stage 2|Withdrawal by Subject|1|||
161572221|NCT02477670|583479771|FG004|Stage 2|Withdrawal by Subject|0|||
161572222|NCT02477670|583479772|FG005|Stage 2|Withdrawal by Subject|0|||
161572223|NCT02477670|583479773|FG006|Stage 2|Withdrawal by Subject|0|||
161572224|NCT02810080|583479774|FG000|Overall Study|Adverse Event|3|||
161572225|NCT02810080|583479775|FG001|Overall Study|Adverse Event|0|||
161572226|NCT02810080|583479774|FG000|Overall Study|Death|0|||
161572227|NCT02810080|583479775|FG001|Overall Study|Death|2|||
161572228|NCT02810080|583479774|FG000|Overall Study|Physician Decision|4|||
161572229|NCT02810080|583479775|FG001|Overall Study|Physician Decision|0|||
161572230|NCT02810080|583479774|FG000|Overall Study|Withdrawal by Subject|0|||
161572231|NCT02810080|583479775|FG001|Overall Study|Withdrawal by Subject|2|||
161572232|NCT01759264|583479776|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
161572233|NCT01759264|583479776|FG000|Overall Study|Adverse Event|1|||
161572234|NCT01759264|583479776|FG000|Overall Study|Other|2|||
161572235|NCT01759264|583479776|FG000|Overall Study|Lost to Follow-up|2|||
161572236|NCT01759264|583479776|FG000|Overall Study|Withdrawal by Subject|3|||
161572237|NCT01759264|583479776|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
161572238|NCT02034916|583479781|FG000|Overall Study|Death|39|||
161572239|NCT02034916|583479782|FG001|Overall Study|Death|28|||
161572240|NCT02034916|583479781|FG000|Overall Study|Withdrawal by Subject|2|||
161572241|NCT02034916|583479782|FG001|Overall Study|Withdrawal by Subject|1|||
161572242|NCT02034916|583479781|FG000|Overall Study|Lost to Follow-up|4|||
161572243|NCT02034916|583479782|FG001|Overall Study|Lost to Follow-up|1|||
161572244|NCT02034916|583479781|FG000|Overall Study|Study terminated by sponsor|4|||
161572245|NCT02034916|583479782|FG001|Overall Study|Study terminated by sponsor|5|||
161572246|NCT00753012|583479786|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
161572247|NCT00753012|583479787|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
161572248|NCT00753012|583479786|FG000|Overall Study|Adverse Event|2|||
161572249|NCT00753012|583479787|FG001|Overall Study|Adverse Event|0|||
161572250|NCT00753012|583479786|FG000|Overall Study|Withdrawal by Subject|0|||
161572251|NCT00753012|583479787|FG001|Overall Study|Withdrawal by Subject|1|||
161572252|NCT00753012|583479786|FG000|Overall Study|Lost to Follow-up|4|||
161572253|NCT00753012|583479787|FG001|Overall Study|Lost to Follow-up|0|||
161572254|NCT00753012|583479786|FG000|Overall Study|Confounded endpoint data|1|||
161572255|NCT00753012|583479787|FG001|Overall Study|Confounded endpoint data|0|||
161572256|NCT01930045|583479788|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
161572257|NCT01930045|583479789|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
161809957|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Physician Decision|1|||
161809958|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Physician Decision|1|||
161809959|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Physician Decision|0|||
161809960|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Physician Decision|0|||
161809961|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Death|0|||
161809962|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Death|0|||
161809963|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Death|0|||
161809964|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Death|0|||
161809965|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Death|0|||
161461295|NCT01401959|583083993|FG001|Treated|Disease Progression|2|||
161461296|NCT01401959|583083994|FG002|Treated|Disease Progression|1|||
161461297|NCT01401959|583083992|FG000|Treated|Adverse Event|4|||
161461298|NCT01401959|583083993|FG001|Treated|Adverse Event|3|||
161461299|NCT01401959|583083994|FG002|Treated|Adverse Event|2|||
161461300|NCT01401959|583083992|FG000|Treated|Withdrawal by Subject|1|||
161461301|NCT01401959|583083993|FG001|Treated|Withdrawal by Subject|2|||
161461302|NCT01401959|583083994|FG002|Treated|Withdrawal by Subject|2|||
161461303|NCT01401959|583083992|FG000|Treated|Protocol Violation|0|||
161461304|NCT01401959|583083993|FG001|Treated|Protocol Violation|1|||
161461305|NCT01401959|583083994|FG002|Treated|Protocol Violation|0|||
161461306|NCT00400153|583083999|FG000|Overall Study|AE due to study disease worsening|14|||
161461307|NCT00400153|583084000|FG001|Overall Study|AE due to study disease worsening|19|||
161461308|NCT00400153|583084001|FG002|Overall Study|AE due to study disease worsening|20|||
161461309|NCT00400153|583083999|FG000|Overall Study|AE due to other disease worsening|2|||
161461310|NCT00400153|583084000|FG001|Overall Study|AE due to other disease worsening|1|||
161461311|NCT00400153|583084001|FG002|Overall Study|AE due to other disease worsening|0|||
161461312|NCT00400153|583083999|FG000|Overall Study|AE due to other condition|3|||
161461313|NCT00400153|583084000|FG001|Overall Study|AE due to other condition|14|||
161461314|NCT00400153|583084001|FG002|Overall Study|AE due to other condition|15|||
161461315|NCT00400153|583083999|FG000|Overall Study|Protocol Violation|7|||
161461316|NCT00400153|583084000|FG001|Overall Study|Protocol Violation|4|||
161461317|NCT00400153|583084001|FG002|Overall Study|Protocol Violation|9|||
161461318|NCT00400153|583083999|FG000|Overall Study|Lost to Follow-up|2|||
161461319|NCT00400153|583084000|FG001|Overall Study|Lost to Follow-up|1|||
161461320|NCT00400153|583084001|FG002|Overall Study|Lost to Follow-up|4|||
161461321|NCT00400153|583083999|FG000|Overall Study|Withdrawal by Subject|12|||
161461322|NCT00400153|583084000|FG001|Overall Study|Withdrawal by Subject|11|||
161461323|NCT00400153|583084001|FG002|Overall Study|Withdrawal by Subject|10|||
161461324|NCT00400153|583083999|FG000|Overall Study|Other reasons - not mentioned above|8|||
161461325|NCT00400153|583084000|FG001|Overall Study|Other reasons - not mentioned above|5|||
161461326|NCT00400153|583084001|FG002|Overall Study|Other reasons - not mentioned above|3|||
161461327|NCT01423604|583084003|FG000|Safety Run-In|Adverse Event|3|||
161461328|NCT01423604|583084004|FG001|Safety Run-In|Adverse Event|0|||
161461329|NCT01423604|583084003|FG000|Safety Run-In|Death|1|||
161461330|NCT01423604|583084004|FG001|Safety Run-In|Death|0|||
161461331|NCT01423604|583084003|FG000|Safety Run-In|Physician Decision|1|||
161461332|NCT01423604|583084004|FG001|Safety Run-In|Physician Decision|0|||
161461333|NCT01423604|583084003|FG000|Safety Run-In|Disease progression|3|||
161461334|NCT01423604|583084004|FG001|Safety Run-In|Disease progression|0|||
161461335|NCT01423604|583084003|FG000|Safety Run-In|Patient decision|1|||
161461336|NCT01423604|583084004|FG001|Safety Run-In|Patient decision|0|||
161461337|NCT01423604|583084003|FG000|Randomized|Adverse Event|4|||
161461338|NCT01423604|583084004|FG001|Randomized|Adverse Event|10|||
161461339|NCT01423604|583084003|FG000|Randomized|Death|1|||
161461340|NCT01423604|583084004|FG001|Randomized|Death|0|||
161461341|NCT01423604|583084003|FG000|Randomized|Physician Decision|16|||
161461342|NCT01423604|583084004|FG001|Randomized|Physician Decision|13|||
161461343|NCT01423604|583084003|FG000|Randomized|Other - unspecified|37|||
161461344|NCT01423604|583084004|FG001|Randomized|Other - unspecified|31|||
161461345|NCT01423604|583084003|FG000|Randomized|Patient decision|5|||
161461346|NCT01423604|583084004|FG001|Randomized|Patient decision|9|||
161461347|NCT02414139|583084007|FG000|Treatment Period|Adverse Event|11|||
161461348|NCT02414139|583084008|FG001|Treatment Period|Adverse Event|6|||
161461349|NCT02414139|583084009|FG002|Treatment Period|Adverse Event|8|||
161461350|NCT02414139|583084010|FG003|Treatment Period|Adverse Event|5|||
161461351|NCT02414139|583084011|FG004|Treatment Period|Adverse Event|14|||
161809966|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Death|0|||
161461352|NCT02414139|583084012|FG005|Treatment Period|Adverse Event|3|||
161461353|NCT02414139|583084013|FG006|Treatment Period|Adverse Event|6|||
161461354|NCT02414139|583084014|FG007|Treatment Period|Adverse Event|1|||
161461355|NCT02414139|583084015|FG008|Treatment Period|Adverse Event|6|||
161461356|NCT02414139|583084016|FG009|Treatment Period|Adverse Event|8|||
161461357|NCT02414139|583084007|FG000|Treatment Period|Death|0|||
161461358|NCT02414139|583084008|FG001|Treatment Period|Death|0|||
161461359|NCT02414139|583084009|FG002|Treatment Period|Death|1|||
161461360|NCT02414139|583084010|FG003|Treatment Period|Death|1|||
161461361|NCT02414139|583084011|FG004|Treatment Period|Death|0|||
161461362|NCT02414139|583084012|FG005|Treatment Period|Death|0|||
161461363|NCT02414139|583084013|FG006|Treatment Period|Death|0|||
161461364|NCT02414139|583084014|FG007|Treatment Period|Death|0|||
161461365|NCT02414139|583084015|FG008|Treatment Period|Death|0|||
161461366|NCT02414139|583084016|FG009|Treatment Period|Death|1|||
161461367|NCT02414139|583084007|FG000|Treatment Period|Physician Decision|5|||
161461368|NCT02414139|583084008|FG001|Treatment Period|Physician Decision|4|||
161461369|NCT02414139|583084009|FG002|Treatment Period|Physician Decision|6|||
161461370|NCT02414139|583084010|FG003|Treatment Period|Physician Decision|1|||
161461371|NCT02414139|583084011|FG004|Treatment Period|Physician Decision|4|||
161461372|NCT02414139|583084012|FG005|Treatment Period|Physician Decision|0|||
161461373|NCT02414139|583084013|FG006|Treatment Period|Physician Decision|2|||
161461374|NCT02414139|583084014|FG007|Treatment Period|Physician Decision|0|||
161461375|NCT02414139|583084015|FG008|Treatment Period|Physician Decision|1|||
161461376|NCT02414139|583084016|FG009|Treatment Period|Physician Decision|4|||
161461377|NCT02414139|583084007|FG000|Treatment Period|Progressive disease|48|||
161461378|NCT02414139|583084008|FG001|Treatment Period|Progressive disease|31|||
161461379|NCT02414139|583084009|FG002|Treatment Period|Progressive disease|37|||
161461380|NCT02414139|583084010|FG003|Treatment Period|Progressive disease|21|||
161461381|NCT02414139|583084011|FG004|Treatment Period|Progressive disease|43|||
161461382|NCT02414139|583084012|FG005|Treatment Period|Progressive disease|12|||
161461383|NCT02414139|583084013|FG006|Treatment Period|Progressive disease|16|||
161461384|NCT02414139|583084014|FG007|Treatment Period|Progressive disease|2|||
161461385|NCT02414139|583084015|FG008|Treatment Period|Progressive disease|20|||
161461386|NCT02414139|583084016|FG009|Treatment Period|Progressive disease|14|||
161461387|NCT02414139|583084007|FG000|Treatment Period|Protocol deviation|0|||
161461388|NCT02414139|583084008|FG001|Treatment Period|Protocol deviation|0|||
161461389|NCT02414139|583084009|FG002|Treatment Period|Protocol deviation|1|||
161461390|NCT02414139|583084010|FG003|Treatment Period|Protocol deviation|0|||
161461391|NCT02414139|583084011|FG004|Treatment Period|Protocol deviation|0|||
161461392|NCT02414139|583084012|FG005|Treatment Period|Protocol deviation|0|||
161461393|NCT02414139|583084013|FG006|Treatment Period|Protocol deviation|0|||
161461394|NCT02414139|583084014|FG007|Treatment Period|Protocol deviation|0|||
161461395|NCT02414139|583084015|FG008|Treatment Period|Protocol deviation|0|||
161572258|NCT01930045|583479790|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
161572259|NCT01930045|583479791|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
161572260|NCT01930045|583479792|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
161572261|NCT01930045|583479793|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
161572262|NCT01930045|583479788|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
161572263|NCT01930045|583479789|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
161572264|NCT01930045|583479790|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
161572265|NCT01930045|583479791|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
161572266|NCT01930045|583479792|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
161572267|NCT01930045|583479793|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
161572268|NCT01370694|583479796|FG000|Overall Study|Switched to rituximab|4|||
161572269|NCT01370694|583479796|FG000|Overall Study|Progressive disease|2|||
161572270|NCT04842604|583479801|FG000|Overall Study|Death|1|||
161572271|NCT04842604|583479802|FG001|Overall Study|Death|0|||
161572272|NCT04842604|583479801|FG000|Overall Study|Other|4|||
161572273|NCT04842604|583479802|FG001|Overall Study|Other|4|||
161572274|NCT04842604|583479801|FG000|Overall Study|Randomized but not treated|1|||
161572275|NCT04842604|583479802|FG001|Overall Study|Randomized but not treated|0|||
161572276|NCT00344019|583479803|FG000|Overall Study|did not meet final inclusion criteria|0|||
161572277|NCT00344019|583479804|FG001|Overall Study|did not meet final inclusion criteria|0|||
161572278|NCT00344019|583479805|FG002|Overall Study|did not meet final inclusion criteria|74|||
161572279|NCT01193153|583479806|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
161572280|NCT01193153|583479807|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
161572281|NCT01193153|583479806|FG000|Open-label Lead in Period|Pregnancy|1|||
161572282|NCT01193153|583479807|FG001|Open-label Lead in Period|Pregnancy|0|||
161572283|NCT01193153|583479806|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
161572284|NCT01193153|583479807|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
161572285|NCT01193153|583479806|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
161809967|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Death|0|||
161809968|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Death|0|||
161461396|NCT02414139|583084016|FG009|Treatment Period|Protocol deviation|0|||
161461397|NCT02414139|583084007|FG000|Treatment Period|Subject/Guardian decision|5|||
161461398|NCT02414139|583084008|FG001|Treatment Period|Subject/Guardian decision|1|||
161461399|NCT02414139|583084009|FG002|Treatment Period|Subject/Guardian decision|1|||
161461400|NCT02414139|583084010|FG003|Treatment Period|Subject/Guardian decision|2|||
161461401|NCT02414139|583084011|FG004|Treatment Period|Subject/Guardian decision|5|||
161461402|NCT02414139|583084012|FG005|Treatment Period|Subject/Guardian decision|0|||
161461403|NCT02414139|583084013|FG006|Treatment Period|Subject/Guardian decision|2|||
161461404|NCT02414139|583084014|FG007|Treatment Period|Subject/Guardian decision|0|||
161461405|NCT02414139|583084015|FG008|Treatment Period|Subject/Guardian decision|1|||
161461406|NCT02414139|583084016|FG009|Treatment Period|Subject/Guardian decision|1|||
161461407|NCT02414139|583084007|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161461408|NCT02414139|583084008|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161461409|NCT02414139|583084009|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161461410|NCT02414139|583084010|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161461411|NCT02414139|583084011|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
161461412|NCT02414139|583084012|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161461413|NCT02414139|583084013|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
161461414|NCT02414139|583084014|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161461415|NCT02414139|583084015|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
161461416|NCT02414139|583084016|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
161461417|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161461418|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461419|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461420|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461421|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
161572286|NCT01193153|583479807|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
161572287|NCT01193153|583479806|FG000|Open-label Lead in Period|Other|14|||
161572288|NCT01193153|583479807|FG001|Open-label Lead in Period|Other|0|||
161572289|NCT01193153|583479806|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
161461422|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461423|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461424|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461425|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161572290|NCT01193153|583479807|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
161572291|NCT01193153|583479806|FG000|Open-label Lead in Period|Adverse Event|41|||
161572292|NCT01193153|583479807|FG001|Open-label Lead in Period|Adverse Event|0|||
161572293|NCT01193153|583479806|FG000|Open-label Lead in Period|Death|1|||
161572294|NCT01193153|583479807|FG001|Open-label Lead in Period|Death|0|||
161572295|NCT01193153|583479806|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
161572296|NCT01193153|583479807|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
161572297|NCT01193153|583479806|FG000|Open-label Stabilization Period|Adverse Event|9|||
161572298|NCT01193153|583479807|FG001|Open-label Stabilization Period|Adverse Event|0|||
161572299|NCT01193153|583479806|FG000|Open-label Stabilization Period|Death|2|||
161572300|NCT01193153|583479807|FG001|Open-label Stabilization Period|Death|0|||
161572301|NCT01193153|583479806|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
161572302|NCT01193153|583479807|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
161572303|NCT01193153|583479806|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
161572304|NCT01193153|583479807|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
161572305|NCT01193153|583479806|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
161572306|NCT01193153|583479807|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
161572307|NCT01193153|583479806|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
161572308|NCT01193153|583479807|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
161572309|NCT01193153|583479806|FG000|Open-label Stabilization Period|Other|8|||
161572310|NCT01193153|583479807|FG001|Open-label Stabilization Period|Other|0|||
161572311|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Other|2|||
161461426|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161461427|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161461428|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Death|1|||
161461429|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Death|0|||
161461430|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Death|0|||
161461431|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Death|1|||
161461432|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Death|0|||
161461433|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Death|0|||
161461434|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Death|0|||
161461435|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Death|0|||
161461436|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Death|1|||
161461437|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
161461438|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461439|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461440|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461441|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461442|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461443|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461444|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461445|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461446|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161461447|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
161461448|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161461449|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
161461450|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161461451|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
161461452|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161461453|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161461454|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161461455|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161461456|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161461457|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
161461458|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
161461459|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
161461460|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
161461461|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
161461462|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
161461463|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
161461464|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
161461465|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161461466|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161461467|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461468|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
161461469|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461470|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461471|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461472|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461473|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461474|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461475|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
161461476|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
161461477|NCT02414139|583084007|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
161461478|NCT02414139|583084008|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161461479|NCT02414139|583084009|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
161461480|NCT02414139|583084010|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161461481|NCT02414139|583084011|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161461482|NCT02414139|583084012|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161461483|NCT02414139|583084013|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
161461484|NCT02414139|583084014|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
161461485|NCT02414139|583084015|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
161461486|NCT02414139|583084016|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161461487|NCT01226121|583084017|FG000|Overall Study|Lost to Follow-up|2|||
161461488|NCT01226121|583084018|FG001|Overall Study|Lost to Follow-up|0|||
161461489|NCT01226121|583084019|FG002|Overall Study|Lost to Follow-up|1|||
161461490|NCT04473482|583084020|FG000|Overall Study|Death|0|||
161461491|NCT04473482|583084021|FG001|Overall Study|Death|3|||
161461492|NCT04473482|583084020|FG000|Overall Study|Lost to Follow-up|9|||
161461493|NCT04473482|583084021|FG001|Overall Study|Lost to Follow-up|7|||
161461494|NCT04473482|583084020|FG000|Overall Study|Withdrawal by Subject|2|||
161461495|NCT04473482|583084021|FG001|Overall Study|Withdrawal by Subject|1|||
161461496|NCT06785857|583084028|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
161461497|NCT06785857|583084029|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
161461498|NCT05952401|583084037|FG000|Overall Study|Lost to Follow-up|4|||
161461499|NCT05952401|583084038|FG001|Overall Study|Lost to Follow-up|1|||
161461500|NCT03954041|583084946|FG000|Overall Study|Lost to Follow-up|3|||
161461501|NCT03954041|583084947|FG001|Overall Study|Lost to Follow-up|3|||
161461502|NCT03954041|583084948|FG002|Overall Study|Lost to Follow-up|6|||
161461503|NCT03954041|583084946|FG000|Overall Study|Death|4|||
161461504|NCT03954041|583084947|FG001|Overall Study|Death|0|||
161461505|NCT03954041|583084948|FG002|Overall Study|Death|1|||
161461506|NCT03954041|583084946|FG000|Overall Study|Death by neurologic criteria|0|||
161461507|NCT03954041|583084947|FG001|Overall Study|Death by neurologic criteria|0|||
161461508|NCT03954041|583084948|FG002|Overall Study|Death by neurologic criteria|1|||
161461509|NCT03954041|583084946|FG000|Overall Study|Reason not specified|7|||
161461510|NCT03954041|583084947|FG001|Overall Study|Reason not specified|4|||
161461511|NCT03954041|583084948|FG002|Overall Study|Reason not specified|2|||
161461512|NCT03954041|583084946|FG000|Overall Study|Withdrew prior to dosing|4|||
161461513|NCT03954041|583084947|FG001|Overall Study|Withdrew prior to dosing|2|||
161461514|NCT03954041|583084948|FG002|Overall Study|Withdrew prior to dosing|0|||
161461515|NCT04565236|583084951|FG000|Overall Study|Patient/Guardian Decision|0|||
161461516|NCT04565236|583084952|FG001|Overall Study|Patient/Guardian Decision|0|||
161461517|NCT04565236|583084953|FG002|Overall Study|Patient/Guardian Decision|1|||
161461518|NCT04565236|583084954|FG003|Overall Study|Patient/Guardian Decision|0|||
161461519|NCT00740246|583084957|FG000|Overall Study|Received Blood Transfusion|0|||
161461520|NCT00740246|583084958|FG001|Overall Study|Received Blood Transfusion|1|||
161461521|NCT00740246|583084957|FG000|Overall Study|Adverse Event|1|||
161461522|NCT00740246|583084958|FG001|Overall Study|Adverse Event|2|||
161461523|NCT00740246|583084957|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
161461524|NCT00740246|583084958|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
161461525|NCT00740246|583084957|FG000|Overall Study|Lost to Follow-up|2|||
161461526|NCT00740246|583084958|FG001|Overall Study|Lost to Follow-up|2|||
161461527|NCT00740246|583084957|FG000|Overall Study|Withdrawal by Subject|4|||
161461528|NCT00740246|583084958|FG001|Overall Study|Withdrawal by Subject|3|||
161461529|NCT00740246|583084957|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
161461530|NCT00740246|583084958|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
161461531|NCT00740246|583084957|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
161461532|NCT00740246|583084958|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
161461533|NCT00740246|583084957|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
161461534|NCT00740246|583084958|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
161461535|NCT00740246|583084957|FG000|Overall Study|Unable To Comply With Study Visits|2|||
161461536|NCT00740246|583084958|FG001|Overall Study|Unable To Comply With Study Visits|0|||
161461537|NCT00740246|583084957|FG000|Overall Study|Unable to Access Vein|0|||
161461538|NCT00740246|583084958|FG001|Overall Study|Unable to Access Vein|2|||
161461539|NCT00740246|583084957|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
161461540|NCT00740246|583084958|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
161461541|NCT01041495|583084959|FG000|Overall Study|Withdrawal by Subject|2|||
161461542|NCT01041495|583084960|FG001|Overall Study|Withdrawal by Subject|5|||
161461543|NCT01041495|583084959|FG000|Overall Study|Adverse Event|2|||
161461544|NCT01041495|583084960|FG001|Overall Study|Adverse Event|1|||
161461545|NCT01041495|583084959|FG000|Overall Study|Lost to Follow-up|0|||
161461546|NCT01041495|583084960|FG001|Overall Study|Lost to Follow-up|1|||
161461547|NCT03584373|583084961|FG000|Overall Study|Lost to Follow-up|7|||
161461548|NCT03584373|583084962|FG001|Overall Study|Lost to Follow-up|8|||
161461549|NCT00662532|583084964|FG000|Overall Study|Adverse Event|0|||
161461550|NCT00662532|583084965|FG001|Overall Study|Adverse Event|1|||
161809969|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Death|0|||
161809970|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Death|0|||
161809971|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Death|2|||
161809972|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Death|0|||
161809973|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Death|0|||
161461551|NCT00662532|583084964|FG000|Overall Study|Lost to Follow-up|0|||
161461552|NCT00662532|583084965|FG001|Overall Study|Lost to Follow-up|1|||
161461553|NCT00366340|583084966|FG000|Infant Series|Protocol Violation|3|||
161461554|NCT00366340|583084967|FG001|Infant Series|Protocol Violation|4|||
161461555|NCT00366340|583084966|FG000|Infant Series|Withdrawal by Subject|3|||
161461556|NCT00366340|583084967|FG001|Infant Series|Withdrawal by Subject|3|||
161461557|NCT00366340|583084966|FG000|Infant Series|Adverse Event|0|||
161461558|NCT00366340|583084967|FG001|Infant Series|Adverse Event|2|||
161461559|NCT00366340|583084966|FG000|Infant Series|Lost to Follow-up|1|||
161461560|NCT00366340|583084967|FG001|Infant Series|Lost to Follow-up|1|||
161461561|NCT00366340|583084966|FG000|Infant Series|Failure to return|1|||
161572312|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Other|3|||
161572313|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
161572314|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
161572315|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Death|2|||
161572316|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Death|0|||
161572317|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
161572318|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
161572319|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
161572320|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
161572321|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
161572322|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
161572323|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
161572324|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
161572325|NCT01193153|583479806|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
161572326|NCT01193153|583479807|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
161572327|NCT02503202|583479810|FG000|Base Study: Up to Month 6|Death|1|||
161572328|NCT02503202|583479811|FG001|Base Study: Up to Month 6|Death|1|||
161572329|NCT02503202|583479812|FG002|Base Study: Up to Month 6|Death|0|||
161572330|NCT02503202|583479813|FG003|Base Study: Up to Month 6|Death|0|||
161572331|NCT02503202|583479814|FG004|Base Study: Up to Month 6|Death|0|||
161572332|NCT02503202|583479810|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
161572333|NCT02503202|583479811|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
161572334|NCT02503202|583479812|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
161572335|NCT02503202|583479813|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
161572336|NCT02503202|583479814|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
161572337|NCT02503202|583479810|FG000|Base Study: Up to Month 6|Physician Decision|0|||
161572338|NCT02503202|583479811|FG001|Base Study: Up to Month 6|Physician Decision|0|||
161572339|NCT02503202|583479812|FG002|Base Study: Up to Month 6|Physician Decision|0|||
161572340|NCT02503202|583479813|FG003|Base Study: Up to Month 6|Physician Decision|0|||
161572341|NCT02503202|583479814|FG004|Base Study: Up to Month 6|Physician Decision|1|||
161572342|NCT02503202|583479810|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
161572343|NCT02503202|583479811|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
161572344|NCT02503202|583479812|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
161572345|NCT02503202|583479813|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
161572346|NCT02503202|583479814|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
161572347|NCT02503202|583479810|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
161572348|NCT02503202|583479811|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
161572349|NCT02503202|583479812|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
161572350|NCT02503202|583479813|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
161572351|NCT02503202|583479814|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
161572352|NCT02503202|583479810|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
161572353|NCT02503202|583479811|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
161572354|NCT02503202|583479812|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
161572355|NCT02503202|583479813|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
161572356|NCT02503202|583479814|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
161572357|NCT02503202|583479810|FG000|Extension: Month 6 to 24|Death|1|||
161572358|NCT02503202|583479811|FG001|Extension: Month 6 to 24|Death|0|||
161572359|NCT02503202|583479812|FG002|Extension: Month 6 to 24|Death|0|||
161572360|NCT02503202|583479813|FG003|Extension: Month 6 to 24|Death|0|||
161572361|NCT02503202|583479814|FG004|Extension: Month 6 to 24|Death|0|||
161572362|NCT02503202|583479810|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
161572363|NCT02503202|583479811|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
161572364|NCT02503202|583479812|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
161572365|NCT02503202|583479813|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
161572366|NCT02503202|583479814|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
161572367|NCT02503202|583479810|FG000|Extension: Month 6 to 24|Physician Decision|1|||
161572368|NCT02503202|583479811|FG001|Extension: Month 6 to 24|Physician Decision|0|||
161572369|NCT02503202|583479812|FG002|Extension: Month 6 to 24|Physician Decision|1|||
161572370|NCT02503202|583479813|FG003|Extension: Month 6 to 24|Physician Decision|3|||
161572371|NCT02503202|583479814|FG004|Extension: Month 6 to 24|Physician Decision|0|||
161572372|NCT02503202|583479810|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
161572373|NCT02503202|583479811|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
161572374|NCT02503202|583479812|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
161572375|NCT02503202|583479813|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
161572376|NCT02503202|583479814|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
161572377|NCT01119950|583479815|FG000|Overall Study|Adverse Event|25|||
161572378|NCT01119950|583479815|FG000|Overall Study|Withdrawal by Subject|9|||
161572379|NCT01119950|583479815|FG000|Overall Study|Protocol Violation|5|||
161572380|NCT01119950|583479815|FG000|Overall Study|Lost to Follow-up|4|||
161572381|NCT01119950|583479815|FG000|Overall Study|Administrative|2|||
161461562|NCT00366340|583084967|FG001|Infant Series|Failure to return|0|||
161461563|NCT00366340|583084966|FG000|After the Infant Series|Parent/legal guardian request|1|||
161461564|NCT00366340|583084967|FG001|After the Infant Series|Parent/legal guardian request|1|||
161461565|NCT00366340|583084966|FG000|After the Infant Series|Failed to return|0|||
161461566|NCT00366340|583084967|FG001|After the Infant Series|Failed to return|1|||
161461567|NCT00366340|583084966|FG000|After the Infant Series|Protocol Violation|2|||
161461568|NCT00366340|583084967|FG001|After the Infant Series|Protocol Violation|2|||
161461569|NCT00366340|583084966|FG000|After the Infant Series|Adverse Event|0|||
161461570|NCT00366340|583084967|FG001|After the Infant Series|Adverse Event|1|||
161461571|NCT00366340|583084966|FG000|After the Infant Series|Lost to Follow-up|0|||
161461572|NCT00366340|583084967|FG001|After the Infant Series|Lost to Follow-up|1|||
161461573|NCT00366340|583084966|FG000|Toddler Dose|Failed to return|1|||
161461574|NCT00366340|583084967|FG001|Toddler Dose|Failed to return|0|||
161461575|NCT00366340|583084966|FG000|Toddler Dose|Parent/legal guardian request|0|||
161461576|NCT00366340|583084967|FG001|Toddler Dose|Parent/legal guardian request|1|||
161461577|NCT00367770|583084968|FG000|Overall Study|Adverse Event|1|||
161461578|NCT00367770|583084968|FG000|Overall Study|Withdrawal by Subject|1|||
161461579|NCT03282565|583084973|FG000|Overall Study|COVID-19 Research Shutdown|0|||
161461580|NCT03282565|583084974|FG001|Overall Study|COVID-19 Research Shutdown|2|||
161461581|NCT03282565|583084975|FG002|Overall Study|COVID-19 Research Shutdown|2|||
161461582|NCT00722371|583084981|FG000|Overall Study|Adverse Event|6|||
161461583|NCT00722371|583084982|FG001|Overall Study|Adverse Event|13|||
161461584|NCT00722371|583084983|FG002|Overall Study|Adverse Event|9|||
161461585|NCT00722371|583084984|FG003|Overall Study|Adverse Event|10|||
161461586|NCT00722371|583084985|FG004|Overall Study|Adverse Event|6|||
161461587|NCT00722371|583084986|FG005|Overall Study|Adverse Event|8|||
161461588|NCT00722371|583084987|FG006|Overall Study|Adverse Event|4|||
161461589|NCT00722371|583084981|FG000|Overall Study|Contraindication|0|||
161461590|NCT00722371|583084982|FG001|Overall Study|Contraindication|0|||
161461591|NCT00722371|583084983|FG002|Overall Study|Contraindication|1|||
161461592|NCT00722371|583084984|FG003|Overall Study|Contraindication|0|||
161461593|NCT00722371|583084985|FG004|Overall Study|Contraindication|0|||
161461594|NCT00722371|583084986|FG005|Overall Study|Contraindication|0|||
161461595|NCT00722371|583084987|FG006|Overall Study|Contraindication|0|||
161461596|NCT00722371|583084981|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
161461597|NCT00722371|583084982|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
161461598|NCT00722371|583084983|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
161461599|NCT00722371|583084984|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
161461600|NCT00722371|583084985|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
161461601|NCT00722371|583084986|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
161461602|NCT00722371|583084987|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
161461603|NCT00722371|583084981|FG000|Overall Study|Excluded medication|0|||
161461604|NCT00722371|583084982|FG001|Overall Study|Excluded medication|1|||
161461605|NCT00722371|583084983|FG002|Overall Study|Excluded medication|1|||
161461606|NCT00722371|583084984|FG003|Overall Study|Excluded medication|0|||
161461607|NCT00722371|583084985|FG004|Overall Study|Excluded medication|0|||
161461608|NCT00722371|583084986|FG005|Overall Study|Excluded medication|0|||
161461609|NCT00722371|583084987|FG006|Overall Study|Excluded medication|1|||
161461610|NCT00722371|583084981|FG000|Overall Study|Hyperglycemia|2|||
161461611|NCT00722371|583084982|FG001|Overall Study|Hyperglycemia|6|||
161461612|NCT00722371|583084983|FG002|Overall Study|Hyperglycemia|4|||
161461613|NCT00722371|583084984|FG003|Overall Study|Hyperglycemia|2|||
161572382|NCT01119950|583479815|FG000|Overall Study|Abnormal lab value|1|||
161809974|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Death|0|||
161809975|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Death|0|||
161461614|NCT00722371|583084985|FG004|Overall Study|Hyperglycemia|5|||
161461615|NCT00722371|583084986|FG005|Overall Study|Hyperglycemia|1|||
161572383|NCT01119950|583479815|FG000|Overall Study|Death|1|||
161809976|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
161461616|NCT00722371|583084987|FG006|Overall Study|Hyperglycemia|1|||
161461617|NCT00722371|583084981|FG000|Overall Study|Hypoglycemia|1|||
161461618|NCT00722371|583084982|FG001|Overall Study|Hypoglycemia|0|||
161461619|NCT00722371|583084983|FG002|Overall Study|Hypoglycemia|0|||
161461620|NCT00722371|583084984|FG003|Overall Study|Hypoglycemia|0|||
161461621|NCT00722371|583084985|FG004|Overall Study|Hypoglycemia|0|||
161461622|NCT00722371|583084986|FG005|Overall Study|Hypoglycemia|0|||
161461623|NCT00722371|583084987|FG006|Overall Study|Hypoglycemia|0|||
161461624|NCT00722371|583084981|FG000|Overall Study|Lack of Efficacy|4|||
161461625|NCT00722371|583084982|FG001|Overall Study|Lack of Efficacy|6|||
161461626|NCT00722371|583084983|FG002|Overall Study|Lack of Efficacy|6|||
161461627|NCT00722371|583084984|FG003|Overall Study|Lack of Efficacy|6|||
161461628|NCT00722371|583084985|FG004|Overall Study|Lack of Efficacy|2|||
161461629|NCT00722371|583084986|FG005|Overall Study|Lack of Efficacy|3|||
161461630|NCT00722371|583084987|FG006|Overall Study|Lack of Efficacy|0|||
161461631|NCT00722371|583084981|FG000|Overall Study|Lost to Follow-up|11|||
161461632|NCT00722371|583084982|FG001|Overall Study|Lost to Follow-up|14|||
161461633|NCT00722371|583084983|FG002|Overall Study|Lost to Follow-up|21|||
161461634|NCT00722371|583084984|FG003|Overall Study|Lost to Follow-up|13|||
161461635|NCT00722371|583084985|FG004|Overall Study|Lost to Follow-up|8|||
161461636|NCT00722371|583084986|FG005|Overall Study|Lost to Follow-up|16|||
161461637|NCT00722371|583084987|FG006|Overall Study|Lost to Follow-up|13|||
161461638|NCT00722371|583084981|FG000|Overall Study|Physician Decision|5|||
161461639|NCT00722371|583084982|FG001|Overall Study|Physician Decision|2|||
161461640|NCT00722371|583084983|FG002|Overall Study|Physician Decision|2|||
161461641|NCT00722371|583084984|FG003|Overall Study|Physician Decision|5|||
161461642|NCT00722371|583084985|FG004|Overall Study|Physician Decision|2|||
161461643|NCT00722371|583084986|FG005|Overall Study|Physician Decision|3|||
161461644|NCT00722371|583084987|FG006|Overall Study|Physician Decision|4|||
161461645|NCT00722371|583084981|FG000|Overall Study|Pregnancy|1|||
161461646|NCT00722371|583084982|FG001|Overall Study|Pregnancy|1|||
161461647|NCT00722371|583084983|FG002|Overall Study|Pregnancy|0|||
161461648|NCT00722371|583084984|FG003|Overall Study|Pregnancy|0|||
161461649|NCT00722371|583084985|FG004|Overall Study|Pregnancy|0|||
161461650|NCT00722371|583084986|FG005|Overall Study|Pregnancy|1|||
161461651|NCT00722371|583084987|FG006|Overall Study|Pregnancy|0|||
161461652|NCT00722371|583084981|FG000|Overall Study|Protocol Violation|6|||
161461653|NCT00722371|583084982|FG001|Overall Study|Protocol Violation|1|||
161461654|NCT00722371|583084983|FG002|Overall Study|Protocol Violation|0|||
161461655|NCT00722371|583084984|FG003|Overall Study|Protocol Violation|1|||
161461656|NCT00722371|583084985|FG004|Overall Study|Protocol Violation|4|||
161461657|NCT00722371|583084986|FG005|Overall Study|Protocol Violation|2|||
161461658|NCT00722371|583084987|FG006|Overall Study|Protocol Violation|1|||
161461659|NCT00722371|583084981|FG000|Overall Study|Withdrawal by Subject|18|||
161461660|NCT00722371|583084982|FG001|Overall Study|Withdrawal by Subject|27|||
161461661|NCT00722371|583084983|FG002|Overall Study|Withdrawal by Subject|19|||
161461662|NCT00722371|583084984|FG003|Overall Study|Withdrawal by Subject|23|||
161461663|NCT00722371|583084985|FG004|Overall Study|Withdrawal by Subject|19|||
161461664|NCT00722371|583084986|FG005|Overall Study|Withdrawal by Subject|18|||
161461665|NCT00722371|583084987|FG006|Overall Study|Withdrawal by Subject|26|||
161461666|NCT00718237|583084988|FG000|Overall Study|Adverse Event|1|||
161461667|NCT00718237|583084989|FG001|Overall Study|Adverse Event|3|||
161461668|NCT00718237|583084988|FG000|Overall Study|Lost to Follow-up|2|||
161461669|NCT00718237|583084989|FG001|Overall Study|Lost to Follow-up|2|||
161461670|NCT00718237|583084988|FG000|Overall Study|Physician Decision|1|||
161461671|NCT00718237|583084989|FG001|Overall Study|Physician Decision|0|||
161461672|NCT00718237|583084988|FG000|Overall Study|Withdrawal by Subject|9|||
161461673|NCT00718237|583084989|FG001|Overall Study|Withdrawal by Subject|10|||
161461674|NCT01185834|583084990|FG000|Overall Study|Lost to Follow-up|2|||
161461675|NCT01185834|583084990|FG000|Overall Study|Discomfort|4|||
161461676|NCT01185834|583084990|FG000|Overall Study|Biomicroscopy|4|||
161461677|NCT01185834|583084990|FG000|Overall Study|Time/Job Conflict|2|||
161461678|NCT01185834|583084990|FG000|Overall Study|Early exit - Site error|2|||
161461679|NCT01244490|583084991|FG000|Overall Study|Lack of Efficacy|14|||
161461680|NCT01244490|583084992|FG001|Overall Study|Lack of Efficacy|5|||
161461681|NCT01244490|583084993|FG002|Overall Study|Lack of Efficacy|5|||
161461682|NCT01244490|583084991|FG000|Overall Study|Withdrawal by Subject|4|||
161461683|NCT01244490|583084992|FG001|Overall Study|Withdrawal by Subject|4|||
161461684|NCT01244490|583084993|FG002|Overall Study|Withdrawal by Subject|9|||
161461685|NCT01244490|583084991|FG000|Overall Study|Adverse Event|1|||
161461686|NCT01244490|583084992|FG001|Overall Study|Adverse Event|9|||
161461687|NCT01244490|583084993|FG002|Overall Study|Adverse Event|5|||
161461688|NCT01244490|583084991|FG000|Overall Study|Lost to Follow-up|0|||
161461689|NCT01244490|583084992|FG001|Overall Study|Lost to Follow-up|6|||
161461690|NCT01244490|583084993|FG002|Overall Study|Lost to Follow-up|3|||
161461691|NCT01244490|583084991|FG000|Overall Study|Other|0|||
161461692|NCT01244490|583084992|FG001|Overall Study|Other|0|||
161461693|NCT01244490|583084993|FG002|Overall Study|Other|1|||
161461694|NCT02290431|583084996|FG000|Overall Study|Adverse Event|20|||
161461695|NCT02290431|583084996|FG000|Overall Study|Progressive disease|4|||
161461696|NCT02290431|583084996|FG000|Overall Study|Study terminated by Sponsor|1|||
161461697|NCT02290431|583084996|FG000|Overall Study|Physician Decision|2|||
161461698|NCT03324581|583084998|FG000|Overall Study|Adverse Event|18|||
161913985|NCT00560404|584733673|FG000|Overall Study|Other withdrawal reason|13|||
161913986|NCT00560404|584733674|FG001|Overall Study|Other withdrawal reason|5|||
161913987|NCT02642042|584733681|FG000|Overall Study|Adverse Event|22|||
161913988|NCT02642042|584733681|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161913989|NCT02642042|584733681|FG000|Overall Study|Progression/Relapse|28|||
161913990|NCT02642042|584733681|FG000|Overall Study|Death|1|||
161913991|NCT02642042|584733681|FG000|Overall Study|Not Protocol Specified|2|||
161913992|NCT03260023|584733682|FG000|Overall Study|Adverse Event|0|||
161913993|NCT03260023|584733683|FG001|Overall Study|Adverse Event|0|||
161913994|NCT03260023|584733684|FG002|Overall Study|Adverse Event|4|||
161913995|NCT03260023|584733685|FG003|Overall Study|Adverse Event|4|||
161913996|NCT03260023|584733686|FG004|Overall Study|Adverse Event|4|||
161913997|NCT03260023|584733687|FG005|Overall Study|Adverse Event|1|||
161913998|NCT03260023|584733688|FG006|Overall Study|Adverse Event|2|||
161913999|NCT03260023|584733682|FG000|Overall Study|Clinical Progression|0|||
161914000|NCT03260023|584733683|FG001|Overall Study|Clinical Progression|1|||
161914001|NCT03260023|584733684|FG002|Overall Study|Clinical Progression|3|||
161914002|NCT03260023|584733685|FG003|Overall Study|Clinical Progression|1|||
161914003|NCT03260023|584733686|FG004|Overall Study|Clinical Progression|0|||
161914004|NCT03260023|584733687|FG005|Overall Study|Clinical Progression|0|||
161914005|NCT03260023|584733688|FG006|Overall Study|Clinical Progression|0|||
161914006|NCT03260023|584733682|FG000|Overall Study|Physician Decision|0|||
161914007|NCT03260023|584733683|FG001|Overall Study|Physician Decision|0|||
161914008|NCT03260023|584733684|FG002|Overall Study|Physician Decision|0|||
161914009|NCT03260023|584733685|FG003|Overall Study|Physician Decision|1|||
161914010|NCT03260023|584733686|FG004|Overall Study|Physician Decision|1|||
161914011|NCT03260023|584733687|FG005|Overall Study|Physician Decision|0|||
161914012|NCT03260023|584733688|FG006|Overall Study|Physician Decision|0|||
161914013|NCT03260023|584733682|FG000|Overall Study|Withdrawal by Subject|0|||
161914014|NCT03260023|584733683|FG001|Overall Study|Withdrawal by Subject|0|||
161914015|NCT03260023|584733684|FG002|Overall Study|Withdrawal by Subject|0|||
161914016|NCT03260023|584733685|FG003|Overall Study|Withdrawal by Subject|0|||
161914017|NCT03260023|584733686|FG004|Overall Study|Withdrawal by Subject|3|||
161914018|NCT03260023|584733687|FG005|Overall Study|Withdrawal by Subject|0|||
161914019|NCT03260023|584733688|FG006|Overall Study|Withdrawal by Subject|0|||
161914020|NCT03260023|584733682|FG000|Overall Study|Under trial intervention|0|||
161914021|NCT03260023|584733683|FG001|Overall Study|Under trial intervention|0|||
161914022|NCT03260023|584733684|FG002|Overall Study|Under trial intervention|2|||
161914023|NCT03260023|584733685|FG003|Overall Study|Under trial intervention|5|||
161914024|NCT03260023|584733686|FG004|Overall Study|Under trial intervention|3|||
161914025|NCT03260023|584733687|FG005|Overall Study|Under trial intervention|0|||
161914026|NCT03260023|584733688|FG006|Overall Study|Under trial intervention|0|||
161914027|NCT05035407|584733691|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
161914028|NCT05035407|584733692|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914029|NCT05035407|584733693|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914030|NCT05035407|584733694|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914031|NCT05035407|584733695|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914032|NCT05035407|584733696|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914033|NCT04220021|584733697|FG000|Overall Study|Withdrawal by Subject|11|||
161914034|NCT04220021|584733697|FG000|Overall Study|Physician Decision|2|||
161914035|NCT04220021|584733697|FG000|Overall Study|Non-study related illness|5|||
161914036|NCT04513366|584733698|FG000|Treatment Phase|Withdrawal by Subject|6|||
161914037|NCT04513366|584733699|FG001|Treatment Phase|Withdrawal by Subject|8|||
161914038|NCT04513366|584733700|FG002|Treatment Phase|Withdrawal by Subject|3|||
161914039|NCT04513366|584733698|FG000|Treatment Phase|Lost to Follow-up|1|||
161914040|NCT04513366|584733699|FG001|Treatment Phase|Lost to Follow-up|2|||
161914041|NCT04513366|584733700|FG002|Treatment Phase|Lost to Follow-up|5|||
161914042|NCT04513366|584733698|FG000|Treatment Phase|Other than Specified|1|||
161914043|NCT04513366|584733699|FG001|Treatment Phase|Other than Specified|0|||
161914044|NCT04513366|584733700|FG002|Treatment Phase|Other than Specified|2|||
161914045|NCT04513366|584733698|FG000|Treatment Phase|Physician Decision|2|||
161914046|NCT04513366|584733699|FG001|Treatment Phase|Physician Decision|0|||
161914047|NCT04513366|584733700|FG002|Treatment Phase|Physician Decision|0|||
161914048|NCT04513366|584733698|FG000|Treatment Phase|Adverse Event|0|||
161914049|NCT04513366|584733699|FG001|Treatment Phase|Adverse Event|1|||
161914050|NCT04513366|584733700|FG002|Treatment Phase|Adverse Event|1|||
161914051|NCT04513366|584733698|FG000|Extension Phase|Withdrawal by Subject|3|||
161914052|NCT04513366|584733699|FG001|Extension Phase|Withdrawal by Subject|1|||
161914053|NCT04513366|584733700|FG002|Extension Phase|Withdrawal by Subject|1|||
161914054|NCT04513366|584733698|FG000|Extension Phase|Other than Specified|4|||
161461699|NCT03324581|583084999|FG001|Overall Study|Adverse Event|11|||
161914055|NCT04513366|584733699|FG001|Extension Phase|Other than Specified|0|||
161914056|NCT04513366|584733700|FG002|Extension Phase|Other than Specified|1|||
161461700|NCT03324581|583085000|FG002|Overall Study|Adverse Event|7|||
161461701|NCT03324581|583084998|FG000|Overall Study|Lack of Efficacy|0|||
161461702|NCT03324581|583084999|FG001|Overall Study|Lack of Efficacy|1|||
161461703|NCT03324581|583085000|FG002|Overall Study|Lack of Efficacy|0|||
161461704|NCT03324581|583084998|FG000|Overall Study|Lost to Follow-up|5|||
161461705|NCT03324581|583084999|FG001|Overall Study|Lost to Follow-up|3|||
161461706|NCT03324581|583085000|FG002|Overall Study|Lost to Follow-up|6|||
161461707|NCT03324581|583084998|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
161461708|NCT03324581|583084999|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
161461709|NCT03324581|583085000|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
161461710|NCT03324581|583084998|FG000|Overall Study|Physician Decision|0|||
161461711|NCT03324581|583084999|FG001|Overall Study|Physician Decision|1|||
161461712|NCT03324581|583085000|FG002|Overall Study|Physician Decision|2|||
161461713|NCT03324581|583084998|FG000|Overall Study|Protocol Deviation|8|||
161461714|NCT03324581|583084999|FG001|Overall Study|Protocol Deviation|9|||
161461715|NCT03324581|583085000|FG002|Overall Study|Protocol Deviation|4|||
161461716|NCT03324581|583084998|FG000|Overall Study|Withdrawal by Subject|6|||
161461717|NCT03324581|583084999|FG001|Overall Study|Withdrawal by Subject|8|||
161461718|NCT03324581|583085000|FG002|Overall Study|Withdrawal by Subject|6|||
161461719|NCT03324581|583084998|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
161461720|NCT03324581|583084999|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
161461721|NCT03324581|583085000|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
161461722|NCT00321893|583085002|FG000|Overall Study|Non-Compliance/Refusal|16|||
161461723|NCT00321893|583085003|FG001|Overall Study|Non-Compliance/Refusal|10|||
161461724|NCT00321893|583085002|FG000|Overall Study|Lost to Follow-up|2|||
161461725|NCT00321893|583085003|FG001|Overall Study|Lost to Follow-up|1|||
161461726|NCT00321893|583085002|FG000|Overall Study|Adverse Event|6|||
161461727|NCT00321893|583085003|FG001|Overall Study|Adverse Event|3|||
161461728|NCT03523000|583085004|FG000|Overall Study|Withdrawal by Subject|3|||
161461729|NCT03523000|583085005|FG001|Overall Study|Withdrawal by Subject|0|||
161461730|NCT03523000|583085004|FG000|Overall Study|Unsuccessful trial|2|||
161461731|NCT03523000|583085005|FG001|Overall Study|Unsuccessful trial|0|||
161461732|NCT03993379|583085006|FG000|Overall Study|The study was terminated early due to business decision.|0|||
161461733|NCT03993379|583085007|FG001|Overall Study|The study was terminated early due to business decision.|2|||
161461734|NCT03993379|583085008|FG002|Overall Study|The study was terminated early due to business decision.|0|||
161461735|NCT03993379|583085009|FG003|Overall Study|The study was terminated early due to business decision.|0|||
161461736|NCT03993379|583085006|FG000|Overall Study|Withdrawal by Subject|0|||
161461737|NCT03993379|583085007|FG001|Overall Study|Withdrawal by Subject|1|||
161461738|NCT03993379|583085008|FG002|Overall Study|Withdrawal by Subject|0|||
161461739|NCT03993379|583085009|FG003|Overall Study|Withdrawal by Subject|0|||
161461740|NCT02380690|583085010|FG000|Overall Study|Lost to Follow-up|14|||
161461741|NCT02380690|583085011|FG001|Overall Study|Lost to Follow-up|4|||
161461742|NCT02380690|583085010|FG000|Overall Study|Withdrawal by Subject|20|||
161461743|NCT02380690|583085011|FG001|Overall Study|Withdrawal by Subject|8|||
161461744|NCT00266864|583085012|FG000|Overall Study|Lost to Follow-up|4|||
161461745|NCT00266864|583085013|FG001|Overall Study|Lost to Follow-up|1|||
161461746|NCT00266864|583085012|FG000|Overall Study|Withdrawal by Subject|1|||
161461747|NCT00266864|583085013|FG001|Overall Study|Withdrawal by Subject|1|||
161461748|NCT00727532|583085014|FG000|Overall Study|Adverse Event|1|||
161461749|NCT00727532|583085014|FG000|Overall Study|Withdrawal by Subject|1|||
161461750|NCT00829933|583085015|FG000|Overall Study|Adverse Event|2|||
161461751|NCT00829933|583085016|FG001|Overall Study|Adverse Event|3|||
161461752|NCT00829933|583085017|FG002|Overall Study|Adverse Event|2|||
161572384|NCT01988233|583479818|FG000|Overall Study|Lost to Follow-up|64|||
161572385|NCT01988233|583479819|FG001|Overall Study|Lost to Follow-up|51|||
161572386|NCT01591616|583479822|FG000|Overall Study|Withdrawal by Subject|1|||
161572387|NCT00758602|583479823|FG000|Overall Study|Adverse Event|11|||
161572388|NCT00758602|583479824|FG001|Overall Study|Adverse Event|10|||
161572389|NCT00758602|583479823|FG000|Overall Study|Lost to Follow-up|4|||
161461753|NCT00829933|583085018|FG003|Overall Study|Adverse Event|1|||
161461754|NCT00829933|583085015|FG000|Overall Study|Death|0|||
161461755|NCT00829933|583085016|FG001|Overall Study|Death|0|||
161461756|NCT00829933|583085017|FG002|Overall Study|Death|1|||
161461757|NCT00829933|583085018|FG003|Overall Study|Death|1|||
161572390|NCT00758602|583479824|FG001|Overall Study|Lost to Follow-up|3|||
161572391|NCT00758602|583479823|FG000|Overall Study|Withdrawal by Subject|1|||
161461758|NCT00829933|583085015|FG000|Overall Study|Lack of Efficacy|0|||
161461759|NCT00829933|583085016|FG001|Overall Study|Lack of Efficacy|1|||
161461760|NCT00829933|583085017|FG002|Overall Study|Lack of Efficacy|0|||
161461761|NCT00829933|583085018|FG003|Overall Study|Lack of Efficacy|0|||
161461762|NCT00829933|583085015|FG000|Overall Study|Physician Decision|5|||
161461763|NCT00829933|583085016|FG001|Overall Study|Physician Decision|7|||
161461764|NCT00829933|583085017|FG002|Overall Study|Physician Decision|8|||
161461765|NCT00829933|583085018|FG003|Overall Study|Physician Decision|1|||
161461766|NCT00829933|583085015|FG000|Overall Study|Pregnancy|0|||
161572392|NCT00758602|583479824|FG001|Overall Study|Withdrawal by Subject|3|||
161572393|NCT00758602|583479823|FG000|Overall Study|Protocol Violation|0|||
161572394|NCT00758602|583479824|FG001|Overall Study|Protocol Violation|2|||
161572395|NCT00758602|583479823|FG000|Overall Study|Death|0|||
161572396|NCT00758602|583479824|FG001|Overall Study|Death|1|||
161572397|NCT00758602|583479823|FG000|Overall Study|Reason not specified|3|||
161572398|NCT00758602|583479824|FG001|Overall Study|Reason not specified|3|||
161572399|NCT02148133|583479837|FG000|Overall Study|Investigator discretion|1|||
161572400|NCT02148133|583479837|FG000|Overall Study|Lack of Efficacy|1|||
161572401|NCT02148133|583479837|FG000|Overall Study|Protocol deviation|1|||
161572402|NCT02148133|583479837|FG000|Overall Study|Protocol-defined stopping criteria|2|||
161572403|NCT03808883|583479838|FG000|Overall Study|Withdrawal by Subject|2|||
161572404|NCT03808883|583479839|FG001|Overall Study|Withdrawal by Subject|0|||
161572405|NCT03808883|583479838|FG000|Overall Study|Did not complete pre test or post test survey|4|||
161572406|NCT03808883|583479839|FG001|Overall Study|Did not complete pre test or post test survey|3|||
161572407|NCT00855465|583479841|FG000|Treatment Period|Adverse Event|4|||
161572408|NCT00855465|583479842|FG001|Treatment Period|Adverse Event|2|||
161572409|NCT00855465|583479841|FG000|Treatment Period|Death|2|||
161572410|NCT00855465|583479842|FG001|Treatment Period|Death|2|||
161572411|NCT00855465|583479841|FG000|Treatment Period|Lack of Efficacy|2|||
161572412|NCT00855465|583479842|FG001|Treatment Period|Lack of Efficacy|1|||
161572413|NCT00855465|583479841|FG000|Treatment Period|Non-compliance|1|||
161572414|NCT00855465|583479842|FG001|Treatment Period|Non-compliance|0|||
161572415|NCT00855465|583479841|FG000|Treatment Period|Protocol Violation|2|||
161572416|NCT00855465|583479842|FG001|Treatment Period|Protocol Violation|0|||
161572417|NCT00855465|583479841|FG000|Treatment Period|Withdrawal by Subject|2|||
161572418|NCT00855465|583479842|FG001|Treatment Period|Withdrawal by Subject|0|||
161572419|NCT00855465|583479841|FG000|Treatment Period|Not treated|1|||
161572420|NCT00855465|583479842|FG001|Treatment Period|Not treated|0|||
161572421|NCT00855465|583479841|FG000|Follow-up Period (FUP)|Adverse Event|0|||
161572422|NCT00855465|583479842|FG001|Follow-up Period (FUP)|Adverse Event|1|||
161572423|NCT00855465|583479841|FG000|Follow-up Period (FUP)|Death|0|||
161572424|NCT00855465|583479842|FG001|Follow-up Period (FUP)|Death|1|||
161572425|NCT00855465|583479841|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
161572426|NCT00855465|583479842|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
161572427|NCT00855465|583479841|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
161572428|NCT00855465|583479842|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
161572429|NCT00855465|583479841|FG000|Follow-up Period (FUP)|Missing|1|||
161572430|NCT00855465|583479842|FG001|Follow-up Period (FUP)|Missing|0|||
161572431|NCT04173572|583479853|FG000|Overall Study|Withdrawal by Subject|1|||
161572432|NCT04173572|583479854|FG001|Overall Study|Withdrawal by Subject|5|||
161572433|NCT04173572|583479853|FG000|Overall Study|Lost to Follow-up|3|||
161572434|NCT04173572|583479854|FG001|Overall Study|Lost to Follow-up|1|||
161572435|NCT02341625|583479855|FG000|Overall Study|Disease Progression|2|||
161572436|NCT02341625|583479856|FG001|Overall Study|Disease Progression|2|||
161572437|NCT02341625|583479857|FG002|Overall Study|Disease Progression|3|||
161572438|NCT02341625|583479858|FG003|Overall Study|Disease Progression|6|||
161572439|NCT02341625|583479859|FG004|Overall Study|Disease Progression|7|||
161572440|NCT02341625|583479860|FG005|Overall Study|Disease Progression|7|||
161572441|NCT02341625|583479861|FG006|Overall Study|Disease Progression|28|||
161572442|NCT02341625|583479862|FG007|Overall Study|Disease Progression|5|||
161572443|NCT02341625|583479863|FG008|Overall Study|Disease Progression|4|||
161572444|NCT02341625|583479864|FG009|Overall Study|Disease Progression|19|||
161572445|NCT02341625|583479855|FG000|Overall Study|Study Drug Toxicity|0|||
161572446|NCT02341625|583479856|FG001|Overall Study|Study Drug Toxicity|0|||
161572447|NCT02341625|583479857|FG002|Overall Study|Study Drug Toxicity|0|||
161572448|NCT02341625|583479858|FG003|Overall Study|Study Drug Toxicity|1|||
161572449|NCT02341625|583479859|FG004|Overall Study|Study Drug Toxicity|0|||
161572450|NCT02341625|583479860|FG005|Overall Study|Study Drug Toxicity|3|||
161572451|NCT02341625|583479861|FG006|Overall Study|Study Drug Toxicity|10|||
161572452|NCT02341625|583479862|FG007|Overall Study|Study Drug Toxicity|0|||
161572453|NCT02341625|583479863|FG008|Overall Study|Study Drug Toxicity|0|||
161572454|NCT02341625|583479864|FG009|Overall Study|Study Drug Toxicity|3|||
161572455|NCT02341625|583479855|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572456|NCT02341625|583479856|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572457|NCT02341625|583479857|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572458|NCT02341625|583479858|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572459|NCT02341625|583479859|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572460|NCT02341625|583479860|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572461|NCT02341625|583479861|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
161572462|NCT02341625|583479862|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161572463|NCT02341625|583479863|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161572464|NCT02341625|583479864|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
161572465|NCT02341625|583479855|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572466|NCT02341625|583479856|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572467|NCT02341625|583479857|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572468|NCT02341625|583479858|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161461767|NCT00829933|583085016|FG001|Overall Study|Pregnancy|0|||
161461768|NCT00829933|583085017|FG002|Overall Study|Pregnancy|0|||
161461769|NCT00829933|583085018|FG003|Overall Study|Pregnancy|2|||
161461770|NCT00829933|583085015|FG000|Overall Study|Protocol Violation|2|||
161461771|NCT00829933|583085016|FG001|Overall Study|Protocol Violation|1|||
161461772|NCT00829933|583085017|FG002|Overall Study|Protocol Violation|0|||
161461773|NCT00829933|583085018|FG003|Overall Study|Protocol Violation|0|||
161461774|NCT00829933|583085015|FG000|Overall Study|withdrew before treatment started|5|||
161461775|NCT00829933|583085016|FG001|Overall Study|withdrew before treatment started|1|||
161809977|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
161809978|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
161809979|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
161809980|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
161461776|NCT00829933|583085017|FG002|Overall Study|withdrew before treatment started|2|||
161461777|NCT00829933|583085018|FG003|Overall Study|withdrew before treatment started|9|||
161461778|NCT03687970|583085022|FG000|Overall Study|visit scheduling conflicts|2|||
161461779|NCT03687970|583085023|FG001|Overall Study|visit scheduling conflicts|0|||
161461780|NCT00686998|583085024|FG000|Overall Study|Adverse Event|3|||
161461781|NCT00686998|583085025|FG001|Overall Study|Adverse Event|2|||
161461782|NCT00686998|583085026|FG002|Overall Study|Adverse Event|1|||
161461783|NCT00686998|583085024|FG000|Overall Study|Withdrawal by Subject|2|||
161461784|NCT00686998|583085025|FG001|Overall Study|Withdrawal by Subject|1|||
161461785|NCT00686998|583085026|FG002|Overall Study|Withdrawal by Subject|2|||
161461786|NCT00686998|583085024|FG000|Overall Study|Lack of Efficacy|7|||
161461787|NCT00686998|583085025|FG001|Overall Study|Lack of Efficacy|5|||
161461788|NCT00686998|583085026|FG002|Overall Study|Lack of Efficacy|0|||
161461789|NCT00686998|583085024|FG000|Overall Study|Other|0|||
161461790|NCT00686998|583085025|FG001|Overall Study|Other|0|||
161461791|NCT00686998|583085026|FG002|Overall Study|Other|1|||
161461792|NCT00686998|583085024|FG000|Overall Study|Safety Reasons|1|||
161461793|NCT00686998|583085025|FG001|Overall Study|Safety Reasons|0|||
161461794|NCT00686998|583085026|FG002|Overall Study|Safety Reasons|0|||
161461795|NCT06374394|583085030|FG000|Overall Study|Adverse Event|0|||
161461796|NCT06374394|583085031|FG001|Overall Study|Adverse Event|2|||
161461797|NCT06374394|583085030|FG000|Overall Study|Lost to Follow-up|6|||
161461798|NCT06374394|583085031|FG001|Overall Study|Lost to Follow-up|9|||
161461799|NCT06374394|583085030|FG000|Overall Study|Withdrawal by Subject|1|||
161461800|NCT06374394|583085031|FG001|Overall Study|Withdrawal by Subject|7|||
161461801|NCT06374394|583085030|FG000|Overall Study|Other|1|||
161461802|NCT06374394|583085031|FG001|Overall Study|Other|0|||
161461803|NCT00356122|583085032|FG000|TREATMENT|Lack of Efficacy|26|||
161461804|NCT00356122|583085032|FG000|TREATMENT|Adverse Event|10|||
161461805|NCT00356122|583085032|FG000|TREATMENT|Subject's request|4|||
161461806|NCT00356122|583085032|FG000|TREATMENT|Other|4|||
161461807|NCT00356122|583085032|FG000|TREATMENT|Did not receive study medication|1|||
161461808|NCT00356122|583085032|FG000|FOLLOW-UP|Death|37|||
161461809|NCT00356122|583085032|FG000|FOLLOW-UP|Lost to Follow-up|2|||
161461810|NCT00356122|583085032|FG000|FOLLOW-UP|Other|2|||
161461811|NCT02483429|583085036|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
161461812|NCT02483429|583085037|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
161461813|NCT03576274|583085038|FG000|Overall Study|Lost to Follow-up|3|||
161461814|NCT03576274|583085039|FG001|Overall Study|Lost to Follow-up|2|||
161461815|NCT03576274|583085040|FG002|Overall Study|Lost to Follow-up|3|||
161461816|NCT03576274|583085041|FG003|Overall Study|Lost to Follow-up|1|||
161461817|NCT03576274|583085042|FG004|Overall Study|Lost to Follow-up|3|||
161461818|NCT03576274|583085038|FG000|Overall Study|Withdrawal by Subject|5|||
161461819|NCT03576274|583085039|FG001|Overall Study|Withdrawal by Subject|3|||
161461820|NCT03576274|583085040|FG002|Overall Study|Withdrawal by Subject|2|||
161461821|NCT03576274|583085041|FG003|Overall Study|Withdrawal by Subject|8|||
161461822|NCT03576274|583085042|FG004|Overall Study|Withdrawal by Subject|6|||
161461823|NCT00543855|583086166|FG000|Overall Study|Adverse Event|3|||
161461824|NCT00543855|583086167|FG001|Overall Study|Adverse Event|1|||
161461825|NCT00543855|583086168|FG002|Overall Study|Adverse Event|3|||
161461826|NCT00543855|583086169|FG003|Overall Study|Adverse Event|4|||
161461827|NCT00543855|583086166|FG000|Overall Study|Lost to Follow-up|0|||
161461828|NCT00543855|583086167|FG001|Overall Study|Lost to Follow-up|0|||
161461829|NCT00543855|583086168|FG002|Overall Study|Lost to Follow-up|1|||
161461830|NCT00543855|583086169|FG003|Overall Study|Lost to Follow-up|0|||
161461831|NCT00543855|583086166|FG000|Overall Study|Withdrawal by Subject|0|||
161461832|NCT00543855|583086167|FG001|Overall Study|Withdrawal by Subject|1|||
161461833|NCT00543855|583086168|FG002|Overall Study|Withdrawal by Subject|2|||
161809981|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
161809982|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
161461834|NCT00543855|583086169|FG003|Overall Study|Withdrawal by Subject|0|||
161461835|NCT00543855|583086166|FG000|Overall Study|Protocol Violation|1|||
161461836|NCT00543855|583086167|FG001|Overall Study|Protocol Violation|0|||
161461837|NCT00543855|583086168|FG002|Overall Study|Protocol Violation|0|||
161461838|NCT00543855|583086169|FG003|Overall Study|Protocol Violation|0|||
161572469|NCT02341625|583479859|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572470|NCT02341625|583479860|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572471|NCT02341625|583479861|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
161572472|NCT02341625|583479862|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
161572473|NCT02341625|583479863|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572474|NCT02341625|583479864|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161572475|NCT02341625|583479855|FG000|Overall Study|Participant Withdrew Consent|0|||
161572476|NCT02341625|583479856|FG001|Overall Study|Participant Withdrew Consent|0|||
161572477|NCT02341625|583479857|FG002|Overall Study|Participant Withdrew Consent|0|||
161572478|NCT02341625|583479858|FG003|Overall Study|Participant Withdrew Consent|1|||
161572479|NCT02341625|583479859|FG004|Overall Study|Participant Withdrew Consent|0|||
161572480|NCT02341625|583479860|FG005|Overall Study|Participant Withdrew Consent|0|||
161572481|NCT02341625|583479861|FG006|Overall Study|Participant Withdrew Consent|0|||
161572482|NCT02341625|583479862|FG007|Overall Study|Participant Withdrew Consent|0|||
161572483|NCT02341625|583479863|FG008|Overall Study|Participant Withdrew Consent|0|||
161572484|NCT02341625|583479864|FG009|Overall Study|Participant Withdrew Consent|0|||
161572485|NCT02341625|583479855|FG000|Overall Study|Completed Treatment as per Protocol|0|||
161572486|NCT02341625|583479856|FG001|Overall Study|Completed Treatment as per Protocol|0|||
161572487|NCT02341625|583479857|FG002|Overall Study|Completed Treatment as per Protocol|0|||
161572488|NCT02341625|583479858|FG003|Overall Study|Completed Treatment as per Protocol|0|||
161572489|NCT02341625|583479859|FG004|Overall Study|Completed Treatment as per Protocol|0|||
161572490|NCT02341625|583479860|FG005|Overall Study|Completed Treatment as per Protocol|0|||
161572491|NCT02341625|583479861|FG006|Overall Study|Completed Treatment as per Protocol|0|||
161572492|NCT02341625|583479862|FG007|Overall Study|Completed Treatment as per Protocol|0|||
161572493|NCT02341625|583479863|FG008|Overall Study|Completed Treatment as per Protocol|0|||
161572494|NCT02341625|583479864|FG009|Overall Study|Completed Treatment as per Protocol|1|||
161572495|NCT02341625|583479855|FG000|Overall Study|Other Reasons|0|||
161572496|NCT02341625|583479856|FG001|Overall Study|Other Reasons|0|||
161572497|NCT02341625|583479857|FG002|Overall Study|Other Reasons|0|||
161572498|NCT02341625|583479858|FG003|Overall Study|Other Reasons|0|||
161572499|NCT02341625|583479859|FG004|Overall Study|Other Reasons|1|||
161572500|NCT02341625|583479860|FG005|Overall Study|Other Reasons|0|||
161572501|NCT02341625|583479861|FG006|Overall Study|Other Reasons|5|||
161572502|NCT02341625|583479862|FG007|Overall Study|Other Reasons|0|||
161572503|NCT02341625|583479863|FG008|Overall Study|Other Reasons|0|||
161572504|NCT02341625|583479864|FG009|Overall Study|Other Reasons|2|||
161572505|NCT02341625|583479855|FG000|Overall Study|Not Reported|0|||
161572506|NCT02341625|583479856|FG001|Overall Study|Not Reported|0|||
161572507|NCT02341625|583479857|FG002|Overall Study|Not Reported|0|||
161572508|NCT02341625|583479858|FG003|Overall Study|Not Reported|0|||
161572509|NCT02341625|583479859|FG004|Overall Study|Not Reported|0|||
161572510|NCT02341625|583479860|FG005|Overall Study|Not Reported|0|||
161809983|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
161809984|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
161809985|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
161809986|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
161809987|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
161809988|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
161809989|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
161809990|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
161809991|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809992|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809993|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809994|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161572511|NCT02341625|583479861|FG006|Overall Study|Not Reported|0|||
161572512|NCT02341625|583479862|FG007|Overall Study|Not Reported|0|||
161572513|NCT02341625|583479863|FG008|Overall Study|Not Reported|0|||
161572514|NCT02341625|583479864|FG009|Overall Study|Not Reported|3|||
161572515|NCT03396913|583479865|FG000|Overall Study|Lost to Follow-up|0|||
161572516|NCT03396913|583479866|FG001|Overall Study|Lost to Follow-up|6|||
161572517|NCT04222959|583479876|FG000|Overall Study|Lost to Follow-up|76|||
161572518|NCT04222959|583479877|FG001|Overall Study|Lost to Follow-up|28|||
161572519|NCT01981356|583479884|FG000|Overall Study|Lost to Follow-up|4|||
161572520|NCT01981356|583479885|FG001|Overall Study|Lost to Follow-up|1|||
161572521|NCT01981356|583479884|FG000|Overall Study|Withdrawal by Subject|1|||
161572522|NCT01981356|583479885|FG001|Overall Study|Withdrawal by Subject|1|||
161572523|NCT01981356|583479884|FG000|Overall Study|Protocol Violation|2|||
161572524|NCT01981356|583479885|FG001|Overall Study|Protocol Violation|0|||
161572525|NCT01867580|583479889|FG000|Overall Study|Withdrawal by Subject|2|||
161809995|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809996|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161572526|NCT01867580|583479890|FG001|Overall Study|Withdrawal by Subject|3|||
161809997|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161461839|NCT04854642|583086170|FG000|Overall Study|Adverse Event|1|||
161461840|NCT04854642|583086171|FG001|Overall Study|Adverse Event|2|||
161461841|NCT04854642|583086170|FG000|Overall Study|Withdrawal by Subject|0|||
161461842|NCT04854642|583086171|FG001|Overall Study|Withdrawal by Subject|1|||
161461843|NCT00301821|583086176|FG000|Overall Study|Ineligible|25|||
161461844|NCT00301821|583086176|FG000|Overall Study|Cancel|1|||
161461845|NCT02294773|583086177|FG000|Overall Study|Withdrawal by Subject|0|||
161461846|NCT02294773|583086178|FG001|Overall Study|Withdrawal by Subject|2|||
161461847|NCT01865084|583086179|FG000|Double Blind Period (DB)|Adverse Event|2|||
161461848|NCT01865084|583086180|FG001|Double Blind Period (DB)|Adverse Event|2|||
161461849|NCT01865084|583086181|FG002|Double Blind Period (DB)|Adverse Event|1|||
161461850|NCT01865084|583086179|FG000|Double Blind Period (DB)|Protocol Violation|0|||
161461851|NCT01865084|583086180|FG001|Double Blind Period (DB)|Protocol Violation|0|||
161461852|NCT01865084|583086181|FG002|Double Blind Period (DB)|Protocol Violation|1|||
161461853|NCT01865084|583086179|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
161461854|NCT01865084|583086180|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
161461855|NCT01865084|583086181|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
161461856|NCT01865084|583086179|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
161461857|NCT01865084|583086180|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
161461858|NCT01865084|583086181|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
161461859|NCT01865084|583086179|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
161461860|NCT01865084|583086180|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
161461861|NCT01865084|583086181|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
161461862|NCT01865084|583086179|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
161461863|NCT01865084|583086180|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
161461864|NCT01865084|583086181|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
161461865|NCT01865084|583086179|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
161461866|NCT01865084|583086180|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
161461867|NCT01865084|583086181|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
161572527|NCT01867580|583479889|FG000|Overall Study|Physician Decision|17|||
161572528|NCT01867580|583479890|FG001|Overall Study|Physician Decision|12|||
161572529|NCT01867580|583479889|FG000|Overall Study|Lost to Follow-up|3|||
161572530|NCT01867580|583479890|FG001|Overall Study|Lost to Follow-up|5|||
161572531|NCT01867580|583479889|FG000|Overall Study|Sponsor terminated study|1|||
161572532|NCT01867580|583479890|FG001|Overall Study|Sponsor terminated study|0|||
161572533|NCT01867580|583479889|FG000|Overall Study|Missed follow-up assessment|2|||
161572534|NCT01867580|583479890|FG001|Overall Study|Missed follow-up assessment|1|||
161572535|NCT01867580|583479889|FG000|Overall Study|Interruption to therapy|3|||
161572536|NCT01867580|583479890|FG001|Overall Study|Interruption to therapy|0|||
161572537|NCT01867580|583479889|FG000|Overall Study|Osteomyelitis|0|||
161572538|NCT01867580|583479890|FG001|Overall Study|Osteomyelitis|1|||
161572539|NCT01867580|583479889|FG000|Overall Study|Continuation of therapy|0|||
161461868|NCT01865084|583086179|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
161461869|NCT01865084|583086180|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
161461870|NCT01865084|583086181|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
161461871|NCT01865084|583086179|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
161461872|NCT01865084|583086180|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
161461873|NCT01865084|583086181|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
161461874|NCT01994590|583086184|FG000|Overall Study|Adverse Event|1|||
161461875|NCT01994590|583086184|FG000|Overall Study|Trial Terminated|1|||
161461876|NCT00719264|583086186|FG000|Overall Study|Adverse Event|41|||
161461877|NCT00719264|583086187|FG001|Overall Study|Adverse Event|49|||
161461878|NCT00719264|583086186|FG000|Overall Study|Death|13|||
161461879|NCT00719264|583086187|FG001|Overall Study|Death|10|||
161461880|NCT00719264|583086186|FG000|Overall Study|Administrative Problems|6|||
161461881|NCT00719264|583086187|FG001|Overall Study|Administrative Problems|4|||
161461882|NCT00719264|583086186|FG000|Overall Study|Lost to Follow-up|1|||
161461883|NCT00719264|583086187|FG001|Overall Study|Lost to Follow-up|1|||
161461884|NCT00719264|583086186|FG000|Overall Study|Withdrawal by Subject|12|||
161461885|NCT00719264|583086187|FG001|Overall Study|Withdrawal by Subject|7|||
161572540|NCT01867580|583479890|FG001|Overall Study|Continuation of therapy|1|||
161461886|NCT00719264|583086186|FG000|Overall Study|Protocol Deviation|1|||
161461887|NCT00719264|583086187|FG001|Overall Study|Protocol Deviation|3|||
161461888|NCT00719264|583086186|FG000|Overall Study|New Cancer Therapy|4|||
161461889|NCT00719264|583086187|FG001|Overall Study|New Cancer Therapy|2|||
161461890|NCT00719264|583086186|FG000|Overall Study|Disease Progression|104|||
161461891|NCT00719264|583086187|FG001|Overall Study|Disease Progression|107|||
161461892|NCT01277042|583086188|FG000|Overall Study|Adverse Event|4|||
161572541|NCT01867580|583479889|FG000|Overall Study|Wound recurrence|0|||
161572542|NCT01867580|583479890|FG001|Overall Study|Wound recurrence|1|||
161572543|NCT01278862|583479891|FG000|Overall Study|Lost to Follow-up|1|||
161572544|NCT01278862|583479892|FG001|Overall Study|Lost to Follow-up|1|||
161572545|NCT02952261|583479894|FG000|Overall Study|Withdrawal by Subject|4|||
161572546|NCT02952261|583479895|FG001|Overall Study|Withdrawal by Subject|5|||
161572547|NCT02952261|583479894|FG000|Overall Study|Protocol Violation|1|||
161914057|NCT04513366|584733698|FG000|Extension Phase|Lost to Follow-up|1|||
161914058|NCT04513366|584733699|FG001|Extension Phase|Lost to Follow-up|1|||
161461893|NCT01277042|583086189|FG001|Overall Study|Adverse Event|3|||
161461894|NCT01277042|583086188|FG000|Overall Study|Lost to Follow-up|2|||
161461895|NCT01277042|583086189|FG001|Overall Study|Lost to Follow-up|2|||
161461896|NCT01277042|583086188|FG000|Overall Study|Withdrawal by Subject|2|||
161461897|NCT01277042|583086189|FG001|Overall Study|Withdrawal by Subject|0|||
161461898|NCT03581786|583086194|FG000|Overall Study|Death|67|||
161461899|NCT03581786|583086195|FG001|Overall Study|Death|47|||
161461900|NCT03581786|583086194|FG000|Overall Study|Withdrawal by Subject|2|||
161914059|NCT04513366|584733700|FG002|Extension Phase|Lost to Follow-up|1|||
161914060|NCT04513366|584733698|FG000|Extension Phase|Sponsor Decision|0|||
161914061|NCT04513366|584733699|FG001|Extension Phase|Sponsor Decision|1|||
161914062|NCT04513366|584733700|FG002|Extension Phase|Sponsor Decision|0|||
161914063|NCT04513366|584733698|FG000|Extension Phase|Death|0|||
161461901|NCT03581786|583086195|FG001|Overall Study|Withdrawal by Subject|5|||
161461902|NCT03581786|583086194|FG000|Overall Study|Lost to Follow-up|7|||
161461903|NCT03581786|583086195|FG001|Overall Study|Lost to Follow-up|4|||
161461904|NCT03581786|583086194|FG000|Overall Study|reason other than specified above|0|||
161461905|NCT03581786|583086195|FG001|Overall Study|reason other than specified above|1|||
161461906|NCT02469038|583086198|FG000|Overall Study|Physician Decision|4|||
161461907|NCT02469038|583086199|FG001|Overall Study|Physician Decision|5|||
161461908|NCT03435640|583086200|FG000|Overall Study|Withdrawal by Subject|0|||
161461909|NCT03435640|583086201|FG001|Overall Study|Withdrawal by Subject|1|||
161461910|NCT03435640|583086202|FG002|Overall Study|Withdrawal by Subject|0|||
161461911|NCT03435640|583086203|FG003|Overall Study|Withdrawal by Subject|2|||
161461912|NCT03435640|583086204|FG004|Overall Study|Withdrawal by Subject|0|||
161461913|NCT03435640|583086205|FG005|Overall Study|Withdrawal by Subject|0|||
161572548|NCT02952261|583479895|FG001|Overall Study|Protocol Violation|0|||
161572549|NCT03141788|583479896|FG000|Overall Study|Lost to Follow-up|1|||
161572550|NCT03141788|583479896|FG000|Overall Study|Protocol Violation|3|||
161572551|NCT03141788|583479896|FG000|Overall Study|Withdrawal by Subject|4|||
161572552|NCT03284957|583481942|FG000|Overall Study|Adverse Event|0|||
161572553|NCT03284957|583481943|FG001|Overall Study|Adverse Event|0|||
161572554|NCT03284957|583481944|FG002|Overall Study|Adverse Event|0|||
161572555|NCT03284957|583481945|FG003|Overall Study|Adverse Event|0|||
161572556|NCT03284957|583481946|FG004|Overall Study|Adverse Event|0|||
161572557|NCT03284957|583481947|FG005|Overall Study|Adverse Event|1|||
161572558|NCT03284957|583481948|FG006|Overall Study|Adverse Event|1|||
161572559|NCT03284957|583481949|FG007|Overall Study|Adverse Event|1|||
161572560|NCT03284957|583481950|FG008|Overall Study|Adverse Event|0|||
161572561|NCT03284957|583481951|FG009|Overall Study|Adverse Event|4|||
161572562|NCT03284957|583481952|FG010|Overall Study|Adverse Event|1|||
161572563|NCT03284957|583481953|FG011|Overall Study|Adverse Event|1|||
161572564|NCT03284957|583481954|FG012|Overall Study|Adverse Event|0|||
161572565|NCT03284957|583481955|FG013|Overall Study|Adverse Event|0|||
161572566|NCT03284957|583481956|FG014|Overall Study|Adverse Event|0|||
161572567|NCT03284957|583481957|FG015|Overall Study|Adverse Event|0|||
161572568|NCT03284957|583481942|FG000|Overall Study|Progressive Disease|3|||
161572569|NCT03284957|583481943|FG001|Overall Study|Progressive Disease|3|||
161572570|NCT03284957|583481944|FG002|Overall Study|Progressive Disease|4|||
161572571|NCT03284957|583481945|FG003|Overall Study|Progressive Disease|3|||
161572572|NCT03284957|583481946|FG004|Overall Study|Progressive Disease|3|||
161572573|NCT03284957|583481947|FG005|Overall Study|Progressive Disease|5|||
161572574|NCT03284957|583481948|FG006|Overall Study|Progressive Disease|45|||
161572575|NCT03284957|583481949|FG007|Overall Study|Progressive Disease|8|||
161572576|NCT03284957|583481950|FG008|Overall Study|Progressive Disease|5|||
161572577|NCT03284957|583481951|FG009|Overall Study|Progressive Disease|18|||
161572578|NCT03284957|583481952|FG010|Overall Study|Progressive Disease|7|||
161572579|NCT03284957|583481953|FG011|Overall Study|Progressive Disease|2|||
161461914|NCT03435640|583086206|FG006|Overall Study|Withdrawal by Subject|3|||
161461915|NCT03435640|583086207|FG007|Overall Study|Withdrawal by Subject|0|||
161461916|NCT03435640|583086208|FG008|Overall Study|Withdrawal by Subject|0|||
161461917|NCT03435640|583086209|FG009|Overall Study|Withdrawal by Subject|2|||
161461918|NCT03435640|583086210|FG010|Overall Study|Withdrawal by Subject|3|||
161461919|NCT03435640|583086200|FG000|Overall Study|Lost to Follow-up|0|||
161572580|NCT03284957|583481954|FG012|Overall Study|Progressive Disease|3|||
161572581|NCT03284957|583481955|FG013|Overall Study|Progressive Disease|1|||
161572582|NCT03284957|583481956|FG014|Overall Study|Progressive Disease|1|||
161572583|NCT03284957|583481957|FG015|Overall Study|Progressive Disease|2|||
161572584|NCT03284957|583481942|FG000|Overall Study|Withdrawal by Subject|0|||
161572585|NCT03284957|583481943|FG001|Overall Study|Withdrawal by Subject|0|||
161461920|NCT03435640|583086201|FG001|Overall Study|Lost to Follow-up|0|||
161572586|NCT03284957|583481944|FG002|Overall Study|Withdrawal by Subject|0|||
161914064|NCT04513366|584733699|FG001|Extension Phase|Death|1|||
161914065|NCT04513366|584733700|FG002|Extension Phase|Death|0|||
161461921|NCT03435640|583086202|FG002|Overall Study|Lost to Follow-up|1|||
161572587|NCT03284957|583481945|FG003|Overall Study|Withdrawal by Subject|0|||
161572588|NCT03284957|583481946|FG004|Overall Study|Withdrawal by Subject|0|||
161914066|NCT04513366|584733698|FG000|Extension Phase|Adverse Event|0|||
161572589|NCT03284957|583481947|FG005|Overall Study|Withdrawal by Subject|0|||
161572590|NCT03284957|583481948|FG006|Overall Study|Withdrawal by Subject|0|||
161572591|NCT03284957|583481949|FG007|Overall Study|Withdrawal by Subject|0|||
161572592|NCT03284957|583481950|FG008|Overall Study|Withdrawal by Subject|0|||
161572593|NCT03284957|583481951|FG009|Overall Study|Withdrawal by Subject|2|||
161572594|NCT03284957|583481952|FG010|Overall Study|Withdrawal by Subject|0|||
161572595|NCT03284957|583481953|FG011|Overall Study|Withdrawal by Subject|0|||
161572596|NCT03284957|583481954|FG012|Overall Study|Withdrawal by Subject|0|||
161572597|NCT03284957|583481955|FG013|Overall Study|Withdrawal by Subject|0|||
161572598|NCT03284957|583481956|FG014|Overall Study|Withdrawal by Subject|0|||
161572599|NCT03284957|583481957|FG015|Overall Study|Withdrawal by Subject|0|||
161572600|NCT03284957|583481942|FG000|Overall Study|Other|0|||
161572601|NCT03284957|583481943|FG001|Overall Study|Other|0|||
161572602|NCT03284957|583481944|FG002|Overall Study|Other|0|||
161572603|NCT03284957|583481945|FG003|Overall Study|Other|0|||
161572604|NCT03284957|583481946|FG004|Overall Study|Other|0|||
161572605|NCT03284957|583481947|FG005|Overall Study|Other|0|||
161461922|NCT03435640|583086203|FG003|Overall Study|Lost to Follow-up|0|||
161461923|NCT03435640|583086204|FG004|Overall Study|Lost to Follow-up|0|||
161461924|NCT03435640|583086205|FG005|Overall Study|Lost to Follow-up|0|||
161461925|NCT03435640|583086206|FG006|Overall Study|Lost to Follow-up|0|||
161461926|NCT03435640|583086207|FG007|Overall Study|Lost to Follow-up|0|||
161461927|NCT03435640|583086208|FG008|Overall Study|Lost to Follow-up|0|||
161461928|NCT03435640|583086209|FG009|Overall Study|Lost to Follow-up|0|||
161461929|NCT03435640|583086210|FG010|Overall Study|Lost to Follow-up|0|||
161461930|NCT01347307|583086211|FG000|Overall Study|Death|0|||
161461931|NCT01347307|583086212|FG001|Overall Study|Death|4|||
161461932|NCT01347307|583086211|FG000|Overall Study|Physician Decision|0|||
161461933|NCT01347307|583086212|FG001|Overall Study|Physician Decision|1|||
161461934|NCT00442468|583086226|FG000|Overall Study|Adverse Event|4|||
161461935|NCT00442468|583086226|FG000|Overall Study|Withdrawal by Subject|91|||
161461936|NCT00442468|583086226|FG000|Overall Study|Did not complete all study procedures|88|||
161461937|NCT00589784|583086227|FG000|Overall Study|Withdrawal by Subject|0|||
161461938|NCT00589784|583086228|FG001|Overall Study|Withdrawal by Subject|6|||
161461939|NCT00589784|583086227|FG000|Overall Study|Patient inevaluable|1|||
161461940|NCT00589784|583086228|FG001|Overall Study|Patient inevaluable|0|||
161461941|NCT00589784|583086227|FG000|Overall Study|Adverse Event|0|||
161461942|NCT00589784|583086228|FG001|Overall Study|Adverse Event|4|||
161461943|NCT00287079|583086230|FG000|Overall Study|Qualifying relapse|12|||
161461944|NCT00287079|583086231|FG001|Overall Study|Qualifying relapse|1|||
161461945|NCT00287079|583086230|FG000|Overall Study|Non-qualifying relapse|1|||
161461946|NCT00287079|583086231|FG001|Overall Study|Non-qualifying relapse|0|||
161461947|NCT00287079|583086230|FG000|Overall Study|Adverse Event|5|||
161461948|NCT00287079|583086231|FG001|Overall Study|Adverse Event|0|||
161461949|NCT00287079|583086230|FG000|Overall Study|Protocol Violation|1|||
161461950|NCT00287079|583086231|FG001|Overall Study|Protocol Violation|0|||
161461951|NCT00287079|583086230|FG000|Overall Study|Other|3|||
161461952|NCT00287079|583086231|FG001|Overall Study|Other|0|||
161461953|NCT00174291|583086232|FG000|Overall Study|Lost to Follow-up|1|||
161461954|NCT00174291|583086233|FG001|Overall Study|Lost to Follow-up|1|||
161461955|NCT00174291|583086232|FG000|Overall Study|Protocol Violation|0|||
161461956|NCT00174291|583086233|FG001|Overall Study|Protocol Violation|2|||
161461957|NCT00174291|583086232|FG000|Overall Study|Study terminated by sponsor|1|||
161461958|NCT00174291|583086233|FG001|Overall Study|Study terminated by sponsor|0|||
161461959|NCT00174291|583086232|FG000|Overall Study|Withdrawal by Subject|3|||
161461960|NCT00174291|583086233|FG001|Overall Study|Withdrawal by Subject|3|||
161461961|NCT03882008|583086234|FG000|Overall Study|Withdrawal by Subject|1|||
161461962|NCT03882008|583086234|FG000|Overall Study|Lost to Follow-up|1|||
161461963|NCT03519386|583086238|FG000|Overall Study|Withdrawal by Subject|4|||
161461964|NCT03519386|583086239|FG001|Overall Study|Withdrawal by Subject|1|||
161461965|NCT03519386|583086240|FG002|Overall Study|Withdrawal by Subject|2|||
161461966|NCT03519386|583086238|FG000|Overall Study|Physician Decision|1|||
161461967|NCT03519386|583086239|FG001|Overall Study|Physician Decision|1|||
161461968|NCT03519386|583086240|FG002|Overall Study|Physician Decision|1|||
161461969|NCT03519386|583086238|FG000|Overall Study|Lost to Follow-up|0|||
161461970|NCT03519386|583086239|FG001|Overall Study|Lost to Follow-up|1|||
161461971|NCT03519386|583086240|FG002|Overall Study|Lost to Follow-up|1|||
161461972|NCT03519386|583086238|FG000|Overall Study|Death|1|||
161461973|NCT03519386|583086239|FG001|Overall Study|Death|0|||
161461974|NCT03519386|583086240|FG002|Overall Study|Death|4|||
161461975|NCT03519386|583086238|FG000|Overall Study|Adverse Event|2|||
161461976|NCT03519386|583086239|FG001|Overall Study|Adverse Event|1|||
161461977|NCT03519386|583086240|FG002|Overall Study|Adverse Event|2|||
161461978|NCT03519386|583086238|FG000|Overall Study|Explanted|2|||
161572606|NCT03284957|583481948|FG006|Overall Study|Other|3|||
161572607|NCT03284957|583481949|FG007|Overall Study|Other|0|||
161461979|NCT03519386|583086239|FG001|Overall Study|Explanted|1|||
161461980|NCT03519386|583086240|FG002|Overall Study|Explanted|0|||
161461981|NCT03519386|583086238|FG000|Overall Study|Ongoing in study|190|||
161461982|NCT03519386|583086239|FG001|Overall Study|Ongoing in study|192|||
161572608|NCT03284957|583481950|FG008|Overall Study|Other|1|||
161461983|NCT03519386|583086240|FG002|Overall Study|Ongoing in study|183|||
161461984|NCT01582854|583086246|FG000|Overall Study|Death|8|||
161461985|NCT01582854|583086247|FG001|Overall Study|Death|5|||
161461986|NCT01582854|583086246|FG000|Overall Study|Adverse Event|2|||
161461987|NCT01582854|583086247|FG001|Overall Study|Adverse Event|3|||
161461988|NCT01582854|583086246|FG000|Overall Study|Withdrawal by Participant|8|||
161461989|NCT01582854|583086247|FG001|Overall Study|Withdrawal by Participant|11|||
161461990|NCT01582854|583086246|FG000|Overall Study|Lost to Follow-up|1|||
161461991|NCT01582854|583086247|FG001|Overall Study|Lost to Follow-up|2|||
161461992|NCT01582854|583086246|FG000|Overall Study|Physician Decision|0|||
161461993|NCT01582854|583086247|FG001|Overall Study|Physician Decision|1|||
161461994|NCT01582854|583086246|FG000|Overall Study|Recurrent Stroke|13|||
161461995|NCT01582854|583086247|FG001|Overall Study|Recurrent Stroke|8|||
161461996|NCT01582854|583086246|FG000|Overall Study|Disallowed Concomitant Medication|3|||
161461997|NCT01582854|583086247|FG001|Overall Study|Disallowed Concomitant Medication|2|||
161461998|NCT01582854|583086246|FG000|Overall Study|Carotid or Neurosurgery|0|||
161461999|NCT01582854|583086247|FG001|Overall Study|Carotid or Neurosurgery|1|||
161462000|NCT01582854|583086246|FG000|Overall Study|General Anaesthesia|0|||
161462001|NCT01582854|583086247|FG001|Overall Study|General Anaesthesia|1|||
161462002|NCT01582854|583086246|FG000|Overall Study|Other Miscellaneous Reason|1|||
161462003|NCT01582854|583086247|FG001|Overall Study|Other Miscellaneous Reason|0|||
161462004|NCT04068896|583086248|FG000|Overall Study|Adverse Event|2|||
161462005|NCT04068896|583086249|FG001|Overall Study|Adverse Event|0|||
161462006|NCT04068896|583086250|FG002|Overall Study|Adverse Event|1|||
161462007|NCT04068896|583086251|FG003|Overall Study|Adverse Event|0|||
161462008|NCT04068896|583086252|FG004|Overall Study|Adverse Event|0|||
161462009|NCT04068896|583086253|FG005|Overall Study|Adverse Event|0|||
161462010|NCT04068896|583086248|FG000|Overall Study|Death|3|||
161462011|NCT04068896|583086249|FG001|Overall Study|Death|1|||
161462012|NCT04068896|583086250|FG002|Overall Study|Death|3|||
161462013|NCT04068896|583086251|FG003|Overall Study|Death|19|||
161462014|NCT04068896|583086252|FG004|Overall Study|Death|17|||
161462015|NCT04068896|583086253|FG005|Overall Study|Death|0|||
161462016|NCT04068896|583086248|FG000|Overall Study|Physician Decision|0|||
161462017|NCT04068896|583086249|FG001|Overall Study|Physician Decision|0|||
161462018|NCT04068896|583086250|FG002|Overall Study|Physician Decision|0|||
161462019|NCT04068896|583086251|FG003|Overall Study|Physician Decision|1|||
161462020|NCT04068896|583086252|FG004|Overall Study|Physician Decision|0|||
161462021|NCT04068896|583086253|FG005|Overall Study|Physician Decision|0|||
161462022|NCT04068896|583086248|FG000|Overall Study|progressive disease|3|||
161462023|NCT04068896|583086249|FG001|Overall Study|progressive disease|5|||
161462024|NCT04068896|583086250|FG002|Overall Study|progressive disease|3|||
161462025|NCT04068896|583086251|FG003|Overall Study|progressive disease|2|||
161462026|NCT04068896|583086252|FG004|Overall Study|progressive disease|1|||
161462027|NCT04068896|583086253|FG005|Overall Study|progressive disease|2|||
161462028|NCT04068896|583086248|FG000|Overall Study|Study terminated by sponsor|0|||
161462029|NCT04068896|583086249|FG001|Overall Study|Study terminated by sponsor|0|||
161462030|NCT04068896|583086250|FG002|Overall Study|Study terminated by sponsor|1|||
161462031|NCT04068896|583086251|FG003|Overall Study|Study terminated by sponsor|2|||
161462032|NCT04068896|583086252|FG004|Overall Study|Study terminated by sponsor|1|||
161462033|NCT04068896|583086253|FG005|Overall Study|Study terminated by sponsor|4|||
161462034|NCT04068896|583086248|FG000|Overall Study|Protocol Violation|0|||
161462035|NCT04068896|583086249|FG001|Overall Study|Protocol Violation|0|||
161462036|NCT04068896|583086250|FG002|Overall Study|Protocol Violation|0|||
161462037|NCT04068896|583086251|FG003|Overall Study|Protocol Violation|1|||
161462038|NCT04068896|583086252|FG004|Overall Study|Protocol Violation|0|||
161462039|NCT04068896|583086253|FG005|Overall Study|Protocol Violation|0|||
161462040|NCT04068896|583086248|FG000|Overall Study|Withdrawal by Subject|0|||
161462041|NCT04068896|583086249|FG001|Overall Study|Withdrawal by Subject|3|||
161462042|NCT04068896|583086250|FG002|Overall Study|Withdrawal by Subject|0|||
161462043|NCT04068896|583086251|FG003|Overall Study|Withdrawal by Subject|2|||
161462044|NCT04068896|583086252|FG004|Overall Study|Withdrawal by Subject|1|||
161462045|NCT04068896|583086253|FG005|Overall Study|Withdrawal by Subject|0|||
161462046|NCT04068896|583086248|FG000|Overall Study|Symptomatic deterioration|2|||
161462047|NCT04068896|583086249|FG001|Overall Study|Symptomatic deterioration|0|||
161462048|NCT04068896|583086250|FG002|Overall Study|Symptomatic deterioration|0|||
161462049|NCT04068896|583086251|FG003|Overall Study|Symptomatic deterioration|0|||
161462050|NCT04068896|583086252|FG004|Overall Study|Symptomatic deterioration|0|||
161462051|NCT04068896|583086253|FG005|Overall Study|Symptomatic deterioration|0|||
161462052|NCT02953509|583086254|FG000|Overall Study|Death|1|||
161462053|NCT02953509|583086255|FG001|Overall Study|Death|3|||
161809998|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161462054|NCT02953509|583086256|FG002|Overall Study|Death|3|||
161462055|NCT02953509|583086257|FG003|Overall Study|Death|4|||
161462056|NCT02953509|583086258|FG004|Overall Study|Death|12|||
161462057|NCT02953509|583086259|FG005|Overall Study|Death|3|||
161462058|NCT02953509|583086260|FG006|Overall Study|Death|25|||
161462059|NCT02953509|583086261|FG007|Overall Study|Death|10|||
161462060|NCT02953509|583086262|FG008|Overall Study|Death|21|||
161462061|NCT02953509|583086263|FG009|Overall Study|Death|20|||
161572609|NCT03284957|583481951|FG009|Overall Study|Other|6|||
161572610|NCT03284957|583481952|FG010|Overall Study|Other|0|||
161572611|NCT03284957|583481953|FG011|Overall Study|Other|0|||
161572612|NCT03284957|583481954|FG012|Overall Study|Other|0|||
161572613|NCT03284957|583481955|FG013|Overall Study|Other|0|||
161572614|NCT03284957|583481956|FG014|Overall Study|Other|2|||
161572615|NCT03284957|583481957|FG015|Overall Study|Other|0|||
161572616|NCT03086369|583481963|FG000|Overall Study|Lost to Follow-up|1|||
161572617|NCT03086369|583481964|FG001|Overall Study|Lost to Follow-up|0|||
161572618|NCT03086369|583481965|FG002|Overall Study|Lost to Follow-up|0|||
161572619|NCT03086369|583481966|FG003|Overall Study|Lost to Follow-up|2|||
161572620|NCT03086369|583481967|FG004|Overall Study|Lost to Follow-up|1|||
161572621|NCT03086369|583481963|FG000|Overall Study|Physician Decision|0|||
161572622|NCT03086369|583481964|FG001|Overall Study|Physician Decision|0|||
161572623|NCT03086369|583481965|FG002|Overall Study|Physician Decision|0|||
161572624|NCT03086369|583481966|FG003|Overall Study|Physician Decision|1|||
161572625|NCT03086369|583481967|FG004|Overall Study|Physician Decision|2|||
161572626|NCT03086369|583481963|FG000|Overall Study|Withdrawal by Subject|0|||
161572627|NCT03086369|583481964|FG001|Overall Study|Withdrawal by Subject|0|||
161572628|NCT03086369|583481965|FG002|Overall Study|Withdrawal by Subject|0|||
161572629|NCT03086369|583481966|FG003|Overall Study|Withdrawal by Subject|5|||
161572630|NCT03086369|583481967|FG004|Overall Study|Withdrawal by Subject|3|||
161572631|NCT03086369|583481963|FG000|Overall Study|Progressive Disease|0|||
161572632|NCT03086369|583481964|FG001|Overall Study|Progressive Disease|0|||
161572633|NCT03086369|583481965|FG002|Overall Study|Progressive Disease|0|||
161572634|NCT03086369|583481966|FG003|Overall Study|Progressive Disease|1|||
161572635|NCT03086369|583481967|FG004|Overall Study|Progressive Disease|1|||
161572636|NCT03169244|583481968|FG000|Overall Study|Lost to Follow-up|1|||
161572637|NCT03169244|583481969|FG001|Overall Study|Lost to Follow-up|2|||
161572638|NCT03169244|583481968|FG000|Overall Study|Adverse Event|1|||
161572639|NCT03169244|583481969|FG001|Overall Study|Adverse Event|0|||
161572640|NCT03169244|583481968|FG000|Overall Study|Withdrawal by Subject|2|||
161572641|NCT03169244|583481969|FG001|Overall Study|Withdrawal by Subject|2|||
161572642|NCT03169244|583481968|FG000|Overall Study|Physician Decision|1|||
161572643|NCT03169244|583481969|FG001|Overall Study|Physician Decision|0|||
161572644|NCT01070888|583481970|FG000|First Intervention (14 Days)|Adverse Event|0|||
161572645|NCT01070888|583481971|FG001|First Intervention (14 Days)|Adverse Event|1|||
161572646|NCT01070888|583481970|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
161572647|NCT01070888|583481971|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
161572648|NCT01070888|583481970|FG000|Washout (14 Days)|Physician Decision|1|||
161572649|NCT01070888|583481971|FG001|Washout (14 Days)|Physician Decision|0|||
161572650|NCT00178399|583481972|FG000|Overall Study|Physician Decision|4|||
161572651|NCT00178399|583481972|FG000|Overall Study|Withdrawal by Subject|8|||
161572652|NCT00178399|583481972|FG000|Overall Study|Lost to Follow-up|1|||
161572653|NCT02631148|583481973|FG000|Overall Study|8 were ineligible|8|||
161572654|NCT02631148|583481974|FG001|Overall Study|8 were ineligible|0|||
161572655|NCT02631148|583481973|FG000|Overall Study|Withdrawal by Subject|1|||
161572656|NCT02631148|583481974|FG001|Overall Study|Withdrawal by Subject|0|||
161572657|NCT02631148|583481973|FG000|Overall Study|PAH not available to study participant|1|||
161572658|NCT02631148|583481974|FG001|Overall Study|PAH not available to study participant|0|||
161572659|NCT00357396|583481975|FG000|Overall Study|Adverse Event|1|||
161572660|NCT00357396|583481976|FG001|Overall Study|Adverse Event|0|||
161572661|NCT00955825|583481977|FG000|Overall Study|Adverse Event|15|||
161572662|NCT00955825|583481978|FG001|Overall Study|Adverse Event|2|||
161572663|NCT00955825|583481977|FG000|Overall Study|Withdrawal by Subject|4|||
161572664|NCT00955825|583481978|FG001|Overall Study|Withdrawal by Subject|6|||
161572665|NCT00955825|583481977|FG000|Overall Study|Any other reason not above-mentioned|7|||
161572666|NCT00955825|583481978|FG001|Overall Study|Any other reason not above-mentioned|9|||
161572667|NCT00708032|583481979|FG000|Overall Study|Adverse Event|0|||
161572668|NCT00708032|583481980|FG001|Overall Study|Adverse Event|2|||
161572669|NCT00708032|583481979|FG000|Overall Study|Lost to Follow-up|1|||
161914067|NCT04513366|584733699|FG001|Extension Phase|Adverse Event|0|||
161572670|NCT00708032|583481980|FG001|Overall Study|Lost to Follow-up|2|||
161572671|NCT00708032|583481979|FG000|Overall Study|Pregnancy|0|||
161572672|NCT00708032|583481980|FG001|Overall Study|Pregnancy|1|||
161572673|NCT00708032|583481979|FG000|Overall Study|Poor vision|0|||
161572674|NCT00708032|583481980|FG001|Overall Study|Poor vision|6|||
161572675|NCT00708032|583481979|FG000|Overall Study|Visit out of range at month 12|4|||
161572676|NCT00708032|583481980|FG001|Overall Study|Visit out of range at month 12|1|||
161572677|NCT00708032|583481979|FG000|Overall Study|Did not meet protocol criteria|1|||
161572678|NCT00708032|583481980|FG001|Overall Study|Did not meet protocol criteria|2|||
161572679|NCT00708032|583481979|FG000|Overall Study|Protocol Violation|4|||
161572680|NCT00708032|583481980|FG001|Overall Study|Protocol Violation|1|||
161572681|NCT00708032|583481979|FG000|Overall Study|Withdrawal by Subject|0|||
161572682|NCT00708032|583481980|FG001|Overall Study|Withdrawal by Subject|1|||
161572683|NCT00150176|583481981|FG000|Overall Study|Adverse Event|16|||
161572684|NCT00150176|583481982|FG001|Overall Study|Adverse Event|53|||
161572685|NCT00150176|583481981|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
161462062|NCT02953509|583086254|FG000|Overall Study|Reason Not Specified|0|||
161462063|NCT02953509|583086255|FG001|Overall Study|Reason Not Specified|2|||
161462064|NCT02953509|583086256|FG002|Overall Study|Reason Not Specified|8|||
161462065|NCT02953509|583086257|FG003|Overall Study|Reason Not Specified|2|||
161462066|NCT02953509|583086258|FG004|Overall Study|Reason Not Specified|11|||
161462067|NCT02953509|583086259|FG005|Overall Study|Reason Not Specified|4|||
161462068|NCT02953509|583086260|FG006|Overall Study|Reason Not Specified|12|||
161462069|NCT02953509|583086261|FG007|Overall Study|Reason Not Specified|2|||
161462070|NCT02953509|583086262|FG008|Overall Study|Reason Not Specified|7|||
161462071|NCT02953509|583086263|FG009|Overall Study|Reason Not Specified|2|||
161462072|NCT02953509|583086254|FG000|Overall Study|Consent Withdrawn|1|||
161462073|NCT02953509|583086255|FG001|Overall Study|Consent Withdrawn|1|||
161462074|NCT02953509|583086256|FG002|Overall Study|Consent Withdrawn|2|||
161462075|NCT02953509|583086257|FG003|Overall Study|Consent Withdrawn|1|||
161462076|NCT02953509|583086258|FG004|Overall Study|Consent Withdrawn|3|||
161462077|NCT02953509|583086259|FG005|Overall Study|Consent Withdrawn|0|||
161462078|NCT02953509|583086260|FG006|Overall Study|Consent Withdrawn|4|||
161462079|NCT02953509|583086261|FG007|Overall Study|Consent Withdrawn|1|||
161462080|NCT02953509|583086262|FG008|Overall Study|Consent Withdrawn|1|||
161462081|NCT02953509|583086263|FG009|Overall Study|Consent Withdrawn|4|||
161462082|NCT02953509|583086254|FG000|Overall Study|Lost to Follow-up|0|||
161462083|NCT02953509|583086255|FG001|Overall Study|Lost to Follow-up|0|||
161462084|NCT02953509|583086256|FG002|Overall Study|Lost to Follow-up|0|||
161462085|NCT02953509|583086257|FG003|Overall Study|Lost to Follow-up|0|||
161462086|NCT02953509|583086258|FG004|Overall Study|Lost to Follow-up|0|||
161462087|NCT02953509|583086259|FG005|Overall Study|Lost to Follow-up|0|||
161462088|NCT02953509|583086260|FG006|Overall Study|Lost to Follow-up|1|||
161462089|NCT02953509|583086261|FG007|Overall Study|Lost to Follow-up|1|||
161462090|NCT02953509|583086262|FG008|Overall Study|Lost to Follow-up|1|||
161462091|NCT02953509|583086263|FG009|Overall Study|Lost to Follow-up|1|||
161462092|NCT02953509|583086254|FG000|Overall Study|Study terminated by sponsor|1|||
161462093|NCT02953509|583086255|FG001|Overall Study|Study terminated by sponsor|0|||
161462094|NCT02953509|583086256|FG002|Overall Study|Study terminated by sponsor|0|||
161462095|NCT02953509|583086257|FG003|Overall Study|Study terminated by sponsor|0|||
161462096|NCT02953509|583086258|FG004|Overall Study|Study terminated by sponsor|0|||
161462097|NCT02953509|583086259|FG005|Overall Study|Study terminated by sponsor|0|||
161462098|NCT02953509|583086260|FG006|Overall Study|Study terminated by sponsor|1|||
161462099|NCT02953509|583086261|FG007|Overall Study|Study terminated by sponsor|0|||
161462100|NCT02953509|583086262|FG008|Overall Study|Study terminated by sponsor|1|||
161462101|NCT02953509|583086263|FG009|Overall Study|Study terminated by sponsor|1|||
161462102|NCT00484185|583086264|FG000|Overall Study|Lost to Follow-up|44|||
161462103|NCT00484185|583086264|FG000|Overall Study|Other|20|||
161462104|NCT00484185|583086264|FG000|Overall Study|Randomized but not treated|5|||
161462105|NCT00484185|583086264|FG000|Overall Study|Death|2|||
161462106|NCT01222403|583086267|FG000|Overall Study|Inappropriate enrollment|0|||
161462107|NCT01222403|583086268|FG001|Overall Study|Inappropriate enrollment|2|||
161462108|NCT02325791|583086269|FG000|Overall Study|Adverse Event|0|||
161462109|NCT02325791|583086270|FG001|Overall Study|Adverse Event|1|||
161462110|NCT02325791|583086271|FG002|Overall Study|Adverse Event|1|||
161462111|NCT02325791|583086272|FG003|Overall Study|Adverse Event|0|||
161462112|NCT02325791|583086269|FG000|Overall Study|Death|0|||
161462113|NCT02325791|583086270|FG001|Overall Study|Death|3|||
161462114|NCT02325791|583086271|FG002|Overall Study|Death|0|||
161462115|NCT02325791|583086272|FG003|Overall Study|Death|1|||
161462116|NCT02325791|583086269|FG000|Overall Study|Lost to Follow-up|0|||
161462117|NCT02325791|583086270|FG001|Overall Study|Lost to Follow-up|15|||
161462118|NCT02325791|583086271|FG002|Overall Study|Lost to Follow-up|14|||
161462119|NCT02325791|583086272|FG003|Overall Study|Lost to Follow-up|9|||
161462120|NCT02325791|583086269|FG000|Overall Study|Physician Decision|0|||
161462121|NCT02325791|583086270|FG001|Overall Study|Physician Decision|1|||
161462122|NCT02325791|583086271|FG002|Overall Study|Physician Decision|1|||
161462123|NCT02325791|583086272|FG003|Overall Study|Physician Decision|0|||
161462124|NCT02325791|583086269|FG000|Overall Study|Protocol Violation|0|||
161462125|NCT02325791|583086270|FG001|Overall Study|Protocol Violation|0|||
161462126|NCT02325791|583086271|FG002|Overall Study|Protocol Violation|1|||
161462127|NCT02325791|583086272|FG003|Overall Study|Protocol Violation|0|||
161462128|NCT02325791|583086269|FG000|Overall Study|Withdrawal by Subject|0|||
161462129|NCT02325791|583086270|FG001|Overall Study|Withdrawal by Subject|5|||
161462130|NCT02325791|583086271|FG002|Overall Study|Withdrawal by Subject|8|||
161462131|NCT02325791|583086272|FG003|Overall Study|Withdrawal by Subject|16|||
161914068|NCT04513366|584733700|FG002|Extension Phase|Adverse Event|1|||
161462132|NCT02068768|583086274|FG000|Overall Study|Lost to Follow-up|5|||
161462133|NCT02068768|583086274|FG000|Overall Study|Early Termination by Sponsor|2|||
161462134|NCT00913692|583086276|FG000|Screening (4 Months)|Physician Decision|3|||
161914069|NCT03344757|584733701|FG000|Overall Study|Withdrawal by Subject|18|||
161462135|NCT00913692|583086276|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
161462136|NCT00913692|583086276|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
161462137|NCT02694718|583086277|FG000|Overall Study|Death|1|||
161914070|NCT03344757|584733702|FG001|Overall Study|Withdrawal by Subject|16|||
161462138|NCT02694718|583086277|FG000|Overall Study|Withdrawal by Subject|1|||
161462139|NCT00322153|583086279|FG000|Overall Study|Adverse Event|21|||
161462140|NCT00322153|583086280|FG001|Overall Study|Adverse Event|34|||
161462141|NCT00322153|583086279|FG000|Overall Study|Protocol Violation|6|||
161462142|NCT00322153|583086280|FG001|Overall Study|Protocol Violation|14|||
161462143|NCT00322153|583086279|FG000|Overall Study|Withdrawal by Subject|18|||
161462144|NCT00322153|583086280|FG001|Overall Study|Withdrawal by Subject|10|||
161462145|NCT00322153|583086279|FG000|Overall Study|Lack of Efficacy|8|||
161462146|NCT00322153|583086280|FG001|Overall Study|Lack of Efficacy|3|||
161462147|NCT00322153|583086279|FG000|Overall Study|Lost to Follow-up|5|||
161462148|NCT00322153|583086280|FG001|Overall Study|Lost to Follow-up|4|||
161462149|NCT00322153|583086279|FG000|Overall Study|Withdrawn for other reasons|5|||
161462150|NCT00322153|583086280|FG001|Overall Study|Withdrawn for other reasons|4|||
161462151|NCT03455764|583086282|FG000|Overall Study|Adverse Event|1|||
161462152|NCT03455764|583086283|FG001|Overall Study|Adverse Event|0|||
161462153|NCT03455764|583086284|FG002|Overall Study|Adverse Event|0|||
161462154|NCT03455764|583086285|FG003|Overall Study|Adverse Event|0|||
161462155|NCT03455764|583086286|FG004|Overall Study|Adverse Event|0|||
161462156|NCT03455764|583086282|FG000|Overall Study|Disease Progression|4|||
161462157|NCT03455764|583086283|FG001|Overall Study|Disease Progression|0|||
161462158|NCT03455764|583086284|FG002|Overall Study|Disease Progression|0|||
161462159|NCT03455764|583086285|FG003|Overall Study|Disease Progression|0|||
161462160|NCT03455764|583086286|FG004|Overall Study|Disease Progression|0|||
161462161|NCT03455764|583086282|FG000|Overall Study|On Treatment|1|||
161462162|NCT03455764|583086283|FG001|Overall Study|On Treatment|0|||
161462163|NCT03455764|583086284|FG002|Overall Study|On Treatment|0|||
161462164|NCT03455764|583086285|FG003|Overall Study|On Treatment|0|||
161462165|NCT03455764|583086286|FG004|Overall Study|On Treatment|0|||
161462166|NCT00772070|583086287|FG000|Overall Study|Lost to Follow-up|0|||
161462167|NCT00772070|583086288|FG001|Overall Study|Lost to Follow-up|8|||
161462168|NCT00772070|583086287|FG000|Overall Study|Withdrawal by Subject|0|||
161462169|NCT00772070|583086288|FG001|Overall Study|Withdrawal by Subject|2|||
161462170|NCT00772070|583086287|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
161462171|NCT00772070|583086288|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
161462172|NCT02361346|583086293|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462173|NCT02361346|583086294|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462174|NCT02361346|583086295|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462175|NCT02361346|583086296|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
161462176|NCT02361346|583086297|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462177|NCT02361346|583086298|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462178|NCT02361346|583086299|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462179|NCT02361346|583086300|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462180|NCT02361346|583086301|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
161462181|NCT02361346|583086293|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462182|NCT02361346|583086294|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462183|NCT02361346|583086295|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462184|NCT02361346|583086296|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462185|NCT02361346|583086297|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
161462186|NCT02361346|583086298|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462187|NCT02361346|583086299|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462188|NCT02361346|583086300|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462189|NCT02361346|583086301|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161462190|NCT02361346|583086293|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
161462191|NCT02361346|583086294|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
161462192|NCT02361346|583086295|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
161462193|NCT02361346|583086296|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
161462194|NCT02361346|583086297|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
161462195|NCT02361346|583086298|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
161462196|NCT02361346|583086299|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
161462197|NCT02361346|583086300|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
161462198|NCT02361346|583086301|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
161462199|NCT02361346|583086293|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462200|NCT02361346|583086294|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462201|NCT02361346|583086295|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462202|NCT02361346|583086296|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462203|NCT02361346|583086297|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462204|NCT02361346|583086298|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462205|NCT02361346|583086299|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462206|NCT02361346|583086300|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
161462207|NCT02361346|583086301|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
161462208|NCT02361346|583086293|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462209|NCT02361346|583086294|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462210|NCT02361346|583086295|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462211|NCT02361346|583086296|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462212|NCT02361346|583086297|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462213|NCT02361346|583086298|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462214|NCT02361346|583086299|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462215|NCT02361346|583086300|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
161462216|NCT02361346|583086301|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
161462217|NCT02361346|583086293|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462218|NCT02361346|583086294|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462219|NCT02361346|583086295|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462220|NCT02361346|583086296|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462221|NCT02361346|583086297|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462222|NCT02361346|583086298|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462223|NCT02361346|583086299|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462224|NCT02361346|583086300|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
161462225|NCT02361346|583086301|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
161462226|NCT01683019|583087995|FG000|Overall Study|Withdrawal by Subject|2|||
161462227|NCT01683019|583087996|FG001|Overall Study|Withdrawal by Subject|1|||
161462228|NCT01683019|583087997|FG002|Overall Study|Withdrawal by Subject|4|||
161462229|NCT03437512|583087998|FG000|Randomized|Withdrawal by Subject|0|||
161462230|NCT03437512|583087999|FG001|Randomized|Withdrawal by Subject|2|||
161462231|NCT03437512|583087998|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
161462232|NCT03437512|583087999|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
161462233|NCT03332771|583088000|FG000|Overall Study|Adverse Event|6|||
161462234|NCT03332771|583088001|FG001|Overall Study|Adverse Event|4|||
161462235|NCT03332771|583088002|FG002|Overall Study|Adverse Event|1|||
161462236|NCT03332771|583088003|FG003|Overall Study|Adverse Event|3|||
161462237|NCT03332771|583088000|FG000|Overall Study|Poor Compliance to Protocol|0|||
161462238|NCT03332771|583088001|FG001|Overall Study|Poor Compliance to Protocol|1|||
161462239|NCT03332771|583088002|FG002|Overall Study|Poor Compliance to Protocol|0|||
161462240|NCT03332771|583088003|FG003|Overall Study|Poor Compliance to Protocol|1|||
161462241|NCT03332771|583088000|FG000|Overall Study|Lost to Follow-up|2|||
161462242|NCT03332771|583088001|FG001|Overall Study|Lost to Follow-up|2|||
161462243|NCT03332771|583088002|FG002|Overall Study|Lost to Follow-up|1|||
161462244|NCT03332771|583088003|FG003|Overall Study|Lost to Follow-up|2|||
161462245|NCT03332771|583088000|FG000|Overall Study|At the Participant's own request|20|||
161462246|NCT03332771|583088001|FG001|Overall Study|At the Participant's own request|26|||
161462247|NCT03332771|583088002|FG002|Overall Study|At the Participant's own request|14|||
161462248|NCT03332771|583088003|FG003|Overall Study|At the Participant's own request|23|||
161462249|NCT03332771|583088000|FG000|Overall Study|Reason Not Specified|6|||
161462250|NCT03332771|583088001|FG001|Overall Study|Reason Not Specified|18|||
161462251|NCT03332771|583088002|FG002|Overall Study|Reason Not Specified|16|||
161462252|NCT03332771|583088003|FG003|Overall Study|Reason Not Specified|19|||
161462253|NCT03442764|583088004|FG000|Overall Study|Adverse Event|1|||
161462254|NCT03442764|583088005|FG001|Overall Study|Adverse Event|0|||
161462255|NCT03442764|583088006|FG002|Overall Study|Adverse Event|0|||
161462256|NCT01801072|583088007|FG000|Overall Study|Lost to Follow-up|17|||
161462257|NCT01801072|583088008|FG001|Overall Study|Lost to Follow-up|14|||
161462258|NCT01801072|583088007|FG000|Overall Study|Physician Decision|2|||
161462259|NCT01801072|583088008|FG001|Overall Study|Physician Decision|3|||
161462260|NCT01801072|583088007|FG000|Overall Study|Withdrawal by Subject|1|||
161462261|NCT01801072|583088008|FG001|Overall Study|Withdrawal by Subject|0|||
161462262|NCT01801072|583088007|FG000|Overall Study|Protocol Violation|2|||
161462263|NCT01801072|583088008|FG001|Overall Study|Protocol Violation|0|||
161462264|NCT01801072|583088007|FG000|Overall Study|Death|7|||
161462265|NCT01801072|583088008|FG001|Overall Study|Death|8|||
161462266|NCT03693170|583088009|FG000|Overall Study|Disease Progression|48|||
161462267|NCT03693170|583088009|FG000|Overall Study|Adverse Event|16|||
161462268|NCT03693170|583088009|FG000|Overall Study|Physician Decision|6|||
161914071|NCT03344757|584733701|FG000|Overall Study|Lost to Follow-up|0|||
161914072|NCT03344757|584733702|FG001|Overall Study|Lost to Follow-up|2|||
161914073|NCT00269152|584733703|FG000|Overall Study|Adverse Event|9|||
161462269|NCT03693170|583088009|FG000|Overall Study|Protocol Violation|2|||
161462270|NCT03693170|583088009|FG000|Overall Study|Death|1|||
161462271|NCT03693170|583088009|FG000|Overall Study|Non compliance with study drug|1|||
161462272|NCT03693170|583088009|FG000|Overall Study|Withdrawal by Subject|1|||
161462273|NCT04444895|583088010|FG000|Overall Study|Adverse Event|2|||
161462274|NCT04444895|583088010|FG000|Overall Study|Lost to Follow-up|2|||
161462275|NCT04444895|583088010|FG000|Overall Study|Withdrawal by Subject|5|||
161462276|NCT03034200|583088011|FG000|Overall Study|Disease progression|8|||
161462277|NCT03034200|583088012|FG001|Overall Study|Disease progression|10|||
161462278|NCT03034200|583088013|FG002|Overall Study|Disease progression|4|||
161462279|NCT03034200|583088011|FG000|Overall Study|Physician Decision|2|||
161914074|NCT00269152|584733704|FG001|Overall Study|Adverse Event|3|||
161914075|NCT00269152|584733703|FG000|Overall Study|Withdrawal by Subject|7|||
161462280|NCT03034200|583088012|FG001|Overall Study|Physician Decision|0|||
161462281|NCT03034200|583088013|FG002|Overall Study|Physician Decision|3|||
161462282|NCT03034200|583088011|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
161462283|NCT03034200|583088012|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
161462284|NCT03034200|583088013|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
161462285|NCT03034200|583088011|FG000|Overall Study|Adjuvant Therapy|0|||
161462286|NCT03034200|583088012|FG001|Overall Study|Adjuvant Therapy|0|||
161462287|NCT03034200|583088013|FG002|Overall Study|Adjuvant Therapy|1|||
161462288|NCT00510874|583088014|FG000|Overall Study|Withdrawal by Subject|1|||
161462289|NCT00510874|583088015|FG001|Overall Study|Withdrawal by Subject|1|||
161462290|NCT00510874|583088016|FG002|Overall Study|Withdrawal by Subject|0|||
161462291|NCT00510874|583088017|FG003|Overall Study|Withdrawal by Subject|0|||
161462292|NCT00510874|583088018|FG004|Overall Study|Withdrawal by Subject|3|||
161462293|NCT00510874|583088019|FG005|Overall Study|Withdrawal by Subject|0|||
161462294|NCT00510874|583088020|FG006|Overall Study|Withdrawal by Subject|0|||
161462295|NCT00510874|583088014|FG000|Overall Study|Lost to Follow-up|2|||
161462296|NCT00510874|583088015|FG001|Overall Study|Lost to Follow-up|3|||
161462297|NCT00510874|583088016|FG002|Overall Study|Lost to Follow-up|1|||
161462298|NCT00510874|583088017|FG003|Overall Study|Lost to Follow-up|3|||
161462299|NCT00510874|583088018|FG004|Overall Study|Lost to Follow-up|4|||
161462300|NCT00510874|583088019|FG005|Overall Study|Lost to Follow-up|0|||
161462301|NCT00510874|583088020|FG006|Overall Study|Lost to Follow-up|1|||
161462302|NCT00636987|583088021|FG000|Overall Study|Death|44|||
161462303|NCT00636987|583088021|FG000|Overall Study|Explanted|13|||
161462304|NCT00636987|583088021|FG000|Overall Study|Lost to Follow-up|63|||
161462305|NCT00636987|583088021|FG000|Overall Study|5 year visit window not complete|69|||
161462306|NCT01251146|583088022|FG000|Overall Study|Lost to Follow-up|3|||
161462307|NCT01251146|583088023|FG001|Overall Study|Lost to Follow-up|10|||
161462308|NCT00053365|583088025|FG000|Overall Study|Incorrect cell type|1|||
161462309|NCT00053365|583088025|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
161462310|NCT00053365|583088025|FG000|Overall Study|Never treated|4|||
161462311|NCT00737464|583088034|FG000|Overall Study|Adverse Event|1|||
161462312|NCT00737464|583088034|FG000|Overall Study|Death|6|||
161462313|NCT00737464|583088034|FG000|Overall Study|Other - Failure to Return|1|||
161462314|NCT00737464|583088034|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
161462315|NCT00737464|583088034|FG000|Overall Study|Other reasons|4|||
161462316|NCT02423109|583088038|FG000|Lens 1|Adverse Event|1|||
161462317|NCT02423109|583088039|FG001|Lens 1|Adverse Event|0|||
161462318|NCT03347188|583088040|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
161462319|NCT03347188|583088041|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
161462320|NCT03347188|583088040|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
161462321|NCT03347188|583088041|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
161462322|NCT03347188|583088040|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
161462323|NCT03347188|583088041|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
161462324|NCT03347188|583088040|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
161462325|NCT03347188|583088041|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
161462326|NCT03347188|583088040|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
161462327|NCT03347188|583088041|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
161462328|NCT03347188|583088040|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
161462329|NCT03347188|583088041|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
161462330|NCT03347188|583088040|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
161462331|NCT03347188|583088041|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
161462332|NCT03347188|583088040|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
161462333|NCT03347188|583088041|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
161462334|NCT03868124|583088042|FG000|Overall Study|Withdrawal by Subject|4|||
161462335|NCT03868124|583088043|FG001|Overall Study|Withdrawal by Subject|0|||
161462336|NCT03868124|583088044|FG002|Overall Study|Withdrawal by Subject|1|||
161462337|NCT03868124|583088042|FG000|Overall Study|Physician Decision|1|||
161914076|NCT00269152|584733704|FG001|Overall Study|Withdrawal by Subject|3|||
161914077|NCT00269152|584733703|FG000|Overall Study|Physician Decision|2|||
161462338|NCT03868124|583088043|FG001|Overall Study|Physician Decision|0|||
161462339|NCT03868124|583088044|FG002|Overall Study|Physician Decision|1|||
161462340|NCT03868124|583088042|FG000|Overall Study|Lost to Follow-up|1|||
161462341|NCT03868124|583088043|FG001|Overall Study|Lost to Follow-up|1|||
161462342|NCT03868124|583088044|FG002|Overall Study|Lost to Follow-up|2|||
161462343|NCT03868124|583088042|FG000|Overall Study|Death|1|||
161462344|NCT03868124|583088043|FG001|Overall Study|Death|1|||
161462345|NCT03868124|583088044|FG002|Overall Study|Death|2|||
161462346|NCT03868124|583088042|FG000|Overall Study|Adverse Event|0|||
161462347|NCT03868124|583088043|FG001|Overall Study|Adverse Event|0|||
161462348|NCT03868124|583088044|FG002|Overall Study|Adverse Event|3|||
161462349|NCT03868124|583088042|FG000|Overall Study|Explanted|2|||
161462350|NCT03868124|583088043|FG001|Overall Study|Explanted|1|||
161462351|NCT03868124|583088044|FG002|Overall Study|Explanted|0|||
161462352|NCT03868124|583088042|FG000|Overall Study|Ongoing in study|176|||
161462353|NCT03868124|583088043|FG001|Overall Study|Ongoing in study|180|||
161462354|NCT03868124|583088044|FG002|Overall Study|Ongoing in study|183|||
161462355|NCT04177355|583088045|FG000|Overall Study|Lost to Follow-up|0|||
161462356|NCT04177355|583088046|FG001|Overall Study|Lost to Follow-up|2|||
161462357|NCT04177355|583088047|FG002|Overall Study|Lost to Follow-up|0|||
161462358|NCT04177355|583088048|FG003|Overall Study|Lost to Follow-up|1|||
161462359|NCT04177355|583088049|FG004|Overall Study|Lost to Follow-up|2|||
161462360|NCT04177355|583088050|FG005|Overall Study|Lost to Follow-up|0|||
161462361|NCT04177355|583088051|FG006|Overall Study|Lost to Follow-up|1|||
161462362|NCT04177355|583088052|FG007|Overall Study|Lost to Follow-up|0|||
161462363|NCT04177355|583088053|FG008|Overall Study|Lost to Follow-up|0|||
161462364|NCT04177355|583088054|FG009|Overall Study|Lost to Follow-up|0|||
161462365|NCT04177355|583088055|FG010|Overall Study|Lost to Follow-up|0|||
161462366|NCT04177355|583088045|FG000|Overall Study|Withdrawal by Subject|0|||
161462367|NCT04177355|583088046|FG001|Overall Study|Withdrawal by Subject|0|||
161462368|NCT04177355|583088047|FG002|Overall Study|Withdrawal by Subject|0|||
161462369|NCT04177355|583088048|FG003|Overall Study|Withdrawal by Subject|1|||
161462370|NCT04177355|583088049|FG004|Overall Study|Withdrawal by Subject|1|||
161462371|NCT04177355|583088050|FG005|Overall Study|Withdrawal by Subject|0|||
161462372|NCT04177355|583088051|FG006|Overall Study|Withdrawal by Subject|0|||
161462373|NCT04177355|583088052|FG007|Overall Study|Withdrawal by Subject|0|||
161462374|NCT04177355|583088053|FG008|Overall Study|Withdrawal by Subject|1|||
161914078|NCT00269152|584733704|FG001|Overall Study|Physician Decision|3|||
161914079|NCT00269152|584733703|FG000|Overall Study|Protocol Violation|0|||
161914080|NCT00269152|584733704|FG001|Overall Study|Protocol Violation|1|||
161914081|NCT01832766|584733707|FG000|Washout|Lost to Follow-up|0|||
161914082|NCT01832766|584733708|FG001|Washout|Lost to Follow-up|1|||
161914083|NCT03533751|584733711|FG000|Overall Study|Withdrawal by Subject|12|||
161914084|NCT03533751|584733712|FG001|Overall Study|Withdrawal by Subject|6|||
161914085|NCT03533751|584733713|FG002|Overall Study|Withdrawal by Subject|11|||
161914086|NCT03533751|584733714|FG003|Overall Study|Withdrawal by Subject|9|||
161914087|NCT03533751|584733715|FG004|Overall Study|Withdrawal by Subject|10|||
161914088|NCT03533751|584733711|FG000|Overall Study|Adverse Event|4|||
161462375|NCT04177355|583088054|FG009|Overall Study|Withdrawal by Subject|0|||
161462376|NCT04177355|583088055|FG010|Overall Study|Withdrawal by Subject|0|||
161462377|NCT02742246|583088056|FG000|Overall Study|Never initiated treatment|5|||
161462378|NCT02742246|583088057|FG001|Overall Study|Never initiated treatment|3|||
161462379|NCT02742246|583088058|FG002|Overall Study|Never initiated treatment|1|||
161462380|NCT02742246|583088056|FG000|Overall Study|dropped out during treatment|7|||
161572686|NCT00150176|583481982|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
161572687|NCT00150176|583481981|FG000|Overall Study|Withdrawal by Subject|19|||
161572688|NCT00150176|583481982|FG001|Overall Study|Withdrawal by Subject|12|||
161572689|NCT00150176|583481981|FG000|Overall Study|Lost to Follow-up|3|||
161914089|NCT03533751|584733712|FG001|Overall Study|Adverse Event|7|||
161914090|NCT03533751|584733713|FG002|Overall Study|Adverse Event|2|||
161914091|NCT03533751|584733714|FG003|Overall Study|Adverse Event|4|||
161914092|NCT03533751|584733715|FG004|Overall Study|Adverse Event|5|||
161914093|NCT03533751|584733711|FG000|Overall Study|Physician Decision|0|||
161914094|NCT03533751|584733712|FG001|Overall Study|Physician Decision|2|||
161914095|NCT03533751|584733713|FG002|Overall Study|Physician Decision|1|||
161914096|NCT03533751|584733714|FG003|Overall Study|Physician Decision|2|||
161914097|NCT03533751|584733715|FG004|Overall Study|Physician Decision|1|||
161914098|NCT03533751|584733711|FG000|Overall Study|Sponsor Decision|0|||
161914099|NCT03533751|584733712|FG001|Overall Study|Sponsor Decision|0|||
161914100|NCT03533751|584733713|FG002|Overall Study|Sponsor Decision|1|||
161914101|NCT03533751|584733714|FG003|Overall Study|Sponsor Decision|1|||
161914102|NCT03533751|584733715|FG004|Overall Study|Sponsor Decision|0|||
161914103|NCT03533751|584733711|FG000|Overall Study|Lost to Follow-up|3|||
161914104|NCT03533751|584733712|FG001|Overall Study|Lost to Follow-up|7|||
161914105|NCT03533751|584733713|FG002|Overall Study|Lost to Follow-up|6|||
161462381|NCT02742246|583088057|FG001|Overall Study|dropped out during treatment|13|||
161462382|NCT02742246|583088058|FG002|Overall Study|dropped out during treatment|10|||
161462383|NCT02742246|583088056|FG000|Overall Study|Death|1|||
161462384|NCT02742246|583088057|FG001|Overall Study|Death|0|||
161462385|NCT02742246|583088058|FG002|Overall Study|Death|0|||
161462386|NCT03489551|583088059|FG000|Overall Study|Withdrawal by Subject|2|||
161462387|NCT00054717|583088060|FG000|Overall Study|Randomized but not treated|2|||
161462388|NCT00054717|583088061|FG001|Overall Study|Randomized but not treated|8|||
161462389|NCT00054717|583088060|FG000|Overall Study|Adverse Event|70|||
161914106|NCT03533751|584733714|FG003|Overall Study|Lost to Follow-up|4|||
161914107|NCT03533751|584733715|FG004|Overall Study|Lost to Follow-up|3|||
161914108|NCT03533751|584733711|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
161914109|NCT03533751|584733712|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
161462390|NCT00054717|583088061|FG001|Overall Study|Adverse Event|22|||
161462391|NCT00054717|583088060|FG000|Overall Study|Protocol Violation|18|||
161462392|NCT00054717|583088061|FG001|Overall Study|Protocol Violation|19|||
161462393|NCT00054717|583088060|FG000|Overall Study|Lost to Follow-up|23|||
161914110|NCT03533751|584733713|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
161914111|NCT03533751|584733714|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
161462394|NCT00054717|583088061|FG001|Overall Study|Lost to Follow-up|13|||
161462395|NCT00054717|583088060|FG000|Overall Study|Withdrawal by Subject|32|||
161462396|NCT00054717|583088061|FG001|Overall Study|Withdrawal by Subject|20|||
161462397|NCT00054717|583088060|FG000|Overall Study|Other reason not defined above|117|||
161462398|NCT00054717|583088061|FG001|Overall Study|Other reason not defined above|217|||
161462399|NCT03139604|583088062|FG000|Overall Study|Other|7|||
161462400|NCT03139604|583088063|FG001|Overall Study|Other|3|||
161462401|NCT03139604|583088062|FG000|Overall Study|Withdrawal by Subject|16|||
161462402|NCT03139604|583088063|FG001|Overall Study|Withdrawal by Subject|17|||
161462403|NCT03139604|583088062|FG000|Overall Study|Physician Decision|1|||
161462404|NCT03139604|583088063|FG001|Overall Study|Physician Decision|2|||
161462405|NCT03139604|583088062|FG000|Overall Study|Lost to Follow-up|3|||
161462406|NCT03139604|583088063|FG001|Overall Study|Lost to Follow-up|1|||
161462407|NCT03139604|583088062|FG000|Overall Study|Death|65|||
161462408|NCT03139604|583088063|FG001|Overall Study|Death|67|||
161462409|NCT03139604|583088062|FG000|Overall Study|Study Terminated by Sponsor|122|||
161462410|NCT03139604|583088063|FG001|Overall Study|Study Terminated by Sponsor|127|||
161462411|NCT03139604|583088062|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
161462412|NCT03139604|583088063|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
161462413|NCT04148911|583088064|FG000|Overall Study|Death|104|||
161462414|NCT04148911|583088064|FG000|Overall Study|Lost to Follow-up|5|||
161462415|NCT04148911|583088064|FG000|Overall Study|Withdrawal by Subject|17|||
161462416|NCT04148911|583088064|FG000|Overall Study|Study Ended by Sponsor|56|||
161462417|NCT00470184|583088069|FG000|Overall Study|Not Treated(became ineligible)|4|||
161462418|NCT00470184|583088069|FG000|Overall Study|Not treated (other)|1|||
161462419|NCT00470184|583088069|FG000|Overall Study|disease Progression|4|||
161462420|NCT00470184|583088069|FG000|Overall Study|Adverse Event|3|||
161462421|NCT00470184|583088069|FG000|Overall Study|Withdrawal by Subject|4|||
161462422|NCT00470184|583088069|FG000|Overall Study|other|5|||
161462423|NCT00470184|583088069|FG000|Overall Study|recurrence|1|||
161462424|NCT01606254|583088072|FG000|Overall Study|Withdrawal by Subject|1|||
161462425|NCT01606254|583088073|FG001|Overall Study|Withdrawal by Subject|3|||
161462426|NCT01606254|583088074|FG002|Overall Study|Withdrawal by Subject|0|||
161462427|NCT01606254|583088075|FG003|Overall Study|Withdrawal by Subject|2|||
161462428|NCT01606254|583088072|FG000|Overall Study|Adverse Event|1|||
161462429|NCT01606254|583088073|FG001|Overall Study|Adverse Event|1|||
161462430|NCT01606254|583088074|FG002|Overall Study|Adverse Event|0|||
161462431|NCT01606254|583088075|FG003|Overall Study|Adverse Event|1|||
161462432|NCT04543409|583088076|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161462433|NCT04543409|583088077|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161462434|NCT04543409|583088076|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
161462435|NCT04543409|583088077|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
161462436|NCT04543409|583088076|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
161462437|NCT04543409|583088077|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
161462438|NCT04543409|583088076|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
161462439|NCT04543409|583088077|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
161462440|NCT04543409|583088076|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
161462441|NCT04543409|583088077|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
161462442|NCT04543409|583088076|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
161462443|NCT04543409|583088077|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
161462444|NCT04543409|583088076|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
161462445|NCT04543409|583088077|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
161462446|NCT04543409|583088076|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
161462447|NCT04543409|583088077|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
161462448|NCT04543409|583088076|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
161462449|NCT04543409|583088077|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
161462450|NCT04543409|583088076|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
161462451|NCT04543409|583088077|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
161462452|NCT04543409|583088076|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
161462453|NCT04543409|583088077|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
161462454|NCT01052844|583088078|FG000|Overall Study|Adverse Event|0|||
161462455|NCT01052844|583088079|FG001|Overall Study|Adverse Event|1|||
161462456|NCT01289782|583088080|FG000|Overall Study|Lost to Follow-up|14|||
161462457|NCT01289782|583088081|FG001|Overall Study|Lost to Follow-up|7|||
161462458|NCT01289782|583088080|FG000|Overall Study|Protocol Violation|1|||
161462459|NCT01289782|583088081|FG001|Overall Study|Protocol Violation|1|||
161462460|NCT01289782|583088080|FG000|Overall Study|Withdrawal by Subject|8|||
161462461|NCT01289782|583088081|FG001|Overall Study|Withdrawal by Subject|2|||
161462462|NCT01289782|583088080|FG000|Overall Study|Sponsor's Decision|1|||
161462463|NCT01289782|583088081|FG001|Overall Study|Sponsor's Decision|0|||
161462464|NCT01289782|583088080|FG000|Overall Study|Reason not specified|1|||
161462465|NCT01289782|583088081|FG001|Overall Study|Reason not specified|2|||
161462466|NCT02093026|583088082|FG000|Overall Study|Adverse Event|26|||
161462467|NCT02093026|583088082|FG000|Overall Study|Death|10|||
161462468|NCT02093026|583088082|FG000|Overall Study|Other|157|||
161462469|NCT02195011|583088094|FG000|Overall Study|Adverse Event|4|||
161462470|NCT02195011|583088095|FG001|Overall Study|Adverse Event|0|||
161462471|NCT02195011|583088094|FG000|Overall Study|Progressive Disease|18|||
161462472|NCT02195011|583088095|FG001|Overall Study|Progressive Disease|1|||
161462473|NCT02195011|583088094|FG000|Overall Study|Withdrawal by Subject|3|||
161462474|NCT02195011|583088095|FG001|Overall Study|Withdrawal by Subject|0|||
161462475|NCT01466595|583088097|FG000|Overall Study|Withdrawal by Subject|0|||
161462476|NCT01466595|583088098|FG001|Overall Study|Withdrawal by Subject|1|||
161462477|NCT00450112|583088101|FG000|Overall Study|Other Treatment Required|5|||
161462478|NCT00450112|583088102|FG001|Overall Study|Other Treatment Required|1|||
161462479|NCT00450112|583088101|FG000|Overall Study|Withdrawal by Subject|4|||
161462480|NCT00450112|583088102|FG001|Overall Study|Withdrawal by Subject|1|||
161462481|NCT00450112|583088101|FG000|Overall Study|Lost to Follow-up|2|||
161462482|NCT00450112|583088102|FG001|Overall Study|Lost to Follow-up|1|||
161462483|NCT00450112|583088101|FG000|Overall Study|Others|2|||
161462484|NCT00450112|583088102|FG001|Overall Study|Others|3|||
161462485|NCT03418571|583088103|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
161462486|NCT03418571|583088104|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
161462487|NCT00559754|583088105|FG000|Overall Study|Disease progression|1|||
161462488|NCT00559754|583088105|FG000|Overall Study|Adverse Event|5|||
161462489|NCT00559754|583088105|FG000|Overall Study|Protocol Violation|1|||
161462490|NCT00559754|583088105|FG000|Overall Study|Investigator criteria|2|||
161462491|NCT00559754|583088105|FG000|Overall Study|Withdrawal by Subject|2|||
161462492|NCT00586326|583088106|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
161462493|NCT00586326|583088106|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
161462494|NCT00586326|583088106|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
161462495|NCT00586326|583088106|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
161462496|NCT00586326|583088106|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
161462497|NCT00586326|583088106|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
161462498|NCT00586326|583088106|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
161462499|NCT00586326|583088106|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
161462500|NCT00586326|583088106|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
161462501|NCT00586326|583088106|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
161462502|NCT00586326|583088106|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
161462503|NCT00586326|583088106|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
161462504|NCT00586326|583088106|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
161462505|NCT00586326|583088106|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
161462506|NCT00586326|583088106|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
161462507|NCT00586326|583088106|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
161462508|NCT00586326|583088106|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
161462509|NCT01439347|583088107|FG000|Overall Study|Death|10|||
161462510|NCT01439347|583088108|FG001|Overall Study|Death|9|||
161462511|NCT01439347|583088107|FG000|Overall Study|Withdrawal by Subject|0|||
161462512|NCT01439347|583088108|FG001|Overall Study|Withdrawal by Subject|1|||
161462513|NCT01439347|583088107|FG000|Overall Study|Physician Decision|1|||
161462514|NCT01439347|583088108|FG001|Overall Study|Physician Decision|0|||
161462515|NCT01439347|583088107|FG000|Overall Study|Sponsor Terminated Study|2|||
161462516|NCT01439347|583088108|FG001|Overall Study|Sponsor Terminated Study|3|||
161462517|NCT03595774|583088109|FG000|Overall Study|Adverse Event|1|||
161462518|NCT03595774|583088110|FG001|Overall Study|Adverse Event|0|||
161462519|NCT03595774|583088111|FG002|Overall Study|Adverse Event|1|||
161462520|NCT03595774|583088112|FG003|Overall Study|Adverse Event|0|||
161462521|NCT03595774|583088109|FG000|Overall Study|screen failure|0|||
161462522|NCT03595774|583088110|FG001|Overall Study|screen failure|1|||
161462523|NCT03595774|583088111|FG002|Overall Study|screen failure|0|||
161462524|NCT03595774|583088112|FG003|Overall Study|screen failure|1|||
161462525|NCT03101267|583088114|FG000|Primary Study Period|Withdrawal by Subject|1|||
161462526|NCT03101267|583088115|FG001|Primary Study Period|Withdrawal by Subject|2|||
161462527|NCT03101267|583088116|FG002|Primary Study Period|Withdrawal by Subject|3|||
161462528|NCT03101267|583088114|FG000|Primary Study Period|Miscellaneous|2|||
161462529|NCT03101267|583088115|FG001|Primary Study Period|Miscellaneous|0|||
161462530|NCT03101267|583088116|FG002|Primary Study Period|Miscellaneous|0|||
161462531|NCT00555425|583088119|FG000|Overall Study|Missed Medication > 1 wk|34|||
161462532|NCT00555425|583088120|FG001|Overall Study|Missed Medication > 1 wk|15|||
161462533|NCT00555425|583088119|FG000|Overall Study|Missed 3 physician management visits|1|||
161462534|NCT00555425|583088120|FG001|Overall Study|Missed 3 physician management visits|0|||
161462535|NCT00555425|583088119|FG000|Overall Study|Met criteria for protective transfer|16|||
161462536|NCT00555425|583088120|FG001|Overall Study|Met criteria for protective transfer|3|||
161462537|NCT00555425|583088119|FG000|Overall Study|Became pregnant and transferred care|0|||
161462538|NCT00555425|583088120|FG001|Overall Study|Became pregnant and transferred care|1|||
161462539|NCT01262352|583088121|FG000|Period 1|Illness after randomization|1|||
161462540|NCT01262352|583088122|FG001|Period 1|Illness after randomization|0|||
161462541|NCT01262352|583088121|FG000|Washout|Adverse Event|1|||
161462542|NCT01262352|583088122|FG001|Washout|Adverse Event|1|||
161462543|NCT01262352|583088121|FG000|Washout|Extended Washout|0|||
161462544|NCT01262352|583088122|FG001|Washout|Extended Washout|1|||
161462545|NCT01298193|583088123|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
161462546|NCT01298193|583088123|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
161462547|NCT01298193|583088123|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
161462548|NCT01298193|583088123|FG000|Efficacy Phase (Second Cycle)|Death|1|||
161462549|NCT01975831|583088124|FG000|Overall Study|Adverse Event|1|||
161462550|NCT01975831|583088125|FG001|Overall Study|Adverse Event|2|||
161462551|NCT01975831|583088126|FG002|Overall Study|Adverse Event|2|||
161462552|NCT01975831|583088127|FG003|Overall Study|Adverse Event|0|||
161462553|NCT01975831|583088128|FG004|Overall Study|Adverse Event|1|||
161462554|NCT01975831|583088129|FG005|Overall Study|Adverse Event|1|||
161914112|NCT03533751|584733715|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
161914113|NCT03533751|584733711|FG000|Overall Study|Other|0|||
161914114|NCT03533751|584733712|FG001|Overall Study|Other|2|||
161914115|NCT03533751|584733713|FG002|Overall Study|Other|1|||
161914116|NCT03533751|584733714|FG003|Overall Study|Other|0|||
161914117|NCT03533751|584733715|FG004|Overall Study|Other|3|||
161462555|NCT01975831|583088130|FG006|Overall Study|Adverse Event|3|||
161462556|NCT01975831|583088131|FG007|Overall Study|Adverse Event|4|||
161462557|NCT01975831|583088132|FG008|Overall Study|Adverse Event|1|||
161462558|NCT01975831|583088124|FG000|Overall Study|Death|1|||
161462559|NCT01975831|583088125|FG001|Overall Study|Death|1|||
161462560|NCT01975831|583088126|FG002|Overall Study|Death|0|||
161462561|NCT01975831|583088127|FG003|Overall Study|Death|0|||
161462562|NCT01975831|583088128|FG004|Overall Study|Death|1|||
161462563|NCT01975831|583088129|FG005|Overall Study|Death|0|||
161462564|NCT01975831|583088130|FG006|Overall Study|Death|1|||
161462565|NCT01975831|583088131|FG007|Overall Study|Death|0|||
161462566|NCT01975831|583088132|FG008|Overall Study|Death|0|||
161462567|NCT01975831|583088124|FG000|Overall Study|Progressive Disease|1|||
161462568|NCT01975831|583088125|FG001|Overall Study|Progressive Disease|3|||
161462569|NCT01975831|583088126|FG002|Overall Study|Progressive Disease|2|||
161462570|NCT01975831|583088127|FG003|Overall Study|Progressive Disease|4|||
161462571|NCT01975831|583088128|FG004|Overall Study|Progressive Disease|13|||
161462572|NCT01975831|583088129|FG005|Overall Study|Progressive Disease|9|||
161462573|NCT01975831|583088130|FG006|Overall Study|Progressive Disease|10|||
161462574|NCT01975831|583088131|FG007|Overall Study|Progressive Disease|8|||
161462575|NCT01975831|583088132|FG008|Overall Study|Progressive Disease|10|||
161462576|NCT01975831|583088124|FG000|Overall Study|Withdrawal by Subject|0|||
161462577|NCT01975831|583088125|FG001|Overall Study|Withdrawal by Subject|3|||
161462578|NCT01975831|583088126|FG002|Overall Study|Withdrawal by Subject|0|||
161462579|NCT01975831|583088127|FG003|Overall Study|Withdrawal by Subject|0|||
161462580|NCT01975831|583088128|FG004|Overall Study|Withdrawal by Subject|3|||
161462581|NCT01975831|583088129|FG005|Overall Study|Withdrawal by Subject|1|||
161462582|NCT01975831|583088130|FG006|Overall Study|Withdrawal by Subject|1|||
161462583|NCT01975831|583088131|FG007|Overall Study|Withdrawal by Subject|0|||
161462584|NCT01975831|583088132|FG008|Overall Study|Withdrawal by Subject|0|||
161462585|NCT01975831|583088124|FG000|Overall Study|Physician Decision|0|||
161462586|NCT01975831|583088125|FG001|Overall Study|Physician Decision|0|||
161462587|NCT01975831|583088126|FG002|Overall Study|Physician Decision|0|||
161462588|NCT01975831|583088127|FG003|Overall Study|Physician Decision|0|||
161462589|NCT01975831|583088128|FG004|Overall Study|Physician Decision|0|||
161462590|NCT01975831|583088129|FG005|Overall Study|Physician Decision|1|||
161462591|NCT01975831|583088130|FG006|Overall Study|Physician Decision|0|||
161462592|NCT01975831|583088131|FG007|Overall Study|Physician Decision|1|||
161462593|NCT01975831|583088132|FG008|Overall Study|Physician Decision|0|||
161462594|NCT01975831|583088124|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
161462595|NCT01975831|583088125|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
161462596|NCT01975831|583088126|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
161462597|NCT01975831|583088127|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
161462598|NCT01975831|583088128|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
161462599|NCT01975831|583088129|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
161462600|NCT01975831|583088130|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
161462601|NCT01975831|583088131|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
161462602|NCT01975831|583088132|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
161462603|NCT01975831|583088124|FG000|Overall Study|Entered Hospice|0|||
161462604|NCT01975831|583088125|FG001|Overall Study|Entered Hospice|0|||
161462605|NCT01975831|583088126|FG002|Overall Study|Entered Hospice|0|||
161462606|NCT01975831|583088127|FG003|Overall Study|Entered Hospice|0|||
161462607|NCT01975831|583088128|FG004|Overall Study|Entered Hospice|0|||
161462608|NCT01975831|583088129|FG005|Overall Study|Entered Hospice|1|||
161462609|NCT01975831|583088130|FG006|Overall Study|Entered Hospice|0|||
161914118|NCT01648764|584735507|FG000|Overall Study|Progressive Disease|0|||
161914119|NCT01648764|584735508|FG001|Overall Study|Progressive Disease|1|||
161914120|NCT01648764|584735509|FG002|Overall Study|Progressive Disease|0|||
161462610|NCT01975831|583088131|FG007|Overall Study|Entered Hospice|0|||
161462611|NCT01975831|583088132|FG008|Overall Study|Entered Hospice|0|||
161462612|NCT01975831|583088124|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462613|NCT01975831|583088125|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462614|NCT01975831|583088126|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462615|NCT01975831|583088127|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462616|NCT01975831|583088128|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462617|NCT01975831|583088129|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462618|NCT01975831|583088130|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
161462619|NCT01975831|583088131|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
161462620|NCT01975831|583088132|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
161462621|NCT02925793|583088133|FG000|Overall Study|Adverse Event|3|||
161462622|NCT02925793|583088134|FG001|Overall Study|Adverse Event|3|||
161462623|NCT02925793|583088135|FG002|Overall Study|Adverse Event|6|||
161914121|NCT01648764|584735510|FG003|Overall Study|Progressive Disease|0|||
161914122|NCT01648764|584735511|FG004|Overall Study|Progressive Disease|0|||
161914123|NCT01648764|584735512|FG005|Overall Study|Progressive Disease|1|||
161914124|NCT01648764|584735513|FG006|Overall Study|Progressive Disease|1|||
161914125|NCT01648764|584735514|FG007|Overall Study|Progressive Disease|0|||
161914126|NCT01648764|584735515|FG008|Overall Study|Progressive Disease|0|||
161914127|NCT01648764|584735516|FG009|Overall Study|Progressive Disease|2|||
161914128|NCT01648764|584735517|FG010|Overall Study|Progressive Disease|0|||
161914129|NCT01648764|584735518|FG011|Overall Study|Progressive Disease|1|||
161914130|NCT01648764|584735519|FG012|Overall Study|Progressive Disease|2|||
161914131|NCT01648764|584735520|FG013|Overall Study|Progressive Disease|1|||
161914132|NCT01648764|584735507|FG000|Overall Study|Adverse Event|0|||
161914133|NCT01648764|584735508|FG001|Overall Study|Adverse Event|0|||
161914134|NCT01648764|584735509|FG002|Overall Study|Adverse Event|0|||
161914135|NCT01648764|584735510|FG003|Overall Study|Adverse Event|0|||
161914136|NCT01648764|584735511|FG004|Overall Study|Adverse Event|0|||
161914137|NCT01648764|584735512|FG005|Overall Study|Adverse Event|1|||
161914138|NCT01648764|584735513|FG006|Overall Study|Adverse Event|0|||
161914139|NCT01648764|584735514|FG007|Overall Study|Adverse Event|0|||
161914140|NCT01648764|584735515|FG008|Overall Study|Adverse Event|0|||
161914141|NCT01648764|584735516|FG009|Overall Study|Adverse Event|1|||
161914142|NCT01648764|584735517|FG010|Overall Study|Adverse Event|0|||
161914143|NCT01648764|584735518|FG011|Overall Study|Adverse Event|3|||
161914144|NCT01648764|584735519|FG012|Overall Study|Adverse Event|1|||
161914145|NCT01648764|584735520|FG013|Overall Study|Adverse Event|1|||
161914146|NCT01648764|584735507|FG000|Overall Study|Death|0|||
161914147|NCT01648764|584735508|FG001|Overall Study|Death|0|||
161914148|NCT01648764|584735509|FG002|Overall Study|Death|0|||
161914149|NCT01648764|584735510|FG003|Overall Study|Death|0|||
161914150|NCT01648764|584735511|FG004|Overall Study|Death|0|||
161914151|NCT01648764|584735512|FG005|Overall Study|Death|0|||
161914152|NCT01648764|584735513|FG006|Overall Study|Death|1|||
161914153|NCT01648764|584735514|FG007|Overall Study|Death|0|||
161914154|NCT01648764|584735515|FG008|Overall Study|Death|0|||
161462624|NCT02925793|583088133|FG000|Overall Study|Withdrawal by Subject|16|||
161462625|NCT02925793|583088134|FG001|Overall Study|Withdrawal by Subject|15|||
161462626|NCT02925793|583088135|FG002|Overall Study|Withdrawal by Subject|13|||
161462627|NCT02925793|583088133|FG000|Overall Study|Investigator Discretion|0|||
161462628|NCT02925793|583088134|FG001|Overall Study|Investigator Discretion|1|||
161462629|NCT02925793|583088135|FG002|Overall Study|Investigator Discretion|1|||
161462630|NCT02925793|583088133|FG000|Overall Study|Lost to Follow-up|2|||
161462631|NCT02925793|583088134|FG001|Overall Study|Lost to Follow-up|3|||
161914155|NCT01648764|584735516|FG009|Overall Study|Death|0|||
161462632|NCT02925793|583088135|FG002|Overall Study|Lost to Follow-up|1|||
161462633|NCT02925793|583088133|FG000|Overall Study|Lack of Efficacy|2|||
161462634|NCT02925793|583088134|FG001|Overall Study|Lack of Efficacy|6|||
161462635|NCT02925793|583088135|FG002|Overall Study|Lack of Efficacy|4|||
161462636|NCT02925793|583088133|FG000|Overall Study|Other:|2|||
161462637|NCT02925793|583088134|FG001|Overall Study|Other:|1|||
161462638|NCT02925793|583088135|FG002|Overall Study|Other:|3|||
161462639|NCT03631355|583088138|FG000|Overall Study|Lost to Follow-up|1|||
161462640|NCT03631355|583088139|FG001|Overall Study|Lost to Follow-up|2|||
161462641|NCT01897714|583089878|FG000|Phase I (Dose Escalation)|Disease progression|3|||
161914156|NCT01648764|584735517|FG010|Overall Study|Death|0|||
161914157|NCT01648764|584735518|FG011|Overall Study|Death|0|||
161914158|NCT01648764|584735519|FG012|Overall Study|Death|0|||
161914159|NCT01648764|584735520|FG013|Overall Study|Death|1|||
161914160|NCT01648764|584735507|FG000|Overall Study|Withdrawal by Subject|0|||
161914161|NCT01648764|584735508|FG001|Overall Study|Withdrawal by Subject|0|||
161462642|NCT01897714|583089879|FG001|Phase I (Dose Escalation)|Disease progression|5|||
161462643|NCT01897714|583089880|FG002|Phase I (Dose Escalation)|Disease progression|1|||
161914162|NCT01648764|584735509|FG002|Overall Study|Withdrawal by Subject|0|||
161914163|NCT01648764|584735510|FG003|Overall Study|Withdrawal by Subject|0|||
161914164|NCT01648764|584735511|FG004|Overall Study|Withdrawal by Subject|0|||
161462644|NCT01897714|583089881|FG003|Phase I (Dose Escalation)|Disease progression|3|||
161462645|NCT01897714|583089882|FG004|Phase I (Dose Escalation)|Disease progression|0|||
161462646|NCT01897714|583089883|FG005|Phase I (Dose Escalation)|Disease progression|0|||
161462647|NCT01897714|583089878|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
161462648|NCT01897714|583089879|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
161462649|NCT01897714|583089880|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
161462650|NCT01897714|583089881|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
161462651|NCT01897714|583089882|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
161462652|NCT01897714|583089883|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
161462653|NCT01897714|583089878|FG000|Phase I (Dose Escalation)|Other|0|||
161462654|NCT01897714|583089879|FG001|Phase I (Dose Escalation)|Other|1|||
161462655|NCT01897714|583089880|FG002|Phase I (Dose Escalation)|Other|0|||
161462656|NCT01897714|583089881|FG003|Phase I (Dose Escalation)|Other|0|||
161462657|NCT01897714|583089882|FG004|Phase I (Dose Escalation)|Other|0|||
161462658|NCT01897714|583089883|FG005|Phase I (Dose Escalation)|Other|0|||
161462659|NCT01897714|583089878|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
161462660|NCT01897714|583089879|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
161462661|NCT01897714|583089880|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
161572690|NCT00150176|583481982|FG001|Overall Study|Lost to Follow-up|3|||
161572691|NCT00150176|583481981|FG000|Overall Study|OTHER|11|||
161462662|NCT01897714|583089881|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
161462663|NCT01897714|583089882|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
161462664|NCT01897714|583089883|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
161462665|NCT01897714|583089878|FG000|Phase II (MTD)|Lost to Follow-up|0|||
161462666|NCT01897714|583089879|FG001|Phase II (MTD)|Lost to Follow-up|0|||
161462667|NCT01897714|583089880|FG002|Phase II (MTD)|Lost to Follow-up|0|||
161462668|NCT01897714|583089881|FG003|Phase II (MTD)|Lost to Follow-up|0|||
161462669|NCT01897714|583089882|FG004|Phase II (MTD)|Lost to Follow-up|1|||
161462670|NCT01897714|583089883|FG005|Phase II (MTD)|Lost to Follow-up|0|||
161462671|NCT01897714|583089878|FG000|Phase II (MTD)|Death|0|||
161462672|NCT01897714|583089879|FG001|Phase II (MTD)|Death|0|||
161462673|NCT01897714|583089880|FG002|Phase II (MTD)|Death|0|||
161462674|NCT01897714|583089881|FG003|Phase II (MTD)|Death|0|||
161462675|NCT01897714|583089882|FG004|Phase II (MTD)|Death|25|||
161462676|NCT01897714|583089883|FG005|Phase II (MTD)|Death|10|||
161462677|NCT01897714|583089878|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
161462678|NCT01897714|583089879|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
161462679|NCT01897714|583089880|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
161462680|NCT01897714|583089881|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
161462681|NCT01897714|583089882|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
161462682|NCT01897714|583089883|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
161462683|NCT01897714|583089878|FG000|Phase II (MTD)|Other|0|||
161462684|NCT01897714|583089879|FG001|Phase II (MTD)|Other|0|||
161462685|NCT01897714|583089880|FG002|Phase II (MTD)|Other|0|||
161462686|NCT01897714|583089881|FG003|Phase II (MTD)|Other|0|||
161462687|NCT01897714|583089882|FG004|Phase II (MTD)|Other|3|||
161462688|NCT01897714|583089883|FG005|Phase II (MTD)|Other|0|||
161462689|NCT05828095|583089890|FG000|Overall Study|Lost to Follow-up|1|||
161462690|NCT05828095|583089891|FG001|Overall Study|Lost to Follow-up|0|||
161462691|NCT05828095|583089890|FG000|Overall Study|Reactogenicity symptom|0|||
161462692|NCT05828095|583089891|FG001|Overall Study|Reactogenicity symptom|1|||
161462693|NCT03206073|583089892|FG000|Overall Study|Participant Noncompliance|0|||
161572692|NCT00150176|583481982|FG001|Overall Study|OTHER|13|||
161572693|NCT04035668|583481987|FG000|Overall Study|Adverse Event|3|||
161572694|NCT04035668|583481988|FG001|Overall Study|Adverse Event|4|||
161572695|NCT04035668|583481989|FG002|Overall Study|Adverse Event|2|||
161572696|NCT04035668|583481987|FG000|Overall Study|Lost to Follow-up|0|||
161462694|NCT03206073|583089893|FG001|Overall Study|Participant Noncompliance|1|||
161462695|NCT03206073|583089894|FG002|Overall Study|Participant Noncompliance|0|||
161462696|NCT03206073|583089895|FG003|Overall Study|Participant Noncompliance|0|||
161462697|NCT03206073|583089892|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
161462698|NCT03206073|583089893|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
161572697|NCT04035668|583481988|FG001|Overall Study|Lost to Follow-up|1|||
161572698|NCT04035668|583481989|FG002|Overall Study|Lost to Follow-up|0|||
161572699|NCT04035668|583481987|FG000|Overall Study|Physician Decision|2|||
161572700|NCT04035668|583481988|FG001|Overall Study|Physician Decision|1|||
161572701|NCT04035668|583481989|FG002|Overall Study|Physician Decision|1|||
161462699|NCT03206073|583089894|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
161462700|NCT03206073|583089895|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
161462701|NCT03206073|583089892|FG000|Overall Study|Death|0|||
161462702|NCT03206073|583089893|FG001|Overall Study|Death|0|||
161572702|NCT04035668|583481987|FG000|Overall Study|Subject Decision|2|||
161572703|NCT04035668|583481988|FG001|Overall Study|Subject Decision|2|||
161462703|NCT03206073|583089894|FG002|Overall Study|Death|1|||
161462704|NCT03206073|583089895|FG003|Overall Study|Death|0|||
161462705|NCT03206073|583089892|FG000|Overall Study|Taken off active treatment|0|||
161572704|NCT04035668|583481989|FG002|Overall Study|Subject Decision|0|||
161462706|NCT03206073|583089893|FG001|Overall Study|Taken off active treatment|0|||
161462707|NCT03206073|583089894|FG002|Overall Study|Taken off active treatment|3|||
161462708|NCT03206073|583089895|FG003|Overall Study|Taken off active treatment|0|||
161462709|NCT05523323|583089896|FG000|Overall Study|Death|26|||
161462710|NCT05523323|583089897|FG001|Overall Study|Death|21|||
161462711|NCT05523323|583089896|FG000|Overall Study|Ongoing participants|35|||
161462712|NCT05523323|583089897|FG001|Overall Study|Ongoing participants|30|||
161462713|NCT02428608|583089902|FG000|Overall Study|Pregnancy|2|||
161462714|NCT02428608|583089902|FG000|Overall Study|Lost to Follow-up|37|||
161462715|NCT02428608|583089902|FG000|Overall Study|Withdrawal by Subject|2|||
161462716|NCT02428608|583089902|FG000|Overall Study|scheduling conflicts|15|||
161462717|NCT02428608|583089902|FG000|Overall Study|moved away|10|||
161462718|NCT02428608|583089902|FG000|Overall Study|Death|1|||
161462719|NCT02428608|583089902|FG000|Overall Study|various|16|||
161462720|NCT01117051|583089906|FG000|Overall Study|Withdrawal by Subject|5|||
161462721|NCT01117051|583089907|FG001|Overall Study|Withdrawal by Subject|3|||
161462722|NCT01117051|583089906|FG000|Overall Study|Adverse Event|4|||
161462723|NCT01117051|583089907|FG001|Overall Study|Adverse Event|3|||
161462724|NCT01117051|583089906|FG000|Overall Study|Lost to Follow-up|0|||
161462725|NCT01117051|583089907|FG001|Overall Study|Lost to Follow-up|1|||
161462726|NCT01117051|583089906|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
161462727|NCT01117051|583089907|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
161462728|NCT01117051|583089906|FG000|Overall Study|Sponsor's decision|3|||
161462729|NCT01117051|583089907|FG001|Overall Study|Sponsor's decision|1|||
161462730|NCT01117051|583089906|FG000|Overall Study|Surgical procedure|0|||
161462731|NCT01117051|583089907|FG001|Overall Study|Surgical procedure|1|||
161462732|NCT01117051|583089906|FG000|Overall Study|Randomized by mistake|0|||
161462733|NCT01117051|583089907|FG001|Overall Study|Randomized by mistake|1|||
161462734|NCT01117051|583089906|FG000|Overall Study|Convenience issue|1|||
161462735|NCT01117051|583089907|FG001|Overall Study|Convenience issue|0|||
161462736|NCT00206076|583089909|FG000|Overall Study|Physician Decision|2|||
161462737|NCT00206076|583089910|FG001|Overall Study|Physician Decision|0|||
161462738|NCT00206076|583089909|FG000|Overall Study|Withdrawal by Subject|1|||
161462739|NCT00206076|583089910|FG001|Overall Study|Withdrawal by Subject|1|||
161462740|NCT00427960|583089911|FG000|Overall Study|Adverse Event|2|||
161462741|NCT00427960|583089912|FG001|Overall Study|Adverse Event|0|||
161462742|NCT00427960|583089911|FG000|Overall Study|Withdrawal by Subject|0|||
161462743|NCT00427960|583089912|FG001|Overall Study|Withdrawal by Subject|3|||
161462744|NCT00427960|583089911|FG000|Overall Study|Other|0|||
161462745|NCT00427960|583089912|FG001|Overall Study|Other|1|||
161462746|NCT01142128|583089913|FG000|Overall Study|Physician Decision|1|||
161462747|NCT01142128|583089913|FG000|Overall Study|Lost to Follow-up|1|||
161572705|NCT02385669|583481990|FG000|Overall Study|Adverse Event|2|||
161572706|NCT00004124|583481991|FG000|Overall Study|Received no protocol therapy|12|||
161809999|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810000|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810001|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
161810002|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
161810003|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810004|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810005|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161462748|NCT01142128|583089913|FG000|Overall Study|Withdrawal by Subject|2|||
161462749|NCT03355664|583089914|FG000|Overall Study|Adverse Event|1|||
161462750|NCT03355664|583089915|FG001|Overall Study|Adverse Event|2|||
161462751|NCT03355664|583089914|FG000|Overall Study|Lost to Follow-up|11|||
161462752|NCT03355664|583089915|FG001|Overall Study|Lost to Follow-up|7|||
161462753|NCT03355664|583089914|FG000|Overall Study|Protocol Violation|1|||
161462754|NCT03355664|583089915|FG001|Overall Study|Protocol Violation|2|||
161462755|NCT03355664|583089914|FG000|Overall Study|Withdrawal by Subject|2|||
161462756|NCT03355664|583089915|FG001|Overall Study|Withdrawal by Subject|1|||
161462757|NCT00521001|583089918|FG000|Overall Study|Ineligible|1|||
161462758|NCT02821910|583089919|FG000|Overall Study|Withdrawal by Subject|0|||
161462759|NCT02821910|583089920|FG001|Overall Study|Withdrawal by Subject|0|||
161462760|NCT02821910|583089921|FG002|Overall Study|Withdrawal by Subject|1|||
161462761|NCT02821910|583089922|FG003|Overall Study|Withdrawal by Subject|0|||
161462762|NCT02821910|583089923|FG004|Overall Study|Withdrawal by Subject|0|||
161462763|NCT02821910|583089924|FG005|Overall Study|Withdrawal by Subject|1|||
161462764|NCT02821910|583089919|FG000|Overall Study|Other than specified|1|||
161462765|NCT02821910|583089920|FG001|Overall Study|Other than specified|0|||
161462766|NCT02821910|583089921|FG002|Overall Study|Other than specified|1|||
161462767|NCT02821910|583089922|FG003|Overall Study|Other than specified|0|||
161462768|NCT02821910|583089923|FG004|Overall Study|Other than specified|0|||
161462769|NCT02821910|583089924|FG005|Overall Study|Other than specified|0|||
161462770|NCT00900601|583089927|FG000|Overall Study|Physician Decision|1|||
161462771|NCT01082640|583089929|FG000|Overall Study|Adverse Event|9|||
161462772|NCT01082640|583089930|FG001|Overall Study|Adverse Event|5|||
161462773|NCT01082640|583089931|FG002|Overall Study|Adverse Event|3|||
161462774|NCT01082640|583089929|FG000|Overall Study|Withdrawal by Subject|3|||
161462775|NCT01082640|583089930|FG001|Overall Study|Withdrawal by Subject|3|||
161462776|NCT01082640|583089931|FG002|Overall Study|Withdrawal by Subject|2|||
161462777|NCT01082640|583089929|FG000|Overall Study|Major protocol deviation|3|||
161462778|NCT01082640|583089930|FG001|Overall Study|Major protocol deviation|3|||
161462779|NCT01082640|583089931|FG002|Overall Study|Major protocol deviation|0|||
161462780|NCT01082640|583089929|FG000|Overall Study|Lost to Follow-up|0|||
161462781|NCT01082640|583089930|FG001|Overall Study|Lost to Follow-up|3|||
161462782|NCT01082640|583089931|FG002|Overall Study|Lost to Follow-up|0|||
161462783|NCT01082640|583089929|FG000|Overall Study|Other|2|||
161462784|NCT01082640|583089930|FG001|Overall Study|Other|1|||
161462785|NCT01082640|583089931|FG002|Overall Study|Other|3|||
161462786|NCT03823378|583089936|FG000|Overall Study|Adverse Event|2|||
161462787|NCT03823378|583089937|FG001|Overall Study|Adverse Event|2|||
161462788|NCT03823378|583089938|FG002|Overall Study|Adverse Event|0|||
161462789|NCT03823378|583089939|FG003|Overall Study|Adverse Event|0|||
161462790|NCT03823378|583089940|FG004|Overall Study|Adverse Event|0|||
161462791|NCT03823378|583089941|FG005|Overall Study|Adverse Event|0|||
161462792|NCT03823378|583089936|FG000|Overall Study|Lost to Follow-up|0|||
161462793|NCT03823378|583089937|FG001|Overall Study|Lost to Follow-up|1|||
161462794|NCT03823378|583089938|FG002|Overall Study|Lost to Follow-up|0|||
161462795|NCT03823378|583089939|FG003|Overall Study|Lost to Follow-up|0|||
161462796|NCT03823378|583089940|FG004|Overall Study|Lost to Follow-up|1|||
161462797|NCT03823378|583089941|FG005|Overall Study|Lost to Follow-up|0|||
161462798|NCT03823378|583089936|FG000|Overall Study|Withdrawal by Subject|0|||
161462799|NCT03823378|583089937|FG001|Overall Study|Withdrawal by Subject|1|||
161572707|NCT00004124|583481992|FG001|Overall Study|Received no protocol therapy|20|||
161572708|NCT02937831|583481993|FG000|Overall Study|Protocol Violation|4|||
161572709|NCT00114244|583481996|FG000|Overall Study|Adverse Event|2|||
161572710|NCT00114244|583481997|FG001|Overall Study|Adverse Event|5|||
161572711|NCT00114244|583481996|FG000|Overall Study|Withdrawal by Subject|0|||
161572712|NCT00114244|583481997|FG001|Overall Study|Withdrawal by Subject|2|||
161572713|NCT03743246|583482000|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161572714|NCT03743246|583482001|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161572715|NCT03743246|583482002|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
161572716|NCT03743246|583482003|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161572717|NCT03743246|583482000|FG000|Pre-Treatment Period|Death|0|||
161572718|NCT03743246|583482001|FG001|Pre-Treatment Period|Death|1|||
161572719|NCT03743246|583482002|FG002|Pre-Treatment Period|Death|0|||
161572720|NCT03743246|583482003|FG003|Pre-Treatment Period|Death|1|||
161572721|NCT03743246|583482000|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
161572722|NCT03743246|583482001|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161572723|NCT03743246|583482002|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161572724|NCT03743246|583482003|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161572725|NCT03743246|583482000|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
161572726|NCT03743246|583482001|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161572727|NCT03743246|583482002|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161572728|NCT03743246|583482003|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161572729|NCT03743246|583482000|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
161572730|NCT03743246|583482001|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161572731|NCT03743246|583482002|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161572732|NCT03743246|583482003|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161572733|NCT03743246|583482000|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161572734|NCT03743246|583482001|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
161572735|NCT03743246|583482002|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161572736|NCT03743246|583482003|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161572737|NCT03743246|583482000|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
161572738|NCT03743246|583482001|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161572739|NCT03743246|583482002|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161572740|NCT03743246|583482003|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161572741|NCT03743246|583482000|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
161572742|NCT03743246|583482001|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
161572743|NCT03743246|583482002|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
161810006|NCT01796171|584347680|FG000|Follow-up Period|Start of further anticancer therapy|4|||
161810007|NCT01796171|584347681|FG001|Follow-up Period|Start of further anticancer therapy|25|||
161810008|NCT01796171|584347682|FG002|Follow-up Period|Start of further anticancer therapy|2|||
161810009|NCT01796171|584347683|FG003|Follow-up Period|Start of further anticancer therapy|1|||
161462800|NCT03823378|583089938|FG002|Overall Study|Withdrawal by Subject|4|||
161462801|NCT03823378|583089939|FG003|Overall Study|Withdrawal by Subject|2|||
161462802|NCT03823378|583089940|FG004|Overall Study|Withdrawal by Subject|0|||
161462803|NCT03823378|583089941|FG005|Overall Study|Withdrawal by Subject|1|||
161462804|NCT03823378|583089936|FG000|Overall Study|Other, not specified|19|||
161462805|NCT03823378|583089937|FG001|Overall Study|Other, not specified|12|||
161462806|NCT03823378|583089938|FG002|Overall Study|Other, not specified|6|||
161462807|NCT03823378|583089939|FG003|Overall Study|Other, not specified|8|||
161462808|NCT03823378|583089940|FG004|Overall Study|Other, not specified|17|||
161462809|NCT03823378|583089941|FG005|Overall Study|Other, not specified|7|||
161462810|NCT03190369|583089942|FG000|Overall Study|Poor compliance to protocol|0|||
161462811|NCT03190369|583089943|FG001|Overall Study|Poor compliance to protocol|1|||
161462812|NCT03190369|583089942|FG000|Overall Study|Withdraw before treatment|1|||
161462813|NCT03190369|583089943|FG001|Overall Study|Withdraw before treatment|5|||
161462814|NCT03190369|583089942|FG000|Overall Study|Randomized but not treated|0|||
161462815|NCT03190369|583089943|FG001|Overall Study|Randomized but not treated|2|||
161462816|NCT01264016|583089946|FG000|Overall Study|Withdrawal by Subject|1|||
161462817|NCT01264016|583089946|FG000|Overall Study|Felt faint at sight of blood|1|||
161462818|NCT01056380|583089947|FG000|Overall Study|Lost to Follow-up|2|||
161462819|NCT01056380|583089948|FG001|Overall Study|Lost to Follow-up|3|||
161462820|NCT01629706|583089949|FG000|Phase 1 PureVision|Screen Failure|4|||
161462821|NCT01629706|583089949|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
161462822|NCT01629706|583089949|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
161462823|NCT01629706|583089949|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
161462824|NCT01629706|583089949|FG000|Phase 2 Habitual|Screen Failure|6|||
161462825|NCT01629706|583089949|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
161462826|NCT01629706|583089949|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
161462827|NCT01629706|583089949|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
161462828|NCT01629706|583089949|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
161462829|NCT00048061|583089950|FG000|Overall Study|Adverse Event|41|||
161462830|NCT00048061|583089951|FG001|Overall Study|Adverse Event|32|||
161462831|NCT00048061|583089952|FG002|Overall Study|Adverse Event|44|||
161462832|NCT00048061|583089953|FG003|Overall Study|Adverse Event|37|||
161462833|NCT00048061|583089950|FG000|Overall Study|Lost to Follow-up|3|||
161462834|NCT00048061|583089951|FG001|Overall Study|Lost to Follow-up|2|||
161462835|NCT00048061|583089952|FG002|Overall Study|Lost to Follow-up|4|||
161462836|NCT00048061|583089953|FG003|Overall Study|Lost to Follow-up|5|||
161462837|NCT00048061|583089950|FG000|Overall Study|Withdrawal by Subject|20|||
161462838|NCT00048061|583089951|FG001|Overall Study|Withdrawal by Subject|29|||
161462839|NCT00048061|583089952|FG002|Overall Study|Withdrawal by Subject|29|||
161462840|NCT00048061|583089953|FG003|Overall Study|Withdrawal by Subject|32|||
161462841|NCT00048061|583089950|FG000|Overall Study|Did not follow-up|5|||
161462842|NCT00048061|583089951|FG001|Overall Study|Did not follow-up|5|||
161462843|NCT00048061|583089952|FG002|Overall Study|Did not follow-up|4|||
161462844|NCT00048061|583089953|FG003|Overall Study|Did not follow-up|5|||
161462845|NCT00048061|583089950|FG000|Overall Study|Early improvement|6|||
161462846|NCT00048061|583089951|FG001|Overall Study|Early improvement|5|||
161462847|NCT00048061|583089952|FG002|Overall Study|Early improvement|3|||
161462848|NCT00048061|583089953|FG003|Overall Study|Early improvement|0|||
161462849|NCT00393042|583089954|FG000|First Intervention|Withdrawal by Subject|1|||
161462850|NCT00393042|583089955|FG001|First Intervention|Withdrawal by Subject|2|||
161462851|NCT00393042|583089954|FG000|First Intervention|Lost to Follow-up|3|||
161462852|NCT00393042|583089955|FG001|First Intervention|Lost to Follow-up|3|||
161462853|NCT00393042|583089954|FG000|First Intervention|Protocol Violation|1|||
161462854|NCT00393042|583089955|FG001|First Intervention|Protocol Violation|0|||
161462855|NCT00393042|583089954|FG000|First Intervention|Adverse Event|0|||
161462856|NCT00393042|583089955|FG001|First Intervention|Adverse Event|1|||
161462857|NCT00393042|583089954|FG000|Second Intervetion|Adverse Event|0|||
161462858|NCT00393042|583089955|FG001|Second Intervetion|Adverse Event|3|||
161462859|NCT00393042|583089954|FG000|Second Intervetion|Withdrawal by Subject|0|||
161462860|NCT00393042|583089955|FG001|Second Intervetion|Withdrawal by Subject|2|||
161462861|NCT00393042|583089954|FG000|Second Intervetion|Lack of Efficacy|1|||
161462862|NCT00393042|583089955|FG001|Second Intervetion|Lack of Efficacy|0|||
161462863|NCT00393042|583089954|FG000|Second Intervetion|Lost to Follow-up|0|||
161462864|NCT00393042|583089955|FG001|Second Intervetion|Lost to Follow-up|2|||
161462865|NCT00393042|583089954|FG000|Second Intervetion|Protocol Violation|1|||
161462866|NCT00393042|583089955|FG001|Second Intervetion|Protocol Violation|1|||
161462867|NCT03475875|583089956|FG000|Period 1|Lost to Follow-up|1|||
161462868|NCT03475875|583089957|FG001|Period 1|Lost to Follow-up|0|||
161462869|NCT03475875|583089956|FG000|Period 1|Adverse Event|2|||
161462870|NCT03475875|583089957|FG001|Period 1|Adverse Event|1|||
161462871|NCT03475875|583089956|FG000|Period 2|Adverse Event|3|||
161462872|NCT03475875|583089957|FG001|Period 2|Adverse Event|0|||
161462873|NCT03475875|583089956|FG000|Period 2|Protocol Violation|0|||
161462874|NCT03475875|583089957|FG001|Period 2|Protocol Violation|1|||
161462875|NCT01642407|583089961|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
161462876|NCT01642407|583089961|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
161462877|NCT01642407|583089961|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
161462878|NCT02045303|583089962|FG000|Overall Study|Protocol Violation|2|||
161462879|NCT02045303|583089963|FG001|Overall Study|Protocol Violation|1|||
161462880|NCT02045303|583089964|FG002|Overall Study|Protocol Violation|0|||
161462881|NCT02045303|583089962|FG000|Overall Study|Withdrawal by Subject|0|||
161572744|NCT03743246|583482003|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
161462882|NCT02045303|583089963|FG001|Overall Study|Withdrawal by Subject|2|||
161462883|NCT02045303|583089964|FG002|Overall Study|Withdrawal by Subject|0|||
161462884|NCT01856023|583089965|FG000|Overall Study|Death|1|||
161462885|NCT01856023|583089966|FG001|Overall Study|Death|2|||
161462886|NCT01856023|583089965|FG000|Overall Study|Adverse Event|2|||
161462887|NCT01856023|583089966|FG001|Overall Study|Adverse Event|1|||
161462888|NCT01856023|583089965|FG000|Overall Study|Lack of Efficacy|5|||
161462889|NCT01856023|583089966|FG001|Overall Study|Lack of Efficacy|5|||
161462890|NCT01856023|583089965|FG000|Overall Study|non compliance, study closure|1|||
161462891|NCT01856023|583089966|FG001|Overall Study|non compliance, study closure|3|||
161462892|NCT01856023|583089965|FG000|Overall Study|Withdrawal by Subject|1|||
161462893|NCT01856023|583089966|FG001|Overall Study|Withdrawal by Subject|1|||
161462894|NCT00829283|583089967|FG000|Overall Study|Lost to Follow-up|7|||
161462895|NCT00829283|583089968|FG001|Overall Study|Lost to Follow-up|25|||
161462896|NCT00424255|583089969|FG000|Overall Study|Death|115|||
161462897|NCT00424255|583089970|FG001|Overall Study|Death|111|||
161462898|NCT00424255|583089969|FG000|Overall Study|Lost to Follow-up|26|||
161462899|NCT00424255|583089970|FG001|Overall Study|Lost to Follow-up|20|||
161462900|NCT00424255|583089969|FG000|Overall Study|Protocol Violation|0|||
161462901|NCT00424255|583089970|FG001|Overall Study|Protocol Violation|1|||
161462902|NCT00424255|583089969|FG000|Overall Study|Withdrawal by Subject|34|||
161462903|NCT00424255|583089970|FG001|Overall Study|Withdrawal by Subject|38|||
161462904|NCT00424255|583089969|FG000|Overall Study|Physician Decision|3|||
161462905|NCT00424255|583089970|FG001|Overall Study|Physician Decision|7|||
161462906|NCT00424255|583089969|FG000|Overall Study|Cognitive Disturbance|1|||
161462907|NCT00424255|583089970|FG001|Overall Study|Cognitive Disturbance|0|||
161462908|NCT00424255|583089969|FG000|Overall Study|Non-compliance by Participants|1|||
161462909|NCT00424255|583089970|FG001|Overall Study|Non-compliance by Participants|0|||
161462910|NCT00424255|583089969|FG000|Overall Study|Fatigue|1|||
161572745|NCT03743246|583482000|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
161572746|NCT03743246|583482001|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161572747|NCT03743246|583482002|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161572748|NCT03743246|583482003|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161462911|NCT00424255|583089970|FG001|Overall Study|Fatigue|0|||
161572749|NCT00395018|583482004|FG000|On-Treatment|Death|4|||
161572750|NCT00395018|583482004|FG000|On-Treatment|Other Reason|2|||
161572751|NCT00395018|583482004|FG000|On-Treatment|Poor/non-compliance|2|||
161572752|NCT00395018|583482004|FG000|On-Treatment|Subject no longer meets study criteria|2|||
161572753|NCT00395018|583482004|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
161572754|NCT00395018|583482004|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
161572755|NCT00395018|583482004|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
161572756|NCT00371566|583482005|FG000|Treatment Phase|Withdrawal by Subject|0|||
161572757|NCT00371566|583482006|FG001|Treatment Phase|Withdrawal by Subject|1|||
161572758|NCT00371566|583482005|FG000|Treatment Phase|Adverse Event|0|||
161572759|NCT00371566|583482006|FG001|Treatment Phase|Adverse Event|1|||
161572760|NCT00371566|583482005|FG000|Treatment Phase|Protocol Violation|0|||
161572761|NCT00371566|583482006|FG001|Treatment Phase|Protocol Violation|1|||
161572762|NCT00371566|583482005|FG000|Chemoradiation Phase|Physician Decision|2|||
161572763|NCT00371566|583482006|FG001|Chemoradiation Phase|Physician Decision|0|||
161572764|NCT00371566|583482005|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
161572765|NCT00371566|583482006|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
161572766|NCT00371566|583482005|FG000|Chemoradiation Phase|Non compliant|0|||
161572767|NCT00371566|583482006|FG001|Chemoradiation Phase|Non compliant|1|||
161572768|NCT00371566|583482005|FG000|Chemoradiation Phase|Progressive Disease|1|||
161572769|NCT00371566|583482006|FG001|Chemoradiation Phase|Progressive Disease|1|||
161572770|NCT00371566|583482005|FG000|Chemoradiation Phase|Death|2|||
161572771|NCT00371566|583482006|FG001|Chemoradiation Phase|Death|0|||
161572772|NCT00371566|583482005|FG000|Follow Up Phase|Death|0|||
161572773|NCT00371566|583482006|FG001|Follow Up Phase|Death|5|||
161810010|NCT01796171|584347684|FG004|Follow-up Period|Start of further anticancer therapy|2|||
161810011|NCT01796171|584347685|FG005|Follow-up Period|Start of further anticancer therapy|2|||
161572774|NCT00371566|583482005|FG000|Follow Up Phase|Disease progression|1|||
161572775|NCT00371566|583482006|FG001|Follow Up Phase|Disease progression|0|||
161572776|NCT00371566|583482005|FG000|Follow Up Phase|Withdrawal by Subject|0|||
161572777|NCT00371566|583482006|FG001|Follow Up Phase|Withdrawal by Subject|1|||
161810012|NCT01796171|584347686|FG006|Follow-up Period|Start of further anticancer therapy|1|||
161462912|NCT00424255|583089969|FG000|Overall Study|Disease Progression|0|||
161462913|NCT00424255|583089970|FG001|Overall Study|Disease Progression|2|||
161462914|NCT00424255|583089969|FG000|Overall Study|Sponsor Terminated Study|161|||
161462915|NCT00424255|583089970|FG001|Overall Study|Sponsor Terminated Study|167|||
161462916|NCT00256282|583089971|FG000|Overall Study|Disease progression, relapse during acti|12|||
161462917|NCT00256282|583089971|FG000|Overall Study|Adverse Event|3|||
161462918|NCT00256282|583089971|FG000|Overall Study|Physician Decision|1|||
161462919|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
161572778|NCT00371566|583482005|FG000|Follow Up Phase|Physician Decision|1|||
161914165|NCT01648764|584735512|FG005|Overall Study|Withdrawal by Subject|0|||
161572779|NCT00371566|583482006|FG001|Follow Up Phase|Physician Decision|1|||
161572780|NCT00371566|583482005|FG000|Follow Up Phase|Lost to Follow-up|1|||
161572781|NCT00371566|583482006|FG001|Follow Up Phase|Lost to Follow-up|0|||
161572782|NCT04439799|583482007|FG000|Overall Study|Lost to Follow-up|6|||
161572783|NCT04439799|583482008|FG001|Overall Study|Lost to Follow-up|6|||
161572784|NCT04439799|583482007|FG000|Overall Study|Withdrawal by Subject|2|||
161572785|NCT04439799|583482008|FG001|Overall Study|Withdrawal by Subject|6|||
161572786|NCT04439799|583482007|FG000|Overall Study|Adverse Event|2|||
161572787|NCT04439799|583482008|FG001|Overall Study|Adverse Event|5|||
161572788|NCT00530842|583482013|FG000|Overall Study|Adverse Event|10|||
161572789|NCT00530842|583482014|FG001|Overall Study|Adverse Event|6|||
161572790|NCT00530842|583482013|FG000|Overall Study|Lack of Efficacy|2|||
161572791|NCT00530842|583482014|FG001|Overall Study|Lack of Efficacy|1|||
161572792|NCT00530842|583482013|FG000|Overall Study|Lost to Follow-up|0|||
161572793|NCT00530842|583482014|FG001|Overall Study|Lost to Follow-up|4|||
161572794|NCT00530842|583482013|FG000|Overall Study|Protocol Violation|3|||
161572795|NCT00530842|583482014|FG001|Overall Study|Protocol Violation|2|||
161572796|NCT00530842|583482013|FG000|Overall Study|Withdrawal by Subject|4|||
161572797|NCT00530842|583482014|FG001|Overall Study|Withdrawal by Subject|5|||
161572798|NCT00530842|583482013|FG000|Overall Study|Individual different reasons|4|||
161572799|NCT00530842|583482014|FG001|Overall Study|Individual different reasons|3|||
161572800|NCT00530842|583482013|FG000|Period 1|Adverse Event|7|||
161572801|NCT00530842|583482014|FG001|Period 1|Adverse Event|3|||
161572802|NCT00530842|583482013|FG000|Period 1|Lack of Efficacy|1|||
161572803|NCT00530842|583482014|FG001|Period 1|Lack of Efficacy|1|||
161572804|NCT00530842|583482013|FG000|Period 1|Protocol Violation|2|||
161572805|NCT00530842|583482014|FG001|Period 1|Protocol Violation|1|||
161572806|NCT00530842|583482013|FG000|Period 1|Withdrawal by Subject|2|||
161572807|NCT00530842|583482014|FG001|Period 1|Withdrawal by Subject|3|||
161572808|NCT00530842|583482013|FG000|Period 1|Individual different reasons|2|||
161572809|NCT00530842|583482014|FG001|Period 1|Individual different reasons|3|||
161572810|NCT00530842|583482013|FG000|Period 2|Adverse Event|3|||
161572811|NCT00530842|583482014|FG001|Period 2|Adverse Event|3|||
161572812|NCT00530842|583482013|FG000|Period 2|Lack of Efficacy|1|||
161572813|NCT00530842|583482014|FG001|Period 2|Lack of Efficacy|0|||
161572814|NCT00530842|583482013|FG000|Period 2|Lost to Follow-up|0|||
161572815|NCT00530842|583482014|FG001|Period 2|Lost to Follow-up|4|||
161572816|NCT00530842|583482013|FG000|Period 2|Protocol Violation|1|||
161572817|NCT00530842|583482014|FG001|Period 2|Protocol Violation|0|||
161572818|NCT00530842|583482013|FG000|Period 2|Withdrawal by Subject|1|||
161572819|NCT00530842|583482014|FG001|Period 2|Withdrawal by Subject|2|||
161572820|NCT00530842|583482013|FG000|Period 2|Individual different reasons|2|||
161572821|NCT00530842|583482014|FG001|Period 2|Individual different reasons|0|||
161572822|NCT03478696|583482030|FG000|Overall Study|Adverse Event|1|||
161572823|NCT03478696|583482031|FG001|Overall Study|Adverse Event|5|||
161572824|NCT03478696|583482030|FG000|Overall Study|Lost to Follow-up|1|||
161572825|NCT03478696|583482031|FG001|Overall Study|Lost to Follow-up|0|||
161572826|NCT03478696|583482030|FG000|Overall Study|Physician Decision|6|||
161572827|NCT03478696|583482031|FG001|Overall Study|Physician Decision|3|||
161572828|NCT03478696|583482030|FG000|Overall Study|Withdrawal by Subject|9|||
161572829|NCT03478696|583482031|FG001|Overall Study|Withdrawal by Subject|4|||
161572830|NCT00082810|583482041|FG000|Overall Study|Adverse Event|3|||
161572831|NCT00082810|583482041|FG000|Overall Study|Progressive disease|24|||
161572832|NCT00082810|583482041|FG000|Overall Study|Withdrawal by Subject|4|||
161572833|NCT00177216|583482042|FG000|Overall Study|Withdrawal by Subject|6|||
161572834|NCT00177216|583482043|FG001|Overall Study|Withdrawal by Subject|3|||
161572835|NCT00177216|583482044|FG002|Overall Study|Withdrawal by Subject|1|||
161572836|NCT01161498|583482047|FG000|Overall Study|Disease Progression|0|||
161572837|NCT01161498|583482048|FG001|Overall Study|Disease Progression|1|||
161572838|NCT00988637|583482049|FG000|Overall Study|Lost to Follow-up|2|||
161572839|NCT00988637|583482050|FG001|Overall Study|Lost to Follow-up|1|||
161572840|NCT00988637|583482049|FG000|Overall Study|Withdrawal by Subject|1|||
161572841|NCT00988637|583482050|FG001|Overall Study|Withdrawal by Subject|1|||
161572842|NCT00988637|583482049|FG000|Overall Study|non-compliance with study drug|0|||
161572843|NCT00988637|583482050|FG001|Overall Study|non-compliance with study drug|1|||
161572844|NCT03310983|583482056|FG000|Overall Study|Lost to Follow-up|15|||
161572845|NCT03310983|583482057|FG001|Overall Study|Lost to Follow-up|17|||
161572846|NCT01656304|583482058|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
161572847|NCT00823979|583482061|FG000|Overall Study|Lack of Efficacy|13|||
161572848|NCT00823979|583482062|FG001|Overall Study|Lack of Efficacy|16|||
161572849|NCT00823979|583482063|FG002|Overall Study|Lack of Efficacy|9|||
161572850|NCT00823979|583482061|FG000|Overall Study|Lost to Follow-up|2|||
161572851|NCT00823979|583482062|FG001|Overall Study|Lost to Follow-up|1|||
161572852|NCT00823979|583482063|FG002|Overall Study|Lost to Follow-up|0|||
161572853|NCT00823979|583482061|FG000|Overall Study|Withdrawal by Subject|2|||
161572854|NCT00823979|583482062|FG001|Overall Study|Withdrawal by Subject|3|||
161914166|NCT01648764|584735513|FG006|Overall Study|Withdrawal by Subject|2|||
161572855|NCT00823979|583482063|FG002|Overall Study|Withdrawal by Subject|2|||
161572856|NCT00823979|583482061|FG000|Overall Study|Protocol Violation|1|||
161462920|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
161462921|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
161462922|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
161462923|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
161462924|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
161462925|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
161462926|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
161462927|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
161462928|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
161462929|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
161462930|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
161462931|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
161462932|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
161462933|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
161462934|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
161462935|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
161462936|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
161462937|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
161462938|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
161462939|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
161462940|NCT02431247|583089972|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
161462941|NCT02431247|583089973|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
161462942|NCT02431247|583089974|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
161462943|NCT02431247|583089972|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161462944|NCT02431247|583089973|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161462945|NCT02431247|583089974|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
161462946|NCT02431247|583089972|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
161462947|NCT02431247|583089973|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
161462948|NCT02431247|583089974|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
161462949|NCT02431247|583089972|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
161572857|NCT00823979|583482062|FG001|Overall Study|Protocol Violation|1|||
161572858|NCT00823979|583482063|FG002|Overall Study|Protocol Violation|0|||
161572859|NCT00823979|583482061|FG000|Overall Study|Pregnancy|0|||
161572860|NCT00823979|583482062|FG001|Overall Study|Pregnancy|1|||
161572861|NCT00823979|583482063|FG002|Overall Study|Pregnancy|0|||
161810013|NCT01796171|584347687|FG007|Follow-up Period|Start of further anticancer therapy|15|||
161810014|NCT01796171|584347688|FG008|Follow-up Period|Start of further anticancer therapy|2|||
161810015|NCT01796171|584347689|FG009|Follow-up Period|Start of further anticancer therapy|0|||
161810016|NCT01796171|584347690|FG010|Follow-up Period|Start of further anticancer therapy|0|||
161810017|NCT01796171|584347691|FG011|Follow-up Period|Start of further anticancer therapy|0|||
161810018|NCT01796171|584347692|FG012|Follow-up Period|Start of further anticancer therapy|0|||
161810019|NCT01796171|584347693|FG013|Follow-up Period|Start of further anticancer therapy|0|||
161810020|NCT01796171|584347694|FG014|Follow-up Period|Start of further anticancer therapy|0|||
161810021|NCT01796171|584347680|FG000|Follow-up Period|Progressive disease|0|||
161810022|NCT01796171|584347681|FG001|Follow-up Period|Progressive disease|1|||
161810023|NCT01796171|584347682|FG002|Follow-up Period|Progressive disease|0|||
161810024|NCT01796171|584347683|FG003|Follow-up Period|Progressive disease|0|||
161810025|NCT01796171|584347684|FG004|Follow-up Period|Progressive disease|0|||
161810026|NCT01796171|584347685|FG005|Follow-up Period|Progressive disease|0|||
161810027|NCT01796171|584347686|FG006|Follow-up Period|Progressive disease|0|||
161810028|NCT01796171|584347687|FG007|Follow-up Period|Progressive disease|3|||
161810029|NCT01796171|584347688|FG008|Follow-up Period|Progressive disease|0|||
161810030|NCT01796171|584347689|FG009|Follow-up Period|Progressive disease|0|||
161810031|NCT01796171|584347690|FG010|Follow-up Period|Progressive disease|0|||
161810032|NCT01796171|584347691|FG011|Follow-up Period|Progressive disease|0|||
161810033|NCT01796171|584347692|FG012|Follow-up Period|Progressive disease|0|||
161810034|NCT01796171|584347693|FG013|Follow-up Period|Progressive disease|0|||
161810035|NCT01796171|584347694|FG014|Follow-up Period|Progressive disease|0|||
161810036|NCT01796171|584347680|FG000|Follow-up Period|Physician Decision|0|||
161810037|NCT01796171|584347681|FG001|Follow-up Period|Physician Decision|2|||
161810038|NCT01796171|584347682|FG002|Follow-up Period|Physician Decision|0|||
161810039|NCT01796171|584347683|FG003|Follow-up Period|Physician Decision|0|||
161810040|NCT01796171|584347684|FG004|Follow-up Period|Physician Decision|0|||
161810041|NCT01796171|584347685|FG005|Follow-up Period|Physician Decision|0|||
161810042|NCT01796171|584347686|FG006|Follow-up Period|Physician Decision|0|||
161810043|NCT01796171|584347687|FG007|Follow-up Period|Physician Decision|0|||
161810044|NCT01796171|584347688|FG008|Follow-up Period|Physician Decision|0|||
161462950|NCT02431247|583089973|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
161572862|NCT00823979|583482061|FG000|Overall Study|Adverse Event|0|||
161572863|NCT00823979|583482062|FG001|Overall Study|Adverse Event|2|||
161462951|NCT02431247|583089974|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
161462952|NCT02431247|583089972|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
161462953|NCT02431247|583089973|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
161462954|NCT02431247|583089974|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
161462955|NCT02431247|583089972|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
161462956|NCT02431247|583089973|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
161462957|NCT02431247|583089974|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
161462958|NCT02431247|583089972|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
161462959|NCT02431247|583089973|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
161462960|NCT02431247|583089974|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
161462961|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
161462962|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
161462963|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Other|2|||
161462964|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Other|2|||
161462965|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Personal reasons|2|||
161462966|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Personal reasons|2|||
161462967|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
161462968|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
161462969|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
161462970|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
161462971|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
161462972|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
161462973|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
161462974|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
161462975|NCT00667446|583089975|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
161462976|NCT00667446|583089976|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
161462977|NCT00667446|583089975|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
161462978|NCT00667446|583089976|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
161462979|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
161462980|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
161462981|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
161462982|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
161462983|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
161462984|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
161462985|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
161462986|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
161462987|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
161462988|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
161462989|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
161462990|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
161462991|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
161462992|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
161462993|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
161462994|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
161462995|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
161462996|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
161462997|NCT00591578|583089978|FG000|Double-Blind Treatment Phase|Other|4|||
161462998|NCT00591578|583089979|FG001|Double-Blind Treatment Phase|Other|9|||
161462999|NCT00591578|583089980|FG002|Double-Blind Treatment Phase|Other|4|||
161463000|NCT00591578|583089978|FG000|Open-Label Extension Phase|Adverse Event|3|||
161463001|NCT00591578|583089979|FG001|Open-Label Extension Phase|Adverse Event|5|||
161463002|NCT00591578|583089980|FG002|Open-Label Extension Phase|Adverse Event|0|||
161463003|NCT00591578|583089978|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
161463004|NCT00591578|583089979|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
161463005|NCT00591578|583089980|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161463006|NCT00591578|583089978|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
161463007|NCT00591578|583089979|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
161463008|NCT00591578|583089980|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
161463009|NCT00591578|583089978|FG000|Open-Label Extension Phase|Other|1|||
161463010|NCT00591578|583089979|FG001|Open-Label Extension Phase|Other|0|||
161463011|NCT00591578|583089980|FG002|Open-Label Extension Phase|Other|0|||
161463012|NCT02810340|583089981|FG000|Overall Study|Withdrawal by Subject|1|||
161463013|NCT02810340|583089982|FG001|Overall Study|Withdrawal by Subject|0|||
161463014|NCT02810340|583089983|FG002|Overall Study|Withdrawal by Subject|0|||
161463015|NCT02810340|583089981|FG000|Overall Study|Incarceration|0|||
161810045|NCT01796171|584347689|FG009|Follow-up Period|Physician Decision|0|||
161810046|NCT01796171|584347690|FG010|Follow-up Period|Physician Decision|5|||
161463016|NCT02810340|583089982|FG001|Overall Study|Incarceration|1|||
161463017|NCT02810340|583089983|FG002|Overall Study|Incarceration|0|||
161463018|NCT02810340|583089981|FG000|Overall Study|Lost to Follow-up|0|||
161810047|NCT01796171|584347691|FG011|Follow-up Period|Physician Decision|0|||
161463019|NCT02810340|583089982|FG001|Overall Study|Lost to Follow-up|0|||
161463020|NCT02810340|583089983|FG002|Overall Study|Lost to Follow-up|1|||
161463021|NCT00473746|583089984|FG000|Period 1 (Phase 1)|Adverse Event|1|||
161463022|NCT00473746|583089985|FG001|Period 1 (Phase 1)|Adverse Event|0|||
161463023|NCT00473746|583089986|FG002|Period 1 (Phase 1)|Adverse Event|0|||
161463024|NCT00473746|583089987|FG003|Period 1 (Phase 1)|Adverse Event|0|||
161463025|NCT00473746|583089988|FG004|Period 1 (Phase 1)|Adverse Event|0|||
161463026|NCT00473746|583089984|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
161463027|NCT00473746|583089985|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
161463028|NCT00473746|583089986|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
161463029|NCT00473746|583089987|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
161463030|NCT00473746|583089988|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
161463031|NCT00473746|583089984|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
161463032|NCT00473746|583089985|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
161463033|NCT00473746|583089986|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
161463034|NCT00473746|583089987|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
161463035|NCT00473746|583089988|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
161463036|NCT00473746|583089984|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
161463037|NCT00473746|583089985|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
161463038|NCT00473746|583089986|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
161463039|NCT00473746|583089987|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
161463040|NCT00473746|583089988|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
161463041|NCT00473746|583089984|FG000|Period 1 (Phase 1)|Reason not specified|0|||
161463042|NCT00473746|583089985|FG001|Period 1 (Phase 1)|Reason not specified|1|||
161463043|NCT00473746|583089986|FG002|Period 1 (Phase 1)|Reason not specified|0|||
161463044|NCT00473746|583089987|FG003|Period 1 (Phase 1)|Reason not specified|0|||
161463045|NCT00473746|583089988|FG004|Period 1 (Phase 1)|Reason not specified|0|||
161463046|NCT00473746|583089984|FG000|Period 2 (Phase 2)|Adverse Event|0|||
161463047|NCT00473746|583089985|FG001|Period 2 (Phase 2)|Adverse Event|0|||
161463048|NCT00473746|583089986|FG002|Period 2 (Phase 2)|Adverse Event|0|||
161463049|NCT00473746|583089987|FG003|Period 2 (Phase 2)|Adverse Event|0|||
161463050|NCT00473746|583089988|FG004|Period 2 (Phase 2)|Adverse Event|3|||
161463051|NCT00473746|583089984|FG000|Period 2 (Phase 2)|Death|0|||
161463052|NCT00473746|583089985|FG001|Period 2 (Phase 2)|Death|0|||
161463053|NCT00473746|583089986|FG002|Period 2 (Phase 2)|Death|0|||
161463054|NCT00473746|583089987|FG003|Period 2 (Phase 2)|Death|0|||
161463055|NCT00473746|583089988|FG004|Period 2 (Phase 2)|Death|1|||
161463056|NCT00473746|583089984|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
161463057|NCT00473746|583089985|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
161463058|NCT00473746|583089986|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
161463059|NCT00473746|583089987|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
161463060|NCT00473746|583089988|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
161463061|NCT00473746|583089984|FG000|Period 2 (Phase 2)|Reason not specified|0|||
161463062|NCT00473746|583089985|FG001|Period 2 (Phase 2)|Reason not specified|0|||
161463063|NCT00473746|583089986|FG002|Period 2 (Phase 2)|Reason not specified|0|||
161463064|NCT00473746|583089987|FG003|Period 2 (Phase 2)|Reason not specified|0|||
161463065|NCT00473746|583089988|FG004|Period 2 (Phase 2)|Reason not specified|3|||
161463066|NCT01962922|583089991|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
161463067|NCT01962922|583089992|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
161463068|NCT01962922|583089991|FG000|PK Portion Day 7|non-compliance|1|||
161463069|NCT01962922|583089992|FG001|PK Portion Day 7|non-compliance|0|||
161463070|NCT01962922|583089991|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
161463071|NCT01962922|583089992|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
161463072|NCT01962922|583089991|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
161463073|NCT01962922|583089992|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
161463074|NCT01307020|583089999|FG000|Overall Study|Lost to Follow-up|0|||
161463075|NCT01307020|583090000|FG001|Overall Study|Lost to Follow-up|0|||
161463076|NCT01307020|583090001|FG002|Overall Study|Lost to Follow-up|1|||
161463077|NCT01307020|583090002|FG003|Overall Study|Lost to Follow-up|1|||
161463078|NCT01307020|583090003|FG004|Overall Study|Lost to Follow-up|0|||
161463079|NCT01307020|583090004|FG005|Overall Study|Lost to Follow-up|0|||
161572864|NCT00823979|583482063|FG002|Overall Study|Adverse Event|4|||
161810048|NCT01796171|584347692|FG012|Follow-up Period|Physician Decision|0|||
161463080|NCT01307020|583090005|FG006|Overall Study|Lost to Follow-up|1|||
161463081|NCT01307020|583090006|FG007|Overall Study|Lost to Follow-up|0|||
161463082|NCT01307020|583090007|FG008|Overall Study|Lost to Follow-up|0|||
161463083|NCT01307020|583090008|FG009|Overall Study|Lost to Follow-up|0|||
161463084|NCT01307020|583089999|FG000|Overall Study|Electronic data capture failure|0|||
161463085|NCT01307020|583090000|FG001|Overall Study|Electronic data capture failure|1|||
161463086|NCT01307020|583090001|FG002|Overall Study|Electronic data capture failure|0|||
161463087|NCT01307020|583090002|FG003|Overall Study|Electronic data capture failure|0|||
161463088|NCT01307020|583090003|FG004|Overall Study|Electronic data capture failure|0|||
161463089|NCT01307020|583090004|FG005|Overall Study|Electronic data capture failure|0|||
161463090|NCT01307020|583090005|FG006|Overall Study|Electronic data capture failure|0|||
161463091|NCT01307020|583090006|FG007|Overall Study|Electronic data capture failure|0|||
161572865|NCT00823979|583482061|FG000|Overall Study|Other|2|||
161463092|NCT01307020|583090007|FG008|Overall Study|Electronic data capture failure|0|||
161463093|NCT01307020|583090008|FG009|Overall Study|Electronic data capture failure|0|||
161463094|NCT00523367|583090009|FG000|Overall Study|19 screen failures|19|||
161463095|NCT00523367|583090009|FG000|Overall Study|4 Withdrawn by PI|4|||
161463096|NCT02793128|583090010|FG000|Overall Study|Death|4|||
161463097|NCT02793128|583090010|FG000|Overall Study|Withdrawal by Subject|2|||
161463098|NCT02793128|583090010|FG000|Overall Study|Physician Decision|1|||
161463099|NCT02793128|583090010|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
161463100|NCT02793128|583090010|FG000|Overall Study|Patient elected nephroureterectomy|1|||
161463101|NCT02125604|583090011|FG000|Overall Study|Other|4|||
161463102|NCT02125604|583090011|FG000|Overall Study|Investigator Decision|1|||
161463103|NCT02125604|583090011|FG000|Overall Study|Lost to Follow-up|2|||
161463104|NCT02125604|583090011|FG000|Overall Study|Consent Withdrawn|4|||
161463105|NCT02125604|583090011|FG000|Overall Study|Adverse Event|20|||
161463106|NCT00782795|583090014|FG000|Overall Study|Withdrawal by Subject|1|||
161463107|NCT00782795|583090015|FG001|Overall Study|Withdrawal by Subject|2|||
161463108|NCT04480424|583090016|FG000|Overall Study|Withdrawal by Subject|0|||
161463109|NCT04480424|583090017|FG001|Overall Study|Withdrawal by Subject|2|||
161463110|NCT04480424|583090016|FG000|Overall Study|Lost to Follow-up|3|||
161463111|NCT04480424|583090017|FG001|Overall Study|Lost to Follow-up|3|||
161463112|NCT04480424|583090016|FG000|Overall Study|Death|14|||
161463113|NCT04480424|583090017|FG001|Overall Study|Death|16|||
161463114|NCT04480424|583090016|FG000|Overall Study|Reason not Specified|5|||
161463115|NCT04480424|583090017|FG001|Overall Study|Reason not Specified|5|||
161463116|NCT00993044|583090018|FG000|Irinotecan 50 mg|Physician Decision|1|||
161463117|NCT00734747|583090020|FG000|SRS Procedure|No staples placed|3|||
161463118|NCT00734747|583090020|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
161463119|NCT00920829|583091643|FG000|Allocation|No post randomization data|3|||
161463120|NCT00920829|583091644|FG001|Allocation|No post randomization data|1|||
161463121|NCT00920829|583091645|FG002|Allocation|No post randomization data|0|||
161463122|NCT00920829|583091646|FG003|Allocation|No post randomization data|2|||
161463123|NCT00920829|583091643|FG000|Available for Analysis|Withdrawal by Subject|6|||
161463124|NCT00920829|583091644|FG001|Available for Analysis|Withdrawal by Subject|6|||
161463125|NCT00920829|583091645|FG002|Available for Analysis|Withdrawal by Subject|6|||
161463126|NCT00920829|583091646|FG003|Available for Analysis|Withdrawal by Subject|10|||
161463127|NCT00920829|583091643|FG000|Available for Analysis|Required Medical Treatment|0|||
161463128|NCT00920829|583091644|FG001|Available for Analysis|Required Medical Treatment|1|||
161463129|NCT00920829|583091645|FG002|Available for Analysis|Required Medical Treatment|2|||
161463130|NCT00920829|583091646|FG003|Available for Analysis|Required Medical Treatment|0|||
161463131|NCT00920829|583091643|FG000|Available for Analysis|Adverse Event|1|||
161463132|NCT00920829|583091644|FG001|Available for Analysis|Adverse Event|2|||
161463133|NCT00920829|583091645|FG002|Available for Analysis|Adverse Event|1|||
161463134|NCT00920829|583091646|FG003|Available for Analysis|Adverse Event|0|||
161463135|NCT00920829|583091643|FG000|Available for Analysis|Death|1|||
161463136|NCT00920829|583091644|FG001|Available for Analysis|Death|0|||
161463137|NCT00920829|583091645|FG002|Available for Analysis|Death|0|||
161463138|NCT00920829|583091646|FG003|Available for Analysis|Death|0|||
161463139|NCT00920829|583091643|FG000|Available for Analysis|Protocol Violation|0|||
161463140|NCT00920829|583091644|FG001|Available for Analysis|Protocol Violation|0|||
161463141|NCT00920829|583091645|FG002|Available for Analysis|Protocol Violation|1|||
161463142|NCT00920829|583091646|FG003|Available for Analysis|Protocol Violation|0|||
161463143|NCT00920829|583091643|FG000|Available for Analysis|Required more treatment|0|||
161463144|NCT00920829|583091644|FG001|Available for Analysis|Required more treatment|2|||
161463145|NCT00920829|583091645|FG002|Available for Analysis|Required more treatment|0|||
161463146|NCT00920829|583091646|FG003|Available for Analysis|Required more treatment|1|||
161463147|NCT03875118|583091647|FG000|Overall Study|Withdrawal by Subject|4|||
161463148|NCT03875118|583091648|FG001|Overall Study|Withdrawal by Subject|4|||
161463149|NCT02237911|583091649|FG000|Overall Study|Withdrawal by Subject|4|||
161463150|NCT02237911|583091650|FG001|Overall Study|Withdrawal by Subject|7|||
161463151|NCT02237911|583091651|FG002|Overall Study|Withdrawal by Subject|2|||
161463152|NCT02237911|583091649|FG000|Overall Study|Lost to Follow-up|3|||
161572866|NCT00823979|583482062|FG001|Overall Study|Other|0|||
161572867|NCT00823979|583482063|FG002|Overall Study|Other|1|||
161463153|NCT02237911|583091650|FG001|Overall Study|Lost to Follow-up|1|||
161463154|NCT02237911|583091651|FG002|Overall Study|Lost to Follow-up|1|||
161463155|NCT00721123|583091652|FG000|Overall Study|Adverse Event|96|||
161463156|NCT00721123|583091652|FG000|Overall Study|Death|10|||
161463157|NCT00721123|583091652|FG000|Overall Study|Insufficient Therapeutic Response|21|||
161463158|NCT00721123|583091652|FG000|Overall Study|Protocol Violation|1|||
161463159|NCT00721123|583091652|FG000|Overall Study|Refused Treatment|41|||
161463160|NCT00721123|583091652|FG000|Overall Study|Failure to Return|9|||
161463161|NCT00721123|583091652|FG000|Overall Study|Withdrawal by Subject|5|||
161463162|NCT00397943|583091653|FG000|Overall Study|Unspecified reasons|12|||
161463163|NCT00397943|583091654|FG001|Overall Study|Unspecified reasons|9|||
161463164|NCT00397943|583091655|FG002|Overall Study|Unspecified reasons|0|||
161572868|NCT00823979|583482061|FG000|Overall Study|Randomized but not Treated|4|||
161463165|NCT00397943|583091656|FG003|Overall Study|Unspecified reasons|0|||
161463166|NCT00397943|583091657|FG004|Overall Study|Unspecified reasons|0|||
161463167|NCT05007717|583091658|FG000|Overall Study|Death|3|||
161463168|NCT05007717|583091659|FG001|Overall Study|Death|2|||
161463169|NCT00423670|583091663|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
161463170|NCT00423670|583091664|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463171|NCT00423670|583091665|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463172|NCT00423670|583091666|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463173|NCT00423670|583091667|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463174|NCT00423670|583091668|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463175|NCT00423670|583091669|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463176|NCT00423670|583091670|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
161463177|NCT00423670|583091663|FG000|Treatment Period|Adverse Event|8|||
161463178|NCT00423670|583091664|FG001|Treatment Period|Adverse Event|12|||
161463179|NCT00423670|583091665|FG002|Treatment Period|Adverse Event|15|||
161463180|NCT00423670|583091666|FG003|Treatment Period|Adverse Event|20|||
161463181|NCT00423670|583091667|FG004|Treatment Period|Adverse Event|9|||
161463182|NCT00423670|583091668|FG005|Treatment Period|Adverse Event|4|||
161463183|NCT00423670|583091669|FG006|Treatment Period|Adverse Event|7|||
161463184|NCT00423670|583091670|FG007|Treatment Period|Adverse Event|2|||
161463185|NCT00423670|583091663|FG000|Treatment Period|Protocol-defined clinical event|0|||
161463186|NCT00423670|583091664|FG001|Treatment Period|Protocol-defined clinical event|7|||
161463187|NCT00423670|583091665|FG002|Treatment Period|Protocol-defined clinical event|4|||
161463188|NCT00423670|583091666|FG003|Treatment Period|Protocol-defined clinical event|12|||
161463189|NCT00423670|583091667|FG004|Treatment Period|Protocol-defined clinical event|5|||
161463190|NCT00423670|583091668|FG005|Treatment Period|Protocol-defined clinical event|4|||
161463191|NCT00423670|583091669|FG006|Treatment Period|Protocol-defined clinical event|16|||
161463192|NCT00423670|583091670|FG007|Treatment Period|Protocol-defined clinical event|15|||
161463193|NCT00423670|583091663|FG000|Treatment Period|Lost to Follow-up|2|||
161463194|NCT00423670|583091664|FG001|Treatment Period|Lost to Follow-up|1|||
161463195|NCT00423670|583091665|FG002|Treatment Period|Lost to Follow-up|3|||
161463196|NCT00423670|583091666|FG003|Treatment Period|Lost to Follow-up|1|||
161463197|NCT00423670|583091667|FG004|Treatment Period|Lost to Follow-up|6|||
161463198|NCT00423670|583091668|FG005|Treatment Period|Lost to Follow-up|0|||
161463199|NCT00423670|583091669|FG006|Treatment Period|Lost to Follow-up|3|||
161463200|NCT00423670|583091670|FG007|Treatment Period|Lost to Follow-up|1|||
161463201|NCT00423670|583091663|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
161463202|NCT00423670|583091664|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
161463203|NCT00423670|583091665|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
161463204|NCT00423670|583091666|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
161463205|NCT00423670|583091667|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
161463206|NCT00423670|583091668|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
161463207|NCT00423670|583091669|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
161463208|NCT00423670|583091670|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
161463209|NCT00423670|583091663|FG000|Treatment Period|Investigator decision|0|||
161463210|NCT00423670|583091664|FG001|Treatment Period|Investigator decision|0|||
161463211|NCT00423670|583091665|FG002|Treatment Period|Investigator decision|0|||
161463212|NCT00423670|583091666|FG003|Treatment Period|Investigator decision|0|||
161463213|NCT00423670|583091667|FG004|Treatment Period|Investigator decision|0|||
161463214|NCT00423670|583091668|FG005|Treatment Period|Investigator decision|0|||
161463215|NCT00423670|583091669|FG006|Treatment Period|Investigator decision|0|||
161463216|NCT00423670|583091670|FG007|Treatment Period|Investigator decision|1|||
161463217|NCT00423670|583091663|FG000|Treatment Period|Non-compliance with protocol|3|||
161463218|NCT00423670|583091664|FG001|Treatment Period|Non-compliance with protocol|1|||
161463219|NCT00423670|583091665|FG002|Treatment Period|Non-compliance with protocol|1|||
161463220|NCT00423670|583091666|FG003|Treatment Period|Non-compliance with protocol|3|||
161463221|NCT00423670|583091667|FG004|Treatment Period|Non-compliance with protocol|2|||
161572869|NCT00823979|583482062|FG001|Overall Study|Randomized but not Treated|3|||
161572870|NCT00823979|583482063|FG002|Overall Study|Randomized but not Treated|1|||
161572871|NCT00823979|583482061|FG000|Overall Study|Study Terminated by Sponsor|5|||
161463222|NCT00423670|583091668|FG005|Treatment Period|Non-compliance with protocol|0|||
161463223|NCT00423670|583091669|FG006|Treatment Period|Non-compliance with protocol|2|||
161463224|NCT00423670|583091670|FG007|Treatment Period|Non-compliance with protocol|2|||
161463225|NCT00423670|583091663|FG000|Follow-up Period|Lost to Follow-up|0|||
161463226|NCT00423670|583091664|FG001|Follow-up Period|Lost to Follow-up|12|||
161572872|NCT00823979|583482062|FG001|Overall Study|Study Terminated by Sponsor|5|||
161463227|NCT00423670|583091665|FG002|Follow-up Period|Lost to Follow-up|8|||
161463228|NCT00423670|583091666|FG003|Follow-up Period|Lost to Follow-up|3|||
161463229|NCT00423670|583091667|FG004|Follow-up Period|Lost to Follow-up|1|||
161463230|NCT00423670|583091668|FG005|Follow-up Period|Lost to Follow-up|0|||
161463231|NCT00423670|583091669|FG006|Follow-up Period|Lost to Follow-up|5|||
161463232|NCT00423670|583091670|FG007|Follow-up Period|Lost to Follow-up|0|||
161572873|NCT00823979|583482063|FG002|Overall Study|Study Terminated by Sponsor|7|||
161463233|NCT00423670|583091663|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
161463234|NCT00423670|583091664|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
161463235|NCT00423670|583091665|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
161463236|NCT00423670|583091666|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
161463237|NCT00423670|583091667|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
161463238|NCT00423670|583091668|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
161463239|NCT00423670|583091669|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
161463240|NCT00423670|583091670|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
161463241|NCT00423670|583091663|FG000|Follow-up Period|Non-compliance with protocol|2|||
161463242|NCT00423670|583091664|FG001|Follow-up Period|Non-compliance with protocol|0|||
161463243|NCT00423670|583091665|FG002|Follow-up Period|Non-compliance with protocol|1|||
161463244|NCT00423670|583091666|FG003|Follow-up Period|Non-compliance with protocol|1|||
161463245|NCT00423670|583091667|FG004|Follow-up Period|Non-compliance with protocol|0|||
161463246|NCT00423670|583091668|FG005|Follow-up Period|Non-compliance with protocol|0|||
161463247|NCT00423670|583091669|FG006|Follow-up Period|Non-compliance with protocol|3|||
161463248|NCT00423670|583091670|FG007|Follow-up Period|Non-compliance with protocol|2|||
161463249|NCT02131532|583091671|FG000|Overall Study|Withdrawal by Subject|1|||
161463250|NCT02131532|583091671|FG000|Overall Study|Physician Decision|1|||
161463251|NCT02131532|583091671|FG000|Overall Study|Other health conditions|2|||
161463252|NCT01241240|583091672|FG000|Overall Study|Adverse Event|5|||
161463253|NCT01241240|583091673|FG001|Overall Study|Adverse Event|4|||
161463254|NCT01241240|583091672|FG000|Overall Study|Lost to Follow-up|2|||
161463255|NCT01241240|583091673|FG001|Overall Study|Lost to Follow-up|4|||
161463256|NCT01241240|583091672|FG000|Overall Study|Personal Reasons|1|||
161463257|NCT01241240|583091673|FG001|Overall Study|Personal Reasons|1|||
161463258|NCT02376829|583091674|FG000|Overall Study|Withdrawal by Subject|27|||
161463259|NCT02376829|583091675|FG001|Overall Study|Withdrawal by Subject|44|||
161463260|NCT03583073|583091676|FG000|Overall Study|Lost to Follow-up|8|||
161463261|NCT03583073|583091677|FG001|Overall Study|Lost to Follow-up|12|||
161463262|NCT02632838|583091678|FG000|Overall Study|Withdrawal by Subject|3|||
161463263|NCT02632838|583091679|FG001|Overall Study|Withdrawal by Subject|0|||
161463264|NCT02632838|583091678|FG000|Overall Study|Lost to Follow-up|0|||
161463265|NCT02632838|583091679|FG001|Overall Study|Lost to Follow-up|2|||
161463266|NCT01343901|583091680|FG000|Overall Study|Death|85|||
161463267|NCT01343901|583091680|FG000|Overall Study|Physician Decision|4|||
161463268|NCT01343901|583091680|FG000|Overall Study|Lost to Follow-up|12|||
161463269|NCT01343901|583091680|FG000|Overall Study|Management by another medical team|11|||
161463270|NCT01343901|583091680|FG000|Overall Study|Participant decision|1|||
161463271|NCT03945175|583091681|FG000|Overall Study|Did not meet inclusion criteria|31|||
161463272|NCT03945175|583091681|FG000|Overall Study|Withdrew consent|2|||
161463273|NCT03945175|583091681|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
161463274|NCT03945175|583091681|FG000|Overall Study|Early termination during Mydayis treatment|1|||
161463275|NCT00870233|583091682|FG000|Overall Study|Withdrawal by Subject|18|||
161463276|NCT00870233|583091682|FG000|Overall Study|Did not undergo laparotomy|3|||
161463277|NCT00870233|583091682|FG000|Overall Study|Incompatible internet browser|2|||
161463278|NCT00870233|583091682|FG000|Overall Study|Death|1|||
161463279|NCT01369485|583091683|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
161463280|NCT01369485|583091684|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
161463281|NCT01369485|583091683|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
161463282|NCT01369485|583091684|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
161463283|NCT01369485|583091683|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
161463284|NCT01369485|583091684|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
161463285|NCT01369485|583091683|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
161463286|NCT01369485|583091684|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
161463287|NCT01369485|583091683|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
161463288|NCT01369485|583091684|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
161463289|NCT01369485|583091683|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
161463290|NCT01369485|583091684|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
161463291|NCT01369485|583091683|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
161463292|NCT01369485|583091684|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
161463293|NCT01369485|583091683|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
161463294|NCT01369485|583091684|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
161463295|NCT01369485|583091683|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
161463296|NCT01369485|583091684|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
161463297|NCT01369485|583091683|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
161463298|NCT01369485|583091684|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
161463299|NCT02942576|583091690|FG000|Overall Study|Adverse Event|28|||
161463300|NCT02942576|583091691|FG001|Overall Study|Adverse Event|6|||
161463301|NCT02942576|583091690|FG000|Overall Study|Withdrawal by Subject|7|||
161463302|NCT02942576|583091691|FG001|Overall Study|Withdrawal by Subject|5|||
161463303|NCT02942576|583091690|FG000|Overall Study|Physician Decision|1|||
161463304|NCT02942576|583091691|FG001|Overall Study|Physician Decision|4|||
161463305|NCT02942576|583091690|FG000|Overall Study|Other|10|||
161463306|NCT02942576|583091691|FG001|Overall Study|Other|8|||
161463307|NCT00769483|583091692|FG000|Overall Study|Withdrawal by Subject|0|||
161463308|NCT00769483|583091693|FG001|Overall Study|Withdrawal by Subject|1|||
161463309|NCT00769483|583091694|FG002|Overall Study|Withdrawal by Subject|0|||
161463310|NCT00769483|583091695|FG003|Overall Study|Withdrawal by Subject|0|||
161463311|NCT00769483|583091696|FG004|Overall Study|Withdrawal by Subject|1|||
161463312|NCT00769483|583091697|FG005|Overall Study|Withdrawal by Subject|0|||
161463313|NCT01306877|583091698|FG000|Overall Study|Lost to Follow-up|3|||
161463314|NCT01306877|583091699|FG001|Overall Study|Lost to Follow-up|3|||
161463315|NCT01306877|583091698|FG000|Overall Study|Physician Decision|0|||
161463316|NCT01306877|583091699|FG001|Overall Study|Physician Decision|1|||
161463317|NCT00006389|583091700|FG000|Overall Study|Adverse Event|1|||
161463318|NCT01285960|583091708|FG000|Overall Study|Withdrawal by Subject|2|||
161463319|NCT01285960|583091708|FG000|Overall Study|Lost to Follow-up|2|||
161463320|NCT01285960|583091708|FG000|Overall Study|2 subjects received less 10 sonications|2|||
161463321|NCT01309308|583091709|FG000|Overall Study|Lost to Follow-up|6|||
161463322|NCT01309308|583091710|FG001|Overall Study|Lost to Follow-up|4|||
161463323|NCT01017575|583091711|FG000|Overall Study|Lack of Efficacy|0|||
161463324|NCT01017575|583091712|FG001|Overall Study|Lack of Efficacy|1|||
161463325|NCT01017575|583091713|FG002|Overall Study|Lack of Efficacy|0|||
161463326|NCT01017575|583091714|FG003|Overall Study|Lack of Efficacy|1|||
161463327|NCT01017575|583091715|FG004|Overall Study|Lack of Efficacy|1|||
161463328|NCT01017575|583091711|FG000|Overall Study|Adverse Event|0|||
161463329|NCT01017575|583091712|FG001|Overall Study|Adverse Event|1|||
161463330|NCT01017575|583091713|FG002|Overall Study|Adverse Event|0|||
161463331|NCT01017575|583091714|FG003|Overall Study|Adverse Event|0|||
161463332|NCT01017575|583091715|FG004|Overall Study|Adverse Event|2|||
161463333|NCT01017575|583091711|FG000|Overall Study|Withdrawal by Subject|1|||
161463334|NCT01017575|583091712|FG001|Overall Study|Withdrawal by Subject|0|||
161463335|NCT01017575|583091713|FG002|Overall Study|Withdrawal by Subject|0|||
161463336|NCT01017575|583091714|FG003|Overall Study|Withdrawal by Subject|0|||
161463337|NCT01017575|583091715|FG004|Overall Study|Withdrawal by Subject|0|||
161463338|NCT00976573|583091722|FG000|Overall Study|Ineligible|0|||
161463339|NCT00976573|583091723|FG001|Overall Study|Ineligible|1|||
161463340|NCT00976573|583091722|FG000|Overall Study|Cancel prior to receiving treatment|4|||
161463341|NCT00976573|583091723|FG001|Overall Study|Cancel prior to receiving treatment|2|||
161463342|NCT02730208|583091724|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161463343|NCT02730208|583091725|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
161572874|NCT03523091|583482064|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
161572875|NCT03523091|583482065|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
161572876|NCT03523091|583482064|FG000|Overall Study|Withdrawal by Subject|0|||
161463344|NCT00995865|583091730|FG000|Overall Study|Protocol Violation|2|||
161463345|NCT00995865|583091731|FG001|Overall Study|Protocol Violation|0|||
161463346|NCT00995865|583091732|FG002|Overall Study|Protocol Violation|0|||
161572877|NCT03523091|583482065|FG001|Overall Study|Withdrawal by Subject|3|||
161572878|NCT03523091|583482064|FG000|Overall Study|Increase Botox dose|0|||
161572879|NCT03523091|583482065|FG001|Overall Study|Increase Botox dose|1|||
161572880|NCT01093534|583482066|FG000|Overall Study|Adverse Event|2|||
161572881|NCT01093534|583482067|FG001|Overall Study|Adverse Event|5|||
161572882|NCT01093534|583482068|FG002|Overall Study|Adverse Event|2|||
161572883|NCT01093534|583482066|FG000|Overall Study|Lack of Efficacy|2|||
161572884|NCT01093534|583482067|FG001|Overall Study|Lack of Efficacy|1|||
161572885|NCT01093534|583482068|FG002|Overall Study|Lack of Efficacy|1|||
161572886|NCT01093534|583482066|FG000|Overall Study|Withdrawal by Subject|5|||
161572887|NCT01093534|583482067|FG001|Overall Study|Withdrawal by Subject|7|||
161572888|NCT01093534|583482068|FG002|Overall Study|Withdrawal by Subject|2|||
161572889|NCT01093534|583482066|FG000|Overall Study|Other|1|||
161572890|NCT01093534|583482067|FG001|Overall Study|Other|3|||
161572891|NCT01093534|583482068|FG002|Overall Study|Other|4|||
161914167|NCT01648764|584735514|FG007|Overall Study|Withdrawal by Subject|0|||
161914168|NCT01648764|584735515|FG008|Overall Study|Withdrawal by Subject|0|||
161914169|NCT01648764|584735516|FG009|Overall Study|Withdrawal by Subject|0|||
161463347|NCT00995865|583091730|FG000|Overall Study|Lost to Follow-up|0|||
161463348|NCT00995865|583091731|FG001|Overall Study|Lost to Follow-up|0|||
161463349|NCT00995865|583091732|FG002|Overall Study|Lost to Follow-up|1|||
161463350|NCT02021656|583091738|FG000|Overall Study|Adverse Event|1|||
161463351|NCT02021656|583091738|FG000|Overall Study|Lack of Efficacy|2|||
161463352|NCT02021656|583091738|FG000|Overall Study|Lost to Follow-up|1|||
161463353|NCT02021656|583091738|FG000|Overall Study|Withdrew Consent|2|||
161463354|NCT00510952|583091741|FG000|Overall Study|Adverse Event|1|||
161463355|NCT00510952|583091742|FG001|Overall Study|Adverse Event|0|||
161463356|NCT00510952|583091741|FG000|Overall Study|Entry Criteria Not Met|3|||
161572892|NCT00741988|583482069|FG000|Overall Study|Adverse Event|2|||
161572893|NCT00741988|583482070|FG001|Overall Study|Adverse Event|4|||
161572894|NCT00741988|583482069|FG000|Overall Study|Lack of Efficacy|2|||
161572895|NCT00741988|583482070|FG001|Overall Study|Lack of Efficacy|0|||
161810049|NCT01796171|584347693|FG013|Follow-up Period|Physician Decision|0|||
161810050|NCT01796171|584347694|FG014|Follow-up Period|Physician Decision|0|||
161810051|NCT01796171|584347680|FG000|Follow-up Period|Withdrawal by Subject|0|||
161810052|NCT01796171|584347681|FG001|Follow-up Period|Withdrawal by Subject|1|||
161810053|NCT01796171|584347682|FG002|Follow-up Period|Withdrawal by Subject|0|||
161810054|NCT01796171|584347683|FG003|Follow-up Period|Withdrawal by Subject|0|||
161810055|NCT01796171|584347684|FG004|Follow-up Period|Withdrawal by Subject|0|||
161810056|NCT01796171|584347685|FG005|Follow-up Period|Withdrawal by Subject|1|||
161810057|NCT01796171|584347686|FG006|Follow-up Period|Withdrawal by Subject|0|||
161810058|NCT01796171|584347687|FG007|Follow-up Period|Withdrawal by Subject|0|||
161810059|NCT01796171|584347688|FG008|Follow-up Period|Withdrawal by Subject|0|||
161810060|NCT01796171|584347689|FG009|Follow-up Period|Withdrawal by Subject|0|||
161810061|NCT01796171|584347690|FG010|Follow-up Period|Withdrawal by Subject|3|||
161810062|NCT01796171|584347691|FG011|Follow-up Period|Withdrawal by Subject|1|||
161810063|NCT01796171|584347692|FG012|Follow-up Period|Withdrawal by Subject|0|||
161810064|NCT01796171|584347693|FG013|Follow-up Period|Withdrawal by Subject|0|||
161810065|NCT01796171|584347694|FG014|Follow-up Period|Withdrawal by Subject|0|||
161914170|NCT01648764|584735517|FG010|Overall Study|Withdrawal by Subject|0|||
161914171|NCT01648764|584735518|FG011|Overall Study|Withdrawal by Subject|0|||
161914172|NCT01648764|584735519|FG012|Overall Study|Withdrawal by Subject|1|||
161914173|NCT01648764|584735520|FG013|Overall Study|Withdrawal by Subject|0|||
161810066|NCT01796171|584347680|FG000|Follow-up Period|Death|0|||
161810067|NCT01796171|584347681|FG001|Follow-up Period|Death|0|||
161810068|NCT01796171|584347682|FG002|Follow-up Period|Death|0|||
161810069|NCT01796171|584347683|FG003|Follow-up Period|Death|0|||
161810070|NCT01796171|584347684|FG004|Follow-up Period|Death|0|||
161914174|NCT01648764|584735507|FG000|Overall Study|Investigator Decision|0|||
161914175|NCT01648764|584735508|FG001|Overall Study|Investigator Decision|0|||
161914176|NCT01648764|584735509|FG002|Overall Study|Investigator Decision|0|||
161914177|NCT01648764|584735510|FG003|Overall Study|Investigator Decision|0|||
161914178|NCT01648764|584735511|FG004|Overall Study|Investigator Decision|0|||
161914179|NCT01648764|584735512|FG005|Overall Study|Investigator Decision|0|||
161914180|NCT01648764|584735513|FG006|Overall Study|Investigator Decision|1|||
161914181|NCT01648764|584735514|FG007|Overall Study|Investigator Decision|0|||
161914182|NCT01648764|584735515|FG008|Overall Study|Investigator Decision|0|||
161914183|NCT01648764|584735516|FG009|Overall Study|Investigator Decision|0|||
161914184|NCT01648764|584735517|FG010|Overall Study|Investigator Decision|0|||
161914185|NCT01648764|584735518|FG011|Overall Study|Investigator Decision|1|||
161914186|NCT01648764|584735519|FG012|Overall Study|Investigator Decision|0|||
161914187|NCT01648764|584735520|FG013|Overall Study|Investigator Decision|0|||
161914188|NCT03801252|584735521|FG000|Overall Study|Protocol Violation|1|||
161914189|NCT03801252|584735522|FG001|Overall Study|Protocol Violation|2|||
161914190|NCT01732692|584735526|FG000|Overall Study|Adverse Event|0|||
161914191|NCT01732692|584735527|FG001|Overall Study|Adverse Event|1|||
161914192|NCT01027949|584735528|FG000|Overall Study|Death|174|||
161914193|NCT01027949|584735528|FG000|Overall Study|Progressive Disease|163|||
161914194|NCT01027949|584735528|FG000|Overall Study|Adverse Event|172|||
161914195|NCT01027949|584735528|FG000|Overall Study|Withdrawal by Subject|113|||
161914196|NCT01027949|584735528|FG000|Overall Study|Lost to Follow-up|17|||
161914197|NCT01027949|584735528|FG000|Overall Study|Protocol Violation|13|||
161914198|NCT01027949|584735528|FG000|Overall Study|PI Decision|8|||
161914199|NCT01027949|584735528|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
161914200|NCT01027949|584735528|FG000|Overall Study|Non-compliance with Study Procedures|7|||
161914201|NCT01027949|584735528|FG000|Overall Study|Lung Transplant|5|||
161914202|NCT01027949|584735528|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
161914203|NCT01027949|584735528|FG000|Overall Study|Use of Excluded Medication|2|||
161914204|NCT01027949|584735528|FG000|Overall Study|Patient Self-discontinuation|1|||
161914205|NCT01027949|584735528|FG000|Overall Study|Pregnancy|1|||
161914206|NCT01027949|584735528|FG000|Overall Study|Surgery|1|||
161914207|NCT00656617|584735529|FG000|Overall Study|Adverse Event|1|||
161914208|NCT00656617|584735529|FG000|Overall Study|Death|2|||
161914209|NCT00656617|584735529|FG000|Overall Study|Insurance Issues|2|||
161914210|NCT00656617|584735529|FG000|Overall Study|Move to different clinical trial|2|||
161810071|NCT01796171|584347685|FG005|Follow-up Period|Death|0|||
161810072|NCT01796171|584347686|FG006|Follow-up Period|Death|1|||
161810073|NCT01796171|584347687|FG007|Follow-up Period|Death|0|||
161810074|NCT01796171|584347688|FG008|Follow-up Period|Death|0|||
161810075|NCT01796171|584347689|FG009|Follow-up Period|Death|0|||
161810076|NCT01796171|584347690|FG010|Follow-up Period|Death|17|||
161810077|NCT01796171|584347691|FG011|Follow-up Period|Death|9|||
161810078|NCT01796171|584347692|FG012|Follow-up Period|Death|1|||
161810079|NCT01796171|584347693|FG013|Follow-up Period|Death|0|||
161810080|NCT01796171|584347694|FG014|Follow-up Period|Death|0|||
161914211|NCT02030600|584735532|FG000|Treatment Period 1|Adverse Event|5|||
161914212|NCT02030600|584735533|FG001|Treatment Period 1|Adverse Event|7|||
161914213|NCT02030600|584735532|FG000|Treatment Period 1|Lack of Efficacy|0|||
161914214|NCT02030600|584735533|FG001|Treatment Period 1|Lack of Efficacy|1|||
161810081|NCT01796171|584347680|FG000|Follow-up Period|Patient transferred to other hospital|0|||
161463357|NCT00510952|583091742|FG001|Overall Study|Entry Criteria Not Met|1|||
161463358|NCT00510952|583091741|FG000|Overall Study|Lost to Follow-up|5|||
161463359|NCT00510952|583091742|FG001|Overall Study|Lost to Follow-up|3|||
161463360|NCT00510952|583091741|FG000|Overall Study|Physician Decision|1|||
161463361|NCT00510952|583091742|FG001|Overall Study|Physician Decision|1|||
161463362|NCT00510952|583091741|FG000|Overall Study|Protocol Violation|7|||
161463363|NCT00510952|583091742|FG001|Overall Study|Protocol Violation|4|||
161463364|NCT00510952|583091741|FG000|Overall Study|Sponsor Decision|1|||
161463365|NCT00510952|583091742|FG001|Overall Study|Sponsor Decision|0|||
161463366|NCT00510952|583091741|FG000|Overall Study|Withdrawal by Subject|6|||
161463367|NCT00510952|583091742|FG001|Overall Study|Withdrawal by Subject|7|||
161463368|NCT00510952|583091741|FG000|Overall Study|Did Not Receive Study Drug|2|||
161463369|NCT00510952|583091742|FG001|Overall Study|Did Not Receive Study Drug|0|||
161463370|NCT00817479|583091749|FG000|Overall Study|Physician Decision|1|||
161463371|NCT00817479|583091750|FG001|Overall Study|Physician Decision|1|||
161463372|NCT05985980|583091753|FG000|Overall Study|Withdrawal by Subject|1|||
161463373|NCT05985980|583091753|FG000|Overall Study|Withdrawal by Subject|1|||
161463374|NCT05985980|583091753|FG000|Overall Study|Withdrawal by Subject|1|||
161463375|NCT05985980|583091753|FG000|Overall Study|Withdrawal by Subject|1|||
161463376|NCT02359851|583091757|FG000|Overall Study|Death|1|||
161914215|NCT02030600|584735532|FG000|Treatment Period 1|Lost to Follow-up|11|||
161914216|NCT02030600|584735533|FG001|Treatment Period 1|Lost to Follow-up|3|||
161914217|NCT02030600|584735532|FG000|Treatment Period 1|Protocol Violation|22|||
161914218|NCT02030600|584735533|FG001|Treatment Period 1|Protocol Violation|17|||
161914219|NCT02030600|584735532|FG000|Treatment Period 1|Withdrawal by Subject|13|||
161914220|NCT02030600|584735533|FG001|Treatment Period 1|Withdrawal by Subject|17|||
161914221|NCT02030600|584735532|FG000|Treatment Period 1|Casebook Unsigned|1|||
161914222|NCT02030600|584735533|FG001|Treatment Period 1|Casebook Unsigned|0|||
161914223|NCT02030600|584735532|FG000|Treatment Period 1|Unclassified|1|||
161914224|NCT02030600|584735533|FG001|Treatment Period 1|Unclassified|0|||
161914225|NCT02030600|584735532|FG000|Treatment Period 2|Adverse Event|4|||
161914226|NCT02030600|584735533|FG001|Treatment Period 2|Adverse Event|4|||
161914227|NCT02030600|584735532|FG000|Treatment Period 2|Lack of Efficacy|2|||
161914228|NCT02030600|584735533|FG001|Treatment Period 2|Lack of Efficacy|1|||
161914229|NCT02030600|584735532|FG000|Treatment Period 2|Lost to Follow-up|4|||
161914230|NCT02030600|584735533|FG001|Treatment Period 2|Lost to Follow-up|2|||
161914231|NCT02030600|584735532|FG000|Treatment Period 2|Protocol Violation|1|||
161914232|NCT02030600|584735533|FG001|Treatment Period 2|Protocol Violation|2|||
161914233|NCT02030600|584735532|FG000|Treatment Period 2|Withdrawal by Subject|13|||
161914234|NCT02030600|584735533|FG001|Treatment Period 2|Withdrawal by Subject|9|||
161914235|NCT02030600|584735532|FG000|Treatment Period 2|Unclassified|1|||
161914236|NCT02030600|584735533|FG001|Treatment Period 2|Unclassified|0|||
161914237|NCT01155323|584735540|FG000|First Intervention|exclusion criteria|1|||
161914238|NCT01155323|584735541|FG001|First Intervention|exclusion criteria|1|||
161914239|NCT01155323|584735540|FG000|Second Intervention|Lost to Follow-up|1|||
161914240|NCT01155323|584735541|FG001|Second Intervention|Lost to Follow-up|1|||
161914241|NCT01208051|584735544|FG000|Total Enrollment|Withdrawal by Subject|0|||
161914242|NCT01208051|584735545|FG001|Total Enrollment|Withdrawal by Subject|1|||
161914243|NCT01208051|584735546|FG002|Total Enrollment|Withdrawal by Subject|0|||
161914244|NCT01208051|584735547|FG003|Total Enrollment|Withdrawal by Subject|0|||
161914245|NCT01208051|584735548|FG004|Total Enrollment|Withdrawal by Subject|2|||
161914246|NCT01208051|584735544|FG000|Total Enrollment|Brain metastases|0|||
161914247|NCT01208051|584735545|FG001|Total Enrollment|Brain metastases|0|||
161914248|NCT01208051|584735546|FG002|Total Enrollment|Brain metastases|1|||
161463377|NCT02359851|583091757|FG000|Overall Study|Disease progression|1|||
161463378|NCT00055471|583091758|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
161572896|NCT03863834|583482080|FG000|Overall Study|Lost to Follow-up|3|||
161572897|NCT02685488|583482081|FG000|Overall Study|Withdrawal by Subject|0|||
161914249|NCT01208051|584735547|FG003|Total Enrollment|Brain metastases|0|||
161914250|NCT01208051|584735548|FG004|Total Enrollment|Brain metastases|0|||
161914251|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
161914252|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
161914253|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
161914254|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
161914255|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
161914256|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
161914257|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
161914258|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
161914259|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161914260|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161914261|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
161914262|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161463379|NCT00055471|583091759|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
161463380|NCT00055471|583091760|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
161463381|NCT00055471|583091758|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
161463382|NCT00055471|583091759|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
161463383|NCT00055471|583091760|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
161463384|NCT00055471|583091758|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
161463385|NCT00055471|583091759|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
161463386|NCT00055471|583091760|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
161463387|NCT01854944|583091761|FG000|Overall Study|Withdrawal by Subject|0|||
161463388|NCT01854944|583091762|FG001|Overall Study|Withdrawal by Subject|0|||
161463389|NCT01854944|583091763|FG002|Overall Study|Withdrawal by Subject|1|||
161463390|NCT00282347|583091766|FG000|Treatment Period|Death|2|||
161463391|NCT00282347|583091767|FG001|Treatment Period|Death|0|||
161463392|NCT00282347|583091766|FG000|Treatment Period|Lost to Follow-up|2|||
161463393|NCT00282347|583091767|FG001|Treatment Period|Lost to Follow-up|5|||
161463394|NCT00282347|583091766|FG000|Treatment Period|Withdrawal by Subject|1|||
161463395|NCT00282347|583091767|FG001|Treatment Period|Withdrawal by Subject|3|||
161463396|NCT00282347|583091766|FG000|Treatment Period|Physician Decision|0|||
161463397|NCT00282347|583091767|FG001|Treatment Period|Physician Decision|1|||
161463398|NCT00282347|583091766|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
161463399|NCT00282347|583091767|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
161463400|NCT00282347|583091766|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
161810082|NCT01796171|584347681|FG001|Follow-up Period|Patient transferred to other hospital|1|||
161463401|NCT00282347|583091767|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
161463402|NCT00282347|583091766|FG000|Safety Follow-up Period|Physician Decision|1|||
161810083|NCT01796171|584347682|FG002|Follow-up Period|Patient transferred to other hospital|0|||
161810084|NCT01796171|584347683|FG003|Follow-up Period|Patient transferred to other hospital|0|||
161810085|NCT01796171|584347684|FG004|Follow-up Period|Patient transferred to other hospital|0|||
161810086|NCT01796171|584347685|FG005|Follow-up Period|Patient transferred to other hospital|0|||
161810087|NCT01796171|584347686|FG006|Follow-up Period|Patient transferred to other hospital|0|||
161810088|NCT01796171|584347687|FG007|Follow-up Period|Patient transferred to other hospital|0|||
161810089|NCT01796171|584347688|FG008|Follow-up Period|Patient transferred to other hospital|0|||
161810090|NCT01796171|584347689|FG009|Follow-up Period|Patient transferred to other hospital|0|||
161810091|NCT01796171|584347690|FG010|Follow-up Period|Patient transferred to other hospital|0|||
161810092|NCT01796171|584347691|FG011|Follow-up Period|Patient transferred to other hospital|0|||
161810093|NCT01796171|584347692|FG012|Follow-up Period|Patient transferred to other hospital|0|||
161810094|NCT01796171|584347693|FG013|Follow-up Period|Patient transferred to other hospital|0|||
161810095|NCT01796171|584347694|FG014|Follow-up Period|Patient transferred to other hospital|0|||
161810096|NCT01796171|584347680|FG000|Follow-up Period|Sponsor Decision|0|||
161810097|NCT01796171|584347681|FG001|Follow-up Period|Sponsor Decision|0|||
161810098|NCT01796171|584347682|FG002|Follow-up Period|Sponsor Decision|0|||
161810099|NCT01796171|584347683|FG003|Follow-up Period|Sponsor Decision|0|||
161463403|NCT00282347|583091767|FG001|Safety Follow-up Period|Physician Decision|1|||
161463404|NCT00282347|583091766|FG000|Safety Follow-up Period|Protocol Deviation|0|||
161463405|NCT00282347|583091767|FG001|Safety Follow-up Period|Protocol Deviation|2|||
161463406|NCT00282347|583091766|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
161463407|NCT00282347|583091767|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
161463408|NCT00282347|583091766|FG000|B Cell Follow-up Period|Physician Decision|1|||
161463409|NCT00282347|583091767|FG001|B Cell Follow-up Period|Physician Decision|0|||
161463410|NCT00282347|583091766|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
161463411|NCT00282347|583091767|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
161463412|NCT02101112|583091768|FG000|Overall Study|Adverse Event|0|||
161463413|NCT02101112|583091769|FG001|Overall Study|Adverse Event|0|||
161463414|NCT02101112|583091770|FG002|Overall Study|Adverse Event|1|||
161463415|NCT02101112|583091771|FG003|Overall Study|Adverse Event|0|||
161463416|NCT02101112|583091772|FG004|Overall Study|Adverse Event|0|||
161463417|NCT02101112|583091773|FG005|Overall Study|Adverse Event|0|||
161463418|NCT02101112|583091768|FG000|Overall Study|Withdrawal by Subject|0|||
161463419|NCT02101112|583091769|FG001|Overall Study|Withdrawal by Subject|0|||
161463420|NCT02101112|583091770|FG002|Overall Study|Withdrawal by Subject|0|||
161463421|NCT02101112|583091771|FG003|Overall Study|Withdrawal by Subject|0|||
161463422|NCT02101112|583091772|FG004|Overall Study|Withdrawal by Subject|1|||
161463423|NCT02101112|583091773|FG005|Overall Study|Withdrawal by Subject|0|||
161463424|NCT04340063|583091774|FG000|Overall Study|Withdrawal by Subject|1|||
161463425|NCT04340063|583091775|FG001|Overall Study|Withdrawal by Subject|2|||
161463426|NCT04340063|583091774|FG000|Overall Study|Lost to Follow-up|3|||
161572898|NCT02685488|583482082|FG001|Overall Study|Withdrawal by Subject|1|||
161463427|NCT04340063|583091775|FG001|Overall Study|Lost to Follow-up|1|||
161463428|NCT04340063|583091774|FG000|Overall Study|Protocol Violation|0|||
161810100|NCT01796171|584347684|FG004|Follow-up Period|Sponsor Decision|0|||
161810101|NCT01796171|584347685|FG005|Follow-up Period|Sponsor Decision|0|||
161810102|NCT01796171|584347686|FG006|Follow-up Period|Sponsor Decision|0|||
161810103|NCT01796171|584347687|FG007|Follow-up Period|Sponsor Decision|0|||
161810104|NCT01796171|584347688|FG008|Follow-up Period|Sponsor Decision|0|||
161810105|NCT01796171|584347689|FG009|Follow-up Period|Sponsor Decision|0|||
161810106|NCT01796171|584347690|FG010|Follow-up Period|Sponsor Decision|40|||
161463429|NCT04340063|583091775|FG001|Overall Study|Protocol Violation|1|||
161463430|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
161463431|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
161463432|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
161463433|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
161463434|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
161463435|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
161463436|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
161463437|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
161463438|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
161463439|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
161463440|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
161463441|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
161463442|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
161463443|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
161914263|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161914264|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161914265|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
161914266|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161914267|NCT02349386|584735549|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
161914268|NCT02349386|584735550|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
161914269|NCT02349386|584735551|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
161914270|NCT02349386|584735552|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
161914271|NCT02349386|584735549|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161914272|NCT02349386|584735550|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161914273|NCT02349386|584735551|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
161914274|NCT02349386|584735552|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161914275|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
161914276|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
161914277|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
161914278|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
161914279|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
161914280|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
161914281|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
161914282|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
161914283|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
161914284|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
161914285|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
161914286|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
161914287|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
161914288|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
161914289|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
161914290|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
161914291|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
161914292|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
161914293|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
161914294|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
161914295|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
161914296|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
161914297|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
161914298|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
161914299|NCT02471339|584735555|FG000|Overall Study|Did not provide follow-up data|2|||
161914300|NCT02471339|584735556|FG001|Overall Study|Did not provide follow-up data|0|||
161914301|NCT06057064|584735557|FG000|Overall Study|Death|2|||
161914302|NCT06057064|584735558|FG001|Overall Study|Death|0|||
161463444|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
161914303|NCT06057064|584735557|FG000|Overall Study|Physician Decision|1|||
161914304|NCT06057064|584735558|FG001|Overall Study|Physician Decision|0|||
161914305|NCT06057064|584735557|FG000|Overall Study|Withdrawal by Subject|1|||
161914306|NCT06057064|584735558|FG001|Overall Study|Withdrawal by Subject|1|||
161463445|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
161463446|NCT00491556|583091776|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
161463447|NCT00491556|583091777|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
161463448|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
161463449|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
161463450|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
161463451|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
161463452|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
161463453|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
161463454|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
161463455|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
161463456|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
161463457|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
161463458|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
161463459|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
161463460|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
161463461|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
161463462|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
161463463|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
161463464|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
161463465|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
161463466|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
161463467|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
161463468|NCT00491556|583091776|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
161463469|NCT00491556|583091777|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
161463470|NCT02782923|583091778|FG000|Overall Study|Lost to Follow-up|15|||
161463471|NCT05063318|583091784|FG000|Overall Study|Progressive disease|2|||
161463472|NCT05063318|583091785|FG001|Overall Study|Progressive disease|0|||
161463473|NCT05063318|583091786|FG002|Overall Study|Progressive disease|3|||
161463474|NCT05063318|583091784|FG000|Overall Study|Compassionate use|1|||
161463475|NCT05063318|583091785|FG001|Overall Study|Compassionate use|3|||
161463476|NCT05063318|583091786|FG002|Overall Study|Compassionate use|3|||
161463477|NCT05063318|583091784|FG000|Overall Study|Adverse Event|0|||
161463478|NCT05063318|583091785|FG001|Overall Study|Adverse Event|1|||
161463479|NCT05063318|583091786|FG002|Overall Study|Adverse Event|0|||
161463480|NCT05063318|583091784|FG000|Overall Study|Withdrawal by Subject|0|||
161463481|NCT05063318|583091785|FG001|Overall Study|Withdrawal by Subject|1|||
161463482|NCT05063318|583091786|FG002|Overall Study|Withdrawal by Subject|0|||
161463483|NCT03287635|583091787|FG000|Overall Study|Lost to Follow-up|5|||
161463484|NCT03287635|583091787|FG000|Overall Study|Withdrawal by Subject|1|||
161572899|NCT04436120|583482083|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
161572900|NCT04436120|583482084|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
161572901|NCT04436120|583482085|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
161572902|NCT04436120|583482086|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
161810107|NCT01796171|584347691|FG011|Follow-up Period|Sponsor Decision|15|||
161810108|NCT01796171|584347692|FG012|Follow-up Period|Sponsor Decision|7|||
161810109|NCT01796171|584347693|FG013|Follow-up Period|Sponsor Decision|0|||
161810110|NCT01796171|584347694|FG014|Follow-up Period|Sponsor Decision|0|||
161810111|NCT00418561|584347695|FG000|Overall Study|Participant's (guardian's) decision|0|||
161810112|NCT00418561|584347696|FG001|Overall Study|Participant's (guardian's) decision|1|||
161810113|NCT00418561|584347697|FG002|Overall Study|Participant's (guardian's) decision|0|||
161810114|NCT00829309|584347698|FG000|Washout: 7 Days|Protocol Violation|1|||
161810115|NCT00829309|584347699|FG001|Washout: 7 Days|Protocol Violation|0|||
161810116|NCT01083693|584347700|FG000|Overall Study|Adverse Event|1|||
161810117|NCT01083693|584347701|FG001|Overall Study|Adverse Event|1|||
161810118|NCT01083693|584347702|FG002|Overall Study|Adverse Event|0|||
161810119|NCT01083693|584347700|FG000|Overall Study|Lost to Follow-up|2|||
161810120|NCT01083693|584347701|FG001|Overall Study|Lost to Follow-up|0|||
161810121|NCT01083693|584347702|FG002|Overall Study|Lost to Follow-up|2|||
161810122|NCT01083693|584347700|FG000|Overall Study|Lack of effectiveness|13|||
161810123|NCT01083693|584347701|FG001|Overall Study|Lack of effectiveness|2|||
161810124|NCT01083693|584347702|FG002|Overall Study|Lack of effectiveness|2|||
161810125|NCT01083693|584347700|FG000|Overall Study|Patient Moved|0|||
161810126|NCT01083693|584347701|FG001|Overall Study|Patient Moved|1|||
161810127|NCT01083693|584347702|FG002|Overall Study|Patient Moved|0|||
161810128|NCT01083693|584347700|FG000|Overall Study|Complete remission|0|||
161810129|NCT01083693|584347701|FG001|Overall Study|Complete remission|1|||
161810130|NCT01083693|584347702|FG002|Overall Study|Complete remission|0|||
161810131|NCT01083693|584347700|FG000|Overall Study|Other medical condition/surgery|1|||
161463485|NCT03287635|583091787|FG000|Overall Study|Physician Decision|1|||
161463486|NCT04090957|583091790|FG000|Overall Study|Lost to Follow-up|22|||
161463487|NCT04090957|583091791|FG001|Overall Study|Lost to Follow-up|25|||
161463488|NCT04090957|583091792|FG002|Overall Study|Lost to Follow-up|25|||
161810132|NCT01083693|584347701|FG001|Overall Study|Other medical condition/surgery|1|||
161463489|NCT04090957|583091793|FG003|Overall Study|Lost to Follow-up|36|||
161463490|NCT04090957|583091790|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
161463491|NCT04090957|583091791|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
161463492|NCT04090957|583091792|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
161463493|NCT04090957|583091793|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
161463494|NCT04090957|583091790|FG000|Overall Study|Adverse Event|19|||
161463495|NCT04090957|583091791|FG001|Overall Study|Adverse Event|25|||
161463496|NCT04090957|583091792|FG002|Overall Study|Adverse Event|8|||
161463497|NCT04090957|583091793|FG003|Overall Study|Adverse Event|104|||
161463498|NCT04090957|583091790|FG000|Overall Study|Other|10|||
161463499|NCT04090957|583091791|FG001|Overall Study|Other|6|||
161463500|NCT04090957|583091792|FG002|Overall Study|Other|5|||
161463501|NCT04090957|583091793|FG003|Overall Study|Other|12|||
161463502|NCT04090957|583091790|FG000|Overall Study|Serious Adverse Event|7|||
161463503|NCT04090957|583091791|FG001|Overall Study|Serious Adverse Event|11|||
161463504|NCT04090957|583091792|FG002|Overall Study|Serious Adverse Event|1|||
161463505|NCT04090957|583091793|FG003|Overall Study|Serious Adverse Event|32|||
161463506|NCT04090957|583091790|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
161463507|NCT04090957|583091791|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
161463508|NCT04090957|583091792|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
161463509|NCT04090957|583091793|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
161463510|NCT04090957|583091790|FG000|Overall Study|Lack of Efficacy|1|||
161463511|NCT04090957|583091791|FG001|Overall Study|Lack of Efficacy|1|||
161463512|NCT04090957|583091792|FG002|Overall Study|Lack of Efficacy|9|||
161463513|NCT04090957|583091793|FG003|Overall Study|Lack of Efficacy|0|||
161463514|NCT04090957|583091790|FG000|Overall Study|Protocol Violation|3|||
161463515|NCT04090957|583091791|FG001|Overall Study|Protocol Violation|5|||
161463516|NCT04090957|583091792|FG002|Overall Study|Protocol Violation|2|||
161463517|NCT04090957|583091793|FG003|Overall Study|Protocol Violation|1|||
161463518|NCT04090957|583091790|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
161463519|NCT04090957|583091791|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
161463520|NCT04090957|583091792|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
161463521|NCT04090957|583091793|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
161463522|NCT04090957|583091790|FG000|Overall Study|COVID-19|2|||
161463523|NCT04090957|583091791|FG001|Overall Study|COVID-19|2|||
161463524|NCT04090957|583091792|FG002|Overall Study|COVID-19|3|||
161463525|NCT04090957|583091793|FG003|Overall Study|COVID-19|7|||
161463526|NCT04090957|583091790|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
161463527|NCT04090957|583091791|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
161463528|NCT04090957|583091792|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
161463529|NCT04090957|583091793|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
161463530|NCT04090957|583091790|FG000|Overall Study|Physician Decision|2|||
161463531|NCT04090957|583091791|FG001|Overall Study|Physician Decision|1|||
161463532|NCT04090957|583091792|FG002|Overall Study|Physician Decision|1|||
161463533|NCT04090957|583091793|FG003|Overall Study|Physician Decision|5|||
161463534|NCT04090957|583091790|FG000|Overall Study|Sponsor Decision|1|||
161463535|NCT04090957|583091791|FG001|Overall Study|Sponsor Decision|1|||
161463536|NCT04090957|583091792|FG002|Overall Study|Sponsor Decision|1|||
161463537|NCT04090957|583091793|FG003|Overall Study|Sponsor Decision|3|||
161463538|NCT04090957|583091790|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
161463539|NCT04090957|583091791|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
161463540|NCT04090957|583091792|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
161463541|NCT04090957|583091793|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
161463542|NCT04090957|583091790|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
161463543|NCT04090957|583091791|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
161463544|NCT04090957|583091792|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
161463545|NCT04090957|583091793|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
161463546|NCT04090957|583091790|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
161463547|NCT04090957|583091791|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
161463548|NCT04090957|583091792|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
161463549|NCT04090957|583091793|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
161463550|NCT04090957|583091790|FG000|Overall Study|Death|1|||
161463551|NCT04090957|583091791|FG001|Overall Study|Death|0|||
161810133|NCT01083693|584347702|FG002|Overall Study|Other medical condition/surgery|0|||
161810134|NCT01083693|584347700|FG000|Overall Study|Withdrawal by Subject|3|||
161463552|NCT04090957|583091792|FG002|Overall Study|Death|0|||
161463553|NCT04090957|583091793|FG003|Overall Study|Death|0|||
161463554|NCT04090957|583091790|FG000|Overall Study|No Treatment Administered|2|||
161463555|NCT04090957|583091791|FG001|Overall Study|No Treatment Administered|1|||
161463556|NCT04090957|583091792|FG002|Overall Study|No Treatment Administered|2|||
161463557|NCT04090957|583091793|FG003|Overall Study|No Treatment Administered|1|||
161463558|NCT03468985|583093456|FG000|Overall Study|Adverse Event|0|||
161463559|NCT03468985|583093457|FG001|Overall Study|Adverse Event|2|||
161463560|NCT03468985|583093458|FG002|Overall Study|Adverse Event|0|||
161463561|NCT03468985|583093459|FG003|Overall Study|Adverse Event|0|||
161463562|NCT03468985|583093456|FG000|Overall Study|Withdrawal by Subject|0|||
161463563|NCT03468985|583093457|FG001|Overall Study|Withdrawal by Subject|0|||
161463564|NCT03468985|583093458|FG002|Overall Study|Withdrawal by Subject|0|||
161463565|NCT03468985|583093459|FG003|Overall Study|Withdrawal by Subject|1|||
161463566|NCT03981822|583093460|FG000|Overall Study|Lost to Follow-up|0|||
161463567|NCT03981822|583093461|FG001|Overall Study|Lost to Follow-up|1|||
161463568|NCT03981822|583093462|FG002|Overall Study|Lost to Follow-up|1|||
161463569|NCT03981822|583093463|FG003|Overall Study|Lost to Follow-up|0|||
161463570|NCT03981822|583093464|FG004|Overall Study|Lost to Follow-up|6|||
161463571|NCT03981822|583093465|FG005|Overall Study|Lost to Follow-up|4|||
161463572|NCT03981822|583093466|FG006|Overall Study|Lost to Follow-up|4|||
161463573|NCT03981822|583093467|FG007|Overall Study|Lost to Follow-up|2|||
161463574|NCT03981822|583093460|FG000|Overall Study|Withdrawal by Subject|0|||
161463575|NCT03981822|583093461|FG001|Overall Study|Withdrawal by Subject|1|||
161463576|NCT03981822|583093462|FG002|Overall Study|Withdrawal by Subject|0|||
161463577|NCT03981822|583093463|FG003|Overall Study|Withdrawal by Subject|0|||
161463578|NCT03981822|583093464|FG004|Overall Study|Withdrawal by Subject|0|||
161463579|NCT03981822|583093465|FG005|Overall Study|Withdrawal by Subject|1|||
161463580|NCT03981822|583093466|FG006|Overall Study|Withdrawal by Subject|0|||
161463581|NCT03981822|583093467|FG007|Overall Study|Withdrawal by Subject|2|||
161463582|NCT03981822|583093460|FG000|Overall Study|COVID-19 Related|0|||
161463583|NCT03981822|583093461|FG001|Overall Study|COVID-19 Related|0|||
161463584|NCT03981822|583093462|FG002|Overall Study|COVID-19 Related|0|||
161463585|NCT03981822|583093463|FG003|Overall Study|COVID-19 Related|0|||
161463586|NCT03981822|583093464|FG004|Overall Study|COVID-19 Related|2|||
161463587|NCT03981822|583093465|FG005|Overall Study|COVID-19 Related|1|||
161463588|NCT03981822|583093466|FG006|Overall Study|COVID-19 Related|2|||
161463589|NCT03981822|583093467|FG007|Overall Study|COVID-19 Related|1|||
161463590|NCT04521777|583093469|FG000|Overall Study|Death|2|||
161463591|NCT04521777|583093469|FG000|Overall Study|Withdrawal by Subject|2|||
161463592|NCT01143207|583093474|FG000|Overall Study|Lost to Follow-up|2|||
161463593|NCT03463031|583093477|FG000|Overall Study|Withdrawal by Subject|4|||
161463594|NCT03463031|583093478|FG001|Overall Study|Withdrawal by Subject|2|||
161463595|NCT03463031|583093477|FG000|Overall Study|Investigator/Sponsor Decision|0|||
161463596|NCT03463031|583093478|FG001|Overall Study|Investigator/Sponsor Decision|1|||
161463597|NCT03463031|583093477|FG000|Overall Study|Lost to Follow-up|1|||
161463598|NCT03463031|583093478|FG001|Overall Study|Lost to Follow-up|1|||
161463599|NCT03463031|583093477|FG000|Overall Study|Adverse Event|4|||
161463600|NCT03463031|583093478|FG001|Overall Study|Adverse Event|1|||
161463601|NCT03463031|583093477|FG000|Overall Study|Use of prohibited medication by subject|1|||
161463602|NCT03463031|583093478|FG001|Overall Study|Use of prohibited medication by subject|0|||
161463603|NCT00057954|583093485|FG000|Overall Study|Death|1|||
161463604|NCT00057954|583093485|FG000|Overall Study|Disease progression|1|||
161463605|NCT01251744|583093486|FG000|Overall Study|Lost to Follow-up|1|||
161463606|NCT01251744|583093487|FG001|Overall Study|Lost to Follow-up|0|||
161463607|NCT03170232|583093488|FG000|Overall Study|Adverse Event|0|||
161463608|NCT03170232|583093489|FG001|Overall Study|Adverse Event|1|||
161463609|NCT03170232|583093488|FG000|Overall Study|Protocol Violation|0|||
161463610|NCT03170232|583093489|FG001|Overall Study|Protocol Violation|1|||
161463611|NCT03170232|583093488|FG000|Overall Study|Lack of Efficacy|0|||
161463612|NCT03170232|583093489|FG001|Overall Study|Lack of Efficacy|1|||
161463613|NCT03170232|583093488|FG000|Overall Study|Study closed/terminated|26|||
161463614|NCT03170232|583093489|FG001|Overall Study|Study closed/terminated|23|||
161463615|NCT03170232|583093488|FG000|Overall Study|Lost to Follow-up|1|||
161463616|NCT03170232|583093489|FG001|Overall Study|Lost to Follow-up|0|||
161463617|NCT03170232|583093488|FG000|Overall Study|Withdrawal by Subject|0|||
161463618|NCT03170232|583093489|FG001|Overall Study|Withdrawal by Subject|1|||
161463619|NCT02147184|583093490|FG000|Overall Study|Lost to Follow-up|28|||
161572903|NCT04436120|583482087|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
161572904|NCT04436120|583482088|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
161463620|NCT02147184|583093491|FG001|Overall Study|Lost to Follow-up|15|||
161463621|NCT02147184|583093490|FG000|Overall Study|Study Burden|11|||
161463622|NCT02147184|583093491|FG001|Overall Study|Study Burden|7|||
161463623|NCT02147184|583093490|FG000|Overall Study|Pregnancy|6|||
161463624|NCT02147184|583093491|FG001|Overall Study|Pregnancy|0|||
161463625|NCT02147184|583093490|FG000|Overall Study|Moved out of state|3|||
161463626|NCT02147184|583093491|FG001|Overall Study|Moved out of state|3|||
161463627|NCT02147184|583093490|FG000|Overall Study|Physician Decision|0|||
161463628|NCT02147184|583093491|FG001|Overall Study|Physician Decision|2|||
161463629|NCT02147184|583093490|FG000|Overall Study|Other|1|||
161463630|NCT02147184|583093491|FG001|Overall Study|Other|0|||
161463631|NCT02117414|583093492|FG000|Overall Study|Death|5|||
161463632|NCT02117414|583093493|FG001|Overall Study|Death|2|||
161463633|NCT02117414|583093492|FG000|Overall Study|Withdrawal by Subject|10|||
161463634|NCT02117414|583093493|FG001|Overall Study|Withdrawal by Subject|4|||
161810135|NCT01083693|584347701|FG001|Overall Study|Withdrawal by Subject|0|||
161810136|NCT01083693|584347702|FG002|Overall Study|Withdrawal by Subject|2|||
161810137|NCT01083693|584347700|FG000|Overall Study|Reason unknown|0|||
161810138|NCT01083693|584347701|FG001|Overall Study|Reason unknown|0|||
161810139|NCT01083693|584347702|FG002|Overall Study|Reason unknown|1|||
161914307|NCT00851591|584735560|FG000|Overall Study|Withdrawal by Subject|2|||
161914308|NCT00851591|584735561|FG001|Overall Study|Withdrawal by Subject|0|||
161914309|NCT02736617|584735562|FG000|Treatment|Adverse Event|1|||
161914310|NCT02736617|584735562|FG000|Treatment|Lack of Efficacy|1|||
161914311|NCT02736617|584735562|FG000|Treatment|Withdrawal by Subject|1|||
161914312|NCT02736617|584735562|FG000|Maintenance|Lack of Efficacy|4|||
161914313|NCT02736617|584735562|FG000|Maintenance|Physician Decision|1|||
161914314|NCT00481676|584735565|FG000|Overall Study|Adverse Event|0|||
161914315|NCT00481676|584735566|FG001|Overall Study|Adverse Event|1|||
161914316|NCT00481676|584735565|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161914317|NCT00481676|584735566|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161914318|NCT00481676|584735565|FG000|Overall Study|Administrative problem|1|||
161914319|NCT00481676|584735566|FG001|Overall Study|Administrative problem|0|||
161914320|NCT02911116|584735567|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161914321|NCT02911116|584735568|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161914322|NCT02911116|584735567|FG000|Overall Study|Lost to Follow-up|0|||
161914323|NCT02911116|584735568|FG001|Overall Study|Lost to Follow-up|1|||
161914324|NCT01513590|584735569|FG000|Overall Study|Adverse Event|2|||
161914325|NCT01513590|584735570|FG001|Overall Study|Adverse Event|3|||
161914326|NCT01513590|584735569|FG000|Overall Study|Withdrawal Criteria|3|||
161914327|NCT01513590|584735570|FG001|Overall Study|Withdrawal Criteria|0|||
161914328|NCT01513590|584735569|FG000|Overall Study|Unclassified|5|||
161914329|NCT01513590|584735570|FG001|Overall Study|Unclassified|10|||
161914330|NCT01240694|584735571|FG000|Overall Study|Adverse Event|9|||
161914331|NCT01240694|584735571|FG000|Overall Study|Lack of Efficacy|6|||
161914332|NCT01240694|584735571|FG000|Overall Study|Withdrawal by Subject|6|||
161914333|NCT01240694|584735571|FG000|Overall Study|Protocol Violation|2|||
161914334|NCT01240694|584735571|FG000|Overall Study|Lost to Follow-up|2|||
161914335|NCT01240694|584735571|FG000|Overall Study|Other than specified|3|||
161914336|NCT01240694|584735571|FG000|Overall Study|Withdrawn due to early study termination|107|||
161914337|NCT02110693|584735572|FG000|Overall Study|Withdrawal by Subject|6|||
161914338|NCT02110693|584735573|FG001|Overall Study|Withdrawal by Subject|7|||
161914339|NCT02110693|584735572|FG000|Overall Study|skipped assessment|15|||
161914340|NCT02110693|584735573|FG001|Overall Study|skipped assessment|18|||
161914341|NCT02110693|584735572|FG000|Overall Study|technical difficulties|6|||
161914342|NCT02110693|584735573|FG001|Overall Study|technical difficulties|4|||
161914343|NCT02110693|584735572|FG000|Overall Study|Other|1|||
161914344|NCT02110693|584735573|FG001|Overall Study|Other|0|||
161914345|NCT01881425|584735574|FG000|Overall Study|Death|5|||
161914346|NCT01881425|584735575|FG001|Overall Study|Death|1|||
161914347|NCT01881425|584735574|FG000|Overall Study|Withdrawal by Subject|8|||
161914348|NCT01881425|584735575|FG001|Overall Study|Withdrawal by Subject|3|||
161914349|NCT01881425|584735574|FG000|Overall Study|Physician Decision|2|||
161914350|NCT01881425|584735575|FG001|Overall Study|Physician Decision|1|||
161810140|NCT00455312|584347703|FG000|Overall Study|Death|0|||
161810141|NCT00455312|584347704|FG001|Overall Study|Death|1|||
161810142|NCT00777023|584347706|FG000|Overall Study|Adverse Event|15|||
161914351|NCT01881425|584735574|FG000|Overall Study|Adverse Event|3|||
161914352|NCT01881425|584735575|FG001|Overall Study|Adverse Event|0|||
161914353|NCT01881425|584735574|FG000|Overall Study|General Anesthesia panic attack|0|||
161914354|NCT01881425|584735575|FG001|Overall Study|General Anesthesia panic attack|1|||
161914355|NCT01881425|584735574|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
161914356|NCT01881425|584735575|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
161914357|NCT01881425|584735574|FG000|Overall Study|Lost to Follow-up|7|||
161914358|NCT01881425|584735575|FG001|Overall Study|Lost to Follow-up|2|||
161914359|NCT04154956|584735580|FG000|Overall Study|Death|109|||
161914360|NCT04154956|584735581|FG001|Overall Study|Death|110|||
161914361|NCT04154956|584735580|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
161914362|NCT04154956|584735581|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
161914363|NCT04154956|584735580|FG000|Overall Study|Withdrawal by Subject|1|||
161914364|NCT04154956|584735581|FG001|Overall Study|Withdrawal by Subject|7|||
161810143|NCT00777023|584347707|FG001|Overall Study|Adverse Event|21|||
161810144|NCT00777023|584347708|FG002|Overall Study|Adverse Event|8|||
161914365|NCT04154956|584735580|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
161914366|NCT04154956|584735581|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
161914367|NCT04424901|584735582|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
161914368|NCT04424901|584735583|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
161914369|NCT00147238|584735584|FG000|Overall Study|Inevaluable|8|||
161914370|NCT04810962|584735585|FG000|Overall Study|Adverse Event|0|||
161914371|NCT04810962|584735586|FG001|Overall Study|Adverse Event|1|||
161914372|NCT04810962|584735585|FG000|Overall Study|Lost to Follow-up|2|||
161914373|NCT04810962|584735586|FG001|Overall Study|Lost to Follow-up|1|||
161914374|NCT04810962|584735585|FG000|Overall Study|Physician Decision|1|||
161914375|NCT04810962|584735586|FG001|Overall Study|Physician Decision|0|||
161914376|NCT04810962|584735585|FG000|Overall Study|Withdrawal by Subject|1|||
161914377|NCT04810962|584735586|FG001|Overall Study|Withdrawal by Subject|3|||
161914378|NCT04810962|584735585|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
161914379|NCT04810962|584735586|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
161914380|NCT01348269|584735587|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
161914381|NCT01348269|584735588|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
161914382|NCT01348269|584735587|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
161914383|NCT01348269|584735588|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
161914384|NCT01348269|584735587|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
161914385|NCT01348269|584735588|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
161463635|NCT02537574|583093495|FG000|Overall Study|Adverse Event|1|||
161463636|NCT02537574|583093496|FG001|Overall Study|Adverse Event|3|||
161463637|NCT02537574|583093497|FG002|Overall Study|Adverse Event|2|||
161463638|NCT02537574|583093495|FG000|Overall Study|Lost to Follow-up|40|||
161463639|NCT02537574|583093496|FG001|Overall Study|Lost to Follow-up|51|||
161463640|NCT02537574|583093497|FG002|Overall Study|Lost to Follow-up|55|||
161463641|NCT02537574|583093495|FG000|Overall Study|Noncompliance with study drug|0|||
161463642|NCT02537574|583093496|FG001|Overall Study|Noncompliance with study drug|1|||
161463643|NCT02537574|583093497|FG002|Overall Study|Noncompliance with study drug|1|||
161463644|NCT02537574|583093495|FG000|Overall Study|Physician Decision|2|||
161463645|NCT02537574|583093496|FG001|Overall Study|Physician Decision|0|||
161463646|NCT02537574|583093497|FG002|Overall Study|Physician Decision|0|||
161463647|NCT02537574|583093495|FG000|Overall Study|Protocol Violation|4|||
161463648|NCT02537574|583093496|FG001|Overall Study|Protocol Violation|2|||
161463649|NCT02537574|583093497|FG002|Overall Study|Protocol Violation|3|||
161463650|NCT02537574|583093495|FG000|Overall Study|Withdrawal by Subject|37|||
161463651|NCT02537574|583093496|FG001|Overall Study|Withdrawal by Subject|27|||
161463652|NCT02537574|583093497|FG002|Overall Study|Withdrawal by Subject|29|||
161463653|NCT02537574|583093495|FG000|Overall Study|Lack of Efficacy|14|||
161463654|NCT02537574|583093496|FG001|Overall Study|Lack of Efficacy|16|||
161463655|NCT02537574|583093497|FG002|Overall Study|Lack of Efficacy|15|||
161463656|NCT02537574|583093495|FG000|Overall Study|Duplicate Patient|1|||
161463657|NCT02537574|583093496|FG001|Overall Study|Duplicate Patient|0|||
161463658|NCT02537574|583093497|FG002|Overall Study|Duplicate Patient|0|||
161463659|NCT02537574|583093495|FG000|Overall Study|Patient not Stable|0|||
161463660|NCT02537574|583093496|FG001|Overall Study|Patient not Stable|1|||
161463661|NCT02537574|583093497|FG002|Overall Study|Patient not Stable|0|||
161463662|NCT02537574|583093495|FG000|Overall Study|Incarceration|0|||
161463663|NCT02537574|583093496|FG001|Overall Study|Incarceration|1|||
161463664|NCT02537574|583093497|FG002|Overall Study|Incarceration|0|||
161463665|NCT02537574|583093495|FG000|Overall Study|Failed Naloxone Challenge|0|||
161463666|NCT02537574|583093496|FG001|Overall Study|Failed Naloxone Challenge|1|||
161463667|NCT02537574|583093497|FG002|Overall Study|Failed Naloxone Challenge|0|||
161463668|NCT02537574|583093495|FG000|Overall Study|Transportation Issues|0|||
161463669|NCT02537574|583093496|FG001|Overall Study|Transportation Issues|0|||
161463670|NCT02537574|583093497|FG002|Overall Study|Transportation Issues|1|||
161463671|NCT02537574|583093495|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
161463672|NCT02537574|583093496|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
161463673|NCT02537574|583093497|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
161463674|NCT02537574|583093495|FG000|Overall Study|Noncompliance with Protocol|0|||
161463675|NCT02537574|583093496|FG001|Overall Study|Noncompliance with Protocol|0|||
161463676|NCT02537574|583093497|FG002|Overall Study|Noncompliance with Protocol|1|||
161463677|NCT02663687|583093498|FG000|Overall Study|Adverse Event|1|||
161463678|NCT02663687|583093499|FG001|Overall Study|Adverse Event|0|||
161914386|NCT00805532|584735589|FG000|Overall Study|invalid data|0|||
161914387|NCT00805532|584735590|FG001|Overall Study|invalid data|1|||
161914388|NCT02412657|584735591|FG000|Overall Study|Lost to Follow-up|1|||
161914389|NCT02412657|584735592|FG001|Overall Study|Lost to Follow-up|0|||
161914390|NCT02412657|584735593|FG002|Overall Study|Lost to Follow-up|0|||
161914391|NCT02412657|584735591|FG000|Overall Study|Protocol Violation|0|||
161914392|NCT02412657|584735592|FG001|Overall Study|Protocol Violation|2|||
161463679|NCT02663687|583093500|FG002|Overall Study|Adverse Event|0|||
161463680|NCT02663687|583093501|FG003|Overall Study|Adverse Event|0|||
161463681|NCT02663687|583093502|FG004|Overall Study|Adverse Event|0|||
161463682|NCT02663687|583093498|FG000|Overall Study|Other|1|||
161463683|NCT02663687|583093499|FG001|Overall Study|Other|0|||
161463684|NCT02663687|583093500|FG002|Overall Study|Other|1|||
161463685|NCT02663687|583093501|FG003|Overall Study|Other|0|||
161463686|NCT02663687|583093502|FG004|Overall Study|Other|0|||
161463687|NCT01151098|583093503|FG000|Overall Study|Adverse Event|82|||
161463688|NCT01151098|583093503|FG000|Overall Study|Lost to Follow-up|6|||
161463689|NCT01151098|583093503|FG000|Overall Study|Lack of Efficacy|15|||
161463690|NCT01151098|583093503|FG000|Overall Study|Protocol Violation|1|||
161463691|NCT01151098|583093503|FG000|Overall Study|Miscellaneous|13|||
161810145|NCT00777023|584347706|FG000|Overall Study|Lack of Efficacy|1|||
161810146|NCT00777023|584347707|FG001|Overall Study|Lack of Efficacy|0|||
161810147|NCT00777023|584347708|FG002|Overall Study|Lack of Efficacy|14|||
161810148|NCT00777023|584347706|FG000|Overall Study|Protocol Violation|2|||
161810149|NCT00777023|584347707|FG001|Overall Study|Protocol Violation|1|||
161810150|NCT00777023|584347708|FG002|Overall Study|Protocol Violation|1|||
161463692|NCT00417482|583093504|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
161463693|NCT00417482|583093505|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
161463694|NCT00417482|583093506|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
161463695|NCT00417482|583093504|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
161463696|NCT00417482|583093505|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
161463697|NCT00417482|583093506|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
161463698|NCT00417482|583093504|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
161463699|NCT00417482|583093505|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
161463700|NCT00417482|583093506|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
161463701|NCT00417482|583093504|FG000|Phase B 1st 16 Weeks|Death|1|||
161463702|NCT00417482|583093505|FG001|Phase B 1st 16 Weeks|Death|0|||
161463703|NCT00417482|583093506|FG002|Phase B 1st 16 Weeks|Death|0|||
161572905|NCT04436120|583482089|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
161572906|NCT02020616|583482090|FG000|Overall Study|Adverse Event|0|||
161572907|NCT02020616|583482091|FG001|Overall Study|Adverse Event|0|||
161572908|NCT02020616|583482092|FG002|Overall Study|Adverse Event|0|||
161572909|NCT02020616|583482093|FG003|Overall Study|Adverse Event|0|||
161572910|NCT02020616|583482094|FG004|Overall Study|Adverse Event|0|||
161572911|NCT02020616|583482095|FG005|Overall Study|Adverse Event|1|||
161572912|NCT02020616|583482096|FG006|Overall Study|Adverse Event|1|||
161572913|NCT02020616|583482090|FG000|Overall Study|Physician Decision|0|||
161572914|NCT02020616|583482091|FG001|Overall Study|Physician Decision|0|||
161572915|NCT02020616|583482092|FG002|Overall Study|Physician Decision|0|||
161572916|NCT02020616|583482093|FG003|Overall Study|Physician Decision|0|||
161572917|NCT02020616|583482094|FG004|Overall Study|Physician Decision|0|||
161572918|NCT02020616|583482095|FG005|Overall Study|Physician Decision|1|||
161572919|NCT02020616|583482096|FG006|Overall Study|Physician Decision|2|||
161572920|NCT02020616|583482090|FG000|Overall Study|Withdrawal by Subject|0|||
161572921|NCT02020616|583482091|FG001|Overall Study|Withdrawal by Subject|0|||
161572922|NCT02020616|583482092|FG002|Overall Study|Withdrawal by Subject|1|||
161572923|NCT02020616|583482093|FG003|Overall Study|Withdrawal by Subject|0|||
161572924|NCT02020616|583482094|FG004|Overall Study|Withdrawal by Subject|0|||
161572925|NCT02020616|583482095|FG005|Overall Study|Withdrawal by Subject|1|||
161810151|NCT00777023|584347706|FG000|Overall Study|Lost to Follow-up|2|||
161810152|NCT00777023|584347707|FG001|Overall Study|Lost to Follow-up|3|||
161810153|NCT00777023|584347708|FG002|Overall Study|Lost to Follow-up|3|||
161810154|NCT00777023|584347706|FG000|Overall Study|Death|0|||
161810155|NCT00777023|584347707|FG001|Overall Study|Death|1|||
161810156|NCT00777023|584347708|FG002|Overall Study|Death|0|||
161810157|NCT00777023|584347706|FG000|Overall Study|Withdrawal by Subject|7|||
161810158|NCT00777023|584347707|FG001|Overall Study|Withdrawal by Subject|7|||
161810159|NCT00777023|584347708|FG002|Overall Study|Withdrawal by Subject|8|||
161810160|NCT00777023|584347706|FG000|Overall Study|Missing data|1|||
161810161|NCT00777023|584347707|FG001|Overall Study|Missing data|1|||
161810162|NCT00777023|584347708|FG002|Overall Study|Missing data|0|||
161810163|NCT00777023|584347706|FG000|Overall Study|Reasons not specified|4|||
161810164|NCT00777023|584347707|FG001|Overall Study|Reasons not specified|4|||
161810165|NCT00777023|584347708|FG002|Overall Study|Reasons not specified|2|||
161810166|NCT00777023|584347706|FG000|Overall Study|Last dose date unknown|3|||
161810167|NCT00777023|584347707|FG001|Overall Study|Last dose date unknown|3|||
161810168|NCT00777023|584347708|FG002|Overall Study|Last dose date unknown|1|||
161810169|NCT02472366|584347711|FG000|Overall Study|Lost to Follow-up|1|||
161810170|NCT02472366|584347712|FG001|Overall Study|Lost to Follow-up|0|||
161810171|NCT03699020|584347713|FG000|Overall Study|Withdrawal by Subject|3|||
161810172|NCT03699020|584347714|FG001|Overall Study|Withdrawal by Subject|2|||
161810173|NCT04274686|584347715|FG000|Overall Study|Physician Decision|1|||
161810174|NCT04274686|584347716|FG001|Overall Study|Physician Decision|0|||
161810175|NCT00089661|584347719|FG000|Overall Study|Adverse Event|0|||
161810176|NCT00089661|584347720|FG001|Overall Study|Adverse Event|2|||
161810177|NCT00089661|584347719|FG000|Overall Study|Death|1|||
161810178|NCT00089661|584347720|FG001|Overall Study|Death|0|||
161810179|NCT00089661|584347719|FG000|Overall Study|Lost to Follow-up|0|||
161810180|NCT00089661|584347720|FG001|Overall Study|Lost to Follow-up|3|||
161810181|NCT00089661|584347719|FG000|Overall Study|Withdrawal by Subject|11|||
161810182|NCT00089661|584347720|FG001|Overall Study|Withdrawal by Subject|9|||
161463704|NCT00417482|583093504|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
161463705|NCT00417482|583093505|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
161572926|NCT02020616|583482096|FG006|Overall Study|Withdrawal by Subject|1|||
161572927|NCT02020616|583482090|FG000|Overall Study|Lost to Follow-up|0|||
161572928|NCT02020616|583482091|FG001|Overall Study|Lost to Follow-up|1|||
161572929|NCT02020616|583482092|FG002|Overall Study|Lost to Follow-up|0|||
161810183|NCT00089661|584347719|FG000|Overall Study|Disease progression|1|||
161810184|NCT00089661|584347720|FG001|Overall Study|Disease progression|3|||
161463706|NCT00417482|583093506|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
161463707|NCT00417482|583093504|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
161463708|NCT00417482|583093505|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
161463709|NCT00417482|583093506|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
161463710|NCT00417482|583093504|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
161463711|NCT00417482|583093505|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
161463712|NCT00417482|583093506|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
161463713|NCT00417482|583093504|FG000|Phase B 2nd 16 Weeks|Death|1|||
161463714|NCT00417482|583093505|FG001|Phase B 2nd 16 Weeks|Death|1|||
161463715|NCT00417482|583093506|FG002|Phase B 2nd 16 Weeks|Death|0|||
161463716|NCT01323946|583093507|FG000|Overall Study|Lost to Follow-up|0|||
161463717|NCT01323946|583093508|FG001|Overall Study|Lost to Follow-up|1|||
161463718|NCT01323946|583093509|FG002|Overall Study|Lost to Follow-up|0|||
161463719|NCT01323946|583093507|FG000|Overall Study|Parents refused the last blood draw|1|||
161463720|NCT01323946|583093508|FG001|Overall Study|Parents refused the last blood draw|0|||
161463721|NCT01323946|583093509|FG002|Overall Study|Parents refused the last blood draw|0|||
161463722|NCT01323946|583093507|FG000|Overall Study|Withdrawal by Subject|2|||
161463723|NCT01323946|583093508|FG001|Overall Study|Withdrawal by Subject|2|||
161463724|NCT01323946|583093509|FG002|Overall Study|Withdrawal by Subject|0|||
161463725|NCT03189381|583093513|FG000|Overall Study|Death|1|||
161463726|NCT03189381|583093514|FG001|Overall Study|Death|0|||
161463727|NCT00107952|583093515|FG000|Overall Study|Death|75|||
161463728|NCT00107952|583093516|FG001|Overall Study|Death|61|||
161463729|NCT00107952|583093515|FG000|Overall Study|Lost to Follow-up|0|||
161463730|NCT00107952|583093516|FG001|Overall Study|Lost to Follow-up|3|||
161463731|NCT00107952|583093515|FG000|Overall Study|Withdrawal by Subject|9|||
161463732|NCT00107952|583093516|FG001|Overall Study|Withdrawal by Subject|6|||
161463733|NCT00107952|583093515|FG000|Overall Study|Other|2|||
161463734|NCT00107952|583093516|FG001|Overall Study|Other|5|||
161463735|NCT00107952|583093515|FG000|Overall Study|Never received study treatment|9|||
161463736|NCT00107952|583093516|FG001|Overall Study|Never received study treatment|6|||
161463737|NCT00251004|583093517|FG000|Overall Study|Withdrawal by Subject|23|||
161463738|NCT00251004|583093518|FG001|Overall Study|Withdrawal by Subject|16|||
161463739|NCT00251004|583093519|FG002|Overall Study|Withdrawal by Subject|14|||
161463740|NCT00251004|583093517|FG000|Overall Study|Death|9|||
161463741|NCT00251004|583093518|FG001|Overall Study|Death|10|||
161463742|NCT00251004|583093519|FG002|Overall Study|Death|8|||
161463743|NCT00251004|583093517|FG000|Overall Study|Lost to Follow-up|1|||
161463744|NCT00251004|583093518|FG001|Overall Study|Lost to Follow-up|2|||
161463745|NCT00251004|583093519|FG002|Overall Study|Lost to Follow-up|1|||
161463746|NCT00251004|583093517|FG000|Overall Study|Graft Loss|12|||
161463747|NCT00251004|583093518|FG001|Overall Study|Graft Loss|13|||
161463748|NCT00251004|583093519|FG002|Overall Study|Graft Loss|8|||
161572930|NCT02020616|583482093|FG003|Overall Study|Lost to Follow-up|1|||
161572931|NCT02020616|583482094|FG004|Overall Study|Lost to Follow-up|1|||
161572932|NCT02020616|583482095|FG005|Overall Study|Lost to Follow-up|1|||
161572933|NCT02020616|583482096|FG006|Overall Study|Lost to Follow-up|0|||
161572934|NCT02020616|583482090|FG000|Overall Study|Early Termination Criteria Met|0|||
161572935|NCT02020616|583482091|FG001|Overall Study|Early Termination Criteria Met|0|||
161572936|NCT02020616|583482092|FG002|Overall Study|Early Termination Criteria Met|1|||
161572937|NCT02020616|583482093|FG003|Overall Study|Early Termination Criteria Met|0|||
161572938|NCT02020616|583482094|FG004|Overall Study|Early Termination Criteria Met|0|||
161572939|NCT02020616|583482095|FG005|Overall Study|Early Termination Criteria Met|1|||
161572940|NCT02020616|583482096|FG006|Overall Study|Early Termination Criteria Met|0|||
161572941|NCT02020616|583482090|FG000|Overall Study|Randomized in Error|0|||
161572942|NCT02020616|583482091|FG001|Overall Study|Randomized in Error|0|||
161572943|NCT02020616|583482092|FG002|Overall Study|Randomized in Error|0|||
161572944|NCT02020616|583482093|FG003|Overall Study|Randomized in Error|1|||
161572945|NCT02020616|583482094|FG004|Overall Study|Randomized in Error|0|||
161572946|NCT02020616|583482095|FG005|Overall Study|Randomized in Error|0|||
161572947|NCT02020616|583482096|FG006|Overall Study|Randomized in Error|0|||
161914393|NCT02412657|584735593|FG002|Overall Study|Protocol Violation|3|||
161463749|NCT00887744|583093520|FG000|Overall Study|Adverse Event|3|||
161463750|NCT00887744|583093520|FG000|Overall Study|Death|1|||
161463751|NCT00887744|583093520|FG000|Overall Study|Lost to Follow-up|3|||
161463752|NCT00887744|583093520|FG000|Overall Study|Withdrawal by Subject|18|||
161463753|NCT00887744|583093520|FG000|Overall Study|Various reasons|9|||
161572948|NCT02020616|583482090|FG000|Overall Study|Lack of Efficacy|0|||
161463754|NCT01569464|583093521|FG000|Overall Study|Adverse Event|4|||
161463755|NCT01569464|583093522|FG001|Overall Study|Adverse Event|0|||
161463756|NCT01569464|583093521|FG000|Overall Study|Lack of Efficacy|1|||
161463757|NCT01569464|583093522|FG001|Overall Study|Lack of Efficacy|0|||
161463758|NCT01569464|583093521|FG000|Overall Study|Protocol Violation|1|||
161463759|NCT01569464|583093522|FG001|Overall Study|Protocol Violation|0|||
161463760|NCT01569464|583093521|FG000|Overall Study|Lost to Follow-up|2|||
161463761|NCT01569464|583093522|FG001|Overall Study|Lost to Follow-up|3|||
161463762|NCT01569464|583093521|FG000|Overall Study|Withdrawal by Subject|1|||
161463763|NCT01569464|583093522|FG001|Overall Study|Withdrawal by Subject|1|||
161914394|NCT00920816|584735597|FG000|Overall Study|Death|116|||
161463764|NCT01569464|583093521|FG000|Overall Study|Other|1|||
161463765|NCT01569464|583093522|FG001|Overall Study|Other|1|||
161463766|NCT04025710|583093528|FG000|Overall Study|Death|3|||
161463767|NCT04025710|583093528|FG000|Overall Study|Lost to Follow-up|5|||
161463768|NCT04025710|583093528|FG000|Overall Study|Withdrawal by Subject|1|||
161463769|NCT04025710|583093528|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
161463770|NCT04025710|583093528|FG000|Overall Study|Drop-out according to protocol|34|||
161463771|NCT03533686|583093531|FG000|Overall Study|Withdrawal by Subject|1|||
161463772|NCT03533686|583093532|FG001|Overall Study|Withdrawal by Subject|0|||
161463773|NCT03533686|583093533|FG002|Overall Study|Withdrawal by Subject|0|||
161463774|NCT03533686|583093534|FG003|Overall Study|Withdrawal by Subject|3|||
161463775|NCT03533686|583093535|FG004|Overall Study|Withdrawal by Subject|5|||
161463776|NCT03533686|583093536|FG005|Overall Study|Withdrawal by Subject|1|||
161463777|NCT03533686|583093531|FG000|Overall Study|Lost to Follow-up|0|||
161463778|NCT03533686|583093532|FG001|Overall Study|Lost to Follow-up|1|||
161463779|NCT03533686|583093533|FG002|Overall Study|Lost to Follow-up|0|||
161463780|NCT03533686|583093534|FG003|Overall Study|Lost to Follow-up|0|||
161463781|NCT03533686|583093535|FG004|Overall Study|Lost to Follow-up|2|||
161463782|NCT03533686|583093536|FG005|Overall Study|Lost to Follow-up|0|||
161463783|NCT03533686|583093531|FG000|Overall Study|Screen Failure|0|||
161463784|NCT03533686|583093532|FG001|Overall Study|Screen Failure|0|||
161463785|NCT03533686|583093533|FG002|Overall Study|Screen Failure|0|||
161463786|NCT03533686|583093534|FG003|Overall Study|Screen Failure|2|||
161463787|NCT03533686|583093535|FG004|Overall Study|Screen Failure|0|||
161463788|NCT03533686|583093536|FG005|Overall Study|Screen Failure|0|||
161463789|NCT03370289|583093544|FG000|Overall Study|Screen Failure|1|||
161463790|NCT03370289|583093544|FG000|Overall Study|Sample Size Sufficient|4|||
161463791|NCT05308290|583093554|FG000|Overall Study|Death|1|||
161463792|NCT05308290|583093555|FG001|Overall Study|Death|0|||
161463793|NCT05308290|583093554|FG000|Overall Study|Lost to Follow-up|2|||
161463794|NCT05308290|583093555|FG001|Overall Study|Lost to Follow-up|1|||
161463795|NCT05308290|583093554|FG000|Overall Study|still in study followup|0|||
161463796|NCT05308290|583093555|FG001|Overall Study|still in study followup|1|||
161463797|NCT03500679|583093556|FG000|Overall Study|Lost to Follow-up|6|||
161463798|NCT03500679|583093557|FG001|Overall Study|Lost to Follow-up|3|||
161463799|NCT03500679|583093556|FG000|Overall Study|Withdrawal by Subject|3|||
161463800|NCT03500679|583093557|FG001|Overall Study|Withdrawal by Subject|0|||
161463801|NCT04706416|583093558|FG000|Overall Study|Lost to Follow-up|2|||
161463802|NCT04706416|583093559|FG001|Overall Study|Lost to Follow-up|0|||
161463803|NCT01484054|583093560|FG000|Period 1|Withdrawal by Subject|0|||
161463804|NCT01484054|583093561|FG001|Period 1|Withdrawal by Subject|1|||
161463805|NCT02117427|583093564|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
161463806|NCT02117427|583093565|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
161463807|NCT02117427|583093566|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
161463808|NCT02117427|583093564|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
161463809|NCT02117427|583093565|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
161463810|NCT02117427|583093566|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
161463811|NCT02117427|583093564|FG000|Overall Study|Physician Decision|0|||
161463812|NCT02117427|583093565|FG001|Overall Study|Physician Decision|2|||
161463813|NCT02117427|583093566|FG002|Overall Study|Physician Decision|0|||
161463814|NCT02117427|583093564|FG000|Overall Study|No longer meets inclusion criteria|0|||
161463815|NCT02117427|583093565|FG001|Overall Study|No longer meets inclusion criteria|1|||
161572949|NCT02020616|583482091|FG001|Overall Study|Lack of Efficacy|0|||
161463816|NCT02117427|583093566|FG002|Overall Study|No longer meets inclusion criteria|0|||
161463817|NCT02117427|583093564|FG000|Overall Study|Death|0|||
161463818|NCT02117427|583093565|FG001|Overall Study|Death|1|||
161463819|NCT02117427|583093566|FG002|Overall Study|Death|0|||
161463820|NCT05281601|583093567|FG000|Overall Study|Physician Decision|2|||
161463821|NCT05281601|583093568|FG001|Overall Study|Physician Decision|0|||
161463822|NCT05281601|583093567|FG000|Overall Study|Lost to Follow-up|2|||
161463823|NCT05281601|583093568|FG001|Overall Study|Lost to Follow-up|0|||
161463824|NCT05281601|583093567|FG000|Overall Study|Death|1|||
161572950|NCT02020616|583482092|FG002|Overall Study|Lack of Efficacy|0|||
161463825|NCT05281601|583093568|FG001|Overall Study|Death|0|||
161463826|NCT05281601|583093567|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161463827|NCT05281601|583093568|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161463828|NCT00410202|583093572|FG000|On-Treatment|Continuing treatment|69|||
161463829|NCT00410202|583093573|FG001|On-Treatment|Continuing treatment|71|||
161463830|NCT00410202|583093574|FG002|On-Treatment|Continuing treatment|66|||
161463831|NCT00410202|583093572|FG000|On-Treatment|Adverse Event|1|||
161463832|NCT00410202|583093573|FG001|On-Treatment|Adverse Event|3|||
161463833|NCT00410202|583093574|FG002|On-Treatment|Adverse Event|2|||
161463834|NCT00410202|583093572|FG000|On-Treatment|Death|1|||
161463835|NCT00410202|583093573|FG001|On-Treatment|Death|0|||
161463836|NCT00410202|583093574|FG002|On-Treatment|Death|0|||
161463837|NCT00410202|583093572|FG000|On-Treatment|Lost to Follow-up|1|||
161463838|NCT00410202|583093573|FG001|On-Treatment|Lost to Follow-up|0|||
161463839|NCT00410202|583093574|FG002|On-Treatment|Lost to Follow-up|1|||
161463840|NCT00410202|583093572|FG000|On-Treatment|Lack of Efficacy|1|||
161463841|NCT00410202|583093573|FG001|On-Treatment|Lack of Efficacy|4|||
161463842|NCT00410202|583093574|FG002|On-Treatment|Lack of Efficacy|0|||
161463843|NCT00410202|583093572|FG000|On-Treatment|Withdrawal by Subject|2|||
161463844|NCT00410202|583093573|FG001|On-Treatment|Withdrawal by Subject|1|||
161463845|NCT00410202|583093574|FG002|On-Treatment|Withdrawal by Subject|1|||
161463846|NCT00410202|583093572|FG000|On-Treatment|Other Reason|0|||
161463847|NCT00410202|583093573|FG001|On-Treatment|Other Reason|0|||
161463848|NCT00410202|583093574|FG002|On-Treatment|Other Reason|1|||
161463849|NCT00410202|583093572|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
161463850|NCT00410202|583093573|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
161463851|NCT00410202|583093574|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
161463852|NCT00410202|583093572|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
161463853|NCT00410202|583093573|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
161463854|NCT00410202|583093574|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
161463855|NCT00410202|583093572|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
161463856|NCT00410202|583093573|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
161463857|NCT00410202|583093574|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
161463858|NCT01178073|583093577|FG000|Overall Study|Adverse Event|34|||
161463859|NCT01178073|583093578|FG001|Overall Study|Adverse Event|27|||
161463860|NCT01178073|583093579|FG002|Overall Study|Adverse Event|24|||
161463861|NCT01178073|583093577|FG000|Overall Study|Protocol Violation|1|||
161463862|NCT01178073|583093578|FG001|Overall Study|Protocol Violation|1|||
161463863|NCT01178073|583093579|FG002|Overall Study|Protocol Violation|1|||
161914395|NCT00920816|584735598|FG001|Overall Study|Death|63|||
161914396|NCT00920816|584735599|FG002|Overall Study|Death|8|||
161914397|NCT00920816|584735600|FG003|Overall Study|Death|3|||
161914398|NCT00920816|584735597|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
161914399|NCT00920816|584735598|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
161914400|NCT00920816|584735599|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
161914401|NCT00920816|584735600|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
161914402|NCT00920816|584735597|FG000|Overall Study|Global deterioration of health status|2|||
161914403|NCT00920816|584735598|FG001|Overall Study|Global deterioration of health status|0|||
161914404|NCT00920816|584735599|FG002|Overall Study|Global deterioration of health status|0|||
161914405|NCT00920816|584735600|FG003|Overall Study|Global deterioration of health status|0|||
161914406|NCT00920816|584735597|FG000|Overall Study|Objective progression or relapse|6|||
161914407|NCT00920816|584735598|FG001|Overall Study|Objective progression or relapse|2|||
161914408|NCT00920816|584735599|FG002|Overall Study|Objective progression or relapse|0|||
161914409|NCT00920816|584735600|FG003|Overall Study|Objective progression or relapse|0|||
161914410|NCT00920816|584735597|FG000|Overall Study|Other|26|||
161463864|NCT01178073|583093577|FG000|Overall Study|Lost to Follow-up|2|||
161463865|NCT01178073|583093578|FG001|Overall Study|Lost to Follow-up|0|||
161463866|NCT01178073|583093579|FG002|Overall Study|Lost to Follow-up|3|||
161463867|NCT01178073|583093577|FG000|Overall Study|Physician Decision|14|||
161463868|NCT01178073|583093578|FG001|Overall Study|Physician Decision|10|||
161463869|NCT01178073|583093579|FG002|Overall Study|Physician Decision|10|||
161463870|NCT01178073|583093577|FG000|Overall Study|Withdrawal by Subject|10|||
161463871|NCT01178073|583093578|FG001|Overall Study|Withdrawal by Subject|6|||
161463872|NCT01178073|583093579|FG002|Overall Study|Withdrawal by Subject|8|||
161463873|NCT01178073|583093577|FG000|Overall Study|Missing Completion Status|1|||
161463874|NCT01178073|583093578|FG001|Overall Study|Missing Completion Status|0|||
161463875|NCT01178073|583093579|FG002|Overall Study|Missing Completion Status|0|||
161463876|NCT01674634|583093580|FG000|Overall Study|Withdrawal by Subject|3|||
161463877|NCT01674634|583093580|FG000|Overall Study|Lost to Follow-up|3|||
161572951|NCT02020616|583482093|FG003|Overall Study|Lack of Efficacy|0|||
161914411|NCT00920816|584735598|FG001|Overall Study|Other|15|||
161914412|NCT00920816|584735599|FG002|Overall Study|Other|1|||
161914413|NCT00920816|584735600|FG003|Overall Study|Other|2|||
161463878|NCT00937391|583093581|FG000|Stage 2|Withdrawal by Subject|1|||
161463879|NCT01226043|583093591|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
161463880|NCT01226043|583093592|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
161572952|NCT02020616|583482094|FG004|Overall Study|Lack of Efficacy|1|||
161914414|NCT00920816|584735597|FG000|Overall Study|Lost to Follow-up|11|||
161914415|NCT00920816|584735598|FG001|Overall Study|Lost to Follow-up|2|||
161914416|NCT00920816|584735599|FG002|Overall Study|Lost to Follow-up|0|||
161914417|NCT00920816|584735600|FG003|Overall Study|Lost to Follow-up|0|||
161463881|NCT01226043|583093593|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
161463882|NCT01226043|583093594|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
161463883|NCT01226043|583093591|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
161463884|NCT01226043|583093592|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
161463885|NCT01226043|583093593|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
161463886|NCT01226043|583093594|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
161463887|NCT01226043|583093591|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
161914418|NCT00920816|584735597|FG000|Overall Study|Adverse Event|1|||
161914419|NCT00920816|584735598|FG001|Overall Study|Adverse Event|1|||
161914420|NCT00920816|584735599|FG002|Overall Study|Adverse Event|1|||
161463888|NCT01226043|583093592|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
161463889|NCT01226043|583093593|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
161463890|NCT01226043|583093594|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
161463891|NCT01226043|583093591|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
161463892|NCT01226043|583093592|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
161463893|NCT01226043|583093593|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
161463894|NCT01226043|583093594|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
161463895|NCT01226043|583093591|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
161463896|NCT01226043|583093592|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
161463897|NCT01226043|583093593|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
161463898|NCT01226043|583093594|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
161463899|NCT01226043|583093591|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
161463900|NCT01226043|583093592|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
161463901|NCT01226043|583093593|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
161463902|NCT01226043|583093594|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
161463903|NCT01226043|583093591|FG000|6-week Re-randomization Phase|Adverse Event|0|||
161914421|NCT00920816|584735600|FG003|Overall Study|Adverse Event|0|||
161914422|NCT00920816|584735597|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
161914423|NCT00920816|584735598|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
161914424|NCT00920816|584735599|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
161914425|NCT00920816|584735600|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
161914426|NCT00920816|584735597|FG000|Overall Study|Randomized but not treated|3|||
161914427|NCT00920816|584735598|FG001|Overall Study|Randomized but not treated|0|||
161914428|NCT00920816|584735599|FG002|Overall Study|Randomized but not treated|0|||
161914429|NCT00920816|584735600|FG003|Overall Study|Randomized but not treated|0|||
161914430|NCT03185208|584735601|FG000|Overall Study|Did not start study medication|0|||
161914431|NCT03185208|584735602|FG001|Overall Study|Did not start study medication|3|||
161914432|NCT03834350|584735603|FG000|Overall Study|Withdrawal by Subject|1|||
161914433|NCT02765165|584735608|FG000|Treatment Period|Progressive disease|3|||
161914434|NCT02765165|584735609|FG001|Treatment Period|Progressive disease|2|||
161914435|NCT02765165|584735610|FG002|Treatment Period|Progressive disease|3|||
161914436|NCT02765165|584735611|FG003|Treatment Period|Progressive disease|3|||
161914437|NCT02765165|584735612|FG004|Treatment Period|Progressive disease|4|||
161914438|NCT02765165|584735613|FG005|Treatment Period|Progressive disease|2|||
161914439|NCT02765165|584735614|FG006|Treatment Period|Progressive disease|2|||
161914440|NCT02765165|584735608|FG000|Treatment Period|Physician Decision|0|||
161914441|NCT02765165|584735609|FG001|Treatment Period|Physician Decision|1|||
161914442|NCT02765165|584735610|FG002|Treatment Period|Physician Decision|0|||
161914443|NCT02765165|584735611|FG003|Treatment Period|Physician Decision|0|||
161914444|NCT02765165|584735612|FG004|Treatment Period|Physician Decision|0|||
161914445|NCT02765165|584735613|FG005|Treatment Period|Physician Decision|0|||
161914446|NCT02765165|584735614|FG006|Treatment Period|Physician Decision|0|||
161914447|NCT02765165|584735608|FG000|Treatment Period|Adverse Event|0|||
161914448|NCT02765165|584735609|FG001|Treatment Period|Adverse Event|1|||
161914449|NCT02765165|584735610|FG002|Treatment Period|Adverse Event|0|||
161914450|NCT02765165|584735611|FG003|Treatment Period|Adverse Event|0|||
161914451|NCT02765165|584735612|FG004|Treatment Period|Adverse Event|0|||
161914452|NCT02765165|584735613|FG005|Treatment Period|Adverse Event|0|||
161914453|NCT02765165|584735614|FG006|Treatment Period|Adverse Event|0|||
161914454|NCT02765165|584735608|FG000|Treatment Period|Withdrawal by Subject|0|||
161914455|NCT02765165|584735609|FG001|Treatment Period|Withdrawal by Subject|0|||
161914456|NCT02765165|584735610|FG002|Treatment Period|Withdrawal by Subject|0|||
161914457|NCT02765165|584735611|FG003|Treatment Period|Withdrawal by Subject|0|||
161914458|NCT02765165|584735612|FG004|Treatment Period|Withdrawal by Subject|2|||
161914459|NCT02765165|584735613|FG005|Treatment Period|Withdrawal by Subject|0|||
161463904|NCT01226043|583093592|FG001|6-week Re-randomization Phase|Adverse Event|0|||
161463905|NCT01226043|583093593|FG002|6-week Re-randomization Phase|Adverse Event|1|||
161463906|NCT01226043|583093594|FG003|6-week Re-randomization Phase|Adverse Event|1|||
161463907|NCT01226043|583093591|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
161914460|NCT02765165|584735614|FG006|Treatment Period|Withdrawal by Subject|0|||
161914461|NCT02765165|584735608|FG000|Treatment Period|Study terminated|0|||
161914462|NCT02765165|584735609|FG001|Treatment Period|Study terminated|0|||
161914463|NCT02765165|584735610|FG002|Treatment Period|Study terminated|0|||
161914464|NCT02765165|584735611|FG003|Treatment Period|Study terminated|0|||
161914465|NCT02765165|584735612|FG004|Treatment Period|Study terminated|0|||
161914466|NCT02765165|584735613|FG005|Treatment Period|Study terminated|1|||
161463908|NCT01226043|583093592|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
161463909|NCT01226043|583093593|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
161914467|NCT02765165|584735614|FG006|Treatment Period|Study terminated|2|||
161914468|NCT02765165|584735608|FG000|Post-treatment Follow-up|Death|1|||
161914469|NCT02765165|584735609|FG001|Post-treatment Follow-up|Death|2|||
161914470|NCT02765165|584735610|FG002|Post-treatment Follow-up|Death|1|||
161914471|NCT02765165|584735611|FG003|Post-treatment Follow-up|Death|1|||
161914472|NCT02765165|584735612|FG004|Post-treatment Follow-up|Death|1|||
161914473|NCT02765165|584735613|FG005|Post-treatment Follow-up|Death|1|||
161914474|NCT02765165|584735614|FG006|Post-treatment Follow-up|Death|0|||
161572953|NCT02020616|583482095|FG005|Overall Study|Lack of Efficacy|0|||
161572954|NCT02020616|583482096|FG006|Overall Study|Lack of Efficacy|0|||
161914475|NCT02765165|584735608|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
161603593|NCT00626795|583602456|FG001|Blinded Treatment|Protocol Violation|1|||
161914476|NCT02765165|584735609|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
161914477|NCT02765165|584735610|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
161463910|NCT01226043|583093594|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
161463911|NCT01226043|583093591|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
161463912|NCT01226043|583093592|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
161463913|NCT01226043|583093593|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
161463914|NCT01226043|583093594|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
161463915|NCT01226043|583093591|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
161463916|NCT01226043|583093592|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
161463917|NCT01226043|583093593|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
161463918|NCT01226043|583093594|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
161463919|NCT01226043|583093591|FG000|6-week Re-randomization Phase|Physician Decision|0|||
161463920|NCT01226043|583093592|FG001|6-week Re-randomization Phase|Physician Decision|0|||
161463921|NCT01226043|583093593|FG002|6-week Re-randomization Phase|Physician Decision|3|||
161463922|NCT01226043|583093594|FG003|6-week Re-randomization Phase|Physician Decision|2|||
161463923|NCT01226043|583093591|FG000|6-week Re-randomization Phase|completed in error|0|||
161463924|NCT01226043|583093592|FG001|6-week Re-randomization Phase|completed in error|0|||
161463925|NCT01226043|583093593|FG002|6-week Re-randomization Phase|completed in error|0|||
161463926|NCT01226043|583093594|FG003|6-week Re-randomization Phase|completed in error|1|||
161463927|NCT01226043|583093591|FG000|30-week Observational Phase|Adverse Event|0|||
161572955|NCT05019729|583482099|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161572956|NCT05019729|583482100|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161572957|NCT05019729|583482101|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161572958|NCT05019729|583482102|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161572959|NCT05019729|583482103|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
161572960|NCT05019729|583482104|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161572961|NCT03008915|583482109|FG000|Treatment 1|Withdrawal by Subject|0|||
161572962|NCT03008915|583482110|FG001|Treatment 1|Withdrawal by Subject|1|||
161572963|NCT00712166|583482113|FG000|Overall Study|Noncompliance|0|||
161572964|NCT00712166|583482114|FG001|Overall Study|Noncompliance|1|||
161463928|NCT01226043|583093592|FG001|30-week Observational Phase|Adverse Event|0|||
161463929|NCT01226043|583093593|FG002|30-week Observational Phase|Adverse Event|1|||
161463930|NCT01226043|583093594|FG003|30-week Observational Phase|Adverse Event|1|||
161463931|NCT01226043|583093591|FG000|30-week Observational Phase|Protocol Violation|0|||
161463932|NCT01226043|583093592|FG001|30-week Observational Phase|Protocol Violation|0|||
161463933|NCT01226043|583093593|FG002|30-week Observational Phase|Protocol Violation|0|||
161463934|NCT01226043|583093594|FG003|30-week Observational Phase|Protocol Violation|1|||
161463935|NCT01226043|583093591|FG000|30-week Observational Phase|Lost to Follow-up|0|||
161463936|NCT01226043|583093592|FG001|30-week Observational Phase|Lost to Follow-up|0|||
161463937|NCT01226043|583093593|FG002|30-week Observational Phase|Lost to Follow-up|2|||
161463938|NCT01226043|583093594|FG003|30-week Observational Phase|Lost to Follow-up|2|||
161463939|NCT01226043|583093591|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
161463940|NCT01226043|583093592|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
161463941|NCT01226043|583093593|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
161463942|NCT01226043|583093594|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
161463943|NCT01226043|583093591|FG000|30-week Observational Phase|Physician Decision|0|||
161463944|NCT01226043|583093592|FG001|30-week Observational Phase|Physician Decision|0|||
161463945|NCT01226043|583093593|FG002|30-week Observational Phase|Physician Decision|2|||
161463946|NCT01226043|583093594|FG003|30-week Observational Phase|Physician Decision|2|||
161463947|NCT00596362|583093605|FG000|Overall Study|Progressive Disease|1|||
161463948|NCT02418156|583093606|FG000|Overall Study|Lost to Follow-up|12|||
161463949|NCT02418156|583093606|FG000|Overall Study|Death|2|||
161463950|NCT02418156|583093606|FG000|Overall Study|Physician Decision|1|||
161463951|NCT02418156|583093606|FG000|Overall Study|Withdrawal by Subject|1|||
161463952|NCT02418156|583093606|FG000|Overall Study|Subject refused to return|1|||
161463953|NCT00323869|583093609|FG000|Overall Study|Death|1|||
161463954|NCT01909453|583093610|FG000|Overall Study|Ongoing|118|||
161463955|NCT01909453|583093611|FG001|Overall Study|Ongoing|103|||
161463956|NCT01909453|583093612|FG002|Overall Study|Ongoing|83|||
161463957|NCT01909453|583093613|FG003|Overall Study|Ongoing|164|||
161463958|NCT01909453|583093614|FG004|Overall Study|Ongoing|50|||
161463959|NCT01909453|583093610|FG000|Overall Study|Death|69|||
161463960|NCT01909453|583093611|FG001|Overall Study|Death|74|||
161463961|NCT01909453|583093612|FG002|Overall Study|Death|88|||
161463962|NCT01909453|583093613|FG003|Overall Study|Death|86|||
161463963|NCT01909453|583093614|FG004|Overall Study|Death|29|||
161463964|NCT01909453|583093610|FG000|Overall Study|Lost to Follow-up|3|||
161463965|NCT01909453|583093611|FG001|Overall Study|Lost to Follow-up|4|||
161463966|NCT01909453|583093612|FG002|Overall Study|Lost to Follow-up|4|||
161463967|NCT01909453|583093613|FG003|Overall Study|Lost to Follow-up|3|||
161463968|NCT01909453|583093614|FG004|Overall Study|Lost to Follow-up|3|||
161463969|NCT01909453|583093610|FG000|Overall Study|Withdrawal by Subject|2|||
161463970|NCT01909453|583093611|FG001|Overall Study|Withdrawal by Subject|13|||
161463971|NCT01909453|583093612|FG002|Overall Study|Withdrawal by Subject|16|||
161463972|NCT01909453|583093613|FG003|Overall Study|Withdrawal by Subject|5|||
161463973|NCT01909453|583093614|FG004|Overall Study|Withdrawal by Subject|4|||
161463974|NCT02247531|583095174|FG000|Overall Study|Adverse Event|3|||
161463975|NCT02247531|583095175|FG001|Overall Study|Adverse Event|4|||
161463976|NCT02247531|583095176|FG002|Overall Study|Adverse Event|9|||
161463977|NCT02247531|583095174|FG000|Overall Study|Death|8|||
161463978|NCT02247531|583095175|FG001|Overall Study|Death|9|||
161463979|NCT02247531|583095176|FG002|Overall Study|Death|5|||
161463980|NCT02247531|583095174|FG000|Overall Study|Lost to Follow-up|1|||
161463981|NCT02247531|583095175|FG001|Overall Study|Lost to Follow-up|8|||
161463982|NCT02247531|583095176|FG002|Overall Study|Lost to Follow-up|3|||
161463983|NCT02247531|583095174|FG000|Overall Study|Non-compliance|2|||
161463984|NCT02247531|583095175|FG001|Overall Study|Non-compliance|2|||
161463985|NCT02247531|583095176|FG002|Overall Study|Non-compliance|0|||
161463986|NCT02247531|583095174|FG000|Overall Study|Withdrawal by Subject|26|||
161463987|NCT02247531|583095175|FG001|Overall Study|Withdrawal by Subject|31|||
161463988|NCT02247531|583095176|FG002|Overall Study|Withdrawal by Subject|25|||
161463989|NCT02247531|583095174|FG000|Overall Study|Study Terminated by Sponsor|64|||
161463990|NCT02247531|583095175|FG001|Overall Study|Study Terminated by Sponsor|66|||
161463991|NCT02247531|583095176|FG002|Overall Study|Study Terminated by Sponsor|62|||
161572965|NCT01773122|583482115|FG000|Overall Study|Due to amended age eligibility criteria|3|||
161572966|NCT01773122|583482116|FG001|Overall Study|Due to amended age eligibility criteria|1|||
161463992|NCT02247531|583095174|FG000|Overall Study|Physician Decision|0|||
161463993|NCT02247531|583095175|FG001|Overall Study|Physician Decision|2|||
161463994|NCT02247531|583095176|FG002|Overall Study|Physician Decision|2|||
161572967|NCT01773122|583482117|FG002|Overall Study|Due to amended age eligibility criteria|0|||
161463995|NCT02247531|583095174|FG000|Overall Study|Unspecified Reason|2|||
161463996|NCT02247531|583095175|FG001|Overall Study|Unspecified Reason|3|||
161463997|NCT02247531|583095176|FG002|Overall Study|Unspecified Reason|4|||
161463998|NCT01751802|583095186|FG000|Overall Study|Adverse Event|4|||
161463999|NCT01751802|583095187|FG001|Overall Study|Adverse Event|2|||
161464000|NCT01229397|583095188|FG000|Overall Study|Withdrawal by Subject|3|||
161464001|NCT01229397|583095189|FG001|Overall Study|Withdrawal by Subject|3|||
161464002|NCT01229397|583095188|FG000|Overall Study|Lost to Follow-up|7|||
161464003|NCT01229397|583095189|FG001|Overall Study|Lost to Follow-up|6|||
161464004|NCT01229397|583095188|FG000|Overall Study|Migrated/moved from study area|1|||
161464005|NCT01229397|583095189|FG001|Overall Study|Migrated/moved from study area|0|||
161464006|NCT00608543|583095190|FG000|Overall Study|Adverse Event|4|||
161464007|NCT01869725|583095191|FG000|Overall Study|ineligible after registration|1|||
161464008|NCT01869725|583095191|FG000|Overall Study|Death|1|||
161464009|NCT01869725|583095191|FG000|Overall Study|Lost to Follow-up|2|||
161464010|NCT03416374|583095194|FG000|Between Treatment Period I and II|Other|0|||
161464011|NCT03416374|583095195|FG001|Between Treatment Period I and II|Other|9|||
161464012|NCT03416374|583095194|FG000|Treatment Period II|Lack of Efficacy|3|||
161464013|NCT03416374|583095195|FG001|Treatment Period II|Lack of Efficacy|11|||
161464014|NCT03416374|583095194|FG000|Treatment Period II|Adverse Event|1|||
161464015|NCT03416374|583095195|FG001|Treatment Period II|Adverse Event|4|||
161464016|NCT03416374|583095194|FG000|Treatment Period II|Death|0|||
161464017|NCT03416374|583095195|FG001|Treatment Period II|Death|1|||
161464018|NCT03416374|583095194|FG000|Treatment Period II|Other|0|||
161464019|NCT03416374|583095195|FG001|Treatment Period II|Other|2|||
161464020|NCT01025154|583095198|FG000|Overall Study|Lost to Follow-up|1|||
161464021|NCT01025154|583095198|FG000|Overall Study|Withdrawal by Subject|1|||
161464022|NCT01810432|583095199|FG000|Washout|Protocol Violation|0|||
161464023|NCT01810432|583095200|FG001|Washout|Protocol Violation|1|||
161464024|NCT01810432|583095199|FG000|Washout|Adverse Event|1|||
161464025|NCT01810432|583095200|FG001|Washout|Adverse Event|0|||
161464026|NCT01810432|583095199|FG000|Period 2|Withdrawal by Subject|2|||
161464027|NCT01810432|583095200|FG001|Period 2|Withdrawal by Subject|1|||
161464028|NCT01810432|583095199|FG000|Period 2|Physician Decision|1|||
161464029|NCT01810432|583095200|FG001|Period 2|Physician Decision|0|||
161464030|NCT01810432|583095199|FG000|Period 2|Lost to Follow-up|1|||
161464031|NCT01810432|583095200|FG001|Period 2|Lost to Follow-up|1|||
161464032|NCT01068652|583095201|FG000|Overall Study|Adverse Event|4|||
161464033|NCT01068652|583095202|FG001|Overall Study|Adverse Event|0|||
161464034|NCT01068652|583095201|FG000|Overall Study|Lack of Efficacy|0|||
161464035|NCT01068652|583095202|FG001|Overall Study|Lack of Efficacy|2|||
161464036|NCT01068652|583095201|FG000|Overall Study|Lost to Follow-up|2|||
161464037|NCT01068652|583095202|FG001|Overall Study|Lost to Follow-up|1|||
161464038|NCT01068652|583095201|FG000|Overall Study|Protocol Violation|3|||
161464039|NCT01068652|583095202|FG001|Overall Study|Protocol Violation|6|||
161464040|NCT01068652|583095201|FG000|Overall Study|Withdrawal criteria|1|||
161464041|NCT01068652|583095202|FG001|Overall Study|Withdrawal criteria|2|||
161464042|NCT01068652|583095201|FG000|Overall Study|Patient was not eligible|1|||
161464043|NCT01068652|583095202|FG001|Overall Study|Patient was not eligible|0|||
161464044|NCT01068652|583095201|FG000|Overall Study|Unclassified|7|||
161464045|NCT01068652|583095202|FG001|Overall Study|Unclassified|4|||
161464046|NCT00214500|583095203|FG000|Treatment Period|Adverse Event|1|||
161464047|NCT00214500|583095203|FG000|Extension Period|Withdrawal by Subject|2|||
161464048|NCT00147251|583095204|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
161464049|NCT00147251|583095205|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
161464050|NCT01562873|583095208|FG000|Overall Study|Disease Progression per RECIST|10|||
161464051|NCT01562873|583095209|FG001|Overall Study|Disease Progression per RECIST|0|||
161464052|NCT01562873|583095208|FG000|Overall Study|Adverse Event|1|||
161464053|NCT01562873|583095209|FG001|Overall Study|Adverse Event|0|||
161464054|NCT01562873|583095208|FG000|Overall Study|Clinical Disease Progression|9|||
161464055|NCT01562873|583095209|FG001|Overall Study|Clinical Disease Progression|0|||
161464056|NCT01562873|583095208|FG000|Overall Study|Clinical PD and adverse event|1|||
161464057|NCT01562873|583095209|FG001|Overall Study|Clinical PD and adverse event|0|||
161464058|NCT01484938|583095210|FG000|Overall Study|Adverse Event|2|||
161464059|NCT01484938|583095210|FG000|Overall Study|Lost to Follow-up|1|||
161464060|NCT01484938|583095210|FG000|Overall Study|Noncompliance|1|||
161464061|NCT02140775|583095212|FG000|Overall Study|Withdrawal by Subject|30|||
161464062|NCT02140775|583095213|FG001|Overall Study|Withdrawal by Subject|7|||
161572968|NCT01773122|583482118|FG003|Overall Study|Due to amended age eligibility criteria|1|||
161572969|NCT00849147|583482121|FG000|Overall Study|Withdrawal by Subject|1|||
161464063|NCT00938964|583095214|FG000|Overall Study|Death|3|||
161464064|NCT00938964|583095215|FG001|Overall Study|Death|3|||
161464065|NCT00938964|583095214|FG000|Overall Study|Lost to Follow-up|2|||
161464066|NCT00938964|583095215|FG001|Overall Study|Lost to Follow-up|3|||
161464067|NCT00938964|583095214|FG000|Overall Study|Withdrawal by Subject|22|||
161464068|NCT00938964|583095215|FG001|Overall Study|Withdrawal by Subject|18|||
161464069|NCT00938964|583095214|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
161464070|NCT00938964|583095215|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
161464071|NCT01858636|583095216|FG000|Overall Study|No Device Deployment Attempted|24|||
161464072|NCT01858636|583095216|FG000|Overall Study|Physician Decision|1|||
161464073|NCT01858636|583095216|FG000|Overall Study|Death|1|||
161464074|NCT01858636|583095216|FG000|Overall Study|Lost to Follow-up|1|||
161464075|NCT01858636|583095216|FG000|Overall Study|Withdrawal by Subject|1|||
161464076|NCT01227564|583095222|FG000|Overall Study|No Longer Willing to Participate|4|||
161464077|NCT01227564|583095223|FG001|Overall Study|No Longer Willing to Participate|2|||
161464078|NCT01227564|583095224|FG002|Overall Study|No Longer Willing to Participate|5|||
161464079|NCT01227564|583095222|FG000|Overall Study|Participant moved to another town|0|||
161464080|NCT01227564|583095223|FG001|Overall Study|Participant moved to another town|0|||
161464081|NCT01227564|583095224|FG002|Overall Study|Participant moved to another town|1|||
161464082|NCT00999921|583095239|FG000|Overall Study|Lost to Follow-up|10|||
161464083|NCT00999921|583095240|FG001|Overall Study|Lost to Follow-up|19|||
161464084|NCT04650854|583095241|FG000|Overall Study|Adverse Event|1|||
161464085|NCT04650854|583095242|FG001|Overall Study|Adverse Event|12|||
161464086|NCT04650854|583095243|FG002|Overall Study|Adverse Event|14|||
161464087|NCT04650854|583095241|FG000|Overall Study|Lack of Efficacy|1|||
161464088|NCT04650854|583095242|FG001|Overall Study|Lack of Efficacy|3|||
161464089|NCT04650854|583095243|FG002|Overall Study|Lack of Efficacy|6|||
161464090|NCT04650854|583095241|FG000|Overall Study|Lost to Follow-up|1|||
161464091|NCT04650854|583095242|FG001|Overall Study|Lost to Follow-up|1|||
161464092|NCT04650854|583095243|FG002|Overall Study|Lost to Follow-up|0|||
161464093|NCT04650854|583095241|FG000|Overall Study|Withdrawal by Subject|2|||
161464094|NCT04650854|583095242|FG001|Overall Study|Withdrawal by Subject|17|||
161464095|NCT04650854|583095243|FG002|Overall Study|Withdrawal by Subject|9|||
161464096|NCT04650854|583095241|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
161464097|NCT04650854|583095242|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
161464098|NCT04650854|583095243|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
161464099|NCT04650854|583095241|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
161464100|NCT04650854|583095242|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
161464101|NCT04650854|583095243|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
161464102|NCT04650854|583095241|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
161464103|NCT04650854|583095242|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
161464104|NCT04650854|583095243|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
161464105|NCT04650854|583095241|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
161464106|NCT04650854|583095242|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
161464107|NCT04650854|583095243|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
161464108|NCT04650854|583095241|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
161464109|NCT04650854|583095242|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
161464110|NCT04650854|583095243|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
161464111|NCT04650854|583095241|FG000|Overall Study|Use of Rescue Medication|0|||
161464112|NCT04650854|583095242|FG001|Overall Study|Use of Rescue Medication|0|||
161464113|NCT04650854|583095243|FG002|Overall Study|Use of Rescue Medication|1|||
161464114|NCT04650854|583095241|FG000|Overall Study|Last Treatment Per Sponsor|0|||
161464115|NCT04650854|583095242|FG001|Overall Study|Last Treatment Per Sponsor|0|||
161464116|NCT04650854|583095243|FG002|Overall Study|Last Treatment Per Sponsor|2|||
161464117|NCT04650854|583095241|FG000|Overall Study|Rescue Medication|0|||
161464118|NCT04650854|583095242|FG001|Overall Study|Rescue Medication|0|||
161464119|NCT04650854|583095243|FG002|Overall Study|Rescue Medication|1|||
161914478|NCT02765165|584735611|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
161914479|NCT02765165|584735612|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
161914480|NCT02765165|584735613|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
161914481|NCT02765165|584735614|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
161464120|NCT04650854|583095241|FG000|Overall Study|Participant Want to Start a Family|0|||
161464121|NCT04650854|583095242|FG001|Overall Study|Participant Want to Start a Family|0|||
161464122|NCT04650854|583095243|FG002|Overall Study|Participant Want to Start a Family|1|||
161464123|NCT04650854|583095241|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
161464124|NCT04650854|583095242|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
161464125|NCT04650854|583095243|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
161464126|NCT04650854|583095241|FG000|Overall Study|Participant Screened For MG0020|0|||
161464127|NCT04650854|583095242|FG001|Overall Study|Participant Screened For MG0020|2|||
161464128|NCT04650854|583095243|FG002|Overall Study|Participant Screened For MG0020|3|||
161464129|NCT04650854|583095241|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
161464130|NCT04650854|583095242|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
161464131|NCT04650854|583095243|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
161572970|NCT00849147|583482121|FG000|Overall Study|Protocol Violation|2|||
161464132|NCT04650854|583095241|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
161572971|NCT00849147|583482121|FG000|Overall Study|Disease Relapse/Progression|2|||
161572972|NCT05147233|583483907|FG000|Overall Study|Adverse Event|0|||
161572973|NCT05147233|583483908|FG001|Overall Study|Adverse Event|1|||
161572974|NCT05147233|583483907|FG000|Overall Study|Lost to Follow-up|1|||
161572975|NCT05147233|583483908|FG001|Overall Study|Lost to Follow-up|1|||
161572976|NCT05147233|583483907|FG000|Overall Study|Protocol Violation|0|||
161572977|NCT05147233|583483908|FG001|Overall Study|Protocol Violation|1|||
161572978|NCT05147233|583483907|FG000|Overall Study|Withdrawal by Subject|2|||
161572979|NCT05147233|583483908|FG001|Overall Study|Withdrawal by Subject|1|||
161572980|NCT04513522|583483909|FG000|Overall Study|Other reasons|1|||
161572981|NCT04513522|583483909|FG000|Overall Study|Adverse event unrelated to study drug|9|||
161572982|NCT04513522|583483909|FG000|Overall Study|Study drug toxicity|14|||
161572983|NCT04513522|583483909|FG000|Overall Study|Disease progression|39|||
161572984|NCT04513522|583483909|FG000|Overall Study|Participants withdrew consent|2|||
161572985|NCT04517864|583483912|FG000|Placebo-Controlled Phase|Adverse Event|1|||
161572986|NCT04517864|583483913|FG001|Placebo-Controlled Phase|Adverse Event|0|||
161572987|NCT04517864|583483914|FG002|Placebo-Controlled Phase|Adverse Event|0|||
161572988|NCT04517864|583483912|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
161572989|NCT04517864|583483913|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
161572990|NCT04517864|583483914|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
161572991|NCT04517864|583483912|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
161572992|NCT04517864|583483913|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
161572993|NCT04517864|583483914|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
161572994|NCT04517864|583483912|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
161572995|NCT04517864|583483913|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
161572996|NCT04517864|583483914|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
161572997|NCT04517864|583483912|FG000|Active Therapy Extension Phase|Adverse Event|1|||
161572998|NCT04517864|583483913|FG001|Active Therapy Extension Phase|Adverse Event|0|||
161572999|NCT04517864|583483914|FG002|Active Therapy Extension Phase|Adverse Event|0|||
161573000|NCT04517864|583483912|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
161573001|NCT04517864|583483913|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
161573002|NCT04517864|583483914|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
161573003|NCT04517864|583483912|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
161573004|NCT04517864|583483913|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
161573005|NCT04517864|583483914|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
161573006|NCT04517864|583483912|FG000|Active Therapy Extension Phase|Physician Decision|1|||
161573007|NCT04517864|583483913|FG001|Active Therapy Extension Phase|Physician Decision|0|||
161573008|NCT04517864|583483914|FG002|Active Therapy Extension Phase|Physician Decision|0|||
161573009|NCT04517864|583483912|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
161573010|NCT04517864|583483913|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
161573011|NCT04517864|583483914|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
161573012|NCT04517864|583483912|FG000|Extension Phase|Adverse Event|0|||
161573013|NCT04517864|583483913|FG001|Extension Phase|Adverse Event|0|||
161573014|NCT04517864|583483914|FG002|Extension Phase|Adverse Event|1|||
161573015|NCT04517864|583483912|FG000|Extension Phase|Lack of Efficacy|0|||
161573016|NCT04517864|583483913|FG001|Extension Phase|Lack of Efficacy|0|||
161573017|NCT04517864|583483914|FG002|Extension Phase|Lack of Efficacy|2|||
161573018|NCT04517864|583483912|FG000|Extension Phase|Study Terminated By Sponsor|0|||
161573019|NCT04517864|583483913|FG001|Extension Phase|Study Terminated By Sponsor|0|||
161573020|NCT04517864|583483914|FG002|Extension Phase|Study Terminated By Sponsor|32|||
161573021|NCT04517864|583483912|FG000|Extension Phase|Withdrawal by Subject|0|||
161573022|NCT04517864|583483913|FG001|Extension Phase|Withdrawal by Subject|0|||
161573023|NCT04517864|583483914|FG002|Extension Phase|Withdrawal by Subject|3|||
161573024|NCT04517864|583483912|FG000|Extension Phase|Approved Drug Available for Indication|0|||
161810185|NCT00089661|584347719|FG000|Overall Study|Ineligibility determined|4|||
161810186|NCT00089661|584347720|FG001|Overall Study|Ineligibility determined|4|||
161810187|NCT00089661|584347719|FG000|Overall Study|Noncompliance|2|||
161810188|NCT00089661|584347720|FG001|Overall Study|Noncompliance|4|||
161810189|NCT00089661|584347719|FG000|Overall Study|Other|2|||
161810190|NCT00089661|584347720|FG001|Overall Study|Other|1|||
161810191|NCT01273805|584347721|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
161810192|NCT01273805|584347722|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
161810193|NCT02647944|584347723|FG000|Overall Study|Withdrawal by Subject|0|||
161810194|NCT02647944|584347724|FG001|Overall Study|Withdrawal by Subject|3|||
161810195|NCT02647944|584347723|FG000|Overall Study|Adverse Event|2|||
161810196|NCT02647944|584347724|FG001|Overall Study|Adverse Event|0|||
161810197|NCT02077465|584347725|FG000|Overall Study|Withdrew Consent|0|||
161810198|NCT02077465|584347726|FG001|Overall Study|Withdrew Consent|1|||
161573025|NCT04517864|583483913|FG001|Extension Phase|Approved Drug Available for Indication|0|||
161573026|NCT04517864|583483914|FG002|Extension Phase|Approved Drug Available for Indication|7|||
161573027|NCT04722003|583483917|FG000|Overall Study|Lost to Follow-up|2|||
161573028|NCT04722003|583483918|FG001|Overall Study|Lost to Follow-up|0|||
161810199|NCT02077465|584347725|FG000|Overall Study|Lost to Follow-up|1|||
161810200|NCT02077465|584347726|FG001|Overall Study|Lost to Follow-up|0|||
161810201|NCT02576938|584347730|FG000|Overall Study|Adverse Event|5|||
161464133|NCT04650854|583095242|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
161464134|NCT04650854|583095243|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
161464135|NCT04650854|583095241|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
161464136|NCT04650854|583095242|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
161464137|NCT04650854|583095243|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
161464138|NCT04650854|583095241|FG000|Overall Study|End Of Study|0|||
161464139|NCT04650854|583095242|FG001|Overall Study|End Of Study|2|||
161464140|NCT04650854|583095243|FG002|Overall Study|End Of Study|1|||
161464141|NCT04650854|583095241|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
161464142|NCT04650854|583095242|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
161464143|NCT04650854|583095243|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
161464144|NCT04650854|583095241|FG000|Overall Study|Participant Received Rescue Medication|0|||
161464145|NCT04650854|583095242|FG001|Overall Study|Participant Received Rescue Medication|1|||
161464146|NCT04650854|583095243|FG002|Overall Study|Participant Received Rescue Medication|0|||
161464147|NCT04650854|583095241|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
161464148|NCT04650854|583095242|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
161464149|NCT04650854|583095243|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
161464150|NCT04650854|583095241|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
161464151|NCT04650854|583095242|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
161464152|NCT04650854|583095243|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
161464153|NCT04650854|583095241|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
161464154|NCT04650854|583095242|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
161464155|NCT04650854|583095243|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
161464156|NCT04650854|583095241|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
161464157|NCT04650854|583095242|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
161464158|NCT04650854|583095243|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
161464159|NCT04650854|583095241|FG000|Overall Study|Enrollment Cup|0|||
161464160|NCT04650854|583095242|FG001|Overall Study|Enrollment Cup|0|||
161464161|NCT04650854|583095243|FG002|Overall Study|Enrollment Cup|1|||
161464162|NCT00704808|583095258|FG000|Overall Study|Discontinued prior to starting treatment|14|||
161464163|NCT00704808|583095258|FG000|Overall Study|Death|7|||
161464164|NCT00704808|583095258|FG000|Overall Study|Tumor progression|80|||
161464165|NCT00704808|583095258|FG000|Overall Study|Patient's decision|11|||
161464166|NCT00704808|583095258|FG000|Overall Study|Early therapy discontinuation|16|||
161464167|NCT00704808|583095258|FG000|Overall Study|Adverse Event|1|||
161464168|NCT00704808|583095258|FG000|Overall Study|Lost to Follow-up|1|||
161464169|NCT00704808|583095258|FG000|Overall Study|Treatment change|1|||
161464170|NCT00667420|583095260|FG000|Overall Study|Adverse Event|2|||
161464171|NCT00667420|583095260|FG000|Overall Study|Lack of Efficacy|5|||
161464172|NCT00667420|583095260|FG000|Overall Study|Physician Decision|1|||
161464173|NCT00667420|583095260|FG000|Overall Study|Withdrawal by Subject|2|||
161464174|NCT04437368|583095264|FG000|Overall Study|Death|3|||
161464175|NCT04437368|583095265|FG001|Overall Study|Death|0|||
161464176|NCT04437368|583095266|FG002|Overall Study|Death|2|||
161464177|NCT04437368|583095264|FG000|Overall Study|Study terminated by sponsor|16|||
161464178|NCT04437368|583095265|FG001|Overall Study|Study terminated by sponsor|1|||
161464179|NCT04437368|583095266|FG002|Overall Study|Study terminated by sponsor|25|||
161464180|NCT04437368|583095264|FG000|Overall Study|Withdrawal by Subject|4|||
161464181|NCT04437368|583095265|FG001|Overall Study|Withdrawal by Subject|0|||
161464182|NCT04437368|583095266|FG002|Overall Study|Withdrawal by Subject|3|||
161464183|NCT04437368|583095264|FG000|Overall Study|Sponsor instructions|23|||
161464184|NCT04437368|583095265|FG001|Overall Study|Sponsor instructions|0|||
161464185|NCT04437368|583095266|FG002|Overall Study|Sponsor instructions|0|||
161464186|NCT01982331|583095270|FG000|Received Vaccination 2|Adverse Event|1|||
161464187|NCT01982331|583095271|FG001|Received Vaccination 2|Adverse Event|2|||
161464188|NCT01982331|583095270|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
161464189|NCT01982331|583095271|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
161464190|NCT01982331|583095270|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
161464191|NCT01982331|583095271|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
161464192|NCT00095628|583095273|FG000|Overall Study|Disease progression prior to treatment|1|||
161464193|NCT00744471|583095274|FG000|Overall Study|Randomized but not treated|1|||
161464194|NCT00744471|583095275|FG001|Overall Study|Randomized but not treated|1|||
161464195|NCT00744471|583095276|FG002|Overall Study|Randomized but not treated|4|||
161464196|NCT00744471|583095277|FG003|Overall Study|Randomized but not treated|0|||
161464197|NCT00744471|583095274|FG000|Overall Study|Death|0|||
161464198|NCT00744471|583095275|FG001|Overall Study|Death|0|||
161464199|NCT00744471|583095276|FG002|Overall Study|Death|0|||
161464200|NCT00744471|583095277|FG003|Overall Study|Death|1|||
161464201|NCT00744471|583095274|FG000|Overall Study|Adverse Event|6|||
161464202|NCT00744471|583095275|FG001|Overall Study|Adverse Event|7|||
161464203|NCT00744471|583095276|FG002|Overall Study|Adverse Event|5|||
161464204|NCT00744471|583095277|FG003|Overall Study|Adverse Event|9|||
161464205|NCT00744471|583095274|FG000|Overall Study|Withdrawal by Subject|9|||
161464206|NCT00744471|583095275|FG001|Overall Study|Withdrawal by Subject|9|||
161464207|NCT00744471|583095276|FG002|Overall Study|Withdrawal by Subject|15|||
161464208|NCT00744471|583095277|FG003|Overall Study|Withdrawal by Subject|12|||
161464209|NCT00744471|583095274|FG000|Overall Study|Protocol Violation|1|||
161464210|NCT00744471|583095275|FG001|Overall Study|Protocol Violation|4|||
161464211|NCT00744471|583095276|FG002|Overall Study|Protocol Violation|1|||
161464212|NCT00744471|583095277|FG003|Overall Study|Protocol Violation|2|||
161464213|NCT00744471|583095274|FG000|Overall Study|Entered extension study|41|||
161464214|NCT00744471|583095275|FG001|Overall Study|Entered extension study|84|||
161464215|NCT00744471|583095276|FG002|Overall Study|Entered extension study|100|||
161464216|NCT00744471|583095277|FG003|Overall Study|Entered extension study|91|||
161464217|NCT00744471|583095274|FG000|Overall Study|Other|2|||
161464218|NCT00744471|583095275|FG001|Overall Study|Other|3|||
161464219|NCT00744471|583095276|FG002|Overall Study|Other|6|||
161464220|NCT00744471|583095277|FG003|Overall Study|Other|2|||
161464221|NCT00744471|583095274|FG000|Overall Study|Lack of Efficacy|83|||
161464222|NCT00744471|583095275|FG001|Overall Study|Lack of Efficacy|37|||
161464223|NCT00744471|583095276|FG002|Overall Study|Lack of Efficacy|19|||
161464224|NCT00744471|583095277|FG003|Overall Study|Lack of Efficacy|31|||
161464225|NCT00744471|583095274|FG000|Overall Study|Lost to Follow-up|0|||
161464226|NCT00744471|583095275|FG001|Overall Study|Lost to Follow-up|0|||
161464227|NCT00744471|583095276|FG002|Overall Study|Lost to Follow-up|2|||
161464228|NCT00744471|583095277|FG003|Overall Study|Lost to Follow-up|0|||
161464229|NCT03224546|583095278|FG000|Overall Study|Lost to Follow-up|9|||
161464230|NCT03224546|583095279|FG001|Overall Study|Lost to Follow-up|8|||
161464231|NCT03224546|583095280|FG002|Overall Study|Lost to Follow-up|3|||
161464232|NCT03224546|583095278|FG000|Overall Study|Withdrawal by Subject|7|||
161464233|NCT03224546|583095279|FG001|Overall Study|Withdrawal by Subject|14|||
161464234|NCT03224546|583095280|FG002|Overall Study|Withdrawal by Subject|12|||
161464235|NCT01280955|583095285|FG000|Overall Study|Death|2|||
161464236|NCT01280955|583095285|FG000|Overall Study|Withdrawal by Subject|1|||
161464237|NCT04223232|583095286|FG000|Overall Study|Withdrawal by Subject|1|||
161464238|NCT00901927|583095289|FG000|Overall Study|Lack of Efficacy|1|||
161464239|NCT00901927|583095289|FG000|Overall Study|Protocol Violation|3|||
161464240|NCT00901927|583095289|FG000|Overall Study|Withdrawal by Subject|2|||
161464241|NCT03119701|583095299|FG000|6-day Dosing|Death|4|||
161464242|NCT03119701|583095300|FG001|6-day Dosing|Death|1|||
161464243|NCT03119701|583095299|FG000|6-day Dosing|Adverse Event|3|||
161464244|NCT03119701|583095300|FG001|6-day Dosing|Adverse Event|0|||
161464245|NCT03119701|583095299|FG000|6-day Dosing|Physician Decision|0|||
161464246|NCT03119701|583095300|FG001|6-day Dosing|Physician Decision|1|||
161464247|NCT03119701|583095299|FG000|6-day Dosing|Withdrawal by Subject|0|||
161464248|NCT03119701|583095300|FG001|6-day Dosing|Withdrawal by Subject|1|||
161464249|NCT03119701|583095299|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
161464250|NCT03119701|583095300|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
161464251|NCT00406718|583095306|FG000|Overall Study|Withdrawal by Subject|2|||
161464252|NCT00406718|583095307|FG001|Overall Study|Withdrawal by Subject|9|||
161464253|NCT00406718|583095308|FG002|Overall Study|Withdrawal by Subject|4|||
161464254|NCT00406718|583095306|FG000|Overall Study|Lost to Follow-up|2|||
161464255|NCT00406718|583095307|FG001|Overall Study|Lost to Follow-up|5|||
161464256|NCT00406718|583095308|FG002|Overall Study|Lost to Follow-up|4|||
161464257|NCT01888003|583095311|FG000|Overall Study|Study Terminated|5|||
161464258|NCT01888003|583095312|FG001|Overall Study|Study Terminated|6|||
161464259|NCT01888003|583095313|FG002|Overall Study|Study Terminated|40|||
161464260|NCT03187756|583095314|FG000|Overall Study|Termination of study|4|||
161464261|NCT03172910|583097215|FG000|Overall Study|Adverse Event|0|||
161464262|NCT03172910|583097216|FG001|Overall Study|Adverse Event|0|||
161464263|NCT03172910|583097217|FG002|Overall Study|Adverse Event|0|||
161573029|NCT04722003|583483917|FG000|Overall Study|Physician Decision|1|||
161573030|NCT04722003|583483918|FG001|Overall Study|Physician Decision|0|||
161464264|NCT03172910|583097218|FG003|Overall Study|Adverse Event|0|||
161464265|NCT03172910|583097219|FG004|Overall Study|Adverse Event|1|||
161464266|NCT01659658|583097220|FG000|Overall Study|Withdrawal by Patient|18|||
161464267|NCT01659658|583097221|FG001|Overall Study|Withdrawal by Patient|4|||
161464268|NCT01659658|583097222|FG002|Overall Study|Withdrawal by Patient|2|||
161573031|NCT03351075|583483919|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
161573032|NCT03351075|583483920|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
161464269|NCT01659658|583097223|FG003|Overall Study|Withdrawal by Patient|0|||
161464270|NCT01659658|583097224|FG004|Overall Study|Withdrawal by Patient|11|||
161464271|NCT01659658|583097220|FG000|Overall Study|Study Terminated by Sponsor|9|||
161464272|NCT01659658|583097221|FG001|Overall Study|Study Terminated by Sponsor|7|||
161464273|NCT01659658|583097222|FG002|Overall Study|Study Terminated by Sponsor|0|||
161464274|NCT01659658|583097223|FG003|Overall Study|Study Terminated by Sponsor|1|||
161464275|NCT01659658|583097224|FG004|Overall Study|Study Terminated by Sponsor|4|||
161464276|NCT01659658|583097220|FG000|Overall Study|Reason not Specified|61|||
161464277|NCT01659658|583097221|FG001|Overall Study|Reason not Specified|15|||
161464278|NCT01659658|583097222|FG002|Overall Study|Reason not Specified|8|||
161464279|NCT01659658|583097223|FG003|Overall Study|Reason not Specified|1|||
161464280|NCT01659658|583097224|FG004|Overall Study|Reason not Specified|34|||
161464281|NCT01659658|583097220|FG000|Overall Study|Lost to Follow-up|2|||
161464282|NCT01659658|583097221|FG001|Overall Study|Lost to Follow-up|0|||
161464283|NCT01659658|583097222|FG002|Overall Study|Lost to Follow-up|0|||
161464284|NCT01659658|583097223|FG003|Overall Study|Lost to Follow-up|0|||
161464285|NCT01659658|583097224|FG004|Overall Study|Lost to Follow-up|0|||
161464286|NCT00122278|583097227|FG000|Overall Study|Lost to Follow-up|2|||
161464287|NCT00122278|583097228|FG001|Overall Study|Lost to Follow-up|0|||
161464288|NCT01002482|583097229|FG000|Overall Study|Withdrawal by Subject|14|||
161464289|NCT01002482|583097230|FG001|Overall Study|Withdrawal by Subject|21|||
161464290|NCT01002482|583097229|FG000|Overall Study|Included twice|1|||
161464291|NCT01002482|583097230|FG001|Overall Study|Included twice|0|||
161464292|NCT04879225|583097231|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
161464293|NCT04879225|583097231|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
161464294|NCT00736957|583097234|FG000|Overall Study|Adverse Event|43|||
161464295|NCT00736957|583097234|FG000|Overall Study|Withdrawal by Subject|49|||
161464296|NCT00736957|583097234|FG000|Overall Study|violation of eligibility criteria|2|||
161464297|NCT00736957|583097234|FG000|Overall Study|did not attend hospital appointments|1|||
161464298|NCT00736957|583097234|FG000|Overall Study|not eligible for Treatment Period I|22|||
161464299|NCT00736957|583097234|FG000|Overall Study|Physician Decision|5|||
161464300|NCT03646643|583097235|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
161464301|NCT03646643|583097236|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
161464302|NCT03646643|583097235|FG000|Overall Study|Lost to Follow-up|0|||
161464303|NCT03646643|583097236|FG001|Overall Study|Lost to Follow-up|1|||
161464304|NCT02806973|583097237|FG000|Period 1|Withdrawal by Subject|0|||
161464305|NCT02806973|583097238|FG001|Period 1|Withdrawal by Subject|2|||
161464306|NCT02806973|583097239|FG002|Period 1|Withdrawal by Subject|1|||
161464307|NCT02806973|583097240|FG003|Period 1|Withdrawal by Subject|1|||
161464308|NCT02806973|583097237|FG000|Period 1|Adverse Event|0|||
161464309|NCT02806973|583097238|FG001|Period 1|Adverse Event|0|||
161464310|NCT02806973|583097239|FG002|Period 1|Adverse Event|0|||
161464311|NCT02806973|583097240|FG003|Period 1|Adverse Event|1|||
161464312|NCT02806973|583097237|FG000|Period 3|Withdrawal by Subject|0|||
161464313|NCT02806973|583097238|FG001|Period 3|Withdrawal by Subject|0|||
161464314|NCT02806973|583097239|FG002|Period 3|Withdrawal by Subject|0|||
161464315|NCT02806973|583097240|FG003|Period 3|Withdrawal by Subject|3|||
161464316|NCT02806973|583097237|FG000|Period 3|Adverse Event|0|||
161464317|NCT02806973|583097238|FG001|Period 3|Adverse Event|0|||
161464318|NCT02806973|583097239|FG002|Period 3|Adverse Event|1|||
161464319|NCT02806973|583097240|FG003|Period 3|Adverse Event|0|||
161464320|NCT04209426|583097243|FG000|Overall Study|Lost to Follow-up|3|||
161464321|NCT04209426|583097244|FG001|Overall Study|Lost to Follow-up|2|||
161464322|NCT04060862|583097245|FG000|Overall Study|Symptomatic Deterioration|1|||
161464323|NCT04060862|583097245|FG000|Overall Study|Un-specified|6|||
161464324|NCT04060862|583097245|FG000|Overall Study|Progressive disease|12|||
161464325|NCT04060862|583097245|FG000|Overall Study|Physician Decision|1|||
161464326|NCT01031381|583097248|FG000|Overall Study|Physician Decision|3|||
161464327|NCT01031381|583097248|FG000|Overall Study|Withdrawal by Subject|6|||
161464328|NCT03343067|583097251|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
161464329|NCT03343067|583097252|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
161464330|NCT03343067|583097253|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
161464331|NCT00542451|583097254|FG000|Overall Study|Adverse Event|31|||
161464332|NCT00542451|583097254|FG000|Overall Study|Withdrawal by Subject|30|||
161464333|NCT00542451|583097254|FG000|Overall Study|Physician Decision|4|||
161464334|NCT00542451|583097254|FG000|Overall Study|Recurrent disease|1|||
161464335|NCT00542451|583097254|FG000|Overall Study|unknown reason|1|||
161464336|NCT00542451|583097254|FG000|Overall Study|Death|2|||
161464337|NCT00542451|583097254|FG000|Overall Study|Lost to Follow-up|10|||
161464338|NCT00116168|583097257|FG000|Overall Study|Lost to Follow-up|6|||
161464339|NCT00116168|583097258|FG001|Overall Study|Lost to Follow-up|5|||
161810202|NCT02576938|584347731|FG001|Overall Study|Adverse Event|3|||
161810203|NCT02576938|584347732|FG002|Overall Study|Adverse Event|6|||
161810204|NCT02576938|584347730|FG000|Overall Study|Protocol Violation|1|||
161810205|NCT02576938|584347731|FG001|Overall Study|Protocol Violation|1|||
161810206|NCT02576938|584347732|FG002|Overall Study|Protocol Violation|1|||
161810207|NCT02576938|584347730|FG000|Overall Study|Withdrawal by Subject|3|||
161810208|NCT02576938|584347731|FG001|Overall Study|Withdrawal by Subject|2|||
161464340|NCT00116168|583097259|FG002|Overall Study|Lost to Follow-up|0|||
161810209|NCT02576938|584347732|FG002|Overall Study|Withdrawal by Subject|4|||
161810210|NCT02576938|584347730|FG000|Overall Study|Lack of Efficacy|9|||
161810211|NCT02576938|584347731|FG001|Overall Study|Lack of Efficacy|4|||
161464341|NCT00116168|583097260|FG003|Overall Study|Lost to Follow-up|0|||
161464342|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
161464343|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
161464344|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
161464345|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
161464346|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
161573033|NCT03351075|583483919|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
161573034|NCT03351075|583483920|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
161573035|NCT03351075|583483919|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
161573036|NCT03351075|583483920|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
161464347|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
161464348|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
161464349|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
161464350|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
161464351|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
161464352|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
161464353|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
161464354|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
161464355|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
161464356|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
161464357|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
161464358|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Program Termination|3|||
161464359|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Program Termination|0|||
161464360|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Program Termination|1|||
161464361|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Program Termination|1|||
161464362|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
161464363|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
161464364|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
161464365|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
161464366|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
161464367|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
161464368|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
161464369|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
161464370|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
161464371|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
161464372|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
161464373|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
161464374|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
161464375|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
161464376|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
161464377|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
161464378|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
161464379|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
161464380|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
161464381|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
161464382|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
161464383|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
161464384|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
161464385|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
161464386|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
161464387|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
161464388|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
161464389|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
161464390|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
161464391|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
161464392|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
161464393|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
161464394|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
161464395|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
161464396|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
161464397|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
161464398|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
161464399|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
161464400|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
161464401|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
161464402|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
161464403|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
161464404|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
161464405|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
161464406|NCT03739840|583097261|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
161464407|NCT03739840|583097262|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
161464408|NCT03739840|583097263|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
161464409|NCT03739840|583097264|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
161464410|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
161464411|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
161464412|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
161464413|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
161464414|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
161464415|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
161464416|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
161464417|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
161464418|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
161464419|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
161464420|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
161464421|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
161464422|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
161464423|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
161464424|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
161464425|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
161464426|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
161464427|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
161464428|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
161464429|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
161464430|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
161464431|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
161464432|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
161464433|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
161464434|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
161464435|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
161464436|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
161464437|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
161464438|NCT03739840|583097261|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
161464439|NCT03739840|583097262|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
161464440|NCT03739840|583097263|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
161464441|NCT03739840|583097264|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
161464442|NCT02788474|583097265|FG000|Double Blind Treatment Period|Not treated|1|||
161464443|NCT02788474|583097266|FG001|Double Blind Treatment Period|Not treated|0|||
161464444|NCT02788474|583097265|FG000|Double Blind Treatment Period|Patient's refusal|3|||
161464445|NCT02788474|583097266|FG001|Double Blind Treatment Period|Patient's refusal|0|||
161464446|NCT02788474|583097265|FG000|Double Blind Treatment Period|Adverse Event|6|||
161464447|NCT02788474|583097266|FG001|Double Blind Treatment Period|Adverse Event|4|||
161464448|NCT02788474|583097265|FG000|Open Label Treatment Period|Adverse Event|29|||
161464449|NCT02788474|583097266|FG001|Open Label Treatment Period|Adverse Event|9|||
161464450|NCT02788474|583097265|FG000|Open Label Treatment Period|Other than reason specified|1|||
161464451|NCT02788474|583097266|FG001|Open Label Treatment Period|Other than reason specified|0|||
161464452|NCT02788474|583097265|FG000|Open Label Treatment Period|Patient's refusal|1|||
161464453|NCT02788474|583097266|FG001|Open Label Treatment Period|Patient's refusal|3|||
161464454|NCT02788474|583097265|FG000|Open Label Treatment Period|Non-compliance|1|||
161464455|NCT02788474|583097266|FG001|Open Label Treatment Period|Non-compliance|0|||
161464456|NCT05153473|583097267|FG000|Overall Study|Death|46|||
161464457|NCT05153473|583097267|FG000|Overall Study|Lost to Follow-up|3|||
161464458|NCT03555435|583097268|FG000|Overall Study|Lost to Follow-up|17|||
161464459|NCT03555435|583097269|FG001|Overall Study|Lost to Follow-up|19|||
161464460|NCT03555435|583097270|FG002|Overall Study|Lost to Follow-up|8|||
161464461|NCT02964507|583097275|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
161464462|NCT02964507|583097276|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
161464463|NCT02964507|583097277|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
161464464|NCT02964507|583097278|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
161464465|NCT02964507|583097279|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
161464466|NCT02964507|583097280|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
161464467|NCT02964507|583097281|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
161810212|NCT02576938|584347732|FG002|Overall Study|Lack of Efficacy|0|||
161464468|NCT02964507|583097282|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
161464469|NCT02964507|583097275|FG000|Overall Study|Study terminated by Sponsor|9|||
161810213|NCT02576938|584347730|FG000|Overall Study|Lost to Follow-up|2|||
161810214|NCT02576938|584347731|FG001|Overall Study|Lost to Follow-up|0|||
161810215|NCT02576938|584347732|FG002|Overall Study|Lost to Follow-up|1|||
161464470|NCT02964507|583097276|FG001|Overall Study|Study terminated by Sponsor|1|||
161464471|NCT02964507|583097277|FG002|Overall Study|Study terminated by Sponsor|9|||
161464472|NCT02964507|583097278|FG003|Overall Study|Study terminated by Sponsor|3|||
161464473|NCT02964507|583097279|FG004|Overall Study|Study terminated by Sponsor|3|||
161464474|NCT02964507|583097280|FG005|Overall Study|Study terminated by Sponsor|2|||
161464475|NCT02964507|583097281|FG006|Overall Study|Study terminated by Sponsor|0|||
161464476|NCT02964507|583097282|FG007|Overall Study|Study terminated by Sponsor|0|||
161464477|NCT02964507|583097275|FG000|Overall Study|Other|3|||
161464478|NCT02964507|583097276|FG001|Overall Study|Other|0|||
161464479|NCT02964507|583097277|FG002|Overall Study|Other|0|||
161464480|NCT02964507|583097278|FG003|Overall Study|Other|0|||
161464481|NCT02964507|583097279|FG004|Overall Study|Other|1|||
161464482|NCT02964507|583097280|FG005|Overall Study|Other|0|||
161464483|NCT02964507|583097281|FG006|Overall Study|Other|0|||
161464484|NCT02964507|583097282|FG007|Overall Study|Other|0|||
161464485|NCT02964507|583097275|FG000|Overall Study|Death|11|||
161464486|NCT02964507|583097276|FG001|Overall Study|Death|9|||
161464487|NCT02964507|583097277|FG002|Overall Study|Death|12|||
161464488|NCT02964507|583097278|FG003|Overall Study|Death|2|||
161464489|NCT02964507|583097279|FG004|Overall Study|Death|10|||
161464490|NCT02964507|583097280|FG005|Overall Study|Death|5|||
161464491|NCT02964507|583097281|FG006|Overall Study|Death|0|||
161464492|NCT02964507|583097282|FG007|Overall Study|Death|0|||
161464493|NCT02964507|583097275|FG000|Overall Study|Withdrawal by Subject|1|||
161464494|NCT02964507|583097276|FG001|Overall Study|Withdrawal by Subject|0|||
161464495|NCT02964507|583097277|FG002|Overall Study|Withdrawal by Subject|1|||
161464496|NCT02964507|583097278|FG003|Overall Study|Withdrawal by Subject|1|||
161464497|NCT02964507|583097279|FG004|Overall Study|Withdrawal by Subject|0|||
161464498|NCT02964507|583097280|FG005|Overall Study|Withdrawal by Subject|1|||
161464499|NCT02964507|583097281|FG006|Overall Study|Withdrawal by Subject|0|||
161464500|NCT02964507|583097282|FG007|Overall Study|Withdrawal by Subject|0|||
161464501|NCT02964507|583097275|FG000|Overall Study|Physician Decision|2|||
161464502|NCT02964507|583097276|FG001|Overall Study|Physician Decision|0|||
161464503|NCT02964507|583097277|FG002|Overall Study|Physician Decision|3|||
161464504|NCT02964507|583097278|FG003|Overall Study|Physician Decision|0|||
161464505|NCT02964507|583097279|FG004|Overall Study|Physician Decision|1|||
161464506|NCT02964507|583097280|FG005|Overall Study|Physician Decision|0|||
161464507|NCT02964507|583097281|FG006|Overall Study|Physician Decision|0|||
161810216|NCT02576938|584347730|FG000|Overall Study|Physician Decision|0|||
161810217|NCT02576938|584347731|FG001|Overall Study|Physician Decision|1|||
161810218|NCT02576938|584347732|FG002|Overall Study|Physician Decision|0|||
161810219|NCT02576938|584347730|FG000|Overall Study|Met Exclusion Criteria|0|||
161810220|NCT02576938|584347731|FG001|Overall Study|Met Exclusion Criteria|1|||
161810221|NCT02576938|584347732|FG002|Overall Study|Met Exclusion Criteria|0|||
161810222|NCT00448591|584347733|FG000|Overall Study|Withdrawal by Subject|178|||
161810223|NCT00448591|584347733|FG000|Overall Study|Progressive Disease|1382|||
161810224|NCT00448591|584347733|FG000|Overall Study|Adverse Event|382|||
161810225|NCT00448591|584347733|FG000|Overall Study|Protocol Violation|41|||
161810226|NCT00448591|584347733|FG000|Overall Study|Lost to Follow-up|19|||
161810227|NCT00448591|584347733|FG000|Overall Study|Treatment Regimen Completed|70|||
161810228|NCT00448591|584347733|FG000|Overall Study|Other|154|||
161810229|NCT00448591|584347733|FG000|Overall Study|Termination of Study|70|||
161810230|NCT00571064|584347737|FG000|Overall Study|Adverse Event|13|||
161810231|NCT00571064|584347737|FG000|Overall Study|Protocol Violation|4|||
161810232|NCT00571064|584347737|FG000|Overall Study|Withdrawal by Subject|2|||
161810233|NCT00571064|584347737|FG000|Overall Study|Other|2|||
161810234|NCT01518972|584347740|FG000|Overall Study|Lost to Follow-up|2|||
161810235|NCT01518972|584347741|FG001|Overall Study|Lost to Follow-up|1|||
161810236|NCT01518972|584347740|FG000|Overall Study|Withdrawal by Subject|1|||
161810237|NCT01518972|584347741|FG001|Overall Study|Withdrawal by Subject|0|||
161810238|NCT01518972|584347740|FG000|Overall Study|Moved from area|1|||
161810239|NCT01518972|584347741|FG001|Overall Study|Moved from area|0|||
161810240|NCT01518972|584347740|FG000|Overall Study|Transportation problems|1|||
161810241|NCT01518972|584347741|FG001|Overall Study|Transportation problems|0|||
161810242|NCT01518972|584347740|FG000|Overall Study|Exclusionary medical condition|1|||
161810243|NCT01518972|584347741|FG001|Overall Study|Exclusionary medical condition|0|||
161810244|NCT01518972|584347740|FG000|Overall Study|Missed safety visits|0|||
161810245|NCT01518972|584347741|FG001|Overall Study|Missed safety visits|1|||
161810246|NCT01518972|584347740|FG000|Overall Study|Exclusionary medication|0|||
161810247|NCT01518972|584347741|FG001|Overall Study|Exclusionary medication|1|||
161810248|NCT01518972|584347740|FG000|Overall Study|Declined medication starting on day 12|0|||
161810249|NCT01518972|584347741|FG001|Overall Study|Declined medication starting on day 12|1|||
161914482|NCT02765165|584735608|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914483|NCT02765165|584735609|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914484|NCT02765165|584735610|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
161810250|NCT00003659|584347743|FG000|Overall Study|Withdrawal by Subject|3|||
161810251|NCT04022954|584347744|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
161810252|NCT04022954|584347744|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
161914485|NCT02765165|584735611|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914486|NCT02765165|584735612|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914487|NCT02765165|584735613|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914488|NCT02765165|584735614|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914489|NCT02765165|584735608|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914490|NCT02765165|584735609|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914491|NCT02765165|584735610|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
161914492|NCT02765165|584735611|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
161914493|NCT02765165|584735612|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914494|NCT02765165|584735613|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914495|NCT02765165|584735614|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161810253|NCT04022954|584347744|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
161810254|NCT03637764|584347745|FG000|Overall Study|Adverse Event|2|||
161810255|NCT03637764|584347746|FG001|Overall Study|Adverse Event|0|||
161810256|NCT03637764|584347747|FG002|Overall Study|Adverse Event|0|||
161810257|NCT03637764|584347748|FG003|Overall Study|Adverse Event|1|||
161464508|NCT02964507|583097282|FG007|Overall Study|Physician Decision|0|||
161464509|NCT04341662|583097284|FG000|Overall Study|Did not have source-verified blood loss data|423|||
161464510|NCT04341662|583097285|FG001|Overall Study|Did not have source-verified blood loss data|514|||
161464511|NCT00245583|583097286|FG000|Overall Study|Lost to Follow-up|1|||
161464512|NCT00245583|583097287|FG001|Overall Study|Lost to Follow-up|5|||
161464513|NCT00245583|583097286|FG000|Overall Study|Adverse Event|2|||
161464514|NCT00245583|583097287|FG001|Overall Study|Adverse Event|1|||
161464515|NCT00245583|583097286|FG000|Overall Study|Lack of Efficacy|1|||
161464516|NCT00245583|583097287|FG001|Overall Study|Lack of Efficacy|0|||
161464517|NCT00245583|583097286|FG000|Overall Study|Withdrawal by Subject|2|||
161464518|NCT00245583|583097287|FG001|Overall Study|Withdrawal by Subject|3|||
161464519|NCT04718103|583097288|FG000|Overall Study|Adverse Event|1|||
161464520|NCT04718103|583097289|FG001|Overall Study|Adverse Event|1|||
161464521|NCT04718103|583097288|FG000|Overall Study|Lack of Efficacy|4|||
161464522|NCT04718103|583097289|FG001|Overall Study|Lack of Efficacy|1|||
161464523|NCT04718103|583097288|FG000|Overall Study|Lost to Follow-up|2|||
161464524|NCT04718103|583097289|FG001|Overall Study|Lost to Follow-up|2|||
161464525|NCT04718103|583097288|FG000|Overall Study|Physician Decision|2|||
161464526|NCT04718103|583097289|FG001|Overall Study|Physician Decision|0|||
161464527|NCT04718103|583097288|FG000|Overall Study|Pregnancy|0|||
161464528|NCT04718103|583097289|FG001|Overall Study|Pregnancy|1|||
161464529|NCT04718103|583097288|FG000|Overall Study|Withdrawal by Subject|10|||
161464530|NCT04718103|583097289|FG001|Overall Study|Withdrawal by Subject|6|||
161464531|NCT04718103|583097288|FG000|Overall Study|Randomized, not treated|4|||
161464532|NCT04718103|583097289|FG001|Overall Study|Randomized, not treated|1|||
161464533|NCT04718103|583097288|FG000|Overall Study|GCP violations|7|||
161464534|NCT04718103|583097289|FG001|Overall Study|GCP violations|5|||
161464535|NCT01309893|583097290|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
161464536|NCT01309893|583097291|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
161464537|NCT01309893|583097290|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
161464538|NCT01309893|583097291|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
161464539|NCT02017171|583097292|FG000|Overall Study|Death|10|||
161464540|NCT02017171|583097293|FG001|Overall Study|Death|4|||
161810258|NCT03637764|584347745|FG000|Overall Study|Progressive Disease|23|||
161810259|NCT03637764|584347746|FG001|Overall Study|Progressive Disease|23|||
161810260|NCT03637764|584347747|FG002|Overall Study|Progressive Disease|18|||
161464541|NCT02017171|583097292|FG000|Overall Study|Withdrawal by Subject|23|||
161464542|NCT02017171|583097293|FG001|Overall Study|Withdrawal by Subject|17|||
161464543|NCT02017171|583097292|FG000|Overall Study|Lost to Follow-up|21|||
161464544|NCT02017171|583097293|FG001|Overall Study|Lost to Follow-up|20|||
161464545|NCT02017171|583097292|FG000|Overall Study|ESKD|6|||
161464546|NCT02017171|583097293|FG001|Overall Study|ESKD|2|||
161464547|NCT02017171|583097292|FG000|Overall Study|Miscellaneous|2|||
161464548|NCT02017171|583097293|FG001|Overall Study|Miscellaneous|3|||
161464549|NCT02220998|583097294|FG000|Overall Study|Randomized but Never Treated|1|||
161464550|NCT02220998|583097295|FG001|Overall Study|Randomized but Never Treated|2|||
161464551|NCT02220998|583097294|FG000|Overall Study|Death|2|||
161464552|NCT02220998|583097295|FG001|Overall Study|Death|0|||
161464553|NCT02220998|583097294|FG000|Overall Study|Lack of Efficacy|0|||
161464554|NCT02220998|583097295|FG001|Overall Study|Lack of Efficacy|5|||
161464555|NCT02220998|583097294|FG000|Overall Study|Lost to Follow-up|4|||
161464556|NCT02220998|583097295|FG001|Overall Study|Lost to Follow-up|4|||
161464557|NCT03309046|583097296|FG000|Overall Study|Withdrawal by Subject|4|||
161464558|NCT03309046|583097297|FG001|Overall Study|Withdrawal by Subject|17|||
161464559|NCT00873860|583097298|FG000|Overall Study|Lost to Follow-up|1|||
161464560|NCT00873860|583097299|FG001|Overall Study|Lost to Follow-up|0|||
161464561|NCT00873860|583097300|FG002|Overall Study|Lost to Follow-up|0|||
161464562|NCT00873860|583097301|FG003|Overall Study|Lost to Follow-up|1|||
161464563|NCT00873860|583097298|FG000|Overall Study|Withdrawal by Subject|1|||
161464564|NCT00873860|583097299|FG001|Overall Study|Withdrawal by Subject|0|||
161464565|NCT00873860|583097300|FG002|Overall Study|Withdrawal by Subject|2|||
161464566|NCT00873860|583097301|FG003|Overall Study|Withdrawal by Subject|0|||
161464567|NCT00873860|583097298|FG000|Overall Study|Death|1|||
161464568|NCT00873860|583097299|FG001|Overall Study|Death|0|||
161464569|NCT00873860|583097300|FG002|Overall Study|Death|0|||
161464570|NCT00873860|583097301|FG003|Overall Study|Death|0|||
161464571|NCT00873860|583097298|FG000|Overall Study|Other|1|||
161464572|NCT00873860|583097299|FG001|Overall Study|Other|0|||
161464573|NCT00873860|583097300|FG002|Overall Study|Other|1|||
161464574|NCT00873860|583097301|FG003|Overall Study|Other|0|||
161464575|NCT02764190|583097302|FG000|Overall Study|Lost to Follow-up|17|||
161464576|NCT02764190|583097303|FG001|Overall Study|Lost to Follow-up|13|||
161464577|NCT01172275|583097306|FG000|Overall Study|Lost to Follow-up|1|||
161464578|NCT01172275|583097307|FG001|Overall Study|Lost to Follow-up|0|||
161464579|NCT01172275|583097306|FG000|Overall Study|Protocol Violation|1|||
161464580|NCT01172275|583097307|FG001|Overall Study|Protocol Violation|0|||
161464581|NCT02862600|583097308|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
161464582|NCT02862600|583097308|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
161810261|NCT03637764|584347748|FG003|Overall Study|Progressive Disease|31|||
161464583|NCT02862600|583097308|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
161464584|NCT02862600|583097308|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
161464585|NCT00194675|583097309|FG000|Overall Study|Lost to Follow-up|1|||
161464586|NCT00194675|583097310|FG001|Overall Study|Lost to Follow-up|1|||
161464587|NCT00194675|583097309|FG000|Overall Study|lack of interest|1|||
161464588|NCT00194675|583097310|FG001|Overall Study|lack of interest|1|||
161464589|NCT00194675|583097309|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
161464590|NCT00194675|583097310|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
161464591|NCT00194675|583097309|FG000|Overall Study|Protocol Violation|1|||
161464592|NCT00194675|583097310|FG001|Overall Study|Protocol Violation|0|||
161464593|NCT00194675|583097309|FG000|Overall Study|Death|1|||
161464594|NCT00194675|583097310|FG001|Overall Study|Death|0|||
161464595|NCT04271280|583097311|FG000|Overall Study|Lost to Follow-up|300|||
161464596|NCT04271280|583097311|FG000|Overall Study|Death|153|||
161464597|NCT04271280|583097311|FG000|Overall Study|Withdrawal of consent by patient|59|||
161464598|NCT04271280|583097311|FG000|Overall Study|Other|51|||
161464599|NCT04271280|583097311|FG000|Overall Study|No end of study information|42|||
161464600|NCT00495131|583097312|FG000|Overall Study|Adverse Event|6|||
161464601|NCT00495131|583097313|FG001|Overall Study|Adverse Event|2|||
161464602|NCT00495131|583097312|FG000|Overall Study|Lack of Efficacy|0|||
161464603|NCT00495131|583097313|FG001|Overall Study|Lack of Efficacy|2|||
161464604|NCT00495131|583097312|FG000|Overall Study|Lost to Follow-up|0|||
161464605|NCT00495131|583097313|FG001|Overall Study|Lost to Follow-up|2|||
161464606|NCT00495131|583097312|FG000|Overall Study|Withdrawal by Subject|1|||
161464607|NCT00495131|583097313|FG001|Overall Study|Withdrawal by Subject|0|||
161914496|NCT02765165|584735608|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914497|NCT02765165|584735609|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
161464608|NCT01539317|583097314|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
161464609|NCT01539317|583097315|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
161464610|NCT00364130|583097316|FG000|Intervention Period|Lost to Follow-up|4|||
161464611|NCT00364130|583097317|FG001|Intervention Period|Lost to Follow-up|3|||
161464612|NCT00364130|583097316|FG000|Intervention Period|Pregnancy|1|||
161464613|NCT00364130|583097317|FG001|Intervention Period|Pregnancy|0|||
161464614|NCT00364130|583097316|FG000|Intervention Period|Withdrawal by Subject|4|||
161464615|NCT00364130|583097317|FG001|Intervention Period|Withdrawal by Subject|5|||
161464616|NCT00364130|583097316|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
161464617|NCT00364130|583097317|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
161464618|NCT00586846|583097325|FG000|Overall Study|Physician Decision|1|||
161464619|NCT00586846|583097325|FG000|Overall Study|Death|1|||
161464620|NCT00586846|583097325|FG000|Overall Study|Evaluable for Toxicity Only|4|||
161464621|NCT01702571|583097332|FG000|Overall Study|Death|1067|||
161464622|NCT01702571|583097333|FG001|Overall Study|Death|76|||
161464623|NCT01702571|583097332|FG000|Overall Study|Lost to Follow-up|144|||
161464624|NCT01702571|583097333|FG001|Overall Study|Lost to Follow-up|10|||
161464625|NCT01702571|583097332|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
161464626|NCT01702571|583097333|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
161464627|NCT01702571|583097332|FG000|Overall Study|Investigator Decision|5|||
161464628|NCT01702571|583097333|FG001|Overall Study|Investigator Decision|0|||
161464629|NCT01702571|583097332|FG000|Overall Study|Not Classifiable|1|||
161464630|NCT01702571|583097333|FG001|Overall Study|Not Classifiable|0|||
161464631|NCT01702571|583097332|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
161464632|NCT01702571|583097333|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
161464633|NCT01702571|583097332|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
161464634|NCT01702571|583097333|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
161464635|NCT01702571|583097332|FG000|Overall Study|Progressive Disease|3|||
161464636|NCT01702571|583097333|FG001|Overall Study|Progressive Disease|0|||
161464637|NCT01702571|583097332|FG000|Overall Study|Protocol Violation|2|||
161464638|NCT01702571|583097333|FG001|Overall Study|Protocol Violation|0|||
161464639|NCT01702571|583097332|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
161464640|NCT01702571|583097333|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
161573037|NCT03351075|583483919|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
161914498|NCT02765165|584735610|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
161464641|NCT01702571|583097332|FG000|Overall Study|Termination By Sponsor|4|||
161464642|NCT01702571|583097333|FG001|Overall Study|Termination By Sponsor|0|||
161464643|NCT01702571|583097332|FG000|Overall Study|Withdrawal by Subject|177|||
161914499|NCT02765165|584735611|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914500|NCT02765165|584735612|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914501|NCT02765165|584735613|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
161464644|NCT01702571|583097333|FG001|Overall Study|Withdrawal by Subject|29|||
161464645|NCT03004443|583097334|FG000|Overall Study|Pregnancy|0|||
161464646|NCT03004443|583097335|FG001|Overall Study|Pregnancy|1|||
161464647|NCT00828854|583097336|FG000|Overall Study|Disease Progression|17|||
161464648|NCT00828854|583097336|FG000|Overall Study|Adverse Event|9|||
161464649|NCT00828854|583097336|FG000|Overall Study|Reason not Specified|1|||
161464650|NCT04221230|583097337|FG000|Overall Study|Lost to Follow-up|12|||
161464651|NCT04221230|583097338|FG001|Overall Study|Lost to Follow-up|12|||
161464652|NCT04221230|583097337|FG000|Overall Study|Protocol Violation|2|||
161464653|NCT04221230|583097338|FG001|Overall Study|Protocol Violation|2|||
161464654|NCT04221230|583097337|FG000|Overall Study|Adverse Event|0|||
161464655|NCT04221230|583097338|FG001|Overall Study|Adverse Event|8|||
161464656|NCT04221230|583097337|FG000|Overall Study|Physician Decision|1|||
161464657|NCT04221230|583097338|FG001|Overall Study|Physician Decision|0|||
161464658|NCT04221230|583097337|FG000|Overall Study|Withdrawal by Subject|13|||
161464659|NCT04221230|583097338|FG001|Overall Study|Withdrawal by Subject|11|||
161464660|NCT04221230|583097337|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161464661|NCT04221230|583097338|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161464662|NCT04221230|583097337|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161464663|NCT04221230|583097338|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161464664|NCT04221230|583097337|FG000|Overall Study|Pregnancy|0|||
161464665|NCT04221230|583097338|FG001|Overall Study|Pregnancy|1|||
161464666|NCT04221230|583097337|FG000|Overall Study|Other|1|||
161464667|NCT04221230|583097338|FG001|Overall Study|Other|2|||
161464668|NCT00915356|583097339|FG000|Overall Study|Withdrawal by Subject|1|||
161464669|NCT00915356|583097340|FG001|Overall Study|Withdrawal by Subject|0|||
161464670|NCT00915356|583097341|FG002|Overall Study|Withdrawal by Subject|0|||
161464671|NCT00915356|583097342|FG003|Overall Study|Withdrawal by Subject|0|||
161464672|NCT00915356|583097343|FG004|Overall Study|Withdrawal by Subject|0|||
161464673|NCT00191646|583097345|FG000|Overall Study|Toxicity|26|||
161464674|NCT00191646|583097346|FG001|Overall Study|Toxicity|37|||
161464675|NCT00191646|583097345|FG000|Overall Study|Disease Progression|5|||
161464676|NCT00191646|583097346|FG001|Overall Study|Disease Progression|6|||
161464677|NCT00191646|583097345|FG000|Overall Study|Physician Decision|20|||
161464678|NCT00191646|583097346|FG001|Overall Study|Physician Decision|11|||
161464679|NCT00191646|583097345|FG000|Overall Study|Withdrawal by Subject|58|||
161464680|NCT00191646|583097346|FG001|Overall Study|Withdrawal by Subject|39|||
161464681|NCT00191646|583097345|FG000|Overall Study|Protocol Violation|5|||
161464682|NCT00191646|583097346|FG001|Overall Study|Protocol Violation|7|||
161464683|NCT00191646|583097345|FG000|Overall Study|Death|6|||
161464684|NCT00191646|583097346|FG001|Overall Study|Death|8|||
161464685|NCT00191646|583097345|FG000|Overall Study|Other|33|||
161464686|NCT00191646|583097346|FG001|Overall Study|Other|34|||
161464687|NCT00191646|583097345|FG000|Overall Study|Missing Data|18|||
161464688|NCT00191646|583097346|FG001|Overall Study|Missing Data|11|||
161464689|NCT05211284|583097354|FG000|Overall Study|Study Terminated|3|||
161464690|NCT05211284|583097355|FG001|Overall Study|Study Terminated|1|||
161810262|NCT03637764|584347745|FG000|Overall Study|Withdrawal by Subject|1|||
161810263|NCT03637764|584347746|FG001|Overall Study|Withdrawal by Subject|3|||
161810264|NCT03637764|584347747|FG002|Overall Study|Withdrawal by Subject|0|||
161810265|NCT03637764|584347748|FG003|Overall Study|Withdrawal by Subject|1|||
161810266|NCT02648438|584347749|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161810267|NCT02648438|584347750|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161810268|NCT02648438|584347751|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161810269|NCT02648438|584347749|FG000|Overall Study|Protocol Violation|2|||
161810270|NCT02648438|584347750|FG001|Overall Study|Protocol Violation|0|||
161810271|NCT02648438|584347751|FG002|Overall Study|Protocol Violation|0|||
161810272|NCT02648438|584347749|FG000|Overall Study|Withdrawal by Subject|1|||
161810273|NCT02648438|584347750|FG001|Overall Study|Withdrawal by Subject|1|||
161810274|NCT02648438|584347751|FG002|Overall Study|Withdrawal by Subject|0|||
161810275|NCT03138967|584347754|FG000|Overall Study|Death|0|||
161810276|NCT03138967|584347755|FG001|Overall Study|Death|1|||
161810277|NCT03138967|584347754|FG000|Overall Study|Physician Decision|1|||
161810278|NCT03138967|584347755|FG001|Overall Study|Physician Decision|3|||
161810279|NCT04604275|584347756|FG000|Washout-1 Week|Withdrawal by Subject|1|||
161810280|NCT04604275|584347757|FG001|Washout-1 Week|Withdrawal by Subject|0|||
161810281|NCT04405570|584347758|FG000|Overall Study|Adverse Event|0|||
161810282|NCT04405570|584347759|FG001|Overall Study|Adverse Event|1|||
161810283|NCT04405570|584347760|FG002|Overall Study|Adverse Event|1|||
161810284|NCT04405570|584347761|FG003|Overall Study|Adverse Event|1|||
161810285|NCT04405570|584347758|FG000|Overall Study|Lost to Follow-up|0|||
161810286|NCT04405570|584347759|FG001|Overall Study|Lost to Follow-up|1|||
161810287|NCT04405570|584347760|FG002|Overall Study|Lost to Follow-up|0|||
161810288|NCT04405570|584347761|FG003|Overall Study|Lost to Follow-up|0|||
161810289|NCT04405570|584347758|FG000|Overall Study|Physician Decision|0|||
161810290|NCT04405570|584347759|FG001|Overall Study|Physician Decision|0|||
161810291|NCT04405570|584347760|FG002|Overall Study|Physician Decision|1|||
161810292|NCT04405570|584347761|FG003|Overall Study|Physician Decision|0|||
161810293|NCT04405570|584347758|FG000|Overall Study|Withdrawal by Subject|0|||
161810294|NCT04405570|584347759|FG001|Overall Study|Withdrawal by Subject|1|||
161464691|NCT00395538|583097361|FG000|Overall Study|Did not re-consent to revised protocol|1|||
161464692|NCT00395538|583097362|FG001|Overall Study|Did not re-consent to revised protocol|10|||
161464693|NCT00395538|583097363|FG002|Overall Study|Did not re-consent to revised protocol|0|||
161464694|NCT00395538|583097361|FG000|Overall Study|FDA partial hold on PTH|0|||
161464695|NCT00395538|583097362|FG001|Overall Study|FDA partial hold on PTH|0|||
161464696|NCT00395538|583097363|FG002|Overall Study|FDA partial hold on PTH|11|||
161464697|NCT00395538|583097361|FG000|Overall Study|Failed screening|0|||
161464698|NCT00395538|583097362|FG001|Overall Study|Failed screening|0|||
161464699|NCT00395538|583097363|FG002|Overall Study|Failed screening|4|||
161464700|NCT00395538|583097361|FG000|Overall Study|Switch to Natpara|0|||
161464701|NCT00395538|583097362|FG001|Overall Study|Switch to Natpara|0|||
161464702|NCT00395538|583097363|FG002|Overall Study|Switch to Natpara|3|||
161464703|NCT00395538|583097361|FG000|Overall Study|Adverse Event|1|||
161464704|NCT00395538|583097362|FG001|Overall Study|Adverse Event|0|||
161464705|NCT00395538|583097363|FG002|Overall Study|Adverse Event|2|||
161464706|NCT00395538|583097361|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
161464707|NCT00395538|583097362|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
161464708|NCT00395538|583097363|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
161464709|NCT00395538|583097361|FG000|Overall Study|Non-compliance with study protocol|0|||
161464710|NCT00395538|583097362|FG001|Overall Study|Non-compliance with study protocol|1|||
161464711|NCT00395538|583097363|FG002|Overall Study|Non-compliance with study protocol|0|||
161464712|NCT00395538|583097361|FG000|Overall Study|PTH resistance|0|||
161464713|NCT00395538|583097362|FG001|Overall Study|PTH resistance|0|||
161464714|NCT00395538|583097363|FG002|Overall Study|PTH resistance|1|||
161464715|NCT00395538|583097361|FG000|Overall Study|Pregnancy|1|||
161464716|NCT00395538|583097362|FG001|Overall Study|Pregnancy|0|||
161464717|NCT00395538|583097363|FG002|Overall Study|Pregnancy|0|||
161914502|NCT02765165|584735614|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914503|NCT02765165|584735608|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914504|NCT02765165|584735609|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914505|NCT02765165|584735610|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914506|NCT02765165|584735611|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914507|NCT02765165|584735612|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
161914508|NCT02765165|584735613|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
161914509|NCT02765165|584735614|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
161914510|NCT02382939|584735617|FG000|Overall Study|Adverse Event|1|||
161914511|NCT02382939|584735618|FG001|Overall Study|Adverse Event|1|||
161914512|NCT02382939|584735617|FG000|Overall Study|Withdrawal by Subject|2|||
161914513|NCT02382939|584735618|FG001|Overall Study|Withdrawal by Subject|2|||
161914514|NCT01189266|584735621|FG000|Overall Study|Adverse Event|1|||
161914515|NCT01189266|584735622|FG001|Overall Study|Adverse Event|0|||
161914516|NCT01189266|584735623|FG002|Overall Study|Adverse Event|5|||
161914517|NCT01189266|584735621|FG000|Overall Study|Death|0|||
161914518|NCT01189266|584735622|FG001|Overall Study|Death|0|||
161914519|NCT01189266|584735623|FG002|Overall Study|Death|5|||
161914520|NCT01189266|584735621|FG000|Overall Study|Lack of Efficacy|4|||
161914521|NCT01189266|584735622|FG001|Overall Study|Lack of Efficacy|5|||
161914522|NCT01189266|584735623|FG002|Overall Study|Lack of Efficacy|44|||
161914523|NCT01189266|584735621|FG000|Overall Study|Physician Decision|0|||
161914524|NCT01189266|584735622|FG001|Overall Study|Physician Decision|0|||
161914525|NCT01189266|584735623|FG002|Overall Study|Physician Decision|1|||
161914526|NCT01189266|584735621|FG000|Overall Study|Protocol Violation|0|||
161914527|NCT01189266|584735622|FG001|Overall Study|Protocol Violation|1|||
161914528|NCT01189266|584735623|FG002|Overall Study|Protocol Violation|1|||
161914529|NCT01189266|584735621|FG000|Overall Study|Withdrawal by Subject|0|||
161914530|NCT01189266|584735622|FG001|Overall Study|Withdrawal by Subject|0|||
161914531|NCT01189266|584735623|FG002|Overall Study|Withdrawal by Subject|1|||
161914532|NCT01189266|584735621|FG000|Overall Study|Patient refuses further therapy|1|||
161914533|NCT01189266|584735622|FG001|Overall Study|Patient refuses further therapy|0|||
161914534|NCT01189266|584735623|FG002|Overall Study|Patient refuses further therapy|7|||
161914535|NCT01189266|584735621|FG000|Overall Study|No treatment|0|||
161914536|NCT01189266|584735622|FG001|Overall Study|No treatment|0|||
161464718|NCT00395538|583097361|FG000|Overall Study|Partial recovery of parathyroid function|0|||
161464719|NCT00395538|583097362|FG001|Overall Study|Partial recovery of parathyroid function|0|||
161464720|NCT00395538|583097363|FG002|Overall Study|Partial recovery of parathyroid function|1|||
161464721|NCT00395538|583097361|FG000|Overall Study|Participant elected to discontinue|0|||
161464722|NCT00395538|583097362|FG001|Overall Study|Participant elected to discontinue|0|||
161464723|NCT00395538|583097363|FG002|Overall Study|Participant elected to discontinue|1|||
161464724|NCT01074047|583097364|FG000|Treatment Phase|Adverse Event|89|||
161464725|NCT01074047|583097365|FG001|Treatment Phase|Adverse Event|66|||
161464726|NCT01074047|583097364|FG000|Treatment Phase|Disease Progression|16|||
161464727|NCT01074047|583097365|FG001|Treatment Phase|Disease Progression|21|||
161464728|NCT01074047|583097364|FG000|Treatment Phase|Withdrawal by Subject|27|||
161464729|NCT01074047|583097365|FG001|Treatment Phase|Withdrawal by Subject|48|||
161914537|NCT01189266|584735623|FG002|Overall Study|No treatment|1|||
161914538|NCT00321763|584735624|FG000|Overall Study|Adverse Event|1|||
161914539|NCT00321763|584735625|FG001|Overall Study|Adverse Event|1|||
161464730|NCT01074047|583097364|FG000|Treatment Phase|Death|53|||
161464731|NCT01074047|583097365|FG001|Treatment Phase|Death|58|||
161464732|NCT01074047|583097364|FG000|Treatment Phase|Lost to Follow-up|0|||
161464733|NCT01074047|583097365|FG001|Treatment Phase|Lost to Follow-up|1|||
161464734|NCT01074047|583097364|FG000|Treatment Phase|Protocol Violation|0|||
161914540|NCT00321763|584735626|FG002|Overall Study|Adverse Event|0|||
161914541|NCT00321763|584735627|FG003|Overall Study|Adverse Event|1|||
161914542|NCT00321763|584735624|FG000|Overall Study|Withdrawal by Subject|2|||
161914543|NCT00321763|584735625|FG001|Overall Study|Withdrawal by Subject|0|||
161914544|NCT00321763|584735626|FG002|Overall Study|Withdrawal by Subject|1|||
161914545|NCT00321763|584735627|FG003|Overall Study|Withdrawal by Subject|0|||
161914546|NCT00321763|584735624|FG000|Overall Study|Lost to Follow-up|3|||
161914547|NCT00321763|584735625|FG001|Overall Study|Lost to Follow-up|1|||
161914548|NCT00321763|584735626|FG002|Overall Study|Lost to Follow-up|5|||
161914549|NCT00321763|584735627|FG003|Overall Study|Lost to Follow-up|4|||
161914550|NCT03530696|584735631|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
161914551|NCT03530696|584735632|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
161914552|NCT01129128|584735633|FG000|Overall Study|Lost to Follow-up|2|||
161914553|NCT01129128|584735634|FG001|Overall Study|Lost to Follow-up|2|||
161914554|NCT01129128|584735635|FG002|Overall Study|Lost to Follow-up|1|||
161914555|NCT01129128|584735633|FG000|Overall Study|Protocol Violation|0|||
161914556|NCT01129128|584735634|FG001|Overall Study|Protocol Violation|1|||
161914557|NCT01129128|584735635|FG002|Overall Study|Protocol Violation|0|||
161914558|NCT01129128|584735633|FG000|Overall Study|Withdrawal by Subject|0|||
161914559|NCT01129128|584735634|FG001|Overall Study|Withdrawal by Subject|1|||
161914560|NCT01129128|584735635|FG002|Overall Study|Withdrawal by Subject|3|||
161914561|NCT01129128|584735633|FG000|Overall Study|Physician Decision|1|||
161914562|NCT01129128|584735634|FG001|Overall Study|Physician Decision|0|||
161914563|NCT01129128|584735635|FG002|Overall Study|Physician Decision|0|||
161914564|NCT01311661|584735638|FG000|Overall Study|Adverse Event|2|||
161914565|NCT01311661|584735638|FG000|Overall Study|Protocol Violation|3|||
161914566|NCT01311661|584735638|FG000|Overall Study|Withdrawal by Subject|2|||
161914567|NCT01900314|584735639|FG000|Overall Study|Lost to Follow-up|1|||
161914568|NCT01900314|584735640|FG001|Overall Study|Lost to Follow-up|0|||
161914569|NCT01900314|584735639|FG000|Overall Study|Protocol Violation|0|||
161914570|NCT01900314|584735640|FG001|Overall Study|Protocol Violation|1|||
161914571|NCT01900314|584735639|FG000|Overall Study|Withdrawal by Subject|3|||
161914572|NCT01900314|584735640|FG001|Overall Study|Withdrawal by Subject|3|||
161914573|NCT04759131|584735641|FG000|Overall Study|Investigator's discretion|1|||
161914574|NCT04759131|584735642|FG001|Overall Study|Investigator's discretion|0|||
161914575|NCT04759131|584735641|FG000|Overall Study|Subject withdrawal|1|||
161914576|NCT04759131|584735642|FG001|Overall Study|Subject withdrawal|0|||
161914577|NCT00289276|584735648|FG000|Second Part of FAST Study (Expansion)|Death|0|||
161914578|NCT00289276|584735649|FG001|Second Part of FAST Study (Expansion)|Death|2|||
161914579|NCT00289276|584735648|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
161914580|NCT00289276|584735649|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
161914581|NCT00869960|584735650|FG000|Overall Study|Lost to Follow-up|2|||
161914582|NCT02187783|584735651|FG000|Overall Study|Adverse Event|8|||
161914583|NCT02187783|584735651|FG000|Overall Study|Death|3|||
161914584|NCT02187783|584735651|FG000|Overall Study|Progressive disease|80|||
161914585|NCT02187783|584735651|FG000|Overall Study|Protocol Violation|3|||
161914586|NCT02187783|584735651|FG000|Overall Study|Physician Decision|2|||
161914587|NCT02187783|584735651|FG000|Overall Study|Withdrawal by Subject|9|||
161914588|NCT02187783|584735651|FG000|Overall Study|Study terminated by sponsor|1|||
161914589|NCT00171249|584735652|FG000|Overall Study|Withdrawal by Subject|2|||
161914590|NCT00171249|584735653|FG001|Overall Study|Withdrawal by Subject|0|||
161914591|NCT00171249|584735654|FG002|Overall Study|Withdrawal by Subject|0|||
161914592|NCT00171249|584735655|FG003|Overall Study|Withdrawal by Subject|6|||
161914593|NCT00171249|584735656|FG004|Overall Study|Withdrawal by Subject|0|||
161914594|NCT00171249|584735657|FG005|Overall Study|Withdrawal by Subject|0|||
161914595|NCT00171249|584735658|FG006|Overall Study|Withdrawal by Subject|0|||
161914596|NCT00171249|584735652|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
161914597|NCT00171249|584735653|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161914598|NCT00171249|584735654|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
161914599|NCT00171249|584735655|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
161914600|NCT00171249|584735656|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161914601|NCT00171249|584735657|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
161914602|NCT00171249|584735658|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161914603|NCT00171249|584735652|FG000|Overall Study|Death|7|||
161914604|NCT00171249|584735653|FG001|Overall Study|Death|1|||
161914605|NCT00171249|584735654|FG002|Overall Study|Death|0|||
161914606|NCT00171249|584735655|FG003|Overall Study|Death|4|||
161914607|NCT00171249|584735656|FG004|Overall Study|Death|0|||
161914608|NCT00171249|584735657|FG005|Overall Study|Death|3|||
161914609|NCT00171249|584735658|FG006|Overall Study|Death|1|||
161914610|NCT00171249|584735652|FG000|Overall Study|Other|10|||
161914611|NCT00171249|584735653|FG001|Overall Study|Other|0|||
161914612|NCT00171249|584735654|FG002|Overall Study|Other|0|||
161914613|NCT00171249|584735655|FG003|Overall Study|Other|43|||
161914614|NCT00171249|584735656|FG004|Overall Study|Other|0|||
161914615|NCT00171249|584735657|FG005|Overall Study|Other|2|||
161914616|NCT00171249|584735658|FG006|Overall Study|Other|0|||
161914617|NCT00171249|584735652|FG000|Overall Study|No Longer Requires Study Drug|4|||
161914618|NCT00171249|584735653|FG001|Overall Study|No Longer Requires Study Drug|0|||
161914619|NCT00171249|584735654|FG002|Overall Study|No Longer Requires Study Drug|0|||
161914620|NCT00171249|584735655|FG003|Overall Study|No Longer Requires Study Drug|3|||
161914621|NCT00171249|584735656|FG004|Overall Study|No Longer Requires Study Drug|0|||
161464735|NCT01074047|583097365|FG001|Treatment Phase|Protocol Violation|1|||
161464736|NCT01074047|583097364|FG000|Treatment Phase|Miscellaneous|32|||
161464737|NCT01074047|583097365|FG001|Treatment Phase|Miscellaneous|39|||
161464738|NCT01074047|583097364|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
161464739|NCT01074047|583097365|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
161464740|NCT01074047|583097364|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
161464741|NCT01074047|583097365|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
161464742|NCT01074047|583097364|FG000|Survival Follow-Up Phase|Death|116|||
161464743|NCT01074047|583097365|FG001|Survival Follow-Up Phase|Death|124|||
161464744|NCT01074047|583097364|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
161464745|NCT01074047|583097365|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
161464746|NCT01074047|583097364|FG000|Extension Phase|Physician Decision|1|||
161464747|NCT01074047|583097365|FG001|Extension Phase|Physician Decision|0|||
161464748|NCT01074047|583097364|FG000|Extension Phase|Adverse Event|5|||
161464749|NCT01074047|583097365|FG001|Extension Phase|Adverse Event|0|||
161464750|NCT01074047|583097364|FG000|Extension Phase|Disease Progression|9|||
161464751|NCT01074047|583097365|FG001|Extension Phase|Disease Progression|0|||
161464752|NCT01074047|583097364|FG000|Extension Phase|Withdrawal by Subject|2|||
161464753|NCT01074047|583097365|FG001|Extension Phase|Withdrawal by Subject|0|||
161464754|NCT01074047|583097364|FG000|Extension Phase|Death|5|||
161464755|NCT01074047|583097365|FG001|Extension Phase|Death|0|||
161464756|NCT02211638|583097366|FG000|Overall Study|Case Report Forms Uncollected|291|||
161464757|NCT02211638|583097366|FG000|Overall Study|Protocol Violation|692|||
161464758|NCT03120624|583097368|FG000|Overall Study|Withdrawal by Subject|0|||
161464759|NCT03120624|583097369|FG001|Overall Study|Withdrawal by Subject|1|||
161464760|NCT03120624|583097370|FG002|Overall Study|Withdrawal by Subject|0|||
161464761|NCT03120624|583097371|FG003|Overall Study|Withdrawal by Subject|0|||
161464762|NCT03120624|583097372|FG004|Overall Study|Withdrawal by Subject|0|||
161464763|NCT03120624|583097373|FG005|Overall Study|Withdrawal by Subject|0|||
161464764|NCT03120624|583097374|FG006|Overall Study|Withdrawal by Subject|0|||
161914622|NCT00171249|584735657|FG005|Overall Study|No Longer Requires Study Drug|5|||
161464765|NCT03120624|583097375|FG007|Overall Study|Withdrawal by Subject|0|||
161464766|NCT05140382|583097376|FG000|Overall Study|Death|3|||
161464767|NCT05140382|583097377|FG001|Overall Study|Death|0|||
161573038|NCT03351075|583483920|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
161573039|NCT05219253|583483921|FG000|Overall Study|Withdrawal by Subject|1|||
161573040|NCT05219253|583483922|FG001|Overall Study|Withdrawal by Subject|2|||
161573041|NCT03544515|583483923|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
161573042|NCT03544515|583483924|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
161573043|NCT03544515|583483923|FG000|Overall Study|Lost to Follow-up|2|||
161573044|NCT03544515|583483924|FG001|Overall Study|Lost to Follow-up|0|||
161573045|NCT00393848|583483927|FG000|Overall Study|Surgical schedule|0|||
161573046|NCT00393848|583483928|FG001|Overall Study|Surgical schedule|0|||
161573047|NCT00393848|583483929|FG002|Overall Study|Surgical schedule|0|||
161573048|NCT00393848|583483930|FG003|Overall Study|Surgical schedule|1|||
161573049|NCT00393848|583483927|FG000|Overall Study|Personal reasons|0|||
161573050|NCT00393848|583483928|FG001|Overall Study|Personal reasons|0|||
161573051|NCT00393848|583483929|FG002|Overall Study|Personal reasons|2|||
161573052|NCT00393848|583483930|FG003|Overall Study|Personal reasons|0|||
161573053|NCT01376089|583483935|FG000|Overall Study|Patient received no contrast media|3|||
161573054|NCT01376089|583483936|FG001|Overall Study|Patient received no contrast media|4|||
161573055|NCT03262935|583483937|FG000|Overall Study|Withdrawal by Subject|6|||
161573056|NCT03262935|583483938|FG001|Overall Study|Withdrawal by Subject|7|||
161573057|NCT03262935|583483937|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
161573058|NCT03262935|583483938|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
161573059|NCT03262935|583483937|FG000|Overall Study|Death|181|||
161573060|NCT03262935|583483938|FG001|Overall Study|Death|94|||
161573061|NCT03262935|583483937|FG000|Overall Study|Lost to Follow-up|9|||
161914623|NCT00171249|584735658|FG006|Overall Study|No Longer Requires Study Drug|0|||
161914624|NCT00171249|584735652|FG000|Overall Study|Administrative Problems|1|||
161573062|NCT03262935|583483938|FG001|Overall Study|Lost to Follow-up|4|||
161573063|NCT03262935|583483937|FG000|Overall Study|Other reason|5|||
161573064|NCT03262935|583483938|FG001|Overall Study|Other reason|0|||
161914625|NCT00171249|584735653|FG001|Overall Study|Administrative Problems|0|||
161464768|NCT05140382|583097378|FG002|Overall Study|Death|0|||
161464769|NCT05140382|583097376|FG000|Overall Study|Investigator decision|1|||
161464770|NCT05140382|583097377|FG001|Overall Study|Investigator decision|0|||
161464771|NCT05140382|583097378|FG002|Overall Study|Investigator decision|0|||
161464772|NCT05140382|583097376|FG000|Overall Study|Other|4|||
161464773|NCT05140382|583097377|FG001|Overall Study|Other|0|||
161464774|NCT05140382|583097378|FG002|Overall Study|Other|1|||
161573065|NCT01811706|583483939|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
161914626|NCT00171249|584735654|FG002|Overall Study|Administrative Problems|0|||
161573066|NCT01811706|583483940|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
161914627|NCT00171249|584735655|FG003|Overall Study|Administrative Problems|2|||
161914628|NCT00171249|584735656|FG004|Overall Study|Administrative Problems|0|||
161914629|NCT00171249|584735657|FG005|Overall Study|Administrative Problems|0|||
161464775|NCT05140382|583097376|FG000|Overall Study|Progressive disease|20|||
161464776|NCT05140382|583097377|FG001|Overall Study|Progressive disease|1|||
161464777|NCT05140382|583097378|FG002|Overall Study|Progressive disease|12|||
161464778|NCT05140382|583097376|FG000|Overall Study|Subjective disease progression|2|||
161464779|NCT05140382|583097377|FG001|Overall Study|Subjective disease progression|1|||
161464780|NCT05140382|583097378|FG002|Overall Study|Subjective disease progression|0|||
161464781|NCT05140382|583097376|FG000|Overall Study|Unknown at data cut-off|0|||
161464782|NCT05140382|583097377|FG001|Overall Study|Unknown at data cut-off|0|||
161464783|NCT05140382|583097378|FG002|Overall Study|Unknown at data cut-off|1|||
161464784|NCT05140382|583097376|FG000|Overall Study|Withdrawal by Subject|1|||
161464785|NCT05140382|583097377|FG001|Overall Study|Withdrawal by Subject|0|||
161464786|NCT05140382|583097378|FG002|Overall Study|Withdrawal by Subject|4|||
161464787|NCT05140382|583097376|FG000|Overall Study|Withdrawal of consent|0|||
161464788|NCT05140382|583097377|FG001|Overall Study|Withdrawal of consent|0|||
161464789|NCT05140382|583097378|FG002|Overall Study|Withdrawal of consent|1|||
161464790|NCT01397201|583098767|FG000|Overall Study|Not treated|0|||
161464791|NCT01397201|583098768|FG001|Overall Study|Not treated|0|||
161464792|NCT01397201|583098769|FG002|Overall Study|Not treated|1|||
161464793|NCT01397201|583098770|FG003|Overall Study|Not treated|0|||
161464794|NCT01397201|583098771|FG004|Overall Study|Not treated|0|||
161464795|NCT01397201|583098767|FG000|Overall Study|Not yet defined|3|||
161464796|NCT01397201|583098768|FG001|Overall Study|Not yet defined|6|||
161464797|NCT01397201|583098769|FG002|Overall Study|Not yet defined|5|||
161464798|NCT01397201|583098770|FG003|Overall Study|Not yet defined|5|||
161464799|NCT01397201|583098771|FG004|Overall Study|Not yet defined|4|||
161464800|NCT01397201|583098767|FG000|Overall Study|Adverse Event|2|||
161464801|NCT01397201|583098768|FG001|Overall Study|Adverse Event|0|||
161464802|NCT01397201|583098769|FG002|Overall Study|Adverse Event|0|||
161464803|NCT01397201|583098770|FG003|Overall Study|Adverse Event|0|||
161464804|NCT01397201|583098771|FG004|Overall Study|Adverse Event|0|||
161464805|NCT02598960|583098778|FG000|Treatment Period|Disease Progression|4|||
161464806|NCT02598960|583098779|FG001|Treatment Period|Disease Progression|4|||
161464807|NCT02598960|583098780|FG002|Treatment Period|Disease Progression|4|||
161464808|NCT02598960|583098781|FG003|Treatment Period|Disease Progression|6|||
161464809|NCT02598960|583098782|FG004|Treatment Period|Disease Progression|8|||
161464810|NCT02598960|583098783|FG005|Treatment Period|Disease Progression|2|||
161464811|NCT02598960|583098784|FG006|Treatment Period|Disease Progression|2|||
161464812|NCT02598960|583098785|FG007|Treatment Period|Disease Progression|3|||
161464813|NCT02598960|583098786|FG008|Treatment Period|Disease Progression|7|||
161464814|NCT02598960|583098787|FG009|Treatment Period|Disease Progression|9|||
161464815|NCT02598960|583098788|FG010|Treatment Period|Disease Progression|7|||
161464816|NCT02598960|583098789|FG011|Treatment Period|Disease Progression|143|||
161464817|NCT02598960|583098790|FG012|Treatment Period|Disease Progression|23|||
161464818|NCT02598960|583098778|FG000|Treatment Period|Study drug toxicity|0|||
161464819|NCT02598960|583098779|FG001|Treatment Period|Study drug toxicity|0|||
161464820|NCT02598960|583098780|FG002|Treatment Period|Study drug toxicity|0|||
161464821|NCT02598960|583098781|FG003|Treatment Period|Study drug toxicity|0|||
161464822|NCT02598960|583098782|FG004|Treatment Period|Study drug toxicity|0|||
161464823|NCT02598960|583098783|FG005|Treatment Period|Study drug toxicity|0|||
161464824|NCT02598960|583098784|FG006|Treatment Period|Study drug toxicity|0|||
161464825|NCT02598960|583098785|FG007|Treatment Period|Study drug toxicity|0|||
161464826|NCT02598960|583098786|FG008|Treatment Period|Study drug toxicity|0|||
161464827|NCT02598960|583098787|FG009|Treatment Period|Study drug toxicity|1|||
161464828|NCT02598960|583098788|FG010|Treatment Period|Study drug toxicity|0|||
161464829|NCT02598960|583098789|FG011|Treatment Period|Study drug toxicity|3|||
161464830|NCT02598960|583098790|FG012|Treatment Period|Study drug toxicity|0|||
161464831|NCT02598960|583098778|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
161464832|NCT02598960|583098779|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
161464833|NCT02598960|583098780|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
161464834|NCT02598960|583098781|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
161464835|NCT02598960|583098782|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
161573067|NCT03557008|583483941|FG000|Overall Study|Withdrawal by Subject|2|||
161573068|NCT03557008|583483942|FG001|Overall Study|Withdrawal by Subject|2|||
161914630|NCT00171249|584735658|FG006|Overall Study|Administrative Problems|0|||
161464836|NCT02598960|583098783|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
161464837|NCT02598960|583098784|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
161464838|NCT02598960|583098785|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
161464839|NCT02598960|583098786|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
161464840|NCT02598960|583098787|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
161464841|NCT02598960|583098788|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
161914631|NCT00171249|584735652|FG000|Overall Study|Adverse Event|3|||
161914632|NCT00171249|584735653|FG001|Overall Study|Adverse Event|1|||
161464842|NCT02598960|583098789|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
161464843|NCT02598960|583098790|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
161464844|NCT02598960|583098778|FG000|Treatment Period|participant request to discontinue|0|||
161464845|NCT02598960|583098779|FG001|Treatment Period|participant request to discontinue|1|||
161464846|NCT02598960|583098780|FG002|Treatment Period|participant request to discontinue|0|||
161464847|NCT02598960|583098781|FG003|Treatment Period|participant request to discontinue|0|||
161464848|NCT02598960|583098782|FG004|Treatment Period|participant request to discontinue|1|||
161464849|NCT02598960|583098783|FG005|Treatment Period|participant request to discontinue|0|||
161464850|NCT02598960|583098784|FG006|Treatment Period|participant request to discontinue|0|||
161464851|NCT02598960|583098785|FG007|Treatment Period|participant request to discontinue|0|||
161464852|NCT02598960|583098786|FG008|Treatment Period|participant request to discontinue|0|||
161464853|NCT02598960|583098787|FG009|Treatment Period|participant request to discontinue|0|||
161464854|NCT02598960|583098788|FG010|Treatment Period|participant request to discontinue|1|||
161464855|NCT02598960|583098789|FG011|Treatment Period|participant request to discontinue|4|||
161464856|NCT02598960|583098790|FG012|Treatment Period|participant request to discontinue|0|||
161464857|NCT02598960|583098778|FG000|Treatment Period|participant withdrew consent|0|||
161464858|NCT02598960|583098779|FG001|Treatment Period|participant withdrew consent|0|||
161464859|NCT02598960|583098780|FG002|Treatment Period|participant withdrew consent|0|||
161464860|NCT02598960|583098781|FG003|Treatment Period|participant withdrew consent|0|||
161464861|NCT02598960|583098782|FG004|Treatment Period|participant withdrew consent|0|||
161464862|NCT02598960|583098783|FG005|Treatment Period|participant withdrew consent|0|||
161464863|NCT02598960|583098784|FG006|Treatment Period|participant withdrew consent|0|||
161464864|NCT02598960|583098785|FG007|Treatment Period|participant withdrew consent|0|||
161464865|NCT02598960|583098786|FG008|Treatment Period|participant withdrew consent|0|||
161464866|NCT02598960|583098787|FG009|Treatment Period|participant withdrew consent|0|||
161464867|NCT02598960|583098788|FG010|Treatment Period|participant withdrew consent|0|||
161464868|NCT02598960|583098789|FG011|Treatment Period|participant withdrew consent|3|||
161464869|NCT02598960|583098790|FG012|Treatment Period|participant withdrew consent|0|||
161464870|NCT02598960|583098778|FG000|Treatment Period|No longer meets study criteria|0|||
161464871|NCT02598960|583098779|FG001|Treatment Period|No longer meets study criteria|0|||
161464872|NCT02598960|583098780|FG002|Treatment Period|No longer meets study criteria|0|||
161464873|NCT02598960|583098781|FG003|Treatment Period|No longer meets study criteria|0|||
161464874|NCT02598960|583098782|FG004|Treatment Period|No longer meets study criteria|0|||
161464875|NCT02598960|583098783|FG005|Treatment Period|No longer meets study criteria|0|||
161464876|NCT02598960|583098784|FG006|Treatment Period|No longer meets study criteria|0|||
161464877|NCT02598960|583098785|FG007|Treatment Period|No longer meets study criteria|0|||
161464878|NCT02598960|583098786|FG008|Treatment Period|No longer meets study criteria|0|||
161464879|NCT02598960|583098787|FG009|Treatment Period|No longer meets study criteria|0|||
161464880|NCT02598960|583098788|FG010|Treatment Period|No longer meets study criteria|0|||
161464881|NCT02598960|583098789|FG011|Treatment Period|No longer meets study criteria|1|||
161464882|NCT02598960|583098790|FG012|Treatment Period|No longer meets study criteria|0|||
161464883|NCT02598960|583098778|FG000|Treatment Period|Other Reasons|0|||
161464884|NCT02598960|583098779|FG001|Treatment Period|Other Reasons|0|||
161464885|NCT02598960|583098780|FG002|Treatment Period|Other Reasons|0|||
161464886|NCT02598960|583098781|FG003|Treatment Period|Other Reasons|0|||
161464887|NCT02598960|583098782|FG004|Treatment Period|Other Reasons|0|||
161464888|NCT02598960|583098783|FG005|Treatment Period|Other Reasons|0|||
161464889|NCT02598960|583098784|FG006|Treatment Period|Other Reasons|0|||
161573069|NCT03557008|583483941|FG000|Overall Study|Early termination from study|3|||
161573070|NCT03557008|583483942|FG001|Overall Study|Early termination from study|1|||
161573071|NCT02224924|583483943|FG000|Overall Study|Withdrawal by Subject|7|||
161573072|NCT02224924|583483944|FG001|Overall Study|Withdrawal by Subject|6|||
161464890|NCT02598960|583098785|FG007|Treatment Period|Other Reasons|0|||
161573073|NCT02224924|583483943|FG000|Overall Study|Biopsy cancelled|20|||
161573074|NCT02224924|583483944|FG001|Overall Study|Biopsy cancelled|14|||
161573075|NCT02224924|583483943|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
161573076|NCT02224924|583483944|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
161573077|NCT02224924|583483943|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
161573078|NCT02224924|583483944|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
161573079|NCT01458210|583483947|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
161573080|NCT01458210|583483947|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
161573081|NCT01458210|583483947|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
161573082|NCT01458210|583483947|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
161573083|NCT03020745|583483948|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573084|NCT03020745|583483949|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573085|NCT03020745|583483950|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
161810295|NCT04405570|584347760|FG002|Overall Study|Withdrawal by Subject|1|||
161810296|NCT04405570|584347761|FG003|Overall Study|Withdrawal by Subject|0|||
161810297|NCT04405570|584347758|FG000|Overall Study|Randomized not dosed|0|||
161810298|NCT04405570|584347759|FG001|Overall Study|Randomized not dosed|2|||
161573086|NCT03020745|583483951|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573087|NCT03020745|583483952|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573088|NCT03020745|583483953|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573089|NCT03020745|583483954|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573090|NCT03020745|583483955|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573091|NCT03020745|583483956|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
161914633|NCT00171249|584735654|FG002|Overall Study|Adverse Event|0|||
161914634|NCT00171249|584735655|FG003|Overall Study|Adverse Event|15|||
161914635|NCT00171249|584735656|FG004|Overall Study|Adverse Event|0|||
161914636|NCT00171249|584735657|FG005|Overall Study|Adverse Event|2|||
161914637|NCT00171249|584735658|FG006|Overall Study|Adverse Event|0|||
161914638|NCT00171249|584735652|FG000|Overall Study|Lost to Follow-up|5|||
161914639|NCT00171249|584735653|FG001|Overall Study|Lost to Follow-up|0|||
161914640|NCT00171249|584735654|FG002|Overall Study|Lost to Follow-up|0|||
161914641|NCT00171249|584735655|FG003|Overall Study|Lost to Follow-up|9|||
161914642|NCT00171249|584735656|FG004|Overall Study|Lost to Follow-up|0|||
161914643|NCT00171249|584735657|FG005|Overall Study|Lost to Follow-up|0|||
161914644|NCT00171249|584735658|FG006|Overall Study|Lost to Follow-up|0|||
161914645|NCT00392223|584735659|FG000|Overall Study|Adverse Event|5|||
161914646|NCT00392223|584735660|FG001|Overall Study|Adverse Event|4|||
161914647|NCT00392223|584735659|FG000|Overall Study|Lost to Follow-up|1|||
161914648|NCT00392223|584735660|FG001|Overall Study|Lost to Follow-up|4|||
161914649|NCT00392223|584735659|FG000|Overall Study|Protocol Violation|0|||
161914650|NCT00392223|584735660|FG001|Overall Study|Protocol Violation|3|||
161914651|NCT00392223|584735659|FG000|Overall Study|Withdrawal by Subject|3|||
161914652|NCT00392223|584735660|FG001|Overall Study|Withdrawal by Subject|2|||
161914653|NCT02908347|584735661|FG000|Overall Study|Adverse Event|0|||
161914654|NCT02908347|584735662|FG001|Overall Study|Adverse Event|1|||
161914655|NCT02908347|584735661|FG000|Overall Study|Lost to Follow-up|1|||
161914656|NCT02908347|584735662|FG001|Overall Study|Lost to Follow-up|0|||
161914657|NCT05516758|584735668|FG000|Overall Study|Adverse Event|5|||
161914658|NCT05516758|584735669|FG001|Overall Study|Adverse Event|1|||
161914659|NCT05516758|584735670|FG002|Overall Study|Adverse Event|3|||
161464891|NCT02598960|583098786|FG008|Treatment Period|Other Reasons|0|||
161464892|NCT02598960|583098787|FG009|Treatment Period|Other Reasons|0|||
161464893|NCT02598960|583098788|FG010|Treatment Period|Other Reasons|0|||
161464894|NCT02598960|583098789|FG011|Treatment Period|Other Reasons|0|||
161464895|NCT02598960|583098790|FG012|Treatment Period|Other Reasons|1|||
161464896|NCT02598960|583098778|FG000|Participants Entering Follow Up Period|Death|1|||
161464897|NCT02598960|583098779|FG001|Participants Entering Follow Up Period|Death|0|||
161464898|NCT02598960|583098780|FG002|Participants Entering Follow Up Period|Death|0|||
161464899|NCT02598960|583098781|FG003|Participants Entering Follow Up Period|Death|0|||
161464900|NCT02598960|583098782|FG004|Participants Entering Follow Up Period|Death|0|||
161464901|NCT02598960|583098783|FG005|Participants Entering Follow Up Period|Death|0|||
161464902|NCT02598960|583098784|FG006|Participants Entering Follow Up Period|Death|0|||
161464903|NCT02598960|583098785|FG007|Participants Entering Follow Up Period|Death|0|||
161464904|NCT02598960|583098786|FG008|Participants Entering Follow Up Period|Death|0|||
161464905|NCT02598960|583098787|FG009|Participants Entering Follow Up Period|Death|1|||
161464906|NCT02598960|583098788|FG010|Participants Entering Follow Up Period|Death|0|||
161464907|NCT02598960|583098789|FG011|Participants Entering Follow Up Period|Death|11|||
161464908|NCT02598960|583098790|FG012|Participants Entering Follow Up Period|Death|2|||
161464909|NCT02598960|583098778|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464910|NCT02598960|583098779|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464911|NCT02598960|583098780|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464912|NCT02598960|583098781|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464913|NCT02598960|583098782|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464914|NCT02598960|583098783|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464915|NCT02598960|583098784|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464916|NCT02598960|583098785|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464917|NCT02598960|583098786|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464918|NCT02598960|583098787|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464919|NCT02598960|583098788|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464920|NCT02598960|583098789|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
161464921|NCT02598960|583098790|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
161464922|NCT02598960|583098778|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
161464923|NCT02598960|583098779|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
161464924|NCT02598960|583098780|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
161464925|NCT02598960|583098781|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
161464926|NCT02598960|583098782|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
161464927|NCT02598960|583098783|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
161464928|NCT02598960|583098784|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
161464929|NCT02598960|583098785|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
161464930|NCT02598960|583098786|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
161464931|NCT02598960|583098787|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
161464932|NCT02598960|583098788|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
161464933|NCT02598960|583098789|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
161464934|NCT02598960|583098790|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
161464935|NCT02598960|583098778|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464936|NCT02598960|583098779|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464937|NCT02598960|583098780|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464938|NCT02598960|583098781|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464939|NCT02598960|583098782|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464940|NCT02598960|583098783|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464941|NCT02598960|583098784|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161573092|NCT03020745|583483957|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
161573093|NCT03020745|583483948|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573094|NCT03020745|583483949|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573095|NCT03020745|583483950|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573096|NCT03020745|583483951|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573097|NCT03020745|583483952|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573098|NCT03020745|583483953|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573099|NCT03020745|583483954|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573100|NCT03020745|583483955|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
161573101|NCT03020745|583483956|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161573102|NCT03020745|583483957|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161810299|NCT04405570|584347760|FG002|Overall Study|Randomized not dosed|0|||
161810300|NCT04405570|584347761|FG003|Overall Study|Randomized not dosed|0|||
161810301|NCT04499963|584347762|FG000|Overall Study|Adverse Event|3|||
161810302|NCT04499963|584347763|FG001|Overall Study|Adverse Event|0|||
161810303|NCT04499963|584347762|FG000|Overall Study|Death|3|||
161810304|NCT04499963|584347763|FG001|Overall Study|Death|0|||
161810305|NCT04499963|584347762|FG000|Overall Study|Lack of Efficacy|7|||
161810306|NCT04499963|584347763|FG001|Overall Study|Lack of Efficacy|0|||
161810307|NCT04499963|584347762|FG000|Overall Study|Lost to Follow-up|2|||
161810308|NCT04499963|584347763|FG001|Overall Study|Lost to Follow-up|0|||
161810309|NCT02601625|584347767|FG000|Overall Study|Lost to Follow-up|0|||
161810310|NCT02601625|584347768|FG001|Overall Study|Lost to Follow-up|0|||
161810311|NCT02601625|584347769|FG002|Overall Study|Lost to Follow-up|1|||
161810312|NCT02601625|584347770|FG003|Overall Study|Lost to Follow-up|1|||
161810313|NCT00838279|584347771|FG000|Washout|Protocol Violation|1|||
161810314|NCT00838279|584347772|FG001|Washout|Protocol Violation|0|||
161810315|NCT00838279|584347771|FG000|Washout|Withdrawal by Subject|0|||
161464942|NCT02598960|583098785|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464943|NCT02598960|583098786|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464944|NCT02598960|583098787|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464945|NCT02598960|583098788|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464946|NCT02598960|583098789|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
161464947|NCT02598960|583098790|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161464948|NCT02598960|583098778|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
161464949|NCT02598960|583098779|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
161464950|NCT02598960|583098780|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
161464951|NCT02598960|583098781|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
161464952|NCT02598960|583098782|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
161573103|NCT03020745|583483948|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573104|NCT03020745|583483949|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573105|NCT03020745|583483950|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161810316|NCT00838279|584347772|FG001|Washout|Withdrawal by Subject|1|||
161810317|NCT04608188|584347773|FG000|Overall Study|Withdrawal by Subject|4|||
161810318|NCT04608188|584347774|FG001|Overall Study|Withdrawal by Subject|8|||
161810319|NCT04419311|584347776|FG000|Overall Study|Lost to Follow-up|1|||
161810320|NCT04419311|584347777|FG001|Overall Study|Lost to Follow-up|0|||
161810321|NCT03586726|584347780|FG000|Overall Study|Withdrawal by Subject|1|||
161810322|NCT01921062|584347781|FG000|Overall Study|Withdrawal by Subject|0|||
161810323|NCT01921062|584347782|FG001|Overall Study|Withdrawal by Subject|7|||
161810324|NCT01921062|584347781|FG000|Overall Study|Adverse Event|5|||
161810325|NCT01921062|584347782|FG001|Overall Study|Adverse Event|6|||
161810326|NCT01921062|584347781|FG000|Overall Study|Protocol Violation|0|||
161810327|NCT01921062|584347782|FG001|Overall Study|Protocol Violation|1|||
161810328|NCT01921062|584347781|FG000|Overall Study|VMIQ score > 72|4|||
161810329|NCT01921062|584347782|FG001|Overall Study|VMIQ score > 72|1|||
161810330|NCT01921062|584347781|FG000|Overall Study|Logistic error|0|||
161810331|NCT01921062|584347782|FG001|Overall Study|Logistic error|1|||
161810332|NCT00965185|584347783|FG000|Overall Study|Lost to Follow-up|2|||
161810333|NCT00965185|584347784|FG001|Overall Study|Lost to Follow-up|0|||
161810334|NCT00965185|584347783|FG000|Overall Study|Withdrawal by Subject|0|||
161810335|NCT00965185|584347784|FG001|Overall Study|Withdrawal by Subject|1|||
161810336|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
161810337|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
161810338|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
161810339|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
161810340|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
161810341|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
161810342|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
161810343|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
161810344|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
161810345|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
161810346|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
161810347|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
161810348|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161810349|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161810350|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161810351|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
161810352|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
161810353|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
161810354|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
161810355|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
161810356|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
161810357|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
161810358|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
161810359|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
161810360|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
161810361|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
161810362|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
161810363|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
161810364|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
161810365|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
161810366|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
161810367|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
161810368|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
161464953|NCT02598960|583098783|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
161464954|NCT02598960|583098784|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
161464955|NCT02598960|583098785|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
161464956|NCT02598960|583098786|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
161464957|NCT02598960|583098787|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
161464958|NCT02598960|583098788|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
161464959|NCT02598960|583098789|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
161464960|NCT02598960|583098790|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
161464961|NCT00398411|583098791|FG000|Overall Study|Death|0|||
161464962|NCT00398411|583098792|FG001|Overall Study|Death|1|||
161464963|NCT00401531|583098793|FG000|Overall Study|Adverse Event|2|||
161464964|NCT00401531|583098794|FG001|Overall Study|Adverse Event|0|||
161464965|NCT00401531|583098793|FG000|Overall Study|Protocol Violation|3|||
161464966|NCT00401531|583098794|FG001|Overall Study|Protocol Violation|7|||
161464967|NCT00401531|583098793|FG000|Overall Study|Lost to Follow-up|1|||
161464968|NCT00401531|583098794|FG001|Overall Study|Lost to Follow-up|1|||
161464969|NCT00401531|583098793|FG000|Overall Study|Withdrawal by Subject|3|||
161464970|NCT00401531|583098794|FG001|Overall Study|Withdrawal by Subject|2|||
161464971|NCT01614600|583098799|FG000|Overall Study|Unacceptable fit|1|||
161464972|NCT01614600|583098799|FG000|Overall Study|Discomfort|1|||
161464973|NCT01614600|583098799|FG000|Overall Study|Unable to remove lens at the end of day|1|||
161464974|NCT01614600|583098799|FG000|Overall Study|Protocol deviation|1|||
161464975|NCT03403374|583098800|FG000|Overall Study|Lost to Follow-up|1|||
161464976|NCT01229371|583098804|FG000|Overall Study|Withdrawal by Subject|0|||
161464977|NCT01229371|583098805|FG001|Overall Study|Withdrawal by Subject|1|||
161464978|NCT01229371|583098806|FG002|Overall Study|Withdrawal by Subject|0|||
161464979|NCT01229371|583098807|FG003|Overall Study|Withdrawal by Subject|0|||
161464980|NCT05314478|583098808|FG000|Overall Study|Physician Decision|1|||
161464981|NCT00145600|583098809|FG000|Overall Study|Death|1|||
161464982|NCT00145600|583098810|FG001|Overall Study|Death|2|||
161464983|NCT00145600|583098811|FG002|Overall Study|Death|2|||
161464984|NCT00145600|583098812|FG003|Overall Study|Death|6|||
161464985|NCT00145600|583098809|FG000|Overall Study|Ineligible|3|||
161464986|NCT00145600|583098810|FG001|Overall Study|Ineligible|0|||
161464987|NCT00145600|583098811|FG002|Overall Study|Ineligible|1|||
161464988|NCT00145600|583098812|FG003|Overall Study|Ineligible|5|||
161464989|NCT00145600|583098809|FG000|Overall Study|Lost to Follow-up|2|||
161464990|NCT00145600|583098810|FG001|Overall Study|Lost to Follow-up|6|||
161464991|NCT00145600|583098811|FG002|Overall Study|Lost to Follow-up|2|||
161464992|NCT00145600|583098812|FG003|Overall Study|Lost to Follow-up|4|||
161464993|NCT00145600|583098809|FG000|Overall Study|Noncompliance|1|||
161464994|NCT00145600|583098810|FG001|Overall Study|Noncompliance|0|||
161464995|NCT00145600|583098811|FG002|Overall Study|Noncompliance|0|||
161464996|NCT00145600|583098812|FG003|Overall Study|Noncompliance|0|||
161464997|NCT00145600|583098809|FG000|Overall Study|Withdrawal by Subject|1|||
161464998|NCT00145600|583098810|FG001|Overall Study|Withdrawal by Subject|2|||
161464999|NCT00145600|583098811|FG002|Overall Study|Withdrawal by Subject|0|||
161465000|NCT00145600|583098812|FG003|Overall Study|Withdrawal by Subject|1|||
161573106|NCT03020745|583483951|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573107|NCT03020745|583483952|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573108|NCT03020745|583483953|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
161573109|NCT03020745|583483954|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573110|NCT03020745|583483955|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573111|NCT03020745|583483956|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
161573112|NCT03020745|583483957|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161573113|NCT03020745|583483948|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573114|NCT03020745|583483949|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573115|NCT03020745|583483950|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573116|NCT03020745|583483951|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573117|NCT03020745|583483952|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573118|NCT03020745|583483953|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573119|NCT03020745|583483954|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161573120|NCT03020745|583483955|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161810369|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
161465001|NCT03583164|583098816|FG000|Overall Study|Death in Main Phase|35|||
161465002|NCT03583164|583098816|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
161465003|NCT03583164|583098816|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
161465004|NCT03583164|583098816|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
161465005|NCT03583164|583098816|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
161465006|NCT03583164|583098816|FG000|Overall Study|Physician decision in Main Phase|1|||
161465007|NCT03583164|583098816|FG000|Overall Study|Physician decision in Extended Phase|2|||
161810370|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
161810371|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
161914660|NCT05516758|584735671|FG003|Overall Study|Adverse Event|0|||
161914661|NCT05516758|584735672|FG004|Overall Study|Adverse Event|1|||
161914662|NCT05516758|584735673|FG005|Overall Study|Adverse Event|3|||
161914663|NCT05516758|584735674|FG006|Overall Study|Adverse Event|5|||
161914664|NCT05516758|584735668|FG000|Overall Study|Assigned treatment by mistake|1|||
161914665|NCT05516758|584735669|FG001|Overall Study|Assigned treatment by mistake|0|||
161914666|NCT05516758|584735670|FG002|Overall Study|Assigned treatment by mistake|0|||
161914667|NCT05516758|584735671|FG003|Overall Study|Assigned treatment by mistake|0|||
161914668|NCT05516758|584735672|FG004|Overall Study|Assigned treatment by mistake|1|||
161914669|NCT05516758|584735673|FG005|Overall Study|Assigned treatment by mistake|0|||
161914670|NCT05516758|584735674|FG006|Overall Study|Assigned treatment by mistake|0|||
161914671|NCT05516758|584735668|FG000|Overall Study|Lack of Efficacy|6|||
161914672|NCT05516758|584735669|FG001|Overall Study|Lack of Efficacy|0|||
161914673|NCT05516758|584735670|FG002|Overall Study|Lack of Efficacy|2|||
161914674|NCT05516758|584735671|FG003|Overall Study|Lack of Efficacy|0|||
161914675|NCT05516758|584735672|FG004|Overall Study|Lack of Efficacy|3|||
161914676|NCT05516758|584735673|FG005|Overall Study|Lack of Efficacy|6|||
161914677|NCT05516758|584735674|FG006|Overall Study|Lack of Efficacy|3|||
161914678|NCT05516758|584735668|FG000|Overall Study|Lost to Follow-up|2|||
161914679|NCT05516758|584735669|FG001|Overall Study|Lost to Follow-up|0|||
161914680|NCT05516758|584735670|FG002|Overall Study|Lost to Follow-up|2|||
161914681|NCT05516758|584735671|FG003|Overall Study|Lost to Follow-up|0|||
161914682|NCT05516758|584735672|FG004|Overall Study|Lost to Follow-up|3|||
161914683|NCT05516758|584735673|FG005|Overall Study|Lost to Follow-up|2|||
161914684|NCT05516758|584735674|FG006|Overall Study|Lost to Follow-up|1|||
161914685|NCT05516758|584735668|FG000|Overall Study|Other- As reported by the site|2|||
161914686|NCT05516758|584735669|FG001|Overall Study|Other- As reported by the site|1|||
161573121|NCT03020745|583483956|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
161573122|NCT03020745|583483957|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161914687|NCT05516758|584735670|FG002|Overall Study|Other- As reported by the site|8|||
161914688|NCT05516758|584735671|FG003|Overall Study|Other- As reported by the site|1|||
161914689|NCT05516758|584735672|FG004|Overall Study|Other- As reported by the site|2|||
161914690|NCT05516758|584735673|FG005|Overall Study|Other- As reported by the site|3|||
161914691|NCT05516758|584735674|FG006|Overall Study|Other- As reported by the site|8|||
161914692|NCT05516758|584735668|FG000|Overall Study|Physician Decision|1|||
161914693|NCT05516758|584735669|FG001|Overall Study|Physician Decision|0|||
161914694|NCT05516758|584735670|FG002|Overall Study|Physician Decision|7|||
161914695|NCT05516758|584735671|FG003|Overall Study|Physician Decision|0|||
161914696|NCT05516758|584735672|FG004|Overall Study|Physician Decision|1|||
161914697|NCT05516758|584735673|FG005|Overall Study|Physician Decision|1|||
161914698|NCT05516758|584735674|FG006|Overall Study|Physician Decision|2|||
161914699|NCT05516758|584735668|FG000|Overall Study|Protocol Deviation|1|||
161914700|NCT05516758|584735669|FG001|Overall Study|Protocol Deviation|0|||
161914701|NCT05516758|584735670|FG002|Overall Study|Protocol Deviation|0|||
161914702|NCT05516758|584735671|FG003|Overall Study|Protocol Deviation|0|||
161914703|NCT05516758|584735672|FG004|Overall Study|Protocol Deviation|0|||
161914704|NCT05516758|584735673|FG005|Overall Study|Protocol Deviation|1|||
161914705|NCT05516758|584735674|FG006|Overall Study|Protocol Deviation|5|||
161914706|NCT05516758|584735668|FG000|Overall Study|Withdrawal by Subject|11|||
161914707|NCT05516758|584735669|FG001|Overall Study|Withdrawal by Subject|1|||
161914708|NCT05516758|584735670|FG002|Overall Study|Withdrawal by Subject|15|||
161914709|NCT05516758|584735671|FG003|Overall Study|Withdrawal by Subject|2|||
161914710|NCT05516758|584735672|FG004|Overall Study|Withdrawal by Subject|7|||
161914711|NCT05516758|584735673|FG005|Overall Study|Withdrawal by Subject|7|||
161914712|NCT05516758|584735674|FG006|Overall Study|Withdrawal by Subject|6|||
161573123|NCT01867216|583483958|FG000|Overall Study|Withdrawal by Subject|2|||
161573124|NCT01867216|583483959|FG001|Overall Study|Withdrawal by Subject|0|||
161573125|NCT01867216|583483960|FG002|Overall Study|Withdrawal by Subject|0|||
161573126|NCT01867216|583483961|FG003|Overall Study|Withdrawal by Subject|0|||
161573127|NCT01867216|583483962|FG004|Overall Study|Withdrawal by Subject|1|||
161573128|NCT01867216|583483963|FG005|Overall Study|Withdrawal by Subject|0|||
161914713|NCT05516758|584735668|FG000|Overall Study|Death|1|||
161914714|NCT05516758|584735669|FG001|Overall Study|Death|0|||
161914715|NCT05516758|584735670|FG002|Overall Study|Death|0|||
161914716|NCT05516758|584735671|FG003|Overall Study|Death|0|||
161914717|NCT05516758|584735672|FG004|Overall Study|Death|0|||
161914718|NCT05516758|584735673|FG005|Overall Study|Death|0|||
161914719|NCT05516758|584735674|FG006|Overall Study|Death|0|||
161914720|NCT05516758|584735668|FG000|Overall Study|Non-compliance With Study Drug|0|||
161914721|NCT05516758|584735669|FG001|Overall Study|Non-compliance With Study Drug|0|||
161573129|NCT01867216|583483964|FG006|Overall Study|Withdrawal by Subject|1|||
161573130|NCT01867216|583483958|FG000|Overall Study|Physician Decision|1|||
161573131|NCT01867216|583483959|FG001|Overall Study|Physician Decision|0|||
161573132|NCT01867216|583483960|FG002|Overall Study|Physician Decision|0|||
161914722|NCT05516758|584735670|FG002|Overall Study|Non-compliance With Study Drug|1|||
161914723|NCT05516758|584735671|FG003|Overall Study|Non-compliance With Study Drug|0|||
161914724|NCT05516758|584735672|FG004|Overall Study|Non-compliance With Study Drug|0|||
161465008|NCT03583164|583098816|FG000|Overall Study|Death in Extended Phase|13|||
161465009|NCT03583164|583098816|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
161465010|NCT03583164|583098816|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
161465011|NCT03583164|583098816|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
161465012|NCT03583164|583098816|FG000|Overall Study|Treatment failure in Main Phase|2|||
161465013|NCT03583164|583098816|FG000|Overall Study|Treatment failure in Extended Phase|4|||
161465014|NCT03583164|583098816|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
161465015|NCT03583164|583098816|FG000|Overall Study|Other not specified reason in Main Phase|2|||
161465016|NCT02694523|583098817|FG000|Part A|Adverse Event|7|||
161465017|NCT02694523|583098818|FG001|Part A|Adverse Event|3|||
161465018|NCT02694523|583098819|FG002|Part A|Adverse Event|0|||
161465019|NCT02694523|583098820|FG003|Part A|Adverse Event|0|||
161465020|NCT02694523|583098821|FG004|Part A|Adverse Event|0|||
161465021|NCT02694523|583098822|FG005|Part A|Adverse Event|0|||
161465022|NCT02694523|583098823|FG006|Part A|Adverse Event|0|||
161465023|NCT02694523|583098817|FG000|Part A|Protocol Violation|1|||
161465024|NCT02694523|583098818|FG001|Part A|Protocol Violation|0|||
161465025|NCT02694523|583098819|FG002|Part A|Protocol Violation|0|||
161465026|NCT02694523|583098820|FG003|Part A|Protocol Violation|0|||
161465027|NCT02694523|583098821|FG004|Part A|Protocol Violation|0|||
161465028|NCT02694523|583098822|FG005|Part A|Protocol Violation|0|||
161465029|NCT02694523|583098823|FG006|Part A|Protocol Violation|0|||
161465030|NCT02694523|583098817|FG000|Part A|Lost to Follow-up|1|||
161465031|NCT02694523|583098818|FG001|Part A|Lost to Follow-up|2|||
161465032|NCT02694523|583098819|FG002|Part A|Lost to Follow-up|0|||
161465033|NCT02694523|583098820|FG003|Part A|Lost to Follow-up|0|||
161465034|NCT02694523|583098821|FG004|Part A|Lost to Follow-up|0|||
161465035|NCT02694523|583098822|FG005|Part A|Lost to Follow-up|0|||
161465036|NCT02694523|583098823|FG006|Part A|Lost to Follow-up|0|||
161465037|NCT02694523|583098817|FG000|Part A|Withdrawal by Subject|3|||
161465038|NCT02694523|583098818|FG001|Part A|Withdrawal by Subject|1|||
161465039|NCT02694523|583098819|FG002|Part A|Withdrawal by Subject|0|||
161465040|NCT02694523|583098820|FG003|Part A|Withdrawal by Subject|0|||
161465041|NCT02694523|583098821|FG004|Part A|Withdrawal by Subject|0|||
161465042|NCT02694523|583098822|FG005|Part A|Withdrawal by Subject|0|||
161465043|NCT02694523|583098823|FG006|Part A|Withdrawal by Subject|0|||
161465044|NCT02694523|583098817|FG000|Part A|Other|1|||
161465045|NCT02694523|583098818|FG001|Part A|Other|1|||
161465046|NCT02694523|583098819|FG002|Part A|Other|0|||
161465047|NCT02694523|583098820|FG003|Part A|Other|0|||
161465048|NCT02694523|583098821|FG004|Part A|Other|0|||
161465049|NCT02694523|583098822|FG005|Part A|Other|0|||
161465050|NCT02694523|583098823|FG006|Part A|Other|0|||
161465051|NCT02694523|583098817|FG000|Part B|Adverse Event|0|||
161465052|NCT02694523|583098818|FG001|Part B|Adverse Event|0|||
161465053|NCT02694523|583098819|FG002|Part B|Adverse Event|7|||
161465054|NCT02694523|583098820|FG003|Part B|Adverse Event|1|||
161465055|NCT02694523|583098821|FG004|Part B|Adverse Event|1|||
161465056|NCT02694523|583098822|FG005|Part B|Adverse Event|2|||
161465057|NCT02694523|583098823|FG006|Part B|Adverse Event|0|||
161465058|NCT02694523|583098817|FG000|Part B|Protocol Violation|0|||
161465059|NCT02694523|583098818|FG001|Part B|Protocol Violation|0|||
161465060|NCT02694523|583098819|FG002|Part B|Protocol Violation|1|||
161465061|NCT02694523|583098820|FG003|Part B|Protocol Violation|0|||
161465062|NCT02694523|583098821|FG004|Part B|Protocol Violation|0|||
161465063|NCT02694523|583098822|FG005|Part B|Protocol Violation|0|||
161465064|NCT02694523|583098823|FG006|Part B|Protocol Violation|0|||
161465065|NCT02694523|583098817|FG000|Part B|Lost to Follow-up|0|||
161465066|NCT02694523|583098818|FG001|Part B|Lost to Follow-up|0|||
161465067|NCT02694523|583098819|FG002|Part B|Lost to Follow-up|2|||
161465068|NCT02694523|583098820|FG003|Part B|Lost to Follow-up|3|||
161465069|NCT02694523|583098821|FG004|Part B|Lost to Follow-up|2|||
161465070|NCT02694523|583098822|FG005|Part B|Lost to Follow-up|0|||
161465071|NCT02694523|583098823|FG006|Part B|Lost to Follow-up|1|||
161465072|NCT02694523|583098817|FG000|Part B|Withdrawal by Subject|0|||
161465073|NCT02694523|583098818|FG001|Part B|Withdrawal by Subject|0|||
161465074|NCT02694523|583098819|FG002|Part B|Withdrawal by Subject|9|||
161465075|NCT02694523|583098820|FG003|Part B|Withdrawal by Subject|0|||
161465076|NCT02694523|583098821|FG004|Part B|Withdrawal by Subject|1|||
161465077|NCT02694523|583098822|FG005|Part B|Withdrawal by Subject|3|||
161465078|NCT02694523|583098823|FG006|Part B|Withdrawal by Subject|0|||
161465079|NCT02694523|583098817|FG000|Part B|Other|0|||
161465080|NCT02694523|583098818|FG001|Part B|Other|0|||
161465081|NCT02694523|583098819|FG002|Part B|Other|1|||
161465082|NCT02694523|583098820|FG003|Part B|Other|0|||
161465083|NCT02694523|583098821|FG004|Part B|Other|0|||
161465084|NCT02694523|583098822|FG005|Part B|Other|0|||
161465085|NCT02694523|583098823|FG006|Part B|Other|1|||
161465086|NCT01058265|583098825|FG000|Overall Study|Lost to Follow-up|11|||
161465087|NCT01058265|583098826|FG001|Overall Study|Lost to Follow-up|12|||
161465088|NCT01243671|583098827|FG000|Overall Study|Adverse Event|3|||
161465089|NCT01243671|583098827|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
161465090|NCT01243671|583098827|FG000|Overall Study|Other|1|||
161465091|NCT02869438|583098828|FG000|Overall Study|Lost to Follow-up|1|||
161465092|NCT02869438|583098829|FG001|Overall Study|Lost to Follow-up|0|||
161465093|NCT02869438|583098828|FG000|Overall Study|Adverse Event|1|||
161465094|NCT02869438|583098829|FG001|Overall Study|Adverse Event|0|||
161465095|NCT02869438|583098828|FG000|Overall Study|Withdrawal by Subject|1|||
161465096|NCT02869438|583098829|FG001|Overall Study|Withdrawal by Subject|2|||
161465097|NCT02962765|583098830|FG000|Overall Study|Protocol Violation|9|||
161465098|NCT02962765|583098830|FG000|Overall Study|Withdrawal by Subject|3|||
161465099|NCT02962765|583098830|FG000|Overall Study|Lost to Follow-up|1|||
161465100|NCT02962765|583098830|FG000|Overall Study|Death|1|||
161465101|NCT02962765|583098830|FG000|Overall Study|Limited access to study medication|3|||
161465102|NCT02169284|583098833|FG000|Overall Study|Physician Decision|0|||
161465103|NCT02169284|583098834|FG001|Overall Study|Physician Decision|1|||
161465104|NCT01367119|583098835|FG000|Overall Study|Adverse Event|1|||
161465105|NCT01367119|583098836|FG001|Overall Study|Adverse Event|0|||
161465106|NCT01367119|583098835|FG000|Overall Study|Withdrawal by Subject|1|||
161465107|NCT01367119|583098836|FG001|Overall Study|Withdrawal by Subject|1|||
161465108|NCT02675231|583098837|FG000|Overall Study|Withdrawal by Subject|2|||
161465109|NCT02675231|583098838|FG001|Overall Study|Withdrawal by Subject|4|||
161465110|NCT02675231|583098839|FG002|Overall Study|Withdrawal by Subject|2|||
161465111|NCT02675231|583098837|FG000|Overall Study|Lost to Follow-up|3|||
161465112|NCT02675231|583098838|FG001|Overall Study|Lost to Follow-up|4|||
161465113|NCT02675231|583098839|FG002|Overall Study|Lost to Follow-up|3|||
161465114|NCT05323656|583098840|FG000|Overall Study|Still On-Treatment|6|||
161465115|NCT05323656|583098841|FG001|Overall Study|Still On-Treatment|6|||
161465116|NCT05323656|583098840|FG000|Overall Study|Progressive Disease|15|||
161465117|NCT05323656|583098841|FG001|Overall Study|Progressive Disease|14|||
161465118|NCT05323656|583098840|FG000|Overall Study|Adverse Event|2|||
161465119|NCT05323656|583098841|FG001|Overall Study|Adverse Event|3|||
161465120|NCT05323656|583098840|FG000|Overall Study|Death|1|||
161465121|NCT05323656|583098841|FG001|Overall Study|Death|2|||
161465122|NCT05323656|583098840|FG000|Overall Study|Withdrawal by Subject|1|||
161465123|NCT05323656|583098841|FG001|Overall Study|Withdrawal by Subject|0|||
161465124|NCT05323656|583098840|FG000|Overall Study|Clinical disease progression|0|||
161465125|NCT05323656|583098841|FG001|Overall Study|Clinical disease progression|1|||
161465126|NCT05323656|583098840|FG000|Overall Study|Patient and Investigator decision|1|||
161465127|NCT05323656|583098841|FG001|Overall Study|Patient and Investigator decision|0|||
161465128|NCT05323656|583098840|FG000|Overall Study|Physician Decision|0|||
161465129|NCT05323656|583098841|FG001|Overall Study|Physician Decision|1|||
161465130|NCT03953183|583098842|FG000|Overall Study|Physician Decision|0|||
161465131|NCT03953183|583098843|FG001|Overall Study|Physician Decision|1|||
161465132|NCT03953183|583098842|FG000|Overall Study|Withdrawal by Subject|0|||
161465133|NCT03953183|583098843|FG001|Overall Study|Withdrawal by Subject|1|||
161465134|NCT01115803|583098854|FG000|Overall Study|Withdrawal by Subject|0|||
161465135|NCT01115803|583098855|FG001|Overall Study|Withdrawal by Subject|0|||
161465136|NCT01115803|583098856|FG002|Overall Study|Withdrawal by Subject|0|||
161465137|NCT01115803|583098857|FG003|Overall Study|Withdrawal by Subject|0|||
161465138|NCT01115803|583098858|FG004|Overall Study|Withdrawal by Subject|0|||
161465139|NCT01115803|583098859|FG005|Overall Study|Withdrawal by Subject|0|||
161465140|NCT01115803|583098860|FG006|Overall Study|Withdrawal by Subject|1|||
161465141|NCT01115803|583098854|FG000|Overall Study|Lost to Follow-up|0|||
161465142|NCT01115803|583098855|FG001|Overall Study|Lost to Follow-up|0|||
161465143|NCT01115803|583098856|FG002|Overall Study|Lost to Follow-up|1|||
161465144|NCT01115803|583098857|FG003|Overall Study|Lost to Follow-up|0|||
161465145|NCT01115803|583098858|FG004|Overall Study|Lost to Follow-up|0|||
161465146|NCT01115803|583098859|FG005|Overall Study|Lost to Follow-up|0|||
161465147|NCT01115803|583098860|FG006|Overall Study|Lost to Follow-up|0|||
161465148|NCT01115803|583098854|FG000|Overall Study|Progressive Disease during Cycle1|0|||
161465149|NCT01115803|583098855|FG001|Overall Study|Progressive Disease during Cycle1|0|||
161465150|NCT01115803|583098856|FG002|Overall Study|Progressive Disease during Cycle1|0|||
161465151|NCT01115803|583098857|FG003|Overall Study|Progressive Disease during Cycle1|0|||
161465152|NCT01115803|583098858|FG004|Overall Study|Progressive Disease during Cycle1|0|||
161465153|NCT01115803|583098859|FG005|Overall Study|Progressive Disease during Cycle1|0|||
161465154|NCT01115803|583098860|FG006|Overall Study|Progressive Disease during Cycle1|1|||
161465155|NCT00064298|583098861|FG000|Overall Study|Withdrawal by Subject|2|||
161465156|NCT00064298|583098862|FG001|Overall Study|Withdrawal by Subject|1|||
161465157|NCT00064298|583098861|FG000|Overall Study|Lost to Follow-up|2|||
161465158|NCT00064298|583098862|FG001|Overall Study|Lost to Follow-up|2|||
161465159|NCT00064298|583098861|FG000|Overall Study|Death|0|||
161465160|NCT00064298|583098862|FG001|Overall Study|Death|1|||
161465161|NCT00064298|583098861|FG000|Overall Study|Disease Progression|2|||
161465162|NCT00064298|583098862|FG001|Overall Study|Disease Progression|1|||
161465163|NCT03063203|583098863|FG000|Overall Study|Chose alternative therapy|3|||
161465164|NCT03063203|583098863|FG000|Overall Study|Death|2|||
161465165|NCT03063203|583098863|FG000|Overall Study|Disease progression|4|||
161465166|NCT03063203|583098863|FG000|Overall Study|Physician Decision|5|||
161465167|NCT00591266|583098864|FG000|Overall Study|Adverse Event|2|||
161465168|NCT00591266|583098865|FG001|Overall Study|Adverse Event|2|||
161465169|NCT00591266|583098866|FG002|Overall Study|Adverse Event|3|||
161465170|NCT00591266|583098864|FG000|Overall Study|Lost to Follow-up|0|||
161465171|NCT00591266|583098865|FG001|Overall Study|Lost to Follow-up|1|||
161465172|NCT00591266|583098866|FG002|Overall Study|Lost to Follow-up|0|||
161465173|NCT00591266|583098864|FG000|Overall Study|Protocol Violation|0|||
161465174|NCT00591266|583098865|FG001|Overall Study|Protocol Violation|0|||
161465175|NCT00591266|583098866|FG002|Overall Study|Protocol Violation|1|||
161465176|NCT00591266|583098864|FG000|Overall Study|Withdrawal by Subject|6|||
161465177|NCT00591266|583098865|FG001|Overall Study|Withdrawal by Subject|2|||
161465178|NCT00591266|583098866|FG002|Overall Study|Withdrawal by Subject|5|||
161465179|NCT00591266|583098864|FG000|Overall Study|Lack of Efficacy|0|||
161465180|NCT00591266|583098865|FG001|Overall Study|Lack of Efficacy|2|||
161465181|NCT00591266|583098866|FG002|Overall Study|Lack of Efficacy|0|||
161465182|NCT00591266|583098864|FG000|Overall Study|Other|1|||
161465183|NCT00591266|583098865|FG001|Overall Study|Other|4|||
161465184|NCT00591266|583098866|FG002|Overall Study|Other|5|||
161465185|NCT03488927|583098867|FG000|Overall Study|Withdrawal by Subject|44|||
161465186|NCT03488927|583098868|FG001|Overall Study|Withdrawal by Subject|118|||
161465187|NCT03488927|583098869|FG002|Overall Study|Withdrawal by Subject|217|||
161465188|NCT05080660|583098870|FG000|Overall Study|Adverse Event|4|||
161465189|NCT05080660|583098871|FG001|Overall Study|Adverse Event|0|||
161465190|NCT05080660|583098870|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
161465191|NCT05080660|583098871|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
161465192|NCT05080660|583098870|FG000|Overall Study|Physician Decision|1|||
161465193|NCT05080660|583098871|FG001|Overall Study|Physician Decision|0|||
161465194|NCT05080660|583098870|FG000|Overall Study|Protocol Deviation|2|||
161465195|NCT05080660|583098871|FG001|Overall Study|Protocol Deviation|0|||
161465196|NCT05080660|583098870|FG000|Overall Study|Withdrawal by Subject|5|||
161465197|NCT05080660|583098871|FG001|Overall Study|Withdrawal by Subject|2|||
161465198|NCT03497676|583098872|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
161465199|NCT03497676|583098873|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
161465200|NCT03497676|583098874|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
161465201|NCT03497676|583098875|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
161465202|NCT03497676|583098872|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
161465203|NCT03497676|583098873|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
161465204|NCT03497676|583098874|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
161573133|NCT01867216|583483961|FG003|Overall Study|Physician Decision|0|||
161573134|NCT01867216|583483962|FG004|Overall Study|Physician Decision|0|||
161573135|NCT01867216|583483963|FG005|Overall Study|Physician Decision|0|||
161573136|NCT01867216|583483964|FG006|Overall Study|Physician Decision|0|||
161573137|NCT01867216|583483958|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
161573138|NCT01867216|583483959|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161573139|NCT01867216|583483960|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161573140|NCT01867216|583483961|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161573141|NCT01867216|583483962|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161573142|NCT01867216|583483963|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161573143|NCT01867216|583483964|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161573144|NCT00186186|583483965|FG000|Overall Study|Lack of Efficacy|3|||
161573145|NCT00186186|583483965|FG000|Overall Study|Withdrawal by Subject|3|||
161573146|NCT00186186|583483965|FG000|Overall Study|Not reported as to reason|2|||
161573147|NCT02567656|583483969|FG000|Overall Study|Premature discontinuation due to PD|1|||
161573148|NCT02567656|583483970|FG001|Overall Study|Premature discontinuation due to PD|1|||
161573149|NCT02567656|583483971|FG002|Overall Study|Premature discontinuation due to PD|2|||
161573150|NCT02567656|583483972|FG003|Overall Study|Premature discontinuation due to PD|0|||
161573151|NCT02567656|583483973|FG004|Overall Study|Premature discontinuation due to PD|0|||
161573152|NCT02567656|583483974|FG005|Overall Study|Premature discontinuation due to PD|0|||
161914725|NCT05516758|584735673|FG005|Overall Study|Non-compliance With Study Drug|0|||
161914726|NCT05516758|584735674|FG006|Overall Study|Non-compliance With Study Drug|0|||
161573153|NCT01616654|583483975|FG000|Overall Study|Lack of Efficacy|1|||
161914727|NCT05516758|584735668|FG000|Overall Study|Site Terminated by Sponsor|2|||
161465205|NCT03497676|583098875|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
161465206|NCT03497676|583098872|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
161465207|NCT03497676|583098873|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
161465208|NCT03497676|583098874|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
161465209|NCT03497676|583098875|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
161465210|NCT03497676|583098872|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
161465211|NCT03497676|583098873|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
161573154|NCT01616654|583483976|FG001|Overall Study|Lack of Efficacy|0|||
161573155|NCT01616654|583483977|FG002|Overall Study|Lack of Efficacy|0|||
161914728|NCT05516758|584735669|FG001|Overall Study|Site Terminated by Sponsor|0|||
161465212|NCT03497676|583098874|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
161465213|NCT03497676|583098875|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
161573156|NCT01616654|583483978|FG003|Overall Study|Lack of Efficacy|0|||
161465214|NCT03497676|583098872|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
161465215|NCT03497676|583098873|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
161465216|NCT03497676|583098874|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
161465217|NCT03497676|583098875|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
161465218|NCT03497676|583098872|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
161465219|NCT03497676|583098873|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
161465220|NCT03497676|583098874|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
161465221|NCT03497676|583098875|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
161465222|NCT03497676|583098872|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
161465223|NCT03497676|583098873|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
161465224|NCT03497676|583098874|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
161465225|NCT03497676|583098875|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
161465226|NCT03497676|583098872|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
161465227|NCT03497676|583098873|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
161465228|NCT03497676|583098874|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
161465229|NCT03497676|583098875|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
161465230|NCT01977937|583098876|FG000|Overall Study|Withdrawal by Subject|2|||
161465231|NCT01977937|583098877|FG001|Overall Study|Withdrawal by Subject|1|||
161465232|NCT01977937|583098876|FG000|Overall Study|Adverse Event|1|||
161465233|NCT01977937|583098877|FG001|Overall Study|Adverse Event|0|||
161465234|NCT01977937|583098876|FG000|Overall Study|Physician Decision|0|||
161465235|NCT01977937|583098877|FG001|Overall Study|Physician Decision|1|||
161465236|NCT03194490|583098881|FG000|Overall Study|Lost to Follow-up|1|||
161465237|NCT03194490|583098882|FG001|Overall Study|Lost to Follow-up|3|||
161465238|NCT03194490|583098881|FG000|Overall Study|participant developed specific neck pain|1|||
161465239|NCT03194490|583098882|FG001|Overall Study|participant developed specific neck pain|0|||
161465240|NCT03911843|583098883|FG000|Overall Study|Adverse Event|2|||
161465241|NCT03911843|583098884|FG001|Overall Study|Adverse Event|0|||
161465242|NCT03911843|583098883|FG000|Overall Study|Protocol Violation|2|||
161465243|NCT03911843|583098884|FG001|Overall Study|Protocol Violation|0|||
161465244|NCT03911843|583098883|FG000|Overall Study|Lost to Follow-up|0|||
161465245|NCT03911843|583098884|FG001|Overall Study|Lost to Follow-up|1|||
161465246|NCT02819518|583098885|FG000|Overall Study|Death|9|||
161465247|NCT02819518|583098886|FG001|Overall Study|Death|12|||
161465248|NCT02819518|583098887|FG002|Overall Study|Death|9|||
161465249|NCT02819518|583098888|FG003|Overall Study|Death|475|||
161465250|NCT02819518|583098889|FG004|Overall Study|Death|244|||
161573157|NCT01616654|583483979|FG004|Overall Study|Lack of Efficacy|1|||
161573158|NCT01616654|583483975|FG000|Overall Study|Adverse Event|0|||
161573159|NCT01616654|583483976|FG001|Overall Study|Adverse Event|1|||
161573160|NCT01616654|583483977|FG002|Overall Study|Adverse Event|2|||
161573161|NCT01616654|583483978|FG003|Overall Study|Adverse Event|1|||
161573162|NCT01616654|583483979|FG004|Overall Study|Adverse Event|0|||
161573163|NCT01616654|583483975|FG000|Overall Study|Withdrawal by Subject|2|||
161573164|NCT01616654|583483976|FG001|Overall Study|Withdrawal by Subject|2|||
161573165|NCT01616654|583483977|FG002|Overall Study|Withdrawal by Subject|3|||
161573166|NCT01616654|583483978|FG003|Overall Study|Withdrawal by Subject|1|||
161573167|NCT01616654|583483979|FG004|Overall Study|Withdrawal by Subject|5|||
161573168|NCT01616654|583483975|FG000|Overall Study|Protocol Violation|0|||
161573169|NCT01616654|583483976|FG001|Overall Study|Protocol Violation|5|||
161573170|NCT01616654|583483977|FG002|Overall Study|Protocol Violation|2|||
161573171|NCT01616654|583483978|FG003|Overall Study|Protocol Violation|4|||
161573172|NCT01616654|583483979|FG004|Overall Study|Protocol Violation|4|||
161573173|NCT01616654|583483975|FG000|Overall Study|Lost to Follow-up|1|||
161573174|NCT01616654|583483976|FG001|Overall Study|Lost to Follow-up|0|||
161573175|NCT01616654|583483977|FG002|Overall Study|Lost to Follow-up|3|||
161573176|NCT01616654|583483978|FG003|Overall Study|Lost to Follow-up|2|||
161573177|NCT01616654|583483979|FG004|Overall Study|Lost to Follow-up|1|||
161573178|NCT01616654|583483975|FG000|Overall Study|Pregnancy|1|||
161573179|NCT01616654|583483976|FG001|Overall Study|Pregnancy|0|||
161573180|NCT01616654|583483977|FG002|Overall Study|Pregnancy|0|||
161465251|NCT02819518|583098885|FG000|Overall Study|Withdrawal by Subject|0|||
161573181|NCT01616654|583483978|FG003|Overall Study|Pregnancy|0|||
161465252|NCT02819518|583098886|FG001|Overall Study|Withdrawal by Subject|0|||
161465253|NCT02819518|583098887|FG002|Overall Study|Withdrawal by Subject|0|||
161465254|NCT02819518|583098888|FG003|Overall Study|Withdrawal by Subject|25|||
161465255|NCT02819518|583098889|FG004|Overall Study|Withdrawal by Subject|8|||
161465256|NCT02819518|583098885|FG000|Overall Study|Lost to Follow-up|0|||
161465257|NCT02819518|583098886|FG001|Overall Study|Lost to Follow-up|0|||
161465258|NCT02819518|583098887|FG002|Overall Study|Lost to Follow-up|0|||
161573182|NCT01616654|583483979|FG004|Overall Study|Pregnancy|1|||
161573183|NCT02057692|583483980|FG000|Overall Study|Adverse Event|1|||
161573184|NCT02057692|583483981|FG001|Overall Study|Adverse Event|0|||
161573185|NCT02057692|583483982|FG002|Overall Study|Adverse Event|0|||
161573186|NCT02057692|583483983|FG003|Overall Study|Adverse Event|0|||
161573187|NCT02057692|583483980|FG000|Overall Study|Lost to Follow-up|0|||
161573188|NCT02057692|583483981|FG001|Overall Study|Lost to Follow-up|0|||
161914729|NCT05516758|584735670|FG002|Overall Study|Site Terminated by Sponsor|0|||
161914730|NCT05516758|584735671|FG003|Overall Study|Site Terminated by Sponsor|0|||
161914731|NCT05516758|584735672|FG004|Overall Study|Site Terminated by Sponsor|0|||
161914732|NCT05516758|584735673|FG005|Overall Study|Site Terminated by Sponsor|0|||
161914733|NCT05516758|584735674|FG006|Overall Study|Site Terminated by Sponsor|0|||
161914734|NCT05516758|584735668|FG000|Overall Study|Study Terminated by Sponsor|4|||
161914735|NCT05516758|584735669|FG001|Overall Study|Study Terminated by Sponsor|0|||
161914736|NCT05516758|584735670|FG002|Overall Study|Study Terminated by Sponsor|3|||
161914737|NCT05516758|584735671|FG003|Overall Study|Study Terminated by Sponsor|0|||
161914738|NCT05516758|584735672|FG004|Overall Study|Study Terminated by Sponsor|2|||
161914739|NCT05516758|584735673|FG005|Overall Study|Study Terminated by Sponsor|3|||
161914740|NCT05516758|584735674|FG006|Overall Study|Study Terminated by Sponsor|0|||
161914741|NCT05516758|584735668|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
161914742|NCT05516758|584735669|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
161914743|NCT05516758|584735670|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
161914744|NCT05516758|584735671|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
161465259|NCT02819518|583098888|FG003|Overall Study|Lost to Follow-up|0|||
161465260|NCT02819518|583098889|FG004|Overall Study|Lost to Follow-up|1|||
161465261|NCT02819518|583098885|FG000|Overall Study|Sponsor Decision|1|||
161465262|NCT02819518|583098886|FG001|Overall Study|Sponsor Decision|1|||
161465263|NCT02819518|583098887|FG002|Overall Study|Sponsor Decision|0|||
161465264|NCT02819518|583098888|FG003|Overall Study|Sponsor Decision|34|||
161573189|NCT02057692|583483982|FG002|Overall Study|Lost to Follow-up|0|||
161573190|NCT02057692|583483983|FG003|Overall Study|Lost to Follow-up|1|||
161573191|NCT03923491|583483984|FG000|Overall Study|Lost to Follow-up|5|||
161573192|NCT03923491|583483985|FG001|Overall Study|Lost to Follow-up|8|||
161465265|NCT02819518|583098889|FG004|Overall Study|Sponsor Decision|17|||
161465266|NCT02819518|583098885|FG000|Overall Study|Transferred to extension study|1|||
161465267|NCT02819518|583098886|FG001|Overall Study|Transferred to extension study|1|||
161465268|NCT02819518|583098887|FG002|Overall Study|Transferred to extension study|1|||
161465269|NCT02819518|583098888|FG003|Overall Study|Transferred to extension study|32|||
161465270|NCT02819518|583098889|FG004|Overall Study|Transferred to extension study|11|||
161465271|NCT00880165|583098890|FG000|Overall Study|Withdrawal by Subject|27|||
161465272|NCT00880165|583098891|FG001|Overall Study|Withdrawal by Subject|23|||
161465273|NCT00880165|583098890|FG000|Overall Study|Not diagnosed with OSA|14|||
161465274|NCT00880165|583098891|FG001|Overall Study|Not diagnosed with OSA|8|||
161465275|NCT00880165|583098890|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
161465276|NCT00880165|583098891|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
161465277|NCT00880165|583098890|FG000|Overall Study|Lost to follow|9|||
161465278|NCT00880165|583098891|FG001|Overall Study|Lost to follow|15|||
161465279|NCT01505647|583098892|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
161465280|NCT01505647|583098893|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
161465281|NCT01505647|583098892|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
161465282|NCT01505647|583098893|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
161465283|NCT01505647|583098892|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
161465284|NCT01505647|583098893|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
161465285|NCT01505647|583098892|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
161465286|NCT01505647|583098893|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
161465287|NCT01505647|583098892|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
161465288|NCT01505647|583098893|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
161465289|NCT02750943|583098897|FG000|Overall Study|Lost to Follow-up|1|||
161465290|NCT02750943|583098898|FG001|Overall Study|Lost to Follow-up|2|||
161465291|NCT02750943|583098897|FG000|Overall Study|Withdrawal by Subject|5|||
161465292|NCT02750943|583098898|FG001|Overall Study|Withdrawal by Subject|7|||
161465293|NCT04597918|583098899|FG000|Overall Study|Withdrawal by Subject|6|||
161465294|NCT04597918|583098899|FG000|Overall Study|Lost to Follow-up|3|||
161465295|NCT04597918|583098899|FG000|Overall Study|Death|1|||
161465296|NCT01927341|583100459|FG000|Phase 1b|Lost to Follow-up|1|||
161465297|NCT01927341|583100460|FG001|Phase 1b|Lost to Follow-up|0|||
161465298|NCT01927341|583100461|FG002|Phase 1b|Lost to Follow-up|0|||
161465299|NCT01927341|583100462|FG003|Phase 1b|Lost to Follow-up|0|||
161573193|NCT03923491|583483984|FG000|Overall Study|Withdrawal by Subject|4|||
161573194|NCT03923491|583483985|FG001|Overall Study|Withdrawal by Subject|6|||
161914745|NCT05516758|584735672|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
161465300|NCT01927341|583100463|FG004|Phase 1b|Lost to Follow-up|0|||
161914746|NCT05516758|584735673|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
161914747|NCT05516758|584735674|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
161465301|NCT01927341|583100459|FG000|Phase 1b|Death|2|||
161465302|NCT01927341|583100460|FG001|Phase 1b|Death|0|||
161465303|NCT01927341|583100461|FG002|Phase 1b|Death|0|||
161465304|NCT01927341|583100462|FG003|Phase 1b|Death|0|||
161465305|NCT01927341|583100463|FG004|Phase 1b|Death|0|||
161573195|NCT03622580|583483990|FG000|Overall Study|Death|16|||
161914748|NCT05516758|584735668|FG000|Overall Study|Other|0|||
161914749|NCT05516758|584735669|FG001|Overall Study|Other|0|||
161914750|NCT05516758|584735670|FG002|Overall Study|Other|0|||
161465306|NCT01927341|583100459|FG000|Phase 1b|Follow-up completed|7|||
161465307|NCT01927341|583100460|FG001|Phase 1b|Follow-up completed|0|||
161465308|NCT01927341|583100461|FG002|Phase 1b|Follow-up completed|0|||
161465309|NCT01927341|583100462|FG003|Phase 1b|Follow-up completed|0|||
161465310|NCT01927341|583100463|FG004|Phase 1b|Follow-up completed|0|||
161465311|NCT01927341|583100459|FG000|Phase 2|Lost to Follow-up|0|||
161465312|NCT01927341|583100460|FG001|Phase 2|Lost to Follow-up|1|||
161465313|NCT01927341|583100461|FG002|Phase 2|Lost to Follow-up|0|||
161465314|NCT01927341|583100462|FG003|Phase 2|Lost to Follow-up|0|||
161465315|NCT01927341|583100463|FG004|Phase 2|Lost to Follow-up|0|||
161573196|NCT03622580|583483991|FG001|Overall Study|Death|21|||
161914751|NCT05516758|584735671|FG003|Overall Study|Other|0|||
161914752|NCT05516758|584735672|FG004|Overall Study|Other|0|||
161914753|NCT05516758|584735673|FG005|Overall Study|Other|0|||
161914754|NCT05516758|584735674|FG006|Overall Study|Other|1|||
161914755|NCT01316575|584735675|FG000|Overall Study|Withdrawal by Subject|2|||
161914756|NCT01316575|584735676|FG001|Overall Study|Withdrawal by Subject|0|||
161914757|NCT01316575|584735675|FG000|Overall Study|Required alternate treatment|0|||
161914758|NCT01316575|584735676|FG001|Overall Study|Required alternate treatment|1|||
161914759|NCT00402831|584735677|FG000|Overall Study|Lost to Follow-up|1|||
161573197|NCT03622580|583483992|FG002|Overall Study|Death|13|||
161573198|NCT03622580|583483990|FG000|Overall Study|Adverse Event|6|||
161573199|NCT03622580|583483991|FG001|Overall Study|Adverse Event|6|||
161573200|NCT03622580|583483992|FG002|Overall Study|Adverse Event|5|||
161573201|NCT03622580|583483990|FG000|Overall Study|Withdrawal by Subject|12|||
161573202|NCT03622580|583483991|FG001|Overall Study|Withdrawal by Subject|7|||
161573203|NCT03622580|583483992|FG002|Overall Study|Withdrawal by Subject|19|||
161573204|NCT03622580|583483990|FG000|Overall Study|Lost to Follow-up|12|||
161573205|NCT03622580|583483991|FG001|Overall Study|Lost to Follow-up|9|||
161573206|NCT03622580|583483992|FG002|Overall Study|Lost to Follow-up|9|||
161573207|NCT03622580|583483990|FG000|Overall Study|Protocol Violation|1|||
161573208|NCT03622580|583483991|FG001|Overall Study|Protocol Violation|0|||
161573209|NCT03622580|583483992|FG002|Overall Study|Protocol Violation|1|||
161573210|NCT03622580|583483990|FG000|Overall Study|Physician Decision|3|||
161573211|NCT03622580|583483991|FG001|Overall Study|Physician Decision|0|||
161573212|NCT03622580|583483992|FG002|Overall Study|Physician Decision|1|||
161573213|NCT03622580|583483990|FG000|Overall Study|Pregnancy|0|||
161573214|NCT03622580|583483991|FG001|Overall Study|Pregnancy|1|||
161573215|NCT03622580|583483992|FG002|Overall Study|Pregnancy|0|||
161573216|NCT03622580|583483990|FG000|Overall Study|Lack of Efficacy|0|||
161573217|NCT03622580|583483991|FG001|Overall Study|Lack of Efficacy|0|||
161573218|NCT03622580|583483992|FG002|Overall Study|Lack of Efficacy|1|||
161573219|NCT03622580|583483990|FG000|Overall Study|Other|2|||
161573220|NCT03622580|583483991|FG001|Overall Study|Other|0|||
161573221|NCT03622580|583483992|FG002|Overall Study|Other|3|||
161573222|NCT03959241|583483997|FG000|Overall Study|Withdrawal by Subject|7|||
161573223|NCT03959241|583483998|FG001|Overall Study|Withdrawal by Subject|8|||
161573224|NCT03959241|583483997|FG000|Overall Study|Lost to Follow-up|1|||
161573225|NCT03959241|583483998|FG001|Overall Study|Lost to Follow-up|0|||
161573226|NCT03959241|583483997|FG000|Overall Study|Move to Hospice Care|1|||
161914760|NCT00402831|584735678|FG001|Overall Study|Lost to Follow-up|2|||
161914761|NCT00402831|584735677|FG000|Overall Study|Non-compliance with protocol|0|||
161914762|NCT00402831|584735678|FG001|Overall Study|Non-compliance with protocol|1|||
161914763|NCT02792504|584735679|FG000|Overall Study|Lost to Follow-up|24|||
161914764|NCT02792504|584735679|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
161465316|NCT01927341|583100459|FG000|Phase 2|Participant withdrew consent|0|||
161465317|NCT01927341|583100460|FG001|Phase 2|Participant withdrew consent|2|||
161465318|NCT01927341|583100461|FG002|Phase 2|Participant withdrew consent|1|||
161465319|NCT01927341|583100462|FG003|Phase 2|Participant withdrew consent|2|||
161573227|NCT03959241|583483998|FG001|Overall Study|Move to Hospice Care|0|||
161573228|NCT03959241|583483997|FG000|Overall Study|Screen Failure|1|||
161573229|NCT03959241|583483998|FG001|Overall Study|Screen Failure|0|||
161573230|NCT03959241|583483997|FG000|Overall Study|Disease Relapse|0|||
161573231|NCT03959241|583483998|FG001|Overall Study|Disease Relapse|1|||
161573232|NCT03959241|583483997|FG000|Overall Study|Off Study|1|||
161573233|NCT03959241|583483998|FG001|Overall Study|Off Study|0|||
161573234|NCT00943735|583483999|FG000|Overall Study|Adverse Event|12|||
161573235|NCT00943735|583483999|FG000|Overall Study|Withdrawal by Subject|8|||
161573236|NCT00943735|583483999|FG000|Overall Study|Death|1|||
161573237|NCT00943735|583483999|FG000|Overall Study|Other|8|||
161914765|NCT02814526|584735686|FG000|Overall Study|Adverse Event|4|||
161914766|NCT02814526|584735687|FG001|Overall Study|Adverse Event|3|||
161914767|NCT02814526|584735686|FG000|Overall Study|Death|1|||
161914768|NCT02814526|584735687|FG001|Overall Study|Death|1|||
161573238|NCT00943735|583483999|FG000|Overall Study|Other|3|||
161573239|NCT00545844|583484000|FG000|Overall Study|Lost to Follow-up|9|||
161573240|NCT00545844|583484000|FG000|Overall Study|Protocol Violation|1|||
161573241|NCT00545844|583484000|FG000|Overall Study|Withdrawal by Subject|2|||
161573242|NCT01329328|583484001|FG000|Overall Study|Withdrawal by Subject|2|||
161573243|NCT01329328|583484002|FG001|Overall Study|Withdrawal by Subject|4|||
161914769|NCT02814526|584735686|FG000|Overall Study|Lost to Follow-up|3|||
161465320|NCT01927341|583100463|FG004|Phase 2|Participant withdrew consent|3|||
161465321|NCT01927341|583100459|FG000|Phase 2|Death|0|||
161465322|NCT01927341|583100460|FG001|Phase 2|Death|4|||
161465323|NCT01927341|583100461|FG002|Phase 2|Death|0|||
161465324|NCT01927341|583100462|FG003|Phase 2|Death|3|||
161465325|NCT01927341|583100463|FG004|Phase 2|Death|2|||
161465326|NCT01927341|583100459|FG000|Phase 2|New cancer therapy|0|||
161465327|NCT01927341|583100460|FG001|Phase 2|New cancer therapy|1|||
161465328|NCT01927341|583100461|FG002|Phase 2|New cancer therapy|0|||
161465329|NCT01927341|583100462|FG003|Phase 2|New cancer therapy|4|||
161465330|NCT01927341|583100463|FG004|Phase 2|New cancer therapy|1|||
161465331|NCT01927341|583100459|FG000|Phase 2|Disease progression|0|||
161465332|NCT01927341|583100460|FG001|Phase 2|Disease progression|1|||
161465333|NCT01927341|583100461|FG002|Phase 2|Disease progression|1|||
161465334|NCT01927341|583100462|FG003|Phase 2|Disease progression|1|||
161465335|NCT01927341|583100463|FG004|Phase 2|Disease progression|0|||
161465336|NCT01927341|583100459|FG000|Phase 2|Follow-up completed|0|||
161465337|NCT01927341|583100460|FG001|Phase 2|Follow-up completed|6|||
161465338|NCT01927341|583100461|FG002|Phase 2|Follow-up completed|3|||
161465339|NCT01927341|583100462|FG003|Phase 2|Follow-up completed|5|||
161465340|NCT01927341|583100463|FG004|Phase 2|Follow-up completed|2|||
161465341|NCT01104701|583100464|FG000|Overall Study|Withdrawal by Subject|0|||
161465342|NCT01104701|583100465|FG001|Overall Study|Withdrawal by Subject|1|||
161465343|NCT01104701|583100466|FG002|Overall Study|Withdrawal by Subject|2|||
161465344|NCT01104701|583100467|FG003|Overall Study|Withdrawal by Subject|1|||
161465345|NCT01104701|583100464|FG000|Overall Study|Adverse Event|0|||
161465346|NCT01104701|583100465|FG001|Overall Study|Adverse Event|0|||
161465347|NCT01104701|583100466|FG002|Overall Study|Adverse Event|0|||
161465348|NCT01104701|583100467|FG003|Overall Study|Adverse Event|1|||
161465349|NCT01104701|583100464|FG000|Overall Study|Physician Decision|0|||
161465350|NCT01104701|583100465|FG001|Overall Study|Physician Decision|2|||
161465351|NCT01104701|583100466|FG002|Overall Study|Physician Decision|0|||
161465352|NCT01104701|583100467|FG003|Overall Study|Physician Decision|0|||
161465353|NCT00423722|583100468|FG000|Overall Study|Death|4|||
161465354|NCT00423722|583100469|FG001|Overall Study|Death|4|||
161465355|NCT00423722|583100468|FG000|Overall Study|Declined to participate|2|||
161465356|NCT00423722|583100469|FG001|Overall Study|Declined to participate|3|||
161465357|NCT00423722|583100468|FG000|Overall Study|Unable to complete questionnaires|4|||
161465358|NCT00423722|583100469|FG001|Overall Study|Unable to complete questionnaires|4|||
161465359|NCT00423722|583100468|FG000|Overall Study|Withdrawal by Subject|4|||
161465360|NCT00423722|583100469|FG001|Overall Study|Withdrawal by Subject|2|||
161465361|NCT00674973|583100470|FG000|Overall Study|Insufficient Therapeutic Response|77|||
161465362|NCT00674973|583100471|FG001|Overall Study|Insufficient Therapeutic Response|72|||
161465363|NCT00674973|583100470|FG000|Overall Study|Refused Treatment|1|||
161465364|NCT00674973|583100471|FG001|Overall Study|Refused Treatment|5|||
161465365|NCT00674973|583100470|FG000|Overall Study|Failure to Return|1|||
161465366|NCT00674973|583100471|FG001|Overall Study|Failure to Return|0|||
161465367|NCT00674973|583100470|FG000|Overall Study|Adverse Event|2|||
161465368|NCT00674973|583100471|FG001|Overall Study|Adverse Event|9|||
161465369|NCT00674973|583100470|FG000|Overall Study|Death|19|||
161465370|NCT00674973|583100471|FG001|Overall Study|Death|15|||
161465371|NCT00674973|583100470|FG000|Overall Study|Protocol Violation|0|||
161465372|NCT00674973|583100471|FG001|Overall Study|Protocol Violation|1|||
161465373|NCT00451451|583100472|FG000|Overall Study|Adverse Event|11|||
161465374|NCT00451451|583100473|FG001|Overall Study|Adverse Event|21|||
161465375|NCT00451451|583100474|FG002|Overall Study|Adverse Event|26|||
161465376|NCT00451451|583100475|FG003|Overall Study|Adverse Event|10|||
161465377|NCT00451451|583100472|FG000|Overall Study|Lost to Follow-up|11|||
161465378|NCT00451451|583100473|FG001|Overall Study|Lost to Follow-up|9|||
161465379|NCT00451451|583100474|FG002|Overall Study|Lost to Follow-up|8|||
161465380|NCT00451451|583100475|FG003|Overall Study|Lost to Follow-up|11|||
161465381|NCT00451451|583100472|FG000|Overall Study|Consent Withdrawn|14|||
161465382|NCT00451451|583100473|FG001|Overall Study|Consent Withdrawn|9|||
161465383|NCT00451451|583100474|FG002|Overall Study|Consent Withdrawn|17|||
161573244|NCT01329328|583484003|FG002|Overall Study|Withdrawal by Subject|3|||
161573245|NCT01565928|583484004|FG000|Overall Study|Adverse Event|3|||
161465384|NCT00451451|583100475|FG003|Overall Study|Consent Withdrawn|17|||
161465385|NCT00451451|583100472|FG000|Overall Study|Investigator Decision|6|||
161465386|NCT00451451|583100473|FG001|Overall Study|Investigator Decision|2|||
161465387|NCT00451451|583100474|FG002|Overall Study|Investigator Decision|1|||
161465388|NCT00451451|583100475|FG003|Overall Study|Investigator Decision|2|||
161465389|NCT00451451|583100472|FG000|Overall Study|Subject Non-Compliance|8|||
161573246|NCT01565928|583484004|FG000|Overall Study|Other|3|||
161573247|NCT01565928|583484004|FG000|Overall Study|Progressive Disease|13|||
161465390|NCT00451451|583100473|FG001|Overall Study|Subject Non-Compliance|4|||
161465391|NCT00451451|583100474|FG002|Overall Study|Subject Non-Compliance|3|||
161465392|NCT00451451|583100475|FG003|Overall Study|Subject Non-Compliance|3|||
161465393|NCT00451451|583100472|FG000|Overall Study|Death|1|||
161465394|NCT00451451|583100473|FG001|Overall Study|Death|0|||
161465395|NCT00451451|583100474|FG002|Overall Study|Death|0|||
161465396|NCT00451451|583100475|FG003|Overall Study|Death|1|||
161465397|NCT00451451|583100472|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
161465398|NCT00451451|583100473|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
161465399|NCT00451451|583100474|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
161465400|NCT00451451|583100475|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
161465401|NCT00084838|583100478|FG000|Overall Study|Death|1|||
161465402|NCT00084838|583100478|FG000|Overall Study|Adverse Event|2|||
161465403|NCT00084838|583100478|FG000|Overall Study|Withdrawal by Subject|1|||
161465404|NCT00084838|583100478|FG000|Overall Study|Progressive Disease|4|||
161465405|NCT00084838|583100478|FG000|Overall Study|Pt Non-Compliance|1|||
161465406|NCT00084838|583100478|FG000|Overall Study|Ineligible|4|||
161465407|NCT00518687|583100479|FG000|Overall Study|Adverse Event|201|||
161465408|NCT00518687|583100480|FG001|Overall Study|Adverse Event|177|||
161465409|NCT00518687|583100479|FG000|Overall Study|Lost to Follow-up|144|||
161465410|NCT00518687|583100480|FG001|Overall Study|Lost to Follow-up|155|||
161465411|NCT00518687|583100479|FG000|Overall Study|Physician Decision|42|||
161465412|NCT00518687|583100480|FG001|Overall Study|Physician Decision|48|||
161465413|NCT00518687|583100479|FG000|Overall Study|Progressive disease|2|||
161465414|NCT00518687|583100480|FG001|Overall Study|Progressive disease|2|||
161465415|NCT00518687|583100479|FG000|Overall Study|Protocol Violation|8|||
161465416|NCT00518687|583100480|FG001|Overall Study|Protocol Violation|10|||
161465417|NCT00518687|583100479|FG000|Overall Study|Study terminated by sponsor|930|||
161465418|NCT00518687|583100480|FG001|Overall Study|Study terminated by sponsor|918|||
161465419|NCT00518687|583100479|FG000|Overall Study|Withdrawal by Subject|110|||
161465420|NCT00518687|583100480|FG001|Overall Study|Withdrawal by Subject|110|||
161465421|NCT00851630|583100482|FG000|Overall Study|Death|2|||
161465422|NCT00851630|583100483|FG001|Overall Study|Death|1|||
161465423|NCT00851630|583100482|FG000|Overall Study|Clinical failure|0|||
161465424|NCT00851630|583100483|FG001|Overall Study|Clinical failure|1|||
161465425|NCT01442038|583100486|FG000|Overall Study|Death|35|||
161465426|NCT01442038|583100487|FG001|Overall Study|Death|29|||
161465427|NCT01442038|583100486|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
161465428|NCT01442038|583100487|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
161465429|NCT01442038|583100486|FG000|Overall Study|Participant Withdrew Consent|137|||
161465430|NCT01442038|583100487|FG001|Overall Study|Participant Withdrew Consent|102|||
161914770|NCT02814526|584735687|FG001|Overall Study|Lost to Follow-up|4|||
161465431|NCT01442038|583100486|FG000|Overall Study|Lost to Follow-up|37|||
161465432|NCT01442038|583100487|FG001|Overall Study|Lost to Follow-up|51|||
161465433|NCT01442038|583100486|FG000|Overall Study|Adverse Event|26|||
161465434|NCT01442038|583100487|FG001|Overall Study|Adverse Event|15|||
161465435|NCT01442038|583100486|FG000|Overall Study|Protocol Deviation|9|||
161465436|NCT01442038|583100487|FG001|Overall Study|Protocol Deviation|20|||
161465437|NCT01442038|583100486|FG000|Overall Study|Investigator's Discretion|13|||
161465438|NCT01442038|583100487|FG001|Overall Study|Investigator's Discretion|16|||
161465439|NCT01442038|583100486|FG000|Overall Study|Study Terminated By Sponsor|2|||
161465440|NCT01442038|583100487|FG001|Overall Study|Study Terminated By Sponsor|3|||
161465441|NCT00089284|583100488|FG000|Overall Study|Adverse event before starting treatment|0|||
161465442|NCT00089284|583100489|FG001|Overall Study|Adverse event before starting treatment|0|||
161465443|NCT00089284|583100490|FG002|Overall Study|Adverse event before starting treatment|0|||
161465444|NCT00089284|583100491|FG003|Overall Study|Adverse event before starting treatment|0|||
161465445|NCT00089284|583100492|FG004|Overall Study|Adverse event before starting treatment|0|||
161465446|NCT00089284|583100493|FG005|Overall Study|Adverse event before starting treatment|0|||
161465447|NCT00089284|583100494|FG006|Overall Study|Adverse event before starting treatment|1|||
161465448|NCT02611960|583100495|FG000|Overall Study|Adverse Event|7|||
161465449|NCT02611960|583100496|FG001|Overall Study|Adverse Event|8|||
161465450|NCT02611960|583100495|FG000|Overall Study|Death|98|||
161465451|NCT02611960|583100496|FG001|Overall Study|Death|92|||
161465452|NCT02611960|583100495|FG000|Overall Study|Withdrawal by Subject|1|||
161465453|NCT02611960|583100496|FG001|Overall Study|Withdrawal by Subject|5|||
161465454|NCT02611960|583100495|FG000|Overall Study|Sponsor Decision|11|||
161465455|NCT02611960|583100496|FG001|Overall Study|Sponsor Decision|11|||
161465456|NCT00137631|583100497|FG000|Overall Study|Lost to Follow-up|37|||
161465457|NCT00137631|583100498|FG001|Overall Study|Lost to Follow-up|41|||
161465458|NCT02395666|583100499|FG000|Overall Study|Physician Decision|3|||
161465459|NCT02395666|583100500|FG001|Overall Study|Physician Decision|0|||
161465460|NCT02395666|583100499|FG000|Overall Study|Lost to Follow-up|1|||
161465461|NCT02395666|583100500|FG001|Overall Study|Lost to Follow-up|0|||
161465462|NCT02395666|583100499|FG000|Overall Study|Withdrawal by Subject|2|||
161465463|NCT02395666|583100500|FG001|Overall Study|Withdrawal by Subject|1|||
161465464|NCT01092507|583100501|FG000|Overall Study|Withdrawal by Subject|2|||
161465465|NCT01092507|583100502|FG001|Overall Study|Withdrawal by Subject|0|||
161465466|NCT00085709|583100514|FG000|Overall Study|Adverse Event|8|||
161465467|NCT00085709|583100515|FG001|Overall Study|Adverse Event|0|||
161465468|NCT00085709|583100514|FG000|Overall Study|Death|8|||
161465469|NCT00085709|583100515|FG001|Overall Study|Death|2|||
161465470|NCT00085709|583100514|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161465471|NCT00085709|583100515|FG001|Overall Study|Refusal unrelated to adverse events|2|||
161914771|NCT02814526|584735686|FG000|Overall Study|non site physician decision|1|||
161573248|NCT01565928|583484004|FG000|Overall Study|Withdrawal by Subject|1|||
161573249|NCT01565928|583484004|FG000|Overall Study|Death|2|||
161573250|NCT02540213|583484007|FG000|Overall Study|Death/adverse event|18|||
161573251|NCT02540213|583484007|FG000|Overall Study|Administrative reasons|3|||
161573252|NCT02540213|583484007|FG000|Overall Study|Kidney transplant|3|||
161573253|NCT02540213|583484007|FG000|Overall Study|Lack of Efficacy|6|||
161573254|NCT02540213|583484007|FG000|Overall Study|Consent withdrawn|7|||
161573255|NCT02540213|583484007|FG000|Overall Study|Enrolled but not treated|2|||
161573256|NCT02289560|583484008|FG000|Overall Study|Lost to Follow-up|6|||
161573257|NCT02289560|583484008|FG000|Overall Study|Alternative Treatment|4|||
161573258|NCT02289560|583484008|FG000|Overall Study|Inadequate Treatment|2|||
161573259|NCT02289560|583484008|FG000|Overall Study|Withdrawal by Subject|23|||
161573260|NCT01264718|583484009|FG000|Overall Study|Lost to Follow-up|3|||
161573261|NCT01264718|583484010|FG001|Overall Study|Lost to Follow-up|2|||
161573262|NCT01264718|583484009|FG000|Overall Study|Withdrawal by Subject|9|||
161573263|NCT01264718|583484010|FG001|Overall Study|Withdrawal by Subject|15|||
161573264|NCT01264718|583484009|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
161573265|NCT01264718|583484010|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
161573266|NCT02908464|583484011|FG000|Overall Study|Withdrawal by Subject|2|||
161573267|NCT02908464|583484012|FG001|Overall Study|Withdrawal by Subject|1|||
161573268|NCT02908464|583484011|FG000|Overall Study|Found ineligible after randomization|0|||
161573269|NCT02908464|583484012|FG001|Overall Study|Found ineligible after randomization|2|||
161573270|NCT01769391|583484015|FG000|Overall Study|Death|10|||
161573271|NCT01769391|583484016|FG001|Overall Study|Death|1|||
161573272|NCT01769391|583484015|FG000|Overall Study|Adverse Event|0|||
161573273|NCT01769391|583484016|FG001|Overall Study|Adverse Event|3|||
161573274|NCT01769391|583484015|FG000|Overall Study|Progressive Disease|1|||
161573275|NCT01769391|583484016|FG001|Overall Study|Progressive Disease|2|||
161573276|NCT01769391|583484015|FG000|Overall Study|Withdrawal by Subject|4|||
161573277|NCT01769391|583484016|FG001|Overall Study|Withdrawal by Subject|3|||
161573278|NCT01769391|583484015|FG000|Overall Study|Investigator Decision|2|||
161573279|NCT01769391|583484016|FG001|Overall Study|Investigator Decision|0|||
161573280|NCT03386929|583484017|FG000|Overall Study|Death|0|||
161573281|NCT03386929|583484018|FG001|Overall Study|Death|0|||
161573282|NCT03386929|583484019|FG002|Overall Study|Death|1|||
161573283|NCT03386929|583484017|FG000|Overall Study|Withdrawal by Subject|0|||
161573284|NCT03386929|583484018|FG001|Overall Study|Withdrawal by Subject|1|||
161573285|NCT03386929|583484019|FG002|Overall Study|Withdrawal by Subject|0|||
161573286|NCT03386929|583484017|FG000|Overall Study|Physician Decision|0|||
161573287|NCT03386929|583484018|FG001|Overall Study|Physician Decision|0|||
161573288|NCT03386929|583484019|FG002|Overall Study|Physician Decision|1|||
161573289|NCT03386929|583484017|FG000|Overall Study|Progression|4|||
161465472|NCT00085709|583100514|FG000|Overall Study|Progression|3|||
161465473|NCT00085709|583100515|FG001|Overall Study|Progression|4|||
161465474|NCT00085709|583100514|FG000|Overall Study|Not protocol specified|12|||
161465475|NCT00085709|583100515|FG001|Overall Study|Not protocol specified|22|||
161465476|NCT00085709|583100514|FG000|Overall Study|Not eligible|19|||
161465477|NCT00085709|583100515|FG001|Overall Study|Not eligible|19|||
161465478|NCT00085709|583100514|FG000|Overall Study|Withdrawal by Subject|2|||
161465479|NCT00085709|583100515|FG001|Overall Study|Withdrawal by Subject|1|||
161465480|NCT04131556|583100516|FG000|Overall Study|Adverse Event|1|||
161465481|NCT04131556|583100516|FG000|Overall Study|Withdrawal by Subject|1|||
161465482|NCT00736879|583100521|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
161465483|NCT00736879|583100522|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161465484|NCT00736879|583100523|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161465485|NCT00736879|583100524|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
161465486|NCT00736879|583100521|FG000|Double Blind Treatment Period|Adverse Event|0|||
161465487|NCT00736879|583100522|FG001|Double Blind Treatment Period|Adverse Event|1|||
161465488|NCT00736879|583100523|FG002|Double Blind Treatment Period|Adverse Event|1|||
161573290|NCT03386929|583484018|FG001|Overall Study|Progression|4|||
161573291|NCT03386929|583484019|FG002|Overall Study|Progression|0|||
161573292|NCT03386929|583484017|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161573293|NCT03386929|583484018|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161573294|NCT03386929|583484019|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161573295|NCT03386929|583484017|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
161573296|NCT03386929|583484018|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
161573297|NCT03386929|583484019|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
161573298|NCT03538054|583484020|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
161573299|NCT03538054|583484020|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
161573300|NCT03538054|583484020|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
161573301|NCT02351180|583484023|FG000|Overall Study|Withdrawal by Subject|1|||
161573302|NCT02351180|583484024|FG001|Overall Study|Withdrawal by Subject|0|||
161573303|NCT00208767|583484025|FG000|Overall Study|Adverse Event|9|||
161573304|NCT00208767|583484026|FG001|Overall Study|Adverse Event|1|||
161465489|NCT00736879|583100524|FG003|Double Blind Treatment Period|Adverse Event|0|||
161573305|NCT00208767|583484025|FG000|Overall Study|Withdrawal by Subject|14|||
161573306|NCT00208767|583484026|FG001|Overall Study|Withdrawal by Subject|3|||
161573307|NCT00208767|583484025|FG000|Overall Study|Death|1|||
161573308|NCT00208767|583484026|FG001|Overall Study|Death|0|||
161573309|NCT00208767|583484025|FG000|Overall Study|Lost to Follow-up|3|||
161573310|NCT00208767|583484026|FG001|Overall Study|Lost to Follow-up|3|||
161573311|NCT02317016|583484027|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
161573312|NCT02317016|583484027|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
161573313|NCT02317016|583484027|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
161573314|NCT02317016|583484027|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
161573315|NCT02317016|583484027|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
161573316|NCT02317016|583484027|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
161573317|NCT02317016|583484027|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
161573318|NCT00536380|583484028|FG000|Overall Study|Adverse Event|0|||
161465490|NCT00736879|583100521|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
161465491|NCT00736879|583100522|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
161465492|NCT00736879|583100523|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
161465493|NCT00736879|583100524|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
161465494|NCT00736879|583100521|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161465495|NCT00736879|583100522|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161465496|NCT00736879|583100523|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
161465497|NCT00736879|583100524|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
161465498|NCT00736879|583100521|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
161465499|NCT00736879|583100522|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
161465500|NCT00736879|583100523|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
161465501|NCT00736879|583100524|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
161465502|NCT00736879|583100521|FG000|Double Blind Treatment Period|No longer met criteria|0|||
161465503|NCT00736879|583100522|FG001|Double Blind Treatment Period|No longer met criteria|1|||
161465504|NCT00736879|583100523|FG002|Double Blind Treatment Period|No longer met criteria|0|||
161465505|NCT00736879|583100524|FG003|Double Blind Treatment Period|No longer met criteria|0|||
161465506|NCT00736879|583100521|FG000|Double Blind Treatment Period|non-specified|0|||
161465507|NCT00736879|583100522|FG001|Double Blind Treatment Period|non-specified|1|||
161465508|NCT00736879|583100523|FG002|Double Blind Treatment Period|non-specified|0|||
161465509|NCT00736879|583100524|FG003|Double Blind Treatment Period|non-specified|0|||
161465510|NCT00736879|583100521|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
161465511|NCT00736879|583100522|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
161465512|NCT00736879|583100523|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
161465513|NCT00736879|583100524|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
161465514|NCT00736879|583100521|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
161465515|NCT00736879|583100522|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
161465516|NCT00736879|583100523|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
161465517|NCT00736879|583100524|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
161465518|NCT00735254|583100530|FG000|Overall Study|Protocol Violation|1|||
161465519|NCT00735254|583100531|FG001|Overall Study|Protocol Violation|1|||
161465520|NCT00735254|583100532|FG002|Overall Study|Protocol Violation|1|||
161465521|NCT00735254|583100533|FG003|Overall Study|Protocol Violation|0|||
161465522|NCT03880461|583100541|FG000|Overall Study|Determined ineligible after enrollment|45|||
161465523|NCT03880461|583100542|FG001|Overall Study|Determined ineligible after enrollment|44|||
161465524|NCT03880461|583100541|FG000|Overall Study|No weight measurement after enrollment|24|||
161465525|NCT03880461|583100542|FG001|Overall Study|No weight measurement after enrollment|17|||
161465526|NCT02652767|583100544|FG000|Overall Study|Death|2|||
161465527|NCT02652767|583100544|FG000|Overall Study|Lost to Follow-up|1|||
161465528|NCT02652767|583100544|FG000|Overall Study|Withdrawal by Subject|1|||
161465529|NCT02273739|583100548|FG000|Overall Study|Progression of Disease|3|||
161465530|NCT02273739|583100549|FG001|Overall Study|Progression of Disease|4|||
161465531|NCT02273739|583100550|FG002|Overall Study|Progression of Disease|5|||
161465532|NCT02273739|583100551|FG003|Overall Study|Progression of Disease|2|||
161465533|NCT02273739|583100548|FG000|Overall Study|Death|0|||
161465534|NCT02273739|583100549|FG001|Overall Study|Death|0|||
161465535|NCT02273739|583100550|FG002|Overall Study|Death|0|||
161465536|NCT02273739|583100551|FG003|Overall Study|Death|2|||
161465537|NCT02273739|583100548|FG000|Overall Study|Adverse Event|0|||
161465538|NCT02273739|583100549|FG001|Overall Study|Adverse Event|0|||
161465539|NCT02273739|583100550|FG002|Overall Study|Adverse Event|0|||
161465540|NCT02273739|583100551|FG003|Overall Study|Adverse Event|1|||
161465541|NCT02273739|583100548|FG000|Overall Study|Withdrawal by Subject|0|||
161465542|NCT02273739|583100549|FG001|Overall Study|Withdrawal by Subject|0|||
161465543|NCT02273739|583100550|FG002|Overall Study|Withdrawal by Subject|2|||
161465544|NCT02273739|583100551|FG003|Overall Study|Withdrawal by Subject|1|||
161465545|NCT02273739|583100548|FG000|Overall Study|Physician Decision|0|||
161465546|NCT02273739|583100549|FG001|Overall Study|Physician Decision|0|||
161465547|NCT02273739|583100550|FG002|Overall Study|Physician Decision|0|||
161465548|NCT02273739|583100551|FG003|Overall Study|Physician Decision|1|||
161465549|NCT02280473|583100553|FG000|Overall Study|Adverse Event|1|||
161465550|NCT02280473|583100554|FG001|Overall Study|Adverse Event|1|||
161465551|NCT02280473|583100553|FG000|Overall Study|Lack of Efficacy|0|||
161465552|NCT02280473|583100554|FG001|Overall Study|Lack of Efficacy|1|||
161465553|NCT02280473|583100553|FG000|Overall Study|Lost to Follow-up|0|||
161465554|NCT02280473|583100554|FG001|Overall Study|Lost to Follow-up|1|||
161465555|NCT02393690|583100555|FG000|Overall Study|Ineligible|0|||
161465556|NCT02393690|583100556|FG001|Overall Study|Ineligible|1|||
161465557|NCT05298306|583100557|FG000|Overall Study|Physician Decision|0|||
161465558|NCT05298306|583100558|FG001|Overall Study|Physician Decision|0|||
161465559|NCT05298306|583100559|FG002|Overall Study|Physician Decision|0|||
161465560|NCT05298306|583100560|FG003|Overall Study|Physician Decision|1|||
161465561|NCT05298306|583100561|FG004|Overall Study|Physician Decision|0|||
161465562|NCT05298306|583100562|FG005|Overall Study|Physician Decision|0|||
161465563|NCT00144027|583100564|FG000|Overall Study|Lost to Follow-up|1|||
161465564|NCT00144027|583100565|FG001|Overall Study|Lost to Follow-up|3|||
161465565|NCT00144027|583100564|FG000|Overall Study|Withdrawal by Subject|2|||
161465566|NCT00144027|583100565|FG001|Overall Study|Withdrawal by Subject|2|||
161465567|NCT00144027|583100564|FG000|Overall Study|did not complete baseline assessment|0|||
161465568|NCT00144027|583100565|FG001|Overall Study|did not complete baseline assessment|6|||
161465569|NCT00237185|583100566|FG000|Core|Adverse Event|3|||
161465570|NCT00237185|583100567|FG001|Core|Adverse Event|4|||
161465571|NCT00237185|583100566|FG000|Core|Abnormal laboratory value|0|||
161465572|NCT00237185|583100567|FG001|Core|Abnormal laboratory value|4|||
161465573|NCT00237185|583100566|FG000|Core|Abnormal test procedure results|1|||
161465574|NCT00237185|583100567|FG001|Core|Abnormal test procedure results|0|||
161465575|NCT00237185|583100566|FG000|Core|Lack of Efficacy|30|||
161465576|NCT00237185|583100567|FG001|Core|Lack of Efficacy|23|||
161465577|NCT00237185|583100566|FG000|Core|Protocol Violation|1|||
161465578|NCT00237185|583100567|FG001|Core|Protocol Violation|1|||
161465579|NCT00237185|583100566|FG000|Core|Withdrawal by Subject|4|||
161465580|NCT00237185|583100567|FG001|Core|Withdrawal by Subject|4|||
161465581|NCT00237185|583100566|FG000|Core|Administrative problems|0|||
161465582|NCT00237185|583100567|FG001|Core|Administrative problems|1|||
161465583|NCT00237185|583100566|FG000|Core|Death|4|||
161465584|NCT00237185|583100567|FG001|Core|Death|0|||
161465585|NCT00237185|583100566|FG000|Core|Determined ineligible post randomization|1|||
161465586|NCT00237185|583100567|FG001|Core|Determined ineligible post randomization|0|||
161465587|NCT00237185|583100566|FG000|Extension|Adverse Event|1|||
161465588|NCT00237185|583100567|FG001|Extension|Adverse Event|0|||
161465589|NCT00237185|583100566|FG000|Extension|Abnormal laboratory value|0|||
161465590|NCT00237185|583100567|FG001|Extension|Abnormal laboratory value|1|||
161465591|NCT00237185|583100566|FG000|Extension|Lack of Efficacy|9|||
161465592|NCT00237185|583100567|FG001|Extension|Lack of Efficacy|14|||
161465593|NCT00237185|583100566|FG000|Extension|Condition no longer required study drug|0|||
161465594|NCT00237185|583100567|FG001|Extension|Condition no longer required study drug|1|||
161465595|NCT00237185|583100566|FG000|Extension|Withdrawal by Subject|3|||
161465596|NCT00237185|583100567|FG001|Extension|Withdrawal by Subject|2|||
161465597|NCT00237185|583100566|FG000|Extension|Lost to Follow-up|1|||
161465598|NCT00237185|583100567|FG001|Extension|Lost to Follow-up|0|||
161465599|NCT00237185|583100566|FG000|Extension|Administrative problems|1|||
161465600|NCT00237185|583100567|FG001|Extension|Administrative problems|0|||
161465601|NCT00237185|583100566|FG000|Extension|Death|1|||
161465602|NCT00237185|583100567|FG001|Extension|Death|1|||
161465603|NCT02204007|583100568|FG000|Overall Study|Surgery Canceled|1|||
161465604|NCT02204007|583100569|FG001|Overall Study|Surgery Canceled|1|||
161465605|NCT00910988|583100570|FG000|Overall Study|Lost to Follow-up|2|||
161465606|NCT00910988|583100571|FG001|Overall Study|Lost to Follow-up|4|||
161465607|NCT00910988|583100572|FG002|Overall Study|Lost to Follow-up|3|||
161465608|NCT00910988|583100573|FG003|Overall Study|Lost to Follow-up|0|||
161465609|NCT02766465|583100574|FG000|Overall Study|Withdrawal by Subject|0|||
161465610|NCT02766465|583100575|FG001|Overall Study|Withdrawal by Subject|10|||
161465611|NCT01907100|583100576|FG000|Overall Study|PD based on modified RECIST criteria|31|||
161465612|NCT01907100|583100577|FG001|Overall Study|PD based on modified RECIST criteria|32|||
161465613|NCT01907100|583100578|FG002|Overall Study|PD based on modified RECIST criteria|95|||
161465614|NCT01907100|583100579|FG003|Overall Study|PD based on modified RECIST criteria|92|||
161465615|NCT01907100|583100576|FG000|Overall Study|Withdrawal by Subject|2|||
161465616|NCT01907100|583100577|FG001|Overall Study|Withdrawal by Subject|5|||
161465617|NCT01907100|583100578|FG002|Overall Study|Withdrawal by Subject|10|||
161465618|NCT01907100|583100579|FG003|Overall Study|Withdrawal by Subject|13|||
161465619|NCT01907100|583100576|FG000|Overall Study|Protocol Violation|0|||
161465620|NCT01907100|583100577|FG001|Overall Study|Protocol Violation|0|||
161465621|NCT01907100|583100578|FG002|Overall Study|Protocol Violation|1|||
161465622|NCT01907100|583100579|FG003|Overall Study|Protocol Violation|1|||
161465623|NCT01907100|583100576|FG000|Overall Study|Lost to Follow-up|0|||
161465624|NCT01907100|583100577|FG001|Overall Study|Lost to Follow-up|0|||
161465625|NCT01907100|583100578|FG002|Overall Study|Lost to Follow-up|0|||
161465626|NCT01907100|583100579|FG003|Overall Study|Lost to Follow-up|1|||
161810372|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
161810373|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
161810374|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
161810375|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
161810376|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
161810377|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
161810378|NCT03686033|584347788|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810379|NCT03686033|584347789|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810380|NCT03686033|584347790|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810381|NCT03686033|584347791|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810382|NCT03686033|584347792|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
161810383|NCT03686033|584347793|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
161914772|NCT02814526|584735687|FG001|Overall Study|non site physician decision|0|||
161914773|NCT02814526|584735686|FG000|Overall Study|participant noncompliance|1|||
161914774|NCT02814526|584735687|FG001|Overall Study|participant noncompliance|1|||
161914775|NCT02814526|584735686|FG000|Overall Study|Withdrawal by Subject|20|||
161914776|NCT02814526|584735687|FG001|Overall Study|Withdrawal by Subject|14|||
161914777|NCT02814526|584735686|FG000|Overall Study|safety risk|2|||
161914778|NCT02814526|584735687|FG001|Overall Study|safety risk|1|||
161914779|NCT02814526|584735686|FG000|Overall Study|early termination-study terminated|1|||
161914780|NCT02814526|584735687|FG001|Overall Study|early termination-study terminated|2|||
161914781|NCT02814526|584735686|FG000|Overall Study|Other|0|||
161914782|NCT02814526|584735687|FG001|Overall Study|Other|4|||
161914783|NCT02485860|584735688|FG000|Overall Study|Lost to Follow-up|4|||
161914784|NCT02485860|584735689|FG001|Overall Study|Lost to Follow-up|1|||
161914785|NCT02485860|584735688|FG000|Overall Study|Physician Decision|1|||
161914786|NCT02485860|584735689|FG001|Overall Study|Physician Decision|2|||
161914787|NCT02485860|584735688|FG000|Overall Study|Health context (COVID-19)|1|||
161914788|NCT02485860|584735689|FG001|Overall Study|Health context (COVID-19)|0|||
161914789|NCT01416571|584735690|FG000|Overall Study|Lost to Follow-up|2|||
161914790|NCT03608163|584735691|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
161914791|NCT03608163|584735692|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
161914792|NCT03454555|584737290|FG000|Overall Study|Death|6|||
161914793|NCT03454555|584737291|FG001|Overall Study|Death|6|||
161914794|NCT03454555|584737290|FG000|Overall Study|Lost to Follow-up|31|||
161914795|NCT03454555|584737291|FG001|Overall Study|Lost to Follow-up|12|||
161914796|NCT03454555|584737290|FG000|Overall Study|Physician Decision|2|||
161914797|NCT03454555|584737291|FG001|Overall Study|Physician Decision|6|||
161914798|NCT03454555|584737290|FG000|Overall Study|Withdrawal by Subject|34|||
161914799|NCT03454555|584737291|FG001|Overall Study|Withdrawal by Subject|5|||
161914800|NCT03454555|584737290|FG000|Overall Study|Ineligible|1|||
161914801|NCT03454555|584737291|FG001|Overall Study|Ineligible|5|||
161914802|NCT05493111|584737292|FG000|Overall Study|Adverse Event|3|||
161914803|NCT05493111|584737293|FG001|Overall Study|Adverse Event|4|||
161914804|NCT05493111|584737292|FG000|Overall Study|Withdrawal of Consent|19|||
161914805|NCT05493111|584737293|FG001|Overall Study|Withdrawal of Consent|10|||
161914806|NCT05493111|584737292|FG000|Overall Study|Non-compliance|1|||
161914807|NCT05493111|584737293|FG001|Overall Study|Non-compliance|1|||
161914808|NCT05493111|584737292|FG000|Overall Study|Lost to Follow-up|8|||
161914809|NCT05493111|584737293|FG001|Overall Study|Lost to Follow-up|1|||
161914810|NCT05493111|584737292|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
161914811|NCT05493111|584737293|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
161914812|NCT05493111|584737292|FG000|Overall Study|Withdrawal by Subject|1|||
161914813|NCT05493111|584737293|FG001|Overall Study|Withdrawal by Subject|1|||
161914814|NCT00375752|584737294|FG000|Overall Study|Lack of Efficacy|4|||
161914815|NCT00375752|584737295|FG001|Overall Study|Lack of Efficacy|4|||
161914816|NCT00375752|584737294|FG000|Overall Study|Adverse Event|1|||
161914817|NCT00375752|584737295|FG001|Overall Study|Adverse Event|6|||
161914818|NCT00375752|584737294|FG000|Overall Study|Withdrawal by Subject|6|||
161914819|NCT00375752|584737295|FG001|Overall Study|Withdrawal by Subject|1|||
161914820|NCT00375752|584737294|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161914821|NCT00375752|584737295|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
161914822|NCT00375752|584737294|FG000|Overall Study|Protocol Violation|0|||
161914823|NCT00375752|584737295|FG001|Overall Study|Protocol Violation|2|||
161914824|NCT00375752|584737294|FG000|Overall Study|Administrative Problems|0|||
161914825|NCT00375752|584737295|FG001|Overall Study|Administrative Problems|1|||
161914826|NCT01140906|584737300|FG000|Overall Study|Adverse Event|7|||
161465627|NCT01907100|583100576|FG000|Overall Study|Not treated|2|||
161465628|NCT01907100|583100577|FG001|Overall Study|Not treated|0|||
161810384|NCT01854047|584347794|FG000|Overall Study|Lack of Efficacy|1|||
161810385|NCT01854047|584347795|FG001|Overall Study|Lack of Efficacy|0|||
161810386|NCT01854047|584347796|FG002|Overall Study|Lack of Efficacy|0|||
161810387|NCT01854047|584347797|FG003|Overall Study|Lack of Efficacy|0|||
161914827|NCT01140906|584737301|FG001|Overall Study|Adverse Event|10|||
161914828|NCT01140906|584737302|FG002|Overall Study|Adverse Event|17|||
161914829|NCT01140906|584737303|FG003|Overall Study|Adverse Event|7|||
161914830|NCT01140906|584737300|FG000|Overall Study|Lack of Efficacy|6|||
161465629|NCT01907100|583100578|FG002|Overall Study|Not treated|1|||
161465630|NCT01907100|583100579|FG003|Overall Study|Not treated|2|||
161465631|NCT01907100|583100576|FG000|Overall Study|Other than reasons specified|1|||
161465632|NCT01907100|583100577|FG001|Overall Study|Other than reasons specified|0|||
161465633|NCT01907100|583100578|FG002|Overall Study|Other than reasons specified|10|||
161465634|NCT01907100|583100579|FG003|Overall Study|Other than reasons specified|6|||
161465635|NCT01907100|583100576|FG000|Overall Study|Adverse event (AE)|6|||
161465636|NCT01907100|583100577|FG001|Overall Study|Adverse event (AE)|3|||
161465637|NCT01907100|583100578|FG002|Overall Study|Adverse event (AE)|22|||
161465638|NCT01907100|583100579|FG003|Overall Study|Adverse event (AE)|23|||
161465639|NCT01907100|583100576|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
161465640|NCT01907100|583100577|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
161465641|NCT01907100|583100578|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
161465642|NCT01907100|583100579|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
161465643|NCT01758289|583100580|FG000|Overall Study|Premature Study Termination|44|||
161465644|NCT01758289|583100580|FG000|Overall Study|Adverse Event|9|||
161465645|NCT01574079|583100581|FG000|Overall Study|Physician Decision|0|||
161465646|NCT01574079|583100582|FG001|Overall Study|Physician Decision|2|||
161465647|NCT01574079|583100581|FG000|Overall Study|Lost to Follow-up|1|||
161465648|NCT01574079|583100582|FG001|Overall Study|Lost to Follow-up|0|||
161465649|NCT02059005|583100583|FG000|Overall Study|Death|1|||
161465650|NCT02059005|583100584|FG001|Overall Study|Death|3|||
161465651|NCT02059005|583100583|FG000|Overall Study|Lost to Follow-up|19|||
161465652|NCT02059005|583100584|FG001|Overall Study|Lost to Follow-up|19|||
161465653|NCT02059005|583100583|FG000|Overall Study|Incarceration|0|||
161465654|NCT02059005|583100584|FG001|Overall Study|Incarceration|1|||
161465655|NCT02059005|583100583|FG000|Overall Study|Inpatient|0|||
161465656|NCT02059005|583100584|FG001|Overall Study|Inpatient|1|||
161465657|NCT00908011|583100587|FG000|Overall Study|Withdrawal by Subject|2|||
161465658|NCT00908011|583100588|FG001|Overall Study|Withdrawal by Subject|2|||
161465659|NCT00843726|583100589|FG000|Overall Study|Death|1|||
161465660|NCT00843726|583100590|FG001|Overall Study|Death|0|||
161465661|NCT00843726|583100589|FG000|Overall Study|Withdrawal by Subject|0|||
161465662|NCT00843726|583100590|FG001|Overall Study|Withdrawal by Subject|1|||
161465663|NCT00667602|583100591|FG000|Overall Study|Withdrawal by Subject|4|||
161465664|NCT00667602|583100592|FG001|Overall Study|Withdrawal by Subject|9|||
161465665|NCT00667602|583100593|FG002|Overall Study|Withdrawal by Subject|10|||
161465666|NCT00667602|583100591|FG000|Overall Study|Lost to Follow-up|4|||
161465667|NCT00667602|583100592|FG001|Overall Study|Lost to Follow-up|5|||
161465668|NCT00667602|583100593|FG002|Overall Study|Lost to Follow-up|6|||
161465669|NCT00667602|583100591|FG000|Overall Study|Administrative reason|0|||
161465670|NCT00667602|583100592|FG001|Overall Study|Administrative reason|0|||
161465671|NCT00667602|583100593|FG002|Overall Study|Administrative reason|2|||
161465672|NCT00667602|583100591|FG000|Overall Study|Protocol Violation|0|||
161465673|NCT00667602|583100592|FG001|Overall Study|Protocol Violation|1|||
161465674|NCT00667602|583100593|FG002|Overall Study|Protocol Violation|0|||
161465675|NCT03640559|583100596|FG000|Overall Study|Physician Decision|1|||
161465676|NCT03640559|583100597|FG001|Overall Study|Physician Decision|1|||
161465677|NCT03640559|583100596|FG000|Overall Study|Withdrawal by Subject|1|||
161465678|NCT03640559|583100597|FG001|Overall Study|Withdrawal by Subject|0|||
161465679|NCT01436162|583100598|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
161465680|NCT01436162|583100599|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
161465681|NCT01436162|583100600|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
161465682|NCT01436162|583100598|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
161465683|NCT01436162|583100599|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
161465684|NCT01436162|583100600|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
161465685|NCT01436162|583100598|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
161465686|NCT01436162|583100599|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
161465687|NCT01436162|583100600|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
161465688|NCT01436162|583100598|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
161465689|NCT01436162|583100599|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
161465690|NCT01436162|583100600|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
161465691|NCT01436162|583100598|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
161465692|NCT01436162|583100599|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161465693|NCT01436162|583100600|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161810388|NCT01854047|584347798|FG004|Overall Study|Lack of Efficacy|0|||
161465694|NCT01436162|583100598|FG000|Single-blind Lead-in Phase|Other|107|||
161465695|NCT01436162|583100599|FG001|Single-blind Lead-in Phase|Other|0|||
161465696|NCT01436162|583100600|FG002|Single-blind Lead-in Phase|Other|0|||
161810389|NCT01854047|584347794|FG000|Overall Study|Poor compliance to protocol|3|||
161465697|NCT01436162|583100598|FG000|Randomized Phase|Adverse Event|1|||
161465698|NCT01436162|583100599|FG001|Randomized Phase|Adverse Event|5|||
161465699|NCT01436162|583100600|FG002|Randomized Phase|Adverse Event|6|||
161465700|NCT01436162|583100598|FG000|Randomized Phase|Protocol Violation|4|||
161465701|NCT01436162|583100599|FG001|Randomized Phase|Protocol Violation|4|||
161465702|NCT01436162|583100600|FG002|Randomized Phase|Protocol Violation|2|||
161465703|NCT01436162|583100598|FG000|Randomized Phase|Withdrawal by Subject|16|||
161465704|NCT01436162|583100599|FG001|Randomized Phase|Withdrawal by Subject|9|||
161465705|NCT01436162|583100600|FG002|Randomized Phase|Withdrawal by Subject|8|||
161465706|NCT01436162|583100598|FG000|Randomized Phase|Lost to Follow-up|17|||
161465707|NCT01436162|583100599|FG001|Randomized Phase|Lost to Follow-up|5|||
161465708|NCT01436162|583100600|FG002|Randomized Phase|Lost to Follow-up|4|||
161465709|NCT01436162|583100598|FG000|Randomized Phase|Lack of Efficacy|0|||
161465710|NCT01436162|583100599|FG001|Randomized Phase|Lack of Efficacy|1|||
161465711|NCT01436162|583100600|FG002|Randomized Phase|Lack of Efficacy|1|||
161573319|NCT00536380|583484029|FG001|Overall Study|Adverse Event|2|||
161573320|NCT00536380|583484030|FG002|Overall Study|Adverse Event|2|||
161573321|NCT00536380|583484028|FG000|Overall Study|Lost to Follow-up|0|||
161573322|NCT00536380|583484029|FG001|Overall Study|Lost to Follow-up|0|||
161573323|NCT00536380|583484030|FG002|Overall Study|Lost to Follow-up|1|||
161573324|NCT00536380|583484028|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
161573325|NCT00536380|583484029|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
161573326|NCT00536380|583484030|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
161573327|NCT00536380|583484028|FG000|Overall Study|Withdrawal related to study drug|7|||
161573328|NCT00536380|583484029|FG001|Overall Study|Withdrawal related to study drug|5|||
161573329|NCT00536380|583484030|FG002|Overall Study|Withdrawal related to study drug|2|||
161573330|NCT00536380|583484028|FG000|Overall Study|Noncompliance with protocol|3|||
161573331|NCT00536380|583484029|FG001|Overall Study|Noncompliance with protocol|2|||
161573332|NCT00536380|583484030|FG002|Overall Study|Noncompliance with protocol|2|||
161573333|NCT00536380|583484028|FG000|Overall Study|Did not meet protocol eligibility|0|||
161573334|NCT00536380|583484029|FG001|Overall Study|Did not meet protocol eligibility|0|||
161573335|NCT00536380|583484030|FG002|Overall Study|Did not meet protocol eligibility|1|||
161573336|NCT00536380|583484028|FG000|Overall Study|Administrative|0|||
161573337|NCT00536380|583484029|FG001|Overall Study|Administrative|0|||
161573338|NCT00536380|583484030|FG002|Overall Study|Administrative|1|||
161573339|NCT03545984|583484031|FG000|Overall Study|CSF cases not present during rotation|11|||
161573340|NCT03545984|583484032|FG001|Overall Study|CSF cases not present during rotation|9|||
161573341|NCT00387465|583484033|FG000|Overall Study|Withdrawal by Subject|0|||
161573342|NCT00387465|583484034|FG001|Overall Study|Withdrawal by Subject|1|||
161573343|NCT00387465|583484035|FG002|Overall Study|Withdrawal by Subject|0|||
161573344|NCT03418324|583484036|FG000|Overall Study|Death|0|||
161573345|NCT03418324|583484037|FG001|Overall Study|Death|1|||
161573346|NCT03418324|583484036|FG000|Overall Study|Physician Decision|1|||
161573347|NCT03418324|583484037|FG001|Overall Study|Physician Decision|1|||
161573348|NCT01768676|583484038|FG000|Overall Study|Adverse Event|3|||
161573349|NCT01768676|583484039|FG001|Overall Study|Adverse Event|3|||
161573350|NCT01768676|583484038|FG000|Overall Study|Lost to Follow-up|13|||
161573351|NCT01768676|583484039|FG001|Overall Study|Lost to Follow-up|16|||
161573352|NCT01768676|583484038|FG000|Overall Study|Protocol Violation|1|||
161573353|NCT01768676|583484039|FG001|Overall Study|Protocol Violation|1|||
161573354|NCT01768676|583484038|FG000|Overall Study|Physician Decision|4|||
161573355|NCT01768676|583484039|FG001|Overall Study|Physician Decision|1|||
161573356|NCT01768676|583484038|FG000|Overall Study|Withdrawal by Subject|3|||
161573357|NCT01768676|583484039|FG001|Overall Study|Withdrawal by Subject|10|||
161573358|NCT00605033|583484040|FG000|Overall Study|Adverse Event|2|||
161573359|NCT00605033|583484041|FG001|Overall Study|Adverse Event|2|||
161573360|NCT00605033|583484040|FG000|Overall Study|Lost to Follow-up|1|||
161573361|NCT00605033|583484041|FG001|Overall Study|Lost to Follow-up|1|||
161573362|NCT00605033|583484040|FG000|Overall Study|Withdrawal by Subject|3|||
161573363|NCT00605033|583484041|FG001|Overall Study|Withdrawal by Subject|4|||
161573364|NCT00605033|583484040|FG000|Overall Study|Protocol Violation|1|||
161810390|NCT01854047|584347795|FG001|Overall Study|Poor compliance to protocol|0|||
161810391|NCT01854047|584347796|FG002|Overall Study|Poor compliance to protocol|2|||
161810392|NCT01854047|584347797|FG003|Overall Study|Poor compliance to protocol|0|||
161810393|NCT01854047|584347798|FG004|Overall Study|Poor compliance to protocol|0|||
161810394|NCT01854047|584347794|FG000|Overall Study|Adverse Event|5|||
161810395|NCT01854047|584347795|FG001|Overall Study|Adverse Event|4|||
161810396|NCT01854047|584347796|FG002|Overall Study|Adverse Event|6|||
161465712|NCT01436162|583100598|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
161573365|NCT00605033|583484041|FG001|Overall Study|Protocol Violation|1|||
161573366|NCT03121950|583484044|FG000|Overall Study|Withdrawal by Subject|11|||
161573367|NCT03121950|583484045|FG001|Overall Study|Withdrawal by Subject|2|||
161573368|NCT02754479|583484049|FG000|Overall Study|Lost to Follow-up|1|||
161573369|NCT03183518|583484050|FG000|Overall Study|Other (Not specified)|2|||
161573370|NCT03183518|583484050|FG000|Overall Study|Other (Withdrawal of consent)|1|||
161573371|NCT02132702|583484051|FG000|Overall Study|Protocol Violation|2|||
161573372|NCT02132702|583484051|FG000|Overall Study|Adverse Event|3|||
161573373|NCT02132702|583484051|FG000|Overall Study|Withdrawal by Subject|3|||
161573374|NCT01244828|583484054|FG000|Overall Study|Adverse Event|37|||
161573375|NCT01244828|583484054|FG000|Overall Study|Withdrawal by Subject|31|||
161573376|NCT01244828|583484054|FG000|Overall Study|Lack of Efficacy|7|||
161573377|NCT01244828|583484054|FG000|Overall Study|Lost to Follow-up|2|||
161810397|NCT01854047|584347797|FG003|Overall Study|Adverse Event|10|||
161573378|NCT01244828|583484054|FG000|Overall Study|Other reason (not specified)|1|||
161573379|NCT00573833|583484055|FG000|Overall Study|Not Treated|2|||
161573380|NCT05052983|583484056|FG000|Overall Study|Lack of Efficacy|3|||
161573381|NCT05052983|583484057|FG001|Overall Study|Lack of Efficacy|12|||
161573382|NCT05052983|583484056|FG000|Overall Study|Adverse Event|1|||
161573383|NCT05052983|583484057|FG001|Overall Study|Adverse Event|0|||
161573384|NCT04493242|583484058|FG000|Overall Study|Death|10|||
161573385|NCT04493242|583484059|FG001|Overall Study|Death|14|||
161573386|NCT04493242|583484060|FG002|Overall Study|Death|16|||
161573387|NCT04493242|583484058|FG000|Overall Study|Lost to Follow-up|1|||
161573388|NCT04493242|583484059|FG001|Overall Study|Lost to Follow-up|1|||
161573389|NCT04493242|583484060|FG002|Overall Study|Lost to Follow-up|0|||
161573390|NCT04493242|583484058|FG000|Overall Study|Withdrawal by Subject|1|||
161573391|NCT04493242|583484059|FG001|Overall Study|Withdrawal by Subject|0|||
161573392|NCT04493242|583484060|FG002|Overall Study|Withdrawal by Subject|0|||
161573393|NCT04493242|583484058|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
161573394|NCT04493242|583484059|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
161573395|NCT04493242|583484060|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
161573396|NCT04493242|583484058|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
161573397|NCT04493242|583484059|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
161573398|NCT04493242|583484060|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
161573399|NCT02027558|583485984|FG000|Overall Study|Death|0|||
161573400|NCT02027558|583485985|FG001|Overall Study|Death|1|||
161573401|NCT02027558|583485984|FG000|Overall Study|Withdrawal by Subject|2|||
161573402|NCT02027558|583485985|FG001|Overall Study|Withdrawal by Subject|0|||
161573403|NCT02027558|583485984|FG000|Overall Study|Lost to Follow-up|4|||
161573404|NCT02027558|583485985|FG001|Overall Study|Lost to Follow-up|1|||
161573405|NCT02027558|583485984|FG000|Overall Study|Refused assessment|3|||
161573406|NCT02027558|583485985|FG001|Overall Study|Refused assessment|0|||
161573407|NCT04218110|583485986|FG000|Overall Study|Withdrawal by Subject|0|||
161573408|NCT04218110|583485987|FG001|Overall Study|Withdrawal by Subject|0|||
161573409|NCT04218110|583485988|FG002|Overall Study|Withdrawal by Subject|0|||
161573410|NCT04218110|583485989|FG003|Overall Study|Withdrawal by Subject|1|||
161573411|NCT00516386|583485990|FG000|Overall Study|not interested in the study|4|||
161573412|NCT00516386|583485990|FG000|Overall Study|Lost to Follow-up|2|||
161573413|NCT02698891|583485991|FG000|Overall Study|Withdrawal by Subject|2|||
161573414|NCT02698891|583485991|FG000|Overall Study|deemed ineligible|1|||
161573415|NCT02698891|583485991|FG000|Overall Study|Adverse Event|9|||
161573416|NCT02694978|583485994|FG000|Overall Study|Adverse Event|10|||
161573417|NCT02694978|583485995|FG001|Overall Study|Adverse Event|9|||
161573418|NCT02694978|583485994|FG000|Overall Study|Withdrawal by Subject|22|||
161573419|NCT02694978|583485995|FG001|Overall Study|Withdrawal by Subject|19|||
161573420|NCT02694978|583485994|FG000|Overall Study|Lost to Follow-up|14|||
161573421|NCT02694978|583485995|FG001|Overall Study|Lost to Follow-up|17|||
161573422|NCT02694978|583485994|FG000|Overall Study|Death|4|||
161573423|NCT02694978|583485995|FG001|Overall Study|Death|1|||
161573424|NCT02694978|583485994|FG000|Overall Study|Other-Decision of Participant|6|||
161573425|NCT02694978|583485995|FG001|Overall Study|Other-Decision of Participant|1|||
161573426|NCT02694978|583485994|FG000|Overall Study|Other-Investigator's decision|1|||
161573427|NCT02694978|583485995|FG001|Overall Study|Other-Investigator's decision|0|||
161573428|NCT02694978|583485994|FG000|Overall Study|Other-Unable to be reached|0|||
161573429|NCT02694978|583485995|FG001|Overall Study|Other-Unable to be reached|1|||
161573430|NCT02694978|583485994|FG000|Overall Study|Other-Protocol noncompliant|2|||
161573431|NCT02694978|583485995|FG001|Overall Study|Other-Protocol noncompliant|1|||
161573432|NCT02694978|583485994|FG000|Overall Study|Other-Personal reasons|3|||
161573433|NCT02694978|583485995|FG001|Overall Study|Other-Personal reasons|3|||
161573434|NCT02694978|583485994|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
161573435|NCT02694978|583485995|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
161573436|NCT00807144|583485998|FG000|Overall Study|Lost to Follow-up|0|||
161573437|NCT00807144|583485999|FG001|Overall Study|Lost to Follow-up|1|||
161573438|NCT03823300|583486002|FG000|Overall Study|Withdrawal by Subject|16|||
161573439|NCT03823300|583486003|FG001|Overall Study|Withdrawal by Subject|22|||
161573440|NCT03823300|583486002|FG000|Overall Study|Death|10|||
161573441|NCT03823300|583486003|FG001|Overall Study|Death|14|||
161573442|NCT03823300|583486002|FG000|Overall Study|Adverse Event|3|||
161573443|NCT03823300|583486003|FG001|Overall Study|Adverse Event|5|||
161573444|NCT03823300|583486002|FG000|Overall Study|Physician Decision|1|||
161573445|NCT03823300|583486003|FG001|Overall Study|Physician Decision|7|||
161573446|NCT03823300|583486002|FG000|Overall Study|Lost to Follow-up|1|||
161573447|NCT03823300|583486003|FG001|Overall Study|Lost to Follow-up|3|||
161573448|NCT03823300|583486002|FG000|Overall Study|Protocol Violation|1|||
161573449|NCT03823300|583486003|FG001|Overall Study|Protocol Violation|1|||
161573450|NCT03823300|583486002|FG000|Overall Study|Lack of Efficacy|1|||
161573451|NCT03823300|583486003|FG001|Overall Study|Lack of Efficacy|1|||
161573452|NCT03823300|583486002|FG000|Overall Study|Not Eligible|0|||
161573453|NCT03823300|583486003|FG001|Overall Study|Not Eligible|1|||
161573454|NCT03823300|583486002|FG000|Overall Study|Other|1|||
161914831|NCT01140906|584737301|FG001|Overall Study|Lack of Efficacy|8|||
161573455|NCT03823300|583486003|FG001|Overall Study|Other|0|||
161573456|NCT00831415|583486004|FG000|Overall Study|Adverse Event|14|||
161573457|NCT00831415|583486004|FG000|Overall Study|Failed to return|3|||
161914832|NCT01140906|584737302|FG002|Overall Study|Lack of Efficacy|2|||
161914833|NCT01140906|584737303|FG003|Overall Study|Lack of Efficacy|1|||
161914834|NCT01140906|584737300|FG000|Overall Study|Non-compliance|0|||
161914835|NCT01140906|584737301|FG001|Overall Study|Non-compliance|1|||
161914836|NCT01140906|584737302|FG002|Overall Study|Non-compliance|0|||
161914837|NCT01140906|584737303|FG003|Overall Study|Non-compliance|1|||
161573458|NCT00831415|583486004|FG000|Overall Study|Physician Decision|6|||
161573459|NCT00831415|583486004|FG000|Overall Study|Lost to Follow-up|9|||
161573460|NCT00831415|583486004|FG000|Overall Study|Protocol Violation|3|||
161573461|NCT00831415|583486004|FG000|Overall Study|Withdrawal by Subject|35|||
161573462|NCT00831415|583486004|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
161573463|NCT00831415|583486004|FG000|Overall Study|Death|1|||
161573464|NCT01290224|583486005|FG000|Overall Study|Adverse Event|1|||
161573465|NCT01290224|583486005|FG000|Overall Study|Refused Further Treatment|4|||
161573466|NCT01027286|583486006|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
161573467|NCT01027286|583486007|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
161573468|NCT01027286|583486006|FG000|Overall Study|Lost to Follow-up|0|||
161573469|NCT01027286|583486007|FG001|Overall Study|Lost to Follow-up|1|||
161573470|NCT03804918|583486008|FG000|Overall Study|Participant did not use the app|1|||
161573471|NCT05694065|583486009|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
161573472|NCT05694065|583486009|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
161573473|NCT05694065|583486009|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
161573474|NCT01087762|583486010|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
161573475|NCT01087762|583486011|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161573476|NCT01087762|583486012|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
161573477|NCT01087762|583486013|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161573478|NCT01087762|583486014|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161573479|NCT01087762|583486010|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
161573480|NCT01087762|583486011|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161573481|NCT01087762|583486012|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
161573482|NCT01087762|583486013|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161573483|NCT01087762|583486014|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161573484|NCT01087762|583486010|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
161573485|NCT01087762|583486011|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
161573486|NCT01087762|583486012|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
161573487|NCT01087762|583486013|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
161573488|NCT01087762|583486014|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
161573489|NCT01087762|583486010|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
161573490|NCT01087762|583486011|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
161573491|NCT01087762|583486012|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
161573492|NCT01087762|583486013|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
161573493|NCT01087762|583486014|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
161573494|NCT01087762|583486010|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
161573495|NCT01087762|583486011|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
161573496|NCT01087762|583486012|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
161573497|NCT01087762|583486013|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
161573498|NCT01087762|583486014|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
161573499|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161573500|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161573501|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161573502|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
161573503|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
161573504|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161573505|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161573506|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161573507|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
161573508|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
161573509|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161573510|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161573511|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161573512|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
161573513|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
161573514|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161573515|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161914838|NCT01140906|584737300|FG000|Overall Study|Protocol Violation|5|||
161914839|NCT01140906|584737301|FG001|Overall Study|Protocol Violation|3|||
161573516|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161573517|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
161573518|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
161573519|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
161573520|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
161573521|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
161573522|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
161573523|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
161573524|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
161573525|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
161573526|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
161573527|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
161573528|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
161573529|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161573530|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161573531|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161573532|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
161573533|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
161573534|NCT01087762|583486010|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161573535|NCT01087762|583486011|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161573536|NCT01087762|583486012|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161573537|NCT01087762|583486013|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
161573538|NCT01087762|583486014|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
161573539|NCT00813904|583486015|FG000|Overall Study|Death|1|||
161573540|NCT01405924|583486018|FG000|Overall Study|Protocol Violation|8|||
161573541|NCT01405924|583486018|FG000|Overall Study|Missing/Incomplete Data|2|||
161573542|NCT02393716|583486019|FG000|Overall Study|Death|29|||
161573543|NCT02393716|583486019|FG000|Overall Study|Withdrawal by Subject|8|||
161573544|NCT02393716|583486019|FG000|Overall Study|Device Explanted|8|||
161573545|NCT02393716|583486019|FG000|Overall Study|Missed visit|16|||
161573546|NCT01924767|583486020|FG000|Overall Study|Adverse Event|1|||
161573547|NCT01924767|583486021|FG001|Overall Study|Adverse Event|0|||
161573548|NCT01924767|583486022|FG002|Overall Study|Adverse Event|1|||
161573549|NCT01924767|583486023|FG003|Overall Study|Adverse Event|0|||
161573550|NCT01924767|583486024|FG004|Overall Study|Adverse Event|0|||
161573551|NCT01648140|583486025|FG000|Overall Study|Physician Decision|1|||
161573552|NCT01648140|583486026|FG001|Overall Study|Physician Decision|0|||
161573553|NCT01648140|583486027|FG002|Overall Study|Physician Decision|0|||
161573554|NCT01648140|583486028|FG003|Overall Study|Physician Decision|0|||
161573555|NCT01648140|583486025|FG000|Overall Study|Lack of Efficacy|4|||
161573556|NCT01648140|583486026|FG001|Overall Study|Lack of Efficacy|7|||
161573557|NCT01648140|583486027|FG002|Overall Study|Lack of Efficacy|1|||
161573558|NCT01648140|583486028|FG003|Overall Study|Lack of Efficacy|0|||
161573559|NCT01648140|583486025|FG000|Overall Study|Adverse Event|3|||
161573560|NCT01648140|583486026|FG001|Overall Study|Adverse Event|1|||
161573561|NCT01648140|583486027|FG002|Overall Study|Adverse Event|2|||
161573562|NCT01648140|583486028|FG003|Overall Study|Adverse Event|0|||
161573563|NCT01648140|583486025|FG000|Overall Study|Withdrawal by Subject|2|||
161573564|NCT01648140|583486026|FG001|Overall Study|Withdrawal by Subject|3|||
161573565|NCT01648140|583486027|FG002|Overall Study|Withdrawal by Subject|3|||
161573566|NCT01648140|583486028|FG003|Overall Study|Withdrawal by Subject|2|||
161573567|NCT01648140|583486025|FG000|Overall Study|Lost to Follow-up|2|||
161573568|NCT01648140|583486026|FG001|Overall Study|Lost to Follow-up|1|||
161573569|NCT01648140|583486027|FG002|Overall Study|Lost to Follow-up|2|||
161573570|NCT01648140|583486028|FG003|Overall Study|Lost to Follow-up|0|||
161573571|NCT03621761|583486035|FG000|Overall Study|Lost to Follow-up|1|||
161573572|NCT03621761|583486036|FG001|Overall Study|Lost to Follow-up|1|||
161573573|NCT03621761|583486037|FG002|Overall Study|Lost to Follow-up|2|||
161573574|NCT03621761|583486035|FG000|Overall Study|Withdrawal by Subject|2|||
161573575|NCT03621761|583486036|FG001|Overall Study|Withdrawal by Subject|1|||
161573576|NCT03621761|583486037|FG002|Overall Study|Withdrawal by Subject|1|||
161573577|NCT03621761|583486035|FG000|Overall Study|Became Ineligible|0|||
161573578|NCT03621761|583486036|FG001|Overall Study|Became Ineligible|2|||
161573579|NCT03621761|583486037|FG002|Overall Study|Became Ineligible|0|||
161573580|NCT01191788|583486038|FG000|Overall Study|Lost to Follow-up|21|||
161573581|NCT01191788|583486039|FG001|Overall Study|Lost to Follow-up|22|||
161810398|NCT01854047|584347798|FG004|Overall Study|Adverse Event|7|||
161573582|NCT01713530|583486042|FG000|Overall Study|Adverse Event|0|||
161573583|NCT01713530|583486043|FG001|Overall Study|Adverse Event|5|||
161573584|NCT01713530|583486042|FG000|Overall Study|Withdrawal criteria|21|||
161573585|NCT01713530|583486043|FG001|Overall Study|Withdrawal criteria|12|||
161573586|NCT01713530|583486042|FG000|Overall Study|Unclassified|4|||
161573587|NCT01713530|583486043|FG001|Overall Study|Unclassified|2|||
161573588|NCT03939819|583486044|FG000|Overall Study|Death|2|||
161573589|NCT03939819|583486045|FG001|Overall Study|Death|0|||
161465713|NCT01436162|583100599|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
161465714|NCT01436162|583100600|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
161465715|NCT01436162|583100598|FG000|Randomized Phase|Other|2|||
161465716|NCT01436162|583100599|FG001|Randomized Phase|Other|5|||
161465717|NCT01436162|583100600|FG002|Randomized Phase|Other|4|||
161465724|NCT04382755|583100607|FG000|Overall Study|Withdrawal by Subject|1|||
161465725|NCT04382755|583100608|FG001|Overall Study|Withdrawal by Subject|0|||
161465726|NCT04382755|583100607|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
161465727|NCT04382755|583100608|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
161465728|NCT04382755|583100607|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
161465729|NCT04382755|583100608|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
161465730|NCT04041700|583100615|FG000|Overall Study|Pregnancy|1|||
161465731|NCT04041700|583100615|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
161465732|NCT00458536|583100619|FG000|Overall Study|Disease progression prior to treatment|7|||
161465733|NCT00458536|583100619|FG000|Overall Study|Unable to make vaccine|3|||
161465734|NCT00458536|583100619|FG000|Overall Study|No measurable disease after surgery|2|||
161465735|NCT00458536|583100619|FG000|Overall Study|Did not have renal cell carcinoma|2|||
161465736|NCT00458536|583100619|FG000|Overall Study|Patient did not have surgery|1|||
161465737|NCT00458536|583100619|FG000|Overall Study|Ineligible due to toxicity|1|||
161465738|NCT00458536|583100619|FG000|Overall Study|Withdrawal by Subject|1|||
161465739|NCT00458536|583100619|FG000|Overall Study|Progressive disease during treatment|2|||
161465740|NCT00285207|583100620|FG000|Overall Study|Lost to Follow-up|3|||
161465741|NCT00285207|583100621|FG001|Overall Study|Lost to Follow-up|2|||
161465742|NCT00285207|583100620|FG000|Overall Study|Withdrawal by Subject|5|||
161465743|NCT00285207|583100621|FG001|Overall Study|Withdrawal by Subject|2|||
161465744|NCT00285207|583100620|FG000|Overall Study|Pregnancy|1|||
161465745|NCT00285207|583100621|FG001|Overall Study|Pregnancy|1|||
161465746|NCT00285207|583100620|FG000|Overall Study|non-compliance|0|||
161465747|NCT00285207|583100621|FG001|Overall Study|non-compliance|1|||
161465748|NCT05419908|583100622|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
161465749|NCT05419908|583100623|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
161465750|NCT05419908|583100622|FG000|Overall Study|Serious Adverse Event|0|||
161465751|NCT05419908|583100623|FG001|Overall Study|Serious Adverse Event|2|||
161465752|NCT05419908|583100622|FG000|Overall Study|Withdrawal by Subject|2|||
161465753|NCT05419908|583100623|FG001|Overall Study|Withdrawal by Subject|0|||
161465754|NCT05419908|583100622|FG000|Overall Study|Miscellaneous|1|||
161465755|NCT05419908|583100623|FG001|Overall Study|Miscellaneous|1|||
161465756|NCT03670836|583100624|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
161465757|NCT03670836|583100625|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
161465758|NCT03670836|583100624|FG000|Per Protocol Population (PP)|Physician Decision|9|||
161465759|NCT03670836|583100625|FG001|Per Protocol Population (PP)|Physician Decision|10|||
161465760|NCT03670836|583100624|FG000|Per Protocol Population (PP)|Physician Decision|4|||
161465761|NCT03670836|583100625|FG001|Per Protocol Population (PP)|Physician Decision|6|||
161465762|NCT03670836|583100624|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
161465763|NCT03670836|583100625|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
161549082|NCT00358215|583400996|FG001|Overall Study|Ineligibility determined|3|||
161549083|NCT00358215|583400995|FG000|Overall Study|Adverse Event|83|||
161549084|NCT00358215|583400996|FG001|Overall Study|Adverse Event|65|||
161549085|NCT00358215|583400995|FG000|Overall Study|Withdrawal by Subject|111|||
161549086|NCT00358215|583400996|FG001|Overall Study|Withdrawal by Subject|102|||
161549087|NCT00358215|583400995|FG000|Overall Study|Participant request|65|||
161549088|NCT00358215|583400996|FG001|Overall Study|Participant request|64|||
161549089|NCT00358215|583400995|FG000|Overall Study|Physician Decision|47|||
161549090|NCT00358215|583400996|FG001|Overall Study|Physician Decision|39|||
161549091|NCT00358215|583400995|FG000|Overall Study|Lost to Follow-up|16|||
161549092|NCT00358215|583400996|FG001|Overall Study|Lost to Follow-up|22|||
161549093|NCT00358215|583400995|FG000|Overall Study|Death|265|||
161549094|NCT00358215|583400996|FG001|Overall Study|Death|281|||
161549095|NCT00358215|583400995|FG000|Overall Study|Protocol Violation|64|||
161549096|NCT00358215|583400996|FG001|Overall Study|Protocol Violation|59|||
161549097|NCT00358215|583400995|FG000|Overall Study|Pregnancy|1|||
161549098|NCT00358215|583400996|FG001|Overall Study|Pregnancy|0|||
161549099|NCT00358215|583400995|FG000|Overall Study|Other|21|||
161549100|NCT00358215|583400996|FG001|Overall Study|Other|14|||
161549101|NCT00358215|583400995|FG000|Overall Study|Did not receive investigational product|2|||
161549102|NCT00358215|583400996|FG001|Overall Study|Did not receive investigational product|3|||
161549103|NCT00871351|583400997|FG000|Overall Study|Withdrawal by Subject|1|||
161573590|NCT03987451|583486046|FG000|Overall Study|Lost to Follow-up|1|||
161573591|NCT03987451|583486047|FG001|Overall Study|Lost to Follow-up|0|||
161573592|NCT03987451|583486046|FG000|Overall Study|Withdrawal by Subject|1|||
161573593|NCT03987451|583486047|FG001|Overall Study|Withdrawal by Subject|1|||
161573594|NCT02441036|583486048|FG000|Overall Study|No tissue resected|0|||
161573595|NCT02441036|583486049|FG001|Overall Study|No tissue resected|1|||
161573596|NCT02441036|583486050|FG002|Overall Study|No tissue resected|0|||
161573597|NCT02441036|583486051|FG003|Overall Study|No tissue resected|1|||
161573598|NCT02441036|583486052|FG004|Overall Study|No tissue resected|0|||
161573599|NCT01183780|583486053|FG000|Overall Study|Withdrawal by Subject|25|||
161573600|NCT01183780|583486054|FG001|Overall Study|Withdrawal by Subject|14|||
161573601|NCT01183780|583486053|FG000|Overall Study|Lost to Follow-up|6|||
161573602|NCT01183780|583486054|FG001|Overall Study|Lost to Follow-up|11|||
161573603|NCT00079183|583486057|FG000|Overall Study|Withdrawal by Subject|4|||
161573604|NCT00079183|583486057|FG000|Overall Study|Study medication non-compliance|2|||
161573605|NCT00079183|583486057|FG000|Overall Study|Specimen collection non-compliance|1|||
161573606|NCT00762606|583486058|FG000|Overall Study|Lost to Follow-up|18|||
161573607|NCT00762606|583486059|FG001|Overall Study|Lost to Follow-up|13|||
161573608|NCT01505881|583486060|FG000|Overall Study|Adverse Event|0|||
161573609|NCT01505881|583486061|FG001|Overall Study|Adverse Event|1|||
161573610|NCT01505881|583486060|FG000|Overall Study|Lost to Follow-up|2|||
161573611|NCT01505881|583486061|FG001|Overall Study|Lost to Follow-up|0|||
161573612|NCT01505881|583486060|FG000|Overall Study|Withdrawal by Subject|2|||
161573613|NCT01505881|583486061|FG001|Overall Study|Withdrawal by Subject|0|||
161573614|NCT01147341|583486062|FG000|Double Blind Period|Lack of Efficacy|1|||
161573615|NCT01147341|583486063|FG001|Double Blind Period|Lack of Efficacy|1|||
161573616|NCT01147341|583486062|FG000|Double Blind Period|Withdrawal by Subject|0|||
161573617|NCT01147341|583486063|FG001|Double Blind Period|Withdrawal by Subject|1|||
161573618|NCT01147341|583486062|FG000|Open Label Period|Lack of Efficacy|3|||
161573619|NCT01147341|583486063|FG001|Open Label Period|Lack of Efficacy|0|||
161573620|NCT01147341|583486062|FG000|Open Label Period|Subject moved|1|||
161573621|NCT01147341|583486063|FG001|Open Label Period|Subject moved|0|||
161573622|NCT01596504|583486064|FG000|Overall Study|Participant's Private Reason|0|||
161573623|NCT01596504|583486065|FG001|Overall Study|Participant's Private Reason|1|||
161573624|NCT01596504|583486066|FG002|Overall Study|Participant's Private Reason|0|||
161573625|NCT01596504|583486064|FG000|Overall Study|Adverse Event|1|||
161573626|NCT01596504|583486065|FG001|Overall Study|Adverse Event|2|||
161573627|NCT01596504|583486066|FG002|Overall Study|Adverse Event|1|||
161573628|NCT01596504|583486064|FG000|Overall Study|Withdrawal by Subject|1|||
161573629|NCT01596504|583486065|FG001|Overall Study|Withdrawal by Subject|0|||
161573630|NCT01596504|583486066|FG002|Overall Study|Withdrawal by Subject|0|||
161573631|NCT00949975|583486067|FG000|Overall Study|Voluntary discontinuation|6|||
161573632|NCT00949975|583486068|FG001|Overall Study|Voluntary discontinuation|5|||
161573633|NCT00949975|583486069|FG002|Overall Study|Voluntary discontinuation|3|||
161573634|NCT00949975|583486070|FG003|Overall Study|Voluntary discontinuation|6|||
161573635|NCT00949975|583486067|FG000|Overall Study|Adverse Event|11|||
161573636|NCT00949975|583486068|FG001|Overall Study|Adverse Event|11|||
161573637|NCT00949975|583486069|FG002|Overall Study|Adverse Event|10|||
161573638|NCT00949975|583486070|FG003|Overall Study|Adverse Event|10|||
161573639|NCT00949975|583486067|FG000|Overall Study|Safety reason|0|||
161573640|NCT00949975|583486068|FG001|Overall Study|Safety reason|1|||
161573641|NCT00949975|583486069|FG002|Overall Study|Safety reason|0|||
161573642|NCT00949975|583486070|FG003|Overall Study|Safety reason|0|||
161573643|NCT00949975|583486067|FG000|Overall Study|Study-specific criteria|0|||
161810399|NCT01854047|584347794|FG000|Overall Study|Randomized but not treated|0|||
161810400|NCT01854047|584347795|FG001|Overall Study|Randomized but not treated|1|||
161810401|NCT01854047|584347796|FG002|Overall Study|Randomized but not treated|2|||
161810402|NCT01854047|584347797|FG003|Overall Study|Randomized but not treated|0|||
161810403|NCT01854047|584347798|FG004|Overall Study|Randomized but not treated|4|||
161810404|NCT01854047|584347794|FG000|Overall Study|Other than specified above|3|||
161810405|NCT01854047|584347795|FG001|Overall Study|Other than specified above|3|||
161810406|NCT01854047|584347796|FG002|Overall Study|Other than specified above|3|||
161810407|NCT01854047|584347797|FG003|Overall Study|Other than specified above|5|||
161810408|NCT01854047|584347798|FG004|Overall Study|Other than specified above|8|||
161810409|NCT02374853|584347806|FG000|Overall Study|Surgery Cancelled|5|||
161810410|NCT02374853|584347807|FG001|Overall Study|Surgery Cancelled|11|||
161810411|NCT02281084|584347810|FG000|Overall Study|Death|21|||
161810412|NCT02281084|584347811|FG001|Overall Study|Death|18|||
161810413|NCT02281084|584347812|FG002|Overall Study|Death|3|||
161914840|NCT01140906|584737302|FG002|Overall Study|Protocol Violation|2|||
161914841|NCT01140906|584737303|FG003|Overall Study|Protocol Violation|1|||
161810414|NCT02281084|584347813|FG003|Overall Study|Death|5|||
161914842|NCT01140906|584737300|FG000|Overall Study|Withdrawal of consent|6|||
161573644|NCT00949975|583486068|FG001|Overall Study|Study-specific criteria|1|||
161573645|NCT00949975|583486069|FG002|Overall Study|Study-specific criteria|1|||
161573646|NCT00949975|583486070|FG003|Overall Study|Study-specific criteria|0|||
161573647|NCT00949975|583486067|FG000|Overall Study|Incorrect enrolment|5|||
161810415|NCT02281084|584347810|FG000|Overall Study|Adverse Event|1|||
161465764|NCT02160782|583102081|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
161465765|NCT02160782|583102082|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
161465766|NCT02160782|583102083|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
161465767|NCT02160782|583102084|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
161465768|NCT02160782|583102085|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
161465769|NCT02160782|583102081|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
161465770|NCT02160782|583102082|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
161465771|NCT02160782|583102083|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
161465772|NCT02160782|583102084|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
161465773|NCT02160782|583102085|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
161465774|NCT02160782|583102081|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
161465775|NCT02160782|583102082|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
161465776|NCT02160782|583102083|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
161465777|NCT02160782|583102084|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
161465778|NCT02160782|583102085|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
161465779|NCT02160782|583102081|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
161465780|NCT02160782|583102082|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
161465781|NCT02160782|583102083|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
161465782|NCT02160782|583102084|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
161465783|NCT02160782|583102085|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
161465784|NCT02160782|583102081|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
161465785|NCT02160782|583102082|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
161465786|NCT02160782|583102083|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
161465787|NCT02160782|583102084|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
161465788|NCT02160782|583102085|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
161465789|NCT02160782|583102081|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
161465790|NCT02160782|583102082|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
161465791|NCT02160782|583102083|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
161465792|NCT02160782|583102084|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
161465793|NCT02160782|583102085|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
161465794|NCT02160782|583102081|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
161465795|NCT02160782|583102082|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
161465796|NCT02160782|583102083|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
161465797|NCT02160782|583102084|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
161465798|NCT02160782|583102085|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
161465799|NCT00215683|583102088|FG000|Overall Study|Adverse Event|15|||
161465800|NCT00215683|583102089|FG001|Overall Study|Adverse Event|16|||
161465801|NCT00215683|583102090|FG002|Overall Study|Adverse Event|15|||
161465802|NCT00215683|583102088|FG000|Overall Study|Lack of Efficacy|5|||
161465803|NCT00215683|583102089|FG001|Overall Study|Lack of Efficacy|1|||
161465804|NCT00215683|583102090|FG002|Overall Study|Lack of Efficacy|2|||
161465805|NCT00215683|583102088|FG000|Overall Study|Lost to Follow-up|0|||
161465806|NCT00215683|583102089|FG001|Overall Study|Lost to Follow-up|2|||
161465807|NCT00215683|583102090|FG002|Overall Study|Lost to Follow-up|1|||
161465808|NCT00215683|583102088|FG000|Overall Study|Withdrawal by Subject|9|||
161465809|NCT00215683|583102089|FG001|Overall Study|Withdrawal by Subject|4|||
161465810|NCT00215683|583102090|FG002|Overall Study|Withdrawal by Subject|13|||
161465811|NCT00215683|583102088|FG000|Overall Study|Physician Decision|0|||
161465812|NCT00215683|583102089|FG001|Overall Study|Physician Decision|0|||
161465813|NCT00215683|583102090|FG002|Overall Study|Physician Decision|1|||
161465814|NCT00215683|583102088|FG000|Overall Study|Difficult to attend visits|0|||
161465815|NCT00215683|583102089|FG001|Overall Study|Difficult to attend visits|1|||
161465816|NCT00215683|583102090|FG002|Overall Study|Difficult to attend visits|0|||
161465817|NCT00215683|583102088|FG000|Overall Study|No study drug available|0|||
161465818|NCT00215683|583102089|FG001|Overall Study|No study drug available|1|||
161465819|NCT00215683|583102090|FG002|Overall Study|No study drug available|0|||
161465820|NCT00215683|583102088|FG000|Overall Study|Intermittent therapy required|0|||
161465821|NCT00215683|583102089|FG001|Overall Study|Intermittent therapy required|1|||
161465822|NCT00215683|583102090|FG002|Overall Study|Intermittent therapy required|0|||
161465823|NCT02171065|583102091|FG000|Overall Study|Withdrawal by Subject|1|||
161573648|NCT00949975|583486068|FG001|Overall Study|Incorrect enrolment|10|||
161573649|NCT00949975|583486069|FG002|Overall Study|Incorrect enrolment|4|||
161573650|NCT00949975|583486070|FG003|Overall Study|Incorrect enrolment|7|||
161573651|NCT00949975|583486067|FG000|Overall Study|Severe non-compliance|3|||
161573652|NCT00949975|583486068|FG001|Overall Study|Severe non-compliance|1|||
161573653|NCT00949975|583486069|FG002|Overall Study|Severe non-compliance|0|||
161573654|NCT00949975|583486070|FG003|Overall Study|Severe non-compliance|2|||
161573655|NCT00949975|583486067|FG000|Overall Study|Lost to Follow-up|1|||
161573656|NCT00949975|583486068|FG001|Overall Study|Lost to Follow-up|0|||
161573657|NCT00949975|583486069|FG002|Overall Study|Lost to Follow-up|1|||
161573658|NCT00949975|583486070|FG003|Overall Study|Lost to Follow-up|3|||
161573659|NCT00949975|583486067|FG000|Overall Study|Other|1|||
161573660|NCT00949975|583486068|FG001|Overall Study|Other|0|||
161573661|NCT00949975|583486069|FG002|Overall Study|Other|0|||
161573662|NCT00949975|583486070|FG003|Overall Study|Other|0|||
161573663|NCT03257813|583486071|FG000|Overall Study|Protocol Violation|6|||
161573664|NCT03257813|583486072|FG001|Overall Study|Protocol Violation|3|||
161573665|NCT02878330|583486073|FG000|Overall Study|Death|3|||
161573666|NCT02878330|583486074|FG001|Overall Study|Death|2|||
161573667|NCT02878330|583486073|FG000|Overall Study|Lost to Follow-up|11|||
161573668|NCT02878330|583486074|FG001|Overall Study|Lost to Follow-up|26|||
161573669|NCT02878330|583486073|FG000|Overall Study|Withdrawal by Subject|11|||
161573670|NCT02878330|583486074|FG001|Overall Study|Withdrawal by Subject|21|||
161573671|NCT02878330|583486073|FG000|Overall Study|Other|4|||
161573672|NCT02878330|583486074|FG001|Overall Study|Other|7|||
161573673|NCT04246762|583486075|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
161573674|NCT03615924|583486076|FG000|Overall Study|Withdrawal by Subject|2|||
161573675|NCT03615924|583486077|FG001|Overall Study|Withdrawal by Subject|5|||
161810416|NCT02281084|584347811|FG001|Overall Study|Adverse Event|0|||
161810417|NCT02281084|584347812|FG002|Overall Study|Adverse Event|0|||
161810418|NCT02281084|584347813|FG003|Overall Study|Adverse Event|0|||
161810419|NCT02281084|584347810|FG000|Overall Study|Withdrawal by Subject|2|||
161810420|NCT02281084|584347811|FG001|Overall Study|Withdrawal by Subject|2|||
161810421|NCT02281084|584347812|FG002|Overall Study|Withdrawal by Subject|0|||
161810422|NCT02281084|584347813|FG003|Overall Study|Withdrawal by Subject|0|||
161810423|NCT02281084|584347810|FG000|Overall Study|Site Closure by Sponsor|5|||
161810424|NCT02281084|584347811|FG001|Overall Study|Site Closure by Sponsor|1|||
161810425|NCT02281084|584347812|FG002|Overall Study|Site Closure by Sponsor|2|||
161810426|NCT02281084|584347813|FG003|Overall Study|Site Closure by Sponsor|0|||
161810427|NCT02335658|584347814|FG000|Overall Study|Adverse Event|18|||
161810428|NCT02335658|584347815|FG001|Overall Study|Adverse Event|12|||
161810429|NCT02335658|584347814|FG000|Overall Study|Lack of Efficacy|4|||
161810430|NCT02335658|584347815|FG001|Overall Study|Lack of Efficacy|5|||
161810431|NCT02335658|584347814|FG000|Overall Study|Pregnancy|1|||
161810432|NCT02335658|584347815|FG001|Overall Study|Pregnancy|0|||
161810433|NCT02335658|584347814|FG000|Overall Study|Withdrawal by Subject|13|||
161810434|NCT02335658|584347815|FG001|Overall Study|Withdrawal by Subject|21|||
161810435|NCT02335658|584347814|FG000|Overall Study|non-compliance|2|||
161810436|NCT02335658|584347815|FG001|Overall Study|non-compliance|3|||
161810437|NCT02335658|584347814|FG000|Overall Study|other reason|2|||
161810438|NCT02335658|584347815|FG001|Overall Study|other reason|3|||
161810439|NCT02957942|584347820|FG000|Overall Study|Withdrawal by Subject|0|||
161810440|NCT02957942|584347821|FG001|Overall Study|Withdrawal by Subject|1|||
161810441|NCT02957942|584347820|FG000|Overall Study|Practicing experiment protocol|0|||
161810442|NCT02957942|584347821|FG001|Overall Study|Practicing experiment protocol|6|||
161810443|NCT02655679|584347825|FG000|Overall Study|Adverse Event|0|||
161810444|NCT02655679|584347826|FG001|Overall Study|Adverse Event|1|||
161810445|NCT02655679|584347827|FG002|Overall Study|Adverse Event|0|||
161810446|NCT02655679|584347828|FG003|Overall Study|Adverse Event|0|||
161810447|NCT02655679|584347829|FG004|Overall Study|Adverse Event|0|||
161810448|NCT02655679|584347825|FG000|Overall Study|Withdrawal by Subject|1|||
161810449|NCT02655679|584347826|FG001|Overall Study|Withdrawal by Subject|1|||
161810450|NCT02655679|584347827|FG002|Overall Study|Withdrawal by Subject|0|||
161810451|NCT02655679|584347828|FG003|Overall Study|Withdrawal by Subject|3|||
161810452|NCT02655679|584347829|FG004|Overall Study|Withdrawal by Subject|1|||
161810453|NCT02655679|584347825|FG000|Overall Study|Inability to Comply with the Protocol|1|||
161810454|NCT02655679|584347826|FG001|Overall Study|Inability to Comply with the Protocol|0|||
161810455|NCT02655679|584347827|FG002|Overall Study|Inability to Comply with the Protocol|0|||
161810456|NCT02655679|584347828|FG003|Overall Study|Inability to Comply with the Protocol|0|||
161810457|NCT02655679|584347829|FG004|Overall Study|Inability to Comply with the Protocol|0|||
161810458|NCT02655679|584347825|FG000|Overall Study|Lost to Follow-up|0|||
161573676|NCT03615924|583486076|FG000|Overall Study|Death|3|||
161810459|NCT02655679|584347826|FG001|Overall Study|Lost to Follow-up|1|||
161810460|NCT02655679|584347827|FG002|Overall Study|Lost to Follow-up|1|||
161810461|NCT02655679|584347828|FG003|Overall Study|Lost to Follow-up|1|||
161914843|NCT01140906|584737301|FG001|Overall Study|Withdrawal of consent|6|||
161810462|NCT02655679|584347829|FG004|Overall Study|Lost to Follow-up|0|||
161573677|NCT03615924|583486077|FG001|Overall Study|Death|1|||
161573678|NCT03615924|583486076|FG000|Overall Study|Lost to Follow-up|1|||
161573679|NCT03615924|583486077|FG001|Overall Study|Lost to Follow-up|0|||
161573680|NCT03615924|583486076|FG000|Overall Study|Randomized in error|1|||
161810463|NCT02655679|584347825|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161810464|NCT02655679|584347826|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161810465|NCT02655679|584347827|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161810466|NCT02655679|584347828|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161465824|NCT02171065|583102092|FG001|Overall Study|Withdrawal by Subject|0|||
161465825|NCT02171065|583102093|FG002|Overall Study|Withdrawal by Subject|0|||
161465826|NCT02171065|583102091|FG000|Overall Study|Lost to Follow-up|0|||
161465827|NCT02171065|583102092|FG001|Overall Study|Lost to Follow-up|0|||
161465828|NCT02171065|583102093|FG002|Overall Study|Lost to Follow-up|1|||
161465829|NCT03061097|583102095|FG000|Overall Study|Withdrawal by Subject|0|||
161465830|NCT03061097|583102096|FG001|Overall Study|Withdrawal by Subject|3|||
161465831|NCT02437513|583102097|FG000|Overall Study|Withdrawal by Subject|2|||
161465832|NCT03956056|583102098|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
161465833|NCT03956056|583102098|FG000|Overall Study|Lack of Efficacy|1|||
161465834|NCT00595465|583102099|FG000|Overall Study|Adverse Event|4|||
161465835|NCT00595465|583102100|FG001|Overall Study|Adverse Event|3|||
161465836|NCT00595465|583102101|FG002|Overall Study|Adverse Event|3|||
161465837|NCT00595465|583102099|FG000|Overall Study|Pregnancy|0|||
161465838|NCT00595465|583102100|FG001|Overall Study|Pregnancy|0|||
161465839|NCT00595465|583102101|FG002|Overall Study|Pregnancy|1|||
161465840|NCT00595465|583102099|FG000|Overall Study|Protocol Violation|2|||
161465841|NCT00595465|583102100|FG001|Overall Study|Protocol Violation|1|||
161465842|NCT00595465|583102101|FG002|Overall Study|Protocol Violation|0|||
161465843|NCT00595465|583102099|FG000|Overall Study|Lost to Follow-up|0|||
161465844|NCT00595465|583102100|FG001|Overall Study|Lost to Follow-up|0|||
161465845|NCT00595465|583102101|FG002|Overall Study|Lost to Follow-up|2|||
161465846|NCT00595465|583102099|FG000|Overall Study|administrative reason|0|||
161465847|NCT00595465|583102100|FG001|Overall Study|administrative reason|0|||
161465848|NCT00595465|583102101|FG002|Overall Study|administrative reason|1|||
161465849|NCT00107783|583102102|FG000|Overall Study|Adverse Event|0|||
161465850|NCT00107783|583102103|FG001|Overall Study|Adverse Event|2|||
161465851|NCT00107783|583102102|FG000|Overall Study|Death|0|||
161465852|NCT00107783|583102103|FG001|Overall Study|Death|1|||
161465853|NCT00107783|583102102|FG000|Overall Study|Withdrawal by Subject|2|||
161465854|NCT00107783|583102103|FG001|Overall Study|Withdrawal by Subject|0|||
161465855|NCT00107783|583102102|FG000|Overall Study|Second hip replacement|1|||
161465856|NCT00107783|583102103|FG001|Overall Study|Second hip replacement|1|||
161465857|NCT01298531|583102104|FG000|Overall Study|Lack of Efficacy|0|||
161465858|NCT01298531|583102105|FG001|Overall Study|Lack of Efficacy|1|||
161465859|NCT01298531|583102104|FG000|Overall Study|Lost to Follow-up|2|||
161465860|NCT01298531|583102105|FG001|Overall Study|Lost to Follow-up|0|||
161465861|NCT01298531|583102104|FG000|Overall Study|Protocol Violation|1|||
161465862|NCT01298531|583102105|FG001|Overall Study|Protocol Violation|1|||
161465863|NCT01298531|583102104|FG000|Overall Study|Adverse Event|4|||
161465864|NCT01298531|583102105|FG001|Overall Study|Adverse Event|3|||
161465865|NCT01298531|583102104|FG000|Overall Study|Does not meet entrance criteria|0|||
161465866|NCT01298531|583102105|FG001|Overall Study|Does not meet entrance criteria|1|||
161465867|NCT01298531|583102104|FG000|Overall Study|Other|2|||
161465868|NCT01298531|583102105|FG001|Overall Study|Other|1|||
161465869|NCT00422097|583102106|FG000|Dose Level 2|Still on treatment|0|||
161465870|NCT00422097|583102107|FG001|Dose Level 2|Still on treatment|1|||
161465871|NCT00422097|583102108|FG002|Dose Level 2|Still on treatment|0|||
161465872|NCT00422097|583102109|FG003|Dose Level 2|Still on treatment|0|||
161465873|NCT00422097|583102110|FG004|Dose Level 2|Still on treatment|0|||
161573681|NCT03615924|583486077|FG001|Overall Study|Randomized in error|0|||
161465874|NCT00422097|583102111|FG005|Dose Level 2|Still on treatment|0|||
161465875|NCT00422097|583102112|FG006|Dose Level 2|Still on treatment|0|||
161465876|NCT00422097|583102113|FG007|Dose Level 2|Still on treatment|0|||
161465877|NCT02360995|583102114|FG000|Overall Study|Lost to Follow-up|2|||
161465878|NCT02360995|583102115|FG001|Overall Study|Lost to Follow-up|0|||
161465879|NCT02360995|583102116|FG002|Overall Study|Lost to Follow-up|2|||
161465880|NCT02360995|583102114|FG000|Overall Study|Withdrawal by Subject|0|||
161465881|NCT02360995|583102115|FG001|Overall Study|Withdrawal by Subject|1|||
161465882|NCT02360995|583102116|FG002|Overall Study|Withdrawal by Subject|0|||
161465883|NCT02231918|583102117|FG000|Overall Study|Withdrawal by Subject|0|||
161465884|NCT02231918|583102118|FG001|Overall Study|Withdrawal by Subject|1|||
161465885|NCT02231918|583102119|FG002|Overall Study|Withdrawal by Subject|0|||
161465886|NCT02231918|583102117|FG000|Overall Study|Adverse Event|0|||
161465887|NCT02231918|583102118|FG001|Overall Study|Adverse Event|0|||
161465888|NCT02231918|583102119|FG002|Overall Study|Adverse Event|1|||
161465889|NCT04622735|583102122|FG000|Overall Study|Lost to Follow-up|1|||
161465890|NCT04622735|583102123|FG001|Overall Study|Lost to Follow-up|2|||
161573682|NCT03615924|583486076|FG000|Overall Study|Study termination by Sponsor|94|||
161465891|NCT04622735|583102124|FG002|Overall Study|Lost to Follow-up|1|||
161465892|NCT04622735|583102122|FG000|Overall Study|Adverse Event|0|||
161465893|NCT04622735|583102123|FG001|Overall Study|Adverse Event|0|||
161465894|NCT04622735|583102124|FG002|Overall Study|Adverse Event|1|||
161465895|NCT04622735|583102122|FG000|Overall Study|Protocol Violation|1|||
161465896|NCT04622735|583102123|FG001|Overall Study|Protocol Violation|0|||
161465897|NCT04622735|583102124|FG002|Overall Study|Protocol Violation|0|||
161465898|NCT04629508|583102126|FG000|Overall Study|Adverse Event|1|||
161465899|NCT04629508|583102126|FG000|Overall Study|Death|2|||
161465900|NCT04629508|583102126|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
161465901|NCT04073368|583102131|FG000|Overall Study|Adverse Event|2|||
161465902|NCT04073368|583102132|FG001|Overall Study|Adverse Event|0|||
161465903|NCT04073368|583102133|FG002|Overall Study|Adverse Event|1|||
161465904|NCT04073368|583102134|FG003|Overall Study|Adverse Event|1|||
161465905|NCT04073368|583102131|FG000|Overall Study|Withdrawal by Subject|2|||
161465906|NCT04073368|583102132|FG001|Overall Study|Withdrawal by Subject|2|||
161465907|NCT04073368|583102133|FG002|Overall Study|Withdrawal by Subject|1|||
161465908|NCT04073368|583102134|FG003|Overall Study|Withdrawal by Subject|1|||
161465909|NCT04073368|583102131|FG000|Overall Study|Lost to Follow-up|1|||
161465910|NCT04073368|583102132|FG001|Overall Study|Lost to Follow-up|1|||
161465911|NCT04073368|583102133|FG002|Overall Study|Lost to Follow-up|1|||
161465912|NCT04073368|583102134|FG003|Overall Study|Lost to Follow-up|0|||
161465913|NCT04073368|583102131|FG000|Overall Study|Protocol Violation|0|||
161465914|NCT04073368|583102132|FG001|Overall Study|Protocol Violation|1|||
161465915|NCT04073368|583102133|FG002|Overall Study|Protocol Violation|0|||
161465916|NCT04073368|583102134|FG003|Overall Study|Protocol Violation|0|||
161465917|NCT04073368|583102131|FG000|Overall Study|Subject noncompliance|7|||
161465918|NCT04073368|583102132|FG001|Overall Study|Subject noncompliance|4|||
161465919|NCT04073368|583102133|FG002|Overall Study|Subject noncompliance|0|||
161465920|NCT04073368|583102134|FG003|Overall Study|Subject noncompliance|0|||
161465921|NCT03026088|583102135|FG000|Overall Study|Study termination|20|||
161465922|NCT02476422|583102136|FG000|Overall Study|Subject/guardian decision|0|||
161465923|NCT02476422|583102137|FG001|Overall Study|Subject/guardian decision|1|||
161465924|NCT03960554|583102143|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
161465925|NCT03960554|583102144|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
161465926|NCT02545075|583102145|FG000|Randomization|Lost to Follow-up|0|||
161465927|NCT02545075|583102146|FG001|Randomization|Lost to Follow-up|1|||
161465928|NCT02545075|583102145|FG000|Randomization|Withdrawal by Subject|0|||
161465929|NCT02545075|583102146|FG001|Randomization|Withdrawal by Subject|6|||
161465930|NCT02545075|583102145|FG000|Treatment|Disease progression|71|||
161465931|NCT02545075|583102146|FG001|Treatment|Disease progression|32|||
161465932|NCT02545075|583102145|FG000|Treatment|Participant dicontinued study treatment|7|||
161465933|NCT02545075|583102146|FG001|Treatment|Participant dicontinued study treatment|9|||
161465934|NCT02545075|583102145|FG000|Treatment|Withdrawal by Subject|1|||
161465935|NCT02545075|583102146|FG001|Treatment|Withdrawal by Subject|0|||
161465936|NCT02545075|583102145|FG000|Treatment|Adverse event not related to study drug|1|||
161465937|NCT02545075|583102146|FG001|Treatment|Adverse event not related to study drug|0|||
161465938|NCT02545075|583102145|FG000|Treatment|Death|1|||
161465939|NCT02545075|583102146|FG001|Treatment|Death|0|||
161465940|NCT02545075|583102145|FG000|Treatment|Participant drug toxicity|1|||
161465941|NCT02545075|583102146|FG001|Treatment|Participant drug toxicity|0|||
161465942|NCT02545075|583102145|FG000|Treatment|Completed treatment|40|||
161465943|NCT02545075|583102146|FG001|Treatment|Completed treatment|12|||
161465944|NCT06400979|583102150|FG000|Overall Study|Lost to Follow-up|29|||
161465945|NCT06400979|583102150|FG000|Overall Study|Withdrawal by Subject|1|||
161465946|NCT00750880|583102157|FG000|Overall Study|Adverse Event|76|||
161465947|NCT00750880|583102157|FG000|Overall Study|Death|4|||
161465948|NCT00750880|583102157|FG000|Overall Study|Lack of Efficacy|46|||
161465949|NCT00750880|583102157|FG000|Overall Study|Lost to Follow-up|10|||
161465950|NCT00750880|583102157|FG000|Overall Study|Protocol Violation|15|||
161573683|NCT03615924|583486077|FG001|Overall Study|Study termination by Sponsor|86|||
161573684|NCT02954848|583486080|FG000|Overall Study|Randomized but Not Treated|0|||
161573685|NCT02954848|583486081|FG001|Overall Study|Randomized but Not Treated|1|||
161573686|NCT02954848|583486080|FG000|Overall Study|Adverse Event|2|||
161573687|NCT02954848|583486081|FG001|Overall Study|Adverse Event|3|||
161573688|NCT02954848|583486080|FG000|Overall Study|Withdrawal by Participant|0|||
161573689|NCT02954848|583486081|FG001|Overall Study|Withdrawal by Participant|1|||
161573690|NCT01069341|583486082|FG000|Overall Study|Lost to Follow-up|1|||
161573691|NCT00922207|583486083|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
161573692|NCT00922207|583486084|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
161573693|NCT00922207|583486085|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
161573694|NCT00922207|583486083|FG000|Overall Study|Insufficient Therapeutic Response|0|||
161573695|NCT00922207|583486084|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161573696|NCT00922207|583486085|FG002|Overall Study|Insufficient Therapeutic Response|1|||
161914844|NCT01140906|584737302|FG002|Overall Study|Withdrawal of consent|2|||
161465951|NCT00750880|583102157|FG000|Overall Study|Withdrawal by Subject|33|||
161573697|NCT00922207|583486083|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161465952|NCT00750880|583102157|FG000|Overall Study|Physician Decision|20|||
161465953|NCT00750880|583102157|FG000|Overall Study|Administrative|11|||
161573698|NCT00922207|583486084|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161573699|NCT00922207|583486085|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161465954|NCT00925990|583102161|FG000|Overall Study|Adverse Event|1|||
161465955|NCT00925990|583102162|FG001|Overall Study|Adverse Event|3|||
161465956|NCT00925990|583102161|FG000|Overall Study|Withdrawal by Subject|2|||
161465957|NCT00925990|583102162|FG001|Overall Study|Withdrawal by Subject|2|||
161465958|NCT00925990|583102161|FG000|Overall Study|Lost to Follow-up|1|||
161573700|NCT00922207|583486083|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
161573701|NCT00922207|583486084|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161465959|NCT00925990|583102162|FG001|Overall Study|Lost to Follow-up|3|||
161465960|NCT00925990|583102161|FG000|Overall Study|Physician Decision|1|||
161465961|NCT00925990|583102162|FG001|Overall Study|Physician Decision|1|||
161465962|NCT00925990|583102161|FG000|Overall Study|moved out of state, missed medication|0|||
161465963|NCT00925990|583102162|FG001|Overall Study|moved out of state, missed medication|2|||
161465964|NCT00573248|583102168|FG000|Overall Study|scheduling conflicts|15|||
161465965|NCT00573248|583102169|FG001|Overall Study|scheduling conflicts|11|||
161465966|NCT01028378|583102170|FG000|Overall Study|Lost to Follow-up|12|||
161465967|NCT01028378|583102170|FG000|Overall Study|Withdrawal by Subject|1|||
161465968|NCT01028378|583102170|FG000|Overall Study|Adminstrative Reasons|4|||
161465969|NCT00450385|583102171|FG000|Overall Study|Death|3|||
161465970|NCT00450385|583102171|FG000|Overall Study|Protocol Violation|1|||
161465971|NCT00450385|583102171|FG000|Overall Study|Withdrawal by Subject|2|||
161465972|NCT00450385|583102171|FG000|Overall Study|Lack of Efficacy|2|||
161465973|NCT00450385|583102171|FG000|Overall Study|Adverse Event|1|||
161465974|NCT00450385|583102171|FG000|Overall Study|Physician Decision|1|||
161465975|NCT00450385|583102171|FG000|Overall Study|Other|3|||
161465976|NCT03091777|583102174|FG000|Overall Study|Pregnancy|2|||
161465977|NCT03091777|583102175|FG001|Overall Study|Pregnancy|1|||
161465978|NCT03091777|583102176|FG002|Overall Study|Pregnancy|0|||
161465979|NCT03091777|583102174|FG000|Overall Study|Adverse Event|2|||
161465980|NCT03091777|583102175|FG001|Overall Study|Adverse Event|1|||
161465981|NCT03091777|583102176|FG002|Overall Study|Adverse Event|4|||
161465982|NCT03091777|583102174|FG000|Overall Study|Withdrawal by Subject|4|||
161465983|NCT03091777|583102175|FG001|Overall Study|Withdrawal by Subject|2|||
161465984|NCT03091777|583102176|FG002|Overall Study|Withdrawal by Subject|6|||
161465985|NCT03091777|583102174|FG000|Overall Study|Protocol Violation|2|||
161465986|NCT03091777|583102175|FG001|Overall Study|Protocol Violation|1|||
161465987|NCT03091777|583102176|FG002|Overall Study|Protocol Violation|1|||
161465988|NCT03091777|583102174|FG000|Overall Study|Lost to Follow-up|12|||
161465989|NCT03091777|583102175|FG001|Overall Study|Lost to Follow-up|14|||
161465990|NCT03091777|583102176|FG002|Overall Study|Lost to Follow-up|7|||
161465991|NCT03091777|583102174|FG000|Overall Study|Lack of Efficacy|0|||
161465992|NCT03091777|583102175|FG001|Overall Study|Lack of Efficacy|0|||
161465993|NCT03091777|583102176|FG002|Overall Study|Lack of Efficacy|5|||
161465994|NCT03091777|583102174|FG000|Overall Study|Noncompliance with study drug|2|||
161465995|NCT03091777|583102175|FG001|Overall Study|Noncompliance with study drug|3|||
161465996|NCT03091777|583102176|FG002|Overall Study|Noncompliance with study drug|1|||
161465997|NCT03091777|583102174|FG000|Overall Study|Physician Decision|1|||
161465998|NCT03091777|583102175|FG001|Overall Study|Physician Decision|0|||
161465999|NCT03091777|583102176|FG002|Overall Study|Physician Decision|1|||
161466000|NCT03091777|583102174|FG000|Overall Study|Abnormal Laboratory Value|7|||
161466001|NCT03091777|583102175|FG001|Overall Study|Abnormal Laboratory Value|11|||
161466002|NCT03091777|583102176|FG002|Overall Study|Abnormal Laboratory Value|12|||
161573702|NCT00922207|583486085|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161573703|NCT00922207|583486083|FG000|Overall Study|Withdrew Consent|2|||
161573704|NCT00922207|583486084|FG001|Overall Study|Withdrew Consent|5|||
161573705|NCT00922207|583486085|FG002|Overall Study|Withdrew Consent|2|||
161466003|NCT02536833|583102177|FG000|Overall Study|Discontinued Before Treatment|0|||
161573706|NCT00922207|583486083|FG000|Overall Study|Abnormality of Laboratory Test|0|||
161573707|NCT00922207|583486084|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161573708|NCT00922207|583486085|FG002|Overall Study|Abnormality of Laboratory Test|1|||
161573709|NCT01802632|583486086|FG000|Overall Study|Death|28|||
161573710|NCT01802632|583486087|FG001|Overall Study|Death|1|||
161573711|NCT01802632|583486088|FG002|Overall Study|Death|38|||
161573712|NCT01802632|583486089|FG003|Overall Study|Death|0|||
161573713|NCT01802632|583486090|FG004|Overall Study|Death|2|||
161466004|NCT02536833|583102178|FG001|Overall Study|Discontinued Before Treatment|0|||
161466005|NCT02536833|583102179|FG002|Overall Study|Discontinued Before Treatment|1|||
161466006|NCT02536833|583102180|FG003|Overall Study|Discontinued Before Treatment|2|||
161573714|NCT01802632|583486091|FG005|Overall Study|Death|0|||
161573715|NCT01802632|583486086|FG000|Overall Study|Withdrawal by Subject|4|||
161573716|NCT01802632|583486087|FG001|Overall Study|Withdrawal by Subject|2|||
161573717|NCT01802632|583486088|FG002|Overall Study|Withdrawal by Subject|7|||
161466007|NCT02536833|583102177|FG000|Overall Study|Adverse Event|1|||
161466008|NCT02536833|583102178|FG001|Overall Study|Adverse Event|3|||
161466009|NCT02536833|583102179|FG002|Overall Study|Adverse Event|4|||
161573718|NCT01802632|583486089|FG003|Overall Study|Withdrawal by Subject|3|||
161573719|NCT01802632|583486090|FG004|Overall Study|Withdrawal by Subject|0|||
161914845|NCT01140906|584737303|FG003|Overall Study|Withdrawal of consent|2|||
161466010|NCT02536833|583102180|FG003|Overall Study|Adverse Event|1|||
161466011|NCT02536833|583102177|FG000|Overall Study|Lost to Follow-up|2|||
161466012|NCT02536833|583102178|FG001|Overall Study|Lost to Follow-up|1|||
161466013|NCT02536833|583102179|FG002|Overall Study|Lost to Follow-up|2|||
161466014|NCT02536833|583102180|FG003|Overall Study|Lost to Follow-up|2|||
161466015|NCT02536833|583102177|FG000|Overall Study|Physician Decision|0|||
161466016|NCT02536833|583102178|FG001|Overall Study|Physician Decision|0|||
161466017|NCT02536833|583102179|FG002|Overall Study|Physician Decision|0|||
161466018|NCT02536833|583102180|FG003|Overall Study|Physician Decision|1|||
161466019|NCT02536833|583102177|FG000|Overall Study|Site Terminated by Sponsor|2|||
161466020|NCT02536833|583102178|FG001|Overall Study|Site Terminated by Sponsor|2|||
161466021|NCT02536833|583102179|FG002|Overall Study|Site Terminated by Sponsor|2|||
161466022|NCT02536833|583102180|FG003|Overall Study|Site Terminated by Sponsor|2|||
161466023|NCT02536833|583102177|FG000|Overall Study|Subject Non-Compliance|0|||
161466024|NCT02536833|583102178|FG001|Overall Study|Subject Non-Compliance|1|||
161466025|NCT02536833|583102179|FG002|Overall Study|Subject Non-Compliance|1|||
161466026|NCT02536833|583102180|FG003|Overall Study|Subject Non-Compliance|0|||
161466027|NCT02536833|583102177|FG000|Overall Study|Withdrawal by Subject|4|||
161466028|NCT02536833|583102178|FG001|Overall Study|Withdrawal by Subject|3|||
161466029|NCT02536833|583102179|FG002|Overall Study|Withdrawal by Subject|5|||
161466030|NCT02536833|583102180|FG003|Overall Study|Withdrawal by Subject|11|||
161466031|NCT00089674|583102181|FG000|Overall Study|Physician Decision|4|||
161466032|NCT00089674|583102182|FG001|Overall Study|Physician Decision|2|||
161466033|NCT00089674|583102181|FG000|Overall Study|Adverse Event|23|||
161466034|NCT00089674|583102182|FG001|Overall Study|Adverse Event|29|||
161466035|NCT00089674|583102181|FG000|Overall Study|Withdrawal by Subject|143|||
161466036|NCT00089674|583102182|FG001|Overall Study|Withdrawal by Subject|127|||
161466037|NCT00089674|583102181|FG000|Overall Study|Death|43|||
161466038|NCT00089674|583102182|FG001|Overall Study|Death|43|||
161466039|NCT00089674|583102181|FG000|Overall Study|Disease progression|21|||
161466040|NCT00089674|583102182|FG001|Overall Study|Disease progression|23|||
161466041|NCT00089674|583102181|FG000|Overall Study|Ineligibility determined|8|||
161466042|NCT00089674|583102182|FG001|Overall Study|Ineligibility determined|10|||
161466043|NCT00089674|583102181|FG000|Overall Study|Lost to Follow-up|21|||
161466044|NCT00089674|583102182|FG001|Overall Study|Lost to Follow-up|17|||
161466045|NCT00089674|583102181|FG000|Overall Study|Noncompliance|7|||
161466046|NCT00089674|583102182|FG001|Overall Study|Noncompliance|3|||
161466047|NCT00089674|583102181|FG000|Overall Study|Other|5|||
161466048|NCT00089674|583102182|FG001|Overall Study|Other|9|||
161466049|NCT00089674|583102181|FG000|Overall Study|Requirement for alternative therapy|14|||
161466050|NCT00089674|583102182|FG001|Overall Study|Requirement for alternative therapy|4|||
161466051|NCT01462227|583102183|FG000|Second Assignment|Lost to Follow-up|1|||
161466052|NCT01462227|583102184|FG001|Second Assignment|Lost to Follow-up|0|||
161466053|NCT01462227|583102185|FG002|Second Assignment|Lost to Follow-up|0|||
161466054|NCT01462227|583102186|FG003|Second Assignment|Lost to Follow-up|0|||
161573720|NCT01802632|583486091|FG005|Overall Study|Withdrawal by Subject|1|||
161573721|NCT01802632|583486086|FG000|Overall Study|Objective Disease Progression|1|||
161573722|NCT01802632|583486087|FG001|Overall Study|Objective Disease Progression|12|||
161573723|NCT01802632|583486088|FG002|Overall Study|Objective Disease Progression|104|||
161573724|NCT01802632|583486089|FG003|Overall Study|Objective Disease Progression|6|||
161573725|NCT01802632|583486090|FG004|Overall Study|Objective Disease Progression|4|||
161573726|NCT01802632|583486091|FG005|Overall Study|Objective Disease Progression|4|||
161573727|NCT01802632|583486086|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
161573728|NCT01802632|583486087|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
161573729|NCT01802632|583486088|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
161573730|NCT01802632|583486089|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
161573731|NCT01802632|583486090|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
161573732|NCT01802632|583486091|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
161573733|NCT01802632|583486086|FG000|Overall Study|Other (not specified)|0|||
161573734|NCT01802632|583486087|FG001|Overall Study|Other (not specified)|0|||
161573735|NCT01802632|583486088|FG002|Overall Study|Other (not specified)|7|||
161573736|NCT01802632|583486089|FG003|Overall Study|Other (not specified)|1|||
161573737|NCT01802632|583486090|FG004|Overall Study|Other (not specified)|0|||
161573738|NCT01802632|583486091|FG005|Overall Study|Other (not specified)|1|||
161573739|NCT03299816|583486096|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
161573740|NCT03299816|583486097|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
161573741|NCT03299816|583486096|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
161573742|NCT03299816|583486097|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
161573743|NCT03299816|583486096|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
161573744|NCT03299816|583486097|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
161573745|NCT00367991|583486098|FG000|Overall Study|Withdrawal by Subject|1|||
161573746|NCT00367991|583486099|FG001|Overall Study|Withdrawal by Subject|1|||
161573747|NCT00367991|583486098|FG000|Overall Study|Adverse Event|1|||
161466055|NCT01462227|583102183|FG000|Second Assignment|Protocol Violation|0|||
161466056|NCT01462227|583102184|FG001|Second Assignment|Protocol Violation|1|||
161466057|NCT01462227|583102185|FG002|Second Assignment|Protocol Violation|1|||
161466058|NCT01462227|583102186|FG003|Second Assignment|Protocol Violation|0|||
161466059|NCT00586066|583102189|FG000|Overall Study|Lost to Follow-up|6|||
161466060|NCT00586066|583102190|FG001|Overall Study|Lost to Follow-up|3|||
161466061|NCT00586066|583102189|FG000|Overall Study|Lack of Efficacy|5|||
161466062|NCT00586066|583102190|FG001|Overall Study|Lack of Efficacy|3|||
161573748|NCT00367991|583486099|FG001|Overall Study|Adverse Event|1|||
161573749|NCT01184508|583486103|FG000|Overall Study|Adverse Event|4|||
161466063|NCT00586066|583102189|FG000|Overall Study|Adverse Event|2|||
161466064|NCT00586066|583102190|FG001|Overall Study|Adverse Event|2|||
161466065|NCT00586066|583102189|FG000|Overall Study|Physician Decision|1|||
161466066|NCT00586066|583102190|FG001|Overall Study|Physician Decision|0|||
161466067|NCT00586066|583102189|FG000|Overall Study|Withdrawal of consent|4|||
161466068|NCT00586066|583102190|FG001|Overall Study|Withdrawal of consent|2|||
161466069|NCT00760084|583102192|FG000|Overall Study|Physician Decision|5|||
161466070|NCT00760084|583102192|FG000|Overall Study|Withdrawal by Subject|2|||
161466071|NCT00760084|583102192|FG000|Overall Study|Progressive Disease|3|||
161466072|NCT02301988|583102193|FG000|Overall Study|Withdrawal by Subject|2|||
161466073|NCT02301988|583102194|FG001|Overall Study|Withdrawal by Subject|1|||
161466074|NCT02301988|583102193|FG000|Overall Study|Physician Decision|2|||
161466075|NCT02301988|583102194|FG001|Overall Study|Physician Decision|2|||
161466076|NCT02301988|583102193|FG000|Overall Study|Unknown Reason|1|||
161466077|NCT02301988|583102194|FG001|Overall Study|Unknown Reason|3|||
161466078|NCT02301988|583102193|FG000|Overall Study|Lack of Efficacy|3|||
161466079|NCT02301988|583102194|FG001|Overall Study|Lack of Efficacy|2|||
161466080|NCT02301988|583102193|FG000|Overall Study|Death|1|||
161466081|NCT02301988|583102194|FG001|Overall Study|Death|0|||
161466082|NCT02301988|583102193|FG000|Overall Study|Adverse Event|1|||
161466083|NCT02301988|583102194|FG001|Overall Study|Adverse Event|1|||
161466084|NCT02567552|583102195|FG000|Overall Study|Adverse Event|0|||
161466085|NCT02567552|583102196|FG001|Overall Study|Adverse Event|1|||
161466086|NCT02891161|583102199|FG000|Study Treatment|Disease Progression|2|||
161466087|NCT02891161|583102200|FG001|Study Treatment|Disease Progression|4|||
161466088|NCT02891161|583102199|FG000|Study Treatment|AE/Side Effects/Complications|1|||
161466089|NCT02891161|583102200|FG001|Study Treatment|AE/Side Effects/Complications|5|||
161466090|NCT02891161|583102199|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
161466091|NCT02891161|583102200|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
161466092|NCT02891161|583102199|FG000|Follow up|Death|4|||
161466093|NCT02891161|583102200|FG001|Follow up|Death|8|||
161466094|NCT02891161|583102199|FG000|Follow up|Refused to Follow up|0|||
161466095|NCT02891161|583102200|FG001|Follow up|Refused to Follow up|2|||
161466096|NCT02891161|583102199|FG000|Follow up|Symptomatic deterioration|0|||
161466097|NCT02891161|583102200|FG001|Follow up|Symptomatic deterioration|1|||
161466098|NCT02891161|583102199|FG000|Follow up|Study terminated|0|||
161466099|NCT02891161|583102200|FG001|Follow up|Study terminated|6|||
161466100|NCT01931202|583102202|FG000|Overall Study|Withdrawal by Subject|0|||
161466101|NCT01931202|583102203|FG001|Overall Study|Withdrawal by Subject|0|||
161466102|NCT01931202|583102204|FG002|Overall Study|Withdrawal by Subject|2|||
161466103|NCT01931202|583102202|FG000|Overall Study|Lost to Follow-up|0|||
161466104|NCT01931202|583102203|FG001|Overall Study|Lost to Follow-up|5|||
161466105|NCT01931202|583102204|FG002|Overall Study|Lost to Follow-up|2|||
161466106|NCT00171054|583102205|FG000|Overall Study|Protocol Violation|1|||
161466107|NCT00171054|583102206|FG001|Overall Study|Protocol Violation|2|||
161466108|NCT00171054|583102205|FG000|Overall Study|Patient withdrew consent|1|||
161466109|NCT00171054|583102206|FG001|Overall Study|Patient withdrew consent|0|||
161573750|NCT01184508|583486104|FG001|Overall Study|Adverse Event|6|||
161573751|NCT01184508|583486103|FG000|Overall Study|Lack of Efficacy|1|||
161573752|NCT01184508|583486104|FG001|Overall Study|Lack of Efficacy|1|||
161573753|NCT01184508|583486103|FG000|Overall Study|Lost to Follow-up|1|||
161573754|NCT01184508|583486104|FG001|Overall Study|Lost to Follow-up|1|||
161810467|NCT02655679|584347829|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161810468|NCT03801707|584347830|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
161810469|NCT01754597|584347831|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
161810470|NCT01754597|584347832|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
161810471|NCT00819741|584347833|FG000|Overall Study|Adverse Event|5|||
161810472|NCT00819741|584347834|FG001|Overall Study|Adverse Event|2|||
161810473|NCT00819741|584347833|FG000|Overall Study|Lack of Efficacy|0|||
161810474|NCT00819741|584347834|FG001|Overall Study|Lack of Efficacy|2|||
161810475|NCT00819741|584347833|FG000|Overall Study|Lost to Follow-up|3|||
161573755|NCT01184508|583486103|FG000|Overall Study|Physician Decision|1|||
161810476|NCT00819741|584347834|FG001|Overall Study|Lost to Follow-up|1|||
161810477|NCT00819741|584347833|FG000|Overall Study|Protocol Violation|3|||
161466110|NCT00171054|583102205|FG000|Overall Study|Lost to Follow-up|0|||
161466111|NCT00171054|583102206|FG001|Overall Study|Lost to Follow-up|1|||
161466112|NCT00171054|583102205|FG000|Overall Study|Adverse Event|8|||
161466113|NCT00171054|583102206|FG001|Overall Study|Adverse Event|8|||
161466114|NCT00171054|583102205|FG000|Overall Study|Condition no longer required study drug|0|||
161466115|NCT00171054|583102206|FG001|Overall Study|Condition no longer required study drug|1|||
161573756|NCT01184508|583486104|FG001|Overall Study|Physician Decision|0|||
161810478|NCT00819741|584347834|FG001|Overall Study|Protocol Violation|4|||
161466116|NCT04669535|583102207|FG000|Overall Study|Death|1|||
161466117|NCT04669535|583102208|FG001|Overall Study|Death|1|||
161466118|NCT04669535|583102209|FG002|Overall Study|Death|0|||
161573757|NCT01184508|583486103|FG000|Overall Study|Protocol Violation|3|||
161466119|NCT04669535|583102210|FG003|Overall Study|Death|0|||
161466120|NCT01876810|583102211|FG000|Overall Study|Physician Decision|0|||
161466121|NCT01876810|583102212|FG001|Overall Study|Physician Decision|1|||
161466122|NCT01857583|583102214|FG000|Overall Study|Adverse Event|0|||
161466123|NCT01857583|583102215|FG001|Overall Study|Adverse Event|0|||
161466124|NCT01857583|583102216|FG002|Overall Study|Adverse Event|1|||
161466125|NCT01857583|583102217|FG003|Overall Study|Adverse Event|1|||
161466126|NCT01857583|583102214|FG000|Overall Study|Death|0|||
161466127|NCT01857583|583102215|FG001|Overall Study|Death|1|||
161466128|NCT01857583|583102216|FG002|Overall Study|Death|1|||
161466129|NCT01857583|583102217|FG003|Overall Study|Death|0|||
161466130|NCT01857583|583102214|FG000|Overall Study|Physician Decision|0|||
161466131|NCT01857583|583102215|FG001|Overall Study|Physician Decision|0|||
161466132|NCT01857583|583102216|FG002|Overall Study|Physician Decision|0|||
161466133|NCT01857583|583102217|FG003|Overall Study|Physician Decision|1|||
161466134|NCT01857583|583102214|FG000|Overall Study|Withdrawal by Subject|1|||
161466135|NCT01857583|583102215|FG001|Overall Study|Withdrawal by Subject|0|||
161466136|NCT01857583|583102216|FG002|Overall Study|Withdrawal by Subject|1|||
161466137|NCT01857583|583102217|FG003|Overall Study|Withdrawal by Subject|2|||
161466138|NCT02775903|583102220|FG000|Overall Study|Death|7|||
161466139|NCT02775903|583102221|FG001|Overall Study|Death|11|||
161466140|NCT02775903|583102222|FG002|Overall Study|Death|12|||
161466141|NCT02775903|583102223|FG003|Overall Study|Death|11|||
161466142|NCT02775903|583102220|FG000|Overall Study|Adverse Event|0|||
161466143|NCT02775903|583102221|FG001|Overall Study|Adverse Event|1|||
161466144|NCT02775903|583102222|FG002|Overall Study|Adverse Event|12|||
161466145|NCT02775903|583102223|FG003|Overall Study|Adverse Event|3|||
161466146|NCT02775903|583102220|FG000|Overall Study|Progressive disease|15|||
161466147|NCT02775903|583102221|FG001|Overall Study|Progressive disease|14|||
161466148|NCT02775903|583102222|FG002|Overall Study|Progressive disease|30|||
161466149|NCT02775903|583102223|FG003|Overall Study|Progressive disease|20|||
161466150|NCT02775903|583102220|FG000|Overall Study|Lack of Efficacy|2|||
161466151|NCT02775903|583102221|FG001|Overall Study|Lack of Efficacy|2|||
161466152|NCT02775903|583102222|FG002|Overall Study|Lack of Efficacy|2|||
161466153|NCT02775903|583102223|FG003|Overall Study|Lack of Efficacy|6|||
161466154|NCT02775903|583102220|FG000|Overall Study|Withdrawal by Subject|7|||
161466155|NCT02775903|583102221|FG001|Overall Study|Withdrawal by Subject|5|||
161466156|NCT02775903|583102222|FG002|Overall Study|Withdrawal by Subject|5|||
161466157|NCT02775903|583102223|FG003|Overall Study|Withdrawal by Subject|8|||
161466158|NCT02775903|583102220|FG000|Overall Study|Other reasons|7|||
161466159|NCT02775903|583102221|FG001|Overall Study|Other reasons|8|||
161466160|NCT02775903|583102222|FG002|Overall Study|Other reasons|2|||
161466161|NCT02775903|583102223|FG003|Overall Study|Other reasons|12|||
161810479|NCT00819741|584347833|FG000|Overall Study|Withdrawal by Subject|2|||
161810480|NCT00819741|584347834|FG001|Overall Study|Withdrawal by Subject|2|||
161810481|NCT00819741|584347833|FG000|Overall Study|Unclassified|6|||
161810482|NCT00819741|584347834|FG001|Overall Study|Unclassified|0|||
161810483|NCT00819741|584347833|FG000|Overall Study|Reasons unknown|3|||
161810484|NCT00819741|584347834|FG001|Overall Study|Reasons unknown|3|||
161810485|NCT03447353|584349418|FG000|Overall Study|Failure at Screening Visit|2|||
161810486|NCT03447353|584349418|FG000|Overall Study|Lost to Follow-up|4|||
161810487|NCT03447353|584349418|FG000|Overall Study|Scheduling Conflicts|3|||
161810488|NCT03447353|584349418|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
161810489|NCT02175095|584349419|FG000|Overall Study|Withdrawal by Subject|3|||
161810490|NCT02635750|584349420|FG000|Part 1, Period 2|Adverse Event|1|||
161810491|NCT02635750|584349421|FG001|Part 1, Period 2|Adverse Event|0|||
161810492|NCT02635750|584349422|FG002|Part 1, Period 2|Adverse Event|0|||
161810493|NCT00462345|584349423|FG000|Overall Study|Withdrawal by Subject|2|||
161810494|NCT00462345|584349423|FG000|Overall Study|Did not complete second course|1|||
161810495|NCT02642653|584349427|FG000|Overall Study|Adverse Event|2|||
161810496|NCT02642653|584349428|FG001|Overall Study|Adverse Event|0|||
161810497|NCT02875392|584349432|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
161466162|NCT03552965|583102227|FG000|Overall Study|Death|1|||
161466163|NCT03552965|583102228|FG001|Overall Study|Death|1|||
161466164|NCT03552965|583102227|FG000|Overall Study|Lost to Follow-up|1|||
161466165|NCT03552965|583102228|FG001|Overall Study|Lost to Follow-up|1|||
161810498|NCT02875392|584349433|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
161810499|NCT00508651|584349437|FG000|Overall Study|Lost to Follow-up|3|||
161466166|NCT03552965|583102227|FG000|Overall Study|Physician Decision|1|||
161466167|NCT03552965|583102228|FG001|Overall Study|Physician Decision|1|||
161466168|NCT03552965|583102227|FG000|Overall Study|Withdrawal by Subject|0|||
161466169|NCT03552965|583102228|FG001|Overall Study|Withdrawal by Subject|2|||
161466170|NCT03552965|583102227|FG000|Overall Study|Continuation not in patient best interest|1|||
161466171|NCT03552965|583102228|FG001|Overall Study|Continuation not in patient best interest|0|||
161466172|NCT03552965|583102227|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
161466173|NCT03552965|583102228|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
161466174|NCT00891462|583103331|FG000|Overall Study|Withdrawal by Subject|9|||
161466175|NCT00891462|583103332|FG001|Overall Study|Withdrawal by Subject|6|||
161466176|NCT00891462|583103333|FG002|Overall Study|Withdrawal by Subject|7|||
161810500|NCT00508651|584349438|FG001|Overall Study|Lost to Follow-up|1|||
161810501|NCT00508651|584349437|FG000|Overall Study|Withdrawal by Subject|1|||
161810502|NCT00508651|584349438|FG001|Overall Study|Withdrawal by Subject|1|||
161810503|NCT03874715|584349441|FG000|Overall Study|Adverse Event|2|||
161810504|NCT03874715|584349442|FG001|Overall Study|Adverse Event|0|||
161810505|NCT03874715|584349441|FG000|Overall Study|Poor compliance to protocol|5|||
161810506|NCT03874715|584349442|FG001|Overall Study|Poor compliance to protocol|1|||
161810507|NCT03874715|584349441|FG000|Overall Study|Withdrawal by Subject|1|||
161810508|NCT03874715|584349442|FG001|Overall Study|Withdrawal by Subject|0|||
161810509|NCT03874715|584349441|FG000|Overall Study|Other-unspecified|1|||
161810510|NCT03874715|584349442|FG001|Overall Study|Other-unspecified|0|||
161810511|NCT00934050|584349445|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
161810512|NCT00934050|584349446|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810513|NCT00934050|584349447|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810514|NCT00934050|584349448|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
161810515|NCT00934050|584349449|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810516|NCT00934050|584349450|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810517|NCT00934050|584349445|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
161810518|NCT00934050|584349446|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
161810519|NCT00934050|584349447|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
161810520|NCT00934050|584349448|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
161810521|NCT00934050|584349449|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
161810522|NCT00934050|584349450|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
161810523|NCT00934050|584349445|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810524|NCT00934050|584349446|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161914846|NCT01140906|584737300|FG000|Overall Study|Lost to Follow-up|1|||
161914847|NCT01140906|584737301|FG001|Overall Study|Lost to Follow-up|1|||
161914848|NCT01140906|584737302|FG002|Overall Study|Lost to Follow-up|0|||
161914849|NCT01140906|584737303|FG003|Overall Study|Lost to Follow-up|2|||
161914850|NCT01140906|584737300|FG000|Overall Study|Administrative or other reason|0|||
161914851|NCT01140906|584737301|FG001|Overall Study|Administrative or other reason|5|||
161914852|NCT01140906|584737302|FG002|Overall Study|Administrative or other reason|3|||
161914853|NCT01140906|584737303|FG003|Overall Study|Administrative or other reason|2|||
161914854|NCT01649765|584737304|FG000|Overall Study|Adverse Event|5|||
161914855|NCT01649765|584737305|FG001|Overall Study|Adverse Event|3|||
161914856|NCT01649765|584737304|FG000|Overall Study|Lack of Efficacy|1|||
161914857|NCT01649765|584737305|FG001|Overall Study|Lack of Efficacy|1|||
161914858|NCT01649765|584737304|FG000|Overall Study|Physician Decision|0|||
161914859|NCT01649765|584737305|FG001|Overall Study|Physician Decision|3|||
161914860|NCT01649765|584737304|FG000|Overall Study|Protocol Violation|1|||
161914861|NCT01649765|584737305|FG001|Overall Study|Protocol Violation|0|||
161914862|NCT01649765|584737304|FG000|Overall Study|Withdrawal by Subject|2|||
161914863|NCT01649765|584737305|FG001|Overall Study|Withdrawal by Subject|1|||
161914864|NCT02469233|584737306|FG000|Overall Study|Death|1|||
161914865|NCT02469233|584737307|FG001|Overall Study|Death|1|||
161914866|NCT02469233|584737306|FG000|Overall Study|Lost to post or 6 month follow up|7|||
161914867|NCT02469233|584737307|FG001|Overall Study|Lost to post or 6 month follow up|2|||
161914868|NCT04889040|584737308|FG000|Overall Study|Withdrawal by Subject|3|||
161914869|NCT04889040|584737309|FG001|Overall Study|Withdrawal by Subject|3|||
161914870|NCT04889040|584737308|FG000|Overall Study|Lost to Follow-up|0|||
161914871|NCT04889040|584737309|FG001|Overall Study|Lost to Follow-up|1|||
161914872|NCT04889040|584737308|FG000|Overall Study|Adverse Event|2|||
161914873|NCT04889040|584737309|FG001|Overall Study|Adverse Event|1|||
161914874|NCT00855582|584737314|FG000|Overall Study|Adverse Event|2|||
161914875|NCT00855582|584737315|FG001|Overall Study|Adverse Event|6|||
161914876|NCT00855582|584737316|FG002|Overall Study|Adverse Event|3|||
161914877|NCT00855582|584737314|FG000|Overall Study|Death|1|||
161914878|NCT00855582|584737315|FG001|Overall Study|Death|0|||
161914879|NCT00855582|584737316|FG002|Overall Study|Death|0|||
161914880|NCT00855582|584737314|FG000|Overall Study|Lack of Efficacy|1|||
161914881|NCT00855582|584737315|FG001|Overall Study|Lack of Efficacy|3|||
161914882|NCT00855582|584737316|FG002|Overall Study|Lack of Efficacy|8|||
161914883|NCT00855582|584737314|FG000|Overall Study|Lost to Follow-up|1|||
161914884|NCT00855582|584737315|FG001|Overall Study|Lost to Follow-up|3|||
161914885|NCT00855582|584737316|FG002|Overall Study|Lost to Follow-up|1|||
161914886|NCT00855582|584737314|FG000|Overall Study|Physician Decision|0|||
161914887|NCT00855582|584737315|FG001|Overall Study|Physician Decision|0|||
161914888|NCT00855582|584737316|FG002|Overall Study|Physician Decision|1|||
161914889|NCT00855582|584737314|FG000|Overall Study|Protocol Violation|6|||
161810525|NCT00934050|584349447|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
161914890|NCT00855582|584737315|FG001|Overall Study|Protocol Violation|2|||
161914891|NCT00855582|584737316|FG002|Overall Study|Protocol Violation|6|||
161466177|NCT00891462|583103331|FG000|Overall Study|Adverse Event|7|||
161466178|NCT00891462|583103332|FG001|Overall Study|Adverse Event|8|||
161466179|NCT00891462|583103333|FG002|Overall Study|Adverse Event|7|||
161466180|NCT00891462|583103331|FG000|Overall Study|Lack of Efficacy|10|||
161466181|NCT00891462|583103332|FG001|Overall Study|Lack of Efficacy|5|||
161466182|NCT00891462|583103333|FG002|Overall Study|Lack of Efficacy|1|||
161466183|NCT00891462|583103331|FG000|Overall Study|COPD exacerbation|7|||
161466184|NCT00891462|583103332|FG001|Overall Study|COPD exacerbation|4|||
161466185|NCT00891462|583103333|FG002|Overall Study|COPD exacerbation|1|||
161466186|NCT00891462|583103331|FG000|Overall Study|Other Reason|2|||
161466187|NCT00891462|583103332|FG001|Overall Study|Other Reason|5|||
161466188|NCT00891462|583103333|FG002|Overall Study|Other Reason|3|||
161466189|NCT00891462|583103331|FG000|Overall Study|Protocol Violation|2|||
161466190|NCT00891462|583103332|FG001|Overall Study|Protocol Violation|1|||
161466191|NCT00891462|583103333|FG002|Overall Study|Protocol Violation|3|||
161466192|NCT00891462|583103331|FG000|Overall Study|Inclusion/exclusion criteria|0|||
161466193|NCT00891462|583103332|FG001|Overall Study|Inclusion/exclusion criteria|2|||
161466194|NCT00891462|583103333|FG002|Overall Study|Inclusion/exclusion criteria|2|||
161466195|NCT00891462|583103331|FG000|Overall Study|Lost to Follow-up|0|||
161466196|NCT00891462|583103332|FG001|Overall Study|Lost to Follow-up|2|||
161466197|NCT00891462|583103333|FG002|Overall Study|Lost to Follow-up|0|||
161466198|NCT01083485|583103334|FG000|Overall Study|Adverse Event|0|||
161466199|NCT01083485|583103335|FG001|Overall Study|Adverse Event|1|||
161466200|NCT01083485|583103334|FG000|Overall Study|Protocol Violation|1|||
161466201|NCT01083485|583103335|FG001|Overall Study|Protocol Violation|0|||
161466202|NCT01083485|583103334|FG000|Overall Study|Withdrawal by Subject|5|||
161466203|NCT01083485|583103335|FG001|Overall Study|Withdrawal by Subject|2|||
161466204|NCT01083485|583103334|FG000|Overall Study|Other|1|||
161466205|NCT01083485|583103335|FG001|Overall Study|Other|0|||
161466206|NCT00761579|583103347|FG000|Overall Study|Adverse Event|10|||
161466207|NCT00761579|583103347|FG000|Overall Study|Death|2|||
161466208|NCT00761579|583103347|FG000|Overall Study|Lack of Efficacy|21|||
161466209|NCT00761579|583103347|FG000|Overall Study|Lost to Follow-up|16|||
161466210|NCT00761579|583103347|FG000|Overall Study|Pregnancy|1|||
161466211|NCT00761579|583103347|FG000|Overall Study|Withdrawal by Subject|34|||
161466212|NCT00761579|583103347|FG000|Overall Study|Lack of compliance|2|||
161466213|NCT00761579|583103347|FG000|Overall Study|Protocol deviation|1|||
161466214|NCT00761579|583103347|FG000|Overall Study|Drug overdose|1|||
161466215|NCT00761579|583103347|FG000|Overall Study|Aggravation of depression|1|||
161466216|NCT00761579|583103347|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
161466217|NCT00761579|583103347|FG000|Overall Study|Lost survey form|1|||
161466218|NCT00761579|583103347|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
161466219|NCT00950911|583103348|FG000|Overall Study|Adverse Event|0|||
161466220|NCT00950911|583103349|FG001|Overall Study|Adverse Event|2|||
161466221|NCT00950911|583103348|FG000|Overall Study|Death|4|||
161466222|NCT00950911|583103349|FG001|Overall Study|Death|6|||
161466223|NCT00950911|583103348|FG000|Overall Study|Disease progression|2|||
161466224|NCT00950911|583103349|FG001|Overall Study|Disease progression|2|||
161466225|NCT00950911|583103348|FG000|Overall Study|Consent withdrawn|1|||
161466226|NCT00950911|583103349|FG001|Overall Study|Consent withdrawn|3|||
161466227|NCT00950911|583103348|FG000|Overall Study|Administrative decision|3|||
161466228|NCT00950911|583103349|FG001|Overall Study|Administrative decision|1|||
161466229|NCT00950911|583103348|FG000|Overall Study|Ineligibility determined|1|||
161466230|NCT00950911|583103349|FG001|Overall Study|Ineligibility determined|0|||
161466231|NCT00950911|583103348|FG000|Overall Study|Noncompliance|1|||
161466232|NCT00950911|583103349|FG001|Overall Study|Noncompliance|0|||
161466233|NCT00950911|583103348|FG000|Overall Study|Poor performance status|0|||
161466234|NCT00950911|583103349|FG001|Overall Study|Poor performance status|1|||
161466235|NCT02063880|583103350|FG000|Overall Study|Death|21|||
161810526|NCT00934050|584349448|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810527|NCT00934050|584349449|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810528|NCT00934050|584349450|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810529|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
161810530|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
161466236|NCT02063880|583103351|FG001|Overall Study|Death|18|||
161466237|NCT02063880|583103350|FG000|Overall Study|Lost to Follow-up|7|||
161466238|NCT02063880|583103351|FG001|Overall Study|Lost to Follow-up|7|||
161466239|NCT02063880|583103350|FG000|Overall Study|Ineligible|0|||
161466240|NCT02063880|583103351|FG001|Overall Study|Ineligible|2|||
161466241|NCT02600351|583103352|FG000|Overall Study|Lack of Efficacy|3|||
161466242|NCT02600351|583103353|FG001|Overall Study|Lack of Efficacy|0|||
161466243|NCT02600351|583103354|FG002|Overall Study|Lack of Efficacy|5|||
161466244|NCT02600351|583103355|FG003|Overall Study|Lack of Efficacy|2|||
161466245|NCT02600351|583103352|FG000|Overall Study|Lost to Follow-up|1|||
161810531|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
161466246|NCT02600351|583103353|FG001|Overall Study|Lost to Follow-up|0|||
161466247|NCT02600351|583103354|FG002|Overall Study|Lost to Follow-up|0|||
161466248|NCT02600351|583103355|FG003|Overall Study|Lost to Follow-up|0|||
161466249|NCT02600351|583103352|FG000|Overall Study|Randomized but Not Treated|1|||
161466250|NCT02600351|583103353|FG001|Overall Study|Randomized but Not Treated|0|||
161466251|NCT02600351|583103354|FG002|Overall Study|Randomized but Not Treated|1|||
161466252|NCT02600351|583103355|FG003|Overall Study|Randomized but Not Treated|3|||
161466253|NCT02106910|583103358|FG000|Overall Study|Lost to Follow-up|1|||
161466254|NCT02106910|583103359|FG001|Overall Study|Lost to Follow-up|1|||
161466255|NCT00567593|583103360|FG000|Overall Study|Adverse Event|1|||
161466256|NCT00567593|583103360|FG000|Overall Study|Physician Decision|1|||
161466257|NCT04087213|583103361|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
161466258|NCT04087213|583103361|FG000|In-Facility Introduction|Adverse Event|1|||
161466259|NCT04087213|583103361|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
161466260|NCT04087213|583103361|FG000|Assisted Evaluable Period|Personal reasons|3|||
161466261|NCT04087213|583103361|FG000|Transition Period B|Renal Transplantation|1|||
161466262|NCT01272661|583103364|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
161466263|NCT01272661|583103365|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
161466264|NCT01272661|583103366|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
161466265|NCT01086423|583103367|FG000|Overall Study|Protocol Violation|0|||
161466266|NCT01086423|583103368|FG001|Overall Study|Protocol Violation|0|||
161466267|NCT01086423|583103369|FG002|Overall Study|Protocol Violation|1|||
161466268|NCT01086423|583103367|FG000|Overall Study|Migrated/moved from study area|2|||
161466269|NCT01086423|583103368|FG001|Overall Study|Migrated/moved from study area|0|||
161466270|NCT01086423|583103369|FG002|Overall Study|Migrated/moved from study area|4|||
161466271|NCT01086423|583103367|FG000|Overall Study|Adverse event, fatal|1|||
161466272|NCT01086423|583103368|FG001|Overall Study|Adverse event, fatal|1|||
161466273|NCT01086423|583103369|FG002|Overall Study|Adverse event, fatal|0|||
161466274|NCT01086423|583103367|FG000|Overall Study|Adverse event, non-fatal|2|||
161466275|NCT01086423|583103368|FG001|Overall Study|Adverse event, non-fatal|1|||
161466276|NCT01086423|583103369|FG002|Overall Study|Adverse event, non-fatal|0|||
161466277|NCT01086423|583103367|FG000|Overall Study|Withdrawal by Subject|5|||
161466278|NCT01086423|583103368|FG001|Overall Study|Withdrawal by Subject|1|||
161466279|NCT01086423|583103369|FG002|Overall Study|Withdrawal by Subject|3|||
161466280|NCT01086423|583103367|FG000|Overall Study|Lost to Follow-up|0|||
161466281|NCT01086423|583103368|FG001|Overall Study|Lost to Follow-up|0|||
161466282|NCT01086423|583103369|FG002|Overall Study|Lost to Follow-up|1|||
161466283|NCT05342532|583103370|FG000|Overall Study|Adverse Event|5|||
161466284|NCT05342532|583103371|FG001|Overall Study|Adverse Event|20|||
161466285|NCT05342532|583103370|FG000|Overall Study|Lost to Follow-up|10|||
161466286|NCT05342532|583103371|FG001|Overall Study|Lost to Follow-up|15|||
161466287|NCT02057393|583103372|FG000|Overall Study|Withdrawal by Subject|1|||
161466288|NCT02057393|583103372|FG000|Overall Study|Patient did not meet criteria|1|||
161466289|NCT02495233|583103376|FG000|Overall Study|Miscellaneous|0|||
161466290|NCT02495233|583103377|FG001|Overall Study|Miscellaneous|1|||
161466291|NCT01130103|583103382|FG000|Randomized Treatment|Adverse Event|1|||
161466292|NCT01130103|583103383|FG001|Randomized Treatment|Adverse Event|1|||
161466293|NCT01130103|583103382|FG000|Randomized Treatment|Lost to Follow-up|1|||
161466294|NCT01130103|583103383|FG001|Randomized Treatment|Lost to Follow-up|0|||
161466295|NCT01130103|583103382|FG000|Randomized Treatment|Protocol Violation|3|||
161466296|NCT01130103|583103383|FG001|Randomized Treatment|Protocol Violation|2|||
161466297|NCT01130103|583103382|FG000|Randomized Treatment|Withdrawal by Subject|1|||
161466298|NCT01130103|583103383|FG001|Randomized Treatment|Withdrawal by Subject|2|||
161466299|NCT01130103|583103382|FG000|Maintenance Treatment|Lack of Efficacy|0|||
161466300|NCT01130103|583103383|FG001|Maintenance Treatment|Lack of Efficacy|1|||
161466301|NCT01130103|583103382|FG000|Maintenance Treatment|Lost to Follow-up|1|||
161466302|NCT01130103|583103383|FG001|Maintenance Treatment|Lost to Follow-up|1|||
161466303|NCT01130103|583103382|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
161466304|NCT01130103|583103383|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
161466305|NCT03614975|583103384|FG000|Overall Study|Physician Decision|7|||
161466306|NCT03614975|583103385|FG001|Overall Study|Physician Decision|5|||
161466307|NCT03614975|583103384|FG000|Overall Study|Withdrawal by Subject|2|||
161466308|NCT03614975|583103385|FG001|Overall Study|Withdrawal by Subject|2|||
161466309|NCT03614975|583103384|FG000|Overall Study|Specimens not in lab batch shipment|1|||
161466310|NCT03614975|583103385|FG001|Overall Study|Specimens not in lab batch shipment|1|||
161466311|NCT01390220|583103386|FG000|Test Dose Phase|Adverse Event|17|||
161466312|NCT01390220|583103387|FG001|Test Dose Phase|Adverse Event|0|||
161466313|NCT01390220|583103388|FG002|Test Dose Phase|Adverse Event|0|||
161466314|NCT01390220|583103386|FG000|Test Dose Phase|Withdrawal by Subject|8|||
161466315|NCT01390220|583103387|FG001|Test Dose Phase|Withdrawal by Subject|0|||
161466316|NCT01390220|583103388|FG002|Test Dose Phase|Withdrawal by Subject|0|||
161466317|NCT01390220|583103386|FG000|Test Dose Phase|Lost to Follow-up|2|||
161466318|NCT01390220|583103387|FG001|Test Dose Phase|Lost to Follow-up|0|||
161466319|NCT01390220|583103388|FG002|Test Dose Phase|Lost to Follow-up|0|||
161466320|NCT01390220|583103386|FG000|Test Dose Phase|Protocol Violation|8|||
161466321|NCT01390220|583103387|FG001|Test Dose Phase|Protocol Violation|0|||
161466322|NCT01390220|583103388|FG002|Test Dose Phase|Protocol Violation|0|||
161466323|NCT01390220|583103386|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
161466324|NCT01390220|583103387|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
161466325|NCT01390220|583103388|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
161466326|NCT01390220|583103386|FG000|Test Dose Phase|Study/Site closure|6|||
161466327|NCT01390220|583103387|FG001|Test Dose Phase|Study/Site closure|0|||
161466328|NCT01390220|583103388|FG002|Test Dose Phase|Study/Site closure|0|||
161466329|NCT01390220|583103386|FG000|Test Dose Phase|Caregiver no longer available|5|||
161466330|NCT01390220|583103387|FG001|Test Dose Phase|Caregiver no longer available|0|||
161466331|NCT01390220|583103388|FG002|Test Dose Phase|Caregiver no longer available|0|||
161466332|NCT01390220|583103386|FG000|Test Dose Phase|Noncompliance|2|||
161466333|NCT01390220|583103387|FG001|Test Dose Phase|Noncompliance|0|||
161466334|NCT01390220|583103388|FG002|Test Dose Phase|Noncompliance|0|||
161466335|NCT01390220|583103386|FG000|Test Dose Phase|Logistical|6|||
161466336|NCT01390220|583103387|FG001|Test Dose Phase|Logistical|0|||
161466337|NCT01390220|583103388|FG002|Test Dose Phase|Logistical|0|||
161466338|NCT01390220|583103386|FG000|Comparative Phase|Withdrawal by Subject|0|||
161466339|NCT01390220|583103387|FG001|Comparative Phase|Withdrawal by Subject|1|||
161466340|NCT01390220|583103388|FG002|Comparative Phase|Withdrawal by Subject|0|||
161466341|NCT00249288|583103389|FG000|Overall Study|Lost to Follow-up|3|||
161810532|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
161810533|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
161810534|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
161466342|NCT00249288|583103390|FG001|Overall Study|Lost to Follow-up|3|||
161466343|NCT00249288|583103389|FG000|Overall Study|Withdrawal by Subject|2|||
161466344|NCT00249288|583103390|FG001|Overall Study|Withdrawal by Subject|2|||
161466345|NCT00136604|583103391|FG000|Overall Study|Lost to Follow-up|1|||
161466346|NCT00136604|583103392|FG001|Overall Study|Lost to Follow-up|0|||
161466347|NCT00136604|583103393|FG002|Overall Study|Lost to Follow-up|0|||
161466348|NCT00136604|583103394|FG003|Overall Study|Lost to Follow-up|0|||
161466349|NCT00136604|583103395|FG004|Overall Study|Lost to Follow-up|1|||
161466350|NCT00136604|583103391|FG000|Overall Study|Migrated/moved from study area|0|||
161466351|NCT00136604|583103392|FG001|Overall Study|Migrated/moved from study area|1|||
161466352|NCT00136604|583103393|FG002|Overall Study|Migrated/moved from study area|0|||
161466353|NCT00136604|583103394|FG003|Overall Study|Migrated/moved from study area|0|||
161466354|NCT00136604|583103395|FG004|Overall Study|Migrated/moved from study area|0|||
161466355|NCT01437878|583103396|FG000|Overall Study|Withdrawal by Subject|1|||
161466356|NCT01437878|583103397|FG001|Overall Study|Withdrawal by Subject|0|||
161466357|NCT01476644|583103404|FG000|Overall Study|Death|5|||
161466358|NCT01476644|583103404|FG000|Overall Study|moved to another state|2|||
161466359|NCT01476644|583103404|FG000|Overall Study|Lost to Follow-up|19|||
161466360|NCT01476644|583103404|FG000|Overall Study|Withdrawal by Subject|13|||
161466361|NCT00471146|583103406|FG000|Overall Study|Adverse Event|32|||
161466362|NCT00471146|583103407|FG001|Overall Study|Adverse Event|33|||
161466363|NCT00471146|583103406|FG000|Overall Study|Withdrawal by Subject|14|||
161466364|NCT00471146|583103407|FG001|Overall Study|Withdrawal by Subject|11|||
161466365|NCT00471146|583103406|FG000|Overall Study|Death|11|||
161466366|NCT00471146|583103407|FG001|Overall Study|Death|12|||
161466367|NCT00471146|583103406|FG000|Overall Study|Lost to Follow-up|4|||
161466368|NCT00471146|583103407|FG001|Overall Study|Lost to Follow-up|2|||
161466369|NCT00471146|583103406|FG000|Overall Study|Protocol Violation|2|||
161466370|NCT00471146|583103407|FG001|Overall Study|Protocol Violation|2|||
161466371|NCT00471146|583103406|FG000|Overall Study|Objective progression or relapse|84|||
161466372|NCT00471146|583103407|FG001|Overall Study|Objective progression or relapse|87|||
161466373|NCT00471146|583103406|FG000|Overall Study|Global deterioration of health status|12|||
161466374|NCT00471146|583103407|FG001|Overall Study|Global deterioration of health status|14|||
161466375|NCT00471146|583103406|FG000|Overall Study|Randomized but not treated|9|||
161466376|NCT00471146|583103407|FG001|Overall Study|Randomized but not treated|8|||
161466377|NCT00471146|583103406|FG000|Overall Study|Other|4|||
161466378|NCT00471146|583103407|FG001|Overall Study|Other|5|||
161466379|NCT00467610|583103410|FG000|Overall Study|Withdrawal by Subject|1|||
161466380|NCT02676466|583103411|FG000|Overall Study|Death|0|||
161466381|NCT02676466|583103412|FG001|Overall Study|Death|2|||
161466382|NCT02676466|583103413|FG002|Overall Study|Death|1|||
161466383|NCT02676466|583103414|FG003|Overall Study|Death|0|||
161466384|NCT02676466|583103415|FG004|Overall Study|Death|0|||
161466385|NCT02676466|583103416|FG005|Overall Study|Death|0|||
161810535|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Death|0|||
161810536|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Death|0|||
161466386|NCT02676466|583103417|FG006|Overall Study|Death|0|||
161466387|NCT02676466|583103418|FG007|Overall Study|Death|0|||
161466388|NCT02676466|583103411|FG000|Overall Study|Withdrawal by Subject|4|||
161466389|NCT02676466|583103412|FG001|Overall Study|Withdrawal by Subject|3|||
161466390|NCT02676466|583103413|FG002|Overall Study|Withdrawal by Subject|1|||
161466391|NCT02676466|583103414|FG003|Overall Study|Withdrawal by Subject|0|||
161466392|NCT02676466|583103415|FG004|Overall Study|Withdrawal by Subject|3|||
161466393|NCT02676466|583103416|FG005|Overall Study|Withdrawal by Subject|1|||
161466394|NCT02676466|583103417|FG006|Overall Study|Withdrawal by Subject|1|||
161466395|NCT02676466|583103418|FG007|Overall Study|Withdrawal by Subject|1|||
161466396|NCT01460368|583103420|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161914892|NCT00855582|584737314|FG000|Overall Study|Entry Criteria Not Met|8|||
161914893|NCT00855582|584737315|FG001|Overall Study|Entry Criteria Not Met|6|||
161914894|NCT00855582|584737316|FG002|Overall Study|Entry Criteria Not Met|3|||
161466397|NCT01460368|583103421|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161466398|NCT01460368|583103422|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161466399|NCT01460368|583103423|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161466400|NCT01460368|583103424|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
161466401|NCT01460368|583103425|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161466402|NCT01460368|583103426|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161466403|NCT01460368|583103420|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
161466404|NCT01460368|583103421|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
161466405|NCT01460368|583103422|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
161466406|NCT01460368|583103423|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
161466407|NCT01460368|583103424|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
161466408|NCT01460368|583103425|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
161466409|NCT01460368|583103426|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
161466410|NCT01460368|583103420|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
161466411|NCT01460368|583103421|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
161466412|NCT01460368|583103422|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
161466413|NCT01460368|583103423|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
161466414|NCT01460368|583103424|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
161466415|NCT01460368|583103425|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
161466416|NCT01460368|583103426|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
161466417|NCT01460368|583103420|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
161466418|NCT01460368|583103421|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
161466419|NCT01460368|583103422|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
161466420|NCT01460368|583103423|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
161466421|NCT01460368|583103424|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
161466422|NCT01460368|583103425|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
161466423|NCT01460368|583103426|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
161466424|NCT01460368|583103420|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
161466425|NCT01460368|583103421|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
161466426|NCT01460368|583103422|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
161466427|NCT01460368|583103423|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
161466428|NCT01460368|583103424|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
161466429|NCT01460368|583103425|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
161466430|NCT01460368|583103426|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
161466431|NCT02001181|583103429|FG000|Overall Study|Adverse Event|0|||
161466432|NCT02001181|583103430|FG001|Overall Study|Adverse Event|2|||
161466433|NCT02001181|583103429|FG000|Overall Study|Lost to Follow-up|1|||
161466434|NCT02001181|583103430|FG001|Overall Study|Lost to Follow-up|0|||
161466435|NCT02001181|583103429|FG000|Overall Study|Withdrawal by Subject|0|||
161466436|NCT02001181|583103430|FG001|Overall Study|Withdrawal by Subject|1|||
161466437|NCT01090973|583103431|FG000|Overall Study|Disease progression|1|||
161466438|NCT00445978|583103433|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
161466439|NCT00445978|583103433|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
161466440|NCT00445978|583103433|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
161466441|NCT00445978|583103433|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
161466442|NCT00445978|583103433|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
161466443|NCT00445978|583103433|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
161466444|NCT00445978|583103433|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
161466445|NCT00445978|583103433|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
161466446|NCT00445978|583103433|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
161466447|NCT00739596|583103434|FG000|Overall Study|Adverse Event|12|||
161466448|NCT00739596|583103435|FG001|Overall Study|Adverse Event|6|||
161466449|NCT00739596|583103434|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161466450|NCT00739596|583103435|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161466451|NCT00739596|583103434|FG000|Overall Study|Patient Withdrew Consent|8|||
161466452|NCT00739596|583103435|FG001|Overall Study|Patient Withdrew Consent|8|||
161466453|NCT00739596|583103434|FG000|Overall Study|Lost to Follow-up|0|||
161466454|NCT00739596|583103435|FG001|Overall Study|Lost to Follow-up|2|||
161466455|NCT00739596|583103434|FG000|Overall Study|Protocol Deviation|1|||
161466456|NCT00739596|583103435|FG001|Overall Study|Protocol Deviation|1|||
161466457|NCT02520661|583103436|FG000|Overall Study|Lost to Follow-up|7|||
161466458|NCT02520661|583103437|FG001|Overall Study|Lost to Follow-up|3|||
161466459|NCT02520661|583103436|FG000|Overall Study|Admitted from ED|49|||
161466460|NCT02520661|583103437|FG001|Overall Study|Admitted from ED|48|||
161466461|NCT02520661|583103436|FG000|Overall Study|ED greater than 24 hours|29|||
161466462|NCT02520661|583103437|FG001|Overall Study|ED greater than 24 hours|38|||
161466463|NCT02520661|583103436|FG000|Overall Study|other ineligibility|14|||
161466464|NCT02520661|583103437|FG001|Overall Study|other ineligibility|22|||
161466465|NCT02520661|583103436|FG000|Overall Study|Withdrawal by Subject|7|||
161466466|NCT02520661|583103437|FG001|Overall Study|Withdrawal by Subject|16|||
161466467|NCT01414608|583103444|FG000|Overall Study|Ineligible|5|||
161466468|NCT01414608|583103445|FG001|Overall Study|Ineligible|2|||
161466469|NCT05108922|583104654|FG000|Overall Study|Adverse Event|2|||
161466470|NCT05108922|583104655|FG001|Overall Study|Adverse Event|3|||
161466471|NCT05108922|583104654|FG000|Overall Study|Lost to Follow-up|2|||
161466472|NCT05108922|583104655|FG001|Overall Study|Lost to Follow-up|1|||
161466473|NCT05108922|583104654|FG000|Overall Study|Inadvertent enrollment|0|||
161466474|NCT05108922|583104655|FG001|Overall Study|Inadvertent enrollment|1|||
161466475|NCT05108922|583104654|FG000|Overall Study|Physician Decision|2|||
161466476|NCT05108922|583104655|FG001|Overall Study|Physician Decision|3|||
161466477|NCT05108922|583104654|FG000|Overall Study|Protocol deviation|1|||
161466478|NCT05108922|583104655|FG001|Overall Study|Protocol deviation|0|||
161466479|NCT05108922|583104654|FG000|Overall Study|Screen failure|1|||
161466480|NCT05108922|583104655|FG001|Overall Study|Screen failure|0|||
161466481|NCT05108922|583104654|FG000|Overall Study|Withdrawal by Subject|11|||
161466482|NCT05108922|583104655|FG001|Overall Study|Withdrawal by Subject|8|||
161466483|NCT05036369|583104656|FG000|Overall Study|Run In non compliance|1|||
161466484|NCT05036369|583104657|FG001|Overall Study|Run In non compliance|2|||
161466485|NCT05036369|583104656|FG000|Overall Study|Change in eligibility criteria|0|||
161466486|NCT05036369|583104657|FG001|Overall Study|Change in eligibility criteria|1|||
161466487|NCT01846104|583104658|FG000|Overall Study|Withdrawal by Subject|1|||
161466488|NCT01854658|583104663|FG000|Overall Study|Protocol Violation|6|||
161466489|NCT01854658|583104664|FG001|Overall Study|Protocol Violation|2|||
161466490|NCT01854658|583104665|FG002|Overall Study|Protocol Violation|2|||
161466491|NCT01854658|583104666|FG003|Overall Study|Protocol Violation|1|||
161466492|NCT01854658|583104663|FG000|Overall Study|Physician Decision|7|||
161466493|NCT01854658|583104664|FG001|Overall Study|Physician Decision|5|||
161466494|NCT01854658|583104665|FG002|Overall Study|Physician Decision|2|||
161466495|NCT01854658|583104666|FG003|Overall Study|Physician Decision|4|||
161466496|NCT01854658|583104663|FG000|Overall Study|Lost to Follow-up|8|||
161466497|NCT01854658|583104664|FG001|Overall Study|Lost to Follow-up|9|||
161466498|NCT01854658|583104665|FG002|Overall Study|Lost to Follow-up|8|||
161466499|NCT01854658|583104666|FG003|Overall Study|Lost to Follow-up|4|||
161466500|NCT01854658|583104663|FG000|Overall Study|Withdrawal by Subject|28|||
161466501|NCT01854658|583104664|FG001|Overall Study|Withdrawal by Subject|21|||
161466502|NCT01854658|583104665|FG002|Overall Study|Withdrawal by Subject|29|||
161466503|NCT01854658|583104666|FG003|Overall Study|Withdrawal by Subject|15|||
161466504|NCT01854658|583104663|FG000|Overall Study|Protocol-specified criteria|15|||
161466505|NCT01854658|583104664|FG001|Overall Study|Protocol-specified criteria|15|||
161466506|NCT01854658|583104665|FG002|Overall Study|Protocol-specified criteria|10|||
161466507|NCT01854658|583104666|FG003|Overall Study|Protocol-specified criteria|7|||
161466508|NCT01854658|583104663|FG000|Overall Study|Lack of Efficacy|3|||
161466509|NCT01854658|583104664|FG001|Overall Study|Lack of Efficacy|8|||
161466510|NCT01854658|583104665|FG002|Overall Study|Lack of Efficacy|4|||
161466511|NCT01854658|583104666|FG003|Overall Study|Lack of Efficacy|7|||
161466512|NCT01854658|583104663|FG000|Overall Study|Adverse Event|21|||
161466513|NCT01854658|583104664|FG001|Overall Study|Adverse Event|14|||
161466514|NCT01854658|583104665|FG002|Overall Study|Adverse Event|23|||
161466515|NCT01854658|583104666|FG003|Overall Study|Adverse Event|19|||
161466516|NCT01854658|583104663|FG000|Overall Study|Administrative reasons|5|||
161466517|NCT01854658|583104664|FG001|Overall Study|Administrative reasons|1|||
161466518|NCT01854658|583104665|FG002|Overall Study|Administrative reasons|2|||
161466519|NCT01854658|583104666|FG003|Overall Study|Administrative reasons|2|||
161466520|NCT03906461|583104667|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
161466521|NCT03906461|583104667|FG000|Completed 12-month Follow-up|Missed Visit|6|||
161466522|NCT01795638|583104670|FG000|Overall Study|Death|0|||
161466523|NCT01795638|583104671|FG001|Overall Study|Death|3|||
161466524|NCT01795638|583104670|FG000|Overall Study|transferred to quaternary hospital|2|||
161466525|NCT01795638|583104671|FG001|Overall Study|transferred to quaternary hospital|3|||
161466526|NCT01795638|583104670|FG000|Overall Study|Protocol Violation|3|||
161466527|NCT01795638|583104671|FG001|Overall Study|Protocol Violation|0|||
161573758|NCT01184508|583486104|FG001|Overall Study|Protocol Violation|1|||
161573759|NCT01184508|583486103|FG000|Overall Study|Sponsor Decision|5|||
161466528|NCT01795638|583104670|FG000|Overall Study|discharged from hospital|7|||
161466529|NCT01795638|583104671|FG001|Overall Study|discharged from hospital|5|||
161466530|NCT01795638|583104670|FG000|Overall Study|Withdrawal by Subject|1|||
161466531|NCT01795638|583104671|FG001|Overall Study|Withdrawal by Subject|0|||
161466532|NCT00331864|583104680|FG000|Overall Study|Adverse Event|30|||
161466533|NCT00331864|583104681|FG001|Overall Study|Adverse Event|1|||
161466534|NCT00331864|583104680|FG000|Overall Study|Lack of Efficacy|4|||
161466535|NCT00331864|583104681|FG001|Overall Study|Lack of Efficacy|0|||
161466536|NCT00331864|583104680|FG000|Overall Study|Protocol Violation|3|||
161466537|NCT00331864|583104681|FG001|Overall Study|Protocol Violation|0|||
161466538|NCT00331864|583104680|FG000|Overall Study|Withdrawal by Subject|10|||
161466539|NCT00331864|583104681|FG001|Overall Study|Withdrawal by Subject|0|||
161466540|NCT00331864|583104680|FG000|Overall Study|Lost to Follow-up|4|||
161466541|NCT00331864|583104681|FG001|Overall Study|Lost to Follow-up|3|||
161466542|NCT00331864|583104680|FG000|Overall Study|Administrative Problems|1|||
161466543|NCT00331864|583104681|FG001|Overall Study|Administrative Problems|0|||
161466544|NCT00331864|583104680|FG000|Overall Study|Death|6|||
161466545|NCT00331864|583104681|FG001|Overall Study|Death|0|||
161466546|NCT00293215|583104683|FG000|Overall Study|Progressive disease|3|||
161466547|NCT00293215|583104684|FG001|Overall Study|Progressive disease|1|||
161466548|NCT00293215|583104683|FG000|Overall Study|Adverse Event|2|||
161466549|NCT00293215|583104684|FG001|Overall Study|Adverse Event|2|||
161466550|NCT01409434|583104685|FG000|Overall Study|Protocol Violation|4|||
161466551|NCT02213042|583104686|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
161466552|NCT02213042|583104687|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
161466553|NCT02213042|583104688|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
161466554|NCT02213042|583104686|FG000|Overall Study|Adverse Event|2|||
161466555|NCT02213042|583104687|FG001|Overall Study|Adverse Event|1|||
161466556|NCT02213042|583104688|FG002|Overall Study|Adverse Event|0|||
161466557|NCT02213042|583104686|FG000|Overall Study|Withdrawal by Subject|0|||
161466558|NCT02213042|583104687|FG001|Overall Study|Withdrawal by Subject|1|||
161466559|NCT02213042|583104688|FG002|Overall Study|Withdrawal by Subject|1|||
161466560|NCT02213042|583104686|FG000|Overall Study|Protocol Violation|1|||
161466561|NCT02213042|583104687|FG001|Overall Study|Protocol Violation|0|||
161466562|NCT02213042|583104688|FG002|Overall Study|Protocol Violation|0|||
161466563|NCT02213042|583104686|FG000|Overall Study|Investigator discretion|0|||
161466564|NCT02213042|583104687|FG001|Overall Study|Investigator discretion|0|||
161466565|NCT02213042|583104688|FG002|Overall Study|Investigator discretion|1|||
161466566|NCT02007512|583104689|FG000|Double Blind Treatment Period|Adverse Event|4|||
161466567|NCT02007512|583104690|FG001|Double Blind Treatment Period|Adverse Event|6|||
161466568|NCT02007512|583104691|FG002|Double Blind Treatment Period|Adverse Event|2|||
161466569|NCT02007512|583104692|FG003|Double Blind Treatment Period|Adverse Event|2|||
161466570|NCT02007512|583104689|FG000|Double Blind Treatment Period|Death|1|||
161466571|NCT02007512|583104690|FG001|Double Blind Treatment Period|Death|0|||
161466572|NCT02007512|583104691|FG002|Double Blind Treatment Period|Death|0|||
161466573|NCT02007512|583104692|FG003|Double Blind Treatment Period|Death|0|||
161466574|NCT02007512|583104689|FG000|Double Blind Treatment Period|Disease progression|51|||
161466575|NCT02007512|583104690|FG001|Double Blind Treatment Period|Disease progression|50|||
161466576|NCT02007512|583104691|FG002|Double Blind Treatment Period|Disease progression|57|||
161466577|NCT02007512|583104692|FG003|Double Blind Treatment Period|Disease progression|52|||
161466578|NCT02007512|583104689|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
161466579|NCT02007512|583104690|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
161466580|NCT02007512|583104691|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
161466581|NCT02007512|583104692|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
161466582|NCT02007512|583104689|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161466583|NCT02007512|583104690|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161466584|NCT02007512|583104691|FG002|Double Blind Treatment Period|Protocol Violation|0|||
161466585|NCT02007512|583104692|FG003|Double Blind Treatment Period|Protocol Violation|1|||
161466586|NCT02007512|583104689|FG000|Double Blind Treatment Period|Other|2|||
161466587|NCT02007512|583104690|FG001|Double Blind Treatment Period|Other|1|||
161466588|NCT02007512|583104691|FG002|Double Blind Treatment Period|Other|1|||
161466589|NCT02007512|583104692|FG003|Double Blind Treatment Period|Other|2|||
161466590|NCT02007512|583104689|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
161466591|NCT02007512|583104690|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
161466592|NCT02007512|583104691|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
161466593|NCT02007512|583104692|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
161466594|NCT02007512|583104689|FG000|Open Label Treatment Period|Adverse Event|1|||
161466595|NCT02007512|583104690|FG001|Open Label Treatment Period|Adverse Event|0|||
161466596|NCT02007512|583104691|FG002|Open Label Treatment Period|Adverse Event|0|||
161466597|NCT02007512|583104692|FG003|Open Label Treatment Period|Adverse Event|0|||
161466598|NCT02007512|583104689|FG000|Open Label Treatment Period|Other|1|||
161466599|NCT02007512|583104690|FG001|Open Label Treatment Period|Other|1|||
161466600|NCT02007512|583104691|FG002|Open Label Treatment Period|Other|0|||
161466601|NCT02007512|583104692|FG003|Open Label Treatment Period|Other|0|||
161466602|NCT02007512|583104689|FG000|Open Label Treatment Period|Disease progression|23|||
161466603|NCT02007512|583104690|FG001|Open Label Treatment Period|Disease progression|11|||
161466604|NCT02007512|583104691|FG002|Open Label Treatment Period|Disease progression|0|||
161466605|NCT02007512|583104692|FG003|Open Label Treatment Period|Disease progression|0|||
161466606|NCT01225887|583104698|FG000|Overall Study|Ineligible:required test not done|2|||
161466607|NCT01225887|583104698|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
161466608|NCT01225887|583104698|FG000|Overall Study|Ineligible:inadequate pathology|2|||
161466609|NCT04505540|583104701|FG000|Baseline|Protocol Violation|10|||
161466610|NCT04505540|583104701|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
161466611|NCT04505540|583104701|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
161466612|NCT04505540|583104701|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
161466613|NCT04505540|583104701|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
161466614|NCT04505540|583104701|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
161466615|NCT04505540|583104701|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
161466616|NCT04505540|583104701|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
161466617|NCT04505540|583104701|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
161466618|NCT04505540|583104701|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
161466619|NCT04505540|583104701|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
161466620|NCT04505540|583104701|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
161466621|NCT04505540|583104701|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
161466622|NCT01123850|583104708|FG000|Overall Study|Slow enrollment|45|||
161466623|NCT03180684|583104709|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
161466624|NCT03180684|583104710|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
161466625|NCT03180684|583104709|FG000|Overall Study|Physician Decision|1|||
161466626|NCT03180684|583104710|FG001|Overall Study|Physician Decision|0|||
161466627|NCT03180684|583104709|FG000|Overall Study|Lost to Follow-up|1|||
161466628|NCT03180684|583104710|FG001|Overall Study|Lost to Follow-up|0|||
161466629|NCT03180684|583104709|FG000|Overall Study|Progressive Disease|1|||
161810537|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Death|0|||
161810538|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Death|0|||
161466630|NCT03180684|583104710|FG001|Overall Study|Progressive Disease|0|||
161466631|NCT00857415|583104711|FG000|Overall Study|Image acquisition failure|2|||
161466632|NCT00857415|583104712|FG001|Overall Study|Image acquisition failure|0|||
161466633|NCT00857415|583104711|FG000|Overall Study|Invalid image or not imaged|3|||
161466634|NCT00857415|583104712|FG001|Overall Study|Invalid image or not imaged|0|||
161466635|NCT00857415|583104711|FG000|Overall Study|Subject still living at end of study|110|||
161466636|NCT00857415|583104712|FG001|Overall Study|Subject still living at end of study|0|||
161466637|NCT00857415|583104711|FG000|Overall Study|Deceased with no autopsy|2|||
161466638|NCT00857415|583104712|FG001|Overall Study|Deceased with no autopsy|0|||
161466639|NCT04508140|583104713|FG000|Overall Study|Adverse Event|2|||
161466640|NCT04508140|583104714|FG001|Overall Study|Adverse Event|2|||
161466641|NCT04508140|583104713|FG000|Overall Study|Withdrawal by Subject|0|||
161466642|NCT04508140|583104714|FG001|Overall Study|Withdrawal by Subject|2|||
161466643|NCT04508140|583104713|FG000|Overall Study|progressive disease|9|||
161466644|NCT04508140|583104714|FG001|Overall Study|progressive disease|3|||
161466645|NCT01822678|583104715|FG000|Overall Study|Withdrawal by Subject|5|||
161466646|NCT01822678|583104716|FG001|Overall Study|Withdrawal by Subject|4|||
161466647|NCT01822678|583104717|FG002|Overall Study|Withdrawal by Subject|4|||
161466648|NCT01822678|583104715|FG000|Overall Study|Adverse Event|4|||
161466649|NCT01822678|583104716|FG001|Overall Study|Adverse Event|3|||
161466650|NCT01822678|583104717|FG002|Overall Study|Adverse Event|1|||
161573760|NCT01184508|583486104|FG001|Overall Study|Sponsor Decision|2|||
161573761|NCT01184508|583486103|FG000|Overall Study|Withdrawal by Subject|1|||
161573762|NCT01184508|583486104|FG001|Overall Study|Withdrawal by Subject|3|||
161573763|NCT01184508|583486103|FG000|Overall Study|Randomized, Not Treated|0|||
161573764|NCT01184508|583486104|FG001|Overall Study|Randomized, Not Treated|1|||
161573765|NCT00790790|583486112|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
161573766|NCT00790790|583486113|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
161573767|NCT00790790|583486114|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
161573768|NCT00790790|583486112|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
161573769|NCT00790790|583486113|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
161573770|NCT00790790|583486114|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
161573771|NCT00790790|583486112|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
161573772|NCT00790790|583486113|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
161573773|NCT00790790|583486114|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
161573774|NCT00790790|583486112|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
161573775|NCT00790790|583486113|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161573776|NCT00790790|583486114|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
161810539|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Death|0|||
161810540|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Death|1|||
161810541|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161810542|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161810543|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161466651|NCT01822678|583104715|FG000|Overall Study|Lack of Efficacy|3|||
161466652|NCT01822678|583104716|FG001|Overall Study|Lack of Efficacy|6|||
161466653|NCT01822678|583104717|FG002|Overall Study|Lack of Efficacy|5|||
161466654|NCT01822678|583104715|FG000|Overall Study|Lost to Follow-up|0|||
161466655|NCT01822678|583104716|FG001|Overall Study|Lost to Follow-up|2|||
161466656|NCT01822678|583104717|FG002|Overall Study|Lost to Follow-up|1|||
161466657|NCT02456103|583104718|FG000|Overall Study|Study Closure|207|||
161466658|NCT02456103|583104718|FG000|Overall Study|Physician Decision|1|||
161573777|NCT00790790|583486112|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
161573778|NCT00790790|583486113|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
161573779|NCT00790790|583486114|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
161573780|NCT02969863|583486115|FG000|Overall Study|Physician Decision|1|||
161573781|NCT02969863|583486116|FG001|Overall Study|Physician Decision|0|||
161573782|NCT02969863|583486117|FG002|Overall Study|Physician Decision|0|||
161573783|NCT02969863|583486118|FG003|Overall Study|Physician Decision|0|||
161573784|NCT02969863|583486119|FG004|Overall Study|Physician Decision|0|||
161573785|NCT02969863|583486120|FG005|Overall Study|Physician Decision|0|||
161573786|NCT02194933|583486122|FG000|Overall Study|Lost to Follow-up|1|||
161573787|NCT02194933|583486123|FG001|Overall Study|Lost to Follow-up|2|||
161573788|NCT02194933|583486122|FG000|Overall Study|Participant met withdrawal criteria|1|||
161573789|NCT02194933|583486123|FG001|Overall Study|Participant met withdrawal criteria|3|||
161573790|NCT02194933|583486122|FG000|Overall Study|Withdrawal by Subject|0|||
161573791|NCT02194933|583486123|FG001|Overall Study|Withdrawal by Subject|2|||
161573792|NCT02194933|583486122|FG000|Overall Study|Lack of Efficacy|1|||
161573793|NCT02194933|583486123|FG001|Overall Study|Lack of Efficacy|2|||
161573794|NCT00756730|583486126|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
161573795|NCT00756730|583486127|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
161573796|NCT00756730|583486126|FG000|Overall Study|persistent low-level viremmia|0|||
161466659|NCT02456103|583104718|FG000|Overall Study|Required prohibited medications|5|||
161466660|NCT02456103|583104718|FG000|Overall Study|Protocol Violation|1|||
161466661|NCT02456103|583104718|FG000|Overall Study|Adverse Event|5|||
161466662|NCT02456103|583104718|FG000|Overall Study|Abnormal Laboratory Value|2|||
161466663|NCT02456103|583104718|FG000|Overall Study|Lost to Follow-up|1|||
161466664|NCT02456103|583104718|FG000|Overall Study|Withdrawal by Subject|24|||
161466665|NCT03059446|583104719|FG000|Overall Study|Adverse Event|11|||
161466666|NCT03059446|583104719|FG000|Overall Study|Withdrawal of Consent|16|||
161466667|NCT03059446|583104719|FG000|Overall Study|Lost to Follow-up|3|||
161573797|NCT00756730|583486127|FG001|Overall Study|persistent low-level viremmia|1|||
161573798|NCT05382104|583486131|FG000|Period 2 (2 Days)|Adverse Event|0|||
161573799|NCT05382104|583486132|FG001|Period 2 (2 Days)|Adverse Event|1|||
161573800|NCT05382104|583486133|FG002|Period 2 (2 Days)|Adverse Event|0|||
161573801|NCT05382104|583486134|FG003|Period 2 (2 Days)|Adverse Event|0|||
161573802|NCT05382104|583486135|FG004|Period 2 (2 Days)|Adverse Event|0|||
161573803|NCT05382104|583486136|FG005|Period 2 (2 Days)|Adverse Event|0|||
161573804|NCT02807493|583486138|FG000|Overall Study|Adverse Event|5|||
161573805|NCT02807493|583486139|FG001|Overall Study|Adverse Event|2|||
161573806|NCT02807493|583486138|FG000|Overall Study|Lost to Follow-up|6|||
161573807|NCT02807493|583486139|FG001|Overall Study|Lost to Follow-up|0|||
161573808|NCT02807493|583486138|FG000|Overall Study|Physician Decision|4|||
161573809|NCT02807493|583486139|FG001|Overall Study|Physician Decision|1|||
161573810|NCT02807493|583486138|FG000|Overall Study|Protocol Violation|7|||
161573811|NCT02807493|583486139|FG001|Overall Study|Protocol Violation|0|||
161573812|NCT02807493|583486138|FG000|Overall Study|Withdrawal by Subject|17|||
161573813|NCT02807493|583486139|FG001|Overall Study|Withdrawal by Subject|10|||
161573814|NCT02807493|583486138|FG000|Overall Study|Other withdrawal|17|||
161573815|NCT02807493|583486139|FG001|Overall Study|Other withdrawal|0|||
161573816|NCT02807493|583486138|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
161573817|NCT02807493|583486139|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
161573818|NCT01493778|583486140|FG000|Overall Study|Withdrawal by Subject|8|||
161573819|NCT05190419|583486141|FG000|Overall Study|Lack of Efficacy|8|||
161573820|NCT05190419|583486142|FG001|Overall Study|Lack of Efficacy|0|||
161573821|NCT05190419|583486143|FG002|Overall Study|Lack of Efficacy|1|||
161573822|NCT05190419|583486144|FG003|Overall Study|Lack of Efficacy|0|||
161573823|NCT05190419|583486141|FG000|Overall Study|Withdrawal by Subject|7|||
161573824|NCT05190419|583486142|FG001|Overall Study|Withdrawal by Subject|1|||
161573825|NCT05190419|583486143|FG002|Overall Study|Withdrawal by Subject|2|||
161573826|NCT05190419|583486144|FG003|Overall Study|Withdrawal by Subject|2|||
161573827|NCT05190419|583486141|FG000|Overall Study|Adverse Event|2|||
161573828|NCT05190419|583486142|FG001|Overall Study|Adverse Event|10|||
161573829|NCT05190419|583486143|FG002|Overall Study|Adverse Event|11|||
161573830|NCT05190419|583486144|FG003|Overall Study|Adverse Event|21|||
161573831|NCT05190419|583486141|FG000|Overall Study|Lost to Follow-up|1|||
161573832|NCT05190419|583486142|FG001|Overall Study|Lost to Follow-up|2|||
161573833|NCT05190419|583486143|FG002|Overall Study|Lost to Follow-up|3|||
161573834|NCT05190419|583486144|FG003|Overall Study|Lost to Follow-up|1|||
161573835|NCT05190419|583486141|FG000|Overall Study|Other|1|||
161573836|NCT05190419|583486142|FG001|Overall Study|Other|1|||
161573837|NCT05190419|583486143|FG002|Overall Study|Other|0|||
161466668|NCT03059446|583104719|FG000|Overall Study|Protocol Violation|1|||
161466669|NCT03059446|583104719|FG000|Overall Study|Study Terminated by Sponsor|131|||
161466670|NCT03059446|583104719|FG000|Overall Study|Reason not Specified|5|||
161573838|NCT05190419|583486144|FG003|Overall Study|Other|3|||
161573839|NCT01227707|583486145|FG000|Overall Study|Adverse Event|10|||
161573840|NCT01227707|583486145|FG000|Overall Study|Progression of disease|3|||
161573841|NCT01227707|583486145|FG000|Overall Study|Withdrawal by Subject|1|||
161573842|NCT01227707|583486145|FG000|Overall Study|Patient non-compliance|3|||
161466671|NCT02448810|583104720|FG000|Overall Study|Adverse Event|0|||
161466672|NCT02448810|583104721|FG001|Overall Study|Adverse Event|0|||
161466673|NCT02448810|583104722|FG002|Overall Study|Adverse Event|1|||
161466674|NCT02448810|583104723|FG003|Overall Study|Adverse Event|0|||
161466675|NCT02448810|583104724|FG004|Overall Study|Adverse Event|0|||
161466676|NCT02448810|583104725|FG005|Overall Study|Adverse Event|0|||
161466677|NCT02448810|583104726|FG006|Overall Study|Adverse Event|0|||
161466678|NCT02448810|583104727|FG007|Overall Study|Adverse Event|0|||
161466679|NCT02448810|583104720|FG000|Overall Study|Withdrawal by Subject|0|||
161573843|NCT01227707|583486145|FG000|Overall Study|Medical decision|6|||
161573844|NCT01227707|583486145|FG000|Overall Study|Death|1|||
161573845|NCT03210402|583486146|FG000|Overall Study|Withdrawal by Subject|0|||
161573846|NCT03210402|583486147|FG001|Overall Study|Withdrawal by Subject|1|||
161573847|NCT00811057|583486148|FG000|Overall Study|Protocol Violation|5|||
161573848|NCT00811057|583486149|FG001|Overall Study|Protocol Violation|10|||
161573849|NCT00811057|583486150|FG002|Overall Study|Protocol Violation|10|||
161573850|NCT03215927|583487584|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
161573851|NCT03215927|583487585|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
161573852|NCT03215927|583487584|FG000|Open Label Extension|Adverse Event|1|||
161573853|NCT03215927|583487585|FG001|Open Label Extension|Adverse Event|0|||
161573854|NCT03215927|583487584|FG000|Open Label Extension|Lack of Efficacy|1|||
161573855|NCT03215927|583487585|FG001|Open Label Extension|Lack of Efficacy|0|||
161573856|NCT03215927|583487584|FG000|Open Label Extension|Death|0|||
161573857|NCT03215927|583487585|FG001|Open Label Extension|Death|1|||
161573858|NCT03779048|583487586|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
161573859|NCT03779048|583487587|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
161573860|NCT03779048|583487588|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
161573861|NCT03779048|583487586|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
161573862|NCT03779048|583487587|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
161573863|NCT03779048|583487588|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
161573864|NCT03779048|583487586|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
161573865|NCT03779048|583487587|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
161573866|NCT03779048|583487588|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
161573867|NCT05328297|583487589|FG000|Overall Study|Adverse Event|5|||
161573868|NCT05328297|583487590|FG001|Overall Study|Adverse Event|7|||
161573869|NCT05328297|583487589|FG000|Overall Study|Withdrawal by Subject|4|||
161573870|NCT05328297|583487590|FG001|Overall Study|Withdrawal by Subject|3|||
161573871|NCT05328297|583487589|FG000|Overall Study|Lack of Efficacy|1|||
161573872|NCT05328297|583487590|FG001|Overall Study|Lack of Efficacy|0|||
161573873|NCT05328297|583487589|FG000|Overall Study|Lost to Follow-up|1|||
161573874|NCT05328297|583487590|FG001|Overall Study|Lost to Follow-up|0|||
161573875|NCT05328297|583487589|FG000|Overall Study|Protocol Violation|1|||
161573876|NCT05328297|583487590|FG001|Overall Study|Protocol Violation|0|||
161573877|NCT05328297|583487589|FG000|Overall Study|Randomized but not treated|1|||
161573878|NCT05328297|583487590|FG001|Overall Study|Randomized but not treated|1|||
161573879|NCT01286272|583487591|FG000|Overall Study|Ineligible after beginning treatment|1|||
161573880|NCT01286272|583487592|FG001|Overall Study|Ineligible after beginning treatment|3|||
161573881|NCT03979365|583487595|FG000|Overall Study|Death|1|||
161573882|NCT03979365|583487596|FG001|Overall Study|Death|3|||
161573883|NCT03979365|583487595|FG000|Overall Study|Withdrawal by Subject|0|||
161573884|NCT03979365|583487596|FG001|Overall Study|Withdrawal by Subject|1|||
161573885|NCT03979365|583487595|FG000|Overall Study|Drug Conversion|0|||
161573886|NCT03979365|583487596|FG001|Overall Study|Drug Conversion|3|||
161466680|NCT02448810|583104721|FG001|Overall Study|Withdrawal by Subject|0|||
161810544|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161466681|NCT02448810|583104722|FG002|Overall Study|Withdrawal by Subject|1|||
161573903|NCT04496960|583487599|FG000|Overall Study|Physician Decision|0|||
161573904|NCT04496960|583487600|FG001|Overall Study|Physician Decision|1|||
161573905|NCT03175172|583487601|FG000|Overall Study|Death|3|||
161466682|NCT02448810|583104723|FG003|Overall Study|Withdrawal by Subject|0|||
161466683|NCT02448810|583104724|FG004|Overall Study|Withdrawal by Subject|3|||
161466684|NCT02448810|583104725|FG005|Overall Study|Withdrawal by Subject|5|||
161466685|NCT02448810|583104726|FG006|Overall Study|Withdrawal by Subject|0|||
161466686|NCT02448810|583104727|FG007|Overall Study|Withdrawal by Subject|2|||
161573906|NCT03175172|583487601|FG000|Overall Study|Withdrawal by Subject|3|||
161573907|NCT03175172|583487601|FG000|Overall Study|Lost to Follow-up|1|||
161573908|NCT03175172|583487601|FG000|Overall Study|Study Terminated by Sponsor|3|||
161573909|NCT00028769|583487606|FG000|Overall Study|Adverse Event|2|||
161573910|NCT00028769|583487606|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
161573911|NCT00028769|583487606|FG000|Overall Study|Progression or Death|31|||
161573912|NCT00028769|583487606|FG000|Overall Study|Other - Not Protocol Specified|1|||
161573913|NCT00028769|583487606|FG000|Overall Study|Ineligible|5|||
161573914|NCT00028769|583487606|FG000|Overall Study|Not Analyzable|1|||
161573915|NCT02496702|583487609|FG000|Overall Study|Lost to Follow-up|8|||
161573916|NCT02496702|583487610|FG001|Overall Study|Lost to Follow-up|6|||
161466687|NCT02448810|583104720|FG000|Overall Study|Other (study terminated by sponsor)|0|||
161466688|NCT02448810|583104721|FG001|Overall Study|Other (study terminated by sponsor)|0|||
161466689|NCT02448810|583104722|FG002|Overall Study|Other (study terminated by sponsor)|0|||
161466690|NCT02448810|583104723|FG003|Overall Study|Other (study terminated by sponsor)|0|||
161466691|NCT02448810|583104724|FG004|Overall Study|Other (study terminated by sponsor)|4|||
161466692|NCT02448810|583104725|FG005|Overall Study|Other (study terminated by sponsor)|2|||
161466693|NCT02448810|583104726|FG006|Overall Study|Other (study terminated by sponsor)|2|||
161466694|NCT02448810|583104727|FG007|Overall Study|Other (study terminated by sponsor)|1|||
161466695|NCT02448810|583104720|FG000|Overall Study|Death|1|||
161466696|NCT02448810|583104721|FG001|Overall Study|Death|0|||
161466697|NCT02448810|583104722|FG002|Overall Study|Death|1|||
161466698|NCT02448810|583104723|FG003|Overall Study|Death|0|||
161466699|NCT02448810|583104724|FG004|Overall Study|Death|1|||
161466700|NCT02448810|583104725|FG005|Overall Study|Death|0|||
161466701|NCT02448810|583104726|FG006|Overall Study|Death|0|||
161466702|NCT02448810|583104727|FG007|Overall Study|Death|0|||
161466703|NCT02448810|583104720|FG000|Overall Study|Other (Progressive disease)|2|||
161466704|NCT02448810|583104721|FG001|Overall Study|Other (Progressive disease)|2|||
161466705|NCT02448810|583104722|FG002|Overall Study|Other (Progressive disease)|0|||
161466706|NCT02448810|583104723|FG003|Overall Study|Other (Progressive disease)|3|||
161466707|NCT02448810|583104724|FG004|Overall Study|Other (Progressive disease)|23|||
161466708|NCT02448810|583104725|FG005|Overall Study|Other (Progressive disease)|9|||
161466709|NCT02448810|583104726|FG006|Overall Study|Other (Progressive disease)|14|||
161466710|NCT02448810|583104727|FG007|Overall Study|Other (Progressive disease)|5|||
161466711|NCT02448810|583104720|FG000|Overall Study|Lost to Follow-up|0|||
161466712|NCT02448810|583104721|FG001|Overall Study|Lost to Follow-up|1|||
161466713|NCT02448810|583104722|FG002|Overall Study|Lost to Follow-up|0|||
161466714|NCT02448810|583104723|FG003|Overall Study|Lost to Follow-up|0|||
161466715|NCT02448810|583104724|FG004|Overall Study|Lost to Follow-up|0|||
161466716|NCT02448810|583104725|FG005|Overall Study|Lost to Follow-up|0|||
161466717|NCT02448810|583104726|FG006|Overall Study|Lost to Follow-up|0|||
161466718|NCT02448810|583104727|FG007|Overall Study|Lost to Follow-up|0|||
161466719|NCT02448810|583104720|FG000|Overall Study|Other (unspecified)|0|||
161466720|NCT02448810|583104721|FG001|Overall Study|Other (unspecified)|0|||
161466721|NCT02448810|583104722|FG002|Overall Study|Other (unspecified)|0|||
161466722|NCT02448810|583104723|FG003|Overall Study|Other (unspecified)|0|||
161466723|NCT02448810|583104724|FG004|Overall Study|Other (unspecified)|0|||
161466724|NCT02448810|583104725|FG005|Overall Study|Other (unspecified)|0|||
161466725|NCT02448810|583104726|FG006|Overall Study|Other (unspecified)|2|||
161466726|NCT02448810|583104727|FG007|Overall Study|Other (unspecified)|0|||
161466727|NCT00470847|583104728|FG000|Overall Study|Pt still receiving treatment|1|||
161466728|NCT01369615|583104730|FG000|Overall Study|Withdrawal by Subject|0|||
161466729|NCT01369615|583104731|FG001|Overall Study|Withdrawal by Subject|1|||
161466730|NCT01369615|583104730|FG000|Overall Study|Lost to Follow-up|0|||
161466731|NCT01369615|583104731|FG001|Overall Study|Lost to Follow-up|1|||
161466732|NCT04263454|583104732|FG000|Overall Study|Adverse Event|0|||
161466733|NCT04263454|583104733|FG001|Overall Study|Adverse Event|2|||
161466734|NCT04263454|583104732|FG000|Overall Study|Physician Decision|3|||
161466735|NCT04263454|583104733|FG001|Overall Study|Physician Decision|5|||
161466736|NCT04263454|583104732|FG000|Overall Study|Poor Data Quality|0|||
161466737|NCT04263454|583104733|FG001|Overall Study|Poor Data Quality|1|||
161466738|NCT00986479|583104734|FG000|Period 1|Improved mood|1|||
161466739|NCT00986479|583104735|FG001|Period 1|Improved mood|0|||
161466740|NCT00986479|583104734|FG000|Period 1|Administrative reasons|1|||
161466741|NCT00986479|583104735|FG001|Period 1|Administrative reasons|0|||
161466742|NCT01721070|583104736|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
161466743|NCT02035475|583104737|FG000|Overall Study|Withdrawal by Subject|4|||
161466744|NCT02035475|583104737|FG000|Overall Study|Physician Decision|1|||
161466745|NCT02035475|583104737|FG000|Overall Study|Equipment Error|1|||
161466746|NCT01231347|583104738|FG000|Overall Study|Full Consent withdrawn|19|||
161466747|NCT01231347|583104739|FG001|Overall Study|Full Consent withdrawn|19|||
161573917|NCT02496702|583487609|FG000|Overall Study|Only partially tested|0|||
161914895|NCT00855582|584737314|FG000|Overall Study|Withdrawal by Subject|7|||
161914896|NCT00855582|584737315|FG001|Overall Study|Withdrawal by Subject|4|||
161914897|NCT00855582|584737316|FG002|Overall Study|Withdrawal by Subject|8|||
161914898|NCT02832037|584737320|FG000|Overall Study|Administrative reasons|0|||
161914899|NCT02832037|584737321|FG001|Overall Study|Administrative reasons|0|||
161914900|NCT02832037|584737322|FG002|Overall Study|Administrative reasons|1|||
161914901|NCT02832037|584737323|FG003|Overall Study|Administrative reasons|0|||
161914902|NCT02832037|584737324|FG004|Overall Study|Administrative reasons|0|||
161914903|NCT02832037|584737320|FG000|Overall Study|Protocol Violation|3|||
161914904|NCT02832037|584737321|FG001|Overall Study|Protocol Violation|0|||
161914905|NCT02832037|584737322|FG002|Overall Study|Protocol Violation|4|||
161914906|NCT02832037|584737323|FG003|Overall Study|Protocol Violation|1|||
161914907|NCT02832037|584737324|FG004|Overall Study|Protocol Violation|2|||
161914908|NCT02832037|584737320|FG000|Overall Study|Lost to Follow-up|2|||
161914909|NCT02832037|584737321|FG001|Overall Study|Lost to Follow-up|0|||
161914910|NCT02832037|584737322|FG002|Overall Study|Lost to Follow-up|3|||
161914911|NCT02832037|584737323|FG003|Overall Study|Lost to Follow-up|0|||
161914912|NCT02832037|584737324|FG004|Overall Study|Lost to Follow-up|5|||
161914913|NCT02832037|584737320|FG000|Overall Study|Withdrawal by Subject|9|||
161914914|NCT02832037|584737321|FG001|Overall Study|Withdrawal by Subject|8|||
161914915|NCT02832037|584737322|FG002|Overall Study|Withdrawal by Subject|0|||
161914916|NCT02832037|584737323|FG003|Overall Study|Withdrawal by Subject|4|||
161914917|NCT02832037|584737324|FG004|Overall Study|Withdrawal by Subject|8|||
161914918|NCT02832037|584737320|FG000|Overall Study|Adverse Event|5|||
161914919|NCT02832037|584737321|FG001|Overall Study|Adverse Event|4|||
161914920|NCT02832037|584737322|FG002|Overall Study|Adverse Event|0|||
161914921|NCT02832037|584737323|FG003|Overall Study|Adverse Event|2|||
161914922|NCT02832037|584737324|FG004|Overall Study|Adverse Event|4|||
161914923|NCT04727749|584737331|FG000|Overall Study|Lost to Follow-up|10|||
161914924|NCT04727749|584737332|FG001|Overall Study|Lost to Follow-up|3|||
161914925|NCT02378181|584737333|FG000|Overall Study|Lost to Follow-up|2|||
161914926|NCT02378181|584737334|FG001|Overall Study|Lost to Follow-up|5|||
161914927|NCT02378181|584737333|FG000|Overall Study|Withdrawal by Subject|1|||
161573918|NCT02496702|583487610|FG001|Overall Study|Only partially tested|2|||
161573919|NCT00941655|583487613|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
161573920|NCT00941655|583487614|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
161573921|NCT00941655|583487613|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
161573922|NCT00941655|583487614|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
161573923|NCT00941655|583487613|FG000|Overall Study|progressed while on chemo|0|||
161573924|NCT00941655|583487614|FG001|Overall Study|progressed while on chemo|2|||
161573925|NCT00941655|583487613|FG000|Overall Study|refused further treatment|0|||
161573926|NCT00941655|583487614|FG001|Overall Study|refused further treatment|1|||
161573927|NCT00941655|583487613|FG000|Overall Study|withdrew consent|0|||
161573928|NCT00941655|583487614|FG001|Overall Study|withdrew consent|1|||
161573929|NCT00941655|583487613|FG000|Overall Study|non-compliant|0|||
161573930|NCT00941655|583487614|FG001|Overall Study|non-compliant|1|||
161573931|NCT00446550|583487615|FG000|Overall Study|Adverse Event|1|||
161573932|NCT00446550|583487616|FG001|Overall Study|Adverse Event|0|||
161573933|NCT02983617|583487617|FG000|Overall Study|Adverse Event|0|||
161573934|NCT02983617|583487618|FG001|Overall Study|Adverse Event|7|||
161573935|NCT02983617|583487617|FG000|Overall Study|Death|0|||
161573936|NCT02983617|583487618|FG001|Overall Study|Death|1|||
161573937|NCT02983617|583487617|FG000|Overall Study|Investigator's Discretion|0|||
161573938|NCT02983617|583487618|FG001|Overall Study|Investigator's Discretion|1|||
161573939|NCT00002842|583487621|FG000|Overall Study|ineligible for surgical resection|27|||
161914928|NCT02378181|584737334|FG001|Overall Study|Withdrawal by Subject|1|||
161914929|NCT02378181|584737333|FG000|Overall Study|Incarcerated|0|||
161914930|NCT02378181|584737334|FG001|Overall Study|Incarcerated|1|||
161573940|NCT01613716|583487624|FG000|Overall Study|screen failures|3|||
161573941|NCT01613716|583487624|FG000|Overall Study|Lost to Follow-up|4|||
161573942|NCT02296424|583487627|FG000|Part 1|New therapy for study indication|0|||
161573943|NCT02296424|583487628|FG001|Part 1|New therapy for study indication|1|||
161573944|NCT02296424|583487629|FG002|Part 1|New therapy for study indication|0|||
161573945|NCT02296424|583487630|FG003|Part 1|New therapy for study indication|0|||
161573946|NCT02296424|583487627|FG000|Part 1|Protocol Violation|0|||
161573947|NCT02296424|583487628|FG001|Part 1|Protocol Violation|1|||
161573948|NCT02296424|583487629|FG002|Part 1|Protocol Violation|0|||
161573949|NCT02296424|583487630|FG003|Part 1|Protocol Violation|0|||
161914931|NCT00297167|584737335|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
161914932|NCT00297167|584737336|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
161914933|NCT00297167|584737337|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
161914934|NCT00297167|584737335|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
161573950|NCT02296424|583487627|FG000|Part 1|Withdrawal by Subject|0|||
161573951|NCT02296424|583487628|FG001|Part 1|Withdrawal by Subject|2|||
161466748|NCT01231347|583104740|FG002|Overall Study|Full Consent withdrawn|11|||
161466749|NCT01231347|583104738|FG000|Overall Study|Lost to Follow-up|4|||
161466750|NCT01231347|583104739|FG001|Overall Study|Lost to Follow-up|2|||
161466751|NCT01231347|583104740|FG002|Overall Study|Lost to Follow-up|2|||
161466752|NCT01231347|583104738|FG000|Overall Study|Death|202|||
161466753|NCT01231347|583104739|FG001|Overall Study|Death|210|||
161466754|NCT01231347|583104740|FG002|Overall Study|Death|101|||
161466755|NCT01231347|583104738|FG000|Overall Study|other event|7|||
161466756|NCT01231347|583104739|FG001|Overall Study|other event|9|||
161466757|NCT01231347|583104740|FG002|Overall Study|other event|3|||
161466758|NCT02047227|583104741|FG000|Overall Study|Adverse Event|2|||
161466759|NCT02047227|583104742|FG001|Overall Study|Adverse Event|4|||
161466760|NCT02047227|583104741|FG000|Overall Study|Lost to Follow-up|0|||
161573952|NCT02296424|583487629|FG002|Part 1|Withdrawal by Subject|0|||
161573953|NCT02296424|583487630|FG003|Part 1|Withdrawal by Subject|0|||
161573954|NCT02296424|583487627|FG000|Part 1|Study terminated by sponsor|0|||
161573955|NCT02296424|583487628|FG001|Part 1|Study terminated by sponsor|1|||
161573956|NCT02296424|583487629|FG002|Part 1|Study terminated by sponsor|0|||
161573957|NCT02296424|583487630|FG003|Part 1|Study terminated by sponsor|0|||
161573958|NCT02296424|583487627|FG000|Part 1|Adverse Event|2|||
161573959|NCT02296424|583487628|FG001|Part 1|Adverse Event|11|||
161573960|NCT02296424|583487629|FG002|Part 1|Adverse Event|0|||
161573961|NCT02296424|583487630|FG003|Part 1|Adverse Event|0|||
161573962|NCT02296424|583487627|FG000|Part 1|Lack of Efficacy|5|||
161573963|NCT02296424|583487628|FG001|Part 1|Lack of Efficacy|17|||
161573964|NCT02296424|583487629|FG002|Part 1|Lack of Efficacy|0|||
161573965|NCT02296424|583487630|FG003|Part 1|Lack of Efficacy|0|||
161573966|NCT02296424|583487627|FG000|Part 1|16 directly started part II|16|||
161573967|NCT02296424|583487628|FG001|Part 1|16 directly started part II|0|||
161573968|NCT02296424|583487629|FG002|Part 1|16 directly started part II|0|||
161573969|NCT02296424|583487630|FG003|Part 1|16 directly started part II|0|||
161573970|NCT02296424|583487627|FG000|Part 2|Lack of Efficacy|0|||
161573971|NCT02296424|583487628|FG001|Part 2|Lack of Efficacy|0|||
161573972|NCT02296424|583487629|FG002|Part 2|Lack of Efficacy|1|||
161573973|NCT02296424|583487630|FG003|Part 2|Lack of Efficacy|0|||
161573974|NCT02296424|583487627|FG000|Part 2|Adverse Event|0|||
161573975|NCT02296424|583487628|FG001|Part 2|Adverse Event|0|||
161573976|NCT02296424|583487629|FG002|Part 2|Adverse Event|1|||
161573977|NCT02296424|583487630|FG003|Part 2|Adverse Event|0|||
161573978|NCT02296424|583487627|FG000|Part 2|Lost to Follow-up|0|||
161573979|NCT02296424|583487628|FG001|Part 2|Lost to Follow-up|0|||
161573980|NCT02296424|583487629|FG002|Part 2|Lost to Follow-up|1|||
161573981|NCT02296424|583487630|FG003|Part 2|Lost to Follow-up|0|||
161573982|NCT00743444|583487631|FG000|First Intervention|Catheter placement problems|0|||
161573983|NCT00743444|583487632|FG001|First Intervention|Catheter placement problems|1|||
161573984|NCT00743444|583487631|FG000|Washout Period|Adverse Event|0|||
161573985|NCT00743444|583487632|FG001|Washout Period|Adverse Event|1|||
161573986|NCT00486330|583487646|FG000|Overall Study|Adverse Event|2|||
161573987|NCT05641311|583487647|FG000|Dosing Period 1|Adverse Event|1|||
161573988|NCT05641311|583487648|FG001|Dosing Period 1|Adverse Event|0|||
161573989|NCT00909363|583487649|FG000|Overall Study|Withdrawal by Subject|1|||
161573990|NCT00909363|583487650|FG001|Overall Study|Withdrawal by Subject|0|||
161573991|NCT00909363|583487651|FG002|Overall Study|Withdrawal by Subject|0|||
161573992|NCT00909363|583487649|FG000|Overall Study|Lack of Efficacy|1|||
161573993|NCT00909363|583487650|FG001|Overall Study|Lack of Efficacy|0|||
161573994|NCT00909363|583487651|FG002|Overall Study|Lack of Efficacy|0|||
161573995|NCT03515304|583487658|FG000|Overall Study|Lost to Follow-up|0|||
161573996|NCT03515304|583487659|FG001|Overall Study|Lost to Follow-up|3|||
161573997|NCT02705586|583487662|FG000|Overall Study|Health Issues|2|||
161810545|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161810546|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
161810547|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161466761|NCT02047227|583104742|FG001|Overall Study|Lost to Follow-up|3|||
161573998|NCT02705586|583487662|FG000|Overall Study|Transportation Difficulties|5|||
161573999|NCT02705586|583487662|FG000|Overall Study|Vacation/Planned Absence|1|||
161574000|NCT02808338|583487663|FG000|Screening|Screen Failure|10|||
161574001|NCT02808338|583487663|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
161574002|NCT02808338|583487663|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
161574003|NCT00057837|583487664|FG000|Overall Study|Progression/relapse|12|||
161574004|NCT00057837|583487665|FG001|Overall Study|Progression/relapse|14|||
161574005|NCT00057837|583487664|FG000|Overall Study|Adverse Event|2|||
161574006|NCT00057837|583487665|FG001|Overall Study|Adverse Event|12|||
161574007|NCT00057837|583487664|FG000|Overall Study|Death|5|||
161574008|NCT00057837|583487665|FG001|Overall Study|Death|4|||
161466762|NCT02047227|583104741|FG000|Overall Study|Protocol Violation|1|||
161810548|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161810549|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161466763|NCT02047227|583104742|FG001|Overall Study|Protocol Violation|0|||
161574009|NCT00057837|583487664|FG000|Overall Study|Withdrawal by Subject|5|||
161574010|NCT00057837|583487665|FG001|Overall Study|Withdrawal by Subject|3|||
161574011|NCT00057837|583487664|FG000|Overall Study|Alternative therapy|0|||
161914935|NCT00297167|584737336|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
161914936|NCT00297167|584737337|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
161914937|NCT01180777|584737339|FG000|Overall Study|Protocol Violation|6|||
161914938|NCT01180777|584737339|FG000|Overall Study|Poor lens fit|4|||
161914939|NCT01180777|584737339|FG000|Overall Study|Lost to Follow-up|1|||
161914940|NCT01180777|584737339|FG000|Overall Study|Adverse Event|1|||
161914941|NCT04167462|584737340|FG000|Overall Study|Other reasons|3|||
161914942|NCT04167462|584737341|FG001|Overall Study|Other reasons|2|||
161914943|NCT04167462|584737340|FG000|Overall Study|Withdrawal by Subject|6|||
161914944|NCT04167462|584737341|FG001|Overall Study|Withdrawal by Subject|7|||
161914945|NCT04167462|584737340|FG000|Overall Study|Adverse Event|4|||
161914946|NCT04167462|584737341|FG001|Overall Study|Adverse Event|0|||
161914947|NCT04167462|584737340|FG000|Overall Study|Pregnancy|1|||
161914948|NCT04167462|584737341|FG001|Overall Study|Pregnancy|0|||
161914949|NCT04167462|584737340|FG000|Overall Study|Lack of Efficacy|0|||
161914950|NCT04167462|584737341|FG001|Overall Study|Lack of Efficacy|1|||
161914951|NCT02320396|584737342|FG000|Overall Study|Adverse Event|2|||
161466764|NCT02047227|583104741|FG000|Overall Study|Spontaneous pregnancy|1|||
161466765|NCT02047227|583104742|FG001|Overall Study|Spontaneous pregnancy|0|||
161466766|NCT02047227|583104741|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
161466767|NCT02047227|583104742|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
161466768|NCT02047227|583104741|FG000|Overall Study|No oocytes retrieved|21|||
161466769|NCT02047227|583104742|FG001|Overall Study|No oocytes retrieved|20|||
161466770|NCT02047227|583104741|FG000|Overall Study|No fertilization|61|||
161466771|NCT02047227|583104742|FG001|Overall Study|No fertilization|51|||
161466772|NCT02047227|583104741|FG000|Overall Study|Intention to freeze all embryos|1|||
161466773|NCT02047227|583104742|FG001|Overall Study|Intention to freeze all embryos|0|||
161466774|NCT02047227|583104741|FG000|Overall Study|All embryos discarded|12|||
161466775|NCT02047227|583104742|FG001|Overall Study|All embryos discarded|11|||
161466776|NCT02047227|583104741|FG000|Overall Study|Other|10|||
161466777|NCT02047227|583104742|FG001|Overall Study|Other|9|||
161466778|NCT01385371|583104755|FG000|Overall Study|Adverse Event|54|||
161466779|NCT01385371|583104756|FG001|Overall Study|Adverse Event|19|||
161466780|NCT01385371|583104755|FG000|Overall Study|Lost to Follow-up|16|||
161466781|NCT01385371|583104756|FG001|Overall Study|Lost to Follow-up|16|||
161466782|NCT01385371|583104755|FG000|Overall Study|Withdrawal by Subject|52|||
161466783|NCT01385371|583104756|FG001|Overall Study|Withdrawal by Subject|39|||
161466784|NCT01385371|583104755|FG000|Overall Study|Protocol Violation|25|||
161466785|NCT01385371|583104756|FG001|Overall Study|Protocol Violation|21|||
161466786|NCT01385371|583104755|FG000|Overall Study|Administrative|2|||
161466787|NCT01385371|583104756|FG001|Overall Study|Administrative|2|||
161466788|NCT03112590|583104765|FG000|Overall Study|Adverse Event|0|||
161466789|NCT03112590|583104766|FG001|Overall Study|Adverse Event|1|||
161466790|NCT03112590|583104767|FG002|Overall Study|Adverse Event|0|||
161466791|NCT02436681|583104768|FG000|Overall Study|Lost to Follow-up|10|||
161466792|NCT02436681|583104768|FG000|Overall Study|Withdrawal by Subject|2|||
161466793|NCT02436681|583104768|FG000|Overall Study|Death|2|||
161466794|NCT03635788|583104774|FG000|Step 1|Death|1|||
161466795|NCT03635788|583104775|FG001|Step 1|Death|0|||
161466796|NCT03635788|583104776|FG002|Step 1|Death|0|||
161466797|NCT03635788|583104774|FG000|Step 1|Lost to Follow-up|31|||
161466798|NCT03635788|583104775|FG001|Step 1|Lost to Follow-up|0|||
161466799|NCT03635788|583104776|FG002|Step 1|Lost to Follow-up|0|||
161466800|NCT03635788|583104774|FG000|Step 1|Pregnancy|1|||
161466801|NCT03635788|583104775|FG001|Step 1|Pregnancy|0|||
161466802|NCT03635788|583104776|FG002|Step 1|Pregnancy|0|||
161466803|NCT03635788|583104774|FG000|Step 1|Protocol Violation|8|||
161466804|NCT03635788|583104775|FG001|Step 1|Protocol Violation|0|||
161466805|NCT03635788|583104776|FG002|Step 1|Protocol Violation|0|||
161466806|NCT03635788|583104774|FG000|Step 1|Withdrawal by Subject|13|||
161466807|NCT03635788|583104775|FG001|Step 1|Withdrawal by Subject|0|||
161466808|NCT03635788|583104776|FG002|Step 1|Withdrawal by Subject|0|||
161466809|NCT03635788|583104774|FG000|Step 1|Other reasons|12|||
161466810|NCT03635788|583104775|FG001|Step 1|Other reasons|0|||
161466811|NCT03635788|583104776|FG002|Step 1|Other reasons|0|||
161466812|NCT03635788|583104774|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
161466813|NCT03635788|583104775|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
161466814|NCT03635788|583104776|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
161466815|NCT03635788|583104774|FG000|Step 2|Lost to Follow-up|0|||
161466816|NCT03635788|583104775|FG001|Step 2|Lost to Follow-up|8|||
161914952|NCT02320396|584737343|FG001|Overall Study|Adverse Event|2|||
161914953|NCT02320396|584737342|FG000|Overall Study|Pregnancy|0|||
161466817|NCT03635788|583104776|FG002|Step 2|Lost to Follow-up|15|||
161466818|NCT03635788|583104774|FG000|Step 2|Withdrawal by Subject|0|||
161466819|NCT03635788|583104775|FG001|Step 2|Withdrawal by Subject|6|||
161466820|NCT03635788|583104776|FG002|Step 2|Withdrawal by Subject|6|||
161466821|NCT03635788|583104774|FG000|Step 2|Death|0|||
161466822|NCT03635788|583104775|FG001|Step 2|Death|2|||
161466823|NCT03635788|583104776|FG002|Step 2|Death|0|||
161466824|NCT03635788|583104774|FG000|Step 2|Incarceration|0|||
161914954|NCT02320396|584737343|FG001|Overall Study|Pregnancy|1|||
161914955|NCT02320396|584737342|FG000|Overall Study|Protocol Violation|0|||
161466825|NCT03635788|583104775|FG001|Step 2|Incarceration|2|||
161466826|NCT03635788|583104776|FG002|Step 2|Incarceration|0|||
161574012|NCT00057837|583487665|FG001|Overall Study|Alternative therapy|1|||
161574013|NCT00057837|583487664|FG000|Overall Study|Other complicating disease|2|||
161574014|NCT00057837|583487665|FG001|Overall Study|Other complicating disease|1|||
161574015|NCT00057837|583487664|FG000|Overall Study|Physician Decision|1|||
161574016|NCT00057837|583487665|FG001|Overall Study|Physician Decision|0|||
161574017|NCT00057837|583487664|FG000|Overall Study|Ineligible|3|||
161574018|NCT00057837|583487665|FG001|Overall Study|Ineligible|3|||
161574019|NCT00057837|583487664|FG000|Overall Study|Never started treatment|1|||
161574020|NCT00057837|583487665|FG001|Overall Study|Never started treatment|1|||
161574021|NCT02000817|583487666|FG000|Overall Study|Withdrawal by Subject|2|||
161574022|NCT02000817|583487667|FG001|Overall Study|Withdrawal by Subject|0|||
161574023|NCT02000817|583487668|FG002|Overall Study|Withdrawal by Subject|0|||
161574024|NCT02000817|583487669|FG003|Overall Study|Withdrawal by Subject|0|||
161574025|NCT02000817|583487666|FG000|Overall Study|Adverse Event|0|||
161574026|NCT02000817|583487667|FG001|Overall Study|Adverse Event|1|||
161574027|NCT02000817|583487668|FG002|Overall Study|Adverse Event|0|||
161574028|NCT02000817|583487669|FG003|Overall Study|Adverse Event|0|||
161574029|NCT02000817|583487666|FG000|Overall Study|Lost to Follow-up|0|||
161574030|NCT02000817|583487667|FG001|Overall Study|Lost to Follow-up|0|||
161574031|NCT02000817|583487668|FG002|Overall Study|Lost to Follow-up|1|||
161574032|NCT02000817|583487669|FG003|Overall Study|Lost to Follow-up|0|||
161574033|NCT01317420|583487670|FG000|Overall Study|Progressive disease according to RECIST|2|||
161574034|NCT01317420|583487671|FG001|Overall Study|Progressive disease according to RECIST|3|||
161574035|NCT01317420|583487672|FG002|Overall Study|Progressive disease according to RECIST|3|||
161574036|NCT01317420|583487673|FG003|Overall Study|Progressive disease according to RECIST|3|||
161574037|NCT01317420|583487674|FG004|Overall Study|Progressive disease according to RECIST|3|||
161466827|NCT03635788|583104774|FG000|Step 2|Non-Compliance With Study Requirements|0|||
161466828|NCT03635788|583104775|FG001|Step 2|Non-Compliance With Study Requirements|1|||
161466829|NCT03635788|583104776|FG002|Step 2|Non-Compliance With Study Requirements|1|||
161466830|NCT03635788|583104774|FG000|Step 2|Confounding Medical Condition|0|||
161574038|NCT01317420|583487675|FG005|Overall Study|Progressive disease according to RECIST|3|||
161574039|NCT01317420|583487676|FG006|Overall Study|Progressive disease according to RECIST|3|||
161574040|NCT01317420|583487677|FG007|Overall Study|Progressive disease according to RECIST|3|||
161574041|NCT01317420|583487678|FG008|Overall Study|Progressive disease according to RECIST|3|||
161574042|NCT01317420|583487679|FG009|Overall Study|Progressive disease according to RECIST|2|||
161574043|NCT01317420|583487680|FG010|Overall Study|Progressive disease according to RECIST|3|||
161574044|NCT01317420|583487681|FG011|Overall Study|Progressive disease according to RECIST|11|||
161574045|NCT01317420|583487682|FG012|Overall Study|Progressive disease according to RECIST|16|||
161574046|NCT01317420|583487670|FG000|Overall Study|Other adverse event|1|||
161574047|NCT01317420|583487671|FG001|Overall Study|Other adverse event|0|||
161574048|NCT01317420|583487672|FG002|Overall Study|Other adverse event|0|||
161574049|NCT01317420|583487673|FG003|Overall Study|Other adverse event|0|||
161574050|NCT01317420|583487674|FG004|Overall Study|Other adverse event|0|||
161574051|NCT01317420|583487675|FG005|Overall Study|Other adverse event|0|||
161574052|NCT01317420|583487676|FG006|Overall Study|Other adverse event|0|||
161574053|NCT01317420|583487677|FG007|Overall Study|Other adverse event|0|||
161574054|NCT01317420|583487678|FG008|Overall Study|Other adverse event|0|||
161574055|NCT01317420|583487679|FG009|Overall Study|Other adverse event|0|||
161574056|NCT01317420|583487680|FG010|Overall Study|Other adverse event|0|||
161574057|NCT01317420|583487681|FG011|Overall Study|Other adverse event|0|||
161574058|NCT01317420|583487682|FG012|Overall Study|Other adverse event|2|||
161914956|NCT02320396|584737343|FG001|Overall Study|Protocol Violation|1|||
161914957|NCT02320396|584737342|FG000|Overall Study|Withdrawal by Subject|2|||
161914958|NCT02320396|584737343|FG001|Overall Study|Withdrawal by Subject|0|||
161466831|NCT03635788|583104775|FG001|Step 2|Confounding Medical Condition|0|||
161466832|NCT03635788|583104776|FG002|Step 2|Confounding Medical Condition|1|||
161466833|NCT03635788|583104774|FG000|Step 2|Out Of State With No Plan To Return|0|||
161466834|NCT03635788|583104775|FG001|Step 2|Out Of State With No Plan To Return|1|||
161466835|NCT03635788|583104776|FG002|Step 2|Out Of State With No Plan To Return|0|||
161466836|NCT03635788|583104774|FG000|Step 2|Switched To Injectables|0|||
161466837|NCT03635788|583104775|FG001|Step 2|Switched To Injectables|0|||
161466838|NCT03635788|583104776|FG002|Step 2|Switched To Injectables|1|||
161466839|NCT03635788|583104774|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
161466840|NCT03635788|583104775|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
161466841|NCT03635788|583104776|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
161466842|NCT04571515|583104780|FG000|Overall Study|Physician Decision|0|||
161466843|NCT04571515|583104781|FG001|Overall Study|Physician Decision|0|||
161466844|NCT04571515|583104782|FG002|Overall Study|Physician Decision|0|||
161466845|NCT04571515|583104783|FG003|Overall Study|Physician Decision|0|||
161466846|NCT04571515|583104784|FG004|Overall Study|Physician Decision|1|||
161574059|NCT01317420|583487670|FG000|Overall Study|Non-compliant with protocol|0|||
161574060|NCT01317420|583487671|FG001|Overall Study|Non-compliant with protocol|0|||
161466847|NCT04571515|583104780|FG000|Overall Study|Withdrawal by Subject|0|||
161466848|NCT04571515|583104781|FG001|Overall Study|Withdrawal by Subject|0|||
161466849|NCT04571515|583104782|FG002|Overall Study|Withdrawal by Subject|0|||
161466850|NCT04571515|583104783|FG003|Overall Study|Withdrawal by Subject|0|||
161466851|NCT04571515|583104784|FG004|Overall Study|Withdrawal by Subject|1|||
161466852|NCT04571515|583104780|FG000|Overall Study|insufficient pain|1|||
161466853|NCT04571515|583104781|FG001|Overall Study|insufficient pain|0|||
161466854|NCT04571515|583104782|FG002|Overall Study|insufficient pain|0|||
161466855|NCT04571515|583104783|FG003|Overall Study|insufficient pain|0|||
161466856|NCT04571515|583104784|FG004|Overall Study|insufficient pain|1|||
161466857|NCT03148275|583104787|FG000|Overall Study|Death|6|||
161466858|NCT03148275|583104787|FG000|Overall Study|Adverse Event|3|||
161466859|NCT03148275|583104787|FG000|Overall Study|Liver transplant|2|||
161466860|NCT03148275|583104787|FG000|Overall Study|Patient decision|5|||
161466861|NCT03148275|583104787|FG000|Overall Study|transition to commercial drug|1|||
161466862|NCT03148275|583104787|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
161466863|NCT05098938|583104788|FG000|Overall Study|Adverse Event|4|||
161466864|NCT05098938|583104789|FG001|Overall Study|Adverse Event|3|||
161466865|NCT05098938|583104788|FG000|Overall Study|inclusion/exclusion criteria change|11|||
161466866|NCT05098938|583104789|FG001|Overall Study|inclusion/exclusion criteria change|5|||
161466867|NCT05098938|583104788|FG000|Overall Study|lack of compliance|26|||
161466868|NCT05098938|583104789|FG001|Overall Study|lack of compliance|19|||
161466869|NCT05098938|583104788|FG000|Overall Study|Lost to Follow-up|37|||
161466870|NCT05098938|583104789|FG001|Overall Study|Lost to Follow-up|40|||
161466871|NCT05098938|583104788|FG000|Overall Study|Lost in treatment period|17|||
161466872|NCT05098938|583104789|FG001|Overall Study|Lost in treatment period|13|||
161466873|NCT05098938|583104788|FG000|Overall Study|Met an exclusion criterion|0|||
161466874|NCT05098938|583104789|FG001|Overall Study|Met an exclusion criterion|3|||
161574061|NCT01317420|583487672|FG002|Overall Study|Non-compliant with protocol|0|||
161466875|NCT05098938|583104788|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
161574062|NCT01317420|583487673|FG003|Overall Study|Non-compliant with protocol|0|||
161574063|NCT01317420|583487674|FG004|Overall Study|Non-compliant with protocol|0|||
161574064|NCT01317420|583487675|FG005|Overall Study|Non-compliant with protocol|0|||
161574065|NCT01317420|583487676|FG006|Overall Study|Non-compliant with protocol|0|||
161574066|NCT01317420|583487677|FG007|Overall Study|Non-compliant with protocol|0|||
161574067|NCT01317420|583487678|FG008|Overall Study|Non-compliant with protocol|0|||
161574068|NCT01317420|583487679|FG009|Overall Study|Non-compliant with protocol|0|||
161574069|NCT01317420|583487680|FG010|Overall Study|Non-compliant with protocol|0|||
161574070|NCT01317420|583487681|FG011|Overall Study|Non-compliant with protocol|0|||
161574071|NCT01317420|583487682|FG012|Overall Study|Non-compliant with protocol|1|||
161574072|NCT01317420|583487670|FG000|Overall Study|Refused to cont. taking trial medication|0|||
161574073|NCT01317420|583487671|FG001|Overall Study|Refused to cont. taking trial medication|0|||
161574074|NCT01317420|583487672|FG002|Overall Study|Refused to cont. taking trial medication|0|||
161574075|NCT01317420|583487673|FG003|Overall Study|Refused to cont. taking trial medication|0|||
161574076|NCT01317420|583487674|FG004|Overall Study|Refused to cont. taking trial medication|0|||
161574077|NCT01317420|583487675|FG005|Overall Study|Refused to cont. taking trial medication|0|||
161574078|NCT01317420|583487676|FG006|Overall Study|Refused to cont. taking trial medication|0|||
161574079|NCT01317420|583487677|FG007|Overall Study|Refused to cont. taking trial medication|0|||
161574080|NCT01317420|583487678|FG008|Overall Study|Refused to cont. taking trial medication|0|||
161574081|NCT01317420|583487679|FG009|Overall Study|Refused to cont. taking trial medication|0|||
161574082|NCT01317420|583487680|FG010|Overall Study|Refused to cont. taking trial medication|0|||
161574083|NCT01317420|583487681|FG011|Overall Study|Refused to cont. taking trial medication|0|||
161574084|NCT01317420|583487682|FG012|Overall Study|Refused to cont. taking trial medication|1|||
161574085|NCT01317420|583487670|FG000|Overall Study|Reason other than those specified|0|||
161574086|NCT01317420|583487671|FG001|Overall Study|Reason other than those specified|0|||
161574087|NCT01317420|583487672|FG002|Overall Study|Reason other than those specified|0|||
161574088|NCT01317420|583487673|FG003|Overall Study|Reason other than those specified|0|||
161574089|NCT01317420|583487674|FG004|Overall Study|Reason other than those specified|0|||
161574090|NCT01317420|583487675|FG005|Overall Study|Reason other than those specified|0|||
161574091|NCT01317420|583487676|FG006|Overall Study|Reason other than those specified|0|||
161574092|NCT01317420|583487677|FG007|Overall Study|Reason other than those specified|0|||
161574093|NCT01317420|583487678|FG008|Overall Study|Reason other than those specified|0|||
161574094|NCT01317420|583487679|FG009|Overall Study|Reason other than those specified|1|||
161810550|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161810551|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
161810552|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
161466876|NCT05098938|583104789|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
161574095|NCT01317420|583487680|FG010|Overall Study|Reason other than those specified|0|||
161574096|NCT01317420|583487681|FG011|Overall Study|Reason other than those specified|0|||
161810553|NCT00461786|584349451|FG000|Overall Study|Entry Criteria Not Met|2|||
161810554|NCT00461786|584349451|FG000|Overall Study|Inevaluable (Never Treated)|1|||
161810555|NCT03570749|584349456|FG000|Overall Study|Ongoing|26|||
161466877|NCT05098938|583104788|FG000|Overall Study|Physician Decision|25|||
161810556|NCT03570749|584349457|FG001|Overall Study|Ongoing|25|||
161466878|NCT05098938|583104789|FG001|Overall Study|Physician Decision|32|||
161914959|NCT00142415|584737344|FG000|Overall Study|Physician Decision|0|||
161914960|NCT00142415|584737345|FG001|Overall Study|Physician Decision|0|||
161914961|NCT00142415|584737346|FG002|Overall Study|Physician Decision|0|||
161914962|NCT00142415|584737347|FG003|Overall Study|Physician Decision|0|||
161914963|NCT00142415|584737348|FG004|Overall Study|Physician Decision|1|||
161466879|NCT05098938|583104788|FG000|Overall Study|Run in failure in treatment phase|1|||
161466880|NCT05098938|583104789|FG001|Overall Study|Run in failure in treatment phase|1|||
161466881|NCT05098938|583104788|FG000|Overall Study|Withdrawal by Subject|0|||
161466882|NCT05098938|583104789|FG001|Overall Study|Withdrawal by Subject|3|||
161466883|NCT05098938|583104788|FG000|Overall Study|Run-in Failure in early study|505|||
161466884|NCT05098938|583104789|FG001|Overall Study|Run-in Failure in early study|514|||
161466885|NCT05098938|583104788|FG000|Overall Study|IMP delivery missed|1|||
161466886|NCT05098938|583104789|FG001|Overall Study|IMP delivery missed|5|||
161466887|NCT05098938|583104788|FG000|Overall Study|6 months visit was missed|2|||
161466888|NCT05098938|583104789|FG001|Overall Study|6 months visit was missed|0|||
161466889|NCT05098938|583104788|FG000|Overall Study|fit for use was not completed within window|3|||
161466890|NCT05098938|583104789|FG001|Overall Study|fit for use was not completed within window|0|||
161466891|NCT05098938|583104788|FG000|Overall Study|V2 visit was not completed within window|0|||
161466892|NCT05098938|583104789|FG001|Overall Study|V2 visit was not completed within window|1|||
161466893|NCT05098938|583104788|FG000|Overall Study|exclusionary medication use|1|||
161466894|NCT05098938|583104789|FG001|Overall Study|exclusionary medication use|2|||
161466895|NCT05098938|583104788|FG000|Overall Study|change in medication|1|||
161466896|NCT05098938|583104789|FG001|Overall Study|change in medication|0|||
161466897|NCT05098938|583104788|FG000|Overall Study|treatment failure|2|||
161466898|NCT05098938|583104789|FG001|Overall Study|treatment failure|1|||
161466899|NCT01828320|583104791|FG000|Overall Study|Lost to Follow-up|1|||
161466900|NCT01828320|583104792|FG001|Overall Study|Lost to Follow-up|3|||
161466901|NCT01828320|583104791|FG000|Overall Study|Withdrawal by Subject|7|||
161466902|NCT01828320|583104792|FG001|Overall Study|Withdrawal by Subject|2|||
161466903|NCT02095223|583106744|FG000|Overall Study|Withdrawal by Subject|1|||
161466904|NCT02095223|583106745|FG001|Overall Study|Withdrawal by Subject|0|||
161466905|NCT01920555|583106746|FG000|Overall Study|Physician Decision|1|||
161466906|NCT01920555|583106747|FG001|Overall Study|Physician Decision|2|||
161466907|NCT01920555|583106748|FG002|Overall Study|Physician Decision|1|||
161466908|NCT01920555|583106749|FG003|Overall Study|Physician Decision|2|||
161466909|NCT01920555|583106750|FG004|Overall Study|Physician Decision|0|||
161466910|NCT01920555|583106746|FG000|Overall Study|Lack of Efficacy|2|||
161466911|NCT01920555|583106747|FG001|Overall Study|Lack of Efficacy|0|||
161466912|NCT01920555|583106748|FG002|Overall Study|Lack of Efficacy|0|||
161466913|NCT01920555|583106749|FG003|Overall Study|Lack of Efficacy|0|||
161466914|NCT01920555|583106750|FG004|Overall Study|Lack of Efficacy|0|||
161466915|NCT01920555|583106746|FG000|Overall Study|Travel Difficulties|1|||
161466916|NCT01920555|583106747|FG001|Overall Study|Travel Difficulties|1|||
161466917|NCT01920555|583106748|FG002|Overall Study|Travel Difficulties|0|||
161466918|NCT01920555|583106749|FG003|Overall Study|Travel Difficulties|0|||
161466919|NCT01920555|583106750|FG004|Overall Study|Travel Difficulties|1|||
161466920|NCT01920555|583106746|FG000|Overall Study|Lost to Follow-up|0|||
161466921|NCT01920555|583106747|FG001|Overall Study|Lost to Follow-up|1|||
161466922|NCT01920555|583106748|FG002|Overall Study|Lost to Follow-up|0|||
161466923|NCT01920555|583106749|FG003|Overall Study|Lost to Follow-up|1|||
161466924|NCT01920555|583106750|FG004|Overall Study|Lost to Follow-up|0|||
161466925|NCT02570074|583106757|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
161466926|NCT02570074|583106758|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
161466927|NCT01859143|583106760|FG000|Overall Study|Lost to Follow-up|2|||
161466928|NCT01859143|583106761|FG001|Overall Study|Lost to Follow-up|0|||
161466929|NCT00760214|583106762|FG000|Overall Study|Adverse Event|8|||
161466930|NCT00760214|583106763|FG001|Overall Study|Adverse Event|9|||
161466931|NCT00760214|583106764|FG002|Overall Study|Adverse Event|12|||
161466932|NCT00760214|583106762|FG000|Overall Study|Protocol Violation|3|||
161466933|NCT00760214|583106763|FG001|Overall Study|Protocol Violation|0|||
161466934|NCT00760214|583106764|FG002|Overall Study|Protocol Violation|3|||
161466935|NCT00760214|583106762|FG000|Overall Study|Lost to Follow-up|0|||
161466936|NCT00760214|583106763|FG001|Overall Study|Lost to Follow-up|0|||
161466937|NCT00760214|583106764|FG002|Overall Study|Lost to Follow-up|1|||
161466938|NCT00760214|583106762|FG000|Overall Study|Withdrawal by Subject|12|||
161466939|NCT00760214|583106763|FG001|Overall Study|Withdrawal by Subject|14|||
161466940|NCT00760214|583106764|FG002|Overall Study|Withdrawal by Subject|13|||
161914964|NCT00142415|584737349|FG005|Overall Study|Physician Decision|2|||
161914965|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
161466941|NCT00760214|583106762|FG000|Overall Study|Lack of Efficacy|3|||
161466942|NCT00760214|583106763|FG001|Overall Study|Lack of Efficacy|2|||
161466943|NCT00760214|583106764|FG002|Overall Study|Lack of Efficacy|4|||
161466944|NCT00760214|583106762|FG000|Overall Study|Pregnancy|0|||
161466945|NCT00760214|583106763|FG001|Overall Study|Pregnancy|0|||
161466946|NCT00760214|583106764|FG002|Overall Study|Pregnancy|1|||
161914966|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
161466947|NCT00760214|583106762|FG000|Overall Study|Physician Decision|1|||
161574097|NCT01317420|583487682|FG012|Overall Study|Reason other than those specified|0|||
161574098|NCT05686421|583487683|FG000|Overall Study|Screen failure|22|||
161574099|NCT05686421|583487684|FG001|Overall Study|Screen failure|0|||
161574100|NCT05686421|583487685|FG002|Overall Study|Screen failure|0|||
161574101|NCT05686421|583487686|FG003|Overall Study|Screen failure|0|||
161574102|NCT04210180|583487687|FG000|Overall Study|Withdrawal by Subject|2|||
161574103|NCT00367055|583487688|FG000|Overall Study|Adverse Event|6|||
161574104|NCT00367055|583487689|FG001|Overall Study|Adverse Event|3|||
161574105|NCT00367055|583487688|FG000|Overall Study|Patient's Willing|3|||
161574106|NCT00367055|583487689|FG001|Overall Study|Patient's Willing|2|||
161574107|NCT00367055|583487688|FG000|Overall Study|Lack of Efficacy|1|||
161574108|NCT00367055|583487689|FG001|Overall Study|Lack of Efficacy|2|||
161574109|NCT00367055|583487688|FG000|Overall Study|Lost to Follow-up|1|||
161574110|NCT00367055|583487689|FG001|Overall Study|Lost to Follow-up|1|||
161574111|NCT00367055|583487688|FG000|Overall Study|Protocol Violation|0|||
161574112|NCT00367055|583487689|FG001|Overall Study|Protocol Violation|1|||
161574113|NCT00367055|583487688|FG000|Overall Study|Stopping Criterion Met|0|||
161574114|NCT00367055|583487689|FG001|Overall Study|Stopping Criterion Met|1|||
161574115|NCT00367055|583487688|FG000|Overall Study|Participant Living too Far from Hospital|0|||
161574116|NCT00367055|583487689|FG001|Overall Study|Participant Living too Far from Hospital|1|||
161574117|NCT00324038|583487703|FG000|Overall Study|Adverse Event|38|||
161574118|NCT00324038|583487704|FG001|Overall Study|Adverse Event|23|||
161574119|NCT00324038|583487703|FG000|Overall Study|Lack of Efficacy|5|||
161574120|NCT00324038|583487704|FG001|Overall Study|Lack of Efficacy|13|||
161574121|NCT00324038|583487703|FG000|Overall Study|Lost to Follow-up|0|||
161574122|NCT00324038|583487704|FG001|Overall Study|Lost to Follow-up|2|||
161574123|NCT00324038|583487703|FG000|Overall Study|Other|6|||
161574124|NCT00324038|583487704|FG001|Overall Study|Other|13|||
161574125|NCT00961636|583487707|FG000|Overall Study|Adverse Event|35|||
161574126|NCT00961636|583487708|FG001|Overall Study|Adverse Event|54|||
161574127|NCT00961636|583487709|FG002|Overall Study|Adverse Event|13|||
161574128|NCT00961636|583487707|FG000|Overall Study|Flushing Symptoms|29|||
161574129|NCT00961636|583487708|FG001|Overall Study|Flushing Symptoms|46|||
161574130|NCT00961636|583487709|FG002|Overall Study|Flushing Symptoms|3|||
161574131|NCT00961636|583487707|FG000|Overall Study|Lost to Follow-up|2|||
161574132|NCT00961636|583487708|FG001|Overall Study|Lost to Follow-up|3|||
161574133|NCT00961636|583487709|FG002|Overall Study|Lost to Follow-up|1|||
161574134|NCT00961636|583487707|FG000|Overall Study|Physician Decision|3|||
161574135|NCT00961636|583487708|FG001|Overall Study|Physician Decision|1|||
161574136|NCT00961636|583487709|FG002|Overall Study|Physician Decision|1|||
161574137|NCT00961636|583487707|FG000|Overall Study|Protocol Violation|9|||
161574138|NCT00961636|583487708|FG001|Overall Study|Protocol Violation|5|||
161574139|NCT00961636|583487709|FG002|Overall Study|Protocol Violation|1|||
161574140|NCT00961636|583487707|FG000|Overall Study|Withdrawal by Subject|29|||
161574141|NCT00961636|583487708|FG001|Overall Study|Withdrawal by Subject|22|||
161466948|NCT00760214|583106763|FG001|Overall Study|Physician Decision|1|||
161466949|NCT00760214|583106764|FG002|Overall Study|Physician Decision|1|||
161466950|NCT00760214|583106762|FG000|Overall Study|Other|3|||
161466951|NCT00760214|583106763|FG001|Overall Study|Other|4|||
161466952|NCT00760214|583106764|FG002|Overall Study|Other|6|||
161466953|NCT00700570|583106765|FG000|Overall Study|Adverse Event|2|||
161466954|NCT00700570|583106766|FG001|Overall Study|Adverse Event|6|||
161574142|NCT00961636|583487709|FG002|Overall Study|Withdrawal by Subject|13|||
161574143|NCT00290706|583487710|FG000|Overall Study|Withdrawal by Subject|2|||
161574144|NCT00290706|583487711|FG001|Overall Study|Withdrawal by Subject|0|||
161574145|NCT00290706|583487712|FG002|Overall Study|Withdrawal by Subject|0|||
161466955|NCT00700570|583106765|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
161466956|NCT00700570|583106766|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
161466957|NCT00700570|583106765|FG000|Overall Study|Disease Progression|8|||
161466958|NCT00700570|583106766|FG001|Overall Study|Disease Progression|11|||
161466959|NCT00700570|583106765|FG000|Overall Study|Withdrawal by Subject|1|||
161574146|NCT00290706|583487713|FG003|Overall Study|Withdrawal by Subject|0|||
161574147|NCT00290706|583487710|FG000|Overall Study|Progressive Disease|3|||
161574148|NCT00290706|583487711|FG001|Overall Study|Progressive Disease|5|||
161574149|NCT00290706|583487712|FG002|Overall Study|Progressive Disease|4|||
161574150|NCT00290706|583487713|FG003|Overall Study|Progressive Disease|10|||
161574151|NCT00290706|583487710|FG000|Overall Study|Adverse Event|0|||
161574152|NCT00290706|583487711|FG001|Overall Study|Adverse Event|1|||
161574153|NCT00290706|583487712|FG002|Overall Study|Adverse Event|2|||
161574154|NCT00290706|583487713|FG003|Overall Study|Adverse Event|0|||
161466960|NCT00700570|583106766|FG001|Overall Study|Withdrawal by Subject|6|||
161466961|NCT01134315|583106767|FG000|Overall Study|Adverse Event|1|||
161466962|NCT01134315|583106768|FG001|Overall Study|Adverse Event|2|||
161574155|NCT00290706|583487710|FG000|Overall Study|Receive auto transplant or radiation|0|||
161574156|NCT00290706|583487711|FG001|Overall Study|Receive auto transplant or radiation|0|||
161574157|NCT00290706|583487712|FG002|Overall Study|Receive auto transplant or radiation|0|||
161574158|NCT00290706|583487713|FG003|Overall Study|Receive auto transplant or radiation|1|||
161574159|NCT00290706|583487710|FG000|Overall Study|Physician Decision|0|||
161574160|NCT00290706|583487711|FG001|Overall Study|Physician Decision|0|||
161466963|NCT01134315|583106767|FG000|Overall Study|Other Reason|8|||
161466964|NCT01134315|583106768|FG001|Overall Study|Other Reason|17|||
161466965|NCT04587271|583106771|FG000|Overall Study|Lost to Follow-up|2|||
161466966|NCT04587271|583106772|FG001|Overall Study|Lost to Follow-up|2|||
161466967|NCT04587271|583106773|FG002|Overall Study|Lost to Follow-up|0|||
161466968|NCT04587271|583106774|FG003|Overall Study|Lost to Follow-up|2|||
161466969|NCT04587271|583106775|FG004|Overall Study|Lost to Follow-up|2|||
161466970|NCT04587271|583106776|FG005|Overall Study|Lost to Follow-up|0|||
161466971|NCT04587271|583106771|FG000|Overall Study|Caregiver brought child to visits|0|||
161466972|NCT04587271|583106772|FG001|Overall Study|Caregiver brought child to visits|0|||
161466973|NCT04587271|583106773|FG002|Overall Study|Caregiver brought child to visits|0|||
161466974|NCT04587271|583106774|FG003|Overall Study|Caregiver brought child to visits|1|||
161466975|NCT04587271|583106775|FG004|Overall Study|Caregiver brought child to visits|0|||
161466976|NCT04587271|583106776|FG005|Overall Study|Caregiver brought child to visits|0|||
161466977|NCT02360111|583106777|FG000|Overall Study|Death|2|||
161466978|NCT00611533|583106778|FG000|First Intervention (6 Weeks)|Never started study|0|||
161574161|NCT00290706|583487712|FG002|Overall Study|Physician Decision|0|||
161574162|NCT00290706|583487713|FG003|Overall Study|Physician Decision|1|||
161574163|NCT01196429|583487715|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161574164|NCT01196429|583487716|FG001|Overall Study|Ineligible - inadequate pathology|0|||
161466979|NCT00611533|583106779|FG001|First Intervention (6 Weeks)|Never started study|1|||
161466980|NCT00611533|583106778|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
161574165|NCT01196429|583487715|FG000|Overall Study|Ineligible - wrong cell type|1|||
161574166|NCT01196429|583487716|FG001|Overall Study|Ineligible - wrong cell type|0|||
161574167|NCT01196429|583487715|FG000|Overall Study|Refused - Never Treated|1|||
161574168|NCT01196429|583487716|FG001|Overall Study|Refused - Never Treated|0|||
161574169|NCT00688519|583487717|FG000|Overall Study|Adverse Event|2|||
161574170|NCT00688519|583487718|FG001|Overall Study|Adverse Event|3|||
161574171|NCT00688519|583487717|FG000|Overall Study|Lost to Follow-up|3|||
161574172|NCT00688519|583487718|FG001|Overall Study|Lost to Follow-up|3|||
161574173|NCT00688519|583487717|FG000|Overall Study|Lack of Efficacy|3|||
161574174|NCT00688519|583487718|FG001|Overall Study|Lack of Efficacy|1|||
161574175|NCT00688519|583487717|FG000|Overall Study|Withdrawal by Subject|7|||
161574176|NCT00688519|583487718|FG001|Overall Study|Withdrawal by Subject|6|||
161574177|NCT00688519|583487717|FG000|Overall Study|Prohibited medication|1|||
161574178|NCT00688519|583487718|FG001|Overall Study|Prohibited medication|0|||
161574179|NCT00688519|583487717|FG000|Overall Study|Non-compliance|0|||
161574180|NCT00688519|583487718|FG001|Overall Study|Non-compliance|1|||
161574181|NCT00688519|583487717|FG000|Overall Study|Subject moved out of state|1|||
161574182|NCT00688519|583487718|FG001|Overall Study|Subject moved out of state|0|||
161574183|NCT00688519|583487717|FG000|Overall Study|Investigator decision|1|||
161574184|NCT00688519|583487718|FG001|Overall Study|Investigator decision|0|||
161574185|NCT00688519|583487717|FG000|Overall Study|Subject moved out of area|1|||
161574186|NCT00688519|583487718|FG001|Overall Study|Subject moved out of area|0|||
161574187|NCT00688519|583487717|FG000|Overall Study|Pregnancy|0|||
161574188|NCT00688519|583487718|FG001|Overall Study|Pregnancy|1|||
161574189|NCT02551055|583487719|FG000|Overall Study|Death|2|||
161574190|NCT02551055|583487720|FG001|Overall Study|Death|4|||
161574191|NCT02551055|583487721|FG002|Overall Study|Death|2|||
161574192|NCT02551055|583487722|FG003|Overall Study|Death|2|||
161574193|NCT02551055|583487723|FG004|Overall Study|Death|2|||
161574194|NCT02551055|583487724|FG005|Overall Study|Death|1|||
161574195|NCT02551055|583487725|FG006|Overall Study|Death|2|||
161574196|NCT02551055|583487726|FG007|Overall Study|Death|0|||
161574197|NCT02551055|583487719|FG000|Overall Study|Study Terminated by Sponsor|1|||
161574198|NCT02551055|583487720|FG001|Overall Study|Study Terminated by Sponsor|1|||
161574199|NCT02551055|583487721|FG002|Overall Study|Study Terminated by Sponsor|0|||
161574200|NCT02551055|583487722|FG003|Overall Study|Study Terminated by Sponsor|2|||
161574201|NCT02551055|583487723|FG004|Overall Study|Study Terminated by Sponsor|2|||
161574202|NCT02551055|583487724|FG005|Overall Study|Study Terminated by Sponsor|0|||
161574203|NCT02551055|583487725|FG006|Overall Study|Study Terminated by Sponsor|0|||
161574204|NCT02551055|583487726|FG007|Overall Study|Study Terminated by Sponsor|0|||
161574205|NCT02551055|583487719|FG000|Overall Study|Withdrawal by Subject|1|||
161574206|NCT02551055|583487720|FG001|Overall Study|Withdrawal by Subject|1|||
161574207|NCT02551055|583487721|FG002|Overall Study|Withdrawal by Subject|0|||
161574208|NCT02551055|583487722|FG003|Overall Study|Withdrawal by Subject|1|||
161574209|NCT02551055|583487723|FG004|Overall Study|Withdrawal by Subject|2|||
161574210|NCT02551055|583487724|FG005|Overall Study|Withdrawal by Subject|0|||
161574211|NCT02551055|583487725|FG006|Overall Study|Withdrawal by Subject|0|||
161574212|NCT02551055|583487726|FG007|Overall Study|Withdrawal by Subject|0|||
161574213|NCT02551055|583487719|FG000|Overall Study|Reason not specified|0|||
161574214|NCT02551055|583487720|FG001|Overall Study|Reason not specified|0|||
161466981|NCT00611533|583106779|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
161466982|NCT00611533|583106778|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
161466983|NCT00611533|583106779|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
161466984|NCT02180165|583106780|FG000|Overall Study|Not Treated|0|||
161574215|NCT02551055|583487721|FG002|Overall Study|Reason not specified|0|||
161574216|NCT02551055|583487722|FG003|Overall Study|Reason not specified|0|||
161574217|NCT02551055|583487723|FG004|Overall Study|Reason not specified|1|||
161574218|NCT02551055|583487724|FG005|Overall Study|Reason not specified|0|||
161574219|NCT02551055|583487725|FG006|Overall Study|Reason not specified|1|||
161574220|NCT02551055|583487726|FG007|Overall Study|Reason not specified|0|||
161574221|NCT00430300|583487727|FG000|Overall Study|Adverse Event|0|||
161574222|NCT00430300|583487728|FG001|Overall Study|Adverse Event|2|||
161574223|NCT00430300|583487729|FG002|Overall Study|Adverse Event|1|||
161574224|NCT00430300|583487730|FG003|Overall Study|Adverse Event|1|||
161574225|NCT00430300|583487727|FG000|Overall Study|Withdrawal by Subject|1|||
161574226|NCT00430300|583487728|FG001|Overall Study|Withdrawal by Subject|0|||
161574227|NCT00430300|583487729|FG002|Overall Study|Withdrawal by Subject|5|||
161574228|NCT00430300|583487730|FG003|Overall Study|Withdrawal by Subject|0|||
161574229|NCT00430300|583487727|FG000|Overall Study|Laboratory abnormality|1|||
161574230|NCT00430300|583487728|FG001|Overall Study|Laboratory abnormality|0|||
161574231|NCT00430300|583487729|FG002|Overall Study|Laboratory abnormality|0|||
161574232|NCT00430300|583487730|FG003|Overall Study|Laboratory abnormality|0|||
161574233|NCT00430300|583487727|FG000|Overall Study|Other|0|||
161574234|NCT00430300|583487728|FG001|Overall Study|Other|0|||
161574235|NCT00430300|583487729|FG002|Overall Study|Other|0|||
161574236|NCT00430300|583487730|FG003|Overall Study|Other|1|||
161574237|NCT01063517|583487735|FG000|Overall Study|Consent withdrawal|1|||
161574238|NCT01063517|583487736|FG001|Overall Study|Consent withdrawal|0|||
161574239|NCT01063517|583487735|FG000|Overall Study|Study reached data cut-off|19|||
161574240|NCT01063517|583487736|FG001|Overall Study|Study reached data cut-off|7|||
161574241|NCT01063517|583487735|FG000|Overall Study|Lost to Follow-up|4|||
161574242|NCT01063517|583487736|FG001|Overall Study|Lost to Follow-up|3|||
161574243|NCT01063517|583487735|FG000|Overall Study|Withdrawal by Subject|1|||
161574244|NCT01063517|583487736|FG001|Overall Study|Withdrawal by Subject|2|||
161574245|NCT01063517|583487735|FG000|Overall Study|Death|33|||
161574246|NCT01063517|583487736|FG001|Overall Study|Death|48|||
161574247|NCT02041104|583487737|FG000|Overall Study|Lost to Follow-up|1|||
161574248|NCT02041104|583487738|FG001|Overall Study|Lost to Follow-up|4|||
161574249|NCT02041104|583487737|FG000|Overall Study|discomfort during OGTT|0|||
161574250|NCT02041104|583487738|FG001|Overall Study|discomfort during OGTT|3|||
161574251|NCT02974634|583489490|FG000|Overall Study|Advanced disease|12|||
161574252|NCT02974634|583489491|FG001|Overall Study|Advanced disease|3|||
161574253|NCT02974634|583489490|FG000|Overall Study|Noncompliance|3|||
161574254|NCT02974634|583489491|FG001|Overall Study|Noncompliance|7|||
161574255|NCT02974634|583489490|FG000|Overall Study|intervention technology related issues|5|||
161574256|NCT02974634|583489491|FG001|Overall Study|intervention technology related issues|0|||
161574257|NCT02974634|583489490|FG000|Overall Study|Death|8|||
161574258|NCT02974634|583489491|FG001|Overall Study|Death|11|||
161574259|NCT05011396|583489492|FG000|Overall Study|Lost to Follow-up|3|||
161574260|NCT05011396|583489493|FG001|Overall Study|Lost to Follow-up|1|||
161574261|NCT05011396|583489492|FG000|Overall Study|Withdrawal by Subject|0|||
161574262|NCT05011396|583489493|FG001|Overall Study|Withdrawal by Subject|1|||
161574263|NCT05011396|583489492|FG000|Overall Study|Positive Drug Screen|0|||
161574264|NCT05011396|583489493|FG001|Overall Study|Positive Drug Screen|1|||
161574265|NCT04668339|583489494|FG000|Overall Study|Physician Decision|1|||
161574266|NCT04668339|583489495|FG001|Overall Study|Physician Decision|0|||
161574267|NCT04668339|583489496|FG002|Overall Study|Physician Decision|1|||
161574268|NCT04668339|583489497|FG003|Overall Study|Physician Decision|1|||
161574269|NCT04668339|583489494|FG000|Overall Study|Lost to Follow-up|14|||
161574270|NCT04668339|583489495|FG001|Overall Study|Lost to Follow-up|12|||
161574271|NCT04668339|583489496|FG002|Overall Study|Lost to Follow-up|8|||
161574272|NCT04668339|583489497|FG003|Overall Study|Lost to Follow-up|5|||
161574273|NCT04668339|583489494|FG000|Overall Study|Adverse Event|0|||
161574274|NCT04668339|583489495|FG001|Overall Study|Adverse Event|0|||
161574275|NCT04668339|583489496|FG002|Overall Study|Adverse Event|1|||
161574276|NCT04668339|583489497|FG003|Overall Study|Adverse Event|0|||
161574277|NCT04668339|583489494|FG000|Overall Study|Other than specified|3|||
161574278|NCT04668339|583489495|FG001|Overall Study|Other than specified|0|||
161574279|NCT04668339|583489496|FG002|Overall Study|Other than specified|1|||
161574280|NCT04668339|583489497|FG003|Overall Study|Other than specified|0|||
161574281|NCT04668339|583489494|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
161574282|NCT04668339|583489495|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
161574283|NCT04668339|583489496|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
161574284|NCT04668339|583489497|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
161574285|NCT04668339|583489494|FG000|Overall Study|Vaccine not Administered|0|||
161574286|NCT04668339|583489495|FG001|Overall Study|Vaccine not Administered|0|||
161574287|NCT04668339|583489496|FG002|Overall Study|Vaccine not Administered|1|||
161574288|NCT04668339|583489497|FG003|Overall Study|Vaccine not Administered|0|||
161574289|NCT04668339|583489494|FG000|Overall Study|Protocol Violation|18|||
161574290|NCT04668339|583489495|FG001|Overall Study|Protocol Violation|23|||
161574291|NCT04668339|583489496|FG002|Overall Study|Protocol Violation|12|||
161810557|NCT03570749|584349458|FG002|Overall Study|Ongoing|25|||
161810558|NCT03570749|584349459|FG003|Overall Study|Ongoing|26|||
161810559|NCT03570749|584349460|FG004|Overall Study|Ongoing|140|||
161810560|NCT03570749|584349461|FG005|Overall Study|Ongoing|142|||
161810561|NCT03570749|584349462|FG006|Overall Study|Ongoing|220|||
161810562|NCT03570749|584349456|FG000|Overall Study|Adverse Event|0|||
161810563|NCT03570749|584349457|FG001|Overall Study|Adverse Event|0|||
161810564|NCT03570749|584349458|FG002|Overall Study|Adverse Event|0|||
161810565|NCT03570749|584349459|FG003|Overall Study|Adverse Event|0|||
161810566|NCT03570749|584349460|FG004|Overall Study|Adverse Event|2|||
161810567|NCT03570749|584349461|FG005|Overall Study|Adverse Event|3|||
161810568|NCT03570749|584349462|FG006|Overall Study|Adverse Event|6|||
161810569|NCT03570749|584349456|FG000|Overall Study|Lack of Efficacy|0|||
161810570|NCT03570749|584349457|FG001|Overall Study|Lack of Efficacy|0|||
161810571|NCT03570749|584349458|FG002|Overall Study|Lack of Efficacy|0|||
161810572|NCT03570749|584349459|FG003|Overall Study|Lack of Efficacy|0|||
161810573|NCT03570749|584349460|FG004|Overall Study|Lack of Efficacy|8|||
161810574|NCT03570749|584349461|FG005|Overall Study|Lack of Efficacy|2|||
161466985|NCT02180165|583106781|FG001|Overall Study|Not Treated|0|||
161466986|NCT02180165|583106782|FG002|Overall Study|Not Treated|1|||
161466987|NCT02180165|583106783|FG003|Overall Study|Not Treated|0|||
161466988|NCT02180165|583106780|FG000|Overall Study|Adverse Event|7|||
161466989|NCT02180165|583106781|FG001|Overall Study|Adverse Event|0|||
161466990|NCT02180165|583106782|FG002|Overall Study|Adverse Event|18|||
161466991|NCT02180165|583106783|FG003|Overall Study|Adverse Event|3|||
161466992|NCT02180165|583106780|FG000|Overall Study|Lack of Efficacy|0|||
161466993|NCT02180165|583106781|FG001|Overall Study|Lack of Efficacy|1|||
161574292|NCT04668339|583489497|FG003|Overall Study|Protocol Violation|20|||
161574293|NCT04668339|583489494|FG000|Overall Study|Withdrawal by Subject|45|||
161574294|NCT04668339|583489495|FG001|Overall Study|Withdrawal by Subject|46|||
161574295|NCT04668339|583489496|FG002|Overall Study|Withdrawal by Subject|46|||
161574296|NCT04668339|583489497|FG003|Overall Study|Withdrawal by Subject|27|||
161574297|NCT04668339|583489494|FG000|Overall Study|Study Terminated by Sponsor|59|||
161574298|NCT04668339|583489495|FG001|Overall Study|Study Terminated by Sponsor|59|||
161574299|NCT04668339|583489496|FG002|Overall Study|Study Terminated by Sponsor|71|||
161574300|NCT04668339|583489497|FG003|Overall Study|Study Terminated by Sponsor|1|||
161574301|NCT03253848|583489501|FG000|Overall Study|Adverse Event|7|||
161574302|NCT03253848|583489501|FG000|Overall Study|Death|5|||
161574303|NCT03253848|583489501|FG000|Overall Study|initiation of other treatments|3|||
161574304|NCT03253848|583489501|FG000|Overall Study|Other complicating disease|1|||
161574305|NCT03253848|583489501|FG000|Overall Study|Withdrawal by Subject|1|||
161574306|NCT03253848|583489501|FG000|Overall Study|Declining health|1|||
161574307|NCT05758415|583489503|FG000|Overall Study|Subject Decision|2|||
161574308|NCT05758415|583489504|FG001|Overall Study|Subject Decision|5|||
161574309|NCT05758415|583489503|FG000|Overall Study|Lost to Follow-up|0|||
161574310|NCT05758415|583489504|FG001|Overall Study|Lost to Follow-up|1|||
161574311|NCT03622593|583489505|FG000|Overall Study|Withdrawal by Subject|11|||
161574312|NCT03622593|583489506|FG001|Overall Study|Withdrawal by Subject|9|||
161574313|NCT03622593|583489507|FG002|Overall Study|Withdrawal by Subject|13|||
161574314|NCT03622593|583489505|FG000|Overall Study|Death|12|||
161574315|NCT03622593|583489506|FG001|Overall Study|Death|9|||
161574316|NCT03622593|583489507|FG002|Overall Study|Death|10|||
161574317|NCT03622593|583489505|FG000|Overall Study|Lost to Follow-up|11|||
161574318|NCT03622593|583489506|FG001|Overall Study|Lost to Follow-up|5|||
161574319|NCT03622593|583489507|FG002|Overall Study|Lost to Follow-up|8|||
161574320|NCT03622593|583489505|FG000|Overall Study|Adverse Event|4|||
161574321|NCT03622593|583489506|FG001|Overall Study|Adverse Event|5|||
161574322|NCT03622593|583489507|FG002|Overall Study|Adverse Event|6|||
161574323|NCT03622593|583489505|FG000|Overall Study|Physician Decision|2|||
161574324|NCT03622593|583489506|FG001|Overall Study|Physician Decision|1|||
161574325|NCT03622593|583489507|FG002|Overall Study|Physician Decision|6|||
161574326|NCT03622593|583489505|FG000|Overall Study|Other|2|||
161574327|NCT03622593|583489506|FG001|Overall Study|Other|2|||
161574328|NCT03622593|583489507|FG002|Overall Study|Other|3|||
161574329|NCT03622593|583489505|FG000|Overall Study|Protocol Violation|0|||
161574330|NCT03622593|583489506|FG001|Overall Study|Protocol Violation|0|||
161810575|NCT03570749|584349462|FG006|Overall Study|Lack of Efficacy|7|||
161574331|NCT03622593|583489507|FG002|Overall Study|Protocol Violation|1|||
161574332|NCT03622593|583489505|FG000|Overall Study|Pregnancy|0|||
161574333|NCT03622593|583489506|FG001|Overall Study|Pregnancy|0|||
161574334|NCT03622593|583489507|FG002|Overall Study|Pregnancy|1|||
161574335|NCT01393119|583489510|FG000|Overall Study|Adverse Event|1|||
161574336|NCT01393119|583489511|FG001|Overall Study|Adverse Event|1|||
161810576|NCT03570749|584349456|FG000|Overall Study|Lost to Follow-up|0|||
161466994|NCT02180165|583106782|FG002|Overall Study|Lack of Efficacy|3|||
161574337|NCT01393119|583489512|FG002|Overall Study|Adverse Event|0|||
161810577|NCT03570749|584349457|FG001|Overall Study|Lost to Follow-up|0|||
161810578|NCT03570749|584349458|FG002|Overall Study|Lost to Follow-up|0|||
161466995|NCT02180165|583106783|FG003|Overall Study|Lack of Efficacy|2|||
161466996|NCT02180165|583106780|FG000|Overall Study|Physician Decision|1|||
161574338|NCT01393119|583489513|FG003|Overall Study|Adverse Event|1|||
161574339|NCT01393119|583489510|FG000|Overall Study|Withdrawal by Subject|0|||
161574340|NCT01393119|583489511|FG001|Overall Study|Withdrawal by Subject|1|||
161574341|NCT01393119|583489512|FG002|Overall Study|Withdrawal by Subject|1|||
161574342|NCT01393119|583489513|FG003|Overall Study|Withdrawal by Subject|0|||
161574343|NCT01393119|583489510|FG000|Overall Study|Lack of Efficacy|1|||
161574344|NCT01393119|583489511|FG001|Overall Study|Lack of Efficacy|0|||
161574345|NCT01393119|583489512|FG002|Overall Study|Lack of Efficacy|2|||
161574346|NCT01393119|583489513|FG003|Overall Study|Lack of Efficacy|1|||
161574347|NCT01393119|583489510|FG000|Overall Study|Protocol Violation|0|||
161574348|NCT01393119|583489511|FG001|Overall Study|Protocol Violation|0|||
161574349|NCT01393119|583489512|FG002|Overall Study|Protocol Violation|1|||
161574350|NCT01393119|583489513|FG003|Overall Study|Protocol Violation|0|||
161574351|NCT01393119|583489510|FG000|Overall Study|Death|0|||
161574352|NCT01393119|583489511|FG001|Overall Study|Death|0|||
161574353|NCT01393119|583489512|FG002|Overall Study|Death|0|||
161574354|NCT01393119|583489513|FG003|Overall Study|Death|1|||
161574355|NCT01393119|583489510|FG000|Overall Study|Randomized but Not treated|1|||
161574356|NCT01393119|583489511|FG001|Overall Study|Randomized but Not treated|0|||
161574357|NCT01393119|583489512|FG002|Overall Study|Randomized but Not treated|1|||
161574358|NCT01393119|583489513|FG003|Overall Study|Randomized but Not treated|1|||
161574359|NCT01393119|583489510|FG000|Overall Study|Sponsor Termination of Study|11|||
161574360|NCT01393119|583489511|FG001|Overall Study|Sponsor Termination of Study|12|||
161574361|NCT01393119|583489512|FG002|Overall Study|Sponsor Termination of Study|9|||
161574362|NCT01393119|583489513|FG003|Overall Study|Sponsor Termination of Study|12|||
161574363|NCT04860258|583489514|FG000|Overall Study|Withdrawal by Subject|0|||
161574364|NCT04860258|583489515|FG001|Overall Study|Withdrawal by Subject|0|||
161574365|NCT04860258|583489516|FG002|Overall Study|Withdrawal by Subject|4|||
161574366|NCT04860258|583489517|FG003|Overall Study|Withdrawal by Subject|1|||
161574367|NCT04860258|583489518|FG004|Overall Study|Withdrawal by Subject|4|||
161574368|NCT04860258|583489519|FG005|Overall Study|Withdrawal by Subject|1|||
161574369|NCT04860258|583489520|FG006|Overall Study|Withdrawal by Subject|0|||
161574370|NCT01266265|583489521|FG000|Overall Study|Death|95|||
161574371|NCT01266265|583489522|FG001|Overall Study|Death|73|||
161574372|NCT01266265|583489521|FG000|Overall Study|Lost to Follow-up|23|||
161574373|NCT01266265|583489522|FG001|Overall Study|Lost to Follow-up|28|||
161574374|NCT01266265|583489521|FG000|Overall Study|Withdrawal by Subject|13|||
161574375|NCT01266265|583489522|FG001|Overall Study|Withdrawal by Subject|11|||
161574376|NCT01266265|583489521|FG000|Overall Study|Respiratory-related adverse event|2|||
161574377|NCT01266265|583489522|FG001|Overall Study|Respiratory-related adverse event|1|||
161574378|NCT01266265|583489521|FG000|Overall Study|Transferred care to another provider|22|||
161574379|NCT01266265|583489522|FG001|Overall Study|Transferred care to another provider|28|||
161574380|NCT01266265|583489521|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
161574381|NCT01266265|583489522|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
161574382|NCT01266265|583489521|FG000|Overall Study|Enrolled in another clinical study|15|||
161574383|NCT01266265|583489522|FG001|Overall Study|Enrolled in another clinical study|26|||
161574384|NCT01266265|583489521|FG000|Overall Study|Non-compliance|8|||
161574385|NCT01266265|583489522|FG001|Overall Study|Non-compliance|5|||
161914967|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
161914968|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
161914969|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
161914970|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
161914971|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
161574386|NCT01266265|583489521|FG000|Overall Study|Lung transplant|6|||
161574387|NCT01266265|583489522|FG001|Overall Study|Lung transplant|5|||
161574388|NCT01266265|583489521|FG000|Overall Study|Site closed early|4|||
161574389|NCT01266265|583489522|FG001|Overall Study|Site closed early|3|||
161574390|NCT01266265|583489521|FG000|Overall Study|Clinical worsening|1|||
161574391|NCT01266265|583489522|FG001|Overall Study|Clinical worsening|1|||
161574392|NCT01580293|583489523|FG000|Part A_Main Trial|Adverse Event|0|||
161574393|NCT01580293|583489524|FG001|Part A_Main Trial|Adverse Event|2|||
161574394|NCT01580293|583489525|FG002|Part A_Main Trial|Adverse Event|0|||
161574395|NCT01580293|583489523|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
161574396|NCT01580293|583489524|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
161574397|NCT01580293|583489525|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
161574398|NCT01580293|583489523|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
161574399|NCT01580293|583489524|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
161574400|NCT01580293|583489525|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
161574401|NCT01580293|583489523|FG000|Part A_Extension|Adverse Event|0|||
161574402|NCT01580293|583489524|FG001|Part A_Extension|Adverse Event|2|||
161574403|NCT01580293|583489525|FG002|Part A_Extension|Adverse Event|0|||
161574404|NCT01580293|583489523|FG000|Part A_Extension|Withdrawal by Subject|0|||
161574405|NCT01580293|583489524|FG001|Part A_Extension|Withdrawal by Subject|3|||
161574406|NCT01580293|583489525|FG002|Part A_Extension|Withdrawal by Subject|0|||
161914972|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
161574407|NCT01580293|583489523|FG000|Part A_Extension|Lost to Follow-up|0|||
161574408|NCT01580293|583489524|FG001|Part A_Extension|Lost to Follow-up|1|||
161574409|NCT01580293|583489525|FG002|Part A_Extension|Lost to Follow-up|0|||
161574410|NCT01580293|583489523|FG000|Part A_Extension|Other Reason|0|||
161574411|NCT01580293|583489524|FG001|Part A_Extension|Other Reason|1|||
161574412|NCT01580293|583489525|FG002|Part A_Extension|Other Reason|0|||
161574413|NCT01580293|583489523|FG000|Part A_Extension|Completed Japan only|0|||
161574414|NCT01580293|583489524|FG001|Part A_Extension|Completed Japan only|5|||
161574415|NCT01580293|583489525|FG002|Part A_Extension|Completed Japan only|0|||
161574416|NCT01580293|583489523|FG000|Part B|Withdrawal by Subject|0|||
161574417|NCT01580293|583489524|FG001|Part B|Withdrawal by Subject|0|||
161574418|NCT01580293|583489525|FG002|Part B|Withdrawal by Subject|1|||
161574419|NCT01580293|583489523|FG000|Part B|Other reason|0|||
161574420|NCT01580293|583489524|FG001|Part B|Other reason|0|||
161574421|NCT01580293|583489525|FG002|Part B|Other reason|1|||
161574422|NCT01134562|583489526|FG000|Overall Study|Adverse Event|0|||
161574423|NCT01134562|583489527|FG001|Overall Study|Adverse Event|1|||
161574424|NCT01134562|583489528|FG002|Overall Study|Adverse Event|0|||
161574425|NCT01134562|583489529|FG003|Overall Study|Adverse Event|0|||
161574426|NCT01134562|583489530|FG004|Overall Study|Adverse Event|0|||
161574427|NCT01499134|583489533|FG000|Overall Study|Withdrawal by Subject|0|||
161574428|NCT01499134|583489534|FG001|Overall Study|Withdrawal by Subject|1|||
161574429|NCT01400776|583489535|FG000|Overall Study|Adverse Event|7|||
161574430|NCT01400776|583489536|FG001|Overall Study|Adverse Event|2|||
161574431|NCT01400776|583489537|FG002|Overall Study|Adverse Event|9|||
161574432|NCT01400776|583489538|FG003|Overall Study|Adverse Event|2|||
161574433|NCT01400776|583489535|FG000|Overall Study|Lost to Follow-up|1|||
161574434|NCT01400776|583489536|FG001|Overall Study|Lost to Follow-up|0|||
161574435|NCT01400776|583489537|FG002|Overall Study|Lost to Follow-up|4|||
161574436|NCT01400776|583489538|FG003|Overall Study|Lost to Follow-up|1|||
161574437|NCT01400776|583489535|FG000|Overall Study|Withdrew Consent|4|||
161574438|NCT01400776|583489536|FG001|Overall Study|Withdrew Consent|2|||
161574439|NCT01400776|583489537|FG002|Overall Study|Withdrew Consent|6|||
161574440|NCT01400776|583489538|FG003|Overall Study|Withdrew Consent|1|||
161574441|NCT01400776|583489535|FG000|Overall Study|Protocol Deviation|6|||
161574442|NCT01400776|583489536|FG001|Overall Study|Protocol Deviation|1|||
161574443|NCT01400776|583489537|FG002|Overall Study|Protocol Deviation|5|||
161574444|NCT01400776|583489538|FG003|Overall Study|Protocol Deviation|2|||
161574445|NCT01400776|583489535|FG000|Overall Study|Reason not Specified|3|||
161574446|NCT01400776|583489536|FG001|Overall Study|Reason not Specified|0|||
161574447|NCT01400776|583489537|FG002|Overall Study|Reason not Specified|4|||
161574448|NCT01400776|583489538|FG003|Overall Study|Reason not Specified|3|||
161574449|NCT05855655|583489547|FG000|Overall Study|Withdrawal by Subject|0|||
161574450|NCT05855655|583489548|FG001|Overall Study|Withdrawal by Subject|1|||
161574451|NCT05855655|583489547|FG000|Overall Study|Lost to Follow-up|4|||
161574452|NCT05855655|583489548|FG001|Overall Study|Lost to Follow-up|0|||
161574453|NCT01426269|583489549|FG000|Period 1: 12 Weeks|Adverse Event|5|||
161574454|NCT01426269|583489550|FG001|Period 1: 12 Weeks|Adverse Event|0|||
161574455|NCT01426269|583489551|FG002|Period 1: 12 Weeks|Adverse Event|0|||
161574456|NCT01426269|583489549|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
161574457|NCT01426269|583489550|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
161574458|NCT01426269|583489551|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
161574459|NCT01426269|583489549|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
161574460|NCT01426269|583489550|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
161574461|NCT01426269|583489551|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
161574462|NCT01426269|583489549|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
161574463|NCT01426269|583489550|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
161574464|NCT01426269|583489551|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
161574465|NCT01426269|583489549|FG000|Period 1: 12 Weeks|Pregnancy|1|||
161574466|NCT01426269|583489550|FG001|Period 1: 12 Weeks|Pregnancy|0|||
161574467|NCT01426269|583489551|FG002|Period 1: 12 Weeks|Pregnancy|0|||
161574468|NCT01426269|583489549|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
161574469|NCT01426269|583489550|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
161574470|NCT01426269|583489551|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
161574471|NCT01426269|583489549|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
161574472|NCT01426269|583489550|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
161810579|NCT03570749|584349459|FG003|Overall Study|Lost to Follow-up|0|||
161810580|NCT03570749|584349460|FG004|Overall Study|Lost to Follow-up|5|||
161810581|NCT03570749|584349461|FG005|Overall Study|Lost to Follow-up|10|||
161810582|NCT03570749|584349462|FG006|Overall Study|Lost to Follow-up|10|||
161810583|NCT03570749|584349456|FG000|Overall Study|Pregnancy|0|||
161810584|NCT03570749|584349457|FG001|Overall Study|Pregnancy|0|||
161810585|NCT03570749|584349458|FG002|Overall Study|Pregnancy|0|||
161810586|NCT03570749|584349459|FG003|Overall Study|Pregnancy|0|||
161810587|NCT03570749|584349460|FG004|Overall Study|Pregnancy|0|||
161810588|NCT03570749|584349461|FG005|Overall Study|Pregnancy|1|||
161810589|NCT03570749|584349462|FG006|Overall Study|Pregnancy|1|||
161810590|NCT03570749|584349456|FG000|Overall Study|Screen Fail|0|||
161466997|NCT02180165|583106781|FG001|Overall Study|Physician Decision|0|||
161466998|NCT02180165|583106782|FG002|Overall Study|Physician Decision|5|||
161466999|NCT02180165|583106783|FG003|Overall Study|Physician Decision|0|||
161467000|NCT02180165|583106780|FG000|Overall Study|Withdrawal by Subject|3|||
161467001|NCT02180165|583106781|FG001|Overall Study|Withdrawal by Subject|0|||
161467002|NCT02180165|583106782|FG002|Overall Study|Withdrawal by Subject|2|||
161467003|NCT02180165|583106783|FG003|Overall Study|Withdrawal by Subject|1|||
161467004|NCT01933217|583106784|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
161467005|NCT01933217|583106785|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
161467006|NCT01933217|583106784|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
161467007|NCT01933217|583106785|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
161467008|NCT03923738|583106789|FG000|Period 1|Adverse Event|1|||
161467009|NCT03923738|583106789|FG000|Period 1|Withdrawal by Subject|1|||
161467010|NCT05246397|583106790|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
161467011|NCT03875768|583106792|FG000|Overall Study|Lost to Follow-up|16|||
161467012|NCT03875768|583106793|FG001|Overall Study|Lost to Follow-up|13|||
161467013|NCT03875768|583106792|FG000|Overall Study|Withdrawal by Subject|10|||
161467014|NCT03875768|583106793|FG001|Overall Study|Withdrawal by Subject|21|||
161467015|NCT03875768|583106792|FG000|Overall Study|Did not complete assessment|21|||
161467016|NCT03875768|583106793|FG001|Overall Study|Did not complete assessment|12|||
161467017|NCT03875768|583106792|FG000|Overall Study|Became ineligible|1|||
161467018|NCT03875768|583106793|FG001|Overall Study|Became ineligible|0|||
161467019|NCT01925274|583106794|FG000|Overall Study|Death|1|||
161574473|NCT01426269|583489551|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
161574474|NCT01426269|583489549|FG000|Period 2: 40 Weeks|Adverse Event|0|||
161574475|NCT01426269|583489550|FG001|Period 2: 40 Weeks|Adverse Event|1|||
161574476|NCT01426269|583489551|FG002|Period 2: 40 Weeks|Adverse Event|2|||
161574477|NCT01426269|583489549|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
161574478|NCT01426269|583489550|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
161574479|NCT01426269|583489551|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
161574480|NCT01426269|583489549|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
161574481|NCT01426269|583489550|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
161574482|NCT01426269|583489551|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
161574483|NCT01426269|583489549|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
161574484|NCT01426269|583489550|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
161574485|NCT01426269|583489551|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
161574486|NCT01426269|583489549|FG000|Period 2: 40 Weeks|Site closed|0|||
161574487|NCT01426269|583489550|FG001|Period 2: 40 Weeks|Site closed|6|||
161574488|NCT01426269|583489551|FG002|Period 2: 40 Weeks|Site closed|5|||
161574489|NCT01426269|583489549|FG000|Period 2: 40 Weeks|Relapsed|0|||
161574490|NCT01426269|583489550|FG001|Period 2: 40 Weeks|Relapsed|9|||
161574491|NCT01426269|583489551|FG002|Period 2: 40 Weeks|Relapsed|18|||
161574492|NCT00419094|583489555|FG000|Overall Study|Adverse Event|3|||
161574493|NCT00419094|583489556|FG001|Overall Study|Adverse Event|7|||
161574494|NCT00419094|583489555|FG000|Overall Study|Lack of Efficacy|1|||
161574495|NCT00419094|583489556|FG001|Overall Study|Lack of Efficacy|0|||
161574496|NCT00419094|583489555|FG000|Overall Study|Lost to Follow-up|0|||
161574497|NCT00419094|583489556|FG001|Overall Study|Lost to Follow-up|2|||
161467020|NCT01925274|583106795|FG001|Overall Study|Death|0|||
161467021|NCT01925274|583106796|FG002|Overall Study|Death|0|||
161467022|NCT01925274|583106794|FG000|Overall Study|Lost to Follow-up|0|||
161467023|NCT01925274|583106795|FG001|Overall Study|Lost to Follow-up|1|||
161467024|NCT01925274|583106796|FG002|Overall Study|Lost to Follow-up|0|||
161574498|NCT00419094|583489555|FG000|Overall Study|Protocol Violation|1|||
161574499|NCT00419094|583489556|FG001|Overall Study|Protocol Violation|14|||
161574500|NCT00419094|583489555|FG000|Overall Study|Withdrawal of consent|1|||
161574501|NCT00419094|583489556|FG001|Overall Study|Withdrawal of consent|5|||
161574502|NCT00419094|583489555|FG000|Overall Study|Other: Error determining exit criteria|1|||
161574503|NCT00419094|583489556|FG001|Overall Study|Other: Error determining exit criteria|0|||
161574504|NCT00419094|583489555|FG000|Overall Study|Other: Patient non-compliant|0|||
161574505|NCT00419094|583489556|FG001|Overall Study|Other: Patient non-compliant|1|||
161467025|NCT01925274|583106794|FG000|Overall Study|Withdrawal by Subject|1|||
161467026|NCT01925274|583106795|FG001|Overall Study|Withdrawal by Subject|2|||
161467027|NCT01925274|583106796|FG002|Overall Study|Withdrawal by Subject|0|||
161467028|NCT01925274|583106794|FG000|Overall Study|Study terminated by sponsor|4|||
161467029|NCT01925274|583106795|FG001|Overall Study|Study terminated by sponsor|0|||
161467030|NCT01925274|583106796|FG002|Overall Study|Study terminated by sponsor|0|||
161467031|NCT01925274|583106794|FG000|Overall Study|Protocol amendment|1|||
161467032|NCT01925274|583106795|FG001|Overall Study|Protocol amendment|3|||
161467033|NCT01925274|583106796|FG002|Overall Study|Protocol amendment|6|||
161467034|NCT04327674|583106797|FG000|Overall Study|Protocol Violation|19|||
161467035|NCT00723398|583106802|FG000|Overall Study|Withdrawal by Subject|2|||
161467036|NCT00723398|583106803|FG001|Overall Study|Withdrawal by Subject|6|||
161467037|NCT00723398|583106804|FG002|Overall Study|Withdrawal by Subject|4|||
161467038|NCT00723398|583106805|FG003|Overall Study|Withdrawal by Subject|4|||
161467039|NCT00723398|583106806|FG004|Overall Study|Withdrawal by Subject|4|||
161467040|NCT00723398|583106802|FG000|Overall Study|Protocol Violation|2|||
161467041|NCT00723398|583106803|FG001|Overall Study|Protocol Violation|1|||
161467042|NCT00723398|583106804|FG002|Overall Study|Protocol Violation|5|||
161467043|NCT00723398|583106805|FG003|Overall Study|Protocol Violation|0|||
161467044|NCT00723398|583106806|FG004|Overall Study|Protocol Violation|0|||
161467045|NCT00723398|583106802|FG000|Overall Study|Physician Decision|2|||
161574506|NCT00419094|583489555|FG000|Overall Study|Other: No contact for extended period|0|||
161574507|NCT00419094|583489556|FG001|Overall Study|Other: No contact for extended period|1|||
161574508|NCT01337635|583489557|FG000|Overall Study|Lost to Follow-up|0|||
161574509|NCT01337635|583489558|FG001|Overall Study|Lost to Follow-up|1|||
161574510|NCT03287622|583489562|FG000|Overall Study|Withdrawal by Subject|1|||
161574511|NCT03287622|583489563|FG001|Overall Study|Withdrawal by Subject|0|||
161574512|NCT03287622|583489562|FG000|Overall Study|Lost to Follow-up|27|||
161574513|NCT03287622|583489563|FG001|Overall Study|Lost to Follow-up|15|||
161574514|NCT03287622|583489562|FG000|Overall Study|No prescripion after surgery|28|||
161574515|NCT03287622|583489563|FG001|Overall Study|No prescripion after surgery|31|||
161574516|NCT03287622|583489562|FG000|Overall Study|prolonged Length of stay|2|||
161574517|NCT03287622|583489563|FG001|Overall Study|prolonged Length of stay|0|||
161467046|NCT00723398|583106803|FG001|Overall Study|Physician Decision|2|||
161467047|NCT00723398|583106804|FG002|Overall Study|Physician Decision|5|||
161467048|NCT00723398|583106805|FG003|Overall Study|Physician Decision|0|||
161467049|NCT00723398|583106806|FG004|Overall Study|Physician Decision|1|||
161467050|NCT00723398|583106802|FG000|Overall Study|Adverse Event|0|||
161467051|NCT00723398|583106803|FG001|Overall Study|Adverse Event|5|||
161467052|NCT00723398|583106804|FG002|Overall Study|Adverse Event|3|||
161467053|NCT00723398|583106805|FG003|Overall Study|Adverse Event|1|||
161467054|NCT00723398|583106806|FG004|Overall Study|Adverse Event|4|||
161574518|NCT03287622|583489562|FG000|Overall Study|surgery related|0|||
161574519|NCT03287622|583489563|FG001|Overall Study|surgery related|2|||
161574520|NCT03192046|583489571|FG000|Overall Study|Withdrawal by Subject|1|||
161574521|NCT03192046|583489572|FG001|Overall Study|Withdrawal by Subject|1|||
161574522|NCT01194154|583489575|FG000|Overall Study|Adverse Event|12|||
161574523|NCT01194154|583489576|FG001|Overall Study|Adverse Event|7|||
161574524|NCT01194154|583489575|FG000|Overall Study|Lost to Follow-up|2|||
161574525|NCT01194154|583489576|FG001|Overall Study|Lost to Follow-up|3|||
161574526|NCT01194154|583489575|FG000|Overall Study|Protocol Violation|0|||
161574527|NCT01194154|583489576|FG001|Overall Study|Protocol Violation|1|||
161574528|NCT01194154|583489575|FG000|Overall Study|Withdrawal by Subject|5|||
161574529|NCT01194154|583489576|FG001|Overall Study|Withdrawal by Subject|6|||
161574530|NCT01194154|583489575|FG000|Overall Study|Blood pressure increase|5|||
161574531|NCT01194154|583489576|FG001|Overall Study|Blood pressure increase|3|||
161574532|NCT01194154|583489575|FG000|Overall Study|Hemoglobin decrease|0|||
161574533|NCT01194154|583489576|FG001|Overall Study|Hemoglobin decrease|1|||
161574534|NCT01194154|583489575|FG000|Overall Study|Hemoglobin increase|12|||
161574535|NCT01194154|583489576|FG001|Overall Study|Hemoglobin increase|3|||
161574536|NCT01194154|583489575|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
161574537|NCT01194154|583489576|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
161574538|NCT01194154|583489575|FG000|Overall Study|Treatment with prohibited medication|4|||
161467055|NCT00723398|583106802|FG000|Overall Study|Lost to Follow-up|0|||
161467056|NCT00723398|583106803|FG001|Overall Study|Lost to Follow-up|1|||
161574539|NCT01194154|583489576|FG001|Overall Study|Treatment with prohibited medication|5|||
161574540|NCT01194154|583489575|FG000|Overall Study|Other|4|||
161467057|NCT00723398|583106804|FG002|Overall Study|Lost to Follow-up|0|||
161467058|NCT00723398|583106805|FG003|Overall Study|Lost to Follow-up|0|||
161467059|NCT00723398|583106806|FG004|Overall Study|Lost to Follow-up|0|||
161467060|NCT00267189|583106807|FG000|Overall Study|Patient withdrew consent|1|||
161467061|NCT00267189|583106808|FG001|Overall Study|Patient withdrew consent|1|||
161467062|NCT00267189|583106807|FG000|Overall Study|Death|1|||
161467063|NCT00267189|583106808|FG001|Overall Study|Death|0|||
161574541|NCT01194154|583489576|FG001|Overall Study|Other|0|||
161574542|NCT01194154|583489575|FG000|Overall Study|Did not receive study medication|2|||
161574543|NCT01194154|583489576|FG001|Overall Study|Did not receive study medication|4|||
161574544|NCT00842257|583489577|FG000|Overall Study|Adverse Event|1|||
161574545|NCT01901276|583489578|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
161574546|NCT01901276|583489579|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
161574547|NCT02314117|583489580|FG000|Overall Study|Lost to Follow-up|9|||
161574548|NCT02314117|583489581|FG001|Overall Study|Lost to Follow-up|14|||
161574549|NCT02314117|583489580|FG000|Overall Study|Withdrawal by Subject|3|||
161574550|NCT02314117|583489581|FG001|Overall Study|Withdrawal by Subject|2|||
161574551|NCT04347954|583489585|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
161574552|NCT04347954|583489586|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
161574553|NCT04347954|583489587|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
161574554|NCT04347954|583489585|FG000|Overall Study|Lost to Follow-up|0|||
161574555|NCT04347954|583489586|FG001|Overall Study|Lost to Follow-up|1|||
161574556|NCT04347954|583489587|FG002|Overall Study|Lost to Follow-up|0|||
161574557|NCT02045836|583489588|FG000|Overall Study|Adverse Event|4|||
161574558|NCT02045836|583489589|FG001|Overall Study|Adverse Event|4|||
161574559|NCT02045836|583489588|FG000|Overall Study|Withdrawal by Subject|1|||
161574560|NCT02045836|583489589|FG001|Overall Study|Withdrawal by Subject|1|||
161574561|NCT02045836|583489588|FG000|Overall Study|Lost to Follow-up|4|||
161574562|NCT02045836|583489589|FG001|Overall Study|Lost to Follow-up|7|||
161574563|NCT02045836|583489588|FG000|Overall Study|Migrated from study area|0|||
161574564|NCT02045836|583489589|FG001|Overall Study|Migrated from study area|2|||
161574565|NCT03383146|583489590|FG000|Overall Study|Screen Failure|1|||
161574566|NCT03383146|583489591|FG001|Overall Study|Screen Failure|0|||
161574567|NCT03383146|583489590|FG000|Overall Study|Adverse Event|6|||
161574568|NCT03383146|583489591|FG001|Overall Study|Adverse Event|18|||
161574569|NCT03383146|583489590|FG000|Overall Study|Lack of Efficacy|0|||
161574570|NCT03383146|583489591|FG001|Overall Study|Lack of Efficacy|3|||
161574571|NCT03383146|583489590|FG000|Overall Study|Withdrawal by Subject|20|||
161574572|NCT03383146|583489591|FG001|Overall Study|Withdrawal by Subject|36|||
161574573|NCT03383146|583489590|FG000|Overall Study|Lost to Follow-up|5|||
161574574|NCT03383146|583489591|FG001|Overall Study|Lost to Follow-up|15|||
161574575|NCT03383146|583489590|FG000|Overall Study|Death|0|||
161467064|NCT00267189|583106807|FG000|Overall Study|Missing|3|||
161467065|NCT00267189|583106808|FG001|Overall Study|Missing|0|||
161467066|NCT00751621|583106809|FG000|Overall Study|Adverse Event|1|||
161467067|NCT00751621|583106809|FG000|Overall Study|Withdrawal by Subject|1|||
161467068|NCT00751621|583106809|FG000|Overall Study|Subject moved to another country|1|||
161467069|NCT00751621|583106809|FG000|Overall Study|Poor adherence to asthma treatment|1|||
161467070|NCT03719586|583106810|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
161467071|NCT03719586|583106811|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
161467072|NCT03719586|583106812|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
161467073|NCT03719586|583106813|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
161467074|NCT02791594|583106814|FG000|Overall Study|Physician Decision|2|||
161467075|NCT01400815|583106815|FG000|Overall Study|Adverse Event|3|||
161467076|NCT01400815|583106816|FG001|Overall Study|Adverse Event|0|||
161467077|NCT01400815|583106815|FG000|Overall Study|Death|0|||
161467078|NCT01400815|583106816|FG001|Overall Study|Death|1|||
161467079|NCT01400815|583106815|FG000|Overall Study|Lost to Follow-up|18|||
161467080|NCT01400815|583106816|FG001|Overall Study|Lost to Follow-up|11|||
161467081|NCT01400815|583106815|FG000|Overall Study|Protocol Violation|0|||
161467082|NCT01400815|583106816|FG001|Overall Study|Protocol Violation|1|||
161467083|NCT01400815|583106815|FG000|Overall Study|Physician Decision|1|||
161467084|NCT01400815|583106816|FG001|Overall Study|Physician Decision|0|||
161467085|NCT01400815|583106815|FG000|Overall Study|Withdrawal by Subject|15|||
161467086|NCT01400815|583106816|FG001|Overall Study|Withdrawal by Subject|8|||
161467087|NCT01400815|583106815|FG000|Overall Study|Subject in jail|1|||
161467088|NCT01400815|583106816|FG001|Overall Study|Subject in jail|0|||
161467089|NCT02310321|583106818|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
161467090|NCT02310321|583106819|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
161467091|NCT02310321|583106820|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
161467092|NCT02310321|583106818|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
161467093|NCT02310321|583106819|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
161467094|NCT02310321|583106820|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
161467095|NCT02310321|583106818|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
161467096|NCT02310321|583106819|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
161467097|NCT02310321|583106820|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
161467098|NCT02310321|583106818|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
161467099|NCT02310321|583106819|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
161467100|NCT02310321|583106820|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
161467101|NCT02310321|583106818|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
161467102|NCT02310321|583106819|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
161467103|NCT02310321|583106820|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
161467104|NCT02310321|583106818|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
161467105|NCT02310321|583106819|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
161467106|NCT02310321|583106820|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
161467107|NCT02310321|583106818|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
161467108|NCT02310321|583106819|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
161467109|NCT02310321|583106820|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
161574576|NCT03383146|583489591|FG001|Overall Study|Death|2|||
161467110|NCT02310321|583106818|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
161467111|NCT02310321|583106819|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
161467112|NCT02310321|583106820|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
161467113|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
161574577|NCT03383146|583489590|FG000|Overall Study|Physician Decision|0|||
161574578|NCT03383146|583489591|FG001|Overall Study|Physician Decision|1|||
161467114|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
161467115|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
161467116|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
161467117|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
161467118|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
161467119|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
161467120|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
161467121|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
161467122|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
161467123|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
161467124|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
161467125|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
161467126|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
161467127|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
161467128|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
161467129|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
161467130|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
161467131|NCT02310321|583106818|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
161467132|NCT02310321|583106819|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
161467133|NCT02310321|583106820|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
161467134|NCT02310321|583106818|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
161467135|NCT02310321|583106819|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
161467136|NCT02310321|583106820|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
161467137|NCT02310321|583106818|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
161467138|NCT02310321|583106819|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
161467139|NCT02310321|583106820|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
161467140|NCT02310321|583106818|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
161467141|NCT02310321|583106819|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
161467142|NCT02310321|583106820|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
161467143|NCT02310321|583106818|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
161467144|NCT02310321|583106819|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
161467145|NCT02310321|583106820|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
161467146|NCT02310321|583106818|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
161467147|NCT02310321|583106819|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
161467148|NCT02310321|583106820|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
161467149|NCT02310321|583106818|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
161467150|NCT02310321|583106819|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
161467151|NCT02310321|583106820|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
161467152|NCT02310321|583106818|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
161467153|NCT02310321|583106819|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
161467154|NCT02310321|583106820|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
161467155|NCT02310321|583106818|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
161467156|NCT02310321|583106819|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
161467157|NCT02310321|583106820|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
161467158|NCT04950166|583106821|FG000|Overall Study|Withdrawal by Subject|1|||
161467159|NCT01698905|583106822|FG000|Overall Study|Adverse Event|4|||
161467160|NCT01698905|583106822|FG000|Overall Study|Physician Decision|2|||
161467161|NCT01698905|583106822|FG000|Overall Study|Pregnancy|1|||
161467162|NCT01698905|583106822|FG000|Overall Study|Protocol Violation|1|||
161467163|NCT01698905|583106822|FG000|Overall Study|Subject/guardian decision|2|||
161467164|NCT01698905|583106822|FG000|Overall Study|Death|1|||
161467165|NCT05896748|583106823|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
161467166|NCT05896748|583106823|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
161467167|NCT05896748|583106823|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
161467168|NCT05896748|583106823|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
161467169|NCT05896748|583106823|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
161467170|NCT00764504|583106830|FG000|Overall Study|Death|12|||
161574579|NCT03383146|583489590|FG000|Overall Study|Protocol Deviation|1|||
161574580|NCT03383146|583489591|FG001|Overall Study|Protocol Deviation|8|||
161574581|NCT03383146|583489590|FG000|Overall Study|Study Terminated by the Sponsor|48|||
161914973|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
161467171|NCT00764504|583106831|FG001|Overall Study|Death|6|||
161467172|NCT00764504|583106832|FG002|Overall Study|Death|13|||
161467173|NCT00764504|583106830|FG000|Overall Study|Revision of Device|12|||
161914974|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
161467174|NCT00764504|583106831|FG001|Overall Study|Revision of Device|23|||
161574582|NCT03383146|583489591|FG001|Overall Study|Study Terminated by the Sponsor|95|||
161467175|NCT00764504|583106832|FG002|Overall Study|Revision of Device|14|||
161467176|NCT00764504|583106830|FG000|Overall Study|Physician Decision|1|||
161467177|NCT00764504|583106831|FG001|Overall Study|Physician Decision|0|||
161467178|NCT00764504|583106832|FG002|Overall Study|Physician Decision|0|||
161467179|NCT00764504|583106830|FG000|Overall Study|Withdrawal by Subject|1|||
161467180|NCT00764504|583106831|FG001|Overall Study|Withdrawal by Subject|7|||
161467181|NCT00764504|583106832|FG002|Overall Study|Withdrawal by Subject|4|||
161467182|NCT00764504|583106830|FG000|Overall Study|Lost to Follow-up|40|||
161467183|NCT00764504|583106831|FG001|Overall Study|Lost to Follow-up|34|||
161467184|NCT00764504|583106832|FG002|Overall Study|Lost to Follow-up|72|||
161467185|NCT01465191|583106836|FG000|Overall Study|Protocol Violation|6|||
161467186|NCT01465191|583106837|FG001|Overall Study|Protocol Violation|3|||
161467187|NCT01465191|583106838|FG002|Overall Study|Protocol Violation|3|||
161467188|NCT01465191|583106836|FG000|Overall Study|Lost to Follow-up|3|||
161467189|NCT01465191|583106837|FG001|Overall Study|Lost to Follow-up|6|||
161467190|NCT01465191|583106838|FG002|Overall Study|Lost to Follow-up|4|||
161467191|NCT00943124|583106839|FG000|Period 1|Withdrawal by Subject|1|||
161467192|NCT00943124|583106840|FG001|Period 1|Withdrawal by Subject|1|||
161467193|NCT00943124|583106839|FG000|Period 1|Did Not Follow Study Procedures|1|||
161467194|NCT00943124|583106840|FG001|Period 1|Did Not Follow Study Procedures|0|||
161467195|NCT00943124|583106839|FG000|Period 1|Personal Reasons|0|||
161467196|NCT00943124|583106840|FG001|Period 1|Personal Reasons|1|||
161467197|NCT02992132|583106841|FG000|Overall Study|Adverse Event|4|||
161467198|NCT02992132|583106842|FG001|Overall Study|Adverse Event|1|||
161467199|NCT02992132|583106843|FG002|Overall Study|Adverse Event|3|||
161467200|NCT02992132|583106841|FG000|Overall Study|Lack of Efficacy|2|||
161467201|NCT02992132|583106842|FG001|Overall Study|Lack of Efficacy|0|||
161467202|NCT02992132|583106843|FG002|Overall Study|Lack of Efficacy|0|||
161467203|NCT02992132|583106841|FG000|Overall Study|Non-compliance with study drug|2|||
161467204|NCT02992132|583106842|FG001|Overall Study|Non-compliance with study drug|0|||
161467205|NCT02992132|583106843|FG002|Overall Study|Non-compliance with study drug|0|||
161467206|NCT02992132|583106841|FG000|Overall Study|Progressive disease|1|||
161467207|NCT02992132|583106842|FG001|Overall Study|Progressive disease|0|||
161467208|NCT02992132|583106843|FG002|Overall Study|Progressive disease|0|||
161467209|NCT02992132|583106841|FG000|Overall Study|Protocol Violation|2|||
161467210|NCT02992132|583106842|FG001|Overall Study|Protocol Violation|2|||
161467211|NCT02992132|583106843|FG002|Overall Study|Protocol Violation|0|||
161467212|NCT02992132|583106841|FG000|Overall Study|Caregiver withdrew consent|2|||
161467213|NCT02992132|583106842|FG001|Overall Study|Caregiver withdrew consent|3|||
161467214|NCT02992132|583106843|FG002|Overall Study|Caregiver withdrew consent|2|||
161467215|NCT02992132|583106841|FG000|Overall Study|Withdrawal by Subject|0|||
161467216|NCT02992132|583106842|FG001|Overall Study|Withdrawal by Subject|2|||
161467217|NCT02992132|583106843|FG002|Overall Study|Withdrawal by Subject|1|||
161467218|NCT02992132|583106841|FG000|Overall Study|Physician Decision|0|||
161467219|NCT02992132|583106842|FG001|Overall Study|Physician Decision|0|||
161467220|NCT02992132|583106843|FG002|Overall Study|Physician Decision|1|||
161467221|NCT04795622|583106846|FG000|Overall Study|Adverse Event|1|||
161467222|NCT04795622|583106847|FG001|Overall Study|Adverse Event|0|||
161467223|NCT04795622|583106846|FG000|Overall Study|Withdrawal by Subject|3|||
161467224|NCT04795622|583106847|FG001|Overall Study|Withdrawal by Subject|3|||
161467225|NCT04795622|583106846|FG000|Overall Study|Protocol Violation|0|||
161467226|NCT04795622|583106847|FG001|Overall Study|Protocol Violation|2|||
161467227|NCT04795622|583106846|FG000|Overall Study|Lost to Follow-up|2|||
161467228|NCT04795622|583106847|FG001|Overall Study|Lost to Follow-up|3|||
161467229|NCT04795622|583106846|FG000|Overall Study|Other|7|||
161467230|NCT04795622|583106847|FG001|Overall Study|Other|8|||
161467231|NCT02314143|583106848|FG000|Overall Study|Adverse Event|0|||
161467232|NCT02314143|583106849|FG001|Overall Study|Adverse Event|6|||
161467233|NCT02314143|583106850|FG002|Overall Study|Adverse Event|4|||
161467234|NCT02314143|583106848|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
161467235|NCT02314143|583106849|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
161467236|NCT02314143|583106850|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
161467237|NCT02314143|583106848|FG000|Overall Study|Physician Decision|2|||
161467238|NCT02314143|583106849|FG001|Overall Study|Physician Decision|1|||
161467239|NCT02314143|583106850|FG002|Overall Study|Physician Decision|0|||
161467240|NCT02314143|583106848|FG000|Overall Study|Withdrawal by Subject|1|||
161467241|NCT02314143|583106849|FG001|Overall Study|Withdrawal by Subject|0|||
161467242|NCT02314143|583106850|FG002|Overall Study|Withdrawal by Subject|1|||
161467243|NCT03963401|583106854|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
161467244|NCT03963401|583106855|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
161467245|NCT03963401|583106856|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
161467246|NCT03963401|583106857|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
161467247|NCT03963401|583106858|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
161467248|NCT03963401|583106859|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
161467249|NCT03963401|583106854|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
161467250|NCT03963401|583106855|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
161467251|NCT03963401|583106856|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
161467252|NCT03963401|583106857|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
161467253|NCT03963401|583106858|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
161467254|NCT03963401|583106859|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
161467255|NCT03963401|583106854|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
161467256|NCT03963401|583106855|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
161467257|NCT03963401|583106856|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
161467258|NCT03963401|583106857|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
161467259|NCT03963401|583106858|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
161467260|NCT03963401|583106859|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
161467261|NCT03963401|583106854|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
161467262|NCT03963401|583106855|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
161467263|NCT03963401|583106856|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
161467264|NCT03963401|583106857|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
161467265|NCT03963401|583106858|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
161467266|NCT03963401|583106859|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
161467267|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
161467268|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
161467269|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
161467270|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
161467271|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
161467272|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
161467273|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
161467274|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
161467275|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
161467276|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
161467277|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
161467278|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
161467279|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
161467280|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
161467281|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
161467282|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
161467283|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
161467284|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
161467285|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
161467286|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
161467287|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
161467288|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
161467289|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
161467290|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
161467291|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
161467292|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
161467293|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
161467294|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
161467295|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
161467296|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
161467297|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
161467298|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161467299|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161467300|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161467301|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161467302|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161467303|NCT03963401|583106854|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
161467304|NCT03963401|583106855|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
161467305|NCT03963401|583106856|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
161467306|NCT03963401|583106857|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
161467307|NCT03963401|583106858|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
161467308|NCT03963401|583106859|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
161467309|NCT01070043|583106871|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
161467310|NCT01070043|583106872|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
161467311|NCT01070043|583106873|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
161467312|NCT01070043|583106871|FG000|Double-Blind Treatment|Adverse Event|0|||
161467313|NCT01070043|583106872|FG001|Double-Blind Treatment|Adverse Event|0|||
161467314|NCT01070043|583106873|FG002|Double-Blind Treatment|Adverse Event|2|||
161467315|NCT01528215|583106874|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
161467316|NCT01528215|583106875|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
161467317|NCT01528215|583106874|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
161467318|NCT01528215|583106875|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
161467319|NCT01528215|583106874|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
161467320|NCT01528215|583106875|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
161467321|NCT01528215|583106874|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
161467322|NCT01528215|583106875|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
161467323|NCT01610271|583106878|FG000|Overall Study|Surgery not complete|0|||
161467324|NCT01610271|583106879|FG001|Overall Study|Surgery not complete|1|||
161467325|NCT01610271|583106878|FG000|Overall Study|Prosthesis not implanted|2|||
161467326|NCT01610271|583106879|FG001|Overall Study|Prosthesis not implanted|3|||
161467327|NCT01638819|583106880|FG000|Overall Study|Lost to Follow-up|1|||
161467328|NCT01638819|583106881|FG001|Overall Study|Lost to Follow-up|0|||
161467329|NCT00923936|583106882|FG000|Overall Study|progressive disease on study|2|||
161467330|NCT00923936|583106883|FG001|Overall Study|progressive disease on study|1|||
161467331|NCT00923936|583106882|FG000|Overall Study|Adverse Event|2|||
161467332|NCT00923936|583106883|FG001|Overall Study|Adverse Event|1|||
161467333|NCT00923936|583106882|FG000|Overall Study|Lost to follow up|2|||
161467334|NCT00923936|583106883|FG001|Overall Study|Lost to follow up|0|||
161467335|NCT00923936|583106882|FG000|Overall Study|Continuing in follow up period|2|||
161467336|NCT00923936|583106883|FG001|Overall Study|Continuing in follow up period|1|||
161467337|NCT02038452|583106884|FG000|Overall Study|Withdrawal by Subject|7|||
161467338|NCT02038452|583106885|FG001|Overall Study|Withdrawal by Subject|9|||
161467339|NCT02038452|583106884|FG000|Overall Study|Lost to Follow-up|31|||
161467340|NCT02038452|583106885|FG001|Overall Study|Lost to Follow-up|28|||
161467341|NCT01626495|583106887|FG000|Overall Study|Adverse Event|3|||
161467342|NCT01626495|583106887|FG000|Overall Study|Disease progression|27|||
161467343|NCT01626495|583106887|FG000|Overall Study|Withdrawal by Subject|1|||
161467344|NCT01626495|583106887|FG000|Overall Study|Administrative problem|1|||
161467345|NCT01626495|583106887|FG000|Overall Study|Death|2|||
161467346|NCT01626495|583106887|FG000|Overall Study|Physician Decision|1|||
161467347|NCT01626495|583106887|FG000|Overall Study|New cancer therapy|16|||
161467348|NCT01626495|583106887|FG000|Overall Study|Manufacturing failure|1|||
161467349|NCT01278160|583106888|FG000|Overall Study|Adverse Event|1|||
161467350|NCT01278160|583106889|FG001|Overall Study|Adverse Event|1|||
161467351|NCT01278160|583106888|FG000|Overall Study|Lost to Follow-up|0|||
161467352|NCT01278160|583106889|FG001|Overall Study|Lost to Follow-up|1|||
161467353|NCT01278160|583106888|FG000|Overall Study|Withdrawal by Subject|3|||
161467354|NCT01278160|583106889|FG001|Overall Study|Withdrawal by Subject|2|||
161467355|NCT01278160|583106888|FG000|Overall Study|Unclassified|1|||
161467356|NCT01278160|583106889|FG001|Overall Study|Unclassified|2|||
161467357|NCT00304239|583106890|FG000|Overall Study|Protocol Deviations/Violations|15|||
161467358|NCT00304239|583106891|FG001|Overall Study|Protocol Deviations/Violations|0|||
161467359|NCT00304239|583106890|FG000|Overall Study|Adverse Event|2|||
161467360|NCT00304239|583106891|FG001|Overall Study|Adverse Event|0|||
161467361|NCT02979197|583106892|FG000|Overall Study|Adverse Event|4|||
161467362|NCT02979197|583106893|FG001|Overall Study|Adverse Event|2|||
161467363|NCT02979197|583106894|FG002|Overall Study|Adverse Event|0|||
161467364|NCT02979197|583106892|FG000|Overall Study|Protocol Violation|0|||
161467365|NCT02979197|583106893|FG001|Overall Study|Protocol Violation|1|||
161467366|NCT02979197|583106894|FG002|Overall Study|Protocol Violation|0|||
161467367|NCT02979197|583106892|FG000|Overall Study|Subject unable to commit to study dates|0|||
161467368|NCT02979197|583106893|FG001|Overall Study|Subject unable to commit to study dates|1|||
161467369|NCT02979197|583106894|FG002|Overall Study|Subject unable to commit to study dates|0|||
161467370|NCT02435069|583106895|FG000|Dose Response - First Intervention|Adverse Event|0|||
161467371|NCT02435069|583106896|FG001|Dose Response - First Intervention|Adverse Event|1|||
161467372|NCT02435069|583106897|FG002|Dose Response - First Intervention|Adverse Event|1|||
161467373|NCT02435069|583106898|FG003|Dose Response - First Intervention|Adverse Event|0|||
161467374|NCT02435069|583106899|FG004|Dose Response - First Intervention|Adverse Event|0|||
161467375|NCT02435069|583106895|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
161467376|NCT02435069|583106896|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
161810591|NCT03570749|584349457|FG001|Overall Study|Screen Fail|0|||
161810592|NCT03570749|584349458|FG002|Overall Study|Screen Fail|0|||
161467377|NCT02435069|583106897|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
161467378|NCT02435069|583106898|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
161467379|NCT02435069|583106899|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
161467380|NCT02030938|583106900|FG000|Overall Study|Lost to Follow-up|4|||
161574583|NCT03383146|583489590|FG000|Overall Study|Reason not Specified|4|||
161574584|NCT03383146|583489591|FG001|Overall Study|Reason not Specified|6|||
161574585|NCT00539292|583489592|FG000|Overall Study|Physician Decision|1|||
161574586|NCT00539292|583489593|FG001|Overall Study|Physician Decision|0|||
161574587|NCT00361283|583489605|FG000|Overall Study|Lost to Follow-up|27|||
161574588|NCT01837641|583489606|FG000|Overall Study|Sponsor decision|1|||
161574589|NCT01837641|583489607|FG001|Overall Study|Sponsor decision|0|||
161574590|NCT01837641|583489608|FG002|Overall Study|Sponsor decision|0|||
161574591|NCT01837641|583489609|FG003|Overall Study|Sponsor decision|0|||
161574592|NCT01837641|583489610|FG004|Overall Study|Sponsor decision|0|||
161574593|NCT01837641|583489611|FG005|Overall Study|Sponsor decision|1|||
161574594|NCT01837641|583489612|FG006|Overall Study|Sponsor decision|0|||
161574595|NCT01837641|583489613|FG007|Overall Study|Sponsor decision|0|||
161574596|NCT01837641|583489606|FG000|Overall Study|Adverse Event|0|||
161574597|NCT01837641|583489607|FG001|Overall Study|Adverse Event|0|||
161574598|NCT01837641|583489608|FG002|Overall Study|Adverse Event|0|||
161574599|NCT01837641|583489609|FG003|Overall Study|Adverse Event|0|||
161574600|NCT01837641|583489610|FG004|Overall Study|Adverse Event|0|||
161574601|NCT01837641|583489611|FG005|Overall Study|Adverse Event|1|||
161574602|NCT01837641|583489612|FG006|Overall Study|Adverse Event|0|||
161574603|NCT01837641|583489613|FG007|Overall Study|Adverse Event|0|||
161574604|NCT01837641|583489606|FG000|Overall Study|Withdrawal by Subject|0|||
161574605|NCT01837641|583489607|FG001|Overall Study|Withdrawal by Subject|0|||
161574606|NCT01837641|583489608|FG002|Overall Study|Withdrawal by Subject|0|||
161574607|NCT01837641|583489609|FG003|Overall Study|Withdrawal by Subject|0|||
161574608|NCT01837641|583489610|FG004|Overall Study|Withdrawal by Subject|1|||
161574609|NCT01837641|583489611|FG005|Overall Study|Withdrawal by Subject|0|||
161574610|NCT01837641|583489612|FG006|Overall Study|Withdrawal by Subject|1|||
161574611|NCT01837641|583489613|FG007|Overall Study|Withdrawal by Subject|0|||
161574612|NCT01579916|583489614|FG000|Overall Study|Lost to Follow-up|6|||
161574613|NCT01579916|583489615|FG001|Overall Study|Lost to Follow-up|1|||
161574614|NCT01579916|583489614|FG000|Overall Study|Withdrawal by Subject|1|||
161574615|NCT01579916|583489615|FG001|Overall Study|Withdrawal by Subject|1|||
161574616|NCT01579916|583489614|FG000|Overall Study|Death|1|||
161810593|NCT03570749|584349459|FG003|Overall Study|Screen Fail|0|||
161810594|NCT03570749|584349460|FG004|Overall Study|Screen Fail|0|||
161810595|NCT03570749|584349461|FG005|Overall Study|Screen Fail|0|||
161467381|NCT02030938|583106900|FG000|Overall Study|Withdrawal by Subject|1|||
161467382|NCT00932737|583106903|FG000|Overall Study|Not treated in second episode|1|||
161467383|NCT00932737|583106904|FG001|Overall Study|Not treated in second episode|0|||
161467384|NCT00932737|583106903|FG000|Overall Study|Adverse Event|0|||
161467385|NCT00932737|583106904|FG001|Overall Study|Adverse Event|1|||
161467386|NCT05430022|583106915|FG000|Overall Study|Withdrawal by Subject|4|||
161467387|NCT05430022|583106916|FG001|Overall Study|Withdrawal by Subject|4|||
161467388|NCT05521906|583106917|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
161467389|NCT05521906|583106918|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
161467390|NCT02452697|583106919|FG000|Overall Study|Physician Decision|4|||
161467391|NCT02452697|583106920|FG001|Overall Study|Physician Decision|4|||
161467392|NCT02452697|583106921|FG002|Overall Study|Physician Decision|3|||
161467393|NCT02452697|583106922|FG003|Overall Study|Physician Decision|2|||
161574617|NCT01579916|583489615|FG001|Overall Study|Death|0|||
161574618|NCT03264456|583489618|FG000|Overall Study|Withdrawal by Subject|3|||
161574619|NCT03264456|583489618|FG000|Overall Study|Lost to Follow-up|1|||
161574620|NCT01123083|583489625|FG000|Overall Study|Investigator recommendation|1|||
161574621|NCT01123083|583489626|FG001|Overall Study|Investigator recommendation|1|||
161574622|NCT01123083|583489625|FG000|Overall Study|Administrative reasons|0|||
161574623|NCT01123083|583489626|FG001|Overall Study|Administrative reasons|4|||
161574624|NCT01123083|583489625|FG000|Overall Study|Lost to Follow-up|2|||
161574625|NCT01123083|583489626|FG001|Overall Study|Lost to Follow-up|6|||
161810596|NCT03570749|584349462|FG006|Overall Study|Screen Fail|1|||
161810597|NCT03570749|584349456|FG000|Overall Study|Withdrawal by Subject|2|||
161810598|NCT03570749|584349457|FG001|Overall Study|Withdrawal by Subject|3|||
161810599|NCT03570749|584349458|FG002|Overall Study|Withdrawal by Subject|2|||
161810600|NCT03570749|584349459|FG003|Overall Study|Withdrawal by Subject|1|||
161810601|NCT03570749|584349460|FG004|Overall Study|Withdrawal by Subject|17|||
161810602|NCT03570749|584349461|FG005|Overall Study|Withdrawal by Subject|12|||
161810603|NCT03570749|584349462|FG006|Overall Study|Withdrawal by Subject|15|||
161810604|NCT03570749|584349456|FG000|Overall Study|Other|0|||
161810605|NCT03570749|584349457|FG001|Overall Study|Other|0|||
161810606|NCT03570749|584349458|FG002|Overall Study|Other|0|||
161810607|NCT03570749|584349459|FG003|Overall Study|Other|0|||
161810608|NCT03570749|584349460|FG004|Overall Study|Other|17|||
161810609|NCT03570749|584349461|FG005|Overall Study|Other|14|||
161810610|NCT03570749|584349462|FG006|Overall Study|Other|21|||
161574626|NCT01123083|583489625|FG000|Overall Study|Adverse Event|1|||
161574627|NCT01123083|583489626|FG001|Overall Study|Adverse Event|0|||
161574628|NCT01123083|583489625|FG000|Overall Study|Withdrew for another reason not covered|0|||
161574629|NCT01123083|583489626|FG001|Overall Study|Withdrew for another reason not covered|1|||
161574630|NCT01123083|583489625|FG000|Overall Study|Participant/legal representative request|7|||
161574631|NCT01123083|583489626|FG001|Overall Study|Participant/legal representative request|3|||
161574632|NCT03768206|583489627|FG000|Overall Study|Lost to Follow-up|2|||
161574633|NCT03768206|583489628|FG001|Overall Study|Lost to Follow-up|1|||
161574634|NCT03768206|583489627|FG000|Overall Study|Withdrawal by Subject|0|||
161574635|NCT03768206|583489628|FG001|Overall Study|Withdrawal by Subject|1|||
161574636|NCT02106442|583489631|FG000|Overall Study|Case Report Forms Uncollected|7|||
161574637|NCT02106442|583489631|FG000|Overall Study|Protocol Deviation|30|||
161574651|NCT06269640|583491820|FG000|Overall Study|Death|1|||
161574652|NCT00423098|583491821|FG000|Overall Study|Adverse Event|1|||
161574653|NCT00423098|583491822|FG001|Overall Study|Adverse Event|2|||
161574654|NCT00423098|583491821|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161574655|NCT00423098|583491822|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161574656|NCT00423098|583491821|FG000|Overall Study|Administrative problems|0|||
161574657|NCT00423098|583491822|FG001|Overall Study|Administrative problems|1|||
161574658|NCT00423098|583491821|FG000|Overall Study|Death|2|||
161574659|NCT00423098|583491822|FG001|Overall Study|Death|0|||
161574660|NCT02383472|583491829|FG000|Overall Study|Withdrawal by Subject|1|||
161574661|NCT02383472|583491830|FG001|Overall Study|Withdrawal by Subject|1|||
161574662|NCT02013830|583491831|FG000|Overall Study|Adverse Event|3|||
161574663|NCT02013830|583491831|FG000|Overall Study|Death|1|||
161574664|NCT02013830|583491831|FG000|Overall Study|Insufficient therapeutic response|25|||
161574665|NCT02013830|583491831|FG000|Overall Study|Refused treatment|1|||
161574666|NCT01111526|583491832|FG000|Overall Study|GVHD Disease Progression|0|||
161574667|NCT01111526|583491833|FG001|Overall Study|GVHD Disease Progression|1|||
161574668|NCT01111526|583491834|FG002|Overall Study|GVHD Disease Progression|2|||
161574669|NCT04424641|583491835|FG000|Overall Study|Death|1|||
161574670|NCT04424641|583491836|FG001|Overall Study|Death|2|||
161574671|NCT04424641|583491837|FG002|Overall Study|Death|3|||
161574672|NCT04424641|583491838|FG003|Overall Study|Death|0|||
161574673|NCT04424641|583491839|FG004|Overall Study|Death|3|||
161574674|NCT04424641|583491840|FG005|Overall Study|Death|0|||
161574675|NCT04424641|583491841|FG006|Overall Study|Death|1|||
161574676|NCT04424641|583491842|FG007|Overall Study|Death|2|||
161574677|NCT04424641|583491835|FG000|Overall Study|Sponsor decision|0|||
161574678|NCT04424641|583491836|FG001|Overall Study|Sponsor decision|2|||
161574679|NCT04424641|583491837|FG002|Overall Study|Sponsor decision|3|||
161574680|NCT04424641|583491838|FG003|Overall Study|Sponsor decision|7|||
161574681|NCT04424641|583491839|FG004|Overall Study|Sponsor decision|2|||
161574682|NCT04424641|583491840|FG005|Overall Study|Sponsor decision|2|||
161574683|NCT04424641|583491841|FG006|Overall Study|Sponsor decision|3|||
161574684|NCT04424641|583491842|FG007|Overall Study|Sponsor decision|4|||
161574685|NCT04424641|583491835|FG000|Overall Study|Withdrawal by Subject|0|||
161574686|NCT04424641|583491836|FG001|Overall Study|Withdrawal by Subject|0|||
161574687|NCT04424641|583491837|FG002|Overall Study|Withdrawal by Subject|0|||
161574688|NCT04424641|583491838|FG003|Overall Study|Withdrawal by Subject|0|||
161574689|NCT04424641|583491839|FG004|Overall Study|Withdrawal by Subject|1|||
161574690|NCT04424641|583491840|FG005|Overall Study|Withdrawal by Subject|0|||
161574691|NCT04424641|583491841|FG006|Overall Study|Withdrawal by Subject|0|||
161574692|NCT04424641|583491842|FG007|Overall Study|Withdrawal by Subject|0|||
161574693|NCT04424641|583491835|FG000|Overall Study|Other|0|||
161574694|NCT04424641|583491836|FG001|Overall Study|Other|0|||
161574695|NCT04424641|583491837|FG002|Overall Study|Other|1|||
161574696|NCT04424641|583491838|FG003|Overall Study|Other|0|||
161574697|NCT04424641|583491839|FG004|Overall Study|Other|0|||
161574698|NCT04424641|583491840|FG005|Overall Study|Other|0|||
161574699|NCT04424641|583491841|FG006|Overall Study|Other|0|||
161574700|NCT04424641|583491842|FG007|Overall Study|Other|0|||
161574701|NCT01171625|583491843|FG000|Overall Study|On-Protocol|67|||
161574702|NCT01171625|583491843|FG000|Overall Study|Death|38|||
161574703|NCT01171625|583491843|FG000|Overall Study|Withdrawal by Subject|31|||
161574704|NCT01171625|583491843|FG000|Overall Study|Explanted|10|||
161467394|NCT02452697|583106919|FG000|Overall Study|Withdrawal by Subject|1|||
161467395|NCT02452697|583106920|FG001|Overall Study|Withdrawal by Subject|0|||
161467396|NCT02452697|583106921|FG002|Overall Study|Withdrawal by Subject|0|||
161467397|NCT02452697|583106922|FG003|Overall Study|Withdrawal by Subject|0|||
161467398|NCT02452697|583106919|FG000|Overall Study|still in follow-up|2|||
161467399|NCT02452697|583106920|FG001|Overall Study|still in follow-up|2|||
161467400|NCT02452697|583106921|FG002|Overall Study|still in follow-up|1|||
161467401|NCT02452697|583106922|FG003|Overall Study|still in follow-up|3|||
161467402|NCT00866788|583109390|FG000|Overall Study|Adverse Event|0|||
161467403|NCT00866788|583109391|FG001|Overall Study|Adverse Event|2|||
161467404|NCT00866788|583109392|FG002|Overall Study|Adverse Event|0|||
161467405|NCT00866788|583109393|FG003|Overall Study|Adverse Event|1|||
161467406|NCT00866788|583109390|FG000|Overall Study|Lost to Follow-up|1|||
161467407|NCT00866788|583109391|FG001|Overall Study|Lost to Follow-up|1|||
161467408|NCT00866788|583109392|FG002|Overall Study|Lost to Follow-up|0|||
161467409|NCT00866788|583109393|FG003|Overall Study|Lost to Follow-up|2|||
161467410|NCT00866788|583109390|FG000|Overall Study|Withdrawal by Subject|2|||
161467411|NCT00866788|583109391|FG001|Overall Study|Withdrawal by Subject|1|||
161467412|NCT00866788|583109392|FG002|Overall Study|Withdrawal by Subject|0|||
161467413|NCT00866788|583109393|FG003|Overall Study|Withdrawal by Subject|1|||
161467414|NCT00866788|583109390|FG000|Overall Study|Pregnancy|0|||
161467415|NCT00866788|583109391|FG001|Overall Study|Pregnancy|1|||
161467416|NCT00866788|583109392|FG002|Overall Study|Pregnancy|0|||
161467417|NCT00866788|583109393|FG003|Overall Study|Pregnancy|0|||
161467418|NCT00866788|583109390|FG000|Overall Study|Disease progression|3|||
161467419|NCT00866788|583109391|FG001|Overall Study|Disease progression|1|||
161467420|NCT00866788|583109392|FG002|Overall Study|Disease progression|1|||
161467421|NCT00866788|583109393|FG003|Overall Study|Disease progression|0|||
161467422|NCT00866788|583109390|FG000|Overall Study|Physician Decision|0|||
161467423|NCT00866788|583109391|FG001|Overall Study|Physician Decision|0|||
161467424|NCT00866788|583109392|FG002|Overall Study|Physician Decision|1|||
161467425|NCT00866788|583109393|FG003|Overall Study|Physician Decision|1|||
161467426|NCT02349061|583109395|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
161467427|NCT02349061|583109396|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
161467428|NCT02349061|583109397|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
161467429|NCT02349061|583109395|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
161467430|NCT02349061|583109396|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
161467431|NCT02349061|583109397|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
161467432|NCT02349061|583109395|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
161467433|NCT02349061|583109396|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
161467434|NCT02349061|583109397|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
161467435|NCT02349061|583109395|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
161467436|NCT02349061|583109396|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
161467437|NCT02349061|583109397|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
161467438|NCT02349061|583109395|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
161467439|NCT02349061|583109396|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
161467440|NCT02349061|583109397|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
161467441|NCT02349061|583109395|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
161467442|NCT02349061|583109396|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
161467443|NCT02349061|583109397|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
161467444|NCT02349061|583109395|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
161467445|NCT02349061|583109396|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
161467446|NCT02349061|583109397|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
161467447|NCT02349061|583109395|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
161467448|NCT02349061|583109396|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
161467449|NCT02349061|583109397|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
161467450|NCT02349061|583109395|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
161467451|NCT02349061|583109396|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
161467452|NCT02349061|583109397|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
161467453|NCT02349061|583109395|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
161467454|NCT02349061|583109396|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
161467455|NCT02349061|583109397|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
161467456|NCT02349061|583109395|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
161467457|NCT02349061|583109396|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
161810611|NCT00561015|584349463|FG000|Overall Study|Adverse Event|0|||
161810612|NCT00561015|584349464|FG001|Overall Study|Adverse Event|0|||
161810613|NCT00561015|584349465|FG002|Overall Study|Adverse Event|0|||
161810614|NCT00561015|584349466|FG003|Overall Study|Adverse Event|0|||
161810615|NCT00561015|584349467|FG004|Overall Study|Adverse Event|1|||
161810616|NCT00561015|584349468|FG005|Overall Study|Adverse Event|0|||
161810617|NCT00561015|584349463|FG000|Overall Study|Lost to Follow-up|2|||
161810618|NCT00561015|584349464|FG001|Overall Study|Lost to Follow-up|0|||
161810619|NCT00561015|584349465|FG002|Overall Study|Lost to Follow-up|0|||
161810620|NCT00561015|584349466|FG003|Overall Study|Lost to Follow-up|1|||
161810621|NCT00561015|584349467|FG004|Overall Study|Lost to Follow-up|0|||
161810622|NCT00561015|584349468|FG005|Overall Study|Lost to Follow-up|3|||
161810623|NCT00561015|584349463|FG000|Overall Study|Participant non-compliance|2|||
161810624|NCT00561015|584349464|FG001|Overall Study|Participant non-compliance|0|||
161467458|NCT02349061|583109397|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
161467459|NCT02349061|583109395|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
161467460|NCT02349061|583109396|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
161467461|NCT02349061|583109397|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
161467462|NCT02349061|583109395|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
161467463|NCT02349061|583109396|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
161467464|NCT02349061|583109397|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
161467465|NCT01397162|583109398|FG000|Overall Study|Adverse Event|4|||
161467466|NCT01397162|583109399|FG001|Overall Study|Adverse Event|0|||
161467467|NCT01397162|583109400|FG002|Overall Study|Adverse Event|0|||
161467468|NCT01397162|583109401|FG003|Overall Study|Adverse Event|0|||
161467469|NCT01397162|583109402|FG004|Overall Study|Adverse Event|0|||
161467470|NCT01397162|583109398|FG000|Overall Study|Not yet defined|3|||
161467471|NCT01397162|583109399|FG001|Overall Study|Not yet defined|4|||
161467472|NCT01397162|583109400|FG002|Overall Study|Not yet defined|3|||
161467473|NCT01397162|583109401|FG003|Overall Study|Not yet defined|5|||
161467474|NCT01397162|583109402|FG004|Overall Study|Not yet defined|3|||
161467475|NCT02339285|583109403|FG000|Overall Study|Withdrawal by Subject|0|||
161467476|NCT02339285|583109404|FG001|Overall Study|Withdrawal by Subject|1|||
161467477|NCT02339285|583109405|FG002|Overall Study|Withdrawal by Subject|1|||
161467478|NCT02339285|583109403|FG000|Overall Study|Lost to Follow-up|1|||
161467479|NCT02339285|583109404|FG001|Overall Study|Lost to Follow-up|1|||
161467480|NCT02339285|583109405|FG002|Overall Study|Lost to Follow-up|1|||
161467481|NCT02339285|583109403|FG000|Overall Study|Protocol Deviation|0|||
161467482|NCT02339285|583109404|FG001|Overall Study|Protocol Deviation|1|||
161467483|NCT02339285|583109405|FG002|Overall Study|Protocol Deviation|0|||
161467484|NCT01507298|583109408|FG000|Overall Study|Protocol Violation|0|||
161467485|NCT01507298|583109409|FG001|Overall Study|Protocol Violation|6|||
161467486|NCT00195273|583109410|FG000|Overall Study|Adverse Event|9|||
161467487|NCT00195273|583109411|FG001|Overall Study|Adverse Event|9|||
161467488|NCT00195273|583109410|FG000|Overall Study|Protocol deviation|0|||
161467489|NCT00195273|583109411|FG001|Overall Study|Protocol deviation|1|||
161467490|NCT00195273|583109410|FG000|Overall Study|Lack of Efficacy|3|||
161467491|NCT00195273|583109411|FG001|Overall Study|Lack of Efficacy|1|||
161467492|NCT00195273|583109410|FG000|Overall Study|Procedural complications|9|||
161467493|NCT00195273|583109411|FG001|Overall Study|Procedural complications|3|||
161467494|NCT02367131|583109412|FG000|Overall Study|Adverse Event|64|||
161467495|NCT02367131|583109412|FG000|Overall Study|No visit since the first visit|3|||
161467496|NCT02367131|583109412|FG000|Overall Study|Request by patient|53|||
161467497|NCT02367131|583109412|FG000|Overall Study|Improvement/remission|2|||
161467498|NCT02367131|583109412|FG000|Overall Study|No change/progressive disease|78|||
161467499|NCT02367131|583109412|FG000|Overall Study|Other than stated above|20|||
161467500|NCT02367131|583109412|FG000|Overall Study|Not treated|2|||
161467501|NCT01051466|583109418|FG000|Overall Study|Adverse Event|1|||
161467502|NCT01051466|583109419|FG001|Overall Study|Adverse Event|0|||
161467503|NCT01051466|583109418|FG000|Overall Study|Lost to Follow-up|1|||
161467504|NCT01051466|583109419|FG001|Overall Study|Lost to Follow-up|1|||
161467505|NCT01051466|583109418|FG000|Overall Study|Withdrawal by Subject|5|||
161467506|NCT01051466|583109419|FG001|Overall Study|Withdrawal by Subject|1|||
161467507|NCT01051466|583109418|FG000|Overall Study|Entry Criteria Not Met|0|||
161467508|NCT01051466|583109419|FG001|Overall Study|Entry Criteria Not Met|3|||
161467509|NCT01051466|583109418|FG000|Overall Study|Physician Decision|1|||
161467510|NCT01051466|583109419|FG001|Overall Study|Physician Decision|0|||
161467511|NCT00810108|583109420|FG000|Overall Study|Withdrawal by Subject|1|||
161467512|NCT00810108|583109421|FG001|Overall Study|Withdrawal by Subject|0|||
161467513|NCT03793556|583109425|FG000|Overall Study|Withdrawal by Subject|12|||
161574705|NCT01171625|583491843|FG000|Overall Study|Lost to Follow-up|5|||
161574706|NCT01171625|583491843|FG000|Overall Study|Patient received valve-in-valve|3|||
161467514|NCT03793556|583109426|FG001|Overall Study|Withdrawal by Subject|1|||
161467515|NCT03793556|583109425|FG000|Overall Study|Lost to Follow-up|1|||
161574707|NCT01171625|583491843|FG000|Overall Study|Other|1|||
161467516|NCT03793556|583109426|FG001|Overall Study|Lost to Follow-up|1|||
161467517|NCT01325623|583109427|FG000|Overall Study|Withdrawal by Subject|3|||
161467518|NCT02556203|583109436|FG000|Overall Study|Withdrawal by Subject|21|||
161467519|NCT02556203|583109437|FG001|Overall Study|Withdrawal by Subject|21|||
161574708|NCT01171625|583491843|FG000|Overall Study|Consented but did not receive device|25|||
161467520|NCT02556203|583109436|FG000|Overall Study|Lost to Follow-up|5|||
161467521|NCT02556203|583109437|FG001|Overall Study|Lost to Follow-up|5|||
161467522|NCT02556203|583109436|FG000|Overall Study|Adverse Event|1|||
161467523|NCT02556203|583109437|FG001|Overall Study|Adverse Event|0|||
161574709|NCT00799396|583491844|FG000|Clopidogrel Treatment|Adverse Event|6|||
161574710|NCT00799396|583491844|FG000|Clopidogrel Treatment|Physician Decision|5|||
161574711|NCT00799396|583491844|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
161574712|NCT00799396|583491844|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
161574713|NCT00799396|583491844|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
161574714|NCT01307267|583491845|FG000|Overall Study|Death|4|||
161574715|NCT01307267|583491846|FG001|Overall Study|Death|3|||
161574716|NCT01307267|583491847|FG002|Overall Study|Death|5|||
161574717|NCT01307267|583491848|FG003|Overall Study|Death|3|||
161574718|NCT01307267|583491849|FG004|Overall Study|Death|1|||
161574719|NCT01307267|583491850|FG005|Overall Study|Death|26|||
161574720|NCT01307267|583491851|FG006|Overall Study|Death|2|||
161574721|NCT01307267|583491852|FG007|Overall Study|Death|2|||
161574722|NCT01307267|583491853|FG008|Overall Study|Death|21|||
161574723|NCT01307267|583491854|FG009|Overall Study|Death|2|||
161574724|NCT01307267|583491855|FG010|Overall Study|Death|3|||
161574725|NCT01307267|583491856|FG011|Overall Study|Death|9|||
161574726|NCT01307267|583491857|FG012|Overall Study|Death|0|||
161574727|NCT01307267|583491858|FG013|Overall Study|Death|0|||
161574728|NCT01307267|583491859|FG014|Overall Study|Death|0|||
161574729|NCT01307267|583491860|FG015|Overall Study|Death|0|||
161574730|NCT01307267|583491861|FG016|Overall Study|Death|1|||
161574731|NCT01307267|583491862|FG017|Overall Study|Death|1|||
161574732|NCT01307267|583491863|FG018|Overall Study|Death|2|||
161574733|NCT01307267|583491864|FG019|Overall Study|Death|8|||
161574734|NCT01307267|583491865|FG020|Overall Study|Death|1|||
161574735|NCT01307267|583491866|FG021|Overall Study|Death|2|||
161574736|NCT01307267|583491867|FG022|Overall Study|Death|2|||
161574737|NCT01307267|583491845|FG000|Overall Study|Lost to Follow-up|0|||
161574738|NCT01307267|583491846|FG001|Overall Study|Lost to Follow-up|0|||
161574739|NCT01307267|583491847|FG002|Overall Study|Lost to Follow-up|0|||
161574740|NCT01307267|583491848|FG003|Overall Study|Lost to Follow-up|0|||
161574741|NCT01307267|583491849|FG004|Overall Study|Lost to Follow-up|0|||
161574742|NCT01307267|583491850|FG005|Overall Study|Lost to Follow-up|7|||
161574743|NCT01307267|583491851|FG006|Overall Study|Lost to Follow-up|0|||
161574744|NCT01307267|583491852|FG007|Overall Study|Lost to Follow-up|0|||
161574745|NCT01307267|583491853|FG008|Overall Study|Lost to Follow-up|1|||
161574746|NCT01307267|583491854|FG009|Overall Study|Lost to Follow-up|2|||
161574747|NCT01307267|583491855|FG010|Overall Study|Lost to Follow-up|1|||
161574748|NCT01307267|583491856|FG011|Overall Study|Lost to Follow-up|0|||
161574749|NCT01307267|583491857|FG012|Overall Study|Lost to Follow-up|0|||
161574750|NCT01307267|583491858|FG013|Overall Study|Lost to Follow-up|0|||
161574751|NCT01307267|583491859|FG014|Overall Study|Lost to Follow-up|0|||
161574752|NCT01307267|583491860|FG015|Overall Study|Lost to Follow-up|0|||
161574753|NCT01307267|583491861|FG016|Overall Study|Lost to Follow-up|0|||
161574754|NCT01307267|583491862|FG017|Overall Study|Lost to Follow-up|0|||
161574755|NCT01307267|583491863|FG018|Overall Study|Lost to Follow-up|0|||
161574756|NCT01307267|583491864|FG019|Overall Study|Lost to Follow-up|2|||
161574757|NCT01307267|583491865|FG020|Overall Study|Lost to Follow-up|0|||
161574758|NCT01307267|583491866|FG021|Overall Study|Lost to Follow-up|0|||
161574759|NCT01307267|583491867|FG022|Overall Study|Lost to Follow-up|0|||
161574760|NCT01307267|583491845|FG000|Overall Study|Withdrawal by Subject|0|||
161574761|NCT01307267|583491846|FG001|Overall Study|Withdrawal by Subject|0|||
161574762|NCT01307267|583491847|FG002|Overall Study|Withdrawal by Subject|0|||
161574763|NCT01307267|583491848|FG003|Overall Study|Withdrawal by Subject|0|||
161574764|NCT01307267|583491849|FG004|Overall Study|Withdrawal by Subject|0|||
161574765|NCT01307267|583491850|FG005|Overall Study|Withdrawal by Subject|1|||
161574766|NCT01307267|583491851|FG006|Overall Study|Withdrawal by Subject|0|||
161574767|NCT01307267|583491852|FG007|Overall Study|Withdrawal by Subject|1|||
161574768|NCT01307267|583491853|FG008|Overall Study|Withdrawal by Subject|5|||
161574769|NCT01307267|583491854|FG009|Overall Study|Withdrawal by Subject|1|||
161574770|NCT01307267|583491855|FG010|Overall Study|Withdrawal by Subject|1|||
161574771|NCT01307267|583491856|FG011|Overall Study|Withdrawal by Subject|1|||
161574772|NCT01307267|583491857|FG012|Overall Study|Withdrawal by Subject|0|||
161574773|NCT01307267|583491858|FG013|Overall Study|Withdrawal by Subject|0|||
161574774|NCT01307267|583491859|FG014|Overall Study|Withdrawal by Subject|0|||
161574775|NCT01307267|583491860|FG015|Overall Study|Withdrawal by Subject|0|||
161574776|NCT01307267|583491861|FG016|Overall Study|Withdrawal by Subject|0|||
161574777|NCT01307267|583491862|FG017|Overall Study|Withdrawal by Subject|0|||
161574778|NCT01307267|583491863|FG018|Overall Study|Withdrawal by Subject|0|||
161574779|NCT01307267|583491864|FG019|Overall Study|Withdrawal by Subject|3|||
161574780|NCT01307267|583491865|FG020|Overall Study|Withdrawal by Subject|0|||
161574781|NCT01307267|583491866|FG021|Overall Study|Withdrawal by Subject|0|||
161574782|NCT01307267|583491867|FG022|Overall Study|Withdrawal by Subject|0|||
161574783|NCT01307267|583491845|FG000|Overall Study|Other|0|||
161574784|NCT01307267|583491846|FG001|Overall Study|Other|0|||
161574785|NCT01307267|583491847|FG002|Overall Study|Other|0|||
161574786|NCT01307267|583491848|FG003|Overall Study|Other|0|||
161574787|NCT01307267|583491849|FG004|Overall Study|Other|0|||
161574788|NCT01307267|583491850|FG005|Overall Study|Other|7|||
161574789|NCT01307267|583491851|FG006|Overall Study|Other|0|||
161574790|NCT01307267|583491852|FG007|Overall Study|Other|1|||
161574791|NCT01307267|583491853|FG008|Overall Study|Other|3|||
161574792|NCT01307267|583491854|FG009|Overall Study|Other|0|||
161574793|NCT01307267|583491855|FG010|Overall Study|Other|1|||
161574794|NCT01307267|583491856|FG011|Overall Study|Other|1|||
161574795|NCT01307267|583491857|FG012|Overall Study|Other|1|||
161574796|NCT01307267|583491858|FG013|Overall Study|Other|0|||
161574797|NCT01307267|583491859|FG014|Overall Study|Other|2|||
161574798|NCT01307267|583491860|FG015|Overall Study|Other|1|||
161574799|NCT01307267|583491861|FG016|Overall Study|Other|0|||
161574800|NCT01307267|583491862|FG017|Overall Study|Other|0|||
161914975|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
161914976|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
161914977|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
161914978|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
161914979|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
161914980|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
161914981|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
161914982|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
161914983|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
161914984|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
161914985|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
161914986|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
161914987|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
161914988|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
161914989|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
161914990|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
161914991|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
161914992|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
161914993|NCT01572792|584737356|FG000|Lead-in Study|Lost to Follow-up|5|||
161914994|NCT01572792|584737357|FG001|Lead-in Study|Lost to Follow-up|9|||
161914995|NCT01572792|584737358|FG002|Lead-in Study|Lost to Follow-up|4|||
161574801|NCT01307267|583491863|FG018|Overall Study|Other|0|||
161574802|NCT01307267|583491864|FG019|Overall Study|Other|19|||
161574803|NCT01307267|583491865|FG020|Overall Study|Other|2|||
161574804|NCT01307267|583491866|FG021|Overall Study|Other|3|||
161574805|NCT01307267|583491867|FG022|Overall Study|Other|2|||
161574806|NCT04956575|583491870|FG000|Overall Study|Death|1|||
161574807|NCT04956575|583491871|FG001|Overall Study|Death|0|||
161574808|NCT04956575|583491872|FG002|Overall Study|Death|0|||
161574809|NCT04956575|583491873|FG003|Overall Study|Death|0|||
161574810|NCT04956575|583491874|FG004|Overall Study|Death|0|||
161574811|NCT04956575|583491875|FG005|Overall Study|Death|0|||
161574812|NCT04956575|583491876|FG006|Overall Study|Death|0|||
161574813|NCT04956575|583491877|FG007|Overall Study|Death|1|||
161574814|NCT04956575|583491878|FG008|Overall Study|Death|0|||
161574815|NCT04956575|583491879|FG009|Overall Study|Death|1|||
161574816|NCT04956575|583491880|FG010|Overall Study|Death|0|||
161574817|NCT04956575|583491881|FG011|Overall Study|Death|0|||
161914996|NCT01572792|584737359|FG003|Lead-in Study|Lost to Follow-up|2|||
161914997|NCT01572792|584737360|FG004|Lead-in Study|Lost to Follow-up|4|||
161574818|NCT04956575|583491870|FG000|Overall Study|Lost to Follow-up|3|||
161574819|NCT04956575|583491871|FG001|Overall Study|Lost to Follow-up|4|||
161574820|NCT04956575|583491872|FG002|Overall Study|Lost to Follow-up|2|||
161574821|NCT04956575|583491873|FG003|Overall Study|Lost to Follow-up|3|||
161574822|NCT04956575|583491874|FG004|Overall Study|Lost to Follow-up|1|||
161574823|NCT04956575|583491875|FG005|Overall Study|Lost to Follow-up|10|||
161574824|NCT04956575|583491876|FG006|Overall Study|Lost to Follow-up|11|||
161574825|NCT04956575|583491877|FG007|Overall Study|Lost to Follow-up|7|||
161467524|NCT02943460|583109443|FG000|Blinded Study Phase|Adverse Event|3|||
161467525|NCT02943460|583109444|FG001|Blinded Study Phase|Adverse Event|0|||
161467526|NCT02943460|583109445|FG002|Blinded Study Phase|Adverse Event|0|||
161467527|NCT02943460|583109443|FG000|Blinded Study Phase|Withdrew Consent|0|||
161467528|NCT02943460|583109444|FG001|Blinded Study Phase|Withdrew Consent|1|||
161467529|NCT02943460|583109445|FG002|Blinded Study Phase|Withdrew Consent|0|||
161467530|NCT02943460|583109443|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
161467531|NCT02943460|583109444|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
161467532|NCT02943460|583109445|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
161467533|NCT02943460|583109443|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
161467534|NCT02943460|583109444|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
161467535|NCT02943460|583109445|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
161467536|NCT02943460|583109443|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
161467537|NCT02943460|583109444|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
161467538|NCT02943460|583109445|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
161467539|NCT00369122|583109446|FG000|Overall Study|Ineligible|10|||
161467540|NCT00369122|583109446|FG000|Overall Study|No protocol treatment|1|||
161467541|NCT04171765|583109447|FG000|Overall Study|Adverse Event|2|||
161467542|NCT04171765|583109448|FG001|Overall Study|Adverse Event|0|||
161467543|NCT04171765|583109449|FG002|Overall Study|Adverse Event|1|||
161467544|NCT04171765|583109450|FG003|Overall Study|Adverse Event|0|||
161467545|NCT04171765|583109447|FG000|Overall Study|Lost to Follow-up|0|||
161467546|NCT04171765|583109448|FG001|Overall Study|Lost to Follow-up|2|||
161467547|NCT04171765|583109449|FG002|Overall Study|Lost to Follow-up|2|||
161467548|NCT04171765|583109450|FG003|Overall Study|Lost to Follow-up|2|||
161467549|NCT04171765|583109447|FG000|Overall Study|Week 58 visit missed|0|||
161467550|NCT04171765|583109448|FG001|Overall Study|Week 58 visit missed|0|||
161467551|NCT04171765|583109449|FG002|Overall Study|Week 58 visit missed|1|||
161467552|NCT04171765|583109450|FG003|Overall Study|Week 58 visit missed|0|||
161467553|NCT04171765|583109447|FG000|Overall Study|Study terminated by sponsor|2|||
161467554|NCT04171765|583109448|FG001|Overall Study|Study terminated by sponsor|0|||
161467555|NCT04171765|583109449|FG002|Overall Study|Study terminated by sponsor|0|||
161467556|NCT04171765|583109450|FG003|Overall Study|Study terminated by sponsor|0|||
161467557|NCT04171765|583109447|FG000|Overall Study|Withdrawal by Subject|1|||
161467558|NCT04171765|583109448|FG001|Overall Study|Withdrawal by Subject|0|||
161467559|NCT04171765|583109449|FG002|Overall Study|Withdrawal by Subject|0|||
161467560|NCT04171765|583109450|FG003|Overall Study|Withdrawal by Subject|3|||
161467561|NCT03633617|583109451|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
161467562|NCT03633617|583109452|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
161467563|NCT03633617|583109453|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467564|NCT03633617|583109454|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467565|NCT03633617|583109455|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467566|NCT03633617|583109456|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467567|NCT03633617|583109457|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467568|NCT03633617|583109458|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467569|NCT03633617|583109459|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467570|NCT03633617|583109460|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467571|NCT03633617|583109461|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
161467572|NCT03633617|583109451|FG000|Part A|Unconfirmed early termination visit|1|||
161467573|NCT03633617|583109452|FG001|Part A|Unconfirmed early termination visit|0|||
161467574|NCT03633617|583109453|FG002|Part A|Unconfirmed early termination visit|0|||
161467575|NCT03633617|583109454|FG003|Part A|Unconfirmed early termination visit|0|||
161467576|NCT03633617|583109455|FG004|Part A|Unconfirmed early termination visit|0|||
161467577|NCT03633617|583109456|FG005|Part A|Unconfirmed early termination visit|0|||
161467578|NCT03633617|583109457|FG006|Part A|Unconfirmed early termination visit|0|||
161467579|NCT03633617|583109458|FG007|Part A|Unconfirmed early termination visit|0|||
161467580|NCT03633617|583109459|FG008|Part A|Unconfirmed early termination visit|0|||
161467581|NCT03633617|583109460|FG009|Part A|Unconfirmed early termination visit|0|||
161467582|NCT03633617|583109461|FG010|Part A|Unconfirmed early termination visit|0|||
161467583|NCT03633617|583109451|FG000|Part A|Adverse Event|0|||
161467584|NCT03633617|583109452|FG001|Part A|Adverse Event|1|||
161810625|NCT00561015|584349465|FG002|Overall Study|Participant non-compliance|0|||
161810626|NCT00561015|584349466|FG003|Overall Study|Participant non-compliance|0|||
161810627|NCT00561015|584349467|FG004|Overall Study|Participant non-compliance|0|||
161810628|NCT00561015|584349468|FG005|Overall Study|Participant non-compliance|0|||
161810629|NCT03616535|584349469|FG000|Overall Study|Death|2|||
161810630|NCT03616535|584349470|FG001|Overall Study|Death|0|||
161810631|NCT03616535|584349471|FG002|Overall Study|Death|0|||
161810632|NCT03616535|584349472|FG003|Overall Study|Death|1|||
161810633|NCT03616535|584349469|FG000|Overall Study|Lost to Follow-up|2|||
161810634|NCT03616535|584349470|FG001|Overall Study|Lost to Follow-up|1|||
161810635|NCT03616535|584349471|FG002|Overall Study|Lost to Follow-up|0|||
161810636|NCT03616535|584349472|FG003|Overall Study|Lost to Follow-up|2|||
161810637|NCT03616535|584349469|FG000|Overall Study|Withdrawal by Subject|1|||
161810638|NCT03616535|584349470|FG001|Overall Study|Withdrawal by Subject|2|||
161810639|NCT03616535|584349471|FG002|Overall Study|Withdrawal by Subject|5|||
161810640|NCT03616535|584349472|FG003|Overall Study|Withdrawal by Subject|1|||
161810641|NCT03616535|584349469|FG000|Overall Study|Not specified or change in eligibility|2|||
161810642|NCT03616535|584349470|FG001|Overall Study|Not specified or change in eligibility|3|||
161810643|NCT03616535|584349471|FG002|Overall Study|Not specified or change in eligibility|3|||
161810644|NCT03616535|584349472|FG003|Overall Study|Not specified or change in eligibility|1|||
161810645|NCT00834418|584349475|FG000|Overall Study|Adverse Event|0|||
161810646|NCT00834418|584349476|FG001|Overall Study|Adverse Event|2|||
161810647|NCT01705574|584349477|FG000|Double-Blind Phase|Lost to Follow-up|12|||
161810648|NCT01705574|584349478|FG001|Double-Blind Phase|Lost to Follow-up|16|||
161810649|NCT01705574|584349479|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161810650|NCT01705574|584349480|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161810651|NCT01705574|584349477|FG000|Double-Blind Phase|Adverse Event|3|||
161810652|NCT01705574|584349478|FG001|Double-Blind Phase|Adverse Event|10|||
161810653|NCT01705574|584349479|FG002|Double-Blind Phase|Adverse Event|0|||
161810654|NCT01705574|584349480|FG003|Double-Blind Phase|Adverse Event|0|||
161810655|NCT01705574|584349477|FG000|Double-Blind Phase|Withdrew Consent|8|||
161810656|NCT01705574|584349478|FG001|Double-Blind Phase|Withdrew Consent|5|||
161810657|NCT01705574|584349479|FG002|Double-Blind Phase|Withdrew Consent|0|||
161810658|NCT01705574|584349480|FG003|Double-Blind Phase|Withdrew Consent|0|||
161810659|NCT01705574|584349477|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
161810660|NCT01705574|584349478|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
161810661|NCT01705574|584349479|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
161810662|NCT01705574|584349480|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
161810663|NCT01705574|584349477|FG000|Double-Blind Phase|Pregnancy|1|||
161810664|NCT01705574|584349478|FG001|Double-Blind Phase|Pregnancy|1|||
161810665|NCT01705574|584349479|FG002|Double-Blind Phase|Pregnancy|0|||
161810666|NCT01705574|584349480|FG003|Double-Blind Phase|Pregnancy|0|||
161810667|NCT01705574|584349477|FG000|Double-Blind Phase|Protocol Violation|1|||
161810668|NCT01705574|584349478|FG001|Double-Blind Phase|Protocol Violation|0|||
161810669|NCT01705574|584349479|FG002|Double-Blind Phase|Protocol Violation|0|||
161810670|NCT01705574|584349480|FG003|Double-Blind Phase|Protocol Violation|0|||
161810671|NCT01705574|584349477|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
161810672|NCT01705574|584349478|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
161810673|NCT01705574|584349479|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
161810674|NCT01705574|584349480|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
161810675|NCT01705574|584349477|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
161810676|NCT01705574|584349478|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161810677|NCT01705574|584349479|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
161810678|NCT01705574|584349480|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
161810679|NCT01705574|584349477|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
161810680|NCT01705574|584349478|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
161810681|NCT01705574|584349479|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
161810682|NCT01705574|584349480|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
161467585|NCT03633617|583109453|FG002|Part A|Adverse Event|0|||
161810683|NCT01705574|584349477|FG000|Open-Label Extension Phase|Adverse Event|3|||
161810684|NCT01705574|584349478|FG001|Open-Label Extension Phase|Adverse Event|0|||
161810685|NCT01705574|584349479|FG002|Open-Label Extension Phase|Adverse Event|0|||
161810686|NCT01705574|584349480|FG003|Open-Label Extension Phase|Adverse Event|1|||
161810687|NCT01705574|584349477|FG000|Open-Label Extension Phase|Death|2|||
161810688|NCT01705574|584349478|FG001|Open-Label Extension Phase|Death|0|||
161810689|NCT01705574|584349479|FG002|Open-Label Extension Phase|Death|1|||
161810690|NCT01705574|584349480|FG003|Open-Label Extension Phase|Death|0|||
161467586|NCT03633617|583109454|FG003|Part A|Adverse Event|0|||
161467587|NCT03633617|583109455|FG004|Part A|Adverse Event|0|||
161467588|NCT03633617|583109456|FG005|Part A|Adverse Event|0|||
161810691|NCT01705574|584349477|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161810692|NCT01705574|584349478|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161810693|NCT01705574|584349479|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
161810694|NCT01705574|584349480|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161810695|NCT01705574|584349477|FG000|Open-Label Extension Phase|Physician Decision|0|||
161810696|NCT01705574|584349478|FG001|Open-Label Extension Phase|Physician Decision|0|||
161810697|NCT01705574|584349479|FG002|Open-Label Extension Phase|Physician Decision|2|||
161810698|NCT01705574|584349480|FG003|Open-Label Extension Phase|Physician Decision|0|||
161810699|NCT01705574|584349477|FG000|Open-Label Extension Phase|Pregnancy|0|||
161810700|NCT01705574|584349478|FG001|Open-Label Extension Phase|Pregnancy|0|||
161810701|NCT01705574|584349479|FG002|Open-Label Extension Phase|Pregnancy|1|||
161810702|NCT01705574|584349480|FG003|Open-Label Extension Phase|Pregnancy|1|||
161810703|NCT02659150|584349481|FG000|Subject Enrollment|Physician Decision|3|||
161810704|NCT02659150|584349481|FG000|Subject Enrollment|Withdrawal by Subject|2|||
161810705|NCT02659150|584349481|FG000|Baseline Imaging|Withdrawal by Subject|1|||
161810706|NCT02659150|584349481|FG000|Baseline Imaging|Physician Decision|1|||
161810707|NCT02659150|584349481|FG000|Study Drug Dosing|Adverse Event|1|||
161810708|NCT02678286|584349482|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
161810709|NCT02678286|584349483|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
161810710|NCT02678286|584349482|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
161810711|NCT02678286|584349483|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
161810712|NCT02678286|584349482|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
161810713|NCT02678286|584349483|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
161810714|NCT02678286|584349482|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
161810715|NCT02678286|584349483|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
161810716|NCT02678286|584349482|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
161810717|NCT02678286|584349483|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
161810718|NCT01827163|584349486|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
161810719|NCT01827163|584349486|FG000|Overall Study|Adverse Event|9|||
161810720|NCT03375463|584349487|FG000|Period 1|Lost to Follow-up|0|||
161810721|NCT03375463|584349488|FG001|Period 1|Lost to Follow-up|0|||
161810722|NCT03375463|584349489|FG002|Period 1|Lost to Follow-up|1|||
161810723|NCT03375463|584349490|FG003|Period 1|Lost to Follow-up|0|||
161810724|NCT03375463|584349491|FG004|Period 1|Lost to Follow-up|0|||
161810725|NCT03375463|584349492|FG005|Period 1|Lost to Follow-up|0|||
161810726|NCT03375463|584349487|FG000|Period 1|Adverse Event|0|||
161810727|NCT03375463|584349488|FG001|Period 1|Adverse Event|0|||
161810728|NCT03375463|584349489|FG002|Period 1|Adverse Event|0|||
161810729|NCT03375463|584349490|FG003|Period 1|Adverse Event|0|||
161810730|NCT03375463|584349491|FG004|Period 1|Adverse Event|1|||
161810731|NCT03375463|584349492|FG005|Period 1|Adverse Event|0|||
161810732|NCT03375463|584349487|FG000|Period 2|Lost to Follow-up|1|||
161810733|NCT03375463|584349488|FG001|Period 2|Lost to Follow-up|1|||
161810734|NCT03375463|584349489|FG002|Period 2|Lost to Follow-up|0|||
161810735|NCT03375463|584349490|FG003|Period 2|Lost to Follow-up|0|||
161810736|NCT03375463|584349491|FG004|Period 2|Lost to Follow-up|0|||
161810737|NCT03375463|584349492|FG005|Period 2|Lost to Follow-up|0|||
161810738|NCT02909907|584349495|FG000|Overall Study|Withdrawal by Subject|0|||
161810739|NCT02909907|584349496|FG001|Overall Study|Withdrawal by Subject|1|||
161810740|NCT02902211|584349497|FG000|First Three Months|Withdrawal by Subject|7|||
161810741|NCT02902211|584349498|FG001|First Three Months|Withdrawal by Subject|3|||
161810742|NCT01513174|584349499|FG000|Overall Study|Inclusion Error|1|||
161810743|NCT01513174|584349500|FG001|Overall Study|Inclusion Error|7|||
161810744|NCT01513174|584349499|FG000|Overall Study|Not receive study treatment|3|||
161810745|NCT01513174|584349500|FG001|Overall Study|Not receive study treatment|1|||
161810746|NCT01900626|584349503|FG000|Overall Study|study was closed due to low enrollment|1|||
161810747|NCT01900626|584349504|FG001|Overall Study|study was closed due to low enrollment|1|||
161810748|NCT03098394|584349512|FG000|Overall Study|Pregnancy|0|||
161467589|NCT03633617|583109457|FG006|Part A|Adverse Event|0|||
161467590|NCT03633617|583109458|FG007|Part A|Adverse Event|0|||
161467591|NCT03633617|583109459|FG008|Part A|Adverse Event|0|||
161467592|NCT03633617|583109460|FG009|Part A|Adverse Event|0|||
161810749|NCT03098394|584349513|FG001|Overall Study|Pregnancy|1|||
161810750|NCT04408794|584349514|FG000|Overall Study|Adverse Event|43|||
161810751|NCT04408794|584349514|FG000|Overall Study|Infrequent study drug usage|43|||
161810752|NCT04408794|584349514|FG000|Overall Study|Lack of Efficacy|61|||
161810753|NCT04408794|584349514|FG000|Overall Study|Lost to Follow-up|33|||
161810754|NCT04408794|584349514|FG000|Overall Study|Non-compliance|6|||
161810755|NCT04408794|584349514|FG000|Overall Study|Physician Decision|1|||
161810756|NCT04408794|584349514|FG000|Overall Study|Pregnancy|6|||
161810757|NCT04408794|584349514|FG000|Overall Study|Protocol Deviation|9|||
161810758|NCT04408794|584349514|FG000|Overall Study|Sheehan-STS Result|1|||
161810759|NCT04408794|584349514|FG000|Overall Study|Withdrawal by Subject|57|||
161810760|NCT04408794|584349514|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
161467593|NCT03633617|583109461|FG010|Part A|Adverse Event|0|||
161467594|NCT03633617|583109451|FG000|Part A|Pregnancy|1|||
161467595|NCT03633617|583109452|FG001|Part A|Pregnancy|0|||
161574826|NCT04956575|583491878|FG008|Overall Study|Lost to Follow-up|4|||
161574827|NCT04956575|583491879|FG009|Overall Study|Lost to Follow-up|2|||
161574828|NCT04956575|583491880|FG010|Overall Study|Lost to Follow-up|3|||
161574829|NCT04956575|583491881|FG011|Overall Study|Lost to Follow-up|8|||
161574830|NCT04956575|583491870|FG000|Overall Study|Withdrawal by Subject|1|||
161574831|NCT04956575|583491871|FG001|Overall Study|Withdrawal by Subject|2|||
161574832|NCT04956575|583491872|FG002|Overall Study|Withdrawal by Subject|1|||
161574833|NCT04956575|583491873|FG003|Overall Study|Withdrawal by Subject|4|||
161574834|NCT04956575|583491874|FG004|Overall Study|Withdrawal by Subject|2|||
161574835|NCT04956575|583491875|FG005|Overall Study|Withdrawal by Subject|8|||
161574836|NCT04956575|583491876|FG006|Overall Study|Withdrawal by Subject|5|||
161574837|NCT04956575|583491877|FG007|Overall Study|Withdrawal by Subject|1|||
161574838|NCT04956575|583491878|FG008|Overall Study|Withdrawal by Subject|1|||
161574839|NCT04956575|583491879|FG009|Overall Study|Withdrawal by Subject|0|||
161574840|NCT04956575|583491880|FG010|Overall Study|Withdrawal by Subject|3|||
161574841|NCT04956575|583491881|FG011|Overall Study|Withdrawal by Subject|1|||
161574842|NCT00854906|583491882|FG000|Overall Study|One person had no ocular history|1|||
161574843|NCT05526248|583491883|FG000|Overall Study|Lost to Follow-up|1|||
161574844|NCT05526248|583491883|FG000|Overall Study|Adverse Event|2|||
161574845|NCT05526248|583491883|FG000|Overall Study|Withdrawal by Subject|1|||
161574846|NCT01135511|583491891|FG000|Overall Study|Adverse Event|0|||
161574847|NCT01135511|583491892|FG001|Overall Study|Adverse Event|1|||
161574848|NCT01135511|583491893|FG002|Overall Study|Adverse Event|2|||
161574849|NCT01135511|583491894|FG003|Overall Study|Adverse Event|0|||
161574850|NCT01135511|583491895|FG004|Overall Study|Adverse Event|0|||
161574851|NCT01135511|583491896|FG005|Overall Study|Adverse Event|1|||
161574852|NCT01135511|583491897|FG006|Overall Study|Adverse Event|0|||
161574853|NCT01135511|583491898|FG007|Overall Study|Adverse Event|1|||
161574854|NCT01135511|583491899|FG008|Overall Study|Adverse Event|0|||
161574855|NCT01135511|583491891|FG000|Overall Study|Lack of Efficacy|0|||
161574856|NCT01135511|583491892|FG001|Overall Study|Lack of Efficacy|1|||
161574857|NCT01135511|583491893|FG002|Overall Study|Lack of Efficacy|1|||
161574858|NCT01135511|583491894|FG003|Overall Study|Lack of Efficacy|2|||
161574859|NCT01135511|583491895|FG004|Overall Study|Lack of Efficacy|0|||
161574860|NCT01135511|583491896|FG005|Overall Study|Lack of Efficacy|0|||
161574861|NCT01135511|583491897|FG006|Overall Study|Lack of Efficacy|0|||
161574862|NCT01135511|583491898|FG007|Overall Study|Lack of Efficacy|0|||
161574863|NCT01135511|583491899|FG008|Overall Study|Lack of Efficacy|0|||
161574864|NCT01135511|583491891|FG000|Overall Study|Protocol Violation|0|||
161574865|NCT01135511|583491892|FG001|Overall Study|Protocol Violation|0|||
161574866|NCT01135511|583491893|FG002|Overall Study|Protocol Violation|3|||
161574867|NCT01135511|583491894|FG003|Overall Study|Protocol Violation|0|||
161574868|NCT01135511|583491895|FG004|Overall Study|Protocol Violation|0|||
161574869|NCT01135511|583491896|FG005|Overall Study|Protocol Violation|0|||
161574870|NCT01135511|583491897|FG006|Overall Study|Protocol Violation|0|||
161574871|NCT01135511|583491898|FG007|Overall Study|Protocol Violation|0|||
161574872|NCT01135511|583491899|FG008|Overall Study|Protocol Violation|0|||
161574873|NCT01135511|583491891|FG000|Overall Study|Pregnancy|0|||
161574874|NCT01135511|583491892|FG001|Overall Study|Pregnancy|0|||
161574875|NCT01135511|583491893|FG002|Overall Study|Pregnancy|0|||
161574876|NCT01135511|583491894|FG003|Overall Study|Pregnancy|1|||
161574877|NCT01135511|583491895|FG004|Overall Study|Pregnancy|0|||
161574878|NCT01135511|583491896|FG005|Overall Study|Pregnancy|0|||
161574879|NCT01135511|583491897|FG006|Overall Study|Pregnancy|0|||
161574880|NCT01135511|583491898|FG007|Overall Study|Pregnancy|0|||
161574881|NCT01135511|583491899|FG008|Overall Study|Pregnancy|0|||
161574882|NCT01135511|583491891|FG000|Overall Study|could not visit the clinic|0|||
161574883|NCT01135511|583491892|FG001|Overall Study|could not visit the clinic|1|||
161574884|NCT01135511|583491893|FG002|Overall Study|could not visit the clinic|2|||
161574885|NCT01135511|583491894|FG003|Overall Study|could not visit the clinic|0|||
161574886|NCT01135511|583491895|FG004|Overall Study|could not visit the clinic|0|||
161574887|NCT01135511|583491896|FG005|Overall Study|could not visit the clinic|0|||
161574888|NCT01135511|583491897|FG006|Overall Study|could not visit the clinic|0|||
161574889|NCT01135511|583491898|FG007|Overall Study|could not visit the clinic|0|||
161574890|NCT01135511|583491899|FG008|Overall Study|could not visit the clinic|0|||
161574891|NCT01135511|583491891|FG000|Overall Study|noncompliance with study drug taken|0|||
161810761|NCT04408794|584349514|FG000|Overall Study|Never Treated Migraine|5|||
161810762|NCT02159950|584349521|FG000|Overall Study|Adverse Event|0|||
161810763|NCT02159950|584349522|FG001|Overall Study|Adverse Event|1|||
161810764|NCT02159950|584349521|FG000|Overall Study|Progression|0|||
161810765|NCT02159950|584349522|FG001|Overall Study|Progression|1|||
161810766|NCT03872128|584349525|FG000|Overall Study|Dropped out before treatment|1|||
161810767|NCT03872128|584349526|FG001|Overall Study|Dropped out before treatment|0|||
161810768|NCT03872128|584349527|FG002|Overall Study|Dropped out before treatment|4|||
161810769|NCT03872128|584349525|FG000|Overall Study|Lost to Follow-up|2|||
161810770|NCT03872128|584349526|FG001|Overall Study|Lost to Follow-up|5|||
161810771|NCT03872128|584349527|FG002|Overall Study|Lost to Follow-up|8|||
161810772|NCT04400890|584349532|FG000|Overall Study|Withdrawal by Subject|3|||
161810773|NCT04400890|584349533|FG001|Overall Study|Withdrawal by Subject|2|||
161810774|NCT03925532|584349534|FG000|Overall Study|Lost to Follow-up|1|||
161810775|NCT02258074|584349535|FG000|Overall Study|Withdrawal by Subject|1|||
161810776|NCT02258074|584349536|FG001|Overall Study|Withdrawal by Subject|0|||
161467596|NCT03633617|583109453|FG002|Part A|Pregnancy|0|||
161467597|NCT03633617|583109454|FG003|Part A|Pregnancy|0|||
161467598|NCT03633617|583109455|FG004|Part A|Pregnancy|0|||
161467599|NCT03633617|583109456|FG005|Part A|Pregnancy|0|||
161467600|NCT03633617|583109457|FG006|Part A|Pregnancy|0|||
161467601|NCT03633617|583109458|FG007|Part A|Pregnancy|0|||
161467602|NCT03633617|583109459|FG008|Part A|Pregnancy|0|||
161467603|NCT03633617|583109460|FG009|Part A|Pregnancy|0|||
161574892|NCT01135511|583491892|FG001|Overall Study|noncompliance with study drug taken|0|||
161574893|NCT01135511|583491893|FG002|Overall Study|noncompliance with study drug taken|0|||
161574894|NCT01135511|583491894|FG003|Overall Study|noncompliance with study drug taken|0|||
161574895|NCT01135511|583491895|FG004|Overall Study|noncompliance with study drug taken|1|||
161574896|NCT01135511|583491896|FG005|Overall Study|noncompliance with study drug taken|0|||
161574897|NCT01135511|583491897|FG006|Overall Study|noncompliance with study drug taken|0|||
161574898|NCT01135511|583491898|FG007|Overall Study|noncompliance with study drug taken|0|||
161574899|NCT01135511|583491899|FG008|Overall Study|noncompliance with study drug taken|0|||
161574900|NCT01135511|583491891|FG000|Overall Study|Withdrawal by Subject|0|||
161574901|NCT01135511|583491892|FG001|Overall Study|Withdrawal by Subject|0|||
161574902|NCT01135511|583491893|FG002|Overall Study|Withdrawal by Subject|0|||
161574903|NCT01135511|583491894|FG003|Overall Study|Withdrawal by Subject|0|||
161574904|NCT01135511|583491895|FG004|Overall Study|Withdrawal by Subject|0|||
161574905|NCT01135511|583491896|FG005|Overall Study|Withdrawal by Subject|0|||
161574906|NCT01135511|583491897|FG006|Overall Study|Withdrawal by Subject|1|||
161574907|NCT01135511|583491898|FG007|Overall Study|Withdrawal by Subject|0|||
161574908|NCT01135511|583491899|FG008|Overall Study|Withdrawal by Subject|1|||
161574909|NCT03482011|583491906|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
161574910|NCT03482011|583491907|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
161574911|NCT03482011|583491908|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161574912|NCT03482011|583491909|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
161574913|NCT03482011|583491910|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161574914|NCT03482011|583491911|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161574915|NCT03482011|583491912|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
161574916|NCT03482011|583491913|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
161574917|NCT03482011|583491906|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
161574918|NCT03482011|583491907|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
161810777|NCT02258074|584349537|FG002|Overall Study|Withdrawal by Subject|0|||
161810778|NCT02258074|584349538|FG003|Overall Study|Withdrawal by Subject|0|||
161467604|NCT03633617|583109461|FG010|Part A|Pregnancy|0|||
161467605|NCT03633617|583109451|FG000|Part A|Withdrawal by Subject|0|||
161467606|NCT03633617|583109452|FG001|Part A|Withdrawal by Subject|1|||
161467607|NCT03633617|583109453|FG002|Part A|Withdrawal by Subject|0|||
161467608|NCT03633617|583109454|FG003|Part A|Withdrawal by Subject|0|||
161467609|NCT03633617|583109455|FG004|Part A|Withdrawal by Subject|0|||
161467610|NCT03633617|583109456|FG005|Part A|Withdrawal by Subject|0|||
161467611|NCT03633617|583109457|FG006|Part A|Withdrawal by Subject|0|||
161467612|NCT03633617|583109458|FG007|Part A|Withdrawal by Subject|0|||
161467613|NCT03633617|583109459|FG008|Part A|Withdrawal by Subject|0|||
161467614|NCT03633617|583109460|FG009|Part A|Withdrawal by Subject|0|||
161467615|NCT03633617|583109461|FG010|Part A|Withdrawal by Subject|0|||
161467616|NCT03633617|583109451|FG000|Part B|Adverse Event|0|||
161574919|NCT03482011|583491908|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161574920|NCT03482011|583491909|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161467617|NCT03633617|583109452|FG001|Part B|Adverse Event|0|||
161467618|NCT03633617|583109453|FG002|Part B|Adverse Event|2|||
161467619|NCT03633617|583109454|FG003|Part B|Adverse Event|2|||
161467620|NCT03633617|583109455|FG004|Part B|Adverse Event|1|||
161810779|NCT05446870|584349539|FG000|Overall Study|Death|6|||
161810780|NCT05446870|584349540|FG001|Overall Study|Death|5|||
161467621|NCT03633617|583109456|FG005|Part B|Adverse Event|0|||
161467622|NCT03633617|583109457|FG006|Part B|Adverse Event|0|||
161467623|NCT03633617|583109458|FG007|Part B|Adverse Event|0|||
161467624|NCT03633617|583109459|FG008|Part B|Adverse Event|0|||
161467625|NCT03633617|583109460|FG009|Part B|Adverse Event|0|||
161810781|NCT05446870|584349539|FG000|Overall Study|Lost to Follow-up|0|||
161810782|NCT05446870|584349540|FG001|Overall Study|Lost to Follow-up|1|||
161810783|NCT05446870|584349539|FG000|Overall Study|Physician Decision|52|||
161810784|NCT05446870|584349540|FG001|Overall Study|Physician Decision|53|||
161810785|NCT05446870|584349539|FG000|Overall Study|Withdrawal by Subject|3|||
161810786|NCT05446870|584349540|FG001|Overall Study|Withdrawal by Subject|3|||
161810787|NCT01615198|584349543|FG000|Overall Study|Withdrawal by Subject|5|||
161810788|NCT01615198|584349544|FG001|Overall Study|Withdrawal by Subject|5|||
161810789|NCT01615198|584349543|FG000|Overall Study|Protocol deviation|1|||
161810790|NCT01615198|584349544|FG001|Overall Study|Protocol deviation|1|||
161810791|NCT01615198|584349543|FG000|Overall Study|Physician Decision|5|||
161810792|NCT01615198|584349544|FG001|Overall Study|Physician Decision|1|||
161810793|NCT01615198|584349543|FG000|Overall Study|Lost to Follow-up|1|||
161914998|NCT01572792|584737356|FG000|Lead-in Study|Withdrawal by Subject|22|||
161467626|NCT03633617|583109461|FG010|Part B|Adverse Event|0|||
161467627|NCT03633617|583109451|FG000|Part B|Withdrawal by Subject|0|||
161467628|NCT03633617|583109452|FG001|Part B|Withdrawal by Subject|0|||
161467629|NCT03633617|583109453|FG002|Part B|Withdrawal by Subject|1|||
161467630|NCT03633617|583109454|FG003|Part B|Withdrawal by Subject|0|||
161467631|NCT03633617|583109455|FG004|Part B|Withdrawal by Subject|2|||
161467632|NCT03633617|583109456|FG005|Part B|Withdrawal by Subject|0|||
161467633|NCT03633617|583109457|FG006|Part B|Withdrawal by Subject|0|||
161467634|NCT03633617|583109458|FG007|Part B|Withdrawal by Subject|0|||
161467635|NCT03633617|583109459|FG008|Part B|Withdrawal by Subject|0|||
161467636|NCT03633617|583109460|FG009|Part B|Withdrawal by Subject|0|||
161467637|NCT03633617|583109461|FG010|Part B|Withdrawal by Subject|0|||
161467638|NCT03633617|583109451|FG000|Part B|Lost to Follow-up|0|||
161467639|NCT03633617|583109452|FG001|Part B|Lost to Follow-up|0|||
161467640|NCT03633617|583109453|FG002|Part B|Lost to Follow-up|0|||
161467641|NCT03633617|583109454|FG003|Part B|Lost to Follow-up|0|||
161467642|NCT03633617|583109455|FG004|Part B|Lost to Follow-up|1|||
161467643|NCT03633617|583109456|FG005|Part B|Lost to Follow-up|0|||
161467644|NCT03633617|583109457|FG006|Part B|Lost to Follow-up|0|||
161467645|NCT03633617|583109458|FG007|Part B|Lost to Follow-up|0|||
161467646|NCT03633617|583109459|FG008|Part B|Lost to Follow-up|0|||
161467647|NCT03633617|583109460|FG009|Part B|Lost to Follow-up|0|||
161467648|NCT03633617|583109461|FG010|Part B|Lost to Follow-up|0|||
161467649|NCT03633617|583109451|FG000|Part B|Physician Decision|0|||
161467650|NCT03633617|583109452|FG001|Part B|Physician Decision|0|||
161467651|NCT03633617|583109453|FG002|Part B|Physician Decision|0|||
161467652|NCT03633617|583109454|FG003|Part B|Physician Decision|0|||
161467653|NCT03633617|583109455|FG004|Part B|Physician Decision|1|||
161467654|NCT03633617|583109456|FG005|Part B|Physician Decision|0|||
161467655|NCT03633617|583109457|FG006|Part B|Physician Decision|0|||
161467656|NCT03633617|583109458|FG007|Part B|Physician Decision|0|||
161467657|NCT03633617|583109459|FG008|Part B|Physician Decision|0|||
161467658|NCT03633617|583109460|FG009|Part B|Physician Decision|0|||
161467659|NCT03633617|583109461|FG010|Part B|Physician Decision|0|||
161467660|NCT03633617|583109451|FG000|Part B|COVID-19 Restrictions|0|||
161467661|NCT03633617|583109452|FG001|Part B|COVID-19 Restrictions|0|||
161467662|NCT03633617|583109453|FG002|Part B|COVID-19 Restrictions|1|||
161467663|NCT03633617|583109454|FG003|Part B|COVID-19 Restrictions|0|||
161467664|NCT03633617|583109455|FG004|Part B|COVID-19 Restrictions|0|||
161467665|NCT03633617|583109456|FG005|Part B|COVID-19 Restrictions|0|||
161467666|NCT03633617|583109457|FG006|Part B|COVID-19 Restrictions|0|||
161467667|NCT03633617|583109458|FG007|Part B|COVID-19 Restrictions|0|||
161467668|NCT03633617|583109459|FG008|Part B|COVID-19 Restrictions|0|||
161467669|NCT03633617|583109460|FG009|Part B|COVID-19 Restrictions|0|||
161467670|NCT03633617|583109461|FG010|Part B|COVID-19 Restrictions|0|||
161467671|NCT03633617|583109451|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467672|NCT03633617|583109452|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161574921|NCT03482011|583491910|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161810794|NCT01615198|584349544|FG001|Overall Study|Lost to Follow-up|1|||
161914999|NCT01572792|584737357|FG001|Lead-in Study|Withdrawal by Subject|11|||
161915000|NCT01572792|584737358|FG002|Lead-in Study|Withdrawal by Subject|12|||
161467673|NCT03633617|583109453|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
161467674|NCT03633617|583109454|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467675|NCT03633617|583109455|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467676|NCT03633617|583109456|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467677|NCT03633617|583109457|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467678|NCT03633617|583109458|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467679|NCT03633617|583109459|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467680|NCT03633617|583109460|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161467681|NCT03633617|583109461|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
161810795|NCT01615198|584349543|FG000|Overall Study|Lack of Efficacy|1|||
161810796|NCT01615198|584349544|FG001|Overall Study|Lack of Efficacy|6|||
161467682|NCT03633617|583109451|FG000|Part C (& Follow-up)|Adverse Event|0|||
161467683|NCT03633617|583109452|FG001|Part C (& Follow-up)|Adverse Event|0|||
161467684|NCT03633617|583109453|FG002|Part C (& Follow-up)|Adverse Event|0|||
161467685|NCT03633617|583109454|FG003|Part C (& Follow-up)|Adverse Event|0|||
161467686|NCT03633617|583109455|FG004|Part C (& Follow-up)|Adverse Event|0|||
161467687|NCT03633617|583109456|FG005|Part C (& Follow-up)|Adverse Event|1|||
161467688|NCT03633617|583109457|FG006|Part C (& Follow-up)|Adverse Event|0|||
161810797|NCT01615198|584349543|FG000|Overall Study|Adverse Event|11|||
161810798|NCT01615198|584349544|FG001|Overall Study|Adverse Event|5|||
161810799|NCT01686438|584349545|FG000|Overall Study|Lost to Follow-up|8|||
161810800|NCT01686438|584349546|FG001|Overall Study|Lost to Follow-up|9|||
161810801|NCT01686438|584349547|FG002|Overall Study|Lost to Follow-up|10|||
161810802|NCT01686438|584349545|FG000|Overall Study|Adverse Event|0|||
161810803|NCT01686438|584349546|FG001|Overall Study|Adverse Event|0|||
161810804|NCT01686438|584349547|FG002|Overall Study|Adverse Event|1|||
161810805|NCT01686438|584349545|FG000|Overall Study|Protocol Violation|0|||
161810806|NCT01686438|584349546|FG001|Overall Study|Protocol Violation|0|||
161810807|NCT01686438|584349547|FG002|Overall Study|Protocol Violation|1|||
161810808|NCT01686438|584349545|FG000|Overall Study|Withdrawal by Subject|0|||
161810809|NCT01686438|584349546|FG001|Overall Study|Withdrawal by Subject|0|||
161810810|NCT01686438|584349547|FG002|Overall Study|Withdrawal by Subject|1|||
161810811|NCT00984126|584349548|FG000|Overall Study|Protocol Violation|0|||
161810812|NCT00984126|584349549|FG001|Overall Study|Protocol Violation|0|||
161810813|NCT00984126|584349550|FG002|Overall Study|Protocol Violation|1|||
161810814|NCT00984126|584349551|FG003|Overall Study|Protocol Violation|2|||
161810815|NCT00984126|584349548|FG000|Overall Study|Adverse Event|0|||
161810816|NCT00984126|584349549|FG001|Overall Study|Adverse Event|0|||
161810817|NCT00984126|584349550|FG002|Overall Study|Adverse Event|0|||
161810818|NCT00984126|584349551|FG003|Overall Study|Adverse Event|2|||
161810819|NCT00984126|584349548|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
161810820|NCT00984126|584349549|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
161810821|NCT00984126|584349550|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
161810822|NCT00984126|584349551|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
161810823|NCT00984126|584349548|FG000|Overall Study|Withdrawal criteria|0|||
161810824|NCT00984126|584349549|FG001|Overall Study|Withdrawal criteria|1|||
161810825|NCT00984126|584349550|FG002|Overall Study|Withdrawal criteria|3|||
161810826|NCT00984126|584349551|FG003|Overall Study|Withdrawal criteria|9|||
161810827|NCT01029340|584349554|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
161810828|NCT01029340|584349555|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
161810829|NCT01029340|584349556|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
161810830|NCT01029340|584349557|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
161810831|NCT01029340|584349558|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
161810832|NCT01029340|584349559|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
161810833|NCT01029340|584349554|FG000|Part B Treatment Period|Protocol Violation|0|||
161810834|NCT01029340|584349555|FG001|Part B Treatment Period|Protocol Violation|0|||
161810835|NCT01029340|584349556|FG002|Part B Treatment Period|Protocol Violation|1|||
161810836|NCT01029340|584349557|FG003|Part B Treatment Period|Protocol Violation|0|||
161810837|NCT01029340|584349558|FG004|Part B Treatment Period|Protocol Violation|0|||
161810838|NCT01029340|584349559|FG005|Part B Treatment Period|Protocol Violation|0|||
161810839|NCT01029340|584349554|FG000|Extension Period|Adverse Event|0|||
161810840|NCT01029340|584349555|FG001|Extension Period|Adverse Event|0|||
161810841|NCT01029340|584349556|FG002|Extension Period|Adverse Event|0|||
161810842|NCT01029340|584349557|FG003|Extension Period|Adverse Event|0|||
161810843|NCT01029340|584349558|FG004|Extension Period|Adverse Event|0|||
161810844|NCT01029340|584349559|FG005|Extension Period|Adverse Event|1|||
161810845|NCT01029340|584349554|FG000|Extension Period|starting another study|0|||
161810846|NCT01029340|584349555|FG001|Extension Period|starting another study|0|||
161810847|NCT01029340|584349556|FG002|Extension Period|starting another study|0|||
161810848|NCT01029340|584349557|FG003|Extension Period|starting another study|0|||
161810849|NCT01029340|584349558|FG004|Extension Period|starting another study|0|||
161810850|NCT01029340|584349559|FG005|Extension Period|starting another study|8|||
161810851|NCT01029340|584349554|FG000|Extension Period|non-compliance|0|||
161810852|NCT01029340|584349555|FG001|Extension Period|non-compliance|0|||
161467689|NCT03633617|583109458|FG007|Part C (& Follow-up)|Adverse Event|1|||
161810853|NCT01029340|584349556|FG002|Extension Period|non-compliance|0|||
161810854|NCT01029340|584349557|FG003|Extension Period|non-compliance|0|||
161810855|NCT01029340|584349558|FG004|Extension Period|non-compliance|0|||
161810856|NCT01029340|584349559|FG005|Extension Period|non-compliance|1|||
161810857|NCT01029340|584349554|FG000|Extension Period|Withdrawal by Subject|0|||
161810858|NCT01029340|584349555|FG001|Extension Period|Withdrawal by Subject|0|||
161810859|NCT01029340|584349556|FG002|Extension Period|Withdrawal by Subject|0|||
161810860|NCT01029340|584349557|FG003|Extension Period|Withdrawal by Subject|0|||
161810861|NCT01029340|584349558|FG004|Extension Period|Withdrawal by Subject|0|||
161810862|NCT01029340|584349559|FG005|Extension Period|Withdrawal by Subject|1|||
161810863|NCT01029340|584349554|FG000|Extension Period|Physician Decision|0|||
161467690|NCT03633617|583109459|FG008|Part C (& Follow-up)|Adverse Event|0|||
161810864|NCT01029340|584349555|FG001|Extension Period|Physician Decision|0|||
161810865|NCT01029340|584349556|FG002|Extension Period|Physician Decision|0|||
161810866|NCT01029340|584349557|FG003|Extension Period|Physician Decision|0|||
161810867|NCT01029340|584349558|FG004|Extension Period|Physician Decision|0|||
161810868|NCT01029340|584349559|FG005|Extension Period|Physician Decision|1|||
161810869|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
161810870|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
161467691|NCT03633617|583109460|FG009|Part C (& Follow-up)|Adverse Event|0|||
161467692|NCT03633617|583109461|FG010|Part C (& Follow-up)|Adverse Event|0|||
161810871|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
161810872|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
161810873|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
161810874|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
161810875|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
161810876|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
161467693|NCT03633617|583109451|FG000|Part C (& Follow-up)|Pregnancy|0|||
161467694|NCT03633617|583109452|FG001|Part C (& Follow-up)|Pregnancy|0|||
161467695|NCT03633617|583109453|FG002|Part C (& Follow-up)|Pregnancy|0|||
161467696|NCT03633617|583109454|FG003|Part C (& Follow-up)|Pregnancy|0|||
161467697|NCT03633617|583109455|FG004|Part C (& Follow-up)|Pregnancy|0|||
161467698|NCT03633617|583109456|FG005|Part C (& Follow-up)|Pregnancy|0|||
161467699|NCT03633617|583109457|FG006|Part C (& Follow-up)|Pregnancy|0|||
161467700|NCT03633617|583109458|FG007|Part C (& Follow-up)|Pregnancy|0|||
161467701|NCT03633617|583109459|FG008|Part C (& Follow-up)|Pregnancy|0|||
161467702|NCT03633617|583109460|FG009|Part C (& Follow-up)|Pregnancy|1|||
161810877|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
161810878|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
161810879|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
161810880|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
161467703|NCT03633617|583109461|FG010|Part C (& Follow-up)|Pregnancy|0|||
161467704|NCT03633617|583109451|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
161467705|NCT03633617|583109452|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
161810881|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
161810882|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
161810883|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
161810884|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
161810885|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
161810886|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
161810887|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Other|13|||
161810888|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Other|0|||
161810889|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Other|0|||
161810890|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
161810891|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
161467706|NCT03633617|583109453|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
161467707|NCT03633617|583109454|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
161467708|NCT03633617|583109455|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
161467709|NCT03633617|583109456|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
161467710|NCT03633617|583109457|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
161467711|NCT03633617|583109458|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
161467712|NCT03633617|583109459|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
161467713|NCT03633617|583109460|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
161467714|NCT03633617|583109461|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
161467715|NCT03633617|583109451|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
161467716|NCT03633617|583109452|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
161467717|NCT03633617|583109453|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
161467718|NCT03633617|583109454|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
161467719|NCT03633617|583109455|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
161467720|NCT03633617|583109456|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
161467721|NCT03633617|583109457|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
161467722|NCT03633617|583109458|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
161467723|NCT03633617|583109459|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
161467724|NCT03633617|583109460|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
161467725|NCT03633617|583109461|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
161467726|NCT03633617|583109451|FG000|Part C (& Follow-up)|Physician Decision|0|||
161467727|NCT03633617|583109452|FG001|Part C (& Follow-up)|Physician Decision|0|||
161467728|NCT03633617|583109453|FG002|Part C (& Follow-up)|Physician Decision|0|||
161467729|NCT03633617|583109454|FG003|Part C (& Follow-up)|Physician Decision|0|||
161467730|NCT03633617|583109455|FG004|Part C (& Follow-up)|Physician Decision|0|||
161467731|NCT03633617|583109456|FG005|Part C (& Follow-up)|Physician Decision|0|||
161467732|NCT03633617|583109457|FG006|Part C (& Follow-up)|Physician Decision|0|||
161467733|NCT03633617|583109458|FG007|Part C (& Follow-up)|Physician Decision|1|||
161467734|NCT03633617|583109459|FG008|Part C (& Follow-up)|Physician Decision|0|||
161467735|NCT03633617|583109460|FG009|Part C (& Follow-up)|Physician Decision|0|||
161467736|NCT03633617|583109461|FG010|Part C (& Follow-up)|Physician Decision|1|||
161467737|NCT03633617|583109451|FG000|Part C (& Follow-up)|COVID-19 related|0|||
161467738|NCT03633617|583109452|FG001|Part C (& Follow-up)|COVID-19 related|0|||
161467739|NCT03633617|583109453|FG002|Part C (& Follow-up)|COVID-19 related|0|||
161467740|NCT03633617|583109454|FG003|Part C (& Follow-up)|COVID-19 related|0|||
161467741|NCT03633617|583109455|FG004|Part C (& Follow-up)|COVID-19 related|0|||
161467742|NCT03633617|583109456|FG005|Part C (& Follow-up)|COVID-19 related|1|||
161467743|NCT03633617|583109457|FG006|Part C (& Follow-up)|COVID-19 related|0|||
161467744|NCT03633617|583109458|FG007|Part C (& Follow-up)|COVID-19 related|0|||
161467745|NCT03633617|583109459|FG008|Part C (& Follow-up)|COVID-19 related|0|||
161467746|NCT03633617|583109460|FG009|Part C (& Follow-up)|COVID-19 related|0|||
161467747|NCT03633617|583109461|FG010|Part C (& Follow-up)|COVID-19 related|0|||
161467748|NCT03633617|583109451|FG000|Part C (& Follow-up)|Protocol Violation|0|||
161467749|NCT03633617|583109452|FG001|Part C (& Follow-up)|Protocol Violation|0|||
161467750|NCT03633617|583109453|FG002|Part C (& Follow-up)|Protocol Violation|0|||
161467751|NCT03633617|583109454|FG003|Part C (& Follow-up)|Protocol Violation|0|||
161467752|NCT03633617|583109455|FG004|Part C (& Follow-up)|Protocol Violation|0|||
161467753|NCT03633617|583109456|FG005|Part C (& Follow-up)|Protocol Violation|0|||
161467754|NCT03633617|583109457|FG006|Part C (& Follow-up)|Protocol Violation|0|||
161467755|NCT03633617|583109458|FG007|Part C (& Follow-up)|Protocol Violation|0|||
161467756|NCT03633617|583109459|FG008|Part C (& Follow-up)|Protocol Violation|0|||
161467757|NCT03633617|583109460|FG009|Part C (& Follow-up)|Protocol Violation|3|||
161810892|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
161810893|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
161810894|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
161810895|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
161810896|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Adverse Event|0|||
161810897|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Adverse Event|0|||
161810898|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Adverse Event|6|||
161810899|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
161467758|NCT03633617|583109461|FG010|Part C (& Follow-up)|Protocol Violation|1|||
161467759|NCT03633617|583109451|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
161467760|NCT03633617|583109452|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
161467761|NCT03633617|583109453|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
161467762|NCT03633617|583109454|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
161467763|NCT03633617|583109455|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
161467764|NCT03633617|583109456|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
161467765|NCT03633617|583109457|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
161467766|NCT03633617|583109458|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
161467767|NCT03633617|583109459|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
161467768|NCT03633617|583109460|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
161467769|NCT03633617|583109461|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
161467770|NCT00809354|583109464|FG000|Overall Study|Adverse Event|32|||
161467771|NCT00809354|583109465|FG001|Overall Study|Adverse Event|45|||
161574922|NCT03482011|583491911|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161574923|NCT03482011|583491912|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161574924|NCT03482011|583491913|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161810900|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
161467772|NCT00809354|583109466|FG002|Overall Study|Adverse Event|37|||
161467773|NCT00809354|583109467|FG003|Overall Study|Adverse Event|53|||
161467774|NCT00809354|583109468|FG004|Overall Study|Adverse Event|26|||
161467775|NCT00809354|583109469|FG005|Overall Study|Adverse Event|33|||
161467776|NCT00809354|583109470|FG006|Overall Study|Adverse Event|44|||
161467777|NCT00809354|583109471|FG007|Overall Study|Adverse Event|40|||
161467778|NCT00809354|583109472|FG008|Overall Study|Adverse Event|46|||
161467779|NCT00809354|583109473|FG009|Overall Study|Adverse Event|26|||
161467780|NCT00809354|583109464|FG000|Overall Study|Lack of Efficacy|23|||
161467781|NCT00809354|583109465|FG001|Overall Study|Lack of Efficacy|23|||
161467782|NCT00809354|583109466|FG002|Overall Study|Lack of Efficacy|22|||
161467783|NCT00809354|583109467|FG003|Overall Study|Lack of Efficacy|15|||
161467784|NCT00809354|583109468|FG004|Overall Study|Lack of Efficacy|40|||
161467785|NCT00809354|583109469|FG005|Overall Study|Lack of Efficacy|19|||
161467786|NCT00809354|583109470|FG006|Overall Study|Lack of Efficacy|21|||
161467787|NCT00809354|583109471|FG007|Overall Study|Lack of Efficacy|15|||
161467788|NCT00809354|583109472|FG008|Overall Study|Lack of Efficacy|18|||
161810901|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
161574925|NCT03482011|583491906|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574926|NCT03482011|583491907|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
161574927|NCT03482011|583491908|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574928|NCT03482011|583491909|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574929|NCT03482011|583491910|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574930|NCT03482011|583491911|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574931|NCT03482011|583491912|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574932|NCT03482011|583491913|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161574933|NCT03482011|583491906|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
161574934|NCT03482011|583491907|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
161574935|NCT03482011|583491908|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
161574936|NCT03482011|583491909|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
161574937|NCT03482011|583491910|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
161574938|NCT03482011|583491911|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
161574939|NCT03482011|583491912|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
161574940|NCT03482011|583491913|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
161574941|NCT03482011|583491906|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
161574942|NCT03482011|583491907|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
161574943|NCT03482011|583491908|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161574944|NCT03482011|583491909|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161574945|NCT03482011|583491910|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161574946|NCT03482011|583491911|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161574947|NCT03482011|583491912|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161574948|NCT03482011|583491913|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161574949|NCT03482011|583491906|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
161574950|NCT03482011|583491907|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
161574951|NCT03482011|583491908|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
161574952|NCT03482011|583491909|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
161574953|NCT03482011|583491910|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
161574954|NCT03482011|583491911|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
161574955|NCT03482011|583491912|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
161574956|NCT03482011|583491913|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
161574957|NCT03482011|583491906|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161574958|NCT03482011|583491907|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161574959|NCT03482011|583491908|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161574960|NCT03482011|583491909|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
161574961|NCT03482011|583491910|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161574962|NCT03482011|583491911|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161574963|NCT03482011|583491912|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161574964|NCT03482011|583491913|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
161574965|NCT03482011|583491906|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161574966|NCT03482011|583491907|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161574967|NCT03482011|583491908|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161574968|NCT03482011|583491909|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161915001|NCT01572792|584737359|FG003|Lead-in Study|Withdrawal by Subject|24|||
161915002|NCT01572792|584737360|FG004|Lead-in Study|Withdrawal by Subject|11|||
161915003|NCT01572792|584737356|FG000|Lead-in Study|Protocol Violation|19|||
161915004|NCT01572792|584737357|FG001|Lead-in Study|Protocol Violation|10|||
161915005|NCT01572792|584737358|FG002|Lead-in Study|Protocol Violation|12|||
161915006|NCT01572792|584737359|FG003|Lead-in Study|Protocol Violation|13|||
161915007|NCT01572792|584737360|FG004|Lead-in Study|Protocol Violation|21|||
161915008|NCT01572792|584737356|FG000|Lead-in Study|Lack of Efficacy|20|||
161915009|NCT01572792|584737357|FG001|Lead-in Study|Lack of Efficacy|5|||
161915010|NCT01572792|584737358|FG002|Lead-in Study|Lack of Efficacy|4|||
161915011|NCT01572792|584737359|FG003|Lead-in Study|Lack of Efficacy|8|||
161915012|NCT01572792|584737360|FG004|Lead-in Study|Lack of Efficacy|10|||
161915013|NCT01572792|584737356|FG000|Lead-in Study|Adverse Event|21|||
161915014|NCT01572792|584737357|FG001|Lead-in Study|Adverse Event|21|||
161915015|NCT01572792|584737358|FG002|Lead-in Study|Adverse Event|22|||
161915016|NCT01572792|584737359|FG003|Lead-in Study|Adverse Event|16|||
161915017|NCT01572792|584737360|FG004|Lead-in Study|Adverse Event|14|||
161915018|NCT01572792|584737356|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
161915019|NCT01572792|584737357|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
161574969|NCT03482011|583491910|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
161574970|NCT03482011|583491911|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161574971|NCT03482011|583491912|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161574972|NCT03482011|583491913|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
161574973|NCT03482011|583491906|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
161915020|NCT01572792|584737358|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
161915021|NCT01572792|584737359|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
161915022|NCT01572792|584737360|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
161915023|NCT01572792|584737356|FG000|Extension Study|Lost to Follow-up|6|||
161810902|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
161810903|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
161810904|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
161810905|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Pregnancy|0|||
161810906|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Pregnancy|0|||
161810907|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Pregnancy|2|||
161810908|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Other|0|||
161810909|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Other|9|||
161810910|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Other|5|||
161810911|NCT02453386|584349567|FG000|Overall Study|Adverse Event|22|||
161810912|NCT02453386|584349568|FG001|Overall Study|Adverse Event|30|||
161810913|NCT02453386|584349569|FG002|Overall Study|Adverse Event|15|||
161810914|NCT02453386|584349567|FG000|Overall Study|Protocol Violation|1|||
161810915|NCT02453386|584349568|FG001|Overall Study|Protocol Violation|0|||
161810916|NCT02453386|584349569|FG002|Overall Study|Protocol Violation|1|||
161810917|NCT02453386|584349567|FG000|Overall Study|Withdrawal by Subject|10|||
161810918|NCT02453386|584349568|FG001|Overall Study|Withdrawal by Subject|9|||
161810919|NCT02453386|584349569|FG002|Overall Study|Withdrawal by Subject|9|||
161810920|NCT02453386|584349567|FG000|Overall Study|Sponsor Terminated Study|14|||
161810921|NCT02453386|584349568|FG001|Overall Study|Sponsor Terminated Study|8|||
161810922|NCT02453386|584349569|FG002|Overall Study|Sponsor Terminated Study|11|||
161810923|NCT02453386|584349567|FG000|Overall Study|Subject Terminated by Sponsor|1|||
161810924|NCT02453386|584349568|FG001|Overall Study|Subject Terminated by Sponsor|1|||
161810925|NCT02453386|584349569|FG002|Overall Study|Subject Terminated by Sponsor|1|||
161810926|NCT02453386|584349567|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
161810927|NCT02453386|584349568|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
161810928|NCT02453386|584349569|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
161810929|NCT02453386|584349567|FG000|Overall Study|Lost to Follow-up|0|||
161810930|NCT02453386|584349568|FG001|Overall Study|Lost to Follow-up|0|||
161810931|NCT02453386|584349569|FG002|Overall Study|Lost to Follow-up|1|||
161810932|NCT02453386|584349567|FG000|Overall Study|Other|1|||
161810933|NCT02453386|584349568|FG001|Overall Study|Other|0|||
161810934|NCT02453386|584349569|FG002|Overall Study|Other|1|||
161810935|NCT00359281|584349570|FG000|Overall Study|Adverse Event|1|||
161810936|NCT00359281|584349571|FG001|Overall Study|Adverse Event|0|||
161810937|NCT00359281|584349572|FG002|Overall Study|Adverse Event|0|||
161810938|NCT00359281|584349573|FG003|Overall Study|Adverse Event|0|||
161810939|NCT00359281|584349574|FG004|Overall Study|Adverse Event|0|||
161810940|NCT00359281|584349575|FG005|Overall Study|Adverse Event|0|||
161810941|NCT00359281|584349576|FG006|Overall Study|Adverse Event|1|||
161810942|NCT00359281|584349577|FG007|Overall Study|Adverse Event|0|||
161810943|NCT00359281|584349578|FG008|Overall Study|Adverse Event|0|||
161810944|NCT00359281|584349570|FG000|Overall Study|Withdrawal by Subject|0|||
161810945|NCT00359281|584349571|FG001|Overall Study|Withdrawal by Subject|0|||
161810946|NCT00359281|584349572|FG002|Overall Study|Withdrawal by Subject|0|||
161810947|NCT00359281|584349573|FG003|Overall Study|Withdrawal by Subject|0|||
161810948|NCT00359281|584349574|FG004|Overall Study|Withdrawal by Subject|0|||
161810949|NCT00359281|584349575|FG005|Overall Study|Withdrawal by Subject|0|||
161810950|NCT00359281|584349576|FG006|Overall Study|Withdrawal by Subject|1|||
161810951|NCT00359281|584349577|FG007|Overall Study|Withdrawal by Subject|0|||
161810952|NCT00359281|584349578|FG008|Overall Study|Withdrawal by Subject|0|||
161810953|NCT01289262|584349581|FG000|Overall Study|Lost to Follow-up|29|||
161915024|NCT01572792|584737357|FG001|Extension Study|Lost to Follow-up|2|||
161915025|NCT01572792|584737358|FG002|Extension Study|Lost to Follow-up|0|||
161915026|NCT01572792|584737359|FG003|Extension Study|Lost to Follow-up|3|||
161915027|NCT01572792|584737360|FG004|Extension Study|Lost to Follow-up|3|||
161915028|NCT01572792|584737356|FG000|Extension Study|Withdrawal by Subject|7|||
161915029|NCT01572792|584737357|FG001|Extension Study|Withdrawal by Subject|6|||
161915030|NCT01572792|584737358|FG002|Extension Study|Withdrawal by Subject|11|||
161915031|NCT01572792|584737359|FG003|Extension Study|Withdrawal by Subject|8|||
161915032|NCT01572792|584737360|FG004|Extension Study|Withdrawal by Subject|14|||
161915033|NCT01572792|584737356|FG000|Extension Study|Protocol Violation|0|||
161915034|NCT01572792|584737357|FG001|Extension Study|Protocol Violation|4|||
161915035|NCT01572792|584737358|FG002|Extension Study|Protocol Violation|3|||
161915036|NCT01572792|584737359|FG003|Extension Study|Protocol Violation|4|||
161574974|NCT03482011|583491907|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
161810954|NCT01289262|584349582|FG001|Overall Study|Lost to Follow-up|16|||
161810955|NCT01289262|584349581|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
161810956|NCT01289262|584349582|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
161810957|NCT01415986|584349585|FG000|Overall Study|Lost to Follow-up|1|||
161810958|NCT01474551|584349586|FG000|Overall Study|Death|1|||
161810959|NCT03122457|584349595|FG000|Overall Study|Withdrawal by Subject|6|||
161810960|NCT00446563|584349599|FG000|Overall Study|Adverse Event|4|||
161810961|NCT00446563|584349600|FG001|Overall Study|Adverse Event|3|||
161915037|NCT01572792|584737360|FG004|Extension Study|Protocol Violation|3|||
161574975|NCT03482011|583491908|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
161574976|NCT03482011|583491909|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
161574977|NCT03482011|583491910|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
161574978|NCT03482011|583491911|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
161574979|NCT03482011|583491912|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
161574980|NCT03482011|583491913|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
161574981|NCT03482011|583491906|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161574982|NCT03482011|583491907|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161574983|NCT03482011|583491908|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161574984|NCT03482011|583491909|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
161574985|NCT03482011|583491910|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161574986|NCT03482011|583491911|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
161574987|NCT03482011|583491912|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161574988|NCT03482011|583491913|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161574989|NCT03482011|583491906|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161574990|NCT03482011|583491907|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161574991|NCT03482011|583491908|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161574992|NCT03482011|583491909|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
161574993|NCT03482011|583491910|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161574994|NCT03482011|583491911|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161574995|NCT03482011|583491912|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161574996|NCT03482011|583491913|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
161574997|NCT03482011|583491906|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
161810962|NCT00446563|584349599|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161810963|NCT00446563|584349600|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161810964|NCT00446563|584349599|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161810965|NCT00446563|584349600|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161810966|NCT00446563|584349599|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161810967|NCT00446563|584349600|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161810968|NCT00446563|584349599|FG000|Overall Study|Withdrawal by Subject|2|||
161810969|NCT00446563|584349600|FG001|Overall Study|Withdrawal by Subject|1|||
161810970|NCT00446563|584349599|FG000|Overall Study|Administrative problems|0|||
161810971|NCT00446563|584349600|FG001|Overall Study|Administrative problems|1|||
161810972|NCT03769025|584349601|FG000|Overall Study|Withdrawal by Subject|1|||
161810973|NCT03769025|584349602|FG001|Overall Study|Withdrawal by Subject|1|||
161810974|NCT03769025|584349601|FG000|Overall Study|Lost to Follow-up|4|||
161810975|NCT03769025|584349602|FG001|Overall Study|Lost to Follow-up|3|||
161810976|NCT01169558|584349603|FG000|Overall Study|Disease progression|98|||
161810977|NCT01169558|584349603|FG000|Overall Study|Adverse Event|25|||
161810978|NCT01169558|584349603|FG000|Overall Study|Withdrawal of Consent|8|||
161810979|NCT01169558|584349603|FG000|Overall Study|Medical Decision|7|||
161810980|NCT01169558|584349603|FG000|Overall Study|Stable Disease|4|||
161810981|NCT01169558|584349603|FG000|Overall Study|Lost to Follow-up|4|||
161810982|NCT01169558|584349603|FG000|Overall Study|Need for Surgery|4|||
161810983|NCT01169558|584349603|FG000|Overall Study|Non-compliance|2|||
161810984|NCT01169558|584349603|FG000|Overall Study|Protocol Violation|2|||
161810985|NCT01169558|584349603|FG000|Overall Study|Partial response|2|||
161810986|NCT02911701|584349606|FG000|Overall Study|Withdrawal by Subject|2|||
161810987|NCT02911701|584349607|FG001|Overall Study|Withdrawal by Subject|4|||
161810988|NCT02911701|584349606|FG000|Overall Study|Adverse Event|1|||
161810989|NCT02911701|584349607|FG001|Overall Study|Adverse Event|0|||
161810990|NCT04659603|584349610|FG000|Overall Study|Study terminated by sponsor|0|||
161810991|NCT04659603|584349611|FG001|Overall Study|Study terminated by sponsor|0|||
161810992|NCT04659603|584349612|FG002|Overall Study|Study terminated by sponsor|2|||
161810993|NCT04659603|584349610|FG000|Overall Study|Withdrawal by Subject|0|||
161810994|NCT04659603|584349611|FG001|Overall Study|Withdrawal by Subject|5|||
161810995|NCT04659603|584349612|FG002|Overall Study|Withdrawal by Subject|0|||
161810996|NCT04659603|584349610|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
161810997|NCT04659603|584349611|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
161810998|NCT04659603|584349612|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
161810999|NCT01110005|584349613|FG000|Overall Study|ineligible|1|||
161811000|NCT01110005|584349614|FG001|Overall Study|ineligible|2|||
161811001|NCT01110005|584349613|FG000|Overall Study|missing consent|3|||
161811002|NCT01110005|584349614|FG001|Overall Study|missing consent|2|||
161811003|NCT01110005|584349613|FG000|Overall Study|Withdrawal by Subject|0|||
161811004|NCT01110005|584349614|FG001|Overall Study|Withdrawal by Subject|1|||
161811005|NCT04646213|584349615|FG000|Overall Study|Physician Decision|3|||
161811006|NCT04646213|584349615|FG000|Overall Study|Withdrawal by Subject|2|||
161811007|NCT02441309|584349616|FG000|Overall Study|Disease progression|2|||
161811008|NCT02441309|584349617|FG001|Overall Study|Disease progression|1|||
161811009|NCT02441309|584349618|FG002|Overall Study|Disease progression|2|||
161811010|NCT02441309|584349616|FG000|Overall Study|Adverse Event|0|||
161811011|NCT02441309|584349617|FG001|Overall Study|Adverse Event|1|||
161811012|NCT02441309|584349618|FG002|Overall Study|Adverse Event|0|||
161811013|NCT02441309|584349616|FG000|Overall Study|Withdrawal by Subject|1|||
161811014|NCT02441309|584349617|FG001|Overall Study|Withdrawal by Subject|0|||
161811015|NCT02441309|584349618|FG002|Overall Study|Withdrawal by Subject|1|||
161811016|NCT02820350|584349635|FG000|Overall Study|Withdrawal by Subject|3|||
161811017|NCT02820350|584349635|FG000|Overall Study|Death|4|||
161811018|NCT02057835|584351342|FG000|Overall Study|Withdrawal by Subject|0|||
161811019|NCT02057835|584351343|FG001|Overall Study|Withdrawal by Subject|2|||
161811020|NCT02057835|584351344|FG002|Overall Study|Withdrawal by Subject|0|||
161467789|NCT00809354|583109473|FG009|Overall Study|Lack of Efficacy|38|||
161811021|NCT02057835|584351345|FG003|Overall Study|Withdrawal by Subject|0|||
161811022|NCT02057835|584351346|FG004|Overall Study|Withdrawal by Subject|0|||
161811023|NCT02057835|584351347|FG005|Overall Study|Withdrawal by Subject|0|||
161811024|NCT02057835|584351348|FG006|Overall Study|Withdrawal by Subject|0|||
161811025|NCT02057835|584351349|FG007|Overall Study|Withdrawal by Subject|0|||
161811026|NCT02057835|584351350|FG008|Overall Study|Withdrawal by Subject|0|||
161811027|NCT02057835|584351351|FG009|Overall Study|Withdrawal by Subject|0|||
161811028|NCT02222818|584351352|FG000|Period 1|Eligibility criteria not met|0|||
161811029|NCT02222818|584351353|FG001|Period 1|Eligibility criteria not met|3|||
161811030|NCT00834717|584351354|FG000|First Intervention|Adverse Event|1|||
161811031|NCT00834717|584351355|FG001|First Intervention|Adverse Event|0|||
161811032|NCT00834717|584351354|FG000|First Intervention|Withdrawal by Subject|0|||
161811033|NCT00834717|584351355|FG001|First Intervention|Withdrawal by Subject|1|||
161811034|NCT01660243|584351356|FG000|Overall Study|Adverse Event|1|||
161811035|NCT01660243|584351357|FG001|Overall Study|Adverse Event|0|||
161811036|NCT01660243|584351358|FG002|Overall Study|Adverse Event|1|||
161811037|NCT01660243|584351359|FG003|Overall Study|Adverse Event|0|||
161574998|NCT03482011|583491907|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
161574999|NCT03482011|583491908|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
161575000|NCT03482011|583491909|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
161575001|NCT03482011|583491910|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
161575002|NCT03482011|583491911|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
161575003|NCT03482011|583491912|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
161575004|NCT03482011|583491913|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
161575005|NCT03482011|583491906|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161575006|NCT03482011|583491907|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161575007|NCT03482011|583491908|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
161575008|NCT03482011|583491909|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
161575009|NCT03482011|583491910|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161575010|NCT03482011|583491911|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161575011|NCT03482011|583491912|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161575012|NCT03482011|583491913|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
161575013|NCT03482011|583491906|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575014|NCT03482011|583491907|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575015|NCT03482011|583491908|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575016|NCT03482011|583491909|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575017|NCT03482011|583491910|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575018|NCT03482011|583491911|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575019|NCT03482011|583491912|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
161575020|NCT03482011|583491913|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
161575021|NCT03482011|583491906|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575022|NCT03482011|583491907|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575023|NCT03482011|583491908|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575024|NCT03482011|583491909|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575025|NCT03482011|583491910|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575026|NCT03482011|583491911|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575027|NCT03482011|583491912|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161575028|NCT03482011|583491913|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
161575029|NCT00468052|583491914|FG000|Overall Study|Protocol Violation|7|||
161575030|NCT00468052|583491915|FG001|Overall Study|Protocol Violation|8|||
161575031|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
161575032|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
161575033|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
161575034|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
161575035|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
161575036|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
161575037|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
161575038|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
161575039|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
161575040|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161575041|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161575042|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161575043|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161575044|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
161575045|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161575046|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575047|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575048|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161811038|NCT01660243|584351356|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
161811039|NCT01660243|584351357|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161811040|NCT01660243|584351358|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161811041|NCT01660243|584351359|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161811042|NCT01660243|584351356|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161811043|NCT01660243|584351357|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161811044|NCT01660243|584351358|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
161811045|NCT01660243|584351359|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161811046|NCT01660243|584351356|FG000|Overall Study|Randomization error|0|||
161811047|NCT01660243|584351357|FG001|Overall Study|Randomization error|0|||
161811048|NCT01660243|584351358|FG002|Overall Study|Randomization error|0|||
161811049|NCT01660243|584351359|FG003|Overall Study|Randomization error|1|||
161811050|NCT04299087|584351360|FG000|Overall Study|Lost to Follow-up|2|||
161811051|NCT04299087|584351361|FG001|Overall Study|Lost to Follow-up|1|||
161811052|NCT03025087|584351362|FG000|Overall Study|Physician Decision|3|||
161811053|NCT03025087|584351363|FG001|Overall Study|Physician Decision|3|||
161811054|NCT03025087|584351364|FG002|Overall Study|Physician Decision|0|||
161811055|NCT03025087|584351365|FG003|Overall Study|Physician Decision|0|||
161811056|NCT03025087|584351366|FG004|Overall Study|Physician Decision|0|||
161811057|NCT03025087|584351362|FG000|Overall Study|Withdrawal by Subject|1|||
161811058|NCT03025087|584351363|FG001|Overall Study|Withdrawal by Subject|1|||
161811059|NCT03025087|584351364|FG002|Overall Study|Withdrawal by Subject|0|||
161811060|NCT03025087|584351365|FG003|Overall Study|Withdrawal by Subject|0|||
161575049|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161811061|NCT03025087|584351366|FG004|Overall Study|Withdrawal by Subject|0|||
161811062|NCT03025087|584351362|FG000|Overall Study|Unable to complete MRI|2|||
161811063|NCT03025087|584351363|FG001|Overall Study|Unable to complete MRI|2|||
161811064|NCT03025087|584351364|FG002|Overall Study|Unable to complete MRI|0|||
161811065|NCT03025087|584351365|FG003|Overall Study|Unable to complete MRI|0|||
161811066|NCT03025087|584351366|FG004|Overall Study|Unable to complete MRI|0|||
161811067|NCT00594035|584351367|FG000|Overall Study|Lost to Follow-up|1|||
161811068|NCT00594035|584351368|FG001|Overall Study|Lost to Follow-up|1|||
161811069|NCT00594035|584351367|FG000|Overall Study|Withdrawal by Subject|1|||
161811070|NCT00594035|584351368|FG001|Overall Study|Withdrawal by Subject|0|||
161811071|NCT00594035|584351367|FG000|Overall Study|Subject transferred to nursing home|0|||
161811072|NCT00594035|584351368|FG001|Overall Study|Subject transferred to nursing home|1|||
161811073|NCT00594035|584351367|FG000|Overall Study|Subject couldn't return due to job|0|||
161811074|NCT00594035|584351368|FG001|Overall Study|Subject couldn't return due to job|1|||
161811075|NCT00795821|584351369|FG000|Acute Treatment Phase|Adverse Event|23|||
161811076|NCT00795821|584351370|FG001|Acute Treatment Phase|Adverse Event|4|||
161811077|NCT00795821|584351369|FG000|Acute Treatment Phase|Death|1|||
161811078|NCT00795821|584351370|FG001|Acute Treatment Phase|Death|0|||
161811079|NCT00795821|584351369|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
161811080|NCT00795821|584351370|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
161811081|NCT00795821|584351369|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
161811082|NCT00795821|584351370|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
161811083|NCT00795821|584351369|FG000|Acute Treatment Phase|Physician Decision|1|||
161811084|NCT00795821|584351370|FG001|Acute Treatment Phase|Physician Decision|1|||
161811085|NCT00795821|584351369|FG000|Acute Treatment Phase|Protocol Violation|1|||
161811086|NCT00795821|584351370|FG001|Acute Treatment Phase|Protocol Violation|2|||
161811087|NCT00795821|584351369|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
161811088|NCT00795821|584351370|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
161811089|NCT00795821|584351369|FG000|Long-term Extension Phase|Adverse Event|25|||
161811090|NCT00795821|584351370|FG001|Long-term Extension Phase|Adverse Event|32|||
161811091|NCT00795821|584351369|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
161811092|NCT00795821|584351370|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
161811093|NCT00795821|584351369|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
161811094|NCT00795821|584351370|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
161811095|NCT00795821|584351369|FG000|Long-term Extension Phase|Physician Decision|1|||
161811096|NCT00795821|584351370|FG001|Long-term Extension Phase|Physician Decision|2|||
161811097|NCT00795821|584351369|FG000|Long-term Extension Phase|Protocol Violation|3|||
161811098|NCT00795821|584351370|FG001|Long-term Extension Phase|Protocol Violation|5|||
161811099|NCT00795821|584351369|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
161811100|NCT00795821|584351370|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
161811101|NCT00795821|584351369|FG000|Taper Phase|Adverse Event|2|||
161915038|NCT01572792|584737356|FG000|Extension Study|Lack of Efficacy|2|||
161915039|NCT01572792|584737357|FG001|Extension Study|Lack of Efficacy|3|||
161915040|NCT01572792|584737358|FG002|Extension Study|Lack of Efficacy|3|||
161915041|NCT01572792|584737359|FG003|Extension Study|Lack of Efficacy|2|||
161915042|NCT01572792|584737360|FG004|Extension Study|Lack of Efficacy|2|||
161915043|NCT01572792|584737356|FG000|Extension Study|Adverse Event|7|||
161915044|NCT01572792|584737357|FG001|Extension Study|Adverse Event|6|||
161915045|NCT01572792|584737358|FG002|Extension Study|Adverse Event|5|||
161915046|NCT01572792|584737359|FG003|Extension Study|Adverse Event|6|||
161915047|NCT01572792|584737360|FG004|Extension Study|Adverse Event|4|||
161915048|NCT01572792|584737356|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
161915049|NCT01572792|584737357|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
161915050|NCT01572792|584737358|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
161915051|NCT01572792|584737359|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
161915052|NCT01572792|584737360|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
161915053|NCT03692949|584737366|FG000|Overall Study|Lost to Follow-up|0|||
161915054|NCT03692949|584737367|FG001|Overall Study|Lost to Follow-up|0|||
161915055|NCT03692949|584737368|FG002|Overall Study|Lost to Follow-up|0|||
161915056|NCT03692949|584737369|FG003|Overall Study|Lost to Follow-up|0|||
161915057|NCT03692949|584737370|FG004|Overall Study|Lost to Follow-up|0|||
161915058|NCT03692949|584737371|FG005|Overall Study|Lost to Follow-up|0|||
161915059|NCT03692949|584737372|FG006|Overall Study|Lost to Follow-up|0|||
161915060|NCT03692949|584737373|FG007|Overall Study|Lost to Follow-up|1|||
161915061|NCT03197129|584737375|FG000|Overall Study|did not answer the VPT: shyness|4|||
161915062|NCT03197129|584737376|FG001|Overall Study|did not answer the VPT: shyness|5|||
161915063|NCT04848480|584737379|FG000|Main Phase (26 Weeks)|Death|1|||
161811102|NCT00795821|584351370|FG001|Taper Phase|Adverse Event|0|||
161811103|NCT00795821|584351369|FG000|Taper Phase|Lost to Follow-up|1|||
161811104|NCT00795821|584351370|FG001|Taper Phase|Lost to Follow-up|0|||
161811105|NCT00795821|584351369|FG000|Taper Phase|Physician Decision|2|||
161811106|NCT00795821|584351370|FG001|Taper Phase|Physician Decision|0|||
161811107|NCT00795821|584351369|FG000|Taper Phase|Withdrawal by Subject|4|||
161811108|NCT00795821|584351370|FG001|Taper Phase|Withdrawal by Subject|0|||
161811109|NCT01376037|584351375|FG000|Overall Study|Lost to Follow-up|0|||
161811110|NCT01376037|584351376|FG001|Overall Study|Lost to Follow-up|2|||
161811111|NCT02328040|584351377|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
161811112|NCT02328040|584351378|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
161811113|NCT02149420|584351379|FG000|Core Study|Administrative problems|0|||
161811114|NCT02149420|584351380|FG001|Core Study|Administrative problems|1|||
161811115|NCT02149420|584351381|FG002|Core Study|Administrative problems|2|||
161811116|NCT02149420|584351379|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
161915064|NCT04848480|584737380|FG001|Main Phase (26 Weeks)|Death|0|||
161915065|NCT04848480|584737379|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
161575050|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575051|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575052|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575053|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575054|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575055|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575056|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161575057|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
161575058|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
161575059|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
161575060|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
161575061|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
161575062|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161575063|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
161575064|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161575065|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161575066|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161575067|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161575068|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161575069|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161575070|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575071|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
161575072|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
161575073|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575074|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
161575075|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575076|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575077|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575078|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575079|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575080|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575081|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575082|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161575083|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161575084|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
161575085|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161575086|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161575087|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
161575088|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575089|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575090|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575091|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161575092|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575093|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575094|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575095|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161575096|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161575097|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575098|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575099|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575100|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575101|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161575102|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
161575103|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161575104|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575105|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575106|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575107|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575108|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161575109|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
161575110|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
161575111|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
161575112|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
161575113|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
161575114|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161575115|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
161575116|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161575117|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161575118|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161575119|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161575120|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161575121|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161575122|NCT04707313|583491917|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575123|NCT04707313|583491918|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575124|NCT04707313|583491919|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
161575125|NCT04707313|583491920|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575126|NCT04707313|583491921|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575127|NCT04707313|583491922|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575128|NCT04707313|583491923|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575129|NCT04707313|583491924|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
161575130|NCT04707313|583491925|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575131|NCT04707313|583491926|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575132|NCT04707313|583491927|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575133|NCT04707313|583491928|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575134|NCT04707313|583491929|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161575135|NCT04707313|583491917|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575136|NCT04707313|583491918|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575137|NCT04707313|583491919|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575138|NCT04707313|583491920|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575139|NCT04707313|583491921|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575140|NCT04707313|583491922|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575141|NCT04707313|583491923|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575142|NCT04707313|583491924|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575143|NCT04707313|583491925|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575144|NCT04707313|583491926|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161575145|NCT04707313|583491927|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
161575146|NCT04707313|583491928|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
161575147|NCT04707313|583491929|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
161575148|NCT04707313|583491917|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575149|NCT04707313|583491918|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575150|NCT04707313|583491919|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575151|NCT04707313|583491920|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575152|NCT04707313|583491921|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575153|NCT04707313|583491922|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575154|NCT04707313|583491923|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575155|NCT04707313|583491924|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575156|NCT04707313|583491925|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575157|NCT04707313|583491926|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
161575158|NCT04707313|583491927|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
161575159|NCT04707313|583491928|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
161575160|NCT04707313|583491929|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161575161|NCT04707313|583491917|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575162|NCT04707313|583491918|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575163|NCT04707313|583491919|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575164|NCT04707313|583491920|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575165|NCT04707313|583491921|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575166|NCT04707313|583491922|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575167|NCT04707313|583491923|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575168|NCT04707313|583491924|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575169|NCT04707313|583491925|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161575170|NCT04707313|583491926|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
161575171|NCT04707313|583491927|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
161575172|NCT04707313|583491928|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
161575173|NCT04707313|583491929|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
161575174|NCT04707313|583491917|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575175|NCT04707313|583491918|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575176|NCT04707313|583491919|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575177|NCT04707313|583491920|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575178|NCT04707313|583491921|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575179|NCT04707313|583491922|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575180|NCT04707313|583491923|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575181|NCT04707313|583491924|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575182|NCT04707313|583491925|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575183|NCT04707313|583491926|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575184|NCT04707313|583491927|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
161575185|NCT04707313|583491928|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
161575186|NCT04707313|583491929|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
161575187|NCT04707313|583491917|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575188|NCT04707313|583491918|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575189|NCT04707313|583491919|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575190|NCT04707313|583491920|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575191|NCT04707313|583491921|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575192|NCT04707313|583491922|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575193|NCT04707313|583491923|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575194|NCT04707313|583491924|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575195|NCT04707313|583491925|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575196|NCT04707313|583491926|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
161575197|NCT04707313|583491927|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
161575198|NCT04707313|583491928|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575199|NCT04707313|583491929|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161575200|NCT04707313|583491917|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575201|NCT04707313|583491918|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575202|NCT04707313|583491919|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161915066|NCT04848480|584737380|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
161915067|NCT04848480|584737379|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
161915068|NCT04848480|584737380|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
161915069|NCT04848480|584737379|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
161915070|NCT04848480|584737380|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
161915071|NCT04848480|584737379|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
161575203|NCT04707313|583491920|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575204|NCT04707313|583491921|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575205|NCT04707313|583491922|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575206|NCT04707313|583491923|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575207|NCT04707313|583491924|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575208|NCT04707313|583491925|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161575209|NCT04707313|583491926|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
161575210|NCT04707313|583491927|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
161575211|NCT04707313|583491928|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
161575212|NCT04707313|583491929|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
161575213|NCT02459899|583491930|FG000|Overall Study|Adverse Event|1|||
161575214|NCT02459899|583491931|FG001|Overall Study|Adverse Event|1|||
161575215|NCT02459899|583491932|FG002|Overall Study|Adverse Event|0|||
161575216|NCT02459899|583491933|FG003|Overall Study|Adverse Event|0|||
161575217|NCT02459899|583491930|FG000|Overall Study|Lost to Follow-up|1|||
161575218|NCT02459899|583491931|FG001|Overall Study|Lost to Follow-up|2|||
161575219|NCT02459899|583491932|FG002|Overall Study|Lost to Follow-up|0|||
161575220|NCT02459899|583491933|FG003|Overall Study|Lost to Follow-up|1|||
161575221|NCT02459899|583491930|FG000|Overall Study|Non-compliance with the treatment|0|||
161575222|NCT02459899|583491931|FG001|Overall Study|Non-compliance with the treatment|0|||
161575223|NCT02459899|583491932|FG002|Overall Study|Non-compliance with the treatment|0|||
161575224|NCT02459899|583491933|FG003|Overall Study|Non-compliance with the treatment|1|||
161915072|NCT04848480|584737380|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
161915073|NCT04848480|584737379|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
161915074|NCT04848480|584737380|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
161915075|NCT05219162|584737381|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
161915076|NCT05219162|584737381|FG000|Overall Study|Withdrawal by Subject|23|||
161467790|NCT00809354|583109464|FG000|Overall Study|Lost to Follow-up|10|||
161467791|NCT00809354|583109465|FG001|Overall Study|Lost to Follow-up|11|||
161467792|NCT00809354|583109466|FG002|Overall Study|Lost to Follow-up|8|||
161467793|NCT00809354|583109467|FG003|Overall Study|Lost to Follow-up|13|||
161467794|NCT00809354|583109468|FG004|Overall Study|Lost to Follow-up|6|||
161467795|NCT00809354|583109469|FG005|Overall Study|Lost to Follow-up|2|||
161467796|NCT00809354|583109470|FG006|Overall Study|Lost to Follow-up|0|||
161467797|NCT00809354|583109471|FG007|Overall Study|Lost to Follow-up|5|||
161467798|NCT00809354|583109472|FG008|Overall Study|Lost to Follow-up|4|||
161467799|NCT00809354|583109473|FG009|Overall Study|Lost to Follow-up|0|||
161467800|NCT00809354|583109464|FG000|Overall Study|Protocol Violation|7|||
161467801|NCT00809354|583109465|FG001|Overall Study|Protocol Violation|14|||
161467802|NCT00809354|583109466|FG002|Overall Study|Protocol Violation|14|||
161467803|NCT00809354|583109467|FG003|Overall Study|Protocol Violation|12|||
161467804|NCT00809354|583109468|FG004|Overall Study|Protocol Violation|14|||
161575225|NCT02459899|583491930|FG000|Overall Study|Withdrawal by Subject|1|||
161575226|NCT02459899|583491931|FG001|Overall Study|Withdrawal by Subject|3|||
161575227|NCT02459899|583491932|FG002|Overall Study|Withdrawal by Subject|0|||
161915077|NCT04428151|584737382|FG000|Overall Study|Death|100|||
161467805|NCT00809354|583109469|FG005|Overall Study|Protocol Violation|6|||
161467806|NCT00809354|583109470|FG006|Overall Study|Protocol Violation|4|||
161467807|NCT00809354|583109471|FG007|Overall Study|Protocol Violation|6|||
161575228|NCT02459899|583491933|FG003|Overall Study|Withdrawal by Subject|0|||
161575229|NCT02739035|583491934|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
161575230|NCT02739035|583491935|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
161575231|NCT02739035|583491934|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
161575232|NCT02739035|583491935|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
161575233|NCT02739035|583491934|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
161575234|NCT02739035|583491935|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
161575235|NCT02739035|583491934|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
161575236|NCT02739035|583491935|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
161575237|NCT00940992|583491938|FG000|Overall Study|Adverse Event|2|||
161575238|NCT00940992|583491939|FG001|Overall Study|Adverse Event|0|||
161575239|NCT00940992|583491940|FG002|Overall Study|Adverse Event|1|||
161575240|NCT00940992|583491938|FG000|Overall Study|subject request|2|||
161575241|NCT00940992|583491939|FG001|Overall Study|subject request|1|||
161575242|NCT00940992|583491940|FG002|Overall Study|subject request|0|||
161575243|NCT00940992|583491938|FG000|Overall Study|Lost to Follow-up|0|||
161575244|NCT00940992|583491939|FG001|Overall Study|Lost to Follow-up|1|||
161575245|NCT00940992|583491940|FG002|Overall Study|Lost to Follow-up|1|||
161575246|NCT04446117|583491941|FG000|Overall Study|No Study Treatment Given|4|||
161575247|NCT04446117|583491942|FG001|Overall Study|No Study Treatment Given|3|||
161575248|NCT04446117|583491941|FG000|Overall Study|Radiographic Disease Progression|132|||
161575249|NCT04446117|583491942|FG001|Overall Study|Radiographic Disease Progression|158|||
161575250|NCT04446117|583491941|FG000|Overall Study|Adverse Event|79|||
161575251|NCT04446117|583491942|FG001|Overall Study|Adverse Event|43|||
161575252|NCT04446117|583491941|FG000|Overall Study|Lack of Clinical Benefit|1|||
161575253|NCT04446117|583491942|FG001|Overall Study|Lack of Clinical Benefit|1|||
161575254|NCT04446117|583491941|FG000|Overall Study|Withdrawal by Subject|24|||
161575255|NCT04446117|583491942|FG001|Overall Study|Withdrawal by Subject|22|||
161575256|NCT04446117|583491941|FG000|Overall Study|Lost to Follow-up|0|||
161575257|NCT04446117|583491942|FG001|Overall Study|Lost to Follow-up|3|||
161575258|NCT04446117|583491941|FG000|Overall Study|Miscellaneous|26|||
161575259|NCT04446117|583491942|FG001|Overall Study|Miscellaneous|36|||
161575260|NCT04446117|583491941|FG000|Overall Study|Missing Data/Data not yet Received|1|||
161575261|NCT04446117|583491942|FG001|Overall Study|Missing Data/Data not yet Received|0|||
161575262|NCT04221438|583491946|FG000|Overall Study|Adverse Event|1|||
161575263|NCT04221438|583491946|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
161575264|NCT02517307|583491951|FG000|Overall Study|Withdrawal by Subject|1|||
161575265|NCT02517307|583491952|FG001|Overall Study|Withdrawal by Subject|0|||
161467808|NCT00809354|583109472|FG008|Overall Study|Protocol Violation|9|||
161467809|NCT00809354|583109473|FG009|Overall Study|Protocol Violation|3|||
161467810|NCT00809354|583109464|FG000|Overall Study|Withdrawal by Subject|32|||
161467811|NCT00809354|583109465|FG001|Overall Study|Withdrawal by Subject|27|||
161467812|NCT00809354|583109466|FG002|Overall Study|Withdrawal by Subject|31|||
161467813|NCT00809354|583109467|FG003|Overall Study|Withdrawal by Subject|33|||
161467814|NCT00809354|583109468|FG004|Overall Study|Withdrawal by Subject|34|||
161467815|NCT00809354|583109469|FG005|Overall Study|Withdrawal by Subject|29|||
161467816|NCT00809354|583109470|FG006|Overall Study|Withdrawal by Subject|27|||
161467817|NCT00809354|583109471|FG007|Overall Study|Withdrawal by Subject|19|||
161467818|NCT00809354|583109472|FG008|Overall Study|Withdrawal by Subject|18|||
161467819|NCT00809354|583109473|FG009|Overall Study|Withdrawal by Subject|20|||
161467820|NCT00809354|583109464|FG000|Overall Study|Other|10|||
161915078|NCT04428151|584737383|FG001|Overall Study|Death|86|||
161915079|NCT04428151|584737384|FG002|Overall Study|Death|57|||
161915080|NCT04428151|584737382|FG000|Overall Study|Lost to Follow-up|1|||
161915081|NCT04428151|584737383|FG001|Overall Study|Lost to Follow-up|1|||
161915082|NCT04428151|584737384|FG002|Overall Study|Lost to Follow-up|0|||
161915083|NCT04428151|584737382|FG000|Overall Study|Withdrawal by Subject|2|||
161915084|NCT04428151|584737383|FG001|Overall Study|Withdrawal by Subject|2|||
161915085|NCT04428151|584737384|FG002|Overall Study|Withdrawal by Subject|3|||
161915086|NCT04428151|584737382|FG000|Overall Study|Participant Ongoing in Study|41|||
161915087|NCT04428151|584737383|FG001|Overall Study|Participant Ongoing in Study|53|||
161915088|NCT04428151|584737384|FG002|Overall Study|Participant Ongoing in Study|28|||
161915089|NCT01114724|584737385|FG000|Overall Study|Death|8|||
161915090|NCT01114724|584737385|FG000|Overall Study|Lost to Follow-up|1|||
161915091|NCT01114724|584737385|FG000|Overall Study|Withdrawal by Subject|1|||
161915092|NCT02273167|584737393|FG000|Overall Study|Adverse Event|1|||
161915093|NCT02273167|584737394|FG001|Overall Study|Adverse Event|0|||
161915094|NCT02273167|584737395|FG002|Overall Study|Adverse Event|0|||
161915095|NCT02273167|584737393|FG000|Overall Study|Protocol Violation|3|||
161915096|NCT02273167|584737394|FG001|Overall Study|Protocol Violation|1|||
161915097|NCT02273167|584737395|FG002|Overall Study|Protocol Violation|1|||
161915098|NCT02273167|584737393|FG000|Overall Study|Lost to Follow-up|0|||
161915099|NCT02273167|584737394|FG001|Overall Study|Lost to Follow-up|1|||
161915100|NCT02273167|584737395|FG002|Overall Study|Lost to Follow-up|1|||
161915101|NCT02273167|584737393|FG000|Overall Study|Withdrawal by Subject|10|||
161915102|NCT02273167|584737394|FG001|Overall Study|Withdrawal by Subject|12|||
161915103|NCT02273167|584737395|FG002|Overall Study|Withdrawal by Subject|11|||
161915104|NCT02273167|584737393|FG000|Overall Study|Various|10|||
161915105|NCT02273167|584737394|FG001|Overall Study|Various|9|||
161915106|NCT02273167|584737395|FG002|Overall Study|Various|8|||
161915107|NCT03082729|584737396|FG000|Overall Study|Lost to Follow-up|7|||
161915108|NCT03082729|584737396|FG000|Overall Study|Physician Decision|2|||
161915109|NCT03082729|584737396|FG000|Overall Study|Withdrawal by Subject|1|||
161915110|NCT03082729|584737396|FG000|Overall Study|Lack of Efficacy|9|||
161915111|NCT03082729|584737396|FG000|Overall Study|Adverse Event|4|||
161915112|NCT03082729|584737396|FG000|Overall Study|Protocol Violation|6|||
161915113|NCT03082729|584737396|FG000|Overall Study|Fear of study procedure|1|||
161915114|NCT03082729|584737396|FG000|Overall Study|Scheduling conflict|1|||
161915115|NCT03836053|584738868|FG000|Overall Study|Protocol-specified criteria|0|||
161915116|NCT03836053|584738869|FG001|Overall Study|Protocol-specified criteria|2|||
161915117|NCT03836053|584738870|FG002|Overall Study|Protocol-specified criteria|1|||
161915118|NCT03836053|584738868|FG000|Overall Study|Death|1|||
161915119|NCT03836053|584738869|FG001|Overall Study|Death|6|||
161915120|NCT03836053|584738870|FG002|Overall Study|Death|4|||
161915121|NCT03836053|584738868|FG000|Overall Study|Withdrawal of consent from study|0|||
161915122|NCT03836053|584738869|FG001|Overall Study|Withdrawal of consent from study|0|||
161915123|NCT03836053|584738870|FG002|Overall Study|Withdrawal of consent from study|1|||
161915124|NCT03836053|584738868|FG000|Overall Study|Decision by sponsor|0|||
161915125|NCT03836053|584738869|FG001|Overall Study|Decision by sponsor|2|||
161915126|NCT03836053|584738870|FG002|Overall Study|Decision by sponsor|4|||
161915127|NCT03846479|584738871|FG000|Overall Study|Death|8|||
161915128|NCT03846479|584738871|FG000|Overall Study|Lost to Follow-up|1|||
161915129|NCT02332707|584738872|FG000|Overall Study|Adverse Event|0|||
161915130|NCT02332707|584738873|FG001|Overall Study|Adverse Event|0|||
161915131|NCT02332707|584738874|FG002|Overall Study|Adverse Event|0|||
161915132|NCT02332707|584738875|FG003|Overall Study|Adverse Event|0|||
161915133|NCT02332707|584738876|FG004|Overall Study|Adverse Event|0|||
161915134|NCT02332707|584738877|FG005|Overall Study|Adverse Event|0|||
161915135|NCT02332707|584738878|FG006|Overall Study|Adverse Event|0|||
161467821|NCT00809354|583109465|FG001|Overall Study|Other|2|||
161467822|NCT00809354|583109466|FG002|Overall Study|Other|7|||
161915136|NCT02332707|584738879|FG007|Overall Study|Adverse Event|0|||
161915137|NCT02332707|584738880|FG008|Overall Study|Adverse Event|0|||
161915138|NCT02332707|584738881|FG009|Overall Study|Adverse Event|0|||
161915139|NCT02332707|584738882|FG010|Overall Study|Adverse Event|0|||
161915140|NCT02332707|584738883|FG011|Overall Study|Adverse Event|0|||
161915141|NCT02332707|584738884|FG012|Overall Study|Adverse Event|1|||
161915142|NCT02332707|584738885|FG013|Overall Study|Adverse Event|0|||
161575266|NCT02517307|583491953|FG002|Overall Study|Withdrawal by Subject|1|||
161575267|NCT02517307|583491954|FG003|Overall Study|Withdrawal by Subject|0|||
161575268|NCT02517307|583491951|FG000|Overall Study|Protocol Violation|0|||
161575269|NCT02517307|583491952|FG001|Overall Study|Protocol Violation|0|||
161575270|NCT02517307|583491953|FG002|Overall Study|Protocol Violation|1|||
161575271|NCT02517307|583491954|FG003|Overall Study|Protocol Violation|1|||
161575272|NCT00843882|583491955|FG000|Step 1|Lack of Efficacy|14|||
161575273|NCT00843882|583491956|FG001|Step 1|Lack of Efficacy|10|||
161575274|NCT00843882|583491957|FG002|Step 1|Lack of Efficacy|21|||
161575275|NCT00843882|583491955|FG000|Step 1|Adverse Event|8|||
161575276|NCT00843882|583491956|FG001|Step 1|Adverse Event|17|||
161575277|NCT00843882|583491957|FG002|Step 1|Adverse Event|20|||
161575278|NCT00843882|583491955|FG000|Step 1|Death|1|||
161575279|NCT00843882|583491956|FG001|Step 1|Death|2|||
161575280|NCT00843882|583491957|FG002|Step 1|Death|4|||
161575281|NCT00843882|583491955|FG000|Step 1|Withdrawal by Subject|6|||
161575282|NCT00843882|583491956|FG001|Step 1|Withdrawal by Subject|12|||
161575283|NCT00843882|583491957|FG002|Step 1|Withdrawal by Subject|9|||
161575284|NCT00843882|583491955|FG000|Step 1|Physician Decision|0|||
161575285|NCT00843882|583491956|FG001|Step 1|Physician Decision|5|||
161575286|NCT00843882|583491957|FG002|Step 1|Physician Decision|1|||
161575287|NCT00843882|583491955|FG000|Step 1|Patient and physician's decision|0|||
161575288|NCT00843882|583491956|FG001|Step 1|Patient and physician's decision|0|||
161575289|NCT00843882|583491957|FG002|Step 1|Patient and physician's decision|1|||
161575290|NCT00843882|583491955|FG000|Step 1|Other complicating disease|1|||
161575291|NCT00843882|583491956|FG001|Step 1|Other complicating disease|3|||
161575292|NCT00843882|583491957|FG002|Step 1|Other complicating disease|4|||
161575293|NCT00843882|583491955|FG000|Step 1|Alternative therapy|0|||
161575294|NCT00843882|583491956|FG001|Step 1|Alternative therapy|1|||
161575295|NCT00843882|583491957|FG002|Step 1|Alternative therapy|1|||
161575296|NCT00843882|583491955|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
161575297|NCT00843882|583491956|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
161575298|NCT00843882|583491957|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
161575299|NCT00843882|583491955|FG000|Step 1|Off treatment reason unknown|0|||
161575300|NCT00843882|583491956|FG001|Step 1|Off treatment reason unknown|1|||
161575301|NCT00843882|583491957|FG002|Step 1|Off treatment reason unknown|4|||
161575302|NCT00843882|583491955|FG000|Step 1|Never started treatment|2|||
161575303|NCT00843882|583491956|FG001|Step 1|Never started treatment|0|||
161575304|NCT00843882|583491957|FG002|Step 1|Never started treatment|0|||
161575305|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
161575306|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
161575307|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
161575308|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
161575309|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
161575310|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
161575311|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
161575312|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
161575313|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
161575314|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
161575315|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
161575316|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
161575317|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
161575318|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
161575319|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
161575320|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
161575321|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
161575322|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
161575323|NCT00843882|583491955|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
161575324|NCT00843882|583491956|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
161575325|NCT00843882|583491957|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
161575326|NCT03586544|583491958|FG000|First Intervention|Adverse Event|0|||
161575327|NCT03586544|583491959|FG001|First Intervention|Adverse Event|1|||
161575328|NCT03586544|583491958|FG000|Second Intervention|Withdrawal by Subject|0|||
161575329|NCT03586544|583491959|FG001|Second Intervention|Withdrawal by Subject|1|||
161575330|NCT00630786|583491960|FG000|Overall Study|Physician Decision|0|||
161575331|NCT00630786|583491961|FG001|Overall Study|Physician Decision|0|||
161575332|NCT00630786|583491962|FG002|Overall Study|Physician Decision|1|||
161575333|NCT00630786|583491960|FG000|Overall Study|Withdrawal by Subject|0|||
161575334|NCT00630786|583491961|FG001|Overall Study|Withdrawal by Subject|1|||
161575335|NCT00630786|583491962|FG002|Overall Study|Withdrawal by Subject|1|||
161575336|NCT00630786|583491960|FG000|Overall Study|Lost to Follow-up|0|||
161575337|NCT00630786|583491961|FG001|Overall Study|Lost to Follow-up|1|||
161575338|NCT00630786|583491962|FG002|Overall Study|Lost to Follow-up|0|||
161575339|NCT00630786|583491960|FG000|Overall Study|Other|1|||
161575340|NCT00630786|583491961|FG001|Overall Study|Other|0|||
161575341|NCT00630786|583491962|FG002|Overall Study|Other|0|||
161575342|NCT01582269|583491963|FG000|Overall Study|Withdrawal by Subject|1|||
161575343|NCT01582269|583491964|FG001|Overall Study|Withdrawal by Subject|0|||
161575344|NCT01582269|583491965|FG002|Overall Study|Withdrawal by Subject|0|||
161575345|NCT02770248|583491967|FG000|Overall Study|Adverse Event|0|||
161575346|NCT02770248|583491968|FG001|Overall Study|Adverse Event|1|||
161575347|NCT02770248|583491967|FG000|Overall Study|Randomized in error, prior to treatment|0|||
161575348|NCT02770248|583491968|FG001|Overall Study|Randomized in error, prior to treatment|1|||
161575351|NCT02486588|583491975|FG000|Overall Study|Randomized in error- ineligible|738|||
161575352|NCT02486588|583491976|FG001|Overall Study|Randomized in error- ineligible|750|||
161575353|NCT02486588|583491977|FG002|Overall Study|Randomized in error- ineligible|755|||
161575354|NCT02486588|583491978|FG003|Overall Study|Randomized in error- ineligible|738|||
161575355|NCT02486588|583491979|FG004|Overall Study|Randomized in error- ineligible|746|||
161575356|NCT02486588|583491980|FG005|Overall Study|Randomized in error- ineligible|746|||
161575357|NCT00546871|583491981|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
161575358|NCT00546871|583491982|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
161575359|NCT00546871|583491981|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
161575360|NCT00546871|583491982|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
161575361|NCT00546871|583491981|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
161575362|NCT00546871|583491982|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
161575363|NCT00546871|583491981|FG000|Study Extension Period|Protocol Violation|1|||
161575364|NCT00546871|583491982|FG001|Study Extension Period|Protocol Violation|0|||
161575365|NCT00546871|583491981|FG000|Study Extension Period|Withdrawal by Subject|0|||
161575366|NCT00546871|583491982|FG001|Study Extension Period|Withdrawal by Subject|1|||
161575367|NCT00711958|583492667|FG000|Overall Study|Withdrawal by Subject|6|||
161575368|NCT00711958|583492668|FG001|Overall Study|Withdrawal by Subject|8|||
161575369|NCT00711958|583492667|FG000|Overall Study|Lack of Efficacy|3|||
161575370|NCT00711958|583492668|FG001|Overall Study|Lack of Efficacy|1|||
161575371|NCT00711958|583492667|FG000|Overall Study|Clinical deterioration|1|||
161575372|NCT00711958|583492668|FG001|Overall Study|Clinical deterioration|0|||
161575373|NCT00711958|583492667|FG000|Overall Study|Adverse Event|9|||
161575374|NCT00711958|583492668|FG001|Overall Study|Adverse Event|7|||
161575375|NCT00711958|583492667|FG000|Overall Study|Protocol Violation|1|||
161575376|NCT00711958|583492668|FG001|Overall Study|Protocol Violation|0|||
161575377|NCT00711958|583492667|FG000|Overall Study|Lost to Follow-up|2|||
161575378|NCT00711958|583492668|FG001|Overall Study|Lost to Follow-up|2|||
161575379|NCT00711958|583492667|FG000|Overall Study|Death|10|||
161575380|NCT00711958|583492668|FG001|Overall Study|Death|5|||
161575381|NCT00711958|583492667|FG000|Overall Study|Progression of disease|1|||
161575382|NCT00711958|583492668|FG001|Overall Study|Progression of disease|0|||
161575383|NCT02015546|583492669|FG000|Overall Study|Withdrawal by Subject|1|||
161575384|NCT02015546|583492670|FG001|Overall Study|Withdrawal by Subject|1|||
161575385|NCT02015546|583492671|FG002|Overall Study|Withdrawal by Subject|1|||
161575386|NCT02015546|583492669|FG000|Overall Study|Screem Failure|2|||
161575387|NCT02015546|583492670|FG001|Overall Study|Screem Failure|1|||
161575388|NCT02015546|583492671|FG002|Overall Study|Screem Failure|3|||
161575389|NCT01113931|583492672|FG000|Overall Study|Adverse Event|2|||
161575390|NCT01113931|583492673|FG001|Overall Study|Adverse Event|2|||
161575391|NCT01113931|583492672|FG000|Overall Study|Physician Decision|0|||
161575392|NCT01113931|583492673|FG001|Overall Study|Physician Decision|2|||
161575393|NCT01113931|583492672|FG000|Overall Study|Lost to Follow-up|12|||
161575394|NCT01113931|583492673|FG001|Overall Study|Lost to Follow-up|9|||
161575395|NCT01113931|583492672|FG000|Overall Study|Various|2|||
161575396|NCT01113931|583492673|FG001|Overall Study|Various|4|||
161575397|NCT01113931|583492672|FG000|Overall Study|Withdrawal by Subject|3|||
161575398|NCT01113931|583492673|FG001|Overall Study|Withdrawal by Subject|0|||
161575399|NCT06119113|583492676|FG000|Overall Study|Lost to Follow-up|15|||
161575400|NCT06119113|583492677|FG001|Overall Study|Lost to Follow-up|13|||
161575401|NCT06119113|583492678|FG002|Overall Study|Lost to Follow-up|21|||
161575402|NCT05136443|583492681|FG000|Overall Study|Lost to Follow-up|2|||
161575403|NCT05136443|583492681|FG000|Overall Study|Adverse Event|2|||
161575404|NCT01786564|583492686|FG000|Overall Study|Lost to Follow-up|47|||
161575405|NCT01786564|583492686|FG000|Overall Study|Ineligible|17|||
161575406|NCT00424762|583492689|FG000|Overall Study|Withdrawal by Subject|18|||
161811117|NCT02149420|584351380|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
161811118|NCT02149420|584351381|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
161811119|NCT00440518|584351382|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
161811120|NCT00440518|584351383|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
161811121|NCT00440518|584351384|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
161811122|NCT00440518|584351382|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
161811123|NCT00440518|584351383|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
161811124|NCT00440518|584351384|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
161811125|NCT00440518|584351382|FG000|Randomized /Titration Period|Protocol Deviation|1|||
161811126|NCT00440518|584351383|FG001|Randomized /Titration Period|Protocol Deviation|0|||
161811127|NCT00440518|584351384|FG002|Randomized /Titration Period|Protocol Deviation|0|||
161811128|NCT00440518|584351382|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
161811129|NCT00440518|584351383|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
161811130|NCT00440518|584351384|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
161811131|NCT00440518|584351382|FG000|Randomized /Titration Period|Other|1|||
161811132|NCT00440518|584351383|FG001|Randomized /Titration Period|Other|0|||
161811133|NCT00440518|584351384|FG002|Randomized /Titration Period|Other|0|||
161811134|NCT00440518|584351382|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
161811135|NCT00440518|584351383|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
161811136|NCT00440518|584351384|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
161811137|NCT00440518|584351382|FG000|Randomized /Titration Period|Adverse Event|2|||
161811138|NCT00440518|584351383|FG001|Randomized /Titration Period|Adverse Event|3|||
161811139|NCT00440518|584351384|FG002|Randomized /Titration Period|Adverse Event|0|||
161811140|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
161811141|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
161811142|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
161811143|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
161811144|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
161811145|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
161811146|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
161811147|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
161811148|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
161811149|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
161811150|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
161811151|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
161811152|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
161915143|NCT02332707|584738886|FG014|Overall Study|Adverse Event|0|||
161915144|NCT02332707|584738887|FG015|Overall Study|Adverse Event|0|||
161915145|NCT02332707|584738888|FG016|Overall Study|Adverse Event|0|||
161915146|NCT02332707|584738889|FG017|Overall Study|Adverse Event|0|||
161915147|NCT02332707|584738872|FG000|Overall Study|Lost to Follow-up|0|||
161915148|NCT02332707|584738873|FG001|Overall Study|Lost to Follow-up|0|||
161915149|NCT02332707|584738874|FG002|Overall Study|Lost to Follow-up|0|||
161915150|NCT02332707|584738875|FG003|Overall Study|Lost to Follow-up|0|||
161915151|NCT02332707|584738876|FG004|Overall Study|Lost to Follow-up|0|||
161915152|NCT02332707|584738877|FG005|Overall Study|Lost to Follow-up|1|||
161915153|NCT02332707|584738878|FG006|Overall Study|Lost to Follow-up|0|||
161915154|NCT02332707|584738879|FG007|Overall Study|Lost to Follow-up|0|||
161915155|NCT02332707|584738880|FG008|Overall Study|Lost to Follow-up|0|||
161915156|NCT02332707|584738881|FG009|Overall Study|Lost to Follow-up|0|||
161915157|NCT02332707|584738882|FG010|Overall Study|Lost to Follow-up|2|||
161915158|NCT02332707|584738883|FG011|Overall Study|Lost to Follow-up|0|||
161915159|NCT02332707|584738884|FG012|Overall Study|Lost to Follow-up|3|||
161915160|NCT02332707|584738885|FG013|Overall Study|Lost to Follow-up|0|||
161915161|NCT02332707|584738886|FG014|Overall Study|Lost to Follow-up|0|||
161915162|NCT02332707|584738887|FG015|Overall Study|Lost to Follow-up|0|||
161915163|NCT02332707|584738888|FG016|Overall Study|Lost to Follow-up|0|||
161915164|NCT02332707|584738889|FG017|Overall Study|Lost to Follow-up|0|||
161915165|NCT02332707|584738872|FG000|Overall Study|Physician Decision|0|||
161915166|NCT02332707|584738873|FG001|Overall Study|Physician Decision|0|||
161915167|NCT02332707|584738874|FG002|Overall Study|Physician Decision|0|||
161915168|NCT02332707|584738875|FG003|Overall Study|Physician Decision|1|||
161915169|NCT02332707|584738876|FG004|Overall Study|Physician Decision|0|||
161915170|NCT02332707|584738877|FG005|Overall Study|Physician Decision|0|||
161915171|NCT02332707|584738878|FG006|Overall Study|Physician Decision|0|||
161915172|NCT02332707|584738879|FG007|Overall Study|Physician Decision|0|||
161915173|NCT02332707|584738880|FG008|Overall Study|Physician Decision|0|||
161915174|NCT02332707|584738881|FG009|Overall Study|Physician Decision|0|||
161915175|NCT02332707|584738882|FG010|Overall Study|Physician Decision|0|||
161915176|NCT02332707|584738883|FG011|Overall Study|Physician Decision|0|||
161915177|NCT02332707|584738884|FG012|Overall Study|Physician Decision|1|||
161915178|NCT02332707|584738885|FG013|Overall Study|Physician Decision|0|||
161915179|NCT02332707|584738886|FG014|Overall Study|Physician Decision|0|||
161467823|NCT00809354|583109467|FG003|Overall Study|Other|10|||
161467824|NCT00809354|583109468|FG004|Overall Study|Other|5|||
161575407|NCT00424762|583492690|FG001|Overall Study|Withdrawal by Subject|19|||
161575408|NCT00424762|583492689|FG000|Overall Study|Lost to Follow-up|2|||
161575409|NCT00424762|583492690|FG001|Overall Study|Lost to Follow-up|3|||
161575410|NCT01145885|583492691|FG000|Overall Study|Progressive Disease|7|||
161575411|NCT05299606|583492692|FG000|Overall Study|Death|1|||
161575412|NCT03460756|583492694|FG000|Overall Study|Adverse Event|0|||
161575413|NCT03460756|583492695|FG001|Overall Study|Adverse Event|0|||
161575414|NCT03460756|583492696|FG002|Overall Study|Adverse Event|0|||
161575415|NCT03460756|583492697|FG003|Overall Study|Adverse Event|1|||
161575416|NCT03460756|583492694|FG000|Overall Study|Lack of Efficacy|0|||
161575417|NCT03460756|583492695|FG001|Overall Study|Lack of Efficacy|0|||
161575418|NCT03460756|583492696|FG002|Overall Study|Lack of Efficacy|0|||
161575419|NCT03460756|583492697|FG003|Overall Study|Lack of Efficacy|2|||
161467825|NCT00809354|583109469|FG005|Overall Study|Other|3|||
161467826|NCT00809354|583109470|FG006|Overall Study|Other|2|||
161467827|NCT00809354|583109471|FG007|Overall Study|Other|3|||
161467828|NCT00809354|583109472|FG008|Overall Study|Other|4|||
161467829|NCT00809354|583109473|FG009|Overall Study|Other|3|||
161467830|NCT00809354|583109464|FG000|Overall Study|Study terminated by sponsor|138|||
161467831|NCT00809354|583109465|FG001|Overall Study|Study terminated by sponsor|134|||
161467832|NCT00809354|583109466|FG002|Overall Study|Study terminated by sponsor|129|||
161467833|NCT00809354|583109467|FG003|Overall Study|Study terminated by sponsor|120|||
161467834|NCT00809354|583109468|FG004|Overall Study|Study terminated by sponsor|126|||
161467835|NCT00809354|583109469|FG005|Overall Study|Study terminated by sponsor|133|||
161467836|NCT00809354|583109470|FG006|Overall Study|Study terminated by sponsor|124|||
161467837|NCT00809354|583109471|FG007|Overall Study|Study terminated by sponsor|148|||
161467838|NCT00809354|583109472|FG008|Overall Study|Study terminated by sponsor|127|||
161467839|NCT00809354|583109473|FG009|Overall Study|Study terminated by sponsor|135|||
161467840|NCT00809354|583109464|FG000|Overall Study|Withdrawn due to pregnancy|0|||
161467841|NCT00809354|583109465|FG001|Overall Study|Withdrawn due to pregnancy|1|||
161467842|NCT00809354|583109466|FG002|Overall Study|Withdrawn due to pregnancy|0|||
161467843|NCT00809354|583109467|FG003|Overall Study|Withdrawn due to pregnancy|0|||
161467844|NCT00809354|583109468|FG004|Overall Study|Withdrawn due to pregnancy|0|||
161467845|NCT00809354|583109469|FG005|Overall Study|Withdrawn due to pregnancy|0|||
161467846|NCT00809354|583109470|FG006|Overall Study|Withdrawn due to pregnancy|0|||
161467847|NCT00809354|583109471|FG007|Overall Study|Withdrawn due to pregnancy|0|||
161467848|NCT00809354|583109472|FG008|Overall Study|Withdrawn due to pregnancy|0|||
161467849|NCT00809354|583109473|FG009|Overall Study|Withdrawn due to pregnancy|0|||
161467850|NCT00809354|583109464|FG000|Overall Study|Randomized but not Treated|3|||
161467851|NCT00809354|583109465|FG001|Overall Study|Randomized but not Treated|1|||
161467852|NCT00809354|583109466|FG002|Overall Study|Randomized but not Treated|6|||
161467853|NCT00809354|583109467|FG003|Overall Study|Randomized but not Treated|0|||
161467854|NCT00809354|583109468|FG004|Overall Study|Randomized but not Treated|5|||
161467855|NCT00809354|583109469|FG005|Overall Study|Randomized but not Treated|0|||
161467856|NCT00809354|583109470|FG006|Overall Study|Randomized but not Treated|1|||
161467857|NCT00809354|583109471|FG007|Overall Study|Randomized but not Treated|1|||
161467858|NCT00809354|583109472|FG008|Overall Study|Randomized but not Treated|2|||
161467859|NCT00809354|583109473|FG009|Overall Study|Randomized but not Treated|1|||
161467860|NCT00809354|583109464|FG000|Overall Study|Death|0|||
161467861|NCT00809354|583109465|FG001|Overall Study|Death|0|||
161467862|NCT00809354|583109466|FG002|Overall Study|Death|0|||
161467863|NCT00809354|583109467|FG003|Overall Study|Death|0|||
161467864|NCT00809354|583109468|FG004|Overall Study|Death|0|||
161467865|NCT00809354|583109469|FG005|Overall Study|Death|0|||
161467866|NCT00809354|583109470|FG006|Overall Study|Death|0|||
161467867|NCT00809354|583109471|FG007|Overall Study|Death|1|||
161467868|NCT00809354|583109472|FG008|Overall Study|Death|0|||
161575420|NCT03460756|583492694|FG000|Overall Study|Lost to Follow-up|0|||
161467869|NCT00809354|583109473|FG009|Overall Study|Death|0|||
161467870|NCT04137224|583109476|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
161467871|NCT04137224|583109477|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
161467872|NCT04137224|583109476|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
161467873|NCT04137224|583109477|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
161467874|NCT04137224|583109476|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
161467875|NCT04137224|583109477|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
161467876|NCT01669928|583109478|FG000|First Intervention|Withdrawal by Subject|3|||
161575421|NCT03460756|583492695|FG001|Overall Study|Lost to Follow-up|1|||
161575422|NCT03460756|583492696|FG002|Overall Study|Lost to Follow-up|2|||
161811153|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
161811154|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
161811155|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
161811156|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
161811157|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
161811158|NCT02146105|584351385|FG000|Overall Study|Adverse Event|1|||
161811159|NCT02146105|584351385|FG000|Overall Study|Withdrawal by Subject|5|||
161811160|NCT01319383|584351386|FG000|Overall Study|No ex vivo or in vivo response|4|||
161811161|NCT01319383|584351387|FG001|Overall Study|No ex vivo or in vivo response|0|||
161811162|NCT01319383|584351386|FG000|Overall Study|Physician Decision|3|||
161811163|NCT01319383|584351387|FG001|Overall Study|Physician Decision|0|||
161811164|NCT01319383|584351386|FG000|Overall Study|Lack of Efficacy|5|||
161811165|NCT01319383|584351387|FG001|Overall Study|Lack of Efficacy|9|||
161811166|NCT01319383|584351386|FG000|Overall Study|No in vivo response to interval doses|0|||
161811167|NCT01319383|584351387|FG001|Overall Study|No in vivo response to interval doses|1|||
161811168|NCT03086460|584351390|FG000|Study Participants|Lost to Follow-up|2|||
161811169|NCT03086460|584351390|FG000|Study Participants|Protocol Violation|1|||
161811170|NCT03086460|584351390|FG000|Study Participants|Withdrawal by Subject|6|||
161811171|NCT03086460|584351390|FG000|Treatment A|Lost to Follow-up|1|||
161811172|NCT03086460|584351390|FG000|Treatment A|Protocol Violation|1|||
161811173|NCT03086460|584351390|FG000|Treatment A|Withdrawal by Subject|2|||
161811174|NCT03086460|584351390|FG000|Treatment C|Withdrawal by Subject|2|||
161811175|NCT03086460|584351390|FG000|Treatment E|Lost to Follow-up|1|||
161811176|NCT03086460|584351390|FG000|Treatment E|Withdrawal by Subject|3|||
161811177|NCT02718326|584351393|FG000|Overall Study|Adverse Event|4|||
161811178|NCT02718326|584351394|FG001|Overall Study|Adverse Event|9|||
161811179|NCT02718326|584351395|FG002|Overall Study|Adverse Event|0|||
161811180|NCT02718326|584351393|FG000|Overall Study|Death|8|||
161811181|NCT02718326|584351394|FG001|Overall Study|Death|1|||
161811182|NCT02718326|584351395|FG002|Overall Study|Death|2|||
161811183|NCT02718326|584351393|FG000|Overall Study|Withdrawal by Subject|4|||
161811184|NCT02718326|584351394|FG001|Overall Study|Withdrawal by Subject|9|||
161811185|NCT02718326|584351395|FG002|Overall Study|Withdrawal by Subject|6|||
161811186|NCT02718326|584351393|FG000|Overall Study|Lost to Follow-up|18|||
161811187|NCT02718326|584351394|FG001|Overall Study|Lost to Follow-up|5|||
161811188|NCT02718326|584351395|FG002|Overall Study|Lost to Follow-up|14|||
161811189|NCT02718326|584351393|FG000|Overall Study|Protocol Deviation|1|||
161811190|NCT02718326|584351394|FG001|Overall Study|Protocol Deviation|0|||
161811191|NCT02718326|584351395|FG002|Overall Study|Protocol Deviation|0|||
161811192|NCT02718326|584351393|FG000|Overall Study|Pregnancy|1|||
161811193|NCT02718326|584351394|FG001|Overall Study|Pregnancy|0|||
161811194|NCT02718326|584351395|FG002|Overall Study|Pregnancy|0|||
161467877|NCT01669928|583109479|FG001|First Intervention|Withdrawal by Subject|5|||
161467878|NCT05085730|583109491|FG000|Overall Study|Withdrawal by Subject|4|||
161467879|NCT05085730|583109491|FG000|Overall Study|Physician Decision|1|||
161811195|NCT06195579|584351399|FG000|Overall Study|Withdrawal by Subject|1|||
161811196|NCT02545283|584351400|FG000|Overall Study|Lost to Follow-up|2|||
161811197|NCT02545283|584351401|FG001|Overall Study|Lost to Follow-up|4|||
161811198|NCT02545283|584351400|FG000|Overall Study|Withdrawal by Subject|5|||
161811199|NCT02545283|584351401|FG001|Overall Study|Withdrawal by Subject|9|||
161811200|NCT02545283|584351400|FG000|Overall Study|Death|109|||
161811201|NCT02545283|584351401|FG001|Overall Study|Death|211|||
161811202|NCT02545283|584351400|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
161811203|NCT02545283|584351401|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
161811204|NCT02545283|584351400|FG000|Overall Study|Study Terminated By Sponsor|33|||
161811205|NCT02545283|584351401|FG001|Overall Study|Study Terminated By Sponsor|71|||
161811206|NCT02436005|584351402|FG000|Second Intervention|Adverse Event|0|||
161811207|NCT02436005|584351403|FG001|Second Intervention|Adverse Event|1|||
161811208|NCT00583453|584351404|FG000|Overall Study|discontinued intervention|0|||
161811209|NCT00583453|584351405|FG001|Overall Study|discontinued intervention|2|||
161811210|NCT00905606|584351406|FG000|Period 1|Adverse Event|0|||
161811211|NCT00905606|584351407|FG001|Period 1|Adverse Event|1|||
161811212|NCT00905606|584351406|FG000|Washout|Withdrawal by Subject|1|||
161811213|NCT00905606|584351407|FG001|Washout|Withdrawal by Subject|0|||
161811214|NCT03868891|584351410|FG000|Overall Study|Adverse Event|1|||
161811215|NCT03868891|584351411|FG001|Overall Study|Adverse Event|0|||
161811216|NCT03868891|584351410|FG000|Overall Study|Lost to Follow-up|2|||
161811217|NCT03868891|584351411|FG001|Overall Study|Lost to Follow-up|1|||
161811218|NCT03868891|584351410|FG000|Overall Study|COVID-19 Restrictions|1|||
161811219|NCT03868891|584351411|FG001|Overall Study|COVID-19 Restrictions|2|||
161811220|NCT02246920|584351412|FG000|Overall Study|Adverse Event|3|||
161811221|NCT02246920|584351413|FG001|Overall Study|Adverse Event|1|||
161811222|NCT02246920|584351414|FG002|Overall Study|Adverse Event|1|||
161811223|NCT02246920|584351412|FG000|Overall Study|Lost to Follow-up|2|||
161811224|NCT02246920|584351413|FG001|Overall Study|Lost to Follow-up|1|||
161811225|NCT02246920|584351414|FG002|Overall Study|Lost to Follow-up|0|||
161811226|NCT02246920|584351412|FG000|Overall Study|Protocol Violation|2|||
161811227|NCT02246920|584351413|FG001|Overall Study|Protocol Violation|5|||
161811228|NCT02246920|584351414|FG002|Overall Study|Protocol Violation|1|||
161811229|NCT02246920|584351412|FG000|Overall Study|Withdrawal by Subject|0|||
161811230|NCT02246920|584351413|FG001|Overall Study|Withdrawal by Subject|0|||
161811231|NCT02246920|584351414|FG002|Overall Study|Withdrawal by Subject|1|||
161811232|NCT01363765|584351415|FG000|Overall Study|non-diagnostic|2621|||
161811233|NCT01363765|584351416|FG001|Overall Study|non-diagnostic|1124|||
161811234|NCT01363765|584351415|FG000|Overall Study|duplicate records|736|||
161811235|NCT01363765|584351416|FG001|Overall Study|duplicate records|3177|||
161811236|NCT01363765|584351415|FG000|Overall Study|non-resident|156|||
161811237|NCT01363765|584351416|FG001|Overall Study|non-resident|76|||
161811238|NCT01363765|584351415|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
161811239|NCT01363765|584351416|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
161811240|NCT01363765|584351415|FG000|Overall Study|smear during intervention|2170|||
161811241|NCT01363765|584351416|FG001|Overall Study|smear during intervention|0|||
161811242|NCT00609674|584351417|FG000|Overall Study|Adverse Event|1|||
161811243|NCT00609674|584351418|FG001|Overall Study|Adverse Event|1|||
161811244|NCT00609674|584351417|FG000|Overall Study|Protocol Violation|3|||
161811245|NCT00609674|584351418|FG001|Overall Study|Protocol Violation|5|||
161811246|NCT00609674|584351417|FG000|Overall Study|Lost to Follow-up|1|||
161811247|NCT00609674|584351418|FG001|Overall Study|Lost to Follow-up|0|||
161467880|NCT01199731|583109492|FG000|Overall Study|Adverse Event|0|||
161811248|NCT00609674|584351417|FG000|Overall Study|Withdrew consent|2|||
161811249|NCT00609674|584351418|FG001|Overall Study|Withdrew consent|1|||
161811250|NCT03285594|584351422|FG000|Overall Study|At the Participant's Own Request|10|||
161811251|NCT03285594|584351423|FG001|Overall Study|At the Participant's Own Request|5|||
161575423|NCT03460756|583492697|FG003|Overall Study|Lost to Follow-up|1|||
161575424|NCT03460756|583492694|FG000|Overall Study|Pregnancy|0|||
161575425|NCT03460756|583492695|FG001|Overall Study|Pregnancy|0|||
161575426|NCT03460756|583492696|FG002|Overall Study|Pregnancy|0|||
161575427|NCT03460756|583492697|FG003|Overall Study|Pregnancy|1|||
161575428|NCT03460756|583492694|FG000|Overall Study|Protocol Violation|0|||
161575429|NCT03460756|583492695|FG001|Overall Study|Protocol Violation|0|||
161575430|NCT03460756|583492696|FG002|Overall Study|Protocol Violation|0|||
161575431|NCT03460756|583492697|FG003|Overall Study|Protocol Violation|1|||
161467881|NCT01199731|583109493|FG001|Overall Study|Adverse Event|1|||
161467882|NCT01199731|583109494|FG002|Overall Study|Adverse Event|0|||
161467883|NCT01199731|583109492|FG000|Overall Study|Study closed/terminated|7|||
161467884|NCT01199731|583109493|FG001|Overall Study|Study closed/terminated|9|||
161467885|NCT01199731|583109494|FG002|Overall Study|Study closed/terminated|7|||
161467886|NCT01199731|583109492|FG000|Overall Study|Lost to Follow-up|0|||
161467887|NCT01199731|583109493|FG001|Overall Study|Lost to Follow-up|0|||
161467888|NCT01199731|583109494|FG002|Overall Study|Lost to Follow-up|2|||
161575432|NCT03460756|583492694|FG000|Overall Study|Withdrawal by Subject|0|||
161575433|NCT03460756|583492695|FG001|Overall Study|Withdrawal by Subject|4|||
161575434|NCT03460756|583492696|FG002|Overall Study|Withdrawal by Subject|7|||
161575435|NCT03460756|583492697|FG003|Overall Study|Withdrawal by Subject|3|||
161575436|NCT00723450|583492699|FG000|Open-Label Phase|Adverse Event|26|||
161575437|NCT00723450|583492700|FG001|Open-Label Phase|Adverse Event|0|||
161575438|NCT00723450|583492701|FG002|Open-Label Phase|Adverse Event|0|||
161575439|NCT00723450|583492699|FG000|Open-Label Phase|Lack of Efficacy|18|||
161575440|NCT00723450|583492700|FG001|Open-Label Phase|Lack of Efficacy|0|||
161575441|NCT00723450|583492701|FG002|Open-Label Phase|Lack of Efficacy|0|||
161575442|NCT00723450|583492699|FG000|Open-Label Phase|Protocol Violation|35|||
161575443|NCT00723450|583492700|FG001|Open-Label Phase|Protocol Violation|0|||
161575444|NCT00723450|583492701|FG002|Open-Label Phase|Protocol Violation|0|||
161575445|NCT00723450|583492699|FG000|Open-Label Phase|Lost to Follow-up|7|||
161575446|NCT00723450|583492700|FG001|Open-Label Phase|Lost to Follow-up|0|||
161575447|NCT00723450|583492701|FG002|Open-Label Phase|Lost to Follow-up|0|||
161575448|NCT00723450|583492699|FG000|Open-Label Phase|Physician Decision|2|||
161575449|NCT00723450|583492700|FG001|Open-Label Phase|Physician Decision|0|||
161575450|NCT00723450|583492701|FG002|Open-Label Phase|Physician Decision|0|||
161575451|NCT00723450|583492699|FG000|Open-Label Phase|Withdrawal by Subject|37|||
161575452|NCT00723450|583492700|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161575453|NCT00723450|583492701|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161575454|NCT00723450|583492699|FG000|Randomized Phase|Adverse Event|0|||
161575455|NCT00723450|583492700|FG001|Randomized Phase|Adverse Event|26|||
161575456|NCT00723450|583492701|FG002|Randomized Phase|Adverse Event|17|||
161575457|NCT00723450|583492699|FG000|Randomized Phase|Lack of Efficacy|0|||
161575458|NCT00723450|583492700|FG001|Randomized Phase|Lack of Efficacy|11|||
161575459|NCT00723450|583492701|FG002|Randomized Phase|Lack of Efficacy|11|||
161575460|NCT00723450|583492699|FG000|Randomized Phase|Protocol Violation|0|||
161575461|NCT00723450|583492700|FG001|Randomized Phase|Protocol Violation|9|||
161575462|NCT00723450|583492701|FG002|Randomized Phase|Protocol Violation|13|||
161575463|NCT00723450|583492699|FG000|Randomized Phase|Lost to Follow-up|0|||
161575464|NCT00723450|583492700|FG001|Randomized Phase|Lost to Follow-up|2|||
161575465|NCT00723450|583492701|FG002|Randomized Phase|Lost to Follow-up|3|||
161575466|NCT00723450|583492699|FG000|Randomized Phase|Physician Decision|0|||
161575467|NCT00723450|583492700|FG001|Randomized Phase|Physician Decision|3|||
161575468|NCT00723450|583492701|FG002|Randomized Phase|Physician Decision|1|||
161575469|NCT00723450|583492699|FG000|Randomized Phase|Withdrawal by Subject|0|||
161575470|NCT00723450|583492700|FG001|Randomized Phase|Withdrawal by Subject|14|||
161575471|NCT00723450|583492701|FG002|Randomized Phase|Withdrawal by Subject|22|||
161467889|NCT01199731|583109492|FG000|Overall Study|Physician Decision|0|||
161467890|NCT01199731|583109493|FG001|Overall Study|Physician Decision|1|||
161467891|NCT01199731|583109494|FG002|Overall Study|Physician Decision|1|||
161575472|NCT02950558|583492705|FG000|Overall Study|Lost to Follow-up|2|||
161575473|NCT02950558|583492706|FG001|Overall Study|Lost to Follow-up|0|||
161575474|NCT02537522|583492712|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
161575475|NCT02537522|583492713|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
161575476|NCT02537522|583492714|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
161575477|NCT02537522|583492715|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
161575478|NCT02537522|583492712|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
161575479|NCT02537522|583492713|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
161811252|NCT03285594|584351424|FG002|Overall Study|At the Participant's Own Request|21|||
161467892|NCT01199731|583109492|FG000|Overall Study|Withdrawal by Subject|2|||
161467893|NCT01199731|583109493|FG001|Overall Study|Withdrawal by Subject|0|||
161575480|NCT02537522|583492714|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
161811253|NCT03285594|584351422|FG000|Overall Study|Adverse Event|2|||
161811254|NCT03285594|584351423|FG001|Overall Study|Adverse Event|2|||
161811255|NCT03285594|584351424|FG002|Overall Study|Adverse Event|6|||
161811256|NCT03285594|584351422|FG000|Overall Study|Poor Compliance to Protocol|0|||
161811257|NCT03285594|584351423|FG001|Overall Study|Poor Compliance to Protocol|0|||
161811258|NCT03285594|584351424|FG002|Overall Study|Poor Compliance to Protocol|1|||
161811259|NCT03285594|584351422|FG000|Overall Study|Lost to Follow-up|0|||
161811260|NCT03285594|584351423|FG001|Overall Study|Lost to Follow-up|0|||
161811261|NCT03285594|584351424|FG002|Overall Study|Lost to Follow-up|1|||
161811262|NCT03285594|584351422|FG000|Overall Study|Reason Not Specified|3|||
161811263|NCT03285594|584351423|FG001|Overall Study|Reason Not Specified|4|||
161811264|NCT03285594|584351424|FG002|Overall Study|Reason Not Specified|8|||
161467894|NCT01199731|583109494|FG002|Overall Study|Withdrawal by Subject|0|||
161467895|NCT04010539|583109495|FG000|Overall Study|Withdrawal by Subject|4|||
161467896|NCT04010539|583109496|FG001|Overall Study|Withdrawal by Subject|1|||
161467897|NCT04010539|583109495|FG000|Overall Study|Physician Decision|0|||
161467898|NCT04010539|583109496|FG001|Overall Study|Physician Decision|2|||
161467899|NCT04010539|583109495|FG000|Overall Study|Lost to Follow-up|10|||
161467900|NCT04010539|583109496|FG001|Overall Study|Lost to Follow-up|14|||
161467901|NCT04010539|583109495|FG000|Overall Study|Adverse Event|3|||
161467902|NCT04010539|583109496|FG001|Overall Study|Adverse Event|0|||
161467903|NCT04010539|583109495|FG000|Overall Study|Participant Did Not Receive IP|0|||
161467904|NCT04010539|583109496|FG001|Overall Study|Participant Did Not Receive IP|1|||
161467905|NCT04010539|583109495|FG000|Overall Study|Protocol Deviation|0|||
161467906|NCT04010539|583109496|FG001|Overall Study|Protocol Deviation|1|||
161467907|NCT04010539|583109495|FG000|Overall Study|Randomized in Error/ Mistake|2|||
161467908|NCT04010539|583109496|FG001|Overall Study|Randomized in Error/ Mistake|0|||
161467909|NCT04010539|583109495|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
161467910|NCT04010539|583109496|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
161467911|NCT02028871|583109497|FG000|Overall Study|Positive urine drug screen|1|||
161467912|NCT02028871|583109498|FG001|Overall Study|Positive urine drug screen|1|||
161467913|NCT02028871|583109497|FG000|Overall Study|Withdrawal by Subject|1|||
161467914|NCT02028871|583109498|FG001|Overall Study|Withdrawal by Subject|2|||
161467915|NCT02028871|583109497|FG000|Overall Study|IV placement difficulty|1|||
161467916|NCT02028871|583109498|FG001|Overall Study|IV placement difficulty|0|||
161467917|NCT02028871|583109497|FG000|Overall Study|Current Illness|1|||
161467918|NCT02028871|583109498|FG001|Overall Study|Current Illness|0|||
161467919|NCT01916967|583109501|FG000|Overall Study|Adverse Event|0|||
161467920|NCT01916967|583109502|FG001|Overall Study|Adverse Event|0|||
161467921|NCT01916967|583109503|FG002|Overall Study|Adverse Event|2|||
161467922|NCT01916967|583109501|FG000|Overall Study|Lack of Efficacy|0|||
161467923|NCT01916967|583109502|FG001|Overall Study|Lack of Efficacy|0|||
161467924|NCT01916967|583109503|FG002|Overall Study|Lack of Efficacy|6|||
161467925|NCT01916967|583109501|FG000|Overall Study|Physician Decision|0|||
161467926|NCT01916967|583109502|FG001|Overall Study|Physician Decision|0|||
161467927|NCT01916967|583109503|FG002|Overall Study|Physician Decision|1|||
161467928|NCT01916967|583109501|FG000|Overall Study|Protocol Violation|0|||
161467929|NCT01916967|583109502|FG001|Overall Study|Protocol Violation|1|||
161467930|NCT01916967|583109503|FG002|Overall Study|Protocol Violation|0|||
161467931|NCT02337738|583109504|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
161467932|NCT02337738|583109505|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
161467933|NCT02337738|583109506|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
161467934|NCT02337738|583109504|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161467935|NCT02337738|583109505|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
161467936|NCT02337738|583109506|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
161467937|NCT02337738|583109504|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
161811265|NCT00834431|584351425|FG000|First Intervention|Adverse Event|0|||
161575481|NCT02537522|583492715|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
161575482|NCT02537522|583492712|FG000|Phase I - Contralateral|incorrect randomization|0|||
161575483|NCT02537522|583492713|FG001|Phase I - Contralateral|incorrect randomization|1|||
161575484|NCT02537522|583492714|FG002|Phase I - Contralateral|incorrect randomization|0|||
161575485|NCT02537522|583492715|FG003|Phase I - Contralateral|incorrect randomization|0|||
161575486|NCT02537522|583492712|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161575487|NCT02537522|583492713|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
161575488|NCT02537522|583492714|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161575489|NCT02537522|583492715|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161575490|NCT02537522|583492712|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
161575491|NCT02537522|583492713|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
161575492|NCT02537522|583492714|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
161575493|NCT02537522|583492715|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
161575494|NCT03920215|583492717|FG000|Overall Study|Lost to Follow-up|1|||
161575495|NCT03920215|583492718|FG001|Overall Study|Lost to Follow-up|2|||
161575496|NCT03920215|583492719|FG002|Overall Study|Lost to Follow-up|0|||
161575497|NCT03920215|583492720|FG003|Overall Study|Lost to Follow-up|0|||
161575498|NCT03920215|583492717|FG000|Overall Study|Death|0|||
161575499|NCT03920215|583492718|FG001|Overall Study|Death|0|||
161575500|NCT03920215|583492719|FG002|Overall Study|Death|0|||
161575501|NCT03920215|583492720|FG003|Overall Study|Death|1|||
161575502|NCT02425111|583492723|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
161575503|NCT02425111|583492723|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
161575504|NCT02425111|583492723|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
161575505|NCT02425111|583492723|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
161575506|NCT02425111|583492723|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
161575507|NCT02425111|583492723|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
161575508|NCT00585533|583492724|FG000|Overall Study|objective or symptomatic progression|9|||
161575509|NCT02547922|583492725|FG000|Overall Study|Withdrawal by Subject|9|||
161575510|NCT02547922|583492726|FG001|Overall Study|Withdrawal by Subject|6|||
161575511|NCT02547922|583492727|FG002|Overall Study|Withdrawal by Subject|10|||
161575512|NCT02547922|583492725|FG000|Overall Study|Adverse Event|3|||
161575513|NCT02547922|583492726|FG001|Overall Study|Adverse Event|1|||
161575514|NCT02547922|583492727|FG002|Overall Study|Adverse Event|2|||
161575515|NCT02547922|583492725|FG000|Overall Study|Lost to Follow-up|1|||
161575516|NCT02547922|583492726|FG001|Overall Study|Lost to Follow-up|0|||
161575517|NCT02547922|583492727|FG002|Overall Study|Lost to Follow-up|0|||
161575518|NCT02547922|583492725|FG000|Overall Study|Lack of Efficacy|5|||
161575519|NCT02547922|583492726|FG001|Overall Study|Lack of Efficacy|7|||
161575520|NCT02547922|583492727|FG002|Overall Study|Lack of Efficacy|4|||
161467938|NCT02337738|583109505|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
161467939|NCT02337738|583109506|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
161467940|NCT02337738|583109504|FG000|Overall Study|Voluntary Withdrawal|10|||
161467941|NCT02337738|583109505|FG001|Overall Study|Voluntary Withdrawal|5|||
161467942|NCT02337738|583109506|FG002|Overall Study|Voluntary Withdrawal|2|||
161467943|NCT02337738|583109504|FG000|Overall Study|Lack of Efficacy|2|||
161467944|NCT02337738|583109505|FG001|Overall Study|Lack of Efficacy|4|||
161467945|NCT02337738|583109506|FG002|Overall Study|Lack of Efficacy|0|||
161467946|NCT02337738|583109504|FG000|Overall Study|Investigator's Judgment|1|||
161467947|NCT02337738|583109505|FG001|Overall Study|Investigator's Judgment|1|||
161467948|NCT02337738|583109506|FG002|Overall Study|Investigator's Judgment|3|||
161467949|NCT02322021|583109507|FG000|Core Phase|Adverse Event|1|||
161467950|NCT02322021|583109508|FG001|Core Phase|Adverse Event|3|||
161467951|NCT02322021|583109509|FG002|Core Phase|Adverse Event|4|||
161467952|NCT02322021|583109510|FG003|Core Phase|Adverse Event|2|||
161467953|NCT02322021|583109511|FG004|Core Phase|Adverse Event|0|||
161467954|NCT02322021|583109507|FG000|Core Phase|Participant Choice|4|||
161467955|NCT02322021|583109508|FG001|Core Phase|Participant Choice|5|||
161467956|NCT02322021|583109509|FG002|Core Phase|Participant Choice|4|||
161467957|NCT02322021|583109510|FG003|Core Phase|Participant Choice|2|||
161467958|NCT02322021|583109511|FG004|Core Phase|Participant Choice|0|||
161467959|NCT02322021|583109507|FG000|Core Phase|Lost to Follow-up|0|||
161467960|NCT02322021|583109508|FG001|Core Phase|Lost to Follow-up|0|||
161467961|NCT02322021|583109509|FG002|Core Phase|Lost to Follow-up|0|||
161467962|NCT02322021|583109510|FG003|Core Phase|Lost to Follow-up|1|||
161467963|NCT02322021|583109511|FG004|Core Phase|Lost to Follow-up|0|||
161467964|NCT02322021|583109507|FG000|Core Phase|Other|0|||
161467965|NCT02322021|583109508|FG001|Core Phase|Other|0|||
161467966|NCT02322021|583109509|FG002|Core Phase|Other|1|||
161467967|NCT02322021|583109510|FG003|Core Phase|Other|0|||
161467968|NCT02322021|583109511|FG004|Core Phase|Other|0|||
161467969|NCT02322021|583109507|FG000|Extension Phase|Adverse Event|0|||
161467970|NCT02322021|583109508|FG001|Extension Phase|Adverse Event|0|||
161467971|NCT02322021|583109509|FG002|Extension Phase|Adverse Event|0|||
161467972|NCT02322021|583109510|FG003|Extension Phase|Adverse Event|0|||
161467973|NCT02322021|583109511|FG004|Extension Phase|Adverse Event|3|||
161467974|NCT02322021|583109507|FG000|Extension Phase|Participant Choice|0|||
161467975|NCT02322021|583109508|FG001|Extension Phase|Participant Choice|0|||
161467976|NCT02322021|583109509|FG002|Extension Phase|Participant Choice|0|||
161467977|NCT02322021|583109510|FG003|Extension Phase|Participant Choice|0|||
161467978|NCT02322021|583109511|FG004|Extension Phase|Participant Choice|6|||
161467979|NCT02322021|583109507|FG000|Extension Phase|Other|0|||
161467980|NCT02322021|583109508|FG001|Extension Phase|Other|0|||
161467981|NCT02322021|583109509|FG002|Extension Phase|Other|0|||
161467982|NCT02322021|583109510|FG003|Extension Phase|Other|0|||
161467983|NCT02322021|583109511|FG004|Extension Phase|Other|3|||
161467984|NCT02322021|583109507|FG000|Extension Phase|Lost to Follow-up|0|||
161467985|NCT02322021|583109508|FG001|Extension Phase|Lost to Follow-up|0|||
161467986|NCT02322021|583109509|FG002|Extension Phase|Lost to Follow-up|0|||
161467987|NCT02322021|583109510|FG003|Extension Phase|Lost to Follow-up|0|||
161467988|NCT02322021|583109511|FG004|Extension Phase|Lost to Follow-up|1|||
161467989|NCT02322021|583109507|FG000|Extension Phase|Study terminated by sponsor|0|||
161467990|NCT02322021|583109508|FG001|Extension Phase|Study terminated by sponsor|0|||
161811266|NCT00834431|584351426|FG001|First Intervention|Adverse Event|1|||
161811267|NCT00834431|584351425|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161811268|NCT00834431|584351426|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161811269|NCT00556322|584351431|FG000|Overall Study|Insufficient therapeutic response|158|||
161811270|NCT00556322|584351432|FG001|Overall Study|Insufficient therapeutic response|168|||
161811271|NCT00556322|584351431|FG000|Overall Study|Adverse Event|7|||
161811272|NCT00556322|584351432|FG001|Overall Study|Adverse Event|4|||
161811273|NCT00556322|584351431|FG000|Overall Study|Other|4|||
161811274|NCT00556322|584351432|FG001|Overall Study|Other|1|||
161811275|NCT00556322|584351431|FG000|Overall Study|Lost to Follow-up|5|||
161811276|NCT00556322|584351432|FG001|Overall Study|Lost to Follow-up|3|||
161811277|NCT00556322|584351431|FG000|Overall Study|Withdrawal by Subject|19|||
161467991|NCT02322021|583109509|FG002|Extension Phase|Study terminated by sponsor|0|||
161467992|NCT02322021|583109510|FG003|Extension Phase|Study terminated by sponsor|0|||
161467993|NCT02322021|583109511|FG004|Extension Phase|Study terminated by sponsor|28|||
161467994|NCT01565642|583109518|FG000|Overall Study|Withdrawal by Subject|2|||
161467995|NCT01565642|583109519|FG001|Overall Study|Withdrawal by Subject|1|||
161467996|NCT01934972|583109520|FG000|Overall Study|Withdrawal by Subject|9|||
161467997|NCT01934972|583109521|FG001|Overall Study|Withdrawal by Subject|6|||
161467998|NCT03438383|583109527|FG000|Overall Study|Protocol Violation|9|||
161467999|NCT03438383|583109528|FG001|Overall Study|Protocol Violation|3|||
161468000|NCT01528033|583109529|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
161468001|NCT01528033|583109530|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
161468002|NCT01528033|583109529|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
161468003|NCT01528033|583109530|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
161811278|NCT00556322|584351432|FG001|Overall Study|Withdrawal by Subject|7|||
161468004|NCT01528033|583109529|FG000|Primary Endpoint Assessment ITT|Death|2|||
161468005|NCT01528033|583109530|FG001|Primary Endpoint Assessment ITT|Death|2|||
161468006|NCT01528033|583109529|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
161468007|NCT01528033|583109530|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
161468008|NCT01528033|583109529|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
161468009|NCT01528033|583109530|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
161468010|NCT01528033|583109529|FG000|Follow Up|No data available|46|||
161468011|NCT01528033|583109530|FG001|Follow Up|No data available|44|||
161468012|NCT03954132|583109534|FG000|Overall Study|Adverse Event|2|||
161468013|NCT03954132|583109535|FG001|Overall Study|Adverse Event|0|||
161468014|NCT03954132|583109534|FG000|Overall Study|Patient's wish|5|||
161468015|NCT03954132|583109535|FG001|Overall Study|Patient's wish|0|||
161468016|NCT03954132|583109534|FG000|Overall Study|Lost to Follow-up|10|||
161468017|NCT03954132|583109535|FG001|Overall Study|Lost to Follow-up|0|||
161468018|NCT03954132|583109534|FG000|Overall Study|Screening failure|0|||
161468019|NCT03954132|583109535|FG001|Overall Study|Screening failure|1|||
161468020|NCT03954132|583109534|FG000|Overall Study|No registration after Visit 1|5|||
161468021|NCT03954132|583109535|FG001|Overall Study|No registration after Visit 1|2|||
161468022|NCT03954132|583109534|FG000|Overall Study|Other reason than listed|2|||
161468023|NCT03954132|583109535|FG001|Overall Study|Other reason than listed|2|||
161468024|NCT03954132|583109534|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
161468025|NCT03954132|583109535|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
161468026|NCT03954132|583109534|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
161468027|NCT03954132|583109535|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
161468028|NCT02949700|583109540|FG000|Phase I|Withdrawal by Subject|1|||
161468029|NCT02949700|583109541|FG001|Phase I|Withdrawal by Subject|1|||
161468030|NCT02949700|583109542|FG002|Phase I|Withdrawal by Subject|0|||
161468031|NCT02949700|583109543|FG003|Phase I|Withdrawal by Subject|0|||
161468032|NCT02949700|583109540|FG000|Phase I|Protocol Violation|1|||
161468033|NCT02949700|583109541|FG001|Phase I|Protocol Violation|0|||
161468034|NCT02949700|583109542|FG002|Phase I|Protocol Violation|0|||
161468035|NCT02949700|583109543|FG003|Phase I|Protocol Violation|0|||
161468036|NCT02949700|583109540|FG000|Phase II|Withdrawal by Subject|0|||
161468037|NCT02949700|583109541|FG001|Phase II|Withdrawal by Subject|0|||
161468038|NCT02949700|583109542|FG002|Phase II|Withdrawal by Subject|0|||
161468039|NCT02949700|583109543|FG003|Phase II|Withdrawal by Subject|2|||
161468040|NCT02949700|583109540|FG000|Phase II|Protocol Violation|0|||
161468041|NCT02949700|583109541|FG001|Phase II|Protocol Violation|0|||
161468042|NCT02949700|583109542|FG002|Phase II|Protocol Violation|1|||
161468043|NCT02949700|583109543|FG003|Phase II|Protocol Violation|3|||
161575521|NCT02547922|583492725|FG000|Overall Study|Death|1|||
161811279|NCT00556322|584351431|FG000|Overall Study|Protocol Violation|5|||
161811280|NCT00556322|584351432|FG001|Overall Study|Protocol Violation|1|||
161811281|NCT00556322|584351431|FG000|Overall Study|Ongoing at data cutoff|3|||
161811282|NCT00556322|584351432|FG001|Overall Study|Ongoing at data cutoff|5|||
161811283|NCT00556322|584351431|FG000|Overall Study|Death|20|||
161811284|NCT00556322|584351432|FG001|Overall Study|Death|14|||
161811285|NCT03733444|584351433|FG000|Overall Study|Adverse Event|8|||
161811286|NCT03733444|584351434|FG001|Overall Study|Adverse Event|10|||
161811287|NCT03733444|584351435|FG002|Overall Study|Adverse Event|5|||
161811288|NCT03733444|584351433|FG000|Overall Study|Death|20|||
161811289|NCT03733444|584351434|FG001|Overall Study|Death|19|||
161811290|NCT03733444|584351435|FG002|Overall Study|Death|11|||
161811291|NCT03733444|584351433|FG000|Overall Study|Lost to Follow-up|3|||
161811292|NCT03733444|584351434|FG001|Overall Study|Lost to Follow-up|0|||
161811293|NCT03733444|584351435|FG002|Overall Study|Lost to Follow-up|1|||
161811294|NCT03733444|584351433|FG000|Overall Study|Lack of Efficacy|0|||
161811295|NCT03733444|584351434|FG001|Overall Study|Lack of Efficacy|1|||
161811296|NCT03733444|584351435|FG002|Overall Study|Lack of Efficacy|1|||
161811297|NCT03733444|584351433|FG000|Overall Study|Physician Decision|2|||
161811298|NCT03733444|584351434|FG001|Overall Study|Physician Decision|1|||
161811299|NCT03733444|584351435|FG002|Overall Study|Physician Decision|0|||
161811300|NCT03733444|584351433|FG000|Overall Study|Protocol Violation|2|||
161915180|NCT02332707|584738887|FG015|Overall Study|Physician Decision|0|||
161915181|NCT02332707|584738888|FG016|Overall Study|Physician Decision|0|||
161915182|NCT02332707|584738889|FG017|Overall Study|Physician Decision|0|||
161915183|NCT02332707|584738872|FG000|Overall Study|Withdrawal by Subject|0|||
161915184|NCT02332707|584738873|FG001|Overall Study|Withdrawal by Subject|0|||
161915185|NCT02332707|584738874|FG002|Overall Study|Withdrawal by Subject|1|||
161915186|NCT02332707|584738875|FG003|Overall Study|Withdrawal by Subject|0|||
161915187|NCT02332707|584738876|FG004|Overall Study|Withdrawal by Subject|0|||
161915188|NCT02332707|584738877|FG005|Overall Study|Withdrawal by Subject|0|||
161915189|NCT02332707|584738878|FG006|Overall Study|Withdrawal by Subject|0|||
161915190|NCT02332707|584738879|FG007|Overall Study|Withdrawal by Subject|0|||
161915191|NCT02332707|584738880|FG008|Overall Study|Withdrawal by Subject|0|||
161468044|NCT05156073|583109544|FG000|Overall Study|Patient canceled appointment with PCP|1|||
161468045|NCT00973349|583109545|FG000|Overall Study|Adverse Event|0|||
161811301|NCT03733444|584351434|FG001|Overall Study|Protocol Violation|1|||
161811302|NCT03733444|584351435|FG002|Overall Study|Protocol Violation|0|||
161811303|NCT03733444|584351433|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
161811304|NCT03733444|584351434|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
161811305|NCT03733444|584351435|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
161811306|NCT03733444|584351433|FG000|Overall Study|Study Terminated by Sponsor|203|||
161811307|NCT03733444|584351434|FG001|Overall Study|Study Terminated by Sponsor|209|||
161811308|NCT03733444|584351435|FG002|Overall Study|Study Terminated by Sponsor|221|||
161811309|NCT03733444|584351433|FG000|Overall Study|Withdrawal by Subject|19|||
161811310|NCT03733444|584351434|FG001|Overall Study|Withdrawal by Subject|18|||
161811311|NCT03733444|584351435|FG002|Overall Study|Withdrawal by Subject|16|||
161811312|NCT03733444|584351433|FG000|Overall Study|Miscellaneous|1|||
161811313|NCT03733444|584351434|FG001|Overall Study|Miscellaneous|0|||
161811314|NCT03733444|584351435|FG002|Overall Study|Miscellaneous|1|||
161811315|NCT03733444|584351433|FG000|Overall Study|Not Treated|1|||
161811316|NCT03733444|584351434|FG001|Overall Study|Not Treated|2|||
161811317|NCT03733444|584351435|FG002|Overall Study|Not Treated|1|||
161811318|NCT01913405|584351436|FG000|Overall Study|Withdrawal by Subject|1|||
161811319|NCT01913405|584351436|FG000|Overall Study|Adverse Event|1|||
161811320|NCT02689505|584351437|FG000|Overall Study|Progressive disease|2|||
161811321|NCT02689505|584351438|FG001|Overall Study|Progressive disease|2|||
161811322|NCT02689505|584351439|FG002|Overall Study|Progressive disease|3|||
161811323|NCT02689505|584351440|FG003|Overall Study|Progressive disease|9|||
161811324|NCT02689505|584351441|FG004|Overall Study|Progressive disease|1|||
161811325|NCT02689505|584351437|FG000|Overall Study|Dose Limiting Toxicity|0|||
161811326|NCT02689505|584351438|FG001|Overall Study|Dose Limiting Toxicity|1|||
161811327|NCT02689505|584351439|FG002|Overall Study|Dose Limiting Toxicity|0|||
161811328|NCT02689505|584351440|FG003|Overall Study|Dose Limiting Toxicity|0|||
161811329|NCT02689505|584351441|FG004|Overall Study|Dose Limiting Toxicity|2|||
161811330|NCT02689505|584351437|FG000|Overall Study|Other AE or clinical progression|0|||
161811331|NCT02689505|584351438|FG001|Overall Study|Other AE or clinical progression|2|||
161811332|NCT02689505|584351439|FG002|Overall Study|Other AE or clinical progression|0|||
161811333|NCT02689505|584351440|FG003|Overall Study|Other AE or clinical progression|2|||
161811334|NCT02689505|584351441|FG004|Overall Study|Other AE or clinical progression|0|||
161811335|NCT04108858|584351442|FG000|Overall Study|Adverse Event|1|||
161811336|NCT03663179|584351443|FG000|Overall Study|Withdrawal by Subject|2|||
161811337|NCT03663179|584351444|FG001|Overall Study|Withdrawal by Subject|0|||
161811338|NCT03663179|584351443|FG000|Overall Study|Lost to Follow-up|1|||
161811339|NCT03663179|584351444|FG001|Overall Study|Lost to Follow-up|1|||
161811340|NCT03663179|584351443|FG000|Overall Study|Revealed exclusionary condition|1|||
161811341|NCT03663179|584351444|FG001|Overall Study|Revealed exclusionary condition|0|||
161811342|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
161811343|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
161811344|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
161811345|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
161811346|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
161811347|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
161811348|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161811349|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161811350|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
161811351|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
161811352|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161811353|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
161811354|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
161811355|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
161811356|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161915192|NCT02332707|584738881|FG009|Overall Study|Withdrawal by Subject|3|||
161915193|NCT02332707|584738882|FG010|Overall Study|Withdrawal by Subject|0|||
161915194|NCT02332707|584738883|FG011|Overall Study|Withdrawal by Subject|0|||
161915195|NCT02332707|584738884|FG012|Overall Study|Withdrawal by Subject|0|||
161915196|NCT02332707|584738885|FG013|Overall Study|Withdrawal by Subject|0|||
161915197|NCT02332707|584738886|FG014|Overall Study|Withdrawal by Subject|0|||
161915198|NCT02332707|584738887|FG015|Overall Study|Withdrawal by Subject|0|||
161915199|NCT02332707|584738888|FG016|Overall Study|Withdrawal by Subject|0|||
161915200|NCT02332707|584738889|FG017|Overall Study|Withdrawal by Subject|0|||
161915201|NCT01473134|584738890|FG000|Overall Study|Lost to Follow-up|21|||
161915202|NCT01473134|584738891|FG001|Overall Study|Lost to Follow-up|13|||
161915203|NCT01473134|584738890|FG000|Overall Study|Protocol Violation|32|||
161915204|NCT01473134|584738891|FG001|Overall Study|Protocol Violation|19|||
161915205|NCT01473134|584738890|FG000|Overall Study|Withdrawal by Subject|1|||
161915206|NCT01473134|584738891|FG001|Overall Study|Withdrawal by Subject|2|||
161915207|NCT01473134|584738890|FG000|Overall Study|Death|0|||
161915208|NCT01473134|584738891|FG001|Overall Study|Death|1|||
161915209|NCT01473134|584738890|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
161915210|NCT01473134|584738891|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
161915211|NCT04761822|584738896|FG000|Overall Study|Adverse Event|3|||
161915212|NCT04761822|584738897|FG001|Overall Study|Adverse Event|1|||
161915213|NCT04761822|584738898|FG002|Overall Study|Adverse Event|1|||
161915214|NCT04761822|584738899|FG003|Overall Study|Adverse Event|3|||
161915215|NCT04761822|584738896|FG000|Overall Study|Lost to Follow-up|1|||
161915216|NCT04761822|584738897|FG001|Overall Study|Lost to Follow-up|0|||
161915217|NCT04761822|584738898|FG002|Overall Study|Lost to Follow-up|2|||
161915218|NCT04761822|584738899|FG003|Overall Study|Lost to Follow-up|3|||
161915219|NCT04761822|584738896|FG000|Overall Study|Physician Decision|0|||
161915220|NCT04761822|584738897|FG001|Overall Study|Physician Decision|1|||
161915221|NCT04761822|584738898|FG002|Overall Study|Physician Decision|0|||
161915222|NCT04761822|584738899|FG003|Overall Study|Physician Decision|0|||
161915223|NCT04761822|584738896|FG000|Overall Study|Withdrawal by Subject|3|||
161915224|NCT04761822|584738897|FG001|Overall Study|Withdrawal by Subject|8|||
161915225|NCT04761822|584738898|FG002|Overall Study|Withdrawal by Subject|1|||
161915226|NCT04761822|584738899|FG003|Overall Study|Withdrawal by Subject|11|||
161915227|NCT04761822|584738896|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
161915228|NCT04761822|584738897|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161915229|NCT04761822|584738898|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161915230|NCT04761822|584738899|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161915231|NCT04761822|584738896|FG000|Overall Study|Participant requested unblinding|0|||
161915232|NCT04761822|584738897|FG001|Overall Study|Participant requested unblinding|0|||
161915233|NCT04761822|584738898|FG002|Overall Study|Participant requested unblinding|0|||
161915234|NCT04761822|584738899|FG003|Overall Study|Participant requested unblinding|1|||
161915235|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
161915236|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
161915237|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Death|1|||
161915238|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Death|3|||
161915239|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
161915240|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
161915241|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
161915242|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
161915243|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
161915244|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
161915245|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
161915246|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
161915247|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
161915248|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
161915249|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
161915250|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
161915251|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
161915252|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
161915253|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
161915254|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
161915255|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
161915256|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
161915257|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
161915258|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
161915259|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
161915260|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
161915261|NCT02233413|584738906|FG000|Overall Study|Lost to Follow-up|7|||
161915262|NCT02233413|584738907|FG001|Overall Study|Lost to Follow-up|9|||
161915263|NCT02233413|584738906|FG000|Overall Study|Withdrawal by Subject|4|||
161915264|NCT02233413|584738907|FG001|Overall Study|Withdrawal by Subject|5|||
161915265|NCT01799889|584738908|FG000|Overall Study|Adverse Event|4|||
161915266|NCT01799889|584738909|FG001|Overall Study|Adverse Event|4|||
161915267|NCT01799889|584738910|FG002|Overall Study|Adverse Event|5|||
161915268|NCT01799889|584738911|FG003|Overall Study|Adverse Event|1|||
161915269|NCT01799889|584738912|FG004|Overall Study|Adverse Event|11|||
161915270|NCT01799889|584738913|FG005|Overall Study|Adverse Event|1|||
161915271|NCT01799889|584738914|FG006|Overall Study|Adverse Event|5|||
161915272|NCT01799889|584738915|FG007|Overall Study|Adverse Event|2|||
161915273|NCT01799889|584738916|FG008|Overall Study|Adverse Event|3|||
161915274|NCT01799889|584738917|FG009|Overall Study|Adverse Event|1|||
161915275|NCT01799889|584738918|FG010|Overall Study|Adverse Event|1|||
161915276|NCT01799889|584738919|FG011|Overall Study|Adverse Event|0|||
161915277|NCT01799889|584738908|FG000|Overall Study|Death|1|||
161915278|NCT01799889|584738909|FG001|Overall Study|Death|0|||
161915279|NCT01799889|584738910|FG002|Overall Study|Death|5|||
161915280|NCT01799889|584738911|FG003|Overall Study|Death|3|||
161915281|NCT01799889|584738912|FG004|Overall Study|Death|1|||
161915282|NCT01799889|584738913|FG005|Overall Study|Death|0|||
161915283|NCT01799889|584738914|FG006|Overall Study|Death|0|||
161915284|NCT01799889|584738915|FG007|Overall Study|Death|0|||
161915285|NCT01799889|584738916|FG008|Overall Study|Death|1|||
161915286|NCT01799889|584738917|FG009|Overall Study|Death|0|||
161915287|NCT01799889|584738918|FG010|Overall Study|Death|1|||
161915288|NCT01799889|584738919|FG011|Overall Study|Death|0|||
161915289|NCT01799889|584738908|FG000|Overall Study|Lack of Efficacy|1|||
161915290|NCT01799889|584738909|FG001|Overall Study|Lack of Efficacy|1|||
161915291|NCT01799889|584738910|FG002|Overall Study|Lack of Efficacy|0|||
161915292|NCT01799889|584738911|FG003|Overall Study|Lack of Efficacy|1|||
161915293|NCT01799889|584738912|FG004|Overall Study|Lack of Efficacy|2|||
161915294|NCT01799889|584738913|FG005|Overall Study|Lack of Efficacy|2|||
161915295|NCT01799889|584738914|FG006|Overall Study|Lack of Efficacy|0|||
161915296|NCT01799889|584738915|FG007|Overall Study|Lack of Efficacy|0|||
161915297|NCT01799889|584738916|FG008|Overall Study|Lack of Efficacy|2|||
161915298|NCT01799889|584738917|FG009|Overall Study|Lack of Efficacy|0|||
161915299|NCT01799889|584738918|FG010|Overall Study|Lack of Efficacy|1|||
161915300|NCT01799889|584738919|FG011|Overall Study|Lack of Efficacy|0|||
161915301|NCT01799889|584738908|FG000|Overall Study|Lost to Follow-up|0|||
161915302|NCT01799889|584738909|FG001|Overall Study|Lost to Follow-up|1|||
161915303|NCT01799889|584738910|FG002|Overall Study|Lost to Follow-up|0|||
161915304|NCT01799889|584738911|FG003|Overall Study|Lost to Follow-up|0|||
161915305|NCT01799889|584738912|FG004|Overall Study|Lost to Follow-up|0|||
161915306|NCT01799889|584738913|FG005|Overall Study|Lost to Follow-up|0|||
161915307|NCT01799889|584738914|FG006|Overall Study|Lost to Follow-up|0|||
161915308|NCT01799889|584738915|FG007|Overall Study|Lost to Follow-up|0|||
161915309|NCT01799889|584738916|FG008|Overall Study|Lost to Follow-up|0|||
161915310|NCT01799889|584738917|FG009|Overall Study|Lost to Follow-up|0|||
161915311|NCT01799889|584738918|FG010|Overall Study|Lost to Follow-up|0|||
161915312|NCT01799889|584738919|FG011|Overall Study|Lost to Follow-up|0|||
161915313|NCT01799889|584738908|FG000|Overall Study|Physician Decision|3|||
161915314|NCT01799889|584738909|FG001|Overall Study|Physician Decision|2|||
161915315|NCT01799889|584738910|FG002|Overall Study|Physician Decision|4|||
161915316|NCT01799889|584738911|FG003|Overall Study|Physician Decision|4|||
161915317|NCT01799889|584738912|FG004|Overall Study|Physician Decision|5|||
161915318|NCT01799889|584738913|FG005|Overall Study|Physician Decision|5|||
161915319|NCT01799889|584738914|FG006|Overall Study|Physician Decision|5|||
161915320|NCT01799889|584738915|FG007|Overall Study|Physician Decision|2|||
161915321|NCT01799889|584738916|FG008|Overall Study|Physician Decision|6|||
161915322|NCT01799889|584738917|FG009|Overall Study|Physician Decision|0|||
161915323|NCT01799889|584738918|FG010|Overall Study|Physician Decision|0|||
161915324|NCT01799889|584738919|FG011|Overall Study|Physician Decision|1|||
161915325|NCT01799889|584738908|FG000|Overall Study|Progressive Disease|30|||
161915326|NCT01799889|584738909|FG001|Overall Study|Progressive Disease|26|||
161915327|NCT01799889|584738910|FG002|Overall Study|Progressive Disease|25|||
161915328|NCT01799889|584738911|FG003|Overall Study|Progressive Disease|30|||
161915329|NCT01799889|584738912|FG004|Overall Study|Progressive Disease|23|||
161468046|NCT00973349|583109546|FG001|Overall Study|Adverse Event|0|||
161915330|NCT01799889|584738913|FG005|Overall Study|Progressive Disease|9|||
161915331|NCT01799889|584738914|FG006|Overall Study|Progressive Disease|8|||
161915332|NCT01799889|584738915|FG007|Overall Study|Progressive Disease|13|||
161915333|NCT01799889|584738916|FG008|Overall Study|Progressive Disease|18|||
161915334|NCT01799889|584738917|FG009|Overall Study|Progressive Disease|5|||
161915335|NCT01799889|584738918|FG010|Overall Study|Progressive Disease|3|||
161915336|NCT01799889|584738919|FG011|Overall Study|Progressive Disease|1|||
161915337|NCT01799889|584738908|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
161915338|NCT01799889|584738909|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
161915339|NCT01799889|584738910|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
161915340|NCT01799889|584738911|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
161915341|NCT01799889|584738912|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
161915342|NCT01799889|584738913|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
161811357|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161811358|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
161811359|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
161811360|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
161811361|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
161811362|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Death|0|||
161811363|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Death|1|||
161811364|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Death|0|||
161811365|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Death|0|||
161811366|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
161915343|NCT01799889|584738914|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
161915344|NCT01799889|584738915|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
161915345|NCT01799889|584738916|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
161915346|NCT01799889|584738917|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
161915347|NCT01799889|584738918|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
161915348|NCT01799889|584738919|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
161915349|NCT01799889|584738908|FG000|Overall Study|Study Terminated By Sponsor|1|||
161915350|NCT01799889|584738909|FG001|Overall Study|Study Terminated By Sponsor|0|||
161915351|NCT01799889|584738910|FG002|Overall Study|Study Terminated By Sponsor|0|||
161915352|NCT01799889|584738911|FG003|Overall Study|Study Terminated By Sponsor|0|||
161915353|NCT01799889|584738912|FG004|Overall Study|Study Terminated By Sponsor|2|||
161915354|NCT01799889|584738913|FG005|Overall Study|Study Terminated By Sponsor|1|||
161915355|NCT01799889|584738914|FG006|Overall Study|Study Terminated By Sponsor|0|||
161915356|NCT01799889|584738915|FG007|Overall Study|Study Terminated By Sponsor|2|||
161915357|NCT01799889|584738916|FG008|Overall Study|Study Terminated By Sponsor|1|||
161915358|NCT01799889|584738917|FG009|Overall Study|Study Terminated By Sponsor|1|||
161915359|NCT01799889|584738918|FG010|Overall Study|Study Terminated By Sponsor|0|||
161915360|NCT01799889|584738919|FG011|Overall Study|Study Terminated By Sponsor|0|||
161915361|NCT01799889|584738908|FG000|Overall Study|Withdrawal by Subject|1|||
161915362|NCT01799889|584738909|FG001|Overall Study|Withdrawal by Subject|6|||
161915363|NCT01799889|584738910|FG002|Overall Study|Withdrawal by Subject|4|||
161915364|NCT01799889|584738911|FG003|Overall Study|Withdrawal by Subject|0|||
161915365|NCT01799889|584738912|FG004|Overall Study|Withdrawal by Subject|5|||
161915366|NCT01799889|584738913|FG005|Overall Study|Withdrawal by Subject|1|||
161811367|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
161811368|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
161811369|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
161811370|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
161811371|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161811372|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161811373|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161811374|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161811375|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161811376|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161811377|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161811378|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161811379|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161811380|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
161811381|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
161811382|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161811383|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161811384|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
161811385|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
161811386|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161811387|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161811388|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
161811389|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161811390|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
161915367|NCT01799889|584738914|FG006|Overall Study|Withdrawal by Subject|3|||
161915368|NCT01799889|584738915|FG007|Overall Study|Withdrawal by Subject|1|||
161915369|NCT01799889|584738916|FG008|Overall Study|Withdrawal by Subject|2|||
161915370|NCT01799889|584738917|FG009|Overall Study|Withdrawal by Subject|1|||
161915371|NCT01799889|584738918|FG010|Overall Study|Withdrawal by Subject|1|||
161915372|NCT01799889|584738919|FG011|Overall Study|Withdrawal by Subject|1|||
161915373|NCT01799889|584738908|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161915374|NCT01799889|584738909|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161915375|NCT01799889|584738910|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161915376|NCT01799889|584738911|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161915377|NCT01799889|584738912|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161915378|NCT01799889|584738913|FG005|Overall Study|Non-Compliance With Study Drug|1|||
161915379|NCT01799889|584738914|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161915380|NCT01799889|584738915|FG007|Overall Study|Non-Compliance With Study Drug|0|||
161915381|NCT01799889|584738916|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161915382|NCT01799889|584738917|FG009|Overall Study|Non-Compliance With Study Drug|0|||
161915383|NCT01799889|584738918|FG010|Overall Study|Non-Compliance With Study Drug|0|||
161915384|NCT01799889|584738919|FG011|Overall Study|Non-Compliance With Study Drug|0|||
161915385|NCT06217380|584738920|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
161811391|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
161811392|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
161811393|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
161811394|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161811395|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161811396|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
161811397|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161811398|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
161811399|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
161811400|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
161811401|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
161811402|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161811403|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161811404|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
161811405|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161811406|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161811407|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161811408|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161811409|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
161811410|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161811411|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161811412|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161811413|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
161811414|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161811415|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161811416|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
161811417|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161811418|NCT03792477|584351456|FG000|Overall Study|Adverse Event|0|||
161811419|NCT03792477|584351457|FG001|Overall Study|Adverse Event|0|||
161811420|NCT03792477|584351458|FG002|Overall Study|Adverse Event|0|||
161811421|NCT03792477|584351459|FG003|Overall Study|Adverse Event|1|||
161811422|NCT03792477|584351460|FG004|Overall Study|Adverse Event|0|||
161811423|NCT03792477|584351456|FG000|Overall Study|Lost to Follow-up|0|||
161811424|NCT03792477|584351457|FG001|Overall Study|Lost to Follow-up|0|||
161811425|NCT03792477|584351458|FG002|Overall Study|Lost to Follow-up|2|||
161811426|NCT03792477|584351459|FG003|Overall Study|Lost to Follow-up|0|||
161811427|NCT03792477|584351460|FG004|Overall Study|Lost to Follow-up|0|||
161811428|NCT03792477|584351456|FG000|Overall Study|Other|0|||
161811429|NCT03792477|584351457|FG001|Overall Study|Other|0|||
161811430|NCT03792477|584351458|FG002|Overall Study|Other|0|||
161811431|NCT03792477|584351459|FG003|Overall Study|Other|0|||
161811432|NCT03792477|584351460|FG004|Overall Study|Other|1|||
161811433|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
161811434|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
161811435|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
161811436|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
161811437|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
161811438|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161811439|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161811440|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161811441|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
161811442|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
161811443|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811444|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
161811445|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811446|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811447|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811448|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161811449|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
161811450|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
161811451|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161811452|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161811453|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161811454|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
161811455|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161811456|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161811457|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
161811458|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
161811459|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811460|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811461|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811462|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811463|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811464|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811465|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811466|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
161811467|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811468|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811469|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
161811470|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811471|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811472|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811473|NCT02605928|584351470|FG000|Overall Study|Model tuning phase|28|||
161811474|NCT02605928|584351470|FG000|Overall Study|Lack of Efficacy|5|||
161811475|NCT03482882|584351473|FG000|Overall Study|Adverse Event|3|||
161811476|NCT03482882|584351473|FG000|Overall Study|Lost to Follow-up|1|||
161811477|NCT03482882|584351473|FG000|Overall Study|Protocol Violation|2|||
161811478|NCT03482882|584351473|FG000|Overall Study|Not further specified|1|||
161811479|NCT05341622|584351480|FG000|Overall Study|Death|0|||
161811480|NCT05341622|584351481|FG001|Overall Study|Death|0|||
161811481|NCT05341622|584351482|FG002|Overall Study|Death|0|||
161811482|NCT05341622|584351483|FG003|Overall Study|Death|0|||
161811483|NCT05341622|584351484|FG004|Overall Study|Death|1|||
161811484|NCT05341622|584351485|FG005|Overall Study|Death|0|||
161811485|NCT05341622|584351486|FG006|Overall Study|Death|0|||
161811486|NCT05341622|584351487|FG007|Overall Study|Death|1|||
161811487|NCT05341622|584351480|FG000|Overall Study|Invalid Address|0|||
161811488|NCT05341622|584351481|FG001|Overall Study|Invalid Address|1|||
161811489|NCT05341622|584351482|FG002|Overall Study|Invalid Address|0|||
161811490|NCT05341622|584351483|FG003|Overall Study|Invalid Address|0|||
161811491|NCT05341622|584351484|FG004|Overall Study|Invalid Address|0|||
161811492|NCT05341622|584351485|FG005|Overall Study|Invalid Address|0|||
161811493|NCT05341622|584351486|FG006|Overall Study|Invalid Address|0|||
161811494|NCT05341622|584351487|FG007|Overall Study|Invalid Address|0|||
161811495|NCT05341622|584351480|FG000|Overall Study|Ineligible|26|||
161811496|NCT05341622|584351481|FG001|Overall Study|Ineligible|21|||
161811497|NCT05341622|584351482|FG002|Overall Study|Ineligible|28|||
161811498|NCT05341622|584351483|FG003|Overall Study|Ineligible|24|||
161811499|NCT05341622|584351484|FG004|Overall Study|Ineligible|29|||
161811500|NCT05341622|584351485|FG005|Overall Study|Ineligible|31|||
161811501|NCT05341622|584351486|FG006|Overall Study|Ineligible|28|||
161811502|NCT05341622|584351487|FG007|Overall Study|Ineligible|26|||
161811503|NCT02658084|584351488|FG000|Overall Study|Withdrawal by Subject|1|||
161811504|NCT02658084|584351489|FG001|Overall Study|Withdrawal by Subject|0|||
161811505|NCT02658084|584351488|FG000|Overall Study|Study Termination|1|||
161915386|NCT06217380|584738920|FG000|Overall Study|Physician Decision|1|||
161915387|NCT06217380|584738920|FG000|Overall Study|Withdrawal by Subject|2|||
161915388|NCT06633965|584738921|FG000|Overall Study|Withdrawal by Subject|0|||
161915389|NCT06633965|584738922|FG001|Overall Study|Withdrawal by Subject|1|||
161811506|NCT02658084|584351489|FG001|Overall Study|Study Termination|0|||
161811507|NCT03290781|584351490|FG000|Overall Study|Adverse Event|5|||
161811508|NCT03290781|584351491|FG001|Overall Study|Adverse Event|7|||
161811509|NCT03290781|584351492|FG002|Overall Study|Adverse Event|4|||
161811510|NCT03290781|584351493|FG003|Overall Study|Adverse Event|1|||
161811511|NCT03290781|584351494|FG004|Overall Study|Adverse Event|0|||
161811512|NCT03290781|584351495|FG005|Overall Study|Adverse Event|0|||
161811513|NCT03290781|584351496|FG006|Overall Study|Adverse Event|0|||
161811514|NCT03290781|584351490|FG000|Overall Study|Death|0|||
161811515|NCT03290781|584351491|FG001|Overall Study|Death|0|||
161468047|NCT00973349|583109547|FG002|Overall Study|Adverse Event|0|||
161468048|NCT00973349|583109548|FG003|Overall Study|Adverse Event|0|||
161468049|NCT00973349|583109549|FG004|Overall Study|Adverse Event|1|||
161811516|NCT03290781|584351492|FG002|Overall Study|Death|1|||
161811517|NCT03290781|584351493|FG003|Overall Study|Death|0|||
161811518|NCT03290781|584351494|FG004|Overall Study|Death|1|||
161811519|NCT03290781|584351495|FG005|Overall Study|Death|0|||
161811520|NCT03290781|584351496|FG006|Overall Study|Death|0|||
161811521|NCT03290781|584351490|FG000|Overall Study|Withdrawal by Subject|6|||
161811522|NCT03290781|584351491|FG001|Overall Study|Withdrawal by Subject|5|||
161811523|NCT03290781|584351492|FG002|Overall Study|Withdrawal by Subject|9|||
161811524|NCT03290781|584351493|FG003|Overall Study|Withdrawal by Subject|10|||
161811525|NCT03290781|584351494|FG004|Overall Study|Withdrawal by Subject|1|||
161811526|NCT03290781|584351495|FG005|Overall Study|Withdrawal by Subject|2|||
161811527|NCT03290781|584351496|FG006|Overall Study|Withdrawal by Subject|0|||
161811528|NCT03290781|584351490|FG000|Overall Study|Physician Decision|0|||
161811529|NCT03290781|584351491|FG001|Overall Study|Physician Decision|1|||
161811530|NCT03290781|584351492|FG002|Overall Study|Physician Decision|0|||
161811531|NCT03290781|584351493|FG003|Overall Study|Physician Decision|0|||
161811532|NCT03290781|584351494|FG004|Overall Study|Physician Decision|0|||
161811533|NCT03290781|584351495|FG005|Overall Study|Physician Decision|0|||
161811534|NCT03290781|584351496|FG006|Overall Study|Physician Decision|0|||
161811535|NCT03290781|584351490|FG000|Overall Study|Site Terminated by Sponsor|1|||
161811536|NCT03290781|584351491|FG001|Overall Study|Site Terminated by Sponsor|0|||
161811537|NCT03290781|584351492|FG002|Overall Study|Site Terminated by Sponsor|2|||
161811538|NCT03290781|584351493|FG003|Overall Study|Site Terminated by Sponsor|1|||
161811539|NCT03290781|584351494|FG004|Overall Study|Site Terminated by Sponsor|0|||
161811540|NCT03290781|584351495|FG005|Overall Study|Site Terminated by Sponsor|0|||
161811541|NCT03290781|584351496|FG006|Overall Study|Site Terminated by Sponsor|0|||
161811542|NCT03290781|584351490|FG000|Overall Study|Lost to Follow-up|0|||
161811543|NCT03290781|584351491|FG001|Overall Study|Lost to Follow-up|0|||
161811544|NCT03290781|584351492|FG002|Overall Study|Lost to Follow-up|0|||
161811545|NCT03290781|584351493|FG003|Overall Study|Lost to Follow-up|1|||
161811546|NCT03290781|584351494|FG004|Overall Study|Lost to Follow-up|0|||
161811547|NCT03290781|584351495|FG005|Overall Study|Lost to Follow-up|0|||
161811548|NCT03290781|584351496|FG006|Overall Study|Lost to Follow-up|0|||
161811549|NCT03290781|584351490|FG000|Overall Study|Protocol Deviation|2|||
161811550|NCT03290781|584351491|FG001|Overall Study|Protocol Deviation|0|||
161811551|NCT03290781|584351492|FG002|Overall Study|Protocol Deviation|0|||
161811552|NCT03290781|584351493|FG003|Overall Study|Protocol Deviation|1|||
161811553|NCT03290781|584351494|FG004|Overall Study|Protocol Deviation|0|||
161811554|NCT03290781|584351495|FG005|Overall Study|Protocol Deviation|0|||
161811555|NCT03290781|584351496|FG006|Overall Study|Protocol Deviation|0|||
161811556|NCT03290781|584351490|FG000|Overall Study|Disease Relapse|32|||
161811557|NCT03290781|584351491|FG001|Overall Study|Disease Relapse|5|||
161811558|NCT03290781|584351492|FG002|Overall Study|Disease Relapse|38|||
161811559|NCT03290781|584351493|FG003|Overall Study|Disease Relapse|7|||
161811560|NCT03290781|584351494|FG004|Overall Study|Disease Relapse|3|||
161811561|NCT03290781|584351495|FG005|Overall Study|Disease Relapse|1|||
161811562|NCT03290781|584351496|FG006|Overall Study|Disease Relapse|4|||
161811563|NCT03290781|584351490|FG000|Overall Study|Other|3|||
161811564|NCT03290781|584351491|FG001|Overall Study|Other|0|||
161811565|NCT03290781|584351492|FG002|Overall Study|Other|2|||
161811566|NCT03290781|584351493|FG003|Overall Study|Other|2|||
161811567|NCT03290781|584351494|FG004|Overall Study|Other|0|||
161811568|NCT03290781|584351495|FG005|Overall Study|Other|0|||
161811569|NCT03290781|584351496|FG006|Overall Study|Other|0|||
161811570|NCT04611789|584351497|FG000|Overall Study|Lost to Follow-up|1|||
161811571|NCT04611789|584351498|FG001|Overall Study|Lost to Follow-up|0|||
161811572|NCT04611789|584351499|FG002|Overall Study|Lost to Follow-up|0|||
161811573|NCT05152576|584351501|FG000|Overall Study|Lost to Follow-up|3|||
161811574|NCT05152576|584351502|FG001|Overall Study|Lost to Follow-up|0|||
161811575|NCT05152576|584351503|FG002|Overall Study|Lost to Follow-up|0|||
161811576|NCT05152576|584351504|FG003|Overall Study|Lost to Follow-up|1|||
161811577|NCT05152576|584351501|FG000|Overall Study|Withdrawal by Subject|0|||
161811578|NCT05152576|584351502|FG001|Overall Study|Withdrawal by Subject|1|||
161811579|NCT05152576|584351503|FG002|Overall Study|Withdrawal by Subject|0|||
161811580|NCT05152576|584351504|FG003|Overall Study|Withdrawal by Subject|1|||
161811581|NCT05152576|584351501|FG000|Overall Study|Other|2|||
161811582|NCT05152576|584351502|FG001|Overall Study|Other|0|||
161811583|NCT05152576|584351503|FG002|Overall Study|Other|0|||
161811584|NCT05152576|584351504|FG003|Overall Study|Other|0|||
161811585|NCT00859430|584351505|FG000|First Intervention|Withdrawal by Subject|0|||
161811586|NCT00859430|584351506|FG001|First Intervention|Withdrawal by Subject|1|||
161811587|NCT02286739|584353029|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
161811588|NCT02286739|584353030|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
161811589|NCT02286739|584353029|FG000|Overall Study|No Verasense type documented|0|||
161811590|NCT02286739|584353030|FG001|Overall Study|No Verasense type documented|23|||
161811591|NCT02286739|584353029|FG000|Overall Study|Adverse Event|1|||
161915390|NCT00300053|584738925|FG000|Overall Study|Patient/Caregiver Preference|2|||
161915391|NCT00300053|584738926|FG001|Overall Study|Patient/Caregiver Preference|2|||
161915392|NCT00300053|584738927|FG002|Overall Study|Patient/Caregiver Preference|3|||
161915393|NCT00300053|584738925|FG000|Overall Study|Death|0|||
161915394|NCT00300053|584738926|FG001|Overall Study|Death|0|||
161915395|NCT00300053|584738927|FG002|Overall Study|Death|3|||
161915396|NCT00300053|584738925|FG000|Overall Study|Lost to Follow-up|0|||
161915397|NCT00300053|584738926|FG001|Overall Study|Lost to Follow-up|1|||
161915398|NCT00300053|584738927|FG002|Overall Study|Lost to Follow-up|0|||
161915399|NCT01963611|584738931|FG000|Overall Study|Adverse Event|1|||
161468050|NCT00973349|583109550|FG005|Overall Study|Adverse Event|0|||
161468051|NCT00973349|583109551|FG006|Overall Study|Adverse Event|0|||
161468052|NCT00973349|583109552|FG007|Overall Study|Adverse Event|0|||
161915400|NCT01963611|584738932|FG001|Overall Study|Adverse Event|1|||
161468053|NCT00973349|583109553|FG008|Overall Study|Adverse Event|1|||
161468054|NCT00973349|583109554|FG009|Overall Study|Adverse Event|0|||
161468055|NCT00973349|583109555|FG010|Overall Study|Adverse Event|0|||
161915401|NCT01963611|584738933|FG002|Overall Study|Adverse Event|3|||
161915402|NCT01963611|584738934|FG003|Overall Study|Adverse Event|4|||
161915403|NCT01963611|584738935|FG004|Overall Study|Adverse Event|3|||
161915404|NCT01963611|584738931|FG000|Overall Study|Protocol Violation|0|||
161915405|NCT01963611|584738932|FG001|Overall Study|Protocol Violation|0|||
161915406|NCT01963611|584738933|FG002|Overall Study|Protocol Violation|0|||
161915407|NCT01963611|584738934|FG003|Overall Study|Protocol Violation|1|||
161915408|NCT01963611|584738935|FG004|Overall Study|Protocol Violation|0|||
161915409|NCT01963611|584738931|FG000|Overall Study|Lack of Efficacy|0|||
161915410|NCT01963611|584738932|FG001|Overall Study|Lack of Efficacy|0|||
161915411|NCT01963611|584738933|FG002|Overall Study|Lack of Efficacy|0|||
161915412|NCT01963611|584738934|FG003|Overall Study|Lack of Efficacy|1|||
161915413|NCT01963611|584738935|FG004|Overall Study|Lack of Efficacy|0|||
161915414|NCT01963611|584738931|FG000|Overall Study|Withdrawal by Subject|3|||
161915415|NCT01963611|584738932|FG001|Overall Study|Withdrawal by Subject|2|||
161915416|NCT01963611|584738933|FG002|Overall Study|Withdrawal by Subject|1|||
161575522|NCT02547922|583492726|FG001|Overall Study|Death|0|||
161575523|NCT02547922|583492727|FG002|Overall Study|Death|0|||
161575524|NCT02547922|583492725|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
161575525|NCT02547922|583492726|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
161575526|NCT02547922|583492727|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
161575527|NCT02547922|583492725|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
161575528|NCT02547922|583492726|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
161575529|NCT02547922|583492727|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
161575530|NCT02547922|583492725|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
161575531|NCT02547922|583492726|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
161915417|NCT01963611|584738934|FG003|Overall Study|Withdrawal by Subject|1|||
161915418|NCT01963611|584738935|FG004|Overall Study|Withdrawal by Subject|3|||
161915419|NCT01963611|584738931|FG000|Overall Study|Other|47|||
161915420|NCT01963611|584738932|FG001|Overall Study|Other|46|||
161915421|NCT01963611|584738933|FG002|Overall Study|Other|48|||
161915422|NCT01963611|584738934|FG003|Overall Study|Other|45|||
161915423|NCT01963611|584738935|FG004|Overall Study|Other|45|||
161915424|NCT01126424|584738937|FG000|Overall Study|Adverse Event|0|||
161915425|NCT01126424|584738938|FG001|Overall Study|Adverse Event|0|||
161915426|NCT01126424|584738939|FG002|Overall Study|Adverse Event|0|||
161915427|NCT01126424|584738940|FG003|Overall Study|Adverse Event|0|||
161915428|NCT01126424|584738941|FG004|Overall Study|Adverse Event|1|||
161915429|NCT01126424|584738942|FG005|Overall Study|Adverse Event|0|||
161915430|NCT01126424|584738937|FG000|Overall Study|Withdrawal by Subject|0|||
161915431|NCT01126424|584738938|FG001|Overall Study|Withdrawal by Subject|0|||
161915432|NCT01126424|584738939|FG002|Overall Study|Withdrawal by Subject|1|||
161915433|NCT01126424|584738940|FG003|Overall Study|Withdrawal by Subject|3|||
161915434|NCT01126424|584738941|FG004|Overall Study|Withdrawal by Subject|1|||
161915435|NCT01126424|584738942|FG005|Overall Study|Withdrawal by Subject|0|||
161915436|NCT02127671|584738943|FG000|Overall Study|Death|2|||
161915437|NCT02127671|584738944|FG001|Overall Study|Death|2|||
161915438|NCT02127671|584738943|FG000|Overall Study|Lost to Follow-up|4|||
161915439|NCT02127671|584738944|FG001|Overall Study|Lost to Follow-up|2|||
161915440|NCT02127671|584738943|FG000|Overall Study|Physician Decision|1|||
161915441|NCT02127671|584738944|FG001|Overall Study|Physician Decision|0|||
161915442|NCT02127671|584738943|FG000|Overall Study|incarceration|0|||
161915443|NCT02127671|584738944|FG001|Overall Study|incarceration|1|||
161915444|NCT02127671|584738943|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
161915445|NCT02127671|584738944|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
161915446|NCT02394275|584738945|FG000|Overall Study|Adverse Event|22|||
161915447|NCT02394275|584738945|FG000|Overall Study|Lost to Follow-up|7|||
161915448|NCT00782067|584738947|FG000|Overall Study|Adverse Event|35|||
161915449|NCT00782067|584738947|FG000|Overall Study|Subject withdrew consent|11|||
161915450|NCT00782067|584738947|FG000|Overall Study|Lost to Follow-up|2|||
161915451|NCT00782067|584738947|FG000|Overall Study|Administrative problems|14|||
161915452|NCT00782067|584738947|FG000|Overall Study|Death|9|||
161915453|NCT00782067|584738947|FG000|Overall Study|Disease progression|43|||
161915454|NCT00782067|584738947|FG000|Overall Study|Protocol deviation|2|||
161915455|NCT02471183|584738948|FG000|Main Treatment Period|Adverse Event|1|||
161915456|NCT02471183|584738948|FG000|Main Treatment Period|Withdrawal by Subject|1|||
161915457|NCT02471183|584738948|FG000|Extended Treatment Period|Lack of Efficacy|1|||
161915458|NCT00614393|584738950|FG000|Overall Study|Adverse Event|20|||
161915459|NCT00614393|584738951|FG001|Overall Study|Adverse Event|2|||
161915460|NCT00614393|584738952|FG002|Overall Study|Adverse Event|3|||
161915461|NCT00614393|584738953|FG003|Overall Study|Adverse Event|13|||
161915462|NCT00614393|584738954|FG004|Overall Study|Adverse Event|21|||
161915463|NCT00614393|584738950|FG000|Overall Study|Lost to Follow-up|0|||
161915464|NCT00614393|584738951|FG001|Overall Study|Lost to Follow-up|0|||
161915465|NCT00614393|584738952|FG002|Overall Study|Lost to Follow-up|0|||
161915466|NCT00614393|584738953|FG003|Overall Study|Lost to Follow-up|1|||
161811592|NCT02286739|584353030|FG001|Overall Study|Adverse Event|2|||
161811593|NCT02286739|584353029|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
161811594|NCT02286739|584353030|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
161811595|NCT00834795|584353031|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
161811596|NCT00834795|584353032|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161811597|NCT00834795|584353031|FG000|Second Intervention|Adverse Event|1|||
161811598|NCT00834795|584353032|FG001|Second Intervention|Adverse Event|0|||
161811599|NCT03697109|584353040|FG000|Open-label (OL) Phase|Adverse Event|24|||
161811600|NCT03697109|584353041|FG001|Open-label (OL) Phase|Adverse Event|0|||
161811601|NCT03697109|584353042|FG002|Open-label (OL) Phase|Adverse Event|0|||
161811602|NCT03697109|584353040|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
161811603|NCT03697109|584353041|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
161811604|NCT03697109|584353042|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
161811605|NCT03697109|584353040|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
161811606|NCT03697109|584353041|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
161811607|NCT03697109|584353042|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
161811608|NCT03697109|584353040|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
161811609|NCT03697109|584353041|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
161811610|NCT03697109|584353042|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
161811611|NCT03697109|584353040|FG000|Open-label (OL) Phase|Physician Decision|2|||
161811612|NCT03697109|584353041|FG001|Open-label (OL) Phase|Physician Decision|0|||
161811613|NCT03697109|584353042|FG002|Open-label (OL) Phase|Physician Decision|0|||
161811614|NCT03697109|584353040|FG000|Open-label (OL) Phase|Death|2|||
161811615|NCT03697109|584353041|FG001|Open-label (OL) Phase|Death|0|||
161811616|NCT03697109|584353042|FG002|Open-label (OL) Phase|Death|0|||
161811617|NCT03697109|584353040|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
161811618|NCT03697109|584353041|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
161811619|NCT03697109|584353042|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
161811620|NCT03697109|584353040|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
161811621|NCT03697109|584353041|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
161811622|NCT03697109|584353042|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
161811623|NCT03697109|584353040|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
161811624|NCT03697109|584353041|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
161811625|NCT03697109|584353042|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
161811626|NCT02301975|584353046|FG000|Overall Study|Adverse Event|8|||
161811627|NCT02301975|584353047|FG001|Overall Study|Adverse Event|3|||
161811628|NCT02301975|584353048|FG002|Overall Study|Adverse Event|2|||
161811629|NCT02301975|584353046|FG000|Overall Study|Lack of Efficacy|1|||
161811630|NCT02301975|584353047|FG001|Overall Study|Lack of Efficacy|1|||
161811631|NCT02301975|584353048|FG002|Overall Study|Lack of Efficacy|1|||
161811632|NCT02301975|584353046|FG000|Overall Study|Protocol Violation|3|||
161811633|NCT02301975|584353047|FG001|Overall Study|Protocol Violation|5|||
161811634|NCT02301975|584353048|FG002|Overall Study|Protocol Violation|3|||
161811635|NCT02301975|584353046|FG000|Overall Study|Lost to Follow-up|0|||
161811636|NCT02301975|584353047|FG001|Overall Study|Lost to Follow-up|2|||
161811637|NCT02301975|584353048|FG002|Overall Study|Lost to Follow-up|2|||
161811638|NCT02301975|584353046|FG000|Overall Study|Physician Decision|4|||
161811639|NCT02301975|584353047|FG001|Overall Study|Physician Decision|2|||
161811640|NCT02301975|584353048|FG002|Overall Study|Physician Decision|3|||
161811641|NCT02301975|584353046|FG000|Overall Study|Withdrawal by Subject|15|||
161811642|NCT02301975|584353047|FG001|Overall Study|Withdrawal by Subject|12|||
161811643|NCT02301975|584353048|FG002|Overall Study|Withdrawal by Subject|11|||
161811644|NCT00835991|584353049|FG000|First Intervention|Adverse Event|0|||
161811645|NCT00835991|584353050|FG001|First Intervention|Adverse Event|1|||
161811646|NCT00835991|584353049|FG000|Washout|Protocol Violation|0|||
161811647|NCT00835991|584353050|FG001|Washout|Protocol Violation|2|||
161811648|NCT00835991|584353049|FG000|Washout|Withdrawal by Subject|3|||
161811649|NCT00835991|584353050|FG001|Washout|Withdrawal by Subject|1|||
161811650|NCT04278560|584353051|FG000|Overall Study|Adverse Event|1|||
161811651|NCT04278560|584353052|FG001|Overall Study|Adverse Event|2|||
161811652|NCT04278560|584353051|FG000|Overall Study|Withdrawal by Subject|0|||
161811653|NCT04278560|584353052|FG001|Overall Study|Withdrawal by Subject|1|||
161811654|NCT00163657|584353053|FG000|Overall Study|Death|12|||
161811655|NCT00163657|584353054|FG001|Overall Study|Death|14|||
161811656|NCT00163657|584353055|FG002|Overall Study|Death|19|||
161811657|NCT00163657|584353053|FG000|Overall Study|graft loss|4|||
161811658|NCT00163657|584353054|FG001|Overall Study|graft loss|1|||
161811659|NCT00163657|584353055|FG002|Overall Study|graft loss|2|||
161811660|NCT00163657|584353053|FG000|Overall Study|Withdrawal by Subject|2|||
161811661|NCT00163657|584353054|FG001|Overall Study|Withdrawal by Subject|3|||
161811662|NCT00163657|584353055|FG002|Overall Study|Withdrawal by Subject|2|||
161811663|NCT00163657|584353053|FG000|Overall Study|Physician Decision|0|||
161811664|NCT00163657|584353054|FG001|Overall Study|Physician Decision|1|||
161915467|NCT00614393|584738954|FG004|Overall Study|Lost to Follow-up|2|||
161811665|NCT00163657|584353055|FG002|Overall Study|Physician Decision|1|||
161811666|NCT00163657|584353053|FG000|Overall Study|Non Compliance|1|||
161915468|NCT00614393|584738950|FG000|Overall Study|Physician Decision|17|||
161915469|NCT00614393|584738951|FG001|Overall Study|Physician Decision|0|||
161915470|NCT00614393|584738952|FG002|Overall Study|Physician Decision|1|||
161915471|NCT00614393|584738953|FG003|Overall Study|Physician Decision|8|||
161915472|NCT00614393|584738954|FG004|Overall Study|Physician Decision|9|||
161915473|NCT00614393|584738950|FG000|Overall Study|Progressive Disease|118|||
161915474|NCT00614393|584738951|FG001|Overall Study|Progressive Disease|5|||
161915475|NCT00614393|584738952|FG002|Overall Study|Progressive Disease|5|||
161915476|NCT00614393|584738953|FG003|Overall Study|Progressive Disease|138|||
161915477|NCT00614393|584738954|FG004|Overall Study|Progressive Disease|130|||
161915478|NCT00614393|584738950|FG000|Overall Study|Protocol Violation|1|||
161915479|NCT00614393|584738951|FG001|Overall Study|Protocol Violation|0|||
161915480|NCT00614393|584738952|FG002|Overall Study|Protocol Violation|0|||
161915481|NCT00614393|584738953|FG003|Overall Study|Protocol Violation|0|||
161915482|NCT00614393|584738954|FG004|Overall Study|Protocol Violation|0|||
161915483|NCT00614393|584738950|FG000|Overall Study|Terminated by Sponsor|0|||
161915484|NCT00614393|584738951|FG001|Overall Study|Terminated by Sponsor|0|||
161915485|NCT00614393|584738952|FG002|Overall Study|Terminated by Sponsor|0|||
161915486|NCT00614393|584738953|FG003|Overall Study|Terminated by Sponsor|0|||
161915487|NCT00614393|584738954|FG004|Overall Study|Terminated by Sponsor|1|||
161915488|NCT00614393|584738950|FG000|Overall Study|Withdrawal by Subject|20|||
161915489|NCT00614393|584738951|FG001|Overall Study|Withdrawal by Subject|1|||
161915490|NCT00614393|584738952|FG002|Overall Study|Withdrawal by Subject|1|||
161915491|NCT00614393|584738953|FG003|Overall Study|Withdrawal by Subject|16|||
161915492|NCT00614393|584738954|FG004|Overall Study|Withdrawal by Subject|13|||
161915493|NCT00614393|584738950|FG000|Overall Study|Other|4|||
161915494|NCT00614393|584738951|FG001|Overall Study|Other|0|||
161915495|NCT00614393|584738952|FG002|Overall Study|Other|0|||
161915496|NCT00614393|584738953|FG003|Overall Study|Other|4|||
161915497|NCT00614393|584738954|FG004|Overall Study|Other|2|||
161915498|NCT00614393|584738950|FG000|Overall Study|Not Treated|0|||
161915499|NCT00614393|584738951|FG001|Overall Study|Not Treated|0|||
161915500|NCT00614393|584738952|FG002|Overall Study|Not Treated|0|||
161915501|NCT00614393|584738953|FG003|Overall Study|Not Treated|0|||
161915502|NCT00614393|584738954|FG004|Overall Study|Not Treated|2|||
161915503|NCT02328105|584738955|FG000|Overall Study|Death|6|||
161915504|NCT02328105|584738955|FG000|Overall Study|Withdrawal by Subject|1|||
161915505|NCT02328105|584738955|FG000|Overall Study|Still On Study in Follow-Up|4|||
161915506|NCT03286504|584738962|FG000|Overall Study|Lost to Follow-up|19|||
161915507|NCT03286504|584738963|FG001|Overall Study|Lost to Follow-up|16|||
161915508|NCT00141921|584738966|FG000|Overall Study|Remain on Study|28|||
161915509|NCT00141921|584738966|FG000|Overall Study|Withdrawal by Subject|42|||
161915510|NCT00141921|584738966|FG000|Overall Study|Lost to Follow-up|19|||
161915511|NCT00141921|584738966|FG000|Overall Study|Noncompliance|17|||
161915512|NCT00141921|584738966|FG000|Overall Study|Disease Progression|7|||
161915513|NCT00141921|584738966|FG000|Overall Study|Protocol Deviation|7|||
161915514|NCT00141921|584738966|FG000|Overall Study|Adverse Event|5|||
161915515|NCT00141921|584738966|FG000|Overall Study|Administrative Decision|2|||
161915516|NCT00141921|584738966|FG000|Overall Study|Pregnancy|4|||
161915517|NCT00141921|584738966|FG000|Overall Study|Ineligibility Determined|2|||
161915518|NCT00141921|584738966|FG000|Overall Study|Other|8|||
161915519|NCT03320369|584738967|FG000|Overall Study|Adverse Event|1|||
161915520|NCT03320369|584738967|FG000|Overall Study|Withdrawal by Subject|2|||
161915521|NCT03813654|584738968|FG000|Overall Study|Protocol Violation|0|||
161915522|NCT03813654|584738969|FG001|Overall Study|Protocol Violation|1|||
161915523|NCT03813654|584738970|FG002|Overall Study|Protocol Violation|2|||
161915524|NCT03813654|584738968|FG000|Overall Study|Withdrawal by Subject|1|||
161915525|NCT03813654|584738969|FG001|Overall Study|Withdrawal by Subject|0|||
161915526|NCT03813654|584738970|FG002|Overall Study|Withdrawal by Subject|0|||
161915527|NCT02783690|584738993|FG000|Overall Study|Withdrawal by Subject|3|||
161915528|NCT02783690|584738994|FG001|Overall Study|Withdrawal by Subject|3|||
161915529|NCT04585893|584738995|FG000|Overall Study|Death|1|||
161915530|NCT04585893|584738996|FG001|Overall Study|Death|0|||
161915531|NCT06178991|584738999|FG000|Overall Study|Withdrawal by Subject|2|||
161915532|NCT06178991|584739000|FG001|Overall Study|Withdrawal by Subject|6|||
161915533|NCT06178991|584739001|FG002|Overall Study|Withdrawal by Subject|44|||
161915534|NCT06178991|584739002|FG003|Overall Study|Withdrawal by Subject|23|||
161915535|NCT06178991|584739003|FG004|Overall Study|Withdrawal by Subject|7|||
161915536|NCT06178991|584739004|FG005|Overall Study|Withdrawal by Subject|7|||
161915537|NCT06178991|584739005|FG006|Overall Study|Withdrawal by Subject|7|||
161915538|NCT06178991|584739006|FG007|Overall Study|Withdrawal by Subject|5|||
161915539|NCT06178991|584738999|FG000|Overall Study|Lost to Follow-up|2|||
161915540|NCT06178991|584739000|FG001|Overall Study|Lost to Follow-up|4|||
161915541|NCT06178991|584739001|FG002|Overall Study|Lost to Follow-up|133|||
161915542|NCT06178991|584739002|FG003|Overall Study|Lost to Follow-up|65|||
161915543|NCT06178991|584739003|FG004|Overall Study|Lost to Follow-up|68|||
161915544|NCT06178991|584739004|FG005|Overall Study|Lost to Follow-up|57|||
161915545|NCT06178991|584739005|FG006|Overall Study|Lost to Follow-up|25|||
161915546|NCT06178991|584739006|FG007|Overall Study|Lost to Follow-up|18|||
161915547|NCT06178991|584738999|FG000|Overall Study|Death|1|||
161915548|NCT06178991|584739000|FG001|Overall Study|Death|0|||
161915549|NCT06178991|584739001|FG002|Overall Study|Death|2|||
161915550|NCT06178991|584739002|FG003|Overall Study|Death|1|||
161915551|NCT06178991|584739003|FG004|Overall Study|Death|1|||
161915552|NCT06178991|584739004|FG005|Overall Study|Death|0|||
161915553|NCT06178991|584739005|FG006|Overall Study|Death|1|||
161915554|NCT06178991|584739006|FG007|Overall Study|Death|1|||
161915555|NCT06178991|584738999|FG000|Overall Study|Randomized but not Vaccinated|4|||
161915556|NCT06178991|584739000|FG001|Overall Study|Randomized but not Vaccinated|1|||
161915557|NCT06178991|584739001|FG002|Overall Study|Randomized but not Vaccinated|15|||
161915558|NCT06178991|584739002|FG003|Overall Study|Randomized but not Vaccinated|9|||
161915559|NCT06178991|584739003|FG004|Overall Study|Randomized but not Vaccinated|8|||
161915560|NCT06178991|584739004|FG005|Overall Study|Randomized but not Vaccinated|4|||
161575532|NCT02547922|583492727|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
161575533|NCT02547922|583492725|FG000|Overall Study|Physician Decision|2|||
161575534|NCT02547922|583492726|FG001|Overall Study|Physician Decision|1|||
161575535|NCT02547922|583492727|FG002|Overall Study|Physician Decision|2|||
161575536|NCT02547922|583492725|FG000|Overall Study|Patients did not receive IP|1|||
161575537|NCT02547922|583492726|FG001|Overall Study|Patients did not receive IP|1|||
161575538|NCT02547922|583492727|FG002|Overall Study|Patients did not receive IP|0|||
161575539|NCT02248480|583492728|FG000|Overall Study|Lack of Efficacy|4|||
161575540|NCT02248480|583492729|FG001|Overall Study|Lack of Efficacy|6|||
161575541|NCT02248480|583492728|FG000|Overall Study|Adverse Event|11|||
161575542|NCT02248480|583492729|FG001|Overall Study|Adverse Event|2|||
161575543|NCT02248480|583492728|FG000|Overall Study|Withdrawal by Subject|2|||
161575544|NCT02248480|583492729|FG001|Overall Study|Withdrawal by Subject|4|||
161575545|NCT02248480|583492728|FG000|Overall Study|Entry Criteria Not Met|0|||
161575546|NCT02248480|583492729|FG001|Overall Study|Entry Criteria Not Met|1|||
161575547|NCT02248480|583492728|FG000|Overall Study|Other:Physician Decision|0|||
161575548|NCT02248480|583492729|FG001|Overall Study|Other:Physician Decision|1|||
161575549|NCT06001177|583493589|FG000|Treatment Phase|Adverse Event|1|||
161575550|NCT06001177|583493590|FG001|Treatment Phase|Adverse Event|0|||
161575551|NCT06001177|583493589|FG000|Treatment Phase|Withdrawal by Subject|1|||
161915561|NCT06178991|584739005|FG006|Overall Study|Randomized but not Vaccinated|2|||
161915562|NCT06178991|584739006|FG007|Overall Study|Randomized but not Vaccinated|2|||
161915563|NCT06178991|584738999|FG000|Overall Study|Other: Unspecified|0|||
161915564|NCT06178991|584739000|FG001|Overall Study|Other: Unspecified|1|||
161915565|NCT06178991|584739001|FG002|Overall Study|Other: Unspecified|7|||
161915566|NCT06178991|584739002|FG003|Overall Study|Other: Unspecified|6|||
161915567|NCT06178991|584739003|FG004|Overall Study|Other: Unspecified|1|||
161915568|NCT06178991|584739004|FG005|Overall Study|Other: Unspecified|1|||
161915569|NCT06178991|584739005|FG006|Overall Study|Other: Unspecified|1|||
161915570|NCT06178991|584739006|FG007|Overall Study|Other: Unspecified|0|||
161915571|NCT06178991|584738999|FG000|Overall Study|Physician Decision|0|||
161915572|NCT06178991|584739000|FG001|Overall Study|Physician Decision|0|||
161915573|NCT06178991|584739001|FG002|Overall Study|Physician Decision|2|||
161915574|NCT06178991|584739002|FG003|Overall Study|Physician Decision|0|||
161915575|NCT06178991|584739003|FG004|Overall Study|Physician Decision|2|||
161915576|NCT06178991|584739004|FG005|Overall Study|Physician Decision|1|||
161915577|NCT06178991|584739005|FG006|Overall Study|Physician Decision|0|||
161915578|NCT06178991|584739006|FG007|Overall Study|Physician Decision|0|||
161915579|NCT06178991|584738999|FG000|Overall Study|Protocol Violation|0|||
161915580|NCT06178991|584739000|FG001|Overall Study|Protocol Violation|0|||
161575552|NCT06001177|583493590|FG001|Treatment Phase|Withdrawal by Subject|0|||
161575553|NCT06001177|583493589|FG000|Observation Phase|Adverse Event|1|||
161575554|NCT06001177|583493590|FG001|Observation Phase|Adverse Event|1|||
161575555|NCT06001177|583493589|FG000|Observation Phase|Withdrawal by Subject|0|||
161575556|NCT06001177|583493590|FG001|Observation Phase|Withdrawal by Subject|1|||
161575557|NCT03593876|583493591|FG000|Overall Study|Withdrawal by Subject|1|||
161575558|NCT03593876|583493591|FG000|Overall Study|Discharged home before intervention completion|2|||
161575559|NCT05309668|583493592|FG000|Overall Study|Ongoing at data cut-off|14|||
161575560|NCT05309668|583493593|FG001|Overall Study|Ongoing at data cut-off|17|||
161575561|NCT05309668|583493594|FG002|Overall Study|Ongoing at data cut-off|4|||
161575562|NCT02696707|583493595|FG000|Per Protocol Population|Physician Decision|2|||
161575563|NCT02696707|583493596|FG001|Per Protocol Population|Physician Decision|1|||
161915581|NCT06178991|584739001|FG002|Overall Study|Protocol Violation|1|||
161915582|NCT06178991|584739002|FG003|Overall Study|Protocol Violation|0|||
161915583|NCT06178991|584739003|FG004|Overall Study|Protocol Violation|0|||
161915584|NCT06178991|584739004|FG005|Overall Study|Protocol Violation|0|||
161915585|NCT06178991|584739005|FG006|Overall Study|Protocol Violation|0|||
161915586|NCT06178991|584739006|FG007|Overall Study|Protocol Violation|0|||
161915587|NCT01366092|584739010|FG000|Overall Study|Progressive cGVHD|2|||
161575564|NCT02696707|583493595|FG000|Per Protocol Population|Participant Decision|0|||
161915588|NCT01366092|584739010|FG000|Overall Study|Physician Decision|1|||
161575565|NCT02696707|583493596|FG001|Per Protocol Population|Participant Decision|2|||
161575566|NCT02696707|583493595|FG000|Completed Study as Planned|Reason = LVEF|2|||
161575567|NCT02696707|583493596|FG001|Completed Study as Planned|Reason = LVEF|2|||
161575568|NCT02696707|583493595|FG000|Completed Study as Planned|Protocol Violation|2|||
161575569|NCT02696707|583493596|FG001|Completed Study as Planned|Protocol Violation|6|||
161575570|NCT02696707|583493595|FG000|Completed Study as Planned|Metastatic disease|3|||
161575571|NCT02696707|583493596|FG001|Completed Study as Planned|Metastatic disease|0|||
161575572|NCT02696707|583493595|FG000|Completed Study as Planned|Location|1|||
161575573|NCT02696707|583493596|FG001|Completed Study as Planned|Location|1|||
161575574|NCT00071799|583493597|FG000|Overall Study|Adverse Event|19|||
161575575|NCT00071799|583493598|FG001|Overall Study|Adverse Event|10|||
161575576|NCT00071799|583493597|FG000|Overall Study|Protocol Violation|1|||
161575577|NCT00071799|583493598|FG001|Overall Study|Protocol Violation|7|||
161575578|NCT00071799|583493597|FG000|Overall Study|Lost to Follow-up|1|||
161575579|NCT00071799|583493598|FG001|Overall Study|Lost to Follow-up|1|||
161575580|NCT00071799|583493597|FG000|Overall Study|Withdrawal by Subject|15|||
161575581|NCT00071799|583493598|FG001|Overall Study|Withdrawal by Subject|37|||
161575582|NCT00071799|583493597|FG000|Overall Study|Physician Decision|0|||
161575583|NCT00071799|583493598|FG001|Overall Study|Physician Decision|2|||
161575584|NCT00071799|583493597|FG000|Overall Study|Lack of Efficacy|11|||
161575585|NCT00071799|583493598|FG001|Overall Study|Lack of Efficacy|18|||
161575586|NCT00071799|583493597|FG000|Overall Study|Disease Progression|23|||
161575587|NCT00071799|583493598|FG001|Overall Study|Disease Progression|20|||
161575588|NCT00071799|583493597|FG000|Overall Study|Different Central+Local Pathology Review|0|||
161575589|NCT00071799|583493598|FG001|Overall Study|Different Central+Local Pathology Review|1|||
161575590|NCT00071799|583493597|FG000|Overall Study|Not Documented|0|||
161575591|NCT00071799|583493598|FG001|Overall Study|Not Documented|2|||
161575592|NCT00814346|583493599|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
161575593|NCT00814346|583493600|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
161575594|NCT00814346|583493599|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
161575595|NCT00814346|583493600|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
161575596|NCT00814346|583493599|FG000|Open Phase (17 Months)|Adverse Event|5|||
161575597|NCT00814346|583493600|FG001|Open Phase (17 Months)|Adverse Event|0|||
161575598|NCT00814346|583493599|FG000|Open Phase (17 Months)|Consent|2|||
161575599|NCT00814346|583493600|FG001|Open Phase (17 Months)|Consent|0|||
161575600|NCT00814346|583493599|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
161575601|NCT00814346|583493600|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
161575602|NCT00814346|583493599|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
161575603|NCT00814346|583493600|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
161575604|NCT00117286|583493608|FG000|Overall Study|Adverse Event|12|||
161575605|NCT00117286|583493609|FG001|Overall Study|Adverse Event|6|||
161575606|NCT00117286|583493608|FG000|Overall Study|Lost to Follow-up|2|||
161575607|NCT00117286|583493609|FG001|Overall Study|Lost to Follow-up|0|||
161575608|NCT00117286|583493608|FG000|Overall Study|Protocol Violation|3|||
161575609|NCT00117286|583493609|FG001|Overall Study|Protocol Violation|3|||
161575610|NCT00117286|583493608|FG000|Overall Study|Withdrawal by Subject|6|||
161575611|NCT00117286|583493609|FG001|Overall Study|Withdrawal by Subject|2|||
161575612|NCT00117286|583493608|FG000|Overall Study|Physician Decision|3|||
161575613|NCT00117286|583493609|FG001|Overall Study|Physician Decision|7|||
161575614|NCT00117286|583493608|FG000|Overall Study|Lack of Efficacy|2|||
161811667|NCT00163657|584353054|FG001|Overall Study|Non Compliance|0|||
161811668|NCT00163657|584353055|FG002|Overall Study|Non Compliance|0|||
161811669|NCT00163657|584353053|FG000|Overall Study|Lost to Follow-up|1|||
161811670|NCT00163657|584353054|FG001|Overall Study|Lost to Follow-up|3|||
161811671|NCT00163657|584353055|FG002|Overall Study|Lost to Follow-up|10|||
161811672|NCT00163657|584353053|FG000|Overall Study|Other reason|0|||
161811673|NCT00163657|584353054|FG001|Overall Study|Other reason|1|||
161811674|NCT00163657|584353055|FG002|Overall Study|Other reason|3|||
161811675|NCT01531894|584353056|FG000|Overall Study|Physician Decision|8|||
161811676|NCT01531894|584353056|FG000|Overall Study|Death|1|||
161811677|NCT03635320|584353057|FG000|Overall Study|not implanted the device|1|||
161811678|NCT03635320|584353058|FG001|Overall Study|not implanted the device|2|||
161811679|NCT03635320|584353057|FG000|Overall Study|Withdrawal by Subject|11|||
161811680|NCT03635320|584353058|FG001|Overall Study|Withdrawal by Subject|6|||
161811681|NCT01558635|584353059|FG000|Overall Study|Death|1|||
161811682|NCT01558635|584353059|FG000|Overall Study|Withdrawal by Subject|2|||
161811683|NCT01558635|584353059|FG000|Overall Study|Physician Decision|1|||
161811684|NCT01558635|584353059|FG000|Overall Study|Subject received other treatment|1|||
161811685|NCT01558635|584353059|FG000|Overall Study|Reveal XT was explanted|1|||
161811686|NCT04994535|584353060|FG000|Overall Study|Lost to Follow-up|7|||
161811687|NCT04994535|584353061|FG001|Overall Study|Lost to Follow-up|7|||
161575615|NCT00117286|583493609|FG001|Overall Study|Lack of Efficacy|1|||
161575616|NCT00117286|583493608|FG000|Overall Study|Research site closing|0|||
161575617|NCT00117286|583493609|FG001|Overall Study|Research site closing|2|||
161575618|NCT00189202|583493610|FG000|Overall Study|Physician Decision|5|||
161575619|NCT02798835|583493615|FG000|Overall Study|Protocol Violation|0|||
161575620|NCT02798835|583493616|FG001|Overall Study|Protocol Violation|0|||
161915589|NCT01366092|584739010|FG000|Overall Study|Withdrawal by Subject|1|||
161915590|NCT03353220|584739015|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
161915591|NCT03353220|584739016|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
161915592|NCT03586479|584739017|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
161915593|NCT03586479|584739018|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
161915594|NCT03586479|584739019|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
161915595|NCT03586479|584739017|FG000|Overall Study|Protocol Violation|2|||
161915596|NCT03586479|584739018|FG001|Overall Study|Protocol Violation|0|||
161915597|NCT03586479|584739019|FG002|Overall Study|Protocol Violation|0|||
161915598|NCT03586479|584739017|FG000|Overall Study|Lost to Follow-up|1|||
161915599|NCT03586479|584739018|FG001|Overall Study|Lost to Follow-up|1|||
161915600|NCT03586479|584739019|FG002|Overall Study|Lost to Follow-up|2|||
161915601|NCT03586479|584739017|FG000|Overall Study|Behavioral Issues|1|||
161915602|NCT03586479|584739018|FG001|Overall Study|Behavioral Issues|0|||
161915603|NCT03586479|584739019|FG002|Overall Study|Behavioral Issues|0|||
161915604|NCT00661388|584739021|FG000|Overall Study|Adverse Event|14|||
161915605|NCT00661388|584739021|FG000|Overall Study|Protocol Violation|7|||
161915606|NCT00661388|584739021|FG000|Overall Study|Renal transplantation|1|||
161915607|NCT00661388|584739021|FG000|Overall Study|Dialysis initiation|1|||
161915608|NCT00661388|584739021|FG000|Overall Study|Administrative reasons|1|||
161915609|NCT02472405|584740491|FG000|Overall Study|Lost to Follow-up|9|||
161915610|NCT02472405|584740491|FG000|Overall Study|Adverse Event|1|||
161915611|NCT03095287|584740492|FG000|Overall Study|Treatment Failure|1|||
161915612|NCT03095287|584740492|FG000|Overall Study|Adverse Event|1|||
161915613|NCT01431976|584740495|FG000|Overall Study|Adverse Event|6|||
161915614|NCT01431976|584740495|FG000|Overall Study|Lack of Efficacy|2|||
161915615|NCT01431976|584740495|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
161915616|NCT01431976|584740495|FG000|Overall Study|Physician Decision|1|||
161915617|NCT01431976|584740495|FG000|Overall Study|Withdrawal by Subject|1|||
161915618|NCT01294514|584740496|FG000|Overall Study|Excluded due to Arrhythmia|1|||
161915619|NCT01013753|584740503|FG000|Overall Study|Adverse Event|8|||
161915620|NCT01013753|584740503|FG000|Overall Study|Protocol Violation|3|||
161915621|NCT01013753|584740503|FG000|Overall Study|Lost to Follow-up|1|||
161915622|NCT01013753|584740503|FG000|Overall Study|Withdrawal by Subject|2|||
161468056|NCT00973349|583109556|FG011|Overall Study|Adverse Event|0|||
161468057|NCT00973349|583109557|FG012|Overall Study|Adverse Event|0|||
161468058|NCT00973349|583109558|FG013|Overall Study|Adverse Event|0|||
161468059|NCT00973349|583109559|FG014|Overall Study|Adverse Event|1|||
161468060|NCT00973349|583109560|FG015|Overall Study|Adverse Event|0|||
161915623|NCT01013753|584740503|FG000|Overall Study|Other|2|||
161468061|NCT00973349|583109545|FG000|Overall Study|Withdrawal by Subject|1|||
161468062|NCT00973349|583109546|FG001|Overall Study|Withdrawal by Subject|2|||
161468063|NCT00973349|583109547|FG002|Overall Study|Withdrawal by Subject|2|||
161915624|NCT05350423|584740504|FG000|Overall Study|Lost to Follow-up|3|||
161915625|NCT05350423|584740505|FG001|Overall Study|Lost to Follow-up|3|||
161811688|NCT04994535|584353060|FG000|Overall Study|Withdrawal by Subject|10|||
161811689|NCT04994535|584353061|FG001|Overall Study|Withdrawal by Subject|7|||
161811690|NCT04994535|584353060|FG000|Overall Study|Other|1|||
161811691|NCT04994535|584353061|FG001|Overall Study|Other|1|||
161811692|NCT01158118|584353062|FG000|Overall Study|Screen failure|1|||
161811693|NCT01158118|584353063|FG001|Overall Study|Screen failure|0|||
161811694|NCT01158118|584353062|FG000|Overall Study|Donor match was a screen failure|0|||
161811695|NCT01158118|584353063|FG001|Overall Study|Donor match was a screen failure|1|||
161811696|NCT01158118|584353062|FG000|Overall Study|Suffered stroke prior to transplant|0|||
161811697|NCT01158118|584353063|FG001|Overall Study|Suffered stroke prior to transplant|1|||
161811698|NCT01158118|584353062|FG000|Overall Study|Death|0|||
161811699|NCT01158118|584353063|FG001|Overall Study|Death|1|||
161811700|NCT00604162|584353064|FG000|Overall Study|Physician Decision|3|||
161811701|NCT00604162|584353064|FG000|Overall Study|Withdrawal by Subject|1|||
161811702|NCT00960297|584353076|FG000|Overall Study|Physician Decision|1|||
161811703|NCT00960297|584353076|FG000|Overall Study|Venous port infection|1|||
161811704|NCT00960297|584353076|FG000|Overall Study|Disease progression|1|||
161811705|NCT03247972|584353081|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
161811706|NCT03247972|584353081|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
161811707|NCT00968812|584353082|FG000|Overall Study|Adverse Event|30|||
161811708|NCT00968812|584353083|FG001|Overall Study|Adverse Event|46|||
161811709|NCT00968812|584353084|FG002|Overall Study|Adverse Event|33|||
161811710|NCT00968812|584353082|FG000|Overall Study|Death|2|||
161811711|NCT00968812|584353083|FG001|Overall Study|Death|2|||
161811712|NCT00968812|584353084|FG002|Overall Study|Death|1|||
161811713|NCT00968812|584353082|FG000|Overall Study|Lack of Efficacy|9|||
161811714|NCT00968812|584353083|FG001|Overall Study|Lack of Efficacy|7|||
161811715|NCT00968812|584353084|FG002|Overall Study|Lack of Efficacy|16|||
161811716|NCT00968812|584353082|FG000|Overall Study|Lost to Follow-up|17|||
161811717|NCT00968812|584353083|FG001|Overall Study|Lost to Follow-up|12|||
161811718|NCT00968812|584353084|FG002|Overall Study|Lost to Follow-up|11|||
161811719|NCT00968812|584353082|FG000|Overall Study|Physician Decision|8|||
161811720|NCT00968812|584353083|FG001|Overall Study|Physician Decision|5|||
161811721|NCT00968812|584353084|FG002|Overall Study|Physician Decision|9|||
161811722|NCT00968812|584353082|FG000|Overall Study|Protocol Violation|7|||
161811723|NCT00968812|584353083|FG001|Overall Study|Protocol Violation|4|||
161811724|NCT00968812|584353084|FG002|Overall Study|Protocol Violation|3|||
161811725|NCT00968812|584353082|FG000|Overall Study|Withdrawal by Subject|17|||
161811726|NCT00968812|584353083|FG001|Overall Study|Withdrawal by Subject|23|||
161811727|NCT00968812|584353084|FG002|Overall Study|Withdrawal by Subject|25|||
161811728|NCT00968812|584353082|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
161811729|NCT00968812|584353083|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
161811730|NCT00968812|584353084|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
161811731|NCT00968812|584353082|FG000|Overall Study|Noncompliance with study drug|4|||
161811732|NCT00968812|584353083|FG001|Overall Study|Noncompliance with study drug|1|||
161811733|NCT00968812|584353084|FG002|Overall Study|Noncompliance with study drug|6|||
161811734|NCT00968812|584353082|FG000|Overall Study|Unable to take rescue therapy|12|||
161915626|NCT05350423|584740504|FG000|Overall Study|screen failure|5|||
161915627|NCT05350423|584740505|FG001|Overall Study|screen failure|6|||
161915628|NCT02097277|584740506|FG000|Overall Study|Subject no longer meets study criteria|0|||
161915629|NCT02097277|584740507|FG001|Overall Study|Subject no longer meets study criteria|1|||
161915630|NCT02097277|584740508|FG002|Overall Study|Subject no longer meets study criteria|0|||
161915631|NCT02097277|584740509|FG003|Overall Study|Subject no longer meets study criteria|1|||
161915632|NCT02097277|584740510|FG004|Overall Study|Subject no longer meets study criteria|0|||
161915633|NCT02097277|584740506|FG000|Overall Study|Subject request to discontinue treatment|0|||
161915634|NCT02097277|584740507|FG001|Overall Study|Subject request to discontinue treatment|0|||
161915635|NCT02097277|584740508|FG002|Overall Study|Subject request to discontinue treatment|0|||
161915636|NCT02097277|584740509|FG003|Overall Study|Subject request to discontinue treatment|0|||
161915637|NCT02097277|584740510|FG004|Overall Study|Subject request to discontinue treatment|1|||
161915638|NCT02097277|584740506|FG000|Overall Study|Lost to Follow-up|0|||
161915639|NCT02097277|584740507|FG001|Overall Study|Lost to Follow-up|1|||
161915640|NCT02097277|584740508|FG002|Overall Study|Lost to Follow-up|1|||
161915641|NCT02097277|584740509|FG003|Overall Study|Lost to Follow-up|0|||
161915642|NCT02097277|584740510|FG004|Overall Study|Lost to Follow-up|0|||
161915643|NCT02097277|584740506|FG000|Overall Study|Withdrawal by Subject|2|||
161915644|NCT02097277|584740507|FG001|Overall Study|Withdrawal by Subject|1|||
161811735|NCT00968812|584353083|FG001|Overall Study|Unable to take rescue therapy|12|||
161811736|NCT00968812|584353084|FG002|Overall Study|Unable to take rescue therapy|17|||
161811737|NCT00968812|584353082|FG000|Overall Study|Other|25|||
161811738|NCT00968812|584353083|FG001|Overall Study|Other|37|||
161915645|NCT02097277|584740508|FG002|Overall Study|Withdrawal by Subject|0|||
161915646|NCT02097277|584740509|FG003|Overall Study|Withdrawal by Subject|1|||
161915647|NCT02097277|584740510|FG004|Overall Study|Withdrawal by Subject|0|||
161915648|NCT02097277|584740506|FG000|Overall Study|Adverse Event|0|||
161811739|NCT00968812|584353084|FG002|Overall Study|Other|40|||
161811740|NCT00834340|584353085|FG000|Washout|Adverse Event|1|||
161575621|NCT02798835|583493617|FG002|Overall Study|Protocol Violation|3|||
161575622|NCT03024606|583493622|FG000|Overall Study|Withdrawal by Subject|9|||
161575623|NCT03024606|583493623|FG001|Overall Study|Withdrawal by Subject|10|||
161575624|NCT01595061|583493634|FG000|Overall Study|Never Treated|3|||
161575625|NCT01595061|583493634|FG000|Overall Study|Inadequate Pathology|1|||
161575626|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
161575627|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161575628|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161575629|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161575630|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161575631|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
161575632|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161575633|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161575634|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161575635|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161575636|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
161575637|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161575638|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161575639|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161575640|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161575641|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
161575642|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161575643|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161575644|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161575645|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161575646|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
161575647|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161575648|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161575649|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161575650|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161575651|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
161575652|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161575653|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161575654|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161575655|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161575656|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
161668067|NCT00406653|583837482|FG006|Induction Period|Patient relocated|0|||
161915649|NCT02097277|584740507|FG001|Overall Study|Adverse Event|0|||
161468064|NCT00973349|583109548|FG003|Overall Study|Withdrawal by Subject|3|||
161468065|NCT00973349|583109549|FG004|Overall Study|Withdrawal by Subject|2|||
161468066|NCT00973349|583109550|FG005|Overall Study|Withdrawal by Subject|0|||
161468067|NCT00973349|583109551|FG006|Overall Study|Withdrawal by Subject|2|||
161468068|NCT00973349|583109552|FG007|Overall Study|Withdrawal by Subject|2|||
161468069|NCT00973349|583109553|FG008|Overall Study|Withdrawal by Subject|0|||
161468070|NCT00973349|583109554|FG009|Overall Study|Withdrawal by Subject|2|||
161468071|NCT00973349|583109555|FG010|Overall Study|Withdrawal by Subject|0|||
161468072|NCT00973349|583109556|FG011|Overall Study|Withdrawal by Subject|1|||
161468073|NCT00973349|583109557|FG012|Overall Study|Withdrawal by Subject|0|||
161468074|NCT00973349|583109558|FG013|Overall Study|Withdrawal by Subject|0|||
161468075|NCT00973349|583109559|FG014|Overall Study|Withdrawal by Subject|0|||
161468076|NCT00973349|583109560|FG015|Overall Study|Withdrawal by Subject|0|||
161468077|NCT00973349|583109545|FG000|Overall Study|Lost to Follow-up|3|||
161468078|NCT00973349|583109546|FG001|Overall Study|Lost to Follow-up|1|||
161468079|NCT00973349|583109547|FG002|Overall Study|Lost to Follow-up|2|||
161468080|NCT00973349|583109548|FG003|Overall Study|Lost to Follow-up|2|||
161468081|NCT00973349|583109549|FG004|Overall Study|Lost to Follow-up|1|||
161468082|NCT00973349|583109550|FG005|Overall Study|Lost to Follow-up|3|||
161468083|NCT00973349|583109551|FG006|Overall Study|Lost to Follow-up|0|||
161468084|NCT00973349|583109552|FG007|Overall Study|Lost to Follow-up|1|||
161468085|NCT00973349|583109553|FG008|Overall Study|Lost to Follow-up|2|||
161468086|NCT00973349|583109554|FG009|Overall Study|Lost to Follow-up|1|||
161468087|NCT00973349|583109555|FG010|Overall Study|Lost to Follow-up|0|||
161468088|NCT00973349|583109556|FG011|Overall Study|Lost to Follow-up|1|||
161468089|NCT00973349|583109557|FG012|Overall Study|Lost to Follow-up|0|||
161468090|NCT00973349|583109558|FG013|Overall Study|Lost to Follow-up|0|||
161575657|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161575658|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161468091|NCT00973349|583109559|FG014|Overall Study|Lost to Follow-up|0|||
161468092|NCT00973349|583109560|FG015|Overall Study|Lost to Follow-up|1|||
161468093|NCT00973349|583109545|FG000|Overall Study|Inappropriate enrolment|0|||
161468094|NCT00973349|583109546|FG001|Overall Study|Inappropriate enrolment|0|||
161468095|NCT00973349|583109547|FG002|Overall Study|Inappropriate enrolment|1|||
161575659|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161915650|NCT02097277|584740508|FG002|Overall Study|Adverse Event|1|||
161915651|NCT02097277|584740509|FG003|Overall Study|Adverse Event|2|||
161575660|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161575661|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
161575662|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161575663|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161575664|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161915652|NCT02097277|584740510|FG004|Overall Study|Adverse Event|0|||
161915653|NCT01461551|584740514|FG000|Overall Study|Physician Decision|2|||
161915654|NCT01461551|584740515|FG001|Overall Study|Physician Decision|1|||
161915655|NCT01461551|584740516|FG002|Overall Study|Physician Decision|2|||
161915656|NCT00303186|584740517|FG000|Overall Study|Other|52|||
161915657|NCT02326883|584740518|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
161915658|NCT02326883|584740519|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
161575665|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161915659|NCT02326883|584740520|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
161575666|NCT02709655|583493637|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
161915660|NCT01385176|584740521|FG000|Randomization Phase|Death|1|||
161915661|NCT01385176|584740522|FG001|Randomization Phase|Death|2|||
161915662|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Death|1|||
161915663|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Death|2|||
161468096|NCT00973349|583109548|FG003|Overall Study|Inappropriate enrolment|0|||
161468097|NCT00973349|583109549|FG004|Overall Study|Inappropriate enrolment|0|||
161468098|NCT00973349|583109550|FG005|Overall Study|Inappropriate enrolment|0|||
161468099|NCT00973349|583109551|FG006|Overall Study|Inappropriate enrolment|0|||
161468100|NCT00973349|583109552|FG007|Overall Study|Inappropriate enrolment|0|||
161468101|NCT00973349|583109553|FG008|Overall Study|Inappropriate enrolment|0|||
161468102|NCT00973349|583109554|FG009|Overall Study|Inappropriate enrolment|2|||
161468103|NCT00973349|583109555|FG010|Overall Study|Inappropriate enrolment|0|||
161468104|NCT00973349|583109556|FG011|Overall Study|Inappropriate enrolment|0|||
161468105|NCT00973349|583109557|FG012|Overall Study|Inappropriate enrolment|1|||
161468106|NCT00973349|583109558|FG013|Overall Study|Inappropriate enrolment|0|||
161468107|NCT00973349|583109559|FG014|Overall Study|Inappropriate enrolment|1|||
161468108|NCT00973349|583109560|FG015|Overall Study|Inappropriate enrolment|1|||
161468109|NCT00973349|583109545|FG000|Overall Study|Protocol Violation|0|||
161468110|NCT00973349|583109546|FG001|Overall Study|Protocol Violation|0|||
161468111|NCT00973349|583109547|FG002|Overall Study|Protocol Violation|0|||
161468112|NCT00973349|583109548|FG003|Overall Study|Protocol Violation|0|||
161468113|NCT00973349|583109549|FG004|Overall Study|Protocol Violation|0|||
161468114|NCT00973349|583109550|FG005|Overall Study|Protocol Violation|0|||
161468115|NCT00973349|583109551|FG006|Overall Study|Protocol Violation|0|||
161468116|NCT00973349|583109552|FG007|Overall Study|Protocol Violation|0|||
161468117|NCT00973349|583109553|FG008|Overall Study|Protocol Violation|1|||
161468118|NCT00973349|583109554|FG009|Overall Study|Protocol Violation|0|||
161468119|NCT00973349|583109555|FG010|Overall Study|Protocol Violation|0|||
161468120|NCT00973349|583109556|FG011|Overall Study|Protocol Violation|0|||
161468121|NCT00973349|583109557|FG012|Overall Study|Protocol Violation|0|||
161468122|NCT00973349|583109558|FG013|Overall Study|Protocol Violation|0|||
161468123|NCT00973349|583109559|FG014|Overall Study|Protocol Violation|0|||
161468124|NCT00973349|583109560|FG015|Overall Study|Protocol Violation|0|||
161468125|NCT00973349|583109545|FG000|Overall Study|Unable to classify|0|||
161468126|NCT00973349|583109546|FG001|Overall Study|Unable to classify|0|||
161468127|NCT00973349|583109547|FG002|Overall Study|Unable to classify|0|||
161468128|NCT00973349|583109548|FG003|Overall Study|Unable to classify|0|||
161468129|NCT00973349|583109549|FG004|Overall Study|Unable to classify|1|||
161468130|NCT00973349|583109550|FG005|Overall Study|Unable to classify|1|||
161468131|NCT00973349|583109551|FG006|Overall Study|Unable to classify|0|||
161468132|NCT00973349|583109552|FG007|Overall Study|Unable to classify|0|||
161468133|NCT00973349|583109553|FG008|Overall Study|Unable to classify|0|||
161468134|NCT00973349|583109554|FG009|Overall Study|Unable to classify|1|||
161468135|NCT00973349|583109555|FG010|Overall Study|Unable to classify|0|||
161468136|NCT00973349|583109556|FG011|Overall Study|Unable to classify|0|||
161468137|NCT00973349|583109557|FG012|Overall Study|Unable to classify|0|||
161468138|NCT00973349|583109558|FG013|Overall Study|Unable to classify|0|||
161468139|NCT00973349|583109559|FG014|Overall Study|Unable to classify|0|||
161468140|NCT00973349|583109560|FG015|Overall Study|Unable to classify|0|||
161468141|NCT02898116|583109561|FG000|Overall Study|Adverse Event|1|||
161468142|NCT02898116|583109561|FG000|Overall Study|Progressive disease|1|||
161468143|NCT00560885|583109573|FG000|Overall Study|Death|7|||
161468144|NCT00560885|583109573|FG000|Overall Study|Withdrawal by Subject|1|||
161468145|NCT03803683|583109574|FG000|Overall Study|Lost to Follow-up|41|||
161468146|NCT03803683|583109575|FG001|Overall Study|Lost to Follow-up|18|||
161468147|NCT03803683|583109576|FG002|Overall Study|Lost to Follow-up|12|||
161468148|NCT03803683|583109574|FG000|Overall Study|Withdrawal by Subject|9|||
161468149|NCT03803683|583109575|FG001|Overall Study|Withdrawal by Subject|1|||
161468150|NCT03803683|583109576|FG002|Overall Study|Withdrawal by Subject|4|||
161468151|NCT02206048|583111143|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
161468152|NCT02925923|583111144|FG000|Overall Study|blood samples hemolyzed|0|||
161468153|NCT02925923|583111145|FG001|Overall Study|blood samples hemolyzed|2|||
161468154|NCT00282412|583111146|FG000|Overall Study|Death|2|||
161468155|NCT00697073|583111147|FG000|Overall Study|Withdrawal by Subject|2|||
161468156|NCT00697073|583111147|FG000|Overall Study|Pregnancy|1|||
161468157|NCT00697073|583111147|FG000|Overall Study|non compliance and other|6|||
161468158|NCT00426231|583111148|FG000|Overall Study|Withdrawal by Subject|9|||
161468159|NCT00426231|583111149|FG001|Overall Study|Withdrawal by Subject|12|||
161468160|NCT03911713|583111150|FG000|Overall Study|Lost to Follow-up|0|||
161468161|NCT03911713|583111151|FG001|Overall Study|Lost to Follow-up|2|||
161468162|NCT03911713|583111152|FG002|Overall Study|Lost to Follow-up|0|||
161468163|NCT03911713|583111153|FG003|Overall Study|Lost to Follow-up|0|||
161468164|NCT03911713|583111154|FG004|Overall Study|Lost to Follow-up|0|||
161468165|NCT03911713|583111150|FG000|Overall Study|Other|0|||
161468166|NCT03911713|583111151|FG001|Overall Study|Other|0|||
161811741|NCT00834340|584353086|FG001|Washout|Adverse Event|0|||
161811742|NCT00834340|584353085|FG000|Washout|Withdrawal by Subject|1|||
161468167|NCT03911713|583111152|FG002|Overall Study|Other|0|||
161468168|NCT03911713|583111153|FG003|Overall Study|Other|1|||
161468169|NCT03911713|583111154|FG004|Overall Study|Other|0|||
161468170|NCT03911713|583111150|FG000|Overall Study|Randomized, Never Dosed|1|||
161468171|NCT03911713|583111151|FG001|Overall Study|Randomized, Never Dosed|0|||
161468172|NCT03911713|583111152|FG002|Overall Study|Randomized, Never Dosed|0|||
161811743|NCT00834340|584353086|FG001|Washout|Withdrawal by Subject|0|||
161811744|NCT00395694|584353087|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
161575667|NCT02709655|583493638|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161575668|NCT02709655|583493639|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161575669|NCT02709655|583493640|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161575670|NCT02709655|583493641|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161575671|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
161575672|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
161575673|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
161575674|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
161575675|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
161575676|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161575677|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
161575678|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161575679|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161575680|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
161575681|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
161575682|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
161575683|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
161575684|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
161575685|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
161575686|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161575687|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
161575688|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161575689|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161575690|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161575691|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
161575692|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161575693|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161575694|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161575695|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
161575696|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161575697|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
161668068|NCT00406653|583837476|FG000|Maintenance Period|Adverse Event|0|||
161811745|NCT00395694|584353088|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
161811746|NCT00395694|584353087|FG000|Continuation Phase|Adverse Event|1|||
161811747|NCT00395694|584353088|FG001|Continuation Phase|Adverse Event|0|||
161915664|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Physician Decision|0|||
161915665|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Physician Decision|1|||
161915666|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
161915667|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
161915668|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
161915669|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
161915670|NCT00284856|584740523|FG000|Overall Study|Adverse Event|3|||
161915671|NCT00284856|584740524|FG001|Overall Study|Adverse Event|3|||
161915672|NCT00284856|584740525|FG002|Overall Study|Adverse Event|3|||
161915673|NCT00284856|584740523|FG000|Overall Study|Lack of Efficacy|2|||
161915674|NCT00284856|584740524|FG001|Overall Study|Lack of Efficacy|1|||
161915675|NCT00284856|584740525|FG002|Overall Study|Lack of Efficacy|8|||
161915676|NCT00284856|584740523|FG000|Overall Study|Lost to Follow-up|25|||
161915677|NCT00284856|584740524|FG001|Overall Study|Lost to Follow-up|21|||
161915678|NCT00284856|584740525|FG002|Overall Study|Lost to Follow-up|22|||
161915679|NCT00284856|584740523|FG000|Overall Study|Protocol Violation|5|||
161915680|NCT00284856|584740524|FG001|Overall Study|Protocol Violation|4|||
161915681|NCT00284856|584740525|FG002|Overall Study|Protocol Violation|5|||
161915682|NCT00284856|584740523|FG000|Overall Study|Withdrawal by Subject|12|||
161915683|NCT00284856|584740524|FG001|Overall Study|Withdrawal by Subject|16|||
161811748|NCT00395694|584353087|FG000|Continuation Phase|Lack of Efficacy|12|||
161811749|NCT00395694|584353088|FG001|Continuation Phase|Lack of Efficacy|11|||
161811750|NCT00395694|584353087|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
161811751|NCT00395694|584353088|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
161811752|NCT00395694|584353087|FG000|Continuation Phase|Poor Compliance|1|||
161811753|NCT00395694|584353088|FG001|Continuation Phase|Poor Compliance|0|||
161915684|NCT00284856|584740525|FG002|Overall Study|Withdrawal by Subject|18|||
161915685|NCT00284856|584740523|FG000|Overall Study|Other|4|||
161915686|NCT00284856|584740524|FG001|Overall Study|Other|5|||
161915687|NCT00284856|584740525|FG002|Overall Study|Other|4|||
161915688|NCT01056536|584740526|FG000|Overall Study|Lost to Follow-up|202|||
161915689|NCT01056536|584740527|FG001|Overall Study|Lost to Follow-up|116|||
161915690|NCT01056536|584740528|FG002|Overall Study|Lost to Follow-up|248|||
161915691|NCT05853120|584740529|FG000|Overall Study|Lost to Follow-up|4|||
161468173|NCT03911713|583111153|FG003|Overall Study|Randomized, Never Dosed|1|||
161468174|NCT03911713|583111154|FG004|Overall Study|Randomized, Never Dosed|0|||
161468175|NCT00108433|583111155|FG000|Overall Study|Lack of Efficacy|1|||
161468176|NCT00108433|583111156|FG001|Overall Study|Lack of Efficacy|2|||
161468177|NCT00108433|583111155|FG000|Overall Study|Death|3|||
161468178|NCT00108433|583111156|FG001|Overall Study|Death|0|||
161468179|NCT00108433|583111155|FG000|Overall Study|Adverse Event|3|||
161468180|NCT00108433|583111156|FG001|Overall Study|Adverse Event|1|||
161468181|NCT00108433|583111155|FG000|Overall Study|Other|14|||
161468182|NCT00108433|583111156|FG001|Overall Study|Other|14|||
161468183|NCT01193660|583111157|FG000|Overall Study|Withdrawal by Subject|2|||
161468184|NCT01193660|583111158|FG001|Overall Study|Withdrawal by Subject|3|||
161468185|NCT01193660|583111159|FG002|Overall Study|Withdrawal by Subject|1|||
161468186|NCT01193660|583111157|FG000|Overall Study|Death|1|||
161468187|NCT01193660|583111158|FG001|Overall Study|Death|0|||
161468188|NCT01193660|583111159|FG002|Overall Study|Death|0|||
161468189|NCT01193660|583111157|FG000|Overall Study|Physician Decision|1|||
161468190|NCT01193660|583111158|FG001|Overall Study|Physician Decision|0|||
161468191|NCT01193660|583111159|FG002|Overall Study|Physician Decision|1|||
161468192|NCT01886716|583111160|FG000|Week 1|Lost to Follow-up|0|||
161468193|NCT01886716|583111161|FG001|Week 1|Lost to Follow-up|0|||
161468194|NCT01886716|583111162|FG002|Week 1|Lost to Follow-up|2|||
161468195|NCT01886716|583111163|FG003|Week 1|Lost to Follow-up|2|||
161468196|NCT01886716|583111160|FG000|Week 2|Lost to Follow-up|3|||
161468197|NCT01886716|583111161|FG001|Week 2|Lost to Follow-up|2|||
161468198|NCT01886716|583111162|FG002|Week 2|Lost to Follow-up|1|||
161468199|NCT01886716|583111163|FG003|Week 2|Lost to Follow-up|3|||
161468200|NCT01886716|583111160|FG000|Week 3|Lost to Follow-up|1|||
161468201|NCT01886716|583111161|FG001|Week 3|Lost to Follow-up|1|||
161468202|NCT01886716|583111162|FG002|Week 3|Lost to Follow-up|0|||
161468203|NCT01886716|583111163|FG003|Week 3|Lost to Follow-up|1|||
161468204|NCT02572388|583111164|FG000|Overall Study|Withdrawal by Subject|1|||
161468205|NCT02572388|583111165|FG001|Overall Study|Withdrawal by Subject|1|||
161468206|NCT02572388|583111166|FG002|Overall Study|Withdrawal by Subject|2|||
161468207|NCT02572388|583111167|FG003|Overall Study|Withdrawal by Subject|2|||
161468208|NCT04806503|583111173|FG000|Overall Study|Lost to Follow-up|0|||
161468209|NCT04806503|583111174|FG001|Overall Study|Lost to Follow-up|0|||
161468210|NCT04806503|583111175|FG002|Overall Study|Lost to Follow-up|1|||
161468211|NCT04806503|583111176|FG003|Overall Study|Lost to Follow-up|0|||
161468212|NCT04806503|583111177|FG004|Overall Study|Lost to Follow-up|0|||
161575698|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161575699|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
161575700|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161575701|NCT02709655|583493637|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
161575702|NCT02709655|583493638|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
161668069|NCT00406653|583837477|FG001|Maintenance Period|Adverse Event|0|||
161811754|NCT00395694|584353087|FG000|Continuation Phase|Withdrawal by Subject|0|||
161811755|NCT00395694|584353088|FG001|Continuation Phase|Withdrawal by Subject|2|||
161811756|NCT04238754|584353092|FG000|Washout - 1 Week|Lost to Follow-up|1|||
161811757|NCT04238754|584353093|FG001|Washout - 1 Week|Lost to Follow-up|0|||
161811758|NCT01175018|584353097|FG000|Overall Study|Adverse Event|3|||
161811759|NCT01175018|584353098|FG001|Overall Study|Adverse Event|1|||
161811760|NCT01788423|584353104|FG000|Overall Study|See Comments in Completed (above)|0|||
161811761|NCT01788423|584353105|FG001|Overall Study|See Comments in Completed (above)|4|||
161811762|NCT01788423|584353106|FG002|Overall Study|See Comments in Completed (above)|5|||
161811763|NCT00835263|584353107|FG000|Second Intervention|Adverse Event|1|||
161811764|NCT00835263|584353108|FG001|Second Intervention|Adverse Event|0|||
161811765|NCT03249454|584353109|FG000|Overall Study|Withdrawal by Subject|0|||
161811766|NCT03249454|584353110|FG001|Overall Study|Withdrawal by Subject|0|||
161811767|NCT03249454|584353111|FG002|Overall Study|Withdrawal by Subject|0|||
161811768|NCT03249454|584353112|FG003|Overall Study|Withdrawal by Subject|0|||
161811769|NCT03249454|584353113|FG004|Overall Study|Withdrawal by Subject|0|||
161811770|NCT03249454|584353114|FG005|Overall Study|Withdrawal by Subject|0|||
161811771|NCT03249454|584353115|FG006|Overall Study|Withdrawal by Subject|0|||
161811772|NCT03249454|584353116|FG007|Overall Study|Withdrawal by Subject|0|||
161811773|NCT03249454|584353117|FG008|Overall Study|Withdrawal by Subject|0|||
161811774|NCT03249454|584353118|FG009|Overall Study|Withdrawal by Subject|1|||
161811775|NCT03249454|584353119|FG010|Overall Study|Withdrawal by Subject|1|||
161811776|NCT03987191|584353122|FG000|Overall Study|COVID-19 related research disruption|0|||
161811777|NCT03987191|584353123|FG001|Overall Study|COVID-19 related research disruption|2|||
161811778|NCT01020474|584353124|FG000|Overall Study|Adverse Event|4|||
161468213|NCT04806503|583111173|FG000|Overall Study|Withdrawal by Subject|1|||
161468214|NCT04806503|583111174|FG001|Overall Study|Withdrawal by Subject|0|||
161468215|NCT04806503|583111175|FG002|Overall Study|Withdrawal by Subject|1|||
161468216|NCT04806503|583111176|FG003|Overall Study|Withdrawal by Subject|1|||
161468217|NCT04806503|583111177|FG004|Overall Study|Withdrawal by Subject|1|||
161468218|NCT04806503|583111173|FG000|Overall Study|Adverse Event|1|||
161468219|NCT04806503|583111174|FG001|Overall Study|Adverse Event|1|||
161575703|NCT02709655|583493639|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
161575704|NCT02709655|583493640|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
161575705|NCT02709655|583493641|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
161575706|NCT00102063|583493642|FG000|Overall Study|Lack of Efficacy|5|||
161575707|NCT00102063|583493643|FG001|Overall Study|Lack of Efficacy|1|||
161575708|NCT00102063|583493644|FG002|Overall Study|Lack of Efficacy|1|||
161575709|NCT00102063|583493642|FG000|Overall Study|Adverse Event|7|||
161575710|NCT00102063|583493643|FG001|Overall Study|Adverse Event|4|||
161575711|NCT00102063|583493644|FG002|Overall Study|Adverse Event|2|||
161575712|NCT00102063|583493642|FG000|Overall Study|Withdrawal by Subject|4|||
161575713|NCT00102063|583493643|FG001|Overall Study|Withdrawal by Subject|12|||
161575714|NCT00102063|583493644|FG002|Overall Study|Withdrawal by Subject|5|||
161575715|NCT00102063|583493642|FG000|Overall Study|Lost to Follow-up|0|||
161575716|NCT00102063|583493643|FG001|Overall Study|Lost to Follow-up|0|||
161575717|NCT00102063|583493644|FG002|Overall Study|Lost to Follow-up|1|||
161575718|NCT00102063|583493642|FG000|Overall Study|Protocol Violation|0|||
161575719|NCT00102063|583493643|FG001|Overall Study|Protocol Violation|1|||
161575720|NCT00102063|583493644|FG002|Overall Study|Protocol Violation|1|||
161575721|NCT00857649|583493645|FG000|Overall Study|Adverse Event|15|||
161575722|NCT00857649|583493646|FG001|Overall Study|Adverse Event|10|||
161575723|NCT00857649|583493645|FG000|Overall Study|Non-compliance|1|||
161575724|NCT00857649|583493646|FG001|Overall Study|Non-compliance|1|||
161575725|NCT00857649|583493645|FG000|Overall Study|Protocol Violation|2|||
161575726|NCT00857649|583493646|FG001|Overall Study|Protocol Violation|2|||
161575727|NCT00857649|583493645|FG000|Overall Study|Withdrawal of Consent|10|||
161575728|NCT00857649|583493646|FG001|Overall Study|Withdrawal of Consent|7|||
161468220|NCT04806503|583111175|FG002|Overall Study|Adverse Event|0|||
161468221|NCT04806503|583111176|FG003|Overall Study|Adverse Event|1|||
161468222|NCT04806503|583111177|FG004|Overall Study|Adverse Event|0|||
161468223|NCT03589469|583111178|FG000|Overall Study|Withdrawal by Subject|8|||
161468224|NCT03589469|583111178|FG000|Overall Study|Physician Decision|20|||
161468225|NCT03589469|583111178|FG000|Overall Study|Death|97|||
161468226|NCT03589469|583111178|FG000|Overall Study|Lost to Follow-up|8|||
161468227|NCT03589469|583111178|FG000|Overall Study|Miscellaneous|1|||
161468228|NCT02202837|583111181|FG000|Overall Study|Enbrel treatment discontinued|36|||
161468229|NCT02202837|583111182|FG001|Overall Study|Enbrel treatment discontinued|4|||
161468230|NCT02202837|583111181|FG000|Overall Study|Other|10|||
161468231|NCT02202837|583111182|FG001|Overall Study|Other|0|||
161468232|NCT02202837|583111181|FG000|Overall Study|Lost to Follow-up|7|||
161468233|NCT02202837|583111182|FG001|Overall Study|Lost to Follow-up|1|||
161468234|NCT00639678|583111185|FG000|Overall Study|Withdrawal by Subject|3|||
161468235|NCT00639678|583111186|FG001|Overall Study|Withdrawal by Subject|0|||
161468236|NCT00639678|583111187|FG002|Overall Study|Withdrawal by Subject|4|||
161468237|NCT00639678|583111188|FG003|Overall Study|Withdrawal by Subject|0|||
161468238|NCT00639678|583111185|FG000|Overall Study|Lost to Follow-up|1|||
161468239|NCT00639678|583111186|FG001|Overall Study|Lost to Follow-up|0|||
161468240|NCT00639678|583111187|FG002|Overall Study|Lost to Follow-up|6|||
161468241|NCT00639678|583111188|FG003|Overall Study|Lost to Follow-up|0|||
161468242|NCT00639678|583111185|FG000|Overall Study|Adverse Event|0|||
161468243|NCT00639678|583111186|FG001|Overall Study|Adverse Event|1|||
161468244|NCT00639678|583111187|FG002|Overall Study|Adverse Event|0|||
161468245|NCT00639678|583111188|FG003|Overall Study|Adverse Event|0|||
161468246|NCT00639678|583111185|FG000|Overall Study|Lack of Compliance|0|||
161468247|NCT00639678|583111186|FG001|Overall Study|Lack of Compliance|0|||
161468248|NCT00639678|583111187|FG002|Overall Study|Lack of Compliance|1|||
161468249|NCT00639678|583111188|FG003|Overall Study|Lack of Compliance|0|||
161468250|NCT01973569|583111189|FG000|Overall Study|Adverse Event|9|||
161468251|NCT01973569|583111190|FG001|Overall Study|Adverse Event|2|||
161468252|NCT01973569|583111191|FG002|Overall Study|Adverse Event|4|||
161468253|NCT01973569|583111189|FG000|Overall Study|Protocol Violation|2|||
161468254|NCT01973569|583111190|FG001|Overall Study|Protocol Violation|1|||
161811779|NCT01020474|584353125|FG001|Overall Study|Adverse Event|4|||
161811780|NCT01020474|584353124|FG000|Overall Study|Protocol Violation|0|||
161811781|NCT01020474|584353125|FG001|Overall Study|Protocol Violation|2|||
161811782|NCT01020474|584353124|FG000|Overall Study|Withdrawal by Subject|5|||
161468255|NCT01973569|583111191|FG002|Overall Study|Protocol Violation|3|||
161468256|NCT01973569|583111189|FG000|Overall Study|Withdrawal by Subject|7|||
161811783|NCT01020474|584353125|FG001|Overall Study|Withdrawal by Subject|7|||
161811784|NCT01020474|584353124|FG000|Overall Study|Other Reasons|1|||
161811785|NCT01020474|584353125|FG001|Overall Study|Other Reasons|1|||
161811786|NCT01020474|584353124|FG000|Overall Study|Insufficient Clinical Response|0|||
161811787|NCT01020474|584353125|FG001|Overall Study|Insufficient Clinical Response|3|||
161811788|NCT03256695|584353127|FG000|Overall Study|Adverse Event|8|||
161811789|NCT03256695|584353127|FG000|Overall Study|Death|2|||
161811790|NCT03256695|584353127|FG000|Overall Study|Withdrawal by Subject|14|||
161811791|NCT03256695|584353127|FG000|Overall Study|Non-compliance with study drug|1|||
161811792|NCT03256695|584353127|FG000|Overall Study|Lost to Follow-up|3|||
161468257|NCT01973569|583111190|FG001|Overall Study|Withdrawal by Subject|5|||
161468258|NCT01973569|583111191|FG002|Overall Study|Withdrawal by Subject|2|||
161468259|NCT01973569|583111189|FG000|Overall Study|Invasive dental treatment|3|||
161468260|NCT01973569|583111190|FG001|Overall Study|Invasive dental treatment|5|||
161468261|NCT01973569|583111191|FG002|Overall Study|Invasive dental treatment|6|||
161468262|NCT01973569|583111189|FG000|Overall Study|Prohibited concomitant d|1|||
161468263|NCT01973569|583111190|FG001|Overall Study|Prohibited concomitant d|5|||
161468264|NCT01973569|583111191|FG002|Overall Study|Prohibited concomitant d|0|||
161468265|NCT01973569|583111189|FG000|Overall Study|Disease progression|0|||
161468266|NCT01973569|583111190|FG001|Overall Study|Disease progression|3|||
161468267|NCT01973569|583111191|FG002|Overall Study|Disease progression|0|||
161468268|NCT01973569|583111189|FG000|Overall Study|Other|1|||
161468269|NCT01973569|583111190|FG001|Overall Study|Other|1|||
161468270|NCT01973569|583111191|FG002|Overall Study|Other|0|||
161468271|NCT01973569|583111189|FG000|Overall Study|Did not receive study drug|6|||
161468272|NCT01973569|583111190|FG001|Overall Study|Did not receive study drug|3|||
161468273|NCT01973569|583111191|FG002|Overall Study|Did not receive study drug|3|||
161468274|NCT00371826|583111192|FG000|Core Phase (12 Months)|Adverse Event|15|||
161468275|NCT00371826|583111193|FG001|Core Phase (12 Months)|Adverse Event|4|||
161468276|NCT00371826|583111194|FG002|Core Phase (12 Months)|Adverse Event|9|||
161468277|NCT00371826|583111192|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
161468278|NCT00371826|583111193|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
161468279|NCT00371826|583111194|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
161468280|NCT00371826|583111192|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
161468281|NCT00371826|583111193|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
161468282|NCT00371826|583111194|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
161468283|NCT00371826|583111192|FG000|Core Phase (12 Months)|Protocol Violation|1|||
161468284|NCT00371826|583111193|FG001|Core Phase (12 Months)|Protocol Violation|0|||
161468285|NCT00371826|583111194|FG002|Core Phase (12 Months)|Protocol Violation|1|||
161468286|NCT00371826|583111192|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
161468287|NCT00371826|583111193|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
161468288|NCT00371826|583111194|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
161468289|NCT00371826|583111192|FG000|Core Phase (12 Months)|Administrative problems|1|||
161468290|NCT00371826|583111193|FG001|Core Phase (12 Months)|Administrative problems|0|||
161468291|NCT00371826|583111194|FG002|Core Phase (12 Months)|Administrative problems|8|||
161468292|NCT00371826|583111192|FG000|Core Phase (12 Months)|Graft Loss|0|||
161468293|NCT00371826|583111193|FG001|Core Phase (12 Months)|Graft Loss|1|||
161468294|NCT00371826|583111194|FG002|Core Phase (12 Months)|Graft Loss|0|||
161468295|NCT00371826|583111192|FG000|Extension Phase (24 Months)|Adverse Event|4|||
161468296|NCT00371826|583111193|FG001|Extension Phase (24 Months)|Adverse Event|5|||
161468297|NCT00371826|583111194|FG002|Extension Phase (24 Months)|Adverse Event|0|||
161468298|NCT00371826|583111192|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
161575729|NCT00857649|583493645|FG000|Overall Study|Nursing Home Placement|2|||
161575730|NCT00857649|583493646|FG001|Overall Study|Nursing Home Placement|9|||
161575731|NCT00857649|583493645|FG000|Overall Study|Other Reasons|1|||
161575732|NCT00857649|583493646|FG001|Overall Study|Other Reasons|3|||
161575733|NCT03388632|583493654|FG000|Triplet C|Clinical progression|0|||
161575734|NCT03388632|583493655|FG001|Triplet C|Clinical progression|0|||
161575735|NCT03388632|583493656|FG002|Triplet C|Clinical progression|0|||
161575736|NCT03388632|583493657|FG003|Triplet C|Clinical progression|0|||
161575737|NCT03388632|583493658|FG004|Triplet C|Clinical progression|1|||
161575738|NCT03388632|583493659|FG005|Triplet C|Clinical progression|0|||
161575739|NCT03388632|583493660|FG006|Triplet C|Clinical progression|0|||
161575740|NCT03388632|583493661|FG007|Triplet C|Clinical progression|0|||
161575741|NCT03388632|583493662|FG008|Triplet C|Clinical progression|0|||
161575742|NCT03388632|583493654|FG000|Triplet C|42-day lapse in tx|0|||
161575743|NCT03388632|583493655|FG001|Triplet C|42-day lapse in tx|0|||
161575744|NCT03388632|583493656|FG002|Triplet C|42-day lapse in tx|0|||
161575745|NCT03388632|583493657|FG003|Triplet C|42-day lapse in tx|0|||
161575746|NCT03388632|583493658|FG004|Triplet C|42-day lapse in tx|1|||
161575747|NCT03388632|583493659|FG005|Triplet C|42-day lapse in tx|0|||
161575748|NCT03388632|583493660|FG006|Triplet C|42-day lapse in tx|0|||
161575749|NCT03388632|583493661|FG007|Triplet C|42-day lapse in tx|0|||
161575750|NCT03388632|583493662|FG008|Triplet C|42-day lapse in tx|0|||
161575751|NCT03388632|583493654|FG000|Triplet C|Adverse Event|0|||
161575752|NCT03388632|583493655|FG001|Triplet C|Adverse Event|0|||
161468299|NCT00371826|583111193|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
161468300|NCT00371826|583111194|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
161468301|NCT00371826|583111192|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
161575753|NCT03388632|583493656|FG002|Triplet C|Adverse Event|0|||
161575754|NCT03388632|583493657|FG003|Triplet C|Adverse Event|0|||
161468302|NCT00371826|583111193|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
161575755|NCT03388632|583493658|FG004|Triplet C|Adverse Event|0|||
161575756|NCT03388632|583493659|FG005|Triplet C|Adverse Event|0|||
161468303|NCT00371826|583111194|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
161468304|NCT00371826|583111192|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
161468305|NCT00371826|583111193|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
161468306|NCT00371826|583111194|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
161575757|NCT03388632|583493660|FG006|Triplet C|Adverse Event|0|||
161575758|NCT03388632|583493661|FG007|Triplet C|Adverse Event|0|||
161575759|NCT03388632|583493662|FG008|Triplet C|Adverse Event|1|||
161575760|NCT03388632|583493654|FG000|Triplet C|Switched to alternative treatment|0|||
161915692|NCT05853120|584740530|FG001|Overall Study|Lost to Follow-up|4|||
161915693|NCT05853120|584740529|FG000|Overall Study|Physician Decision|3|||
161915694|NCT05853120|584740530|FG001|Overall Study|Physician Decision|0|||
161915695|NCT05853120|584740529|FG000|Overall Study|Withdrawal by Subject|5|||
161915696|NCT05853120|584740530|FG001|Overall Study|Withdrawal by Subject|2|||
161915697|NCT00790036|584740531|FG000|Overall Study|Abnormal lab values|3|||
161915698|NCT00790036|584740532|FG001|Overall Study|Abnormal lab values|2|||
161468307|NCT00371826|583111192|FG000|Extension Phase (24 Months)|Administrative problems|0|||
161468308|NCT00371826|583111193|FG001|Extension Phase (24 Months)|Administrative problems|0|||
161468309|NCT00371826|583111194|FG002|Extension Phase (24 Months)|Administrative problems|2|||
161468310|NCT05061966|583111195|FG000|Overall Study|Lost to Follow-up|13|||
161468311|NCT05061966|583111196|FG001|Overall Study|Lost to Follow-up|13|||
161468312|NCT02923427|583111197|FG000|Overall Study|convert to laparatomy|2|||
161468313|NCT02923427|583111198|FG001|Overall Study|convert to laparatomy|2|||
161468314|NCT02923427|583111197|FG000|Overall Study|destaturation|1|||
161468315|NCT02923427|583111198|FG001|Overall Study|destaturation|0|||
161468316|NCT02923427|583111197|FG000|Overall Study|can not replace LMA|1|||
161468317|NCT02923427|583111198|FG001|Overall Study|can not replace LMA|0|||
161468318|NCT01539642|583111203|FG000|Overall Study|Lack of Efficacy|20|||
161468319|NCT01539642|583111204|FG001|Overall Study|Lack of Efficacy|18|||
161468320|NCT01539642|583111203|FG000|Overall Study|Patient ready for early discharge|8|||
161468321|NCT01539642|583111204|FG001|Overall Study|Patient ready for early discharge|7|||
161468322|NCT01539642|583111203|FG000|Overall Study|Adverse Event|6|||
161468323|NCT01539642|583111204|FG001|Overall Study|Adverse Event|4|||
161468324|NCT01539642|583111203|FG000|Overall Study|Withdrawal by Subject|2|||
161468325|NCT01539642|583111204|FG001|Overall Study|Withdrawal by Subject|2|||
161468326|NCT03611010|583111205|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
161468327|NCT03611010|583111206|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
161468328|NCT03611010|583111207|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
161468329|NCT03611010|583111208|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
161468330|NCT00598702|583111209|FG000|Overall Study|Other|0|||
161468331|NCT00598702|583111210|FG001|Overall Study|Other|2|||
161468332|NCT00598702|583111211|FG002|Overall Study|Other|0|||
161468333|NCT00598702|583111212|FG003|Overall Study|Other|0|||
161468334|NCT00598702|583111213|FG004|Overall Study|Other|0|||
161468335|NCT00598702|583111214|FG005|Overall Study|Other|1|||
161468336|NCT00598702|583111215|FG006|Overall Study|Other|0|||
161468337|NCT00598702|583111216|FG007|Overall Study|Other|0|||
161468338|NCT00598702|583111209|FG000|Overall Study|Early discharge from hospital|0|||
161468339|NCT00598702|583111210|FG001|Overall Study|Early discharge from hospital|0|||
161468340|NCT00598702|583111211|FG002|Overall Study|Early discharge from hospital|2|||
161468341|NCT00598702|583111212|FG003|Overall Study|Early discharge from hospital|5|||
161468342|NCT00598702|583111213|FG004|Overall Study|Early discharge from hospital|0|||
161468343|NCT00598702|583111214|FG005|Overall Study|Early discharge from hospital|10|||
161468344|NCT00598702|583111215|FG006|Overall Study|Early discharge from hospital|1|||
161468345|NCT00598702|583111216|FG007|Overall Study|Early discharge from hospital|0|||
161468346|NCT00598702|583111209|FG000|Overall Study|Adverse Event|0|||
161468347|NCT00598702|583111210|FG001|Overall Study|Adverse Event|0|||
161468348|NCT00598702|583111211|FG002|Overall Study|Adverse Event|0|||
161468349|NCT00598702|583111212|FG003|Overall Study|Adverse Event|1|||
161468350|NCT00598702|583111213|FG004|Overall Study|Adverse Event|0|||
161468351|NCT00598702|583111214|FG005|Overall Study|Adverse Event|0|||
161468352|NCT00598702|583111215|FG006|Overall Study|Adverse Event|0|||
161468353|NCT00598702|583111216|FG007|Overall Study|Adverse Event|0|||
161468354|NCT00598702|583111209|FG000|Overall Study|Withdrawal by Subject|0|||
161468355|NCT00598702|583111210|FG001|Overall Study|Withdrawal by Subject|0|||
161468356|NCT00598702|583111211|FG002|Overall Study|Withdrawal by Subject|0|||
161468357|NCT00598702|583111212|FG003|Overall Study|Withdrawal by Subject|1|||
161468358|NCT00598702|583111213|FG004|Overall Study|Withdrawal by Subject|1|||
161468359|NCT00598702|583111214|FG005|Overall Study|Withdrawal by Subject|0|||
161468360|NCT00598702|583111215|FG006|Overall Study|Withdrawal by Subject|0|||
161468361|NCT00598702|583111216|FG007|Overall Study|Withdrawal by Subject|0|||
161468362|NCT00598702|583111209|FG000|Overall Study|Physician Decision|0|||
161468363|NCT00598702|583111210|FG001|Overall Study|Physician Decision|0|||
161668070|NCT00406653|583837478|FG002|Maintenance Period|Adverse Event|0|||
161468364|NCT00598702|583111211|FG002|Overall Study|Physician Decision|0|||
161468365|NCT00598702|583111212|FG003|Overall Study|Physician Decision|0|||
161915699|NCT00790036|584740531|FG000|Overall Study|Administrative problems|5|||
161468366|NCT00598702|583111213|FG004|Overall Study|Physician Decision|1|||
161468367|NCT00598702|583111214|FG005|Overall Study|Physician Decision|0|||
161468368|NCT00598702|583111215|FG006|Overall Study|Physician Decision|0|||
161468369|NCT00598702|583111216|FG007|Overall Study|Physician Decision|0|||
161468370|NCT00598702|583111209|FG000|Overall Study|Dose limiting toxicity|0|||
161468371|NCT00598702|583111210|FG001|Overall Study|Dose limiting toxicity|0|||
161468372|NCT00598702|583111211|FG002|Overall Study|Dose limiting toxicity|0|||
161468373|NCT00598702|583111212|FG003|Overall Study|Dose limiting toxicity|1|||
161468374|NCT00598702|583111213|FG004|Overall Study|Dose limiting toxicity|1|||
161468375|NCT00598702|583111214|FG005|Overall Study|Dose limiting toxicity|1|||
161468376|NCT00598702|583111215|FG006|Overall Study|Dose limiting toxicity|0|||
161468377|NCT00598702|583111216|FG007|Overall Study|Dose limiting toxicity|0|||
161468378|NCT02413372|583111220|FG000|Treatment|Lost to Follow-up|0|||
161468379|NCT02413372|583111221|FG001|Treatment|Lost to Follow-up|2|||
161468380|NCT02413372|583111222|FG002|Treatment|Lost to Follow-up|1|||
161468381|NCT02413372|583111220|FG000|Treatment|Withdrawal by Subject|1|||
161468382|NCT02413372|583111221|FG001|Treatment|Withdrawal by Subject|0|||
161468383|NCT02413372|583111222|FG002|Treatment|Withdrawal by Subject|0|||
161468384|NCT02413372|583111220|FG000|Follow-up|Lost to Follow-up|1|||
161468385|NCT02413372|583111221|FG001|Follow-up|Lost to Follow-up|1|||
161468386|NCT02413372|583111222|FG002|Follow-up|Lost to Follow-up|0|||
161468387|NCT02413372|583111220|FG000|Follow-up|Subject Withdrew Consent|1|||
161468388|NCT02413372|583111221|FG001|Follow-up|Subject Withdrew Consent|0|||
161575761|NCT03388632|583493655|FG001|Triplet C|Switched to alternative treatment|0|||
161575762|NCT03388632|583493656|FG002|Triplet C|Switched to alternative treatment|0|||
161575763|NCT03388632|583493657|FG003|Triplet C|Switched to alternative treatment|0|||
161575764|NCT03388632|583493658|FG004|Triplet C|Switched to alternative treatment|0|||
161575765|NCT03388632|583493659|FG005|Triplet C|Switched to alternative treatment|0|||
161575766|NCT03388632|583493660|FG006|Triplet C|Switched to alternative treatment|0|||
161575767|NCT03388632|583493661|FG007|Triplet C|Switched to alternative treatment|1|||
161575768|NCT03388632|583493662|FG008|Triplet C|Switched to alternative treatment|0|||
161575769|NCT03388632|583493654|FG000|Triplet C|Participant choice|0|||
161575770|NCT03388632|583493655|FG001|Triplet C|Participant choice|0|||
161575771|NCT03388632|583493656|FG002|Triplet C|Participant choice|0|||
161575772|NCT03388632|583493657|FG003|Triplet C|Participant choice|0|||
161575773|NCT03388632|583493658|FG004|Triplet C|Participant choice|0|||
161575774|NCT03388632|583493659|FG005|Triplet C|Participant choice|1|||
161575775|NCT03388632|583493660|FG006|Triplet C|Participant choice|0|||
161575776|NCT03388632|583493661|FG007|Triplet C|Participant choice|0|||
161575777|NCT03388632|583493662|FG008|Triplet C|Participant choice|0|||
161575778|NCT02115282|583493663|FG000|Overall Study|Disease progression during treatment|216|||
161575779|NCT02115282|583493664|FG001|Overall Study|Disease progression during treatment|229|||
161575780|NCT02115282|583493663|FG000|Overall Study|Adverse Event|49|||
161575781|NCT02115282|583493664|FG001|Overall Study|Adverse Event|23|||
161575782|NCT02115282|583493663|FG000|Overall Study|Death|1|||
161575783|NCT02115282|583493664|FG001|Overall Study|Death|3|||
161575784|NCT02115282|583493663|FG000|Overall Study|Alternative therapy|1|||
161575785|NCT02115282|583493664|FG001|Overall Study|Alternative therapy|1|||
161575786|NCT02115282|583493663|FG000|Overall Study|Complicating disease|0|||
161575787|NCT02115282|583493664|FG001|Overall Study|Complicating disease|3|||
161575788|NCT02115282|583493663|FG000|Overall Study|Withdrawal by Subject|12|||
161575789|NCT02115282|583493664|FG001|Overall Study|Withdrawal by Subject|10|||
161575790|NCT02115282|583493663|FG000|Overall Study|Symptomatic progression/deterioration|7|||
161575791|NCT02115282|583493664|FG001|Overall Study|Symptomatic progression/deterioration|18|||
161575792|NCT02115282|583493663|FG000|Overall Study|Non-compliance|5|||
161575793|NCT02115282|583493664|FG001|Overall Study|Non-compliance|1|||
161575794|NCT02115282|583493663|FG000|Overall Study|Protocol Violation|2|||
161575795|NCT02115282|583493664|FG001|Overall Study|Protocol Violation|2|||
161575796|NCT02115282|583493663|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
161575797|NCT02115282|583493664|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
161575798|NCT02115282|583493663|FG000|Overall Study|Not start protocol therapy|9|||
161575799|NCT02115282|583493664|FG001|Overall Study|Not start protocol therapy|10|||
161575800|NCT06218251|583493667|FG000|Overall Study|Lost to Follow-up|4|||
161575801|NCT00997386|583493670|FG000|Overall Study|Death|7|||
161575802|NCT03492177|583493671|FG000|Overall Study|Adverse Event|1|||
161575803|NCT03492177|583493672|FG001|Overall Study|Adverse Event|0|||
161575804|NCT03492177|583493673|FG002|Overall Study|Adverse Event|0|||
161575805|NCT03492177|583493671|FG000|Overall Study|Death|3|||
161575806|NCT03492177|583493672|FG001|Overall Study|Death|0|||
161575807|NCT03492177|583493673|FG002|Overall Study|Death|3|||
161575808|NCT03492177|583493671|FG000|Overall Study|Lack of Efficacy|1|||
161575809|NCT03492177|583493672|FG001|Overall Study|Lack of Efficacy|2|||
161468389|NCT02413372|583111222|FG002|Follow-up|Subject Withdrew Consent|1|||
161468390|NCT02413372|583111220|FG000|Follow-up|Subject unable to return for visit|0|||
161575810|NCT03492177|583493673|FG002|Overall Study|Lack of Efficacy|0|||
161468391|NCT02413372|583111221|FG001|Follow-up|Subject unable to return for visit|0|||
161468392|NCT02413372|583111222|FG002|Follow-up|Subject unable to return for visit|1|||
161575811|NCT03492177|583493671|FG000|Overall Study|Other|1|||
161915700|NCT00790036|584740532|FG001|Overall Study|Administrative problems|9|||
161468393|NCT03053271|583111232|FG000|Overall Study|Did not meet randomization criteria|3|||
161575812|NCT03492177|583493672|FG001|Overall Study|Other|0|||
161575813|NCT03492177|583493673|FG002|Overall Study|Other|0|||
161575814|NCT03492177|583493671|FG000|Overall Study|Ongoing|16|||
161575815|NCT03492177|583493672|FG001|Overall Study|Ongoing|19|||
161575816|NCT03492177|583493673|FG002|Overall Study|Ongoing|17|||
161575817|NCT01713946|583493674|FG000|Overall Study|Death|0|||
161468394|NCT03053271|583111232|FG000|Overall Study|Withdrawal by Subject|1|||
161468395|NCT00580970|583111233|FG000|Pre-treatment|Non-compliance|1|||
161468396|NCT00580970|583111233|FG000|Treatment (Lovastatin)|Non-compliance|6|||
161468397|NCT00580970|583111233|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
161468398|NCT00580970|583111233|FG000|Treatment (Lovastatin)|Physician Decision|4|||
161468399|NCT00580970|583111233|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
161468400|NCT00580970|583111233|FG000|Treatment (Lovastatin)|Death|1|||
161468401|NCT03161093|583111236|FG000|Overall Study|Protocol Violation|11|||
161468402|NCT03161093|583111237|FG001|Overall Study|Protocol Violation|14|||
161468403|NCT03161093|583111238|FG002|Overall Study|Protocol Violation|6|||
161468404|NCT03161093|583111239|FG003|Overall Study|Protocol Violation|13|||
161468405|NCT03161093|583111240|FG004|Overall Study|Protocol Violation|1|||
161468406|NCT03161093|583111241|FG005|Overall Study|Protocol Violation|0|||
161468407|NCT03161093|583111236|FG000|Overall Study|Adverse Event|5|||
161468408|NCT03161093|583111237|FG001|Overall Study|Adverse Event|21|||
161468409|NCT03161093|583111238|FG002|Overall Study|Adverse Event|16|||
161468410|NCT03161093|583111239|FG003|Overall Study|Adverse Event|35|||
161468411|NCT03161093|583111240|FG004|Overall Study|Adverse Event|2|||
161468412|NCT03161093|583111241|FG005|Overall Study|Adverse Event|1|||
161468413|NCT03161093|583111236|FG000|Overall Study|Lack of Efficacy|9|||
161468414|NCT03161093|583111237|FG001|Overall Study|Lack of Efficacy|13|||
161468415|NCT03161093|583111238|FG002|Overall Study|Lack of Efficacy|9|||
161468416|NCT03161093|583111239|FG003|Overall Study|Lack of Efficacy|24|||
161468417|NCT03161093|583111240|FG004|Overall Study|Lack of Efficacy|4|||
161468418|NCT03161093|583111241|FG005|Overall Study|Lack of Efficacy|1|||
161468419|NCT03161093|583111236|FG000|Overall Study|Physician Decision|0|||
161468420|NCT03161093|583111237|FG001|Overall Study|Physician Decision|1|||
161468421|NCT03161093|583111238|FG002|Overall Study|Physician Decision|0|||
161468422|NCT03161093|583111239|FG003|Overall Study|Physician Decision|2|||
161468423|NCT03161093|583111240|FG004|Overall Study|Physician Decision|17|||
161468424|NCT03161093|583111241|FG005|Overall Study|Physician Decision|15|||
161468425|NCT03161093|583111236|FG000|Overall Study|Withdrawal by Subject|24|||
161468426|NCT03161093|583111237|FG001|Overall Study|Withdrawal by Subject|73|||
161468427|NCT03161093|583111238|FG002|Overall Study|Withdrawal by Subject|44|||
161468428|NCT03161093|583111239|FG003|Overall Study|Withdrawal by Subject|97|||
161468429|NCT03161093|583111240|FG004|Overall Study|Withdrawal by Subject|11|||
161468430|NCT03161093|583111241|FG005|Overall Study|Withdrawal by Subject|10|||
161468431|NCT03161093|583111236|FG000|Overall Study|Lost to Follow-up|3|||
161468432|NCT03161093|583111237|FG001|Overall Study|Lost to Follow-up|12|||
161468433|NCT03161093|583111238|FG002|Overall Study|Lost to Follow-up|4|||
161468434|NCT03161093|583111239|FG003|Overall Study|Lost to Follow-up|7|||
161468435|NCT03161093|583111240|FG004|Overall Study|Lost to Follow-up|8|||
161468436|NCT03161093|583111241|FG005|Overall Study|Lost to Follow-up|13|||
161468437|NCT03161093|583111236|FG000|Overall Study|Death|3|||
161468438|NCT03161093|583111237|FG001|Overall Study|Death|9|||
161468439|NCT03161093|583111238|FG002|Overall Study|Death|7|||
161468440|NCT03161093|583111239|FG003|Overall Study|Death|9|||
161468441|NCT03161093|583111240|FG004|Overall Study|Death|0|||
161468442|NCT03161093|583111241|FG005|Overall Study|Death|0|||
161468443|NCT03161093|583111236|FG000|Overall Study|Unknown - Not reported|0|||
161468444|NCT03161093|583111237|FG001|Overall Study|Unknown - Not reported|1|||
161468445|NCT03161093|583111238|FG002|Overall Study|Unknown - Not reported|0|||
161468446|NCT03161093|583111239|FG003|Overall Study|Unknown - Not reported|0|||
161468447|NCT03161093|583111240|FG004|Overall Study|Unknown - Not reported|0|||
161468448|NCT03161093|583111241|FG005|Overall Study|Unknown - Not reported|1|||
161468449|NCT00570765|583111242|FG000|DB Phase|Withdrawal by Subject|1|||
161468450|NCT00570765|583111243|FG001|DB Phase|Withdrawal by Subject|0|||
161468451|NCT00570765|583111244|FG002|DB Phase|Withdrawal by Subject|0|||
161468452|NCT00570765|583111245|FG003|DB Phase|Withdrawal by Subject|0|||
161468453|NCT00570765|583111242|FG000|DB Phase|Protocol Violation|0|||
161468454|NCT00570765|583111243|FG001|DB Phase|Protocol Violation|1|||
161468455|NCT00570765|583111244|FG002|DB Phase|Protocol Violation|0|||
161468456|NCT00570765|583111245|FG003|DB Phase|Protocol Violation|0|||
161468457|NCT00570765|583111242|FG000|DB Phase|Adverse Event|3|||
161468458|NCT00570765|583111243|FG001|DB Phase|Adverse Event|6|||
161468459|NCT00570765|583111244|FG002|DB Phase|Adverse Event|0|||
161468460|NCT00570765|583111245|FG003|DB Phase|Adverse Event|0|||
161468461|NCT00570765|583111242|FG000|DB Phase|Did Not Receive Study Drug|0|||
161468462|NCT00570765|583111243|FG001|DB Phase|Did Not Receive Study Drug|0|||
161468463|NCT00570765|583111244|FG002|DB Phase|Did Not Receive Study Drug|1|||
161468464|NCT00570765|583111245|FG003|DB Phase|Did Not Receive Study Drug|0|||
161468465|NCT00570765|583111242|FG000|LTSE Phase|Withdrawal by Subject|0|||
161468466|NCT00570765|583111243|FG001|LTSE Phase|Withdrawal by Subject|0|||
161468467|NCT00570765|583111244|FG002|LTSE Phase|Withdrawal by Subject|0|||
161468468|NCT00570765|583111245|FG003|LTSE Phase|Withdrawal by Subject|1|||
161575818|NCT01713946|583493675|FG001|Overall Study|Death|2|||
161575819|NCT01713946|583493676|FG002|Overall Study|Death|2|||
161811793|NCT03256695|584353127|FG000|Overall Study|Lack of Efficacy|3|||
161811794|NCT03256695|584353127|FG000|Overall Study|Protocol Violation|5|||
161811795|NCT03256695|584353127|FG000|Overall Study|Other than specified|3|||
161811796|NCT01103713|584353133|FG000|Overall Study|Lost to Follow-up|2|||
161811797|NCT01103713|584353133|FG000|Overall Study|Withdrawal by Subject|8|||
161811798|NCT01103713|584353133|FG000|Overall Study|Study terminated by sponsor|2|||
161811799|NCT01103713|584353133|FG000|Overall Study|Other|1|||
161811800|NCT02089685|584353134|FG000|Overall Study|Adverse Event|1|||
161811801|NCT02089685|584353135|FG001|Overall Study|Adverse Event|0|||
161811802|NCT02089685|584353136|FG002|Overall Study|Adverse Event|0|||
161811803|NCT02089685|584353137|FG003|Overall Study|Adverse Event|0|||
161811804|NCT02089685|584353138|FG004|Overall Study|Adverse Event|1|||
161811805|NCT02089685|584353139|FG005|Overall Study|Adverse Event|0|||
161811806|NCT02089685|584353134|FG000|Overall Study|Clinical Progression|4|||
161811807|NCT02089685|584353135|FG001|Overall Study|Clinical Progression|0|||
161811808|NCT02089685|584353136|FG002|Overall Study|Clinical Progression|0|||
161811809|NCT02089685|584353137|FG003|Overall Study|Clinical Progression|5|||
161811810|NCT02089685|584353138|FG004|Overall Study|Clinical Progression|1|||
161811811|NCT02089685|584353139|FG005|Overall Study|Clinical Progression|2|||
161811812|NCT02089685|584353134|FG000|Overall Study|Excluded Medication|1|||
161811813|NCT02089685|584353135|FG001|Overall Study|Excluded Medication|0|||
161811814|NCT02089685|584353136|FG002|Overall Study|Excluded Medication|0|||
161811815|NCT02089685|584353137|FG003|Overall Study|Excluded Medication|11|||
161811816|NCT02089685|584353138|FG004|Overall Study|Excluded Medication|2|||
161811817|NCT02089685|584353139|FG005|Overall Study|Excluded Medication|1|||
161811818|NCT02089685|584353134|FG000|Overall Study|Progressive disease|13|||
161811819|NCT02089685|584353135|FG001|Overall Study|Progressive disease|10|||
161811820|NCT02089685|584353136|FG002|Overall Study|Progressive disease|3|||
161811821|NCT02089685|584353137|FG003|Overall Study|Progressive disease|51|||
161811822|NCT02089685|584353138|FG004|Overall Study|Progressive disease|17|||
161811823|NCT02089685|584353139|FG005|Overall Study|Progressive disease|12|||
161811824|NCT02089685|584353134|FG000|Overall Study|Follow up ended by sponsor|2|||
161811825|NCT02089685|584353135|FG001|Overall Study|Follow up ended by sponsor|2|||
161811826|NCT02089685|584353136|FG002|Overall Study|Follow up ended by sponsor|0|||
161468469|NCT00570765|583111242|FG000|LTSE Phase|Adverse Event|0|||
161468470|NCT00570765|583111243|FG001|LTSE Phase|Adverse Event|0|||
161575820|NCT01713946|583493674|FG000|Overall Study|Adverse Event|19|||
161811827|NCT02089685|584353137|FG003|Overall Study|Follow up ended by sponsor|70|||
161811828|NCT02089685|584353138|FG004|Overall Study|Follow up ended by sponsor|26|||
161811829|NCT02089685|584353139|FG005|Overall Study|Follow up ended by sponsor|26|||
161811830|NCT02089685|584353134|FG000|Overall Study|Withdrawal by Subject|0|||
161468471|NCT00570765|583111244|FG002|LTSE Phase|Adverse Event|0|||
161811831|NCT02089685|584353135|FG001|Overall Study|Withdrawal by Subject|2|||
161468472|NCT00570765|583111245|FG003|LTSE Phase|Adverse Event|7|||
161468473|NCT00570765|583111242|FG000|LTSE Phase|Physician Decision|0|||
161811832|NCT02089685|584353136|FG002|Overall Study|Withdrawal by Subject|0|||
161468474|NCT00570765|583111243|FG001|LTSE Phase|Physician Decision|0|||
161575821|NCT01713946|583493675|FG001|Overall Study|Adverse Event|14|||
161575822|NCT01713946|583493676|FG002|Overall Study|Adverse Event|13|||
161575823|NCT01713946|583493674|FG000|Overall Study|Withdrawal by Subject|12|||
161575824|NCT01713946|583493675|FG001|Overall Study|Withdrawal by Subject|12|||
161575825|NCT01713946|583493676|FG002|Overall Study|Withdrawal by Subject|8|||
161575826|NCT01713946|583493674|FG000|Overall Study|Lack of Efficacy|8|||
161575827|NCT01713946|583493675|FG001|Overall Study|Lack of Efficacy|8|||
161575828|NCT01713946|583493676|FG002|Overall Study|Lack of Efficacy|14|||
161575829|NCT01713946|583493674|FG000|Overall Study|Protocol Violation|2|||
161575830|NCT01713946|583493675|FG001|Overall Study|Protocol Violation|4|||
161575831|NCT01713946|583493676|FG002|Overall Study|Protocol Violation|1|||
161575832|NCT01713946|583493674|FG000|Overall Study|Lost to Follow-up|0|||
161575833|NCT01713946|583493675|FG001|Overall Study|Lost to Follow-up|0|||
161575834|NCT01713946|583493676|FG002|Overall Study|Lost to Follow-up|1|||
161575835|NCT01713946|583493674|FG000|Overall Study|Administrative problems|1|||
161575836|NCT01713946|583493675|FG001|Overall Study|Administrative problems|0|||
161575837|NCT01713946|583493676|FG002|Overall Study|Administrative problems|0|||
161575838|NCT01713946|583493674|FG000|Overall Study|Did not continue in Ext|0|||
161575839|NCT01713946|583493675|FG001|Overall Study|Did not continue in Ext|3|||
161575840|NCT01713946|583493676|FG002|Overall Study|Did not continue in Ext|0|||
161575841|NCT01713946|583493674|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
161575842|NCT01713946|583493675|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
161575843|NCT01713946|583493676|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
161575844|NCT01713946|583493674|FG000|Overall Study|Patients never switched to everolimus|0|||
161575845|NCT01713946|583493675|FG001|Overall Study|Patients never switched to everolimus|0|||
161915701|NCT00790036|584740531|FG000|Overall Study|Adverse Event|113|||
161915702|NCT00790036|584740532|FG001|Overall Study|Adverse Event|44|||
161915703|NCT00790036|584740531|FG000|Overall Study|Death|1|||
161915704|NCT00790036|584740532|FG001|Overall Study|Death|0|||
161915705|NCT00790036|584740531|FG000|Overall Study|Disease progression|24|||
161915706|NCT00790036|584740532|FG001|Overall Study|Disease progression|48|||
161915707|NCT00790036|584740531|FG000|Overall Study|Lost to Follow-up|1|||
161915708|NCT00790036|584740532|FG001|Overall Study|Lost to Follow-up|2|||
161915709|NCT00790036|584740531|FG000|Overall Study|Protocol Violation|10|||
161915710|NCT00790036|584740532|FG001|Overall Study|Protocol Violation|2|||
161915711|NCT00790036|584740531|FG000|Overall Study|Withdrawal by Subject|18|||
161915712|NCT00790036|584740532|FG001|Overall Study|Withdrawal by Subject|7|||
161915713|NCT00790036|584740531|FG000|Overall Study|Subject/guardian decision|20|||
161915714|NCT00790036|584740532|FG001|Overall Study|Subject/guardian decision|7|||
161915715|NCT01285518|584740533|FG000|Overall Study|Lost to Follow-up|0|||
161915716|NCT01285518|584740534|FG001|Overall Study|Lost to Follow-up|0|||
161915717|NCT01285518|584740535|FG002|Overall Study|Lost to Follow-up|0|||
161915718|NCT01285518|584740536|FG003|Overall Study|Lost to Follow-up|0|||
161915719|NCT01285518|584740537|FG004|Overall Study|Lost to Follow-up|0|||
161915720|NCT01285518|584740538|FG005|Overall Study|Lost to Follow-up|1|||
161915721|NCT01285518|584740539|FG006|Overall Study|Lost to Follow-up|0|||
161915722|NCT01285518|584740540|FG007|Overall Study|Lost to Follow-up|0|||
161915723|NCT00639509|584740547|FG000|Overall Study|Death|1|||
161915724|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Adverse Event|6|||
161915725|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Adverse Event|15|||
161915726|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Adverse Event|0|||
161915727|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Death|0|||
161915728|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Death|2|||
161915729|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Death|0|||
161915730|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
161915731|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
161915732|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
161915733|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
161915734|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
161915735|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
161915736|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Physician Decision|1|||
161915737|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Physician Decision|1|||
161915738|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Physician Decision|0|||
161915739|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
161915740|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
161915741|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
161915742|NCT02921256|584740548|FG000|Arm Ib v Arm III|Adverse Event|9|||
161915743|NCT02921256|584740549|FG001|Arm Ib v Arm III|Adverse Event|0|||
161915744|NCT02921256|584740550|FG002|Arm Ib v Arm III|Adverse Event|4|||
161468475|NCT00570765|583111244|FG002|LTSE Phase|Physician Decision|0|||
161468476|NCT00570765|583111245|FG003|LTSE Phase|Physician Decision|4|||
161468477|NCT01031706|583111246|FG000|Overall Study|Adverse Event|1|||
161468478|NCT01031706|583111247|FG001|Overall Study|Adverse Event|0|||
161468479|NCT01031706|583111246|FG000|Overall Study|Withdrawal by Subject|1|||
161468480|NCT01031706|583111247|FG001|Overall Study|Withdrawal by Subject|1|||
161468481|NCT02124161|583111248|FG000|Overall Study|Other unspecified|0|||
161468482|NCT02124161|583111249|FG001|Overall Study|Other unspecified|1|||
161468483|NCT02124161|583111248|FG000|Overall Study|Death|1|||
161575846|NCT01713946|583493676|FG002|Overall Study|Patients never switched to everolimus|5|||
161468484|NCT02124161|583111249|FG001|Overall Study|Death|0|||
161468485|NCT02124161|583111248|FG000|Overall Study|Protocol Violation|2|||
161468486|NCT02124161|583111249|FG001|Overall Study|Protocol Violation|1|||
161468487|NCT02124161|583111248|FG000|Overall Study|Withdrawal by Subject|1|||
161468488|NCT02124161|583111249|FG001|Overall Study|Withdrawal by Subject|2|||
161468489|NCT02124161|583111248|FG000|Overall Study|Adverse Event|2|||
161468490|NCT02124161|583111249|FG001|Overall Study|Adverse Event|0|||
161468491|NCT02124161|583111248|FG000|Overall Study|Does not meet entrance criteria|2|||
161468492|NCT02124161|583111249|FG001|Overall Study|Does not meet entrance criteria|3|||
161468493|NCT02124161|583111248|FG000|Overall Study|No longer meets eligibility criteria|5|||
161468494|NCT02124161|583111249|FG001|Overall Study|No longer meets eligibility criteria|4|||
161468495|NCT02124161|583111248|FG000|Overall Study|Lost to Follow-up|3|||
161468496|NCT02124161|583111249|FG001|Overall Study|Lost to Follow-up|4|||
161468497|NCT01954342|583111255|FG000|Overall Study|Missing data from 13-16week study visit|0|||
161468498|NCT01954342|583111256|FG001|Overall Study|Missing data from 13-16week study visit|0|||
161468499|NCT01954342|583111257|FG002|Overall Study|Missing data from 13-16week study visit|0|||
161468500|NCT01954342|583111258|FG003|Overall Study|Missing data from 13-16week study visit|1|||
161468501|NCT01954342|583111255|FG000|Overall Study|Miscarriage|0|||
161468502|NCT01954342|583111256|FG001|Overall Study|Miscarriage|0|||
161468503|NCT01954342|583111257|FG002|Overall Study|Miscarriage|0|||
161468504|NCT01954342|583111258|FG003|Overall Study|Miscarriage|3|||
161468505|NCT01954342|583111255|FG000|Overall Study|Lost to Follow-up|0|||
161468506|NCT01954342|583111256|FG001|Overall Study|Lost to Follow-up|0|||
161468507|NCT01954342|583111257|FG002|Overall Study|Lost to Follow-up|0|||
161468508|NCT01954342|583111258|FG003|Overall Study|Lost to Follow-up|5|||
161468509|NCT01954342|583111255|FG000|Overall Study|Preterm delivery|0|||
161468510|NCT01954342|583111256|FG001|Overall Study|Preterm delivery|0|||
161468511|NCT01954342|583111257|FG002|Overall Study|Preterm delivery|0|||
161468512|NCT01954342|583111258|FG003|Overall Study|Preterm delivery|3|||
161468513|NCT01954342|583111255|FG000|Overall Study|Pre-eclampsia|0|||
161468514|NCT01954342|583111256|FG001|Overall Study|Pre-eclampsia|0|||
161468515|NCT01954342|583111257|FG002|Overall Study|Pre-eclampsia|0|||
161468516|NCT01954342|583111258|FG003|Overall Study|Pre-eclampsia|4|||
161468517|NCT01954342|583111255|FG000|Overall Study|Unreliable Data|0|||
161468518|NCT01954342|583111256|FG001|Overall Study|Unreliable Data|0|||
161468519|NCT01954342|583111257|FG002|Overall Study|Unreliable Data|0|||
161468520|NCT01954342|583111258|FG003|Overall Study|Unreliable Data|2|||
161468521|NCT00984568|583111260|FG000|Overall Study|Withdrawal by Subject|1|||
161468522|NCT00984568|583111261|FG001|Overall Study|Withdrawal by Subject|2|||
161468523|NCT00984568|583111260|FG000|Overall Study|Lack of Efficacy|2|||
161468524|NCT00984568|583111261|FG001|Overall Study|Lack of Efficacy|0|||
161468525|NCT00984568|583111260|FG000|Overall Study|Adverse Event|2|||
161468526|NCT00984568|583111261|FG001|Overall Study|Adverse Event|0|||
161811833|NCT02089685|584353137|FG003|Overall Study|Withdrawal by Subject|8|||
161811834|NCT02089685|584353138|FG004|Overall Study|Withdrawal by Subject|1|||
161468527|NCT00984568|583111260|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
161468528|NCT00984568|583111261|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
161468529|NCT00984568|583111260|FG000|Overall Study|Lost to Follow-up|0|||
161468530|NCT00984568|583111261|FG001|Overall Study|Lost to Follow-up|1|||
161811835|NCT02089685|584353139|FG005|Overall Study|Withdrawal by Subject|1|||
161811836|NCT02089685|584353134|FG000|Overall Study|Status not recorded|1|||
161811837|NCT02089685|584353135|FG001|Overall Study|Status not recorded|0|||
161811838|NCT02089685|584353136|FG002|Overall Study|Status not recorded|0|||
161811839|NCT02089685|584353137|FG003|Overall Study|Status not recorded|0|||
161811840|NCT02089685|584353138|FG004|Overall Study|Status not recorded|1|||
161811841|NCT02089685|584353139|FG005|Overall Study|Status not recorded|0|||
161811842|NCT02089685|584353134|FG000|Overall Study|Death|0|||
161811843|NCT02089685|584353135|FG001|Overall Study|Death|0|||
161468531|NCT00984568|583111260|FG000|Overall Study|Opportunistic Infection|1|||
161811844|NCT02089685|584353136|FG002|Overall Study|Death|0|||
161811845|NCT02089685|584353137|FG003|Overall Study|Death|7|||
161915745|NCT02921256|584740548|FG000|Arm Ib v Arm III|Death|1|||
161915746|NCT02921256|584740549|FG001|Arm Ib v Arm III|Death|0|||
161915747|NCT02921256|584740550|FG002|Arm Ib v Arm III|Death|1|||
161915748|NCT02921256|584740548|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
161915749|NCT02921256|584740549|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
161915750|NCT02921256|584740550|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
161915751|NCT02921256|584740548|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
161915752|NCT02921256|584740549|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
161915753|NCT02921256|584740550|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
161915754|NCT02921256|584740548|FG000|Arm Ib v Arm III|Physician Decision|4|||
161915755|NCT02921256|584740549|FG001|Arm Ib v Arm III|Physician Decision|0|||
161915756|NCT02921256|584740550|FG002|Arm Ib v Arm III|Physician Decision|1|||
161915757|NCT02921256|584740548|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
161915758|NCT02921256|584740549|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
161915759|NCT02921256|584740550|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
161915760|NCT03507790|584740551|FG000|Overall Study|Adverse Event|0|||
161915761|NCT03507790|584740552|FG001|Overall Study|Adverse Event|11|||
161468532|NCT00984568|583111261|FG001|Overall Study|Opportunistic Infection|0|||
161468533|NCT00984568|583111260|FG000|Overall Study|Unknown Reason|1|||
161468534|NCT00984568|583111261|FG001|Overall Study|Unknown Reason|3|||
161468535|NCT01649804|583111262|FG000|Overall Study|Administrative/Other|8|||
161468536|NCT03845543|583111263|FG000|Overall Study|Death|25|||
161468537|NCT03845543|583111263|FG000|Overall Study|Withdrawal by Subject|2|||
161468538|NCT03845543|583111263|FG000|Overall Study|Lost to Follow-up|12|||
161468539|NCT03845543|583111263|FG000|Overall Study|Adverse Event|17|||
161468540|NCT01912963|583111269|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
161468541|NCT01912963|583111270|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
161468542|NCT01912963|583111271|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
161468543|NCT01912963|583111269|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
161468544|NCT01912963|583111270|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
161468545|NCT01912963|583111271|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
161468546|NCT01912963|583111269|FG000|Overall Study|Adverse Event|0|||
161468547|NCT01912963|583111270|FG001|Overall Study|Adverse Event|1|||
161468548|NCT01912963|583111271|FG002|Overall Study|Adverse Event|1|||
161468549|NCT01912963|583111269|FG000|Overall Study|Withdrawal by Subject|0|||
161468550|NCT01912963|583111270|FG001|Overall Study|Withdrawal by Subject|1|||
161468551|NCT01912963|583111271|FG002|Overall Study|Withdrawal by Subject|0|||
161468552|NCT01912963|583111269|FG000|Overall Study|Sought treatment locally|0|||
161468553|NCT01912963|583111270|FG001|Overall Study|Sought treatment locally|1|||
161468554|NCT01912963|583111271|FG002|Overall Study|Sought treatment locally|0|||
161468555|NCT01336569|583111275|FG000|Overall Study|Lost to Follow-up|4|||
161468556|NCT00406354|583111276|FG000|All Randomized Patients|Protocol Violation|0|||
161468557|NCT00406354|583111277|FG001|All Randomized Patients|Protocol Violation|0|||
161468558|NCT00406354|583111278|FG002|All Randomized Patients|Protocol Violation|1|||
161468559|NCT00406354|583111276|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
161468560|NCT00406354|583111277|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
161468561|NCT00406354|583111278|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
161468562|NCT00406354|583111276|FG000|All Randomized and Treated Patients|Adverse Event|6|||
161468563|NCT00406354|583111277|FG001|All Randomized and Treated Patients|Adverse Event|2|||
161468564|NCT00406354|583111278|FG002|All Randomized and Treated Patients|Adverse Event|1|||
161468565|NCT00406354|583111276|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
161468566|NCT00406354|583111277|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
161468567|NCT00406354|583111278|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
161468568|NCT00406354|583111276|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
161468569|NCT00406354|583111277|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
161468570|NCT00406354|583111278|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
161468571|NCT00406354|583111276|FG000|All Randomized and Treated Patients|Physician Decision|0|||
161468572|NCT00406354|583111277|FG001|All Randomized and Treated Patients|Physician Decision|0|||
161468573|NCT00406354|583111278|FG002|All Randomized and Treated Patients|Physician Decision|1|||
161468574|NCT02027376|583111287|FG000|Overall Study|Death|1|||
161468575|NCT02027376|583111288|FG001|Overall Study|Death|0|||
161468576|NCT02027376|583111289|FG002|Overall Study|Death|0|||
161468577|NCT02130024|583111290|FG000|Overall Study|Adverse Event|10|||
161468578|NCT02130024|583111291|FG001|Overall Study|Adverse Event|11|||
161468579|NCT02130024|583111290|FG000|Overall Study|Death|2|||
161468580|NCT02130024|583111291|FG001|Overall Study|Death|2|||
161468581|NCT02130024|583111290|FG000|Overall Study|Lost to Follow-up|1|||
161468582|NCT02130024|583111291|FG001|Overall Study|Lost to Follow-up|1|||
161468583|NCT02130024|583111290|FG000|Overall Study|Physician Decision|1|||
161468584|NCT02130024|583111291|FG001|Overall Study|Physician Decision|3|||
161468585|NCT02130024|583111290|FG000|Overall Study|Protocol Deviation|4|||
161915762|NCT03507790|584740553|FG002|Overall Study|Adverse Event|3|||
161915763|NCT03507790|584740551|FG000|Overall Study|Withdrawal by Subject|2|||
161915764|NCT03507790|584740552|FG001|Overall Study|Withdrawal by Subject|0|||
161915765|NCT03507790|584740553|FG002|Overall Study|Withdrawal by Subject|0|||
161468586|NCT02130024|583111291|FG001|Overall Study|Protocol Deviation|0|||
161468587|NCT02130024|583111290|FG000|Overall Study|Site Administration Problems|1|||
161468588|NCT02130024|583111291|FG001|Overall Study|Site Administration Problems|0|||
161468589|NCT02130024|583111290|FG000|Overall Study|Subject Withdrew Consent|6|||
161468590|NCT02130024|583111291|FG001|Overall Study|Subject Withdrew Consent|14|||
161468591|NCT05597020|583111292|FG000|Washout|Forbidden medication|2|||
161468592|NCT05597020|583111293|FG001|Washout|Forbidden medication|0|||
161468593|NCT05597020|583111292|FG000|Treatment Period II|Advice from primary care physician|1|||
161468594|NCT05597020|583111293|FG001|Treatment Period II|Advice from primary care physician|0|||
161468595|NCT05597020|583111292|FG000|Treatment Period II|Subject lost investigational product|1|||
161468596|NCT05597020|583111293|FG001|Treatment Period II|Subject lost investigational product|0|||
161468597|NCT05597020|583111292|FG000|Treatment Period II|Private reasons|0|||
161468598|NCT05597020|583111293|FG001|Treatment Period II|Private reasons|1|||
161468599|NCT05736224|583111294|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
161468600|NCT01015131|583111295|FG000|Overall Study|Physician Decision|1|||
161468601|NCT01015131|583111295|FG000|Overall Study|Protocol Violation|1|||
161468602|NCT01015131|583111295|FG000|Overall Study|Withdrawal by Subject|2|||
161468603|NCT01015131|583111295|FG000|Overall Study|Other Protocol Specified Criteria|4|||
161468604|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
161468605|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
161468606|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
161468607|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
161468608|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
161468609|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
161468610|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
161468611|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
161468612|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
161468613|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
161468614|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
161468615|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
161468616|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
161468617|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
161468618|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
161468619|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
161468620|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
161468621|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
161468622|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
161468623|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
161468624|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
161468625|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
161468626|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
161468627|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
161468628|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
161468629|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
161468630|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
161468631|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
161468632|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
161468633|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
161468634|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
161468635|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
161468636|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
161468637|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
161668071|NCT00406653|583837479|FG003|Maintenance Period|Adverse Event|0|||
161811846|NCT02089685|584353138|FG004|Overall Study|Death|2|||
161811847|NCT02089685|584353139|FG005|Overall Study|Death|5|||
161811848|NCT02089685|584353134|FG000|Overall Study|Lost to Follow-up|0|||
161811849|NCT02089685|584353135|FG001|Overall Study|Lost to Follow-up|0|||
161811850|NCT02089685|584353136|FG002|Overall Study|Lost to Follow-up|0|||
161811851|NCT02089685|584353137|FG003|Overall Study|Lost to Follow-up|1|||
161811852|NCT02089685|584353138|FG004|Overall Study|Lost to Follow-up|0|||
161811853|NCT02089685|584353139|FG005|Overall Study|Lost to Follow-up|0|||
161811854|NCT02089685|584353134|FG000|Overall Study|Physician Decision|0|||
161811855|NCT02089685|584353135|FG001|Overall Study|Physician Decision|0|||
161811856|NCT02089685|584353136|FG002|Overall Study|Physician Decision|0|||
161811857|NCT02089685|584353137|FG003|Overall Study|Physician Decision|0|||
161811858|NCT02089685|584353138|FG004|Overall Study|Physician Decision|0|||
161811859|NCT02089685|584353139|FG005|Overall Study|Physician Decision|4|||
161811860|NCT02089685|584353134|FG000|Overall Study|Screen failure|1|||
161811861|NCT02089685|584353135|FG001|Overall Study|Screen failure|0|||
161811862|NCT02089685|584353136|FG002|Overall Study|Screen failure|0|||
161811863|NCT02089685|584353137|FG003|Overall Study|Screen failure|0|||
161811864|NCT02089685|584353138|FG004|Overall Study|Screen failure|0|||
161811865|NCT02089685|584353139|FG005|Overall Study|Screen failure|0|||
161811866|NCT04887415|584353140|FG000|Overall Study|Lost to Follow-up|2|||
161811867|NCT00840411|584353141|FG000|First Intervention|Adverse Event|1|||
161811868|NCT00840411|584353142|FG001|First Intervention|Adverse Event|0|||
161811869|NCT00840411|584353141|FG000|Washout|Withdrawal by Subject|1|||
161811870|NCT00840411|584353142|FG001|Washout|Withdrawal by Subject|0|||
161811871|NCT00657553|584353144|FG000|Overall Study|low accrual, no analysis run|5|||
161811872|NCT00657553|584353145|FG001|Overall Study|low accrual, no analysis run|5|||
161811873|NCT01566721|584353146|FG000|Treatment Period|Withdrawal by Subject|35|||
161811874|NCT01566721|584353147|FG001|Treatment Period|Withdrawal by Subject|9|||
161811875|NCT01566721|584353146|FG000|Treatment Period|Disease Progression/Recurrence|37|||
161811876|NCT01566721|584353147|FG001|Treatment Period|Disease Progression/Recurrence|13|||
161811877|NCT01566721|584353146|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
161811878|NCT01566721|584353147|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
161811879|NCT01566721|584353146|FG000|Treatment Period|Other|13|||
161811880|NCT01566721|584353147|FG001|Treatment Period|Other|2|||
161811881|NCT01566721|584353146|FG000|Treatment Period|Lack of Compliance|5|||
161811882|NCT01566721|584353147|FG001|Treatment Period|Lack of Compliance|1|||
161811883|NCT01566721|584353146|FG000|Treatment Period|Adverse Event|100|||
161811884|NCT01566721|584353147|FG001|Treatment Period|Adverse Event|30|||
161811885|NCT01566721|584353146|FG000|Treatment Period|Pregnancy|1|||
161811886|NCT01566721|584353147|FG001|Treatment Period|Pregnancy|0|||
161811887|NCT01566721|584353146|FG000|Safety Follow-up|Physician Decision|6|||
161811888|NCT01566721|584353147|FG001|Safety Follow-up|Physician Decision|4|||
161811889|NCT01566721|584353146|FG000|Safety Follow-up|Lost to Follow-up|101|||
161811890|NCT01566721|584353147|FG001|Safety Follow-up|Lost to Follow-up|48|||
161811891|NCT01566721|584353146|FG000|Safety Follow-up|Withdrawal by Subject|155|||
161811892|NCT01566721|584353147|FG001|Safety Follow-up|Withdrawal by Subject|49|||
161811893|NCT01566721|584353146|FG000|Safety Follow-up|Death|28|||
161811894|NCT01566721|584353147|FG001|Safety Follow-up|Death|4|||
161811895|NCT01566721|584353146|FG000|Safety Follow-up|Non-compliance|7|||
161811896|NCT01566721|584353147|FG001|Safety Follow-up|Non-compliance|3|||
161811897|NCT01566721|584353146|FG000|Safety Follow-up|Protocol Violation|7|||
161811898|NCT01566721|584353147|FG001|Safety Follow-up|Protocol Violation|0|||
161811899|NCT01566721|584353146|FG000|Safety Follow-up|Site closure|2|||
161811900|NCT01566721|584353147|FG001|Safety Follow-up|Site closure|3|||
161811901|NCT01566721|584353146|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
161811902|NCT01566721|584353147|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
161811903|NCT01566721|584353146|FG000|Safety Follow-up|Missing|7|||
161811904|NCT01566721|584353147|FG001|Safety Follow-up|Missing|2|||
161811905|NCT01566721|584353146|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
161811906|NCT01566721|584353147|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
161811907|NCT01566721|584353146|FG000|Safety Follow-up|Sponsor decision|1|||
161811908|NCT01566721|584353147|FG001|Safety Follow-up|Sponsor decision|0|||
161811909|NCT01566721|584353146|FG000|Safety Follow-up|Adverse Event|8|||
161811910|NCT01566721|584353147|FG001|Safety Follow-up|Adverse Event|4|||
161811911|NCT00811655|584353152|FG000|Overall Study|Physician Decision|1|||
161811912|NCT00119015|584353154|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
161811913|NCT00119015|584353155|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
161811914|NCT00119015|584353156|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
161811915|NCT00787254|584353159|FG000|Overall Study|Adverse Event|24|||
161811916|NCT00787254|584353160|FG001|Overall Study|Adverse Event|23|||
161811917|NCT00787254|584353159|FG000|Overall Study|Protocol Violation|26|||
161811918|NCT00787254|584353160|FG001|Overall Study|Protocol Violation|23|||
161811919|NCT00787254|584353159|FG000|Overall Study|Withdrawal by Subject|16|||
161811920|NCT00787254|584353160|FG001|Overall Study|Withdrawal by Subject|11|||
161811921|NCT00787254|584353159|FG000|Overall Study|Lack of Efficacy|4|||
161811922|NCT00787254|584353160|FG001|Overall Study|Lack of Efficacy|15|||
161468638|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
161468639|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
161468640|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
161468641|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
161468642|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
161468643|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
161468644|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
161468645|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
161468646|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
161468647|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
161468648|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
161468649|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
161468650|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
161468651|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
161468652|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
161468653|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
161468654|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
161468655|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
161468656|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
161468657|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
161468658|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
161468659|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
161468660|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
161468661|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
161468662|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
161468663|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
161468664|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
161468665|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
161468666|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
161468667|NCT04526509|583111296|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
161468668|NCT04526509|583111297|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
161468669|NCT04526509|583111298|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
161468670|NCT04526509|583111299|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
161468671|NCT04526509|583111300|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
161468672|NCT04526509|583111301|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
161468673|NCT04526509|583111302|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
161575847|NCT03723616|583494957|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
161575848|NCT03723616|583494958|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
161575849|NCT03723616|583494959|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
161575850|NCT03723616|583494960|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
161575851|NCT03723616|583494961|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
161603594|NCT00626795|583602457|FG002|Blinded Treatment|Protocol Violation|1|||
161915766|NCT03507790|584740551|FG000|Overall Study|Subject moved to another location|1|||
161915767|NCT03507790|584740552|FG001|Overall Study|Subject moved to another location|2|||
161915768|NCT03507790|584740553|FG002|Overall Study|Subject moved to another location|0|||
161915769|NCT03507790|584740551|FG000|Overall Study|Non-compliance with study drug|0|||
161468674|NCT04526509|583111296|FG000|Enrolled|Study Terminated by Sponsor|0|||
161468675|NCT04526509|583111297|FG001|Enrolled|Study Terminated by Sponsor|0|||
161468676|NCT04526509|583111298|FG002|Enrolled|Study Terminated by Sponsor|0|||
161468677|NCT04526509|583111299|FG003|Enrolled|Study Terminated by Sponsor|0|||
161468678|NCT04526509|583111300|FG004|Enrolled|Study Terminated by Sponsor|0|||
161468679|NCT04526509|583111301|FG005|Enrolled|Study Terminated by Sponsor|0|||
161468680|NCT04526509|583111302|FG006|Enrolled|Study Terminated by Sponsor|1|||
161468681|NCT04526509|583111296|FG000|Enrolled|Death prior to lymphodepletion|0|||
161468682|NCT04526509|583111297|FG001|Enrolled|Death prior to lymphodepletion|0|||
161468683|NCT04526509|583111298|FG002|Enrolled|Death prior to lymphodepletion|0|||
161468684|NCT04526509|583111299|FG003|Enrolled|Death prior to lymphodepletion|1|||
161468685|NCT04526509|583111300|FG004|Enrolled|Death prior to lymphodepletion|0|||
161468686|NCT04526509|583111301|FG005|Enrolled|Death prior to lymphodepletion|0|||
161468687|NCT04526509|583111302|FG006|Enrolled|Death prior to lymphodepletion|0|||
161468688|NCT04526509|583111296|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
161468689|NCT04526509|583111297|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
161468690|NCT04526509|583111298|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
161468691|NCT04526509|583111299|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
161468692|NCT04526509|583111300|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
161468693|NCT04526509|583111301|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
161468694|NCT04526509|583111302|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
161468695|NCT04526509|583111296|FG000|Enrolled|Physician Decision|0|||
161468696|NCT04526509|583111297|FG001|Enrolled|Physician Decision|1|||
161468697|NCT04526509|583111298|FG002|Enrolled|Physician Decision|0|||
161468698|NCT04526509|583111299|FG003|Enrolled|Physician Decision|0|||
161668072|NCT00406653|583837480|FG004|Maintenance Period|Adverse Event|1|||
161468699|NCT04526509|583111300|FG004|Enrolled|Physician Decision|0|||
161468700|NCT04526509|583111301|FG005|Enrolled|Physician Decision|0|||
161468701|NCT04526509|583111302|FG006|Enrolled|Physician Decision|0|||
161468702|NCT02887859|583111303|FG000|Overall Study|Ongoing|6|||
161468703|NCT02887859|583111303|FG000|Overall Study|Adverse Event|7|||
161468704|NCT02887859|583111303|FG000|Overall Study|Death|1|||
161468705|NCT02887859|583111303|FG000|Overall Study|Physician Decision|1|||
161468706|NCT01554397|583111304|FG000|Overall Study|Withdrawal by Subject|1|||
161468707|NCT01554397|583111305|FG001|Overall Study|Withdrawal by Subject|0|||
161468708|NCT01554397|583111304|FG000|Overall Study|Ineligible|7|||
161468709|NCT01554397|583111305|FG001|Overall Study|Ineligible|0|||
161468710|NCT03817879|583113345|FG000|Overall Study|Drop out|5|||
161468711|NCT03817879|583113346|FG001|Overall Study|Drop out|12|||
161468712|NCT03817879|583113345|FG000|Overall Study|Withdrawal by Subject|0|||
161468713|NCT03817879|583113346|FG001|Overall Study|Withdrawal by Subject|1|||
161468714|NCT04493333|583113347|FG000|Overall Study|Withdrawal by Subject|1|||
161468715|NCT04493333|583113348|FG001|Overall Study|Withdrawal by Subject|1|||
161468716|NCT04493333|583113347|FG000|Overall Study|Ineligible|0|||
161468717|NCT04493333|583113348|FG001|Overall Study|Ineligible|1|||
161468718|NCT04493333|583113347|FG000|Overall Study|Noncompliance|2|||
161468719|NCT04493333|583113348|FG001|Overall Study|Noncompliance|1|||
161468720|NCT02742441|583113354|FG000|Overall Study|Lost to Follow-up|4|||
161468721|NCT02742441|583113355|FG001|Overall Study|Lost to Follow-up|4|||
161468722|NCT02742441|583113354|FG000|Overall Study|Withdrawal by Subject|2|||
161468723|NCT02742441|583113355|FG001|Overall Study|Withdrawal by Subject|2|||
161468724|NCT02742441|583113354|FG000|Overall Study|Adverse Event|0|||
161468725|NCT02742441|583113355|FG001|Overall Study|Adverse Event|2|||
161468726|NCT02203071|583113358|FG000|Overall Study|Lost to Follow-up|3|||
161468727|NCT02203071|583113359|FG001|Overall Study|Lost to Follow-up|1|||
161468728|NCT01845818|583113360|FG000|Overall Study|Withdrawal by Subject|0|||
161468729|NCT01845818|583113361|FG001|Overall Study|Withdrawal by Subject|1|||
161468730|NCT01845818|583113360|FG000|Overall Study|Lost to Follow-up|7|||
161468731|NCT01845818|583113361|FG001|Overall Study|Lost to Follow-up|5|||
161468732|NCT01845818|583113360|FG000|Overall Study|Administrative Reasons|3|||
161468733|NCT01845818|583113361|FG001|Overall Study|Administrative Reasons|1|||
161468734|NCT01845818|583113360|FG000|Overall Study|Serious Adverse Event|1|||
161468735|NCT01845818|583113361|FG001|Overall Study|Serious Adverse Event|1|||
161468736|NCT01845818|583113360|FG000|Overall Study|Other|25|||
161468737|NCT01845818|583113361|FG001|Overall Study|Other|8|||
161468738|NCT01845818|583113360|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
161468739|NCT01845818|583113361|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
161468740|NCT01845818|583113360|FG000|Overall Study|No Follow-Up Data Available|4|||
161468741|NCT01845818|583113361|FG001|Overall Study|No Follow-Up Data Available|1|||
161468742|NCT02595970|583113362|FG000|Overall Study|Withdrawal by Subject|2|||
161468743|NCT02595970|583113362|FG000|Overall Study|Physician Decision|2|||
161468744|NCT02595970|583113362|FG000|Overall Study|Protocol Violation|4|||
161468745|NCT02595970|583113362|FG000|Overall Study|Adverse Event|5|||
161468746|NCT02595970|583113362|FG000|Overall Study|Lack of Efficacy|7|||
161468747|NCT01871142|583113363|FG000|Overall Study|Adverse Event|1|||
161468748|NCT00231842|583113373|FG000|Overall Study|Withdrawal by Subject|3|||
161468749|NCT00231842|583113373|FG000|Overall Study|Did not complete the last 3 cycle|8|||
161468750|NCT02422303|583113374|FG000|Overall Study|Lost to Follow-up|1|||
161468751|NCT02422303|583113375|FG001|Overall Study|Lost to Follow-up|1|||
161468752|NCT00428792|583113377|FG000|Overall Study|Lack of Efficacy|1|||
161468753|NCT00428792|583113378|FG001|Overall Study|Lack of Efficacy|3|||
161468754|NCT00428792|583113377|FG000|Overall Study|Lost to Follow-up|0|||
161468755|NCT00428792|583113378|FG001|Overall Study|Lost to Follow-up|1|||
161468756|NCT00850343|583113380|FG000|Overall Study|Withdrawal by Subject|11|||
161468757|NCT00850343|583113381|FG001|Overall Study|Withdrawal by Subject|0|||
161468758|NCT00850343|583113382|FG002|Overall Study|Withdrawal by Subject|3|||
161468759|NCT00850343|583113383|FG003|Overall Study|Withdrawal by Subject|2|||
161468760|NCT00850343|583113380|FG000|Overall Study|Adverse Event|15|||
161468761|NCT00850343|583113381|FG001|Overall Study|Adverse Event|2|||
161575852|NCT03723616|583494962|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
161575853|NCT00493649|583494965|FG000|Overall Study|Adverse Event|44|||
161575854|NCT00493649|583494965|FG000|Overall Study|Patient Request|21|||
161575855|NCT00493649|583494965|FG000|Overall Study|Investigator Request|2|||
161575856|NCT00493649|583494965|FG000|Overall Study|Disease Progression|1|||
161575857|NCT00493649|583494965|FG000|Overall Study|Lost to Follow-up|1|||
161575858|NCT00493649|583494965|FG000|Overall Study|Other|13|||
161575859|NCT00925899|583494968|FG000|Part 1|Death|1|||
161575860|NCT00925899|583494969|FG001|Part 1|Death|2|||
161575861|NCT00925899|583494968|FG000|Part 1|Withdrawal by Subject|10|||
161575862|NCT00925899|583494969|FG001|Part 1|Withdrawal by Subject|9|||
161575863|NCT03648762|583494972|FG000|Overall Study|Lost to Follow-up|1|||
161575864|NCT03648762|583494973|FG001|Overall Study|Lost to Follow-up|2|||
161575865|NCT03648762|583494974|FG002|Overall Study|Lost to Follow-up|0|||
161575866|NCT03648762|583494972|FG000|Overall Study|Withdrawal by Subject|5|||
161575867|NCT03648762|583494973|FG001|Overall Study|Withdrawal by Subject|2|||
161575868|NCT03648762|583494974|FG002|Overall Study|Withdrawal by Subject|1|||
161575869|NCT01662336|583494984|FG000|Overall Study|Adverse Event|1|||
161575870|NCT01662336|583494984|FG000|Overall Study|No longer on LPV/r|30|||
161575871|NCT01662336|583494984|FG000|Overall Study|Other|29|||
161575872|NCT01662336|583494984|FG000|Overall Study|Withdrawal by Subject|6|||
161575873|NCT02189252|583494985|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161575874|NCT02189252|583494986|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
161575875|NCT02189252|583494987|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161575876|NCT02189252|583494988|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161575877|NCT02189252|583494985|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161575878|NCT02189252|583494986|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
161575879|NCT02189252|583494987|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161575880|NCT02189252|583494988|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161575883|NCT05764161|583494995|FG000|12-week DBVC Period|Lack of Efficacy|2|||
161575884|NCT05764161|583494996|FG001|12-week DBVC Period|Lack of Efficacy|1|||
161575885|NCT05764161|583494995|FG000|12-week DBVC Period|Lost to Follow-up|0|||
161575886|NCT05764161|583494996|FG001|12-week DBVC Period|Lost to Follow-up|2|||
161575887|NCT05764161|583494995|FG000|12-week DBVC Period|Protocol Violation|2|||
161575888|NCT05764161|583494996|FG001|12-week DBVC Period|Protocol Violation|4|||
161575889|NCT05764161|583494995|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
161575890|NCT05764161|583494996|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
161575891|NCT05764161|583494995|FG000|40-week OLE Period|Lack of Efficacy|0|||
161575892|NCT05764161|583494996|FG001|40-week OLE Period|Lack of Efficacy|1|||
161575893|NCT05764161|583494995|FG000|40-week OLE Period|Lost to Follow-up|1|||
161575894|NCT05764161|583494996|FG001|40-week OLE Period|Lost to Follow-up|4|||
161575895|NCT05764161|583494995|FG000|40-week OLE Period|Withdrawal by Subject|2|||
161575896|NCT05764161|583494996|FG001|40-week OLE Period|Withdrawal by Subject|7|||
161575897|NCT05764161|583494995|FG000|40-week OLE Period|Extended Travel|0|||
161575898|NCT05764161|583494996|FG001|40-week OLE Period|Extended Travel|1|||
161575899|NCT05764161|583494995|FG000|40-week OLE Period|Ongoing|66|||
161575900|NCT05764161|583494996|FG001|40-week OLE Period|Ongoing|59|||
161575901|NCT00507689|583494997|FG000|Pre-Randomization Period|Adverse Event|1|||
161468762|NCT00850343|583113382|FG002|Overall Study|Adverse Event|6|||
161468763|NCT00850343|583113383|FG003|Overall Study|Adverse Event|6|||
161468764|NCT00850343|583113380|FG000|Overall Study|Pregnancy|0|||
161575902|NCT00507689|583494998|FG001|Pre-Randomization Period|Adverse Event|0|||
161575903|NCT00507689|583494997|FG000|Pre-Randomization Period|Physician Decision|1|||
161575904|NCT00507689|583494998|FG001|Pre-Randomization Period|Physician Decision|0|||
161575905|NCT00507689|583494997|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
161575906|NCT00507689|583494998|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
161575907|NCT00507689|583494997|FG000|Randomized Period|Adverse Event|1|||
161575908|NCT00507689|583494998|FG001|Randomized Period|Adverse Event|1|||
161575909|NCT00507689|583494997|FG000|Randomized Period|Withdrawal by Subject|0|||
161575910|NCT00507689|583494998|FG001|Randomized Period|Withdrawal by Subject|1|||
161575911|NCT01241292|583494999|FG000|Overall Study|Administrative Reason by Sponsor|1|||
161468765|NCT00850343|583113381|FG001|Overall Study|Pregnancy|0|||
161468766|NCT00850343|583113382|FG002|Overall Study|Pregnancy|0|||
161468767|NCT00850343|583113383|FG003|Overall Study|Pregnancy|1|||
161468768|NCT00850343|583113380|FG000|Overall Study|Lack of Efficacy|17|||
161468769|NCT00850343|583113381|FG001|Overall Study|Lack of Efficacy|0|||
161468770|NCT00850343|583113382|FG002|Overall Study|Lack of Efficacy|3|||
161468771|NCT00850343|583113383|FG003|Overall Study|Lack of Efficacy|2|||
161468772|NCT00850343|583113380|FG000|Overall Study|Non-compliance with Study Procedures|1|||
161468773|NCT00850343|583113381|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161468774|NCT00850343|583113382|FG002|Overall Study|Non-compliance with Study Procedures|1|||
161468775|NCT00850343|583113383|FG003|Overall Study|Non-compliance with Study Procedures|1|||
161468776|NCT00850343|583113380|FG000|Overall Study|Physician Decision|2|||
161468777|NCT00850343|583113381|FG001|Overall Study|Physician Decision|1|||
161468778|NCT00850343|583113382|FG002|Overall Study|Physician Decision|1|||
161468779|NCT00850343|583113383|FG003|Overall Study|Physician Decision|1|||
161468780|NCT02468232|583113384|FG000|Core Part of Study|Adverse Event|0|||
161468781|NCT02468232|583113385|FG001|Core Part of Study|Adverse Event|1|||
161468782|NCT02468232|583113386|FG002|Core Part of Study|Adverse Event|0|||
161468783|NCT02468232|583113387|FG003|Core Part of Study|Adverse Event|0|||
161468784|NCT02468232|583113384|FG000|Core Part of Study|Death|20|||
161468785|NCT02468232|583113385|FG001|Core Part of Study|Death|17|||
161468786|NCT02468232|583113386|FG002|Core Part of Study|Death|0|||
161468787|NCT02468232|583113387|FG003|Core Part of Study|Death|0|||
161468788|NCT02468232|583113384|FG000|Core Part of Study|Technical Problems|1|||
161468789|NCT02468232|583113385|FG001|Core Part of Study|Technical Problems|1|||
161468790|NCT02468232|583113386|FG002|Core Part of Study|Technical Problems|0|||
161468791|NCT02468232|583113387|FG003|Core Part of Study|Technical Problems|0|||
161468792|NCT02468232|583113384|FG000|OLE Part of Study|Adverse Event|0|||
161468793|NCT02468232|583113385|FG001|OLE Part of Study|Adverse Event|0|||
161468794|NCT02468232|583113386|FG002|OLE Part of Study|Adverse Event|4|||
161468795|NCT02468232|583113387|FG003|OLE Part of Study|Adverse Event|5|||
161468796|NCT02468232|583113384|FG000|OLE Part of Study|Death|0|||
161468797|NCT02468232|583113385|FG001|OLE Part of Study|Death|0|||
161468798|NCT02468232|583113386|FG002|OLE Part of Study|Death|4|||
161468799|NCT02468232|583113387|FG003|OLE Part of Study|Death|2|||
161468800|NCT02468232|583113384|FG000|OLE Part of Study|Physician Decision|0|||
161468801|NCT02468232|583113385|FG001|OLE Part of Study|Physician Decision|0|||
161468802|NCT02468232|583113386|FG002|OLE Part of Study|Physician Decision|4|||
161468803|NCT02468232|583113387|FG003|OLE Part of Study|Physician Decision|0|||
161468804|NCT02468232|583113384|FG000|OLE Part of Study|Subject/Guardian decision|0|||
161468805|NCT02468232|583113385|FG001|OLE Part of Study|Subject/Guardian decision|0|||
161468806|NCT02468232|583113386|FG002|OLE Part of Study|Subject/Guardian decision|2|||
161575912|NCT01241292|583495000|FG001|Overall Study|Administrative Reason by Sponsor|0|||
161575913|NCT01241292|583494999|FG000|Overall Study|Disease Progression|2|||
161575914|NCT01241292|583495000|FG001|Overall Study|Disease Progression|0|||
161575915|NCT01241292|583494999|FG000|Overall Study|Study Drug Toxicity|0|||
161468807|NCT02468232|583113387|FG003|OLE Part of Study|Subject/Guardian decision|5|||
161468808|NCT02436304|583113388|FG000|Overall Study|Lost to Follow-up|0|||
161468809|NCT02436304|583113389|FG001|Overall Study|Lost to Follow-up|1|||
161575916|NCT01241292|583495000|FG001|Overall Study|Study Drug Toxicity|1|||
161575917|NCT01241292|583494999|FG000|Overall Study|Participant Discontinued Treatment|0|||
161468810|NCT02436304|583113390|FG002|Overall Study|Lost to Follow-up|0|||
161468811|NCT02436304|583113388|FG000|Overall Study|Withdrawal by Subject|0|||
161468812|NCT02436304|583113389|FG001|Overall Study|Withdrawal by Subject|1|||
161468813|NCT02436304|583113390|FG002|Overall Study|Withdrawal by Subject|0|||
161468814|NCT02436304|583113388|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
161575918|NCT01241292|583495000|FG001|Overall Study|Participant Discontinued Treatment|2|||
161575919|NCT03034915|583495003|FG000|Overall Study|Adverse Event|29|||
161575920|NCT03034915|583495004|FG001|Overall Study|Adverse Event|32|||
161468815|NCT02436304|583113389|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
161468816|NCT02436304|583113390|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
161468817|NCT04540497|583113395|FG000|Overall Study|Adverse Event|0|||
161668073|NCT00406653|583837481|FG005|Maintenance Period|Adverse Event|1|||
161668074|NCT00406653|583837482|FG006|Maintenance Period|Adverse Event|0|||
161668075|NCT00406653|583837476|FG000|Maintenance Period|Lack of Efficacy|0|||
161668076|NCT00406653|583837477|FG001|Maintenance Period|Lack of Efficacy|0|||
161668077|NCT00406653|583837478|FG002|Maintenance Period|Lack of Efficacy|0|||
161668078|NCT00406653|583837479|FG003|Maintenance Period|Lack of Efficacy|0|||
161668079|NCT00406653|583837480|FG004|Maintenance Period|Lack of Efficacy|20|||
161668080|NCT00406653|583837481|FG005|Maintenance Period|Lack of Efficacy|26|||
161811923|NCT00787254|584353159|FG000|Overall Study|NSAIDs discontinuation|1|||
161811924|NCT00787254|584353160|FG001|Overall Study|NSAIDs discontinuation|2|||
161668081|NCT00406653|583837482|FG006|Maintenance Period|Lack of Efficacy|0|||
161668082|NCT00406653|583837476|FG000|Maintenance Period|Lost to Follow-up|0|||
161668083|NCT00406653|583837477|FG001|Maintenance Period|Lost to Follow-up|0|||
161811925|NCT00787254|584353159|FG000|Overall Study|Institution closed|1|||
161811926|NCT00787254|584353160|FG001|Overall Study|Institution closed|0|||
161811927|NCT00787254|584353159|FG000|Overall Study|Physician Decision|4|||
161811928|NCT00787254|584353160|FG001|Overall Study|Physician Decision|8|||
161811929|NCT00316186|584353161|FG000|Overall Study|Adverse Event|6|||
161811930|NCT00316186|584353161|FG000|Overall Study|Disease Progression|4|||
161811931|NCT00316186|584353161|FG000|Overall Study|Lost to Follow-up|1|||
161811932|NCT00316186|584353161|FG000|Overall Study|Other|1|||
161811933|NCT01802320|584353164|FG000|Overall Study|Death|1|||
161811934|NCT01802320|584353164|FG000|Overall Study|Withdrawal by Subject|1|||
161811935|NCT05265624|584355009|FG000|Overall Study|Lost to Follow-up|3|||
161811936|NCT05265624|584355010|FG001|Overall Study|Lost to Follow-up|0|||
161811937|NCT05265624|584355009|FG000|Overall Study|Withdrawal by Subject|1|||
161811938|NCT05265624|584355010|FG001|Overall Study|Withdrawal by Subject|0|||
161811939|NCT00001703|584355011|FG000|Overall Study|progressed disease|2|||
161811940|NCT00001703|584355011|FG000|Overall Study|No evidence of disease|1|||
161811941|NCT00001703|584355011|FG000|Overall Study|recurrent disease|2|||
161811942|NCT00665925|584355012|FG000|Overall Study|Lack of Efficacy|10|||
161811943|NCT00665925|584355013|FG001|Overall Study|Lack of Efficacy|8|||
161811944|NCT00665925|584355014|FG002|Overall Study|Lack of Efficacy|9|||
161811945|NCT00665925|584355015|FG003|Overall Study|Lack of Efficacy|8|||
161811946|NCT00665925|584355012|FG000|Overall Study|Lost to Follow-up|1|||
161811947|NCT00665925|584355013|FG001|Overall Study|Lost to Follow-up|2|||
161811948|NCT00665925|584355014|FG002|Overall Study|Lost to Follow-up|2|||
161811949|NCT00665925|584355015|FG003|Overall Study|Lost to Follow-up|2|||
161811950|NCT00665925|584355012|FG000|Overall Study|Withdrawal by Subject|2|||
161811951|NCT00665925|584355013|FG001|Overall Study|Withdrawal by Subject|2|||
161811952|NCT00665925|584355014|FG002|Overall Study|Withdrawal by Subject|3|||
161811953|NCT00665925|584355015|FG003|Overall Study|Withdrawal by Subject|2|||
161811954|NCT00665925|584355012|FG000|Overall Study|Physician Decision|0|||
161811955|NCT00665925|584355013|FG001|Overall Study|Physician Decision|0|||
161811956|NCT00665925|584355014|FG002|Overall Study|Physician Decision|1|||
161811957|NCT00665925|584355015|FG003|Overall Study|Physician Decision|2|||
161811958|NCT00665925|584355012|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
161811959|NCT00665925|584355013|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
161811960|NCT00665925|584355014|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161811961|NCT00665925|584355015|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
161811962|NCT00665925|584355012|FG000|Overall Study|Adverse Event|1|||
161811963|NCT00665925|584355013|FG001|Overall Study|Adverse Event|5|||
161811964|NCT00665925|584355014|FG002|Overall Study|Adverse Event|10|||
161811965|NCT00665925|584355015|FG003|Overall Study|Adverse Event|5|||
161811966|NCT00665925|584355012|FG000|Overall Study|Enrolled by mistake|0|||
161811967|NCT00665925|584355013|FG001|Overall Study|Enrolled by mistake|0|||
161811968|NCT00665925|584355014|FG002|Overall Study|Enrolled by mistake|0|||
161811969|NCT00665925|584355015|FG003|Overall Study|Enrolled by mistake|1|||
161811970|NCT00665925|584355012|FG000|Overall Study|Due to exclusion criteria|1|||
161811971|NCT00665925|584355013|FG001|Overall Study|Due to exclusion criteria|0|||
161811972|NCT00665925|584355014|FG002|Overall Study|Due to exclusion criteria|0|||
161811973|NCT00665925|584355015|FG003|Overall Study|Due to exclusion criteria|0|||
161811974|NCT04035187|584355018|FG000|Overall Study|Withdrawal by Subject|2|||
161811975|NCT04035187|584355019|FG001|Overall Study|Withdrawal by Subject|1|||
161811976|NCT04035187|584355020|FG002|Overall Study|Withdrawal by Subject|0|||
161811977|NCT04035187|584355021|FG003|Overall Study|Withdrawal by Subject|0|||
161668084|NCT00406653|583837478|FG002|Maintenance Period|Lost to Follow-up|0|||
161668085|NCT00406653|583837479|FG003|Maintenance Period|Lost to Follow-up|0|||
161811978|NCT04035187|584355018|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
161811979|NCT04035187|584355019|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
161811980|NCT04035187|584355020|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
161811981|NCT04035187|584355021|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
161915770|NCT03507790|584740552|FG001|Overall Study|Non-compliance with study drug|0|||
161915771|NCT03507790|584740553|FG002|Overall Study|Non-compliance with study drug|1|||
161915772|NCT03507790|584740551|FG000|Overall Study|COVID 19 Pandemic|0|||
161468818|NCT04540497|583113396|FG001|Overall Study|Adverse Event|2|||
161468819|NCT04540497|583113395|FG000|Overall Study|Lost to Follow-up|1|||
161468820|NCT04540497|583113396|FG001|Overall Study|Lost to Follow-up|0|||
161468821|NCT04540497|583113395|FG000|Overall Study|Withdrawal by Subject|1|||
161468822|NCT04540497|583113396|FG001|Overall Study|Withdrawal by Subject|1|||
161468823|NCT04540497|583113395|FG000|Overall Study|Miscellaneous|2|||
161468824|NCT04540497|583113396|FG001|Overall Study|Miscellaneous|1|||
161468825|NCT05274815|583113400|FG000|Overall Study|Adverse Event|1|||
161468826|NCT05274815|583113400|FG000|Overall Study|Death|2|||
161468827|NCT05274815|583113400|FG000|Overall Study|Lost to Follow-up|4|||
161468828|NCT05274815|583113400|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
161468829|NCT05274815|583113400|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
161468830|NCT05274815|583113400|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
161468831|NCT05274815|583113400|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
161468832|NCT05274815|583113400|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
161468833|NCT05274815|583113400|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
161468834|NCT05274815|583113400|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
161468835|NCT05274815|583113400|FG000|Overall Study|Withdrawal by Subject|11|||
161468836|NCT04416633|583113401|FG000|Overall Study|Death|1|||
161468837|NCT04416633|583113401|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
161468838|NCT04416633|583113401|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
161468839|NCT04416633|583113401|FG000|Overall Study|Adverse Event|6|||
161468840|NCT04416633|583113401|FG000|Overall Study|Withdrawal by Subject|6|||
161468841|NCT03914326|583113402|FG000|Overall Study|Withdrawal by Subject|27|||
161468842|NCT03914326|583113403|FG001|Overall Study|Withdrawal by Subject|34|||
161468843|NCT03914326|583113402|FG000|Overall Study|Lost to Follow-up|43|||
161468844|NCT03914326|583113403|FG001|Overall Study|Lost to Follow-up|51|||
161468845|NCT03914326|583113402|FG000|Overall Study|Randomised more than once|0|||
161468846|NCT03914326|583113403|FG001|Overall Study|Randomised more than once|1|||
161468847|NCT04612790|583113404|FG000|DB Period (Up to 36 Weeks)|Death|1|||
161468848|NCT04612790|583113405|FG001|DB Period (Up to 36 Weeks)|Death|1|||
161468849|NCT04612790|583113406|FG002|DB Period (Up to 36 Weeks)|Death|0|||
161468850|NCT04612790|583113407|FG003|DB Period (Up to 36 Weeks)|Death|0|||
161468851|NCT04612790|583113404|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
161468852|NCT04612790|583113405|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
161468853|NCT04612790|583113406|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
161468854|NCT04612790|583113407|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
161468855|NCT04612790|583113404|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
161468856|NCT04612790|583113405|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
161468857|NCT04612790|583113406|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
161468858|NCT04612790|583113407|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
161468859|NCT04612790|583113404|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
161468860|NCT04612790|583113405|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
161468861|NCT04612790|583113406|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
161468862|NCT04612790|583113407|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
161468863|NCT04612790|583113404|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
161468864|NCT04612790|583113405|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
161468865|NCT04612790|583113406|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
161468866|NCT04612790|583113407|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
161468867|NCT04612790|583113404|FG000|DB Period (Up to 36 Weeks)|Other|1|||
161468868|NCT04612790|583113405|FG001|DB Period (Up to 36 Weeks)|Other|0|||
161468869|NCT04612790|583113406|FG002|DB Period (Up to 36 Weeks)|Other|0|||
161468870|NCT04612790|583113407|FG003|DB Period (Up to 36 Weeks)|Other|0|||
161468871|NCT04612790|583113404|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
161468872|NCT04612790|583113405|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
161468873|NCT04612790|583113406|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
161468874|NCT04612790|583113407|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
161468875|NCT04612790|583113404|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
161468876|NCT04612790|583113405|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
161468877|NCT04612790|583113406|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
161468878|NCT04612790|583113407|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
161575921|NCT03034915|583495005|FG002|Overall Study|Adverse Event|22|||
161575922|NCT03034915|583495003|FG000|Overall Study|Lost to Follow-up|5|||
161575923|NCT03034915|583495004|FG001|Overall Study|Lost to Follow-up|13|||
161575924|NCT03034915|583495005|FG002|Overall Study|Lost to Follow-up|3|||
161575925|NCT03034915|583495003|FG000|Overall Study|Withdrawal by Subject|29|||
161575926|NCT03034915|583495004|FG001|Overall Study|Withdrawal by Subject|46|||
161575927|NCT03034915|583495005|FG002|Overall Study|Withdrawal by Subject|41|||
161575928|NCT03034915|583495003|FG000|Overall Study|Protocol Deviation|2|||
161575929|NCT03034915|583495004|FG001|Overall Study|Protocol Deviation|14|||
161575930|NCT03034915|583495005|FG002|Overall Study|Protocol Deviation|7|||
161575931|NCT03034915|583495003|FG000|Overall Study|Lack of Efficacy|8|||
161468879|NCT04612790|583113404|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
161468880|NCT04612790|583113405|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
161468881|NCT04612790|583113406|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
161468882|NCT04612790|583113407|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
161468883|NCT04612790|583113404|FG000|OLE Period (Up to 1 Year)|Other|0|||
161468884|NCT04612790|583113405|FG001|OLE Period (Up to 1 Year)|Other|0|||
161468885|NCT04612790|583113406|FG002|OLE Period (Up to 1 Year)|Other|0|||
161468886|NCT04612790|583113407|FG003|OLE Period (Up to 1 Year)|Other|1|||
161468887|NCT00785928|583113408|FG000|Treatment Phase|Adverse Event|1|||
161468888|NCT00785928|583113409|FG001|Treatment Phase|Adverse Event|1|||
161468889|NCT00785928|583113410|FG002|Treatment Phase|Adverse Event|2|||
161468890|NCT00785928|583113411|FG003|Treatment Phase|Adverse Event|0|||
161468891|NCT00785928|583113412|FG004|Treatment Phase|Adverse Event|0|||
161468892|NCT00785928|583113413|FG005|Treatment Phase|Adverse Event|0|||
161468893|NCT00785928|583113414|FG006|Treatment Phase|Adverse Event|2|||
161468894|NCT00785928|583113408|FG000|Treatment Phase|Inadequate Response|0|||
161468895|NCT00785928|583113409|FG001|Treatment Phase|Inadequate Response|1|||
161468896|NCT00785928|583113410|FG002|Treatment Phase|Inadequate Response|0|||
161468897|NCT00785928|583113411|FG003|Treatment Phase|Inadequate Response|0|||
161468898|NCT00785928|583113412|FG004|Treatment Phase|Inadequate Response|0|||
161468899|NCT00785928|583113413|FG005|Treatment Phase|Inadequate Response|0|||
161468900|NCT00785928|583113414|FG006|Treatment Phase|Inadequate Response|0|||
161468901|NCT00785928|583113408|FG000|Treatment Phase|Lack of Efficacy|0|||
161468902|NCT00785928|583113409|FG001|Treatment Phase|Lack of Efficacy|1|||
161468903|NCT00785928|583113410|FG002|Treatment Phase|Lack of Efficacy|1|||
161468904|NCT00785928|583113411|FG003|Treatment Phase|Lack of Efficacy|0|||
161468905|NCT00785928|583113412|FG004|Treatment Phase|Lack of Efficacy|0|||
161468906|NCT00785928|583113413|FG005|Treatment Phase|Lack of Efficacy|0|||
161468907|NCT00785928|583113414|FG006|Treatment Phase|Lack of Efficacy|0|||
161468908|NCT00785928|583113408|FG000|Treatment Phase|Physician Decision|0|||
161468909|NCT00785928|583113409|FG001|Treatment Phase|Physician Decision|0|||
161468910|NCT00785928|583113410|FG002|Treatment Phase|Physician Decision|0|||
161468911|NCT00785928|583113411|FG003|Treatment Phase|Physician Decision|0|||
161468912|NCT00785928|583113412|FG004|Treatment Phase|Physician Decision|1|||
161468913|NCT00785928|583113413|FG005|Treatment Phase|Physician Decision|0|||
161468914|NCT00785928|583113414|FG006|Treatment Phase|Physician Decision|0|||
161468915|NCT00785928|583113408|FG000|Treatment Phase|Sponsor Decision|1|||
161468916|NCT00785928|583113409|FG001|Treatment Phase|Sponsor Decision|0|||
161468917|NCT00785928|583113410|FG002|Treatment Phase|Sponsor Decision|0|||
161468918|NCT00785928|583113411|FG003|Treatment Phase|Sponsor Decision|0|||
161468919|NCT00785928|583113412|FG004|Treatment Phase|Sponsor Decision|0|||
161468920|NCT00785928|583113413|FG005|Treatment Phase|Sponsor Decision|0|||
161468921|NCT00785928|583113414|FG006|Treatment Phase|Sponsor Decision|1|||
161468922|NCT00785928|583113408|FG000|Treatment Phase|Withdrawal by Subject|1|||
161468923|NCT00785928|583113409|FG001|Treatment Phase|Withdrawal by Subject|2|||
161468924|NCT00785928|583113410|FG002|Treatment Phase|Withdrawal by Subject|0|||
161468925|NCT00785928|583113411|FG003|Treatment Phase|Withdrawal by Subject|0|||
161468926|NCT00785928|583113412|FG004|Treatment Phase|Withdrawal by Subject|1|||
161468927|NCT00785928|583113413|FG005|Treatment Phase|Withdrawal by Subject|0|||
161468928|NCT00785928|583113414|FG006|Treatment Phase|Withdrawal by Subject|0|||
161468929|NCT03323502|583113420|FG000|Overall Study|Resident could not be linked to CMS data|594|||
161468930|NCT03323502|583113421|FG001|Overall Study|Resident could not be linked to CMS data|435|||
161468931|NCT03323502|583113420|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
161668086|NCT00406653|583837480|FG004|Maintenance Period|Lost to Follow-up|2|||
161668087|NCT00406653|583837481|FG005|Maintenance Period|Lost to Follow-up|1|||
161668088|NCT00406653|583837482|FG006|Maintenance Period|Lost to Follow-up|0|||
161668089|NCT00406653|583837476|FG000|Maintenance Period|Withdrawal of Consent|0|||
161668090|NCT00406653|583837477|FG001|Maintenance Period|Withdrawal of Consent|0|||
161811982|NCT03165994|584355034|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
161811983|NCT03165994|584355034|FG000|Overall Study|Death|2|||
161468932|NCT03323502|583113421|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
161468933|NCT03323502|583113420|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
161468934|NCT03323502|583113421|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
161468935|NCT03323502|583113420|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
161468936|NCT03323502|583113421|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
161468937|NCT03323502|583113420|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
161468938|NCT03323502|583113421|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
161468939|NCT01675427|583113426|FG000|Overall Study|Withdrawal by Subject|7|||
161468940|NCT01675427|583113426|FG000|Overall Study|Participant Refused Sample Collection|18|||
161468941|NCT01675427|583113426|FG000|Overall Study|Sample not Collected by Mistake|2|||
161668091|NCT00406653|583837478|FG002|Maintenance Period|Withdrawal of Consent|0|||
161668092|NCT00406653|583837479|FG003|Maintenance Period|Withdrawal of Consent|0|||
161468942|NCT01675427|583113426|FG000|Overall Study|Lost to Follow-up|5|||
161468943|NCT01675427|583113426|FG000|Overall Study|Other|2|||
161468944|NCT05021081|583113430|FG000|Phase 2|Subject enrolled in error|1|||
161468945|NCT05021081|583113431|FG001|Phase 2|Subject enrolled in error|1|||
161468946|NCT05021081|583113432|FG002|Phase 2|Subject enrolled in error|0|||
161468947|NCT01890746|583113437|FG000|Overall Study|Death|39|||
161468948|NCT01890746|583113438|FG001|Overall Study|Death|30|||
161468949|NCT01890746|583113437|FG000|Overall Study|Adverse Event|1|||
161468950|NCT01890746|583113438|FG001|Overall Study|Adverse Event|0|||
161468951|NCT01890746|583113437|FG000|Overall Study|Lost to Follow-up|4|||
161468952|NCT01890746|583113438|FG001|Overall Study|Lost to Follow-up|1|||
161468953|NCT01890746|583113437|FG000|Overall Study|Physician Decision|3|||
161468954|NCT01890746|583113438|FG001|Overall Study|Physician Decision|2|||
161468955|NCT01890746|583113437|FG000|Overall Study|Withdrawal by Subject|5|||
161468956|NCT01890746|583113438|FG001|Overall Study|Withdrawal by Subject|8|||
161468957|NCT03257371|583113443|FG000|Overall Study|Lost to Follow-up|1|||
161468958|NCT02477839|583113444|FG000|Overall Study|Adverse Event|0|||
161468959|NCT02477839|583113445|FG001|Overall Study|Adverse Event|1|||
161468960|NCT02477839|583113444|FG000|Overall Study|Protocol Violation|0|||
161468961|NCT02477839|583113445|FG001|Overall Study|Protocol Violation|2|||
161468962|NCT02477839|583113444|FG000|Overall Study|Withdrawal by Subject|3|||
161468963|NCT02477839|583113445|FG001|Overall Study|Withdrawal by Subject|3|||
161468964|NCT02477839|583113444|FG000|Overall Study|Participant had PGS during V6|0|||
161468965|NCT02477839|583113445|FG001|Overall Study|Participant had PGS during V6|1|||
161468966|NCT02477839|583113444|FG000|Overall Study|Parents decided to stop medication|0|||
161468967|NCT02477839|583113445|FG001|Overall Study|Parents decided to stop medication|1|||
161668093|NCT00406653|583837480|FG004|Maintenance Period|Withdrawal of Consent|2|||
161668094|NCT00406653|583837481|FG005|Maintenance Period|Withdrawal of Consent|0|||
161668095|NCT00406653|583837482|FG006|Maintenance Period|Withdrawal of Consent|0|||
161668096|NCT00406653|583837476|FG000|Maintenance Period|Pregnancy|0|||
161668097|NCT00406653|583837477|FG001|Maintenance Period|Pregnancy|0|||
161668098|NCT00406653|583837478|FG002|Maintenance Period|Pregnancy|0|||
161668099|NCT00406653|583837479|FG003|Maintenance Period|Pregnancy|0|||
161668100|NCT00406653|583837480|FG004|Maintenance Period|Pregnancy|0|||
161668101|NCT00406653|583837481|FG005|Maintenance Period|Pregnancy|1|||
161668102|NCT00406653|583837482|FG006|Maintenance Period|Pregnancy|0|||
161668103|NCT00406653|583837476|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
161668104|NCT00406653|583837477|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
161668105|NCT00406653|583837478|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
161668106|NCT00406653|583837479|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
161668107|NCT00406653|583837480|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
161668108|NCT00406653|583837481|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
161668109|NCT00406653|583837482|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
161668110|NCT00406653|583837476|FG000|Maintenance Period|Error in disease score evaluation|0|||
161668111|NCT00406653|583837477|FG001|Maintenance Period|Error in disease score evaluation|0|||
161668112|NCT00406653|583837478|FG002|Maintenance Period|Error in disease score evaluation|0|||
161668113|NCT00406653|583837479|FG003|Maintenance Period|Error in disease score evaluation|0|||
161668114|NCT00406653|583837480|FG004|Maintenance Period|Error in disease score evaluation|1|||
161668115|NCT00406653|583837481|FG005|Maintenance Period|Error in disease score evaluation|0|||
161668116|NCT00406653|583837482|FG006|Maintenance Period|Error in disease score evaluation|0|||
161668117|NCT00406653|583837476|FG000|Open-Label Period|Death|0|||
161468968|NCT02477839|583113444|FG000|Overall Study|Lack of tolerability|0|||
161468969|NCT02477839|583113445|FG001|Overall Study|Lack of tolerability|1|||
161668118|NCT00406653|583837477|FG001|Open-Label Period|Death|0|||
161668119|NCT00406653|583837478|FG002|Open-Label Period|Death|0|||
161668120|NCT00406653|583837479|FG003|Open-Label Period|Death|0|||
161668121|NCT00406653|583837480|FG004|Open-Label Period|Death|0|||
161668122|NCT00406653|583837481|FG005|Open-Label Period|Death|0|||
161915773|NCT03507790|584740552|FG001|Overall Study|COVID 19 Pandemic|1|||
161468970|NCT02477839|583113444|FG000|Overall Study|Exclusion criterion|0|||
161468971|NCT02477839|583113445|FG001|Overall Study|Exclusion criterion|1|||
161468972|NCT03114488|583113448|FG000|Time Period 2|Withdrawal by Subject|1|||
161468973|NCT03114488|583113449|FG001|Time Period 2|Withdrawal by Subject|3|||
161468974|NCT03711266|583113451|FG000|Overall Study|Lost to Follow-up|10|||
161468975|NCT03387683|583113452|FG000|Overall Study|In receipt of disallowed medication|1|||
161468976|NCT03387683|583113453|FG001|Overall Study|In receipt of disallowed medication|0|||
161468977|NCT03387683|583113452|FG000|Overall Study|Did not receive treatment|1|||
161468978|NCT03387683|583113453|FG001|Overall Study|Did not receive treatment|0|||
161468979|NCT00566501|583113456|FG000|Overall Study|Adverse Event|68|||
161468980|NCT00566501|583113457|FG001|Overall Study|Adverse Event|59|||
161468981|NCT00566501|583113456|FG000|Overall Study|Medication Non-compliance|5|||
161668123|NCT00406653|583837482|FG006|Open-Label Period|Death|1|||
161668124|NCT00406653|583837476|FG000|Open-Label Period|Adverse Event|0|||
161668125|NCT00406653|583837477|FG001|Open-Label Period|Adverse Event|0|||
161668126|NCT00406653|583837478|FG002|Open-Label Period|Adverse Event|0|||
161668127|NCT00406653|583837479|FG003|Open-Label Period|Adverse Event|0|||
161668128|NCT00406653|583837480|FG004|Open-Label Period|Adverse Event|0|||
161468982|NCT00566501|583113457|FG001|Overall Study|Medication Non-compliance|0|||
161468983|NCT00566501|583113456|FG000|Overall Study|Protocol Violation|2|||
161468984|NCT00566501|583113457|FG001|Overall Study|Protocol Violation|2|||
161468985|NCT00566501|583113456|FG000|Overall Study|Request of Investigator or Sponsor|6|||
161468986|NCT00566501|583113457|FG001|Overall Study|Request of Investigator or Sponsor|7|||
161468987|NCT00566501|583113456|FG000|Overall Study|Withdrawal by Subject|33|||
161468988|NCT00566501|583113457|FG001|Overall Study|Withdrawal by Subject|30|||
161468989|NCT00566501|583113456|FG000|Overall Study|Lack of Efficacy|8|||
161468990|NCT00566501|583113457|FG001|Overall Study|Lack of Efficacy|3|||
161468991|NCT00566501|583113456|FG000|Overall Study|Other|25|||
161468992|NCT00566501|583113457|FG001|Overall Study|Other|21|||
161468993|NCT00057876|583113460|FG000|Overall Study|Adverse Event|8|||
161468994|NCT00057876|583113461|FG001|Overall Study|Adverse Event|8|||
161468995|NCT00057876|583113460|FG000|Overall Study|Death|2|||
161468996|NCT00057876|583113461|FG001|Overall Study|Death|1|||
161468997|NCT00057876|583113460|FG000|Overall Study|Withdrawal by Subject|5|||
161468998|NCT00057876|583113461|FG001|Overall Study|Withdrawal by Subject|6|||
161468999|NCT00057876|583113460|FG000|Overall Study|Lack of Efficacy|10|||
161469000|NCT00057876|583113461|FG001|Overall Study|Lack of Efficacy|8|||
161469001|NCT00057876|583113460|FG000|Overall Study|Ineligible|1|||
161469002|NCT00057876|583113461|FG001|Overall Study|Ineligible|2|||
161469003|NCT00057876|583113460|FG000|Overall Study|other reason|2|||
161469004|NCT00057876|583113461|FG001|Overall Study|other reason|2|||
161469005|NCT00057876|583113460|FG000|Overall Study|other complicating disease|1|||
161469006|NCT00057876|583113461|FG001|Overall Study|other complicating disease|0|||
161469007|NCT05095454|583113462|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
161469008|NCT05095454|583113463|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
161469009|NCT01368432|583113464|FG000|Overall Study|Lost to Follow-up|0|||
161469010|NCT01368432|583113465|FG001|Overall Study|Lost to Follow-up|1|||
161469011|NCT00853073|583113466|FG000|Overall Study|Withdrawal by Subject|3|||
161469012|NCT00853073|583113467|FG001|Overall Study|Withdrawal by Subject|2|||
161469013|NCT02758171|583113468|FG000|Wash-out|Withdrawal by Subject|1|||
161469014|NCT02758171|583113469|FG001|Wash-out|Withdrawal by Subject|0|||
161469015|NCT02758171|583113468|FG000|Wash-out|Other reason|1|||
161469016|NCT02758171|583113469|FG001|Wash-out|Other reason|0|||
161469017|NCT01999114|583113470|FG000|Overall Study|Adverse Event|8|||
161469018|NCT01999114|583113471|FG001|Overall Study|Adverse Event|7|||
161469019|NCT01999114|583113472|FG002|Overall Study|Adverse Event|2|||
161469020|NCT01999114|583113473|FG003|Overall Study|Adverse Event|2|||
161469021|NCT01999114|583113474|FG004|Overall Study|Adverse Event|1|||
161469022|NCT01999114|583113470|FG000|Overall Study|Withdrawal by Subject|0|||
161469023|NCT01999114|583113471|FG001|Overall Study|Withdrawal by Subject|0|||
161469024|NCT01999114|583113472|FG002|Overall Study|Withdrawal by Subject|1|||
161469025|NCT01999114|583113473|FG003|Overall Study|Withdrawal by Subject|0|||
161469026|NCT01999114|583113474|FG004|Overall Study|Withdrawal by Subject|1|||
161469027|NCT01999114|583113470|FG000|Overall Study|Lost to Follow-up|0|||
161469028|NCT01999114|583113471|FG001|Overall Study|Lost to Follow-up|0|||
161469029|NCT01999114|583113472|FG002|Overall Study|Lost to Follow-up|1|||
161469030|NCT01999114|583113473|FG003|Overall Study|Lost to Follow-up|0|||
161469031|NCT01999114|583113474|FG004|Overall Study|Lost to Follow-up|0|||
161469032|NCT01999114|583113470|FG000|Overall Study|Administrative|0|||
161469033|NCT01999114|583113471|FG001|Overall Study|Administrative|0|||
161469034|NCT01999114|583113472|FG002|Overall Study|Administrative|1|||
161469035|NCT01999114|583113473|FG003|Overall Study|Administrative|1|||
161469036|NCT01999114|583113474|FG004|Overall Study|Administrative|2|||
161469037|NCT03840174|583113475|FG000|Overall Study|Withdrawal by Subject|1|||
161469038|NCT03840174|583113476|FG001|Overall Study|Withdrawal by Subject|0|||
161469039|NCT03840174|583113477|FG002|Overall Study|Withdrawal by Subject|0|||
161469040|NCT03840174|583113478|FG003|Overall Study|Withdrawal by Subject|0|||
161469041|NCT01008150|583113479|FG000|Overall Study|did not receive study drug|1|||
161469042|NCT01008150|583113480|FG001|Overall Study|did not receive study drug|1|||
161469043|NCT01008150|583113481|FG002|Overall Study|did not receive study drug|1|||
161469044|NCT01008150|583113482|FG003|Overall Study|did not receive study drug|0|||
161469045|NCT01497275|583113483|FG000|Overall Study|Death|1|||
161469046|NCT01497275|583113483|FG000|Overall Study|Adverse Event|1|||
161469047|NCT00381381|583113492|FG000|Overall Study|Adverse Event|3|||
161469048|NCT00381381|583113492|FG000|Overall Study|Lost to Follow-up|52|||
161469049|NCT00381381|583113492|FG000|Overall Study|Withdrawal by Subject|9|||
161469050|NCT00568685|583113493|FG000|Overall Study|Adverse Event|2|||
161575932|NCT03034915|583495004|FG001|Overall Study|Lack of Efficacy|16|||
161575933|NCT03034915|583495005|FG002|Overall Study|Lack of Efficacy|18|||
161575934|NCT03034915|583495003|FG000|Overall Study|Site closed|2|||
161575935|NCT03034915|583495004|FG001|Overall Study|Site closed|2|||
161575936|NCT03034915|583495005|FG002|Overall Study|Site closed|4|||
161575937|NCT03034915|583495003|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
161575938|NCT03034915|583495004|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
161575939|NCT03034915|583495005|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
161575940|NCT03034915|583495003|FG000|Overall Study|Physician Decision|1|||
161575941|NCT03034915|583495004|FG001|Overall Study|Physician Decision|5|||
161575942|NCT03034915|583495005|FG002|Overall Study|Physician Decision|2|||
161575943|NCT03861767|583495006|FG000|Overall Study|Withdrawal by Subject|2|||
161575944|NCT03861767|583495007|FG001|Overall Study|Withdrawal by Subject|1|||
161575945|NCT03861767|583495008|FG002|Overall Study|Withdrawal by Subject|0|||
161575946|NCT03861767|583495009|FG003|Overall Study|Withdrawal by Subject|5|||
161575947|NCT03861767|583495010|FG004|Overall Study|Withdrawal by Subject|2|||
161575948|NCT03861767|583495011|FG005|Overall Study|Withdrawal by Subject|1|||
161575949|NCT03861767|583495012|FG006|Overall Study|Withdrawal by Subject|3|||
161575950|NCT03861767|583495013|FG007|Overall Study|Withdrawal by Subject|1|||
161575951|NCT03861767|583495014|FG008|Overall Study|Withdrawal by Subject|0|||
161575952|NCT03861767|583495015|FG009|Overall Study|Withdrawal by Subject|5|||
161575953|NCT00346333|583495016|FG000|Overall Study|Death|1|||
161575954|NCT00346333|583495017|FG001|Overall Study|Death|0|||
161575955|NCT00346333|583495016|FG000|Overall Study|unwilling or unable to continue|4|||
161575956|NCT00346333|583495017|FG001|Overall Study|unwilling or unable to continue|8|||
161575957|NCT00588770|583495025|FG000|Overall Study|Disease progression|85|||
161575958|NCT00588770|583495026|FG001|Overall Study|Disease progression|68|||
161575959|NCT00588770|583495025|FG000|Overall Study|Adverse Event|29|||
161575960|NCT00588770|583495026|FG001|Overall Study|Adverse Event|58|||
161575961|NCT00588770|583495025|FG000|Overall Study|Death|13|||
161575962|NCT00588770|583495026|FG001|Overall Study|Death|22|||
161575963|NCT00588770|583495025|FG000|Overall Study|Withdrawal by Subject|15|||
161575964|NCT00588770|583495026|FG001|Overall Study|Withdrawal by Subject|25|||
161575965|NCT00588770|583495025|FG000|Overall Study|Alternative therapy|2|||
161575966|NCT00588770|583495026|FG001|Overall Study|Alternative therapy|4|||
161575967|NCT00588770|583495025|FG000|Overall Study|Other complicating disease|3|||
161575968|NCT00588770|583495026|FG001|Overall Study|Other complicating disease|2|||
161575969|NCT00588770|583495025|FG000|Overall Study|Not start protocol therapy|0|||
161575970|NCT00588770|583495026|FG001|Overall Study|Not start protocol therapy|9|||
161575971|NCT00588770|583495025|FG000|Overall Study|Lack of Efficacy|8|||
161575972|NCT00588770|583495026|FG001|Overall Study|Lack of Efficacy|10|||
161575973|NCT00588770|583495025|FG000|Overall Study|Physician discretion|2|||
161575974|NCT00588770|583495026|FG001|Overall Study|Physician discretion|0|||
161575975|NCT00588770|583495025|FG000|Overall Study|Patient non-compliance|2|||
161575976|NCT00588770|583495026|FG001|Overall Study|Patient non-compliance|2|||
161575977|NCT04697628|583495027|FG000|Overall Study|Withdrawal by Subject|17|||
161575978|NCT04697628|583495028|FG001|Overall Study|Withdrawal by Subject|23|||
161575979|NCT04697628|583495027|FG000|Overall Study|Lost to Follow-up|0|||
161575980|NCT04697628|583495028|FG001|Overall Study|Lost to Follow-up|4|||
161575981|NCT04697628|583495027|FG000|Overall Study|On-going in study|122|||
161575982|NCT04697628|583495028|FG001|Overall Study|On-going in study|91|||
161575983|NCT04177394|583495029|FG000|Overall Study|Death|16|||
161575984|NCT04177394|583495029|FG000|Overall Study|Withdrawal by Subject|19|||
161575985|NCT04177394|583495029|FG000|Overall Study|Missed visits|61|||
161575986|NCT04177394|583495029|FG000|Overall Study|Expected Visits|15|||
161575987|NCT00256243|583495030|FG000|Overall Study|Lost to Follow-up|2|||
161575988|NCT00256243|583495030|FG000|Overall Study|Death|7|||
161575989|NCT00256243|583495030|FG000|Overall Study|Not treated|1|||
161575990|NCT06129045|583495031|FG000|Overall Study|Lost to Follow-up|1|||
161575991|NCT06129045|583495032|FG001|Overall Study|Lost to Follow-up|1|||
161575992|NCT06129045|583495033|FG002|Overall Study|Lost to Follow-up|4|||
161575993|NCT02031471|583495034|FG000|24 Week Treatment Period|Adverse Event|6|||
161575994|NCT02031471|583495034|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
161575995|NCT02031471|583495034|FG000|24 Week Treatment Period|Protocol Violation|1|||
161575996|NCT02031471|583495034|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
161575997|NCT02031471|583495034|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
161575998|NCT02031471|583495034|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
161575999|NCT02031471|583495034|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
161576000|NCT00617201|583495038|FG000|Overall Study|Lost to Follow-up|9|||
161576001|NCT00617201|583495039|FG001|Overall Study|Lost to Follow-up|13|||
161469051|NCT00568685|583113494|FG001|Overall Study|Adverse Event|3|||
161469052|NCT00568685|583113495|FG002|Overall Study|Adverse Event|3|||
161469053|NCT00568685|583113493|FG000|Overall Study|Withdrawal by Subject|7|||
161469054|NCT00568685|583113494|FG001|Overall Study|Withdrawal by Subject|2|||
161469055|NCT00568685|583113495|FG002|Overall Study|Withdrawal by Subject|2|||
161469056|NCT00568685|583113493|FG000|Overall Study|Protocol Violation|1|||
161469057|NCT00568685|583113494|FG001|Overall Study|Protocol Violation|0|||
161469058|NCT00568685|583113495|FG002|Overall Study|Protocol Violation|0|||
161469059|NCT02787551|583113496|FG000|Core Period: 26 Weeks|Adverse Event|10|||
161469060|NCT02787551|583113497|FG001|Core Period: 26 Weeks|Adverse Event|0|||
161469061|NCT02787551|583113496|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
161469062|NCT02787551|583113497|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
161469063|NCT02787551|583113496|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
161469064|NCT02787551|583113497|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
161469065|NCT02787551|583113496|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
161469066|NCT02787551|583113497|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
161469067|NCT02787551|583113496|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
161469068|NCT02787551|583113497|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
161469069|NCT02787551|583113496|FG000|Core Period: 26 Weeks|Other than specified|3|||
161469070|NCT02787551|583113497|FG001|Core Period: 26 Weeks|Other than specified|1|||
161469071|NCT02787551|583113496|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
161469072|NCT02787551|583113497|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
161469073|NCT02787551|583113496|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
161469074|NCT02787551|583113497|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
161469075|NCT02787551|583113496|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
161469076|NCT02787551|583113497|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
161469077|NCT03799211|583113498|FG000|Overall Study|Lost to Follow-up|2|||
161469078|NCT03799211|583113499|FG001|Overall Study|Lost to Follow-up|13|||
161469079|NCT03799211|583113498|FG000|Overall Study|Withdrawal by Subject|2|||
161469080|NCT03799211|583113499|FG001|Overall Study|Withdrawal by Subject|0|||
161469081|NCT00764491|583113500|FG000|Overall Study|Lost to Follow-up|35|||
161469082|NCT00764491|583113501|FG001|Overall Study|Lost to Follow-up|17|||
161469083|NCT03538431|583113504|FG000|Overall Study|Physician Decision|0|||
161469084|NCT03538431|583113505|FG001|Overall Study|Physician Decision|1|||
161469085|NCT03538431|583113504|FG000|Overall Study|Withdrawal by Subject|1|||
161469086|NCT03538431|583113505|FG001|Overall Study|Withdrawal by Subject|0|||
161469087|NCT00620464|583113506|FG000|Overall Study|Adverse Event|15|||
161469088|NCT00620464|583113507|FG001|Overall Study|Adverse Event|17|||
161469089|NCT00620464|583113506|FG000|Overall Study|Lost to Follow-up|1|||
161469090|NCT00620464|583113507|FG001|Overall Study|Lost to Follow-up|1|||
161469091|NCT00620464|583113506|FG000|Overall Study|Planning Pregnancy|1|||
161469092|NCT00620464|583113507|FG001|Overall Study|Planning Pregnancy|4|||
161469093|NCT00620464|583113506|FG000|Overall Study|Personal|2|||
161469094|NCT00620464|583113507|FG001|Overall Study|Personal|2|||
161469095|NCT00620464|583113506|FG000|Overall Study|Used prohibited medication|1|||
161469096|NCT00620464|583113507|FG001|Overall Study|Used prohibited medication|0|||
161469097|NCT03139279|583113508|FG000|Overall Study|Physician Decision|2|||
161469098|NCT03139279|583113509|FG001|Overall Study|Physician Decision|0|||
161469099|NCT03139279|583113508|FG000|Overall Study|Protocol Violation|5|||
161469100|NCT03139279|583113509|FG001|Overall Study|Protocol Violation|4|||
161469101|NCT03139279|583113508|FG000|Overall Study|Withdrawal by Subject|0|||
161469102|NCT03139279|583113509|FG001|Overall Study|Withdrawal by Subject|2|||
161469103|NCT05394350|583113510|FG000|Overall Study|Death|2|||
161469104|NCT05394350|583113511|FG001|Overall Study|Death|2|||
161469105|NCT05394350|583113512|FG002|Overall Study|Death|4|||
161469106|NCT05394350|583113513|FG003|Overall Study|Death|0|||
161811984|NCT03165994|584355034|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
161811985|NCT03165994|584355034|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
161811986|NCT03165994|584355034|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
161811987|NCT03165994|584355034|FG000|Overall Study|Miscellaneous|1|||
161811988|NCT03600805|584355045|FG000|Overall Study|Adverse Event|2|||
161469107|NCT05394350|583113514|FG004|Overall Study|Death|1|||
161469108|NCT05394350|583113515|FG005|Overall Study|Death|0|||
161469109|NCT05394350|583113510|FG000|Overall Study|Study terminated by sponsor|1|||
161811989|NCT03600805|584355046|FG001|Overall Study|Adverse Event|1|||
161469110|NCT05394350|583113511|FG001|Overall Study|Study terminated by sponsor|1|||
161811990|NCT03600805|584355047|FG002|Overall Study|Adverse Event|1|||
161811991|NCT03600805|584355048|FG003|Overall Study|Adverse Event|7|||
161811992|NCT03600805|584355045|FG000|Overall Study|Lack of Efficacy|2|||
161811993|NCT03600805|584355046|FG001|Overall Study|Lack of Efficacy|1|||
161811994|NCT03600805|584355047|FG002|Overall Study|Lack of Efficacy|0|||
161811995|NCT03600805|584355048|FG003|Overall Study|Lack of Efficacy|0|||
161915774|NCT03507790|584740553|FG002|Overall Study|COVID 19 Pandemic|0|||
161811996|NCT03600805|584355045|FG000|Overall Study|Withdrawal by Subject|1|||
161811997|NCT03600805|584355046|FG001|Overall Study|Withdrawal by Subject|0|||
161811998|NCT03600805|584355047|FG002|Overall Study|Withdrawal by Subject|0|||
161469111|NCT05394350|583113512|FG002|Overall Study|Study terminated by sponsor|7|||
161469112|NCT05394350|583113513|FG003|Overall Study|Study terminated by sponsor|3|||
161469113|NCT05394350|583113514|FG004|Overall Study|Study terminated by sponsor|2|||
161469114|NCT05394350|583113515|FG005|Overall Study|Study terminated by sponsor|4|||
161469115|NCT02024555|583113520|FG000|Overall Study|Lost to Follow-up|1|||
161469116|NCT02024555|583113521|FG001|Overall Study|Lost to Follow-up|1|||
161469117|NCT02024555|583113520|FG000|Overall Study|Withdrawal by Subject|5|||
161469118|NCT02024555|583113521|FG001|Overall Study|Withdrawal by Subject|1|||
161469119|NCT00492050|583113522|FG000|Overall Study|Adverse Event|1|||
161469120|NCT00492050|583113522|FG000|Overall Study|Lack of Efficacy|1|||
161469121|NCT00492050|583113522|FG000|Overall Study|Withdrawal by Subject|3|||
161469122|NCT00492050|583113522|FG000|Overall Study|Unable to collect SCT|2|||
161469123|NCT00492050|583113522|FG000|Overall Study|Progressive Disease|2|||
161469124|NCT04246372|583115246|FG000|Overall Study|Adverse Event|1|||
161469125|NCT04246372|583115246|FG000|Overall Study|Withdrawal by Subject|1|||
161469126|NCT04246372|583115246|FG000|Overall Study|Protocol Violation|2|||
161469127|NCT04246372|583115246|FG000|Overall Study|Physician Decision|1|||
161469128|NCT00257608|583115248|FG000|Chemotherapy Phase|Adverse Event|138|||
161469129|NCT00257608|583115249|FG001|Chemotherapy Phase|Adverse Event|0|||
161469130|NCT00257608|583115250|FG002|Chemotherapy Phase|Adverse Event|0|||
161469131|NCT00257608|583115248|FG000|Chemotherapy Phase|Disease progression|139|||
161469132|NCT00257608|583115249|FG001|Chemotherapy Phase|Disease progression|0|||
161469133|NCT00257608|583115250|FG002|Chemotherapy Phase|Disease progression|0|||
161469134|NCT00257608|583115248|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
161469135|NCT00257608|583115249|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
161469136|NCT00257608|583115250|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
161469137|NCT00257608|583115248|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
161469138|NCT00257608|583115249|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
161469139|NCT00257608|583115250|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
161469140|NCT00257608|583115248|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
161469141|NCT00257608|583115249|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
161469142|NCT00257608|583115250|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
161469143|NCT00257608|583115248|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
161469144|NCT00257608|583115249|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
161469145|NCT00257608|583115250|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
161469146|NCT00257608|583115248|FG000|Chemotherapy Phase|Physician Decision|28|||
161469147|NCT00257608|583115249|FG001|Chemotherapy Phase|Physician Decision|0|||
161469148|NCT00257608|583115250|FG002|Chemotherapy Phase|Physician Decision|0|||
161469149|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Adverse Event|0|||
161469150|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Adverse Event|34|||
161469151|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Adverse Event|38|||
161469152|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Disease progression|0|||
161469153|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Disease progression|204|||
161469154|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Disease progression|168|||
161469155|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
161469156|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
161469157|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
161469158|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
161469159|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
161469160|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
161469161|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
161469162|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
161469163|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
161469164|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
161469165|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
161469166|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
161469167|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
161469168|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
161469169|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
161469170|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Physician Decision|0|||
161469171|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Physician Decision|8|||
161469172|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Physician Decision|11|||
161469173|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
161576002|NCT01350804|583495040|FG000|Core Study|Withdrawal by Subject|11|||
161469174|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
161469175|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
161469176|NCT00257608|583115248|FG000|Post Chemotherapy Phase|Not treated|0|||
161469177|NCT00257608|583115249|FG001|Post Chemotherapy Phase|Not treated|4|||
161469178|NCT00257608|583115250|FG002|Post Chemotherapy Phase|Not treated|7|||
161576003|NCT01350804|583495041|FG001|Core Study|Withdrawal by Subject|17|||
161915775|NCT03507790|584740551|FG000|Overall Study|Lost to Follow-up|0|||
161469179|NCT03673046|583115251|FG000|Overall Study|Adverse Event|1|||
161469180|NCT03673046|583115252|FG001|Overall Study|Adverse Event|1|||
161469181|NCT03673046|583115251|FG000|Overall Study|Withdrawal by Subject|8|||
161469182|NCT03673046|583115252|FG001|Overall Study|Withdrawal by Subject|2|||
161469183|NCT00392015|583115253|FG000|Overall Study|Lost to Follow-up|2|||
161668129|NCT00406653|583837481|FG005|Open-Label Period|Adverse Event|0|||
161668130|NCT00406653|583837482|FG006|Open-Label Period|Adverse Event|18|||
161668131|NCT00406653|583837476|FG000|Open-Label Period|Lack of Efficacy|0|||
161668132|NCT00406653|583837477|FG001|Open-Label Period|Lack of Efficacy|0|||
161668133|NCT00406653|583837478|FG002|Open-Label Period|Lack of Efficacy|0|||
161668134|NCT00406653|583837479|FG003|Open-Label Period|Lack of Efficacy|0|||
161668135|NCT00406653|583837480|FG004|Open-Label Period|Lack of Efficacy|0|||
161668136|NCT00406653|583837481|FG005|Open-Label Period|Lack of Efficacy|0|||
161668137|NCT00406653|583837482|FG006|Open-Label Period|Lack of Efficacy|160|||
161469184|NCT00392015|583115254|FG001|Overall Study|Lost to Follow-up|0|||
161469185|NCT00392015|583115255|FG002|Overall Study|Lost to Follow-up|2|||
161469186|NCT00392015|583115256|FG003|Overall Study|Lost to Follow-up|1|||
161668138|NCT00406653|583837476|FG000|Open-Label Period|Lost to Follow-up|0|||
161915776|NCT03507790|584740552|FG001|Overall Study|Lost to Follow-up|1|||
161915777|NCT03507790|584740553|FG002|Overall Study|Lost to Follow-up|0|||
161915778|NCT03507790|584740551|FG000|Overall Study|Discontinuation of the trial at the site|1|||
161915779|NCT03507790|584740552|FG001|Overall Study|Discontinuation of the trial at the site|1|||
161915780|NCT03507790|584740553|FG002|Overall Study|Discontinuation of the trial at the site|0|||
161915781|NCT03507790|584740551|FG000|Overall Study|Randomized in error|0|||
161915782|NCT03507790|584740552|FG001|Overall Study|Randomized in error|0|||
161915783|NCT03507790|584740553|FG002|Overall Study|Randomized in error|1|||
161915784|NCT00157755|584740555|FG000|Overall Study|Death|2|||
161915785|NCT00157755|584740556|FG001|Overall Study|Death|3|||
161915786|NCT00157755|584740557|FG002|Overall Study|Death|3|||
161915787|NCT00157755|584740558|FG003|Overall Study|Death|2|||
161915788|NCT00157755|584740559|FG004|Overall Study|Death|0|||
161915789|NCT00157755|584740560|FG005|Overall Study|Death|0|||
161915790|NCT00157755|584740555|FG000|Overall Study|Lost to Follow-up|0|||
161915791|NCT00157755|584740556|FG001|Overall Study|Lost to Follow-up|0|||
161915792|NCT00157755|584740557|FG002|Overall Study|Lost to Follow-up|1|||
161915793|NCT00157755|584740558|FG003|Overall Study|Lost to Follow-up|0|||
161915794|NCT00157755|584740559|FG004|Overall Study|Lost to Follow-up|0|||
161915795|NCT00157755|584740560|FG005|Overall Study|Lost to Follow-up|0|||
161915796|NCT00157755|584740555|FG000|Overall Study|Withdrawal by Subject|0|||
161915797|NCT00157755|584740556|FG001|Overall Study|Withdrawal by Subject|0|||
161915798|NCT00157755|584740557|FG002|Overall Study|Withdrawal by Subject|1|||
161915799|NCT00157755|584740558|FG003|Overall Study|Withdrawal by Subject|1|||
161915800|NCT00157755|584740559|FG004|Overall Study|Withdrawal by Subject|1|||
161915801|NCT00157755|584740560|FG005|Overall Study|Withdrawal by Subject|2|||
161915802|NCT00157755|584740555|FG000|Overall Study|Explant due to infection|0|||
161915803|NCT00157755|584740556|FG001|Overall Study|Explant due to infection|0|||
161915804|NCT00157755|584740557|FG002|Overall Study|Explant due to infection|1|||
161915805|NCT00157755|584740558|FG003|Overall Study|Explant due to infection|0|||
161915806|NCT00157755|584740559|FG004|Overall Study|Explant due to infection|0|||
161915807|NCT00157755|584740560|FG005|Overall Study|Explant due to infection|0|||
161915808|NCT00157755|584740555|FG000|Overall Study|Medical reason|0|||
161915809|NCT00157755|584740556|FG001|Overall Study|Medical reason|0|||
161915810|NCT00157755|584740557|FG002|Overall Study|Medical reason|1|||
161915811|NCT00157755|584740558|FG003|Overall Study|Medical reason|1|||
161915812|NCT00157755|584740559|FG004|Overall Study|Medical reason|0|||
161915813|NCT00157755|584740560|FG005|Overall Study|Medical reason|0|||
161915814|NCT00157755|584740555|FG000|Overall Study|Study site closure|0|||
161915815|NCT00157755|584740556|FG001|Overall Study|Study site closure|1|||
161915816|NCT00157755|584740557|FG002|Overall Study|Study site closure|0|||
161915817|NCT00157755|584740558|FG003|Overall Study|Study site closure|0|||
161915818|NCT00157755|584740559|FG004|Overall Study|Study site closure|0|||
161915819|NCT00157755|584740560|FG005|Overall Study|Study site closure|0|||
161915820|NCT00157755|584740555|FG000|Overall Study|Subject non-compliance|0|||
161915821|NCT00157755|584740556|FG001|Overall Study|Subject non-compliance|0|||
161915822|NCT00157755|584740557|FG002|Overall Study|Subject non-compliance|0|||
161915823|NCT00157755|584740558|FG003|Overall Study|Subject non-compliance|0|||
161915824|NCT00157755|584740559|FG004|Overall Study|Subject non-compliance|0|||
161915825|NCT00157755|584740560|FG005|Overall Study|Subject non-compliance|1|||
161915826|NCT00157755|584740555|FG000|Overall Study|Study completion|0|||
161915827|NCT00157755|584740556|FG001|Overall Study|Study completion|0|||
161915828|NCT00157755|584740557|FG002|Overall Study|Study completion|0|||
161915829|NCT00157755|584740558|FG003|Overall Study|Study completion|0|||
161915830|NCT00157755|584740559|FG004|Overall Study|Study completion|1|||
161915831|NCT00157755|584740560|FG005|Overall Study|Study completion|2|||
161915832|NCT00671788|584740564|FG000|Overall Study|Adverse Event|8|||
161915833|NCT00671788|584740564|FG000|Overall Study|Refused further treatment|3|||
161469187|NCT00392015|583115257|FG004|Overall Study|Lost to Follow-up|1|||
161469188|NCT00392015|583115258|FG005|Overall Study|Lost to Follow-up|0|||
161469189|NCT00392015|583115253|FG000|Overall Study|Withdrawal by Subject|0|||
161469190|NCT00392015|583115254|FG001|Overall Study|Withdrawal by Subject|0|||
161469191|NCT00392015|583115255|FG002|Overall Study|Withdrawal by Subject|2|||
161469192|NCT00392015|583115256|FG003|Overall Study|Withdrawal by Subject|0|||
161469193|NCT00392015|583115257|FG004|Overall Study|Withdrawal by Subject|0|||
161469194|NCT00392015|583115258|FG005|Overall Study|Withdrawal by Subject|0|||
161469195|NCT00392015|583115253|FG000|Overall Study|Adverse Event|0|||
161469196|NCT00392015|583115254|FG001|Overall Study|Adverse Event|0|||
161469197|NCT00392015|583115255|FG002|Overall Study|Adverse Event|0|||
161469198|NCT00392015|583115256|FG003|Overall Study|Adverse Event|0|||
161469199|NCT00392015|583115257|FG004|Overall Study|Adverse Event|1|||
161469200|NCT00392015|583115258|FG005|Overall Study|Adverse Event|0|||
161469201|NCT00392015|583115253|FG000|Overall Study|Previous trial recipient|0|||
161469202|NCT00392015|583115254|FG001|Overall Study|Previous trial recipient|0|||
161469203|NCT00392015|583115255|FG002|Overall Study|Previous trial recipient|0|||
161469204|NCT00392015|583115256|FG003|Overall Study|Previous trial recipient|0|||
161469205|NCT00392015|583115257|FG004|Overall Study|Previous trial recipient|1|||
161469206|NCT00392015|583115258|FG005|Overall Study|Previous trial recipient|0|||
161469207|NCT03693300|583115260|FG000|Overall Study|Withdrawal by Subject|6|||
161469208|NCT03693300|583115261|FG001|Overall Study|Withdrawal by Subject|0|||
161469209|NCT03693300|583115260|FG000|Overall Study|Death|50|||
161469210|NCT03693300|583115261|FG001|Overall Study|Death|2|||
161469211|NCT03693300|583115260|FG000|Overall Study|Lost to Follow-up|2|||
161469212|NCT03693300|583115261|FG001|Overall Study|Lost to Follow-up|0|||
161469213|NCT00537238|583115262|FG000|Overall Study|Death|1|||
161469214|NCT00537238|583115263|FG001|Overall Study|Death|2|||
161469215|NCT00537238|583115262|FG000|Overall Study|Adverse Event|31|||
161469216|NCT00537238|583115263|FG001|Overall Study|Adverse Event|22|||
161469217|NCT00537238|583115262|FG000|Overall Study|Lack of Efficacy|20|||
161469218|NCT00537238|583115263|FG001|Overall Study|Lack of Efficacy|21|||
161469219|NCT00537238|583115262|FG000|Overall Study|Lost to Follow-up|12|||
161469220|NCT00537238|583115263|FG001|Overall Study|Lost to Follow-up|8|||
161469221|NCT00537238|583115262|FG000|Overall Study|Withdrawal by Subject|51|||
161469222|NCT00537238|583115263|FG001|Overall Study|Withdrawal by Subject|47|||
161469223|NCT00537238|583115262|FG000|Overall Study|Protocol Violation|15|||
161469224|NCT00537238|583115263|FG001|Overall Study|Protocol Violation|19|||
161469225|NCT00537238|583115262|FG000|Overall Study|Does not meet entrance criteria|0|||
161469226|NCT00537238|583115263|FG001|Overall Study|Does not meet entrance criteria|2|||
161469227|NCT00537238|583115262|FG000|Overall Study|Other|44|||
161469228|NCT00537238|583115263|FG001|Overall Study|Other|52|||
161469229|NCT03265665|583115266|FG000|24-week Data Collection|Withdrawal by Subject|2|||
161469230|NCT03265665|583115267|FG001|24-week Data Collection|Withdrawal by Subject|2|||
161469231|NCT03265665|583115266|FG000|24-week Data Collection|Lost to Follow-up|4|||
161469232|NCT03265665|583115267|FG001|24-week Data Collection|Lost to Follow-up|5|||
161469233|NCT03265665|583115266|FG000|36-week Data Collection|Lost to Follow-up|6|||
161469234|NCT03265665|583115267|FG001|36-week Data Collection|Lost to Follow-up|8|||
161469235|NCT01858376|583115268|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
161469236|NCT01680965|583115272|FG000|Overall Study|Death|0|||
161668139|NCT00406653|583837477|FG001|Open-Label Period|Lost to Follow-up|0|||
161668140|NCT00406653|583837478|FG002|Open-Label Period|Lost to Follow-up|0|||
161668141|NCT00406653|583837479|FG003|Open-Label Period|Lost to Follow-up|0|||
161668142|NCT00406653|583837480|FG004|Open-Label Period|Lost to Follow-up|0|||
161469237|NCT01680965|583115273|FG001|Overall Study|Death|0|||
161469238|NCT01680965|583115274|FG002|Overall Study|Death|0|||
161469239|NCT01680965|583115275|FG003|Overall Study|Death|6|||
161469240|NCT02486302|583115287|FG000|Overall Study|Discontinued prematurely|410|||
161469241|NCT02486302|583115287|FG000|Overall Study|Documentation not completed|255|||
161469242|NCT02486302|583115287|FG000|Overall Study|Excluded due to legal reasons|8|||
161469243|NCT02486302|583115287|FG000|Overall Study|Not treated|3|||
161469244|NCT00734474|583115290|FG000|Overall Study|Entry Criteria Not Met|0|||
161668143|NCT00406653|583837481|FG005|Open-Label Period|Lost to Follow-up|0|||
161668144|NCT00406653|583837482|FG006|Open-Label Period|Lost to Follow-up|6|||
161915834|NCT00671788|584740564|FG000|Overall Study|Ineligible|1|||
161469245|NCT00734474|583115291|FG001|Overall Study|Entry Criteria Not Met|0|||
161469246|NCT00734474|583115292|FG002|Overall Study|Entry Criteria Not Met|5|||
161469247|NCT00734474|583115293|FG003|Overall Study|Entry Criteria Not Met|0|||
161469248|NCT00734474|583115294|FG004|Overall Study|Entry Criteria Not Met|3|||
161469249|NCT00734474|583115295|FG005|Overall Study|Entry Criteria Not Met|1|||
161469250|NCT00734474|583115296|FG006|Overall Study|Entry Criteria Not Met|0|||
161469251|NCT00734474|583115297|FG007|Overall Study|Entry Criteria Not Met|1|||
161469252|NCT00734474|583115298|FG008|Overall Study|Entry Criteria Not Met|1|||
161469253|NCT00734474|583115290|FG000|Overall Study|Lost to Follow-up|1|||
161469254|NCT00734474|583115291|FG001|Overall Study|Lost to Follow-up|0|||
161469255|NCT00734474|583115292|FG002|Overall Study|Lost to Follow-up|13|||
161469256|NCT00734474|583115293|FG003|Overall Study|Lost to Follow-up|0|||
161668145|NCT00406653|583837476|FG000|Open-Label Period|Withdrawal of Consent|0|||
161469257|NCT00734474|583115294|FG004|Overall Study|Lost to Follow-up|11|||
161469258|NCT00734474|583115295|FG005|Overall Study|Lost to Follow-up|1|||
161469259|NCT00734474|583115296|FG006|Overall Study|Lost to Follow-up|0|||
161469260|NCT00734474|583115297|FG007|Overall Study|Lost to Follow-up|9|||
161469261|NCT00734474|583115298|FG008|Overall Study|Lost to Follow-up|4|||
161668146|NCT00406653|583837477|FG001|Open-Label Period|Withdrawal of Consent|0|||
161668147|NCT00406653|583837478|FG002|Open-Label Period|Withdrawal of Consent|0|||
161668148|NCT00406653|583837479|FG003|Open-Label Period|Withdrawal of Consent|0|||
161668149|NCT00406653|583837480|FG004|Open-Label Period|Withdrawal of Consent|0|||
161668150|NCT00406653|583837481|FG005|Open-Label Period|Withdrawal of Consent|0|||
161668151|NCT00406653|583837482|FG006|Open-Label Period|Withdrawal of Consent|11|||
161668152|NCT00406653|583837476|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161668153|NCT00406653|583837477|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161668154|NCT00406653|583837478|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161668155|NCT00406653|583837479|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161668156|NCT00406653|583837480|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161469262|NCT00734474|583115290|FG000|Overall Study|Withdrawal by Subject|2|||
161469263|NCT00734474|583115291|FG001|Overall Study|Withdrawal by Subject|1|||
161469264|NCT00734474|583115292|FG002|Overall Study|Withdrawal by Subject|18|||
161469265|NCT00734474|583115293|FG003|Overall Study|Withdrawal by Subject|0|||
161469266|NCT00734474|583115294|FG004|Overall Study|Withdrawal by Subject|24|||
161469267|NCT00734474|583115295|FG005|Overall Study|Withdrawal by Subject|2|||
161469268|NCT00734474|583115296|FG006|Overall Study|Withdrawal by Subject|0|||
161469269|NCT00734474|583115297|FG007|Overall Study|Withdrawal by Subject|36|||
161469270|NCT00734474|583115298|FG008|Overall Study|Withdrawal by Subject|21|||
161469271|NCT00734474|583115290|FG000|Overall Study|Physician Decision|0|||
161469272|NCT00734474|583115291|FG001|Overall Study|Physician Decision|0|||
161469273|NCT00734474|583115292|FG002|Overall Study|Physician Decision|4|||
161469274|NCT00734474|583115293|FG003|Overall Study|Physician Decision|1|||
161469275|NCT00734474|583115294|FG004|Overall Study|Physician Decision|11|||
161469276|NCT00734474|583115295|FG005|Overall Study|Physician Decision|0|||
161469277|NCT00734474|583115296|FG006|Overall Study|Physician Decision|0|||
161469278|NCT00734474|583115297|FG007|Overall Study|Physician Decision|9|||
161469279|NCT00734474|583115298|FG008|Overall Study|Physician Decision|9|||
161469280|NCT00734474|583115290|FG000|Overall Study|Adverse Event|4|||
161469281|NCT00734474|583115291|FG001|Overall Study|Adverse Event|4|||
161469282|NCT00734474|583115292|FG002|Overall Study|Adverse Event|63|||
161469283|NCT00734474|583115293|FG003|Overall Study|Adverse Event|1|||
161469284|NCT00734474|583115294|FG004|Overall Study|Adverse Event|64|||
161469285|NCT00734474|583115295|FG005|Overall Study|Adverse Event|0|||
161469286|NCT00734474|583115296|FG006|Overall Study|Adverse Event|1|||
161469287|NCT00734474|583115297|FG007|Overall Study|Adverse Event|65|||
161469288|NCT00734474|583115298|FG008|Overall Study|Adverse Event|39|||
161469289|NCT00734474|583115290|FG000|Overall Study|Protocol Violation|0|||
161469290|NCT00734474|583115291|FG001|Overall Study|Protocol Violation|0|||
161469291|NCT00734474|583115292|FG002|Overall Study|Protocol Violation|4|||
161469292|NCT00734474|583115293|FG003|Overall Study|Protocol Violation|0|||
161668157|NCT00406653|583837481|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161668158|NCT00406653|583837482|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
161668159|NCT00406653|583837476|FG000|Open-Label Period|Pregnancy|0|||
161469293|NCT00734474|583115294|FG004|Overall Study|Protocol Violation|3|||
161469294|NCT00734474|583115295|FG005|Overall Study|Protocol Violation|0|||
161469295|NCT00734474|583115296|FG006|Overall Study|Protocol Violation|0|||
161469296|NCT00734474|583115297|FG007|Overall Study|Protocol Violation|3|||
161469297|NCT00734474|583115298|FG008|Overall Study|Protocol Violation|1|||
161469298|NCT00734474|583115290|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
161469299|NCT00734474|583115291|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
161469300|NCT00734474|583115292|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
161469301|NCT00734474|583115293|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
161469302|NCT00734474|583115294|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
161469303|NCT00734474|583115295|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
161469304|NCT00734474|583115296|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
161469305|NCT00734474|583115297|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
161469306|NCT00734474|583115298|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
161469307|NCT00734474|583115290|FG000|Overall Study|Sponsor Decision|0|||
161469308|NCT00734474|583115291|FG001|Overall Study|Sponsor Decision|0|||
161469309|NCT00734474|583115292|FG002|Overall Study|Sponsor Decision|0|||
161469310|NCT00734474|583115293|FG003|Overall Study|Sponsor Decision|0|||
161469311|NCT00734474|583115294|FG004|Overall Study|Sponsor Decision|2|||
161668160|NCT00406653|583837477|FG001|Open-Label Period|Pregnancy|0|||
161668161|NCT00406653|583837478|FG002|Open-Label Period|Pregnancy|0|||
161469312|NCT00734474|583115295|FG005|Overall Study|Sponsor Decision|0|||
161469313|NCT00734474|583115296|FG006|Overall Study|Sponsor Decision|0|||
161469314|NCT00734474|583115297|FG007|Overall Study|Sponsor Decision|0|||
161469315|NCT00734474|583115298|FG008|Overall Study|Sponsor Decision|0|||
161469316|NCT00734474|583115290|FG000|Overall Study|Death|0|||
161469317|NCT00734474|583115291|FG001|Overall Study|Death|0|||
161469318|NCT00734474|583115292|FG002|Overall Study|Death|1|||
161469319|NCT00734474|583115293|FG003|Overall Study|Death|0|||
161469320|NCT00734474|583115294|FG004|Overall Study|Death|0|||
161469321|NCT00734474|583115295|FG005|Overall Study|Death|0|||
161469322|NCT00734474|583115296|FG006|Overall Study|Death|0|||
161469323|NCT00734474|583115297|FG007|Overall Study|Death|2|||
161469324|NCT00734474|583115298|FG008|Overall Study|Death|1|||
161469325|NCT00734474|583115290|FG000|Overall Study|Lack of Efficacy|0|||
161469326|NCT00734474|583115291|FG001|Overall Study|Lack of Efficacy|0|||
161469327|NCT00734474|583115292|FG002|Overall Study|Lack of Efficacy|4|||
161469328|NCT00734474|583115293|FG003|Overall Study|Lack of Efficacy|0|||
161469329|NCT00734474|583115294|FG004|Overall Study|Lack of Efficacy|0|||
161469330|NCT00734474|583115295|FG005|Overall Study|Lack of Efficacy|0|||
161469331|NCT00734474|583115296|FG006|Overall Study|Lack of Efficacy|0|||
161469332|NCT00734474|583115297|FG007|Overall Study|Lack of Efficacy|4|||
161469333|NCT00734474|583115298|FG008|Overall Study|Lack of Efficacy|6|||
161469334|NCT02104752|583115299|FG000|Overall Study|Withdrawal by Subject|1|||
161469335|NCT02104752|583115300|FG001|Overall Study|Withdrawal by Subject|0|||
161469336|NCT02104752|583115299|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
161469337|NCT02104752|583115300|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
161469338|NCT02899299|583115301|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
161469339|NCT02899299|583115302|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
161469340|NCT02899299|583115301|FG000|Pre-treatment|Participant withdrew consent|1|||
161469341|NCT02899299|583115302|FG001|Pre-treatment|Participant withdrew consent|11|||
161469342|NCT02899299|583115301|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
161469343|NCT02899299|583115302|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
161469344|NCT02899299|583115301|FG000|Pre-treatment|Not reported|0|||
161469345|NCT02899299|583115302|FG001|Pre-treatment|Not reported|1|||
161469346|NCT02899299|583115301|FG000|Treatment|Disease Progression|182|||
161469347|NCT02899299|583115302|FG001|Treatment|Disease Progression|43|||
161469348|NCT02899299|583115301|FG000|Treatment|Study Drug Toxicity|60|||
161469349|NCT02899299|583115302|FG001|Treatment|Study Drug Toxicity|24|||
161469350|NCT02899299|583115301|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
161469351|NCT02899299|583115302|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
161469352|NCT02899299|583115301|FG000|Treatment|Participant request to discontinue Study treatment|4|||
161469353|NCT02899299|583115302|FG001|Treatment|Participant request to discontinue Study treatment|10|||
161469354|NCT02899299|583115301|FG000|Treatment|Participant withdrew consent|6|||
161469355|NCT02899299|583115302|FG001|Treatment|Participant withdrew consent|3|||
161469356|NCT02899299|583115301|FG000|Treatment|Lost to Follow-up|0|||
161469357|NCT02899299|583115302|FG001|Treatment|Lost to Follow-up|2|||
161469358|NCT02899299|583115301|FG000|Treatment|Maximum Clinical Benefit|11|||
161469359|NCT02899299|583115302|FG001|Treatment|Maximum Clinical Benefit|2|||
161469360|NCT02899299|583115301|FG000|Treatment|Poor/Non-compliance|1|||
161469361|NCT02899299|583115302|FG001|Treatment|Poor/Non-compliance|0|||
161469362|NCT02899299|583115301|FG000|Treatment|Participant no longer meets Study criteria|4|||
161469363|NCT02899299|583115302|FG001|Treatment|Participant no longer meets Study criteria|0|||
161469364|NCT02899299|583115301|FG000|Treatment|Administrative reason by Sponsor|2|||
161469365|NCT02899299|583115302|FG001|Treatment|Administrative reason by Sponsor|0|||
161469366|NCT02899299|583115301|FG000|Treatment|Other reasons|12|||
161469367|NCT02899299|583115302|FG001|Treatment|Other reasons|2|||
161469368|NCT02899299|583115301|FG000|Treatment|Not reported|7|||
161469369|NCT02899299|583115302|FG001|Treatment|Not reported|0|||
161469370|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
161469371|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
161576004|NCT01350804|583495042|FG002|Core Study|Withdrawal by Subject|16|||
161576005|NCT01350804|583495043|FG003|Core Study|Withdrawal by Subject|7|||
161576006|NCT01350804|583495040|FG000|Core Study|Study terminated by Sponsor|0|||
161576007|NCT01350804|583495041|FG001|Core Study|Study terminated by Sponsor|0|||
161576008|NCT01350804|583495042|FG002|Core Study|Study terminated by Sponsor|0|||
161576009|NCT01350804|583495043|FG003|Core Study|Study terminated by Sponsor|2|||
161576010|NCT01350804|583495040|FG000|Core Study|Protocol deviation|1|||
161576011|NCT01350804|583495041|FG001|Core Study|Protocol deviation|0|||
161576012|NCT01350804|583495042|FG002|Core Study|Protocol deviation|1|||
161576013|NCT01350804|583495043|FG003|Core Study|Protocol deviation|0|||
161469372|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
161469373|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
161469374|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
161469375|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
161469376|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
161469377|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
161469378|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
161469379|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
161469380|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
161469381|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
161469382|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
161469383|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
161469384|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
161469385|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
161469386|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
161469387|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
161469388|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
161469389|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
161469390|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
161469391|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
161469392|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
161469393|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
161469394|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
161469395|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
161469396|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
161469397|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
161469398|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
161469399|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
161469400|NCT00313300|583115303|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
161469401|NCT00313300|583115304|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
161469402|NCT00313300|583115305|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
161469403|NCT00313300|583115306|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
161469404|NCT00313300|583115307|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
161469405|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
161469406|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
161469407|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
161469408|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
161469409|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
161469410|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
161469411|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
161469412|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
161469413|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
161469414|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
161469415|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
161469416|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
161469417|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
161469418|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
161469419|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
161469420|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
161469421|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
161469422|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
161469423|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
161469424|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
161469425|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
161469426|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
161469427|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
161469428|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
161469429|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
161469430|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
161469431|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
161469432|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
161469433|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
161469434|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
161469435|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
161469436|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
161469437|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
161469438|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
161469439|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
161469440|NCT00313300|583115303|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
161469441|NCT00313300|583115304|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
161469442|NCT00313300|583115305|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
161469443|NCT00313300|583115306|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
161469444|NCT00313300|583115307|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
161469445|NCT00313300|583115303|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
161469446|NCT00313300|583115304|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
161469447|NCT00313300|583115305|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
161469448|NCT00313300|583115306|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
161469449|NCT00313300|583115307|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
161469450|NCT00313300|583115303|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
161469451|NCT00313300|583115304|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
161469452|NCT00313300|583115305|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
161469453|NCT00313300|583115306|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
161469454|NCT00313300|583115307|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
161469455|NCT00313300|583115303|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
161469456|NCT00313300|583115304|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
161469457|NCT00313300|583115305|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
161469458|NCT00313300|583115306|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
161469459|NCT00313300|583115307|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
161469460|NCT00313300|583115303|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
161469461|NCT00313300|583115304|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
161469462|NCT00313300|583115305|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
161469463|NCT00313300|583115306|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
161469464|NCT00313300|583115307|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
161469465|NCT00313300|583115303|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
161469466|NCT00313300|583115304|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
161469467|NCT00313300|583115305|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
161469468|NCT00313300|583115306|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
161469469|NCT00313300|583115307|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
161469470|NCT00313300|583115303|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
161469471|NCT00313300|583115304|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
161469472|NCT00313300|583115305|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
161469473|NCT00313300|583115306|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
161469474|NCT00313300|583115307|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
161469475|NCT00902668|583115316|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
161469476|NCT01914757|583115317|FG000|Overall Study|Severe non-compliance to protocol|3|||
161469477|NCT01914757|583115318|FG001|Overall Study|Severe non-compliance to protocol|1|||
161469478|NCT01914757|583115319|FG002|Overall Study|Severe non-compliance to protocol|2|||
161469479|NCT01914757|583115317|FG000|Overall Study|Lost to Follow-up|5|||
161469480|NCT01914757|583115318|FG001|Overall Study|Lost to Follow-up|8|||
161469481|NCT01914757|583115319|FG002|Overall Study|Lost to Follow-up|6|||
161811999|NCT03600805|584355048|FG003|Overall Study|Withdrawal by Subject|1|||
161812000|NCT03600805|584355045|FG000|Overall Study|Other unspecified|14|||
161812001|NCT03600805|584355046|FG001|Overall Study|Other unspecified|6|||
161812002|NCT03600805|584355047|FG002|Overall Study|Other unspecified|7|||
161812003|NCT03600805|584355048|FG003|Overall Study|Other unspecified|11|||
161812004|NCT00804856|584355054|FG000|Overall Study|Progressive Disease|3|||
161812005|NCT00804856|584355055|FG001|Overall Study|Progressive Disease|2|||
161812006|NCT00804856|584355056|FG002|Overall Study|Progressive Disease|4|||
161812007|NCT00804856|584355057|FG003|Overall Study|Progressive Disease|6|||
161812008|NCT00804856|584355058|FG004|Overall Study|Progressive Disease|4|||
161812009|NCT00804856|584355059|FG005|Overall Study|Progressive Disease|1|||
161812010|NCT00804856|584355060|FG006|Overall Study|Progressive Disease|8|||
161812011|NCT00804856|584355061|FG007|Overall Study|Progressive Disease|2|||
161812012|NCT00804856|584355062|FG008|Overall Study|Progressive Disease|4|||
161812013|NCT00804856|584355063|FG009|Overall Study|Progressive Disease|5|||
161812014|NCT00804856|584355064|FG010|Overall Study|Progressive Disease|12|||
161812015|NCT00804856|584355065|FG011|Overall Study|Progressive Disease|2|||
161812016|NCT00804856|584355066|FG012|Overall Study|Progressive Disease|2|||
161469482|NCT01914757|583115317|FG000|Overall Study|Withdrawal by Subject|15|||
161469483|NCT01914757|583115318|FG001|Overall Study|Withdrawal by Subject|27|||
161469484|NCT01914757|583115319|FG002|Overall Study|Withdrawal by Subject|19|||
161812017|NCT00804856|584355067|FG013|Overall Study|Progressive Disease|26|||
161469485|NCT01914757|583115317|FG000|Overall Study|Death|2|||
161469486|NCT01914757|583115318|FG001|Overall Study|Death|2|||
161812018|NCT00804856|584355068|FG014|Overall Study|Progressive Disease|20|||
161812019|NCT00804856|584355054|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812020|NCT00804856|584355055|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812021|NCT00804856|584355056|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812022|NCT00804856|584355057|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161469487|NCT01914757|583115319|FG002|Overall Study|Death|1|||
161469488|NCT01914757|583115317|FG000|Overall Study|Adverse Event|4|||
161469489|NCT01914757|583115318|FG001|Overall Study|Adverse Event|3|||
161469490|NCT01914757|583115319|FG002|Overall Study|Adverse Event|4|||
161469491|NCT01914757|583115317|FG000|Overall Study|Study specific withdrawal criteria|0|||
161469492|NCT01914757|583115318|FG001|Overall Study|Study specific withdrawal criteria|1|||
161469493|NCT01914757|583115319|FG002|Overall Study|Study specific withdrawal criteria|0|||
161469494|NCT01914757|583115317|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161469495|NCT01914757|583115318|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161469496|NCT01914757|583115319|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
161469497|NCT01914757|583115317|FG000|Overall Study|Other reasons|5|||
161469498|NCT01914757|583115318|FG001|Overall Study|Other reasons|9|||
161469499|NCT01914757|583115319|FG002|Overall Study|Other reasons|4|||
161469500|NCT00408629|583115322|FG000|Overall Study|Adverse Event|13|||
161469501|NCT00408629|583115323|FG001|Overall Study|Adverse Event|27|||
161469502|NCT00408629|583115322|FG000|Overall Study|Withdrawal by Subject|8|||
161469503|NCT00408629|583115323|FG001|Overall Study|Withdrawal by Subject|4|||
161469504|NCT00408629|583115322|FG000|Overall Study|Lost to Follow-up|1|||
161469505|NCT00408629|583115323|FG001|Overall Study|Lost to Follow-up|1|||
161469506|NCT00408629|583115322|FG000|Overall Study|Lack of Efficacy|63|||
161469507|NCT00408629|583115323|FG001|Overall Study|Lack of Efficacy|73|||
161469508|NCT00408629|583115322|FG000|Overall Study|Protocol Violation|1|||
161469509|NCT00408629|583115323|FG001|Overall Study|Protocol Violation|5|||
161469510|NCT00408629|583115322|FG000|Overall Study|Miscellaneous|11|||
161469511|NCT00408629|583115323|FG001|Overall Study|Miscellaneous|15|||
161469512|NCT01461980|583115324|FG000|Overall Study|Other|9|||
161915835|NCT00671788|584740564|FG000|Overall Study|MD Decision|1|||
161915836|NCT00671788|584740564|FG000|Overall Study|Other|1|||
161915837|NCT01035138|584740565|FG000|Overall Study|Adverse Event|4|||
161915838|NCT01035138|584740566|FG001|Overall Study|Adverse Event|0|||
161915839|NCT01035138|584740567|FG002|Overall Study|Adverse Event|2|||
161915840|NCT01035138|584740565|FG000|Overall Study|Caregiver Decision|2|||
161915841|NCT01035138|584740566|FG001|Overall Study|Caregiver Decision|0|||
161915842|NCT01035138|584740567|FG002|Overall Study|Caregiver Decision|1|||
161915843|NCT01035138|584740565|FG000|Overall Study|Withdrawal by Subject|1|||
161469513|NCT01461980|583115325|FG001|Overall Study|Other|8|||
161469514|NCT01461980|583115326|FG002|Overall Study|Other|6|||
161469515|NCT01461980|583115324|FG000|Overall Study|Medication error|7|||
161469516|NCT01461980|583115325|FG001|Overall Study|Medication error|5|||
161469517|NCT01461980|583115326|FG002|Overall Study|Medication error|6|||
161469518|NCT01461980|583115324|FG000|Overall Study|Adverse Event|12|||
161469519|NCT01461980|583115325|FG001|Overall Study|Adverse Event|5|||
161469520|NCT01461980|583115326|FG002|Overall Study|Adverse Event|6|||
161469521|NCT01461980|583115324|FG000|Overall Study|Protocol Violation|12|||
161469522|NCT01461980|583115325|FG001|Overall Study|Protocol Violation|19|||
161469523|NCT01461980|583115326|FG002|Overall Study|Protocol Violation|16|||
161469524|NCT01461980|583115324|FG000|Overall Study|No longer meets eligibility criteria|18|||
161469525|NCT01461980|583115325|FG001|Overall Study|No longer meets eligibility criteria|9|||
161469526|NCT01461980|583115326|FG002|Overall Study|No longer meets eligibility criteria|19|||
161469527|NCT01461980|583115324|FG000|Overall Study|Lost to Follow-up|52|||
161469528|NCT01461980|583115325|FG001|Overall Study|Lost to Follow-up|53|||
161469529|NCT01461980|583115326|FG002|Overall Study|Lost to Follow-up|51|||
161469530|NCT01461980|583115324|FG000|Overall Study|No longer willing to participate|52|||
161469531|NCT01461980|583115325|FG001|Overall Study|No longer willing to participate|38|||
161469532|NCT01461980|583115326|FG002|Overall Study|No longer willing to participate|54|||
161469533|NCT01461980|583115324|FG000|Overall Study|Randomized but not vaccinated|4|||
161469534|NCT01461980|583115325|FG001|Overall Study|Randomized but not vaccinated|8|||
161469535|NCT01461980|583115326|FG002|Overall Study|Randomized but not vaccinated|7|||
161469536|NCT00122109|583115327|FG000|Overall Study|Did not meet criteria|6|||
161915844|NCT01035138|584740566|FG001|Overall Study|Withdrawal by Subject|0|||
161915845|NCT01035138|584740567|FG002|Overall Study|Withdrawal by Subject|0|||
161915846|NCT01035138|584740565|FG000|Overall Study|Physician Decision|0|||
161469537|NCT00122109|583115328|FG001|Overall Study|Did not meet criteria|7|||
161469538|NCT00100178|583115329|FG000|Overall Study|Lost to Follow-up|0|||
161469539|NCT00100178|583115330|FG001|Overall Study|Lost to Follow-up|6|||
161469540|NCT00100178|583115331|FG002|Overall Study|Lost to Follow-up|5|||
161469541|NCT00100178|583115329|FG000|Overall Study|Adverse Event|2|||
161469542|NCT00100178|583115330|FG001|Overall Study|Adverse Event|2|||
161469543|NCT00100178|583115331|FG002|Overall Study|Adverse Event|1|||
161469544|NCT00100178|583115329|FG000|Overall Study|Withdrawal by Subject|1|||
161469545|NCT00100178|583115330|FG001|Overall Study|Withdrawal by Subject|1|||
161469546|NCT00100178|583115331|FG002|Overall Study|Withdrawal by Subject|1|||
161469547|NCT00100178|583115329|FG000|Overall Study|Physician Decision|6|||
161469548|NCT00100178|583115330|FG001|Overall Study|Physician Decision|1|||
161469549|NCT00100178|583115331|FG002|Overall Study|Physician Decision|3|||
161469550|NCT00631696|583115332|FG000|Overall Study|Entered, not randomized to treatment|1|||
161469551|NCT00631696|583115333|FG001|Overall Study|Entered, not randomized to treatment|1|||
161469552|NCT00631696|583115332|FG000|Overall Study|Discontinued after database release date|1|||
161469553|NCT00631696|583115333|FG001|Overall Study|Discontinued after database release date|0|||
161469554|NCT00631696|583115332|FG000|Overall Study|Follow up after database release date|1|||
161469555|NCT00631696|583115333|FG001|Overall Study|Follow up after database release date|0|||
161469556|NCT00631696|583115332|FG000|Overall Study|Lost to Follow-up|7|||
161576014|NCT01350804|583495040|FG000|Core Study|Physician Decision|1|||
161576015|NCT01350804|583495041|FG001|Core Study|Physician Decision|0|||
161576016|NCT01350804|583495042|FG002|Core Study|Physician Decision|1|||
161576017|NCT01350804|583495043|FG003|Core Study|Physician Decision|3|||
161576018|NCT01350804|583495040|FG000|Core Study|Lost to Follow-up|3|||
161576019|NCT01350804|583495041|FG001|Core Study|Lost to Follow-up|0|||
161576020|NCT01350804|583495042|FG002|Core Study|Lost to Follow-up|2|||
161576021|NCT01350804|583495043|FG003|Core Study|Lost to Follow-up|1|||
161576022|NCT01350804|583495040|FG000|Core Study|Lack of Efficacy|16|||
161576023|NCT01350804|583495041|FG001|Core Study|Lack of Efficacy|19|||
161576024|NCT01350804|583495042|FG002|Core Study|Lack of Efficacy|18|||
161576025|NCT01350804|583495043|FG003|Core Study|Lack of Efficacy|5|||
161576026|NCT01350804|583495040|FG000|Core Study|Death|1|||
161576027|NCT01350804|583495041|FG001|Core Study|Death|1|||
161576028|NCT01350804|583495042|FG002|Core Study|Death|1|||
161576029|NCT01350804|583495043|FG003|Core Study|Death|0|||
161576030|NCT01350804|583495040|FG000|Core Study|Adverse Event|8|||
161576031|NCT01350804|583495041|FG001|Core Study|Adverse Event|10|||
161576032|NCT01350804|583495042|FG002|Core Study|Adverse Event|8|||
161576033|NCT01350804|583495043|FG003|Core Study|Adverse Event|8|||
161576034|NCT01350804|583495040|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
161576035|NCT01350804|583495041|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
161576036|NCT01350804|583495042|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
161576037|NCT01350804|583495043|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
161576038|NCT01350804|583495040|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
161576039|NCT01350804|583495041|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
161576040|NCT01350804|583495042|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
161576041|NCT01350804|583495043|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
161576042|NCT01350804|583495040|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
161576043|NCT01350804|583495041|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
161576044|NCT01350804|583495042|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
161576045|NCT01350804|583495043|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
161576046|NCT01350804|583495040|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161576047|NCT01350804|583495041|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
161576048|NCT01350804|583495042|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161576049|NCT01350804|583495043|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161576050|NCT01350804|583495040|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
161576051|NCT01350804|583495041|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
161576052|NCT01350804|583495042|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
161576053|NCT01350804|583495043|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
161576054|NCT01350804|583495040|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
161576055|NCT01350804|583495041|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
161576056|NCT01350804|583495042|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
161576057|NCT01350804|583495043|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
161576058|NCT05850520|583495047|FG000|Overall Study|Withdrawal by Subject|8|||
161576059|NCT05850520|583495048|FG001|Overall Study|Withdrawal by Subject|8|||
161469557|NCT00631696|583115333|FG001|Overall Study|Lost to Follow-up|10|||
161469558|NCT00631696|583115332|FG000|Overall Study|Withdrawal by Subject|2|||
161469559|NCT00631696|583115333|FG001|Overall Study|Withdrawal by Subject|9|||
161469560|NCT00631696|583115332|FG000|Overall Study|Other|8|||
161469561|NCT00631696|583115333|FG001|Overall Study|Other|8|||
161469562|NCT00631696|583115332|FG000|Overall Study|Protocol Violation|9|||
161576060|NCT05850520|583495049|FG002|Overall Study|Withdrawal by Subject|16|||
161576061|NCT05850520|583495047|FG000|Overall Study|Lost to Follow-up|2|||
161576062|NCT05850520|583495048|FG001|Overall Study|Lost to Follow-up|2|||
161668162|NCT00406653|583837479|FG003|Open-Label Period|Pregnancy|0|||
161668163|NCT00406653|583837480|FG004|Open-Label Period|Pregnancy|0|||
161668164|NCT00406653|583837481|FG005|Open-Label Period|Pregnancy|0|||
161668165|NCT00406653|583837482|FG006|Open-Label Period|Pregnancy|2|||
161668166|NCT00406653|583837476|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
161668167|NCT00406653|583837477|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
161668168|NCT00406653|583837478|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
161668169|NCT00406653|583837479|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
161668170|NCT00406653|583837480|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
161668171|NCT00406653|583837481|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
161668172|NCT00406653|583837482|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
161668173|NCT00406653|583837476|FG000|Open-Label Period|Declined participation but followup done|0|||
161668174|NCT00406653|583837477|FG001|Open-Label Period|Declined participation but followup done|0|||
161668175|NCT00406653|583837478|FG002|Open-Label Period|Declined participation but followup done|0|||
161668176|NCT00406653|583837479|FG003|Open-Label Period|Declined participation but followup done|0|||
161668177|NCT00406653|583837480|FG004|Open-Label Period|Declined participation but followup done|0|||
161668178|NCT00406653|583837481|FG005|Open-Label Period|Declined participation but followup done|0|||
161668179|NCT00406653|583837482|FG006|Open-Label Period|Declined participation but followup done|8|||
161668180|NCT00406653|583837476|FG000|Open-Label Period|Discontinued by Sponsor|0|||
161668181|NCT00406653|583837477|FG001|Open-Label Period|Discontinued by Sponsor|0|||
161668182|NCT00406653|583837478|FG002|Open-Label Period|Discontinued by Sponsor|0|||
161668183|NCT00406653|583837479|FG003|Open-Label Period|Discontinued by Sponsor|0|||
161668184|NCT00406653|583837480|FG004|Open-Label Period|Discontinued by Sponsor|0|||
161915847|NCT01035138|584740566|FG001|Overall Study|Physician Decision|0|||
161915848|NCT01035138|584740567|FG002|Overall Study|Physician Decision|1|||
161915849|NCT01035138|584740565|FG000|Overall Study|Sponsor Decision|66|||
161915850|NCT01035138|584740566|FG001|Overall Study|Sponsor Decision|60|||
161915851|NCT01035138|584740567|FG002|Overall Study|Sponsor Decision|42|||
161915852|NCT01035138|584740565|FG000|Overall Study|Lost to Follow-up|0|||
161915853|NCT01035138|584740566|FG001|Overall Study|Lost to Follow-up|0|||
161915854|NCT01035138|584740567|FG002|Overall Study|Lost to Follow-up|1|||
161668185|NCT00406653|583837481|FG005|Open-Label Period|Discontinued by Sponsor|0|||
161668186|NCT00406653|583837482|FG006|Open-Label Period|Discontinued by Sponsor|1|||
161668187|NCT00406653|583837476|FG000|Open-Label Period|Refused followup|0|||
161668188|NCT00406653|583837477|FG001|Open-Label Period|Refused followup|0|||
161668189|NCT00406653|583837478|FG002|Open-Label Period|Refused followup|0|||
161668190|NCT00406653|583837479|FG003|Open-Label Period|Refused followup|0|||
161668191|NCT00406653|583837480|FG004|Open-Label Period|Refused followup|0|||
161668192|NCT00406653|583837481|FG005|Open-Label Period|Refused followup|0|||
161668193|NCT00406653|583837482|FG006|Open-Label Period|Refused followup|1|||
161668194|NCT00731120|583837483|FG000|Overall Study|Adverse Event|7|||
161668195|NCT00731120|583837484|FG001|Overall Study|Adverse Event|6|||
161668196|NCT00731120|583837485|FG002|Overall Study|Adverse Event|8|||
161668197|NCT00731120|583837483|FG000|Overall Study|Lack of Efficacy|4|||
161668198|NCT00731120|583837484|FG001|Overall Study|Lack of Efficacy|5|||
161668199|NCT00731120|583837485|FG002|Overall Study|Lack of Efficacy|4|||
161668200|NCT00731120|583837483|FG000|Overall Study|Noncompliance with Study Drug|3|||
161668201|NCT00731120|583837484|FG001|Overall Study|Noncompliance with Study Drug|3|||
161668202|NCT00731120|583837485|FG002|Overall Study|Noncompliance with Study Drug|1|||
161668203|NCT00731120|583837483|FG000|Overall Study|Protocol Deviations|1|||
161668204|NCT00731120|583837484|FG001|Overall Study|Protocol Deviations|6|||
161668205|NCT00731120|583837485|FG002|Overall Study|Protocol Deviations|1|||
161668206|NCT00731120|583837483|FG000|Overall Study|Withdrawal of Consent|13|||
161668207|NCT00731120|583837484|FG001|Overall Study|Withdrawal of Consent|8|||
161668208|NCT00731120|583837485|FG002|Overall Study|Withdrawal of Consent|4|||
161668209|NCT00731120|583837483|FG000|Overall Study|Lost to Follow-up|10|||
161668210|NCT00731120|583837484|FG001|Overall Study|Lost to Follow-up|15|||
161668211|NCT00731120|583837485|FG002|Overall Study|Lost to Follow-up|17|||
161668212|NCT00731120|583837483|FG000|Overall Study|Other|4|||
161668213|NCT00731120|583837484|FG001|Overall Study|Other|0|||
161668214|NCT00731120|583837485|FG002|Overall Study|Other|1|||
161668215|NCT02434939|583837488|FG000|Overall Study|Lack of Efficacy|34|||
161668216|NCT02434939|583837489|FG001|Overall Study|Lack of Efficacy|48|||
161668217|NCT02434939|583837488|FG000|Overall Study|Withdrawal by Subject|3|||
161668218|NCT02434939|583837489|FG001|Overall Study|Withdrawal by Subject|0|||
161915855|NCT02966834|584740568|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915856|NCT02966834|584740569|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915857|NCT02966834|584740570|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915858|NCT02966834|584740571|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161668219|NCT02434939|583837488|FG000|Overall Study|Adverse Event|0|||
161668220|NCT02434939|583837489|FG001|Overall Study|Adverse Event|1|||
161668221|NCT01326533|583837490|FG000|Overall Study|Lost to Follow-up|2|||
161668222|NCT01326533|583837491|FG001|Overall Study|Lost to Follow-up|0|||
161668223|NCT01326533|583837490|FG000|Overall Study|Withdrawal by Subject|1|||
161668224|NCT01326533|583837491|FG001|Overall Study|Withdrawal by Subject|0|||
161812023|NCT00804856|584355058|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161812024|NCT00804856|584355059|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812025|NCT00804856|584355060|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812026|NCT00804856|584355061|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812027|NCT00804856|584355062|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812028|NCT00804856|584355063|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812029|NCT00804856|584355064|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812030|NCT00804856|584355065|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812031|NCT00804856|584355066|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812032|NCT00804856|584355067|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812033|NCT00804856|584355068|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161812034|NCT00804856|584355054|FG000|Overall Study|Other Adverse Event|1|||
161812035|NCT00804856|584355055|FG001|Overall Study|Other Adverse Event|1|||
161812036|NCT00804856|584355056|FG002|Overall Study|Other Adverse Event|1|||
161812037|NCT00804856|584355057|FG003|Overall Study|Other Adverse Event|2|||
161812038|NCT00804856|584355058|FG004|Overall Study|Other Adverse Event|2|||
161812039|NCT00804856|584355059|FG005|Overall Study|Other Adverse Event|1|||
161812040|NCT00804856|584355060|FG006|Overall Study|Other Adverse Event|3|||
161812041|NCT00804856|584355061|FG007|Overall Study|Other Adverse Event|0|||
161812042|NCT00804856|584355062|FG008|Overall Study|Other Adverse Event|0|||
161812043|NCT00804856|584355063|FG009|Overall Study|Other Adverse Event|1|||
161812044|NCT00804856|584355064|FG010|Overall Study|Other Adverse Event|5|||
161812045|NCT00804856|584355065|FG011|Overall Study|Other Adverse Event|2|||
161812046|NCT00804856|584355066|FG012|Overall Study|Other Adverse Event|0|||
161812047|NCT00804856|584355067|FG013|Overall Study|Other Adverse Event|6|||
161812048|NCT00804856|584355068|FG014|Overall Study|Other Adverse Event|13|||
161812049|NCT00804856|584355054|FG000|Overall Study|Non compliance with protocol|0|||
161812050|NCT00804856|584355055|FG001|Overall Study|Non compliance with protocol|0|||
161812051|NCT00804856|584355056|FG002|Overall Study|Non compliance with protocol|0|||
161812052|NCT00804856|584355057|FG003|Overall Study|Non compliance with protocol|0|||
161812053|NCT00804856|584355058|FG004|Overall Study|Non compliance with protocol|0|||
161812054|NCT00804856|584355059|FG005|Overall Study|Non compliance with protocol|0|||
161812055|NCT00804856|584355060|FG006|Overall Study|Non compliance with protocol|0|||
161812056|NCT00804856|584355061|FG007|Overall Study|Non compliance with protocol|0|||
161812057|NCT00804856|584355062|FG008|Overall Study|Non compliance with protocol|0|||
161812058|NCT00804856|584355063|FG009|Overall Study|Non compliance with protocol|0|||
161812059|NCT00804856|584355064|FG010|Overall Study|Non compliance with protocol|0|||
161812060|NCT00804856|584355065|FG011|Overall Study|Non compliance with protocol|0|||
161812061|NCT00804856|584355066|FG012|Overall Study|Non compliance with protocol|0|||
161812062|NCT00804856|584355067|FG013|Overall Study|Non compliance with protocol|2|||
161812063|NCT00804856|584355068|FG014|Overall Study|Non compliance with protocol|0|||
161812064|NCT00804856|584355054|FG000|Overall Study|Refused to continue medication|0|||
161812065|NCT00804856|584355055|FG001|Overall Study|Refused to continue medication|0|||
161812066|NCT00804856|584355056|FG002|Overall Study|Refused to continue medication|0|||
161812067|NCT00804856|584355057|FG003|Overall Study|Refused to continue medication|1|||
161812068|NCT00804856|584355058|FG004|Overall Study|Refused to continue medication|1|||
161812069|NCT00804856|584355059|FG005|Overall Study|Refused to continue medication|0|||
161812070|NCT00804856|584355060|FG006|Overall Study|Refused to continue medication|0|||
161812071|NCT00804856|584355061|FG007|Overall Study|Refused to continue medication|0|||
161812072|NCT00804856|584355062|FG008|Overall Study|Refused to continue medication|0|||
161812073|NCT00804856|584355063|FG009|Overall Study|Refused to continue medication|0|||
161812074|NCT00804856|584355064|FG010|Overall Study|Refused to continue medication|3|||
161812075|NCT00804856|584355065|FG011|Overall Study|Refused to continue medication|0|||
161812076|NCT00804856|584355066|FG012|Overall Study|Refused to continue medication|1|||
161812077|NCT00804856|584355067|FG013|Overall Study|Refused to continue medication|1|||
161812078|NCT00804856|584355068|FG014|Overall Study|Refused to continue medication|5|||
161812079|NCT00804856|584355054|FG000|Overall Study|Other reason than listed above|0|||
161812080|NCT00804856|584355055|FG001|Overall Study|Other reason than listed above|0|||
161812081|NCT00804856|584355056|FG002|Overall Study|Other reason than listed above|0|||
161812082|NCT00804856|584355057|FG003|Overall Study|Other reason than listed above|0|||
161812083|NCT00804856|584355058|FG004|Overall Study|Other reason than listed above|0|||
161812084|NCT00804856|584355059|FG005|Overall Study|Other reason than listed above|1|||
161812085|NCT00804856|584355060|FG006|Overall Study|Other reason than listed above|0|||
161812086|NCT00804856|584355061|FG007|Overall Study|Other reason than listed above|0|||
161812087|NCT00804856|584355062|FG008|Overall Study|Other reason than listed above|1|||
161812088|NCT00804856|584355063|FG009|Overall Study|Other reason than listed above|0|||
161668225|NCT01326533|583837490|FG000|Overall Study|Adverse Event|1|||
161668226|NCT01326533|583837491|FG001|Overall Study|Adverse Event|0|||
161812089|NCT00804856|584355064|FG010|Overall Study|Other reason than listed above|3|||
161812090|NCT00804856|584355065|FG011|Overall Study|Other reason than listed above|1|||
161812091|NCT00804856|584355066|FG012|Overall Study|Other reason than listed above|1|||
161812092|NCT00804856|584355067|FG013|Overall Study|Other reason than listed above|10|||
161668227|NCT04079803|583837492|FG000|Overall Study|Withdrawal by Subject|0|||
161668228|NCT04079803|583837493|FG001|Overall Study|Withdrawal by Subject|0|||
161668229|NCT04079803|583837494|FG002|Overall Study|Withdrawal by Subject|1|||
161668230|NCT03353350|583837495|FG000|30-week Core Treatment Period|Protocol Violation|1|||
161668231|NCT03353350|583837496|FG001|30-week Core Treatment Period|Protocol Violation|1|||
161668232|NCT03353350|583837497|FG002|30-week Core Treatment Period|Protocol Violation|1|||
161668233|NCT03353350|583837498|FG003|30-week Core Treatment Period|Protocol Violation|0|||
161668234|NCT03353350|583837495|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
161668235|NCT03353350|583837496|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
161668236|NCT03353350|583837497|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
161668237|NCT03353350|583837498|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
161668238|NCT03353350|583837495|FG000|30-week Core Treatment Period|Adverse Event|0|||
161668239|NCT03353350|583837496|FG001|30-week Core Treatment Period|Adverse Event|4|||
161668240|NCT03353350|583837497|FG002|30-week Core Treatment Period|Adverse Event|2|||
161668241|NCT03353350|583837498|FG003|30-week Core Treatment Period|Adverse Event|3|||
161668242|NCT03353350|583837495|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
161668243|NCT03353350|583837496|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
161668244|NCT03353350|583837497|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
161668245|NCT03353350|583837498|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
161469563|NCT00631696|583115333|FG001|Overall Study|Protocol Violation|9|||
161469564|NCT00631696|583115332|FG000|Overall Study|Study terminated by sponsor|3|||
161668246|NCT03353350|583837495|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
161668247|NCT03353350|583837496|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
161668248|NCT03353350|583837497|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
161668249|NCT03353350|583837498|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
161668250|NCT03353350|583837495|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
161668251|NCT03353350|583837496|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
161812093|NCT00804856|584355068|FG014|Overall Study|Other reason than listed above|3|||
161812094|NCT03343535|584355069|FG000|Overall Study|Lost to Follow-up|1|||
161812095|NCT03343535|584355069|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
161812096|NCT03343535|584355069|FG000|Overall Study|Death|12|||
161469565|NCT00631696|583115333|FG001|Overall Study|Study terminated by sponsor|3|||
161469566|NCT00631696|583115332|FG000|Overall Study|Adverse Event|5|||
161469567|NCT00631696|583115333|FG001|Overall Study|Adverse Event|0|||
161469568|NCT01439568|583115335|FG000|Overall Study|Lost to Follow-up|1|||
161469569|NCT01439568|583115336|FG001|Overall Study|Lost to Follow-up|0|||
161469570|NCT01439568|583115335|FG000|Overall Study|Withdrawal by Subject|2|||
161469571|NCT01439568|583115336|FG001|Overall Study|Withdrawal by Subject|2|||
161469572|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
161469573|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
161469574|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
161469575|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
161469576|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
161469577|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
161469578|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
161469579|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
161469580|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
161469581|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
161469582|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
161469583|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
161469584|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
161469585|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
161469586|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
161469587|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
161469588|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
161469589|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
161469590|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
161469591|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
161469592|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
161469593|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
161469594|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
161469595|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
161469596|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Death|2|||
161812097|NCT03049748|584355074|FG000|Overall Study|Lost to Follow-up|1|||
161812098|NCT03049748|584355075|FG001|Overall Study|Lost to Follow-up|0|||
161812099|NCT03049748|584355074|FG000|Overall Study|Death|3|||
161812100|NCT03049748|584355075|FG001|Overall Study|Death|0|||
161812101|NCT03049748|584355074|FG000|Overall Study|Withdrawal by Subject|0|||
161812102|NCT03049748|584355075|FG001|Overall Study|Withdrawal by Subject|3|||
161812103|NCT03049748|584355074|FG000|Overall Study|Protocol Violation|0|||
161469597|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Death|1|||
161469598|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Death|0|||
161469599|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Death|0|||
161469600|NCT02607930|583115337|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
161469601|NCT02607930|583115338|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
161469602|NCT02607930|583115339|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
161469603|NCT02607930|583115340|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
161469604|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161469605|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161469606|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
161469607|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
161469608|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
161469609|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
161469610|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
161469611|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
161469612|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
161469613|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
161469614|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
161469615|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
161469616|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
161469617|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
161469618|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
161469619|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
161469620|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
161469621|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
161469622|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
161469623|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
161469624|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
161469625|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
161469626|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
161469627|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
161469628|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
161469629|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
161469630|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
161469631|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
161469632|NCT02607930|583115337|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
161469633|NCT02607930|583115338|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
161469634|NCT02607930|583115339|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
161469635|NCT02607930|583115340|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
161469636|NCT03198078|583115343|FG000|Overall Study|Adverse Event|0|||
161469637|NCT03198078|583115344|FG001|Overall Study|Adverse Event|1|||
161469638|NCT03198078|583115345|FG002|Overall Study|Adverse Event|2|||
161469639|NCT03198078|583115343|FG000|Overall Study|Lack of Efficacy|0|||
161469640|NCT03198078|583115344|FG001|Overall Study|Lack of Efficacy|0|||
161469641|NCT03198078|583115345|FG002|Overall Study|Lack of Efficacy|3|||
161469642|NCT03198078|583115343|FG000|Overall Study|Lost to Follow-up|1|||
161469643|NCT03198078|583115344|FG001|Overall Study|Lost to Follow-up|0|||
161469644|NCT03198078|583115345|FG002|Overall Study|Lost to Follow-up|0|||
161469645|NCT03198078|583115343|FG000|Overall Study|Pregnancy|0|||
161469646|NCT03198078|583115344|FG001|Overall Study|Pregnancy|1|||
161469647|NCT03198078|583115345|FG002|Overall Study|Pregnancy|0|||
161469648|NCT03198078|583115343|FG000|Overall Study|Withdrawal by Subject|1|||
161469649|NCT03198078|583115344|FG001|Overall Study|Withdrawal by Subject|0|||
161469650|NCT03198078|583115345|FG002|Overall Study|Withdrawal by Subject|2|||
161469651|NCT03198078|583115343|FG000|Overall Study|Withdrawal by Caregiver|1|||
161469652|NCT03198078|583115344|FG001|Overall Study|Withdrawal by Caregiver|3|||
161469653|NCT03198078|583115345|FG002|Overall Study|Withdrawal by Caregiver|5|||
161469654|NCT01578330|583115346|FG000|Overall Study|Adverse Event|2|||
161469655|NCT01578330|583115346|FG000|Overall Study|Protocol Violation|5|||
161469656|NCT01676727|583115347|FG000|Overall Study|Death|18|||
161469657|NCT01676727|583115347|FG000|Overall Study|Withdrawal by Subject|6|||
161469658|NCT01676727|583115347|FG000|Overall Study|Screening failure|5|||
161812104|NCT03049748|584355075|FG001|Overall Study|Protocol Violation|2|||
161469659|NCT01676727|583115347|FG000|Overall Study|Not willing to attend 1-year visit|2|||
161812105|NCT03049748|584355074|FG000|Overall Study|Moved out of state (relocation)|0|||
161812106|NCT03049748|584355075|FG001|Overall Study|Moved out of state (relocation)|1|||
161469660|NCT01676727|583115347|FG000|Overall Study|Valve explanted|1|||
161469661|NCT01134731|583115348|FG000|Overall Study|Adverse Event|3|||
161469662|NCT01134731|583115349|FG001|Overall Study|Adverse Event|2|||
161469663|NCT01134731|583115350|FG002|Overall Study|Adverse Event|1|||
161469664|NCT01134731|583115348|FG000|Overall Study|Physician Decision|2|||
161469665|NCT01134731|583115349|FG001|Overall Study|Physician Decision|2|||
161469666|NCT01134731|583115350|FG002|Overall Study|Physician Decision|2|||
161469667|NCT01134731|583115348|FG000|Overall Study|Lack of Efficacy|0|||
161469668|NCT01134731|583115349|FG001|Overall Study|Lack of Efficacy|0|||
161469669|NCT01134731|583115350|FG002|Overall Study|Lack of Efficacy|1|||
161469670|NCT01134731|583115348|FG000|Overall Study|Withdrawal by Subject|3|||
161469671|NCT01134731|583115349|FG001|Overall Study|Withdrawal by Subject|3|||
161469672|NCT01134731|583115350|FG002|Overall Study|Withdrawal by Subject|1|||
161469673|NCT01134731|583115348|FG000|Overall Study|Lost to Follow-up|5|||
161469674|NCT01134731|583115349|FG001|Overall Study|Lost to Follow-up|4|||
161469675|NCT01134731|583115350|FG002|Overall Study|Lost to Follow-up|3|||
161469676|NCT01050543|583115351|FG000|Overall Study|Withdrawal by Subject|0|||
161469677|NCT01050543|583115352|FG001|Overall Study|Withdrawal by Subject|2|||
161469678|NCT01050543|583115351|FG000|Overall Study|Protocol Violation|0|||
161469679|NCT01050543|583115352|FG001|Overall Study|Protocol Violation|1|||
161469680|NCT01050543|583115351|FG000|Overall Study|Administrative|4|||
161469681|NCT01050543|583115352|FG001|Overall Study|Administrative|1|||
161469682|NCT02517866|583115356|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161469683|NCT02517866|583115357|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
161469684|NCT02517866|583115358|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161469685|NCT02517866|583115356|FG000|Overall Study|Significant Protocol Deviation|4|||
161469686|NCT02517866|583115357|FG001|Overall Study|Significant Protocol Deviation|1|||
161469687|NCT02517866|583115358|FG002|Overall Study|Significant Protocol Deviation|0|||
161469688|NCT02517866|583115356|FG000|Overall Study|Lost to Follow-up|1|||
161469689|NCT02517866|583115357|FG001|Overall Study|Lost to Follow-up|0|||
161469690|NCT02517866|583115358|FG002|Overall Study|Lost to Follow-up|0|||
161469691|NCT02517866|583115356|FG000|Overall Study|Voluntary Withdrawal|2|||
161469692|NCT02517866|583115357|FG001|Overall Study|Voluntary Withdrawal|2|||
161469693|NCT02517866|583115358|FG002|Overall Study|Voluntary Withdrawal|0|||
161469694|NCT02517866|583115356|FG000|Overall Study|Investigator Decision|2|||
161469695|NCT02517866|583115357|FG001|Overall Study|Investigator Decision|1|||
161469696|NCT02517866|583115358|FG002|Overall Study|Investigator Decision|0|||
161469697|NCT02517866|583115356|FG000|Overall Study|Reason not specified|2|||
161469698|NCT02517866|583115357|FG001|Overall Study|Reason not specified|0|||
161469699|NCT02517866|583115358|FG002|Overall Study|Reason not specified|0|||
161469700|NCT01646073|583115359|FG000|Period A (12 Weeks)|Adverse Event|0|||
161469701|NCT01646073|583115360|FG001|Period A (12 Weeks)|Adverse Event|2|||
161469702|NCT01646073|583115359|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
161469703|NCT01646073|583115360|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
161469704|NCT01646073|583115359|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
161469705|NCT01646073|583115360|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
161469706|NCT01646073|583115359|FG000|Period A (12 Weeks)|Protocol Violation|0|||
161469707|NCT01646073|583115360|FG001|Period A (12 Weeks)|Protocol Violation|1|||
161469708|NCT01646073|583115359|FG000|Period A (12 Weeks)|Other|0|||
161469709|NCT01646073|583115360|FG001|Period A (12 Weeks)|Other|1|||
161469710|NCT01646073|583115359|FG000|Period B (12 Weeks)|Adverse Event|0|||
161469711|NCT01646073|583115360|FG001|Period B (12 Weeks)|Adverse Event|7|||
161469712|NCT01646073|583115359|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
161469713|NCT01646073|583115360|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
161469714|NCT01646073|583115359|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
161469715|NCT01646073|583115360|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
161469716|NCT00679055|583115361|FG000|Overall Study|Adverse Event|0|||
161812107|NCT01735994|584355076|FG000|Overall Study|Withdrawal by Subject|6|||
161812108|NCT01735994|584355077|FG001|Overall Study|Withdrawal by Subject|4|||
161812109|NCT01735994|584355076|FG000|Overall Study|Injury|2|||
161812110|NCT01735994|584355077|FG001|Overall Study|Injury|0|||
161812111|NCT01735994|584355076|FG000|Overall Study|Kicked off team|5|||
161812112|NCT01735994|584355077|FG001|Overall Study|Kicked off team|0|||
161812113|NCT01735994|584355076|FG000|Overall Study|Lost to Follow-up|50|||
161812114|NCT01735994|584355077|FG001|Overall Study|Lost to Follow-up|62|||
161812115|NCT03437265|584355083|FG000|Overall Study|Protocol Violation|6|||
161915859|NCT02966834|584740572|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
161915860|NCT02966834|584740573|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915861|NCT02966834|584740568|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
161915862|NCT02966834|584740569|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161915863|NCT02966834|584740570|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161915864|NCT02966834|584740571|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161915865|NCT02966834|584740572|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161469717|NCT00679055|583115362|FG001|Overall Study|Adverse Event|1|||
161469718|NCT00679055|583115361|FG000|Overall Study|Other|0|||
161469719|NCT00679055|583115362|FG001|Overall Study|Other|3|||
161469720|NCT00679055|583115361|FG000|Overall Study|Study Terminated|2|||
161469721|NCT00679055|583115362|FG001|Overall Study|Study Terminated|1|||
161469722|NCT00629772|583115363|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
161469723|NCT00629772|583115364|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
161812116|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
161812117|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
161812118|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
161812119|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
161812120|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
161812121|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
161812122|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
161812123|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
161812124|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
161812125|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
161812126|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
161812127|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
161812128|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
161812129|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
161812130|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
161812131|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
161812132|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
161812133|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
161812134|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
161812135|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
161812136|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
161812137|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
161812138|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
161812139|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
161812140|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
161812141|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
161812142|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
161812143|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
161812144|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
161812145|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
161812146|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
161812147|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
161812148|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
161812149|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
161812150|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
161812151|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
161812152|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
161812153|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
161812154|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
161812155|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
161812156|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
161812157|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
161812158|NCT01444378|584355101|FG000|Overall Study|Lost to Follow-up|1|||
161812159|NCT01444378|584355101|FG000|Overall Study|Withdrawal by Subject|1|||
161812160|NCT01444378|584355101|FG000|Overall Study|Death|3|||
161812161|NCT01444378|584355101|FG000|Overall Study|Administrative Closure Of The Study|2|||
161812162|NCT01444378|584355101|FG000|Overall Study|Missed Visits|10|||
161812163|NCT02911792|584355102|FG000|Overall Study|Lost to Follow-up|3|||
161812164|NCT02911792|584355103|FG001|Overall Study|Lost to Follow-up|3|||
161812165|NCT02911792|584355104|FG002|Overall Study|Lost to Follow-up|3|||
161812166|NCT02911792|584355105|FG003|Overall Study|Lost to Follow-up|3|||
161812167|NCT00840073|584355108|FG000|Second Intervention|Missed 72 hour blood draw|1|||
161812168|NCT00840073|584355109|FG001|Second Intervention|Missed 72 hour blood draw|1|||
161812169|NCT00107991|584355110|FG000|Eligibility Assessment|Disease not severe enough|7|||
161812170|NCT00107991|584355110|FG000|Eligibility Assessment|Unwilling to participate|7|||
161812171|NCT00107991|584355110|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
161812172|NCT00107991|584355110|FG000|Eligibility Assessment|Abnormal labs|2|||
161812173|NCT00107991|584355110|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
161812174|NCT00107991|584355110|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
161812175|NCT00107991|584355110|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
161812176|NCT00107991|584355110|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
161812177|NCT00107991|584355110|FG000|12 Week Treatment Period|Adverse Event|1|||
161812178|NCT00107991|584355110|FG000|12 Week Treatment Period|Protocol Violation|1|||
161812179|NCT00107991|584355110|FG000|12 Week Treatment Period|Incarcerated|1|||
161915866|NCT02966834|584740573|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161812180|NCT00107991|584355110|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
161812181|NCT03669861|584355111|FG000|Overall Study|Disease Flare|5|||
161812182|NCT03669861|584355111|FG000|Overall Study|Lack of Efficacy|2|||
161812183|NCT02760927|584355112|FG000|Overall Study|Tube Slippage from Device|1|||
161469724|NCT00629772|583115363|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
161469725|NCT00629772|583115364|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
161469726|NCT01393301|583115367|FG000|Overall Study|Lost to Follow-up|5|||
161469727|NCT01393301|583115368|FG001|Overall Study|Lost to Follow-up|3|||
161469728|NCT01393301|583115367|FG000|Overall Study|Withdrawal by Subject|2|||
161469729|NCT01393301|583115368|FG001|Overall Study|Withdrawal by Subject|0|||
161469730|NCT01393301|583115367|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
161469731|NCT01393301|583115368|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
161469732|NCT03342963|583115371|FG000|Overall Study|Adverse Event|1|||
161469733|NCT03342963|583115372|FG001|Overall Study|Adverse Event|2|||
161469734|NCT03342963|583115373|FG002|Overall Study|Adverse Event|0|||
161469735|NCT03342963|583115374|FG003|Overall Study|Adverse Event|0|||
161469736|NCT03342963|583115371|FG000|Overall Study|Withdrawal by Subject|1|||
161469737|NCT03342963|583115372|FG001|Overall Study|Withdrawal by Subject|0|||
161469738|NCT03342963|583115373|FG002|Overall Study|Withdrawal by Subject|0|||
161469739|NCT03342963|583115374|FG003|Overall Study|Withdrawal by Subject|0|||
161469740|NCT01309165|583115375|FG000|Overall Study|Lost to Follow-up|4|||
161469741|NCT01309165|583115376|FG001|Overall Study|Lost to Follow-up|3|||
161469742|NCT01309165|583115375|FG000|Overall Study|Return to work|1|||
161469743|NCT01309165|583115376|FG001|Overall Study|Return to work|2|||
161469744|NCT01309165|583115375|FG000|Overall Study|Left country|0|||
161469745|NCT01309165|583115376|FG001|Overall Study|Left country|1|||
161469746|NCT01309165|583115375|FG000|Overall Study|No transportation|0|||
161469747|NCT01309165|583115376|FG001|Overall Study|No transportation|1|||
161469748|NCT01309165|583115375|FG000|Overall Study|Admitted to hospital for second stroke|1|||
161469749|NCT01309165|583115376|FG001|Overall Study|Admitted to hospital for second stroke|0|||
161469750|NCT01950169|583115377|FG000|Overall Study|Withdrawal by Subject|2|||
161469751|NCT01950169|583115378|FG001|Overall Study|Withdrawal by Subject|8|||
161469752|NCT01950169|583115379|FG002|Overall Study|Withdrawal by Subject|1|||
161469753|NCT01950169|583115377|FG000|Overall Study|Death|1|||
161469754|NCT01950169|583115378|FG001|Overall Study|Death|0|||
161469755|NCT01950169|583115379|FG002|Overall Study|Death|0|||
161469756|NCT00437320|583115380|FG000|Overall Study|Participant request|2|||
161469757|NCT00437320|583115381|FG001|Overall Study|Participant request|1|||
161469758|NCT00437320|583115382|FG002|Overall Study|Participant request|4|||
161469759|NCT01938573|583115383|FG000|Overall Study|Lack of Efficacy|1|||
161469760|NCT01938573|583115384|FG001|Overall Study|Lack of Efficacy|0|||
161469761|NCT01938573|583115383|FG000|Overall Study|Operation at other hospital|1|||
161469762|NCT01938573|583115384|FG001|Overall Study|Operation at other hospital|0|||
161469763|NCT00737438|583115385|FG000|Overall Study|Withdrawal by Subject|2|||
161469764|NCT00737438|583115385|FG000|Overall Study|Patient ineligible|1|||
161469765|NCT02410551|583115386|FG000|Overall Study|Adverse Event|1|||
161469766|NCT02410551|583115386|FG000|Overall Study|Withdrawal by Subject|1|||
161469767|NCT02410551|583115386|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
161469768|NCT01739309|583115387|FG000|Overall Study|Adverse Event|1|||
161469769|NCT01739309|583115387|FG000|Overall Study|Withdrawal by Subject|1|||
161469770|NCT05447897|583115388|FG000|Overall Study|Did not participate in survey|2|||
161469771|NCT00178633|583115389|FG000|Overall Study|Lost to Follow-up|6|||
161469772|NCT04810481|583115391|FG000|Overall Study|Disqualified data sets|10|||
161469773|NCT04810481|583115392|FG001|Overall Study|Disqualified data sets|28|||
161469774|NCT01484132|583115398|FG000|Overall Study|Lost to Follow-up|8|||
161469775|NCT01484132|583115398|FG000|Overall Study|Difficulty with time commitment|2|||
161469776|NCT01484132|583115398|FG000|Overall Study|Ineligible|1|||
161469777|NCT01484132|583115398|FG000|Overall Study|No pre-treatment urine sample collected|1|||
161469778|NCT01484132|583115398|FG000|Overall Study|No post-treatment urine sample collected|10|||
161469779|NCT03643159|583115399|FG000|Overall Study|Adverse Event|1|||
161469780|NCT03643159|583115399|FG000|Overall Study|Withdrawal by Subject|1|||
161469781|NCT01631812|583115400|FG000|Overall Study|Adverse Event|25|||
161812184|NCT00705666|584355113|FG000|Overall Study|No post-treatment questionnaire|279|||
161469782|NCT01631812|583115400|FG000|Overall Study|Lack of Efficacy|5|||
161469783|NCT01631812|583115400|FG000|Overall Study|Withdrawal by Subject|4|||
161469784|NCT01631812|583115400|FG000|Overall Study|Physician Decision|3|||
161469785|NCT03698331|583115401|FG000|Overall Study|Adverse Event|2|||
161812185|NCT00705666|584355113|FG000|Overall Study|Withdrawal by Subject|21|||
161469786|NCT03698331|583115402|FG001|Overall Study|Adverse Event|3|||
161469787|NCT03698331|583115401|FG000|Overall Study|Withdrawal by Subject|1|||
161469788|NCT03698331|583115402|FG001|Overall Study|Withdrawal by Subject|1|||
161469789|NCT03698331|583115401|FG000|Overall Study|Lost to Follow-up|0|||
161812186|NCT00705666|584355113|FG000|Overall Study|Physician Decision|7|||
161812187|NCT00705666|584355113|FG000|Overall Study|Lost to Follow-up|5|||
161812188|NCT00705666|584355113|FG000|Overall Study|Death|1|||
161812189|NCT00705666|584355113|FG000|Overall Study|Adverse Event|4|||
161812190|NCT00705666|584355113|FG000|Overall Study|Other|12|||
161469790|NCT03698331|583115402|FG001|Overall Study|Lost to Follow-up|2|||
161469791|NCT03698331|583115401|FG000|Overall Study|Non-compliance with study drug|1|||
161469792|NCT03698331|583115402|FG001|Overall Study|Non-compliance with study drug|0|||
161812191|NCT00705666|584355113|FG000|Overall Study|Other|2|||
161469793|NCT05628103|583115418|FG000|Overall Study|Adverse Event|7|||
161469794|NCT05628103|583115418|FG000|Overall Study|Withdrawal by Subject|3|||
161469795|NCT05628103|583115418|FG000|Overall Study|Lost to Follow-up|3|||
161469796|NCT05628103|583115418|FG000|Overall Study|Lack of Efficacy|1|||
161469797|NCT05628103|583115418|FG000|Overall Study|Non-Compliance With Study Drug|4|||
161469798|NCT02718300|583115419|FG000|Overall Study|Death|4|||
161469799|NCT02718300|583115420|FG001|Overall Study|Death|5|||
161469800|NCT02718300|583115421|FG002|Overall Study|Death|17|||
161812192|NCT00705666|584355113|FG000|Overall Study|Lack of data|3|||
161812193|NCT00705666|584355113|FG000|Overall Study|Untreated|5|||
161469801|NCT02718300|583115419|FG000|Overall Study|Lost to Follow-up|1|||
161576063|NCT05850520|583495049|FG002|Overall Study|Lost to Follow-up|2|||
161469802|NCT02718300|583115420|FG001|Overall Study|Lost to Follow-up|0|||
161469803|NCT02718300|583115421|FG002|Overall Study|Lost to Follow-up|2|||
161576064|NCT05850520|583495047|FG000|Overall Study|Death|2|||
161469804|NCT02718300|583115419|FG000|Overall Study|Physician Decision|1|||
161469805|NCT02718300|583115420|FG001|Overall Study|Physician Decision|0|||
161469806|NCT02718300|583115421|FG002|Overall Study|Physician Decision|2|||
161469807|NCT02718300|583115419|FG000|Overall Study|Study Terminated by Sponsor|6|||
161469808|NCT02718300|583115420|FG001|Overall Study|Study Terminated by Sponsor|3|||
161469809|NCT02718300|583115421|FG002|Overall Study|Study Terminated by Sponsor|4|||
161469810|NCT02718300|583115419|FG000|Overall Study|Withdrawal by Subject|0|||
161469811|NCT02718300|583115420|FG001|Overall Study|Withdrawal by Subject|4|||
161469812|NCT02718300|583115421|FG002|Overall Study|Withdrawal by Subject|3|||
161469813|NCT02718300|583115419|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
161469814|NCT02718300|583115420|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
161469815|NCT02718300|583115421|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
161469816|NCT05741528|583115422|FG000|Overall Study|Withdrawal by Subject|11|||
161469817|NCT05741528|583115422|FG000|Overall Study|Lost to Follow-up|3|||
161469818|NCT05741528|583115422|FG000|Overall Study|Adverse Event|2|||
161469819|NCT05741528|583115422|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161469820|NCT05741528|583115422|FG000|Overall Study|Reason Not Specified|1|||
161469821|NCT01896050|583117228|FG000|Overall Study|Adverse Event|37|||
161469822|NCT01896050|583117229|FG001|Overall Study|Adverse Event|2|||
161469823|NCT01896050|583117228|FG000|Overall Study|Death|1|||
161469824|NCT01896050|583117229|FG001|Overall Study|Death|0|||
161469825|NCT01824342|583117230|FG000|Overall Study|Withdrawal by Subject|0|||
161469826|NCT01824342|583117231|FG001|Overall Study|Withdrawal by Subject|3|||
161469827|NCT01824342|583117230|FG000|Overall Study|Adverse Event|1|||
161469828|NCT01824342|583117231|FG001|Overall Study|Adverse Event|1|||
161469829|NCT01824342|583117230|FG000|Overall Study|Disease Progression|1|||
161469830|NCT01824342|583117231|FG001|Overall Study|Disease Progression|1|||
161469831|NCT01824342|583117230|FG000|Overall Study|Physician Decision|5|||
161469832|NCT01824342|583117231|FG001|Overall Study|Physician Decision|0|||
161469833|NCT01824342|583117230|FG000|Overall Study|Death|2|||
161469834|NCT01824342|583117231|FG001|Overall Study|Death|0|||
161469835|NCT01926015|583117232|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161469836|NCT01926015|583117233|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161469837|NCT01926015|583117232|FG000|Overall Study|Randomized not treated|2|||
161469838|NCT01926015|583117233|FG001|Overall Study|Randomized not treated|0|||
161469839|NCT01364649|583117234|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
161469840|NCT01364649|583117235|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
161469841|NCT01364649|583117234|FG000|Overall Study|Lack of Efficacy|6|||
161469842|NCT01364649|583117235|FG001|Overall Study|Lack of Efficacy|0|||
161469843|NCT01364649|583117234|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
161469844|NCT01364649|583117235|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
161469845|NCT01364649|583117234|FG000|Overall Study|Protocol Deviations|4|||
161469846|NCT01364649|583117235|FG001|Overall Study|Protocol Deviations|8|||
161469847|NCT01364649|583117234|FG000|Overall Study|Withdrawal of Consent|9|||
161469848|NCT01364649|583117235|FG001|Overall Study|Withdrawal of Consent|7|||
161469849|NCT01364649|583117234|FG000|Overall Study|Lost to Follow-up|12|||
161469850|NCT01364649|583117235|FG001|Overall Study|Lost to Follow-up|13|||
161469851|NCT01364649|583117234|FG000|Overall Study|Other|4|||
161469852|NCT01364649|583117235|FG001|Overall Study|Other|1|||
161469853|NCT01826604|583117236|FG000|Overall Study|Lost to Follow-up|8|||
161469854|NCT01826604|583117237|FG001|Overall Study|Lost to Follow-up|9|||
161469855|NCT06132659|583117238|FG000|Overall Study|Lost to Follow-up|0|||
161469856|NCT06132659|583117239|FG001|Overall Study|Lost to Follow-up|1|||
161469857|NCT06132659|583117240|FG002|Overall Study|Lost to Follow-up|0|||
161469858|NCT03615326|583117241|FG000|Overall Study|Death|266|||
161469859|NCT03615326|583117242|FG001|Overall Study|Death|286|||
161469860|NCT03615326|583117243|FG002|Overall Study|Death|14|||
161469861|NCT03615326|583117244|FG003|Overall Study|Death|17|||
161469862|NCT03615326|583117241|FG000|Overall Study|Lost to Follow-up|0|||
161469863|NCT03615326|583117242|FG001|Overall Study|Lost to Follow-up|1|||
161469864|NCT03615326|583117243|FG002|Overall Study|Lost to Follow-up|0|||
161469865|NCT03615326|583117244|FG003|Overall Study|Lost to Follow-up|0|||
161469866|NCT03615326|583117241|FG000|Overall Study|Withdrawal by Subject|1|||
161469867|NCT03615326|583117242|FG001|Overall Study|Withdrawal by Subject|3|||
161469868|NCT03615326|583117243|FG002|Overall Study|Withdrawal by Subject|0|||
161469869|NCT03615326|583117244|FG003|Overall Study|Withdrawal by Subject|0|||
161469870|NCT03615326|583117241|FG000|Overall Study|Participants Ongoing|83|||
161469871|NCT03615326|583117242|FG001|Overall Study|Participants Ongoing|58|||
161469872|NCT03615326|583117243|FG002|Overall Study|Participants Ongoing|6|||
161469873|NCT03615326|583117244|FG003|Overall Study|Participants Ongoing|3|||
161469874|NCT03794583|583117245|FG000|Overall Study|Death|8|||
161469875|NCT03794583|583117245|FG000|Overall Study|Study Terminated by Sponsor|24|||
161469876|NCT03794583|583117245|FG000|Overall Study|Withdrawal by Subject|9|||
161469877|NCT02497612|583117246|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
161469878|NCT02497612|583117247|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
161469879|NCT02497612|583117248|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
161469880|NCT02497612|583117249|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
161469881|NCT02497612|583117246|FG000|Overall Study|Participant's request|2|||
161469882|NCT02497612|583117247|FG001|Overall Study|Participant's request|3|||
161469883|NCT02497612|583117248|FG002|Overall Study|Participant's request|4|||
161469884|NCT02497612|583117249|FG003|Overall Study|Participant's request|1|||
161469885|NCT02497612|583117246|FG000|Overall Study|Investigator's judgement|1|||
161469886|NCT02497612|583117247|FG001|Overall Study|Investigator's judgement|0|||
161469887|NCT02497612|583117248|FG002|Overall Study|Investigator's judgement|0|||
161469888|NCT02497612|583117249|FG003|Overall Study|Investigator's judgement|2|||
161469889|NCT02497612|583117246|FG000|Overall Study|Adverse Event|3|||
161469890|NCT02497612|583117247|FG001|Overall Study|Adverse Event|1|||
161469891|NCT02497612|583117248|FG002|Overall Study|Adverse Event|4|||
161469892|NCT02497612|583117249|FG003|Overall Study|Adverse Event|1|||
161469893|NCT02497612|583117246|FG000|Overall Study|Lost to Follow-up|1|||
161469894|NCT02497612|583117247|FG001|Overall Study|Lost to Follow-up|1|||
161469895|NCT02497612|583117248|FG002|Overall Study|Lost to Follow-up|0|||
161469896|NCT02497612|583117249|FG003|Overall Study|Lost to Follow-up|1|||
161469897|NCT02497612|583117246|FG000|Overall Study|Other unspecified|1|||
161469898|NCT02497612|583117247|FG001|Overall Study|Other unspecified|1|||
161469899|NCT02497612|583117248|FG002|Overall Study|Other unspecified|2|||
161469900|NCT02497612|583117249|FG003|Overall Study|Other unspecified|0|||
161469901|NCT02497612|583117246|FG000|Overall Study|Not eligible|1|||
161469902|NCT02497612|583117247|FG001|Overall Study|Not eligible|0|||
161469903|NCT02497612|583117248|FG002|Overall Study|Not eligible|0|||
161469904|NCT02497612|583117249|FG003|Overall Study|Not eligible|1|||
161469905|NCT02651467|583117250|FG000|Overall Study|Withdrawal by Subject|0|||
161469906|NCT02651467|583117251|FG001|Overall Study|Withdrawal by Subject|0|||
161469907|NCT02651467|583117252|FG002|Overall Study|Withdrawal by Subject|2|||
161469908|NCT02651467|583117250|FG000|Overall Study|Other (Not specified)|1|||
161469909|NCT02651467|583117251|FG001|Overall Study|Other (Not specified)|0|||
161469910|NCT02651467|583117252|FG002|Overall Study|Other (Not specified)|2|||
161469911|NCT05469113|583117253|FG000|Period 2|Adverse Event|0|||
161469912|NCT05469113|583117254|FG001|Period 2|Adverse Event|3|||
161469913|NCT04553679|583117255|FG000|Overall Study|Withdrawal by Subject|2|||
161469914|NCT04553679|583117256|FG001|Overall Study|Withdrawal by Subject|0|||
161469915|NCT04553679|583117255|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
161469916|NCT04553679|583117256|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
161469917|NCT01230710|583117258|FG000|Overall Study|Disease Progression|41|||
161469918|NCT01230710|583117258|FG000|Overall Study|Lost to Follow-up|3|||
161469919|NCT01230710|583117258|FG000|Overall Study|Death|4|||
161469920|NCT01230710|583117258|FG000|Overall Study|Withdrawal of Consent|1|||
161469921|NCT02905149|583117259|FG000|Overall Study|Lost to Follow-up|2|||
161469922|NCT02905149|583117260|FG001|Overall Study|Lost to Follow-up|0|||
161469923|NCT00747812|583117261|FG000|Overall Study|Research Site Staff Relocation|5|||
161469924|NCT00747812|583117262|FG001|Overall Study|Research Site Staff Relocation|3|||
161469925|NCT01708161|583117263|FG000|Overall Study|Adverse Event|1|||
161469926|NCT01708161|583117264|FG001|Overall Study|Adverse Event|3|||
161469927|NCT01708161|583117265|FG002|Overall Study|Adverse Event|4|||
161668252|NCT03353350|583837497|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
161668253|NCT03353350|583837498|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
161668254|NCT03353350|583837495|FG000|26-week Treatment Extension Period|Adverse Event|1|||
161668255|NCT03353350|583837496|FG001|26-week Treatment Extension Period|Adverse Event|0|||
161668256|NCT03353350|583837497|FG002|26-week Treatment Extension Period|Adverse Event|0|||
161668257|NCT03353350|583837498|FG003|26-week Treatment Extension Period|Adverse Event|1|||
161668258|NCT03353350|583837495|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
161668259|NCT03353350|583837496|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
161668260|NCT03353350|583837497|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
161668261|NCT03353350|583837498|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
161668262|NCT00807235|583837503|FG000|Overall Study|Adverse Event|1|||
161668263|NCT00807235|583837504|FG001|Overall Study|Adverse Event|0|||
161668264|NCT00985153|583837507|FG000|Overall Study|Lost to Follow-up|16|||
161668265|NCT00985153|583837508|FG001|Overall Study|Lost to Follow-up|19|||
161469928|NCT01708161|583117266|FG003|Overall Study|Adverse Event|2|||
161469929|NCT01708161|583117267|FG004|Overall Study|Adverse Event|3|||
161469930|NCT01708161|583117268|FG005|Overall Study|Adverse Event|0|||
161469931|NCT01708161|583117263|FG000|Overall Study|Death|0|||
161469932|NCT01708161|583117264|FG001|Overall Study|Death|0|||
161469933|NCT01708161|583117265|FG002|Overall Study|Death|0|||
161469934|NCT01708161|583117266|FG003|Overall Study|Death|1|||
161469935|NCT01708161|583117267|FG004|Overall Study|Death|0|||
161469936|NCT01708161|583117268|FG005|Overall Study|Death|1|||
161469937|NCT01708161|583117263|FG000|Overall Study|Withdrawal by Subject|0|||
161469938|NCT01708161|583117264|FG001|Overall Study|Withdrawal by Subject|1|||
161469939|NCT01708161|583117265|FG002|Overall Study|Withdrawal by Subject|1|||
161469940|NCT01708161|583117266|FG003|Overall Study|Withdrawal by Subject|0|||
161469941|NCT01708161|583117267|FG004|Overall Study|Withdrawal by Subject|0|||
161469942|NCT01708161|583117268|FG005|Overall Study|Withdrawal by Subject|0|||
161469943|NCT01708161|583117263|FG000|Overall Study|Administrative problems|0|||
161469944|NCT01708161|583117264|FG001|Overall Study|Administrative problems|1|||
161469945|NCT01708161|583117265|FG002|Overall Study|Administrative problems|0|||
161469946|NCT01708161|583117266|FG003|Overall Study|Administrative problems|0|||
161469947|NCT01708161|583117267|FG004|Overall Study|Administrative problems|0|||
161469948|NCT01708161|583117268|FG005|Overall Study|Administrative problems|0|||
161469949|NCT01708161|583117263|FG000|Overall Study|Disease progression|3|||
161469950|NCT01708161|583117264|FG001|Overall Study|Disease progression|5|||
161469951|NCT01708161|583117265|FG002|Overall Study|Disease progression|5|||
161469952|NCT01708161|583117266|FG003|Overall Study|Disease progression|13|||
161469953|NCT01708161|583117267|FG004|Overall Study|Disease progression|3|||
161469954|NCT01708161|583117268|FG005|Overall Study|Disease progression|0|||
161469955|NCT02633501|583117270|FG000|Overall Study|Adverse Event|0|||
161469956|NCT02633501|583117271|FG001|Overall Study|Adverse Event|0|||
161469957|NCT02633501|583117272|FG002|Overall Study|Adverse Event|1|||
161469958|NCT02633501|583117273|FG003|Overall Study|Adverse Event|0|||
161469959|NCT02633501|583117274|FG004|Overall Study|Adverse Event|1|||
161469960|NCT02633501|583117275|FG005|Overall Study|Adverse Event|1|||
161469961|NCT02633501|583117270|FG000|Overall Study|Withdrawal by Subject|2|||
161469962|NCT02633501|583117271|FG001|Overall Study|Withdrawal by Subject|1|||
161469963|NCT02633501|583117272|FG002|Overall Study|Withdrawal by Subject|2|||
161469964|NCT02633501|583117273|FG003|Overall Study|Withdrawal by Subject|2|||
161469965|NCT02633501|583117274|FG004|Overall Study|Withdrawal by Subject|1|||
161469966|NCT02633501|583117275|FG005|Overall Study|Withdrawal by Subject|3|||
161469967|NCT02633501|583117270|FG000|Overall Study|Various other reasons|0|||
161469968|NCT02633501|583117271|FG001|Overall Study|Various other reasons|2|||
161469969|NCT02633501|583117272|FG002|Overall Study|Various other reasons|4|||
161469970|NCT02633501|583117273|FG003|Overall Study|Various other reasons|1|||
161469971|NCT02633501|583117274|FG004|Overall Study|Various other reasons|7|||
161469972|NCT02633501|583117275|FG005|Overall Study|Various other reasons|11|||
161469973|NCT02633501|583117270|FG000|Overall Study|Lost to Follow-up|0|||
161469974|NCT02633501|583117271|FG001|Overall Study|Lost to Follow-up|0|||
161812194|NCT02964039|584355115|FG000|Overall Study|Medical reason unrelated to study participation|1|||
161812195|NCT02964039|584355116|FG001|Overall Study|Medical reason unrelated to study participation|0|||
161812196|NCT02964039|584355117|FG002|Overall Study|Medical reason unrelated to study participation|3|||
161812197|NCT02964039|584355115|FG000|Overall Study|Research shutdown due to pandemic|2|||
161812198|NCT02964039|584355116|FG001|Overall Study|Research shutdown due to pandemic|0|||
161812199|NCT02964039|584355117|FG002|Overall Study|Research shutdown due to pandemic|1|||
161812200|NCT02964039|584355115|FG000|Overall Study|Withdrawal by Subject|0|||
161812201|NCT02964039|584355116|FG001|Overall Study|Withdrawal by Subject|1|||
161812202|NCT02964039|584355117|FG002|Overall Study|Withdrawal by Subject|0|||
161812203|NCT02964039|584355115|FG000|Overall Study|Lost to Follow-up|1|||
161812204|NCT02964039|584355116|FG001|Overall Study|Lost to Follow-up|0|||
161812205|NCT02964039|584355117|FG002|Overall Study|Lost to Follow-up|1|||
161812206|NCT02645409|584355118|FG000|Overall Study|Withdrawal by Subject|3|||
161812207|NCT02645409|584355119|FG001|Overall Study|Withdrawal by Subject|0|||
161812208|NCT02645409|584355118|FG000|Overall Study|Physician Decision|1|||
161812209|NCT02645409|584355119|FG001|Overall Study|Physician Decision|0|||
161812210|NCT03552393|584355124|FG000|Core Period|Kidney Transplant|1|||
161812211|NCT03552393|584355124|FG000|Core Period|Prohibited Medication|1|||
161812212|NCT03552393|584355124|FG000|Safety Extension Period|Kidney Transplant|4|||
161812213|NCT05646251|584355127|FG000|Overall Study|Physician Decision|1|||
161812214|NCT05646251|584355128|FG001|Overall Study|Physician Decision|0|||
161812215|NCT05646251|584355129|FG002|Overall Study|Physician Decision|2|||
161812216|NCT01576042|584355131|FG000|Overall Study|Physician Decision|2|||
161812217|NCT01576042|584355132|FG001|Overall Study|Physician Decision|0|||
161812218|NCT00465270|584355133|FG000|Overall Study|Death|7|||
161812219|NCT00465270|584355134|FG001|Overall Study|Death|11|||
161812220|NCT00465270|584355133|FG000|Overall Study|Withdrawal by Subject|34|||
161812221|NCT00465270|584355134|FG001|Overall Study|Withdrawal by Subject|78|||
161812222|NCT00465270|584355133|FG000|Overall Study|Lost to Follow-up|60|||
161812223|NCT00465270|584355134|FG001|Overall Study|Lost to Follow-up|67|||
161812224|NCT00465270|584355133|FG000|Overall Study|Investigator request|3|||
161812225|NCT00465270|584355134|FG001|Overall Study|Investigator request|4|||
161812226|NCT03233724|584355135|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161812227|NCT03233724|584355136|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161469975|NCT02633501|583117272|FG002|Overall Study|Lost to Follow-up|0|||
161469976|NCT02633501|583117273|FG003|Overall Study|Lost to Follow-up|1|||
161469977|NCT02633501|583117274|FG004|Overall Study|Lost to Follow-up|2|||
161469978|NCT02633501|583117275|FG005|Overall Study|Lost to Follow-up|0|||
161812228|NCT03233724|584355137|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161469979|NCT01986140|583117277|FG000|Overall Study|Withdrawal by Subject|31|||
161469980|NCT01986140|583117278|FG001|Overall Study|Withdrawal by Subject|25|||
161469981|NCT01986140|583117277|FG000|Overall Study|alternative treatment|1|||
161469982|NCT01986140|583117278|FG001|Overall Study|alternative treatment|1|||
161469983|NCT01986140|583117277|FG000|Overall Study|found not eligible|3|||
161469984|NCT01986140|583117278|FG001|Overall Study|found not eligible|0|||
161469985|NCT01986140|583117277|FG000|Overall Study|Adverse Event|0|||
161469986|NCT01986140|583117278|FG001|Overall Study|Adverse Event|1|||
161469987|NCT01986140|583117277|FG000|Overall Study|progression disease|0|||
161469988|NCT01986140|583117278|FG001|Overall Study|progression disease|1|||
161469989|NCT01104155|583117283|FG000|Overall Study|Adverse Event|15|||
161469990|NCT01104155|583117284|FG001|Overall Study|Adverse Event|8|||
161469991|NCT01104155|583117283|FG000|Overall Study|Participant choice|6|||
161469992|NCT01104155|583117284|FG001|Overall Study|Participant choice|5|||
161469993|NCT01104155|583117283|FG000|Overall Study|Withdrawal of consent|1|||
161576065|NCT05850520|583495048|FG001|Overall Study|Death|2|||
161576066|NCT05850520|583495049|FG002|Overall Study|Death|3|||
161576067|NCT05850520|583495047|FG000|Overall Study|Adverse Event|2|||
161576068|NCT05850520|583495048|FG001|Overall Study|Adverse Event|0|||
161576069|NCT05850520|583495049|FG002|Overall Study|Adverse Event|1|||
161576070|NCT05850520|583495047|FG000|Overall Study|Physician Decision|0|||
161576071|NCT05850520|583495048|FG001|Overall Study|Physician Decision|1|||
161576072|NCT05850520|583495049|FG002|Overall Study|Physician Decision|0|||
161576073|NCT05850520|583495047|FG000|Overall Study|Protocol deviation|0|||
161576074|NCT05850520|583495048|FG001|Overall Study|Protocol deviation|0|||
161576075|NCT05850520|583495049|FG002|Overall Study|Protocol deviation|1|||
161576076|NCT05850520|583495047|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
161576077|NCT05850520|583495048|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
161576078|NCT05850520|583495049|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
161576079|NCT03889925|583496083|FG000|Overall Study|Lost to Follow-up|11|||
161576080|NCT03889925|583496084|FG001|Overall Study|Lost to Follow-up|10|||
161576081|NCT05777785|583496085|FG000|Overall Study|Withdrawal by Subject|5|||
161576082|NCT05777785|583496085|FG000|Overall Study|Lost to Follow-up|1|||
161576083|NCT05644444|583496086|FG000|Tolerance Phase|Adverse Event|0|||
161576084|NCT05644444|583496087|FG001|Tolerance Phase|Adverse Event|2|||
161576085|NCT05644444|583496086|FG000|Treatment Phase|Adverse Event|0|||
161576086|NCT05644444|583496087|FG001|Treatment Phase|Adverse Event|2|||
161576087|NCT00683696|583496089|FG000|Overall Study|Withdrawn due to study closure|337|||
161576088|NCT00683696|583496090|FG001|Overall Study|Withdrawn due to study closure|338|||
161576089|NCT00683696|583496089|FG000|Overall Study|Withdrawn prior to study closure|13|||
161576090|NCT00683696|583496090|FG001|Overall Study|Withdrawn prior to study closure|28|||
161576091|NCT00683696|583496089|FG000|Overall Study|Lost to Follow-up|5|||
161576092|NCT00683696|583496090|FG001|Overall Study|Lost to Follow-up|6|||
161576093|NCT00683696|583496089|FG000|Overall Study|Vital status follow-up only|3|||
161576094|NCT00683696|583496090|FG001|Overall Study|Vital status follow-up only|3|||
161576095|NCT00683696|583496089|FG000|Overall Study|Death|46|||
161812229|NCT03233724|584355138|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161812230|NCT03233724|584355139|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
161812231|NCT03233724|584355135|FG000|Phase I Dose Escalation|Best interest of participant|1|||
161812232|NCT03233724|584355136|FG001|Phase I Dose Escalation|Best interest of participant|1|||
161812233|NCT03233724|584355137|FG002|Phase I Dose Escalation|Best interest of participant|1|||
161812234|NCT03233724|584355138|FG003|Phase I Dose Escalation|Best interest of participant|0|||
161812235|NCT03233724|584355139|FG004|Phase I Dose Escalation|Best interest of participant|0|||
161812236|NCT03233724|584355135|FG000|Phase I Dose Escalation|Physician Decision|0|||
161812237|NCT03233724|584355136|FG001|Phase I Dose Escalation|Physician Decision|0|||
161812238|NCT03233724|584355137|FG002|Phase I Dose Escalation|Physician Decision|1|||
161812239|NCT03233724|584355138|FG003|Phase I Dose Escalation|Physician Decision|0|||
161812240|NCT03233724|584355139|FG004|Phase I Dose Escalation|Physician Decision|0|||
161812241|NCT03233724|584355135|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812242|NCT03233724|584355136|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812243|NCT03233724|584355137|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
161812244|NCT03233724|584355138|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812245|NCT03233724|584355139|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812246|NCT00651820|584355142|FG000|Overall Study|Lost to Follow-up|2|||
161915867|NCT02966834|584740568|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161915868|NCT02966834|584740569|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161576096|NCT00683696|583496090|FG001|Overall Study|Death|30|||
161812247|NCT02388191|584355143|FG000|Overall Study|Patient did not receive IUD|1|||
161469994|NCT01104155|583117284|FG001|Overall Study|Withdrawal of consent|1|||
161469995|NCT01104155|583117283|FG000|Overall Study|Other|3|||
161469996|NCT01104155|583117284|FG001|Overall Study|Other|4|||
161576097|NCT00089544|583496091|FG000|Overall Study|Ineligible|1|||
161576098|NCT00089544|583496092|FG001|Overall Study|Ineligible|0|||
161576099|NCT02396316|583496093|FG000|Overall Study|Physician Decision|1|||
161576100|NCT02396316|583496094|FG001|Overall Study|Physician Decision|0|||
161812248|NCT02388191|584355144|FG001|Overall Study|Patient did not receive IUD|0|||
161812249|NCT01911676|584355145|FG000|Period 1 of Study|Withdrawal by Subject|4|||
161812250|NCT01911676|584355146|FG001|Period 1 of Study|Withdrawal by Subject|2|||
161812251|NCT01911676|584355147|FG002|Period 1 of Study|Withdrawal by Subject|1|||
161812252|NCT01911676|584355148|FG003|Period 1 of Study|Withdrawal by Subject|2|||
161812253|NCT01911676|584355145|FG000|Period 1 of Study|Physician Decision|2|||
161812254|NCT01911676|584355146|FG001|Period 1 of Study|Physician Decision|0|||
161812255|NCT01911676|584355147|FG002|Period 1 of Study|Physician Decision|0|||
161812256|NCT01911676|584355148|FG003|Period 1 of Study|Physician Decision|1|||
161812257|NCT01911676|584355145|FG000|Period 2 of Study|Physician Decision|2|||
161812258|NCT01911676|584355146|FG001|Period 2 of Study|Physician Decision|0|||
161812259|NCT01911676|584355147|FG002|Period 2 of Study|Physician Decision|0|||
161812260|NCT01911676|584355148|FG003|Period 2 of Study|Physician Decision|1|||
161812261|NCT01911676|584355145|FG000|Period 2 of Study|Lost to Follow-up|0|||
161812262|NCT01911676|584355146|FG001|Period 2 of Study|Lost to Follow-up|0|||
161812263|NCT01911676|584355147|FG002|Period 2 of Study|Lost to Follow-up|0|||
161812264|NCT01911676|584355148|FG003|Period 2 of Study|Lost to Follow-up|1|||
161812265|NCT00773253|584355151|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
161812266|NCT00773253|584355152|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
161812267|NCT03173547|584355153|FG000|Overall Study|Adverse Event|2|||
161812268|NCT03173547|584355154|FG001|Overall Study|Adverse Event|0|||
161812269|NCT03173547|584355153|FG000|Overall Study|Withdrawal by Subject|2|||
161812270|NCT03173547|584355154|FG001|Overall Study|Withdrawal by Subject|2|||
161812271|NCT02530905|584355155|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
161812272|NCT02530905|584355156|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
161469997|NCT01069627|583117296|FG000|Overall Study|Disease progression|7|||
161469998|NCT01069627|583117296|FG000|Overall Study|Adverse Event|12|||
161469999|NCT01069627|583117296|FG000|Overall Study|Protocol Violation|1|||
161470000|NCT02963935|583117301|FG000|Overall Study|Adverse Event|12|||
161470001|NCT02963935|583117302|FG001|Overall Study|Adverse Event|6|||
161470002|NCT02963935|583117301|FG000|Overall Study|Protocol Violation|2|||
161470003|NCT02963935|583117302|FG001|Overall Study|Protocol Violation|1|||
161470004|NCT02963935|583117301|FG000|Overall Study|Lack of Efficacy|0|||
161470005|NCT02963935|583117302|FG001|Overall Study|Lack of Efficacy|2|||
161470006|NCT02963935|583117301|FG000|Overall Study|Lost to Follow-up|1|||
161470007|NCT02963935|583117302|FG001|Overall Study|Lost to Follow-up|6|||
161470008|NCT02963935|583117301|FG000|Overall Study|Unclassified|13|||
161470009|NCT02963935|583117302|FG001|Overall Study|Unclassified|22|||
161470010|NCT00464269|583117303|FG000|Overall Study|Lack of Efficacy|1|||
161470011|NCT00464269|583117304|FG001|Overall Study|Lack of Efficacy|0|||
161470012|NCT00464269|583117305|FG002|Overall Study|Lack of Efficacy|0|||
161470013|NCT00464269|583117306|FG003|Overall Study|Lack of Efficacy|0|||
161470014|NCT00464269|583117303|FG000|Overall Study|Lost to Follow-up|0|||
161470015|NCT00464269|583117304|FG001|Overall Study|Lost to Follow-up|4|||
161470016|NCT00464269|583117305|FG002|Overall Study|Lost to Follow-up|0|||
161470017|NCT00464269|583117306|FG003|Overall Study|Lost to Follow-up|1|||
161470018|NCT00464269|583117303|FG000|Overall Study|Withdrawal by Subject|0|||
161470019|NCT00464269|583117304|FG001|Overall Study|Withdrawal by Subject|2|||
161470020|NCT00464269|583117305|FG002|Overall Study|Withdrawal by Subject|1|||
161470021|NCT00464269|583117306|FG003|Overall Study|Withdrawal by Subject|1|||
161470022|NCT00464269|583117303|FG000|Overall Study|Other reason|3|||
161470023|NCT00464269|583117304|FG001|Overall Study|Other reason|3|||
161470024|NCT00464269|583117305|FG002|Overall Study|Other reason|1|||
161470025|NCT00464269|583117306|FG003|Overall Study|Other reason|1|||
161470026|NCT00464269|583117303|FG000|Overall Study|AE, serious fatal|0|||
161470027|NCT00464269|583117304|FG001|Overall Study|AE, serious fatal|0|||
161470028|NCT00464269|583117305|FG002|Overall Study|AE, serious fatal|1|||
161470029|NCT00464269|583117306|FG003|Overall Study|AE, serious fatal|1|||
161470030|NCT00464269|583117303|FG000|Overall Study|SAE, non-fatal|0|||
161470031|NCT00464269|583117304|FG001|Overall Study|SAE, non-fatal|0|||
161470032|NCT00464269|583117305|FG002|Overall Study|SAE, non-fatal|0|||
161470033|NCT00464269|583117306|FG003|Overall Study|SAE, non-fatal|1|||
161470034|NCT00464269|583117303|FG000|Overall Study|AE, non-serious non-fatal|2|||
161470035|NCT00464269|583117304|FG001|Overall Study|AE, non-serious non-fatal|8|||
161470036|NCT00464269|583117305|FG002|Overall Study|AE, non-serious non-fatal|3|||
161470037|NCT00464269|583117306|FG003|Overall Study|AE, non-serious non-fatal|4|||
161470038|NCT00464269|583117303|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161470039|NCT00464269|583117304|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161470040|NCT00464269|583117305|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161470041|NCT00464269|583117306|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161470042|NCT03911154|583117307|FG000|Overall Study|Withdrawal by Subject|1|||
161470043|NCT05055128|583117308|FG000|Overall Study|Adverse Event|0|||
161470044|NCT05055128|583117309|FG001|Overall Study|Adverse Event|0|||
161470045|NCT05055128|583117310|FG002|Overall Study|Adverse Event|0|||
161470046|NCT05055128|583117311|FG003|Overall Study|Adverse Event|1|||
161470047|NCT05055128|583117312|FG004|Overall Study|Adverse Event|1|||
161470048|NCT05055128|583117308|FG000|Overall Study|Protocol Violation|0|||
161470049|NCT05055128|583117309|FG001|Overall Study|Protocol Violation|0|||
161470050|NCT05055128|583117310|FG002|Overall Study|Protocol Violation|0|||
161470051|NCT05055128|583117311|FG003|Overall Study|Protocol Violation|1|||
161470052|NCT05055128|583117312|FG004|Overall Study|Protocol Violation|0|||
161470053|NCT05055128|583117308|FG000|Overall Study|Withdrawal by Subject|5|||
161470054|NCT05055128|583117309|FG001|Overall Study|Withdrawal by Subject|2|||
161470055|NCT05055128|583117310|FG002|Overall Study|Withdrawal by Subject|2|||
161812273|NCT02530905|584355157|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
161812274|NCT01231906|584355158|FG000|Overall Study|Lack of Efficacy|75|||
161812275|NCT01231906|584355159|FG001|Overall Study|Lack of Efficacy|68|||
161812276|NCT01231906|584355158|FG000|Overall Study|Lost to Follow-up|1|||
161812277|NCT01231906|584355159|FG001|Overall Study|Lost to Follow-up|0|||
161812278|NCT01231906|584355158|FG000|Overall Study|Physician Decision|34|||
161812279|NCT01231906|584355159|FG001|Overall Study|Physician Decision|24|||
161915869|NCT02966834|584740570|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
161470056|NCT05055128|583117311|FG003|Overall Study|Withdrawal by Subject|4|||
161470057|NCT05055128|583117312|FG004|Overall Study|Withdrawal by Subject|2|||
161470058|NCT05055128|583117308|FG000|Overall Study|Randomized By Mistake|0|||
161470059|NCT05055128|583117309|FG001|Overall Study|Randomized By Mistake|1|||
161470060|NCT05055128|583117310|FG002|Overall Study|Randomized By Mistake|0|||
161470061|NCT05055128|583117311|FG003|Overall Study|Randomized By Mistake|0|||
161470062|NCT05055128|583117312|FG004|Overall Study|Randomized By Mistake|0|||
161470063|NCT05055128|583117308|FG000|Overall Study|Other|1|||
161470064|NCT05055128|583117309|FG001|Overall Study|Other|0|||
161470065|NCT05055128|583117310|FG002|Overall Study|Other|0|||
161812280|NCT01231906|584355158|FG000|Overall Study|Withdrawal by Subject|0|||
161470066|NCT05055128|583117311|FG003|Overall Study|Other|0|||
161470067|NCT05055128|583117312|FG004|Overall Study|Other|0|||
161470068|NCT00292318|583117314|FG000|Overall Study|Study terminated by officials|2|||
161470069|NCT00292318|583117315|FG001|Overall Study|Study terminated by officials|1|||
161470070|NCT01822496|583117316|FG000|Overall Study|Protocol Violation|2|||
161470071|NCT01822496|583117317|FG001|Overall Study|Protocol Violation|2|||
161470072|NCT01822496|583117318|FG002|Overall Study|Protocol Violation|0|||
161470073|NCT01822496|583117319|FG003|Overall Study|Protocol Violation|1|||
161470074|NCT01822496|583117316|FG000|Overall Study|Withdrawal by Subject|0|||
161470075|NCT01822496|583117317|FG001|Overall Study|Withdrawal by Subject|0|||
161470076|NCT01822496|583117318|FG002|Overall Study|Withdrawal by Subject|0|||
161470077|NCT01822496|583117319|FG003|Overall Study|Withdrawal by Subject|3|||
161470078|NCT00543543|583117320|FG000|Base Study|Adverse Event|1|||
161470079|NCT00543543|583117321|FG001|Base Study|Adverse Event|11|||
161470080|NCT00543543|583117322|FG002|Base Study|Adverse Event|0|||
161470081|NCT00543543|583117323|FG003|Base Study|Adverse Event|5|||
161470082|NCT00543543|583117320|FG000|Base Study|Lost to Follow-up|12|||
161470083|NCT00543543|583117321|FG001|Base Study|Lost to Follow-up|749|||
161470084|NCT00543543|583117322|FG002|Base Study|Lost to Follow-up|9|||
161470085|NCT00543543|583117323|FG003|Base Study|Lost to Follow-up|701|||
161470086|NCT00543543|583117320|FG000|Base Study|Physician Decision|0|||
161470087|NCT00543543|583117321|FG001|Base Study|Physician Decision|4|||
161470088|NCT00543543|583117322|FG002|Base Study|Physician Decision|0|||
161470089|NCT00543543|583117323|FG003|Base Study|Physician Decision|7|||
161470090|NCT00543543|583117320|FG000|Base Study|Protocol Violation|0|||
161470091|NCT00543543|583117321|FG001|Base Study|Protocol Violation|6|||
161470092|NCT00543543|583117322|FG002|Base Study|Protocol Violation|0|||
161470093|NCT00543543|583117323|FG003|Base Study|Protocol Violation|6|||
161470094|NCT00543543|583117320|FG000|Base Study|Withdrawal by Subject|7|||
161470095|NCT00543543|583117321|FG001|Base Study|Withdrawal by Subject|482|||
161470096|NCT00543543|583117322|FG002|Base Study|Withdrawal by Subject|5|||
161470097|NCT00543543|583117323|FG003|Base Study|Withdrawal by Subject|503|||
161470098|NCT00543543|583117320|FG000|Extension Study|Adverse Event|0|||
161470099|NCT00543543|583117321|FG001|Extension Study|Adverse Event|0|||
161470100|NCT00543543|583117322|FG002|Extension Study|Adverse Event|0|||
161470101|NCT00543543|583117323|FG003|Extension Study|Adverse Event|5|||
161470102|NCT00543543|583117320|FG000|Extension Study|Lost to Follow-up|0|||
161470103|NCT00543543|583117321|FG001|Extension Study|Lost to Follow-up|0|||
161470104|NCT00543543|583117322|FG002|Extension Study|Lost to Follow-up|0|||
161470105|NCT00543543|583117323|FG003|Extension Study|Lost to Follow-up|77|||
161470106|NCT00543543|583117320|FG000|Extension Study|Physician Decision|0|||
161470107|NCT00543543|583117321|FG001|Extension Study|Physician Decision|0|||
161470108|NCT00543543|583117322|FG002|Extension Study|Physician Decision|0|||
161470109|NCT00543543|583117323|FG003|Extension Study|Physician Decision|7|||
161470110|NCT00543543|583117320|FG000|Extension Study|Pregnancy|0|||
161470111|NCT00543543|583117321|FG001|Extension Study|Pregnancy|0|||
161470112|NCT00543543|583117322|FG002|Extension Study|Pregnancy|0|||
161470113|NCT00543543|583117323|FG003|Extension Study|Pregnancy|6|||
161470114|NCT00543543|583117320|FG000|Extension Study|Protocol Violation|0|||
161470115|NCT00543543|583117321|FG001|Extension Study|Protocol Violation|0|||
161470116|NCT00543543|583117322|FG002|Extension Study|Protocol Violation|0|||
161470117|NCT00543543|583117323|FG003|Extension Study|Protocol Violation|11|||
161470118|NCT00543543|583117320|FG000|Extension Study|Withdrawal by Subject|0|||
161470119|NCT00543543|583117321|FG001|Extension Study|Withdrawal by Subject|0|||
161470120|NCT00543543|583117322|FG002|Extension Study|Withdrawal by Subject|0|||
161470121|NCT00543543|583117323|FG003|Extension Study|Withdrawal by Subject|120|||
161470122|NCT00945555|583117324|FG000|Overall Study|Referred to another hospital|5|||
161470123|NCT00945555|583117324|FG000|Overall Study|Worsening condition, intensive care unit|1|||
161470124|NCT00945555|583117324|FG000|Overall Study|Withdrawal by Subject|2|||
161470125|NCT00945555|583117324|FG000|Overall Study|Participant continued treatment at home|1|||
161470126|NCT00945555|583117324|FG000|Overall Study|Death|18|||
161470127|NCT00945555|583117324|FG000|Overall Study|Other|1|||
161470128|NCT04502979|583117325|FG000|Overall Study|Lost to Follow-up|1|||
161470129|NCT04502979|583117326|FG001|Overall Study|Lost to Follow-up|3|||
161812281|NCT01231906|584355159|FG001|Overall Study|Withdrawal by Subject|4|||
161470130|NCT04502979|583117325|FG000|Overall Study|Withdrawal by Subject|2|||
161576101|NCT02396316|583496093|FG000|Overall Study|Progressive disease|6|||
161576102|NCT02396316|583496094|FG001|Overall Study|Progressive disease|3|||
161470131|NCT04502979|583117326|FG001|Overall Study|Withdrawal by Subject|1|||
161470132|NCT00586625|583117330|FG000|Overall Study|Adverse Event|6|||
161470133|NCT00586625|583117331|FG001|Overall Study|Adverse Event|6|||
161470134|NCT00586625|583117330|FG000|Overall Study|Protocol Violation|3|||
161470135|NCT00586625|583117331|FG001|Overall Study|Protocol Violation|0|||
161470136|NCT00586625|583117330|FG000|Overall Study|Withdrawal by Subject|32|||
161470137|NCT00586625|583117331|FG001|Overall Study|Withdrawal by Subject|10|||
161470138|NCT00586625|583117330|FG000|Overall Study|Subject non-compliance|0|||
161470139|NCT00586625|583117331|FG001|Overall Study|Subject non-compliance|1|||
161470140|NCT00586625|583117330|FG000|Overall Study|Subject unable to return for visit|2|||
161812282|NCT01231906|584355158|FG000|Overall Study|Ineligible|10|||
161812283|NCT01231906|584355159|FG001|Overall Study|Ineligible|3|||
161812284|NCT01231906|584355158|FG000|Overall Study|No treatment|1|||
161812285|NCT01231906|584355159|FG001|Overall Study|No treatment|2|||
161812286|NCT01136174|584355160|FG000|Overall Study|Adverse Event|0|||
161812287|NCT01136174|584355161|FG001|Overall Study|Adverse Event|0|||
161812288|NCT01136174|584355162|FG002|Overall Study|Adverse Event|0|||
161812289|NCT01136174|584355163|FG003|Overall Study|Adverse Event|4|||
161812290|NCT01249651|584355166|FG000|Overall Study|Withdrawal by Subject|4|||
161812291|NCT01249651|584355166|FG000|Overall Study|Adverse Event|1|||
161812292|NCT01249651|584355166|FG000|Overall Study|Protocol Violation|1|||
161812293|NCT01249651|584355166|FG000|Overall Study|Sponsor Decision|1|||
161812294|NCT03873272|584355173|FG000|Overall Study|Withdrawal by Subject|2|||
161812295|NCT03873272|584355174|FG001|Overall Study|Withdrawal by Subject|0|||
161812296|NCT03873272|584355175|FG002|Overall Study|Withdrawal by Subject|1|||
161812297|NCT03873272|584355173|FG000|Overall Study|Death|0|||
161812298|NCT03873272|584355174|FG001|Overall Study|Death|2|||
161812299|NCT03873272|584355175|FG002|Overall Study|Death|1|||
161812300|NCT03761173|584355176|FG000|Overall Study|Lost to Follow-up|93|||
161812301|NCT03761173|584355176|FG000|Overall Study|Withdrawal by Subject|74|||
161812302|NCT03761173|584355176|FG000|Overall Study|Death|45|||
161812303|NCT03761173|584355176|FG000|Overall Study|Withdrawal for Other Reasons|29|||
161812304|NCT03761173|584355176|FG000|Overall Study|Protocol Violation|1|||
161812305|NCT01952691|584356151|FG000|Overall Study|Lost to Follow-up|2|||
161812306|NCT05776901|584356152|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
161812307|NCT02255149|584356157|FG000|Overall Study|Lost to Follow-up|2|||
161812308|NCT02255149|584356157|FG000|Overall Study|Withdrawal by Subject|1|||
161812309|NCT02255149|584356157|FG000|Overall Study|Withdrawal by PI|1|||
161812310|NCT02255149|584356157|FG000|Overall Study|Implant Failure|1|||
161812311|NCT00373256|584356158|FG000|Overall Study|Adverse Event (AE)|1|||
161812312|NCT00373256|584356159|FG001|Overall Study|Adverse Event (AE)|5|||
161812313|NCT00373256|584356158|FG000|Overall Study|Lost to Follow-up|2|||
161812314|NCT00373256|584356159|FG001|Overall Study|Lost to Follow-up|1|||
161812315|NCT00373256|584356158|FG000|Overall Study|Death|9|||
161812316|NCT00373256|584356159|FG001|Overall Study|Death|8|||
161812317|NCT00373256|584356158|FG000|Overall Study|Objective Progression or Relapse|111|||
161812318|NCT00373256|584356159|FG001|Overall Study|Objective Progression or Relapse|104|||
161812319|NCT00373256|584356158|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
161812320|NCT00373256|584356159|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
161812321|NCT00373256|584356158|FG000|Overall Study|Other|73|||
161812322|NCT00373256|584356159|FG001|Overall Study|Other|107|||
161812323|NCT00373256|584356158|FG000|Overall Study|Protocol Violation|0|||
161812324|NCT00373256|584356159|FG001|Overall Study|Protocol Violation|2|||
161812325|NCT00373256|584356158|FG000|Overall Study|Study Terminated by Sponsor|41|||
161812326|NCT00373256|584356159|FG001|Overall Study|Study Terminated by Sponsor|13|||
161812327|NCT03032172|584356162|FG000|Treatment Period|Adverse Event|0|||
161812328|NCT03032172|584356163|FG001|Treatment Period|Adverse Event|1|||
161812329|NCT03032172|584356164|FG002|Treatment Period|Adverse Event|0|||
161812330|NCT03032172|584356165|FG003|Treatment Period|Adverse Event|0|||
161812331|NCT03032172|584356166|FG004|Treatment Period|Adverse Event|0|||
161812332|NCT03032172|584356167|FG005|Treatment Period|Adverse Event|0|||
161812333|NCT03032172|584356168|FG006|Treatment Period|Adverse Event|0|||
161812334|NCT03032172|584356169|FG007|Treatment Period|Adverse Event|0|||
161812335|NCT03032172|584356162|FG000|Treatment Period|Lack of Efficacy|0|||
161812336|NCT03032172|584356163|FG001|Treatment Period|Lack of Efficacy|1|||
161812337|NCT03032172|584356164|FG002|Treatment Period|Lack of Efficacy|0|||
161812338|NCT03032172|584356165|FG003|Treatment Period|Lack of Efficacy|0|||
161812339|NCT03032172|584356166|FG004|Treatment Period|Lack of Efficacy|0|||
161812340|NCT03032172|584356167|FG005|Treatment Period|Lack of Efficacy|0|||
161812341|NCT03032172|584356168|FG006|Treatment Period|Lack of Efficacy|0|||
161812342|NCT03032172|584356169|FG007|Treatment Period|Lack of Efficacy|0|||
161812343|NCT03032172|584356162|FG000|Treatment Period|Non-compliance With Study Drug|0|||
161812344|NCT03032172|584356163|FG001|Treatment Period|Non-compliance With Study Drug|1|||
161812345|NCT03032172|584356164|FG002|Treatment Period|Non-compliance With Study Drug|0|||
161812346|NCT03032172|584356165|FG003|Treatment Period|Non-compliance With Study Drug|0|||
161576103|NCT02396316|583496093|FG000|Overall Study|Protocol Violation|0|||
161576104|NCT02396316|583496094|FG001|Overall Study|Protocol Violation|1|||
161576105|NCT02396316|583496093|FG000|Overall Study|Treatment unblinded|0|||
161576106|NCT02396316|583496094|FG001|Overall Study|Treatment unblinded|1|||
161576107|NCT01823536|583496095|FG000|Overall Study|Lost to Follow-up|1|||
161576108|NCT01823536|583496096|FG001|Overall Study|Lost to Follow-up|0|||
161576109|NCT01823536|583496097|FG002|Overall Study|Lost to Follow-up|0|||
161576110|NCT01823536|583496098|FG003|Overall Study|Lost to Follow-up|1|||
161576111|NCT01823536|583496099|FG004|Overall Study|Lost to Follow-up|1|||
161576112|NCT01823536|583496100|FG005|Overall Study|Lost to Follow-up|0|||
161812347|NCT03032172|584356166|FG004|Treatment Period|Non-compliance With Study Drug|0|||
161812348|NCT03032172|584356167|FG005|Treatment Period|Non-compliance With Study Drug|0|||
161812349|NCT03032172|584356168|FG006|Treatment Period|Non-compliance With Study Drug|0|||
161470141|NCT00586625|583117331|FG001|Overall Study|Subject unable to return for visit|0|||
161470142|NCT02906332|583117334|FG000|Overall Study|Withdrawal by Subject|1|||
161470143|NCT00165984|583117335|FG000|Overall Study|Death|15|||
161470144|NCT03945266|583117339|FG000|Overall Study|Withdrawal by Subject|1|||
161470145|NCT03945266|583117340|FG001|Overall Study|Withdrawal by Subject|0|||
161470146|NCT03945266|583117339|FG000|Overall Study|Miscarriage|0|||
161470147|NCT03945266|583117340|FG001|Overall Study|Miscarriage|2|||
161470148|NCT03945266|583117339|FG000|Overall Study|Lost to Follow-up|1|||
161470149|NCT03945266|583117340|FG001|Overall Study|Lost to Follow-up|0|||
161470150|NCT01686828|583117341|FG000|Overall Study|Physician Decision|1|||
161470151|NCT01686828|583117342|FG001|Overall Study|Physician Decision|0|||
161470152|NCT01686828|583117343|FG002|Overall Study|Physician Decision|0|||
161470153|NCT01686828|583117344|FG003|Overall Study|Physician Decision|0|||
161470154|NCT01686828|583117341|FG000|Overall Study|New Job|0|||
161470155|NCT01686828|583117342|FG001|Overall Study|New Job|1|||
161470156|NCT01686828|583117343|FG002|Overall Study|New Job|0|||
161470157|NCT01686828|583117344|FG003|Overall Study|New Job|0|||
161470158|NCT01686828|583117341|FG000|Overall Study|Weight Loss|0|||
161470159|NCT01686828|583117342|FG001|Overall Study|Weight Loss|0|||
161470160|NCT01686828|583117343|FG002|Overall Study|Weight Loss|1|||
161470161|NCT01686828|583117344|FG003|Overall Study|Weight Loss|0|||
161470162|NCT02734433|583117347|FG000|Overall Study|Disease progression|1|||
161470163|NCT02734433|583117348|FG001|Overall Study|Disease progression|5|||
161470164|NCT02734433|583117347|FG000|Overall Study|Clinical progression|0|||
161470165|NCT02734433|583117348|FG001|Overall Study|Clinical progression|1|||
161470166|NCT02734433|583117347|FG000|Overall Study|Withdrawal by Subject|1|||
161470167|NCT02734433|583117348|FG001|Overall Study|Withdrawal by Subject|2|||
161470168|NCT04916769|583117355|FG000|Period 1|Physician Decision|0|||
161470169|NCT04916769|583117356|FG001|Period 1|Physician Decision|0|||
161470170|NCT04916769|583117357|FG002|Period 1|Physician Decision|0|||
161470171|NCT04916769|583117358|FG003|Period 1|Physician Decision|0|||
161470172|NCT04916769|583117359|FG004|Period 1|Physician Decision|0|||
161470173|NCT04916769|583117360|FG005|Period 1|Physician Decision|1|||
161470174|NCT04916769|583117355|FG000|Period 2|Physician Decision|0|||
161470175|NCT04916769|583117356|FG001|Period 2|Physician Decision|1|||
161470176|NCT04916769|583117357|FG002|Period 2|Physician Decision|0|||
161470177|NCT04916769|583117358|FG003|Period 2|Physician Decision|0|||
161470178|NCT04916769|583117359|FG004|Period 2|Physician Decision|0|||
161470179|NCT04916769|583117360|FG005|Period 2|Physician Decision|0|||
161470180|NCT04941456|583117361|FG000|Overall Study|Withdrawal by Subject|1|||
161470181|NCT04941456|583117362|FG001|Overall Study|Withdrawal by Subject|0|||
161470182|NCT04941456|583117361|FG000|Overall Study|Protocol Violation|1|||
161470183|NCT04941456|583117362|FG001|Overall Study|Protocol Violation|0|||
161470184|NCT04840888|583117365|FG000|Period 1|Withdrawal by Subject|0|||
161470185|NCT04840888|583117366|FG001|Period 1|Withdrawal by Subject|0|||
161470186|NCT04840888|583117367|FG002|Period 1|Withdrawal by Subject|0|||
161470187|NCT04840888|583117368|FG003|Period 1|Withdrawal by Subject|0|||
161470188|NCT04840888|583117369|FG004|Period 1|Withdrawal by Subject|1|||
161470189|NCT04840888|583117370|FG005|Period 1|Withdrawal by Subject|0|||
161470190|NCT04840888|583117365|FG000|Period 1|Adverse Event|0|||
161470191|NCT04840888|583117366|FG001|Period 1|Adverse Event|0|||
161470192|NCT04840888|583117367|FG002|Period 1|Adverse Event|1|||
161470193|NCT04840888|583117368|FG003|Period 1|Adverse Event|1|||
161470194|NCT04840888|583117369|FG004|Period 1|Adverse Event|10|||
161470195|NCT04840888|583117370|FG005|Period 1|Adverse Event|1|||
161812350|NCT03032172|584356169|FG007|Treatment Period|Non-compliance With Study Drug|0|||
161812351|NCT03032172|584356162|FG000|Treatment Period|Reason Not Specified|0|||
161812352|NCT03032172|584356163|FG001|Treatment Period|Reason Not Specified|4|||
161812353|NCT03032172|584356164|FG002|Treatment Period|Reason Not Specified|1|||
161470196|NCT02719327|583117373|FG000|Overall Study|Withdrawal by Subject|11|||
161470197|NCT02719327|583117374|FG001|Overall Study|Withdrawal by Subject|8|||
161470198|NCT04340193|583117375|FG000|Overall Study|Other reason|0|||
161470199|NCT04340193|583117376|FG001|Overall Study|Other reason|0|||
161470200|NCT04340193|583117377|FG002|Overall Study|Other reason|1|||
161470201|NCT04340193|583117375|FG000|Overall Study|Disease recurrence|0|||
161470202|NCT04340193|583117376|FG001|Overall Study|Disease recurrence|1|||
161470203|NCT04340193|583117377|FG002|Overall Study|Disease recurrence|0|||
161470204|NCT04340193|583117375|FG000|Overall Study|Study drug toxicity|1|||
161470205|NCT04340193|583117376|FG001|Overall Study|Study drug toxicity|0|||
161470206|NCT04340193|583117377|FG002|Overall Study|Study drug toxicity|0|||
161470207|NCT04340193|583117375|FG000|Overall Study|Disease progression|1|||
161470208|NCT04340193|583117376|FG001|Overall Study|Disease progression|2|||
161470209|NCT04340193|583117377|FG002|Overall Study|Disease progression|3|||
161470210|NCT04340193|583117375|FG000|Overall Study|Administrative reasons by sponsor|0|||
161470211|NCT04340193|583117376|FG001|Overall Study|Administrative reasons by sponsor|1|||
161470212|NCT04340193|583117377|FG002|Overall Study|Administrative reasons by sponsor|0|||
161470213|NCT04340193|583117375|FG000|Overall Study|Adverse Event|1|||
161470214|NCT04340193|583117376|FG001|Overall Study|Adverse Event|1|||
161470215|NCT04340193|583117377|FG002|Overall Study|Adverse Event|0|||
161470216|NCT04823650|583117381|FG000|Overall Study|Withdrawal by Subject|0|||
161470217|NCT04823650|583117382|FG001|Overall Study|Withdrawal by Subject|0|||
161470218|NCT04823650|583117383|FG002|Overall Study|Withdrawal by Subject|0|||
161470219|NCT04823650|583117384|FG003|Overall Study|Withdrawal by Subject|0|||
161470220|NCT04823650|583117385|FG004|Overall Study|Withdrawal by Subject|1|||
161470221|NCT04823650|583117386|FG005|Overall Study|Withdrawal by Subject|0|||
161470222|NCT04063384|583118587|FG000|Overall Study|placebo manipulation issue|1|||
161470223|NCT04063384|583118588|FG001|Overall Study|placebo manipulation issue|2|||
161470224|NCT04063384|583118589|FG002|Overall Study|placebo manipulation issue|1|||
161470225|NCT04063384|583118590|FG003|Overall Study|placebo manipulation issue|1|||
161470226|NCT03894046|583118596|FG000|Overall Study|Protocol Violation|1|||
161470227|NCT03894046|583118597|FG001|Overall Study|Protocol Violation|0|||
161470228|NCT03894046|583118598|FG002|Overall Study|Protocol Violation|0|||
161470229|NCT03894046|583118596|FG000|Overall Study|Adverse Event|0|||
161470230|NCT03894046|583118597|FG001|Overall Study|Adverse Event|1|||
161470231|NCT03894046|583118598|FG002|Overall Study|Adverse Event|0|||
161470232|NCT03894046|583118596|FG000|Overall Study|Withdrawal by Subject|2|||
161470233|NCT03894046|583118597|FG001|Overall Study|Withdrawal by Subject|3|||
161470234|NCT03894046|583118598|FG002|Overall Study|Withdrawal by Subject|1|||
161470235|NCT03894046|583118596|FG000|Overall Study|Death|15|||
161470236|NCT03894046|583118597|FG001|Overall Study|Death|21|||
161470237|NCT03894046|583118598|FG002|Overall Study|Death|4|||
161470238|NCT03894046|583118596|FG000|Overall Study|No growth of ABC|2|||
161470239|NCT03894046|583118597|FG001|Overall Study|No growth of ABC|1|||
161470240|NCT03894046|583118598|FG002|Overall Study|No growth of ABC|0|||
161470241|NCT03894046|583118596|FG000|Overall Study|Physician Decision|1|||
161470242|NCT03894046|583118597|FG001|Overall Study|Physician Decision|1|||
161470243|NCT03894046|583118598|FG002|Overall Study|Physician Decision|1|||
161470244|NCT03894046|583118596|FG000|Overall Study|Prohibited concomitant medication|1|||
161470245|NCT03894046|583118597|FG001|Overall Study|Prohibited concomitant medication|0|||
161470246|NCT03894046|583118598|FG002|Overall Study|Prohibited concomitant medication|0|||
161470247|NCT03894046|583118596|FG000|Overall Study|Transferred to other arm/group|1|||
161470248|NCT03894046|583118597|FG001|Overall Study|Transferred to other arm/group|1|||
161470249|NCT03894046|583118598|FG002|Overall Study|Transferred to other arm/group|0|||
161470250|NCT03270644|583118601|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
161470251|NCT03270644|583118601|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
161470252|NCT00004635|583118602|FG000|Period One|refused|2|||
161470253|NCT00004635|583118603|FG001|Period One|refused|1|||
161470254|NCT00004635|583118602|FG000|Period One|Withdrawal by Subject|1|||
161470255|NCT00004635|583118603|FG001|Period One|Withdrawal by Subject|1|||
161470256|NCT00004635|583118602|FG000|Period One|Protocol Violation|1|||
161470257|NCT00004635|583118603|FG001|Period One|Protocol Violation|0|||
161470258|NCT00004635|583118602|FG000|Period One|PSA did not go <5 ng/mL|1|||
161812354|NCT03032172|584356165|FG003|Treatment Period|Reason Not Specified|0|||
161812355|NCT03032172|584356166|FG004|Treatment Period|Reason Not Specified|0|||
161812356|NCT03032172|584356167|FG005|Treatment Period|Reason Not Specified|0|||
161812357|NCT03032172|584356168|FG006|Treatment Period|Reason Not Specified|0|||
161812358|NCT03032172|584356169|FG007|Treatment Period|Reason Not Specified|0|||
161812359|NCT03032172|584356162|FG000|Treatment Period|Physician Decision|0|||
161812360|NCT03032172|584356163|FG001|Treatment Period|Physician Decision|2|||
161812361|NCT03032172|584356164|FG002|Treatment Period|Physician Decision|1|||
161812362|NCT03032172|584356165|FG003|Treatment Period|Physician Decision|0|||
161812363|NCT03032172|584356166|FG004|Treatment Period|Physician Decision|0|||
161812364|NCT03032172|584356167|FG005|Treatment Period|Physician Decision|0|||
161470259|NCT00004635|583118603|FG001|Period One|PSA did not go <5 ng/mL|0|||
161470260|NCT00004635|583118602|FG000|Period One|second malignancy|1|||
161470261|NCT00004635|583118603|FG001|Period One|second malignancy|0|||
161812365|NCT03032172|584356168|FG006|Treatment Period|Physician Decision|0|||
161812366|NCT03032172|584356169|FG007|Treatment Period|Physician Decision|0|||
161812367|NCT03032172|584356162|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161470262|NCT00004635|583118602|FG000|Period One|progressed|0|||
161470263|NCT00004635|583118603|FG001|Period One|progressed|2|||
161470264|NCT00004635|583118602|FG000|Period One|health problem|0|||
161470265|NCT00004635|583118603|FG001|Period One|health problem|1|||
161470266|NCT00004635|583118602|FG000|Period One|discrepancy in data entry|0|||
161470267|NCT00004635|583118603|FG001|Period One|discrepancy in data entry|1|||
161470268|NCT00004635|583118602|FG000|Period Two|progression|2|||
161470269|NCT00004635|583118603|FG001|Period Two|progression|3|||
161470270|NCT00004635|583118602|FG000|Period Two|Adverse Event|1|||
161470271|NCT00004635|583118603|FG001|Period Two|Adverse Event|0|||
161470272|NCT00004635|583118602|FG000|Period Two|refused|0|||
161470273|NCT00004635|583118603|FG001|Period Two|refused|2|||
161812368|NCT03032172|584356163|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
161470274|NCT00004635|583118602|FG000|Period Two|health problem|1|||
161470275|NCT00004635|583118603|FG001|Period Two|health problem|1|||
161470276|NCT00004635|583118602|FG000|Period Two|travel issues|0|||
161470277|NCT00004635|583118603|FG001|Period Two|travel issues|1|||
161470278|NCT00004635|583118602|FG000|Period Two|secondary malignancy|1|||
161470279|NCT00004635|583118603|FG001|Period Two|secondary malignancy|1|||
161470280|NCT00004635|583118602|FG000|Period Two|Lost to Follow-up|1|||
161470281|NCT00004635|583118603|FG001|Period Two|Lost to Follow-up|0|||
161470282|NCT00004635|583118602|FG000|Period Two|discrepancy in data entry|0|||
161470283|NCT00004635|583118603|FG001|Period Two|discrepancy in data entry|1|||
161470284|NCT00191906|583118604|FG000|Study Period II|Adverse Event|0|||
161470285|NCT00191906|583118605|FG001|Study Period II|Adverse Event|1|||
161470286|NCT00191906|583118606|FG002|Study Period II|Adverse Event|0|||
161470287|NCT00191906|583118607|FG003|Study Period II|Adverse Event|0|||
161470288|NCT00191906|583118604|FG000|Study Period II|Withdrawal by Subject|0|||
161470289|NCT00191906|583118605|FG001|Study Period II|Withdrawal by Subject|3|||
161470290|NCT00191906|583118606|FG002|Study Period II|Withdrawal by Subject|0|||
161470291|NCT00191906|583118607|FG003|Study Period II|Withdrawal by Subject|0|||
161470292|NCT00191906|583118604|FG000|Study Period II|Parent/Caregiver Decision|0|||
161470293|NCT00191906|583118605|FG001|Study Period II|Parent/Caregiver Decision|1|||
161470294|NCT00191906|583118606|FG002|Study Period II|Parent/Caregiver Decision|0|||
161470295|NCT00191906|583118607|FG003|Study Period II|Parent/Caregiver Decision|0|||
161470296|NCT00191906|583118604|FG000|Study Period II|Entry Criteria Exclusion|0|||
161470297|NCT00191906|583118605|FG001|Study Period II|Entry Criteria Exclusion|0|||
161470298|NCT00191906|583118606|FG002|Study Period II|Entry Criteria Exclusion|1|||
161470299|NCT00191906|583118607|FG003|Study Period II|Entry Criteria Exclusion|0|||
161470300|NCT00191906|583118604|FG000|Study Period III|Adverse Event|1|||
161470301|NCT00191906|583118605|FG001|Study Period III|Adverse Event|0|||
161470302|NCT00191906|583118606|FG002|Study Period III|Adverse Event|0|||
161470303|NCT00191906|583118607|FG003|Study Period III|Adverse Event|0|||
161470304|NCT00191906|583118604|FG000|Study Period III|Lost to Follow-up|0|||
161470305|NCT00191906|583118605|FG001|Study Period III|Lost to Follow-up|1|||
161470306|NCT00191906|583118606|FG002|Study Period III|Lost to Follow-up|0|||
161470307|NCT00191906|583118607|FG003|Study Period III|Lost to Follow-up|0|||
161470308|NCT00191906|583118604|FG000|Study Period III|Parent/Caregiver Decision|1|||
161470309|NCT00191906|583118605|FG001|Study Period III|Parent/Caregiver Decision|0|||
161470310|NCT00191906|583118606|FG002|Study Period III|Parent/Caregiver Decision|0|||
161470311|NCT00191906|583118607|FG003|Study Period III|Parent/Caregiver Decision|0|||
161470312|NCT00191906|583118604|FG000|Study Period III|Lack of Efficacy|3|||
161470313|NCT00191906|583118605|FG001|Study Period III|Lack of Efficacy|3|||
161470314|NCT00191906|583118606|FG002|Study Period III|Lack of Efficacy|0|||
161470315|NCT00191906|583118607|FG003|Study Period III|Lack of Efficacy|0|||
161470316|NCT00573937|583118608|FG000|Overall Study|Study Terminated|0|||
161470317|NCT00573937|583118609|FG001|Overall Study|Study Terminated|1|||
161470318|NCT00333801|583118610|FG000|Overall Study|Moved to another state|5|||
161470319|NCT00333801|583118611|FG001|Overall Study|Moved to another state|3|||
161470320|NCT00333801|583118610|FG000|Overall Study|Lost to Follow-up|2|||
161470321|NCT00333801|583118611|FG001|Overall Study|Lost to Follow-up|0|||
161470322|NCT00333801|583118610|FG000|Overall Study|Incarcerated|1|||
161470323|NCT00333801|583118611|FG001|Overall Study|Incarcerated|2|||
161470324|NCT00333801|583118610|FG000|Overall Study|Withdrawal by Subject|0|||
161470325|NCT00333801|583118611|FG001|Overall Study|Withdrawal by Subject|1|||
161470326|NCT02476201|583118612|FG000|Overall Study|Unable to program MPP|9|||
161470327|NCT02476201|583118612|FG000|Overall Study|Study echo not performed|5|||
161470328|NCT02476201|583118612|FG000|Overall Study|Adverse Event|4|||
161470329|NCT02476201|583118612|FG000|Overall Study|Death|2|||
161470330|NCT02476201|583118612|FG000|Overall Study|Lost to Follow-up|2|||
161470331|NCT02476201|583118612|FG000|Overall Study|MPP programmed to OFF|2|||
161470332|NCT02476201|583118612|FG000|Overall Study|Withdrawal by Subject|1|||
161812369|NCT03032172|584356164|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
161812370|NCT03032172|584356165|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
161812371|NCT03032172|584356166|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161812372|NCT03032172|584356167|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161812373|NCT03032172|584356168|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161470333|NCT02476201|583118612|FG000|Overall Study|Unsuccessful implant|1|||
161470334|NCT00777205|583118613|FG000|Overall Study|Lost to Follow-up|25|||
161470335|NCT00777205|583118614|FG001|Overall Study|Lost to Follow-up|9|||
161470336|NCT00777205|583118613|FG000|Overall Study|Withdrawal by Subject|6|||
161470337|NCT00777205|583118614|FG001|Overall Study|Withdrawal by Subject|4|||
161576113|NCT01823536|583496095|FG000|Overall Study|Protocol Violation|0|||
161470338|NCT00777205|583118613|FG000|Overall Study|Death|0|||
161470339|NCT00777205|583118614|FG001|Overall Study|Death|2|||
161470340|NCT00777205|583118613|FG000|Overall Study|Protocol Violation|0|||
161470341|NCT00777205|583118614|FG001|Overall Study|Protocol Violation|56|||
161470342|NCT00722423|583118618|FG000|Overall Study|Protocol Violation|0|||
161812374|NCT03032172|584356169|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161812375|NCT03032172|584356162|FG000|Treatment Period|Withdrawal by Subject|2|||
161812376|NCT03032172|584356163|FG001|Treatment Period|Withdrawal by Subject|0|||
161576114|NCT01823536|583496096|FG001|Overall Study|Protocol Violation|1|||
161576115|NCT01823536|583496097|FG002|Overall Study|Protocol Violation|0|||
161576116|NCT01823536|583496098|FG003|Overall Study|Protocol Violation|0|||
161576117|NCT01823536|583496099|FG004|Overall Study|Protocol Violation|0|||
161576118|NCT01823536|583496100|FG005|Overall Study|Protocol Violation|0|||
161576119|NCT01823536|583496095|FG000|Overall Study|Withdrawal by Subject|1|||
161576120|NCT01823536|583496096|FG001|Overall Study|Withdrawal by Subject|1|||
161576121|NCT01823536|583496097|FG002|Overall Study|Withdrawal by Subject|0|||
161576122|NCT01823536|583496098|FG003|Overall Study|Withdrawal by Subject|0|||
161576123|NCT01823536|583496099|FG004|Overall Study|Withdrawal by Subject|0|||
161576124|NCT01823536|583496100|FG005|Overall Study|Withdrawal by Subject|0|||
161576125|NCT01823536|583496095|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161576126|NCT01823536|583496096|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161576127|NCT01823536|583496097|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
161576128|NCT01823536|583496098|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161576129|NCT01823536|583496099|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161576130|NCT01823536|583496100|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161668266|NCT00985153|583837509|FG002|Overall Study|Lost to Follow-up|17|||
161668267|NCT00985153|583837510|FG003|Overall Study|Lost to Follow-up|20|||
161668268|NCT00985153|583837507|FG000|Overall Study|Protocol Violation|3|||
161668269|NCT00985153|583837508|FG001|Overall Study|Protocol Violation|2|||
161668270|NCT00985153|583837509|FG002|Overall Study|Protocol Violation|4|||
161668271|NCT00985153|583837510|FG003|Overall Study|Protocol Violation|3|||
161668272|NCT00985153|583837507|FG000|Overall Study|Withdrawal by Subject|6|||
161668273|NCT00985153|583837508|FG001|Overall Study|Withdrawal by Subject|11|||
161668274|NCT00985153|583837509|FG002|Overall Study|Withdrawal by Subject|11|||
161668275|NCT00985153|583837510|FG003|Overall Study|Withdrawal by Subject|10|||
161576131|NCT01823536|583496095|FG000|Overall Study|Met exclusion criterion No 6|0|||
161576132|NCT01823536|583496096|FG001|Overall Study|Met exclusion criterion No 6|0|||
161576133|NCT01823536|583496097|FG002|Overall Study|Met exclusion criterion No 6|0|||
161576134|NCT01823536|583496098|FG003|Overall Study|Met exclusion criterion No 6|1|||
161576135|NCT01823536|583496099|FG004|Overall Study|Met exclusion criterion No 6|0|||
161576136|NCT01823536|583496100|FG005|Overall Study|Met exclusion criterion No 6|0|||
161576137|NCT01823536|583496095|FG000|Overall Study|Subject moved out of the state|0|||
161576138|NCT01823536|583496096|FG001|Overall Study|Subject moved out of the state|0|||
161576139|NCT01823536|583496097|FG002|Overall Study|Subject moved out of the state|0|||
161576140|NCT01823536|583496098|FG003|Overall Study|Subject moved out of the state|0|||
161668276|NCT00985153|583837507|FG000|Overall Study|Missed One or More Bleeds|7|||
161668277|NCT00985153|583837508|FG001|Overall Study|Missed One or More Bleeds|7|||
161668278|NCT00985153|583837509|FG002|Overall Study|Missed One or More Bleeds|8|||
161668279|NCT00985153|583837510|FG003|Overall Study|Missed One or More Bleeds|10|||
161668280|NCT00985153|583837507|FG000|Overall Study|Incomplete Safety Follow-up|3|||
161668281|NCT00985153|583837508|FG001|Overall Study|Incomplete Safety Follow-up|5|||
161668282|NCT00985153|583837509|FG002|Overall Study|Incomplete Safety Follow-up|4|||
161668283|NCT00985153|583837510|FG003|Overall Study|Incomplete Safety Follow-up|4|||
161668284|NCT01679405|583837511|FG000|Overall Study|Death|2|||
161668285|NCT01679405|583837512|FG001|Overall Study|Death|5|||
161668286|NCT01536015|583837513|FG000|Overall Study|Adverse Event|1|||
161668287|NCT01536015|583837514|FG001|Overall Study|Adverse Event|4|||
161668288|NCT01536015|583837513|FG000|Overall Study|Lost to Follow-up|0|||
161668289|NCT01536015|583837514|FG001|Overall Study|Lost to Follow-up|1|||
161668290|NCT01536015|583837513|FG000|Overall Study|Inclusion Criterion not met|2|||
161668291|NCT01536015|583837514|FG001|Overall Study|Inclusion Criterion not met|0|||
161668292|NCT01536015|583837513|FG000|Overall Study|Study closure|5|||
161668293|NCT01536015|583837514|FG001|Overall Study|Study closure|5|||
161668294|NCT01668667|583837517|FG000|Overall Study|Adverse Event|3|||
161668295|NCT01668667|583837518|FG001|Overall Study|Adverse Event|6|||
161668296|NCT01668667|583837519|FG002|Overall Study|Adverse Event|4|||
161470343|NCT00722423|583118619|FG001|Overall Study|Protocol Violation|1|||
161470344|NCT00747461|583118620|FG000|Overall Study|study terminated by sponsor|5|||
161470345|NCT02149875|583118621|FG000|Overall Study|Lost to Follow-up|3|||
161470346|NCT02149875|583118622|FG001|Overall Study|Lost to Follow-up|4|||
161470347|NCT02149875|583118623|FG002|Overall Study|Lost to Follow-up|5|||
161470348|NCT02149875|583118621|FG000|Overall Study|Withdrawal by Subject|3|||
161470349|NCT02149875|583118622|FG001|Overall Study|Withdrawal by Subject|2|||
161470350|NCT02149875|583118623|FG002|Overall Study|Withdrawal by Subject|2|||
161470351|NCT02149875|583118621|FG000|Overall Study|Physician Decision|1|||
161470352|NCT02149875|583118622|FG001|Overall Study|Physician Decision|2|||
161470353|NCT02149875|583118623|FG002|Overall Study|Physician Decision|2|||
161470354|NCT00299182|583118625|FG000|Overall Study|Withdrawal by Subject|0|||
161470355|NCT00299182|583118626|FG001|Overall Study|Withdrawal by Subject|0|||
161470356|NCT00299182|583118627|FG002|Overall Study|Withdrawal by Subject|1|||
161470357|NCT00299182|583118628|FG003|Overall Study|Withdrawal by Subject|0|||
161470358|NCT00299182|583118629|FG004|Overall Study|Withdrawal by Subject|1|||
161470359|NCT00299182|583118630|FG005|Overall Study|Withdrawal by Subject|2|||
161470360|NCT00299182|583118631|FG006|Overall Study|Withdrawal by Subject|0|||
161470361|NCT00299182|583118625|FG000|Overall Study|Chemotherapy Changed|0|||
161470362|NCT00299182|583118626|FG001|Overall Study|Chemotherapy Changed|0|||
161470363|NCT00299182|583118627|FG002|Overall Study|Chemotherapy Changed|1|||
161470364|NCT00299182|583118628|FG003|Overall Study|Chemotherapy Changed|0|||
161470365|NCT00299182|583118629|FG004|Overall Study|Chemotherapy Changed|1|||
161470366|NCT00299182|583118630|FG005|Overall Study|Chemotherapy Changed|0|||
161470367|NCT00299182|583118631|FG006|Overall Study|Chemotherapy Changed|1|||
161470368|NCT00299182|583118625|FG000|Overall Study|Adverse Event|0|||
161470369|NCT00299182|583118626|FG001|Overall Study|Adverse Event|0|||
161470370|NCT00299182|583118627|FG002|Overall Study|Adverse Event|0|||
161470371|NCT00299182|583118628|FG003|Overall Study|Adverse Event|0|||
161470372|NCT00299182|583118629|FG004|Overall Study|Adverse Event|0|||
161470373|NCT00299182|583118630|FG005|Overall Study|Adverse Event|1|||
161470374|NCT00299182|583118631|FG006|Overall Study|Adverse Event|0|||
161470375|NCT00299182|583118625|FG000|Overall Study|Not Eligible|0|||
161470376|NCT00299182|583118626|FG001|Overall Study|Not Eligible|0|||
161470377|NCT00299182|583118627|FG002|Overall Study|Not Eligible|0|||
161470378|NCT00299182|583118628|FG003|Overall Study|Not Eligible|0|||
161470379|NCT00299182|583118629|FG004|Overall Study|Not Eligible|1|||
161470380|NCT00299182|583118630|FG005|Overall Study|Not Eligible|0|||
161470381|NCT00299182|583118631|FG006|Overall Study|Not Eligible|0|||
161470382|NCT00771316|583118642|FG000|Overall Study|Adverse Event|0|||
161470383|NCT00771316|583118643|FG001|Overall Study|Adverse Event|1|||
161470384|NCT00771316|583118642|FG000|Overall Study|Patient withdrew consent|1|||
161470385|NCT00771316|583118643|FG001|Overall Study|Patient withdrew consent|0|||
161470386|NCT00771316|583118642|FG000|Overall Study|Discontinued due to early termination|1|||
161470387|NCT00771316|583118643|FG001|Overall Study|Discontinued due to early termination|0|||
161470388|NCT04043728|583118646|FG000|Overall Study|Lost to Follow-up|1|||
161470389|NCT04043728|583118647|FG001|Overall Study|Lost to Follow-up|2|||
161470390|NCT04043728|583118648|FG002|Overall Study|Lost to Follow-up|0|||
161470391|NCT04308304|583118649|FG000|Overall Study|Withdrawal by Subject|4|||
161470392|NCT04308304|583118650|FG001|Overall Study|Withdrawal by Subject|0|||
161470393|NCT04308304|583118649|FG000|Overall Study|Protocol Violation|1|||
161470394|NCT04308304|583118650|FG001|Overall Study|Protocol Violation|0|||
161470395|NCT04430738|583118654|FG000|Phase 1: Dose Escalation|Death|1|||
161470396|NCT04430738|583118655|FG001|Phase 1: Dose Escalation|Death|4|||
161470397|NCT04430738|583118656|FG002|Phase 1: Dose Escalation|Death|4|||
161470398|NCT04430738|583118657|FG003|Phase 1: Dose Escalation|Death|1|||
161470399|NCT04430738|583118658|FG004|Phase 1: Dose Escalation|Death|6|||
161470400|NCT04430738|583118659|FG005|Phase 1: Dose Escalation|Death|0|||
161470401|NCT04430738|583118654|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
161470402|NCT04430738|583118655|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
161470403|NCT04430738|583118656|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
161470404|NCT04430738|583118657|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
161470405|NCT04430738|583118658|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
161470406|NCT04430738|583118659|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
161470407|NCT04430738|583118654|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
161470408|NCT04430738|583118655|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
161470409|NCT04430738|583118656|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
161470410|NCT04430738|583118657|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
161470411|NCT04430738|583118658|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
161470412|NCT04430738|583118659|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
161470413|NCT04430738|583118654|FG000|Phase 1: Dose Escalation|Other|1|||
161812377|NCT03032172|584356164|FG002|Treatment Period|Withdrawal by Subject|3|||
161812378|NCT03032172|584356165|FG003|Treatment Period|Withdrawal by Subject|0|||
161812379|NCT03032172|584356166|FG004|Treatment Period|Withdrawal by Subject|0|||
161812380|NCT03032172|584356167|FG005|Treatment Period|Withdrawal by Subject|0|||
161812381|NCT03032172|584356168|FG006|Treatment Period|Withdrawal by Subject|0|||
161812382|NCT03032172|584356169|FG007|Treatment Period|Withdrawal by Subject|0|||
161812383|NCT03032172|584356162|FG000|Open-label Extension Period|Death|0|||
161812384|NCT03032172|584356163|FG001|Open-label Extension Period|Death|0|||
161812385|NCT03032172|584356164|FG002|Open-label Extension Period|Death|0|||
161812386|NCT03032172|584356165|FG003|Open-label Extension Period|Death|0|||
161812387|NCT03032172|584356166|FG004|Open-label Extension Period|Death|0|||
161812388|NCT03032172|584356167|FG005|Open-label Extension Period|Death|0|||
161812389|NCT03032172|584356168|FG006|Open-label Extension Period|Death|0|||
161812390|NCT03032172|584356169|FG007|Open-label Extension Period|Death|2|||
161812391|NCT03032172|584356162|FG000|Open-label Extension Period|Reason Not Specified|0|||
161812392|NCT03032172|584356163|FG001|Open-label Extension Period|Reason Not Specified|0|||
161812393|NCT03032172|584356164|FG002|Open-label Extension Period|Reason Not Specified|0|||
161812394|NCT03032172|584356165|FG003|Open-label Extension Period|Reason Not Specified|0|||
161812395|NCT03032172|584356166|FG004|Open-label Extension Period|Reason Not Specified|0|||
161812396|NCT03032172|584356167|FG005|Open-label Extension Period|Reason Not Specified|5|||
161812397|NCT03032172|584356168|FG006|Open-label Extension Period|Reason Not Specified|3|||
161812398|NCT03032172|584356169|FG007|Open-label Extension Period|Reason Not Specified|0|||
161812399|NCT03032172|584356162|FG000|Open-label Extension Period|Pregnancy|0|||
161812400|NCT03032172|584356163|FG001|Open-label Extension Period|Pregnancy|0|||
161812401|NCT03032172|584356164|FG002|Open-label Extension Period|Pregnancy|0|||
161812402|NCT03032172|584356165|FG003|Open-label Extension Period|Pregnancy|0|||
161812403|NCT03032172|584356166|FG004|Open-label Extension Period|Pregnancy|0|||
161812404|NCT03032172|584356167|FG005|Open-label Extension Period|Pregnancy|0|||
161812405|NCT03032172|584356168|FG006|Open-label Extension Period|Pregnancy|1|||
161812406|NCT03032172|584356169|FG007|Open-label Extension Period|Pregnancy|0|||
161812407|NCT03032172|584356162|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161812408|NCT03032172|584356163|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161812409|NCT03032172|584356164|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161812410|NCT03032172|584356165|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
161812411|NCT03032172|584356166|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
161812412|NCT03032172|584356167|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
161812413|NCT03032172|584356168|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
161812414|NCT03032172|584356169|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
161812415|NCT06144424|584356174|FG000|Overall Study|Withdrawal by Subject|2|||
161812416|NCT06144424|584356175|FG001|Overall Study|Withdrawal by Subject|0|||
161812417|NCT06144424|584356174|FG000|Overall Study|Incarceration|1|||
161812418|NCT06144424|584356175|FG001|Overall Study|Incarceration|0|||
161812419|NCT06284525|584356177|FG000|Overall Study|Withdrawal by Subject|1|||
161812420|NCT00834522|584356178|FG000|Washout|Adverse Event|1|||
161812421|NCT00834522|584356179|FG001|Washout|Adverse Event|0|||
161812422|NCT00834522|584356178|FG000|Washout|Withdrawal by Subject|2|||
161812423|NCT00834522|584356179|FG001|Washout|Withdrawal by Subject|1|||
161812424|NCT00519194|584356180|FG000|Overall Study|Withdrawal by Subject|9|||
161812425|NCT00519194|584356180|FG000|Overall Study|Death|9|||
161812426|NCT00519194|584356180|FG000|Overall Study|Lost to Follow-up|3|||
161812427|NCT01111461|584356181|FG000|Overall Study|Adverse Event|32|||
161812428|NCT01111461|584356181|FG000|Overall Study|Participant choice|11|||
161812429|NCT01111461|584356181|FG000|Overall Study|Lost to Follow-up|1|||
161812430|NCT01111461|584356181|FG000|Overall Study|Withdrawal by Subject|1|||
161812431|NCT01111461|584356181|FG000|Overall Study|Other|6|||
161812432|NCT03415308|584356192|FG000|Overall Study|Lost to Follow-up|0|||
161812433|NCT03415308|584356193|FG001|Overall Study|Lost to Follow-up|0|||
161812434|NCT03415308|584356194|FG002|Overall Study|Lost to Follow-up|1|||
161812435|NCT03415308|584356192|FG000|Overall Study|Scheduling Conflicts|0|||
161812436|NCT03415308|584356193|FG001|Overall Study|Scheduling Conflicts|0|||
161812437|NCT03415308|584356194|FG002|Overall Study|Scheduling Conflicts|7|||
161812438|NCT01471353|584356197|FG000|Overall Study|remain on study|3|||
161812439|NCT03123094|584356199|FG000|Overall Study|Withdrawal by Subject|0|||
161812440|NCT03123094|584356200|FG001|Overall Study|Withdrawal by Subject|2|||
161812441|NCT03123094|584356201|FG002|Overall Study|Withdrawal by Subject|1|||
161812442|NCT03123094|584356202|FG003|Overall Study|Withdrawal by Subject|0|||
161812443|NCT03123094|584356203|FG004|Overall Study|Withdrawal by Subject|1|||
161812444|NCT00736190|584356204|FG000|Overall Study|Pregnancy|1|||
161812445|NCT00736190|584356204|FG000|Overall Study|Withdrawal by Subject|1|||
161812446|NCT00736190|584356204|FG000|Overall Study|Adverse Event|1|||
161812447|NCT03246503|584356205|FG000|Overall Study|Lost to Follow-up|23|||
161812448|NCT03246503|584356205|FG000|Overall Study|Withdrawal by Subject|20|||
161470414|NCT04430738|583118655|FG001|Phase 1: Dose Escalation|Other|0|||
161668297|NCT01668667|583837520|FG003|Overall Study|Adverse Event|4|||
161668298|NCT01668667|583837517|FG000|Overall Study|Lack of Efficacy|3|||
161668299|NCT01668667|583837518|FG001|Overall Study|Lack of Efficacy|2|||
161668300|NCT01668667|583837519|FG002|Overall Study|Lack of Efficacy|2|||
161668301|NCT01668667|583837520|FG003|Overall Study|Lack of Efficacy|3|||
161668302|NCT01668667|583837517|FG000|Overall Study|Protocol Violation|6|||
161668303|NCT01668667|583837518|FG001|Overall Study|Protocol Violation|10|||
161668304|NCT01668667|583837519|FG002|Overall Study|Protocol Violation|12|||
161668305|NCT01668667|583837520|FG003|Overall Study|Protocol Violation|5|||
161668306|NCT01668667|583837517|FG000|Overall Study|Lost to Follow-up|9|||
161668307|NCT01668667|583837518|FG001|Overall Study|Lost to Follow-up|4|||
161668308|NCT01668667|583837519|FG002|Overall Study|Lost to Follow-up|7|||
161668309|NCT01668667|583837520|FG003|Overall Study|Lost to Follow-up|6|||
161668310|NCT01668667|583837517|FG000|Overall Study|Physician Decision|3|||
161668311|NCT01668667|583837518|FG001|Overall Study|Physician Decision|0|||
161668312|NCT01668667|583837519|FG002|Overall Study|Physician Decision|1|||
161470415|NCT04430738|583118656|FG002|Phase 1: Dose Escalation|Other|0|||
161470416|NCT04430738|583118657|FG003|Phase 1: Dose Escalation|Other|0|||
161470417|NCT04430738|583118658|FG004|Phase 1: Dose Escalation|Other|0|||
161470418|NCT04430738|583118659|FG005|Phase 1: Dose Escalation|Other|0|||
161470419|NCT04430738|583118654|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
161470420|NCT04430738|583118655|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
161470421|NCT04430738|583118656|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
161470422|NCT04430738|583118657|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
161470423|NCT04430738|583118658|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
161470424|NCT04430738|583118659|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
161470425|NCT04430738|583118654|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
161470426|NCT04430738|583118655|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
161470427|NCT04430738|583118656|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
161470428|NCT04430738|583118657|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
161470429|NCT04430738|583118658|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
161470430|NCT04430738|583118659|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
161470431|NCT05274165|583118660|FG000|Overall Study|Withdrawal by Subject|3|||
161470432|NCT05274165|583118661|FG001|Overall Study|Withdrawal by Subject|3|||
161470433|NCT03659916|583118663|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
161470434|NCT03659916|583118664|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
161470435|NCT03659916|583118665|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
161470436|NCT03659916|583118663|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
161470437|NCT03659916|583118664|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
161470438|NCT03659916|583118665|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
161470439|NCT03659916|583118663|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
161470440|NCT03659916|583118664|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
161470441|NCT03659916|583118665|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
161470442|NCT03659916|583118663|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
161470443|NCT03659916|583118664|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
161470444|NCT03659916|583118665|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
161470445|NCT03659916|583118663|FG000|Treatment Period (72 Weeks)|Other|1|||
161470446|NCT03659916|583118664|FG001|Treatment Period (72 Weeks)|Other|3|||
161470447|NCT03659916|583118665|FG002|Treatment Period (72 Weeks)|Other|9|||
161470448|NCT03659916|583118663|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
161470449|NCT03659916|583118664|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
161470450|NCT03659916|583118665|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
161470451|NCT03659916|583118663|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
161470452|NCT03659916|583118664|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
161470453|NCT03659916|583118665|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
161470454|NCT03659916|583118663|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
161470455|NCT03659916|583118664|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
161470456|NCT03659916|583118665|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
161470457|NCT03659916|583118663|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
161470458|NCT03659916|583118664|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
161470459|NCT03659916|583118665|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
161470460|NCT03659916|583118663|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
161470461|NCT03659916|583118664|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
161470462|NCT03659916|583118665|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
161470463|NCT03659916|583118663|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
161470464|NCT03659916|583118664|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
161470465|NCT03659916|583118665|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
161668313|NCT01668667|583837520|FG003|Overall Study|Physician Decision|0|||
161668314|NCT01668667|583837517|FG000|Overall Study|Withdrawal by Subject|7|||
161668315|NCT01668667|583837518|FG001|Overall Study|Withdrawal by Subject|4|||
161668316|NCT01668667|583837519|FG002|Overall Study|Withdrawal by Subject|5|||
161668317|NCT01668667|583837520|FG003|Overall Study|Withdrawal by Subject|5|||
161812449|NCT03246503|584356205|FG000|Overall Study|Physician Decision|5|||
161470472|NCT03805646|583118669|FG000|Overall Study|Death|40|||
161470473|NCT03805646|583118670|FG001|Overall Study|Death|49|||
161812450|NCT03246503|584356205|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
161812451|NCT05014828|584356206|FG000|Overall Study|Study Completed by Sponsor|16|||
161812452|NCT05014828|584356207|FG001|Overall Study|Study Completed by Sponsor|16|||
161812453|NCT05014828|584356208|FG002|Overall Study|Study Completed by Sponsor|3|||
161470474|NCT03805646|583118669|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
161470475|NCT03805646|583118670|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
161470476|NCT04452344|583118671|FG000|Overall Study|Withdrawal by Subject|3|||
161470477|NCT04452344|583118672|FG001|Overall Study|Withdrawal by Subject|6|||
161470478|NCT04452344|583118671|FG000|Overall Study|Adverse Event|1|||
161470479|NCT04452344|583118672|FG001|Overall Study|Adverse Event|2|||
161470480|NCT04452344|583118671|FG000|Overall Study|Lost to Follow-up|2|||
161470481|NCT04452344|583118672|FG001|Overall Study|Lost to Follow-up|2|||
161470482|NCT04452344|583118671|FG000|Overall Study|No Post-Op Visit|6|||
161470483|NCT04452344|583118672|FG001|Overall Study|No Post-Op Visit|7|||
161470484|NCT05171777|583118673|FG000|Treatment Crossover Period|Adverse Event|9|||
161470485|NCT05171777|583118674|FG001|Treatment Crossover Period|Adverse Event|6|||
161470486|NCT05171777|583118675|FG002|Treatment Crossover Period|Adverse Event|0|||
161470487|NCT05171777|583118676|FG003|Treatment Crossover Period|Adverse Event|0|||
161470488|NCT05171777|583118673|FG000|Treatment Crossover Period|Death|5|||
161470489|NCT05171777|583118674|FG001|Treatment Crossover Period|Death|5|||
161470490|NCT05171777|583118675|FG002|Treatment Crossover Period|Death|0|||
161470491|NCT05171777|583118676|FG003|Treatment Crossover Period|Death|0|||
161470492|NCT05171777|583118673|FG000|Treatment Crossover Period|Disease Relapse|1|||
161470493|NCT05171777|583118674|FG001|Treatment Crossover Period|Disease Relapse|0|||
161470494|NCT05171777|583118675|FG002|Treatment Crossover Period|Disease Relapse|0|||
161470495|NCT05171777|583118676|FG003|Treatment Crossover Period|Disease Relapse|0|||
161470496|NCT05171777|583118673|FG000|Treatment Crossover Period|Reason not Specified|1|||
161470497|NCT05171777|583118674|FG001|Treatment Crossover Period|Reason not Specified|1|||
161470498|NCT05171777|583118675|FG002|Treatment Crossover Period|Reason not Specified|0|||
161470499|NCT05171777|583118676|FG003|Treatment Crossover Period|Reason not Specified|0|||
161668318|NCT02988622|583837521|FG000|Overall Study|Lost to Follow-up|17|||
161668319|NCT03261700|583837522|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
161668320|NCT03261700|583837523|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
161668321|NCT01204398|583837524|FG000|Overall Study|Adverse Event|1|||
161668322|NCT04640077|583837527|FG000|Period 1|Withdrawal by Subject|4|||
161668323|NCT04640077|583837528|FG001|Period 1|Withdrawal by Subject|5|||
161470500|NCT05171777|583118673|FG000|Treatment Crossover Period|Physician Decision|0|||
161470501|NCT05171777|583118674|FG001|Treatment Crossover Period|Physician Decision|1|||
161470502|NCT05171777|583118675|FG002|Treatment Crossover Period|Physician Decision|0|||
161470503|NCT05171777|583118676|FG003|Treatment Crossover Period|Physician Decision|0|||
161470504|NCT05171777|583118673|FG000|Treatment Crossover Period|Progressive Disease|14|||
161470505|NCT05171777|583118674|FG001|Treatment Crossover Period|Progressive Disease|10|||
161470506|NCT05171777|583118675|FG002|Treatment Crossover Period|Progressive Disease|0|||
161470507|NCT05171777|583118676|FG003|Treatment Crossover Period|Progressive Disease|0|||
161470508|NCT05171777|583118673|FG000|Treatment Crossover Period|Protocol Violation|0|||
161470509|NCT05171777|583118674|FG001|Treatment Crossover Period|Protocol Violation|2|||
161470510|NCT05171777|583118675|FG002|Treatment Crossover Period|Protocol Violation|0|||
161470511|NCT05171777|583118676|FG003|Treatment Crossover Period|Protocol Violation|0|||
161470512|NCT05171777|583118673|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
161470513|NCT05171777|583118674|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
161470514|NCT05171777|583118675|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
161470515|NCT05171777|583118676|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
161470516|NCT05171777|583118673|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
161470517|NCT05171777|583118674|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
161470518|NCT05171777|583118675|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
161470519|NCT05171777|583118676|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
161470520|NCT05171777|583118673|FG000|Treatment Continuation Period|Adverse Event|0|||
161470521|NCT05171777|583118674|FG001|Treatment Continuation Period|Adverse Event|0|||
161470522|NCT05171777|583118675|FG002|Treatment Continuation Period|Adverse Event|3|||
161470523|NCT05171777|583118676|FG003|Treatment Continuation Period|Adverse Event|6|||
161668324|NCT04640077|583837529|FG002|Period 1|Withdrawal by Subject|0|||
161668325|NCT04640077|583837527|FG000|Period 1|Adverse Event|1|||
161668326|NCT04640077|583837528|FG001|Period 1|Adverse Event|1|||
161470524|NCT05171777|583118673|FG000|Treatment Continuation Period|Death|0|||
161470525|NCT05171777|583118674|FG001|Treatment Continuation Period|Death|0|||
161470526|NCT05171777|583118675|FG002|Treatment Continuation Period|Death|1|||
161668327|NCT04640077|583837529|FG002|Period 1|Adverse Event|0|||
161668328|NCT04640077|583837527|FG000|Period 1|Screen Failure|2|||
161812454|NCT05014828|584356209|FG003|Overall Study|Study Completed by Sponsor|3|||
161470527|NCT05171777|583118676|FG003|Treatment Continuation Period|Death|3|||
161470528|NCT05171777|583118673|FG000|Treatment Continuation Period|Disease Relapse|0|||
161470529|NCT05171777|583118674|FG001|Treatment Continuation Period|Disease Relapse|0|||
161470530|NCT05171777|583118675|FG002|Treatment Continuation Period|Disease Relapse|1|||
161668329|NCT04640077|583837528|FG001|Period 1|Screen Failure|0|||
161668330|NCT04640077|583837529|FG002|Period 1|Screen Failure|0|||
161668331|NCT04640077|583837527|FG000|Period 2|Withdrawal by Subject|0|||
161668332|NCT04640077|583837528|FG001|Period 2|Withdrawal by Subject|0|||
161668333|NCT04640077|583837529|FG002|Period 2|Withdrawal by Subject|18|||
161668334|NCT04640077|583837527|FG000|Period 2|Adverse Event|0|||
161668335|NCT04640077|583837528|FG001|Period 2|Adverse Event|0|||
161668336|NCT04640077|583837529|FG002|Period 2|Adverse Event|6|||
161668337|NCT04640077|583837527|FG000|Period 2|Lost to Follow-up|0|||
161915870|NCT02966834|584740571|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
161915871|NCT02966834|584740572|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161915872|NCT02966834|584740573|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
161915873|NCT02966834|584740568|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161915874|NCT02966834|584740569|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161915875|NCT02966834|584740570|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
161915876|NCT02966834|584740571|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
161915877|NCT02966834|584740572|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161915878|NCT02966834|584740573|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
161915879|NCT02966834|584740568|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915880|NCT02966834|584740569|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915881|NCT02966834|584740570|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915882|NCT02966834|584740571|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
161915883|NCT02966834|584740572|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915884|NCT02966834|584740573|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915885|NCT02966834|584740568|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915886|NCT02966834|584740569|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915887|NCT02966834|584740570|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915888|NCT02966834|584740571|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
161915889|NCT02966834|584740572|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915890|NCT02966834|584740573|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915891|NCT04739800|584740577|FG000|Overall Study|Adverse Event|2|||
161915892|NCT04739800|584740578|FG001|Overall Study|Adverse Event|1|||
161915893|NCT04739800|584740579|FG002|Overall Study|Adverse Event|4|||
161915894|NCT04739800|584740580|FG003|Overall Study|Adverse Event|5|||
161915895|NCT04739800|584740577|FG000|Overall Study|Never Treated|2|||
161915896|NCT04739800|584740578|FG001|Overall Study|Never Treated|0|||
161915897|NCT04739800|584740579|FG002|Overall Study|Never Treated|1|||
161915898|NCT04739800|584740580|FG003|Overall Study|Never Treated|1|||
161915899|NCT04739800|584740577|FG000|Overall Study|On Treatment|5|||
161915900|NCT04739800|584740578|FG001|Overall Study|On Treatment|9|||
161915901|NCT04739800|584740579|FG002|Overall Study|On Treatment|9|||
161915902|NCT04739800|584740580|FG003|Overall Study|On Treatment|9|||
161915903|NCT04739800|584740577|FG000|Overall Study|Symptomatic Deterioration|1|||
161915904|NCT04739800|584740578|FG001|Overall Study|Symptomatic Deterioration|1|||
161915905|NCT04739800|584740579|FG002|Overall Study|Symptomatic Deterioration|3|||
161915906|NCT04739800|584740580|FG003|Overall Study|Symptomatic Deterioration|0|||
161915907|NCT04739800|584740577|FG000|Overall Study|Withdrawal by Subject|1|||
161915908|NCT04739800|584740578|FG001|Overall Study|Withdrawal by Subject|2|||
161915909|NCT04739800|584740579|FG002|Overall Study|Withdrawal by Subject|1|||
161915910|NCT04739800|584740580|FG003|Overall Study|Withdrawal by Subject|3|||
161915911|NCT04739800|584740577|FG000|Overall Study|Other Reason|1|||
161915912|NCT04739800|584740578|FG001|Overall Study|Other Reason|3|||
161915913|NCT04739800|584740579|FG002|Overall Study|Other Reason|5|||
161915914|NCT04739800|584740580|FG003|Overall Study|Other Reason|4|||
161915915|NCT03415178|584740582|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
161915916|NCT03415178|584740583|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
161915917|NCT03415178|584740582|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
161915918|NCT03415178|584740583|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
161915919|NCT04880850|584740584|FG000|Overall Study|Death|2|||
161915920|NCT04880850|584740585|FG001|Overall Study|Death|1|||
161915921|NCT04880850|584740584|FG000|Overall Study|Lost to Follow-up|3|||
161915922|NCT04880850|584740585|FG001|Overall Study|Lost to Follow-up|6|||
161915923|NCT04880850|584740584|FG000|Overall Study|Physician Decision|2|||
161915924|NCT04880850|584740585|FG001|Overall Study|Physician Decision|1|||
161915925|NCT04880850|584740584|FG000|Overall Study|Withdrawal by Subject|9|||
161915926|NCT04880850|584740585|FG001|Overall Study|Withdrawal by Subject|10|||
161915927|NCT03907488|584740586|FG000|Overall Study|Adverse Event|20|||
161915928|NCT03907488|584740587|FG001|Overall Study|Adverse Event|20|||
161915929|NCT03907488|584740586|FG000|Overall Study|Withdrawal by Subject|9|||
161915930|NCT03907488|584740587|FG001|Overall Study|Withdrawal by Subject|13|||
161915931|NCT03907488|584740586|FG000|Overall Study|Lack of Efficacy|0|||
161915932|NCT03907488|584740587|FG001|Overall Study|Lack of Efficacy|9|||
161915933|NCT03907488|584740586|FG000|Overall Study|Death|3|||
161915934|NCT03907488|584740587|FG001|Overall Study|Death|8|||
161915935|NCT03907488|584740586|FG000|Overall Study|not protocol specified|5|||
161915936|NCT03907488|584740587|FG001|Overall Study|not protocol specified|8|||
161915937|NCT03907488|584740586|FG000|Overall Study|Ineligible|9|||
161812455|NCT05014828|584356206|FG000|Overall Study|Death|11|||
161812456|NCT05014828|584356207|FG001|Overall Study|Death|6|||
161812457|NCT05014828|584356208|FG002|Overall Study|Death|0|||
161812458|NCT05014828|584356209|FG003|Overall Study|Death|0|||
161812459|NCT05014828|584356206|FG000|Overall Study|Lost to Follow-up|0|||
161812460|NCT05014828|584356207|FG001|Overall Study|Lost to Follow-up|0|||
161812461|NCT05014828|584356208|FG002|Overall Study|Lost to Follow-up|2|||
161812462|NCT05014828|584356209|FG003|Overall Study|Lost to Follow-up|0|||
161812463|NCT05014828|584356206|FG000|Overall Study|Miscellaneous.|0|||
161812464|NCT05014828|584356207|FG001|Overall Study|Miscellaneous.|1|||
161812465|NCT05014828|584356208|FG002|Overall Study|Miscellaneous.|0|||
161812466|NCT05014828|584356209|FG003|Overall Study|Miscellaneous.|0|||
161812467|NCT02682238|584356212|FG000|Overall Study|Lost to Follow-up|0|||
161812468|NCT02682238|584356213|FG001|Overall Study|Lost to Follow-up|2|||
161812469|NCT02682238|584356212|FG000|Overall Study|Withdrawal by Subject|1|||
161812470|NCT02682238|584356213|FG001|Overall Study|Withdrawal by Subject|0|||
161812471|NCT02682238|584356212|FG000|Overall Study|Adverse Event|1|||
161812472|NCT02682238|584356213|FG001|Overall Study|Adverse Event|0|||
161812473|NCT02682238|584356212|FG000|Overall Study|Non-compliance with Study Drug|1|||
161812474|NCT02682238|584356213|FG001|Overall Study|Non-compliance with Study Drug|0|||
161812475|NCT02682238|584356212|FG000|Overall Study|Non-compliance with Protocol|0|||
161812476|NCT02682238|584356213|FG001|Overall Study|Non-compliance with Protocol|2|||
161812477|NCT01370317|584356214|FG000|Overall Study|Participant withdrew consent|1|||
161812478|NCT01370317|584356215|FG001|Overall Study|Participant withdrew consent|0|||
161812479|NCT01370317|584356214|FG000|Overall Study|Protocol deviation|0|||
161812480|NCT01370317|584356215|FG001|Overall Study|Protocol deviation|1|||
161812481|NCT00075478|584356216|FG000|Overall Study|not eligible|1|||
161470531|NCT05171777|583118676|FG003|Treatment Continuation Period|Disease Relapse|0|||
161470532|NCT05171777|583118673|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
161470533|NCT05171777|583118674|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
161812482|NCT00075478|584356217|FG001|Overall Study|not eligible|0|||
161812483|NCT00075478|584356216|FG000|Overall Study|Physician Decision|0|||
161812484|NCT00075478|584356217|FG001|Overall Study|Physician Decision|1|||
161470534|NCT05171777|583118675|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
161470535|NCT05171777|583118676|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
161470536|NCT05171777|583118673|FG000|Treatment Continuation Period|Physician Decision|0|||
161470537|NCT05171777|583118674|FG001|Treatment Continuation Period|Physician Decision|0|||
161470538|NCT05171777|583118675|FG002|Treatment Continuation Period|Physician Decision|0|||
161470539|NCT05171777|583118676|FG003|Treatment Continuation Period|Physician Decision|4|||
161470540|NCT05171777|583118673|FG000|Treatment Continuation Period|Progressive Disease|0|||
161470541|NCT05171777|583118674|FG001|Treatment Continuation Period|Progressive Disease|0|||
161470542|NCT05171777|583118675|FG002|Treatment Continuation Period|Progressive Disease|6|||
161470543|NCT05171777|583118676|FG003|Treatment Continuation Period|Progressive Disease|20|||
161470544|NCT05171777|583118673|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
161470545|NCT05171777|583118674|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
161470546|NCT05171777|583118675|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
161470547|NCT05171777|583118676|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
161470548|NCT05171777|583118673|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
161470549|NCT05171777|583118674|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
161470550|NCT05171777|583118675|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
161470551|NCT05171777|583118676|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
161470552|NCT05171777|583118673|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
161470553|NCT05171777|583118674|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
161470554|NCT05171777|583118675|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
161470555|NCT05171777|583118676|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
161470556|NCT02364713|583118677|FG000|Overall Study|Ineligible|2|||
161470557|NCT02364713|583118678|FG001|Overall Study|Ineligible|2|||
161470558|NCT04686786|583118679|FG000|Overall Study|Adverse Event|9|||
161470559|NCT04686786|583118679|FG000|Overall Study|Death|1|||
161470560|NCT04686786|583118679|FG000|Overall Study|Lack of Efficacy|25|||
161470561|NCT04686786|583118679|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
161470562|NCT04686786|583118679|FG000|Overall Study|Study Terminated by Sponsor|14|||
161470563|NCT04686786|583118679|FG000|Overall Study|Withdrawal by Subject|15|||
161470564|NCT04686786|583118679|FG000|Overall Study|Other than specified|1|||
161470565|NCT03924869|583118680|FG000|Overall Study|Death|73|||
161470566|NCT03924869|583118681|FG001|Overall Study|Death|62|||
161470567|NCT03924869|583118680|FG000|Overall Study|Lost to Follow-up|3|||
161470568|NCT03924869|583118681|FG001|Overall Study|Lost to Follow-up|0|||
161470569|NCT03924869|583118680|FG000|Overall Study|Physician Decision|0|||
161470570|NCT03924869|583118681|FG001|Overall Study|Physician Decision|3|||
161470571|NCT03924869|583118680|FG000|Overall Study|Withdrawal by Subject|7|||
161470572|NCT03924869|583118681|FG001|Overall Study|Withdrawal by Subject|3|||
161470573|NCT03924869|583118680|FG000|Overall Study|Study Terminated By Sponsor|144|||
161470574|NCT03924869|583118681|FG001|Overall Study|Study Terminated By Sponsor|153|||
161470575|NCT03001882|583118684|FG000|Overall Study|Death|1|||
161470576|NCT03001882|583118685|FG001|Overall Study|Death|0|||
161470577|NCT03001882|583118686|FG002|Overall Study|Death|0|||
161470578|NCT03001882|583118687|FG003|Overall Study|Death|3|||
161470579|NCT03001882|583118684|FG000|Overall Study|Participant withdrew consent|0|||
161470580|NCT03001882|583118685|FG001|Overall Study|Participant withdrew consent|1|||
161470581|NCT03001882|583118686|FG002|Overall Study|Participant withdrew consent|0|||
161470582|NCT03001882|583118687|FG003|Overall Study|Participant withdrew consent|5|||
161470583|NCT03001882|583118684|FG000|Overall Study|Other reasons|1|||
161470584|NCT03001882|583118685|FG001|Overall Study|Other reasons|2|||
161470585|NCT03001882|583118686|FG002|Overall Study|Other reasons|0|||
161470586|NCT03001882|583118687|FG003|Overall Study|Other reasons|5|||
161470587|NCT03001882|583118684|FG000|Overall Study|Administrative reason by sponsor|0|||
161470588|NCT03001882|583118685|FG001|Overall Study|Administrative reason by sponsor|0|||
161470589|NCT03001882|583118686|FG002|Overall Study|Administrative reason by sponsor|0|||
161470590|NCT03001882|583118687|FG003|Overall Study|Administrative reason by sponsor|1|||
161470591|NCT03001882|583118684|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
161470592|NCT03001882|583118685|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
161470593|NCT03001882|583118686|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
161576141|NCT01823536|583496099|FG004|Overall Study|Subject moved out of the state|1|||
161576142|NCT01823536|583496100|FG005|Overall Study|Subject moved out of the state|0|||
161576143|NCT00566735|583496104|FG000|Overall Study|Withdrawal by Subject|0|||
161576144|NCT00566735|583496105|FG001|Overall Study|Withdrawal by Subject|1|||
161470594|NCT03001882|583118687|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
161470595|NCT03001882|583118684|FG000|Overall Study|Not reported|0|||
161470596|NCT03001882|583118685|FG001|Overall Study|Not reported|0|||
161470597|NCT03001882|583118686|FG002|Overall Study|Not reported|0|||
161470598|NCT03001882|583118687|FG003|Overall Study|Not reported|6|||
161470599|NCT03001882|583118684|FG000|Overall Study|Maximum clinical benefit|2|||
161470600|NCT03001882|583118685|FG001|Overall Study|Maximum clinical benefit|3|||
161470601|NCT03001882|583118686|FG002|Overall Study|Maximum clinical benefit|0|||
161576145|NCT00566735|583496104|FG000|Overall Study|Refused neuropsychological testing|2|||
161470602|NCT03001882|583118687|FG003|Overall Study|Maximum clinical benefit|10|||
161470603|NCT03001882|583118684|FG000|Overall Study|AE unrelated to study drug|3|||
161470604|NCT03001882|583118685|FG001|Overall Study|AE unrelated to study drug|3|||
161470605|NCT03001882|583118686|FG002|Overall Study|AE unrelated to study drug|0|||
161470606|NCT03001882|583118687|FG003|Overall Study|AE unrelated to study drug|11|||
161470607|NCT03001882|583118684|FG000|Overall Study|Study Drug Toxicity|8|||
161470608|NCT03001882|583118685|FG001|Overall Study|Study Drug Toxicity|5|||
161470609|NCT03001882|583118686|FG002|Overall Study|Study Drug Toxicity|0|||
161470610|NCT03001882|583118687|FG003|Overall Study|Study Drug Toxicity|37|||
161470611|NCT03001882|583118684|FG000|Overall Study|Disease progression|16|||
161470612|NCT03001882|583118685|FG001|Overall Study|Disease progression|14|||
161470613|NCT03001882|583118686|FG002|Overall Study|Disease progression|1|||
161470614|NCT03001882|583118687|FG003|Overall Study|Disease progression|90|||
161470615|NCT05268055|583118689|FG000|Overall Study|Lost to Follow-up|68|||
161470616|NCT05268055|583118690|FG001|Overall Study|Lost to Follow-up|68|||
161470617|NCT05268055|583118689|FG000|Overall Study|Withdrawal by Subject|12|||
161470618|NCT05268055|583118690|FG001|Overall Study|Withdrawal by Subject|8|||
161470619|NCT03507400|583118691|FG000|Overall Study|discontinued|5|||
161470620|NCT03507400|583118692|FG001|Overall Study|discontinued|1|||
161470621|NCT03507400|583118691|FG000|Overall Study|Lost to Follow-up|8|||
161470622|NCT03507400|583118692|FG001|Overall Study|Lost to Follow-up|6|||
161470623|NCT03507400|583118691|FG000|Overall Study|Protocol Violation|0|||
161470624|NCT03507400|583118692|FG001|Overall Study|Protocol Violation|1|||
161470625|NCT01555983|583118693|FG000|Overall Study|Withdrawal by Subject|1|||
161470626|NCT01555983|583118694|FG001|Overall Study|Withdrawal by Subject|0|||
161470627|NCT01555983|583118695|FG002|Overall Study|Withdrawal by Subject|0|||
161470628|NCT01555983|583118696|FG003|Overall Study|Withdrawal by Subject|0|||
161470629|NCT01555983|583118697|FG004|Overall Study|Withdrawal by Subject|1|||
161470630|NCT01555983|583118698|FG005|Overall Study|Withdrawal by Subject|1|||
161470631|NCT04026711|583118699|FG000|Overall Study|Withdrawal by Subject|1|||
161470632|NCT04026711|583118700|FG001|Overall Study|Withdrawal by Subject|0|||
161470633|NCT04026711|583118699|FG000|Overall Study|mental health crisis|1|||
161470634|NCT04026711|583118700|FG001|Overall Study|mental health crisis|0|||
161470635|NCT05985395|583118706|FG000|Overall Study|Physician Decision|2|||
161470636|NCT05985395|583118707|FG001|Overall Study|Physician Decision|1|||
161470637|NCT05985395|583118706|FG000|Overall Study|Withdrawal by Subject|1|||
161470638|NCT05985395|583118707|FG001|Overall Study|Withdrawal by Subject|0|||
161470639|NCT00717093|583119761|FG000|Overall Study|Adverse Event|19|||
161470640|NCT00717093|583119762|FG001|Overall Study|Adverse Event|9|||
161470641|NCT00717093|583119761|FG000|Overall Study|Lack of Efficacy|3|||
161470642|NCT00717093|583119762|FG001|Overall Study|Lack of Efficacy|13|||
161470643|NCT00717093|583119761|FG000|Overall Study|Lost to Follow-up|9|||
161470644|NCT00717093|583119762|FG001|Overall Study|Lost to Follow-up|6|||
161470645|NCT00717093|583119761|FG000|Overall Study|Withdrawal by Subject|12|||
161470646|NCT00717093|583119762|FG001|Overall Study|Withdrawal by Subject|19|||
161470647|NCT00717093|583119761|FG000|Overall Study|Other|0|||
161470648|NCT00717093|583119762|FG001|Overall Study|Other|1|||
161576146|NCT00566735|583496105|FG001|Overall Study|Refused neuropsychological testing|5|||
161576147|NCT00566735|583496104|FG000|Overall Study|Switched into a manic episode|0|||
161576148|NCT00566735|583496105|FG001|Overall Study|Switched into a manic episode|1|||
161576149|NCT04603924|583496106|FG000|Overall Study|Not Dosed|2|||
161576150|NCT04603924|583496107|FG001|Overall Study|Not Dosed|1|||
161576151|NCT04603924|583496106|FG000|Overall Study|Withdrawal by Subject|6|||
161576152|NCT04603924|583496107|FG001|Overall Study|Withdrawal by Subject|6|||
161576153|NCT04603924|583496106|FG000|Overall Study|Adverse Event|2|||
161576154|NCT04603924|583496107|FG001|Overall Study|Adverse Event|2|||
161576155|NCT00768664|583496110|FG000|Overall Study|Death|57|||
161576156|NCT00768664|583496110|FG000|Overall Study|Lost to Follow-up|2|||
161576157|NCT00768664|583496110|FG000|Overall Study|Other|9|||
161576158|NCT00768664|583496110|FG000|Overall Study|Participant refused|1|||
161576159|NCT02544152|583496111|FG000|Overall Study|Adverse Event|0|||
161576160|NCT02544152|583496112|FG001|Overall Study|Adverse Event|4|||
161576161|NCT02544152|583496111|FG000|Overall Study|Withdrawal by Subject|0|||
161576162|NCT02544152|583496112|FG001|Overall Study|Withdrawal by Subject|3|||
161576163|NCT02544152|583496111|FG000|Overall Study|Other|1|||
161576164|NCT02544152|583496112|FG001|Overall Study|Other|0|||
161576165|NCT02320123|583496113|FG000|Overall Study|Lost to Follow-up|4|||
161576166|NCT02320123|583496114|FG001|Overall Study|Lost to Follow-up|6|||
161576167|NCT02320123|583496113|FG000|Overall Study|Death|6|||
161576168|NCT02320123|583496114|FG001|Overall Study|Death|5|||
161576169|NCT04480827|583496115|FG000|Overall Study|Adverse Event|0|||
161576170|NCT04480827|583496116|FG001|Overall Study|Adverse Event|0|||
161576171|NCT04480827|583496117|FG002|Overall Study|Adverse Event|0|||
161576172|NCT04480827|583496118|FG003|Overall Study|Adverse Event|0|||
161576173|NCT04480827|583496119|FG004|Overall Study|Adverse Event|0|||
161576174|NCT04480827|583496120|FG005|Overall Study|Adverse Event|1|||
161576175|NCT04480827|583496121|FG006|Overall Study|Adverse Event|0|||
161576176|NCT00465816|583496122|FG000|Overall Study|Lost to Follow-up|0|||
161576177|NCT00465816|583496123|FG001|Overall Study|Lost to Follow-up|0|||
161576178|NCT00465816|583496124|FG002|Overall Study|Lost to Follow-up|2|||
161470649|NCT00717093|583119761|FG000|Overall Study|Randomized but not treated|1|||
161470650|NCT00717093|583119762|FG001|Overall Study|Randomized but not treated|0|||
161470651|NCT02699697|583119768|FG000|Overall Study|Death|18|||
161470652|NCT02699697|583119769|FG001|Overall Study|Death|15|||
161470653|NCT02699697|583119768|FG000|Overall Study|Physician Decision|0|||
161470654|NCT02699697|583119769|FG001|Overall Study|Physician Decision|1|||
161470655|NCT02699697|583119768|FG000|Overall Study|Lost to Follow-up|2|||
161470656|NCT02699697|583119769|FG001|Overall Study|Lost to Follow-up|3|||
161470657|NCT02699697|583119768|FG000|Overall Study|Refused to follow up|1|||
161470658|NCT02699697|583119769|FG001|Overall Study|Refused to follow up|1|||
161470659|NCT02699697|583119768|FG000|Overall Study|Entered hospice care|5|||
161470660|NCT02699697|583119769|FG001|Overall Study|Entered hospice care|2|||
161470661|NCT02699697|583119768|FG000|Overall Study|Missing reason for discontinuation|6|||
161470662|NCT02699697|583119769|FG001|Overall Study|Missing reason for discontinuation|5|||
161470663|NCT02362035|583119770|FG000|Overall Study|Death|67|||
161470664|NCT02362035|583119770|FG000|Overall Study|Lost to Follow-up|3|||
161470665|NCT02362035|583119770|FG000|Overall Study|Adverse Event|1|||
161470666|NCT02362035|583119770|FG000|Overall Study|Physician Decision|1|||
161470667|NCT02362035|583119770|FG000|Overall Study|Subject started another cancer therapy|10|||
161470668|NCT02362035|583119770|FG000|Overall Study|Study terminated by sponsor|45|||
161470669|NCT02362035|583119770|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
161470670|NCT02362035|583119770|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
161470671|NCT02362035|583119770|FG000|Overall Study|Disease progression|11|||
161470672|NCT02362035|583119770|FG000|Overall Study|Withdrawal by Subject|20|||
161470673|NCT00354614|583119771|FG000|Overall Study|Lack of Efficacy|28|||
161470674|NCT01823146|583119774|FG000|Overall Study|Withdrawal by Subject|0|||
161812485|NCT00824291|584356223|FG000|Overall Study|Adverse Event|15|||
161470675|NCT01823146|583119775|FG001|Overall Study|Withdrawal by Subject|1|||
161812486|NCT00824291|584356224|FG001|Overall Study|Adverse Event|6|||
161470676|NCT01823146|583119774|FG000|Overall Study|Lost to Follow-up|2|||
161470677|NCT01823146|583119775|FG001|Overall Study|Lost to Follow-up|1|||
161470678|NCT01426438|583119776|FG000|Overall Study|Lost to Follow-up|1|||
161470679|NCT01426438|583119777|FG001|Overall Study|Lost to Follow-up|3|||
161812487|NCT00824291|584356223|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161812488|NCT00824291|584356224|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
161812489|NCT00824291|584356223|FG000|Overall Study|Lost to Follow-up|11|||
161812490|NCT00824291|584356224|FG001|Overall Study|Lost to Follow-up|9|||
161812491|NCT00824291|584356223|FG000|Overall Study|Non-compliance|1|||
161812492|NCT00824291|584356224|FG001|Overall Study|Non-compliance|1|||
161812493|NCT00824291|584356223|FG000|Overall Study|Protocol Violation|4|||
161812494|NCT00824291|584356224|FG001|Overall Study|Protocol Violation|1|||
161812495|NCT00824291|584356223|FG000|Overall Study|Withdrawal by Subject|14|||
161470680|NCT01426438|583119776|FG000|Overall Study|Off study Treatment|9|||
161470681|NCT01426438|583119777|FG001|Overall Study|Off study Treatment|3|||
161470682|NCT01426438|583119776|FG000|Overall Study|Poor scan quality|3|||
161470683|NCT01426438|583119777|FG001|Overall Study|Poor scan quality|2|||
161470684|NCT01426438|583119776|FG000|Overall Study|Missed Scan|2|||
161470685|NCT01426438|583119777|FG001|Overall Study|Missed Scan|2|||
161470686|NCT01788046|583119778|FG000|Overall Study|Withdrawal by Subject|12|||
161470687|NCT01788046|583119779|FG001|Overall Study|Withdrawal by Subject|12|||
161470688|NCT01788046|583119778|FG000|Overall Study|Lost to Follow-up|12|||
161470689|NCT01788046|583119779|FG001|Overall Study|Lost to Follow-up|19|||
161470690|NCT01788046|583119778|FG000|Overall Study|Death|7|||
161470691|NCT01788046|583119779|FG001|Overall Study|Death|5|||
161470692|NCT01788046|583119778|FG000|Overall Study|Protocol Specified Criteria|25|||
161470693|NCT01788046|583119779|FG001|Overall Study|Protocol Specified Criteria|1|||
161470694|NCT01797731|583119785|FG000|Overall Study|Didn't have proper radiographs required|3|||
161470695|NCT01797731|583119786|FG001|Overall Study|Didn't have proper radiographs required|3|||
161470696|NCT01604408|583119787|FG000|Treatment Period 1|Protocol Violation|0|||
161470697|NCT01604408|583119788|FG001|Treatment Period 1|Protocol Violation|1|||
161470698|NCT01604408|583119787|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161470699|NCT01604408|583119788|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161470700|NCT01604408|583119787|FG000|Treatment Period 2|Protocol Violation|1|||
161470701|NCT01604408|583119788|FG001|Treatment Period 2|Protocol Violation|0|||
161470702|NCT01604408|583119787|FG000|Treatment Period 2|Adverse Event|0|||
161470703|NCT01604408|583119788|FG001|Treatment Period 2|Adverse Event|1|||
161470704|NCT01604408|583119787|FG000|Treatment Period 3|Protocol Violation|1|||
161470705|NCT01604408|583119788|FG001|Treatment Period 3|Protocol Violation|1|||
161470706|NCT01604408|583119787|FG000|Treatment Period 3|Adverse Event|0|||
161470707|NCT01604408|583119788|FG001|Treatment Period 3|Adverse Event|3|||
161470708|NCT01604408|583119787|FG000|Treatment Period 3|Withdrawal by Subject|3|||
161470709|NCT01604408|583119788|FG001|Treatment Period 3|Withdrawal by Subject|1|||
161470710|NCT01604408|583119787|FG000|Treatment Period 3|Sponsor Decision|1|||
161470711|NCT01604408|583119788|FG001|Treatment Period 3|Sponsor Decision|0|||
161470712|NCT01604408|583119787|FG000|Treatment Period 4|Death|1|||
161470713|NCT01604408|583119788|FG001|Treatment Period 4|Death|0|||
161470714|NCT01604408|583119787|FG000|Treatment Period 4|Withdrawal by Subject|2|||
161470715|NCT01604408|583119788|FG001|Treatment Period 4|Withdrawal by Subject|1|||
161470716|NCT01604408|583119787|FG000|Treatment Period 4|Adverse Event|0|||
161470717|NCT01604408|583119788|FG001|Treatment Period 4|Adverse Event|1|||
161470718|NCT01604408|583119787|FG000|Treatment Period 5|Adverse Event|4|||
161470719|NCT01604408|583119788|FG001|Treatment Period 5|Adverse Event|0|||
161470720|NCT01604408|583119787|FG000|Treatment Period 6|Lost to Follow-up|0|||
161470721|NCT01604408|583119788|FG001|Treatment Period 6|Lost to Follow-up|1|||
161470722|NCT01604408|583119787|FG000|Treatment Period 6|Adverse Event|2|||
161470723|NCT01604408|583119788|FG001|Treatment Period 6|Adverse Event|0|||
161470724|NCT01604408|583119787|FG000|Treatment Period 6|Sponsor decision|0|||
161470725|NCT01604408|583119788|FG001|Treatment Period 6|Sponsor decision|1|||
161470726|NCT01604408|583119787|FG000|Observation Period|Adverse Event|1|||
161470727|NCT01604408|583119788|FG001|Observation Period|Adverse Event|1|||
161470728|NCT01604408|583119787|FG000|Observation Period|Withdrawal by Subject|0|||
161470729|NCT01604408|583119788|FG001|Observation Period|Withdrawal by Subject|2|||
161470730|NCT01189604|583119793|FG000|Overall Study|Impossible to visit|0|||
161470731|NCT01189604|583119794|FG001|Overall Study|Impossible to visit|0|||
161470732|NCT01189604|583119795|FG002|Overall Study|Impossible to visit|0|||
161470733|NCT01189604|583119796|FG003|Overall Study|Impossible to visit|0|||
161470734|NCT01189604|583119797|FG004|Overall Study|Impossible to visit|0|||
161470735|NCT01189604|583119798|FG005|Overall Study|Impossible to visit|1|||
161470736|NCT01189604|583119799|FG006|Overall Study|Impossible to visit|0|||
161470737|NCT01189604|583119793|FG000|Overall Study|Adverse Event|0|||
161470738|NCT01189604|583119794|FG001|Overall Study|Adverse Event|1|||
161470739|NCT01189604|583119795|FG002|Overall Study|Adverse Event|0|||
161470740|NCT01189604|583119796|FG003|Overall Study|Adverse Event|0|||
161470741|NCT01189604|583119797|FG004|Overall Study|Adverse Event|2|||
161470742|NCT01189604|583119798|FG005|Overall Study|Adverse Event|0|||
161668338|NCT04640077|583837528|FG001|Period 2|Lost to Follow-up|0|||
161470743|NCT01189604|583119799|FG006|Overall Study|Adverse Event|1|||
161470744|NCT01189604|583119793|FG000|Overall Study|Withdrawal by Subject|1|||
161470745|NCT01189604|583119794|FG001|Overall Study|Withdrawal by Subject|0|||
161470746|NCT01189604|583119795|FG002|Overall Study|Withdrawal by Subject|0|||
161470747|NCT01189604|583119796|FG003|Overall Study|Withdrawal by Subject|0|||
161470748|NCT01189604|583119797|FG004|Overall Study|Withdrawal by Subject|0|||
161470749|NCT01189604|583119798|FG005|Overall Study|Withdrawal by Subject|0|||
161470750|NCT01189604|583119799|FG006|Overall Study|Withdrawal by Subject|0|||
161470751|NCT00808483|583119800|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
161470752|NCT00808483|583119801|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
161470753|NCT00808483|583119800|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
161470754|NCT00808483|583119801|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
161470755|NCT00808483|583119800|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
161470756|NCT00808483|583119801|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
161470757|NCT03945214|583119802|FG000|Overall Study|Lost to Follow-up|3|||
161470758|NCT03945214|583119803|FG001|Overall Study|Lost to Follow-up|4|||
161470759|NCT03945214|583119804|FG002|Overall Study|Lost to Follow-up|7|||
161470760|NCT03945214|583119805|FG003|Overall Study|Lost to Follow-up|4|||
161470761|NCT04102098|583119823|FG000|Main Study Period|Ongoing in study|302|||
161470762|NCT04102098|583119824|FG001|Main Study Period|Ongoing in study|291|||
161470763|NCT04102098|583119823|FG000|Main Study Period|Death|20|||
161470764|NCT04102098|583119824|FG001|Main Study Period|Death|27|||
161470765|NCT04102098|583119823|FG000|Main Study Period|Lost to Follow-up|1|||
161470766|NCT04102098|583119824|FG001|Main Study Period|Lost to Follow-up|1|||
161576179|NCT02139046|583496125|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161576180|NCT02139046|583496126|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
161576181|NCT02139046|583496127|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
161576182|NCT02139046|583496128|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
161576183|NCT02139046|583496129|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
161576184|NCT02139046|583496125|FG000|Overall Study|Major Protocol Deviation|9|||
161576185|NCT02139046|583496126|FG001|Overall Study|Major Protocol Deviation|10|||
161576186|NCT02139046|583496127|FG002|Overall Study|Major Protocol Deviation|16|||
161576187|NCT02139046|583496128|FG003|Overall Study|Major Protocol Deviation|12|||
161576188|NCT02139046|583496129|FG004|Overall Study|Major Protocol Deviation|6|||
161576189|NCT02139046|583496125|FG000|Overall Study|Lost to Follow-up|13|||
161576190|NCT02139046|583496126|FG001|Overall Study|Lost to Follow-up|16|||
161576191|NCT02139046|583496127|FG002|Overall Study|Lost to Follow-up|16|||
161576192|NCT02139046|583496128|FG003|Overall Study|Lost to Follow-up|18|||
161576193|NCT02139046|583496129|FG004|Overall Study|Lost to Follow-up|13|||
161576194|NCT02139046|583496125|FG000|Overall Study|Voluntary Withdrawal|20|||
161576195|NCT02139046|583496126|FG001|Overall Study|Voluntary Withdrawal|8|||
161576196|NCT02139046|583496127|FG002|Overall Study|Voluntary Withdrawal|10|||
161576197|NCT02139046|583496128|FG003|Overall Study|Voluntary Withdrawal|15|||
161576198|NCT02139046|583496129|FG004|Overall Study|Voluntary Withdrawal|16|||
161576199|NCT02139046|583496125|FG000|Overall Study|Lack of Efficacy|0|||
161576200|NCT02139046|583496126|FG001|Overall Study|Lack of Efficacy|1|||
161576201|NCT02139046|583496127|FG002|Overall Study|Lack of Efficacy|2|||
161576202|NCT02139046|583496128|FG003|Overall Study|Lack of Efficacy|1|||
161576203|NCT02139046|583496129|FG004|Overall Study|Lack of Efficacy|2|||
161576204|NCT02139046|583496125|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
161576205|NCT02139046|583496126|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
161576206|NCT02139046|583496127|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
161576207|NCT02139046|583496128|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
161576208|NCT02139046|583496129|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
161576209|NCT02139046|583496125|FG000|Overall Study|Other Miscellaneous Reasons|10|||
161470767|NCT04102098|583119823|FG000|Main Study Period|Physician Decision|0|||
161470768|NCT04102098|583119824|FG001|Main Study Period|Physician Decision|1|||
161470769|NCT04102098|583119823|FG000|Main Study Period|Withdrawal by Subject|11|||
161470770|NCT04102098|583119824|FG001|Main Study Period|Withdrawal by Subject|14|||
161470771|NCT04102098|583119823|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
161470772|NCT04102098|583119824|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
161470773|NCT04102098|583119823|FG000|Crossover: AS Who Crossed Over|Death|11|||
161470774|NCT04102098|583119824|FG001|Crossover: AS Who Crossed Over|Death|0|||
161470775|NCT04102098|583119823|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
161470776|NCT04102098|583119824|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
161470777|NCT03150173|583119827|FG000|Overall Study|Lost to Follow-up|13|||
161470778|NCT03150173|583119828|FG001|Overall Study|Lost to Follow-up|5|||
161576210|NCT02139046|583496126|FG001|Overall Study|Other Miscellaneous Reasons|9|||
161576211|NCT02139046|583496127|FG002|Overall Study|Other Miscellaneous Reasons|4|||
161576212|NCT02139046|583496128|FG003|Overall Study|Other Miscellaneous Reasons|9|||
161576213|NCT02139046|583496129|FG004|Overall Study|Other Miscellaneous Reasons|12|||
161576214|NCT00818454|583496132|FG000|Treatment Period 1|Adverse Event|0|||
161576215|NCT00818454|583496133|FG001|Treatment Period 1|Adverse Event|1|||
161576216|NCT00818454|583496134|FG002|Treatment Period 1|Adverse Event|0|||
161576217|NCT00818454|583496135|FG003|Treatment Period 1|Adverse Event|0|||
161576218|NCT00818454|583496132|FG000|Treatment Period 1|Other|3|||
161576219|NCT00818454|583496133|FG001|Treatment Period 1|Other|0|||
161576220|NCT00818454|583496134|FG002|Treatment Period 1|Other|0|||
161576221|NCT00818454|583496135|FG003|Treatment Period 1|Other|0|||
161576222|NCT00818454|583496132|FG000|Washout Period of 1 Week|Adverse Event|1|||
161576223|NCT00818454|583496133|FG001|Washout Period of 1 Week|Adverse Event|1|||
161576224|NCT00818454|583496134|FG002|Washout Period of 1 Week|Adverse Event|0|||
161576225|NCT00818454|583496135|FG003|Washout Period of 1 Week|Adverse Event|0|||
161576226|NCT00818454|583496132|FG000|Washout Period of 1 Week|Protocol Violation|2|||
161576227|NCT00818454|583496133|FG001|Washout Period of 1 Week|Protocol Violation|0|||
161470779|NCT03755791|583119829|FG000|Overall Study|Did not receive any study treatment|3|||
161470780|NCT03755791|583119830|FG001|Overall Study|Did not receive any study treatment|0|||
161576228|NCT00818454|583496134|FG002|Washout Period of 1 Week|Protocol Violation|0|||
161576229|NCT00818454|583496135|FG003|Washout Period of 1 Week|Protocol Violation|0|||
161576230|NCT00818454|583496132|FG000|Washout Period of 1 Week|Other|1|||
161576231|NCT00818454|583496133|FG001|Washout Period of 1 Week|Other|2|||
161470781|NCT03755791|583119831|FG002|Overall Study|Did not receive any study treatment|10|||
161470782|NCT03755791|583119829|FG000|Overall Study|Radiographic progression|204|||
161470783|NCT03755791|583119830|FG001|Overall Study|Radiographic progression|92|||
161470784|NCT03755791|583119831|FG002|Overall Study|Radiographic progression|115|||
161470785|NCT03755791|583119829|FG000|Overall Study|Adverse Event|140|||
161470786|NCT03755791|583119830|FG001|Overall Study|Adverse Event|60|||
161470787|NCT03755791|583119831|FG002|Overall Study|Adverse Event|51|||
161470788|NCT03755791|583119829|FG000|Overall Study|Lack of Efficacy|12|||
161470789|NCT03755791|583119830|FG001|Overall Study|Lack of Efficacy|6|||
161470790|NCT03755791|583119831|FG002|Overall Study|Lack of Efficacy|6|||
161470791|NCT03755791|583119829|FG000|Overall Study|Withdrawal by Subject|26|||
161470792|NCT03755791|583119830|FG001|Overall Study|Withdrawal by Subject|23|||
161470793|NCT03755791|583119831|FG002|Overall Study|Withdrawal by Subject|24|||
161470794|NCT03755791|583119829|FG000|Overall Study|Sponsor decision,|41|||
161470795|NCT03755791|583119830|FG001|Overall Study|Sponsor decision,|5|||
161470796|NCT03755791|583119831|FG002|Overall Study|Sponsor decision,|7|||
161470797|NCT03755791|583119829|FG000|Overall Study|Lost to Follow-up|1|||
161470798|NCT03755791|583119830|FG001|Overall Study|Lost to Follow-up|0|||
161470799|NCT03755791|583119831|FG002|Overall Study|Lost to Follow-up|2|||
161470800|NCT03755791|583119829|FG000|Overall Study|Protocol Violation|0|||
161470801|NCT03755791|583119830|FG001|Overall Study|Protocol Violation|0|||
161470802|NCT03755791|583119831|FG002|Overall Study|Protocol Violation|2|||
161470803|NCT03755791|583119829|FG000|Overall Study|Other than specified|5|||
161470804|NCT03755791|583119830|FG001|Overall Study|Other than specified|2|||
161470805|NCT03755791|583119831|FG002|Overall Study|Other than specified|0|||
161470806|NCT01756053|583119835|FG000|Period 1 (10 Days)|Protocol Violation|1|||
161470807|NCT01756053|583119836|FG001|Period 1 (10 Days)|Protocol Violation|1|||
161470808|NCT01756053|583119835|FG000|Period 2 (10 Days)|Protocol Violation|0|||
161470809|NCT01756053|583119836|FG001|Period 2 (10 Days)|Protocol Violation|2|||
161470810|NCT02083081|583119837|FG000|Overall Study|Lost to Follow-up|31|||
161470811|NCT02083081|583119838|FG001|Overall Study|Lost to Follow-up|9|||
161470812|NCT00285818|583119839|FG000|Overall Study|Withdrawal by Subject|3|||
161470813|NCT00285818|583119840|FG001|Overall Study|Withdrawal by Subject|2|||
161470814|NCT00285818|583119839|FG000|Overall Study|Lost to Follow-up|1|||
161470815|NCT00285818|583119840|FG001|Overall Study|Lost to Follow-up|0|||
161470816|NCT03277690|583119843|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
161470817|NCT03277690|583119844|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
161470818|NCT03277690|583119843|FG000|Dose Titration and Maintenance|Physician Decision|1|||
161470819|NCT03277690|583119844|FG001|Dose Titration and Maintenance|Physician Decision|0|||
161470820|NCT03277690|583119843|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
161470821|NCT03277690|583119844|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
161470822|NCT03277690|583119843|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
161470823|NCT03277690|583119844|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
161470824|NCT03277690|583119843|FG000|Dose Titration and Maintenance|Adverse Event|15|||
161470825|NCT03277690|583119844|FG001|Dose Titration and Maintenance|Adverse Event|0|||
161470826|NCT03277690|583119843|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
161470827|NCT03277690|583119844|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
161470828|NCT03277690|583119843|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
161470829|NCT03277690|583119844|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
161470830|NCT03109847|583119845|FG000|Overall Study|Withdrawal by Subject|1|||
161470831|NCT03109847|583119846|FG001|Overall Study|Withdrawal by Subject|0|||
161470832|NCT04209348|583119847|FG000|Overall Study|Lost to Follow-up|1|||
161470833|NCT04209348|583119848|FG001|Overall Study|Lost to Follow-up|0|||
161470834|NCT02853344|583119849|FG000|Overall Study|Lost to Follow-up|1|||
161470835|NCT02853344|583119850|FG001|Overall Study|Lost to Follow-up|1|||
161470836|NCT02853344|583119849|FG000|Overall Study|Withdrawal by Subject|2|||
161470837|NCT02853344|583119850|FG001|Overall Study|Withdrawal by Subject|4|||
161470838|NCT02853344|583119849|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
161470839|NCT02853344|583119850|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
161470840|NCT02853344|583119849|FG000|Overall Study|Death|70|||
161470841|NCT02853344|583119850|FG001|Overall Study|Death|112|||
161812496|NCT00824291|584356224|FG001|Overall Study|Withdrawal by Subject|8|||
161576232|NCT00818454|583496134|FG002|Washout Period of 1 Week|Other|0|||
161812497|NCT00824291|584356223|FG000|Overall Study|Lack of Efficacy|7|||
161812498|NCT00824291|584356224|FG001|Overall Study|Lack of Efficacy|8|||
161470842|NCT02955797|583119851|FG000|Overall Study|Protocol Violation|1|||
161470843|NCT02955797|583119852|FG001|Overall Study|Protocol Violation|0|||
161576233|NCT00818454|583496135|FG003|Washout Period of 1 Week|Other|0|||
161812499|NCT00824291|584356223|FG000|Overall Study|Participant on prohibited medication|1|||
161470844|NCT02955797|583119853|FG002|Overall Study|Protocol Violation|0|||
161470845|NCT02955797|583119854|FG003|Overall Study|Protocol Violation|1|||
161470846|NCT02955797|583119851|FG000|Overall Study|Withdrawal by Subject|2|||
161470847|NCT02955797|583119852|FG001|Overall Study|Withdrawal by Subject|2|||
161470848|NCT02955797|583119853|FG002|Overall Study|Withdrawal by Subject|0|||
161470849|NCT02955797|583119854|FG003|Overall Study|Withdrawal by Subject|1|||
161576234|NCT00818454|583496132|FG000|Treatment Period 2|Other|2|||
161470850|NCT02955797|583119851|FG000|Overall Study|Lost to Follow-up|0|||
161470851|NCT02955797|583119852|FG001|Overall Study|Lost to Follow-up|1|||
161470852|NCT02955797|583119853|FG002|Overall Study|Lost to Follow-up|0|||
161470853|NCT02955797|583119854|FG003|Overall Study|Lost to Follow-up|0|||
161470854|NCT03131453|583119856|FG000|Overall Study|Study terminated by Sponsor|424|||
161470855|NCT03131453|583119857|FG001|Overall Study|Study terminated by Sponsor|222|||
161470856|NCT03131453|583119858|FG002|Overall Study|Study terminated by Sponsor|438|||
161470857|NCT03131453|583119856|FG000|Overall Study|Withdrawal by Subject|18|||
161470858|NCT03131453|583119857|FG001|Overall Study|Withdrawal by Subject|7|||
161470859|NCT03131453|583119858|FG002|Overall Study|Withdrawal by Subject|13|||
161470860|NCT03131453|583119856|FG000|Overall Study|Adverse Event|10|||
161470861|NCT03131453|583119857|FG001|Overall Study|Adverse Event|3|||
161470862|NCT03131453|583119858|FG002|Overall Study|Adverse Event|3|||
161470863|NCT03131453|583119856|FG000|Overall Study|Lost to Follow-up|1|||
161470864|NCT03131453|583119857|FG001|Overall Study|Lost to Follow-up|0|||
161470865|NCT03131453|583119858|FG002|Overall Study|Lost to Follow-up|1|||
161470866|NCT03131453|583119856|FG000|Overall Study|Physician Decision|1|||
161470867|NCT03131453|583119857|FG001|Overall Study|Physician Decision|0|||
161470868|NCT03131453|583119858|FG002|Overall Study|Physician Decision|1|||
161470869|NCT03131453|583119856|FG000|Overall Study|Non-compliance with study treatment|1|||
161470870|NCT03131453|583119857|FG001|Overall Study|Non-compliance with study treatment|0|||
161470871|NCT03131453|583119858|FG002|Overall Study|Non-compliance with study treatment|0|||
161470872|NCT03131453|583119856|FG000|Overall Study|Technical problems|1|||
161470873|NCT03131453|583119857|FG001|Overall Study|Technical problems|0|||
161470874|NCT03131453|583119858|FG002|Overall Study|Technical problems|0|||
161668339|NCT04640077|583837529|FG002|Period 2|Lost to Follow-up|2|||
161668340|NCT04640077|583837527|FG000|Period 2|Death|0|||
161470875|NCT03131453|583119856|FG000|Overall Study|Protocol deviation|0|||
161470876|NCT03131453|583119857|FG001|Overall Study|Protocol deviation|1|||
161470877|NCT03131453|583119858|FG002|Overall Study|Protocol deviation|0|||
161470878|NCT02081183|583119859|FG000|Overall Study|Lost to Follow-up|0|||
161470879|NCT02081183|583119860|FG001|Overall Study|Lost to Follow-up|1|||
161470880|NCT02081183|583119859|FG000|Overall Study|Protocol Violation|1|||
161470881|NCT02081183|583119860|FG001|Overall Study|Protocol Violation|0|||
161470882|NCT02081183|583119859|FG000|Overall Study|Other|3|||
161470883|NCT02081183|583119860|FG001|Overall Study|Other|3|||
161470884|NCT02840721|583119861|FG000|Treatment Period|Adverse Event|1|||
161470885|NCT02840721|583119861|FG000|Follow-Up|Lack of Efficacy|1|||
161470886|NCT02840721|583119861|FG000|Follow-Up|Withdrawal by Subject|4|||
161470887|NCT02840721|583119861|FG000|Follow-Up|Withdrawal of Consent|2|||
161470888|NCT05535972|583119865|FG000|Overall Study|Withdrawal by Subject|31|||
161470889|NCT05535972|583119865|FG000|Overall Study|Lost to Follow-up|5|||
161470890|NCT05535972|583119865|FG000|Overall Study|Adverse Event|6|||
161470891|NCT05535972|583119865|FG000|Overall Study|Protocol Deviation|2|||
161470892|NCT02649894|583119866|FG000|Overall Study|Adverse Event|1|||
161470893|NCT02649894|583119867|FG001|Overall Study|Adverse Event|0|||
161470894|NCT02649894|583119866|FG000|Overall Study|Physician Decision|0|||
161470895|NCT02649894|583119867|FG001|Overall Study|Physician Decision|1|||
161470896|NCT02649894|583119866|FG000|Overall Study|Withdrawal by Subject|5|||
161470897|NCT02649894|583119867|FG001|Overall Study|Withdrawal by Subject|2|||
161470898|NCT02649894|583119866|FG000|Overall Study|Lost to Follow-up|2|||
161668341|NCT04640077|583837528|FG001|Period 2|Death|0|||
161668342|NCT04640077|583837529|FG002|Period 2|Death|2|||
161668343|NCT04640077|583837527|FG000|Period 2|Progressive Disease|0|||
161668344|NCT04640077|583837528|FG001|Period 2|Progressive Disease|0|||
161668345|NCT04640077|583837529|FG002|Period 2|Progressive Disease|1|||
161470899|NCT02649894|583119867|FG001|Overall Study|Lost to Follow-up|1|||
161470900|NCT02649894|583119866|FG000|Overall Study|Death|30|||
161470901|NCT02649894|583119867|FG001|Overall Study|Death|7|||
161470902|NCT02649894|583119866|FG000|Overall Study|Other, not specified|6|||
161470903|NCT02649894|583119867|FG001|Overall Study|Other, not specified|0|||
161470904|NCT04590963|583119868|FG000|Overall Study|Death|118|||
161470905|NCT04590963|583119869|FG001|Overall Study|Death|59|||
161470906|NCT04590963|583119868|FG000|Overall Study|Lost to Follow-up|1|||
161915938|NCT03907488|584740587|FG001|Overall Study|Ineligible|15|||
161470907|NCT04590963|583119869|FG001|Overall Study|Lost to Follow-up|1|||
161470908|NCT04590963|583119868|FG000|Overall Study|Progressive disease|0|||
161668346|NCT04640077|583837527|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
161470909|NCT04590963|583119869|FG001|Overall Study|Progressive disease|1|||
161470910|NCT04590963|583119868|FG000|Overall Study|Study terminated by sponsor|103|||
161470911|NCT04590963|583119869|FG001|Overall Study|Study terminated by sponsor|50|||
161915939|NCT01093846|584740589|FG000|Overall Study|Adverse Event|0|||
161470912|NCT04590963|583119868|FG000|Overall Study|Withdrawal by Subject|15|||
161470913|NCT04590963|583119869|FG001|Overall Study|Withdrawal by Subject|8|||
161470914|NCT04590963|583119868|FG000|Overall Study|Ongoing at data cut-off|9|||
161470915|NCT04590963|583119869|FG001|Overall Study|Ongoing at data cut-off|4|||
161470916|NCT04590963|583119868|FG000|Overall Study|Screen failure|1|||
161470917|NCT04590963|583119869|FG001|Overall Study|Screen failure|0|||
161668347|NCT04640077|583837528|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
161915940|NCT01093846|584740590|FG001|Overall Study|Adverse Event|0|||
161470918|NCT01736124|583119870|FG000|Post-intervention Assessment|Death|2|||
161470919|NCT01736124|583119871|FG001|Post-intervention Assessment|Death|2|||
161470920|NCT01736124|583119870|FG000|Post-intervention Assessment|lost computer access|1|||
161470921|NCT01736124|583119871|FG001|Post-intervention Assessment|lost computer access|1|||
161470922|NCT01736124|583119870|FG000|Post-intervention Assessment|Moved away|3|||
161470923|NCT01736124|583119871|FG001|Post-intervention Assessment|Moved away|1|||
161470924|NCT01736124|583119870|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
161470925|NCT01736124|583119871|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
161470926|NCT01736124|583119870|FG000|Post-intervention Assessment|Illness|3|||
161470927|NCT01736124|583119871|FG001|Post-intervention Assessment|Illness|2|||
161470928|NCT01736124|583119870|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
161470929|NCT01736124|583119871|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
161470930|NCT01736124|583119870|FG000|Post-intervention Assessment|Temporarily away|3|||
161470931|NCT01736124|583119871|FG001|Post-intervention Assessment|Temporarily away|1|||
161470932|NCT01736124|583119870|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
161470933|NCT01736124|583119871|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
161470934|NCT01736124|583119870|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
161470935|NCT01736124|583119871|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
161470936|NCT01736124|583119870|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
161470937|NCT01736124|583119871|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
161470938|NCT01736124|583119870|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
161470939|NCT01736124|583119871|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
161470940|NCT01736124|583119870|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
161470941|NCT01736124|583119871|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
161470942|NCT01736124|583119870|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
161470943|NCT01736124|583119871|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
161470944|NCT01736124|583119870|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
161470945|NCT01736124|583119871|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
161470946|NCT01736124|583119870|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
161470947|NCT01736124|583119871|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
161470948|NCT01736124|583119870|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
161470949|NCT01736124|583119871|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
161470950|NCT04176705|583119873|FG000|Overall Study|Withdrawal by Subject|4|||
161470951|NCT04176705|583119874|FG001|Overall Study|Withdrawal by Subject|4|||
161470952|NCT04176705|583119873|FG000|Overall Study|Death|1|||
161470953|NCT04176705|583119874|FG001|Overall Study|Death|1|||
161470954|NCT04176705|583119873|FG000|Overall Study|Lost to Follow-up|3|||
161470955|NCT04176705|583119874|FG001|Overall Study|Lost to Follow-up|3|||
161470956|NCT02628769|583119875|FG000|First Intervention|Adverse Event|1|||
161470957|NCT02628769|583119876|FG001|First Intervention|Adverse Event|0|||
161470958|NCT02628769|583119875|FG000|First Intervention|Withdrawal by Subject|0|||
161470959|NCT02628769|583119876|FG001|First Intervention|Withdrawal by Subject|1|||
161470960|NCT02628769|583119875|FG000|Second Intervention|Adverse Event|2|||
161470961|NCT02628769|583119876|FG001|Second Intervention|Adverse Event|0|||
161470962|NCT02628769|583119875|FG000|Second Intervention|Physician Decision|0|||
161470963|NCT02628769|583119876|FG001|Second Intervention|Physician Decision|1|||
161470964|NCT01467583|583119877|FG000|Overall Study|Death|1|||
161470965|NCT01467583|583119878|FG001|Overall Study|Death|1|||
161470966|NCT01467583|583119879|FG002|Overall Study|Death|0|||
161470967|NCT01467583|583119877|FG000|Overall Study|Withdrawal by Subject|1|||
161812500|NCT00824291|584356224|FG001|Overall Study|Participant on prohibited medication|0|||
161812501|NCT00123734|584356229|FG000|Overall Study|Death|3|||
161812502|NCT00123734|584356229|FG000|Overall Study|Lost to Follow-up|3|||
161812503|NCT00123734|584356229|FG000|Overall Study|Dropout|1|||
161812504|NCT00123734|584356229|FG000|Overall Study|Withdrawal by Subject|1|||
161812505|NCT00113386|584356230|FG000|Overall Study|Withdrawal by Subject|1|||
161812506|NCT00113386|584356231|FG001|Overall Study|Withdrawal by Subject|0|||
161812507|NCT00113386|584356230|FG000|Overall Study|Physician Decision|0|||
161470968|NCT01467583|583119878|FG001|Overall Study|Withdrawal by Subject|0|||
161470969|NCT01467583|583119879|FG002|Overall Study|Withdrawal by Subject|0|||
161470970|NCT01467583|583119877|FG000|Overall Study|Protocol Violation|0|||
161470971|NCT01467583|583119878|FG001|Overall Study|Protocol Violation|0|||
161470972|NCT01467583|583119879|FG002|Overall Study|Protocol Violation|2|||
161470973|NCT01543698|583121683|FG000|Phase 1b|Disease progression|2|||
161470974|NCT01543698|583121684|FG001|Phase 1b|Disease progression|4|||
161470975|NCT01543698|583121685|FG002|Phase 1b|Disease progression|3|||
161812508|NCT00113386|584356231|FG001|Overall Study|Physician Decision|1|||
161812509|NCT00113386|584356230|FG000|Overall Study|Toxicity|3|||
161470976|NCT01543698|583121686|FG003|Phase 1b|Disease progression|2|||
161470977|NCT01543698|583121687|FG004|Phase 1b|Disease progression|10|||
161470978|NCT01543698|583121688|FG005|Phase 1b|Disease progression|6|||
161470979|NCT01543698|583121689|FG006|Phase 1b|Disease progression|5|||
161470980|NCT01543698|583121690|FG007|Phase 1b|Disease progression|3|||
161812510|NCT00113386|584356231|FG001|Overall Study|Toxicity|0|||
161470981|NCT01543698|583121691|FG008|Phase 1b|Disease progression|4|||
161470982|NCT01543698|583121692|FG009|Phase 1b|Disease progression|5|||
161470983|NCT01543698|583121693|FG010|Phase 1b|Disease progression|1|||
161470984|NCT01543698|583121694|FG011|Phase 1b|Disease progression|0|||
161470985|NCT01543698|583121695|FG012|Phase 1b|Disease progression|0|||
161470986|NCT01543698|583121696|FG013|Phase 1b|Disease progression|0|||
161470987|NCT01543698|583121697|FG014|Phase 1b|Disease progression|0|||
161470988|NCT01543698|583121683|FG000|Phase 1b|Death|0|||
161470989|NCT01543698|583121684|FG001|Phase 1b|Death|0|||
161470990|NCT01543698|583121685|FG002|Phase 1b|Death|1|||
161470991|NCT01543698|583121686|FG003|Phase 1b|Death|1|||
161470992|NCT01543698|583121687|FG004|Phase 1b|Death|0|||
161470993|NCT01543698|583121688|FG005|Phase 1b|Death|0|||
161470994|NCT01543698|583121689|FG006|Phase 1b|Death|0|||
161470995|NCT01543698|583121690|FG007|Phase 1b|Death|0|||
161470996|NCT01543698|583121691|FG008|Phase 1b|Death|0|||
161470997|NCT01543698|583121692|FG009|Phase 1b|Death|0|||
161470998|NCT01543698|583121693|FG010|Phase 1b|Death|1|||
161470999|NCT01543698|583121694|FG011|Phase 1b|Death|0|||
161471000|NCT01543698|583121695|FG012|Phase 1b|Death|0|||
161471001|NCT01543698|583121696|FG013|Phase 1b|Death|0|||
161471002|NCT01543698|583121697|FG014|Phase 1b|Death|0|||
161471003|NCT01543698|583121683|FG000|Phase 1b|Withdrawal by Subject|0|||
161471004|NCT01543698|583121684|FG001|Phase 1b|Withdrawal by Subject|1|||
161471005|NCT01543698|583121685|FG002|Phase 1b|Withdrawal by Subject|0|||
161471006|NCT01543698|583121686|FG003|Phase 1b|Withdrawal by Subject|1|||
161471007|NCT01543698|583121687|FG004|Phase 1b|Withdrawal by Subject|0|||
161471008|NCT01543698|583121688|FG005|Phase 1b|Withdrawal by Subject|0|||
161471009|NCT01543698|583121689|FG006|Phase 1b|Withdrawal by Subject|1|||
161471010|NCT01543698|583121690|FG007|Phase 1b|Withdrawal by Subject|0|||
161471011|NCT01543698|583121691|FG008|Phase 1b|Withdrawal by Subject|0|||
161471012|NCT01543698|583121692|FG009|Phase 1b|Withdrawal by Subject|0|||
161471013|NCT01543698|583121693|FG010|Phase 1b|Withdrawal by Subject|0|||
161471014|NCT01543698|583121694|FG011|Phase 1b|Withdrawal by Subject|0|||
161471015|NCT01543698|583121695|FG012|Phase 1b|Withdrawal by Subject|0|||
161471016|NCT01543698|583121696|FG013|Phase 1b|Withdrawal by Subject|0|||
161471017|NCT01543698|583121697|FG014|Phase 1b|Withdrawal by Subject|0|||
161471018|NCT01543698|583121683|FG000|Phase 1b|Adverse Event|1|||
161471019|NCT01543698|583121684|FG001|Phase 1b|Adverse Event|0|||
161471020|NCT01543698|583121685|FG002|Phase 1b|Adverse Event|0|||
161471021|NCT01543698|583121686|FG003|Phase 1b|Adverse Event|1|||
161471022|NCT01543698|583121687|FG004|Phase 1b|Adverse Event|2|||
161471023|NCT01543698|583121688|FG005|Phase 1b|Adverse Event|2|||
161471024|NCT01543698|583121689|FG006|Phase 1b|Adverse Event|0|||
161471025|NCT01543698|583121690|FG007|Phase 1b|Adverse Event|0|||
161471026|NCT01543698|583121691|FG008|Phase 1b|Adverse Event|1|||
161471027|NCT01543698|583121692|FG009|Phase 1b|Adverse Event|1|||
161471028|NCT01543698|583121693|FG010|Phase 1b|Adverse Event|2|||
161471029|NCT01543698|583121694|FG011|Phase 1b|Adverse Event|0|||
161471030|NCT01543698|583121695|FG012|Phase 1b|Adverse Event|0|||
161471031|NCT01543698|583121696|FG013|Phase 1b|Adverse Event|0|||
161471032|NCT01543698|583121697|FG014|Phase 1b|Adverse Event|0|||
161471033|NCT01543698|583121683|FG000|Phase 1b|Administrative problems|1|||
161471034|NCT01543698|583121684|FG001|Phase 1b|Administrative problems|0|||
161471035|NCT01543698|583121685|FG002|Phase 1b|Administrative problems|0|||
161471036|NCT01543698|583121686|FG003|Phase 1b|Administrative problems|0|||
161471037|NCT01543698|583121687|FG004|Phase 1b|Administrative problems|1|||
161471038|NCT01543698|583121688|FG005|Phase 1b|Administrative problems|0|||
161471039|NCT01543698|583121689|FG006|Phase 1b|Administrative problems|0|||
161471040|NCT01543698|583121690|FG007|Phase 1b|Administrative problems|1|||
161471041|NCT01543698|583121691|FG008|Phase 1b|Administrative problems|0|||
161471042|NCT01543698|583121692|FG009|Phase 1b|Administrative problems|0|||
161471043|NCT01543698|583121693|FG010|Phase 1b|Administrative problems|2|||
161471044|NCT01543698|583121694|FG011|Phase 1b|Administrative problems|0|||
161471045|NCT01543698|583121695|FG012|Phase 1b|Administrative problems|0|||
161471046|NCT01543698|583121696|FG013|Phase 1b|Administrative problems|0|||
161471047|NCT01543698|583121697|FG014|Phase 1b|Administrative problems|0|||
161471048|NCT01543698|583121683|FG000|Phase 1b|Protocol Violation|2|||
161471049|NCT01543698|583121684|FG001|Phase 1b|Protocol Violation|0|||
161471050|NCT01543698|583121685|FG002|Phase 1b|Protocol Violation|0|||
161471051|NCT01543698|583121686|FG003|Phase 1b|Protocol Violation|0|||
161471052|NCT01543698|583121687|FG004|Phase 1b|Protocol Violation|0|||
161471053|NCT01543698|583121688|FG005|Phase 1b|Protocol Violation|0|||
161471054|NCT01543698|583121689|FG006|Phase 1b|Protocol Violation|0|||
161471055|NCT01543698|583121690|FG007|Phase 1b|Protocol Violation|0|||
161471056|NCT01543698|583121691|FG008|Phase 1b|Protocol Violation|0|||
161471057|NCT01543698|583121692|FG009|Phase 1b|Protocol Violation|0|||
161471058|NCT01543698|583121693|FG010|Phase 1b|Protocol Violation|0|||
161471059|NCT01543698|583121694|FG011|Phase 1b|Protocol Violation|0|||
161471060|NCT01543698|583121695|FG012|Phase 1b|Protocol Violation|0|||
161471061|NCT01543698|583121696|FG013|Phase 1b|Protocol Violation|0|||
161471062|NCT01543698|583121697|FG014|Phase 1b|Protocol Violation|0|||
161471063|NCT01543698|583121683|FG000|Phase 2|Protocol Violation|0|||
161668348|NCT04640077|583837529|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
161668349|NCT02041520|583837531|FG000|Overall Study|Adverse Event|2|||
161668350|NCT02041520|583837532|FG001|Overall Study|Adverse Event|1|||
161471064|NCT01543698|583121684|FG001|Phase 2|Protocol Violation|0|||
161471065|NCT01543698|583121685|FG002|Phase 2|Protocol Violation|0|||
161471066|NCT01543698|583121686|FG003|Phase 2|Protocol Violation|0|||
161668351|NCT02041520|583837531|FG000|Overall Study|Withdrawal by Subject|3|||
161668352|NCT02041520|583837532|FG001|Overall Study|Withdrawal by Subject|4|||
161668353|NCT02041520|583837531|FG000|Overall Study|Protocol Violation|1|||
161668354|NCT02041520|583837532|FG001|Overall Study|Protocol Violation|0|||
161668355|NCT02041520|583837531|FG000|Overall Study|Lost to Follow-up|0|||
161668356|NCT02041520|583837532|FG001|Overall Study|Lost to Follow-up|1|||
161668357|NCT02041520|583837531|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
161668358|NCT02041520|583837532|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
161668359|NCT00413972|583837533|FG000|Overall Study|Adverse Event|2|||
161668360|NCT00413972|583837534|FG001|Overall Study|Adverse Event|1|||
161668361|NCT00413972|583837535|FG002|Overall Study|Adverse Event|0|||
161668362|NCT00413972|583837536|FG003|Overall Study|Adverse Event|0|||
161668363|NCT00413972|583837533|FG000|Overall Study|Lost to Follow-up|1|||
161668364|NCT00413972|583837534|FG001|Overall Study|Lost to Follow-up|2|||
161668365|NCT00413972|583837535|FG002|Overall Study|Lost to Follow-up|1|||
161668366|NCT00413972|583837536|FG003|Overall Study|Lost to Follow-up|0|||
161668367|NCT00413972|583837533|FG000|Overall Study|Withdrawal by Subject|4|||
161668368|NCT00413972|583837534|FG001|Overall Study|Withdrawal by Subject|5|||
161668369|NCT00413972|583837535|FG002|Overall Study|Withdrawal by Subject|7|||
161668370|NCT00413972|583837536|FG003|Overall Study|Withdrawal by Subject|2|||
161668371|NCT00413972|583837533|FG000|Overall Study|Protocol Violation|0|||
161668372|NCT00413972|583837534|FG001|Overall Study|Protocol Violation|0|||
161668373|NCT00413972|583837535|FG002|Overall Study|Protocol Violation|2|||
161668374|NCT00413972|583837536|FG003|Overall Study|Protocol Violation|0|||
161668375|NCT00413972|583837533|FG000|Overall Study|Other|0|||
161668376|NCT00413972|583837534|FG001|Overall Study|Other|0|||
161668377|NCT00413972|583837535|FG002|Overall Study|Other|0|||
161668378|NCT00413972|583837536|FG003|Overall Study|Other|1|||
161668379|NCT03164564|583837544|FG000|Overall Study|Death|3|||
161668380|NCT03164564|583837545|FG001|Overall Study|Death|0|||
161668381|NCT03164564|583837544|FG000|Overall Study|Withdrawal by Subject|20|||
161668382|NCT03164564|583837545|FG001|Overall Study|Withdrawal by Subject|15|||
161668383|NCT03164564|583837544|FG000|Overall Study|Lost to Follow-up|2|||
161668384|NCT03164564|583837545|FG001|Overall Study|Lost to Follow-up|0|||
161668385|NCT03164564|583837544|FG000|Overall Study|Physician Decision|0|||
161668386|NCT03164564|583837545|FG001|Overall Study|Physician Decision|1|||
161668387|NCT03164564|583837544|FG000|Overall Study|Adverse Event|0|||
161668388|NCT03164564|583837545|FG001|Overall Study|Adverse Event|1|||
161668389|NCT03164564|583837544|FG000|Overall Study|Ongoing|1586|||
161668390|NCT03164564|583837545|FG001|Overall Study|Ongoing|1586|||
161668391|NCT01910181|583837550|FG000|Overall Study|Death|37|||
161668392|NCT01910181|583837550|FG000|Overall Study|Lost to Follow-up|3|||
161668393|NCT01910181|583837550|FG000|Overall Study|Study Terminated by Sponsor|6|||
161668394|NCT02656823|583837551|FG000|Overall Study|Adverse Event|3|||
161668395|NCT02656823|583837551|FG000|Overall Study|Lost to Follow-up|2|||
161668396|NCT03567434|583837555|FG000|Overall Study|Lost to Follow-up|1|||
161668397|NCT03567434|583837556|FG001|Overall Study|Lost to Follow-up|3|||
161668398|NCT05269355|583837558|FG000|Overall Study|Progressive Disease|104|||
161668399|NCT05269355|583837559|FG001|Overall Study|Progressive Disease|68|||
161668400|NCT05269355|583837558|FG000|Overall Study|Study Terminated by Sponsor|87|||
161668401|NCT05269355|583837559|FG001|Overall Study|Study Terminated by Sponsor|29|||
161668402|NCT05269355|583837558|FG000|Overall Study|Adverse Event|15|||
161668403|NCT05269355|583837559|FG001|Overall Study|Adverse Event|8|||
161668404|NCT05269355|583837558|FG000|Overall Study|Withdrawal by Subject|18|||
161668405|NCT05269355|583837559|FG001|Overall Study|Withdrawal by Subject|5|||
161668406|NCT05269355|583837558|FG000|Overall Study|Physician Decision|6|||
161668407|NCT05269355|583837559|FG001|Overall Study|Physician Decision|4|||
161668408|NCT05269355|583837558|FG000|Overall Study|Death|3|||
161668409|NCT05269355|583837559|FG001|Overall Study|Death|5|||
161668410|NCT05269355|583837558|FG000|Overall Study|Other Than Specified|5|||
161668411|NCT05269355|583837559|FG001|Overall Study|Other Than Specified|1|||
161668412|NCT05269355|583837558|FG000|Overall Study|Randomized But Not Treated|1|||
161668413|NCT05269355|583837559|FG001|Overall Study|Randomized But Not Treated|0|||
161668414|NCT01050790|583837560|FG000|Overall Study|Adverse Event|1|||
161668415|NCT03705832|583837561|FG000|Overall Study|Physician Decision|0|||
161668416|NCT03705832|583837562|FG001|Overall Study|Physician Decision|1|||
161668417|NCT03705832|583837561|FG000|Overall Study|Withdrawal by Subject|1|||
161668418|NCT03705832|583837562|FG001|Overall Study|Withdrawal by Subject|0|||
161471067|NCT01543698|583121687|FG004|Phase 2|Protocol Violation|0|||
161668419|NCT01880528|583837563|FG000|Overall Study|Other|1|||
161668420|NCT01880528|583837564|FG001|Overall Study|Other|1|||
161668421|NCT00081497|583837565|FG000|Overall Study|Adverse Event|2|||
161668422|NCT00081497|583837566|FG001|Overall Study|Adverse Event|0|||
161471068|NCT01543698|583121688|FG005|Phase 2|Protocol Violation|0|||
161471069|NCT01543698|583121689|FG006|Phase 2|Protocol Violation|0|||
161471070|NCT01543698|583121690|FG007|Phase 2|Protocol Violation|0|||
161471071|NCT01543698|583121691|FG008|Phase 2|Protocol Violation|0|||
161471072|NCT01543698|583121692|FG009|Phase 2|Protocol Violation|0|||
161471073|NCT01543698|583121693|FG010|Phase 2|Protocol Violation|0|||
161471074|NCT01543698|583121694|FG011|Phase 2|Protocol Violation|0|||
161471075|NCT01543698|583121695|FG012|Phase 2|Protocol Violation|1|||
161471076|NCT01543698|583121696|FG013|Phase 2|Protocol Violation|0|||
161471077|NCT01543698|583121697|FG014|Phase 2|Protocol Violation|0|||
161471078|NCT01543698|583121683|FG000|Phase 2|Disease progression|0|||
161471079|NCT01543698|583121684|FG001|Phase 2|Disease progression|0|||
161471080|NCT01543698|583121685|FG002|Phase 2|Disease progression|0|||
161471081|NCT01543698|583121686|FG003|Phase 2|Disease progression|0|||
161471082|NCT01543698|583121687|FG004|Phase 2|Disease progression|0|||
161471083|NCT01543698|583121688|FG005|Phase 2|Disease progression|0|||
161471084|NCT01543698|583121689|FG006|Phase 2|Disease progression|0|||
161471085|NCT01543698|583121690|FG007|Phase 2|Disease progression|0|||
161471086|NCT01543698|583121691|FG008|Phase 2|Disease progression|0|||
161471087|NCT01543698|583121692|FG009|Phase 2|Disease progression|0|||
161471088|NCT01543698|583121693|FG010|Phase 2|Disease progression|0|||
161471089|NCT01543698|583121694|FG011|Phase 2|Disease progression|10|||
161471090|NCT01543698|583121695|FG012|Phase 2|Disease progression|21|||
161471091|NCT01543698|583121696|FG013|Phase 2|Disease progression|30|||
161471092|NCT01543698|583121697|FG014|Phase 2|Disease progression|25|||
161471093|NCT01543698|583121683|FG000|Phase 2|Death|0|||
161471094|NCT01543698|583121684|FG001|Phase 2|Death|0|||
161471095|NCT01543698|583121685|FG002|Phase 2|Death|0|||
161471096|NCT01543698|583121686|FG003|Phase 2|Death|0|||
161471097|NCT01543698|583121687|FG004|Phase 2|Death|0|||
161471098|NCT01543698|583121688|FG005|Phase 2|Death|0|||
161471099|NCT01543698|583121689|FG006|Phase 2|Death|0|||
161471100|NCT01543698|583121690|FG007|Phase 2|Death|0|||
161471101|NCT01543698|583121691|FG008|Phase 2|Death|0|||
161471102|NCT01543698|583121692|FG009|Phase 2|Death|0|||
161471103|NCT01543698|583121693|FG010|Phase 2|Death|0|||
161471104|NCT01543698|583121694|FG011|Phase 2|Death|0|||
161471105|NCT01543698|583121695|FG012|Phase 2|Death|1|||
161471106|NCT01543698|583121696|FG013|Phase 2|Death|1|||
161471107|NCT01543698|583121697|FG014|Phase 2|Death|1|||
161471108|NCT01543698|583121683|FG000|Phase 2|Administrative problems|0|||
161471109|NCT01543698|583121684|FG001|Phase 2|Administrative problems|0|||
161471110|NCT01543698|583121685|FG002|Phase 2|Administrative problems|0|||
161668423|NCT00081497|583837565|FG000|Overall Study|Death|0|||
161668424|NCT00081497|583837566|FG001|Overall Study|Death|1|||
161668425|NCT00081497|583837565|FG000|Overall Study|Withdrawal by Subject|1|||
161668426|NCT00081497|583837566|FG001|Overall Study|Withdrawal by Subject|0|||
161668427|NCT00081497|583837565|FG000|Overall Study|Non-compliance|0|||
161668428|NCT00081497|583837566|FG001|Overall Study|Non-compliance|1|||
161668429|NCT01439360|583837567|FG000|Overall Study|Adverse Event|4|||
161668430|NCT01439360|583837568|FG001|Overall Study|Adverse Event|16|||
161668431|NCT01439360|583837567|FG000|Overall Study|Lost to Follow-up|43|||
161668432|NCT01439360|583837568|FG001|Overall Study|Lost to Follow-up|58|||
161668433|NCT01439360|583837567|FG000|Overall Study|Others|10|||
161668434|NCT01439360|583837568|FG001|Overall Study|Others|5|||
161668435|NCT01439360|583837567|FG000|Overall Study|Protocol Violation|1|||
161668436|NCT01439360|583837568|FG001|Overall Study|Protocol Violation|0|||
161668437|NCT01439360|583837567|FG000|Overall Study|Withdrawal by Subject|140|||
161668438|NCT01439360|583837568|FG001|Overall Study|Withdrawal by Subject|129|||
161668439|NCT02544217|583839764|FG000|Overall Study|Withdrawal by Subject|1|||
161471111|NCT01543698|583121686|FG003|Phase 2|Administrative problems|0|||
161668440|NCT02544217|583839765|FG001|Overall Study|Withdrawal by Subject|1|||
161668441|NCT02544217|583839766|FG002|Overall Study|Withdrawal by Subject|0|||
161471112|NCT01543698|583121687|FG004|Phase 2|Administrative problems|0|||
161471113|NCT01543698|583121688|FG005|Phase 2|Administrative problems|0|||
161668442|NCT02544217|583839767|FG003|Overall Study|Withdrawal by Subject|0|||
161471114|NCT01543698|583121689|FG006|Phase 2|Administrative problems|0|||
161471115|NCT01543698|583121690|FG007|Phase 2|Administrative problems|0|||
161471116|NCT01543698|583121691|FG008|Phase 2|Administrative problems|0|||
161471117|NCT01543698|583121692|FG009|Phase 2|Administrative problems|0|||
161471118|NCT01543698|583121693|FG010|Phase 2|Administrative problems|0|||
161471119|NCT01543698|583121694|FG011|Phase 2|Administrative problems|0|||
161471120|NCT01543698|583121695|FG012|Phase 2|Administrative problems|0|||
161471121|NCT01543698|583121696|FG013|Phase 2|Administrative problems|3|||
161471122|NCT01543698|583121697|FG014|Phase 2|Administrative problems|1|||
161471123|NCT01543698|583121683|FG000|Phase 2|Withdrawal by Subject|0|||
161471124|NCT01543698|583121684|FG001|Phase 2|Withdrawal by Subject|0|||
161471125|NCT01543698|583121685|FG002|Phase 2|Withdrawal by Subject|0|||
161668443|NCT02544217|583839768|FG004|Overall Study|Withdrawal by Subject|0|||
161668444|NCT02544217|583839769|FG005|Overall Study|Withdrawal by Subject|0|||
161668445|NCT02027701|583839771|FG000|Overall Study|Adverse Event|3|||
161668446|NCT02027701|583839771|FG000|Overall Study|Lack of Efficacy|8|||
161668447|NCT02027701|583839771|FG000|Overall Study|Physician Decision|2|||
161812511|NCT00113386|584356230|FG000|Overall Study|Ineligible|1|||
161812512|NCT00113386|584356231|FG001|Overall Study|Ineligible|2|||
161812513|NCT00113386|584356230|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
161812514|NCT00113386|584356231|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
161812515|NCT02849457|584356232|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161812516|NCT02849457|584356233|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161812517|NCT02849457|584356234|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
161812518|NCT02849457|584356235|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161812519|NCT01778010|584356239|FG000|Overall Study|Withdrawal by Subject|2|||
161915941|NCT01093846|584740591|FG002|Overall Study|Adverse Event|1|||
161915942|NCT01093846|584740589|FG000|Overall Study|Lack of Efficacy|0|||
161915943|NCT01093846|584740590|FG001|Overall Study|Lack of Efficacy|0|||
161915944|NCT01093846|584740591|FG002|Overall Study|Lack of Efficacy|4|||
161915945|NCT01093846|584740589|FG000|Overall Study|Condition no longer required study drug|1|||
161915946|NCT01093846|584740590|FG001|Overall Study|Condition no longer required study drug|1|||
161915947|NCT01093846|584740591|FG002|Overall Study|Condition no longer required study drug|1|||
161915948|NCT01093846|584740589|FG000|Overall Study|Administrative Problems|18|||
161915949|NCT01093846|584740590|FG001|Overall Study|Administrative Problems|17|||
161915950|NCT01093846|584740591|FG002|Overall Study|Administrative Problems|15|||
161915951|NCT02781324|584740592|FG000|Overall Study|Withdrawal by Subject|1|||
161915952|NCT02781324|584740593|FG001|Overall Study|Withdrawal by Subject|0|||
161915953|NCT02781324|584740592|FG000|Overall Study|Physician Decision|1|||
161915954|NCT02781324|584740593|FG001|Overall Study|Physician Decision|2|||
161915955|NCT03074500|584740594|FG000|Overall Study|Lost to Follow-up|1|||
161915956|NCT03074500|584740595|FG001|Overall Study|Lost to Follow-up|0|||
161915957|NCT03074500|584740596|FG002|Overall Study|Lost to Follow-up|0|||
161915958|NCT03074500|584740594|FG000|Overall Study|Lack of Efficacy|0|||
161915959|NCT03074500|584740595|FG001|Overall Study|Lack of Efficacy|1|||
161915960|NCT03074500|584740596|FG002|Overall Study|Lack of Efficacy|0|||
161915961|NCT03074500|584740594|FG000|Overall Study|Adverse Event|0|||
161915962|NCT03074500|584740595|FG001|Overall Study|Adverse Event|0|||
161915963|NCT03074500|584740596|FG002|Overall Study|Adverse Event|1|||
161915964|NCT03321721|584740597|FG000|Overall Study|Lost to Follow-up|4|||
161915965|NCT03321721|584740598|FG001|Overall Study|Lost to Follow-up|8|||
161915966|NCT03321721|584740599|FG002|Overall Study|Lost to Follow-up|11|||
161915967|NCT05020015|584742340|FG000|Overall Study|Ongoing on study|1|||
161915968|NCT05020015|584742341|FG001|Overall Study|Ongoing on study|3|||
161915969|NCT05020015|584742342|FG002|Overall Study|Ongoing on study|4|||
161915970|NCT05020015|584742343|FG003|Overall Study|Ongoing on study|7|||
161915971|NCT05020015|584742340|FG000|Overall Study|Death|2|||
161915972|NCT05020015|584742341|FG001|Overall Study|Death|3|||
161915973|NCT05020015|584742342|FG002|Overall Study|Death|4|||
161915974|NCT05020015|584742343|FG003|Overall Study|Death|0|||
161915975|NCT05020015|584742340|FG000|Overall Study|Withdrawal by Subject|0|||
161915976|NCT05020015|584742341|FG001|Overall Study|Withdrawal by Subject|0|||
161915977|NCT05020015|584742342|FG002|Overall Study|Withdrawal by Subject|1|||
161915978|NCT05020015|584742343|FG003|Overall Study|Withdrawal by Subject|0|||
161915979|NCT05020015|584742340|FG000|Overall Study|Reason Not Specified|0|||
161915980|NCT05020015|584742341|FG001|Overall Study|Reason Not Specified|0|||
161915981|NCT05020015|584742342|FG002|Overall Study|Reason Not Specified|2|||
161915982|NCT05020015|584742343|FG003|Overall Study|Reason Not Specified|0|||
161915983|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
161915984|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
161915985|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
161915986|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
161915987|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
161915988|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
161915989|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
161915990|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
161915991|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
161576235|NCT00818454|583496133|FG001|Treatment Period 2|Other|1|||
161915992|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
161915993|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
161915994|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
161915995|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
161915996|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
161915997|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
161915998|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
161915999|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
161916000|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
161916001|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
161916002|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
161916003|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
161916004|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
161916005|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
161916006|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
161916007|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
161916008|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
161576236|NCT00818454|583496134|FG002|Treatment Period 2|Other|0|||
161916009|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
161471126|NCT01543698|583121686|FG003|Phase 2|Withdrawal by Subject|0|||
161471127|NCT01543698|583121687|FG004|Phase 2|Withdrawal by Subject|0|||
161471128|NCT01543698|583121688|FG005|Phase 2|Withdrawal by Subject|0|||
161471129|NCT01543698|583121689|FG006|Phase 2|Withdrawal by Subject|0|||
161471130|NCT01543698|583121690|FG007|Phase 2|Withdrawal by Subject|0|||
161471131|NCT01543698|583121691|FG008|Phase 2|Withdrawal by Subject|0|||
161471132|NCT01543698|583121692|FG009|Phase 2|Withdrawal by Subject|0|||
161471133|NCT01543698|583121693|FG010|Phase 2|Withdrawal by Subject|0|||
161471134|NCT01543698|583121694|FG011|Phase 2|Withdrawal by Subject|0|||
161471135|NCT01543698|583121695|FG012|Phase 2|Withdrawal by Subject|0|||
161471136|NCT01543698|583121696|FG013|Phase 2|Withdrawal by Subject|3|||
161471137|NCT01543698|583121697|FG014|Phase 2|Withdrawal by Subject|1|||
161471138|NCT01543698|583121683|FG000|Phase 2|Adverse Event|0|||
161471139|NCT01543698|583121684|FG001|Phase 2|Adverse Event|0|||
161471140|NCT01543698|583121685|FG002|Phase 2|Adverse Event|0|||
161471141|NCT01543698|583121686|FG003|Phase 2|Adverse Event|0|||
161471142|NCT01543698|583121687|FG004|Phase 2|Adverse Event|0|||
161471143|NCT01543698|583121688|FG005|Phase 2|Adverse Event|0|||
161471144|NCT01543698|583121689|FG006|Phase 2|Adverse Event|0|||
161471145|NCT01543698|583121690|FG007|Phase 2|Adverse Event|0|||
161471146|NCT01543698|583121691|FG008|Phase 2|Adverse Event|0|||
161471147|NCT01543698|583121692|FG009|Phase 2|Adverse Event|0|||
161471148|NCT01543698|583121693|FG010|Phase 2|Adverse Event|0|||
161471149|NCT01543698|583121694|FG011|Phase 2|Adverse Event|1|||
161471150|NCT01543698|583121695|FG012|Phase 2|Adverse Event|3|||
161471151|NCT01543698|583121696|FG013|Phase 2|Adverse Event|5|||
161916010|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
161916011|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
161916012|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
161916013|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
161916014|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
161916015|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
161916016|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
161916017|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
161916018|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
161916019|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
161916020|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
161916021|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
161916022|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
161916023|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
161916024|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
161916025|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
161916026|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
161916027|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
161916028|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
161916029|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
161916030|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
161471152|NCT01543698|583121697|FG014|Phase 2|Adverse Event|14|||
161471153|NCT00217620|583121698|FG000|Overall Study|Adverse Event|2|||
161471154|NCT00217620|583121698|FG000|Overall Study|Progression|31|||
161812520|NCT01778010|584356239|FG000|Overall Study|abnormal ECG before meds|1|||
161812521|NCT01778010|584356239|FG000|Overall Study|Arrested|1|||
161812522|NCT01778010|584356239|FG000|Overall Study|rash while on placebo|1|||
161812523|NCT02159183|584356242|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
161812524|NCT02159183|584356243|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
161812525|NCT02159183|584356242|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
161812526|NCT02159183|584356243|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
161812527|NCT02159183|584356242|FG000|Analysis After the 36 Months Follow-up|Death|0|||
161812528|NCT02159183|584356243|FG001|Analysis After the 36 Months Follow-up|Death|1|||
161471155|NCT00217620|583121698|FG000|Overall Study|Not Protocol Specified|4|||
161471156|NCT00217620|583121698|FG000|Overall Study|Ineligible|13|||
161471157|NCT00217620|583121698|FG000|Overall Study|Never received treatment|1|||
161471158|NCT01314703|583121711|FG000|Overall Study|screen failure and closed enrollment|8|||
161471159|NCT01863953|583121712|FG000|Overall Study|Adverse Event|0|||
161471160|NCT01863953|583121713|FG001|Overall Study|Adverse Event|0|||
161471161|NCT01863953|583121714|FG002|Overall Study|Adverse Event|1|||
161471162|NCT04195906|583121718|FG000|Part 1|Adverse Event|3|||
161812529|NCT02159183|584356242|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
161576237|NCT00818454|583496135|FG003|Treatment Period 2|Other|0|||
161812530|NCT02159183|584356243|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
161812531|NCT02159183|584356242|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
161812532|NCT02159183|584356243|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
161812533|NCT02558491|584356245|FG000|First Invention|Withdrawal by Subject|3|||
161812534|NCT02558491|584356246|FG001|First Invention|Withdrawal by Subject|1|||
161812535|NCT02558491|584356245|FG000|First Invention|Data collection issues|1|||
161812536|NCT02558491|584356246|FG001|First Invention|Data collection issues|0|||
161812537|NCT02558491|584356245|FG000|First Invention|Stopping criteria|0|||
161812538|NCT02558491|584356246|FG001|First Invention|Stopping criteria|1|||
161812539|NCT02558491|584356245|FG000|First Invention|Changed parameters during trial|1|||
161812540|NCT02558491|584356246|FG001|First Invention|Changed parameters during trial|0|||
161812541|NCT02558491|584356245|FG000|Second Intervention|Withdrawal by Subject|1|||
161812542|NCT02558491|584356246|FG001|Second Intervention|Withdrawal by Subject|0|||
161812543|NCT02558491|584356245|FG000|Second Intervention|Stopping Criteria|1|||
161812544|NCT02558491|584356246|FG001|Second Intervention|Stopping Criteria|0|||
161812545|NCT00429416|584356247|FG000|Overall Study|Death|1|||
161812546|NCT00415363|584356249|FG000|Overall Study|Withdrawal by Subject|4|||
161812547|NCT00415363|584356250|FG001|Overall Study|Withdrawal by Subject|4|||
161812548|NCT00415363|584356249|FG000|Overall Study|Adverse Event|4|||
161812549|NCT00415363|584356250|FG001|Overall Study|Adverse Event|4|||
161812550|NCT00415363|584356249|FG000|Overall Study|Lost to Follow-up|2|||
161812551|NCT00415363|584356250|FG001|Overall Study|Lost to Follow-up|1|||
161812552|NCT00415363|584356249|FG000|Overall Study|Physician Decision|3|||
161812553|NCT00415363|584356250|FG001|Overall Study|Physician Decision|1|||
161812554|NCT00415363|584356249|FG000|Overall Study|Death|16|||
161812555|NCT00415363|584356250|FG001|Overall Study|Death|12|||
161812556|NCT00415363|584356249|FG000|Overall Study|Progressive disease|26|||
161812557|NCT00415363|584356250|FG001|Overall Study|Progressive disease|32|||
161812558|NCT00813592|584356252|FG000|Overall Study|Disease assessment was not completed per|2|||
161812559|NCT01588236|584356261|FG000|Overall Study|Adverse Event|5|||
161812560|NCT01588236|584356262|FG001|Overall Study|Adverse Event|4|||
161812561|NCT01588236|584356263|FG002|Overall Study|Adverse Event|1|||
161812562|NCT01588236|584356261|FG000|Overall Study|Lost to Follow-up|8|||
161812563|NCT01588236|584356262|FG001|Overall Study|Lost to Follow-up|13|||
161812564|NCT01588236|584356263|FG002|Overall Study|Lost to Follow-up|6|||
161812565|NCT01588236|584356261|FG000|Overall Study|Physician Decision|1|||
161812566|NCT01588236|584356262|FG001|Overall Study|Physician Decision|2|||
161812567|NCT01588236|584356263|FG002|Overall Study|Physician Decision|0|||
161812568|NCT01588236|584356261|FG000|Overall Study|Protocol Violation|0|||
161812569|NCT01588236|584356262|FG001|Overall Study|Protocol Violation|1|||
161812570|NCT01588236|584356263|FG002|Overall Study|Protocol Violation|1|||
161812571|NCT01588236|584356261|FG000|Overall Study|Withdrawal by Subject|14|||
161812572|NCT01588236|584356262|FG001|Overall Study|Withdrawal by Subject|16|||
161812573|NCT01588236|584356263|FG002|Overall Study|Withdrawal by Subject|18|||
161812574|NCT01588236|584356261|FG000|Overall Study|Exclusion Criteria met during study|2|||
161812575|NCT01588236|584356262|FG001|Overall Study|Exclusion Criteria met during study|1|||
161812576|NCT01588236|584356263|FG002|Overall Study|Exclusion Criteria met during study|0|||
161812577|NCT01588236|584356261|FG000|Overall Study|sponsor decision|1|||
161812578|NCT01588236|584356262|FG001|Overall Study|sponsor decision|6|||
161812579|NCT01588236|584356263|FG002|Overall Study|sponsor decision|2|||
161812580|NCT00199901|584357287|FG000|Overall Study|Protocol Violation|2|||
161812581|NCT00199901|584357288|FG001|Overall Study|Protocol Violation|0|||
161812582|NCT00199901|584357287|FG000|Overall Study|Withdrawal by Subject|1|||
161812583|NCT00199901|584357288|FG001|Overall Study|Withdrawal by Subject|0|||
161812584|NCT00199901|584357287|FG000|Overall Study|Progressive Disease|24|||
161812585|NCT00199901|584357288|FG001|Overall Study|Progressive Disease|24|||
161812586|NCT01958294|584357296|FG000|Overall Study|Clinical Circumstances|2|||
161812587|NCT02566850|584357298|FG000|Overall Study|Protocol Violation|1|||
161812588|NCT00682461|584357299|FG000|Overall Study|Adverse Event|5|||
161812589|NCT00682461|584357300|FG001|Overall Study|Adverse Event|7|||
161812590|NCT00682461|584357299|FG000|Overall Study|Lost to Follow-up|8|||
161812591|NCT00682461|584357300|FG001|Overall Study|Lost to Follow-up|5|||
161812592|NCT00682461|584357299|FG000|Overall Study|Withdrawal by Subject|12|||
161812593|NCT00682461|584357300|FG001|Overall Study|Withdrawal by Subject|19|||
161812594|NCT06298396|584357313|FG000|Default MAP|Protocol Violation|1|||
161812595|NCT06137781|584357314|FG000|Baseline measurements|Lost to Follow-up|2|||
161812596|NCT06137781|584357314|FG000|Baseline measurements|Withdrawal by Subject|1|||
161812597|NCT06137781|584357314|FG000|Baseline measurements|Expedited surgery|1|||
161812598|NCT06137781|584357314|FG000|Intervention period|Lost to Follow-up|2|||
161812599|NCT06137781|584357314|FG000|Intervention period|Withdrawal by Subject|3|||
161812600|NCT06137781|584357314|FG000|Intervention period|Expedited surgery|1|||
161812601|NCT06137781|584357314|FG000|Intervention period|Adverse Event|1|||
161812602|NCT05604170|584357319|FG000|Overall Study|Lack of Efficacy|5|||
161812603|NCT05604170|584357319|FG000|Overall Study|Adverse Event|6|||
161812604|NCT05604170|584357319|FG000|Overall Study|Physician Decision|6|||
161812605|NCT05604170|584357319|FG000|Overall Study|Lost to Follow-up|6|||
161812606|NCT05604170|584357319|FG000|Overall Study|Withdrawal by Subject|11|||
161916031|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
161916032|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
161916033|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
161916034|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
161916035|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
161916036|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
161916037|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
161471163|NCT04195906|583121719|FG001|Part 1|Adverse Event|7|||
161471164|NCT04195906|583121718|FG000|Part 1|Withdrawal by Subject|0|||
161471165|NCT04195906|583121719|FG001|Part 1|Withdrawal by Subject|1|||
161471166|NCT04195906|583121718|FG000|Part 2|Adverse Event|1|||
161471167|NCT04195906|583121719|FG001|Part 2|Adverse Event|1|||
161471168|NCT04195906|583121718|FG000|Part 2|Withdrawal by Subject|0|||
161471169|NCT04195906|583121719|FG001|Part 2|Withdrawal by Subject|3|||
161471170|NCT04195906|583121718|FG000|Part 2|Other|1|||
161471171|NCT04195906|583121719|FG001|Part 2|Other|3|||
161471172|NCT02024529|583121720|FG000|Overall Study|Withdrawal by Subject|11|||
161471173|NCT02024529|583121721|FG001|Overall Study|Withdrawal by Subject|21|||
161471174|NCT02024529|583121720|FG000|Overall Study|Lost to Follow-up|2|||
161471175|NCT02024529|583121721|FG001|Overall Study|Lost to Follow-up|4|||
161471176|NCT00691301|583121722|FG000|Overall Study|Adverse Event|10|||
161668448|NCT02027701|583839771|FG000|Overall Study|Withdrawal by Subject|3|||
161668449|NCT00820027|583839772|FG000|Overall Study|Adverse Event|15|||
161916038|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
161916039|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
161916040|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
161916041|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
161916042|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
161916043|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
161916044|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
161916045|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
161916046|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
161916047|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
161916048|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
161916049|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
161916050|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
161916051|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
161916052|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
161916053|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
161916054|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
161916055|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
161916056|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
161916057|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
161916058|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
161916059|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
161916060|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
161916061|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
161916062|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
161916063|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
161916064|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
161916065|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
161916066|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
161916067|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
161916068|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
161916069|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
161916070|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
161916071|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
161916072|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
161916073|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
161916074|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
161916075|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
161916076|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
161916077|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
161916078|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
161471177|NCT00691301|583121722|FG000|Overall Study|Death|2|||
161471178|NCT00691301|583121722|FG000|Overall Study|Lack of Efficacy|32|||
161916079|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
161916080|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
161916081|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
161916082|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
161916083|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
161916084|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
161916085|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
161916086|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
161916087|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
161916088|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
161916089|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
161916090|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
161916091|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
161916092|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
161916093|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
161916094|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
161916095|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
161916096|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
161916097|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
161916098|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
161916099|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
161916100|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
161916101|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
161916102|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
161916103|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
161916104|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
161916105|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
161916106|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
161916107|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
161916108|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
161916109|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
161812607|NCT05604170|584357319|FG000|Overall Study|Early study termination by sponsor|77|||
161812608|NCT05604170|584357319|FG000|Overall Study|Other|6|||
161812609|NCT01547286|584357322|FG000|Overall Study|Did not meet all eligibility criteria|1|||
161812610|NCT01547286|584357322|FG000|Overall Study|Physician Decision|1|||
161812611|NCT00081653|584357324|FG000|Overall Study|Adverse Event|23|||
161812612|NCT00081653|584357325|FG001|Overall Study|Adverse Event|17|||
161812613|NCT00081653|584357324|FG000|Overall Study|Lost to Follow-up|2|||
161812614|NCT00081653|584357325|FG001|Overall Study|Lost to Follow-up|4|||
161812615|NCT00081653|584357324|FG000|Overall Study|Refused Treatment|18|||
161812616|NCT00081653|584357325|FG001|Overall Study|Refused Treatment|14|||
161812617|NCT00081653|584357324|FG000|Overall Study|Low bone mineral density|1|||
161812618|NCT00081653|584357325|FG001|Overall Study|Low bone mineral density|0|||
161812619|NCT00081653|584357324|FG000|Overall Study|Bone loss|2|||
161812620|NCT00081653|584357325|FG001|Overall Study|Bone loss|0|||
161812621|NCT00081653|584357324|FG000|Overall Study|Participant leaving country|1|||
161812622|NCT00081653|584357325|FG001|Overall Study|Participant leaving country|0|||
161812623|NCT00081653|584357324|FG000|Overall Study|Loss of bone mass|0|||
161812624|NCT00081653|584357325|FG001|Overall Study|Loss of bone mass|2|||
161812625|NCT00392665|584357326|FG000|Overall Study|Death|16|||
161812626|NCT00392665|584357327|FG001|Overall Study|Death|14|||
161812627|NCT00392665|584357326|FG000|Overall Study|Lost to Follow-up|1|||
161812628|NCT00392665|584357327|FG001|Overall Study|Lost to Follow-up|1|||
161812629|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
161812630|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812631|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812632|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812633|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812634|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812635|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812636|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
161576238|NCT00818454|583496132|FG000|Treatment Period 3|Adverse Event|0|||
161812637|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
161812638|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812639|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
161916110|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
161916111|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
161916112|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
161916113|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
161916114|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
161916115|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
161916116|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
161916117|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
161916118|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
161471179|NCT00691301|583121722|FG000|Overall Study|Withdrawal by Subject|4|||
161471180|NCT00691301|583121722|FG000|Overall Study|Concurrent illness|2|||
161471181|NCT00691301|583121722|FG000|Overall Study|other reason|3|||
161471182|NCT00691301|583121722|FG000|Overall Study|Did not initiate study treatment|1|||
161471183|NCT02642029|583121723|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
161471184|NCT02642029|583121724|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
161471185|NCT02642029|583121725|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
161471186|NCT02642029|583121726|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
161471187|NCT02642029|583121727|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
161471188|NCT02642029|583121728|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
161471189|NCT02642029|583121723|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
161471190|NCT02642029|583121724|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
161916119|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
161916120|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
161916121|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
161916122|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
161916123|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
161916124|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Death|1|||
161916125|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Death|0|||
161916126|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Death|1|||
161916127|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
161916128|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
161916129|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
161916130|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
161916131|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
161916132|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
161916133|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
161916134|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
161916135|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
161916136|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
161916137|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
161916138|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
161916139|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
161916140|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
161916141|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
161916142|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
161916143|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
161916144|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
161916145|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
161916146|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
161916147|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
161916148|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Depression|0|||
161916149|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Depression|1|||
161916150|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Depression|0|||
161916151|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
161916152|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
161916153|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
161576239|NCT00818454|583496133|FG001|Treatment Period 3|Adverse Event|0|||
161916154|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Jailed|0|||
161916155|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Jailed|1|||
161471191|NCT02642029|583121725|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
161471192|NCT02642029|583121726|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
161471193|NCT02642029|583121727|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
161471194|NCT02642029|583121728|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
161471195|NCT02642029|583121723|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
161471196|NCT02642029|583121724|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
161471197|NCT02642029|583121725|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
161471198|NCT02642029|583121726|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
161471199|NCT02642029|583121727|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
161471200|NCT02642029|583121728|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
161471201|NCT02642029|583121723|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
161471202|NCT02642029|583121724|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
161471203|NCT02642029|583121725|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
161471204|NCT02642029|583121726|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
161471205|NCT02642029|583121727|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
161471206|NCT02642029|583121728|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
161471207|NCT02642029|583121723|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
161471208|NCT02642029|583121724|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
161471209|NCT02642029|583121725|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
161471210|NCT02642029|583121726|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
161471211|NCT02642029|583121727|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
161471212|NCT02642029|583121728|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
161471213|NCT02642029|583121723|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
161471214|NCT02642029|583121724|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
161471215|NCT02642029|583121725|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
161471216|NCT02642029|583121726|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
161471217|NCT02642029|583121727|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
161471218|NCT02642029|583121728|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
161471219|NCT00463580|583121729|FG000|Overall Study|Lost to Follow-up|1|||
161471220|NCT00463580|583121730|FG001|Overall Study|Lost to Follow-up|0|||
161471221|NCT00463580|583121729|FG000|Overall Study|Schedule conflict|2|||
161471222|NCT00463580|583121730|FG001|Overall Study|Schedule conflict|0|||
161471223|NCT00463580|583121729|FG000|Overall Study|Medical/psychiatric complications|0|||
161471224|NCT00463580|583121730|FG001|Overall Study|Medical/psychiatric complications|2|||
161471225|NCT01495975|583121732|FG000|Overall Study|Lost to Follow-up|1|||
161471226|NCT01495975|583121733|FG001|Overall Study|Lost to Follow-up|0|||
161471227|NCT02038881|583121736|FG000|Overall Study|Withdrawal by Subject|0|||
161471228|NCT02038881|583121737|FG001|Overall Study|Withdrawal by Subject|0|||
161471229|NCT02038881|583121738|FG002|Overall Study|Withdrawal by Subject|1|||
161471230|NCT02038881|583121736|FG000|Overall Study|Lost to Follow-up|2|||
161471231|NCT02038881|583121737|FG001|Overall Study|Lost to Follow-up|0|||
161471232|NCT02038881|583121738|FG002|Overall Study|Lost to Follow-up|0|||
161471233|NCT02038881|583121736|FG000|Overall Study|incarcerated|1|||
161471234|NCT02038881|583121737|FG001|Overall Study|incarcerated|0|||
161471235|NCT02038881|583121738|FG002|Overall Study|incarcerated|0|||
161471236|NCT00333840|583121739|FG000|First-line Treatment Period|Adverse Event|38|||
161471237|NCT00333840|583121740|FG001|First-line Treatment Period|Adverse Event|37|||
161471238|NCT00333840|583121741|FG002|First-line Treatment Period|Adverse Event|0|||
161471239|NCT00333840|583121742|FG003|First-line Treatment Period|Adverse Event|0|||
161471240|NCT00333840|583121739|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
161471241|NCT00333840|583121740|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
161471242|NCT00333840|583121741|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
161471243|NCT00333840|583121742|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
161471244|NCT00333840|583121739|FG000|First-line Treatment Period|Abnormal procedure|2|||
161471245|NCT00333840|583121740|FG001|First-line Treatment Period|Abnormal procedure|0|||
161471246|NCT00333840|583121741|FG002|First-line Treatment Period|Abnormal procedure|0|||
161471247|NCT00333840|583121742|FG003|First-line Treatment Period|Abnormal procedure|0|||
161471248|NCT00333840|583121739|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
161471249|NCT00333840|583121740|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
161471250|NCT00333840|583121741|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
161471251|NCT00333840|583121742|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
161471252|NCT00333840|583121739|FG000|First-line Treatment Period|No longer required study drug|21|||
161471253|NCT00333840|583121740|FG001|First-line Treatment Period|No longer required study drug|8|||
161916156|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Jailed|0|||
161916157|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Other|0|||
161916158|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Other|1|||
161916159|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Other|0|||
161916160|NCT00947544|584742351|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
161471254|NCT00333840|583121741|FG002|First-line Treatment Period|No longer required study drug|0|||
161471255|NCT00333840|583121742|FG003|First-line Treatment Period|No longer required study drug|0|||
161471256|NCT00333840|583121739|FG000|First-line Treatment Period|Protocol Violation|17|||
161471257|NCT00333840|583121740|FG001|First-line Treatment Period|Protocol Violation|17|||
161471258|NCT00333840|583121741|FG002|First-line Treatment Period|Protocol Violation|0|||
161471259|NCT00333840|583121742|FG003|First-line Treatment Period|Protocol Violation|0|||
161471260|NCT00333840|583121739|FG000|First-line Treatment Period|Subject withdrew consent|57|||
161471261|NCT00333840|583121740|FG001|First-line Treatment Period|Subject withdrew consent|77|||
161471262|NCT00333840|583121741|FG002|First-line Treatment Period|Subject withdrew consent|0|||
161471263|NCT00333840|583121742|FG003|First-line Treatment Period|Subject withdrew consent|0|||
161471264|NCT00333840|583121739|FG000|First-line Treatment Period|Lost to Follow-up|15|||
161471265|NCT00333840|583121740|FG001|First-line Treatment Period|Lost to Follow-up|6|||
161471266|NCT00333840|583121741|FG002|First-line Treatment Period|Lost to Follow-up|0|||
161471267|NCT00333840|583121742|FG003|First-line Treatment Period|Lost to Follow-up|0|||
161471268|NCT00333840|583121739|FG000|First-line Treatment Period|Administrative problems|12|||
161471269|NCT00333840|583121740|FG001|First-line Treatment Period|Administrative problems|6|||
161471270|NCT00333840|583121741|FG002|First-line Treatment Period|Administrative problems|0|||
161471271|NCT00333840|583121742|FG003|First-line Treatment Period|Administrative problems|0|||
161471272|NCT00333840|583121739|FG000|First-line Treatment Period|Death|19|||
161471273|NCT00333840|583121740|FG001|First-line Treatment Period|Death|2|||
161471274|NCT00333840|583121741|FG002|First-line Treatment Period|Death|0|||
161471275|NCT00333840|583121742|FG003|First-line Treatment Period|Death|0|||
161471276|NCT00333840|583121739|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
161471277|NCT00333840|583121740|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
161471278|NCT00333840|583121741|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
161471279|NCT00333840|583121742|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
161471280|NCT00333840|583121739|FG000|Second-line Treatment Period|Adverse Event|0|||
161471281|NCT00333840|583121740|FG001|Second-line Treatment Period|Adverse Event|0|||
161471282|NCT00333840|583121741|FG002|Second-line Treatment Period|Adverse Event|3|||
161471283|NCT00333840|583121742|FG003|Second-line Treatment Period|Adverse Event|34|||
161471284|NCT00333840|583121739|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
161471285|NCT00333840|583121740|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
161471286|NCT00333840|583121741|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
161471287|NCT00333840|583121742|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
161471288|NCT00333840|583121739|FG000|Second-line Treatment Period|Abnormal procedure|0|||
161471289|NCT00333840|583121740|FG001|Second-line Treatment Period|Abnormal procedure|0|||
161471290|NCT00333840|583121741|FG002|Second-line Treatment Period|Abnormal procedure|0|||
161471291|NCT00333840|583121742|FG003|Second-line Treatment Period|Abnormal procedure|1|||
161471292|NCT00333840|583121739|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
161471293|NCT00333840|583121740|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
161471294|NCT00333840|583121741|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
161471295|NCT00333840|583121742|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
161471296|NCT00333840|583121739|FG000|Second-line Treatment Period|No longer required study drug|0|||
161471297|NCT00333840|583121740|FG001|Second-line Treatment Period|No longer required study drug|0|||
161471298|NCT00333840|583121741|FG002|Second-line Treatment Period|No longer required study drug|1|||
161471299|NCT00333840|583121742|FG003|Second-line Treatment Period|No longer required study drug|14|||
161471300|NCT00333840|583121739|FG000|Second-line Treatment Period|Protocol Violation|0|||
161471301|NCT00333840|583121740|FG001|Second-line Treatment Period|Protocol Violation|0|||
161471302|NCT00333840|583121741|FG002|Second-line Treatment Period|Protocol Violation|1|||
161471303|NCT00333840|583121742|FG003|Second-line Treatment Period|Protocol Violation|10|||
161471304|NCT00333840|583121739|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
161471305|NCT00333840|583121740|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
161471306|NCT00333840|583121741|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
161471307|NCT00333840|583121742|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
161471308|NCT00333840|583121739|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
161471309|NCT00333840|583121740|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
161471310|NCT00333840|583121741|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
161471311|NCT00333840|583121742|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
161576240|NCT00818454|583496134|FG002|Treatment Period 3|Adverse Event|0|||
161576241|NCT00818454|583496135|FG003|Treatment Period 3|Adverse Event|1|||
161576242|NCT01765543|583496142|FG000|Overall Study|Death|1|||
161668450|NCT00820027|583839773|FG001|Overall Study|Adverse Event|8|||
161471312|NCT00333840|583121739|FG000|Second-line Treatment Period|Administrative problems|0|||
161471313|NCT00333840|583121740|FG001|Second-line Treatment Period|Administrative problems|0|||
161471314|NCT00333840|583121741|FG002|Second-line Treatment Period|Administrative problems|0|||
161471315|NCT00333840|583121742|FG003|Second-line Treatment Period|Administrative problems|7|||
161471316|NCT00333840|583121739|FG000|Second-line Treatment Period|Death|0|||
161471317|NCT00333840|583121740|FG001|Second-line Treatment Period|Death|0|||
161471318|NCT00333840|583121741|FG002|Second-line Treatment Period|Death|0|||
161471319|NCT00333840|583121742|FG003|Second-line Treatment Period|Death|9|||
161471320|NCT02357979|583121743|FG000|Overall Study|Lost to Follow-up|5|||
161471321|NCT02357979|583121744|FG001|Overall Study|Lost to Follow-up|5|||
161471322|NCT01453725|583121745|FG000|Overall Study|Adverse Event|3|||
161471323|NCT01453725|583121746|FG001|Overall Study|Adverse Event|3|||
161471324|NCT01453725|583121745|FG000|Overall Study|Lost to Follow-up|4|||
161471325|NCT01453725|583121746|FG001|Overall Study|Lost to Follow-up|0|||
161471326|NCT01453725|583121745|FG000|Overall Study|Non-compliance With Protocol|1|||
161471327|NCT01453725|583121746|FG001|Overall Study|Non-compliance With Protocol|2|||
161471328|NCT01453725|583121745|FG000|Overall Study|Protocol Violation|1|||
161471329|NCT01453725|583121746|FG001|Overall Study|Protocol Violation|0|||
161471330|NCT01453725|583121745|FG000|Overall Study|Withdrawal by Subject|2|||
161471331|NCT01453725|583121746|FG001|Overall Study|Withdrawal by Subject|3|||
161471332|NCT01453725|583121745|FG000|Overall Study|Pregnancy Wish|0|||
161471333|NCT01453725|583121746|FG001|Overall Study|Pregnancy Wish|2|||
161471334|NCT01453725|583121745|FG000|Overall Study|Pregnancy|1|||
161471335|NCT01453725|583121746|FG001|Overall Study|Pregnancy|0|||
161471336|NCT01453725|583121745|FG000|Overall Study|Physician Decision|1|||
161471337|NCT01453725|583121746|FG001|Overall Study|Physician Decision|1|||
161471338|NCT03449901|583121747|FG000|Overall Study|Progression|57|||
161471339|NCT03449901|583121748|FG001|Overall Study|Progression|12|||
161471340|NCT03449901|583121747|FG000|Overall Study|Adverse Event|3|||
161471341|NCT03449901|583121748|FG001|Overall Study|Adverse Event|0|||
161471342|NCT03449901|583121747|FG000|Overall Study|Death|6|||
161471343|NCT03449901|583121748|FG001|Overall Study|Death|2|||
161471344|NCT03449901|583121747|FG000|Overall Study|Withdrawal by Subject|12|||
161471345|NCT03449901|583121748|FG001|Overall Study|Withdrawal by Subject|1|||
161471346|NCT03449901|583121747|FG000|Overall Study|Physician Decision|1|||
161471347|NCT03449901|583121748|FG001|Overall Study|Physician Decision|0|||
161471348|NCT03449901|583121747|FG000|Overall Study|Patient elected for surgical intervention|1|||
161471349|NCT03449901|583121748|FG001|Overall Study|Patient elected for surgical intervention|0|||
161471350|NCT03449901|583121747|FG000|Overall Study|Patient off for other complicating disease|1|||
161471351|NCT03449901|583121748|FG001|Overall Study|Patient off for other complicating disease|0|||
161916161|NCT00947544|584742352|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
161916162|NCT02566005|584742354|FG000|Overall Study|vaginal bleeding|0|||
161916163|NCT02566005|584742355|FG001|Overall Study|vaginal bleeding|1|||
161916164|NCT02566005|584742354|FG000|Overall Study|received foley|8|||
161916165|NCT02566005|584742355|FG001|Overall Study|received foley|0|||
161916166|NCT02566005|584742354|FG000|Overall Study|did not receive foley|0|||
161471352|NCT03605212|583121754|FG000|Treatment Period|Adverse Event|1|||
161471353|NCT03605212|583121755|FG001|Treatment Period|Adverse Event|0|||
161471354|NCT03605212|583121756|FG002|Treatment Period|Adverse Event|0|||
161916167|NCT02566005|584742355|FG001|Overall Study|did not receive foley|1|||
161916168|NCT02566005|584742354|FG000|Overall Study|labor after randomization|0|||
161916169|NCT02566005|584742355|FG001|Overall Study|labor after randomization|4|||
161916170|NCT01134042|584742358|FG000|Overall Study|Adverse Event|3|||
161471355|NCT03605212|583121757|FG003|Treatment Period|Adverse Event|0|||
161471356|NCT03605212|583121758|FG004|Treatment Period|Adverse Event|0|||
161471357|NCT03605212|583121754|FG000|Treatment Period|Physician Decision|0|||
161471358|NCT03605212|583121755|FG001|Treatment Period|Physician Decision|0|||
161471359|NCT03605212|583121756|FG002|Treatment Period|Physician Decision|0|||
161471360|NCT03605212|583121757|FG003|Treatment Period|Physician Decision|0|||
161471361|NCT03605212|583121758|FG004|Treatment Period|Physician Decision|1|||
161471362|NCT01254292|583121759|FG000|Comparative Phase|Adverse Event|25|||
161916171|NCT01134042|584742359|FG001|Overall Study|Adverse Event|7|||
161916172|NCT01134042|584742360|FG002|Overall Study|Adverse Event|2|||
161471363|NCT01254292|583121760|FG001|Comparative Phase|Adverse Event|25|||
161471364|NCT01254292|583121759|FG000|Comparative Phase|Lost to Follow-up|3|||
161471365|NCT01254292|583121760|FG001|Comparative Phase|Lost to Follow-up|21|||
161471366|NCT01254292|583121759|FG000|Comparative Phase|Pregnancy|2|||
161471367|NCT01254292|583121760|FG001|Comparative Phase|Pregnancy|6|||
161471368|NCT01254292|583121759|FG000|Comparative Phase|Withdrawal by Subject|20|||
161471369|NCT01254292|583121760|FG001|Comparative Phase|Withdrawal by Subject|21|||
161471370|NCT01254292|583121759|FG000|Comparative Phase|Protocol Violation|1|||
161471371|NCT01254292|583121760|FG001|Comparative Phase|Protocol Violation|2|||
161471372|NCT01254292|583121759|FG000|Comparative Phase|Wish for pregnancy|4|||
161471373|NCT01254292|583121760|FG001|Comparative Phase|Wish for pregnancy|6|||
161471374|NCT01254292|583121759|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
161471375|NCT01254292|583121760|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
161471376|NCT01254292|583121759|FG000|LCS12 Extension Phase|Adverse Event|9|||
161471377|NCT01254292|583121760|FG001|LCS12 Extension Phase|Adverse Event|0|||
161471378|NCT01254292|583121759|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
161471379|NCT01254292|583121760|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
161471380|NCT01254292|583121759|FG000|LCS12 Extension Phase|Other unknown|4|||
161471381|NCT01254292|583121760|FG001|LCS12 Extension Phase|Other unknown|0|||
161471382|NCT01254292|583121759|FG000|LCS12 Extension Phase|Pregnancy|2|||
161471383|NCT01254292|583121760|FG001|LCS12 Extension Phase|Pregnancy|0|||
161471384|NCT01254292|583121759|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
161471385|NCT01254292|583121760|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
161471386|NCT01268150|583121766|FG000|Treatment Phase|Progression of disease|18|||
161471387|NCT01268150|583121766|FG000|Treatment Phase|Adverse Event|3|||
161471388|NCT01268150|583121766|FG000|Treatment Phase|Withdrawal by Subject|3|||
161471389|NCT01268150|583121766|FG000|Treatment Phase|Other|4|||
161471390|NCT01268150|583121766|FG000|Extension Phase|Adverse Event|3|||
161471391|NCT01268150|583121766|FG000|Extension Phase|Disease progression|18|||
161471392|NCT01268150|583121766|FG000|Extension Phase|Other|6|||
161471393|NCT01672736|583121768|FG000|Overall Study|Available drug expired on 31 May 16|3|||
161471394|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
161471395|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
161471396|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Death|1|||
161471397|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Death|0|||
161471398|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
161471399|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
161471400|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
161471401|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
161471402|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
161471403|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
161471404|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
161471405|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
161471406|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
161471407|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
161471408|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
161471409|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
161471410|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
161471411|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
161471412|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
161471413|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
161471414|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
161471415|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
161471416|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
161471417|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
161812640|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812641|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812642|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812643|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812644|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812645|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812646|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
161812647|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812648|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812649|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812650|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812651|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812652|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
161471418|NCT02927262|583121769|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
161471419|NCT02927262|583121770|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
161471420|NCT02927262|583121769|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
161471421|NCT02927262|583121770|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
161471422|NCT02927262|583121769|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
161471423|NCT02927262|583121770|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
161471424|NCT02927262|583121769|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
161471425|NCT02927262|583121770|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
161471426|NCT02913612|583121771|FG000|Overall Study|Lost to Follow-up|6|||
161471427|NCT02913612|583121772|FG001|Overall Study|Lost to Follow-up|5|||
161471428|NCT02913612|583121773|FG002|Overall Study|Lost to Follow-up|2|||
161471429|NCT02913612|583121774|FG003|Overall Study|Lost to Follow-up|0|||
161471430|NCT02913612|583121771|FG000|Overall Study|Physician Decision|1|||
161471431|NCT02913612|583121772|FG001|Overall Study|Physician Decision|4|||
161471432|NCT02913612|583121773|FG002|Overall Study|Physician Decision|1|||
161471433|NCT02913612|583121774|FG003|Overall Study|Physician Decision|0|||
161471434|NCT02913612|583121771|FG000|Overall Study|Withdrawal by Subject|2|||
161471435|NCT02913612|583121772|FG001|Overall Study|Withdrawal by Subject|4|||
161471436|NCT02913612|583121773|FG002|Overall Study|Withdrawal by Subject|0|||
161471437|NCT02913612|583121774|FG003|Overall Study|Withdrawal by Subject|0|||
161471438|NCT02913612|583121771|FG000|Overall Study|Hemangioma resolved|1|||
161471439|NCT02913612|583121772|FG001|Overall Study|Hemangioma resolved|0|||
161471440|NCT02913612|583121773|FG002|Overall Study|Hemangioma resolved|0|||
161471441|NCT02913612|583121774|FG003|Overall Study|Hemangioma resolved|0|||
161471442|NCT02913612|583121771|FG000|Overall Study|Local IRB decision|1|||
161471443|NCT02913612|583121772|FG001|Overall Study|Local IRB decision|0|||
161471444|NCT02913612|583121773|FG002|Overall Study|Local IRB decision|0|||
161471445|NCT02913612|583121774|FG003|Overall Study|Local IRB decision|0|||
161471446|NCT02913612|583121771|FG000|Overall Study|Study drug non-compliance|1|||
161471447|NCT02913612|583121772|FG001|Overall Study|Study drug non-compliance|1|||
161471448|NCT02913612|583121773|FG002|Overall Study|Study drug non-compliance|0|||
161471449|NCT02913612|583121774|FG003|Overall Study|Study drug non-compliance|0|||
161471450|NCT02913612|583121771|FG000|Overall Study|Insurance issues|0|||
161471451|NCT02913612|583121772|FG001|Overall Study|Insurance issues|1|||
161471452|NCT02913612|583121773|FG002|Overall Study|Insurance issues|0|||
161471453|NCT02913612|583121774|FG003|Overall Study|Insurance issues|0|||
161471454|NCT02913612|583121771|FG000|Overall Study|Needed to treat second hemangioma|0|||
161471455|NCT02913612|583121772|FG001|Overall Study|Needed to treat second hemangioma|1|||
161471456|NCT02913612|583121773|FG002|Overall Study|Needed to treat second hemangioma|0|||
161471457|NCT02913612|583121774|FG003|Overall Study|Needed to treat second hemangioma|0|||
161471458|NCT02913612|583121771|FG000|Overall Study|Study completion criteria not met|0|||
161471459|NCT02913612|583121772|FG001|Overall Study|Study completion criteria not met|1|||
161471460|NCT02913612|583121773|FG002|Overall Study|Study completion criteria not met|0|||
161471461|NCT02913612|583121774|FG003|Overall Study|Study completion criteria not met|0|||
161471462|NCT02913612|583121771|FG000|Overall Study|Ineligible|0|||
161471463|NCT02913612|583121772|FG001|Overall Study|Ineligible|1|||
161471464|NCT02913612|583121773|FG002|Overall Study|Ineligible|0|||
161471465|NCT02913612|583121774|FG003|Overall Study|Ineligible|0|||
161471466|NCT04251273|583121775|FG000|Overall Study|Lost to Follow-up|331|||
161471467|NCT04251273|583121776|FG001|Overall Study|Lost to Follow-up|290|||
161471468|NCT04402060|583121777|FG000|Overall Study|Death|1|||
161471469|NCT04402060|583121778|FG001|Overall Study|Death|12|||
161471470|NCT04402060|583121779|FG002|Overall Study|Death|7|||
161471471|NCT04402060|583121777|FG000|Overall Study|Adverse Event|0|||
161471472|NCT04402060|583121778|FG001|Overall Study|Adverse Event|0|||
161812653|NCT03673670|584357328|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812654|NCT03673670|584357329|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812655|NCT03673670|584357330|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
161812656|NCT03673670|584357331|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812657|NCT03673670|584357332|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
161812658|NCT03673670|584357333|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812659|NCT03673670|584357328|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161812660|NCT03673670|584357329|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161471473|NCT04402060|583121779|FG002|Overall Study|Adverse Event|1|||
161471474|NCT04402060|583121777|FG000|Overall Study|Withdrawal by Subject|0|||
161471475|NCT04402060|583121778|FG001|Overall Study|Withdrawal by Subject|1|||
161812661|NCT03673670|584357330|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161471476|NCT04402060|583121779|FG002|Overall Study|Withdrawal by Subject|2|||
161471477|NCT04402060|583121777|FG000|Overall Study|Sponsor Request|0|||
161471478|NCT04402060|583121778|FG001|Overall Study|Sponsor Request|2|||
161471479|NCT04402060|583121779|FG002|Overall Study|Sponsor Request|0|||
161471480|NCT04402060|583121777|FG000|Overall Study|Physician Decision|0|||
161471481|NCT04402060|583121778|FG001|Overall Study|Physician Decision|0|||
161471482|NCT04402060|583121779|FG002|Overall Study|Physician Decision|1|||
161471483|NCT04402060|583121777|FG000|Overall Study|Other|0|||
161471484|NCT04402060|583121778|FG001|Overall Study|Other|1|||
161471485|NCT04402060|583121779|FG002|Overall Study|Other|0|||
161471486|NCT00936611|583121780|FG000|Overall Study|Progressive Disease|3|||
161471487|NCT00936611|583121780|FG000|Overall Study|New Systemic Therapy|22|||
161471488|NCT00936611|583121780|FG000|Overall Study|Lost to Follow-up|1|||
161471489|NCT00936611|583121780|FG000|Overall Study|Withdrawal by Subject|2|||
161471490|NCT00936611|583121780|FG000|Overall Study|Still on Follow-up|1|||
161471491|NCT00936611|583121780|FG000|Overall Study|Still on Active Therapy|7|||
161471492|NCT00936611|583121780|FG000|Overall Study|Ineligible for Study Drug|3|||
161471493|NCT02282358|583121789|FG000|Overall Study|Nonevaluable|1|||
161471494|NCT01898208|583121790|FG000|Overall Study|Positive blood culture|17|||
161471495|NCT01898208|583121791|FG001|Overall Study|Positive blood culture|23|||
161471496|NCT01898208|583121792|FG002|Overall Study|Positive blood culture|15|||
161471497|NCT01898208|583121790|FG000|Overall Study|Death/comfort care within 24 hours|10|||
161471498|NCT01898208|583121791|FG001|Overall Study|Death/comfort care within 24 hours|9|||
161471499|NCT01898208|583121792|FG002|Overall Study|Death/comfort care within 24 hours|8|||
161471500|NCT01898208|583121790|FG000|Overall Study|Negative Gram Stain|6|||
161471501|NCT01898208|583121791|FG001|Overall Study|Negative Gram Stain|9|||
161471502|NCT01898208|583121792|FG002|Overall Study|Negative Gram Stain|6|||
161471503|NCT01898208|583121790|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
161471504|NCT01898208|583121791|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
161471505|NCT01898208|583121792|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
161471506|NCT01898208|583121790|FG000|Overall Study|System/Technical Error|1|||
161471507|NCT01898208|583121791|FG001|Overall Study|System/Technical Error|2|||
161471508|NCT01898208|583121792|FG002|Overall Study|System/Technical Error|3|||
161471509|NCT01898208|583121790|FG000|Overall Study|Lost to Follow-up|3|||
161471510|NCT01898208|583121791|FG001|Overall Study|Lost to Follow-up|1|||
161471511|NCT01898208|583121792|FG002|Overall Study|Lost to Follow-up|1|||
161471512|NCT02155881|583121793|FG000|Overall Study|Withdrawal by Subject|0|||
161471513|NCT02155881|583121794|FG001|Overall Study|Withdrawal by Subject|2|||
161471514|NCT02155881|583121793|FG000|Overall Study|Inappropriately randomized|2|||
161471515|NCT02155881|583121794|FG001|Overall Study|Inappropriately randomized|2|||
161471516|NCT00961649|583121795|FG000|Overall Study|Adverse Event|4|||
161471517|NCT00961649|583121796|FG001|Overall Study|Adverse Event|0|||
161471518|NCT00961649|583121797|FG002|Overall Study|Adverse Event|0|||
161471519|NCT00961649|583121798|FG003|Overall Study|Adverse Event|2|||
161471520|NCT00961649|583121795|FG000|Overall Study|Inadequate control of IOP|0|||
161471521|NCT00961649|583121796|FG001|Overall Study|Inadequate control of IOP|0|||
161471522|NCT00961649|583121797|FG002|Overall Study|Inadequate control of IOP|0|||
161471523|NCT00961649|583121798|FG003|Overall Study|Inadequate control of IOP|1|||
161471524|NCT00961649|583121795|FG000|Overall Study|Patient has travel plans during holidays|0|||
161471525|NCT00961649|583121796|FG001|Overall Study|Patient has travel plans during holidays|0|||
161471526|NCT00961649|583121797|FG002|Overall Study|Patient has travel plans during holidays|1|||
161471527|NCT00961649|583121798|FG003|Overall Study|Patient has travel plans during holidays|0|||
161471528|NCT00961649|583121795|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
161471529|NCT00961649|583121796|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
161471530|NCT00961649|583121797|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
161471531|NCT00961649|583121798|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
161471532|NCT00961649|583121795|FG000|Overall Study|Study terminated by sponsor|4|||
161471533|NCT00961649|583121796|FG001|Overall Study|Study terminated by sponsor|4|||
161471534|NCT00961649|583121797|FG002|Overall Study|Study terminated by sponsor|4|||
161471535|NCT00961649|583121798|FG003|Overall Study|Study terminated by sponsor|1|||
161471536|NCT02711345|583121799|FG000|Overall Study|Adverse Event|0|||
161471537|NCT02711345|583121800|FG001|Overall Study|Adverse Event|0|||
161471538|NCT02711345|583121801|FG002|Overall Study|Adverse Event|0|||
161471539|NCT02711345|583121802|FG003|Overall Study|Adverse Event|1|||
161471540|NCT02711345|583121803|FG004|Overall Study|Adverse Event|1|||
161471541|NCT02711345|583121804|FG005|Overall Study|Adverse Event|2|||
161471542|NCT02711345|583121805|FG006|Overall Study|Adverse Event|1|||
161471543|NCT02711345|583121806|FG007|Overall Study|Adverse Event|0|||
161471544|NCT02711345|583121807|FG008|Overall Study|Adverse Event|0|||
161471545|NCT02711345|583121808|FG009|Overall Study|Adverse Event|2|||
161471546|NCT02711345|583121799|FG000|Overall Study|Physician Decision|0|||
161471547|NCT02711345|583121800|FG001|Overall Study|Physician Decision|0|||
161471548|NCT02711345|583121801|FG002|Overall Study|Physician Decision|1|||
161471549|NCT02711345|583121802|FG003|Overall Study|Physician Decision|0|||
161471550|NCT02711345|583121803|FG004|Overall Study|Physician Decision|0|||
161471551|NCT02711345|583121804|FG005|Overall Study|Physician Decision|0|||
161471552|NCT02711345|583121805|FG006|Overall Study|Physician Decision|0|||
161471553|NCT02711345|583121806|FG007|Overall Study|Physician Decision|0|||
161471554|NCT02711345|583121807|FG008|Overall Study|Physician Decision|1|||
161471555|NCT02711345|583121808|FG009|Overall Study|Physician Decision|0|||
161471556|NCT02711345|583121799|FG000|Overall Study|Progressive disease|1|||
161471557|NCT02711345|583121800|FG001|Overall Study|Progressive disease|3|||
161471558|NCT02711345|583121801|FG002|Overall Study|Progressive disease|5|||
161471559|NCT02711345|583121802|FG003|Overall Study|Progressive disease|3|||
161471560|NCT02711345|583121803|FG004|Overall Study|Progressive disease|7|||
161916173|NCT01134042|584742358|FG000|Overall Study|Lack of Efficacy|21|||
161916174|NCT01134042|584742359|FG001|Overall Study|Lack of Efficacy|6|||
161916175|NCT01134042|584742360|FG002|Overall Study|Lack of Efficacy|18|||
161916176|NCT01134042|584742358|FG000|Overall Study|Protocol Violation|5|||
161916177|NCT01134042|584742359|FG001|Overall Study|Protocol Violation|3|||
161916178|NCT01134042|584742360|FG002|Overall Study|Protocol Violation|5|||
161916179|NCT01134042|584742358|FG000|Overall Study|Lost to Follow-up|2|||
161916180|NCT01134042|584742359|FG001|Overall Study|Lost to Follow-up|0|||
161916181|NCT01134042|584742360|FG002|Overall Study|Lost to Follow-up|1|||
161916182|NCT01134042|584742358|FG000|Overall Study|Physician Decision|4|||
161916183|NCT01134042|584742359|FG001|Overall Study|Physician Decision|8|||
161916184|NCT01134042|584742360|FG002|Overall Study|Physician Decision|1|||
161916185|NCT01134042|584742358|FG000|Overall Study|Withdrawal by Subject|13|||
161916186|NCT01134042|584742359|FG001|Overall Study|Withdrawal by Subject|4|||
161916187|NCT01134042|584742360|FG002|Overall Study|Withdrawal by Subject|7|||
161916188|NCT03345004|584742361|FG000|Overall Study|Physician Decision|1|||
161916189|NCT03345004|584742362|FG001|Overall Study|Physician Decision|0|||
161916190|NCT03345004|584742361|FG000|Overall Study|Withdrawal by Subject|0|||
161916191|NCT03345004|584742362|FG001|Overall Study|Withdrawal by Subject|1|||
161916192|NCT01091259|584742367|FG000|Overall Study|Adverse Event|3|||
161916193|NCT01091259|584742367|FG000|Overall Study|Lack of Efficacy|2|||
161916194|NCT00984867|584742368|FG000|Overall Study|Adverse Event|3|||
161916195|NCT00984867|584742369|FG001|Overall Study|Adverse Event|7|||
161916196|NCT00984867|584742368|FG000|Overall Study|Death|1|||
161916197|NCT00984867|584742369|FG001|Overall Study|Death|0|||
161916198|NCT00984867|584742368|FG000|Overall Study|Withdrawal by Subject|13|||
161916199|NCT00984867|584742369|FG001|Overall Study|Withdrawal by Subject|4|||
161916200|NCT00984867|584742368|FG000|Overall Study|Lost to Follow-up|3|||
161916201|NCT00984867|584742369|FG001|Overall Study|Lost to Follow-up|4|||
161916202|NCT00984867|584742368|FG000|Overall Study|Poor/non-compliance|0|||
161916203|NCT00984867|584742369|FG001|Overall Study|Poor/non-compliance|1|||
161916204|NCT00984867|584742368|FG000|Overall Study|Subject no longer meets study criteria|1|||
161916205|NCT00984867|584742369|FG001|Overall Study|Subject no longer meets study criteria|1|||
161916206|NCT00984867|584742368|FG000|Overall Study|site closing|1|||
161916207|NCT00984867|584742369|FG001|Overall Study|site closing|0|||
161916208|NCT00984867|584742368|FG000|Overall Study|lack of efficacy and subject compliance|1|||
161916209|NCT00984867|584742369|FG001|Overall Study|lack of efficacy and subject compliance|0|||
161916210|NCT00671060|584742370|FG000|Overall Study|Protocol Violation|1|||
161916211|NCT00671060|584742371|FG001|Overall Study|Protocol Violation|0|||
161916212|NCT00671060|584742370|FG000|Overall Study|Physician Decision|0|||
161916213|NCT00671060|584742371|FG001|Overall Study|Physician Decision|1|||
161916214|NCT01541748|584742372|FG000|Overall Study|Lost to Follow-up|17|||
161916215|NCT01541748|584742372|FG000|Overall Study|Moved out of state|1|||
161916216|NCT01541748|584742372|FG000|Overall Study|Withdrawal by Subject|7|||
161916217|NCT01541748|584742372|FG000|Overall Study|Screen failure|5|||
161916218|NCT01541748|584742372|FG000|Overall Study|Did not receive study device|1|||
161916219|NCT00626639|584742380|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
161916220|NCT00626639|584742381|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
161916221|NCT01155141|584742382|FG000|Overall Study|Withdrawal by Subject|1|||
161916222|NCT01155141|584742382|FG000|Overall Study|Screen Failure|1|||
161916223|NCT03473197|584742383|FG000|Overall Study|Adverse Event|4|||
161916224|NCT03473197|584742383|FG000|Overall Study|Lost to Follow-up|1|||
161916225|NCT03473197|584742383|FG000|Overall Study|Withdrawal by Subject|5|||
161916226|NCT00785629|584742386|FG000|Overall Study|Adverse Event|2|||
161916227|NCT00785629|584742387|FG001|Overall Study|Adverse Event|1|||
161471561|NCT02711345|583121804|FG005|Overall Study|Progressive disease|2|||
161471562|NCT02711345|583121805|FG006|Overall Study|Progressive disease|8|||
161471563|NCT02711345|583121806|FG007|Overall Study|Progressive disease|4|||
161471564|NCT02711345|583121807|FG008|Overall Study|Progressive disease|5|||
161471565|NCT02711345|583121808|FG009|Overall Study|Progressive disease|6|||
161471566|NCT02711345|583121799|FG000|Overall Study|Subject/guardian decision|0|||
161471567|NCT02711345|583121800|FG001|Overall Study|Subject/guardian decision|0|||
161471568|NCT02711345|583121801|FG002|Overall Study|Subject/guardian decision|0|||
161471569|NCT02711345|583121802|FG003|Overall Study|Subject/guardian decision|0|||
161471570|NCT02711345|583121803|FG004|Overall Study|Subject/guardian decision|0|||
161471571|NCT02711345|583121804|FG005|Overall Study|Subject/guardian decision|2|||
161471572|NCT02711345|583121805|FG006|Overall Study|Subject/guardian decision|3|||
161471573|NCT02711345|583121806|FG007|Overall Study|Subject/guardian decision|1|||
161471574|NCT02711345|583121807|FG008|Overall Study|Subject/guardian decision|0|||
161471575|NCT02711345|583121808|FG009|Overall Study|Subject/guardian decision|4|||
161471576|NCT02711345|583121799|FG000|Overall Study|Death|1|||
161471577|NCT02711345|583121800|FG001|Overall Study|Death|0|||
161471578|NCT02711345|583121801|FG002|Overall Study|Death|0|||
161471579|NCT02711345|583121802|FG003|Overall Study|Death|0|||
161471580|NCT02711345|583121803|FG004|Overall Study|Death|0|||
161471581|NCT02711345|583121804|FG005|Overall Study|Death|0|||
161471582|NCT02711345|583121805|FG006|Overall Study|Death|0|||
161471583|NCT02711345|583121806|FG007|Overall Study|Death|1|||
161471584|NCT02711345|583121807|FG008|Overall Study|Death|0|||
161471585|NCT02711345|583121808|FG009|Overall Study|Death|0|||
161471586|NCT04357782|583121809|FG000|Overall Study|Discharged from hospital|1|||
161471587|NCT04357782|583121810|FG001|Overall Study|Discharged from hospital|0|||
161471588|NCT04357782|583121809|FG000|Overall Study|Death|0|||
161812662|NCT03673670|584357331|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161812663|NCT03673670|584357332|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
161471589|NCT04357782|583121810|FG001|Overall Study|Death|2|||
161471590|NCT01786148|583121811|FG000|Overall Study|Lost to Follow-up|21|||
161471591|NCT01786148|583121812|FG001|Overall Study|Lost to Follow-up|13|||
161471592|NCT01786148|583121811|FG000|Overall Study|Death|0|||
161471593|NCT01786148|583121812|FG001|Overall Study|Death|1|||
161471594|NCT01786148|583121811|FG000|Overall Study|Withdrawal by Subject|0|||
161471595|NCT01786148|583121812|FG001|Overall Study|Withdrawal by Subject|7|||
161471596|NCT01786148|583121811|FG000|Overall Study|Incarceration|1|||
161471597|NCT01786148|583121812|FG001|Overall Study|Incarceration|1|||
161471598|NCT03780543|583121814|FG000|Overall Study|Adverse Event|1|||
161471599|NCT03780543|583121815|FG001|Overall Study|Adverse Event|0|||
161471600|NCT03780543|583121816|FG002|Overall Study|Adverse Event|2|||
161471601|NCT03780543|583121814|FG000|Overall Study|Lost to Follow-up|2|||
161471602|NCT03780543|583121815|FG001|Overall Study|Lost to Follow-up|0|||
161471603|NCT03780543|583121816|FG002|Overall Study|Lost to Follow-up|1|||
161471604|NCT03780543|583121814|FG000|Overall Study|Study terminated by Sponsor|8|||
161471605|NCT03780543|583121815|FG001|Overall Study|Study terminated by Sponsor|7|||
161471606|NCT03780543|583121816|FG002|Overall Study|Study terminated by Sponsor|13|||
161471607|NCT03780543|583121814|FG000|Overall Study|Withdrawal by Subject|1|||
161471608|NCT03780543|583121815|FG001|Overall Study|Withdrawal by Subject|8|||
161471609|NCT03780543|583121816|FG002|Overall Study|Withdrawal by Subject|1|||
161471610|NCT03780543|583121814|FG000|Overall Study|Noncompliance with study drug|1|||
161471611|NCT03780543|583121815|FG001|Overall Study|Noncompliance with study drug|0|||
161471612|NCT03780543|583121816|FG002|Overall Study|Noncompliance with study drug|0|||
161471613|NCT01033851|583121817|FG000|Overall Study|Withdrawal by Subject|3|||
161471614|NCT01033851|583121818|FG001|Overall Study|Withdrawal by Subject|7|||
161471615|NCT00338104|583121819|FG000|Overall Study|Protocol Violation|2|||
161471616|NCT00338104|583121820|FG001|Overall Study|Protocol Violation|1|||
161471617|NCT00338104|583121821|FG002|Overall Study|Protocol Violation|3|||
161471618|NCT02362269|583121824|FG000|Overall Study|Moved|1|||
161471619|NCT02362269|583121825|FG001|Overall Study|Moved|0|||
161471620|NCT02362269|583121824|FG000|Overall Study|Lost to Follow-up|0|||
161471621|NCT02362269|583121825|FG001|Overall Study|Lost to Follow-up|6|||
161471622|NCT03841448|583121826|FG000|Double-blind Treatment (DBT) Period|Death|1|||
161471623|NCT03841448|583121827|FG001|Double-blind Treatment (DBT) Period|Death|1|||
161471624|NCT03841448|583121828|FG002|Double-blind Treatment (DBT) Period|Death|0|||
161471625|NCT03841448|583121829|FG003|Double-blind Treatment (DBT) Period|Death|0|||
161471626|NCT03841448|583121826|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
161471627|NCT03841448|583121827|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
161471628|NCT03841448|583121828|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
161471629|NCT03841448|583121829|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
161471630|NCT03841448|583121826|FG000|Open-Label Extension (OLE) Period|Death|0|||
161471631|NCT03841448|583121827|FG001|Open-Label Extension (OLE) Period|Death|0|||
161471632|NCT03841448|583121828|FG002|Open-Label Extension (OLE) Period|Death|0|||
161471633|NCT03841448|583121829|FG003|Open-Label Extension (OLE) Period|Death|1|||
161471634|NCT03841448|583121826|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
161471635|NCT03841448|583121827|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
161471636|NCT03841448|583121828|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
161471637|NCT03841448|583121829|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
161471638|NCT03841448|583121826|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
161471639|NCT03841448|583121827|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
161471640|NCT03841448|583121828|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
161471641|NCT03841448|583121829|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
161471642|NCT03841448|583121826|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
161471643|NCT03841448|583121827|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
161471644|NCT03841448|583121828|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
161471645|NCT03841448|583121829|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
161471646|NCT04068610|583121830|FG000|Overall Study|Death|4|||
161471647|NCT04068610|583121831|FG001|Overall Study|Death|8|||
161471648|NCT04068610|583121832|FG002|Overall Study|Death|13|||
161471649|NCT04068610|583121830|FG000|Overall Study|Lost to Follow-up|0|||
161471650|NCT04068610|583121831|FG001|Overall Study|Lost to Follow-up|2|||
161471651|NCT04068610|583121832|FG002|Overall Study|Lost to Follow-up|0|||
161471652|NCT04068610|583121830|FG000|Overall Study|Withdrawal by Subject|0|||
161471653|NCT04068610|583121831|FG001|Overall Study|Withdrawal by Subject|4|||
161471654|NCT04068610|583121832|FG002|Overall Study|Withdrawal by Subject|2|||
161471655|NCT04068610|583121830|FG000|Overall Study|Other|3|||
161471656|NCT04068610|583121831|FG001|Overall Study|Other|12|||
161471657|NCT04068610|583121832|FG002|Overall Study|Other|11|||
161471658|NCT00072176|583121833|FG000|Overall Study|Withdrawal by Subject|1|||
161471659|NCT00072176|583121834|FG001|Overall Study|Withdrawal by Subject|0|||
161812664|NCT03673670|584357333|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161471660|NCT00072176|583121833|FG000|Overall Study|Protocol Violation|0|||
161471661|NCT00072176|583121834|FG001|Overall Study|Protocol Violation|1|||
161471662|NCT02586064|583121835|FG000|Overall Study|Other Obligations|6|||
161471663|NCT02586064|583121836|FG001|Overall Study|Other Obligations|6|||
161471664|NCT02586064|583121835|FG000|Overall Study|Other|3|||
161471665|NCT02586064|583121836|FG001|Overall Study|Other|7|||
161471666|NCT02586064|583121835|FG000|Overall Study|Never Started|3|||
161471667|NCT02586064|583121836|FG001|Overall Study|Never Started|3|||
161471668|NCT02586064|583121835|FG000|Overall Study|Lost Interest|1|||
161471669|NCT02586064|583121836|FG001|Overall Study|Lost Interest|4|||
161471670|NCT02586064|583121835|FG000|Overall Study|Miscellaneous Life Issues|0|||
161471671|NCT02586064|583121836|FG001|Overall Study|Miscellaneous Life Issues|5|||
161471672|NCT02586064|583121835|FG000|Overall Study|Infrequent Attendance|2|||
161812665|NCT03673670|584357328|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812666|NCT03673670|584357329|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812667|NCT03673670|584357330|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
161471673|NCT02586064|583121836|FG001|Overall Study|Infrequent Attendance|1|||
161471674|NCT02586064|583121835|FG000|Overall Study|Timed Out|2|||
161471675|NCT02586064|583121836|FG001|Overall Study|Timed Out|0|||
161471676|NCT02586064|583121835|FG000|Overall Study|AUD relapse|0|||
161471677|NCT02586064|583121836|FG001|Overall Study|AUD relapse|2|||
161471678|NCT02586064|583121835|FG000|Overall Study|Legal Issue|1|||
161471679|NCT02586064|583121836|FG001|Overall Study|Legal Issue|0|||
161471680|NCT02158975|583121837|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
161471681|NCT04815031|583121840|FG000|Overall Study|No adverse event information (missing information)|33|||
161471682|NCT00484094|583121841|FG000|Overall Study|Discontinued|39|||
161471683|NCT00484094|583121841|FG000|Overall Study|Other|3|||
161471684|NCT02728596|583121842|FG000|Overall Study|Refusal unrelated to adverse event|3|||
161471685|NCT02728596|583121843|FG001|Overall Study|Refusal unrelated to adverse event|6|||
161471686|NCT02728596|583121844|FG002|Overall Study|Refusal unrelated to adverse event|7|||
161471687|NCT02728596|583121845|FG003|Overall Study|Refusal unrelated to adverse event|7|||
161471688|NCT02728596|583121842|FG000|Overall Study|Death|44|||
161471689|NCT02728596|583121843|FG001|Overall Study|Death|42|||
161471690|NCT02728596|583121844|FG002|Overall Study|Death|123|||
161471691|NCT02728596|583121845|FG003|Overall Study|Death|68|||
161471692|NCT00309985|583121849|FG000|Overall Study|Disease progression|12|||
161471693|NCT00309985|583121850|FG001|Overall Study|Disease progression|0|||
161471694|NCT00309985|583121849|FG000|Overall Study|Adverse Event|30|||
161471695|NCT00309985|583121850|FG001|Overall Study|Adverse Event|0|||
161471696|NCT00309985|583121849|FG000|Overall Study|Death|2|||
161471697|NCT00309985|583121850|FG001|Overall Study|Death|0|||
161471698|NCT00309985|583121849|FG000|Overall Study|Withdrawal by Subject|5|||
161471699|NCT00309985|583121850|FG001|Overall Study|Withdrawal by Subject|1|||
161471700|NCT00309985|583121849|FG000|Overall Study|Physician Decision|3|||
161471701|NCT00309985|583121850|FG001|Overall Study|Physician Decision|0|||
161471702|NCT00309985|583121849|FG000|Overall Study|Never started treatment|7|||
161471703|NCT00309985|583121850|FG001|Overall Study|Never started treatment|0|||
161471704|NCT00309985|583121849|FG000|Overall Study|Complicating disease|1|||
161471705|NCT00309985|583121850|FG001|Overall Study|Complicating disease|0|||
161471706|NCT00309985|583121849|FG000|Overall Study|Non-compliance|1|||
161916228|NCT00785629|584742388|FG002|Overall Study|Adverse Event|1|||
161916229|NCT00785629|584742389|FG003|Overall Study|Adverse Event|5|||
161916230|NCT00785629|584742386|FG000|Overall Study|Protocol Violation|1|||
161916231|NCT00785629|584742387|FG001|Overall Study|Protocol Violation|2|||
161916232|NCT00785629|584742388|FG002|Overall Study|Protocol Violation|4|||
161916233|NCT00785629|584742389|FG003|Overall Study|Protocol Violation|5|||
161916234|NCT00785629|584742386|FG000|Overall Study|administrative decision|5|||
161916235|NCT00785629|584742387|FG001|Overall Study|administrative decision|1|||
161916236|NCT00785629|584742388|FG002|Overall Study|administrative decision|3|||
161916237|NCT00785629|584742389|FG003|Overall Study|administrative decision|4|||
161916238|NCT00785629|584742386|FG000|Overall Study|Withdrawal by Subject|0|||
161916239|NCT00785629|584742387|FG001|Overall Study|Withdrawal by Subject|1|||
161916240|NCT00785629|584742388|FG002|Overall Study|Withdrawal by Subject|2|||
161916241|NCT00785629|584742389|FG003|Overall Study|Withdrawal by Subject|2|||
161916242|NCT02020941|584742390|FG000|Overall Study|Adverse Event|1|||
161916243|NCT02020941|584742390|FG000|Overall Study|Physician Decision|2|||
161916244|NCT02020941|584742390|FG000|Overall Study|Withdrawal by Subject|1|||
161916245|NCT02020941|584742390|FG000|Overall Study|Disease Progression|4|||
161916246|NCT02107898|584742393|FG000|Overall Study|Adverse Event|4|||
161916247|NCT02107898|584742394|FG001|Overall Study|Adverse Event|7|||
161916248|NCT02107898|584742393|FG000|Overall Study|Poor compliance to protocol|0|||
161916249|NCT02107898|584742394|FG001|Overall Study|Poor compliance to protocol|1|||
161916250|NCT02107898|584742393|FG000|Overall Study|Participant moved|0|||
161916251|NCT02107898|584742394|FG001|Overall Study|Participant moved|2|||
161916252|NCT02107898|584742393|FG000|Overall Study|Consent withdrawn by participant|2|||
161916253|NCT02107898|584742394|FG001|Overall Study|Consent withdrawn by participant|1|||
161916254|NCT02107898|584742393|FG000|Overall Study|Randomized but not treated|0|||
161471707|NCT00309985|583121850|FG001|Overall Study|Non-compliance|0|||
161471708|NCT00309985|583121849|FG000|Overall Study|Chemotherapy discontinued only|1|||
161471709|NCT00309985|583121850|FG001|Overall Study|Chemotherapy discontinued only|0|||
161471710|NCT03672643|583121851|FG000|Overall Study|Adverse Event|3|||
161471711|NCT03672643|583121851|FG000|Overall Study|Death|2|||
161471712|NCT03672643|583121851|FG000|Overall Study|Withdrawal by Subject|1|||
161916255|NCT02107898|584742394|FG001|Overall Study|Randomized but not treated|1|||
161916256|NCT00634504|584742395|FG000|Overall Study|Protocol Violation|1|||
161916257|NCT00634504|584742396|FG001|Overall Study|Protocol Violation|0|||
161916258|NCT03329989|584742397|FG000|Overall Study|Withdrawal by Subject|9|||
161916259|NCT03329989|584742397|FG000|Overall Study|Lost to Follow-up|8|||
161916260|NCT03329989|584742397|FG000|Overall Study|Adverse Event|5|||
161471713|NCT03672643|583121851|FG000|Overall Study|Progressive disease|11|||
161916261|NCT03329989|584742397|FG000|Overall Study|Protocol Violation|1|||
161916262|NCT01283386|584742398|FG000|Overall Study|Death|2|||
161471714|NCT03672643|583121851|FG000|Overall Study|Global deterioration of health status|1|||
161471715|NCT03672643|583121851|FG000|Overall Study|Refused further treatment|7|||
161916263|NCT01283386|584742399|FG001|Overall Study|Death|0|||
161471716|NCT03672643|583121851|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
161471717|NCT04102189|583121852|FG000|Overall Study|Withdrawal by Subject|1|||
161471718|NCT04102189|583121853|FG001|Overall Study|Withdrawal by Subject|2|||
161471719|NCT04102189|583121852|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161471720|NCT04102189|583121853|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161471721|NCT04102189|583121852|FG000|Overall Study|Lost to Follow-up|1|||
161471722|NCT04102189|583121853|FG001|Overall Study|Lost to Follow-up|0|||
161471723|NCT00316719|583123400|FG000|Overall Study|Adverse Event|0|||
161471724|NCT00316719|583123401|FG001|Overall Study|Adverse Event|6|||
161471725|NCT00316719|583123400|FG000|Overall Study|Consent withdrawn|2|||
161471726|NCT00316719|583123401|FG001|Overall Study|Consent withdrawn|0|||
161471727|NCT02008318|583123404|FG000|Overall Study|Adverse Event|4|||
161471728|NCT02008318|583123405|FG001|Overall Study|Adverse Event|0|||
161471729|NCT02008318|583123404|FG000|Overall Study|Physician Decision|2|||
161471730|NCT02008318|583123405|FG001|Overall Study|Physician Decision|0|||
161471731|NCT02008318|583123404|FG000|Overall Study|Progressive Disease|2|||
161471732|NCT02008318|583123405|FG001|Overall Study|Progressive Disease|0|||
161471733|NCT02008318|583123404|FG000|Overall Study|Protocol Violation|1|||
161471734|NCT02008318|583123405|FG001|Overall Study|Protocol Violation|1|||
161471735|NCT02008318|583123404|FG000|Overall Study|Withdrawal by Subject|3|||
161471736|NCT02008318|583123405|FG001|Overall Study|Withdrawal by Subject|0|||
161471737|NCT02281773|583123406|FG000|Overall Study|Adverse Event|6|||
161471738|NCT02281773|583123407|FG001|Overall Study|Adverse Event|1|||
161471739|NCT02281773|583123408|FG002|Overall Study|Adverse Event|4|||
161471740|NCT02281773|583123409|FG003|Overall Study|Adverse Event|8|||
161471741|NCT02281773|583123410|FG004|Overall Study|Adverse Event|9|||
161471742|NCT02281773|583123406|FG000|Overall Study|Protocol Violation|1|||
161471743|NCT02281773|583123407|FG001|Overall Study|Protocol Violation|0|||
161471744|NCT02281773|583123408|FG002|Overall Study|Protocol Violation|0|||
161471745|NCT02281773|583123409|FG003|Overall Study|Protocol Violation|2|||
161471746|NCT02281773|583123410|FG004|Overall Study|Protocol Violation|2|||
161471747|NCT02281773|583123406|FG000|Overall Study|Lost to Follow-up|2|||
161471748|NCT02281773|583123407|FG001|Overall Study|Lost to Follow-up|2|||
161471749|NCT02281773|583123408|FG002|Overall Study|Lost to Follow-up|6|||
161471750|NCT02281773|583123409|FG003|Overall Study|Lost to Follow-up|2|||
161471751|NCT02281773|583123410|FG004|Overall Study|Lost to Follow-up|10|||
161471752|NCT02281773|583123406|FG000|Overall Study|Withdrawal by Subject|2|||
161471753|NCT02281773|583123407|FG001|Overall Study|Withdrawal by Subject|8|||
161471754|NCT02281773|583123408|FG002|Overall Study|Withdrawal by Subject|6|||
161471755|NCT02281773|583123409|FG003|Overall Study|Withdrawal by Subject|6|||
161471756|NCT02281773|583123410|FG004|Overall Study|Withdrawal by Subject|8|||
161471757|NCT02281773|583123406|FG000|Overall Study|Other Reason|0|||
161471758|NCT02281773|583123407|FG001|Overall Study|Other Reason|4|||
161471759|NCT02281773|583123408|FG002|Overall Study|Other Reason|2|||
161471760|NCT02281773|583123409|FG003|Overall Study|Other Reason|3|||
161471761|NCT02281773|583123410|FG004|Overall Study|Other Reason|1|||
161471762|NCT00385762|583123411|FG000|Overall Study|Adverse Event|1|||
161471763|NCT00385762|583123411|FG000|Overall Study|Lost to Follow-up|1|||
161471764|NCT05439941|583123412|FG000|Overall Study|Lack of Efficacy|8|||
161471765|NCT05439941|583123413|FG001|Overall Study|Lack of Efficacy|5|||
161471766|NCT05439941|583123414|FG002|Overall Study|Lack of Efficacy|3|||
161471767|NCT05439941|583123412|FG000|Overall Study|Treatment Failure|0|||
161471768|NCT05439941|583123413|FG001|Overall Study|Treatment Failure|1|||
161471769|NCT05439941|583123414|FG002|Overall Study|Treatment Failure|0|||
161471770|NCT05439941|583123412|FG000|Overall Study|Adverse Event|1|||
161471771|NCT05439941|583123413|FG001|Overall Study|Adverse Event|3|||
161471772|NCT05439941|583123414|FG002|Overall Study|Adverse Event|0|||
161471773|NCT05439941|583123412|FG000|Overall Study|Adverse Event - Parent Study|1|||
161471774|NCT05439941|583123413|FG001|Overall Study|Adverse Event - Parent Study|0|||
161471775|NCT05439941|583123414|FG002|Overall Study|Adverse Event - Parent Study|0|||
161471776|NCT05439941|583123412|FG000|Overall Study|Pregnancy|1|||
161471777|NCT05439941|583123413|FG001|Overall Study|Pregnancy|0|||
161576243|NCT01765543|583496142|FG000|Overall Study|Withdrawal by Subject|2|||
161471778|NCT05439941|583123414|FG002|Overall Study|Pregnancy|0|||
161471779|NCT05439941|583123412|FG000|Overall Study|Withdrawal by Subject|9|||
161471780|NCT05439941|583123413|FG001|Overall Study|Withdrawal by Subject|6|||
161471781|NCT05439941|583123414|FG002|Overall Study|Withdrawal by Subject|10|||
161471782|NCT05439941|583123412|FG000|Overall Study|Non-Compliance|1|||
161812668|NCT03673670|584357331|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812669|NCT03673670|584357332|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
161812670|NCT03673670|584357333|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812671|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Adverse Event|8|||
161812672|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Adverse Event|15|||
161812673|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Adverse Event|25|||
161812674|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
161812675|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
161812676|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
161471783|NCT05439941|583123413|FG001|Overall Study|Non-Compliance|1|||
161471784|NCT05439941|583123414|FG002|Overall Study|Non-Compliance|1|||
161471785|NCT05439941|583123412|FG000|Overall Study|Lost to Follow-up|2|||
161471786|NCT05439941|583123413|FG001|Overall Study|Lost to Follow-up|2|||
161471787|NCT05439941|583123414|FG002|Overall Study|Lost to Follow-up|0|||
161471788|NCT05439941|583123412|FG000|Overall Study|Physician Decision|1|||
161812677|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
161812678|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
161812679|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
161812680|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
161812681|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
161812682|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
161812683|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161812684|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161812685|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
161812686|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
161812687|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
161812688|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
161812689|NCT02294786|584357339|FG000|Overall Study|Withdrawal by Subject|0|||
161812690|NCT02294786|584357340|FG001|Overall Study|Withdrawal by Subject|1|||
161812691|NCT02294786|584357339|FG000|Overall Study|Physician Decision|6|||
161812692|NCT02294786|584357340|FG001|Overall Study|Physician Decision|7|||
161812693|NCT02294786|584357339|FG000|Overall Study|Lost to Follow-up|1|||
161812694|NCT02294786|584357340|FG001|Overall Study|Lost to Follow-up|2|||
161812695|NCT02294786|584357339|FG000|Overall Study|Protocol Violation|1|||
161812696|NCT02294786|584357340|FG001|Overall Study|Protocol Violation|0|||
161812697|NCT02294786|584357339|FG000|Overall Study|Adverse Event|1|||
161812698|NCT02294786|584357340|FG001|Overall Study|Adverse Event|1|||
161812699|NCT02294786|584357339|FG000|Overall Study|Death|2|||
161812700|NCT02294786|584357340|FG001|Overall Study|Death|3|||
161812701|NCT03261167|584357341|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
161812702|NCT03261167|584357342|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
161812703|NCT03261167|584357341|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
161812704|NCT03261167|584357342|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
161812705|NCT03261167|584357341|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
161812706|NCT03261167|584357342|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
161812707|NCT03261167|584357341|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
161812708|NCT03261167|584357342|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
161812709|NCT03261167|584357341|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
161812710|NCT03261167|584357342|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
161812711|NCT03406156|584357349|FG000|Overall Study|Death|9|||
161812712|NCT03406156|584357350|FG001|Overall Study|Death|3|||
161812713|NCT03406156|584357349|FG000|Overall Study|Withdrawal by Subject|1|||
161812714|NCT03406156|584357350|FG001|Overall Study|Withdrawal by Subject|2|||
161812715|NCT03406156|584357349|FG000|Overall Study|COVID-19 infection|1|||
161812716|NCT03406156|584357350|FG001|Overall Study|COVID-19 infection|0|||
161812717|NCT03406156|584357349|FG000|Overall Study|Non-compliance with study procedures|1|||
161812718|NCT03406156|584357350|FG001|Overall Study|Non-compliance with study procedures|1|||
161812719|NCT03406156|584357349|FG000|Overall Study|Lost to Follow-up|0|||
161812720|NCT03406156|584357350|FG001|Overall Study|Lost to Follow-up|2|||
161812721|NCT03406156|584357349|FG000|Overall Study|Other, not specified|72|||
161812722|NCT03406156|584357350|FG001|Overall Study|Other, not specified|28|||
161812723|NCT05479058|584357353|FG000|Overall Study|Withdrawal by Subject|1|||
161812724|NCT05479058|584357354|FG001|Overall Study|Withdrawal by Subject|1|||
161812725|NCT05479058|584357353|FG000|Overall Study|Study terminated by sponsor|10|||
161812726|NCT05479058|584357354|FG001|Overall Study|Study terminated by sponsor|10|||
161812727|NCT05630885|584357355|FG000|Study Completion|Took prohibited medications|2|||
161812728|NCT05630885|584357356|FG001|Study Completion|Took prohibited medications|0|||
161812729|NCT05630885|584357355|FG000|Study Completion|Non-compliance with study drug|1|||
161812730|NCT05630885|584357356|FG001|Study Completion|Non-compliance with study drug|0|||
161812731|NCT05630885|584357355|FG000|Study Completion|Adverse Event|1|||
161812732|NCT05630885|584357356|FG001|Study Completion|Adverse Event|0|||
161812733|NCT05630885|584357355|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
161812734|NCT05630885|584357356|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
161471789|NCT05439941|583123413|FG001|Overall Study|Physician Decision|0|||
161668451|NCT00820027|583839774|FG002|Overall Study|Adverse Event|10|||
161668452|NCT00820027|583839775|FG003|Overall Study|Adverse Event|5|||
161668453|NCT00820027|583839772|FG000|Overall Study|Lack of Efficacy|2|||
161812735|NCT05630885|584357355|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
161812736|NCT05630885|584357356|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
161812737|NCT03419403|584357359|FG000|Overall Study|Withdrawal by Subject|5|||
161812738|NCT03419403|584357360|FG001|Overall Study|Withdrawal by Subject|2|||
161812739|NCT03419403|584357361|FG002|Overall Study|Withdrawal by Subject|5|||
161812740|NCT03419403|584357362|FG003|Overall Study|Withdrawal by Subject|1|||
161812741|NCT03419403|584357359|FG000|Overall Study|Progressive disease (per protocol)|0|||
161812742|NCT03419403|584357360|FG001|Overall Study|Progressive disease (per protocol)|2|||
161812743|NCT03419403|584357361|FG002|Overall Study|Progressive disease (per protocol)|2|||
161812744|NCT03419403|584357362|FG003|Overall Study|Progressive disease (per protocol)|0|||
161812745|NCT03419403|584357359|FG000|Overall Study|Other, not specified|6|||
161812746|NCT03419403|584357360|FG001|Overall Study|Other, not specified|4|||
161812747|NCT03419403|584357361|FG002|Overall Study|Other, not specified|5|||
161812748|NCT03419403|584357362|FG003|Overall Study|Other, not specified|1|||
161812749|NCT03419403|584357359|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
161812750|NCT03419403|584357360|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
161812751|NCT03419403|584357361|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
161812752|NCT03419403|584357362|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
161812753|NCT00505622|584357365|FG000|Overall Study|Adverse Event|5|||
161812754|NCT00505622|584357366|FG001|Overall Study|Adverse Event|6|||
161812755|NCT00505622|584357367|FG002|Overall Study|Adverse Event|4|||
161812756|NCT00505622|584357365|FG000|Overall Study|Protocol Violation|1|||
161812757|NCT00505622|584357366|FG001|Overall Study|Protocol Violation|1|||
161812758|NCT00505622|584357367|FG002|Overall Study|Protocol Violation|0|||
161812759|NCT00505622|584357365|FG000|Overall Study|Withdrawal by Subject|0|||
161812760|NCT00505622|584357366|FG001|Overall Study|Withdrawal by Subject|3|||
161812761|NCT00505622|584357367|FG002|Overall Study|Withdrawal by Subject|2|||
161812762|NCT00505622|584357365|FG000|Overall Study|Study termination by sponsor|115|||
161812763|NCT00505622|584357366|FG001|Overall Study|Study termination by sponsor|98|||
161812764|NCT00505622|584357367|FG002|Overall Study|Study termination by sponsor|90|||
161812765|NCT03084471|584357370|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
161812766|NCT03084471|584357370|FG000|Overall Study|Condition under investigation worsened|84|||
161812767|NCT03084471|584357370|FG000|Overall Study|Lack of therapeutic response|2|||
161812768|NCT03084471|584357370|FG000|Overall Study|Protocol Violation|1|||
161812769|NCT03084471|584357370|FG000|Overall Study|Adverse Event|73|||
161812770|NCT03084471|584357370|FG000|Overall Study|Withdrawal by Subject|12|||
161812771|NCT03084471|584357370|FG000|Overall Study|Disease relapse|181|||
161812772|NCT03084471|584357370|FG000|Overall Study|Subjective disease progression|359|||
161812773|NCT03084471|584357370|FG000|Overall Study|Other (as recorded)|33|||
161812774|NCT03084471|584357370|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
161812775|NCT02414152|584357375|FG000|Overall Study|Withdrawal by Subject|1|||
161812776|NCT02414152|584357375|FG000|Overall Study|Lack of Efficacy|1|||
161812777|NCT01757392|584357376|FG000|Overall Study|Withdrawal by Subject|1|||
161812778|NCT01757392|584357376|FG000|Overall Study|Screen Fail|3|||
161812779|NCT00841698|584357383|FG000|First Intervention|Withdrawal by Subject|1|||
161812780|NCT00841698|584357384|FG001|First Intervention|Withdrawal by Subject|0|||
161812781|NCT04078022|584357389|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
161812782|NCT04078022|584357390|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
161812783|NCT01250912|584357391|FG000|Overall Study|Lost to Follow-up|1|||
161812784|NCT01929863|584357394|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
161812785|NCT01929863|584357395|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
161812786|NCT01929863|584357394|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
161812787|NCT01929863|584357395|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
161812788|NCT01929863|584357394|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
161812789|NCT01929863|584357395|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
161812790|NCT02152163|584357396|FG000|Overall Study|Physician Decision|12|||
161812791|NCT02152163|584357397|FG001|Overall Study|Physician Decision|13|||
161812792|NCT00730691|584357398|FG000|Overall Study|Adverse Event|4|||
161812793|NCT00730691|584357399|FG001|Overall Study|Adverse Event|8|||
161812794|NCT00730691|584357400|FG002|Overall Study|Adverse Event|11|||
161812795|NCT00730691|584357401|FG003|Overall Study|Adverse Event|11|||
161812796|NCT00730691|584357402|FG004|Overall Study|Adverse Event|23|||
161812797|NCT00730691|584357398|FG000|Overall Study|Lack of Efficacy|4|||
161812798|NCT00730691|584357399|FG001|Overall Study|Lack of Efficacy|4|||
161812799|NCT00730691|584357400|FG002|Overall Study|Lack of Efficacy|2|||
161812800|NCT00730691|584357401|FG003|Overall Study|Lack of Efficacy|1|||
161812801|NCT00730691|584357402|FG004|Overall Study|Lack of Efficacy|1|||
161812802|NCT00730691|584357398|FG000|Overall Study|Non-compliance with Study Drug|6|||
161471790|NCT05439941|583123414|FG002|Overall Study|Physician Decision|0|||
161471791|NCT05439941|583123412|FG000|Overall Study|Trial Termination by Sponsor|78|||
161471792|NCT05439941|583123413|FG001|Overall Study|Trial Termination by Sponsor|83|||
161471793|NCT05439941|583123414|FG002|Overall Study|Trial Termination by Sponsor|65|||
161471794|NCT05439941|583123412|FG000|Overall Study|Other than Reasons Listed|2|||
161471795|NCT05439941|583123413|FG001|Overall Study|Other than Reasons Listed|1|||
161471796|NCT05439941|583123414|FG002|Overall Study|Other than Reasons Listed|0|||
161471797|NCT00573183|583123415|FG000|Overall Study|Lost to Follow-up|52|||
161471798|NCT00573183|583123416|FG001|Overall Study|Lost to Follow-up|50|||
161471799|NCT00573183|583123415|FG000|Overall Study|Withdrawal by Subject|8|||
161471800|NCT00573183|583123416|FG001|Overall Study|Withdrawal by Subject|2|||
161471801|NCT00573183|583123415|FG000|Overall Study|Death|0|||
161471802|NCT00573183|583123416|FG001|Overall Study|Death|1|||
161471803|NCT00573183|583123415|FG000|Overall Study|Adverse Event|2|||
161471804|NCT00573183|583123416|FG001|Overall Study|Adverse Event|0|||
161471805|NCT00573183|583123415|FG000|Overall Study|Incarceration|5|||
161471806|NCT00573183|583123416|FG001|Overall Study|Incarceration|8|||
161471807|NCT00573183|583123415|FG000|Overall Study|Other|5|||
161471808|NCT00573183|583123416|FG001|Overall Study|Other|2|||
161471809|NCT02336373|583123419|FG000|Overall Study|Protocol closed early|4|||
161471810|NCT02336373|583123419|FG000|Overall Study|Physician Decision|14|||
161471811|NCT04798781|583123424|FG000|Overall Study|Withdrawal by Subject|1|||
161471812|NCT00615108|583123427|FG000|Overall Study|Adverse Event|122|||
161812803|NCT00730691|584357399|FG001|Overall Study|Non-compliance with Study Drug|1|||
161812804|NCT00730691|584357400|FG002|Overall Study|Non-compliance with Study Drug|6|||
161471813|NCT00615108|583123427|FG000|Overall Study|Other|370|||
161471814|NCT00615108|583123427|FG000|Overall Study|Lost to Follow-up|15|||
161471815|NCT00676338|583123428|FG000|Overall Study|Adverse Event|6|||
161471816|NCT00676338|583123429|FG001|Overall Study|Adverse Event|6|||
161471817|NCT00676338|583123430|FG002|Overall Study|Adverse Event|5|||
161471818|NCT00676338|583123431|FG003|Overall Study|Adverse Event|1|||
161471819|NCT00676338|583123428|FG000|Overall Study|Lost to Follow-up|4|||
161471820|NCT00676338|583123429|FG001|Overall Study|Lost to Follow-up|1|||
161471821|NCT00676338|583123430|FG002|Overall Study|Lost to Follow-up|3|||
161471822|NCT00676338|583123431|FG003|Overall Study|Lost to Follow-up|4|||
161471823|NCT00676338|583123428|FG000|Overall Study|Physician Decision|3|||
161471824|NCT00676338|583123429|FG001|Overall Study|Physician Decision|3|||
161471825|NCT00676338|583123430|FG002|Overall Study|Physician Decision|2|||
161471826|NCT00676338|583123431|FG003|Overall Study|Physician Decision|3|||
161471827|NCT00676338|583123428|FG000|Overall Study|Protocol Violation|5|||
161471828|NCT00676338|583123429|FG001|Overall Study|Protocol Violation|9|||
161471829|NCT00676338|583123430|FG002|Overall Study|Protocol Violation|2|||
161471830|NCT00676338|583123431|FG003|Overall Study|Protocol Violation|5|||
161471831|NCT00676338|583123428|FG000|Overall Study|Withdrawal by Subject|17|||
161471832|NCT00676338|583123429|FG001|Overall Study|Withdrawal by Subject|9|||
161471833|NCT00676338|583123430|FG002|Overall Study|Withdrawal by Subject|12|||
161471834|NCT00676338|583123431|FG003|Overall Study|Withdrawal by Subject|6|||
161471835|NCT00676338|583123428|FG000|Overall Study|Entry Criteria Not Met|0|||
161471836|NCT00676338|583123429|FG001|Overall Study|Entry Criteria Not Met|2|||
161471837|NCT00676338|583123430|FG002|Overall Study|Entry Criteria Not Met|1|||
161471838|NCT00676338|583123431|FG003|Overall Study|Entry Criteria Not Met|1|||
161471839|NCT00676338|583123428|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
161471840|NCT00676338|583123429|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
161471841|NCT00676338|583123430|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
161471842|NCT00676338|583123431|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
161471843|NCT02122458|583123432|FG000|Overall Study|Withdrawal by Subject|0|||
161812805|NCT00730691|584357401|FG003|Overall Study|Non-compliance with Study Drug|3|||
161812806|NCT00730691|584357402|FG004|Overall Study|Non-compliance with Study Drug|3|||
161812807|NCT00730691|584357398|FG000|Overall Study|Protocol Deviations|3|||
161812808|NCT00730691|584357399|FG001|Overall Study|Protocol Deviations|5|||
161812809|NCT00730691|584357400|FG002|Overall Study|Protocol Deviations|3|||
161812810|NCT00730691|584357401|FG003|Overall Study|Protocol Deviations|7|||
161471844|NCT02122458|583123433|FG001|Overall Study|Withdrawal by Subject|0|||
161471845|NCT02122458|583123434|FG002|Overall Study|Withdrawal by Subject|0|||
161471846|NCT02122458|583123435|FG003|Overall Study|Withdrawal by Subject|4|||
161471847|NCT02122458|583123436|FG004|Overall Study|Withdrawal by Subject|4|||
161471848|NCT02122458|583123437|FG005|Overall Study|Withdrawal by Subject|4|||
161471849|NCT02122458|583123438|FG006|Overall Study|Withdrawal by Subject|0|||
161471850|NCT02122458|583123432|FG000|Overall Study|Lost to Follow-up|1|||
161471851|NCT02122458|583123433|FG001|Overall Study|Lost to Follow-up|3|||
161471852|NCT02122458|583123434|FG002|Overall Study|Lost to Follow-up|0|||
161471853|NCT02122458|583123435|FG003|Overall Study|Lost to Follow-up|7|||
161471854|NCT02122458|583123436|FG004|Overall Study|Lost to Follow-up|5|||
161471855|NCT02122458|583123437|FG005|Overall Study|Lost to Follow-up|15|||
161812811|NCT00730691|584357402|FG004|Overall Study|Protocol Deviations|5|||
161812812|NCT00730691|584357398|FG000|Overall Study|Withdrawal of Consent|7|||
161812813|NCT00730691|584357399|FG001|Overall Study|Withdrawal of Consent|9|||
161812814|NCT00730691|584357400|FG002|Overall Study|Withdrawal of Consent|3|||
161812815|NCT00730691|584357401|FG003|Overall Study|Withdrawal of Consent|6|||
161812816|NCT00730691|584357402|FG004|Overall Study|Withdrawal of Consent|3|||
161812817|NCT00730691|584357398|FG000|Overall Study|Lost to Follow-up|11|||
161812818|NCT00730691|584357399|FG001|Overall Study|Lost to Follow-up|8|||
161812819|NCT00730691|584357400|FG002|Overall Study|Lost to Follow-up|13|||
161812820|NCT00730691|584357401|FG003|Overall Study|Lost to Follow-up|15|||
161812821|NCT00730691|584357402|FG004|Overall Study|Lost to Follow-up|13|||
161812822|NCT00730691|584357398|FG000|Overall Study|Other|1|||
161812823|NCT00730691|584357399|FG001|Overall Study|Other|1|||
161812824|NCT00730691|584357400|FG002|Overall Study|Other|1|||
161812825|NCT00730691|584357401|FG003|Overall Study|Other|2|||
161812826|NCT00730691|584357402|FG004|Overall Study|Other|2|||
161812827|NCT04825275|584359745|FG000|Overall Study|Withdrawal by Subject|1|||
161812828|NCT04825275|584359746|FG001|Overall Study|Withdrawal by Subject|0|||
161812829|NCT05710718|584359752|FG000|Overall Study|Withdrawal by Subject|5|||
161812830|NCT05710718|584359753|FG001|Overall Study|Withdrawal by Subject|1|||
161812831|NCT05710718|584359752|FG000|Overall Study|Lost to Follow-up|0|||
161812832|NCT05710718|584359753|FG001|Overall Study|Lost to Follow-up|1|||
161812833|NCT05710718|584359752|FG000|Overall Study|Death|0|||
161812834|NCT05710718|584359753|FG001|Overall Study|Death|1|||
161812835|NCT04372238|584359754|FG000|Overall Study|Duplicate|3|||
161812836|NCT04372238|584359755|FG001|Overall Study|Duplicate|3|||
161812837|NCT04372238|584359754|FG000|Overall Study|Did not consent for data linkage|6|||
161812838|NCT04372238|584359755|FG001|Overall Study|Did not consent for data linkage|10|||
161812839|NCT02591420|584359756|FG000|Overall Study|Lost to Follow-up|0|||
161812840|NCT02591420|584359757|FG001|Overall Study|Lost to Follow-up|1|||
161812841|NCT02591420|584359758|FG002|Overall Study|Lost to Follow-up|2|||
161812842|NCT04241458|584359759|FG000|Overall Study|Withdrawal by Subject|0|||
161812843|NCT04241458|584359760|FG001|Overall Study|Withdrawal by Subject|0|||
161812844|NCT04241458|584359761|FG002|Overall Study|Withdrawal by Subject|0|||
161812845|NCT04241458|584359762|FG003|Overall Study|Withdrawal by Subject|0|||
161812846|NCT04241458|584359763|FG004|Overall Study|Withdrawal by Subject|1|||
161812847|NCT05005442|584359764|FG000|Overall Study|Death|14|||
161812848|NCT05005442|584359765|FG001|Overall Study|Death|10|||
161812849|NCT05005442|584359766|FG002|Overall Study|Death|8|||
161812850|NCT05005442|584359767|FG003|Overall Study|Death|22|||
161812851|NCT05005442|584359768|FG004|Overall Study|Death|13|||
161812852|NCT05005442|584359769|FG005|Overall Study|Death|15|||
161812853|NCT05005442|584359764|FG000|Overall Study|Lost to Follow-up|0|||
161812854|NCT05005442|584359765|FG001|Overall Study|Lost to Follow-up|2|||
161812855|NCT05005442|584359766|FG002|Overall Study|Lost to Follow-up|0|||
161812856|NCT05005442|584359767|FG003|Overall Study|Lost to Follow-up|0|||
161812857|NCT05005442|584359768|FG004|Overall Study|Lost to Follow-up|1|||
161812858|NCT05005442|584359769|FG005|Overall Study|Lost to Follow-up|0|||
161812859|NCT05005442|584359764|FG000|Overall Study|Physician Decision|0|||
161812860|NCT05005442|584359765|FG001|Overall Study|Physician Decision|0|||
161812861|NCT05005442|584359766|FG002|Overall Study|Physician Decision|1|||
161812862|NCT05005442|584359767|FG003|Overall Study|Physician Decision|0|||
161812863|NCT05005442|584359768|FG004|Overall Study|Physician Decision|2|||
161812864|NCT05005442|584359769|FG005|Overall Study|Physician Decision|0|||
161812865|NCT05005442|584359764|FG000|Overall Study|Sponsor decision|26|||
161812866|NCT05005442|584359765|FG001|Overall Study|Sponsor decision|26|||
161812867|NCT05005442|584359766|FG002|Overall Study|Sponsor decision|10|||
161812868|NCT05005442|584359767|FG003|Overall Study|Sponsor decision|5|||
161812869|NCT05005442|584359768|FG004|Overall Study|Sponsor decision|9|||
161812870|NCT05005442|584359769|FG005|Overall Study|Sponsor decision|12|||
161812871|NCT05005442|584359764|FG000|Overall Study|Withdrawal by Subject|2|||
161812872|NCT05005442|584359765|FG001|Overall Study|Withdrawal by Subject|2|||
161812873|NCT05005442|584359766|FG002|Overall Study|Withdrawal by Subject|1|||
161812874|NCT05005442|584359767|FG003|Overall Study|Withdrawal by Subject|3|||
161812875|NCT05005442|584359768|FG004|Overall Study|Withdrawal by Subject|0|||
161812876|NCT05005442|584359769|FG005|Overall Study|Withdrawal by Subject|5|||
161471856|NCT02122458|583123438|FG006|Overall Study|Lost to Follow-up|1|||
161471857|NCT02122458|583123432|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
161471858|NCT02122458|583123433|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
161471859|NCT02122458|583123434|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
161471860|NCT02122458|583123435|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
161471861|NCT02122458|583123436|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
161471862|NCT02122458|583123437|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
161471863|NCT02122458|583123438|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
161471864|NCT02122458|583123432|FG000|Overall Study|Adverse Event|1|||
161471865|NCT02122458|583123433|FG001|Overall Study|Adverse Event|0|||
161471866|NCT02122458|583123434|FG002|Overall Study|Adverse Event|0|||
161471867|NCT02122458|583123435|FG003|Overall Study|Adverse Event|0|||
161471868|NCT02122458|583123436|FG004|Overall Study|Adverse Event|0|||
161471869|NCT02122458|583123437|FG005|Overall Study|Adverse Event|0|||
161471870|NCT02122458|583123438|FG006|Overall Study|Adverse Event|0|||
161471871|NCT02122458|583123432|FG000|Overall Study|Experimental Error|0|||
161471872|NCT02122458|583123433|FG001|Overall Study|Experimental Error|0|||
161471873|NCT02122458|583123434|FG002|Overall Study|Experimental Error|0|||
161471874|NCT02122458|583123435|FG003|Overall Study|Experimental Error|0|||
161471875|NCT02122458|583123436|FG004|Overall Study|Experimental Error|3|||
161471876|NCT02122458|583123437|FG005|Overall Study|Experimental Error|0|||
161471877|NCT02122458|583123438|FG006|Overall Study|Experimental Error|0|||
161471878|NCT02122458|583123432|FG000|Overall Study|Deployed or Moved|0|||
161471879|NCT02122458|583123433|FG001|Overall Study|Deployed or Moved|0|||
161471880|NCT02122458|583123434|FG002|Overall Study|Deployed or Moved|0|||
161471881|NCT02122458|583123435|FG003|Overall Study|Deployed or Moved|0|||
161471882|NCT02122458|583123436|FG004|Overall Study|Deployed or Moved|1|||
161471883|NCT02122458|583123437|FG005|Overall Study|Deployed or Moved|0|||
161471884|NCT02122458|583123438|FG006|Overall Study|Deployed or Moved|0|||
161471885|NCT02122458|583123432|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
161471886|NCT02122458|583123433|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
161471887|NCT02122458|583123434|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
161471888|NCT02122458|583123435|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
161471889|NCT02122458|583123436|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
161471890|NCT02122458|583123437|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
161471891|NCT02122458|583123438|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
161471892|NCT02122458|583123432|FG000|Overall Study|Noncompliance|0|||
161471893|NCT02122458|583123433|FG001|Overall Study|Noncompliance|1|||
161471894|NCT02122458|583123434|FG002|Overall Study|Noncompliance|0|||
161471895|NCT02122458|583123435|FG003|Overall Study|Noncompliance|0|||
161471896|NCT02122458|583123436|FG004|Overall Study|Noncompliance|0|||
161471897|NCT02122458|583123437|FG005|Overall Study|Noncompliance|0|||
161471898|NCT02122458|583123438|FG006|Overall Study|Noncompliance|0|||
161471899|NCT00412542|583123439|FG000|Overall Study|Withdrawal by Subject|0|||
161471900|NCT00412542|583123440|FG001|Overall Study|Withdrawal by Subject|2|||
161471901|NCT00412542|583123439|FG000|Overall Study|Not Eligible|0|||
161916264|NCT01283386|584742398|FG000|Overall Study|Withdrawal by Subject|2|||
161916265|NCT01283386|584742399|FG001|Overall Study|Withdrawal by Subject|1|||
161916266|NCT01283386|584742398|FG000|Overall Study|Relapse of underlying disease|1|||
161916267|NCT01283386|584742399|FG001|Overall Study|Relapse of underlying disease|3|||
161916268|NCT01283386|584742398|FG000|Overall Study|Progression of underlying disease|2|||
161916269|NCT01283386|584742399|FG001|Overall Study|Progression of underlying disease|7|||
161916270|NCT01283386|584742398|FG000|Overall Study|Reason not specified|1|||
161916271|NCT01283386|584742399|FG001|Overall Study|Reason not specified|0|||
161916272|NCT01283386|584742398|FG000|Overall Study|Protocol Violation|0|||
161916273|NCT01283386|584742399|FG001|Overall Study|Protocol Violation|1|||
161916274|NCT02469857|584742400|FG000|Overall Study|Death|24|||
161916275|NCT02469857|584742401|FG001|Overall Study|Death|29|||
161916276|NCT02469857|584742400|FG000|Overall Study|Discontinuation|1|||
161916277|NCT02469857|584742401|FG001|Overall Study|Discontinuation|3|||
161916278|NCT00937950|584742402|FG000|Overall Study|Withdrawal by Subject|23|||
161916279|NCT00937950|584742402|FG000|Overall Study|Migrated/moved from study area|27|||
161916280|NCT00937950|584742402|FG000|Overall Study|Lost to Follow-up|144|||
161916281|NCT00937950|584742402|FG000|Overall Study|Missing confirmed|4|||
161916282|NCT00937950|584742402|FG000|Overall Study|Other|18|||
161916283|NCT01137786|584742405|FG000|Overall Study|Lost to Follow-up|0|||
161916284|NCT01137786|584742406|FG001|Overall Study|Lost to Follow-up|2|||
161916285|NCT01137786|584742405|FG000|Overall Study|Withdrawal by Subject|1|||
161916286|NCT01137786|584742406|FG001|Overall Study|Withdrawal by Subject|1|||
161916287|NCT01531153|584742409|FG000|Overall Study|Withdrawal by Subject|10|||
161916288|NCT01531153|584742410|FG001|Overall Study|Withdrawal by Subject|9|||
161916289|NCT01531153|584742411|FG002|Overall Study|Withdrawal by Subject|15|||
161471902|NCT00412542|583123440|FG001|Overall Study|Not Eligible|1|||
161471903|NCT02833350|583123441|FG000|Overall Study|Adverse Event|0|||
161471904|NCT02833350|583123442|FG001|Overall Study|Adverse Event|3|||
161471905|NCT02833350|583123443|FG002|Overall Study|Adverse Event|4|||
161471906|NCT02833350|583123444|FG003|Overall Study|Adverse Event|4|||
161471907|NCT02833350|583123445|FG004|Overall Study|Adverse Event|1|||
161471908|NCT02833350|583123446|FG005|Overall Study|Adverse Event|0|||
161471909|NCT02833350|583123447|FG006|Overall Study|Adverse Event|1|||
161471910|NCT02833350|583123441|FG000|Overall Study|Death|0|||
161471911|NCT02833350|583123442|FG001|Overall Study|Death|0|||
161471912|NCT02833350|583123443|FG002|Overall Study|Death|1|||
161471913|NCT02833350|583123444|FG003|Overall Study|Death|0|||
161471914|NCT02833350|583123445|FG004|Overall Study|Death|0|||
161471915|NCT02833350|583123446|FG005|Overall Study|Death|0|||
161471916|NCT02833350|583123447|FG006|Overall Study|Death|0|||
161471917|NCT02833350|583123441|FG000|Overall Study|Lack of Efficacy|0|||
161471918|NCT02833350|583123442|FG001|Overall Study|Lack of Efficacy|2|||
161471919|NCT02833350|583123443|FG002|Overall Study|Lack of Efficacy|1|||
161471920|NCT02833350|583123444|FG003|Overall Study|Lack of Efficacy|4|||
161471921|NCT02833350|583123445|FG004|Overall Study|Lack of Efficacy|0|||
161471922|NCT02833350|583123446|FG005|Overall Study|Lack of Efficacy|1|||
161471923|NCT02833350|583123447|FG006|Overall Study|Lack of Efficacy|1|||
161471924|NCT02833350|583123441|FG000|Overall Study|Lost to Follow-up|0|||
161471925|NCT02833350|583123442|FG001|Overall Study|Lost to Follow-up|1|||
161471926|NCT02833350|583123443|FG002|Overall Study|Lost to Follow-up|0|||
161471927|NCT02833350|583123444|FG003|Overall Study|Lost to Follow-up|0|||
161471928|NCT02833350|583123445|FG004|Overall Study|Lost to Follow-up|0|||
161471929|NCT02833350|583123446|FG005|Overall Study|Lost to Follow-up|0|||
161471930|NCT02833350|583123447|FG006|Overall Study|Lost to Follow-up|1|||
161471931|NCT02833350|583123441|FG000|Overall Study|Withdrawal by Subject|3|||
161471932|NCT02833350|583123442|FG001|Overall Study|Withdrawal by Subject|3|||
161471933|NCT02833350|583123443|FG002|Overall Study|Withdrawal by Subject|2|||
161471934|NCT02833350|583123444|FG003|Overall Study|Withdrawal by Subject|0|||
161471935|NCT02833350|583123445|FG004|Overall Study|Withdrawal by Subject|2|||
161471936|NCT02833350|583123446|FG005|Overall Study|Withdrawal by Subject|0|||
161471937|NCT02833350|583123447|FG006|Overall Study|Withdrawal by Subject|2|||
161471938|NCT00075218|583123448|FG000|Double-Blind Treatment|Adverse Event|23|||
161471939|NCT00075218|583123449|FG001|Double-Blind Treatment|Adverse Event|4|||
161471940|NCT00075218|583123450|FG002|Double-Blind Treatment|Adverse Event|0|||
161471941|NCT00075218|583123448|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
161471942|NCT00075218|583123449|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
161471943|NCT00075218|583123450|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
161471944|NCT00075218|583123448|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
161471945|NCT00075218|583123449|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
161471946|NCT00075218|583123450|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
161471947|NCT00075218|583123448|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
161471948|NCT00075218|583123449|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
161471949|NCT00075218|583123450|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
161471950|NCT00075218|583123448|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
161471951|NCT00075218|583123449|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
161471952|NCT00075218|583123450|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
161471953|NCT00075218|583123448|FG000|Double-Blind Treatment|No study medication taken|2|||
161471954|NCT00075218|583123449|FG001|Double-Blind Treatment|No study medication taken|0|||
161471955|NCT00075218|583123450|FG002|Double-Blind Treatment|No study medication taken|0|||
161471956|NCT00075218|583123448|FG000|Open-Label Treatment|Lack of Efficacy|0|||
161471957|NCT00075218|583123449|FG001|Open-Label Treatment|Lack of Efficacy|0|||
161471958|NCT00075218|583123450|FG002|Open-Label Treatment|Lack of Efficacy|174|||
161471959|NCT00075218|583123448|FG000|Open-Label Treatment|Adverse Event|0|||
161471960|NCT00075218|583123449|FG001|Open-Label Treatment|Adverse Event|0|||
161471961|NCT00075218|583123450|FG002|Open-Label Treatment|Adverse Event|51|||
161471962|NCT00075218|583123448|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
161471963|NCT00075218|583123449|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161471964|NCT00075218|583123450|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
161471965|NCT00075218|583123448|FG000|Open-Label Treatment|Decision of Sponsor|0|||
161471966|NCT00075218|583123449|FG001|Open-Label Treatment|Decision of Sponsor|0|||
161471967|NCT00075218|583123450|FG002|Open-Label Treatment|Decision of Sponsor|8|||
161812877|NCT05005442|584359764|FG000|Overall Study|Site terminated by sponsor|0|||
161812878|NCT05005442|584359765|FG001|Overall Study|Site terminated by sponsor|2|||
161812879|NCT05005442|584359766|FG002|Overall Study|Site terminated by sponsor|0|||
161471968|NCT00075218|583123448|FG000|Open-Label Treatment|Protocol Violation|0|||
161471969|NCT00075218|583123449|FG001|Open-Label Treatment|Protocol Violation|0|||
161471970|NCT00075218|583123450|FG002|Open-Label Treatment|Protocol Violation|1|||
161471971|NCT00075218|583123448|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
161471972|NCT00075218|583123449|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
161471973|NCT00075218|583123450|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
161471974|NCT03643575|583123451|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
161471975|NCT03643575|583123452|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
161471976|NCT03643575|583123453|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
161471977|NCT03643575|583123454|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
161471978|NCT03643575|583123455|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
161471979|NCT03643575|583123456|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
161471980|NCT03643575|583123451|FG000|Washout: 7 Days|Adverse Event|1|||
161471981|NCT03643575|583123452|FG001|Washout: 7 Days|Adverse Event|0|||
161471982|NCT03643575|583123453|FG002|Washout: 7 Days|Adverse Event|0|||
161471983|NCT03643575|583123454|FG003|Washout: 7 Days|Adverse Event|0|||
161471984|NCT03643575|583123455|FG004|Washout: 7 Days|Adverse Event|0|||
161471985|NCT03643575|583123456|FG005|Washout: 7 Days|Adverse Event|0|||
161471986|NCT03643575|583123451|FG000|Washout: 7 Days|Non compliance check in|0|||
161471987|NCT03643575|583123452|FG001|Washout: 7 Days|Non compliance check in|1|||
161471988|NCT03643575|583123453|FG002|Washout: 7 Days|Non compliance check in|0|||
161471989|NCT03643575|583123454|FG003|Washout: 7 Days|Non compliance check in|0|||
161471990|NCT03643575|583123455|FG004|Washout: 7 Days|Non compliance check in|0|||
161471991|NCT03643575|583123456|FG005|Washout: 7 Days|Non compliance check in|0|||
161471992|NCT00131508|583123457|FG000|Overall Study|Disease progression|0|||
161471993|NCT00131508|583123458|FG001|Overall Study|Disease progression|2|||
161471994|NCT00131508|583123457|FG000|Overall Study|Non-Compliance|2|||
161471995|NCT00131508|583123458|FG001|Overall Study|Non-Compliance|4|||
161471996|NCT00131508|583123457|FG000|Overall Study|Withdrawal by Subject|1|||
161471997|NCT00131508|583123458|FG001|Overall Study|Withdrawal by Subject|2|||
161471998|NCT00875979|583123459|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
161471999|NCT00875979|583123460|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
161472000|NCT00875979|583123459|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
161472001|NCT00875979|583123460|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
161472002|NCT00875979|583123459|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
161472003|NCT00875979|583123460|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
161472004|NCT00875979|583123459|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
161472005|NCT00875979|583123460|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
161472006|NCT00875979|583123459|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
161472007|NCT00875979|583123460|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
161472008|NCT00875979|583123459|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
161472009|NCT00875979|583123460|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
161472010|NCT00875979|583123459|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
161812880|NCT05005442|584359767|FG003|Overall Study|Site terminated by sponsor|0|||
161472011|NCT00875979|583123460|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
161472012|NCT00875979|583123459|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
161472013|NCT00875979|583123460|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
161472014|NCT00875979|583123459|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
161472015|NCT00875979|583123460|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
161472016|NCT00538291|583123462|FG000|Overall Study|Adverse Event|2|||
161472017|NCT00538291|583123462|FG000|Overall Study|Withdrawal by Subject|1|||
161472018|NCT00694707|583123463|FG000|Overall Study|Did Not Receive Treatment|0|||
161472019|NCT00694707|583123464|FG001|Overall Study|Did Not Receive Treatment|0|||
161472020|NCT00694707|583123465|FG002|Overall Study|Did Not Receive Treatment|1|||
161472021|NCT00694707|583123466|FG003|Overall Study|Did Not Receive Treatment|1|||
161472022|NCT00694707|583123467|FG004|Overall Study|Did Not Receive Treatment|1|||
161472023|NCT00694707|583123463|FG000|Overall Study|Adverse Event|22|||
161472024|NCT00694707|583123464|FG001|Overall Study|Adverse Event|14|||
161472025|NCT00694707|583123465|FG002|Overall Study|Adverse Event|8|||
161472026|NCT00694707|583123466|FG003|Overall Study|Adverse Event|12|||
161472027|NCT00694707|583123467|FG004|Overall Study|Adverse Event|13|||
161472028|NCT00694707|583123463|FG000|Overall Study|Insufficient Therapeutic Response|33|||
161472029|NCT00694707|583123464|FG001|Overall Study|Insufficient Therapeutic Response|18|||
161472030|NCT00694707|583123465|FG002|Overall Study|Insufficient Therapeutic Response|17|||
161472031|NCT00694707|583123466|FG003|Overall Study|Insufficient Therapeutic Response|15|||
161472032|NCT00694707|583123467|FG004|Overall Study|Insufficient Therapeutic Response|10|||
161472033|NCT00694707|583123463|FG000|Overall Study|Protocol Violation|1|||
161472034|NCT00694707|583123464|FG001|Overall Study|Protocol Violation|2|||
161472035|NCT00694707|583123465|FG002|Overall Study|Protocol Violation|1|||
161472036|NCT00694707|583123466|FG003|Overall Study|Protocol Violation|3|||
161472037|NCT00694707|583123467|FG004|Overall Study|Protocol Violation|1|||
161472038|NCT00694707|583123463|FG000|Overall Study|Withdrawal of Consent|14|||
161472039|NCT00694707|583123464|FG001|Overall Study|Withdrawal of Consent|18|||
161472040|NCT00694707|583123465|FG002|Overall Study|Withdrawal of Consent|22|||
161472041|NCT00694707|583123466|FG003|Overall Study|Withdrawal of Consent|16|||
161472042|NCT00694707|583123467|FG004|Overall Study|Withdrawal of Consent|15|||
161472043|NCT00694707|583123463|FG000|Overall Study|Lost to Follow-up|0|||
161472044|NCT00694707|583123464|FG001|Overall Study|Lost to Follow-up|1|||
161472045|NCT00694707|583123465|FG002|Overall Study|Lost to Follow-up|2|||
161472046|NCT00694707|583123466|FG003|Overall Study|Lost to Follow-up|0|||
161472047|NCT00694707|583123467|FG004|Overall Study|Lost to Follow-up|0|||
161472048|NCT00694707|583123463|FG000|Overall Study|Jeopardizing Parole Status|1|||
161472049|NCT00694707|583123464|FG001|Overall Study|Jeopardizing Parole Status|0|||
161472050|NCT00694707|583123465|FG002|Overall Study|Jeopardizing Parole Status|0|||
161472051|NCT00694707|583123466|FG003|Overall Study|Jeopardizing Parole Status|0|||
161472052|NCT00694707|583123467|FG004|Overall Study|Jeopardizing Parole Status|0|||
161472053|NCT00694707|583123463|FG000|Overall Study|Death in the Family|1|||
161472054|NCT00694707|583123464|FG001|Overall Study|Death in the Family|0|||
161472055|NCT00694707|583123465|FG002|Overall Study|Death in the Family|0|||
161472056|NCT00694707|583123466|FG003|Overall Study|Death in the Family|0|||
161472057|NCT00694707|583123467|FG004|Overall Study|Death in the Family|0|||
161472058|NCT00694707|583123463|FG000|Overall Study|Arrest by Police|0|||
161472059|NCT00694707|583123464|FG001|Overall Study|Arrest by Police|1|||
161472060|NCT00694707|583123465|FG002|Overall Study|Arrest by Police|0|||
161472061|NCT00694707|583123466|FG003|Overall Study|Arrest by Police|0|||
161472062|NCT00694707|583123467|FG004|Overall Study|Arrest by Police|0|||
161472063|NCT00694707|583123463|FG000|Overall Study|Administrative Reasons|0|||
161472064|NCT00694707|583123464|FG001|Overall Study|Administrative Reasons|1|||
161472065|NCT00694707|583123465|FG002|Overall Study|Administrative Reasons|0|||
161472066|NCT00694707|583123466|FG003|Overall Study|Administrative Reasons|2|||
161472067|NCT00694707|583123467|FG004|Overall Study|Administrative Reasons|0|||
161472068|NCT00694707|583123463|FG000|Overall Study|Notification of Past Head Injury|0|||
161472069|NCT00694707|583123464|FG001|Overall Study|Notification of Past Head Injury|0|||
161472070|NCT00694707|583123465|FG002|Overall Study|Notification of Past Head Injury|0|||
161472071|NCT00694707|583123466|FG003|Overall Study|Notification of Past Head Injury|1|||
161472072|NCT00694707|583123467|FG004|Overall Study|Notification of Past Head Injury|0|||
161472073|NCT01696695|583123468|FG000|Overall Study|Disease progression|373|||
161472074|NCT01696695|583123468|FG000|Overall Study|Death|29|||
161472075|NCT01696695|583123468|FG000|Overall Study|Adverse Event|74|||
161472076|NCT01696695|583123468|FG000|Overall Study|Withdrawal by Subject|92|||
161472077|NCT01696695|583123468|FG000|Overall Study|Lost to Follow-up|48|||
161472078|NCT01696695|583123468|FG000|Overall Study|Other|74|||
161472079|NCT01696695|583123468|FG000|Overall Study|Major Protocol Violation|192|||
161472080|NCT01904058|583123474|FG000|Overall Study|Adverse Event|2|||
161472081|NCT01904058|583123475|FG001|Overall Study|Adverse Event|0|||
161472082|NCT01904058|583123476|FG002|Overall Study|Adverse Event|0|||
161472083|NCT01904058|583123477|FG003|Overall Study|Adverse Event|0|||
161472084|NCT01904058|583123474|FG000|Overall Study|Withdrawal by Subject|1|||
161472085|NCT01904058|583123475|FG001|Overall Study|Withdrawal by Subject|0|||
161472086|NCT01904058|583123476|FG002|Overall Study|Withdrawal by Subject|1|||
161472087|NCT01904058|583123477|FG003|Overall Study|Withdrawal by Subject|0|||
161472088|NCT01904058|583123474|FG000|Overall Study|Pregnancy|0|||
161472089|NCT01904058|583123475|FG001|Overall Study|Pregnancy|0|||
161472090|NCT01904058|583123476|FG002|Overall Study|Pregnancy|0|||
161472091|NCT01904058|583123477|FG003|Overall Study|Pregnancy|1|||
161472092|NCT04041375|583123481|FG000|Intervention Phase|Withdrawal by Subject|2|||
161472093|NCT04041375|583123482|FG001|Intervention Phase|Withdrawal by Subject|2|||
161472094|NCT04041375|583123481|FG000|Follow-up Phase|Death|2|||
161472095|NCT04041375|583123482|FG001|Follow-up Phase|Death|0|||
161472096|NCT04041375|583123481|FG000|Follow-up Phase|Lost to Follow-up|2|||
161472097|NCT04041375|583123482|FG001|Follow-up Phase|Lost to Follow-up|1|||
161472098|NCT04041375|583123481|FG000|Follow-up Phase|Too ill|3|||
161472099|NCT04041375|583123482|FG001|Follow-up Phase|Too ill|0|||
161472100|NCT02404220|583123488|FG000|Overall Study|Adverse Event|0|||
161472101|NCT02404220|583123489|FG001|Overall Study|Adverse Event|0|||
161472102|NCT02404220|583123490|FG002|Overall Study|Adverse Event|1|||
161472103|NCT02404220|583123491|FG003|Overall Study|Adverse Event|0|||
161472104|NCT02404220|583123488|FG000|Overall Study|Death|5|||
161472105|NCT02404220|583123489|FG001|Overall Study|Death|5|||
161472106|NCT02404220|583123490|FG002|Overall Study|Death|3|||
161472107|NCT02404220|583123491|FG003|Overall Study|Death|8|||
161472108|NCT02404220|583123488|FG000|Overall Study|Progressive Disease|0|||
161472109|NCT02404220|583123489|FG001|Overall Study|Progressive Disease|0|||
161472110|NCT02404220|583123490|FG002|Overall Study|Progressive Disease|1|||
161472111|NCT02404220|583123491|FG003|Overall Study|Progressive Disease|1|||
161472112|NCT02404220|583123488|FG000|Overall Study|Study Terminated by Sponsor|0|||
161472113|NCT02404220|583123489|FG001|Overall Study|Study Terminated by Sponsor|0|||
161472114|NCT02404220|583123490|FG002|Overall Study|Study Terminated by Sponsor|2|||
161472115|NCT02404220|583123491|FG003|Overall Study|Study Terminated by Sponsor|1|||
161472116|NCT02404220|583123488|FG000|Overall Study|Withdrawal by Subject|0|||
161472117|NCT02404220|583123489|FG001|Overall Study|Withdrawal by Subject|1|||
161472118|NCT02404220|583123490|FG002|Overall Study|Withdrawal by Subject|0|||
161472119|NCT02404220|583123491|FG003|Overall Study|Withdrawal by Subject|0|||
161472120|NCT02404220|583123488|FG000|Overall Study|Enrolled but Never Treated|0|||
161472121|NCT02404220|583123489|FG001|Overall Study|Enrolled but Never Treated|2|||
161472122|NCT02404220|583123490|FG002|Overall Study|Enrolled but Never Treated|0|||
161472123|NCT02404220|583123491|FG003|Overall Study|Enrolled but Never Treated|0|||
161472124|NCT00395733|583123492|FG000|Period 2|Withdrawal by Subject|1|||
161472125|NCT00395733|583123493|FG001|Period 2|Withdrawal by Subject|2|||
161472126|NCT00395733|583123492|FG000|Period 2|Protocol Violation|0|||
161472127|NCT00395733|583123493|FG001|Period 2|Protocol Violation|1|||
161472128|NCT00395733|583123492|FG000|Period 2|Adverse Event|0|||
161472129|NCT00395733|583123493|FG001|Period 2|Adverse Event|2|||
161472130|NCT00395733|583123492|FG000|Period 2|Technical problems|1|||
161472131|NCT00395733|583123493|FG001|Period 2|Technical problems|0|||
161472132|NCT01147172|583123498|FG000|Overall Study|Withdrawal by Subject|2|||
161472133|NCT01147172|583123498|FG000|Overall Study|Lost to Follow-up|2|||
161472134|NCT01697358|583123499|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
161472135|NCT01697358|583123500|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
161472136|NCT01697358|583123499|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
161472137|NCT01697358|583123500|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
161472138|NCT01697358|583123499|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
161472139|NCT01697358|583123500|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
161472140|NCT01697358|583123499|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
161472141|NCT01697358|583123500|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
161472142|NCT01697358|583123499|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
161472143|NCT01697358|583123500|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
161472144|NCT01697358|583123499|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
161472145|NCT01697358|583123500|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
161472146|NCT01697358|583123499|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
161472147|NCT01697358|583123500|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
161472148|NCT01697358|583123499|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
161472149|NCT01697358|583123500|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
161916290|NCT03483103|584742412|FG000|Pre-Treatment Phase|Other reasons|1|||
161916291|NCT03483103|584742412|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
161916292|NCT03483103|584742412|FG000|Pre-Treatment Phase|Disease-related complications|1|||
161916293|NCT03483103|584742412|FG000|Pre-Treatment Phase|Death|5|||
161916294|NCT03483103|584742412|FG000|Treatment Phase|Withdrawal by Subject|7|||
161916295|NCT03483103|584742412|FG000|Treatment Phase|Other reasons|1|||
161916296|NCT03483103|584742412|FG000|Treatment Phase|Death|23|||
161916297|NCT03483103|584742412|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
161916298|NCT03483103|584742412|FG000|Treatment Phase|Received nonconforming product|1|||
161916299|NCT02475213|584742413|FG000|Overall Study|Adverse Event|2|||
161916300|NCT02475213|584742414|FG001|Overall Study|Adverse Event|0|||
161916301|NCT02475213|584742415|FG002|Overall Study|Adverse Event|0|||
161916302|NCT02475213|584742416|FG003|Overall Study|Adverse Event|1|||
161472150|NCT01697358|583123499|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
161472151|NCT01697358|583123500|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
161472152|NCT01697358|583123499|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
161472153|NCT01697358|583123500|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
161472154|NCT02507973|583123503|FG000|Overall Study|Adverse Event|1|||
161472155|NCT02345226|583123506|FG000|Double-Blind Phase|Adverse Event|5|||
161472156|NCT02345226|583123507|FG001|Double-Blind Phase|Adverse Event|6|||
161472157|NCT02345226|583123506|FG000|Double-Blind Phase|Death|3|||
161472158|NCT02345226|583123507|FG001|Double-Blind Phase|Death|0|||
161472159|NCT02345226|583123506|FG000|Double-Blind Phase|Pregnancy|0|||
161472160|NCT02345226|583123507|FG001|Double-Blind Phase|Pregnancy|1|||
161472161|NCT02345226|583123506|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161472162|NCT02345226|583123507|FG001|Double-Blind Phase|Lack of Efficacy|0|||
161472163|NCT02345226|583123506|FG000|Double-Blind Phase|Investigator's Discretion|4|||
161472164|NCT02345226|583123507|FG001|Double-Blind Phase|Investigator's Discretion|3|||
161472165|NCT02345226|583123506|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161472166|NCT02345226|583123507|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
161472167|NCT02345226|583123506|FG000|Double-Blind Phase|Withdrew Consent|41|||
161472168|NCT02345226|583123507|FG001|Double-Blind Phase|Withdrew Consent|39|||
161472169|NCT02345226|583123506|FG000|Double-Blind Phase|Lost to Follow-up|12|||
161472170|NCT02345226|583123507|FG001|Double-Blind Phase|Lost to Follow-up|16|||
161472171|NCT02345226|583123506|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
161472172|NCT02345226|583123507|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
161472173|NCT02345226|583123506|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161472174|NCT02345226|583123507|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161472175|NCT03386474|583123508|FG000|Overall Study|Death|1|||
161472176|NCT03386474|583123509|FG001|Overall Study|Death|0|||
161472177|NCT03386474|583123508|FG000|Overall Study|Adverse Event|0|||
161472178|NCT03386474|583123509|FG001|Overall Study|Adverse Event|1|||
161472179|NCT03896165|583123512|FG000|Overall Study|Withdrawal by Subject|2|||
161472180|NCT01163266|583123513|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
161472181|NCT01163266|583123514|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
161472182|NCT01163266|583123515|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
161472183|NCT01163266|583123513|FG000|Overall Study|Lack of Efficacy|1|||
161472184|NCT01163266|583123514|FG001|Overall Study|Lack of Efficacy|3|||
161472185|NCT01163266|583123515|FG002|Overall Study|Lack of Efficacy|1|||
161472186|NCT01163266|583123513|FG000|Overall Study|Noncompliance with Study Drug|0|||
161472187|NCT01163266|583123514|FG001|Overall Study|Noncompliance with Study Drug|2|||
161472188|NCT01163266|583123515|FG002|Overall Study|Noncompliance with Study Drug|0|||
161472189|NCT01163266|583123513|FG000|Overall Study|Protocol Deviations|2|||
161472190|NCT01163266|583123514|FG001|Overall Study|Protocol Deviations|2|||
161472191|NCT01163266|583123515|FG002|Overall Study|Protocol Deviations|5|||
161472192|NCT01163266|583123513|FG000|Overall Study|Withdrawal of Consent|5|||
161472193|NCT01163266|583123514|FG001|Overall Study|Withdrawal of Consent|7|||
161472194|NCT01163266|583123515|FG002|Overall Study|Withdrawal of Consent|3|||
161472195|NCT01163266|583123513|FG000|Overall Study|Lost to Follow-up|7|||
161472196|NCT01163266|583123514|FG001|Overall Study|Lost to Follow-up|7|||
161472197|NCT01163266|583123515|FG002|Overall Study|Lost to Follow-up|10|||
161472198|NCT01163266|583123513|FG000|Overall Study|Other|1|||
161472199|NCT01163266|583123514|FG001|Overall Study|Other|1|||
161472200|NCT01163266|583123515|FG002|Overall Study|Other|2|||
161472201|NCT02919696|583123516|FG000|Overall Study|Adverse Event|1|||
161472202|NCT02919696|583123517|FG001|Overall Study|Adverse Event|2|||
161472203|NCT02919696|583123516|FG000|Overall Study|Withdrawal by Subject|2|||
161472204|NCT02919696|583123517|FG001|Overall Study|Withdrawal by Subject|1|||
161472205|NCT02919696|583123516|FG000|Overall Study|Sponsor Decision|1|||
161472206|NCT02919696|583123517|FG001|Overall Study|Sponsor Decision|1|||
161472207|NCT02919696|583123516|FG000|Overall Study|Never Treated|0|||
161472208|NCT02919696|583123517|FG001|Overall Study|Never Treated|1|||
161472209|NCT03181893|583123518|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472210|NCT03181893|583123519|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
161472211|NCT03181893|583123520|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472212|NCT03181893|583123521|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472213|NCT03181893|583123522|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161668454|NCT00820027|583839773|FG001|Overall Study|Lack of Efficacy|1|||
161668455|NCT00820027|583839774|FG002|Overall Study|Lack of Efficacy|2|||
161668456|NCT00820027|583839775|FG003|Overall Study|Lack of Efficacy|2|||
161472214|NCT03181893|583123523|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472215|NCT03181893|583123524|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472216|NCT03181893|583123525|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472217|NCT03181893|583123526|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472218|NCT03181893|583123527|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472219|NCT03181893|583123528|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
161472220|NCT03181893|583123518|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
161472221|NCT03181893|583123519|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
161472222|NCT03181893|583123520|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472223|NCT03181893|583123521|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472224|NCT03181893|583123522|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472225|NCT03181893|583123523|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472226|NCT03181893|583123524|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472227|NCT03181893|583123525|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472228|NCT03181893|583123526|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472229|NCT03181893|583123527|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472230|NCT03181893|583123528|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161472231|NCT03181893|583123518|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472232|NCT03181893|583123519|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472233|NCT03181893|583123520|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472234|NCT03181893|583123521|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472235|NCT03181893|583123522|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472236|NCT03181893|583123523|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472237|NCT03181893|583123524|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472238|NCT03181893|583123525|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
161472239|NCT03181893|583123526|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
161472240|NCT03181893|583123527|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472241|NCT03181893|583123528|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
161472242|NCT03181893|583123518|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472243|NCT03181893|583123519|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472244|NCT03181893|583123520|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472245|NCT03181893|583123521|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472246|NCT03181893|583123522|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472247|NCT03181893|583123523|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472248|NCT03181893|583123524|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472249|NCT03181893|583123525|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472250|NCT03181893|583123526|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472251|NCT03181893|583123527|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
161472252|NCT03181893|583123528|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
161472253|NCT03181893|583123518|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472254|NCT03181893|583123519|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472255|NCT03181893|583123520|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472256|NCT03181893|583123521|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472257|NCT03181893|583123522|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472258|NCT03181893|583123523|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472259|NCT03181893|583123524|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472260|NCT03181893|583123525|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472261|NCT03181893|583123526|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472262|NCT03181893|583123527|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
161472263|NCT03181893|583123528|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
161472264|NCT03021304|583123530|FG000|Overall Study|Lack of Efficacy|1|||
161472265|NCT03594994|583123533|FG000|Overall Study|Adverse Event|1|||
161472266|NCT03594994|583123534|FG001|Overall Study|Adverse Event|0|||
161472267|NCT03594994|583123533|FG000|Overall Study|Withdrawal by Subject|0|||
161472268|NCT03594994|583123534|FG001|Overall Study|Withdrawal by Subject|1|||
161472269|NCT03774082|583123537|FG000|Overall Study|Death|6|||
161472270|NCT03774082|583123538|FG001|Overall Study|Death|3|||
161472271|NCT03774082|583123539|FG002|Overall Study|Death|2|||
161472272|NCT03774082|583123537|FG000|Overall Study|Subject decision|0|||
161472273|NCT03774082|583123538|FG001|Overall Study|Subject decision|3|||
161472274|NCT03774082|583123539|FG002|Overall Study|Subject decision|0|||
161472275|NCT03774082|583123537|FG000|Overall Study|Lost to Follow-up|2|||
161472276|NCT03774082|583123538|FG001|Overall Study|Lost to Follow-up|0|||
161472277|NCT03774082|583123539|FG002|Overall Study|Lost to Follow-up|0|||
161472278|NCT03774082|583123537|FG000|Overall Study|Guardian decision|0|||
161472279|NCT03774082|583123538|FG001|Overall Study|Guardian decision|0|||
161472280|NCT03774082|583123539|FG002|Overall Study|Guardian decision|1|||
161472281|NCT03774082|583123537|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
161472282|NCT03774082|583123538|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
161472283|NCT03774082|583123539|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
161472284|NCT01950390|583123540|FG000|Overall Study|Never started treatment|3|||
161472285|NCT01950390|583123541|FG001|Overall Study|Never started treatment|2|||
161472286|NCT01950390|583123540|FG000|Overall Study|Disease progression|45|||
161472287|NCT01950390|583123541|FG001|Overall Study|Disease progression|52|||
161472288|NCT01950390|583123540|FG000|Overall Study|Adverse Event|22|||
161472289|NCT01950390|583123541|FG001|Overall Study|Adverse Event|16|||
161472290|NCT01950390|583123540|FG000|Overall Study|Death|5|||
161472291|NCT01950390|583123541|FG001|Overall Study|Death|3|||
161472292|NCT01950390|583123540|FG000|Overall Study|Withdrawal by Subject|5|||
161472293|NCT01950390|583123541|FG001|Overall Study|Withdrawal by Subject|1|||
161472294|NCT01950390|583123540|FG000|Overall Study|Alternative therapy|0|||
161472295|NCT01950390|583123541|FG001|Overall Study|Alternative therapy|3|||
161472296|NCT01950390|583123540|FG000|Overall Study|Complicating disease|1|||
161472297|NCT01950390|583123541|FG001|Overall Study|Complicating disease|0|||
161472298|NCT01950390|583123540|FG000|Overall Study|On treatment|1|||
161472299|NCT01950390|583123541|FG001|Overall Study|On treatment|0|||
161472300|NCT01950390|583123540|FG000|Overall Study|Symptomatic deterioration|2|||
161472301|NCT01950390|583123541|FG001|Overall Study|Symptomatic deterioration|1|||
161472302|NCT01950390|583123540|FG000|Overall Study|Physician Decision|0|||
161472303|NCT01950390|583123541|FG001|Overall Study|Physician Decision|4|||
161472304|NCT01950390|583123540|FG000|Overall Study|Lack of clinical benefit|0|||
161472305|NCT01950390|583123541|FG001|Overall Study|Lack of clinical benefit|1|||
161472306|NCT01950390|583123540|FG000|Overall Study|Maintained PR and moved to observation only|0|||
161472307|NCT01950390|583123541|FG001|Overall Study|Maintained PR and moved to observation only|1|||
161472308|NCT05938920|583123542|FG000|Overall Study|Adverse Event|1|||
161472309|NCT05938920|583123543|FG001|Overall Study|Adverse Event|3|||
161472310|NCT05938920|583123544|FG002|Overall Study|Adverse Event|2|||
161472311|NCT05938920|583123545|FG003|Overall Study|Adverse Event|1|||
161472312|NCT05938920|583123542|FG000|Overall Study|Death|0|||
161472313|NCT05938920|583123543|FG001|Overall Study|Death|1|||
161472314|NCT05938920|583123544|FG002|Overall Study|Death|0|||
161472315|NCT05938920|583123545|FG003|Overall Study|Death|0|||
161472316|NCT05938920|583123542|FG000|Overall Study|Lost to Follow-up|0|||
161472317|NCT05938920|583123543|FG001|Overall Study|Lost to Follow-up|0|||
161472318|NCT05938920|583123544|FG002|Overall Study|Lost to Follow-up|1|||
161472319|NCT05938920|583123545|FG003|Overall Study|Lost to Follow-up|0|||
161472320|NCT05938920|583123542|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
161472321|NCT05938920|583123543|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
161472322|NCT05938920|583123544|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
161472323|NCT05938920|583123545|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
161472324|NCT05938920|583123542|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
161472325|NCT05938920|583123543|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
161472326|NCT05938920|583123544|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
161472327|NCT05938920|583123545|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
161472328|NCT05938920|583123542|FG000|Overall Study|Participant Refused to Come In|0|||
161472329|NCT05938920|583123543|FG001|Overall Study|Participant Refused to Come In|0|||
161472330|NCT05938920|583123544|FG002|Overall Study|Participant Refused to Come In|1|||
161472331|NCT05938920|583123545|FG003|Overall Study|Participant Refused to Come In|0|||
161472332|NCT01251861|583123546|FG000|Overall Study|Disease progression|6|||
161472333|NCT01251861|583123547|FG001|Overall Study|Disease progression|6|||
161472334|NCT01251861|583123546|FG000|Overall Study|Adverse Event|2|||
161472335|NCT01251861|583123547|FG001|Overall Study|Adverse Event|17|||
161472336|NCT01251861|583123546|FG000|Overall Study|Withdrawal by Subject|2|||
161472337|NCT01251861|583123547|FG001|Overall Study|Withdrawal by Subject|2|||
161472338|NCT01251861|583123546|FG000|Overall Study|Alternative therapy|1|||
161472339|NCT01251861|583123547|FG001|Overall Study|Alternative therapy|0|||
161472340|NCT01251861|583123546|FG000|Overall Study|Other complicating disease|0|||
161472341|NCT01251861|583123547|FG001|Overall Study|Other complicating disease|1|||
161472342|NCT01251861|583123546|FG000|Overall Study|Physician Decision|1|||
161472343|NCT01251861|583123547|FG001|Overall Study|Physician Decision|0|||
161472344|NCT01251861|583123546|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
161472345|NCT01251861|583123547|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
161472346|NCT01251861|583123546|FG000|Overall Study|Other|1|||
161472347|NCT01251861|583123547|FG001|Overall Study|Other|0|||
161472348|NCT01251861|583123546|FG000|Overall Study|Never started therapy|4|||
161812881|NCT05005442|584359768|FG004|Overall Study|Site terminated by sponsor|0|||
161812882|NCT05005442|584359769|FG005|Overall Study|Site terminated by sponsor|1|||
161812883|NCT03696160|584359772|FG000|Overall Study|Withdrew before IMP dosing|2|||
161812884|NCT03696160|584359773|FG001|Overall Study|Withdrew before IMP dosing|3|||
161472349|NCT01251861|583123547|FG001|Overall Study|Never started therapy|1|||
161472350|NCT01251861|583123546|FG000|Overall Study|Potential interaction of drugs|0|||
161812885|NCT00334815|584359774|FG000|Overall Study|Adverse Event|3|||
161812886|NCT00334815|584359775|FG001|Overall Study|Adverse Event|2|||
161472351|NCT01251861|583123547|FG001|Overall Study|Potential interaction of drugs|1|||
161812887|NCT00334815|584359774|FG000|Overall Study|Death|0|||
161812888|NCT00334815|584359775|FG001|Overall Study|Death|2|||
161472352|NCT02975336|583125000|FG000|DBPC (52 Weeks)|Adverse Event|16|||
161472353|NCT02975336|583125001|FG001|DBPC (52 Weeks)|Adverse Event|17|||
161472354|NCT02975336|583125002|FG002|DBPC (52 Weeks)|Adverse Event|13|||
161472355|NCT02975336|583125003|FG003|DBPC (52 Weeks)|Adverse Event|18|||
161472356|NCT02975336|583125004|FG004|DBPC (52 Weeks)|Adverse Event|0|||
161472357|NCT02975336|583125005|FG005|DBPC (52 Weeks)|Adverse Event|0|||
161812889|NCT00334815|584359774|FG000|Overall Study|Progression|1|||
161472358|NCT02975336|583125006|FG006|DBPC (52 Weeks)|Adverse Event|0|||
161472359|NCT02975336|583125007|FG007|DBPC (52 Weeks)|Adverse Event|0|||
161472360|NCT02975336|583125000|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
161472361|NCT02975336|583125001|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
161472362|NCT02975336|583125002|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
161472363|NCT02975336|583125003|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
161472364|NCT02975336|583125004|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
161472365|NCT02975336|583125005|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
161472366|NCT02975336|583125006|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
161472367|NCT02975336|583125007|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
161472368|NCT02975336|583125000|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
161472369|NCT02975336|583125001|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
161472370|NCT02975336|583125002|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
161472371|NCT02975336|583125003|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
161472372|NCT02975336|583125004|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
161472373|NCT02975336|583125005|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
161472374|NCT02975336|583125006|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
161472375|NCT02975336|583125007|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
161472376|NCT02975336|583125000|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
161472377|NCT02975336|583125001|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
161472378|NCT02975336|583125002|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
161472379|NCT02975336|583125003|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
161472380|NCT02975336|583125004|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
161472381|NCT02975336|583125005|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
161472382|NCT02975336|583125006|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
161472383|NCT02975336|583125007|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
161472384|NCT02975336|583125000|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
161472385|NCT02975336|583125001|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
161472386|NCT02975336|583125002|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
161472387|NCT02975336|583125003|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
161472388|NCT02975336|583125004|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
161472389|NCT02975336|583125005|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
161472390|NCT02975336|583125006|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
161472391|NCT02975336|583125007|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
161472392|NCT02975336|583125000|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
161472393|NCT02975336|583125001|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
161472394|NCT02975336|583125002|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
161472395|NCT02975336|583125003|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
161472396|NCT02975336|583125004|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
161472397|NCT02975336|583125005|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
161472398|NCT02975336|583125006|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
161472399|NCT02975336|583125007|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
161472400|NCT02975336|583125000|FG000|LTE (104 Weeks)|Adverse Event|0|||
161472401|NCT02975336|583125001|FG001|LTE (104 Weeks)|Adverse Event|0|||
161472402|NCT02975336|583125002|FG002|LTE (104 Weeks)|Adverse Event|0|||
161472403|NCT02975336|583125003|FG003|LTE (104 Weeks)|Adverse Event|0|||
161472404|NCT02975336|583125004|FG004|LTE (104 Weeks)|Adverse Event|7|||
161472405|NCT02975336|583125005|FG005|LTE (104 Weeks)|Adverse Event|4|||
161472406|NCT02975336|583125006|FG006|LTE (104 Weeks)|Adverse Event|2|||
161472407|NCT02975336|583125007|FG007|LTE (104 Weeks)|Adverse Event|0|||
161472408|NCT02975336|583125000|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
161472409|NCT02975336|583125001|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
161472410|NCT02975336|583125002|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
161472411|NCT02975336|583125003|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
161472412|NCT02975336|583125004|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
161472413|NCT02975336|583125005|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
161472414|NCT02975336|583125006|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
161472415|NCT02975336|583125007|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
161472416|NCT02975336|583125000|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
161472417|NCT02975336|583125001|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
161472418|NCT02975336|583125002|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
161472419|NCT02975336|583125003|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
161472420|NCT02975336|583125004|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
161472421|NCT02975336|583125005|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
161472422|NCT02975336|583125006|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
161472423|NCT02975336|583125007|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
161472424|NCT02975336|583125000|FG000|LTE (104 Weeks)|Other|0|||
161472425|NCT02975336|583125001|FG001|LTE (104 Weeks)|Other|0|||
161472426|NCT02975336|583125002|FG002|LTE (104 Weeks)|Other|0|||
161472427|NCT02975336|583125003|FG003|LTE (104 Weeks)|Other|0|||
161472428|NCT02975336|583125004|FG004|LTE (104 Weeks)|Other|55|||
161472429|NCT02975336|583125005|FG005|LTE (104 Weeks)|Other|63|||
161472430|NCT02975336|583125006|FG006|LTE (104 Weeks)|Other|76|||
161472431|NCT02975336|583125007|FG007|LTE (104 Weeks)|Other|72|||
161472432|NCT03355365|583125011|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
161472433|NCT03355365|583125012|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
161472434|NCT03355365|583125011|FG000|Year 1, First Intervention|Protocol Violation|1|||
161472435|NCT03355365|583125012|FG001|Year 1, First Intervention|Protocol Violation|0|||
161472436|NCT03355365|583125011|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
161472437|NCT03355365|583125012|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
161472438|NCT03355365|583125011|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
161472439|NCT03355365|583125012|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
161472440|NCT03355365|583125011|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
161472441|NCT03355365|583125012|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
161472442|NCT03355365|583125011|FG000|Year 2, Crossover Intervention|severe COVID|0|||
161472443|NCT03355365|583125012|FG001|Year 2, Crossover Intervention|severe COVID|1|||
161472444|NCT03355365|583125011|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
161472445|NCT03355365|583125012|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
161472446|NCT01500031|583125015|FG000|Overall Study|Death|1|||
161472447|NCT01500031|583125015|FG000|Overall Study|Withdrawal by Subject|4|||
161472448|NCT01147640|583125016|FG000|Overall Study|Adverse Event|2|||
161472449|NCT01147640|583125017|FG001|Overall Study|Adverse Event|0|||
161472450|NCT01147640|583125016|FG000|Overall Study|Physician Decision|1|||
161472451|NCT01147640|583125017|FG001|Overall Study|Physician Decision|0|||
161472452|NCT01147640|583125016|FG000|Overall Study|Withdrawal by Subject|1|||
161472453|NCT01147640|583125017|FG001|Overall Study|Withdrawal by Subject|0|||
161472454|NCT01147640|583125016|FG000|Overall Study|Lost to Follow-up|0|||
161472455|NCT01147640|583125017|FG001|Overall Study|Lost to Follow-up|1|||
161472456|NCT01147640|583125016|FG000|Overall Study|Didn't meet eligibility criteria|1|||
161472457|NCT01147640|583125017|FG001|Overall Study|Didn't meet eligibility criteria|0|||
161472458|NCT01856907|583125018|FG000|Overall Study|Pregnancy|0|||
161472459|NCT01856907|583125019|FG001|Overall Study|Pregnancy|1|||
161472460|NCT01856907|583125020|FG002|Overall Study|Pregnancy|0|||
161472461|NCT01856907|583125018|FG000|Overall Study|Pregnancy|0|||
161472462|NCT01856907|583125019|FG001|Overall Study|Pregnancy|1|||
161472463|NCT01856907|583125020|FG002|Overall Study|Pregnancy|0|||
161472464|NCT01856907|583125018|FG000|Overall Study|Withdrawal by Subject|0|||
161472465|NCT01856907|583125019|FG001|Overall Study|Withdrawal by Subject|1|||
161472466|NCT01856907|583125020|FG002|Overall Study|Withdrawal by Subject|0|||
161472467|NCT00091442|583125023|FG000|Overall Study|Progressive Disease|220|||
161472468|NCT00091442|583125024|FG001|Overall Study|Progressive Disease|189|||
161472469|NCT00091442|583125023|FG000|Overall Study|Physician Decision|61|||
161472470|NCT00091442|583125024|FG001|Overall Study|Physician Decision|58|||
161472471|NCT00091442|583125023|FG000|Overall Study|Withdrawal by Subject|38|||
161472472|NCT00091442|583125024|FG001|Overall Study|Withdrawal by Subject|46|||
161472473|NCT00091442|583125023|FG000|Overall Study|Adverse Event|29|||
161472474|NCT00091442|583125024|FG001|Overall Study|Adverse Event|48|||
161472475|NCT00091442|583125023|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
161472476|NCT00091442|583125024|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
161472477|NCT00091442|583125023|FG000|Overall Study|Death|9|||
161472478|NCT00091442|583125024|FG001|Overall Study|Death|7|||
161472479|NCT00091442|583125023|FG000|Overall Study|Lost to Follow-up|1|||
161472480|NCT00091442|583125024|FG001|Overall Study|Lost to Follow-up|3|||
161472481|NCT00091442|583125023|FG000|Overall Study|Other|2|||
161472482|NCT00091442|583125024|FG001|Overall Study|Other|6|||
161472483|NCT00917501|583125025|FG000|Overall Study|Lost to Follow-up|4|||
161472484|NCT00917501|583125026|FG001|Overall Study|Lost to Follow-up|1|||
161472485|NCT00917501|583125025|FG000|Overall Study|Withdrawal by Subject|3|||
161472486|NCT00917501|583125026|FG001|Overall Study|Withdrawal by Subject|1|||
161472487|NCT00917501|583125025|FG000|Overall Study|Lack of Efficacy|1|||
161472488|NCT00917501|583125026|FG001|Overall Study|Lack of Efficacy|2|||
161472489|NCT00917501|583125025|FG000|Overall Study|trouble swollowing capsules|0|||
161472490|NCT00917501|583125026|FG001|Overall Study|trouble swollowing capsules|1|||
161472491|NCT00986830|583125027|FG000|Overall Study|Death|1|||
161472492|NCT00986830|583125027|FG000|Overall Study|Lost to Follow-up|1|||
161472493|NCT00986830|583125027|FG000|Overall Study|Lack of Efficacy|1|||
161472494|NCT00986830|583125027|FG000|Overall Study|Unable to access sinus with device|5|||
161668457|NCT00820027|583839772|FG000|Overall Study|Physician Decision|0|||
161472495|NCT00845858|583125028|FG000|Overall Study|Withdrawal by Subject|5|||
161472496|NCT00845858|583125029|FG001|Overall Study|Withdrawal by Subject|1|||
161472497|NCT00845858|583125030|FG002|Overall Study|Withdrawal by Subject|1|||
161472498|NCT00845858|583125028|FG000|Overall Study|Adverse Event|3|||
161472499|NCT00845858|583125029|FG001|Overall Study|Adverse Event|8|||
161472500|NCT00845858|583125030|FG002|Overall Study|Adverse Event|4|||
161472501|NCT00845858|583125028|FG000|Overall Study|Protocol Violation|0|||
161472502|NCT00845858|583125029|FG001|Overall Study|Protocol Violation|0|||
161472503|NCT00845858|583125030|FG002|Overall Study|Protocol Violation|1|||
161472504|NCT00845858|583125028|FG000|Overall Study|not eligible|0|||
161472505|NCT00845858|583125029|FG001|Overall Study|not eligible|3|||
161472506|NCT00845858|583125030|FG002|Overall Study|not eligible|2|||
161472507|NCT01436396|583125031|FG000|Overall Study|Protocol Violation|7|||
161472508|NCT01436396|583125032|FG001|Overall Study|Protocol Violation|5|||
161472509|NCT01436396|583125031|FG000|Overall Study|Adverse Event|1|||
161472510|NCT01436396|583125032|FG001|Overall Study|Adverse Event|2|||
161472511|NCT01436396|583125031|FG000|Overall Study|Withdrawal by Subject|19|||
161472512|NCT01436396|583125032|FG001|Overall Study|Withdrawal by Subject|29|||
161472513|NCT01436396|583125031|FG000|Overall Study|Serious adverse event|2|||
161472514|NCT01436396|583125032|FG001|Overall Study|Serious adverse event|3|||
161472515|NCT01436396|583125031|FG000|Overall Study|Lost to Follow-up|3|||
161472516|NCT01436396|583125032|FG001|Overall Study|Lost to Follow-up|3|||
161472517|NCT00216476|583125033|FG000|Overall Study|Withdrawal by Subject|59|||
161472518|NCT00216476|583125034|FG001|Overall Study|Withdrawal by Subject|72|||
161472519|NCT00216476|583125035|FG002|Overall Study|Withdrawal by Subject|9|||
161472520|NCT00216476|583125033|FG000|Overall Study|Lost to Follow-up|10|||
161472521|NCT00216476|583125034|FG001|Overall Study|Lost to Follow-up|9|||
161472522|NCT00216476|583125035|FG002|Overall Study|Lost to Follow-up|1|||
161472523|NCT00216476|583125033|FG000|Overall Study|Adverse Event|6|||
161472524|NCT00216476|583125034|FG001|Overall Study|Adverse Event|10|||
161472525|NCT00216476|583125035|FG002|Overall Study|Adverse Event|1|||
161472526|NCT00216476|583125033|FG000|Overall Study|Lack of Efficacy|4|||
161472527|NCT00216476|583125034|FG001|Overall Study|Lack of Efficacy|3|||
161472528|NCT00216476|583125035|FG002|Overall Study|Lack of Efficacy|0|||
161472529|NCT00216476|583125033|FG000|Overall Study|Death|2|||
161472530|NCT00216476|583125034|FG001|Overall Study|Death|0|||
161472531|NCT00216476|583125035|FG002|Overall Study|Death|0|||
161472532|NCT00216476|583125033|FG000|Overall Study|Pregnancy|0|||
161472533|NCT00216476|583125034|FG001|Overall Study|Pregnancy|1|||
161472534|NCT00216476|583125035|FG002|Overall Study|Pregnancy|1|||
161472535|NCT00216476|583125033|FG000|Overall Study|Other|0|||
161472536|NCT00216476|583125034|FG001|Overall Study|Other|0|||
161472537|NCT00216476|583125035|FG002|Overall Study|Other|1|||
161472538|NCT00216476|583125033|FG000|Overall Study|Refuses Injection|11|||
161472539|NCT00216476|583125034|FG001|Overall Study|Refuses Injection|0|||
161472540|NCT00216476|583125035|FG002|Overall Study|Refuses Injection|0|||
161472541|NCT00216476|583125033|FG000|Overall Study|No Further Need for Treatment|3|||
161472542|NCT00216476|583125034|FG001|Overall Study|No Further Need for Treatment|4|||
161472543|NCT00216476|583125035|FG002|Overall Study|No Further Need for Treatment|1|||
161472544|NCT00216476|583125033|FG000|Overall Study|Non-compliance|0|||
161472545|NCT00216476|583125034|FG001|Overall Study|Non-compliance|4|||
161472546|NCT00216476|583125035|FG002|Overall Study|Non-compliance|1|||
161472547|NCT00216476|583125033|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
161472548|NCT00216476|583125034|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
161472549|NCT00216476|583125035|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
161472550|NCT00216476|583125033|FG000|Overall Study|Administrative Reasons|1|||
161472551|NCT00216476|583125034|FG001|Overall Study|Administrative Reasons|1|||
161472552|NCT00216476|583125035|FG002|Overall Study|Administrative Reasons|0|||
161472553|NCT00216476|583125033|FG000|Overall Study|Protocol Deviation|5|||
161472554|NCT00216476|583125034|FG001|Overall Study|Protocol Deviation|1|||
161472555|NCT00216476|583125035|FG002|Overall Study|Protocol Deviation|0|||
161472556|NCT00216476|583125033|FG000|Overall Study|Patient Moved|2|||
161472557|NCT00216476|583125034|FG001|Overall Study|Patient Moved|2|||
161472558|NCT00216476|583125035|FG002|Overall Study|Patient Moved|0|||
161472559|NCT01522248|583125038|FG000|Overall Study|Lost to Follow-up|1|||
161472560|NCT01522248|583125039|FG001|Overall Study|Lost to Follow-up|0|||
161472561|NCT02191137|583125041|FG000|Treatment|Death|4|||
161472562|NCT02191137|583125041|FG000|Treatment|Withdrawal by Subject|3|||
161472563|NCT02191137|583125041|FG000|Treatment|Adverse Event|2|||
161472564|NCT02191137|583125041|FG000|Treatment|Other|1|||
161472565|NCT02191137|583125041|FG000|Follow-up|Lost to Follow-up|2|||
161472566|NCT02191137|583125041|FG000|Follow-up|Ongoing/unknown|2|||
161472567|NCT02191137|583125041|FG000|Follow-up|Adverse Event|1|||
161472568|NCT01332331|583125042|FG000|Overall Study|Lost to Follow-up|0|||
161472569|NCT01332331|583125043|FG001|Overall Study|Lost to Follow-up|1|||
161472570|NCT01332331|583125042|FG000|Overall Study|Adverse Event|1|||
161472571|NCT01332331|583125043|FG001|Overall Study|Adverse Event|1|||
161472572|NCT01332331|583125042|FG000|Overall Study|Physician Decision|1|||
161472573|NCT01332331|583125043|FG001|Overall Study|Physician Decision|0|||
161472574|NCT03096483|583125044|FG000|Overall Study|Withdrawal by site|1|||
161472575|NCT00369707|583125046|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
161472576|NCT00369707|583125046|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
161472577|NCT00369707|583125046|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
161812890|NCT00334815|584359775|FG001|Overall Study|Progression|0|||
161812891|NCT00334815|584359774|FG000|Overall Study|ineligible|1|||
161812892|NCT00334815|584359775|FG001|Overall Study|ineligible|1|||
161812893|NCT00334815|584359774|FG000|Overall Study|patient refused treatment|0|||
161812894|NCT00334815|584359775|FG001|Overall Study|patient refused treatment|1|||
161812895|NCT00334815|584359774|FG000|Overall Study|Physician Decision|2|||
161812896|NCT00334815|584359775|FG001|Overall Study|Physician Decision|4|||
161812897|NCT04970810|584359776|FG000|Overall Study|deemed ineligible after randomization|3|||
161812898|NCT04970810|584359777|FG001|Overall Study|deemed ineligible after randomization|0|||
161812899|NCT04970810|584359778|FG002|Overall Study|deemed ineligible after randomization|4|||
161812900|NCT04742491|584359781|FG000|Overall Study|Death|2|||
161812901|NCT04742491|584359782|FG001|Overall Study|Death|0|||
161812902|NCT04742491|584359781|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
161812903|NCT04742491|584359782|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
161812904|NCT04742491|584359781|FG000|Overall Study|Lost to Follow-up|6|||
161812905|NCT04742491|584359782|FG001|Overall Study|Lost to Follow-up|8|||
161472578|NCT00369707|583125046|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
161472579|NCT00369707|583125046|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
161812906|NCT04742491|584359781|FG000|Overall Study|Withdrawal by Subject|4|||
161812907|NCT04742491|584359782|FG001|Overall Study|Withdrawal by Subject|2|||
161812908|NCT04742491|584359781|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
161916303|NCT02475213|584742417|FG004|Overall Study|Adverse Event|1|||
161916304|NCT02475213|584742418|FG005|Overall Study|Adverse Event|4|||
161916305|NCT02475213|584742419|FG006|Overall Study|Adverse Event|6|||
161916306|NCT02475213|584742420|FG007|Overall Study|Adverse Event|2|||
161916307|NCT02475213|584742413|FG000|Overall Study|Physician Decision|1|||
161916308|NCT02475213|584742414|FG001|Overall Study|Physician Decision|1|||
161916309|NCT02475213|584742415|FG002|Overall Study|Physician Decision|1|||
161472580|NCT00369707|583125046|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
161472581|NCT00369707|583125046|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
161472582|NCT00369707|583125046|FG000|Follow up for 2 Years After Treatment|Death|1|||
161472583|NCT00369707|583125046|FG000|Follow up for 2 Years After Treatment|Other|2|||
161472584|NCT02046733|583125047|FG000|Overall Study|never initiated 'treatment visits'|6|||
161472585|NCT02046733|583125048|FG001|Overall Study|never initiated 'treatment visits'|0|||
161916310|NCT02475213|584742416|FG003|Overall Study|Physician Decision|0|||
161916311|NCT02475213|584742417|FG004|Overall Study|Physician Decision|0|||
161472586|NCT04515394|583125058|FG000|Overall Study|Participant did not receive treatment|1|||
161472587|NCT04674644|583125059|FG000|Overall Study|with missing data|37|||
161472588|NCT00199875|583125060|FG000|Overall Study|Withdrawal by Subject|0|||
161472589|NCT00199875|583125061|FG001|Overall Study|Withdrawal by Subject|0|||
161472590|NCT00199875|583125062|FG002|Overall Study|Withdrawal by Subject|0|||
161472591|NCT00199875|583125063|FG003|Overall Study|Withdrawal by Subject|0|||
161916312|NCT02475213|584742418|FG005|Overall Study|Physician Decision|1|||
161472592|NCT00199875|583125064|FG004|Overall Study|Withdrawal by Subject|1|||
161472593|NCT03469934|583125065|FG000|Overall Study|Withdrawal by Subject|0|||
161916313|NCT02475213|584742419|FG006|Overall Study|Physician Decision|4|||
161916314|NCT02475213|584742420|FG007|Overall Study|Physician Decision|0|||
161916315|NCT02475213|584742413|FG000|Overall Study|Progressive Disease|3|||
161472594|NCT03469934|583125066|FG001|Overall Study|Withdrawal by Subject|1|||
161472595|NCT01024231|583125068|FG000|Overall Study|Other Reasons|1|||
161472596|NCT01024231|583125069|FG001|Overall Study|Other Reasons|2|||
161472597|NCT01024231|583125070|FG002|Overall Study|Other Reasons|0|||
161472598|NCT01024231|583125071|FG003|Overall Study|Other Reasons|0|||
161472599|NCT01024231|583125072|FG004|Overall Study|Other Reasons|2|||
161472600|NCT01024231|583125073|FG005|Overall Study|Other Reasons|0|||
161472601|NCT01024231|583125074|FG006|Overall Study|Other Reasons|1|||
161916316|NCT02475213|584742414|FG001|Overall Study|Progressive Disease|2|||
161472602|NCT01024231|583125068|FG000|Overall Study|Maximum Clinical Benefit|1|||
161472603|NCT01024231|583125069|FG001|Overall Study|Maximum Clinical Benefit|2|||
161472604|NCT01024231|583125070|FG002|Overall Study|Maximum Clinical Benefit|0|||
161812909|NCT04742491|584359782|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
161812910|NCT04742491|584359781|FG000|Overall Study|Participant refused further participation|2|||
161812911|NCT04742491|584359782|FG001|Overall Study|Participant refused further participation|7|||
161916317|NCT02475213|584742415|FG002|Overall Study|Progressive Disease|2|||
161916318|NCT02475213|584742416|FG003|Overall Study|Progressive Disease|13|||
161916319|NCT02475213|584742417|FG004|Overall Study|Progressive Disease|15|||
161916320|NCT02475213|584742418|FG005|Overall Study|Progressive Disease|25|||
161472605|NCT01024231|583125071|FG003|Overall Study|Maximum Clinical Benefit|1|||
161472606|NCT01024231|583125072|FG004|Overall Study|Maximum Clinical Benefit|1|||
161472607|NCT01024231|583125073|FG005|Overall Study|Maximum Clinical Benefit|0|||
161472608|NCT01024231|583125074|FG006|Overall Study|Maximum Clinical Benefit|0|||
161472609|NCT01024231|583125068|FG000|Overall Study|Disease Progression|3|||
161472610|NCT01024231|583125069|FG001|Overall Study|Disease Progression|1|||
161472611|NCT01024231|583125070|FG002|Overall Study|Disease Progression|3|||
161472612|NCT01024231|583125071|FG003|Overall Study|Disease Progression|0|||
161472613|NCT01024231|583125072|FG004|Overall Study|Disease Progression|4|||
161472614|NCT01024231|583125073|FG005|Overall Study|Disease Progression|11|||
161472615|NCT01024231|583125074|FG006|Overall Study|Disease Progression|6|||
161472616|NCT01024231|583125068|FG000|Overall Study|AE unrelated to Study Drug|0|||
161472617|NCT01024231|583125069|FG001|Overall Study|AE unrelated to Study Drug|1|||
161472618|NCT01024231|583125070|FG002|Overall Study|AE unrelated to Study Drug|0|||
161472619|NCT01024231|583125071|FG003|Overall Study|AE unrelated to Study Drug|0|||
161472620|NCT01024231|583125072|FG004|Overall Study|AE unrelated to Study Drug|0|||
161472621|NCT01024231|583125073|FG005|Overall Study|AE unrelated to Study Drug|0|||
161472622|NCT01024231|583125074|FG006|Overall Study|AE unrelated to Study Drug|0|||
161472623|NCT01024231|583125068|FG000|Overall Study|No longer meets criteria|0|||
161472624|NCT01024231|583125069|FG001|Overall Study|No longer meets criteria|0|||
161472625|NCT01024231|583125070|FG002|Overall Study|No longer meets criteria|0|||
161472626|NCT01024231|583125071|FG003|Overall Study|No longer meets criteria|0|||
161472627|NCT01024231|583125072|FG004|Overall Study|No longer meets criteria|1|||
161472628|NCT01024231|583125073|FG005|Overall Study|No longer meets criteria|0|||
161472629|NCT01024231|583125074|FG006|Overall Study|No longer meets criteria|1|||
161472630|NCT01024231|583125068|FG000|Overall Study|Study Drug Toxicity|1|||
161472631|NCT01024231|583125069|FG001|Overall Study|Study Drug Toxicity|6|||
161472632|NCT01024231|583125070|FG002|Overall Study|Study Drug Toxicity|6|||
161472633|NCT01024231|583125071|FG003|Overall Study|Study Drug Toxicity|4|||
161472634|NCT01024231|583125072|FG004|Overall Study|Study Drug Toxicity|2|||
161472635|NCT01024231|583125073|FG005|Overall Study|Study Drug Toxicity|0|||
161472636|NCT01024231|583125074|FG006|Overall Study|Study Drug Toxicity|7|||
161472637|NCT01024231|583125068|FG000|Overall Study|Death|6|||
161472638|NCT01024231|583125069|FG001|Overall Study|Death|2|||
161472639|NCT01024231|583125070|FG002|Overall Study|Death|1|||
161472640|NCT01024231|583125071|FG003|Overall Study|Death|0|||
161472641|NCT01024231|583125072|FG004|Overall Study|Death|4|||
161472642|NCT01024231|583125073|FG005|Overall Study|Death|3|||
161472643|NCT01024231|583125074|FG006|Overall Study|Death|5|||
161472644|NCT01024231|583125068|FG000|Overall Study|Lost to Follow-up|0|||
161472645|NCT01024231|583125069|FG001|Overall Study|Lost to Follow-up|0|||
161472646|NCT01024231|583125070|FG002|Overall Study|Lost to Follow-up|0|||
161472647|NCT01024231|583125071|FG003|Overall Study|Lost to Follow-up|0|||
161472648|NCT01024231|583125072|FG004|Overall Study|Lost to Follow-up|0|||
161472649|NCT01024231|583125073|FG005|Overall Study|Lost to Follow-up|0|||
161472650|NCT01024231|583125074|FG006|Overall Study|Lost to Follow-up|1|||
161668458|NCT00820027|583839773|FG001|Overall Study|Physician Decision|1|||
161812912|NCT04742491|584359781|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
161812913|NCT04742491|584359782|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
161812914|NCT04742491|584359781|FG000|Overall Study|Other reasons|3|||
161812915|NCT04742491|584359782|FG001|Overall Study|Other reasons|4|||
161812916|NCT03317899|584359783|FG000|Overall Study|Death|6|||
161812917|NCT03317899|584359784|FG001|Overall Study|Death|9|||
161812918|NCT01528696|584359787|FG000|Overall Study|See detailed description|18|||
161812919|NCT01528696|584359788|FG001|Overall Study|See detailed description|19|||
161812920|NCT00446966|584359789|FG000|Overall Study|Lost to Follow-up|10|||
161812921|NCT00446966|584359790|FG001|Overall Study|Lost to Follow-up|7|||
161812922|NCT00836472|584359792|FG000|Washout|Adverse Event|1|||
161812923|NCT00836472|584359793|FG001|Washout|Adverse Event|2|||
161812924|NCT00836472|584359792|FG000|Washout|Withdrawal by Subject|1|||
161812925|NCT00836472|584359793|FG001|Washout|Withdrawal by Subject|1|||
161812926|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
161812927|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
161812928|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
161812929|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
161812930|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161472651|NCT01024231|583125068|FG000|Overall Study|Withdrew Consent|0|||
161472652|NCT01024231|583125069|FG001|Overall Study|Withdrew Consent|1|||
161472653|NCT01024231|583125070|FG002|Overall Study|Withdrew Consent|0|||
161472654|NCT01024231|583125071|FG003|Overall Study|Withdrew Consent|0|||
161472655|NCT01024231|583125072|FG004|Overall Study|Withdrew Consent|0|||
161472656|NCT01024231|583125073|FG005|Overall Study|Withdrew Consent|0|||
161472657|NCT01024231|583125074|FG006|Overall Study|Withdrew Consent|0|||
161472658|NCT01024231|583125068|FG000|Overall Study|Continuing on Treatment|0|||
161472659|NCT01024231|583125069|FG001|Overall Study|Continuing on Treatment|0|||
161472660|NCT01024231|583125070|FG002|Overall Study|Continuing on Treatment|0|||
161472661|NCT01024231|583125071|FG003|Overall Study|Continuing on Treatment|0|||
161812931|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161472662|NCT01024231|583125072|FG004|Overall Study|Continuing on Treatment|3|||
161472663|NCT01024231|583125073|FG005|Overall Study|Continuing on Treatment|2|||
161472664|NCT01024231|583125074|FG006|Overall Study|Continuing on Treatment|0|||
161472665|NCT02761733|583125076|FG000|Overall Study|Death|3|||
161472666|NCT02761733|583125077|FG001|Overall Study|Death|5|||
161472667|NCT02761733|583125078|FG002|Overall Study|Death|1|||
161472668|NCT02761733|583125079|FG003|Overall Study|Death|1|||
161472669|NCT02761733|583125076|FG000|Overall Study|Lost to Follow-up|6|||
161472670|NCT02761733|583125077|FG001|Overall Study|Lost to Follow-up|7|||
161472671|NCT02761733|583125078|FG002|Overall Study|Lost to Follow-up|0|||
161472672|NCT02761733|583125079|FG003|Overall Study|Lost to Follow-up|3|||
161472673|NCT02761733|583125076|FG000|Overall Study|Physician Decision|4|||
161472674|NCT02761733|583125077|FG001|Overall Study|Physician Decision|0|||
161472675|NCT02761733|583125078|FG002|Overall Study|Physician Decision|0|||
161472676|NCT02761733|583125079|FG003|Overall Study|Physician Decision|0|||
161472677|NCT02761733|583125076|FG000|Overall Study|Withdrawal by Subject|2|||
161472678|NCT02761733|583125077|FG001|Overall Study|Withdrawal by Subject|0|||
161472679|NCT02761733|583125078|FG002|Overall Study|Withdrawal by Subject|0|||
161472680|NCT02761733|583125079|FG003|Overall Study|Withdrawal by Subject|0|||
161472681|NCT02761733|583125076|FG000|Overall Study|Discharged from Study Site|10|||
161472682|NCT02761733|583125077|FG001|Overall Study|Discharged from Study Site|9|||
161472683|NCT02761733|583125078|FG002|Overall Study|Discharged from Study Site|25|||
161472684|NCT02761733|583125079|FG003|Overall Study|Discharged from Study Site|11|||
161472685|NCT02761733|583125076|FG000|Overall Study|Cognitive Impairment|5|||
161472686|NCT02761733|583125077|FG001|Overall Study|Cognitive Impairment|0|||
161472687|NCT02761733|583125078|FG002|Overall Study|Cognitive Impairment|1|||
161472688|NCT02761733|583125079|FG003|Overall Study|Cognitive Impairment|0|||
161472689|NCT00669396|583125080|FG000|Overall Study|Lost to Follow-up|10|||
161472690|NCT00669396|583125081|FG001|Overall Study|Lost to Follow-up|12|||
161472691|NCT01262573|583125082|FG000|Overall Study|Withdrawal by Subject|0|||
161472692|NCT01262573|583125083|FG001|Overall Study|Withdrawal by Subject|1|||
161472693|NCT00810693|583125084|FG000|Treatment Period|Adverse Event|8|||
161472694|NCT00810693|583125085|FG001|Treatment Period|Adverse Event|1|||
161472695|NCT00810693|583125086|FG002|Treatment Period|Adverse Event|7|||
161472696|NCT00810693|583125084|FG000|Treatment Period|Death|0|||
161472697|NCT00810693|583125085|FG001|Treatment Period|Death|1|||
161472698|NCT00810693|583125086|FG002|Treatment Period|Death|2|||
161472699|NCT00810693|583125084|FG000|Treatment Period|Lack of Efficacy|0|||
161472700|NCT00810693|583125085|FG001|Treatment Period|Lack of Efficacy|0|||
161472701|NCT00810693|583125086|FG002|Treatment Period|Lack of Efficacy|1|||
161472702|NCT00810693|583125084|FG000|Treatment Period|Lost to Follow-up|1|||
161472703|NCT00810693|583125085|FG001|Treatment Period|Lost to Follow-up|0|||
161472704|NCT00810693|583125086|FG002|Treatment Period|Lost to Follow-up|0|||
161472705|NCT00810693|583125084|FG000|Treatment Period|Non-compliance|1|||
161472706|NCT00810693|583125085|FG001|Treatment Period|Non-compliance|0|||
161472707|NCT00810693|583125086|FG002|Treatment Period|Non-compliance|0|||
161472708|NCT00810693|583125084|FG000|Treatment Period|Protocol Violation|1|||
161472709|NCT00810693|583125085|FG001|Treatment Period|Protocol Violation|2|||
161472710|NCT00810693|583125086|FG002|Treatment Period|Protocol Violation|2|||
161472711|NCT00810693|583125084|FG000|Treatment Period|Withdrawal by Subject|6|||
161472712|NCT00810693|583125085|FG001|Treatment Period|Withdrawal by Subject|2|||
161472713|NCT00810693|583125086|FG002|Treatment Period|Withdrawal by Subject|3|||
161472714|NCT00810693|583125084|FG000|Treatment Period|Not treated|0|||
161812932|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812933|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812934|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812935|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812936|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812937|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812938|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812939|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812940|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161812941|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161812942|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161812943|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
161916321|NCT02475213|584742419|FG006|Overall Study|Progressive Disease|30|||
161472715|NCT00810693|583125085|FG001|Treatment Period|Not treated|1|||
161472716|NCT00810693|583125086|FG002|Treatment Period|Not treated|1|||
161472717|NCT00810693|583125084|FG000|Follow-up Period (FUP)|Adverse Event|3|||
161472718|NCT00810693|583125085|FG001|Follow-up Period (FUP)|Adverse Event|1|||
161472719|NCT00810693|583125086|FG002|Follow-up Period (FUP)|Adverse Event|1|||
161472720|NCT00810693|583125084|FG000|Follow-up Period (FUP)|Death|2|||
161472721|NCT00810693|583125085|FG001|Follow-up Period (FUP)|Death|0|||
161472722|NCT00810693|583125086|FG002|Follow-up Period (FUP)|Death|1|||
161472723|NCT00810693|583125084|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
161472724|NCT00810693|583125085|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
161472725|NCT00810693|583125086|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
161472726|NCT00810693|583125084|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
161472727|NCT00810693|583125085|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
161472728|NCT00810693|583125086|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
161472729|NCT00810693|583125084|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
161472730|NCT00810693|583125085|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
161472731|NCT00810693|583125086|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
161472732|NCT04295772|583125087|FG000|Overall Study|Protocol Violation|1|||
161472733|NCT04295772|583125088|FG001|Overall Study|Protocol Violation|0|||
161472734|NCT04295772|583125087|FG000|Overall Study|Ongoing for safety monitoring|14|||
161472735|NCT04295772|583125088|FG001|Overall Study|Ongoing for safety monitoring|1|||
161472736|NCT04295772|583125087|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
161472737|NCT04295772|583125088|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
161472738|NCT00331422|583125089|FG000|Overall Study|Did not receive entire study regimen|5|||
161472739|NCT00066729|583125098|FG000|Overall Study|Lost to Follow-up|1|||
161472740|NCT00066729|583125098|FG000|Overall Study|Disease progression|1|||
161472741|NCT02349542|583125101|FG000|Overall Study|Withdrawal by Subject|5|||
161472742|NCT04128371|583125102|FG000|Overall Study|Lack of Efficacy|1|||
161472743|NCT01361568|583125103|FG000|Overall Study|Adverse Event|0|||
161472744|NCT01361568|583125104|FG001|Overall Study|Adverse Event|0|||
161472745|NCT01361568|583125105|FG002|Overall Study|Adverse Event|0|||
161472746|NCT01361568|583125106|FG003|Overall Study|Adverse Event|0|||
161472747|NCT01361568|583125107|FG004|Overall Study|Adverse Event|1|||
161472748|NCT01361568|583125108|FG005|Overall Study|Adverse Event|0|||
161472749|NCT01361568|583125103|FG000|Overall Study|Physician Decision|0|||
161472750|NCT01361568|583125104|FG001|Overall Study|Physician Decision|0|||
161472751|NCT01361568|583125105|FG002|Overall Study|Physician Decision|0|||
161472752|NCT01361568|583125106|FG003|Overall Study|Physician Decision|0|||
161472753|NCT01361568|583125107|FG004|Overall Study|Physician Decision|0|||
161472754|NCT01361568|583125108|FG005|Overall Study|Physician Decision|1|||
161472755|NCT01361568|583125103|FG000|Overall Study|Withdrawal by Subject|2|||
161472756|NCT01361568|583125104|FG001|Overall Study|Withdrawal by Subject|1|||
161472757|NCT01361568|583125105|FG002|Overall Study|Withdrawal by Subject|0|||
161472758|NCT01361568|583125106|FG003|Overall Study|Withdrawal by Subject|0|||
161472759|NCT01361568|583125107|FG004|Overall Study|Withdrawal by Subject|0|||
161472760|NCT01361568|583125108|FG005|Overall Study|Withdrawal by Subject|1|||
161472761|NCT03308786|583125109|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
161472762|NCT01999868|583125110|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
161472763|NCT01999868|583125111|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
161472764|NCT01999868|583125112|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
161472765|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
161576244|NCT03454529|583496143|FG000|Overall Study|Did not receive treatment|6|||
161812944|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812945|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161472766|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
161472767|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
161472768|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
161472769|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
161472770|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
161472771|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
161472772|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
161472773|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
161472774|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
161472775|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
161472776|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
161472777|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
161472778|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
161472779|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
161472780|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
161472781|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
161472782|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
161472783|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
161472784|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
161472785|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
161472786|NCT01999868|583125110|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
161472787|NCT01999868|583125111|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
161472788|NCT01999868|583125112|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
161472789|NCT01999868|583125110|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
161472790|NCT01999868|583125111|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
161472791|NCT01999868|583125112|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
161472792|NCT01999868|583125110|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
161472793|NCT01999868|583125111|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
161472794|NCT01999868|583125112|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
161472795|NCT01999868|583125110|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
161472796|NCT01999868|583125111|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
161472797|NCT01999868|583125112|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
161472798|NCT01999868|583125110|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
161472799|NCT01999868|583125111|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
161472800|NCT01999868|583125112|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
161472801|NCT01999868|583125110|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
161472802|NCT01999868|583125111|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
161472803|NCT01999868|583125112|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
161472804|NCT01999868|583125110|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
161472805|NCT01999868|583125111|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
161472806|NCT01999868|583125112|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
161472807|NCT00761631|583125113|FG000|Overall Study|Parent/legal guardian request|8|||
161472808|NCT00761631|583125114|FG001|Overall Study|Parent/legal guardian request|3|||
161472809|NCT00761631|583125115|FG002|Overall Study|Parent/legal guardian request|8|||
161472810|NCT00761631|583125116|FG003|Overall Study|Parent/legal guardian request|0|||
161472811|NCT00761631|583125117|FG004|Overall Study|Parent/legal guardian request|5|||
161472812|NCT00761631|583125118|FG005|Overall Study|Parent/legal guardian request|0|||
161472813|NCT00761631|583125113|FG000|Overall Study|Lost to Follow-up|2|||
161472814|NCT00761631|583125114|FG001|Overall Study|Lost to Follow-up|4|||
161472815|NCT00761631|583125115|FG002|Overall Study|Lost to Follow-up|7|||
161472816|NCT00761631|583125116|FG003|Overall Study|Lost to Follow-up|1|||
161472817|NCT00761631|583125117|FG004|Overall Study|Lost to Follow-up|6|||
161472818|NCT00761631|583125118|FG005|Overall Study|Lost to Follow-up|1|||
161472819|NCT00761631|583125113|FG000|Overall Study|Protocol Violation|2|||
161472820|NCT00761631|583125114|FG001|Overall Study|Protocol Violation|0|||
161472821|NCT00761631|583125115|FG002|Overall Study|Protocol Violation|0|||
161472822|NCT00761631|583125116|FG003|Overall Study|Protocol Violation|1|||
161472823|NCT00761631|583125117|FG004|Overall Study|Protocol Violation|5|||
161472824|NCT00761631|583125118|FG005|Overall Study|Protocol Violation|1|||
161472825|NCT00761631|583125113|FG000|Overall Study|Randomized, not treated|1|||
161472826|NCT00761631|583125114|FG001|Overall Study|Randomized, not treated|0|||
161472827|NCT00761631|583125115|FG002|Overall Study|Randomized, not treated|0|||
161472828|NCT00761631|583125116|FG003|Overall Study|Randomized, not treated|0|||
161472829|NCT00761631|583125117|FG004|Overall Study|Randomized, not treated|0|||
161472830|NCT00761631|583125118|FG005|Overall Study|Randomized, not treated|0|||
161472831|NCT00761631|583125113|FG000|Overall Study|Failed to return|1|||
161472832|NCT00761631|583125114|FG001|Overall Study|Failed to return|0|||
161472833|NCT00761631|583125115|FG002|Overall Study|Failed to return|1|||
161472834|NCT00761631|583125116|FG003|Overall Study|Failed to return|1|||
161472835|NCT00761631|583125117|FG004|Overall Study|Failed to return|5|||
161472836|NCT00761631|583125118|FG005|Overall Study|Failed to return|2|||
161472837|NCT00761631|583125113|FG000|Overall Study|Physician Decision|1|||
161812946|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812947|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812948|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161472838|NCT00761631|583125114|FG001|Overall Study|Physician Decision|0|||
161472839|NCT00761631|583125115|FG002|Overall Study|Physician Decision|0|||
161472840|NCT00761631|583125116|FG003|Overall Study|Physician Decision|0|||
161472841|NCT00761631|583125117|FG004|Overall Study|Physician Decision|0|||
161472842|NCT00761631|583125118|FG005|Overall Study|Physician Decision|0|||
161472843|NCT00761631|583125113|FG000|Overall Study|Other|0|||
161472844|NCT00761631|583125114|FG001|Overall Study|Other|0|||
161472845|NCT00761631|583125115|FG002|Overall Study|Other|0|||
161472846|NCT00761631|583125116|FG003|Overall Study|Other|0|||
161472847|NCT00761631|583125117|FG004|Overall Study|Other|1|||
161472848|NCT00761631|583125118|FG005|Overall Study|Other|1|||
161472849|NCT00289016|583125119|FG000|Overall Study|Disease Progression|29|||
161472850|NCT00289016|583125119|FG000|Overall Study|Death|2|||
161472851|NCT00289016|583125119|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
161472852|NCT00289016|583125119|FG000|Overall Study|Withdrawal by Subject|2|||
161472853|NCT00289016|583125119|FG000|Overall Study|Adverse Event|1|||
161472854|NCT00289016|583125119|FG000|Overall Study|Other|1|||
161472855|NCT03553927|583125120|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
161472856|NCT03553927|583125121|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
161472857|NCT03553927|583125120|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
161472858|NCT03553927|583125121|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
161472859|NCT03350620|583125123|FG000|Stage 2|Adverse Event|0|||
161472860|NCT03350620|583125124|FG001|Stage 2|Adverse Event|1|||
161472861|NCT03350620|583125125|FG002|Stage 2|Adverse Event|1|||
161472862|NCT03350620|583125123|FG000|Stage 2|Lack of Efficacy|0|||
161472863|NCT03350620|583125124|FG001|Stage 2|Lack of Efficacy|2|||
161472864|NCT03350620|583125125|FG002|Stage 2|Lack of Efficacy|0|||
161472865|NCT03350620|583125123|FG000|Stage 2|Lost to Follow-up|1|||
161472866|NCT03350620|583125124|FG001|Stage 2|Lost to Follow-up|2|||
161472867|NCT03350620|583125125|FG002|Stage 2|Lost to Follow-up|2|||
161472868|NCT03350620|583125123|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
161472869|NCT03350620|583125124|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
161472870|NCT03350620|583125125|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
161472871|NCT00566111|583125126|FG000|Overall Study|Adverse Event|0|||
161472872|NCT00566111|583125127|FG001|Overall Study|Adverse Event|2|||
161472873|NCT00531934|583126960|FG000|Overall Study|Adverse Event|4|||
161472874|NCT00531934|583126961|FG001|Overall Study|Adverse Event|8|||
161472875|NCT00531934|583126960|FG000|Overall Study|Progression|52|||
161472876|NCT00531934|583126961|FG001|Overall Study|Progression|42|||
161472877|NCT00531934|583126960|FG000|Overall Study|Death|7|||
161472878|NCT00531934|583126961|FG001|Overall Study|Death|10|||
161472879|NCT00531934|583126960|FG000|Overall Study|Withdrawal by Subject|1|||
161472880|NCT00531934|583126961|FG001|Overall Study|Withdrawal by Subject|1|||
161472881|NCT00531934|583126960|FG000|Overall Study|Other|2|||
161472882|NCT00531934|583126961|FG001|Overall Study|Other|2|||
161472883|NCT00150709|583126962|FG000|Overall Study|Protocol Violation|7|||
161472884|NCT00150709|583126963|FG001|Overall Study|Protocol Violation|8|||
161472885|NCT00150709|583126964|FG002|Overall Study|Protocol Violation|3|||
161472886|NCT00150709|583126965|FG003|Overall Study|Protocol Violation|1|||
161472887|NCT00150709|583126962|FG000|Overall Study|Adverse Event|8|||
161472888|NCT00150709|583126963|FG001|Overall Study|Adverse Event|2|||
161472889|NCT00150709|583126964|FG002|Overall Study|Adverse Event|2|||
161472890|NCT00150709|583126965|FG003|Overall Study|Adverse Event|3|||
161472891|NCT00150709|583126962|FG000|Overall Study|Lack of Efficacy|6|||
161472892|NCT00150709|583126963|FG001|Overall Study|Lack of Efficacy|11|||
161472893|NCT00150709|583126964|FG002|Overall Study|Lack of Efficacy|9|||
161472894|NCT00150709|583126965|FG003|Overall Study|Lack of Efficacy|0|||
161472895|NCT00150709|583126962|FG000|Overall Study|Withdrawal by Subject|7|||
161472896|NCT00150709|583126963|FG001|Overall Study|Withdrawal by Subject|10|||
161472897|NCT00150709|583126964|FG002|Overall Study|Withdrawal by Subject|5|||
161472898|NCT00150709|583126965|FG003|Overall Study|Withdrawal by Subject|0|||
161812949|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812950|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812951|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812952|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812953|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812954|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
161812955|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812956|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
161812957|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812958|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812959|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812960|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812961|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812962|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812963|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161472899|NCT00150709|583126962|FG000|Overall Study|Lost to Follow-up|3|||
161472900|NCT00150709|583126963|FG001|Overall Study|Lost to Follow-up|2|||
161472901|NCT00150709|583126964|FG002|Overall Study|Lost to Follow-up|0|||
161472902|NCT00150709|583126965|FG003|Overall Study|Lost to Follow-up|0|||
161472903|NCT00150709|583126962|FG000|Overall Study|Sponsor decision|0|||
161472904|NCT00150709|583126963|FG001|Overall Study|Sponsor decision|0|||
161472905|NCT00150709|583126964|FG002|Overall Study|Sponsor decision|0|||
161472906|NCT00150709|583126965|FG003|Overall Study|Sponsor decision|1|||
161472907|NCT00150709|583126962|FG000|Overall Study|Site/Investigator discontinued the study|5|||
161472908|NCT00150709|583126963|FG001|Overall Study|Site/Investigator discontinued the study|5|||
161472909|NCT00150709|583126964|FG002|Overall Study|Site/Investigator discontinued the study|2|||
161472910|NCT00150709|583126965|FG003|Overall Study|Site/Investigator discontinued the study|0|||
161472911|NCT00150709|583126962|FG000|Overall Study|Decision of parent(s)|1|||
161472912|NCT00150709|583126963|FG001|Overall Study|Decision of parent(s)|2|||
161472913|NCT00150709|583126964|FG002|Overall Study|Decision of parent(s)|0|||
161472914|NCT00150709|583126965|FG003|Overall Study|Decision of parent(s)|0|||
161472915|NCT00150709|583126962|FG000|Overall Study|Decision of parent(s) and investigator|3|||
161472916|NCT00150709|583126963|FG001|Overall Study|Decision of parent(s) and investigator|0|||
161472917|NCT00150709|583126964|FG002|Overall Study|Decision of parent(s) and investigator|0|||
161472918|NCT00150709|583126965|FG003|Overall Study|Decision of parent(s) and investigator|0|||
161472919|NCT00150709|583126962|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
161472920|NCT00150709|583126963|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
161472921|NCT00150709|583126964|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
161472922|NCT00150709|583126965|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
161472923|NCT00150709|583126962|FG000|Overall Study|Investigator decision|1|||
161472924|NCT00150709|583126963|FG001|Overall Study|Investigator decision|0|||
161472925|NCT00150709|583126964|FG002|Overall Study|Investigator decision|0|||
161472926|NCT00150709|583126965|FG003|Overall Study|Investigator decision|1|||
161472927|NCT00150709|583126962|FG000|Overall Study|Subject relocated|2|||
161472928|NCT00150709|583126963|FG001|Overall Study|Subject relocated|2|||
161472929|NCT00150709|583126964|FG002|Overall Study|Subject relocated|1|||
161472930|NCT00150709|583126965|FG003|Overall Study|Subject relocated|0|||
161472931|NCT00150709|583126962|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
161472932|NCT00150709|583126963|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
161472933|NCT00150709|583126964|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
161472934|NCT00150709|583126965|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
161472935|NCT00150709|583126962|FG000|Overall Study|Convenience|0|||
161472936|NCT00150709|583126963|FG001|Overall Study|Convenience|1|||
161472937|NCT00150709|583126964|FG002|Overall Study|Convenience|0|||
161472938|NCT00150709|583126965|FG003|Overall Study|Convenience|0|||
161472939|NCT00150709|583126962|FG000|Overall Study|Subject entered new drug study|0|||
161472940|NCT00150709|583126963|FG001|Overall Study|Subject entered new drug study|1|||
161472941|NCT00150709|583126964|FG002|Overall Study|Subject entered new drug study|0|||
161472942|NCT00150709|583126965|FG003|Overall Study|Subject entered new drug study|0|||
161472943|NCT00150709|583126962|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
161472944|NCT00150709|583126963|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
161472945|NCT00150709|583126964|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
161472946|NCT00150709|583126965|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
161472947|NCT00150709|583126962|FG000|Overall Study|Lack of ease of swallowing|0|||
161472948|NCT00150709|583126963|FG001|Overall Study|Lack of ease of swallowing|1|||
161472949|NCT00150709|583126964|FG002|Overall Study|Lack of ease of swallowing|0|||
161472950|NCT00150709|583126965|FG003|Overall Study|Lack of ease of swallowing|0|||
161472951|NCT01816074|583126967|FG000|Phase 1|Time commitment issues|0|||
161472952|NCT01816074|583126968|FG001|Phase 1|Time commitment issues|0|||
161472953|NCT01816074|583126969|FG002|Phase 1|Time commitment issues|1|||
161472954|NCT01816074|583126970|FG003|Phase 1|Time commitment issues|0|||
161472955|NCT01816074|583126967|FG000|Phase 2|Time commitment Issues|0|||
161472956|NCT01816074|583126968|FG001|Phase 2|Time commitment Issues|2|||
161472957|NCT01816074|583126969|FG002|Phase 2|Time commitment Issues|0|||
161472958|NCT01816074|583126970|FG003|Phase 2|Time commitment Issues|0|||
161472959|NCT01816074|583126967|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
161472960|NCT01816074|583126968|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
161472961|NCT01816074|583126969|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
161472962|NCT01816074|583126970|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
161472963|NCT01816074|583126967|FG000|Phase 2|Physician Decision|0|||
161472964|NCT01816074|583126968|FG001|Phase 2|Physician Decision|0|||
161472965|NCT01816074|583126969|FG002|Phase 2|Physician Decision|0|||
161472966|NCT01816074|583126970|FG003|Phase 2|Physician Decision|1|||
161472967|NCT01816074|583126967|FG000|Phase 2|Withdrawal by Subject|1|||
161472968|NCT01816074|583126968|FG001|Phase 2|Withdrawal by Subject|0|||
161472969|NCT01816074|583126969|FG002|Phase 2|Withdrawal by Subject|0|||
161472970|NCT01816074|583126970|FG003|Phase 2|Withdrawal by Subject|0|||
161472971|NCT01303861|583126983|FG000|Overall Study|Lost to Follow-up|34|||
161472972|NCT01303861|583126984|FG001|Overall Study|Lost to Follow-up|14|||
161472973|NCT01303861|583126985|FG002|Overall Study|Lost to Follow-up|27|||
161472974|NCT01303861|583126986|FG003|Overall Study|Lost to Follow-up|31|||
161472975|NCT01303861|583126983|FG000|Overall Study|Lack of Efficacy|3|||
161472976|NCT01303861|583126984|FG001|Overall Study|Lack of Efficacy|2|||
161472977|NCT01303861|583126985|FG002|Overall Study|Lack of Efficacy|1|||
161472978|NCT01303861|583126986|FG003|Overall Study|Lack of Efficacy|0|||
161472979|NCT01303861|583126983|FG000|Overall Study|Withdrawal by Subject|16|||
161472980|NCT01303861|583126984|FG001|Overall Study|Withdrawal by Subject|8|||
161472981|NCT01303861|583126985|FG002|Overall Study|Withdrawal by Subject|8|||
161472982|NCT01303861|583126986|FG003|Overall Study|Withdrawal by Subject|23|||
161472983|NCT01303861|583126983|FG000|Overall Study|Adverse Event|4|||
161472984|NCT01303861|583126984|FG001|Overall Study|Adverse Event|1|||
161472985|NCT01303861|583126985|FG002|Overall Study|Adverse Event|0|||
161472986|NCT01303861|583126986|FG003|Overall Study|Adverse Event|5|||
161472987|NCT01303861|583126983|FG000|Overall Study|Pregnancy|1|||
161472988|NCT01303861|583126984|FG001|Overall Study|Pregnancy|0|||
161472989|NCT01303861|583126985|FG002|Overall Study|Pregnancy|0|||
161472990|NCT01303861|583126986|FG003|Overall Study|Pregnancy|0|||
161472991|NCT03650556|583127004|FG000|Overall Study|Death|2|||
161472992|NCT03650556|583127004|FG000|Overall Study|Withdrawal by Subject|20|||
161472993|NCT03650556|583127004|FG000|Overall Study|Physician Decision|2|||
161472994|NCT03650556|583127004|FG000|Overall Study|Lost to Follow-up|8|||
161472995|NCT03650556|583127004|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
161472996|NCT03650556|583127004|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
161472997|NCT03917459|583127006|FG000|Overall Study|Adverse Event|1|||
161472998|NCT03917459|583127007|FG001|Overall Study|Adverse Event|0|||
161472999|NCT03917459|583127006|FG000|Overall Study|Withdrawal by Subject|0|||
161473000|NCT03917459|583127007|FG001|Overall Study|Withdrawal by Subject|1|||
161473001|NCT00736944|583127008|FG000|Induction|Death|1|||
161473002|NCT00736944|583127008|FG000|Definitive Treatment|Physician Decision|1|||
161473003|NCT00894166|583127009|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
161473004|NCT00894166|583127010|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
161473005|NCT00894166|583127011|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
161473006|NCT00894166|583127012|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
161473007|NCT00894166|583127013|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
161473008|NCT00894166|583127014|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
161473009|NCT00894166|583127015|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
161473010|NCT00894166|583127016|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
161473011|NCT00894166|583127009|FG000|Overall Study|Death|0|||
161473012|NCT00894166|583127010|FG001|Overall Study|Death|0|||
161473013|NCT00894166|583127011|FG002|Overall Study|Death|0|||
161473014|NCT00894166|583127012|FG003|Overall Study|Death|1|||
161473015|NCT00894166|583127013|FG004|Overall Study|Death|0|||
161473016|NCT00894166|583127014|FG005|Overall Study|Death|0|||
161473017|NCT00894166|583127015|FG006|Overall Study|Death|0|||
161473018|NCT00894166|583127016|FG007|Overall Study|Death|0|||
161473019|NCT01601132|583127018|FG000|Overall Study|Patient withdrew consent|1|||
161473020|NCT01601132|583127018|FG000|Overall Study|Protocol deviation|1|||
161473021|NCT00850070|583127023|FG000|Overall Study|Lack of Efficacy|1|||
161473022|NCT00850070|583127024|FG001|Overall Study|Lack of Efficacy|1|||
161473023|NCT00850070|583127023|FG000|Overall Study|Adverse Event|2|||
161473024|NCT00850070|583127024|FG001|Overall Study|Adverse Event|0|||
161473025|NCT05224141|583127029|FG000|Overall Study|Ongoing|75|||
161473026|NCT05224141|583127030|FG001|Overall Study|Ongoing|88|||
161473027|NCT05224141|583127029|FG000|Overall Study|Withdrawal by Subject|2|||
161473028|NCT05224141|583127030|FG001|Overall Study|Withdrawal by Subject|4|||
161473029|NCT05224141|583127029|FG000|Overall Study|Death|153|||
161473030|NCT05224141|583127030|FG001|Overall Study|Death|138|||
161473031|NCT01691898|583127034|FG000|Overall Study|Death|34|||
161473032|NCT01691898|583127035|FG001|Overall Study|Death|32|||
161473033|NCT01691898|583127036|FG002|Overall Study|Death|6|||
161473034|NCT01691898|583127037|FG003|Overall Study|Death|3|||
161473035|NCT01691898|583127038|FG004|Overall Study|Death|8|||
161473036|NCT01691898|583127039|FG005|Overall Study|Death|31|||
161473037|NCT01691898|583127034|FG000|Overall Study|Adverse Event|0|||
161473038|NCT01691898|583127035|FG001|Overall Study|Adverse Event|1|||
161473039|NCT01691898|583127036|FG002|Overall Study|Adverse Event|0|||
161473040|NCT01691898|583127037|FG003|Overall Study|Adverse Event|1|||
161473041|NCT01691898|583127038|FG004|Overall Study|Adverse Event|1|||
161473042|NCT01691898|583127039|FG005|Overall Study|Adverse Event|0|||
161473043|NCT01691898|583127034|FG000|Overall Study|Progression of Disease|1|||
161473044|NCT01691898|583127035|FG001|Overall Study|Progression of Disease|2|||
161473045|NCT01691898|583127036|FG002|Overall Study|Progression of Disease|1|||
161473046|NCT01691898|583127037|FG003|Overall Study|Progression of Disease|0|||
161473047|NCT01691898|583127038|FG004|Overall Study|Progression of Disease|0|||
161473048|NCT01691898|583127039|FG005|Overall Study|Progression of Disease|1|||
161473049|NCT01691898|583127034|FG000|Overall Study|Lost to Follow-up|3|||
161473050|NCT01691898|583127035|FG001|Overall Study|Lost to Follow-up|1|||
161473051|NCT01691898|583127036|FG002|Overall Study|Lost to Follow-up|0|||
161473052|NCT01691898|583127037|FG003|Overall Study|Lost to Follow-up|0|||
161473053|NCT01691898|583127038|FG004|Overall Study|Lost to Follow-up|1|||
161916322|NCT02475213|584742420|FG007|Overall Study|Progressive Disease|10|||
161916323|NCT02475213|584742413|FG000|Overall Study|Death|0|||
161916324|NCT02475213|584742414|FG001|Overall Study|Death|0|||
161916325|NCT02475213|584742415|FG002|Overall Study|Death|0|||
161916326|NCT02475213|584742416|FG003|Overall Study|Death|0|||
161916327|NCT02475213|584742417|FG004|Overall Study|Death|0|||
161916328|NCT02475213|584742418|FG005|Overall Study|Death|4|||
161916329|NCT02475213|584742419|FG006|Overall Study|Death|1|||
161916330|NCT02475213|584742420|FG007|Overall Study|Death|0|||
161916331|NCT02475213|584742413|FG000|Overall Study|Protocol Violation|0|||
161916332|NCT02475213|584742414|FG001|Overall Study|Protocol Violation|0|||
161916333|NCT02475213|584742415|FG002|Overall Study|Protocol Violation|0|||
161916334|NCT02475213|584742416|FG003|Overall Study|Protocol Violation|0|||
161916335|NCT02475213|584742417|FG004|Overall Study|Protocol Violation|1|||
161916336|NCT02475213|584742418|FG005|Overall Study|Protocol Violation|0|||
161916337|NCT02475213|584742419|FG006|Overall Study|Protocol Violation|0|||
161916338|NCT02475213|584742420|FG007|Overall Study|Protocol Violation|0|||
161916339|NCT02475213|584742413|FG000|Overall Study|Withdrawal by Subject|0|||
161916340|NCT02475213|584742414|FG001|Overall Study|Withdrawal by Subject|0|||
161916341|NCT02475213|584742415|FG002|Overall Study|Withdrawal by Subject|0|||
161916342|NCT02475213|584742416|FG003|Overall Study|Withdrawal by Subject|1|||
161916343|NCT02475213|584742417|FG004|Overall Study|Withdrawal by Subject|0|||
161916344|NCT02475213|584742418|FG005|Overall Study|Withdrawal by Subject|2|||
161916345|NCT02475213|584742419|FG006|Overall Study|Withdrawal by Subject|2|||
161916346|NCT02475213|584742420|FG007|Overall Study|Withdrawal by Subject|0|||
161916347|NCT02475213|584742413|FG000|Overall Study|Other|0|||
161916348|NCT02475213|584742414|FG001|Overall Study|Other|0|||
161916349|NCT02475213|584742415|FG002|Overall Study|Other|0|||
161916350|NCT02475213|584742416|FG003|Overall Study|Other|1|||
161916351|NCT02475213|584742417|FG004|Overall Study|Other|3|||
161916352|NCT02475213|584742418|FG005|Overall Study|Other|1|||
161916353|NCT02475213|584742419|FG006|Overall Study|Other|0|||
161916354|NCT02475213|584742420|FG007|Overall Study|Other|0|||
161916355|NCT00505921|584742421|FG000|Overall Study|Ineligible|1|||
161916356|NCT00505921|584742421|FG000|Overall Study|Failed to Mobilize|8|||
161916357|NCT00797563|584742422|FG000|Overall Study|Adverse Event|1|||
161916358|NCT03416179|584742423|FG000|Overall Study|Death|90|||
161916359|NCT03416179|584742424|FG001|Overall Study|Death|87|||
161916360|NCT03416179|584742425|FG002|Overall Study|Death|117|||
161916361|NCT03416179|584742426|FG003|Overall Study|Death|113|||
161916362|NCT03416179|584742423|FG000|Overall Study|Withdrawal by Subject|15|||
161916363|NCT03416179|584742424|FG001|Overall Study|Withdrawal by Subject|20|||
161916364|NCT03416179|584742425|FG002|Overall Study|Withdrawal by Subject|6|||
161916365|NCT03416179|584742426|FG003|Overall Study|Withdrawal by Subject|9|||
161916366|NCT03416179|584742423|FG000|Overall Study|Lost to Follow-up|1|||
161916367|NCT03416179|584742424|FG001|Overall Study|Lost to Follow-up|1|||
161916368|NCT03416179|584742425|FG002|Overall Study|Lost to Follow-up|0|||
161916369|NCT03416179|584742426|FG003|Overall Study|Lost to Follow-up|3|||
161916370|NCT03416179|584742423|FG000|Overall Study|Study participation terminated by Sponsor|93|||
161916371|NCT03416179|584742424|FG001|Overall Study|Study participation terminated by Sponsor|91|||
161916372|NCT03416179|584742425|FG002|Overall Study|Study participation terminated by Sponsor|26|||
161916373|NCT03416179|584742426|FG003|Overall Study|Study participation terminated by Sponsor|31|||
161916374|NCT03416179|584742423|FG000|Overall Study|Other|2|||
161916375|NCT03416179|584742424|FG001|Overall Study|Other|3|||
161916376|NCT03416179|584742425|FG002|Overall Study|Other|1|||
161916377|NCT03416179|584742426|FG003|Overall Study|Other|0|||
161916378|NCT00879658|584742432|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161916379|NCT00879658|584742433|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161916380|NCT00879658|584742434|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161916381|NCT00879658|584742435|FG003|Overall Study|Abnormal laboratory value(s)|1|||
161916382|NCT00879658|584742436|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161916383|NCT00879658|584742437|FG005|Overall Study|Abnormal laboratory value(s)|0|||
161916384|NCT00879658|584742438|FG006|Overall Study|Abnormal laboratory value(s)|0|||
161916385|NCT00879658|584742432|FG000|Overall Study|Administrative problems|2|||
161916386|NCT00879658|584742433|FG001|Overall Study|Administrative problems|1|||
161916387|NCT00879658|584742434|FG002|Overall Study|Administrative problems|0|||
161916388|NCT00879658|584742435|FG003|Overall Study|Administrative problems|1|||
161916389|NCT00879658|584742436|FG004|Overall Study|Administrative problems|0|||
161916390|NCT00879658|584742437|FG005|Overall Study|Administrative problems|0|||
161916391|NCT00879658|584742438|FG006|Overall Study|Administrative problems|0|||
161916392|NCT00879658|584742432|FG000|Overall Study|Adverse Event|6|||
161916393|NCT00879658|584742433|FG001|Overall Study|Adverse Event|4|||
161916394|NCT00879658|584742434|FG002|Overall Study|Adverse Event|3|||
161668459|NCT00820027|583839774|FG002|Overall Study|Physician Decision|1|||
161916395|NCT00879658|584742435|FG003|Overall Study|Adverse Event|1|||
161916396|NCT00879658|584742436|FG004|Overall Study|Adverse Event|2|||
161916397|NCT00879658|584742437|FG005|Overall Study|Adverse Event|0|||
161916398|NCT00879658|584742438|FG006|Overall Study|Adverse Event|0|||
161916399|NCT00879658|584742432|FG000|Overall Study|Protocol Violation|1|||
161473054|NCT01691898|583127039|FG005|Overall Study|Lost to Follow-up|0|||
161473055|NCT01691898|583127034|FG000|Overall Study|Withdrawal by Subject|9|||
161473056|NCT01691898|583127035|FG001|Overall Study|Withdrawal by Subject|8|||
161473057|NCT01691898|583127036|FG002|Overall Study|Withdrawal by Subject|2|||
161473058|NCT01691898|583127037|FG003|Overall Study|Withdrawal by Subject|1|||
161473059|NCT01691898|583127038|FG004|Overall Study|Withdrawal by Subject|3|||
161473060|NCT01691898|583127039|FG005|Overall Study|Withdrawal by Subject|3|||
161473061|NCT01691898|583127034|FG000|Overall Study|Non-Compliance|0|||
161473062|NCT01691898|583127035|FG001|Overall Study|Non-Compliance|0|||
161473063|NCT01691898|583127036|FG002|Overall Study|Non-Compliance|0|||
161473064|NCT01691898|583127037|FG003|Overall Study|Non-Compliance|0|||
161473065|NCT01691898|583127038|FG004|Overall Study|Non-Compliance|1|||
161473066|NCT01691898|583127039|FG005|Overall Study|Non-Compliance|0|||
161473067|NCT01013350|583127040|FG000|Overall Study|Lost to Follow-up|15|||
161473068|NCT01013350|583127041|FG001|Overall Study|Lost to Follow-up|95|||
161473069|NCT01013350|583127040|FG000|Overall Study|Adverse Event|0|||
161473070|NCT01013350|583127041|FG001|Overall Study|Adverse Event|1|||
161473071|NCT01013350|583127040|FG000|Overall Study|Physician Decision|4|||
161473072|NCT01013350|583127041|FG001|Overall Study|Physician Decision|20|||
161473073|NCT01013350|583127040|FG000|Overall Study|Withdrawal by Subject|15|||
161473074|NCT01013350|583127041|FG001|Overall Study|Withdrawal by Subject|38|||
161473075|NCT01013350|583127040|FG000|Overall Study|Death|3|||
161473076|NCT01013350|583127041|FG001|Overall Study|Death|5|||
161473077|NCT01013350|583127040|FG000|Overall Study|Participant entered interventional study|0|||
161473078|NCT01013350|583127041|FG001|Overall Study|Participant entered interventional study|8|||
161473079|NCT01013350|583127040|FG000|Overall Study|Other|1|||
161473080|NCT01013350|583127041|FG001|Overall Study|Other|25|||
161473081|NCT02019277|583127042|FG000|Overall Study|Withdrawal by Subject|3|||
161473082|NCT02019277|583127042|FG000|Overall Study|Death|7|||
161473083|NCT02019277|583127042|FG000|Overall Study|Did no Cooperate|1|||
161473084|NCT02019277|583127042|FG000|Overall Study|Adverse Event|1|||
161473085|NCT03725852|583127043|FG000|Overall Study|Death|1|||
161473086|NCT03725852|583127044|FG001|Overall Study|Death|0|||
161473087|NCT03725852|583127043|FG000|Overall Study|Withdrawal by Subject|1|||
161473088|NCT03725852|583127044|FG001|Overall Study|Withdrawal by Subject|0|||
161473089|NCT03725852|583127043|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
161473090|NCT03725852|583127044|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
161473091|NCT04738734|583127046|FG000|Overall Study|Withdrawal by Subject|2|||
161473092|NCT04738734|583127047|FG001|Overall Study|Withdrawal by Subject|4|||
161473093|NCT04738734|583127046|FG000|Overall Study|Lost to Follow-up|5|||
161473094|NCT04738734|583127047|FG001|Overall Study|Lost to Follow-up|2|||
161473095|NCT04738734|583127046|FG000|Overall Study|Physician Decision|0|||
161473096|NCT04738734|583127047|FG001|Overall Study|Physician Decision|1|||
161473097|NCT04738734|583127046|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
161473098|NCT04738734|583127047|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
161473099|NCT04093414|583127050|FG000|3 Month Follow up|Physician Decision|0|||
161473100|NCT04093414|583127051|FG001|3 Month Follow up|Physician Decision|1|||
161473101|NCT04093414|583127050|FG000|6month Follow up|Physician Decision|1|||
161473102|NCT04093414|583127051|FG001|6month Follow up|Physician Decision|3|||
161473103|NCT03452228|583127052|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161473104|NCT03452228|583127053|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
161473105|NCT03452228|583127054|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161473106|NCT03452228|583127052|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161473107|NCT03452228|583127053|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161473108|NCT03452228|583127054|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161473109|NCT03452228|583127052|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
161473110|NCT03452228|583127053|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
161473111|NCT03452228|583127054|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
161473112|NCT03452228|583127052|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161812964|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812965|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812966|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812967|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812968|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161812969|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161812970|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161812971|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812972|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812973|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812974|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812975|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812976|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161916400|NCT00879658|584742433|FG001|Overall Study|Protocol Violation|0|||
161473113|NCT03452228|583127053|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161473114|NCT03452228|583127054|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161473115|NCT01297920|583127057|FG000|Overall Study|Adverse Event|42|||
161473116|NCT01297920|583127058|FG001|Overall Study|Adverse Event|10|||
161473117|NCT01297920|583127059|FG002|Overall Study|Adverse Event|38|||
161473118|NCT01297920|583127057|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
161473119|NCT01297920|583127058|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
161473120|NCT01297920|583127059|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
161473121|NCT01297920|583127057|FG000|Overall Study|Noncompliance|1|||
161473122|NCT01297920|583127058|FG001|Overall Study|Noncompliance|0|||
161473123|NCT01297920|583127059|FG002|Overall Study|Noncompliance|0|||
161473124|NCT01297920|583127057|FG000|Overall Study|Protocol Violation|1|||
161473125|NCT01297920|583127058|FG001|Overall Study|Protocol Violation|3|||
161473126|NCT01297920|583127059|FG002|Overall Study|Protocol Violation|0|||
161473127|NCT01297920|583127057|FG000|Overall Study|Inadequate Control of IOP|7|||
161473128|NCT01297920|583127058|FG001|Overall Study|Inadequate Control of IOP|9|||
161473129|NCT01297920|583127059|FG002|Overall Study|Inadequate Control of IOP|17|||
161473130|NCT01297920|583127057|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
161473131|NCT01297920|583127058|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
161473132|NCT01297920|583127059|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
161473133|NCT01710046|583127060|FG000|Overall Study|Lost to Follow-up|1|||
161473134|NCT01710046|583127061|FG001|Overall Study|Lost to Follow-up|0|||
161473135|NCT02215096|583127062|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
161473136|NCT02215096|583127063|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
161473137|NCT02215096|583127064|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
161473138|NCT02215096|583127065|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
161473139|NCT02215096|583127066|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
161473140|NCT02215096|583127062|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
161473141|NCT02215096|583127063|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
161473142|NCT02215096|583127064|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
161473143|NCT02215096|583127065|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
161473144|NCT02215096|583127066|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
161473145|NCT02215096|583127062|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
161473146|NCT02215096|583127063|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
161473147|NCT02215096|583127064|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
161473148|NCT02215096|583127065|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
161473149|NCT02215096|583127066|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
161473150|NCT02215096|583127062|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
161473151|NCT02215096|583127063|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
161473152|NCT02215096|583127064|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
161473153|NCT02215096|583127065|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
161473154|NCT02215096|583127066|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
161473155|NCT03439657|583127067|FG000|Overall Study|Adverse Event|2|||
161473156|NCT03439657|583127068|FG001|Overall Study|Adverse Event|3|||
161473157|NCT03439657|583127067|FG000|Overall Study|Lost to Follow-up|1|||
161473158|NCT03439657|583127068|FG001|Overall Study|Lost to Follow-up|0|||
161473159|NCT03439657|583127067|FG000|Overall Study|Protocol Violation|1|||
161473160|NCT03439657|583127068|FG001|Overall Study|Protocol Violation|1|||
161473161|NCT03439657|583127067|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
161473162|NCT03439657|583127068|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
161473163|NCT00370071|583127069|FG000|Overall Study|Withdrawal by Subject|2|||
161473164|NCT02004522|583127070|FG000|Overall Study|Adverse Event|55|||
161473165|NCT02004522|583127071|FG001|Overall Study|Adverse Event|6|||
161473166|NCT02004522|583127070|FG000|Overall Study|Withdrawal by Subject|13|||
161473167|NCT02004522|583127071|FG001|Overall Study|Withdrawal by Subject|7|||
161473168|NCT02004522|583127070|FG000|Overall Study|Death|12|||
161473169|NCT02004522|583127071|FG001|Overall Study|Death|3|||
161473170|NCT02004522|583127070|FG000|Overall Study|Physician Decision|3|||
161473171|NCT02004522|583127071|FG001|Overall Study|Physician Decision|4|||
161473172|NCT02004522|583127070|FG000|Overall Study|Protocol Violation|1|||
161576245|NCT03454529|583496143|FG000|Overall Study|Received < 80% doses|1|||
161916401|NCT00879658|584742434|FG002|Overall Study|Protocol Violation|0|||
161916402|NCT00879658|584742435|FG003|Overall Study|Protocol Violation|0|||
161916403|NCT00879658|584742436|FG004|Overall Study|Protocol Violation|0|||
161916404|NCT00879658|584742437|FG005|Overall Study|Protocol Violation|0|||
161916405|NCT00879658|584742438|FG006|Overall Study|Protocol Violation|0|||
161916406|NCT00879658|584742432|FG000|Overall Study|Withdrawal by Subject|3|||
161916407|NCT00879658|584742433|FG001|Overall Study|Withdrawal by Subject|0|||
161916408|NCT00879658|584742434|FG002|Overall Study|Withdrawal by Subject|2|||
161916409|NCT00879658|584742435|FG003|Overall Study|Withdrawal by Subject|0|||
161916410|NCT00879658|584742436|FG004|Overall Study|Withdrawal by Subject|0|||
161916411|NCT00879658|584742437|FG005|Overall Study|Withdrawal by Subject|1|||
161916412|NCT00879658|584742438|FG006|Overall Study|Withdrawal by Subject|0|||
161812977|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812978|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812979|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812980|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812981|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812982|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
161812983|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812984|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
161812985|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812986|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812987|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812988|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812989|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812990|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812991|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812992|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812993|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812994|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812995|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812996|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161812997|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161812998|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161812999|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813000|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813001|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813002|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813003|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813004|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813005|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813006|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813007|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813008|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813009|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813010|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
161813011|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813012|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813013|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813014|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813015|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813016|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813017|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813018|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813019|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813020|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813021|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813022|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813023|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813024|NCT01695239|584359794|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813025|NCT01695239|584359795|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813026|NCT01695239|584359796|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161473173|NCT02004522|583127071|FG001|Overall Study|Protocol Violation|0|||
161473174|NCT02004522|583127070|FG000|Overall Study|Other is reason listed by PI|4|||
161473175|NCT02004522|583127071|FG001|Overall Study|Other is reason listed by PI|1|||
161473176|NCT02004522|583127070|FG000|Overall Study|Never Dosed|2|||
161473177|NCT02004522|583127071|FG001|Overall Study|Never Dosed|4|||
161473178|NCT02004522|583127070|FG000|Overall Study|Disease Progression|35|||
161473179|NCT02004522|583127071|FG001|Overall Study|Disease Progression|31|||
161473180|NCT02004522|583127070|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
161473181|NCT02004522|583127071|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
161473182|NCT01787331|583127073|FG000|Overall Study|Physician Decision|1|||
161473183|NCT01787331|583127073|FG000|Overall Study|Withdrawal by Subject|1|||
161473184|NCT00319501|583127078|FG000|Double-blind Period|Withdrawal by Subject|0|||
161473185|NCT00319501|583127079|FG001|Double-blind Period|Withdrawal by Subject|3|||
161473186|NCT00319501|583127078|FG000|Double-blind Period|Sponsor Request|1|||
161473187|NCT00319501|583127079|FG001|Double-blind Period|Sponsor Request|0|||
161473188|NCT00319501|583127078|FG000|Double-blind Period|Did not receive treatment|42|||
161473189|NCT00319501|583127079|FG001|Double-blind Period|Did not receive treatment|29|||
161473190|NCT00319501|583127078|FG000|Open-label Period|Adverse Event|5|||
161473191|NCT00319501|583127079|FG001|Open-label Period|Adverse Event|0|||
161473192|NCT00319501|583127078|FG000|Open-label Period|Protocol Violation|6|||
161473193|NCT00319501|583127079|FG001|Open-label Period|Protocol Violation|0|||
161473194|NCT00319501|583127078|FG000|Open-label Period|Withdrawal by Subject|38|||
161473195|NCT00319501|583127079|FG001|Open-label Period|Withdrawal by Subject|0|||
161473196|NCT00319501|583127078|FG000|Open-label Period|Principal Investigator decision|6|||
161473197|NCT00319501|583127079|FG001|Open-label Period|Principal Investigator decision|0|||
161473198|NCT00319501|583127078|FG000|Open-label Period|Sponsor request|12|||
161473199|NCT00319501|583127079|FG001|Open-label Period|Sponsor request|0|||
161473200|NCT00319501|583127078|FG000|Open-label Period|Lost to Follow-up|5|||
161473201|NCT00319501|583127079|FG001|Open-label Period|Lost to Follow-up|0|||
161473202|NCT00319501|583127078|FG000|Open-label Period|Did not receive treatment|33|||
161473203|NCT00319501|583127079|FG001|Open-label Period|Did not receive treatment|0|||
161473204|NCT00319501|583127078|FG000|Open-label Period|Other|11|||
161473205|NCT00319501|583127079|FG001|Open-label Period|Other|0|||
161473206|NCT00319501|583127078|FG000|Open-label Extension Period|Adverse Event|2|||
161473207|NCT00319501|583127079|FG001|Open-label Extension Period|Adverse Event|0|||
161473208|NCT00319501|583127078|FG000|Open-label Extension Period|Did not receive treatment|18|||
161473209|NCT00319501|583127079|FG001|Open-label Extension Period|Did not receive treatment|0|||
161473210|NCT00319501|583127078|FG000|Open-label Extension Period|Other|1|||
161473211|NCT00319501|583127079|FG001|Open-label Extension Period|Other|0|||
161473212|NCT00319501|583127078|FG000|Open-label Extension Period|Principal investigator decision|2|||
161473213|NCT00319501|583127079|FG001|Open-label Extension Period|Principal investigator decision|0|||
161473214|NCT00319501|583127078|FG000|Open-label Extension Period|Sponsor request|26|||
161473215|NCT00319501|583127079|FG001|Open-label Extension Period|Sponsor request|0|||
161473216|NCT00319501|583127078|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
161473217|NCT00319501|583127079|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161473218|NCT00667875|583127081|FG000|Overall Study|Adverse Event|0|||
161473219|NCT00667875|583127082|FG001|Overall Study|Adverse Event|2|||
161473220|NCT00667875|583127083|FG002|Overall Study|Adverse Event|6|||
161473221|NCT00667875|583127081|FG000|Overall Study|Withdrawal by Subject|10|||
161473222|NCT00667875|583127082|FG001|Overall Study|Withdrawal by Subject|9|||
161473223|NCT00667875|583127083|FG002|Overall Study|Withdrawal by Subject|7|||
161473224|NCT00450255|583127084|FG000|Overall Study|Prior RFA ablation of liver|1|||
161473225|NCT02764697|583127086|FG000|Overall Study|Lack of Efficacy|3|||
161473226|NCT02612129|583127089|FG000|Single Dose Treatment Period|Screening Failure|1|||
161473227|NCT02612129|583127090|FG001|Single Dose Treatment Period|Screening Failure|0|||
161473228|NCT02612129|583127091|FG002|Single Dose Treatment Period|Screening Failure|0|||
161473229|NCT02612129|583127089|FG000|Continuous Treatment Period|Early Escape|0|||
161473230|NCT02612129|583127090|FG001|Continuous Treatment Period|Early Escape|2|||
161473231|NCT02612129|583127091|FG002|Continuous Treatment Period|Early Escape|0|||
161473232|NCT02612129|583127089|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
161473233|NCT02612129|583127090|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
161473234|NCT02612129|583127091|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
161473235|NCT02612129|583127089|FG000|Continuous Treatment Period|Safety Reasons|0|||
161473236|NCT02612129|583127090|FG001|Continuous Treatment Period|Safety Reasons|3|||
161473237|NCT02612129|583127091|FG002|Continuous Treatment Period|Safety Reasons|0|||
161473238|NCT02612129|583127089|FG000|Continuous Treatment Period|Death|0|||
161473239|NCT02612129|583127090|FG001|Continuous Treatment Period|Death|1|||
161473240|NCT02612129|583127091|FG002|Continuous Treatment Period|Death|0|||
161473241|NCT02612129|583127089|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
161473242|NCT02612129|583127090|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
161473243|NCT02612129|583127091|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
161473244|NCT02557295|583127092|FG000|Overall Study|Withdrawal by Subject|9|||
161473245|NCT02557295|583127093|FG001|Overall Study|Withdrawal by Subject|2|||
161473246|NCT02557295|583127094|FG002|Overall Study|Withdrawal by Subject|4|||
161473247|NCT02557295|583127095|FG003|Overall Study|Withdrawal by Subject|0|||
161473248|NCT02557295|583127096|FG004|Overall Study|Withdrawal by Subject|0|||
161473249|NCT02557295|583127097|FG005|Overall Study|Withdrawal by Subject|0|||
161473250|NCT02557295|583127098|FG006|Overall Study|Withdrawal by Subject|15|||
161473251|NCT02557295|583127099|FG007|Overall Study|Withdrawal by Subject|1|||
161473252|NCT02557295|583127100|FG008|Overall Study|Withdrawal by Subject|3|||
161473253|NCT02557295|583127092|FG000|Overall Study|Disease Progression|0|||
161473254|NCT02557295|583127093|FG001|Overall Study|Disease Progression|0|||
161473255|NCT02557295|583127094|FG002|Overall Study|Disease Progression|0|||
161473256|NCT02557295|583127095|FG003|Overall Study|Disease Progression|0|||
161473257|NCT02557295|583127096|FG004|Overall Study|Disease Progression|0|||
161473258|NCT02557295|583127097|FG005|Overall Study|Disease Progression|0|||
161473259|NCT02557295|583127098|FG006|Overall Study|Disease Progression|1|||
161473260|NCT02557295|583127099|FG007|Overall Study|Disease Progression|0|||
161473261|NCT02557295|583127100|FG008|Overall Study|Disease Progression|0|||
161473262|NCT02557295|583127092|FG000|Overall Study|Lack of Efficacy|24|||
161473263|NCT02557295|583127093|FG001|Overall Study|Lack of Efficacy|1|||
161473264|NCT02557295|583127094|FG002|Overall Study|Lack of Efficacy|3|||
161473265|NCT02557295|583127095|FG003|Overall Study|Lack of Efficacy|0|||
161473266|NCT02557295|583127096|FG004|Overall Study|Lack of Efficacy|0|||
161473267|NCT02557295|583127097|FG005|Overall Study|Lack of Efficacy|0|||
161473268|NCT02557295|583127098|FG006|Overall Study|Lack of Efficacy|12|||
161473269|NCT02557295|583127099|FG007|Overall Study|Lack of Efficacy|1|||
161473270|NCT02557295|583127100|FG008|Overall Study|Lack of Efficacy|0|||
161473271|NCT02557295|583127092|FG000|Overall Study|Adverse Event|16|||
161473272|NCT02557295|583127093|FG001|Overall Study|Adverse Event|2|||
161473273|NCT02557295|583127094|FG002|Overall Study|Adverse Event|3|||
161473274|NCT02557295|583127095|FG003|Overall Study|Adverse Event|0|||
161473275|NCT02557295|583127096|FG004|Overall Study|Adverse Event|0|||
161473276|NCT02557295|583127097|FG005|Overall Study|Adverse Event|0|||
161473277|NCT02557295|583127098|FG006|Overall Study|Adverse Event|2|||
161813027|NCT01695239|584359797|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813028|NCT01695239|584359798|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161473278|NCT02557295|583127099|FG007|Overall Study|Adverse Event|1|||
161813029|NCT01695239|584359799|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161916413|NCT00879658|584742432|FG000|Overall Study|Lack of Efficacy|0|||
161473279|NCT02557295|583127100|FG008|Overall Study|Adverse Event|1|||
161473280|NCT02557295|583127092|FG000|Overall Study|Lost to Follow-up|4|||
161473281|NCT02557295|583127093|FG001|Overall Study|Lost to Follow-up|0|||
161473282|NCT02557295|583127094|FG002|Overall Study|Lost to Follow-up|0|||
161473283|NCT02557295|583127095|FG003|Overall Study|Lost to Follow-up|0|||
161668460|NCT00820027|583839775|FG003|Overall Study|Physician Decision|0|||
161473284|NCT02557295|583127096|FG004|Overall Study|Lost to Follow-up|0|||
161473285|NCT02557295|583127097|FG005|Overall Study|Lost to Follow-up|0|||
161916414|NCT00879658|584742433|FG001|Overall Study|Lack of Efficacy|0|||
161916415|NCT00879658|584742434|FG002|Overall Study|Lack of Efficacy|2|||
161916416|NCT00879658|584742435|FG003|Overall Study|Lack of Efficacy|0|||
161813030|NCT01695239|584359800|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813031|NCT01695239|584359801|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
161813032|NCT01695239|584359802|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161473286|NCT02557295|583127098|FG006|Overall Study|Lost to Follow-up|9|||
161473287|NCT02557295|583127099|FG007|Overall Study|Lost to Follow-up|0|||
161473288|NCT02557295|583127100|FG008|Overall Study|Lost to Follow-up|0|||
161473289|NCT02557295|583127092|FG000|Overall Study|Study Close|54|||
161473290|NCT02557295|583127093|FG001|Overall Study|Study Close|3|||
161473291|NCT02557295|583127094|FG002|Overall Study|Study Close|5|||
161473292|NCT02557295|583127095|FG003|Overall Study|Study Close|3|||
161473293|NCT02557295|583127096|FG004|Overall Study|Study Close|0|||
161473294|NCT02557295|583127097|FG005|Overall Study|Study Close|0|||
161473295|NCT02557295|583127098|FG006|Overall Study|Study Close|37|||
161473296|NCT02557295|583127099|FG007|Overall Study|Study Close|3|||
161473297|NCT02557295|583127100|FG008|Overall Study|Study Close|19|||
161473298|NCT02557295|583127092|FG000|Overall Study|except for study close|4|||
161473299|NCT02557295|583127093|FG001|Overall Study|except for study close|0|||
161473300|NCT02557295|583127094|FG002|Overall Study|except for study close|0|||
161473301|NCT02557295|583127095|FG003|Overall Study|except for study close|0|||
161473302|NCT02557295|583127096|FG004|Overall Study|except for study close|0|||
161473303|NCT02557295|583127097|FG005|Overall Study|except for study close|0|||
161473304|NCT02557295|583127098|FG006|Overall Study|except for study close|5|||
161473305|NCT02557295|583127099|FG007|Overall Study|except for study close|1|||
161473306|NCT02557295|583127100|FG008|Overall Study|except for study close|0|||
161473307|NCT01066000|583127101|FG000|Overall Study|Protocol Violation|4|||
161473308|NCT01066000|583127101|FG000|Overall Study|Death|3|||
161473309|NCT01066000|583127101|FG000|Overall Study|Withdrawal by Subject|1|||
161473310|NCT01066000|583127101|FG000|Overall Study|Adverse Event|1|||
161473311|NCT01386008|583127102|FG000|Overall Study|exited w/o incident /study discontinued|17|||
161473312|NCT01386008|583127102|FG000|Overall Study|Adverse Event|3|||
161473313|NCT01067976|583127103|FG000|Overall Study|Study drug never administered|20|||
161473314|NCT01067976|583127103|FG000|Overall Study|Study prematurely discontinued|2|||
161473315|NCT04449861|583127104|FG000|Overall Study|Withdrawal by Subject|4|||
161473316|NCT04449861|583127104|FG000|Overall Study|Lost to Follow-up|5|||
161473317|NCT04449861|583127104|FG000|Overall Study|Death|112|||
161473318|NCT00976677|583127105|FG000|Overall Study|Adverse Event|1|||
161473319|NCT00976677|583127106|FG001|Overall Study|Adverse Event|0|||
161473320|NCT00976677|583127105|FG000|Overall Study|Withdrawal by Subject|0|||
161473321|NCT00976677|583127106|FG001|Overall Study|Withdrawal by Subject|2|||
161473322|NCT00976677|583127105|FG000|Overall Study|Disease progression|1|||
161473323|NCT00976677|583127106|FG001|Overall Study|Disease progression|1|||
161473324|NCT00976677|583127105|FG000|Overall Study|Trial unblinded|2|||
161473325|NCT00976677|583127106|FG001|Overall Study|Trial unblinded|2|||
161473326|NCT00976677|583127105|FG000|Overall Study|Unknown/Missing|1|||
161473327|NCT00976677|583127106|FG001|Overall Study|Unknown/Missing|0|||
161473328|NCT03487549|583127111|FG000|Overall Study|Protocol Violation|0|||
161473329|NCT03487549|583127112|FG001|Overall Study|Protocol Violation|1|||
161473330|NCT03487549|583127111|FG000|Overall Study|Lost to Follow-up|2|||
161473331|NCT03487549|583127112|FG001|Overall Study|Lost to Follow-up|1|||
161473332|NCT03487549|583127111|FG000|Overall Study|Withdrawal by Subject|2|||
161813033|NCT01695239|584359803|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813034|NCT01695239|584359804|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813035|NCT01695239|584359805|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813036|NCT01695239|584359806|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813037|NCT01695239|584359807|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813038|NCT01695239|584359794|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813039|NCT01695239|584359795|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813040|NCT01695239|584359796|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813041|NCT01695239|584359797|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813042|NCT01695239|584359798|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813043|NCT01695239|584359799|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161473333|NCT03487549|583127112|FG001|Overall Study|Withdrawal by Subject|0|||
161473334|NCT04092582|583128580|FG000|Overall Study|Death|1|||
161473335|NCT04092582|583128581|FG001|Overall Study|Death|1|||
161473336|NCT04092582|583128580|FG000|Overall Study|Withdrawal by Subject|4|||
161473337|NCT04092582|583128581|FG001|Overall Study|Withdrawal by Subject|1|||
161473338|NCT04092582|583128580|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
161473339|NCT04092582|583128581|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
161473340|NCT03019185|583128586|FG000|Overall Study|Lost to Follow-up|3|||
161473341|NCT03019185|583128587|FG001|Overall Study|Lost to Follow-up|0|||
161473342|NCT03019185|583128588|FG002|Overall Study|Lost to Follow-up|2|||
161473343|NCT03019185|583128586|FG000|Overall Study|Withdrawal by Subject|1|||
161473344|NCT03019185|583128587|FG001|Overall Study|Withdrawal by Subject|1|||
161473345|NCT03019185|583128588|FG002|Overall Study|Withdrawal by Subject|0|||
161473346|NCT03019185|583128586|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
161473347|NCT03019185|583128587|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
161473348|NCT03019185|583128588|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
161473349|NCT03019185|583128586|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
161473350|NCT03019185|583128587|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
161473351|NCT03019185|583128588|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
161473352|NCT02764333|583128589|FG000|Overall Study|Ineligible|1|||
161473353|NCT01200524|583128591|FG000|Overall Study|Withdrawal by Subject|1|||
161473354|NCT01200524|583128592|FG001|Overall Study|Withdrawal by Subject|1|||
161473355|NCT01200524|583128593|FG002|Overall Study|Withdrawal by Subject|3|||
161473356|NCT01200524|583128591|FG000|Overall Study|Adverse Event|1|||
161473357|NCT01200524|583128592|FG001|Overall Study|Adverse Event|0|||
161473358|NCT01200524|583128593|FG002|Overall Study|Adverse Event|0|||
161473359|NCT01200524|583128591|FG000|Overall Study|Non availability of study nurse|0|||
161473360|NCT01200524|583128592|FG001|Overall Study|Non availability of study nurse|0|||
161473361|NCT01200524|583128593|FG002|Overall Study|Non availability of study nurse|1|||
161473362|NCT01868503|583128594|FG000|Overall Study|Withdrawal by Subject|1|||
161473363|NCT01868503|583128594|FG000|Overall Study|Protocol Violation|1|||
161473364|NCT00491764|583128596|FG000|Overall Study|Adverse Event|1|||
161473365|NCT00491764|583128597|FG001|Overall Study|Adverse Event|2|||
161473366|NCT00491764|583128598|FG002|Overall Study|Adverse Event|4|||
161473367|NCT00491764|583128599|FG003|Overall Study|Adverse Event|4|||
161473368|NCT00491764|583128600|FG004|Overall Study|Adverse Event|0|||
161473369|NCT00491764|583128601|FG005|Overall Study|Adverse Event|1|||
161473370|NCT00491764|583128596|FG000|Overall Study|Lost to Follow-up|0|||
161473371|NCT00491764|583128597|FG001|Overall Study|Lost to Follow-up|1|||
161473372|NCT00491764|583128598|FG002|Overall Study|Lost to Follow-up|0|||
161473373|NCT00491764|583128599|FG003|Overall Study|Lost to Follow-up|1|||
161473374|NCT00491764|583128600|FG004|Overall Study|Lost to Follow-up|0|||
161473375|NCT00491764|583128601|FG005|Overall Study|Lost to Follow-up|3|||
161473376|NCT00491764|583128596|FG000|Overall Study|Withdrawal by Subject|2|||
161473377|NCT00491764|583128597|FG001|Overall Study|Withdrawal by Subject|3|||
161473378|NCT00491764|583128598|FG002|Overall Study|Withdrawal by Subject|1|||
161473379|NCT00491764|583128599|FG003|Overall Study|Withdrawal by Subject|2|||
161473380|NCT00491764|583128600|FG004|Overall Study|Withdrawal by Subject|2|||
161473381|NCT00491764|583128601|FG005|Overall Study|Withdrawal by Subject|4|||
161473382|NCT00491764|583128596|FG000|Overall Study|Non Compliance with the Protocol|1|||
161473383|NCT00491764|583128597|FG001|Overall Study|Non Compliance with the Protocol|0|||
161473384|NCT00491764|583128598|FG002|Overall Study|Non Compliance with the Protocol|0|||
161473385|NCT00491764|583128599|FG003|Overall Study|Non Compliance with the Protocol|0|||
161473386|NCT00491764|583128600|FG004|Overall Study|Non Compliance with the Protocol|0|||
161473387|NCT00491764|583128601|FG005|Overall Study|Non Compliance with the Protocol|0|||
161473388|NCT00491764|583128596|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
161473389|NCT00491764|583128597|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
161473390|NCT00491764|583128598|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
161473391|NCT00491764|583128599|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
161473392|NCT00491764|583128600|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
161473393|NCT00491764|583128601|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
161473394|NCT00491764|583128596|FG000|Overall Study|Administrative|1|||
161473395|NCT00491764|583128597|FG001|Overall Study|Administrative|0|||
161473396|NCT00491764|583128598|FG002|Overall Study|Administrative|2|||
161473397|NCT00491764|583128599|FG003|Overall Study|Administrative|1|||
161473398|NCT00491764|583128600|FG004|Overall Study|Administrative|0|||
161473399|NCT00491764|583128601|FG005|Overall Study|Administrative|0|||
161473400|NCT02110238|583128602|FG000|12 Week Pivotal Phase|Adverse Event|3|||
161473401|NCT02110238|583128603|FG001|12 Week Pivotal Phase|Adverse Event|0|||
161473402|NCT02110238|583128602|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
161473403|NCT02110238|583128603|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
161473404|NCT02110238|583128602|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
161473405|NCT02110238|583128603|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
161473406|NCT02110238|583128602|FG000|12 Week Pivotal Phase|Physician Decision|0|||
161473407|NCT02110238|583128603|FG001|12 Week Pivotal Phase|Physician Decision|2|||
161473408|NCT02110238|583128602|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
161576246|NCT01040689|583496148|FG000|Overall Study|Adverse Event|0|||
161916417|NCT00879658|584742436|FG004|Overall Study|Lack of Efficacy|0|||
161916418|NCT00879658|584742437|FG005|Overall Study|Lack of Efficacy|0|||
161916419|NCT00879658|584742438|FG006|Overall Study|Lack of Efficacy|0|||
161916420|NCT00879658|584742432|FG000|Overall Study|misrandomized (never received study med)|0|||
161916421|NCT00879658|584742433|FG001|Overall Study|misrandomized (never received study med)|0|||
161916422|NCT00879658|584742434|FG002|Overall Study|misrandomized (never received study med)|0|||
161916423|NCT00879658|584742435|FG003|Overall Study|misrandomized (never received study med)|1|||
161916424|NCT00879658|584742436|FG004|Overall Study|misrandomized (never received study med)|0|||
161916425|NCT00879658|584742437|FG005|Overall Study|misrandomized (never received study med)|0|||
161916426|NCT00879658|584742438|FG006|Overall Study|misrandomized (never received study med)|0|||
161916427|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
161473409|NCT02110238|583128603|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
161473410|NCT02110238|583128602|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
161473411|NCT02110238|583128603|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
161473412|NCT02110238|583128602|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
161473413|NCT02110238|583128603|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
161473414|NCT02110238|583128602|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
161473415|NCT02110238|583128603|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
161473416|NCT02110238|583128602|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
161473417|NCT02110238|583128603|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
161473418|NCT02110238|583128602|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
161473419|NCT02110238|583128603|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
161473420|NCT02110238|583128602|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
161473421|NCT02110238|583128603|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
161473422|NCT03228433|583128608|FG000|Overall Study|Lost to Follow-up|1|||
161473423|NCT03228433|583128609|FG001|Overall Study|Lost to Follow-up|0|||
161473424|NCT03228433|583128610|FG002|Overall Study|Lost to Follow-up|0|||
161473425|NCT03228433|583128611|FG003|Overall Study|Lost to Follow-up|0|||
161473426|NCT03228433|583128612|FG004|Overall Study|Lost to Follow-up|0|||
161473427|NCT03228433|583128613|FG005|Overall Study|Lost to Follow-up|0|||
161473428|NCT03228433|583128608|FG000|Overall Study|Positive alcohol test|0|||
161473429|NCT03228433|583128609|FG001|Overall Study|Positive alcohol test|0|||
161473430|NCT03228433|583128610|FG002|Overall Study|Positive alcohol test|0|||
161473431|NCT03228433|583128611|FG003|Overall Study|Positive alcohol test|1|||
161473432|NCT03228433|583128612|FG004|Overall Study|Positive alcohol test|0|||
161473433|NCT03228433|583128613|FG005|Overall Study|Positive alcohol test|0|||
161473434|NCT03626168|583128616|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161473435|NCT03626168|583128617|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161473436|NCT03626168|583128616|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
161473437|NCT03626168|583128617|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
161473438|NCT03626168|583128616|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161473439|NCT03626168|583128617|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
161473440|NCT01419626|583128618|FG000|Overall Study|Protocol Violation|3|||
161473441|NCT01419626|583128619|FG001|Overall Study|Protocol Violation|2|||
161473442|NCT01419626|583128620|FG002|Overall Study|Protocol Violation|2|||
161473443|NCT01419626|583128618|FG000|Overall Study|Withdrawal by Subject|1|||
161473444|NCT01419626|583128619|FG001|Overall Study|Withdrawal by Subject|0|||
161473445|NCT01419626|583128620|FG002|Overall Study|Withdrawal by Subject|0|||
161473446|NCT01419626|583128618|FG000|Overall Study|Lost to Follow-up|0|||
161813044|NCT01695239|584359800|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813045|NCT01695239|584359801|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
161813046|NCT01695239|584359802|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813047|NCT01695239|584359803|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813048|NCT01695239|584359804|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813049|NCT01695239|584359805|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813050|NCT01695239|584359806|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813051|NCT01695239|584359807|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813052|NCT01695239|584359794|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813053|NCT01695239|584359795|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813054|NCT01695239|584359796|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813055|NCT01695239|584359797|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813056|NCT01695239|584359798|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813057|NCT01695239|584359799|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813058|NCT01695239|584359800|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161473447|NCT01419626|583128619|FG001|Overall Study|Lost to Follow-up|1|||
161473448|NCT01419626|583128620|FG002|Overall Study|Lost to Follow-up|1|||
161473449|NCT03212690|583128630|FG000|Overall Study|Protocol Violation|1|||
161473450|NCT03208127|583128632|FG000|Overall Study|Death|1|||
161473451|NCT01254331|583128637|FG000|Initial Phase|Adverse Event|3|||
161473452|NCT01254331|583128637|FG000|Initial Phase|Withdrawal by Subject|1|||
161473453|NCT01254331|583128637|FG000|Initial Phase|Pregnancy|1|||
161473454|NCT01254331|583128637|FG000|Extension Phase|Lack of Efficacy|1|||
161473455|NCT01254331|583128637|FG000|Extension Phase|Lost to Follow-up|3|||
161473456|NCT01011738|583128638|FG000|Overall Study|Death|12|||
161473457|NCT01011738|583128639|FG001|Overall Study|Death|3|||
161916428|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
161916429|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
161916430|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
161916431|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Death|38|||
161916432|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Death|10|||
161916433|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
161916434|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
161916435|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
161916436|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
161916437|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
161916438|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
161916439|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
161916440|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
161916441|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
161916442|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
161473458|NCT01011738|583128640|FG002|Overall Study|Death|0|||
161473459|NCT01011738|583128638|FG000|Overall Study|Unknown reasons|312|||
161473460|NCT01011738|583128639|FG001|Overall Study|Unknown reasons|291|||
161473461|NCT01011738|583128640|FG002|Overall Study|Unknown reasons|17|||
161473462|NCT00287365|583128641|FG000|Overall Study|sample not acquired|13|||
161473463|NCT00968864|583128642|FG000|Overall Study|Protocol exception/ not evaluable|1|||
161916443|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
161916444|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
161916445|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
161916446|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
161916447|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
161916448|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
161916449|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Death|118|||
161916450|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Death|65|||
161916451|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
161473464|NCT01346969|583128643|FG000|Overall Study|Withdrawal by Subject|0|||
161473465|NCT01346969|583128644|FG001|Overall Study|Withdrawal by Subject|0|||
161916452|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
161916453|NCT01925417|584742455|FG000|Overall Study|Withdrawal by Subject|2|||
161916454|NCT01925417|584742455|FG000|Overall Study|Death|1|||
161916455|NCT00655889|584742456|FG000|Overall Study|Inadequate cell growth|1|||
161916456|NCT00655889|584742456|FG000|Overall Study|Protocol Violation|1|||
161916457|NCT03573297|584742460|FG000|Open Label Treatment Period|Adverse Event|67|||
161916458|NCT03573297|584742461|FG001|Open Label Treatment Period|Adverse Event|0|||
161916459|NCT03573297|584742462|FG002|Open Label Treatment Period|Adverse Event|0|||
161916460|NCT03573297|584742463|FG003|Open Label Treatment Period|Adverse Event|0|||
161916461|NCT03573297|584742460|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
161916462|NCT03573297|584742461|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
161916463|NCT03573297|584742462|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
161916464|NCT03573297|584742463|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
161916465|NCT03573297|584742460|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
161916466|NCT03573297|584742461|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
161916467|NCT03573297|584742462|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
161916468|NCT03573297|584742463|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
161916469|NCT03573297|584742460|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
161916470|NCT03573297|584742461|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
161916471|NCT03573297|584742462|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
161916472|NCT03573297|584742463|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
161916473|NCT03573297|584742460|FG000|Open Label Treatment Period|Pregnancy|1|||
161916474|NCT03573297|584742461|FG001|Open Label Treatment Period|Pregnancy|0|||
161473466|NCT01346969|583128645|FG002|Overall Study|Withdrawal by Subject|1|||
161473467|NCT01346969|583128646|FG003|Overall Study|Withdrawal by Subject|0|||
161473468|NCT01346969|583128643|FG000|Overall Study|Lost to Follow-up|1|||
161473469|NCT01346969|583128644|FG001|Overall Study|Lost to Follow-up|0|||
161473470|NCT01346969|583128645|FG002|Overall Study|Lost to Follow-up|2|||
161473471|NCT01346969|583128646|FG003|Overall Study|Lost to Follow-up|0|||
161473472|NCT01346969|583128643|FG000|Overall Study|Physician Decision|0|||
161473473|NCT01346969|583128644|FG001|Overall Study|Physician Decision|0|||
161473474|NCT01346969|583128645|FG002|Overall Study|Physician Decision|0|||
161473475|NCT01346969|583128646|FG003|Overall Study|Physician Decision|1|||
161473476|NCT01346969|583128643|FG000|Overall Study|Randomized but not treated|1|||
161916475|NCT03573297|584742462|FG002|Open Label Treatment Period|Pregnancy|0|||
161916476|NCT03573297|584742463|FG003|Open Label Treatment Period|Pregnancy|0|||
161473477|NCT01346969|583128644|FG001|Overall Study|Randomized but not treated|0|||
161473478|NCT01346969|583128645|FG002|Overall Study|Randomized but not treated|0|||
161473479|NCT01346969|583128646|FG003|Overall Study|Randomized but not treated|0|||
161473480|NCT01967173|583128647|FG000|Overall Study|Lost to Follow-up|5|||
161473481|NCT01967173|583128648|FG001|Overall Study|Lost to Follow-up|3|||
161473482|NCT01967173|583128649|FG002|Overall Study|Lost to Follow-up|2|||
161473483|NCT01967173|583128650|FG003|Overall Study|Lost to Follow-up|4|||
161473484|NCT01967173|583128651|FG004|Overall Study|Lost to Follow-up|8|||
161473485|NCT01967173|583128652|FG005|Overall Study|Lost to Follow-up|12|||
161473486|NCT01967173|583128653|FG006|Overall Study|Lost to Follow-up|6|||
161473487|NCT01967173|583128654|FG007|Overall Study|Lost to Follow-up|8|||
161473488|NCT01967173|583128647|FG000|Overall Study|Physician Decision|2|||
161473489|NCT01967173|583128648|FG001|Overall Study|Physician Decision|0|||
161473490|NCT01967173|583128649|FG002|Overall Study|Physician Decision|2|||
161473491|NCT01967173|583128650|FG003|Overall Study|Physician Decision|1|||
161813059|NCT01695239|584359801|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
161813060|NCT01695239|584359802|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813061|NCT01695239|584359803|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813062|NCT01695239|584359804|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813063|NCT01695239|584359805|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813064|NCT01695239|584359806|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813065|NCT01695239|584359807|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813066|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813067|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813068|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813069|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813070|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813071|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813072|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813073|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813074|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
161813075|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
161813076|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813077|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813078|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813079|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813080|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
161813081|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
161813082|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
161813083|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
161813084|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
161813085|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
161813086|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
161813087|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
161813088|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
161813089|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
161813090|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
161813091|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
161813092|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
161813093|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
161813094|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813095|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813096|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813097|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813098|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813099|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813100|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813101|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813102|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
161813103|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
161813104|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813105|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813106|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813107|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813108|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
161813109|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
161813110|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
161813111|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
161813112|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
161813113|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
161813114|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
161473492|NCT01967173|583128651|FG004|Overall Study|Physician Decision|1|||
161473493|NCT01967173|583128652|FG005|Overall Study|Physician Decision|1|||
161473494|NCT01967173|583128653|FG006|Overall Study|Physician Decision|1|||
161473495|NCT01967173|583128654|FG007|Overall Study|Physician Decision|0|||
161473496|NCT01967173|583128647|FG000|Overall Study|Lack of Efficacy|2|||
161473497|NCT01967173|583128648|FG001|Overall Study|Lack of Efficacy|0|||
161473498|NCT01967173|583128649|FG002|Overall Study|Lack of Efficacy|2|||
161473499|NCT01967173|583128650|FG003|Overall Study|Lack of Efficacy|2|||
161473500|NCT01967173|583128651|FG004|Overall Study|Lack of Efficacy|0|||
161473501|NCT01967173|583128652|FG005|Overall Study|Lack of Efficacy|1|||
161473502|NCT01967173|583128653|FG006|Overall Study|Lack of Efficacy|0|||
161473503|NCT01967173|583128654|FG007|Overall Study|Lack of Efficacy|2|||
161473504|NCT01967173|583128647|FG000|Overall Study|Pregnancy|0|||
161473505|NCT01967173|583128648|FG001|Overall Study|Pregnancy|0|||
161473506|NCT01967173|583128649|FG002|Overall Study|Pregnancy|0|||
161473507|NCT01967173|583128650|FG003|Overall Study|Pregnancy|0|||
161473508|NCT01967173|583128651|FG004|Overall Study|Pregnancy|0|||
161473509|NCT01967173|583128652|FG005|Overall Study|Pregnancy|0|||
161473510|NCT01967173|583128653|FG006|Overall Study|Pregnancy|1|||
161473511|NCT01967173|583128654|FG007|Overall Study|Pregnancy|1|||
161473512|NCT01967173|583128647|FG000|Overall Study|Adverse Event|0|||
161473513|NCT01967173|583128648|FG001|Overall Study|Adverse Event|0|||
161473514|NCT01967173|583128649|FG002|Overall Study|Adverse Event|0|||
161473515|NCT01967173|583128650|FG003|Overall Study|Adverse Event|0|||
161473516|NCT01967173|583128651|FG004|Overall Study|Adverse Event|0|||
161473517|NCT01967173|583128652|FG005|Overall Study|Adverse Event|0|||
161473518|NCT01967173|583128653|FG006|Overall Study|Adverse Event|0|||
161473519|NCT01967173|583128654|FG007|Overall Study|Adverse Event|1|||
161473520|NCT01967173|583128647|FG000|Overall Study|Withdrawal by Subject|15|||
161473521|NCT01967173|583128648|FG001|Overall Study|Withdrawal by Subject|14|||
161473522|NCT01967173|583128649|FG002|Overall Study|Withdrawal by Subject|10|||
161473523|NCT01967173|583128650|FG003|Overall Study|Withdrawal by Subject|7|||
161473524|NCT01967173|583128651|FG004|Overall Study|Withdrawal by Subject|8|||
161473525|NCT01967173|583128652|FG005|Overall Study|Withdrawal by Subject|9|||
161473526|NCT01967173|583128653|FG006|Overall Study|Withdrawal by Subject|10|||
161916477|NCT03573297|584742460|FG000|Open Label Treatment Period|Protocol Violation|17|||
161916478|NCT03573297|584742461|FG001|Open Label Treatment Period|Protocol Violation|0|||
161916479|NCT03573297|584742462|FG002|Open Label Treatment Period|Protocol Violation|0|||
161916480|NCT03573297|584742463|FG003|Open Label Treatment Period|Protocol Violation|0|||
161916481|NCT03573297|584742460|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
161916482|NCT03573297|584742461|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161916483|NCT03573297|584742462|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161916484|NCT03573297|584742463|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161916485|NCT03573297|584742460|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
161916486|NCT03573297|584742461|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161916487|NCT03573297|584742462|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161916488|NCT03573297|584742463|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161916489|NCT03573297|584742460|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
161916490|NCT03573297|584742461|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161916491|NCT03573297|584742462|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161916492|NCT03573297|584742463|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161916493|NCT03573297|584742460|FG000|Open Label Treatment Period|Other, Not Specified|7|||
161916494|NCT03573297|584742461|FG001|Open Label Treatment Period|Other, Not Specified|0|||
161916495|NCT03573297|584742462|FG002|Open Label Treatment Period|Other, Not Specified|0|||
161916496|NCT03573297|584742463|FG003|Open Label Treatment Period|Other, Not Specified|0|||
161473527|NCT01967173|583128654|FG007|Overall Study|Withdrawal by Subject|12|||
161473528|NCT03666624|583128656|FG000|Overall Study|participant grieving over recent death of parent|1|||
161473529|NCT03666624|583128657|FG001|Overall Study|participant grieving over recent death of parent|0|||
161473530|NCT05213481|583128659|FG000|Overall Study|Adverse Event|3|||
161473531|NCT05213481|583128659|FG000|Overall Study|Lost to Follow-up|1|||
161473532|NCT00447005|583128661|FG000|Overall Study|Adverse Event|1|||
161473533|NCT00447005|583128661|FG000|Overall Study|Lack of Efficacy|11|||
161473534|NCT00423514|583128662|FG000|Overall Study|Ineligible|1|||
161473535|NCT00423514|583128663|FG001|Overall Study|Ineligible|0|||
161473536|NCT00397215|583128664|FG000|Month 0 (Day 0)|Adverse Event|0|||
161916497|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
161916498|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
161916499|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
161916500|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
161916501|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161916502|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161916503|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Adverse Event|5|||
161916504|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Adverse Event|1|||
161916505|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161916506|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161916507|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161916508|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
161916509|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161916510|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
161916511|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
161916512|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
161916513|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161916514|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
161916515|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
161916516|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
161916517|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161916518|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
161916519|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
161916520|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
161916521|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
161916522|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
161916523|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
161916524|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
161916525|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
161916526|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
161916527|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
161916528|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
161916529|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
161473537|NCT00397215|583128665|FG001|Month 0 (Day 0)|Adverse Event|1|||
161473538|NCT00397215|583128666|FG002|Month 0 (Day 0)|Adverse Event|0|||
161473539|NCT00397215|583128667|FG003|Month 0 (Day 0)|Adverse Event|0|||
161473540|NCT00397215|583128664|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
161473541|NCT00397215|583128665|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
161473542|NCT00397215|583128666|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
161473543|NCT00397215|583128667|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
161473544|NCT00397215|583128664|FG000|Month 0 (Day 0)|Other|4|||
161473545|NCT00397215|583128665|FG001|Month 0 (Day 0)|Other|1|||
161473546|NCT00397215|583128666|FG002|Month 0 (Day 0)|Other|3|||
161473547|NCT00397215|583128667|FG003|Month 0 (Day 0)|Other|3|||
161473548|NCT00397215|583128664|FG000|Month 6 (Day 180)|Adverse Event|0|||
161473549|NCT00397215|583128665|FG001|Month 6 (Day 180)|Adverse Event|3|||
161473550|NCT00397215|583128666|FG002|Month 6 (Day 180)|Adverse Event|2|||
161473551|NCT00397215|583128667|FG003|Month 6 (Day 180)|Adverse Event|0|||
161473552|NCT00397215|583128664|FG000|Month 6 (Day 180)|Other|2|||
161473553|NCT00397215|583128665|FG001|Month 6 (Day 180)|Other|0|||
161473554|NCT00397215|583128666|FG002|Month 6 (Day 180)|Other|3|||
161473555|NCT00397215|583128667|FG003|Month 6 (Day 180)|Other|0|||
161473556|NCT02128932|583128668|FG000|Overall Study|Withdrawal by Subject|11|||
161473557|NCT02128932|583128669|FG001|Overall Study|Withdrawal by Subject|7|||
161473558|NCT02128932|583128670|FG002|Overall Study|Withdrawal by Subject|8|||
161473559|NCT02128932|583128668|FG000|Overall Study|Death|2|||
161473560|NCT02128932|583128669|FG001|Overall Study|Death|0|||
161473561|NCT02128932|583128670|FG002|Overall Study|Death|2|||
161473562|NCT02128932|583128668|FG000|Overall Study|Lost to Follow-up|2|||
161473563|NCT02128932|583128669|FG001|Overall Study|Lost to Follow-up|1|||
161473564|NCT02128932|583128670|FG002|Overall Study|Lost to Follow-up|1|||
161473565|NCT02128932|583128668|FG000|Overall Study|No reason for withdrawal|12|||
161473566|NCT02128932|583128669|FG001|Overall Study|No reason for withdrawal|11|||
161473567|NCT02128932|583128670|FG002|Overall Study|No reason for withdrawal|7|||
161813115|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
161813116|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
161813117|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
161813118|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
161813119|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
161813120|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
161813121|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
161813122|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161916530|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
161916531|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
161916532|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Death|0|||
161916533|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Death|0|||
161916534|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Death|1|||
161916535|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
161916536|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
161916537|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
161916538|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
161916539|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
161916540|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
161916541|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
161916542|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
161916543|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
161916544|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
161916545|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
161916546|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
161916547|NCT02696798|584742465|FG000|Extended Treatment Period|Adverse Event|1|||
161916548|NCT02696798|584742466|FG001|Extended Treatment Period|Adverse Event|4|||
161916549|NCT02696798|584742467|FG002|Extended Treatment Period|Adverse Event|5|||
161916550|NCT02696798|584742465|FG000|Extended Treatment Period|Lack of Efficacy|7|||
161916551|NCT02696798|584742466|FG001|Extended Treatment Period|Lack of Efficacy|2|||
161916552|NCT02696798|584742467|FG002|Extended Treatment Period|Lack of Efficacy|2|||
161916553|NCT02696798|584742465|FG000|Extended Treatment Period|Lost to Follow-up|1|||
161916554|NCT02696798|584742466|FG001|Extended Treatment Period|Lost to Follow-up|0|||
161916555|NCT02696798|584742467|FG002|Extended Treatment Period|Lost to Follow-up|0|||
161916556|NCT02696798|584742465|FG000|Extended Treatment Period|Physician Decision|0|||
161916557|NCT02696798|584742466|FG001|Extended Treatment Period|Physician Decision|1|||
161916558|NCT02696798|584742467|FG002|Extended Treatment Period|Physician Decision|0|||
161916559|NCT02696798|584742465|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
161916560|NCT02696798|584742466|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
161916561|NCT02696798|584742467|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
161916562|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
161916563|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
161916564|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
161916565|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
161473568|NCT03685123|583128675|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
161473569|NCT03685123|583128676|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
161473570|NCT03685123|583128677|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
161473571|NCT03685123|583128675|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
161473572|NCT03685123|583128676|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
161473573|NCT03685123|583128677|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
161473574|NCT03685123|583128675|FG000|Weight Loss Phase|Lost to Follow-up|1|||
161473575|NCT03685123|583128676|FG001|Weight Loss Phase|Lost to Follow-up|0|||
161473576|NCT03685123|583128677|FG002|Weight Loss Phase|Lost to Follow-up|0|||
161813123|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813124|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813125|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813126|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813127|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813128|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813129|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813130|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
161813131|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
161813132|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813133|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813134|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813135|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161916566|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
161916567|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
161916568|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
161916569|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
161916570|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
161916571|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
161916572|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
161916573|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
161916574|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
161916575|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
161916576|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
161916577|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
161916578|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
161916579|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
161916580|NCT04091451|584742468|FG000|Overall Study|Adverse Event|15|||
161916581|NCT04091451|584742469|FG001|Overall Study|Adverse Event|10|||
161916582|NCT04091451|584742468|FG000|Overall Study|Lost to Follow-up|8|||
161916583|NCT04091451|584742469|FG001|Overall Study|Lost to Follow-up|8|||
161916584|NCT04091451|584742468|FG000|Overall Study|Protocol Violation|5|||
161916585|NCT04091451|584742469|FG001|Overall Study|Protocol Violation|4|||
161916586|NCT04091451|584742468|FG000|Overall Study|Withdrawal by Subject|21|||
161916587|NCT04091451|584742469|FG001|Overall Study|Withdrawal by Subject|27|||
161916588|NCT04091451|584742468|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
161916589|NCT04091451|584742469|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
161916590|NCT04091451|584742468|FG000|Overall Study|Migrated/moved from the study area|3|||
161916591|NCT04091451|584742469|FG001|Overall Study|Migrated/moved from the study area|5|||
161916592|NCT04091451|584742468|FG000|Overall Study|Suspected HZ episode|1|||
161916593|NCT04091451|584742469|FG001|Overall Study|Suspected HZ episode|0|||
161916594|NCT04115059|584744259|FG000|Overall Study|Withdrawal by Subject|1|||
161916595|NCT04115059|584744259|FG000|Overall Study|Lack of Efficacy|2|||
161916596|NCT00630292|584744260|FG000|Overall Study|Withdrawal by Subject|1|||
161916597|NCT00717886|584744262|FG000|Overall Study|Withdrawal by Subject|3|||
161916598|NCT00717886|584744262|FG000|Overall Study|Treatment Failure|1|||
161916599|NCT01553851|584744263|FG000|Overall Study|Adverse Event|2|||
161916600|NCT01553851|584744263|FG000|Overall Study|constipation|1|||
161916601|NCT02313155|584744268|FG000|Overall Study|Lost to Follow-up|0|||
161916602|NCT02313155|584744269|FG001|Overall Study|Lost to Follow-up|1|||
161916603|NCT03822416|584744271|FG000|Overall Study|Lost to Follow-up|1|||
161916604|NCT03822416|584744272|FG001|Overall Study|Lost to Follow-up|0|||
161916605|NCT03822416|584744271|FG000|Overall Study|Withdrawal by Subject|0|||
161916606|NCT03822416|584744272|FG001|Overall Study|Withdrawal by Subject|1|||
161916607|NCT04666298|584744273|FG000|Overall Study|Subject decision|1|||
161916608|NCT04666298|584744274|FG001|Overall Study|Subject decision|0|||
161916609|NCT04666298|584744275|FG002|Overall Study|Subject decision|0|||
161916610|NCT04666298|584744276|FG003|Overall Study|Subject decision|2|||
161916611|NCT04666298|584744273|FG000|Overall Study|Death|1|||
161916612|NCT04666298|584744274|FG001|Overall Study|Death|0|||
161916613|NCT04666298|584744275|FG002|Overall Study|Death|0|||
161473577|NCT03685123|583128675|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
161916614|NCT04666298|584744276|FG003|Overall Study|Death|0|||
161916615|NCT04666298|584744273|FG000|Overall Study|Lost to Follow-up|0|||
161916616|NCT04666298|584744274|FG001|Overall Study|Lost to Follow-up|0|||
161916617|NCT04666298|584744275|FG002|Overall Study|Lost to Follow-up|0|||
161916618|NCT04666298|584744276|FG003|Overall Study|Lost to Follow-up|1|||
161916619|NCT04666298|584744273|FG000|Overall Study|Physician Decision|0|||
161916620|NCT04666298|584744274|FG001|Overall Study|Physician Decision|0|||
161916621|NCT04666298|584744275|FG002|Overall Study|Physician Decision|0|||
161916622|NCT04666298|584744276|FG003|Overall Study|Physician Decision|1|||
161916623|NCT04666298|584744273|FG000|Overall Study|Protocol deviation|0|||
161916624|NCT04666298|584744274|FG001|Overall Study|Protocol deviation|0|||
161916625|NCT04666298|584744275|FG002|Overall Study|Protocol deviation|1|||
161916626|NCT04666298|584744276|FG003|Overall Study|Protocol deviation|0|||
161916627|NCT00844519|584744277|FG000|Overall Study|Withdrawal by Subject|1|||
161916628|NCT00844519|584744278|FG001|Overall Study|Withdrawal by Subject|1|||
161916629|NCT00844519|584744277|FG000|Overall Study|Adverse Event|1|||
161916630|NCT00844519|584744278|FG001|Overall Study|Adverse Event|0|||
161916631|NCT01303419|584744281|FG000|Overall Study|Discontinuation of study|60|||
161916632|NCT01303419|584744281|FG000|Overall Study|Did not complete both imaging methods|5|||
161916633|NCT01303419|584744281|FG000|Overall Study|Did not meet all I/E after screening|31|||
161916634|NCT06438601|584744282|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
161916635|NCT06438601|584744283|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
161916636|NCT06438601|584744282|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
161916637|NCT06438601|584744283|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
161916638|NCT03329001|584744284|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916639|NCT03329001|584744285|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916640|NCT03329001|584744286|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
161916641|NCT03329001|584744287|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
161916642|NCT03329001|584744288|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916643|NCT03329001|584744289|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916644|NCT03329001|584744290|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916645|NCT03329001|584744291|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916646|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916647|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916648|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916649|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
161916650|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916651|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916652|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916653|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916654|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916655|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916656|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161473578|NCT03685123|583128676|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
161473579|NCT03685123|583128677|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
161473580|NCT03685123|583128675|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
161473581|NCT03685123|583128676|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
161473582|NCT03685123|583128677|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
161473583|NCT03685123|583128675|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
161473584|NCT03685123|583128676|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
161473585|NCT03685123|583128677|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
161473586|NCT01254630|583128678|FG000|Overall Study|Adverse Event|36|||
161473587|NCT01254630|583128679|FG001|Overall Study|Adverse Event|15|||
161473588|NCT01254630|583128680|FG002|Overall Study|Adverse Event|40|||
161473589|NCT01254630|583128681|FG003|Overall Study|Adverse Event|8|||
161473590|NCT01254630|583128678|FG000|Overall Study|Death|461|||
161473591|NCT01254630|583128679|FG001|Overall Study|Death|151|||
161473592|NCT01254630|583128680|FG002|Overall Study|Death|478|||
161473593|NCT01254630|583128681|FG003|Overall Study|Death|139|||
161473594|NCT01254630|583128678|FG000|Overall Study|Lost to Follow-up|80|||
161473595|NCT01254630|583128679|FG001|Overall Study|Lost to Follow-up|26|||
161473596|NCT01254630|583128680|FG002|Overall Study|Lost to Follow-up|89|||
161473597|NCT01254630|583128681|FG003|Overall Study|Lost to Follow-up|32|||
161473598|NCT01254630|583128678|FG000|Overall Study|Physician Decision|24|||
161473599|NCT01254630|583128679|FG001|Overall Study|Physician Decision|8|||
161473600|NCT01254630|583128680|FG002|Overall Study|Physician Decision|16|||
161473601|NCT01254630|583128681|FG003|Overall Study|Physician Decision|7|||
161473602|NCT01254630|583128678|FG000|Overall Study|Withdrawal by Subject|201|||
161473603|NCT01254630|583128679|FG001|Overall Study|Withdrawal by Subject|94|||
161473604|NCT01254630|583128680|FG002|Overall Study|Withdrawal by Subject|188|||
161473605|NCT01254630|583128681|FG003|Overall Study|Withdrawal by Subject|89|||
161916657|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
161916658|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916659|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916660|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916661|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916662|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916663|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916664|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916665|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
161916666|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916667|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916668|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916669|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916670|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916671|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916672|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
161916673|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916674|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916675|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916676|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916677|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916678|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916679|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916680|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
161916681|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916682|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916683|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916684|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916685|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916686|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916687|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161473606|NCT01254630|583128678|FG000|Overall Study|Study terminated by sponsor|0|||
161473607|NCT01254630|583128679|FG001|Overall Study|Study terminated by sponsor|994|||
161813136|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813137|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813138|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813139|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813140|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813141|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813142|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813143|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813144|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
161813145|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
161813146|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813147|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813148|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813149|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813150|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Death|0|||
161813151|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Death|0|||
161813152|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Death|0|||
161813153|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Death|0|||
161813154|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Death|0|||
161813155|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Death|0|||
161813156|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Death|0|||
161813157|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Death|0|||
161813158|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Death|1|||
161813159|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Death|0|||
161813160|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Death|0|||
161813161|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Death|0|||
161813162|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Death|0|||
161813163|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Death|0|||
161813164|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813165|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813166|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813167|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813168|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813169|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813170|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813171|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813172|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813173|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813174|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813175|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
161813176|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
161813177|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161813178|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813179|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813180|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813181|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813182|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813183|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813184|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813185|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813186|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813187|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813188|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813189|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813190|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161813191|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161813192|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813193|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813194|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813195|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813196|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813197|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813198|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813199|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813200|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
161473608|NCT01254630|583128680|FG002|Overall Study|Study terminated by sponsor|0|||
161813201|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813202|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813203|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813204|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
161813205|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813206|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813207|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813208|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813209|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813210|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813211|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813212|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813213|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813214|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813215|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813216|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813217|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813218|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813219|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
161813220|NCT03502811|584359808|FG000|Overall Study|Death|157|||
161813221|NCT03502811|584359808|FG000|Overall Study|Withdrawal by Subject|105|||
161813222|NCT03502811|584359808|FG000|Overall Study|Lost to Follow-up|26|||
161813223|NCT03502811|584359808|FG000|Overall Study|No Visits (Missed)|31|||
161813224|NCT03913377|584359809|FG000|Period 1|Test Article no longer available|0|||
161813225|NCT03913377|584359810|FG001|Period 1|Test Article no longer available|1|||
161813226|NCT03913377|584359811|FG002|Period 1|Test Article no longer available|0|||
161813227|NCT03913377|584359809|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
161813228|NCT03913377|584359810|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
161813229|NCT03913377|584359811|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
161813230|NCT05239195|584359812|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
161813231|NCT05239195|584359813|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
161813232|NCT00933686|584359814|FG000|Overall Study|Protocol Violation|0|||
161813233|NCT00933686|584359815|FG001|Overall Study|Protocol Violation|1|||
161813234|NCT00933686|584359814|FG000|Overall Study|Lost to Follow-up|2|||
161813235|NCT00933686|584359815|FG001|Overall Study|Lost to Follow-up|2|||
161813236|NCT00933686|584359814|FG000|Overall Study|Withdrawal by Subject|6|||
161813237|NCT00933686|584359815|FG001|Overall Study|Withdrawal by Subject|5|||
161813238|NCT00933686|584359814|FG000|Overall Study|Adverse Event|1|||
161813239|NCT00933686|584359815|FG001|Overall Study|Adverse Event|1|||
161813240|NCT00933686|584359814|FG000|Overall Study|Physician Decision|1|||
161813241|NCT00933686|584359815|FG001|Overall Study|Physician Decision|0|||
161813242|NCT00933686|584359814|FG000|Overall Study|Failure to show up at endpoint visits|0|||
161813243|NCT00933686|584359815|FG001|Overall Study|Failure to show up at endpoint visits|2|||
161813244|NCT01244620|584359818|FG000|Overall Study|Study terminated|4|||
161813245|NCT01244620|584359819|FG001|Overall Study|Study terminated|4|||
161813246|NCT01244620|584359820|FG002|Overall Study|Study terminated|4|||
161813247|NCT01244620|584359821|FG003|Overall Study|Study terminated|4|||
161813248|NCT01663233|584359822|FG000|Overall Study|Withdrawal by Subject|3|||
161813249|NCT01663233|584359823|FG001|Overall Study|Withdrawal by Subject|2|||
161813250|NCT01663233|584359822|FG000|Overall Study|Protocol Deviation|1|||
161813251|NCT01663233|584359823|FG001|Overall Study|Protocol Deviation|4|||
161813252|NCT01663233|584359822|FG000|Overall Study|Lost to Follow-up|0|||
161813253|NCT01663233|584359823|FG001|Overall Study|Lost to Follow-up|1|||
161813254|NCT02321098|584359824|FG000|12 Weeks Treament|Lost to Follow-up|1|||
161813255|NCT02321098|584359825|FG001|12 Weeks Treament|Lost to Follow-up|1|||
161813256|NCT02321098|584359826|FG002|12 Weeks Treament|Lost to Follow-up|0|||
161813257|NCT02321098|584359824|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
161813258|NCT02321098|584359825|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
161813259|NCT02321098|584359826|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
161813260|NCT02321098|584359824|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
161813261|NCT02321098|584359825|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
161813262|NCT02321098|584359826|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
161473609|NCT01254630|583128681|FG003|Overall Study|Study terminated by sponsor|1010|||
161473610|NCT01254630|583128678|FG000|Overall Study|Status not recorded|0|||
161473611|NCT01254630|583128679|FG001|Overall Study|Status not recorded|0|||
161813263|NCT02321098|584359824|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
161813264|NCT02321098|584359825|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
161813265|NCT02321098|584359826|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
161473612|NCT01254630|583128680|FG002|Overall Study|Status not recorded|1|||
161473613|NCT01254630|583128681|FG003|Overall Study|Status not recorded|0|||
161473614|NCT02959983|583128682|FG000|Overall Study|Protocol Violation|0|||
161813266|NCT00796328|584359829|FG000|Overall Study|experienced hypotension requiring tx|6|||
161813267|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Adverse Event|11|||
161813268|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Adverse Event|23|||
161813269|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Adverse Event|29|||
161813270|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Adverse Event|2|||
161813271|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Adverse Event|8|||
161813272|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
161813273|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
161813274|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
161813275|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
161813276|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
161813277|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
161813278|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
161813279|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
161813280|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
161813281|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
161813282|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
161813283|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
161813284|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
161813285|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
161813286|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
161813287|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813288|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
161813289|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813290|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813291|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813292|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
161813293|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
161813294|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
161813295|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
161813296|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
161813297|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
161813298|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
161813299|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
161813300|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
161813301|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
161813302|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Move|0|||
161813303|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Move|1|||
161813304|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Move|0|||
161813305|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Move|0|||
161813306|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Move|0|||
161813307|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813308|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813309|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813310|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813311|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
161813312|NCT00318461|584359832|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
161813313|NCT00318461|584359833|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161813314|NCT00318461|584359834|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161813315|NCT00318461|584359835|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
161813316|NCT00318461|584359836|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161813317|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Work commitment|0|||
161813318|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Work commitment|0|||
161813319|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Work commitment|0|||
161813320|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Work commitment|0|||
161813321|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Work commitment|1|||
161813322|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Investigator decision|0|||
161813323|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Investigator decision|0|||
161813324|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Investigator decision|0|||
161813325|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Investigator decision|0|||
161813326|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Investigator decision|1|||
161813327|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Lack of time|1|||
161813328|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Lack of time|0|||
161813329|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Lack of time|0|||
161813330|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Lack of time|0|||
161813331|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Lack of time|0|||
161813332|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161813333|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161813334|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161916688|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
161916689|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916690|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916691|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916692|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916693|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916694|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916695|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916696|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
161916697|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916698|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916699|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916700|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916701|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916702|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916703|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916704|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
161916705|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
161916706|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916707|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916708|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916709|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916710|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916711|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916712|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
161916713|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916714|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916715|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916716|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916717|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916718|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916719|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916720|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
161916721|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
161916722|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916723|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916724|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916725|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916726|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916727|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916728|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
161916729|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
161916730|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916731|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916732|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916733|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916734|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916735|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916736|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
161916737|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
161916738|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916739|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916740|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916741|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916742|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916743|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916744|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916745|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
161916746|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916747|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916748|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916749|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916750|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916751|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916752|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916753|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
161916754|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916755|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916756|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916757|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916758|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916759|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916760|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
161916761|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916762|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916763|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916764|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916765|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916766|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916767|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916768|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
161916769|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
161916770|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916771|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916772|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916773|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916774|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916775|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916776|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
161916777|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916778|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916779|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916780|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916781|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916782|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916783|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916784|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
161916785|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916786|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916787|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916788|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916789|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916790|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916791|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916792|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916793|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
161916794|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916795|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916796|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916797|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916798|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916799|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916800|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916801|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916802|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916803|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
161916804|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916805|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916806|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916807|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916808|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916809|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916810|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
161916811|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916812|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916813|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916814|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916815|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916816|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916817|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916818|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
161916819|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
161916820|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916821|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916822|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916823|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916824|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916825|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916826|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
161916827|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916828|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916829|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916830|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916831|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916832|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161473615|NCT02959983|583128683|FG001|Overall Study|Protocol Violation|1|||
161473616|NCT02959983|583128682|FG000|Overall Study|Lack of Efficacy|0|||
161473617|NCT02959983|583128683|FG001|Overall Study|Lack of Efficacy|1|||
161473618|NCT02959983|583128682|FG000|Overall Study|Lost to Follow-up|12|||
161473619|NCT02959983|583128683|FG001|Overall Study|Lost to Follow-up|9|||
161473620|NCT02959983|583128682|FG000|Overall Study|Other|1|||
161473621|NCT02959983|583128683|FG001|Overall Study|Other|1|||
161473622|NCT02959983|583128682|FG000|Overall Study|Physician Decision|1|||
161473623|NCT02959983|583128683|FG001|Overall Study|Physician Decision|0|||
161576247|NCT01040689|583496149|FG001|Overall Study|Adverse Event|0|||
161576248|NCT01040689|583496150|FG002|Overall Study|Adverse Event|2|||
161473624|NCT02959983|583128682|FG000|Overall Study|Adverse Event|5|||
161473625|NCT02959983|583128683|FG001|Overall Study|Adverse Event|1|||
161473626|NCT02959983|583128682|FG000|Overall Study|Withdrawal by Subject|7|||
161473627|NCT02959983|583128683|FG001|Overall Study|Withdrawal by Subject|12|||
161473628|NCT02925117|583128689|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
161473629|NCT02925117|583128690|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
161473630|NCT02925117|583128691|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
161473631|NCT02925117|583128692|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
161473632|NCT02925117|583128693|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473633|NCT02925117|583128694|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473634|NCT02925117|583128695|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473635|NCT02925117|583128696|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473636|NCT02925117|583128697|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473637|NCT02925117|583128698|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473638|NCT02925117|583128699|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473639|NCT02925117|583128700|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
161473640|NCT02925117|583128689|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
161473641|NCT02925117|583128690|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
161473642|NCT02925117|583128691|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
161473643|NCT02925117|583128692|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473644|NCT02925117|583128693|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473645|NCT02925117|583128694|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161813335|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161813336|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
161813337|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813338|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813339|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813340|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
161473646|NCT02925117|583128695|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473647|NCT02925117|583128696|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161813341|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813342|NCT00318461|584359832|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813343|NCT00318461|584359833|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813344|NCT00318461|584359834|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813345|NCT00318461|584359835|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813346|NCT00318461|584359836|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
161813347|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813348|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
161813349|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813350|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813351|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813352|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
161813353|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
161813354|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
161813355|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
161813356|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
161813357|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
161813358|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
161813359|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
161813360|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
161813361|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
161813362|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
161813363|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
161813364|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
161473648|NCT02925117|583128697|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473649|NCT02925117|583128698|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473650|NCT02925117|583128699|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473651|NCT02925117|583128700|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161473652|NCT02925117|583128689|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
161473653|NCT02925117|583128690|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
161473654|NCT02925117|583128691|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473655|NCT02925117|583128692|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473656|NCT02925117|583128693|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473657|NCT02925117|583128694|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473658|NCT02925117|583128695|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473659|NCT02925117|583128696|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473660|NCT02925117|583128697|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473661|NCT02925117|583128698|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473662|NCT02925117|583128699|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473663|NCT02925117|583128700|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
161473664|NCT02925117|583128689|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
161473665|NCT02925117|583128690|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
161473666|NCT02925117|583128691|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
161473667|NCT02925117|583128692|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
161473668|NCT02925117|583128693|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
161473669|NCT02925117|583128694|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
161473670|NCT02925117|583128695|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
161473671|NCT02925117|583128696|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
161473672|NCT02925117|583128697|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
161473673|NCT02925117|583128698|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
161473674|NCT02925117|583128699|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
161473675|NCT02925117|583128700|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
161473676|NCT02925117|583128689|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161473677|NCT02925117|583128690|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161473678|NCT02925117|583128691|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161473679|NCT02925117|583128692|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161813365|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
161813366|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
161813367|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
161813368|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
161813369|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
161813370|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
161813371|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
161813372|NCT00796653|584359837|FG000|Overall Study|Adverse Event|19|||
161813373|NCT00796653|584359838|FG001|Overall Study|Adverse Event|16|||
161813374|NCT00796653|584359839|FG002|Overall Study|Adverse Event|16|||
161813375|NCT00796653|584359840|FG003|Overall Study|Adverse Event|16|||
161813376|NCT00796653|584359837|FG000|Overall Study|Lost to Follow-up|2|||
161813377|NCT00796653|584359838|FG001|Overall Study|Lost to Follow-up|1|||
161813378|NCT00796653|584359839|FG002|Overall Study|Lost to Follow-up|2|||
161813379|NCT00796653|584359840|FG003|Overall Study|Lost to Follow-up|3|||
161813380|NCT00796653|584359837|FG000|Overall Study|Withdrawal by Subject|16|||
161813381|NCT00796653|584359838|FG001|Overall Study|Withdrawal by Subject|8|||
161813382|NCT00796653|584359839|FG002|Overall Study|Withdrawal by Subject|8|||
161813383|NCT00796653|584359840|FG003|Overall Study|Withdrawal by Subject|13|||
161813384|NCT00796653|584359837|FG000|Overall Study|Lack of Efficacy|8|||
161813385|NCT00796653|584359838|FG001|Overall Study|Lack of Efficacy|1|||
161813386|NCT00796653|584359839|FG002|Overall Study|Lack of Efficacy|3|||
161813387|NCT00796653|584359840|FG003|Overall Study|Lack of Efficacy|2|||
161813388|NCT00796653|584359837|FG000|Overall Study|Non compliance with protocol|2|||
161813389|NCT00796653|584359838|FG001|Overall Study|Non compliance with protocol|2|||
161813390|NCT00796653|584359839|FG002|Overall Study|Non compliance with protocol|0|||
161813391|NCT00796653|584359840|FG003|Overall Study|Non compliance with protocol|2|||
161813392|NCT00796653|584359837|FG000|Overall Study|Other reason not described above|4|||
161813393|NCT00796653|584359838|FG001|Overall Study|Other reason not described above|9|||
161813394|NCT00796653|584359839|FG002|Overall Study|Other reason not described above|7|||
161813395|NCT00796653|584359840|FG003|Overall Study|Other reason not described above|4|||
161813396|NCT00835692|584359842|FG000|First Intervention|Withdrawal by Subject|1|||
161813397|NCT00835692|584359843|FG001|First Intervention|Withdrawal by Subject|0|||
161813398|NCT00191815|584359846|FG000|Overall Study|Adverse Event|2|||
161813399|NCT00191815|584359846|FG000|Overall Study|Disease progression or relapse|24|||
161813400|NCT00191815|584359846|FG000|Overall Study|Death|2|||
161813401|NCT00191815|584359846|FG000|Overall Study|Protocol Violation|3|||
161813402|NCT00191815|584359846|FG000|Overall Study|Physician Decision|2|||
161813403|NCT00191815|584359846|FG000|Overall Study|Withdrawal by Subject|7|||
161813404|NCT03644550|584359847|FG000|Overall Study|Withdrawal by Subject|3|||
161813405|NCT03644550|584359847|FG000|Overall Study|Progressive disease|15|||
161813406|NCT01218867|584359848|FG000|Overall Study|Death during treatment|0|||
161813407|NCT01218867|584359849|FG001|Overall Study|Death during treatment|0|||
161813408|NCT01218867|584359850|FG002|Overall Study|Death during treatment|0|||
161813409|NCT01218867|584359851|FG003|Overall Study|Death during treatment|0|||
161813410|NCT01218867|584359852|FG004|Overall Study|Death during treatment|0|||
161813411|NCT01218867|584359853|FG005|Overall Study|Death during treatment|0|||
161813412|NCT01218867|584359854|FG006|Overall Study|Death during treatment|1|||
161813413|NCT01218867|584359855|FG007|Overall Study|Death during treatment|0|||
161813414|NCT01218867|584359856|FG008|Overall Study|Death during treatment|0|||
161813415|NCT01218867|584359857|FG009|Overall Study|Death during treatment|0|||
161813416|NCT01218867|584359858|FG010|Overall Study|Death during treatment|0|||
161813417|NCT00251979|584359859|FG000|Overall Study|Protocol Violation|3|||
161813418|NCT00251979|584359860|FG001|Overall Study|Protocol Violation|5|||
161813419|NCT00251979|584359859|FG000|Overall Study|Adverse Event|11|||
161473680|NCT02925117|583128693|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161813420|NCT00251979|584359860|FG001|Overall Study|Adverse Event|17|||
161813421|NCT00251979|584359859|FG000|Overall Study|Withdrawal by Subject|13|||
161473681|NCT02925117|583128694|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
161473682|NCT02925117|583128695|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161916833|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916834|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
161916835|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
161916836|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916837|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916838|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916839|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916840|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916841|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916842|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916843|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916844|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
161916845|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
161916846|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916847|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916848|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916849|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916850|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916851|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916852|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
161916853|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916854|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916855|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916856|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916857|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916858|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916859|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916860|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
161916861|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
161916862|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916863|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916864|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916865|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916866|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916867|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916868|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
161916869|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
161916870|NCT02178956|584744292|FG000|Overall Study|Lost to Follow-up|4|||
161916871|NCT02178956|584744293|FG001|Overall Study|Lost to Follow-up|4|||
161916872|NCT02178956|584744292|FG000|Overall Study|Sponsor terminated study|49|||
161916873|NCT02178956|584744293|FG001|Overall Study|Sponsor terminated study|58|||
161916874|NCT02178956|584744292|FG000|Overall Study|Withdrawal by Subject|15|||
161916875|NCT02178956|584744293|FG001|Overall Study|Withdrawal by Subject|11|||
161916876|NCT02178956|584744292|FG000|Overall Study|Various Reasons|3|||
161916877|NCT02178956|584744293|FG001|Overall Study|Various Reasons|5|||
161916878|NCT02709369|584744299|FG000|Overall Study|Lost to Follow-up|15|||
161916879|NCT02709369|584744299|FG000|Overall Study|Withdrawal by Subject|10|||
161916880|NCT02709369|584744299|FG000|Overall Study|Did not received intervention|2|||
161916881|NCT01104766|584744301|FG000|Overall Study|Did not meet inc/exc criteria|1|||
161916882|NCT01104766|584744302|FG001|Overall Study|Did not meet inc/exc criteria|0|||
161916883|NCT01104766|584744303|FG002|Overall Study|Did not meet inc/exc criteria|0|||
161916884|NCT01104766|584744304|FG003|Overall Study|Did not meet inc/exc criteria|0|||
161916885|NCT01104766|584744301|FG000|Overall Study|Adverse Event|17|||
161916886|NCT01104766|584744302|FG001|Overall Study|Adverse Event|15|||
161916887|NCT01104766|584744303|FG002|Overall Study|Adverse Event|20|||
161916888|NCT01104766|584744304|FG003|Overall Study|Adverse Event|14|||
161916889|NCT01104766|584744301|FG000|Overall Study|Lack of Efficacy|20|||
161916890|NCT01104766|584744302|FG001|Overall Study|Lack of Efficacy|15|||
161916891|NCT01104766|584744303|FG002|Overall Study|Lack of Efficacy|14|||
161916892|NCT01104766|584744304|FG003|Overall Study|Lack of Efficacy|8|||
161916893|NCT01104766|584744301|FG000|Overall Study|Protocol Violation|2|||
161916894|NCT01104766|584744302|FG001|Overall Study|Protocol Violation|0|||
161916895|NCT01104766|584744303|FG002|Overall Study|Protocol Violation|0|||
161916896|NCT01104766|584744304|FG003|Overall Study|Protocol Violation|0|||
161916897|NCT01104766|584744301|FG000|Overall Study|Withdrawal by Subject|17|||
161916898|NCT01104766|584744302|FG001|Overall Study|Withdrawal by Subject|19|||
161916899|NCT01104766|584744303|FG002|Overall Study|Withdrawal by Subject|25|||
161916900|NCT01104766|584744304|FG003|Overall Study|Withdrawal by Subject|15|||
161916901|NCT01104766|584744301|FG000|Overall Study|Lost to Follow-up|1|||
161916902|NCT01104766|584744302|FG001|Overall Study|Lost to Follow-up|2|||
161916903|NCT01104766|584744303|FG002|Overall Study|Lost to Follow-up|1|||
161916904|NCT01104766|584744304|FG003|Overall Study|Lost to Follow-up|1|||
161813422|NCT00251979|584359860|FG001|Overall Study|Withdrawal by Subject|7|||
161813423|NCT00251979|584359859|FG000|Overall Study|Lost to Follow-up|8|||
161813424|NCT00251979|584359860|FG001|Overall Study|Lost to Follow-up|6|||
161813425|NCT00251979|584359859|FG000|Overall Study|Death|3|||
161813426|NCT00251979|584359860|FG001|Overall Study|Death|5|||
161813427|NCT01348789|584359870|FG000|Overall Study|Protocol Violation|2|||
161813428|NCT01348789|584359870|FG000|Overall Study|Withdrawal by Subject|2|||
161813429|NCT01878292|584359871|FG000|Randomized|Protocol Violation|1|||
161813430|NCT01878292|584359872|FG001|Randomized|Protocol Violation|0|||
161813431|NCT01878292|584359873|FG002|Randomized|Protocol Violation|0|||
161813432|NCT01878292|584359871|FG000|Randomized|Lost to Follow-up|1|||
161813433|NCT01878292|584359872|FG001|Randomized|Lost to Follow-up|0|||
161813434|NCT01878292|584359873|FG002|Randomized|Lost to Follow-up|0|||
161813435|NCT01878292|584359871|FG000|Randomized|Adverse Event|1|||
161813436|NCT01878292|584359872|FG001|Randomized|Adverse Event|0|||
161813437|NCT01878292|584359873|FG002|Randomized|Adverse Event|0|||
161813438|NCT01878292|584359871|FG000|Double-blind Treatment Period|Other Reasons|2|||
161813439|NCT01878292|584359872|FG001|Double-blind Treatment Period|Other Reasons|0|||
161813440|NCT01878292|584359873|FG002|Double-blind Treatment Period|Other Reasons|0|||
161813441|NCT01878292|584359871|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
161813442|NCT01878292|584359872|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
161813443|NCT01878292|584359873|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161813444|NCT01878292|584359871|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
161813445|NCT01878292|584359872|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
161813446|NCT01878292|584359873|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
161813447|NCT01878292|584359871|FG000|Double-blind Treatment Period|Protocol Violation|3|||
161813448|NCT01878292|584359872|FG001|Double-blind Treatment Period|Protocol Violation|4|||
161813449|NCT01878292|584359873|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161813450|NCT01878292|584359871|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
161813451|NCT01878292|584359872|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
161813452|NCT01878292|584359873|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161813453|NCT01878292|584359871|FG000|Double-blind Treatment Period|Adverse Event|4|||
161813454|NCT01878292|584359872|FG001|Double-blind Treatment Period|Adverse Event|9|||
161813455|NCT01878292|584359873|FG002|Double-blind Treatment Period|Adverse Event|8|||
161813456|NCT01878292|584359871|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
161813457|NCT01878292|584359872|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
161813458|NCT01878292|584359873|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
161916905|NCT01341470|584744305|FG000|Overall Study|Sponsor decision|0|||
161916906|NCT01341470|584744306|FG001|Overall Study|Sponsor decision|0|||
161916907|NCT01341470|584744307|FG002|Overall Study|Sponsor decision|1|||
161916908|NCT01341470|584744308|FG003|Overall Study|Sponsor decision|1|||
161916909|NCT01341470|584744309|FG004|Overall Study|Sponsor decision|0|||
161916910|NCT01341470|584744310|FG005|Overall Study|Sponsor decision|1|||
161916911|NCT05452239|584744314|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
161916912|NCT05452239|584744315|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
161916913|NCT05452239|584744314|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
161916914|NCT05452239|584744315|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
161916915|NCT05452239|584744314|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
161916916|NCT05452239|584744315|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
161916917|NCT05452239|584744314|FG000|Placebo-controlled Period|Randomized but not treated|2|||
161916918|NCT05452239|584744315|FG001|Placebo-controlled Period|Randomized but not treated|2|||
161916919|NCT05452239|584744314|FG000|Placebo-controlled Period|Other than specified|1|||
161916920|NCT05452239|584744315|FG001|Placebo-controlled Period|Other than specified|1|||
161916921|NCT05452239|584744314|FG000|Open-label Period|Withdrawal by Subject|2|||
161916922|NCT05452239|584744315|FG001|Open-label Period|Withdrawal by Subject|1|||
161916923|NCT05452239|584744314|FG000|Open-label Period|Lost to Follow-up|3|||
161916924|NCT05452239|584744315|FG001|Open-label Period|Lost to Follow-up|0|||
161916925|NCT05452239|584744314|FG000|Open-label Period|Other than specified|1|||
161916926|NCT05452239|584744315|FG001|Open-label Period|Other than specified|2|||
161916927|NCT03965923|584744316|FG000|Overall Study|Withdrawal by Subject|1|||
161916928|NCT03965923|584744317|FG001|Overall Study|Withdrawal by Subject|2|||
161916929|NCT03965923|584744318|FG002|Overall Study|Withdrawal by Subject|3|||
161916930|NCT03965923|584744319|FG003|Overall Study|Withdrawal by Subject|1|||
161916931|NCT03965923|584744320|FG004|Overall Study|Withdrawal by Subject|2|||
161813459|NCT00323882|584359874|FG000|Overall Study|Adverse Event|2|||
161916932|NCT03965923|584744321|FG005|Overall Study|Withdrawal by Subject|0|||
161916933|NCT03965923|584744322|FG006|Overall Study|Withdrawal by Subject|4|||
161916934|NCT03965923|584744323|FG007|Overall Study|Withdrawal by Subject|3|||
161916935|NCT03965923|584744324|FG008|Overall Study|Withdrawal by Subject|4|||
161916936|NCT03965923|584744325|FG009|Overall Study|Withdrawal by Subject|0|||
161916937|NCT03965923|584744326|FG010|Overall Study|Withdrawal by Subject|2|||
161916938|NCT03965923|584744327|FG011|Overall Study|Withdrawal by Subject|0|||
161916939|NCT03965923|584744316|FG000|Overall Study|Lost to Follow-up|2|||
161916940|NCT03965923|584744317|FG001|Overall Study|Lost to Follow-up|1|||
161916941|NCT03965923|584744318|FG002|Overall Study|Lost to Follow-up|1|||
161916942|NCT03965923|584744319|FG003|Overall Study|Lost to Follow-up|0|||
161916943|NCT03965923|584744320|FG004|Overall Study|Lost to Follow-up|2|||
161916944|NCT03965923|584744321|FG005|Overall Study|Lost to Follow-up|1|||
161916945|NCT03965923|584744322|FG006|Overall Study|Lost to Follow-up|2|||
161916946|NCT03965923|584744323|FG007|Overall Study|Lost to Follow-up|1|||
161916947|NCT03965923|584744324|FG008|Overall Study|Lost to Follow-up|0|||
161916948|NCT03965923|584744325|FG009|Overall Study|Lost to Follow-up|2|||
161916949|NCT03965923|584744326|FG010|Overall Study|Lost to Follow-up|0|||
161916950|NCT03965923|584744327|FG011|Overall Study|Lost to Follow-up|0|||
161916951|NCT03965923|584744316|FG000|Overall Study|Death|0|||
161916952|NCT03965923|584744317|FG001|Overall Study|Death|0|||
161916953|NCT03965923|584744318|FG002|Overall Study|Death|0|||
161916954|NCT03965923|584744319|FG003|Overall Study|Death|0|||
161916955|NCT03965923|584744320|FG004|Overall Study|Death|0|||
161916956|NCT03965923|584744321|FG005|Overall Study|Death|0|||
161916957|NCT03965923|584744322|FG006|Overall Study|Death|0|||
161916958|NCT03965923|584744323|FG007|Overall Study|Death|1|||
161916959|NCT03965923|584744324|FG008|Overall Study|Death|4|||
161916960|NCT03965923|584744325|FG009|Overall Study|Death|0|||
161916961|NCT03965923|584744326|FG010|Overall Study|Death|4|||
161916962|NCT03965923|584744327|FG011|Overall Study|Death|0|||
161916963|NCT03965923|584744316|FG000|Overall Study|Other reason|0|||
161916964|NCT03965923|584744317|FG001|Overall Study|Other reason|0|||
161916965|NCT03965923|584744318|FG002|Overall Study|Other reason|0|||
161916966|NCT03965923|584744319|FG003|Overall Study|Other reason|1|||
161916967|NCT03965923|584744320|FG004|Overall Study|Other reason|0|||
161916968|NCT03965923|584744321|FG005|Overall Study|Other reason|0|||
161916969|NCT03965923|584744322|FG006|Overall Study|Other reason|0|||
161916970|NCT03965923|584744323|FG007|Overall Study|Other reason|0|||
161916971|NCT03965923|584744324|FG008|Overall Study|Other reason|0|||
161916972|NCT03965923|584744325|FG009|Overall Study|Other reason|0|||
161916973|NCT03965923|584744326|FG010|Overall Study|Other reason|2|||
161916974|NCT03965923|584744327|FG011|Overall Study|Other reason|0|||
161916975|NCT03282097|584744328|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
161916976|NCT03282097|584744329|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
161916977|NCT03282097|584744328|FG000|Intervention Visit Complete|Patient Death|13|||
161916978|NCT03282097|584744329|FG001|Intervention Visit Complete|Patient Death|15|||
161916979|NCT03282097|584744328|FG000|Intervention Visit Complete|Caregiver Death|0|||
161916980|NCT03282097|584744329|FG001|Intervention Visit Complete|Caregiver Death|3|||
161916981|NCT03282097|584744328|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
161916982|NCT03282097|584744329|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
161916983|NCT03282097|584744328|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
161916984|NCT03282097|584744329|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
161916985|NCT03282097|584744328|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
161916986|NCT03282097|584744329|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
161916987|NCT03282097|584744328|FG000|Primary Outcome Data Collection Complete|Missing|2|||
161916988|NCT03282097|584744329|FG001|Primary Outcome Data Collection Complete|Missing|3|||
161916989|NCT03282097|584744328|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
161916990|NCT03282097|584744329|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
161916991|NCT03282097|584744328|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
161916992|NCT03282097|584744329|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
161916993|NCT03282097|584744328|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
161916994|NCT03282097|584744329|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
161916995|NCT02755090|584744330|FG000|Overall Study|equipment malfunction|1|||
161916996|NCT02755090|584744331|FG001|Overall Study|equipment malfunction|0|||
161916997|NCT00207740|584744332|FG000|Overall Study|Adverse Event|4|||
161916998|NCT00207740|584744333|FG001|Overall Study|Adverse Event|14|||
161916999|NCT00207740|584744334|FG002|Overall Study|Adverse Event|14|||
161917000|NCT00207740|584744335|FG003|Overall Study|Adverse Event|11|||
161917001|NCT00207740|584744332|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161917002|NCT00207740|584744333|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161917003|NCT00207740|584744334|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161917004|NCT00207740|584744335|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
161917005|NCT00207740|584744332|FG000|Overall Study|Lost to Follow-up|0|||
161917006|NCT00207740|584744333|FG001|Overall Study|Lost to Follow-up|2|||
161917007|NCT00207740|584744334|FG002|Overall Study|Lost to Follow-up|1|||
161917008|NCT00207740|584744335|FG003|Overall Study|Lost to Follow-up|1|||
161917009|NCT00207740|584744332|FG000|Overall Study|Death|0|||
161473683|NCT02925117|583128696|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161473684|NCT02925117|583128697|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161917010|NCT00207740|584744333|FG001|Overall Study|Death|0|||
161917011|NCT00207740|584744334|FG002|Overall Study|Death|0|||
161473685|NCT02925117|583128698|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
161473686|NCT02925117|583128699|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
161473687|NCT02925117|583128700|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
161917012|NCT00207740|584744335|FG003|Overall Study|Death|1|||
161917013|NCT00207740|584744332|FG000|Overall Study|Sponsor Directive|22|||
161917014|NCT00207740|584744333|FG001|Overall Study|Sponsor Directive|15|||
161917015|NCT00207740|584744334|FG002|Overall Study|Sponsor Directive|16|||
161917016|NCT00207740|584744335|FG003|Overall Study|Sponsor Directive|21|||
161917017|NCT00207740|584744332|FG000|Overall Study|Other|2|||
161917018|NCT00207740|584744333|FG001|Overall Study|Other|10|||
161917019|NCT00207740|584744334|FG002|Overall Study|Other|7|||
161917020|NCT00207740|584744335|FG003|Overall Study|Other|5|||
161917021|NCT03034967|584744338|FG000|Overall Study|Withdrawal by Subject|9|||
161917022|NCT03034967|584744339|FG001|Overall Study|Withdrawal by Subject|2|||
161917023|NCT03034967|584744340|FG002|Overall Study|Withdrawal by Subject|6|||
161917024|NCT03034967|584744341|FG003|Overall Study|Withdrawal by Subject|6|||
161917025|NCT03034967|584744342|FG004|Overall Study|Withdrawal by Subject|9|||
161917026|NCT03034967|584744343|FG005|Overall Study|Withdrawal by Subject|2|||
161917027|NCT03034967|584744338|FG000|Overall Study|Physician Decision|1|||
161917028|NCT03034967|584744339|FG001|Overall Study|Physician Decision|0|||
161917029|NCT03034967|584744340|FG002|Overall Study|Physician Decision|1|||
161917030|NCT03034967|584744341|FG003|Overall Study|Physician Decision|1|||
161917031|NCT03034967|584744342|FG004|Overall Study|Physician Decision|1|||
161917032|NCT03034967|584744343|FG005|Overall Study|Physician Decision|0|||
161917033|NCT03034967|584744338|FG000|Overall Study|Lost to Follow-up|0|||
161917034|NCT03034967|584744339|FG001|Overall Study|Lost to Follow-up|0|||
161917035|NCT03034967|584744340|FG002|Overall Study|Lost to Follow-up|0|||
161917036|NCT03034967|584744341|FG003|Overall Study|Lost to Follow-up|1|||
161917037|NCT03034967|584744342|FG004|Overall Study|Lost to Follow-up|0|||
161917038|NCT03034967|584744343|FG005|Overall Study|Lost to Follow-up|2|||
161917039|NCT03034967|584744338|FG000|Overall Study|Liver function test abnormality|0|||
161917040|NCT03034967|584744339|FG001|Overall Study|Liver function test abnormality|0|||
161917041|NCT03034967|584744340|FG002|Overall Study|Liver function test abnormality|1|||
161917042|NCT03034967|584744341|FG003|Overall Study|Liver function test abnormality|0|||
161917043|NCT03034967|584744342|FG004|Overall Study|Liver function test abnormality|0|||
161917044|NCT03034967|584744343|FG005|Overall Study|Liver function test abnormality|0|||
161917045|NCT03034967|584744338|FG000|Overall Study|Protocol Violation|1|||
161917046|NCT03034967|584744339|FG001|Overall Study|Protocol Violation|0|||
161917047|NCT03034967|584744340|FG002|Overall Study|Protocol Violation|0|||
161917048|NCT03034967|584744341|FG003|Overall Study|Protocol Violation|0|||
161473688|NCT02925117|583128689|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
161473689|NCT02925117|583128690|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
161473690|NCT02925117|583128691|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
161473691|NCT02925117|583128692|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
161473692|NCT02925117|583128693|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
161473693|NCT02925117|583128694|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
161473694|NCT02925117|583128695|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
161473695|NCT02925117|583128696|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
161473696|NCT02925117|583128697|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
161473697|NCT02925117|583128698|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
161473698|NCT02925117|583128699|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
161473699|NCT02925117|583128700|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
161473700|NCT02925117|583128689|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
161917049|NCT03034967|584744342|FG004|Overall Study|Protocol Violation|0|||
161917050|NCT03034967|584744343|FG005|Overall Study|Protocol Violation|2|||
161917051|NCT03034967|584744338|FG000|Overall Study|Lack of Efficacy|0|||
161917052|NCT03034967|584744339|FG001|Overall Study|Lack of Efficacy|1|||
161917053|NCT03034967|584744340|FG002|Overall Study|Lack of Efficacy|2|||
161473701|NCT02925117|583128690|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
161473702|NCT02925117|583128691|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
161473703|NCT02925117|583128692|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
161473704|NCT02925117|583128693|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
161917054|NCT03034967|584744341|FG003|Overall Study|Lack of Efficacy|1|||
161917055|NCT03034967|584744342|FG004|Overall Study|Lack of Efficacy|1|||
161576249|NCT01040689|583496151|FG003|Overall Study|Adverse Event|4|||
161917056|NCT03034967|584744343|FG005|Overall Study|Lack of Efficacy|0|||
161917057|NCT03034967|584744338|FG000|Overall Study|Adverse Event, non-fatal|3|||
161917058|NCT03034967|584744339|FG001|Overall Study|Adverse Event, non-fatal|1|||
161473705|NCT02925117|583128694|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
161473706|NCT02925117|583128695|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
161473707|NCT02925117|583128696|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
161473708|NCT02925117|583128697|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
161473709|NCT02925117|583128698|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
161473710|NCT02925117|583128699|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
161473711|NCT02925117|583128700|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
161473712|NCT02925117|583128689|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
161473713|NCT02925117|583128690|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
161473714|NCT02925117|583128691|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
161473715|NCT02925117|583128692|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
161473716|NCT02925117|583128693|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
161473717|NCT02925117|583128694|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
161473718|NCT02925117|583128695|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
161473719|NCT02925117|583128696|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
161473720|NCT02925117|583128697|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
161473721|NCT02925117|583128698|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
161473722|NCT02925117|583128699|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
161473723|NCT02925117|583128700|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
161473724|NCT04032652|583128701|FG000|Overall Study|The study was terminated and the PI has|1|||
161473725|NCT04032652|583128702|FG001|Overall Study|The study was terminated and the PI has|1|||
161473726|NCT02663908|583128703|FG000|Overall Study|Withdrawal by Subject|8|||
161473727|NCT02663908|583128704|FG001|Overall Study|Withdrawal by Subject|5|||
161473728|NCT02663908|583128703|FG000|Overall Study|Lost to Follow-up|1|||
161473729|NCT02663908|583128704|FG001|Overall Study|Lost to Follow-up|5|||
161473730|NCT02663908|583128703|FG000|Overall Study|Adverse Event|13|||
161813460|NCT00323882|584359875|FG001|Overall Study|Adverse Event|1|||
161813461|NCT00323882|584359876|FG002|Overall Study|Adverse Event|1|||
161813462|NCT00323882|584359877|FG003|Overall Study|Adverse Event|1|||
161813463|NCT00323882|584359878|FG004|Overall Study|Adverse Event|3|||
161813464|NCT00323882|584359874|FG000|Overall Study|Disease Progression|6|||
161813465|NCT00323882|584359875|FG001|Overall Study|Disease Progression|4|||
161813466|NCT00323882|584359876|FG002|Overall Study|Disease Progression|10|||
161813467|NCT00323882|584359877|FG003|Overall Study|Disease Progression|5|||
161813468|NCT00323882|584359878|FG004|Overall Study|Disease Progression|22|||
161813469|NCT00323882|584359874|FG000|Overall Study|Death|0|||
161813470|NCT00323882|584359875|FG001|Overall Study|Death|1|||
161813471|NCT00323882|584359876|FG002|Overall Study|Death|1|||
161813472|NCT00323882|584359877|FG003|Overall Study|Death|0|||
161813473|NCT00323882|584359878|FG004|Overall Study|Death|5|||
161813474|NCT00323882|584359874|FG000|Overall Study|Lost to Follow-up|0|||
161813475|NCT00323882|584359875|FG001|Overall Study|Lost to Follow-up|0|||
161813476|NCT00323882|584359876|FG002|Overall Study|Lost to Follow-up|1|||
161813477|NCT00323882|584359877|FG003|Overall Study|Lost to Follow-up|0|||
161813478|NCT00323882|584359878|FG004|Overall Study|Lost to Follow-up|1|||
161813479|NCT00323882|584359874|FG000|Overall Study|Other|0|||
161813480|NCT00323882|584359875|FG001|Overall Study|Other|0|||
161813481|NCT00323882|584359876|FG002|Overall Study|Other|0|||
161813482|NCT00323882|584359877|FG003|Overall Study|Other|1|||
161813483|NCT00323882|584359878|FG004|Overall Study|Other|1|||
161813484|NCT03123471|584359887|FG000|Placebo-controlled Phase|Adverse Event|3|||
161813485|NCT03123471|584359888|FG001|Placebo-controlled Phase|Adverse Event|8|||
161813486|NCT03123471|584359887|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
161813487|NCT03123471|584359888|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
161813488|NCT03123471|584359887|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
161813489|NCT03123471|584359888|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
161813490|NCT03123471|584359887|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
161813491|NCT03123471|584359888|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
161813492|NCT03123471|584359887|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
161813493|NCT03123471|584359888|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
161813494|NCT03123471|584359887|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
161813495|NCT03123471|584359888|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
161813496|NCT03123471|584359887|FG000|Placebo-controlled Phase|Miscellaneous|0|||
161813497|NCT03123471|584359888|FG001|Placebo-controlled Phase|Miscellaneous|1|||
161813498|NCT03123471|584359887|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
161813499|NCT03123471|584359888|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
161917059|NCT03034967|584744340|FG002|Overall Study|Adverse Event, non-fatal|2|||
161917060|NCT03034967|584744341|FG003|Overall Study|Adverse Event, non-fatal|0|||
161917061|NCT03034967|584744342|FG004|Overall Study|Adverse Event, non-fatal|2|||
161813500|NCT03123471|584359887|FG000|Apremilast Extension Phase|Adverse Event|1|||
161813501|NCT03123471|584359888|FG001|Apremilast Extension Phase|Adverse Event|5|||
161813502|NCT03123471|584359887|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
161813503|NCT03123471|584359888|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
161473731|NCT02663908|583128704|FG001|Overall Study|Adverse Event|11|||
161473732|NCT02663908|583128703|FG000|Overall Study|Protocol Violation|1|||
161473733|NCT02663908|583128704|FG001|Overall Study|Protocol Violation|2|||
161813504|NCT03123471|584359887|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
161473734|NCT02663908|583128703|FG000|Overall Study|Lack of therapeutic response|2|||
161473735|NCT02663908|583128704|FG001|Overall Study|Lack of therapeutic response|0|||
161473736|NCT02663908|583128703|FG000|Overall Study|COVID-19|1|||
161473737|NCT02663908|583128704|FG001|Overall Study|COVID-19|0|||
161473738|NCT02663908|583128703|FG000|Overall Study|Site closed|1|||
161473739|NCT02663908|583128704|FG001|Overall Study|Site closed|0|||
161473740|NCT02663908|583128703|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
161473741|NCT02663908|583128704|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
161473742|NCT02663908|583128703|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
161813505|NCT03123471|584359888|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
161473743|NCT02663908|583128704|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
161473744|NCT02663908|583128703|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
161813506|NCT02358538|584359891|FG000|Through Week 26|Adverse Event|0|||
161813507|NCT02358538|584359892|FG001|Through Week 26|Adverse Event|1|||
161813508|NCT02358538|584359893|FG002|Through Week 26|Adverse Event|1|||
161813509|NCT02358538|584359894|FG003|Through Week 26|Adverse Event|2|||
161813510|NCT02358538|584359891|FG000|Through Week 26|Lack of Efficacy|1|||
161813511|NCT02358538|584359892|FG001|Through Week 26|Lack of Efficacy|1|||
161813512|NCT02358538|584359893|FG002|Through Week 26|Lack of Efficacy|3|||
161813513|NCT02358538|584359894|FG003|Through Week 26|Lack of Efficacy|3|||
161813514|NCT02358538|584359891|FG000|Through Week 26|Withdrawal by Subject|1|||
161813515|NCT02358538|584359892|FG001|Through Week 26|Withdrawal by Subject|0|||
161813516|NCT02358538|584359893|FG002|Through Week 26|Withdrawal by Subject|0|||
161813517|NCT02358538|584359894|FG003|Through Week 26|Withdrawal by Subject|0|||
161813518|NCT02358538|584359891|FG000|Through Week 26|Non-Compliance|0|||
161813519|NCT02358538|584359892|FG001|Through Week 26|Non-Compliance|0|||
161813520|NCT02358538|584359893|FG002|Through Week 26|Non-Compliance|1|||
161813521|NCT02358538|584359894|FG003|Through Week 26|Non-Compliance|0|||
161813522|NCT02358538|584359891|FG000|Through Week 26|Family did not see benefit from IP|1|||
161813523|NCT02358538|584359892|FG001|Through Week 26|Family did not see benefit from IP|0|||
161813524|NCT02358538|584359893|FG002|Through Week 26|Family did not see benefit from IP|0|||
161813525|NCT02358538|584359894|FG003|Through Week 26|Family did not see benefit from IP|0|||
161813526|NCT02358538|584359891|FG000|52 Week Extension Period|Lack of Efficacy|0|||
161813527|NCT02358538|584359892|FG001|52 Week Extension Period|Lack of Efficacy|0|||
161813528|NCT02358538|584359893|FG002|52 Week Extension Period|Lack of Efficacy|2|||
161813529|NCT02358538|584359894|FG003|52 Week Extension Period|Lack of Efficacy|4|||
161813530|NCT01686477|584359895|FG000|Feeding Intervention|Death|1|||
161813531|NCT01686477|584359896|FG001|Feeding Intervention|Death|0|||
161813532|NCT01686477|584359897|FG002|Feeding Intervention|Death|1|||
161813533|NCT01686477|584359895|FG000|Feeding Intervention|Withdrawal by Subject|0|||
161813534|NCT01686477|584359896|FG001|Feeding Intervention|Withdrawal by Subject|6|||
161813535|NCT01686477|584359897|FG002|Feeding Intervention|Withdrawal by Subject|0|||
161813536|NCT01686477|584359895|FG000|Feeding Intervention|Physician Decision|1|||
161813537|NCT01686477|584359896|FG001|Feeding Intervention|Physician Decision|2|||
161813538|NCT01686477|584359897|FG002|Feeding Intervention|Physician Decision|0|||
161813539|NCT01686477|584359895|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
161813540|NCT01686477|584359896|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
161917062|NCT03034967|584744343|FG005|Overall Study|Adverse Event, non-fatal|8|||
161917063|NCT03034967|584744338|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
161917064|NCT03034967|584744339|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
161917065|NCT03034967|584744340|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
161917066|NCT03034967|584744341|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
161917067|NCT03034967|584744342|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
161917068|NCT03034967|584744343|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
161917069|NCT03806296|584744344|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
161917070|NCT03806296|584744345|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
161917071|NCT03806296|584744346|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
161917072|NCT03806296|584744344|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
161917073|NCT03806296|584744345|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
161917074|NCT03806296|584744346|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
161917075|NCT03806296|584744344|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
161917076|NCT03806296|584744345|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
161917077|NCT03806296|584744346|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
161917078|NCT02763566|584744354|FG000|Overall Study|Lost to Follow-up|1|||
161917079|NCT02763566|584744355|FG001|Overall Study|Lost to Follow-up|4|||
161917080|NCT02763566|584744356|FG002|Overall Study|Lost to Follow-up|0|||
161917081|NCT02763566|584744357|FG003|Overall Study|Lost to Follow-up|1|||
161917082|NCT02763566|584744354|FG000|Overall Study|On study treatment at study conclusion|114|||
161917083|NCT02763566|584744355|FG001|Overall Study|On study treatment at study conclusion|34|||
161917084|NCT02763566|584744356|FG002|Overall Study|On study treatment at study conclusion|54|||
161917085|NCT02763566|584744357|FG003|Overall Study|On study treatment at study conclusion|13|||
161917086|NCT02763566|584744354|FG000|Overall Study|Withdrawal by Subject|3|||
161917087|NCT02763566|584744355|FG001|Overall Study|Withdrawal by Subject|1|||
161917088|NCT02763566|584744356|FG002|Overall Study|Withdrawal by Subject|0|||
161917089|NCT02763566|584744357|FG003|Overall Study|Withdrawal by Subject|0|||
161917090|NCT04896385|584744358|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
161917091|NCT04896385|584744359|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
161917092|NCT04896385|584744360|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
161917093|NCT04896385|584744361|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
161917094|NCT04896385|584744358|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
161917095|NCT04896385|584744359|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
161917096|NCT04896385|584744360|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161917097|NCT04896385|584744361|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161917098|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161917099|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161917100|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
161917101|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
161917102|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161917103|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161917104|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
161917105|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
161917106|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
161917107|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
161917108|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
161917109|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
161917110|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
161917111|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
161917112|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
161917113|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
161917114|NCT05291689|584744365|FG000|Overall Study|Adverse Event|3|||
161917115|NCT05291689|584744365|FG000|Overall Study|Lack of Efficacy|10|||
161917116|NCT05291689|584744365|FG000|Overall Study|Withdrawal by Subject|4|||
161917117|NCT01931098|584744366|FG000|Overall Study|Withdrawal by Subject|0|||
161917118|NCT01931098|584744367|FG001|Overall Study|Withdrawal by Subject|1|||
161917119|NCT01931098|584744366|FG000|Overall Study|Enrolled in different protocol|0|||
161917120|NCT01931098|584744367|FG001|Overall Study|Enrolled in different protocol|1|||
161917121|NCT01931098|584744366|FG000|Overall Study|Unable to begin trmt:active infection|0|||
161917122|NCT01931098|584744367|FG001|Overall Study|Unable to begin trmt:active infection|1|||
161917123|NCT01931098|584744366|FG000|Overall Study|Refused further treatment|0|||
161917124|NCT01931098|584744367|FG001|Overall Study|Refused further treatment|1|||
161917125|NCT02612155|584744368|FG000|Overall Study|Death|1|||
161917126|NCT02612155|584744369|FG001|Overall Study|Death|1|||
161917127|NCT02612155|584744368|FG000|Overall Study|Lost to Follow-up|2|||
161917128|NCT02612155|584744369|FG001|Overall Study|Lost to Follow-up|2|||
161917129|NCT04235374|584744370|FG000|Overall Study|Death|91|||
161917130|NCT04235374|584744371|FG001|Overall Study|Death|91|||
161917131|NCT04235374|584744370|FG000|Overall Study|Refused|2|||
161917132|NCT04235374|584744371|FG001|Overall Study|Refused|2|||
161917133|NCT04235374|584744370|FG000|Overall Study|Unavailable|12|||
161917134|NCT04235374|584744371|FG001|Overall Study|Unavailable|3|||
161917135|NCT04235374|584744370|FG000|Overall Study|Withdrawal by Subject|0|||
161917136|NCT04235374|584744371|FG001|Overall Study|Withdrawal by Subject|1|||
161917137|NCT04235374|584744370|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
161917138|NCT04235374|584744371|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
161917139|NCT01551173|584744372|FG000|Overall Study|Withdrawal by Subject|11|||
161917140|NCT01551173|584744373|FG001|Overall Study|Withdrawal by Subject|16|||
161917141|NCT01551173|584744372|FG000|Overall Study|Adverse Event|7|||
161917142|NCT01551173|584744373|FG001|Overall Study|Adverse Event|6|||
161917143|NCT01551173|584744372|FG000|Overall Study|Lost to Follow-up|5|||
161917144|NCT01551173|584744373|FG001|Overall Study|Lost to Follow-up|7|||
161917145|NCT01551173|584744372|FG000|Overall Study|Other|5|||
161917146|NCT01551173|584744373|FG001|Overall Study|Other|3|||
161917147|NCT01394276|584744374|FG000|Overall Study|Related Adverse event (AEs)|15|||
161917148|NCT01394276|584744374|FG000|Overall Study|Not related AEs|9|||
161917149|NCT01394276|584744374|FG000|Overall Study|Remission of disease|2|||
161917150|NCT01394276|584744374|FG000|Overall Study|Insufficient therapeutic effect|17|||
161917151|NCT01394276|584744374|FG000|Overall Study|Insufficient compliance|9|||
161917152|NCT01394276|584744374|FG000|Overall Study|Lost to Follow-up|5|||
161917153|NCT01394276|584744374|FG000|Overall Study|Participant moved to another site|1|||
161917154|NCT01394276|584744374|FG000|Overall Study|Pregnancy|1|||
161917155|NCT01394276|584744374|FG000|Overall Study|unavailability of drug at the Hospital|2|||
161917156|NCT01394276|584744374|FG000|Overall Study|Symptoms of concurrent diseases|1|||
161917157|NCT04530344|584744375|FG000|Overall Study|Lost to Follow-up|3|||
161917158|NCT04530344|584744376|FG001|Overall Study|Lost to Follow-up|3|||
161917159|NCT04530344|584744377|FG002|Overall Study|Lost to Follow-up|3|||
161917160|NCT04530344|584744378|FG003|Overall Study|Lost to Follow-up|10|||
161917161|NCT04530344|584744375|FG000|Overall Study|Withdrawal by Subject|14|||
161917162|NCT04530344|584744376|FG001|Overall Study|Withdrawal by Subject|5|||
161917163|NCT04530344|584744377|FG002|Overall Study|Withdrawal by Subject|18|||
161917164|NCT04530344|584744378|FG003|Overall Study|Withdrawal by Subject|33|||
161917165|NCT04530344|584744375|FG000|Overall Study|Adverse Event|0|||
161917166|NCT04530344|584744376|FG001|Overall Study|Adverse Event|0|||
161917167|NCT04530344|584744377|FG002|Overall Study|Adverse Event|0|||
161917168|NCT04530344|584744378|FG003|Overall Study|Adverse Event|1|||
161917169|NCT04530344|584744375|FG000|Overall Study|Lack of Efficacy|0|||
161917170|NCT04530344|584744376|FG001|Overall Study|Lack of Efficacy|0|||
161917171|NCT04530344|584744377|FG002|Overall Study|Lack of Efficacy|0|||
161917172|NCT04530344|584744378|FG003|Overall Study|Lack of Efficacy|1|||
161917173|NCT04530344|584744375|FG000|Overall Study|Physician Decision|0|||
161917174|NCT04530344|584744376|FG001|Overall Study|Physician Decision|0|||
161917175|NCT04530344|584744377|FG002|Overall Study|Physician Decision|1|||
161917176|NCT04530344|584744378|FG003|Overall Study|Physician Decision|1|||
161917177|NCT04530344|584744375|FG000|Overall Study|Pregnancy|0|||
161917178|NCT04530344|584744376|FG001|Overall Study|Pregnancy|0|||
161917179|NCT04530344|584744377|FG002|Overall Study|Pregnancy|2|||
161917180|NCT04530344|584744378|FG003|Overall Study|Pregnancy|1|||
161917181|NCT04530344|584744375|FG000|Overall Study|Protocol Violation|0|||
161917182|NCT04530344|584744376|FG001|Overall Study|Protocol Violation|0|||
161917183|NCT04530344|584744377|FG002|Overall Study|Protocol Violation|0|||
161917184|NCT04530344|584744378|FG003|Overall Study|Protocol Violation|1|||
161917185|NCT04530344|584744375|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
161917186|NCT04530344|584744376|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
161917187|NCT04530344|584744377|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
161917188|NCT04530344|584744378|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
161917189|NCT04530344|584744375|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161917190|NCT04530344|584744376|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161917191|NCT04530344|584744377|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
161917192|NCT04530344|584744378|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161917193|NCT04530344|584744375|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
161917194|NCT04530344|584744376|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
161917195|NCT04530344|584744377|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
161917196|NCT04530344|584744378|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
161917197|NCT04530344|584744375|FG000|Overall Study|Personal Reasons|0|||
161917198|NCT04530344|584744376|FG001|Overall Study|Personal Reasons|0|||
161917199|NCT04530344|584744377|FG002|Overall Study|Personal Reasons|0|||
161917200|NCT04530344|584744378|FG003|Overall Study|Personal Reasons|1|||
161917201|NCT04530344|584744375|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161917202|NCT04530344|584744376|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161917203|NCT04530344|584744377|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161917204|NCT04530344|584744378|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
161917205|NCT01402700|584744379|FG000|Overall Study|Death|3|||
161917206|NCT01402700|584744379|FG000|Overall Study|Withdrawal by Subject|3|||
161917207|NCT01402700|584744379|FG000|Overall Study|Missed Visit|1|||
161917208|NCT01933594|584744380|FG000|Overall Study|Lost to Follow-up|1|||
161917209|NCT01933594|584744381|FG001|Overall Study|Lost to Follow-up|0|||
161917210|NCT01933594|584744382|FG002|Overall Study|Lost to Follow-up|0|||
161917211|NCT01933594|584744383|FG003|Overall Study|Lost to Follow-up|0|||
161917212|NCT01933594|584744384|FG004|Overall Study|Lost to Follow-up|1|||
161917213|NCT01933594|584744385|FG005|Overall Study|Lost to Follow-up|0|||
161917214|NCT01933594|584744380|FG000|Overall Study|Ineligible for subsequent study step|0|||
161917215|NCT01933594|584744381|FG001|Overall Study|Ineligible for subsequent study step|0|||
161917216|NCT01933594|584744382|FG002|Overall Study|Ineligible for subsequent study step|0|||
161917217|NCT01933594|584744383|FG003|Overall Study|Ineligible for subsequent study step|0|||
161917218|NCT01933594|584744384|FG004|Overall Study|Ineligible for subsequent study step|1|||
161917219|NCT01933594|584744385|FG005|Overall Study|Ineligible for subsequent study step|0|||
161917220|NCT05352399|584744399|FG000|Overall Study|Discontinued intervention|6|||
161917221|NCT04478266|584744400|FG000|Overall Study|Adverse Event|20|||
161917222|NCT04478266|584744401|FG001|Overall Study|Adverse Event|21|||
161917223|NCT04478266|584744400|FG000|Overall Study|Progressive disease|146|||
161917224|NCT04478266|584744401|FG001|Overall Study|Progressive disease|168|||
161917225|NCT04478266|584744400|FG000|Overall Study|Poor compliance to protocol|1|||
161917226|NCT04478266|584744401|FG001|Overall Study|Poor compliance to protocol|0|||
161917227|NCT04478266|584744400|FG000|Overall Study|Withdrawal by Subject|19|||
161917228|NCT04478266|584744401|FG001|Overall Study|Withdrawal by Subject|16|||
161917229|NCT04478266|584744400|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
161917230|NCT04478266|584744401|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
161917231|NCT04478266|584744400|FG000|Overall Study|Study terminated by sponsor|33|||
161917232|NCT04478266|584744401|FG001|Overall Study|Study terminated by sponsor|35|||
161917233|NCT04478266|584744400|FG000|Overall Study|Other: unspecified|5|||
161917234|NCT04478266|584744401|FG001|Overall Study|Other: unspecified|7|||
161917235|NCT04478266|584744400|FG000|Overall Study|Randomized but not treated|1|||
161917236|NCT04478266|584744401|FG001|Overall Study|Randomized but not treated|1|||
161917237|NCT04058717|584744402|FG000|Randomization Period|Lost to Follow-up|2|||
161917238|NCT04058717|584744403|FG001|Randomization Period|Lost to Follow-up|3|||
161473745|NCT02663908|583128704|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
161473746|NCT02663908|583128703|FG000|Overall Study|Death|1|||
161473747|NCT02663908|583128704|FG001|Overall Study|Death|0|||
161473748|NCT02663908|583128703|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
161473749|NCT02663908|583128704|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
161473750|NCT02663908|583128703|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
161549104|NCT00871351|583400998|FG001|Overall Study|Withdrawal by Subject|0|||
161813541|NCT01686477|584359897|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
161813542|NCT01686477|584359895|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
161813543|NCT01686477|584359896|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
161813544|NCT01686477|584359897|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
161813545|NCT01686477|584359895|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
161813546|NCT01686477|584359896|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
161813547|NCT01686477|584359897|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
161813548|NCT01686477|584359895|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
161813549|NCT01686477|584359896|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
161813550|NCT01686477|584359897|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
161813551|NCT01686477|584359895|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
161813552|NCT01686477|584359896|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
161813553|NCT01686477|584359897|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
161813554|NCT01686477|584359895|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
161813555|NCT01686477|584359896|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
161813556|NCT01686477|584359897|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
161813557|NCT01686477|584359895|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
161813558|NCT01686477|584359896|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
161813559|NCT01686477|584359897|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
161813560|NCT06999265|584359899|FG000|Overall Study|Lost to Follow-up|1|||
161813561|NCT06999265|584359900|FG001|Overall Study|Lost to Follow-up|1|||
161813562|NCT02178787|584359901|FG000|Overall Study|Lost to Follow-up|1|||
161813563|NCT02178787|584359902|FG001|Overall Study|Lost to Follow-up|0|||
161813564|NCT02178787|584359901|FG000|Overall Study|Withdrawal by Subject|0|||
161813565|NCT02178787|584359902|FG001|Overall Study|Withdrawal by Subject|2|||
161813566|NCT02178787|584359901|FG000|Overall Study|No TCD window|3|||
161813567|NCT02178787|584359902|FG001|Overall Study|No TCD window|7|||
161917239|NCT04058717|584744404|FG002|Randomization Period|Lost to Follow-up|4|||
161917240|NCT04058717|584744405|FG003|Randomization Period|Lost to Follow-up|4|||
161917241|NCT04058717|584744402|FG000|Randomization Period|Withdrawal by Subject|1|||
161917242|NCT04058717|584744403|FG001|Randomization Period|Withdrawal by Subject|3|||
161917243|NCT04058717|584744404|FG002|Randomization Period|Withdrawal by Subject|3|||
161917244|NCT04058717|584744405|FG003|Randomization Period|Withdrawal by Subject|3|||
161917245|NCT04058717|584744402|FG000|Randomization Period|PI decision|0|||
161917246|NCT04058717|584744403|FG001|Randomization Period|PI decision|1|||
161917247|NCT04058717|584744404|FG002|Randomization Period|PI decision|0|||
161917248|NCT04058717|584744405|FG003|Randomization Period|PI decision|0|||
161917249|NCT02799602|584744407|FG000|Overall Study|Protocol Violation|1|||
161917250|NCT02799602|584744408|FG001|Overall Study|Protocol Violation|0|||
161813568|NCT02178787|584359901|FG000|Overall Study|Physician Decision|1|||
161917251|NCT02799602|584744407|FG000|Overall Study|Physician Decision|5|||
161917252|NCT02799602|584744408|FG001|Overall Study|Physician Decision|6|||
161917253|NCT02799602|584744407|FG000|Overall Study|Lost to Follow-up|4|||
161917254|NCT02799602|584744408|FG001|Overall Study|Lost to Follow-up|2|||
161917255|NCT02799602|584744407|FG000|Overall Study|Additional primary malignancy|11|||
161917256|NCT02799602|584744408|FG001|Overall Study|Additional primary malignancy|6|||
161917257|NCT02799602|584744407|FG000|Overall Study|Non-compliance with study drug|14|||
161917258|NCT02799602|584744408|FG001|Overall Study|Non-compliance with study drug|12|||
161917259|NCT02799602|584744407|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
161917260|NCT02799602|584744408|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
161917261|NCT02799602|584744407|FG000|Overall Study|Withdrawal by Subject|26|||
161917262|NCT02799602|584744408|FG001|Overall Study|Withdrawal by Subject|40|||
161917263|NCT02799602|584744407|FG000|Overall Study|Progressive disease - clinical progression|131|||
161917264|NCT02799602|584744408|FG001|Overall Study|Progressive disease - clinical progression|276|||
161917265|NCT02799602|584744407|FG000|Overall Study|Progressive disease - radiological progression|90|||
161917266|NCT02799602|584744408|FG001|Overall Study|Progressive disease - radiological progression|133|||
161917267|NCT02799602|584744407|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
161917268|NCT02799602|584744408|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
161917269|NCT02799602|584744407|FG000|Overall Study|Death|9|||
161917270|NCT02799602|584744408|FG001|Overall Study|Death|5|||
161917271|NCT02799602|584744407|FG000|Overall Study|Other|287|||
161917272|NCT02799602|584744408|FG001|Overall Study|Other|118|||
161917273|NCT02799602|584744407|FG000|Overall Study|Study drug never administered|0|||
161917274|NCT02799602|584744408|FG001|Overall Study|Study drug never administered|3|||
161813569|NCT02178787|584359902|FG001|Overall Study|Physician Decision|0|||
161813570|NCT02430480|584359903|FG000|Overall Study|Death|1|||
161813571|NCT02430480|584359903|FG000|Overall Study|Anesthesia concerns|1|||
161813572|NCT02430480|584359903|FG000|Overall Study|Progressed on treatment|1|||
161813573|NCT01030133|584359904|FG000|Overall Study|failed to experience pain at level 7/10|2|||
161813574|NCT01030133|584359905|FG001|Overall Study|failed to experience pain at level 7/10|2|||
161813575|NCT01097577|584359913|FG000|Overall Study|Adverse Event|0|||
161813576|NCT01097577|584359914|FG001|Overall Study|Adverse Event|1|||
161813577|NCT04493684|584359915|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161813578|NCT04493684|584359916|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813579|NCT04493684|584359917|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161813580|NCT04493684|584359918|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813581|NCT04493684|584359919|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813582|NCT04493684|584359920|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161813583|NCT04493684|584359921|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161917275|NCT01101178|584744413|FG000|Period 1|Withdrawal by Subject|1|||
161917276|NCT01101178|584744414|FG001|Period 1|Withdrawal by Subject|2|||
161917277|NCT01101178|584744413|FG000|Period 1|Positive drug screen|1|||
161917278|NCT01101178|584744414|FG001|Period 1|Positive drug screen|1|||
161917279|NCT01101178|584744413|FG000|Period 1|Adverse Event|2|||
161917280|NCT01101178|584744414|FG001|Period 1|Adverse Event|1|||
161917281|NCT01101178|584744413|FG000|Period 2|Withdrawal by Subject|0|||
161917282|NCT01101178|584744414|FG001|Period 2|Withdrawal by Subject|1|||
161917283|NCT01850641|584744415|FG000|Overall Study|Physician Decision|1|||
161917284|NCT01850641|584744415|FG000|Overall Study|Decrease in serum phosphorus|1|||
161917285|NCT01850641|584744415|FG000|Overall Study|Decrease in serum calcium|2|||
161917286|NCT01850641|584744415|FG000|Overall Study|Increase in serum ferritin|1|||
161917287|NCT00141817|584744416|FG000|Overall Study|Protocol Violation|0|||
161917288|NCT00141817|584744417|FG001|Overall Study|Protocol Violation|0|||
161917289|NCT00141817|584744418|FG002|Overall Study|Protocol Violation|1|||
161917290|NCT00141817|584744419|FG003|Overall Study|Protocol Violation|0|||
161917291|NCT00141817|584744416|FG000|Overall Study|Parent request|1|||
161917292|NCT00141817|584744417|FG001|Overall Study|Parent request|0|||
161917293|NCT00141817|584744418|FG002|Overall Study|Parent request|0|||
161917294|NCT00141817|584744419|FG003|Overall Study|Parent request|0|||
161917295|NCT00127803|584744420|FG000|Overall Study|Adverse Event|2|||
161917296|NCT00127803|584744421|FG001|Overall Study|Adverse Event|0|||
161917297|NCT00127803|584744422|FG002|Overall Study|Adverse Event|0|||
161917298|NCT00127803|584744423|FG003|Overall Study|Adverse Event|0|||
161917299|NCT00127803|584744420|FG000|Overall Study|Withdrawal by Subject|1|||
161917300|NCT00127803|584744421|FG001|Overall Study|Withdrawal by Subject|0|||
161917301|NCT00127803|584744422|FG002|Overall Study|Withdrawal by Subject|0|||
161917302|NCT00127803|584744423|FG003|Overall Study|Withdrawal by Subject|0|||
161917303|NCT00127803|584744420|FG000|Overall Study|Lost to Follow-up|0|||
161917304|NCT00127803|584744421|FG001|Overall Study|Lost to Follow-up|0|||
161917305|NCT00127803|584744422|FG002|Overall Study|Lost to Follow-up|0|||
161917306|NCT00127803|584744423|FG003|Overall Study|Lost to Follow-up|1|||
161917307|NCT04809974|584745966|FG000|Lead-in Phase|Withdrawal by Subject|3|||
161917308|NCT04809974|584745967|FG001|Lead-in Phase|Withdrawal by Subject|0|||
161917309|NCT04809974|584745968|FG002|Lead-in Phase|Withdrawal by Subject|0|||
161917310|NCT04809974|584745966|FG000|Lead-in Phase|No longer eligible|11|||
161917311|NCT04809974|584745967|FG001|Lead-in Phase|No longer eligible|0|||
161917312|NCT04809974|584745968|FG002|Lead-in Phase|No longer eligible|0|||
161917313|NCT04809974|584745966|FG000|Randomized Phase|Lost to Follow-up|0|||
161917314|NCT04809974|584745967|FG001|Randomized Phase|Lost to Follow-up|1|||
161917315|NCT04809974|584745968|FG002|Randomized Phase|Lost to Follow-up|5|||
161917316|NCT04809974|584745966|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
161917317|NCT04809974|584745967|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
161917318|NCT04809974|584745968|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
161917319|NCT04809974|584745966|FG000|Randomized Phase|Adverse Event|0|||
161917320|NCT04809974|584745967|FG001|Randomized Phase|Adverse Event|1|||
161917321|NCT04809974|584745968|FG002|Randomized Phase|Adverse Event|4|||
161917322|NCT04809974|584745966|FG000|Randomized Phase|Withdrawal by Subject|0|||
161917323|NCT04809974|584745967|FG001|Randomized Phase|Withdrawal by Subject|0|||
161917324|NCT04809974|584745968|FG002|Randomized Phase|Withdrawal by Subject|5|||
161917325|NCT04338581|584745969|FG000|Overall Study|Lack of Efficacy|1|||
161917326|NCT04338581|584745970|FG001|Overall Study|Lack of Efficacy|0|||
161917327|NCT04338581|584745969|FG000|Overall Study|Withdrawal by Subject|4|||
161917328|NCT04338581|584745970|FG001|Overall Study|Withdrawal by Subject|4|||
161917329|NCT04338581|584745969|FG000|Overall Study|Prohibited Medication|1|||
161917330|NCT04338581|584745970|FG001|Overall Study|Prohibited Medication|0|||
161917331|NCT00549055|584745971|FG000|Overall Study|Adverse Event|4|||
161917332|NCT00549055|584745971|FG000|Overall Study|Lack of Efficacy|18|||
161917333|NCT00549055|584745971|FG000|Overall Study|Stabilization|5|||
161917334|NCT00549055|584745971|FG000|Overall Study|Progression to fibrosis|2|||
161917335|NCT00549055|584745971|FG000|Overall Study|Decrease of size|1|||
161917336|NCT00549055|584745971|FG000|Overall Study|Active choroidal neovascula increased|1|||
161917337|NCT00549055|584745971|FG000|Overall Study|Vitreous hemorrhage|1|||
161917338|NCT00549055|584745971|FG000|Overall Study|Growth choroidal neovascularisation|1|||
161917339|NCT00549055|584745971|FG000|Overall Study|Choroidal neovascularization|1|||
161917340|NCT00549055|584745971|FG000|Overall Study|Very low visual acuity (VA)|1|||
161917341|NCT00770809|584745972|FG000|Overall Study|Adverse Event|9|||
161917342|NCT00770809|584745973|FG001|Overall Study|Adverse Event|1|||
161917343|NCT00770809|584745974|FG002|Overall Study|Adverse Event|12|||
161917344|NCT00770809|584745972|FG000|Overall Study|Death|1|||
161917345|NCT00770809|584745973|FG001|Overall Study|Death|0|||
161917346|NCT00770809|584745974|FG002|Overall Study|Death|0|||
161917347|NCT00770809|584745972|FG000|Overall Study|Withdrawal by Subject|3|||
161917348|NCT00770809|584745973|FG001|Overall Study|Withdrawal by Subject|3|||
161917349|NCT00770809|584745974|FG002|Overall Study|Withdrawal by Subject|7|||
161917350|NCT00770809|584745972|FG000|Overall Study|Progression|2|||
161917351|NCT00770809|584745973|FG001|Overall Study|Progression|2|||
161917352|NCT00770809|584745974|FG002|Overall Study|Progression|0|||
161917353|NCT00770809|584745972|FG000|Overall Study|Complicating illness|0|||
161917354|NCT00770809|584745973|FG001|Overall Study|Complicating illness|0|||
161917355|NCT00770809|584745974|FG002|Overall Study|Complicating illness|1|||
161917356|NCT00770809|584745972|FG000|Overall Study|Other Medical Reasons|2|||
161917357|NCT00770809|584745973|FG001|Overall Study|Other Medical Reasons|4|||
161917358|NCT00770809|584745974|FG002|Overall Study|Other Medical Reasons|3|||
161917359|NCT00764517|584745979|FG000|Overall Study|Adverse Event|9|||
161917360|NCT00764517|584745980|FG001|Overall Study|Adverse Event|3|||
161917361|NCT00764517|584745979|FG000|Overall Study|Death|3|||
161917362|NCT00764517|584745980|FG001|Overall Study|Death|11|||
161917363|NCT00764517|584745979|FG000|Overall Study|Physician Decision|3|||
161917364|NCT00764517|584745980|FG001|Overall Study|Physician Decision|0|||
161917365|NCT00770367|584745981|FG000|First Intervention|Withdrawal by Subject|0|||
161917366|NCT00770367|584745982|FG001|First Intervention|Withdrawal by Subject|2|||
161917367|NCT00770367|584745981|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
161917368|NCT00770367|584745982|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
161917369|NCT00770367|584745981|FG000|Second Intervention|Lost to Follow-up|2|||
161917370|NCT00770367|584745982|FG001|Second Intervention|Lost to Follow-up|0|||
161917371|NCT00435942|584745983|FG000|Overall Study|Death|17|||
161917372|NCT00435942|584745984|FG001|Overall Study|Death|10|||
161917373|NCT00435942|584745983|FG000|Overall Study|Withdrawal by Subject|2|||
161917374|NCT00435942|584745984|FG001|Overall Study|Withdrawal by Subject|0|||
161917375|NCT00435942|584745983|FG000|Overall Study|Lost to Follow-up|0|||
161917376|NCT00435942|584745984|FG001|Overall Study|Lost to Follow-up|16|||
161917377|NCT00435942|584745983|FG000|Overall Study|Conversion to Open Repair|1|||
161917378|NCT00435942|584745984|FG001|Overall Study|Conversion to Open Repair|0|||
161917379|NCT00435942|584745983|FG000|Overall Study|Technical Failure|3|||
161917380|NCT00435942|584745984|FG001|Overall Study|Technical Failure|0|||
161917381|NCT00435942|584745983|FG000|Overall Study|Other|0|||
161917382|NCT00435942|584745984|FG001|Overall Study|Other|1|||
161917383|NCT00460798|584745985|FG000|Overall Study|Death|59|||
161917384|NCT00460798|584745985|FG000|Overall Study|Adverse Event|27|||
161917385|NCT00460798|584745985|FG000|Overall Study|Lost to Follow-up|19|||
161917386|NCT00460798|584745985|FG000|Overall Study|Progressive Disease|99|||
161917387|NCT00460798|584745985|FG000|Overall Study|Other|27|||
161917388|NCT00460798|584745985|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
161917389|NCT00460798|584745985|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
161917390|NCT01898130|584745986|FG000|Treatment|Withdrawal by Subject|2|||
161917391|NCT01898130|584745986|FG000|Treatment|Progressive Disease|4|||
161917392|NCT01898130|584745986|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
161917393|NCT04491994|584745990|FG000|Overall Study|Withdrawal by Subject|10|||
161917394|NCT04491994|584745991|FG001|Overall Study|Withdrawal by Subject|5|||
161917395|NCT04491994|584745990|FG000|Overall Study|developed fever > 3 days|4|||
161473751|NCT02663908|583128704|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
161917396|NCT04491994|584745991|FG001|Overall Study|developed fever > 3 days|1|||
161917397|NCT04491994|584745990|FG000|Overall Study|Protocol Violation|11|||
161917398|NCT04491994|584745991|FG001|Overall Study|Protocol Violation|2|||
161917399|NCT04491994|584745990|FG000|Overall Study|Lost to Follow-up|4|||
161917400|NCT04491994|584745991|FG001|Overall Study|Lost to Follow-up|3|||
161917401|NCT03517137|584745999|FG000|Overall Study|Lack of Efficacy|1|||
161917402|NCT03517137|584745999|FG000|Overall Study|Adverse Event|2|||
161917403|NCT03517137|584745999|FG000|Overall Study|Withdrawal by Subject|2|||
161917404|NCT03517137|584745999|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
161917405|NCT03575364|584746000|FG000|Overall Study|Death|45|||
161917406|NCT03575364|584746000|FG000|Overall Study|Lost to Follow-up|114|||
161917407|NCT03575364|584746000|FG000|Overall Study|Withdrawal by Subject|21|||
161917408|NCT03575364|584746000|FG000|Overall Study|Physician Decision|11|||
161473752|NCT00302107|583128705|FG000|Overall Study|Lost to Follow-up|6|||
161473753|NCT00302107|583128706|FG001|Overall Study|Lost to Follow-up|5|||
161473754|NCT00302107|583128705|FG000|Overall Study|Protocol Violation|1|||
161473755|NCT00302107|583128706|FG001|Overall Study|Protocol Violation|0|||
161473756|NCT00302107|583128705|FG000|Overall Study|Relocation|0|||
161917409|NCT03575364|584746000|FG000|Overall Study|Subject Refused Follow-up|13|||
161917410|NCT03575364|584746000|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
161473757|NCT00302107|583128706|FG001|Overall Study|Relocation|1|||
161473758|NCT00302107|583128705|FG000|Overall Study|Withdrawal by Subject|0|||
161473759|NCT00302107|583128706|FG001|Overall Study|Withdrawal by Subject|3|||
161917411|NCT03575364|584746000|FG000|Overall Study|Patient moved out of the state|1|||
161917412|NCT03575364|584746000|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
161917413|NCT03575364|584746000|FG000|Overall Study|Patient is lost to follow up|1|||
161917414|NCT03575364|584746000|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
161917415|NCT01186770|584746001|FG000|Overall Study|Ineligibility|0|||
161917416|NCT01186770|584746002|FG001|Overall Study|Ineligibility|0|||
161917417|NCT01186770|584746003|FG002|Overall Study|Ineligibility|2|||
161917418|NCT01186770|584746004|FG003|Overall Study|Ineligibility|0|||
161917419|NCT01186770|584746001|FG000|Overall Study|Protocol Violation|7|||
161917420|NCT01186770|584746002|FG001|Overall Study|Protocol Violation|9|||
161917421|NCT01186770|584746003|FG002|Overall Study|Protocol Violation|12|||
161473760|NCT00302107|583128705|FG000|Overall Study|Adverse Event|1|||
161473761|NCT00302107|583128706|FG001|Overall Study|Adverse Event|0|||
161917422|NCT01186770|584746004|FG003|Overall Study|Protocol Violation|14|||
161917423|NCT01186770|584746001|FG000|Overall Study|Adverse Event|2|||
161917424|NCT01186770|584746002|FG001|Overall Study|Adverse Event|9|||
161917425|NCT01186770|584746003|FG002|Overall Study|Adverse Event|7|||
161917426|NCT01186770|584746004|FG003|Overall Study|Adverse Event|9|||
161917427|NCT01186770|584746001|FG000|Overall Study|Withdrawal by Subject|15|||
161917428|NCT01186770|584746002|FG001|Overall Study|Withdrawal by Subject|13|||
161917429|NCT01186770|584746003|FG002|Overall Study|Withdrawal by Subject|11|||
161917430|NCT01186770|584746004|FG003|Overall Study|Withdrawal by Subject|17|||
161917431|NCT01186770|584746001|FG000|Overall Study|Lost to Follow-up|10|||
161917432|NCT01186770|584746002|FG001|Overall Study|Lost to Follow-up|6|||
161917433|NCT01186770|584746003|FG002|Overall Study|Lost to Follow-up|14|||
161917434|NCT01186770|584746004|FG003|Overall Study|Lost to Follow-up|9|||
161917435|NCT01186770|584746001|FG000|Overall Study|Insufficient response to treatment|7|||
161917436|NCT01186770|584746002|FG001|Overall Study|Insufficient response to treatment|8|||
161917437|NCT01186770|584746003|FG002|Overall Study|Insufficient response to treatment|5|||
161917438|NCT01186770|584746004|FG003|Overall Study|Insufficient response to treatment|7|||
161917439|NCT01186770|584746001|FG000|Overall Study|Other than specified|0|||
161917440|NCT01186770|584746002|FG001|Overall Study|Other than specified|1|||
161917441|NCT01186770|584746003|FG002|Overall Study|Other than specified|1|||
161917442|NCT01186770|584746004|FG003|Overall Study|Other than specified|2|||
161917443|NCT02567188|584746005|FG000|Overall Study|Death|10|||
161917444|NCT02567188|584746005|FG000|Overall Study|Terminated Mircera Treatment|9|||
161917445|NCT02567188|584746005|FG000|Overall Study|Lost to Follow-up|5|||
161917446|NCT02567188|584746005|FG000|Overall Study|Adverse Event|1|||
161917447|NCT02567188|584746005|FG000|Overall Study|Withdrawal by Subject|1|||
161917448|NCT02567188|584746005|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
161917449|NCT02567188|584746005|FG000|Overall Study|Moved and Changed Clinic|1|||
161917450|NCT02567188|584746005|FG000|Overall Study|Started Hemodialysis|2|||
161917451|NCT02567188|584746005|FG000|Overall Study|Protocol Violation|5|||
161917452|NCT02441283|584746006|FG000|Overall Study|Withdrew consent|15|||
161917453|NCT02441283|584746006|FG000|Overall Study|Lost to Follow-up|42|||
161917454|NCT02441283|584746006|FG000|Overall Study|Death|1|||
161917455|NCT02441283|584746006|FG000|Overall Study|Other, not specified|32|||
161917456|NCT01033136|584746007|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
161917457|NCT01033136|584746008|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
161917458|NCT05383209|584746009|FG000|Overall Study|Adverse Event: Non-ocular|0|||
161917459|NCT05383209|584746010|FG001|Overall Study|Adverse Event: Non-ocular|1|||
161917460|NCT05383209|584746011|FG002|Overall Study|Adverse Event: Non-ocular|0|||
161917461|NCT05383209|584746009|FG000|Overall Study|Lost to Follow-up|2|||
161917462|NCT05383209|584746010|FG001|Overall Study|Lost to Follow-up|1|||
161917463|NCT05383209|584746011|FG002|Overall Study|Lost to Follow-up|4|||
161917464|NCT05383209|584746009|FG000|Overall Study|Withdrawal by Subject|2|||
161917465|NCT05383209|584746010|FG001|Overall Study|Withdrawal by Subject|0|||
161917466|NCT05383209|584746011|FG002|Overall Study|Withdrawal by Subject|1|||
161917467|NCT05383209|584746009|FG000|Overall Study|Death|1|||
161917468|NCT05383209|584746010|FG001|Overall Study|Death|0|||
161917469|NCT05383209|584746011|FG002|Overall Study|Death|0|||
161917470|NCT05383209|584746009|FG000|Overall Study|Other|0|||
161917471|NCT05383209|584746010|FG001|Overall Study|Other|1|||
161917472|NCT05383209|584746011|FG002|Overall Study|Other|0|||
161917473|NCT01369433|584746012|FG000|Overall Study|Adverse Event|31|||
161917474|NCT01369433|584746013|FG001|Overall Study|Adverse Event|1|||
161917475|NCT01369433|584746012|FG000|Overall Study|Required significant surgical procedure|1|||
161917476|NCT01369433|584746013|FG001|Overall Study|Required significant surgical procedure|0|||
161917477|NCT01369433|584746012|FG000|Overall Study|Non-compliance|1|||
161917478|NCT01369433|584746013|FG001|Overall Study|Non-compliance|0|||
161917479|NCT01369433|584746012|FG000|Overall Study|Withdrawal by Subject|5|||
161917480|NCT01369433|584746013|FG001|Overall Study|Withdrawal by Subject|2|||
161917481|NCT01369433|584746012|FG000|Overall Study|Study terminated by Sponsor|67|||
161917482|NCT01369433|584746013|FG001|Overall Study|Study terminated by Sponsor|0|||
161917483|NCT01369433|584746012|FG000|Overall Study|Lost to Follow-up|1|||
161917484|NCT01369433|584746013|FG001|Overall Study|Lost to Follow-up|0|||
161917485|NCT01369433|584746012|FG000|Overall Study|Death|5|||
161917486|NCT01369433|584746013|FG001|Overall Study|Death|0|||
161917487|NCT01369433|584746012|FG000|Overall Study|Investigator discretion|6|||
161917488|NCT01369433|584746013|FG001|Overall Study|Investigator discretion|1|||
161917489|NCT01369433|584746012|FG000|Overall Study|Progressive Disease|92|||
161917490|NCT01369433|584746013|FG001|Overall Study|Progressive Disease|12|||
161917491|NCT02472353|584746016|FG000|Overall Study|Lost to Follow-up|1|||
161917492|NCT02472353|584746017|FG001|Overall Study|Lost to Follow-up|1|||
161917493|NCT02472353|584746016|FG000|Overall Study|Withdrawal by Subject|2|||
161917494|NCT02472353|584746017|FG001|Overall Study|Withdrawal by Subject|1|||
161917495|NCT02472353|584746016|FG000|Overall Study|Study Termination|1|||
161917496|NCT02472353|584746017|FG001|Overall Study|Study Termination|4|||
161917497|NCT02101294|584746018|FG000|Overall Study|Withdrawal by Subject|5|||
161917498|NCT02101294|584746018|FG000|Overall Study|Lost to Follow-up|6|||
161917499|NCT00688597|584746021|FG000|Overall Study|Adverse Event|2|||
161917500|NCT00688597|584746022|FG001|Overall Study|Adverse Event|0|||
161917501|NCT00688597|584746023|FG002|Overall Study|Adverse Event|0|||
161917502|NCT00688597|584746021|FG000|Overall Study|Physician Decision|1|||
161917503|NCT00688597|584746022|FG001|Overall Study|Physician Decision|0|||
161917504|NCT00688597|584746023|FG002|Overall Study|Physician Decision|0|||
161917505|NCT00933933|584746027|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
161917506|NCT00933933|584746028|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
161917507|NCT00933933|584746029|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
161917508|NCT00933933|584746027|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
161917509|NCT00933933|584746028|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
161917510|NCT00933933|584746029|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
161473762|NCT00437983|583128707|FG000|Overall Study|Adverse Event|6|||
161473763|NCT00437983|583128708|FG001|Overall Study|Adverse Event|6|||
161473764|NCT00437983|583128707|FG000|Overall Study|Protocol Violation|2|||
161473765|NCT00437983|583128708|FG001|Overall Study|Protocol Violation|1|||
161473766|NCT00437983|583128707|FG000|Overall Study|Withdrawal by Subject|5|||
161473767|NCT00437983|583128708|FG001|Overall Study|Withdrawal by Subject|6|||
161473768|NCT01790932|583128709|FG000|Overall Study|Disease Progression|41|||
161473769|NCT01790932|583128709|FG000|Overall Study|Adverse Event|7|||
161473770|NCT01790932|583128709|FG000|Overall Study|Physician Decision|1|||
161473771|NCT01790932|583128709|FG000|Overall Study|Withdrawal by Subject|1|||
161473772|NCT01441180|583128715|FG000|Overall Study|Lost to Follow-up|1|||
161473773|NCT01441180|583128716|FG001|Overall Study|Lost to Follow-up|1|||
161473774|NCT01441180|583128717|FG002|Overall Study|Lost to Follow-up|1|||
161473775|NCT01441180|583128715|FG000|Overall Study|Discontinued|0|||
161473776|NCT01441180|583128716|FG001|Overall Study|Discontinued|0|||
161473777|NCT01441180|583128717|FG002|Overall Study|Discontinued|2|||
161473778|NCT01558739|583128720|FG000|Overall Study|Adverse Event|7|||
161473779|NCT01558739|583128720|FG000|Overall Study|Withdrawal by Subject|2|||
161473780|NCT01558739|583128720|FG000|Overall Study|Death|3|||
161473781|NCT01558739|583128720|FG000|Overall Study|Disease Progression|4|||
161473782|NCT01558739|583128720|FG000|Overall Study|Protocol Violation|1|||
161473783|NCT01402011|583128725|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
161473784|NCT01402011|583128726|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
161473785|NCT01402011|583128727|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
161917511|NCT01995201|584746030|FG000|From Baseline Until Week 24|Adverse Event|4|||
161917512|NCT01995201|584746031|FG001|From Baseline Until Week 24|Adverse Event|15|||
161917513|NCT01995201|584746032|FG002|From Baseline Until Week 24|Adverse Event|0|||
161917514|NCT01995201|584746033|FG003|From Baseline Until Week 24|Adverse Event|0|||
161917515|NCT01995201|584746034|FG004|From Baseline Until Week 24|Adverse Event|0|||
161917516|NCT01995201|584746035|FG005|From Baseline Until Week 24|Adverse Event|0|||
161917517|NCT01995201|584746036|FG006|From Baseline Until Week 24|Adverse Event|0|||
161917518|NCT01995201|584746030|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917519|NCT01995201|584746031|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
161917520|NCT01995201|584746032|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917521|NCT01995201|584746033|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917522|NCT01995201|584746034|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917523|NCT01995201|584746035|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917524|NCT01995201|584746036|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917525|NCT01995201|584746030|FG000|From Baseline Until Week 24|Death|0|||
161917526|NCT01995201|584746031|FG001|From Baseline Until Week 24|Death|1|||
161917527|NCT01995201|584746032|FG002|From Baseline Until Week 24|Death|0|||
161917528|NCT01995201|584746033|FG003|From Baseline Until Week 24|Death|0|||
161917529|NCT01995201|584746034|FG004|From Baseline Until Week 24|Death|0|||
161917530|NCT01995201|584746035|FG005|From Baseline Until Week 24|Death|0|||
161917531|NCT01995201|584746036|FG006|From Baseline Until Week 24|Death|0|||
161917532|NCT01995201|584746030|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
161917533|NCT01995201|584746031|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
161473786|NCT01402011|583128725|FG000|Active Treatment Period|Withdrawal by Subject|1|||
161473787|NCT01402011|583128726|FG001|Active Treatment Period|Withdrawal by Subject|3|||
161473788|NCT01402011|583128727|FG002|Active Treatment Period|Withdrawal by Subject|0|||
161917534|NCT01995201|584746032|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
161473789|NCT01402011|583128725|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
161473790|NCT01402011|583128726|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
161917535|NCT01995201|584746033|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
161917536|NCT01995201|584746034|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
161917537|NCT01995201|584746035|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
161473791|NCT01402011|583128727|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
161473792|NCT00594659|583128728|FG000|Overall Study|Lost to Follow-up|13|||
161473793|NCT00594659|583128729|FG001|Overall Study|Lost to Follow-up|9|||
161473794|NCT00594659|583128730|FG002|Overall Study|Lost to Follow-up|7|||
161473795|NCT00142298|583128732|FG000|Overall Study|Adverse Event|10|||
161473796|NCT00142298|583128733|FG001|Overall Study|Adverse Event|10|||
161473797|NCT00142298|583128734|FG002|Overall Study|Adverse Event|1|||
161473798|NCT00142298|583128735|FG003|Overall Study|Adverse Event|5|||
161473799|NCT00142298|583128736|FG004|Overall Study|Adverse Event|2|||
161473800|NCT00142298|583128737|FG005|Overall Study|Adverse Event|2|||
161473801|NCT00142298|583128738|FG006|Overall Study|Adverse Event|0|||
161473802|NCT00142298|583128739|FG007|Overall Study|Adverse Event|0|||
161473803|NCT00142298|583128740|FG008|Overall Study|Adverse Event|0|||
161473804|NCT00142298|583128741|FG009|Overall Study|Adverse Event|0|||
161473805|NCT00142298|583128732|FG000|Overall Study|Clinical disease progression|1|||
161473806|NCT00142298|583128733|FG001|Overall Study|Clinical disease progression|0|||
161473807|NCT00142298|583128734|FG002|Overall Study|Clinical disease progression|0|||
161473808|NCT00142298|583128735|FG003|Overall Study|Clinical disease progression|0|||
161473809|NCT00142298|583128736|FG004|Overall Study|Clinical disease progression|0|||
161473810|NCT00142298|583128737|FG005|Overall Study|Clinical disease progression|0|||
161473811|NCT00142298|583128738|FG006|Overall Study|Clinical disease progression|0|||
161473812|NCT00142298|583128739|FG007|Overall Study|Clinical disease progression|0|||
161473813|NCT00142298|583128740|FG008|Overall Study|Clinical disease progression|0|||
161473814|NCT00142298|583128741|FG009|Overall Study|Clinical disease progression|0|||
161473815|NCT00142298|583128732|FG000|Overall Study|Death|1|||
161473816|NCT00142298|583128733|FG001|Overall Study|Death|1|||
161473817|NCT00142298|583128734|FG002|Overall Study|Death|1|||
161473818|NCT00142298|583128735|FG003|Overall Study|Death|0|||
161473819|NCT00142298|583128736|FG004|Overall Study|Death|0|||
161473820|NCT00142298|583128737|FG005|Overall Study|Death|6|||
161473821|NCT00142298|583128738|FG006|Overall Study|Death|0|||
161473822|NCT00142298|583128739|FG007|Overall Study|Death|0|||
161473823|NCT00142298|583128740|FG008|Overall Study|Death|0|||
161473824|NCT00142298|583128741|FG009|Overall Study|Death|0|||
161473825|NCT00142298|583128732|FG000|Overall Study|Lack of Efficacy|44|||
161473826|NCT00142298|583128733|FG001|Overall Study|Lack of Efficacy|62|||
161473827|NCT00142298|583128734|FG002|Overall Study|Lack of Efficacy|9|||
161473828|NCT00142298|583128735|FG003|Overall Study|Lack of Efficacy|12|||
161473829|NCT00142298|583128736|FG004|Overall Study|Lack of Efficacy|1|||
161473830|NCT00142298|583128737|FG005|Overall Study|Lack of Efficacy|0|||
161473831|NCT00142298|583128738|FG006|Overall Study|Lack of Efficacy|0|||
161473832|NCT00142298|583128739|FG007|Overall Study|Lack of Efficacy|1|||
161473833|NCT00142298|583128740|FG008|Overall Study|Lack of Efficacy|0|||
161473834|NCT00142298|583128741|FG009|Overall Study|Lack of Efficacy|0|||
161473835|NCT00142298|583128732|FG000|Overall Study|Non-compliance|15|||
161473836|NCT00142298|583128733|FG001|Overall Study|Non-compliance|13|||
161917538|NCT01995201|584746036|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
161917539|NCT01995201|584746030|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
161917540|NCT01995201|584746031|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
161917541|NCT01995201|584746032|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
161917542|NCT01995201|584746033|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
161917543|NCT01995201|584746034|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
161917544|NCT01995201|584746035|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
161917545|NCT01995201|584746036|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
161917546|NCT01995201|584746030|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
161917547|NCT01995201|584746031|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
161917548|NCT01995201|584746032|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917549|NCT01995201|584746033|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917550|NCT01995201|584746034|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917551|NCT01995201|584746035|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917552|NCT01995201|584746036|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
161473837|NCT00142298|583128734|FG002|Overall Study|Non-compliance|0|||
161473838|NCT00142298|583128735|FG003|Overall Study|Non-compliance|6|||
161473839|NCT00142298|583128736|FG004|Overall Study|Non-compliance|1|||
161473840|NCT00142298|583128737|FG005|Overall Study|Non-compliance|0|||
161473841|NCT00142298|583128738|FG006|Overall Study|Non-compliance|0|||
161473842|NCT00142298|583128739|FG007|Overall Study|Non-compliance|3|||
161473843|NCT00142298|583128740|FG008|Overall Study|Non-compliance|3|||
161473844|NCT00142298|583128741|FG009|Overall Study|Non-compliance|0|||
161473845|NCT00142298|583128732|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
161473846|NCT00142298|583128733|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
161473847|NCT00142298|583128734|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
161473848|NCT00142298|583128735|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
161473849|NCT00142298|583128736|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
161473850|NCT00142298|583128737|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
161473851|NCT00142298|583128738|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
161473852|NCT00142298|583128739|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
161473853|NCT00142298|583128740|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
161473854|NCT00142298|583128741|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
161473855|NCT00142298|583128732|FG000|Overall Study|Pregnancy|4|||
161473856|NCT00142298|583128733|FG001|Overall Study|Pregnancy|4|||
161473857|NCT00142298|583128734|FG002|Overall Study|Pregnancy|2|||
161473858|NCT00142298|583128735|FG003|Overall Study|Pregnancy|3|||
161473859|NCT00142298|583128736|FG004|Overall Study|Pregnancy|0|||
161473860|NCT00142298|583128737|FG005|Overall Study|Pregnancy|0|||
161473861|NCT00142298|583128738|FG006|Overall Study|Pregnancy|0|||
161473862|NCT00142298|583128739|FG007|Overall Study|Pregnancy|0|||
161473863|NCT00142298|583128740|FG008|Overall Study|Pregnancy|1|||
161473864|NCT00142298|583128741|FG009|Overall Study|Pregnancy|0|||
161473865|NCT00142298|583128732|FG000|Overall Study|Virologic breakthrough|19|||
161473866|NCT00142298|583128733|FG001|Overall Study|Virologic breakthrough|23|||
161473867|NCT00142298|583128734|FG002|Overall Study|Virologic breakthrough|9|||
161473868|NCT00142298|583128735|FG003|Overall Study|Virologic breakthrough|7|||
161473869|NCT00142298|583128736|FG004|Overall Study|Virologic breakthrough|2|||
161473870|NCT00142298|583128737|FG005|Overall Study|Virologic breakthrough|3|||
161473871|NCT00142298|583128738|FG006|Overall Study|Virologic breakthrough|3|||
161473872|NCT00142298|583128739|FG007|Overall Study|Virologic breakthrough|0|||
161473873|NCT00142298|583128740|FG008|Overall Study|Virologic breakthrough|0|||
161473874|NCT00142298|583128741|FG009|Overall Study|Virologic breakthrough|0|||
161813584|NCT04493684|584359922|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161473875|NCT00142298|583128732|FG000|Overall Study|Other- not specified|0|||
161813585|NCT04493684|584359923|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813586|NCT04493684|584359924|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813587|NCT04493684|584359925|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813588|NCT04493684|584359926|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813589|NCT04493684|584359927|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813590|NCT04493684|584359928|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813591|NCT04493684|584359929|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813592|NCT04493684|584359930|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813593|NCT04493684|584359931|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813594|NCT04493684|584359915|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
161813595|NCT04493684|584359916|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813596|NCT04493684|584359917|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813597|NCT04493684|584359918|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813598|NCT04493684|584359919|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813599|NCT04493684|584359920|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813600|NCT04493684|584359921|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813601|NCT04493684|584359922|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813602|NCT04493684|584359923|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813603|NCT04493684|584359924|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813604|NCT04493684|584359925|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813605|NCT04493684|584359926|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813606|NCT04493684|584359927|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813607|NCT04493684|584359928|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161473876|NCT00142298|583128733|FG001|Overall Study|Other- not specified|3|||
161473877|NCT00142298|583128734|FG002|Overall Study|Other- not specified|0|||
161473878|NCT00142298|583128735|FG003|Overall Study|Other- not specified|1|||
161473879|NCT00142298|583128736|FG004|Overall Study|Other- not specified|0|||
161473880|NCT00142298|583128737|FG005|Overall Study|Other- not specified|0|||
161473881|NCT00142298|583128738|FG006|Overall Study|Other- not specified|0|||
161473882|NCT00142298|583128739|FG007|Overall Study|Other- not specified|0|||
161473883|NCT00142298|583128740|FG008|Overall Study|Other- not specified|0|||
161473884|NCT00142298|583128741|FG009|Overall Study|Other- not specified|0|||
161473885|NCT00142298|583128732|FG000|Overall Study|Lost to Follow-up|0|||
161473886|NCT00142298|583128733|FG001|Overall Study|Lost to Follow-up|0|||
161473887|NCT00142298|583128734|FG002|Overall Study|Lost to Follow-up|0|||
161473888|NCT00142298|583128735|FG003|Overall Study|Lost to Follow-up|0|||
161473889|NCT00142298|583128736|FG004|Overall Study|Lost to Follow-up|0|||
161473890|NCT00142298|583128737|FG005|Overall Study|Lost to Follow-up|0|||
161473891|NCT00142298|583128738|FG006|Overall Study|Lost to Follow-up|2|||
161473892|NCT00142298|583128739|FG007|Overall Study|Lost to Follow-up|0|||
161473893|NCT00142298|583128740|FG008|Overall Study|Lost to Follow-up|0|||
161473894|NCT00142298|583128741|FG009|Overall Study|Lost to Follow-up|0|||
161473895|NCT00142298|583128732|FG000|Overall Study|Treatment Failure|0|||
161473896|NCT00142298|583128733|FG001|Overall Study|Treatment Failure|0|||
161473897|NCT00142298|583128734|FG002|Overall Study|Treatment Failure|0|||
161473898|NCT00142298|583128735|FG003|Overall Study|Treatment Failure|0|||
161473899|NCT00142298|583128736|FG004|Overall Study|Treatment Failure|0|||
161473900|NCT00142298|583128737|FG005|Overall Study|Treatment Failure|2|||
161473901|NCT00142298|583128738|FG006|Overall Study|Treatment Failure|2|||
161473902|NCT00142298|583128739|FG007|Overall Study|Treatment Failure|0|||
161473903|NCT00142298|583128740|FG008|Overall Study|Treatment Failure|0|||
161473904|NCT00142298|583128741|FG009|Overall Study|Treatment Failure|0|||
161473905|NCT02423772|583128743|FG000|Overall Study|Lost to Follow-up|3|||
161473906|NCT02423772|583128744|FG001|Overall Study|Lost to Follow-up|3|||
161473907|NCT02423772|583128743|FG000|Overall Study|Did not begin intervention|2|||
161473908|NCT02423772|583128744|FG001|Overall Study|Did not begin intervention|5|||
161473909|NCT06238362|583128745|FG000|Overall Study|Insufficient total sleep time|1|||
161473910|NCT06238362|583128746|FG001|Overall Study|Insufficient total sleep time|0|||
161473911|NCT06238362|583128745|FG000|Overall Study|Inadequate signal quality|1|||
161473912|NCT06238362|583128746|FG001|Overall Study|Inadequate signal quality|0|||
161473913|NCT01798004|583130619|FG000|Overall Study|Death|2|||
161473914|NCT01798004|583130619|FG000|Overall Study|Lack of Efficacy|8|||
161473915|NCT01798004|583130619|FG000|Overall Study|Physician Decision|25|||
161473916|NCT01798004|583130619|FG000|Overall Study|Withdrawal by Subject|4|||
161473917|NCT01798004|583130619|FG000|Overall Study|Ineligible|4|||
161473918|NCT01798004|583130619|FG000|Overall Study|Patient/parent refusal|7|||
161473919|NCT01798004|583130619|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
161473920|NCT01798004|583130619|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
161473921|NCT03320057|583130620|FG000|Overall Study|Lost to Follow-up|4|||
161473922|NCT03320057|583130621|FG001|Overall Study|Lost to Follow-up|17|||
161473923|NCT03320057|583130620|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
161473924|NCT03320057|583130621|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
161473925|NCT06956170|583130622|FG000|Overall Study|Death|2|||
161473926|NCT06956170|583130623|FG001|Overall Study|Death|1|||
161473927|NCT06956170|583130622|FG000|Overall Study|Withdrawal by Subject|1|||
161473928|NCT06956170|583130623|FG001|Overall Study|Withdrawal by Subject|0|||
161473929|NCT06956170|583130622|FG000|Overall Study|Ongoing|7|||
161473930|NCT06956170|583130623|FG001|Overall Study|Ongoing|10|||
161473931|NCT02323113|583130624|FG000|Overall Study|Adverse Event|3|||
161473932|NCT02323113|583130625|FG001|Overall Study|Adverse Event|3|||
161473933|NCT02323113|583130626|FG002|Overall Study|Adverse Event|2|||
161473934|NCT02323113|583130627|FG003|Overall Study|Adverse Event|5|||
161473935|NCT02323113|583130628|FG004|Overall Study|Adverse Event|8|||
161473936|NCT02323113|583130629|FG005|Overall Study|Adverse Event|3|||
161473937|NCT02323113|583130630|FG006|Overall Study|Adverse Event|6|||
161473938|NCT02323113|583130631|FG007|Overall Study|Adverse Event|0|||
161473939|NCT02323113|583130624|FG000|Overall Study|Progressive Disease|0|||
161473940|NCT02323113|583130625|FG001|Overall Study|Progressive Disease|1|||
161473941|NCT02323113|583130626|FG002|Overall Study|Progressive Disease|1|||
161473942|NCT02323113|583130627|FG003|Overall Study|Progressive Disease|0|||
161473943|NCT02323113|583130628|FG004|Overall Study|Progressive Disease|0|||
161473944|NCT02323113|583130629|FG005|Overall Study|Progressive Disease|3|||
161473945|NCT02323113|583130630|FG006|Overall Study|Progressive Disease|0|||
161473946|NCT02323113|583130631|FG007|Overall Study|Progressive Disease|0|||
161473947|NCT02323113|583130624|FG000|Overall Study|Symptomatic Deterioration|0|||
161473948|NCT02323113|583130625|FG001|Overall Study|Symptomatic Deterioration|0|||
161473949|NCT02323113|583130626|FG002|Overall Study|Symptomatic Deterioration|1|||
161473950|NCT02323113|583130627|FG003|Overall Study|Symptomatic Deterioration|0|||
161473951|NCT02323113|583130628|FG004|Overall Study|Symptomatic Deterioration|1|||
161473952|NCT02323113|583130629|FG005|Overall Study|Symptomatic Deterioration|0|||
161813608|NCT04493684|584359929|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813609|NCT04493684|584359930|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161473953|NCT02323113|583130630|FG006|Overall Study|Symptomatic Deterioration|0|||
161473954|NCT02323113|583130631|FG007|Overall Study|Symptomatic Deterioration|0|||
161473955|NCT02323113|583130624|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161473956|NCT02323113|583130625|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
161473957|NCT02323113|583130626|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161473958|NCT02323113|583130627|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
161473959|NCT02323113|583130628|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
161473960|NCT02323113|583130629|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
161473961|NCT02323113|583130630|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
161473962|NCT02323113|583130631|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
161473963|NCT02323113|583130624|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473964|NCT02323113|583130625|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
161473965|NCT02323113|583130626|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473966|NCT02323113|583130627|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473967|NCT02323113|583130628|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473968|NCT02323113|583130629|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473969|NCT02323113|583130630|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473970|NCT02323113|583130631|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
161473971|NCT02280304|583130636|FG000|Overall Study|Lost to Follow-up|7|||
161473972|NCT02280304|583130637|FG001|Overall Study|Lost to Follow-up|8|||
161473973|NCT04805541|583130638|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
161473974|NCT00713323|583130649|FG000|Overall Study|Adverse Event|75|||
161473975|NCT00713323|583130649|FG000|Overall Study|Withdrawal by Subject|15|||
161473976|NCT00713323|583130649|FG000|Overall Study|Lost to Follow-up|11|||
161473977|NCT00713323|583130649|FG000|Overall Study|Lack of Efficacy|36|||
161473978|NCT00713323|583130649|FG000|Overall Study|Low creatine clearance at screening|1|||
161473979|NCT00713323|583130649|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
161473980|NCT00713323|583130649|FG000|Overall Study|Surgery cured allodynic pain|1|||
161473981|NCT00713323|583130649|FG000|Overall Study|Pain free|1|||
161473982|NCT00713323|583130649|FG000|Overall Study|Non-compliance|1|||
161473983|NCT00713323|583130649|FG000|Overall Study|Pain resolved|1|||
161473984|NCT00713323|583130649|FG000|Overall Study|Subject travelling to USA|1|||
161473985|NCT00713323|583130649|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
161473986|NCT00713323|583130649|FG000|Overall Study|Treatment that may interact with Sativex|1|||
161473987|NCT05154578|583130650|FG000|Overall Study|Withdrawal by Subject|2|||
161473988|NCT05154578|583130651|FG001|Overall Study|Withdrawal by Subject|3|||
161473989|NCT05154578|583130652|FG002|Overall Study|Withdrawal by Subject|2|||
161473990|NCT05154578|583130653|FG003|Overall Study|Withdrawal by Subject|4|||
161473991|NCT05154578|583130654|FG004|Overall Study|Withdrawal by Subject|0|||
161473992|NCT05154578|583130650|FG000|Overall Study|Lost to Follow-up|0|||
161473993|NCT05154578|583130651|FG001|Overall Study|Lost to Follow-up|1|||
161473994|NCT05154578|583130652|FG002|Overall Study|Lost to Follow-up|0|||
161473995|NCT05154578|583130653|FG003|Overall Study|Lost to Follow-up|3|||
161473996|NCT05154578|583130654|FG004|Overall Study|Lost to Follow-up|0|||
161473997|NCT05154578|583130650|FG000|Overall Study|Adverse Event|0|||
161473998|NCT05154578|583130651|FG001|Overall Study|Adverse Event|0|||
161473999|NCT05154578|583130652|FG002|Overall Study|Adverse Event|0|||
161474000|NCT05154578|583130653|FG003|Overall Study|Adverse Event|1|||
161474001|NCT05154578|583130654|FG004|Overall Study|Adverse Event|0|||
161474002|NCT05154578|583130650|FG000|Overall Study|Relocated to another province|0|||
161474003|NCT05154578|583130651|FG001|Overall Study|Relocated to another province|0|||
161474004|NCT05154578|583130652|FG002|Overall Study|Relocated to another province|1|||
161474005|NCT05154578|583130653|FG003|Overall Study|Relocated to another province|0|||
161474006|NCT05154578|583130654|FG004|Overall Study|Relocated to another province|1|||
161474007|NCT05154578|583130650|FG000|Overall Study|Baby loss|0|||
161917553|NCT01995201|584746030|FG000|From Baseline Until Week 24|Physician Decision|0|||
161917554|NCT01995201|584746031|FG001|From Baseline Until Week 24|Physician Decision|2|||
161917555|NCT01995201|584746032|FG002|From Baseline Until Week 24|Physician Decision|0|||
161917556|NCT01995201|584746033|FG003|From Baseline Until Week 24|Physician Decision|0|||
161917557|NCT01995201|584746034|FG004|From Baseline Until Week 24|Physician Decision|0|||
161917558|NCT01995201|584746035|FG005|From Baseline Until Week 24|Physician Decision|0|||
161917559|NCT01995201|584746036|FG006|From Baseline Until Week 24|Physician Decision|0|||
161917560|NCT01995201|584746030|FG000|From Baseline Until Week 24|Protocol Violation|0|||
161917561|NCT01995201|584746031|FG001|From Baseline Until Week 24|Protocol Violation|9|||
161917562|NCT01995201|584746032|FG002|From Baseline Until Week 24|Protocol Violation|0|||
161474008|NCT05154578|583130651|FG001|Overall Study|Baby loss|1|||
161917563|NCT01995201|584746033|FG003|From Baseline Until Week 24|Protocol Violation|0|||
161474009|NCT05154578|583130652|FG002|Overall Study|Baby loss|0|||
161474010|NCT05154578|583130653|FG003|Overall Study|Baby loss|0|||
161917564|NCT01995201|584746034|FG004|From Baseline Until Week 24|Protocol Violation|0|||
161917565|NCT01995201|584746035|FG005|From Baseline Until Week 24|Protocol Violation|0|||
161917566|NCT01995201|584746036|FG006|From Baseline Until Week 24|Protocol Violation|0|||
161917567|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Adverse Event|0|||
161917568|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Adverse Event|0|||
161917569|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Adverse Event|2|||
161917570|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Adverse Event|1|||
161917571|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Adverse Event|1|||
161813610|NCT04493684|584359931|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813611|NCT04493684|584359915|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813612|NCT04493684|584359916|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813613|NCT04493684|584359917|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813614|NCT04493684|584359918|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813615|NCT04493684|584359919|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813616|NCT04493684|584359920|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813617|NCT04493684|584359921|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
161813618|NCT04493684|584359922|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813619|NCT04493684|584359923|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813620|NCT04493684|584359924|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813621|NCT04493684|584359925|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813622|NCT04493684|584359926|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813623|NCT04493684|584359927|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813624|NCT04493684|584359928|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813625|NCT04493684|584359929|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813626|NCT04493684|584359930|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813627|NCT04493684|584359931|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813628|NCT04493684|584359915|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
161813629|NCT04493684|584359916|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813630|NCT04493684|584359917|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813631|NCT04493684|584359918|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813632|NCT04493684|584359919|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813633|NCT04493684|584359920|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813634|NCT04493684|584359921|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813635|NCT04493684|584359922|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813636|NCT04493684|584359923|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813637|NCT04493684|584359924|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813638|NCT04493684|584359925|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813639|NCT04493684|584359926|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813640|NCT04493684|584359927|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813641|NCT04493684|584359928|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813642|NCT04493684|584359929|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813643|NCT04493684|584359930|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813644|NCT04493684|584359931|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813645|NCT04493684|584359915|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813646|NCT04493684|584359916|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813647|NCT04493684|584359917|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813648|NCT04493684|584359918|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813649|NCT04493684|584359919|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813650|NCT04493684|584359920|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
161917572|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Adverse Event|3|||
161917573|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Adverse Event|1|||
161917574|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Death|0|||
161917575|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Death|0|||
161917576|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Death|0|||
161917577|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Death|0|||
161917578|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Death|0|||
161917579|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Death|2|||
161917580|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Death|0|||
161917581|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917582|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917583|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
161917584|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917585|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917586|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
161917587|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
161917588|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917589|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917590|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917591|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917592|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
161917593|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
161917594|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917595|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917596|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917597|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
161917598|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917599|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
161917600|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917601|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917602|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Physician Decision|0|||
161917603|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Physician Decision|0|||
161917604|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Physician Decision|0|||
161917605|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Physician Decision|0|||
161917606|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Physician Decision|1|||
161917607|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Physician Decision|0|||
161917608|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Physician Decision|0|||
161917609|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
161917610|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
161917611|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
161917612|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
161917613|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
161917614|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
161917615|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
161917616|NCT01138046|584746037|FG000|Overall Study|Withdrawal due to death|6|||
161917617|NCT01136915|584746038|FG000|Overall Study|Lost to Follow-up|2|||
161917618|NCT01136915|584746039|FG001|Overall Study|Lost to Follow-up|0|||
161917619|NCT01136915|584746038|FG000|Overall Study|Exclusion criterion met|0|||
161917620|NCT01136915|584746039|FG001|Overall Study|Exclusion criterion met|1|||
161917621|NCT04797169|584746040|FG000|Overall Study|Lost to Follow-up|84|||
161917622|NCT04797169|584746041|FG001|Overall Study|Lost to Follow-up|67|||
161917623|NCT04797169|584746040|FG000|Overall Study|Pregnancy|1|||
161917624|NCT04797169|584746041|FG001|Overall Study|Pregnancy|3|||
161917625|NCT04797169|584746040|FG000|Overall Study|Withdrawal by Subject|27|||
161917626|NCT04797169|584746041|FG001|Overall Study|Withdrawal by Subject|35|||
161813651|NCT04493684|584359921|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813652|NCT04493684|584359922|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813653|NCT04493684|584359923|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813654|NCT04493684|584359924|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813655|NCT04493684|584359925|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813656|NCT04493684|584359926|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813657|NCT04493684|584359927|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813658|NCT04493684|584359928|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813659|NCT04493684|584359929|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813660|NCT04493684|584359930|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813661|NCT04493684|584359931|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813662|NCT04493684|584359915|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813663|NCT04493684|584359916|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813664|NCT04493684|584359917|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813665|NCT04493684|584359918|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161917627|NCT03916926|584746042|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
161917628|NCT03916926|584746043|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
161917629|NCT03916926|584746042|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
161917630|NCT03916926|584746043|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
161917631|NCT03916926|584746042|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
161917632|NCT03916926|584746043|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
161917633|NCT03916926|584746042|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
161917634|NCT03916926|584746043|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
161917635|NCT03188822|584746048|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
161917636|NCT03188822|584746048|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
161917637|NCT05233761|584746063|FG000|Treatment Period A|Withdrawal by Subject|12|||
161917638|NCT05233761|584746064|FG001|Treatment Period A|Withdrawal by Subject|10|||
161917639|NCT05233761|584746063|FG000|Treatment Period A|Lost to Follow-up|6|||
161917640|NCT05233761|584746064|FG001|Treatment Period A|Lost to Follow-up|12|||
161917641|NCT05233761|584746063|FG000|Treatment Period A|Protocol Violation|8|||
161917642|NCT05233761|584746064|FG001|Treatment Period A|Protocol Violation|15|||
161917643|NCT03314935|584746067|FG000|Phase 1|Death|4|||
161917644|NCT03314935|584746068|FG001|Phase 1|Death|2|||
161917645|NCT03314935|584746069|FG002|Phase 1|Death|5|||
161917646|NCT03314935|584746070|FG003|Phase 1|Death|4|||
161917647|NCT03314935|584746071|FG004|Phase 1|Death|3|||
161917648|NCT03314935|584746072|FG005|Phase 1|Death|4|||
161917649|NCT03314935|584746073|FG006|Phase 1|Death|5|||
161917650|NCT03314935|584746074|FG007|Phase 1|Death|4|||
161917651|NCT03314935|584746075|FG008|Phase 1|Death|3|||
161917652|NCT03314935|584746076|FG009|Phase 1|Death|0|||
161917653|NCT03314935|584746077|FG010|Phase 1|Death|0|||
161917654|NCT03314935|584746078|FG011|Phase 1|Death|0|||
161917655|NCT03314935|584746079|FG012|Phase 1|Death|0|||
161917656|NCT03314935|584746080|FG013|Phase 1|Death|0|||
161917657|NCT03314935|584746081|FG014|Phase 1|Death|0|||
161917658|NCT03314935|584746067|FG000|Phase 1|Withdrawal by Subject|2|||
161917659|NCT03314935|584746068|FG001|Phase 1|Withdrawal by Subject|1|||
161917660|NCT03314935|584746069|FG002|Phase 1|Withdrawal by Subject|1|||
161917661|NCT03314935|584746070|FG003|Phase 1|Withdrawal by Subject|2|||
161917662|NCT03314935|584746071|FG004|Phase 1|Withdrawal by Subject|1|||
161917663|NCT03314935|584746072|FG005|Phase 1|Withdrawal by Subject|0|||
161917664|NCT03314935|584746073|FG006|Phase 1|Withdrawal by Subject|1|||
161917665|NCT03314935|584746074|FG007|Phase 1|Withdrawal by Subject|0|||
161917666|NCT03314935|584746075|FG008|Phase 1|Withdrawal by Subject|1|||
161917667|NCT03314935|584746076|FG009|Phase 1|Withdrawal by Subject|0|||
161917668|NCT03314935|584746077|FG010|Phase 1|Withdrawal by Subject|0|||
161917669|NCT03314935|584746078|FG011|Phase 1|Withdrawal by Subject|0|||
161917670|NCT03314935|584746079|FG012|Phase 1|Withdrawal by Subject|0|||
161917671|NCT03314935|584746080|FG013|Phase 1|Withdrawal by Subject|0|||
161917672|NCT03314935|584746081|FG014|Phase 1|Withdrawal by Subject|0|||
161917673|NCT03314935|584746067|FG000|Phase 1|Progressive Disease|2|||
161917674|NCT03314935|584746068|FG001|Phase 1|Progressive Disease|0|||
161917675|NCT03314935|584746069|FG002|Phase 1|Progressive Disease|0|||
161917676|NCT03314935|584746070|FG003|Phase 1|Progressive Disease|1|||
161917677|NCT03314935|584746071|FG004|Phase 1|Progressive Disease|0|||
161917678|NCT03314935|584746072|FG005|Phase 1|Progressive Disease|0|||
161917679|NCT03314935|584746073|FG006|Phase 1|Progressive Disease|0|||
161917680|NCT03314935|584746074|FG007|Phase 1|Progressive Disease|0|||
161917681|NCT03314935|584746075|FG008|Phase 1|Progressive Disease|0|||
161917682|NCT03314935|584746076|FG009|Phase 1|Progressive Disease|0|||
161917683|NCT03314935|584746077|FG010|Phase 1|Progressive Disease|0|||
161917684|NCT03314935|584746078|FG011|Phase 1|Progressive Disease|0|||
161917685|NCT03314935|584746079|FG012|Phase 1|Progressive Disease|0|||
161917686|NCT03314935|584746080|FG013|Phase 1|Progressive Disease|0|||
161917687|NCT03314935|584746081|FG014|Phase 1|Progressive Disease|0|||
161917688|NCT03314935|584746067|FG000|Phase 1|Study Terminated by Sponsor|0|||
161917689|NCT03314935|584746068|FG001|Phase 1|Study Terminated by Sponsor|1|||
161917690|NCT03314935|584746069|FG002|Phase 1|Study Terminated by Sponsor|0|||
161917691|NCT03314935|584746070|FG003|Phase 1|Study Terminated by Sponsor|0|||
161917692|NCT03314935|584746071|FG004|Phase 1|Study Terminated by Sponsor|0|||
161917693|NCT03314935|584746072|FG005|Phase 1|Study Terminated by Sponsor|0|||
161917694|NCT03314935|584746073|FG006|Phase 1|Study Terminated by Sponsor|0|||
161917695|NCT03314935|584746074|FG007|Phase 1|Study Terminated by Sponsor|0|||
161917696|NCT03314935|584746075|FG008|Phase 1|Study Terminated by Sponsor|1|||
161917697|NCT03314935|584746076|FG009|Phase 1|Study Terminated by Sponsor|0|||
161917698|NCT03314935|584746077|FG010|Phase 1|Study Terminated by Sponsor|0|||
161917699|NCT03314935|584746078|FG011|Phase 1|Study Terminated by Sponsor|0|||
161917700|NCT03314935|584746079|FG012|Phase 1|Study Terminated by Sponsor|0|||
161917701|NCT03314935|584746080|FG013|Phase 1|Study Terminated by Sponsor|0|||
161917702|NCT03314935|584746081|FG014|Phase 1|Study Terminated by Sponsor|0|||
161917703|NCT03314935|584746067|FG000|Phase 1|"Captured as Other in Database"|0|||
161813666|NCT04493684|584359919|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813667|NCT04493684|584359920|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813668|NCT04493684|584359921|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813669|NCT04493684|584359922|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813670|NCT04493684|584359923|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813671|NCT04493684|584359924|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813672|NCT04493684|584359925|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813673|NCT04493684|584359926|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
161813674|NCT04493684|584359927|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813675|NCT04493684|584359928|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813676|NCT04493684|584359929|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813677|NCT04493684|584359930|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813678|NCT04493684|584359931|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813679|NCT04493684|584359915|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813680|NCT04493684|584359916|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813681|NCT04493684|584359917|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813682|NCT04493684|584359918|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813683|NCT04493684|584359919|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813684|NCT04493684|584359920|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813685|NCT04493684|584359921|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813686|NCT04493684|584359922|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813687|NCT04493684|584359923|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813688|NCT04493684|584359924|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813689|NCT04493684|584359925|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813690|NCT04493684|584359926|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813691|NCT04493684|584359927|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813692|NCT04493684|584359928|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813693|NCT04493684|584359929|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813694|NCT04493684|584359930|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
161813695|NCT04493684|584359931|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813696|NCT04493684|584359915|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813697|NCT04493684|584359916|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813698|NCT04493684|584359917|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813699|NCT04493684|584359918|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813700|NCT04493684|584359919|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813701|NCT04493684|584359920|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813702|NCT04493684|584359921|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813703|NCT04493684|584359922|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161917704|NCT03314935|584746068|FG001|Phase 1|"Captured as Other in Database"|2|||
161917705|NCT03314935|584746069|FG002|Phase 1|"Captured as Other in Database"|0|||
161917706|NCT03314935|584746070|FG003|Phase 1|"Captured as Other in Database"|0|||
161917707|NCT03314935|584746071|FG004|Phase 1|"Captured as Other in Database"|0|||
161917708|NCT03314935|584746072|FG005|Phase 1|"Captured as Other in Database"|0|||
161917709|NCT03314935|584746073|FG006|Phase 1|"Captured as Other in Database"|1|||
161917710|NCT03314935|584746074|FG007|Phase 1|"Captured as Other in Database"|1|||
161917711|NCT03314935|584746075|FG008|Phase 1|"Captured as Other in Database"|1|||
161917712|NCT03314935|584746076|FG009|Phase 1|"Captured as Other in Database"|0|||
161917713|NCT03314935|584746077|FG010|Phase 1|"Captured as Other in Database"|0|||
161917714|NCT03314935|584746078|FG011|Phase 1|"Captured as Other in Database"|0|||
161917715|NCT03314935|584746079|FG012|Phase 1|"Captured as Other in Database"|0|||
161917716|NCT03314935|584746080|FG013|Phase 1|"Captured as Other in Database"|0|||
161917717|NCT03314935|584746081|FG014|Phase 1|"Captured as Other in Database"|0|||
161917718|NCT03314935|584746067|FG000|Phase 1|Lost to Follow-up|0|||
161917719|NCT03314935|584746068|FG001|Phase 1|Lost to Follow-up|0|||
161917720|NCT03314935|584746069|FG002|Phase 1|Lost to Follow-up|0|||
161917721|NCT03314935|584746070|FG003|Phase 1|Lost to Follow-up|0|||
161917722|NCT03314935|584746071|FG004|Phase 1|Lost to Follow-up|0|||
161917723|NCT03314935|584746072|FG005|Phase 1|Lost to Follow-up|0|||
161917724|NCT03314935|584746073|FG006|Phase 1|Lost to Follow-up|0|||
161917725|NCT03314935|584746074|FG007|Phase 1|Lost to Follow-up|0|||
161917726|NCT03314935|584746075|FG008|Phase 1|Lost to Follow-up|1|||
161917727|NCT03314935|584746076|FG009|Phase 1|Lost to Follow-up|0|||
161917728|NCT03314935|584746077|FG010|Phase 1|Lost to Follow-up|0|||
161917729|NCT03314935|584746078|FG011|Phase 1|Lost to Follow-up|0|||
161474011|NCT05154578|583130654|FG004|Overall Study|Baby loss|0|||
161917730|NCT03314935|584746079|FG012|Phase 1|Lost to Follow-up|0|||
161917731|NCT03314935|584746080|FG013|Phase 1|Lost to Follow-up|0|||
161917732|NCT03314935|584746081|FG014|Phase 1|Lost to Follow-up|0|||
161917733|NCT03314935|584746067|FG000|Phase 2|Death|0|||
161917734|NCT03314935|584746068|FG001|Phase 2|Death|0|||
161917735|NCT03314935|584746069|FG002|Phase 2|Death|0|||
161917736|NCT03314935|584746070|FG003|Phase 2|Death|0|||
161917737|NCT03314935|584746071|FG004|Phase 2|Death|0|||
161917738|NCT03314935|584746072|FG005|Phase 2|Death|0|||
161917739|NCT03314935|584746073|FG006|Phase 2|Death|0|||
161917740|NCT03314935|584746074|FG007|Phase 2|Death|0|||
161917741|NCT03314935|584746075|FG008|Phase 2|Death|0|||
161917742|NCT03314935|584746076|FG009|Phase 2|Death|5|||
161917743|NCT03314935|584746077|FG010|Phase 2|Death|20|||
161917744|NCT03314935|584746078|FG011|Phase 2|Death|6|||
161917745|NCT03314935|584746079|FG012|Phase 2|Death|7|||
161917746|NCT03314935|584746080|FG013|Phase 2|Death|6|||
161917747|NCT03314935|584746081|FG014|Phase 2|Death|17|||
161917748|NCT03314935|584746067|FG000|Phase 2|Withdrawal by Subject|0|||
161917749|NCT03314935|584746068|FG001|Phase 2|Withdrawal by Subject|0|||
161917750|NCT03314935|584746069|FG002|Phase 2|Withdrawal by Subject|0|||
161917751|NCT03314935|584746070|FG003|Phase 2|Withdrawal by Subject|0|||
161917752|NCT03314935|584746071|FG004|Phase 2|Withdrawal by Subject|0|||
161917753|NCT03314935|584746072|FG005|Phase 2|Withdrawal by Subject|0|||
161917754|NCT03314935|584746073|FG006|Phase 2|Withdrawal by Subject|0|||
161917755|NCT03314935|584746074|FG007|Phase 2|Withdrawal by Subject|0|||
161917756|NCT03314935|584746075|FG008|Phase 2|Withdrawal by Subject|0|||
161917757|NCT03314935|584746076|FG009|Phase 2|Withdrawal by Subject|1|||
161917758|NCT03314935|584746077|FG010|Phase 2|Withdrawal by Subject|4|||
161917759|NCT03314935|584746078|FG011|Phase 2|Withdrawal by Subject|0|||
161917760|NCT03314935|584746079|FG012|Phase 2|Withdrawal by Subject|1|||
161917761|NCT03314935|584746080|FG013|Phase 2|Withdrawal by Subject|0|||
161917762|NCT03314935|584746081|FG014|Phase 2|Withdrawal by Subject|1|||
161917763|NCT03314935|584746067|FG000|Phase 2|Progressive Disease|0|||
161917764|NCT03314935|584746068|FG001|Phase 2|Progressive Disease|0|||
161917765|NCT03314935|584746069|FG002|Phase 2|Progressive Disease|0|||
161917766|NCT03314935|584746070|FG003|Phase 2|Progressive Disease|0|||
161917767|NCT03314935|584746071|FG004|Phase 2|Progressive Disease|0|||
161917768|NCT03314935|584746072|FG005|Phase 2|Progressive Disease|0|||
161917769|NCT03314935|584746073|FG006|Phase 2|Progressive Disease|0|||
161917770|NCT03314935|584746074|FG007|Phase 2|Progressive Disease|0|||
161917771|NCT03314935|584746075|FG008|Phase 2|Progressive Disease|0|||
161917772|NCT03314935|584746076|FG009|Phase 2|Progressive Disease|1|||
161917773|NCT03314935|584746077|FG010|Phase 2|Progressive Disease|1|||
161917774|NCT03314935|584746078|FG011|Phase 2|Progressive Disease|1|||
161917775|NCT03314935|584746079|FG012|Phase 2|Progressive Disease|2|||
161917776|NCT03314935|584746080|FG013|Phase 2|Progressive Disease|0|||
161917777|NCT03314935|584746081|FG014|Phase 2|Progressive Disease|1|||
161917778|NCT03314935|584746067|FG000|Phase 2|Study Terminated by Sponsor|0|||
161917779|NCT03314935|584746068|FG001|Phase 2|Study Terminated by Sponsor|0|||
161917780|NCT03314935|584746069|FG002|Phase 2|Study Terminated by Sponsor|0|||
161917781|NCT03314935|584746070|FG003|Phase 2|Study Terminated by Sponsor|0|||
161917782|NCT03314935|584746071|FG004|Phase 2|Study Terminated by Sponsor|0|||
161917783|NCT03314935|584746072|FG005|Phase 2|Study Terminated by Sponsor|0|||
161917784|NCT03314935|584746073|FG006|Phase 2|Study Terminated by Sponsor|0|||
161917785|NCT03314935|584746074|FG007|Phase 2|Study Terminated by Sponsor|0|||
161474012|NCT01146912|583130655|FG000|Overall Study|Already received influenza vaccination|817|||
161917786|NCT03314935|584746075|FG008|Phase 2|Study Terminated by Sponsor|0|||
161917787|NCT03314935|584746076|FG009|Phase 2|Study Terminated by Sponsor|0|||
161917788|NCT03314935|584746077|FG010|Phase 2|Study Terminated by Sponsor|7|||
161917789|NCT03314935|584746078|FG011|Phase 2|Study Terminated by Sponsor|2|||
161917790|NCT03314935|584746079|FG012|Phase 2|Study Terminated by Sponsor|1|||
161917791|NCT03314935|584746080|FG013|Phase 2|Study Terminated by Sponsor|4|||
161917792|NCT03314935|584746081|FG014|Phase 2|Study Terminated by Sponsor|4|||
161917793|NCT03314935|584746067|FG000|Phase 2|Lost to Follow-up|0|||
161917794|NCT03314935|584746068|FG001|Phase 2|Lost to Follow-up|0|||
161917795|NCT03314935|584746069|FG002|Phase 2|Lost to Follow-up|0|||
161917796|NCT03314935|584746070|FG003|Phase 2|Lost to Follow-up|0|||
161917797|NCT03314935|584746071|FG004|Phase 2|Lost to Follow-up|0|||
161917798|NCT03314935|584746072|FG005|Phase 2|Lost to Follow-up|0|||
161917799|NCT03314935|584746073|FG006|Phase 2|Lost to Follow-up|0|||
161917800|NCT03314935|584746074|FG007|Phase 2|Lost to Follow-up|0|||
161917801|NCT03314935|584746075|FG008|Phase 2|Lost to Follow-up|0|||
161917802|NCT03314935|584746076|FG009|Phase 2|Lost to Follow-up|1|||
161917803|NCT03314935|584746077|FG010|Phase 2|Lost to Follow-up|0|||
161917804|NCT03314935|584746078|FG011|Phase 2|Lost to Follow-up|0|||
161917805|NCT03314935|584746079|FG012|Phase 2|Lost to Follow-up|0|||
161917806|NCT03314935|584746080|FG013|Phase 2|Lost to Follow-up|0|||
161917807|NCT03314935|584746081|FG014|Phase 2|Lost to Follow-up|1|||
161917808|NCT03314935|584746067|FG000|Phase 2|Physician Decision|0|||
161917809|NCT03314935|584746068|FG001|Phase 2|Physician Decision|0|||
161917810|NCT03314935|584746069|FG002|Phase 2|Physician Decision|0|||
161917811|NCT03314935|584746070|FG003|Phase 2|Physician Decision|0|||
161917812|NCT03314935|584746071|FG004|Phase 2|Physician Decision|0|||
161917813|NCT03314935|584746072|FG005|Phase 2|Physician Decision|0|||
161917814|NCT03314935|584746073|FG006|Phase 2|Physician Decision|0|||
161917815|NCT03314935|584746074|FG007|Phase 2|Physician Decision|0|||
161917816|NCT03314935|584746075|FG008|Phase 2|Physician Decision|0|||
161917817|NCT03314935|584746076|FG009|Phase 2|Physician Decision|0|||
161917818|NCT03314935|584746077|FG010|Phase 2|Physician Decision|1|||
161917819|NCT03314935|584746078|FG011|Phase 2|Physician Decision|0|||
161917820|NCT03314935|584746079|FG012|Phase 2|Physician Decision|0|||
161917821|NCT03314935|584746080|FG013|Phase 2|Physician Decision|0|||
161917822|NCT03314935|584746081|FG014|Phase 2|Physician Decision|0|||
161917823|NCT05252702|584746082|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
161917824|NCT05252702|584746082|FG000|Overall Study|Death|16|||
161917825|NCT05252702|584746082|FG000|Overall Study|System explant|5|||
161917826|NCT05252702|584746082|FG000|Overall Study|Lost to Follow-up|1|||
161917827|NCT05252702|584746082|FG000|Overall Study|Withdrawn by investigator|1|||
161917828|NCT05252702|584746082|FG000|Overall Study|Visit not due|306|||
161917829|NCT05252702|584746082|FG000|Overall Study|Visit within window but not completed|92|||
161917830|NCT05252702|584746082|FG000|Overall Study|Unsuccessful implant|1|||
161917831|NCT04153864|584746083|FG000|Overall Study|Withdrawal by Subject|21|||
161917832|NCT04153864|584746084|FG001|Overall Study|Withdrawal by Subject|7|||
161917833|NCT04153864|584746085|FG002|Overall Study|Withdrawal by Subject|23|||
161917834|NCT04153864|584746086|FG003|Overall Study|Withdrawal by Subject|2|||
161917835|NCT04153864|584746083|FG000|Overall Study|Lost to Follow-up|4|||
161917836|NCT04153864|584746084|FG001|Overall Study|Lost to Follow-up|0|||
161917837|NCT04153864|584746085|FG002|Overall Study|Lost to Follow-up|3|||
161917838|NCT04153864|584746086|FG003|Overall Study|Lost to Follow-up|0|||
161917839|NCT04153864|584746083|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
161917840|NCT04153864|584746084|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
161917841|NCT04153864|584746085|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
161917842|NCT04153864|584746086|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
161917843|NCT01654276|584746088|FG000|Overall Study|Lack of Efficacy|1|||
161917844|NCT01654276|584746088|FG000|Overall Study|Lost to Follow-up|4|||
161917845|NCT01654276|584746088|FG000|Overall Study|Withdrawal by Subject|1|||
161917846|NCT02657551|584746089|FG000|Overall Study|Adverse Event|2|||
161917847|NCT02657551|584746089|FG000|Overall Study|Withdrawal by Subject|1|||
161917848|NCT02657551|584746089|FG000|Overall Study|Non-Compliance|1|||
161917849|NCT02657551|584746089|FG000|Overall Study|Progression / Relapse|4|||
161917858|NCT01192178|584746093|FG000|Overall Study|Withdrawal by Subject|6|||
161917859|NCT01192178|584746094|FG001|Overall Study|Withdrawal by Subject|10|||
161917860|NCT01192178|584746093|FG000|Overall Study|Protocol Violation|10|||
161917861|NCT01192178|584746094|FG001|Overall Study|Protocol Violation|3|||
161917862|NCT01192178|584746093|FG000|Overall Study|Physician Decision|2|||
161917863|NCT01192178|584746094|FG001|Overall Study|Physician Decision|4|||
161917864|NCT01192178|584746093|FG000|Overall Study|Lost to Follow-up|3|||
161917865|NCT01192178|584746094|FG001|Overall Study|Lost to Follow-up|3|||
161917866|NCT01192178|584746093|FG000|Overall Study|Adverse Event|2|||
161917867|NCT01192178|584746094|FG001|Overall Study|Adverse Event|1|||
161917868|NCT01192178|584746093|FG000|Overall Study|Lack of Efficacy|1|||
161917869|NCT01192178|584746094|FG001|Overall Study|Lack of Efficacy|2|||
161917870|NCT00296517|584746095|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
161917871|NCT00296517|584746096|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
161917872|NCT00296517|584746095|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
161917873|NCT00296517|584746096|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
161917874|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
161917875|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
161917876|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
161917877|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
161917878|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
161917879|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
161917880|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
161917881|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
161917882|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
161917883|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
161917884|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
161917885|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
161917886|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
161917887|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
161917888|NCT02164916|584746097|FG000|Overall Study|Adverse Event|3|||
161917889|NCT02164916|584746098|FG001|Overall Study|Adverse Event|8|||
161917890|NCT02164916|584746097|FG000|Overall Study|Death|1|||
161917891|NCT02164916|584746098|FG001|Overall Study|Death|1|||
161917892|NCT02164916|584746097|FG000|Overall Study|Refusal unrelated to adverse event|3|||
161917893|NCT02164916|584746098|FG001|Overall Study|Refusal unrelated to adverse event|7|||
161917894|NCT02164916|584746097|FG000|Overall Study|Progression|37|||
161917895|NCT02164916|584746098|FG001|Overall Study|Progression|26|||
161917896|NCT02164916|584746097|FG000|Overall Study|Not protocol specified|5|||
161917897|NCT02164916|584746098|FG001|Overall Study|Not protocol specified|1|||
161917898|NCT02164916|584746097|FG000|Overall Study|Reason under review|1|||
161917899|NCT02164916|584746098|FG001|Overall Study|Reason under review|6|||
161917900|NCT02164916|584746097|FG000|Overall Study|Not eligible|2|||
161917901|NCT02164916|584746098|FG001|Overall Study|Not eligible|5|||
161917902|NCT00964782|584746101|FG000|Overall Study|Lost to Follow-up|1|||
161917903|NCT00964782|584746102|FG001|Overall Study|Lost to Follow-up|0|||
161917904|NCT00596635|584746105|FG000|Overall Study|Lost to Follow-up|0|||
161917905|NCT00596635|584746106|FG001|Overall Study|Lost to Follow-up|2|||
161917906|NCT00596635|584746107|FG002|Overall Study|Lost to Follow-up|0|||
161917907|NCT00596635|584746105|FG000|Overall Study|Treatment for symptomatic UTI|4|||
161917908|NCT00596635|584746106|FG001|Overall Study|Treatment for symptomatic UTI|6|||
161917909|NCT00596635|584746107|FG002|Overall Study|Treatment for symptomatic UTI|3|||
161917910|NCT00596635|584746105|FG000|Overall Study|Hip fracture|2|||
161917911|NCT00596635|584746106|FG001|Overall Study|Hip fracture|3|||
161917912|NCT00596635|584746107|FG002|Overall Study|Hip fracture|3|||
161917913|NCT00596635|584746105|FG000|Overall Study|Could not provide urine specimen|1|||
161917914|NCT00596635|584746106|FG001|Overall Study|Could not provide urine specimen|2|||
161917915|NCT00596635|584746107|FG002|Overall Study|Could not provide urine specimen|2|||
161917916|NCT01143324|584746109|FG000|Overall Study|Lost to Follow-up|11|||
161917917|NCT01143324|584746109|FG000|Overall Study|Withdrawal by Subject|4|||
161917918|NCT01143324|584746109|FG000|Overall Study|Explant of the device|4|||
161917919|NCT00858988|584746116|FG000|Analysis|Lactulose unable to be detected in urine|2|||
161917920|NCT00858988|584746117|FG001|Analysis|Lactulose unable to be detected in urine|1|||
161917921|NCT00846365|584746120|FG000|Overall Study|Adverse Event|20|||
161917922|NCT00846365|584746121|FG001|Overall Study|Adverse Event|30|||
161917923|NCT00846365|584746122|FG002|Overall Study|Adverse Event|11|||
161917924|NCT00846365|584746120|FG000|Overall Study|Protocol Violation|5|||
161917925|NCT00846365|584746121|FG001|Overall Study|Protocol Violation|4|||
161917926|NCT00846365|584746122|FG002|Overall Study|Protocol Violation|0|||
161917927|NCT00846365|584746120|FG000|Overall Study|Lost to Follow-up|8|||
161917928|NCT00846365|584746121|FG001|Overall Study|Lost to Follow-up|2|||
161917929|NCT00846365|584746122|FG002|Overall Study|Lost to Follow-up|5|||
161917930|NCT00846365|584746120|FG000|Overall Study|Withdrawal by Subject|11|||
161917931|NCT00846365|584746121|FG001|Overall Study|Withdrawal by Subject|11|||
161917932|NCT00846365|584746122|FG002|Overall Study|Withdrawal by Subject|9|||
161917933|NCT00846365|584746120|FG000|Overall Study|Pregnancy|1|||
161917934|NCT00846365|584746121|FG001|Overall Study|Pregnancy|0|||
161917935|NCT00846365|584746122|FG002|Overall Study|Pregnancy|0|||
161917936|NCT00846365|584746120|FG000|Overall Study|Lack of Efficacy|1|||
161917937|NCT00846365|584746121|FG001|Overall Study|Lack of Efficacy|1|||
161917938|NCT00846365|584746122|FG002|Overall Study|Lack of Efficacy|2|||
161917939|NCT00846365|584746120|FG000|Overall Study|Other|9|||
161917940|NCT00846365|584746121|FG001|Overall Study|Other|1|||
161917941|NCT00846365|584746122|FG002|Overall Study|Other|6|||
161917942|NCT01277861|584746130|FG000|Overall Study|Physician Decision|2|||
161917943|NCT01277861|584746131|FG001|Overall Study|Physician Decision|2|||
161917944|NCT05032196|584746132|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917945|NCT05032196|584746133|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
161917946|NCT05032196|584746134|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917947|NCT05032196|584746135|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917948|NCT05032196|584746136|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917949|NCT05032196|584746137|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917950|NCT05032196|584746132|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917951|NCT05032196|584746133|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917952|NCT05032196|584746134|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917953|NCT05032196|584746135|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
161917954|NCT05032196|584746136|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917955|NCT05032196|584746137|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917956|NCT05032196|584746132|FG000|Period 2 (Multidose)|Physician Decision|0|||
161917957|NCT05032196|584746133|FG001|Period 2 (Multidose)|Physician Decision|0|||
161917958|NCT05032196|584746134|FG002|Period 2 (Multidose)|Physician Decision|0|||
161917959|NCT05032196|584746135|FG003|Period 2 (Multidose)|Physician Decision|0|||
161917960|NCT05032196|584746136|FG004|Period 2 (Multidose)|Physician Decision|1|||
161917961|NCT05032196|584746137|FG005|Period 2 (Multidose)|Physician Decision|0|||
161917962|NCT00857389|584746138|FG000|Overall Study|Did not proceed to transplant|2|||
161917963|NCT00689936|584747146|FG000|Active Treatment Phase|Adverse Event|68|||
161917964|NCT00689936|584747147|FG001|Active Treatment Phase|Adverse Event|71|||
161917965|NCT00689936|584747148|FG002|Active Treatment Phase|Adverse Event|76|||
161917966|NCT00689936|584747146|FG000|Active Treatment Phase|Disease Progression|273|||
161917967|NCT00689936|584747147|FG001|Active Treatment Phase|Disease Progression|362|||
161917968|NCT00689936|584747148|FG002|Active Treatment Phase|Disease Progression|339|||
161917969|NCT00689936|584747146|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
161917970|NCT00689936|584747147|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
161917971|NCT00689936|584747148|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
161917972|NCT00689936|584747146|FG000|Active Treatment Phase|Death|60|||
161917973|NCT00689936|584747147|FG001|Active Treatment Phase|Death|28|||
161917974|NCT00689936|584747148|FG002|Active Treatment Phase|Death|37|||
161917975|NCT00689936|584747146|FG000|Active Treatment Phase|Lost to Follow-up|0|||
161917976|NCT00689936|584747147|FG001|Active Treatment Phase|Lost to Follow-up|2|||
161917977|NCT00689936|584747148|FG002|Active Treatment Phase|Lost to Follow-up|2|||
161917978|NCT00689936|584747146|FG000|Active Treatment Phase|Protocol Violation|2|||
161917979|NCT00689936|584747147|FG001|Active Treatment Phase|Protocol Violation|2|||
161917980|NCT00689936|584747148|FG002|Active Treatment Phase|Protocol Violation|4|||
161917981|NCT00689936|584747146|FG000|Active Treatment Phase|Study Close Out|64|||
161917982|NCT00689936|584747147|FG001|Active Treatment Phase|Study Close Out|26|||
161917983|NCT00689936|584747148|FG002|Active Treatment Phase|Study Close Out|21|||
161917984|NCT00689936|584747146|FG000|Active Treatment Phase|Miscellaneous|52|||
161917985|NCT00689936|584747147|FG001|Active Treatment Phase|Miscellaneous|34|||
161917986|NCT00689936|584747148|FG002|Active Treatment Phase|Miscellaneous|47|||
161917987|NCT00689936|584747146|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
161917988|NCT00689936|584747147|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
161917989|NCT00689936|584747148|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
161917990|NCT06001866|584747155|FG000|Overall Study|Withdrawal by Subject|0|||
161917991|NCT06001866|584747156|FG001|Overall Study|Withdrawal by Subject|2|||
161917992|NCT06001866|584747155|FG000|Overall Study|Protocol Violation|0|||
161917993|NCT06001866|584747156|FG001|Overall Study|Protocol Violation|2|||
161917994|NCT04703192|584747157|FG000|Overall Study|Withdrawal by Subject|2|||
161917995|NCT04703192|584747158|FG001|Overall Study|Withdrawal by Subject|0|||
161917996|NCT04703192|584747157|FG000|Overall Study|Death|3|||
161917997|NCT04703192|584747158|FG001|Overall Study|Death|1|||
161917998|NCT04703192|584747157|FG000|Overall Study|Adverse Event|13|||
161917999|NCT04703192|584747158|FG001|Overall Study|Adverse Event|2|||
161918000|NCT04703192|584747157|FG000|Overall Study|Progressive or Relapsed Disease|46|||
161918001|NCT04703192|584747158|FG001|Overall Study|Progressive or Relapsed Disease|7|||
161918002|NCT04703192|584747157|FG000|Overall Study|Clinical Progression|19|||
161918003|NCT04703192|584747158|FG001|Overall Study|Clinical Progression|8|||
161918004|NCT04703192|584747157|FG000|Overall Study|Lost to Follow-up|1|||
161918005|NCT04703192|584747158|FG001|Overall Study|Lost to Follow-up|0|||
161918006|NCT04703192|584747157|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
161918007|NCT04703192|584747158|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
161918008|NCT04703192|584747157|FG000|Overall Study|Other|5|||
161918009|NCT04703192|584747158|FG001|Overall Study|Other|1|||
161918010|NCT04725188|584747161|FG000|Overall Study|Death|72|||
161918011|NCT04725188|584747162|FG001|Overall Study|Death|69|||
161918012|NCT04725188|584747163|FG002|Overall Study|Death|76|||
161918013|NCT04725188|584747161|FG000|Overall Study|Lost to Follow-up|1|||
161918014|NCT04725188|584747162|FG001|Overall Study|Lost to Follow-up|0|||
161918015|NCT04725188|584747163|FG002|Overall Study|Lost to Follow-up|1|||
161918016|NCT04725188|584747161|FG000|Overall Study|Withdrawal by Subject|2|||
161918017|NCT04725188|584747162|FG001|Overall Study|Withdrawal by Subject|2|||
161918018|NCT04725188|584747163|FG002|Overall Study|Withdrawal by Subject|1|||
161918019|NCT04725188|584747161|FG000|Overall Study|Sponsor Decision|12|||
161918020|NCT04725188|584747162|FG001|Overall Study|Sponsor Decision|12|||
161918021|NCT04725188|584747163|FG002|Overall Study|Sponsor Decision|7|||
161918022|NCT00390013|584747165|FG000|Phase 1|tired|0|||
161918023|NCT00390013|584747166|FG001|Phase 1|tired|0|||
161918024|NCT00390013|584747167|FG002|Phase 1|tired|0|||
161918025|NCT00390013|584747168|FG003|Phase 1|tired|1|||
161918026|NCT00390013|584747165|FG000|Phase 2 First Treatment|tired|1|||
161918027|NCT00390013|584747166|FG001|Phase 2 First Treatment|tired|0|||
161918028|NCT00390013|584747167|FG002|Phase 2 First Treatment|tired|0|||
161918029|NCT00390013|584747168|FG003|Phase 2 First Treatment|tired|0|||
161918030|NCT00390013|584747165|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
161918031|NCT00390013|584747166|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
161918032|NCT00390013|584747167|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
161918033|NCT00390013|584747168|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
161918034|NCT03839641|584747169|FG000|Overall Study|Withdrawal by Subject|1|||
161918035|NCT03839641|584747170|FG001|Overall Study|Withdrawal by Subject|1|||
161918036|NCT04537299|584747177|FG000|Overall Study|Withdrawal by Subject|2|||
161918037|NCT04537299|584747178|FG001|Overall Study|Withdrawal by Subject|0|||
161918038|NCT04537299|584747177|FG000|Overall Study|Protocol Violation|1|||
161918039|NCT04537299|584747178|FG001|Overall Study|Protocol Violation|1|||
161918040|NCT00876343|584747179|FG000|Overall Study|Adverse Event|7|||
161918041|NCT00876343|584747180|FG001|Overall Study|Adverse Event|8|||
161918042|NCT00876343|584747181|FG002|Overall Study|Adverse Event|2|||
161918043|NCT00876343|584747179|FG000|Overall Study|Withdrawal by Subject|4|||
161918044|NCT00876343|584747180|FG001|Overall Study|Withdrawal by Subject|4|||
161918045|NCT00876343|584747181|FG002|Overall Study|Withdrawal by Subject|3|||
161918046|NCT00876343|584747179|FG000|Overall Study|Lack of Efficacy|0|||
161918047|NCT00876343|584747180|FG001|Overall Study|Lack of Efficacy|0|||
161918048|NCT00876343|584747181|FG002|Overall Study|Lack of Efficacy|1|||
161918049|NCT00876343|584747179|FG000|Overall Study|Protocol Violation|4|||
161918050|NCT00876343|584747180|FG001|Overall Study|Protocol Violation|1|||
161918051|NCT00876343|584747181|FG002|Overall Study|Protocol Violation|1|||
161918052|NCT00876343|584747179|FG000|Overall Study|Physician Decision|0|||
161918053|NCT00876343|584747180|FG001|Overall Study|Physician Decision|1|||
161918054|NCT00876343|584747181|FG002|Overall Study|Physician Decision|1|||
161918055|NCT00876343|584747179|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
161918056|NCT00876343|584747180|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
161918057|NCT00876343|584747181|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
161918058|NCT00876343|584747179|FG000|Overall Study|Change of residence or other commitments|2|||
161918059|NCT00876343|584747180|FG001|Overall Study|Change of residence or other commitments|2|||
161918060|NCT00876343|584747181|FG002|Overall Study|Change of residence or other commitments|3|||
161918061|NCT00924898|584747185|FG000|Overall Study|Withdrawal by Subject|2|||
161918062|NCT04717557|584747188|FG000|Overall Study|Withdrawal by Subject|2|||
161918063|NCT04717557|584747189|FG001|Overall Study|Withdrawal by Subject|0|||
161918064|NCT04717557|584747188|FG000|Overall Study|Death|1|||
161918065|NCT04717557|584747189|FG001|Overall Study|Death|0|||
161918066|NCT06354257|584747190|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161918067|NCT06354257|584747190|FG000|Treatment Period 2|Adverse Event|1|||
161918068|NCT02401230|584747191|FG000|Overall Study|Adverse Event|3|||
161918069|NCT02401230|584747192|FG001|Overall Study|Adverse Event|2|||
161918070|NCT02401230|584747193|FG002|Overall Study|Adverse Event|0|||
161918071|NCT02401230|584747191|FG000|Overall Study|Withdrawal by Subject|2|||
161918072|NCT02401230|584747192|FG001|Overall Study|Withdrawal by Subject|1|||
161918073|NCT02401230|584747193|FG002|Overall Study|Withdrawal by Subject|1|||
161918074|NCT02401230|584747191|FG000|Overall Study|Lost to Follow-up|1|||
161918075|NCT02401230|584747192|FG001|Overall Study|Lost to Follow-up|3|||
161918076|NCT02401230|584747193|FG002|Overall Study|Lost to Follow-up|3|||
161918077|NCT00720759|584747198|FG000|Overall Study|Lost to Follow-up|0|||
161918078|NCT00720759|584747199|FG001|Overall Study|Lost to Follow-up|1|||
161918079|NCT00720759|584747200|FG002|Overall Study|Lost to Follow-up|1|||
161918080|NCT00720759|584747201|FG003|Overall Study|Lost to Follow-up|0|||
161918081|NCT02318940|584747202|FG000|Overall Study|lost the record|1|||
161918082|NCT02318940|584747203|FG001|Overall Study|lost the record|0|||
161918083|NCT01047319|584747204|FG000|Overall Study|Teva requested participant withdrawal|3|||
161918084|NCT01047319|584747205|FG001|Overall Study|Teva requested participant withdrawal|0|||
161918085|NCT01047319|584747206|FG002|Overall Study|Teva requested participant withdrawal|1|||
161918086|NCT01047319|584747204|FG000|Overall Study|Protocol Violation|3|||
161918087|NCT01047319|584747205|FG001|Overall Study|Protocol Violation|2|||
161918088|NCT01047319|584747206|FG002|Overall Study|Protocol Violation|4|||
161918089|NCT01047319|584747204|FG000|Overall Study|Lack of Efficacy|4|||
161918090|NCT01047319|584747205|FG001|Overall Study|Lack of Efficacy|3|||
161918091|NCT01047319|584747206|FG002|Overall Study|Lack of Efficacy|3|||
161918092|NCT01047319|584747204|FG000|Overall Study|Death|5|||
161918093|NCT01047319|584747205|FG001|Overall Study|Death|1|||
161918094|NCT01047319|584747206|FG002|Overall Study|Death|5|||
161918095|NCT01047319|584747204|FG000|Overall Study|Pregnancy|13|||
161918096|NCT01047319|584747205|FG001|Overall Study|Pregnancy|8|||
161918097|NCT01047319|584747206|FG002|Overall Study|Pregnancy|8|||
161918098|NCT01047319|584747204|FG000|Overall Study|Physician Decision|12|||
161918099|NCT01047319|584747205|FG001|Overall Study|Physician Decision|9|||
161918100|NCT01047319|584747206|FG002|Overall Study|Physician Decision|10|||
161918101|NCT01047319|584747204|FG000|Overall Study|Lost to Follow-up|14|||
161918102|NCT01047319|584747205|FG001|Overall Study|Lost to Follow-up|10|||
161918103|NCT01047319|584747206|FG002|Overall Study|Lost to Follow-up|10|||
161918104|NCT01047319|584747204|FG000|Overall Study|Adverse Event|16|||
161918105|NCT01047319|584747205|FG001|Overall Study|Adverse Event|27|||
161918106|NCT01047319|584747206|FG002|Overall Study|Adverse Event|21|||
161918107|NCT01047319|584747204|FG000|Overall Study|Withdrawal by Subject|77|||
161918108|NCT01047319|584747205|FG001|Overall Study|Withdrawal by Subject|75|||
161918109|NCT01047319|584747206|FG002|Overall Study|Withdrawal by Subject|87|||
161918110|NCT01047319|584747204|FG000|Overall Study|Study terminated by Sponsor|198|||
161918111|NCT01047319|584747205|FG001|Overall Study|Study terminated by Sponsor|215|||
161918112|NCT01047319|584747206|FG002|Overall Study|Study terminated by Sponsor|203|||
161918113|NCT05759338|584747212|FG000|Overall Study|Withdrawal by Subject|3|||
161918114|NCT04611126|584747213|FG000|Overall Study|TIL expansion unsuccessful|1|||
161918115|NCT04611126|584747214|FG001|Overall Study|TIL expansion unsuccessful|0|||
161918116|NCT05260008|584747215|FG000|Overall Study|Physician Decision|0|||
161918117|NCT05260008|584747216|FG001|Overall Study|Physician Decision|1|||
161918118|NCT05260008|584747217|FG002|Overall Study|Physician Decision|0|||
161918119|NCT05260008|584747218|FG003|Overall Study|Physician Decision|0|||
161918120|NCT01157845|584747221|FG000|Overall Study|Lost to Follow-up|5|||
161918121|NCT01157845|584747221|FG000|Overall Study|Withdrawal by Subject|12|||
161918122|NCT01157845|584747221|FG000|Overall Study|Physician Decision|3|||
161918123|NCT01157845|584747221|FG000|Overall Study|Protocol Violation|13|||
161918124|NCT01157845|584747221|FG000|Overall Study|Study was ended|1|||
161918125|NCT01157845|584747221|FG000|Overall Study|Device malfunction|1|||
161918126|NCT04584788|584747222|FG000|Overall Study|Physician Decision|8|||
161918127|NCT04584788|584747222|FG000|Overall Study|Withdrawal by Subject|1|||
161918128|NCT04584788|584747222|FG000|Overall Study|Adverse Event|3|||
161918129|NCT03311555|584747223|FG000|Overall Study|Adverse Event|1|||
161918130|NCT04284774|584747229|FG000|Overall Study|Progressive disease|5|||
161918131|NCT04817410|584748633|FG000|Overall Study|Withdrawal by Subject|5|||
161918132|NCT04817410|584748633|FG000|Overall Study|Physician Decision|3|||
161918133|NCT03595748|584748634|FG000|Overall Study|Death|11|||
161918134|NCT03595748|584748635|FG001|Overall Study|Death|12|||
161918135|NCT03595748|584748634|FG000|Overall Study|Withdrawal by Subject|28|||
161918136|NCT03595748|584748635|FG001|Overall Study|Withdrawal by Subject|29|||
161918137|NCT03595748|584748634|FG000|Overall Study|Protocol Violation|0|||
161918138|NCT03595748|584748635|FG001|Overall Study|Protocol Violation|1|||
161918139|NCT02328014|584748636|FG000|Overall Study|Adverse Event|1|||
161918140|NCT02328014|584748637|FG001|Overall Study|Adverse Event|0|||
161918141|NCT02328014|584748638|FG002|Overall Study|Adverse Event|0|||
161918142|NCT02328014|584748639|FG003|Overall Study|Adverse Event|1|||
161918143|NCT02328014|584748636|FG000|Overall Study|Death|0|||
161918144|NCT02328014|584748637|FG001|Overall Study|Death|0|||
161918145|NCT02328014|584748638|FG002|Overall Study|Death|0|||
161918146|NCT02328014|584748639|FG003|Overall Study|Death|4|||
161918147|NCT02328014|584748636|FG000|Overall Study|Physician Decision|0|||
161918148|NCT02328014|584748637|FG001|Overall Study|Physician Decision|0|||
161918149|NCT02328014|584748638|FG002|Overall Study|Physician Decision|0|||
161918150|NCT02328014|584748639|FG003|Overall Study|Physician Decision|1|||
161918151|NCT02328014|584748636|FG000|Overall Study|Disease Progression|1|||
161918152|NCT02328014|584748637|FG001|Overall Study|Disease Progression|0|||
161918153|NCT02328014|584748638|FG002|Overall Study|Disease Progression|1|||
161918154|NCT02328014|584748639|FG003|Overall Study|Disease Progression|3|||
161918155|NCT02328014|584748636|FG000|Overall Study|Study Terminated by Sponsor|4|||
161918156|NCT02328014|584748637|FG001|Overall Study|Study Terminated by Sponsor|1|||
161918157|NCT02328014|584748638|FG002|Overall Study|Study Terminated by Sponsor|1|||
161918158|NCT02328014|584748639|FG003|Overall Study|Study Terminated by Sponsor|0|||
161918159|NCT02328014|584748636|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
161918160|NCT02328014|584748637|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
161918161|NCT02328014|584748638|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
161918162|NCT02328014|584748639|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
161918163|NCT02328014|584748636|FG000|Overall Study|Withdrawal by Subject|0|||
161918164|NCT02328014|584748637|FG001|Overall Study|Withdrawal by Subject|0|||
161918165|NCT02328014|584748638|FG002|Overall Study|Withdrawal by Subject|0|||
161918166|NCT02328014|584748639|FG003|Overall Study|Withdrawal by Subject|1|||
161918167|NCT05028569|584748656|FG000|Double-Blind Phase|Death|0|||
161918168|NCT05028569|584748657|FG001|Double-Blind Phase|Death|0|||
161918169|NCT05028569|584748658|FG002|Double-Blind Phase|Death|0|||
161918170|NCT05028569|584748659|FG003|Double-Blind Phase|Death|1|||
161918171|NCT05028569|584748660|FG004|Double-Blind Phase|Death|0|||
161918172|NCT05028569|584748661|FG005|Double-Blind Phase|Death|0|||
161918173|NCT05028569|584748662|FG006|Double-Blind Phase|Death|0|||
161918174|NCT05028569|584748656|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161918175|NCT05028569|584748657|FG001|Double-Blind Phase|Lost to Follow-up|6|||
161918176|NCT05028569|584748658|FG002|Double-Blind Phase|Lost to Follow-up|3|||
161813704|NCT04493684|584359923|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813705|NCT04493684|584359924|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813706|NCT04493684|584359925|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813707|NCT04493684|584359926|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813708|NCT04493684|584359927|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813709|NCT04493684|584359928|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813710|NCT04493684|584359929|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813711|NCT04493684|584359930|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
161813712|NCT04493684|584359931|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813713|NCT01056484|584361226|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
161813714|NCT01056484|584361227|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
161813715|NCT01056484|584361226|FG000|Randomized Controlled Trial|Physician Decision|1|||
161813716|NCT01056484|584361227|FG001|Randomized Controlled Trial|Physician Decision|0|||
161813717|NCT01056484|584361226|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
161813718|NCT01056484|584361227|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
161813719|NCT01440803|584361230|FG000|Overall Study|Met study stopping rule|2|||
161918177|NCT05028569|584748659|FG003|Double-Blind Phase|Lost to Follow-up|9|||
161918178|NCT05028569|584748660|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161918179|NCT05028569|584748661|FG005|Double-Blind Phase|Lost to Follow-up|0|||
161918180|NCT05028569|584748662|FG006|Double-Blind Phase|Lost to Follow-up|0|||
161918181|NCT05028569|584748656|FG000|Double-Blind Phase|Protocol Deviation|0|||
161918182|NCT05028569|584748657|FG001|Double-Blind Phase|Protocol Deviation|2|||
161918183|NCT05028569|584748658|FG002|Double-Blind Phase|Protocol Deviation|0|||
161918184|NCT05028569|584748659|FG003|Double-Blind Phase|Protocol Deviation|0|||
161918185|NCT05028569|584748660|FG004|Double-Blind Phase|Protocol Deviation|0|||
161918186|NCT05028569|584748661|FG005|Double-Blind Phase|Protocol Deviation|0|||
161918187|NCT05028569|584748662|FG006|Double-Blind Phase|Protocol Deviation|0|||
161918188|NCT05028569|584748656|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161918189|NCT05028569|584748657|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
161918190|NCT05028569|584748658|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
161918191|NCT05028569|584748659|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
161918192|NCT05028569|584748660|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161918193|NCT05028569|584748661|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
161918194|NCT05028569|584748662|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
161668461|NCT00820027|583839772|FG000|Overall Study|Protocol Violation|3|||
161918195|NCT05028569|584748656|FG000|Double-Blind Phase|Other, not specified|0|||
161918196|NCT05028569|584748657|FG001|Double-Blind Phase|Other, not specified|5|||
161918197|NCT05028569|584748658|FG002|Double-Blind Phase|Other, not specified|4|||
161918198|NCT05028569|584748659|FG003|Double-Blind Phase|Other, not specified|6|||
161918199|NCT05028569|584748660|FG004|Double-Blind Phase|Other, not specified|0|||
161918200|NCT05028569|584748661|FG005|Double-Blind Phase|Other, not specified|0|||
161918201|NCT05028569|584748662|FG006|Double-Blind Phase|Other, not specified|0|||
161918202|NCT05028569|584748656|FG000|Open-Label Phase|Death|0|||
161918203|NCT05028569|584748657|FG001|Open-Label Phase|Death|0|||
161918204|NCT05028569|584748658|FG002|Open-Label Phase|Death|0|||
161918205|NCT05028569|584748659|FG003|Open-Label Phase|Death|0|||
161918206|NCT05028569|584748660|FG004|Open-Label Phase|Death|0|||
161918207|NCT05028569|584748661|FG005|Open-Label Phase|Death|0|||
161918208|NCT05028569|584748662|FG006|Open-Label Phase|Death|1|||
161918209|NCT05028569|584748656|FG000|Open-Label Phase|Lost to Follow-up|0|||
161918210|NCT05028569|584748657|FG001|Open-Label Phase|Lost to Follow-up|0|||
161918211|NCT05028569|584748658|FG002|Open-Label Phase|Lost to Follow-up|0|||
161918212|NCT05028569|584748659|FG003|Open-Label Phase|Lost to Follow-up|0|||
161918213|NCT05028569|584748660|FG004|Open-Label Phase|Lost to Follow-up|5|||
161918214|NCT05028569|584748661|FG005|Open-Label Phase|Lost to Follow-up|5|||
161918215|NCT05028569|584748662|FG006|Open-Label Phase|Lost to Follow-up|4|||
161918216|NCT05028569|584748656|FG000|Open-Label Phase|Protocol Deviation|0|||
161918217|NCT05028569|584748657|FG001|Open-Label Phase|Protocol Deviation|0|||
161918218|NCT05028569|584748658|FG002|Open-Label Phase|Protocol Deviation|0|||
161918219|NCT05028569|584748659|FG003|Open-Label Phase|Protocol Deviation|0|||
161918220|NCT05028569|584748660|FG004|Open-Label Phase|Protocol Deviation|1|||
161918221|NCT05028569|584748661|FG005|Open-Label Phase|Protocol Deviation|0|||
161918222|NCT05028569|584748662|FG006|Open-Label Phase|Protocol Deviation|0|||
161918223|NCT05028569|584748656|FG000|Open-Label Phase|Pregnancy|0|||
161918224|NCT05028569|584748657|FG001|Open-Label Phase|Pregnancy|0|||
161918225|NCT05028569|584748658|FG002|Open-Label Phase|Pregnancy|0|||
161918226|NCT05028569|584748659|FG003|Open-Label Phase|Pregnancy|0|||
161918227|NCT05028569|584748660|FG004|Open-Label Phase|Pregnancy|0|||
161918228|NCT05028569|584748661|FG005|Open-Label Phase|Pregnancy|1|||
161918229|NCT05028569|584748662|FG006|Open-Label Phase|Pregnancy|0|||
161918230|NCT05028569|584748656|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161918231|NCT05028569|584748657|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161918232|NCT05028569|584748658|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161918233|NCT05028569|584748659|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161918234|NCT05028569|584748660|FG004|Open-Label Phase|Withdrawal by Subject|15|||
161918235|NCT05028569|584748661|FG005|Open-Label Phase|Withdrawal by Subject|8|||
161918236|NCT05028569|584748662|FG006|Open-Label Phase|Withdrawal by Subject|13|||
161918237|NCT05028569|584748656|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
161918238|NCT05028569|584748657|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161918239|NCT05028569|584748658|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161918240|NCT05028569|584748659|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
161918241|NCT05028569|584748660|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
161918242|NCT05028569|584748661|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
161918243|NCT05028569|584748662|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
161918244|NCT05028569|584748656|FG000|Open-Label Phase|Other, not specified|0|||
161918245|NCT05028569|584748657|FG001|Open-Label Phase|Other, not specified|0|||
161918246|NCT05028569|584748658|FG002|Open-Label Phase|Other, not specified|0|||
161918247|NCT05028569|584748659|FG003|Open-Label Phase|Other, not specified|0|||
161918248|NCT05028569|584748660|FG004|Open-Label Phase|Other, not specified|6|||
161918249|NCT05028569|584748661|FG005|Open-Label Phase|Other, not specified|5|||
161918250|NCT05028569|584748662|FG006|Open-Label Phase|Other, not specified|7|||
161918251|NCT05028569|584748656|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918252|NCT05028569|584748657|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918253|NCT05028569|584748658|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918254|NCT05028569|584748659|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918255|NCT05028569|584748660|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918256|NCT05028569|584748661|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
161918257|NCT05028569|584748662|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918258|NCT05028569|584748656|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918259|NCT05028569|584748657|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918260|NCT05028569|584748658|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918261|NCT05028569|584748659|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918262|NCT05028569|584748660|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918263|NCT05028569|584748661|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918264|NCT05028569|584748662|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
161918265|NCT04609553|584748663|FG000|Overall Study|Lost to Follow-up|27|||
161918266|NCT04609553|584748664|FG001|Overall Study|Lost to Follow-up|31|||
161918267|NCT04609553|584748665|FG002|Overall Study|Lost to Follow-up|24|||
161918268|NCT04609553|584748663|FG000|Overall Study|Discontinued|12|||
161918269|NCT04609553|584748664|FG001|Overall Study|Discontinued|10|||
161918270|NCT04609553|584748665|FG002|Overall Study|Discontinued|9|||
161918271|NCT01240746|584748666|FG000|Overall Study|Adverse Event|2|||
161918272|NCT01240746|584748667|FG001|Overall Study|Adverse Event|0|||
161918273|NCT01240746|584748668|FG002|Overall Study|Adverse Event|10|||
161918274|NCT01240746|584748666|FG000|Overall Study|Lost to Follow-up|23|||
161918275|NCT01240746|584748667|FG001|Overall Study|Lost to Follow-up|20|||
161918276|NCT01240746|584748668|FG002|Overall Study|Lost to Follow-up|102|||
161918277|NCT01240746|584748666|FG000|Overall Study|Protocol Violation|24|||
161918278|NCT01240746|584748667|FG001|Overall Study|Protocol Violation|15|||
161918279|NCT01240746|584748668|FG002|Overall Study|Protocol Violation|72|||
161918280|NCT01240746|584748666|FG000|Overall Study|Withdrawal by Subject|10|||
161918281|NCT01240746|584748667|FG001|Overall Study|Withdrawal by Subject|13|||
161918282|NCT01240746|584748668|FG002|Overall Study|Withdrawal by Subject|59|||
161918283|NCT01136954|584748669|FG000|Overall Study|Adverse Event|3|||
161918284|NCT01136954|584748670|FG001|Overall Study|Adverse Event|2|||
161918285|NCT01136954|584748669|FG000|Overall Study|Withdrawal by Subject|6|||
161918286|NCT01136954|584748670|FG001|Overall Study|Withdrawal by Subject|2|||
161918287|NCT01136954|584748669|FG000|Overall Study|Lack of Efficacy|14|||
161918288|NCT01136954|584748670|FG001|Overall Study|Lack of Efficacy|13|||
161918289|NCT01136954|584748669|FG000|Overall Study|Physician Decision|0|||
161918290|NCT01136954|584748670|FG001|Overall Study|Physician Decision|1|||
161918291|NCT01136954|584748669|FG000|Overall Study|Other|1|||
161918292|NCT01136954|584748670|FG001|Overall Study|Other|3|||
161918293|NCT02362451|584748688|FG000|Overall Study|Withdrawal by Subject|0|||
161918294|NCT02362451|584748689|FG001|Overall Study|Withdrawal by Subject|1|||
161918295|NCT02362451|584748688|FG000|Overall Study|Lack of Efficacy|2|||
161918296|NCT02362451|584748689|FG001|Overall Study|Lack of Efficacy|0|||
161918297|NCT02362451|584748688|FG000|Overall Study|Progression|1|||
161918298|NCT02362451|584748689|FG001|Overall Study|Progression|0|||
161918299|NCT02362451|584748688|FG000|Overall Study|Participant chose other therapy.|1|||
161918300|NCT02362451|584748689|FG001|Overall Study|Participant chose other therapy.|0|||
161918301|NCT02239328|584748692|FG000|Overall Study|Benign disease noted at time of surgery|6|||
161918302|NCT02239328|584748692|FG000|Overall Study|Equipment or website malfunction|2|||
161918303|NCT02278354|584748697|FG000|Overall Study|Lost to Follow-up|2|||
161918304|NCT02278354|584748698|FG001|Overall Study|Lost to Follow-up|2|||
161918305|NCT02278354|584748697|FG000|Overall Study|Withdrawal by Subject|0|||
161918306|NCT02278354|584748698|FG001|Overall Study|Withdrawal by Subject|1|||
161918307|NCT02278354|584748697|FG000|Overall Study|<10 professional fights|2|||
161918308|NCT02278354|584748698|FG001|Overall Study|<10 professional fights|0|||
161918309|NCT01925794|584748703|FG000|180 Days|Death|2|||
161918310|NCT01925794|584748703|FG000|180 Days|Withdrawal by Subject|2|||
161918311|NCT01925794|584748703|FG000|270 Days|Death|2|||
161918312|NCT01925794|584748703|FG000|270 Days|Protocol Violation|3|||
161918313|NCT01901562|584748704|FG000|Overall Study|Protocol Violation|5|||
161918314|NCT01901562|584748704|FG000|Overall Study|Excluded intraoperatively|4|||
161918315|NCT03126110|584748705|FG000|Phase 1|Death|2|||
161918316|NCT03126110|584748706|FG001|Phase 1|Death|2|||
161918317|NCT03126110|584748707|FG002|Phase 1|Death|4|||
161918318|NCT03126110|584748708|FG003|Phase 1|Death|3|||
161918319|NCT03126110|584748709|FG004|Phase 1|Death|4|||
161918320|NCT03126110|584748710|FG005|Phase 1|Death|4|||
161918321|NCT03126110|584748711|FG006|Phase 1|Death|3|||
161918322|NCT03126110|584748712|FG007|Phase 1|Death|4|||
161918323|NCT03126110|584748713|FG008|Phase 1|Death|5|||
161918324|NCT03126110|584748714|FG009|Phase 1|Death|2|||
161918325|NCT03126110|584748715|FG010|Phase 1|Death|6|||
161918326|NCT03126110|584748716|FG011|Phase 1|Death|0|||
161918327|NCT03126110|584748717|FG012|Phase 1|Death|0|||
161918328|NCT03126110|584748718|FG013|Phase 1|Death|0|||
161918329|NCT03126110|584748719|FG014|Phase 1|Death|0|||
161918330|NCT03126110|584748720|FG015|Phase 1|Death|0|||
161918331|NCT03126110|584748721|FG016|Phase 1|Death|0|||
161918332|NCT03126110|584748705|FG000|Phase 1|Lost to Follow-up|0|||
161918333|NCT03126110|584748706|FG001|Phase 1|Lost to Follow-up|1|||
161918334|NCT03126110|584748707|FG002|Phase 1|Lost to Follow-up|0|||
161918335|NCT03126110|584748708|FG003|Phase 1|Lost to Follow-up|0|||
161918336|NCT03126110|584748709|FG004|Phase 1|Lost to Follow-up|0|||
161918337|NCT03126110|584748710|FG005|Phase 1|Lost to Follow-up|0|||
161918338|NCT03126110|584748711|FG006|Phase 1|Lost to Follow-up|0|||
161918339|NCT03126110|584748712|FG007|Phase 1|Lost to Follow-up|0|||
161918340|NCT03126110|584748713|FG008|Phase 1|Lost to Follow-up|1|||
161918341|NCT03126110|584748714|FG009|Phase 1|Lost to Follow-up|0|||
161918342|NCT03126110|584748715|FG010|Phase 1|Lost to Follow-up|0|||
161918343|NCT03126110|584748716|FG011|Phase 1|Lost to Follow-up|0|||
161918344|NCT03126110|584748717|FG012|Phase 1|Lost to Follow-up|0|||
161918345|NCT03126110|584748718|FG013|Phase 1|Lost to Follow-up|0|||
161918346|NCT03126110|584748719|FG014|Phase 1|Lost to Follow-up|0|||
161918347|NCT03126110|584748720|FG015|Phase 1|Lost to Follow-up|0|||
161918348|NCT03126110|584748721|FG016|Phase 1|Lost to Follow-up|0|||
161918349|NCT03126110|584748705|FG000|Phase 1|Withdrawal by Subject|1|||
161918350|NCT03126110|584748706|FG001|Phase 1|Withdrawal by Subject|0|||
161918351|NCT03126110|584748707|FG002|Phase 1|Withdrawal by Subject|0|||
161918352|NCT03126110|584748708|FG003|Phase 1|Withdrawal by Subject|1|||
161918353|NCT03126110|584748709|FG004|Phase 1|Withdrawal by Subject|1|||
161918354|NCT03126110|584748710|FG005|Phase 1|Withdrawal by Subject|0|||
161918355|NCT03126110|584748711|FG006|Phase 1|Withdrawal by Subject|0|||
161918356|NCT03126110|584748712|FG007|Phase 1|Withdrawal by Subject|0|||
161918357|NCT03126110|584748713|FG008|Phase 1|Withdrawal by Subject|2|||
161918358|NCT03126110|584748714|FG009|Phase 1|Withdrawal by Subject|1|||
161918359|NCT03126110|584748715|FG010|Phase 1|Withdrawal by Subject|0|||
161918360|NCT03126110|584748716|FG011|Phase 1|Withdrawal by Subject|0|||
161918361|NCT03126110|584748717|FG012|Phase 1|Withdrawal by Subject|0|||
161918362|NCT03126110|584748718|FG013|Phase 1|Withdrawal by Subject|0|||
161918363|NCT03126110|584748719|FG014|Phase 1|Withdrawal by Subject|0|||
161918364|NCT03126110|584748720|FG015|Phase 1|Withdrawal by Subject|0|||
161918365|NCT03126110|584748721|FG016|Phase 1|Withdrawal by Subject|0|||
161918366|NCT03126110|584748705|FG000|Phase 1|Safety follow-up no longer necessary|1|||
161918367|NCT03126110|584748706|FG001|Phase 1|Safety follow-up no longer necessary|0|||
161918368|NCT03126110|584748707|FG002|Phase 1|Safety follow-up no longer necessary|0|||
161918369|NCT03126110|584748708|FG003|Phase 1|Safety follow-up no longer necessary|0|||
161918370|NCT03126110|584748709|FG004|Phase 1|Safety follow-up no longer necessary|0|||
161918371|NCT03126110|584748710|FG005|Phase 1|Safety follow-up no longer necessary|0|||
161918372|NCT03126110|584748711|FG006|Phase 1|Safety follow-up no longer necessary|0|||
161918373|NCT03126110|584748712|FG007|Phase 1|Safety follow-up no longer necessary|0|||
161918374|NCT03126110|584748713|FG008|Phase 1|Safety follow-up no longer necessary|0|||
161918375|NCT03126110|584748714|FG009|Phase 1|Safety follow-up no longer necessary|0|||
161918376|NCT03126110|584748715|FG010|Phase 1|Safety follow-up no longer necessary|0|||
161918377|NCT03126110|584748716|FG011|Phase 1|Safety follow-up no longer necessary|0|||
161918378|NCT03126110|584748717|FG012|Phase 1|Safety follow-up no longer necessary|0|||
161918379|NCT03126110|584748718|FG013|Phase 1|Safety follow-up no longer necessary|0|||
161918380|NCT03126110|584748719|FG014|Phase 1|Safety follow-up no longer necessary|0|||
161918381|NCT03126110|584748720|FG015|Phase 1|Safety follow-up no longer necessary|0|||
161918382|NCT03126110|584748721|FG016|Phase 1|Safety follow-up no longer necessary|0|||
161918383|NCT03126110|584748705|FG000|Phase 1|Survival follow-up no longer necessary|0|||
161918384|NCT03126110|584748706|FG001|Phase 1|Survival follow-up no longer necessary|0|||
161918385|NCT03126110|584748707|FG002|Phase 1|Survival follow-up no longer necessary|1|||
161918386|NCT03126110|584748708|FG003|Phase 1|Survival follow-up no longer necessary|0|||
161918387|NCT03126110|584748709|FG004|Phase 1|Survival follow-up no longer necessary|0|||
161918388|NCT03126110|584748710|FG005|Phase 1|Survival follow-up no longer necessary|0|||
161918389|NCT03126110|584748711|FG006|Phase 1|Survival follow-up no longer necessary|0|||
161918390|NCT03126110|584748712|FG007|Phase 1|Survival follow-up no longer necessary|0|||
161918391|NCT03126110|584748713|FG008|Phase 1|Survival follow-up no longer necessary|0|||
161918392|NCT03126110|584748714|FG009|Phase 1|Survival follow-up no longer necessary|0|||
161918393|NCT03126110|584748715|FG010|Phase 1|Survival follow-up no longer necessary|0|||
161918394|NCT03126110|584748716|FG011|Phase 1|Survival follow-up no longer necessary|0|||
161918395|NCT03126110|584748717|FG012|Phase 1|Survival follow-up no longer necessary|0|||
161918396|NCT03126110|584748718|FG013|Phase 1|Survival follow-up no longer necessary|0|||
161918397|NCT03126110|584748719|FG014|Phase 1|Survival follow-up no longer necessary|0|||
161918398|NCT03126110|584748720|FG015|Phase 1|Survival follow-up no longer necessary|0|||
161918399|NCT03126110|584748721|FG016|Phase 1|Survival follow-up no longer necessary|0|||
161918400|NCT03126110|584748705|FG000|Phase 2|Study terminated by the sponsor|0|||
161918401|NCT03126110|584748706|FG001|Phase 2|Study terminated by the sponsor|0|||
161918402|NCT03126110|584748707|FG002|Phase 2|Study terminated by the sponsor|0|||
161918403|NCT03126110|584748708|FG003|Phase 2|Study terminated by the sponsor|0|||
161918404|NCT03126110|584748709|FG004|Phase 2|Study terminated by the sponsor|0|||
161918405|NCT03126110|584748710|FG005|Phase 2|Study terminated by the sponsor|0|||
161918406|NCT03126110|584748711|FG006|Phase 2|Study terminated by the sponsor|0|||
161918407|NCT03126110|584748712|FG007|Phase 2|Study terminated by the sponsor|0|||
161918408|NCT03126110|584748713|FG008|Phase 2|Study terminated by the sponsor|0|||
161918409|NCT03126110|584748714|FG009|Phase 2|Study terminated by the sponsor|0|||
161918410|NCT03126110|584748715|FG010|Phase 2|Study terminated by the sponsor|0|||
161918411|NCT03126110|584748716|FG011|Phase 2|Study terminated by the sponsor|0|||
161918412|NCT03126110|584748717|FG012|Phase 2|Study terminated by the sponsor|0|||
161918413|NCT03126110|584748718|FG013|Phase 2|Study terminated by the sponsor|4|||
161918414|NCT03126110|584748719|FG014|Phase 2|Study terminated by the sponsor|0|||
161918415|NCT03126110|584748720|FG015|Phase 2|Study terminated by the sponsor|0|||
161918416|NCT03126110|584748721|FG016|Phase 2|Study terminated by the sponsor|0|||
161918417|NCT03126110|584748705|FG000|Phase 2|Withdrawal by Subject|0|||
161918418|NCT03126110|584748706|FG001|Phase 2|Withdrawal by Subject|0|||
161918419|NCT03126110|584748707|FG002|Phase 2|Withdrawal by Subject|0|||
161918420|NCT03126110|584748708|FG003|Phase 2|Withdrawal by Subject|0|||
161918421|NCT03126110|584748709|FG004|Phase 2|Withdrawal by Subject|0|||
161918422|NCT03126110|584748710|FG005|Phase 2|Withdrawal by Subject|0|||
161918423|NCT03126110|584748711|FG006|Phase 2|Withdrawal by Subject|0|||
161918424|NCT03126110|584748712|FG007|Phase 2|Withdrawal by Subject|0|||
161918425|NCT03126110|584748713|FG008|Phase 2|Withdrawal by Subject|0|||
161918426|NCT03126110|584748714|FG009|Phase 2|Withdrawal by Subject|0|||
161918427|NCT03126110|584748715|FG010|Phase 2|Withdrawal by Subject|0|||
161918428|NCT03126110|584748716|FG011|Phase 2|Withdrawal by Subject|1|||
161918429|NCT03126110|584748717|FG012|Phase 2|Withdrawal by Subject|3|||
161918430|NCT03126110|584748718|FG013|Phase 2|Withdrawal by Subject|3|||
161918431|NCT03126110|584748719|FG014|Phase 2|Withdrawal by Subject|2|||
161813720|NCT01440803|584361231|FG001|Overall Study|Met study stopping rule|1|||
161813721|NCT01440803|584361230|FG000|Overall Study|Lost to Follow-up|0|||
161813722|NCT01440803|584361231|FG001|Overall Study|Lost to Follow-up|2|||
161813723|NCT01440803|584361230|FG000|Overall Study|Withdrawal by Subject|0|||
161813724|NCT01440803|584361231|FG001|Overall Study|Withdrawal by Subject|1|||
161813725|NCT02197416|584361234|FG000|Overall Study|Other reasons|0|||
161813726|NCT02197416|584361235|FG001|Overall Study|Other reasons|2|||
161813727|NCT02197416|584361236|FG002|Overall Study|Other reasons|5|||
161813728|NCT02197416|584361234|FG000|Overall Study|Withdrawal by Subject|0|||
161813729|NCT02197416|584361235|FG001|Overall Study|Withdrawal by Subject|2|||
161813730|NCT02197416|584361236|FG002|Overall Study|Withdrawal by Subject|1|||
161813731|NCT02197416|584361234|FG000|Overall Study|Protocol Violation|1|||
161813732|NCT02197416|584361235|FG001|Overall Study|Protocol Violation|0|||
161813733|NCT02197416|584361236|FG002|Overall Study|Protocol Violation|1|||
161813734|NCT02197416|584361234|FG000|Overall Study|Adverse Event|0|||
161813735|NCT02197416|584361235|FG001|Overall Study|Adverse Event|0|||
161813736|NCT02197416|584361236|FG002|Overall Study|Adverse Event|1|||
161813737|NCT01492439|584361237|FG000|Overall Study|Withdrew from RTE|4|||
161813738|NCT01492439|584361238|FG001|Overall Study|Withdrew from RTE|9|||
161813739|NCT00716625|584361239|FG000|Overall Study|Safety was not Assessable|1|||
161813740|NCT04349267|584361240|FG000|Overall Study|Adverse Event|0|||
161813741|NCT04349267|584361241|FG001|Overall Study|Adverse Event|0|||
161813742|NCT04349267|584361242|FG002|Overall Study|Adverse Event|0|||
161813743|NCT04349267|584361243|FG003|Overall Study|Adverse Event|0|||
161813744|NCT04349267|584361244|FG004|Overall Study|Adverse Event|0|||
161813745|NCT04349267|584361245|FG005|Overall Study|Adverse Event|1|||
161813746|NCT04349267|584361246|FG006|Overall Study|Adverse Event|0|||
161813747|NCT04349267|584361240|FG000|Overall Study|Other reason|0|||
161813748|NCT04349267|584361241|FG001|Overall Study|Other reason|1|||
161813749|NCT04349267|584361242|FG002|Overall Study|Other reason|0|||
161813750|NCT04349267|584361243|FG003|Overall Study|Other reason|0|||
161918432|NCT03126110|584748720|FG015|Phase 2|Withdrawal by Subject|1|||
161918433|NCT03126110|584748721|FG016|Phase 2|Withdrawal by Subject|0|||
161918434|NCT03126110|584748705|FG000|Phase 2|Lost to Follow-up|0|||
161813751|NCT04349267|584361244|FG004|Overall Study|Other reason|1|||
161576250|NCT01040689|583496148|FG000|Overall Study|Lack of Efficacy|0|||
161576251|NCT01040689|583496149|FG001|Overall Study|Lack of Efficacy|0|||
161576252|NCT01040689|583496150|FG002|Overall Study|Lack of Efficacy|1|||
161813752|NCT04349267|584361245|FG005|Overall Study|Other reason|1|||
161813753|NCT04349267|584361246|FG006|Overall Study|Other reason|1|||
161813754|NCT04349267|584361240|FG000|Overall Study|Disease Progression|2|||
161813755|NCT04349267|584361241|FG001|Overall Study|Disease Progression|0|||
161813756|NCT04349267|584361242|FG002|Overall Study|Disease Progression|2|||
161813757|NCT04349267|584361243|FG003|Overall Study|Disease Progression|3|||
161813758|NCT04349267|584361244|FG004|Overall Study|Disease Progression|3|||
161813759|NCT04349267|584361245|FG005|Overall Study|Disease Progression|7|||
161813760|NCT04349267|584361246|FG006|Overall Study|Disease Progression|10|||
161813761|NCT04349267|584361240|FG000|Overall Study|Participant withdrew consent|0|||
161813762|NCT04349267|584361241|FG001|Overall Study|Participant withdrew consent|1|||
161813763|NCT04349267|584361242|FG002|Overall Study|Participant withdrew consent|0|||
161813764|NCT04349267|584361243|FG003|Overall Study|Participant withdrew consent|0|||
161813765|NCT04349267|584361244|FG004|Overall Study|Participant withdrew consent|0|||
161813766|NCT04349267|584361245|FG005|Overall Study|Participant withdrew consent|0|||
161813767|NCT04349267|584361246|FG006|Overall Study|Participant withdrew consent|1|||
161813768|NCT03689400|584361247|FG000|Overall Study|Lost to Follow-up|4|||
161813769|NCT01204294|584361248|FG000|Overall Study|Adverse Event|2|||
161813770|NCT01204294|584361249|FG001|Overall Study|Adverse Event|6|||
161813771|NCT01204294|584361250|FG002|Overall Study|Adverse Event|0|||
161813772|NCT01204294|584361251|FG003|Overall Study|Adverse Event|7|||
161813773|NCT01204294|584361252|FG004|Overall Study|Adverse Event|1|||
161813774|NCT01204294|584361253|FG005|Overall Study|Adverse Event|4|||
161813775|NCT01204294|584361254|FG006|Overall Study|Adverse Event|0|||
161813776|NCT01204294|584361248|FG000|Overall Study|Protocol Violation|1|||
161813777|NCT01204294|584361249|FG001|Overall Study|Protocol Violation|0|||
161813778|NCT01204294|584361250|FG002|Overall Study|Protocol Violation|2|||
161813779|NCT01204294|584361251|FG003|Overall Study|Protocol Violation|1|||
161813780|NCT01204294|584361252|FG004|Overall Study|Protocol Violation|0|||
161813781|NCT01204294|584361253|FG005|Overall Study|Protocol Violation|0|||
161813782|NCT01204294|584361254|FG006|Overall Study|Protocol Violation|0|||
161813783|NCT01204294|584361248|FG000|Overall Study|Withdrawal by Subject|0|||
161813784|NCT01204294|584361249|FG001|Overall Study|Withdrawal by Subject|2|||
161813785|NCT01204294|584361250|FG002|Overall Study|Withdrawal by Subject|2|||
161813786|NCT01204294|584361251|FG003|Overall Study|Withdrawal by Subject|1|||
161813787|NCT01204294|584361252|FG004|Overall Study|Withdrawal by Subject|1|||
161813788|NCT01204294|584361253|FG005|Overall Study|Withdrawal by Subject|1|||
161813789|NCT01204294|584361254|FG006|Overall Study|Withdrawal by Subject|2|||
161813790|NCT01204294|584361248|FG000|Overall Study|Lack of Efficacy|0|||
161813791|NCT01204294|584361249|FG001|Overall Study|Lack of Efficacy|0|||
161813792|NCT01204294|584361250|FG002|Overall Study|Lack of Efficacy|0|||
161813793|NCT01204294|584361251|FG003|Overall Study|Lack of Efficacy|2|||
161813794|NCT01204294|584361252|FG004|Overall Study|Lack of Efficacy|0|||
161813795|NCT01204294|584361253|FG005|Overall Study|Lack of Efficacy|0|||
161813796|NCT01204294|584361254|FG006|Overall Study|Lack of Efficacy|0|||
161813797|NCT01204294|584361248|FG000|Overall Study|Other (house moving)|0|||
161813798|NCT01204294|584361249|FG001|Overall Study|Other (house moving)|0|||
161813799|NCT01204294|584361250|FG002|Overall Study|Other (house moving)|1|||
161813800|NCT01204294|584361251|FG003|Overall Study|Other (house moving)|0|||
161813801|NCT01204294|584361252|FG004|Overall Study|Other (house moving)|0|||
161813802|NCT01204294|584361253|FG005|Overall Study|Other (house moving)|0|||
161813803|NCT01204294|584361254|FG006|Overall Study|Other (house moving)|0|||
161813804|NCT03128723|584361255|FG000|Overall Study|Withdrawal by Subject|2|||
161813805|NCT04618211|584361256|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
161813806|NCT04618211|584361257|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
161813807|NCT04618211|584361258|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
161813808|NCT04618211|584361256|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
161813809|NCT04618211|584361257|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
161813810|NCT04618211|584361258|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
161813811|NCT04618211|584361256|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
161813812|NCT04618211|584361257|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
161813813|NCT04618211|584361258|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
161813814|NCT02075463|584361259|FG000|Overall Study|Adverse Event|3|||
161813815|NCT02075463|584361259|FG000|Overall Study|Par. reached stopping criteria|4|||
161813816|NCT02075463|584361259|FG000|Overall Study|Withdrawal by Subject|1|||
161813817|NCT00673660|584361260|FG000|Overall Study|Lost to Follow-up|107|||
161813818|NCT01527006|584361261|FG000|Core Study|Adverse Event|0|||
161813819|NCT01527006|584361262|FG001|Core Study|Adverse Event|2|||
161576253|NCT01040689|583496151|FG003|Overall Study|Lack of Efficacy|0|||
161813820|NCT01527006|584361261|FG000|Core Study|Lost to Follow-up|0|||
161813821|NCT01527006|584361262|FG001|Core Study|Lost to Follow-up|1|||
161813822|NCT01527006|584361261|FG000|Core Study|Subject Choice|1|||
161813823|NCT01527006|584361262|FG001|Core Study|Subject Choice|0|||
161918435|NCT03126110|584748706|FG001|Phase 2|Lost to Follow-up|0|||
161918436|NCT03126110|584748707|FG002|Phase 2|Lost to Follow-up|0|||
161918437|NCT03126110|584748708|FG003|Phase 2|Lost to Follow-up|0|||
161918438|NCT03126110|584748709|FG004|Phase 2|Lost to Follow-up|0|||
161918439|NCT03126110|584748710|FG005|Phase 2|Lost to Follow-up|0|||
161918440|NCT03126110|584748711|FG006|Phase 2|Lost to Follow-up|0|||
161918441|NCT03126110|584748712|FG007|Phase 2|Lost to Follow-up|0|||
161918442|NCT03126110|584748713|FG008|Phase 2|Lost to Follow-up|0|||
161918443|NCT03126110|584748714|FG009|Phase 2|Lost to Follow-up|0|||
161918444|NCT03126110|584748715|FG010|Phase 2|Lost to Follow-up|0|||
161918445|NCT03126110|584748716|FG011|Phase 2|Lost to Follow-up|1|||
161918446|NCT03126110|584748717|FG012|Phase 2|Lost to Follow-up|1|||
161918447|NCT03126110|584748718|FG013|Phase 2|Lost to Follow-up|1|||
161918448|NCT03126110|584748719|FG014|Phase 2|Lost to Follow-up|2|||
161918449|NCT03126110|584748720|FG015|Phase 2|Lost to Follow-up|0|||
161918450|NCT03126110|584748721|FG016|Phase 2|Lost to Follow-up|0|||
161918451|NCT03126110|584748705|FG000|Phase 2|Death|0|||
161918452|NCT03126110|584748706|FG001|Phase 2|Death|0|||
161918453|NCT03126110|584748707|FG002|Phase 2|Death|0|||
161918454|NCT03126110|584748708|FG003|Phase 2|Death|0|||
161918455|NCT03126110|584748709|FG004|Phase 2|Death|0|||
161918456|NCT03126110|584748710|FG005|Phase 2|Death|0|||
161918457|NCT03126110|584748711|FG006|Phase 2|Death|0|||
161918458|NCT03126110|584748712|FG007|Phase 2|Death|0|||
161918459|NCT03126110|584748713|FG008|Phase 2|Death|0|||
161918460|NCT03126110|584748714|FG009|Phase 2|Death|0|||
161918461|NCT03126110|584748715|FG010|Phase 2|Death|0|||
161918462|NCT03126110|584748716|FG011|Phase 2|Death|6|||
161918463|NCT03126110|584748717|FG012|Phase 2|Death|12|||
161918464|NCT03126110|584748718|FG013|Phase 2|Death|25|||
161918465|NCT03126110|584748719|FG014|Phase 2|Death|11|||
161918466|NCT03126110|584748720|FG015|Phase 2|Death|3|||
161918467|NCT03126110|584748721|FG016|Phase 2|Death|2|||
161918468|NCT03126110|584748705|FG000|Phase 2|Progressive Disease|0|||
161918469|NCT03126110|584748706|FG001|Phase 2|Progressive Disease|0|||
161918470|NCT03126110|584748707|FG002|Phase 2|Progressive Disease|0|||
161918471|NCT03126110|584748708|FG003|Phase 2|Progressive Disease|0|||
161918472|NCT03126110|584748709|FG004|Phase 2|Progressive Disease|0|||
161918473|NCT03126110|584748710|FG005|Phase 2|Progressive Disease|0|||
161918474|NCT03126110|584748711|FG006|Phase 2|Progressive Disease|0|||
161918475|NCT03126110|584748712|FG007|Phase 2|Progressive Disease|0|||
161918476|NCT03126110|584748713|FG008|Phase 2|Progressive Disease|0|||
161918477|NCT03126110|584748714|FG009|Phase 2|Progressive Disease|0|||
161918478|NCT03126110|584748715|FG010|Phase 2|Progressive Disease|0|||
161576254|NCT01040689|583496148|FG000|Overall Study|Lost to Follow-up|1|||
161918479|NCT03126110|584748716|FG011|Phase 2|Progressive Disease|0|||
161918480|NCT03126110|584748717|FG012|Phase 2|Progressive Disease|0|||
161918481|NCT03126110|584748718|FG013|Phase 2|Progressive Disease|1|||
161918482|NCT03126110|584748719|FG014|Phase 2|Progressive Disease|0|||
161918483|NCT03126110|584748720|FG015|Phase 2|Progressive Disease|0|||
161918484|NCT03126110|584748721|FG016|Phase 2|Progressive Disease|0|||
161918485|NCT03126110|584748705|FG000|Phase 2|Started new treatment|0|||
161918486|NCT03126110|584748706|FG001|Phase 2|Started new treatment|0|||
161918487|NCT03126110|584748707|FG002|Phase 2|Started new treatment|0|||
161918488|NCT03126110|584748708|FG003|Phase 2|Started new treatment|0|||
161918489|NCT03126110|584748709|FG004|Phase 2|Started new treatment|0|||
161918490|NCT03126110|584748710|FG005|Phase 2|Started new treatment|0|||
161918491|NCT03126110|584748711|FG006|Phase 2|Started new treatment|0|||
161918492|NCT03126110|584748712|FG007|Phase 2|Started new treatment|0|||
161918493|NCT03126110|584748713|FG008|Phase 2|Started new treatment|0|||
161918494|NCT03126110|584748714|FG009|Phase 2|Started new treatment|0|||
161918495|NCT03126110|584748715|FG010|Phase 2|Started new treatment|0|||
161918496|NCT03126110|584748716|FG011|Phase 2|Started new treatment|0|||
161918497|NCT03126110|584748717|FG012|Phase 2|Started new treatment|0|||
161918498|NCT03126110|584748718|FG013|Phase 2|Started new treatment|0|||
161918499|NCT03126110|584748719|FG014|Phase 2|Started new treatment|1|||
161918500|NCT03126110|584748720|FG015|Phase 2|Started new treatment|0|||
161918501|NCT03126110|584748721|FG016|Phase 2|Started new treatment|0|||
161918502|NCT00314145|584748722|FG000|Overall Study|Withdrawal by Subject|8|||
161918503|NCT00314145|584748723|FG001|Overall Study|Withdrawal by Subject|10|||
161918504|NCT00314145|584748722|FG000|Overall Study|Lost to Follow-up|5|||
161918505|NCT00314145|584748723|FG001|Overall Study|Lost to Follow-up|12|||
161918506|NCT00314145|584748722|FG000|Overall Study|Physician Decision|3|||
161918507|NCT00314145|584748723|FG001|Overall Study|Physician Decision|4|||
161918508|NCT00314145|584748722|FG000|Overall Study|Adverse Event|0|||
161918509|NCT00314145|584748723|FG001|Overall Study|Adverse Event|3|||
161918510|NCT00314145|584748722|FG000|Overall Study|Protocol Violation|3|||
161918511|NCT00314145|584748723|FG001|Overall Study|Protocol Violation|0|||
161918512|NCT00314145|584748722|FG000|Overall Study|Sponsor Decision|2|||
161918513|NCT00314145|584748723|FG001|Overall Study|Sponsor Decision|0|||
161918514|NCT00294658|584748724|FG000|Overall Study|Death|0|||
161918515|NCT00294658|584748725|FG001|Overall Study|Death|1|||
161918516|NCT00294658|584748724|FG000|Overall Study|Lost to Follow-up|4|||
161918517|NCT00294658|584748725|FG001|Overall Study|Lost to Follow-up|0|||
161918518|NCT00294658|584748724|FG000|Overall Study|Physician Decision|1|||
161918519|NCT00294658|584748725|FG001|Overall Study|Physician Decision|2|||
161918520|NCT00294658|584748724|FG000|Overall Study|Pregnancy|0|||
161918521|NCT00294658|584748725|FG001|Overall Study|Pregnancy|1|||
161918522|NCT00294658|584748724|FG000|Overall Study|Withdrawal by Subject|0|||
161918523|NCT00294658|584748725|FG001|Overall Study|Withdrawal by Subject|4|||
161918524|NCT00294658|584748724|FG000|Overall Study|Found to have invasive thymoma|1|||
161918525|NCT00294658|584748725|FG001|Overall Study|Found to have invasive thymoma|0|||
161918526|NCT00294658|584748724|FG000|Overall Study|Patient and family were not satisfied|0|||
161918527|NCT00294658|584748725|FG001|Overall Study|Patient and family were not satisfied|1|||
161918528|NCT00976027|584748727|FG000|Overall Study|Serious Adverse Event|36|||
161918529|NCT00976027|584748728|FG001|Overall Study|Serious Adverse Event|17|||
161918530|NCT00976027|584748727|FG000|Overall Study|Adverse Event|0|||
161918531|NCT00976027|584748728|FG001|Overall Study|Adverse Event|2|||
161918532|NCT00976027|584748727|FG000|Overall Study|Protocol Violation|60|||
161918533|NCT00976027|584748728|FG001|Overall Study|Protocol Violation|27|||
161918534|NCT00976027|584748727|FG000|Overall Study|Lost to Follow-up|208|||
161918535|NCT00976027|584748728|FG001|Overall Study|Lost to Follow-up|103|||
161918536|NCT00976027|584748727|FG000|Overall Study|Withdrawal by Subject|107|||
161918537|NCT00976027|584748728|FG001|Overall Study|Withdrawal by Subject|66|||
161918538|NCT01771107|584748734|FG000|Overall Study|Adverse Event|1|||
161918539|NCT01771107|584748735|FG001|Overall Study|Adverse Event|3|||
161918540|NCT01771107|584748734|FG000|Overall Study|Withdrawal by Subject|0|||
161918541|NCT01771107|584748735|FG001|Overall Study|Withdrawal by Subject|2|||
161918542|NCT01771107|584748734|FG000|Overall Study|Lost to Follow-up|0|||
161918543|NCT01771107|584748735|FG001|Overall Study|Lost to Follow-up|1|||
161918544|NCT01771107|584748734|FG000|Overall Study|participant moved|0|||
161918545|NCT01771107|584748735|FG001|Overall Study|participant moved|1|||
161918546|NCT01771107|584748734|FG000|Overall Study|Other|0|||
161918547|NCT01771107|584748735|FG001|Overall Study|Other|1|||
161918548|NCT03805841|584748736|FG000|Overall Study|Clinical Progression|2|||
161918549|NCT03805841|584748737|FG001|Overall Study|Clinical Progression|0|||
161918550|NCT03805841|584748738|FG002|Overall Study|Clinical Progression|0|||
161918551|NCT03805841|584748736|FG000|Overall Study|Death|0|||
161918552|NCT03805841|584748737|FG001|Overall Study|Death|3|||
161918553|NCT03805841|584748738|FG002|Overall Study|Death|1|||
161918554|NCT03805841|584748736|FG000|Overall Study|Lost to Follow-up|0|||
161918555|NCT03805841|584748737|FG001|Overall Study|Lost to Follow-up|0|||
161918556|NCT03805841|584748738|FG002|Overall Study|Lost to Follow-up|1|||
161918557|NCT03805841|584748736|FG000|Overall Study|Withdrawal by Subject|2|||
161918558|NCT03805841|584748737|FG001|Overall Study|Withdrawal by Subject|3|||
161918559|NCT03805841|584748738|FG002|Overall Study|Withdrawal by Subject|0|||
161918560|NCT03805841|584748736|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
161918561|NCT03805841|584748737|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
161918562|NCT03805841|584748738|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
161918563|NCT05049122|584748741|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
161918564|NCT05049122|584748741|FG000|Overall Study|Participant moved|1|||
161918565|NCT05049122|584748741|FG000|Overall Study|At the direction of the doctor|1|||
161918566|NCT05845619|584748742|FG000|Overall Study|duplicate enrollment|2|||
161918567|NCT05845619|584748743|FG001|Overall Study|duplicate enrollment|2|||
161918568|NCT05845619|584748744|FG002|Overall Study|duplicate enrollment|1|||
161813824|NCT01527006|584361261|FG000|Core Study|Inadequate Therapeutic Effect|1|||
161813825|NCT01527006|584361262|FG001|Core Study|Inadequate Therapeutic Effect|0|||
161813826|NCT01527006|584361261|FG000|Core Study|Withdrawal by Subject|0|||
161813827|NCT01527006|584361262|FG001|Core Study|Withdrawal by Subject|1|||
161813828|NCT01527006|584361261|FG000|Core Study|Other|0|||
161813829|NCT01527006|584361262|FG001|Core Study|Other|2|||
161813830|NCT01527006|584361261|FG000|Extension Phase|Adverse Event|4|||
161813831|NCT01527006|584361262|FG001|Extension Phase|Adverse Event|2|||
161813832|NCT01527006|584361261|FG000|Extension Phase|Lost to Follow-up|0|||
161813833|NCT01527006|584361262|FG001|Extension Phase|Lost to Follow-up|1|||
161813834|NCT01527006|584361261|FG000|Extension Phase|Subject Choice|1|||
161813835|NCT01527006|584361262|FG001|Extension Phase|Subject Choice|1|||
161918569|NCT03621592|584748745|FG000|Overall Study|Lost to Follow-up|1|||
161918570|NCT03621592|584748746|FG001|Overall Study|Lost to Follow-up|0|||
161918571|NCT03621592|584748745|FG000|Overall Study|Lack of Improvement|1|||
161918572|NCT03621592|584748746|FG001|Overall Study|Lack of Improvement|0|||
161813836|NCT01527006|584361261|FG000|Extension Phase|Inadequate therapeutic effect|1|||
161813837|NCT01527006|584361262|FG001|Extension Phase|Inadequate therapeutic effect|1|||
161918573|NCT03621592|584748745|FG000|Overall Study|Preference to receive wound care closer to home|1|||
161918574|NCT03621592|584748746|FG001|Overall Study|Preference to receive wound care closer to home|0|||
161918575|NCT03621592|584748745|FG000|Overall Study|Lack of healing|0|||
161918576|NCT03621592|584748746|FG001|Overall Study|Lack of healing|2|||
161918577|NCT00831844|584748754|FG000|Overall Study|Adverse Event|2|||
161918578|NCT00831844|584748755|FG001|Overall Study|Adverse Event|0|||
161918579|NCT00831844|584748756|FG002|Overall Study|Adverse Event|0|||
161918580|NCT00831844|584748757|FG003|Overall Study|Adverse Event|0|||
161813838|NCT01527006|584361261|FG000|Extension Phase|Other|0|||
161918581|NCT00831844|584748758|FG004|Overall Study|Adverse Event|1|||
161918582|NCT00831844|584748759|FG005|Overall Study|Adverse Event|1|||
161918583|NCT00831844|584748760|FG006|Overall Study|Adverse Event|2|||
161918584|NCT00831844|584748761|FG007|Overall Study|Adverse Event|0|||
161918585|NCT00831844|584748762|FG008|Overall Study|Adverse Event|0|||
161918586|NCT00831844|584748763|FG009|Overall Study|Adverse Event|0|||
161918587|NCT00831844|584748754|FG000|Overall Study|Death|0|||
161918588|NCT00831844|584748755|FG001|Overall Study|Death|0|||
161918589|NCT00831844|584748756|FG002|Overall Study|Death|0|||
161918590|NCT00831844|584748757|FG003|Overall Study|Death|1|||
161918591|NCT00831844|584748758|FG004|Overall Study|Death|0|||
161918592|NCT00831844|584748759|FG005|Overall Study|Death|0|||
161918593|NCT00831844|584748760|FG006|Overall Study|Death|0|||
161918594|NCT00831844|584748761|FG007|Overall Study|Death|0|||
161918595|NCT00831844|584748762|FG008|Overall Study|Death|0|||
161918596|NCT00831844|584748763|FG009|Overall Study|Death|0|||
161918597|NCT00831844|584748754|FG000|Overall Study|Lack of Efficacy|8|||
161918598|NCT00831844|584748755|FG001|Overall Study|Lack of Efficacy|10|||
161918599|NCT00831844|584748756|FG002|Overall Study|Lack of Efficacy|15|||
161918600|NCT00831844|584748757|FG003|Overall Study|Lack of Efficacy|8|||
161918601|NCT00831844|584748758|FG004|Overall Study|Lack of Efficacy|11|||
161918602|NCT00831844|584748759|FG005|Overall Study|Lack of Efficacy|17|||
161918603|NCT00831844|584748760|FG006|Overall Study|Lack of Efficacy|8|||
161918604|NCT00831844|584748761|FG007|Overall Study|Lack of Efficacy|9|||
161918605|NCT00831844|584748762|FG008|Overall Study|Lack of Efficacy|7|||
161918606|NCT00831844|584748763|FG009|Overall Study|Lack of Efficacy|0|||
161918607|NCT00831844|584748754|FG000|Overall Study|Physician Decision|0|||
161918608|NCT00831844|584748755|FG001|Overall Study|Physician Decision|1|||
161918609|NCT00831844|584748756|FG002|Overall Study|Physician Decision|3|||
161918610|NCT00831844|584748757|FG003|Overall Study|Physician Decision|1|||
161918611|NCT00831844|584748758|FG004|Overall Study|Physician Decision|1|||
161918612|NCT00831844|584748759|FG005|Overall Study|Physician Decision|1|||
161918613|NCT00831844|584748760|FG006|Overall Study|Physician Decision|0|||
161918614|NCT00831844|584748761|FG007|Overall Study|Physician Decision|0|||
161918615|NCT00831844|584748762|FG008|Overall Study|Physician Decision|1|||
161918616|NCT00831844|584748763|FG009|Overall Study|Physician Decision|0|||
161918617|NCT00831844|584748754|FG000|Overall Study|Withdrawal by Subject|0|||
161918618|NCT00831844|584748755|FG001|Overall Study|Withdrawal by Subject|0|||
161918619|NCT00831844|584748756|FG002|Overall Study|Withdrawal by Subject|1|||
161918620|NCT00831844|584748757|FG003|Overall Study|Withdrawal by Subject|0|||
161918621|NCT00831844|584748758|FG004|Overall Study|Withdrawal by Subject|0|||
161918622|NCT00831844|584748759|FG005|Overall Study|Withdrawal by Subject|0|||
161918623|NCT00831844|584748760|FG006|Overall Study|Withdrawal by Subject|0|||
161918624|NCT00831844|584748761|FG007|Overall Study|Withdrawal by Subject|1|||
161918625|NCT00831844|584748762|FG008|Overall Study|Withdrawal by Subject|1|||
161918626|NCT00831844|584748763|FG009|Overall Study|Withdrawal by Subject|0|||
161918627|NCT00831844|584748754|FG000|Overall Study|Ineligible|0|||
161918628|NCT00831844|584748755|FG001|Overall Study|Ineligible|1|||
161918629|NCT00831844|584748756|FG002|Overall Study|Ineligible|1|||
161918630|NCT00831844|584748757|FG003|Overall Study|Ineligible|0|||
161918631|NCT00831844|584748758|FG004|Overall Study|Ineligible|1|||
161918632|NCT00831844|584748759|FG005|Overall Study|Ineligible|0|||
161918633|NCT00831844|584748760|FG006|Overall Study|Ineligible|0|||
161918634|NCT00831844|584748761|FG007|Overall Study|Ineligible|0|||
161918635|NCT00831844|584748762|FG008|Overall Study|Ineligible|0|||
161918636|NCT00831844|584748763|FG009|Overall Study|Ineligible|0|||
161918637|NCT04133909|584748766|FG000|Overall Study|Death|11|||
161918638|NCT04133909|584748767|FG001|Overall Study|Death|11|||
161918639|NCT04133909|584748766|FG000|Overall Study|Adverse Event|4|||
161918640|NCT04133909|584748767|FG001|Overall Study|Adverse Event|5|||
161918641|NCT04133909|584748766|FG000|Overall Study|Lost to Follow-up|3|||
161918642|NCT04133909|584748767|FG001|Overall Study|Lost to Follow-up|5|||
161918643|NCT04133909|584748766|FG000|Overall Study|Physician Decision|4|||
161918644|NCT04133909|584748767|FG001|Overall Study|Physician Decision|7|||
161918645|NCT04133909|584748766|FG000|Overall Study|Withdrawal by Subject|40|||
161918646|NCT04133909|584748767|FG001|Overall Study|Withdrawal by Subject|35|||
161918647|NCT04133909|584748766|FG000|Overall Study|Lack of Efficacy|2|||
161918648|NCT04133909|584748767|FG001|Overall Study|Lack of Efficacy|7|||
161918649|NCT04133909|584748766|FG000|Overall Study|Randomized in error|1|||
161918650|NCT04133909|584748767|FG001|Overall Study|Randomized in error|1|||
161918651|NCT02340949|584748768|FG000|Overall Study|Adverse Event|4|||
161918652|NCT02340949|584748769|FG001|Overall Study|Adverse Event|2|||
161918653|NCT02340949|584748768|FG000|Overall Study|Withdrawal by Subject|2|||
161918654|NCT02340949|584748769|FG001|Overall Study|Withdrawal by Subject|0|||
161918655|NCT02340949|584748768|FG000|Overall Study|Progression disease|6|||
161918656|NCT02340949|584748769|FG001|Overall Study|Progression disease|2|||
161918657|NCT02340949|584748768|FG000|Overall Study|Death|3|||
161918658|NCT02340949|584748769|FG001|Overall Study|Death|0|||
161918659|NCT02340949|584748768|FG000|Overall Study|Physician Decision|1|||
161918660|NCT02340949|584748769|FG001|Overall Study|Physician Decision|0|||
161918661|NCT03980223|584748770|FG000|Overall Study|Lost to Follow-up|3|||
161918662|NCT03980223|584748771|FG001|Overall Study|Lost to Follow-up|7|||
161918663|NCT03980223|584748772|FG002|Overall Study|Lost to Follow-up|10|||
161918664|NCT03980223|584748773|FG003|Overall Study|Lost to Follow-up|8|||
161918665|NCT03980223|584748770|FG000|Overall Study|Withdrawal by Subject|0|||
161918666|NCT03980223|584748771|FG001|Overall Study|Withdrawal by Subject|0|||
161918667|NCT03980223|584748772|FG002|Overall Study|Withdrawal by Subject|1|||
161918668|NCT03980223|584748773|FG003|Overall Study|Withdrawal by Subject|2|||
161918669|NCT03980223|584748770|FG000|Overall Study|Physician Decision|0|||
161918670|NCT03980223|584748771|FG001|Overall Study|Physician Decision|0|||
161918671|NCT03980223|584748772|FG002|Overall Study|Physician Decision|1|||
161918672|NCT03980223|584748773|FG003|Overall Study|Physician Decision|0|||
161918673|NCT03980223|584748770|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
161918674|NCT03980223|584748771|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
161918675|NCT03980223|584748772|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
161918676|NCT03980223|584748773|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
161918677|NCT02460289|584748777|FG000|Overall Study|Adverse Event|1|||
161918678|NCT02460289|584748777|FG000|Overall Study|Withdrawal by Subject|8|||
161918679|NCT02460289|584748777|FG000|Overall Study|Lost to Follow-up|1|||
161918680|NCT02916927|584748778|FG000|Overall Study|Discharged prior to study drug receipt|0|||
161918681|NCT02916927|584748779|FG001|Overall Study|Discharged prior to study drug receipt|2|||
161918682|NCT02916927|584748778|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
161918683|NCT02916927|584748779|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
161918684|NCT02916927|584748778|FG000|Overall Study|Withdrawal before first time point|1|||
161918685|NCT02916927|584748779|FG001|Overall Study|Withdrawal before first time point|0|||
161918686|NCT01020123|584748780|FG000|Main Period|Withdrawal by Subject|6|||
161918687|NCT01020123|584748781|FG001|Main Period|Withdrawal by Subject|5|||
161918688|NCT01020123|584748782|FG002|Main Period|Withdrawal by Subject|3|||
161918689|NCT01020123|584748783|FG003|Main Period|Withdrawal by Subject|1|||
161918690|NCT01020123|584748784|FG004|Main Period|Withdrawal by Subject|6|||
161918691|NCT01020123|584748785|FG005|Main Period|Withdrawal by Subject|3|||
161918692|NCT01020123|584748786|FG006|Main Period|Withdrawal by Subject|2|||
161918693|NCT01020123|584748780|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
161918694|NCT01020123|584748781|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
161918695|NCT01020123|584748782|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
161918696|NCT01020123|584748783|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
161918697|NCT01020123|584748784|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
161918698|NCT01020123|584748785|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
161918699|NCT01020123|584748786|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
161918700|NCT01020123|584748780|FG000|Main Period|Adverse Event|5|||
161918701|NCT01020123|584748781|FG001|Main Period|Adverse Event|2|||
161918702|NCT01020123|584748782|FG002|Main Period|Adverse Event|2|||
161918703|NCT01020123|584748783|FG003|Main Period|Adverse Event|1|||
161918704|NCT01020123|584748784|FG004|Main Period|Adverse Event|1|||
161918705|NCT01020123|584748785|FG005|Main Period|Adverse Event|2|||
161918706|NCT01020123|584748786|FG006|Main Period|Adverse Event|1|||
161918707|NCT01020123|584748780|FG000|Main Period|Protocol Violation|4|||
161918708|NCT01020123|584748781|FG001|Main Period|Protocol Violation|4|||
161918709|NCT01020123|584748782|FG002|Main Period|Protocol Violation|2|||
161918710|NCT01020123|584748783|FG003|Main Period|Protocol Violation|5|||
161918711|NCT01020123|584748784|FG004|Main Period|Protocol Violation|2|||
161918712|NCT01020123|584748785|FG005|Main Period|Protocol Violation|3|||
161918713|NCT01020123|584748786|FG006|Main Period|Protocol Violation|2|||
161918714|NCT01020123|584748780|FG000|Main Period|Lost to Follow-up|0|||
161918715|NCT01020123|584748781|FG001|Main Period|Lost to Follow-up|2|||
161918716|NCT01020123|584748782|FG002|Main Period|Lost to Follow-up|0|||
161918717|NCT01020123|584748783|FG003|Main Period|Lost to Follow-up|0|||
161918718|NCT01020123|584748784|FG004|Main Period|Lost to Follow-up|0|||
161918719|NCT01020123|584748785|FG005|Main Period|Lost to Follow-up|0|||
161918720|NCT01020123|584748786|FG006|Main Period|Lost to Follow-up|0|||
161918721|NCT01020123|584748780|FG000|Main Period|Unclasified|2|||
161918722|NCT01020123|584748781|FG001|Main Period|Unclasified|0|||
161918723|NCT01020123|584748782|FG002|Main Period|Unclasified|1|||
161918724|NCT01020123|584748783|FG003|Main Period|Unclasified|0|||
161918725|NCT01020123|584748784|FG004|Main Period|Unclasified|1|||
161918726|NCT01020123|584748785|FG005|Main Period|Unclasified|3|||
161918727|NCT01020123|584748786|FG006|Main Period|Unclasified|6|||
161918728|NCT01020123|584748780|FG000|Extention Period|Withdrawal by Subject|2|||
161918729|NCT01020123|584748781|FG001|Extention Period|Withdrawal by Subject|1|||
161918730|NCT01020123|584748782|FG002|Extention Period|Withdrawal by Subject|1|||
161918731|NCT01020123|584748783|FG003|Extention Period|Withdrawal by Subject|0|||
161918732|NCT01020123|584748784|FG004|Extention Period|Withdrawal by Subject|0|||
161918733|NCT01020123|584748785|FG005|Extention Period|Withdrawal by Subject|0|||
161918734|NCT01020123|584748786|FG006|Extention Period|Withdrawal by Subject|0|||
161918735|NCT01020123|584748780|FG000|Extention Period|Adverse Event|0|||
161918736|NCT01020123|584748781|FG001|Extention Period|Adverse Event|0|||
161918737|NCT01020123|584748782|FG002|Extention Period|Adverse Event|0|||
161918738|NCT01020123|584748783|FG003|Extention Period|Adverse Event|1|||
161918739|NCT01020123|584748784|FG004|Extention Period|Adverse Event|0|||
161918740|NCT01020123|584748785|FG005|Extention Period|Adverse Event|0|||
161918741|NCT01020123|584748786|FG006|Extention Period|Adverse Event|0|||
161918742|NCT01020123|584748780|FG000|Extention Period|Protocol Violation|1|||
161918743|NCT01020123|584748781|FG001|Extention Period|Protocol Violation|1|||
161918744|NCT01020123|584748782|FG002|Extention Period|Protocol Violation|1|||
161918745|NCT01020123|584748783|FG003|Extention Period|Protocol Violation|0|||
161918746|NCT01020123|584748784|FG004|Extention Period|Protocol Violation|0|||
161918747|NCT01020123|584748785|FG005|Extention Period|Protocol Violation|0|||
161918748|NCT01020123|584748786|FG006|Extention Period|Protocol Violation|1|||
161918749|NCT01020123|584748780|FG000|Extention Period|Lost to Follow-up|0|||
161918750|NCT01020123|584748781|FG001|Extention Period|Lost to Follow-up|0|||
161918751|NCT01020123|584748782|FG002|Extention Period|Lost to Follow-up|0|||
161918752|NCT01020123|584748783|FG003|Extention Period|Lost to Follow-up|0|||
161918753|NCT01020123|584748784|FG004|Extention Period|Lost to Follow-up|0|||
161918754|NCT01020123|584748785|FG005|Extention Period|Lost to Follow-up|2|||
161918755|NCT01020123|584748786|FG006|Extention Period|Lost to Follow-up|0|||
161918756|NCT01349595|584748787|FG000|Overall Study|Lack of funding|2|||
161918757|NCT01349595|584748788|FG001|Overall Study|Lack of funding|2|||
161918758|NCT03479905|584748789|FG000|Overall Study|Other airway method used|4|||
161918759|NCT03479905|584748790|FG001|Overall Study|Other airway method used|5|||
161918760|NCT03479905|584748791|FG002|Overall Study|Other airway method used|5|||
161918761|NCT01706328|584748796|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
161918762|NCT01706328|584748797|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161918763|NCT01706328|584748798|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161918764|NCT01706328|584748796|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
161918765|NCT01706328|584748797|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161918766|NCT01706328|584748798|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161918767|NCT01706328|584748796|FG000|2-week Run-in Period|Physician Decision|4|||
161918768|NCT01706328|584748797|FG001|2-week Run-in Period|Physician Decision|0|||
161576255|NCT01040689|583496149|FG001|Overall Study|Lost to Follow-up|0|||
161576256|NCT01040689|583496150|FG002|Overall Study|Lost to Follow-up|0|||
161813839|NCT01527006|584361262|FG001|Extension Phase|Other|3|||
161813840|NCT01383486|584361263|FG000|Overall Study|Lost to Follow-up|10|||
161813841|NCT01383486|584361263|FG000|Overall Study|Incomplete information for analysis|2|||
161813842|NCT01383486|584361263|FG000|Overall Study|Did not take any product|6|||
161813843|NCT00245063|584361264|FG000|Overall Study|Adverse Event|6|||
161813844|NCT00245063|584361265|FG001|Overall Study|Adverse Event|5|||
161813845|NCT00245063|584361264|FG000|Overall Study|Death|1|||
161813846|NCT00245063|584361265|FG001|Overall Study|Death|0|||
161813847|NCT01839279|584361268|FG000|Overall Study|Adverse Event|4|||
161813848|NCT01839279|584361269|FG001|Overall Study|Adverse Event|1|||
161918769|NCT01706328|584748798|FG002|2-week Run-in Period|Physician Decision|0|||
161918770|NCT01706328|584748796|FG000|2-week Run-in Period|Adverse Event|4|||
161918771|NCT01706328|584748797|FG001|2-week Run-in Period|Adverse Event|0|||
161918772|NCT01706328|584748798|FG002|2-week Run-in Period|Adverse Event|0|||
161918773|NCT01706328|584748796|FG000|2-week Run-in Period|Lost to Follow-up|2|||
161918774|NCT01706328|584748797|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161918775|NCT01706328|584748798|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161918776|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
161918777|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
161918778|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
161918779|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
161918780|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
161918781|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
161918782|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
161918783|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
161918784|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
161918785|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
161918786|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
161918787|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
161918788|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
161918789|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
161918790|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
161918791|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
161918792|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
161918793|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
161918794|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161918795|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
161918796|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
161918797|NCT06481579|584748800|FG000|Overall Study|Death|1|||
161918798|NCT06481579|584748801|FG001|Overall Study|Death|0|||
161918799|NCT06481579|584748800|FG000|Overall Study|Withdrawal by Subject|3|||
161918800|NCT06481579|584748801|FG001|Overall Study|Withdrawal by Subject|0|||
161918801|NCT06481579|584748800|FG000|Overall Study|Other|1|||
161918802|NCT06481579|584748801|FG001|Overall Study|Other|1|||
161918803|NCT04190225|584751312|FG000|Overall Study|Lost to Follow-up|2|||
161918804|NCT04190225|584751313|FG001|Overall Study|Lost to Follow-up|3|||
161918805|NCT04190225|584751312|FG000|Overall Study|Withdrawal by Subject|3|||
161918806|NCT04190225|584751313|FG001|Overall Study|Withdrawal by Subject|2|||
161918807|NCT04190225|584751312|FG000|Overall Study|Unrelated health condition|2|||
161918808|NCT04190225|584751313|FG001|Overall Study|Unrelated health condition|0|||
161918809|NCT01732783|584751314|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
161918810|NCT01732783|584751315|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
161918811|NCT01732783|584751316|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
161918812|NCT01732783|584751314|FG000|Overall Study|Death|13|||
161918813|NCT01732783|584751315|FG001|Overall Study|Death|4|||
161918814|NCT01732783|584751316|FG002|Overall Study|Death|1|||
161918815|NCT01732783|584751314|FG000|Overall Study|Lost to Follow-up|7|||
161918816|NCT01732783|584751315|FG001|Overall Study|Lost to Follow-up|1|||
161918817|NCT01732783|584751316|FG002|Overall Study|Lost to Follow-up|1|||
161918818|NCT01732783|584751314|FG000|Overall Study|Administrative Decision|8|||
161918819|NCT01732783|584751315|FG001|Overall Study|Administrative Decision|2|||
161918820|NCT01732783|584751316|FG002|Overall Study|Administrative Decision|1|||
161918821|NCT01732783|584751314|FG000|Overall Study|Withdrawal by Subject|1|||
161918822|NCT01732783|584751315|FG001|Overall Study|Withdrawal by Subject|0|||
161918823|NCT01732783|584751316|FG002|Overall Study|Withdrawal by Subject|0|||
161918824|NCT04429971|584751317|FG000|Overall Study|Lost to Follow-up|7|||
161918825|NCT04429971|584751318|FG001|Overall Study|Lost to Follow-up|8|||
161918826|NCT03331562|584751319|FG000|Overall Study|Adverse Event|2|||
161918827|NCT03331562|584751320|FG001|Overall Study|Adverse Event|0|||
161918828|NCT03331562|584751319|FG000|Overall Study|Death|1|||
161918829|NCT03331562|584751320|FG001|Overall Study|Death|0|||
161918830|NCT03718000|584751328|FG000|Overall Study|Relocation|2|||
161918831|NCT03718000|584751329|FG001|Overall Study|Relocation|4|||
161918832|NCT03718000|584751328|FG000|Overall Study|Pregnancy|0|||
161918833|NCT03718000|584751329|FG001|Overall Study|Pregnancy|1|||
161918834|NCT05522751|584751335|FG000|Overall Study|Adverse Event|1|||
161918835|NCT04044690|584751337|FG000|Period 1|Lack of Efficacy|1|||
161918836|NCT04044690|584751338|FG001|Period 1|Lack of Efficacy|1|||
161918837|NCT04044690|584751337|FG000|Period 1|Adverse Event|4|||
161918838|NCT04044690|584751338|FG001|Period 1|Adverse Event|2|||
161918839|NCT04044690|584751337|FG000|Period 1|Physician Decision|0|||
161918840|NCT04044690|584751338|FG001|Period 1|Physician Decision|1|||
161918841|NCT04044690|584751337|FG000|Period 1|Withdrawal by Subject|2|||
161918842|NCT04044690|584751338|FG001|Period 1|Withdrawal by Subject|5|||
161918843|NCT04044690|584751337|FG000|Period 1|Protocol Deviation|2|||
161918844|NCT04044690|584751338|FG001|Period 1|Protocol Deviation|0|||
161918845|NCT04044690|584751337|FG000|Period 1|Site Terminated by Sponsor|0|||
161918846|NCT04044690|584751338|FG001|Period 1|Site Terminated by Sponsor|1|||
161918847|NCT04044690|584751337|FG000|Period 1|Study Terminated by Sponsor|0|||
161918848|NCT04044690|584751338|FG001|Period 1|Study Terminated by Sponsor|1|||
161918849|NCT04044690|584751337|FG000|Period 1|Death|1|||
161918850|NCT04044690|584751338|FG001|Period 1|Death|1|||
161918851|NCT04044690|584751337|FG000|Period 1|Other: Unspecified|1|||
161918852|NCT04044690|584751338|FG001|Period 1|Other: Unspecified|0|||
161918853|NCT04044690|584751337|FG000|Period 2|Lack of Efficacy|0|||
161918854|NCT04044690|584751338|FG001|Period 2|Lack of Efficacy|1|||
161918855|NCT04044690|584751337|FG000|Period 2|Adverse Event|0|||
161918856|NCT04044690|584751338|FG001|Period 2|Adverse Event|1|||
161918857|NCT04044690|584751337|FG000|Period 2|Physician Decision|0|||
161918858|NCT04044690|584751338|FG001|Period 2|Physician Decision|2|||
161918859|NCT04044690|584751337|FG000|Period 2|Withdrawal by Subject|5|||
161918860|NCT04044690|584751338|FG001|Period 2|Withdrawal by Subject|5|||
161918861|NCT04044690|584751337|FG000|Period 2|Lost to Follow-up|0|||
161918862|NCT04044690|584751338|FG001|Period 2|Lost to Follow-up|1|||
161918863|NCT04044690|584751337|FG000|Period 2|Site Terminated by Sponsor|1|||
161918864|NCT04044690|584751338|FG001|Period 2|Site Terminated by Sponsor|3|||
161918865|NCT04044690|584751337|FG000|Period 2|Study Terminated by Sponsor|8|||
161918866|NCT04044690|584751338|FG001|Period 2|Study Terminated by Sponsor|3|||
161918867|NCT04044690|584751337|FG000|Period 2|Death|1|||
161918868|NCT04044690|584751338|FG001|Period 2|Death|0|||
161918869|NCT04044690|584751337|FG000|Period 2|Other: Unspecified|1|||
161918870|NCT04044690|584751338|FG001|Period 2|Other: Unspecified|1|||
161918871|NCT04044690|584751337|FG000|Period 3|Site Terminated by Sponsor|1|||
161918872|NCT04044690|584751338|FG001|Period 3|Site Terminated by Sponsor|2|||
161918873|NCT04044690|584751337|FG000|Period 3|Study Terminated by Sponsor|24|||
161918874|NCT04044690|584751338|FG001|Period 3|Study Terminated by Sponsor|18|||
161918875|NCT04044690|584751337|FG000|Period 3|Missing|0|||
161918876|NCT04044690|584751338|FG001|Period 3|Missing|2|||
161918877|NCT01582451|584751344|FG000|Overall Study|Adverse Event|1|||
161918878|NCT01582451|584751345|FG001|Overall Study|Adverse Event|3|||
161918879|NCT01582451|584751344|FG000|Overall Study|Death|3|||
161918880|NCT01582451|584751345|FG001|Overall Study|Death|3|||
161918881|NCT01582451|584751344|FG000|Overall Study|Lost to Follow-up|0|||
161918882|NCT01582451|584751345|FG001|Overall Study|Lost to Follow-up|2|||
161918883|NCT01582451|584751344|FG000|Overall Study|Protocol Violation|11|||
161918884|NCT01582451|584751345|FG001|Overall Study|Protocol Violation|3|||
161918885|NCT01582451|584751344|FG000|Overall Study|Withdrawal by Subject|13|||
161918886|NCT01582451|584751345|FG001|Overall Study|Withdrawal by Subject|9|||
161918887|NCT01582451|584751344|FG000|Overall Study|Physician Decision|3|||
161918888|NCT01582451|584751345|FG001|Overall Study|Physician Decision|0|||
161918889|NCT01582451|584751344|FG000|Overall Study|Sponsor Decision|1|||
161918890|NCT01582451|584751345|FG001|Overall Study|Sponsor Decision|0|||
161918891|NCT00716417|584751348|FG000|Overall Study|Adverse Event|0|||
161918892|NCT00716417|584751349|FG001|Overall Study|Adverse Event|0|||
161918893|NCT00716417|584751350|FG002|Overall Study|Adverse Event|2|||
161918894|NCT00716417|584751351|FG003|Overall Study|Adverse Event|1|||
161918895|NCT00716417|584751352|FG004|Overall Study|Adverse Event|0|||
161918896|NCT00716417|584751353|FG005|Overall Study|Adverse Event|0|||
161918897|NCT00716417|584751354|FG006|Overall Study|Adverse Event|3|||
161918898|NCT00716417|584751355|FG007|Overall Study|Adverse Event|1|||
161918899|NCT00716417|584751356|FG008|Overall Study|Adverse Event|0|||
161918900|NCT00716417|584751357|FG009|Overall Study|Adverse Event|3|||
161918901|NCT00716417|584751348|FG000|Overall Study|Withdrawal by Subject|0|||
161918902|NCT00716417|584751349|FG001|Overall Study|Withdrawal by Subject|1|||
161918903|NCT00716417|584751350|FG002|Overall Study|Withdrawal by Subject|0|||
161813849|NCT01839279|584361270|FG002|Overall Study|Adverse Event|1|||
161813850|NCT01839279|584361268|FG000|Overall Study|Withdrawal by Subject|4|||
161813851|NCT01839279|584361269|FG001|Overall Study|Withdrawal by Subject|1|||
161813852|NCT01839279|584361270|FG002|Overall Study|Withdrawal by Subject|1|||
161813853|NCT01839279|584361268|FG000|Overall Study|Classified as 'Other'|5|||
161813854|NCT01839279|584361269|FG001|Overall Study|Classified as 'Other'|0|||
161813855|NCT01839279|584361270|FG002|Overall Study|Classified as 'Other'|0|||
161813856|NCT05919823|584361274|FG000|Pre-Treatment Period|Screen failure|1|||
161918904|NCT00716417|584751351|FG003|Overall Study|Withdrawal by Subject|2|||
161813857|NCT05919823|584361275|FG001|Pre-Treatment Period|Screen failure|0|||
161813858|NCT05919823|584361276|FG002|Pre-Treatment Period|Screen failure|0|||
161918905|NCT00716417|584751352|FG004|Overall Study|Withdrawal by Subject|0|||
161918906|NCT00716417|584751353|FG005|Overall Study|Withdrawal by Subject|0|||
161918907|NCT00716417|584751354|FG006|Overall Study|Withdrawal by Subject|1|||
161918908|NCT00716417|584751355|FG007|Overall Study|Withdrawal by Subject|0|||
161918909|NCT00716417|584751356|FG008|Overall Study|Withdrawal by Subject|0|||
161918910|NCT00716417|584751357|FG009|Overall Study|Withdrawal by Subject|0|||
161918911|NCT00716417|584751348|FG000|Overall Study|Progressive disease|3|||
161918912|NCT00716417|584751349|FG001|Overall Study|Progressive disease|5|||
161918913|NCT00716417|584751350|FG002|Overall Study|Progressive disease|3|||
161668462|NCT00820027|583839773|FG001|Overall Study|Protocol Violation|0|||
161668463|NCT00820027|583839774|FG002|Overall Study|Protocol Violation|4|||
161918914|NCT00716417|584751351|FG003|Overall Study|Progressive disease|8|||
161813859|NCT05919823|584361277|FG003|Pre-Treatment Period|Screen failure|0|||
161813860|NCT05919823|584361274|FG000|Pre-Treatment Period|Protocol Violation|0|||
161813861|NCT05919823|584361275|FG001|Pre-Treatment Period|Protocol Violation|1|||
161813862|NCT05919823|584361276|FG002|Pre-Treatment Period|Protocol Violation|0|||
161813863|NCT05919823|584361277|FG003|Pre-Treatment Period|Protocol Violation|0|||
161813864|NCT05919823|584361274|FG000|Double-Blind Period|Adverse Event|8|||
161813865|NCT05919823|584361275|FG001|Double-Blind Period|Adverse Event|9|||
161813866|NCT05919823|584361276|FG002|Double-Blind Period|Adverse Event|0|||
161813867|NCT05919823|584361277|FG003|Double-Blind Period|Adverse Event|0|||
161813868|NCT05919823|584361274|FG000|Double-Blind Period|Protocol Violation|2|||
161813869|NCT05919823|584361275|FG001|Double-Blind Period|Protocol Violation|1|||
161813870|NCT05919823|584361276|FG002|Double-Blind Period|Protocol Violation|0|||
161813871|NCT05919823|584361277|FG003|Double-Blind Period|Protocol Violation|0|||
161813872|NCT05919823|584361274|FG000|Double-Blind Period|Participant withdrew consent|11|||
161813873|NCT05919823|584361275|FG001|Double-Blind Period|Participant withdrew consent|7|||
161813874|NCT05919823|584361276|FG002|Double-Blind Period|Participant withdrew consent|0|||
161813875|NCT05919823|584361277|FG003|Double-Blind Period|Participant withdrew consent|0|||
161813876|NCT05919823|584361274|FG000|Double-Blind Period|Other reasons|2|||
161813877|NCT05919823|584361275|FG001|Double-Blind Period|Other reasons|3|||
161813878|NCT05919823|584361276|FG002|Double-Blind Period|Other reasons|0|||
161813879|NCT05919823|584361277|FG003|Double-Blind Period|Other reasons|0|||
161813880|NCT05919823|584361274|FG000|Open Label Period|Adverse Event|0|||
161813881|NCT05919823|584361275|FG001|Open Label Period|Adverse Event|0|||
161813882|NCT05919823|584361276|FG002|Open Label Period|Adverse Event|2|||
161813883|NCT05919823|584361277|FG003|Open Label Period|Adverse Event|4|||
161813884|NCT05919823|584361274|FG000|Open Label Period|Lost to Follow-up|0|||
161813885|NCT05919823|584361275|FG001|Open Label Period|Lost to Follow-up|0|||
161813886|NCT05919823|584361276|FG002|Open Label Period|Lost to Follow-up|1|||
161813887|NCT05919823|584361277|FG003|Open Label Period|Lost to Follow-up|0|||
161813888|NCT05919823|584361274|FG000|Open Label Period|Protocol Violation|0|||
161813889|NCT05919823|584361275|FG001|Open Label Period|Protocol Violation|0|||
161813890|NCT05919823|584361276|FG002|Open Label Period|Protocol Violation|0|||
161813891|NCT05919823|584361277|FG003|Open Label Period|Protocol Violation|1|||
161813892|NCT05919823|584361274|FG000|Open Label Period|Participant withdrew consent|0|||
161813893|NCT05919823|584361275|FG001|Open Label Period|Participant withdrew consent|0|||
161813894|NCT05919823|584361276|FG002|Open Label Period|Participant withdrew consent|8|||
161813895|NCT05919823|584361277|FG003|Open Label Period|Participant withdrew consent|6|||
161813896|NCT05919823|584361274|FG000|Open Label Period|Death|0|||
161813897|NCT05919823|584361275|FG001|Open Label Period|Death|0|||
161813898|NCT05919823|584361276|FG002|Open Label Period|Death|0|||
161813899|NCT05919823|584361277|FG003|Open Label Period|Death|1|||
161813900|NCT05919823|584361274|FG000|Open Label Period|Other reasons|0|||
161813901|NCT05919823|584361275|FG001|Open Label Period|Other reasons|0|||
161813902|NCT05919823|584361276|FG002|Open Label Period|Other reasons|9|||
161813903|NCT05919823|584361277|FG003|Open Label Period|Other reasons|5|||
161813904|NCT01648582|584361278|FG000|Overall Study|Adverse Event|6|||
161813905|NCT01648582|584361279|FG001|Overall Study|Adverse Event|11|||
161813906|NCT01648582|584361280|FG002|Overall Study|Adverse Event|2|||
161813907|NCT01648582|584361278|FG000|Overall Study|Lost to Follow-up|9|||
161813908|NCT01648582|584361279|FG001|Overall Study|Lost to Follow-up|6|||
161813909|NCT01648582|584361280|FG002|Overall Study|Lost to Follow-up|8|||
161813910|NCT01648582|584361278|FG000|Overall Study|Protocol Violation|1|||
161813911|NCT01648582|584361279|FG001|Overall Study|Protocol Violation|2|||
161813912|NCT01648582|584361280|FG002|Overall Study|Protocol Violation|1|||
161813913|NCT01648582|584361278|FG000|Overall Study|Withdrawal by Subject|15|||
161813914|NCT01648582|584361279|FG001|Overall Study|Withdrawal by Subject|17|||
161813915|NCT01648582|584361280|FG002|Overall Study|Withdrawal by Subject|17|||
161813916|NCT01648582|584361278|FG000|Overall Study|Physician Decision|0|||
161813917|NCT01648582|584361279|FG001|Overall Study|Physician Decision|1|||
161813918|NCT01648582|584361280|FG002|Overall Study|Physician Decision|3|||
161813919|NCT01648582|584361278|FG000|Overall Study|Death|1|||
161813920|NCT01648582|584361279|FG001|Overall Study|Death|0|||
161813921|NCT01648582|584361280|FG002|Overall Study|Death|0|||
161813922|NCT01648582|584361278|FG000|Overall Study|Sponsor Decision|0|||
161813923|NCT01648582|584361279|FG001|Overall Study|Sponsor Decision|1|||
161813924|NCT01648582|584361280|FG002|Overall Study|Sponsor Decision|1|||
161813925|NCT00466167|584361292|FG000|Overall Study|Adverse Event|8|||
161813926|NCT00466167|584361293|FG001|Overall Study|Adverse Event|8|||
161813927|NCT00466167|584361294|FG002|Overall Study|Adverse Event|7|||
161813928|NCT00466167|584361292|FG000|Overall Study|Lack of Efficacy|2|||
161813929|NCT00466167|584361293|FG001|Overall Study|Lack of Efficacy|0|||
161813930|NCT00466167|584361294|FG002|Overall Study|Lack of Efficacy|3|||
161813931|NCT00466167|584361292|FG000|Overall Study|Protocol Violation|1|||
161813932|NCT00466167|584361293|FG001|Overall Study|Protocol Violation|1|||
161813933|NCT00466167|584361294|FG002|Overall Study|Protocol Violation|2|||
161813934|NCT00466167|584361292|FG000|Overall Study|Lost to Follow-up|3|||
161813935|NCT00466167|584361293|FG001|Overall Study|Lost to Follow-up|2|||
161813936|NCT00466167|584361294|FG002|Overall Study|Lost to Follow-up|2|||
161813937|NCT00466167|584361292|FG000|Overall Study|Withdrawal by Subject|4|||
161668464|NCT00820027|583839775|FG003|Overall Study|Protocol Violation|0|||
161918915|NCT00716417|584751352|FG004|Overall Study|Progressive disease|0|||
161918916|NCT00716417|584751353|FG005|Overall Study|Progressive disease|3|||
161918917|NCT00716417|584751354|FG006|Overall Study|Progressive disease|3|||
161918918|NCT00716417|584751355|FG007|Overall Study|Progressive disease|1|||
161918919|NCT00716417|584751356|FG008|Overall Study|Progressive disease|5|||
161918920|NCT00716417|584751357|FG009|Overall Study|Progressive disease|0|||
161918921|NCT00716417|584751348|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
161918922|NCT00716417|584751349|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
161918923|NCT00716417|584751350|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
161918924|NCT00716417|584751351|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
161918925|NCT00716417|584751352|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
161918926|NCT00716417|584751353|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
161918927|NCT00716417|584751354|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
161918928|NCT00716417|584751355|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
161918929|NCT00716417|584751356|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
161918930|NCT00716417|584751357|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
161918931|NCT00716417|584751348|FG000|Overall Study|On patient request due to toxicities|0|||
161918932|NCT00716417|584751349|FG001|Overall Study|On patient request due to toxicities|0|||
161918933|NCT00716417|584751350|FG002|Overall Study|On patient request due to toxicities|0|||
161918934|NCT00716417|584751351|FG003|Overall Study|On patient request due to toxicities|0|||
161918935|NCT00716417|584751352|FG004|Overall Study|On patient request due to toxicities|0|||
161918936|NCT00716417|584751353|FG005|Overall Study|On patient request due to toxicities|0|||
161918937|NCT00716417|584751354|FG006|Overall Study|On patient request due to toxicities|0|||
161918938|NCT00716417|584751355|FG007|Overall Study|On patient request due to toxicities|1|||
161918939|NCT00716417|584751356|FG008|Overall Study|On patient request due to toxicities|0|||
161918940|NCT00716417|584751357|FG009|Overall Study|On patient request due to toxicities|0|||
161918941|NCT00487188|584751358|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
161918942|NCT00487188|584751359|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
161918943|NCT00487188|584751360|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
161918944|NCT00487188|584751358|FG000|Induction Phase|Adverse Event|5|||
161918945|NCT00487188|584751359|FG001|Induction Phase|Adverse Event|0|||
161918946|NCT00487188|584751360|FG002|Induction Phase|Adverse Event|0|||
161918947|NCT00487188|584751358|FG000|Induction Phase|Lack of Efficacy|0|||
161918948|NCT00487188|584751359|FG001|Induction Phase|Lack of Efficacy|1|||
161918949|NCT00487188|584751360|FG002|Induction Phase|Lack of Efficacy|0|||
161918950|NCT00487188|584751358|FG000|Induction Phase|Protocol Violation|1|||
161918951|NCT00487188|584751359|FG001|Induction Phase|Protocol Violation|0|||
161918952|NCT00487188|584751360|FG002|Induction Phase|Protocol Violation|0|||
161918953|NCT00487188|584751358|FG000|Induction Phase|Refused Treatment|1|||
161918954|NCT00487188|584751359|FG001|Induction Phase|Refused Treatment|2|||
161918955|NCT00487188|584751360|FG002|Induction Phase|Refused Treatment|0|||
161918956|NCT00487188|584751358|FG000|Induction Phase|Lost to Follow-up|2|||
161918957|NCT00487188|584751359|FG001|Induction Phase|Lost to Follow-up|2|||
161918958|NCT00487188|584751360|FG002|Induction Phase|Lost to Follow-up|0|||
161918959|NCT00487188|584751358|FG000|Induction Phase|Administrative|0|||
161918960|NCT00487188|584751359|FG001|Induction Phase|Administrative|1|||
161918961|NCT00487188|584751360|FG002|Induction Phase|Administrative|0|||
161918962|NCT00487188|584751358|FG000|Maintenance Phase|Adverse Event|1|||
161918963|NCT00487188|584751359|FG001|Maintenance Phase|Adverse Event|0|||
161918964|NCT00487188|584751360|FG002|Maintenance Phase|Adverse Event|0|||
161918965|NCT00487188|584751358|FG000|Maintenance Phase|Death|1|||
161918966|NCT00487188|584751359|FG001|Maintenance Phase|Death|0|||
161918967|NCT00487188|584751360|FG002|Maintenance Phase|Death|0|||
161918968|NCT00487188|584751358|FG000|Maintenance Phase|Lost to Follow-up|1|||
161918969|NCT00487188|584751359|FG001|Maintenance Phase|Lost to Follow-up|0|||
161918970|NCT00487188|584751360|FG002|Maintenance Phase|Lost to Follow-up|0|||
161918971|NCT00487188|584751358|FG000|Maintenance Phase|Administrative|0|||
161918972|NCT00487188|584751359|FG001|Maintenance Phase|Administrative|0|||
161918973|NCT00487188|584751360|FG002|Maintenance Phase|Administrative|1|||
161918974|NCT01838876|584751361|FG000|Overall Study|Adverse Event|49|||
161918975|NCT01838876|584751361|FG000|Overall Study|Insufficient Therapeutic Response|10|||
161918976|NCT01838876|584751361|FG000|Overall Study|Protocol Violation|34|||
161918977|NCT01838876|584751361|FG000|Overall Study|Withdrawal of Consent|33|||
161918978|NCT01838876|584751361|FG000|Overall Study|Lost to Follow-up|21|||
161918979|NCT01838876|584751361|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
161918980|NCT01838876|584751361|FG000|Overall Study|Reason not Specified|7|||
161918981|NCT01838876|584751361|FG000|Overall Study|Did not meet eligibility criteria|78|||
161918982|NCT01682031|584751362|FG000|Overall Study|Withdrawal by Subject|0|||
161918983|NCT01682031|584751363|FG001|Overall Study|Withdrawal by Subject|1|||
161918984|NCT01682031|584751362|FG000|Overall Study|Adverse Event|0|||
161918985|NCT01682031|584751363|FG001|Overall Study|Adverse Event|2|||
161918986|NCT01682031|584751362|FG000|Overall Study|MRI results indicate increased nodul|0|||
161918987|NCT01682031|584751363|FG001|Overall Study|MRI results indicate increased nodul|1|||
161918988|NCT01682031|584751362|FG000|Overall Study|Patient could not swallow tablets|1|||
161918989|NCT01682031|584751363|FG001|Overall Study|Patient could not swallow tablets|0|||
161918990|NCT01682031|584751362|FG000|Overall Study|Patient stopped selenium on his own|0|||
161918991|NCT01682031|584751363|FG001|Overall Study|Patient stopped selenium on his own|1|||
161918992|NCT03881371|584751368|FG000|Overall Study|Adverse Event|8|||
161918993|NCT03881371|584751369|FG001|Overall Study|Adverse Event|9|||
161918994|NCT03881371|584751368|FG000|Overall Study|Death|1|||
161918995|NCT03881371|584751369|FG001|Overall Study|Death|0|||
161918996|NCT03881371|584751368|FG000|Overall Study|Lost to Follow-up|1|||
161918997|NCT03881371|584751369|FG001|Overall Study|Lost to Follow-up|0|||
161918998|NCT03881371|584751368|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161918999|NCT03881371|584751369|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161919000|NCT03881371|584751368|FG000|Overall Study|Physician Decision|3|||
161919001|NCT03881371|584751369|FG001|Overall Study|Physician Decision|3|||
161919002|NCT03881371|584751368|FG000|Overall Study|Withdrawal by Subject|2|||
161919003|NCT03881371|584751369|FG001|Overall Study|Withdrawal by Subject|10|||
161919004|NCT03881371|584751368|FG000|Overall Study|Discontinuation from Study|1|||
161919005|NCT03881371|584751369|FG001|Overall Study|Discontinuation from Study|0|||
161919006|NCT00963235|584751375|FG000|Overall Study|Withdrawal by Subject|22|||
161919007|NCT00963235|584751375|FG000|Overall Study|Lost to Follow-up|14|||
161919008|NCT00963235|584751375|FG000|Overall Study|Failed to return|9|||
161919009|NCT00963235|584751375|FG000|Overall Study|Protocol Violation|7|||
161919010|NCT00963235|584751375|FG000|Overall Study|Adverse Event|5|||
161919011|NCT00963235|584751375|FG000|Overall Study|Physician Decision|2|||
161919012|NCT00963235|584751375|FG000|Overall Study|Other|1|||
161919013|NCT01756235|584751376|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
161919014|NCT05376358|584751377|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
161919015|NCT05376358|584751378|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
161919016|NCT05376358|584751377|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
161919017|NCT05376358|584751378|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
161919018|NCT05376358|584751377|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
161919019|NCT05376358|584751378|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
161919020|NCT05376358|584751377|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
161919021|NCT05376358|584751378|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
161919022|NCT05376358|584751377|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
161919023|NCT05376358|584751378|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
161919024|NCT05376358|584751377|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
161919025|NCT05376358|584751378|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
161919026|NCT04225832|584751379|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
161919027|NCT04225832|584751380|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
161919028|NCT04225832|584751379|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
161919029|NCT04225832|584751380|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
161919030|NCT00311168|584751381|FG000|First Intervention|Withdrawal by Subject|2|||
161919031|NCT00311168|584751382|FG001|First Intervention|Withdrawal by Subject|2|||
161919032|NCT00311168|584751381|FG000|First Intervention|Lost to Follow-up|1|||
161919033|NCT00311168|584751382|FG001|First Intervention|Lost to Follow-up|1|||
161919034|NCT00311168|584751381|FG000|First Intervention|Protocol Violation|1|||
161919035|NCT00311168|584751382|FG001|First Intervention|Protocol Violation|1|||
161919036|NCT00311168|584751381|FG000|First Intervention|Adverse Event|1|||
161919037|NCT00311168|584751382|FG001|First Intervention|Adverse Event|0|||
161919038|NCT00311168|584751381|FG000|First Intervention|Other|2|||
161919039|NCT00311168|584751382|FG001|First Intervention|Other|2|||
161919040|NCT00311168|584751381|FG000|Second Intervention|Lost to Follow-up|9|||
161919041|NCT00311168|584751382|FG001|Second Intervention|Lost to Follow-up|2|||
161919042|NCT00311168|584751381|FG000|Second Intervention|Withdrawal by Subject|0|||
161919043|NCT00311168|584751382|FG001|Second Intervention|Withdrawal by Subject|1|||
161919044|NCT00311168|584751381|FG000|Second Intervention|Other|1|||
161919045|NCT00311168|584751382|FG001|Second Intervention|Other|1|||
161919046|NCT05472142|584751385|FG000|Total Participants|Lost to Follow-up|312|||
161919047|NCT05472142|584751386|FG001|Total Participants|Lost to Follow-up|0|||
161919048|NCT05472142|584751385|FG000|Clinic Patients|Lost to Follow-up|312|||
161919049|NCT05472142|584751386|FG001|Clinic Patients|Lost to Follow-up|0|||
161919050|NCT02452190|584751387|FG000|Overall Study|Withdrawal by Sponsor|1|||
161919051|NCT02452190|584751388|FG001|Overall Study|Withdrawal by Sponsor|3|||
161919052|NCT02452190|584751387|FG000|Overall Study|Pregnancy|1|||
161919053|NCT02452190|584751388|FG001|Overall Study|Pregnancy|0|||
161919054|NCT02452190|584751387|FG000|Overall Study|Investigator's Decision|2|||
161919055|NCT02452190|584751388|FG001|Overall Study|Investigator's Decision|0|||
161919056|NCT02452190|584751387|FG000|Overall Study|Lack of Efficacy|3|||
161919057|NCT02452190|584751388|FG001|Overall Study|Lack of Efficacy|1|||
161919058|NCT02452190|584751387|FG000|Overall Study|Lost to Follow-up|4|||
161919059|NCT02452190|584751388|FG001|Overall Study|Lost to Follow-up|3|||
161919060|NCT02452190|584751387|FG000|Overall Study|Adverse Event|2|||
161919061|NCT02452190|584751388|FG001|Overall Study|Adverse Event|5|||
161919062|NCT02452190|584751387|FG000|Overall Study|Withdrawal by Subject|20|||
161919063|NCT02452190|584751388|FG001|Overall Study|Withdrawal by Subject|11|||
161919064|NCT02452190|584751387|FG000|Overall Study|Noncompliance with study drug|1|||
161919065|NCT02452190|584751388|FG001|Overall Study|Noncompliance with study drug|0|||
161919066|NCT02452190|584751387|FG000|Overall Study|Participant traveled abroad|1|||
161919067|NCT02452190|584751388|FG001|Overall Study|Participant traveled abroad|0|||
161919068|NCT02452190|584751387|FG000|Overall Study|Death|0|||
161919069|NCT02452190|584751388|FG001|Overall Study|Death|1|||
161919070|NCT02327078|584751393|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161919071|NCT02327078|584751394|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161919072|NCT02327078|584751395|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
161919073|NCT02327078|584751396|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161919074|NCT02327078|584751397|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161813938|NCT00466167|584361293|FG001|Overall Study|Withdrawal by Subject|1|||
161813939|NCT00466167|584361294|FG002|Overall Study|Withdrawal by Subject|6|||
161813940|NCT00466167|584361292|FG000|Overall Study|patient did not meet inclusion criteria|1|||
161813941|NCT00466167|584361293|FG001|Overall Study|patient did not meet inclusion criteria|0|||
161813942|NCT00466167|584361294|FG002|Overall Study|patient did not meet inclusion criteria|1|||
161813943|NCT00466167|584361292|FG000|Overall Study|Not treated|1|||
161813944|NCT00466167|584361293|FG001|Overall Study|Not treated|0|||
161813945|NCT00466167|584361294|FG002|Overall Study|Not treated|0|||
161813946|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
161813947|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
161813948|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
161813949|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
161813950|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
161813951|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
161813952|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
161813953|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
161813954|NCT03199963|584361295|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
161813955|NCT03199963|584361296|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
161813956|NCT03199963|584361295|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
161813957|NCT03199963|584361296|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
161813958|NCT02105272|584361303|FG000|Overall Study|Adverse Event|1|||
161813959|NCT02105272|584361304|FG001|Overall Study|Adverse Event|2|||
161813960|NCT02105272|584361303|FG000|Overall Study|Physician Decision|0|||
161813961|NCT02105272|584361304|FG001|Overall Study|Physician Decision|1|||
161813962|NCT02105272|584361303|FG000|Overall Study|Protocol Violation|2|||
161813963|NCT02105272|584361304|FG001|Overall Study|Protocol Violation|0|||
161813964|NCT02105272|584361303|FG000|Overall Study|Withdrawal by Subject|2|||
161813965|NCT02105272|584361304|FG001|Overall Study|Withdrawal by Subject|0|||
161813966|NCT03930732|584361305|FG000|Overall Study|Adverse Event|9|||
161813967|NCT03930732|584361306|FG001|Overall Study|Adverse Event|7|||
161813968|NCT03930732|584361305|FG000|Overall Study|Poor compliance to protocol|0|||
161813969|NCT03930732|584361306|FG001|Overall Study|Poor compliance to protocol|1|||
161813970|NCT03930732|584361305|FG000|Overall Study|Withdrawal by Subject|23|||
161813971|NCT03930732|584361306|FG001|Overall Study|Withdrawal by Subject|11|||
161813972|NCT03930732|584361305|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
161813973|NCT03930732|584361306|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
161813974|NCT03930732|584361305|FG000|Overall Study|Other reason not related to COVID-19|5|||
161813975|NCT03930732|584361306|FG001|Overall Study|Other reason not related to COVID-19|8|||
161813976|NCT04128761|584361313|FG000|Overall Study|Lost to Follow-up|5|||
161813977|NCT04128761|584361314|FG001|Overall Study|Lost to Follow-up|6|||
161813978|NCT06539676|584361315|FG000|Overall Study|Early study termination|1|||
161813979|NCT06539676|584361316|FG001|Overall Study|Early study termination|0|||
161813980|NCT06539676|584361317|FG002|Overall Study|Early study termination|6|||
161813981|NCT00830024|584361320|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161813982|NCT00830024|584361321|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161813983|NCT02554890|584361322|FG000|Double-blind|Adverse Event|45|||
161813984|NCT02554890|584361323|FG001|Double-blind|Adverse Event|51|||
161813985|NCT02554890|584361322|FG000|Double-blind|Death|6|||
161813986|NCT02554890|584361323|FG001|Double-blind|Death|4|||
161813987|NCT02554890|584361322|FG000|Double-blind|Protocol Violation|1|||
161813988|NCT02554890|584361323|FG001|Double-blind|Protocol Violation|1|||
161813989|NCT02554890|584361322|FG000|Double-blind|Physician Decision|4|||
161813990|NCT02554890|584361323|FG001|Double-blind|Physician Decision|3|||
161813991|NCT02554890|584361322|FG000|Double-blind|Subject/Guardian decision|21|||
161813992|NCT02554890|584361323|FG001|Double-blind|Subject/Guardian decision|16|||
161813993|NCT02554890|584361322|FG000|Double-blind|Lost to Follow-up|7|||
161813994|NCT02554890|584361323|FG001|Double-blind|Lost to Follow-up|5|||
161813995|NCT02554890|584361322|FG000|Double-blind|Technical problems|1|||
161813996|NCT02554890|584361323|FG001|Double-blind|Technical problems|0|||
161813997|NCT02554890|584361322|FG000|Double-blind|Withdrawal by Subject|5|||
161813998|NCT02554890|584361323|FG001|Double-blind|Withdrawal by Subject|6|||
161813999|NCT02554890|584361322|FG000|Double-blind|Noncompliance with study treatment|6|||
161814000|NCT02554890|584361323|FG001|Double-blind|Noncompliance with study treatment|5|||
161814001|NCT02554890|584361322|FG000|Open-label|Adverse Event|0|||
161814002|NCT02554890|584361323|FG001|Open-label|Adverse Event|30|||
161814003|NCT02554890|584361322|FG000|Open-label|Death|0|||
161814004|NCT02554890|584361323|FG001|Open-label|Death|1|||
161814005|NCT02554890|584361322|FG000|Open-label|Physician Decision|0|||
161814006|NCT02554890|584361323|FG001|Open-label|Physician Decision|1|||
161814007|NCT02554890|584361322|FG000|Open-label|Subject/Guardian decision|0|||
161919075|NCT02327078|584751398|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161919076|NCT02327078|584751399|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161919077|NCT02327078|584751400|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
161919078|NCT02327078|584751401|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
161919079|NCT02327078|584751393|FG000|Overall Study|Death|2|||
161919080|NCT02327078|584751394|FG001|Overall Study|Death|4|||
161919081|NCT02327078|584751395|FG002|Overall Study|Death|10|||
161919082|NCT02327078|584751396|FG003|Overall Study|Death|6|||
161919083|NCT02327078|584751397|FG004|Overall Study|Death|4|||
161919084|NCT02327078|584751398|FG005|Overall Study|Death|3|||
161919085|NCT02327078|584751399|FG006|Overall Study|Death|2|||
161919086|NCT02327078|584751400|FG007|Overall Study|Death|51|||
161919087|NCT02327078|584751401|FG008|Overall Study|Death|97|||
161919088|NCT02327078|584751393|FG000|Overall Study|Lost to Follow-up|0|||
161919089|NCT02327078|584751394|FG001|Overall Study|Lost to Follow-up|1|||
161919090|NCT02327078|584751395|FG002|Overall Study|Lost to Follow-up|1|||
161919091|NCT02327078|584751396|FG003|Overall Study|Lost to Follow-up|0|||
161919092|NCT02327078|584751397|FG004|Overall Study|Lost to Follow-up|0|||
161919093|NCT02327078|584751398|FG005|Overall Study|Lost to Follow-up|0|||
161919094|NCT02327078|584751399|FG006|Overall Study|Lost to Follow-up|0|||
161919095|NCT02327078|584751400|FG007|Overall Study|Lost to Follow-up|2|||
161919096|NCT02327078|584751401|FG008|Overall Study|Lost to Follow-up|5|||
161919097|NCT02327078|584751393|FG000|Overall Study|Site Terminated by Sponsor|1|||
161919098|NCT02327078|584751394|FG001|Overall Study|Site Terminated by Sponsor|0|||
161919099|NCT02327078|584751395|FG002|Overall Study|Site Terminated by Sponsor|1|||
161919100|NCT02327078|584751396|FG003|Overall Study|Site Terminated by Sponsor|4|||
161919101|NCT02327078|584751397|FG004|Overall Study|Site Terminated by Sponsor|0|||
161919102|NCT02327078|584751398|FG005|Overall Study|Site Terminated by Sponsor|0|||
161919103|NCT02327078|584751399|FG006|Overall Study|Site Terminated by Sponsor|0|||
161919104|NCT02327078|584751400|FG007|Overall Study|Site Terminated by Sponsor|11|||
161919105|NCT02327078|584751401|FG008|Overall Study|Site Terminated by Sponsor|25|||
161919106|NCT02327078|584751393|FG000|Overall Study|Physician Decision|0|||
161919107|NCT02327078|584751394|FG001|Overall Study|Physician Decision|0|||
161919108|NCT02327078|584751395|FG002|Overall Study|Physician Decision|0|||
161919109|NCT02327078|584751396|FG003|Overall Study|Physician Decision|1|||
161919110|NCT02327078|584751397|FG004|Overall Study|Physician Decision|0|||
161474013|NCT01146912|583130656|FG001|Overall Study|Already received influenza vaccination|822|||
161919111|NCT02327078|584751398|FG005|Overall Study|Physician Decision|0|||
161919112|NCT02327078|584751399|FG006|Overall Study|Physician Decision|0|||
161919113|NCT02327078|584751400|FG007|Overall Study|Physician Decision|0|||
161919114|NCT02327078|584751401|FG008|Overall Study|Physician Decision|1|||
161919115|NCT02327078|584751393|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161919116|NCT02327078|584751394|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161919117|NCT02327078|584751395|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161474014|NCT01146912|583130657|FG002|Overall Study|Already received influenza vaccination|13|||
161474015|NCT01146912|583130658|FG003|Overall Study|Already received influenza vaccination|15|||
161474016|NCT01146912|583130659|FG004|Overall Study|Already received influenza vaccination|41|||
161474017|NCT01146912|583130660|FG005|Overall Study|Already received influenza vaccination|61|||
161474018|NCT01146912|583130661|FG006|Overall Study|Already received influenza vaccination|56|||
161474019|NCT01146912|583130662|FG007|Overall Study|Already received influenza vaccination|0|||
161474020|NCT01146912|583130655|FG000|Overall Study|< 14 weeks gestational age|0|||
161474021|NCT01146912|583130656|FG001|Overall Study|< 14 weeks gestational age|0|||
161474022|NCT01146912|583130657|FG002|Overall Study|< 14 weeks gestational age|3|||
161474023|NCT01146912|583130658|FG003|Overall Study|< 14 weeks gestational age|2|||
161474024|NCT01146912|583130659|FG004|Overall Study|< 14 weeks gestational age|0|||
161814008|NCT02554890|584361323|FG001|Open-label|Subject/Guardian decision|11|||
161814009|NCT02554890|584361322|FG000|Open-label|Lost to Follow-up|0|||
161814010|NCT02554890|584361323|FG001|Open-label|Lost to Follow-up|7|||
161814011|NCT02554890|584361322|FG000|Open-label|Technical problems|0|||
161814012|NCT02554890|584361323|FG001|Open-label|Technical problems|1|||
161814013|NCT02554890|584361322|FG000|Open-label|Withdrawal by Subject|0|||
161814014|NCT02554890|584361323|FG001|Open-label|Withdrawal by Subject|1|||
161814015|NCT03649477|584361326|FG000|Overall Study|Adverse Event|2|||
161814016|NCT03649477|584361327|FG001|Overall Study|Adverse Event|0|||
161814017|NCT03649477|584361328|FG002|Overall Study|Adverse Event|0|||
161814018|NCT04544410|584361329|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161814019|NCT04544410|584361330|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161814020|NCT04544410|584361329|FG000|Double-blind Treatment Period|Adverse Event|1|||
161814021|NCT04544410|584361330|FG001|Double-blind Treatment Period|Adverse Event|0|||
161814022|NCT04544410|584361329|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161814023|NCT04544410|584361330|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161814024|NCT04544410|584361329|FG000|Double-blind Treatment Period|Protocol Violation|1|||
161814025|NCT04544410|584361330|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161814026|NCT04544410|584361329|FG000|Open-Label Treatment Period|Study Terminated|15|||
161814027|NCT04544410|584361330|FG001|Open-Label Treatment Period|Study Terminated|19|||
161814028|NCT04544410|584361329|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
161814029|NCT04544410|584361330|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
161814030|NCT04544410|584361329|FG000|Open-Label Treatment Period|Adverse Event|0|||
161814031|NCT04544410|584361330|FG001|Open-Label Treatment Period|Adverse Event|1|||
161814032|NCT04544410|584361329|FG000|Open-Label Treatment Period|Physician Decision|1|||
161814033|NCT04544410|584361330|FG001|Open-Label Treatment Period|Physician Decision|0|||
161814034|NCT04544410|584361329|FG000|Open-Label Treatment Period|Other|0|||
161814035|NCT04544410|584361330|FG001|Open-Label Treatment Period|Other|1|||
161814036|NCT01624233|584362868|FG000|Period 2 - Induction|Adverse Event|1|||
161814037|NCT01624233|584362868|FG000|Period 3 - Maintenance|Adverse Event|2|||
161814038|NCT01624233|584362868|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
161814039|NCT01624233|584362868|FG000|Period 3 - Maintenance|Physician Decision|2|||
161814040|NCT01624233|584362868|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
161814041|NCT01624233|584362868|FG000|Period 4 - Drug Free Period|Relapsed|61|||
161814042|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
161814043|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
161814044|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
161814045|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
161814046|NCT01624233|584362868|FG000|Period 6: Follow-up|Adverse Event|3|||
161814047|NCT01624233|584362868|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
161814048|NCT01624233|584362868|FG000|Period 6: Follow-up|Physician Decision|1|||
161814049|NCT01624233|584362868|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
161814050|NCT03121586|584362869|FG000|Overall Study|Study terminated by sponsor|0|||
161814051|NCT03121586|584362870|FG001|Overall Study|Study terminated by sponsor|0|||
161814052|NCT03121586|584362871|FG002|Overall Study|Study terminated by sponsor|99|||
161814053|NCT03121586|584362869|FG000|Overall Study|Withdrawal by Subject|37|||
161814054|NCT03121586|584362870|FG001|Overall Study|Withdrawal by Subject|14|||
161814055|NCT03121586|584362871|FG002|Overall Study|Withdrawal by Subject|9|||
161814056|NCT03121586|584362869|FG000|Overall Study|Not further specified|6|||
161814057|NCT03121586|584362870|FG001|Overall Study|Not further specified|11|||
161814058|NCT03121586|584362871|FG002|Overall Study|Not further specified|10|||
161814059|NCT03121586|584362869|FG000|Overall Study|Adverse Event|16|||
161814060|NCT03121586|584362870|FG001|Overall Study|Adverse Event|5|||
161814061|NCT03121586|584362871|FG002|Overall Study|Adverse Event|6|||
161814062|NCT03121586|584362869|FG000|Overall Study|Protocol Violation|0|||
161814063|NCT03121586|584362870|FG001|Overall Study|Protocol Violation|5|||
161814064|NCT03121586|584362871|FG002|Overall Study|Protocol Violation|0|||
161814065|NCT03121586|584362869|FG000|Overall Study|Lack of Efficacy|3|||
161814066|NCT03121586|584362870|FG001|Overall Study|Lack of Efficacy|3|||
161814067|NCT03121586|584362871|FG002|Overall Study|Lack of Efficacy|1|||
161814068|NCT03121586|584362869|FG000|Overall Study|Physician Decision|2|||
161814069|NCT03121586|584362870|FG001|Overall Study|Physician Decision|2|||
161814070|NCT03121586|584362871|FG002|Overall Study|Physician Decision|0|||
161919118|NCT02327078|584751396|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161919119|NCT02327078|584751397|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161919120|NCT02327078|584751398|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161919121|NCT02327078|584751399|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161919122|NCT02327078|584751400|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
161919123|NCT02327078|584751401|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
161919124|NCT02327078|584751393|FG000|Overall Study|Reason not Specified|0|||
161919125|NCT02327078|584751394|FG001|Overall Study|Reason not Specified|0|||
161919126|NCT02327078|584751395|FG002|Overall Study|Reason not Specified|0|||
161919127|NCT02327078|584751396|FG003|Overall Study|Reason not Specified|0|||
161919128|NCT02327078|584751397|FG004|Overall Study|Reason not Specified|0|||
161919129|NCT02327078|584751398|FG005|Overall Study|Reason not Specified|0|||
161919130|NCT02327078|584751399|FG006|Overall Study|Reason not Specified|0|||
161474025|NCT01146912|583130660|FG005|Overall Study|< 14 weeks gestational age|0|||
161474026|NCT01146912|583130661|FG006|Overall Study|< 14 weeks gestational age|0|||
161474027|NCT01146912|583130662|FG007|Overall Study|< 14 weeks gestational age|0|||
161474028|NCT01146912|583130655|FG000|Overall Study|Duplicate patient|0|||
161919131|NCT02327078|584751400|FG007|Overall Study|Reason not Specified|5|||
161919132|NCT02327078|584751401|FG008|Overall Study|Reason not Specified|12|||
161919133|NCT06001021|584751402|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
161919134|NCT06001021|584751403|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161919135|NCT06001021|584751404|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161919136|NCT06001021|584751405|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
161919137|NCT06001021|584751406|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
161919138|NCT06001021|584751407|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
161919139|NCT06001021|584751408|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161919140|NCT06001021|584751402|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
161919141|NCT06001021|584751403|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161919142|NCT06001021|584751404|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161474029|NCT01146912|583130656|FG001|Overall Study|Duplicate patient|0|||
161474030|NCT01146912|583130657|FG002|Overall Study|Duplicate patient|1|||
161474031|NCT01146912|583130658|FG003|Overall Study|Duplicate patient|0|||
161474032|NCT01146912|583130659|FG004|Overall Study|Duplicate patient|0|||
161474033|NCT01146912|583130660|FG005|Overall Study|Duplicate patient|0|||
161474034|NCT01146912|583130661|FG006|Overall Study|Duplicate patient|0|||
161474035|NCT01146912|583130662|FG007|Overall Study|Duplicate patient|0|||
161474036|NCT02980783|583130663|FG000|Overall Study|Lost to Follow-up|1|||
161474037|NCT00880542|583130664|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
161474038|NCT00880542|583130664|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
161474039|NCT00880542|583130664|FG000|REP: Surgical Resection|progressive disease|1|||
161474040|NCT05047770|583130665|FG000|Overall Study|Withdrawal by Subject|15|||
161474041|NCT05047770|583130666|FG001|Overall Study|Withdrawal by Subject|10|||
161474042|NCT05047770|583130667|FG002|Overall Study|Withdrawal by Subject|6|||
161474043|NCT05047770|583130668|FG003|Overall Study|Withdrawal by Subject|12|||
161474044|NCT05047770|583130665|FG000|Overall Study|Lost to Follow-up|7|||
161474045|NCT05047770|583130666|FG001|Overall Study|Lost to Follow-up|5|||
161474046|NCT05047770|583130667|FG002|Overall Study|Lost to Follow-up|12|||
161474047|NCT05047770|583130668|FG003|Overall Study|Lost to Follow-up|13|||
161474048|NCT05047770|583130665|FG000|Overall Study|Other|1|||
161474049|NCT05047770|583130666|FG001|Overall Study|Other|0|||
161474050|NCT05047770|583130667|FG002|Overall Study|Other|1|||
161474051|NCT05047770|583130668|FG003|Overall Study|Other|0|||
161474052|NCT01772160|583130669|FG000|Overall Study|Death|3|||
161474053|NCT01772160|583130669|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
161474054|NCT01772160|583130669|FG000|Overall Study|Consent withdrawal|3|||
161474055|NCT01772160|583130669|FG000|Overall Study|Migrated / moved from the study area|4|||
161474056|NCT01772160|583130669|FG000|Overall Study|Lost to Follow-up|30|||
161474057|NCT01772160|583130669|FG000|Overall Study|Other|5|||
161474058|NCT02202980|583130670|FG000|Overall Study|Lack of Efficacy|1|||
161474059|NCT02202980|583130671|FG001|Overall Study|Lack of Efficacy|0|||
161474060|NCT02202980|583130672|FG002|Overall Study|Lack of Efficacy|7|||
161474061|NCT02202980|583130673|FG003|Overall Study|Lack of Efficacy|0|||
161474062|NCT02202980|583130674|FG004|Overall Study|Lack of Efficacy|3|||
161474063|NCT02202980|583130675|FG005|Overall Study|Lack of Efficacy|1|||
161474064|NCT02202980|583130676|FG006|Overall Study|Lack of Efficacy|11|||
161474065|NCT02202980|583130677|FG007|Overall Study|Lack of Efficacy|2|||
161474066|NCT02202980|583130678|FG008|Overall Study|Lack of Efficacy|2|||
161474067|NCT02202980|583130679|FG009|Overall Study|Lack of Efficacy|0|||
161474068|NCT02202980|583130680|FG010|Overall Study|Lack of Efficacy|0|||
161474069|NCT02202980|583130681|FG011|Overall Study|Lack of Efficacy|3|||
161474070|NCT02202980|583130682|FG012|Overall Study|Lack of Efficacy|10|||
161474071|NCT02202980|583130683|FG013|Overall Study|Lack of Efficacy|0|||
161474072|NCT02202980|583130670|FG000|Overall Study|Protocol Violation|0|||
161474073|NCT02202980|583130671|FG001|Overall Study|Protocol Violation|0|||
161474074|NCT02202980|583130672|FG002|Overall Study|Protocol Violation|0|||
161474075|NCT02202980|583130673|FG003|Overall Study|Protocol Violation|3|||
161474076|NCT02202980|583130674|FG004|Overall Study|Protocol Violation|3|||
161474077|NCT02202980|583130675|FG005|Overall Study|Protocol Violation|0|||
161474078|NCT02202980|583130676|FG006|Overall Study|Protocol Violation|0|||
161474079|NCT02202980|583130677|FG007|Overall Study|Protocol Violation|0|||
161814071|NCT03121586|584362869|FG000|Overall Study|Noncompliance with study drug|5|||
161814072|NCT03121586|584362870|FG001|Overall Study|Noncompliance with study drug|3|||
161814073|NCT03121586|584362871|FG002|Overall Study|Noncompliance with study drug|5|||
161814074|NCT03121586|584362869|FG000|Overall Study|Lost to Follow-up|4|||
161814075|NCT03121586|584362870|FG001|Overall Study|Lost to Follow-up|2|||
161814076|NCT03121586|584362871|FG002|Overall Study|Lost to Follow-up|0|||
161814077|NCT03121586|584362869|FG000|Overall Study|Death|2|||
161814078|NCT03121586|584362870|FG001|Overall Study|Death|0|||
161814079|NCT03121586|584362871|FG002|Overall Study|Death|0|||
161814080|NCT06381102|584362872|FG000|Washout 5 Days|Withdrawal by Subject|0|||
161814081|NCT06381102|584362873|FG001|Washout 5 Days|Withdrawal by Subject|2|||
161814082|NCT02832063|584362875|FG000|Overall Study|Adverse Event|2|||
161814083|NCT02832063|584362876|FG001|Overall Study|Adverse Event|1|||
161814084|NCT02832063|584362875|FG000|Overall Study|Physician Decision|5|||
161814085|NCT02832063|584362876|FG001|Overall Study|Physician Decision|7|||
161814086|NCT02832063|584362875|FG000|Overall Study|Lost to Follow-up|15|||
161814087|NCT02832063|584362876|FG001|Overall Study|Lost to Follow-up|8|||
161814088|NCT02832063|584362875|FG000|Overall Study|Withdrawal by Subject|10|||
161814089|NCT02832063|584362876|FG001|Overall Study|Withdrawal by Subject|21|||
161814090|NCT02832063|584362875|FG000|Overall Study|Other|2|||
161814091|NCT02832063|584362876|FG001|Overall Study|Other|1|||
161814092|NCT03733730|584362877|FG000|Overall Study|Lost to Follow-up|1|||
161814093|NCT03733730|584362878|FG001|Overall Study|Lost to Follow-up|32|||
161814094|NCT03733730|584362877|FG000|Overall Study|Other|1|||
161814095|NCT03733730|584362878|FG001|Overall Study|Other|0|||
161814096|NCT03733730|584362877|FG000|Overall Study|Adverse Event|0|||
161814097|NCT03733730|584362878|FG001|Overall Study|Adverse Event|4|||
161814098|NCT03733730|584362877|FG000|Overall Study|Death|0|||
161814099|NCT03733730|584362878|FG001|Overall Study|Death|5|||
161814100|NCT03733730|584362877|FG000|Overall Study|Withdrawal by Subject|0|||
161814101|NCT03733730|584362878|FG001|Overall Study|Withdrawal by Subject|8|||
161814102|NCT00772603|584362879|FG000|Overall Study|Withdrawal by Subject|11|||
161814103|NCT00772603|584362880|FG001|Overall Study|Withdrawal by Subject|10|||
161814104|NCT00772603|584362881|FG002|Overall Study|Withdrawal by Subject|6|||
161919143|NCT06001021|584751405|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
161919144|NCT06001021|584751406|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
161919145|NCT06001021|584751407|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161919146|NCT06001021|584751408|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161919147|NCT03112603|584751410|FG000|End of Randomization Period|Lost to Follow-up|3|||
161919148|NCT03112603|584751411|FG001|End of Randomization Period|Lost to Follow-up|0|||
161919149|NCT03112603|584751412|FG002|End of Randomization Period|Lost to Follow-up|0|||
161919150|NCT03112603|584751410|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
161919151|NCT03112603|584751411|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
161919152|NCT03112603|584751412|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
161919153|NCT03112603|584751410|FG000|End of Randomization Period|Physician Decision|43|||
161919154|NCT03112603|584751411|FG001|End of Randomization Period|Physician Decision|18|||
161919155|NCT03112603|584751412|FG002|End of Randomization Period|Physician Decision|0|||
161919156|NCT03112603|584751410|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
161919157|NCT03112603|584751411|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
161919158|NCT03112603|584751412|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
161919159|NCT03112603|584751410|FG000|End of Randomization Period|Death|10|||
161919160|NCT03112603|584751411|FG001|End of Randomization Period|Death|7|||
161919161|NCT03112603|584751412|FG002|End of Randomization Period|Death|0|||
161919162|NCT03112603|584751410|FG000|End of Randomization Period|Disease Relapse|12|||
161919163|NCT03112603|584751411|FG001|End of Randomization Period|Disease Relapse|7|||
161919164|NCT03112603|584751412|FG002|End of Randomization Period|Disease Relapse|0|||
161919165|NCT03112603|584751410|FG000|End of Randomization Period|Lack of Efficacy|25|||
161919166|NCT03112603|584751411|FG001|End of Randomization Period|Lack of Efficacy|77|||
161474080|NCT02202980|583130678|FG008|Overall Study|Protocol Violation|0|||
161814105|NCT00772603|584362879|FG000|Overall Study|Adverse Event|37|||
161814106|NCT00772603|584362880|FG001|Overall Study|Adverse Event|18|||
161814107|NCT00772603|584362881|FG002|Overall Study|Adverse Event|10|||
161814108|NCT00772603|584362879|FG000|Overall Study|Subject Non-compliance|1|||
161814109|NCT00772603|584362880|FG001|Overall Study|Subject Non-compliance|6|||
161814110|NCT00772603|584362881|FG002|Overall Study|Subject Non-compliance|4|||
161814111|NCT00772603|584362879|FG000|Overall Study|Protocol Violation|0|||
161814112|NCT00772603|584362880|FG001|Overall Study|Protocol Violation|1|||
161474081|NCT02202980|583130679|FG009|Overall Study|Protocol Violation|0|||
161474082|NCT02202980|583130680|FG010|Overall Study|Protocol Violation|0|||
161474083|NCT02202980|583130681|FG011|Overall Study|Protocol Violation|0|||
161474084|NCT02202980|583130682|FG012|Overall Study|Protocol Violation|0|||
161474085|NCT02202980|583130683|FG013|Overall Study|Protocol Violation|0|||
161474086|NCT02202980|583130670|FG000|Overall Study|Lost to Follow-up|0|||
161474087|NCT02202980|583130671|FG001|Overall Study|Lost to Follow-up|1|||
161474088|NCT02202980|583130672|FG002|Overall Study|Lost to Follow-up|1|||
161474089|NCT02202980|583130673|FG003|Overall Study|Lost to Follow-up|1|||
161474090|NCT02202980|583130674|FG004|Overall Study|Lost to Follow-up|0|||
161474091|NCT02202980|583130675|FG005|Overall Study|Lost to Follow-up|0|||
161474092|NCT02202980|583130676|FG006|Overall Study|Lost to Follow-up|0|||
161474093|NCT02202980|583130677|FG007|Overall Study|Lost to Follow-up|1|||
161474094|NCT02202980|583130678|FG008|Overall Study|Lost to Follow-up|1|||
161474095|NCT02202980|583130679|FG009|Overall Study|Lost to Follow-up|0|||
161474096|NCT02202980|583130680|FG010|Overall Study|Lost to Follow-up|0|||
161474097|NCT02202980|583130681|FG011|Overall Study|Lost to Follow-up|0|||
161474098|NCT02202980|583130682|FG012|Overall Study|Lost to Follow-up|1|||
161474099|NCT02202980|583130683|FG013|Overall Study|Lost to Follow-up|0|||
161474100|NCT02202980|583130670|FG000|Overall Study|Withdrew Consent|0|||
161474101|NCT02202980|583130671|FG001|Overall Study|Withdrew Consent|1|||
161474102|NCT02202980|583130672|FG002|Overall Study|Withdrew Consent|2|||
161474103|NCT02202980|583130673|FG003|Overall Study|Withdrew Consent|0|||
161474104|NCT02202980|583130674|FG004|Overall Study|Withdrew Consent|0|||
161474105|NCT02202980|583130675|FG005|Overall Study|Withdrew Consent|0|||
161474106|NCT02202980|583130676|FG006|Overall Study|Withdrew Consent|0|||
161474107|NCT02202980|583130677|FG007|Overall Study|Withdrew Consent|0|||
161474108|NCT02202980|583130678|FG008|Overall Study|Withdrew Consent|1|||
161474109|NCT02202980|583130679|FG009|Overall Study|Withdrew Consent|0|||
161474110|NCT02202980|583130680|FG010|Overall Study|Withdrew Consent|0|||
161474111|NCT02202980|583130681|FG011|Overall Study|Withdrew Consent|0|||
161474112|NCT02202980|583130682|FG012|Overall Study|Withdrew Consent|0|||
161474113|NCT02202980|583130683|FG013|Overall Study|Withdrew Consent|0|||
161474114|NCT01952145|583130684|FG000|Overall Study|Protocol Violation|2|||
161474115|NCT01952145|583130685|FG001|Overall Study|Protocol Violation|1|||
161474116|NCT01952145|583130684|FG000|Overall Study|Death|0|||
161474117|NCT01952145|583130685|FG001|Overall Study|Death|1|||
161474118|NCT01952145|583130684|FG000|Overall Study|Adverse Event|9|||
161474119|NCT01952145|583130685|FG001|Overall Study|Adverse Event|0|||
161474120|NCT01952145|583130684|FG000|Overall Study|Withdrawal Criteria|16|||
161474121|NCT01952145|583130685|FG001|Overall Study|Withdrawal Criteria|11|||
161474122|NCT01952145|583130684|FG000|Overall Study|Unclassified|1|||
161474123|NCT01952145|583130685|FG001|Overall Study|Unclassified|1|||
161474124|NCT01540838|583130689|FG000|Overall Study|Open nasogastric tube|9|||
161474125|NCT01540838|583130690|FG001|Overall Study|Open nasogastric tube|7|||
161474126|NCT01540838|583130689|FG000|Overall Study|Treatment doses missing|8|||
161474127|NCT01540838|583130690|FG001|Overall Study|Treatment doses missing|12|||
161474128|NCT01540838|583130689|FG000|Overall Study|Additional antibiotic treatment|1|||
161474129|NCT01540838|583130690|FG001|Overall Study|Additional antibiotic treatment|2|||
161474130|NCT01540838|583130689|FG000|Overall Study|Died before treatment initiation|1|||
161474131|NCT01540838|583130690|FG001|Overall Study|Died before treatment initiation|1|||
161474132|NCT01540838|583130689|FG000|Overall Study|Not BM. Other treatment|3|||
161474133|NCT01540838|583130690|FG001|Overall Study|Not BM. Other treatment|1|||
161474134|NCT02130570|583130691|FG000|Overall Study|Death|3|||
161474135|NCT02130570|583130692|FG001|Overall Study|Death|5|||
161474136|NCT02130570|583130691|FG000|Overall Study|Withdrawal by Subject|6|||
161474137|NCT02130570|583130692|FG001|Overall Study|Withdrawal by Subject|3|||
161474138|NCT02130570|583130691|FG000|Overall Study|Part of practice that discontinued study|0|||
161474139|NCT02130570|583130692|FG001|Overall Study|Part of practice that discontinued study|5|||
161474140|NCT02808650|583130702|FG000|Overall Study|Death|0|||
161474141|NCT02808650|583130703|FG001|Overall Study|Death|0|||
161474142|NCT02808650|583130704|FG002|Overall Study|Death|0|||
161474143|NCT02808650|583130705|FG003|Overall Study|Death|0|||
161474144|NCT02808650|583130706|FG004|Overall Study|Death|1|||
161474145|NCT02808650|583130702|FG000|Overall Study|Lack of Efficacy|5|||
161474146|NCT02808650|583130703|FG001|Overall Study|Lack of Efficacy|5|||
161474147|NCT02808650|583130704|FG002|Overall Study|Lack of Efficacy|6|||
161474148|NCT02808650|583130705|FG003|Overall Study|Lack of Efficacy|5|||
161474149|NCT02808650|583130706|FG004|Overall Study|Lack of Efficacy|4|||
161474150|NCT02808650|583130702|FG000|Overall Study|Physician Decision|1|||
161474151|NCT02808650|583130703|FG001|Overall Study|Physician Decision|1|||
161474152|NCT02808650|583130704|FG002|Overall Study|Physician Decision|0|||
161474153|NCT02808650|583130705|FG003|Overall Study|Physician Decision|0|||
161474154|NCT02808650|583130706|FG004|Overall Study|Physician Decision|0|||
161474155|NCT02808650|583130702|FG000|Overall Study|Withdrawal by Subject|0|||
161474156|NCT02808650|583130703|FG001|Overall Study|Withdrawal by Subject|0|||
161814113|NCT00772603|584362881|FG002|Overall Study|Protocol Violation|1|||
161814114|NCT00772603|584362879|FG000|Overall Study|Lost to Follow-up|1|||
161814115|NCT00772603|584362880|FG001|Overall Study|Lost to Follow-up|5|||
161814116|NCT00772603|584362881|FG002|Overall Study|Lost to Follow-up|2|||
161814117|NCT00772603|584362879|FG000|Overall Study|Physician Decision|0|||
161814118|NCT00772603|584362880|FG001|Overall Study|Physician Decision|0|||
161814119|NCT00772603|584362881|FG002|Overall Study|Physician Decision|1|||
161814120|NCT00772603|584362879|FG000|Overall Study|Other|2|||
161814121|NCT00772603|584362880|FG001|Overall Study|Other|0|||
161814122|NCT00772603|584362881|FG002|Overall Study|Other|2|||
161814123|NCT00835575|584362882|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
161814124|NCT00835575|584362883|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
161814125|NCT01564394|584362886|FG000|Overall Study|Withdrawal by Subject|6|||
161814126|NCT01564394|584362887|FG001|Overall Study|Withdrawal by Subject|10|||
161814127|NCT00859521|584362888|FG000|Washout|Withdrawal by Subject|0|||
161814128|NCT00859521|584362889|FG001|Washout|Withdrawal by Subject|1|||
161814129|NCT01609257|584362890|FG000|Overall Study|Lost to Follow-up|2|||
161814130|NCT01609257|584362891|FG001|Overall Study|Lost to Follow-up|1|||
161814131|NCT01609257|584362890|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
161814132|NCT01609257|584362891|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
161814133|NCT01609257|584362890|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
161814134|NCT01609257|584362891|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
161814135|NCT02125461|584362892|FG000|Overall Study|Withdrawal by Subject|30|||
161814136|NCT02125461|584362893|FG001|Overall Study|Withdrawal by Subject|16|||
161814137|NCT02125461|584362892|FG000|Overall Study|Lost to Follow-up|8|||
161814138|NCT02125461|584362893|FG001|Overall Study|Lost to Follow-up|3|||
161814139|NCT02125461|584362892|FG000|Overall Study|Death|260|||
161814140|NCT02125461|584362893|FG001|Overall Study|Death|149|||
161814141|NCT02125461|584362892|FG000|Overall Study|Missing Termination Reason|0|||
161814142|NCT02125461|584362893|FG001|Overall Study|Missing Termination Reason|1|||
161814143|NCT03552484|584362902|FG000|Overall Study|Death|6|||
161814144|NCT03552484|584362903|FG001|Overall Study|Death|4|||
161814145|NCT03552484|584362902|FG000|Overall Study|Lost to Follow-up|0|||
161814146|NCT03552484|584362903|FG001|Overall Study|Lost to Follow-up|16|||
161814147|NCT03499353|584362904|FG000|Treatment|Adverse Event|3|||
161814148|NCT03499353|584362904|FG000|Treatment|Progressive Disease|10|||
161814149|NCT03499353|584362904|FG000|Treatment|Other|1|||
161814150|NCT03499353|584362904|FG000|Treatment|Withdrawal by Subject|2|||
161814151|NCT03499353|584362904|FG000|Long-Term Follow-up|Death|2|||
161814152|NCT03499353|584362904|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
161814153|NCT03499353|584362904|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
161814154|NCT02241551|584362905|FG000|Overall Study|Adverse Event|1|||
161814155|NCT02241551|584362906|FG001|Overall Study|Adverse Event|0|||
161814156|NCT00469898|584362913|FG000|Overall Study|Adverse Event|7|||
161814157|NCT00469898|584362913|FG000|Overall Study|Withdrawal by Subject|4|||
161814158|NCT00469898|584362913|FG000|Overall Study|Death|4|||
161814159|NCT00469898|584362913|FG000|Overall Study|Disease progression|9|||
161814160|NCT00469898|584362913|FG000|Overall Study|Decreased performance status|1|||
161814161|NCT02663349|584362916|FG000|Overall Study|Withdrawal by Subject|6|||
161814162|NCT02751424|584362924|FG000|Part 2|Adverse Event|0|||
161814163|NCT02751424|584362925|FG001|Part 2|Adverse Event|0|||
161814164|NCT02751424|584362926|FG002|Part 2|Adverse Event|0|||
161474157|NCT02808650|583130704|FG002|Overall Study|Withdrawal by Subject|0|||
161474158|NCT02808650|583130705|FG003|Overall Study|Withdrawal by Subject|1|||
161814165|NCT02751424|584362927|FG003|Part 2|Adverse Event|0|||
161814166|NCT02751424|584362928|FG004|Part 2|Adverse Event|0|||
161814167|NCT02751424|584362929|FG005|Part 2|Adverse Event|0|||
161814168|NCT02751424|584362930|FG006|Part 2|Adverse Event|0|||
161814169|NCT02751424|584362931|FG007|Part 2|Adverse Event|5|||
161814170|NCT02751424|584362932|FG008|Part 2|Adverse Event|0|||
161814171|NCT00848536|584362933|FG000|Overall Study|Adverse Event|2|||
161814172|NCT00848536|584362934|FG001|Overall Study|Adverse Event|2|||
161814173|NCT00848536|584362933|FG000|Overall Study|Withdrawal by Subject|0|||
161814174|NCT00848536|584362934|FG001|Overall Study|Withdrawal by Subject|1|||
161814175|NCT00848536|584362933|FG000|Overall Study|Protocol Violation|0|||
161814176|NCT00848536|584362934|FG001|Overall Study|Protocol Violation|1|||
161814177|NCT00848536|584362933|FG000|Overall Study|Noncompliance|1|||
161474159|NCT02808650|583130706|FG004|Overall Study|Withdrawal by Subject|1|||
161814178|NCT00848536|584362934|FG001|Overall Study|Noncompliance|0|||
161919167|NCT03112603|584751412|FG002|End of Randomization Period|Lack of Efficacy|0|||
161919168|NCT03112603|584751410|FG000|End of Randomization Period|Adverse Event|32|||
161919169|NCT03112603|584751411|FG001|End of Randomization Period|Adverse Event|12|||
161919170|NCT03112603|584751412|FG002|End of Randomization Period|Adverse Event|0|||
161919171|NCT03112603|584751410|FG000|End of Cross Over Period|Death|0|||
161919172|NCT03112603|584751411|FG001|End of Cross Over Period|Death|0|||
161474160|NCT04889222|583130712|FG000|Overall Study|Did not meet eligibility criteria|8|||
161474161|NCT04889222|583130712|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
161474162|NCT04889222|583130712|FG000|Overall Study|Did not proceed due to time constraints|5|||
161474163|NCT01180647|583130713|FG000|Overall Study|Lost to Follow-up|5|||
161474164|NCT01180647|583130714|FG001|Overall Study|Lost to Follow-up|6|||
161474165|NCT00071396|583130721|FG000|Overall Study|Withdrawal by Subject|1|||
161474166|NCT00071396|583130721|FG000|Overall Study|Physician Decision|2|||
161474167|NCT04545554|583130722|FG000|Overall Study|Withdrawal by Subject|0|||
161474168|NCT04545554|583130723|FG001|Overall Study|Withdrawal by Subject|0|||
161474169|NCT04545554|583130724|FG002|Overall Study|Withdrawal by Subject|0|||
161474170|NCT04545554|583130725|FG003|Overall Study|Withdrawal by Subject|1|||
161474171|NCT04545554|583130726|FG004|Overall Study|Withdrawal by Subject|0|||
161919173|NCT03112603|584751412|FG002|End of Cross Over Period|Death|2|||
161919174|NCT03112603|584751410|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
161474172|NCT04545554|583130727|FG005|Overall Study|Withdrawal by Subject|0|||
161474173|NCT02639546|583130728|FG000|Overall Study|Death|2|||
161474174|NCT02639546|583130729|FG001|Overall Study|Death|2|||
161474175|NCT02639546|583130730|FG002|Overall Study|Death|1|||
161474176|NCT02639546|583130731|FG003|Overall Study|Death|2|||
161474177|NCT02639546|583130732|FG004|Overall Study|Death|2|||
161474178|NCT02639546|583130733|FG005|Overall Study|Death|2|||
161474179|NCT02639546|583130734|FG006|Overall Study|Death|0|||
161474180|NCT02639546|583130735|FG007|Overall Study|Death|0|||
161474181|NCT02639546|583130728|FG000|Overall Study|Lost to Follow-up|0|||
161474182|NCT02639546|583130729|FG001|Overall Study|Lost to Follow-up|0|||
161474183|NCT02639546|583130730|FG002|Overall Study|Lost to Follow-up|1|||
161474184|NCT02639546|583130731|FG003|Overall Study|Lost to Follow-up|0|||
161474185|NCT02639546|583130732|FG004|Overall Study|Lost to Follow-up|1|||
161474186|NCT02639546|583130733|FG005|Overall Study|Lost to Follow-up|1|||
161474187|NCT02639546|583130734|FG006|Overall Study|Lost to Follow-up|0|||
161474188|NCT02639546|583130735|FG007|Overall Study|Lost to Follow-up|1|||
161474189|NCT02639546|583130728|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
161474190|NCT02639546|583130729|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
161474191|NCT02639546|583130730|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
161474192|NCT02639546|583130731|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
161474193|NCT02639546|583130732|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
161474194|NCT02639546|583130733|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
161474195|NCT02639546|583130734|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
161474196|NCT02639546|583130735|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
161474197|NCT02639546|583130728|FG000|Overall Study|Study Terminated By Sponsor|0|||
161474198|NCT02639546|583130729|FG001|Overall Study|Study Terminated By Sponsor|2|||
161474199|NCT02639546|583130730|FG002|Overall Study|Study Terminated By Sponsor|3|||
161474200|NCT02639546|583130731|FG003|Overall Study|Study Terminated By Sponsor|4|||
161474201|NCT02639546|583130732|FG004|Overall Study|Study Terminated By Sponsor|4|||
161474202|NCT02639546|583130733|FG005|Overall Study|Study Terminated By Sponsor|3|||
161474203|NCT02639546|583130734|FG006|Overall Study|Study Terminated By Sponsor|3|||
161474204|NCT02639546|583130735|FG007|Overall Study|Study Terminated By Sponsor|9|||
161474205|NCT02639546|583130728|FG000|Overall Study|Withdrawal by Subject|2|||
161474206|NCT02639546|583130729|FG001|Overall Study|Withdrawal by Subject|2|||
161919175|NCT03112603|584751411|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
161474207|NCT02639546|583130730|FG002|Overall Study|Withdrawal by Subject|1|||
161474208|NCT02639546|583130731|FG003|Overall Study|Withdrawal by Subject|0|||
161474209|NCT02639546|583130732|FG004|Overall Study|Withdrawal by Subject|0|||
161474210|NCT02639546|583130733|FG005|Overall Study|Withdrawal by Subject|1|||
161474211|NCT02639546|583130734|FG006|Overall Study|Withdrawal by Subject|2|||
161474212|NCT02639546|583130735|FG007|Overall Study|Withdrawal by Subject|1|||
161474213|NCT02478372|583130736|FG000|Overall Study|Protocol Violation|12|||
161474214|NCT02478372|583130737|FG001|Overall Study|Protocol Violation|8|||
161474215|NCT02478372|583130736|FG000|Overall Study|Lost to Follow-up|1|||
161474216|NCT02478372|583130737|FG001|Overall Study|Lost to Follow-up|4|||
161474217|NCT02478372|583130736|FG000|Overall Study|Death|0|||
161474218|NCT02478372|583130737|FG001|Overall Study|Death|2|||
161474219|NCT00116428|583130738|FG000|Overall Study|Withdrawal by Subject|2|||
161474220|NCT00116428|583130739|FG001|Overall Study|Withdrawal by Subject|5|||
161474221|NCT00116428|583130738|FG000|Overall Study|Did not meet inclusion criteria|1|||
161474222|NCT00116428|583130739|FG001|Overall Study|Did not meet inclusion criteria|0|||
161474223|NCT01032174|583130740|FG000|Overall Study|Adverse Event|0|||
161474224|NCT01032174|583130741|FG001|Overall Study|Adverse Event|1|||
161474225|NCT00113087|583130742|FG000|Overall Study|Death or Transplant|14|||
161474226|NCT00113087|583130743|FG001|Overall Study|Death or Transplant|16|||
161474227|NCT00113087|583130742|FG000|Overall Study|Family or MD withdrew subject|10|||
161474228|NCT00113087|583130743|FG001|Overall Study|Family or MD withdrew subject|5|||
161474229|NCT00386607|583130744|FG000|Core|Adverse Event|40|||
161474230|NCT00386607|583130745|FG001|Core|Adverse Event|0|||
161474231|NCT00386607|583130744|FG000|Core|Abnormal laboratory value(s)|3|||
161474232|NCT00386607|583130745|FG001|Core|Abnormal laboratory value(s)|0|||
161474233|NCT00386607|583130744|FG000|Core|Unsatisfactory therapeutic effect|23|||
161474234|NCT00386607|583130745|FG001|Core|Unsatisfactory therapeutic effect|0|||
161474235|NCT00386607|583130744|FG000|Core|Condition no longer requires study drug|4|||
161474236|NCT00386607|583130745|FG001|Core|Condition no longer requires study drug|0|||
161474237|NCT00386607|583130744|FG000|Core|Patient withdrew consent|15|||
161474238|NCT00386607|583130745|FG001|Core|Patient withdrew consent|0|||
161474239|NCT00386607|583130744|FG000|Core|Lost to Follow-up|23|||
161474240|NCT00386607|583130745|FG001|Core|Lost to Follow-up|0|||
161474241|NCT00386607|583130744|FG000|Core|Administrative problems|1|||
161474242|NCT00386607|583130745|FG001|Core|Administrative problems|0|||
161474243|NCT00386607|583130744|FG000|Core|Protocol Deviation|6|||
161474244|NCT00386607|583130745|FG001|Core|Protocol Deviation|0|||
161474245|NCT00386607|583130744|FG000|Extension|Adverse Event|0|||
161474246|NCT00386607|583130745|FG001|Extension|Adverse Event|6|||
161474247|NCT00386607|583130744|FG000|Extension|Abnormal laboratory value(s)|0|||
161474248|NCT00386607|583130745|FG001|Extension|Abnormal laboratory value(s)|1|||
161474249|NCT00386607|583130744|FG000|Extension|Administrative problems|0|||
161474250|NCT00386607|583130745|FG001|Extension|Administrative problems|1|||
161474251|NCT00386607|583130744|FG000|Extension|Lost to Follow-up|0|||
161474252|NCT00386607|583130745|FG001|Extension|Lost to Follow-up|3|||
161474253|NCT00386607|583130744|FG000|Extension|Patient withdrew consent|0|||
161474254|NCT00386607|583130745|FG001|Extension|Patient withdrew consent|5|||
161474255|NCT00386607|583130744|FG000|Extension|Unsatisfactory therapeutic effect|0|||
161919176|NCT03112603|584751412|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
161919177|NCT03112603|584751410|FG000|End of Cross Over Period|Physician Decision|0|||
161919178|NCT03112603|584751411|FG001|End of Cross Over Period|Physician Decision|0|||
161919179|NCT03112603|584751412|FG002|End of Cross Over Period|Physician Decision|29|||
161919180|NCT03112603|584751410|FG000|End of Cross Over Period|Lack of Efficacy|0|||
161919181|NCT03112603|584751411|FG001|End of Cross Over Period|Lack of Efficacy|0|||
161919182|NCT03112603|584751412|FG002|End of Cross Over Period|Lack of Efficacy|8|||
161919183|NCT03112603|584751410|FG000|End of Cross Over Period|Adverse Event|0|||
161919184|NCT03112603|584751411|FG001|End of Cross Over Period|Adverse Event|0|||
161919185|NCT03112603|584751412|FG002|End of Cross Over Period|Adverse Event|6|||
161919186|NCT03112603|584751410|FG000|End of Cross Over Period|Disease Relapse|0|||
161919187|NCT03112603|584751411|FG001|End of Cross Over Period|Disease Relapse|0|||
161919188|NCT03112603|584751412|FG002|End of Cross Over Period|Disease Relapse|2|||
161919189|NCT04092777|584751413|FG000|Overall Study|Lost to Follow-up|28|||
161919190|NCT04092777|584751414|FG001|Overall Study|Lost to Follow-up|46|||
161919191|NCT04092777|584751413|FG000|Overall Study|Withdrawal by Subject|8|||
161919192|NCT04092777|584751414|FG001|Overall Study|Withdrawal by Subject|5|||
161919193|NCT03330197|584751417|FG000|Overall Study|Adverse Event|0|||
161919194|NCT03330197|584751418|FG001|Overall Study|Adverse Event|1|||
161474256|NCT00386607|583130745|FG001|Extension|Unsatisfactory therapeutic effect|1|||
161474257|NCT02713204|583130746|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
161919195|NCT03330197|584751417|FG000|Overall Study|Withdrawal by Subject|0|||
161919196|NCT03330197|584751418|FG001|Overall Study|Withdrawal by Subject|1|||
161919197|NCT03765073|584751419|FG000|Stage 1|Lost to Follow-up|1|||
161919198|NCT03765073|584751420|FG001|Stage 1|Lost to Follow-up|0|||
161919199|NCT03765073|584751421|FG002|Stage 1|Lost to Follow-up|0|||
161919200|NCT03765073|584751422|FG003|Stage 1|Lost to Follow-up|0|||
161919201|NCT03765073|584751423|FG004|Stage 1|Lost to Follow-up|0|||
161474258|NCT02713204|583130747|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
161474259|NCT02713204|583130748|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
161474260|NCT02713204|583130749|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
161919202|NCT03765073|584751424|FG005|Stage 1|Lost to Follow-up|0|||
161919203|NCT03765073|584751425|FG006|Stage 1|Lost to Follow-up|0|||
161919204|NCT03765073|584751426|FG007|Stage 1|Lost to Follow-up|0|||
161919205|NCT03765073|584751427|FG008|Stage 1|Lost to Follow-up|0|||
161919206|NCT03765073|584751428|FG009|Stage 1|Lost to Follow-up|0|||
161919207|NCT03765073|584751429|FG010|Stage 1|Lost to Follow-up|0|||
161474261|NCT02713204|583130750|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
161474262|NCT02713204|583130751|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
161474263|NCT02713204|583130752|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
161474264|NCT02713204|583130753|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
161474265|NCT02713204|583130746|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474266|NCT02713204|583130747|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474267|NCT02713204|583130748|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
161474268|NCT02713204|583130749|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474269|NCT02713204|583130750|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474270|NCT02713204|583130751|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474271|NCT02713204|583130752|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474272|NCT02713204|583130753|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161474273|NCT02713204|583130746|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474274|NCT02713204|583130747|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
161474275|NCT02713204|583130748|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474276|NCT02713204|583130749|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474277|NCT02713204|583130750|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474278|NCT02713204|583130751|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474279|NCT02713204|583130752|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474280|NCT02713204|583130753|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161474281|NCT02713204|583130746|FG000|From Week 12 up to Week 36|Adverse Event|1|||
161474282|NCT02713204|583130747|FG001|From Week 12 up to Week 36|Adverse Event|0|||
161474283|NCT02713204|583130748|FG002|From Week 12 up to Week 36|Adverse Event|0|||
161474284|NCT02713204|583130749|FG003|From Week 12 up to Week 36|Adverse Event|1|||
161474285|NCT02713204|583130750|FG004|From Week 12 up to Week 36|Adverse Event|1|||
161474286|NCT02713204|583130751|FG005|From Week 12 up to Week 36|Adverse Event|0|||
161474287|NCT02713204|583130752|FG006|From Week 12 up to Week 36|Adverse Event|2|||
161474288|NCT02713204|583130753|FG007|From Week 12 up to Week 36|Adverse Event|1|||
161814179|NCT00848536|584362933|FG000|Overall Study|Inadequate Control of IOP|1|||
161474289|NCT02713204|583130746|FG000|From Week 12 up to Week 36|Death|0|||
161474290|NCT02713204|583130747|FG001|From Week 12 up to Week 36|Death|0|||
161474291|NCT02713204|583130748|FG002|From Week 12 up to Week 36|Death|0|||
161474292|NCT02713204|583130749|FG003|From Week 12 up to Week 36|Death|1|||
161474293|NCT02713204|583130750|FG004|From Week 12 up to Week 36|Death|0|||
161474294|NCT02713204|583130751|FG005|From Week 12 up to Week 36|Death|1|||
161474295|NCT02713204|583130752|FG006|From Week 12 up to Week 36|Death|0|||
161474296|NCT02713204|583130753|FG007|From Week 12 up to Week 36|Death|3|||
161474297|NCT02713204|583130746|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474298|NCT02713204|583130747|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474299|NCT02713204|583130748|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474300|NCT02713204|583130749|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
161474301|NCT02713204|583130750|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474302|NCT02713204|583130751|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474303|NCT02713204|583130752|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474304|NCT02713204|583130753|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
161474305|NCT02713204|583130746|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
161474306|NCT02713204|583130747|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
161474307|NCT02713204|583130748|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
161474308|NCT02713204|583130749|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
161474309|NCT02713204|583130750|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
161474310|NCT02713204|583130751|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
161474311|NCT02713204|583130752|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
161474312|NCT02713204|583130753|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
161474313|NCT00474760|583130757|FG000|Overall Study|Death|0|||
161474314|NCT00474760|583130758|FG001|Overall Study|Death|0|||
161814180|NCT00848536|584362934|FG001|Overall Study|Inadequate Control of IOP|1|||
161814181|NCT00848536|584362933|FG000|Overall Study|Patient Moved|0|||
161474315|NCT00474760|583130759|FG002|Overall Study|Death|0|||
161474316|NCT00474760|583130760|FG003|Overall Study|Death|0|||
161474317|NCT00474760|583130761|FG004|Overall Study|Death|2|||
161474318|NCT00474760|583130762|FG005|Overall Study|Death|0|||
161474319|NCT00474760|583130763|FG006|Overall Study|Death|0|||
161474320|NCT00474760|583130757|FG000|Overall Study|Adverse Event|0|||
161474321|NCT00474760|583130758|FG001|Overall Study|Adverse Event|0|||
161474322|NCT00474760|583130759|FG002|Overall Study|Adverse Event|0|||
161474323|NCT00474760|583130760|FG003|Overall Study|Adverse Event|0|||
161474324|NCT00474760|583130761|FG004|Overall Study|Adverse Event|1|||
161474325|NCT00474760|583130762|FG005|Overall Study|Adverse Event|7|||
161474326|NCT00474760|583130763|FG006|Overall Study|Adverse Event|0|||
161474327|NCT00474760|583130757|FG000|Overall Study|Laboratory abnormality|0|||
161474328|NCT00474760|583130758|FG001|Overall Study|Laboratory abnormality|0|||
161474329|NCT00474760|583130759|FG002|Overall Study|Laboratory abnormality|0|||
161474330|NCT00474760|583130760|FG003|Overall Study|Laboratory abnormality|0|||
161474331|NCT00474760|583130761|FG004|Overall Study|Laboratory abnormality|0|||
161474332|NCT00474760|583130762|FG005|Overall Study|Laboratory abnormality|1|||
161474333|NCT00474760|583130763|FG006|Overall Study|Laboratory abnormality|0|||
161474334|NCT00474760|583130757|FG000|Overall Study|Withdrawal by Subject|0|||
161474335|NCT00474760|583130758|FG001|Overall Study|Withdrawal by Subject|0|||
161474336|NCT00474760|583130759|FG002|Overall Study|Withdrawal by Subject|0|||
161474337|NCT00474760|583130760|FG003|Overall Study|Withdrawal by Subject|1|||
161474338|NCT00474760|583130761|FG004|Overall Study|Withdrawal by Subject|0|||
161814182|NCT00848536|584362934|FG001|Overall Study|Patient Moved|2|||
161814183|NCT01175135|584362935|FG000|Overall Study|Adverse Event|2|||
161814184|NCT01175135|584362936|FG001|Overall Study|Adverse Event|5|||
161814185|NCT01175135|584362937|FG002|Overall Study|Adverse Event|3|||
161474339|NCT00474760|583130762|FG005|Overall Study|Withdrawal by Subject|1|||
161814186|NCT01175135|584362938|FG003|Overall Study|Adverse Event|4|||
161814187|NCT01175135|584362935|FG000|Overall Study|Death|1|||
161814188|NCT01175135|584362936|FG001|Overall Study|Death|0|||
161814189|NCT01175135|584362937|FG002|Overall Study|Death|0|||
161814190|NCT01175135|584362938|FG003|Overall Study|Death|0|||
161814191|NCT01175135|584362935|FG000|Overall Study|Lack of Efficacy|4|||
161814192|NCT01175135|584362936|FG001|Overall Study|Lack of Efficacy|5|||
161814193|NCT01175135|584362937|FG002|Overall Study|Lack of Efficacy|0|||
161814194|NCT01175135|584362938|FG003|Overall Study|Lack of Efficacy|5|||
161814195|NCT01175135|584362935|FG000|Overall Study|Lost to Follow-up|1|||
161814196|NCT01175135|584362936|FG001|Overall Study|Lost to Follow-up|2|||
161474340|NCT00474760|583130763|FG006|Overall Study|Withdrawal by Subject|1|||
161814197|NCT01175135|584362937|FG002|Overall Study|Lost to Follow-up|0|||
161814198|NCT01175135|584362938|FG003|Overall Study|Lost to Follow-up|0|||
161814199|NCT01175135|584362935|FG000|Overall Study|Protocol Violation|1|||
161814200|NCT01175135|584362936|FG001|Overall Study|Protocol Violation|1|||
161474341|NCT00474760|583130757|FG000|Overall Study|Other|0|||
161814201|NCT01175135|584362937|FG002|Overall Study|Protocol Violation|0|||
161814202|NCT01175135|584362938|FG003|Overall Study|Protocol Violation|0|||
161814203|NCT01175135|584362935|FG000|Overall Study|Withdrawal by Subject|4|||
161814204|NCT01175135|584362936|FG001|Overall Study|Withdrawal by Subject|8|||
161814205|NCT01175135|584362937|FG002|Overall Study|Withdrawal by Subject|5|||
161814206|NCT01175135|584362938|FG003|Overall Study|Withdrawal by Subject|5|||
161814207|NCT01175135|584362935|FG000|Overall Study|Other|3|||
161814208|NCT01175135|584362936|FG001|Overall Study|Other|1|||
161814209|NCT01175135|584362937|FG002|Overall Study|Other|3|||
161814210|NCT01175135|584362938|FG003|Overall Study|Other|0|||
161814211|NCT01175135|584362935|FG000|Overall Study|Randomized But Not Treated|0|||
161814212|NCT01175135|584362936|FG001|Overall Study|Randomized But Not Treated|0|||
161814213|NCT01175135|584362937|FG002|Overall Study|Randomized But Not Treated|1|||
161814214|NCT01175135|584362938|FG003|Overall Study|Randomized But Not Treated|0|||
161814215|NCT01590563|584362941|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
161814216|NCT03534193|584362944|FG000|Overall Study|Lost to Follow-up|1|||
161814217|NCT03534193|584362945|FG001|Overall Study|Lost to Follow-up|3|||
161814218|NCT02699463|584362946|FG000|Overall Study|Lost to Follow-up|11|||
161814219|NCT02699463|584362947|FG001|Overall Study|Lost to Follow-up|8|||
161814220|NCT02699463|584362946|FG000|Overall Study|Withdrawal by Subject|4|||
161474342|NCT00474760|583130758|FG001|Overall Study|Other|1|||
161814221|NCT02699463|584362947|FG001|Overall Study|Withdrawal by Subject|1|||
161814222|NCT02488239|584362948|FG000|Overall Study|Death|3|||
161814223|NCT02488239|584362948|FG000|Overall Study|Withdrawal by Subject|3|||
161814224|NCT02488239|584362948|FG000|Overall Study|Physician Decision|2|||
161814225|NCT02488239|584362948|FG000|Overall Study|Consent ineligible|1|||
161814226|NCT02488239|584362948|FG000|Overall Study|Did not undergo implant procedure|1|||
161814227|NCT04414930|584362950|FG000|Overall Study|Withdrawal by Subject|1|||
161814228|NCT04414930|584362951|FG001|Overall Study|Withdrawal by Subject|3|||
161814229|NCT05470699|584362952|FG000|Overall Study|Did not receive intervention|13|||
161814230|NCT05470699|584362952|FG000|Overall Study|Ineligible|1|||
161814231|NCT03325881|584362953|FG000|Overall Study|Protocol Violation|0|||
161814232|NCT03325881|584362954|FG001|Overall Study|Protocol Violation|1|||
161814233|NCT03325881|584362953|FG000|Overall Study|Withdrawal by Subject|0|||
161814234|NCT03325881|584362954|FG001|Overall Study|Withdrawal by Subject|2|||
161814235|NCT03325881|584362953|FG000|Overall Study|Lack of Efficacy|2|||
161814236|NCT03325881|584362954|FG001|Overall Study|Lack of Efficacy|0|||
161814237|NCT03325881|584362953|FG000|Overall Study|Not treated|1|||
161814238|NCT03325881|584362954|FG001|Overall Study|Not treated|0|||
161814239|NCT01848938|584362974|FG000|Overall Study|Lost to Follow-up|1|||
161814240|NCT01848938|584362975|FG001|Overall Study|Lost to Follow-up|1|||
161814241|NCT00909038|584362976|FG000|Overall Study|Protocol Violation|187|||
161814242|NCT00909038|584362976|FG000|Overall Study|Non-evaluable Subjects|230|||
161814243|NCT00207090|584362977|FG000|Overall Study|Study drug toxicity|3|||
161814244|NCT00207090|584362977|FG000|Overall Study|Chest wall mass larger|1|||
161814245|NCT00207090|584362977|FG000|Overall Study|Disease progression/relapse|2|||
161814246|NCT00207090|584362977|FG000|Overall Study|Physician Decision|1|||
161814247|NCT00909753|584362980|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
161814248|NCT00909753|584362981|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
161814249|NCT00909753|584362980|FG000|Period: Second Intervention|Protocol Violation|1|||
161814250|NCT00909753|584362981|FG001|Period: Second Intervention|Protocol Violation|0|||
161814251|NCT03480763|584362986|FG000|Overall Study|Withdrawal by Subject|18|||
161814252|NCT03480763|584362987|FG001|Overall Study|Withdrawal by Subject|10|||
161814253|NCT03480763|584362986|FG000|Overall Study|Lost to Follow-up|4|||
161814254|NCT03480763|584362987|FG001|Overall Study|Lost to Follow-up|7|||
161814255|NCT03480763|584362986|FG000|Overall Study|non-study pneumococcal vaccine|1|||
161814256|NCT03480763|584362987|FG001|Overall Study|non-study pneumococcal vaccine|0|||
161814257|NCT03480763|584362986|FG000|Overall Study|oncological treatment|0|||
161814258|NCT03480763|584362987|FG001|Overall Study|oncological treatment|2|||
161814259|NCT03480763|584362986|FG000|Overall Study|pain with vaccination|1|||
161814260|NCT03480763|584362987|FG001|Overall Study|pain with vaccination|0|||
161814261|NCT01895335|584362988|FG000|Overall Study|Adverse Event|106|||
161814262|NCT01895335|584362988|FG000|Overall Study|Lack of Efficacy|53|||
161814263|NCT01895335|584362988|FG000|Overall Study|Poor Compliance to Protocol|11|||
161814264|NCT01895335|584362988|FG000|Overall Study|Included But Not treated|1|||
161814265|NCT01895335|584362988|FG000|Overall Study|Other than Specified Above|44|||
161814266|NCT01647828|584362989|FG000|Overall Study|Death|3|||
161814267|NCT01647828|584362990|FG001|Overall Study|Death|4|||
161814268|NCT01647828|584362991|FG002|Overall Study|Death|4|||
161814269|NCT01647828|584362992|FG003|Overall Study|Death|5|||
161814270|NCT01647828|584362993|FG004|Overall Study|Death|6|||
161474343|NCT00474760|583130759|FG002|Overall Study|Other|0|||
161814271|NCT01647828|584362994|FG005|Overall Study|Death|3|||
161814272|NCT01647828|584362995|FG006|Overall Study|Death|10|||
161814273|NCT01647828|584362996|FG007|Overall Study|Death|60|||
161814274|NCT01647828|584362997|FG008|Overall Study|Death|71|||
161814275|NCT01647828|584362989|FG000|Overall Study|Withdrawal by Subject|2|||
161814276|NCT01647828|584362990|FG001|Overall Study|Withdrawal by Subject|0|||
161814277|NCT01647828|584362991|FG002|Overall Study|Withdrawal by Subject|0|||
161814278|NCT01647828|584362992|FG003|Overall Study|Withdrawal by Subject|1|||
161814279|NCT01647828|584362993|FG004|Overall Study|Withdrawal by Subject|0|||
161814280|NCT01647828|584362994|FG005|Overall Study|Withdrawal by Subject|0|||
161814281|NCT01647828|584362995|FG006|Overall Study|Withdrawal by Subject|1|||
161814282|NCT01647828|584362996|FG007|Overall Study|Withdrawal by Subject|0|||
161814283|NCT01647828|584362997|FG008|Overall Study|Withdrawal by Subject|2|||
161814284|NCT01647828|584362989|FG000|Overall Study|Study terminated by Sponsor|0|||
161814285|NCT01647828|584362990|FG001|Overall Study|Study terminated by Sponsor|0|||
161814286|NCT01647828|584362991|FG002|Overall Study|Study terminated by Sponsor|0|||
161814287|NCT01647828|584362992|FG003|Overall Study|Study terminated by Sponsor|0|||
161814288|NCT01647828|584362993|FG004|Overall Study|Study terminated by Sponsor|0|||
161814289|NCT01647828|584362994|FG005|Overall Study|Study terminated by Sponsor|0|||
161814290|NCT01647828|584362995|FG006|Overall Study|Study terminated by Sponsor|1|||
161814291|NCT01647828|584362996|FG007|Overall Study|Study terminated by Sponsor|26|||
161814292|NCT01647828|584362997|FG008|Overall Study|Study terminated by Sponsor|16|||
161814293|NCT01647828|584362989|FG000|Overall Study|Lost to Follow-up|0|||
161814294|NCT01647828|584362990|FG001|Overall Study|Lost to Follow-up|0|||
161474344|NCT00474760|583130760|FG003|Overall Study|Other|0|||
161474345|NCT00474760|583130761|FG004|Overall Study|Other|1|||
161474346|NCT00474760|583130762|FG005|Overall Study|Other|0|||
161474347|NCT00474760|583130763|FG006|Overall Study|Other|0|||
161474348|NCT00474760|583130757|FG000|Overall Study|Progressive disease|3|||
161474349|NCT00474760|583130758|FG001|Overall Study|Progressive disease|2|||
161474350|NCT00474760|583130759|FG002|Overall Study|Progressive disease|3|||
161474351|NCT00474760|583130760|FG003|Overall Study|Progressive disease|2|||
161474352|NCT00474760|583130761|FG004|Overall Study|Progressive disease|8|||
161474353|NCT00474760|583130762|FG005|Overall Study|Progressive disease|20|||
161474354|NCT00474760|583130763|FG006|Overall Study|Progressive disease|7|||
161474355|NCT00474760|583130757|FG000|Overall Study|Terminated by sponsor|0|||
161474356|NCT00474760|583130758|FG001|Overall Study|Terminated by sponsor|0|||
161474357|NCT00474760|583130759|FG002|Overall Study|Terminated by sponsor|0|||
161474358|NCT00474760|583130760|FG003|Overall Study|Terminated by sponsor|0|||
161474359|NCT00474760|583130761|FG004|Overall Study|Terminated by sponsor|0|||
161474360|NCT00474760|583130762|FG005|Overall Study|Terminated by sponsor|0|||
161814295|NCT01647828|584362991|FG002|Overall Study|Lost to Follow-up|0|||
161814296|NCT01647828|584362992|FG003|Overall Study|Lost to Follow-up|0|||
161474361|NCT00474760|583130763|FG006|Overall Study|Terminated by sponsor|2|||
161474362|NCT01927627|583130765|FG000|Overall Study|Adverse Event|3|||
161474363|NCT01927627|583130765|FG000|Overall Study|Lack of Efficacy|1|||
161474364|NCT01927627|583130765|FG000|Overall Study|Financial Concerns|1|||
161814297|NCT01647828|584362993|FG004|Overall Study|Lost to Follow-up|0|||
161814298|NCT01647828|584362994|FG005|Overall Study|Lost to Follow-up|0|||
161474365|NCT02635776|583130766|FG000|Overall Study|Physician Decision|1|||
161474366|NCT02635776|583130767|FG001|Overall Study|Physician Decision|0|||
161919208|NCT03765073|584751430|FG011|Stage 1|Lost to Follow-up|0|||
161919209|NCT03765073|584751431|FG012|Stage 1|Lost to Follow-up|0|||
161919210|NCT03765073|584751432|FG013|Stage 1|Lost to Follow-up|0|||
161919211|NCT03765073|584751433|FG014|Stage 1|Lost to Follow-up|0|||
161919212|NCT03765073|584751434|FG015|Stage 1|Lost to Follow-up|0|||
161919213|NCT03765073|584751435|FG016|Stage 1|Lost to Follow-up|0|||
161919214|NCT03765073|584751436|FG017|Stage 1|Lost to Follow-up|0|||
161919215|NCT03765073|584751437|FG018|Stage 1|Lost to Follow-up|0|||
161919216|NCT03765073|584751438|FG019|Stage 1|Lost to Follow-up|0|||
161919217|NCT03765073|584751439|FG020|Stage 1|Lost to Follow-up|0|||
161919218|NCT03765073|584751419|FG000|Stage 1|Withdrawal by participant|0|||
161919219|NCT03765073|584751420|FG001|Stage 1|Withdrawal by participant|1|||
161919220|NCT03765073|584751421|FG002|Stage 1|Withdrawal by participant|0|||
161919221|NCT03765073|584751422|FG003|Stage 1|Withdrawal by participant|0|||
161919222|NCT03765073|584751423|FG004|Stage 1|Withdrawal by participant|0|||
161919223|NCT03765073|584751424|FG005|Stage 1|Withdrawal by participant|0|||
161919224|NCT03765073|584751425|FG006|Stage 1|Withdrawal by participant|0|||
161919225|NCT03765073|584751426|FG007|Stage 1|Withdrawal by participant|0|||
161919226|NCT03765073|584751427|FG008|Stage 1|Withdrawal by participant|0|||
161919227|NCT03765073|584751428|FG009|Stage 1|Withdrawal by participant|0|||
161919228|NCT03765073|584751429|FG010|Stage 1|Withdrawal by participant|0|||
161919229|NCT03765073|584751430|FG011|Stage 1|Withdrawal by participant|0|||
161919230|NCT03765073|584751431|FG012|Stage 1|Withdrawal by participant|0|||
161919231|NCT03765073|584751432|FG013|Stage 1|Withdrawal by participant|0|||
161919232|NCT03765073|584751433|FG014|Stage 1|Withdrawal by participant|0|||
161919233|NCT03765073|584751434|FG015|Stage 1|Withdrawal by participant|0|||
161919234|NCT03765073|584751435|FG016|Stage 1|Withdrawal by participant|0|||
161919235|NCT03765073|584751436|FG017|Stage 1|Withdrawal by participant|0|||
161919236|NCT03765073|584751437|FG018|Stage 1|Withdrawal by participant|0|||
161919237|NCT03765073|584751438|FG019|Stage 1|Withdrawal by participant|0|||
161919238|NCT03765073|584751439|FG020|Stage 1|Withdrawal by participant|0|||
161919239|NCT03765073|584751419|FG000|Stage 2|Death|0|||
161919240|NCT03765073|584751420|FG001|Stage 2|Death|0|||
161919241|NCT03765073|584751421|FG002|Stage 2|Death|0|||
161919242|NCT03765073|584751422|FG003|Stage 2|Death|0|||
161919243|NCT03765073|584751423|FG004|Stage 2|Death|0|||
161919244|NCT03765073|584751424|FG005|Stage 2|Death|0|||
161919245|NCT03765073|584751425|FG006|Stage 2|Death|0|||
161919246|NCT03765073|584751426|FG007|Stage 2|Death|0|||
161919247|NCT03765073|584751427|FG008|Stage 2|Death|0|||
161919248|NCT03765073|584751428|FG009|Stage 2|Death|1|||
161919249|NCT03765073|584751429|FG010|Stage 2|Death|0|||
161919250|NCT03765073|584751430|FG011|Stage 2|Death|1|||
161919251|NCT03765073|584751431|FG012|Stage 2|Death|0|||
161919252|NCT03765073|584751432|FG013|Stage 2|Death|0|||
161919253|NCT03765073|584751433|FG014|Stage 2|Death|0|||
161919254|NCT03765073|584751434|FG015|Stage 2|Death|0|||
161919255|NCT03765073|584751435|FG016|Stage 2|Death|2|||
161919256|NCT03765073|584751436|FG017|Stage 2|Death|0|||
161919257|NCT03765073|584751437|FG018|Stage 2|Death|0|||
161919258|NCT03765073|584751438|FG019|Stage 2|Death|0|||
161919259|NCT03765073|584751439|FG020|Stage 2|Death|0|||
161919260|NCT03765073|584751419|FG000|Stage 2|Lost to Follow-up|0|||
161919261|NCT03765073|584751420|FG001|Stage 2|Lost to Follow-up|0|||
161919262|NCT03765073|584751421|FG002|Stage 2|Lost to Follow-up|0|||
161919263|NCT03765073|584751422|FG003|Stage 2|Lost to Follow-up|5|||
161919264|NCT03765073|584751423|FG004|Stage 2|Lost to Follow-up|1|||
161919265|NCT03765073|584751424|FG005|Stage 2|Lost to Follow-up|0|||
161919266|NCT03765073|584751425|FG006|Stage 2|Lost to Follow-up|3|||
161919267|NCT03765073|584751426|FG007|Stage 2|Lost to Follow-up|3|||
161919268|NCT03765073|584751427|FG008|Stage 2|Lost to Follow-up|1|||
161919269|NCT03765073|584751428|FG009|Stage 2|Lost to Follow-up|6|||
161919270|NCT03765073|584751429|FG010|Stage 2|Lost to Follow-up|5|||
161919271|NCT03765073|584751430|FG011|Stage 2|Lost to Follow-up|1|||
161919272|NCT03765073|584751431|FG012|Stage 2|Lost to Follow-up|1|||
161919273|NCT03765073|584751432|FG013|Stage 2|Lost to Follow-up|3|||
161919274|NCT03765073|584751433|FG014|Stage 2|Lost to Follow-up|3|||
161919275|NCT03765073|584751434|FG015|Stage 2|Lost to Follow-up|1|||
161919276|NCT03765073|584751435|FG016|Stage 2|Lost to Follow-up|6|||
161919277|NCT03765073|584751436|FG017|Stage 2|Lost to Follow-up|0|||
161919278|NCT03765073|584751437|FG018|Stage 2|Lost to Follow-up|0|||
161919279|NCT03765073|584751438|FG019|Stage 2|Lost to Follow-up|0|||
161919280|NCT03765073|584751439|FG020|Stage 2|Lost to Follow-up|0|||
161919281|NCT03765073|584751419|FG000|Stage 2|Other|0|||
161919282|NCT03765073|584751420|FG001|Stage 2|Other|0|||
161474367|NCT02635776|583130766|FG000|Overall Study|Adverse Event|51|||
161919283|NCT03765073|584751421|FG002|Stage 2|Other|0|||
161919284|NCT03765073|584751422|FG003|Stage 2|Other|0|||
161919285|NCT03765073|584751423|FG004|Stage 2|Other|0|||
161919286|NCT03765073|584751424|FG005|Stage 2|Other|0|||
161919287|NCT03765073|584751425|FG006|Stage 2|Other|0|||
161919288|NCT03765073|584751426|FG007|Stage 2|Other|1|||
161919289|NCT03765073|584751427|FG008|Stage 2|Other|1|||
161919290|NCT03765073|584751428|FG009|Stage 2|Other|3|||
161919291|NCT03765073|584751429|FG010|Stage 2|Other|0|||
161919292|NCT03765073|584751430|FG011|Stage 2|Other|0|||
161919293|NCT03765073|584751431|FG012|Stage 2|Other|0|||
161919294|NCT03765073|584751432|FG013|Stage 2|Other|0|||
161919295|NCT03765073|584751433|FG014|Stage 2|Other|0|||
161919296|NCT03765073|584751434|FG015|Stage 2|Other|1|||
161919297|NCT03765073|584751435|FG016|Stage 2|Other|2|||
161919298|NCT03765073|584751436|FG017|Stage 2|Other|0|||
161919299|NCT03765073|584751437|FG018|Stage 2|Other|0|||
161919300|NCT03765073|584751438|FG019|Stage 2|Other|0|||
161919301|NCT03765073|584751439|FG020|Stage 2|Other|0|||
161919302|NCT03765073|584751419|FG000|Stage 2|Withdrawal by parent/guardian|0|||
161919303|NCT03765073|584751420|FG001|Stage 2|Withdrawal by parent/guardian|0|||
161919304|NCT03765073|584751421|FG002|Stage 2|Withdrawal by parent/guardian|0|||
161919305|NCT03765073|584751422|FG003|Stage 2|Withdrawal by parent/guardian|0|||
161919306|NCT03765073|584751423|FG004|Stage 2|Withdrawal by parent/guardian|0|||
161919307|NCT03765073|584751424|FG005|Stage 2|Withdrawal by parent/guardian|0|||
161919308|NCT03765073|584751425|FG006|Stage 2|Withdrawal by parent/guardian|0|||
161919309|NCT03765073|584751426|FG007|Stage 2|Withdrawal by parent/guardian|0|||
161919310|NCT03765073|584751427|FG008|Stage 2|Withdrawal by parent/guardian|0|||
161919311|NCT03765073|584751428|FG009|Stage 2|Withdrawal by parent/guardian|0|||
161919312|NCT03765073|584751429|FG010|Stage 2|Withdrawal by parent/guardian|3|||
161919313|NCT03765073|584751430|FG011|Stage 2|Withdrawal by parent/guardian|3|||
161919314|NCT03765073|584751431|FG012|Stage 2|Withdrawal by parent/guardian|3|||
161919315|NCT03765073|584751432|FG013|Stage 2|Withdrawal by parent/guardian|1|||
161919316|NCT03765073|584751433|FG014|Stage 2|Withdrawal by parent/guardian|1|||
161919317|NCT03765073|584751434|FG015|Stage 2|Withdrawal by parent/guardian|0|||
161919318|NCT03765073|584751435|FG016|Stage 2|Withdrawal by parent/guardian|3|||
161919319|NCT03765073|584751436|FG017|Stage 2|Withdrawal by parent/guardian|0|||
161919320|NCT03765073|584751437|FG018|Stage 2|Withdrawal by parent/guardian|0|||
161919321|NCT03765073|584751438|FG019|Stage 2|Withdrawal by parent/guardian|0|||
161919322|NCT03765073|584751439|FG020|Stage 2|Withdrawal by parent/guardian|0|||
161919323|NCT03765073|584751419|FG000|Stage 2|Withdrawal by Subject|0|||
161919324|NCT03765073|584751420|FG001|Stage 2|Withdrawal by Subject|0|||
161919325|NCT03765073|584751421|FG002|Stage 2|Withdrawal by Subject|0|||
161919326|NCT03765073|584751422|FG003|Stage 2|Withdrawal by Subject|3|||
161919327|NCT03765073|584751423|FG004|Stage 2|Withdrawal by Subject|3|||
161919328|NCT03765073|584751424|FG005|Stage 2|Withdrawal by Subject|3|||
161919329|NCT03765073|584751425|FG006|Stage 2|Withdrawal by Subject|0|||
161919330|NCT03765073|584751426|FG007|Stage 2|Withdrawal by Subject|1|||
161919331|NCT03765073|584751427|FG008|Stage 2|Withdrawal by Subject|0|||
161919332|NCT03765073|584751428|FG009|Stage 2|Withdrawal by Subject|5|||
161919333|NCT03765073|584751429|FG010|Stage 2|Withdrawal by Subject|0|||
161919334|NCT03765073|584751430|FG011|Stage 2|Withdrawal by Subject|0|||
161919335|NCT03765073|584751431|FG012|Stage 2|Withdrawal by Subject|0|||
161919336|NCT03765073|584751432|FG013|Stage 2|Withdrawal by Subject|0|||
161919337|NCT03765073|584751433|FG014|Stage 2|Withdrawal by Subject|0|||
161919338|NCT03765073|584751434|FG015|Stage 2|Withdrawal by Subject|0|||
161919339|NCT03765073|584751435|FG016|Stage 2|Withdrawal by Subject|0|||
161919340|NCT03765073|584751436|FG017|Stage 2|Withdrawal by Subject|0|||
161919341|NCT03765073|584751437|FG018|Stage 2|Withdrawal by Subject|0|||
161919342|NCT03765073|584751438|FG019|Stage 2|Withdrawal by Subject|0|||
161919343|NCT03765073|584751439|FG020|Stage 2|Withdrawal by Subject|0|||
161919344|NCT03765073|584751419|FG000|Stage 3|Adverse Event|0|||
161919345|NCT03765073|584751420|FG001|Stage 3|Adverse Event|0|||
161919346|NCT03765073|584751421|FG002|Stage 3|Adverse Event|0|||
161919347|NCT03765073|584751422|FG003|Stage 3|Adverse Event|0|||
161919348|NCT03765073|584751423|FG004|Stage 3|Adverse Event|0|||
161919349|NCT03765073|584751424|FG005|Stage 3|Adverse Event|0|||
161919350|NCT03765073|584751425|FG006|Stage 3|Adverse Event|0|||
161919351|NCT03765073|584751426|FG007|Stage 3|Adverse Event|0|||
161919352|NCT03765073|584751427|FG008|Stage 3|Adverse Event|0|||
161919353|NCT03765073|584751428|FG009|Stage 3|Adverse Event|0|||
161919354|NCT03765073|584751429|FG010|Stage 3|Adverse Event|0|||
161919355|NCT03765073|584751430|FG011|Stage 3|Adverse Event|0|||
161919356|NCT03765073|584751431|FG012|Stage 3|Adverse Event|0|||
161919357|NCT03765073|584751432|FG013|Stage 3|Adverse Event|0|||
161919358|NCT03765073|584751433|FG014|Stage 3|Adverse Event|0|||
161919359|NCT03765073|584751434|FG015|Stage 3|Adverse Event|0|||
161919360|NCT03765073|584751435|FG016|Stage 3|Adverse Event|0|||
161919361|NCT03765073|584751436|FG017|Stage 3|Adverse Event|0|||
161919362|NCT03765073|584751437|FG018|Stage 3|Adverse Event|1|||
161919363|NCT03765073|584751438|FG019|Stage 3|Adverse Event|0|||
161919364|NCT03765073|584751439|FG020|Stage 3|Adverse Event|0|||
161919365|NCT03765073|584751419|FG000|Stage 3|Death|0|||
161919366|NCT03765073|584751420|FG001|Stage 3|Death|0|||
161919367|NCT03765073|584751421|FG002|Stage 3|Death|0|||
161919368|NCT03765073|584751422|FG003|Stage 3|Death|0|||
161919369|NCT03765073|584751423|FG004|Stage 3|Death|0|||
161919370|NCT03765073|584751424|FG005|Stage 3|Death|0|||
161919371|NCT03765073|584751425|FG006|Stage 3|Death|0|||
161919372|NCT03765073|584751426|FG007|Stage 3|Death|0|||
161919373|NCT03765073|584751427|FG008|Stage 3|Death|0|||
161919374|NCT03765073|584751428|FG009|Stage 3|Death|0|||
161919375|NCT03765073|584751429|FG010|Stage 3|Death|0|||
161919376|NCT03765073|584751430|FG011|Stage 3|Death|0|||
161919377|NCT03765073|584751431|FG012|Stage 3|Death|0|||
161919378|NCT03765073|584751432|FG013|Stage 3|Death|0|||
161919379|NCT03765073|584751433|FG014|Stage 3|Death|0|||
161919380|NCT03765073|584751434|FG015|Stage 3|Death|0|||
161919381|NCT03765073|584751435|FG016|Stage 3|Death|0|||
161814299|NCT01647828|584362995|FG006|Overall Study|Lost to Follow-up|0|||
161814300|NCT01647828|584362996|FG007|Overall Study|Lost to Follow-up|2|||
161814301|NCT01647828|584362997|FG008|Overall Study|Lost to Follow-up|0|||
161814302|NCT00115063|584363000|FG000|Overall Study|Lost to Follow-up|98|||
161814303|NCT00115063|584363001|FG001|Overall Study|Lost to Follow-up|104|||
161814304|NCT00115063|584363000|FG000|Overall Study|Death|1|||
161814305|NCT00115063|584363001|FG001|Overall Study|Death|0|||
161814306|NCT00185458|584363004|FG000|Contraception Phase|Adverse Event|37|||
161814307|NCT00185458|584363004|FG000|Contraception Phase|Lost to Follow-up|10|||
161814308|NCT00185458|584363004|FG000|Contraception Phase|Protocol Violation|2|||
161814309|NCT00185458|584363004|FG000|Contraception Phase|Physician Decision|2|||
161814310|NCT00185458|584363004|FG000|Contraception Phase|Withdrawal by Subject|7|||
161814311|NCT00185458|584363004|FG000|HRT Phase|Adverse Event|18|||
161814312|NCT00185458|584363004|FG000|HRT Phase|Lost to Follow-up|4|||
161814313|NCT00185458|584363004|FG000|HRT Phase|Protocol Violation|2|||
161814314|NCT00185458|584363004|FG000|HRT Phase|Withdrawal by Subject|3|||
161814315|NCT01750294|584363955|FG000|Overall Study|Withdrawal by Subject|1|||
161814316|NCT01750294|584363955|FG000|Overall Study|Safety Endpoint|1|||
161814317|NCT01370733|584363958|FG000|Overall Study|Withdrawal by Subject|8|||
161814318|NCT01370733|584363959|FG001|Overall Study|Withdrawal by Subject|8|||
161814319|NCT01370733|584363958|FG000|Overall Study|Lost to Follow-up|3|||
161576257|NCT01040689|583496151|FG003|Overall Study|Lost to Follow-up|0|||
161814320|NCT01370733|584363959|FG001|Overall Study|Lost to Follow-up|0|||
161814321|NCT01370733|584363958|FG000|Overall Study|Adverse Event|2|||
161814322|NCT01370733|584363959|FG001|Overall Study|Adverse Event|4|||
161814323|NCT01370733|584363958|FG000|Overall Study|Lack of Efficacy|3|||
161814324|NCT01370733|584363959|FG001|Overall Study|Lack of Efficacy|5|||
161576258|NCT01040689|583496148|FG000|Overall Study|Withdrawal by Subject|2|||
161919382|NCT03765073|584751436|FG017|Stage 3|Death|0|||
161919383|NCT03765073|584751437|FG018|Stage 3|Death|0|||
161919384|NCT03765073|584751438|FG019|Stage 3|Death|3|||
161919385|NCT03765073|584751439|FG020|Stage 3|Death|2|||
161919386|NCT03765073|584751419|FG000|Stage 3|Lost to Follow-up|0|||
161919387|NCT03765073|584751420|FG001|Stage 3|Lost to Follow-up|0|||
161919388|NCT03765073|584751421|FG002|Stage 3|Lost to Follow-up|0|||
161919389|NCT03765073|584751422|FG003|Stage 3|Lost to Follow-up|0|||
161919390|NCT03765073|584751423|FG004|Stage 3|Lost to Follow-up|0|||
161919391|NCT03765073|584751424|FG005|Stage 3|Lost to Follow-up|0|||
161919392|NCT03765073|584751425|FG006|Stage 3|Lost to Follow-up|0|||
161919393|NCT03765073|584751426|FG007|Stage 3|Lost to Follow-up|0|||
161919394|NCT03765073|584751427|FG008|Stage 3|Lost to Follow-up|0|||
161919395|NCT03765073|584751428|FG009|Stage 3|Lost to Follow-up|0|||
161919396|NCT03765073|584751429|FG010|Stage 3|Lost to Follow-up|0|||
161919397|NCT03765073|584751430|FG011|Stage 3|Lost to Follow-up|0|||
161919398|NCT03765073|584751431|FG012|Stage 3|Lost to Follow-up|0|||
161919399|NCT03765073|584751432|FG013|Stage 3|Lost to Follow-up|0|||
161919400|NCT03765073|584751433|FG014|Stage 3|Lost to Follow-up|0|||
161919401|NCT03765073|584751434|FG015|Stage 3|Lost to Follow-up|0|||
161919402|NCT03765073|584751435|FG016|Stage 3|Lost to Follow-up|0|||
161919403|NCT03765073|584751436|FG017|Stage 3|Lost to Follow-up|8|||
161919404|NCT03765073|584751437|FG018|Stage 3|Lost to Follow-up|5|||
161474368|NCT02635776|583130767|FG001|Overall Study|Adverse Event|3|||
161474369|NCT02635776|583130766|FG000|Overall Study|Withdrawal by Subject|41|||
161474370|NCT02635776|583130767|FG001|Overall Study|Withdrawal by Subject|7|||
161474371|NCT02635776|583130766|FG000|Overall Study|Lost to Follow-up|4|||
161474372|NCT02635776|583130767|FG001|Overall Study|Lost to Follow-up|0|||
161474373|NCT02635776|583130766|FG000|Overall Study|Other reasons|5|||
161474374|NCT02635776|583130767|FG001|Overall Study|Other reasons|1|||
161474375|NCT00660673|583130768|FG000|Overall Study|Adverse Event|84|||
161474376|NCT00660673|583130768|FG000|Overall Study|Lack of Efficacy|7|||
161474377|NCT00660673|583130768|FG000|Overall Study|Withdrawal by Subject|22|||
161474378|NCT00660673|583130768|FG000|Overall Study|Administrative|2|||
161474379|NCT00660673|583130768|FG000|Overall Study|Protocol Violation|2|||
161474380|NCT00579098|583130769|FG000|Overall Study|Lost to Follow-up|2|||
161474381|NCT00579098|583130770|FG001|Overall Study|Lost to Follow-up|0|||
161474382|NCT00579098|583130769|FG000|Overall Study|Adverse Event|2|||
161474383|NCT00579098|583130770|FG001|Overall Study|Adverse Event|3|||
161919405|NCT03765073|584751438|FG019|Stage 3|Lost to Follow-up|7|||
161919406|NCT03765073|584751439|FG020|Stage 3|Lost to Follow-up|4|||
161919407|NCT03765073|584751419|FG000|Stage 3|No longer meets eligibility criteria|0|||
161919408|NCT03765073|584751420|FG001|Stage 3|No longer meets eligibility criteria|0|||
161919409|NCT03765073|584751421|FG002|Stage 3|No longer meets eligibility criteria|0|||
161919410|NCT03765073|584751422|FG003|Stage 3|No longer meets eligibility criteria|0|||
161919411|NCT03765073|584751423|FG004|Stage 3|No longer meets eligibility criteria|0|||
161919412|NCT03765073|584751424|FG005|Stage 3|No longer meets eligibility criteria|0|||
161919413|NCT03765073|584751425|FG006|Stage 3|No longer meets eligibility criteria|0|||
161919414|NCT03765073|584751426|FG007|Stage 3|No longer meets eligibility criteria|0|||
161919415|NCT03765073|584751427|FG008|Stage 3|No longer meets eligibility criteria|0|||
161919416|NCT03765073|584751428|FG009|Stage 3|No longer meets eligibility criteria|0|||
161919417|NCT03765073|584751429|FG010|Stage 3|No longer meets eligibility criteria|0|||
161919418|NCT03765073|584751430|FG011|Stage 3|No longer meets eligibility criteria|0|||
161919419|NCT03765073|584751431|FG012|Stage 3|No longer meets eligibility criteria|0|||
161919420|NCT03765073|584751432|FG013|Stage 3|No longer meets eligibility criteria|0|||
161919421|NCT03765073|584751433|FG014|Stage 3|No longer meets eligibility criteria|0|||
161919422|NCT03765073|584751434|FG015|Stage 3|No longer meets eligibility criteria|0|||
161919423|NCT03765073|584751435|FG016|Stage 3|No longer meets eligibility criteria|0|||
161919424|NCT03765073|584751436|FG017|Stage 3|No longer meets eligibility criteria|0|||
161919425|NCT03765073|584751437|FG018|Stage 3|No longer meets eligibility criteria|1|||
161919426|NCT03765073|584751438|FG019|Stage 3|No longer meets eligibility criteria|0|||
161919427|NCT03765073|584751439|FG020|Stage 3|No longer meets eligibility criteria|1|||
161919428|NCT03765073|584751419|FG000|Stage 3|Other|0|||
161919429|NCT03765073|584751420|FG001|Stage 3|Other|0|||
161919430|NCT03765073|584751421|FG002|Stage 3|Other|0|||
161919431|NCT03765073|584751422|FG003|Stage 3|Other|0|||
161919432|NCT03765073|584751423|FG004|Stage 3|Other|0|||
161919433|NCT03765073|584751424|FG005|Stage 3|Other|0|||
161919434|NCT03765073|584751425|FG006|Stage 3|Other|0|||
161919435|NCT03765073|584751426|FG007|Stage 3|Other|0|||
161919436|NCT03765073|584751427|FG008|Stage 3|Other|0|||
161919437|NCT03765073|584751428|FG009|Stage 3|Other|0|||
161919438|NCT03765073|584751429|FG010|Stage 3|Other|0|||
161919439|NCT03765073|584751430|FG011|Stage 3|Other|0|||
161919440|NCT03765073|584751431|FG012|Stage 3|Other|0|||
161919441|NCT03765073|584751432|FG013|Stage 3|Other|0|||
161919442|NCT03765073|584751433|FG014|Stage 3|Other|0|||
161919443|NCT03765073|584751434|FG015|Stage 3|Other|0|||
161919444|NCT03765073|584751435|FG016|Stage 3|Other|0|||
161919445|NCT03765073|584751436|FG017|Stage 3|Other|1|||
161919446|NCT03765073|584751437|FG018|Stage 3|Other|2|||
161919447|NCT03765073|584751438|FG019|Stage 3|Other|2|||
161919448|NCT03765073|584751439|FG020|Stage 3|Other|2|||
161919449|NCT03765073|584751419|FG000|Stage 3|Withdrawal by parent/guardian|0|||
161919450|NCT03765073|584751420|FG001|Stage 3|Withdrawal by parent/guardian|0|||
161919451|NCT03765073|584751421|FG002|Stage 3|Withdrawal by parent/guardian|0|||
161919452|NCT03765073|584751422|FG003|Stage 3|Withdrawal by parent/guardian|0|||
161919453|NCT03765073|584751423|FG004|Stage 3|Withdrawal by parent/guardian|0|||
161919454|NCT03765073|584751424|FG005|Stage 3|Withdrawal by parent/guardian|0|||
161919455|NCT03765073|584751425|FG006|Stage 3|Withdrawal by parent/guardian|0|||
161919456|NCT03765073|584751426|FG007|Stage 3|Withdrawal by parent/guardian|0|||
161919457|NCT03765073|584751427|FG008|Stage 3|Withdrawal by parent/guardian|0|||
161919458|NCT03765073|584751428|FG009|Stage 3|Withdrawal by parent/guardian|0|||
161919459|NCT03765073|584751429|FG010|Stage 3|Withdrawal by parent/guardian|0|||
161919460|NCT03765073|584751430|FG011|Stage 3|Withdrawal by parent/guardian|0|||
161919461|NCT03765073|584751431|FG012|Stage 3|Withdrawal by parent/guardian|0|||
161576259|NCT01040689|583496149|FG001|Overall Study|Withdrawal by Subject|1|||
161576260|NCT01040689|583496150|FG002|Overall Study|Withdrawal by Subject|1|||
161576261|NCT01040689|583496151|FG003|Overall Study|Withdrawal by Subject|0|||
161576262|NCT01040689|583496148|FG000|Overall Study|Other reasons not listed above|0|||
161576263|NCT01040689|583496149|FG001|Overall Study|Other reasons not listed above|1|||
161576264|NCT01040689|583496150|FG002|Overall Study|Other reasons not listed above|0|||
161919462|NCT03765073|584751432|FG013|Stage 3|Withdrawal by parent/guardian|0|||
161576265|NCT01040689|583496151|FG003|Overall Study|Other reasons not listed above|0|||
161919463|NCT03765073|584751433|FG014|Stage 3|Withdrawal by parent/guardian|0|||
161576266|NCT02755805|583496154|FG000|Overall Study|Lost to Follow-up|1|||
161919464|NCT03765073|584751434|FG015|Stage 3|Withdrawal by parent/guardian|0|||
161919465|NCT03765073|584751435|FG016|Stage 3|Withdrawal by parent/guardian|0|||
161919466|NCT03765073|584751436|FG017|Stage 3|Withdrawal by parent/guardian|0|||
161919467|NCT03765073|584751437|FG018|Stage 3|Withdrawal by parent/guardian|0|||
161919468|NCT03765073|584751438|FG019|Stage 3|Withdrawal by parent/guardian|6|||
161919469|NCT03765073|584751439|FG020|Stage 3|Withdrawal by parent/guardian|9|||
161919470|NCT03765073|584751419|FG000|Stage 3|Withdrawal by Subject|0|||
161919471|NCT03765073|584751420|FG001|Stage 3|Withdrawal by Subject|0|||
161919472|NCT03765073|584751421|FG002|Stage 3|Withdrawal by Subject|0|||
161919473|NCT03765073|584751422|FG003|Stage 3|Withdrawal by Subject|0|||
161919474|NCT03765073|584751423|FG004|Stage 3|Withdrawal by Subject|0|||
161919475|NCT03765073|584751424|FG005|Stage 3|Withdrawal by Subject|0|||
161919476|NCT03765073|584751425|FG006|Stage 3|Withdrawal by Subject|0|||
161919477|NCT03765073|584751426|FG007|Stage 3|Withdrawal by Subject|0|||
161919478|NCT03765073|584751427|FG008|Stage 3|Withdrawal by Subject|0|||
161919479|NCT03765073|584751428|FG009|Stage 3|Withdrawal by Subject|0|||
161919480|NCT03765073|584751429|FG010|Stage 3|Withdrawal by Subject|0|||
161919481|NCT03765073|584751430|FG011|Stage 3|Withdrawal by Subject|0|||
161919482|NCT03765073|584751431|FG012|Stage 3|Withdrawal by Subject|0|||
161919483|NCT03765073|584751432|FG013|Stage 3|Withdrawal by Subject|0|||
161919484|NCT03765073|584751433|FG014|Stage 3|Withdrawal by Subject|0|||
161919485|NCT03765073|584751434|FG015|Stage 3|Withdrawal by Subject|0|||
161919486|NCT03765073|584751435|FG016|Stage 3|Withdrawal by Subject|0|||
161919487|NCT03765073|584751436|FG017|Stage 3|Withdrawal by Subject|8|||
161919488|NCT03765073|584751437|FG018|Stage 3|Withdrawal by Subject|11|||
161919489|NCT03765073|584751438|FG019|Stage 3|Withdrawal by Subject|0|||
161919490|NCT03765073|584751439|FG020|Stage 3|Withdrawal by Subject|0|||
161919491|NCT02802228|584751440|FG000|Overall Study|Withdrawal by Subject|2|||
161919492|NCT02802228|584751441|FG001|Overall Study|Withdrawal by Subject|0|||
161919493|NCT02802228|584751440|FG000|Overall Study|Lost to Follow-up|1|||
161919494|NCT02802228|584751441|FG001|Overall Study|Lost to Follow-up|0|||
161919495|NCT02802228|584751440|FG000|Overall Study|Adverse Event|1|||
161919496|NCT02802228|584751441|FG001|Overall Study|Adverse Event|0|||
161919497|NCT02802228|584751440|FG000|Overall Study|Physician Decision|1|||
161919498|NCT02802228|584751441|FG001|Overall Study|Physician Decision|0|||
161919499|NCT00695019|584751442|FG000|Overall Study|Withdrawal by Subject|8|||
161919500|NCT00695019|584751443|FG001|Overall Study|Withdrawal by Subject|6|||
161474384|NCT00579098|583130769|FG000|Overall Study|Withdrawal by Subject|2|||
161474385|NCT00579098|583130770|FG001|Overall Study|Withdrawal by Subject|3|||
161474386|NCT00579098|583130769|FG000|Overall Study|AF returned after ablation|3|||
161474387|NCT00579098|583130770|FG001|Overall Study|AF returned after ablation|2|||
161474388|NCT00633750|583130777|FG000|Overall Study|Adverse Event|2|||
161474389|NCT00633750|583130777|FG000|Overall Study|Withdrawal by Subject|3|||
161474390|NCT01903031|583130778|FG000|Overall Study|Not Able to Attend Clinic|1|||
161474391|NCT01903031|583130779|FG001|Overall Study|Not Able to Attend Clinic|1|||
161474392|NCT01903031|583130780|FG002|Overall Study|Not Able to Attend Clinic|0|||
161474393|NCT01903031|583130778|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
161474394|NCT01903031|583130779|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
161474395|NCT01903031|583130780|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
161474396|NCT01903031|583130778|FG000|Overall Study|Adverse Event|0|||
161474397|NCT01903031|583130779|FG001|Overall Study|Adverse Event|1|||
161474398|NCT01903031|583130780|FG002|Overall Study|Adverse Event|0|||
161474399|NCT01903031|583130778|FG000|Overall Study|Withdrawal by Subject|0|||
161474400|NCT01903031|583130779|FG001|Overall Study|Withdrawal by Subject|1|||
161474401|NCT01903031|583130780|FG002|Overall Study|Withdrawal by Subject|1|||
161474402|NCT01903031|583130778|FG000|Overall Study|Protocol Violation|0|||
161474403|NCT01903031|583130779|FG001|Overall Study|Protocol Violation|0|||
161474404|NCT01903031|583130780|FG002|Overall Study|Protocol Violation|2|||
161474405|NCT01903031|583130778|FG000|Overall Study|Lost to Follow-up|0|||
161474406|NCT01903031|583130779|FG001|Overall Study|Lost to Follow-up|0|||
161474407|NCT01903031|583130780|FG002|Overall Study|Lost to Follow-up|1|||
161474408|NCT01903031|583130778|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
161474409|NCT01903031|583130779|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
161474410|NCT01903031|583130780|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
161474411|NCT01811225|583130781|FG000|Treatment Period 1|Adverse Event|2|||
161474412|NCT01811225|583130782|FG001|Treatment Period 1|Adverse Event|3|||
161474413|NCT01811225|583130781|FG000|Treatment Period 1|Lost to Follow-up|12|||
161474414|NCT01811225|583130782|FG001|Treatment Period 1|Lost to Follow-up|8|||
161474415|NCT01811225|583130781|FG000|Treatment Period 1|transporation|1|||
161474416|NCT01811225|583130782|FG001|Treatment Period 1|transporation|0|||
161474417|NCT01811225|583130781|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
161474418|NCT01811225|583130782|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
161474419|NCT01811225|583130781|FG000|Treatment Period 2|Lost to Follow-up|1|||
161474420|NCT01811225|583130782|FG001|Treatment Period 2|Lost to Follow-up|2|||
161474421|NCT01811225|583130781|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
161474422|NCT01811225|583130782|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
161474423|NCT03000569|583130783|FG000|Overall Study|Withdrawal by Subject|1|||
161474424|NCT03000569|583130784|FG001|Overall Study|Withdrawal by Subject|0|||
161474425|NCT02298023|583130785|FG000|Overall Study|Withdrawal by Subject|1|||
161474426|NCT02298023|583130786|FG001|Overall Study|Withdrawal by Subject|0|||
161474427|NCT02298023|583130787|FG002|Overall Study|Withdrawal by Subject|0|||
161474428|NCT00492531|583130795|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
161474429|NCT00492531|583130796|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
161474430|NCT04122534|583130800|FG000|Overall Study|Lost to Follow-up|4|||
161919501|NCT00695019|584751444|FG002|Overall Study|Withdrawal by Subject|4|||
161919502|NCT00695019|584751442|FG000|Overall Study|Protocol Violation|1|||
161919503|NCT00695019|584751443|FG001|Overall Study|Protocol Violation|3|||
161919504|NCT00695019|584751444|FG002|Overall Study|Protocol Violation|1|||
161576267|NCT02755805|583496155|FG001|Overall Study|Lost to Follow-up|2|||
161576268|NCT02755805|583496154|FG000|Overall Study|Refused assessments|1|||
161576269|NCT02755805|583496155|FG001|Overall Study|Refused assessments|0|||
161576270|NCT02755805|583496154|FG000|Overall Study|Withdrawal by Subject|0|||
161576271|NCT02755805|583496155|FG001|Overall Study|Withdrawal by Subject|2|||
161576272|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
161576273|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161576274|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161576275|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161576276|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
161576277|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161576278|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161576279|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161576280|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
161576281|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161576282|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161576283|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161576284|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
161576285|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161576286|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161576287|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161576288|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
161576289|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
161576290|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
161576291|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
161576292|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
161576293|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161576294|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161576295|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161576296|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
161576297|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161576298|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161576299|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161576300|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
161576301|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161576302|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161576303|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161576304|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
161576305|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161576306|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161576307|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161576308|NCT03593213|583496158|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
161576309|NCT03593213|583496159|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161576310|NCT03593213|583496160|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161576311|NCT03593213|583496161|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161576312|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
161576313|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
161576314|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
161576315|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
161576316|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
161576317|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
161576318|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
161576319|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
161576320|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
161576321|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
161576322|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
161576323|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
161576324|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
161576325|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
161576326|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
161576327|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
161576328|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161576329|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161576330|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161576331|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
161576332|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
161576333|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
161576334|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
161576335|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
161576336|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
161576337|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
161576338|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
161576339|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
161576340|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
161576341|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
161576342|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
161576343|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
161576344|NCT03593213|583496158|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
161576345|NCT03593213|583496159|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
161576346|NCT03593213|583496160|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
161576347|NCT03593213|583496161|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
161576348|NCT03184558|583496162|FG000|Overall Study|Withdrawal by Subject|2|||
161576349|NCT03184558|583496162|FG000|Overall Study|Death|16|||
161576350|NCT03184558|583496162|FG000|Overall Study|Lost to Follow-up|2|||
161576351|NCT03184558|583496162|FG000|Overall Study|Other|9|||
161576352|NCT01831791|583496163|FG000|Overall Study|Withdrawal by Subject|10|||
161576353|NCT01190007|583496164|FG000|Overall Study|Withdrawal by Subject|4|||
161576354|NCT01190007|583496164|FG000|Overall Study|Adverse Event|8|||
161576355|NCT01190007|583496164|FG000|Overall Study|Difficulty of visit for complications|1|||
161576356|NCT01190007|583496164|FG000|Overall Study|Participant was arrested|1|||
161576357|NCT03194958|583496168|FG000|Overall Study|Death|0|||
161576358|NCT03194958|583496169|FG001|Overall Study|Death|1|||
161576359|NCT03194958|583496170|FG002|Overall Study|Death|1|||
161576360|NCT03194958|583496171|FG003|Overall Study|Death|1|||
161576361|NCT03194958|583496168|FG000|Overall Study|Withdrawal by Subject|24|||
161576362|NCT03194958|583496169|FG001|Overall Study|Withdrawal by Subject|27|||
161576363|NCT03194958|583496170|FG002|Overall Study|Withdrawal by Subject|7|||
161576364|NCT03194958|583496171|FG003|Overall Study|Withdrawal by Subject|22|||
161576365|NCT03194958|583496168|FG000|Overall Study|Lost to Follow-up|168|||
161576366|NCT03194958|583496169|FG001|Overall Study|Lost to Follow-up|196|||
161576367|NCT03194958|583496170|FG002|Overall Study|Lost to Follow-up|174|||
161576368|NCT03194958|583496171|FG003|Overall Study|Lost to Follow-up|186|||
161576369|NCT00356265|583496172|FG000|Overall Study|Withdrawal by Subject|0|||
161576370|NCT00356265|583496173|FG001|Overall Study|Withdrawal by Subject|0|||
161576371|NCT00356265|583496174|FG002|Overall Study|Withdrawal by Subject|1|||
161576372|NCT01179334|583496177|FG000|Treatment Period|Adverse Event|1|||
161576373|NCT01179334|583496178|FG001|Treatment Period|Adverse Event|0|||
161576374|NCT01179334|583496177|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
161576375|NCT01179334|583496178|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
161576376|NCT01179334|583496177|FG000|Long-term Extension (LTE) Period|Death|3|||
161576377|NCT01179334|583496178|FG001|Long-term Extension (LTE) Period|Death|0|||
161576378|NCT01179334|583496177|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
161576379|NCT01179334|583496178|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
161576380|NCT03654768|583496179|FG000|Overall Study|Adverse Event|1|||
161576381|NCT03654768|583496180|FG001|Overall Study|Adverse Event|6|||
161576382|NCT03654768|583496179|FG000|Overall Study|Loss of response|2|||
161576383|NCT03654768|583496180|FG001|Overall Study|Loss of response|2|||
161576384|NCT03654768|583496179|FG000|Overall Study|Non-compliance|0|||
161576385|NCT03654768|583496180|FG001|Overall Study|Non-compliance|1|||
161576386|NCT03654768|583496179|FG000|Overall Study|Refusal not related to toxicity|1|||
161576387|NCT03654768|583496180|FG001|Overall Study|Refusal not related to toxicity|5|||
161576388|NCT03654768|583496179|FG000|Overall Study|Did not receive protocol therapy|1|||
161576389|NCT03654768|583496180|FG001|Overall Study|Did not receive protocol therapy|1|||
161576390|NCT01152190|583496183|FG000|Overall Study|Adverse Event|2|||
161576391|NCT01152190|583496184|FG001|Overall Study|Adverse Event|4|||
161576392|NCT01152190|583496183|FG000|Overall Study|Death|1|||
161576393|NCT01152190|583496184|FG001|Overall Study|Death|0|||
161814325|NCT01370733|584363958|FG000|Overall Study|Physician Decision|0|||
161814326|NCT01370733|584363959|FG001|Overall Study|Physician Decision|2|||
161814327|NCT01370733|584363958|FG000|Overall Study|Protocol Violation|1|||
161814328|NCT01370733|584363959|FG001|Overall Study|Protocol Violation|3|||
161576394|NCT01152190|583496183|FG000|Overall Study|Protocol Violation|1|||
161576395|NCT01152190|583496184|FG001|Overall Study|Protocol Violation|1|||
161576396|NCT01152190|583496183|FG000|Overall Study|Withdrawal by Subject|1|||
161814329|NCT03676634|584363960|FG000|Overall Study|Red blood cell loss|1|||
161576397|NCT01152190|583496184|FG001|Overall Study|Withdrawal by Subject|3|||
161576398|NCT03070483|583496185|FG000|Overall Study|Lost to Follow-up|2|||
161474431|NCT01193842|583130814|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
161576399|NCT05797155|583496192|FG000|Overall Study|Lost to Follow-up|33|||
161576400|NCT05797155|583496193|FG001|Overall Study|Lost to Follow-up|12|||
161576401|NCT01390402|583496198|FG000|Overall Study|Death|1|||
161576402|NCT01390402|583496198|FG000|Overall Study|Disease Progression|4|||
161474432|NCT01193842|583130815|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
161474433|NCT01193842|583130816|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
161474434|NCT01193842|583130817|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
161474435|NCT01193842|583130818|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
161474436|NCT01193842|583130814|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
161474437|NCT01193842|583130815|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
161474438|NCT01193842|583130816|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
161474439|NCT01193842|583130817|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
161474440|NCT01193842|583130818|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
161474441|NCT01193842|583130814|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
161474442|NCT01193842|583130815|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
161474443|NCT01193842|583130816|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
161474444|NCT01193842|583130817|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
161474445|NCT01193842|583130818|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
161474446|NCT01193842|583130814|FG000|Phase II: Randomized Groups|Death|0|||
161474447|NCT01193842|583130815|FG001|Phase II: Randomized Groups|Death|0|||
161474448|NCT01193842|583130816|FG002|Phase II: Randomized Groups|Death|0|||
161474449|NCT01193842|583130817|FG003|Phase II: Randomized Groups|Death|1|||
161474450|NCT01193842|583130818|FG004|Phase II: Randomized Groups|Death|1|||
161474451|NCT01193842|583130814|FG000|Phase II: Randomized Groups|Adverse Event|0|||
161474452|NCT01193842|583130815|FG001|Phase II: Randomized Groups|Adverse Event|0|||
161474453|NCT01193842|583130816|FG002|Phase II: Randomized Groups|Adverse Event|0|||
161474454|NCT01193842|583130817|FG003|Phase II: Randomized Groups|Adverse Event|5|||
161474455|NCT01193842|583130818|FG004|Phase II: Randomized Groups|Adverse Event|3|||
161474456|NCT01193842|583130814|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
161474457|NCT01193842|583130815|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
161474458|NCT01193842|583130816|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
161474459|NCT01193842|583130817|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
161474460|NCT01193842|583130818|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
161474461|NCT01193842|583130814|FG000|Phase II: Randomized Groups|Ineligible|0|||
161474462|NCT01193842|583130815|FG001|Phase II: Randomized Groups|Ineligible|0|||
161474463|NCT01193842|583130816|FG002|Phase II: Randomized Groups|Ineligible|0|||
161474464|NCT01193842|583130817|FG003|Phase II: Randomized Groups|Ineligible|0|||
161474465|NCT01193842|583130818|FG004|Phase II: Randomized Groups|Ineligible|1|||
161474466|NCT01193842|583130814|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
161474467|NCT01193842|583130815|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
161474468|NCT01193842|583130816|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
161474469|NCT01193842|583130817|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
161576430|NCT02611037|583496202|FG000|Overall Study|Withdrawal prior to treatment|2|||
161814330|NCT03676634|584363960|FG000|Overall Study|Out-of-limit pulse|2|||
161919505|NCT00695019|584751442|FG000|Overall Study|Lack of Efficacy|0|||
161919506|NCT00695019|584751443|FG001|Overall Study|Lack of Efficacy|0|||
161919507|NCT00695019|584751444|FG002|Overall Study|Lack of Efficacy|1|||
161919508|NCT00695019|584751442|FG000|Overall Study|Various|4|||
161919509|NCT00695019|584751443|FG001|Overall Study|Various|5|||
161919510|NCT00695019|584751444|FG002|Overall Study|Various|4|||
161919511|NCT01564407|584751453|FG000|Overall Study|Lost to Follow-up|0|||
161919512|NCT01564407|584751454|FG001|Overall Study|Lost to Follow-up|1|||
161919513|NCT01564407|584751455|FG002|Overall Study|Lost to Follow-up|0|||
161919514|NCT01564407|584751456|FG003|Overall Study|Lost to Follow-up|0|||
161919515|NCT01564407|584751457|FG004|Overall Study|Lost to Follow-up|0|||
161919516|NCT01564407|584751453|FG000|Overall Study|Withdrawal by Subject|0|||
161919517|NCT01564407|584751454|FG001|Overall Study|Withdrawal by Subject|1|||
161919518|NCT01564407|584751455|FG002|Overall Study|Withdrawal by Subject|0|||
161919519|NCT01564407|584751456|FG003|Overall Study|Withdrawal by Subject|0|||
161919520|NCT01564407|584751457|FG004|Overall Study|Withdrawal by Subject|0|||
161919521|NCT01564407|584751453|FG000|Overall Study|funding lost, study ended|0|||
161919522|NCT01564407|584751454|FG001|Overall Study|funding lost, study ended|0|||
161919523|NCT01564407|584751455|FG002|Overall Study|funding lost, study ended|0|||
161919524|NCT01564407|584751456|FG003|Overall Study|funding lost, study ended|1|||
161919525|NCT01564407|584751457|FG004|Overall Study|funding lost, study ended|0|||
161919526|NCT01723774|584751459|FG000|Neoadjuvant|Ki67 > 10%|4|||
161919527|NCT01723774|584751460|FG001|Neoadjuvant|Ki67 > 10%|0|||
161919528|NCT01723774|584751461|FG002|Neoadjuvant|Ki67 > 10%|10|||
161919529|NCT01723774|584751462|FG003|Neoadjuvant|Ki67 > 10%|0|||
161474470|NCT01193842|583130818|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
161474471|NCT01313858|583132455|FG000|Overall Study|Premature Treatment Termination|251|||
161474472|NCT01313858|583132456|FG001|Overall Study|Premature Treatment Termination|219|||
161474473|NCT01313858|583132457|FG002|Overall Study|Premature Treatment Termination|191|||
161474474|NCT01313858|583132455|FG000|Overall Study|Lost to Follow-up|35|||
161474475|NCT01313858|583132456|FG001|Overall Study|Lost to Follow-up|51|||
161474476|NCT01313858|583132457|FG002|Overall Study|Lost to Follow-up|47|||
161474477|NCT03689530|583132461|FG000|Overall Study|Withdrawal by Subject|53|||
161474478|NCT03689530|583132462|FG001|Overall Study|Withdrawal by Subject|16|||
161474479|NCT01392443|583132463|FG000|Overall Study|Disease progression|30|||
161474480|NCT01392443|583132463|FG000|Overall Study|Adverse Event|24|||
161474481|NCT01392443|583132463|FG000|Overall Study|Death|7|||
161474482|NCT01392443|583132463|FG000|Overall Study|Withdrawal by Subject|5|||
161474483|NCT01392443|583132463|FG000|Overall Study|Lost to Follow-up|1|||
161474484|NCT01392443|583132463|FG000|Overall Study|Protocol Violation|1|||
161474485|NCT01977794|583132466|FG000|Overall Study|Adverse Event|2|||
161474486|NCT01977794|583132467|FG001|Overall Study|Adverse Event|2|||
161474487|NCT01977794|583132466|FG000|Overall Study|Lost to Follow-up|2|||
161474488|NCT01977794|583132467|FG001|Overall Study|Lost to Follow-up|1|||
161474489|NCT01977794|583132466|FG000|Overall Study|Protocol Violation|1|||
161474490|NCT01977794|583132467|FG001|Overall Study|Protocol Violation|0|||
161474491|NCT01977794|583132466|FG000|Overall Study|Death|1|||
161474492|NCT01977794|583132467|FG001|Overall Study|Death|1|||
161474493|NCT01977794|583132466|FG000|Overall Study|Withdrew consent|2|||
161474494|NCT01977794|583132467|FG001|Overall Study|Withdrew consent|1|||
161474495|NCT01977794|583132466|FG000|Overall Study|Other|0|||
161474496|NCT01977794|583132467|FG001|Overall Study|Other|1|||
161474497|NCT00533897|583132468|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
161474498|NCT00533897|583132469|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
161474499|NCT00533897|583132470|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
161474500|NCT00533897|583132471|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
161474501|NCT00533897|583132472|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
161474502|NCT00533897|583132473|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
161474503|NCT00533897|583132474|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
161474504|NCT00533897|583132475|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
161474505|NCT00533897|583132468|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
161474506|NCT00533897|583132469|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474507|NCT00533897|583132470|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474508|NCT00533897|583132471|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474509|NCT00533897|583132472|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474510|NCT00533897|583132473|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474511|NCT00533897|583132474|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474512|NCT00533897|583132475|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
161474513|NCT00533897|583132468|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
161474514|NCT00533897|583132469|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161474515|NCT00533897|583132470|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161474516|NCT00533897|583132471|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161919530|NCT01723774|584751459|FG000|Neoadjuvant|Withdrawal by Subject|3|||
161919531|NCT01723774|584751460|FG001|Neoadjuvant|Withdrawal by Subject|1|||
161919532|NCT01723774|584751461|FG002|Neoadjuvant|Withdrawal by Subject|0|||
161919533|NCT01723774|584751462|FG003|Neoadjuvant|Withdrawal by Subject|0|||
161919534|NCT01723774|584751459|FG000|Neoadjuvant|Disease progression|0|||
161576431|NCT02611037|583496203|FG001|Overall Study|Withdrawal prior to treatment|0|||
161576432|NCT01170026|583497359|FG000|Overall Study|Lost to Follow-up|4|||
161576433|NCT01170026|583497360|FG001|Overall Study|Lost to Follow-up|2|||
161576434|NCT03785782|583497361|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
161576435|NCT03785782|583497362|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
161576436|NCT03785782|583497361|FG000|Overall Study|Withdrawal by Subject|1|||
161576437|NCT03785782|583497362|FG001|Overall Study|Withdrawal by Subject|1|||
161576438|NCT03785782|583497361|FG000|Overall Study|insufficient image quality.|3|||
161576439|NCT03785782|583497362|FG001|Overall Study|insufficient image quality.|0|||
161576440|NCT04817670|583497363|FG000|Overall Study|Withdrawal by Subject|1|||
161576441|NCT04817670|583497364|FG001|Overall Study|Withdrawal by Subject|0|||
161576442|NCT04817670|583497365|FG002|Overall Study|Withdrawal by Subject|0|||
161576443|NCT04817670|583497366|FG003|Overall Study|Withdrawal by Subject|0|||
161576444|NCT04817670|583497367|FG004|Overall Study|Withdrawal by Subject|0|||
161576445|NCT04817670|583497363|FG000|Overall Study|Lost to Follow-up|0|||
161576446|NCT04817670|583497364|FG001|Overall Study|Lost to Follow-up|0|||
161576447|NCT04817670|583497365|FG002|Overall Study|Lost to Follow-up|1|||
161576448|NCT04817670|583497366|FG003|Overall Study|Lost to Follow-up|0|||
161576449|NCT04817670|583497367|FG004|Overall Study|Lost to Follow-up|0|||
161576450|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
161576451|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
161576452|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
161576453|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
161576454|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
161576455|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
161576456|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
161576457|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
161576458|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
161576459|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
161576460|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
161576461|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
161576462|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
161576463|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
161576464|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
161576465|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
161576466|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
161576467|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
161576468|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
161576469|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
161576470|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
161576471|NCT00304031|583497368|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
161576472|NCT00304031|583497369|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
161814331|NCT02294981|584363961|FG000|Overall Study|Lost to Follow-up|1|||
161814332|NCT00829712|584363962|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161814333|NCT00829712|584363963|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161814334|NCT01188681|584363964|FG000|Overall Study|bladder cancer|0|||
161814335|NCT01188681|584363965|FG001|Overall Study|bladder cancer|0|||
161814336|NCT01188681|584363966|FG002|Overall Study|bladder cancer|1|||
161814337|NCT01188681|584363967|FG003|Overall Study|bladder cancer|0|||
161814338|NCT01188681|584363964|FG000|Overall Study|Withdrawal by Subject|0|||
161814339|NCT01188681|584363965|FG001|Overall Study|Withdrawal by Subject|0|||
161814340|NCT01188681|584363966|FG002|Overall Study|Withdrawal by Subject|0|||
161814341|NCT01188681|584363967|FG003|Overall Study|Withdrawal by Subject|1|||
161814342|NCT00835536|584363970|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
161814343|NCT00835536|584363971|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
161814344|NCT01004510|584363977|FG000|Overall Study|Adverse Event|1|||
161814345|NCT01983969|584363980|FG000|Overall Study|Disease Progression|0|||
161814346|NCT01983969|584363981|FG001|Overall Study|Disease Progression|1|||
161814347|NCT01983969|584363982|FG002|Overall Study|Disease Progression|0|||
161814348|NCT02911025|584363983|FG000|Overall Study|Lost to Follow-up|3|||
161814349|NCT03719040|584363984|FG000|Overall Study|Withdrawal by Subject|177|||
161814350|NCT03719040|584363984|FG000|Overall Study|Lost to Follow-up|26|||
161576473|NCT00304031|583497370|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
161576474|NCT00304031|583497368|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161576475|NCT00304031|583497369|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161576476|NCT00304031|583497370|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
161814351|NCT00268203|584363985|FG000|Overall Study|Lost to Follow-up|92|||
161814352|NCT00268203|584363985|FG000|Overall Study|Withdrawal by Subject|9|||
161814353|NCT00268203|584363985|FG000|Overall Study|Received Other NHL Therapy|7|||
161814354|NCT00268203|584363985|FG000|Overall Study|Progressive Disease|359|||
161814355|NCT00268203|584363985|FG000|Overall Study|Death|84|||
161474517|NCT00533897|583132472|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161474518|NCT00533897|583132473|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161474519|NCT00533897|583132474|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161474520|NCT00533897|583132475|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
161474521|NCT00533897|583132468|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
161474522|NCT00533897|583132469|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161474523|NCT00533897|583132470|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161576477|NCT01188655|583497374|FG000|Overall Study|Lack of Efficacy|1|||
161576478|NCT01188655|583497374|FG000|Overall Study|Lost to Follow-up|1|||
161576479|NCT01188655|583497374|FG000|Overall Study|Other|11|||
161576480|NCT03762668|583497375|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
161576481|NCT03762668|583497376|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
161576482|NCT00686855|583497380|FG000|Overall Study|Lost to Follow-up|1|||
161576483|NCT00686855|583497381|FG001|Overall Study|Lost to Follow-up|0|||
161576484|NCT00686855|583497380|FG000|Overall Study|Progressive GVHD|0|||
161576485|NCT00686855|583497381|FG001|Overall Study|Progressive GVHD|1|||
161576486|NCT02731755|583497384|FG000|First Intervention|Withdrawal by Subject|0|||
161576487|NCT02731755|583497385|FG001|First Intervention|Withdrawal by Subject|2|||
161576488|NCT05876949|583497386|FG000|Overall Study|Withdrawal by Subject|1|||
161576489|NCT05876949|583497387|FG001|Overall Study|Withdrawal by Subject|3|||
161576490|NCT05876949|583497386|FG000|Overall Study|Physician Decision|0|||
161576491|NCT05876949|583497387|FG001|Overall Study|Physician Decision|2|||
161576492|NCT05876949|583497386|FG000|Overall Study|Death|0|||
161576493|NCT05876949|583497387|FG001|Overall Study|Death|1|||
161576494|NCT03718767|583497395|FG000|Overall Study|Declined to participate (before treatment started)|0|||
161576495|NCT03718767|583497396|FG001|Overall Study|Declined to participate (before treatment started)|0|||
161576496|NCT03718767|583497397|FG002|Overall Study|Declined to participate (before treatment started)|7|||
161576497|NCT03718767|583497395|FG000|Overall Study|Ineligible|0|||
161576498|NCT03718767|583497396|FG001|Overall Study|Ineligible|0|||
161576499|NCT03718767|583497397|FG002|Overall Study|Ineligible|17|||
161576500|NCT00494442|583497398|FG000|Overall Study|Death|1|||
161576501|NCT00494442|583497399|FG001|Overall Study|Death|1|||
161576502|NCT00494442|583497398|FG000|Overall Study|Lack of Efficacy|16|||
161576503|NCT00494442|583497399|FG001|Overall Study|Lack of Efficacy|10|||
161576504|NCT00494442|583497398|FG000|Overall Study|Adverse Event|0|||
161576505|NCT00494442|583497399|FG001|Overall Study|Adverse Event|2|||
161576506|NCT00494442|583497398|FG000|Overall Study|Physician Decision|0|||
161576507|NCT00494442|583497399|FG001|Overall Study|Physician Decision|1|||
161576508|NCT00494442|583497398|FG000|Overall Study|Non-compliance|0|||
161576509|NCT00494442|583497399|FG001|Overall Study|Non-compliance|1|||
161576510|NCT00494442|583497398|FG000|Overall Study|Intercurrent illness|0|||
161576511|NCT00494442|583497399|FG001|Overall Study|Intercurrent illness|1|||
161576512|NCT03691428|583497404|FG000|Overall Study|Withdrawal by Subject|6|||
161576513|NCT03691428|583497405|FG001|Overall Study|Withdrawal by Subject|8|||
161576514|NCT01460290|583497406|FG000|Overall Study|Adverse Event|3|||
161576515|NCT01460290|583497406|FG000|Overall Study|Elevated liver function|1|||
161576516|NCT01254019|583497411|FG000|Overall Study|Adverse Event|0|||
161576517|NCT01254019|583497412|FG001|Overall Study|Adverse Event|2|||
161576518|NCT01254019|583497411|FG000|Overall Study|Protocol Violation|1|||
161576519|NCT01254019|583497412|FG001|Overall Study|Protocol Violation|0|||
161576520|NCT01254019|583497411|FG000|Overall Study|Withdrawal by Subject|0|||
161576521|NCT01254019|583497412|FG001|Overall Study|Withdrawal by Subject|2|||
161576522|NCT03061474|583497413|FG000|Overall Study|Adverse Event|2|||
161576523|NCT03061474|583497414|FG001|Overall Study|Adverse Event|0|||
161576524|NCT03061474|583497413|FG000|Overall Study|Safety Risk|0|||
161576525|NCT03061474|583497414|FG001|Overall Study|Safety Risk|1|||
161576526|NCT03061474|583497413|FG000|Overall Study|Participant unwilling or unable to participate|0|||
161814356|NCT00268203|584363985|FG000|Overall Study|Reason Not Specified|34|||
161814357|NCT00268203|584363985|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
161814358|NCT04589650|584363988|FG000|Overall Study|Subject decision|6|||
161814359|NCT04589650|584363989|FG001|Overall Study|Subject decision|2|||
161814360|NCT04589650|584363990|FG002|Overall Study|Subject decision|2|||
161814361|NCT04589650|584363991|FG003|Overall Study|Subject decision|0|||
161814362|NCT04589650|584363992|FG004|Overall Study|Subject decision|0|||
161814363|NCT04589650|584363993|FG005|Overall Study|Subject decision|0|||
161814364|NCT04589650|584363988|FG000|Overall Study|Adverse Event|3|||
161814365|NCT04589650|584363989|FG001|Overall Study|Adverse Event|1|||
161474524|NCT00533897|583132471|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161474525|NCT00533897|583132472|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161576527|NCT03061474|583497414|FG001|Overall Study|Participant unwilling or unable to participate|2|||
161814366|NCT04589650|584363990|FG002|Overall Study|Adverse Event|1|||
161576528|NCT03061474|583497413|FG000|Overall Study|Lost to Follow-up|0|||
161576529|NCT03061474|583497414|FG001|Overall Study|Lost to Follow-up|1|||
161576530|NCT00845832|583497417|FG000|Treatment Period|Adverse Event|0|||
161576531|NCT00845832|583497418|FG001|Treatment Period|Adverse Event|2|||
161576532|NCT00845832|583497419|FG002|Treatment Period|Adverse Event|0|||
161576533|NCT00845832|583497417|FG000|Treatment Period|Protocol Violation|1|||
161919535|NCT01723774|584751460|FG001|Neoadjuvant|Disease progression|1|||
161919536|NCT01723774|584751461|FG002|Neoadjuvant|Disease progression|1|||
161919537|NCT01723774|584751462|FG003|Neoadjuvant|Disease progression|0|||
161919538|NCT01723774|584751459|FG000|Neoadjuvant|Adverse Event|0|||
161919539|NCT01723774|584751460|FG001|Neoadjuvant|Adverse Event|1|||
161919540|NCT01723774|584751461|FG002|Neoadjuvant|Adverse Event|2|||
161576534|NCT00845832|583497418|FG001|Treatment Period|Protocol Violation|1|||
161576535|NCT00845832|583497419|FG002|Treatment Period|Protocol Violation|0|||
161576536|NCT00845832|583497417|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
161576537|NCT00845832|583497418|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
161576538|NCT00845832|583497419|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
161576539|NCT00845832|583497417|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
161576540|NCT00845832|583497418|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
161576541|NCT00845832|583497419|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
161576542|NCT01391130|583497420|FG000|Overall Study|Withdrawal by Subject|3|||
161576543|NCT01391130|583497421|FG001|Overall Study|Withdrawal by Subject|2|||
161576544|NCT01391130|583497420|FG000|Overall Study|Physician Decision|2|||
161576545|NCT01391130|583497421|FG001|Overall Study|Physician Decision|3|||
161576546|NCT01391130|583497420|FG000|Overall Study|Did not Receive Drug|1|||
161576547|NCT01391130|583497421|FG001|Overall Study|Did not Receive Drug|1|||
161576548|NCT03520413|583497428|FG000|Overall Study|Lost to Follow-up|1|||
161576549|NCT03520413|583497429|FG001|Overall Study|Lost to Follow-up|1|||
161576550|NCT03520413|583497428|FG000|Overall Study|Withdrawal by Subject|1|||
161576551|NCT03520413|583497429|FG001|Overall Study|Withdrawal by Subject|2|||
161576552|NCT03520413|583497428|FG000|Overall Study|Death|0|||
161576553|NCT03520413|583497429|FG001|Overall Study|Death|1|||
161576554|NCT03520413|583497428|FG000|Overall Study|Physician Decision|3|||
161576555|NCT03520413|583497429|FG001|Overall Study|Physician Decision|3|||
161576556|NCT03520413|583497428|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
161576557|NCT03520413|583497429|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
161576558|NCT00869323|583497430|FG000|Maintenance Therapy|concurrent illness|1|||
161576559|NCT02880241|583497431|FG000|Overall Study|Lack of Efficacy|1|||
161576560|NCT02880241|583497432|FG001|Overall Study|Lack of Efficacy|0|||
161576561|NCT02880241|583497433|FG002|Overall Study|Lack of Efficacy|0|||
161576562|NCT02880241|583497434|FG003|Overall Study|Lack of Efficacy|0|||
161576563|NCT02880241|583497435|FG004|Overall Study|Lack of Efficacy|0|||
161576564|NCT02880241|583497436|FG005|Overall Study|Lack of Efficacy|0|||
161576565|NCT00638963|583497437|FG000|Overall Study|Withdrawal by Subject|1|||
161576566|NCT00638963|583497438|FG001|Overall Study|Withdrawal by Subject|0|||
161576567|NCT00566527|583497441|FG000|Overall Study|Reason not provided|3|||
161576568|NCT00566527|583497442|FG001|Overall Study|Reason not provided|11|||
161576569|NCT00566527|583497443|FG002|Overall Study|Reason not provided|10|||
161576570|NCT00566527|583497441|FG000|Overall Study|Adverse Event|2|||
161576571|NCT00566527|583497442|FG001|Overall Study|Adverse Event|0|||
161576572|NCT00566527|583497443|FG002|Overall Study|Adverse Event|1|||
161576573|NCT00566527|583497441|FG000|Overall Study|Physician Decision|3|||
161576574|NCT00566527|583497442|FG001|Overall Study|Physician Decision|8|||
161576575|NCT00566527|583497443|FG002|Overall Study|Physician Decision|20|||
161576576|NCT00566527|583497441|FG000|Overall Study|Lost to Follow-up|3|||
161576577|NCT00566527|583497442|FG001|Overall Study|Lost to Follow-up|4|||
161576578|NCT00566527|583497443|FG002|Overall Study|Lost to Follow-up|4|||
161576579|NCT00566527|583497441|FG000|Overall Study|Withdrawal by Subject|6|||
161576580|NCT00566527|583497442|FG001|Overall Study|Withdrawal by Subject|43|||
161576581|NCT00566527|583497443|FG002|Overall Study|Withdrawal by Subject|43|||
161576582|NCT04975308|583497444|FG000|Overall Study|Withdrawal by Subject|6|||
161576583|NCT04975308|583497445|FG001|Overall Study|Withdrawal by Subject|16|||
161576584|NCT04975308|583497446|FG002|Overall Study|Withdrawal by Subject|6|||
161576585|NCT04975308|583497444|FG000|Overall Study|Physician Decision|0|||
161576586|NCT04975308|583497445|FG001|Overall Study|Physician Decision|3|||
161576587|NCT04975308|583497446|FG002|Overall Study|Physician Decision|1|||
161576588|NCT04975308|583497444|FG000|Overall Study|Adverse Event|10|||
161576589|NCT04975308|583497445|FG001|Overall Study|Adverse Event|1|||
161576590|NCT04975308|583497446|FG002|Overall Study|Adverse Event|12|||
161576591|NCT04975308|583497444|FG000|Overall Study|On study treatment (Ongoing)|65|||
161576592|NCT04975308|583497445|FG001|Overall Study|On study treatment (Ongoing)|43|||
161576593|NCT04975308|583497446|FG002|Overall Study|On study treatment (Ongoing)|75|||
161576594|NCT04975308|583497444|FG000|Overall Study|Protocol Deviation|4|||
161576595|NCT04975308|583497445|FG001|Overall Study|Protocol Deviation|3|||
161576596|NCT04975308|583497446|FG002|Overall Study|Protocol Deviation|2|||
161576597|NCT00547118|583497452|FG000|Overall Study|Did not qualify prior to starting drug|1|||
161576598|NCT00547118|583497453|FG001|Overall Study|Did not qualify prior to starting drug|1|||
161576599|NCT00547118|583497452|FG000|Overall Study|Study suspended|7|||
161576600|NCT00547118|583497453|FG001|Overall Study|Study suspended|8|||
161576601|NCT00373529|583497455|FG000|Overall Study|Physician Decision|19|||
161576602|NCT00373529|583497455|FG000|Overall Study|Withdrawal by Subject|7|||
161919541|NCT01723774|584751462|FG003|Neoadjuvant|Adverse Event|0|||
161919542|NCT01723774|584751459|FG000|Neoadjuvant|High estradiol|0|||
161919543|NCT01723774|584751460|FG001|Neoadjuvant|High estradiol|1|||
161576603|NCT00373529|583497455|FG000|Overall Study|Adverse Event|7|||
161576604|NCT00373529|583497455|FG000|Overall Study|Treatment failure|36|||
161576605|NCT00373529|583497455|FG000|Overall Study|Disease recurrence|10|||
161576606|NCT00373529|583497455|FG000|Overall Study|Death|16|||
161576607|NCT00373529|583497455|FG000|Overall Study|Need for treatment prohibited by study|1|||
161576608|NCT00373529|583497455|FG000|Overall Study|Other|8|||
161576609|NCT00373529|583497455|FG000|Overall Study|Failed independent confirmation of AML|3|||
161576610|NCT00373529|583497455|FG000|Overall Study|Consent violation|1|||
161576611|NCT04795752|583497456|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
161576612|NCT04795752|583497457|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
161576613|NCT04795752|583497456|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
161576614|NCT04795752|583497457|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
161576615|NCT04795752|583497456|FG000|Primary Endpoint Phase|Physician Decision|2|||
161576616|NCT04795752|583497457|FG001|Primary Endpoint Phase|Physician Decision|0|||
161576617|NCT04795752|583497456|FG000|Primary Endpoint Phase|Other|4|||
161576618|NCT04795752|583497457|FG001|Primary Endpoint Phase|Other|1|||
161576619|NCT04795752|583497456|FG000|Primary Endpoint Phase|Protocol Violation|1|||
161576620|NCT04795752|583497457|FG001|Primary Endpoint Phase|Protocol Violation|0|||
161576621|NCT04795752|583497456|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
161576622|NCT04795752|583497457|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
161576623|NCT04795752|583497456|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
161576624|NCT04795752|583497457|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
161576625|NCT04795752|583497456|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
161576626|NCT04795752|583497457|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
161576627|NCT04795752|583497456|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
161576628|NCT04795752|583497457|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
161576629|NCT04795752|583497456|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
161576630|NCT04795752|583497457|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
161576631|NCT00792948|583497458|FG000|Overall Study|Adverse Event|6|||
161576632|NCT00792948|583497458|FG000|Overall Study|Death|4|||
161576633|NCT00792948|583497458|FG000|Overall Study|Withdrawal by Subject|3|||
161576634|NCT00792948|583497458|FG000|Overall Study|Ineligible|2|||
161576635|NCT00792948|583497458|FG000|Overall Study|Insurance denial - not treated|1|||
161576636|NCT00792948|583497458|FG000|Overall Study|Physician Decision|11|||
161576637|NCT00792948|583497458|FG000|Overall Study|Protocol Violation|1|||
161576638|NCT01585558|583497465|FG000|Overall Study|Withdrawal by Subject|4|||
161576639|NCT01585558|583497466|FG001|Overall Study|Withdrawal by Subject|5|||
161576640|NCT01585558|583497467|FG002|Overall Study|Withdrawal by Subject|8|||
161576641|NCT01585558|583497465|FG000|Overall Study|Lost to Follow-up|2|||
161576642|NCT01585558|583497466|FG001|Overall Study|Lost to Follow-up|0|||
161576643|NCT01585558|583497467|FG002|Overall Study|Lost to Follow-up|3|||
161576644|NCT01585558|583497465|FG000|Overall Study|Adverse Event|3|||
161576645|NCT01585558|583497466|FG001|Overall Study|Adverse Event|4|||
161576646|NCT01585558|583497467|FG002|Overall Study|Adverse Event|1|||
161576647|NCT01585558|583497465|FG000|Overall Study|Protocol Violation|4|||
161576648|NCT01585558|583497466|FG001|Overall Study|Protocol Violation|3|||
161576649|NCT01585558|583497467|FG002|Overall Study|Protocol Violation|2|||
161576650|NCT01585558|583497465|FG000|Overall Study|Lack of Efficacy|0|||
161576651|NCT01585558|583497466|FG001|Overall Study|Lack of Efficacy|0|||
161576652|NCT01585558|583497467|FG002|Overall Study|Lack of Efficacy|1|||
161576653|NCT01810263|583497472|FG000|Overall Study|Lost to Follow-up|8|||
161576654|NCT01810263|583497473|FG001|Overall Study|Lost to Follow-up|7|||
161576655|NCT00026312|583497476|FG000|Overall Study|Adverse Event|0|||
161576656|NCT00026312|583497477|FG001|Overall Study|Adverse Event|32|||
161576657|NCT00026312|583497476|FG000|Overall Study|Death|1|||
161576658|NCT00026312|583497477|FG001|Overall Study|Death|7|||
161576659|NCT00026312|583497476|FG000|Overall Study|Lack of Efficacy|19|||
161576660|NCT00026312|583497477|FG001|Overall Study|Lack of Efficacy|114|||
161576661|NCT00026312|583497476|FG000|Overall Study|Lost to Follow-up|0|||
161576662|NCT00026312|583497477|FG001|Overall Study|Lost to Follow-up|5|||
161576663|NCT00026312|583497476|FG000|Overall Study|Physician Decision|1|||
161576664|NCT00026312|583497477|FG001|Overall Study|Physician Decision|37|||
161576665|NCT00026312|583497476|FG000|Overall Study|Protocol Violation|0|||
161576666|NCT00026312|583497477|FG001|Overall Study|Protocol Violation|3|||
161576667|NCT00026312|583497476|FG000|Overall Study|Withdrawal by Subject|1|||
161576668|NCT00026312|583497477|FG001|Overall Study|Withdrawal by Subject|6|||
161576669|NCT00026312|583497476|FG000|Overall Study|Ineligible|4|||
161814367|NCT04589650|584363991|FG003|Overall Study|Adverse Event|1|||
161576670|NCT00026312|583497477|FG001|Overall Study|Ineligible|5|||
161576671|NCT00026312|583497476|FG000|Overall Study|Entry onto another COG study|0|||
161576672|NCT00026312|583497477|FG001|Overall Study|Entry onto another COG study|1|||
161576673|NCT00026312|583497476|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
161576674|NCT00026312|583497477|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
161576675|NCT01185561|583498451|FG000|Overall Study|Lost to Follow-up|0|||
161576676|NCT01185561|583498452|FG001|Overall Study|Lost to Follow-up|4|||
161576677|NCT01185561|583498451|FG000|Overall Study|Withdrawal by Subject|2|||
161814368|NCT04589650|584363992|FG004|Overall Study|Adverse Event|0|||
161576678|NCT01185561|583498452|FG001|Overall Study|Withdrawal by Subject|8|||
161576679|NCT02613871|583498453|FG000|Overall Study|Death|2|||
161576680|NCT02613871|583498453|FG000|Overall Study|Withdrew Consent|1|||
161576681|NCT02448446|583498455|FG000|Overall Study|Withdrawal by Subject|1|||
161576682|NCT02448446|583498456|FG001|Overall Study|Withdrawal by Subject|0|||
161576683|NCT00712335|583498457|FG000|Overall Study|Withdrawal by Subject|0|||
161576684|NCT00712335|583498458|FG001|Overall Study|Withdrawal by Subject|7|||
161576685|NCT00712335|583498459|FG002|Overall Study|Withdrawal by Subject|2|||
161576686|NCT00712335|583498460|FG003|Overall Study|Withdrawal by Subject|3|||
161576687|NCT00712335|583498461|FG004|Overall Study|Withdrawal by Subject|0|||
161576688|NCT00712335|583498457|FG000|Overall Study|Lost to Follow-up|2|||
161576689|NCT00712335|583498458|FG001|Overall Study|Lost to Follow-up|5|||
161576690|NCT00712335|583498459|FG002|Overall Study|Lost to Follow-up|0|||
161576691|NCT00712335|583498460|FG003|Overall Study|Lost to Follow-up|1|||
161576692|NCT00712335|583498461|FG004|Overall Study|Lost to Follow-up|0|||
161576693|NCT00712335|583498457|FG000|Overall Study|Protocol Violation|1|||
161576694|NCT00712335|583498458|FG001|Overall Study|Protocol Violation|2|||
161576695|NCT00712335|583498459|FG002|Overall Study|Protocol Violation|1|||
161576696|NCT00712335|583498460|FG003|Overall Study|Protocol Violation|0|||
161576697|NCT00712335|583498461|FG004|Overall Study|Protocol Violation|0|||
161576698|NCT00712335|583498457|FG000|Overall Study|Lack of Efficacy|0|||
161576699|NCT00712335|583498458|FG001|Overall Study|Lack of Efficacy|0|||
161576700|NCT00712335|583498459|FG002|Overall Study|Lack of Efficacy|1|||
161576701|NCT00712335|583498460|FG003|Overall Study|Lack of Efficacy|1|||
161576702|NCT00712335|583498461|FG004|Overall Study|Lack of Efficacy|0|||
161576703|NCT00712335|583498457|FG000|Overall Study|Other Reason|0|||
161576704|NCT00712335|583498458|FG001|Overall Study|Other Reason|3|||
161576705|NCT00712335|583498459|FG002|Overall Study|Other Reason|1|||
161576706|NCT00712335|583498460|FG003|Overall Study|Other Reason|0|||
161576707|NCT00712335|583498461|FG004|Overall Study|Other Reason|0|||
161576708|NCT03401112|583498462|FG000|Overall Study|Adverse Event|1|||
161576709|NCT03401112|583498463|FG001|Overall Study|Adverse Event|2|||
161576710|NCT03401112|583498464|FG002|Overall Study|Adverse Event|3|||
161576711|NCT03401112|583498465|FG003|Overall Study|Adverse Event|2|||
161576712|NCT03401112|583498466|FG004|Overall Study|Adverse Event|0|||
161576713|NCT03401112|583498462|FG000|Overall Study|Lost to Follow-up|1|||
161576714|NCT03401112|583498463|FG001|Overall Study|Lost to Follow-up|0|||
161576715|NCT03401112|583498464|FG002|Overall Study|Lost to Follow-up|0|||
161576716|NCT03401112|583498465|FG003|Overall Study|Lost to Follow-up|0|||
161576717|NCT03401112|583498466|FG004|Overall Study|Lost to Follow-up|0|||
161576718|NCT03401112|583498462|FG000|Overall Study|Noncompliance|1|||
161576719|NCT03401112|583498463|FG001|Overall Study|Noncompliance|2|||
161576720|NCT03401112|583498464|FG002|Overall Study|Noncompliance|3|||
161576721|NCT03401112|583498465|FG003|Overall Study|Noncompliance|0|||
161576722|NCT03401112|583498466|FG004|Overall Study|Noncompliance|0|||
161576723|NCT03401112|583498462|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
161576724|NCT03401112|583498463|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
161576725|NCT03401112|583498464|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
161576726|NCT03401112|583498465|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
161576727|NCT03401112|583498466|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
161576728|NCT03401112|583498462|FG000|Overall Study|Withdrawal by Subject|0|||
161576729|NCT03401112|583498463|FG001|Overall Study|Withdrawal by Subject|3|||
161576730|NCT03401112|583498464|FG002|Overall Study|Withdrawal by Subject|2|||
161576731|NCT03401112|583498465|FG003|Overall Study|Withdrawal by Subject|1|||
161576732|NCT03401112|583498466|FG004|Overall Study|Withdrawal by Subject|0|||
161576733|NCT03401112|583498462|FG000|Overall Study|Physician Decision|0|||
161576734|NCT03401112|583498463|FG001|Overall Study|Physician Decision|0|||
161576735|NCT03401112|583498464|FG002|Overall Study|Physician Decision|0|||
161576736|NCT03401112|583498465|FG003|Overall Study|Physician Decision|2|||
161576737|NCT03401112|583498466|FG004|Overall Study|Physician Decision|0|||
161576738|NCT03401112|583498462|FG000|Overall Study|Study was Terminated by Sponsor|0|||
161576739|NCT03401112|583498463|FG001|Overall Study|Study was Terminated by Sponsor|0|||
161576740|NCT03401112|583498464|FG002|Overall Study|Study was Terminated by Sponsor|0|||
161576741|NCT03401112|583498465|FG003|Overall Study|Study was Terminated by Sponsor|1|||
161576742|NCT03401112|583498466|FG004|Overall Study|Study was Terminated by Sponsor|0|||
161576743|NCT03401112|583498462|FG000|Overall Study|Day 1 Assessment not Done|1|||
161814369|NCT04589650|584363993|FG005|Overall Study|Adverse Event|1|||
161814370|NCT04589650|584363988|FG000|Overall Study|Physician Decision|1|||
161576744|NCT03401112|583498463|FG001|Overall Study|Day 1 Assessment not Done|0|||
161576745|NCT03401112|583498464|FG002|Overall Study|Day 1 Assessment not Done|0|||
161576746|NCT03401112|583498465|FG003|Overall Study|Day 1 Assessment not Done|0|||
161576747|NCT03401112|583498466|FG004|Overall Study|Day 1 Assessment not Done|0|||
161576748|NCT03401112|583498462|FG000|Overall Study|Not Dosed|0|||
161576749|NCT03401112|583498463|FG001|Overall Study|Not Dosed|0|||
161576750|NCT03401112|583498464|FG002|Overall Study|Not Dosed|1|||
161576751|NCT03401112|583498465|FG003|Overall Study|Not Dosed|0|||
161576752|NCT03401112|583498466|FG004|Overall Study|Not Dosed|0|||
161576753|NCT03401112|583498462|FG000|Overall Study|Missed Clinical Visit|0|||
161814371|NCT04589650|584363989|FG001|Overall Study|Physician Decision|1|||
161474526|NCT00533897|583132473|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161474527|NCT00533897|583132474|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161474528|NCT00533897|583132475|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161474529|NCT00533897|583132468|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
161474530|NCT00533897|583132469|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161576754|NCT03401112|583498463|FG001|Overall Study|Missed Clinical Visit|0|||
161576755|NCT03401112|583498464|FG002|Overall Study|Missed Clinical Visit|1|||
161576756|NCT03401112|583498465|FG003|Overall Study|Missed Clinical Visit|0|||
161576757|NCT03401112|583498466|FG004|Overall Study|Missed Clinical Visit|0|||
161576758|NCT03401112|583498462|FG000|Overall Study|Missed Doses|0|||
161576759|NCT03401112|583498463|FG001|Overall Study|Missed Doses|0|||
161576760|NCT03401112|583498464|FG002|Overall Study|Missed Doses|1|||
161576761|NCT03401112|583498465|FG003|Overall Study|Missed Doses|0|||
161576762|NCT03401112|583498466|FG004|Overall Study|Missed Doses|0|||
161576763|NCT01264679|583498467|FG000|Overall Study|Participation in Another Clinical Trial|1|||
161576764|NCT01264679|583498467|FG000|Overall Study|Physician Decision|1|||
161576765|NCT01264679|583498467|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
161576766|NCT01264679|583498467|FG000|Overall Study|Withdrawal by Subject|1|||
161576767|NCT03475316|583498468|FG000|6 Month Intervention|Adverse Event|2|||
161576768|NCT03475316|583498469|FG001|6 Month Intervention|Adverse Event|1|||
161576769|NCT03475316|583498468|FG000|6 Month Intervention|Withdrawal by Subject|2|||
161576770|NCT03475316|583498469|FG001|6 Month Intervention|Withdrawal by Subject|0|||
161576771|NCT03475316|583498468|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
161576772|NCT03475316|583498469|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
161576773|NCT03475316|583498468|FG000|9 Months|Study stopped due to COVID pandemic|3|||
161576774|NCT03475316|583498469|FG001|9 Months|Study stopped due to COVID pandemic|4|||
161576775|NCT00424645|583498474|FG000|Overall Study|Death|1|||
161576776|NCT00424645|583498475|FG001|Overall Study|Death|0|||
161576777|NCT02555215|583498476|FG000|Overall Study|Other|1|||
161576778|NCT02555215|583498476|FG000|Overall Study|Investigator Decision|2|||
161576779|NCT00529789|583498477|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
161576780|NCT00529789|583498477|FG000|Study Period II/III|Adverse Event|3|||
161576781|NCT00529789|583498477|FG000|Study Period II/III|Lack of Efficacy|2|||
161576782|NCT00529789|583498477|FG000|Study Period II/III|Withdrawal by Subject|1|||
161576783|NCT00529789|583498477|FG000|Study Period II/III|Protocol Violation|3|||
161576784|NCT00529789|583498477|FG000|Study Period II/III|Physician Decision|3|||
161576785|NCT00529789|583498477|FG000|Study Period II/III|Lost to Follow-up|3|||
161576786|NCT00529789|583498477|FG000|Study Period IV|Parent/Caregiver Decision|1|||
161576787|NCT00529789|583498477|FG000|Study Period IV|Adverse Event|1|||
161576788|NCT00529789|583498477|FG000|Study Period IV|Lack of Efficacy|1|||
161576789|NCT00529789|583498477|FG000|Study Period IV|Lost to Follow-up|3|||
161576790|NCT00457743|583498480|FG000|Overall Study|Adverse Event|0|||
161576791|NCT00457743|583498481|FG001|Overall Study|Adverse Event|4|||
161576792|NCT00457743|583498482|FG002|Overall Study|Adverse Event|0|||
161576793|NCT00457743|583498480|FG000|Overall Study|Lack of Efficacy|3|||
161474531|NCT00533897|583132470|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161474532|NCT00533897|583132471|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161474533|NCT00533897|583132472|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161474534|NCT00533897|583132473|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161474535|NCT00533897|583132474|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161474536|NCT00533897|583132475|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
161474537|NCT00533897|583132468|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
161474538|NCT00533897|583132469|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474539|NCT00533897|583132470|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474540|NCT00533897|583132471|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474541|NCT00533897|583132472|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474542|NCT00533897|583132473|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474543|NCT00533897|583132474|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474544|NCT00533897|583132475|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
161474545|NCT00533897|583132468|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161474546|NCT00533897|583132469|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
161474547|NCT00533897|583132470|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
161474548|NCT00533897|583132471|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161474549|NCT00533897|583132472|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161576794|NCT00457743|583498481|FG001|Overall Study|Lack of Efficacy|23|||
161576795|NCT00457743|583498482|FG002|Overall Study|Lack of Efficacy|3|||
161576796|NCT00959946|583498483|FG000|Overall Study|Adverse Event|0|||
161576797|NCT00959946|583498484|FG001|Overall Study|Adverse Event|0|||
161576798|NCT00959946|583498485|FG002|Overall Study|Adverse Event|2|||
161576799|NCT00959946|583498486|FG003|Overall Study|Adverse Event|1|||
161576800|NCT00959946|583498487|FG004|Overall Study|Adverse Event|0|||
161576801|NCT00959946|583498488|FG005|Overall Study|Adverse Event|1|||
161576802|NCT00959946|583498489|FG006|Overall Study|Adverse Event|0|||
161576803|NCT00959946|583498490|FG007|Overall Study|Adverse Event|0|||
161576804|NCT00959946|583498483|FG000|Overall Study|Death|0|||
161576805|NCT00959946|583498484|FG001|Overall Study|Death|0|||
161576806|NCT00959946|583498485|FG002|Overall Study|Death|0|||
161576807|NCT00959946|583498486|FG003|Overall Study|Death|0|||
161576808|NCT00959946|583498487|FG004|Overall Study|Death|0|||
161576809|NCT00959946|583498488|FG005|Overall Study|Death|1|||
161576810|NCT00959946|583498489|FG006|Overall Study|Death|0|||
161576811|NCT00959946|583498490|FG007|Overall Study|Death|0|||
161576812|NCT00959946|583498483|FG000|Overall Study|Disease Progression|2|||
161576813|NCT00959946|583498484|FG001|Overall Study|Disease Progression|4|||
161576814|NCT00959946|583498485|FG002|Overall Study|Disease Progression|2|||
161576815|NCT00959946|583498486|FG003|Overall Study|Disease Progression|4|||
161576816|NCT00959946|583498487|FG004|Overall Study|Disease Progression|4|||
161576817|NCT00959946|583498488|FG005|Overall Study|Disease Progression|6|||
161576818|NCT00959946|583498489|FG006|Overall Study|Disease Progression|2|||
161576819|NCT00959946|583498490|FG007|Overall Study|Disease Progression|2|||
161576820|NCT00959946|583498483|FG000|Overall Study|Withdrawal by Subject|0|||
161576821|NCT00959946|583498484|FG001|Overall Study|Withdrawal by Subject|0|||
161576822|NCT00959946|583498485|FG002|Overall Study|Withdrawal by Subject|0|||
161576823|NCT00959946|583498486|FG003|Overall Study|Withdrawal by Subject|0|||
161576824|NCT00959946|583498487|FG004|Overall Study|Withdrawal by Subject|0|||
161576825|NCT00959946|583498488|FG005|Overall Study|Withdrawal by Subject|1|||
161576826|NCT00959946|583498489|FG006|Overall Study|Withdrawal by Subject|0|||
161576827|NCT00959946|583498490|FG007|Overall Study|Withdrawal by Subject|0|||
161576828|NCT01837966|583498492|FG000|Overall Study|Withdrawal by Subject|2|||
161576829|NCT01837966|583498493|FG001|Overall Study|Withdrawal by Subject|1|||
161576830|NCT00468910|583498497|FG000|Overall Study|Lost to Follow-up|2|||
161576831|NCT00468910|583498498|FG001|Overall Study|Lost to Follow-up|1|||
161576832|NCT00468910|583498497|FG000|Overall Study|Withdrawal by Subject|2|||
161576833|NCT00468910|583498498|FG001|Overall Study|Withdrawal by Subject|1|||
161576834|NCT00468910|583498497|FG000|Overall Study|Medical Contraindication|0|||
161576835|NCT00468910|583498498|FG001|Overall Study|Medical Contraindication|1|||
161576836|NCT01909778|583498499|FG000|Overall Study|failed screening|1|||
161576837|NCT01943916|583498500|FG000|Overall Study|Technically invalid images|10|||
161576838|NCT01943916|583498500|FG000|Overall Study|Enrollment Failure|23|||
161576839|NCT01943916|583498500|FG000|Overall Study|Pilot Phase exclusion|100|||
161576840|NCT01943916|583498500|FG000|Overall Study|Quality Assurance Reader Fail|130|||
161576841|NCT01943916|583498500|FG000|Overall Study|Technical Failure|39|||
161576842|NCT01943916|583498500|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
161576843|NCT01943916|583498500|FG000|Overall Study|No Truth Panel Review|38|||
161576844|NCT01943916|583498500|FG000|Overall Study|Protocol Deviation|1|||
161576845|NCT05323734|583498501|FG000|Overall Study|Adverse Event|5|||
161576846|NCT05323734|583498502|FG001|Overall Study|Adverse Event|2|||
161576847|NCT05323734|583498501|FG000|Overall Study|Physician Decision|1|||
161576848|NCT05323734|583498502|FG001|Overall Study|Physician Decision|0|||
161576849|NCT05323734|583498501|FG000|Overall Study|Lack of Efficacy|1|||
161576850|NCT05323734|583498502|FG001|Overall Study|Lack of Efficacy|2|||
161576851|NCT05323734|583498501|FG000|Overall Study|Withdrawal by Subject|2|||
161576852|NCT05323734|583498502|FG001|Overall Study|Withdrawal by Subject|0|||
161576853|NCT05323734|583498501|FG000|Overall Study|Participant Withdrawn Due|0|||
161576854|NCT05323734|583498502|FG001|Overall Study|Participant Withdrawn Due|1|||
161576855|NCT01595321|583498503|FG000|Overall Study|Adverse Event|1|||
161576856|NCT01595321|583498504|FG001|Overall Study|Adverse Event|1|||
161576857|NCT01595321|583498505|FG002|Overall Study|Adverse Event|1|||
161576858|NCT01595321|583498503|FG000|Overall Study|Lack of Efficacy|0|||
161576859|NCT01595321|583498504|FG001|Overall Study|Lack of Efficacy|0|||
161576860|NCT01595321|583498505|FG002|Overall Study|Lack of Efficacy|4|||
161576861|NCT00834834|583498506|FG000|Overall Study|Withdrawal by Subject|4|||
161576862|NCT00834834|583498507|FG001|Overall Study|Withdrawal by Subject|3|||
161576863|NCT00841035|583498512|FG000|Phase 1 Overall Study|Physician Decision|13|||
161576864|NCT00433199|583498517|FG000|Double-Blind Period|Adverse Event|0|||
161576865|NCT00433199|583498518|FG001|Double-Blind Period|Adverse Event|25|||
161814372|NCT04589650|584363990|FG002|Overall Study|Physician Decision|0|||
161576866|NCT00433199|583498517|FG000|Double-Blind Period|Lack of Efficacy|0|||
161576867|NCT00433199|583498518|FG001|Double-Blind Period|Lack of Efficacy|2|||
161814373|NCT04589650|584363991|FG003|Overall Study|Physician Decision|0|||
161576868|NCT00433199|583498517|FG000|Double-Blind Period|Lost to Follow-up|2|||
161576869|NCT00433199|583498518|FG001|Double-Blind Period|Lost to Follow-up|5|||
161576870|NCT00433199|583498517|FG000|Double-Blind Period|Withdrawal by Subject|8|||
161814374|NCT04589650|584363992|FG004|Overall Study|Physician Decision|0|||
161576871|NCT00433199|583498518|FG001|Double-Blind Period|Withdrawal by Subject|19|||
161576872|NCT00433199|583498517|FG000|Double-Blind Period|Protocol Violation|1|||
161576873|NCT00433199|583498518|FG001|Double-Blind Period|Protocol Violation|10|||
161576874|NCT00433199|583498517|FG000|Double-Blind Period|Administrative|1|||
161576875|NCT00433199|583498518|FG001|Double-Blind Period|Administrative|5|||
161576876|NCT00433199|583498517|FG000|Open-Label Period|Adverse Event|0|||
161576877|NCT00433199|583498518|FG001|Open-Label Period|Adverse Event|19|||
161576878|NCT00433199|583498517|FG000|Open-Label Period|Lack of Efficacy|0|||
161814375|NCT04589650|584363993|FG005|Overall Study|Physician Decision|0|||
161576879|NCT00433199|583498518|FG001|Open-Label Period|Lack of Efficacy|2|||
161576880|NCT00433199|583498517|FG000|Open-Label Period|Lost to Follow-up|0|||
161576881|NCT00433199|583498518|FG001|Open-Label Period|Lost to Follow-up|3|||
161576882|NCT00433199|583498517|FG000|Open-Label Period|Withdrawal by Subject|0|||
161576883|NCT00433199|583498518|FG001|Open-Label Period|Withdrawal by Subject|7|||
161576884|NCT00433199|583498517|FG000|Open-Label Period|Protocol Violation|0|||
161576885|NCT00433199|583498518|FG001|Open-Label Period|Protocol Violation|2|||
161576886|NCT00433199|583498517|FG000|Open-Label Period|Administrative|0|||
161576887|NCT00433199|583498518|FG001|Open-Label Period|Administrative|1|||
161576888|NCT00357097|583498519|FG000|Overall Study|Did not meet inclusion criteria|5|||
161576889|NCT00357097|583498520|FG001|Overall Study|Did not meet inclusion criteria|3|||
161576890|NCT00357097|583498519|FG000|Overall Study|Adverse Event|34|||
161576891|NCT00357097|583498520|FG001|Overall Study|Adverse Event|6|||
161576892|NCT00357097|583498519|FG000|Overall Study|Withdrawal by Subject|8|||
161576893|NCT00357097|583498520|FG001|Overall Study|Withdrawal by Subject|7|||
161576894|NCT00357097|583498519|FG000|Overall Study|Non-compliance|1|||
161576895|NCT00357097|583498520|FG001|Overall Study|Non-compliance|2|||
161576896|NCT00357097|583498519|FG000|Overall Study|Lack of Efficacy|2|||
161576897|NCT00357097|583498520|FG001|Overall Study|Lack of Efficacy|8|||
161576898|NCT00357097|583498519|FG000|Overall Study|Met Exclusion Criteria|3|||
161576899|NCT00357097|583498520|FG001|Overall Study|Met Exclusion Criteria|1|||
161576900|NCT00357097|583498519|FG000|Overall Study|Other|1|||
161576901|NCT00357097|583498520|FG001|Overall Study|Other|1|||
161576902|NCT00357097|583498519|FG000|Overall Study|Increase of RLS Symptoms|0|||
161576903|NCT00357097|583498520|FG001|Overall Study|Increase of RLS Symptoms|1|||
161576904|NCT00658996|583498521|FG000|First Intervention|Positive slit lamp finding|1|||
161576905|NCT00658996|583498522|FG001|First Intervention|Positive slit lamp finding|0|||
161576906|NCT00658996|583498521|FG000|First Intervention|Lack of lenses|0|||
161576907|NCT00658996|583498522|FG001|First Intervention|Lack of lenses|1|||
161576908|NCT00658996|583498521|FG000|Crossover Period|Physician Decision|1|||
161576909|NCT00658996|583498522|FG001|Crossover Period|Physician Decision|0|||
161576910|NCT00658996|583498521|FG000|Crossover Period|Ineligible|1|||
161576911|NCT00658996|583498522|FG001|Crossover Period|Ineligible|1|||
161576912|NCT00658996|583498521|FG000|Second Intervention|Developed a stye on upper lid|1|||
161576913|NCT00658996|583498522|FG001|Second Intervention|Developed a stye on upper lid|0|||
161576914|NCT00658996|583498521|FG000|Second Intervention|Positive slit lamp finding|0|||
161576915|NCT00658996|583498522|FG001|Second Intervention|Positive slit lamp finding|1|||
161576916|NCT02994654|583498525|FG000|Overall Study|Lost to Follow-up|1|||
161576917|NCT03603717|583498532|FG000|Overall Study|Lost to Follow-up|20|||
161576918|NCT03603717|583498533|FG001|Overall Study|Lost to Follow-up|20|||
161576919|NCT03603717|583498532|FG000|Overall Study|Withdrawal by Subject|16|||
161576920|NCT03603717|583498533|FG001|Overall Study|Withdrawal by Subject|10|||
161576921|NCT00732381|583498536|FG000|Overall Study|Adverse Event|1|||
161576922|NCT00732381|583498537|FG001|Overall Study|Adverse Event|0|||
161576923|NCT00732381|583498536|FG000|Overall Study|Treatment Failure|1|||
161576924|NCT00732381|583498537|FG001|Overall Study|Treatment Failure|1|||
161576925|NCT00457691|583498538|FG000|Overall Study|Adverse Event|4|||
161576926|NCT00457691|583498539|FG001|Overall Study|Adverse Event|1|||
161576927|NCT00457691|583498538|FG000|Overall Study|Death|163|||
161576928|NCT00457691|583498539|FG001|Overall Study|Death|148|||
161576929|NCT00457691|583498538|FG000|Overall Study|Protocol Violation|1|||
161576930|NCT00457691|583498539|FG001|Overall Study|Protocol Violation|3|||
161576931|NCT00457691|583498538|FG000|Overall Study|Lost to Follow-up|23|||
161576932|NCT00457691|583498539|FG001|Overall Study|Lost to Follow-up|14|||
161576933|NCT00457691|583498538|FG000|Overall Study|Study terminated by Sponsor|1|||
161576934|NCT00457691|583498539|FG001|Overall Study|Study terminated by Sponsor|1|||
161576935|NCT00457691|583498538|FG000|Overall Study|Subject refused (reason other than AE)|14|||
161576936|NCT00457691|583498539|FG001|Overall Study|Subject refused (reason other than AE)|19|||
161576937|NCT00457691|583498538|FG000|Overall Study|Disease progression, study terminated|180|||
161576938|NCT00457691|583498539|FG001|Overall Study|Disease progression, study terminated|196|||
161576939|NCT01460446|583499690|FG000|Overall Study|Non-compliance|2|||
161576940|NCT01460446|583499691|FG001|Overall Study|Non-compliance|9|||
161576941|NCT01460446|583499690|FG000|Overall Study|Consent Withdrawn|0|||
161576942|NCT01460446|583499691|FG001|Overall Study|Consent Withdrawn|4|||
161576943|NCT01460446|583499690|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
161576944|NCT01460446|583499691|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
161576945|NCT01460446|583499690|FG000|Overall Study|Surgery/Illness|1|||
161576946|NCT01460446|583499691|FG001|Overall Study|Surgery/Illness|1|||
161576947|NCT01460446|583499690|FG000|Overall Study|Pregnancy|1|||
161576948|NCT01460446|583499691|FG001|Overall Study|Pregnancy|0|||
161576949|NCT01460446|583499690|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
161576950|NCT01460446|583499691|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
161576951|NCT00516321|583499692|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
161576952|NCT00516321|583499693|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
161576953|NCT00516321|583499694|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
161576954|NCT00516321|583499692|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
161576955|NCT00516321|583499693|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
161576956|NCT00516321|583499694|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
161576957|NCT00516321|583499692|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
161576958|NCT00516321|583499693|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
161576959|NCT00516321|583499694|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
161576960|NCT00516321|583499692|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
161576961|NCT00516321|583499693|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
161576962|NCT00516321|583499694|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
161576963|NCT00516321|583499692|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
161576964|NCT00516321|583499693|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
161576965|NCT00516321|583499694|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
161576966|NCT00516321|583499692|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
161576967|NCT00516321|583499693|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
161576968|NCT00516321|583499694|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
161576969|NCT00516321|583499692|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
161576970|NCT00516321|583499693|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
161576971|NCT00516321|583499694|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
161576972|NCT00516321|583499692|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
161576973|NCT00516321|583499693|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
161576974|NCT00516321|583499694|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
161576975|NCT00516321|583499692|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
161576976|NCT00516321|583499693|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
161576977|NCT00516321|583499694|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
161474550|NCT00533897|583132473|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161474551|NCT00533897|583132474|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161474552|NCT00533897|583132475|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161474553|NCT00533897|583132468|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474554|NCT00533897|583132469|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474555|NCT00533897|583132470|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
161474556|NCT00533897|583132471|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474557|NCT00533897|583132472|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474558|NCT00533897|583132473|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474559|NCT00533897|583132474|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474560|NCT00533897|583132475|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
161474561|NCT00533897|583132468|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474562|NCT00533897|583132469|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474563|NCT00533897|583132470|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474564|NCT00533897|583132471|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474565|NCT00533897|583132472|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474566|NCT00533897|583132473|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
161474567|NCT00533897|583132474|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474568|NCT00533897|583132475|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
161474569|NCT00533897|583132468|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474570|NCT00533897|583132469|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474571|NCT00533897|583132470|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474572|NCT00533897|583132471|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474573|NCT00533897|583132472|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474574|NCT00533897|583132473|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
161474575|NCT00533897|583132474|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474576|NCT00533897|583132475|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161474577|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
161474578|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
161474579|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
161474580|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
161474581|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
161474582|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
161474583|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
161474584|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
161474585|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Death|0|||
161474586|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Death|0|||
161474587|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Death|0|||
161474588|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Death|0|||
161474589|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Death|0|||
161474590|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Death|0|||
161576978|NCT00516321|583499692|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
161576979|NCT00516321|583499693|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
161576980|NCT00516321|583499694|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
161576981|NCT00516321|583499692|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
161576982|NCT00516321|583499693|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
161576983|NCT00516321|583499694|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
161576984|NCT00414544|583499695|FG000|Overall Study|Lost to Follow-up|14|||
161814376|NCT04589650|584363988|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161814377|NCT04589650|584363989|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161814378|NCT04589650|584363990|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161814379|NCT04589650|584363991|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161814380|NCT04589650|584363992|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161814381|NCT04589650|584363993|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161814382|NCT04589650|584363988|FG000|Overall Study|Death|0|||
161814383|NCT04589650|584363989|FG001|Overall Study|Death|0|||
161474591|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Death|1|||
161474592|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Death|3|||
161474593|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
161474594|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
161474595|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
161474596|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
161474597|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
161474598|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
161474599|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
161474600|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
161474601|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474602|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474603|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474604|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474605|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474606|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474607|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
161474608|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161474609|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Adverse Event|0|||
161474610|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Adverse Event|0|||
161474611|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Adverse Event|0|||
161474612|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Adverse Event|0|||
161474613|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Adverse Event|0|||
161474614|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Adverse Event|0|||
161474615|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Adverse Event|2|||
161474616|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Adverse Event|5|||
161474617|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Pregnancy|0|||
161474618|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Pregnancy|0|||
161474619|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Pregnancy|0|||
161474620|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Pregnancy|0|||
161474621|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Pregnancy|0|||
161474622|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Pregnancy|0|||
161474623|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Pregnancy|0|||
161474624|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Pregnancy|2|||
161576985|NCT01318382|583499697|FG000|Overall Study|Physician Decision|2|||
161576986|NCT01318382|583499697|FG000|Overall Study|Device Malfunction|10|||
161576987|NCT01318382|583499697|FG000|Overall Study|Protocol Violation|1|||
161576988|NCT01599104|583499700|FG000|Overall Study|Withdrawal by Subject|1|||
161576989|NCT01599104|583499701|FG001|Overall Study|Withdrawal by Subject|1|||
161576990|NCT01599104|583499702|FG002|Overall Study|Withdrawal by Subject|2|||
161576991|NCT01599104|583499700|FG000|Overall Study|Technical Problems|1|||
161576992|NCT01599104|583499701|FG001|Overall Study|Technical Problems|0|||
161576993|NCT01599104|583499702|FG002|Overall Study|Technical Problems|0|||
161576994|NCT01599104|583499700|FG000|Overall Study|Physician Decision|3|||
161576995|NCT01599104|583499701|FG001|Overall Study|Physician Decision|2|||
161576996|NCT01599104|583499702|FG002|Overall Study|Physician Decision|2|||
161576997|NCT01599104|583499700|FG000|Overall Study|Non-compliance with study treatment|0|||
161576998|NCT01599104|583499701|FG001|Overall Study|Non-compliance with study treatment|1|||
161576999|NCT01599104|583499702|FG002|Overall Study|Non-compliance with study treatment|0|||
161577000|NCT01599104|583499700|FG000|Overall Study|Lack of Efficacy|4|||
161577001|NCT01599104|583499701|FG001|Overall Study|Lack of Efficacy|4|||
161577002|NCT01599104|583499702|FG002|Overall Study|Lack of Efficacy|10|||
161814384|NCT04589650|584363990|FG002|Overall Study|Death|0|||
161814385|NCT04589650|584363991|FG003|Overall Study|Death|1|||
161474625|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
161474626|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
161577003|NCT01599104|583499700|FG000|Overall Study|Adverse Event|7|||
161577004|NCT01599104|583499701|FG001|Overall Study|Adverse Event|6|||
161577005|NCT01599104|583499702|FG002|Overall Study|Adverse Event|12|||
161577006|NCT00714714|583499705|FG000|Overall Study|Adverse Event|1|||
161577007|NCT01308567|583499708|FG000|Overall Study|Lost to Follow-up|2|||
161577008|NCT01308567|583499709|FG001|Overall Study|Lost to Follow-up|4|||
161577009|NCT01308567|583499710|FG002|Overall Study|Lost to Follow-up|4|||
161814386|NCT04589650|584363992|FG004|Overall Study|Death|0|||
161814387|NCT04589650|584363993|FG005|Overall Study|Death|0|||
161814388|NCT04589650|584363988|FG000|Overall Study|Guardian Decision|0|||
161814389|NCT04589650|584363989|FG001|Overall Study|Guardian Decision|0|||
161814390|NCT04589650|584363990|FG002|Overall Study|Guardian Decision|0|||
161814391|NCT04589650|584363991|FG003|Overall Study|Guardian Decision|1|||
161814392|NCT04589650|584363992|FG004|Overall Study|Guardian Decision|0|||
161814393|NCT04589650|584363993|FG005|Overall Study|Guardian Decision|0|||
161814394|NCT00950989|584363994|FG000|Overall Study|Death|0|||
161814395|NCT00950989|584363995|FG001|Overall Study|Death|0|||
161814396|NCT00950989|584363996|FG002|Overall Study|Death|1|||
161814397|NCT00950989|584363997|FG003|Overall Study|Death|0|||
161814398|NCT00950989|584363994|FG000|Overall Study|Administrative Decision|0|||
161814399|NCT00950989|584363995|FG001|Overall Study|Administrative Decision|1|||
161814400|NCT00950989|584363996|FG002|Overall Study|Administrative Decision|0|||
161814401|NCT00950989|584363997|FG003|Overall Study|Administrative Decision|0|||
161814402|NCT00950989|584363994|FG000|Overall Study|Disease Progression|0|||
161814403|NCT00950989|584363995|FG001|Overall Study|Disease Progression|0|||
161814404|NCT00950989|584363996|FG002|Overall Study|Disease Progression|1|||
161814405|NCT00950989|584363997|FG003|Overall Study|Disease Progression|0|||
161814406|NCT00950989|584363994|FG000|Overall Study|Withdrawal by Subject|2|||
161814407|NCT00950989|584363995|FG001|Overall Study|Withdrawal by Subject|1|||
161814408|NCT00950989|584363996|FG002|Overall Study|Withdrawal by Subject|0|||
161814409|NCT00950989|584363997|FG003|Overall Study|Withdrawal by Subject|0|||
161814410|NCT00950989|584363994|FG000|Overall Study|Adverse Event|2|||
161814411|NCT00950989|584363995|FG001|Overall Study|Adverse Event|1|||
161814412|NCT00950989|584363996|FG002|Overall Study|Adverse Event|1|||
161814413|NCT00950989|584363997|FG003|Overall Study|Adverse Event|0|||
161814414|NCT03804983|584363998|FG000|Overall Study|Adverse Event|0|||
161814415|NCT03804983|584363999|FG001|Overall Study|Adverse Event|1|||
161814416|NCT03804983|584363998|FG000|Overall Study|Family Obligation|1|||
161814417|NCT03804983|584363999|FG001|Overall Study|Family Obligation|0|||
161814418|NCT03600376|584364000|FG000|Overall Study|Adverse Event|1|||
161814419|NCT03600376|584364001|FG001|Overall Study|Adverse Event|1|||
161814420|NCT03600376|584364000|FG000|Overall Study|Transferred to other facility|1|||
161814421|NCT03600376|584364001|FG001|Overall Study|Transferred to other facility|0|||
161814422|NCT03600376|584364000|FG000|Overall Study|Investigator Decision|0|||
161814423|NCT03600376|584364001|FG001|Overall Study|Investigator Decision|4|||
161814424|NCT03600376|584364000|FG000|Overall Study|Determined to be ineligible for study|0|||
161814425|NCT03600376|584364001|FG001|Overall Study|Determined to be ineligible for study|1|||
161814426|NCT00796562|584364005|FG000|Overall Study|Death|49|||
161814427|NCT05655520|584364006|FG000|Overall Study|Adverse Event|2|||
161814428|NCT05655520|584364007|FG001|Overall Study|Adverse Event|3|||
161814429|NCT05655520|584364006|FG000|Overall Study|Physician Decision|2|||
161814430|NCT05655520|584364007|FG001|Overall Study|Physician Decision|0|||
161814431|NCT05655520|584364006|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161814432|NCT05655520|584364007|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161814433|NCT05655520|584364006|FG000|Overall Study|Lost to Follow-up|1|||
161814434|NCT05655520|584364007|FG001|Overall Study|Lost to Follow-up|0|||
161814435|NCT05655520|584364006|FG000|Overall Study|Withdrawal by Subject|4|||
161814436|NCT05655520|584364007|FG001|Overall Study|Withdrawal by Subject|4|||
161814437|NCT05655520|584364006|FG000|Overall Study|Study Terminated by Sponsor|61|||
161814438|NCT05655520|584364007|FG001|Overall Study|Study Terminated by Sponsor|68|||
161814439|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
161814440|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
161814441|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
161814442|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
161814443|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
161814444|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
161814445|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
161814446|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
161814447|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
161919544|NCT01723774|584751461|FG002|Neoadjuvant|High estradiol|0|||
161919545|NCT01723774|584751462|FG003|Neoadjuvant|High estradiol|0|||
161577010|NCT01078116|583499715|FG000|Overall Study|Lost to Follow-up|17|||
161814448|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
161814449|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
161814450|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
161814451|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Adverse Event|22|||
161814452|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Adverse Event|12|||
161814453|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Progression of disease|92|||
161919546|NCT04967222|584751465|FG000|Randomized|Lost to Follow-up|0|||
161474627|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
161474628|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
161474629|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
161474630|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
161474631|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
161474632|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
161474633|NCT00533897|583132468|FG000|Long Term Extension (LTE)|Other|0|||
161474634|NCT00533897|583132469|FG001|Long Term Extension (LTE)|Other|0|||
161474635|NCT00533897|583132470|FG002|Long Term Extension (LTE)|Other|0|||
161474636|NCT00533897|583132471|FG003|Long Term Extension (LTE)|Other|0|||
161474637|NCT00533897|583132472|FG004|Long Term Extension (LTE)|Other|0|||
161814454|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Progression of disease|128|||
161814455|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
161814456|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
161814457|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
161814458|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
161474638|NCT00533897|583132473|FG005|Long Term Extension (LTE)|Other|0|||
161474639|NCT00533897|583132474|FG006|Long Term Extension (LTE)|Other|1|||
161474640|NCT00533897|583132475|FG007|Long Term Extension (LTE)|Other|6|||
161814459|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Death|11|||
161814460|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Death|11|||
161814461|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Other|5|||
161814462|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Other|4|||
161474641|NCT01546207|583132478|FG000|Overall Study|Death|1|||
161474642|NCT01626456|583132479|FG000|Overall Study|Withdrawal by Subject|21|||
161474643|NCT01626456|583132480|FG001|Overall Study|Withdrawal by Subject|46|||
161474644|NCT01626456|583132479|FG000|Overall Study|Adverse Event|2|||
161474645|NCT01626456|583132480|FG001|Overall Study|Adverse Event|27|||
161474646|NCT01626456|583132479|FG000|Overall Study|Lost to Follow-up|2|||
161474647|NCT01626456|583132480|FG001|Overall Study|Lost to Follow-up|27|||
161474648|NCT01626456|583132479|FG000|Overall Study|Lack of Efficacy|6|||
161474649|NCT01626456|583132480|FG001|Overall Study|Lack of Efficacy|7|||
161474650|NCT01626456|583132479|FG000|Overall Study|Physician Decision|1|||
161474651|NCT01626456|583132480|FG001|Overall Study|Physician Decision|4|||
161474652|NCT01626456|583132479|FG000|Overall Study|Protocol Violation|1|||
161474653|NCT01626456|583132480|FG001|Overall Study|Protocol Violation|1|||
161474654|NCT01626456|583132479|FG000|Overall Study|Site Closure|2|||
161474655|NCT01626456|583132480|FG001|Overall Study|Site Closure|3|||
161474656|NCT01626456|583132479|FG000|Overall Study|Incarceration|0|||
161474657|NCT01626456|583132480|FG001|Overall Study|Incarceration|2|||
161474658|NCT00506662|583132482|FG000|Overall Study|Adverse Event|0|||
161474659|NCT00506662|583132483|FG001|Overall Study|Adverse Event|2|||
161474660|NCT00506662|583132482|FG000|Overall Study|Lack of Efficacy|1|||
161474661|NCT00506662|583132483|FG001|Overall Study|Lack of Efficacy|0|||
161474662|NCT00506662|583132482|FG000|Overall Study|Protocol Violation|2|||
161474663|NCT00506662|583132483|FG001|Overall Study|Protocol Violation|4|||
161474664|NCT00506662|583132482|FG000|Overall Study|Trial terminated|10|||
161474665|NCT00506662|583132483|FG001|Overall Study|Trial terminated|16|||
161474666|NCT00506662|583132482|FG000|Overall Study|Not recorded|4|||
161474667|NCT00506662|583132483|FG001|Overall Study|Not recorded|6|||
161474668|NCT04015336|583132484|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
161474669|NCT00491075|583132485|FG000|Overall Study|Withdrawal by Subject|1|||
161474670|NCT00491075|583132485|FG000|Overall Study|Physician Decision|1|||
161474671|NCT01603355|583132486|FG000|Overall Study|Lack of Efficacy|2|||
161474672|NCT00246753|583132487|FG000|Overall Study|Withdrawal by Subject|2|||
161474673|NCT00246753|583132487|FG000|Overall Study|Physician Decision|2|||
161474674|NCT00246753|583132487|FG000|Overall Study|Adverse Event|2|||
161474675|NCT00246753|583132487|FG000|Overall Study|Unacceptable toxicity|2|||
161474676|NCT01030536|583132490|FG000|Overall Study|Withdrawal by Subject|0|||
161474677|NCT01030536|583132491|FG001|Overall Study|Withdrawal by Subject|0|||
161474678|NCT01030536|583132492|FG002|Overall Study|Withdrawal by Subject|1|||
161474679|NCT01030536|583132493|FG003|Overall Study|Withdrawal by Subject|0|||
161814463|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
161474680|NCT01030536|583132494|FG004|Overall Study|Withdrawal by Subject|0|||
161474681|NCT01030536|583132490|FG000|Overall Study|undefined|1|||
161474682|NCT01030536|583132491|FG001|Overall Study|undefined|0|||
161474683|NCT01030536|583132492|FG002|Overall Study|undefined|1|||
161474684|NCT01030536|583132493|FG003|Overall Study|undefined|1|||
161474685|NCT01030536|583132494|FG004|Overall Study|undefined|0|||
161474686|NCT01030536|583132490|FG000|Overall Study|Adverse Event|0|||
161474687|NCT01030536|583132491|FG001|Overall Study|Adverse Event|3|||
161474688|NCT01030536|583132492|FG002|Overall Study|Adverse Event|1|||
161474689|NCT01030536|583132493|FG003|Overall Study|Adverse Event|0|||
161474690|NCT01030536|583132494|FG004|Overall Study|Adverse Event|1|||
161474691|NCT01030536|583132490|FG000|Overall Study|Progressive disease|6|||
161474692|NCT01030536|583132491|FG001|Overall Study|Progressive disease|2|||
161474693|NCT01030536|583132492|FG002|Overall Study|Progressive disease|3|||
161919547|NCT04967222|584751466|FG001|Randomized|Lost to Follow-up|1|||
161919548|NCT04967222|584751467|FG002|Randomized|Lost to Follow-up|1|||
161919549|NCT04967222|584751465|FG000|Randomized|Physician Decision|0|||
161919550|NCT04967222|584751466|FG001|Randomized|Physician Decision|0|||
161919551|NCT04967222|584751467|FG002|Randomized|Physician Decision|1|||
161919552|NCT04967222|584751465|FG000|Randomized|Withdrawal by Subject|0|||
161919553|NCT04967222|584751466|FG001|Randomized|Withdrawal by Subject|0|||
161919554|NCT04967222|584751467|FG002|Randomized|Withdrawal by Subject|2|||
161919555|NCT04967222|584751465|FG000|Randomized|abnormal finding in MRI|0|||
161919556|NCT04967222|584751466|FG001|Randomized|abnormal finding in MRI|2|||
161919557|NCT04967222|584751467|FG002|Randomized|abnormal finding in MRI|0|||
161919558|NCT02629159|584751468|FG000|Overall Study|Adverse Event|17|||
161919559|NCT02629159|584751469|FG001|Overall Study|Adverse Event|20|||
161919560|NCT02629159|584751470|FG002|Overall Study|Adverse Event|22|||
161919561|NCT02629159|584751468|FG000|Overall Study|Withdrawal by Subject|22|||
161919562|NCT02629159|584751469|FG001|Overall Study|Withdrawal by Subject|11|||
161919563|NCT02629159|584751470|FG002|Overall Study|Withdrawal by Subject|15|||
161919564|NCT02629159|584751468|FG000|Overall Study|Lost to Follow-up|7|||
161919565|NCT02629159|584751469|FG001|Overall Study|Lost to Follow-up|4|||
161919566|NCT02629159|584751470|FG002|Overall Study|Lost to Follow-up|5|||
161919567|NCT02629159|584751468|FG000|Overall Study|Lack of Efficacy|4|||
161919568|NCT02629159|584751469|FG001|Overall Study|Lack of Efficacy|0|||
161919569|NCT02629159|584751470|FG002|Overall Study|Lack of Efficacy|1|||
161919570|NCT02629159|584751468|FG000|Overall Study|Other|6|||
161919571|NCT02629159|584751469|FG001|Overall Study|Other|4|||
161919572|NCT02629159|584751470|FG002|Overall Study|Other|8|||
161919573|NCT05722015|584751472|FG000|Overall Study|Death|57|||
161919574|NCT05722015|584751473|FG001|Overall Study|Death|37|||
161919575|NCT05722015|584751472|FG000|Overall Study|Lost to Follow-up|1|||
161919576|NCT05722015|584751473|FG001|Overall Study|Lost to Follow-up|0|||
161919577|NCT05722015|584751472|FG000|Overall Study|Withdrawal by Subject|5|||
161919578|NCT05722015|584751473|FG001|Overall Study|Withdrawal by Subject|1|||
161919579|NCT05722015|584751472|FG000|Overall Study|Participants Ongoing|188|||
161919580|NCT05722015|584751473|FG001|Overall Study|Participants Ongoing|88|||
161919581|NCT01802281|584751476|FG000|Overall Study|Death|1|||
161919582|NCT01802281|584751477|FG001|Overall Study|Death|2|||
161919583|NCT01802281|584751476|FG000|Overall Study|Withdrawal by Subject|2|||
161919584|NCT01802281|584751477|FG001|Overall Study|Withdrawal by Subject|1|||
161919585|NCT01802281|584751476|FG000|Overall Study|Ineligible|5|||
161919586|NCT01802281|584751477|FG001|Overall Study|Ineligible|3|||
161919587|NCT02685735|584751478|FG000|Overall Study|Surgery Cancelled|4|||
161919588|NCT02685735|584751479|FG001|Overall Study|Surgery Cancelled|9|||
161919589|NCT02685735|584751478|FG000|Overall Study|Adverse Event|10|||
161919590|NCT02685735|584751479|FG001|Overall Study|Adverse Event|3|||
161919591|NCT02685735|584751478|FG000|Overall Study|Preop testing found to be incomplete|2|||
161919592|NCT02685735|584751479|FG001|Overall Study|Preop testing found to be incomplete|2|||
161919593|NCT02685735|584751478|FG000|Overall Study|Withdrawal by Subject|1|||
161919594|NCT02685735|584751479|FG001|Overall Study|Withdrawal by Subject|2|||
161919595|NCT02685735|584751478|FG000|Overall Study|Death|1|||
161919596|NCT02685735|584751479|FG001|Overall Study|Death|0|||
161919597|NCT05020743|584751480|FG000|Overall Study|Enrollment in Interventional Study|2|||
161919598|NCT05020743|584751481|FG001|Overall Study|Enrollment in Interventional Study|9|||
161919599|NCT05020743|584751482|FG002|Overall Study|Enrollment in Interventional Study|0|||
161919600|NCT05020743|584751480|FG000|Overall Study|Withdrawal by Subject|0|||
161919601|NCT05020743|584751481|FG001|Overall Study|Withdrawal by Subject|3|||
161919602|NCT05020743|584751482|FG002|Overall Study|Withdrawal by Subject|1|||
161919603|NCT05020743|584751480|FG000|Overall Study|Lost to Follow-up|1|||
161919604|NCT05020743|584751481|FG001|Overall Study|Lost to Follow-up|0|||
161919605|NCT05020743|584751482|FG002|Overall Study|Lost to Follow-up|0|||
161919606|NCT05020743|584751480|FG000|Overall Study|Study Termination by Sponsor|10|||
161919607|NCT05020743|584751481|FG001|Overall Study|Study Termination by Sponsor|11|||
161919608|NCT05020743|584751482|FG002|Overall Study|Study Termination by Sponsor|10|||
161919609|NCT03488524|584751483|FG000|Overall Study|Withdrawal by Subject|51|||
161919610|NCT03488524|584751483|FG000|Overall Study|Death|19|||
161919611|NCT03488524|584751483|FG000|Overall Study|Study Sponsor|11|||
161577011|NCT01078116|583499715|FG000|Overall Study|Adverse Event|5|||
161919612|NCT03488524|584751483|FG000|Overall Study|Physician Decision|4|||
161919613|NCT03488524|584751483|FG000|Overall Study|Lost to Follow-up|3|||
161919614|NCT02003924|584751484|FG000|Double-blind Phase|Lost to Follow-up|2|||
161919615|NCT02003924|584751485|FG001|Double-blind Phase|Lost to Follow-up|1|||
161919616|NCT02003924|584751486|FG002|Double-blind Phase|Lost to Follow-up|0|||
161919617|NCT02003924|584751484|FG000|Double-blind Phase|Protocol Violation|1|||
161919618|NCT02003924|584751485|FG001|Double-blind Phase|Protocol Violation|2|||
161919619|NCT02003924|584751486|FG002|Double-blind Phase|Protocol Violation|0|||
161919620|NCT02003924|584751484|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
161919621|NCT02003924|584751485|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
161919622|NCT02003924|584751486|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
161919623|NCT02003924|584751484|FG000|Double-blind Phase|Disease Progression|229|||
161474694|NCT01030536|583132493|FG003|Overall Study|Progressive disease|2|||
161474695|NCT01030536|583132494|FG004|Overall Study|Progressive disease|0|||
161474696|NCT01030536|583132490|FG000|Overall Study|Death|0|||
161474697|NCT01030536|583132491|FG001|Overall Study|Death|1|||
161474698|NCT01030536|583132492|FG002|Overall Study|Death|0|||
161474699|NCT01030536|583132493|FG003|Overall Study|Death|0|||
161474700|NCT01030536|583132494|FG004|Overall Study|Death|0|||
161474701|NCT01065597|583132495|FG000|Overall Study|Adverse Event|1|||
161474702|NCT01781975|583132496|FG000|Overall Study|Death|1|||
161474703|NCT01781975|583132497|FG001|Overall Study|Death|0|||
161474704|NCT01781975|583132496|FG000|Overall Study|Withdrawal by Subject|1|||
161474705|NCT01781975|583132497|FG001|Overall Study|Withdrawal by Subject|1|||
161474706|NCT01622231|583132498|FG000|Overall Study|Physician Decision|1|||
161474707|NCT01622231|583132498|FG000|Overall Study|Withdrawal by Subject|1|||
161474708|NCT01058655|583132500|FG000|Overall Study|Withdrawal by Subject|1|||
161474709|NCT01058655|583132501|FG001|Overall Study|Withdrawal by Subject|0|||
161474710|NCT01058655|583132502|FG002|Overall Study|Withdrawal by Subject|3|||
161919624|NCT02003924|584751485|FG001|Double-blind Phase|Disease Progression|247|||
161919625|NCT02003924|584751486|FG002|Double-blind Phase|Disease Progression|0|||
161919626|NCT02003924|584751484|FG000|Double-blind Phase|Adverse Event|120|||
161919627|NCT02003924|584751485|FG001|Double-blind Phase|Adverse Event|31|||
161474711|NCT01058655|583132503|FG003|Overall Study|Withdrawal by Subject|4|||
161474712|NCT01058655|583132500|FG000|Overall Study|Prolonged Treatment Delay|0|||
161474713|NCT01058655|583132501|FG001|Overall Study|Prolonged Treatment Delay|0|||
161474714|NCT01058655|583132502|FG002|Overall Study|Prolonged Treatment Delay|0|||
161474715|NCT01058655|583132503|FG003|Overall Study|Prolonged Treatment Delay|2|||
161474716|NCT01058655|583132500|FG000|Overall Study|Symptomatic Deterioration|0|||
161474717|NCT01058655|583132501|FG001|Overall Study|Symptomatic Deterioration|0|||
161474718|NCT01058655|583132502|FG002|Overall Study|Symptomatic Deterioration|0|||
161474719|NCT01058655|583132503|FG003|Overall Study|Symptomatic Deterioration|1|||
161474720|NCT01058655|583132500|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
161474721|NCT01058655|583132501|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
161474722|NCT01058655|583132502|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
161474723|NCT01058655|583132503|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
161474724|NCT01058655|583132500|FG000|Overall Study|Death|0|||
161474725|NCT01058655|583132501|FG001|Overall Study|Death|1|||
161474726|NCT01058655|583132502|FG002|Overall Study|Death|1|||
161474727|NCT01058655|583132503|FG003|Overall Study|Death|0|||
161474728|NCT01058655|583132500|FG000|Overall Study|Disease Progression|1|||
161474729|NCT01058655|583132501|FG001|Overall Study|Disease Progression|2|||
161474730|NCT01058655|583132502|FG002|Overall Study|Disease Progression|4|||
161474731|NCT01058655|583132503|FG003|Overall Study|Disease Progression|24|||
161474732|NCT01058655|583132500|FG000|Overall Study|Other|0|||
161474733|NCT01058655|583132501|FG001|Overall Study|Other|0|||
161474734|NCT01058655|583132502|FG002|Overall Study|Other|0|||
161474735|NCT01058655|583132503|FG003|Overall Study|Other|4|||
161474736|NCT04545060|583132504|FG000|Overall Study|Adverse Event|0|||
161474737|NCT04545060|583132505|FG001|Overall Study|Adverse Event|1|||
161474738|NCT04545060|583132504|FG000|Overall Study|Death|0|||
161474739|NCT04545060|583132505|FG001|Overall Study|Death|5|||
161474740|NCT04545060|583132504|FG000|Overall Study|Lost to Follow-up|10|||
161474741|NCT04545060|583132505|FG001|Overall Study|Lost to Follow-up|13|||
161474742|NCT04545060|583132504|FG000|Overall Study|Physician Decision|3|||
161474743|NCT04545060|583132505|FG001|Overall Study|Physician Decision|0|||
161474744|NCT04545060|583132504|FG000|Overall Study|Withdrawal by Subject|17|||
161474745|NCT04545060|583132505|FG001|Overall Study|Withdrawal by Subject|22|||
161474746|NCT00619177|583132506|FG000|Overall Study|Adverse Event|18|||
161474747|NCT00619177|583132506|FG000|Overall Study|Lost to Follow-up|2|||
161474748|NCT00619177|583132506|FG000|Overall Study|Lack of Efficacy|1|||
161474749|NCT00619177|583132506|FG000|Overall Study|Missing termination information|481|||
161474750|NCT00619177|583132506|FG000|Overall Study|Not specified reasons|6|||
161474751|NCT01281137|583132511|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
161474752|NCT01281137|583132512|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
161474753|NCT01281137|583132511|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
161474754|NCT01281137|583132512|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
161474755|NCT01281137|583132511|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
161474756|NCT01281137|583132512|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
161474757|NCT01281137|583132511|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
161474758|NCT01281137|583132512|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
161474759|NCT01281137|583132511|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
161474760|NCT01281137|583132512|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
161919628|NCT02003924|584751486|FG002|Double-blind Phase|Adverse Event|0|||
161474761|NCT00788073|583132515|FG000|STX209 Then Placebo|Adverse Event|1|||
161474762|NCT00788073|583132516|FG001|STX209 Then Placebo|Adverse Event|0|||
161474763|NCT00788073|583132515|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
161474764|NCT00788073|583132516|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
161474765|NCT00788073|583132515|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
161919629|NCT02003924|584751484|FG000|Double-blind Phase|Randomized But not Treated|3|||
161919630|NCT02003924|584751485|FG001|Double-blind Phase|Randomized But not Treated|3|||
161474766|NCT00788073|583132516|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
161474767|NCT00788073|583132515|FG000|STX209 Then Placebo|unable to return due to travel|0|||
161919631|NCT02003924|584751486|FG002|Double-blind Phase|Randomized But not Treated|0|||
161919632|NCT02003924|584751484|FG000|Double-blind Phase|Other|29|||
161919633|NCT02003924|584751485|FG001|Double-blind Phase|Other|50|||
161919634|NCT02003924|584751486|FG002|Double-blind Phase|Other|0|||
161919635|NCT02003924|584751484|FG000|Open-label Phase|Lost to Follow-up|0|||
161919636|NCT02003924|584751485|FG001|Open-label Phase|Lost to Follow-up|0|||
161919637|NCT02003924|584751486|FG002|Open-label Phase|Lost to Follow-up|1|||
161919638|NCT02003924|584751484|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
161919639|NCT02003924|584751485|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
161919640|NCT02003924|584751486|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
161919641|NCT02003924|584751484|FG000|Open-label Phase|Disease Progression|59|||
161919642|NCT02003924|584751485|FG001|Open-label Phase|Disease Progression|0|||
161919643|NCT02003924|584751486|FG002|Open-label Phase|Disease Progression|5|||
161919644|NCT02003924|584751484|FG000|Open-label Phase|Adverse Event|25|||
161919645|NCT02003924|584751485|FG001|Open-label Phase|Adverse Event|0|||
161919646|NCT02003924|584751486|FG002|Open-label Phase|Adverse Event|10|||
161919647|NCT02003924|584751484|FG000|Open-label Phase|Other|7|||
161919648|NCT02003924|584751485|FG001|Open-label Phase|Other|0|||
161919649|NCT02003924|584751486|FG002|Open-label Phase|Other|0|||
161919650|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Death|288|||
161919651|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Death|174|||
161919652|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Death|4|||
161919653|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
161919654|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
161919655|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
161919656|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
161919657|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
161919658|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
161919659|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Other|5|||
161919660|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Other|2|||
161919661|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Other|1|||
161919662|NCT00315445|584751487|FG000|Overall Study|Adverse Event|7|||
161919663|NCT00315445|584751488|FG001|Overall Study|Adverse Event|12|||
161919664|NCT00315445|584751489|FG002|Overall Study|Adverse Event|15|||
161919665|NCT00315445|584751487|FG000|Overall Study|Lack of Efficacy|16|||
161919666|NCT00315445|584751488|FG001|Overall Study|Lack of Efficacy|1|||
161919667|NCT00315445|584751489|FG002|Overall Study|Lack of Efficacy|7|||
161919668|NCT00315445|584751487|FG000|Overall Study|Lost to Follow-up|1|||
161919669|NCT00315445|584751488|FG001|Overall Study|Lost to Follow-up|0|||
161919670|NCT00315445|584751489|FG002|Overall Study|Lost to Follow-up|1|||
161919671|NCT00315445|584751487|FG000|Overall Study|Protocol Violation|2|||
161919672|NCT00315445|584751488|FG001|Overall Study|Protocol Violation|0|||
161919673|NCT00315445|584751489|FG002|Overall Study|Protocol Violation|1|||
161919674|NCT00315445|584751487|FG000|Overall Study|Other|1|||
161919675|NCT00315445|584751488|FG001|Overall Study|Other|3|||
161474768|NCT00788073|583132516|FG001|STX209 Then Placebo|unable to return due to travel|1|||
161474769|NCT00788073|583132515|FG000|Placebo Then STX209|Adverse Event|2|||
161474770|NCT00788073|583132516|FG001|Placebo Then STX209|Adverse Event|0|||
161474771|NCT00788073|583132515|FG000|Placebo Then STX209|Protocol Violation|0|||
161474772|NCT00788073|583132516|FG001|Placebo Then STX209|Protocol Violation|1|||
161474773|NCT03608254|583132517|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
161919676|NCT00315445|584751489|FG002|Overall Study|Other|0|||
161919677|NCT01299909|584751490|FG000|Overall Study|Lost to Follow-up|22|||
161919678|NCT01299909|584751491|FG001|Overall Study|Lost to Follow-up|18|||
161919679|NCT01299909|584751492|FG002|Overall Study|Lost to Follow-up|17|||
161919680|NCT01811238|584751493|FG000|Overall Study|Withdrawal by Subject|42|||
161919681|NCT01811238|584751493|FG000|Overall Study|Adverse Event|25|||
161474774|NCT03608254|583132517|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
161474775|NCT00910273|583132518|FG000|Overall Study|Lack of Efficacy|6|||
161919682|NCT01811238|584751493|FG000|Overall Study|Protocol Violation|4|||
161919683|NCT01811238|584751493|FG000|Overall Study|Lack of Efficacy|4|||
161919684|NCT01811238|584751493|FG000|Overall Study|subject refused study medication|6|||
161919685|NCT01155570|584751494|FG000|Overall Study|Adverse Event|39|||
161919686|NCT01155570|584751494|FG000|Overall Study|Lack of Efficacy|46|||
161919687|NCT01155570|584751494|FG000|Overall Study|Participant's Economic Reasons|17|||
161919688|NCT01155570|584751494|FG000|Overall Study|No Hospital Visits|7|||
161919689|NCT01155570|584751494|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
161474776|NCT00910273|583132519|FG001|Overall Study|Lack of Efficacy|9|||
161474777|NCT00910273|583132518|FG000|Overall Study|Adverse Event|1|||
161474778|NCT00910273|583132519|FG001|Overall Study|Adverse Event|1|||
161474779|NCT00910273|583132518|FG000|Overall Study|Withdrawal by Subject|1|||
161474780|NCT00910273|583132519|FG001|Overall Study|Withdrawal by Subject|0|||
161474781|NCT00910273|583132518|FG000|Overall Study|Discontinuation of study by sponsor|8|||
161474782|NCT00910273|583132519|FG001|Overall Study|Discontinuation of study by sponsor|2|||
161474783|NCT00910273|583132518|FG000|Overall Study|Protocol Violation|1|||
161474784|NCT00910273|583132519|FG001|Overall Study|Protocol Violation|0|||
161474785|NCT00910273|583132518|FG000|Overall Study|Lost to Follow-up|1|||
161474786|NCT00910273|583132519|FG001|Overall Study|Lost to Follow-up|1|||
161474787|NCT03540030|583132520|FG000|Overall Study|Withdrawal by Subject|2|||
161474788|NCT03540030|583132521|FG001|Overall Study|Withdrawal by Subject|1|||
161814464|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
161814465|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
161814466|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
161814467|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
161814468|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
161814469|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
161814470|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
161814471|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
161814472|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
161814473|NCT01229150|584364013|FG000|Overall Study|Toxicity|2|||
161814474|NCT01229150|584364014|FG001|Overall Study|Toxicity|2|||
161814475|NCT01229150|584364015|FG002|Overall Study|Toxicity|0|||
161814476|NCT01229150|584364016|FG003|Overall Study|Toxicity|0|||
161814477|NCT05248204|584364017|FG000|Overall Study|Lost to Follow-up|13|||
161814478|NCT05248204|584364018|FG001|Overall Study|Lost to Follow-up|13|||
161814479|NCT05248204|584364017|FG000|Overall Study|Protocol Violation|1|||
161814480|NCT05248204|584364018|FG001|Overall Study|Protocol Violation|0|||
161814481|NCT03100344|584364019|FG000|Overall Study|Adverse Event|0|||
161814482|NCT03100344|584364020|FG001|Overall Study|Adverse Event|3|||
161814483|NCT03100344|584364021|FG002|Overall Study|Adverse Event|2|||
161814484|NCT03100344|584364022|FG003|Overall Study|Adverse Event|3|||
161814485|NCT03100344|584364019|FG000|Overall Study|Lack of Efficacy|2|||
161814486|NCT03100344|584364020|FG001|Overall Study|Lack of Efficacy|0|||
161814487|NCT03100344|584364021|FG002|Overall Study|Lack of Efficacy|0|||
161814488|NCT03100344|584364022|FG003|Overall Study|Lack of Efficacy|0|||
161814489|NCT03100344|584364019|FG000|Overall Study|Protocol Violation|1|||
161814490|NCT03100344|584364020|FG001|Overall Study|Protocol Violation|0|||
161814491|NCT03100344|584364021|FG002|Overall Study|Protocol Violation|0|||
161814492|NCT03100344|584364022|FG003|Overall Study|Protocol Violation|0|||
161814493|NCT03100344|584364019|FG000|Overall Study|Withdrawal by Subject|10|||
161814494|NCT03100344|584364020|FG001|Overall Study|Withdrawal by Subject|7|||
161814495|NCT03100344|584364021|FG002|Overall Study|Withdrawal by Subject|4|||
161814496|NCT03100344|584364022|FG003|Overall Study|Withdrawal by Subject|8|||
161814497|NCT03100344|584364019|FG000|Overall Study|Lost to Follow-up|1|||
161814498|NCT03100344|584364020|FG001|Overall Study|Lost to Follow-up|1|||
161814499|NCT03100344|584364021|FG002|Overall Study|Lost to Follow-up|1|||
161814500|NCT03100344|584364022|FG003|Overall Study|Lost to Follow-up|1|||
161814501|NCT01010503|584364023|FG000|Overall Study|Adverse Event|1|||
161814502|NCT01010503|584364023|FG000|Overall Study|Death|1|||
161814503|NCT06336356|584364024|FG000|Overall Study|Withdrawal by Subject|1|||
161814504|NCT06336356|584364025|FG001|Overall Study|Withdrawal by Subject|0|||
161814505|NCT06336356|584364024|FG000|Overall Study|Lost to Follow Up|1|||
161814506|NCT06336356|584364025|FG001|Overall Study|Lost to Follow Up|0|||
161814507|NCT04827394|584364030|FG000|Overall Study|Physician Decision|0|||
161814508|NCT04827394|584364031|FG001|Overall Study|Physician Decision|2|||
161814509|NCT01154231|584364032|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
161814510|NCT01154231|584364032|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
161814511|NCT06041256|584364033|FG000|Overall Study|Withdrawal by Subject|1|||
161814512|NCT06041256|584364034|FG001|Overall Study|Withdrawal by Subject|0|||
161814513|NCT06041256|584364035|FG002|Overall Study|Withdrawal by Subject|3|||
161814514|NCT06041256|584364036|FG003|Overall Study|Withdrawal by Subject|1|||
161814515|NCT06041256|584364037|FG004|Overall Study|Withdrawal by Subject|1|||
161814516|NCT06041256|584364033|FG000|Overall Study|Rescue|17|||
161814517|NCT06041256|584364034|FG001|Overall Study|Rescue|6|||
161814518|NCT06041256|584364035|FG002|Overall Study|Rescue|9|||
161814519|NCT06041256|584364036|FG003|Overall Study|Rescue|6|||
161474789|NCT03540030|583132520|FG000|Overall Study|screen fail|7|||
161474790|NCT03540030|583132521|FG001|Overall Study|screen fail|1|||
161474791|NCT03540030|583132520|FG000|Overall Study|never had surgery after signing consent|9|||
161814520|NCT06041256|584364037|FG004|Overall Study|Rescue|2|||
161814521|NCT01963728|584364038|FG000|Overall Study|Study terminated early|0|||
161814522|NCT01963728|584364039|FG001|Overall Study|Study terminated early|1|||
161814523|NCT03578809|584365317|FG000|Overall Study|Death|0|||
161814524|NCT03578809|584365318|FG001|Overall Study|Death|2|||
161814525|NCT03578809|584365319|FG002|Overall Study|Death|0|||
161919690|NCT01155570|584751494|FG000|Overall Study|Adverse Event + Other Reasons|7|||
161919691|NCT01155570|584751494|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
161919692|NCT01155570|584751494|FG000|Overall Study|Other Reasons|23|||
161919693|NCT01922934|584751495|FG000|Eligible Patients|Death|0|||
161919694|NCT01922934|584751496|FG001|Eligible Patients|Death|7|||
161919695|NCT01922934|584751495|FG000|Eligible Patients|Physician Decision|17|||
161919696|NCT01922934|584751496|FG001|Eligible Patients|Physician Decision|0|||
161919697|NCT01922934|584751495|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
161919698|NCT01922934|584751496|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
161919699|NCT01922934|584751495|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
161919700|NCT01922934|584751496|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
161919701|NCT01922934|584751495|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
161919702|NCT01922934|584751496|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
161919703|NCT01922934|584751495|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
161919704|NCT01922934|584751496|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
161919705|NCT02774889|584751499|FG000|Overall Study|Lost to Follow-up|2|||
161919706|NCT02774889|584751500|FG001|Overall Study|Lost to Follow-up|1|||
161919707|NCT00724945|584751501|FG000|Period 1|non-compliance|1|||
161919708|NCT00724945|584751502|FG001|Period 1|non-compliance|0|||
161919709|NCT00724945|584751501|FG000|Period 1|Adverse Event|1|||
161919710|NCT00724945|584751502|FG001|Period 1|Adverse Event|1|||
161919711|NCT00724945|584751501|FG000|Period 1|Lost to Follow-up|1|||
161919712|NCT00724945|584751502|FG001|Period 1|Lost to Follow-up|0|||
161919713|NCT00724945|584751501|FG000|Period 2|lens comfort issue|3|||
161919714|NCT00724945|584751502|FG001|Period 2|lens comfort issue|0|||
161919715|NCT00724945|584751501|FG000|Period 2|lens physiology issue|1|||
161919716|NCT00724945|584751502|FG001|Period 2|lens physiology issue|0|||
161919717|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
161919718|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
161919719|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
161919720|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
161919721|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
161919722|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
161919723|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
161919724|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
161919725|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
161919726|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
161919727|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
161919728|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
161919729|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
161919730|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
161919731|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
161919732|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
161919733|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
161919734|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
161919735|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Removal|1|||
161919736|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Removal|0|||
161919737|NCT05166876|584751505|FG000|Overall Study|Withdrawal by Subject|1|||
161919738|NCT05166876|584751506|FG001|Overall Study|Withdrawal by Subject|0|||
161919739|NCT05166876|584751507|FG002|Overall Study|Withdrawal by Subject|0|||
161919740|NCT00658528|584751508|FG000|Overall Study|Adverse Event|5|||
161474792|NCT03540030|583132521|FG001|Overall Study|never had surgery after signing consent|1|||
161474793|NCT00569270|583132522|FG000|Period: First Intervention|Protocol Violation|0|||
161474794|NCT00569270|583132523|FG001|Period: First Intervention|Protocol Violation|1|||
161474795|NCT00810355|583132524|FG000|Overall Study|Lost to Follow-up|13|||
161474796|NCT00810355|583132525|FG001|Overall Study|Lost to Follow-up|17|||
161474797|NCT00810355|583132526|FG002|Overall Study|Lost to Follow-up|11|||
161474798|NCT00810355|583132524|FG000|Overall Study|Withdrawal by Subject|1|||
161474799|NCT00810355|583132525|FG001|Overall Study|Withdrawal by Subject|0|||
161474800|NCT00810355|583132526|FG002|Overall Study|Withdrawal by Subject|0|||
161474801|NCT00657358|583132527|FG000|Overall Study|Lack of Efficacy|6|||
161474802|NCT04729621|583132529|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
161474803|NCT04729621|583132530|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
161919741|NCT00658528|584751509|FG001|Overall Study|Adverse Event|7|||
161474804|NCT04729621|583132531|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
161474805|NCT04729621|583132532|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
161474806|NCT04729621|583132533|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
161919742|NCT00658528|584751508|FG000|Overall Study|Lost to Follow-up|14|||
161919743|NCT00658528|584751509|FG001|Overall Study|Lost to Follow-up|22|||
161919744|NCT00658528|584751508|FG000|Overall Study|Withdrawal by Subject|8|||
161919745|NCT00658528|584751509|FG001|Overall Study|Withdrawal by Subject|6|||
161919746|NCT00658528|584751508|FG000|Overall Study|Withdrawal of consent|5|||
161919747|NCT00658528|584751509|FG001|Overall Study|Withdrawal of consent|6|||
161919748|NCT00658528|584751508|FG000|Overall Study|Other|8|||
161919749|NCT00658528|584751509|FG001|Overall Study|Other|4|||
161919750|NCT01147458|584751516|FG000|First Intervention|Study terminated by sponsor|8|||
161919751|NCT01147458|584751517|FG001|First Intervention|Study terminated by sponsor|8|||
161919752|NCT01147458|584751518|FG002|First Intervention|Study terminated by sponsor|7|||
161919753|NCT01147458|584751519|FG003|First Intervention|Study terminated by sponsor|8|||
161919754|NCT01147458|584751516|FG000|First Intervention|Protocol Violation|2|||
161919755|NCT01147458|584751517|FG001|First Intervention|Protocol Violation|3|||
161919756|NCT01147458|584751518|FG002|First Intervention|Protocol Violation|2|||
161919757|NCT01147458|584751519|FG003|First Intervention|Protocol Violation|3|||
161919758|NCT01147458|584751516|FG000|First Intervention|Withdrawal by Subject|3|||
161919759|NCT01147458|584751517|FG001|First Intervention|Withdrawal by Subject|0|||
161919760|NCT01147458|584751518|FG002|First Intervention|Withdrawal by Subject|1|||
161919761|NCT01147458|584751519|FG003|First Intervention|Withdrawal by Subject|0|||
161919762|NCT01147458|584751516|FG000|First Intervention|Adverse Event|0|||
161919763|NCT01147458|584751517|FG001|First Intervention|Adverse Event|3|||
161919764|NCT01147458|584751518|FG002|First Intervention|Adverse Event|2|||
161919765|NCT01147458|584751519|FG003|First Intervention|Adverse Event|3|||
161919766|NCT01147458|584751516|FG000|First Intervention|Other|1|||
161919767|NCT01147458|584751517|FG001|First Intervention|Other|2|||
161919768|NCT01147458|584751518|FG002|First Intervention|Other|0|||
161919769|NCT01147458|584751519|FG003|First Intervention|Other|0|||
161919770|NCT01147458|584751516|FG000|Second Intervention|Study terminated by sponsor|7|||
161919771|NCT01147458|584751517|FG001|Second Intervention|Study terminated by sponsor|5|||
161919772|NCT01147458|584751518|FG002|Second Intervention|Study terminated by sponsor|5|||
161919773|NCT01147458|584751519|FG003|Second Intervention|Study terminated by sponsor|3|||
161919774|NCT01147458|584751516|FG000|Second Intervention|Protocol Violation|0|||
161919775|NCT01147458|584751517|FG001|Second Intervention|Protocol Violation|1|||
161919776|NCT01147458|584751518|FG002|Second Intervention|Protocol Violation|1|||
161919777|NCT01147458|584751519|FG003|Second Intervention|Protocol Violation|0|||
161919778|NCT01147458|584751516|FG000|Second Intervention|Withdrawal by Subject|0|||
161919779|NCT01147458|584751517|FG001|Second Intervention|Withdrawal by Subject|1|||
161919780|NCT01147458|584751518|FG002|Second Intervention|Withdrawal by Subject|0|||
161919781|NCT01147458|584751519|FG003|Second Intervention|Withdrawal by Subject|0|||
161919782|NCT01147458|584751516|FG000|Second Intervention|Adverse Event|2|||
161919783|NCT01147458|584751517|FG001|Second Intervention|Adverse Event|0|||
161919784|NCT01147458|584751518|FG002|Second Intervention|Adverse Event|1|||
161919785|NCT01147458|584751519|FG003|Second Intervention|Adverse Event|1|||
161919786|NCT01147458|584751516|FG000|Second Intervention|Other|0|||
161919787|NCT01147458|584751517|FG001|Second Intervention|Other|0|||
161919788|NCT01147458|584751518|FG002|Second Intervention|Other|1|||
161919789|NCT01147458|584751519|FG003|Second Intervention|Other|0|||
161474807|NCT04729621|583132529|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
161474808|NCT04729621|583132530|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
161474809|NCT04729621|583132531|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
161474810|NCT04729621|583132532|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
161474811|NCT04729621|583132533|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
161474812|NCT04729621|583132529|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
161474813|NCT04729621|583132530|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
161919790|NCT02811159|584751531|FG000|Treatment Course 1|Lost to Follow-up|1|||
161919791|NCT04603066|584751532|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
161919792|NCT04603066|584751533|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
161919793|NCT04409002|584751534|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
161919794|NCT00580840|584753160|FG000|Run-in|Adverse Event|17|||
161919795|NCT00580840|584753161|FG001|Run-in|Adverse Event|0|||
161919796|NCT00580840|584753162|FG002|Run-in|Adverse Event|0|||
161919797|NCT00580840|584753163|FG003|Run-in|Adverse Event|0|||
161919798|NCT00580840|584753160|FG000|Run-in|Lack of Efficacy|93|||
161919799|NCT00580840|584753161|FG001|Run-in|Lack of Efficacy|0|||
161919800|NCT00580840|584753162|FG002|Run-in|Lack of Efficacy|0|||
161919801|NCT00580840|584753163|FG003|Run-in|Lack of Efficacy|0|||
161474814|NCT04729621|583132531|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
161919802|NCT00580840|584753160|FG000|Run-in|Loss of Efficacy|1|||
161919803|NCT00580840|584753161|FG001|Run-in|Loss of Efficacy|0|||
161919804|NCT00580840|584753162|FG002|Run-in|Loss of Efficacy|0|||
161919805|NCT00580840|584753163|FG003|Run-in|Loss of Efficacy|0|||
161919806|NCT00580840|584753160|FG000|Run-in|Lost to Follow-up|4|||
161919807|NCT00580840|584753161|FG001|Run-in|Lost to Follow-up|0|||
161919808|NCT00580840|584753162|FG002|Run-in|Lost to Follow-up|0|||
161919809|NCT00580840|584753163|FG003|Run-in|Lost to Follow-up|0|||
161919810|NCT00580840|584753160|FG000|Run-in|Withdrawal by Subject|5|||
161814526|NCT03578809|584365320|FG003|Overall Study|Death|1|||
161814527|NCT03578809|584365317|FG000|Overall Study|Lost to Follow-up|0|||
161814528|NCT03578809|584365318|FG001|Overall Study|Lost to Follow-up|1|||
161814529|NCT03578809|584365319|FG002|Overall Study|Lost to Follow-up|0|||
161814530|NCT03578809|584365320|FG003|Overall Study|Lost to Follow-up|0|||
161814531|NCT03578809|584365317|FG000|Overall Study|Withdrawal by Subject|3|||
161814532|NCT03578809|584365318|FG001|Overall Study|Withdrawal by Subject|5|||
161814533|NCT03578809|584365319|FG002|Overall Study|Withdrawal by Subject|2|||
161814534|NCT03578809|584365320|FG003|Overall Study|Withdrawal by Subject|0|||
161814535|NCT03578809|584365317|FG000|Overall Study|Other|3|||
161814536|NCT03578809|584365318|FG001|Overall Study|Other|6|||
161814537|NCT03578809|584365319|FG002|Overall Study|Other|2|||
161814538|NCT03578809|584365320|FG003|Overall Study|Other|8|||
161814539|NCT03599193|584365321|FG000|Overall Study|Adverse Event|0|||
161814540|NCT03599193|584365322|FG001|Overall Study|Adverse Event|2|||
161814541|NCT03599193|584365321|FG000|Overall Study|Withdrawal by Subject|1|||
161814542|NCT03599193|584365322|FG001|Overall Study|Withdrawal by Subject|0|||
161814543|NCT03599193|584365321|FG000|Overall Study|Protocol Violation|1|||
161814544|NCT03599193|584365322|FG001|Overall Study|Protocol Violation|0|||
161814545|NCT03599193|584365321|FG000|Overall Study|Lost to Follow-up|0|||
161814546|NCT03599193|584365322|FG001|Overall Study|Lost to Follow-up|1|||
161814547|NCT00835705|584365323|FG000|First Intervention|Difficulty with vein|1|||
161814548|NCT00835705|584365324|FG001|First Intervention|Difficulty with vein|0|||
161814549|NCT00835705|584365323|FG000|Second Intervention|Difficulty with vein|1|||
161814550|NCT00835705|584365324|FG001|Second Intervention|Difficulty with vein|0|||
161814551|NCT01116739|584365325|FG000|Overall Study|Child had 2 years of HS|110|||
161814552|NCT01116739|584365326|FG001|Overall Study|Child had 2 years of HS|128|||
161814553|NCT01116739|584365325|FG000|Overall Study|Withdrawal by Subject|6|||
161814554|NCT01116739|584365326|FG001|Overall Study|Withdrawal by Subject|0|||
161814555|NCT01116739|584365325|FG000|Overall Study|child too young|2|||
161814556|NCT01116739|584365326|FG001|Overall Study|child too young|6|||
161814557|NCT01116739|584365325|FG000|Overall Study|child not enrolled in head start|10|||
161814558|NCT01116739|584365326|FG001|Overall Study|child not enrolled in head start|2|||
161814559|NCT01116739|584365325|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
161814560|NCT01116739|584365326|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
161814561|NCT05090839|584365327|FG000|Overall Study|Lost to Follow-up|2|||
161814562|NCT05090839|584365328|FG001|Overall Study|Lost to Follow-up|3|||
161814563|NCT05090839|584365329|FG002|Overall Study|Lost to Follow-up|1|||
161814564|NCT05090839|584365330|FG003|Overall Study|Lost to Follow-up|1|||
161814565|NCT01987765|584365333|FG000|Overall Study|Protocol Violation|65|||
161814566|NCT01987765|584365333|FG000|Overall Study|Lost to Follow-up|37|||
161814567|NCT00443651|584365338|FG000|Overall Study|Death|1|||
161814568|NCT00443651|584365339|FG001|Overall Study|Death|5|||
161814569|NCT00443651|584365338|FG000|Overall Study|Adverse Event|5|||
161814570|NCT00443651|584365339|FG001|Overall Study|Adverse Event|6|||
161814571|NCT00443651|584365338|FG000|Overall Study|Lost to Follow-up|18|||
161814572|NCT00443651|584365339|FG001|Overall Study|Lost to Follow-up|12|||
161814573|NCT00443651|584365338|FG000|Overall Study|Patient's/Guardian's Decision|58|||
161814574|NCT00443651|584365339|FG001|Overall Study|Patient's/Guardian's Decision|30|||
161814575|NCT00443651|584365338|FG000|Overall Study|Physician Decision|13|||
161814576|NCT00443651|584365339|FG001|Overall Study|Physician Decision|4|||
161814577|NCT00443651|584365338|FG000|Overall Study|Pregnancy|0|||
161814578|NCT00443651|584365339|FG001|Overall Study|Pregnancy|1|||
161814579|NCT03606174|584365340|FG000|Overall Study|Death|37|||
161814580|NCT03606174|584365341|FG001|Overall Study|Death|15|||
161814581|NCT03606174|584365342|FG002|Overall Study|Death|15|||
161814582|NCT03606174|584365343|FG003|Overall Study|Death|7|||
161814583|NCT03606174|584365344|FG004|Overall Study|Death|35|||
161814584|NCT03606174|584365345|FG005|Overall Study|Death|12|||
161474815|NCT04729621|583132532|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
161474816|NCT04729621|583132533|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
161474817|NCT04729621|583132529|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161474818|NCT04729621|583132530|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161474819|NCT04729621|583132531|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
161474820|NCT04729621|583132532|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
161474821|NCT04729621|583132533|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
161474822|NCT04729621|583132529|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
161474823|NCT04729621|583132530|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
161814585|NCT03606174|584365346|FG006|Overall Study|Death|35|||
161814586|NCT03606174|584365347|FG007|Overall Study|Death|8|||
161814587|NCT03606174|584365348|FG008|Overall Study|Death|5|||
161814588|NCT03606174|584365349|FG009|Overall Study|Death|3|||
161814589|NCT03606174|584365350|FG010|Overall Study|Death|0|||
161814590|NCT03606174|584365340|FG000|Overall Study|Lost to Follow-up|0|||
161814591|NCT03606174|584365341|FG001|Overall Study|Lost to Follow-up|0|||
161814592|NCT03606174|584365342|FG002|Overall Study|Lost to Follow-up|0|||
161814593|NCT03606174|584365343|FG003|Overall Study|Lost to Follow-up|0|||
161814594|NCT03606174|584365344|FG004|Overall Study|Lost to Follow-up|1|||
161577012|NCT01078116|583499715|FG000|Overall Study|Withdrawal by Subject|8|||
161814595|NCT03606174|584365345|FG005|Overall Study|Lost to Follow-up|1|||
161814596|NCT03606174|584365346|FG006|Overall Study|Lost to Follow-up|0|||
161814597|NCT03606174|584365347|FG007|Overall Study|Lost to Follow-up|0|||
161814598|NCT03606174|584365348|FG008|Overall Study|Lost to Follow-up|0|||
161814599|NCT03606174|584365349|FG009|Overall Study|Lost to Follow-up|0|||
161814600|NCT03606174|584365350|FG010|Overall Study|Lost to Follow-up|0|||
161814601|NCT03606174|584365340|FG000|Overall Study|Withdrawal by Subject|6|||
161814602|NCT03606174|584365341|FG001|Overall Study|Withdrawal by Subject|0|||
161814603|NCT03606174|584365342|FG002|Overall Study|Withdrawal by Subject|0|||
161814604|NCT03606174|584365343|FG003|Overall Study|Withdrawal by Subject|1|||
161814605|NCT03606174|584365344|FG004|Overall Study|Withdrawal by Subject|2|||
161814606|NCT03606174|584365345|FG005|Overall Study|Withdrawal by Subject|1|||
161814607|NCT03606174|584365346|FG006|Overall Study|Withdrawal by Subject|4|||
161814608|NCT03606174|584365347|FG007|Overall Study|Withdrawal by Subject|0|||
161814609|NCT03606174|584365348|FG008|Overall Study|Withdrawal by Subject|0|||
161814610|NCT03606174|584365349|FG009|Overall Study|Withdrawal by Subject|0|||
161814611|NCT03606174|584365350|FG010|Overall Study|Withdrawal by Subject|1|||
161814612|NCT03606174|584365340|FG000|Overall Study|Study Terminated by Sponsor|5|||
161814613|NCT03606174|584365341|FG001|Overall Study|Study Terminated by Sponsor|7|||
161814614|NCT03606174|584365342|FG002|Overall Study|Study Terminated by Sponsor|3|||
161814615|NCT03606174|584365343|FG003|Overall Study|Study Terminated by Sponsor|0|||
161814616|NCT03606174|584365344|FG004|Overall Study|Study Terminated by Sponsor|11|||
161814617|NCT03606174|584365345|FG005|Overall Study|Study Terminated by Sponsor|6|||
161814618|NCT03606174|584365346|FG006|Overall Study|Study Terminated by Sponsor|12|||
161814619|NCT03606174|584365347|FG007|Overall Study|Study Terminated by Sponsor|1|||
161814620|NCT03606174|584365348|FG008|Overall Study|Study Terminated by Sponsor|3|||
161814621|NCT03606174|584365349|FG009|Overall Study|Study Terminated by Sponsor|1|||
161814622|NCT03606174|584365350|FG010|Overall Study|Study Terminated by Sponsor|2|||
161814623|NCT03606174|584365340|FG000|Overall Study|Miscellaneous|1|||
161814624|NCT03606174|584365341|FG001|Overall Study|Miscellaneous|1|||
161814625|NCT03606174|584365342|FG002|Overall Study|Miscellaneous|0|||
161814626|NCT03606174|584365343|FG003|Overall Study|Miscellaneous|1|||
161814627|NCT03606174|584365344|FG004|Overall Study|Miscellaneous|4|||
161814628|NCT03606174|584365345|FG005|Overall Study|Miscellaneous|7|||
161814629|NCT03606174|584365346|FG006|Overall Study|Miscellaneous|5|||
161814630|NCT03606174|584365347|FG007|Overall Study|Miscellaneous|0|||
161814631|NCT03606174|584365348|FG008|Overall Study|Miscellaneous|0|||
161814632|NCT03606174|584365349|FG009|Overall Study|Miscellaneous|0|||
161814633|NCT03606174|584365350|FG010|Overall Study|Miscellaneous|1|||
161814634|NCT01896934|584365353|FG000|Overall Study|Adverse Event|1|||
161814635|NCT01896934|584365353|FG000|Overall Study|Withdrawal by Subject|1|||
161814636|NCT00316277|584365355|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
161814637|NCT00316277|584365356|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
161814638|NCT00316277|584365355|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
161814639|NCT00316277|584365356|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
161814640|NCT00316277|584365355|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
161814641|NCT00316277|584365356|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
161814642|NCT00316277|584365355|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
161814643|NCT00316277|584365356|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
161814644|NCT00316277|584365355|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
161814645|NCT00316277|584365356|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
161814646|NCT01572662|584365357|FG000|Overall Study|Withdrawal by Subject|1|||
161814647|NCT01572662|584365358|FG001|Overall Study|Withdrawal by Subject|0|||
161814648|NCT01572662|584365357|FG000|Overall Study|Physician Decision|0|||
161814649|NCT01572662|584365358|FG001|Overall Study|Physician Decision|1|||
161814650|NCT03364192|584365359|FG000|Overall Study|Ineligible|10|||
161814651|NCT03364192|584365359|FG000|Overall Study|Withdrawal by Subject|5|||
161814652|NCT03364192|584365359|FG000|Overall Study|Lost to Follow-up|1|||
161814653|NCT04692155|584365360|FG000|Overall Study|Death|1|||
161814654|NCT04547192|584365361|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
161814655|NCT04547192|584365362|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
161919811|NCT00580840|584753161|FG001|Run-in|Withdrawal by Subject|0|||
161919812|NCT00580840|584753162|FG002|Run-in|Withdrawal by Subject|0|||
161919813|NCT00580840|584753163|FG003|Run-in|Withdrawal by Subject|0|||
161919814|NCT00580840|584753160|FG000|Run-in|Other: Per Sponsor Request|2|||
161919815|NCT00580840|584753161|FG001|Run-in|Other: Per Sponsor Request|0|||
161919816|NCT00580840|584753162|FG002|Run-in|Other: Per Sponsor Request|0|||
161919817|NCT00580840|584753163|FG003|Run-in|Other: Per Sponsor Request|0|||
161919818|NCT00580840|584753160|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
161919819|NCT00580840|584753161|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161919820|NCT00580840|584753162|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161919821|NCT00580840|584753163|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161919822|NCT00580840|584753160|FG000|Run-in|Other: Exclusionary Lab Value|1|||
161919823|NCT00580840|584753161|FG001|Run-in|Other: Exclusionary Lab Value|0|||
161919824|NCT00580840|584753162|FG002|Run-in|Other: Exclusionary Lab Value|0|||
161919825|NCT00580840|584753163|FG003|Run-in|Other: Exclusionary Lab Value|0|||
161919826|NCT00580840|584753160|FG000|Double-Blind|Adverse Event|0|||
161919827|NCT00580840|584753161|FG001|Double-Blind|Adverse Event|3|||
161919828|NCT00580840|584753162|FG002|Double-Blind|Adverse Event|4|||
161919829|NCT00580840|584753163|FG003|Double-Blind|Adverse Event|1|||
161919830|NCT00580840|584753160|FG000|Double-Blind|Loss of Efficacy|0|||
161919831|NCT00580840|584753161|FG001|Double-Blind|Loss of Efficacy|1|||
161919832|NCT00580840|584753162|FG002|Double-Blind|Loss of Efficacy|2|||
161919833|NCT00580840|584753163|FG003|Double-Blind|Loss of Efficacy|10|||
161919834|NCT00580840|584753160|FG000|Double-Blind|Lost to Follow-up|0|||
161919835|NCT00580840|584753161|FG001|Double-Blind|Lost to Follow-up|1|||
161919836|NCT00580840|584753162|FG002|Double-Blind|Lost to Follow-up|0|||
161919837|NCT00580840|584753163|FG003|Double-Blind|Lost to Follow-up|2|||
161919838|NCT00580840|584753160|FG000|Double-Blind|Withdrawal by Subject|0|||
161919839|NCT00580840|584753161|FG001|Double-Blind|Withdrawal by Subject|1|||
161919840|NCT00580840|584753162|FG002|Double-Blind|Withdrawal by Subject|2|||
161919841|NCT00580840|584753163|FG003|Double-Blind|Withdrawal by Subject|2|||
161919842|NCT00580840|584753160|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
161577013|NCT01078116|583499715|FG000|Overall Study|Lack of effectiveness|15|||
161577014|NCT01078116|583499715|FG000|Overall Study|Case report form not completed|3|||
161577015|NCT00585052|583499716|FG000|Overall Study|Withdrawal by Subject|1|||
161577016|NCT02616900|583499717|FG000|Overall Study|Lack of Efficacy|7|||
161577017|NCT02616900|583499717|FG000|Overall Study|Lost to Follow-up|2|||
161577018|NCT02616900|583499717|FG000|Overall Study|Protocol Violation|5|||
161577019|NCT02616900|583499717|FG000|Overall Study|Withdrawal by Subject|3|||
161577020|NCT02616900|583499717|FG000|Overall Study|Incomplete data|6|||
161577021|NCT04425863|583499718|FG000|Overall Study|Death|0|||
161577022|NCT04425863|583499719|FG001|Overall Study|Death|0|||
161577023|NCT04425863|583499720|FG002|Overall Study|Death|1|||
161919843|NCT00580840|584753161|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
161919844|NCT00580840|584753162|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
161919845|NCT00580840|584753163|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
161919846|NCT00580840|584753160|FG000|Double-Blind|Other: Forbidden Medication|0|||
161919847|NCT00580840|584753161|FG001|Double-Blind|Other: Forbidden Medication|0|||
161919848|NCT00580840|584753162|FG002|Double-Blind|Other: Forbidden Medication|1|||
161919849|NCT00580840|584753163|FG003|Double-Blind|Other: Forbidden Medication|0|||
161919850|NCT04435626|584753166|FG000|Overall Study|Lost to Follow-up|1|||
161919851|NCT04435626|584753167|FG001|Overall Study|Lost to Follow-up|5|||
161919852|NCT04435626|584753166|FG000|Overall Study|Withdrawal by Subject|6|||
161919853|NCT04435626|584753167|FG001|Overall Study|Withdrawal by Subject|7|||
161919854|NCT04435626|584753166|FG000|Overall Study|major GCP violations|8|||
161919855|NCT04435626|584753167|FG001|Overall Study|major GCP violations|7|||
161919856|NCT01160614|584753175|FG000|Overall Study|Withdrawal by Subject|0|||
161577024|NCT02527148|583499722|FG000|Overall Study|Did not receive study intervention|1|||
161577025|NCT02527148|583499723|FG001|Overall Study|Did not receive study intervention|0|||
161577026|NCT02918279|583499724|FG000|Overall Study|Lost to Follow-up|3|||
161577027|NCT02918279|583499725|FG001|Overall Study|Lost to Follow-up|6|||
161577028|NCT02918279|583499724|FG000|Overall Study|Withdrawal by Subject|5|||
161919857|NCT01160614|584753176|FG001|Overall Study|Withdrawal by Subject|2|||
161919858|NCT00984399|584753177|FG000|Overall Study|Adverse Event|0|||
161919859|NCT00984399|584753178|FG001|Overall Study|Adverse Event|1|||
161919860|NCT00984399|584753177|FG000|Overall Study|Physician Decision|1|||
161919861|NCT00984399|584753178|FG001|Overall Study|Physician Decision|0|||
161919862|NCT00984399|584753177|FG000|Overall Study|Withdrawal by Subject|1|||
161577029|NCT02918279|583499725|FG001|Overall Study|Withdrawal by Subject|15|||
161577030|NCT02918279|583499724|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161577031|NCT02918279|583499725|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161814656|NCT04547192|584365363|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
161814657|NCT04547192|584365364|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
161814658|NCT04547192|584365361|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
161814659|NCT04547192|584365362|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
161814660|NCT04547192|584365363|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
161814661|NCT04547192|584365364|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
161814662|NCT04547192|584365361|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
161814663|NCT04547192|584365362|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
161814664|NCT04547192|584365363|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
161814665|NCT04547192|584365364|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
161814666|NCT04547192|584365361|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
161814667|NCT04547192|584365362|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
161814668|NCT04547192|584365363|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
161814669|NCT04547192|584365364|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
161814670|NCT04547192|584365361|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
161814671|NCT04547192|584365362|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
161814672|NCT04547192|584365363|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
161814673|NCT04547192|584365364|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
161814674|NCT01535222|584365365|FG000|Overall Study|Inclusion/exclusion|0|||
161814675|NCT01535222|584365366|FG001|Overall Study|Inclusion/exclusion|0|||
161814676|NCT01535222|584365367|FG002|Overall Study|Inclusion/exclusion|1|||
161814677|NCT01535222|584365368|FG003|Overall Study|Inclusion/exclusion|0|||
161814678|NCT01535222|584365369|FG004|Overall Study|Inclusion/exclusion|0|||
161814679|NCT01535222|584365370|FG005|Overall Study|Inclusion/exclusion|0|||
161814680|NCT00935012|584365373|FG000|Overall Study|Death|19|||
161814681|NCT00935012|584365373|FG000|Overall Study|Withdrawal by Subject|3|||
161814682|NCT00935012|584365373|FG000|Overall Study|Other|5|||
161814683|NCT00935012|584365373|FG000|Overall Study|Adverse Event|2|||
161814684|NCT01442155|584365374|FG000|Overall Study|Complete remission|35|||
161814685|NCT01442155|584365374|FG000|Overall Study|Recurrence|26|||
161814686|NCT01442155|584365374|FG000|Overall Study|Adverse Event|2|||
161814687|NCT01442155|584365374|FG000|Overall Study|Lost to Follow-up|2|||
161814688|NCT01484912|584365383|FG000|Overall Study|Withdrawal by Subject|1|||
161814689|NCT01484912|584365384|FG001|Overall Study|Withdrawal by Subject|0|||
161814690|NCT01484912|584365383|FG000|Overall Study|Physician Decision|0|||
161814691|NCT01484912|584365384|FG001|Overall Study|Physician Decision|1|||
161814692|NCT04345653|584365385|FG000|Overall Study|Withdrawal by Subject|2|||
161814693|NCT00418938|584365386|FG000|Overall Study|Reimbursement|1|||
161814694|NCT00418938|584365387|FG001|Overall Study|Reimbursement|0|||
161814695|NCT00418938|584365386|FG000|Overall Study|Administrative decision|3|||
161814696|NCT00418938|584365387|FG001|Overall Study|Administrative decision|3|||
161814697|NCT00418938|584365386|FG000|Overall Study|Withdrawal by Subject|16|||
161577032|NCT02918279|583499724|FG000|Overall Study|Other|3|||
161814698|NCT00418938|584365387|FG001|Overall Study|Withdrawal by Subject|15|||
161814699|NCT00418938|584365386|FG000|Overall Study|Lost to Follow-up|1|||
161814700|NCT00418938|584365387|FG001|Overall Study|Lost to Follow-up|3|||
161814701|NCT00418938|584365386|FG000|Overall Study|Adverse Event|1|||
161814702|NCT00418938|584365387|FG001|Overall Study|Adverse Event|1|||
161814703|NCT00418938|584365386|FG000|Overall Study|On-going|1|||
161919863|NCT00984399|584753178|FG001|Overall Study|Withdrawal by Subject|1|||
161919864|NCT00984399|584753177|FG000|Overall Study|Protocol Violation|0|||
161919865|NCT00984399|584753178|FG001|Overall Study|Protocol Violation|1|||
161919866|NCT00984399|584753177|FG000|Overall Study|Pts did not start treatment|2|||
161919867|NCT00984399|584753178|FG001|Overall Study|Pts did not start treatment|2|||
161919868|NCT05248386|584753180|FG000|Overall Study|Technical problems|0|||
161919869|NCT05248386|584753181|FG001|Overall Study|Technical problems|1|||
161919870|NCT05248386|584753180|FG000|Overall Study|Withdrawal by Subject|15|||
161919871|NCT05248386|584753181|FG001|Overall Study|Withdrawal by Subject|10|||
161919872|NCT05248386|584753180|FG000|Overall Study|Physician Decision|0|||
161919873|NCT05248386|584753181|FG001|Overall Study|Physician Decision|1|||
161919874|NCT05248386|584753180|FG000|Overall Study|Adverse Event|2|||
161919875|NCT05248386|584753181|FG001|Overall Study|Adverse Event|4|||
161919876|NCT05248386|584753180|FG000|Overall Study|Other|1|||
161919877|NCT05248386|584753181|FG001|Overall Study|Other|0|||
161919878|NCT05248386|584753180|FG000|Overall Study|Lack of Efficacy|14|||
161919879|NCT05248386|584753181|FG001|Overall Study|Lack of Efficacy|12|||
161919880|NCT01910441|584753182|FG000|Overall Study|Sponsor decision|0|||
161919881|NCT01910441|584753183|FG001|Overall Study|Sponsor decision|2|||
161919882|NCT01910441|584753182|FG000|Overall Study|Lost to Follow-up|6|||
161919883|NCT01910441|584753183|FG001|Overall Study|Lost to Follow-up|5|||
161919884|NCT01910441|584753182|FG000|Overall Study|Withdrawal by Subject|0|||
161919885|NCT01910441|584753183|FG001|Overall Study|Withdrawal by Subject|1|||
161919886|NCT01910441|584753182|FG000|Overall Study|Non-compliance|0|||
161919887|NCT01910441|584753183|FG001|Overall Study|Non-compliance|1|||
161919888|NCT01910441|584753182|FG000|Overall Study|Adverse Event|1|||
161919889|NCT01910441|584753183|FG001|Overall Study|Adverse Event|0|||
161919890|NCT01910441|584753182|FG000|Overall Study|Physician Decision|0|||
161919891|NCT01910441|584753183|FG001|Overall Study|Physician Decision|1|||
161919892|NCT02964182|584753184|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919893|NCT02964182|584753185|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
161919894|NCT02964182|584753186|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919895|NCT02964182|584753187|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919896|NCT02964182|584753188|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919897|NCT02964182|584753189|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
161919898|NCT02964182|584753190|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919899|NCT02964182|584753191|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919900|NCT02964182|584753184|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919901|NCT02964182|584753185|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919902|NCT02964182|584753186|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919903|NCT02964182|584753187|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919904|NCT02964182|584753188|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919905|NCT02964182|584753189|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
161919906|NCT02964182|584753190|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919907|NCT02964182|584753191|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919908|NCT02964182|584753184|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161577033|NCT02918279|583499725|FG001|Overall Study|Other|1|||
161919909|NCT02964182|584753185|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
161919910|NCT02964182|584753186|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919911|NCT02964182|584753187|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919912|NCT02964182|584753188|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919913|NCT02964182|584753189|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
161919914|NCT02964182|584753190|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919915|NCT02964182|584753191|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919916|NCT02964182|584753184|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919917|NCT02964182|584753185|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919918|NCT02964182|584753186|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
161919919|NCT02964182|584753187|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
161919920|NCT02964182|584753188|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919921|NCT02964182|584753189|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919922|NCT02964182|584753190|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
161919923|NCT02964182|584753191|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919924|NCT02964182|584753184|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919925|NCT02964182|584753185|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919926|NCT02964182|584753186|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
161919927|NCT02964182|584753187|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
161577034|NCT00309907|583499726|FG000|Overall Study|Death|4|||
161577035|NCT00309907|583499726|FG000|Overall Study|Physician Decision|1|||
161919928|NCT02964182|584753188|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919929|NCT02964182|584753189|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919930|NCT02964182|584753190|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919931|NCT02964182|584753191|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
161919932|NCT02964182|584753184|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919933|NCT02964182|584753185|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919934|NCT02964182|584753186|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
161919935|NCT02964182|584753187|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
161919936|NCT02964182|584753188|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919937|NCT02964182|584753189|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919938|NCT02964182|584753190|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919939|NCT02964182|584753191|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919940|NCT02964182|584753184|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919941|NCT02964182|584753185|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919942|NCT02964182|584753186|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
161919943|NCT02964182|584753187|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
161919944|NCT02964182|584753188|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919945|NCT02964182|584753189|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919946|NCT02964182|584753190|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
161919947|NCT02964182|584753191|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919948|NCT03636477|584753193|FG000|Overall Study|Adverse Event|0|||
161919949|NCT03636477|584753194|FG001|Overall Study|Adverse Event|0|||
161919950|NCT03636477|584753195|FG002|Overall Study|Adverse Event|1|||
161919951|NCT02382380|584753197|FG000|Overall Study|Withdrawal by Subject|2|||
161919952|NCT02382380|584753198|FG001|Overall Study|Withdrawal by Subject|2|||
161919953|NCT02382380|584753197|FG000|Overall Study|Lost to Follow-up|0|||
161919954|NCT02382380|584753198|FG001|Overall Study|Lost to Follow-up|1|||
161919955|NCT01295944|584753199|FG000|Overall Study|Switched to alternative treatment|1|||
161919956|NCT01295944|584753199|FG000|Overall Study|Ineligible|9|||
161919957|NCT01295944|584753199|FG000|Overall Study|Withdrawal by Subject|1|||
161919958|NCT01295944|584753199|FG000|Overall Study|Participant chose to be treated in Peru|1|||
161919959|NCT01295944|584753199|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
161474824|NCT04729621|583132531|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
161474825|NCT04729621|583132532|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
161474826|NCT04729621|583132533|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
161474827|NCT04729621|583132529|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
161474828|NCT04729621|583132530|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
161474829|NCT04729621|583132531|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
161474830|NCT04729621|583132532|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
161474831|NCT04729621|583132533|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
161474832|NCT01449539|583132537|FG000|Overall Study|Withdrawal by Subject|3|||
161474833|NCT01449539|583132537|FG000|Overall Study|Toxicity not study related|1|||
161474834|NCT01387789|583132540|FG000|Overall Study|Adverse Event|5|||
161474835|NCT01387789|583132540|FG000|Overall Study|Lack of Efficacy|2|||
161474836|NCT01387789|583132540|FG000|Overall Study|Lost to Follow-up|1|||
161474837|NCT00913380|583132541|FG000|Clinical Outcomes|Lost to Follow-up|6|||
161919960|NCT01295944|584753199|FG000|Overall Study|Physician Decision|1|||
161919961|NCT01295944|584753199|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
161919962|NCT01295944|584753199|FG000|Overall Study|Disease progression|4|||
161919963|NCT01295944|584753199|FG000|Overall Study|Transferred care before starting new treatment|1|||
161919964|NCT03785366|584753207|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
161919965|NCT03785366|584753208|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
161919966|NCT03785366|584753207|FG000|Overall Study|Lost to Follow-up|1|||
161474838|NCT00913380|583132542|FG001|Clinical Outcomes|Lost to Follow-up|6|||
161474839|NCT02187744|583132547|FG000|Study|Participant refused further follow-up|1|||
161474840|NCT02187744|583132548|FG001|Study|Participant refused further follow-up|0|||
161474841|NCT02187744|583132547|FG000|Study|Other|2|||
161474842|NCT02187744|583132548|FG001|Study|Other|1|||
161474843|NCT02187744|583132547|FG000|Study|Lost to Follow-up|0|||
161919967|NCT03785366|584753208|FG001|Overall Study|Lost to Follow-up|0|||
161919968|NCT03785366|584753207|FG000|Overall Study|Partial IUD Expulsion|0|||
161919969|NCT03785366|584753208|FG001|Overall Study|Partial IUD Expulsion|2|||
161919970|NCT03785366|584753207|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
161919971|NCT03785366|584753208|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
161919972|NCT05168800|584753209|FG000|Time 1 Survey|Did not start T1 survey|182|||
161474844|NCT02187744|583132548|FG001|Study|Lost to Follow-up|2|||
161474845|NCT02187744|583132547|FG000|Study|Related adverse event, not serious|0|||
161474846|NCT02187744|583132548|FG001|Study|Related adverse event, not serious|2|||
161919973|NCT05168800|584753210|FG001|Time 1 Survey|Did not start T1 survey|150|||
161919974|NCT05168800|584753211|FG002|Time 1 Survey|Did not start T1 survey|140|||
161919975|NCT05168800|584753209|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
161919976|NCT05168800|584753210|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
161919977|NCT05168800|584753211|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
161919978|NCT05168800|584753209|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
161474847|NCT02187744|583132547|FG000|Study|Death|1|||
161919979|NCT05168800|584753210|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
161474848|NCT02187744|583132548|FG001|Study|Death|0|||
161474849|NCT02187744|583132547|FG000|Study|Related adverse event, serious non-fatal|0|||
161474850|NCT02187744|583132548|FG001|Study|Related adverse event, serious non-fatal|1|||
161474851|NCT02187744|583132547|FG000|Treatment|Death|1|||
161474852|NCT02187744|583132548|FG001|Treatment|Death|0|||
161577036|NCT00309907|583499726|FG000|Overall Study|Ineligible|11|||
161919980|NCT05168800|584753211|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
161919981|NCT05168800|584753209|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
161919982|NCT05168800|584753210|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
161919983|NCT05168800|584753211|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
161919984|NCT05168800|584753209|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
161919985|NCT05168800|584753210|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
161919986|NCT05168800|584753211|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
161919987|NCT05168800|584753209|FG000|Time 1 Survey|Withdrawal by Subject|6|||
161919988|NCT05168800|584753210|FG001|Time 1 Survey|Withdrawal by Subject|3|||
161919989|NCT05168800|584753211|FG002|Time 1 Survey|Withdrawal by Subject|2|||
161919990|NCT05168800|584753209|FG000|Time 2 Survey|Already excluded at Time 1|228|||
161919991|NCT05168800|584753210|FG001|Time 2 Survey|Already excluded at Time 1|202|||
161919992|NCT05168800|584753211|FG002|Time 2 Survey|Already excluded at Time 1|173|||
161919993|NCT05168800|584753209|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
161919994|NCT05168800|584753210|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
161919995|NCT05168800|584753211|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
161919996|NCT05168800|584753209|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
161919997|NCT05168800|584753210|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
161919998|NCT05168800|584753211|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
161919999|NCT05168800|584753209|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
161920000|NCT05168800|584753210|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
161920001|NCT05168800|584753211|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
161920002|NCT05168800|584753209|FG000|Time 2 Survey|Withdrawal by Subject|1|||
161920003|NCT05168800|584753210|FG001|Time 2 Survey|Withdrawal by Subject|0|||
161920004|NCT05168800|584753211|FG002|Time 2 Survey|Withdrawal by Subject|1|||
161920005|NCT05168800|584753209|FG000|Time 3 Survey|Already excluded at Time 1|228|||
161920006|NCT05168800|584753210|FG001|Time 3 Survey|Already excluded at Time 1|200|||
161920007|NCT05168800|584753211|FG002|Time 3 Survey|Already excluded at Time 1|173|||
161920008|NCT05168800|584753209|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
161920009|NCT05168800|584753210|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
161920010|NCT05168800|584753211|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
161920011|NCT05168800|584753209|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
161920012|NCT05168800|584753210|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
161920013|NCT05168800|584753211|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
161920014|NCT05168800|584753209|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
161920015|NCT05168800|584753210|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
161920016|NCT05168800|584753211|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
161920017|NCT03240874|584753212|FG000|Overall Study|Lost to Follow-up|0|||
161920018|NCT03240874|584753213|FG001|Overall Study|Lost to Follow-up|2|||
161920019|NCT03240874|584753214|FG002|Overall Study|Lost to Follow-up|4|||
161920020|NCT03240874|584753215|FG003|Overall Study|Lost to Follow-up|1|||
161920021|NCT04958707|584753216|FG000|Post Intervention|Withdrawal by Subject|1|||
161920022|NCT04958707|584753217|FG001|Post Intervention|Withdrawal by Subject|0|||
161920023|NCT04958707|584753218|FG002|Post Intervention|Withdrawal by Subject|0|||
161920024|NCT04958707|584753216|FG000|3 Months Follow- up|Lost to Follow-up|0|||
161920025|NCT04958707|584753217|FG001|3 Months Follow- up|Lost to Follow-up|3|||
161920026|NCT04958707|584753218|FG002|3 Months Follow- up|Lost to Follow-up|0|||
161920027|NCT04958707|584753216|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
161920028|NCT04958707|584753217|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
161920029|NCT04958707|584753218|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
161920030|NCT04279522|584753221|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
161920031|NCT04279522|584753222|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
161920032|NCT04279522|584753221|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
161920033|NCT04279522|584753222|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
161920034|NCT04279522|584753221|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
161920035|NCT04279522|584753222|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
161920036|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
161920037|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
161920038|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
161920039|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
161920040|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Physician Decision|0|||
161920041|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Physician Decision|3|||
161920042|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Adverse Event|0|||
161474853|NCT02187744|583132547|FG000|Treatment|Related adverse event, serious non-fatal|0|||
161474854|NCT02187744|583132548|FG001|Treatment|Related adverse event, serious non-fatal|1|||
161474855|NCT02187744|583132547|FG000|Treatment|Related adverse event, not serious|0|||
161920043|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Adverse Event|1|||
161474856|NCT02187744|583132548|FG001|Treatment|Related adverse event, not serious|2|||
161920044|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
161920045|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
161920046|NCT02783274|584753235|FG000|Overall Study|Withdrawal by Subject|16|||
161920047|NCT02783274|584753235|FG000|Overall Study|Physician Decision|6|||
161920048|NCT02783274|584753235|FG000|Overall Study|Death|9|||
161920049|NCT02783274|584753235|FG000|Overall Study|Lost to Follow-up|22|||
161920050|NCT02783274|584753235|FG000|Overall Study|Other|22|||
161920051|NCT05567172|584753239|FG000|Overall Study|Death|3|||
161920052|NCT05523297|584753240|FG000|Overall Study|Death|7|||
161920053|NCT05523297|584753241|FG001|Overall Study|Death|8|||
161920054|NCT05523297|584753240|FG000|Overall Study|Lost to Follow-up|2|||
161920055|NCT05523297|584753241|FG001|Overall Study|Lost to Follow-up|1|||
161920056|NCT03168672|584753244|FG000|Overall Study|Withdrawal by Subject|13|||
161920057|NCT03168672|584753244|FG000|Overall Study|Death|3|||
161920058|NCT03168672|584753244|FG000|Overall Study|Investigator's Decision|137|||
161920059|NCT03168672|584753244|FG000|Overall Study|Adverse Event|1|||
161920060|NCT03168672|584753244|FG000|Overall Study|Other|2|||
161920061|NCT03168672|584753244|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
161920062|NCT02246777|584753245|FG000|Overall Study|Adverse Event|2|||
161920063|NCT02246777|584753245|FG000|Overall Study|Change of residence|1|||
161920064|NCT00927472|584753246|FG000|Overall Study|Withdrawal by Subject|10|||
161920065|NCT00927472|584753247|FG001|Overall Study|Withdrawal by Subject|11|||
161920066|NCT00927472|584753246|FG000|Overall Study|Lost to Follow-up|1|||
161920067|NCT00927472|584753247|FG001|Overall Study|Lost to Follow-up|6|||
161920068|NCT00927472|584753246|FG000|Overall Study|Protocol Violation|0|||
161920069|NCT00927472|584753247|FG001|Overall Study|Protocol Violation|1|||
161920070|NCT00927472|584753246|FG000|Overall Study|Post treatment Assessment out of window|0|||
161920071|NCT00927472|584753247|FG001|Overall Study|Post treatment Assessment out of window|4|||
161920072|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
161920073|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
161920074|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
161920075|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
161920076|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
161920077|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
161920078|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
161474857|NCT02187744|583132547|FG000|Treatment|Lost to Follow-up|0|||
161474858|NCT02187744|583132548|FG001|Treatment|Lost to Follow-up|1|||
161474859|NCT02187744|583132547|FG000|Treatment|Other|2|||
161474860|NCT02187744|583132548|FG001|Treatment|Other|0|||
161474861|NCT02187744|583132547|FG000|Treatment|Participant refused continued treatment|1|||
161474862|NCT02187744|583132548|FG001|Treatment|Participant refused continued treatment|1|||
161474863|NCT01788228|583132549|FG000|Overall Study|Migrated/moved from study area|1|||
161474864|NCT01788228|583132550|FG001|Overall Study|Migrated/moved from study area|0|||
161474865|NCT01972568|583132551|FG000|Overall Study|Other events|3|||
161474866|NCT01972568|583132552|FG001|Overall Study|Other events|0|||
161474867|NCT01972568|583132553|FG002|Overall Study|Other events|0|||
161920079|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
161920080|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
161474868|NCT01972568|583132551|FG000|Overall Study|Lack of Efficacy|0|||
161474869|NCT01972568|583132552|FG001|Overall Study|Lack of Efficacy|1|||
161474870|NCT01972568|583132553|FG002|Overall Study|Lack of Efficacy|2|||
161920081|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
161920082|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
161920083|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
161474871|NCT01972568|583132551|FG000|Overall Study|Protocol Violation|1|||
161474872|NCT01972568|583132552|FG001|Overall Study|Protocol Violation|2|||
161474873|NCT01972568|583132553|FG002|Overall Study|Protocol Violation|2|||
161474874|NCT01972568|583132551|FG000|Overall Study|Withdrawal by Subject|6|||
161474875|NCT01972568|583132552|FG001|Overall Study|Withdrawal by Subject|3|||
161474876|NCT01972568|583132553|FG002|Overall Study|Withdrawal by Subject|7|||
161474877|NCT01972568|583132551|FG000|Overall Study|Lost to Follow-up|1|||
161474878|NCT01972568|583132552|FG001|Overall Study|Lost to Follow-up|0|||
161474879|NCT01972568|583132553|FG002|Overall Study|Lost to Follow-up|0|||
161920084|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
161920085|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
161920086|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
161920087|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
161920088|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
161920089|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
161920090|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
161920091|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
161920092|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
161920093|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
161920094|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
161920095|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
161920096|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
161920097|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
161920098|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
161920099|NCT04707469|584753251|FG000|Overall Study|Site closure|0|||
161920100|NCT04707469|584753252|FG001|Overall Study|Site closure|2|||
161920101|NCT04707469|584753253|FG002|Overall Study|Site closure|0|||
161920102|NCT04707469|584753251|FG000|Overall Study|Physician Decision|2|||
161920103|NCT04707469|584753252|FG001|Overall Study|Physician Decision|2|||
161920104|NCT04707469|584753253|FG002|Overall Study|Physician Decision|2|||
161920105|NCT04707469|584753251|FG000|Overall Study|Death|1|||
161920106|NCT04707469|584753252|FG001|Overall Study|Death|6|||
161920107|NCT04707469|584753253|FG002|Overall Study|Death|2|||
161920108|NCT04707469|584753251|FG000|Overall Study|Lost to Follow-up|9|||
161920109|NCT04707469|584753252|FG001|Overall Study|Lost to Follow-up|19|||
161920110|NCT04707469|584753253|FG002|Overall Study|Lost to Follow-up|14|||
161920111|NCT04707469|584753251|FG000|Overall Study|Withdrawal by Subject|17|||
161920112|NCT04707469|584753252|FG001|Overall Study|Withdrawal by Subject|16|||
161920113|NCT04707469|584753253|FG002|Overall Study|Withdrawal by Subject|12|||
161920114|NCT04635423|584753266|FG000|Overall Study|Ongoing|493|||
161920115|NCT04635423|584753267|FG001|Overall Study|Ongoing|501|||
161920116|NCT04635423|584753266|FG000|Overall Study|Withdrawal by Subject|36|||
161920117|NCT04635423|584753267|FG001|Overall Study|Withdrawal by Subject|29|||
161920118|NCT05556057|584753268|FG000|Overall Study|Lost to Follow-up|5|||
161920119|NCT05556057|584753269|FG001|Overall Study|Lost to Follow-up|4|||
161920120|NCT05556057|584753268|FG000|Overall Study|Withdrawal by Subject|0|||
161920121|NCT05556057|584753269|FG001|Overall Study|Withdrawal by Subject|2|||
161920122|NCT00830765|584753280|FG000|Overall Study|Protocol Violation|3|||
161920123|NCT00830765|584753281|FG001|Overall Study|Protocol Violation|2|||
161920124|NCT02390284|584753282|FG000|Overall Study|Physician Decision|0|||
161920125|NCT02390284|584753283|FG001|Overall Study|Physician Decision|0|||
161920126|NCT02390284|584753284|FG002|Overall Study|Physician Decision|9|||
161920127|NCT01977846|584753285|FG000|Total Study - Prospective|Death|0|||
161920128|NCT01977846|584753286|FG001|Total Study - Prospective|Death|1|||
161920129|NCT01977846|584753285|FG000|Total Study - Prospective|Lost to Follow-up|0|||
161920130|NCT01977846|584753286|FG001|Total Study - Prospective|Lost to Follow-up|8|||
161920131|NCT01977846|584753285|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
161920132|NCT01977846|584753286|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
161920133|NCT01977846|584753285|FG000|Total Study - Prospective|Not available at time of visit|0|||
161920134|NCT01977846|584753286|FG001|Total Study - Prospective|Not available at time of visit|5|||
161920135|NCT01977846|584753285|FG000|Total Study - Prospective|No show|0|||
161920136|NCT01977846|584753286|FG001|Total Study - Prospective|No show|1|||
161920137|NCT01977846|584753285|FG000|Total Study - Prospective|Protocol Violation|0|||
161920138|NCT01977846|584753286|FG001|Total Study - Prospective|Protocol Violation|1|||
161920139|NCT00143507|584754523|FG000|Overall Study|Death|572|||
161920140|NCT00143507|584754524|FG001|Overall Study|Death|547|||
161920141|NCT00143507|584754523|FG000|Overall Study|Withdrawal by Subject|114|||
161920142|NCT00143507|584754524|FG001|Overall Study|Withdrawal by Subject|102|||
161920143|NCT00143507|584754523|FG000|Overall Study|Lost to Follow-up|1|||
161920144|NCT00143507|584754524|FG001|Overall Study|Lost to Follow-up|0|||
161920145|NCT00143507|584754523|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
161920146|NCT00143507|584754524|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
161920147|NCT00177671|584754525|FG000|Overall Study|Withdrawal by Subject|5|||
161920148|NCT00177671|584754526|FG001|Overall Study|Withdrawal by Subject|6|||
161920149|NCT00177671|584754525|FG000|Overall Study|medical complications|2|||
161920150|NCT00177671|584754526|FG001|Overall Study|medical complications|0|||
161920151|NCT00177671|584754525|FG000|Overall Study|Adverse Event|6|||
161920152|NCT00177671|584754526|FG001|Overall Study|Adverse Event|0|||
161920153|NCT00177671|584754525|FG000|Overall Study|Physician Decision|12|||
161920154|NCT00177671|584754526|FG001|Overall Study|Physician Decision|8|||
161920155|NCT00690898|584754527|FG000|SCREENING|Screen failure|18|||
161920156|NCT00690898|584754527|FG000|TREATMENT|Adverse Event|3|||
161920157|NCT00690898|584754527|FG000|TREATMENT|Lack of Efficacy|18|||
161920158|NCT00690898|584754527|FG000|TREATMENT|Withdrawal by Subject|4|||
161920159|NCT00690898|584754527|FG000|TREATMENT|Other (not otherwise specified)|1|||
161920160|NCT01121926|584754528|FG000|First Intervention Period|Adverse Event|1|||
161920161|NCT01121926|584754529|FG001|First Intervention Period|Adverse Event|0|||
161920162|NCT01121926|584754528|FG000|Washout Period|Adverse Event|0|||
161920163|NCT01121926|584754529|FG001|Washout Period|Adverse Event|1|||
161920164|NCT01121926|584754528|FG000|Washout Period|Positive pregnancy test|0|||
161920165|NCT01121926|584754529|FG001|Washout Period|Positive pregnancy test|1|||
161920166|NCT02782468|584754530|FG000|Overall Study|Progressive Disease|2|||
161920167|NCT02782468|584754531|FG001|Overall Study|Progressive Disease|5|||
161920168|NCT02782468|584754532|FG002|Overall Study|Progressive Disease|0|||
161920169|NCT02782468|584754533|FG003|Overall Study|Progressive Disease|4|||
161920170|NCT02782468|584754530|FG000|Overall Study|Adverse Event|0|||
161920171|NCT02782468|584754531|FG001|Overall Study|Adverse Event|2|||
161920172|NCT02782468|584754532|FG002|Overall Study|Adverse Event|2|||
161920173|NCT02782468|584754533|FG003|Overall Study|Adverse Event|3|||
161920174|NCT02782468|584754530|FG000|Overall Study|Other|0|||
161920175|NCT02782468|584754531|FG001|Overall Study|Other|0|||
161920176|NCT02782468|584754532|FG002|Overall Study|Other|1|||
161920177|NCT02782468|584754533|FG003|Overall Study|Other|1|||
161920178|NCT02782468|584754530|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161920179|NCT02782468|584754531|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161920180|NCT02782468|584754532|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161920181|NCT02782468|584754533|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
161920182|NCT02782468|584754530|FG000|Overall Study|Symptomatic Deterioration|0|||
161920183|NCT02782468|584754531|FG001|Overall Study|Symptomatic Deterioration|0|||
161920184|NCT02782468|584754532|FG002|Overall Study|Symptomatic Deterioration|0|||
161920185|NCT02782468|584754533|FG003|Overall Study|Symptomatic Deterioration|1|||
161920186|NCT02782468|584754530|FG000|Overall Study|Withdrawal by Subject|1|||
161920187|NCT02782468|584754531|FG001|Overall Study|Withdrawal by Subject|0|||
161920188|NCT02782468|584754532|FG002|Overall Study|Withdrawal by Subject|0|||
161920189|NCT02782468|584754533|FG003|Overall Study|Withdrawal by Subject|0|||
161920190|NCT00356590|584754534|FG000|Overall Study|Adverse Event|54|||
161920191|NCT00356590|584754534|FG000|Overall Study|Death|10|||
161920192|NCT00356590|584754534|FG000|Overall Study|Lost to Follow-up|35|||
161920193|NCT00356590|584754534|FG000|Overall Study|Physician Decision|46|||
161920194|NCT00356590|584754534|FG000|Overall Study|Withdrawal by Subject|41|||
161920195|NCT00356590|584754534|FG000|Overall Study|Completed month 12 only|2|||
161920196|NCT00356590|584754534|FG000|Overall Study|Protocol issues|6|||
161920197|NCT00356590|584754534|FG000|Overall Study|Response status|28|||
161920198|NCT00356590|584754534|FG000|Overall Study|Other|52|||
161920199|NCT01496456|584754536|FG000|Overall Study|Protocol Violation|1|||
161920200|NCT01496456|584754536|FG000|Overall Study|Lost to Follow-up|7|||
161920201|NCT04919161|584754537|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
161920202|NCT04919161|584754538|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
161920203|NCT04919161|584754537|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
161920204|NCT04919161|584754538|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
161920205|NCT04919161|584754537|FG000|Overall Study|Acute ankle sprain after session 1|0|||
161920206|NCT04919161|584754538|FG001|Overall Study|Acute ankle sprain after session 1|1|||
161920207|NCT02175758|584754539|FG000|Treatment Phase|Lost to Follow-up|0|||
161920208|NCT02175758|584754540|FG001|Treatment Phase|Lost to Follow-up|1|||
161920209|NCT02175758|584754541|FG002|Treatment Phase|Lost to Follow-up|0|||
161920210|NCT02175758|584754542|FG003|Treatment Phase|Lost to Follow-up|0|||
161920211|NCT02175758|584754543|FG004|Treatment Phase|Lost to Follow-up|0|||
161920212|NCT02175758|584754544|FG005|Treatment Phase|Lost to Follow-up|0|||
161920213|NCT02175758|584754539|FG000|Treatment Phase|Adverse Event|0|||
161920214|NCT02175758|584754540|FG001|Treatment Phase|Adverse Event|0|||
161920215|NCT02175758|584754541|FG002|Treatment Phase|Adverse Event|0|||
161920216|NCT02175758|584754542|FG003|Treatment Phase|Adverse Event|0|||
161920217|NCT02175758|584754543|FG004|Treatment Phase|Adverse Event|1|||
161920218|NCT02175758|584754544|FG005|Treatment Phase|Adverse Event|0|||
161920219|NCT02489773|584754545|FG000|Overall Study|Lost to Follow-up|4|||
161920220|NCT02489773|584754546|FG001|Overall Study|Lost to Follow-up|1|||
161920221|NCT02489773|584754545|FG000|Overall Study|Physician Decision|1|||
161920222|NCT02489773|584754546|FG001|Overall Study|Physician Decision|0|||
161920223|NCT02489773|584754545|FG000|Overall Study|Withdrawal by Subject|1|||
161920224|NCT02489773|584754546|FG001|Overall Study|Withdrawal by Subject|0|||
161920225|NCT02489773|584754545|FG000|Overall Study|Leave the country or the state|1|||
161920226|NCT02489773|584754546|FG001|Overall Study|Leave the country or the state|1|||
161920227|NCT00712920|584754547|FG000|Overall Study|Adverse Event|3|||
161920228|NCT00712920|584754548|FG001|Overall Study|Adverse Event|4|||
161920229|NCT00712920|584754549|FG002|Overall Study|Adverse Event|7|||
161920230|NCT00712920|584754547|FG000|Overall Study|Withdrawal by Subject|4|||
161920231|NCT00712920|584754548|FG001|Overall Study|Withdrawal by Subject|2|||
161920232|NCT00712920|584754549|FG002|Overall Study|Withdrawal by Subject|1|||
161920233|NCT00712920|584754547|FG000|Overall Study|Lost to Follow-up|1|||
161920234|NCT00712920|584754548|FG001|Overall Study|Lost to Follow-up|4|||
161920235|NCT00712920|584754549|FG002|Overall Study|Lost to Follow-up|0|||
161920236|NCT00712920|584754547|FG000|Overall Study|Lack of Efficacy|1|||
161920237|NCT00712920|584754548|FG001|Overall Study|Lack of Efficacy|0|||
161920238|NCT00712920|584754549|FG002|Overall Study|Lack of Efficacy|1|||
161920239|NCT00712920|584754547|FG000|Overall Study|Other|5|||
161920240|NCT00712920|584754548|FG001|Overall Study|Other|7|||
161920241|NCT00712920|584754549|FG002|Overall Study|Other|3|||
161920242|NCT00712920|584754547|FG000|Overall Study|Non-compliance|3|||
161920243|NCT00712920|584754548|FG001|Overall Study|Non-compliance|0|||
161920244|NCT00712920|584754549|FG002|Overall Study|Non-compliance|0|||
161577037|NCT00309907|583499726|FG000|Overall Study|Major infectious event|4|||
161577038|NCT00494780|583499727|FG000|Overall Study|Adverse Event|1|||
161577039|NCT00494780|583499728|FG001|Overall Study|Adverse Event|0|||
161577040|NCT00494780|583499727|FG000|Overall Study|Withdrew before Dosed|0|||
161577041|NCT00494780|583499728|FG001|Overall Study|Withdrew before Dosed|1|||
161577042|NCT00494780|583499727|FG000|Overall Study|Progression of Study Disease|7|||
161577043|NCT00494780|583499728|FG001|Overall Study|Progression of Study Disease|8|||
161577044|NCT00494780|583499727|FG000|Overall Study|New Treatment|2|||
161577045|NCT00494780|583499728|FG001|Overall Study|New Treatment|2|||
161577046|NCT00494780|583499727|FG000|Overall Study|Non-compliance|1|||
161577047|NCT00494780|583499728|FG001|Overall Study|Non-compliance|0|||
161577048|NCT00494780|583499727|FG000|Overall Study|Residual Tumour Mass|0|||
161577049|NCT00494780|583499728|FG001|Overall Study|Residual Tumour Mass|1|||
161577050|NCT00494780|583499727|FG000|Overall Study|Insurance Issues|0|||
161577051|NCT00494780|583499728|FG001|Overall Study|Insurance Issues|1|||
161577052|NCT01641198|583499729|FG000|After 12 Months of Function|Lost to Follow-up|3|||
161577053|NCT01641198|583499730|FG001|After 12 Months of Function|Lost to Follow-up|2|||
161577054|NCT01641198|583499731|FG002|After 12 Months of Function|Lost to Follow-up|2|||
161577055|NCT01641198|583499729|FG000|After 12 Months of Function|Protocol Violation|1|||
161577056|NCT01641198|583499730|FG001|After 12 Months of Function|Protocol Violation|0|||
161577057|NCT01641198|583499731|FG002|After 12 Months of Function|Protocol Violation|0|||
161577058|NCT01641198|583499729|FG000|After 12 Months of Function|Adverse Event|0|||
161577059|NCT01641198|583499730|FG001|After 12 Months of Function|Adverse Event|1|||
161577060|NCT01641198|583499731|FG002|After 12 Months of Function|Adverse Event|0|||
161577061|NCT01641198|583499729|FG000|After 24 Months of Function|Lost to Follow-up|4|||
161577062|NCT01641198|583499730|FG001|After 24 Months of Function|Lost to Follow-up|9|||
161577063|NCT01641198|583499731|FG002|After 24 Months of Function|Lost to Follow-up|6|||
161577064|NCT01641198|583499729|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
161577065|NCT01641198|583499730|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
161577066|NCT01641198|583499731|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
161577067|NCT01641198|583499729|FG000|At 15-20 Years of Function|Death|1|||
161577068|NCT01641198|583499730|FG001|At 15-20 Years of Function|Death|0|||
161577069|NCT01641198|583499731|FG002|At 15-20 Years of Function|Death|1|||
161577070|NCT00346151|583499732|FG000|Overall Study|Withdrawal by Subject|3|||
161577071|NCT01075217|583499733|FG000|Overall Study|Adverse Event|1|||
161577072|NCT01075217|583499734|FG001|Overall Study|Adverse Event|1|||
161577073|NCT01075217|583499733|FG000|Overall Study|Physician Decision|1|||
161577074|NCT01075217|583499734|FG001|Overall Study|Physician Decision|0|||
161920245|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
161920246|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
161920247|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
161920248|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
161920249|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
161920250|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
161920251|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920252|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920253|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
161920254|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
161920255|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
161920256|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
161920257|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
161920258|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
161920259|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
161577075|NCT03260140|583499735|FG000|Overall Study|Death|4|||
161920260|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
161920261|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920262|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
161920263|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920264|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920265|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161920266|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
161920267|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161920268|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161920269|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
161920270|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
161920271|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
161920272|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
161920273|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
161920274|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
161920275|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
161920276|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
161920277|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
161920278|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
161920279|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
161920280|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
161920281|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
161920282|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
161920283|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
161920284|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
161920285|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
161920286|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
161920287|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
161920288|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
161920289|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
161920290|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
161920291|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
161920292|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
161920293|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
161920294|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
161920295|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
161920296|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
161920297|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
161920298|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
161920299|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
161920300|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
161920301|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
161920302|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
161920303|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
161920304|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
161920305|NCT02550795|584754563|FG000|Overall Study|Physician Decision|0|||
161920306|NCT02550795|584754564|FG001|Overall Study|Physician Decision|1|||
161920307|NCT02550795|584754565|FG002|Overall Study|Physician Decision|0|||
161920308|NCT02225587|584754566|FG000|Overall Study|Adverse Event|5|||
161920309|NCT02225587|584754567|FG001|Overall Study|Adverse Event|5|||
161920310|NCT02225587|584754566|FG000|Overall Study|Lost to Follow-up|5|||
161920311|NCT02225587|584754567|FG001|Overall Study|Lost to Follow-up|5|||
161920312|NCT02225587|584754566|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161920313|NCT02225587|584754567|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161920314|NCT02225587|584754566|FG000|Overall Study|Physician Decision|2|||
161920315|NCT02225587|584754567|FG001|Overall Study|Physician Decision|0|||
161920316|NCT02225587|584754566|FG000|Overall Study|Protocol Violation|1|||
161920317|NCT02225587|584754567|FG001|Overall Study|Protocol Violation|0|||
161920318|NCT02225587|584754566|FG000|Overall Study|Participant Moved|1|||
161920319|NCT02225587|584754567|FG001|Overall Study|Participant Moved|0|||
161920320|NCT02225587|584754566|FG000|Overall Study|Withdrawal by Subject|13|||
161920321|NCT02225587|584754567|FG001|Overall Study|Withdrawal by Subject|28|||
161920322|NCT03483584|584754570|FG000|Overall Study|Lost to Follow-up|40|||
161920323|NCT03483584|584754571|FG001|Overall Study|Lost to Follow-up|7|||
161920324|NCT03483584|584754570|FG000|Overall Study|Withdrawal by Subject|4|||
161920325|NCT03483584|584754571|FG001|Overall Study|Withdrawal by Subject|1|||
161920326|NCT02879695|584754572|FG000|Overall Study|Did not start study treatment|2|||
161920327|NCT02879695|584754573|FG001|Overall Study|Did not start study treatment|0|||
161920328|NCT02879695|584754574|FG002|Overall Study|Did not start study treatment|3|||
161920329|NCT02879695|584754575|FG003|Overall Study|Did not start study treatment|0|||
161920330|NCT04063163|584754576|FG000|Overall Study|Death|281|||
161920331|NCT04063163|584754577|FG001|Overall Study|Death|166|||
161920332|NCT04063163|584754576|FG000|Overall Study|Lost to Follow-up|12|||
161920333|NCT04063163|584754577|FG001|Overall Study|Lost to Follow-up|8|||
161920334|NCT04063163|584754576|FG000|Overall Study|Withdrawal by Subject|19|||
161920335|NCT04063163|584754577|FG001|Overall Study|Withdrawal by Subject|10|||
161920336|NCT02572167|584754578|FG000|Overall Study|Withdrawal by Subject|0|||
161814704|NCT00418938|584365387|FG001|Overall Study|On-going|1|||
161814705|NCT00418938|584365386|FG000|Overall Study|Ineligibility Determined|1|||
161814706|NCT00418938|584365387|FG001|Overall Study|Ineligibility Determined|0|||
161814707|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
161814708|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
161814709|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
161814710|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
161814711|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
161814712|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
161814713|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Death|9|||
161814714|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Death|7|||
161814715|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Death|14|||
161814716|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Death|7|||
161814717|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Death|0|||
161814718|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Death|0|||
161814719|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
161814720|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
161814721|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
161814722|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
161814723|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
161814724|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
161814725|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Other Event|49|||
161814726|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Other Event|52|||
161814727|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Other Event|41|||
161814728|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Other Event|58|||
161814729|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Other Event|0|||
161814730|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Other Event|0|||
161814731|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
161814732|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
161814733|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
161814734|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
161814735|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
161814736|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
161814737|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
161814738|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
161814739|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
161814740|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
161814741|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
161814742|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
161814743|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
161814744|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
161814745|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
161814746|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
161814747|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
161814748|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
161814749|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
161814750|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
161814751|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
161814752|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
161814753|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
161814754|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
161814755|NCT00205777|584365388|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
161814756|NCT00205777|584365389|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
161814757|NCT00205777|584365390|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
161814758|NCT00205777|584365391|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
161814759|NCT00205777|584365392|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
161814760|NCT00205777|584365393|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
161814761|NCT00205777|584365388|FG000|Completed Core Study, Entered SE I|Other Event|52|||
161814762|NCT00205777|584365389|FG001|Completed Core Study, Entered SE I|Other Event|46|||
161814763|NCT00205777|584365390|FG002|Completed Core Study, Entered SE I|Other Event|47|||
161814764|NCT00205777|584365391|FG003|Completed Core Study, Entered SE I|Other Event|50|||
161814765|NCT00205777|584365392|FG004|Completed Core Study, Entered SE I|Other Event|0|||
161814766|NCT00205777|584365393|FG005|Completed Core Study, Entered SE I|Other Event|0|||
161814767|NCT00205777|584365388|FG000|Study Extension I|Adverse Event|57|||
161814768|NCT00205777|584365389|FG001|Study Extension I|Adverse Event|0|||
161814769|NCT00205777|584365390|FG002|Study Extension I|Adverse Event|0|||
161814770|NCT00205777|584365391|FG003|Study Extension I|Adverse Event|61|||
161814771|NCT00205777|584365392|FG004|Study Extension I|Adverse Event|58|||
161814772|NCT00205777|584365393|FG005|Study Extension I|Adverse Event|0|||
161814773|NCT00205777|584365388|FG000|Study Extension I|Death|5|||
161814774|NCT00205777|584365389|FG001|Study Extension I|Death|0|||
161814775|NCT00205777|584365390|FG002|Study Extension I|Death|0|||
161920337|NCT02572167|584754579|FG001|Overall Study|Withdrawal by Subject|3|||
161920338|NCT02572167|584754580|FG002|Overall Study|Withdrawal by Subject|0|||
161920339|NCT02572167|584754578|FG000|Overall Study|Lost to Follow-up|2|||
161920340|NCT02572167|584754579|FG001|Overall Study|Lost to Follow-up|5|||
161920341|NCT02572167|584754580|FG002|Overall Study|Lost to Follow-up|3|||
161920342|NCT02572167|584754578|FG000|Overall Study|Death|0|||
161920343|NCT02572167|584754579|FG001|Overall Study|Death|8|||
161920344|NCT02572167|584754580|FG002|Overall Study|Death|3|||
161920345|NCT02572167|584754578|FG000|Overall Study|Did not meet inclusion criteria|0|||
161920346|NCT02572167|584754579|FG001|Overall Study|Did not meet inclusion criteria|0|||
161920347|NCT02572167|584754580|FG002|Overall Study|Did not meet inclusion criteria|1|||
161920348|NCT02572167|584754578|FG000|Overall Study|Study closure by Sponsor|4|||
161920349|NCT02572167|584754579|FG001|Overall Study|Study closure by Sponsor|40|||
161920350|NCT02572167|584754580|FG002|Overall Study|Study closure by Sponsor|24|||
161920351|NCT00005047|584754581|FG000|Overall Study|Withdrawal by Subject|12|||
161920352|NCT00005047|584754582|FG001|Overall Study|Withdrawal by Subject|0|||
161920353|NCT00005047|584754583|FG002|Overall Study|Withdrawal by Subject|0|||
161920354|NCT00005047|584754584|FG003|Overall Study|Withdrawal by Subject|0|||
161920355|NCT00005047|584754581|FG000|Overall Study|Adverse Event|5|||
161920356|NCT00005047|584754582|FG001|Overall Study|Adverse Event|0|||
161920357|NCT00005047|584754583|FG002|Overall Study|Adverse Event|0|||
161920358|NCT00005047|584754584|FG003|Overall Study|Adverse Event|0|||
161920359|NCT00005047|584754581|FG000|Overall Study|Lost to Follow-up|1|||
161920360|NCT00005047|584754582|FG001|Overall Study|Lost to Follow-up|0|||
161920361|NCT00005047|584754583|FG002|Overall Study|Lost to Follow-up|0|||
161920362|NCT00005047|584754584|FG003|Overall Study|Lost to Follow-up|0|||
161920363|NCT00005047|584754581|FG000|Overall Study|Lack of Efficacy|1|||
161920364|NCT00005047|584754582|FG001|Overall Study|Lack of Efficacy|0|||
161920365|NCT00005047|584754583|FG002|Overall Study|Lack of Efficacy|0|||
161920366|NCT00005047|584754584|FG003|Overall Study|Lack of Efficacy|0|||
161920367|NCT03036254|584754587|FG000|Overall Study|Adverse Event|6|||
161920368|NCT03036254|584754588|FG001|Overall Study|Adverse Event|4|||
161920369|NCT03036254|584754587|FG000|Overall Study|Death|3|||
161920370|NCT03036254|584754588|FG001|Overall Study|Death|1|||
161920371|NCT03036254|584754587|FG000|Overall Study|Lack of Efficacy|5|||
161920372|NCT03036254|584754588|FG001|Overall Study|Lack of Efficacy|1|||
161920373|NCT03036254|584754587|FG000|Overall Study|Withdrawal by Subject|3|||
161920374|NCT03036254|584754588|FG001|Overall Study|Withdrawal by Subject|5|||
161920375|NCT04556097|584754589|FG000|Overall Study|Death|0|||
161920376|NCT04556097|584754590|FG001|Overall Study|Death|5|||
161920377|NCT04556097|584754591|FG002|Overall Study|Death|0|||
161920378|NCT04556097|584754592|FG003|Overall Study|Death|0|||
161920379|NCT04556097|584754589|FG000|Overall Study|No caregiver|43|||
161920380|NCT04556097|584754590|FG001|Overall Study|No caregiver|53|||
161920381|NCT04556097|584754591|FG002|Overall Study|No caregiver|0|||
161474880|NCT01972568|583132551|FG000|Overall Study|Adverse Event|5|||
161474881|NCT01972568|583132552|FG001|Overall Study|Adverse Event|6|||
161474882|NCT01972568|583132553|FG002|Overall Study|Adverse Event|5|||
161920382|NCT04556097|584754592|FG003|Overall Study|No caregiver|0|||
161920383|NCT04556097|584754589|FG000|Overall Study|Ineligible, SNF|2|||
161920384|NCT04556097|584754590|FG001|Overall Study|Ineligible, SNF|2|||
161920385|NCT04556097|584754591|FG002|Overall Study|Ineligible, SNF|0|||
161474883|NCT02059408|583132557|FG000|Overall Study|Did not get tested|0|||
161474884|NCT02059408|583132558|FG001|Overall Study|Did not get tested|330|||
161920386|NCT04556097|584754592|FG003|Overall Study|Ineligible, SNF|0|||
161920387|NCT04556097|584754589|FG000|Overall Study|Ineligible, health|3|||
161920388|NCT04556097|584754590|FG001|Overall Study|Ineligible, health|4|||
161920389|NCT04556097|584754591|FG002|Overall Study|Ineligible, health|0|||
161920390|NCT04556097|584754592|FG003|Overall Study|Ineligible, health|0|||
161920391|NCT04556097|584754589|FG000|Overall Study|Ineligible, language|0|||
161577076|NCT03260140|583499736|FG001|Overall Study|Death|1|||
161577077|NCT03260140|583499735|FG000|Overall Study|Withdrawal by Subject|1|||
161577078|NCT03260140|583499736|FG001|Overall Study|Withdrawal by Subject|4|||
161577079|NCT00463788|583499737|FG000|Overall Study|Progressive Disease|86|||
161577080|NCT00463788|583499738|FG001|Overall Study|Progressive Disease|42|||
161577081|NCT00463788|583499737|FG000|Overall Study|Adverse Event|6|||
161577082|NCT00463788|583499738|FG001|Overall Study|Adverse Event|2|||
161577083|NCT00463788|583499737|FG000|Overall Study|Withdrawal by Subject|6|||
161577084|NCT00463788|583499738|FG001|Overall Study|Withdrawal by Subject|2|||
161577085|NCT00463788|583499737|FG000|Overall Study|Death|4|||
161577086|NCT00463788|583499738|FG001|Overall Study|Death|3|||
161577087|NCT00463788|583499737|FG000|Overall Study|Symptomatic Deterioration|2|||
161577088|NCT00463788|583499738|FG001|Overall Study|Symptomatic Deterioration|3|||
161577089|NCT00463788|583499737|FG000|Overall Study|Lost to Follow-up|1|||
161577090|NCT00463788|583499738|FG001|Overall Study|Lost to Follow-up|0|||
161577091|NCT00463788|583499737|FG000|Overall Study|Protocol Violation|0|||
161577092|NCT00463788|583499738|FG001|Overall Study|Protocol Violation|1|||
161577093|NCT00463788|583499737|FG000|Overall Study|Other|3|||
161577094|NCT00463788|583499738|FG001|Overall Study|Other|0|||
161577095|NCT00463788|583499737|FG000|Overall Study|Randomized but not treated|1|||
161577096|NCT00463788|583499738|FG001|Overall Study|Randomized but not treated|1|||
161577097|NCT00360698|583499739|FG000|Run-In|Physician Decision|0|||
161577098|NCT00360698|583499740|FG001|Run-In|Physician Decision|1|||
161577099|NCT00360698|583499739|FG000|Run-In|Withdrawal by Subject|0|||
161577100|NCT00360698|583499740|FG001|Run-In|Withdrawal by Subject|2|||
161577101|NCT00360698|583499739|FG000|Run-In|Non compliance with treatment procedure|0|||
161577102|NCT00360698|583499740|FG001|Run-In|Non compliance with treatment procedure|1|||
161577103|NCT00360698|583499739|FG000|Run-In|Sponsor request|0|||
161577104|NCT00360698|583499740|FG001|Run-In|Sponsor request|2|||
161577105|NCT00360698|583499739|FG000|Run-In|Patient did not meet inclusion criteria|0|||
161577106|NCT00360698|583499740|FG001|Run-In|Patient did not meet inclusion criteria|1|||
161577107|NCT00360698|583499739|FG000|Run-In|Patient personal reasons|0|||
161577108|NCT00360698|583499740|FG001|Run-In|Patient personal reasons|2|||
161577109|NCT00360698|583499739|FG000|Run-In|Need of insulin with meals|0|||
161577110|NCT00360698|583499740|FG001|Run-In|Need of insulin with meals|1|||
161814776|NCT00205777|584365391|FG003|Study Extension I|Death|1|||
161814777|NCT00205777|584365392|FG004|Study Extension I|Death|2|||
161814778|NCT00205777|584365393|FG005|Study Extension I|Death|0|||
161814779|NCT00205777|584365388|FG000|Study Extension I|Withdrawal by Subject|99|||
161814780|NCT00205777|584365389|FG001|Study Extension I|Withdrawal by Subject|0|||
161814781|NCT00205777|584365390|FG002|Study Extension I|Withdrawal by Subject|0|||
161814782|NCT00205777|584365391|FG003|Study Extension I|Withdrawal by Subject|106|||
161814783|NCT00205777|584365392|FG004|Study Extension I|Withdrawal by Subject|89|||
161814784|NCT00205777|584365393|FG005|Study Extension I|Withdrawal by Subject|0|||
161814785|NCT00205777|584365388|FG000|Study Extension I|Protocol Violation|4|||
161814786|NCT00205777|584365389|FG001|Study Extension I|Protocol Violation|0|||
161814787|NCT00205777|584365390|FG002|Study Extension I|Protocol Violation|0|||
161814788|NCT00205777|584365391|FG003|Study Extension I|Protocol Violation|8|||
161814789|NCT00205777|584365392|FG004|Study Extension I|Protocol Violation|8|||
161814790|NCT00205777|584365393|FG005|Study Extension I|Protocol Violation|0|||
161814791|NCT00205777|584365388|FG000|Study Extension I|Lack of Efficacy|0|||
161814792|NCT00205777|584365389|FG001|Study Extension I|Lack of Efficacy|0|||
161814793|NCT00205777|584365390|FG002|Study Extension I|Lack of Efficacy|0|||
161814794|NCT00205777|584365391|FG003|Study Extension I|Lack of Efficacy|1|||
161814795|NCT00205777|584365392|FG004|Study Extension I|Lack of Efficacy|2|||
161814796|NCT00205777|584365393|FG005|Study Extension I|Lack of Efficacy|0|||
161814797|NCT00205777|584365388|FG000|Study Extension I|Failed to return|15|||
161814798|NCT00205777|584365389|FG001|Study Extension I|Failed to return|0|||
161814799|NCT00205777|584365390|FG002|Study Extension I|Failed to return|0|||
161814800|NCT00205777|584365391|FG003|Study Extension I|Failed to return|17|||
161814801|NCT00205777|584365392|FG004|Study Extension I|Failed to return|13|||
161814802|NCT00205777|584365393|FG005|Study Extension I|Failed to return|0|||
161814803|NCT00205777|584365388|FG000|Study Extension I|Other Event|34|||
161814804|NCT00205777|584365389|FG001|Study Extension I|Other Event|0|||
161814805|NCT00205777|584365390|FG002|Study Extension I|Other Event|0|||
161814806|NCT00205777|584365391|FG003|Study Extension I|Other Event|34|||
161814807|NCT00205777|584365392|FG004|Study Extension I|Other Event|29|||
161814808|NCT00205777|584365393|FG005|Study Extension I|Other Event|0|||
161814809|NCT00205777|584365388|FG000|Study Extension I|Withdrawn as per protocol|0|||
161814810|NCT00205777|584365389|FG001|Study Extension I|Withdrawn as per protocol|0|||
161814811|NCT00205777|584365390|FG002|Study Extension I|Withdrawn as per protocol|1070|||
161814812|NCT00205777|584365391|FG003|Study Extension I|Withdrawn as per protocol|0|||
161814813|NCT00205777|584365392|FG004|Study Extension I|Withdrawn as per protocol|0|||
161814814|NCT00205777|584365393|FG005|Study Extension I|Withdrawn as per protocol|0|||
161814815|NCT00205777|584365388|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
161920392|NCT04556097|584754590|FG001|Overall Study|Ineligible, language|1|||
161920393|NCT04556097|584754591|FG002|Overall Study|Ineligible, language|0|||
161920394|NCT04556097|584754592|FG003|Overall Study|Ineligible, language|0|||
161920395|NCT04556097|584754589|FG000|Overall Study|Ineligible, no longer in care management|0|||
161920396|NCT04556097|584754590|FG001|Overall Study|Ineligible, no longer in care management|2|||
161920397|NCT04556097|584754591|FG002|Overall Study|Ineligible, no longer in care management|1|||
161920398|NCT04556097|584754592|FG003|Overall Study|Ineligible, no longer in care management|0|||
161920399|NCT04556097|584754589|FG000|Overall Study|No dementia|13|||
161920400|NCT04556097|584754590|FG001|Overall Study|No dementia|3|||
161920401|NCT04556097|584754591|FG002|Overall Study|No dementia|0|||
161920402|NCT04556097|584754592|FG003|Overall Study|No dementia|0|||
161920403|NCT04556097|584754589|FG000|Overall Study|Missing identifier|2|||
161920404|NCT04556097|584754590|FG001|Overall Study|Missing identifier|4|||
161920405|NCT04556097|584754591|FG002|Overall Study|Missing identifier|0|||
161920406|NCT04556097|584754592|FG003|Overall Study|Missing identifier|0|||
161920407|NCT04556097|584754589|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
161920408|NCT04556097|584754590|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
161920409|NCT04556097|584754591|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
161920410|NCT04556097|584754592|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
161920411|NCT05436613|584754593|FG000|Overall Study|Lost to Follow-up|9|||
161920412|NCT05436613|584754593|FG000|Overall Study|Withdrawal by Subject|3|||
161920413|NCT05317546|584754596|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
161920414|NCT05317546|584754597|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
161920415|NCT04364646|584754598|FG000|Overall Study|Lost to Follow-up|1|||
161920416|NCT04364646|584754599|FG001|Overall Study|Lost to Follow-up|0|||
161920417|NCT04364646|584754598|FG000|Overall Study|Withdrawal by Subject|7|||
161920418|NCT04364646|584754599|FG001|Overall Study|Withdrawal by Subject|14|||
161920419|NCT04364646|584754598|FG000|Overall Study|Protocol Violation|4|||
161920420|NCT04364646|584754599|FG001|Overall Study|Protocol Violation|5|||
161920421|NCT02555878|584754613|FG000|Overall Study|Lost to Follow-up|2|||
161920422|NCT02555878|584754614|FG001|Overall Study|Lost to Follow-up|3|||
161920423|NCT02555878|584754613|FG000|Overall Study|Withdrawal by Subject|48|||
161920424|NCT02555878|584754614|FG001|Overall Study|Withdrawal by Subject|48|||
161920425|NCT02555878|584754613|FG000|Overall Study|Adverse Event|12|||
161920426|NCT02555878|584754614|FG001|Overall Study|Adverse Event|8|||
161920427|NCT02555878|584754613|FG000|Overall Study|Death|74|||
161920428|NCT02555878|584754614|FG001|Overall Study|Death|59|||
161920429|NCT02555878|584754613|FG000|Overall Study|Protocol Violation|1|||
161920430|NCT02555878|584754614|FG001|Overall Study|Protocol Violation|2|||
161920431|NCT02555878|584754613|FG000|Overall Study|Physician Decision|12|||
161920432|NCT02555878|584754614|FG001|Overall Study|Physician Decision|13|||
161920433|NCT02555878|584754613|FG000|Overall Study|Other|17|||
161920434|NCT02555878|584754614|FG001|Overall Study|Other|17|||
161920435|NCT00765076|584754615|FG000|Overall Study|Adverse Event|1|||
161920436|NCT00765076|584754616|FG001|Overall Study|Adverse Event|0|||
161920437|NCT00765076|584754617|FG002|Overall Study|Adverse Event|0|||
161920438|NCT00765076|584754615|FG000|Overall Study|Withdrawal by Subject|0|||
161920439|NCT00765076|584754616|FG001|Overall Study|Withdrawal by Subject|0|||
161920440|NCT00765076|584754617|FG002|Overall Study|Withdrawal by Subject|1|||
161920441|NCT01164475|584754618|FG000|Overall Study|Lack of Efficacy|1|||
161920442|NCT01164475|584754619|FG001|Overall Study|Lack of Efficacy|0|||
161920443|NCT01164475|584754618|FG000|Overall Study|Other|0|||
161920444|NCT01164475|584754619|FG001|Overall Study|Other|1|||
161920445|NCT01164475|584754618|FG000|Overall Study|Progressive disease|0|||
161920446|NCT01164475|584754619|FG001|Overall Study|Progressive disease|1|||
161920447|NCT01164475|584754618|FG000|Overall Study|Protocol Violation|1|||
161920448|NCT01164475|584754619|FG001|Overall Study|Protocol Violation|0|||
161920449|NCT02335944|584754620|FG000|Treatment Phase|Progressive Disease|2|||
161920450|NCT02335944|584754621|FG001|Treatment Phase|Progressive Disease|5|||
161920451|NCT02335944|584754622|FG002|Treatment Phase|Progressive Disease|2|||
161920452|NCT02335944|584754623|FG003|Treatment Phase|Progressive Disease|11|||
161920453|NCT02335944|584754624|FG004|Treatment Phase|Progressive Disease|4|||
161920454|NCT02335944|584754625|FG005|Treatment Phase|Progressive Disease|25|||
161920455|NCT02335944|584754626|FG006|Treatment Phase|Progressive Disease|2|||
161920456|NCT02335944|584754627|FG007|Treatment Phase|Progressive Disease|30|||
161920457|NCT02335944|584754628|FG008|Treatment Phase|Progressive Disease|27|||
161474885|NCT02059408|583132559|FG002|Overall Study|Did not get tested|358|||
161474886|NCT00508755|583132562|FG000|Overall Study|Withdrawal by Subject|1|||
161920458|NCT02335944|584754629|FG009|Treatment Phase|Progressive Disease|0|||
161920459|NCT02335944|584754620|FG000|Treatment Phase|Adverse Event|2|||
161920460|NCT02335944|584754621|FG001|Treatment Phase|Adverse Event|0|||
161920461|NCT02335944|584754622|FG002|Treatment Phase|Adverse Event|0|||
161920462|NCT02335944|584754623|FG003|Treatment Phase|Adverse Event|2|||
161920463|NCT02335944|584754624|FG004|Treatment Phase|Adverse Event|1|||
161920464|NCT02335944|584754625|FG005|Treatment Phase|Adverse Event|15|||
161920465|NCT02335944|584754626|FG006|Treatment Phase|Adverse Event|0|||
161920466|NCT02335944|584754627|FG007|Treatment Phase|Adverse Event|5|||
161920467|NCT02335944|584754628|FG008|Treatment Phase|Adverse Event|7|||
161920468|NCT02335944|584754629|FG009|Treatment Phase|Adverse Event|0|||
161920469|NCT02335944|584754620|FG000|Treatment Phase|Physician Decision|0|||
161920470|NCT02335944|584754621|FG001|Treatment Phase|Physician Decision|0|||
161920471|NCT02335944|584754622|FG002|Treatment Phase|Physician Decision|0|||
161920472|NCT02335944|584754623|FG003|Treatment Phase|Physician Decision|1|||
161920473|NCT02335944|584754624|FG004|Treatment Phase|Physician Decision|0|||
161920474|NCT02335944|584754625|FG005|Treatment Phase|Physician Decision|6|||
161920475|NCT02335944|584754626|FG006|Treatment Phase|Physician Decision|1|||
161920476|NCT02335944|584754627|FG007|Treatment Phase|Physician Decision|2|||
161920477|NCT02335944|584754628|FG008|Treatment Phase|Physician Decision|1|||
161920478|NCT02335944|584754629|FG009|Treatment Phase|Physician Decision|0|||
161920479|NCT02335944|584754620|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
161920480|NCT02335944|584754621|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
161920481|NCT02335944|584754622|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
161920482|NCT02335944|584754623|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
161920483|NCT02335944|584754624|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
161920484|NCT02335944|584754625|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
161920485|NCT02335944|584754626|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
161920486|NCT02335944|584754627|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
161920487|NCT02335944|584754628|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
161920488|NCT02335944|584754629|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
161920489|NCT02335944|584754620|FG000|Treatment Phase|Subject/Guardian Decision|0|||
161920490|NCT02335944|584754621|FG001|Treatment Phase|Subject/Guardian Decision|0|||
161920491|NCT02335944|584754622|FG002|Treatment Phase|Subject/Guardian Decision|1|||
161920492|NCT02335944|584754623|FG003|Treatment Phase|Subject/Guardian Decision|0|||
161920493|NCT02335944|584754624|FG004|Treatment Phase|Subject/Guardian Decision|0|||
161920494|NCT02335944|584754625|FG005|Treatment Phase|Subject/Guardian Decision|1|||
161920495|NCT02335944|584754626|FG006|Treatment Phase|Subject/Guardian Decision|0|||
161920496|NCT02335944|584754627|FG007|Treatment Phase|Subject/Guardian Decision|4|||
161920497|NCT02335944|584754628|FG008|Treatment Phase|Subject/Guardian Decision|0|||
161920498|NCT02335944|584754629|FG009|Treatment Phase|Subject/Guardian Decision|0|||
161920499|NCT02335944|584754620|FG000|Post-treatment Follow-up|Progressive Disease|0|||
161920500|NCT02335944|584754621|FG001|Post-treatment Follow-up|Progressive Disease|0|||
161920501|NCT02335944|584754622|FG002|Post-treatment Follow-up|Progressive Disease|0|||
161577111|NCT00360698|583499739|FG000|Treatment Period|Non compliance with treatment procedure|1|||
161577112|NCT00360698|583499740|FG001|Treatment Period|Non compliance with treatment procedure|0|||
161577113|NCT00360698|583499739|FG000|Treatment Period|Early termination by error|0|||
161920502|NCT02335944|584754623|FG003|Post-treatment Follow-up|Progressive Disease|1|||
161920503|NCT02335944|584754624|FG004|Post-treatment Follow-up|Progressive Disease|0|||
161920504|NCT02335944|584754625|FG005|Post-treatment Follow-up|Progressive Disease|9|||
161920505|NCT02335944|584754626|FG006|Post-treatment Follow-up|Progressive Disease|0|||
161920506|NCT02335944|584754627|FG007|Post-treatment Follow-up|Progressive Disease|2|||
161920507|NCT02335944|584754628|FG008|Post-treatment Follow-up|Progressive Disease|3|||
161920508|NCT02335944|584754629|FG009|Post-treatment Follow-up|Progressive Disease|0|||
161920509|NCT02335944|584754620|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920510|NCT02335944|584754621|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920511|NCT02335944|584754622|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920512|NCT02335944|584754623|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920513|NCT02335944|584754624|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161577114|NCT00360698|583499740|FG001|Treatment Period|Early termination by error|1|||
161577115|NCT01692938|583499749|FG000|Overall Study|Protocol Deviation|1|||
161577116|NCT01692938|583499750|FG001|Overall Study|Protocol Deviation|1|||
161577117|NCT01692938|583499749|FG000|Overall Study|Study completed prior to site completion|3|||
161577118|NCT01692938|583499750|FG001|Overall Study|Study completed prior to site completion|3|||
161577119|NCT01444417|583499756|FG000|Overall Study|Ineligibility Determined|0|||
161577120|NCT01444417|583499757|FG001|Overall Study|Ineligibility Determined|1|||
161577121|NCT01444417|583499756|FG000|Overall Study|Withdrawal by Subject|2|||
161577122|NCT01444417|583499757|FG001|Overall Study|Withdrawal by Subject|0|||
161577123|NCT02423291|583499758|FG000|Overall Study|Lack of Efficacy|14|||
161577124|NCT02423291|583499758|FG000|Overall Study|Adverse Event|1|||
161577125|NCT02200770|583499759|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
161577126|NCT02200770|583499760|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
161577127|NCT02200770|583499759|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
161577128|NCT02200770|583499760|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
161577129|NCT02200770|583499759|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
161577130|NCT02200770|583499760|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
161577131|NCT02200770|583499759|FG000|Randomized-controlled Period (RCP)|Other|1|||
161577132|NCT02200770|583499760|FG001|Randomized-controlled Period (RCP)|Other|2|||
161577133|NCT02200770|583499759|FG000|Open-label Period (OLP)|Adverse Event|1|||
161577134|NCT02200770|583499760|FG001|Open-label Period (OLP)|Adverse Event|2|||
161577135|NCT02200770|583499759|FG000|Open-label Period (OLP)|Death|1|||
161577136|NCT02200770|583499760|FG001|Open-label Period (OLP)|Death|2|||
161577137|NCT02200770|583499759|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
161577138|NCT02200770|583499760|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
161577139|NCT02200770|583499759|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
161577140|NCT02200770|583499760|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
161577141|NCT02200770|583499759|FG000|Open-label Period (OLP)|Other|6|||
161577142|NCT02200770|583499760|FG001|Open-label Period (OLP)|Other|15|||
161577143|NCT05283395|583499764|FG000|Overall Study|Adverse Event|4|||
161577144|NCT05283395|583499765|FG001|Overall Study|Adverse Event|4|||
161577145|NCT05283395|583499766|FG002|Overall Study|Adverse Event|0|||
161577146|NCT05283395|583499764|FG000|Overall Study|Patient Lost to Follow-Up|0|||
161577147|NCT05283395|583499765|FG001|Overall Study|Patient Lost to Follow-Up|0|||
161577148|NCT05283395|583499766|FG002|Overall Study|Patient Lost to Follow-Up|1|||
161577149|NCT05283395|583499764|FG000|Overall Study|Patient Withdrawal|2|||
161577150|NCT05283395|583499765|FG001|Overall Study|Patient Withdrawal|4|||
161577151|NCT05283395|583499766|FG002|Overall Study|Patient Withdrawal|2|||
161577152|NCT05283395|583499764|FG000|Overall Study|Investigator Decision|1|||
161577153|NCT05283395|583499765|FG001|Overall Study|Investigator Decision|0|||
161577154|NCT05283395|583499766|FG002|Overall Study|Investigator Decision|1|||
161577155|NCT05283395|583499764|FG000|Overall Study|Enrolled in error|0|||
161577156|NCT05283395|583499765|FG001|Overall Study|Enrolled in error|0|||
161577157|NCT05283395|583499766|FG002|Overall Study|Enrolled in error|1|||
161577158|NCT02214160|583499767|FG000|Overall Study|Withdrawal by Subject|1|||
161577159|NCT02214160|583499768|FG001|Overall Study|Withdrawal by Subject|0|||
161577160|NCT02214160|583499769|FG002|Overall Study|Withdrawal by Subject|6|||
161577161|NCT02214160|583499767|FG000|Overall Study|Death|2|||
161577162|NCT02214160|583499768|FG001|Overall Study|Death|2|||
161577163|NCT02214160|583499769|FG002|Overall Study|Death|1|||
161577164|NCT02214160|583499767|FG000|Overall Study|Subject Non-Compliance|0|||
161577165|NCT02214160|583499768|FG001|Overall Study|Subject Non-Compliance|3|||
161577166|NCT02214160|583499769|FG002|Overall Study|Subject Non-Compliance|1|||
161577167|NCT02214160|583499767|FG000|Overall Study|Adverse Event|0|||
161577168|NCT02214160|583499768|FG001|Overall Study|Adverse Event|1|||
161577169|NCT02214160|583499769|FG002|Overall Study|Adverse Event|1|||
161577170|NCT02214160|583499767|FG000|Overall Study|Sponsor Decision|0|||
161577171|NCT02214160|583499768|FG001|Overall Study|Sponsor Decision|2|||
161577172|NCT02214160|583499769|FG002|Overall Study|Sponsor Decision|0|||
161577173|NCT02214160|583499767|FG000|Overall Study|Protocol Violation|1|||
161814816|NCT00205777|584365389|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161814817|NCT00205777|584365390|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161814818|NCT00205777|584365391|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
161814819|NCT00205777|584365392|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
161814820|NCT00205777|584365393|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161814821|NCT00205777|584365388|FG000|Study Extension II|Adverse Event|0|||
161814822|NCT00205777|584365389|FG001|Study Extension II|Adverse Event|0|||
161814823|NCT00205777|584365390|FG002|Study Extension II|Adverse Event|0|||
161814824|NCT00205777|584365391|FG003|Study Extension II|Adverse Event|14|||
161814825|NCT00205777|584365392|FG004|Study Extension II|Adverse Event|0|||
161814826|NCT00205777|584365393|FG005|Study Extension II|Adverse Event|30|||
161814827|NCT00205777|584365388|FG000|Study Extension II|Death|0|||
161814828|NCT00205777|584365389|FG001|Study Extension II|Death|0|||
161814829|NCT00205777|584365390|FG002|Study Extension II|Death|0|||
161577174|NCT02214160|583499768|FG001|Overall Study|Protocol Violation|0|||
161577175|NCT02214160|583499769|FG002|Overall Study|Protocol Violation|0|||
161577176|NCT02214160|583499767|FG000|Overall Study|Physician Decision|0|||
161577177|NCT02214160|583499768|FG001|Overall Study|Physician Decision|0|||
161577178|NCT02214160|583499769|FG002|Overall Study|Physician Decision|1|||
161577179|NCT01063972|583499770|FG000|Overall Study|Death|12|||
161577180|NCT01063972|583499771|FG001|Overall Study|Death|11|||
161577181|NCT01063972|583499770|FG000|Overall Study|Incarcerated|2|||
161577182|NCT01063972|583499771|FG001|Overall Study|Incarcerated|1|||
161474887|NCT00957580|583132563|FG000|Overall Study|Ongoing at data cut-off|0|||
161474888|NCT00957580|583132564|FG001|Overall Study|Ongoing at data cut-off|1|||
161474889|NCT00957580|583132565|FG002|Overall Study|Ongoing at data cut-off|0|||
161474890|NCT00957580|583132563|FG000|Overall Study|Enrolled but not treated|0|||
161474891|NCT00957580|583132564|FG001|Overall Study|Enrolled but not treated|1|||
161474892|NCT00957580|583132565|FG002|Overall Study|Enrolled but not treated|0|||
161577183|NCT01510717|583499773|FG000|Overall Study|Adverse Event|1|||
161577184|NCT01510717|583499774|FG001|Overall Study|Adverse Event|2|||
161577185|NCT01510717|583499773|FG000|Overall Study|Death|1|||
161577186|NCT01510717|583499774|FG001|Overall Study|Death|0|||
161577187|NCT01510717|583499773|FG000|Overall Study|Lost to Follow-up|0|||
161577188|NCT01510717|583499774|FG001|Overall Study|Lost to Follow-up|1|||
161577189|NCT01510717|583499773|FG000|Overall Study|Withdrawal by Subject|0|||
161577190|NCT01510717|583499774|FG001|Overall Study|Withdrawal by Subject|2|||
161577191|NCT01430611|583499776|FG000|Overall Study|Adverse Event|0|||
161577192|NCT01430611|583499777|FG001|Overall Study|Adverse Event|1|||
161577193|NCT01430611|583499776|FG000|Overall Study|Protocol Violation|1|||
161577194|NCT01430611|583499777|FG001|Overall Study|Protocol Violation|0|||
161577195|NCT01430611|583499776|FG000|Overall Study|Lost to Follow-up|1|||
161577196|NCT01430611|583499777|FG001|Overall Study|Lost to Follow-up|0|||
161577197|NCT01430611|583499776|FG000|Overall Study|Withdrawal by Subject|15|||
161577198|NCT01430611|583499777|FG001|Overall Study|Withdrawal by Subject|14|||
161577199|NCT02204982|583499778|FG000|Overall Study|Patient ineligible-medical monitor|1|||
161577200|NCT02204982|583499779|FG001|Overall Study|Patient ineligible-medical monitor|0|||
161577201|NCT02204982|583499778|FG000|Overall Study|Withdrawal by Subject|1|||
161577202|NCT02204982|583499779|FG001|Overall Study|Withdrawal by Subject|0|||
161577203|NCT02204982|583499778|FG000|Overall Study|Adverse Event|1|||
161920514|NCT02335944|584754625|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
161577204|NCT02204982|583499779|FG001|Overall Study|Adverse Event|0|||
161577205|NCT02204982|583499778|FG000|Overall Study|Adverse Event and Investigator decision|1|||
161577206|NCT02204982|583499779|FG001|Overall Study|Adverse Event and Investigator decision|0|||
161577207|NCT02204982|583499778|FG000|Overall Study|Physician Decision|0|||
161577208|NCT02204982|583499779|FG001|Overall Study|Physician Decision|2|||
161577209|NCT02204982|583499778|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
161577210|NCT02204982|583499779|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
161577211|NCT02204982|583499778|FG000|Overall Study|Termination of Study bySponsor|0|||
161577212|NCT02204982|583499779|FG001|Overall Study|Termination of Study bySponsor|1|||
161577213|NCT01968226|583499780|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
161577214|NCT00919763|583499781|FG000|Overall Study|Adverse Event|7|||
161577215|NCT00919763|583499782|FG001|Overall Study|Adverse Event|1|||
161577216|NCT00919763|583499781|FG000|Overall Study|Lost to Follow-up|1|||
161577217|NCT00919763|583499782|FG001|Overall Study|Lost to Follow-up|0|||
161920515|NCT02335944|584754626|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920516|NCT02335944|584754627|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920517|NCT02335944|584754628|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920518|NCT02335944|584754629|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920519|NCT02335944|584754620|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
161474893|NCT01187433|583132569|FG000|Overall Study|Protocol Violation|6|||
161474894|NCT01187433|583132570|FG001|Overall Study|Protocol Violation|2|||
161474895|NCT01187433|583132569|FG000|Overall Study|Withdrawal by Subject|5|||
161474896|NCT01187433|583132570|FG001|Overall Study|Withdrawal by Subject|2|||
161474897|NCT00621959|583132571|FG000|Overall Study|Adverse Event|4|||
161474898|NCT00621959|583132572|FG001|Overall Study|Adverse Event|2|||
161474899|NCT00621959|583132571|FG000|Overall Study|Lack of Efficacy|1|||
161474900|NCT00621959|583132572|FG001|Overall Study|Lack of Efficacy|1|||
161474901|NCT00621959|583132571|FG000|Overall Study|Lost to Follow-up|0|||
161474902|NCT00621959|583132572|FG001|Overall Study|Lost to Follow-up|2|||
161474903|NCT00621959|583132571|FG000|Overall Study|Withdrawal by Subject|1|||
161474904|NCT00621959|583132572|FG001|Overall Study|Withdrawal by Subject|1|||
161920520|NCT02335944|584754621|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920521|NCT02335944|584754622|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
161474905|NCT00621959|583132571|FG000|Overall Study|Other|1|||
161474906|NCT00621959|583132572|FG001|Overall Study|Other|3|||
161474907|NCT04223973|583132575|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
161577218|NCT00919763|583499781|FG000|Overall Study|Protocol Violation|1|||
161577219|NCT00919763|583499782|FG001|Overall Study|Protocol Violation|1|||
161577220|NCT00919763|583499781|FG000|Overall Study|Withdrawal by Subject|3|||
161577221|NCT00919763|583499782|FG001|Overall Study|Withdrawal by Subject|1|||
161577222|NCT00919763|583499781|FG000|Overall Study|Non-compliance|0|||
161577223|NCT00919763|583499782|FG001|Overall Study|Non-compliance|1|||
161577224|NCT04740164|583499783|FG000|Overall Study|Lack of Efficacy|4|||
161577225|NCT04740164|583499784|FG001|Overall Study|Lack of Efficacy|0|||
161577226|NCT04740164|583499783|FG000|Overall Study|Physician Decision|3|||
161577227|NCT04740164|583499784|FG001|Overall Study|Physician Decision|3|||
161577228|NCT00258895|583499790|FG000|Overall Study|Lost to Follow-up|3|||
161577229|NCT00258895|583499791|FG001|Overall Study|Lost to Follow-up|1|||
161577230|NCT00258895|583499790|FG000|Overall Study|Protocol Violation|6|||
161577231|NCT00258895|583499791|FG001|Overall Study|Protocol Violation|2|||
161577232|NCT00258895|583499790|FG000|Overall Study|Withdrawal by Subject|1|||
161577233|NCT00258895|583499791|FG001|Overall Study|Withdrawal by Subject|0|||
161577234|NCT00442117|583499792|FG000|Overall Study|Adverse Event|3|||
161577235|NCT00442117|583499793|FG001|Overall Study|Adverse Event|2|||
161577236|NCT00442117|583499792|FG000|Overall Study|Lack of Efficacy|2|||
161577237|NCT00442117|583499793|FG001|Overall Study|Lack of Efficacy|6|||
161577238|NCT00442117|583499792|FG000|Overall Study|Lost to Follow-up|1|||
161577239|NCT00442117|583499793|FG001|Overall Study|Lost to Follow-up|2|||
161577240|NCT00442117|583499792|FG000|Overall Study|Withdrawal by Subject|2|||
161577241|NCT00442117|583499793|FG001|Overall Study|Withdrawal by Subject|2|||
161577242|NCT00442117|583499792|FG000|Overall Study|Major Deviation|25|||
161577243|NCT00442117|583499793|FG001|Overall Study|Major Deviation|20|||
161577244|NCT00442117|583499792|FG000|Overall Study|Non compliance with protocol|3|||
161577245|NCT00442117|583499793|FG001|Overall Study|Non compliance with protocol|5|||
161577246|NCT00442117|583499792|FG000|Overall Study|Met Withdrawal Criteria|2|||
161577247|NCT00442117|583499793|FG001|Overall Study|Met Withdrawal Criteria|1|||
161577248|NCT01121549|583499799|FG000|Overall Study|Adverse Event|10|||
161577249|NCT01121549|583499799|FG000|Overall Study|Lack of Efficacy|11|||
161577250|NCT01121549|583499799|FG000|Overall Study|Lost to Follow-up|12|||
161577251|NCT01121549|583499799|FG000|Overall Study|Did not meet entrance criteria|9|||
161577252|NCT01121549|583499799|FG000|Overall Study|Study terminated by sponsor|197|||
161577253|NCT01121549|583499799|FG000|Overall Study|Pregnancy|1|||
161577254|NCT01121549|583499799|FG000|Overall Study|Protocol Violation|33|||
161577255|NCT01121549|583499799|FG000|Overall Study|Withdrawal by Subject|16|||
161577256|NCT01121549|583499799|FG000|Overall Study|Other|58|||
161577257|NCT03073941|583501883|FG000|Overall Study|Received non-study device intraoperatively|0|||
161577258|NCT03073941|583501884|FG001|Overall Study|Received non-study device intraoperatively|2|||
161577259|NCT03073941|583501883|FG000|Overall Study|Death|1|||
161577260|NCT03073941|583501884|FG001|Overall Study|Death|0|||
161577261|NCT03073941|583501883|FG000|Overall Study|Withdrawal by Subject|1|||
161577262|NCT03073941|583501884|FG001|Overall Study|Withdrawal by Subject|3|||
161577263|NCT03073941|583501883|FG000|Overall Study|Lost to Follow-up|5|||
161577264|NCT03073941|583501884|FG001|Overall Study|Lost to Follow-up|4|||
161577265|NCT03073941|583501883|FG000|Overall Study|Adverse Event|4|||
161577266|NCT03073941|583501884|FG001|Overall Study|Adverse Event|2|||
161577267|NCT03073941|583501883|FG000|Overall Study|Met an exclusion criterion|0|||
161577268|NCT03073941|583501884|FG001|Overall Study|Met an exclusion criterion|1|||
161577269|NCT04250883|583501886|FG000|Overall Study|Lost to Follow-up|1|||
161577270|NCT04250883|583501887|FG001|Overall Study|Lost to Follow-up|0|||
161577271|NCT02763319|583501888|FG000|Overall Study|Adverse Event|12|||
161577272|NCT02763319|583501889|FG001|Overall Study|Adverse Event|3|||
161577273|NCT02763319|583501888|FG000|Overall Study|Death|123|||
161577274|NCT02763319|583501889|FG001|Overall Study|Death|123|||
161577275|NCT02763319|583501888|FG000|Overall Study|Lost to Follow-up|6|||
161474908|NCT04223973|583132576|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
161474909|NCT04223973|583132575|FG000|Overall Study|Adverse Event|4|||
161474910|NCT04223973|583132576|FG001|Overall Study|Adverse Event|0|||
161474911|NCT04223973|583132575|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
161474912|NCT04223973|583132576|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
161474913|NCT04223973|583132575|FG000|Overall Study|Physician Decision|1|||
161474914|NCT04223973|583132576|FG001|Overall Study|Physician Decision|1|||
161474915|NCT04223973|583132575|FG000|Overall Study|Withdrawal by Subject|0|||
161474916|NCT04223973|583132576|FG001|Overall Study|Withdrawal by Subject|1|||
161474917|NCT03360747|583132577|FG000|Overall Study|Voluntary Withdrawal|1|||
161474918|NCT02569671|583132585|FG000|Overall Study|Lost to Follow-up|2|||
161577276|NCT02763319|583501889|FG001|Overall Study|Lost to Follow-up|7|||
161577277|NCT02763319|583501888|FG000|Overall Study|Noncompliance with Study Drug|2|||
161577278|NCT02763319|583501889|FG001|Overall Study|Noncompliance with Study Drug|0|||
161577279|NCT02763319|583501888|FG000|Overall Study|"Captured as Other in Database"|29|||
161577280|NCT02763319|583501889|FG001|Overall Study|"Captured as Other in Database"|34|||
161577281|NCT02763319|583501888|FG000|Overall Study|Physician Decision|1|||
161577282|NCT02763319|583501889|FG001|Overall Study|Physician Decision|7|||
161577283|NCT02763319|583501888|FG000|Overall Study|Progressive Disease|24|||
161577284|NCT02763319|583501889|FG001|Overall Study|Progressive Disease|27|||
161577285|NCT02763319|583501888|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
161577286|NCT02763319|583501889|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
161577287|NCT02763319|583501888|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
161577288|NCT02763319|583501889|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
161577289|NCT02763319|583501888|FG000|Overall Study|Withdrawal by Subject|26|||
161577290|NCT02763319|583501889|FG001|Overall Study|Withdrawal by Subject|25|||
161577291|NCT03936660|583501891|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
161577292|NCT03936660|583501892|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
161577293|NCT00722046|583501893|FG000|Overall Study|Adverse Event|0|||
161577294|NCT00722046|583501894|FG001|Overall Study|Adverse Event|1|||
161577295|NCT00722046|583501895|FG002|Overall Study|Adverse Event|2|||
161577296|NCT00722046|583501896|FG003|Overall Study|Adverse Event|1|||
161577297|NCT00722046|583501897|FG004|Overall Study|Adverse Event|2|||
161577298|NCT00722046|583501898|FG005|Overall Study|Adverse Event|1|||
161577299|NCT00722046|583501899|FG006|Overall Study|Adverse Event|0|||
161577300|NCT00722046|583501893|FG000|Overall Study|Death|0|||
161577301|NCT00722046|583501894|FG001|Overall Study|Death|1|||
161577302|NCT00722046|583501895|FG002|Overall Study|Death|0|||
161577303|NCT00722046|583501896|FG003|Overall Study|Death|0|||
161577304|NCT00722046|583501897|FG004|Overall Study|Death|0|||
161577305|NCT00722046|583501898|FG005|Overall Study|Death|0|||
161577306|NCT00722046|583501899|FG006|Overall Study|Death|2|||
161577307|NCT00722046|583501893|FG000|Overall Study|Protocol Violation|1|||
161577308|NCT00722046|583501894|FG001|Overall Study|Protocol Violation|0|||
161577309|NCT00722046|583501895|FG002|Overall Study|Protocol Violation|0|||
161577310|NCT00722046|583501896|FG003|Overall Study|Protocol Violation|0|||
161577311|NCT00722046|583501897|FG004|Overall Study|Protocol Violation|0|||
161577312|NCT00722046|583501898|FG005|Overall Study|Protocol Violation|1|||
161577313|NCT00722046|583501899|FG006|Overall Study|Protocol Violation|0|||
161577314|NCT00722046|583501893|FG000|Overall Study|Withdrawal by Subject|3|||
161577315|NCT00722046|583501894|FG001|Overall Study|Withdrawal by Subject|3|||
161577316|NCT00722046|583501895|FG002|Overall Study|Withdrawal by Subject|4|||
161577317|NCT00722046|583501896|FG003|Overall Study|Withdrawal by Subject|4|||
161577318|NCT00722046|583501897|FG004|Overall Study|Withdrawal by Subject|4|||
161577319|NCT00722046|583501898|FG005|Overall Study|Withdrawal by Subject|7|||
161577320|NCT00722046|583501899|FG006|Overall Study|Withdrawal by Subject|3|||
161577321|NCT00722046|583501893|FG000|Overall Study|Randomized, but not treated|1|||
161577322|NCT00722046|583501894|FG001|Overall Study|Randomized, but not treated|1|||
161577323|NCT00722046|583501895|FG002|Overall Study|Randomized, but not treated|0|||
161577324|NCT00722046|583501896|FG003|Overall Study|Randomized, but not treated|2|||
161577325|NCT00722046|583501897|FG004|Overall Study|Randomized, but not treated|0|||
161577326|NCT00722046|583501898|FG005|Overall Study|Randomized, but not treated|0|||
161577327|NCT00722046|583501899|FG006|Overall Study|Randomized, but not treated|0|||
161577328|NCT00722046|583501893|FG000|Overall Study|Other|0|||
161577329|NCT00722046|583501894|FG001|Overall Study|Other|0|||
161577330|NCT00722046|583501895|FG002|Overall Study|Other|1|||
161577331|NCT00722046|583501896|FG003|Overall Study|Other|1|||
161577332|NCT00722046|583501897|FG004|Overall Study|Other|3|||
161577333|NCT00722046|583501898|FG005|Overall Study|Other|2|||
161577334|NCT00722046|583501899|FG006|Overall Study|Other|1|||
161577335|NCT00925587|583501900|FG000|Overall Study|Protocol Specified Criteria|6|||
161577336|NCT00925587|583501901|FG001|Overall Study|Protocol Specified Criteria|6|||
161577337|NCT00925587|583501900|FG000|Overall Study|Physician Decision|4|||
161577338|NCT00925587|583501901|FG001|Overall Study|Physician Decision|1|||
161577339|NCT00925587|583501900|FG000|Overall Study|Protocol Violation|6|||
161577340|NCT00925587|583501901|FG001|Overall Study|Protocol Violation|4|||
161577341|NCT00925587|583501900|FG000|Overall Study|Withdrawal by Subject|9|||
161577342|NCT00925587|583501901|FG001|Overall Study|Withdrawal by Subject|6|||
161577343|NCT00925587|583501900|FG000|Overall Study|Death|5|||
161577344|NCT00925587|583501901|FG001|Overall Study|Death|5|||
161577345|NCT00925587|583501900|FG000|Overall Study|Adverse Event|6|||
161577346|NCT00925587|583501901|FG001|Overall Study|Adverse Event|2|||
161577347|NCT00925587|583501900|FG000|Overall Study|Lost to Follow-up|0|||
161577348|NCT00925587|583501901|FG001|Overall Study|Lost to Follow-up|1|||
161577349|NCT02271854|583501909|FG000|Overall Study|Withdrawal by Subject|2|||
161577350|NCT02271854|583501909|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
161577351|NCT02271854|583501909|FG000|Overall Study|Lost to Follow-up|1|||
161577352|NCT01571596|583501912|FG000|Overall Study|Adverse Event|2|||
161577353|NCT01571596|583501913|FG001|Overall Study|Adverse Event|0|||
161577354|NCT01571596|583501914|FG002|Overall Study|Adverse Event|0|||
161577355|NCT01571596|583501912|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161577356|NCT01571596|583501913|FG001|Overall Study|Study Terminated by the Sponsor|1|||
161577357|NCT01571596|583501914|FG002|Overall Study|Study Terminated by the Sponsor|1|||
161577358|NCT01582100|583501917|FG000|Overall Study|Adverse Event|1|||
161577359|NCT01582100|583501917|FG000|Overall Study|Withdrawal by Subject|1|||
161920522|NCT02335944|584754623|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920523|NCT02335944|584754624|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920524|NCT02335944|584754625|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920525|NCT02335944|584754626|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920526|NCT02335944|584754627|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
161920527|NCT02335944|584754628|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920528|NCT02335944|584754629|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920529|NCT02335944|584754620|FG000|Post-treatment Follow-up|Adverse Event|0|||
161920530|NCT02335944|584754621|FG001|Post-treatment Follow-up|Adverse Event|0|||
161920531|NCT02335944|584754622|FG002|Post-treatment Follow-up|Adverse Event|0|||
161920532|NCT02335944|584754623|FG003|Post-treatment Follow-up|Adverse Event|0|||
161920533|NCT02335944|584754624|FG004|Post-treatment Follow-up|Adverse Event|0|||
161920534|NCT02335944|584754625|FG005|Post-treatment Follow-up|Adverse Event|1|||
161920535|NCT02335944|584754626|FG006|Post-treatment Follow-up|Adverse Event|0|||
161920536|NCT02335944|584754627|FG007|Post-treatment Follow-up|Adverse Event|0|||
161920537|NCT02335944|584754628|FG008|Post-treatment Follow-up|Adverse Event|0|||
161920538|NCT02335944|584754629|FG009|Post-treatment Follow-up|Adverse Event|0|||
161920539|NCT02335944|584754620|FG000|Post-treatment Follow-up|Death|0|||
161920540|NCT02335944|584754621|FG001|Post-treatment Follow-up|Death|0|||
161920541|NCT02335944|584754622|FG002|Post-treatment Follow-up|Death|0|||
161920542|NCT02335944|584754623|FG003|Post-treatment Follow-up|Death|1|||
161920543|NCT02335944|584754624|FG004|Post-treatment Follow-up|Death|0|||
161920544|NCT02335944|584754625|FG005|Post-treatment Follow-up|Death|1|||
161920545|NCT02335944|584754626|FG006|Post-treatment Follow-up|Death|0|||
161474919|NCT02569671|583132586|FG001|Overall Study|Lost to Follow-up|1|||
161474920|NCT02569671|583132585|FG000|Overall Study|Withdrawal by Subject|1|||
161920546|NCT02335944|584754627|FG007|Post-treatment Follow-up|Death|0|||
161920547|NCT02335944|584754628|FG008|Post-treatment Follow-up|Death|0|||
161920548|NCT02335944|584754629|FG009|Post-treatment Follow-up|Death|0|||
161920549|NCT02335944|584754620|FG000|Post-treatment Follow-up|Physician Decision|1|||
161920550|NCT02335944|584754621|FG001|Post-treatment Follow-up|Physician Decision|0|||
161920551|NCT02335944|584754622|FG002|Post-treatment Follow-up|Physician Decision|0|||
161474921|NCT02569671|583132586|FG001|Overall Study|Withdrawal by Subject|3|||
161474922|NCT01757535|583132587|FG000|Overall Study|Disease Relapse|151|||
161474923|NCT01757535|583132588|FG001|Overall Study|Disease Relapse|181|||
161474924|NCT01757535|583132587|FG000|Overall Study|Other Reasons|28|||
161474925|NCT01757535|583132588|FG001|Overall Study|Other Reasons|27|||
161474926|NCT01757535|583132587|FG000|Overall Study|Adverse Event|31|||
161474927|NCT01757535|583132588|FG001|Overall Study|Adverse Event|11|||
161474928|NCT01757535|583132587|FG000|Overall Study|Withdrew Consent|19|||
161474929|NCT01757535|583132588|FG001|Overall Study|Withdrew Consent|13|||
161474930|NCT01757535|583132587|FG000|Overall Study|Physician Decision|7|||
161474931|NCT01757535|583132588|FG001|Overall Study|Physician Decision|0|||
161474932|NCT01757535|583132587|FG000|Overall Study|Death|2|||
161474933|NCT01757535|583132588|FG001|Overall Study|Death|2|||
161474934|NCT00589290|583132589|FG000|Overall Study|Withdrawal by Subject|1|||
161474935|NCT03730012|583132590|FG000|Overall Study|Adverse Event|0|||
161474936|NCT03730012|583132591|FG001|Overall Study|Adverse Event|1|||
161474937|NCT03730012|583132590|FG000|Overall Study|Lack of Efficacy|1|||
161474938|NCT03730012|583132591|FG001|Overall Study|Lack of Efficacy|5|||
161474939|NCT03730012|583132590|FG000|Overall Study|Withdrawal by Subject|0|||
161474940|NCT03730012|583132591|FG001|Overall Study|Withdrawal by Subject|1|||
161474941|NCT03730012|583132590|FG000|Overall Study|Miscellaneous|2|||
161474942|NCT03730012|583132591|FG001|Overall Study|Miscellaneous|1|||
161474943|NCT01995825|583134404|FG000|Overall Study|Withdrawal by Subject|1|||
161474944|NCT01995825|583134405|FG001|Overall Study|Withdrawal by Subject|0|||
161920552|NCT02335944|584754623|FG003|Post-treatment Follow-up|Physician Decision|0|||
161474945|NCT01367002|583134406|FG000|Overall Study|Withdrawal by Subject|1|||
161474946|NCT01367002|583134407|FG001|Overall Study|Withdrawal by Subject|0|||
161577360|NCT00774397|583501920|FG000|Overall Study|Adverse Event|1|||
161577361|NCT00774397|583501921|FG001|Overall Study|Adverse Event|3|||
161577362|NCT00774397|583501922|FG002|Overall Study|Adverse Event|16|||
161577363|NCT00774397|583501923|FG003|Overall Study|Adverse Event|8|||
161577364|NCT00774397|583501924|FG004|Overall Study|Adverse Event|8|||
161577365|NCT00774397|583501925|FG005|Overall Study|Adverse Event|3|||
161577366|NCT00774397|583501926|FG006|Overall Study|Adverse Event|16|||
161577367|NCT00774397|583501920|FG000|Overall Study|Lack of Efficacy|11|||
161577368|NCT00774397|583501921|FG001|Overall Study|Lack of Efficacy|4|||
161577369|NCT00774397|583501922|FG002|Overall Study|Lack of Efficacy|5|||
161577370|NCT00774397|583501923|FG003|Overall Study|Lack of Efficacy|3|||
161577371|NCT00774397|583501924|FG004|Overall Study|Lack of Efficacy|27|||
161577372|NCT00774397|583501925|FG005|Overall Study|Lack of Efficacy|15|||
161577373|NCT00774397|583501926|FG006|Overall Study|Lack of Efficacy|9|||
161577374|NCT00774397|583501920|FG000|Overall Study|Protocol Violation|0|||
161577375|NCT00774397|583501921|FG001|Overall Study|Protocol Violation|1|||
161577376|NCT00774397|583501922|FG002|Overall Study|Protocol Violation|3|||
161577377|NCT00774397|583501923|FG003|Overall Study|Protocol Violation|1|||
161577378|NCT00774397|583501924|FG004|Overall Study|Protocol Violation|2|||
161577379|NCT00774397|583501925|FG005|Overall Study|Protocol Violation|1|||
161577380|NCT00774397|583501926|FG006|Overall Study|Protocol Violation|0|||
161577381|NCT00774397|583501920|FG000|Overall Study|Lost to Follow-up|0|||
161577382|NCT00774397|583501921|FG001|Overall Study|Lost to Follow-up|1|||
161577383|NCT00774397|583501922|FG002|Overall Study|Lost to Follow-up|1|||
161577384|NCT00774397|583501923|FG003|Overall Study|Lost to Follow-up|1|||
161577385|NCT00774397|583501924|FG004|Overall Study|Lost to Follow-up|0|||
161920553|NCT02335944|584754624|FG004|Post-treatment Follow-up|Physician Decision|0|||
161920554|NCT02335944|584754625|FG005|Post-treatment Follow-up|Physician Decision|0|||
161920555|NCT02335944|584754626|FG006|Post-treatment Follow-up|Physician Decision|0|||
161920556|NCT02335944|584754627|FG007|Post-treatment Follow-up|Physician Decision|1|||
161577386|NCT00774397|583501925|FG005|Overall Study|Lost to Follow-up|1|||
161577387|NCT00774397|583501926|FG006|Overall Study|Lost to Follow-up|0|||
161577388|NCT00774397|583501920|FG000|Overall Study|Refused to continue trial medication|1|||
161577389|NCT00774397|583501921|FG001|Overall Study|Refused to continue trial medication|3|||
161577390|NCT00774397|583501922|FG002|Overall Study|Refused to continue trial medication|2|||
161577391|NCT00774397|583501923|FG003|Overall Study|Refused to continue trial medication|2|||
161577392|NCT00774397|583501924|FG004|Overall Study|Refused to continue trial medication|6|||
161577393|NCT00774397|583501925|FG005|Overall Study|Refused to continue trial medication|2|||
161577394|NCT00774397|583501926|FG006|Overall Study|Refused to continue trial medication|3|||
161577395|NCT00774397|583501920|FG000|Overall Study|Not treated|0|||
161577396|NCT00774397|583501921|FG001|Overall Study|Not treated|0|||
161577397|NCT00774397|583501922|FG002|Overall Study|Not treated|0|||
161577398|NCT00774397|583501923|FG003|Overall Study|Not treated|0|||
161577399|NCT00774397|583501924|FG004|Overall Study|Not treated|1|||
161577400|NCT00774397|583501925|FG005|Overall Study|Not treated|0|||
161577401|NCT00774397|583501926|FG006|Overall Study|Not treated|1|||
161920557|NCT02335944|584754628|FG008|Post-treatment Follow-up|Physician Decision|0|||
161920558|NCT02335944|584754629|FG009|Post-treatment Follow-up|Physician Decision|0|||
161920559|NCT00832975|584754630|FG000|Overall Study|Lost to Follow-up|7|||
161920560|NCT00832975|584754630|FG000|Overall Study|Protocol Violation|6|||
161577402|NCT00774397|583501920|FG000|Overall Study|Other than those stated above|1|||
161577403|NCT00774397|583501921|FG001|Overall Study|Other than those stated above|1|||
161577404|NCT00774397|583501922|FG002|Overall Study|Other than those stated above|3|||
161577405|NCT00774397|583501923|FG003|Overall Study|Other than those stated above|2|||
161577406|NCT00774397|583501924|FG004|Overall Study|Other than those stated above|2|||
161577407|NCT00774397|583501925|FG005|Overall Study|Other than those stated above|0|||
161577408|NCT00774397|583501926|FG006|Overall Study|Other than those stated above|1|||
161577409|NCT02499159|583501927|FG000|Randomization|Protocol Violation|1|||
161577410|NCT02499159|583501928|FG001|Randomization|Protocol Violation|1|||
161577411|NCT02499159|583501927|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
161577412|NCT02499159|583501928|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
161577413|NCT02499159|583501927|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
161577414|NCT02499159|583501928|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
161814830|NCT00205777|584365391|FG003|Study Extension II|Death|2|||
161814831|NCT00205777|584365392|FG004|Study Extension II|Death|0|||
161814832|NCT00205777|584365393|FG005|Study Extension II|Death|5|||
161814833|NCT00205777|584365388|FG000|Study Extension II|Withdrawal by Subject|0|||
161814834|NCT00205777|584365389|FG001|Study Extension II|Withdrawal by Subject|0|||
161814835|NCT00205777|584365390|FG002|Study Extension II|Withdrawal by Subject|0|||
161814836|NCT00205777|584365391|FG003|Study Extension II|Withdrawal by Subject|35|||
161814837|NCT00205777|584365392|FG004|Study Extension II|Withdrawal by Subject|0|||
161814838|NCT00205777|584365393|FG005|Study Extension II|Withdrawal by Subject|59|||
161814839|NCT00205777|584365388|FG000|Study Extension II|Protocol Violation|0|||
161814840|NCT00205777|584365389|FG001|Study Extension II|Protocol Violation|0|||
161814841|NCT00205777|584365390|FG002|Study Extension II|Protocol Violation|0|||
161814842|NCT00205777|584365391|FG003|Study Extension II|Protocol Violation|1|||
161577415|NCT02499159|583501927|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
161577416|NCT02499159|583501928|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
161577417|NCT02499159|583501927|FG000|30-Day Follow-Up Phone Call|Other|1|||
161577418|NCT02499159|583501928|FG001|30-Day Follow-Up Phone Call|Other|0|||
161577419|NCT02242487|583501929|FG000|Overall Study|Adverse Event|13|||
161577420|NCT02242487|583501930|FG001|Overall Study|Adverse Event|15|||
161577421|NCT02242487|583501929|FG000|Overall Study|Lack of Efficacy|4|||
161577422|NCT02242487|583501930|FG001|Overall Study|Lack of Efficacy|6|||
161577423|NCT02242487|583501929|FG000|Overall Study|Protocol Violation|2|||
161577424|NCT02242487|583501930|FG001|Overall Study|Protocol Violation|0|||
161577425|NCT02242487|583501929|FG000|Overall Study|Lost to Follow-up|2|||
161577426|NCT02242487|583501930|FG001|Overall Study|Lost to Follow-up|1|||
161577427|NCT02242487|583501929|FG000|Overall Study|Other - Miscellaneous|4|||
161577428|NCT02242487|583501930|FG001|Overall Study|Other - Miscellaneous|6|||
161577429|NCT02242487|583501929|FG000|Overall Study|Withdrawal by Subject|37|||
161577430|NCT02242487|583501930|FG001|Overall Study|Withdrawal by Subject|19|||
161577431|NCT03644849|583501931|FG000|Overall Study|Lost to Follow-up|1|||
161577432|NCT03644849|583501932|FG001|Overall Study|Lost to Follow-up|3|||
161577433|NCT02564744|583501933|FG000|Overall Study|Investigator decision|0|||
161577434|NCT02564744|583501934|FG001|Overall Study|Investigator decision|0|||
161577435|NCT02564744|583501935|FG002|Overall Study|Investigator decision|0|||
161577436|NCT02564744|583501936|FG003|Overall Study|Investigator decision|0|||
161577437|NCT02564744|583501937|FG004|Overall Study|Investigator decision|1|||
161577438|NCT02564744|583501933|FG000|Overall Study|Death|10|||
161577439|NCT02564744|583501934|FG001|Overall Study|Death|5|||
161577440|NCT02564744|583501935|FG002|Overall Study|Death|4|||
161577441|NCT02564744|583501936|FG003|Overall Study|Death|16|||
161577442|NCT02564744|583501937|FG004|Overall Study|Death|16|||
161577443|NCT02564744|583501933|FG000|Overall Study|End of study Page Missing|0|||
161577444|NCT02564744|583501934|FG001|Overall Study|End of study Page Missing|0|||
161577445|NCT02564744|583501935|FG002|Overall Study|End of study Page Missing|3|||
161577446|NCT02564744|583501936|FG003|Overall Study|End of study Page Missing|3|||
161577447|NCT02564744|583501937|FG004|Overall Study|End of study Page Missing|0|||
161577448|NCT02564744|583501933|FG000|Overall Study|Subject Withdrew Consent|1|||
161577449|NCT02564744|583501934|FG001|Overall Study|Subject Withdrew Consent|1|||
161577450|NCT02564744|583501935|FG002|Overall Study|Subject Withdrew Consent|1|||
161577451|NCT02564744|583501936|FG003|Overall Study|Subject Withdrew Consent|0|||
161577452|NCT02564744|583501937|FG004|Overall Study|Subject Withdrew Consent|2|||
161577453|NCT02564744|583501933|FG000|Overall Study|Lost to Follow-up|0|||
161577454|NCT02564744|583501934|FG001|Overall Study|Lost to Follow-up|1|||
161577455|NCT02564744|583501935|FG002|Overall Study|Lost to Follow-up|0|||
161577456|NCT02564744|583501936|FG003|Overall Study|Lost to Follow-up|0|||
161577457|NCT02564744|583501937|FG004|Overall Study|Lost to Follow-up|1|||
161577458|NCT02564744|583501933|FG000|Overall Study|Reason not specified|1|||
161577459|NCT02564744|583501934|FG001|Overall Study|Reason not specified|0|||
161577460|NCT02564744|583501935|FG002|Overall Study|Reason not specified|0|||
161577461|NCT02564744|583501936|FG003|Overall Study|Reason not specified|0|||
161577462|NCT02564744|583501937|FG004|Overall Study|Reason not specified|0|||
161577463|NCT00979992|583501939|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161577464|NCT00979992|583501939|FG000|Overall Study|Ineligible - wrong cell type|2|||
161577465|NCT00979992|583501939|FG000|Overall Study|Refused - Never Treated|2|||
161577466|NCT01140048|583501949|FG000|Overall Study|Physician Decision|1|||
161577467|NCT01140048|583501949|FG000|Overall Study|Withdrawal by Subject|13|||
161577468|NCT01140048|583501949|FG000|Overall Study|Lost to Follow-up|31|||
161577469|NCT00869258|583501950|FG000|Overall Study|Physician Decision|1|||
161577470|NCT02888080|583501951|FG000|Overall Study|Subject / Guardian decision|1|||
161577471|NCT02888080|583501952|FG001|Overall Study|Subject / Guardian decision|3|||
161577472|NCT02888080|583501951|FG000|Overall Study|New Therapy for study indication|1|||
161577473|NCT02888080|583501952|FG001|Overall Study|New Therapy for study indication|0|||
161577474|NCT02888080|583501951|FG000|Overall Study|Lack of Efficacy|0|||
161577475|NCT02888080|583501952|FG001|Overall Study|Lack of Efficacy|1|||
161577476|NCT02888080|583501951|FG000|Overall Study|Adverse Event|0|||
161577477|NCT02888080|583501952|FG001|Overall Study|Adverse Event|1|||
161577478|NCT00980330|583501954|FG000|Overall Study|Adverse Event|0|||
161577479|NCT00980330|583501955|FG001|Overall Study|Adverse Event|0|||
161577480|NCT00980330|583501956|FG002|Overall Study|Adverse Event|0|||
161577481|NCT00980330|583501957|FG003|Overall Study|Adverse Event|1|||
161577482|NCT00980330|583501958|FG004|Overall Study|Adverse Event|0|||
161577483|NCT00980330|583501959|FG005|Overall Study|Adverse Event|0|||
161577484|NCT00980330|583501960|FG006|Overall Study|Adverse Event|0|||
161577485|NCT00980330|583501954|FG000|Overall Study|Lost to Follow-up|1|||
161577486|NCT00980330|583501955|FG001|Overall Study|Lost to Follow-up|1|||
161577487|NCT00980330|583501956|FG002|Overall Study|Lost to Follow-up|4|||
161577488|NCT00980330|583501957|FG003|Overall Study|Lost to Follow-up|2|||
161577489|NCT00980330|583501958|FG004|Overall Study|Lost to Follow-up|1|||
161577490|NCT00980330|583501959|FG005|Overall Study|Lost to Follow-up|1|||
161577491|NCT00980330|583501960|FG006|Overall Study|Lost to Follow-up|2|||
161920561|NCT00832975|584754630|FG000|Overall Study|Death|5|||
161920562|NCT00832975|584754630|FG000|Overall Study|Physician Decision|4|||
161920563|NCT00832975|584754630|FG000|Overall Study|Withdrawal by Subject|3|||
161920564|NCT00832975|584754630|FG000|Overall Study|Other reasons|14|||
161920565|NCT06081829|584754633|FG000|Overall Study|Participants still on-study|8|||
161920566|NCT06081829|584754633|FG000|Overall Study|Death|4|||
161920567|NCT01525589|584754634|FG000|Overall Study|Non-treatment-related AE|1|||
161920568|NCT01525589|584754635|FG001|Overall Study|Non-treatment-related AE|0|||
161920569|NCT01525589|584754636|FG002|Overall Study|Non-treatment-related AE|0|||
161920570|NCT01525589|584754634|FG000|Overall Study|Progressive disease|48|||
161920571|NCT01525589|584754635|FG001|Overall Study|Progressive disease|15|||
161920572|NCT01525589|584754636|FG002|Overall Study|Progressive disease|29|||
161920573|NCT01525589|584754634|FG000|Overall Study|Never treated|2|||
161920574|NCT01525589|584754635|FG001|Overall Study|Never treated|0|||
161920575|NCT01525589|584754636|FG002|Overall Study|Never treated|0|||
161920576|NCT01525589|584754634|FG000|Overall Study|Physician Decision|4|||
161920577|NCT01525589|584754635|FG001|Overall Study|Physician Decision|2|||
161474947|NCT01367002|583134406|FG000|Overall Study|Physician Decision|0|||
161474948|NCT01367002|583134407|FG001|Overall Study|Physician Decision|2|||
161474949|NCT00354744|583134410|FG000|Overall Study|Adverse Event|2|||
161474950|NCT00354744|583134410|FG000|Overall Study|Death|2|||
161474951|NCT00354744|583134410|FG000|Overall Study|Lack of Efficacy|11|||
161474952|NCT00354744|583134410|FG000|Overall Study|Lost to Follow-up|2|||
161474953|NCT00354744|583134410|FG000|Overall Study|Physician Decision|11|||
161474954|NCT00354744|583134410|FG000|Overall Study|Withdrawal by Subject|14|||
161474955|NCT00541931|583134411|FG000|Overall Study|Adverse Event|1|||
161474956|NCT00541931|583134412|FG001|Overall Study|Adverse Event|0|||
161474957|NCT00541931|583134411|FG000|Overall Study|Lost to Follow-up|3|||
161474958|NCT00541931|583134412|FG001|Overall Study|Lost to Follow-up|3|||
161474959|NCT00541931|583134411|FG000|Overall Study|Withdrawal by Subject|1|||
161474960|NCT00541931|583134412|FG001|Overall Study|Withdrawal by Subject|0|||
161474961|NCT00541931|583134411|FG000|Overall Study|Transportation Issue|0|||
161474962|NCT00541931|583134412|FG001|Overall Study|Transportation Issue|1|||
161474963|NCT03094169|583134416|FG000|Overall Study|Lack of Efficacy|0|||
161474964|NCT03094169|583134417|FG001|Overall Study|Lack of Efficacy|0|||
161474965|NCT03094169|583134418|FG002|Overall Study|Lack of Efficacy|0|||
161474966|NCT03094169|583134419|FG003|Overall Study|Lack of Efficacy|0|||
161474967|NCT03094169|583134420|FG004|Overall Study|Lack of Efficacy|0|||
161474968|NCT03094169|583134421|FG005|Overall Study|Lack of Efficacy|0|||
161474969|NCT03094169|583134422|FG006|Overall Study|Lack of Efficacy|0|||
161474970|NCT03094169|583134423|FG007|Overall Study|Lack of Efficacy|21|||
161474971|NCT03094169|583134416|FG000|Overall Study|Adverse Event|0|||
161474972|NCT03094169|583134417|FG001|Overall Study|Adverse Event|0|||
161474973|NCT03094169|583134418|FG002|Overall Study|Adverse Event|0|||
161474974|NCT03094169|583134419|FG003|Overall Study|Adverse Event|0|||
161474975|NCT03094169|583134420|FG004|Overall Study|Adverse Event|0|||
161474976|NCT03094169|583134421|FG005|Overall Study|Adverse Event|0|||
161474977|NCT03094169|583134422|FG006|Overall Study|Adverse Event|0|||
161474978|NCT03094169|583134423|FG007|Overall Study|Adverse Event|2|||
161474979|NCT03094169|583134416|FG000|Overall Study|Withdrawal by Subject|0|||
161474980|NCT03094169|583134417|FG001|Overall Study|Withdrawal by Subject|0|||
161474981|NCT03094169|583134418|FG002|Overall Study|Withdrawal by Subject|0|||
161474982|NCT03094169|583134419|FG003|Overall Study|Withdrawal by Subject|0|||
161474983|NCT03094169|583134420|FG004|Overall Study|Withdrawal by Subject|0|||
161474984|NCT03094169|583134421|FG005|Overall Study|Withdrawal by Subject|0|||
161474985|NCT03094169|583134422|FG006|Overall Study|Withdrawal by Subject|1|||
161474986|NCT03094169|583134423|FG007|Overall Study|Withdrawal by Subject|1|||
161474987|NCT03094169|583134416|FG000|Overall Study|Trial Termination|0|||
161474988|NCT03094169|583134417|FG001|Overall Study|Trial Termination|0|||
161474989|NCT03094169|583134418|FG002|Overall Study|Trial Termination|0|||
161474990|NCT03094169|583134419|FG003|Overall Study|Trial Termination|0|||
161474991|NCT03094169|583134420|FG004|Overall Study|Trial Termination|0|||
161474992|NCT03094169|583134421|FG005|Overall Study|Trial Termination|0|||
161474993|NCT03094169|583134422|FG006|Overall Study|Trial Termination|0|||
161474994|NCT03094169|583134423|FG007|Overall Study|Trial Termination|1|||
161474995|NCT00617851|583134424|FG000|Overall Study|Death|0|||
161474996|NCT00617851|583134425|FG001|Overall Study|Death|0|||
161474997|NCT00617851|583134426|FG002|Overall Study|Death|0|||
161474998|NCT00617851|583134427|FG003|Overall Study|Death|1|||
161474999|NCT00617851|583134424|FG000|Overall Study|Withdrawal by Subject|14|||
161475000|NCT00617851|583134425|FG001|Overall Study|Withdrawal by Subject|7|||
161475001|NCT00617851|583134426|FG002|Overall Study|Withdrawal by Subject|12|||
161475002|NCT00617851|583134427|FG003|Overall Study|Withdrawal by Subject|4|||
161475003|NCT00617851|583134424|FG000|Overall Study|Lost to Follow-up|27|||
161475004|NCT00617851|583134425|FG001|Overall Study|Lost to Follow-up|29|||
161475005|NCT00617851|583134426|FG002|Overall Study|Lost to Follow-up|31|||
161475006|NCT00617851|583134427|FG003|Overall Study|Lost to Follow-up|19|||
161475007|NCT00617851|583134424|FG000|Overall Study|Inappropriate Enrollment|5|||
161475008|NCT00617851|583134425|FG001|Overall Study|Inappropriate Enrollment|4|||
161920578|NCT01525589|584754636|FG002|Overall Study|Physician Decision|2|||
161475009|NCT00617851|583134426|FG002|Overall Study|Inappropriate Enrollment|1|||
161475010|NCT00617851|583134427|FG003|Overall Study|Inappropriate Enrollment|1|||
161475011|NCT00617851|583134424|FG000|Overall Study|Unable to classify|1|||
161475012|NCT00617851|583134425|FG001|Overall Study|Unable to classify|0|||
161475013|NCT00617851|583134426|FG002|Overall Study|Unable to classify|1|||
161475014|NCT00617851|583134427|FG003|Overall Study|Unable to classify|0|||
161475015|NCT05350410|583134430|FG000|Overall Study|Withdrawal by Subject|1|||
161920579|NCT01525589|584754634|FG000|Overall Study|Death|0|||
161920580|NCT01525589|584754635|FG001|Overall Study|Death|0|||
161920581|NCT01525589|584754636|FG002|Overall Study|Death|2|||
161920582|NCT01525589|584754634|FG000|Overall Study|Treatment-related AE|1|||
161920583|NCT01525589|584754635|FG001|Overall Study|Treatment-related AE|1|||
161577492|NCT00980330|583501954|FG000|Overall Study|Withdrawal by Subject|2|||
161577493|NCT00980330|583501955|FG001|Overall Study|Withdrawal by Subject|4|||
161577494|NCT00980330|583501956|FG002|Overall Study|Withdrawal by Subject|4|||
161577495|NCT00980330|583501957|FG003|Overall Study|Withdrawal by Subject|1|||
161577496|NCT00980330|583501958|FG004|Overall Study|Withdrawal by Subject|3|||
161577497|NCT00980330|583501959|FG005|Overall Study|Withdrawal by Subject|2|||
161577498|NCT00980330|583501960|FG006|Overall Study|Withdrawal by Subject|5|||
161577499|NCT00980330|583501954|FG000|Overall Study|(not specified)|2|||
161577500|NCT00980330|583501955|FG001|Overall Study|(not specified)|0|||
161577501|NCT00980330|583501956|FG002|Overall Study|(not specified)|0|||
161577502|NCT00980330|583501957|FG003|Overall Study|(not specified)|1|||
161577503|NCT00980330|583501958|FG004|Overall Study|(not specified)|1|||
161577504|NCT00980330|583501959|FG005|Overall Study|(not specified)|1|||
161577505|NCT00980330|583501960|FG006|Overall Study|(not specified)|0|||
161577506|NCT01039688|583501961|FG000|Overall Study|Adverse Event|38|||
161577507|NCT01039688|583501962|FG001|Overall Study|Adverse Event|39|||
161577508|NCT01039688|583501963|FG002|Overall Study|Adverse Event|24|||
161577509|NCT01039688|583501961|FG000|Overall Study|Lack of Efficacy|20|||
161577510|NCT01039688|583501962|FG001|Overall Study|Lack of Efficacy|11|||
161577511|NCT01039688|583501963|FG002|Overall Study|Lack of Efficacy|26|||
161577512|NCT01039688|583501961|FG000|Overall Study|Lost to Follow-up|11|||
161577513|NCT01039688|583501962|FG001|Overall Study|Lost to Follow-up|9|||
161577514|NCT01039688|583501963|FG002|Overall Study|Lost to Follow-up|5|||
161577515|NCT01039688|583501961|FG000|Overall Study|Other|13|||
161577516|NCT01039688|583501962|FG001|Overall Study|Other|25|||
161577517|NCT01039688|583501963|FG002|Overall Study|Other|12|||
161577518|NCT01039688|583501961|FG000|Overall Study|Withdrawal by Subject|23|||
161577519|NCT01039688|583501962|FG001|Overall Study|Withdrawal by Subject|27|||
161577520|NCT01039688|583501963|FG002|Overall Study|Withdrawal by Subject|13|||
161577521|NCT01039688|583501961|FG000|Overall Study|Death|2|||
161577522|NCT01039688|583501962|FG001|Overall Study|Death|0|||
161577523|NCT01039688|583501963|FG002|Overall Study|Death|0|||
161577524|NCT03844269|583501969|FG000|Overall Study|Withdrawal pre-intervention|1|||
161577525|NCT03844269|583501969|FG000|Overall Study|Did not complete the intervention|2|||
161577526|NCT03737240|583501977|FG000|Overall Study|Lost to Follow-up|16|||
161577527|NCT03737240|583501978|FG001|Overall Study|Lost to Follow-up|15|||
161577528|NCT00891930|583501979|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
161577529|NCT00891930|583501979|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
161577530|NCT00891930|583501979|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
161577531|NCT00891930|583501979|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
161577532|NCT00891930|583501979|FG000|Part 2 Panitumumab + AMG479|Death|30|||
161577533|NCT02512965|583501982|FG000|Overall Study|Withdrawal by Subject|0|||
161577534|NCT02512965|583501983|FG001|Overall Study|Withdrawal by Subject|4|||
161920584|NCT01525589|584754636|FG002|Overall Study|Treatment-related AE|2|||
161920585|NCT01525589|584754634|FG000|Overall Study|Other reasons|0|||
161920586|NCT01525589|584754635|FG001|Overall Study|Other reasons|1|||
161475016|NCT03750955|583134437|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
161475017|NCT03750955|583134438|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
161475018|NCT03750955|583134437|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
161475019|NCT03750955|583134438|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
161577535|NCT05001945|583501987|FG000|Overall Study|Adverse Event|0|||
161577536|NCT05001945|583501988|FG001|Overall Study|Adverse Event|0|||
161577537|NCT05001945|583501989|FG002|Overall Study|Adverse Event|0|||
161577538|NCT05001945|583501990|FG003|Overall Study|Adverse Event|1|||
161577539|NCT05001945|583501991|FG004|Overall Study|Adverse Event|0|||
161577540|NCT05001945|583501992|FG005|Overall Study|Adverse Event|0|||
161577541|NCT05001945|583501993|FG006|Overall Study|Adverse Event|0|||
161920587|NCT01525589|584754636|FG002|Overall Study|Other reasons|0|||
161920588|NCT01525589|584754634|FG000|Overall Study|Withdrawal by Subject|0|||
161920589|NCT01525589|584754635|FG001|Overall Study|Withdrawal by Subject|1|||
161920590|NCT01525589|584754636|FG002|Overall Study|Withdrawal by Subject|0|||
161920591|NCT04835441|584754638|FG000|Overall Study|Physician Decision|4|||
161920592|NCT04835441|584754639|FG001|Overall Study|Physician Decision|4|||
161920593|NCT04835441|584754638|FG000|Overall Study|Other|1|||
161920594|NCT04835441|584754639|FG001|Overall Study|Other|1|||
161920595|NCT04835441|584754638|FG000|Overall Study|Lost to Follow-up|0|||
161920596|NCT04835441|584754639|FG001|Overall Study|Lost to Follow-up|1|||
161920597|NCT05253807|584754640|FG000|Overall Study|Death|1|||
161920598|NCT05253807|584754641|FG001|Overall Study|Death|4|||
161920599|NCT05253807|584754640|FG000|Overall Study|Withdrawal by Subject|1|||
161920600|NCT05253807|584754641|FG001|Overall Study|Withdrawal by Subject|0|||
161920601|NCT05253807|584754640|FG000|Overall Study|Study Terminated by Sponsor|1|||
161577542|NCT05001945|583501994|FG007|Overall Study|Adverse Event|0|||
161577543|NCT05001945|583501987|FG000|Overall Study|Lost to Follow-up|0|||
161577544|NCT05001945|583501988|FG001|Overall Study|Lost to Follow-up|1|||
161577545|NCT05001945|583501989|FG002|Overall Study|Lost to Follow-up|1|||
161577546|NCT05001945|583501990|FG003|Overall Study|Lost to Follow-up|2|||
161577547|NCT05001945|583501991|FG004|Overall Study|Lost to Follow-up|0|||
161577548|NCT05001945|583501992|FG005|Overall Study|Lost to Follow-up|1|||
161577549|NCT05001945|583501993|FG006|Overall Study|Lost to Follow-up|0|||
161577550|NCT05001945|583501994|FG007|Overall Study|Lost to Follow-up|0|||
161577551|NCT05001945|583501987|FG000|Overall Study|Protocol Violation|1|||
161577552|NCT05001945|583501988|FG001|Overall Study|Protocol Violation|0|||
161577553|NCT05001945|583501989|FG002|Overall Study|Protocol Violation|1|||
161577554|NCT05001945|583501990|FG003|Overall Study|Protocol Violation|1|||
161577555|NCT05001945|583501991|FG004|Overall Study|Protocol Violation|0|||
161577556|NCT05001945|583501992|FG005|Overall Study|Protocol Violation|1|||
161577557|NCT05001945|583501993|FG006|Overall Study|Protocol Violation|0|||
161577558|NCT05001945|583501994|FG007|Overall Study|Protocol Violation|0|||
161577559|NCT05001945|583501987|FG000|Overall Study|Withdrawal by Subject|0|||
161577560|NCT05001945|583501988|FG001|Overall Study|Withdrawal by Subject|0|||
161577561|NCT05001945|583501989|FG002|Overall Study|Withdrawal by Subject|0|||
161577562|NCT05001945|583501990|FG003|Overall Study|Withdrawal by Subject|1|||
161577563|NCT05001945|583501991|FG004|Overall Study|Withdrawal by Subject|1|||
161577564|NCT05001945|583501992|FG005|Overall Study|Withdrawal by Subject|1|||
161577565|NCT05001945|583501993|FG006|Overall Study|Withdrawal by Subject|0|||
161577566|NCT05001945|583501994|FG007|Overall Study|Withdrawal by Subject|1|||
161577567|NCT05001945|583501987|FG000|Overall Study|Not specified by Investigator|0|||
161577568|NCT05001945|583501988|FG001|Overall Study|Not specified by Investigator|3|||
161577569|NCT05001945|583501989|FG002|Overall Study|Not specified by Investigator|0|||
161577570|NCT05001945|583501990|FG003|Overall Study|Not specified by Investigator|0|||
161577571|NCT05001945|583501991|FG004|Overall Study|Not specified by Investigator|1|||
161577572|NCT05001945|583501992|FG005|Overall Study|Not specified by Investigator|0|||
161577573|NCT05001945|583501993|FG006|Overall Study|Not specified by Investigator|0|||
161577574|NCT05001945|583501994|FG007|Overall Study|Not specified by Investigator|0|||
161577575|NCT02570711|583501995|FG000|Overall Study|Death|1|||
161577576|NCT02570711|583501996|FG001|Overall Study|Death|0|||
161577577|NCT02570711|583501995|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
161577578|NCT02570711|583501996|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
161577579|NCT01369498|583501997|FG000|Overall Study|Lack of Efficacy|9|||
161577580|NCT01369498|583501998|FG001|Overall Study|Lack of Efficacy|9|||
161577581|NCT01369498|583501999|FG002|Overall Study|Lack of Efficacy|1|||
161577582|NCT01369498|583502000|FG003|Overall Study|Lack of Efficacy|3|||
161577583|NCT01369498|583501997|FG000|Overall Study|Adverse Event|1|||
161577584|NCT01369498|583501998|FG001|Overall Study|Adverse Event|2|||
161577585|NCT01369498|583501999|FG002|Overall Study|Adverse Event|0|||
161577586|NCT01369498|583502000|FG003|Overall Study|Adverse Event|1|||
161577587|NCT01369498|583501997|FG000|Overall Study|Withdrawal of Consent|0|||
161577588|NCT01369498|583501998|FG001|Overall Study|Withdrawal of Consent|1|||
161577589|NCT01369498|583501999|FG002|Overall Study|Withdrawal of Consent|1|||
161577590|NCT01369498|583502000|FG003|Overall Study|Withdrawal of Consent|1|||
161577591|NCT01369498|583501997|FG000|Overall Study|Death|0|||
161577592|NCT01369498|583501998|FG001|Overall Study|Death|0|||
161577593|NCT01369498|583501999|FG002|Overall Study|Death|1|||
161577594|NCT01369498|583502000|FG003|Overall Study|Death|0|||
161577595|NCT01369498|583501997|FG000|Overall Study|Investigator's Discretion|1|||
161577596|NCT01369498|583501998|FG001|Overall Study|Investigator's Discretion|0|||
161577597|NCT01369498|583501999|FG002|Overall Study|Investigator's Discretion|1|||
161577598|NCT01369498|583502000|FG003|Overall Study|Investigator's Discretion|3|||
161577599|NCT01369498|583501997|FG000|Overall Study|Unknown Reason|1|||
161577600|NCT01369498|583501998|FG001|Overall Study|Unknown Reason|0|||
161577601|NCT01369498|583501999|FG002|Overall Study|Unknown Reason|11|||
161577602|NCT01369498|583502000|FG003|Overall Study|Unknown Reason|6|||
161577603|NCT01369498|583501997|FG000|Overall Study|Disease Progression|0|||
161577604|NCT01369498|583501998|FG001|Overall Study|Disease Progression|0|||
161668465|NCT00820027|583839772|FG000|Overall Study|Withdrawal by Subject|6|||
161668466|NCT00820027|583839773|FG001|Overall Study|Withdrawal by Subject|4|||
161920602|NCT05253807|584754641|FG001|Overall Study|Study Terminated by Sponsor|1|||
161920603|NCT02145390|584754644|FG000|Overall Study|Withdrawal by Subject|1|||
161920604|NCT02293499|584755757|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
161577605|NCT01369498|583501999|FG002|Overall Study|Disease Progression|0|||
161577606|NCT01369498|583502000|FG003|Overall Study|Disease Progression|1|||
161577607|NCT00545077|583502002|FG000|Overall Study|Treatment not received|5|||
161577608|NCT00545077|583502003|FG001|Overall Study|Treatment not received|1|||
161814843|NCT00205777|584365392|FG004|Study Extension II|Protocol Violation|0|||
161814844|NCT00205777|584365393|FG005|Study Extension II|Protocol Violation|10|||
161814845|NCT00205777|584365388|FG000|Study Extension II|Lack of Efficacy|0|||
161814846|NCT00205777|584365389|FG001|Study Extension II|Lack of Efficacy|0|||
161814847|NCT00205777|584365390|FG002|Study Extension II|Lack of Efficacy|0|||
161577609|NCT00545077|583502002|FG000|Overall Study|Disease Progression|131|||
161577610|NCT00545077|583502003|FG001|Overall Study|Disease Progression|98|||
161577611|NCT00545077|583502002|FG000|Overall Study|Withdrawal by Subject|3|||
161577612|NCT00545077|583502003|FG001|Overall Study|Withdrawal by Subject|14|||
161577613|NCT00545077|583502002|FG000|Overall Study|Physician Decision|6|||
161577614|NCT00545077|583502003|FG001|Overall Study|Physician Decision|3|||
161577615|NCT00545077|583502002|FG000|Overall Study|Lost to Follow-up|2|||
161577616|NCT00545077|583502003|FG001|Overall Study|Lost to Follow-up|0|||
161577617|NCT00545077|583502002|FG000|Overall Study|Protocol Violation|1|||
161577618|NCT00545077|583502003|FG001|Overall Study|Protocol Violation|0|||
161577619|NCT00545077|583502002|FG000|Overall Study|Adverse Event|0|||
161577620|NCT00545077|583502003|FG001|Overall Study|Adverse Event|31|||
161577621|NCT00545077|583502002|FG000|Overall Study|Death|0|||
161577622|NCT00545077|583502003|FG001|Overall Study|Death|8|||
161577623|NCT02957136|583502008|FG000|Overall Study|Withdrawal by Subject|2|||
161577624|NCT02957136|583502009|FG001|Overall Study|Withdrawal by Subject|1|||
161577625|NCT02755116|583502011|FG000|Overall Study|surgery converted to open, pt admitted|3|||
161577626|NCT02755116|583502012|FG001|Overall Study|surgery converted to open, pt admitted|1|||
161577627|NCT02115139|583502015|FG000|Overall Study|Protocol Violation|1|||
161577628|NCT02115139|583502015|FG000|Overall Study|treatment discontinuation|6|||
161577629|NCT01597258|583502019|FG000|Overall Study|No Drug Administration|1|||
161577630|NCT04789408|583502020|FG000|Overall Study|Death|4|||
161577631|NCT04789408|583502021|FG001|Overall Study|Death|3|||
161577632|NCT04789408|583502022|FG002|Overall Study|Death|6|||
161577633|NCT04789408|583502020|FG000|Overall Study|Did not meet eligibility criteria|1|||
161577634|NCT04789408|583502021|FG001|Overall Study|Did not meet eligibility criteria|0|||
161577635|NCT04789408|583502022|FG002|Overall Study|Did not meet eligibility criteria|0|||
161577636|NCT04789408|583502020|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
161577637|NCT04789408|583502021|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
161603595|NCT00626795|583602455|FG000|Blinded Treatment|Withdrawal by Subject|1|||
161920605|NCT02293499|584755758|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
161920606|NCT02293499|584755759|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
161920607|NCT02293499|584755757|FG000|Intervention - Camp|Withdrawal by Subject|3|||
161920608|NCT02293499|584755758|FG001|Intervention - Camp|Withdrawal by Subject|6|||
161577638|NCT04789408|583502022|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
161577639|NCT05938413|583503283|FG000|Overall Study|Lost to Follow-up|1|||
161577640|NCT05938413|583503284|FG001|Overall Study|Lost to Follow-up|7|||
161577641|NCT05938413|583503283|FG000|Overall Study|Withdrawal by Subject|1|||
161577642|NCT05938413|583503284|FG001|Overall Study|Withdrawal by Subject|1|||
161577643|NCT03312907|583503285|FG000|Overall Study|Adverse Event|1|||
161577644|NCT03312907|583503286|FG001|Overall Study|Adverse Event|6|||
161577645|NCT03312907|583503287|FG002|Overall Study|Adverse Event|1|||
161577646|NCT03312907|583503285|FG000|Overall Study|Protocol Violation|2|||
161577647|NCT03312907|583503286|FG001|Overall Study|Protocol Violation|3|||
161577648|NCT03312907|583503287|FG002|Overall Study|Protocol Violation|4|||
161577649|NCT03312907|583503285|FG000|Overall Study|Lost to Follow-up|2|||
161577650|NCT03312907|583503286|FG001|Overall Study|Lost to Follow-up|3|||
161577651|NCT03312907|583503287|FG002|Overall Study|Lost to Follow-up|2|||
161577652|NCT03312907|583503285|FG000|Overall Study|Physician Decision|3|||
161577653|NCT03312907|583503286|FG001|Overall Study|Physician Decision|4|||
161577654|NCT03312907|583503287|FG002|Overall Study|Physician Decision|2|||
161577655|NCT03312907|583503285|FG000|Overall Study|Withdrawal by Subject|9|||
161577656|NCT03312907|583503286|FG001|Overall Study|Withdrawal by Subject|14|||
161577657|NCT03312907|583503287|FG002|Overall Study|Withdrawal by Subject|10|||
161577658|NCT00840177|583503289|FG000|Overall Study|Adverse Event|5|||
161577659|NCT00840177|583503290|FG001|Overall Study|Adverse Event|1|||
161577660|NCT00840177|583503291|FG002|Overall Study|Adverse Event|1|||
161577661|NCT00840177|583503289|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161577662|NCT00840177|583503290|FG001|Overall Study|Refusal unrelated to adverse events|0|||
161577663|NCT00840177|583503291|FG002|Overall Study|Refusal unrelated to adverse events|1|||
161577664|NCT00840177|583503289|FG000|Overall Study|Progression/relapse|2|||
161577665|NCT00840177|583503290|FG001|Overall Study|Progression/relapse|0|||
161577666|NCT00840177|583503291|FG002|Overall Study|Progression/relapse|0|||
161577667|NCT00840177|583503289|FG000|Overall Study|Death|4|||
161577668|NCT00840177|583503290|FG001|Overall Study|Death|5|||
161577669|NCT00840177|583503291|FG002|Overall Study|Death|5|||
161577670|NCT00840177|583503289|FG000|Overall Study|not protocol specified|6|||
161577671|NCT00840177|583503290|FG001|Overall Study|not protocol specified|3|||
161577672|NCT00840177|583503291|FG002|Overall Study|not protocol specified|0|||
161577673|NCT00840177|583503289|FG000|Overall Study|Ineligible|0|||
161577674|NCT00840177|583503290|FG001|Overall Study|Ineligible|0|||
161577675|NCT00840177|583503291|FG002|Overall Study|Ineligible|3|||
161577676|NCT00840177|583503289|FG000|Overall Study|Did not start treatment|0|||
161577677|NCT00840177|583503290|FG001|Overall Study|Did not start treatment|0|||
161577678|NCT00840177|583503291|FG002|Overall Study|Did not start treatment|1|||
161577679|NCT01599793|583503297|FG000|Overall Study|Adverse Event|2|||
161577680|NCT02652442|583503309|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
161577681|NCT02252042|583503310|FG000|Overall Study|Adverse Event|9|||
161577682|NCT02252042|583503311|FG001|Overall Study|Adverse Event|6|||
161577683|NCT02252042|583503310|FG000|Overall Study|Death|209|||
161577684|NCT02252042|583503311|FG001|Overall Study|Death|217|||
161577685|NCT02252042|583503310|FG000|Overall Study|Physician Decision|0|||
161577686|NCT02252042|583503311|FG001|Overall Study|Physician Decision|2|||
161577687|NCT02252042|583503310|FG000|Overall Study|Transferred to Extension Study|7|||
161577688|NCT02252042|583503311|FG001|Overall Study|Transferred to Extension Study|1|||
161577689|NCT02252042|583503310|FG000|Overall Study|Did Not Continue on Extension Study|7|||
161577690|NCT02252042|583503311|FG001|Overall Study|Did Not Continue on Extension Study|2|||
161577691|NCT02252042|583503310|FG000|Overall Study|Withdrawal by Subject|15|||
161577692|NCT02252042|583503311|FG001|Overall Study|Withdrawal by Subject|20|||
161577693|NCT02593149|583503314|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
161577694|NCT02593149|583503315|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
161577695|NCT02593149|583503314|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
161577696|NCT02593149|583503315|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
161577697|NCT01177670|583503316|FG000|Overall Study|Study Terminated|115|||
161577698|NCT01177670|583503316|FG000|Overall Study|Physician Decision|50|||
161577699|NCT01177670|583503316|FG000|Overall Study|Withdrawal by Subject|4|||
161577700|NCT01636687|583503317|FG000|Induction Period|Withdrawal by Subject|1|||
161577701|NCT01636687|583503318|FG001|Induction Period|Withdrawal by Subject|0|||
161577702|NCT01636687|583503319|FG002|Induction Period|Withdrawal by Subject|0|||
161577703|NCT01636687|583503320|FG003|Induction Period|Withdrawal by Subject|0|||
161577704|NCT01636687|583503321|FG004|Induction Period|Withdrawal by Subject|0|||
161577705|NCT01636687|583503317|FG000|Induction Period|Adverse Event|1|||
161577706|NCT01636687|583503318|FG001|Induction Period|Adverse Event|0|||
161577707|NCT01636687|583503319|FG002|Induction Period|Adverse Event|0|||
161577708|NCT01636687|583503320|FG003|Induction Period|Adverse Event|0|||
161577709|NCT01636687|583503321|FG004|Induction Period|Adverse Event|1|||
161577710|NCT01636687|583503317|FG000|Induction Period|Lack of Efficacy|0|||
161920609|NCT02293499|584755759|FG002|Intervention - Camp|Withdrawal by Subject|2|||
161920610|NCT02293499|584755757|FG000|Intervention - Camp|these are those not showing up at camp|24|||
161920611|NCT02293499|584755758|FG001|Intervention - Camp|these are those not showing up at camp|28|||
161920612|NCT02293499|584755759|FG002|Intervention - Camp|these are those not showing up at camp|4|||
161920613|NCT02293499|584755757|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
161920614|NCT02293499|584755758|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
161920615|NCT02293499|584755759|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
161920616|NCT02293499|584755757|FG000|3 Month Follow Up|Lost to Follow-up|14|||
161920617|NCT02293499|584755758|FG001|3 Month Follow Up|Lost to Follow-up|15|||
161920618|NCT02293499|584755759|FG002|3 Month Follow Up|Lost to Follow-up|6|||
161920619|NCT02293499|584755757|FG000|6 Month Follow Up|Lost to Follow-up|17|||
161920620|NCT02293499|584755758|FG001|6 Month Follow Up|Lost to Follow-up|27|||
161920621|NCT02293499|584755759|FG002|6 Month Follow Up|Lost to Follow-up|6|||
161920622|NCT02293499|584755757|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
161920623|NCT02293499|584755758|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
161920624|NCT02293499|584755759|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
161920625|NCT02293499|584755757|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
161920626|NCT02293499|584755758|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
161920627|NCT02293499|584755759|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
161920628|NCT02293499|584755757|FG000|9 Month Follow Up|Lost to Follow-up|24|||
161920629|NCT02293499|584755758|FG001|9 Month Follow Up|Lost to Follow-up|28|||
161920630|NCT02293499|584755759|FG002|9 Month Follow Up|Lost to Follow-up|4|||
161920631|NCT02293499|584755757|FG000|12 Month Follow Up|Lost to Follow-up|26|||
161920632|NCT02293499|584755758|FG001|12 Month Follow Up|Lost to Follow-up|25|||
161920633|NCT02293499|584755759|FG002|12 Month Follow Up|Lost to Follow-up|6|||
161920634|NCT02293499|584755757|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
161920635|NCT02293499|584755758|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
161920636|NCT02293499|584755759|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
161920637|NCT02293499|584755757|FG000|15 Month Follow Up|Lost to Follow-up|22|||
161920638|NCT02293499|584755758|FG001|15 Month Follow Up|Lost to Follow-up|22|||
161920639|NCT02293499|584755759|FG002|15 Month Follow Up|Lost to Follow-up|7|||
161920640|NCT05977868|584755760|FG000|Overall Study|Withdrawal by Subject|1|||
161920641|NCT05977868|584755761|FG001|Overall Study|Withdrawal by Subject|2|||
161920642|NCT05977868|584755760|FG000|Overall Study|Transitioned to comfort care|1|||
161920643|NCT05977868|584755761|FG001|Overall Study|Transitioned to comfort care|0|||
161920644|NCT00876395|584755762|FG000|Overall Study|Untreated|8|||
161920645|NCT00876395|584755763|FG001|Overall Study|Untreated|1|||
161920646|NCT00876395|584755762|FG000|Overall Study|Adverse Event|63|||
161920647|NCT00876395|584755763|FG001|Overall Study|Adverse Event|11|||
161920648|NCT00876395|584755762|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161920649|NCT00876395|584755763|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161920650|NCT00876395|584755762|FG000|Overall Study|Disease progression|259|||
161920651|NCT00876395|584755763|FG001|Overall Study|Disease progression|162|||
161920652|NCT00876395|584755762|FG000|Overall Study|New cancer therapy|25|||
161920653|NCT00876395|584755763|FG001|Overall Study|New cancer therapy|7|||
161920654|NCT00876395|584755762|FG000|Overall Study|Protocol Violation|5|||
161920655|NCT00876395|584755763|FG001|Overall Study|Protocol Violation|2|||
161920656|NCT00876395|584755762|FG000|Overall Study|Withdrawal by Subject|66|||
161920657|NCT00876395|584755763|FG001|Overall Study|Withdrawal by Subject|33|||
161920658|NCT00876395|584755762|FG000|Overall Study|Lost to Follow-up|2|||
161920659|NCT00876395|584755763|FG001|Overall Study|Lost to Follow-up|0|||
161920660|NCT00876395|584755762|FG000|Overall Study|Administrative problems|39|||
161920661|NCT00876395|584755763|FG001|Overall Study|Administrative problems|23|||
161920662|NCT00876395|584755762|FG000|Overall Study|Death|12|||
161920663|NCT00876395|584755763|FG001|Overall Study|Death|0|||
161920664|NCT01787838|584755772|FG000|Overall Study|refused|1413|||
161920665|NCT01991314|584755791|FG000|Overall Study|Adverse Event|5|||
161920666|NCT01991314|584755792|FG001|Overall Study|Adverse Event|1|||
161920667|NCT01991314|584755791|FG000|Overall Study|Lost to Follow-up|6|||
161920668|NCT01991314|584755792|FG001|Overall Study|Lost to Follow-up|10|||
161920669|NCT03915067|584755794|FG000|Overall Study|Adverse Event|0|||
161920670|NCT03915067|584755795|FG001|Overall Study|Adverse Event|0|||
161920671|NCT03915067|584755796|FG002|Overall Study|Adverse Event|1|||
161920672|NCT03915067|584755794|FG000|Overall Study|Withdrawal by Subject|4|||
161920673|NCT03915067|584755795|FG001|Overall Study|Withdrawal by Subject|3|||
161920674|NCT03915067|584755796|FG002|Overall Study|Withdrawal by Subject|0|||
161920675|NCT03915067|584755794|FG000|Overall Study|Lost to Follow-up|3|||
161920676|NCT03915067|584755795|FG001|Overall Study|Lost to Follow-up|2|||
161920677|NCT03915067|584755796|FG002|Overall Study|Lost to Follow-up|0|||
161920678|NCT03915067|584755794|FG000|Overall Study|Protocol Deviation|0|||
161920679|NCT03915067|584755795|FG001|Overall Study|Protocol Deviation|0|||
161920680|NCT03915067|584755796|FG002|Overall Study|Protocol Deviation|1|||
161920681|NCT03915067|584755794|FG000|Overall Study|Covid-19 Related Issues|2|||
161920682|NCT03915067|584755795|FG001|Overall Study|Covid-19 Related Issues|4|||
161920683|NCT03915067|584755796|FG002|Overall Study|Covid-19 Related Issues|4|||
161920684|NCT03915067|584755794|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
161920685|NCT03915067|584755795|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
161920686|NCT03915067|584755796|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
161920687|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
161920688|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
161920689|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
161920690|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
161920691|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
161920692|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920693|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
161920694|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920695|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920696|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920697|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Death|0|||
161920698|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Death|0|||
161920699|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Death|1|||
161920700|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Death|0|||
161920701|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Death|0|||
161920702|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
161920703|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
161920704|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
161920705|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
161920706|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
161920707|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Other|2|||
161920708|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Other|1|||
161920709|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Other|0|||
161920710|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Other|0|||
161920711|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Other|0|||
161920712|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920713|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920714|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
161920715|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920716|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920717|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161920718|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
161920719|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161920720|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
161920721|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161920722|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
161920723|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
161920724|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
161920725|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
161920726|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
161920727|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
161920728|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920729|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920730|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920731|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920732|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920733|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920734|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
161920735|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920736|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920737|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
161920738|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
161920739|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
161920740|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
161920741|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
161920742|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
161920743|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
161920744|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
161577711|NCT01636687|583503318|FG001|Induction Period|Lack of Efficacy|0|||
161577712|NCT01636687|583503319|FG002|Induction Period|Lack of Efficacy|0|||
161577713|NCT01636687|583503320|FG003|Induction Period|Lack of Efficacy|0|||
161577714|NCT01636687|583503321|FG004|Induction Period|Lack of Efficacy|1|||
161577715|NCT01636687|583503317|FG000|Induction Period|Physician Decision|1|||
161577716|NCT01636687|583503318|FG001|Induction Period|Physician Decision|0|||
161577717|NCT01636687|583503319|FG002|Induction Period|Physician Decision|0|||
161577718|NCT01636687|583503320|FG003|Induction Period|Physician Decision|0|||
161577719|NCT01636687|583503321|FG004|Induction Period|Physician Decision|0|||
161577720|NCT01636687|583503317|FG000|Maintenance Period|Withdrawal by Subject|2|||
161577721|NCT01636687|583503318|FG001|Maintenance Period|Withdrawal by Subject|0|||
161577722|NCT01636687|583503319|FG002|Maintenance Period|Withdrawal by Subject|2|||
161577723|NCT01636687|583503320|FG003|Maintenance Period|Withdrawal by Subject|0|||
161577724|NCT01636687|583503321|FG004|Maintenance Period|Withdrawal by Subject|0|||
161577725|NCT01636687|583503317|FG000|Maintenance Period|Adverse Event|1|||
161577726|NCT01636687|583503318|FG001|Maintenance Period|Adverse Event|0|||
161577727|NCT01636687|583503319|FG002|Maintenance Period|Adverse Event|0|||
161577728|NCT01636687|583503320|FG003|Maintenance Period|Adverse Event|0|||
161577729|NCT01636687|583503321|FG004|Maintenance Period|Adverse Event|0|||
161577730|NCT01636687|583503317|FG000|Maintenance Period|Lack of Efficacy|4|||
161577731|NCT01636687|583503318|FG001|Maintenance Period|Lack of Efficacy|1|||
161577732|NCT01636687|583503319|FG002|Maintenance Period|Lack of Efficacy|0|||
161577733|NCT01636687|583503320|FG003|Maintenance Period|Lack of Efficacy|0|||
161577734|NCT01636687|583503321|FG004|Maintenance Period|Lack of Efficacy|0|||
161577735|NCT01636687|583503317|FG000|Maintenance Period|Lost to Follow-up|1|||
161577736|NCT01636687|583503318|FG001|Maintenance Period|Lost to Follow-up|1|||
161577737|NCT01636687|583503319|FG002|Maintenance Period|Lost to Follow-up|0|||
161577738|NCT01636687|583503320|FG003|Maintenance Period|Lost to Follow-up|0|||
161577739|NCT01636687|583503321|FG004|Maintenance Period|Lost to Follow-up|1|||
161577740|NCT01636687|583503317|FG000|Maintenance Period|Physician Decision|0|||
161577741|NCT01636687|583503318|FG001|Maintenance Period|Physician Decision|0|||
161577742|NCT01636687|583503319|FG002|Maintenance Period|Physician Decision|0|||
161577743|NCT01636687|583503320|FG003|Maintenance Period|Physician Decision|0|||
161577744|NCT01636687|583503321|FG004|Maintenance Period|Physician Decision|1|||
161577745|NCT01636687|583503317|FG000|Extension Period|technical problems|0|||
161577746|NCT01636687|583503318|FG001|Extension Period|technical problems|1|||
161577747|NCT01636687|583503319|FG002|Extension Period|technical problems|2|||
161577748|NCT01636687|583503320|FG003|Extension Period|technical problems|1|||
161814848|NCT00205777|584365391|FG003|Study Extension II|Lack of Efficacy|0|||
161814849|NCT00205777|584365392|FG004|Study Extension II|Lack of Efficacy|0|||
161814850|NCT00205777|584365393|FG005|Study Extension II|Lack of Efficacy|1|||
161814851|NCT00205777|584365388|FG000|Study Extension II|Failed to return|0|||
161814852|NCT00205777|584365389|FG001|Study Extension II|Failed to return|0|||
161814853|NCT00205777|584365390|FG002|Study Extension II|Failed to return|0|||
161814854|NCT00205777|584365391|FG003|Study Extension II|Failed to return|14|||
161814855|NCT00205777|584365392|FG004|Study Extension II|Failed to return|0|||
161814856|NCT00205777|584365393|FG005|Study Extension II|Failed to return|26|||
161814857|NCT00205777|584365388|FG000|Study Extension II|Other Event|0|||
161814858|NCT00205777|584365389|FG001|Study Extension II|Other Event|0|||
161814859|NCT00205777|584365390|FG002|Study Extension II|Other Event|0|||
161814860|NCT00205777|584365391|FG003|Study Extension II|Other Event|12|||
161814861|NCT00205777|584365392|FG004|Study Extension II|Other Event|0|||
161814862|NCT00205777|584365393|FG005|Study Extension II|Other Event|20|||
161814863|NCT00205777|584365388|FG000|Study Extension II|Enrolled but not treated|0|||
161814864|NCT00205777|584365389|FG001|Study Extension II|Enrolled but not treated|0|||
161814865|NCT00205777|584365390|FG002|Study Extension II|Enrolled but not treated|0|||
161814866|NCT00205777|584365391|FG003|Study Extension II|Enrolled but not treated|71|||
161814867|NCT00205777|584365392|FG004|Study Extension II|Enrolled but not treated|0|||
161814868|NCT00205777|584365393|FG005|Study Extension II|Enrolled but not treated|131|||
161814869|NCT00700739|584365397|FG000|Overall Study|Lost to Follow-up|4|||
161814870|NCT00700739|584365398|FG001|Overall Study|Lost to Follow-up|4|||
161814871|NCT00003470|584365402|FG000|Overall Study|Not evaluable|6|||
161814872|NCT02923349|584365415|FG000|Overall Study|Other|1|||
161814873|NCT02923349|584365416|FG001|Overall Study|Other|2|||
161814874|NCT02923349|584365417|FG002|Overall Study|Other|4|||
161814875|NCT02923349|584365418|FG003|Overall Study|Other|1|||
161814876|NCT02923349|584365419|FG004|Overall Study|Other|3|||
161814877|NCT02923349|584365420|FG005|Overall Study|Other|0|||
161814878|NCT02923349|584365421|FG006|Overall Study|Other|1|||
161814879|NCT02923349|584365415|FG000|Overall Study|Withdrawal by Subject|2|||
161814880|NCT02923349|584365416|FG001|Overall Study|Withdrawal by Subject|2|||
161577749|NCT01636687|583503321|FG004|Extension Period|technical problems|0|||
161577750|NCT01636687|583503317|FG000|Extension Period|Adverse Event|4|||
161577751|NCT01636687|583503318|FG001|Extension Period|Adverse Event|3|||
161577752|NCT01636687|583503319|FG002|Extension Period|Adverse Event|2|||
161814881|NCT02923349|584365417|FG002|Overall Study|Withdrawal by Subject|8|||
161814882|NCT02923349|584365418|FG003|Overall Study|Withdrawal by Subject|10|||
161577753|NCT01636687|583503320|FG003|Extension Period|Adverse Event|1|||
161577754|NCT01636687|583503321|FG004|Extension Period|Adverse Event|0|||
161577755|NCT01636687|583503317|FG000|Extension Period|Lack of Efficacy|7|||
161577756|NCT01636687|583503318|FG001|Extension Period|Lack of Efficacy|0|||
161577757|NCT01636687|583503319|FG002|Extension Period|Lack of Efficacy|2|||
161577758|NCT01636687|583503320|FG003|Extension Period|Lack of Efficacy|1|||
161577759|NCT01636687|583503321|FG004|Extension Period|Lack of Efficacy|0|||
161577760|NCT01636687|583503317|FG000|Extension Period|Lost to Follow-up|1|||
161577761|NCT01636687|583503318|FG001|Extension Period|Lost to Follow-up|0|||
161577762|NCT01636687|583503319|FG002|Extension Period|Lost to Follow-up|1|||
161577763|NCT01636687|583503320|FG003|Extension Period|Lost to Follow-up|0|||
161577764|NCT01636687|583503321|FG004|Extension Period|Lost to Follow-up|0|||
161577765|NCT01636687|583503317|FG000|Extension Period|Physician Decision|1|||
161577766|NCT01636687|583503318|FG001|Extension Period|Physician Decision|0|||
161577767|NCT01636687|583503319|FG002|Extension Period|Physician Decision|0|||
161577768|NCT01636687|583503320|FG003|Extension Period|Physician Decision|1|||
161577769|NCT01636687|583503321|FG004|Extension Period|Physician Decision|0|||
161577770|NCT01636687|583503317|FG000|Extension Period|study terminated by sponsor|33|||
161577771|NCT01636687|583503318|FG001|Extension Period|study terminated by sponsor|50|||
161577772|NCT01636687|583503319|FG002|Extension Period|study terminated by sponsor|17|||
161577773|NCT01636687|583503320|FG003|Extension Period|study terminated by sponsor|23|||
161577774|NCT01636687|583503321|FG004|Extension Period|study terminated by sponsor|0|||
161920745|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
161920746|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
161920747|NCT03317496|584755797|FG000|Phase 2: Treatment|Adverse Event|0|||
161920748|NCT03317496|584755798|FG001|Phase 2: Treatment|Adverse Event|0|||
161920749|NCT03317496|584755799|FG002|Phase 2: Treatment|Adverse Event|0|||
161920750|NCT03317496|584755800|FG003|Phase 2: Treatment|Adverse Event|0|||
161920751|NCT03317496|584755801|FG004|Phase 2: Treatment|Adverse Event|6|||
161920752|NCT03317496|584755797|FG000|Phase 2: Treatment|Progressive disease|0|||
161920753|NCT03317496|584755798|FG001|Phase 2: Treatment|Progressive disease|0|||
161920754|NCT03317496|584755799|FG002|Phase 2: Treatment|Progressive disease|0|||
161920755|NCT03317496|584755800|FG003|Phase 2: Treatment|Progressive disease|0|||
161920756|NCT03317496|584755801|FG004|Phase 2: Treatment|Progressive disease|22|||
161920757|NCT03317496|584755797|FG000|Phase 2: Treatment|Other|0|||
161920758|NCT03317496|584755798|FG001|Phase 2: Treatment|Other|0|||
161920759|NCT03317496|584755799|FG002|Phase 2: Treatment|Other|0|||
161920760|NCT03317496|584755800|FG003|Phase 2: Treatment|Other|0|||
161577775|NCT01636687|583503317|FG000|Extension Period|Withdrawal by Subject|1|||
161577776|NCT01636687|583503318|FG001|Extension Period|Withdrawal by Subject|0|||
161577777|NCT01636687|583503319|FG002|Extension Period|Withdrawal by Subject|1|||
161577778|NCT01636687|583503320|FG003|Extension Period|Withdrawal by Subject|1|||
161577779|NCT01636687|583503321|FG004|Extension Period|Withdrawal by Subject|0|||
161577780|NCT01636687|583503317|FG000|Follow-up Period|Withdrawal by Subject|1|||
161577781|NCT01636687|583503318|FG001|Follow-up Period|Withdrawal by Subject|0|||
161577782|NCT01636687|583503319|FG002|Follow-up Period|Withdrawal by Subject|0|||
161577783|NCT01636687|583503320|FG003|Follow-up Period|Withdrawal by Subject|0|||
161577784|NCT01636687|583503321|FG004|Follow-up Period|Withdrawal by Subject|1|||
161577785|NCT00666276|583503324|FG000|Overall Study|Protocol Violation|34|||
161577786|NCT02594735|583503325|FG000|Overall Study|Adverse Event|1|||
161577787|NCT00101010|583503326|FG000|Overall Study|Physician Decision|1|||
161577788|NCT00364013|583503333|FG000|Overall Study|Ineligibility determined|4|||
161577789|NCT00364013|583503334|FG001|Overall Study|Ineligibility determined|2|||
161577790|NCT00364013|583503333|FG000|Overall Study|Adverse Event|4|||
161577791|NCT00364013|583503334|FG001|Overall Study|Adverse Event|3|||
161577792|NCT00364013|583503333|FG000|Overall Study|Withdrawal by Subject|13|||
161577793|NCT00364013|583503334|FG001|Overall Study|Withdrawal by Subject|18|||
161577794|NCT00364013|583503333|FG000|Overall Study|Physician Decision|3|||
161577795|NCT00364013|583503334|FG001|Overall Study|Physician Decision|3|||
161577796|NCT00364013|583503333|FG000|Overall Study|Lost to Follow-up|10|||
161920761|NCT03317496|584755801|FG004|Phase 2: Treatment|Other|4|||
161920762|NCT03317496|584755797|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
161920763|NCT03317496|584755798|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
161577797|NCT00364013|583503334|FG001|Overall Study|Lost to Follow-up|3|||
161577798|NCT00364013|583503333|FG000|Overall Study|Protocol-specified criteria|6|||
161577799|NCT00364013|583503334|FG001|Overall Study|Protocol-specified criteria|6|||
161577800|NCT00364013|583503333|FG000|Overall Study|Other|41|||
161577801|NCT00364013|583503334|FG001|Overall Study|Other|47|||
161577802|NCT00364013|583503333|FG000|Overall Study|Ongoing|20|||
161577803|NCT00364013|583503334|FG001|Overall Study|Ongoing|13|||
161577804|NCT00835770|583503335|FG000|Overall Study|MS Relapse|17|||
161814883|NCT02923349|584365419|FG004|Overall Study|Withdrawal by Subject|12|||
161814884|NCT02923349|584365420|FG005|Overall Study|Withdrawal by Subject|3|||
161814885|NCT02923349|584365421|FG006|Overall Study|Withdrawal by Subject|0|||
161814886|NCT02923349|584365415|FG000|Overall Study|Physician Decision|0|||
161814887|NCT02923349|584365416|FG001|Overall Study|Physician Decision|0|||
161814888|NCT02923349|584365417|FG002|Overall Study|Physician Decision|0|||
161814889|NCT02923349|584365418|FG003|Overall Study|Physician Decision|1|||
161814890|NCT02923349|584365419|FG004|Overall Study|Physician Decision|1|||
161814891|NCT02923349|584365420|FG005|Overall Study|Physician Decision|0|||
161814892|NCT02923349|584365421|FG006|Overall Study|Physician Decision|2|||
161814893|NCT02923349|584365415|FG000|Overall Study|Lost to Follow-up|0|||
161814894|NCT02923349|584365416|FG001|Overall Study|Lost to Follow-up|0|||
161814895|NCT02923349|584365417|FG002|Overall Study|Lost to Follow-up|3|||
161814896|NCT02923349|584365418|FG003|Overall Study|Lost to Follow-up|0|||
161814897|NCT02923349|584365419|FG004|Overall Study|Lost to Follow-up|1|||
161814898|NCT02923349|584365420|FG005|Overall Study|Lost to Follow-up|1|||
161814899|NCT02923349|584365421|FG006|Overall Study|Lost to Follow-up|0|||
161814900|NCT02923349|584365415|FG000|Overall Study|Death|1|||
161814901|NCT02923349|584365416|FG001|Overall Study|Death|0|||
161814902|NCT02923349|584365417|FG002|Overall Study|Death|2|||
161814903|NCT02923349|584365418|FG003|Overall Study|Death|4|||
161814904|NCT02923349|584365419|FG004|Overall Study|Death|2|||
161814905|NCT02923349|584365420|FG005|Overall Study|Death|3|||
161814906|NCT02923349|584365421|FG006|Overall Study|Death|0|||
161814907|NCT01473953|584365424|FG000|Overall Study|Other|1|||
161814908|NCT01473953|584365425|FG001|Overall Study|Other|0|||
161814909|NCT01473953|584365426|FG002|Overall Study|Other|0|||
161814910|NCT01473953|584365427|FG003|Overall Study|Other|0|||
161814911|NCT01473953|584365428|FG004|Overall Study|Other|0|||
161814912|NCT00725322|584365429|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
161814913|NCT00725322|584365430|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
161814914|NCT00725322|584365429|FG000|Washout (28 Days)|Protocol Violation|0|||
161814915|NCT00725322|584365430|FG001|Washout (28 Days)|Protocol Violation|1|||
161814916|NCT05871151|584365431|FG000|Overall Study|Lost to Follow-up|1|||
161814917|NCT05871151|584365432|FG001|Overall Study|Lost to Follow-up|0|||
161814918|NCT05871151|584365431|FG000|Overall Study|Unrelated illness|0|||
161814919|NCT05871151|584365432|FG001|Overall Study|Unrelated illness|1|||
161814920|NCT03114891|584365433|FG000|First Treatment Round|Lost to Follow-up|0|||
161814921|NCT03114891|584365434|FG001|First Treatment Round|Lost to Follow-up|1|||
161814922|NCT03114891|584365435|FG002|First Treatment Round|Lost to Follow-up|1|||
161814923|NCT03114891|584365436|FG003|First Treatment Round|Lost to Follow-up|0|||
161814924|NCT03114891|584365433|FG000|First Treatment Round|Withdrawal by Subject|0|||
161814925|NCT03114891|584365434|FG001|First Treatment Round|Withdrawal by Subject|2|||
161814926|NCT03114891|584365435|FG002|First Treatment Round|Withdrawal by Subject|0|||
161814927|NCT03114891|584365436|FG003|First Treatment Round|Withdrawal by Subject|1|||
161814928|NCT03114891|584365433|FG000|3 Week Break|Lost to Follow-up|1|||
161814929|NCT03114891|584365434|FG001|3 Week Break|Lost to Follow-up|0|||
161814930|NCT03114891|584365435|FG002|3 Week Break|Lost to Follow-up|0|||
161814931|NCT03114891|584365436|FG003|3 Week Break|Lost to Follow-up|1|||
161814932|NCT03114891|584365433|FG000|3 Week Break|Withdrawal by Subject|0|||
161814933|NCT03114891|584365434|FG001|3 Week Break|Withdrawal by Subject|1|||
161814934|NCT03114891|584365435|FG002|3 Week Break|Withdrawal by Subject|0|||
161814935|NCT03114891|584365436|FG003|3 Week Break|Withdrawal by Subject|0|||
161814936|NCT03114891|584365433|FG000|Second Treatment Round|Lost to Follow-up|1|||
161814937|NCT03114891|584365434|FG001|Second Treatment Round|Lost to Follow-up|0|||
161814938|NCT03114891|584365435|FG002|Second Treatment Round|Lost to Follow-up|0|||
161814939|NCT03114891|584365436|FG003|Second Treatment Round|Lost to Follow-up|0|||
161814940|NCT03114891|584365433|FG000|Second Treatment Round|Physician Decision|1|||
161814941|NCT03114891|584365434|FG001|Second Treatment Round|Physician Decision|0|||
161814942|NCT03114891|584365435|FG002|Second Treatment Round|Physician Decision|0|||
161814943|NCT03114891|584365436|FG003|Second Treatment Round|Physician Decision|0|||
161814944|NCT00830258|584366820|FG000|First Intervention|Adverse Event|1|||
161814945|NCT00830258|584366821|FG001|First Intervention|Adverse Event|0|||
161814946|NCT00830258|584366820|FG000|Washout: 7 Days|Protocol Violation|1|||
161814947|NCT00830258|584366821|FG001|Washout: 7 Days|Protocol Violation|0|||
161814948|NCT00798603|584366822|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
161814949|NCT00798603|584366822|FG000|Overall Study|Withdrawal by Subject|10|||
161814950|NCT00798603|584366822|FG000|Overall Study|Adverse Event|22|||
161814951|NCT00798603|584366822|FG000|Overall Study|Physician Decision|1|||
161814952|NCT00798603|584366822|FG000|Overall Study|Lack of insurance coverage|1|||
161814953|NCT05511935|584366823|FG000|Overall Study|Lost to Follow-up|9|||
161577805|NCT00835770|583503336|FG001|Overall Study|MS Relapse|23|||
161814954|NCT05511935|584366824|FG001|Overall Study|Lost to Follow-up|27|||
161814955|NCT04406194|584366825|FG000|Period 1|Withdrawal by Subject|0|||
161814956|NCT04406194|584366826|FG001|Period 1|Withdrawal by Subject|1|||
161814957|NCT04102345|584366827|FG000|Overall Study|Withdrawal by Subject|1|||
161814958|NCT04102345|584366828|FG001|Overall Study|Withdrawal by Subject|0|||
161577806|NCT00835770|583503335|FG000|Overall Study|MS Progression|14|||
161577807|NCT00835770|583503336|FG001|Overall Study|MS Progression|9|||
161577808|NCT00835770|583503335|FG000|Overall Study|Adverse Event|113|||
161577809|NCT00835770|583503336|FG001|Overall Study|Adverse Event|124|||
161577810|NCT00835770|583503335|FG000|Overall Study|Lost to Follow-up|22|||
161577811|NCT00835770|583503336|FG001|Overall Study|Lost to Follow-up|19|||
161577812|NCT00835770|583503335|FG000|Overall Study|Consent Withdrawn|144|||
161577813|NCT00835770|583503336|FG001|Overall Study|Consent Withdrawn|156|||
161577814|NCT00835770|583503335|FG000|Overall Study|Investigator Decision|42|||
161577815|NCT00835770|583503336|FG001|Overall Study|Investigator Decision|42|||
161577816|NCT00835770|583503335|FG000|Overall Study|Participant Non-Compliance|11|||
161577817|NCT00835770|583503336|FG001|Overall Study|Participant Non-Compliance|9|||
161475020|NCT00697788|583134444|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161475021|NCT00697788|583134445|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
161577818|NCT00835770|583503335|FG000|Overall Study|Death|4|||
161577819|NCT00835770|583503336|FG001|Overall Study|Death|6|||
161577820|NCT00835770|583503335|FG000|Overall Study|Other|115|||
161577821|NCT00835770|583503336|FG001|Overall Study|Other|104|||
161475022|NCT00697788|583134446|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161475023|NCT00697788|583134447|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161475024|NCT00697788|583134448|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161475025|NCT00697788|583134449|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161577822|NCT00835770|583503335|FG000|Overall Study|Other|2|||
161577823|NCT00835770|583503336|FG001|Overall Study|Other|1|||
161475026|NCT00697788|583134450|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161475027|NCT00697788|583134451|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
161475028|NCT00697788|583134444|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475029|NCT00697788|583134445|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475030|NCT00697788|583134446|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475031|NCT00697788|583134447|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475032|NCT00697788|583134448|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
161475033|NCT00697788|583134449|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475034|NCT00697788|583134450|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475035|NCT00697788|583134451|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161475036|NCT00142935|583134453|FG000|Overall Study|Other reason|1|||
161475037|NCT00142935|583134454|FG001|Overall Study|Other reason|1|||
161475038|NCT00142935|583134455|FG002|Overall Study|Other reason|1|||
161475039|NCT00142935|583134453|FG000|Overall Study|Lost to Follow-up|2|||
161475040|NCT00142935|583134454|FG001|Overall Study|Lost to Follow-up|5|||
161475041|NCT00142935|583134455|FG002|Overall Study|Lost to Follow-up|5|||
161475042|NCT00142935|583134453|FG000|Overall Study|Death|0|||
161475043|NCT00142935|583134454|FG001|Overall Study|Death|2|||
161475044|NCT00142935|583134455|FG002|Overall Study|Death|1|||
161475045|NCT01180985|583134460|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
161475046|NCT01180985|583134461|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
161475047|NCT00705289|583134462|FG000|Overall Study|Subject or treating physician's choice|131|||
161475048|NCT03345914|583134467|FG000|Overall Study|Transition to another study at week 16|80|||
161475049|NCT03345914|583134468|FG001|Overall Study|Transition to another study at week 16|86|||
161475050|NCT03345914|583134469|FG002|Overall Study|Transition to another study at week 16|78|||
161475051|NCT03345914|583134467|FG000|Overall Study|Transition to OLE during follow-up|37|||
161475052|NCT03345914|583134468|FG001|Overall Study|Transition to OLE during follow-up|33|||
161475053|NCT03345914|583134469|FG002|Overall Study|Transition to OLE during follow-up|39|||
161475054|NCT03345914|583134467|FG000|Overall Study|Physician Decision|0|||
161475055|NCT03345914|583134468|FG001|Overall Study|Physician Decision|1|||
161814959|NCT02888756|584366829|FG000|Analytical Treatment Interruption|Physician Decision|10|||
161814960|NCT02888756|584366830|FG001|Analytical Treatment Interruption|Physician Decision|6|||
161814961|NCT02888756|584366831|FG002|Analytical Treatment Interruption|Physician Decision|5|||
161814962|NCT01015287|584366834|FG000|Overall Study|Death|21|||
161814963|NCT01015287|584366835|FG001|Overall Study|Death|16|||
161814964|NCT01015287|584366834|FG000|Overall Study|Adverse Event|1|||
161814965|NCT01015287|584366835|FG001|Overall Study|Adverse Event|0|||
161814966|NCT01015287|584366834|FG000|Overall Study|Sponsor Decision|3|||
161814967|NCT01015287|584366835|FG001|Overall Study|Sponsor Decision|7|||
161814968|NCT01015287|584366834|FG000|Overall Study|Physician Decision|19|||
161920764|NCT03317496|584755799|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
161475056|NCT03345914|583134469|FG002|Overall Study|Physician Decision|1|||
161475057|NCT03345914|583134467|FG000|Overall Study|Withdrawal by Subject|5|||
161475058|NCT03345914|583134468|FG001|Overall Study|Withdrawal by Subject|1|||
161475059|NCT03345914|583134469|FG002|Overall Study|Withdrawal by Subject|2|||
161475060|NCT03345914|583134467|FG000|Overall Study|Other|1|||
161577824|NCT02202499|583503340|FG000|Overall Study|Cancer diagnosis|0|||
161577825|NCT02202499|583503341|FG001|Overall Study|Cancer diagnosis|0|||
161577826|NCT02202499|583503342|FG002|Overall Study|Cancer diagnosis|1|||
161577827|NCT02202499|583503340|FG000|Overall Study|Moved from area|0|||
161475061|NCT03345914|583134468|FG001|Overall Study|Other|1|||
161475062|NCT03345914|583134469|FG002|Overall Study|Other|1|||
161475063|NCT03345914|583134467|FG000|Overall Study|Ongoing|0|||
161475064|NCT03345914|583134468|FG001|Overall Study|Ongoing|0|||
161475065|NCT03345914|583134469|FG002|Overall Study|Ongoing|1|||
161475066|NCT02601027|583134472|FG000|Registration to Surgery|Withdrawal by Subject|20|||
161475067|NCT02601027|583134473|FG001|Registration to Surgery|Withdrawal by Subject|10|||
161475068|NCT01330030|583134474|FG000|Overall Study|Lost to Follow-up|16|||
161475069|NCT01330030|583134475|FG001|Overall Study|Lost to Follow-up|17|||
161475070|NCT01365052|583134476|FG000|Overall Study|Adverse Event|4|||
161475071|NCT01365052|583134477|FG001|Overall Study|Adverse Event|4|||
161577828|NCT02202499|583503341|FG001|Overall Study|Moved from area|0|||
161577829|NCT02202499|583503342|FG002|Overall Study|Moved from area|1|||
161577830|NCT02202499|583503340|FG000|Overall Study|Declined before randomization|1|||
161577831|NCT02202499|583503341|FG001|Overall Study|Declined before randomization|0|||
161577832|NCT02202499|583503342|FG002|Overall Study|Declined before randomization|0|||
161577833|NCT02202499|583503340|FG000|Overall Study|Auto accident|1|||
161577834|NCT02202499|583503341|FG001|Overall Study|Auto accident|0|||
161577835|NCT02202499|583503342|FG002|Overall Study|Auto accident|0|||
161577836|NCT00535145|583503344|FG000|Phase I|Adverse Event|3|||
161577837|NCT00535145|583503344|FG000|Phase I|Lost to Follow-up|7|||
161577838|NCT00535145|583503344|FG000|Phase I|Withdrawal by Subject|6|||
161577839|NCT00535145|583503344|FG000|Phase I|(eligibility)|8|||
161577840|NCT00535145|583503344|FG000|Phase I|(protocol violation)|1|||
161577841|NCT00535145|583503344|FG000|Phase I|(PI decision)|1|||
161577842|NCT00535145|583503344|FG000|Phase I|(diagnosis)|3|||
161577843|NCT00535145|583503344|FG000|Phase II|Adverse Event|2|||
161577844|NCT00535145|583503344|FG000|Phase II|Lack of Efficacy|1|||
161577845|NCT00535145|583503344|FG000|Phase II|Lost to Follow-up|5|||
161577846|NCT00535145|583503344|FG000|Phase II|Withdrawal by Subject|5|||
161577847|NCT00535145|583503344|FG000|Phase II|Subject non-compliance|2|||
161577848|NCT05082935|583503349|FG000|Overall Study|Lost to Follow-up|549|||
161577849|NCT05082935|583503350|FG001|Overall Study|Lost to Follow-up|631|||
161577850|NCT05082935|583503349|FG000|Overall Study|Withdrawal by Subject|27|||
161577851|NCT05082935|583503350|FG001|Overall Study|Withdrawal by Subject|58|||
161577852|NCT00439569|583503351|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
161577853|NCT00439569|583503351|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
161577854|NCT00439569|583503351|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
161577855|NCT01124734|583503352|FG000|Overall Study|Disease progression|13|||
161577856|NCT01124734|583503352|FG000|Overall Study|Adverse Event|1|||
161577857|NCT01124734|583503352|FG000|Overall Study|Withdrawal by Subject|1|||
161577858|NCT01124734|583503352|FG000|Overall Study|Elected for alternative treatment|2|||
161577859|NCT02423798|583503353|FG000|Overall Study|Withdrawal by Subject|3|||
161814969|NCT01015287|584366835|FG001|Overall Study|Physician Decision|21|||
161475072|NCT02248701|583134480|FG000|Overall Study|Withdrawal by Subject|2|||
161475073|NCT02248701|583134481|FG001|Overall Study|Withdrawal by Subject|1|||
161475074|NCT02248701|583134480|FG000|Overall Study|Physician Decision|0|||
161475075|NCT02248701|583134481|FG001|Overall Study|Physician Decision|1|||
161475076|NCT02248701|583134480|FG000|Overall Study|Adverse Event|1|||
161475077|NCT02248701|583134481|FG001|Overall Study|Adverse Event|0|||
161475078|NCT02248701|583134480|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
161475079|NCT02248701|583134481|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
161475080|NCT00885846|583134484|FG000|Overall Study|Withdrawal by Subject|2|||
161475081|NCT00885846|583134485|FG001|Overall Study|Withdrawal by Subject|5|||
161475082|NCT00885846|583134486|FG002|Overall Study|Withdrawal by Subject|2|||
161475083|NCT00074984|583134487|FG000|Overall Study|Death|1|||
161475084|NCT00074984|583134488|FG001|Overall Study|Death|2|||
161475085|NCT00074984|583134487|FG000|Overall Study|Withdrawal by Subject|2|||
161475086|NCT00074984|583134488|FG001|Overall Study|Withdrawal by Subject|3|||
161475087|NCT00074984|583134487|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
161475088|NCT00074984|583134488|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
161475089|NCT03758443|583134489|FG000|Induction Period|Adverse Event|2|||
161475090|NCT03758443|583134490|FG001|Induction Period|Adverse Event|4|||
161475091|NCT03758443|583134491|FG002|Induction Period|Adverse Event|2|||
161577860|NCT00939510|583503357|FG000|Overall Study|Withdrawal by Subject|1|||
161577861|NCT01202955|583503358|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
161577862|NCT01202955|583503359|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
161577863|NCT00159783|583503364|FG000|Overall Study|Adverse Event|5|||
161577864|NCT00159783|583503365|FG001|Overall Study|Adverse Event|7|||
161577865|NCT00159783|583503366|FG002|Overall Study|Adverse Event|9|||
161577866|NCT00159783|583503364|FG000|Overall Study|Lack of Efficacy|1|||
161814970|NCT01015287|584366834|FG000|Overall Study|Withdrawal by Subject|14|||
161814971|NCT01015287|584366835|FG001|Overall Study|Withdrawal by Subject|19|||
161814972|NCT01015287|584366834|FG000|Overall Study|Entry Criteria not Met|11|||
161814973|NCT01015287|584366835|FG001|Overall Study|Entry Criteria not Met|14|||
161814974|NCT01015287|584366834|FG000|Overall Study|Lost to Follow-up|2|||
161814975|NCT01015287|584366835|FG001|Overall Study|Lost to Follow-up|1|||
161475092|NCT03758443|583134492|FG003|Induction Period|Adverse Event|3|||
161475093|NCT03758443|583134489|FG000|Induction Period|Physician Decision|1|||
161475094|NCT03758443|583134490|FG001|Induction Period|Physician Decision|1|||
161475095|NCT03758443|583134491|FG002|Induction Period|Physician Decision|3|||
161475096|NCT03758443|583134492|FG003|Induction Period|Physician Decision|0|||
161475097|NCT03758443|583134489|FG000|Induction Period|Protocol Violation|0|||
161475098|NCT03758443|583134490|FG001|Induction Period|Protocol Violation|0|||
161475099|NCT03758443|583134491|FG002|Induction Period|Protocol Violation|0|||
161475100|NCT03758443|583134492|FG003|Induction Period|Protocol Violation|1|||
161475101|NCT03758443|583134489|FG000|Induction Period|Withdrawal by Subject|3|||
161475102|NCT03758443|583134490|FG001|Induction Period|Withdrawal by Subject|2|||
161475103|NCT03758443|583134491|FG002|Induction Period|Withdrawal by Subject|2|||
161475104|NCT03758443|583134492|FG003|Induction Period|Withdrawal by Subject|4|||
161475105|NCT03758443|583134489|FG000|Extended Induction Period|Adverse Event|1|||
161814976|NCT01015287|584366834|FG000|Overall Study|Protocol Violation|1|||
161814977|NCT01015287|584366835|FG001|Overall Study|Protocol Violation|1|||
161814978|NCT01592240|584366836|FG000|Overall Study|Adverse Event|1|||
161814979|NCT01592240|584366837|FG001|Overall Study|Adverse Event|0|||
161814980|NCT01592240|584366838|FG002|Overall Study|Adverse Event|0|||
161814981|NCT01592240|584366839|FG003|Overall Study|Adverse Event|1|||
161814982|NCT01592240|584366840|FG004|Overall Study|Adverse Event|1|||
161814983|NCT01592240|584366841|FG005|Overall Study|Adverse Event|0|||
161814984|NCT01592240|584366842|FG006|Overall Study|Adverse Event|0|||
161814985|NCT01592240|584366836|FG000|Overall Study|Death|0|||
161814986|NCT01592240|584366837|FG001|Overall Study|Death|1|||
161814987|NCT01592240|584366838|FG002|Overall Study|Death|0|||
161814988|NCT01592240|584366839|FG003|Overall Study|Death|0|||
161814989|NCT01592240|584366840|FG004|Overall Study|Death|0|||
161814990|NCT01592240|584366841|FG005|Overall Study|Death|0|||
161814991|NCT01592240|584366842|FG006|Overall Study|Death|0|||
161814992|NCT01592240|584366836|FG000|Overall Study|Lost to Follow-up|1|||
161814993|NCT01592240|584366837|FG001|Overall Study|Lost to Follow-up|3|||
161814994|NCT01592240|584366838|FG002|Overall Study|Lost to Follow-up|1|||
161814995|NCT01592240|584366839|FG003|Overall Study|Lost to Follow-up|0|||
161814996|NCT01592240|584366840|FG004|Overall Study|Lost to Follow-up|3|||
161814997|NCT01592240|584366841|FG005|Overall Study|Lost to Follow-up|2|||
161814998|NCT01592240|584366842|FG006|Overall Study|Lost to Follow-up|0|||
161814999|NCT01592240|584366836|FG000|Overall Study|Protocol Violation|0|||
161815000|NCT01592240|584366837|FG001|Overall Study|Protocol Violation|0|||
161815001|NCT01592240|584366838|FG002|Overall Study|Protocol Violation|0|||
161815002|NCT01592240|584366839|FG003|Overall Study|Protocol Violation|0|||
161475106|NCT03758443|583134490|FG001|Extended Induction Period|Adverse Event|1|||
161475107|NCT03758443|583134491|FG002|Extended Induction Period|Adverse Event|0|||
161577867|NCT00159783|583503365|FG001|Overall Study|Lack of Efficacy|2|||
161577868|NCT00159783|583503366|FG002|Overall Study|Lack of Efficacy|3|||
161577869|NCT00159783|583503364|FG000|Overall Study|Withdrawal by Subject|7|||
161577870|NCT00159783|583503365|FG001|Overall Study|Withdrawal by Subject|11|||
161577871|NCT00159783|583503366|FG002|Overall Study|Withdrawal by Subject|12|||
161577872|NCT00159783|583503364|FG000|Overall Study|Lost to Follow-up|6|||
161815003|NCT01592240|584366840|FG004|Overall Study|Protocol Violation|0|||
161815004|NCT01592240|584366841|FG005|Overall Study|Protocol Violation|1|||
161815005|NCT01592240|584366842|FG006|Overall Study|Protocol Violation|0|||
161815006|NCT01592240|584366836|FG000|Overall Study|Withdrawal by Subject|0|||
161475108|NCT03758443|583134492|FG003|Extended Induction Period|Adverse Event|1|||
161475109|NCT03758443|583134489|FG000|Extended Induction Period|Lost to Follow-up|1|||
161475110|NCT03758443|583134490|FG001|Extended Induction Period|Lost to Follow-up|0|||
161475111|NCT03758443|583134491|FG002|Extended Induction Period|Lost to Follow-up|0|||
161577873|NCT00159783|583503365|FG001|Overall Study|Lost to Follow-up|5|||
161815007|NCT01592240|584366837|FG001|Overall Study|Withdrawal by Subject|4|||
161815008|NCT01592240|584366838|FG002|Overall Study|Withdrawal by Subject|4|||
161577874|NCT00159783|583503366|FG002|Overall Study|Lost to Follow-up|11|||
161815009|NCT01592240|584366839|FG003|Overall Study|Withdrawal by Subject|1|||
161815010|NCT01592240|584366840|FG004|Overall Study|Withdrawal by Subject|3|||
161475112|NCT03758443|583134492|FG003|Extended Induction Period|Lost to Follow-up|0|||
161815011|NCT01592240|584366841|FG005|Overall Study|Withdrawal by Subject|0|||
161815012|NCT01592240|584366842|FG006|Overall Study|Withdrawal by Subject|2|||
161815013|NCT01592240|584366836|FG000|Overall Study|Other|0|||
161815014|NCT01592240|584366837|FG001|Overall Study|Other|3|||
161815015|NCT01592240|584366838|FG002|Overall Study|Other|1|||
161815016|NCT01592240|584366839|FG003|Overall Study|Other|1|||
161815017|NCT01592240|584366840|FG004|Overall Study|Other|0|||
161815018|NCT01592240|584366841|FG005|Overall Study|Other|0|||
161815019|NCT01592240|584366842|FG006|Overall Study|Other|1|||
161815020|NCT01592240|584366836|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161815021|NCT01592240|584366837|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161815022|NCT01592240|584366838|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
161815023|NCT01592240|584366839|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
161815024|NCT01592240|584366840|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
161815025|NCT01592240|584366841|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
161815026|NCT01592240|584366842|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
161815027|NCT01117623|584366843|FG000|Overall Study|Adverse Event|0|||
161815028|NCT01117623|584366844|FG001|Overall Study|Adverse Event|2|||
161815029|NCT01117623|584366845|FG002|Overall Study|Adverse Event|4|||
161815030|NCT01117623|584366846|FG003|Overall Study|Adverse Event|0|||
161815031|NCT01117623|584366847|FG004|Overall Study|Adverse Event|2|||
161815032|NCT01117623|584366848|FG005|Overall Study|Adverse Event|0|||
161815033|NCT01117623|584366849|FG006|Overall Study|Adverse Event|0|||
161815034|NCT01117623|584366850|FG007|Overall Study|Adverse Event|2|||
161815035|NCT01117623|584366843|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
161815036|NCT01117623|584366844|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
161815037|NCT01117623|584366845|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
161815038|NCT01117623|584366846|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
161815039|NCT01117623|584366847|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
161815040|NCT01117623|584366848|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
161815041|NCT01117623|584366849|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
161815042|NCT01117623|584366850|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
161815043|NCT01117623|584366843|FG000|Overall Study|Withdrawal by Subject|0|||
161815044|NCT01117623|584366844|FG001|Overall Study|Withdrawal by Subject|0|||
161815045|NCT01117623|584366845|FG002|Overall Study|Withdrawal by Subject|2|||
161815046|NCT01117623|584366846|FG003|Overall Study|Withdrawal by Subject|0|||
161815047|NCT01117623|584366847|FG004|Overall Study|Withdrawal by Subject|0|||
161815048|NCT01117623|584366848|FG005|Overall Study|Withdrawal by Subject|1|||
161815049|NCT01117623|584366849|FG006|Overall Study|Withdrawal by Subject|1|||
161815050|NCT01117623|584366850|FG007|Overall Study|Withdrawal by Subject|1|||
161815051|NCT01117623|584366843|FG000|Overall Study|Non-compliance with study medication|0|||
161815052|NCT01117623|584366844|FG001|Overall Study|Non-compliance with study medication|0|||
161815053|NCT01117623|584366845|FG002|Overall Study|Non-compliance with study medication|0|||
161815054|NCT01117623|584366846|FG003|Overall Study|Non-compliance with study medication|0|||
161815055|NCT01117623|584366847|FG004|Overall Study|Non-compliance with study medication|0|||
161815056|NCT01117623|584366848|FG005|Overall Study|Non-compliance with study medication|0|||
161815057|NCT01117623|584366849|FG006|Overall Study|Non-compliance with study medication|0|||
161815058|NCT01117623|584366850|FG007|Overall Study|Non-compliance with study medication|1|||
161815059|NCT01117623|584366843|FG000|Overall Study|Invest. text: completed all planned txs|0|||
161815060|NCT01117623|584366844|FG001|Overall Study|Invest. text: completed all planned txs|0|||
161815061|NCT01117623|584366845|FG002|Overall Study|Invest. text: completed all planned txs|0|||
161815062|NCT01117623|584366846|FG003|Overall Study|Invest. text: completed all planned txs|0|||
161815063|NCT01117623|584366847|FG004|Overall Study|Invest. text: completed all planned txs|0|||
161815064|NCT01117623|584366848|FG005|Overall Study|Invest. text: completed all planned txs|1|||
161815065|NCT01117623|584366849|FG006|Overall Study|Invest. text: completed all planned txs|0|||
161815066|NCT01117623|584366850|FG007|Overall Study|Invest. text: completed all planned txs|0|||
161815067|NCT01205035|584366854|FG000|Overall Study|Withdrawal by Subject|1|||
161815068|NCT01205035|584366855|FG001|Overall Study|Withdrawal by Subject|0|||
161815069|NCT01205035|584366854|FG000|Overall Study|Physician Decision|1|||
161815070|NCT01205035|584366855|FG001|Overall Study|Physician Decision|0|||
161815071|NCT02727192|584366862|FG000|Overall Study|Lost to Follow-up|1|||
161815072|NCT02727192|584366863|FG001|Overall Study|Lost to Follow-up|0|||
161920765|NCT03317496|584755800|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
161475113|NCT03758443|583134489|FG000|Extended Induction Period|Physician Decision|2|||
161815073|NCT02727192|584366864|FG002|Overall Study|Lost to Follow-up|0|||
161815074|NCT00928057|584366866|FG000|Overall Study|Adverse Event|1|||
161815075|NCT00928057|584366867|FG001|Overall Study|Adverse Event|2|||
161815076|NCT00928057|584366866|FG000|Overall Study|Withdrawal by Subject|1|||
161475114|NCT03758443|583134490|FG001|Extended Induction Period|Physician Decision|1|||
161815077|NCT00928057|584366867|FG001|Overall Study|Withdrawal by Subject|0|||
161815078|NCT00928057|584366866|FG000|Overall Study|Lost to Follow-up|0|||
161815079|NCT00928057|584366867|FG001|Overall Study|Lost to Follow-up|1|||
161920766|NCT03317496|584755801|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
161920767|NCT03317496|584755797|FG000|Phase 2: Treatment|Physician Decision|0|||
161920768|NCT03317496|584755798|FG001|Phase 2: Treatment|Physician Decision|0|||
161920769|NCT03317496|584755799|FG002|Phase 2: Treatment|Physician Decision|0|||
161920770|NCT03317496|584755800|FG003|Phase 2: Treatment|Physician Decision|0|||
161920771|NCT03317496|584755801|FG004|Phase 2: Treatment|Physician Decision|1|||
161920772|NCT03317496|584755797|FG000|Phase 2: Treatment|Death|0|||
161920773|NCT03317496|584755798|FG001|Phase 2: Treatment|Death|0|||
161920774|NCT03317496|584755799|FG002|Phase 2: Treatment|Death|0|||
161920775|NCT03317496|584755800|FG003|Phase 2: Treatment|Death|0|||
161920776|NCT03317496|584755801|FG004|Phase 2: Treatment|Death|1|||
161920777|NCT03317496|584755797|FG000|Phase 2: Follow-up|Death|0|||
161920778|NCT03317496|584755798|FG001|Phase 2: Follow-up|Death|0|||
161920779|NCT03317496|584755799|FG002|Phase 2: Follow-up|Death|0|||
161920780|NCT03317496|584755800|FG003|Phase 2: Follow-up|Death|0|||
161920781|NCT03317496|584755801|FG004|Phase 2: Follow-up|Death|24|||
161920782|NCT03317496|584755797|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
161475115|NCT03758443|583134491|FG002|Extended Induction Period|Physician Decision|2|||
161475116|NCT03758443|583134492|FG003|Extended Induction Period|Physician Decision|2|||
161475117|NCT03758443|583134489|FG000|Extended Induction Period|Protocol Violation|0|||
161475118|NCT03758443|583134490|FG001|Extended Induction Period|Protocol Violation|0|||
161668467|NCT00820027|583839774|FG002|Overall Study|Withdrawal by Subject|4|||
161668468|NCT00820027|583839775|FG003|Overall Study|Withdrawal by Subject|6|||
161668469|NCT02604433|583839776|FG000|Overall Study|Withdrawal by Subject|37|||
161475119|NCT03758443|583134491|FG002|Extended Induction Period|Protocol Violation|0|||
161475120|NCT03758443|583134492|FG003|Extended Induction Period|Protocol Violation|1|||
161475121|NCT03758443|583134489|FG000|Extended Induction Period|Withdrawal by Subject|8|||
161475122|NCT03758443|583134490|FG001|Extended Induction Period|Withdrawal by Subject|1|||
161475123|NCT03758443|583134491|FG002|Extended Induction Period|Withdrawal by Subject|7|||
161475124|NCT03758443|583134492|FG003|Extended Induction Period|Withdrawal by Subject|3|||
161475125|NCT03758443|583134489|FG000|Extended Induction Period|Miscellaneous|1|||
161475126|NCT03758443|583134490|FG001|Extended Induction Period|Miscellaneous|0|||
161475127|NCT03758443|583134491|FG002|Extended Induction Period|Miscellaneous|0|||
161475128|NCT03758443|583134492|FG003|Extended Induction Period|Miscellaneous|0|||
161475129|NCT03758443|583134489|FG000|Maintenance Period|Adverse Event|1|||
161475130|NCT03758443|583134490|FG001|Maintenance Period|Adverse Event|2|||
161475131|NCT03758443|583134491|FG002|Maintenance Period|Adverse Event|0|||
161475132|NCT03758443|583134492|FG003|Maintenance Period|Adverse Event|0|||
161475133|NCT03758443|583134489|FG000|Maintenance Period|Lost to Follow-up|0|||
161475134|NCT03758443|583134490|FG001|Maintenance Period|Lost to Follow-up|0|||
161475135|NCT03758443|583134491|FG002|Maintenance Period|Lost to Follow-up|0|||
161475136|NCT03758443|583134492|FG003|Maintenance Period|Lost to Follow-up|1|||
161475137|NCT03758443|583134489|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
161475138|NCT03758443|583134490|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
161475139|NCT03758443|583134491|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
161475140|NCT03758443|583134492|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
161475141|NCT03758443|583134489|FG000|Maintenance Period|Protocol Violation|0|||
161475142|NCT03758443|583134490|FG001|Maintenance Period|Protocol Violation|1|||
161475143|NCT03758443|583134491|FG002|Maintenance Period|Protocol Violation|0|||
161475144|NCT03758443|583134492|FG003|Maintenance Period|Protocol Violation|0|||
161475145|NCT03758443|583134489|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
161475146|NCT03758443|583134490|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
161475147|NCT03758443|583134491|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
161475148|NCT03758443|583134492|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
161475149|NCT03758443|583134489|FG000|Maintenance Period|Withdrawal by Subject|1|||
161475150|NCT03758443|583134490|FG001|Maintenance Period|Withdrawal by Subject|0|||
161475151|NCT03758443|583134491|FG002|Maintenance Period|Withdrawal by Subject|1|||
161475152|NCT03758443|583134492|FG003|Maintenance Period|Withdrawal by Subject|1|||
161475153|NCT03758443|583134489|FG000|Maintenance Period|Miscellaneous|0|||
161475154|NCT03758443|583134490|FG001|Maintenance Period|Miscellaneous|0|||
161475155|NCT03758443|583134491|FG002|Maintenance Period|Miscellaneous|1|||
161475156|NCT03758443|583134492|FG003|Maintenance Period|Miscellaneous|0|||
161475157|NCT03080454|583134493|FG000|Baseline|Adverse Event|2|||
161920783|NCT03317496|584755798|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
161920784|NCT03317496|584755799|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
161920785|NCT03317496|584755800|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
161920786|NCT03317496|584755801|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
161920787|NCT03317496|584755797|FG000|Phase 2: Follow-up|Other|0|||
161920788|NCT03317496|584755798|FG001|Phase 2: Follow-up|Other|0|||
161475158|NCT03080454|583134493|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
161475159|NCT03080454|583134493|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
161475160|NCT02747875|583134494|FG000|Overall Study|Physician Decision|1|||
161475161|NCT02747875|583134495|FG001|Overall Study|Physician Decision|0|||
161475162|NCT02747875|583134494|FG000|Overall Study|Adverse Event|0|||
161920789|NCT03317496|584755799|FG002|Phase 2: Follow-up|Other|0|||
161920790|NCT03317496|584755800|FG003|Phase 2: Follow-up|Other|0|||
161577875|NCT00159783|583503364|FG000|Overall Study|Other|0|||
161577876|NCT00159783|583503365|FG001|Overall Study|Other|2|||
161577877|NCT00159783|583503366|FG002|Overall Study|Other|4|||
161475163|NCT02747875|583134495|FG001|Overall Study|Adverse Event|1|||
161475164|NCT00762385|583134496|FG000|First Intervention|Lens Issue|1|||
161475165|NCT00762385|583134497|FG001|First Intervention|Lens Issue|1|||
161475166|NCT00762385|583134496|FG000|First Intervention|Lost to Follow-up|0|||
161475167|NCT00762385|583134497|FG001|First Intervention|Lost to Follow-up|2|||
161475168|NCT00762385|583134496|FG000|First Intervention|Ineligible|1|||
161475169|NCT00762385|583134497|FG001|First Intervention|Ineligible|0|||
161475170|NCT00762385|583134496|FG000|First Intervention|Protocol Violation|0|||
161475171|NCT00762385|583134497|FG001|First Intervention|Protocol Violation|1|||
161475172|NCT00762385|583134496|FG000|Second Intervention|Protocol Violation|3|||
161475173|NCT00762385|583134497|FG001|Second Intervention|Protocol Violation|3|||
161475174|NCT03863197|583134501|FG000|Overall Study|Lost to Follow-up|2|||
161475175|NCT03863197|583134502|FG001|Overall Study|Lost to Follow-up|3|||
161475176|NCT03863197|583134501|FG000|Overall Study|Withdrawal by Subject|4|||
161475177|NCT03863197|583134502|FG001|Overall Study|Withdrawal by Subject|0|||
161475178|NCT03863197|583134501|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
161475179|NCT03863197|583134502|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
161475180|NCT00973674|583134508|FG000|Overall Study|Protocol Violation|2|||
161475181|NCT00973674|583134509|FG001|Overall Study|Protocol Violation|0|||
161475182|NCT02846324|583134512|FG000|Overall Study|Other|1|||
161475183|NCT02846324|583134513|FG001|Overall Study|Other|0|||
161475184|NCT02846324|583134514|FG002|Overall Study|Other|0|||
161475185|NCT02846324|583134515|FG003|Overall Study|Other|0|||
161577878|NCT02928224|583503367|FG000|Overall Study|Lost to Follow-up|1|||
161577879|NCT02928224|583503368|FG001|Overall Study|Lost to Follow-up|1|||
161577880|NCT02928224|583503369|FG002|Overall Study|Lost to Follow-up|3|||
161577881|NCT02928224|583503370|FG003|Overall Study|Lost to Follow-up|0|||
161577882|NCT02928224|583503367|FG000|Overall Study|Death|30|||
161577883|NCT02928224|583503368|FG001|Overall Study|Death|209|||
161577884|NCT02928224|583503369|FG002|Overall Study|Death|193|||
161577885|NCT02928224|583503370|FG003|Overall Study|Death|198|||
161577886|NCT02928224|583503367|FG000|Overall Study|Withdrawal by Subject|0|||
161577887|NCT02928224|583503368|FG001|Overall Study|Withdrawal by Subject|3|||
161577888|NCT02928224|583503369|FG002|Overall Study|Withdrawal by Subject|7|||
161577889|NCT02928224|583503370|FG003|Overall Study|Withdrawal by Subject|20|||
161577890|NCT02928224|583503367|FG000|Overall Study|Study participation terminated by sponsor|3|||
161577891|NCT02928224|583503368|FG001|Overall Study|Study participation terminated by sponsor|8|||
161577892|NCT02928224|583503369|FG002|Overall Study|Study participation terminated by sponsor|12|||
161577893|NCT02928224|583503370|FG003|Overall Study|Study participation terminated by sponsor|3|||
161577894|NCT02928224|583503367|FG000|Overall Study|Other|3|||
161577895|NCT02928224|583503368|FG001|Overall Study|Other|3|||
161577896|NCT02928224|583503369|FG002|Overall Study|Other|5|||
161577897|NCT02928224|583503370|FG003|Overall Study|Other|0|||
161577898|NCT02538107|583503371|FG000|Overall Study|Did not receive any Mircera dose|11|||
161577899|NCT02538107|583503371|FG000|Overall Study|Missing|5|||
161668470|NCT02604433|583839777|FG001|Overall Study|Withdrawal by Subject|16|||
161668471|NCT02604433|583839776|FG000|Overall Study|Adverse Event|4|||
161668472|NCT02604433|583839777|FG001|Overall Study|Adverse Event|0|||
161668473|NCT02604433|583839776|FG000|Overall Study|Other reasons|3|||
161668474|NCT02604433|583839777|FG001|Overall Study|Other reasons|5|||
161668475|NCT02604433|583839776|FG000|Overall Study|Death|4|||
161668476|NCT02604433|583839777|FG001|Overall Study|Death|1|||
161668477|NCT02604433|583839776|FG000|Overall Study|Transition to Rollover Protocol|169|||
161668478|NCT02604433|583839777|FG001|Overall Study|Transition to Rollover Protocol|82|||
161668479|NCT02604433|583839776|FG000|Overall Study|Physician Decision|1|||
161668480|NCT02604433|583839777|FG001|Overall Study|Physician Decision|1|||
161668481|NCT02604433|583839776|FG000|Overall Study|Lack of Efficacy|0|||
161668482|NCT02604433|583839777|FG001|Overall Study|Lack of Efficacy|1|||
161668483|NCT03285178|583839778|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
161668484|NCT03285178|583839779|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161815080|NCT00928057|584366866|FG000|Overall Study|Protocol Violation|0|||
161475186|NCT02846324|583134512|FG000|Overall Study|Withdrawal by Subject|1|||
161577900|NCT02538107|583503371|FG000|Overall Study|Necessity of dialysis|20|||
161577901|NCT02538107|583503371|FG000|Overall Study|Administration of other ESA|11|||
161475187|NCT02846324|583134513|FG001|Overall Study|Withdrawal by Subject|0|||
161475188|NCT02846324|583134514|FG002|Overall Study|Withdrawal by Subject|4|||
161577902|NCT02538107|583503371|FG000|Overall Study|No further treatment necessary|18|||
161577903|NCT02538107|583503371|FG000|Overall Study|Withdrawal by Subject|17|||
161475189|NCT02846324|583134515|FG003|Overall Study|Withdrawal by Subject|0|||
161475190|NCT00400764|583134520|FG000|Phase Ib|Adverse Event|1|||
161577904|NCT02538107|583503371|FG000|Overall Study|Death|4|||
161577905|NCT02538107|583503371|FG000|Overall Study|Administrative reason|5|||
161815081|NCT00928057|584366867|FG001|Overall Study|Protocol Violation|1|||
161815082|NCT05497557|584366868|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
161815083|NCT05497557|584366869|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
161815084|NCT05497557|584366870|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
161815085|NCT03206749|584366871|FG000|Overall Study|Withdrawal of consent|5|||
161815086|NCT03206749|584366872|FG001|Overall Study|Withdrawal of consent|3|||
161815087|NCT03206749|584366873|FG002|Overall Study|Withdrawal of consent|6|||
161815088|NCT03206749|584366871|FG000|Overall Study|Lost to Follow-up|0|||
161815089|NCT03206749|584366872|FG001|Overall Study|Lost to Follow-up|0|||
161815090|NCT03206749|584366873|FG002|Overall Study|Lost to Follow-up|1|||
161815091|NCT04590027|584366875|FG000|Overall Study|Lost to Follow-up|17|||
161815092|NCT04590027|584366876|FG001|Overall Study|Lost to Follow-up|14|||
161815093|NCT04590027|584366875|FG000|Overall Study|Protocol Violation|0|||
161815094|NCT04590027|584366876|FG001|Overall Study|Protocol Violation|3|||
161815095|NCT00927069|584366879|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
161815096|NCT00927069|584366880|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
161815097|NCT00927069|584366881|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
161815098|NCT00927069|584366882|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
161815099|NCT00927069|584366879|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
161815100|NCT00927069|584366880|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
161815101|NCT00927069|584366881|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
161815102|NCT00927069|584366882|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
161815103|NCT00927069|584366879|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
161475191|NCT00400764|583134521|FG001|Phase Ib|Adverse Event|0|||
161475192|NCT00400764|583134522|FG002|Phase Ib|Adverse Event|0|||
161815104|NCT00927069|584366880|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
161815105|NCT00927069|584366881|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
161815106|NCT00927069|584366882|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
161815107|NCT00927069|584366879|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
161815108|NCT00927069|584366880|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
161815109|NCT00927069|584366881|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
161815110|NCT00927069|584366882|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
161815111|NCT00927069|584366879|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
161815112|NCT00927069|584366880|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161815113|NCT00927069|584366881|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161815114|NCT00927069|584366882|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161815115|NCT04089553|584366883|FG000|Overall Study|Death|1|||
161815116|NCT04089553|584366884|FG001|Overall Study|Death|1|||
161815117|NCT04089553|584366883|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
161815118|NCT04089553|584366884|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
161815119|NCT04089553|584366883|FG000|Overall Study|Withdrawal by Subject|3|||
161815120|NCT04089553|584366884|FG001|Overall Study|Withdrawal by Subject|3|||
161815121|NCT04089553|584366883|FG000|Overall Study|Physician Decision|1|||
161815122|NCT04089553|584366884|FG001|Overall Study|Physician Decision|0|||
161815123|NCT04089553|584366883|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
161815124|NCT04089553|584366884|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
161815125|NCT04089553|584366883|FG000|Overall Study|Other|1|||
161815126|NCT04089553|584366884|FG001|Overall Study|Other|0|||
161815127|NCT04089553|584366883|FG000|Overall Study|Adverse Event|1|||
161815128|NCT04089553|584366884|FG001|Overall Study|Adverse Event|1|||
161815129|NCT03497130|584366885|FG000|Overall Study|Lost to Follow-up|1|||
161815130|NCT03497130|584366886|FG001|Overall Study|Lost to Follow-up|1|||
161815131|NCT04631562|584366887|FG000|Overall Study|Withdrawal by Subject|0|||
161815132|NCT04631562|584366888|FG001|Overall Study|Withdrawal by Subject|0|||
161815133|NCT04631562|584366889|FG002|Overall Study|Withdrawal by Subject|0|||
161815134|NCT04631562|584366890|FG003|Overall Study|Withdrawal by Subject|0|||
161815135|NCT04631562|584366891|FG004|Overall Study|Withdrawal by Subject|0|||
161815136|NCT04631562|584366892|FG005|Overall Study|Withdrawal by Subject|0|||
161815137|NCT04631562|584366893|FG006|Overall Study|Withdrawal by Subject|0|||
161815138|NCT04631562|584366894|FG007|Overall Study|Withdrawal by Subject|1|||
161815139|NCT04631562|584366895|FG008|Overall Study|Withdrawal by Subject|0|||
161815140|NCT04631562|584366887|FG000|Overall Study|Other|0|||
161815141|NCT04631562|584366888|FG001|Overall Study|Other|0|||
161815142|NCT04631562|584366889|FG002|Overall Study|Other|0|||
161815143|NCT04631562|584366890|FG003|Overall Study|Other|0|||
161815144|NCT04631562|584366891|FG004|Overall Study|Other|0|||
161815145|NCT04631562|584366892|FG005|Overall Study|Other|0|||
161815146|NCT04631562|584366893|FG006|Overall Study|Other|0|||
161475193|NCT00400764|583134523|FG003|Phase Ib|Adverse Event|0|||
161475194|NCT00400764|583134524|FG004|Phase Ib|Adverse Event|0|||
161475195|NCT00400764|583134520|FG000|Phase Ib|Death|1|||
161475196|NCT00400764|583134521|FG001|Phase Ib|Death|0|||
161475197|NCT00400764|583134522|FG002|Phase Ib|Death|0|||
161475198|NCT00400764|583134523|FG003|Phase Ib|Death|0|||
161475199|NCT00400764|583134524|FG004|Phase Ib|Death|0|||
161475200|NCT00400764|583134520|FG000|Phase Ib|Disease Progression|4|||
161475201|NCT00400764|583134521|FG001|Phase Ib|Disease Progression|4|||
161475202|NCT00400764|583134522|FG002|Phase Ib|Disease Progression|0|||
161475203|NCT00400764|583134523|FG003|Phase Ib|Disease Progression|0|||
161475204|NCT00400764|583134524|FG004|Phase Ib|Disease Progression|0|||
161475205|NCT00400764|583134520|FG000|Phase II|Death|0|||
161475206|NCT00400764|583134521|FG001|Phase II|Death|0|||
161475207|NCT00400764|583134522|FG002|Phase II|Death|1|||
161475208|NCT00400764|583134523|FG003|Phase II|Death|2|||
161475209|NCT00400764|583134524|FG004|Phase II|Death|0|||
161475210|NCT00400764|583134520|FG000|Phase II|Lost to Follow-up|0|||
161815147|NCT04631562|584366894|FG007|Overall Study|Other|0|||
161815148|NCT04631562|584366895|FG008|Overall Study|Other|1|||
161815149|NCT04631562|584366887|FG000|Overall Study|Lost to Follow-up|0|||
161815150|NCT04631562|584366888|FG001|Overall Study|Lost to Follow-up|0|||
161815151|NCT04631562|584366889|FG002|Overall Study|Lost to Follow-up|0|||
161815152|NCT04631562|584366890|FG003|Overall Study|Lost to Follow-up|1|||
161815153|NCT04631562|584366891|FG004|Overall Study|Lost to Follow-up|0|||
161815154|NCT04631562|584366892|FG005|Overall Study|Lost to Follow-up|0|||
161815155|NCT04631562|584366893|FG006|Overall Study|Lost to Follow-up|0|||
161815156|NCT04631562|584366894|FG007|Overall Study|Lost to Follow-up|0|||
161815157|NCT04631562|584366895|FG008|Overall Study|Lost to Follow-up|0|||
161815158|NCT04631562|584366887|FG000|Overall Study|Adverse Event|0|||
161815159|NCT04631562|584366888|FG001|Overall Study|Adverse Event|0|||
161815160|NCT04631562|584366889|FG002|Overall Study|Adverse Event|0|||
161815161|NCT04631562|584366890|FG003|Overall Study|Adverse Event|0|||
161815162|NCT04631562|584366891|FG004|Overall Study|Adverse Event|0|||
161815163|NCT04631562|584366892|FG005|Overall Study|Adverse Event|0|||
161815164|NCT04631562|584366893|FG006|Overall Study|Adverse Event|1|||
161815165|NCT04631562|584366894|FG007|Overall Study|Adverse Event|0|||
161815166|NCT04631562|584366895|FG008|Overall Study|Adverse Event|0|||
161815167|NCT03503318|584366896|FG000|Overall Study|Death|1|||
161815168|NCT03503318|584366897|FG001|Overall Study|Death|0|||
161815169|NCT03503318|584366898|FG002|Overall Study|Death|4|||
161815170|NCT03503318|584366896|FG000|Overall Study|Adverse Event|3|||
161815171|NCT03503318|584366897|FG001|Overall Study|Adverse Event|4|||
161815172|NCT03503318|584366898|FG002|Overall Study|Adverse Event|2|||
161815173|NCT03503318|584366896|FG000|Overall Study|Withdrawal by Subject|12|||
161815174|NCT03503318|584366897|FG001|Overall Study|Withdrawal by Subject|17|||
161815175|NCT03503318|584366898|FG002|Overall Study|Withdrawal by Subject|16|||
161815176|NCT03503318|584366896|FG000|Overall Study|Protocol Violation|5|||
161815177|NCT03503318|584366897|FG001|Overall Study|Protocol Violation|0|||
161815178|NCT03503318|584366898|FG002|Overall Study|Protocol Violation|3|||
161815179|NCT03503318|584366896|FG000|Overall Study|Lost to Follow-up|17|||
161815180|NCT03503318|584366897|FG001|Overall Study|Lost to Follow-up|15|||
161815181|NCT03503318|584366898|FG002|Overall Study|Lost to Follow-up|12|||
161815182|NCT03503318|584366896|FG000|Overall Study|Other than specified|1|||
161815183|NCT03503318|584366897|FG001|Overall Study|Other than specified|3|||
161815184|NCT03503318|584366898|FG002|Overall Study|Other than specified|3|||
161815185|NCT01794845|584366901|FG000|Overall Study|Withdrawal by Subject|1|||
161815186|NCT02139826|584366902|FG000|Overall Study|Adverse Event|1|||
161815187|NCT03498560|584366903|FG000|Overall Study|Found Ineligible|2|||
161815188|NCT03498560|584366903|FG000|Overall Study|Withdrawal by Subject|14|||
161815189|NCT03498560|584366903|FG000|Overall Study|Lost to Follow-up|4|||
161815190|NCT03498560|584366903|FG000|Overall Study|Death|1|||
161815191|NCT00867360|584366904|FG000|Overall Study|Withdrawal by Subject|1|||
161815192|NCT00867360|584366905|FG001|Overall Study|Withdrawal by Subject|0|||
161815193|NCT00867360|584366904|FG000|Overall Study|Physician Decision|0|||
161815194|NCT00867360|584366905|FG001|Overall Study|Physician Decision|1|||
161815195|NCT01824576|584366907|FG000|Overall Study|Device deficiency|2|||
161815196|NCT00436163|584366911|FG000|Overall Study|Lost to Follow-up|2|||
161815197|NCT00436163|584366911|FG000|Overall Study|Adverse Event|1|||
161815198|NCT02597049|584366912|FG000|Overall Study|Lost to Follow-up|0|||
161815199|NCT02597049|584366913|FG001|Overall Study|Lost to Follow-up|3|||
161815200|NCT02597049|584366914|FG002|Overall Study|Lost to Follow-up|2|||
161815201|NCT02597049|584366912|FG000|Overall Study|Withdrawal by Subject|2|||
161815202|NCT02597049|584366913|FG001|Overall Study|Withdrawal by Subject|2|||
161920791|NCT03317496|584755801|FG004|Phase 2: Follow-up|Other|1|||
161920792|NCT03317496|584755797|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
161475211|NCT00400764|583134521|FG001|Phase II|Lost to Follow-up|0|||
161815203|NCT02597049|584366914|FG002|Overall Study|Withdrawal by Subject|1|||
161815204|NCT02597049|584366912|FG000|Overall Study|Adverse Event|2|||
161815205|NCT02597049|584366913|FG001|Overall Study|Adverse Event|0|||
161815206|NCT02597049|584366914|FG002|Overall Study|Adverse Event|0|||
161815207|NCT02597049|584366912|FG000|Overall Study|Death|2|||
161815208|NCT02597049|584366913|FG001|Overall Study|Death|0|||
161815209|NCT02597049|584366914|FG002|Overall Study|Death|0|||
161815210|NCT02597049|584366912|FG000|Overall Study|Noncompliant with Study Visits|1|||
161815211|NCT02597049|584366913|FG001|Overall Study|Noncompliant with Study Visits|0|||
161815212|NCT02597049|584366914|FG002|Overall Study|Noncompliant with Study Visits|0|||
161815213|NCT06647173|584366917|FG000|Overall Study|Lost to Follow-up|24|||
161475212|NCT00400764|583134522|FG002|Phase II|Lost to Follow-up|1|||
161475213|NCT00400764|583134523|FG003|Phase II|Lost to Follow-up|0|||
161475214|NCT00400764|583134524|FG004|Phase II|Lost to Follow-up|0|||
161475215|NCT00400764|583134520|FG000|Phase II|Physician Decision|0|||
161475216|NCT00400764|583134521|FG001|Phase II|Physician Decision|0|||
161475217|NCT00400764|583134522|FG002|Phase II|Physician Decision|1|||
161475218|NCT00400764|583134523|FG003|Phase II|Physician Decision|1|||
161475219|NCT00400764|583134524|FG004|Phase II|Physician Decision|0|||
161475220|NCT00400764|583134520|FG000|Phase II|Sponsor's decision to terminate|0|||
161577906|NCT02538107|583503371|FG000|Overall Study|Adverse Event|4|||
161577907|NCT02538107|583503371|FG000|Overall Study|Surgery|1|||
161577908|NCT02538107|583503371|FG000|Overall Study|Other|7|||
161577909|NCT02538107|583503371|FG000|Overall Study|Not recorded|7|||
161577910|NCT01278394|583503372|FG000|Overall Study|Lost to Follow-up|1|||
161475221|NCT00400764|583134521|FG001|Phase II|Sponsor's decision to terminate|0|||
161577911|NCT02471755|583503373|FG000|Overall Study|Withdrawal by Subject|1|||
161577912|NCT02471755|583503374|FG001|Overall Study|Withdrawal by Subject|0|||
161577913|NCT02471755|583503373|FG000|Overall Study|Lost to Follow-up|0|||
161577914|NCT02471755|583503374|FG001|Overall Study|Lost to Follow-up|1|||
161577915|NCT00958633|583503377|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
161577916|NCT00958633|583503378|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
161577917|NCT00958633|583503379|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
161577918|NCT00958633|583503377|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
161577919|NCT00958633|583503378|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
161577920|NCT00958633|583503379|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
161577921|NCT00958633|583503377|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
161577922|NCT00958633|583503378|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
161577923|NCT00958633|583503379|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
161577924|NCT00958633|583503377|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
161577925|NCT00958633|583503378|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
161577926|NCT00958633|583503379|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
161577927|NCT00958633|583503377|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
161577928|NCT00958633|583503378|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
161577929|NCT00958633|583503379|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
161475222|NCT00400764|583134522|FG002|Phase II|Sponsor's decision to terminate|18|||
161475223|NCT00400764|583134523|FG003|Phase II|Sponsor's decision to terminate|22|||
161475224|NCT00400764|583134524|FG004|Phase II|Sponsor's decision to terminate|11|||
161475225|NCT00400764|583134520|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
161475226|NCT00400764|583134521|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
161475227|NCT00400764|583134522|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
161475228|NCT00400764|583134523|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
161475229|NCT00400764|583134524|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
161475230|NCT00400764|583134520|FG000|Phase II|Withdrawal by Subject|0|||
161475231|NCT00400764|583134521|FG001|Phase II|Withdrawal by Subject|0|||
161475232|NCT00400764|583134522|FG002|Phase II|Withdrawal by Subject|1|||
161475233|NCT00400764|583134523|FG003|Phase II|Withdrawal by Subject|1|||
161475234|NCT00400764|583134524|FG004|Phase II|Withdrawal by Subject|0|||
161475235|NCT03113916|583134528|FG000|Overall Study|Withdrawal by Subject|9|||
161475236|NCT03113916|583134529|FG001|Overall Study|Withdrawal by Subject|7|||
161475237|NCT03113916|583134528|FG000|Overall Study|Pregnancy|1|||
161475238|NCT03113916|583134529|FG001|Overall Study|Pregnancy|3|||
161475239|NCT03113916|583134528|FG000|Overall Study|Lost to Follow-up|1|||
161577930|NCT00958633|583503377|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
161577931|NCT00958633|583503378|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
161577932|NCT00958633|583503379|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
161577933|NCT00958633|583503377|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
161577934|NCT00958633|583503378|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
161577935|NCT00958633|583503379|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
161577936|NCT00305695|583503381|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
161577937|NCT00305695|583503382|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
161577938|NCT00305695|583503381|FG000|Overall Study|Did not have baseline scan|1|||
161475240|NCT03113916|583134529|FG001|Overall Study|Lost to Follow-up|2|||
161475241|NCT01758523|583134531|FG000|Overall Study|Adverse Event|2|||
161475242|NCT01758523|583134532|FG001|Overall Study|Adverse Event|1|||
161475243|NCT01758523|583134531|FG000|Overall Study|Lack of Efficacy|4|||
161475244|NCT01758523|583134532|FG001|Overall Study|Lack of Efficacy|2|||
161475245|NCT01758523|583134531|FG000|Overall Study|Lost to Follow-up|3|||
161475246|NCT01758523|583134532|FG001|Overall Study|Lost to Follow-up|4|||
161475247|NCT01758523|583134531|FG000|Overall Study|Withdrawal by Subject|12|||
161475248|NCT01758523|583134532|FG001|Overall Study|Withdrawal by Subject|7|||
161475249|NCT01893203|583134533|FG000|Overall Study|Withdrawal by Subject|1|||
161577939|NCT00305695|583503382|FG001|Overall Study|Did not have baseline scan|1|||
161577940|NCT00094575|583503386|FG000|Overall Study|Death|146|||
161475250|NCT00722800|583134534|FG000|Overall Study|Withdrawal by Subject|1|||
161475251|NCT00722800|583134535|FG001|Overall Study|Withdrawal by Subject|0|||
161475252|NCT00722800|583134534|FG000|Overall Study|Physician Decision|1|||
161475253|NCT00722800|583134535|FG001|Overall Study|Physician Decision|0|||
161475254|NCT02130297|583134540|FG000|Overall Study|Lost to Follow-up|4|||
161475255|NCT00347360|583134551|FG000|Overall Study|Adverse Event|1|||
161475256|NCT00347360|583134552|FG001|Overall Study|Adverse Event|2|||
161475257|NCT00347360|583134553|FG002|Overall Study|Adverse Event|0|||
161475258|NCT00347360|583134554|FG003|Overall Study|Adverse Event|4|||
161475259|NCT00347360|583134555|FG004|Overall Study|Adverse Event|1|||
161475260|NCT00347360|583134556|FG005|Overall Study|Adverse Event|2|||
161475261|NCT00347360|583134557|FG006|Overall Study|Adverse Event|2|||
161475262|NCT00347360|583134558|FG007|Overall Study|Adverse Event|0|||
161475263|NCT00347360|583134559|FG008|Overall Study|Adverse Event|2|||
161475264|NCT00347360|583134560|FG009|Overall Study|Adverse Event|3|||
161475265|NCT00347360|583134561|FG010|Overall Study|Adverse Event|3|||
161475266|NCT00347360|583134562|FG011|Overall Study|Adverse Event|1|||
161475267|NCT00347360|583134563|FG012|Overall Study|Adverse Event|3|||
161475268|NCT00347360|583134564|FG013|Overall Study|Adverse Event|2|||
161475269|NCT00347360|583134565|FG014|Overall Study|Adverse Event|2|||
161475270|NCT00347360|583134551|FG000|Overall Study|Lost to Follow-up|0|||
161475271|NCT00347360|583134552|FG001|Overall Study|Lost to Follow-up|0|||
161475272|NCT00347360|583134553|FG002|Overall Study|Lost to Follow-up|0|||
161475273|NCT00347360|583134554|FG003|Overall Study|Lost to Follow-up|2|||
161475274|NCT00347360|583134555|FG004|Overall Study|Lost to Follow-up|1|||
161475275|NCT00347360|583134556|FG005|Overall Study|Lost to Follow-up|1|||
161475276|NCT00347360|583134557|FG006|Overall Study|Lost to Follow-up|0|||
161475277|NCT00347360|583134558|FG007|Overall Study|Lost to Follow-up|1|||
161475278|NCT00347360|583134559|FG008|Overall Study|Lost to Follow-up|1|||
161475279|NCT00347360|583134560|FG009|Overall Study|Lost to Follow-up|2|||
161475280|NCT00347360|583134561|FG010|Overall Study|Lost to Follow-up|0|||
161475281|NCT00347360|583134562|FG011|Overall Study|Lost to Follow-up|0|||
161475282|NCT00347360|583134563|FG012|Overall Study|Lost to Follow-up|1|||
161475283|NCT00347360|583134564|FG013|Overall Study|Lost to Follow-up|0|||
161475284|NCT00347360|583134565|FG014|Overall Study|Lost to Follow-up|0|||
161475285|NCT00347360|583134551|FG000|Overall Study|Protocol Violation|2|||
161475286|NCT00347360|583134552|FG001|Overall Study|Protocol Violation|3|||
161475287|NCT00347360|583134553|FG002|Overall Study|Protocol Violation|1|||
161475288|NCT00347360|583134554|FG003|Overall Study|Protocol Violation|2|||
161475289|NCT00347360|583134555|FG004|Overall Study|Protocol Violation|1|||
161475290|NCT00347360|583134556|FG005|Overall Study|Protocol Violation|2|||
161475291|NCT00347360|583134557|FG006|Overall Study|Protocol Violation|0|||
161475292|NCT00347360|583134558|FG007|Overall Study|Protocol Violation|0|||
161475293|NCT00347360|583134559|FG008|Overall Study|Protocol Violation|1|||
161475294|NCT00347360|583134560|FG009|Overall Study|Protocol Violation|2|||
161475295|NCT00347360|583134561|FG010|Overall Study|Protocol Violation|0|||
161475296|NCT00347360|583134562|FG011|Overall Study|Protocol Violation|0|||
161475297|NCT00347360|583134563|FG012|Overall Study|Protocol Violation|0|||
161475298|NCT00347360|583134564|FG013|Overall Study|Protocol Violation|1|||
161475299|NCT00347360|583134565|FG014|Overall Study|Protocol Violation|0|||
161577941|NCT00094575|583503387|FG001|Overall Study|Death|146|||
161577942|NCT00794118|583503388|FG000|Overall Study|Lost to Follow-up|16|||
161577943|NCT00794118|583503388|FG000|Overall Study|Withdrawal by Subject|9|||
161577944|NCT00794118|583503388|FG000|Overall Study|Changed hospital center|2|||
161577945|NCT00837616|583503389|FG000|Overall Study|Withdrawal by Subject|0|||
161577946|NCT00837616|583503390|FG001|Overall Study|Withdrawal by Subject|1|||
161577947|NCT04411056|583505055|FG000|Overall Study|surgery cancelled|1|||
161475300|NCT00347360|583134551|FG000|Overall Study|Withdrawal by Subject|0|||
161475301|NCT00347360|583134552|FG001|Overall Study|Withdrawal by Subject|1|||
161475302|NCT00347360|583134553|FG002|Overall Study|Withdrawal by Subject|2|||
161475303|NCT00347360|583134554|FG003|Overall Study|Withdrawal by Subject|4|||
161475304|NCT00347360|583134555|FG004|Overall Study|Withdrawal by Subject|1|||
161475305|NCT00347360|583134556|FG005|Overall Study|Withdrawal by Subject|2|||
161475306|NCT00347360|583134557|FG006|Overall Study|Withdrawal by Subject|1|||
161475307|NCT00347360|583134558|FG007|Overall Study|Withdrawal by Subject|1|||
161475308|NCT00347360|583134559|FG008|Overall Study|Withdrawal by Subject|1|||
161475309|NCT00347360|583134560|FG009|Overall Study|Withdrawal by Subject|1|||
161475310|NCT00347360|583134561|FG010|Overall Study|Withdrawal by Subject|0|||
161475311|NCT00347360|583134562|FG011|Overall Study|Withdrawal by Subject|3|||
161475312|NCT00347360|583134563|FG012|Overall Study|Withdrawal by Subject|4|||
161475313|NCT00347360|583134564|FG013|Overall Study|Withdrawal by Subject|2|||
161475314|NCT00347360|583134565|FG014|Overall Study|Withdrawal by Subject|1|||
161577948|NCT04411056|583505056|FG001|Overall Study|surgery cancelled|0|||
161577949|NCT04411056|583505055|FG000|Overall Study|Equipment problem during intubation|0|||
161475315|NCT00347360|583134551|FG000|Overall Study|Lack of Efficacy|1|||
161577950|NCT04411056|583505056|FG001|Overall Study|Equipment problem during intubation|1|||
161577951|NCT04623008|583505057|FG000|Baseline to T2|Withdrawal by Subject|4|||
161475316|NCT00347360|583134552|FG001|Overall Study|Lack of Efficacy|1|||
161475317|NCT00347360|583134553|FG002|Overall Study|Lack of Efficacy|3|||
161475318|NCT00347360|583134554|FG003|Overall Study|Lack of Efficacy|1|||
161475319|NCT00347360|583134555|FG004|Overall Study|Lack of Efficacy|0|||
161475320|NCT00347360|583134556|FG005|Overall Study|Lack of Efficacy|1|||
161577952|NCT04623008|583505058|FG001|Baseline to T2|Withdrawal by Subject|2|||
161475321|NCT00347360|583134557|FG006|Overall Study|Lack of Efficacy|0|||
161475322|NCT00347360|583134558|FG007|Overall Study|Lack of Efficacy|1|||
161475323|NCT00347360|583134559|FG008|Overall Study|Lack of Efficacy|1|||
161475324|NCT00347360|583134560|FG009|Overall Study|Lack of Efficacy|0|||
161475325|NCT00347360|583134561|FG010|Overall Study|Lack of Efficacy|0|||
161475326|NCT00347360|583134562|FG011|Overall Study|Lack of Efficacy|0|||
161475327|NCT00347360|583134563|FG012|Overall Study|Lack of Efficacy|0|||
161475328|NCT00347360|583134564|FG013|Overall Study|Lack of Efficacy|0|||
161475329|NCT00347360|583134565|FG014|Overall Study|Lack of Efficacy|0|||
161475330|NCT00347360|583134551|FG000|Overall Study|Reason not listed/blank|1|||
161475331|NCT00347360|583134552|FG001|Overall Study|Reason not listed/blank|0|||
161475332|NCT00347360|583134553|FG002|Overall Study|Reason not listed/blank|0|||
161475333|NCT00347360|583134554|FG003|Overall Study|Reason not listed/blank|0|||
161475334|NCT00347360|583134555|FG004|Overall Study|Reason not listed/blank|0|||
161475335|NCT00347360|583134556|FG005|Overall Study|Reason not listed/blank|0|||
161475336|NCT00347360|583134557|FG006|Overall Study|Reason not listed/blank|1|||
161475337|NCT00347360|583134558|FG007|Overall Study|Reason not listed/blank|0|||
161475338|NCT00347360|583134559|FG008|Overall Study|Reason not listed/blank|0|||
161475339|NCT00347360|583134560|FG009|Overall Study|Reason not listed/blank|0|||
161475340|NCT00347360|583134561|FG010|Overall Study|Reason not listed/blank|0|||
161475341|NCT00347360|583134562|FG011|Overall Study|Reason not listed/blank|0|||
161475342|NCT00347360|583134563|FG012|Overall Study|Reason not listed/blank|0|||
161475343|NCT00347360|583134564|FG013|Overall Study|Reason not listed/blank|1|||
161475344|NCT00347360|583134565|FG014|Overall Study|Reason not listed/blank|0|||
161475345|NCT00347360|583134551|FG000|Overall Study|Per sponsors instruction|0|||
161475346|NCT00347360|583134552|FG001|Overall Study|Per sponsors instruction|1|||
161475347|NCT00347360|583134553|FG002|Overall Study|Per sponsors instruction|0|||
161475348|NCT00347360|583134554|FG003|Overall Study|Per sponsors instruction|0|||
161475349|NCT00347360|583134555|FG004|Overall Study|Per sponsors instruction|0|||
161475350|NCT00347360|583134556|FG005|Overall Study|Per sponsors instruction|0|||
161475351|NCT00347360|583134557|FG006|Overall Study|Per sponsors instruction|0|||
161475352|NCT00347360|583134558|FG007|Overall Study|Per sponsors instruction|0|||
161475353|NCT00347360|583134559|FG008|Overall Study|Per sponsors instruction|0|||
161475354|NCT00347360|583134560|FG009|Overall Study|Per sponsors instruction|0|||
161475355|NCT00347360|583134561|FG010|Overall Study|Per sponsors instruction|0|||
161475356|NCT00347360|583134562|FG011|Overall Study|Per sponsors instruction|0|||
161475357|NCT00347360|583134563|FG012|Overall Study|Per sponsors instruction|0|||
161475358|NCT00347360|583134564|FG013|Overall Study|Per sponsors instruction|0|||
161475359|NCT00347360|583134565|FG014|Overall Study|Per sponsors instruction|0|||
161475360|NCT00347360|583134551|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
161475361|NCT00347360|583134552|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
161475362|NCT00347360|583134553|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
161475363|NCT00347360|583134554|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
161475364|NCT00347360|583134555|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
161475365|NCT00347360|583134556|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
161475366|NCT00347360|583134557|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
161475367|NCT00347360|583134558|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
161475368|NCT00347360|583134559|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
161475369|NCT00347360|583134560|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
161475370|NCT00347360|583134561|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
161475371|NCT00347360|583134562|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
161475372|NCT00347360|583134563|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
161475373|NCT00347360|583134564|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
161475374|NCT00347360|583134565|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
161475375|NCT00347360|583134551|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
161475376|NCT00347360|583134552|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
161475377|NCT00347360|583134553|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
161475378|NCT00347360|583134554|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
161475379|NCT00347360|583134555|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
161475380|NCT00347360|583134556|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
161475381|NCT00347360|583134557|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
161475382|NCT00347360|583134558|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
161475383|NCT00347360|583134559|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
161475384|NCT00347360|583134560|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
161475385|NCT00347360|583134561|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
161475386|NCT00347360|583134562|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
161475387|NCT00347360|583134563|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
161920793|NCT03317496|584755798|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
161475388|NCT00347360|583134564|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
161577953|NCT04623008|583505057|FG000|Baseline to T3|Withdrawal by Subject|4|||
161577954|NCT04623008|583505058|FG001|Baseline to T3|Withdrawal by Subject|2|||
161475389|NCT00347360|583134565|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
161475390|NCT00347360|583134551|FG000|Overall Study|Abnormal lab values|0|||
161475391|NCT00347360|583134552|FG001|Overall Study|Abnormal lab values|0|||
161475392|NCT00347360|583134553|FG002|Overall Study|Abnormal lab values|0|||
161475393|NCT00347360|583134554|FG003|Overall Study|Abnormal lab values|0|||
161475394|NCT00347360|583134555|FG004|Overall Study|Abnormal lab values|0|||
161475395|NCT00347360|583134556|FG005|Overall Study|Abnormal lab values|0|||
161475396|NCT00347360|583134557|FG006|Overall Study|Abnormal lab values|1|||
161475397|NCT00347360|583134558|FG007|Overall Study|Abnormal lab values|0|||
161475398|NCT00347360|583134559|FG008|Overall Study|Abnormal lab values|0|||
161475399|NCT00347360|583134560|FG009|Overall Study|Abnormal lab values|0|||
161475400|NCT00347360|583134561|FG010|Overall Study|Abnormal lab values|0|||
161475401|NCT00347360|583134562|FG011|Overall Study|Abnormal lab values|0|||
161475402|NCT00347360|583134563|FG012|Overall Study|Abnormal lab values|0|||
161475403|NCT00347360|583134564|FG013|Overall Study|Abnormal lab values|0|||
161475404|NCT00347360|583134565|FG014|Overall Study|Abnormal lab values|0|||
161475405|NCT00347360|583134551|FG000|Overall Study|PI recommended early withdrawal|0|||
161475406|NCT00347360|583134552|FG001|Overall Study|PI recommended early withdrawal|0|||
161475407|NCT00347360|583134553|FG002|Overall Study|PI recommended early withdrawal|0|||
161475408|NCT00347360|583134554|FG003|Overall Study|PI recommended early withdrawal|0|||
161475409|NCT00347360|583134555|FG004|Overall Study|PI recommended early withdrawal|0|||
161475410|NCT00347360|583134556|FG005|Overall Study|PI recommended early withdrawal|0|||
161475411|NCT00347360|583134557|FG006|Overall Study|PI recommended early withdrawal|0|||
161475412|NCT00347360|583134558|FG007|Overall Study|PI recommended early withdrawal|0|||
161475413|NCT00347360|583134559|FG008|Overall Study|PI recommended early withdrawal|0|||
161475414|NCT00347360|583134560|FG009|Overall Study|PI recommended early withdrawal|1|||
161475415|NCT00347360|583134561|FG010|Overall Study|PI recommended early withdrawal|0|||
161475416|NCT00347360|583134562|FG011|Overall Study|PI recommended early withdrawal|0|||
161475417|NCT00347360|583134563|FG012|Overall Study|PI recommended early withdrawal|0|||
161475418|NCT00347360|583134564|FG013|Overall Study|PI recommended early withdrawal|0|||
161475419|NCT00347360|583134565|FG014|Overall Study|PI recommended early withdrawal|0|||
161475420|NCT00347360|583134551|FG000|Overall Study|Did not meet criteria before ABPM|0|||
161475421|NCT00347360|583134552|FG001|Overall Study|Did not meet criteria before ABPM|0|||
161577955|NCT04688450|583505067|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
161577956|NCT04688450|583505067|FG000|Overall Study|Withdrawal by Subject|1|||
161577957|NCT03481777|583505072|FG000|Overall Study|Withdrawal by Subject|36|||
161577958|NCT03481777|583505073|FG001|Overall Study|Withdrawal by Subject|31|||
161577959|NCT03481777|583505072|FG000|Overall Study|Non stroke = non target population|277|||
161475422|NCT00347360|583134553|FG002|Overall Study|Did not meet criteria before ABPM|0|||
161577960|NCT03481777|583505073|FG001|Overall Study|Non stroke = non target population|254|||
161577961|NCT03189524|583505074|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
161577962|NCT03189524|583505075|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
161577963|NCT03189524|583505076|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
161577964|NCT03189524|583505074|FG000|Overall Study|Death|2|||
161577965|NCT03189524|583505075|FG001|Overall Study|Death|2|||
161577966|NCT03189524|583505076|FG002|Overall Study|Death|1|||
161577967|NCT03189524|583505074|FG000|Overall Study|Lost to Follow-up|1|||
161577968|NCT03189524|583505075|FG001|Overall Study|Lost to Follow-up|0|||
161577969|NCT03189524|583505076|FG002|Overall Study|Lost to Follow-up|8|||
161577970|NCT03189524|583505074|FG000|Overall Study|Withdrawal by Subject|1|||
161577971|NCT03189524|583505075|FG001|Overall Study|Withdrawal by Subject|1|||
161577972|NCT03189524|583505076|FG002|Overall Study|Withdrawal by Subject|3|||
161577973|NCT03189524|583505074|FG000|Overall Study|Progressive Disease|0|||
161815214|NCT01120028|584366918|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
161475423|NCT00347360|583134554|FG003|Overall Study|Did not meet criteria before ABPM|0|||
161475424|NCT00347360|583134555|FG004|Overall Study|Did not meet criteria before ABPM|0|||
161475425|NCT00347360|583134556|FG005|Overall Study|Did not meet criteria before ABPM|0|||
161475426|NCT00347360|583134557|FG006|Overall Study|Did not meet criteria before ABPM|0|||
161475427|NCT00347360|583134558|FG007|Overall Study|Did not meet criteria before ABPM|0|||
161475428|NCT00347360|583134559|FG008|Overall Study|Did not meet criteria before ABPM|0|||
161475429|NCT00347360|583134560|FG009|Overall Study|Did not meet criteria before ABPM|0|||
161815215|NCT01120028|584366919|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
161815216|NCT01120028|584366920|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
161815217|NCT01120028|584366921|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
161577974|NCT03189524|583505075|FG001|Overall Study|Progressive Disease|2|||
161577975|NCT03189524|583505076|FG002|Overall Study|Progressive Disease|0|||
161475430|NCT00347360|583134561|FG010|Overall Study|Did not meet criteria before ABPM|1|||
161475431|NCT00347360|583134562|FG011|Overall Study|Did not meet criteria before ABPM|0|||
161577976|NCT01780298|583505078|FG000|Overall Study|Physician Decision|1|||
161577977|NCT01780298|583505079|FG001|Overall Study|Physician Decision|5|||
161475432|NCT00347360|583134563|FG012|Overall Study|Did not meet criteria before ABPM|0|||
161475433|NCT00347360|583134564|FG013|Overall Study|Did not meet criteria before ABPM|0|||
161475434|NCT00347360|583134565|FG014|Overall Study|Did not meet criteria before ABPM|0|||
161475435|NCT00347360|583134551|FG000|Overall Study|Randomized in error|0|||
161475436|NCT00347360|583134552|FG001|Overall Study|Randomized in error|0|||
161475437|NCT00347360|583134553|FG002|Overall Study|Randomized in error|0|||
161475438|NCT00347360|583134554|FG003|Overall Study|Randomized in error|0|||
161475439|NCT00347360|583134555|FG004|Overall Study|Randomized in error|0|||
161475440|NCT00347360|583134556|FG005|Overall Study|Randomized in error|0|||
161475441|NCT00347360|583134557|FG006|Overall Study|Randomized in error|0|||
161475442|NCT00347360|583134558|FG007|Overall Study|Randomized in error|0|||
161475443|NCT00347360|583134559|FG008|Overall Study|Randomized in error|0|||
161475444|NCT00347360|583134560|FG009|Overall Study|Randomized in error|0|||
161475445|NCT00347360|583134561|FG010|Overall Study|Randomized in error|0|||
161475446|NCT00347360|583134562|FG011|Overall Study|Randomized in error|1|||
161475447|NCT00347360|583134563|FG012|Overall Study|Randomized in error|0|||
161475448|NCT00347360|583134564|FG013|Overall Study|Randomized in error|0|||
161475449|NCT00347360|583134565|FG014|Overall Study|Randomized in error|0|||
161475450|NCT00347360|583134551|FG000|Overall Study|Failed inclusion criteria #4|0|||
161475451|NCT00347360|583134552|FG001|Overall Study|Failed inclusion criteria #4|0|||
161475452|NCT00347360|583134553|FG002|Overall Study|Failed inclusion criteria #4|0|||
161475453|NCT00347360|583134554|FG003|Overall Study|Failed inclusion criteria #4|0|||
161475454|NCT00347360|583134555|FG004|Overall Study|Failed inclusion criteria #4|0|||
161475455|NCT00347360|583134556|FG005|Overall Study|Failed inclusion criteria #4|0|||
161475456|NCT00347360|583134557|FG006|Overall Study|Failed inclusion criteria #4|0|||
161475457|NCT00347360|583134558|FG007|Overall Study|Failed inclusion criteria #4|0|||
161475458|NCT00347360|583134559|FG008|Overall Study|Failed inclusion criteria #4|0|||
161475459|NCT00347360|583134560|FG009|Overall Study|Failed inclusion criteria #4|0|||
161475460|NCT00347360|583134561|FG010|Overall Study|Failed inclusion criteria #4|0|||
161475461|NCT00347360|583134562|FG011|Overall Study|Failed inclusion criteria #4|1|||
161475462|NCT00347360|583134563|FG012|Overall Study|Failed inclusion criteria #4|0|||
161475463|NCT00347360|583134564|FG013|Overall Study|Failed inclusion criteria #4|0|||
161475464|NCT00347360|583134565|FG014|Overall Study|Failed inclusion criteria #4|0|||
161475465|NCT00347360|583134551|FG000|Overall Study|Prolonged duration between visits|0|||
161475466|NCT00347360|583134552|FG001|Overall Study|Prolonged duration between visits|0|||
161475467|NCT00347360|583134553|FG002|Overall Study|Prolonged duration between visits|0|||
161475468|NCT00347360|583134554|FG003|Overall Study|Prolonged duration between visits|0|||
161475469|NCT00347360|583134555|FG004|Overall Study|Prolonged duration between visits|0|||
161475470|NCT00347360|583134556|FG005|Overall Study|Prolonged duration between visits|0|||
161475471|NCT00347360|583134557|FG006|Overall Study|Prolonged duration between visits|0|||
161475472|NCT00347360|583134558|FG007|Overall Study|Prolonged duration between visits|0|||
161475473|NCT00347360|583134559|FG008|Overall Study|Prolonged duration between visits|0|||
161475474|NCT00347360|583134560|FG009|Overall Study|Prolonged duration between visits|0|||
161475475|NCT00347360|583134561|FG010|Overall Study|Prolonged duration between visits|0|||
161577978|NCT01780298|583505080|FG002|Overall Study|Physician Decision|1|||
161815218|NCT01120028|584366918|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
161815219|NCT01120028|584366919|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
161815220|NCT01120028|584366920|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
161815221|NCT01120028|584366921|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
161815222|NCT03250117|584366922|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
161815223|NCT03250117|584366923|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161815224|NCT03250117|584366924|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161815225|NCT03250117|584366925|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161815226|NCT04063878|584366926|FG000|Overall Study|Withdrawal by Subject|2|||
161815227|NCT04063878|584366926|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
161815228|NCT02751827|584366927|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
161815229|NCT02751827|584366928|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
161815230|NCT02751827|584366929|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
161815231|NCT01248728|584366930|FG000|Overall Study|Adverse Event|1|||
161815232|NCT01248728|584366931|FG001|Overall Study|Adverse Event|1|||
161815233|NCT01248728|584366930|FG000|Overall Study|Withdrawal by Subject|2|||
161815234|NCT01248728|584366931|FG001|Overall Study|Withdrawal by Subject|1|||
161815235|NCT01248728|584366930|FG000|Overall Study|Lack of Efficacy|1|||
161815236|NCT01248728|584366931|FG001|Overall Study|Lack of Efficacy|0|||
161815237|NCT00147498|584366932|FG000|Overall Study|Adverse Event|1|||
161815238|NCT00147498|584366933|FG001|Overall Study|Adverse Event|6|||
161475476|NCT00347360|583134562|FG011|Overall Study|Prolonged duration between visits|0|||
161815239|NCT00147498|584366934|FG002|Overall Study|Adverse Event|7|||
161920794|NCT03317496|584755799|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
161920795|NCT03317496|584755800|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
161920796|NCT03317496|584755801|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
161475477|NCT00347360|583134563|FG012|Overall Study|Prolonged duration between visits|1|||
161475478|NCT00347360|583134564|FG013|Overall Study|Prolonged duration between visits|0|||
161475479|NCT00347360|583134565|FG014|Overall Study|Prolonged duration between visits|0|||
161475480|NCT00347360|583134551|FG000|Overall Study|Subject left town, ran out of study drug|0|||
161475481|NCT00347360|583134552|FG001|Overall Study|Subject left town, ran out of study drug|0|||
161475482|NCT00347360|583134553|FG002|Overall Study|Subject left town, ran out of study drug|0|||
161475483|NCT00347360|583134554|FG003|Overall Study|Subject left town, ran out of study drug|0|||
161475484|NCT00347360|583134555|FG004|Overall Study|Subject left town, ran out of study drug|0|||
161475485|NCT00347360|583134556|FG005|Overall Study|Subject left town, ran out of study drug|0|||
161475486|NCT00347360|583134557|FG006|Overall Study|Subject left town, ran out of study drug|0|||
161475487|NCT00347360|583134558|FG007|Overall Study|Subject left town, ran out of study drug|0|||
161475488|NCT00347360|583134559|FG008|Overall Study|Subject left town, ran out of study drug|0|||
161475489|NCT00347360|583134560|FG009|Overall Study|Subject left town, ran out of study drug|0|||
161475490|NCT00347360|583134561|FG010|Overall Study|Subject left town, ran out of study drug|0|||
161475491|NCT00347360|583134562|FG011|Overall Study|Subject left town, ran out of study drug|0|||
161475492|NCT00347360|583134563|FG012|Overall Study|Subject left town, ran out of study drug|0|||
161475493|NCT00347360|583134564|FG013|Overall Study|Subject left town, ran out of study drug|1|||
161475494|NCT00347360|583134565|FG014|Overall Study|Subject left town, ran out of study drug|0|||
161475495|NCT00347360|583134551|FG000|Overall Study|Subject refuse to sign updated consent|0|||
161475496|NCT00347360|583134552|FG001|Overall Study|Subject refuse to sign updated consent|0|||
161475497|NCT00347360|583134553|FG002|Overall Study|Subject refuse to sign updated consent|0|||
161475498|NCT00347360|583134554|FG003|Overall Study|Subject refuse to sign updated consent|0|||
161475499|NCT00347360|583134555|FG004|Overall Study|Subject refuse to sign updated consent|0|||
161475500|NCT00347360|583134556|FG005|Overall Study|Subject refuse to sign updated consent|0|||
161475501|NCT00347360|583134557|FG006|Overall Study|Subject refuse to sign updated consent|0|||
161475502|NCT00347360|583134558|FG007|Overall Study|Subject refuse to sign updated consent|0|||
161475503|NCT00347360|583134559|FG008|Overall Study|Subject refuse to sign updated consent|0|||
161475504|NCT00347360|583134560|FG009|Overall Study|Subject refuse to sign updated consent|0|||
161475505|NCT00347360|583134561|FG010|Overall Study|Subject refuse to sign updated consent|0|||
161475506|NCT00347360|583134562|FG011|Overall Study|Subject refuse to sign updated consent|0|||
161475507|NCT00347360|583134563|FG012|Overall Study|Subject refuse to sign updated consent|0|||
161475508|NCT00347360|583134564|FG013|Overall Study|Subject refuse to sign updated consent|0|||
161475509|NCT00347360|583134565|FG014|Overall Study|Subject refuse to sign updated consent|1|||
161475510|NCT00347360|583134551|FG000|Overall Study|Visits conflicted with new job|0|||
161475511|NCT00347360|583134552|FG001|Overall Study|Visits conflicted with new job|0|||
161475512|NCT00347360|583134553|FG002|Overall Study|Visits conflicted with new job|0|||
161475513|NCT00347360|583134554|FG003|Overall Study|Visits conflicted with new job|0|||
161475514|NCT00347360|583134555|FG004|Overall Study|Visits conflicted with new job|0|||
161475515|NCT00347360|583134556|FG005|Overall Study|Visits conflicted with new job|0|||
161475516|NCT00347360|583134557|FG006|Overall Study|Visits conflicted with new job|1|||
161475517|NCT00347360|583134558|FG007|Overall Study|Visits conflicted with new job|0|||
161475518|NCT00347360|583134559|FG008|Overall Study|Visits conflicted with new job|0|||
161475519|NCT00347360|583134560|FG009|Overall Study|Visits conflicted with new job|0|||
161475520|NCT00347360|583134561|FG010|Overall Study|Visits conflicted with new job|0|||
161475521|NCT00347360|583134562|FG011|Overall Study|Visits conflicted with new job|0|||
161475522|NCT00347360|583134563|FG012|Overall Study|Visits conflicted with new job|0|||
161475523|NCT00347360|583134564|FG013|Overall Study|Visits conflicted with new job|0|||
161475524|NCT00347360|583134565|FG014|Overall Study|Visits conflicted with new job|0|||
161475525|NCT00945893|583134566|FG000|Overall Study|Lost to Follow-up|2|||
161475526|NCT00945893|583134567|FG001|Overall Study|Lost to Follow-up|8|||
161475527|NCT00945893|583134566|FG000|Overall Study|Withdrawal of consent|1|||
161475528|NCT00945893|583134567|FG001|Overall Study|Withdrawal of consent|2|||
161475529|NCT03113071|583134568|FG000|Overall Study|Withdrawal by Subject|1|||
161475530|NCT03113071|583134569|FG001|Overall Study|Withdrawal by Subject|0|||
161475531|NCT01602120|583134570|FG000|Overall Study|Adverse Event|3|||
161475532|NCT01602120|583134571|FG001|Overall Study|Adverse Event|6|||
161475533|NCT01602120|583134572|FG002|Overall Study|Adverse Event|0|||
161475534|NCT01602120|583134573|FG003|Overall Study|Adverse Event|2|||
161475535|NCT01602120|583134570|FG000|Overall Study|Death|0|||
161475536|NCT01602120|583134571|FG001|Overall Study|Death|4|||
161577979|NCT01780298|583505081|FG003|Overall Study|Physician Decision|1|||
161577980|NCT01780298|583505078|FG000|Overall Study|Subject not matched|1|||
161577981|NCT01780298|583505079|FG001|Overall Study|Subject not matched|0|||
161577982|NCT01780298|583505080|FG002|Overall Study|Subject not matched|1|||
161577983|NCT01780298|583505081|FG003|Overall Study|Subject not matched|0|||
161577984|NCT01780298|583505078|FG000|Overall Study|Adverse Event|0|||
161475537|NCT01602120|583134572|FG002|Overall Study|Death|0|||
161475538|NCT01602120|583134573|FG003|Overall Study|Death|0|||
161577985|NCT01780298|583505079|FG001|Overall Study|Adverse Event|0|||
161577986|NCT01780298|583505080|FG002|Overall Study|Adverse Event|2|||
161577987|NCT01780298|583505081|FG003|Overall Study|Adverse Event|0|||
161475539|NCT01602120|583134570|FG000|Overall Study|Lost to Follow-up|0|||
161475540|NCT01602120|583134571|FG001|Overall Study|Lost to Follow-up|1|||
161475541|NCT01602120|583134572|FG002|Overall Study|Lost to Follow-up|0|||
161475542|NCT01602120|583134573|FG003|Overall Study|Lost to Follow-up|1|||
161475543|NCT01602120|583134570|FG000|Overall Study|Protocol Violation|1|||
161475544|NCT01602120|583134571|FG001|Overall Study|Protocol Violation|1|||
161475545|NCT01602120|583134572|FG002|Overall Study|Protocol Violation|0|||
161475546|NCT01602120|583134573|FG003|Overall Study|Protocol Violation|0|||
161475547|NCT01602120|583134570|FG000|Overall Study|Non-compliance|0|||
161475548|NCT01602120|583134571|FG001|Overall Study|Non-compliance|3|||
161475549|NCT01602120|583134572|FG002|Overall Study|Non-compliance|0|||
161475550|NCT01602120|583134573|FG003|Overall Study|Non-compliance|1|||
161475551|NCT01602120|583134570|FG000|Overall Study|Withdrawal by Subject|8|||
161475552|NCT01602120|583134571|FG001|Overall Study|Withdrawal by Subject|17|||
161475553|NCT01602120|583134572|FG002|Overall Study|Withdrawal by Subject|0|||
161475554|NCT01602120|583134573|FG003|Overall Study|Withdrawal by Subject|3|||
161475555|NCT01602120|583134570|FG000|Overall Study|Study Terminated by Sponsor|12|||
161475556|NCT01602120|583134571|FG001|Overall Study|Study Terminated by Sponsor|24|||
161475557|NCT01602120|583134572|FG002|Overall Study|Study Terminated by Sponsor|17|||
161475558|NCT01602120|583134573|FG003|Overall Study|Study Terminated by Sponsor|44|||
161475559|NCT01602120|583134570|FG000|Overall Study|Physician Decision|2|||
161475560|NCT01602120|583134571|FG001|Overall Study|Physician Decision|3|||
161475561|NCT01602120|583134572|FG002|Overall Study|Physician Decision|0|||
161475562|NCT01602120|583134573|FG003|Overall Study|Physician Decision|0|||
161475563|NCT01602120|583134570|FG000|Overall Study|Unspecified Reason|3|||
161475564|NCT01602120|583134571|FG001|Overall Study|Unspecified Reason|1|||
161475565|NCT01602120|583134572|FG002|Overall Study|Unspecified Reason|0|||
161475566|NCT01602120|583134573|FG003|Overall Study|Unspecified Reason|2|||
161475567|NCT04502433|583134574|FG000|Overall Study|Death|2|||
161475568|NCT04502433|583134575|FG001|Overall Study|Death|4|||
161475569|NCT04502433|583134574|FG000|Overall Study|Lost to Follow-up|1|||
161475570|NCT04502433|583134575|FG001|Overall Study|Lost to Follow-up|0|||
161577988|NCT02407249|583505097|FG000|Overall Study|Did not complete 12-month follow-up|13|||
161577989|NCT02407249|583505097|FG000|Overall Study|Not treated|13|||
161577990|NCT01391832|583505098|FG000|Overall Study|Withdrawal by Subject|21|||
161475571|NCT04502433|583134574|FG000|Overall Study|Physician Decision|0|||
161475572|NCT04502433|583134575|FG001|Overall Study|Physician Decision|1|||
161475573|NCT02369016|583134578|FG000|Overall Study|AE associated with clinical disease progression|2|||
161475574|NCT02369016|583134579|FG001|Overall Study|AE associated with clinical disease progression|1|||
161475575|NCT02369016|583134578|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
161815240|NCT00147498|584366935|FG003|Overall Study|Adverse Event|3|||
161475576|NCT02369016|583134579|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
161475577|NCT02369016|583134578|FG000|Overall Study|Progressive disease - clinical progression|1|||
161475578|NCT02369016|583134579|FG001|Overall Study|Progressive disease - clinical progression|4|||
161475579|NCT02369016|583134578|FG000|Overall Study|withdrawal by patient|4|||
161475580|NCT02369016|583134579|FG001|Overall Study|withdrawal by patient|0|||
161475581|NCT02369016|583134578|FG000|Overall Study|Progressive disease - radiological progression|6|||
161475582|NCT02369016|583134579|FG001|Overall Study|Progressive disease - radiological progression|2|||
161475583|NCT04203797|583134580|FG000|Overall Study|Adverse Event|1|||
161475584|NCT04203797|583134581|FG001|Overall Study|Adverse Event|0|||
161475585|NCT04203797|583134580|FG000|Overall Study|Did not complete End of Study follow-up|1|||
161475586|NCT04203797|583134581|FG001|Overall Study|Did not complete End of Study follow-up|0|||
161475587|NCT00300274|583134582|FG000|Overall Study|Withdrawal by Subject|12|||
161815241|NCT00147498|584366932|FG000|Overall Study|Lack of Efficacy|1|||
161815242|NCT00147498|584366933|FG001|Overall Study|Lack of Efficacy|1|||
161815243|NCT00147498|584366934|FG002|Overall Study|Lack of Efficacy|1|||
161815244|NCT00147498|584366935|FG003|Overall Study|Lack of Efficacy|8|||
161815245|NCT00147498|584366932|FG000|Overall Study|Laboratory abnormality|0|||
161815246|NCT00147498|584366933|FG001|Overall Study|Laboratory abnormality|0|||
161815247|NCT00147498|584366934|FG002|Overall Study|Laboratory abnormality|2|||
161815248|NCT00147498|584366935|FG003|Overall Study|Laboratory abnormality|0|||
161815249|NCT00147498|584366932|FG000|Overall Study|Participant defaulted|0|||
161815250|NCT00147498|584366933|FG001|Overall Study|Participant defaulted|1|||
161815251|NCT00147498|584366934|FG002|Overall Study|Participant defaulted|4|||
161475588|NCT00300274|583134583|FG001|Overall Study|Withdrawal by Subject|3|||
161475589|NCT00300274|583134584|FG002|Overall Study|Withdrawal by Subject|14|||
161475590|NCT00300274|583134582|FG000|Overall Study|Lost to Follow-up|3|||
161475591|NCT00300274|583134583|FG001|Overall Study|Lost to Follow-up|4|||
161475592|NCT00300274|583134584|FG002|Overall Study|Lost to Follow-up|5|||
161475593|NCT00300274|583134582|FG000|Overall Study|Death|31|||
161475594|NCT00300274|583134583|FG001|Overall Study|Death|20|||
161475595|NCT00300274|583134584|FG002|Overall Study|Death|25|||
161475596|NCT00300274|583134582|FG000|Overall Study|Re-transplant|0|||
161475597|NCT00300274|583134583|FG001|Overall Study|Re-transplant|0|||
161815252|NCT00147498|584366935|FG003|Overall Study|Participant defaulted|3|||
161815253|NCT00147498|584366932|FG000|Overall Study|Other|1|||
161475598|NCT00300274|583134584|FG002|Overall Study|Re-transplant|1|||
161475599|NCT00242216|583134585|FG000|Overall Study|Lost to Follow-up|12|||
161475600|NCT00242216|583134586|FG001|Overall Study|Lost to Follow-up|17|||
161475601|NCT00242216|583134585|FG000|Overall Study|Death|4|||
161475602|NCT00242216|583134586|FG001|Overall Study|Death|2|||
161475603|NCT00242216|583134585|FG000|Overall Study|Lack of Efficacy|1|||
161475604|NCT00242216|583134586|FG001|Overall Study|Lack of Efficacy|2|||
161475605|NCT00242216|583134585|FG000|Overall Study|no medicaiton dispensed|1|||
161475606|NCT00242216|583134586|FG001|Overall Study|no medicaiton dispensed|1|||
161475607|NCT02484690|583134587|FG000|Overall Study|Adverse Event|1|||
161475608|NCT02484690|583134588|FG001|Overall Study|Adverse Event|3|||
161475609|NCT02484690|583134589|FG002|Overall Study|Adverse Event|0|||
161475610|NCT02484690|583134590|FG003|Overall Study|Adverse Event|0|||
161475611|NCT02484690|583134591|FG004|Overall Study|Adverse Event|5|||
161475612|NCT02484690|583134587|FG000|Overall Study|Death|0|||
161475613|NCT02484690|583134588|FG001|Overall Study|Death|0|||
161475614|NCT02484690|583134589|FG002|Overall Study|Death|0|||
161475615|NCT02484690|583134590|FG003|Overall Study|Death|0|||
161475616|NCT02484690|583134591|FG004|Overall Study|Death|1|||
161475617|NCT02484690|583134587|FG000|Overall Study|Withdrawal by Subject|1|||
161475618|NCT02484690|583134588|FG001|Overall Study|Withdrawal by Subject|3|||
161475619|NCT02484690|583134589|FG002|Overall Study|Withdrawal by Subject|1|||
161475620|NCT02484690|583134590|FG003|Overall Study|Withdrawal by Subject|2|||
161475621|NCT02484690|583134591|FG004|Overall Study|Withdrawal by Subject|0|||
161475622|NCT02484690|583134587|FG000|Overall Study|Physician Decision|2|||
161475623|NCT02484690|583134588|FG001|Overall Study|Physician Decision|0|||
161475624|NCT02484690|583134589|FG002|Overall Study|Physician Decision|1|||
161475625|NCT02484690|583134590|FG003|Overall Study|Physician Decision|0|||
161475626|NCT02484690|583134591|FG004|Overall Study|Physician Decision|0|||
161475627|NCT02484690|583134587|FG000|Overall Study|Lost to Follow-up|0|||
161475628|NCT02484690|583134588|FG001|Overall Study|Lost to Follow-up|0|||
161475629|NCT02484690|583134589|FG002|Overall Study|Lost to Follow-up|1|||
161475630|NCT02484690|583134590|FG003|Overall Study|Lost to Follow-up|0|||
161475631|NCT02484690|583134591|FG004|Overall Study|Lost to Follow-up|0|||
161475632|NCT01759511|583134592|FG000|Overall Study|Adverse Event|4|||
161475633|NCT01759511|583134592|FG000|Overall Study|Death|2|||
161475634|NCT01759511|583134592|FG000|Overall Study|Lack of Efficacy|2|||
161475635|NCT01759511|583134592|FG000|Overall Study|Physician Decision|1|||
161475636|NCT01759511|583134592|FG000|Overall Study|Progressive Disease|5|||
161475637|NCT01759511|583134592|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
161475638|NCT01759511|583134592|FG000|Overall Study|Study Terminated by Sponsor|13|||
161475639|NCT01759511|583134592|FG000|Overall Study|Withdrawal by Subject|3|||
161475640|NCT04439201|583134595|FG000|Overall Study|Ineligible|2|||
161475641|NCT04439201|583134595|FG000|Overall Study|Never start protocol therapy|1|||
161475642|NCT04439201|583134595|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
161475643|NCT04439201|583134595|FG000|Overall Study|Mutation status not confirmed|4|||
161475644|NCT04439201|583134595|FG000|Overall Study|Adverse Event|1|||
161475645|NCT04439201|583134595|FG000|Overall Study|Death|7|||
161475646|NCT04439201|583134595|FG000|Overall Study|Withdrawal by Subject|2|||
161475647|NCT04439201|583134595|FG000|Overall Study|Disease progression|20|||
161475648|NCT04439201|583134595|FG000|Overall Study|Alternative therapy|1|||
161475649|NCT04439201|583134595|FG000|Overall Study|Physician Decision|1|||
161475650|NCT01516437|583136149|FG000|Overall Study|Reason not specified|0|||
161475651|NCT01516437|583136150|FG001|Overall Study|Reason not specified|0|||
161475652|NCT01516437|583136151|FG002|Overall Study|Reason not specified|1|||
161475653|NCT01516437|583136152|FG003|Overall Study|Reason not specified|1|||
161475654|NCT00403234|583136153|FG000|Overall Study|Withdrawal by Subject|0|||
161475655|NCT00403234|583136154|FG001|Overall Study|Withdrawal by Subject|1|||
161475656|NCT00403234|583136155|FG002|Overall Study|Withdrawal by Subject|0|||
161475657|NCT00403234|583136156|FG003|Overall Study|Withdrawal by Subject|0|||
161475658|NCT00403234|583136153|FG000|Overall Study|Adverse Event|1|||
161475659|NCT00403234|583136154|FG001|Overall Study|Adverse Event|0|||
161475660|NCT00403234|583136155|FG002|Overall Study|Adverse Event|1|||
161475661|NCT00403234|583136156|FG003|Overall Study|Adverse Event|0|||
161475662|NCT00560105|583136159|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
161475663|NCT00560105|583136160|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
161475664|NCT01550289|583136161|FG000|Overall Study|Protocol Violation|1|||
161475665|NCT01550289|583136162|FG001|Overall Study|Protocol Violation|0|||
161475666|NCT01550289|583136161|FG000|Overall Study|Lost to Follow-up|1|||
161475667|NCT01550289|583136162|FG001|Overall Study|Lost to Follow-up|1|||
161475668|NCT01550289|583136161|FG000|Overall Study|Withdrawal by Subject|11|||
161475669|NCT01550289|583136162|FG001|Overall Study|Withdrawal by Subject|3|||
161475670|NCT03539081|583136163|FG000|Overall Study|Withdrawal by Subject|2|||
161475671|NCT03539081|583136164|FG001|Overall Study|Withdrawal by Subject|3|||
161475672|NCT03539081|583136165|FG002|Overall Study|Withdrawal by Subject|0|||
161475673|NCT03539081|583136163|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
161475674|NCT03539081|583136164|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
161475675|NCT03539081|583136165|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
161475676|NCT02555683|583136174|FG000|Overall Study|Physician Decision|1|||
161475677|NCT02555683|583136175|FG001|Overall Study|Physician Decision|0|||
161475678|NCT02555683|583136176|FG002|Overall Study|Physician Decision|2|||
161475679|NCT02555683|583136174|FG000|Overall Study|Lost to Follow-up|2|||
161475680|NCT02555683|583136175|FG001|Overall Study|Lost to Follow-up|1|||
161475681|NCT02555683|583136176|FG002|Overall Study|Lost to Follow-up|2|||
161475682|NCT02555683|583136174|FG000|Overall Study|Technical Problems|1|||
161475683|NCT02555683|583136175|FG001|Overall Study|Technical Problems|1|||
161475684|NCT02555683|583136176|FG002|Overall Study|Technical Problems|0|||
161475685|NCT02555683|583136174|FG000|Overall Study|Protocol deviation|0|||
161475686|NCT02555683|583136175|FG001|Overall Study|Protocol deviation|1|||
161475687|NCT02555683|583136176|FG002|Overall Study|Protocol deviation|0|||
161475688|NCT02555683|583136174|FG000|Overall Study|Lack of Efficacy|2|||
161475689|NCT02555683|583136175|FG001|Overall Study|Lack of Efficacy|0|||
161475690|NCT02555683|583136176|FG002|Overall Study|Lack of Efficacy|0|||
161475691|NCT02555683|583136174|FG000|Overall Study|Death|0|||
161475692|NCT02555683|583136175|FG001|Overall Study|Death|1|||
161475693|NCT02555683|583136176|FG002|Overall Study|Death|2|||
161475694|NCT02555683|583136174|FG000|Overall Study|Adverse Event|1|||
161475695|NCT02555683|583136175|FG001|Overall Study|Adverse Event|0|||
161475696|NCT02555683|583136176|FG002|Overall Study|Adverse Event|1|||
161475697|NCT02555683|583136174|FG000|Overall Study|Subject/guardian decision|12|||
161475698|NCT02555683|583136175|FG001|Overall Study|Subject/guardian decision|12|||
161475699|NCT02555683|583136176|FG002|Overall Study|Subject/guardian decision|22|||
161475700|NCT02555683|583136174|FG000|Overall Study|Death post Treatment/safety period|0|||
161475701|NCT02555683|583136175|FG001|Overall Study|Death post Treatment/safety period|1|||
161475702|NCT02555683|583136176|FG002|Overall Study|Death post Treatment/safety period|0|||
161475703|NCT01397890|583136186|FG000|Overall Study|Withdrawal by Subject|7|||
161475704|NCT01397890|583136187|FG001|Overall Study|Withdrawal by Subject|11|||
161475705|NCT01397890|583136186|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
161475706|NCT01397890|583136187|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
161475707|NCT01397890|583136186|FG000|Overall Study|Death|2|||
161475708|NCT01397890|583136187|FG001|Overall Study|Death|3|||
161475709|NCT01397890|583136186|FG000|Overall Study|Lost to Follow-up|1|||
161475710|NCT01397890|583136187|FG001|Overall Study|Lost to Follow-up|4|||
161475711|NCT01397890|583136186|FG000|Overall Study|Condition under Investigation Worsened|1|||
161475712|NCT01397890|583136187|FG001|Overall Study|Condition under Investigation Worsened|3|||
161475713|NCT01397890|583136186|FG000|Overall Study|Adverse Event|1|||
161475714|NCT01397890|583136187|FG001|Overall Study|Adverse Event|2|||
161475715|NCT01397890|583136186|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
161475716|NCT01397890|583136187|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
161475717|NCT01397890|583136186|FG000|Overall Study|Others|2|||
161577991|NCT01391832|583505099|FG001|Overall Study|Withdrawal by Subject|22|||
161577992|NCT01391832|583505098|FG000|Overall Study|Lost to Follow-up|0|||
161475718|NCT01397890|583136187|FG001|Overall Study|Others|1|||
161475719|NCT04622306|583136188|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
161475720|NCT04622306|583136189|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
161475721|NCT04622306|583136190|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
161475722|NCT04622306|583136191|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
161475723|NCT04622306|583136192|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
161475724|NCT04622306|583136193|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
161475725|NCT04622306|583136188|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
161475726|NCT04622306|583136189|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
161475727|NCT04622306|583136190|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
161475728|NCT04622306|583136191|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
161475729|NCT04622306|583136192|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
161475730|NCT04622306|583136193|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
161475731|NCT02763462|583136195|FG000|Overall Study|Protocol Violation|6|||
161475732|NCT00129272|583136196|FG000|Overall Study|Lost to Follow-up|12|||
161475733|NCT00129272|583136197|FG001|Overall Study|Lost to Follow-up|11|||
161475734|NCT00129272|583136196|FG000|Overall Study|Withdrawal by Subject|5|||
161475735|NCT00129272|583136197|FG001|Overall Study|Withdrawal by Subject|11|||
161475736|NCT00675948|583136199|FG000|Overall Study|Adverse Event|23|||
161475737|NCT00675948|583136200|FG001|Overall Study|Adverse Event|1|||
161475738|NCT00675948|583136199|FG000|Overall Study|Lack of Efficacy|3|||
161475739|NCT00675948|583136200|FG001|Overall Study|Lack of Efficacy|0|||
161475740|NCT00675948|583136199|FG000|Overall Study|Withdrawal by Subject|7|||
161475741|NCT00675948|583136200|FG001|Overall Study|Withdrawal by Subject|0|||
161475742|NCT00675948|583136199|FG000|Overall Study|Lost to Follow-up|2|||
161475743|NCT00675948|583136200|FG001|Overall Study|Lost to Follow-up|0|||
161475744|NCT00675948|583136199|FG000|Overall Study|Protocol Violation|1|||
161475745|NCT00675948|583136200|FG001|Overall Study|Protocol Violation|0|||
161475746|NCT00675948|583136199|FG000|Overall Study|Pain under control|1|||
161475747|NCT00675948|583136200|FG001|Overall Study|Pain under control|0|||
161475748|NCT00675948|583136199|FG000|Overall Study|Sponsor decision|0|||
161475749|NCT00675948|583136200|FG001|Overall Study|Sponsor decision|1|||
161475750|NCT00675948|583136199|FG000|Overall Study|Patient died|1|||
161475751|NCT00675948|583136200|FG001|Overall Study|Patient died|0|||
161475752|NCT00675948|583136199|FG000|Overall Study|Patient unable to comply with diaries|1|||
161475753|NCT00675948|583136200|FG001|Overall Study|Patient unable to comply with diaries|0|||
161475754|NCT00675948|583136199|FG000|Overall Study|Patient feels unable to take medication|0|||
161475755|NCT00675948|583136200|FG001|Overall Study|Patient feels unable to take medication|1|||
161475756|NCT02100514|583136204|FG000|Treatment Period|Adverse Event|0|||
161475757|NCT02100514|583136205|FG001|Treatment Period|Adverse Event|5|||
161475758|NCT02100514|583136206|FG002|Treatment Period|Adverse Event|0|||
161475759|NCT02100514|583136207|FG003|Treatment Period|Adverse Event|0|||
161475760|NCT02100514|583136208|FG004|Treatment Period|Adverse Event|0|||
161475761|NCT02100514|583136204|FG000|Treatment Period|Death|2|||
161475762|NCT02100514|583136205|FG001|Treatment Period|Death|2|||
161475763|NCT02100514|583136206|FG002|Treatment Period|Death|0|||
161577993|NCT01391832|583505099|FG001|Overall Study|Lost to Follow-up|1|||
161577994|NCT03345901|583505100|FG000|Overall Study|The study was terminated|18|||
161577995|NCT04252586|583505101|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161577996|NCT04252586|583505101|FG000|Overall Study|Adverse Event|1|||
161577997|NCT04252586|583505101|FG000|Overall Study|Death|2|||
161577998|NCT04252586|583505101|FG000|Overall Study|Study terminated by sponsor|4|||
161577999|NCT04252586|583505101|FG000|Overall Study|Sponsor request|10|||
161578000|NCT04252586|583505101|FG000|Overall Study|Did not complete treatment period|1|||
161578001|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Death|186|||
161475764|NCT02100514|583136207|FG003|Treatment Period|Death|0|||
161475765|NCT02100514|583136208|FG004|Treatment Period|Death|0|||
161475766|NCT02100514|583136204|FG000|Treatment Period|Lost to Follow-up|5|||
161578002|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Death|222|||
161578003|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Death|0|||
161578004|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
161578005|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
161475767|NCT02100514|583136205|FG001|Treatment Period|Lost to Follow-up|17|||
161475768|NCT02100514|583136206|FG002|Treatment Period|Lost to Follow-up|0|||
161475769|NCT02100514|583136207|FG003|Treatment Period|Lost to Follow-up|0|||
161475770|NCT02100514|583136208|FG004|Treatment Period|Lost to Follow-up|0|||
161475771|NCT02100514|583136204|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
161578006|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
161578007|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
161578008|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
161578009|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
161578010|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
161578011|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
161475772|NCT02100514|583136205|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
161578012|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
161815254|NCT00147498|584366933|FG001|Overall Study|Other|1|||
161475773|NCT02100514|583136206|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
161475774|NCT02100514|583136207|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
161475775|NCT02100514|583136208|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
161475776|NCT02100514|583136204|FG000|Treatment Period|Protocol Violation|1|||
161475777|NCT02100514|583136205|FG001|Treatment Period|Protocol Violation|1|||
161578013|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Adverse Event|83|||
161578014|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Adverse Event|100|||
161578015|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Adverse Event|0|||
161578016|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Other|70|||
161475778|NCT02100514|583136206|FG002|Treatment Period|Protocol Violation|0|||
161475779|NCT02100514|583136207|FG003|Treatment Period|Protocol Violation|0|||
161475780|NCT02100514|583136208|FG004|Treatment Period|Protocol Violation|0|||
161475781|NCT02100514|583136204|FG000|Treatment Period|Withdrawal by Subject|12|||
161475782|NCT02100514|583136205|FG001|Treatment Period|Withdrawal by Subject|37|||
161475783|NCT02100514|583136206|FG002|Treatment Period|Withdrawal by Subject|0|||
161475784|NCT02100514|583136207|FG003|Treatment Period|Withdrawal by Subject|0|||
161475785|NCT02100514|583136208|FG004|Treatment Period|Withdrawal by Subject|0|||
161475786|NCT02100514|583136204|FG000|Treatment Period|Other|9|||
161475787|NCT02100514|583136205|FG001|Treatment Period|Other|11|||
161475788|NCT02100514|583136206|FG002|Treatment Period|Other|0|||
161475789|NCT02100514|583136207|FG003|Treatment Period|Other|0|||
161475790|NCT02100514|583136208|FG004|Treatment Period|Other|0|||
161475791|NCT02100514|583136204|FG000|Extension Period|Withdrew consent|0|||
161475792|NCT02100514|583136205|FG001|Extension Period|Withdrew consent|0|||
161475793|NCT02100514|583136206|FG002|Extension Period|Withdrew consent|2|||
161475794|NCT02100514|583136207|FG003|Extension Period|Withdrew consent|0|||
161475795|NCT02100514|583136208|FG004|Extension Period|Withdrew consent|0|||
161475796|NCT01145625|583136209|FG000|Overall Study|Lost to Follow-up|8|||
161475797|NCT01145625|583136210|FG001|Overall Study|Lost to Follow-up|9|||
161475798|NCT01145625|583136209|FG000|Overall Study|Adverse Event|6|||
161475799|NCT01145625|583136210|FG001|Overall Study|Adverse Event|4|||
161475800|NCT01145625|583136209|FG000|Overall Study|Protocol Violation|3|||
161475801|NCT01145625|583136210|FG001|Overall Study|Protocol Violation|1|||
161475802|NCT01145625|583136209|FG000|Overall Study|Withdrawal by Subject|7|||
161475803|NCT01145625|583136210|FG001|Overall Study|Withdrawal by Subject|16|||
161475804|NCT01145625|583136209|FG000|Overall Study|Pregnancy|0|||
161475805|NCT01145625|583136210|FG001|Overall Study|Pregnancy|1|||
161475806|NCT01896102|583136211|FG000|Overall Study|Death|1|||
161475807|NCT01896102|583136211|FG000|Overall Study|Participant to receive allogenic transplant|2|||
161475808|NCT01751178|583136213|FG000|Overall Study|Adverse Event|2|||
161475809|NCT01751178|583136214|FG001|Overall Study|Adverse Event|0|||
161475810|NCT01751178|583136215|FG002|Overall Study|Adverse Event|0|||
161475811|NCT01751178|583136213|FG000|Overall Study|Other Reason (unknown)|1|||
161475812|NCT01751178|583136214|FG001|Overall Study|Other Reason (unknown)|0|||
161475813|NCT01751178|583136215|FG002|Overall Study|Other Reason (unknown)|2|||
161475814|NCT04289623|583136216|FG000|Wave 1 Emails|Email was not delivered|268|||
161475815|NCT04289623|583136217|FG001|Wave 1 Emails|Email was not delivered|257|||
161475816|NCT04289623|583136218|FG002|Wave 1 Emails|Email was not delivered|0|||
161475817|NCT04289623|583136219|FG003|Wave 1 Emails|Email was not delivered|0|||
161475818|NCT04289623|583136220|FG004|Wave 1 Emails|Email was not delivered|0|||
161475819|NCT04289623|583136221|FG005|Wave 1 Emails|Email was not delivered|0|||
161475820|NCT04138810|583136228|FG000|Overall Study|Withdrawal by Subject|0|||
161475821|NCT04138810|583136229|FG001|Overall Study|Withdrawal by Subject|1|||
161475822|NCT04138810|583136228|FG000|Overall Study|Subject cancelled surgery|1|||
161475823|NCT04138810|583136229|FG001|Overall Study|Subject cancelled surgery|0|||
161475824|NCT00696800|583136230|FG000|Overall Study|Adverse Event|16|||
161475825|NCT00696800|583136231|FG001|Overall Study|Adverse Event|3|||
161475826|NCT00696800|583136230|FG000|Overall Study|Insufficient compliance with medication|2|||
161475827|NCT00696800|583136231|FG001|Overall Study|Insufficient compliance with medication|1|||
161475828|NCT00696800|583136230|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
161475829|NCT00696800|583136231|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
161475830|NCT00696800|583136230|FG000|Overall Study|Insufficient ovarian response|4|||
161475831|NCT00696800|583136231|FG001|Overall Study|Insufficient ovarian response|1|||
161475832|NCT00696800|583136230|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
161475833|NCT00696800|583136231|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
161475834|NCT00696800|583136230|FG000|Overall Study|Too high ovarian response|6|||
161475835|NCT00696800|583136231|FG001|Overall Study|Too high ovarian response|1|||
161475836|NCT00696800|583136230|FG000|Overall Study|No/too few/bad quality oocytes|4|||
161475837|NCT00696800|583136231|FG001|Overall Study|No/too few/bad quality oocytes|3|||
161475838|NCT00696800|583136230|FG000|Overall Study|No/abnormal fertilization|11|||
161475839|NCT00696800|583136231|FG001|Overall Study|No/abnormal fertilization|13|||
161475840|NCT00696800|583136230|FG000|Overall Study|No/too few/bad quality embryos|24|||
161475841|NCT00696800|583136231|FG001|Overall Study|No/too few/bad quality embryos|18|||
161815255|NCT00147498|584366934|FG002|Overall Study|Other|3|||
161815256|NCT00147498|584366935|FG003|Overall Study|Other|3|||
161475842|NCT00696800|583136230|FG000|Overall Study|Other Reasons|5|||
161475843|NCT00696800|583136231|FG001|Overall Study|Other Reasons|3|||
161475844|NCT00696800|583136230|FG000|Overall Study|Not treated|1|||
161815257|NCT01841554|584366936|FG000|Overall Study|Death|7|||
161475845|NCT00696800|583136231|FG001|Overall Study|Not treated|2|||
161475846|NCT00591344|583136232|FG000|Overall Study|Transportation issues|1|||
161475847|NCT00591344|583136233|FG001|Overall Study|Transportation issues|0|||
161475848|NCT00591344|583136232|FG000|Overall Study|Moved out of state|1|||
161475849|NCT00591344|583136233|FG001|Overall Study|Moved out of state|0|||
161475850|NCT00591344|583136232|FG000|Overall Study|Medical complications|1|||
161815258|NCT01841554|584366936|FG000|Overall Study|No Implantation|1|||
161475851|NCT00591344|583136233|FG001|Overall Study|Medical complications|3|||
161475852|NCT00591344|583136232|FG000|Overall Study|Underwent DBS|2|||
161475853|NCT00591344|583136233|FG001|Overall Study|Underwent DBS|2|||
161475854|NCT00591344|583136232|FG000|Overall Study|Death|0|||
161475855|NCT00591344|583136233|FG001|Overall Study|Death|1|||
161475856|NCT00591344|583136232|FG000|Overall Study|Lost to Follow-up|0|||
161475857|NCT00591344|583136233|FG001|Overall Study|Lost to Follow-up|1|||
161475858|NCT00591344|583136232|FG000|Overall Study|Did not want to come off medication|0|||
161475859|NCT00591344|583136233|FG001|Overall Study|Did not want to come off medication|1|||
161475860|NCT00493025|583136234|FG000|Overall Study|Physician Decision|19|||
161475861|NCT02435147|583136236|FG000|Overall Study|non-evaluable DXA scan|11|||
161475862|NCT02939079|583136237|FG000|Overall Study|Adverse Event|2|||
161475863|NCT02939079|583136238|FG001|Overall Study|Adverse Event|1|||
161475864|NCT02939079|583136237|FG000|Overall Study|Lost to Follow-up|0|||
161475865|NCT02939079|583136238|FG001|Overall Study|Lost to Follow-up|2|||
161475866|NCT02939079|583136237|FG000|Overall Study|Protocol Violation|1|||
161475867|NCT02939079|583136238|FG001|Overall Study|Protocol Violation|0|||
161475868|NCT02939079|583136237|FG000|Overall Study|Withdrawal by Subject|0|||
161475869|NCT02939079|583136238|FG001|Overall Study|Withdrawal by Subject|1|||
161475870|NCT02939079|583136237|FG000|Overall Study|relapse during the study|1|||
161475871|NCT02939079|583136238|FG001|Overall Study|relapse during the study|1|||
161475872|NCT01609231|583136239|FG000|Overall Study|Adverse Event|1|||
161475873|NCT01609231|583136240|FG001|Overall Study|Adverse Event|3|||
161475874|NCT01609231|583136239|FG000|Overall Study|Physician Decision|1|||
161475875|NCT01609231|583136240|FG001|Overall Study|Physician Decision|0|||
161475876|NCT01609231|583136239|FG000|Overall Study|Withdrawal by Subject|1|||
161475877|NCT01609231|583136240|FG001|Overall Study|Withdrawal by Subject|0|||
161475878|NCT00494299|583136247|FG000|Overall Study|Adverse Event|93|||
161475879|NCT00494299|583136248|FG001|Overall Study|Adverse Event|13|||
161475880|NCT00494299|583136247|FG000|Overall Study|Lost to Follow-up|1|||
161475881|NCT00494299|583136248|FG001|Overall Study|Lost to Follow-up|0|||
161475882|NCT00494299|583136247|FG000|Overall Study|Physician Decision|0|||
161475883|NCT00494299|583136248|FG001|Overall Study|Physician Decision|2|||
161475884|NCT00494299|583136247|FG000|Overall Study|Protocol Violation|1|||
161475885|NCT00494299|583136248|FG001|Overall Study|Protocol Violation|2|||
161578017|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Other|75|||
161578018|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Other|0|||
161578019|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
161578020|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
161578021|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
161578022|NCT00232180|583505102|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
161578023|NCT00232180|583505103|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
161578024|NCT00232180|583505104|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
161578025|NCT00232180|583505102|FG000|Open Label Phase|Death|0|||
161578026|NCT00232180|583505103|FG001|Open Label Phase|Death|0|||
161578027|NCT00232180|583505104|FG002|Open Label Phase|Death|48|||
161578028|NCT00232180|583505102|FG000|Open Label Phase|Lost to Follow-up|0|||
161578029|NCT00232180|583505103|FG001|Open Label Phase|Lost to Follow-up|0|||
161578030|NCT00232180|583505104|FG002|Open Label Phase|Lost to Follow-up|5|||
161578031|NCT00232180|583505102|FG000|Open Label Phase|Protocol Violation|0|||
161578032|NCT00232180|583505103|FG001|Open Label Phase|Protocol Violation|0|||
161815259|NCT01841554|584366936|FG000|Overall Study|Discontinued Follow Up|5|||
161815260|NCT01841554|584366936|FG000|Overall Study|Study exit due to secondary intervention|6|||
161815261|NCT01838681|584366937|FG000|Period A|Adverse Event|39|||
161815262|NCT01838681|584366938|FG001|Period A|Adverse Event|0|||
161815263|NCT01838681|584366939|FG002|Period A|Adverse Event|0|||
161815264|NCT01838681|584366940|FG003|Period A|Adverse Event|0|||
161815265|NCT01838681|584366937|FG000|Period A|Lack of Efficacy|21|||
161815266|NCT01838681|584366938|FG001|Period A|Lack of Efficacy|0|||
161815267|NCT01838681|584366939|FG002|Period A|Lack of Efficacy|0|||
161815268|NCT01838681|584366940|FG003|Period A|Lack of Efficacy|0|||
161815269|NCT01838681|584366937|FG000|Period A|Early response|148|||
161475886|NCT00494299|583136247|FG000|Overall Study|Withdrawal by Subject|8|||
161475887|NCT00494299|583136248|FG001|Overall Study|Withdrawal by Subject|3|||
161475888|NCT00494299|583136247|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
161475889|NCT00494299|583136248|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
161475890|NCT00494299|583136247|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
161475891|NCT00494299|583136248|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
161578033|NCT00232180|583505104|FG002|Open Label Phase|Protocol Violation|3|||
161578034|NCT00232180|583505102|FG000|Open Label Phase|Study terminated by sponsor|0|||
161578035|NCT00232180|583505103|FG001|Open Label Phase|Study terminated by sponsor|0|||
161815270|NCT01838681|584366938|FG001|Period A|Early response|0|||
161815271|NCT01838681|584366939|FG002|Period A|Early response|0|||
161815272|NCT01838681|584366940|FG003|Period A|Early response|0|||
161815273|NCT01838681|584366937|FG000|Period A|Withdrawal by Subject|70|||
161815274|NCT01838681|584366938|FG001|Period A|Withdrawal by Subject|0|||
161475892|NCT00494299|583136247|FG000|Overall Study|Site Closed by Sponsor|6|||
161475893|NCT00494299|583136248|FG001|Overall Study|Site Closed by Sponsor|0|||
161475894|NCT00494299|583136247|FG000|Overall Study|Protocol Driven Decision Point|11|||
161475895|NCT00494299|583136248|FG001|Overall Study|Protocol Driven Decision Point|22|||
161475896|NCT03576495|583136250|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
161475897|NCT03576495|583136251|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
161475898|NCT00516074|583136254|FG000|Overall Study|Adverse Event|0|||
161475899|NCT00516074|583136255|FG001|Overall Study|Adverse Event|1|||
161475900|NCT00516074|583136254|FG000|Overall Study|Subject Decision|4|||
161475901|NCT00516074|583136255|FG001|Overall Study|Subject Decision|2|||
161475902|NCT00516074|583136254|FG000|Overall Study|Loss of Glucose Control|2|||
161475903|NCT00516074|583136255|FG001|Overall Study|Loss of Glucose Control|0|||
161475904|NCT05306977|583136256|FG000|Overall Study|Withdrawal by Subject|1|||
161475905|NCT00369824|583136257|FG000|Overall Study|Adverse Event|0|||
161475906|NCT00369824|583136258|FG001|Overall Study|Adverse Event|2|||
161475907|NCT00369824|583136259|FG002|Overall Study|Adverse Event|0|||
161475908|NCT00369824|583136260|FG003|Overall Study|Adverse Event|0|||
161475909|NCT00369824|583136261|FG004|Overall Study|Adverse Event|1|||
161475910|NCT00369824|583136262|FG005|Overall Study|Adverse Event|0|||
161475911|NCT00369824|583136257|FG000|Overall Study|Protocol Violation|0|||
161475912|NCT00369824|583136258|FG001|Overall Study|Protocol Violation|1|||
161475913|NCT00369824|583136259|FG002|Overall Study|Protocol Violation|0|||
161475914|NCT00369824|583136260|FG003|Overall Study|Protocol Violation|1|||
161815275|NCT01838681|584366939|FG002|Period A|Withdrawal by Subject|0|||
161815276|NCT01838681|584366940|FG003|Period A|Withdrawal by Subject|0|||
161475915|NCT00369824|583136261|FG004|Overall Study|Protocol Violation|1|||
161475916|NCT00369824|583136262|FG005|Overall Study|Protocol Violation|0|||
161475917|NCT00369824|583136257|FG000|Overall Study|Withdrawal by Subject|9|||
161475918|NCT00369824|583136258|FG001|Overall Study|Withdrawal by Subject|5|||
161475919|NCT00369824|583136259|FG002|Overall Study|Withdrawal by Subject|5|||
161475920|NCT00369824|583136260|FG003|Overall Study|Withdrawal by Subject|4|||
161475921|NCT00369824|583136261|FG004|Overall Study|Withdrawal by Subject|6|||
161475922|NCT00369824|583136262|FG005|Overall Study|Withdrawal by Subject|2|||
161475923|NCT00369824|583136257|FG000|Overall Study|Lost to Follow-up|6|||
161475924|NCT00369824|583136258|FG001|Overall Study|Lost to Follow-up|11|||
161475925|NCT00369824|583136259|FG002|Overall Study|Lost to Follow-up|7|||
161475926|NCT00369824|583136260|FG003|Overall Study|Lost to Follow-up|8|||
161475927|NCT00369824|583136261|FG004|Overall Study|Lost to Follow-up|9|||
161475928|NCT00369824|583136262|FG005|Overall Study|Lost to Follow-up|6|||
161475929|NCT00369824|583136257|FG000|Overall Study|Other|0|||
161475930|NCT00369824|583136258|FG001|Overall Study|Other|0|||
161475931|NCT00369824|583136259|FG002|Overall Study|Other|0|||
161475932|NCT00369824|583136260|FG003|Overall Study|Other|2|||
161475933|NCT00369824|583136261|FG004|Overall Study|Other|1|||
161475934|NCT00369824|583136262|FG005|Overall Study|Other|3|||
161475935|NCT03822182|583136268|FG000|Overall Study|Protocol Violation|0|||
161475936|NCT03822182|583136269|FG001|Overall Study|Protocol Violation|1|||
161475937|NCT03822182|583136270|FG002|Overall Study|Protocol Violation|1|||
161475938|NCT01484275|583136272|FG000|Overall Study|Study terminated by sponsor|28|||
161475939|NCT01484275|583136273|FG001|Overall Study|Study terminated by sponsor|32|||
161475940|NCT01484275|583136272|FG000|Overall Study|Other|10|||
161475941|NCT01484275|583136273|FG001|Overall Study|Other|0|||
161475942|NCT01484275|583136272|FG000|Overall Study|Death|3|||
161475943|NCT01484275|583136273|FG001|Overall Study|Death|4|||
161475944|NCT01484275|583136272|FG000|Overall Study|Withdrawal by Subject|1|||
161475945|NCT01484275|583136273|FG001|Overall Study|Withdrawal by Subject|5|||
161578036|NCT00232180|583505104|FG002|Open Label Phase|Study terminated by sponsor|3|||
161578037|NCT00232180|583505102|FG000|Open Label Phase|Withdrawal by Subject|0|||
161578038|NCT00232180|583505103|FG001|Open Label Phase|Withdrawal by Subject|0|||
161578039|NCT00232180|583505104|FG002|Open Label Phase|Withdrawal by Subject|37|||
161578040|NCT00232180|583505102|FG000|Open Label Phase|Other|0|||
161578041|NCT00232180|583505103|FG001|Open Label Phase|Other|0|||
161578042|NCT00232180|583505104|FG002|Open Label Phase|Other|16|||
161578043|NCT00232180|583505102|FG000|Open Label Phase|Adverse Event|0|||
161578044|NCT00232180|583505103|FG001|Open Label Phase|Adverse Event|0|||
161475946|NCT01484275|583136272|FG000|Overall Study|Lost to Follow-up|1|||
161475947|NCT01484275|583136273|FG001|Overall Study|Lost to Follow-up|1|||
161475948|NCT00003487|583136274|FG000|Overall Study|Not evaluable|2|||
161475949|NCT04154930|583136277|FG000|Overall Study|Withdrawal by Subject|15|||
161475950|NCT04154930|583136278|FG001|Overall Study|Withdrawal by Subject|6|||
161475951|NCT04154930|583136277|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
161475952|NCT04154930|583136278|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
161475953|NCT04154930|583136277|FG000|Overall Study|Lost to Follow-up|14|||
161475954|NCT04154930|583136278|FG001|Overall Study|Lost to Follow-up|6|||
161578045|NCT00232180|583505104|FG002|Open Label Phase|Adverse Event|25|||
161815277|NCT01838681|584366937|FG000|Period A|Protocol Violation|16|||
161815278|NCT01838681|584366938|FG001|Period A|Protocol Violation|0|||
161475955|NCT04154930|583136277|FG000|Overall Study|Other|6|||
161475956|NCT04154930|583136278|FG001|Overall Study|Other|0|||
161475957|NCT02020577|583136282|FG000|Overall Study|Progressive disease|3|||
161475958|NCT02020577|583136283|FG001|Overall Study|Progressive disease|38|||
161475959|NCT02020577|583136282|FG000|Overall Study|Other AE or clinical progression|0|||
161475960|NCT02020577|583136283|FG001|Overall Study|Other AE or clinical progression|15|||
161475961|NCT02020577|583136282|FG000|Overall Study|Withdrawal by Subject|0|||
161475962|NCT02020577|583136283|FG001|Overall Study|Withdrawal by Subject|1|||
161475963|NCT02020577|583136282|FG000|Overall Study|Other than stated above|0|||
161475964|NCT02020577|583136283|FG001|Overall Study|Other than stated above|1|||
161475965|NCT01611155|583136284|FG000|Overall Study|Adverse Event|1|||
161475966|NCT01611155|583136285|FG001|Overall Study|Adverse Event|1|||
161475967|NCT01611155|583136284|FG000|Overall Study|Refused further treatment|6|||
161475968|NCT01611155|583136285|FG001|Overall Study|Refused further treatment|4|||
161475969|NCT01611155|583136284|FG000|Overall Study|Disease progression|1|||
161475970|NCT01611155|583136285|FG001|Overall Study|Disease progression|0|||
161475971|NCT01611155|583136284|FG000|Overall Study|Withdrawal by Subject|1|||
161475972|NCT01611155|583136285|FG001|Overall Study|Withdrawal by Subject|0|||
161475973|NCT01611155|583136284|FG000|Overall Study|Alternative treatment|0|||
161475974|NCT01611155|583136285|FG001|Overall Study|Alternative treatment|1|||
161475975|NCT01611155|583136284|FG000|Overall Study|Ineligible patient|0|||
161475976|NCT01611155|583136285|FG001|Overall Study|Ineligible patient|1|||
161475977|NCT01681472|583136288|FG000|Overall Study|Adverse Event|0|||
161475978|NCT01681472|583136289|FG001|Overall Study|Adverse Event|1|||
161475979|NCT01681472|583136290|FG002|Overall Study|Adverse Event|0|||
161475980|NCT01681472|583136291|FG003|Overall Study|Adverse Event|0|||
161475981|NCT01696071|583136304|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
161475982|NCT01696071|583136305|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
161475983|NCT00678080|583136309|FG000|Overall Study|Physician Decision|2|||
161475984|NCT00678080|583136310|FG001|Overall Study|Physician Decision|0|||
161475985|NCT00678080|583136309|FG000|Overall Study|Lost to Follow-up|1|||
161475986|NCT00678080|583136310|FG001|Overall Study|Lost to Follow-up|0|||
161475987|NCT00678080|583136309|FG000|Overall Study|Withdrawal by Subject|0|||
161475988|NCT00678080|583136310|FG001|Overall Study|Withdrawal by Subject|1|||
161475989|NCT05136690|583136311|FG000|Period 1|Withdrawal by Subject|0|||
161475990|NCT05136690|583136312|FG001|Period 1|Withdrawal by Subject|1|||
161475991|NCT05136690|583136311|FG000|Period 2|Lost to Follow-up|0|||
161475992|NCT05136690|583136312|FG001|Period 2|Lost to Follow-up|3|||
161475993|NCT05136690|583136311|FG000|Period 2|Withdrawal by Subject|0|||
161475994|NCT05136690|583136312|FG001|Period 2|Withdrawal by Subject|1|||
161475995|NCT01453361|583136313|FG000|Overall Study|Disease Progression|6|||
161475996|NCT01453361|583136313|FG000|Overall Study|Screen-Failures|10|||
161475997|NCT01752985|583136314|FG000|Treatment Period|Subject request to discontinue treatment|1|||
161475998|NCT01752985|583136315|FG001|Treatment Period|Subject request to discontinue treatment|0|||
161475999|NCT01752985|583136316|FG002|Treatment Period|Subject request to discontinue treatment|1|||
161476000|NCT01752985|583136314|FG000|Treatment Period|Subject no longer meets study criteria|0|||
161476001|NCT01752985|583136315|FG001|Treatment Period|Subject no longer meets study criteria|1|||
161476002|NCT01752985|583136316|FG002|Treatment Period|Subject no longer meets study criteria|1|||
161476003|NCT01752985|583136314|FG000|Treatment Period|Adverse Event|2|||
161476004|NCT01752985|583136315|FG001|Treatment Period|Adverse Event|1|||
161476005|NCT01752985|583136316|FG002|Treatment Period|Adverse Event|2|||
161476006|NCT01752985|583136314|FG000|Treatment Period|Withdrawal by Subject|1|||
161476007|NCT01752985|583136315|FG001|Treatment Period|Withdrawal by Subject|1|||
161476008|NCT01752985|583136316|FG002|Treatment Period|Withdrawal by Subject|0|||
161476009|NCT01752985|583136314|FG000|Treatment Period|Lost to Follow-up|0|||
161476010|NCT01752985|583136315|FG001|Treatment Period|Lost to Follow-up|0|||
161476011|NCT01752985|583136316|FG002|Treatment Period|Lost to Follow-up|1|||
161476012|NCT02025621|583137469|FG000|Overall Study|Withdrawal by Subject|1|||
161476013|NCT02025621|583137470|FG001|Overall Study|Withdrawal by Subject|0|||
161476014|NCT02025621|583137469|FG000|Overall Study|Death|0|||
161476015|NCT02025621|583137470|FG001|Overall Study|Death|1|||
161476016|NCT02025621|583137469|FG000|Overall Study|No longer eligible|10|||
161476017|NCT02025621|583137470|FG001|Overall Study|No longer eligible|15|||
161476018|NCT02025621|583137469|FG000|Overall Study|Surgery initiated before infusion|3|||
161476019|NCT02025621|583137470|FG001|Overall Study|Surgery initiated before infusion|3|||
161476020|NCT00739674|583137471|FG000|Overall Study|Screening failures|19|||
161476021|NCT00739674|583137472|FG001|Overall Study|Screening failures|17|||
161476022|NCT00739674|583137471|FG000|Overall Study|Site 212 removal|19|||
161476023|NCT00739674|583137472|FG001|Overall Study|Site 212 removal|13|||
161476024|NCT00739674|583137471|FG000|Overall Study|No follow-up data|33|||
161476025|NCT00739674|583137472|FG001|Overall Study|No follow-up data|18|||
161476026|NCT00739674|583137471|FG000|Overall Study|Dietician consultation >30 days|1|||
161476027|NCT00739674|583137472|FG001|Overall Study|Dietician consultation >30 days|9|||
161476028|NCT00739674|583137471|FG000|Overall Study|Adverse Event|22|||
161476029|NCT00739674|583137472|FG001|Overall Study|Adverse Event|13|||
161476030|NCT00739674|583137471|FG000|Overall Study|Death|1|||
161476031|NCT00739674|583137472|FG001|Overall Study|Death|0|||
161476032|NCT00739674|583137471|FG000|Overall Study|Lack of Efficacy|1|||
161476033|NCT00739674|583137472|FG001|Overall Study|Lack of Efficacy|0|||
161476034|NCT00739674|583137471|FG000|Overall Study|Lost to Follow-up|52|||
161476035|NCT00739674|583137472|FG001|Overall Study|Lost to Follow-up|30|||
161476036|NCT00739674|583137471|FG000|Overall Study|Protocol Violation|5|||
161476037|NCT00739674|583137472|FG001|Overall Study|Protocol Violation|5|||
161476038|NCT00739674|583137471|FG000|Overall Study|Withdrawal by Subject|9|||
161476039|NCT00739674|583137472|FG001|Overall Study|Withdrawal by Subject|9|||
161476040|NCT00739674|583137471|FG000|Overall Study|Reason missing|2|||
161476041|NCT00739674|583137472|FG001|Overall Study|Reason missing|0|||
161476042|NCT00739674|583137471|FG000|Overall Study|Clinic closed|6|||
161476043|NCT00739674|583137472|FG001|Overall Study|Clinic closed|4|||
161476044|NCT00739674|583137471|FG000|Overall Study|Patient moved|3|||
161476045|NCT00739674|583137472|FG001|Overall Study|Patient moved|2|||
161476046|NCT00739674|583137471|FG000|Overall Study|Non compliant|4|||
161476047|NCT00739674|583137472|FG001|Overall Study|Non compliant|0|||
161476048|NCT00739674|583137471|FG000|Overall Study|Unable to attend visit|3|||
161476049|NCT00739674|583137472|FG001|Overall Study|Unable to attend visit|1|||
161476050|NCT00739674|583137471|FG000|Overall Study|Home monitoring off meds|1|||
161476051|NCT00739674|583137472|FG001|Overall Study|Home monitoring off meds|0|||
161476052|NCT00739674|583137471|FG000|Overall Study|Erectile dysfunction|0|||
161476053|NCT00739674|583137472|FG001|Overall Study|Erectile dysfunction|1|||
161476054|NCT01897454|583137473|FG000|Overall Study|Withdrawal by Subject|1|||
161476055|NCT02195583|583137475|FG000|Overall Study|Lost to Follow-up|1|||
161476056|NCT02195583|583137475|FG000|Overall Study|Withdrawal by Subject|4|||
161476057|NCT02195583|583137475|FG000|Overall Study|Adverse Event|2|||
161476058|NCT02195583|583137475|FG000|Overall Study|Other Reason|2|||
161476059|NCT01560403|583137476|FG000|Overall Study|Lost to Follow-up|0|||
161476060|NCT01560403|583137477|FG001|Overall Study|Lost to Follow-up|1|||
161476061|NCT00983437|583137479|FG000|Overall Study|Adverse Event|9|||
161476062|NCT00983437|583137479|FG000|Overall Study|Lack of Efficacy|1|||
161476063|NCT00983437|583137479|FG000|Overall Study|Withdrawal by Subject|8|||
161476064|NCT00983437|583137479|FG000|Overall Study|Noncompliance to Study Procedures|1|||
161476065|NCT00983437|583137479|FG000|Overall Study|Lost to Follow-up|2|||
161476066|NCT00983437|583137479|FG000|Overall Study|Other Reason|26|||
161476067|NCT04019288|583137480|FG000|Overall Study|Death|1|||
161476068|NCT04019288|583137481|FG001|Overall Study|Death|0|||
161476069|NCT04019288|583137482|FG002|Overall Study|Death|0|||
161476070|NCT00094172|583137484|FG000|Overall Study|Adverse Event|0|||
161476071|NCT00094172|583137485|FG001|Overall Study|Adverse Event|1|||
161476072|NCT00094172|583137484|FG000|Overall Study|Lost to Follow-up|2|||
161476073|NCT00094172|583137485|FG001|Overall Study|Lost to Follow-up|0|||
161476074|NCT00094172|583137484|FG000|Overall Study|Protocol Violation|0|||
161476075|NCT00094172|583137485|FG001|Overall Study|Protocol Violation|1|||
161476076|NCT00094172|583137484|FG000|Overall Study|Withdrawal by Subject|10|||
161476077|NCT00094172|583137485|FG001|Overall Study|Withdrawal by Subject|5|||
161476078|NCT00094172|583137484|FG000|Overall Study|Primary endpoint met.|1|||
161476079|NCT00094172|583137485|FG001|Overall Study|Primary endpoint met.|0|||
161476080|NCT00094172|583137484|FG000|Overall Study|Started other MS therapy due to disease|1|||
161476081|NCT00094172|583137485|FG001|Overall Study|Started other MS therapy due to disease|0|||
161476082|NCT01020981|583137488|FG000|Overall Study|Did not return mailed survey|74|||
161476083|NCT01020981|583137489|FG001|Overall Study|Did not return mailed survey|58|||
161476084|NCT01020981|583137488|FG000|Overall Study|Survey returned undeliverable|8|||
161476085|NCT01020981|583137489|FG001|Overall Study|Survey returned undeliverable|32|||
161476086|NCT01020981|583137488|FG000|Overall Study|Participant declined to complete survey|2|||
161476087|NCT01020981|583137489|FG001|Overall Study|Participant declined to complete survey|0|||
161578046|NCT00232180|583505102|FG000|Open Label Phase|Laboratory abnormality|0|||
161578047|NCT00232180|583505103|FG001|Open Label Phase|Laboratory abnormality|0|||
161578048|NCT00232180|583505104|FG002|Open Label Phase|Laboratory abnormality|10|||
161578049|NCT00232180|583505102|FG000|Open Label Phase|Randomized but not treated|0|||
161476088|NCT00289133|583137496|FG000|Overall Study|Non-study device implanted|12|||
161476089|NCT00289133|583137497|FG001|Overall Study|Non-study device implanted|0|||
161578050|NCT00232180|583505103|FG001|Open Label Phase|Randomized but not treated|0|||
161578051|NCT00232180|583505104|FG002|Open Label Phase|Randomized but not treated|1|||
161476090|NCT00289133|583137496|FG000|Overall Study|Protocol Violation|32|||
161476091|NCT00289133|583137497|FG001|Overall Study|Protocol Violation|38|||
161476092|NCT00289133|583137496|FG000|Overall Study|Withdrawal by Subject|9|||
161578052|NCT02748317|583505105|FG000|Overall Study|Withdrawal by Subject|14|||
161578053|NCT02748317|583505105|FG000|Overall Study|Lost to Follow-up|8|||
161476093|NCT00289133|583137497|FG001|Overall Study|Withdrawal by Subject|10|||
161683056|NCT00666458|583891220|FG001|Overall Study|Medical history of anemia|0|||
161476094|NCT00289133|583137496|FG000|Overall Study|Death|5|||
161476095|NCT00289133|583137497|FG001|Overall Study|Death|10|||
161476096|NCT00289133|583137496|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
161476097|NCT00289133|583137497|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
161476098|NCT00289133|583137496|FG000|Overall Study|Physician Decision|41|||
161476099|NCT00289133|583137497|FG001|Overall Study|Physician Decision|45|||
161476100|NCT00289133|583137496|FG000|Overall Study|Revision|8|||
161476101|NCT00289133|583137497|FG001|Overall Study|Revision|6|||
161578054|NCT02748317|583505105|FG000|Overall Study|Death|1|||
161815279|NCT01838681|584366939|FG002|Period A|Protocol Violation|0|||
161815280|NCT01838681|584366940|FG003|Period A|Protocol Violation|0|||
161476102|NCT00289133|583137496|FG000|Overall Study|Lost to Follow-up|92|||
161476103|NCT00289133|583137497|FG001|Overall Study|Lost to Follow-up|115|||
161476104|NCT03372096|583137499|FG000|Overall Study|Study Closed|8|||
161476105|NCT00040365|583137500|FG000|Overall Study|Death|1|||
161476106|NCT00040365|583137500|FG000|Overall Study|Progressive disease|7|||
161476107|NCT00040365|583137500|FG000|Overall Study|Lost to Follow-up|3|||
161476108|NCT00319553|583137505|FG000|Overall Study|Protocol Violation|1|||
161476109|NCT00319553|583137506|FG001|Overall Study|Protocol Violation|2|||
161476110|NCT00319553|583137505|FG000|Overall Study|Lost to Follow-up|2|||
161476111|NCT00319553|583137506|FG001|Overall Study|Lost to Follow-up|1|||
161476112|NCT00319553|583137505|FG000|Overall Study|Withdrawal by Subject|1|||
161476113|NCT00319553|583137506|FG001|Overall Study|Withdrawal by Subject|1|||
161476114|NCT03641339|583137509|FG000|Overall Study|Physician Decision|1|||
161476115|NCT03641339|583137510|FG001|Overall Study|Physician Decision|0|||
161476116|NCT03641339|583137511|FG002|Overall Study|Physician Decision|0|||
161476117|NCT03641339|583137512|FG003|Overall Study|Physician Decision|0|||
161476118|NCT03641339|583137513|FG004|Overall Study|Physician Decision|0|||
161476119|NCT03641339|583137514|FG005|Overall Study|Physician Decision|0|||
161476120|NCT03641339|583137509|FG000|Overall Study|Withdrawal by Subject|0|||
161476121|NCT03641339|583137510|FG001|Overall Study|Withdrawal by Subject|2|||
161476122|NCT03641339|583137511|FG002|Overall Study|Withdrawal by Subject|0|||
161476123|NCT03641339|583137512|FG003|Overall Study|Withdrawal by Subject|2|||
161476124|NCT03641339|583137513|FG004|Overall Study|Withdrawal by Subject|0|||
161476125|NCT03641339|583137514|FG005|Overall Study|Withdrawal by Subject|1|||
161476126|NCT02329080|583137515|FG000|Overall Study|Adverse Event|1|||
161476127|NCT02329080|583137515|FG000|Overall Study|Death|4|||
161476128|NCT02329080|583137515|FG000|Overall Study|Lack of Efficacy|22|||
161476129|NCT02329080|583137515|FG000|Overall Study|Lost to Follow-up|1|||
161476130|NCT02329080|583137515|FG000|Overall Study|Physician Decision|2|||
161476131|NCT02329080|583137515|FG000|Overall Study|Partial response|4|||
161476132|NCT02329080|583137515|FG000|Overall Study|Complete response|4|||
161476133|NCT00413244|583137517|FG000|Overall Study|Withdrawal by Subject|10|||
161476134|NCT00413244|583137518|FG001|Overall Study|Withdrawal by Subject|1|||
161476135|NCT02319837|583137521|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
161476136|NCT02319837|583137522|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
161476137|NCT02319837|583137523|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
161476138|NCT02319837|583137521|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
161476139|NCT02319837|583137522|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
161476140|NCT02319837|583137523|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
161476141|NCT02319837|583137521|FG000|Study Treatment Phase|Adverse Event|73|||
161476142|NCT02319837|583137522|FG001|Study Treatment Phase|Adverse Event|36|||
161476143|NCT02319837|583137523|FG002|Study Treatment Phase|Adverse Event|63|||
161476144|NCT02319837|583137521|FG000|Study Treatment Phase|Development of castration resistance|0|||
161476145|NCT02319837|583137522|FG001|Study Treatment Phase|Development of castration resistance|2|||
161476146|NCT02319837|583137523|FG002|Study Treatment Phase|Development of castration resistance|0|||
161476147|NCT02319837|583137521|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
161476148|NCT02319837|583137522|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
161476149|NCT02319837|583137523|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
161476150|NCT02319837|583137521|FG000|Study Treatment Phase|Protocol Violation|2|||
161476151|NCT02319837|583137522|FG001|Study Treatment Phase|Protocol Violation|2|||
161476152|NCT02319837|583137523|FG002|Study Treatment Phase|Protocol Violation|1|||
161578055|NCT00434304|583505106|FG000|Overall Study|Adverse Event|14|||
161578056|NCT00434304|583505106|FG000|Overall Study|Lack of Efficacy|2|||
161578057|NCT00434304|583505106|FG000|Overall Study|Withdrawal by Subject|4|||
161578058|NCT05262738|583505107|FG000|Overall Study|Withdrawal by Subject|1|||
161578059|NCT05262738|583505108|FG001|Overall Study|Withdrawal by Subject|0|||
161578060|NCT01424397|583505112|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578061|NCT01424397|583505113|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578062|NCT01424397|583505114|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
161578063|NCT01424397|583505115|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578064|NCT01424397|583505116|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578065|NCT01424397|583505117|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578066|NCT01424397|583505118|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578067|NCT01424397|583505119|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
161668485|NCT03285178|583839780|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161815281|NCT01838681|584366937|FG000|Period A|Non-compliance with IMP|6|||
161578068|NCT01424397|583505120|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
161476153|NCT02319837|583137521|FG000|Study Treatment Phase|Lost to Follow-up|0|||
161476154|NCT02319837|583137522|FG001|Study Treatment Phase|Lost to Follow-up|1|||
161476155|NCT02319837|583137523|FG002|Study Treatment Phase|Lost to Follow-up|0|||
161476156|NCT02319837|583137521|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
161578069|NCT01424397|583505121|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
161578070|NCT01424397|583505122|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
161476157|NCT02319837|583137522|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
161476158|NCT02319837|583137523|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
161476159|NCT02319837|583137521|FG000|Study Treatment Phase|Other|0|||
161476160|NCT02319837|583137522|FG001|Study Treatment Phase|Other|1|||
161476161|NCT02319837|583137523|FG002|Study Treatment Phase|Other|0|||
161476162|NCT02319837|583137521|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
161476163|NCT02319837|583137522|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
161476164|NCT02319837|583137523|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
161476165|NCT02319837|583137521|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
161476166|NCT02319837|583137522|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
161476167|NCT02319837|583137523|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
161476168|NCT02319837|583137521|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
161476169|NCT02319837|583137522|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
161476170|NCT02319837|583137523|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
161476171|NCT02319837|583137521|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
161476172|NCT02319837|583137522|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
161476173|NCT02319837|583137523|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
161476174|NCT02319837|583137521|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
161476175|NCT02319837|583137522|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
161476176|NCT02319837|583137523|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
161476177|NCT02319837|583137521|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
161476178|NCT02319837|583137522|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
161476179|NCT02319837|583137523|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
161476180|NCT02319837|583137521|FG000|Long-Term Follow-Up Phase|Death|33|||
161476181|NCT02319837|583137522|FG001|Long-Term Follow-Up Phase|Death|54|||
161476182|NCT02319837|583137523|FG002|Long-Term Follow-Up Phase|Death|42|||
161476183|NCT00839852|583137526|FG000|Overall Study|Adverse Event|10|||
161476184|NCT00839852|583137526|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161476185|NCT00839852|583137526|FG000|Overall Study|Protocol Violation|9|||
161476186|NCT00839852|583137526|FG000|Overall Study|Withdrawal of Consent|16|||
161476187|NCT00839852|583137526|FG000|Overall Study|Lost to Follow-up|7|||
161476188|NCT00839852|583137526|FG000|Overall Study|Lack of Compliance While in Jail|1|||
161476189|NCT00839852|583137526|FG000|Overall Study|Pregnancy|1|||
161476190|NCT03082261|583137527|FG000|Overall Study|Death|4|||
161476191|NCT03082261|583137527|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
161476192|NCT03082261|583137527|FG000|Overall Study|Insurance denial|1|||
161476193|NCT03082261|583137527|FG000|Overall Study|Peripheral lead added|1|||
161476194|NCT03082261|583137527|FG000|Overall Study|Withdrawal by Subject|40|||
161476195|NCT03082261|583137527|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
161476196|NCT03082261|583137527|FG000|Overall Study|Subject implanted with device other than study device|1|||
161476197|NCT03082261|583137527|FG000|Overall Study|Lost to Follow-up|14|||
161476198|NCT03082261|583137527|FG000|Overall Study|Subject moved to a different state|1|||
161476199|NCT03082261|583137527|FG000|Overall Study|Subject non-compliance|2|||
161476200|NCT03082261|583137527|FG000|Overall Study|Subject participation terminated by investigator|9|||
161476201|NCT03082261|583137527|FG000|Overall Study|Subject participation terminated by sponsor|4|||
161476202|NCT03082261|583137527|FG000|Overall Study|System explant|19|||
161476203|NCT03082261|583137527|FG000|Overall Study|Unable to place lead(s)|2|||
161476204|NCT03082261|583137527|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
161476205|NCT01313312|583137531|FG000|Overall Study|Adverse Event|5|||
161476206|NCT01313312|583137531|FG000|Overall Study|Withdrawal by Subject|18|||
161476207|NCT01313312|583137531|FG000|Overall Study|Lack of Efficacy|3|||
161476208|NCT01313312|583137531|FG000|Overall Study|Investigator Decision|1|||
161476209|NCT01313312|583137531|FG000|Overall Study|Observational Phase|1|||
161476210|NCT01313312|583137531|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
161476211|NCT01313312|583137531|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
161476212|NCT01206166|583137539|FG000|Overall Study|No evaluable data|2|||
161476213|NCT01206166|583137540|FG001|Overall Study|No evaluable data|3|||
161476214|NCT02716805|583137541|FG000|Overall Study|Progressive disease|2|||
161476215|NCT02716805|583137542|FG001|Overall Study|Progressive disease|0|||
161476216|NCT02716805|583137543|FG002|Overall Study|Progressive disease|0|||
161476217|NCT02716805|583137544|FG003|Overall Study|Progressive disease|0|||
161476218|NCT00066365|583137545|FG000|Overall Study|Adverse Event|1|||
161476219|NCT00066365|583137546|FG001|Overall Study|Adverse Event|0|||
161476220|NCT00066365|583137545|FG000|Overall Study|Lack of Efficacy|15|||
161476221|NCT00066365|583137546|FG001|Overall Study|Lack of Efficacy|12|||
161476222|NCT00066365|583137545|FG000|Overall Study|Physician Decision|1|||
161476223|NCT00066365|583137546|FG001|Overall Study|Physician Decision|0|||
161476224|NCT00066365|583137545|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
161476225|NCT00066365|583137546|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
161476226|NCT00066365|583137545|FG000|Overall Study|Ineligible|4|||
161476227|NCT00066365|583137546|FG001|Overall Study|Ineligible|2|||
161476228|NCT00467857|583137549|FG000|Overall Study|Adverse Event|1|||
161476229|NCT00467857|583137550|FG001|Overall Study|Adverse Event|0|||
161476230|NCT00467857|583137549|FG000|Overall Study|Withdrew consent|2|||
161476231|NCT00467857|583137550|FG001|Overall Study|Withdrew consent|0|||
161476232|NCT00467857|583137549|FG000|Overall Study|Death|0|||
161476233|NCT00467857|583137550|FG001|Overall Study|Death|1|||
161476234|NCT00467857|583137549|FG000|Overall Study|Discharged from court service|0|||
161476235|NCT00467857|583137550|FG001|Overall Study|Discharged from court service|1|||
161476236|NCT00467857|583137549|FG000|Overall Study|Emergency care required|0|||
161476237|NCT00467857|583137550|FG001|Overall Study|Emergency care required|1|||
161476238|NCT00467857|583137549|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
161476239|NCT00467857|583137550|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
161476240|NCT00467857|583137549|FG000|Overall Study|Discontinuation reason missing|0|||
161476241|NCT00467857|583137550|FG001|Overall Study|Discontinuation reason missing|3|||
161476242|NCT01443078|583137555|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
161476243|NCT01443078|583137555|FG000|Overall Study|Withdrawal by Subject|1|||
161476244|NCT01443078|583137555|FG000|Overall Study|Patient had brain mets|1|||
161476245|NCT01390649|583137556|FG000|Overall Study|Physician Decision|1|||
161476246|NCT00415168|583137557|FG000|Overall Study|Death|26|||
161476247|NCT00415168|583137557|FG000|Overall Study|Lost to Follow-up|3|||
161476248|NCT00415168|583137557|FG000|Overall Study|Physician Decision|13|||
161476249|NCT00415168|583137557|FG000|Overall Study|Sponsor Decision|4|||
161476250|NCT00415168|583137557|FG000|Overall Study|Withdrawal by Subject|6|||
161476251|NCT02628938|583137558|FG000|Overall Study|Did not attend the follow up recall|2|||
161476252|NCT02628938|583137559|FG001|Overall Study|Did not attend the follow up recall|2|||
161476253|NCT02628938|583137560|FG002|Overall Study|Did not attend the follow up recall|1|||
161476254|NCT02628938|583137558|FG000|Overall Study|Failure to comply with the instructions|3|||
161476255|NCT02628938|583137559|FG001|Overall Study|Failure to comply with the instructions|0|||
161476256|NCT02628938|583137560|FG002|Overall Study|Failure to comply with the instructions|3|||
161476257|NCT02058693|583137561|FG000|Phase 1|Withdrawal by Subject|3|||
161476258|NCT02058693|583137562|FG001|Phase 1|Withdrawal by Subject|2|||
161476259|NCT02058693|583137561|FG000|Phase 1|Adverse Event|0|||
161476260|NCT02058693|583137562|FG001|Phase 1|Adverse Event|1|||
161476261|NCT02058693|583137561|FG000|Phase 1|Lack of Efficacy|1|||
161476262|NCT02058693|583137562|FG001|Phase 1|Lack of Efficacy|0|||
161476263|NCT02058693|583137561|FG000|Phase 1|Physician Decision|1|||
161476264|NCT02058693|583137562|FG001|Phase 1|Physician Decision|1|||
161476265|NCT02058693|583137561|FG000|Phase 2|Withdrawal by Subject|0|||
161476266|NCT02058693|583137562|FG001|Phase 2|Withdrawal by Subject|2|||
161476267|NCT00241358|583137563|FG000|Overall Study|Determined to be not ineligible|0|||
161476268|NCT00241358|583137564|FG001|Overall Study|Determined to be not ineligible|1|||
161476269|NCT00241358|583137565|FG002|Overall Study|Determined to be not ineligible|1|||
161476270|NCT03855228|583137566|FG000|Overall Study|Adverse Event|2|||
161476271|NCT03855228|583137567|FG001|Overall Study|Adverse Event|4|||
161476272|NCT03855228|583137568|FG002|Overall Study|Adverse Event|4|||
161476273|NCT03855228|583137569|FG003|Overall Study|Adverse Event|8|||
161476274|NCT03855228|583137566|FG000|Overall Study|Treatment Failure|1|||
161476275|NCT03855228|583137567|FG001|Overall Study|Treatment Failure|2|||
161476276|NCT03855228|583137568|FG002|Overall Study|Treatment Failure|1|||
161476277|NCT03855228|583137569|FG003|Overall Study|Treatment Failure|8|||
161476278|NCT03855228|583137566|FG000|Overall Study|Lost to Follow-up|0|||
161476279|NCT03855228|583137567|FG001|Overall Study|Lost to Follow-up|0|||
161476280|NCT03855228|583137568|FG002|Overall Study|Lost to Follow-up|0|||
161476281|NCT03855228|583137569|FG003|Overall Study|Lost to Follow-up|1|||
161476282|NCT03855228|583137566|FG000|Overall Study|Protocol Violation|0|||
161476283|NCT03855228|583137567|FG001|Overall Study|Protocol Violation|1|||
161476284|NCT03855228|583137568|FG002|Overall Study|Protocol Violation|2|||
161476285|NCT03855228|583137569|FG003|Overall Study|Protocol Violation|1|||
161476286|NCT03855228|583137566|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
161476287|NCT03855228|583137567|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
161476288|NCT03855228|583137568|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
161476289|NCT03855228|583137569|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
161476290|NCT00590135|583137570|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
161476291|NCT00190671|583137571|FG000|Overall Study|Satisfactory Response|4|||
161476292|NCT00190671|583137572|FG001|Overall Study|Satisfactory Response|7|||
161476293|NCT00190671|583137571|FG000|Overall Study|Lack of Efficacy|19|||
161476294|NCT00190671|583137572|FG001|Overall Study|Lack of Efficacy|24|||
161476295|NCT00190671|583137571|FG000|Overall Study|Death from Study Disease|1|||
161476296|NCT00190671|583137572|FG001|Overall Study|Death from Study Disease|1|||
161476297|NCT00190671|583137571|FG000|Overall Study|Adverse Event|3|||
161476298|NCT00190671|583137572|FG001|Overall Study|Adverse Event|2|||
161476299|NCT00190671|583137571|FG000|Overall Study|Clinical Relapse|0|||
161476300|NCT00190671|583137572|FG001|Overall Study|Clinical Relapse|1|||
161476301|NCT00190671|583137571|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
161476302|NCT00190671|583137572|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
161476303|NCT00190671|583137571|FG000|Overall Study|Death from Other Causes|0|||
161476304|NCT00190671|583137572|FG001|Overall Study|Death from Other Causes|2|||
161476305|NCT00190671|583137571|FG000|Overall Study|Protocol Violation|0|||
161476306|NCT00190671|583137572|FG001|Overall Study|Protocol Violation|1|||
161476307|NCT00190671|583137571|FG000|Overall Study|Withdrawal by Subject|0|||
161476308|NCT00190671|583137572|FG001|Overall Study|Withdrawal by Subject|2|||
161476309|NCT00967668|583139035|FG000|Overall Study|Withdrawal by Subject|13|||
161476310|NCT00967668|583139036|FG001|Overall Study|Withdrawal by Subject|8|||
161476311|NCT00967668|583139037|FG002|Overall Study|Withdrawal by Subject|8|||
161476312|NCT00967668|583139035|FG000|Overall Study|Death|0|||
161476313|NCT00967668|583139036|FG001|Overall Study|Death|2|||
161476314|NCT00967668|583139037|FG002|Overall Study|Death|4|||
161476315|NCT00967668|583139035|FG000|Overall Study|Removed due to behavior|1|||
161476316|NCT00967668|583139036|FG001|Overall Study|Removed due to behavior|1|||
161476317|NCT00967668|583139037|FG002|Overall Study|Removed due to behavior|2|||
161476318|NCT00967668|583139035|FG000|Overall Study|Refused Year 2|11|||
161476319|NCT00967668|583139036|FG001|Overall Study|Refused Year 2|6|||
161476320|NCT00967668|583139037|FG002|Overall Study|Refused Year 2|4|||
161476321|NCT00967668|583139035|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
161476322|NCT00967668|583139036|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
161476323|NCT00967668|583139037|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
161476324|NCT00967668|583139035|FG000|Overall Study|Lost to Follow-up|15|||
161476325|NCT00967668|583139036|FG001|Overall Study|Lost to Follow-up|9|||
161476326|NCT00967668|583139037|FG002|Overall Study|Lost to Follow-up|16|||
161476327|NCT00967668|583139035|FG000|Overall Study|Refused 12-mo assessment|3|||
161476328|NCT00967668|583139036|FG001|Overall Study|Refused 12-mo assessment|1|||
161476329|NCT00967668|583139037|FG002|Overall Study|Refused 12-mo assessment|9|||
161476330|NCT00967668|583139035|FG000|Overall Study|Pregnancy|1|||
161476331|NCT00967668|583139036|FG001|Overall Study|Pregnancy|0|||
161476332|NCT00967668|583139037|FG002|Overall Study|Pregnancy|0|||
161476333|NCT00825682|583139038|FG000|Overall Study|personal reasons/ inconvenience|13|||
161476334|NCT00825682|583139039|FG001|Overall Study|personal reasons/ inconvenience|5|||
161476335|NCT02400333|583139042|FG000|Overall Study|Withdrawal by Subject|0|||
161476336|NCT02400333|583139043|FG001|Overall Study|Withdrawal by Subject|1|||
161476337|NCT02400333|583139044|FG002|Overall Study|Withdrawal by Subject|0|||
161476338|NCT02400333|583139045|FG003|Overall Study|Withdrawal by Subject|1|||
161476339|NCT02400333|583139042|FG000|Overall Study|Protocol Violation|1|||
161476340|NCT02400333|583139043|FG001|Overall Study|Protocol Violation|0|||
161476341|NCT02400333|583139044|FG002|Overall Study|Protocol Violation|2|||
161476342|NCT02400333|583139045|FG003|Overall Study|Protocol Violation|1|||
161476343|NCT02468674|583139046|FG000|Overall Study|Adverse Event|0|||
161476344|NCT02468674|583139047|FG001|Overall Study|Adverse Event|0|||
161476345|NCT02468674|583139048|FG002|Overall Study|Adverse Event|0|||
161476346|NCT02468674|583139049|FG003|Overall Study|Adverse Event|1|||
161476347|NCT02468674|583139050|FG004|Overall Study|Adverse Event|0|||
161476348|NCT02468674|583139051|FG005|Overall Study|Adverse Event|1|||
161476349|NCT02468674|583139052|FG006|Overall Study|Adverse Event|0|||
161476350|NCT02468674|583139053|FG007|Overall Study|Adverse Event|0|||
161476351|NCT02468674|583139054|FG008|Overall Study|Adverse Event|0|||
161476352|NCT02468674|583139046|FG000|Overall Study|Lost to Follow-up|1|||
161476353|NCT02468674|583139047|FG001|Overall Study|Lost to Follow-up|0|||
161476354|NCT02468674|583139048|FG002|Overall Study|Lost to Follow-up|0|||
161476355|NCT02468674|583139049|FG003|Overall Study|Lost to Follow-up|0|||
161476356|NCT02468674|583139050|FG004|Overall Study|Lost to Follow-up|0|||
161476357|NCT02468674|583139051|FG005|Overall Study|Lost to Follow-up|0|||
161476358|NCT02468674|583139052|FG006|Overall Study|Lost to Follow-up|0|||
161476359|NCT02468674|583139053|FG007|Overall Study|Lost to Follow-up|1|||
161476360|NCT02468674|583139054|FG008|Overall Study|Lost to Follow-up|1|||
161476361|NCT02468674|583139046|FG000|Overall Study|Physician Decision|0|||
161476362|NCT02468674|583139047|FG001|Overall Study|Physician Decision|0|||
161476363|NCT02468674|583139048|FG002|Overall Study|Physician Decision|0|||
161578071|NCT01424397|583505123|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
161476364|NCT02468674|583139049|FG003|Overall Study|Physician Decision|0|||
161476365|NCT02468674|583139050|FG004|Overall Study|Physician Decision|0|||
161815282|NCT01838681|584366938|FG001|Period A|Non-compliance with IMP|0|||
161476366|NCT02468674|583139051|FG005|Overall Study|Physician Decision|0|||
161476367|NCT02468674|583139052|FG006|Overall Study|Physician Decision|1|||
161476368|NCT02468674|583139053|FG007|Overall Study|Physician Decision|0|||
161476369|NCT02468674|583139054|FG008|Overall Study|Physician Decision|0|||
161815283|NCT01838681|584366939|FG002|Period A|Non-compliance with IMP|0|||
161476370|NCT02468674|583139046|FG000|Overall Study|Patient/Guardian Decision|0|||
161476371|NCT02468674|583139047|FG001|Overall Study|Patient/Guardian Decision|0|||
161476372|NCT02468674|583139048|FG002|Overall Study|Patient/Guardian Decision|0|||
161476373|NCT02468674|583139049|FG003|Overall Study|Patient/Guardian Decision|0|||
161476374|NCT02468674|583139050|FG004|Overall Study|Patient/Guardian Decision|1|||
161476375|NCT02468674|583139051|FG005|Overall Study|Patient/Guardian Decision|0|||
161578072|NCT01149369|583505124|FG000|Overall Study|Adverse Event|6|||
161476376|NCT02468674|583139052|FG006|Overall Study|Patient/Guardian Decision|0|||
161476377|NCT02468674|583139053|FG007|Overall Study|Patient/Guardian Decision|2|||
161476378|NCT02468674|583139054|FG008|Overall Study|Patient/Guardian Decision|1|||
161476379|NCT02468674|583139046|FG000|Overall Study|Protocol Deviation|0|||
161476380|NCT02468674|583139047|FG001|Overall Study|Protocol Deviation|0|||
161476381|NCT02468674|583139048|FG002|Overall Study|Protocol Deviation|0|||
161476382|NCT02468674|583139049|FG003|Overall Study|Protocol Deviation|0|||
161476383|NCT02468674|583139050|FG004|Overall Study|Protocol Deviation|0|||
161476384|NCT02468674|583139051|FG005|Overall Study|Protocol Deviation|0|||
161476385|NCT02468674|583139052|FG006|Overall Study|Protocol Deviation|0|||
161815284|NCT01838681|584366940|FG003|Period A|Non-compliance with IMP|0|||
161815285|NCT01838681|584366937|FG000|Period A|Lost to Follow-up|4|||
161476386|NCT02468674|583139053|FG007|Overall Study|Protocol Deviation|1|||
161476387|NCT02468674|583139054|FG008|Overall Study|Protocol Deviation|1|||
161476388|NCT03281577|583139060|FG000|Overall Study|Adverse Event|0|||
161476389|NCT03281577|583139061|FG001|Overall Study|Adverse Event|0|||
161476390|NCT03281577|583139062|FG002|Overall Study|Adverse Event|0|||
161476391|NCT03281577|583139063|FG003|Overall Study|Adverse Event|1|||
161476392|NCT03281577|583139060|FG000|Overall Study|Withdrawal by Subject|1|||
161476393|NCT03281577|583139061|FG001|Overall Study|Withdrawal by Subject|0|||
161476394|NCT03281577|583139062|FG002|Overall Study|Withdrawal by Subject|0|||
161476395|NCT03281577|583139063|FG003|Overall Study|Withdrawal by Subject|0|||
161476396|NCT01644565|583139066|FG000|Overall Study|Undisclosed Medical History|1|||
161476397|NCT01644565|583139067|FG001|Overall Study|Undisclosed Medical History|0|||
161476398|NCT01644565|583139068|FG002|Overall Study|Undisclosed Medical History|0|||
161476399|NCT01644565|583139069|FG003|Overall Study|Undisclosed Medical History|0|||
161476400|NCT01644565|583139070|FG004|Overall Study|Undisclosed Medical History|0|||
161476401|NCT01644565|583139071|FG005|Overall Study|Undisclosed Medical History|0|||
161476402|NCT01644565|583139072|FG006|Overall Study|Undisclosed Medical History|0|||
161476403|NCT01644565|583139073|FG007|Overall Study|Undisclosed Medical History|0|||
161476404|NCT01644565|583139074|FG008|Overall Study|Undisclosed Medical History|0|||
161476405|NCT01644565|583139066|FG000|Overall Study|Lost to Follow-up|0|||
161476406|NCT01644565|583139067|FG001|Overall Study|Lost to Follow-up|0|||
161476407|NCT01644565|583139068|FG002|Overall Study|Lost to Follow-up|0|||
161476408|NCT01644565|583139069|FG003|Overall Study|Lost to Follow-up|1|||
161476409|NCT01644565|583139070|FG004|Overall Study|Lost to Follow-up|0|||
161476410|NCT01644565|583139071|FG005|Overall Study|Lost to Follow-up|0|||
161476411|NCT01644565|583139072|FG006|Overall Study|Lost to Follow-up|0|||
161476412|NCT01644565|583139073|FG007|Overall Study|Lost to Follow-up|2|||
161476413|NCT01644565|583139074|FG008|Overall Study|Lost to Follow-up|0|||
161476414|NCT01644565|583139066|FG000|Overall Study|Family emergency|0|||
161476415|NCT01644565|583139067|FG001|Overall Study|Family emergency|0|||
161476416|NCT01644565|583139068|FG002|Overall Study|Family emergency|0|||
161476417|NCT01644565|583139069|FG003|Overall Study|Family emergency|0|||
161476418|NCT01644565|583139070|FG004|Overall Study|Family emergency|1|||
161476419|NCT01644565|583139071|FG005|Overall Study|Family emergency|0|||
161476420|NCT01644565|583139072|FG006|Overall Study|Family emergency|0|||
161476421|NCT01644565|583139073|FG007|Overall Study|Family emergency|0|||
161476422|NCT01644565|583139074|FG008|Overall Study|Family emergency|0|||
161476423|NCT01644565|583139066|FG000|Overall Study|Relocation|0|||
161476424|NCT01644565|583139067|FG001|Overall Study|Relocation|0|||
161476425|NCT01644565|583139068|FG002|Overall Study|Relocation|0|||
161476426|NCT01644565|583139069|FG003|Overall Study|Relocation|0|||
161476427|NCT01644565|583139070|FG004|Overall Study|Relocation|0|||
161476428|NCT01644565|583139071|FG005|Overall Study|Relocation|0|||
161476429|NCT01644565|583139072|FG006|Overall Study|Relocation|0|||
161476430|NCT01644565|583139073|FG007|Overall Study|Relocation|0|||
161476431|NCT01644565|583139074|FG008|Overall Study|Relocation|1|||
161476432|NCT01687998|583139075|FG000|Overall Study|Withdrawal by Subject|49|||
161476433|NCT01687998|583139076|FG001|Overall Study|Withdrawal by Subject|51|||
161476434|NCT01687998|583139075|FG000|Overall Study|Known to be Alive at Study End|54|||
161476435|NCT01687998|583139076|FG001|Overall Study|Known to be Alive at Study End|62|||
161476436|NCT01687998|583139075|FG000|Overall Study|Lost to Follow-up|9|||
161476437|NCT01687998|583139076|FG001|Overall Study|Lost to Follow-up|7|||
161476438|NCT00443261|583139079|FG000|Overall Study|Death|1|||
161476439|NCT01663532|583139080|FG000|Overall Study|Lost to Follow-up|9|||
161476440|NCT01663532|583139081|FG001|Overall Study|Lost to Follow-up|10|||
161476441|NCT01663532|583139080|FG000|Overall Study|Adverse Event|7|||
161476442|NCT01663532|583139081|FG001|Overall Study|Adverse Event|13|||
161476443|NCT01663532|583139080|FG000|Overall Study|Met Withdrawal Criteria|7|||
161476444|NCT01663532|583139081|FG001|Overall Study|Met Withdrawal Criteria|6|||
161578073|NCT01149369|583505125|FG001|Overall Study|Adverse Event|3|||
161815286|NCT01838681|584366938|FG001|Period A|Lost to Follow-up|0|||
161476445|NCT01663532|583139080|FG000|Overall Study|Physician Decision|1|||
161476446|NCT01663532|583139081|FG001|Overall Study|Physician Decision|1|||
161476447|NCT01663532|583139080|FG000|Overall Study|Withdrawal by Subject|35|||
161476448|NCT01663532|583139081|FG001|Overall Study|Withdrawal by Subject|17|||
161476449|NCT01663532|583139080|FG000|Overall Study|Lack of Efficacy|15|||
161476450|NCT01663532|583139081|FG001|Overall Study|Lack of Efficacy|60|||
161578074|NCT02767765|583505126|FG000|Overall Study|Adverse Event|4|||
161476451|NCT01871532|583139087|FG000|Overall Study|Withdrawal by Subject|1|||
161476452|NCT01871532|583139088|FG001|Overall Study|Withdrawal by Subject|2|||
161476453|NCT00283400|583139089|FG000|Overall Study|Withdrawal by Subject|1|||
161476454|NCT00283400|583139090|FG001|Overall Study|Withdrawal by Subject|1|||
161476455|NCT00283400|583139091|FG002|Overall Study|Withdrawal by Subject|0|||
161476456|NCT00283400|583139092|FG003|Overall Study|Withdrawal by Subject|0|||
161476457|NCT00283400|583139089|FG000|Overall Study|Death|1|||
161476458|NCT00283400|583139090|FG001|Overall Study|Death|0|||
161476459|NCT00283400|583139091|FG002|Overall Study|Death|1|||
161476460|NCT00283400|583139092|FG003|Overall Study|Death|0|||
161476461|NCT00934089|583139096|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
161476462|NCT00934089|583139097|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
161476463|NCT00934089|583139096|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
161476464|NCT00934089|583139097|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
161476465|NCT00680017|583139098|FG000|Overall Study|Adverse Event|13|||
161476466|NCT00680017|583139099|FG001|Overall Study|Adverse Event|7|||
161476467|NCT00680017|583139098|FG000|Overall Study|Withdrawal by Subject|2|||
161476468|NCT00680017|583139099|FG001|Overall Study|Withdrawal by Subject|5|||
161476469|NCT00680017|583139098|FG000|Overall Study|Lost to Follow-up|2|||
161476470|NCT00680017|583139099|FG001|Overall Study|Lost to Follow-up|0|||
161476471|NCT01434667|583139100|FG000|Overall Study|Lost to Follow-up|5|||
161476472|NCT01434667|583139101|FG001|Overall Study|Lost to Follow-up|10|||
161476473|NCT02034110|583139104|FG000|Overall Study|Physician Decision|0|||
161476474|NCT02034110|583139105|FG001|Overall Study|Physician Decision|0|||
161476475|NCT02034110|583139106|FG002|Overall Study|Physician Decision|0|||
161476476|NCT02034110|583139107|FG003|Overall Study|Physician Decision|0|||
161476477|NCT02034110|583139108|FG004|Overall Study|Physician Decision|2|||
161476478|NCT02034110|583139109|FG005|Overall Study|Physician Decision|0|||
161476479|NCT02034110|583139110|FG006|Overall Study|Physician Decision|1|||
161476480|NCT02034110|583139111|FG007|Overall Study|Physician Decision|0|||
161476481|NCT02034110|583139104|FG000|Overall Study|Lost to Follow-up|1|||
161476482|NCT02034110|583139105|FG001|Overall Study|Lost to Follow-up|0|||
161476483|NCT02034110|583139106|FG002|Overall Study|Lost to Follow-up|0|||
161476484|NCT02034110|583139107|FG003|Overall Study|Lost to Follow-up|0|||
161476485|NCT02034110|583139108|FG004|Overall Study|Lost to Follow-up|1|||
161476486|NCT02034110|583139109|FG005|Overall Study|Lost to Follow-up|0|||
161476487|NCT02034110|583139110|FG006|Overall Study|Lost to Follow-up|1|||
161476488|NCT02034110|583139111|FG007|Overall Study|Lost to Follow-up|0|||
161476489|NCT02034110|583139104|FG000|Overall Study|Withdrawal by Subject|5|||
161476490|NCT02034110|583139105|FG001|Overall Study|Withdrawal by Subject|7|||
161476491|NCT02034110|583139106|FG002|Overall Study|Withdrawal by Subject|0|||
161476492|NCT02034110|583139107|FG003|Overall Study|Withdrawal by Subject|3|||
161476493|NCT02034110|583139108|FG004|Overall Study|Withdrawal by Subject|7|||
161476494|NCT02034110|583139109|FG005|Overall Study|Withdrawal by Subject|0|||
161476495|NCT02034110|583139110|FG006|Overall Study|Withdrawal by Subject|3|||
161476496|NCT02034110|583139111|FG007|Overall Study|Withdrawal by Subject|1|||
161476497|NCT02034110|583139104|FG000|Overall Study|Study closed by sponsor|6|||
161476498|NCT02034110|583139105|FG001|Overall Study|Study closed by sponsor|2|||
161476499|NCT02034110|583139106|FG002|Overall Study|Study closed by sponsor|0|||
161476500|NCT02034110|583139107|FG003|Overall Study|Study closed by sponsor|6|||
161476501|NCT02034110|583139108|FG004|Overall Study|Study closed by sponsor|7|||
161476502|NCT02034110|583139109|FG005|Overall Study|Study closed by sponsor|0|||
161476503|NCT02034110|583139110|FG006|Overall Study|Study closed by sponsor|42|||
161476504|NCT02034110|583139111|FG007|Overall Study|Study closed by sponsor|0|||
161476505|NCT00064337|583139112|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
161476506|NCT00064337|583139112|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
161476507|NCT00064337|583139112|FG000|PBSCC or Induction/PBSCC|Progression|3|||
161476508|NCT00064337|583139112|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
161476509|NCT00064337|583139112|FG000|PBSCC or Induction/PBSCC|Death|2|||
161476510|NCT00064337|583139112|FG000|Transplant|Adverse Event|9|||
161476511|NCT00064337|583139112|FG000|Transplant|Not protocol-specified|5|||
161476512|NCT00064337|583139112|FG000|Transplant|Death|3|||
161476513|NCT00064337|583139112|FG000|Transplant|Patient Refusal|2|||
161476514|NCT00064337|583139112|FG000|Transplant|Progression|2|||
161476515|NCT00064337|583139112|FG000|Maintenance|Adverse Event|3|||
161476516|NCT00064337|583139112|FG000|Maintenance|Progression|2|||
161476517|NCT00064337|583139112|FG000|Maintenance|On treatment at time of analysis|2|||
161476518|NCT00064337|583139112|FG000|Maintenance|Not protocol-specified|2|||
161476519|NCT00064337|583139112|FG000|Maintenance|Death|1|||
161476520|NCT02279420|583139113|FG000|Overall Study|Lost to Follow-up|23|||
161476521|NCT03535844|583139116|FG000|Overall Study|Withdrawal by Subject|0|||
161476522|NCT03535844|583139117|FG001|Overall Study|Withdrawal by Subject|1|||
161476523|NCT00612040|583139118|FG000|Overall Study|Adverse Event|0|||
161476524|NCT00612040|583139119|FG001|Overall Study|Adverse Event|2|||
161476525|NCT00612040|583139120|FG002|Overall Study|Adverse Event|1|||
161476526|NCT00612040|583139118|FG000|Overall Study|Protocol Violation|1|||
161476527|NCT00612040|583139119|FG001|Overall Study|Protocol Violation|2|||
161476528|NCT00612040|583139120|FG002|Overall Study|Protocol Violation|1|||
161476529|NCT00612040|583139118|FG000|Overall Study|Lack of Efficacy|2|||
161476530|NCT00612040|583139119|FG001|Overall Study|Lack of Efficacy|1|||
161476531|NCT00612040|583139120|FG002|Overall Study|Lack of Efficacy|0|||
161476532|NCT00612040|583139118|FG000|Overall Study|Unclassified|2|||
161476533|NCT00612040|583139119|FG001|Overall Study|Unclassified|2|||
161476534|NCT00612040|583139120|FG002|Overall Study|Unclassified|5|||
161476535|NCT00297830|583139121|FG000|6 Month Visit|Death|1|||
161476536|NCT00297830|583139122|FG001|6 Month Visit|Death|0|||
161476537|NCT00297830|583139123|FG002|6 Month Visit|Death|2|||
161476538|NCT00297830|583139121|FG000|6 Month Visit|Withdrawal by Subject|2|||
161476539|NCT00297830|583139122|FG001|6 Month Visit|Withdrawal by Subject|1|||
161476540|NCT00297830|583139123|FG002|6 Month Visit|Withdrawal by Subject|1|||
161476541|NCT00297830|583139121|FG000|6 Month Visit|Adverse Event|0|||
161476542|NCT00297830|583139122|FG001|6 Month Visit|Adverse Event|1|||
161476543|NCT00297830|583139123|FG002|6 Month Visit|Adverse Event|0|||
161476544|NCT00297830|583139121|FG000|12 Month Visit|Lost to Follow-up|1|||
161476545|NCT00297830|583139122|FG001|12 Month Visit|Lost to Follow-up|0|||
161476546|NCT00297830|583139123|FG002|12 Month Visit|Lost to Follow-up|0|||
161476547|NCT00297830|583139121|FG000|12 Month Visit|Adverse Event|0|||
161476548|NCT00297830|583139122|FG001|12 Month Visit|Adverse Event|3|||
161476549|NCT00297830|583139123|FG002|12 Month Visit|Adverse Event|0|||
161476550|NCT00297830|583139121|FG000|12 Month Visit|Withdrawal by Subject|0|||
161476551|NCT00297830|583139122|FG001|12 Month Visit|Withdrawal by Subject|3|||
161476552|NCT00297830|583139123|FG002|12 Month Visit|Withdrawal by Subject|0|||
161476553|NCT02835820|583139124|FG000|Overall Study|Baseline Screen Failure|0|||
161476554|NCT02835820|583139125|FG001|Overall Study|Baseline Screen Failure|3|||
161476555|NCT00827502|583139126|FG000|Overall Study|randomized but not treated|11|||
161476556|NCT00827502|583139126|FG000|Overall Study|Adverse Event|1|||
161476557|NCT00827502|583139126|FG000|Overall Study|Lost to Follow-up|4|||
161476558|NCT00827502|583139126|FG000|Overall Study|Withdrawal by Subject|5|||
161476559|NCT05096221|583139127|FG000|Part 2|Physician Decision|0|||
161476560|NCT05096221|583139128|FG001|Part 2|Physician Decision|1|||
161476561|NCT02478632|583139135|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
161476562|NCT02478632|583139136|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
161476563|NCT02478632|583139135|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
161476564|NCT02478632|583139136|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
161476565|NCT02478632|583139135|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
161476566|NCT02478632|583139136|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
161476567|NCT01867424|583139138|FG000|Overall Study|Patient noncompliance|2|||
161476568|NCT01867424|583139139|FG001|Overall Study|Patient noncompliance|1|||
161476569|NCT04645953|583139140|FG000|Overall Study|Lost to Follow-up|2|||
161476570|NCT04645953|583139141|FG001|Overall Study|Lost to Follow-up|1|||
161476571|NCT04645953|583139142|FG002|Overall Study|Lost to Follow-up|1|||
161476572|NCT04645953|583139140|FG000|Overall Study|Withdrawal by Subject|0|||
161476573|NCT04645953|583139141|FG001|Overall Study|Withdrawal by Subject|1|||
161476574|NCT04645953|583139142|FG002|Overall Study|Withdrawal by Subject|0|||
161476575|NCT04645953|583139140|FG000|Overall Study|Physician Decision|0|||
161476576|NCT04645953|583139141|FG001|Overall Study|Physician Decision|1|||
161476577|NCT04645953|583139142|FG002|Overall Study|Physician Decision|0|||
161476578|NCT04645953|583139140|FG000|Overall Study|Discontinued Prior to Dosing|0|||
161476579|NCT04645953|583139141|FG001|Overall Study|Discontinued Prior to Dosing|0|||
161476580|NCT04645953|583139142|FG002|Overall Study|Discontinued Prior to Dosing|2|||
161476581|NCT04613375|583139143|FG000|Overall Study|Death|198|||
161476582|NCT04613375|583139143|FG000|Overall Study|Withdrawal by Subject|3|||
161476583|NCT00434954|583139144|FG000|Overall Study|Adverse Event|17|||
161476584|NCT00434954|583139145|FG001|Overall Study|Adverse Event|2|||
161476585|NCT00434954|583139144|FG000|Overall Study|Entry criteria not met|14|||
161476586|NCT00434954|583139145|FG001|Overall Study|Entry criteria not met|16|||
161476587|NCT00434954|583139144|FG000|Overall Study|Lost to Follow-up|0|||
161476588|NCT00434954|583139145|FG001|Overall Study|Lost to Follow-up|1|||
161476589|NCT00434954|583139144|FG000|Overall Study|Physician Decision|6|||
161476590|NCT00434954|583139145|FG001|Overall Study|Physician Decision|3|||
161476591|NCT00434954|583139144|FG000|Overall Study|Protocol Violation|36|||
161476592|NCT00434954|583139145|FG001|Overall Study|Protocol Violation|27|||
161476593|NCT00434954|583139144|FG000|Overall Study|Sponsor decision|1|||
161578075|NCT02767765|583505126|FG000|Overall Study|Death|1|||
161476594|NCT00434954|583139145|FG001|Overall Study|Sponsor decision|0|||
161476595|NCT00434954|583139144|FG000|Overall Study|Subject decision|8|||
161476596|NCT00434954|583139145|FG001|Overall Study|Subject decision|22|||
161476597|NCT00002651|583139146|FG000|Induction|Adverse Event|44|||
161476598|NCT00002651|583139147|FG001|Induction|Adverse Event|0|||
161476599|NCT00002651|583139148|FG002|Induction|Adverse Event|0|||
161476600|NCT00002651|583139146|FG000|Induction|Refusal unrelated to adverse event|50|||
161476601|NCT00002651|583139147|FG001|Induction|Refusal unrelated to adverse event|0|||
161578076|NCT02767765|583505126|FG000|Overall Study|Insufficient response|1|||
161815287|NCT01838681|584366939|FG002|Period A|Lost to Follow-up|0|||
161476602|NCT00002651|583139148|FG002|Induction|Refusal unrelated to adverse event|0|||
161476603|NCT00002651|583139146|FG000|Induction|Progression/relapse|274|||
161476604|NCT00002651|583139147|FG001|Induction|Progression/relapse|0|||
161476605|NCT00002651|583139148|FG002|Induction|Progression/relapse|0|||
161476606|NCT00002651|583139146|FG000|Induction|Death|62|||
161476607|NCT00002651|583139147|FG001|Induction|Death|0|||
161476608|NCT00002651|583139148|FG002|Induction|Death|0|||
161476609|NCT00002651|583139146|FG000|Induction|Other|823|||
161476610|NCT00002651|583139147|FG001|Induction|Other|0|||
161476611|NCT00002651|583139148|FG002|Induction|Other|0|||
161476612|NCT00002651|583139146|FG000|Induction|not eligible|90|||
161476613|NCT00002651|583139147|FG001|Induction|not eligible|0|||
161476614|NCT00002651|583139148|FG002|Induction|not eligible|0|||
161476615|NCT00002651|583139146|FG000|Consolidation and Randomization|Adverse Event|0|||
161476616|NCT00002651|583139147|FG001|Consolidation and Randomization|Adverse Event|36|||
161476617|NCT00002651|583139148|FG002|Consolidation and Randomization|Adverse Event|14|||
161476618|NCT00002651|583139146|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
161476619|NCT00002651|583139147|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
161476620|NCT00002651|583139148|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
161476621|NCT00002651|583139146|FG000|Consolidation and Randomization|Progression/relapse|0|||
161476622|NCT00002651|583139147|FG001|Consolidation and Randomization|Progression/relapse|295|||
161476623|NCT00002651|583139148|FG002|Consolidation and Randomization|Progression/relapse|298|||
161476624|NCT00002651|583139146|FG000|Consolidation and Randomization|Death|0|||
161476625|NCT00002651|583139147|FG001|Consolidation and Randomization|Death|38|||
161476626|NCT00002651|583139148|FG002|Consolidation and Randomization|Death|48|||
161476627|NCT00002651|583139146|FG000|Consolidation and Randomization|Other|0|||
161476628|NCT00002651|583139147|FG001|Consolidation and Randomization|Other|314|||
161476629|NCT00002651|583139148|FG002|Consolidation and Randomization|Other|313|||
161476630|NCT00002651|583139146|FG000|Consolidation and Randomization|not eligible|0|||
161476631|NCT00002651|583139147|FG001|Consolidation and Randomization|not eligible|102|||
161476632|NCT00002651|583139148|FG002|Consolidation and Randomization|not eligible|112|||
161476633|NCT03417219|583139151|FG000|Overall Study|Lost to Follow-up|0|||
161476634|NCT03417219|583139152|FG001|Overall Study|Lost to Follow-up|3|||
161476635|NCT02264639|583139164|FG000|Overall Study|Death (after completing single-dose phase)|1|||
161476636|NCT02264639|583139165|FG001|Overall Study|Death (after completing single-dose phase)|0|||
161476637|NCT02264639|583139166|FG002|Overall Study|Death (after completing single-dose phase)|0|||
161476638|NCT02264639|583139167|FG003|Overall Study|Death (after completing single-dose phase)|0|||
161476639|NCT02264639|583139168|FG004|Overall Study|Death (after completing single-dose phase)|0|||
161476640|NCT02264639|583139164|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
161476641|NCT02264639|583139165|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
161476642|NCT02264639|583139166|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
161476643|NCT02264639|583139167|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
161476644|NCT02264639|583139168|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
161476645|NCT02264639|583139164|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
161476646|NCT02264639|583139165|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
161476647|NCT02264639|583139166|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
161476648|NCT02264639|583139167|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
161476649|NCT02264639|583139168|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
161476650|NCT02264639|583139164|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
161476651|NCT02264639|583139165|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
161476652|NCT02264639|583139166|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
161476653|NCT02264639|583139167|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
161476654|NCT02264639|583139168|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
161476655|NCT01612858|583139169|FG000|Overall Study|Withdrawal by Subject|5|||
161476656|NCT01612858|583139170|FG001|Overall Study|Withdrawal by Subject|1|||
161476657|NCT00005044|583139171|FG000|Overall Study|Protocol Violation|37|||
161476658|NCT00005044|583139172|FG001|Overall Study|Protocol Violation|46|||
161476659|NCT00005044|583139171|FG000|Overall Study|Withdrawal by Subject|1|||
161476660|NCT00005044|583139172|FG001|Overall Study|Withdrawal by Subject|5|||
161476661|NCT00005044|583139171|FG000|Overall Study|No protocol treatment|0|||
161476662|NCT00005044|583139172|FG001|Overall Study|No protocol treatment|1|||
161476663|NCT00843856|583139173|FG000|Overall Study|Lost to Follow-up|1|||
161476664|NCT00843856|583139174|FG001|Overall Study|Lost to Follow-up|2|||
161476665|NCT02993757|583139179|FG000|Overall Study|Non compliance with the protocol|155|||
161476666|NCT02993757|583139180|FG001|Overall Study|Non compliance with the protocol|170|||
161476667|NCT02993757|583139179|FG000|Overall Study|Lost to Follow-up|1|||
161476668|NCT02993757|583139180|FG001|Overall Study|Lost to Follow-up|0|||
161476669|NCT02993757|583139179|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
161476670|NCT02993757|583139180|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
161476671|NCT00087607|583139190|FG000|Overall Study|Adverse Event|14|||
161476672|NCT00087607|583139191|FG001|Overall Study|Adverse Event|24|||
161476673|NCT00087607|583139190|FG000|Overall Study|Death|0|||
161476674|NCT00087607|583139191|FG001|Overall Study|Death|1|||
161476675|NCT00087607|583139190|FG000|Overall Study|Insufficient Therapeutic Response|53|||
161476676|NCT00087607|583139191|FG001|Overall Study|Insufficient Therapeutic Response|42|||
161476677|NCT00087607|583139190|FG000|Overall Study|Failure to return|21|||
161476678|NCT00087607|583139191|FG001|Overall Study|Failure to return|17|||
161476679|NCT00087607|583139190|FG000|Overall Study|Withdrew Consent|12|||
161476680|NCT00087607|583139191|FG001|Overall Study|Withdrew Consent|16|||
161476681|NCT00087607|583139190|FG000|Overall Study|Administrative|12|||
161476682|NCT00087607|583139191|FG001|Overall Study|Administrative|12|||
161476683|NCT00087607|583139190|FG000|Overall Study|Refused Treatment|5|||
161476684|NCT00087607|583139191|FG001|Overall Study|Refused Treatment|7|||
161476685|NCT00087607|583139190|FG000|Overall Study|Other Protocol Violation|5|||
161476686|NCT00087607|583139191|FG001|Overall Study|Other Protocol Violation|2|||
161476687|NCT00087607|583139190|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161476688|NCT00087607|583139191|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161476689|NCT02699593|583139192|FG000|Period 1|Unsatisfactory Visual Response|0|||
161476690|NCT02699593|583139193|FG001|Period 1|Unsatisfactory Visual Response|1|||
161476691|NCT02699593|583139192|FG000|Period 1|Torn Contact Len|4|||
161476692|NCT02699593|583139193|FG001|Period 1|Torn Contact Len|3|||
161476693|NCT02699593|583139192|FG000|Period 1|Protocol Violation|0|||
161476694|NCT02699593|583139193|FG001|Period 1|Protocol Violation|1|||
161476695|NCT02699593|583139192|FG000|Period 1|Withdrawal by Subject|0|||
161476696|NCT02699593|583139193|FG001|Period 1|Withdrawal by Subject|1|||
161476697|NCT02699593|583139192|FG000|Period 1|Adverse Event|1|||
161476698|NCT02699593|583139193|FG001|Period 1|Adverse Event|1|||
161476699|NCT02699593|583139192|FG000|Period 2|Adverse Event|1|||
161476700|NCT02699593|583139193|FG001|Period 2|Adverse Event|1|||
161476701|NCT02699593|583139192|FG000|Period 2|Lost Contact Lens|0|||
161476702|NCT02699593|583139193|FG001|Period 2|Lost Contact Lens|1|||
161476703|NCT02699593|583139192|FG000|Period 2|Torn Contact Lens|1|||
161476704|NCT02699593|583139193|FG001|Period 2|Torn Contact Lens|0|||
161476705|NCT02015754|583139194|FG000|Overall Study|Disease progression|5|||
161476706|NCT02015754|583139194|FG000|Overall Study|Change in treatment modality|5|||
161476707|NCT02015754|583139194|FG000|Overall Study|Lost to Follow-up|1|||
161476708|NCT02229383|583139195|FG000|Overall Study|Adverse Event|7|||
161476709|NCT02229383|583139196|FG001|Overall Study|Adverse Event|4|||
161476710|NCT02229383|583139195|FG000|Overall Study|Death|0|||
161476711|NCT02229383|583139196|FG001|Overall Study|Death|1|||
161476712|NCT02229383|583139195|FG000|Overall Study|Lost to Follow-up|5|||
161476713|NCT02229383|583139196|FG001|Overall Study|Lost to Follow-up|3|||
161476714|NCT02229383|583139195|FG000|Overall Study|Withdrawal by Subject|4|||
161476715|NCT02229383|583139196|FG001|Overall Study|Withdrawal by Subject|6|||
161476716|NCT02229383|583139195|FG000|Overall Study|Did not receive treatment|1|||
161476717|NCT02229383|583139196|FG001|Overall Study|Did not receive treatment|0|||
161476718|NCT02229383|583139195|FG000|Overall Study|Other|3|||
161476719|NCT02229383|583139196|FG001|Overall Study|Other|8|||
161476720|NCT00873015|583139200|FG000|Overall Study|Withdrawal by Subject|0|||
161476721|NCT00873015|583139201|FG001|Overall Study|Withdrawal by Subject|1|||
161578077|NCT02767765|583505126|FG000|Overall Study|Lost to Follow-up|2|||
161578078|NCT02767765|583505126|FG000|Overall Study|Investigator decision|1|||
161578079|NCT02767765|583505126|FG000|Overall Study|Non-Compliance|1|||
161578080|NCT02767765|583505126|FG000|Overall Study|Withdrawal by Subject|1|||
161578081|NCT01972724|583505129|FG000|Double-Blind|Rescue Criteria Met|1|||
161578082|NCT01972724|583505130|FG001|Double-Blind|Rescue Criteria Met|0|||
161578083|NCT01972724|583505131|FG002|Double-Blind|Rescue Criteria Met|0|||
161578084|NCT01972724|583505129|FG000|Double-Blind|Adverse Event|1|||
161578085|NCT01972724|583505130|FG001|Double-Blind|Adverse Event|0|||
161578086|NCT01972724|583505131|FG002|Double-Blind|Adverse Event|0|||
161578087|NCT01972724|583505129|FG000|Double-Blind|Withdrawal of Consent|2|||
161476722|NCT00873015|583139202|FG002|Overall Study|Withdrawal by Subject|0|||
161476723|NCT00873015|583139203|FG003|Overall Study|Withdrawal by Subject|0|||
161476724|NCT03128411|583139204|FG000|Treatment Phase|Adverse Event|21|||
161476725|NCT03128411|583139204|FG000|Treatment Phase|Physician Decision|1|||
161476726|NCT03128411|583139204|FG000|Treatment Phase|Other|2|||
161476727|NCT03128411|583139204|FG000|Long Term Follow-up Phase|Death|2|||
161476728|NCT03298867|583139214|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
161476729|NCT03298867|583139215|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
161476730|NCT03298867|583139214|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
161476731|NCT03298867|583139215|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
161476732|NCT03298867|583139214|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
161476733|NCT03298867|583139215|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
161578088|NCT01972724|583505130|FG001|Double-Blind|Withdrawal of Consent|1|||
161578089|NCT01972724|583505131|FG002|Double-Blind|Withdrawal of Consent|0|||
161578090|NCT01972724|583505129|FG000|Double-Blind|Significant Protocol Deviation|5|||
161578091|NCT01972724|583505130|FG001|Double-Blind|Significant Protocol Deviation|8|||
161578092|NCT01972724|583505131|FG002|Double-Blind|Significant Protocol Deviation|0|||
161578093|NCT01972724|583505129|FG000|Open-Label|Withdrew Consent|0|||
161578094|NCT01972724|583505130|FG001|Open-Label|Withdrew Consent|0|||
161578095|NCT01972724|583505131|FG002|Open-Label|Withdrew Consent|3|||
161578096|NCT01972724|583505129|FG000|Open-Label|Significant Protocol Deviation|0|||
161578097|NCT01972724|583505130|FG001|Open-Label|Significant Protocol Deviation|0|||
161578098|NCT01972724|583505131|FG002|Open-Label|Significant Protocol Deviation|2|||
161578099|NCT00277355|583505133|FG000|Overall Study|Withdrawal by Subject|3|||
161578100|NCT00277355|583505134|FG001|Overall Study|Withdrawal by Subject|3|||
161578101|NCT00277355|583505133|FG000|Overall Study|Lost to Follow-up|2|||
161578102|NCT00277355|583505134|FG001|Overall Study|Lost to Follow-up|2|||
161578103|NCT00277355|583505133|FG000|Overall Study|Adverse Event|5|||
161578104|NCT00277355|583505134|FG001|Overall Study|Adverse Event|0|||
161578105|NCT00277355|583505133|FG000|Overall Study|Death|3|||
161578106|NCT00277355|583505134|FG001|Overall Study|Death|0|||
161578107|NCT00277355|583505133|FG000|Overall Study|Physician Decision|1|||
161578108|NCT00277355|583505134|FG001|Overall Study|Physician Decision|0|||
161578109|NCT02675244|583505137|FG000|Overall Study|Death|9|||
161578110|NCT02675244|583505138|FG001|Overall Study|Death|6|||
161578111|NCT02675244|583505137|FG000|Overall Study|Withdrawal by Subject|3|||
161578112|NCT02675244|583505138|FG001|Overall Study|Withdrawal by Subject|6|||
161578113|NCT02675244|583505137|FG000|Overall Study|Lost to Follow-up|1|||
161578114|NCT02675244|583505138|FG001|Overall Study|Lost to Follow-up|1|||
161476734|NCT03298867|583139214|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
161476735|NCT03298867|583139215|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
161476736|NCT03298867|583139214|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
161476737|NCT03298867|583139215|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
161476738|NCT03298867|583139214|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
161476739|NCT03298867|583139215|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
161476740|NCT03298867|583139214|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
161476741|NCT03298867|583139215|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
161476742|NCT03298867|583139214|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
161476743|NCT03298867|583139215|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
161476744|NCT03298867|583139214|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
161578115|NCT02675244|583505137|FG000|Overall Study|Ongoing at 2 Years|190|||
161578116|NCT02675244|583505138|FG001|Overall Study|Ongoing at 2 Years|185|||
161578117|NCT00636207|583505142|FG000|Overall Study|Adverse Event|1|||
161476745|NCT03298867|583139215|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
161578118|NCT00636207|583505143|FG001|Overall Study|Adverse Event|0|||
161578119|NCT00636207|583505144|FG002|Overall Study|Adverse Event|0|||
161578120|NCT00636207|583505145|FG003|Overall Study|Adverse Event|0|||
161578121|NCT00636207|583505146|FG004|Overall Study|Adverse Event|0|||
161578122|NCT00636207|583505147|FG005|Overall Study|Adverse Event|0|||
161578123|NCT00636207|583505148|FG006|Overall Study|Adverse Event|0|||
161578124|NCT00636207|583505142|FG000|Overall Study|Withdrawal by Subject|0|||
161578125|NCT00636207|583505143|FG001|Overall Study|Withdrawal by Subject|1|||
161578126|NCT00636207|583505144|FG002|Overall Study|Withdrawal by Subject|0|||
161578127|NCT00636207|583505145|FG003|Overall Study|Withdrawal by Subject|0|||
161578128|NCT00636207|583505146|FG004|Overall Study|Withdrawal by Subject|1|||
161578129|NCT00636207|583505147|FG005|Overall Study|Withdrawal by Subject|0|||
161578130|NCT00636207|583505148|FG006|Overall Study|Withdrawal by Subject|0|||
161578131|NCT04054635|583505149|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
161578132|NCT04054635|583505150|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
161578133|NCT04054635|583505151|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
161578134|NCT04054635|583505149|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
161578135|NCT04054635|583505150|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
161476746|NCT06934993|583139220|FG000|Overall Study|Withdrawal by Subject|29|||
161476747|NCT06934993|583139220|FG000|Overall Study|elevated postoperative creatinine level|11|||
161476748|NCT06934993|583139220|FG000|Overall Study|Death|3|||
161476749|NCT01218113|583141637|FG000|Overall Study|Withdrawal by Subject|1|||
161476750|NCT01218113|583141638|FG001|Overall Study|Withdrawal by Subject|0|||
161476751|NCT01218113|583141639|FG002|Overall Study|Withdrawal by Subject|1|||
161476752|NCT01218113|583141637|FG000|Overall Study|Lost to Follow-up|4|||
161476753|NCT01218113|583141638|FG001|Overall Study|Lost to Follow-up|1|||
161476754|NCT01218113|583141639|FG002|Overall Study|Lost to Follow-up|4|||
161476755|NCT01218113|583141637|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
161476756|NCT01218113|583141638|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
161476757|NCT01218113|583141639|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
161476758|NCT01385566|583141641|FG000|Overall Study|Lost to Follow-up|1|||
161476759|NCT01385566|583141642|FG001|Overall Study|Lost to Follow-up|0|||
161476760|NCT01385566|583141643|FG002|Overall Study|Lost to Follow-up|0|||
161476761|NCT01385566|583141644|FG003|Overall Study|Lost to Follow-up|0|||
161476762|NCT01385566|583141645|FG004|Overall Study|Lost to Follow-up|0|||
161476763|NCT01385566|583141646|FG005|Overall Study|Lost to Follow-up|0|||
161578136|NCT04054635|583505151|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
161476764|NCT01385566|583141641|FG000|Overall Study|Withdrawal by Subject|0|||
161476765|NCT01385566|583141642|FG001|Overall Study|Withdrawal by Subject|0|||
161476766|NCT01385566|583141643|FG002|Overall Study|Withdrawal by Subject|0|||
161476767|NCT01385566|583141644|FG003|Overall Study|Withdrawal by Subject|1|||
161476768|NCT01385566|583141645|FG004|Overall Study|Withdrawal by Subject|0|||
161476769|NCT01385566|583141646|FG005|Overall Study|Withdrawal by Subject|0|||
161476770|NCT00787891|583141647|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
161476771|NCT00787891|583141648|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
161476772|NCT00787891|583141647|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
161476773|NCT00787891|583141648|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
161476774|NCT00787891|583141647|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
161476775|NCT00787891|583141648|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
161476776|NCT00787891|583141647|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
161476777|NCT00787891|583141648|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
161476778|NCT00787891|583141647|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
161476779|NCT00787891|583141648|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
161476780|NCT00787891|583141647|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
161476781|NCT00787891|583141648|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
161476782|NCT00787891|583141647|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
161476783|NCT00787891|583141648|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
161476784|NCT00787891|583141647|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
161476785|NCT00787891|583141648|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
161476786|NCT00787891|583141647|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
161476787|NCT00787891|583141648|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
161476788|NCT00787891|583141647|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
161476789|NCT00787891|583141648|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
161476790|NCT01594281|583141649|FG000|Interventional Core Phase|Protocol Deviation|1|||
161476791|NCT01594281|583141650|FG001|Interventional Core Phase|Protocol Deviation|0|||
161476792|NCT01594281|583141651|FG002|Interventional Core Phase|Protocol Deviation|0|||
161476793|NCT01594281|583141649|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
161476794|NCT01594281|583141650|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
161476795|NCT01594281|583141651|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
161476796|NCT01594281|583141649|FG000|Interventional Core Phase|Death|1|||
161476797|NCT01594281|583141650|FG001|Interventional Core Phase|Death|1|||
161476798|NCT01594281|583141651|FG002|Interventional Core Phase|Death|2|||
161476799|NCT01594281|583141649|FG000|Interventional Core Phase|Lost to Follow-up|1|||
161476800|NCT01594281|583141650|FG001|Interventional Core Phase|Lost to Follow-up|4|||
161476801|NCT01594281|583141651|FG002|Interventional Core Phase|Lost to Follow-up|1|||
161476802|NCT01594281|583141649|FG000|Interventional Core Phase|Adverse Event|4|||
161476803|NCT01594281|583141650|FG001|Interventional Core Phase|Adverse Event|4|||
161476804|NCT01594281|583141651|FG002|Interventional Core Phase|Adverse Event|4|||
161476805|NCT01594281|583141649|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
161476806|NCT01594281|583141650|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
161476807|NCT01594281|583141651|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
161476808|NCT01594281|583141649|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
161476809|NCT01594281|583141650|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
161476810|NCT01594281|583141651|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
161476811|NCT01594281|583141649|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
161476812|NCT01594281|583141650|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
161476813|NCT01594281|583141651|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
161476814|NCT02550106|583141653|FG000|Overall Study|Adverse Event|1|||
161476815|NCT02550106|583141653|FG000|Overall Study|Lack of Efficacy|3|||
161476816|NCT02550106|583141653|FG000|Overall Study|Protocol Violation|6|||
161815288|NCT01838681|584366940|FG003|Period A|Lost to Follow-up|0|||
161815289|NCT01838681|584366937|FG000|Period A|Withdrawal before treatment|4|||
161815290|NCT01838681|584366938|FG001|Period A|Withdrawal before treatment|0|||
161815291|NCT01838681|584366939|FG002|Period A|Withdrawal before treatment|0|||
161815292|NCT01838681|584366940|FG003|Period A|Withdrawal before treatment|0|||
161815293|NCT01838681|584366937|FG000|Period A|Administrative or other reasons|17|||
161815294|NCT01838681|584366938|FG001|Period A|Administrative or other reasons|0|||
161815295|NCT01838681|584366939|FG002|Period A|Administrative or other reasons|0|||
161815296|NCT01838681|584366940|FG003|Period A|Administrative or other reasons|0|||
161476817|NCT02550106|583141653|FG000|Overall Study|Withdrawal by Subject|2|||
161476818|NCT01193530|583141656|FG000|Overall Study|Withdrawal by Subject|2|||
161476819|NCT01193530|583141657|FG001|Overall Study|Withdrawal by Subject|2|||
161476820|NCT01193530|583141656|FG000|Overall Study|Began Contraindicated Therapy|1|||
161476821|NCT01193530|583141657|FG001|Overall Study|Began Contraindicated Therapy|0|||
161578137|NCT01185782|583505158|FG000|Overall Study|Adverse Event|0|||
161815297|NCT01838681|584366937|FG000|Period B/A+|Adverse Event|0|||
161476822|NCT01193530|583141656|FG000|Overall Study|Lost Light Box|0|||
161476823|NCT01193530|583141657|FG001|Overall Study|Lost Light Box|1|||
161476824|NCT01193530|583141656|FG000|Overall Study|Returned home - out of state|0|||
161476825|NCT01193530|583141657|FG001|Overall Study|Returned home - out of state|1|||
161476826|NCT01193530|583141656|FG000|Overall Study|Non-Compliance|0|||
161476827|NCT01193530|583141657|FG001|Overall Study|Non-Compliance|1|||
161476828|NCT01890473|583141658|FG000|Overall Study|Lost to Follow-up|1|||
161476829|NCT01890473|583141659|FG001|Overall Study|Lost to Follow-up|0|||
161476830|NCT01890473|583141658|FG000|Overall Study|Poor/non-compliance|1|||
161476831|NCT01890473|583141659|FG001|Overall Study|Poor/non-compliance|0|||
161476832|NCT03166735|583141660|FG000|Overall Study|Not Treated|1|||
161476833|NCT03166735|583141661|FG001|Overall Study|Not Treated|0|||
161476834|NCT03166735|583141662|FG002|Overall Study|Not Treated|0|||
161476835|NCT03166735|583141663|FG003|Overall Study|Not Treated|0|||
161476836|NCT03166735|583141664|FG004|Overall Study|Not Treated|0|||
161476837|NCT03166735|583141660|FG000|Overall Study|follow-up not completed as planned|0|||
161476838|NCT03166735|583141661|FG001|Overall Study|follow-up not completed as planned|1|||
161476839|NCT03166735|583141662|FG002|Overall Study|follow-up not completed as planned|1|||
161476840|NCT03166735|583141663|FG003|Overall Study|follow-up not completed as planned|0|||
161476841|NCT03166735|583141664|FG004|Overall Study|follow-up not completed as planned|1|||
161476842|NCT03166735|583141660|FG000|Overall Study|Withdrawal by Subject|0|||
161476843|NCT03166735|583141661|FG001|Overall Study|Withdrawal by Subject|0|||
161476844|NCT03166735|583141662|FG002|Overall Study|Withdrawal by Subject|1|||
161476845|NCT03166735|583141663|FG003|Overall Study|Withdrawal by Subject|1|||
161476846|NCT03166735|583141664|FG004|Overall Study|Withdrawal by Subject|2|||
161476847|NCT03166735|583141660|FG000|Overall Study|Lost to Follow-up|0|||
161476848|NCT03166735|583141661|FG001|Overall Study|Lost to Follow-up|2|||
161476849|NCT03166735|583141662|FG002|Overall Study|Lost to Follow-up|1|||
161815298|NCT01838681|584366938|FG001|Period B/A+|Adverse Event|13|||
161476850|NCT03166735|583141663|FG003|Overall Study|Lost to Follow-up|0|||
161476851|NCT03166735|583141664|FG004|Overall Study|Lost to Follow-up|1|||
161476852|NCT01543958|583141665|FG000|Overall Study|Loss to follow-up|3|||
161476853|NCT01543958|583141665|FG000|Overall Study|ART initiation|1|||
161476854|NCT01945281|583141666|FG000|Overall Study|Adverse Event|1|||
161476855|NCT01945281|583141667|FG001|Overall Study|Adverse Event|0|||
161476856|NCT01945281|583141666|FG000|Overall Study|Death|3|||
161476857|NCT01945281|583141667|FG001|Overall Study|Death|3|||
161476858|NCT01945281|583141666|FG000|Overall Study|Physician Decision|1|||
161476859|NCT01945281|583141667|FG001|Overall Study|Physician Decision|1|||
161476860|NCT01945281|583141666|FG000|Overall Study|Technical Problems|1|||
161476861|NCT01945281|583141667|FG001|Overall Study|Technical Problems|0|||
161476862|NCT00926328|583141668|FG000|Overall Study|Lost to Follow-up|12|||
161476863|NCT00926328|583141669|FG001|Overall Study|Lost to Follow-up|14|||
161476864|NCT00726986|583141670|FG000|Induction Phase|Adverse Event|4|||
161476865|NCT00726986|583141670|FG000|Induction Phase|Withdrawal by Subject|2|||
161476866|NCT00726986|583141670|FG000|Induction Phase|Death|2|||
161476867|NCT00726986|583141670|FG000|Induction Phase|Lack of Efficacy|5|||
161476868|NCT00726986|583141670|FG000|Induction Phase|Secondary Disease|2|||
161476869|NCT00726986|583141670|FG000|Maintenance Phase|Adverse Event|1|||
161476870|NCT00726986|583141670|FG000|Maintenance Phase|Lack of Efficacy|2|||
161476871|NCT01819831|583141675|FG000|Overall Study|Withdrawal by Subject|1|||
161476872|NCT05074667|583141676|FG000|Overall Study|Death|1|||
161476873|NCT05074667|583141676|FG000|Overall Study|Withdrawal by Subject|4|||
161476874|NCT05074667|583141676|FG000|Overall Study|Lost to Follow-up|10|||
161476875|NCT01947582|583141677|FG000|Overall Study|Withdrawal by Subject|1|||
161476876|NCT01086033|583141678|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
161476877|NCT01086033|583141678|FG000|Overall Study|Lost to Follow-up|86|||
161476878|NCT01086033|583141678|FG000|Overall Study|Adverse Event|42|||
161476879|NCT01086033|583141678|FG000|Overall Study|Withdrawal by Subject|41|||
161476880|NCT01086033|583141678|FG000|Overall Study|Other|14|||
161476881|NCT01086033|583141678|FG000|Overall Study|Other|13|||
161815299|NCT01838681|584366939|FG002|Period B/A+|Adverse Event|27|||
161578138|NCT01185782|583505159|FG001|Overall Study|Adverse Event|1|||
161815300|NCT01838681|584366940|FG003|Period B/A+|Adverse Event|16|||
161815301|NCT01838681|584366937|FG000|Period B/A+|Lack of Efficacy|0|||
161815302|NCT01838681|584366938|FG001|Period B/A+|Lack of Efficacy|9|||
161815303|NCT01838681|584366939|FG002|Period B/A+|Lack of Efficacy|11|||
161815304|NCT01838681|584366940|FG003|Period B/A+|Lack of Efficacy|6|||
161815305|NCT01838681|584366937|FG000|Period B/A+|Withdrawal by Subject|0|||
161815306|NCT01838681|584366938|FG001|Period B/A+|Withdrawal by Subject|28|||
161815307|NCT01838681|584366939|FG002|Period B/A+|Withdrawal by Subject|35|||
161815308|NCT01838681|584366940|FG003|Period B/A+|Withdrawal by Subject|47|||
161815309|NCT01838681|584366937|FG000|Period B/A+|Protocol Violation|0|||
161815310|NCT01838681|584366938|FG001|Period B/A+|Protocol Violation|1|||
161815311|NCT01838681|584366939|FG002|Period B/A+|Protocol Violation|4|||
161815312|NCT01838681|584366940|FG003|Period B/A+|Protocol Violation|6|||
161815313|NCT01838681|584366937|FG000|Period B/A+|Non-compliance with IMP|0|||
161815314|NCT01838681|584366938|FG001|Period B/A+|Non-compliance with IMP|2|||
161815315|NCT01838681|584366939|FG002|Period B/A+|Non-compliance with IMP|3|||
161815316|NCT01838681|584366940|FG003|Period B/A+|Non-compliance with IMP|3|||
161815317|NCT01838681|584366937|FG000|Period B/A+|Lost to Follow-up|0|||
161815318|NCT01838681|584366938|FG001|Period B/A+|Lost to Follow-up|2|||
161815319|NCT01838681|584366939|FG002|Period B/A+|Lost to Follow-up|5|||
161815320|NCT01838681|584366940|FG003|Period B/A+|Lost to Follow-up|11|||
161815321|NCT01838681|584366937|FG000|Period B/A+|Withdrawal before treatment|0|||
161815322|NCT01838681|584366938|FG001|Period B/A+|Withdrawal before treatment|1|||
161815323|NCT01838681|584366939|FG002|Period B/A+|Withdrawal before treatment|0|||
161815324|NCT01838681|584366940|FG003|Period B/A+|Withdrawal before treatment|0|||
161815325|NCT01838681|584366937|FG000|Period B/A+|Administrative or other reasons|0|||
161815326|NCT01838681|584366938|FG001|Period B/A+|Administrative or other reasons|6|||
161815327|NCT01838681|584366939|FG002|Period B/A+|Administrative or other reasons|10|||
161815328|NCT01838681|584366940|FG003|Period B/A+|Administrative or other reasons|28|||
161815329|NCT00312897|584366941|FG000|Overall Study|Adverse Event|1|||
161815330|NCT00312897|584366942|FG001|Overall Study|Adverse Event|0|||
161815331|NCT00312897|584366941|FG000|Overall Study|Lost to Follow-up|2|||
161815332|NCT00312897|584366942|FG001|Overall Study|Lost to Follow-up|0|||
161815333|NCT00312897|584366941|FG000|Overall Study|Physician Decision|1|||
161815334|NCT00312897|584366942|FG001|Overall Study|Physician Decision|0|||
161815335|NCT00312897|584366941|FG000|Overall Study|Withdrawal by Subject|1|||
161815336|NCT00312897|584366942|FG001|Overall Study|Withdrawal by Subject|3|||
161815337|NCT00312897|584366941|FG000|Overall Study|Pregnancy|1|||
161815338|NCT00312897|584366942|FG001|Overall Study|Pregnancy|0|||
161815339|NCT00312897|584366941|FG000|Overall Study|discontinued prior to getting treatment|0|||
161815340|NCT00312897|584366942|FG001|Overall Study|discontinued prior to getting treatment|3|||
161815341|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
161815342|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815343|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815344|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815345|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815346|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815347|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
161815348|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815349|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815350|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815351|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815352|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815353|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
161815354|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815355|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815356|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815357|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815358|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815359|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
161815360|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161476882|NCT01086033|583141678|FG000|Overall Study|AE and Withdrew Consent|5|||
161476883|NCT01086033|583141678|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
161476884|NCT01086033|583141678|FG000|Overall Study|Withdrew consent and Other Reason|4|||
161476885|NCT01086033|583141678|FG000|Overall Study|AE and Lack of Efficacy|4|||
161815361|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815362|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815363|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815364|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815365|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
161815366|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815367|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815368|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815369|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815370|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815371|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
161476886|NCT01086033|583141678|FG000|Overall Study|Death|1|||
161476887|NCT01086033|583141678|FG000|Overall Study|AE and Lost to Follow-up|1|||
161476888|NCT01086033|583141678|FG000|Overall Study|AE and Other Reason|1|||
161476889|NCT01086033|583141678|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
161476890|NCT02193867|583141679|FG000|Overall Study|Death|2|||
161476891|NCT02193867|583141679|FG000|Overall Study|Sponsor Study Termination|2|||
161476892|NCT02924571|583141680|FG000|Overall Study|Lost to Follow-up|1|||
161476893|NCT02924571|583141681|FG001|Overall Study|Lost to Follow-up|1|||
161476894|NCT02924571|583141682|FG002|Overall Study|Lost to Follow-up|0|||
161476895|NCT01705730|583141686|FG000|Overall Study|Lack of Efficacy|1|||
161476896|NCT01705730|583141686|FG000|Overall Study|Adverse Event|3|||
161476897|NCT01705730|583141686|FG000|Overall Study|Lost to Follow-up|1|||
161476898|NCT01705730|583141686|FG000|Overall Study|Reason not Specified|4|||
161476899|NCT04891978|583141689|FG000|Baseline|Protocol Violation|2|||
161476900|NCT04891978|583141690|FG001|Baseline|Protocol Violation|1|||
161476901|NCT04891978|583141691|FG002|Baseline|Protocol Violation|0|||
161476902|NCT04891978|583141689|FG000|Baseline|Missing AIRQ|1|||
161476903|NCT04891978|583141690|FG001|Baseline|Missing AIRQ|0|||
161476904|NCT04891978|583141691|FG002|Baseline|Missing AIRQ|0|||
161476905|NCT04891978|583141689|FG000|Baseline|Did not attend a baseline visit|0|||
161476906|NCT04891978|583141690|FG001|Baseline|Did not attend a baseline visit|0|||
161476907|NCT04891978|583141691|FG002|Baseline|Did not attend a baseline visit|9|||
161476908|NCT01776840|583141692|FG000|Overall Study|Lost to Follow-up|12|||
161476909|NCT01776840|583141693|FG001|Overall Study|Lost to Follow-up|7|||
161476910|NCT01776840|583141692|FG000|Overall Study|Withdrawal by Subject|32|||
161476911|NCT01776840|583141693|FG001|Overall Study|Withdrawal by Subject|48|||
161476912|NCT01776840|583141692|FG000|Overall Study|Sponsor decision|89|||
161476913|NCT01776840|583141693|FG001|Overall Study|Sponsor decision|87|||
161476914|NCT03068455|583141694|FG000|Pre-treatment Period|Disease progression|0|||
161476915|NCT03068455|583141695|FG001|Pre-treatment Period|Disease progression|1|||
161476916|NCT03068455|583141694|FG000|Pre-treatment Period|Participant withdrew consent|1|||
161476917|NCT03068455|583141695|FG001|Pre-treatment Period|Participant withdrew consent|1|||
161476918|NCT03068455|583141694|FG000|Pre-treatment Period|Poor/non-compliance|0|||
161476919|NCT03068455|583141695|FG001|Pre-treatment Period|Poor/non-compliance|1|||
161476920|NCT03068455|583141694|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
161476921|NCT03068455|583141695|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
161476922|NCT03068455|583141694|FG000|Pre-treatment Period|Not reported|2|||
161476923|NCT03068455|583141695|FG001|Pre-treatment Period|Not reported|1|||
161476924|NCT03068455|583141694|FG000|Treatment Period|Disease progression|166|||
161476925|NCT03068455|583141695|FG001|Treatment Period|Disease progression|208|||
161476926|NCT03068455|583141694|FG000|Treatment Period|Study drug toxicity|317|||
161476927|NCT03068455|583141695|FG001|Treatment Period|Study drug toxicity|104|||
161476928|NCT03068455|583141694|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
161476929|NCT03068455|583141695|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
161476930|NCT03068455|583141694|FG000|Treatment Period|Participant request to stop therapy|33|||
161476931|NCT03068455|583141695|FG001|Treatment Period|Participant request to stop therapy|20|||
161476932|NCT03068455|583141694|FG000|Treatment Period|Participant withdrew consent|5|||
161476933|NCT03068455|583141695|FG001|Treatment Period|Participant withdrew consent|10|||
161476934|NCT03068455|583141694|FG000|Treatment Period|Poor/non-compliance|3|||
161476935|NCT03068455|583141695|FG001|Treatment Period|Poor/non-compliance|0|||
161476936|NCT03068455|583141694|FG000|Treatment Period|Participant no longer meets study criteria|1|||
161476937|NCT03068455|583141695|FG001|Treatment Period|Participant no longer meets study criteria|3|||
161476938|NCT03068455|583141694|FG000|Treatment Period|Other reasons|12|||
161476939|NCT03068455|583141695|FG001|Treatment Period|Other reasons|4|||
161476940|NCT05338216|583141697|FG000|Overall Study|Withdrawal by Subject|1|||
161476941|NCT05338216|583141698|FG001|Overall Study|Withdrawal by Subject|1|||
161476942|NCT04457336|583141699|FG000|Period 2: Part A|Withdrawal by Subject|0|||
161476943|NCT04457336|583141700|FG001|Period 2: Part A|Withdrawal by Subject|1|||
161578139|NCT01185782|583505158|FG000|Overall Study|Protocol Violation|1|||
161578140|NCT01185782|583505159|FG001|Overall Study|Protocol Violation|0|||
161578141|NCT01185782|583505158|FG000|Overall Study|Poor Response to Treatment|3|||
161578142|NCT01185782|583505159|FG001|Overall Study|Poor Response to Treatment|1|||
161578143|NCT01185782|583505158|FG000|Overall Study|Other|2|||
161578144|NCT01185782|583505159|FG001|Overall Study|Other|5|||
161578145|NCT01185782|583505158|FG000|Overall Study|Randomized but not treated|0|||
161578146|NCT01185782|583505159|FG001|Overall Study|Randomized but not treated|4|||
161578147|NCT02507752|583505160|FG000|Overall Study|Adverse Event|1|||
161578148|NCT02507752|583505160|FG000|Overall Study|Protocol Violation|6|||
161578149|NCT02507752|583505160|FG000|Overall Study|Lost to Follow-up|7|||
161578150|NCT02507752|583505160|FG000|Overall Study|Infusion reaction at first infusion|1|||
161578151|NCT02507752|583505160|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
161578152|NCT02507752|583505160|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
161578153|NCT01254188|583505166|FG000|Overall Study|Disease Progression|6|||
161578154|NCT01254188|583505166|FG000|Overall Study|Protocol Violation|6|||
161578155|NCT01254188|583505166|FG000|Overall Study|Pregnancy|2|||
161578156|NCT01254188|583505166|FG000|Overall Study|Death|4|||
161578157|NCT01254188|583505166|FG000|Overall Study|Lost to Follow-up|5|||
161578158|NCT01254188|583505166|FG000|Overall Study|Withdrawal by Subject|7|||
161815372|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
161578159|NCT01254188|583505166|FG000|Overall Study|Adverse Event|43|||
161578160|NCT01254188|583505166|FG000|Overall Study|per investigator discretion|20|||
161578161|NCT04530747|583505167|FG000|Overall Study|Withdrawal by Subject|1|||
161578162|NCT04530747|583505168|FG001|Overall Study|Withdrawal by Subject|0|||
161578163|NCT03292913|583505169|FG000|Overall Study|Death|9|||
161578164|NCT03292913|583505170|FG001|Overall Study|Death|3|||
161578165|NCT03292913|583505169|FG000|Overall Study|Lost to Follow-up|49|||
161578166|NCT03292913|583505170|FG001|Overall Study|Lost to Follow-up|49|||
161578167|NCT03292913|583505169|FG000|Overall Study|Withdrawal by Subject|2|||
161578168|NCT03292913|583505170|FG001|Overall Study|Withdrawal by Subject|0|||
161578169|NCT03292913|583505169|FG000|Overall Study|Clinic closed due to COVID|22|||
161578170|NCT03292913|583505170|FG001|Overall Study|Clinic closed due to COVID|36|||
161578171|NCT03950622|583505171|FG000|Overall Study|Withdrawal by Subject|1|||
161920797|NCT02693418|584755802|FG000|Overall Study|Lost to Follow-up|1|||
161920798|NCT02693418|584755803|FG001|Overall Study|Lost to Follow-up|2|||
161920799|NCT02693418|584755804|FG002|Overall Study|Lost to Follow-up|0|||
161920800|NCT02693418|584755805|FG003|Overall Study|Lost to Follow-up|0|||
161815373|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
161815374|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161815375|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161815376|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161815377|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
161815378|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
161815379|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
161815380|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161815381|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161815382|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161815383|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
161815384|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815385|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
161815386|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815387|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815388|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815389|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
161815390|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
161920801|NCT02693418|584755806|FG004|Overall Study|Lost to Follow-up|0|||
161920802|NCT02693418|584755802|FG000|Overall Study|Menses during study period|0|||
161920803|NCT02693418|584755803|FG001|Overall Study|Menses during study period|0|||
161920804|NCT02693418|584755804|FG002|Overall Study|Menses during study period|2|||
161920805|NCT02693418|584755805|FG003|Overall Study|Menses during study period|0|||
161920806|NCT02693418|584755806|FG004|Overall Study|Menses during study period|0|||
161920807|NCT01750346|584755807|FG000|Overall Study|Adverse Event|1|||
161920808|NCT01750346|584755808|FG001|Overall Study|Adverse Event|0|||
161920809|NCT01750346|584755809|FG002|Overall Study|Adverse Event|0|||
161578172|NCT03950622|583505172|FG001|Overall Study|Withdrawal by Subject|0|||
161578173|NCT03950622|583505171|FG000|Overall Study|Protocol Deviation|0|||
161578174|NCT03950622|583505172|FG001|Overall Study|Protocol Deviation|1|||
161578175|NCT03950622|583505171|FG000|Overall Study|Physician Decision|1|||
161920810|NCT01001104|584755812|FG000|Overall Study|Adverse Event|2|||
161920811|NCT01001104|584755813|FG001|Overall Study|Adverse Event|1|||
161920812|NCT01001104|584755814|FG002|Overall Study|Adverse Event|0|||
161920813|NCT01001104|584755815|FG003|Overall Study|Adverse Event|0|||
161920814|NCT01001104|584755812|FG000|Overall Study|Lost to Follow-up|0|||
161920815|NCT01001104|584755813|FG001|Overall Study|Lost to Follow-up|0|||
161920816|NCT01001104|584755814|FG002|Overall Study|Lost to Follow-up|1|||
161920817|NCT01001104|584755815|FG003|Overall Study|Lost to Follow-up|0|||
161920818|NCT01001104|584755812|FG000|Overall Study|Entry Criteria Not Met|0|||
161920819|NCT01001104|584755813|FG001|Overall Study|Entry Criteria Not Met|0|||
161920820|NCT01001104|584755814|FG002|Overall Study|Entry Criteria Not Met|0|||
161920821|NCT01001104|584755815|FG003|Overall Study|Entry Criteria Not Met|1|||
161920822|NCT01001104|584755812|FG000|Overall Study|Withdrawal by Subject|0|||
161920823|NCT01001104|584755813|FG001|Overall Study|Withdrawal by Subject|0|||
161920824|NCT01001104|584755814|FG002|Overall Study|Withdrawal by Subject|0|||
161920825|NCT01001104|584755815|FG003|Overall Study|Withdrawal by Subject|2|||
161920826|NCT02034591|584755816|FG000|Overall Study|Withdrawal by Subject|0|||
161920827|NCT02034591|584755817|FG001|Overall Study|Withdrawal by Subject|0|||
161920828|NCT02034591|584755818|FG002|Overall Study|Withdrawal by Subject|0|||
161920829|NCT02034591|584755819|FG003|Overall Study|Withdrawal by Subject|0|||
161920830|NCT02034591|584755820|FG004|Overall Study|Withdrawal by Subject|1|||
161920831|NCT02034591|584755821|FG005|Overall Study|Withdrawal by Subject|0|||
161920832|NCT00599313|584755824|FG000|Overall Study|Adverse Event|19|||
161920833|NCT00599313|584755824|FG000|Overall Study|Disease Progression|12|||
161920834|NCT00599313|584755824|FG000|Overall Study|Patient Request|4|||
161920835|NCT00599313|584755824|FG000|Overall Study|Ineligible|1|||
161920836|NCT05350202|584755825|FG000|Visit 1 - Baseline|Not-treated|18|||
161920837|NCT05350202|584755826|FG001|Visit 1 - Baseline|Not-treated|0|||
161920838|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
161920839|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
161920840|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
161920841|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
161920842|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
161920843|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
161920844|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
161920845|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
161920846|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
161920847|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
161920848|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
161920849|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
161920850|NCT02924376|584755831|FG000|Overall Study|Progressive Disease|4|||
161920851|NCT02924376|584755832|FG001|Overall Study|Progressive Disease|0|||
161920852|NCT02924376|584755833|FG002|Overall Study|Progressive Disease|1|||
161920853|NCT02924376|584755834|FG003|Overall Study|Progressive Disease|0|||
161920854|NCT02924376|584755831|FG000|Overall Study|Death|73|||
161920855|NCT02924376|584755832|FG001|Overall Study|Death|18|||
161920856|NCT02924376|584755833|FG002|Overall Study|Death|15|||
161920857|NCT02924376|584755834|FG003|Overall Study|Death|2|||
161920858|NCT02924376|584755831|FG000|Overall Study|Lost to Follow-up|3|||
161920859|NCT02924376|584755832|FG001|Overall Study|Lost to Follow-up|0|||
161920860|NCT02924376|584755833|FG002|Overall Study|Lost to Follow-up|0|||
161920861|NCT02924376|584755834|FG003|Overall Study|Lost to Follow-up|0|||
161476944|NCT04457336|583141701|FG002|Period 2: Part A|Withdrawal by Subject|1|||
161476945|NCT04457336|583141702|FG003|Period 2: Part A|Withdrawal by Subject|1|||
161476946|NCT04457336|583141703|FG004|Period 2: Part A|Withdrawal by Subject|0|||
161476947|NCT04457336|583141704|FG005|Period 2: Part A|Withdrawal by Subject|0|||
161476948|NCT04457336|583141705|FG006|Period 2: Part A|Withdrawal by Subject|0|||
161476949|NCT04457336|583141706|FG007|Period 2: Part A|Withdrawal by Subject|0|||
161476950|NCT04457336|583141699|FG000|Period 2: Part A|Adverse Event|0|||
161920862|NCT02924376|584755831|FG000|Overall Study|Study Terminated by Sponsor|19|||
161920863|NCT02924376|584755832|FG001|Overall Study|Study Terminated by Sponsor|0|||
161920864|NCT02924376|584755833|FG002|Overall Study|Study Terminated by Sponsor|0|||
161920865|NCT02924376|584755834|FG003|Overall Study|Study Terminated by Sponsor|0|||
161920866|NCT02924376|584755831|FG000|Overall Study|Physician Decision|1|||
161920867|NCT02924376|584755832|FG001|Overall Study|Physician Decision|0|||
161920868|NCT02924376|584755833|FG002|Overall Study|Physician Decision|0|||
161920869|NCT02924376|584755834|FG003|Overall Study|Physician Decision|0|||
161920870|NCT02924376|584755831|FG000|Overall Study|Withdrawal by Subject|7|||
161476951|NCT04457336|583141700|FG001|Period 2: Part A|Adverse Event|0|||
161476952|NCT04457336|583141701|FG002|Period 2: Part A|Adverse Event|1|||
161476953|NCT04457336|583141702|FG003|Period 2: Part A|Adverse Event|1|||
161920871|NCT02924376|584755832|FG001|Overall Study|Withdrawal by Subject|2|||
161920872|NCT02924376|584755833|FG002|Overall Study|Withdrawal by Subject|1|||
161920873|NCT02924376|584755834|FG003|Overall Study|Withdrawal by Subject|0|||
161920874|NCT02924376|584755831|FG000|Overall Study|Rolled Over to Another Study|1|||
161920875|NCT02924376|584755832|FG001|Overall Study|Rolled Over to Another Study|0|||
161815391|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
161815392|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
161815393|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
161815394|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
161815395|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
161815396|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
161815397|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
161815398|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161476954|NCT04457336|583141703|FG004|Period 2: Part A|Adverse Event|0|||
161476955|NCT04457336|583141704|FG005|Period 2: Part A|Adverse Event|0|||
161476956|NCT04457336|583141705|FG006|Period 2: Part A|Adverse Event|0|||
161476957|NCT04457336|583141706|FG007|Period 2: Part A|Adverse Event|0|||
161476958|NCT04457336|583141699|FG000|Period 2: Part A|Study Terminated|0|||
161476959|NCT04457336|583141700|FG001|Period 2: Part A|Study Terminated|0|||
161476960|NCT04457336|583141701|FG002|Period 2: Part A|Study Terminated|1|||
161476961|NCT04457336|583141702|FG003|Period 2: Part A|Study Terminated|0|||
161476962|NCT04457336|583141703|FG004|Period 2: Part A|Study Terminated|0|||
161476963|NCT04457336|583141704|FG005|Period 2: Part A|Study Terminated|0|||
161476964|NCT04457336|583141705|FG006|Period 2: Part A|Study Terminated|0|||
161476965|NCT04457336|583141706|FG007|Period 2: Part A|Study Terminated|0|||
161476966|NCT04457336|583141699|FG000|Period 2: Part A|Protocol Violation|0|||
161476967|NCT04457336|583141700|FG001|Period 2: Part A|Protocol Violation|1|||
161476968|NCT04457336|583141701|FG002|Period 2: Part A|Protocol Violation|0|||
161476969|NCT04457336|583141702|FG003|Period 2: Part A|Protocol Violation|0|||
161476970|NCT04457336|583141703|FG004|Period 2: Part A|Protocol Violation|0|||
161476971|NCT04457336|583141704|FG005|Period 2: Part A|Protocol Violation|0|||
161476972|NCT04457336|583141705|FG006|Period 2: Part A|Protocol Violation|0|||
161476973|NCT04457336|583141706|FG007|Period 2: Part A|Protocol Violation|0|||
161476974|NCT04457336|583141699|FG000|Period 2: Part A|Lost to Follow-up|0|||
161476975|NCT04457336|583141700|FG001|Period 2: Part A|Lost to Follow-up|1|||
161476976|NCT04457336|583141701|FG002|Period 2: Part A|Lost to Follow-up|0|||
161476977|NCT04457336|583141702|FG003|Period 2: Part A|Lost to Follow-up|0|||
161476978|NCT04457336|583141703|FG004|Period 2: Part A|Lost to Follow-up|0|||
161476979|NCT04457336|583141704|FG005|Period 2: Part A|Lost to Follow-up|0|||
161578176|NCT03950622|583505172|FG001|Overall Study|Physician Decision|0|||
161578177|NCT03950622|583505171|FG000|Overall Study|Lost to Follow-up|5|||
161578178|NCT03950622|583505172|FG001|Overall Study|Lost to Follow-up|5|||
161578179|NCT03950622|583505171|FG000|Overall Study|Death|1|||
161578180|NCT03950622|583505172|FG001|Overall Study|Death|1|||
161476980|NCT04457336|583141705|FG006|Period 2: Part A|Lost to Follow-up|0|||
161476981|NCT04457336|583141706|FG007|Period 2: Part A|Lost to Follow-up|0|||
161476982|NCT04457336|583141699|FG000|Period 2: Part A|Other|0|||
161476983|NCT04457336|583141700|FG001|Period 2: Part A|Other|1|||
161476984|NCT04457336|583141701|FG002|Period 2: Part A|Other|0|||
161476985|NCT04457336|583141702|FG003|Period 2: Part A|Other|0|||
161578181|NCT03531840|583505176|FG000|Overall Study|Death on study|3|||
161578182|NCT03531840|583505177|FG001|Overall Study|Death on study|2|||
161578183|NCT03531840|583505178|FG002|Overall Study|Death on study|1|||
161578184|NCT03531840|583505179|FG003|Overall Study|Death on study|2|||
161578185|NCT03531840|583505176|FG000|Overall Study|Death during follow up|2|||
161578186|NCT03531840|583505177|FG001|Overall Study|Death during follow up|3|||
161578187|NCT03531840|583505178|FG002|Overall Study|Death during follow up|4|||
161578188|NCT03531840|583505179|FG003|Overall Study|Death during follow up|1|||
161476986|NCT04457336|583141703|FG004|Period 2: Part A|Other|0|||
161476987|NCT04457336|583141704|FG005|Period 2: Part A|Other|0|||
161476988|NCT04457336|583141705|FG006|Period 2: Part A|Other|0|||
161578189|NCT02267824|583505181|FG000|Overall Study|Pregnancy|1|||
161578190|NCT02267824|583505182|FG001|Overall Study|Pregnancy|1|||
161578191|NCT02267824|583505181|FG000|Overall Study|Lost to Follow-up|4|||
161815399|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161815400|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161815401|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
161815402|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
161815403|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
161815404|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
161815405|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
161815406|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
161815407|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815408|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
161815409|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815410|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815411|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815412|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815413|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815414|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
161815415|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815416|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815417|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815418|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815419|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815420|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
161815421|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815422|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815423|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815424|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815425|NCT00902538|584366945|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161815426|NCT00902538|584366946|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161815427|NCT00902538|584366947|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161815428|NCT00902538|584366948|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
161815429|NCT00902538|584366949|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
161815430|NCT00902538|584366950|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
161815431|NCT00902538|584366945|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161815432|NCT00902538|584366946|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161476989|NCT04457336|583141706|FG007|Period 2: Part A|Other|0|||
161476990|NCT04457336|583141699|FG000|Period 2: Part A|Physician Decision|0|||
161476991|NCT04457336|583141700|FG001|Period 2: Part A|Physician Decision|0|||
161476992|NCT04457336|583141701|FG002|Period 2: Part A|Physician Decision|0|||
161476993|NCT04457336|583141702|FG003|Period 2: Part A|Physician Decision|1|||
161476994|NCT04457336|583141703|FG004|Period 2: Part A|Physician Decision|0|||
161476995|NCT04457336|583141704|FG005|Period 2: Part A|Physician Decision|0|||
161476996|NCT04457336|583141705|FG006|Period 2: Part A|Physician Decision|0|||
161476997|NCT04457336|583141706|FG007|Period 2: Part A|Physician Decision|0|||
161476998|NCT04457336|583141699|FG000|Period 3: Part B|Study Terminated|0|||
161476999|NCT04457336|583141700|FG001|Period 3: Part B|Study Terminated|0|||
161477000|NCT04457336|583141701|FG002|Period 3: Part B|Study Terminated|0|||
161477001|NCT04457336|583141702|FG003|Period 3: Part B|Study Terminated|0|||
161477002|NCT04457336|583141703|FG004|Period 3: Part B|Study Terminated|1|||
161477003|NCT04457336|583141704|FG005|Period 3: Part B|Study Terminated|10|||
161477004|NCT04457336|583141705|FG006|Period 3: Part B|Study Terminated|13|||
161578192|NCT02267824|583505182|FG001|Overall Study|Lost to Follow-up|0|||
161477005|NCT04457336|583141706|FG007|Period 3: Part B|Study Terminated|0|||
161477006|NCT04457336|583141699|FG000|Period 3: Part B|Withdrawal by Subject|0|||
161477007|NCT04457336|583141700|FG001|Period 3: Part B|Withdrawal by Subject|0|||
161477008|NCT04457336|583141701|FG002|Period 3: Part B|Withdrawal by Subject|0|||
161578193|NCT02267824|583505181|FG000|Overall Study|Protocol Violation|3|||
161578194|NCT02267824|583505182|FG001|Overall Study|Protocol Violation|0|||
161920876|NCT02924376|584755833|FG002|Overall Study|Rolled Over to Another Study|0|||
161920877|NCT02924376|584755834|FG003|Overall Study|Rolled Over to Another Study|0|||
161920878|NCT03608033|584755835|FG000|Treatment Period|Death|0|||
161920879|NCT03608033|584755836|FG001|Treatment Period|Death|1|||
161920880|NCT03608033|584755835|FG000|Treatment Period|Adverse Event|1|||
161920881|NCT03608033|584755836|FG001|Treatment Period|Adverse Event|5|||
161920882|NCT03608033|584755835|FG000|Treatment Period|Lack of Efficacy|4|||
161920883|NCT03608033|584755836|FG001|Treatment Period|Lack of Efficacy|3|||
161920884|NCT03608033|584755835|FG000|Treatment Period|Lost to Follow-up|2|||
161920885|NCT03608033|584755836|FG001|Treatment Period|Lost to Follow-up|6|||
161920886|NCT03608033|584755835|FG000|Treatment Period|Physician Decision|6|||
161920887|NCT03608033|584755836|FG001|Treatment Period|Physician Decision|10|||
161920888|NCT03608033|584755835|FG000|Treatment Period|Pregnancy|1|||
161920889|NCT03608033|584755836|FG001|Treatment Period|Pregnancy|0|||
161920890|NCT03608033|584755835|FG000|Treatment Period|Protocol Violation|1|||
161920891|NCT03608033|584755836|FG001|Treatment Period|Protocol Violation|2|||
161920892|NCT03608033|584755835|FG000|Treatment Period|Withdrawal by Subject|46|||
161920893|NCT03608033|584755836|FG001|Treatment Period|Withdrawal by Subject|45|||
161920894|NCT03608033|584755835|FG000|Treatment Period|Study terminated by sponsor|82|||
161477009|NCT04457336|583141702|FG003|Period 3: Part B|Withdrawal by Subject|0|||
161477010|NCT04457336|583141703|FG004|Period 3: Part B|Withdrawal by Subject|0|||
161477011|NCT04457336|583141704|FG005|Period 3: Part B|Withdrawal by Subject|1|||
161477012|NCT04457336|583141705|FG006|Period 3: Part B|Withdrawal by Subject|2|||
161477013|NCT04457336|583141706|FG007|Period 3: Part B|Withdrawal by Subject|0|||
161920895|NCT03608033|584755836|FG001|Treatment Period|Study terminated by sponsor|68|||
161920896|NCT03608033|584755835|FG000|Treatment Period|Site Terminated by Sponsor|1|||
161920897|NCT03608033|584755836|FG001|Treatment Period|Site Terminated by Sponsor|0|||
161920898|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Adverse Event|1|||
161920899|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Adverse Event|0|||
161920900|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
161920901|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
161920902|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
161920903|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
161920904|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
161920905|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
161920906|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
161920907|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
161920908|NCT02360579|584755838|FG000|Initial|Death|16|||
161920909|NCT02360579|584755839|FG001|Initial|Death|49|||
161920910|NCT02360579|584755840|FG002|Initial|Death|0|||
161920911|NCT02360579|584755841|FG003|Initial|Death|71|||
161920912|NCT02360579|584755838|FG000|Initial|Lost to Follow-up|0|||
161920913|NCT02360579|584755839|FG001|Initial|Lost to Follow-up|4|||
161920914|NCT02360579|584755840|FG002|Initial|Lost to Follow-up|0|||
161920915|NCT02360579|584755841|FG003|Initial|Lost to Follow-up|1|||
161920916|NCT02360579|584755838|FG000|Initial|Withdrawal by Subject|0|||
161920917|NCT02360579|584755839|FG001|Initial|Withdrawal by Subject|0|||
161920918|NCT02360579|584755840|FG002|Initial|Withdrawal by Subject|0|||
161920919|NCT02360579|584755841|FG003|Initial|Withdrawal by Subject|3|||
161920920|NCT02360579|584755838|FG000|Initial|Other|7|||
161920921|NCT02360579|584755839|FG001|Initial|Other|0|||
161920922|NCT02360579|584755840|FG002|Initial|Other|0|||
161920923|NCT02360579|584755841|FG003|Initial|Other|0|||
161920924|NCT02360579|584755838|FG000|Initial|Did not receive TIL|8|||
161920925|NCT02360579|584755839|FG001|Initial|Did not receive TIL|11|||
161920926|NCT02360579|584755840|FG002|Initial|Did not receive TIL|0|||
161920927|NCT02360579|584755841|FG003|Initial|Did not receive TIL|22|||
161477014|NCT04457336|583141699|FG000|Period 4: Part C|Study Terminated|0|||
161477015|NCT04457336|583141700|FG001|Period 4: Part C|Study Terminated|0|||
161477016|NCT04457336|583141701|FG002|Period 4: Part C|Study Terminated|0|||
161477017|NCT04457336|583141702|FG003|Period 4: Part C|Study Terminated|0|||
161920928|NCT02360579|584755838|FG000|Retreatment|Death|0|||
161920929|NCT02360579|584755839|FG001|Retreatment|Death|0|||
161920930|NCT02360579|584755840|FG002|Retreatment|Death|11|||
161920931|NCT02360579|584755841|FG003|Retreatment|Death|0|||
161920932|NCT06455111|584755844|FG000|Overall Study|Withdrawal by Subject|11|||
161920933|NCT06455111|584755845|FG001|Overall Study|Withdrawal by Subject|4|||
161477018|NCT04457336|583141703|FG004|Period 4: Part C|Study Terminated|0|||
161477019|NCT04457336|583141704|FG005|Period 4: Part C|Study Terminated|0|||
161477020|NCT04457336|583141705|FG006|Period 4: Part C|Study Terminated|0|||
161477021|NCT04457336|583141706|FG007|Period 4: Part C|Study Terminated|30|||
161477022|NCT04457336|583141699|FG000|Period 4: Part C|Adverse Event|0|||
161477023|NCT04457336|583141700|FG001|Period 4: Part C|Adverse Event|0|||
161477024|NCT04457336|583141701|FG002|Period 4: Part C|Adverse Event|0|||
161477025|NCT04457336|583141702|FG003|Period 4: Part C|Adverse Event|0|||
161920934|NCT03682848|584755846|FG000|Overall Study|Withdrawal by Subject|3|||
161920935|NCT03682848|584755846|FG000|Overall Study|Site closed|5|||
161920936|NCT03682848|584755846|FG000|Overall Study|Protocol Deviation|1|||
161920937|NCT03682848|584755846|FG000|Overall Study|Adverse Event|2|||
161920938|NCT03682848|584755846|FG000|Overall Study|Lack of Efficacy|1|||
161477026|NCT04457336|583141703|FG004|Period 4: Part C|Adverse Event|0|||
161477027|NCT04457336|583141704|FG005|Period 4: Part C|Adverse Event|0|||
161477028|NCT04457336|583141705|FG006|Period 4: Part C|Adverse Event|0|||
161477029|NCT04457336|583141706|FG007|Period 4: Part C|Adverse Event|2|||
161815433|NCT00902538|584366947|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161815434|NCT00902538|584366948|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
161815435|NCT00902538|584366949|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
161815436|NCT00902538|584366950|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161815437|NCT00902538|584366945|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815438|NCT00902538|584366946|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815439|NCT00902538|584366947|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815440|NCT00902538|584366948|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
161815441|NCT00902538|584366949|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815442|NCT00902538|584366950|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815443|NCT01279486|584366953|FG000|Overall Study|Lost to Follow-up|1|||
161815444|NCT03215706|584366956|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161815445|NCT03215706|584366957|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161815446|NCT03215706|584366956|FG000|Randomization|participant withdrew consent|1|||
161815447|NCT03215706|584366957|FG001|Randomization|participant withdrew consent|3|||
161815448|NCT03215706|584366956|FG000|Randomization|no longer meets study criteria|1|||
161815449|NCT03215706|584366957|FG001|Randomization|no longer meets study criteria|4|||
161815450|NCT03215706|584366956|FG000|Randomization|other reasons|0|||
161815451|NCT03215706|584366957|FG001|Randomization|other reasons|2|||
161815452|NCT03215706|584366956|FG000|Treatment Period|Disease Progression|184|||
161477030|NCT04457336|583141699|FG000|Period 4: Part C|Site Terminated|0|||
161477031|NCT04457336|583141700|FG001|Period 4: Part C|Site Terminated|0|||
161477032|NCT04457336|583141701|FG002|Period 4: Part C|Site Terminated|0|||
161477033|NCT04457336|583141702|FG003|Period 4: Part C|Site Terminated|0|||
161477034|NCT04457336|583141703|FG004|Period 4: Part C|Site Terminated|0|||
161477035|NCT04457336|583141704|FG005|Period 4: Part C|Site Terminated|0|||
161477036|NCT04457336|583141705|FG006|Period 4: Part C|Site Terminated|0|||
161477037|NCT04457336|583141706|FG007|Period 4: Part C|Site Terminated|1|||
161477038|NCT04457336|583141699|FG000|Period 4: Part C|Other|0|||
161477039|NCT04457336|583141700|FG001|Period 4: Part C|Other|0|||
161477040|NCT04457336|583141701|FG002|Period 4: Part C|Other|0|||
161477041|NCT04457336|583141702|FG003|Period 4: Part C|Other|0|||
161477042|NCT04457336|583141703|FG004|Period 4: Part C|Other|0|||
161477043|NCT04457336|583141704|FG005|Period 4: Part C|Other|0|||
161477044|NCT04457336|583141705|FG006|Period 4: Part C|Other|0|||
161477045|NCT04457336|583141706|FG007|Period 4: Part C|Other|2|||
161477046|NCT04457336|583141699|FG000|Period 4: Part C|Withdrawal by Subject|0|||
161477047|NCT04457336|583141700|FG001|Period 4: Part C|Withdrawal by Subject|0|||
161477048|NCT04457336|583141701|FG002|Period 4: Part C|Withdrawal by Subject|0|||
161477049|NCT04457336|583141702|FG003|Period 4: Part C|Withdrawal by Subject|0|||
161477050|NCT04457336|583141703|FG004|Period 4: Part C|Withdrawal by Subject|0|||
161477051|NCT04457336|583141704|FG005|Period 4: Part C|Withdrawal by Subject|0|||
161477052|NCT04457336|583141705|FG006|Period 4: Part C|Withdrawal by Subject|0|||
161477053|NCT04457336|583141706|FG007|Period 4: Part C|Withdrawal by Subject|3|||
161477054|NCT05379231|583141707|FG000|Home Visit|Withdrawal by Subject|2|||
161477055|NCT05379231|583141707|FG000|In-lab Visit|Withdrawal by Subject|2|||
161477056|NCT02589405|583141714|FG000|Overall Study|Adverse Event|3|||
161477057|NCT02589405|583141714|FG000|Overall Study|Withdrawal by Subject|1|||
161477058|NCT00446251|583141715|FG000|Overall Study|On-study Transplants|2|||
161477059|NCT00446251|583141715|FG000|Overall Study|Rituximab Infusion Reaction|2|||
161477060|NCT00446251|583141715|FG000|Overall Study|Lost to Follow-up|1|||
161477061|NCT01416272|583141717|FG000|Overall Study|Unacceptable distance visual acuity|2|||
161477062|NCT01416272|583141717|FG000|Overall Study|Lost to Follow-up|1|||
161477063|NCT01416272|583141717|FG000|Overall Study|Study related complaints|1|||
161477064|NCT02693119|583141718|FG000|Open-Label Period|Withdrawal by Subject|0|||
161477065|NCT02693119|583141719|FG001|Open-Label Period|Withdrawal by Subject|1|||
161477066|NCT01719783|583141720|FG000|Dose 2|Physician Decision|1|||
161477067|NCT01719783|583141721|FG001|Dose 2|Physician Decision|0|||
161477068|NCT01350492|583141722|FG000|Intervention|Lost to Follow-up|2|||
161477069|NCT01350492|583141723|FG001|Intervention|Lost to Follow-up|5|||
161477070|NCT01350492|583141722|FG000|Intervention|Withdrawal by Subject|3|||
161477071|NCT01350492|583141723|FG001|Intervention|Withdrawal by Subject|1|||
161477072|NCT01350492|583141722|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
161477073|NCT01350492|583141723|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
161477074|NCT01350492|583141722|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
161477075|NCT01350492|583141723|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
161477076|NCT00753766|583141724|FG000|Overall Study|Physician Decision|1|||
161477077|NCT00753766|583141725|FG001|Overall Study|Physician Decision|0|||
161477078|NCT03800173|583141728|FG000|Overall Study|Lost to Follow-up|0|||
161477079|NCT03800173|583141729|FG001|Overall Study|Lost to Follow-up|0|||
161477080|NCT03800173|583141730|FG002|Overall Study|Lost to Follow-up|0|||
161815453|NCT03215706|584366957|FG001|Treatment Period|Disease Progression|174|||
161578195|NCT02267824|583505181|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
161578196|NCT02267824|583505182|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
161578197|NCT01546753|583505183|FG000|Overall Study|anxiety|1|||
161578198|NCT01546753|583505184|FG001|Overall Study|anxiety|1|||
161578199|NCT01546753|583505183|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
161578200|NCT01546753|583505184|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
161578201|NCT01236560|583505192|FG000|Overall Study|Adverse Event|0|||
161578202|NCT01236560|583505193|FG001|Overall Study|Adverse Event|2|||
161578203|NCT01236560|583505194|FG002|Overall Study|Adverse Event|1|||
161578204|NCT01236560|583505195|FG003|Overall Study|Adverse Event|3|||
161578205|NCT01236560|583505196|FG004|Overall Study|Adverse Event|0|||
161578206|NCT01236560|583505197|FG005|Overall Study|Adverse Event|0|||
161578207|NCT01236560|583505192|FG000|Overall Study|Death|0|||
161578208|NCT01236560|583505193|FG001|Overall Study|Death|1|||
161578209|NCT01236560|583505194|FG002|Overall Study|Death|0|||
161578210|NCT01236560|583505195|FG003|Overall Study|Death|1|||
161578211|NCT01236560|583505196|FG004|Overall Study|Death|0|||
161578212|NCT01236560|583505197|FG005|Overall Study|Death|0|||
161578213|NCT01236560|583505192|FG000|Overall Study|Lost to Follow-up|0|||
161578214|NCT01236560|583505193|FG001|Overall Study|Lost to Follow-up|1|||
161578215|NCT01236560|583505194|FG002|Overall Study|Lost to Follow-up|1|||
161578216|NCT01236560|583505195|FG003|Overall Study|Lost to Follow-up|0|||
161578217|NCT01236560|583505196|FG004|Overall Study|Lost to Follow-up|0|||
161578218|NCT01236560|583505197|FG005|Overall Study|Lost to Follow-up|0|||
161578219|NCT01236560|583505192|FG000|Overall Study|Physician Decision|0|||
161578220|NCT01236560|583505193|FG001|Overall Study|Physician Decision|1|||
161578221|NCT01236560|583505194|FG002|Overall Study|Physician Decision|8|||
161578222|NCT01236560|583505195|FG003|Overall Study|Physician Decision|0|||
161578223|NCT01236560|583505196|FG004|Overall Study|Physician Decision|0|||
161578224|NCT01236560|583505197|FG005|Overall Study|Physician Decision|0|||
161578225|NCT01236560|583505192|FG000|Overall Study|Withdrawal by Subject|0|||
161578226|NCT01236560|583505193|FG001|Overall Study|Withdrawal by Subject|0|||
161578227|NCT01236560|583505194|FG002|Overall Study|Withdrawal by Subject|1|||
161578228|NCT01236560|583505195|FG003|Overall Study|Withdrawal by Subject|2|||
161578229|NCT01236560|583505196|FG004|Overall Study|Withdrawal by Subject|0|||
161578230|NCT01236560|583505197|FG005|Overall Study|Withdrawal by Subject|0|||
161578231|NCT01236560|583505192|FG000|Overall Study|Progressive disease|5|||
161578232|NCT01236560|583505193|FG001|Overall Study|Progressive disease|19|||
161578233|NCT01236560|583505194|FG002|Overall Study|Progressive disease|9|||
161578234|NCT01236560|583505195|FG003|Overall Study|Progressive disease|16|||
161578235|NCT01236560|583505196|FG004|Overall Study|Progressive disease|0|||
161578236|NCT01236560|583505197|FG005|Overall Study|Progressive disease|0|||
161578237|NCT01576484|583505200|FG000|Overall Study|Adverse Event|1|||
161578238|NCT01576484|583505201|FG001|Overall Study|Adverse Event|1|||
161578239|NCT01576484|583505200|FG000|Overall Study|Protocol Violation|0|||
161578240|NCT01576484|583505201|FG001|Overall Study|Protocol Violation|2|||
161578241|NCT01576484|583505200|FG000|Overall Study|Sponsor Decision|2|||
161578242|NCT01576484|583505201|FG001|Overall Study|Sponsor Decision|8|||
161578243|NCT01576484|583505200|FG000|Overall Study|Withdrawal by Subject|0|||
161920939|NCT02337686|584755850|FG000|Overall Study|Adverse Event|1|||
161920940|NCT00970944|584757107|FG000|Overall Study|Death|1|||
161477081|NCT03800173|583141731|FG003|Overall Study|Lost to Follow-up|0|||
161477082|NCT03800173|583141732|FG004|Overall Study|Lost to Follow-up|1|||
161477083|NCT00932126|583141735|FG000|Overall Study|Adverse Event|0|||
161477084|NCT00932126|583141736|FG001|Overall Study|Adverse Event|0|||
161477085|NCT00932126|583141737|FG002|Overall Study|Adverse Event|0|||
161477086|NCT00932126|583141738|FG003|Overall Study|Adverse Event|0|||
161477087|NCT00932126|583141739|FG004|Overall Study|Adverse Event|0|||
161477088|NCT00932126|583141740|FG005|Overall Study|Adverse Event|0|||
161477089|NCT00932126|583141741|FG006|Overall Study|Adverse Event|1|||
161477090|NCT00932126|583141742|FG007|Overall Study|Adverse Event|2|||
161477091|NCT00932126|583141735|FG000|Overall Study|Protocol Violation|0|||
161477092|NCT00932126|583141736|FG001|Overall Study|Protocol Violation|0|||
161477093|NCT00932126|583141737|FG002|Overall Study|Protocol Violation|0|||
161477094|NCT00932126|583141738|FG003|Overall Study|Protocol Violation|0|||
161477095|NCT00932126|583141739|FG004|Overall Study|Protocol Violation|1|||
161477096|NCT00932126|583141740|FG005|Overall Study|Protocol Violation|0|||
161477097|NCT00932126|583141741|FG006|Overall Study|Protocol Violation|0|||
161477098|NCT00932126|583141742|FG007|Overall Study|Protocol Violation|0|||
161477099|NCT00932126|583141735|FG000|Overall Study|Withdrawal by Subject|0|||
161477100|NCT00932126|583141736|FG001|Overall Study|Withdrawal by Subject|0|||
161477101|NCT00932126|583141737|FG002|Overall Study|Withdrawal by Subject|1|||
161477102|NCT00932126|583141738|FG003|Overall Study|Withdrawal by Subject|0|||
161477103|NCT00932126|583141739|FG004|Overall Study|Withdrawal by Subject|0|||
161477104|NCT00932126|583141740|FG005|Overall Study|Withdrawal by Subject|0|||
161477105|NCT00932126|583141741|FG006|Overall Study|Withdrawal by Subject|0|||
161477106|NCT00932126|583141742|FG007|Overall Study|Withdrawal by Subject|1|||
161578244|NCT01576484|583505201|FG001|Overall Study|Withdrawal by Subject|3|||
161578245|NCT01576484|583505200|FG000|Overall Study|Other|2|||
161920941|NCT00970944|584757108|FG001|Overall Study|Death|0|||
161477107|NCT00932126|583141735|FG000|Overall Study|Objective progression or relapse|3|||
161477108|NCT00932126|583141736|FG001|Overall Study|Objective progression or relapse|3|||
161477109|NCT00932126|583141737|FG002|Overall Study|Objective progression or relapse|2|||
161477110|NCT00932126|583141738|FG003|Overall Study|Objective progression or relapse|3|||
161477111|NCT00932126|583141739|FG004|Overall Study|Objective progression or relapse|3|||
161477112|NCT00932126|583141740|FG005|Overall Study|Objective progression or relapse|3|||
161477113|NCT00932126|583141741|FG006|Overall Study|Objective progression or relapse|3|||
161477114|NCT00932126|583141742|FG007|Overall Study|Objective progression or relapse|5|||
161477115|NCT00932126|583141735|FG000|Overall Study|Other|0|||
161477116|NCT00932126|583141736|FG001|Overall Study|Other|0|||
161477117|NCT00932126|583141737|FG002|Overall Study|Other|0|||
161477118|NCT00932126|583141738|FG003|Overall Study|Other|0|||
161477119|NCT00932126|583141739|FG004|Overall Study|Other|1|||
161477120|NCT00932126|583141740|FG005|Overall Study|Other|0|||
161477121|NCT00932126|583141741|FG006|Overall Study|Other|1|||
161477122|NCT00932126|583141742|FG007|Overall Study|Other|2|||
161477123|NCT02121522|583141750|FG000|Overall Study|Adverse Event|1|||
161477124|NCT01235689|583141751|FG000|Overall Study|Adverse Event|12|||
161477125|NCT01235689|583141752|FG001|Overall Study|Adverse Event|16|||
161477126|NCT01235689|583141751|FG000|Overall Study|Lack of Efficacy|12|||
161477127|NCT01235689|583141752|FG001|Overall Study|Lack of Efficacy|5|||
161477128|NCT01235689|583141751|FG000|Overall Study|Withdrawal by Subject|3|||
161477129|NCT01235689|583141752|FG001|Overall Study|Withdrawal by Subject|4|||
161477130|NCT01235689|583141751|FG000|Overall Study|Lost to Follow-up|1|||
161477131|NCT01235689|583141752|FG001|Overall Study|Lost to Follow-up|2|||
161477132|NCT01235689|583141751|FG000|Overall Study|Miscellaneous|1|||
161477133|NCT01235689|583141752|FG001|Overall Study|Miscellaneous|5|||
161477134|NCT02217878|583141753|FG000|Overall Study|required morphine due to chest pain|1|||
161815454|NCT03215706|584366956|FG000|Treatment Period|Study Drug Toxicity|70|||
161477135|NCT02217878|583141754|FG001|Overall Study|required morphine due to chest pain|2|||
161815455|NCT03215706|584366957|FG001|Treatment Period|Study Drug Toxicity|24|||
161815456|NCT03215706|584366956|FG000|Treatment Period|Death|7|||
161815457|NCT03215706|584366957|FG001|Treatment Period|Death|1|||
161815458|NCT03215706|584366956|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
161815459|NCT03215706|584366957|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
161815460|NCT03215706|584366956|FG000|Treatment Period|Request to D/C treatment|2|||
161815461|NCT03215706|584366957|FG001|Treatment Period|Request to D/C treatment|10|||
161815462|NCT03215706|584366956|FG000|Treatment Period|Participant withdrew consent|4|||
161815463|NCT03215706|584366957|FG001|Treatment Period|Participant withdrew consent|5|||
161815464|NCT03215706|584366956|FG000|Treatment Period|Lost to Follow-up|0|||
161815465|NCT03215706|584366957|FG001|Treatment Period|Lost to Follow-up|1|||
161815466|NCT03215706|584366956|FG000|Treatment Period|Administrative reason by sponsor|0|||
161815467|NCT03215706|584366957|FG001|Treatment Period|Administrative reason by sponsor|2|||
161815468|NCT03215706|584366956|FG000|Treatment Period|other reasons|10|||
161815469|NCT03215706|584366957|FG001|Treatment Period|other reasons|5|||
161815470|NCT03215706|584366956|FG000|Treatment Period|Not reported|1|||
161815471|NCT03215706|584366957|FG001|Treatment Period|Not reported|0|||
161815472|NCT03506633|584368657|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
161815473|NCT03506633|584368658|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
161815474|NCT03247686|584368663|FG000|Overall Study|Withdrawal by Subject|1|||
161815475|NCT03247686|584368664|FG001|Overall Study|Withdrawal by Subject|2|||
161815476|NCT02302716|584368665|FG000|Overall Study|Adverse Event|1|||
161815477|NCT02302716|584368666|FG001|Overall Study|Adverse Event|1|||
161815478|NCT02302716|584368665|FG000|Overall Study|Death|0|||
161815479|NCT02302716|584368666|FG001|Overall Study|Death|1|||
161815480|NCT02302716|584368665|FG000|Overall Study|Lack of Efficacy|0|||
161815481|NCT02302716|584368666|FG001|Overall Study|Lack of Efficacy|1|||
161815482|NCT02302716|584368665|FG000|Overall Study|Lost to Follow-up|2|||
161815483|NCT02302716|584368666|FG001|Overall Study|Lost to Follow-up|4|||
161815484|NCT02302716|584368665|FG000|Overall Study|Physician Decision|3|||
161815485|NCT02302716|584368666|FG001|Overall Study|Physician Decision|4|||
161815486|NCT02302716|584368665|FG000|Overall Study|Withdrawal by Subject|13|||
161815487|NCT02302716|584368666|FG001|Overall Study|Withdrawal by Subject|7|||
161815488|NCT02302716|584368665|FG000|Overall Study|Protocol Violation|0|||
161477136|NCT02217878|583141753|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
161477137|NCT02217878|583141754|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
161477138|NCT00806351|583141757|FG000|Overall Study|Death|5|||
161815489|NCT02302716|584368666|FG001|Overall Study|Protocol Violation|1|||
161815490|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Subject request|8|||
161815491|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Subject request|11|||
161815492|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
161815493|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
161477139|NCT00806351|583141758|FG001|Overall Study|Death|4|||
161815494|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
161815495|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
161477140|NCT02151110|583141759|FG000|Overall Study|Withdrawal by Subject|0|||
161815496|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
161815497|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
161815498|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
161815499|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
161815500|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
161815501|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
161815502|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Death|1|||
161815503|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Death|0|||
161815504|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
161815505|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
161815506|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
161815507|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
161815508|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
161815509|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
161815510|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
161815511|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
161477141|NCT02151110|583141760|FG001|Overall Study|Withdrawal by Subject|0|||
161477142|NCT02151110|583141761|FG002|Overall Study|Withdrawal by Subject|0|||
161477143|NCT02151110|583141762|FG003|Overall Study|Withdrawal by Subject|0|||
161477144|NCT02151110|583141763|FG004|Overall Study|Withdrawal by Subject|0|||
161815512|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
161815513|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
161815514|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
161815515|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
161477145|NCT02151110|583141764|FG005|Overall Study|Withdrawal by Subject|0|||
161477146|NCT02151110|583141765|FG006|Overall Study|Withdrawal by Subject|0|||
161815516|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
161815517|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
161815518|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
161815519|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
161815520|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
161815521|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
161815522|NCT00521586|584368671|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
161815523|NCT00521586|584368672|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
161815524|NCT00521586|584368671|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
161815525|NCT00521586|584368672|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
161815526|NCT00521586|584368671|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
161815527|NCT00521586|584368672|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
161815528|NCT00529763|584368673|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161815529|NCT00529763|584368674|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
161815530|NCT00529763|584368675|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161815531|NCT00529763|584368673|FG000|Overall Study|Death|1|||
161920942|NCT00970944|584757107|FG000|Overall Study|Physician Decision|0|||
161920943|NCT00970944|584757108|FG001|Overall Study|Physician Decision|2|||
161920944|NCT02008370|584757109|FG000|Overall Study|Lost to Follow-up|7|||
161920945|NCT00662259|584757110|FG000|Overall Study|Adverse Event|2|||
161920946|NCT00662259|584757111|FG001|Overall Study|Adverse Event|0|||
161477147|NCT02151110|583141766|FG007|Overall Study|Withdrawal by Subject|1|||
161477148|NCT02151110|583141759|FG000|Overall Study|Lost to Follow-up|0|||
161477149|NCT02151110|583141760|FG001|Overall Study|Lost to Follow-up|0|||
161477150|NCT02151110|583141761|FG002|Overall Study|Lost to Follow-up|0|||
161477151|NCT02151110|583141762|FG003|Overall Study|Lost to Follow-up|0|||
161477152|NCT02151110|583141763|FG004|Overall Study|Lost to Follow-up|0|||
161477153|NCT02151110|583141764|FG005|Overall Study|Lost to Follow-up|0|||
161477154|NCT02151110|583141765|FG006|Overall Study|Lost to Follow-up|0|||
161477155|NCT02151110|583141766|FG007|Overall Study|Lost to Follow-up|2|||
161477156|NCT00672646|583141770|FG000|Overall Study|Lost to Follow-up|0|||
161477157|NCT00672646|583141771|FG001|Overall Study|Lost to Follow-up|1|||
161477158|NCT00672646|583141772|FG002|Overall Study|Lost to Follow-up|2|||
161920947|NCT00972738|584757112|FG000|Overall Study|Adverse Event|7|||
161920948|NCT00972738|584757113|FG001|Overall Study|Adverse Event|1|||
161920949|NCT00972738|584757114|FG002|Overall Study|Adverse Event|8|||
161920950|NCT00972738|584757112|FG000|Overall Study|Protocol Violation|2|||
161920951|NCT00972738|584757113|FG001|Overall Study|Protocol Violation|1|||
161477159|NCT00672646|583141770|FG000|Overall Study|Withdrawal by Subject|0|||
161477160|NCT00672646|583141771|FG001|Overall Study|Withdrawal by Subject|0|||
161477161|NCT00672646|583141772|FG002|Overall Study|Withdrawal by Subject|1|||
161477162|NCT01999179|583141773|FG000|Overall Study|Adverse Event|1|||
161920952|NCT00972738|584757114|FG002|Overall Study|Protocol Violation|3|||
161920953|NCT00972738|584757112|FG000|Overall Study|Lost to Follow-up|1|||
161920954|NCT00972738|584757113|FG001|Overall Study|Lost to Follow-up|0|||
161477163|NCT01999179|583141773|FG000|Overall Study|Lost to Follow-up|1|||
161477164|NCT01999179|583141773|FG000|Overall Study|Change in Therapy|3|||
161477165|NCT01999179|583141773|FG000|Overall Study|New catheter|2|||
161477166|NCT00289783|583141774|FG000|Primary Phase|Adverse Event|10|||
161477167|NCT00289783|583141775|FG001|Primary Phase|Adverse Event|1|||
161477168|NCT00289783|583141774|FG000|Primary Phase|Protocol Violation|27|||
161477169|NCT00289783|583141775|FG001|Primary Phase|Protocol Violation|6|||
161477170|NCT00289783|583141774|FG000|Primary Phase|Withdrawal by Subject|93|||
161477171|NCT00289783|583141775|FG001|Primary Phase|Withdrawal by Subject|40|||
161477172|NCT00289783|583141774|FG000|Primary Phase|Lost to Follow-up|60|||
161815532|NCT00529763|584368674|FG001|Overall Study|Death|1|||
161815533|NCT00529763|584368675|FG002|Overall Study|Death|1|||
161815534|NCT00529763|584368673|FG000|Overall Study|Disease Progression|10|||
161815535|NCT00529763|584368674|FG001|Overall Study|Disease Progression|16|||
161815536|NCT00529763|584368675|FG002|Overall Study|Disease Progression|11|||
161815537|NCT00529763|584368673|FG000|Overall Study|Lost to Follow-up|1|||
161815538|NCT00529763|584368674|FG001|Overall Study|Lost to Follow-up|2|||
161815539|NCT00529763|584368675|FG002|Overall Study|Lost to Follow-up|3|||
161815540|NCT00529763|584368673|FG000|Overall Study|Stem Cell Transplant|0|||
161815541|NCT00529763|584368674|FG001|Overall Study|Stem Cell Transplant|3|||
161815542|NCT00529763|584368675|FG002|Overall Study|Stem Cell Transplant|1|||
161815543|NCT00529763|584368673|FG000|Overall Study|Study Drug Toxicity|3|||
161815544|NCT00529763|584368674|FG001|Overall Study|Study Drug Toxicity|6|||
161815545|NCT00529763|584368675|FG002|Overall Study|Study Drug Toxicity|4|||
161815546|NCT00529763|584368673|FG000|Overall Study|Participant Withdrew Consent|2|||
161815547|NCT00529763|584368674|FG001|Overall Study|Participant Withdrew Consent|3|||
161815548|NCT00529763|584368675|FG002|Overall Study|Participant Withdrew Consent|4|||
161815549|NCT00529763|584368673|FG000|Overall Study|Other reasons|2|||
161815550|NCT00529763|584368674|FG001|Overall Study|Other reasons|0|||
161815551|NCT00529763|584368675|FG002|Overall Study|Other reasons|2|||
161815552|NCT00529763|584368673|FG000|Overall Study|Participant request to discontinue treatment|1|||
161815553|NCT00529763|584368674|FG001|Overall Study|Participant request to discontinue treatment|1|||
161815554|NCT00529763|584368675|FG002|Overall Study|Participant request to discontinue treatment|3|||
161815555|NCT03669250|584368676|FG000|Overall Study|Adverse Event|0|||
161815556|NCT03669250|584368677|FG001|Overall Study|Adverse Event|0|||
161815557|NCT03669250|584368678|FG002|Overall Study|Adverse Event|0|||
161815558|NCT03669250|584368679|FG003|Overall Study|Adverse Event|0|||
161815559|NCT03669250|584368680|FG004|Overall Study|Adverse Event|1|||
161815560|NCT03669250|584368681|FG005|Overall Study|Adverse Event|0|||
161815561|NCT03669250|584368676|FG000|Overall Study|Withdrawal by Subject|0|||
161815562|NCT03669250|584368677|FG001|Overall Study|Withdrawal by Subject|1|||
161815563|NCT03669250|584368678|FG002|Overall Study|Withdrawal by Subject|0|||
161815564|NCT03669250|584368679|FG003|Overall Study|Withdrawal by Subject|1|||
161815565|NCT03669250|584368680|FG004|Overall Study|Withdrawal by Subject|0|||
161815566|NCT03669250|584368681|FG005|Overall Study|Withdrawal by Subject|0|||
161815567|NCT00828321|584368682|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
161815568|NCT00828321|584368683|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
161815569|NCT00828321|584368682|FG000|Second Intervention|Protocol Violation|0|||
161815570|NCT00828321|584368683|FG001|Second Intervention|Protocol Violation|1|||
161815571|NCT02997176|584368684|FG000|Overall Study|Adverse Event|0|||
161815572|NCT02997176|584368685|FG001|Overall Study|Adverse Event|0|||
161815573|NCT02997176|584368686|FG002|Overall Study|Adverse Event|0|||
161815574|NCT02997176|584368687|FG003|Overall Study|Adverse Event|8|||
161815575|NCT02997176|584368684|FG000|Overall Study|Progressive Disease|1|||
161815576|NCT02997176|584368685|FG001|Overall Study|Progressive Disease|0|||
161815577|NCT02997176|584368686|FG002|Overall Study|Progressive Disease|1|||
161815578|NCT02997176|584368687|FG003|Overall Study|Progressive Disease|1|||
161815579|NCT02997176|584368684|FG000|Overall Study|Death|0|||
161815580|NCT02997176|584368685|FG001|Overall Study|Death|0|||
161815581|NCT02997176|584368686|FG002|Overall Study|Death|1|||
161815582|NCT02997176|584368687|FG003|Overall Study|Death|1|||
161815583|NCT02997176|584368684|FG000|Overall Study|Withdrawal by Subject|0|||
161815584|NCT02997176|584368685|FG001|Overall Study|Withdrawal by Subject|2|||
161815585|NCT02997176|584368686|FG002|Overall Study|Withdrawal by Subject|0|||
161815586|NCT02997176|584368687|FG003|Overall Study|Withdrawal by Subject|1|||
161815587|NCT04523480|584368688|FG000|Overall Study|Lost to Follow-up|30|||
161815588|NCT04523480|584368689|FG001|Overall Study|Lost to Follow-up|35|||
161815589|NCT04523480|584368690|FG002|Overall Study|Lost to Follow-up|0|||
161815590|NCT00488774|584368691|FG000|Overall Study|Withdrawal of consent|2|||
161815591|NCT00488774|584368692|FG001|Overall Study|Withdrawal of consent|2|||
161815592|NCT00488774|584368693|FG002|Overall Study|Withdrawal of consent|2|||
161815593|NCT00488774|584368694|FG003|Overall Study|Withdrawal of consent|0|||
161815594|NCT00488774|584368691|FG000|Overall Study|Other|6|||
161815595|NCT00488774|584368692|FG001|Overall Study|Other|3|||
161815596|NCT00488774|584368693|FG002|Overall Study|Other|2|||
161815597|NCT00488774|584368694|FG003|Overall Study|Other|2|||
161815598|NCT00488774|584368691|FG000|Overall Study|Lost to Follow-up|0|||
161815599|NCT00488774|584368692|FG001|Overall Study|Lost to Follow-up|0|||
161815600|NCT00488774|584368693|FG002|Overall Study|Lost to Follow-up|1|||
161477173|NCT00289783|583141775|FG001|Primary Phase|Lost to Follow-up|14|||
161477174|NCT00289783|583141774|FG000|Primary Phase|Migration from the study area|26|||
161477175|NCT00289783|583141775|FG001|Primary Phase|Migration from the study area|10|||
161477176|NCT00289783|583141774|FG000|Primary Phase|Other|32|||
161477177|NCT00289783|583141775|FG001|Primary Phase|Other|12|||
161477178|NCT00289783|583141774|FG000|Fourth Dose Phase|Adverse Event|1|||
161477179|NCT00289783|583141775|FG001|Fourth Dose Phase|Adverse Event|0|||
161477180|NCT00289783|583141774|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
161477181|NCT00289783|583141775|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
161477182|NCT00289783|583141774|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
161477183|NCT00289783|583141775|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
161477184|NCT00289783|583141774|FG000|Fourth Dose Phase|Migration from the study area|1|||
161477185|NCT00289783|583141775|FG001|Fourth Dose Phase|Migration from the study area|1|||
161477186|NCT00289783|583141774|FG000|Fourth Dose Phase|Other|22|||
161477187|NCT00289783|583141775|FG001|Fourth Dose Phase|Other|10|||
161477188|NCT05248867|583141778|FG000|Double-blind Period|Lost to Follow-up|0|||
161477189|NCT05248867|583141779|FG001|Double-blind Period|Lost to Follow-up|3|||
161477190|NCT05248867|583141780|FG002|Double-blind Period|Lost to Follow-up|0|||
161477191|NCT05248867|583141781|FG003|Double-blind Period|Lost to Follow-up|0|||
161477192|NCT05248867|583141782|FG004|Double-blind Period|Lost to Follow-up|0|||
161477193|NCT05248867|583141783|FG005|Double-blind Period|Lost to Follow-up|0|||
161477194|NCT05248867|583141778|FG000|Double-blind Period|Withdrawal by Subject|5|||
161477195|NCT05248867|583141779|FG001|Double-blind Period|Withdrawal by Subject|14|||
161477196|NCT05248867|583141780|FG002|Double-blind Period|Withdrawal by Subject|0|||
161477197|NCT05248867|583141781|FG003|Double-blind Period|Withdrawal by Subject|0|||
161477198|NCT05248867|583141782|FG004|Double-blind Period|Withdrawal by Subject|0|||
161477199|NCT05248867|583141783|FG005|Double-blind Period|Withdrawal by Subject|0|||
161477200|NCT05248867|583141778|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
161477201|NCT05248867|583141779|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
161477202|NCT05248867|583141780|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
161477203|NCT05248867|583141781|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
161477204|NCT05248867|583141782|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
161477205|NCT05248867|583141783|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
161477206|NCT05248867|583141778|FG000|Double-blind Period|Other, not specified|3|||
161477207|NCT05248867|583141779|FG001|Double-blind Period|Other, not specified|8|||
161477208|NCT05248867|583141780|FG002|Double-blind Period|Other, not specified|0|||
161477209|NCT05248867|583141781|FG003|Double-blind Period|Other, not specified|0|||
161477210|NCT05248867|583141782|FG004|Double-blind Period|Other, not specified|0|||
161477211|NCT05248867|583141783|FG005|Double-blind Period|Other, not specified|0|||
161477212|NCT05248867|583141778|FG000|Open-label Period|Withdrawal by Subject|0|||
161477213|NCT05248867|583141779|FG001|Open-label Period|Withdrawal by Subject|0|||
161477214|NCT05248867|583141780|FG002|Open-label Period|Withdrawal by Subject|3|||
161477215|NCT05248867|583141781|FG003|Open-label Period|Withdrawal by Subject|1|||
161477216|NCT05248867|583141782|FG004|Open-label Period|Withdrawal by Subject|7|||
161477217|NCT05248867|583141783|FG005|Open-label Period|Withdrawal by Subject|9|||
161477218|NCT05248867|583141778|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
161477219|NCT05248867|583141779|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
161477220|NCT05248867|583141780|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
161477221|NCT05248867|583141781|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
161477222|NCT05248867|583141782|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
161477223|NCT05248867|583141783|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
161477224|NCT05248867|583141778|FG000|Open-label Period|Lost to Follow-up|0|||
161477225|NCT05248867|583141779|FG001|Open-label Period|Lost to Follow-up|0|||
161920955|NCT00972738|584757114|FG002|Overall Study|Lost to Follow-up|1|||
161920956|NCT00972738|584757112|FG000|Overall Study|Lack of Efficacy|5|||
161920957|NCT00972738|584757113|FG001|Overall Study|Lack of Efficacy|1|||
161920958|NCT00972738|584757114|FG002|Overall Study|Lack of Efficacy|11|||
161920959|NCT00972738|584757112|FG000|Overall Study|Withdrawal by Subject|5|||
161920960|NCT00972738|584757113|FG001|Overall Study|Withdrawal by Subject|1|||
161920961|NCT00972738|584757114|FG002|Overall Study|Withdrawal by Subject|4|||
161920962|NCT00972738|584757112|FG000|Overall Study|Moved|0|||
161920963|NCT00972738|584757113|FG001|Overall Study|Moved|0|||
161920964|NCT00972738|584757114|FG002|Overall Study|Moved|1|||
161477226|NCT05248867|583141780|FG002|Open-label Period|Lost to Follow-up|0|||
161477227|NCT05248867|583141781|FG003|Open-label Period|Lost to Follow-up|0|||
161477228|NCT05248867|583141782|FG004|Open-label Period|Lost to Follow-up|5|||
161477229|NCT05248867|583141783|FG005|Open-label Period|Lost to Follow-up|2|||
161477230|NCT05248867|583141778|FG000|Open-label Period|COVID-19 Infection|0|||
161477231|NCT05248867|583141779|FG001|Open-label Period|COVID-19 Infection|0|||
161477232|NCT05248867|583141780|FG002|Open-label Period|COVID-19 Infection|0|||
161477233|NCT05248867|583141781|FG003|Open-label Period|COVID-19 Infection|0|||
161477234|NCT05248867|583141782|FG004|Open-label Period|COVID-19 Infection|1|||
161578246|NCT01576484|583505201|FG001|Overall Study|Other|5|||
161920965|NCT00972738|584757112|FG000|Overall Study|Other|1|||
161920966|NCT00972738|584757113|FG001|Overall Study|Other|2|||
161477235|NCT05248867|583141783|FG005|Open-label Period|COVID-19 Infection|0|||
161477236|NCT05248867|583141778|FG000|Open-label Period|Other, not specified|0|||
161477237|NCT05248867|583141779|FG001|Open-label Period|Other, not specified|0|||
161477238|NCT05248867|583141780|FG002|Open-label Period|Other, not specified|0|||
161477239|NCT05248867|583141781|FG003|Open-label Period|Other, not specified|0|||
161477240|NCT05248867|583141782|FG004|Open-label Period|Other, not specified|4|||
161477241|NCT05248867|583141783|FG005|Open-label Period|Other, not specified|0|||
161477242|NCT00345839|583141785|FG000|Overall Study|Withdrawal by Subject|91|||
161477243|NCT00345839|583141786|FG001|Overall Study|Withdrawal by Subject|98|||
161477244|NCT00345839|583141785|FG000|Overall Study|Lost to Follow-up|58|||
161477245|NCT00345839|583141786|FG001|Overall Study|Lost to Follow-up|61|||
161477246|NCT03749447|583143282|FG000|Overall Study|Adverse Event|11|||
161477247|NCT03749447|583143283|FG001|Overall Study|Adverse Event|3|||
161477248|NCT03749447|583143282|FG000|Overall Study|Death|1|||
161477249|NCT03749447|583143283|FG001|Overall Study|Death|1|||
161477250|NCT03749447|583143282|FG000|Overall Study|Lost to Follow-up|2|||
161477251|NCT03749447|583143283|FG001|Overall Study|Lost to Follow-up|2|||
161477252|NCT03749447|583143282|FG000|Overall Study|Reason Not Specified|0|||
161477253|NCT03749447|583143283|FG001|Overall Study|Reason Not Specified|3|||
161477254|NCT03749447|583143282|FG000|Overall Study|Physician Decision|4|||
161477255|NCT03749447|583143283|FG001|Overall Study|Physician Decision|3|||
161477256|NCT03749447|583143282|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
161477257|NCT03749447|583143283|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
161477258|NCT03749447|583143282|FG000|Overall Study|Study Terminated By Sponsor|112|||
161477259|NCT03749447|583143283|FG001|Overall Study|Study Terminated By Sponsor|105|||
161477260|NCT03749447|583143282|FG000|Overall Study|Withdrawal by Subject|12|||
161477261|NCT03749447|583143283|FG001|Overall Study|Withdrawal by Subject|6|||
161477262|NCT03749447|583143282|FG000|Overall Study|Non-compliance With Study Drug|0|||
161477263|NCT03749447|583143283|FG001|Overall Study|Non-compliance With Study Drug|1|||
161477264|NCT01575769|583143287|FG000|Overall Study|Adverse Event|1|||
161477265|NCT01575769|583143287|FG000|Overall Study|Study terminated by sponsor|40|||
161477266|NCT01673867|583143288|FG000|Randomization|Adverse event unrelated to study drug|1|||
161477267|NCT01673867|583143289|FG001|Randomization|Adverse event unrelated to study drug|0|||
161477268|NCT01673867|583143288|FG000|Randomization|Participant request to discontinue study treatment|0|||
161477269|NCT01673867|583143289|FG001|Randomization|Participant request to discontinue study treatment|4|||
161477270|NCT01673867|583143288|FG000|Randomization|Withdrawal by participant|0|||
161477271|NCT01673867|583143289|FG001|Randomization|Withdrawal by participant|12|||
161477272|NCT01673867|583143288|FG000|Randomization|Lost to Follow-up|0|||
161477273|NCT01673867|583143289|FG001|Randomization|Lost to Follow-up|1|||
161477274|NCT01673867|583143288|FG000|Randomization|Participant no longer meets study criteria|4|||
161477275|NCT01673867|583143289|FG001|Randomization|Participant no longer meets study criteria|5|||
161477276|NCT01673867|583143288|FG000|Treatment|Disease Progression|208|||
161477277|NCT01673867|583143289|FG001|Treatment|Disease Progression|178|||
161477278|NCT01673867|583143288|FG000|Treatment|Study Drug Toxicity|23|||
161477279|NCT01673867|583143289|FG001|Treatment|Study Drug Toxicity|43|||
161477280|NCT01673867|583143288|FG000|Treatment|Death|2|||
161477281|NCT01673867|583143289|FG001|Treatment|Death|3|||
161477282|NCT01673867|583143288|FG000|Treatment|Adverse event unrelated to study drug|23|||
161477283|NCT01673867|583143289|FG001|Treatment|Adverse event unrelated to study drug|10|||
161477284|NCT01673867|583143288|FG000|Treatment|Participant request to discontinue study treatment|7|||
161920967|NCT00972738|584757114|FG002|Overall Study|Other|1|||
161477285|NCT01673867|583143289|FG001|Treatment|Participant request to discontinue study treatment|17|||
161477286|NCT01673867|583143288|FG000|Treatment|Withdrawal by participant|5|||
161477287|NCT01673867|583143289|FG001|Treatment|Withdrawal by participant|5|||
161920968|NCT01793935|584757117|FG000|Overall Study|Pregnancy|1|||
161920969|NCT01793935|584757118|FG001|Overall Study|Pregnancy|0|||
161920970|NCT01793935|584757117|FG000|Overall Study|Protocol Violation|2|||
161920971|NCT01793935|584757118|FG001|Overall Study|Protocol Violation|1|||
161920972|NCT01793935|584757117|FG000|Overall Study|Adverse Event|2|||
161920973|NCT01793935|584757118|FG001|Overall Study|Adverse Event|0|||
161920974|NCT01793935|584757117|FG000|Overall Study|Patient did not take study medication|1|||
161920975|NCT01793935|584757118|FG001|Overall Study|Patient did not take study medication|1|||
161920976|NCT01793935|584757117|FG000|Overall Study|Lost to Follow-up|0|||
161920977|NCT01793935|584757118|FG001|Overall Study|Lost to Follow-up|1|||
161920978|NCT00817063|584757121|FG000|Overall Study|Adverse Event|32|||
161477288|NCT01673867|583143288|FG000|Treatment|Maximum clinical benefit|1|||
161477289|NCT01673867|583143289|FG001|Treatment|Maximum clinical benefit|10|||
161477290|NCT01673867|583143288|FG000|Treatment|Participant no longer meets study criteria|2|||
161477291|NCT01673867|583143289|FG001|Treatment|Participant no longer meets study criteria|0|||
161477292|NCT01673867|583143288|FG000|Treatment|Administrative reason by sponsor|3|||
161477293|NCT01673867|583143289|FG001|Treatment|Administrative reason by sponsor|0|||
161477294|NCT01673867|583143288|FG000|Treatment|Other reason|11|||
161477295|NCT01673867|583143289|FG001|Treatment|Other reason|2|||
161920979|NCT00817063|584757122|FG001|Overall Study|Adverse Event|13|||
161920980|NCT00817063|584757121|FG000|Overall Study|Death|1|||
161920981|NCT00817063|584757122|FG001|Overall Study|Death|1|||
161477296|NCT01473836|583143290|FG000|Overall Study|Adverse Event|4|||
161477297|NCT01473836|583143290|FG000|Overall Study|Lack of Efficacy|1|||
161477298|NCT01473836|583143290|FG000|Overall Study|Does not meet entrance criteria|1|||
161477299|NCT01709513|583143291|FG000|Overall Study|Randomized but not treated|0|||
161477300|NCT01709513|583143292|FG001|Overall Study|Randomized but not treated|1|||
161477301|NCT01709513|583143293|FG002|Overall Study|Randomized but not treated|0|||
161477302|NCT01709513|583143291|FG000|Overall Study|Adverse Event|16|||
161477303|NCT01709513|583143292|FG001|Overall Study|Adverse Event|31|||
161477304|NCT01709513|583143293|FG002|Overall Study|Adverse Event|23|||
161477305|NCT01709513|583143291|FG000|Overall Study|Poor compliance to protocol|2|||
161477306|NCT01709513|583143292|FG001|Overall Study|Poor compliance to protocol|0|||
161477307|NCT01709513|583143293|FG002|Overall Study|Poor compliance to protocol|0|||
161578247|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
161578248|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
161578249|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
161578250|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
161578251|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
161578252|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
161578253|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
161578254|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
161578255|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
161578256|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
161578257|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
161920982|NCT00817063|584757121|FG000|Overall Study|Lack of Efficacy|33|||
161920983|NCT00817063|584757122|FG001|Overall Study|Lack of Efficacy|86|||
161920984|NCT00817063|584757121|FG000|Overall Study|Failure to Return|13|||
161920985|NCT00817063|584757122|FG001|Overall Study|Failure to Return|12|||
161920986|NCT00817063|584757121|FG000|Overall Study|Violation of Selection at Entry|7|||
161920987|NCT00817063|584757122|FG001|Overall Study|Violation of Selection at Entry|4|||
161920988|NCT00817063|584757121|FG000|Overall Study|Protocol Violation|3|||
161920989|NCT00817063|584757122|FG001|Overall Study|Protocol Violation|8|||
161920990|NCT00817063|584757121|FG000|Overall Study|Withdrawal by Subject|17|||
161920991|NCT00817063|584757122|FG001|Overall Study|Withdrawal by Subject|37|||
161920992|NCT00817063|584757121|FG000|Overall Study|Early Improvement|19|||
161920993|NCT00817063|584757122|FG001|Overall Study|Early Improvement|4|||
161920994|NCT00817063|584757121|FG000|Overall Study|Administrative|10|||
161920995|NCT00817063|584757122|FG001|Overall Study|Administrative|4|||
161920996|NCT00817063|584757121|FG000|Overall Study|Abnormality of Laboratory Test|2|||
161920997|NCT00817063|584757122|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161920998|NCT00529035|584757123|FG000|Overall Study|Withdrawal by Subject|1|||
161920999|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Other|4|||
161921000|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Other|1|||
161921001|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
161921002|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161921003|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
161921004|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
161921005|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
161921006|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161921007|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Death|1|||
161921008|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Death|2|||
161921009|NCT02636283|584757126|FG000|Overall Study|Adverse Event|2|||
161921010|NCT02636283|584757127|FG001|Overall Study|Adverse Event|0|||
161921011|NCT02636283|584757126|FG000|Overall Study|Trial Terminated Prematurely|0|||
161921012|NCT02636283|584757127|FG001|Overall Study|Trial Terminated Prematurely|3|||
161921013|NCT03418675|584757128|FG000|Overall Study|Lost to Follow-up|13|||
161921014|NCT03418675|584757129|FG001|Overall Study|Lost to Follow-up|10|||
161921015|NCT03418675|584757128|FG000|Overall Study|Adverse Event|2|||
161921016|NCT03418675|584757129|FG001|Overall Study|Adverse Event|0|||
161921017|NCT01879852|584757130|FG000|Overall Study|Withdrawal by Subject|2|||
161921018|NCT01879852|584757131|FG001|Overall Study|Withdrawal by Subject|0|||
161921019|NCT02696616|584757133|FG000|Overall Study|Adverse Event|0|||
161921020|NCT02696616|584757134|FG001|Overall Study|Adverse Event|1|||
161921021|NCT02696616|584757135|FG002|Overall Study|Adverse Event|0|||
161477308|NCT01709513|583143291|FG000|Overall Study|Other|3|||
161477309|NCT01709513|583143292|FG001|Overall Study|Other|11|||
161477310|NCT01709513|583143293|FG002|Overall Study|Other|7|||
161477311|NCT04218695|583143294|FG000|Overall Study|Adverse Event|1|||
161477312|NCT04218695|583143295|FG001|Overall Study|Adverse Event|0|||
161921022|NCT02696616|584757136|FG003|Overall Study|Adverse Event|0|||
161921023|NCT02696616|584757137|FG004|Overall Study|Adverse Event|0|||
161921024|NCT02696616|584757138|FG005|Overall Study|Adverse Event|0|||
161921025|NCT02696616|584757139|FG006|Overall Study|Adverse Event|0|||
161921026|NCT03086343|584757140|FG000|Period 1|Adverse Event|7|||
161921027|NCT03086343|584757141|FG001|Period 1|Adverse Event|7|||
161921028|NCT03086343|584757142|FG002|Period 1|Adverse Event|0|||
161477313|NCT01513343|583143296|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
161477314|NCT01513343|583143297|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
161477315|NCT01513343|583143296|FG000|Post Data Collection|Dropped/withdrew from study|7|||
161477316|NCT01513343|583143297|FG001|Post Data Collection|Dropped/withdrew from study|1|||
161477317|NCT01513343|583143296|FG000|Post Data Collection|Lost to Follow-up|10|||
161477318|NCT01513343|583143297|FG001|Post Data Collection|Lost to Follow-up|23|||
161477319|NCT01513343|583143296|FG000|6-month Follow-up|Lost to Follow-up|28|||
161815601|NCT00488774|584368694|FG003|Overall Study|Lost to Follow-up|1|||
161815602|NCT05523895|584368695|FG000|Overall Study|Adverse Event|2|||
161815603|NCT05523895|584368696|FG001|Overall Study|Adverse Event|1|||
161815604|NCT05523895|584368697|FG002|Overall Study|Adverse Event|1|||
161815605|NCT05523895|584368695|FG000|Overall Study|Lost to Follow-up|0|||
161815606|NCT05523895|584368696|FG001|Overall Study|Lost to Follow-up|1|||
161815607|NCT05523895|584368697|FG002|Overall Study|Lost to Follow-up|2|||
161815608|NCT05523895|584368695|FG000|Overall Study|Noncompliance with study drug|1|||
161815609|NCT05523895|584368696|FG001|Overall Study|Noncompliance with study drug|1|||
161815610|NCT05523895|584368697|FG002|Overall Study|Noncompliance with study drug|1|||
161815611|NCT05523895|584368695|FG000|Overall Study|Protocol Violation|0|||
161815612|NCT05523895|584368696|FG001|Overall Study|Protocol Violation|2|||
161815613|NCT05523895|584368697|FG002|Overall Study|Protocol Violation|0|||
161815614|NCT05523895|584368695|FG000|Overall Study|Withdrawal by Subject|1|||
161815615|NCT05523895|584368696|FG001|Overall Study|Withdrawal by Subject|3|||
161815616|NCT05523895|584368697|FG002|Overall Study|Withdrawal by Subject|1|||
161815617|NCT05523895|584368695|FG000|Overall Study|Not further specified|0|||
161815618|NCT05523895|584368696|FG001|Overall Study|Not further specified|3|||
161815619|NCT05523895|584368697|FG002|Overall Study|Not further specified|1|||
161815620|NCT03674892|584368698|FG000|Overall Study|Lack of Efficacy|5|||
161815621|NCT03674892|584368698|FG000|Overall Study|Lost to Follow-up|3|||
161815622|NCT03674892|584368698|FG000|Overall Study|Migraine|2|||
161815623|NCT03674892|584368698|FG000|Overall Study|Excessive Tearing|1|||
161815624|NCT03674892|584368698|FG000|Overall Study|Increased Eye Pain|1|||
161815625|NCT03674892|584368698|FG000|Overall Study|Increased Facial Pain|1|||
161815626|NCT03674892|584368698|FG000|Overall Study|Sinus Irritation|1|||
161815627|NCT03674892|584368698|FG000|Overall Study|Sinus Infection|1|||
161815628|NCT05099380|584368699|FG000|Overall Study|Subject enrolled in error|1|||
161815629|NCT05099380|584368700|FG001|Overall Study|Subject enrolled in error|0|||
161815630|NCT05099380|584368699|FG000|Overall Study|Study Procedure|1|||
161815631|NCT05099380|584368700|FG001|Overall Study|Study Procedure|0|||
161815632|NCT05099380|584368699|FG000|Overall Study|Protocol Violation|1|||
161815633|NCT05099380|584368700|FG001|Overall Study|Protocol Violation|0|||
161815634|NCT05099380|584368699|FG000|Overall Study|Adverse Event|1|||
161815635|NCT05099380|584368700|FG001|Overall Study|Adverse Event|1|||
161815636|NCT05099380|584368699|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
161815637|NCT05099380|584368700|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
161815638|NCT01959672|584368706|FG000|Overall Study|Death|1|||
161815639|NCT02392195|584368707|FG000|Overall Study|Lost to Follow-up|4|||
161815640|NCT02392195|584368707|FG000|Overall Study|Withdrawal by Subject|4|||
161815641|NCT03276754|584368708|FG000|Overall Study|Withdrawal of informed consent|4|||
161815642|NCT03276754|584368708|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
161815643|NCT03276754|584368708|FG000|Overall Study|Lost to Follow-up|27|||
161815644|NCT03276754|584368708|FG000|Overall Study|No data reported at Month 24|31|||
161815645|NCT03276754|584368708|FG000|Overall Study|Death|39|||
161815646|NCT00545792|584368709|FG000|Overall Study|Withdrawal by Subject|1|||
161815647|NCT05041361|584368711|FG000|Overall Study|Lost to Follow-up|1|||
161815648|NCT05041361|584368712|FG001|Overall Study|Lost to Follow-up|3|||
161815649|NCT01642277|584368713|FG000|Overall Study|Adverse Event|10|||
161815650|NCT01642277|584368714|FG001|Overall Study|Adverse Event|0|||
161815651|NCT01642277|584368713|FG000|Overall Study|Physician Decision|2|||
161815652|NCT01642277|584368714|FG001|Overall Study|Physician Decision|0|||
161815653|NCT01642277|584368713|FG000|Overall Study|Protocol Violation|1|||
161815654|NCT01642277|584368714|FG001|Overall Study|Protocol Violation|0|||
161815655|NCT01642277|584368713|FG000|Overall Study|Withdrawal by Subject|11|||
161815656|NCT01642277|584368714|FG001|Overall Study|Withdrawal by Subject|0|||
161815657|NCT03679598|584368715|FG000|Overall Study|Adverse Event|2|||
161815658|NCT03679598|584368716|FG001|Overall Study|Adverse Event|0|||
161815659|NCT03605342|584368717|FG000|Overall Study|Withdrawal by Subject|9|||
161815660|NCT03605342|584368718|FG001|Overall Study|Withdrawal by Subject|7|||
161815661|NCT03605342|584368717|FG000|Overall Study|Lost to Follow-up|1|||
161815662|NCT03605342|584368718|FG001|Overall Study|Lost to Follow-up|1|||
161815663|NCT02842853|584368721|FG000|Overall Study|Non-compliance with the protocol|3|||
161815664|NCT02842853|584368722|FG001|Overall Study|Non-compliance with the protocol|7|||
161815665|NCT02842853|584368723|FG002|Overall Study|Non-compliance with the protocol|2|||
161815666|NCT02842853|584368724|FG003|Overall Study|Non-compliance with the protocol|5|||
161815667|NCT02842853|584368721|FG000|Overall Study|Subject met exclusion criteria|0|||
161815668|NCT02842853|584368722|FG001|Overall Study|Subject met exclusion criteria|1|||
161477320|NCT01513343|583143297|FG001|6-month Follow-up|Lost to Follow-up|17|||
161477321|NCT01513343|583143296|FG000|12-month Follow-up|Lost to Follow-up|10|||
161477322|NCT01513343|583143297|FG001|12-month Follow-up|Lost to Follow-up|3|||
161477323|NCT00599924|583143298|FG000|Overall Study|Lack of Efficacy|3|||
161477324|NCT00599924|583143299|FG001|Overall Study|Lack of Efficacy|5|||
161477325|NCT00599924|583143300|FG002|Overall Study|Lack of Efficacy|1|||
161477326|NCT00599924|583143301|FG003|Overall Study|Lack of Efficacy|2|||
161477327|NCT00599924|583143302|FG004|Overall Study|Lack of Efficacy|3|||
161477328|NCT00599924|583143303|FG005|Overall Study|Lack of Efficacy|2|||
161477329|NCT00599924|583143304|FG006|Overall Study|Lack of Efficacy|0|||
161477330|NCT00599924|583143298|FG000|Overall Study|Adverse Event|0|||
161477331|NCT00599924|583143299|FG001|Overall Study|Adverse Event|0|||
161477332|NCT00599924|583143300|FG002|Overall Study|Adverse Event|0|||
161477333|NCT00599924|583143301|FG003|Overall Study|Adverse Event|2|||
161477334|NCT00599924|583143302|FG004|Overall Study|Adverse Event|0|||
161477335|NCT00599924|583143303|FG005|Overall Study|Adverse Event|0|||
161477336|NCT00599924|583143304|FG006|Overall Study|Adverse Event|2|||
161477337|NCT00599924|583143298|FG000|Overall Study|Death|0|||
161477338|NCT00599924|583143299|FG001|Overall Study|Death|0|||
161477339|NCT00599924|583143300|FG002|Overall Study|Death|0|||
161477340|NCT00599924|583143301|FG003|Overall Study|Death|2|||
161477341|NCT00599924|583143302|FG004|Overall Study|Death|0|||
161815669|NCT02842853|584368723|FG002|Overall Study|Subject met exclusion criteria|0|||
161815670|NCT02842853|584368724|FG003|Overall Study|Subject met exclusion criteria|0|||
161815671|NCT02842853|584368721|FG000|Overall Study|Withdrawal by Subject|11|||
161815672|NCT02842853|584368722|FG001|Overall Study|Withdrawal by Subject|13|||
161815673|NCT02842853|584368723|FG002|Overall Study|Withdrawal by Subject|9|||
161815674|NCT02842853|584368724|FG003|Overall Study|Withdrawal by Subject|8|||
161815675|NCT02842853|584368721|FG000|Overall Study|Lost to Follow-up|9|||
161815676|NCT02842853|584368722|FG001|Overall Study|Lost to Follow-up|13|||
161815677|NCT02842853|584368723|FG002|Overall Study|Lost to Follow-up|10|||
161815678|NCT02842853|584368724|FG003|Overall Study|Lost to Follow-up|11|||
161815679|NCT00918645|584368733|FG000|Overall Study|Withdrawal by Subject|1|||
161815680|NCT05133180|584368736|FG000|Overall Study|Withdrawal of consent|1|||
161815681|NCT05133180|584368737|FG001|Overall Study|Withdrawal of consent|1|||
161815682|NCT05133180|584368736|FG000|Overall Study|Lost to Follow-up|1|||
161815683|NCT05133180|584368737|FG001|Overall Study|Lost to Follow-up|1|||
161815684|NCT05133180|584368736|FG000|Overall Study|Documented disease progression|0|||
161815685|NCT05133180|584368737|FG001|Overall Study|Documented disease progression|1|||
161815686|NCT04723693|584368738|FG000|Overall Study|Withdrawal by Subject|2|||
161815687|NCT02157974|584368739|FG000|Overall Study|Withdrawal by Subject|0|||
161815688|NCT02157974|584368740|FG001|Overall Study|Withdrawal by Subject|1|||
161815689|NCT02157974|584368741|FG002|Overall Study|Withdrawal by Subject|0|||
161921029|NCT03086343|584757143|FG003|Period 1|Adverse Event|1|||
161921030|NCT03086343|584757140|FG000|Period 1|Withdrawal by Subject|6|||
161921031|NCT03086343|584757141|FG001|Period 1|Withdrawal by Subject|10|||
161921032|NCT03086343|584757142|FG002|Period 1|Withdrawal by Subject|0|||
161921033|NCT03086343|584757143|FG003|Period 1|Withdrawal by Subject|0|||
161921034|NCT03086343|584757140|FG000|Period 1|Lost to Follow-up|1|||
161921035|NCT03086343|584757141|FG001|Period 1|Lost to Follow-up|3|||
161921036|NCT03086343|584757142|FG002|Period 1|Lost to Follow-up|1|||
161921037|NCT03086343|584757143|FG003|Period 1|Lost to Follow-up|0|||
161921038|NCT03086343|584757140|FG000|Period 1|Other, Not Specified|10|||
161921039|NCT03086343|584757141|FG001|Period 1|Other, Not Specified|12|||
161921040|NCT03086343|584757142|FG002|Period 1|Other, Not Specified|2|||
161921041|NCT03086343|584757143|FG003|Period 1|Other, Not Specified|1|||
161921042|NCT03086343|584757140|FG000|Period 1|Missing|1|||
161921043|NCT03086343|584757141|FG001|Period 1|Missing|0|||
161921044|NCT03086343|584757142|FG002|Period 1|Missing|0|||
161921045|NCT03086343|584757143|FG003|Period 1|Missing|0|||
161921046|NCT03086343|584757140|FG000|Period 2|Adverse Event|20|||
161921047|NCT03086343|584757141|FG001|Period 2|Adverse Event|11|||
161921048|NCT03086343|584757142|FG002|Period 2|Adverse Event|1|||
161921049|NCT03086343|584757143|FG003|Period 2|Adverse Event|2|||
161921050|NCT03086343|584757140|FG000|Period 2|Withdrawal by Subject|15|||
161477342|NCT00599924|583143303|FG005|Overall Study|Death|2|||
161477343|NCT00599924|583143304|FG006|Overall Study|Death|1|||
161477344|NCT00599924|583143298|FG000|Overall Study|Protocol Violation|0|||
161477345|NCT00599924|583143299|FG001|Overall Study|Protocol Violation|0|||
161815690|NCT02157974|584368742|FG003|Overall Study|Withdrawal by Subject|0|||
161477346|NCT00599924|583143300|FG002|Overall Study|Protocol Violation|0|||
161477347|NCT00599924|583143301|FG003|Overall Study|Protocol Violation|1|||
161921051|NCT03086343|584757141|FG001|Period 2|Withdrawal by Subject|25|||
161921052|NCT03086343|584757142|FG002|Period 2|Withdrawal by Subject|2|||
161477348|NCT00599924|583143302|FG004|Overall Study|Protocol Violation|0|||
161477349|NCT00599924|583143303|FG005|Overall Study|Protocol Violation|0|||
161921053|NCT03086343|584757143|FG003|Period 2|Withdrawal by Subject|2|||
161921054|NCT03086343|584757140|FG000|Period 2|Lost to Follow-up|6|||
161921055|NCT03086343|584757141|FG001|Period 2|Lost to Follow-up|11|||
161921056|NCT03086343|584757142|FG002|Period 2|Lost to Follow-up|1|||
161921057|NCT03086343|584757143|FG003|Period 2|Lost to Follow-up|0|||
161578258|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
161578259|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
161578260|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
161578261|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
161578262|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
161578263|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
161578264|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
161578265|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
161578266|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
161578267|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
161578268|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
161578269|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
161578270|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
161578271|NCT00311363|583505204|FG000|24-Week Single-Blind Treatment Period|Death|1|||
161578272|NCT00311363|583505205|FG001|24-Week Single-Blind Treatment Period|Death|0|||
161578273|NCT00311363|583505206|FG002|24-Week Single-Blind Treatment Period|Death|0|||
161815691|NCT02157974|584368743|FG004|Overall Study|Withdrawal by Subject|0|||
161815692|NCT02157974|584368739|FG000|Overall Study|Screen Failure|0|||
161815693|NCT02157974|584368740|FG001|Overall Study|Screen Failure|1|||
161815694|NCT02157974|584368741|FG002|Overall Study|Screen Failure|0|||
161815695|NCT02157974|584368742|FG003|Overall Study|Screen Failure|0|||
161815696|NCT02157974|584368743|FG004|Overall Study|Screen Failure|0|||
161815697|NCT02157974|584368739|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815698|NCT02157974|584368740|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
161815699|NCT02157974|584368741|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815700|NCT02157974|584368742|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815701|NCT02157974|584368743|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815702|NCT03366792|584368746|FG000|Overall Study|Withdrawal by Subject|7|||
161815703|NCT03366792|584368746|FG000|Overall Study|Lost to Follow-up|2|||
161815704|NCT03366792|584368746|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
161815705|NCT03366792|584368746|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
161815706|NCT01808651|584368747|FG000|Study Period 1|Lost to Follow-up|1|||
161815707|NCT01808651|584368748|FG001|Study Period 1|Lost to Follow-up|3|||
161815708|NCT01808651|584368749|FG002|Study Period 1|Lost to Follow-up|0|||
161815709|NCT01808651|584368747|FG000|Study Period 1|Protocol Violation|1|||
161815710|NCT01808651|584368748|FG001|Study Period 1|Protocol Violation|0|||
161815711|NCT01808651|584368749|FG002|Study Period 1|Protocol Violation|1|||
161815712|NCT01808651|584368747|FG000|Study Period 1|Physician Decision|3|||
161815713|NCT01808651|584368748|FG001|Study Period 1|Physician Decision|2|||
161815714|NCT01808651|584368749|FG002|Study Period 1|Physician Decision|0|||
161815715|NCT01808651|584368747|FG000|Study Period 1|Lack of Efficacy|2|||
161815716|NCT01808651|584368748|FG001|Study Period 1|Lack of Efficacy|1|||
161815717|NCT01808651|584368749|FG002|Study Period 1|Lack of Efficacy|0|||
161815718|NCT01808651|584368747|FG000|Study Period 1|Adverse Event|10|||
161815719|NCT01808651|584368748|FG001|Study Period 1|Adverse Event|4|||
161815720|NCT01808651|584368749|FG002|Study Period 1|Adverse Event|1|||
161815721|NCT01808651|584368747|FG000|Study Period 1|Participant Decision|9|||
161815722|NCT01808651|584368748|FG001|Study Period 1|Participant Decision|7|||
161815723|NCT01808651|584368749|FG002|Study Period 1|Participant Decision|3|||
161815724|NCT00216736|584368754|FG000|Overall Study|Lost to Follow-up|1|||
161815725|NCT00216736|584368755|FG001|Overall Study|Lost to Follow-up|1|||
161815726|NCT00807495|584368756|FG000|Overall Study|Adverse Event|6|||
161815727|NCT00807495|584368757|FG001|Overall Study|Adverse Event|3|||
161815728|NCT00807495|584368758|FG002|Overall Study|Adverse Event|1|||
161815729|NCT00807495|584368759|FG003|Overall Study|Adverse Event|1|||
161815730|NCT00807495|584368760|FG004|Overall Study|Adverse Event|2|||
161815731|NCT00807495|584368756|FG000|Overall Study|Withdrawal by Patient|2|||
161815732|NCT00807495|584368757|FG001|Overall Study|Withdrawal by Patient|0|||
161815733|NCT00807495|584368758|FG002|Overall Study|Withdrawal by Patient|1|||
161815734|NCT00807495|584368759|FG003|Overall Study|Withdrawal by Patient|0|||
161815735|NCT00807495|584368760|FG004|Overall Study|Withdrawal by Patient|0|||
161815736|NCT00807495|584368756|FG000|Overall Study|Reason Not Specified|0|||
161815737|NCT00807495|584368757|FG001|Overall Study|Reason Not Specified|3|||
161815738|NCT00807495|584368758|FG002|Overall Study|Reason Not Specified|2|||
161815739|NCT00807495|584368759|FG003|Overall Study|Reason Not Specified|0|||
161815740|NCT00807495|584368760|FG004|Overall Study|Reason Not Specified|3|||
161815741|NCT00841542|584368762|FG000|Period 1|Adverse Event|1|||
161815742|NCT00841542|584368763|FG001|Period 1|Adverse Event|0|||
161815743|NCT03214588|584368764|FG000|Overall Study|Adverse Event|1|||
161815744|NCT03214588|584368765|FG001|Overall Study|Adverse Event|0|||
161815745|NCT03214588|584368766|FG002|Overall Study|Adverse Event|2|||
161815746|NCT03214588|584368764|FG000|Overall Study|Reason Not Specified|0|||
161815747|NCT03214588|584368765|FG001|Overall Study|Reason Not Specified|1|||
161578274|NCT00311363|583505204|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
161578275|NCT00311363|583505205|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
161477350|NCT00599924|583143304|FG006|Overall Study|Protocol Violation|0|||
161477351|NCT00599924|583143298|FG000|Overall Study|Withdrawal by Subject|0|||
161477352|NCT00599924|583143299|FG001|Overall Study|Withdrawal by Subject|0|||
161477353|NCT00599924|583143300|FG002|Overall Study|Withdrawal by Subject|1|||
161477354|NCT00599924|583143301|FG003|Overall Study|Withdrawal by Subject|0|||
161477355|NCT00599924|583143302|FG004|Overall Study|Withdrawal by Subject|1|||
161477356|NCT00599924|583143303|FG005|Overall Study|Withdrawal by Subject|0|||
161477357|NCT00599924|583143304|FG006|Overall Study|Withdrawal by Subject|0|||
161477358|NCT00599924|583143298|FG000|Overall Study|Other|0|||
161477359|NCT00599924|583143299|FG001|Overall Study|Other|0|||
161477360|NCT00599924|583143300|FG002|Overall Study|Other|0|||
161477361|NCT00599924|583143301|FG003|Overall Study|Other|1|||
161477362|NCT00599924|583143302|FG004|Overall Study|Other|2|||
161477363|NCT00599924|583143303|FG005|Overall Study|Other|0|||
161477364|NCT00599924|583143304|FG006|Overall Study|Other|2|||
161477365|NCT02587234|583143305|FG000|Overall Study|Withdrawal by Subject|1|||
161477366|NCT02587234|583143306|FG001|Overall Study|Withdrawal by Subject|1|||
161477367|NCT02587234|583143305|FG000|Overall Study|Lost to Follow-up|0|||
161477368|NCT02587234|583143306|FG001|Overall Study|Lost to Follow-up|2|||
161477369|NCT02165215|583143307|FG000|Induction Phase|Adverse Event|1|||
161477370|NCT02165215|583143308|FG001|Induction Phase|Adverse Event|0|||
161477371|NCT02165215|583143309|FG002|Induction Phase|Adverse Event|0|||
161477372|NCT02165215|583143307|FG000|Induction Phase|Withdrawal by Subject|10|||
161477373|NCT02165215|583143308|FG001|Induction Phase|Withdrawal by Subject|0|||
161477374|NCT02165215|583143309|FG002|Induction Phase|Withdrawal by Subject|0|||
161477375|NCT02165215|583143307|FG000|Induction Phase|Protocol Violation|1|||
161477376|NCT02165215|583143308|FG001|Induction Phase|Protocol Violation|0|||
161477377|NCT02165215|583143309|FG002|Induction Phase|Protocol Violation|0|||
161477378|NCT02165215|583143307|FG000|Induction Phase|Physician Decision|1|||
161477379|NCT02165215|583143308|FG001|Induction Phase|Physician Decision|0|||
161477380|NCT02165215|583143309|FG002|Induction Phase|Physician Decision|0|||
161477381|NCT02165215|583143307|FG000|Induction Phase|Lack of Efficacy|2|||
161477382|NCT02165215|583143308|FG001|Induction Phase|Lack of Efficacy|0|||
161477383|NCT02165215|583143309|FG002|Induction Phase|Lack of Efficacy|0|||
161477384|NCT02165215|583143307|FG000|Induction Phase|Non-Compliance|2|||
161477385|NCT02165215|583143308|FG001|Induction Phase|Non-Compliance|0|||
161477386|NCT02165215|583143309|FG002|Induction Phase|Non-Compliance|0|||
161477387|NCT02165215|583143307|FG000|Induction Phase|Lost to Follow-up|6|||
161477388|NCT02165215|583143308|FG001|Induction Phase|Lost to Follow-up|0|||
161477389|NCT02165215|583143309|FG002|Induction Phase|Lost to Follow-up|0|||
161477390|NCT02165215|583143307|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161477391|NCT02165215|583143308|FG001|Maintenance Phase|Withdrawal by Subject|7|||
161477392|NCT02165215|583143309|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161477393|NCT02165215|583143307|FG000|Maintenance Phase|Multiple reasons|0|||
161477394|NCT02165215|583143308|FG001|Maintenance Phase|Multiple reasons|2|||
161477395|NCT02165215|583143309|FG002|Maintenance Phase|Multiple reasons|1|||
161477396|NCT02165215|583143307|FG000|Maintenance Phase|Lost to Follow-up|0|||
161477397|NCT02165215|583143308|FG001|Maintenance Phase|Lost to Follow-up|2|||
161477398|NCT02165215|583143309|FG002|Maintenance Phase|Lost to Follow-up|0|||
161477399|NCT02165215|583143307|FG000|Maintenance Phase|Adverse Event|0|||
161477400|NCT02165215|583143308|FG001|Maintenance Phase|Adverse Event|1|||
161578276|NCT00311363|583505206|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
161578277|NCT00311363|583505204|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161578278|NCT00311363|583505205|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161578279|NCT00311363|583505206|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161578280|NCT00311363|583505204|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
161578281|NCT00311363|583505205|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
161477401|NCT02165215|583143309|FG002|Maintenance Phase|Adverse Event|1|||
161477402|NCT01877265|583143310|FG000|Treatment Period 1|Sponsor Decision|0|||
161578282|NCT00311363|583505206|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
161477403|NCT01877265|583143311|FG001|Treatment Period 1|Sponsor Decision|0|||
161477404|NCT01877265|583143312|FG002|Treatment Period 1|Sponsor Decision|1|||
161477405|NCT01877265|583143313|FG003|Treatment Period 1|Sponsor Decision|0|||
161477406|NCT01877265|583143314|FG004|Treatment Period 1|Sponsor Decision|0|||
161815748|NCT03214588|584368766|FG002|Overall Study|Reason Not Specified|0|||
161477407|NCT01877265|583143315|FG005|Treatment Period 1|Sponsor Decision|0|||
161477408|NCT01877265|583143310|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
161477409|NCT01877265|583143311|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
161477410|NCT01877265|583143312|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
161477411|NCT01877265|583143313|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
161477412|NCT01877265|583143314|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
161477413|NCT01877265|583143315|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
161477414|NCT01877265|583143310|FG000|Treatment Period 3|Lost to Follow-up|1|||
161477415|NCT01877265|583143311|FG001|Treatment Period 3|Lost to Follow-up|0|||
161477416|NCT01877265|583143312|FG002|Treatment Period 3|Lost to Follow-up|0|||
161477417|NCT01877265|583143313|FG003|Treatment Period 3|Lost to Follow-up|0|||
161477418|NCT01877265|583143314|FG004|Treatment Period 3|Lost to Follow-up|0|||
161477419|NCT01877265|583143315|FG005|Treatment Period 3|Lost to Follow-up|0|||
161477420|NCT00592384|583143316|FG000|Overall Study|Withdrawal by Subject|5|||
161477421|NCT00592384|583143317|FG001|Overall Study|Withdrawal by Subject|6|||
161477422|NCT01153347|583143325|FG000|Overall Study|Withdrawal by Subject|7|||
161477423|NCT01153347|583143326|FG001|Overall Study|Withdrawal by Subject|7|||
161477424|NCT01153347|583143327|FG002|Overall Study|Withdrawal by Subject|7|||
161477425|NCT01153347|583143328|FG003|Overall Study|Withdrawal by Subject|7|||
161477426|NCT01153347|583143325|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161477427|NCT01153347|583143326|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161477428|NCT01153347|583143327|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
161477429|NCT01153347|583143328|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161477430|NCT01153347|583143325|FG000|Overall Study|Adverse Event|3|||
161477431|NCT01153347|583143326|FG001|Overall Study|Adverse Event|9|||
161477432|NCT01153347|583143327|FG002|Overall Study|Adverse Event|21|||
161477433|NCT01153347|583143328|FG003|Overall Study|Adverse Event|7|||
161477434|NCT01153347|583143325|FG000|Overall Study|Severe non-compliance to protocol|6|||
161477435|NCT01153347|583143326|FG001|Overall Study|Severe non-compliance to protocol|7|||
161477436|NCT01153347|583143327|FG002|Overall Study|Severe non-compliance to protocol|4|||
161477437|NCT01153347|583143328|FG003|Overall Study|Severe non-compliance to protocol|3|||
161477438|NCT01153347|583143325|FG000|Overall Study|Condition under investigation worsened|1|||
161477439|NCT01153347|583143326|FG001|Overall Study|Condition under investigation worsened|1|||
161477440|NCT01153347|583143327|FG002|Overall Study|Condition under investigation worsened|0|||
161477441|NCT01153347|583143328|FG003|Overall Study|Condition under investigation worsened|0|||
161477442|NCT01153347|583143325|FG000|Overall Study|Lack of Efficacy|2|||
161477443|NCT01153347|583143326|FG001|Overall Study|Lack of Efficacy|2|||
161477444|NCT01153347|583143327|FG002|Overall Study|Lack of Efficacy|0|||
161477445|NCT01153347|583143328|FG003|Overall Study|Lack of Efficacy|4|||
161477446|NCT01153347|583143325|FG000|Overall Study|Study-specific withdrawal criteria|4|||
161477447|NCT01153347|583143326|FG001|Overall Study|Study-specific withdrawal criteria|3|||
161477448|NCT01153347|583143327|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161477449|NCT01153347|583143328|FG003|Overall Study|Study-specific withdrawal criteria|2|||
161477450|NCT01153347|583143325|FG000|Overall Study|Lost to Follow-up|4|||
161477451|NCT01153347|583143326|FG001|Overall Study|Lost to Follow-up|9|||
161477452|NCT01153347|583143327|FG002|Overall Study|Lost to Follow-up|11|||
161477453|NCT01153347|583143328|FG003|Overall Study|Lost to Follow-up|8|||
161477454|NCT01153347|583143325|FG000|Overall Study|Other|5|||
161477455|NCT01153347|583143326|FG001|Overall Study|Other|5|||
161477456|NCT01153347|583143327|FG002|Overall Study|Other|4|||
161477457|NCT01153347|583143328|FG003|Overall Study|Other|0|||
161477458|NCT01153347|583143325|FG000|Overall Study|Death|1|||
161477459|NCT01153347|583143326|FG001|Overall Study|Death|0|||
161477460|NCT01153347|583143327|FG002|Overall Study|Death|0|||
161477461|NCT01153347|583143328|FG003|Overall Study|Death|0|||
161477462|NCT04401423|583143332|FG000|Overall Study|Withdrawal by Subject|3|||
161477463|NCT04401423|583143333|FG001|Overall Study|Withdrawal by Subject|1|||
161477464|NCT04401423|583143332|FG000|Overall Study|Physician Decision|2|||
161477465|NCT04401423|583143333|FG001|Overall Study|Physician Decision|1|||
161477466|NCT00003473|583143334|FG000|Overall Study|Three patients were not evaluable.|3|||
161477467|NCT04678661|583143335|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
161477468|NCT04678661|583143336|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
161477469|NCT04678661|583143335|FG000|Overall Study|Protocol Violation|2|||
161477470|NCT04678661|583143336|FG001|Overall Study|Protocol Violation|0|||
161477471|NCT04678661|583143335|FG000|Overall Study|Withdrawal by Subject|1|||
161477472|NCT04678661|583143336|FG001|Overall Study|Withdrawal by Subject|0|||
161477473|NCT04678661|583143335|FG000|Overall Study|Lost to Follow-up|2|||
161477474|NCT04678661|583143336|FG001|Overall Study|Lost to Follow-up|0|||
161477475|NCT04678661|583143335|FG000|Overall Study|Death|2|||
161477476|NCT04678661|583143336|FG001|Overall Study|Death|0|||
161477477|NCT03039283|583143340|FG000|Overall Study|Protocol Violation|2|||
161477478|NCT03639935|583143341|FG000|Overall Study|Death|3|||
161477479|NCT03639935|583143341|FG000|Overall Study|Adverse Event|1|||
161477480|NCT00864721|583143342|FG000|Overall Study|Patient request|11|||
161477481|NCT00864721|583143342|FG000|Overall Study|Hospitalized|1|||
161477482|NCT00864721|583143342|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
161477483|NCT00864721|583143342|FG000|Overall Study|Adverse Event|21|||
161477484|NCT01921387|583143345|FG000|Overall Study|Adverse Event|1|||
161477485|NCT01773733|583143346|FG000|Overall Study|Adverse Event|3286|||
161477486|NCT01773733|583143347|FG001|Overall Study|Adverse Event|540|||
161477487|NCT01773733|583143346|FG000|Overall Study|Pregnancy|28|||
161477488|NCT01773733|583143347|FG001|Overall Study|Pregnancy|0|||
161477489|NCT01773733|583143346|FG000|Overall Study|Other different categories of not compl|55415|||
161477490|NCT01773733|583143347|FG001|Overall Study|Other different categories of not compl|7781|||
161578283|NCT00311363|583505204|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
161578284|NCT00311363|583505205|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
161578285|NCT00311363|583505206|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
161578286|NCT00311363|583505204|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
161578287|NCT00311363|583505205|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
161578288|NCT00311363|583505206|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
161578289|NCT00311363|583505204|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
161578290|NCT00311363|583505205|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
161578291|NCT00311363|583505206|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
161578292|NCT00206375|583505207|FG000|Overall Study|Lost to Follow-up|1|||
161578293|NCT00206375|583505208|FG001|Overall Study|Lost to Follow-up|0|||
161477491|NCT03741062|583143348|FG000|Overall Study|Protocol Violation|1|||
161477492|NCT03741062|583143349|FG001|Overall Study|Protocol Violation|0|||
161477493|NCT00261807|583143350|FG000|Overall Study|Lost to Follow-up|2|||
161477494|NCT00261807|583143350|FG000|Overall Study|Adverse Event|2|||
161477495|NCT00261807|583143350|FG000|Overall Study|Death|1|||
161477496|NCT00261807|583143350|FG000|Overall Study|Protocol Violation|2|||
161477497|NCT02527161|583143351|FG000|Overall Study|Failed MRI|52|||
161578294|NCT00206375|583505209|FG002|Overall Study|Lost to Follow-up|0|||
161578295|NCT00206375|583505207|FG000|Overall Study|Withdrawal by Subject|2|||
161578296|NCT00206375|583505208|FG001|Overall Study|Withdrawal by Subject|1|||
161578297|NCT00206375|583505209|FG002|Overall Study|Withdrawal by Subject|3|||
161578298|NCT00206375|583505207|FG000|Overall Study|Study terminated due to lack of funds|0|||
161578299|NCT00206375|583505208|FG001|Overall Study|Study terminated due to lack of funds|1|||
161578300|NCT00206375|583505209|FG002|Overall Study|Study terminated due to lack of funds|1|||
161578301|NCT03512756|583505217|FG000|Part 1|Death|23|||
161578302|NCT03512756|583505218|FG001|Part 1|Death|18|||
161578303|NCT03512756|583505219|FG002|Part 1|Death|0|||
161578304|NCT03512756|583505220|FG003|Part 1|Death|0|||
161578305|NCT03512756|583505217|FG000|Part 1|Lost to Follow-up|0|||
161578306|NCT03512756|583505218|FG001|Part 1|Lost to Follow-up|3|||
161668486|NCT03285178|583839781|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161668487|NCT03285178|583839782|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161668488|NCT03285178|583839783|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161668489|NCT03285178|583839784|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161668490|NCT03285178|583839778|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
161668491|NCT03285178|583839779|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161668492|NCT03285178|583839780|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161668493|NCT03285178|583839781|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161668494|NCT03285178|583839782|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161668495|NCT03285178|583839783|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161668496|NCT03285178|583839784|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161668497|NCT03285178|583839778|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
161668498|NCT03285178|583839779|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
161668499|NCT03285178|583839780|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
161668500|NCT03285178|583839781|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
161668501|NCT03285178|583839782|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
161668502|NCT03285178|583839783|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
161668503|NCT03285178|583839784|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
161668504|NCT03285178|583839778|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
161668505|NCT03285178|583839779|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161668506|NCT03285178|583839780|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161668507|NCT03285178|583839781|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161668508|NCT03285178|583839782|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161668509|NCT03285178|583839783|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161668510|NCT03285178|583839784|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161668511|NCT03285178|583839778|FG000|Single-Blind Run-In Period|Physician Decision|2|||
161668512|NCT03285178|583839779|FG001|Single-Blind Run-In Period|Physician Decision|0|||
161668513|NCT03285178|583839780|FG002|Single-Blind Run-In Period|Physician Decision|0|||
161921058|NCT03086343|584757140|FG000|Period 2|COVID-19 Infection|5|||
161477498|NCT02527161|583143351|FG000|Overall Study|Withdrawal by Subject|19|||
161578307|NCT03512756|583505219|FG002|Part 1|Lost to Follow-up|0|||
161578308|NCT03512756|583505220|FG003|Part 1|Lost to Follow-up|0|||
161578309|NCT03512756|583505217|FG000|Part 1|Physician Decision|0|||
161578310|NCT03512756|583505218|FG001|Part 1|Physician Decision|1|||
161578311|NCT03512756|583505219|FG002|Part 1|Physician Decision|0|||
161477499|NCT02527161|583143351|FG000|Overall Study|Delay in or unfit for surgery|16|||
161477500|NCT02527161|583143351|FG000|Overall Study|MRI contraindication|6|||
161477501|NCT02527161|583143351|FG000|Overall Study|Consent violation|4|||
161477502|NCT02527161|583143351|FG000|Overall Study|Only Recruited to Part A|27|||
161477503|NCT02527161|583143351|FG000|Overall Study|Physician Decision|1|||
161477504|NCT02527161|583143351|FG000|Overall Study|Adverse Event|1|||
161477505|NCT02527161|583143351|FG000|Overall Study|Lost to Follow-up|6|||
161477506|NCT00762229|583143354|FG000|Overall Study|Lost to Follow-up|1|||
161477507|NCT00762229|583143355|FG001|Overall Study|Lost to Follow-up|1|||
161477508|NCT00762229|583143354|FG000|Overall Study|did not recveive intervention|0|||
161477509|NCT00762229|583143355|FG001|Overall Study|did not recveive intervention|1|||
161477510|NCT02609828|583143356|FG000|Overall Study|Adverse Event|8|||
161477511|NCT02609828|583143357|FG001|Overall Study|Adverse Event|1|||
161477512|NCT02609828|583143358|FG002|Overall Study|Adverse Event|0|||
161477513|NCT02609828|583143359|FG003|Overall Study|Adverse Event|6|||
161477514|NCT02609828|583143356|FG000|Overall Study|Death|15|||
161477515|NCT02609828|583143357|FG001|Overall Study|Death|1|||
161578312|NCT03512756|583505220|FG003|Part 1|Physician Decision|0|||
161578313|NCT03512756|583505217|FG000|Part 1|Withdrawal by Subject|2|||
161578314|NCT03512756|583505218|FG001|Part 1|Withdrawal by Subject|2|||
161578315|NCT03512756|583505219|FG002|Part 1|Withdrawal by Subject|0|||
161578316|NCT03512756|583505220|FG003|Part 1|Withdrawal by Subject|0|||
161578317|NCT03512756|583505217|FG000|Part 2|Death|0|||
161578318|NCT03512756|583505218|FG001|Part 2|Death|0|||
161578319|NCT03512756|583505219|FG002|Part 2|Death|32|||
161578320|NCT03512756|583505220|FG003|Part 2|Death|21|||
161578321|NCT03512756|583505217|FG000|Part 2|Lost to Follow-up|0|||
161578322|NCT03512756|583505218|FG001|Part 2|Lost to Follow-up|0|||
161578323|NCT03512756|583505219|FG002|Part 2|Lost to Follow-up|1|||
161578324|NCT03512756|583505220|FG003|Part 2|Lost to Follow-up|0|||
161578325|NCT03512756|583505217|FG000|Part 2|Physician Decision|0|||
161578326|NCT03512756|583505218|FG001|Part 2|Physician Decision|0|||
161578327|NCT03512756|583505219|FG002|Part 2|Physician Decision|2|||
161578328|NCT03512756|583505220|FG003|Part 2|Physician Decision|4|||
161578329|NCT03512756|583505217|FG000|Part 2|Study Terminated by Sponsor|0|||
161578330|NCT03512756|583505218|FG001|Part 2|Study Terminated by Sponsor|0|||
161578331|NCT03512756|583505219|FG002|Part 2|Study Terminated by Sponsor|2|||
161578332|NCT03512756|583505220|FG003|Part 2|Study Terminated by Sponsor|6|||
161578333|NCT03512756|583505217|FG000|Part 2|Protocol Violation|0|||
161578334|NCT03512756|583505218|FG001|Part 2|Protocol Violation|0|||
161578335|NCT03512756|583505219|FG002|Part 2|Protocol Violation|1|||
161578336|NCT03512756|583505220|FG003|Part 2|Protocol Violation|0|||
161578337|NCT03512756|583505217|FG000|Part 2|Withdrawal by Subject|0|||
161578338|NCT03512756|583505218|FG001|Part 2|Withdrawal by Subject|0|||
161578339|NCT03512756|583505219|FG002|Part 2|Withdrawal by Subject|3|||
161578340|NCT03512756|583505220|FG003|Part 2|Withdrawal by Subject|9|||
161578341|NCT01212991|583505221|FG000|Double-blind|Lost to Follow-up|8|||
161578342|NCT01212991|583505222|FG001|Double-blind|Lost to Follow-up|4|||
161578343|NCT01212991|583505223|FG002|Double-blind|Lost to Follow-up|0|||
161578344|NCT01212991|583505221|FG000|Double-blind|Death|699|||
161578345|NCT01212991|583505222|FG001|Double-blind|Death|550|||
161578346|NCT01212991|583505223|FG002|Double-blind|Death|0|||
161578347|NCT01212991|583505221|FG000|Double-blind|Withdrawal by Subject|16|||
161578348|NCT01212991|583505222|FG001|Double-blind|Withdrawal by Subject|19|||
161578349|NCT01212991|583505223|FG002|Double-blind|Withdrawal by Subject|0|||
161578350|NCT01212991|583505221|FG000|Double-blind|Other|7|||
161578351|NCT01212991|583505222|FG001|Double-blind|Other|0|||
161578352|NCT01212991|583505223|FG002|Double-blind|Other|0|||
161578353|NCT01212991|583505221|FG000|Double-blind|Sponsor decision|142|||
161578354|NCT01212991|583505222|FG001|Double-blind|Sponsor decision|38|||
161578355|NCT01212991|583505223|FG002|Double-blind|Sponsor decision|0|||
161578356|NCT01212991|583505221|FG000|Open-label|Death|0|||
161578357|NCT01212991|583505222|FG001|Open-label|Death|0|||
161578358|NCT01212991|583505223|FG002|Open-label|Death|166|||
161578359|NCT01212991|583505221|FG000|Open-label|Lost to Follow-up|0|||
161578360|NCT01212991|583505222|FG001|Open-label|Lost to Follow-up|0|||
161578361|NCT01212991|583505223|FG002|Open-label|Lost to Follow-up|5|||
161578362|NCT01212991|583505221|FG000|Open-label|Withdrawal by Subject|0|||
161578363|NCT01212991|583505222|FG001|Open-label|Withdrawal by Subject|0|||
161815749|NCT03808376|584368767|FG000|Overall Study|Withdrawal by Subject|10|||
161578364|NCT01212991|583505223|FG002|Open-label|Withdrawal by Subject|7|||
161578365|NCT01212991|583505221|FG000|Open-label|Sponsor decision|0|||
161578366|NCT01212991|583505222|FG001|Open-label|Sponsor decision|0|||
161578367|NCT01212991|583505223|FG002|Open-label|Sponsor decision|53|||
161578368|NCT01212991|583505221|FG000|Open-label|Other|0|||
161578369|NCT01212991|583505222|FG001|Open-label|Other|0|||
161578370|NCT01212991|583505223|FG002|Open-label|Other|3|||
161578371|NCT05985044|583506494|FG000|Overall Study|Death|6|||
161578372|NCT05985044|583506494|FG000|Overall Study|Lost to Follow-up|4|||
161815750|NCT02679729|584368768|FG000|Overall Study|Lost to Follow-up|0|||
161477516|NCT02609828|583143358|FG002|Overall Study|Death|1|||
161477517|NCT02609828|583143359|FG003|Overall Study|Death|19|||
161578373|NCT05985044|583506494|FG000|Overall Study|Incapacitation|3|||
161578374|NCT05985044|583506494|FG000|Overall Study|Withdrawal by Subject|2|||
161578375|NCT02279095|583506497|FG000|Overall Study|Non-Compliance|1|||
161578376|NCT02279095|583506497|FG000|Overall Study|Withdrawal by Subject|8|||
161815751|NCT02679729|584368769|FG001|Overall Study|Lost to Follow-up|1|||
161578377|NCT02279095|583506497|FG000|Overall Study|Adverse Event|2|||
161578378|NCT02279095|583506497|FG000|Overall Study|Other|7|||
161578379|NCT02279095|583506497|FG000|Overall Study|Lost to Follow-up|1|||
161578380|NCT02300298|583506501|FG000|Disposition for Nintedanib|Progressive disease|10|||
161578381|NCT02300298|583506502|FG001|Disposition for Nintedanib|Progressive disease|0|||
161578382|NCT02300298|583506501|FG000|Disposition for Docetaxel|Progressive disease|0|||
161578383|NCT02300298|583506502|FG001|Disposition for Docetaxel|Progressive disease|6|||
161578384|NCT02300298|583506501|FG000|Disposition for Docetaxel|other adverse event|0|||
161578385|NCT02300298|583506502|FG001|Disposition for Docetaxel|other adverse event|4|||
161578386|NCT03452189|583506503|FG000|First Intervention (3 Months)|Adverse Event|1|||
161578387|NCT03452189|583506504|FG001|First Intervention (3 Months)|Adverse Event|0|||
161578388|NCT03452189|583506503|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
161578389|NCT03452189|583506504|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
161578390|NCT02724592|583506505|FG000|Overall Study|Lost to Follow-up|4|||
161578391|NCT02724592|583506506|FG001|Overall Study|Lost to Follow-up|1|||
161578392|NCT01951170|583506507|FG000|Overall Study|Investigator decision|1|||
161578393|NCT02597920|583506513|FG000|Overall Study|Worsening of other pre-existing disease|0|||
161578394|NCT02597920|583506514|FG001|Overall Study|Worsening of other pre-existing disease|1|||
161578395|NCT02597920|583506515|FG002|Overall Study|Worsening of other pre-existing disease|0|||
161578396|NCT02597920|583506513|FG000|Overall Study|Other adverse event|20|||
161578397|NCT02597920|583506514|FG001|Overall Study|Other adverse event|30|||
161578398|NCT02597920|583506515|FG002|Overall Study|Other adverse event|0|||
161578399|NCT02597920|583506513|FG000|Overall Study|Lost to Follow-up|7|||
161578400|NCT02597920|583506514|FG001|Overall Study|Lost to Follow-up|9|||
161578401|NCT02597920|583506515|FG002|Overall Study|Lost to Follow-up|0|||
161578402|NCT02597920|583506513|FG000|Overall Study|Refuse to continue in the study|3|||
161578403|NCT02597920|583506514|FG001|Overall Study|Refuse to continue in the study|13|||
161578404|NCT02597920|583506515|FG002|Overall Study|Refuse to continue in the study|1|||
161578405|NCT02597920|583506513|FG000|Overall Study|Other than specified|10|||
161578406|NCT02597920|583506514|FG001|Overall Study|Other than specified|31|||
161578407|NCT02597920|583506515|FG002|Overall Study|Other than specified|5|||
161578408|NCT02597920|583506513|FG000|Overall Study|Other|1|||
161578409|NCT02597920|583506514|FG001|Overall Study|Other|0|||
161578410|NCT02597920|583506515|FG002|Overall Study|Other|0|||
161578411|NCT00668863|583506516|FG000|Overall Study|Objective Progression or Relapse|42|||
161578412|NCT00668863|583506516|FG000|Overall Study|Adverse Event|13|||
161578413|NCT00668863|583506516|FG000|Overall Study|Study Terminated by Sponsor|8|||
161578414|NCT00668863|583506516|FG000|Overall Study|Global Deterioration of Health Status|4|||
161578415|NCT00668863|583506516|FG000|Overall Study|Withdrawal by Subject|1|||
161578416|NCT00668863|583506516|FG000|Overall Study|Surgery|1|||
161578417|NCT00668863|583506516|FG000|Overall Study|Subject's work scheduling problem|1|||
161578418|NCT00668863|583506516|FG000|Overall Study|Physician Decision|1|||
161578419|NCT01068743|583506517|FG000|Period 3|Adverse Event|0|||
161578420|NCT01068743|583506518|FG001|Period 3|Adverse Event|1|||
161578421|NCT01068743|583506519|FG002|Period 3|Adverse Event|0|||
161578422|NCT01068743|583506520|FG003|Period 3|Adverse Event|0|||
161578423|NCT00293293|583506521|FG000|Overall Study|Withdrawal by Subject|1|||
161578424|NCT00293293|583506522|FG001|Overall Study|Withdrawal by Subject|1|||
161578425|NCT00293293|583506521|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
161578426|NCT00293293|583506522|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
161578427|NCT00293293|583506521|FG000|Overall Study|Patient discontinued chemotherapy|0|||
161578428|NCT00293293|583506522|FG001|Overall Study|Patient discontinued chemotherapy|1|||
161578429|NCT03740009|583506523|FG000|Overall Study|Physician Decision|9|||
161578430|NCT03740009|583506523|FG000|Overall Study|Lost to Follow-up|1|||
161578431|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
161578432|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
161578433|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
161578434|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
161578435|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
161578436|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
161578437|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
161578438|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
161578439|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
161578440|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
161578441|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
161578442|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
161578443|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
161578444|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
161578445|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
161477518|NCT02609828|583143356|FG000|Overall Study|Insufficient clinical response|2|||
161477519|NCT02609828|583143357|FG001|Overall Study|Insufficient clinical response|1|||
161477520|NCT02609828|583143358|FG002|Overall Study|Insufficient clinical response|0|||
161477521|NCT02609828|583143359|FG003|Overall Study|Insufficient clinical response|0|||
161477522|NCT02609828|583143356|FG000|Overall Study|Lost to Follow-up|0|||
161477523|NCT02609828|583143357|FG001|Overall Study|Lost to Follow-up|0|||
161477524|NCT02609828|583143358|FG002|Overall Study|Lost to Follow-up|0|||
161477525|NCT02609828|583143359|FG003|Overall Study|Lost to Follow-up|1|||
161477526|NCT02609828|583143356|FG000|Overall Study|Protocol Violation|2|||
161477527|NCT02609828|583143357|FG001|Overall Study|Protocol Violation|0|||
161477528|NCT02609828|583143358|FG002|Overall Study|Protocol Violation|0|||
161477529|NCT02609828|583143359|FG003|Overall Study|Protocol Violation|1|||
161477530|NCT02609828|583143356|FG000|Overall Study|Withdrawal by Subject|12|||
161477531|NCT02609828|583143357|FG001|Overall Study|Withdrawal by Subject|1|||
161477532|NCT02609828|583143358|FG002|Overall Study|Withdrawal by Subject|0|||
161477533|NCT02609828|583143359|FG003|Overall Study|Withdrawal by Subject|10|||
161477534|NCT02609828|583143356|FG000|Overall Study|Other|3|||
161477535|NCT02609828|583143357|FG001|Overall Study|Other|0|||
161668514|NCT03285178|583839781|FG003|Single-Blind Run-In Period|Physician Decision|0|||
161668515|NCT03285178|583839782|FG004|Single-Blind Run-In Period|Physician Decision|0|||
161668516|NCT03285178|583839783|FG005|Single-Blind Run-In Period|Physician Decision|0|||
161668517|NCT03285178|583839784|FG006|Single-Blind Run-In Period|Physician Decision|0|||
161683057|NCT02554019|583891221|FG000|Overall Study|Withdrawal by Subject|1|||
161477536|NCT02609828|583143358|FG002|Overall Study|Other|0|||
161477537|NCT02609828|583143359|FG003|Overall Study|Other|6|||
161477538|NCT02609828|583143356|FG000|Overall Study|Randomized but not treated|1|||
161477539|NCT02609828|583143357|FG001|Overall Study|Randomized but not treated|0|||
161477540|NCT02609828|583143358|FG002|Overall Study|Randomized but not treated|0|||
161477541|NCT02609828|583143359|FG003|Overall Study|Randomized but not treated|0|||
161477542|NCT01081678|583143361|FG000|Overall Study|Ineligibility Determined|0|||
161477543|NCT01081678|583143362|FG001|Overall Study|Ineligibility Determined|0|||
161477544|NCT01081678|583143363|FG002|Overall Study|Ineligibility Determined|1|||
161477545|NCT01081678|583143364|FG003|Overall Study|Ineligibility Determined|1|||
161477546|NCT01081678|583143361|FG000|Overall Study|Noncompliance|3|||
161477547|NCT01081678|583143362|FG001|Overall Study|Noncompliance|4|||
161477548|NCT01081678|583143363|FG002|Overall Study|Noncompliance|5|||
161477549|NCT01081678|583143364|FG003|Overall Study|Noncompliance|2|||
161477550|NCT01081678|583143361|FG000|Overall Study|Adverse Event|2|||
161477551|NCT01081678|583143362|FG001|Overall Study|Adverse Event|1|||
161477552|NCT01081678|583143363|FG002|Overall Study|Adverse Event|2|||
161477553|NCT01081678|583143364|FG003|Overall Study|Adverse Event|2|||
161477554|NCT01081678|583143361|FG000|Overall Study|Withdrawal by Subject|15|||
161477555|NCT01081678|583143362|FG001|Overall Study|Withdrawal by Subject|7|||
161477556|NCT01081678|583143363|FG002|Overall Study|Withdrawal by Subject|17|||
161477557|NCT01081678|583143364|FG003|Overall Study|Withdrawal by Subject|14|||
161477558|NCT01081678|583143361|FG000|Overall Study|Administrative Decision|1|||
161477559|NCT01081678|583143362|FG001|Overall Study|Administrative Decision|0|||
161477560|NCT01081678|583143363|FG002|Overall Study|Administrative Decision|0|||
161477561|NCT01081678|583143364|FG003|Overall Study|Administrative Decision|1|||
161477562|NCT01081678|583143361|FG000|Overall Study|Lost to Follow-up|4|||
161477563|NCT01081678|583143362|FG001|Overall Study|Lost to Follow-up|1|||
161477564|NCT01081678|583143363|FG002|Overall Study|Lost to Follow-up|4|||
161477565|NCT01081678|583143364|FG003|Overall Study|Lost to Follow-up|3|||
161477566|NCT01081678|583143361|FG000|Overall Study|Death|2|||
161477567|NCT01081678|583143362|FG001|Overall Study|Death|2|||
161477568|NCT01081678|583143363|FG002|Overall Study|Death|2|||
161477569|NCT01081678|583143364|FG003|Overall Study|Death|6|||
161477570|NCT01081678|583143361|FG000|Overall Study|Other|0|||
161477571|NCT01081678|583143362|FG001|Overall Study|Other|1|||
161477572|NCT01081678|583143363|FG002|Overall Study|Other|0|||
161477573|NCT01081678|583143364|FG003|Overall Study|Other|0|||
161477574|NCT01619423|583143369|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
161477575|NCT01619423|583143370|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
161477576|NCT01619423|583143371|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
161477577|NCT01619423|583143372|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
161477578|NCT01281865|583143379|FG000|Overall Study|Adverse Event|1|||
161477579|NCT01281865|583143380|FG001|Overall Study|Adverse Event|1|||
161477580|NCT01281865|583143379|FG000|Overall Study|Withdrawal by Subject|1|||
161477581|NCT01281865|583143380|FG001|Overall Study|Withdrawal by Subject|0|||
161477582|NCT01281865|583143379|FG000|Overall Study|Lack of Efficacy|1|||
161477583|NCT01281865|583143380|FG001|Overall Study|Lack of Efficacy|0|||
161477584|NCT03478657|583143381|FG000|Overall Study|Withdrawal by Subject|0|||
161477585|NCT03478657|583143382|FG001|Overall Study|Withdrawal by Subject|1|||
161477586|NCT02590003|583143383|FG000|Overall Study|Death|1|||
161477587|NCT02590003|583143384|FG001|Overall Study|Death|2|||
161477588|NCT03733470|583143385|FG000|Overall Study|PI Decision|1|||
161477589|NCT03733470|583143386|FG001|Overall Study|PI Decision|1|||
161477590|NCT01786668|583143390|FG000|Overall Study|Adverse Event|0|||
161477591|NCT01786668|583143391|FG001|Overall Study|Adverse Event|1|||
161477592|NCT01786668|583143392|FG002|Overall Study|Adverse Event|1|||
161477593|NCT01786668|583143393|FG003|Overall Study|Adverse Event|2|||
161477594|NCT01786668|583143390|FG000|Overall Study|Withdrawal by Subject|0|||
161477595|NCT01786668|583143391|FG001|Overall Study|Withdrawal by Subject|0|||
161477596|NCT01786668|583143392|FG002|Overall Study|Withdrawal by Subject|3|||
161477597|NCT01786668|583143393|FG003|Overall Study|Withdrawal by Subject|1|||
161477598|NCT01786668|583143390|FG000|Overall Study|Pregnancy|0|||
161477599|NCT01786668|583143391|FG001|Overall Study|Pregnancy|0|||
161477600|NCT01786668|583143392|FG002|Overall Study|Pregnancy|0|||
161477601|NCT01786668|583143393|FG003|Overall Study|Pregnancy|1|||
161477602|NCT01786668|583143390|FG000|Overall Study|Lost to Follow-up|1|||
161477603|NCT01786668|583143391|FG001|Overall Study|Lost to Follow-up|0|||
161578446|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
161578447|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
161578448|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
161578449|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
161578450|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
161578451|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
161578452|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
161578453|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
161578454|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
161578455|NCT01061151|583506524|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
161578456|NCT01061151|583506525|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
161578457|NCT01061151|583506526|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
161578458|NCT01061151|583506527|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
161578459|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
161578460|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
161578461|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
161578462|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
161477604|NCT01786668|583143392|FG002|Overall Study|Lost to Follow-up|1|||
161477605|NCT01786668|583143393|FG003|Overall Study|Lost to Follow-up|0|||
161477606|NCT00702689|583143403|FG000|Overall Study|Withdrawal by Subject|4|||
161477607|NCT00702689|583143403|FG000|Overall Study|Recurrent malignancy|1|||
161477608|NCT00702689|583143403|FG000|Overall Study|Adverse Event|1|||
161477609|NCT01986907|583143406|FG000|Overall Study|Adverse Event|11|||
161477610|NCT01986907|583143406|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
161477611|NCT01986907|583143406|FG000|Overall Study|Protocol Violation|4|||
161477612|NCT01986907|583143406|FG000|Overall Study|Withdrawal by Subject|76|||
161477613|NCT01986907|583143406|FG000|Overall Study|Lost to Follow-up|38|||
161477614|NCT01986907|583143406|FG000|Overall Study|Death|9|||
161477615|NCT00939640|583143410|FG000|Overall Study|Physician Decision|1|||
161477616|NCT00239590|583143411|FG000|Randomized|Lost to Follow-up|0|||
161477617|NCT00239590|583143412|FG001|Randomized|Lost to Follow-up|1|||
161477618|NCT00239590|583143411|FG000|Randomized|Withdrawal by Subject|0|||
161477619|NCT00239590|583143412|FG001|Randomized|Withdrawal by Subject|1|||
161477620|NCT00239590|583143411|FG000|Completed Study Protocol|Adverse Event|1|||
161477621|NCT00239590|583143412|FG001|Completed Study Protocol|Adverse Event|1|||
161477622|NCT00239590|583143411|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
161477623|NCT00239590|583143412|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
161477624|NCT00892047|583143417|FG000|Overall Study|Adverse Event|2|||
161477625|NCT00892047|583143418|FG001|Overall Study|Adverse Event|2|||
161477626|NCT00892047|583143417|FG000|Overall Study|subject burden|2|||
161477627|NCT00892047|583143418|FG001|Overall Study|subject burden|3|||
161477628|NCT00892047|583143417|FG000|Overall Study|Lack of Efficacy|0|||
161477629|NCT00892047|583143418|FG001|Overall Study|Lack of Efficacy|2|||
161477630|NCT01201785|583143419|FG000|Overall Study|Lost to Follow-up|16|||
161477631|NCT01146665|583143420|FG000|Overall Study|Withdrawal by Subject|10|||
161477632|NCT01146665|583143421|FG001|Overall Study|Withdrawal by Subject|16|||
161477633|NCT01064310|583143422|FG000|Period 1|Adverse Event|7|||
161477634|NCT01064310|583143423|FG001|Period 1|Adverse Event|10|||
161477635|NCT01064310|583143424|FG002|Period 1|Adverse Event|0|||
161477636|NCT01064310|583143422|FG000|Period 1|Physician Decision|1|||
161477637|NCT01064310|583143423|FG001|Period 1|Physician Decision|0|||
161477638|NCT01064310|583143424|FG002|Period 1|Physician Decision|0|||
161477639|NCT01064310|583143422|FG000|Period 1|Withdrawal by Subject|2|||
161477640|NCT01064310|583143423|FG001|Period 1|Withdrawal by Subject|2|||
161477641|NCT01064310|583143424|FG002|Period 1|Withdrawal by Subject|0|||
161477642|NCT01064310|583143422|FG000|Period 1|Lack of Efficacy|3|||
161477643|NCT01064310|583143423|FG001|Period 1|Lack of Efficacy|5|||
161477644|NCT01064310|583143424|FG002|Period 1|Lack of Efficacy|0|||
161477645|NCT01064310|583143422|FG000|Period 1|Entered Open-label Period|1|||
161477646|NCT01064310|583143423|FG001|Period 1|Entered Open-label Period|1|||
161477647|NCT01064310|583143424|FG002|Period 1|Entered Open-label Period|0|||
161477648|NCT01064310|583143422|FG000|Period 2|Adverse Event|2|||
161477649|NCT01064310|583143423|FG001|Period 2|Adverse Event|1|||
161477650|NCT01064310|583143424|FG002|Period 2|Adverse Event|0|||
161477651|NCT01064310|583143422|FG000|Period 2|Physician Decision|0|||
161477652|NCT01064310|583143423|FG001|Period 2|Physician Decision|1|||
161477653|NCT01064310|583143424|FG002|Period 2|Physician Decision|0|||
161477654|NCT01064310|583143422|FG000|Period 2|Entered Open-label Period|1|||
161477655|NCT01064310|583143423|FG001|Period 2|Entered Open-label Period|0|||
161477656|NCT01064310|583143424|FG002|Period 2|Entered Open-label Period|0|||
161477657|NCT01064310|583143422|FG000|Period 2|Lack of Efficacy|1|||
161477658|NCT01064310|583143423|FG001|Period 2|Lack of Efficacy|4|||
161477659|NCT01064310|583143424|FG002|Period 2|Lack of Efficacy|0|||
161477660|NCT01064310|583143422|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
161477661|NCT01064310|583143423|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
161477662|NCT01064310|583143424|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
161477663|NCT01064310|583143422|FG000|Open Label Pazopinib|Adverse Event|0|||
161477664|NCT01064310|583143423|FG001|Open Label Pazopinib|Adverse Event|0|||
161668518|NCT03285178|583839778|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161668519|NCT03285178|583839779|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
161683058|NCT02554019|583891222|FG001|Overall Study|Withdrawal by Subject|0|||
161477665|NCT01064310|583143424|FG002|Open Label Pazopinib|Adverse Event|12|||
161477666|NCT01064310|583143422|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
161477667|NCT01064310|583143423|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
161477668|NCT01064310|583143424|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
161477669|NCT01064310|583143422|FG000|Open Label Pazopinib|Physician Decision|0|||
161477670|NCT01064310|583143423|FG001|Open Label Pazopinib|Physician Decision|0|||
161477671|NCT01064310|583143424|FG002|Open Label Pazopinib|Physician Decision|20|||
161477672|NCT00001880|583143425|FG000|Overall Study|Death|14|||
161477673|NCT02639065|583143426|FG000|Study Treatment|Disease Progression|13|||
161477674|NCT02639065|583143426|FG000|Study Treatment|Adverse Event|9|||
161477675|NCT02639065|583143426|FG000|Study Treatment|Withdrawal by Subject|1|||
161477676|NCT02639065|583143426|FG000|Follow up|Subject refused to follow up|1|||
161477677|NCT02639065|583143426|FG000|Follow up|Symptomatic Deterioration|2|||
161477678|NCT02639065|583143426|FG000|Follow up|Death|2|||
161477679|NCT02639065|583143426|FG000|Follow up|Study Terminated|1|||
161477680|NCT02639065|583143426|FG000|Follow up|Disease Progression|3|||
161477681|NCT00660699|583143427|FG000|Overall Study|Withdrawal by Subject|2|||
161477682|NCT05147428|583143428|FG000|Overall Study|Removed prior to mailing|289|||
161477683|NCT05147428|583143429|FG001|Overall Study|Removed prior to mailing|306|||
161477684|NCT05147428|583143430|FG002|Overall Study|Removed prior to mailing|270|||
161477685|NCT05147428|583143428|FG000|Overall Study|Died or disenrolled during blackout period|239|||
161477686|NCT05147428|583143429|FG001|Overall Study|Died or disenrolled during blackout period|278|||
161477687|NCT05147428|583143430|FG002|Overall Study|Died or disenrolled during blackout period|273|||
161477688|NCT03128047|583143431|FG000|Overall Study|Withdrawal by Subject|1|||
161477689|NCT00688753|583144835|FG000|Overall Study|Disease progression|55|||
161477690|NCT00688753|583144835|FG000|Overall Study|Missing|1|||
161477691|NCT00688753|583144835|FG000|Overall Study|Death|9|||
161477692|NCT00688753|583144835|FG000|Overall Study|Withdrawal by Subject|3|||
161477693|NCT00688753|583144835|FG000|Overall Study|Adverse Event|20|||
161477694|NCT00688753|583144835|FG000|Overall Study|Protocol Violation|1|||
161477695|NCT00688753|583144835|FG000|Overall Study|Lost to Follow-up|3|||
161477696|NCT05996718|583144837|FG000|Overall Study|Lost to Follow-up|3|||
161477697|NCT01713686|583144838|FG000|Overall Study|Lost to Follow-up|9|||
161477698|NCT01713686|583144838|FG000|Overall Study|Withdrawal by Subject|6|||
161477699|NCT03187197|583144840|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
161477700|NCT03187197|583144841|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
161477701|NCT03187197|583144842|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
161477702|NCT03187197|583144840|FG000|Overall Study|Withdrawal by Subject|8|||
161477703|NCT03187197|583144841|FG001|Overall Study|Withdrawal by Subject|63|||
161477704|NCT03187197|583144842|FG002|Overall Study|Withdrawal by Subject|4|||
161477705|NCT03187197|583144840|FG000|Overall Study|Lost to Follow-up|1|||
161477706|NCT03187197|583144841|FG001|Overall Study|Lost to Follow-up|60|||
161477707|NCT03187197|583144842|FG002|Overall Study|Lost to Follow-up|7|||
161477708|NCT03187197|583144840|FG000|Overall Study|Adverse Event|6|||
161477709|NCT03187197|583144841|FG001|Overall Study|Adverse Event|29|||
161477710|NCT03187197|583144842|FG002|Overall Study|Adverse Event|0|||
161477711|NCT03187197|583144840|FG000|Overall Study|Death|0|||
161477712|NCT03187197|583144841|FG001|Overall Study|Death|11|||
161477713|NCT03187197|583144842|FG002|Overall Study|Death|0|||
161477714|NCT03187197|583144840|FG000|Overall Study|Administrative problem|1|||
161477715|NCT03187197|583144841|FG001|Overall Study|Administrative problem|1|||
161477716|NCT03187197|583144842|FG002|Overall Study|Administrative problem|0|||
161477717|NCT03187197|583144840|FG000|Overall Study|Reason not listed|2|||
161477718|NCT03187197|583144841|FG001|Overall Study|Reason not listed|54|||
161477719|NCT03187197|583144842|FG002|Overall Study|Reason not listed|1|||
161477720|NCT03187197|583144840|FG000|Overall Study|Missing|1|||
161477721|NCT03187197|583144841|FG001|Overall Study|Missing|32|||
161477722|NCT03187197|583144842|FG002|Overall Study|Missing|3|||
161477723|NCT03187197|583144840|FG000|Overall Study|Status missing|2|||
161477724|NCT03187197|583144841|FG001|Overall Study|Status missing|33|||
161477725|NCT03187197|583144842|FG002|Overall Study|Status missing|3|||
161477726|NCT03187197|583144840|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
161477727|NCT03187197|583144841|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
161477728|NCT03187197|583144842|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
161477729|NCT02385045|583144843|FG000|Overall Study|Endoscopy could not be completed|4|||
161477730|NCT00115739|583144844|FG000|Overall Study|Lost to Follow-up|3|||
161477731|NCT00259649|583144847|FG000|Overall Study|Lost to Follow-up|7|||
161477732|NCT00259649|583144847|FG000|Overall Study|irregular menses|3|||
161477733|NCT02200211|583144849|FG000|Overall Study|Lost to Follow-up|7|||
161477734|NCT02200211|583144850|FG001|Overall Study|Lost to Follow-up|7|||
161477735|NCT02200211|583144851|FG002|Overall Study|Lost to Follow-up|1|||
161477736|NCT02200211|583144852|FG003|Overall Study|Lost to Follow-up|2|||
161477737|NCT02200211|583144849|FG000|Overall Study|Withdrawal by Subject|1|||
161477738|NCT02200211|583144850|FG001|Overall Study|Withdrawal by Subject|0|||
161477739|NCT02200211|583144851|FG002|Overall Study|Withdrawal by Subject|0|||
161477740|NCT02200211|583144852|FG003|Overall Study|Withdrawal by Subject|0|||
161477741|NCT00381485|583144853|FG000|Open-Label Run-In Period|Adverse Event|9|||
161477742|NCT00381485|583144854|FG001|Open-Label Run-In Period|Adverse Event|0|||
161477743|NCT00381485|583144855|FG002|Open-Label Run-In Period|Adverse Event|0|||
161477744|NCT00381485|583144856|FG003|Open-Label Run-In Period|Adverse Event|0|||
161477745|NCT00381485|583144853|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
161477746|NCT00381485|583144854|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
161477747|NCT00381485|583144855|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
161477748|NCT00381485|583144856|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
161477749|NCT00381485|583144853|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
161477750|NCT00381485|583144854|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
161477751|NCT00381485|583144855|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
161477752|NCT00381485|583144856|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
161477753|NCT00381485|583144853|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
161477754|NCT00381485|583144854|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
161477755|NCT00381485|583144855|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
161477756|NCT00381485|583144856|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
161668520|NCT03285178|583839780|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
161668521|NCT03285178|583839781|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161668522|NCT03285178|583839782|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161668523|NCT03285178|583839783|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161668524|NCT03285178|583839784|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161668525|NCT03285178|583839778|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161668526|NCT03285178|583839779|FG001|Double-Blind Treatment Period|Adverse Event|0|||
161668527|NCT03285178|583839780|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161668528|NCT03285178|583839781|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161668529|NCT03285178|583839782|FG004|Double-Blind Treatment Period|Adverse Event|0|||
161668530|NCT03285178|583839783|FG005|Double-Blind Treatment Period|Adverse Event|0|||
161668531|NCT03285178|583839784|FG006|Double-Blind Treatment Period|Adverse Event|2|||
161668532|NCT03285178|583839778|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161668533|NCT03285178|583839779|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161815752|NCT02679729|584368770|FG002|Overall Study|Lost to Follow-up|0|||
161815753|NCT02679729|584368771|FG003|Overall Study|Lost to Follow-up|0|||
161477757|NCT00381485|583144853|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
161477758|NCT00381485|583144854|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
161477759|NCT00381485|583144855|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
161477760|NCT00381485|583144856|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
161477761|NCT00381485|583144853|FG000|Open-Label Run-In Period|Treatment failure|1|||
161477762|NCT00381485|583144854|FG001|Open-Label Run-In Period|Treatment failure|0|||
161477763|NCT00381485|583144855|FG002|Open-Label Run-In Period|Treatment failure|0|||
161477764|NCT00381485|583144856|FG003|Open-Label Run-In Period|Treatment failure|0|||
161477765|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161477766|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161477767|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Adverse Event|2|||
161477768|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Adverse Event|5|||
161477769|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161477770|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
161477771|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
161477772|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
161477773|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161477774|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161477775|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
161477776|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
161477777|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
161477778|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
161477779|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
161477780|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
161477781|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
161477782|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161477783|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
161477784|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161477785|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
161477786|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
161477787|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
161477788|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
161477789|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
161477790|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
161477791|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
161477792|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
161477793|NCT00381485|583144853|FG000|Double-Blind Treatment Period|Administrative|0|||
161477794|NCT00381485|583144854|FG001|Double-Blind Treatment Period|Administrative|1|||
161477795|NCT00381485|583144855|FG002|Double-Blind Treatment Period|Administrative|0|||
161477796|NCT00381485|583144856|FG003|Double-Blind Treatment Period|Administrative|1|||
161477797|NCT01235351|583144857|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
161477798|NCT01235351|583144858|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
161477799|NCT00745823|583144859|FG000|Overall Study|Adverse Event|5|||
161477800|NCT00745823|583144860|FG001|Overall Study|Adverse Event|3|||
161477801|NCT00745823|583144859|FG000|Overall Study|Lack of Efficacy|20|||
161477802|NCT00745823|583144860|FG001|Overall Study|Lack of Efficacy|6|||
161477803|NCT00745823|583144859|FG000|Overall Study|Lost to Follow-up|10|||
161668534|NCT03285178|583839780|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161668535|NCT03285178|583839781|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
161815754|NCT02679729|584368772|FG004|Overall Study|Lost to Follow-up|1|||
161477804|NCT00745823|583144860|FG001|Overall Study|Lost to Follow-up|11|||
161477805|NCT00745823|583144859|FG000|Overall Study|Physician Decision|10|||
161477806|NCT00745823|583144860|FG001|Overall Study|Physician Decision|5|||
161477807|NCT00745823|583144859|FG000|Overall Study|Pregnancy|0|||
161477808|NCT00745823|583144860|FG001|Overall Study|Pregnancy|4|||
161477809|NCT00745823|583144859|FG000|Overall Study|Withdrawal by Subject|14|||
161477810|NCT00745823|583144860|FG001|Overall Study|Withdrawal by Subject|8|||
161477811|NCT00745823|583144859|FG000|Overall Study|Study Terminated by Sponsor|326|||
161477812|NCT00745823|583144860|FG001|Overall Study|Study Terminated by Sponsor|349|||
161477813|NCT02980601|583144870|FG000|Overall Study|Lost to Follow-up|2|||
161477814|NCT02980601|583144871|FG001|Overall Study|Lost to Follow-up|2|||
161477815|NCT02980601|583144870|FG000|Overall Study|Death|0|||
161477816|NCT02980601|583144871|FG001|Overall Study|Death|1|||
161477817|NCT02980601|583144870|FG000|Overall Study|Graft loss|1|||
161477818|NCT02980601|583144871|FG001|Overall Study|Graft loss|0|||
161477819|NCT02980601|583144870|FG000|Overall Study|Failed to sign consent|2|||
161477820|NCT02980601|583144871|FG001|Overall Study|Failed to sign consent|0|||
161477821|NCT00290888|583144872|FG000|Overall Study|Physician Decision|3|||
161477822|NCT00290888|583144873|FG001|Overall Study|Physician Decision|1|||
161477823|NCT01034631|583144874|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
161477824|NCT01034631|583144875|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
161477825|NCT01034631|583144876|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
161477826|NCT01034631|583144874|FG000|Phase II|Not Evaluable per protocol|0|||
161477827|NCT01034631|583144875|FG001|Phase II|Not Evaluable per protocol|0|||
161477828|NCT01034631|583144876|FG002|Phase II|Not Evaluable per protocol|2|||
161477829|NCT01034631|583144874|FG000|Phase II|Determined Ineligible per protocol|0|||
161477830|NCT01034631|583144875|FG001|Phase II|Determined Ineligible per protocol|1|||
161477831|NCT01034631|583144876|FG002|Phase II|Determined Ineligible per protocol|0|||
161477832|NCT00799383|583144877|FG000|Overall Study|Protocol Violation|1|||
161477833|NCT00799383|583144878|FG001|Overall Study|Protocol Violation|1|||
161477834|NCT00799383|583144877|FG000|Overall Study|Adverse Event|0|||
161477835|NCT00799383|583144878|FG001|Overall Study|Adverse Event|1|||
161477836|NCT00799383|583144877|FG000|Overall Study|Lost to Follow-up|1|||
161477837|NCT00799383|583144878|FG001|Overall Study|Lost to Follow-up|2|||
161477838|NCT00799383|583144877|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
161477839|NCT00799383|583144878|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
161668536|NCT03285178|583839782|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
161668537|NCT03285178|583839783|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
161921059|NCT03086343|584757141|FG001|Period 2|COVID-19 Infection|0|||
161921060|NCT03086343|584757142|FG002|Period 2|COVID-19 Infection|0|||
161477840|NCT00799383|583144877|FG000|Overall Study|Withdrawal by Subject|0|||
161477841|NCT00799383|583144878|FG001|Overall Study|Withdrawal by Subject|1|||
161477842|NCT03486223|583144888|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
161477843|NCT03486223|583144889|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
161477844|NCT01806298|583144898|FG000|Overall Study|Adverse Event|3|||
161477845|NCT01806298|583144898|FG000|Overall Study|Protocol Non-compliance|1|||
161477846|NCT01806298|583144898|FG000|Overall Study|Withdrawal by Subject|1|||
161477847|NCT01806298|583144898|FG000|Overall Study|Other|5|||
161477848|NCT03068130|583144899|FG000|Overall Study|Adverse Event|19|||
161477849|NCT03068130|583144899|FG000|Overall Study|Death|14|||
161477850|NCT03068130|583144899|FG000|Overall Study|Lost to Follow-up|4|||
161477851|NCT03068130|583144899|FG000|Overall Study|Withdrawal by Subject|26|||
161477852|NCT03068130|583144899|FG000|Overall Study|Administrative Reasons|3|||
161477853|NCT03068130|583144899|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
161477854|NCT03068130|583144899|FG000|Overall Study|Study terminated by sponsor|194|||
161477855|NCT00590720|583144900|FG000|Overall Study|Lost to Follow-up|1|||
161477856|NCT00590720|583144901|FG001|Overall Study|Lost to Follow-up|0|||
161477857|NCT00590720|583144900|FG000|Overall Study|Withdrawal by Subject|0|||
161477858|NCT00590720|583144901|FG001|Overall Study|Withdrawal by Subject|1|||
161477859|NCT01001377|583144902|FG000|Overall Study|Ineligibility determined|2|||
161477860|NCT01001377|583144903|FG001|Overall Study|Ineligibility determined|0|||
161477861|NCT01001377|583144902|FG000|Overall Study|Withdrawal by Subject|19|||
161477862|NCT01001377|583144903|FG001|Overall Study|Withdrawal by Subject|20|||
161477863|NCT01001377|583144902|FG000|Overall Study|Lost to Follow-up|14|||
161477864|NCT01001377|583144903|FG001|Overall Study|Lost to Follow-up|17|||
161477865|NCT01001377|583144902|FG000|Overall Study|Death|391|||
161477866|NCT01001377|583144903|FG001|Overall Study|Death|384|||
161477867|NCT00134082|583144906|FG000|Overall Study|Adverse Event|2|||
161477868|NCT00134082|583144906|FG000|Overall Study|Death|1|||
161477869|NCT02805972|583144907|FG000|Washout Period|Lost to Follow-up|3|||
161921061|NCT03086343|584757143|FG003|Period 2|COVID-19 Infection|0|||
161668538|NCT03285178|583839784|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
161477870|NCT02805972|583144908|FG001|Washout Period|Lost to Follow-up|0|||
161477871|NCT00389597|583144913|FG000|Overall Study|Lost to Follow-up|8|||
161477872|NCT00389597|583144914|FG001|Overall Study|Lost to Follow-up|6|||
161477873|NCT00389597|583144915|FG002|Overall Study|Lost to Follow-up|4|||
161921062|NCT03086343|584757140|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
161668539|NCT03285178|583839778|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161668540|NCT03285178|583839779|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161921063|NCT03086343|584757141|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
161921064|NCT03086343|584757142|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
161921065|NCT03086343|584757143|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
161668541|NCT03285178|583839780|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161668542|NCT03285178|583839781|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161668543|NCT03285178|583839782|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161668544|NCT03285178|583839783|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161668545|NCT03285178|583839784|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161668546|NCT03285178|583839778|FG000|Double-Blind Treatment Period|COVID-19|0|||
161668547|NCT03285178|583839779|FG001|Double-Blind Treatment Period|COVID-19|0|||
161921066|NCT03086343|584757140|FG000|Period 2|Other, Not Specified|23|||
161668548|NCT03285178|583839780|FG002|Double-Blind Treatment Period|COVID-19|1|||
161668549|NCT03285178|583839781|FG003|Double-Blind Treatment Period|COVID-19|0|||
161668550|NCT03285178|583839782|FG004|Double-Blind Treatment Period|COVID-19|0|||
161668551|NCT03285178|583839783|FG005|Double-Blind Treatment Period|COVID-19|0|||
161668552|NCT03285178|583839784|FG006|Double-Blind Treatment Period|COVID-19|0|||
161668553|NCT01128894|583839785|FG000|Overall Study|Adverse Event|31|||
161668554|NCT01128894|583839786|FG001|Overall Study|Adverse Event|41|||
161668555|NCT01128894|583839785|FG000|Overall Study|Protocol Violation|2|||
161668556|NCT01128894|583839786|FG001|Overall Study|Protocol Violation|1|||
161668557|NCT01128894|583839785|FG000|Overall Study|Noncompliance|4|||
161668558|NCT01128894|583839786|FG001|Overall Study|Noncompliance|5|||
161668559|NCT01128894|583839785|FG000|Overall Study|Lost to Follow-up|8|||
161668560|NCT01128894|583839786|FG001|Overall Study|Lost to Follow-up|8|||
161668561|NCT01128894|583839785|FG000|Overall Study|Withdrawal by Subject|10|||
161668562|NCT01128894|583839786|FG001|Overall Study|Withdrawal by Subject|12|||
161668563|NCT01128894|583839785|FG000|Overall Study|Physician Decision|2|||
161668564|NCT01128894|583839786|FG001|Overall Study|Physician Decision|1|||
161668565|NCT01128894|583839785|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
161668566|NCT01128894|583839786|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
161668567|NCT01128738|583839787|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
161668568|NCT01128738|583839788|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
161668569|NCT01128738|583839787|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
161668570|NCT01128738|583839788|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
161668571|NCT01128738|583839787|FG000|Second TP|Lost to Follow-up|0|||
161668572|NCT01128738|583839788|FG001|Second TP|Lost to Follow-up|1|||
161668573|NCT01128738|583839787|FG000|Second TP|Withdrawal by Subject|0|||
161921067|NCT03086343|584757141|FG001|Period 2|Other, Not Specified|22|||
161921068|NCT03086343|584757142|FG002|Period 2|Other, Not Specified|2|||
161921069|NCT03086343|584757143|FG003|Period 2|Other, Not Specified|4|||
161921070|NCT04900272|584757144|FG000|Overall Study|Lost to Follow-up|2|||
161921071|NCT04900272|584757144|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
161921072|NCT04900272|584757144|FG000|Overall Study|Withdrawal by Subject|1|||
161668574|NCT01128738|583839788|FG001|Second TP|Withdrawal by Subject|2|||
161668575|NCT00973362|583839789|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
161668576|NCT00973362|583839790|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
161668577|NCT00973362|583839789|FG000|Baseline Evaluation|No colposcopy visit|62|||
161668578|NCT00973362|583839790|FG001|Baseline Evaluation|No colposcopy visit|0|||
161668579|NCT00973362|583839789|FG000|Baseline Evaluation|Inevaluable|686|||
161668580|NCT00973362|583839790|FG001|Baseline Evaluation|Inevaluable|223|||
161668581|NCT00973362|583839789|FG000|3-Year Follow-up|Lost to Follow-up|17|||
161921073|NCT01625182|584757146|FG000|Overall Study|Administrative problems|1|||
161477874|NCT00389597|583144916|FG003|Overall Study|Lost to Follow-up|6|||
161668582|NCT00973362|583839790|FG001|3-Year Follow-up|Lost to Follow-up|0|||
161668583|NCT00887679|583839793|FG000|Overall Study|Withdrawal by Subject|1|||
161668584|NCT00887679|583839793|FG000|Overall Study|Lost to Follow-up|4|||
161668585|NCT00887679|583839793|FG000|Overall Study|Physician Decision|5|||
161668586|NCT02683941|583839794|FG000|Double-blind Phase|Adverse Event|0|||
161921074|NCT01625182|584757147|FG001|Overall Study|Administrative problems|0|||
161921075|NCT01625182|584757146|FG000|Overall Study|Protocol deviation|0|||
161668587|NCT02683941|583839795|FG001|Double-blind Phase|Adverse Event|1|||
161668588|NCT02683941|583839794|FG000|Double-blind Phase|Withdrawal by Subject|4|||
161668589|NCT02683941|583839795|FG001|Double-blind Phase|Withdrawal by Subject|2|||
161477875|NCT00306189|583144919|FG000|Overall Study|Physician Decision|0|||
161477876|NCT00306189|583144920|FG001|Overall Study|Physician Decision|0|||
161477877|NCT00306189|583144921|FG002|Overall Study|Physician Decision|0|||
161477878|NCT00306189|583144922|FG003|Overall Study|Physician Decision|1|||
161477879|NCT00306189|583144919|FG000|Overall Study|Adverse Event|3|||
161477880|NCT00306189|583144920|FG001|Overall Study|Adverse Event|3|||
161477881|NCT00306189|583144921|FG002|Overall Study|Adverse Event|2|||
161477882|NCT00306189|583144922|FG003|Overall Study|Adverse Event|2|||
161477883|NCT00306189|583144919|FG000|Overall Study|Withdrawal by Subject|4|||
161477884|NCT00306189|583144920|FG001|Overall Study|Withdrawal by Subject|2|||
161477885|NCT00306189|583144921|FG002|Overall Study|Withdrawal by Subject|8|||
161477886|NCT00306189|583144922|FG003|Overall Study|Withdrawal by Subject|1|||
161477887|NCT00306189|583144919|FG000|Overall Study|Ineligibility determined|1|||
161477888|NCT00306189|583144920|FG001|Overall Study|Ineligibility determined|1|||
161477889|NCT00306189|583144921|FG002|Overall Study|Ineligibility determined|1|||
161477890|NCT00306189|583144922|FG003|Overall Study|Ineligibility determined|1|||
161477891|NCT00306189|583144919|FG000|Overall Study|Other|1|||
161477892|NCT00306189|583144920|FG001|Overall Study|Other|0|||
161477893|NCT00306189|583144921|FG002|Overall Study|Other|0|||
161477894|NCT00306189|583144922|FG003|Overall Study|Other|0|||
161477895|NCT00259610|583144923|FG000|Overall Study|Withdrawal by Subject|33|||
161477896|NCT00259610|583144924|FG001|Overall Study|Withdrawal by Subject|25|||
161477897|NCT00259610|583144925|FG002|Overall Study|Withdrawal by Subject|29|||
161477898|NCT00259610|583144926|FG003|Overall Study|Withdrawal by Subject|19|||
161477899|NCT00259610|583144923|FG000|Overall Study|Lost to Follow-up|19|||
161578463|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
161578464|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161578465|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161578466|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161578467|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
161668590|NCT02683941|583839794|FG000|Double-blind Phase|Lost to Follow-up|1|||
161578468|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
161578469|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
161578470|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
161578471|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
161578472|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
161578473|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
161578474|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
161578475|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
161578476|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
161578477|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
161578478|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
161578479|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
161578480|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
161578481|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
161578482|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
161578483|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
161578484|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
161578485|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
161578486|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
161578487|NCT01061151|583506524|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
161578488|NCT01061151|583506525|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
161578489|NCT01061151|583506526|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
161668591|NCT02683941|583839795|FG001|Double-blind Phase|Lost to Follow-up|0|||
161668592|NCT02683941|583839794|FG000|Double-blind Phase|Disease Progression|5|||
161668593|NCT02683941|583839795|FG001|Double-blind Phase|Disease Progression|2|||
161477900|NCT00259610|583144924|FG001|Overall Study|Lost to Follow-up|8|||
161477901|NCT00259610|583144925|FG002|Overall Study|Lost to Follow-up|18|||
161477902|NCT00259610|583144926|FG003|Overall Study|Lost to Follow-up|15|||
161477903|NCT00259610|583144923|FG000|Overall Study|Physician Decision|6|||
161477904|NCT00259610|583144924|FG001|Overall Study|Physician Decision|4|||
161477905|NCT00259610|583144925|FG002|Overall Study|Physician Decision|7|||
161477906|NCT00259610|583144926|FG003|Overall Study|Physician Decision|2|||
161477907|NCT00259610|583144923|FG000|Overall Study|Death|1|||
161477908|NCT00259610|583144924|FG001|Overall Study|Death|1|||
161477909|NCT00259610|583144925|FG002|Overall Study|Death|2|||
161477910|NCT00259610|583144926|FG003|Overall Study|Death|0|||
161477911|NCT00259610|583144923|FG000|Overall Study|non medical reason|6|||
161477912|NCT00259610|583144924|FG001|Overall Study|non medical reason|2|||
161477913|NCT00259610|583144925|FG002|Overall Study|non medical reason|10|||
161477914|NCT00259610|583144926|FG003|Overall Study|non medical reason|3|||
161477915|NCT00259610|583144923|FG000|Overall Study|Adverse Event|3|||
161477916|NCT00259610|583144924|FG001|Overall Study|Adverse Event|4|||
161477917|NCT00259610|583144925|FG002|Overall Study|Adverse Event|5|||
161477918|NCT00259610|583144926|FG003|Overall Study|Adverse Event|2|||
161477919|NCT00259610|583144923|FG000|Overall Study|Serious Adverse Event|8|||
161477920|NCT00259610|583144924|FG001|Overall Study|Serious Adverse Event|2|||
161477921|NCT00259610|583144925|FG002|Overall Study|Serious Adverse Event|2|||
161477922|NCT00259610|583144926|FG003|Overall Study|Serious Adverse Event|2|||
161477923|NCT00282984|583144930|FG000|Overall Study|Death|2|||
161477924|NCT00282984|583144931|FG001|Overall Study|Death|5|||
161477925|NCT00282984|583144930|FG000|Overall Study|Adverse Event|8|||
161477926|NCT00282984|583144931|FG001|Overall Study|Adverse Event|5|||
161477927|NCT00282984|583144930|FG000|Overall Study|Lack of Efficacy|0|||
161477928|NCT00282984|583144931|FG001|Overall Study|Lack of Efficacy|2|||
161477929|NCT00282984|583144930|FG000|Overall Study|Lost to Follow-up|14|||
161477930|NCT00282984|583144931|FG001|Overall Study|Lost to Follow-up|10|||
161477931|NCT00282984|583144930|FG000|Overall Study|Withdrawal by Participant|22|||
161477932|NCT00282984|583144931|FG001|Overall Study|Withdrawal by Participant|34|||
161477933|NCT00282984|583144930|FG000|Overall Study|Participant stopped study medication|2|||
161477934|NCT00282984|583144931|FG001|Overall Study|Participant stopped study medication|2|||
161477935|NCT00282984|583144930|FG000|Overall Study|Participant only allowed phone follow-up|0|||
161477936|NCT00282984|583144931|FG001|Overall Study|Participant only allowed phone follow-up|1|||
161477937|NCT00282984|583144930|FG000|Overall Study|Participant used antipsychosis meds|0|||
161477938|NCT00282984|583144931|FG001|Overall Study|Participant used antipsychosis meds|1|||
161477939|NCT00282984|583144930|FG000|Overall Study|lack of motivation|1|||
161477940|NCT00282984|583144931|FG001|Overall Study|lack of motivation|0|||
161477941|NCT00282984|583144930|FG000|Overall Study|in prison|0|||
161477942|NCT00282984|583144931|FG001|Overall Study|in prison|1|||
161477943|NCT00282984|583144930|FG000|Overall Study|Protocol Violation|2|||
161477944|NCT00282984|583144931|FG001|Overall Study|Protocol Violation|0|||
161477945|NCT00868608|583144932|FG000|Overall Study|Withdrawal by Subject|3|||
161477946|NCT00868608|583144933|FG001|Overall Study|Withdrawal by Subject|1|||
161477947|NCT00868608|583144934|FG002|Overall Study|Withdrawal by Subject|0|||
161477948|NCT00868608|583144932|FG000|Overall Study|Lost to Follow-up|3|||
161477949|NCT00868608|583144933|FG001|Overall Study|Lost to Follow-up|0|||
161477950|NCT00868608|583144934|FG002|Overall Study|Lost to Follow-up|1|||
161477951|NCT00868608|583144932|FG000|Overall Study|Death|16|||
161477952|NCT00868608|583144933|FG001|Overall Study|Death|2|||
161477953|NCT00868608|583144934|FG002|Overall Study|Death|4|||
161477954|NCT00868608|583144932|FG000|Overall Study|Other - Unspecified|1|||
161477955|NCT00868608|583144933|FG001|Overall Study|Other - Unspecified|0|||
161477956|NCT00868608|583144934|FG002|Overall Study|Other - Unspecified|0|||
161477957|NCT00457301|583144935|FG000|Overall Study|Withdrawal by Subject|3|||
161477958|NCT00457301|583144936|FG001|Overall Study|Withdrawal by Subject|3|||
161477959|NCT00457301|583144935|FG000|Overall Study|Censored out of the study|15|||
161477960|NCT00457301|583144936|FG001|Overall Study|Censored out of the study|14|||
161477961|NCT00457301|583144935|FG000|Overall Study|Death|5|||
161477962|NCT00457301|583144936|FG001|Overall Study|Death|7|||
161477963|NCT00191269|583144937|FG000|Overall Study|Protocol Violation|0|||
161477964|NCT00191269|583144938|FG001|Overall Study|Protocol Violation|2|||
161477965|NCT00191269|583144937|FG000|Overall Study|Adverse Event|1|||
161477966|NCT00191269|583144938|FG001|Overall Study|Adverse Event|4|||
161477967|NCT00191269|583144937|FG000|Overall Study|Progression of Disease|4|||
161477968|NCT00191269|583144938|FG001|Overall Study|Progression of Disease|42|||
161477969|NCT00191269|583144937|FG000|Overall Study|Lack of Efficacy|1|||
161477970|NCT00191269|583144938|FG001|Overall Study|Lack of Efficacy|5|||
161477971|NCT00191269|583144937|FG000|Overall Study|Withdrawal by Subject|0|||
161477972|NCT00191269|583144938|FG001|Overall Study|Withdrawal by Subject|1|||
161477973|NCT00191269|583144937|FG000|Overall Study|Pathologic Aggrevation|0|||
161477974|NCT00191269|583144938|FG001|Overall Study|Pathologic Aggrevation|1|||
161578490|NCT01061151|583506527|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
161578491|NCT00960141|583506532|FG000|Overall Study|Adverse Event|4|||
161578492|NCT00960141|583506533|FG001|Overall Study|Adverse Event|8|||
161578493|NCT00960141|583506534|FG002|Overall Study|Adverse Event|2|||
161578494|NCT00960141|583506532|FG000|Overall Study|Lack of Efficacy|3|||
161578495|NCT00960141|583506533|FG001|Overall Study|Lack of Efficacy|4|||
161477975|NCT00191269|583144937|FG000|Overall Study|Physician Decision|0|||
161477976|NCT00191269|583144938|FG001|Overall Study|Physician Decision|3|||
161477977|NCT00674362|583144939|FG000|Double Blind|Adverse Event|6|||
161477978|NCT00674362|583144940|FG001|Double Blind|Adverse Event|6|||
161477979|NCT00674362|583144939|FG000|Double Blind|Lack of Efficacy|2|||
161477980|NCT00674362|583144940|FG001|Double Blind|Lack of Efficacy|6|||
161578496|NCT00960141|583506534|FG002|Overall Study|Lack of Efficacy|2|||
161815755|NCT02679729|584368773|FG005|Overall Study|Lost to Follow-up|0|||
161477981|NCT00674362|583144939|FG000|Double Blind|Loss of efficacy|0|||
161477982|NCT00674362|583144940|FG001|Double Blind|Loss of efficacy|1|||
161477983|NCT00674362|583144939|FG000|Double Blind|Withdrawal by Subject|4|||
161578497|NCT00960141|583506532|FG000|Overall Study|Lost to Follow-up|1|||
161668594|NCT02683941|583839794|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
161668595|NCT02683941|583839795|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
161668596|NCT02683941|583839794|FG000|Open-label Treatment Phase|Disease Progression|1|||
161668597|NCT02683941|583839795|FG001|Open-label Treatment Phase|Disease Progression|2|||
161668598|NCT02683941|583839794|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
161668599|NCT02683941|583839795|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
161668600|NCT02683941|583839794|FG000|Open-label Treatment Phase|Other|1|||
161668601|NCT02683941|583839795|FG001|Open-label Treatment Phase|Other|0|||
161668602|NCT02683941|583839794|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
161668603|NCT02683941|583839795|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
161668604|NCT02683941|583839794|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
161921076|NCT01625182|584757147|FG001|Overall Study|Protocol deviation|2|||
161921077|NCT01625182|584757146|FG000|Overall Study|Adverse Event|2|||
161921078|NCT01625182|584757147|FG001|Overall Study|Adverse Event|0|||
161921079|NCT01625182|584757146|FG000|Overall Study|Withdrawal by Subject|5|||
161921080|NCT01625182|584757147|FG001|Overall Study|Withdrawal by Subject|1|||
161921081|NCT01625182|584757146|FG000|Overall Study|Lack of Efficacy|12|||
161921082|NCT01625182|584757147|FG001|Overall Study|Lack of Efficacy|8|||
161921083|NCT01500083|584757148|FG000|Overall Study|Adverse Event|4|||
161921084|NCT01500083|584757149|FG001|Overall Study|Adverse Event|17|||
161921085|NCT01500083|584757148|FG000|Overall Study|Death|0|||
161921086|NCT01500083|584757149|FG001|Overall Study|Death|2|||
161921087|NCT01500083|584757148|FG000|Overall Study|Lost to Follow-up|1|||
161921088|NCT01500083|584757149|FG001|Overall Study|Lost to Follow-up|0|||
161921089|NCT01500083|584757148|FG000|Overall Study|Withdrawal of Consent|0|||
161921090|NCT01500083|584757149|FG001|Overall Study|Withdrawal of Consent|1|||
161668605|NCT02683941|583839795|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
161668606|NCT02683941|583839794|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
161668607|NCT02683941|583839795|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
161668608|NCT02683941|583839794|FG000|Open-label Follow-up Phase|Other|8|||
161668609|NCT02683941|583839795|FG001|Open-label Follow-up Phase|Other|1|||
161668610|NCT00325039|583839796|FG000|Overall Study|Lost to Follow-up|18|||
161477984|NCT00674362|583144940|FG001|Double Blind|Withdrawal by Subject|3|||
161668611|NCT00325039|583839797|FG001|Overall Study|Lost to Follow-up|14|||
161921091|NCT01500083|584757148|FG000|Overall Study|Disease Progression|2|||
161921092|NCT01500083|584757149|FG001|Overall Study|Disease Progression|10|||
161921093|NCT01500083|584757148|FG000|Overall Study|Investigator Discretion|3|||
161921094|NCT01500083|584757149|FG001|Overall Study|Investigator Discretion|8|||
161921095|NCT01500083|584757148|FG000|Overall Study|Other Reasons|2|||
161921096|NCT01500083|584757149|FG001|Overall Study|Other Reasons|5|||
161921097|NCT00741611|584757150|FG000|Overall Study|Death|0|||
161921098|NCT00741611|584757151|FG001|Overall Study|Death|0|||
161921099|NCT00741611|584757152|FG002|Overall Study|Death|1|||
161921100|NCT00741611|584757150|FG000|Overall Study|Withdrawal by Subject|0|||
161921101|NCT00741611|584757151|FG001|Overall Study|Withdrawal by Subject|2|||
161921102|NCT00741611|584757152|FG002|Overall Study|Withdrawal by Subject|2|||
161921103|NCT01970371|584757153|FG000|Overall Study|Death|8|||
161921104|NCT01970371|584757154|FG001|Overall Study|Death|13|||
161921105|NCT01970371|584757155|FG002|Overall Study|Death|12|||
161921106|NCT01970371|584757153|FG000|Overall Study|Lost to Follow-up|0|||
161921107|NCT01970371|584757154|FG001|Overall Study|Lost to Follow-up|0|||
161921108|NCT01970371|584757155|FG002|Overall Study|Lost to Follow-up|1|||
161921109|NCT01481779|584757156|FG000|Overall Study|Adverse Event|23|||
161921110|NCT01481779|584757157|FG001|Overall Study|Adverse Event|5|||
161921111|NCT01481779|584757156|FG000|Overall Study|Lost to Follow-up|3|||
161921112|NCT01481779|584757157|FG001|Overall Study|Lost to Follow-up|2|||
161921113|NCT01481779|584757156|FG000|Overall Study|Protocol Violation|2|||
161921114|NCT01481779|584757157|FG001|Overall Study|Protocol Violation|3|||
161921115|NCT01481779|584757156|FG000|Overall Study|Withdrawal by Subject|26|||
161921116|NCT01481779|584757157|FG001|Overall Study|Withdrawal by Subject|13|||
161921117|NCT01481779|584757156|FG000|Overall Study|Physician Decision|13|||
161921118|NCT01481779|584757157|FG001|Overall Study|Physician Decision|4|||
161921119|NCT01481779|584757156|FG000|Overall Study|Sponsor Decision|3|||
161921120|NCT01481779|584757157|FG001|Overall Study|Sponsor Decision|1|||
161921121|NCT01555931|584757160|FG000|Overall Study|Lost to Follow-up|2|||
161921122|NCT01555931|584757161|FG001|Overall Study|Lost to Follow-up|5|||
161921123|NCT01922011|584757162|FG000|Overall Study|Protocol Violation|0|||
161921124|NCT01922011|584757163|FG001|Overall Study|Protocol Violation|1|||
161921125|NCT01922011|584757162|FG000|Overall Study|Physician Decision|0|||
161921126|NCT01922011|584757163|FG001|Overall Study|Physician Decision|1|||
161578498|NCT00960141|583506533|FG001|Overall Study|Lost to Follow-up|0|||
161578499|NCT00960141|583506534|FG002|Overall Study|Lost to Follow-up|0|||
161578500|NCT00960141|583506532|FG000|Overall Study|Protocol Violation|1|||
161578501|NCT00960141|583506533|FG001|Overall Study|Protocol Violation|3|||
161578502|NCT00960141|583506534|FG002|Overall Study|Protocol Violation|2|||
161578503|NCT00960141|583506532|FG000|Overall Study|Withdrawal by Subject|1|||
161578504|NCT00960141|583506533|FG001|Overall Study|Withdrawal by Subject|2|||
161578505|NCT00960141|583506534|FG002|Overall Study|Withdrawal by Subject|1|||
161578506|NCT03036813|583506535|FG000|Overall Study|Adverse Event|6|||
161578507|NCT03036813|583506536|FG001|Overall Study|Adverse Event|11|||
161578508|NCT03036813|583506537|FG002|Overall Study|Adverse Event|6|||
161578509|NCT03036813|583506535|FG000|Overall Study|Withdrawal by Subject|12|||
161578510|NCT03036813|583506536|FG001|Overall Study|Withdrawal by Subject|6|||
161578511|NCT03036813|583506537|FG002|Overall Study|Withdrawal by Subject|10|||
161578512|NCT03036813|583506535|FG000|Overall Study|Lost to Follow-up|1|||
161578513|NCT03036813|583506536|FG001|Overall Study|Lost to Follow-up|1|||
161578514|NCT03036813|583506537|FG002|Overall Study|Lost to Follow-up|0|||
161578515|NCT03036813|583506535|FG000|Overall Study|Physician Decision|2|||
161578516|NCT03036813|583506536|FG001|Overall Study|Physician Decision|1|||
161578517|NCT03036813|583506537|FG002|Overall Study|Physician Decision|1|||
161578518|NCT03036813|583506535|FG000|Overall Study|Non-Compliance|1|||
161578519|NCT03036813|583506536|FG001|Overall Study|Non-Compliance|5|||
161578520|NCT03036813|583506537|FG002|Overall Study|Non-Compliance|3|||
161578521|NCT03036813|583506535|FG000|Overall Study|Pregnancy|0|||
161921127|NCT01922011|584757162|FG000|Overall Study|Parent/Guardian Decision|3|||
161921128|NCT01922011|584757163|FG001|Overall Study|Parent/Guardian Decision|0|||
161921129|NCT01922011|584757162|FG000|Overall Study|Lost to Follow-up|0|||
161921130|NCT01922011|584757163|FG001|Overall Study|Lost to Follow-up|1|||
161921131|NCT01922011|584757162|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
161921132|NCT01922011|584757163|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
161477985|NCT00674362|583144939|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
161477986|NCT00674362|583144940|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
161477987|NCT00674362|583144939|FG000|Double Blind|Other: Surgery|0|||
161477988|NCT00674362|583144940|FG001|Double Blind|Other: Surgery|1|||
161477989|NCT00674362|583144939|FG000|Open Label|Adverse Event|1|||
161477990|NCT00674362|583144940|FG001|Open Label|Adverse Event|0|||
161477991|NCT00674362|583144939|FG000|Open Label|Other: Subject moved to extension study|1|||
161477992|NCT00674362|583144940|FG001|Open Label|Other: Subject moved to extension study|0|||
161477993|NCT00939770|583144943|FG000|Overall Study|Adverse Event|1|||
161477994|NCT00939770|583144944|FG001|Overall Study|Adverse Event|1|||
161477995|NCT00939770|583144945|FG002|Overall Study|Adverse Event|0|||
161477996|NCT00939770|583144946|FG003|Overall Study|Adverse Event|0|||
161477997|NCT00939770|583144947|FG004|Overall Study|Adverse Event|6|||
161477998|NCT00939770|583144948|FG005|Overall Study|Adverse Event|2|||
161815756|NCT02679729|584368774|FG006|Overall Study|Lost to Follow-up|0|||
161815757|NCT02679729|584368775|FG007|Overall Study|Lost to Follow-up|0|||
161815758|NCT02679729|584368776|FG008|Overall Study|Lost to Follow-up|0|||
161815759|NCT02679729|584368768|FG000|Overall Study|Participant decision|0|||
161815760|NCT02679729|584368769|FG001|Overall Study|Participant decision|1|||
161815761|NCT02679729|584368770|FG002|Overall Study|Participant decision|0|||
161815762|NCT02679729|584368771|FG003|Overall Study|Participant decision|0|||
161815763|NCT02679729|584368772|FG004|Overall Study|Participant decision|0|||
161815764|NCT02679729|584368773|FG005|Overall Study|Participant decision|0|||
161815765|NCT02679729|584368774|FG006|Overall Study|Participant decision|1|||
161815766|NCT02679729|584368775|FG007|Overall Study|Participant decision|0|||
161815767|NCT02679729|584368776|FG008|Overall Study|Participant decision|0|||
161815768|NCT00748566|584368777|FG000|Overall Study|Adverse Event|49|||
161815769|NCT00748566|584368777|FG000|Overall Study|Death|1|||
161815770|NCT00748566|584368777|FG000|Overall Study|Lack of Efficacy|12|||
161815771|NCT00748566|584368777|FG000|Overall Study|Lost to Follow-up|1|||
161815772|NCT00748566|584368777|FG000|Overall Study|Protocol Violation|13|||
161815773|NCT00748566|584368777|FG000|Overall Study|Withdrawal by Subject|22|||
161815774|NCT00748566|584368777|FG000|Overall Study|Study terminated by sponsor|5|||
161815775|NCT00748566|584368777|FG000|Overall Study|Other|9|||
161815776|NCT00624286|584368780|FG000|Overall Study|Protocol Deviation|7|||
161815777|NCT00624286|584368781|FG001|Overall Study|Protocol Deviation|9|||
161815778|NCT00624286|584368780|FG000|Overall Study|Adverse Event|6|||
161815779|NCT00624286|584368781|FG001|Overall Study|Adverse Event|3|||
161815780|NCT00624286|584368780|FG000|Overall Study|Withdrawal by Subject|5|||
161477999|NCT00939770|583144949|FG006|Overall Study|Adverse Event|1|||
161478000|NCT00939770|583144950|FG007|Overall Study|Adverse Event|1|||
161478001|NCT00939770|583144943|FG000|Overall Study|Lack of Efficacy|4|||
161478002|NCT00939770|583144944|FG001|Overall Study|Lack of Efficacy|6|||
161478003|NCT00939770|583144945|FG002|Overall Study|Lack of Efficacy|13|||
161478004|NCT00939770|583144946|FG003|Overall Study|Lack of Efficacy|9|||
161478005|NCT00939770|583144947|FG004|Overall Study|Lack of Efficacy|16|||
161478006|NCT00939770|583144948|FG005|Overall Study|Lack of Efficacy|8|||
161478007|NCT00939770|583144949|FG006|Overall Study|Lack of Efficacy|11|||
161478008|NCT00939770|583144950|FG007|Overall Study|Lack of Efficacy|1|||
161478009|NCT00939770|583144943|FG000|Overall Study|Lost to Follow-up|0|||
161478010|NCT00939770|583144944|FG001|Overall Study|Lost to Follow-up|0|||
161478011|NCT00939770|583144945|FG002|Overall Study|Lost to Follow-up|0|||
161478012|NCT00939770|583144946|FG003|Overall Study|Lost to Follow-up|0|||
161478013|NCT00939770|583144947|FG004|Overall Study|Lost to Follow-up|1|||
161478014|NCT00939770|583144948|FG005|Overall Study|Lost to Follow-up|0|||
161478015|NCT00939770|583144949|FG006|Overall Study|Lost to Follow-up|0|||
161478016|NCT00939770|583144950|FG007|Overall Study|Lost to Follow-up|0|||
161478017|NCT00939770|583144943|FG000|Overall Study|Physician Decision|0|||
161478018|NCT00939770|583144944|FG001|Overall Study|Physician Decision|0|||
161478019|NCT00939770|583144945|FG002|Overall Study|Physician Decision|2|||
161478020|NCT00939770|583144946|FG003|Overall Study|Physician Decision|0|||
161478021|NCT00939770|583144947|FG004|Overall Study|Physician Decision|7|||
161478022|NCT00939770|583144948|FG005|Overall Study|Physician Decision|1|||
161668612|NCT01009203|583839799|FG000|Overall Study|Withdrawal by Subject|1|||
161815781|NCT00624286|584368781|FG001|Overall Study|Withdrawal by Subject|4|||
161815782|NCT00624286|584368780|FG000|Overall Study|Lost to Follow-up|3|||
161815783|NCT00624286|584368781|FG001|Overall Study|Lost to Follow-up|2|||
161815784|NCT00624286|584368780|FG000|Overall Study|Administrative problems|3|||
161815785|NCT00624286|584368781|FG001|Overall Study|Administrative problems|0|||
161815786|NCT00624286|584368780|FG000|Overall Study|Lack of Efficacy|1|||
161815787|NCT00624286|584368781|FG001|Overall Study|Lack of Efficacy|6|||
161478023|NCT00939770|583144949|FG006|Overall Study|Physician Decision|0|||
161478024|NCT00939770|583144950|FG007|Overall Study|Physician Decision|6|||
161478025|NCT00939770|583144943|FG000|Overall Study|Protocol Violation|0|||
161478026|NCT00939770|583144944|FG001|Overall Study|Protocol Violation|0|||
161478027|NCT00939770|583144945|FG002|Overall Study|Protocol Violation|0|||
161478028|NCT00939770|583144946|FG003|Overall Study|Protocol Violation|0|||
161478029|NCT00939770|583144947|FG004|Overall Study|Protocol Violation|1|||
161478030|NCT00939770|583144948|FG005|Overall Study|Protocol Violation|0|||
161478031|NCT00939770|583144949|FG006|Overall Study|Protocol Violation|0|||
161478032|NCT00939770|583144950|FG007|Overall Study|Protocol Violation|0|||
161478033|NCT00939770|583144943|FG000|Overall Study|Withdrawal by Subject|0|||
161478034|NCT00939770|583144944|FG001|Overall Study|Withdrawal by Subject|1|||
161478035|NCT00939770|583144945|FG002|Overall Study|Withdrawal by Subject|5|||
161478036|NCT00939770|583144946|FG003|Overall Study|Withdrawal by Subject|2|||
161478037|NCT00939770|583144947|FG004|Overall Study|Withdrawal by Subject|6|||
161478038|NCT00939770|583144948|FG005|Overall Study|Withdrawal by Subject|0|||
161478039|NCT00939770|583144949|FG006|Overall Study|Withdrawal by Subject|2|||
161478040|NCT00939770|583144950|FG007|Overall Study|Withdrawal by Subject|2|||
161478041|NCT04665856|583144951|FG000|Overall Study|Site Terminated by Sponsor|1|||
161478042|NCT04665856|583144952|FG001|Overall Study|Site Terminated by Sponsor|0|||
161478043|NCT04665856|583144951|FG000|Overall Study|Withdrawal by Subject|2|||
161478044|NCT04665856|583144952|FG001|Overall Study|Withdrawal by Subject|0|||
161478045|NCT04665856|583144951|FG000|Overall Study|Lost to Follow-up|3|||
161478046|NCT04665856|583144952|FG001|Overall Study|Lost to Follow-up|2|||
161478047|NCT04665856|583144951|FG000|Overall Study|Death|39|||
161478048|NCT04665856|583144952|FG001|Overall Study|Death|44|||
161478049|NCT04665856|583144951|FG000|Overall Study|Ongoing in study|17|||
161478050|NCT04665856|583144952|FG001|Overall Study|Ongoing in study|15|||
161478051|NCT03386448|583144953|FG000|Overall Study|Adverse Event|0|||
161478052|NCT03386448|583144954|FG001|Overall Study|Adverse Event|2|||
161478053|NCT02564796|583144955|FG000|Overall Study|Physician Decision|2|||
161478054|NCT02564796|583144956|FG001|Overall Study|Physician Decision|2|||
161478055|NCT00114530|583144957|FG000|Overall Study|Death|3|||
161478056|NCT00114530|583144958|FG001|Overall Study|Death|11|||
161478057|NCT00114530|583144957|FG000|Overall Study|Lost to Follow-up|1|||
161478058|NCT00114530|583144958|FG001|Overall Study|Lost to Follow-up|1|||
161478059|NCT00114530|583144957|FG000|Overall Study|Physician Decision|1|||
161478060|NCT00114530|583144958|FG001|Overall Study|Physician Decision|1|||
161478061|NCT00114530|583144957|FG000|Overall Study|Withdrawal by Subject|2|||
161478062|NCT00114530|583144958|FG001|Overall Study|Withdrawal by Subject|6|||
161478063|NCT00114530|583144957|FG000|Overall Study|Breast Cancer|1|||
161478064|NCT00114530|583144958|FG001|Overall Study|Breast Cancer|0|||
161478065|NCT00114530|583144957|FG000|Overall Study|Subject decision after endpoint failure|0|||
161478066|NCT00114530|583144958|FG001|Overall Study|Subject decision after endpoint failure|1|||
161478067|NCT00114530|583144957|FG000|Overall Study|Ineligible|1|||
161478068|NCT00114530|583144958|FG001|Overall Study|Ineligible|0|||
161478069|NCT02538029|583144961|FG000|Overall Study|unable to complete cognitive assessments|1|||
161478070|NCT02538029|583144962|FG001|Overall Study|unable to complete cognitive assessments|0|||
161478071|NCT02538029|583144963|FG002|Overall Study|unable to complete cognitive assessments|1|||
161478072|NCT01466153|583144964|FG000|Overall Study|Disease Progression|2|||
161478073|NCT01466153|583144965|FG001|Overall Study|Disease Progression|2|||
161478074|NCT01466153|583144966|FG002|Overall Study|Disease Progression|0|||
161478075|NCT01466153|583144964|FG000|Overall Study|Adverse Event|14|||
161478076|NCT01466153|583144965|FG001|Overall Study|Adverse Event|13|||
161478077|NCT01466153|583144966|FG002|Overall Study|Adverse Event|17|||
161478078|NCT01466153|583144964|FG000|Overall Study|Withdrawal of Consent|2|||
161478079|NCT01466153|583144965|FG001|Overall Study|Withdrawal of Consent|0|||
161478080|NCT01466153|583144966|FG002|Overall Study|Withdrawal of Consent|0|||
161478081|NCT01466153|583144964|FG000|Overall Study|Investigator Discretion|3|||
161478082|NCT01466153|583144965|FG001|Overall Study|Investigator Discretion|2|||
161478083|NCT01466153|583144966|FG002|Overall Study|Investigator Discretion|2|||
161478084|NCT01466153|583144964|FG000|Overall Study|Randomized-Not Treated|2|||
161478085|NCT01466153|583144965|FG001|Overall Study|Randomized-Not Treated|3|||
161478086|NCT01466153|583144966|FG002|Overall Study|Randomized-Not Treated|4|||
161478087|NCT01466153|583144964|FG000|Overall Study|Other-Unspecified|6|||
161478088|NCT01466153|583144965|FG001|Overall Study|Other-Unspecified|4|||
161478089|NCT01466153|583144966|FG002|Overall Study|Other-Unspecified|2|||
161478090|NCT01088997|583144969|FG000|Overall Study|Physician Decision|1|||
161478091|NCT01088997|583144970|FG001|Overall Study|Physician Decision|1|||
161478092|NCT01088997|583144969|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
161478093|NCT01088997|583144970|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
161478094|NCT01088997|583144969|FG000|Overall Study|Excluded prior to receiving drug|1|||
161478095|NCT01088997|583144970|FG001|Overall Study|Excluded prior to receiving drug|1|||
161478096|NCT01095731|583144975|FG000|Overall Study|Protocol Violation|1|||
161478097|NCT01095731|583144976|FG001|Overall Study|Protocol Violation|1|||
161478098|NCT01095731|583144975|FG000|Overall Study|Withdrawal by Subject|0|||
161478099|NCT01095731|583144976|FG001|Overall Study|Withdrawal by Subject|1|||
161478100|NCT02302807|583144979|FG000|Overall Study|Withdrawal by Subject|28|||
161478101|NCT02302807|583144980|FG001|Overall Study|Withdrawal by Subject|11|||
161478102|NCT02302807|583144979|FG000|Overall Study|Lost to Follow-up|4|||
161478103|NCT02302807|583144980|FG001|Overall Study|Lost to Follow-up|6|||
161478104|NCT02302807|583144979|FG000|Overall Study|Death|397|||
161478105|NCT02302807|583144980|FG001|Overall Study|Death|385|||
161478106|NCT02302807|583144979|FG000|Overall Study|Study Terminated By Sponsor|35|||
161478107|NCT02302807|583144980|FG001|Overall Study|Study Terminated By Sponsor|64|||
161478108|NCT02302807|583144979|FG000|Overall Study|Physician Decision|0|||
161921133|NCT01922011|584757162|FG000|Overall Study|Not Treated|1|||
161921134|NCT01922011|584757163|FG001|Overall Study|Not Treated|0|||
161921135|NCT01922011|584757162|FG000|Overall Study|Lack of willing home health agency|1|||
161921136|NCT01922011|584757163|FG001|Overall Study|Lack of willing home health agency|0|||
161921137|NCT01922011|584757162|FG000|Overall Study|Randomized in error|1|||
161921138|NCT01922011|584757163|FG001|Overall Study|Randomized in error|0|||
161921139|NCT01510756|584757164|FG000|Overall Study|Death|1|||
161478109|NCT02302807|583144980|FG001|Overall Study|Physician Decision|1|||
161478110|NCT01980940|583144982|FG000|Overall Study|Protocol Violation|0|||
161478111|NCT01980940|583144983|FG001|Overall Study|Protocol Violation|0|||
161478112|NCT01980940|583144984|FG002|Overall Study|Protocol Violation|0|||
161478113|NCT01980940|583144985|FG003|Overall Study|Protocol Violation|0|||
161478114|NCT01980940|583144986|FG004|Overall Study|Protocol Violation|0|||
161478115|NCT01980940|583144987|FG005|Overall Study|Protocol Violation|2|||
161478116|NCT01980940|583144988|FG006|Overall Study|Protocol Violation|0|||
161478117|NCT01980940|583144989|FG007|Overall Study|Protocol Violation|0|||
161478118|NCT03192462|583146603|FG000|Overall Study|Death|13|||
161478119|NCT03192462|583146604|FG001|Overall Study|Death|11|||
161478120|NCT03192462|583146605|FG002|Overall Study|Death|10|||
161478121|NCT03192462|583146603|FG000|Overall Study|Lost to Follow-up|0|||
161478122|NCT03192462|583146604|FG001|Overall Study|Lost to Follow-up|1|||
161478123|NCT03192462|583146605|FG002|Overall Study|Lost to Follow-up|0|||
161478124|NCT04840615|583146606|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
161478125|NCT04840615|583146607|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
161478126|NCT04840615|583146608|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
161478127|NCT02501473|583146609|FG000|Overall Study|Study Terminated|2|||
161478128|NCT02501473|583146610|FG001|Overall Study|Study Terminated|3|||
161478129|NCT02501473|583146611|FG002|Overall Study|Study Terminated|7|||
161478130|NCT02501473|583146612|FG003|Overall Study|Study Terminated|9|||
161478131|NCT02501473|583146613|FG004|Overall Study|Study Terminated|2|||
161478132|NCT02501473|583146614|FG005|Overall Study|Study Terminated|10|||
161478133|NCT02501473|583146615|FG006|Overall Study|Study Terminated|1|||
161478134|NCT02501473|583146616|FG007|Overall Study|Study Terminated|0|||
161478135|NCT02501473|583146609|FG000|Overall Study|Withdrawal by Subject|0|||
161478136|NCT02501473|583146610|FG001|Overall Study|Withdrawal by Subject|0|||
161478137|NCT02501473|583146611|FG002|Overall Study|Withdrawal by Subject|3|||
161478138|NCT02501473|583146612|FG003|Overall Study|Withdrawal by Subject|3|||
161478139|NCT02501473|583146613|FG004|Overall Study|Withdrawal by Subject|2|||
161478140|NCT02501473|583146614|FG005|Overall Study|Withdrawal by Subject|2|||
161478141|NCT02501473|583146615|FG006|Overall Study|Withdrawal by Subject|0|||
161478142|NCT02501473|583146616|FG007|Overall Study|Withdrawal by Subject|0|||
161478143|NCT02501473|583146609|FG000|Overall Study|Death|0|||
161478144|NCT02501473|583146610|FG001|Overall Study|Death|0|||
161478145|NCT02501473|583146611|FG002|Overall Study|Death|1|||
161478146|NCT02501473|583146612|FG003|Overall Study|Death|1|||
161478147|NCT02501473|583146613|FG004|Overall Study|Death|0|||
161478148|NCT02501473|583146614|FG005|Overall Study|Death|1|||
161478149|NCT02501473|583146615|FG006|Overall Study|Death|0|||
161478150|NCT02501473|583146616|FG007|Overall Study|Death|0|||
161478151|NCT02501473|583146609|FG000|Overall Study|Lost to Follow-up|1|||
161478152|NCT02501473|583146610|FG001|Overall Study|Lost to Follow-up|0|||
161478153|NCT02501473|583146611|FG002|Overall Study|Lost to Follow-up|1|||
161478154|NCT02501473|583146612|FG003|Overall Study|Lost to Follow-up|0|||
161478155|NCT02501473|583146613|FG004|Overall Study|Lost to Follow-up|0|||
161478156|NCT02501473|583146614|FG005|Overall Study|Lost to Follow-up|1|||
161478157|NCT02501473|583146615|FG006|Overall Study|Lost to Follow-up|0|||
161478158|NCT02501473|583146616|FG007|Overall Study|Lost to Follow-up|0|||
161478159|NCT02501473|583146609|FG000|Overall Study|Reason not specified|0|||
161478160|NCT02501473|583146610|FG001|Overall Study|Reason not specified|0|||
161478161|NCT02501473|583146611|FG002|Overall Study|Reason not specified|1|||
161478162|NCT02501473|583146612|FG003|Overall Study|Reason not specified|1|||
161478163|NCT02501473|583146613|FG004|Overall Study|Reason not specified|0|||
161478164|NCT02501473|583146614|FG005|Overall Study|Reason not specified|0|||
161921140|NCT01510756|584757164|FG000|Overall Study|Lack of Efficacy|2|||
161921141|NCT01510756|584757164|FG000|Overall Study|Physician Decision|1|||
161478165|NCT02501473|583146615|FG006|Overall Study|Reason not specified|0|||
161478166|NCT02501473|583146616|FG007|Overall Study|Reason not specified|0|||
161478167|NCT02954237|583146617|FG000|Overall Study|Withdrawal by Subject|25|||
161478168|NCT02954237|583146617|FG000|Overall Study|Missed visit|16|||
161478169|NCT02954237|583146617|FG000|Overall Study|Death|2|||
161478170|NCT00674700|583146618|FG000|Year 1|Adverse Event|17|||
161478171|NCT00674700|583146619|FG001|Year 1|Adverse Event|20|||
161478172|NCT00674700|583146620|FG002|Year 1|Adverse Event|5|||
161478173|NCT00674700|583146618|FG000|Year 1|Withdrawal by Subject|7|||
161478174|NCT00674700|583146619|FG001|Year 1|Withdrawal by Subject|7|||
161478175|NCT00674700|583146620|FG002|Year 1|Withdrawal by Subject|6|||
161478176|NCT00674700|583146618|FG000|Year 1|Any other reason not above-mentioned|7|||
161921142|NCT04398134|584757171|FG000|Overall Study|Adverse Event|0|||
161921143|NCT04398134|584757172|FG001|Overall Study|Adverse Event|0|||
161478177|NCT00674700|583146619|FG001|Year 1|Any other reason not above-mentioned|7|||
161478178|NCT00674700|583146620|FG002|Year 1|Any other reason not above-mentioned|6|||
161478179|NCT00674700|583146618|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
161478180|NCT00674700|583146619|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
161478181|NCT00674700|583146620|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
161478182|NCT00674700|583146618|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
161478183|NCT00674700|583146619|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
161478184|NCT00674700|583146620|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
161478185|NCT00674700|583146618|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
161478186|NCT00674700|583146619|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
161478187|NCT00674700|583146620|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
161478188|NCT00621985|583146631|FG000|Dexamethasone Admission|Adverse Event|1|||
161478189|NCT02732119|583146634|FG000|Phase I|Adverse Event|1|||
161478190|NCT02732119|583146635|FG001|Phase I|Adverse Event|3|||
161478191|NCT02732119|583146636|FG002|Phase I|Adverse Event|1|||
161478192|NCT02732119|583146637|FG003|Phase I|Adverse Event|0|||
161478193|NCT02732119|583146638|FG004|Phase I|Adverse Event|0|||
161478194|NCT02732119|583146634|FG000|Phase I|Progressive disease|7|||
161478195|NCT02732119|583146635|FG001|Phase I|Progressive disease|3|||
161478196|NCT02732119|583146636|FG002|Phase I|Progressive disease|2|||
161478197|NCT02732119|583146637|FG003|Phase I|Progressive disease|0|||
161478198|NCT02732119|583146638|FG004|Phase I|Progressive disease|0|||
161478199|NCT02732119|583146634|FG000|Phase I|Protocol deviation|0|||
161478200|NCT02732119|583146635|FG001|Phase I|Protocol deviation|1|||
161478201|NCT02732119|583146636|FG002|Phase I|Protocol deviation|0|||
161478202|NCT02732119|583146637|FG003|Phase I|Protocol deviation|0|||
161478203|NCT02732119|583146638|FG004|Phase I|Protocol deviation|0|||
161478204|NCT02732119|583146634|FG000|Phase I|Physician Decision|0|||
161478205|NCT02732119|583146635|FG001|Phase I|Physician Decision|3|||
161478206|NCT02732119|583146636|FG002|Phase I|Physician Decision|4|||
161478207|NCT02732119|583146637|FG003|Phase I|Physician Decision|0|||
161478208|NCT02732119|583146638|FG004|Phase I|Physician Decision|0|||
161478209|NCT02732119|583146634|FG000|Phase II|Adverse Event|0|||
161478210|NCT02732119|583146635|FG001|Phase II|Adverse Event|0|||
161478211|NCT02732119|583146636|FG002|Phase II|Adverse Event|0|||
161478212|NCT02732119|583146637|FG003|Phase II|Adverse Event|3|||
161478213|NCT02732119|583146638|FG004|Phase II|Adverse Event|3|||
161478214|NCT02732119|583146634|FG000|Phase II|Death|0|||
161478215|NCT02732119|583146635|FG001|Phase II|Death|0|||
161478216|NCT02732119|583146636|FG002|Phase II|Death|0|||
161478217|NCT02732119|583146637|FG003|Phase II|Death|1|||
161478218|NCT02732119|583146638|FG004|Phase II|Death|0|||
161478219|NCT02732119|583146634|FG000|Phase II|Progressive dissease|0|||
161478220|NCT02732119|583146635|FG001|Phase II|Progressive dissease|0|||
161478221|NCT02732119|583146636|FG002|Phase II|Progressive dissease|0|||
161478222|NCT02732119|583146637|FG003|Phase II|Progressive dissease|30|||
161478223|NCT02732119|583146638|FG004|Phase II|Progressive dissease|23|||
161478224|NCT02732119|583146634|FG000|Phase II|Study terminated by sponsor|0|||
161478225|NCT02732119|583146635|FG001|Phase II|Study terminated by sponsor|0|||
161478226|NCT02732119|583146636|FG002|Phase II|Study terminated by sponsor|0|||
161478227|NCT02732119|583146637|FG003|Phase II|Study terminated by sponsor|2|||
161478228|NCT02732119|583146638|FG004|Phase II|Study terminated by sponsor|2|||
161478229|NCT02732119|583146634|FG000|Phase II|Other|0|||
161478230|NCT02732119|583146635|FG001|Phase II|Other|0|||
161578522|NCT03036813|583506536|FG001|Overall Study|Pregnancy|0|||
161578523|NCT03036813|583506537|FG002|Overall Study|Pregnancy|1|||
161578524|NCT03036813|583506535|FG000|Overall Study|Other|0|||
161578525|NCT03036813|583506536|FG001|Overall Study|Other|3|||
161578526|NCT03036813|583506537|FG002|Overall Study|Other|5|||
161578527|NCT01102231|583506538|FG000|Overall Study|Protocol Violation|3|||
161478231|NCT02732119|583146636|FG002|Phase II|Other|0|||
161578528|NCT01102231|583506538|FG000|Overall Study|Lack of Efficacy|2|||
161578529|NCT01102231|583506538|FG000|Overall Study|Death|2|||
161578530|NCT01102231|583506538|FG000|Overall Study|Adverse Event|3|||
161478232|NCT02732119|583146637|FG003|Phase II|Other|2|||
161578531|NCT01102231|583506538|FG000|Overall Study|Withdrawal by Subject|1|||
161478233|NCT02732119|583146638|FG004|Phase II|Other|0|||
161578532|NCT01102231|583506538|FG000|Overall Study|Did not received the treatment|4|||
161578533|NCT00546754|583506539|FG000|Overall Study|Serious Adverse Event|1|||
161478234|NCT02732119|583146634|FG000|Phase II|Physician Decision|0|||
161478235|NCT02732119|583146635|FG001|Phase II|Physician Decision|0|||
161478236|NCT02732119|583146636|FG002|Phase II|Physician Decision|0|||
161478237|NCT02732119|583146637|FG003|Phase II|Physician Decision|8|||
161478238|NCT02732119|583146638|FG004|Phase II|Physician Decision|5|||
161478239|NCT00964860|583146639|FG000|Overall Study|Withdrawal by Subject|0|||
161478240|NCT00964860|583146640|FG001|Overall Study|Withdrawal by Subject|1|||
161478241|NCT00867568|583146641|FG000|Overall Study|Lack of Efficacy|10|||
161578534|NCT00546754|583506540|FG001|Overall Study|Serious Adverse Event|1|||
161478242|NCT00867568|583146641|FG000|Overall Study|Adverse Event|4|||
161478243|NCT00867568|583146641|FG000|Overall Study|Withdrawal by Subject|1|||
161478244|NCT04343261|583146642|FG000|Overall Study|Adverse Event|1|||
161478245|NCT04343261|583146642|FG000|Overall Study|received inadequate amount of antibodies|7|||
161478246|NCT01056653|583146643|FG000|Overall Study|Lost to Follow-up|0|||
161478247|NCT01056653|583146644|FG001|Overall Study|Lost to Follow-up|0|||
161478248|NCT01056653|583146645|FG002|Overall Study|Lost to Follow-up|2|||
161478249|NCT05275400|583146646|FG000|Treatment Period|Adverse Event|7|||
161478250|NCT05275400|583146647|FG001|Treatment Period|Adverse Event|1|||
161478251|NCT05275400|583146646|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
161478252|NCT05275400|583146647|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
161478253|NCT05275400|583146646|FG000|Treatment Period|Death|5|||
161668613|NCT01009203|583839799|FG000|Overall Study|Adverse Event|5|||
161668614|NCT01009203|583839799|FG000|Overall Study|Treatment-unrelated death|1|||
161668615|NCT00892723|583839803|FG000|Overall Study|Lost to Follow-up|1|||
161668616|NCT00892723|583839804|FG001|Overall Study|Lost to Follow-up|3|||
161668617|NCT00892723|583839805|FG002|Overall Study|Lost to Follow-up|1|||
161668618|NCT00892723|583839803|FG000|Overall Study|Withdrawal by Subject|1|||
161668619|NCT00892723|583839804|FG001|Overall Study|Withdrawal by Subject|1|||
161668620|NCT00892723|583839805|FG002|Overall Study|Withdrawal by Subject|1|||
161668621|NCT02974088|583839806|FG000|Overall Study|Lost to Follow-up|0|||
161668622|NCT02974088|583839807|FG001|Overall Study|Lost to Follow-up|2|||
161668623|NCT02974088|583839806|FG000|Overall Study|Adverse Event|0|||
161668624|NCT02974088|583839807|FG001|Overall Study|Adverse Event|1|||
161668625|NCT00150969|583839810|FG000|24 Month Main Study|Adverse Event|3|||
161668626|NCT00150969|583839811|FG001|24 Month Main Study|Adverse Event|4|||
161668627|NCT00150969|583839810|FG000|24 Month Main Study|Death|1|||
161668628|NCT00150969|583839811|FG001|24 Month Main Study|Death|1|||
161668629|NCT00150969|583839810|FG000|24 Month Main Study|Lack of Efficacy|1|||
161668630|NCT00150969|583839811|FG001|24 Month Main Study|Lack of Efficacy|8|||
161668631|NCT00150969|583839810|FG000|24 Month Main Study|Lost to Follow-up|3|||
161668632|NCT00150969|583839811|FG001|24 Month Main Study|Lost to Follow-up|2|||
161668633|NCT00150969|583839810|FG000|24 Month Main Study|Protocol Violation|4|||
161478254|NCT05275400|583146647|FG001|Treatment Period|Death|2|||
161478255|NCT05275400|583146646|FG000|Treatment Period|Protocol Violation|1|||
161478256|NCT05275400|583146647|FG001|Treatment Period|Protocol Violation|0|||
161478257|NCT05275400|583146646|FG000|Treatment Period|Physician Decision|5|||
161478258|NCT05275400|583146647|FG001|Treatment Period|Physician Decision|4|||
161478259|NCT05275400|583146646|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
161478260|NCT05275400|583146647|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
161478261|NCT05275400|583146646|FG000|Treatment Period|Withdrawal by Subject|30|||
161478262|NCT05275400|583146647|FG001|Treatment Period|Withdrawal by Subject|12|||
161478263|NCT05275400|583146646|FG000|Treatment Period|Lost to Follow-up|1|||
161478264|NCT05275400|583146647|FG001|Treatment Period|Lost to Follow-up|5|||
161478265|NCT05275400|583146646|FG000|Treatment Period|Lack of Efficacy|1|||
161478266|NCT05275400|583146647|FG001|Treatment Period|Lack of Efficacy|0|||
161478267|NCT05275400|583146646|FG000|Treatment Period|Sponsor Decision|1|||
161478268|NCT05275400|583146647|FG001|Treatment Period|Sponsor Decision|0|||
161478269|NCT05275400|583146646|FG000|Follow-Up Period|Death|2|||
161478270|NCT05275400|583146647|FG001|Follow-Up Period|Death|0|||
161478271|NCT05275400|583146646|FG000|Follow-Up Period|Protocol Violation|1|||
161478272|NCT05275400|583146647|FG001|Follow-Up Period|Protocol Violation|0|||
161478273|NCT05275400|583146646|FG000|Follow-Up Period|Withdrawal by Subject|3|||
161478274|NCT05275400|583146647|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161478275|NCT02585960|583146648|FG000|PK/Safety Assessment Period|Physician Decision|0|||
161478276|NCT02585960|583146649|FG001|PK/Safety Assessment Period|Physician Decision|1|||
161478277|NCT02585960|583146650|FG002|PK/Safety Assessment Period|Physician Decision|0|||
161478278|NCT02585960|583146648|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
161478279|NCT02585960|583146649|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
161478280|NCT02585960|583146650|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
161478281|NCT02585960|583146648|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
161478282|NCT02585960|583146649|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
161478283|NCT02585960|583146650|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
161478284|NCT02585960|583146648|FG000|PK/Safety Assessment Period|Other|4|||
161478285|NCT02585960|583146649|FG001|PK/Safety Assessment Period|Other|4|||
161478286|NCT02585960|583146650|FG002|PK/Safety Assessment Period|Other|0|||
161478287|NCT02585960|583146648|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
161478288|NCT02585960|583146649|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
161478289|NCT02585960|583146650|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
161478290|NCT02585960|583146648|FG000|PK/Safety Assessment Period|Screen Failure|0|||
161478291|NCT02585960|583146649|FG001|PK/Safety Assessment Period|Screen Failure|0|||
161478292|NCT02585960|583146650|FG002|PK/Safety Assessment Period|Screen Failure|1|||
161478293|NCT02585960|583146648|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
161478294|NCT02585960|583146649|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
161478295|NCT02585960|583146650|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
161478296|NCT02585960|583146648|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
161668634|NCT00150969|583839811|FG001|24 Month Main Study|Protocol Violation|2|||
161478297|NCT02585960|583146649|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
161478298|NCT02585960|583146650|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
161478299|NCT06333613|583146652|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
161478300|NCT03727230|583146653|FG000|Overall Study|Lost to Follow-up|12|||
161478301|NCT00724932|583146657|FG000|Overall Study|Lost to Follow-up|1|||
161478302|NCT00724932|583146658|FG001|Overall Study|Lost to Follow-up|0|||
161478303|NCT00724932|583146657|FG000|Overall Study|Not treated|4|||
161478304|NCT00724932|583146658|FG001|Overall Study|Not treated|3|||
161478305|NCT02849678|583146659|FG000|Overall Study|Protocol Violation|3|||
161478306|NCT02849678|583146660|FG001|Overall Study|Protocol Violation|6|||
161478307|NCT00288054|583146666|FG000|Overall Study|Protocol Violation|2|||
161478308|NCT00288054|583146666|FG000|Overall Study|Lack of Efficacy|16|||
161478309|NCT00288054|583146666|FG000|Overall Study|Adverse Event|3|||
161478310|NCT00288054|583146666|FG000|Overall Study|Withdrawal by Subject|1|||
161478311|NCT00288054|583146666|FG000|Overall Study|Not protocol specified|2|||
161478312|NCT00289991|583146667|FG000|Overall Study|Death|35|||
161478313|NCT00289991|583146668|FG001|Overall Study|Death|38|||
161478314|NCT00289991|583146667|FG000|Overall Study|Adverse Event|15|||
161478315|NCT00289991|583146668|FG001|Overall Study|Adverse Event|13|||
161478316|NCT00289991|583146667|FG000|Overall Study|Failure of prophylaxis|1|||
161478317|NCT00289991|583146668|FG001|Overall Study|Failure of prophylaxis|1|||
161478318|NCT00289991|583146667|FG000|Overall Study|Fungal breakthrough infection|0|||
161478319|NCT00289991|583146668|FG001|Overall Study|Fungal breakthrough infection|1|||
161478320|NCT00289991|583146667|FG000|Overall Study|Lost to Follow-up|0|||
161478321|NCT00289991|583146668|FG001|Overall Study|Lost to Follow-up|1|||
161478322|NCT00289991|583146667|FG000|Overall Study|Withdrawal by Subject|2|||
161478323|NCT00289991|583146668|FG001|Overall Study|Withdrawal by Subject|12|||
161478324|NCT00289991|583146667|FG000|Overall Study|Other|5|||
161478325|NCT00289991|583146668|FG001|Overall Study|Other|14|||
161478326|NCT01091974|583146669|FG000|Overall Study|Did not start intervention|3|||
161478327|NCT01091974|583146670|FG001|Overall Study|Did not start intervention|1|||
161478328|NCT01091974|583146671|FG002|Overall Study|Did not start intervention|3|||
161478329|NCT01091974|583146672|FG003|Overall Study|Did not start intervention|1|||
161478330|NCT01091974|583146669|FG000|Overall Study|resumed sleep medication|0|||
161478331|NCT01091974|583146670|FG001|Overall Study|resumed sleep medication|0|||
161478332|NCT01091974|583146671|FG002|Overall Study|resumed sleep medication|1|||
161478333|NCT01091974|583146672|FG003|Overall Study|resumed sleep medication|2|||
161478334|NCT01091974|583146669|FG000|Overall Study|Withdrawal by Subject|1|||
161478335|NCT01091974|583146670|FG001|Overall Study|Withdrawal by Subject|3|||
161478336|NCT01091974|583146671|FG002|Overall Study|Withdrawal by Subject|2|||
161478337|NCT01091974|583146672|FG003|Overall Study|Withdrawal by Subject|2|||
161478338|NCT01091974|583146669|FG000|Overall Study|side-effects|1|||
161478339|NCT01091974|583146670|FG001|Overall Study|side-effects|1|||
161478340|NCT01091974|583146671|FG002|Overall Study|side-effects|0|||
161478341|NCT01091974|583146672|FG003|Overall Study|side-effects|2|||
161478342|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
161478343|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
161478344|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
161478345|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
161478346|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
161478347|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
161478348|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
161478349|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
161478350|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
161478351|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
161478352|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
161478353|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
161478354|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
161478355|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
161478356|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
161478357|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
161478358|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
161478359|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
161478360|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
161478361|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
161478362|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
161478363|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
161478364|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
161478365|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
161478366|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
161478367|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
161478368|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
161478369|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
161478370|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
161478371|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
161478372|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
161478373|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
161478374|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
161478375|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
161478376|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
161478377|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
161478378|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
161478379|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
161478380|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
161478381|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
161478382|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
161478383|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
161578535|NCT00546754|583506539|FG000|Overall Study|Adverse Event|11|||
161578536|NCT00546754|583506540|FG001|Overall Study|Adverse Event|16|||
161578537|NCT00546754|583506539|FG000|Overall Study|Lack of Efficacy|1|||
161668635|NCT00150969|583839810|FG000|24 Month Main Study|Withdrawal by Subject|7|||
161668636|NCT00150969|583839811|FG001|24 Month Main Study|Withdrawal by Subject|4|||
161668637|NCT00150969|583839810|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
161668638|NCT00150969|583839811|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
161578538|NCT00546754|583506540|FG001|Overall Study|Lack of Efficacy|1|||
161578539|NCT00546754|583506539|FG000|Overall Study|Lost to Follow-up|9|||
161578540|NCT00546754|583506540|FG001|Overall Study|Lost to Follow-up|15|||
161578541|NCT00546754|583506539|FG000|Overall Study|Protocol Violation|3|||
161578542|NCT00546754|583506540|FG001|Overall Study|Protocol Violation|0|||
161578543|NCT00546754|583506539|FG000|Overall Study|Withdrawal by Subject|6|||
161578544|NCT00546754|583506540|FG001|Overall Study|Withdrawal by Subject|7|||
161578545|NCT00546754|583506539|FG000|Overall Study|Dyspnea|1|||
161578546|NCT00546754|583506540|FG001|Overall Study|Dyspnea|0|||
161578547|NCT00546754|583506539|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
161578548|NCT00546754|583506540|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
161578549|NCT00546754|583506539|FG000|Overall Study|Hip Replacement|1|||
161578550|NCT00546754|583506540|FG001|Overall Study|Hip Replacement|0|||
161578551|NCT00546754|583506539|FG000|Overall Study|Suicide|1|||
161578552|NCT00546754|583506540|FG001|Overall Study|Suicide|0|||
161578553|NCT00546754|583506539|FG000|Overall Study|Missing Cooperation|1|||
161578554|NCT00546754|583506540|FG001|Overall Study|Missing Cooperation|0|||
161578555|NCT00546754|583506539|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
161578556|NCT00546754|583506540|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
161578557|NCT00546754|583506539|FG000|Overall Study|Patient's Decision|0|||
161578558|NCT00546754|583506540|FG001|Overall Study|Patient's Decision|1|||
161578559|NCT00546754|583506539|FG000|Overall Study|Missing|14|||
161578560|NCT00546754|583506540|FG001|Overall Study|Missing|7|||
161578561|NCT05061693|583506547|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161578562|NCT05061693|583506548|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161578563|NCT05061693|583506549|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161578564|NCT05061693|583506550|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578565|NCT05061693|583506551|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578566|NCT05061693|583506552|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578567|NCT05061693|583506553|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578568|NCT05061693|583506554|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578569|NCT05061693|583506555|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578570|NCT05061693|583506556|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578571|NCT05061693|583506557|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578572|NCT05061693|583506558|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161578573|NCT05061693|583506547|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
161578574|NCT05061693|583506548|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
161668639|NCT00150969|583839810|FG000|24-48 Month Extension|Lack of Efficacy|0|||
161668640|NCT00150969|583839811|FG001|24-48 Month Extension|Lack of Efficacy|1|||
161668641|NCT00150969|583839810|FG000|24-48 Month Extension|Adverse Event|1|||
161478384|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
161478385|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
161478386|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
161478387|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
161578575|NCT05061693|583506549|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
161578576|NCT05061693|583506550|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
161578577|NCT05061693|583506551|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
161578578|NCT05061693|583506552|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
161578579|NCT05061693|583506553|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
161478388|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
161478389|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
161478390|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
161478391|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
161478392|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
161478393|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
161478394|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
161478395|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
161478396|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
161478397|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
161478398|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
161478399|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
161478400|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
161478401|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
161478402|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
161478403|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
161478404|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
161478405|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
161668642|NCT00150969|583839811|FG001|24-48 Month Extension|Adverse Event|3|||
161668643|NCT00150969|583839810|FG000|24-48 Month Extension|Other Reason|81|||
161668644|NCT00150969|583839811|FG001|24-48 Month Extension|Other Reason|91|||
161668645|NCT00146757|583839812|FG000|Overall Study|Death|1|||
161668646|NCT00146757|583839813|FG001|Overall Study|Death|0|||
161668647|NCT00146757|583839812|FG000|Overall Study|Adverse Event|1|||
161668648|NCT00146757|583839813|FG001|Overall Study|Adverse Event|0|||
161668649|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
161668650|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
161668651|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
161668652|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
161668653|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
161668654|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
161668655|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
161668656|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
161668657|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
161668658|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
161668659|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
161668660|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
161668661|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
161668662|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
161668663|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
161668664|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
161815788|NCT00624286|584368780|FG000|Overall Study|Not stated|0|||
161478406|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
161478407|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
161478408|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
161478409|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
161478410|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
161478411|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
161478412|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Change of location|0|||
161478413|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Change of location|0|||
161478414|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Change of location|0|||
161478415|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Change of location|1|||
161478416|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Change of location|0|||
161478417|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
161478418|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
161478419|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
161478420|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
161478421|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
161478422|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
161478423|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
161478424|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
161478425|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
161478426|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
161478427|NCT00730405|583146676|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
161478428|NCT00730405|583146677|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
161478429|NCT00730405|583146678|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
161478430|NCT00730405|583146679|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
161478431|NCT00730405|583146680|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
161478432|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
161478433|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
161478434|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
161478435|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
161478436|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
161478437|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
161478438|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
161478439|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
161578580|NCT05061693|583506554|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
161668665|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
161668666|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
161668667|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
161578581|NCT05061693|583506555|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
161578582|NCT05061693|583506556|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
161578583|NCT05061693|583506557|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
161578584|NCT05061693|583506558|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
161578585|NCT05061693|583506547|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
161578586|NCT05061693|583506548|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578587|NCT05061693|583506549|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578588|NCT05061693|583506550|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578589|NCT05061693|583506551|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578590|NCT05061693|583506552|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578591|NCT05061693|583506553|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578592|NCT05061693|583506554|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578593|NCT05061693|583506555|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578594|NCT05061693|583506556|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578595|NCT05061693|583506557|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578596|NCT05061693|583506558|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161578597|NCT05061693|583506547|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578598|NCT05061693|583506548|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578599|NCT05061693|583506549|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
161578600|NCT05061693|583506550|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578601|NCT05061693|583506551|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578602|NCT05061693|583506552|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578603|NCT05061693|583506553|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578604|NCT05061693|583506554|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578605|NCT05061693|583506555|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578606|NCT05061693|583506556|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578607|NCT05061693|583506557|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578608|NCT05061693|583506558|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161578609|NCT05061693|583506547|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161578610|NCT05061693|583506548|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161578611|NCT05061693|583506549|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161578612|NCT05061693|583506550|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
161578613|NCT05061693|583506551|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578614|NCT05061693|583506552|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578615|NCT05061693|583506553|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578616|NCT05061693|583506554|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578617|NCT05061693|583506555|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578618|NCT05061693|583506556|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578619|NCT05061693|583506557|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161578620|NCT05061693|583506558|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161668668|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
161478440|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
161478441|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
161478442|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
161478443|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
161478444|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
161478445|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
161478446|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
161578621|NCT05061693|583506547|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161668669|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
161815789|NCT00624286|584368781|FG001|Overall Study|Not stated|1|||
161815790|NCT00624286|584368780|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161815791|NCT00624286|584368781|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161815792|NCT00624286|584368780|FG000|Overall Study|Death|0|||
161815793|NCT00624286|584368781|FG001|Overall Study|Death|1|||
161815794|NCT01442376|584368786|FG000|Overall Study|Adverse Event|0|||
161815795|NCT01442376|584368787|FG001|Overall Study|Adverse Event|3|||
161478447|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Death|0|||
161478448|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Death|1|||
161478449|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Death|0|||
161478450|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Death|1|||
161478451|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Death|0|||
161478452|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Change of location|1|||
161478453|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Change of location|1|||
161478454|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Change of location|0|||
161478455|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Change of location|1|||
161478456|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Change of location|0|||
161478457|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
161478458|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
161478459|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
161478460|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
161478461|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
161478462|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
161478463|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
161478464|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
161478465|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
161478466|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
161478467|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
161478468|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
161478469|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
161478470|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
161478471|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
161478472|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
161478473|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
161478474|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
161478475|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
161478476|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
161478477|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
161478478|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
161478479|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
161478480|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
161478481|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
161478482|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
161478483|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
161478484|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
161478485|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
161478486|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
161478487|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
161478488|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
161478489|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
161478490|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
161815796|NCT01442376|584368788|FG002|Overall Study|Adverse Event|2|||
161815797|NCT01442376|584368786|FG000|Overall Study|Death|0|||
161815798|NCT01442376|584368787|FG001|Overall Study|Death|1|||
161478491|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
161478492|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
161478493|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
161478494|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
161478495|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
161478496|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
161478497|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
161478498|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
161478499|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
161478500|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
161921144|NCT04398134|584757173|FG002|Overall Study|Adverse Event|1|||
161815799|NCT01442376|584368788|FG002|Overall Study|Death|1|||
161815800|NCT01442376|584368786|FG000|Overall Study|Withdrawal of consent|0|||
161921145|NCT04398134|584757174|FG003|Overall Study|Adverse Event|0|||
161478501|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
161478502|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
161478503|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
161478504|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
161478505|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
161478506|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
161478507|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Missing|0|||
161478508|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Missing|0|||
161478509|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Missing|2|||
161815801|NCT01442376|584368787|FG001|Overall Study|Withdrawal of consent|0|||
161815802|NCT01442376|584368788|FG002|Overall Study|Withdrawal of consent|1|||
161815803|NCT01442376|584368786|FG000|Overall Study|Patients not treated|2|||
161815804|NCT01442376|584368787|FG001|Overall Study|Patients not treated|3|||
161478510|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Missing|0|||
161815805|NCT01442376|584368788|FG002|Overall Study|Patients not treated|1|||
161478511|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Missing|0|||
161478512|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
161478513|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
161478514|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
161478515|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
161478516|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
161478517|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
161815806|NCT01442376|584368786|FG000|Overall Study|Not eligible for subsequent cycles|1|||
161815807|NCT01442376|584368787|FG001|Overall Study|Not eligible for subsequent cycles|2|||
161478518|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
161478519|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
161478520|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
161478521|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
161478522|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
161478523|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
161478524|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
161478525|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
161478526|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
161478527|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
161478528|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
161478529|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
161478530|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
161478531|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
161478532|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
161478533|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
161478534|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
161478535|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
161478536|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
161478537|NCT00730405|583146676|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
161478538|NCT00730405|583146677|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
161478539|NCT00730405|583146678|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
161478540|NCT00730405|583146679|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
161478541|NCT00730405|583146680|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
161478542|NCT01496807|583146681|FG000|Overall Study|Progressive Disease|21|||
161478543|NCT01496807|583146681|FG000|Overall Study|Participant preference/toxicity|8|||
161478544|NCT01496807|583146681|FG000|Overall Study|Change in diagnosis|1|||
161478545|NCT03330288|583146684|FG000|Overall Study|Other reason|1|||
161478546|NCT03330288|583146685|FG001|Overall Study|Other reason|1|||
161478547|NCT03330288|583146684|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
161478548|NCT03330288|583146685|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
161478549|NCT03330288|583146684|FG000|Overall Study|Adverse Event|1|||
161478550|NCT03330288|583146685|FG001|Overall Study|Adverse Event|0|||
161478551|NCT03330288|583146684|FG000|Overall Study|Withdrawal by Subject|1|||
161478552|NCT03330288|583146685|FG001|Overall Study|Withdrawal by Subject|0|||
161478553|NCT03330288|583146684|FG000|Overall Study|Lost to Follow-up|26|||
161478554|NCT03330288|583146685|FG001|Overall Study|Lost to Follow-up|7|||
161478555|NCT04447794|583146686|FG000|Overall Study|Lost to Follow-up|2|||
161478556|NCT04447794|583146687|FG001|Overall Study|Lost to Follow-up|3|||
161478557|NCT04447794|583146688|FG002|Overall Study|Lost to Follow-up|8|||
161478558|NCT04447794|583146686|FG000|Overall Study|Withdrawal by Subject|1|||
161478559|NCT04447794|583146687|FG001|Overall Study|Withdrawal by Subject|1|||
161815808|NCT01442376|584368788|FG002|Overall Study|Not eligible for subsequent cycles|0|||
161478560|NCT04447794|583146688|FG002|Overall Study|Withdrawal by Subject|0|||
161478561|NCT00205881|583146693|FG000|Overall Study|Withdrawal by Subject|16|||
161478562|NCT04203498|583146696|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
161478563|NCT04203498|583146697|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
161478564|NCT04203498|583146696|FG000|Overall Study|Withdrawal of patient consent|7|||
161478565|NCT04203498|583146697|FG001|Overall Study|Withdrawal of patient consent|2|||
161478566|NCT04203498|583146696|FG000|Overall Study|Adverse Event|4|||
161478567|NCT04203498|583146697|FG001|Overall Study|Adverse Event|1|||
161478568|NCT04203498|583146696|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
161478569|NCT04203498|583146697|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
161478570|NCT04203498|583146696|FG000|Overall Study|Did not receive IMP|2|||
161478571|NCT04203498|583146697|FG001|Overall Study|Did not receive IMP|0|||
161478572|NCT00334958|583146699|FG000|Overall Study|Medication Noncompliance|0|||
161478573|NCT00334958|583146700|FG001|Overall Study|Medication Noncompliance|3|||
161478574|NCT00334958|583146699|FG000|Overall Study|Protocol Violation|2|||
161478575|NCT00334958|583146700|FG001|Overall Study|Protocol Violation|2|||
161478576|NCT00334958|583146699|FG000|Overall Study|Request of the investigator or sponsor|0|||
161478577|NCT00334958|583146700|FG001|Overall Study|Request of the investigator or sponsor|1|||
161478578|NCT00334958|583146699|FG000|Overall Study|Withdrawal by Subject|7|||
161478579|NCT00334958|583146700|FG001|Overall Study|Withdrawal by Subject|4|||
161478580|NCT00334958|583146699|FG000|Overall Study|Adverse Event|27|||
161478581|NCT00334958|583146700|FG001|Overall Study|Adverse Event|12|||
161478582|NCT00334958|583146699|FG000|Overall Study|Other|1|||
161478583|NCT00334958|583146700|FG001|Overall Study|Other|2|||
161478584|NCT01548287|583146701|FG000|Screening|No reason provided|0|||
161478585|NCT01548287|583146702|FG001|Screening|No reason provided|0|||
161478586|NCT01548287|583146703|FG002|Screening|No reason provided|0|||
161478587|NCT01548287|583146704|FG003|Screening|No reason provided|0|||
161478588|NCT01548287|583146705|FG004|Screening|No reason provided|9|||
161478589|NCT01548287|583146701|FG000|Screening|Did not meet eligibility criteria|0|||
161478590|NCT01548287|583146702|FG001|Screening|Did not meet eligibility criteria|0|||
161478591|NCT01548287|583146703|FG002|Screening|Did not meet eligibility criteria|0|||
161478592|NCT01548287|583146704|FG003|Screening|Did not meet eligibility criteria|0|||
161478593|NCT01548287|583146705|FG004|Screening|Did not meet eligibility criteria|74|||
161478594|NCT01548287|583146701|FG000|Randomized Period|Did not meet inclusion criteria|0|||
161478595|NCT01548287|583146702|FG001|Randomized Period|Did not meet inclusion criteria|0|||
161478596|NCT01548287|583146703|FG002|Randomized Period|Did not meet inclusion criteria|2|||
161478597|NCT01548287|583146704|FG003|Randomized Period|Did not meet inclusion criteria|0|||
161478598|NCT01548287|583146705|FG004|Randomized Period|Did not meet inclusion criteria|0|||
161478599|NCT01548287|583146701|FG000|Randomized Period|Adverse Event|0|||
161478600|NCT01548287|583146702|FG001|Randomized Period|Adverse Event|2|||
161478601|NCT01548287|583146703|FG002|Randomized Period|Adverse Event|5|||
161478602|NCT01548287|583146704|FG003|Randomized Period|Adverse Event|0|||
161478603|NCT01548287|583146705|FG004|Randomized Period|Adverse Event|0|||
161578622|NCT05061693|583506548|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
161578623|NCT05061693|583506549|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161578624|NCT05061693|583506550|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161578625|NCT05061693|583506551|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578626|NCT05061693|583506552|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578627|NCT05061693|583506553|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578628|NCT05061693|583506554|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578629|NCT05061693|583506555|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578630|NCT05061693|583506556|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161478604|NCT02762578|583146710|FG000|Overall Study|Adverse Event|1|||
161478605|NCT02762578|583146711|FG001|Overall Study|Adverse Event|6|||
161478606|NCT02762578|583146710|FG000|Overall Study|Protocol Violation|4|||
161478607|NCT02762578|583146711|FG001|Overall Study|Protocol Violation|2|||
161478608|NCT02762578|583146710|FG000|Overall Study|Withdrawal by Subject|4|||
161478609|NCT02762578|583146711|FG001|Overall Study|Withdrawal by Subject|2|||
161478610|NCT02762578|583146710|FG000|Overall Study|Unclassified|6|||
161478611|NCT02762578|583146711|FG001|Overall Study|Unclassified|0|||
161478612|NCT01090492|583146712|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
161478613|NCT01090492|583146713|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
161478614|NCT01090492|583146714|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
161478615|NCT01090492|583146715|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
161478616|NCT01090492|583146716|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
161478617|NCT01090492|583146717|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
161478618|NCT01090492|583146718|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
161478619|NCT01090492|583146719|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
161478620|NCT01090492|583146712|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
161478621|NCT01090492|583146713|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
161478622|NCT01090492|583146714|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
161478623|NCT01090492|583146715|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
161478624|NCT01090492|583146716|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
161478625|NCT01090492|583146717|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
161478626|NCT01090492|583146718|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
161478627|NCT01090492|583146719|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
161478628|NCT01090492|583146712|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478629|NCT01090492|583146713|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478630|NCT01090492|583146714|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
161478631|NCT01090492|583146715|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478632|NCT01090492|583146716|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478633|NCT01090492|583146717|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478634|NCT01090492|583146718|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478635|NCT01090492|583146719|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478636|NCT01090492|583146712|FG000|First Intervention Period (4 Weeks)|Other|0|||
161478637|NCT01090492|583146713|FG001|First Intervention Period (4 Weeks)|Other|0|||
161478638|NCT01090492|583146714|FG002|First Intervention Period (4 Weeks)|Other|1|||
161478639|NCT01090492|583146715|FG003|First Intervention Period (4 Weeks)|Other|1|||
161478640|NCT01090492|583146716|FG004|First Intervention Period (4 Weeks)|Other|2|||
161478641|NCT01090492|583146717|FG005|First Intervention Period (4 Weeks)|Other|0|||
161478642|NCT01090492|583146718|FG006|First Intervention Period (4 Weeks)|Other|0|||
161478643|NCT01090492|583146719|FG007|First Intervention Period (4 Weeks)|Other|0|||
161478644|NCT01090492|583146712|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478645|NCT01090492|583146713|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478646|NCT01090492|583146714|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478647|NCT01090492|583146715|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478648|NCT01090492|583146716|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
161478649|NCT01090492|583146717|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478650|NCT01090492|583146718|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478651|NCT01090492|583146719|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
161478652|NCT01090492|583146712|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
161578631|NCT05061693|583506557|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578632|NCT05061693|583506558|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161578633|NCT05061693|583506547|FG000|24-week Extension Period|Adverse Event|0|||
161578634|NCT05061693|583506548|FG001|24-week Extension Period|Adverse Event|0|||
161578635|NCT05061693|583506549|FG002|24-week Extension Period|Adverse Event|0|||
161578636|NCT05061693|583506550|FG003|24-week Extension Period|Adverse Event|0|||
161578637|NCT05061693|583506551|FG004|24-week Extension Period|Adverse Event|0|||
161578638|NCT05061693|583506552|FG005|24-week Extension Period|Adverse Event|0|||
161578639|NCT05061693|583506553|FG006|24-week Extension Period|Adverse Event|0|||
161578640|NCT05061693|583506554|FG007|24-week Extension Period|Adverse Event|2|||
161578641|NCT05061693|583506555|FG008|24-week Extension Period|Adverse Event|2|||
161578642|NCT05061693|583506556|FG009|24-week Extension Period|Adverse Event|0|||
161578643|NCT05061693|583506557|FG010|24-week Extension Period|Adverse Event|1|||
161578644|NCT05061693|583506558|FG011|24-week Extension Period|Adverse Event|3|||
161578645|NCT05061693|583506547|FG000|24-week Extension Period|Lack of Efficacy|0|||
161578646|NCT05061693|583506548|FG001|24-week Extension Period|Lack of Efficacy|0|||
161578647|NCT05061693|583506549|FG002|24-week Extension Period|Lack of Efficacy|0|||
161578648|NCT05061693|583506550|FG003|24-week Extension Period|Lack of Efficacy|0|||
161578649|NCT05061693|583506551|FG004|24-week Extension Period|Lack of Efficacy|0|||
161578650|NCT05061693|583506552|FG005|24-week Extension Period|Lack of Efficacy|0|||
161578651|NCT05061693|583506553|FG006|24-week Extension Period|Lack of Efficacy|0|||
161578652|NCT05061693|583506554|FG007|24-week Extension Period|Lack of Efficacy|0|||
161578653|NCT05061693|583506555|FG008|24-week Extension Period|Lack of Efficacy|0|||
161578654|NCT05061693|583506556|FG009|24-week Extension Period|Lack of Efficacy|0|||
161578655|NCT05061693|583506557|FG010|24-week Extension Period|Lack of Efficacy|2|||
161578656|NCT05061693|583506558|FG011|24-week Extension Period|Lack of Efficacy|0|||
161578657|NCT05061693|583506547|FG000|24-week Extension Period|Lost to Follow-up|0|||
161578658|NCT05061693|583506548|FG001|24-week Extension Period|Lost to Follow-up|0|||
161578659|NCT05061693|583506549|FG002|24-week Extension Period|Lost to Follow-up|0|||
161578660|NCT05061693|583506550|FG003|24-week Extension Period|Lost to Follow-up|0|||
161578661|NCT05061693|583506551|FG004|24-week Extension Period|Lost to Follow-up|0|||
161578662|NCT05061693|583506552|FG005|24-week Extension Period|Lost to Follow-up|0|||
161578663|NCT05061693|583506553|FG006|24-week Extension Period|Lost to Follow-up|1|||
161578664|NCT05061693|583506554|FG007|24-week Extension Period|Lost to Follow-up|0|||
161578665|NCT05061693|583506555|FG008|24-week Extension Period|Lost to Follow-up|1|||
161578666|NCT05061693|583506556|FG009|24-week Extension Period|Lost to Follow-up|1|||
161578667|NCT05061693|583506557|FG010|24-week Extension Period|Lost to Follow-up|0|||
161578668|NCT05061693|583506558|FG011|24-week Extension Period|Lost to Follow-up|0|||
161578669|NCT05061693|583506547|FG000|24-week Extension Period|Withdrawal by Subject|0|||
161668670|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
161668671|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
161668672|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
161668673|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
161668674|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
161668675|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
161668676|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
161668677|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
161668678|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
161668679|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Other|10|||
161668680|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Other|7|||
161668681|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Other|8|||
161668682|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Other|8|||
161668683|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Other|0|||
161668684|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
161668685|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
161668686|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
161668687|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
161668688|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
161668689|NCT00615836|583839814|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
161668690|NCT00615836|583839815|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161668691|NCT00615836|583839816|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161668692|NCT00615836|583839817|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161668693|NCT00615836|583839818|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161668694|NCT01630434|583839819|FG000|Overall Study|Donor lungs turned down|1|||
161668695|NCT01630434|583839820|FG001|Overall Study|Donor lungs turned down|0|||
161668696|NCT01630434|583839819|FG000|Overall Study|Protocol Violation|9|||
161578670|NCT05061693|583506548|FG001|24-week Extension Period|Withdrawal by Subject|0|||
161578671|NCT05061693|583506549|FG002|24-week Extension Period|Withdrawal by Subject|0|||
161578672|NCT05061693|583506550|FG003|24-week Extension Period|Withdrawal by Subject|0|||
161578673|NCT05061693|583506551|FG004|24-week Extension Period|Withdrawal by Subject|0|||
161668697|NCT01630434|583839820|FG001|Overall Study|Protocol Violation|4|||
161815809|NCT04404725|584368789|FG000|First Intervention|Withdrawal by Subject|0|||
161815810|NCT04404725|584368790|FG001|First Intervention|Withdrawal by Subject|2|||
161815811|NCT04404725|584368789|FG000|Second Intervention|Adverse Event|1|||
161578674|NCT05061693|583506552|FG005|24-week Extension Period|Withdrawal by Subject|0|||
161578675|NCT05061693|583506553|FG006|24-week Extension Period|Withdrawal by Subject|0|||
161578676|NCT05061693|583506554|FG007|24-week Extension Period|Withdrawal by Subject|0|||
161578677|NCT05061693|583506555|FG008|24-week Extension Period|Withdrawal by Subject|1|||
161578678|NCT05061693|583506556|FG009|24-week Extension Period|Withdrawal by Subject|2|||
161578679|NCT05061693|583506557|FG010|24-week Extension Period|Withdrawal by Subject|2|||
161578680|NCT05061693|583506558|FG011|24-week Extension Period|Withdrawal by Subject|1|||
161578681|NCT05061693|583506547|FG000|24-week Extension Period|Sponsor Decision|0|||
161578682|NCT05061693|583506548|FG001|24-week Extension Period|Sponsor Decision|0|||
161578683|NCT05061693|583506549|FG002|24-week Extension Period|Sponsor Decision|0|||
161578684|NCT05061693|583506550|FG003|24-week Extension Period|Sponsor Decision|0|||
161668698|NCT01630434|583839819|FG000|Overall Study|Death|20|||
161668699|NCT01630434|583839820|FG001|Overall Study|Death|26|||
161668700|NCT00687973|583839821|FG000|Overall Study|Adverse Event|18|||
161668701|NCT00687973|583839822|FG001|Overall Study|Adverse Event|28|||
161815812|NCT04404725|584368790|FG001|Second Intervention|Adverse Event|1|||
161815813|NCT04404725|584368789|FG000|Second Intervention|Withdrawal by Subject|0|||
161478653|NCT01090492|583146713|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
161478654|NCT01090492|583146714|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
161478655|NCT01090492|583146715|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
161478656|NCT01090492|583146716|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
161478657|NCT01090492|583146717|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
161478658|NCT01090492|583146718|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
161478659|NCT01090492|583146719|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
161478660|NCT01090492|583146712|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
161478661|NCT01090492|583146713|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
161478662|NCT01090492|583146714|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
161478663|NCT01090492|583146715|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
161478664|NCT01090492|583146716|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
161478665|NCT01090492|583146717|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
161478666|NCT01090492|583146718|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
161478667|NCT01090492|583146719|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
161478668|NCT01090492|583146712|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478669|NCT01090492|583146713|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
161478670|NCT01090492|583146714|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478671|NCT01090492|583146715|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478672|NCT01090492|583146716|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478673|NCT01090492|583146717|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478674|NCT01090492|583146718|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478675|NCT01090492|583146719|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
161478676|NCT01090492|583146712|FG000|Second Intervention Period (4 Weeks)|Other|0|||
161478677|NCT01090492|583146713|FG001|Second Intervention Period (4 Weeks)|Other|1|||
161478678|NCT01090492|583146714|FG002|Second Intervention Period (4 Weeks)|Other|1|||
161478679|NCT01090492|583146715|FG003|Second Intervention Period (4 Weeks)|Other|0|||
161478680|NCT01090492|583146716|FG004|Second Intervention Period (4 Weeks)|Other|0|||
161478681|NCT01090492|583146717|FG005|Second Intervention Period (4 Weeks)|Other|0|||
161478682|NCT01090492|583146718|FG006|Second Intervention Period (4 Weeks)|Other|0|||
161478683|NCT01090492|583146719|FG007|Second Intervention Period (4 Weeks)|Other|0|||
161478684|NCT01090492|583146712|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
161478685|NCT01090492|583146713|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
161478686|NCT01090492|583146714|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
161478687|NCT01090492|583146715|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
161478688|NCT01090492|583146716|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
161478689|NCT01090492|583146717|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
161478690|NCT01090492|583146718|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
161478691|NCT01090492|583146719|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
161478692|NCT01090492|583146712|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478693|NCT01090492|583146713|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478694|NCT01090492|583146714|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478695|NCT01090492|583146715|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478696|NCT01090492|583146716|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478697|NCT01090492|583146717|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478698|NCT01090492|583146718|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
161478699|NCT01090492|583146719|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
161478700|NCT02083965|583146720|FG000|Treatment Period|Other|1|||
161478701|NCT02083965|583146721|FG001|Treatment Period|Other|0|||
161478702|NCT00911547|583146723|FG000|Overall Study|Adverse Event|8|||
161478703|NCT00911547|583146724|FG001|Overall Study|Adverse Event|27|||
161478704|NCT00911547|583146725|FG002|Overall Study|Adverse Event|11|||
161478705|NCT00911547|583146726|FG003|Overall Study|Adverse Event|6|||
161478706|NCT00911547|583146723|FG000|Overall Study|Lost to Follow-up|0|||
161478707|NCT00911547|583146724|FG001|Overall Study|Lost to Follow-up|0|||
161478708|NCT00911547|583146725|FG002|Overall Study|Lost to Follow-up|2|||
161478709|NCT00911547|583146726|FG003|Overall Study|Lost to Follow-up|1|||
161478710|NCT00911547|583146723|FG000|Overall Study|Protocol Violation|0|||
161478711|NCT00911547|583146724|FG001|Overall Study|Protocol Violation|5|||
161478712|NCT00911547|583146725|FG002|Overall Study|Protocol Violation|5|||
161478713|NCT00911547|583146726|FG003|Overall Study|Protocol Violation|1|||
161478714|NCT00911547|583146723|FG000|Overall Study|Withdrawal by Subject|3|||
161478715|NCT00911547|583146724|FG001|Overall Study|Withdrawal by Subject|10|||
161478716|NCT00911547|583146725|FG002|Overall Study|Withdrawal by Subject|4|||
161478717|NCT00911547|583146726|FG003|Overall Study|Withdrawal by Subject|8|||
161478718|NCT03583697|583146729|FG000|Overall Study|Withdrawal by Subject|0|||
161478719|NCT03583697|583146730|FG001|Overall Study|Withdrawal by Subject|0|||
161478720|NCT03583697|583146731|FG002|Overall Study|Withdrawal by Subject|1|||
161478721|NCT03583697|583146729|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
161478722|NCT03583697|583146730|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
161478723|NCT03583697|583146731|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
161478724|NCT00365508|583146732|FG000|Overall Study|Lost to Follow-up|139|||
161921146|NCT04398134|584757171|FG000|Overall Study|Withdrawal by Subject|2|||
161921147|NCT04398134|584757172|FG001|Overall Study|Withdrawal by Subject|0|||
161921148|NCT04398134|584757173|FG002|Overall Study|Withdrawal by Subject|0|||
161921149|NCT04398134|584757174|FG003|Overall Study|Withdrawal by Subject|1|||
161921150|NCT04398134|584757171|FG000|Overall Study|Study Terminated by Sponsor|30|||
161921151|NCT04398134|584757172|FG001|Overall Study|Study Terminated by Sponsor|11|||
161921152|NCT04398134|584757173|FG002|Overall Study|Study Terminated by Sponsor|32|||
161921153|NCT04398134|584757174|FG003|Overall Study|Study Terminated by Sponsor|11|||
161921154|NCT06420232|584757178|FG000|Overall Study|Withdrawal by Subject|3|||
161921155|NCT01697579|584757180|FG000|Base Study-Cycle 1|Adverse Event|1|||
161921156|NCT01697579|584757181|FG001|Base Study-Cycle 1|Adverse Event|0|||
161921157|NCT01697579|584757182|FG002|Base Study-Cycle 1|Adverse Event|0|||
161921158|NCT01697579|584757183|FG003|Base Study-Cycle 1|Adverse Event|0|||
161921159|NCT01697579|584757184|FG004|Base Study-Cycle 1|Adverse Event|0|||
161921160|NCT01697579|584757185|FG005|Base Study-Cycle 1|Adverse Event|0|||
161921161|NCT01697579|584757186|FG006|Base Study-Cycle 1|Adverse Event|0|||
161921162|NCT01697579|584757180|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
161921163|NCT01697579|584757181|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161668702|NCT00687973|583839821|FG000|Overall Study|Lack of Efficacy|2|||
161668703|NCT00687973|583839822|FG001|Overall Study|Lack of Efficacy|3|||
161668704|NCT00687973|583839821|FG000|Overall Study|Protocol Violation|1|||
161668705|NCT00687973|583839822|FG001|Overall Study|Protocol Violation|2|||
161668706|NCT00687973|583839821|FG000|Overall Study|Administrative Reasons|0|||
161668707|NCT00687973|583839822|FG001|Overall Study|Administrative Reasons|2|||
161668708|NCT00687973|583839821|FG000|Overall Study|Withdrawal by Subject|3|||
161668709|NCT00687973|583839822|FG001|Overall Study|Withdrawal by Subject|3|||
161668710|NCT02075541|583839824|FG000|Overall Study|Serious Adverse Event|1|||
161668711|NCT02075541|583839825|FG001|Overall Study|Serious Adverse Event|4|||
161668712|NCT02075541|583839824|FG000|Overall Study|Protocol Violation|1|||
161668713|NCT02075541|583839825|FG001|Overall Study|Protocol Violation|0|||
161668714|NCT02075541|583839824|FG000|Overall Study|Withdrawal by Subject|1|||
161668715|NCT02075541|583839825|FG001|Overall Study|Withdrawal by Subject|3|||
161668716|NCT02075541|583839824|FG000|Overall Study|Sponsor study termination|0|||
161668717|NCT02075541|583839825|FG001|Overall Study|Sponsor study termination|1|||
161668718|NCT02075541|583839824|FG000|Overall Study|Other- unable to perform study procedure|1|||
161668719|NCT02075541|583839825|FG001|Overall Study|Other- unable to perform study procedure|0|||
161578685|NCT05061693|583506551|FG004|24-week Extension Period|Sponsor Decision|0|||
161578686|NCT05061693|583506552|FG005|24-week Extension Period|Sponsor Decision|0|||
161578687|NCT05061693|583506553|FG006|24-week Extension Period|Sponsor Decision|0|||
161578688|NCT05061693|583506554|FG007|24-week Extension Period|Sponsor Decision|1|||
161578689|NCT05061693|583506555|FG008|24-week Extension Period|Sponsor Decision|0|||
161578690|NCT05061693|583506556|FG009|24-week Extension Period|Sponsor Decision|0|||
161578691|NCT05061693|583506557|FG010|24-week Extension Period|Sponsor Decision|0|||
161578692|NCT05061693|583506558|FG011|24-week Extension Period|Sponsor Decision|0|||
161578693|NCT05061693|583506547|FG000|24-week Extension Period|Site Closure|0|||
161578694|NCT05061693|583506548|FG001|24-week Extension Period|Site Closure|0|||
161578695|NCT05061693|583506549|FG002|24-week Extension Period|Site Closure|0|||
161578696|NCT05061693|583506550|FG003|24-week Extension Period|Site Closure|0|||
161578697|NCT05061693|583506551|FG004|24-week Extension Period|Site Closure|0|||
161578698|NCT05061693|583506552|FG005|24-week Extension Period|Site Closure|0|||
161578699|NCT05061693|583506553|FG006|24-week Extension Period|Site Closure|0|||
161578700|NCT05061693|583506554|FG007|24-week Extension Period|Site Closure|0|||
161578701|NCT05061693|583506555|FG008|24-week Extension Period|Site Closure|1|||
161578702|NCT05061693|583506556|FG009|24-week Extension Period|Site Closure|0|||
161578703|NCT05061693|583506557|FG010|24-week Extension Period|Site Closure|0|||
161578704|NCT05061693|583506558|FG011|24-week Extension Period|Site Closure|1|||
161578705|NCT03823911|583506559|FG000|Overall Study|Lost to Follow-up|1|||
161578706|NCT03823911|583506560|FG001|Overall Study|Lost to Follow-up|5|||
161578707|NCT03823911|583506561|FG002|Overall Study|Lost to Follow-up|2|||
161578708|NCT03823911|583506559|FG000|Overall Study|Did not meet eligibility criteria|13|||
161578709|NCT03823911|583506560|FG001|Overall Study|Did not meet eligibility criteria|7|||
161578710|NCT03823911|583506561|FG002|Overall Study|Did not meet eligibility criteria|4|||
161578711|NCT03823911|583506559|FG000|Overall Study|Death|0|||
161578712|NCT03823911|583506560|FG001|Overall Study|Death|1|||
161578713|NCT03823911|583506561|FG002|Overall Study|Death|0|||
161578714|NCT00396084|583506564|FG000|Overall Study|Adverse Event|0|||
161578715|NCT00396084|583506565|FG001|Overall Study|Adverse Event|0|||
161578716|NCT00396084|583506566|FG002|Overall Study|Adverse Event|0|||
161578717|NCT00396084|583506567|FG003|Overall Study|Adverse Event|0|||
161578718|NCT00396084|583506568|FG004|Overall Study|Adverse Event|1|||
161578719|NCT00396084|583506569|FG005|Overall Study|Adverse Event|2|||
161578720|NCT00396084|583506564|FG000|Overall Study|Withdrawal by Subject|0|||
161578721|NCT00396084|583506565|FG001|Overall Study|Withdrawal by Subject|0|||
161578722|NCT00396084|583506566|FG002|Overall Study|Withdrawal by Subject|0|||
161578723|NCT00396084|583506567|FG003|Overall Study|Withdrawal by Subject|1|||
161578724|NCT00396084|583506568|FG004|Overall Study|Withdrawal by Subject|0|||
161578725|NCT00396084|583506569|FG005|Overall Study|Withdrawal by Subject|0|||
161668720|NCT02349360|583839826|FG000|Overall Study|Withdrawal by Subject|0|||
161578726|NCT04009577|583506570|FG000|Core Study|Adverse Event|1|||
161578727|NCT04009577|583506571|FG001|Core Study|Adverse Event|0|||
161578728|NCT04009577|583506572|FG002|Core Study|Adverse Event|2|||
161668721|NCT02349360|583839827|FG001|Overall Study|Withdrawal by Subject|1|||
161578729|NCT04009577|583506573|FG003|Core Study|Adverse Event|4|||
161578730|NCT04009577|583506570|FG000|Core Study|Withdrawal by Subject|0|||
161578731|NCT04009577|583506571|FG001|Core Study|Withdrawal by Subject|0|||
161668722|NCT01054846|583839828|FG000|Overall Study|Lost to Follow-up|76|||
161578732|NCT04009577|583506572|FG002|Core Study|Withdrawal by Subject|2|||
161578733|NCT04009577|583506573|FG003|Core Study|Withdrawal by Subject|0|||
161578734|NCT04009577|583506570|FG000|Core Study|Other|0|||
161578735|NCT04009577|583506571|FG001|Core Study|Other|0|||
161668723|NCT01054846|583839829|FG001|Overall Study|Lost to Follow-up|17|||
161668724|NCT00394953|583839830|FG000|First Treatment Period|Adverse Event|1|||
161668725|NCT00394953|583839831|FG001|First Treatment Period|Adverse Event|2|||
161668726|NCT00394953|583839830|FG000|First Treatment Period|Death|6|||
161478725|NCT00365508|583146733|FG001|Overall Study|Lost to Follow-up|154|||
161478726|NCT00404235|583146736|FG000|Overall Study|Withdrawal by Subject|1|||
161478727|NCT00404235|583146737|FG001|Overall Study|Withdrawal by Subject|2|||
161478728|NCT00679432|583146738|FG000|Overall Study|Adverse Event|5|||
161478729|NCT00679432|583146739|FG001|Overall Study|Adverse Event|6|||
161478730|NCT00679432|583146740|FG002|Overall Study|Adverse Event|10|||
161478731|NCT00679432|583146741|FG003|Overall Study|Adverse Event|7|||
161478732|NCT00679432|583146738|FG000|Overall Study|Protocol Violation|1|||
161478733|NCT00679432|583146739|FG001|Overall Study|Protocol Violation|1|||
161478734|NCT00679432|583146740|FG002|Overall Study|Protocol Violation|2|||
161478735|NCT00679432|583146741|FG003|Overall Study|Protocol Violation|1|||
161478736|NCT00679432|583146738|FG000|Overall Study|Withdrawal by Subject|8|||
161478737|NCT00679432|583146739|FG001|Overall Study|Withdrawal by Subject|11|||
161478738|NCT00679432|583146740|FG002|Overall Study|Withdrawal by Subject|10|||
161478739|NCT00679432|583146741|FG003|Overall Study|Withdrawal by Subject|9|||
161578736|NCT04009577|583506572|FG002|Core Study|Other|0|||
161578737|NCT04009577|583506573|FG003|Core Study|Other|1|||
161578738|NCT04009577|583506570|FG000|Extension Phase|Adverse Event|0|||
161578739|NCT04009577|583506571|FG001|Extension Phase|Adverse Event|0|||
161578740|NCT04009577|583506572|FG002|Extension Phase|Adverse Event|0|||
161578741|NCT04009577|583506573|FG003|Extension Phase|Adverse Event|1|||
161578742|NCT04009577|583506570|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161578743|NCT04009577|583506571|FG001|Extension Phase|Inadequate therapeutic effect|0|||
161578744|NCT04009577|583506572|FG002|Extension Phase|Inadequate therapeutic effect|1|||
161578745|NCT04009577|583506573|FG003|Extension Phase|Inadequate therapeutic effect|0|||
161578746|NCT04009577|583506570|FG000|Extension Phase|Withdrawal by Subject|0|||
161578747|NCT04009577|583506571|FG001|Extension Phase|Withdrawal by Subject|0|||
161578748|NCT04009577|583506572|FG002|Extension Phase|Withdrawal by Subject|1|||
161578749|NCT04009577|583506573|FG003|Extension Phase|Withdrawal by Subject|0|||
161578750|NCT04009577|583506570|FG000|Extension Phase|Not Treated|0|||
161578751|NCT04009577|583506571|FG001|Extension Phase|Not Treated|0|||
161578752|NCT04009577|583506572|FG002|Extension Phase|Not Treated|2|||
161578753|NCT04009577|583506573|FG003|Extension Phase|Not Treated|0|||
161578754|NCT01832480|583506574|FG000|Overall Study|Lost to Follow-up|33|||
161578755|NCT01832480|583506575|FG001|Overall Study|Lost to Follow-up|30|||
161578756|NCT01832480|583506574|FG000|Overall Study|Withdrawal by Subject|0|||
161578757|NCT01832480|583506575|FG001|Overall Study|Withdrawal by Subject|2|||
161578758|NCT01832480|583506574|FG000|Overall Study|post randomization ineligible|8|||
161578759|NCT01832480|583506575|FG001|Overall Study|post randomization ineligible|10|||
161578760|NCT02261467|583506577|FG000|Overall Study|Enrolled in Error|1|||
161578761|NCT02261467|583506578|FG001|Overall Study|Enrolled in Error|0|||
161578762|NCT02261467|583506577|FG000|Overall Study|Protocol Violation|0|||
161578763|NCT02261467|583506578|FG001|Overall Study|Protocol Violation|1|||
161578764|NCT02261467|583506577|FG000|Overall Study|Personal Reasons|17|||
161578765|NCT02261467|583506578|FG001|Overall Study|Personal Reasons|22|||
161578766|NCT02261467|583506577|FG000|Overall Study|Lost to Follow-up|2|||
161578767|NCT02261467|583506578|FG001|Overall Study|Lost to Follow-up|13|||
161578768|NCT02261467|583506577|FG000|Overall Study|Adverse Event|1|||
161578769|NCT02261467|583506578|FG001|Overall Study|Adverse Event|1|||
161578770|NCT04305405|583506581|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161578771|NCT04305405|583506582|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161578772|NCT02674750|583506587|FG000|Overall Study|Death|4|||
161578773|NCT02674750|583506588|FG001|Overall Study|Death|5|||
161578774|NCT02674750|583506589|FG002|Overall Study|Death|8|||
161578775|NCT02674750|583506587|FG000|Overall Study|Lost to Follow-up|0|||
161578776|NCT02674750|583506588|FG001|Overall Study|Lost to Follow-up|8|||
161578777|NCT02674750|583506589|FG002|Overall Study|Lost to Follow-up|0|||
161578778|NCT02674750|583506587|FG000|Overall Study|Lack of Efficacy|1|||
161578779|NCT02674750|583506588|FG001|Overall Study|Lack of Efficacy|17|||
161578780|NCT02674750|583506589|FG002|Overall Study|Lack of Efficacy|3|||
161668727|NCT00394953|583839831|FG001|First Treatment Period|Death|7|||
161668728|NCT00394953|583839830|FG000|First Treatment Period|Lack of Efficacy|1|||
161578781|NCT02674750|583506587|FG000|Overall Study|Withdrawal by Subject|0|||
161578782|NCT02674750|583506588|FG001|Overall Study|Withdrawal by Subject|7|||
161578783|NCT02674750|583506589|FG002|Overall Study|Withdrawal by Subject|1|||
161578784|NCT02674750|583506587|FG000|Overall Study|Other|0|||
161578785|NCT02674750|583506588|FG001|Overall Study|Other|8|||
161578786|NCT02674750|583506589|FG002|Overall Study|Other|0|||
161578787|NCT01685606|583506592|FG000|Overall Study|Withdrawal by Subject|1|||
161578788|NCT01787760|583506593|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
161578789|NCT01787760|583506594|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
161578790|NCT01787760|583506595|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
161578791|NCT01787760|583506593|FG000|Overall Study|Decompensated on left exotropia|0|||
161578792|NCT01787760|583506594|FG001|Overall Study|Decompensated on left exotropia|0|||
161478740|NCT00679432|583146738|FG000|Overall Study|Lost to Follow-up|1|||
161478741|NCT00679432|583146739|FG001|Overall Study|Lost to Follow-up|5|||
161478742|NCT00679432|583146740|FG002|Overall Study|Lost to Follow-up|4|||
161578793|NCT01787760|583506595|FG002|Overall Study|Decompensated on left exotropia|1|||
161478743|NCT00679432|583146741|FG003|Overall Study|Lost to Follow-up|2|||
161478744|NCT00679432|583146738|FG000|Overall Study|Physician Decision|3|||
161478745|NCT00679432|583146739|FG001|Overall Study|Physician Decision|2|||
161478746|NCT00679432|583146740|FG002|Overall Study|Physician Decision|2|||
161478747|NCT00679432|583146741|FG003|Overall Study|Physician Decision|2|||
161478748|NCT00679432|583146738|FG000|Overall Study|Sponsor decision|1|||
161478749|NCT00679432|583146739|FG001|Overall Study|Sponsor decision|0|||
161478750|NCT00679432|583146740|FG002|Overall Study|Sponsor decision|0|||
161478751|NCT00679432|583146741|FG003|Overall Study|Sponsor decision|0|||
161478752|NCT00679432|583146738|FG000|Overall Study|Lack of Efficacy|13|||
161478753|NCT00679432|583146739|FG001|Overall Study|Lack of Efficacy|9|||
161478754|NCT00679432|583146740|FG002|Overall Study|Lack of Efficacy|14|||
161478755|NCT00679432|583146741|FG003|Overall Study|Lack of Efficacy|8|||
161478756|NCT00679432|583146738|FG000|Overall Study|Infectious colitis, normal histology|5|||
161478757|NCT00679432|583146739|FG001|Overall Study|Infectious colitis, normal histology|4|||
161478758|NCT00679432|583146740|FG002|Overall Study|Infectious colitis, normal histology|8|||
161478759|NCT00679432|583146741|FG003|Overall Study|Infectious colitis, normal histology|3|||
161478760|NCT00679432|583146738|FG000|Overall Study|Randomization error, return to prior Rx|0|||
161478761|NCT00679432|583146739|FG001|Overall Study|Randomization error, return to prior Rx|0|||
161478762|NCT00679432|583146740|FG002|Overall Study|Randomization error, return to prior Rx|3|||
161478763|NCT00679432|583146741|FG003|Overall Study|Randomization error, return to prior Rx|0|||
161478764|NCT00824720|583146742|FG000|Overall Study|failed plug insertion|3|||
161478765|NCT00824720|583146743|FG001|Overall Study|failed plug insertion|1|||
161478766|NCT00824720|583146744|FG002|Overall Study|failed plug insertion|0|||
161478767|NCT00824720|583146742|FG000|Overall Study|Protocol Violation|0|||
161478768|NCT00824720|583146743|FG001|Overall Study|Protocol Violation|0|||
161478769|NCT00824720|583146744|FG002|Overall Study|Protocol Violation|1|||
161478770|NCT01558271|583146747|FG000|Overall Study|Adverse Event|6|||
161478771|NCT01558271|583146748|FG001|Overall Study|Adverse Event|3|||
161478772|NCT01558271|583146749|FG002|Overall Study|Adverse Event|4|||
161478773|NCT01558271|583146747|FG000|Overall Study|Lost to Follow-up|1|||
161478774|NCT01558271|583146748|FG001|Overall Study|Lost to Follow-up|0|||
161478775|NCT01558271|583146749|FG002|Overall Study|Lost to Follow-up|0|||
161478776|NCT01558271|583146747|FG000|Overall Study|Protocol Violation|1|||
161478777|NCT01558271|583146748|FG001|Overall Study|Protocol Violation|0|||
161478778|NCT01558271|583146749|FG002|Overall Study|Protocol Violation|0|||
161478779|NCT01558271|583146747|FG000|Overall Study|Withdrawal by Subject|10|||
161478780|NCT01558271|583146748|FG001|Overall Study|Withdrawal by Subject|6|||
161478781|NCT01558271|583146749|FG002|Overall Study|Withdrawal by Subject|12|||
161478782|NCT01558271|583146747|FG000|Overall Study|Physician Decision|0|||
161478783|NCT01558271|583146748|FG001|Overall Study|Physician Decision|2|||
161478784|NCT01558271|583146749|FG002|Overall Study|Physician Decision|1|||
161478785|NCT02610725|583146750|FG000|Overall Study|Lost to Follow-up|197|||
161478786|NCT02610725|583146750|FG000|Overall Study|self-reported contraindication|9|||
161478787|NCT04094883|583146751|FG000|Overall Study|Withdrawal by Subject|1|||
161478788|NCT00743483|583146752|FG000|Baseline Period|Physician Decision|1|||
161478789|NCT00743483|583146752|FG000|Treatment Period|Adverse Event|1|||
161478790|NCT01084083|583146753|FG000|Overall Study|Adverse Event|5|||
161478791|NCT01084083|583146753|FG000|Overall Study|Death|1|||
161478792|NCT01084083|583146753|FG000|Overall Study|Withdrawal by Subject|2|||
161478793|NCT01084083|583146753|FG000|Overall Study|Complicating disease|1|||
161478794|NCT01084083|583146753|FG000|Overall Study|Other|2|||
161478795|NCT01084083|583146753|FG000|Overall Study|Never started assigned therapy|1|||
161478796|NCT00873912|583146755|FG000|Overall Study|Withdrawal by Subject|1|||
161478797|NCT00873912|583146756|FG001|Overall Study|Withdrawal by Subject|0|||
161478798|NCT00873912|583146755|FG000|Overall Study|Lost to Follow-up|2|||
161478799|NCT00873912|583146756|FG001|Overall Study|Lost to Follow-up|0|||
161478800|NCT05570500|583146759|FG000|Overall Study|Lost to Follow-up|7|||
161578794|NCT01787760|583506593|FG000|Overall Study|Dryness|0|||
161578795|NCT01787760|583506594|FG001|Overall Study|Dryness|1|||
161578796|NCT01787760|583506595|FG002|Overall Study|Dryness|0|||
161578797|NCT01787760|583506593|FG000|Overall Study|Relocation|1|||
161578798|NCT01787760|583506594|FG001|Overall Study|Relocation|1|||
161578799|NCT01787760|583506595|FG002|Overall Study|Relocation|0|||
161578800|NCT01787760|583506593|FG000|Overall Study|Lens discomfort|3|||
161578801|NCT01787760|583506594|FG001|Overall Study|Lens discomfort|0|||
161578802|NCT01787760|583506595|FG002|Overall Study|Lens discomfort|0|||
161578803|NCT01787760|583506593|FG000|Overall Study|Lens handling difficulty|1|||
161815814|NCT04404725|584368790|FG001|Second Intervention|Withdrawal by Subject|1|||
161578804|NCT01787760|583506594|FG001|Overall Study|Lens handling difficulty|2|||
161478801|NCT05570500|583146760|FG001|Overall Study|Lost to Follow-up|5|||
161478802|NCT04731363|583146764|FG000|Overall Study|Could not obtain samples|0|||
161478803|NCT04731363|583146765|FG001|Overall Study|Could not obtain samples|1|||
161478804|NCT04731363|583146766|FG002|Overall Study|Could not obtain samples|0|||
161478805|NCT04731363|583146767|FG003|Overall Study|Could not obtain samples|0|||
161478806|NCT04731363|583146764|FG000|Overall Study|Physician Decision|0|||
161478807|NCT04731363|583146765|FG001|Overall Study|Physician Decision|1|||
161478808|NCT04731363|583146766|FG002|Overall Study|Physician Decision|0|||
161478809|NCT04731363|583146767|FG003|Overall Study|Physician Decision|0|||
161478810|NCT00982137|583148947|FG000|Overall Study|Lost to Follow-up|0|||
161478811|NCT00982137|583148948|FG001|Overall Study|Lost to Follow-up|0|||
161668729|NCT00394953|583839831|FG001|First Treatment Period|Lack of Efficacy|1|||
161478812|NCT00982137|583148949|FG002|Overall Study|Lost to Follow-up|0|||
161478813|NCT00982137|583148950|FG003|Overall Study|Lost to Follow-up|1|||
161478814|NCT00982137|583148947|FG000|Overall Study|Withdrawal by Subject|0|||
161478815|NCT00982137|583148948|FG001|Overall Study|Withdrawal by Subject|1|||
161478816|NCT00982137|583148949|FG002|Overall Study|Withdrawal by Subject|0|||
161478817|NCT00982137|583148950|FG003|Overall Study|Withdrawal by Subject|0|||
161478818|NCT00126191|583148951|FG000|Overall Study|Physician Decision|0|||
161478819|NCT00126191|583148952|FG001|Overall Study|Physician Decision|1|||
161478820|NCT00126191|583148951|FG000|Overall Study|Death|0|||
161478821|NCT00126191|583148952|FG001|Overall Study|Death|1|||
161478822|NCT02469298|583148966|FG000|Overall Study|Protocol Violation|0|||
161478823|NCT02469298|583148967|FG001|Overall Study|Protocol Violation|1|||
161478824|NCT02469298|583148968|FG002|Overall Study|Protocol Violation|1|||
161478825|NCT02469298|583148969|FG003|Overall Study|Protocol Violation|0|||
161478826|NCT02469298|583148966|FG000|Overall Study|Lost to Follow-up|1|||
161478827|NCT02469298|583148967|FG001|Overall Study|Lost to Follow-up|0|||
161478828|NCT02469298|583148968|FG002|Overall Study|Lost to Follow-up|1|||
161478829|NCT02469298|583148969|FG003|Overall Study|Lost to Follow-up|0|||
161478830|NCT02469298|583148966|FG000|Overall Study|Physician Decision|0|||
161478831|NCT02469298|583148967|FG001|Overall Study|Physician Decision|0|||
161478832|NCT02469298|583148968|FG002|Overall Study|Physician Decision|0|||
161478833|NCT02469298|583148969|FG003|Overall Study|Physician Decision|1|||
161478834|NCT02469298|583148966|FG000|Overall Study|Withdrawal by Subject|0|||
161478835|NCT02469298|583148967|FG001|Overall Study|Withdrawal by Subject|0|||
161478836|NCT02469298|583148968|FG002|Overall Study|Withdrawal by Subject|0|||
161478837|NCT02469298|583148969|FG003|Overall Study|Withdrawal by Subject|1|||
161478838|NCT00307294|583148970|FG000|Overall Study|Withdrawal by Subject|1|||
161478839|NCT03311724|583148971|FG000|Overall Study|Physician Decision|0|||
161478840|NCT03311724|583148972|FG001|Overall Study|Physician Decision|0|||
161478841|NCT03311724|583148973|FG002|Overall Study|Physician Decision|0|||
161478842|NCT03311724|583148974|FG003|Overall Study|Physician Decision|1|||
161478843|NCT03311724|583148971|FG000|Overall Study|Protocol Violation|1|||
161478844|NCT03311724|583148972|FG001|Overall Study|Protocol Violation|0|||
161478845|NCT03311724|583148973|FG002|Overall Study|Protocol Violation|1|||
161478846|NCT03311724|583148974|FG003|Overall Study|Protocol Violation|0|||
161478847|NCT03311724|583148971|FG000|Overall Study|Withdrawal by Subject|1|||
161478848|NCT03311724|583148972|FG001|Overall Study|Withdrawal by Subject|1|||
161478849|NCT03311724|583148973|FG002|Overall Study|Withdrawal by Subject|0|||
161478850|NCT03311724|583148974|FG003|Overall Study|Withdrawal by Subject|0|||
161478851|NCT03311724|583148971|FG000|Overall Study|Lost to Follow-up|1|||
161478852|NCT03311724|583148972|FG001|Overall Study|Lost to Follow-up|0|||
161478853|NCT03311724|583148973|FG002|Overall Study|Lost to Follow-up|0|||
161478854|NCT03311724|583148974|FG003|Overall Study|Lost to Follow-up|0|||
161478855|NCT03311724|583148971|FG000|Overall Study|Sponsor Decision|0|||
161478856|NCT03311724|583148972|FG001|Overall Study|Sponsor Decision|0|||
161478857|NCT03311724|583148973|FG002|Overall Study|Sponsor Decision|1|||
161478858|NCT03311724|583148974|FG003|Overall Study|Sponsor Decision|0|||
161478859|NCT01433991|583148983|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
161478860|NCT01433991|583148984|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
161478861|NCT01433991|583148985|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
161478862|NCT01433991|583148986|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
161478863|NCT01433991|583148983|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
161478864|NCT01433991|583148984|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
161478865|NCT01433991|583148985|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
161478866|NCT01433991|583148986|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
161478867|NCT01433991|583148983|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
161668730|NCT00394953|583839830|FG000|First Treatment Period|Withdrawal by Subject|6|||
161668731|NCT00394953|583839831|FG001|First Treatment Period|Withdrawal by Subject|3|||
161478868|NCT01433991|583148984|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
161478869|NCT01433991|583148985|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
161478870|NCT01433991|583148986|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
161478871|NCT01433991|583148983|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
161478872|NCT01433991|583148984|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
161478873|NCT01433991|583148985|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
161478874|NCT01433991|583148986|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
161478875|NCT01433991|583148983|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
161478876|NCT01433991|583148984|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
161478877|NCT01433991|583148985|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
161478878|NCT01433991|583148986|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
161478879|NCT01433991|583148983|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
161668732|NCT00394953|583839830|FG000|First Treatment Period|Lost to Follow-up|0|||
161478880|NCT01433991|583148984|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
161478881|NCT01433991|583148985|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
161478882|NCT01433991|583148986|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
161478883|NCT01433991|583148983|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
161478884|NCT01433991|583148984|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
161478885|NCT01433991|583148985|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
161478886|NCT01433991|583148986|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
161478887|NCT02955602|583148989|FG000|Overall Study|Adverse Event|0|||
161478888|NCT02955602|583148990|FG001|Overall Study|Adverse Event|3|||
161478889|NCT02955602|583148991|FG002|Overall Study|Adverse Event|0|||
161478890|NCT02955602|583148989|FG000|Overall Study|Withdrawal of informed consent|1|||
161478891|NCT02955602|583148990|FG001|Overall Study|Withdrawal of informed consent|3|||
161478892|NCT02955602|583148991|FG002|Overall Study|Withdrawal of informed consent|2|||
161478893|NCT02955602|583148989|FG000|Overall Study|Lost to Follow-up|0|||
161478894|NCT02955602|583148990|FG001|Overall Study|Lost to Follow-up|0|||
161478895|NCT02955602|583148991|FG002|Overall Study|Lost to Follow-up|1|||
161478896|NCT02955602|583148989|FG000|Overall Study|Other|0|||
161478897|NCT02955602|583148990|FG001|Overall Study|Other|1|||
161478898|NCT02955602|583148991|FG002|Overall Study|Other|3|||
161478899|NCT03000439|583148994|FG000|Open Label Part 1|Adverse Event|6|||
161478900|NCT03000439|583148995|FG001|Open Label Part 1|Adverse Event|0|||
161478901|NCT03000439|583148996|FG002|Open Label Part 1|Adverse Event|0|||
161478902|NCT03000439|583148997|FG003|Open Label Part 1|Adverse Event|0|||
161478903|NCT03000439|583148994|FG000|Open Label Part 1|Other|2|||
161478904|NCT03000439|583148995|FG001|Open Label Part 1|Other|0|||
161478905|NCT03000439|583148996|FG002|Open Label Part 1|Other|0|||
161478906|NCT03000439|583148997|FG003|Open Label Part 1|Other|0|||
161478907|NCT03000439|583148994|FG000|Open Label Part 1|Insufficient clinical response|16|||
161478908|NCT03000439|583148995|FG001|Open Label Part 1|Insufficient clinical response|0|||
161478909|NCT03000439|583148996|FG002|Open Label Part 1|Insufficient clinical response|0|||
161478910|NCT03000439|583148997|FG003|Open Label Part 1|Insufficient clinical response|0|||
161478911|NCT03000439|583148994|FG000|Open Label Part 2|Other|0|||
161478912|NCT03000439|583148995|FG001|Open Label Part 2|Other|5|||
161478913|NCT03000439|583148996|FG002|Open Label Part 2|Other|0|||
161478914|NCT03000439|583148997|FG003|Open Label Part 2|Other|0|||
161478915|NCT03000439|583148994|FG000|Open Label Part 2|Insufficient clinical response|0|||
161478916|NCT03000439|583148995|FG001|Open Label Part 2|Insufficient clinical response|12|||
161478917|NCT03000439|583148996|FG002|Open Label Part 2|Insufficient clinical response|0|||
161478918|NCT03000439|583148997|FG003|Open Label Part 2|Insufficient clinical response|0|||
161478919|NCT03000439|583148994|FG000|Double Blind Phase|Adverse Event|0|||
161478920|NCT03000439|583148995|FG001|Double Blind Phase|Adverse Event|0|||
161478921|NCT03000439|583148996|FG002|Double Blind Phase|Adverse Event|2|||
161478922|NCT03000439|583148997|FG003|Double Blind Phase|Adverse Event|1|||
161478923|NCT03000439|583148994|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
161478924|NCT03000439|583148995|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
161478925|NCT03000439|583148996|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
161478926|NCT03000439|583148997|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
161478927|NCT03000439|583148994|FG000|Double Blind Phase|Other|0|||
161478928|NCT03000439|583148995|FG001|Double Blind Phase|Other|0|||
161478929|NCT03000439|583148996|FG002|Double Blind Phase|Other|10|||
161478930|NCT03000439|583148997|FG003|Double Blind Phase|Other|11|||
161478931|NCT03000439|583148994|FG000|Double Blind Phase|Insufficient clinical response|0|||
161478932|NCT03000439|583148995|FG001|Double Blind Phase|Insufficient clinical response|0|||
161478933|NCT03000439|583148996|FG002|Double Blind Phase|Insufficient clinical response|0|||
161478934|NCT03000439|583148997|FG003|Double Blind Phase|Insufficient clinical response|2|||
161478935|NCT00980057|583148998|FG000|Overall Study|Death|13|||
161478936|NCT00980057|583148999|FG001|Overall Study|Death|3|||
161668733|NCT00394953|583839831|FG001|First Treatment Period|Lost to Follow-up|1|||
161668734|NCT00394953|583839830|FG000|First Treatment Period|Renal transplant|11|||
161668735|NCT00394953|583839831|FG001|First Treatment Period|Renal transplant|7|||
161668736|NCT00394953|583839830|FG000|First Treatment Period|Not defined|4|||
161921164|NCT01697579|584757182|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921165|NCT01697579|584757183|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921166|NCT01697579|584757184|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161478937|NCT00980057|583148998|FG000|Overall Study|Adverse Event|0|||
161478938|NCT00980057|583148999|FG001|Overall Study|Adverse Event|1|||
161478939|NCT00980057|583148998|FG000|Overall Study|Physician Decision|4|||
161478940|NCT00980057|583148999|FG001|Overall Study|Physician Decision|0|||
161478941|NCT00980057|583148998|FG000|Overall Study|Lost to Follow-up|1|||
161478942|NCT00980057|583148999|FG001|Overall Study|Lost to Follow-up|0|||
161478943|NCT00980057|583148998|FG000|Overall Study|Withdrawal by Subject|1|||
161478944|NCT00980057|583148999|FG001|Overall Study|Withdrawal by Subject|1|||
161478945|NCT00691015|583149003|FG000|Overall Study|Refused further treatment|1|||
161478946|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
161478947|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
161668737|NCT00394953|583839831|FG001|First Treatment Period|Not defined|1|||
161668738|NCT00394953|583839830|FG000|Second Treatment Period|Adverse Event|2|||
161668739|NCT00394953|583839831|FG001|Second Treatment Period|Adverse Event|5|||
161668740|NCT00394953|583839830|FG000|Second Treatment Period|Death|8|||
161668741|NCT00394953|583839831|FG001|Second Treatment Period|Death|4|||
161668742|NCT00394953|583839830|FG000|Second Treatment Period|Lack of Efficacy|9|||
161668743|NCT00394953|583839831|FG001|Second Treatment Period|Lack of Efficacy|47|||
161668744|NCT00394953|583839830|FG000|Second Treatment Period|Withdrawal by Subject|3|||
161668745|NCT00394953|583839831|FG001|Second Treatment Period|Withdrawal by Subject|3|||
161668746|NCT00394953|583839830|FG000|Second Treatment Period|Lost to Follow-up|0|||
161668747|NCT00394953|583839831|FG001|Second Treatment Period|Lost to Follow-up|1|||
161668748|NCT00394953|583839830|FG000|Second Treatment Period|Renal transplant|4|||
161668749|NCT00394953|583839831|FG001|Second Treatment Period|Renal transplant|6|||
161668750|NCT00394953|583839830|FG000|Second Treatment Period|Not defined|3|||
161478948|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
161478949|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
161478950|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478951|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478952|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478953|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478954|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478955|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478956|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
161478957|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
161478958|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
161478959|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
161478960|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
161478961|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478962|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478963|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478964|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478965|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478966|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478967|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
161478968|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
161478969|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
161478970|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
161478971|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
161478972|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478973|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478974|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478975|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478976|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478977|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478978|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
161478979|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478980|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478981|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478982|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
161478983|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478984|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478985|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161668751|NCT00394953|583839831|FG001|Second Treatment Period|Not defined|8|||
161668752|NCT02446886|583839838|FG000|Overall Study|Adverse Event|1|||
161815815|NCT01075516|584368791|FG000|Overall Study|Death|5|||
161815816|NCT01075516|584368792|FG001|Overall Study|Death|9|||
161815817|NCT01075516|584368791|FG000|Overall Study|Lost to Follow-up|10|||
161815818|NCT01075516|584368792|FG001|Overall Study|Lost to Follow-up|2|||
161815819|NCT01075516|584368791|FG000|Overall Study|Withdrawal by Subject|3|||
161815820|NCT01075516|584368792|FG001|Overall Study|Withdrawal by Subject|5|||
161815821|NCT02252016|584368793|FG000|Overall Study|Lost to Follow-up|2|||
161815822|NCT02252016|584368794|FG001|Overall Study|Lost to Follow-up|1|||
161478986|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161668753|NCT02446886|583839839|FG001|Overall Study|Adverse Event|3|||
161668754|NCT02446886|583839838|FG000|Overall Study|Withdrawal by Subject|1|||
161815823|NCT02252016|584368793|FG000|Overall Study|Physician Decision|1|||
161815824|NCT02252016|584368794|FG001|Overall Study|Physician Decision|0|||
161815825|NCT02252016|584368793|FG000|Overall Study|Withdrawal by Subject|0|||
161478987|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478988|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478989|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161478990|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
161478991|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
161478992|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
161478993|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
161478994|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161478995|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161478996|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161478997|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161478998|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161478999|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161479000|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
161479001|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
161479002|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
161479003|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
161479004|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
161479005|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479006|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479007|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479008|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479009|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479010|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479011|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
161479012|NCT01847274|583149004|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
161479013|NCT01847274|583149005|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
161479014|NCT01847274|583149006|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
161479015|NCT01847274|583149007|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
161479016|NCT01847274|583149008|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479017|NCT01847274|583149009|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479018|NCT01847274|583149010|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479019|NCT01847274|583149011|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479020|NCT01847274|583149012|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479021|NCT01847274|583149013|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479022|NCT01847274|583149014|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161479023|NCT01847274|583149004|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479024|NCT01847274|583149005|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479025|NCT01847274|583149006|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479026|NCT01847274|583149007|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479027|NCT01847274|583149008|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479028|NCT01847274|583149009|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
161479029|NCT01847274|583149010|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479030|NCT01847274|583149011|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161921167|NCT01697579|584757185|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921168|NCT01697579|584757186|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921169|NCT01697579|584757180|FG000|Base Study-Cycle 1|Protocol Violation|0|||
161921170|NCT01697579|584757181|FG001|Base Study-Cycle 1|Protocol Violation|0|||
161479031|NCT01847274|583149012|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161668755|NCT02446886|583839839|FG001|Overall Study|Withdrawal by Subject|1|||
161668756|NCT03021954|583839847|FG000|Overall Study|Lost to Follow-up|10|||
161668757|NCT03021954|583839848|FG001|Overall Study|Lost to Follow-up|43|||
161668758|NCT03021954|583839847|FG000|Overall Study|Subjects had avulsion trauma|4|||
161668759|NCT03021954|583839848|FG001|Overall Study|Subjects had avulsion trauma|1|||
161479032|NCT01847274|583149013|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479033|NCT01847274|583149014|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
161479034|NCT01847274|583149004|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479035|NCT01847274|583149005|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479036|NCT01847274|583149006|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479037|NCT01847274|583149007|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479038|NCT01847274|583149008|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
161479039|NCT01847274|583149009|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479040|NCT01847274|583149010|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161668760|NCT02196714|583839851|FG000|Overall Study|Protocol Violation|0|||
161921171|NCT01697579|584757182|FG002|Base Study-Cycle 1|Protocol Violation|0|||
161921172|NCT01697579|584757183|FG003|Base Study-Cycle 1|Protocol Violation|0|||
161479041|NCT01847274|583149011|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479042|NCT01847274|583149012|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479043|NCT01847274|583149013|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479044|NCT01847274|583149014|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161479045|NCT01847274|583149004|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479046|NCT01847274|583149005|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479047|NCT01847274|583149006|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479048|NCT01847274|583149007|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479049|NCT01847274|583149008|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479050|NCT01847274|583149009|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479051|NCT01847274|583149010|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
161479052|NCT01847274|583149011|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479053|NCT01847274|583149012|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479054|NCT01847274|583149013|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479055|NCT01847274|583149014|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
161479056|NCT01847274|583149004|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479057|NCT01847274|583149005|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479058|NCT01847274|583149006|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479059|NCT01847274|583149007|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479060|NCT01847274|583149008|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479061|NCT01847274|583149009|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479062|NCT01847274|583149010|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
161479063|NCT01847274|583149011|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479064|NCT01847274|583149012|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479065|NCT01847274|583149013|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479066|NCT01847274|583149014|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
161479067|NCT01847274|583149004|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479068|NCT01847274|583149005|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479069|NCT01847274|583149006|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479070|NCT01847274|583149007|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479071|NCT01847274|583149008|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479072|NCT01847274|583149009|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479073|NCT01847274|583149010|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
161479074|NCT01847274|583149011|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479075|NCT01847274|583149012|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479076|NCT01847274|583149013|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479077|NCT01847274|583149014|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161479078|NCT01847274|583149004|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479079|NCT01847274|583149005|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479080|NCT01847274|583149006|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479081|NCT01847274|583149007|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479082|NCT01847274|583149008|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479083|NCT01847274|583149009|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479084|NCT01847274|583149010|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161479085|NCT01847274|583149011|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
161479086|NCT01847274|583149012|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
161479087|NCT01847274|583149013|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
161479088|NCT01847274|583149014|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
161479089|NCT01847274|583149004|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479090|NCT01847274|583149005|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479091|NCT01847274|583149006|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479092|NCT01847274|583149007|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479093|NCT01847274|583149008|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479094|NCT01847274|583149009|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479095|NCT01847274|583149010|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479096|NCT01847274|583149011|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
161479097|NCT01847274|583149012|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479098|NCT01847274|583149013|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
161479099|NCT01847274|583149014|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
161479100|NCT01847274|583149004|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479101|NCT01847274|583149005|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479102|NCT01847274|583149006|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479103|NCT01847274|583149007|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479104|NCT01847274|583149008|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479105|NCT01847274|583149009|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479106|NCT01847274|583149010|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479107|NCT01847274|583149011|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
161479108|NCT01847274|583149012|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
161479109|NCT01847274|583149013|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
161479110|NCT01847274|583149014|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
161479111|NCT01847274|583149004|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479112|NCT01847274|583149005|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479113|NCT01847274|583149006|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479114|NCT01847274|583149007|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161578805|NCT01787760|583506595|FG002|Overall Study|Lens handling difficulty|0|||
161578806|NCT01787760|583506593|FG000|Overall Study|Protocol Violation|6|||
161578807|NCT01787760|583506594|FG001|Overall Study|Protocol Violation|0|||
161578808|NCT01787760|583506595|FG002|Overall Study|Protocol Violation|1|||
161578809|NCT01787760|583506593|FG000|Overall Study|Withdrawal by Subject|5|||
161578810|NCT01787760|583506594|FG001|Overall Study|Withdrawal by Subject|1|||
161578811|NCT01787760|583506595|FG002|Overall Study|Withdrawal by Subject|2|||
161578812|NCT01787760|583506593|FG000|Overall Study|Lost to Follow-up|1|||
161578813|NCT01787760|583506594|FG001|Overall Study|Lost to Follow-up|0|||
161578814|NCT01787760|583506595|FG002|Overall Study|Lost to Follow-up|1|||
161578815|NCT01787760|583506593|FG000|Overall Study|Stroke|1|||
161578816|NCT01787760|583506594|FG001|Overall Study|Stroke|0|||
161578817|NCT01787760|583506595|FG002|Overall Study|Stroke|0|||
161578818|NCT01787760|583506593|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
161578819|NCT01787760|583506594|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
161578820|NCT01787760|583506595|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
161578821|NCT01787760|583506593|FG000|Overall Study|Unsatisfactory physiological response|2|||
161578822|NCT01787760|583506594|FG001|Overall Study|Unsatisfactory physiological response|4|||
161578823|NCT01787760|583506595|FG002|Overall Study|Unsatisfactory physiological response|0|||
161578824|NCT01787760|583506593|FG000|Overall Study|Unsatisfactory visual response|1|||
161578825|NCT01787760|583506594|FG001|Overall Study|Unsatisfactory visual response|1|||
161578826|NCT01787760|583506595|FG002|Overall Study|Unsatisfactory visual response|0|||
161578827|NCT01787760|583506593|FG000|Overall Study|Near vision blur|1|||
161578828|NCT01787760|583506594|FG001|Overall Study|Near vision blur|0|||
161578829|NCT01787760|583506595|FG002|Overall Study|Near vision blur|0|||
161578830|NCT01353963|583506596|FG000|Overall Study|Adverse Event|2|||
161578831|NCT03473340|583506597|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
161578832|NCT03473340|583506598|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
161578833|NCT03473340|583506597|FG000|Overall Study|Withdrawal by Subject|1|||
161578834|NCT03473340|583506598|FG001|Overall Study|Withdrawal by Subject|0|||
161578835|NCT03473340|583506597|FG000|Overall Study|Lost to Follow-up|1|||
161578836|NCT03473340|583506598|FG001|Overall Study|Lost to Follow-up|2|||
161578837|NCT02079844|583506599|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
161578838|NCT02079844|583506600|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
161578839|NCT02079844|583506601|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
161578840|NCT02079844|583506599|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
161578841|NCT02079844|583506600|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
161578842|NCT02079844|583506601|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
161578843|NCT01420549|583506602|FG000|Overall Study|Adverse Event|1|||
161578844|NCT01420549|583506603|FG001|Overall Study|Adverse Event|1|||
161578845|NCT01420549|583506602|FG000|Overall Study|Lost to Follow-up|2|||
161578846|NCT01420549|583506603|FG001|Overall Study|Lost to Follow-up|2|||
161578847|NCT01420549|583506602|FG000|Overall Study|Protocol Violation|0|||
161578848|NCT01420549|583506603|FG001|Overall Study|Protocol Violation|1|||
161578849|NCT01420549|583506602|FG000|Overall Study|Non-adherence to medication|4|||
161578850|NCT01420549|583506603|FG001|Overall Study|Non-adherence to medication|1|||
161578851|NCT03394885|583506604|FG000|Overall Study|Adverse Event|4|||
161578852|NCT03394885|583506604|FG000|Overall Study|Lack of Efficacy|1|||
161578853|NCT03394885|583506604|FG000|Overall Study|Physician Decision|1|||
161578854|NCT03394885|583506604|FG000|Overall Study|Withdrawal by Subject|8|||
161578855|NCT03394885|583506604|FG000|Overall Study|Alternative Therapy|1|||
161578856|NCT00203411|583506605|FG000|Follow-up|Progressive Disease|4|||
161578857|NCT04980755|583506606|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
161578858|NCT04980755|583506606|FG000|Body Reprogramming Courses|Work commitment|2|||
161578859|NCT04980755|583506606|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
161479115|NCT01847274|583149008|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161578860|NCT04980755|583506606|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
161578861|NCT00632424|583506611|FG000|Overall Study|Disease Progression|17|||
161578862|NCT00632424|583506611|FG000|Overall Study|Study Drug Toxicity|1|||
161578863|NCT02531113|583506612|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
161479116|NCT01847274|583149009|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479117|NCT01847274|583149010|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479118|NCT01847274|583149011|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479119|NCT01847274|583149012|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161479120|NCT01847274|583149013|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
161479121|NCT01847274|583149014|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161815826|NCT02252016|584368794|FG001|Overall Study|Withdrawal by Subject|2|||
161815827|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
161815828|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
161815829|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
161815830|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
161815831|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
161815832|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815833|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815834|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815835|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815836|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815837|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815838|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815839|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815840|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815841|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815842|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815843|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815844|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815845|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815846|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
161479122|NCT01706146|583149015|FG000|Overall Study|Withdrawal by Subject|1|||
161815847|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815848|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815849|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815850|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815851|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815852|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815853|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815854|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
161815855|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815856|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815857|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815858|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815859|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815860|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815861|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815862|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815863|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815864|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161479123|NCT01706146|583149015|FG000|Overall Study|Adverse Event|3|||
161479124|NCT01706146|583149015|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
161479125|NCT02582983|583149017|FG000|Overall Study|Death|3|||
161479126|NCT02582983|583149017|FG000|Overall Study|Withdrawal by Subject|2|||
161479127|NCT02582983|583149017|FG000|Overall Study|Adverse Event|1|||
161479128|NCT02059395|583149018|FG000|Overall Study|Lost to Follow-up|2|||
161479129|NCT02059395|583149019|FG001|Overall Study|Lost to Follow-up|4|||
161479130|NCT05209360|583149020|FG000|Overall Study|Withdrawal by Subject|0|||
161479131|NCT05209360|583149021|FG001|Overall Study|Withdrawal by Subject|0|||
161479132|NCT05209360|583149022|FG002|Overall Study|Withdrawal by Subject|1|||
161479133|NCT05209360|583149023|FG003|Overall Study|Withdrawal by Subject|0|||
161479134|NCT05209360|583149024|FG004|Overall Study|Withdrawal by Subject|0|||
161479135|NCT05209360|583149025|FG005|Overall Study|Withdrawal by Subject|0|||
161479136|NCT02021331|583149026|FG000|Overall Study|Adverse Event|0|||
161479137|NCT02021331|583149027|FG001|Overall Study|Adverse Event|2|||
161479138|NCT01488370|583149028|FG000|Overall Study|Protocol Violation|0|||
161479139|NCT01488370|583149029|FG001|Overall Study|Protocol Violation|1|||
161479140|NCT01488370|583149030|FG002|Overall Study|Protocol Violation|1|||
161479141|NCT02340975|583149044|FG000|Overall Study|Death|6|||
161479142|NCT02340975|583149045|FG001|Overall Study|Death|23|||
161479143|NCT02340975|583149046|FG002|Overall Study|Death|21|||
161479144|NCT02340975|583149047|FG003|Overall Study|Death|7|||
161479145|NCT02340975|583149048|FG004|Overall Study|Death|21|||
161578864|NCT02531113|583506612|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
161815865|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815866|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161668761|NCT02196714|583839852|FG001|Overall Study|Protocol Violation|0|||
161668762|NCT02196714|583839853|FG002|Overall Study|Protocol Violation|1|||
161668763|NCT02196714|583839854|FG003|Overall Study|Protocol Violation|0|||
161668764|NCT01592864|583839856|FG000|Overall Study|Withdrawal by Subject|0|||
161668765|NCT01592864|583839857|FG001|Overall Study|Withdrawal by Subject|1|||
161668766|NCT04677179|583839862|FG000|Induction Treatment Period|Adverse Event|1|||
161668767|NCT04677179|583839863|FG001|Induction Treatment Period|Adverse Event|0|||
161668768|NCT04677179|583839864|FG002|Induction Treatment Period|Adverse Event|0|||
161668769|NCT04677179|583839865|FG003|Induction Treatment Period|Adverse Event|0|||
161668770|NCT04677179|583839866|FG004|Induction Treatment Period|Adverse Event|0|||
161668771|NCT04677179|583839867|FG005|Induction Treatment Period|Adverse Event|0|||
161668772|NCT04677179|583839868|FG006|Induction Treatment Period|Adverse Event|0|||
161668773|NCT04677179|583839869|FG007|Induction Treatment Period|Adverse Event|0|||
161668774|NCT04677179|583839870|FG008|Induction Treatment Period|Adverse Event|0|||
161668775|NCT04677179|583839871|FG009|Induction Treatment Period|Adverse Event|0|||
161668776|NCT04677179|583839862|FG000|Induction Treatment Period|Physician Decision|1|||
161668777|NCT04677179|583839863|FG001|Induction Treatment Period|Physician Decision|0|||
161668778|NCT04677179|583839864|FG002|Induction Treatment Period|Physician Decision|1|||
161668779|NCT04677179|583839865|FG003|Induction Treatment Period|Physician Decision|0|||
161668780|NCT04677179|583839866|FG004|Induction Treatment Period|Physician Decision|0|||
161668781|NCT04677179|583839867|FG005|Induction Treatment Period|Physician Decision|0|||
161668782|NCT04677179|583839868|FG006|Induction Treatment Period|Physician Decision|0|||
161668783|NCT04677179|583839869|FG007|Induction Treatment Period|Physician Decision|0|||
161668784|NCT04677179|583839870|FG008|Induction Treatment Period|Physician Decision|0|||
161668785|NCT04677179|583839871|FG009|Induction Treatment Period|Physician Decision|0|||
161668786|NCT04677179|583839862|FG000|Induction Treatment Period|Protocol Violation|0|||
161668787|NCT04677179|583839863|FG001|Induction Treatment Period|Protocol Violation|1|||
161668788|NCT04677179|583839864|FG002|Induction Treatment Period|Protocol Violation|0|||
161668789|NCT04677179|583839865|FG003|Induction Treatment Period|Protocol Violation|0|||
161668790|NCT04677179|583839866|FG004|Induction Treatment Period|Protocol Violation|0|||
161668791|NCT04677179|583839867|FG005|Induction Treatment Period|Protocol Violation|0|||
161668792|NCT04677179|583839868|FG006|Induction Treatment Period|Protocol Violation|0|||
161668793|NCT04677179|583839869|FG007|Induction Treatment Period|Protocol Violation|0|||
161668794|NCT04677179|583839870|FG008|Induction Treatment Period|Protocol Violation|0|||
161668795|NCT04677179|583839871|FG009|Induction Treatment Period|Protocol Violation|0|||
161668796|NCT04677179|583839862|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
161668797|NCT04677179|583839863|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
161815867|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815868|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815869|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815870|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815871|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815872|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161479146|NCT02340975|583149049|FG005|Overall Study|Death|13|||
161479147|NCT02340975|583149044|FG000|Overall Study|Lost to Follow-up|0|||
161479148|NCT02340975|583149045|FG001|Overall Study|Lost to Follow-up|0|||
161479149|NCT02340975|583149046|FG002|Overall Study|Lost to Follow-up|0|||
161479150|NCT02340975|583149047|FG003|Overall Study|Lost to Follow-up|0|||
161479151|NCT02340975|583149048|FG004|Overall Study|Lost to Follow-up|2|||
161479152|NCT02340975|583149049|FG005|Overall Study|Lost to Follow-up|0|||
161479153|NCT02340975|583149044|FG000|Overall Study|Withdrawal by Subject|0|||
161479154|NCT02340975|583149045|FG001|Overall Study|Withdrawal by Subject|0|||
161479155|NCT02340975|583149046|FG002|Overall Study|Withdrawal by Subject|3|||
161479156|NCT02340975|583149047|FG003|Overall Study|Withdrawal by Subject|3|||
161479157|NCT02340975|583149048|FG004|Overall Study|Withdrawal by Subject|2|||
161479158|NCT02340975|583149049|FG005|Overall Study|Withdrawal by Subject|0|||
161479159|NCT02340975|583149044|FG000|Overall Study|Other|0|||
161815873|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815874|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815875|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815876|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815877|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815878|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161921173|NCT01697579|584757184|FG004|Base Study-Cycle 1|Protocol Violation|3|||
161479160|NCT02340975|583149045|FG001|Overall Study|Other|4|||
161479161|NCT02340975|583149046|FG002|Overall Study|Other|0|||
161479162|NCT02340975|583149047|FG003|Overall Study|Other|2|||
161479163|NCT02340975|583149048|FG004|Overall Study|Other|0|||
161479164|NCT02340975|583149049|FG005|Overall Study|Other|6|||
161668798|NCT04677179|583839864|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
161668799|NCT04677179|583839865|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
161668800|NCT04677179|583839866|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
161668801|NCT04677179|583839867|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
161815879|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161668802|NCT04677179|583839868|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
161668803|NCT04677179|583839869|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
161668804|NCT04677179|583839870|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
161668805|NCT04677179|583839871|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
161668806|NCT04677179|583839862|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
161668807|NCT04677179|583839863|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
161668808|NCT04677179|583839864|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
161668809|NCT04677179|583839865|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
161668810|NCT04677179|583839866|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
161668811|NCT04677179|583839867|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
161668812|NCT04677179|583839868|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
161668813|NCT04677179|583839869|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
161668814|NCT04677179|583839870|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
161668815|NCT04677179|583839871|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
161668816|NCT04677179|583839862|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
161668817|NCT04677179|583839863|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
161668818|NCT04677179|583839864|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
161668819|NCT04677179|583839865|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
161668820|NCT04677179|583839866|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
161668821|NCT04677179|583839867|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
161668822|NCT04677179|583839868|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
161668823|NCT04677179|583839869|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
161668824|NCT04677179|583839870|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
161668825|NCT04677179|583839871|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
161668826|NCT04677179|583839862|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668827|NCT04677179|583839863|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668828|NCT04677179|583839864|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668829|NCT04677179|583839865|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
161479165|NCT01007812|583149052|FG000|Period 1, One Week|Lost to Follow-up|0|||
161479166|NCT01007812|583149053|FG001|Period 1, One Week|Lost to Follow-up|1|||
161479167|NCT01007812|583149052|FG000|Period 1, One Week|Discomfort|1|||
161479168|NCT01007812|583149053|FG001|Period 1, One Week|Discomfort|0|||
161668830|NCT04677179|583839866|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668831|NCT04677179|583839867|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668832|NCT04677179|583839868|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668833|NCT04677179|583839869|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668834|NCT04677179|583839870|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
161815880|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
161815881|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815882|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161479169|NCT03948581|583149054|FG000|Overall Study|Lost to Follow-up|0|||
161479170|NCT03948581|583149055|FG001|Overall Study|Lost to Follow-up|1|||
161479171|NCT03173313|583149056|FG000|Overall Study|Lost to Follow-up|2|||
161479172|NCT03173313|583149057|FG001|Overall Study|Lost to Follow-up|3|||
161479173|NCT03173313|583149056|FG000|Overall Study|Withdrawal by Subject|0|||
161479174|NCT03173313|583149057|FG001|Overall Study|Withdrawal by Subject|1|||
161479175|NCT03173313|583149056|FG000|Overall Study|Death|5|||
161479176|NCT03173313|583149057|FG001|Overall Study|Death|0|||
161479177|NCT03173313|583149056|FG000|Overall Study|Physician Decision|1|||
161479178|NCT03173313|583149057|FG001|Overall Study|Physician Decision|0|||
161479179|NCT03173313|583149056|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
161479180|NCT03173313|583149057|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
161479181|NCT03173313|583149056|FG000|Overall Study|Bone Fracture|1|||
161815883|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815884|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815885|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815886|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815887|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815888|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815889|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161479182|NCT03173313|583149057|FG001|Overall Study|Bone Fracture|0|||
161479183|NCT01876420|583149058|FG000|Overall Study|Missed 30 day visit|1|||
161479184|NCT00963937|583149061|FG000|Overall Study|Protocol Violation|1|||
161479185|NCT00963937|583149062|FG001|Overall Study|Protocol Violation|1|||
161479186|NCT00963937|583149063|FG002|Overall Study|Protocol Violation|0|||
161479187|NCT00963937|583149061|FG000|Overall Study|Physician Decision|18|||
161668835|NCT04677179|583839871|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
161668836|NCT04677179|583839862|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
161668837|NCT04677179|583839863|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
161668838|NCT04677179|583839864|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
161815890|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161479188|NCT00963937|583149062|FG001|Overall Study|Physician Decision|10|||
161479189|NCT00963937|583149063|FG002|Overall Study|Physician Decision|4|||
161479190|NCT02106975|583149064|FG000|Overall Study|Death|25|||
161479191|NCT02106975|583149065|FG001|Overall Study|Death|39|||
161479192|NCT00622401|583149066|FG000|Overall Study|Disease progression prior to treatment|3|||
161479193|NCT00622401|583149067|FG001|Overall Study|Disease progression prior to treatment|2|||
161479194|NCT00622401|583149068|FG002|Overall Study|Disease progression prior to treatment|0|||
161479195|NCT03546062|583149069|FG000|Overall Study|Adverse Event|6|||
161479196|NCT03546062|583149070|FG001|Overall Study|Adverse Event|5|||
161479197|NCT03546062|583149071|FG002|Overall Study|Adverse Event|8|||
161479198|NCT00181155|583149072|FG000|Overall Study|Physician Decision|1|||
161479199|NCT00181155|583149073|FG001|Overall Study|Physician Decision|0|||
161479200|NCT00181155|583149072|FG000|Overall Study|Withdrawal by Subject|1|||
161479201|NCT00181155|583149073|FG001|Overall Study|Withdrawal by Subject|0|||
161479202|NCT02572401|583149074|FG000|Overall Study|Lost to Follow-up|5|||
161479203|NCT02572401|583149075|FG001|Overall Study|Lost to Follow-up|8|||
161479204|NCT02572401|583149076|FG002|Overall Study|Lost to Follow-up|9|||
161479205|NCT02572401|583149077|FG003|Overall Study|Lost to Follow-up|9|||
161479206|NCT02572401|583149074|FG000|Overall Study|Death|0|||
161479207|NCT02572401|583149075|FG001|Overall Study|Death|0|||
161479208|NCT02572401|583149076|FG002|Overall Study|Death|0|||
161479209|NCT02572401|583149077|FG003|Overall Study|Death|1|||
161479210|NCT01768286|583149083|FG000|Overall Study|Randomized But Not Treated|0|||
161479211|NCT01768286|583149084|FG001|Overall Study|Randomized But Not Treated|0|||
161479212|NCT01768286|583149085|FG002|Overall Study|Randomized But Not Treated|1|||
161479213|NCT01768286|583149086|FG003|Overall Study|Randomized But Not Treated|0|||
161479214|NCT01768286|583149083|FG000|Overall Study|Lack of Efficacy|7|||
161479215|NCT01768286|583149084|FG001|Overall Study|Lack of Efficacy|4|||
161479216|NCT01768286|583149085|FG002|Overall Study|Lack of Efficacy|0|||
161479217|NCT01768286|583149086|FG003|Overall Study|Lack of Efficacy|1|||
161479218|NCT01768286|583149083|FG000|Overall Study|Withdrew Consent|0|||
161479219|NCT01768286|583149084|FG001|Overall Study|Withdrew Consent|0|||
161479220|NCT01768286|583149085|FG002|Overall Study|Withdrew Consent|1|||
161479221|NCT01768286|583149086|FG003|Overall Study|Withdrew Consent|0|||
161479222|NCT02243696|583149087|FG000|Overall Study|Death|282|||
161479223|NCT02243696|583149087|FG000|Overall Study|Withdrawal by Subject|79|||
161479224|NCT02243696|583149087|FG000|Overall Study|Lost to Follow-up|57|||
161479225|NCT02243696|583149087|FG000|Overall Study|Subject No Longer has Study System|42|||
161479226|NCT02243696|583149087|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
161479227|NCT02243696|583149087|FG000|Overall Study|Study Terminated for EP PASSION|961|||
161479228|NCT00622284|583149088|FG000|Overall Study|Lack of Efficacy|45|||
161479229|NCT00622284|583149089|FG001|Overall Study|Lack of Efficacy|15|||
161479230|NCT00622284|583149088|FG000|Overall Study|Adverse Event|61|||
161479231|NCT00622284|583149089|FG001|Overall Study|Adverse Event|90|||
161479232|NCT00622284|583149088|FG000|Overall Study|Protocol Violation|12|||
161479233|NCT00622284|583149089|FG001|Overall Study|Protocol Violation|5|||
161479234|NCT00622284|583149088|FG000|Overall Study|Lost to Follow-up|11|||
161479235|NCT00622284|583149089|FG001|Overall Study|Lost to Follow-up|13|||
161479236|NCT00622284|583149088|FG000|Overall Study|Withdrawal by Subject|27|||
161479237|NCT00622284|583149089|FG001|Overall Study|Withdrawal by Subject|24|||
161479238|NCT00622284|583149088|FG000|Overall Study|Other reason (not specified)|33|||
161479239|NCT00622284|583149089|FG001|Overall Study|Other reason (not specified)|24|||
161479240|NCT02935842|583149090|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
161479241|NCT02935842|583149091|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
161479242|NCT02935842|583149092|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
161479243|NCT02935842|583149093|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
161479244|NCT02935842|583149090|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
161479245|NCT02935842|583149091|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
161479246|NCT02935842|583149092|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
161578865|NCT02531113|583506612|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
161578866|NCT02531113|583506612|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
161815891|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815892|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815893|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161479247|NCT02935842|583149093|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
161479248|NCT02935842|583149090|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
161479249|NCT02935842|583149091|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
161479250|NCT02935842|583149092|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
161479251|NCT02935842|583149093|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
161479252|NCT02935842|583149090|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
161479253|NCT02935842|583149091|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
161479254|NCT02935842|583149092|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
161479255|NCT02935842|583149093|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
161479256|NCT02935842|583149090|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
161479257|NCT02935842|583149091|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
161479258|NCT02935842|583149092|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
161479259|NCT02935842|583149093|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
161479260|NCT03344796|583149096|FG000|Overall Study|Lost to Follow-up|0|||
161479261|NCT03344796|583149097|FG001|Overall Study|Lost to Follow-up|0|||
161479262|NCT03344796|583149098|FG002|Overall Study|Lost to Follow-up|0|||
161479263|NCT03344796|583149099|FG003|Overall Study|Lost to Follow-up|0|||
161479264|NCT03344796|583149100|FG004|Overall Study|Lost to Follow-up|0|||
161479265|NCT03344796|583149101|FG005|Overall Study|Lost to Follow-up|2|||
161479266|NCT00915278|583149102|FG000|Overall Study|Death|1|||
161479267|NCT00915278|583149103|FG001|Overall Study|Death|0|||
161479268|NCT00915278|583149104|FG002|Overall Study|Death|0|||
161479269|NCT00915278|583149105|FG003|Overall Study|Death|0|||
161479270|NCT00915278|583149106|FG004|Overall Study|Death|0|||
161479271|NCT00915278|583149107|FG005|Overall Study|Death|0|||
161479272|NCT00915278|583149102|FG000|Overall Study|Lost to Follow-up|0|||
161479273|NCT00915278|583149103|FG001|Overall Study|Lost to Follow-up|1|||
161479274|NCT00915278|583149104|FG002|Overall Study|Lost to Follow-up|0|||
161479275|NCT00915278|583149105|FG003|Overall Study|Lost to Follow-up|0|||
161479276|NCT00915278|583149106|FG004|Overall Study|Lost to Follow-up|0|||
161479277|NCT00915278|583149107|FG005|Overall Study|Lost to Follow-up|0|||
161479278|NCT00915278|583149102|FG000|Overall Study|Withdrawal by Subject|0|||
161479279|NCT00915278|583149103|FG001|Overall Study|Withdrawal by Subject|1|||
161479280|NCT00915278|583149104|FG002|Overall Study|Withdrawal by Subject|0|||
161479281|NCT00915278|583149105|FG003|Overall Study|Withdrawal by Subject|0|||
161479282|NCT00915278|583149106|FG004|Overall Study|Withdrawal by Subject|1|||
161479283|NCT00915278|583149107|FG005|Overall Study|Withdrawal by Subject|4|||
161479284|NCT00915278|583149102|FG000|Overall Study|Adverse Event|4|||
161479285|NCT00915278|583149103|FG001|Overall Study|Adverse Event|1|||
161479286|NCT00915278|583149104|FG002|Overall Study|Adverse Event|0|||
161479287|NCT00915278|583149105|FG003|Overall Study|Adverse Event|0|||
161479288|NCT00915278|583149106|FG004|Overall Study|Adverse Event|0|||
161479289|NCT00915278|583149107|FG005|Overall Study|Adverse Event|0|||
161479290|NCT00915278|583149102|FG000|Overall Study|Progressive disease/clinical progression|0|||
161479291|NCT00915278|583149103|FG001|Overall Study|Progressive disease/clinical progression|0|||
161479292|NCT00915278|583149104|FG002|Overall Study|Progressive disease/clinical progression|0|||
161479293|NCT00915278|583149105|FG003|Overall Study|Progressive disease/clinical progression|3|||
161479294|NCT00915278|583149106|FG004|Overall Study|Progressive disease/clinical progression|1|||
161479295|NCT00915278|583149107|FG005|Overall Study|Progressive disease/clinical progression|2|||
161479296|NCT00915278|583149102|FG000|Overall Study|Infusion related AEs|0|||
161479297|NCT00915278|583149103|FG001|Overall Study|Infusion related AEs|0|||
161479298|NCT00915278|583149104|FG002|Overall Study|Infusion related AEs|0|||
161479299|NCT00915278|583149105|FG003|Overall Study|Infusion related AEs|0|||
161479300|NCT00915278|583149106|FG004|Overall Study|Infusion related AEs|0|||
161479301|NCT00915278|583149107|FG005|Overall Study|Infusion related AEs|2|||
161479302|NCT00915278|583149102|FG000|Overall Study|Admission to hospice|0|||
161479303|NCT00915278|583149103|FG001|Overall Study|Admission to hospice|0|||
161479304|NCT00915278|583149104|FG002|Overall Study|Admission to hospice|1|||
161479305|NCT00915278|583149105|FG003|Overall Study|Admission to hospice|0|||
161479306|NCT00915278|583149106|FG004|Overall Study|Admission to hospice|0|||
161479307|NCT00915278|583149107|FG005|Overall Study|Admission to hospice|0|||
161479308|NCT02412618|583149108|FG000|Overall Study|Withdrawal by Subject|1|||
161479309|NCT02412618|583149109|FG001|Overall Study|Withdrawal by Subject|1|||
161479310|NCT02412618|583149108|FG000|Overall Study|Expulsion|1|||
161479311|NCT02412618|583149109|FG001|Overall Study|Expulsion|1|||
161479312|NCT01201850|583149111|FG000|Overall Study|Tumor progression|4|||
161479313|NCT03137537|583149112|FG000|Overall Study|Adverse Event|0|||
161479314|NCT03137537|583149113|FG001|Overall Study|Adverse Event|1|||
161578867|NCT02531113|583506612|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
161578868|NCT02531113|583506612|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
161578869|NCT02531113|583506612|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
161479315|NCT04066023|583149114|FG000|Overall Study|Adverse Event|0|||
161479316|NCT04066023|583149115|FG001|Overall Study|Adverse Event|0|||
161479317|NCT04066023|583149116|FG002|Overall Study|Adverse Event|1|||
161479318|NCT04066023|583149114|FG000|Overall Study|Sponsor decision|3|||
161479319|NCT04066023|583149115|FG001|Overall Study|Sponsor decision|6|||
161479320|NCT04066023|583149116|FG002|Overall Study|Sponsor decision|2|||
161479321|NCT04066023|583149114|FG000|Overall Study|Physician Decision|0|||
161479322|NCT04066023|583149115|FG001|Overall Study|Physician Decision|0|||
161479323|NCT04066023|583149116|FG002|Overall Study|Physician Decision|1|||
161479324|NCT04066023|583149114|FG000|Overall Study|Lost to Follow-up|0|||
161479325|NCT04066023|583149115|FG001|Overall Study|Lost to Follow-up|1|||
161479326|NCT04066023|583149116|FG002|Overall Study|Lost to Follow-up|1|||
161578870|NCT02531113|583506612|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
161479327|NCT04066023|583149114|FG000|Overall Study|Noncompliance|0|||
161479328|NCT04066023|583149115|FG001|Overall Study|Noncompliance|1|||
161668839|NCT04677179|583839865|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
161668840|NCT04677179|583839866|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
161668841|NCT04677179|583839867|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
161668842|NCT04677179|583839868|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
161479329|NCT04066023|583149116|FG002|Overall Study|Noncompliance|1|||
161479330|NCT01552694|583149117|FG000|Overall Study|Lost to Follow-up|0|||
161479331|NCT01552694|583149118|FG001|Overall Study|Lost to Follow-up|1|||
161479332|NCT01552694|583149117|FG000|Overall Study|Protocol Violation|0|||
161479333|NCT01552694|583149118|FG001|Overall Study|Protocol Violation|1|||
161479334|NCT03338010|583149120|FG000|Overall Study|Withdrawal by Subject|14|||
161479335|NCT03338010|583149121|FG001|Overall Study|Withdrawal by Subject|8|||
161479336|NCT03338010|583149120|FG000|Overall Study|Lost to Follow-up|4|||
161479337|NCT03338010|583149121|FG001|Overall Study|Lost to Follow-up|2|||
161479338|NCT03338010|583149120|FG000|Overall Study|Adverse Event|3|||
161479339|NCT03338010|583149121|FG001|Overall Study|Adverse Event|2|||
161479340|NCT03338010|583149120|FG000|Overall Study|Physician Decision|2|||
161479341|NCT03338010|583149121|FG001|Overall Study|Physician Decision|2|||
161668843|NCT04677179|583839869|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
161668844|NCT04677179|583839870|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
161668845|NCT04677179|583839871|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
161668846|NCT04677179|583839862|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161668847|NCT04677179|583839863|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161668848|NCT04677179|583839864|FG002|Extension Treatment Period|Lack of Efficacy|0|||
161668849|NCT04677179|583839865|FG003|Extension Treatment Period|Lack of Efficacy|0|||
161668850|NCT04677179|583839866|FG004|Extension Treatment Period|Lack of Efficacy|0|||
161668851|NCT04677179|583839867|FG005|Extension Treatment Period|Lack of Efficacy|0|||
161668852|NCT04677179|583839868|FG006|Extension Treatment Period|Lack of Efficacy|6|||
161668853|NCT04677179|583839869|FG007|Extension Treatment Period|Lack of Efficacy|0|||
161668854|NCT04677179|583839870|FG008|Extension Treatment Period|Lack of Efficacy|0|||
161479342|NCT03338010|583149120|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161479343|NCT03338010|583149121|FG001|Overall Study|Non-Compliance with Study Drug|3|||
161479344|NCT03338010|583149120|FG000|Overall Study|Protocol Violation|0|||
161479345|NCT03338010|583149121|FG001|Overall Study|Protocol Violation|1|||
161479346|NCT00629707|583149126|FG000|Overall Study|Withdrawal by Subject|0|||
161479347|NCT00629707|583149127|FG001|Overall Study|Withdrawal by Subject|1|||
161479348|NCT00629707|583149126|FG000|Overall Study|Physician Decision|0|||
161479349|NCT00629707|583149127|FG001|Overall Study|Physician Decision|1|||
161479350|NCT00293033|583149128|FG000|Open-label Titration Period|Adverse Event|10|||
161668855|NCT04677179|583839871|FG009|Extension Treatment Period|Lack of Efficacy|0|||
161668856|NCT04677179|583839862|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
161668857|NCT04677179|583839863|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161668858|NCT04677179|583839864|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161668859|NCT04677179|583839865|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
161668860|NCT04677179|583839866|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
161815894|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815895|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815896|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815897|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815898|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815899|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815900|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815901|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815902|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815903|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815904|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815905|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161815906|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815907|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
161815908|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161815909|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161815910|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815911|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815912|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815913|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161479351|NCT00293033|583149128|FG000|Open-label Titration Period|Death|3|||
161668861|NCT04677179|583839867|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
161479352|NCT00293033|583149128|FG000|Open-label Titration Period|Lack of Efficacy|5|||
161479353|NCT00293033|583149128|FG000|Open-label Titration Period|Protocol Violation|2|||
161668862|NCT04677179|583839868|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
161815914|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815915|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161479354|NCT00293033|583149128|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
161479355|NCT00293033|583149128|FG000|Open-label Titration Period|Noncompliance and other|27|||
161479356|NCT00293033|583149128|FG000|Double-blind Treatment Period|Adverse Event|3|||
161479357|NCT00293033|583149128|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
161479358|NCT00293033|583149128|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
161479359|NCT00293033|583149128|FG000|Double-blind Treatment Period|Noncompliance|4|||
161479360|NCT00453063|583149129|FG000|Overall Study|Adverse Event|1|||
161479361|NCT00453063|583149130|FG001|Overall Study|Adverse Event|2|||
161479362|NCT00453063|583149129|FG000|Overall Study|Withdrawal by Subject|1|||
161479363|NCT00453063|583149130|FG001|Overall Study|Withdrawal by Subject|1|||
161479364|NCT00453063|583149129|FG000|Overall Study|Protocol Violation|1|||
161668863|NCT04677179|583839869|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
161668864|NCT04677179|583839870|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
161479365|NCT00453063|583149130|FG001|Overall Study|Protocol Violation|0|||
161479366|NCT00837811|583149131|FG000|Overall Study|Adverse Event|4|||
161479367|NCT00837811|583149132|FG001|Overall Study|Adverse Event|6|||
161479368|NCT00837811|583149133|FG002|Overall Study|Adverse Event|0|||
161479369|NCT00837811|583149131|FG000|Overall Study|Death|1|||
161668865|NCT04677179|583839871|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
161668866|NCT04677179|583839862|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
161668867|NCT04677179|583839863|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
161668868|NCT04677179|583839864|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
161668869|NCT04677179|583839865|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
161668870|NCT04677179|583839866|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
161668871|NCT04677179|583839867|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
161668872|NCT04677179|583839868|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
161668873|NCT04677179|583839869|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
161668874|NCT04677179|583839870|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
161668875|NCT04677179|583839871|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
161668876|NCT04677179|583839862|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
161668877|NCT04677179|583839863|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
161668878|NCT04677179|583839864|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
161668879|NCT04677179|583839865|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
161668880|NCT04677179|583839866|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
161668881|NCT04677179|583839867|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
161668882|NCT04677179|583839868|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
161668883|NCT04677179|583839869|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
161668884|NCT04677179|583839870|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
161668885|NCT04677179|583839871|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
161668886|NCT04677179|583839862|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668887|NCT04677179|583839863|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668888|NCT04677179|583839864|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668889|NCT04677179|583839865|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668890|NCT04677179|583839866|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668891|NCT04677179|583839867|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668892|NCT04677179|583839868|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668893|NCT04677179|583839869|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
161668894|NCT04677179|583839870|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
161668895|NCT04677179|583839871|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161668896|NCT04677179|583839862|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668897|NCT04677179|583839863|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668898|NCT04677179|583839864|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668899|NCT04677179|583839865|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668900|NCT04677179|583839866|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668901|NCT04677179|583839867|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668902|NCT04677179|583839868|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668903|NCT04677179|583839869|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
161668904|NCT04677179|583839870|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161668905|NCT04677179|583839871|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161479370|NCT00837811|583149132|FG001|Overall Study|Death|1|||
161479371|NCT00837811|583149133|FG002|Overall Study|Death|0|||
161668906|NCT04677179|583839862|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161479372|NCT00837811|583149131|FG000|Overall Study|Lack of Efficacy|0|||
161668907|NCT04677179|583839863|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161668908|NCT04677179|583839864|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161668909|NCT04677179|583839865|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161668910|NCT04677179|583839866|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161668911|NCT04677179|583839867|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161668912|NCT04677179|583839868|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161479373|NCT00837811|583149132|FG001|Overall Study|Lack of Efficacy|11|||
161479374|NCT00837811|583149133|FG002|Overall Study|Lack of Efficacy|0|||
161815916|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815917|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815918|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815919|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815920|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815921|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161479375|NCT00837811|583149131|FG000|Overall Study|Lost to Follow-up|1|||
161479376|NCT00837811|583149132|FG001|Overall Study|Lost to Follow-up|3|||
161479377|NCT00837811|583149133|FG002|Overall Study|Lost to Follow-up|0|||
161479378|NCT00837811|583149131|FG000|Overall Study|Physician Decision|0|||
161479379|NCT00837811|583149132|FG001|Overall Study|Physician Decision|2|||
161479380|NCT00837811|583149133|FG002|Overall Study|Physician Decision|1|||
161479381|NCT00837811|583149131|FG000|Overall Study|Withdrawal by Subject|1|||
161479382|NCT00837811|583149132|FG001|Overall Study|Withdrawal by Subject|9|||
161479383|NCT00837811|583149133|FG002|Overall Study|Withdrawal by Subject|0|||
161479384|NCT00837811|583149131|FG000|Overall Study|Sponsor Decision|0|||
161479385|NCT00837811|583149132|FG001|Overall Study|Sponsor Decision|2|||
161479386|NCT00837811|583149133|FG002|Overall Study|Sponsor Decision|0|||
161479387|NCT01918774|583150791|FG000|Overall Study|Lost prior to first CBTw session|4|||
161479388|NCT01918774|583150791|FG000|Overall Study|Lost to Follow-up|1|||
161479389|NCT00717197|583150795|FG000|Overall Study|Unable to purchase study drug|5|||
161479390|NCT00717197|583150795|FG000|Overall Study|Tumor Progression|1|||
161479391|NCT00717197|583150795|FG000|Overall Study|Physician Decision|1|||
161479392|NCT01898806|583150798|FG000|Overall Study|Withdrawal by Subject|2|||
161479393|NCT01898806|583150798|FG000|Overall Study|Physician Decision|1|||
161479394|NCT03003390|583150799|FG000|Overall Study|Physician Decision|2|||
161479395|NCT03003390|583150800|FG001|Overall Study|Physician Decision|0|||
161479396|NCT03003390|583150799|FG000|Overall Study|Parent refused intervention|2|||
161479397|NCT03003390|583150800|FG001|Overall Study|Parent refused intervention|0|||
161479398|NCT01648101|583150801|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
161479399|NCT01648101|583150802|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
161479400|NCT01648101|583150803|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
161479401|NCT01648101|583150801|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
161479402|NCT01648101|583150802|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
161479403|NCT01648101|583150803|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
161479404|NCT01648101|583150801|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
161479405|NCT01648101|583150802|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
161479406|NCT01648101|583150803|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
161479407|NCT01648101|583150801|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
161479408|NCT01648101|583150802|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
161479409|NCT01648101|583150803|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
161479410|NCT01648101|583150801|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
161479411|NCT01648101|583150802|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
161479412|NCT01648101|583150803|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
161479413|NCT01648101|583150801|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
161479414|NCT01648101|583150802|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
161479415|NCT01648101|583150803|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
161479416|NCT01648101|583150801|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
161479417|NCT01648101|583150802|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
161479418|NCT01648101|583150803|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
161479419|NCT01648101|583150801|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
161479420|NCT01648101|583150802|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
161479421|NCT01648101|583150803|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
161479422|NCT01648101|583150801|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
161578871|NCT00801983|583506613|FG000|Period 1|Lost to Follow-up|2|||
161578872|NCT00801983|583506614|FG001|Period 1|Lost to Follow-up|0|||
161578873|NCT00801983|583506613|FG000|Period 1|Withdrawal by Subject|2|||
161578874|NCT00801983|583506614|FG001|Period 1|Withdrawal by Subject|8|||
161578875|NCT00801983|583506613|FG000|Period 2|Withdrawal by Subject|2|||
161578876|NCT00801983|583506614|FG001|Period 2|Withdrawal by Subject|1|||
161578877|NCT03122886|583508053|FG000|Overall Study|Withdrawal by Subject|1|||
161578878|NCT03122886|583508054|FG001|Overall Study|Withdrawal by Subject|2|||
161578879|NCT02544074|583508055|FG000|Overall Study|Withdrawal by Subject|0|||
161578880|NCT02544074|583508056|FG001|Overall Study|Withdrawal by Subject|1|||
161578881|NCT02544074|583508057|FG002|Overall Study|Withdrawal by Subject|0|||
161578882|NCT02544074|583508058|FG003|Overall Study|Withdrawal by Subject|0|||
161578883|NCT02544074|583508059|FG004|Overall Study|Withdrawal by Subject|0|||
161578884|NCT02544074|583508060|FG005|Overall Study|Withdrawal by Subject|0|||
161578885|NCT02544074|583508061|FG006|Overall Study|Withdrawal by Subject|0|||
161578886|NCT02544074|583508062|FG007|Overall Study|Withdrawal by Subject|0|||
161578887|NCT02544074|583508063|FG008|Overall Study|Withdrawal by Subject|0|||
161578888|NCT02544074|583508064|FG009|Overall Study|Withdrawal by Subject|0|||
161578889|NCT02544074|583508065|FG010|Overall Study|Withdrawal by Subject|0|||
161578890|NCT02544074|583508066|FG011|Overall Study|Withdrawal by Subject|0|||
161479423|NCT01648101|583150802|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
161479424|NCT01648101|583150803|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
161479425|NCT01648101|583150801|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
161479426|NCT01648101|583150802|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
161479427|NCT01648101|583150803|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
161479428|NCT01648101|583150801|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
161479429|NCT01648101|583150802|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
161479430|NCT01648101|583150803|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
161479431|NCT01581931|583150808|FG000|Washout|Adverse Event|0|||
161479432|NCT01581931|583150809|FG001|Washout|Adverse Event|1|||
161479433|NCT00395304|583150816|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161479434|NCT00395304|583150817|FG001|Treatment Period 1|Withdrawal by Subject|3|||
161479435|NCT00395304|583150818|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161479436|NCT00395304|583150819|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161479437|NCT00395304|583150820|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161479438|NCT00395304|583150821|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161479439|NCT00395304|583150816|FG000|Treatment Period 1|Lost to Follow-up|1|||
161479440|NCT00395304|583150817|FG001|Treatment Period 1|Lost to Follow-up|0|||
161479441|NCT00395304|583150818|FG002|Treatment Period 1|Lost to Follow-up|0|||
161479442|NCT00395304|583150819|FG003|Treatment Period 1|Lost to Follow-up|1|||
161479443|NCT00395304|583150820|FG004|Treatment Period 1|Lost to Follow-up|0|||
161479444|NCT00395304|583150821|FG005|Treatment Period 1|Lost to Follow-up|1|||
161479445|NCT00395304|583150816|FG000|Treatment Period 1|Physician Decision|0|||
161479446|NCT00395304|583150817|FG001|Treatment Period 1|Physician Decision|1|||
161479447|NCT00395304|583150818|FG002|Treatment Period 1|Physician Decision|0|||
161479448|NCT00395304|583150819|FG003|Treatment Period 1|Physician Decision|0|||
161479449|NCT00395304|583150820|FG004|Treatment Period 1|Physician Decision|0|||
161479450|NCT00395304|583150821|FG005|Treatment Period 1|Physician Decision|0|||
161479451|NCT00395304|583150816|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161479452|NCT00395304|583150817|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161479453|NCT00395304|583150818|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161479454|NCT00395304|583150819|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161921174|NCT01697579|584757185|FG005|Base Study-Cycle 1|Protocol Violation|0|||
161921175|NCT01697579|584757186|FG006|Base Study-Cycle 1|Protocol Violation|0|||
161921176|NCT01697579|584757180|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161921177|NCT01697579|584757181|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
161479455|NCT00395304|583150820|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161479456|NCT00395304|583150821|FG005|Treatment Period 2|Withdrawal by Subject|2|||
161479457|NCT00395304|583150816|FG000|Treatment Period 2|Lost to Follow-up|0|||
161479458|NCT00395304|583150817|FG001|Treatment Period 2|Lost to Follow-up|3|||
161479459|NCT00395304|583150818|FG002|Treatment Period 2|Lost to Follow-up|0|||
161479460|NCT00395304|583150819|FG003|Treatment Period 2|Lost to Follow-up|0|||
161479461|NCT00395304|583150820|FG004|Treatment Period 2|Lost to Follow-up|0|||
161479462|NCT00395304|583150821|FG005|Treatment Period 2|Lost to Follow-up|0|||
161479463|NCT00395304|583150816|FG000|Treatment Period 2|Physician Decision|0|||
161479464|NCT00395304|583150817|FG001|Treatment Period 2|Physician Decision|0|||
161479465|NCT00395304|583150818|FG002|Treatment Period 2|Physician Decision|1|||
161479466|NCT00395304|583150819|FG003|Treatment Period 2|Physician Decision|0|||
161479467|NCT00395304|583150820|FG004|Treatment Period 2|Physician Decision|0|||
161479468|NCT00395304|583150821|FG005|Treatment Period 2|Physician Decision|0|||
161479469|NCT00395304|583150816|FG000|Treatment Period 2|Other|0|||
161479470|NCT00395304|583150817|FG001|Treatment Period 2|Other|1|||
161479471|NCT00395304|583150818|FG002|Treatment Period 2|Other|0|||
161479472|NCT00395304|583150819|FG003|Treatment Period 2|Other|0|||
161479473|NCT00395304|583150820|FG004|Treatment Period 2|Other|0|||
161479474|NCT00395304|583150821|FG005|Treatment Period 2|Other|0|||
161479475|NCT00395304|583150816|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161479476|NCT00395304|583150817|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161479477|NCT00395304|583150818|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161479478|NCT00395304|583150819|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161479479|NCT00395304|583150820|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161479480|NCT00395304|583150821|FG005|Treatment Period 3|Withdrawal by Subject|1|||
161479481|NCT00395304|583150816|FG000|Treatment Period 3|Lost to Follow-up|1|||
161479482|NCT00395304|583150817|FG001|Treatment Period 3|Lost to Follow-up|1|||
161479483|NCT00395304|583150818|FG002|Treatment Period 3|Lost to Follow-up|0|||
161479484|NCT00395304|583150819|FG003|Treatment Period 3|Lost to Follow-up|0|||
161479485|NCT00395304|583150820|FG004|Treatment Period 3|Lost to Follow-up|0|||
161479486|NCT00395304|583150821|FG005|Treatment Period 3|Lost to Follow-up|0|||
161479487|NCT00395304|583150816|FG000|Treatment Period 3|Physician Decision|0|||
161479488|NCT00395304|583150817|FG001|Treatment Period 3|Physician Decision|1|||
161479489|NCT00395304|583150818|FG002|Treatment Period 3|Physician Decision|0|||
161479490|NCT00395304|583150819|FG003|Treatment Period 3|Physician Decision|0|||
161479491|NCT00395304|583150820|FG004|Treatment Period 3|Physician Decision|0|||
161479492|NCT00395304|583150821|FG005|Treatment Period 3|Physician Decision|0|||
161479493|NCT00395304|583150816|FG000|Treatment Period 3|Other|0|||
161668913|NCT04677179|583839869|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
161668914|NCT04677179|583839870|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
161668915|NCT04677179|583839871|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161668916|NCT04677179|583839862|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668917|NCT04677179|583839863|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668918|NCT04677179|583839864|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668919|NCT04677179|583839865|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668920|NCT04677179|583839866|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668921|NCT04677179|583839867|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668922|NCT04677179|583839868|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161668923|NCT04677179|583839869|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
161668924|NCT04677179|583839870|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
161668925|NCT04677179|583839871|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
161668926|NCT01723254|583839872|FG000|Overall Study|Conflict with work schedule|0|||
161668927|NCT01723254|583839873|FG001|Overall Study|Conflict with work schedule|0|||
161668928|NCT01723254|583839874|FG002|Overall Study|Conflict with work schedule|0|||
161668929|NCT01723254|583839875|FG003|Overall Study|Conflict with work schedule|0|||
161668930|NCT01723254|583839876|FG004|Overall Study|Conflict with work schedule|0|||
161668931|NCT01723254|583839877|FG005|Overall Study|Conflict with work schedule|0|||
161668932|NCT01723254|583839878|FG006|Overall Study|Conflict with work schedule|0|||
161668933|NCT01723254|583839879|FG007|Overall Study|Conflict with work schedule|1|||
161668934|NCT01723254|583839872|FG000|Overall Study|Personal issues|0|||
161668935|NCT01723254|583839873|FG001|Overall Study|Personal issues|0|||
161668936|NCT01723254|583839874|FG002|Overall Study|Personal issues|0|||
161668937|NCT01723254|583839875|FG003|Overall Study|Personal issues|0|||
161668938|NCT01723254|583839876|FG004|Overall Study|Personal issues|0|||
161668939|NCT01723254|583839877|FG005|Overall Study|Personal issues|1|||
161668940|NCT01723254|583839878|FG006|Overall Study|Personal issues|0|||
161668941|NCT01723254|583839879|FG007|Overall Study|Personal issues|0|||
161668942|NCT01723254|583839872|FG000|Overall Study|No longer have time to participate|0|||
161668943|NCT01723254|583839873|FG001|Overall Study|No longer have time to participate|0|||
161668944|NCT01723254|583839874|FG002|Overall Study|No longer have time to participate|0|||
161668945|NCT01723254|583839875|FG003|Overall Study|No longer have time to participate|1|||
161668946|NCT01723254|583839876|FG004|Overall Study|No longer have time to participate|0|||
161668947|NCT01723254|583839877|FG005|Overall Study|No longer have time to participate|0|||
161668948|NCT01723254|583839878|FG006|Overall Study|No longer have time to participate|0|||
161668949|NCT01723254|583839879|FG007|Overall Study|No longer have time to participate|0|||
161668950|NCT01723254|583839872|FG000|Overall Study|Move/Left to another country/city|0|||
161668951|NCT01723254|583839873|FG001|Overall Study|Move/Left to another country/city|0|||
161668952|NCT01723254|583839874|FG002|Overall Study|Move/Left to another country/city|2|||
161668953|NCT01723254|583839875|FG003|Overall Study|Move/Left to another country/city|1|||
161668954|NCT01723254|583839876|FG004|Overall Study|Move/Left to another country/city|1|||
161668955|NCT01723254|583839877|FG005|Overall Study|Move/Left to another country/city|0|||
161668956|NCT01723254|583839878|FG006|Overall Study|Move/Left to another country/city|0|||
161668957|NCT01723254|583839879|FG007|Overall Study|Move/Left to another country/city|0|||
161668958|NCT01723254|583839872|FG000|Overall Study|Protocol Violation|0|||
161668959|NCT01723254|583839873|FG001|Overall Study|Protocol Violation|1|||
161668960|NCT01723254|583839874|FG002|Overall Study|Protocol Violation|0|||
161668961|NCT01723254|583839875|FG003|Overall Study|Protocol Violation|0|||
161668962|NCT01723254|583839876|FG004|Overall Study|Protocol Violation|0|||
161668963|NCT01723254|583839877|FG005|Overall Study|Protocol Violation|0|||
161668964|NCT01723254|583839878|FG006|Overall Study|Protocol Violation|0|||
161815922|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161668965|NCT01723254|583839879|FG007|Overall Study|Protocol Violation|0|||
161668966|NCT01723254|583839872|FG000|Overall Study|Withdrawal by Subject|1|||
161668967|NCT01723254|583839873|FG001|Overall Study|Withdrawal by Subject|2|||
161668968|NCT01723254|583839874|FG002|Overall Study|Withdrawal by Subject|1|||
161668969|NCT01723254|583839875|FG003|Overall Study|Withdrawal by Subject|0|||
161668970|NCT01723254|583839876|FG004|Overall Study|Withdrawal by Subject|1|||
161668971|NCT01723254|583839877|FG005|Overall Study|Withdrawal by Subject|1|||
161668972|NCT01723254|583839878|FG006|Overall Study|Withdrawal by Subject|1|||
161668973|NCT01723254|583839879|FG007|Overall Study|Withdrawal by Subject|2|||
161668974|NCT01201265|583839880|FG000|Overall Study|Death|14|||
161668975|NCT01201265|583839880|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161668976|NCT01201265|583839880|FG000|Overall Study|Lost to Follow-up|10|||
161668977|NCT01201265|583839880|FG000|Overall Study|Withdrawal by Subject|7|||
161668978|NCT01201265|583839880|FG000|Overall Study|Disease Progression|4|||
161668979|NCT01257425|583839881|FG000|Overall Study|Lack of Efficacy|3|||
161668980|NCT01257425|583839882|FG001|Overall Study|Lack of Efficacy|3|||
161668981|NCT01257425|583839881|FG000|Overall Study|Adverse Event|1|||
161668982|NCT01257425|583839882|FG001|Overall Study|Adverse Event|1|||
161668983|NCT01257425|583839881|FG000|Overall Study|Protocol Violation|1|||
161668984|NCT01257425|583839882|FG001|Overall Study|Protocol Violation|1|||
161668985|NCT01257425|583839881|FG000|Overall Study|Withdrawal by Subject|0|||
161668986|NCT01257425|583839882|FG001|Overall Study|Withdrawal by Subject|1|||
161668987|NCT01257425|583839881|FG000|Overall Study|Death|1|||
161668988|NCT01257425|583839882|FG001|Overall Study|Death|0|||
161668989|NCT02254278|583839884|FG000|Overall Study|Protocol Violation|1|||
161668990|NCT02254278|583839885|FG001|Overall Study|Protocol Violation|1|||
161668991|NCT02903368|583839889|FG000|Part 1|Adverse Event|3|||
161668992|NCT02903368|583839890|FG001|Part 1|Adverse Event|0|||
161668993|NCT02903368|583839891|FG002|Part 1|Adverse Event|0|||
161668994|NCT02903368|583839892|FG003|Part 1|Adverse Event|0|||
161668995|NCT02903368|583839889|FG000|Part 1|Withdrawal by Subject|1|||
161668996|NCT02903368|583839890|FG001|Part 1|Withdrawal by Subject|0|||
161668997|NCT02903368|583839891|FG002|Part 1|Withdrawal by Subject|0|||
161479494|NCT00395304|583150817|FG001|Treatment Period 3|Other|0|||
161479495|NCT00395304|583150818|FG002|Treatment Period 3|Other|0|||
161479496|NCT00395304|583150819|FG003|Treatment Period 3|Other|1|||
161479497|NCT00395304|583150820|FG004|Treatment Period 3|Other|0|||
161479498|NCT00395304|583150821|FG005|Treatment Period 3|Other|0|||
161479499|NCT01397084|583150826|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
161668998|NCT02903368|583839892|FG003|Part 1|Withdrawal by Subject|0|||
161668999|NCT02903368|583839889|FG000|Part 2|Adverse Event|0|||
161669000|NCT02903368|583839890|FG001|Part 2|Adverse Event|0|||
161479500|NCT01397084|583150826|FG000|Overall Study|Protocol Violation|2|||
161669001|NCT02903368|583839891|FG002|Part 2|Adverse Event|5|||
161669002|NCT02903368|583839892|FG003|Part 2|Adverse Event|0|||
161669003|NCT02903368|583839889|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
161669004|NCT02903368|583839890|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
161669005|NCT02903368|583839891|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
161669006|NCT02903368|583839892|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
161669007|NCT02903368|583839889|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
161479501|NCT01397084|583150826|FG000|Overall Study|Adverse Event|2|||
161479502|NCT01397084|583150826|FG000|Overall Study|Withdrawal by Subject|1|||
161479503|NCT01397084|583150826|FG000|Overall Study|Lost to Follow-up|1|||
161479504|NCT01397084|583150826|FG000|Overall Study|Used other proton pump inhibitor|1|||
161479505|NCT04160195|583150829|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
161479506|NCT04160195|583150830|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
161479507|NCT03766581|583150833|FG000|Randomization|Other reasons|2|||
161479508|NCT03766581|583150834|FG001|Randomization|Other reasons|1|||
161479509|NCT03766581|583150835|FG002|Randomization|Other reasons|0|||
161479510|NCT03766581|583150836|FG003|Randomization|Other reasons|1|||
161479511|NCT03766581|583150837|FG004|Randomization|Other reasons|0|||
161479512|NCT03766581|583150838|FG005|Randomization|Other reasons|0|||
161479513|NCT03766581|583150839|FG006|Randomization|Other reasons|0|||
161479514|NCT03766581|583150840|FG007|Randomization|Other reasons|0|||
161479515|NCT03766581|583150833|FG000|Randomization|Participant no longer meets study criteria|5|||
161479516|NCT03766581|583150834|FG001|Randomization|Participant no longer meets study criteria|3|||
161479517|NCT03766581|583150835|FG002|Randomization|Participant no longer meets study criteria|4|||
161479518|NCT03766581|583150836|FG003|Randomization|Participant no longer meets study criteria|0|||
161479519|NCT03766581|583150837|FG004|Randomization|Participant no longer meets study criteria|2|||
161479520|NCT03766581|583150838|FG005|Randomization|Participant no longer meets study criteria|3|||
161479521|NCT03766581|583150839|FG006|Randomization|Participant no longer meets study criteria|0|||
161479522|NCT03766581|583150840|FG007|Randomization|Participant no longer meets study criteria|1|||
161479523|NCT03766581|583150833|FG000|Randomization|Participant request to discontinue study treatment|1|||
161479524|NCT03766581|583150834|FG001|Randomization|Participant request to discontinue study treatment|0|||
161479525|NCT03766581|583150835|FG002|Randomization|Participant request to discontinue study treatment|0|||
161479526|NCT03766581|583150836|FG003|Randomization|Participant request to discontinue study treatment|0|||
161479527|NCT03766581|583150837|FG004|Randomization|Participant request to discontinue study treatment|1|||
161479528|NCT03766581|583150838|FG005|Randomization|Participant request to discontinue study treatment|2|||
161479529|NCT03766581|583150839|FG006|Randomization|Participant request to discontinue study treatment|0|||
161669008|NCT02903368|583839890|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
161479530|NCT03766581|583150840|FG007|Randomization|Participant request to discontinue study treatment|0|||
161479531|NCT03766581|583150833|FG000|Randomization|Participant withdrew consent|1|||
161479532|NCT03766581|583150834|FG001|Randomization|Participant withdrew consent|0|||
161479533|NCT03766581|583150835|FG002|Randomization|Participant withdrew consent|1|||
161479534|NCT03766581|583150836|FG003|Randomization|Participant withdrew consent|2|||
161479535|NCT03766581|583150837|FG004|Randomization|Participant withdrew consent|1|||
161479536|NCT03766581|583150838|FG005|Randomization|Participant withdrew consent|1|||
161479537|NCT03766581|583150839|FG006|Randomization|Participant withdrew consent|0|||
161479538|NCT03766581|583150840|FG007|Randomization|Participant withdrew consent|0|||
161479539|NCT03766581|583150833|FG000|Treatment|Adverse Event|82|||
161479540|NCT03766581|583150834|FG001|Treatment|Adverse Event|44|||
161479541|NCT03766581|583150835|FG002|Treatment|Adverse Event|47|||
161479542|NCT03766581|583150836|FG003|Treatment|Adverse Event|46|||
161479543|NCT03766581|583150837|FG004|Treatment|Adverse Event|50|||
161479544|NCT03766581|583150838|FG005|Treatment|Adverse Event|77|||
161479545|NCT03766581|583150839|FG006|Treatment|Adverse Event|5|||
161479546|NCT03766581|583150840|FG007|Treatment|Adverse Event|2|||
161479547|NCT03766581|583150833|FG000|Treatment|Participant request to discontinue treatment|34|||
161479548|NCT03766581|583150834|FG001|Treatment|Participant request to discontinue treatment|6|||
161479549|NCT03766581|583150835|FG002|Treatment|Participant request to discontinue treatment|10|||
161479550|NCT03766581|583150836|FG003|Treatment|Participant request to discontinue treatment|10|||
161479551|NCT03766581|583150837|FG004|Treatment|Participant request to discontinue treatment|14|||
161479552|NCT03766581|583150838|FG005|Treatment|Participant request to discontinue treatment|15|||
161479553|NCT03766581|583150839|FG006|Treatment|Participant request to discontinue treatment|0|||
161479554|NCT03766581|583150840|FG007|Treatment|Participant request to discontinue treatment|1|||
161479555|NCT03766581|583150833|FG000|Treatment|Participant withdrew consent|11|||
161479556|NCT03766581|583150834|FG001|Treatment|Participant withdrew consent|4|||
161479557|NCT03766581|583150835|FG002|Treatment|Participant withdrew consent|5|||
161479558|NCT03766581|583150836|FG003|Treatment|Participant withdrew consent|5|||
161479559|NCT03766581|583150837|FG004|Treatment|Participant withdrew consent|4|||
161479560|NCT03766581|583150838|FG005|Treatment|Participant withdrew consent|4|||
161479561|NCT03766581|583150839|FG006|Treatment|Participant withdrew consent|0|||
161479562|NCT03766581|583150840|FG007|Treatment|Participant withdrew consent|0|||
161479563|NCT03766581|583150833|FG000|Treatment|Death|1|||
161479564|NCT03766581|583150834|FG001|Treatment|Death|0|||
161479565|NCT03766581|583150835|FG002|Treatment|Death|0|||
161479566|NCT03766581|583150836|FG003|Treatment|Death|0|||
161479567|NCT03766581|583150837|FG004|Treatment|Death|0|||
161479568|NCT03766581|583150838|FG005|Treatment|Death|0|||
161479569|NCT03766581|583150839|FG006|Treatment|Death|0|||
161578891|NCT02544074|583508067|FG012|Overall Study|Withdrawal by Subject|0|||
161578892|NCT02544074|583508068|FG013|Overall Study|Withdrawal by Subject|0|||
161578893|NCT02544074|583508069|FG014|Overall Study|Withdrawal by Subject|0|||
161578894|NCT02544074|583508070|FG015|Overall Study|Withdrawal by Subject|0|||
161578895|NCT02544074|583508071|FG016|Overall Study|Withdrawal by Subject|0|||
161578896|NCT02544074|583508072|FG017|Overall Study|Withdrawal by Subject|0|||
161578897|NCT02544074|583508073|FG018|Overall Study|Withdrawal by Subject|0|||
161578898|NCT02544074|583508074|FG019|Overall Study|Withdrawal by Subject|0|||
161578899|NCT02544074|583508075|FG020|Overall Study|Withdrawal by Subject|0|||
161578900|NCT02544074|583508055|FG000|Overall Study|Tablet error|0|||
161578901|NCT02544074|583508056|FG001|Overall Study|Tablet error|0|||
161578902|NCT02544074|583508057|FG002|Overall Study|Tablet error|0|||
161578903|NCT02544074|583508058|FG003|Overall Study|Tablet error|0|||
161578904|NCT02544074|583508059|FG004|Overall Study|Tablet error|0|||
161578905|NCT02544074|583508060|FG005|Overall Study|Tablet error|1|||
161578906|NCT02544074|583508061|FG006|Overall Study|Tablet error|0|||
161578907|NCT02544074|583508062|FG007|Overall Study|Tablet error|0|||
161578908|NCT02544074|583508063|FG008|Overall Study|Tablet error|0|||
161578909|NCT02544074|583508064|FG009|Overall Study|Tablet error|1|||
161578910|NCT02544074|583508065|FG010|Overall Study|Tablet error|0|||
161578911|NCT02544074|583508066|FG011|Overall Study|Tablet error|0|||
161578912|NCT02544074|583508067|FG012|Overall Study|Tablet error|0|||
161815923|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161479570|NCT03766581|583150840|FG007|Treatment|Death|0|||
161479571|NCT03766581|583150833|FG000|Treatment|Lost to Follow-up|1|||
161479572|NCT03766581|583150834|FG001|Treatment|Lost to Follow-up|0|||
161479573|NCT03766581|583150835|FG002|Treatment|Lost to Follow-up|0|||
161479574|NCT03766581|583150836|FG003|Treatment|Lost to Follow-up|1|||
161479575|NCT03766581|583150837|FG004|Treatment|Lost to Follow-up|0|||
161479576|NCT03766581|583150838|FG005|Treatment|Lost to Follow-up|0|||
161479577|NCT03766581|583150839|FG006|Treatment|Lost to Follow-up|0|||
161479578|NCT03766581|583150840|FG007|Treatment|Lost to Follow-up|0|||
161479579|NCT03766581|583150833|FG000|Treatment|Poor/Non compliance|2|||
161479580|NCT03766581|583150834|FG001|Treatment|Poor/Non compliance|2|||
161479581|NCT03766581|583150835|FG002|Treatment|Poor/Non compliance|1|||
161578913|NCT02544074|583508068|FG013|Overall Study|Tablet error|0|||
161578914|NCT02544074|583508069|FG014|Overall Study|Tablet error|0|||
161578915|NCT02544074|583508070|FG015|Overall Study|Tablet error|0|||
161578916|NCT02544074|583508071|FG016|Overall Study|Tablet error|0|||
161578917|NCT02544074|583508072|FG017|Overall Study|Tablet error|0|||
161578918|NCT02544074|583508073|FG018|Overall Study|Tablet error|0|||
161578919|NCT02544074|583508074|FG019|Overall Study|Tablet error|0|||
161578920|NCT02544074|583508075|FG020|Overall Study|Tablet error|0|||
161578921|NCT05672667|583508076|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
161578922|NCT04524390|583508077|FG000|Double Blind|Consent Withdrawal by subject|2|||
161578923|NCT04524390|583508078|FG001|Double Blind|Consent Withdrawal by subject|1|||
161578924|NCT04524390|583508079|FG002|Double Blind|Consent Withdrawal by subject|0|||
161578925|NCT04524390|583508077|FG000|Double Blind|Adverse Event|5|||
161578926|NCT04524390|583508078|FG001|Double Blind|Adverse Event|3|||
161578927|NCT04524390|583508079|FG002|Double Blind|Adverse Event|0|||
161578928|NCT04524390|583508077|FG000|Double Blind|Liver Transplant|5|||
161578929|NCT04524390|583508078|FG001|Double Blind|Liver Transplant|6|||
161578930|NCT04524390|583508079|FG002|Double Blind|Liver Transplant|0|||
161578931|NCT04524390|583508077|FG000|Double Blind|Disease Progression|0|||
161578932|NCT04524390|583508078|FG001|Double Blind|Disease Progression|1|||
161578933|NCT04524390|583508079|FG002|Double Blind|Disease Progression|0|||
161578934|NCT04524390|583508077|FG000|Open-Label|Drug interruption criteria|0|||
161578935|NCT04524390|583508078|FG001|Open-Label|Drug interruption criteria|0|||
161578936|NCT04524390|583508079|FG002|Open-Label|Drug interruption criteria|1|||
161578937|NCT04524390|583508077|FG000|Open-Label|Liver Transplant|0|||
161578938|NCT04524390|583508078|FG001|Open-Label|Liver Transplant|0|||
161578939|NCT04524390|583508079|FG002|Open-Label|Liver Transplant|1|||
161578940|NCT04524390|583508077|FG000|Open-Label|Disease Progression|0|||
161578941|NCT04524390|583508078|FG001|Open-Label|Disease Progression|0|||
161578942|NCT04524390|583508079|FG002|Open-Label|Disease Progression|1|||
161578943|NCT04524390|583508077|FG000|Open-Label|Adverse Event|0|||
161578944|NCT04524390|583508078|FG001|Open-Label|Adverse Event|0|||
161578945|NCT04524390|583508079|FG002|Open-Label|Adverse Event|3|||
161578946|NCT04524390|583508077|FG000|Open-Label|Study Termination by sponsor|0|||
161578947|NCT04524390|583508078|FG001|Open-Label|Study Termination by sponsor|0|||
161578948|NCT04524390|583508079|FG002|Open-Label|Study Termination by sponsor|45|||
161578949|NCT03613740|583508080|FG000|Overall Study|Lost to Follow-up|1|||
161578950|NCT03613740|583508081|FG001|Overall Study|Lost to Follow-up|1|||
161578951|NCT01693120|583508082|FG000|Enrollment|Lost to Follow-up|1|||
161578952|NCT01693120|583508082|FG000|Enrollment|Withdrawal by Subject|10|||
161578953|NCT01693120|583508082|FG000|Enrollment|Protocol Violation|46|||
161578954|NCT01693120|583508082|FG000|Enrollment|Physician Decision|3|||
161578955|NCT01693120|583508082|FG000|Enrollment|Adverse Event|1|||
161578956|NCT01693120|583508082|FG000|Enrollment|Study closed|8|||
161578957|NCT01693120|583508082|FG000|Enrollment|Other|1|||
161578958|NCT01693120|583508082|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
161578959|NCT01693120|583508082|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
161578960|NCT01693120|583508082|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
161578961|NCT01693120|583508082|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
161578962|NCT01693120|583508082|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
161578963|NCT04723394|583508100|FG000|Overall Study|Adverse Event|0|||
161578964|NCT04723394|583508101|FG001|Overall Study|Adverse Event|3|||
161578965|NCT04723394|583508100|FG000|Overall Study|Death|8|||
161578966|NCT04723394|583508101|FG001|Overall Study|Death|8|||
161578967|NCT04723394|583508100|FG000|Overall Study|Lost to Follow-up|20|||
161578968|NCT04723394|583508101|FG001|Overall Study|Lost to Follow-up|17|||
161578969|NCT04723394|583508100|FG000|Overall Study|Physician Decision|1|||
161578970|NCT04723394|583508101|FG001|Overall Study|Physician Decision|0|||
161578971|NCT04723394|583508100|FG000|Overall Study|Withdrawal by Subject|20|||
161578972|NCT04723394|583508101|FG001|Overall Study|Withdrawal by Subject|34|||
161578973|NCT04723394|583508100|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
161578974|NCT04723394|583508101|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
161578975|NCT00446459|583508102|FG000|8 Months|Protocol Violation|12|||
161815924|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815925|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815926|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161578976|NCT00446459|583508102|FG000|12 Months|Protocol Violation|4|||
161578977|NCT00446459|583508102|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
161578978|NCT00858117|583508104|FG000|Treatment on Study|Adverse Event|2|||
161578979|NCT00858117|583508104|FG000|Follow up for 5 Years|Death|4|||
161578980|NCT00858117|583508104|FG000|Follow up for 5 Years|No further data collected for study|9|||
161815927|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161578981|NCT00371787|583508105|FG000|Overall Study|Withdrawal by Subject|3|||
161578982|NCT00371787|583508106|FG001|Overall Study|Withdrawal by Subject|1|||
161578983|NCT00077675|583508107|FG000|Overall Study|Adverse Event|1|||
161578984|NCT00077675|583508108|FG001|Overall Study|Adverse Event|2|||
161578985|NCT00077675|583508107|FG000|Overall Study|Lost to Follow-up|6|||
161578986|NCT00077675|583508108|FG001|Overall Study|Lost to Follow-up|3|||
161815928|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161578987|NCT00077675|583508107|FG000|Overall Study|Withdrawal by Subject|1|||
161578988|NCT00077675|583508108|FG001|Overall Study|Withdrawal by Subject|0|||
161578989|NCT00077675|583508107|FG000|Overall Study|Other|0|||
161578990|NCT00077675|583508108|FG001|Overall Study|Other|1|||
161578991|NCT00077675|583508107|FG000|Overall Study|Never received study treatment|3|||
161578992|NCT00077675|583508108|FG001|Overall Study|Never received study treatment|3|||
161578993|NCT02601820|583508109|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
161578994|NCT02601820|583508109|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
161578995|NCT02601820|583508109|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
161578996|NCT02601820|583508109|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
161578997|NCT04532528|583508115|FG000|Overall Study|Adverse Event|12|||
161578998|NCT04532528|583508116|FG001|Overall Study|Adverse Event|17|||
161578999|NCT04532528|583508115|FG000|Overall Study|Withdrawal of consent|16|||
161579000|NCT04532528|583508116|FG001|Overall Study|Withdrawal of consent|17|||
161579001|NCT04532528|583508115|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
161579002|NCT04532528|583508116|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
161579003|NCT04532528|583508115|FG000|Overall Study|Lost to Follow-up|69|||
161579004|NCT04532528|583508116|FG001|Overall Study|Lost to Follow-up|68|||
161579005|NCT04532528|583508115|FG000|Overall Study|Administrative problems|12|||
161579006|NCT04532528|583508116|FG001|Overall Study|Administrative problems|14|||
161579007|NCT04532528|583508115|FG000|Overall Study|Death|3|||
161579008|NCT04532528|583508116|FG001|Overall Study|Death|3|||
161579009|NCT04532528|583508115|FG000|Overall Study|Other|38|||
161579010|NCT04532528|583508116|FG001|Overall Study|Other|46|||
161579011|NCT00665444|583508121|FG000|Overall Study|Physician Decision|1|||
161579012|NCT00665444|583508121|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
161579013|NCT01414738|583508135|FG000|Overall Study|Death|26|||
161579014|NCT01414738|583508135|FG000|Overall Study|Refused testing|5|||
161579015|NCT01414738|583508135|FG000|Overall Study|Lost to Follow-up|2|||
161579016|NCT01414738|583508135|FG000|Overall Study|Refused, disease progression|8|||
161579017|NCT01414738|583508135|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
161579018|NCT01266122|583508136|FG000|Overall Study|Lost to Follow-up|6|||
161579019|NCT01266122|583508137|FG001|Overall Study|Lost to Follow-up|6|||
161579020|NCT03756571|583508138|FG000|Overall Study|Lost to Follow-up|1|||
161579021|NCT03756571|583508139|FG001|Overall Study|Lost to Follow-up|1|||
161579022|NCT02379819|583508140|FG000|Overall Study|Withdrawal by Subject|10|||
161579023|NCT02379819|583508140|FG000|Overall Study|Death|2|||
161579024|NCT02379819|583508140|FG000|Overall Study|Lack of Efficacy|1|||
161579025|NCT02379819|583508140|FG000|Overall Study|Lost to Follow-up|1|||
161579026|NCT00529516|583508141|FG000|Overall Study|Adverse Event|2|||
161579027|NCT00529516|583508142|FG001|Overall Study|Adverse Event|1|||
161579028|NCT00529516|583508143|FG002|Overall Study|Adverse Event|0|||
161579029|NCT00529516|583508141|FG000|Overall Study|Withdrawal by Subject|1|||
161579030|NCT00529516|583508142|FG001|Overall Study|Withdrawal by Subject|1|||
161579031|NCT00529516|583508143|FG002|Overall Study|Withdrawal by Subject|0|||
161579032|NCT00529516|583508141|FG000|Overall Study|Lost to Follow-up|0|||
161579033|NCT00529516|583508142|FG001|Overall Study|Lost to Follow-up|0|||
161815929|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815930|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815931|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
161815932|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
161815933|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
161815934|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
161815935|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
161815936|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161579034|NCT00529516|583508143|FG002|Overall Study|Lost to Follow-up|1|||
161579035|NCT03752151|583508144|FG000|Overall Study|Withdrawal by Subject|1|||
161579036|NCT03752151|583508144|FG000|Overall Study|Protocol Violation|1|||
161579037|NCT04056624|583508145|FG000|Overall Study|Withdrawal by Subject|0|||
161579038|NCT04056624|583508146|FG001|Overall Study|Withdrawal by Subject|0|||
161579039|NCT04056624|583508147|FG002|Overall Study|Withdrawal by Subject|1|||
161815937|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815938|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161579040|NCT04056624|583508145|FG000|Overall Study|Protocol Violation|1|||
161579041|NCT04056624|583508146|FG001|Overall Study|Protocol Violation|2|||
161579042|NCT04056624|583508147|FG002|Overall Study|Protocol Violation|0|||
161579043|NCT00703820|583508151|FG000|Overall Study|Adverse Event|12|||
161579044|NCT00703820|583508152|FG001|Overall Study|Adverse Event|17|||
161579045|NCT00703820|583508151|FG000|Overall Study|Death|5|||
161579046|NCT00703820|583508152|FG001|Overall Study|Death|0|||
161579047|NCT00703820|583508151|FG000|Overall Study|Lack of Efficacy|11|||
161579048|NCT00703820|583508152|FG001|Overall Study|Lack of Efficacy|11|||
161479582|NCT03766581|583150836|FG003|Treatment|Poor/Non compliance|1|||
161479583|NCT03766581|583150837|FG004|Treatment|Poor/Non compliance|1|||
161479584|NCT03766581|583150838|FG005|Treatment|Poor/Non compliance|1|||
161479585|NCT03766581|583150839|FG006|Treatment|Poor/Non compliance|0|||
161479586|NCT03766581|583150840|FG007|Treatment|Poor/Non compliance|0|||
161479587|NCT03766581|583150833|FG000|Treatment|Participant no longer meets study criteria|9|||
161479588|NCT03766581|583150834|FG001|Treatment|Participant no longer meets study criteria|1|||
161479589|NCT03766581|583150835|FG002|Treatment|Participant no longer meets study criteria|5|||
161479590|NCT03766581|583150836|FG003|Treatment|Participant no longer meets study criteria|4|||
161479591|NCT03766581|583150837|FG004|Treatment|Participant no longer meets study criteria|4|||
161479592|NCT03766581|583150838|FG005|Treatment|Participant no longer meets study criteria|4|||
161479593|NCT03766581|583150839|FG006|Treatment|Participant no longer meets study criteria|2|||
161479594|NCT03766581|583150840|FG007|Treatment|Participant no longer meets study criteria|0|||
161479595|NCT03766581|583150833|FG000|Treatment|Other reasons|13|||
161479596|NCT03766581|583150834|FG001|Treatment|Other reasons|8|||
161479597|NCT03766581|583150835|FG002|Treatment|Other reasons|3|||
161479598|NCT03766581|583150836|FG003|Treatment|Other reasons|7|||
161669009|NCT02903368|583839891|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
161669010|NCT02903368|583839892|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
161815939|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815940|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815941|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815942|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815943|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815944|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815945|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815946|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815947|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815948|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815949|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815950|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815951|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815952|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815953|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815954|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815955|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815956|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815957|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|moved|0|||
161815958|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|moved|1|||
161815959|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|moved|1|||
161815960|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|moved|0|||
161815961|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|moved|0|||
161815962|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|moved|0|||
161815963|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|moved|0|||
161815964|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|moved|0|||
161815965|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|moved|0|||
161815966|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|moved|0|||
161815967|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|moved|0|||
161815968|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|moved|0|||
161815969|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|moved|0|||
161815970|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|moved|0|||
161815971|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|moved|0|||
161815972|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|moved|0|||
161815973|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|moved|0|||
161815974|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|moved|0|||
161815975|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|moved|0|||
161815976|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|moved|0|||
161815977|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|moved|0|||
161815978|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|moved|0|||
161815979|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|moved|0|||
161815980|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|moved|0|||
161815981|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|moved|0|||
161815982|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|moved|0|||
161815983|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161479599|NCT03766581|583150837|FG004|Treatment|Other reasons|3|||
161479600|NCT03766581|583150838|FG005|Treatment|Other reasons|3|||
161479601|NCT03766581|583150839|FG006|Treatment|Other reasons|0|||
161479602|NCT03766581|583150840|FG007|Treatment|Other reasons|0|||
161479603|NCT03716024|583150841|FG000|Overall Study|Randomized, not Treated|7|||
161479604|NCT03716024|583150842|FG001|Overall Study|Randomized, not Treated|8|||
161479605|NCT03716024|583150841|FG000|Overall Study|Adverse Event|1|||
161479606|NCT03716024|583150842|FG001|Overall Study|Adverse Event|2|||
161479607|NCT03716024|583150841|FG000|Overall Study|Treatment Failure|1|||
161479608|NCT03716024|583150842|FG001|Overall Study|Treatment Failure|0|||
161479609|NCT03716024|583150841|FG000|Overall Study|Lost to Follow-up|2|||
161479610|NCT03716024|583150842|FG001|Overall Study|Lost to Follow-up|6|||
161479611|NCT03716024|583150841|FG000|Overall Study|Withdrawal by Subject|0|||
161479612|NCT03716024|583150842|FG001|Overall Study|Withdrawal by Subject|1|||
161479613|NCT03716024|583150841|FG000|Overall Study|Missing Reason|0|||
161479614|NCT03716024|583150842|FG001|Overall Study|Missing Reason|1|||
161479615|NCT01651039|583150844|FG000|Overall Study|Non-evaluables|5|||
161479616|NCT01651039|583150844|FG000|Overall Study|Physician Decision|2|||
161479617|NCT01651039|583150844|FG000|Overall Study|Withdrawal by Subject|1|||
161479618|NCT01651039|583150844|FG000|Overall Study|Progressive Disease|22|||
161479619|NCT03600818|583150846|FG000|Overall Study|Adverse Event|4|||
161479620|NCT03600818|583150847|FG001|Overall Study|Adverse Event|7|||
161479621|NCT03600818|583150846|FG000|Overall Study|Lack of Efficacy|9|||
161479622|NCT03600818|583150847|FG001|Overall Study|Lack of Efficacy|4|||
161479623|NCT03600818|583150846|FG000|Overall Study|Withdrawal by Subject|4|||
161479624|NCT03600818|583150847|FG001|Overall Study|Withdrawal by Subject|3|||
161479625|NCT03600818|583150846|FG000|Overall Study|Other-unspecified|5|||
161479626|NCT03600818|583150847|FG001|Overall Study|Other-unspecified|3|||
161479627|NCT03600818|583150846|FG000|Overall Study|Randomized and not treated|0|||
161479628|NCT03600818|583150847|FG001|Overall Study|Randomized and not treated|1|||
161479629|NCT04377620|583150850|FG000|Overall Study|Death|42|||
161479630|NCT04377620|583150851|FG001|Overall Study|Death|48|||
161479631|NCT04377620|583150852|FG002|Overall Study|Death|36|||
161479632|NCT04377620|583150850|FG000|Overall Study|Withdrawal by Subject|0|||
161479633|NCT04377620|583150851|FG001|Overall Study|Withdrawal by Subject|2|||
161479634|NCT04377620|583150852|FG002|Overall Study|Withdrawal by Subject|0|||
161479635|NCT04930965|583150853|FG000|Overall Study|Lost to Follow-up|7|||
161479636|NCT04930965|583150854|FG001|Overall Study|Lost to Follow-up|5|||
161479637|NCT04189081|583150856|FG000|Overall Study|Lost to Follow-up|1|||
161479638|NCT04189081|583150857|FG001|Overall Study|Lost to Follow-up|0|||
161479639|NCT04189081|583150858|FG002|Overall Study|Lost to Follow-up|0|||
161479640|NCT04189081|583150856|FG000|Overall Study|Withdrawal by Subject|0|||
161479641|NCT04189081|583150857|FG001|Overall Study|Withdrawal by Subject|0|||
161479642|NCT04189081|583150858|FG002|Overall Study|Withdrawal by Subject|1|||
161479643|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
161479644|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
161479645|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
161479646|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
161479647|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
161479648|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
161479649|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
161479650|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
161479651|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
161479652|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
161479653|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
161479654|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
161479655|NCT00044083|583150859|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
161479656|NCT00044083|583150860|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
161479657|NCT00044083|583150859|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
161479658|NCT00044083|583150860|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
161479659|NCT00044083|583150859|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
161479660|NCT00044083|583150860|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
161479661|NCT00044083|583150859|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
161479662|NCT00044083|583150860|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
161479663|NCT00444912|583150861|FG000|Overall Study|Death|1|||
161479664|NCT00444912|583150862|FG001|Overall Study|Death|2|||
161479665|NCT00444912|583150861|FG000|Overall Study|Lost to Follow-up|1|||
161579049|NCT00703820|583508151|FG000|Overall Study|Received non-protocol therapy|1|||
161815984|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161479666|NCT00444912|583150862|FG001|Overall Study|Lost to Follow-up|0|||
161479667|NCT00444912|583150861|FG000|Overall Study|Participant Failed Mobilization|1|||
161479668|NCT00444912|583150862|FG001|Overall Study|Participant Failed Mobilization|0|||
161479669|NCT03758066|583150863|FG000|Overall Study|Lost to Follow-up|14|||
161479670|NCT00518284|583150870|FG000|Overall Study|Adverse Event|0|||
161479671|NCT00518284|583150871|FG001|Overall Study|Adverse Event|1|||
161479672|NCT00518284|583150872|FG002|Overall Study|Adverse Event|0|||
161479673|NCT00518284|583150873|FG003|Overall Study|Adverse Event|0|||
161479674|NCT00518284|583150870|FG000|Overall Study|Study Termination|0|||
161479675|NCT00518284|583150871|FG001|Overall Study|Study Termination|2|||
161479676|NCT00518284|583150872|FG002|Overall Study|Study Termination|1|||
161479677|NCT00518284|583150873|FG003|Overall Study|Study Termination|2|||
161479678|NCT03570697|583150874|FG000|Overall Study|Lost to Follow-up|0|||
161479679|NCT03570697|583150875|FG001|Overall Study|Lost to Follow-up|1|||
161479680|NCT03570697|583150874|FG000|Overall Study|Death|2|||
161479681|NCT03570697|583150875|FG001|Overall Study|Death|0|||
161479682|NCT03570697|583150874|FG000|Overall Study|Withdrawal by Subject|4|||
161479683|NCT03570697|583150875|FG001|Overall Study|Withdrawal by Subject|2|||
161479684|NCT01849783|583150876|FG000|Overall Study|Adverse Event|5|||
161479685|NCT01849783|583150876|FG000|Overall Study|Death|2|||
161479686|NCT01849783|583150876|FG000|Overall Study|Physician Decision|1|||
161479687|NCT01849783|583150876|FG000|Overall Study|Withdrawal by Subject|1|||
161479688|NCT01849783|583150876|FG000|Overall Study|Unable to comply|2|||
161479689|NCT01849783|583150876|FG000|Overall Study|Disease progression|11|||
161479690|NCT02571777|583150878|FG000|Overall Study|Subject/guardian decision|34|||
161479691|NCT02571777|583150879|FG001|Overall Study|Subject/guardian decision|26|||
161479692|NCT02571777|583150880|FG002|Overall Study|Subject/guardian decision|26|||
161479693|NCT02571777|583150881|FG003|Overall Study|Subject/guardian decision|25|||
161479694|NCT02571777|583150882|FG004|Overall Study|Subject/guardian decision|27|||
161479695|NCT02571777|583150878|FG000|Overall Study|Protocol Deviation|2|||
161479696|NCT02571777|583150879|FG001|Overall Study|Protocol Deviation|3|||
161479697|NCT02571777|583150880|FG002|Overall Study|Protocol Deviation|4|||
161479698|NCT02571777|583150881|FG003|Overall Study|Protocol Deviation|8|||
161479699|NCT02571777|583150882|FG004|Overall Study|Protocol Deviation|4|||
161479700|NCT02571777|583150878|FG000|Overall Study|Death|1|||
161479701|NCT02571777|583150879|FG001|Overall Study|Death|1|||
161479702|NCT02571777|583150880|FG002|Overall Study|Death|4|||
161479703|NCT02571777|583150881|FG003|Overall Study|Death|0|||
161479704|NCT02571777|583150882|FG004|Overall Study|Death|0|||
161479705|NCT02571777|583150878|FG000|Overall Study|Lost to Follow-up|1|||
161479706|NCT02571777|583150879|FG001|Overall Study|Lost to Follow-up|1|||
161479707|NCT02571777|583150880|FG002|Overall Study|Lost to Follow-up|2|||
161479708|NCT02571777|583150881|FG003|Overall Study|Lost to Follow-up|0|||
161479709|NCT02571777|583150882|FG004|Overall Study|Lost to Follow-up|1|||
161479710|NCT02571777|583150878|FG000|Overall Study|Physician Decision|1|||
161479711|NCT02571777|583150879|FG001|Overall Study|Physician Decision|7|||
161479712|NCT02571777|583150880|FG002|Overall Study|Physician Decision|5|||
161479713|NCT02571777|583150881|FG003|Overall Study|Physician Decision|2|||
161479714|NCT02571777|583150882|FG004|Overall Study|Physician Decision|4|||
161479715|NCT02571777|583150878|FG000|Overall Study|Pregnancy|0|||
161479716|NCT02571777|583150879|FG001|Overall Study|Pregnancy|0|||
161479717|NCT02571777|583150880|FG002|Overall Study|Pregnancy|0|||
161479718|NCT02571777|583150881|FG003|Overall Study|Pregnancy|2|||
161579050|NCT00703820|583508152|FG001|Overall Study|Received non-protocol therapy|0|||
161579051|NCT00703820|583508151|FG000|Overall Study|Physician Decision|4|||
161579052|NCT00703820|583508152|FG001|Overall Study|Physician Decision|5|||
161579053|NCT00703820|583508151|FG000|Overall Study|Withdrawal by Subject|2|||
161579054|NCT00703820|583508152|FG001|Overall Study|Withdrawal by Subject|1|||
161579055|NCT02092116|583508156|FG000|Overall Study|Withdrawal by Subject|0|||
161579056|NCT02092116|583508157|FG001|Overall Study|Withdrawal by Subject|3|||
161579057|NCT02092116|583508156|FG000|Overall Study|Adverse Event|0|||
161579058|NCT02092116|583508157|FG001|Overall Study|Adverse Event|1|||
161579059|NCT01007396|583508158|FG000|Overall Study|Lost to Follow-up|47|||
161579060|NCT01792830|583508159|FG000|Overall Study|Withdrawal by Subject|22|||
161579061|NCT01792830|583508160|FG001|Overall Study|Withdrawal by Subject|0|||
161579062|NCT01792830|583508161|FG002|Overall Study|Withdrawal by Subject|0|||
161579063|NCT01792830|583508162|FG003|Overall Study|Withdrawal by Subject|2|||
161579064|NCT01792830|583508163|FG004|Overall Study|Withdrawal by Subject|1|||
161579065|NCT01792830|583508164|FG005|Overall Study|Withdrawal by Subject|1|||
161579066|NCT01792830|583508165|FG006|Overall Study|Withdrawal by Subject|1|||
161579067|NCT01792830|583508166|FG007|Overall Study|Withdrawal by Subject|1|||
161579068|NCT01792830|583508167|FG008|Overall Study|Withdrawal by Subject|7|||
161579069|NCT01792830|583508168|FG009|Overall Study|Withdrawal by Subject|0|||
161921178|NCT01697579|584757182|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161479719|NCT02571777|583150882|FG004|Overall Study|Pregnancy|0|||
161479720|NCT03706079|583150885|FG000|Predecessor Study|Death|0|||
161479721|NCT03706079|583150886|FG001|Predecessor Study|Death|2|||
161579070|NCT01792830|583508169|FG010|Overall Study|Withdrawal by Subject|2|||
161579071|NCT01792830|583508159|FG000|Overall Study|Death|3|||
161579072|NCT01792830|583508160|FG001|Overall Study|Death|0|||
161579073|NCT01792830|583508161|FG002|Overall Study|Death|0|||
161921179|NCT01697579|584757183|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161921180|NCT01697579|584757184|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161921181|NCT01697579|584757185|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161479722|NCT03706079|583150887|FG002|Predecessor Study|Death|0|||
161479723|NCT03706079|583150888|FG003|Predecessor Study|Death|1|||
161579074|NCT01792830|583508162|FG003|Overall Study|Death|1|||
161579075|NCT01792830|583508163|FG004|Overall Study|Death|0|||
161479724|NCT03706079|583150889|FG004|Predecessor Study|Death|0|||
161479725|NCT03706079|583150890|FG005|Predecessor Study|Death|0|||
161479726|NCT03706079|583150885|FG000|Predecessor Study|Lost to Follow-up|5|||
161479727|NCT03706079|583150886|FG001|Predecessor Study|Lost to Follow-up|2|||
161479728|NCT03706079|583150887|FG002|Predecessor Study|Lost to Follow-up|0|||
161479729|NCT03706079|583150888|FG003|Predecessor Study|Lost to Follow-up|0|||
161479730|NCT03706079|583150889|FG004|Predecessor Study|Lost to Follow-up|1|||
161479731|NCT03706079|583150890|FG005|Predecessor Study|Lost to Follow-up|0|||
161479732|NCT03706079|583150885|FG000|Predecessor Study|Withdrawal by Subject|8|||
161479733|NCT03706079|583150886|FG001|Predecessor Study|Withdrawal by Subject|15|||
161479734|NCT03706079|583150887|FG002|Predecessor Study|Withdrawal by Subject|0|||
161479735|NCT03706079|583150888|FG003|Predecessor Study|Withdrawal by Subject|5|||
161479736|NCT03706079|583150889|FG004|Predecessor Study|Withdrawal by Subject|2|||
161479737|NCT03706079|583150890|FG005|Predecessor Study|Withdrawal by Subject|0|||
161479738|NCT03706079|583150885|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
161479739|NCT03706079|583150886|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
161479740|NCT03706079|583150887|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
161479741|NCT03706079|583150888|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
161479742|NCT03706079|583150889|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
161579076|NCT01792830|583508164|FG005|Overall Study|Death|0|||
161579077|NCT01792830|583508165|FG006|Overall Study|Death|1|||
161579078|NCT01792830|583508166|FG007|Overall Study|Death|0|||
161579079|NCT01792830|583508167|FG008|Overall Study|Death|1|||
161579080|NCT01792830|583508168|FG009|Overall Study|Death|0|||
161579081|NCT01792830|583508169|FG010|Overall Study|Death|1|||
161579082|NCT01792830|583508159|FG000|Overall Study|Adverse Event|0|||
161579083|NCT01792830|583508160|FG001|Overall Study|Adverse Event|0|||
161579084|NCT01792830|583508161|FG002|Overall Study|Adverse Event|0|||
161579085|NCT01792830|583508162|FG003|Overall Study|Adverse Event|0|||
161579086|NCT01792830|583508163|FG004|Overall Study|Adverse Event|0|||
161579087|NCT01792830|583508164|FG005|Overall Study|Adverse Event|0|||
161579088|NCT01792830|583508165|FG006|Overall Study|Adverse Event|0|||
161579089|NCT01792830|583508166|FG007|Overall Study|Adverse Event|0|||
161579090|NCT01792830|583508167|FG008|Overall Study|Adverse Event|1|||
161579091|NCT01792830|583508168|FG009|Overall Study|Adverse Event|0|||
161579092|NCT01792830|583508169|FG010|Overall Study|Adverse Event|0|||
161579093|NCT05274217|583508185|FG000|Overall Study|Study terminated.|11|||
161579094|NCT05274217|583508186|FG001|Overall Study|Study terminated.|0|||
161579095|NCT03811574|583508187|FG000|Overall Study|Withdrawal by Subject|2|||
161579096|NCT03811574|583508188|FG001|Overall Study|Withdrawal by Subject|4|||
161579097|NCT03811574|583508189|FG002|Overall Study|Withdrawal by Subject|0|||
161579098|NCT01697969|583508190|FG000|Overall Study|Did not meet inc/exc criteria|3|||
161579099|NCT00736853|583508195|FG000|Open-Label Period|Physician Decision|2|||
161579100|NCT00736853|583508196|FG001|Open-Label Period|Physician Decision|0|||
161579101|NCT00736853|583508197|FG002|Open-Label Period|Physician Decision|0|||
161579102|NCT00736853|583508195|FG000|Open-Label Period|Adverse Event|31|||
161579103|NCT00736853|583508196|FG001|Open-Label Period|Adverse Event|0|||
161579104|NCT00736853|583508197|FG002|Open-Label Period|Adverse Event|0|||
161579105|NCT00736853|583508195|FG000|Open-Label Period|Withdrawal by Subject|16|||
161579106|NCT00736853|583508196|FG001|Open-Label Period|Withdrawal by Subject|0|||
161579107|NCT00736853|583508197|FG002|Open-Label Period|Withdrawal by Subject|0|||
161579108|NCT00736853|583508195|FG000|Open-Label Period|Started but not treated|42|||
161579109|NCT00736853|583508196|FG001|Open-Label Period|Started but not treated|0|||
161579110|NCT00736853|583508197|FG002|Open-Label Period|Started but not treated|0|||
161579111|NCT00736853|583508195|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
161579112|NCT00736853|583508196|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
161579113|NCT00736853|583508197|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
161579114|NCT00736853|583508195|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
161579115|NCT00736853|583508196|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
161579116|NCT00736853|583508197|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
161579117|NCT00736853|583508195|FG000|Double-Blind Period|Lack of Efficacy|0|||
161579118|NCT00736853|583508196|FG001|Double-Blind Period|Lack of Efficacy|19|||
161579119|NCT00736853|583508197|FG002|Double-Blind Period|Lack of Efficacy|42|||
161579120|NCT00736853|583508195|FG000|Double-Blind Period|Adverse Event|0|||
161579121|NCT00736853|583508196|FG001|Double-Blind Period|Adverse Event|3|||
161579122|NCT00736853|583508197|FG002|Double-Blind Period|Adverse Event|2|||
161579123|NCT00736853|583508195|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161579124|NCT00736853|583508196|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161579125|NCT00736853|583508197|FG002|Double-Blind Period|Withdrawal by Subject|4|||
161579126|NCT00736853|583508195|FG000|Double-Blind Period|Ineligible to participate the study|0|||
161579127|NCT00736853|583508196|FG001|Double-Blind Period|Ineligible to participate the study|1|||
161579128|NCT00736853|583508197|FG002|Double-Blind Period|Ineligible to participate the study|0|||
161579129|NCT01764464|583508198|FG000|First Intervention|Withdrawal by Subject|1|||
161579130|NCT01764464|583508199|FG001|First Intervention|Withdrawal by Subject|0|||
161579131|NCT01764464|583508198|FG000|First Intervention|Lost to Follow-up|1|||
161579132|NCT01764464|583508199|FG001|First Intervention|Lost to Follow-up|0|||
161479743|NCT03706079|583150890|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
161479744|NCT03706079|583150885|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
161479745|NCT03706079|583150886|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
161479746|NCT03706079|583150887|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
161479747|NCT03706079|583150888|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
161479748|NCT03706079|583150889|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
161479749|NCT03706079|583150890|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
161815985|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815986|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
161815987|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815988|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815989|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161479750|NCT03706079|583150885|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
161479751|NCT03706079|583150886|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
161479752|NCT03706079|583150887|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
161479753|NCT03706079|583150888|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
161479754|NCT03706079|583150889|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
161479755|NCT03706079|583150890|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
161479756|NCT03706079|583150885|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
161479757|NCT03706079|583150886|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
161479758|NCT03706079|583150887|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
161479759|NCT03706079|583150888|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
161479760|NCT03706079|583150889|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
161479761|NCT03706079|583150890|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
161479762|NCT03706079|583150885|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
161479763|NCT03706079|583150886|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
161479764|NCT03706079|583150887|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
161479765|NCT03706079|583150888|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
161479766|NCT03706079|583150889|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
161479767|NCT03706079|583150890|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
161479768|NCT03706079|583150885|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
161579133|NCT01764464|583508198|FG000|First Intervention|Adverse Event|0|||
161815990|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815991|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815992|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815993|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815994|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815995|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815996|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815997|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815998|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815999|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816000|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816001|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816002|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816003|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816004|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816005|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816006|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816007|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816008|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816009|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816010|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816011|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816012|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816013|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
161816014|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816015|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816016|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161921182|NCT01697579|584757186|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161579134|NCT01764464|583508199|FG001|First Intervention|Adverse Event|2|||
161579135|NCT01764464|583508198|FG000|First Intervention|did not receive study drug|0|||
161579136|NCT01764464|583508199|FG001|First Intervention|did not receive study drug|1|||
161579137|NCT01764464|583508198|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
161579138|NCT01764464|583508199|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
161579139|NCT01616459|583508203|FG000|Overall Study|Adverse Event|1|||
161579140|NCT01616459|583508204|FG001|Overall Study|Adverse Event|1|||
161579141|NCT01616459|583508205|FG002|Overall Study|Adverse Event|2|||
161579142|NCT01616459|583508206|FG003|Overall Study|Adverse Event|0|||
161579143|NCT01616459|583508203|FG000|Overall Study|Lost to Follow-up|1|||
161579144|NCT01616459|583508204|FG001|Overall Study|Lost to Follow-up|11|||
161579145|NCT01616459|583508205|FG002|Overall Study|Lost to Follow-up|3|||
161579146|NCT01616459|583508206|FG003|Overall Study|Lost to Follow-up|2|||
161579147|NCT01616459|583508203|FG000|Overall Study|Protocol Violation|0|||
161579148|NCT01616459|583508204|FG001|Overall Study|Protocol Violation|0|||
161579149|NCT01616459|583508205|FG002|Overall Study|Protocol Violation|0|||
161579150|NCT01616459|583508206|FG003|Overall Study|Protocol Violation|2|||
161579151|NCT01616459|583508203|FG000|Overall Study|Withdrawal by Subject|2|||
161579152|NCT01616459|583508204|FG001|Overall Study|Withdrawal by Subject|4|||
161579153|NCT01616459|583508205|FG002|Overall Study|Withdrawal by Subject|4|||
161579154|NCT01616459|583508206|FG003|Overall Study|Withdrawal by Subject|4|||
161579155|NCT01616459|583508203|FG000|Overall Study|Other reason|0|||
161579156|NCT01616459|583508204|FG001|Overall Study|Other reason|1|||
161579157|NCT01616459|583508205|FG002|Overall Study|Other reason|1|||
161579158|NCT01616459|583508206|FG003|Overall Study|Other reason|0|||
161603596|NCT00626795|583602456|FG001|Blinded Treatment|Withdrawal by Subject|1|||
161603597|NCT00626795|583602457|FG002|Blinded Treatment|Withdrawal by Subject|0|||
161603598|NCT00626795|583602455|FG000|Blinded Treatment|Other reasons|2|||
161603599|NCT00626795|583602456|FG001|Blinded Treatment|Other reasons|0|||
161603600|NCT00626795|583602457|FG002|Blinded Treatment|Other reasons|2|||
161603601|NCT00626795|583602455|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
161603602|NCT00626795|583602456|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
161603603|NCT00626795|583602457|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
161603604|NCT04499521|583602458|FG000|Overall Study|Disease Progression|1|||
161603605|NCT04499521|583602459|FG001|Overall Study|Disease Progression|0|||
161603606|NCT05412004|583603299|FG000|Overall Study|Adverse Event|0|||
161603607|NCT05412004|583603300|FG001|Overall Study|Adverse Event|2|||
161603608|NCT05412004|583603301|FG002|Overall Study|Adverse Event|1|||
161603609|NCT05412004|583603302|FG003|Overall Study|Adverse Event|5|||
161603610|NCT05412004|583603299|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161603611|NCT05412004|583603300|FG001|Overall Study|Assigned Treatment by Mistake|10|||
161603612|NCT05412004|583603301|FG002|Overall Study|Assigned Treatment by Mistake|2|||
161603613|NCT05412004|583603302|FG003|Overall Study|Assigned Treatment by Mistake|5|||
161603614|NCT05412004|583603299|FG000|Overall Study|Lost to Follow-up|3|||
161603615|NCT05412004|583603300|FG001|Overall Study|Lost to Follow-up|0|||
161603616|NCT05412004|583603301|FG002|Overall Study|Lost to Follow-up|0|||
161603617|NCT05412004|583603302|FG003|Overall Study|Lost to Follow-up|0|||
161603618|NCT05412004|583603299|FG000|Overall Study|Patient could not travel to site|0|||
161603619|NCT05412004|583603300|FG001|Overall Study|Patient could not travel to site|1|||
161603620|NCT05412004|583603301|FG002|Overall Study|Patient could not travel to site|0|||
161603621|NCT05412004|583603302|FG003|Overall Study|Patient could not travel to site|0|||
161816017|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816018|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816019|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816020|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816021|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816022|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816023|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816024|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816025|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816026|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161921183|NCT01697579|584757180|FG000|Base Study-Cycle 1|Technical Problems|0|||
161921184|NCT01697579|584757181|FG001|Base Study-Cycle 1|Technical Problems|0|||
161603622|NCT05412004|583603299|FG000|Overall Study|Physician Decision|0|||
161603623|NCT05412004|583603300|FG001|Overall Study|Physician Decision|1|||
161603624|NCT05412004|583603301|FG002|Overall Study|Physician Decision|0|||
161603625|NCT05412004|583603302|FG003|Overall Study|Physician Decision|0|||
161603626|NCT05412004|583603299|FG000|Overall Study|Pregnancy|0|||
161603627|NCT05412004|583603300|FG001|Overall Study|Pregnancy|1|||
161603628|NCT05412004|583603301|FG002|Overall Study|Pregnancy|0|||
161603629|NCT05412004|583603302|FG003|Overall Study|Pregnancy|0|||
161603630|NCT05412004|583603299|FG000|Overall Study|Protocol Violation|1|||
161603631|NCT05412004|583603300|FG001|Overall Study|Protocol Violation|0|||
161603632|NCT05412004|583603301|FG002|Overall Study|Protocol Violation|0|||
161603633|NCT05412004|583603302|FG003|Overall Study|Protocol Violation|0|||
161479769|NCT03706079|583150886|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
161479770|NCT03706079|583150887|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
161479771|NCT03706079|583150888|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
161479772|NCT03706079|583150889|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
161479773|NCT03706079|583150890|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
161479774|NCT03706079|583150885|FG000|Long Term Extension (DESTINATION)|Death|8|||
161479775|NCT03706079|583150886|FG001|Long Term Extension (DESTINATION)|Death|2|||
161479776|NCT03706079|583150887|FG002|Long Term Extension (DESTINATION)|Death|2|||
161479777|NCT03706079|583150888|FG003|Long Term Extension (DESTINATION)|Death|1|||
161479778|NCT03706079|583150889|FG004|Long Term Extension (DESTINATION)|Death|0|||
161479779|NCT03706079|583150890|FG005|Long Term Extension (DESTINATION)|Death|0|||
161479780|NCT00329238|583150891|FG000|Overall Study|Adverse Event|147|||
161479781|NCT00329238|583150892|FG001|Overall Study|Adverse Event|129|||
161479782|NCT00329238|583150891|FG000|Overall Study|Protocol Violation|23|||
161479783|NCT00329238|583150892|FG001|Overall Study|Protocol Violation|34|||
161479784|NCT00329238|583150891|FG000|Overall Study|Lost to Follow-up|2|||
161479785|NCT00329238|583150892|FG001|Overall Study|Lost to Follow-up|6|||
161479786|NCT00329238|583150891|FG000|Overall Study|Withdrawal by Subject|64|||
161479787|NCT00329238|583150892|FG001|Overall Study|Withdrawal by Subject|58|||
161479788|NCT00329238|583150891|FG000|Overall Study|Other reason (not specified)|40|||
161479789|NCT00329238|583150892|FG001|Overall Study|Other reason (not specified)|54|||
161479790|NCT00801632|583150893|FG000|Overall Study|Re-transplant|1|||
161479791|NCT01042678|583150901|FG000|Overall Study|Physician Decision|1|||
161479792|NCT01042678|583150902|FG001|Overall Study|Physician Decision|0|||
161479793|NCT01042678|583150903|FG002|Overall Study|Physician Decision|0|||
161479794|NCT01042678|583150904|FG003|Overall Study|Physician Decision|0|||
161479795|NCT01042678|583150905|FG004|Overall Study|Physician Decision|0|||
161479796|NCT01042678|583150906|FG005|Overall Study|Physician Decision|0|||
161479797|NCT02571075|583150909|FG000|Overall Study|Lost to Follow-up|20|||
161479798|NCT02571075|583150910|FG001|Overall Study|Lost to Follow-up|24|||
161479799|NCT02197520|583150918|FG000|Period 1|Withdrawal by Subject|1|||
161479800|NCT02197520|583150919|FG001|Period 1|Withdrawal by Subject|0|||
161479801|NCT02197520|583150918|FG000|Period 2|Adverse Event|0|||
161479802|NCT02197520|583150919|FG001|Period 2|Adverse Event|2|||
161479803|NCT02197520|583150918|FG000|Period 2|Withdrawal by Subject|1|||
161479804|NCT02197520|583150919|FG001|Period 2|Withdrawal by Subject|0|||
161479805|NCT00913497|583150920|FG000|Overall Study|Adverse Event|1|||
161479806|NCT00913497|583150920|FG000|Overall Study|Withdrawal by Subject|2|||
161479807|NCT01306942|583150921|FG000|Phase I|Adverse Event|2|||
161479808|NCT01306942|583150922|FG001|Phase I|Adverse Event|2|||
161479809|NCT01306942|583150923|FG002|Phase I|Adverse Event|0|||
161479810|NCT01306942|583150924|FG003|Phase I|Adverse Event|0|||
161479811|NCT01306942|583150921|FG000|Phase I|Physician Decision|3|||
161479812|NCT01306942|583150922|FG001|Phase I|Physician Decision|1|||
161479813|NCT01306942|583150923|FG002|Phase I|Physician Decision|0|||
161479814|NCT01306942|583150924|FG003|Phase I|Physician Decision|0|||
161479815|NCT01306942|583150921|FG000|Phase II|Adverse Event|0|||
161479816|NCT01306942|583150922|FG001|Phase II|Adverse Event|0|||
161479817|NCT01306942|583150923|FG002|Phase II|Adverse Event|0|||
161479818|NCT01306942|583150924|FG003|Phase II|Adverse Event|6|||
161479819|NCT01306942|583150921|FG000|Phase II|Physician Decision|2|||
161479820|NCT01306942|583150922|FG001|Phase II|Physician Decision|0|||
161479821|NCT01306942|583150923|FG002|Phase II|Physician Decision|0|||
161479822|NCT01306942|583150924|FG003|Phase II|Physician Decision|5|||
161479823|NCT01306942|583150921|FG000|Phase II|Withdrawal by Subject|0|||
161479824|NCT01306942|583150922|FG001|Phase II|Withdrawal by Subject|0|||
161479825|NCT01306942|583150923|FG002|Phase II|Withdrawal by Subject|0|||
161479826|NCT01306942|583150924|FG003|Phase II|Withdrawal by Subject|2|||
161479827|NCT01306942|583150921|FG000|Phase II|Death|0|||
161479828|NCT01306942|583150922|FG001|Phase II|Death|0|||
161479829|NCT01306942|583150923|FG002|Phase II|Death|0|||
161479830|NCT01306942|583150924|FG003|Phase II|Death|1|||
161479831|NCT01306942|583150921|FG000|Phase II|Not finished treatment|0|||
161479832|NCT01306942|583150922|FG001|Phase II|Not finished treatment|0|||
161479833|NCT01306942|583150923|FG002|Phase II|Not finished treatment|0|||
161479834|NCT01306942|583150924|FG003|Phase II|Not finished treatment|1|||
161479835|NCT01306942|583150921|FG000|Phase II|Protocol Violation|0|||
161479836|NCT01306942|583150922|FG001|Phase II|Protocol Violation|0|||
161479837|NCT01306942|583150923|FG002|Phase II|Protocol Violation|0|||
161479838|NCT01306942|583150924|FG003|Phase II|Protocol Violation|1|||
161479839|NCT03190915|583150925|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
161479840|NCT03190915|583150925|FG000|Overall Study|Progressive Disease|3|||
161479841|NCT03988088|583150929|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
161479842|NCT03988088|583150930|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
161479843|NCT03988088|583150931|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
161479844|NCT03988088|583150932|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
161479845|NCT03988088|583150929|FG000|Open-Label Addendum|Lost to Follow-up|0|||
161479846|NCT03988088|583150930|FG001|Open-Label Addendum|Lost to Follow-up|0|||
161479847|NCT03988088|583150931|FG002|Open-Label Addendum|Lost to Follow-up|1|||
161669011|NCT02903368|583839889|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
161669012|NCT02903368|583839890|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
161669013|NCT02903368|583839891|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
161669014|NCT02903368|583839892|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
161669015|NCT05437510|583839893|FG000|Overall Study|Adverse Event|2|||
161669016|NCT05437510|583839894|FG001|Overall Study|Adverse Event|1|||
161669017|NCT05437510|583839893|FG000|Overall Study|Protocol Deviation|1|||
161669018|NCT05437510|583839894|FG001|Overall Study|Protocol Deviation|6|||
161669019|NCT05437510|583839893|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
161669020|NCT05437510|583839894|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
161669021|NCT05437510|583839893|FG000|Overall Study|Lost to Follow-up|265|||
161669022|NCT05437510|583839894|FG001|Overall Study|Lost to Follow-up|358|||
161669023|NCT03769181|583841340|FG000|Overall Study|Adverse Event|1|||
161669024|NCT03769181|583841341|FG001|Overall Study|Adverse Event|0|||
161669025|NCT03769181|583841342|FG002|Overall Study|Adverse Event|2|||
161669026|NCT03769181|583841343|FG003|Overall Study|Adverse Event|4|||
161669027|NCT03769181|583841340|FG000|Overall Study|Withdrawal by Subject|1|||
161669028|NCT03769181|583841341|FG001|Overall Study|Withdrawal by Subject|0|||
161669029|NCT03769181|583841342|FG002|Overall Study|Withdrawal by Subject|2|||
161669030|NCT03769181|583841343|FG003|Overall Study|Withdrawal by Subject|1|||
161669031|NCT03769181|583841340|FG000|Overall Study|Progressive disease|9|||
161669032|NCT03769181|583841341|FG001|Overall Study|Progressive disease|7|||
161669033|NCT03769181|583841342|FG002|Overall Study|Progressive disease|13|||
161669034|NCT03769181|583841343|FG003|Overall Study|Progressive disease|6|||
161669035|NCT03769181|583841340|FG000|Overall Study|Other - Unspecified|2|||
161669036|NCT03769181|583841341|FG001|Overall Study|Other - Unspecified|1|||
161669037|NCT03769181|583841342|FG002|Overall Study|Other - Unspecified|0|||
161669038|NCT03769181|583841343|FG003|Overall Study|Other - Unspecified|0|||
161479848|NCT03988088|583150932|FG003|Open-Label Addendum|Lost to Follow-up|0|||
161479849|NCT01546883|583150933|FG000|Overall Study|Withdrawal by Subject|3|||
161479850|NCT01546883|583150933|FG000|Overall Study|Adverse Event|4|||
161479851|NCT01546883|583150933|FG000|Overall Study|Lost to Follow-up|2|||
161479852|NCT01546883|583150933|FG000|Overall Study|early closure of study|2|||
161479853|NCT01546883|583150933|FG000|Overall Study|other unrelated illness|1|||
161479854|NCT00923156|583150936|FG000|Overall Study|Adverse Event|0|||
161479855|NCT00923156|583150937|FG001|Overall Study|Adverse Event|2|||
161479856|NCT00923156|583150938|FG002|Overall Study|Adverse Event|1|||
161479857|NCT00923156|583150936|FG000|Overall Study|Abnormal laboratory values|0|||
161479858|NCT00923156|583150937|FG001|Overall Study|Abnormal laboratory values|0|||
161479859|NCT00923156|583150938|FG002|Overall Study|Abnormal laboratory values|1|||
161479860|NCT00923156|583150936|FG000|Overall Study|Withdrawal by Subject|0|||
161479861|NCT00923156|583150937|FG001|Overall Study|Withdrawal by Subject|1|||
161479862|NCT00923156|583150938|FG002|Overall Study|Withdrawal by Subject|0|||
161479863|NCT00923156|583150936|FG000|Overall Study|Death|0|||
161479864|NCT00923156|583150937|FG001|Overall Study|Death|1|||
161479865|NCT00923156|583150938|FG002|Overall Study|Death|0|||
161479866|NCT00923156|583150936|FG000|Overall Study|Lack of Efficacy|0|||
161479867|NCT00923156|583150937|FG001|Overall Study|Lack of Efficacy|0|||
161479868|NCT00923156|583150938|FG002|Overall Study|Lack of Efficacy|1|||
161479869|NCT00191139|583150941|FG000|Overall Study|Adverse Event|2|||
161479870|NCT00191139|583150942|FG001|Overall Study|Adverse Event|6|||
161479871|NCT00191139|583150941|FG000|Overall Study|Death|2|||
161479872|NCT00191139|583150942|FG001|Overall Study|Death|0|||
161479873|NCT00191139|583150941|FG000|Overall Study|Withdrawal by Subject|0|||
161479874|NCT00191139|583150942|FG001|Overall Study|Withdrawal by Subject|3|||
161479875|NCT00191139|583150941|FG000|Overall Study|Disease Progression|0|||
161479876|NCT00191139|583150942|FG001|Overall Study|Disease Progression|1|||
161479877|NCT00191139|583150941|FG000|Overall Study|Other|1|||
161479878|NCT00191139|583150942|FG001|Overall Study|Other|2|||
161479879|NCT02465515|583150945|FG000|Overall Study|Investigator site closed|4|||
161479880|NCT02465515|583150946|FG001|Overall Study|Investigator site closed|5|||
161479881|NCT02465515|583150945|FG000|Overall Study|Withdrawal by Subject|74|||
161479882|NCT02465515|583150946|FG001|Overall Study|Withdrawal by Subject|43|||
161479883|NCT02465515|583150945|FG000|Overall Study|Physician Decision|8|||
161479884|NCT02465515|583150946|FG001|Overall Study|Physician Decision|12|||
161479885|NCT02465515|583150945|FG000|Overall Study|Lost to Follow-up|68|||
161479886|NCT02465515|583150946|FG001|Overall Study|Lost to Follow-up|51|||
161479887|NCT00816595|583150947|FG000|Overall Study|Withdrawal by Subject|2|||
161479888|NCT00816595|583150948|FG001|Overall Study|Withdrawal by Subject|0|||
161479889|NCT00481078|583150952|FG000|Overall Study|Progression of disease|11|||
161479890|NCT00481078|583150953|FG001|Overall Study|Progression of disease|11|||
161479891|NCT00481078|583150952|FG000|Overall Study|Adverse Event|15|||
161669039|NCT00826111|583841350|FG000|Overall Study|Lost to Follow-up|0|||
161479892|NCT00481078|583150953|FG001|Overall Study|Adverse Event|3|||
161479893|NCT00481078|583150952|FG000|Overall Study|Death|5|||
161479894|NCT00481078|583150953|FG001|Overall Study|Death|3|||
161479895|NCT00481078|583150952|FG000|Overall Study|Intercurrent illness|1|||
161579159|NCT03237481|583509156|FG000|Overall Study|Lost to Follow-up|1|||
161579160|NCT03237481|583509157|FG001|Overall Study|Lost to Follow-up|0|||
161579161|NCT03237481|583509158|FG002|Overall Study|Lost to Follow-up|0|||
161579162|NCT03237481|583509156|FG000|Overall Study|Protocol Violation|1|||
161579163|NCT03237481|583509157|FG001|Overall Study|Protocol Violation|0|||
161579164|NCT03237481|583509158|FG002|Overall Study|Protocol Violation|0|||
161579165|NCT03237481|583509156|FG000|Overall Study|Withdrawal by Subject|3|||
161579166|NCT03237481|583509157|FG001|Overall Study|Withdrawal by Subject|2|||
161579167|NCT03237481|583509158|FG002|Overall Study|Withdrawal by Subject|1|||
161579168|NCT04714320|583509163|FG000|Overall Study|Voluntary Withdrawal|4|||
161579169|NCT04714320|583509164|FG001|Overall Study|Voluntary Withdrawal|1|||
161579170|NCT04714320|583509165|FG002|Overall Study|Voluntary Withdrawal|2|||
161579171|NCT04714320|583509163|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161579172|NCT04714320|583509164|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161579173|NCT04714320|583509165|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
161579174|NCT04714320|583509163|FG000|Overall Study|Reason Not Specified|1|||
161579175|NCT04714320|583509164|FG001|Overall Study|Reason Not Specified|3|||
161579176|NCT04714320|583509165|FG002|Overall Study|Reason Not Specified|3|||
161579177|NCT04755660|583509166|FG000|Overall Study|Lost to Follow-up|1|||
161579178|NCT04755660|583509167|FG001|Overall Study|Lost to Follow-up|1|||
161579179|NCT04755660|583509168|FG002|Overall Study|Lost to Follow-up|0|||
161579180|NCT04755660|583509166|FG000|Overall Study|Withdrawal by Subject|0|||
161579181|NCT04755660|583509167|FG001|Overall Study|Withdrawal by Subject|1|||
161579182|NCT04755660|583509168|FG002|Overall Study|Withdrawal by Subject|1|||
161579183|NCT04755660|583509166|FG000|Overall Study|Physician Decision|0|||
161579184|NCT04755660|583509167|FG001|Overall Study|Physician Decision|0|||
161579185|NCT04755660|583509168|FG002|Overall Study|Physician Decision|1|||
161579186|NCT03873779|583509169|FG000|Overall Study|Withdrawal by Subject|1|||
161579187|NCT02581215|583509170|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
161579188|NCT02581215|583509171|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
161579189|NCT02581215|583509170|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161579190|NCT02581215|583509171|FG001|Overall Study|Eligibility Criteria Not Met|1|||
161579191|NCT04279574|583509174|FG000|Overall Study|Death|1|||
161579192|NCT04279574|583509175|FG001|Overall Study|Death|0|||
161579193|NCT04279574|583509174|FG000|Overall Study|lost restoration, tooth fracture|1|||
161579194|NCT04279574|583509175|FG001|Overall Study|lost restoration, tooth fracture|0|||
161579195|NCT04279574|583509174|FG000|Overall Study|Lost to Follow-up|0|||
161579196|NCT04279574|583509175|FG001|Overall Study|Lost to Follow-up|1|||
161579197|NCT04153565|583509177|FG000|Overall Study|Death|13|||
161579198|NCT02991807|583509179|FG000|Overall Study|Withdrawal by Subject|2|||
161579199|NCT02991807|583509180|FG001|Overall Study|Withdrawal by Subject|1|||
161579200|NCT02991807|583509179|FG000|Overall Study|Physician Decision|0|||
161579201|NCT02991807|583509180|FG001|Overall Study|Physician Decision|1|||
161579202|NCT02991807|583509179|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
161579203|NCT02991807|583509180|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
161579204|NCT02566902|583509181|FG000|Overall Study|Protocol Violation|2|||
161579205|NCT02566902|583509182|FG001|Overall Study|Protocol Violation|1|||
161579206|NCT01875848|583509183|FG000|Overall Study|Withdrawal by Subject|2|||
161579207|NCT01875848|583509184|FG001|Overall Study|Withdrawal by Subject|0|||
161579208|NCT02411084|583509185|FG000|Overall Study|Lack of Efficacy|6|||
161579209|NCT02411084|583509186|FG001|Overall Study|Lack of Efficacy|3|||
161579210|NCT02411084|583509185|FG000|Overall Study|Death|5|||
161579211|NCT02411084|583509186|FG001|Overall Study|Death|4|||
161579212|NCT02411084|583509185|FG000|Overall Study|Adverse Event|2|||
161579213|NCT02411084|583509186|FG001|Overall Study|Adverse Event|1|||
161579214|NCT02411084|583509185|FG000|Overall Study|Other reasons|0|||
161579215|NCT02411084|583509186|FG001|Overall Study|Other reasons|5|||
161579216|NCT01622868|583509187|FG000|Overall Study|Protocol Violation|7|||
161579217|NCT01622868|583509188|FG001|Overall Study|Protocol Violation|0|||
161579218|NCT03285763|583509190|FG000|Overall Study|Death|470|||
161579219|NCT03285763|583509190|FG000|Overall Study|Lost to Follow-up|18|||
161579220|NCT03285763|583509190|FG000|Overall Study|Physician Decision|2|||
161579221|NCT03285763|583509190|FG000|Overall Study|Study Terminated By Sponsor|79|||
161579222|NCT03285763|583509190|FG000|Overall Study|Withdrawal by Subject|33|||
161579223|NCT02374463|583509192|FG000|Overall Study|Withdrawal by Subject|3|||
161579224|NCT02374463|583509193|FG001|Overall Study|Withdrawal by Subject|3|||
161579225|NCT01236001|583509196|FG000|Overall Study|Adverse Event|5|||
161579226|NCT01236001|583509197|FG001|Overall Study|Adverse Event|14|||
161579227|NCT01236001|583509196|FG000|Overall Study|Lack of Efficacy|6|||
161579228|NCT01236001|583509197|FG001|Overall Study|Lack of Efficacy|6|||
161579229|NCT01236001|583509196|FG000|Overall Study|Lost to Follow-up|6|||
161579230|NCT01236001|583509197|FG001|Overall Study|Lost to Follow-up|1|||
161579231|NCT01236001|583509196|FG000|Overall Study|Incompliance|1|||
161579232|NCT01236001|583509197|FG001|Overall Study|Incompliance|0|||
161579233|NCT01236001|583509196|FG000|Overall Study|Planned Visit After End of Study|0|||
161579234|NCT01236001|583509197|FG001|Overall Study|Planned Visit After End of Study|1|||
161669040|NCT00826111|583841351|FG001|Overall Study|Lost to Follow-up|1|||
161921185|NCT01697579|584757182|FG002|Base Study-Cycle 1|Technical Problems|1|||
161921186|NCT01697579|584757183|FG003|Base Study-Cycle 1|Technical Problems|1|||
161921187|NCT01697579|584757184|FG004|Base Study-Cycle 1|Technical Problems|0|||
161921188|NCT01697579|584757185|FG005|Base Study-Cycle 1|Technical Problems|0|||
161921189|NCT01697579|584757186|FG006|Base Study-Cycle 1|Technical Problems|0|||
161921190|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Death|0|||
161921191|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Death|0|||
161921192|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Death|0|||
161921193|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Death|0|||
161921194|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Death|0|||
161921195|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Death|0|||
161921196|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Death|2|||
161921197|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161921198|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161921199|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161579235|NCT03451721|583509198|FG000|Overall Study|Death|1|||
161579236|NCT02574455|583509201|FG000|Overall Study|Death|197|||
161579237|NCT02574455|583509202|FG001|Overall Study|Death|210|||
161579238|NCT02574455|583509201|FG000|Overall Study|Withdrawal of Consent|11|||
161579239|NCT02574455|583509202|FG001|Overall Study|Withdrawal of Consent|28|||
161579240|NCT02574455|583509201|FG000|Overall Study|Lost to Follow-up|4|||
161579241|NCT02574455|583509202|FG001|Overall Study|Lost to Follow-up|4|||
161579242|NCT02574455|583509201|FG000|Overall Study|Sponsor's Decision|55|||
161579243|NCT02574455|583509202|FG001|Overall Study|Sponsor's Decision|20|||
161579244|NCT03144674|583509211|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
161579245|NCT03144674|583509212|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
161579246|NCT03144674|583509213|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
161579247|NCT03144674|583509214|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
161579248|NCT03144674|583509211|FG000|Overall Study|Death|3|||
161579249|NCT03144674|583509212|FG001|Overall Study|Death|2|||
161579250|NCT03144674|583509213|FG002|Overall Study|Death|6|||
161579251|NCT03144674|583509214|FG003|Overall Study|Death|24|||
161579252|NCT03144674|583509211|FG000|Overall Study|Lost to Follow-up|0|||
161579253|NCT03144674|583509212|FG001|Overall Study|Lost to Follow-up|1|||
161579254|NCT03144674|583509213|FG002|Overall Study|Lost to Follow-up|0|||
161579255|NCT03144674|583509214|FG003|Overall Study|Lost to Follow-up|4|||
161579256|NCT03144674|583509211|FG000|Overall Study|Withdrawal by Participant|0|||
161579257|NCT03144674|583509212|FG001|Overall Study|Withdrawal by Participant|0|||
161579258|NCT03144674|583509213|FG002|Overall Study|Withdrawal by Participant|2|||
161579259|NCT03144674|583509214|FG003|Overall Study|Withdrawal by Participant|6|||
161579260|NCT03144674|583509211|FG000|Overall Study|Discharged from the Trust|0|||
161579261|NCT03144674|583509212|FG001|Overall Study|Discharged from the Trust|0|||
161579262|NCT03144674|583509213|FG002|Overall Study|Discharged from the Trust|1|||
161579263|NCT03144674|583509214|FG003|Overall Study|Discharged from the Trust|0|||
161579264|NCT03144674|583509211|FG000|Overall Study|Exclusion Criteria Met|0|||
161579265|NCT03144674|583509212|FG001|Overall Study|Exclusion Criteria Met|0|||
161579266|NCT03144674|583509213|FG002|Overall Study|Exclusion Criteria Met|1|||
161579267|NCT03144674|583509214|FG003|Overall Study|Exclusion Criteria Met|0|||
161579268|NCT03144674|583509211|FG000|Overall Study|Changed Physicians|0|||
161579269|NCT03144674|583509212|FG001|Overall Study|Changed Physicians|0|||
161579270|NCT03144674|583509213|FG002|Overall Study|Changed Physicians|0|||
161579271|NCT03144674|583509214|FG003|Overall Study|Changed Physicians|1|||
161579272|NCT03144674|583509211|FG000|Overall Study|Removed for Safety|0|||
161579273|NCT03144674|583509212|FG001|Overall Study|Removed for Safety|0|||
161579274|NCT03144674|583509213|FG002|Overall Study|Removed for Safety|0|||
161579275|NCT03144674|583509214|FG003|Overall Study|Removed for Safety|1|||
161579276|NCT03144674|583509211|FG000|Overall Study|Site Closed|0|||
161579277|NCT03144674|583509212|FG001|Overall Study|Site Closed|0|||
161579278|NCT03144674|583509213|FG002|Overall Study|Site Closed|0|||
161579279|NCT03144674|583509214|FG003|Overall Study|Site Closed|1|||
161579280|NCT03144674|583509211|FG000|Overall Study|Histological Criteria Not Met|0|||
161579281|NCT03144674|583509212|FG001|Overall Study|Histological Criteria Not Met|0|||
161579282|NCT03144674|583509213|FG002|Overall Study|Histological Criteria Not Met|0|||
161579283|NCT03144674|583509214|FG003|Overall Study|Histological Criteria Not Met|1|||
161579284|NCT03144674|583509211|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
161579285|NCT03144674|583509212|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
161579286|NCT03144674|583509213|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
161579287|NCT03144674|583509214|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
161579288|NCT03144674|583509211|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161579289|NCT03144674|583509212|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161579290|NCT03144674|583509213|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161579291|NCT03144674|583509214|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
161479896|NCT00481078|583150953|FG001|Overall Study|Intercurrent illness|0|||
161479897|NCT00481078|583150952|FG000|Overall Study|Withdrawal by Subject|7|||
161479898|NCT00481078|583150953|FG001|Overall Study|Withdrawal by Subject|1|||
161479899|NCT00481078|583150952|FG000|Overall Study|Information not available|1|||
161479900|NCT00481078|583150953|FG001|Overall Study|Information not available|0|||
161479901|NCT00481078|583150952|FG000|Overall Study|Received other treatment|2|||
161479902|NCT00481078|583150953|FG001|Overall Study|Received other treatment|1|||
161479903|NCT00481078|583150952|FG000|Overall Study|Brain metastasis|0|||
161479904|NCT00481078|583150953|FG001|Overall Study|Brain metastasis|1|||
161479905|NCT00228384|583150954|FG000|Overall Study|Death|9|||
161479906|NCT00228384|583150955|FG001|Overall Study|Death|3|||
161479907|NCT00228384|583150954|FG000|Overall Study|Lost to Follow-up|6|||
161479908|NCT00228384|583150955|FG001|Overall Study|Lost to Follow-up|10|||
161479909|NCT00228384|583150954|FG000|Overall Study|Surgical Intervention (bypass)|5|||
161479910|NCT00228384|583150955|FG001|Overall Study|Surgical Intervention (bypass)|5|||
161479911|NCT00228384|583150954|FG000|Overall Study|Withdrawal by Subject|9|||
161479912|NCT00228384|583150955|FG001|Overall Study|Withdrawal by Subject|10|||
161479913|NCT00228384|583150954|FG000|Overall Study|Physician Decision|0|||
161479914|NCT00228384|583150955|FG001|Overall Study|Physician Decision|1|||
161479915|NCT01970397|583152641|FG000|Overall Study|Adverse Event|0|||
161479916|NCT01970397|583152642|FG001|Overall Study|Adverse Event|1|||
161479917|NCT01970397|583152641|FG000|Overall Study|Lost to Follow-up|0|||
161479918|NCT01970397|583152642|FG001|Overall Study|Lost to Follow-up|1|||
161479919|NCT01970397|583152641|FG000|Overall Study|Personal Reasons|1|||
161479920|NCT01970397|583152642|FG001|Overall Study|Personal Reasons|2|||
161479921|NCT01970397|583152641|FG000|Overall Study|Protocol Violation|1|||
161479922|NCT01970397|583152642|FG001|Overall Study|Protocol Violation|1|||
161479923|NCT01389817|583152643|FG000|Overall Study|Physician Decision|1|||
161479924|NCT01389817|583152644|FG001|Overall Study|Physician Decision|0|||
161479925|NCT01389817|583152643|FG000|Overall Study|Lost to Follow-up|1|||
161479926|NCT01389817|583152644|FG001|Overall Study|Lost to Follow-up|0|||
161479927|NCT01389817|583152643|FG000|Overall Study|Withdrawal by Subject|2|||
161479928|NCT01389817|583152644|FG001|Overall Study|Withdrawal by Subject|0|||
161479929|NCT01749137|583152645|FG000|Overall Study|Adverse Event|4|||
161479930|NCT01749137|583152646|FG001|Overall Study|Adverse Event|4|||
161479931|NCT01749137|583152645|FG000|Overall Study|Lost to Follow-up|2|||
161479932|NCT01749137|583152646|FG001|Overall Study|Lost to Follow-up|3|||
161479933|NCT01749137|583152645|FG000|Overall Study|Physician Decision|1|||
161479934|NCT01749137|583152646|FG001|Overall Study|Physician Decision|0|||
161479935|NCT01749137|583152645|FG000|Overall Study|Withdrawal by Subject|8|||
161479936|NCT01749137|583152646|FG001|Overall Study|Withdrawal by Subject|4|||
161479937|NCT04980040|583152648|FG000|Overall Study|Violated the Inclusion Criteria|260|||
161479938|NCT04980040|583152648|FG000|Overall Study|Violated the Administration & Dosage|225|||
161479939|NCT04980040|583152648|FG000|Overall Study|Lost to Safety-Follow-up|4|||
161479940|NCT04980040|583152648|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
161479941|NCT01408485|583152649|FG000|Overall Study|Withdrawal by Subject|21|||
161479942|NCT01342796|583152650|FG000|Overall Study|Withdrawal by Subject|2|||
161479943|NCT01342796|583152651|FG001|Overall Study|Withdrawal by Subject|0|||
161479944|NCT01342796|583152650|FG000|Overall Study|Lost to Follow-up|0|||
161479945|NCT01342796|583152651|FG001|Overall Study|Lost to Follow-up|3|||
161479946|NCT01342796|583152650|FG000|Overall Study|Inappropriate enrollment|1|||
161479947|NCT01342796|583152651|FG001|Overall Study|Inappropriate enrollment|0|||
161479948|NCT03130257|583152652|FG000|Overall Study|Withdrawal by Subject|1|||
161479949|NCT03130257|583152653|FG001|Overall Study|Withdrawal by Subject|0|||
161479950|NCT03130257|583152654|FG002|Overall Study|Withdrawal by Subject|2|||
161479951|NCT01751867|583152655|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
161479952|NCT01751867|583152656|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
161479953|NCT01751867|583152655|FG000|Overall Study|Diease Progression|4|||
161479954|NCT01751867|583152656|FG001|Overall Study|Diease Progression|18|||
161479955|NCT01751867|583152655|FG000|Overall Study|Adverse Event|8|||
161479956|NCT01751867|583152656|FG001|Overall Study|Adverse Event|15|||
161479957|NCT01751867|583152655|FG000|Overall Study|Poor Compliance|0|||
161479958|NCT01751867|583152656|FG001|Overall Study|Poor Compliance|5|||
161479959|NCT01751867|583152655|FG000|Overall Study|Withdrawal by Subject|3|||
161479960|NCT01751867|583152656|FG001|Overall Study|Withdrawal by Subject|1|||
161479961|NCT01751867|583152655|FG000|Overall Study|Physician Decision|4|||
161479962|NCT01751867|583152656|FG001|Overall Study|Physician Decision|7|||
161479963|NCT01751867|583152655|FG000|Overall Study|Protocol Violation|0|||
161479964|NCT01751867|583152656|FG001|Overall Study|Protocol Violation|2|||
161479965|NCT01751867|583152655|FG000|Overall Study|Death|0|||
161479966|NCT01751867|583152656|FG001|Overall Study|Death|5|||
161479967|NCT01751867|583152655|FG000|Overall Study|Other|11|||
161479968|NCT01751867|583152656|FG001|Overall Study|Other|37|||
161479969|NCT01751867|583152655|FG000|Overall Study|Randomized but not treated.|2|||
161479970|NCT01751867|583152656|FG001|Overall Study|Randomized but not treated.|1|||
161479971|NCT01508650|583152657|FG000|Overall Study|Lost to Follow-up|0|||
161479972|NCT01508650|583152658|FG001|Overall Study|Lost to Follow-up|3|||
161479973|NCT02064894|583152659|FG000|Overall Study|Withdrawal by Subject|43|||
161479974|NCT02064894|583152660|FG001|Overall Study|Withdrawal by Subject|102|||
161479975|NCT02064894|583152661|FG002|Overall Study|Withdrawal by Subject|115|||
161669041|NCT00826111|583841350|FG000|Overall Study|Protocol Violation|1|||
161669042|NCT00826111|583841351|FG001|Overall Study|Protocol Violation|0|||
161669043|NCT00826111|583841350|FG000|Overall Study|Withdrawal by Subject|5|||
161669044|NCT00826111|583841351|FG001|Overall Study|Withdrawal by Subject|0|||
161669045|NCT00826111|583841350|FG000|Overall Study|Physician Decision|1|||
161669046|NCT00826111|583841351|FG001|Overall Study|Physician Decision|1|||
161669047|NCT01195545|583841352|FG000|Overall Study|Protocol Violation|4|||
161669048|NCT01929980|583841353|FG000|Overall Study|Physician Decision|1|||
161669049|NCT00792805|583841354|FG000|Overall Study|Adverse Event|12|||
161669050|NCT00792805|583841355|FG001|Overall Study|Adverse Event|10|||
161669051|NCT00792805|583841356|FG002|Overall Study|Adverse Event|10|||
161669052|NCT00792805|583841354|FG000|Overall Study|Subject withdrew consent|5|||
161669053|NCT00792805|583841355|FG001|Overall Study|Subject withdrew consent|6|||
161669054|NCT00792805|583841356|FG002|Overall Study|Subject withdrew consent|5|||
161669055|NCT00792805|583841354|FG000|Overall Study|Administrative problems|2|||
161479976|NCT01976338|583152662|FG000|Overall Study|Physician Decision|0|||
161479977|NCT01976338|583152663|FG001|Overall Study|Physician Decision|1|||
161479978|NCT01976338|583152662|FG000|Overall Study|Lost to Follow-up|3|||
161479979|NCT01976338|583152663|FG001|Overall Study|Lost to Follow-up|0|||
161479980|NCT01976338|583152662|FG000|Overall Study|Withdrawal by Subject|5|||
161479981|NCT01976338|583152663|FG001|Overall Study|Withdrawal by Subject|2|||
161479982|NCT01976338|583152662|FG000|Overall Study|Adverse Event|5|||
161479983|NCT01976338|583152663|FG001|Overall Study|Adverse Event|1|||
161479984|NCT05988619|583152664|FG000|Overall Study|Lost to Follow-up|1|||
161479985|NCT05988619|583152665|FG001|Overall Study|Lost to Follow-up|4|||
161479986|NCT05988619|583152664|FG000|Overall Study|Withdrawal by Subject|2|||
161479987|NCT05988619|583152665|FG001|Overall Study|Withdrawal by Subject|9|||
161479988|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Death|0|||
161479989|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Death|0|||
161479990|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Death|0|||
161479991|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Death|0|||
161479992|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Death|1|||
161479993|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Death|0|||
161479994|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Death|0|||
161479995|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Death|0|||
161479996|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
161479997|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
161479998|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
161479999|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
161480000|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
161480001|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
161579292|NCT05510245|583509215|FG000|Overall Study|Withdrawal by Subject|1|||
161579293|NCT05510245|583509216|FG001|Overall Study|Withdrawal by Subject|0|||
161579294|NCT05510245|583509217|FG002|Overall Study|Withdrawal by Subject|0|||
161579295|NCT01373346|583509218|FG000|Overall Study|Death|1|||
161579296|NCT01198028|583509219|FG000|Overall Study|Adverse Event|5|||
161579297|NCT01198028|583509219|FG000|Overall Study|Death|3|||
161579298|NCT01198028|583509219|FG000|Overall Study|Physician Decision|2|||
161579299|NCT01395758|583509221|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
161579300|NCT01395758|583509222|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161579301|NCT01395758|583509223|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161669056|NCT00792805|583841355|FG001|Overall Study|Administrative problems|0|||
161816027|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816028|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816029|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816030|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816031|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816032|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816033|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161480002|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
161480003|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
161579302|NCT01565148|583509224|FG000|Overall Study|Withdrawal by Subject|1|||
161579303|NCT01565148|583509225|FG001|Overall Study|Withdrawal by Subject|1|||
161669057|NCT00792805|583841356|FG002|Overall Study|Administrative problems|4|||
161816034|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161669058|NCT00792805|583841354|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161669059|NCT00792805|583841355|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161669060|NCT00792805|583841356|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161669061|NCT00792805|583841354|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161480004|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
161480005|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
161480006|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
161480007|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
161480008|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
161480009|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
161480010|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
161480011|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
161480012|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
161480013|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
161480014|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
161480015|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
161480016|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
161480017|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
161480018|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
161480019|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
161480020|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
161480021|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
161480022|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
161480023|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
161480024|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
161480025|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
161480026|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
161480027|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
161480028|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
161480029|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
161480030|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
161480031|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
161480032|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
161480033|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
161480034|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
161480035|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
161480036|NCT00726232|583152666|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
161480037|NCT00726232|583152667|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480038|NCT00726232|583152668|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480039|NCT00726232|583152669|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480040|NCT00726232|583152670|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480041|NCT00726232|583152671|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480042|NCT00726232|583152672|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480043|NCT00726232|583152673|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
161480044|NCT00726232|583152666|FG000|Expansion Phase|Death|0|||
161480045|NCT00726232|583152667|FG001|Expansion Phase|Death|0|||
161480046|NCT00726232|583152668|FG002|Expansion Phase|Death|0|||
161480047|NCT00726232|583152669|FG003|Expansion Phase|Death|0|||
161480048|NCT00726232|583152670|FG004|Expansion Phase|Death|0|||
161480049|NCT00726232|583152671|FG005|Expansion Phase|Death|0|||
161480050|NCT00726232|583152672|FG006|Expansion Phase|Death|0|||
161579304|NCT01565148|583509226|FG002|Overall Study|Withdrawal by Subject|1|||
161579305|NCT01565148|583509227|FG003|Overall Study|Withdrawal by Subject|2|||
161579306|NCT01565148|583509224|FG000|Overall Study|Lost to Follow-up|4|||
161579307|NCT01565148|583509225|FG001|Overall Study|Lost to Follow-up|4|||
161579308|NCT01565148|583509226|FG002|Overall Study|Lost to Follow-up|0|||
161579309|NCT01565148|583509227|FG003|Overall Study|Lost to Follow-up|3|||
161579310|NCT01565148|583509224|FG000|Overall Study|Rescue Therapy|8|||
161579311|NCT01565148|583509225|FG001|Overall Study|Rescue Therapy|5|||
161579312|NCT01565148|583509226|FG002|Overall Study|Rescue Therapy|5|||
161579313|NCT01565148|583509227|FG003|Overall Study|Rescue Therapy|8|||
161579314|NCT01565148|583509224|FG000|Overall Study|Death|0|||
161579315|NCT01565148|583509225|FG001|Overall Study|Death|0|||
161579316|NCT01565148|583509226|FG002|Overall Study|Death|1|||
161579317|NCT01565148|583509227|FG003|Overall Study|Death|0|||
161480051|NCT00726232|583152673|FG007|Expansion Phase|Death|1|||
161480052|NCT00726232|583152666|FG000|Expansion Phase|Adverse Event|0|||
161480053|NCT00726232|583152667|FG001|Expansion Phase|Adverse Event|0|||
161480054|NCT00726232|583152668|FG002|Expansion Phase|Adverse Event|0|||
161579318|NCT01565148|583509224|FG000|Overall Study|Physician Decision|2|||
161579319|NCT01565148|583509225|FG001|Overall Study|Physician Decision|5|||
161579320|NCT01565148|583509226|FG002|Overall Study|Physician Decision|0|||
161579321|NCT01565148|583509227|FG003|Overall Study|Physician Decision|0|||
161669062|NCT00792805|583841355|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161669063|NCT00792805|583841356|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
161480055|NCT00726232|583152669|FG003|Expansion Phase|Adverse Event|0|||
161480056|NCT00726232|583152670|FG004|Expansion Phase|Adverse Event|0|||
161480057|NCT00726232|583152671|FG005|Expansion Phase|Adverse Event|0|||
161480058|NCT00726232|583152672|FG006|Expansion Phase|Adverse Event|6|||
161480059|NCT00726232|583152673|FG007|Expansion Phase|Adverse Event|11|||
161480060|NCT00726232|583152666|FG000|Expansion Phase|Withdrawal by Subject|0|||
161480061|NCT00726232|583152667|FG001|Expansion Phase|Withdrawal by Subject|0|||
161480062|NCT00726232|583152668|FG002|Expansion Phase|Withdrawal by Subject|0|||
161480063|NCT00726232|583152669|FG003|Expansion Phase|Withdrawal by Subject|0|||
161480064|NCT00726232|583152670|FG004|Expansion Phase|Withdrawal by Subject|0|||
161669064|NCT00792805|583841354|FG000|Overall Study|Lost to Follow-up|1|||
161669065|NCT00792805|583841355|FG001|Overall Study|Lost to Follow-up|1|||
161669066|NCT00792805|583841356|FG002|Overall Study|Lost to Follow-up|6|||
161669067|NCT00792805|583841354|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161669068|NCT00792805|583841355|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161669069|NCT00792805|583841356|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161921200|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161480065|NCT00726232|583152671|FG005|Expansion Phase|Withdrawal by Subject|0|||
161480066|NCT00726232|583152672|FG006|Expansion Phase|Withdrawal by Subject|2|||
161480067|NCT00726232|583152673|FG007|Expansion Phase|Withdrawal by Subject|3|||
161480068|NCT00726232|583152666|FG000|Expansion Phase|Disease progression|0|||
161480069|NCT00726232|583152667|FG001|Expansion Phase|Disease progression|0|||
161480070|NCT00726232|583152668|FG002|Expansion Phase|Disease progression|0|||
161480071|NCT00726232|583152669|FG003|Expansion Phase|Disease progression|0|||
161480072|NCT00726232|583152670|FG004|Expansion Phase|Disease progression|0|||
161480073|NCT00726232|583152671|FG005|Expansion Phase|Disease progression|0|||
161480074|NCT00726232|583152672|FG006|Expansion Phase|Disease progression|4|||
161480075|NCT00726232|583152673|FG007|Expansion Phase|Disease progression|0|||
161480076|NCT00726232|583152666|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
161480077|NCT00726232|583152667|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
161480078|NCT00726232|583152668|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
161480079|NCT00726232|583152669|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
161480080|NCT00726232|583152670|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
161480081|NCT00726232|583152671|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
161480082|NCT00726232|583152672|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
161480083|NCT00726232|583152673|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
161480084|NCT00726232|583152666|FG000|Expansion Phase|Per Investigator: lack of response|0|||
161480085|NCT00726232|583152667|FG001|Expansion Phase|Per Investigator: lack of response|0|||
161480086|NCT00726232|583152668|FG002|Expansion Phase|Per Investigator: lack of response|0|||
161480087|NCT00726232|583152669|FG003|Expansion Phase|Per Investigator: lack of response|0|||
161480088|NCT00726232|583152670|FG004|Expansion Phase|Per Investigator: lack of response|0|||
161480089|NCT00726232|583152671|FG005|Expansion Phase|Per Investigator: lack of response|0|||
161480090|NCT00726232|583152672|FG006|Expansion Phase|Per Investigator: lack of response|1|||
161480091|NCT00726232|583152673|FG007|Expansion Phase|Per Investigator: lack of response|7|||
161480092|NCT00726232|583152666|FG000|Expansion Phase|Unspecified reason|0|||
161480093|NCT00726232|583152667|FG001|Expansion Phase|Unspecified reason|0|||
161480094|NCT00726232|583152668|FG002|Expansion Phase|Unspecified reason|0|||
161480095|NCT00726232|583152669|FG003|Expansion Phase|Unspecified reason|0|||
161480096|NCT00726232|583152670|FG004|Expansion Phase|Unspecified reason|0|||
161480097|NCT00726232|583152671|FG005|Expansion Phase|Unspecified reason|0|||
161480098|NCT00726232|583152672|FG006|Expansion Phase|Unspecified reason|1|||
161480099|NCT00726232|583152673|FG007|Expansion Phase|Unspecified reason|0|||
161480100|NCT02864498|583152674|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
161480101|NCT02864498|583152675|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
161480102|NCT02864498|583152676|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
161480103|NCT02864498|583152674|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
161480104|NCT02864498|583152675|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
161480105|NCT02864498|583152676|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
161480106|NCT02864498|583152674|FG000|Overall Study|Investigator Discretion|0|||
161480107|NCT02864498|583152675|FG001|Overall Study|Investigator Discretion|2|||
161480108|NCT02864498|583152676|FG002|Overall Study|Investigator Discretion|1|||
161480109|NCT02864498|583152674|FG000|Overall Study|Lost to Follow-up|8|||
161480110|NCT02864498|583152675|FG001|Overall Study|Lost to Follow-up|6|||
161480111|NCT02864498|583152676|FG002|Overall Study|Lost to Follow-up|3|||
161480112|NCT02864498|583152674|FG000|Overall Study|Lack of Efficacy|5|||
161480113|NCT02864498|583152675|FG001|Overall Study|Lack of Efficacy|3|||
161480114|NCT02864498|583152676|FG002|Overall Study|Lack of Efficacy|3|||
161480115|NCT02864498|583152674|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
161549105|NCT00871351|583400999|FG002|Overall Study|Withdrawal by Subject|0|||
161669070|NCT00792805|583841354|FG000|Overall Study|Protocol deviation|0|||
161480116|NCT02864498|583152675|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
161480117|NCT02864498|583152676|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
161480118|NCT02864498|583152674|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
161480119|NCT02864498|583152675|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
161480120|NCT02864498|583152676|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
161480121|NCT02864498|583152674|FG000|Overall Study|Subject moved out of the country.|0|||
161480122|NCT02864498|583152675|FG001|Overall Study|Subject moved out of the country.|0|||
161480123|NCT02864498|583152676|FG002|Overall Study|Subject moved out of the country.|1|||
161480124|NCT00705484|583152679|FG000|Overall Study|Adverse Event|28|||
161480125|NCT00705484|583152680|FG001|Overall Study|Adverse Event|27|||
161480126|NCT00705484|583152679|FG000|Overall Study|Lost to Follow-up|169|||
161480127|NCT00705484|583152680|FG001|Overall Study|Lost to Follow-up|250|||
161480128|NCT00705484|583152679|FG000|Overall Study|Withdrawal by Subject|96|||
161480129|NCT00705484|583152680|FG001|Overall Study|Withdrawal by Subject|72|||
161480130|NCT00705484|583152679|FG000|Overall Study|Administrative|89|||
161480131|NCT00705484|583152680|FG001|Overall Study|Administrative|59|||
161480132|NCT02197247|583152681|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
161549106|NCT00871351|583400997|FG000|Overall Study|Adverse Event|3|||
161816035|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
161816036|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
161816037|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
161549107|NCT00871351|583400998|FG001|Overall Study|Adverse Event|1|||
161549108|NCT00871351|583400999|FG002|Overall Study|Adverse Event|0|||
161549109|NCT00744237|583401000|FG000|Overall Study|Lack of Efficacy|1|||
161549110|NCT00744237|583401001|FG001|Overall Study|Lack of Efficacy|1|||
161549111|NCT00744237|583401002|FG002|Overall Study|Lack of Efficacy|0|||
161549112|NCT00744237|583401000|FG000|Overall Study|Withdrawal by Subject|9|||
161549113|NCT00744237|583401001|FG001|Overall Study|Withdrawal by Subject|5|||
161549114|NCT00744237|583401002|FG002|Overall Study|Withdrawal by Subject|3|||
161549115|NCT00744237|583401000|FG000|Overall Study|Lost to Follow-up|1|||
161549116|NCT00744237|583401001|FG001|Overall Study|Lost to Follow-up|1|||
161549117|NCT00744237|583401002|FG002|Overall Study|Lost to Follow-up|1|||
161549118|NCT00744237|583401000|FG000|Overall Study|Protocol Violation|3|||
161549119|NCT00744237|583401001|FG001|Overall Study|Protocol Violation|4|||
161549120|NCT00744237|583401002|FG002|Overall Study|Protocol Violation|3|||
161549121|NCT00744237|583401000|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
161549122|NCT00744237|583401001|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
161549123|NCT00744237|583401002|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
161549124|NCT00744237|583401000|FG000|Overall Study|Dosing Error|1|||
161549125|NCT00744237|583401001|FG001|Overall Study|Dosing Error|0|||
161549126|NCT00744237|583401002|FG002|Overall Study|Dosing Error|1|||
161549127|NCT00744237|583401000|FG000|Overall Study|Study Drug Error|1|||
161549128|NCT00744237|583401001|FG001|Overall Study|Study Drug Error|0|||
161549129|NCT00744237|583401002|FG002|Overall Study|Study Drug Error|0|||
161549130|NCT00744237|583401000|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161549131|NCT00744237|583401001|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161549132|NCT00744237|583401002|FG002|Overall Study|Prohibited Concomitant Medication|1|||
161549133|NCT00744237|583401000|FG000|Overall Study|Poor Compliance|0|||
161549134|NCT00744237|583401001|FG001|Overall Study|Poor Compliance|2|||
161549135|NCT00744237|583401002|FG002|Overall Study|Poor Compliance|0|||
161549136|NCT00744237|583401000|FG000|Overall Study|Administrative. Site Closed|1|||
161549137|NCT00744237|583401001|FG001|Overall Study|Administrative. Site Closed|1|||
161549138|NCT00744237|583401002|FG002|Overall Study|Administrative. Site Closed|1|||
161549139|NCT00744237|583401000|FG000|Overall Study|Adverse Event|9|||
161549140|NCT00744237|583401001|FG001|Overall Study|Adverse Event|13|||
161549141|NCT00744237|583401002|FG002|Overall Study|Adverse Event|5|||
161549142|NCT02032173|583401005|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
161549143|NCT02291289|583401009|FG000|Induction Treatment|Withdrawal by Subject|0|||
161549144|NCT02291289|583401010|FG001|Induction Treatment|Withdrawal by Subject|0|||
161549145|NCT02291289|583401011|FG002|Induction Treatment|Withdrawal by Subject|0|||
161549146|NCT02291289|583401012|FG003|Induction Treatment|Withdrawal by Subject|24|||
161549147|NCT02291289|583401013|FG004|Induction Treatment|Withdrawal by Subject|0|||
161549148|NCT02291289|583401014|FG005|Induction Treatment|Withdrawal by Subject|0|||
161549149|NCT02291289|583401015|FG006|Induction Treatment|Withdrawal by Subject|0|||
161549150|NCT02291289|583401016|FG007|Induction Treatment|Withdrawal by Subject|0|||
161549151|NCT02291289|583401017|FG008|Induction Treatment|Withdrawal by Subject|0|||
161549152|NCT02291289|583401018|FG009|Induction Treatment|Withdrawal by Subject|18|||
161549153|NCT02291289|583401019|FG010|Induction Treatment|Withdrawal by Subject|0|||
161549154|NCT02291289|583401020|FG011|Induction Treatment|Withdrawal by Subject|0|||
161549155|NCT02291289|583401021|FG012|Induction Treatment|Withdrawal by Subject|0|||
161549156|NCT02291289|583401009|FG000|Induction Treatment|Adverse Event|0|||
161549157|NCT02291289|583401010|FG001|Induction Treatment|Adverse Event|0|||
161579322|NCT01759771|583509228|FG000|Overall Study|Withdrawal by Subject|1|||
161579323|NCT01759771|583509229|FG001|Overall Study|Withdrawal by Subject|1|||
161579324|NCT00529659|583509232|FG000|Overall Study|Adverse Event|8|||
161579325|NCT00529659|583509233|FG001|Overall Study|Adverse Event|7|||
161579326|NCT00529659|583509232|FG000|Overall Study|Lost to Follow-up|0|||
161579327|NCT00529659|583509233|FG001|Overall Study|Lost to Follow-up|2|||
161579328|NCT00529659|583509232|FG000|Overall Study|Physician Decision|0|||
161579329|NCT00529659|583509233|FG001|Overall Study|Physician Decision|2|||
161579330|NCT00529659|583509232|FG000|Overall Study|Protocol Violation|2|||
161579331|NCT00529659|583509233|FG001|Overall Study|Protocol Violation|6|||
161579332|NCT00529659|583509232|FG000|Overall Study|Withdrawal by Subject|1|||
161579333|NCT00529659|583509233|FG001|Overall Study|Withdrawal by Subject|6|||
161579334|NCT01692730|583509236|FG000|Overall Study|Lost to Follow-up|225|||
161579335|NCT01692730|583509237|FG001|Overall Study|Lost to Follow-up|227|||
161579336|NCT01415349|583509238|FG000|Treatment Period 1|Adverse Event|0|||
161579337|NCT01415349|583509239|FG001|Treatment Period 1|Adverse Event|1|||
161579338|NCT01415349|583509238|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161579339|NCT01415349|583509239|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161579340|NCT02139943|583509240|FG000|Overall Study|Adverse Event|0|||
161579341|NCT02139943|583509241|FG001|Overall Study|Adverse Event|1|||
161579342|NCT02139943|583509242|FG002|Overall Study|Adverse Event|2|||
161579343|NCT02139943|583509240|FG000|Overall Study|Lost to Follow-up|3|||
161579344|NCT02139943|583509241|FG001|Overall Study|Lost to Follow-up|2|||
161579345|NCT02139943|583509242|FG002|Overall Study|Lost to Follow-up|2|||
161579346|NCT02139943|583509240|FG000|Overall Study|Withdrawal by Subject|4|||
161579347|NCT02139943|583509241|FG001|Overall Study|Withdrawal by Subject|3|||
161579348|NCT02139943|583509242|FG002|Overall Study|Withdrawal by Subject|0|||
161579349|NCT02139943|583509240|FG000|Overall Study|Other|0|||
161579350|NCT02139943|583509241|FG001|Overall Study|Other|0|||
161579351|NCT02139943|583509242|FG002|Overall Study|Other|1|||
161579352|NCT02139943|583509240|FG000|Overall Study|Participant wishes to discontinue|2|||
161579353|NCT02139943|583509241|FG001|Overall Study|Participant wishes to discontinue|0|||
161579354|NCT02139943|583509242|FG002|Overall Study|Participant wishes to discontinue|0|||
161579355|NCT02139943|583509240|FG000|Overall Study|Participant in Poor Compliance|1|||
161579356|NCT02139943|583509241|FG001|Overall Study|Participant in Poor Compliance|0|||
161579357|NCT02139943|583509242|FG002|Overall Study|Participant in Poor Compliance|1|||
161579358|NCT02139943|583509240|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
161579359|NCT02139943|583509241|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
161579360|NCT02139943|583509242|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
161579361|NCT01041417|583509243|FG000|Overall Study|Adverse Event|5|||
161579362|NCT01041417|583509244|FG001|Overall Study|Adverse Event|2|||
161579363|NCT01041417|583509243|FG000|Overall Study|Lost to Follow-up|1|||
161579364|NCT01041417|583509244|FG001|Overall Study|Lost to Follow-up|1|||
161579365|NCT01041417|583509243|FG000|Overall Study|Death|1|||
161579366|NCT01041417|583509244|FG001|Overall Study|Death|0|||
161579367|NCT02918071|583509250|FG000|Overall Study|Withdrawal by Subject|2|||
161579368|NCT02918071|583509250|FG000|Overall Study|Lost to Follow-up|1|||
161579369|NCT03960463|583511065|FG000|Overall Study|Withdrawal by Subject|2|||
161579370|NCT03960463|583511066|FG001|Overall Study|Withdrawal by Subject|0|||
161579371|NCT03422276|583511067|FG000|Overall Study|Withdrawal by Subject|21|||
161579372|NCT03422276|583511068|FG001|Overall Study|Withdrawal by Subject|25|||
161579373|NCT03422276|583511069|FG002|Overall Study|Withdrawal by Subject|14|||
161579374|NCT03422276|583511070|FG003|Overall Study|Withdrawal by Subject|16|||
161579375|NCT03422276|583511067|FG000|Overall Study|Death|14|||
161579376|NCT03422276|583511068|FG001|Overall Study|Death|21|||
161579377|NCT03422276|583511069|FG002|Overall Study|Death|3|||
161579378|NCT03422276|583511070|FG003|Overall Study|Death|1|||
161579379|NCT03422276|583511067|FG000|Overall Study|Discontinued, ineligible|4|||
161579380|NCT03422276|583511068|FG001|Overall Study|Discontinued, ineligible|3|||
161579381|NCT03422276|583511069|FG002|Overall Study|Discontinued, ineligible|0|||
161579382|NCT03422276|583511070|FG003|Overall Study|Discontinued, ineligible|0|||
161579383|NCT03422276|583511067|FG000|Overall Study|Lost to Follow-up|15|||
161579384|NCT03422276|583511068|FG001|Overall Study|Lost to Follow-up|8|||
161816038|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
161816039|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
161579385|NCT03422276|583511069|FG002|Overall Study|Lost to Follow-up|13|||
161579386|NCT03422276|583511070|FG003|Overall Study|Lost to Follow-up|4|||
161579387|NCT03422276|583511067|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
161579388|NCT03422276|583511068|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
161579389|NCT03422276|583511069|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
161579390|NCT03422276|583511070|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
161579391|NCT03422276|583511067|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
161579392|NCT03422276|583511068|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
161579393|NCT03422276|583511069|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
161579394|NCT03422276|583511070|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
161816040|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
161480133|NCT02197247|583152681|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
161480134|NCT02197247|583152681|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
161480135|NCT02197247|583152681|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
161480136|NCT02197247|583152681|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
161480137|NCT02197247|583152681|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
161816041|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
161816042|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
161816043|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
161816044|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
161816045|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
161816046|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
161816047|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
161816048|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
161816049|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
161816050|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
161816051|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
161816052|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
161816053|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
161816054|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
161816055|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
161816056|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
161816057|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
161816058|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
161480138|NCT02197247|583152681|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
161480139|NCT02197247|583152681|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
161480140|NCT01606007|583152682|FG000|Overall Study|Reason 'Other' in the protocol|0|||
161480141|NCT01606007|583152683|FG001|Overall Study|Reason 'Other' in the protocol|1|||
161480142|NCT01606007|583152684|FG002|Overall Study|Reason 'Other' in the protocol|1|||
161480143|NCT01606007|583152682|FG000|Overall Study|Pregnancy|0|||
161480144|NCT01606007|583152683|FG001|Overall Study|Pregnancy|1|||
161480145|NCT01606007|583152684|FG002|Overall Study|Pregnancy|1|||
161480146|NCT01606007|583152682|FG000|Overall Study|Withdrawal by Subject|8|||
161480147|NCT01606007|583152683|FG001|Overall Study|Withdrawal by Subject|6|||
161480148|NCT01606007|583152684|FG002|Overall Study|Withdrawal by Subject|1|||
161480149|NCT01606007|583152682|FG000|Overall Study|Adverse Event|0|||
161480150|NCT01606007|583152683|FG001|Overall Study|Adverse Event|1|||
161480151|NCT01606007|583152684|FG002|Overall Study|Adverse Event|1|||
161480152|NCT01606007|583152682|FG000|Overall Study|discontinue study treatment|0|||
161480153|NCT01606007|583152683|FG001|Overall Study|discontinue study treatment|2|||
161480154|NCT01606007|583152684|FG002|Overall Study|discontinue study treatment|1|||
161480155|NCT01606007|583152682|FG000|Overall Study|Lost to Follow-up|6|||
161480156|NCT01606007|583152683|FG001|Overall Study|Lost to Follow-up|8|||
161480157|NCT01606007|583152684|FG002|Overall Study|Lost to Follow-up|5|||
161480158|NCT01606007|583152682|FG000|Overall Study|Poor/Non-compliance|1|||
161480159|NCT01606007|583152683|FG001|Overall Study|Poor/Non-compliance|0|||
161480160|NCT01606007|583152684|FG002|Overall Study|Poor/Non-compliance|0|||
161480161|NCT00851747|583152686|FG000|Overall Study|Physician Decision|6|||
161480162|NCT00851747|583152687|FG001|Overall Study|Physician Decision|6|||
161480163|NCT00851747|583152688|FG002|Overall Study|Physician Decision|6|||
161480164|NCT02499783|583152691|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
161480165|NCT02499783|583152692|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
161480166|NCT02499783|583152693|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
161480167|NCT02499783|583152691|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
161480168|NCT02499783|583152692|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
161480169|NCT02499783|583152693|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
161480170|NCT02499783|583152691|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
161480171|NCT02499783|583152692|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
161480172|NCT02499783|583152693|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
161480173|NCT02499783|583152691|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
161480174|NCT02499783|583152692|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
161480175|NCT02499783|583152693|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
161480176|NCT02499783|583152691|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
161480177|NCT02499783|583152692|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
161480178|NCT02499783|583152693|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
161480179|NCT02499783|583152691|FG000|DB Period: Weeks 0-8|Other|1|||
161480180|NCT02499783|583152692|FG001|DB Period: Weeks 0-8|Other|1|||
161480181|NCT02499783|583152693|FG002|DB Period: Weeks 0-8|Other|0|||
161480182|NCT02499783|583152691|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
161816059|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
161816060|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
161816061|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816062|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161921201|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161921202|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
161921203|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
161921204|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921205|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921206|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921207|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921208|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
161579395|NCT03422276|583511067|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
161579396|NCT03422276|583511068|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
161579397|NCT03422276|583511069|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
161579398|NCT03422276|583511070|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
161579399|NCT03422276|583511067|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
161579400|NCT03422276|583511068|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
161579401|NCT03422276|583511069|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
161579402|NCT03422276|583511070|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
161579403|NCT03422276|583511067|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161579404|NCT03422276|583511068|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161579405|NCT03422276|583511069|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
161579406|NCT03422276|583511070|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161579407|NCT05194917|583511071|FG000|Overall Study|Lost to Follow-up|7|||
161579408|NCT05194917|583511072|FG001|Overall Study|Lost to Follow-up|5|||
161579409|NCT05194917|583511073|FG002|Overall Study|Lost to Follow-up|6|||
161579410|NCT05194917|583511074|FG003|Overall Study|Lost to Follow-up|5|||
161579411|NCT04922021|583511075|FG000|Overall Study|Withdrawal by Subject|4|||
161579412|NCT04922021|583511076|FG001|Overall Study|Withdrawal by Subject|10|||
161579413|NCT04922021|583511075|FG000|Overall Study|Adverse Event|2|||
161579414|NCT04922021|583511076|FG001|Overall Study|Adverse Event|2|||
161579415|NCT04922021|583511075|FG000|Overall Study|Lack of Efficacy|0|||
161579416|NCT04922021|583511076|FG001|Overall Study|Lack of Efficacy|1|||
161579417|NCT04922021|583511075|FG000|Overall Study|Multiple reasons|1|||
161579418|NCT04922021|583511076|FG001|Overall Study|Multiple reasons|0|||
161579419|NCT04941287|583511086|FG000|Overall Study|Rapid decline before starting treatment|3|||
161579420|NCT04941287|583511087|FG001|Overall Study|Rapid decline before starting treatment|1|||
161579421|NCT01998984|583511092|FG000|Overall Study|Adverse Event|0|||
161579422|NCT01998984|583511093|FG001|Overall Study|Adverse Event|0|||
161579423|NCT01998984|583511094|FG002|Overall Study|Adverse Event|0|||
161579424|NCT01998984|583511095|FG003|Overall Study|Adverse Event|1|||
161579425|NCT01998984|583511092|FG000|Overall Study|Lost to Follow-up|0|||
161579426|NCT01998984|583511093|FG001|Overall Study|Lost to Follow-up|1|||
161579427|NCT01998984|583511094|FG002|Overall Study|Lost to Follow-up|0|||
161579428|NCT01998984|583511095|FG003|Overall Study|Lost to Follow-up|1|||
161579429|NCT01998984|583511092|FG000|Overall Study|Withdrawal by Subject|0|||
161579430|NCT01998984|583511093|FG001|Overall Study|Withdrawal by Subject|0|||
161579431|NCT01998984|583511094|FG002|Overall Study|Withdrawal by Subject|1|||
161579432|NCT01998984|583511095|FG003|Overall Study|Withdrawal by Subject|0|||
161579433|NCT01998984|583511092|FG000|Overall Study|Other|0|||
161579434|NCT01998984|583511093|FG001|Overall Study|Other|0|||
161579435|NCT01998984|583511094|FG002|Overall Study|Other|0|||
161579436|NCT01998984|583511095|FG003|Overall Study|Other|1|||
161579437|NCT04300647|583511096|FG000|Pre-Crossover|Death|19|||
161579438|NCT04300647|583511097|FG001|Pre-Crossover|Death|58|||
161579439|NCT04300647|583511098|FG002|Pre-Crossover|Death|0|||
161579440|NCT04300647|583511096|FG000|Pre-Crossover|Lost to Follow-up|0|||
161579441|NCT04300647|583511097|FG001|Pre-Crossover|Lost to Follow-up|3|||
161579442|NCT04300647|583511098|FG002|Pre-Crossover|Lost to Follow-up|0|||
161579443|NCT04300647|583511096|FG000|Pre-Crossover|Withdrawal by Subject|2|||
161579444|NCT04300647|583511097|FG001|Pre-Crossover|Withdrawal by Subject|4|||
161579445|NCT04300647|583511098|FG002|Pre-Crossover|Withdrawal by Subject|0|||
161579446|NCT04300647|583511096|FG000|Pre-Crossover|On-going in Study|24|||
161579447|NCT04300647|583511097|FG001|Pre-Crossover|On-going in Study|61|||
161579448|NCT04300647|583511098|FG002|Pre-Crossover|On-going in Study|0|||
161579449|NCT04300647|583511096|FG000|Post-Crossover|Death|0|||
161579450|NCT04300647|583511097|FG001|Post-Crossover|Death|0|||
161579451|NCT04300647|583511098|FG002|Post-Crossover|Death|3|||
161579452|NCT04300647|583511096|FG000|Post-Crossover|Lost to Follow-up|0|||
161579453|NCT04300647|583511097|FG001|Post-Crossover|Lost to Follow-up|0|||
161579454|NCT04300647|583511098|FG002|Post-Crossover|Lost to Follow-up|1|||
161579455|NCT04300647|583511096|FG000|Post-Crossover|Withdrawal by Subject|0|||
161579456|NCT04300647|583511097|FG001|Post-Crossover|Withdrawal by Subject|0|||
161579457|NCT04300647|583511098|FG002|Post-Crossover|Withdrawal by Subject|1|||
161921209|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
161669071|NCT00792805|583841355|FG001|Overall Study|Protocol deviation|1|||
161669072|NCT00792805|583841356|FG002|Overall Study|Protocol deviation|1|||
161669073|NCT02072434|583841357|FG000|Overall Study|Protocol Violation|10|||
161669074|NCT02072434|583841358|FG001|Overall Study|Protocol Violation|9|||
161669075|NCT02072434|583841357|FG000|Overall Study|Physician Decision|5|||
161669076|NCT02072434|583841358|FG001|Overall Study|Physician Decision|10|||
161669077|NCT02072434|583841357|FG000|Overall Study|Adverse event, serious fatal|1|||
161669078|NCT02072434|583841358|FG001|Overall Study|Adverse event, serious fatal|6|||
161669079|NCT02072434|583841357|FG000|Overall Study|Adverse Event|7|||
161669080|NCT02072434|583841358|FG001|Overall Study|Adverse Event|6|||
161669081|NCT02072434|583841357|FG000|Overall Study|Withdrawal by Subject|17|||
161669082|NCT02072434|583841358|FG001|Overall Study|Withdrawal by Subject|29|||
161669083|NCT02072434|583841357|FG000|Overall Study|Other|14|||
161669084|NCT02072434|583841358|FG001|Overall Study|Other|29|||
161669085|NCT02072434|583841357|FG000|Overall Study|Lost to Follow-up|0|||
161669086|NCT02072434|583841358|FG001|Overall Study|Lost to Follow-up|1|||
161669087|NCT02276872|583841359|FG000|Overall Study|Adverse Event|1|||
161669088|NCT02276872|583841360|FG001|Overall Study|Adverse Event|0|||
161669089|NCT02276872|583841361|FG002|Overall Study|Adverse Event|0|||
161669090|NCT04175808|583841362|FG000|Part A|Miscellaneous|2|||
161549158|NCT02291289|583401011|FG002|Induction Treatment|Adverse Event|0|||
161549159|NCT02291289|583401012|FG003|Induction Treatment|Adverse Event|3|||
161549160|NCT02291289|583401013|FG004|Induction Treatment|Adverse Event|0|||
161549161|NCT02291289|583401014|FG005|Induction Treatment|Adverse Event|0|||
161549162|NCT02291289|583401015|FG006|Induction Treatment|Adverse Event|0|||
161549163|NCT02291289|583401016|FG007|Induction Treatment|Adverse Event|0|||
161549164|NCT02291289|583401017|FG008|Induction Treatment|Adverse Event|0|||
161549165|NCT02291289|583401018|FG009|Induction Treatment|Adverse Event|1|||
161549166|NCT02291289|583401019|FG010|Induction Treatment|Adverse Event|0|||
161549167|NCT02291289|583401020|FG011|Induction Treatment|Adverse Event|0|||
161549168|NCT02291289|583401021|FG012|Induction Treatment|Adverse Event|0|||
161549169|NCT02291289|583401009|FG000|Induction Treatment|Death|25|||
161549170|NCT02291289|583401010|FG001|Induction Treatment|Death|0|||
161549171|NCT02291289|583401011|FG002|Induction Treatment|Death|0|||
161549172|NCT02291289|583401012|FG003|Induction Treatment|Death|111|||
161549173|NCT02291289|583401013|FG004|Induction Treatment|Death|0|||
161549174|NCT02291289|583401014|FG005|Induction Treatment|Death|0|||
161549175|NCT02291289|583401015|FG006|Induction Treatment|Death|1|||
161549176|NCT02291289|583401016|FG007|Induction Treatment|Death|0|||
161549177|NCT02291289|583401017|FG008|Induction Treatment|Death|0|||
161549178|NCT02291289|583401018|FG009|Induction Treatment|Death|82|||
161549179|NCT02291289|583401019|FG010|Induction Treatment|Death|0|||
161549180|NCT02291289|583401020|FG011|Induction Treatment|Death|0|||
161549181|NCT02291289|583401021|FG012|Induction Treatment|Death|0|||
161549182|NCT02291289|583401009|FG000|Induction Treatment|Lost to Follow-up|1|||
161549183|NCT02291289|583401010|FG001|Induction Treatment|Lost to Follow-up|0|||
161549184|NCT02291289|583401011|FG002|Induction Treatment|Lost to Follow-up|0|||
161549185|NCT02291289|583401012|FG003|Induction Treatment|Lost to Follow-up|12|||
161549186|NCT02291289|583401013|FG004|Induction Treatment|Lost to Follow-up|0|||
161549187|NCT02291289|583401014|FG005|Induction Treatment|Lost to Follow-up|0|||
161549188|NCT02291289|583401015|FG006|Induction Treatment|Lost to Follow-up|0|||
161549189|NCT02291289|583401016|FG007|Induction Treatment|Lost to Follow-up|0|||
161549190|NCT02291289|583401017|FG008|Induction Treatment|Lost to Follow-up|0|||
161549191|NCT02291289|583401018|FG009|Induction Treatment|Lost to Follow-up|9|||
161549192|NCT02291289|583401019|FG010|Induction Treatment|Lost to Follow-up|0|||
161549193|NCT02291289|583401020|FG011|Induction Treatment|Lost to Follow-up|0|||
161549194|NCT02291289|583401021|FG012|Induction Treatment|Lost to Follow-up|0|||
161549195|NCT02291289|583401009|FG000|Induction Treatment|Non-Compliance|0|||
161549196|NCT02291289|583401010|FG001|Induction Treatment|Non-Compliance|0|||
161549197|NCT02291289|583401011|FG002|Induction Treatment|Non-Compliance|0|||
161549198|NCT02291289|583401012|FG003|Induction Treatment|Non-Compliance|1|||
161549199|NCT02291289|583401013|FG004|Induction Treatment|Non-Compliance|0|||
161549200|NCT02291289|583401014|FG005|Induction Treatment|Non-Compliance|0|||
161549201|NCT02291289|583401015|FG006|Induction Treatment|Non-Compliance|0|||
161549202|NCT02291289|583401016|FG007|Induction Treatment|Non-Compliance|0|||
161549203|NCT02291289|583401017|FG008|Induction Treatment|Non-Compliance|0|||
161549204|NCT02291289|583401018|FG009|Induction Treatment|Non-Compliance|1|||
161549205|NCT02291289|583401019|FG010|Induction Treatment|Non-Compliance|0|||
161549206|NCT02291289|583401020|FG011|Induction Treatment|Non-Compliance|0|||
161549207|NCT02291289|583401021|FG012|Induction Treatment|Non-Compliance|0|||
161549208|NCT02291289|583401009|FG000|Induction Treatment|Reason Not Specified|0|||
161549209|NCT02291289|583401010|FG001|Induction Treatment|Reason Not Specified|0|||
161549210|NCT02291289|583401011|FG002|Induction Treatment|Reason Not Specified|0|||
161549211|NCT02291289|583401012|FG003|Induction Treatment|Reason Not Specified|4|||
161549212|NCT02291289|583401013|FG004|Induction Treatment|Reason Not Specified|0|||
161549213|NCT02291289|583401014|FG005|Induction Treatment|Reason Not Specified|0|||
161549214|NCT02291289|583401015|FG006|Induction Treatment|Reason Not Specified|0|||
161579458|NCT04300647|583511096|FG000|Post-Crossover|On-going in Study|0|||
161579459|NCT04300647|583511097|FG001|Post-Crossover|On-going in Study|0|||
161579460|NCT04300647|583511098|FG002|Post-Crossover|On-going in Study|8|||
161579461|NCT05386238|583511099|FG000|Overall Study|Lost to Follow-up|3|||
161579462|NCT05386238|583511100|FG001|Overall Study|Lost to Follow-up|2|||
161579463|NCT05386238|583511099|FG000|Overall Study|Withdrawal by Subject|0|||
161579464|NCT05386238|583511100|FG001|Overall Study|Withdrawal by Subject|1|||
161579465|NCT04907474|583511101|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
161579466|NCT04907474|583511102|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
161579467|NCT01353313|583511105|FG000|Overall Study|Lost to Follow-up|22|||
161579468|NCT01353313|583511106|FG001|Overall Study|Lost to Follow-up|23|||
161579469|NCT01353313|583511105|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
161579470|NCT01353313|583511106|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
161579471|NCT04425629|583511107|FG000|Overall Study|Adverse Event|0|||
161579472|NCT04425629|583511108|FG001|Overall Study|Adverse Event|0|||
161579473|NCT04425629|583511109|FG002|Overall Study|Adverse Event|0|||
161579474|NCT04425629|583511110|FG003|Overall Study|Adverse Event|0|||
161579475|NCT04425629|583511111|FG004|Overall Study|Adverse Event|1|||
161579476|NCT04425629|583511112|FG005|Overall Study|Adverse Event|0|||
161579477|NCT04425629|583511113|FG006|Overall Study|Adverse Event|0|||
161579478|NCT04425629|583511114|FG007|Overall Study|Adverse Event|0|||
161579479|NCT04425629|583511115|FG008|Overall Study|Adverse Event|0|||
161579480|NCT04425629|583511116|FG009|Overall Study|Adverse Event|3|||
161579481|NCT04425629|583511117|FG010|Overall Study|Adverse Event|2|||
161579482|NCT04425629|583511118|FG011|Overall Study|Adverse Event|1|||
161579483|NCT04425629|583511119|FG012|Overall Study|Adverse Event|1|||
161579484|NCT04425629|583511120|FG013|Overall Study|Adverse Event|0|||
161579485|NCT04425629|583511121|FG014|Overall Study|Adverse Event|0|||
161579486|NCT04425629|583511122|FG015|Overall Study|Adverse Event|0|||
161579487|NCT04425629|583511123|FG016|Overall Study|Adverse Event|0|||
161579488|NCT04425629|583511124|FG017|Overall Study|Adverse Event|0|||
161579489|NCT04425629|583511125|FG018|Overall Study|Adverse Event|0|||
161579490|NCT04425629|583511107|FG000|Overall Study|Lost to Follow-up|1|||
161579491|NCT04425629|583511108|FG001|Overall Study|Lost to Follow-up|3|||
161579492|NCT04425629|583511109|FG002|Overall Study|Lost to Follow-up|1|||
161579493|NCT04425629|583511110|FG003|Overall Study|Lost to Follow-up|7|||
161579494|NCT04425629|583511111|FG004|Overall Study|Lost to Follow-up|1|||
161579495|NCT04425629|583511112|FG005|Overall Study|Lost to Follow-up|2|||
161579496|NCT04425629|583511113|FG006|Overall Study|Lost to Follow-up|1|||
161579497|NCT04425629|583511114|FG007|Overall Study|Lost to Follow-up|0|||
161579498|NCT04425629|583511115|FG008|Overall Study|Lost to Follow-up|1|||
161579499|NCT04425629|583511116|FG009|Overall Study|Lost to Follow-up|64|||
161579500|NCT04425629|583511117|FG010|Overall Study|Lost to Follow-up|70|||
161579501|NCT04425629|583511118|FG011|Overall Study|Lost to Follow-up|98|||
161579502|NCT04425629|583511119|FG012|Overall Study|Lost to Follow-up|30|||
161579503|NCT04425629|583511120|FG013|Overall Study|Lost to Follow-up|0|||
161579504|NCT04425629|583511121|FG014|Overall Study|Lost to Follow-up|5|||
161579505|NCT04425629|583511122|FG015|Overall Study|Lost to Follow-up|4|||
161579506|NCT04425629|583511123|FG016|Overall Study|Lost to Follow-up|0|||
161579507|NCT04425629|583511124|FG017|Overall Study|Lost to Follow-up|3|||
161579508|NCT04425629|583511125|FG018|Overall Study|Lost to Follow-up|1|||
161579509|NCT04425629|583511107|FG000|Overall Study|Subject Decision|0|||
161579510|NCT04425629|583511108|FG001|Overall Study|Subject Decision|2|||
161579511|NCT04425629|583511109|FG002|Overall Study|Subject Decision|1|||
161579512|NCT04425629|583511110|FG003|Overall Study|Subject Decision|3|||
161579513|NCT04425629|583511111|FG004|Overall Study|Subject Decision|6|||
161579514|NCT04425629|583511112|FG005|Overall Study|Subject Decision|6|||
161579515|NCT04425629|583511113|FG006|Overall Study|Subject Decision|3|||
161579516|NCT04425629|583511114|FG007|Overall Study|Subject Decision|3|||
161579517|NCT04425629|583511115|FG008|Overall Study|Subject Decision|1|||
161579518|NCT04425629|583511116|FG009|Overall Study|Subject Decision|70|||
161579519|NCT04425629|583511117|FG010|Overall Study|Subject Decision|95|||
161579520|NCT04425629|583511118|FG011|Overall Study|Subject Decision|124|||
161579521|NCT04425629|583511119|FG012|Overall Study|Subject Decision|25|||
161579522|NCT04425629|583511120|FG013|Overall Study|Subject Decision|0|||
161579523|NCT04425629|583511121|FG014|Overall Study|Subject Decision|1|||
161579524|NCT04425629|583511122|FG015|Overall Study|Subject Decision|4|||
161579525|NCT04425629|583511123|FG016|Overall Study|Subject Decision|1|||
161579526|NCT04425629|583511124|FG017|Overall Study|Subject Decision|0|||
161579527|NCT04425629|583511125|FG018|Overall Study|Subject Decision|2|||
161579528|NCT04425629|583511107|FG000|Overall Study|Death|0|||
161579529|NCT04425629|583511108|FG001|Overall Study|Death|0|||
161579530|NCT04425629|583511109|FG002|Overall Study|Death|0|||
161579531|NCT04425629|583511110|FG003|Overall Study|Death|0|||
161579532|NCT04425629|583511111|FG004|Overall Study|Death|0|||
161579533|NCT04425629|583511112|FG005|Overall Study|Death|0|||
161579534|NCT04425629|583511113|FG006|Overall Study|Death|0|||
161579535|NCT04425629|583511114|FG007|Overall Study|Death|0|||
161579536|NCT04425629|583511115|FG008|Overall Study|Death|0|||
161480183|NCT02499783|583152692|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
161480184|NCT02499783|583152693|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
161480185|NCT02499783|583152691|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
161480186|NCT02499783|583152692|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
161480187|NCT02499783|583152693|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
161480188|NCT02499783|583152691|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
161480189|NCT02499783|583152692|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
161480190|NCT02499783|583152693|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
161480191|NCT02499783|583152691|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
161480192|NCT02499783|583152692|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
161480193|NCT02499783|583152693|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
161480194|NCT02228460|583152694|FG000|Overall Study|Adverse Event|1|||
161480195|NCT02228460|583152694|FG000|Overall Study|Lost to Follow-up|1|||
161480196|NCT01243892|583152695|FG000|Overall Study|Did not meet eligibility criteria|2|||
161480197|NCT01243892|583152696|FG001|Overall Study|Did not meet eligibility criteria|0|||
161480198|NCT00119106|583152697|FG000|Overall Study|HIV infected at baseline|179|||
161480199|NCT00119106|583152698|FG001|Overall Study|HIV infected at baseline|178|||
161480200|NCT01866293|583152699|FG000|Overall Study|Adverse Event|2|||
161480201|NCT01010061|583152700|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
161480202|NCT01010061|583152701|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
161480203|NCT01010061|583152700|FG000|Overall Study|Disease Progression|2|||
161480204|NCT01010061|583152701|FG001|Overall Study|Disease Progression|8|||
161480205|NCT01010061|583152700|FG000|Overall Study|Withdrew Consent|5|||
161480206|NCT01010061|583152701|FG001|Overall Study|Withdrew Consent|1|||
161480207|NCT01010061|583152700|FG000|Overall Study|Death|3|||
161480208|NCT01010061|583152701|FG001|Overall Study|Death|6|||
161480209|NCT01010061|583152700|FG000|Overall Study|Administrative/Other|0|||
161480210|NCT01010061|583152701|FG001|Overall Study|Administrative/Other|1|||
161480211|NCT01010061|583152700|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
161480212|NCT01010061|583152701|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161480213|NCT01010061|583152700|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161480214|NCT01010061|583152701|FG001|Overall Study|Insufficient Therapeutic Response|5|||
161480215|NCT01010061|583152700|FG000|Overall Study|Violation of Selection Criteria|0|||
161480216|NCT01010061|583152701|FG001|Overall Study|Violation of Selection Criteria|1|||
161480217|NCT01010061|583152700|FG000|Overall Study|Did Not Receive Treatment|2|||
161480218|NCT01010061|583152701|FG001|Overall Study|Did Not Receive Treatment|2|||
161480219|NCT03066804|583152702|FG000|Overall Study|Physician Decision|0|||
161480220|NCT03066804|583152703|FG001|Overall Study|Physician Decision|4|||
161480221|NCT03066804|583152702|FG000|Overall Study|Death|23|||
161480222|NCT03066804|583152703|FG001|Overall Study|Death|17|||
161480223|NCT03066804|583152702|FG000|Overall Study|Withdrawal by Subject|19|||
161480224|NCT03066804|583152703|FG001|Overall Study|Withdrawal by Subject|25|||
161480225|NCT03066804|583152702|FG000|Overall Study|Lost to Follow-up|2|||
161480226|NCT03066804|583152703|FG001|Overall Study|Lost to Follow-up|0|||
161480227|NCT03066804|583152702|FG000|Overall Study|Adverse Event|2|||
161480228|NCT03066804|583152703|FG001|Overall Study|Adverse Event|3|||
161480229|NCT03066804|583152702|FG000|Overall Study|Technical problems|5|||
161480230|NCT03066804|583152703|FG001|Overall Study|Technical problems|1|||
161480243|NCT03982368|583152712|FG000|Overall Study|Adverse Event|6|||
161480244|NCT03982368|583152713|FG001|Overall Study|Adverse Event|4|||
161480245|NCT03982368|583152714|FG002|Overall Study|Adverse Event|3|||
161480246|NCT03982368|583152712|FG000|Overall Study|Lost to Follow-up|2|||
161480247|NCT03982368|583152713|FG001|Overall Study|Lost to Follow-up|1|||
161480248|NCT03982368|583152714|FG002|Overall Study|Lost to Follow-up|0|||
161480249|NCT03982368|583152712|FG000|Overall Study|Withdrawal by Subject|1|||
161480250|NCT03982368|583152713|FG001|Overall Study|Withdrawal by Subject|2|||
161480251|NCT03982368|583152714|FG002|Overall Study|Withdrawal by Subject|0|||
161480252|NCT03982368|583152712|FG000|Overall Study|unknow|4|||
161480253|NCT03982368|583152713|FG001|Overall Study|unknow|0|||
161480254|NCT03982368|583152714|FG002|Overall Study|unknow|2|||
161480255|NCT05393895|583152718|FG000|Overall Study|Adverse Event|2|||
161480256|NCT05393895|583152719|FG001|Overall Study|Adverse Event|3|||
161480257|NCT05393895|583152718|FG000|Overall Study|Lost to Follow-up|4|||
161480258|NCT05393895|583152719|FG001|Overall Study|Lost to Follow-up|3|||
161480259|NCT05393895|583152718|FG000|Overall Study|Protocol Violation|1|||
161480260|NCT05393895|583152719|FG001|Overall Study|Protocol Violation|0|||
161480261|NCT05393895|583152718|FG000|Overall Study|Withdrawal by Subject|1|||
161480262|NCT05393895|583152719|FG001|Overall Study|Withdrawal by Subject|4|||
161480263|NCT01203098|583152724|FG000|Overall Study|Adverse Event|3|||
161480264|NCT01203098|583152725|FG001|Overall Study|Adverse Event|1|||
161480265|NCT01203098|583152726|FG002|Overall Study|Adverse Event|7|||
161480266|NCT01203098|583152724|FG000|Overall Study|Lost to Follow-up|0|||
161480267|NCT01203098|583152725|FG001|Overall Study|Lost to Follow-up|0|||
161480268|NCT01203098|583152726|FG002|Overall Study|Lost to Follow-up|1|||
161480269|NCT01203098|583152724|FG000|Overall Study|Physician Decision|2|||
161480270|NCT01203098|583152725|FG001|Overall Study|Physician Decision|2|||
161480271|NCT01203098|583152726|FG002|Overall Study|Physician Decision|0|||
161480272|NCT01203098|583152724|FG000|Overall Study|Withdrawal by Subject|1|||
161480273|NCT01203098|583152725|FG001|Overall Study|Withdrawal by Subject|1|||
161480274|NCT01203098|583152726|FG002|Overall Study|Withdrawal by Subject|3|||
161480275|NCT03851705|583152731|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
161480276|NCT03851705|583152732|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161480277|NCT03851705|583152733|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161480278|NCT03851705|583152734|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161480279|NCT03851705|583152731|FG000|Part 1: Double-Blind Period|Other reason|1|||
161480280|NCT03851705|583152732|FG001|Part 1: Double-Blind Period|Other reason|0|||
161480281|NCT03851705|583152733|FG002|Part 1: Double-Blind Period|Other reason|0|||
161480282|NCT03851705|583152734|FG003|Part 1: Double-Blind Period|Other reason|0|||
161480283|NCT03851705|583152731|FG000|Part 2: Open-Label Period|Other reason|0|||
161480284|NCT03851705|583152732|FG001|Part 2: Open-Label Period|Other reason|0|||
161480285|NCT03851705|583152733|FG002|Part 2: Open-Label Period|Other reason|0|||
161480286|NCT03851705|583152734|FG003|Part 2: Open-Label Period|Other reason|1|||
161480287|NCT03851705|583152731|FG000|Part 2: Open-Label Period|Death|0|||
161480288|NCT03851705|583152732|FG001|Part 2: Open-Label Period|Death|0|||
161480289|NCT03851705|583152733|FG002|Part 2: Open-Label Period|Death|3|||
161480290|NCT03851705|583152734|FG003|Part 2: Open-Label Period|Death|0|||
161480291|NCT03851705|583152731|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
161669091|NCT04175808|583841363|FG001|Part A|Miscellaneous|0|||
161480292|NCT03851705|583152732|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
161480293|NCT03851705|583152733|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
161480294|NCT03851705|583152734|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
161480295|NCT03095612|583152735|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
161480296|NCT03095612|583152736|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
161480297|NCT03095612|583152737|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
161480298|NCT03095612|583152738|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
161480299|NCT03095612|583152739|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
161669092|NCT04175808|583841364|FG002|Part A|Miscellaneous|0|||
161669093|NCT04175808|583841365|FG003|Part A|Miscellaneous|0|||
161669094|NCT04175808|583841366|FG004|Part A|Miscellaneous|0|||
161669095|NCT04175808|583841367|FG005|Part A|Miscellaneous|0|||
161669096|NCT04175808|583841368|FG006|Part A|Miscellaneous|0|||
161669097|NCT00402363|583841370|FG000|Overall Study|Adverse Event|9|||
161669098|NCT00402363|583841371|FG001|Overall Study|Adverse Event|14|||
161480300|NCT03095612|583152740|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
161480301|NCT03095612|583152741|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
161480302|NCT00621582|583152742|FG000|Overall Study|Adverse Event|7|||
161480303|NCT00621582|583152742|FG000|Overall Study|Protocol Violation|57|||
161480304|NCT00621582|583152742|FG000|Overall Study|Lost to Follow-up|24|||
161480305|NCT00621582|583152742|FG000|Overall Study|issues not identified by investigators|18|||
161480306|NCT03617185|583152743|FG000|Baseline|Lost to Follow-up|0|||
161480307|NCT03617185|583152744|FG001|Baseline|Lost to Follow-up|2|||
161480308|NCT03617185|583152745|FG002|Baseline|Lost to Follow-up|1|||
161480309|NCT03617185|583152746|FG003|Baseline|Lost to Follow-up|1|||
161480310|NCT03617185|583152743|FG000|Baseline|Withdrawal by Subject|0|||
161480311|NCT03617185|583152744|FG001|Baseline|Withdrawal by Subject|1|||
161480312|NCT03617185|583152745|FG002|Baseline|Withdrawal by Subject|0|||
161480313|NCT03617185|583152746|FG003|Baseline|Withdrawal by Subject|1|||
161480314|NCT03617185|583152743|FG000|Baseline|Driving Distance/Travel|0|||
161480315|NCT03617185|583152744|FG001|Baseline|Driving Distance/Travel|0|||
161480316|NCT03617185|583152745|FG002|Baseline|Driving Distance/Travel|2|||
161480317|NCT03617185|583152746|FG003|Baseline|Driving Distance/Travel|0|||
161669099|NCT00402363|583841372|FG002|Overall Study|Adverse Event|2|||
161480318|NCT03617185|583152743|FG000|Baseline|Family Obligations|0|||
161480319|NCT03617185|583152744|FG001|Baseline|Family Obligations|0|||
161480320|NCT03617185|583152745|FG002|Baseline|Family Obligations|0|||
161669100|NCT00402363|583841373|FG003|Overall Study|Adverse Event|2|||
161669101|NCT00402363|583841370|FG000|Overall Study|Withdrew Consent|10|||
161669102|NCT00402363|583841371|FG001|Overall Study|Withdrew Consent|5|||
161669103|NCT00402363|583841372|FG002|Overall Study|Withdrew Consent|2|||
161669104|NCT00402363|583841373|FG003|Overall Study|Withdrew Consent|1|||
161480321|NCT03617185|583152746|FG003|Baseline|Family Obligations|1|||
161480322|NCT03617185|583152743|FG000|3 Months|Lost to Follow-up|4|||
161480323|NCT03617185|583152744|FG001|3 Months|Lost to Follow-up|1|||
161480324|NCT03617185|583152745|FG002|3 Months|Lost to Follow-up|0|||
161480325|NCT03617185|583152746|FG003|3 Months|Lost to Follow-up|2|||
161480326|NCT03617185|583152743|FG000|3 Months|Withdrawal by Subject|1|||
161480327|NCT03617185|583152744|FG001|3 Months|Withdrawal by Subject|3|||
161480328|NCT03617185|583152745|FG002|3 Months|Withdrawal by Subject|0|||
161480329|NCT03617185|583152746|FG003|3 Months|Withdrawal by Subject|0|||
161480330|NCT03617185|583152743|FG000|3 Months|Driving Distance/Travel|1|||
161480331|NCT03617185|583152744|FG001|3 Months|Driving Distance/Travel|0|||
161480332|NCT03617185|583152745|FG002|3 Months|Driving Distance/Travel|0|||
161480333|NCT03617185|583152746|FG003|3 Months|Driving Distance/Travel|0|||
161480334|NCT03617185|583152743|FG000|3 Months|Family Obligations|0|||
161480335|NCT03617185|583152744|FG001|3 Months|Family Obligations|0|||
161480336|NCT03617185|583152745|FG002|3 Months|Family Obligations|0|||
161480337|NCT03617185|583152746|FG003|3 Months|Family Obligations|1|||
161480338|NCT03617185|583152743|FG000|12 Months|Lost to Follow-up|3|||
161480339|NCT03617185|583152744|FG001|12 Months|Lost to Follow-up|1|||
161480340|NCT03617185|583152745|FG002|12 Months|Lost to Follow-up|3|||
161480341|NCT03617185|583152746|FG003|12 Months|Lost to Follow-up|0|||
161480342|NCT03617185|583152743|FG000|12 Months|Withdrawal by Subject|0|||
161480343|NCT03617185|583152744|FG001|12 Months|Withdrawal by Subject|0|||
161480344|NCT03617185|583152745|FG002|12 Months|Withdrawal by Subject|0|||
161480345|NCT03617185|583152746|FG003|12 Months|Withdrawal by Subject|1|||
161480346|NCT03617185|583152743|FG000|12 Months|Driving Distance/Travel|0|||
161480347|NCT03617185|583152744|FG001|12 Months|Driving Distance/Travel|0|||
161480348|NCT03617185|583152745|FG002|12 Months|Driving Distance/Travel|1|||
161480349|NCT03617185|583152746|FG003|12 Months|Driving Distance/Travel|0|||
161480350|NCT01387932|583152748|FG000|Randomized and Treated|Physician Decision|3|||
161480351|NCT01387932|583152749|FG001|Randomized and Treated|Physician Decision|2|||
161480352|NCT01387932|583152748|FG000|Randomized and Treated|Withdrawal by Subject|4|||
161480353|NCT01387932|583152749|FG001|Randomized and Treated|Withdrawal by Subject|2|||
161480354|NCT01387932|583152748|FG000|Survival Follow-up|Liver Transplant|24|||
161480355|NCT01387932|583152749|FG001|Survival Follow-up|Liver Transplant|28|||
161480356|NCT01387932|583152748|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
161480357|NCT01387932|583152749|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
161480358|NCT01387932|583152748|FG000|Survival Follow-up|Withdrawal by Subject|2|||
161480359|NCT01387932|583152749|FG001|Survival Follow-up|Withdrawal by Subject|4|||
161480360|NCT01387932|583152748|FG000|Survival Follow-up|Lost to Follow-up|6|||
161480361|NCT01387932|583152749|FG001|Survival Follow-up|Lost to Follow-up|5|||
161480362|NCT01964430|583152750|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
161480363|NCT01964430|583152751|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
161480364|NCT01964430|583152750|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
161480365|NCT01964430|583152751|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
161480366|NCT01964430|583152750|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
161480367|NCT01964430|583152751|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
161480368|NCT01964430|583152750|FG000|Treatment Period|Adverse Event|71|||
161480369|NCT01964430|583152751|FG001|Treatment Period|Adverse Event|37|||
161480370|NCT01964430|583152750|FG000|Treatment Period|Withdrawal by Subject|36|||
161480371|NCT01964430|583152751|FG001|Treatment Period|Withdrawal by Subject|27|||
161480372|NCT01964430|583152750|FG000|Treatment Period|Death|1|||
161480373|NCT01964430|583152751|FG001|Treatment Period|Death|3|||
161480374|NCT01964430|583152750|FG000|Treatment Period|Protocol Deviation|0|||
161480375|NCT01964430|583152751|FG001|Treatment Period|Protocol Deviation|1|||
161480376|NCT01964430|583152750|FG000|Treatment Period|Physician Decision|5|||
161480377|NCT01964430|583152751|FG001|Treatment Period|Physician Decision|4|||
161480378|NCT01964430|583152750|FG000|Treatment Period|Disease Relapse|28|||
161480379|NCT01964430|583152751|FG001|Treatment Period|Disease Relapse|38|||
161480380|NCT01964430|583152750|FG000|Treatment Period|Other reasons|1|||
161480381|NCT01964430|583152751|FG001|Treatment Period|Other reasons|3|||
161480382|NCT02591290|583152752|FG000|Overall Study|Withdrawal by Subject|2|||
161480383|NCT02021773|583152767|FG000|Overall Study|Adverse Event|1|||
161480384|NCT02021773|583152768|FG001|Overall Study|Adverse Event|4|||
161480385|NCT02021773|583152769|FG002|Overall Study|Adverse Event|3|||
161480386|NCT02021773|583152767|FG000|Overall Study|Lack of Efficacy|2|||
161480387|NCT02021773|583152768|FG001|Overall Study|Lack of Efficacy|2|||
161480388|NCT02021773|583152769|FG002|Overall Study|Lack of Efficacy|2|||
161480389|NCT02021773|583152767|FG000|Overall Study|Protocol Violation|2|||
161480390|NCT02021773|583152768|FG001|Overall Study|Protocol Violation|3|||
161480391|NCT02021773|583152769|FG002|Overall Study|Protocol Violation|1|||
161480392|NCT02021773|583152767|FG000|Overall Study|Withdrawal by Subject|3|||
161480393|NCT02021773|583152768|FG001|Overall Study|Withdrawal by Subject|4|||
161480394|NCT02021773|583152769|FG002|Overall Study|Withdrawal by Subject|5|||
161480395|NCT02021773|583152767|FG000|Overall Study|Lost to Follow-up|1|||
161480396|NCT02021773|583152768|FG001|Overall Study|Lost to Follow-up|3|||
161669105|NCT00402363|583841370|FG000|Overall Study|Protocol Violation|3|||
161669106|NCT00402363|583841371|FG001|Overall Study|Protocol Violation|5|||
161669107|NCT00402363|583841372|FG002|Overall Study|Protocol Violation|0|||
161480397|NCT02021773|583152769|FG002|Overall Study|Lost to Follow-up|0|||
161480398|NCT02021773|583152767|FG000|Overall Study|Reason not specified|3|||
161480399|NCT02021773|583152768|FG001|Overall Study|Reason not specified|0|||
161480400|NCT02021773|583152769|FG002|Overall Study|Reason not specified|0|||
161480401|NCT01253408|583152773|FG000|Overall Study|Adverse Event|0|||
161480402|NCT01253408|583152774|FG001|Overall Study|Adverse Event|1|||
161480403|NCT01253408|583152775|FG002|Overall Study|Adverse Event|0|||
161480404|NCT03408483|583152776|FG000|Overall Study|Physician Decision|3|||
161480405|NCT03408483|583152777|FG001|Overall Study|Physician Decision|3|||
161480406|NCT03408483|583152776|FG000|Overall Study|Lost to Follow-up|3|||
161480407|NCT03408483|583152777|FG001|Overall Study|Lost to Follow-up|0|||
161480408|NCT00478231|583152778|FG000|Overall Study|Death|7|||
161480409|NCT00478231|583152778|FG000|Overall Study|Lack of Efficacy|47|||
161480410|NCT00478231|583152778|FG000|Overall Study|Lost to Follow-up|7|||
161480411|NCT00478231|583152778|FG000|Overall Study|Withdrawal by Subject|6|||
161480412|NCT00478231|583152778|FG000|Overall Study|Other|9|||
161480413|NCT00478231|583152778|FG000|Overall Study|Adverse Event|5|||
161480414|NCT00478231|583152778|FG000|Overall Study|Randomized, not treated|3|||
161480415|NCT01817530|583152779|FG000|Overall Study|Exclusionary Medication Received|0|||
161480416|NCT01817530|583152780|FG001|Overall Study|Exclusionary Medication Received|0|||
161480417|NCT01817530|583152781|FG002|Overall Study|Exclusionary Medication Received|0|||
161480418|NCT01817530|583152782|FG003|Overall Study|Exclusionary Medication Received|0|||
161480419|NCT01817530|583152783|FG004|Overall Study|Exclusionary Medication Received|1|||
161480420|NCT01817530|583152784|FG005|Overall Study|Exclusionary Medication Received|0|||
161480421|NCT01817530|583152785|FG006|Overall Study|Exclusionary Medication Received|0|||
161480422|NCT01817530|583152786|FG007|Overall Study|Exclusionary Medication Received|0|||
161480423|NCT01817530|583152779|FG000|Overall Study|Adverse Event|6|||
161480424|NCT01817530|583152780|FG001|Overall Study|Adverse Event|3|||
161480425|NCT01817530|583152781|FG002|Overall Study|Adverse Event|2|||
161480426|NCT01817530|583152782|FG003|Overall Study|Adverse Event|5|||
161480427|NCT01817530|583152783|FG004|Overall Study|Adverse Event|0|||
161480428|NCT01817530|583152784|FG005|Overall Study|Adverse Event|10|||
161480429|NCT01817530|583152785|FG006|Overall Study|Adverse Event|5|||
161480430|NCT01817530|583152786|FG007|Overall Study|Adverse Event|8|||
161480431|NCT01817530|583152779|FG000|Overall Study|Subject Noncompliant|3|||
161480432|NCT01817530|583152780|FG001|Overall Study|Subject Noncompliant|1|||
161480433|NCT01817530|583152781|FG002|Overall Study|Subject Noncompliant|0|||
161480434|NCT01817530|583152782|FG003|Overall Study|Subject Noncompliant|4|||
161480435|NCT01817530|583152783|FG004|Overall Study|Subject Noncompliant|0|||
161480436|NCT01817530|583152784|FG005|Overall Study|Subject Noncompliant|1|||
161480437|NCT01817530|583152785|FG006|Overall Study|Subject Noncompliant|1|||
161480438|NCT01817530|583152786|FG007|Overall Study|Subject Noncompliant|1|||
161480439|NCT01817530|583152779|FG000|Overall Study|Lack of Efficacy|1|||
161480440|NCT01817530|583152780|FG001|Overall Study|Lack of Efficacy|0|||
161480441|NCT01817530|583152781|FG002|Overall Study|Lack of Efficacy|0|||
161480442|NCT01817530|583152782|FG003|Overall Study|Lack of Efficacy|0|||
161480443|NCT01817530|583152783|FG004|Overall Study|Lack of Efficacy|0|||
161480444|NCT01817530|583152784|FG005|Overall Study|Lack of Efficacy|1|||
161480445|NCT01817530|583152785|FG006|Overall Study|Lack of Efficacy|0|||
161480446|NCT01817530|583152786|FG007|Overall Study|Lack of Efficacy|1|||
161480447|NCT01817530|583152779|FG000|Overall Study|Pregnancy|0|||
161480448|NCT01817530|583152780|FG001|Overall Study|Pregnancy|0|||
161480449|NCT01817530|583152781|FG002|Overall Study|Pregnancy|0|||
161480450|NCT01817530|583152782|FG003|Overall Study|Pregnancy|0|||
161480451|NCT01817530|583152783|FG004|Overall Study|Pregnancy|0|||
161480452|NCT01817530|583152784|FG005|Overall Study|Pregnancy|1|||
161480453|NCT01817530|583152785|FG006|Overall Study|Pregnancy|0|||
161480454|NCT01817530|583152786|FG007|Overall Study|Pregnancy|0|||
161480455|NCT01817530|583152779|FG000|Overall Study|Other|0|||
161480456|NCT01817530|583152780|FG001|Overall Study|Other|1|||
161480457|NCT01817530|583152781|FG002|Overall Study|Other|0|||
161480458|NCT01817530|583152782|FG003|Overall Study|Other|0|||
161480459|NCT01817530|583152783|FG004|Overall Study|Other|1|||
161480460|NCT01817530|583152784|FG005|Overall Study|Other|0|||
161480461|NCT01817530|583152785|FG006|Overall Study|Other|5|||
161480462|NCT01817530|583152786|FG007|Overall Study|Other|0|||
161480463|NCT01817530|583152779|FG000|Overall Study|Surgery or Invasive Intervention|1|||
161480464|NCT01817530|583152780|FG001|Overall Study|Surgery or Invasive Intervention|0|||
161480465|NCT01817530|583152781|FG002|Overall Study|Surgery or Invasive Intervention|0|||
161480466|NCT01817530|583152782|FG003|Overall Study|Surgery or Invasive Intervention|0|||
161480467|NCT01817530|583152783|FG004|Overall Study|Surgery or Invasive Intervention|1|||
161480468|NCT01817530|583152784|FG005|Overall Study|Surgery or Invasive Intervention|1|||
161480469|NCT01817530|583152785|FG006|Overall Study|Surgery or Invasive Intervention|1|||
161480470|NCT01817530|583152786|FG007|Overall Study|Surgery or Invasive Intervention|0|||
161480471|NCT01817530|583152779|FG000|Overall Study|Consent Withdrawn by Subject|3|||
161669108|NCT00402363|583841373|FG003|Overall Study|Protocol Violation|3|||
161480472|NCT01817530|583152780|FG001|Overall Study|Consent Withdrawn by Subject|4|||
161480473|NCT01817530|583152781|FG002|Overall Study|Consent Withdrawn by Subject|7|||
161480474|NCT01817530|583152782|FG003|Overall Study|Consent Withdrawn by Subject|3|||
161480475|NCT01817530|583152783|FG004|Overall Study|Consent Withdrawn by Subject|5|||
161480476|NCT01817530|583152784|FG005|Overall Study|Consent Withdrawn by Subject|3|||
161480477|NCT01817530|583152785|FG006|Overall Study|Consent Withdrawn by Subject|3|||
161480478|NCT01817530|583152786|FG007|Overall Study|Consent Withdrawn by Subject|10|||
161480479|NCT01817530|583152779|FG000|Overall Study|Lost to Follow-up|1|||
161480480|NCT01817530|583152780|FG001|Overall Study|Lost to Follow-up|4|||
161480481|NCT01817530|583152781|FG002|Overall Study|Lost to Follow-up|2|||
161480482|NCT01817530|583152782|FG003|Overall Study|Lost to Follow-up|1|||
161480483|NCT01817530|583152783|FG004|Overall Study|Lost to Follow-up|3|||
161480484|NCT01817530|583152784|FG005|Overall Study|Lost to Follow-up|2|||
161480485|NCT01817530|583152785|FG006|Overall Study|Lost to Follow-up|8|||
161480486|NCT01817530|583152786|FG007|Overall Study|Lost to Follow-up|4|||
161480487|NCT00566995|583152787|FG000|Overall Study|Toxicity|4|||
161480488|NCT00566995|583152787|FG000|Overall Study|Withdrew consent|3|||
161480489|NCT02657369|583152788|FG000|Overall Study|Death|27|||
161480490|NCT02657369|583152788|FG000|Overall Study|Study terminated by sponsor|7|||
161480491|NCT00074152|583152789|FG000|Overall Study|Death|21|||
161480492|NCT00074152|583152790|FG001|Overall Study|Death|9|||
161480493|NCT00074152|583152789|FG000|Overall Study|Lack of Efficacy|34|||
161480494|NCT00074152|583152790|FG001|Overall Study|Lack of Efficacy|24|||
161480495|NCT01785069|583152791|FG000|Overall Study|Implanted with nonstudy device|1|||
161480496|NCT01785069|583152792|FG001|Overall Study|Implanted with nonstudy device|2|||
161480497|NCT01785069|583152793|FG002|Overall Study|Implanted with nonstudy device|1|||
161480498|NCT01785069|583152794|FG003|Overall Study|Implanted with nonstudy device|0|||
161480499|NCT01785069|583152791|FG000|Overall Study|Death|0|||
161480500|NCT01785069|583152792|FG001|Overall Study|Death|0|||
161480501|NCT01785069|583152793|FG002|Overall Study|Death|2|||
161480502|NCT01785069|583152794|FG003|Overall Study|Death|0|||
161480503|NCT01785069|583152791|FG000|Overall Study|Subject choice|2|||
161480504|NCT01785069|583152792|FG001|Overall Study|Subject choice|2|||
161480505|NCT01785069|583152793|FG002|Overall Study|Subject choice|0|||
161480506|NCT01785069|583152794|FG003|Overall Study|Subject choice|1|||
161480507|NCT01785069|583152791|FG000|Overall Study|Lost to Follow-up|1|||
161480508|NCT01785069|583152792|FG001|Overall Study|Lost to Follow-up|2|||
161480509|NCT01785069|583152793|FG002|Overall Study|Lost to Follow-up|4|||
161480510|NCT01785069|583152794|FG003|Overall Study|Lost to Follow-up|1|||
161480511|NCT01785069|583152791|FG000|Overall Study|Reason not Specified|1|||
161480512|NCT01785069|583152792|FG001|Overall Study|Reason not Specified|2|||
161480513|NCT01785069|583152793|FG002|Overall Study|Reason not Specified|1|||
161480514|NCT01785069|583152794|FG003|Overall Study|Reason not Specified|4|||
161480515|NCT01785069|583152791|FG000|Overall Study|Not evaluable|7|||
161480516|NCT01785069|583152792|FG001|Overall Study|Not evaluable|4|||
161480517|NCT01785069|583152793|FG002|Overall Study|Not evaluable|5|||
161480518|NCT01785069|583152794|FG003|Overall Study|Not evaluable|8|||
161480519|NCT03288129|583152795|FG000|Overall Study|Adverse Event|10|||
161480520|NCT03288129|583152795|FG000|Overall Study|Lost to Follow-up|3|||
161480521|NCT03288129|583152795|FG000|Overall Study|Withdrawal by Subject|3|||
161480522|NCT03288129|583152795|FG000|Overall Study|Withdrawal of consent/assent|1|||
161480523|NCT03288129|583152795|FG000|Overall Study|Other|5|||
161480524|NCT01744197|583152798|FG000|Overall Study|Received 1 patch|2|||
161480525|NCT01744197|583152799|FG001|Overall Study|Received 1 patch|1|||
161480526|NCT01744197|583152798|FG000|Overall Study|No patch received|2|||
161480527|NCT01744197|583152799|FG001|Overall Study|No patch received|2|||
161480528|NCT02777333|583152800|FG000|Overall Study|Withdrawal by Subject|0|||
161480529|NCT02777333|583152801|FG001|Overall Study|Withdrawal by Subject|1|||
161480530|NCT02777333|583152800|FG000|Overall Study|Lost to Follow-up|0|||
161480531|NCT02777333|583152801|FG001|Overall Study|Lost to Follow-up|1|||
161480532|NCT01606800|583154679|FG000|Overall Study|Adverse Event|3|||
161480533|NCT01606800|583154680|FG001|Overall Study|Adverse Event|1|||
161480534|NCT01606800|583154679|FG000|Overall Study|Participant withdrew consent|0|||
161480535|NCT01606800|583154680|FG001|Overall Study|Participant withdrew consent|1|||
161480536|NCT01606800|583154679|FG000|Overall Study|Missing completion status|2|||
161480537|NCT01606800|583154680|FG001|Overall Study|Missing completion status|0|||
161480538|NCT02370160|583154683|FG000|Overall Study|Death|3|||
161480539|NCT02370160|583154684|FG001|Overall Study|Death|4|||
161480540|NCT02370160|583154685|FG002|Overall Study|Death|1|||
161480541|NCT04487730|583154686|FG000|Overall Study|Withdrawal by Subject|3|||
161480542|NCT04487730|583154687|FG001|Overall Study|Withdrawal by Subject|1|||
161480543|NCT04487730|583154686|FG000|Overall Study|Lost to Follow-up|0|||
161579537|NCT04425629|583511116|FG009|Overall Study|Death|11|||
161480544|NCT04487730|583154687|FG001|Overall Study|Lost to Follow-up|1|||
161480545|NCT04487730|583154686|FG000|Overall Study|Physician Decision|0|||
161480546|NCT04487730|583154687|FG001|Overall Study|Physician Decision|1|||
161480547|NCT00907777|583154688|FG000|Overall Study|Withdrawal by Subject|0|||
161480548|NCT00907777|583154689|FG001|Overall Study|Withdrawal by Subject|1|||
161480549|NCT03305575|583154692|FG000|Overall Study|Physician Decision|1|||
161480550|NCT03305575|583154693|FG001|Overall Study|Physician Decision|0|||
161480551|NCT02871297|583154701|FG000|Overall Study|Adverse Event|34|||
161480552|NCT02871297|583154701|FG000|Overall Study|Lack of Efficacy|10|||
161480553|NCT02871297|583154701|FG000|Overall Study|Non-compliance with study drug|15|||
161480554|NCT02871297|583154701|FG000|Overall Study|Protocol Violation|3|||
161480555|NCT02871297|583154701|FG000|Overall Study|Withdrawal by Subject|20|||
161480556|NCT02871297|583154701|FG000|Overall Study|Lost to Follow-up|13|||
161480557|NCT02871297|583154701|FG000|Overall Study|Rolled over to 13546A|2|||
161480558|NCT02871297|583154701|FG000|Overall Study|Other than specified|39|||
161480559|NCT04115839|583154705|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
161480560|NCT04115839|583154706|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
161480561|NCT04115839|583154707|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
161480562|NCT04115839|583154708|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
161480563|NCT04115839|583154709|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
161480564|NCT04115839|583154710|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
161480565|NCT04115839|583154711|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
161480566|NCT04115839|583154705|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
161480567|NCT04115839|583154706|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
161480568|NCT04115839|583154707|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
161480569|NCT04115839|583154708|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
161480570|NCT04115839|583154709|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
161480571|NCT04115839|583154710|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
161480572|NCT04115839|583154711|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
161480573|NCT04115839|583154705|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
161480574|NCT04115839|583154706|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
161480575|NCT04115839|583154707|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
161480576|NCT04115839|583154708|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
161480577|NCT04115839|583154709|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
161480578|NCT04115839|583154710|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
161480579|NCT04115839|583154711|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
161480580|NCT04115839|583154705|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
161480581|NCT04115839|583154706|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
161480582|NCT04115839|583154707|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
161480583|NCT04115839|583154708|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
161480584|NCT04115839|583154709|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
161480585|NCT04115839|583154710|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
161480586|NCT04115839|583154711|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
161480587|NCT04115839|583154705|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
161480588|NCT04115839|583154706|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
161480589|NCT04115839|583154707|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
161480590|NCT04115839|583154708|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
161480591|NCT04115839|583154709|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
161480592|NCT04115839|583154710|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
161480593|NCT04115839|583154711|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
161480594|NCT04115839|583154705|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
161480595|NCT04115839|583154706|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
161480596|NCT04115839|583154707|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
161480597|NCT04115839|583154708|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
161480598|NCT04115839|583154709|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
161480599|NCT04115839|583154710|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
161480600|NCT04115839|583154711|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
161480601|NCT02966028|583154712|FG000|Overall Study|Adverse Event|7|||
161480602|NCT02966028|583154713|FG001|Overall Study|Adverse Event|13|||
161480603|NCT02966028|583154714|FG002|Overall Study|Adverse Event|10|||
161480604|NCT02966028|583154712|FG000|Overall Study|Physician Decision|1|||
161480605|NCT02966028|583154713|FG001|Overall Study|Physician Decision|0|||
161480606|NCT02966028|583154714|FG002|Overall Study|Physician Decision|2|||
161480607|NCT02966028|583154712|FG000|Overall Study|Withdrawal by Subject|7|||
161480608|NCT02966028|583154713|FG001|Overall Study|Withdrawal by Subject|5|||
161480609|NCT02966028|583154714|FG002|Overall Study|Withdrawal by Subject|5|||
161480610|NCT02966028|583154712|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
161480611|NCT02966028|583154713|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
161480612|NCT02966028|583154714|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
161480613|NCT02151591|583154716|FG000|Overall Study|Lost to Follow-up|6|||
161480614|NCT02151591|583154717|FG001|Overall Study|Lost to Follow-up|3|||
161480615|NCT01396148|583154718|FG000|Overall Study|Patient Decision|1|||
161480616|NCT00224042|583154727|FG000|Overall Study|Adverse Event|2|||
161579538|NCT04425629|583511117|FG010|Overall Study|Death|2|||
161579539|NCT04425629|583511118|FG011|Overall Study|Death|4|||
161579540|NCT04425629|583511119|FG012|Overall Study|Death|0|||
161480617|NCT00224042|583154728|FG001|Overall Study|Adverse Event|1|||
161480618|NCT00224042|583154727|FG000|Overall Study|Protocol Violation|0|||
161480619|NCT00224042|583154728|FG001|Overall Study|Protocol Violation|1|||
161480620|NCT00224042|583154727|FG000|Overall Study|Physician Decision|0|||
161480621|NCT00224042|583154728|FG001|Overall Study|Physician Decision|1|||
161480622|NCT00224042|583154727|FG000|Overall Study|Did not meet lab incusion criteria|2|||
161480623|NCT00224042|583154728|FG001|Overall Study|Did not meet lab incusion criteria|3|||
161480624|NCT00224042|583154727|FG000|Overall Study|Other|2|||
161480625|NCT00224042|583154728|FG001|Overall Study|Other|0|||
161480626|NCT00840450|583154729|FG000|Overall Study|Adverse Event|1|||
161480627|NCT00840450|583154729|FG000|Overall Study|Lack of Efficacy|2|||
161480628|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
161480629|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
161480630|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
161480631|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
161480632|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
161480633|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
161480634|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
161480635|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
161480636|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
161480637|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
161480638|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
161480639|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
161480640|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
161480641|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
161480642|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
161480643|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
161480644|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
161921210|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
161480645|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
161480646|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161480647|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161480648|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161480649|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161480650|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161480651|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161579541|NCT04425629|583511120|FG013|Overall Study|Death|0|||
161579542|NCT04425629|583511121|FG014|Overall Study|Death|0|||
161579543|NCT04425629|583511122|FG015|Overall Study|Death|0|||
161579544|NCT04425629|583511123|FG016|Overall Study|Death|0|||
161579545|NCT04425629|583511124|FG017|Overall Study|Death|0|||
161579546|NCT04425629|583511125|FG018|Overall Study|Death|0|||
161579547|NCT04425629|583511107|FG000|Overall Study|Sponsor Request|0|||
161579548|NCT04425629|583511108|FG001|Overall Study|Sponsor Request|0|||
161921211|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921212|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161480652|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161480653|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
161480654|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161921213|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921214|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921215|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161480655|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161480656|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161480657|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161579549|NCT04425629|583511109|FG002|Overall Study|Sponsor Request|0|||
161579550|NCT04425629|583511110|FG003|Overall Study|Sponsor Request|2|||
161579551|NCT04425629|583511111|FG004|Overall Study|Sponsor Request|2|||
161921216|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921217|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
161921218|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161921219|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161921220|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161480658|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161480659|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
161480660|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
161480661|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
161579552|NCT04425629|583511112|FG005|Overall Study|Sponsor Request|2|||
161579553|NCT04425629|583511113|FG006|Overall Study|Sponsor Request|1|||
161921221|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161579554|NCT04425629|583511114|FG007|Overall Study|Sponsor Request|0|||
161579555|NCT04425629|583511115|FG008|Overall Study|Sponsor Request|0|||
161579556|NCT04425629|583511116|FG009|Overall Study|Sponsor Request|9|||
161579557|NCT04425629|583511117|FG010|Overall Study|Sponsor Request|9|||
161579558|NCT04425629|583511118|FG011|Overall Study|Sponsor Request|10|||
161579559|NCT04425629|583511119|FG012|Overall Study|Sponsor Request|8|||
161579560|NCT04425629|583511120|FG013|Overall Study|Sponsor Request|0|||
161579561|NCT04425629|583511121|FG014|Overall Study|Sponsor Request|0|||
161579562|NCT04425629|583511122|FG015|Overall Study|Sponsor Request|1|||
161579563|NCT04425629|583511123|FG016|Overall Study|Sponsor Request|0|||
161579564|NCT04425629|583511124|FG017|Overall Study|Sponsor Request|0|||
161579565|NCT04425629|583511125|FG018|Overall Study|Sponsor Request|0|||
161579566|NCT04425629|583511107|FG000|Overall Study|Physician Decision|0|||
161579567|NCT04425629|583511108|FG001|Overall Study|Physician Decision|0|||
161579568|NCT04425629|583511109|FG002|Overall Study|Physician Decision|0|||
161579569|NCT04425629|583511110|FG003|Overall Study|Physician Decision|0|||
161579570|NCT04425629|583511111|FG004|Overall Study|Physician Decision|0|||
161579571|NCT04425629|583511112|FG005|Overall Study|Physician Decision|0|||
161579572|NCT04425629|583511113|FG006|Overall Study|Physician Decision|0|||
161579573|NCT04425629|583511114|FG007|Overall Study|Physician Decision|0|||
161579574|NCT04425629|583511115|FG008|Overall Study|Physician Decision|0|||
161579575|NCT04425629|583511116|FG009|Overall Study|Physician Decision|4|||
161579576|NCT04425629|583511117|FG010|Overall Study|Physician Decision|3|||
161579577|NCT04425629|583511118|FG011|Overall Study|Physician Decision|5|||
161579578|NCT04425629|583511119|FG012|Overall Study|Physician Decision|1|||
161579579|NCT04425629|583511120|FG013|Overall Study|Physician Decision|0|||
161579580|NCT04425629|583511121|FG014|Overall Study|Physician Decision|0|||
161579581|NCT04425629|583511122|FG015|Overall Study|Physician Decision|1|||
161579582|NCT04425629|583511123|FG016|Overall Study|Physician Decision|0|||
161579583|NCT04425629|583511124|FG017|Overall Study|Physician Decision|0|||
161579584|NCT04425629|583511125|FG018|Overall Study|Physician Decision|0|||
161579585|NCT04425629|583511107|FG000|Overall Study|Lack of Efficacy|0|||
161579586|NCT04425629|583511108|FG001|Overall Study|Lack of Efficacy|0|||
161579587|NCT04425629|583511109|FG002|Overall Study|Lack of Efficacy|0|||
161579588|NCT04425629|583511110|FG003|Overall Study|Lack of Efficacy|0|||
161579589|NCT04425629|583511111|FG004|Overall Study|Lack of Efficacy|0|||
161579590|NCT04425629|583511112|FG005|Overall Study|Lack of Efficacy|0|||
161579591|NCT04425629|583511113|FG006|Overall Study|Lack of Efficacy|0|||
161579592|NCT04425629|583511114|FG007|Overall Study|Lack of Efficacy|0|||
161579593|NCT04425629|583511115|FG008|Overall Study|Lack of Efficacy|0|||
161579594|NCT04425629|583511116|FG009|Overall Study|Lack of Efficacy|0|||
161579595|NCT04425629|583511117|FG010|Overall Study|Lack of Efficacy|1|||
161579596|NCT04425629|583511118|FG011|Overall Study|Lack of Efficacy|0|||
161579597|NCT04425629|583511119|FG012|Overall Study|Lack of Efficacy|0|||
161579598|NCT04425629|583511120|FG013|Overall Study|Lack of Efficacy|0|||
161579599|NCT04425629|583511121|FG014|Overall Study|Lack of Efficacy|0|||
161579600|NCT04425629|583511122|FG015|Overall Study|Lack of Efficacy|0|||
161579601|NCT04425629|583511123|FG016|Overall Study|Lack of Efficacy|0|||
161579602|NCT04425629|583511124|FG017|Overall Study|Lack of Efficacy|0|||
161579603|NCT04425629|583511125|FG018|Overall Study|Lack of Efficacy|0|||
161579604|NCT00610649|583511128|FG000|Overall Study|Adverse Event|1|||
161579605|NCT00610649|583511129|FG001|Overall Study|Adverse Event|0|||
161579606|NCT00610649|583511130|FG002|Overall Study|Adverse Event|0|||
161579607|NCT00610649|583511131|FG003|Overall Study|Adverse Event|0|||
161579608|NCT00610649|583511132|FG004|Overall Study|Adverse Event|0|||
161579609|NCT00610649|583511133|FG005|Overall Study|Adverse Event|0|||
161579610|NCT00610649|583511134|FG006|Overall Study|Adverse Event|0|||
161579611|NCT00610649|583511135|FG007|Overall Study|Adverse Event|0|||
161579612|NCT00610649|583511136|FG008|Overall Study|Adverse Event|0|||
161579613|NCT00610649|583511137|FG009|Overall Study|Adverse Event|0|||
161579614|NCT00610649|583511138|FG010|Overall Study|Adverse Event|1|||
161579615|NCT00610649|583511128|FG000|Overall Study|Family Emergency|0|||
161579616|NCT00610649|583511129|FG001|Overall Study|Family Emergency|1|||
161579617|NCT00610649|583511130|FG002|Overall Study|Family Emergency|0|||
161579618|NCT00610649|583511131|FG003|Overall Study|Family Emergency|0|||
161579619|NCT00610649|583511132|FG004|Overall Study|Family Emergency|0|||
161579620|NCT00610649|583511133|FG005|Overall Study|Family Emergency|0|||
161579621|NCT00610649|583511134|FG006|Overall Study|Family Emergency|0|||
161579622|NCT00610649|583511135|FG007|Overall Study|Family Emergency|0|||
161579623|NCT00610649|583511136|FG008|Overall Study|Family Emergency|0|||
161579624|NCT00610649|583511137|FG009|Overall Study|Family Emergency|0|||
161579625|NCT00610649|583511138|FG010|Overall Study|Family Emergency|0|||
161579626|NCT00610649|583511128|FG000|Overall Study|Withdrawal by Subject|0|||
161579627|NCT00610649|583511129|FG001|Overall Study|Withdrawal by Subject|0|||
161579628|NCT00610649|583511130|FG002|Overall Study|Withdrawal by Subject|0|||
161579629|NCT00610649|583511131|FG003|Overall Study|Withdrawal by Subject|0|||
161579630|NCT00610649|583511132|FG004|Overall Study|Withdrawal by Subject|0|||
161579631|NCT00610649|583511133|FG005|Overall Study|Withdrawal by Subject|0|||
161480662|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
161816063|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816064|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816065|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816066|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
161480663|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
161480664|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
161480665|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
161480666|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
161480667|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
161480668|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
161480669|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480670|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480671|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480672|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480673|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480674|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480675|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
161480676|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
161480677|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
161480678|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
161480679|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
161480680|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
161480681|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
161480682|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
161480683|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
161480684|NCT03095066|583154730|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
161480685|NCT03095066|583154731|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
161480686|NCT03095066|583154732|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
161480687|NCT03095066|583154733|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
161480688|NCT03095066|583154734|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
161480689|NCT03095066|583154735|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
161480690|NCT03095066|583154736|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
161480691|NCT03095066|583154737|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
161480692|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
161480693|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
161480694|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
161480695|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
161480696|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
161480697|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
161480698|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
161480699|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
161480700|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
161480701|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
161480702|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
161480703|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
161480704|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
161579632|NCT00610649|583511134|FG006|Overall Study|Withdrawal by Subject|0|||
161579633|NCT00610649|583511135|FG007|Overall Study|Withdrawal by Subject|0|||
161579634|NCT00610649|583511136|FG008|Overall Study|Withdrawal by Subject|0|||
161579635|NCT00610649|583511137|FG009|Overall Study|Withdrawal by Subject|1|||
161579636|NCT00610649|583511138|FG010|Overall Study|Withdrawal by Subject|0|||
161579637|NCT04259450|583511142|FG000|Overall Study|Adverse event/ Toxicity|0|||
161579638|NCT04259450|583511143|FG001|Overall Study|Adverse event/ Toxicity|3|||
161579639|NCT04259450|583511144|FG002|Overall Study|Adverse event/ Toxicity|0|||
161579640|NCT04259450|583511145|FG003|Overall Study|Adverse event/ Toxicity|1|||
161579641|NCT04259450|583511146|FG004|Overall Study|Adverse event/ Toxicity|0|||
161579642|NCT04259450|583511147|FG005|Overall Study|Adverse event/ Toxicity|0|||
161579643|NCT04259450|583511148|FG006|Overall Study|Adverse event/ Toxicity|0|||
161579644|NCT04259450|583511149|FG007|Overall Study|Adverse event/ Toxicity|1|||
161579645|NCT04259450|583511150|FG008|Overall Study|Adverse event/ Toxicity|0|||
161579646|NCT04259450|583511151|FG009|Overall Study|Adverse event/ Toxicity|3|||
161579647|NCT04259450|583511142|FG000|Overall Study|Disease progression|2|||
161579648|NCT04259450|583511143|FG001|Overall Study|Disease progression|3|||
161579649|NCT04259450|583511144|FG002|Overall Study|Disease progression|4|||
161816067|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
161480705|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
161480706|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
161480707|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
161480708|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
161480709|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
161480710|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
161480711|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
161480712|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
161480713|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
161480714|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
161480715|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
161480716|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161480717|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161480718|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
161480719|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161480720|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161480721|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161480722|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161480723|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
161480724|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480725|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480726|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
161480727|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480728|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480729|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480730|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480731|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
161480732|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
161480733|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
161480734|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
161480735|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
161816068|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816069|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816070|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
161816071|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816072|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816073|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816074|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816075|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816076|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816077|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816078|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816079|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816080|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816081|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816082|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816083|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816084|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816085|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816086|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816087|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816088|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816089|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816090|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816091|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816092|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816093|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816094|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816095|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
161816096|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816097|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816098|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816099|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816100|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816101|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816102|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816103|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161579650|NCT04259450|583511145|FG003|Overall Study|Disease progression|4|||
161579651|NCT04259450|583511146|FG004|Overall Study|Disease progression|6|||
161579652|NCT04259450|583511147|FG005|Overall Study|Disease progression|6|||
161579653|NCT04259450|583511148|FG006|Overall Study|Disease progression|6|||
161579654|NCT04259450|583511149|FG007|Overall Study|Disease progression|15|||
161579655|NCT04259450|583511150|FG008|Overall Study|Disease progression|6|||
161579656|NCT04259450|583511151|FG009|Overall Study|Disease progression|18|||
161816104|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816105|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816106|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816107|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816108|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816109|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816110|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816111|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816112|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816113|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816114|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816115|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816116|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816117|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816118|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816119|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816120|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816121|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
161816122|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816123|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816124|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816125|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816126|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816127|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816128|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816129|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816130|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816131|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816132|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816133|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816134|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816135|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
161579657|NCT04259450|583511142|FG000|Overall Study|Death|0|||
161579658|NCT04259450|583511143|FG001|Overall Study|Death|0|||
161579659|NCT04259450|583511144|FG002|Overall Study|Death|0|||
161579660|NCT04259450|583511145|FG003|Overall Study|Death|0|||
161579661|NCT04259450|583511146|FG004|Overall Study|Death|0|||
161579662|NCT04259450|583511147|FG005|Overall Study|Death|0|||
161579663|NCT04259450|583511148|FG006|Overall Study|Death|0|||
161579664|NCT04259450|583511149|FG007|Overall Study|Death|1|||
161816136|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816137|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
161921222|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161921223|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
161921224|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
161921225|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921226|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921227|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921228|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921229|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921230|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
161921231|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921232|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921233|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921234|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921235|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921236|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921237|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
161921238|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
161921239|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921240|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921241|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921242|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921243|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921244|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
161921245|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
161921246|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921247|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921248|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921249|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921250|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921251|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921252|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
161921253|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921254|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921255|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921256|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921257|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921258|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921259|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
161921260|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921261|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921262|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921263|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921264|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921265|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921266|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
161921267|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921268|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921269|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921270|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921271|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161579665|NCT04259450|583511150|FG008|Overall Study|Death|1|||
161579666|NCT04259450|583511151|FG009|Overall Study|Death|0|||
161579667|NCT04259450|583511142|FG000|Overall Study|Withdrawal by Subject|0|||
161579668|NCT04259450|583511143|FG001|Overall Study|Withdrawal by Subject|0|||
161579669|NCT04259450|583511144|FG002|Overall Study|Withdrawal by Subject|0|||
161579670|NCT04259450|583511145|FG003|Overall Study|Withdrawal by Subject|0|||
161579671|NCT04259450|583511146|FG004|Overall Study|Withdrawal by Subject|0|||
161579672|NCT04259450|583511147|FG005|Overall Study|Withdrawal by Subject|0|||
161579673|NCT04259450|583511148|FG006|Overall Study|Withdrawal by Subject|0|||
161579674|NCT04259450|583511149|FG007|Overall Study|Withdrawal by Subject|1|||
161579675|NCT04259450|583511150|FG008|Overall Study|Withdrawal by Subject|0|||
161579676|NCT04259450|583511151|FG009|Overall Study|Withdrawal by Subject|0|||
161579677|NCT04259450|583511142|FG000|Overall Study|Other than listed|0|||
161579678|NCT04259450|583511143|FG001|Overall Study|Other than listed|0|||
161579679|NCT04259450|583511144|FG002|Overall Study|Other than listed|0|||
161579680|NCT04259450|583511145|FG003|Overall Study|Other than listed|0|||
161669109|NCT00402363|583841370|FG000|Overall Study|Lost to Follow-up|5|||
161669110|NCT00402363|583841371|FG001|Overall Study|Lost to Follow-up|4|||
161669111|NCT00402363|583841372|FG002|Overall Study|Lost to Follow-up|0|||
161669112|NCT00402363|583841373|FG003|Overall Study|Lost to Follow-up|2|||
161579681|NCT04259450|583511146|FG004|Overall Study|Other than listed|0|||
161579682|NCT04259450|583511147|FG005|Overall Study|Other than listed|0|||
161579683|NCT04259450|583511148|FG006|Overall Study|Other than listed|0|||
161579684|NCT04259450|583511149|FG007|Overall Study|Other than listed|1|||
161579685|NCT04259450|583511150|FG008|Overall Study|Other than listed|1|||
161579686|NCT04259450|583511151|FG009|Overall Study|Other than listed|2|||
161579687|NCT00332241|583511152|FG000|Overall Study|Lack of Efficacy|6|||
161669113|NCT00402363|583841370|FG000|Overall Study|"Captured as Other"|6|||
161669114|NCT00402363|583841371|FG001|Overall Study|"Captured as Other"|2|||
161669115|NCT00402363|583841372|FG002|Overall Study|"Captured as Other"|2|||
161669116|NCT00402363|583841373|FG003|Overall Study|"Captured as Other"|2|||
161579688|NCT00332241|583511153|FG001|Overall Study|Lack of Efficacy|1|||
161579689|NCT00332241|583511152|FG000|Overall Study|Adverse Event|3|||
161579690|NCT00332241|583511153|FG001|Overall Study|Adverse Event|5|||
161579691|NCT00332241|583511152|FG000|Overall Study|Withdrawal by Subject|2|||
161579692|NCT00332241|583511153|FG001|Overall Study|Withdrawal by Subject|1|||
161579693|NCT00332241|583511152|FG000|Overall Study|Lost to Follow-up|4|||
161579694|NCT00332241|583511153|FG001|Overall Study|Lost to Follow-up|1|||
161579695|NCT00542789|583511161|FG000|Overall Study|Adverse Event|18|||
161579696|NCT00542789|583511162|FG001|Overall Study|Adverse Event|17|||
161579697|NCT00542789|583511161|FG000|Overall Study|Withdrawal by Subject|7|||
161579698|NCT00542789|583511162|FG001|Overall Study|Withdrawal by Subject|3|||
161579699|NCT00542789|583511161|FG000|Overall Study|Protocol Violation|8|||
161579700|NCT00542789|583511162|FG001|Overall Study|Protocol Violation|1|||
161579701|NCT00542789|583511161|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
161579702|NCT00542789|583511162|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
161579703|NCT02584829|583511163|FG000|Overall Study|Physician Decision|1|||
161579704|NCT02584829|583511164|FG001|Overall Study|Physician Decision|0|||
161669117|NCT00937833|583841382|FG000|Overall Study|Protocol Violation|1|||
161669118|NCT00937833|583841383|FG001|Overall Study|Protocol Violation|2|||
161480736|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
161480737|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
161480738|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
161480739|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
161480740|NCT03095066|583154730|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161579705|NCT02584829|583511163|FG000|Overall Study|Withdrawal by Subject|0|||
161579706|NCT02584829|583511164|FG001|Overall Study|Withdrawal by Subject|1|||
161579707|NCT02584829|583511163|FG000|Overall Study|Progressive Disease|0|||
161579708|NCT02584829|583511164|FG001|Overall Study|Progressive Disease|3|||
161579709|NCT02647905|583511172|FG000|Overall Study|Lost to Follow-up|1|||
161579710|NCT02647905|583511172|FG000|Overall Study|Withdrawal by Subject|2|||
161579711|NCT02765100|583511173|FG000|Overall Study|subject found ineligible after baseline|1|||
161579712|NCT02765100|583511174|FG001|Overall Study|subject found ineligible after baseline|1|||
161579713|NCT02765100|583511173|FG000|Overall Study|Lost to Follow-up|0|||
161579714|NCT02765100|583511174|FG001|Overall Study|Lost to Follow-up|1|||
161579715|NCT00642850|583511180|FG000|Overall Study|Death|7|||
161579716|NCT00642850|583511180|FG000|Overall Study|Adverse Event|2|||
161579717|NCT00642850|583511180|FG000|Overall Study|Lack of Efficacy|1|||
161579718|NCT00642850|583511180|FG000|Overall Study|Protocol Violation|2|||
161579719|NCT00642850|583511180|FG000|Overall Study|Kidney transplantation|8|||
161579720|NCT00642850|583511180|FG000|Overall Study|Blood transfusion|6|||
161579721|NCT00642850|583511180|FG000|Overall Study|Other reasons|7|||
161579722|NCT00244855|583511181|FG000|Overall Study|Withdrawal by Subject|0|||
161579723|NCT00244855|583511182|FG001|Overall Study|Withdrawal by Subject|1|||
161579724|NCT00106080|583511185|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
161579725|NCT00106080|583511186|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
161579726|NCT01839331|583511187|FG000|Overall Study|Early Termination|3|||
161579727|NCT01839331|583511188|FG001|Overall Study|Early Termination|0|||
161579728|NCT01839331|583511189|FG002|Overall Study|Early Termination|1|||
161579729|NCT01839331|583511190|FG003|Overall Study|Early Termination|2|||
161579730|NCT01839331|583511187|FG000|Overall Study|Protocol Violation|1|||
161579731|NCT01839331|583511188|FG001|Overall Study|Protocol Violation|6|||
161579732|NCT01839331|583511189|FG002|Overall Study|Protocol Violation|4|||
161579733|NCT01839331|583511190|FG003|Overall Study|Protocol Violation|3|||
161579734|NCT00761605|583511191|FG000|Overall Study|Adverse Event|26|||
161579735|NCT00761605|583511191|FG000|Overall Study|Death|2|||
161579736|NCT00761605|583511191|FG000|Overall Study|Lack of Efficacy|26|||
161579737|NCT00761605|583511191|FG000|Overall Study|Lost to Follow-up|29|||
161579738|NCT00761605|583511191|FG000|Overall Study|Withdrawal by Subject|37|||
161579739|NCT00761605|583511191|FG000|Overall Study|Other|21|||
161579740|NCT03074331|583511192|FG000|Overall Study|Enrolled but Not Treated|1|||
161579741|NCT03074331|583511192|FG000|Overall Study|Lost to Follow-up|5|||
161579742|NCT03074331|583511192|FG000|Overall Study|Withdrew Consent|1|||
161579743|NCT00350792|583511194|FG000|Overall Study|Adverse Event|11|||
161579744|NCT00350792|583511194|FG000|Overall Study|Death from Study Disease|1|||
161579745|NCT00350792|583511194|FG000|Overall Study|Death from Study Drug Toxicity|1|||
161669119|NCT00937833|583841382|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
161480741|NCT03095066|583154731|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161480742|NCT03095066|583154732|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161480743|NCT03095066|583154733|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161480744|NCT03095066|583154734|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161480745|NCT03095066|583154735|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161480746|NCT03095066|583154736|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
161480747|NCT03095066|583154737|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
161480748|NCT03095066|583154730|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161480749|NCT03095066|583154731|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161480750|NCT03095066|583154732|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161480751|NCT03095066|583154733|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161480752|NCT03095066|583154734|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161579746|NCT00350792|583511194|FG000|Overall Study|Death Not Study Drug Related|2|||
161816138|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816139|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816140|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816141|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816142|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816143|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161480753|NCT03095066|583154735|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
161579747|NCT00350792|583511194|FG000|Overall Study|Protocol Violation|1|||
161579748|NCT00350792|583511194|FG000|Overall Study|Withdrawal by Subject|4|||
161480754|NCT03095066|583154736|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161480755|NCT03095066|583154737|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
161480756|NCT03095066|583154730|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
161579749|NCT00350792|583511194|FG000|Overall Study|Physician Decision|2|||
161579750|NCT00350792|583511194|FG000|Overall Study|Lack of Efficacy|11|||
161579751|NCT03283371|583511195|FG000|Placebo-controlled|Adverse Event|1|||
161579752|NCT03283371|583511196|FG001|Placebo-controlled|Adverse Event|1|||
161669120|NCT00937833|583841383|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
161669121|NCT00937833|583841382|FG000|Overall Study|Lost to Follow-up|10|||
161669122|NCT00937833|583841383|FG001|Overall Study|Lost to Follow-up|8|||
161669123|NCT00937833|583841382|FG000|Overall Study|Withdrawal by Subject|4|||
161669124|NCT00937833|583841383|FG001|Overall Study|Withdrawal by Subject|6|||
161669125|NCT03278106|583841385|FG000|Overall Study|No protocol treatment|1|||
161669126|NCT02175004|583841386|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
161669127|NCT02175004|583841387|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
161669128|NCT02175004|583841386|FG000|Overall Study|Investigator Judgment|1|||
161669129|NCT02175004|583841387|FG001|Overall Study|Investigator Judgment|4|||
161669130|NCT02175004|583841386|FG000|Overall Study|Voluntary Withdrawal|6|||
161669131|NCT02175004|583841387|FG001|Overall Study|Voluntary Withdrawal|19|||
161669132|NCT02175004|583841386|FG000|Overall Study|Liver Transplant|1|||
161669133|NCT02175004|583841387|FG001|Overall Study|Liver Transplant|0|||
161669134|NCT02175004|583841386|FG000|Overall Study|Disease Progression|1|||
161669135|NCT02175004|583841387|FG001|Overall Study|Disease Progression|0|||
161669136|NCT02175004|583841386|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
161669137|NCT02175004|583841387|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
161669138|NCT00162032|583841389|FG000|Overall Study|Lost to Follow-up|4|||
161669139|NCT00162032|583841390|FG001|Overall Study|Lost to Follow-up|2|||
161669140|NCT00162032|583841389|FG000|Overall Study|Reason not specified|1|||
161669141|NCT00162032|583841390|FG001|Overall Study|Reason not specified|0|||
161669142|NCT01137955|583841391|FG000|Overall Study|Withdrawal by Subject|5|||
161669143|NCT01137955|583841392|FG001|Overall Study|Withdrawal by Subject|4|||
161669144|NCT04263909|583841393|FG000|Overall Study|Physician Decision|1|||
161669145|NCT04263909|583841394|FG001|Overall Study|Physician Decision|0|||
161669146|NCT04263909|583841395|FG002|Overall Study|Physician Decision|0|||
161669147|NCT04263909|583841393|FG000|Overall Study|Adverse Event|3|||
161669148|NCT04263909|583841394|FG001|Overall Study|Adverse Event|0|||
161669149|NCT04263909|583841395|FG002|Overall Study|Adverse Event|0|||
161669150|NCT04263909|583841393|FG000|Overall Study|Protocol Violation|5|||
161669151|NCT04263909|583841394|FG001|Overall Study|Protocol Violation|0|||
161669152|NCT04263909|583841395|FG002|Overall Study|Protocol Violation|0|||
161669153|NCT00068588|583841396|FG000|Overall Study|Adverse Event|0|||
161669154|NCT00068588|583841397|FG001|Overall Study|Adverse Event|0|||
161669155|NCT00068588|583841398|FG002|Overall Study|Adverse Event|2|||
161669156|NCT00068588|583841396|FG000|Overall Study|Withdrawal by Subject|0|||
161669157|NCT00068588|583841397|FG001|Overall Study|Withdrawal by Subject|0|||
161669158|NCT00068588|583841398|FG002|Overall Study|Withdrawal by Subject|1|||
161669159|NCT00068588|583841396|FG000|Overall Study|Poor KPS|0|||
161669160|NCT00068588|583841397|FG001|Overall Study|Poor KPS|0|||
161669161|NCT00068588|583841398|FG002|Overall Study|Poor KPS|1|||
161669162|NCT03840486|583841399|FG000|Overall Study|Withdrawal by Subject|0|||
161669163|NCT03840486|583841400|FG001|Overall Study|Withdrawal by Subject|1|||
161669164|NCT03840486|583841401|FG002|Overall Study|Withdrawal by Subject|0|||
161816144|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161816145|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161816146|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
161816147|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
161816148|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161816149|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816150|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816151|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816152|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816153|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816154|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816155|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816156|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816157|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816158|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816159|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816160|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816161|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816162|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816163|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816164|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816165|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161669165|NCT03840486|583841402|FG003|Overall Study|Withdrawal by Subject|0|||
161669166|NCT03840486|583841403|FG004|Overall Study|Withdrawal by Subject|0|||
161669167|NCT03840486|583841404|FG005|Overall Study|Withdrawal by Subject|0|||
161669168|NCT03840486|583841405|FG006|Overall Study|Withdrawal by Subject|0|||
161669169|NCT03840486|583841406|FG007|Overall Study|Withdrawal by Subject|0|||
161816166|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161669170|NCT03840486|583841407|FG008|Overall Study|Withdrawal by Subject|0|||
161669171|NCT03840486|583841408|FG009|Overall Study|Withdrawal by Subject|0|||
161669172|NCT03840486|583841409|FG010|Overall Study|Withdrawal by Subject|0|||
161669173|NCT03840486|583841410|FG011|Overall Study|Withdrawal by Subject|0|||
161669174|NCT05116046|583841413|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161669175|NCT05116046|583841414|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161669176|NCT05116046|583841415|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161669177|NCT05116046|583841413|FG000|Overall Study|Study terminated by sponsor|14|||
161669178|NCT05116046|583841414|FG001|Overall Study|Study terminated by sponsor|16|||
161669179|NCT05116046|583841415|FG002|Overall Study|Study terminated by sponsor|1|||
161669180|NCT02076178|583841430|FG000|Oral Phase|Adverse Event|0|||
161669181|NCT02076178|583841431|FG001|Oral Phase|Adverse Event|7|||
161669182|NCT02076178|583841430|FG000|Oral Phase|Withdrawal by Subject|0|||
161669183|NCT02076178|583841431|FG001|Oral Phase|Withdrawal by Subject|4|||
161669184|NCT02076178|583841430|FG000|Oral Phase|Physician Decision|0|||
161669185|NCT02076178|583841431|FG001|Oral Phase|Physician Decision|1|||
161669186|NCT02076178|583841430|FG000|Injection Phase|Protocol defined stopping criteria|1|||
161669187|NCT02076178|583841431|FG001|Injection Phase|Protocol defined stopping criteria|0|||
161669188|NCT02076178|583841430|FG000|Injection Phase|Withdrawal by Subject|0|||
161669189|NCT02076178|583841431|FG001|Injection Phase|Withdrawal by Subject|3|||
161669190|NCT02076178|583841430|FG000|Injection Phase|Physician Decision|0|||
161669191|NCT02076178|583841431|FG001|Injection Phase|Physician Decision|3|||
161669192|NCT02076178|583841430|FG000|Injection Phase|Lost to Follow-up|0|||
161669193|NCT02076178|583841431|FG001|Injection Phase|Lost to Follow-up|1|||
161669194|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
161669195|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
161669196|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Death|0|||
161669197|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Death|2|||
161669198|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161669199|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
161669200|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
161669201|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
161669202|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
161669203|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
161669204|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
161669205|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
161669206|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
161669207|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
161669208|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
161669209|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
161669210|NCT00343252|583841432|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
161669211|NCT00343252|583841433|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
161669212|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
161669213|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
161669214|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Death|3|||
161669215|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Death|3|||
161669216|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161669217|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161669218|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
161669219|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
161669220|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
161669221|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
161669222|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
161669223|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
161669224|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
161669225|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
161669226|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
161669227|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
161669228|NCT00343252|583841432|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
161669229|NCT00343252|583841433|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
161669230|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
161669231|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
161669232|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Death|4|||
161669233|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Death|5|||
161669234|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
161669235|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161669236|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
161669237|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
161669238|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
161669239|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
161669240|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
161669241|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
161669242|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
161669243|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
161669244|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
161669245|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
161669246|NCT00343252|583841432|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
161669247|NCT00343252|583841433|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
161669248|NCT01026454|583841434|FG000|Second Intervention|Pregnancy|1|||
161669249|NCT01026454|583841435|FG001|Second Intervention|Pregnancy|1|||
161669250|NCT02893930|583841436|FG000|Overall Study|Adverse Event|3|||
161669251|NCT02893930|583841436|FG000|Overall Study|Death|1|||
161669252|NCT02893930|583841436|FG000|Overall Study|Disease progression|5|||
161669253|NCT02893930|583841436|FG000|Overall Study|Withdrawal by Subject|2|||
161669254|NCT02893930|583841436|FG000|Overall Study|Physician Decision|1|||
161669255|NCT02893930|583841436|FG000|Overall Study|Ineligible|1|||
161669256|NCT01971203|583841445|FG000|Overall Study|Protocol Violation|3|||
161669257|NCT01971203|583841446|FG001|Overall Study|Protocol Violation|2|||
161669258|NCT01971203|583841445|FG000|Overall Study|Withdrawal by Subject|5|||
161669259|NCT01971203|583841446|FG001|Overall Study|Withdrawal by Subject|6|||
161669260|NCT01971203|583841445|FG000|Overall Study|Adverse Event|1|||
161669261|NCT01971203|583841446|FG001|Overall Study|Adverse Event|0|||
161669262|NCT03037619|583841447|FG000|Overall Study|Lost to Follow-up|0|||
161669263|NCT03037619|583841448|FG001|Overall Study|Lost to Follow-up|1|||
161669264|NCT00307125|583841453|FG000|Screening Phase|Adverse Event|1|||
161669265|NCT00307125|583841454|FG001|Screening Phase|Adverse Event|0|||
161669266|NCT00307125|583841455|FG002|Screening Phase|Adverse Event|0|||
161669267|NCT00307125|583841453|FG000|Screening Phase|Protocol Violation|27|||
161669268|NCT00307125|583841454|FG001|Screening Phase|Protocol Violation|0|||
161669269|NCT00307125|583841455|FG002|Screening Phase|Protocol Violation|0|||
161669270|NCT00307125|583841453|FG000|Screening Phase|Lost to Follow-up|87|||
161669271|NCT00307125|583841454|FG001|Screening Phase|Lost to Follow-up|0|||
161669272|NCT00307125|583841455|FG002|Screening Phase|Lost to Follow-up|0|||
161669273|NCT00307125|583841453|FG000|Screening Phase|Death|10|||
161669274|NCT00307125|583841454|FG001|Screening Phase|Death|0|||
161669275|NCT00307125|583841455|FG002|Screening Phase|Death|0|||
161669276|NCT00307125|583841453|FG000|Screening Phase|Withdrawal by Subject|77|||
161669277|NCT00307125|583841454|FG001|Screening Phase|Withdrawal by Subject|0|||
161669278|NCT00307125|583841455|FG002|Screening Phase|Withdrawal by Subject|0|||
161669279|NCT00307125|583841453|FG000|Screening Phase|Physician Decision|26|||
161669280|NCT00307125|583841454|FG001|Screening Phase|Physician Decision|0|||
161669281|NCT00307125|583841455|FG002|Screening Phase|Physician Decision|0|||
161579753|NCT03283371|583511197|FG002|Placebo-controlled|Adverse Event|0|||
161579754|NCT03283371|583511198|FG003|Placebo-controlled|Adverse Event|0|||
161579755|NCT03283371|583511195|FG000|Placebo-controlled|Lack of Efficacy|1|||
161579756|NCT03283371|583511196|FG001|Placebo-controlled|Lack of Efficacy|0|||
161579757|NCT03283371|583511197|FG002|Placebo-controlled|Lack of Efficacy|0|||
161579758|NCT03283371|583511198|FG003|Placebo-controlled|Lack of Efficacy|0|||
161579759|NCT03283371|583511195|FG000|Placebo-controlled|Withdrawal by Subject|1|||
161579760|NCT03283371|583511196|FG001|Placebo-controlled|Withdrawal by Subject|1|||
161579761|NCT03283371|583511197|FG002|Placebo-controlled|Withdrawal by Subject|0|||
161579762|NCT03283371|583511198|FG003|Placebo-controlled|Withdrawal by Subject|0|||
161579763|NCT03283371|583511195|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161579764|NCT03283371|583511196|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
161579765|NCT03283371|583511197|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161579766|NCT03283371|583511198|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161579767|NCT03283371|583511195|FG000|Open-label Phase|Adverse Event|0|||
161579768|NCT03283371|583511196|FG001|Open-label Phase|Adverse Event|0|||
161579769|NCT03283371|583511197|FG002|Open-label Phase|Adverse Event|2|||
161579770|NCT03283371|583511198|FG003|Open-label Phase|Adverse Event|0|||
161579771|NCT03283371|583511195|FG000|Open-label Phase|Withdrawal by Subject|0|||
161579772|NCT03283371|583511196|FG001|Open-label Phase|Withdrawal by Subject|0|||
161579773|NCT03283371|583511197|FG002|Open-label Phase|Withdrawal by Subject|1|||
161579774|NCT03283371|583511198|FG003|Open-label Phase|Withdrawal by Subject|0|||
161579775|NCT03283371|583511195|FG000|Open-label Phase|Other|0|||
161579776|NCT03283371|583511196|FG001|Open-label Phase|Other|0|||
161579777|NCT03283371|583511197|FG002|Open-label Phase|Other|1|||
161579778|NCT03283371|583511198|FG003|Open-label Phase|Other|1|||
161579779|NCT01290341|583511199|FG000|Overall Study|Protocol Violation|7|||
161579780|NCT01290341|583511200|FG001|Overall Study|Protocol Violation|3|||
161669282|NCT00307125|583841453|FG000|Screening Phase|Sponsor Decision|4|||
161669283|NCT00307125|583841454|FG001|Screening Phase|Sponsor Decision|0|||
161669284|NCT00307125|583841455|FG002|Screening Phase|Sponsor Decision|0|||
161579781|NCT01290341|583511199|FG000|Overall Study|Adverse Event|1|||
161669285|NCT00307125|583841453|FG000|Screening Phase|Study Terminated|17|||
161669286|NCT00307125|583841454|FG001|Screening Phase|Study Terminated|0|||
161669287|NCT00307125|583841455|FG002|Screening Phase|Study Terminated|0|||
161669288|NCT00307125|583841453|FG000|Screening Phase|Graft Loss|3|||
161669289|NCT00307125|583841454|FG001|Screening Phase|Graft Loss|0|||
161669290|NCT00307125|583841455|FG002|Screening Phase|Graft Loss|0|||
161669291|NCT00307125|583841453|FG000|Screening Phase|Graft Failure|8|||
161669292|NCT00307125|583841454|FG001|Screening Phase|Graft Failure|0|||
161669293|NCT00307125|583841455|FG002|Screening Phase|Graft Failure|0|||
161669294|NCT00307125|583841453|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
161669295|NCT00307125|583841454|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
161669296|NCT00307125|583841455|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
161669297|NCT00307125|583841453|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
161669298|NCT00307125|583841454|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
161669299|NCT00307125|583841455|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
161669300|NCT00307125|583841453|FG000|Screening Phase|Moved or transferred facilities|34|||
161669301|NCT00307125|583841454|FG001|Screening Phase|Moved or transferred facilities|0|||
161669302|NCT00307125|583841455|FG002|Screening Phase|Moved or transferred facilities|0|||
161669303|NCT00307125|583841453|FG000|Screening Phase|Received Pancreas Transplant|8|||
161669304|NCT00307125|583841454|FG001|Screening Phase|Received Pancreas Transplant|0|||
161669305|NCT00307125|583841455|FG002|Screening Phase|Received Pancreas Transplant|0|||
161669306|NCT00307125|583841453|FG000|Screening Phase|Ineligible for pilot|4|||
161669307|NCT00307125|583841454|FG001|Screening Phase|Ineligible for pilot|0|||
161669308|NCT00307125|583841455|FG002|Screening Phase|Ineligible for pilot|0|||
161669309|NCT00307125|583841453|FG000|Screening Phase|Try to get pregnant|1|||
161669310|NCT00307125|583841454|FG001|Screening Phase|Try to get pregnant|0|||
161669311|NCT00307125|583841455|FG002|Screening Phase|Try to get pregnant|0|||
161669312|NCT00307125|583841453|FG000|Screening Phase|Developed acute leukemia|1|||
161669313|NCT00307125|583841454|FG001|Screening Phase|Developed acute leukemia|0|||
161669314|NCT00307125|583841455|FG002|Screening Phase|Developed acute leukemia|0|||
161669315|NCT00307125|583841453|FG000|Screening Phase|Metastatic colon cancer|1|||
161669316|NCT00307125|583841454|FG001|Screening Phase|Metastatic colon cancer|0|||
161669317|NCT00307125|583841455|FG002|Screening Phase|Metastatic colon cancer|0|||
161669318|NCT00307125|583841453|FG000|Screening Phase|Malignancy|1|||
161669319|NCT00307125|583841454|FG001|Screening Phase|Malignancy|0|||
161669320|NCT00307125|583841455|FG002|Screening Phase|Malignancy|0|||
161669321|NCT00307125|583841453|FG000|Screening Phase|PAK|1|||
161669322|NCT00307125|583841454|FG001|Screening Phase|PAK|0|||
161669323|NCT00307125|583841455|FG002|Screening Phase|PAK|0|||
161669324|NCT00307125|583841453|FG000|Screening Phase|Ineligible|1|||
161669325|NCT00307125|583841454|FG001|Screening Phase|Ineligible|0|||
161669326|NCT00307125|583841455|FG002|Screening Phase|Ineligible|0|||
161669327|NCT00307125|583841453|FG000|Screening Phase|Screen Error|1|||
161669328|NCT00307125|583841454|FG001|Screening Phase|Screen Error|0|||
161816167|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816168|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816169|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816170|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816171|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816172|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816173|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816174|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
161816175|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816176|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816177|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816178|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816179|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816180|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816181|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816182|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161921272|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
161921273|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
161669329|NCT00307125|583841455|FG002|Screening Phase|Screen Error|0|||
161669330|NCT00307125|583841453|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
161669331|NCT00307125|583841454|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
161669332|NCT00307125|583841455|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
161669333|NCT00307125|583841453|FG000|Screening Phase|AMR and treated with rituximab|1|||
161669334|NCT00307125|583841454|FG001|Screening Phase|AMR and treated with rituximab|0|||
161669335|NCT00307125|583841455|FG002|Screening Phase|AMR and treated with rituximab|0|||
161669336|NCT00307125|583841453|FG000|Screening Phase|Coronary artery bypass|1|||
161669337|NCT00307125|583841454|FG001|Screening Phase|Coronary artery bypass|0|||
161669338|NCT00307125|583841455|FG002|Screening Phase|Coronary artery bypass|0|||
161816183|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161579782|NCT01290341|583511200|FG001|Overall Study|Adverse Event|0|||
161579783|NCT01290341|583511199|FG000|Overall Study|Lost to Follow-up|21|||
161579784|NCT01290341|583511200|FG001|Overall Study|Lost to Follow-up|10|||
161579785|NCT01290341|583511199|FG000|Overall Study|Withdrawal by Subject|19|||
161579786|NCT01290341|583511200|FG001|Overall Study|Withdrawal by Subject|5|||
161579787|NCT01290341|583511199|FG000|Overall Study|Negative baseline culture and others|44|||
161579788|NCT01290341|583511200|FG001|Overall Study|Negative baseline culture and others|11|||
161579789|NCT03076515|583511208|FG000|Overall Study|DMC decision based on interim analysis|25|||
161579790|NCT03076515|583511209|FG001|Overall Study|DMC decision based on interim analysis|29|||
161579791|NCT00174382|583511210|FG000|Overall Study|Death|2|||
161579792|NCT00174382|583511210|FG000|Overall Study|Adverse Event|19|||
161579793|NCT00174382|583511210|FG000|Overall Study|Withdrawal by Subject|6|||
161579794|NCT00174382|583511210|FG000|Overall Study|Protocol Violation|3|||
161579795|NCT00174382|583511210|FG000|Overall Study|Arrived early for last visit in error|1|||
161579796|NCT00174382|583511210|FG000|Overall Study|Subject felt pill not effective enough|1|||
161579797|NCT00174382|583511210|FG000|Overall Study|Lost to Follow-up|1|||
161579798|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
161579799|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
161579800|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
161579801|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
161579802|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
161579803|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
161579804|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
161579805|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
161579806|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161579807|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161579808|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161579809|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161579810|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
161579811|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
161579812|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161579813|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161579814|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161579815|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161579816|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161579817|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161579818|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161579819|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161816184|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816185|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816186|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816187|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816188|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816189|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816190|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161480757|NCT03095066|583154731|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
161480758|NCT03095066|583154732|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
161480759|NCT03095066|583154733|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
161480760|NCT03095066|583154734|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
161480761|NCT03095066|583154735|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
161480762|NCT03095066|583154736|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
161480763|NCT03095066|583154737|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
161480764|NCT03095066|583154730|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
161480765|NCT03095066|583154731|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
161480766|NCT03095066|583154732|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
161480767|NCT03095066|583154733|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
161480768|NCT03095066|583154734|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
161480769|NCT03095066|583154735|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
161816191|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816192|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816193|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
161480770|NCT03095066|583154736|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
161579820|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
161579821|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
161579822|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579823|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
161669339|NCT00307125|583841453|FG000|Pilot Phase|Lost to Follow-up|0|||
161669340|NCT00307125|583841454|FG001|Pilot Phase|Lost to Follow-up|1|||
161579824|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579825|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579826|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579827|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579828|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579829|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
161579830|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
161579831|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
161579832|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
161579833|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
161579834|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
161579835|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
161579836|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
161579837|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
161579838|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579839|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579840|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579841|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
161579842|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579843|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579844|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579845|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161579846|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161579847|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
161579848|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161579849|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161579850|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
161579851|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161579852|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
161579853|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
161579854|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
161579855|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161579856|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161579857|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161579858|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161579859|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
161579860|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161579861|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161579862|NCT03903822|583511211|FG000|Treatment Phase (6 Weeks)|Other|2|||
161579863|NCT03903822|583511212|FG001|Treatment Phase (6 Weeks)|Other|1|||
161579864|NCT03903822|583511213|FG002|Treatment Phase (6 Weeks)|Other|0|||
161579865|NCT03903822|583511214|FG003|Treatment Phase (6 Weeks)|Other|0|||
161579866|NCT03903822|583511215|FG004|Treatment Phase (6 Weeks)|Other|1|||
161579867|NCT03903822|583511216|FG005|Treatment Phase (6 Weeks)|Other|1|||
161579868|NCT03903822|583511217|FG006|Treatment Phase (6 Weeks)|Other|0|||
161579869|NCT03903822|583511218|FG007|Treatment Phase (6 Weeks)|Other|0|||
161579870|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
161579871|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
161579872|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
161579873|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
161579874|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
161579875|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
161579876|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
161579877|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
161579878|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579879|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579880|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579881|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579882|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
161579883|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579884|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579885|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161579886|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
161579887|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161669341|NCT00307125|583841455|FG002|Pilot Phase|Lost to Follow-up|0|||
161669342|NCT00307125|583841453|FG000|Pilot Phase|Withdrawal by Subject|0|||
161579888|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161579889|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161579890|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161579891|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161579892|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
161579893|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
161816194|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816195|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816196|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816197|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816198|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816199|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816200|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
161816201|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816202|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816203|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816204|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816205|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816206|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
161480771|NCT03095066|583154737|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
161480772|NCT03095066|583154730|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
161480773|NCT03095066|583154731|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
161669343|NCT00307125|583841454|FG001|Pilot Phase|Withdrawal by Subject|1|||
161669344|NCT00307125|583841455|FG002|Pilot Phase|Withdrawal by Subject|1|||
161669345|NCT02571049|583841456|FG000|Screening|Did not meet entry criteria|2|||
161669346|NCT02571049|583841457|FG001|Screening|Did not meet entry criteria|2|||
161669347|NCT02571049|583841456|FG000|Randomization|No migraine attack|0|||
161669348|NCT02571049|583841457|FG001|Randomization|No migraine attack|1|||
161669349|NCT02571049|583841456|FG000|Randomization|Adverse Event|0|||
161669350|NCT02571049|583841457|FG001|Randomization|Adverse Event|1|||
161669351|NCT01055262|583841460|FG000|Overall Study|Adverse Event|5|||
161669352|NCT01055262|583841460|FG000|Overall Study|Protocol Violation|3|||
161669353|NCT01055262|583841460|FG000|Overall Study|Uncooperativeness|1|||
161669354|NCT03370471|583841461|FG000|Overall Study|Withdrawal by Subject|6|||
161669355|NCT03370471|583841462|FG001|Overall Study|Withdrawal by Subject|1|||
161669356|NCT03370471|583841461|FG000|Overall Study|Unable to access veins for blood draw|0|||
161669357|NCT03370471|583841462|FG001|Overall Study|Unable to access veins for blood draw|1|||
161669358|NCT03370471|583841461|FG000|Overall Study|Screen fail|1|||
161669359|NCT03370471|583841462|FG001|Overall Study|Screen fail|0|||
161669360|NCT00561951|583841465|FG000|Overall Study|Adverse Event|11|||
161669361|NCT00561951|583841466|FG001|Overall Study|Adverse Event|14|||
161669362|NCT00561951|583841467|FG002|Overall Study|Adverse Event|14|||
161669363|NCT00561951|583841465|FG000|Overall Study|Lack of Efficacy|5|||
161669364|NCT00561951|583841466|FG001|Overall Study|Lack of Efficacy|3|||
161669365|NCT00561951|583841467|FG002|Overall Study|Lack of Efficacy|2|||
161669366|NCT00561951|583841465|FG000|Overall Study|Lost to Follow-up|1|||
161669367|NCT00561951|583841466|FG001|Overall Study|Lost to Follow-up|1|||
161669368|NCT00561951|583841467|FG002|Overall Study|Lost to Follow-up|0|||
161669369|NCT00561951|583841465|FG000|Overall Study|Withdrawal by Subject|10|||
161669370|NCT00561951|583841466|FG001|Overall Study|Withdrawal by Subject|9|||
161669371|NCT00561951|583841467|FG002|Overall Study|Withdrawal by Subject|10|||
161669372|NCT00561951|583841465|FG000|Overall Study|Protocol Violation|4|||
161669373|NCT00561951|583841466|FG001|Overall Study|Protocol Violation|3|||
161669374|NCT00561951|583841467|FG002|Overall Study|Protocol Violation|4|||
161669375|NCT00561951|583841465|FG000|Overall Study|Physician Decision|1|||
161669376|NCT00561951|583841466|FG001|Overall Study|Physician Decision|0|||
161669377|NCT00561951|583841467|FG002|Overall Study|Physician Decision|0|||
161669378|NCT00561951|583841465|FG000|Overall Study|Pregnancy|0|||
161669379|NCT00561951|583841466|FG001|Overall Study|Pregnancy|1|||
161669380|NCT00561951|583841467|FG002|Overall Study|Pregnancy|0|||
161669381|NCT00561951|583841465|FG000|Overall Study|Meet Withdrawal Criterion|0|||
161669382|NCT00561951|583841466|FG001|Overall Study|Meet Withdrawal Criterion|1|||
161669383|NCT00561951|583841467|FG002|Overall Study|Meet Withdrawal Criterion|1|||
161669384|NCT00561951|583841465|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
161669385|NCT00561951|583841466|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
161669386|NCT00561951|583841467|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
161669387|NCT01765179|583841468|FG000|Overall Study|Adverse Event|3|||
161669388|NCT01765179|583841468|FG000|Overall Study|Lost to Follow-up|5|||
161669389|NCT01765179|583841468|FG000|Overall Study|Non-compliance with study drug|2|||
161669390|NCT01765179|583841468|FG000|Overall Study|Protocol Violation|1|||
161669391|NCT01765179|583841468|FG000|Overall Study|Withdrawal by Subject|8|||
161669392|NCT01765179|583841468|FG000|Overall Study|Hematocrit >54%|3|||
161669393|NCT01765179|583841468|FG000|Overall Study|prohibited med|1|||
161669394|NCT01765179|583841468|FG000|Overall Study|Out of country unable to finish study|1|||
161816207|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816208|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
161921274|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161669395|NCT01765179|583841468|FG000|Overall Study|lack of venous access|1|||
161669396|NCT01765179|583841468|FG000|Overall Study|work conflict|1|||
161669397|NCT01765179|583841468|FG000|Overall Study|Ca elevated 10.6|1|||
161669398|NCT02640157|583841469|FG000|Overall Study|Adverse Event|2|||
161921275|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921276|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921277|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921278|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921279|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921280|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
161921281|NCT01044498|584757187|FG000|Overall Study|Withdrew consent|1|||
161921282|NCT01044498|584757188|FG001|Overall Study|Withdrew consent|1|||
161480774|NCT03095066|583154732|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
161480775|NCT03095066|583154733|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
161480776|NCT03095066|583154734|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
161480777|NCT03095066|583154735|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
161480778|NCT03095066|583154736|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
161480779|NCT03095066|583154737|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
161480780|NCT03095066|583154730|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
161480781|NCT03095066|583154731|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
161480782|NCT03095066|583154732|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
161480783|NCT03095066|583154733|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
161480784|NCT03095066|583154734|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
161480785|NCT03095066|583154735|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
161480786|NCT03095066|583154736|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
161480787|NCT03095066|583154737|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
161480788|NCT00160693|583154738|FG000|Overall Study|Adverse Event|97|||
161480789|NCT00160693|583154738|FG000|Overall Study|Lack of Efficacy|30|||
161480790|NCT00160693|583154738|FG000|Overall Study|Protocol Violation|24|||
161480791|NCT00160693|583154738|FG000|Overall Study|Lost to Follow-up|15|||
161480792|NCT00160693|583154738|FG000|Overall Study|Withdrawal by Subject|54|||
161480793|NCT00160693|583154738|FG000|Overall Study|Study terminated by sponsor|15|||
161480794|NCT03052725|583154739|FG000|Overall Study|Adverse Event|2|||
161480795|NCT03052725|583154740|FG001|Overall Study|Adverse Event|0|||
161480796|NCT03052725|583154739|FG000|Overall Study|Withdrawal by Subject|3|||
161480797|NCT03052725|583154740|FG001|Overall Study|Withdrawal by Subject|4|||
161480798|NCT03052725|583154739|FG000|Overall Study|Pregnancy|0|||
161480799|NCT03052725|583154740|FG001|Overall Study|Pregnancy|1|||
161480800|NCT03052725|583154739|FG000|Overall Study|Site closure|0|||
161480801|NCT03052725|583154740|FG001|Overall Study|Site closure|1|||
161480802|NCT03052725|583154739|FG000|Overall Study|Study terminated by sponsor|143|||
161480803|NCT03052725|583154740|FG001|Overall Study|Study terminated by sponsor|144|||
161579894|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
161579895|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
161579896|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
161579897|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
161579898|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
161579899|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
161579900|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
161579901|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
161579902|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161579903|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
161579904|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161579905|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161579906|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161579907|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161579908|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161579909|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161579910|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579911|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579912|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579913|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579914|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579915|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
161579916|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579917|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161579918|NCT03903822|583511211|FG000|Follow up Phase (4 Weeks)|Other|1|||
161579919|NCT03903822|583511212|FG001|Follow up Phase (4 Weeks)|Other|1|||
161579920|NCT03903822|583511213|FG002|Follow up Phase (4 Weeks)|Other|0|||
161579921|NCT03903822|583511214|FG003|Follow up Phase (4 Weeks)|Other|0|||
161579922|NCT03903822|583511215|FG004|Follow up Phase (4 Weeks)|Other|0|||
161579923|NCT03903822|583511216|FG005|Follow up Phase (4 Weeks)|Other|0|||
161579924|NCT03903822|583511217|FG006|Follow up Phase (4 Weeks)|Other|0|||
161579925|NCT03903822|583511218|FG007|Follow up Phase (4 Weeks)|Other|0|||
161579926|NCT00296036|583511219|FG000|Overall Study|Withdrawal by Subject|1|||
161921283|NCT01044498|584757187|FG000|Overall Study|Adverse Event|1|||
161921284|NCT01044498|584757188|FG001|Overall Study|Adverse Event|1|||
161669399|NCT02640157|583841470|FG001|Overall Study|Adverse Event|2|||
161669400|NCT02640157|583841471|FG002|Overall Study|Adverse Event|1|||
161669401|NCT02640157|583841469|FG000|Overall Study|Withdrew consent|2|||
161669402|NCT02640157|583841470|FG001|Overall Study|Withdrew consent|0|||
161669403|NCT02640157|583841471|FG002|Overall Study|Withdrew consent|2|||
161669404|NCT02640157|583841469|FG000|Overall Study|Lost to Follow-up|9|||
161669405|NCT02640157|583841470|FG001|Overall Study|Lost to Follow-up|2|||
161669406|NCT02640157|583841471|FG002|Overall Study|Lost to Follow-up|7|||
161669407|NCT02640157|583841469|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
161669408|NCT02640157|583841470|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
161669409|NCT02640157|583841471|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
161669410|NCT01596621|583841472|FG000|Overall Study|Death|4|||
161816209|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816210|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816211|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816212|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816213|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816214|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816215|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816216|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816217|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Moved|0|||
161816218|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Moved|0|||
161816219|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Moved|0|||
161816220|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Moved|0|||
161816221|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Moved|0|||
161816222|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Moved|0|||
161816223|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Moved|0|||
161816224|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Moved|0|||
161816225|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Moved|0|||
161816226|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Moved|1|||
161816227|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Moved|0|||
161816228|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Moved|0|||
161816229|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Moved|0|||
161816230|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Moved|0|||
161816231|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Moved|0|||
161816232|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Moved|0|||
161816233|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Moved|0|||
161816234|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Moved|0|||
161816235|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Moved|0|||
161816236|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Moved|0|||
161816237|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Moved|0|||
161816238|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Moved|0|||
161816239|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Moved|0|||
161816240|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Moved|0|||
161816241|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Moved|0|||
161816242|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Moved|0|||
161816243|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
161816244|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
161816245|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
161816246|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
161816247|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
161816248|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
161816249|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
161816250|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
161816251|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
161816252|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
161816253|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
161816254|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
161816255|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
161816256|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
161816257|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
161816258|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
161816259|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
161816260|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
161816261|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
161816262|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
161816263|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
161816264|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
161816265|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
161816266|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
161816267|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
161669411|NCT01596621|583841472|FG000|Overall Study|Withdrawal by Subject|9|||
161669412|NCT01596621|583841472|FG000|Overall Study|Disease Progression|49|||
161669413|NCT01596621|583841472|FG000|Overall Study|Lost to Follow-up|3|||
161816268|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
161921285|NCT01044498|584757187|FG000|Overall Study|Other|1|||
161921286|NCT01044498|584757188|FG001|Overall Study|Other|0|||
161816269|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816270|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816271|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816272|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816273|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816274|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816275|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816276|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816277|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816278|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816279|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816280|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161816281|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816282|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161816283|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816284|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161816285|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816286|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816287|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
161816288|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816289|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816290|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816291|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816292|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816293|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816294|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816295|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816296|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816297|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161579927|NCT00296036|583511220|FG001|Overall Study|Withdrawal by Subject|0|||
161579928|NCT00296036|583511221|FG002|Overall Study|Withdrawal by Subject|2|||
161579929|NCT00296036|583511222|FG003|Overall Study|Withdrawal by Subject|1|||
161579930|NCT00296036|583511223|FG004|Overall Study|Withdrawal by Subject|2|||
161579931|NCT00296036|583511224|FG005|Overall Study|Withdrawal by Subject|1|||
161579932|NCT00296036|583511219|FG000|Overall Study|Protocol Violation|0|||
161579933|NCT00296036|583511220|FG001|Overall Study|Protocol Violation|0|||
161579934|NCT00296036|583511221|FG002|Overall Study|Protocol Violation|0|||
161579935|NCT00296036|583511222|FG003|Overall Study|Protocol Violation|0|||
161579936|NCT00296036|583511223|FG004|Overall Study|Protocol Violation|0|||
161579937|NCT00296036|583511224|FG005|Overall Study|Protocol Violation|3|||
161579938|NCT00785512|583511227|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
161579939|NCT00785512|583511228|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
161669414|NCT01596621|583841472|FG000|Overall Study|Other than specified|13|||
161669415|NCT00710021|583841473|FG000|Overall Study|Lost to Follow-up|1|||
161669416|NCT00710021|583841474|FG001|Overall Study|Lost to Follow-up|0|||
161669417|NCT00710021|583841475|FG002|Overall Study|Lost to Follow-up|0|||
161669418|NCT00710021|583841473|FG000|Overall Study|Subject's Decision|0|||
161669419|NCT00710021|583841474|FG001|Overall Study|Subject's Decision|1|||
161669420|NCT00710021|583841475|FG002|Overall Study|Subject's Decision|0|||
161669421|NCT00710021|583841473|FG000|Overall Study|Subject misrandomized|0|||
161669422|NCT00710021|583841474|FG001|Overall Study|Subject misrandomized|1|||
161669423|NCT00710021|583841475|FG002|Overall Study|Subject misrandomized|1|||
161669424|NCT00710021|583841473|FG000|Overall Study|Physician Decision|0|||
161669425|NCT00710021|583841474|FG001|Overall Study|Physician Decision|1|||
161669426|NCT00710021|583841475|FG002|Overall Study|Physician Decision|0|||
161669427|NCT00421707|583841476|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
161669428|NCT00421707|583841477|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
161669429|NCT00421707|583841476|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
161816298|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816299|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816300|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816301|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816302|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816303|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816304|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161579940|NCT00785512|583511227|FG000|Overall Study|Adverse Event|0|||
161579941|NCT00785512|583511228|FG001|Overall Study|Adverse Event|0|||
161579942|NCT00785512|583511227|FG000|Overall Study|Lack of Efficacy|0|||
161579943|NCT00785512|583511228|FG001|Overall Study|Lack of Efficacy|2|||
161579944|NCT00785512|583511227|FG000|Overall Study|Withdrawal by Subject|0|||
161669430|NCT00421707|583841477|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
161669431|NCT00421707|583841476|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
161480804|NCT00777608|583154742|FG000|Overall Study|Lost to Follow-up|1|||
161480805|NCT00777608|583154743|FG001|Overall Study|Lost to Follow-up|1|||
161480806|NCT00777608|583154742|FG000|Overall Study|Withdrawal by Subject|1|||
161480807|NCT00777608|583154743|FG001|Overall Study|Withdrawal by Subject|3|||
161480808|NCT00777608|583154742|FG000|Overall Study|Protocol Violation|1|||
161480809|NCT00777608|583154743|FG001|Overall Study|Protocol Violation|0|||
161480810|NCT00777608|583154742|FG000|Overall Study|Investigator Decision|1|||
161480811|NCT00777608|583154743|FG001|Overall Study|Investigator Decision|2|||
161480812|NCT00520936|583154745|FG000|Overall Study|Physician Decision|0|||
161480813|NCT00520936|583154746|FG001|Overall Study|Physician Decision|2|||
161480814|NCT00520936|583154747|FG002|Overall Study|Physician Decision|1|||
161480815|NCT00520936|583154748|FG003|Overall Study|Physician Decision|0|||
161480816|NCT00520936|583154749|FG004|Overall Study|Physician Decision|0|||
161480817|NCT00520936|583154750|FG005|Overall Study|Physician Decision|0|||
161480818|NCT00520936|583154751|FG006|Overall Study|Physician Decision|0|||
161480819|NCT00520936|583154752|FG007|Overall Study|Physician Decision|0|||
161480820|NCT00520936|583154745|FG000|Overall Study|Withdrawal by Subject|0|||
161480821|NCT00520936|583154746|FG001|Overall Study|Withdrawal by Subject|0|||
161480822|NCT00520936|583154747|FG002|Overall Study|Withdrawal by Subject|0|||
161480823|NCT00520936|583154748|FG003|Overall Study|Withdrawal by Subject|0|||
161480824|NCT00520936|583154749|FG004|Overall Study|Withdrawal by Subject|0|||
161480825|NCT00520936|583154750|FG005|Overall Study|Withdrawal by Subject|0|||
161480826|NCT00520936|583154751|FG006|Overall Study|Withdrawal by Subject|0|||
161480827|NCT00520936|583154752|FG007|Overall Study|Withdrawal by Subject|1|||
161480828|NCT00520936|583154745|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
161480829|NCT00520936|583154746|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
161480830|NCT00520936|583154747|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
161480831|NCT00520936|583154748|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
161480832|NCT00520936|583154749|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
161480833|NCT00520936|583154750|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
161480834|NCT00520936|583154751|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
161480835|NCT00520936|583154752|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
161480836|NCT00520936|583154745|FG000|Overall Study|Death|0|||
161480837|NCT00520936|583154746|FG001|Overall Study|Death|0|||
161480838|NCT00520936|583154747|FG002|Overall Study|Death|0|||
161480839|NCT00520936|583154748|FG003|Overall Study|Death|0|||
161480840|NCT00520936|583154749|FG004|Overall Study|Death|0|||
161480841|NCT00520936|583154750|FG005|Overall Study|Death|0|||
161480842|NCT00520936|583154751|FG006|Overall Study|Death|1|||
161480843|NCT00520936|583154752|FG007|Overall Study|Death|0|||
161480844|NCT00520936|583154745|FG000|Overall Study|Protocol Violation|0|||
161480845|NCT00520936|583154746|FG001|Overall Study|Protocol Violation|1|||
161480846|NCT00520936|583154747|FG002|Overall Study|Protocol Violation|1|||
161480847|NCT00520936|583154748|FG003|Overall Study|Protocol Violation|0|||
161480848|NCT00520936|583154749|FG004|Overall Study|Protocol Violation|1|||
161480849|NCT00520936|583154750|FG005|Overall Study|Protocol Violation|0|||
161480850|NCT00520936|583154751|FG006|Overall Study|Protocol Violation|1|||
161480851|NCT00520936|583154752|FG007|Overall Study|Protocol Violation|0|||
161480852|NCT01471171|583154755|FG000|Treatment Period 1|Adverse Event|4|||
161480853|NCT01471171|583154756|FG001|Treatment Period 1|Adverse Event|1|||
161480854|NCT01471171|583154755|FG000|Treatment Period 2|Adverse Event|1|||
161480855|NCT01471171|583154756|FG001|Treatment Period 2|Adverse Event|0|||
161480856|NCT00730132|583154759|FG000|Overall Study|Protocol Violation|154|||
161480857|NCT00730132|583154759|FG000|Overall Study|Death|1|||
161480858|NCT00370032|583154760|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
161480859|NCT00370032|583154761|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
161480860|NCT00370032|583154760|FG000|Washout Period|Withdrawal by Subject|0|||
161480861|NCT00370032|583154761|FG001|Washout Period|Withdrawal by Subject|1|||
161480862|NCT00370032|583154760|FG000|Washout Period|Lost to Follow-up|0|||
161480863|NCT00370032|583154761|FG001|Washout Period|Lost to Follow-up|1|||
161480864|NCT00370032|583154760|FG000|Washout Period|Adverse Event|1|||
161480865|NCT00370032|583154761|FG001|Washout Period|Adverse Event|0|||
161480866|NCT00370032|583154760|FG000|Follow-up Period|Withdrawal by Subject|1|||
161480867|NCT00370032|583154761|FG001|Follow-up Period|Withdrawal by Subject|0|||
161480868|NCT03208244|583154765|FG000|Overall Study|Death|1|||
161480869|NCT04431453|583154766|FG000|Overall Study|Withdrew Consent|0|||
161480870|NCT04431453|583154767|FG001|Overall Study|Withdrew Consent|1|||
161480871|NCT04431453|583154768|FG002|Overall Study|Withdrew Consent|0|||
161480872|NCT04431453|583154769|FG003|Overall Study|Withdrew Consent|2|||
161480873|NCT04431453|583154770|FG004|Overall Study|Withdrew Consent|0|||
161480874|NCT04431453|583154771|FG005|Overall Study|Withdrew Consent|0|||
161480875|NCT04431453|583154772|FG006|Overall Study|Withdrew Consent|0|||
161480876|NCT04431453|583154773|FG007|Overall Study|Withdrew Consent|0|||
161480877|NCT04431453|583154766|FG000|Overall Study|Death|1|||
161480878|NCT04431453|583154767|FG001|Overall Study|Death|0|||
161480879|NCT04431453|583154768|FG002|Overall Study|Death|0|||
161480880|NCT04431453|583154769|FG003|Overall Study|Death|0|||
161921287|NCT02903914|584757193|FG000|Overall Study|Adverse Event|0|||
161480881|NCT04431453|583154770|FG004|Overall Study|Death|0|||
161480882|NCT04431453|583154771|FG005|Overall Study|Death|0|||
161480883|NCT04431453|583154772|FG006|Overall Study|Death|0|||
161480884|NCT04431453|583154773|FG007|Overall Study|Death|1|||
161480885|NCT04431453|583154766|FG000|Overall Study|Lost to Follow-up|0|||
161480886|NCT04431453|583154767|FG001|Overall Study|Lost to Follow-up|0|||
161480887|NCT04431453|583154768|FG002|Overall Study|Lost to Follow-up|1|||
161480888|NCT04431453|583154769|FG003|Overall Study|Lost to Follow-up|1|||
161579945|NCT00785512|583511228|FG001|Overall Study|Withdrawal by Subject|1|||
161579946|NCT00785512|583511227|FG000|Overall Study|Lost to Follow-up|3|||
161579947|NCT00785512|583511228|FG001|Overall Study|Lost to Follow-up|0|||
161579948|NCT00785512|583511227|FG000|Overall Study|Precedure Refused|0|||
161579949|NCT00785512|583511228|FG001|Overall Study|Precedure Refused|0|||
161579950|NCT00785512|583511227|FG000|Overall Study|IVRS Programing Error|0|||
161579951|NCT00785512|583511228|FG001|Overall Study|IVRS Programing Error|0|||
161579952|NCT00785512|583511227|FG000|Overall Study|Physician Decision|0|||
161579953|NCT00785512|583511228|FG001|Overall Study|Physician Decision|0|||
161579954|NCT00785512|583511227|FG000|Overall Study|Lack of compliance|0|||
161579955|NCT00785512|583511228|FG001|Overall Study|Lack of compliance|1|||
161579956|NCT01943799|583511229|FG000|Overall Study|Lost to Follow-up|0|||
161579957|NCT01943799|583511230|FG001|Overall Study|Lost to Follow-up|1|||
161579958|NCT01943799|583511231|FG002|Overall Study|Lost to Follow-up|1|||
161579959|NCT01943799|583511232|FG003|Overall Study|Lost to Follow-up|0|||
161579960|NCT01943799|583511229|FG000|Overall Study|Protocol Violation|1|||
161579961|NCT01943799|583511230|FG001|Overall Study|Protocol Violation|0|||
161579962|NCT01943799|583511231|FG002|Overall Study|Protocol Violation|0|||
161579963|NCT01943799|583511232|FG003|Overall Study|Protocol Violation|0|||
161579964|NCT01943799|583511229|FG000|Overall Study|Withdrawal by Subject|4|||
161579965|NCT01943799|583511230|FG001|Overall Study|Withdrawal by Subject|2|||
161579966|NCT01943799|583511231|FG002|Overall Study|Withdrawal by Subject|1|||
161579967|NCT01943799|583511232|FG003|Overall Study|Withdrawal by Subject|0|||
161579968|NCT04594759|583511233|FG000|Overall Study|Lost to Follow-up|3|||
161579969|NCT04556981|583511237|FG000|Overall Study|Death|0|||
161579970|NCT04556981|583511238|FG001|Overall Study|Death|1|||
161579971|NCT04556981|583511237|FG000|Overall Study|Lost to Follow-up|2|||
161579972|NCT04556981|583511238|FG001|Overall Study|Lost to Follow-up|11|||
161579973|NCT04556981|583511237|FG000|Overall Study|Moved from the study area|1|||
161579974|NCT04556981|583511238|FG001|Overall Study|Moved from the study area|4|||
161579975|NCT04556981|583511237|FG000|Overall Study|Withdrawal by Subject|2|||
161579976|NCT04556981|583511238|FG001|Overall Study|Withdrawal by Subject|2|||
161579977|NCT04556981|583511237|FG000|Overall Study|Other|2|||
161579978|NCT04556981|583511238|FG001|Overall Study|Other|1|||
161579979|NCT03764475|583511239|FG000|Overall Study|Adverse Event|11|||
161480889|NCT04431453|583154770|FG004|Overall Study|Lost to Follow-up|0|||
161579980|NCT03764475|583511240|FG001|Overall Study|Adverse Event|2|||
161579981|NCT03764475|583511239|FG000|Overall Study|Lost to Follow-up|24|||
161579982|NCT03764475|583511240|FG001|Overall Study|Lost to Follow-up|10|||
161579983|NCT03764475|583511239|FG000|Overall Study|Withdrawal by Subject|26|||
161579984|NCT03764475|583511240|FG001|Overall Study|Withdrawal by Subject|10|||
161669432|NCT00421707|583841477|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
161669433|NCT00421707|583841476|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
161480890|NCT04431453|583154771|FG005|Overall Study|Lost to Follow-up|0|||
161669434|NCT00421707|583841477|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
161669435|NCT00421707|583841476|FG000|Period 2: Washout|Adverse Event|1|||
161669436|NCT00421707|583841477|FG001|Period 2: Washout|Adverse Event|1|||
161480891|NCT04431453|583154772|FG006|Overall Study|Lost to Follow-up|0|||
161480892|NCT04431453|583154773|FG007|Overall Study|Lost to Follow-up|0|||
161480893|NCT04431453|583154766|FG000|Overall Study|Enrolled but Never Treated|0|||
161480894|NCT04431453|583154767|FG001|Overall Study|Enrolled but Never Treated|0|||
161480895|NCT04431453|583154768|FG002|Overall Study|Enrolled but Never Treated|0|||
161480896|NCT04431453|583154769|FG003|Overall Study|Enrolled but Never Treated|0|||
161480897|NCT04431453|583154770|FG004|Overall Study|Enrolled but Never Treated|1|||
161480898|NCT04431453|583154771|FG005|Overall Study|Enrolled but Never Treated|0|||
161480899|NCT04431453|583154772|FG006|Overall Study|Enrolled but Never Treated|0|||
161579985|NCT03764475|583511239|FG000|Overall Study|Lack of Efficacy|3|||
161579986|NCT03764475|583511240|FG001|Overall Study|Lack of Efficacy|0|||
161579987|NCT03764475|583511239|FG000|Overall Study|COVID-19 Disruption|2|||
161579988|NCT03764475|583511240|FG001|Overall Study|COVID-19 Disruption|0|||
161579989|NCT00580866|583511241|FG000|Overall Study|Lost to Follow-up|2|||
161579990|NCT00580866|583511242|FG001|Overall Study|Lost to Follow-up|2|||
161480900|NCT04431453|583154773|FG007|Overall Study|Enrolled but Never Treated|0|||
161579991|NCT02477605|583511246|FG000|Overall Study|Discontinued prior to treatment|1|||
161480901|NCT03385564|583154774|FG000|Overall Study|Adverse Event|0|||
161480902|NCT03385564|583154775|FG001|Overall Study|Adverse Event|0|||
161480903|NCT03385564|583154776|FG002|Overall Study|Adverse Event|3|||
161480904|NCT03385564|583154777|FG003|Overall Study|Adverse Event|3|||
161480905|NCT03385564|583154774|FG000|Overall Study|Other than listed|0|||
161480906|NCT03385564|583154775|FG001|Overall Study|Other than listed|0|||
161480907|NCT03385564|583154776|FG002|Overall Study|Other than listed|0|||
161480908|NCT03385564|583154777|FG003|Overall Study|Other than listed|5|||
161480909|NCT03385564|583154774|FG000|Overall Study|Withdrawal by Subject|0|||
161480910|NCT03385564|583154775|FG001|Overall Study|Withdrawal by Subject|1|||
161480911|NCT03385564|583154776|FG002|Overall Study|Withdrawal by Subject|1|||
161480912|NCT03385564|583154777|FG003|Overall Study|Withdrawal by Subject|0|||
161480913|NCT03385564|583154774|FG000|Overall Study|Lack of Efficacy|0|||
161480914|NCT03385564|583154775|FG001|Overall Study|Lack of Efficacy|0|||
161480915|NCT03385564|583154776|FG002|Overall Study|Lack of Efficacy|0|||
161480916|NCT03385564|583154777|FG003|Overall Study|Lack of Efficacy|1|||
161480917|NCT03385564|583154774|FG000|Overall Study|Death|0|||
161480918|NCT03385564|583154775|FG001|Overall Study|Death|0|||
161480919|NCT03385564|583154776|FG002|Overall Study|Death|1|||
161480920|NCT03385564|583154777|FG003|Overall Study|Death|0|||
161480921|NCT01702961|583154784|FG000|Overall Study|Additional treatment|3|||
161480922|NCT01702961|583154784|FG000|Overall Study|Progressive disease|5|||
161480923|NCT01702961|583154784|FG000|Overall Study|Relapse|20|||
161480924|NCT01702961|583154784|FG000|Overall Study|Death|6|||
161480925|NCT01702961|583154784|FG000|Overall Study|Lost to Follow-up|2|||
161480926|NCT01702961|583154784|FG000|Overall Study|Ongoing|11|||
161480927|NCT03724032|583154787|FG000|Overall Study|Physician Decision|1|||
161480928|NCT03724032|583154788|FG001|Overall Study|Physician Decision|0|||
161480929|NCT03724032|583154789|FG002|Overall Study|Physician Decision|0|||
161480930|NCT03724032|583154787|FG000|Overall Study|Protocol Violation|2|||
161816305|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161480931|NCT03724032|583154788|FG001|Overall Study|Protocol Violation|2|||
161480932|NCT03724032|583154789|FG002|Overall Study|Protocol Violation|1|||
161480933|NCT00751933|583154790|FG000|Overall Study|Withdrawal by Subject|0|||
161480934|NCT00751933|583154791|FG001|Overall Study|Withdrawal by Subject|1|||
161480935|NCT00751933|583154792|FG002|Overall Study|Withdrawal by Subject|0|||
161480936|NCT00751933|583154793|FG003|Overall Study|Withdrawal by Subject|0|||
161480937|NCT00751933|583154790|FG000|Overall Study|Physician Decision|0|||
161480938|NCT00751933|583154791|FG001|Overall Study|Physician Decision|0|||
161480939|NCT00751933|583154792|FG002|Overall Study|Physician Decision|1|||
161480940|NCT00751933|583154793|FG003|Overall Study|Physician Decision|1|||
161480941|NCT00361569|583154795|FG000|Overall Study|Protocol Violation|3|||
161480942|NCT00361569|583154796|FG001|Overall Study|Protocol Violation|2|||
161480943|NCT00361569|583154797|FG002|Overall Study|Protocol Violation|4|||
161480944|NCT00361569|583154798|FG003|Overall Study|Protocol Violation|2|||
161480945|NCT00361569|583154795|FG000|Overall Study|Withdrawal by Subject|2|||
161480946|NCT00361569|583154796|FG001|Overall Study|Withdrawal by Subject|1|||
161480947|NCT00361569|583154797|FG002|Overall Study|Withdrawal by Subject|9|||
161480948|NCT00361569|583154798|FG003|Overall Study|Withdrawal by Subject|14|||
161480949|NCT00361569|583154795|FG000|Overall Study|Adverse Event|3|||
161480950|NCT00361569|583154796|FG001|Overall Study|Adverse Event|5|||
161480951|NCT00361569|583154797|FG002|Overall Study|Adverse Event|2|||
161480952|NCT00361569|583154798|FG003|Overall Study|Adverse Event|2|||
161480953|NCT00361569|583154795|FG000|Overall Study|Lost to Follow-up|2|||
161480954|NCT00361569|583154796|FG001|Overall Study|Lost to Follow-up|3|||
161480955|NCT00361569|583154797|FG002|Overall Study|Lost to Follow-up|3|||
161480956|NCT00361569|583154798|FG003|Overall Study|Lost to Follow-up|2|||
161480957|NCT00361569|583154795|FG000|Overall Study|Not specified by investigator|2|||
161480958|NCT00361569|583154796|FG001|Overall Study|Not specified by investigator|0|||
161480959|NCT00361569|583154797|FG002|Overall Study|Not specified by investigator|0|||
161480960|NCT00361569|583154798|FG003|Overall Study|Not specified by investigator|1|||
161480961|NCT02605824|583154799|FG000|Overall Study|Physician Decision|1|||
161480962|NCT02605824|583154800|FG001|Overall Study|Physician Decision|0|||
161579992|NCT02477605|583511247|FG001|Overall Study|Discontinued prior to treatment|0|||
161579993|NCT02477605|583511246|FG000|Overall Study|Lost to Follow-up|0|||
161816306|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161480963|NCT04875195|583154801|FG000|Overall Study|Death|9|||
161579994|NCT02477605|583511247|FG001|Overall Study|Lost to Follow-up|2|||
161816307|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816308|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161480964|NCT04875195|583154802|FG001|Overall Study|Death|3|||
161480965|NCT04875195|583154801|FG000|Overall Study|Withdrawal by Subject|2|||
161480966|NCT04875195|583154802|FG001|Overall Study|Withdrawal by Subject|1|||
161579995|NCT02477605|583511246|FG000|Overall Study|Withdrawal by Subject|0|||
161480967|NCT04875195|583154801|FG000|Overall Study|Ongoing in study|49|||
161480968|NCT04875195|583154802|FG001|Overall Study|Ongoing in study|2|||
161579996|NCT02477605|583511247|FG001|Overall Study|Withdrawal by Subject|1|||
161480969|NCT02339584|583154803|FG000|Overall Study|Adverse Event|11|||
161480970|NCT02339584|583154804|FG001|Overall Study|Adverse Event|7|||
161669437|NCT00421707|583841476|FG000|Period 2: Washout|Withdrawal by Subject|0|||
161669438|NCT00421707|583841477|FG001|Period 2: Washout|Withdrawal by Subject|1|||
161669439|NCT00421707|583841476|FG000|Period 2: Washout|Lost to Follow-up|0|||
161669440|NCT00421707|583841477|FG001|Period 2: Washout|Lost to Follow-up|1|||
161669441|NCT00421707|583841476|FG000|Period 2: Washout|Other: Pregnancy|0|||
161669442|NCT00421707|583841477|FG001|Period 2: Washout|Other: Pregnancy|1|||
161669443|NCT00421707|583841476|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
161669444|NCT00421707|583841477|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
161669445|NCT00421707|583841476|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
161669446|NCT00421707|583841477|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
161669447|NCT00421707|583841476|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
161669448|NCT00421707|583841477|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
161669449|NCT01898923|583841480|FG000|Overall Study|Lack of Efficacy|5|||
161579997|NCT02477605|583511246|FG000|Overall Study|Administered gas during surgery|0|||
161579998|NCT02477605|583511247|FG001|Overall Study|Administered gas during surgery|1|||
161669450|NCT01898923|583841481|FG001|Overall Study|Lack of Efficacy|6|||
161669451|NCT01898923|583841480|FG000|Overall Study|Adverse Event|3|||
161669452|NCT01898923|583841481|FG001|Overall Study|Adverse Event|1|||
161579999|NCT00970359|583511249|FG000|Overall Study|Not Treated|4|||
161580000|NCT01499199|583511250|FG000|Overall Study|Adverse Event|1|||
161580001|NCT01499199|583511250|FG000|Overall Study|Lack of Efficacy|1|||
161580002|NCT00933400|583511251|FG000|Overall Study|Withdrawal by Subject|21|||
161669453|NCT01898923|583841480|FG000|Overall Study|Lost to Follow-up|0|||
161669454|NCT01898923|583841481|FG001|Overall Study|Lost to Follow-up|1|||
161669455|NCT01898923|583841480|FG000|Overall Study|Withdrawal by Subject|4|||
161669456|NCT01898923|583841481|FG001|Overall Study|Withdrawal by Subject|7|||
161669457|NCT01898923|583841480|FG000|Overall Study|Physician Decision|3|||
161669458|NCT01898923|583841481|FG001|Overall Study|Physician Decision|4|||
161669459|NCT01898923|583841480|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
161669460|NCT01898923|583841481|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
161580003|NCT00933400|583511252|FG001|Overall Study|Withdrawal by Subject|1|||
161580004|NCT01849055|583511253|FG000|Overall Study|Withdrawal by Subject|0|||
161580005|NCT01849055|583511254|FG001|Overall Study|Withdrawal by Subject|0|||
161580006|NCT01849055|583511255|FG002|Overall Study|Withdrawal by Subject|1|||
161580007|NCT01849055|583511256|FG003|Overall Study|Withdrawal by Subject|0|||
161580008|NCT01849055|583511257|FG004|Overall Study|Withdrawal by Subject|0|||
161580009|NCT01849055|583511258|FG005|Overall Study|Withdrawal by Subject|0|||
161580010|NCT00223795|583511259|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
161580011|NCT00223795|583511260|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
161580012|NCT00223795|583511259|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
161580013|NCT00223795|583511260|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
161580014|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
161580015|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
161580016|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
161580017|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
161580018|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
161580019|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
161580020|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
161580021|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
161580022|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
161580023|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
161580024|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
161580025|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
161580026|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161580027|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
161580028|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
161669461|NCT00723021|583841482|FG000|Intervention Period 4|Adverse Event|0|||
161669462|NCT00723021|583841483|FG001|Intervention Period 4|Adverse Event|0|||
161669463|NCT00723021|583841484|FG002|Intervention Period 4|Adverse Event|0|||
161669464|NCT00723021|583841485|FG003|Intervention Period 4|Adverse Event|0|||
161669465|NCT00723021|583841486|FG004|Intervention Period 4|Adverse Event|1|||
161669466|NCT00147823|583841490|FG000|Overall Study|Lost to Follow-up|6|||
161669467|NCT00147823|583841491|FG001|Overall Study|Lost to Follow-up|12|||
161669468|NCT00147823|583841490|FG000|Overall Study|Physician Decision|1|||
161669469|NCT00147823|583841491|FG001|Overall Study|Physician Decision|0|||
161669470|NCT00147823|583841490|FG000|Overall Study|Withdrawal by Subject|0|||
161816309|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816310|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
161816311|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816312|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161669471|NCT00147823|583841491|FG001|Overall Study|Withdrawal by Subject|1|||
161480971|NCT02339584|583154803|FG000|Overall Study|Lack of Efficacy|0|||
161480972|NCT02339584|583154804|FG001|Overall Study|Lack of Efficacy|1|||
161480973|NCT02339584|583154803|FG000|Overall Study|Physician Decision|1|||
161480974|NCT02339584|583154804|FG001|Overall Study|Physician Decision|2|||
161480975|NCT02339584|583154803|FG000|Overall Study|Protocol Violation|1|||
161480976|NCT02339584|583154804|FG001|Overall Study|Protocol Violation|1|||
161480977|NCT02339584|583154803|FG000|Overall Study|Withdrawal by Subject|2|||
161480978|NCT02339584|583154804|FG001|Overall Study|Withdrawal by Subject|4|||
161480979|NCT00826943|583154805|FG000|Overall Study|Withdrawal by Subject|0|||
161480980|NCT00826943|583154806|FG001|Overall Study|Withdrawal by Subject|0|||
161480981|NCT00826943|583154807|FG002|Overall Study|Withdrawal by Subject|0|||
161480982|NCT00826943|583154808|FG003|Overall Study|Withdrawal by Subject|0|||
161480983|NCT00826943|583154809|FG004|Overall Study|Withdrawal by Subject|1|||
161480984|NCT00826943|583154810|FG005|Overall Study|Withdrawal by Subject|0|||
161480985|NCT03715530|583154811|FG000|Overall Study|Lost to Follow-up|3|||
161480986|NCT03715530|583154812|FG001|Overall Study|Lost to Follow-up|1|||
161480987|NCT03715530|583154813|FG002|Overall Study|Lost to Follow-up|2|||
161480988|NCT01594762|583154814|FG000|Overall Study|Withdrawal by Subject|1|||
161480989|NCT01594762|583154815|FG001|Overall Study|Withdrawal by Subject|0|||
161480990|NCT01594762|583154814|FG000|Overall Study|Lost to Follow-up|10|||
161480991|NCT01594762|583154815|FG001|Overall Study|Lost to Follow-up|10|||
161480992|NCT03338998|583154819|FG000|Treatment Period|Withdrawal by Subject|1|||
161480993|NCT03338998|583154820|FG001|Treatment Period|Withdrawal by Subject|1|||
161480994|NCT03338998|583154819|FG000|Treatment Period|Adverse Event|0|||
161480995|NCT03338998|583154820|FG001|Treatment Period|Adverse Event|2|||
161480996|NCT03338998|583154819|FG000|Treatment Period|Protocol deviation|1|||
161480997|NCT03338998|583154820|FG001|Treatment Period|Protocol deviation|0|||
161480998|NCT03338998|583154819|FG000|Treatment Period|Physician Decision|2|||
161480999|NCT03338998|583154820|FG001|Treatment Period|Physician Decision|0|||
161481000|NCT03338998|583154819|FG000|Treatment Period|Subject failed swallow test|4|||
161481001|NCT03338998|583154820|FG001|Treatment Period|Subject failed swallow test|0|||
161481002|NCT03338998|583154819|FG000|Safety Follow-Up Period|Adverse Event|0|||
161481003|NCT03338998|583154820|FG001|Safety Follow-Up Period|Adverse Event|1|||
161481004|NCT03338998|583154819|FG000|Safety Follow-Up Period|Protocol deviation|1|||
161481005|NCT03338998|583154820|FG001|Safety Follow-Up Period|Protocol deviation|0|||
161481006|NCT03338998|583154819|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
161481007|NCT03338998|583154820|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
161481008|NCT04706091|583154823|FG000|Treatment 2|Withdrawal by Subject|1|||
161481009|NCT04706091|583154824|FG001|Treatment 2|Withdrawal by Subject|0|||
161481010|NCT03329573|583154825|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
161481011|NCT03329573|583154826|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
161481012|NCT03329573|583154827|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
161481013|NCT03329573|583154828|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
161481014|NCT03329573|583154825|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
161481015|NCT03329573|583154826|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
161481016|NCT03329573|583154827|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161481017|NCT03329573|583154828|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161481018|NCT03329573|583154825|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
161481019|NCT03329573|583154826|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
161481020|NCT03329573|583154827|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
161481021|NCT03329573|583154828|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
161481022|NCT03329573|583154825|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
161481023|NCT03329573|583154826|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
161481024|NCT03329573|583154827|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
161481025|NCT03329573|583154828|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
161481026|NCT05695209|583154838|FG000|3-months|Withdrawal by Subject|2|||
161481027|NCT05695209|583154839|FG001|3-months|Withdrawal by Subject|0|||
161481028|NCT05695209|583154838|FG000|3-months|Unable to contact for 3-month data collection|0|||
161481029|NCT05695209|583154839|FG001|3-months|Unable to contact for 3-month data collection|1|||
161481030|NCT05695209|583154838|FG000|6-months|Lost to Follow-up|1|||
161481031|NCT05695209|583154839|FG001|6-months|Lost to Follow-up|1|||
161481032|NCT04698187|583154842|FG000|Overall Study|Withdrawal by Subject|7|||
161481033|NCT04698187|583154842|FG000|Overall Study|Death|21|||
161481034|NCT04698187|583154842|FG000|Overall Study|Sponsor Decision|15|||
161481035|NCT04698187|583154842|FG000|Overall Study|In-transit Disease|1|||
161481036|NCT03069378|583154843|FG000|Overall Study|Withdrawal by Subject|1|||
161481037|NCT02993146|583154844|FG000|Overall Study|Withdrawal by Subject|0|||
161580029|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161481038|NCT02993146|583154845|FG001|Overall Study|Withdrawal by Subject|0|||
161481039|NCT02993146|583154846|FG002|Overall Study|Withdrawal by Subject|1|||
161481040|NCT02993146|583154847|FG003|Overall Study|Withdrawal by Subject|1|||
161481041|NCT01397708|583154848|FG000|Overall Study|Withdrawal by Subject|0|||
161481042|NCT01397708|583154849|FG001|Overall Study|Withdrawal by Subject|0|||
161481043|NCT01397708|583154850|FG002|Overall Study|Withdrawal by Subject|1|||
161816313|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816314|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816315|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816316|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816317|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816318|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816319|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816320|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816321|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816322|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816323|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816324|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816325|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816326|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816327|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816328|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816329|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816330|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816331|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816332|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816333|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816334|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816335|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816336|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
161816337|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816338|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816339|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816340|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816341|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816342|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816343|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816344|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816345|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816346|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816347|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816348|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816349|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816350|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816351|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816352|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816353|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816354|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816355|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816356|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816357|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816358|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
161816359|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816360|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816361|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
161816362|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816363|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816364|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816365|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816366|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816367|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816368|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816369|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816370|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816371|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816372|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816373|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816374|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816375|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816376|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816377|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816378|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816379|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816380|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161669472|NCT00147823|583841490|FG000|Overall Study|Did not receive vitoss due to infection|6|||
161669473|NCT00147823|583841491|FG001|Overall Study|Did not receive vitoss due to infection|2|||
161669474|NCT04751656|583843078|FG000|Overall Study|Lost to Follow-up|1|||
161669475|NCT01485354|583843084|FG000|Overall Study|Withdrawal by Subject|5|||
161669476|NCT03566810|583843085|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161669477|NCT03566810|583843086|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
161669478|NCT03566810|583843087|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161669479|NCT03566810|583843088|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161669480|NCT01444651|583843091|FG000|Overall Study|Adverse Event|3|||
161669481|NCT01444651|583843092|FG001|Overall Study|Adverse Event|2|||
161669482|NCT01444651|583843091|FG000|Overall Study|Lost to Follow-up|5|||
161669483|NCT01444651|583843092|FG001|Overall Study|Lost to Follow-up|5|||
161669484|NCT01444651|583843091|FG000|Overall Study|Non-fasting|2|||
161669485|NCT01444651|583843092|FG001|Overall Study|Non-fasting|1|||
161669486|NCT01444651|583843091|FG000|Overall Study|Missing data|1|||
161669487|NCT01444651|583843092|FG001|Overall Study|Missing data|1|||
161669488|NCT03338192|583843093|FG000|Year One to Year Two|High Blood Pressure|7|||
161669489|NCT03338192|583843094|FG001|Year One to Year Two|High Blood Pressure|1|||
161669490|NCT03338192|583843093|FG000|Year One to Year Two|HIV +|1|||
161669491|NCT03338192|583843094|FG001|Year One to Year Two|HIV +|0|||
161669492|NCT03338192|583843093|FG000|Year Two to Year Four|High Blood Pressure|1|||
161669493|NCT03338192|583843094|FG001|Year Two to Year Four|High Blood Pressure|0|||
161669494|NCT03338192|583843093|FG000|Year Two to Year Four|HIV +|2|||
161669495|NCT03338192|583843094|FG001|Year Two to Year Four|HIV +|0|||
161669496|NCT03338192|583843093|FG000|Year Four to Year Six|High Blood Pressure|2|||
161669497|NCT03338192|583843094|FG001|Year Four to Year Six|High Blood Pressure|1|||
161669498|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
161669499|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
161669500|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
161669501|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
161669502|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
161669503|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
161669504|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
161669505|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
161669506|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
161669507|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
161669508|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
161669509|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
161669510|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Death|3|||
161669511|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Death|1|||
161669512|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
161669513|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
161669514|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Adverse Event|7|||
161669515|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Adverse Event|8|||
161669516|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Captured as Other|1|||
161669517|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Captured as Other|2|||
161669518|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
161669519|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
161669520|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
161669521|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
161669522|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
161669523|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
161669524|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Death|0|||
161669525|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Death|1|||
161669526|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
161669527|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
161669528|NCT02952001|583843101|FG000|Overall Study|Adverse Event|3|||
161669529|NCT02952001|583843102|FG001|Overall Study|Adverse Event|0|||
161669530|NCT02952001|583843101|FG000|Overall Study|Prohibited therapy|10|||
161669531|NCT02952001|583843102|FG001|Overall Study|Prohibited therapy|3|||
161669532|NCT02952001|583843101|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
161669533|NCT02952001|583843102|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
161669534|NCT01681628|583843105|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
161669535|NCT01681628|583843106|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
161669536|NCT01681628|583843105|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
161669537|NCT01681628|583843106|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
161669538|NCT01681628|583843105|FG000|19 Months Follow-up|Death|1|||
161669539|NCT01681628|583843106|FG001|19 Months Follow-up|Death|0|||
161669540|NCT01681628|583843105|FG000|19 Months Follow-up|Lost to Follow-up|61|||
161669541|NCT01681628|583843106|FG001|19 Months Follow-up|Lost to Follow-up|43|||
161669542|NCT01794520|583843107|FG000|Overall Study|Adverse events- related to progression|0|||
161481044|NCT01397708|583154851|FG003|Overall Study|Withdrawal by Subject|0|||
161481045|NCT01397708|583154852|FG004|Overall Study|Withdrawal by Subject|0|||
161481046|NCT01397708|583154853|FG005|Overall Study|Withdrawal by Subject|0|||
161481047|NCT01397708|583154854|FG006|Overall Study|Withdrawal by Subject|0|||
161481048|NCT01397708|583154855|FG007|Overall Study|Withdrawal by Subject|1|||
161481049|NCT01397708|583154848|FG000|Overall Study|Death|0|||
161481050|NCT01397708|583154849|FG001|Overall Study|Death|0|||
161481051|NCT01397708|583154850|FG002|Overall Study|Death|1|||
161481052|NCT01397708|583154851|FG003|Overall Study|Death|1|||
161481053|NCT01397708|583154852|FG004|Overall Study|Death|0|||
161481054|NCT01397708|583154853|FG005|Overall Study|Death|0|||
161481055|NCT01397708|583154854|FG006|Overall Study|Death|0|||
161481056|NCT01397708|583154855|FG007|Overall Study|Death|0|||
161481057|NCT01397708|583154848|FG000|Overall Study|Lost to Follow-up|0|||
161481058|NCT01397708|583154849|FG001|Overall Study|Lost to Follow-up|0|||
161481059|NCT01397708|583154850|FG002|Overall Study|Lost to Follow-up|0|||
161481060|NCT01397708|583154851|FG003|Overall Study|Lost to Follow-up|0|||
161481061|NCT01397708|583154852|FG004|Overall Study|Lost to Follow-up|1|||
161481062|NCT01397708|583154853|FG005|Overall Study|Lost to Follow-up|0|||
161481063|NCT01397708|583154854|FG006|Overall Study|Lost to Follow-up|0|||
161481064|NCT01397708|583154855|FG007|Overall Study|Lost to Follow-up|0|||
161481065|NCT01397708|583154848|FG000|Overall Study|Other|0|||
161481066|NCT01397708|583154849|FG001|Overall Study|Other|0|||
161481067|NCT01397708|583154850|FG002|Overall Study|Other|0|||
161481068|NCT01397708|583154851|FG003|Overall Study|Other|0|||
161481069|NCT01397708|583154852|FG004|Overall Study|Other|0|||
161481070|NCT01397708|583154853|FG005|Overall Study|Other|0|||
161481071|NCT01397708|583154854|FG006|Overall Study|Other|1|||
161481072|NCT01397708|583154855|FG007|Overall Study|Other|0|||
161481073|NCT04362072|583154856|FG000|Treatment|Adverse Event|1|||
161481074|NCT04362072|583154856|FG000|Treatment|Death|9|||
161481075|NCT04362072|583154856|FG000|Treatment|Physician Decision|2|||
161481076|NCT04362072|583154856|FG000|Treatment|Progressive disease|27|||
161481077|NCT04362072|583154856|FG000|Treatment|Withdrawal by Subject|4|||
161481078|NCT04362072|583154856|FG000|Treatment|Global deterioration of health status|1|||
161481079|NCT04362072|583154856|FG000|Treatment|Switched to commercial Lorlatinib|13|||
161481080|NCT04362072|583154856|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
161481081|NCT04362072|583154856|FG000|Treatment|Other|3|||
161481082|NCT04362072|583154856|FG000|Follow up|Death|2|||
161816381|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816382|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816383|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
161816384|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
161816385|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816386|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816387|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816388|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816389|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816390|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816391|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816392|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816393|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816394|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161481083|NCT04362072|583154856|FG000|Follow up|Other|2|||
161481084|NCT04524689|583154857|FG000|Overall Study|Withdrawal by Subject|1|||
161481085|NCT04524689|583154858|FG001|Overall Study|Withdrawal by Subject|1|||
161580030|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161580031|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161580032|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
161580033|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
161580034|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
161580035|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161669543|NCT01794520|583843108|FG001|Overall Study|Adverse events- related to progression|0|||
161481086|NCT04524689|583154859|FG002|Overall Study|Withdrawal by Subject|0|||
161481087|NCT04524689|583154860|FG003|Overall Study|Withdrawal by Subject|0|||
161481088|NCT04524689|583154861|FG004|Overall Study|Withdrawal by Subject|2|||
161481089|NCT04524689|583154862|FG005|Overall Study|Withdrawal by Subject|0|||
161481090|NCT04524689|583154857|FG000|Overall Study|Study terminated by Sponsor|6|||
161481091|NCT04524689|583154858|FG001|Overall Study|Study terminated by Sponsor|0|||
161481092|NCT04524689|583154859|FG002|Overall Study|Study terminated by Sponsor|1|||
161481093|NCT04524689|583154860|FG003|Overall Study|Study terminated by Sponsor|0|||
161481094|NCT04524689|583154861|FG004|Overall Study|Study terminated by Sponsor|4|||
161481095|NCT04524689|583154862|FG005|Overall Study|Study terminated by Sponsor|0|||
161481096|NCT04524689|583154857|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
161481097|NCT04524689|583154858|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
161481098|NCT04524689|583154859|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
161481099|NCT04524689|583154860|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
161481100|NCT04524689|583154861|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
161481101|NCT04524689|583154862|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
161481102|NCT01133522|583154863|FG000|Overall Study|Withdrawal by Subject|0|||
161481103|NCT01133522|583154864|FG001|Overall Study|Withdrawal by Subject|1|||
161481104|NCT01133522|583154865|FG002|Overall Study|Withdrawal by Subject|0|||
161481105|NCT01133522|583154866|FG003|Overall Study|Withdrawal by Subject|1|||
161481106|NCT01133522|583154867|FG004|Overall Study|Withdrawal by Subject|0|||
161481107|NCT01133522|583154868|FG005|Overall Study|Withdrawal by Subject|0|||
161481108|NCT01133522|583154869|FG006|Overall Study|Withdrawal by Subject|0|||
161481109|NCT01133522|583154870|FG007|Overall Study|Withdrawal by Subject|0|||
161481110|NCT01133522|583154871|FG008|Overall Study|Withdrawal by Subject|0|||
161481111|NCT01133522|583154872|FG009|Overall Study|Withdrawal by Subject|0|||
161481112|NCT01133522|583154863|FG000|Overall Study|Physician Decision|0|||
161481113|NCT01133522|583154864|FG001|Overall Study|Physician Decision|0|||
161481114|NCT01133522|583154865|FG002|Overall Study|Physician Decision|0|||
161481115|NCT01133522|583154866|FG003|Overall Study|Physician Decision|0|||
161481116|NCT01133522|583154867|FG004|Overall Study|Physician Decision|1|||
161481117|NCT01133522|583154868|FG005|Overall Study|Physician Decision|0|||
161481118|NCT01133522|583154869|FG006|Overall Study|Physician Decision|0|||
161481119|NCT01133522|583154870|FG007|Overall Study|Physician Decision|0|||
161921288|NCT02903914|584757194|FG001|Overall Study|Adverse Event|0|||
161481120|NCT01133522|583154871|FG008|Overall Study|Physician Decision|0|||
161481121|NCT01133522|583154872|FG009|Overall Study|Physician Decision|0|||
161481122|NCT04997304|583154873|FG000|Overall Study|Lost to Follow-up|11|||
161481123|NCT04997304|583154873|FG000|Overall Study|Death|1|||
161481124|NCT04997304|583154873|FG000|Overall Study|Withdrawal by Subject|14|||
161481125|NCT00612690|583156498|FG000|Overall Study|Lost to Follow-up|72|||
161481126|NCT00612690|583156499|FG001|Overall Study|Lost to Follow-up|98|||
161481127|NCT00612690|583156498|FG000|Overall Study|Withdrawal by Subject|32|||
161481128|NCT00612690|583156499|FG001|Overall Study|Withdrawal by Subject|20|||
161481129|NCT00612690|583156498|FG000|Overall Study|Withdrawal by Site|11|||
161481130|NCT00612690|583156499|FG001|Overall Study|Withdrawal by Site|0|||
161481131|NCT00638378|583156500|FG000|Overall Study|Death|2|||
161481132|NCT00638378|583156500|FG000|Overall Study|Adverse Event|1|||
161481133|NCT00638378|583156500|FG000|Overall Study|Disease progression|15|||
161481134|NCT00638378|583156500|FG000|Overall Study|Physician Decision|4|||
161481135|NCT03291808|583156501|FG000|Overall Study|Lost to Follow-up|6|||
161481136|NCT03291808|583156501|FG000|Overall Study|Research burden|4|||
161481137|NCT03364023|583156504|FG000|Overall Study|Lost to Follow-up|3|||
161481138|NCT03364023|583156504|FG000|Overall Study|Death|14|||
161481139|NCT02891850|583156505|FG000|Overall Study|Adverse Event|3|||
161481140|NCT02891850|583156506|FG001|Overall Study|Adverse Event|0|||
161481141|NCT02891850|583156505|FG000|Overall Study|Death|0|||
161481142|NCT02891850|583156506|FG001|Overall Study|Death|4|||
161481143|NCT02891850|583156505|FG000|Overall Study|Physician Decision|1|||
161481144|NCT02891850|583156506|FG001|Overall Study|Physician Decision|0|||
161481145|NCT02891850|583156505|FG000|Overall Study|Pregnancy|1|||
161481146|NCT02891850|583156506|FG001|Overall Study|Pregnancy|0|||
161481147|NCT02891850|583156505|FG000|Overall Study|Withdrawal by Subject|2|||
161481148|NCT02891850|583156506|FG001|Overall Study|Withdrawal by Subject|3|||
161481149|NCT03797014|583156507|FG000|Overall Study|Withdrawal by Subject|1|||
161481150|NCT03797014|583156507|FG000|Overall Study|Lost to Follow-up|1|||
161481151|NCT03797014|583156507|FG000|Overall Study|Protocol Violation|1|||
161481152|NCT00105469|583156510|FG000|Overall Study|Adverse Event|9|||
161481153|NCT00105469|583156511|FG001|Overall Study|Adverse Event|8|||
161481154|NCT00105469|583156510|FG000|Overall Study|Protocol Violation|4|||
161481155|NCT00105469|583156511|FG001|Overall Study|Protocol Violation|0|||
161481156|NCT00105469|583156510|FG000|Overall Study|Withdrawal by Subject|2|||
161481157|NCT00105469|583156511|FG001|Overall Study|Withdrawal by Subject|3|||
161481158|NCT00105469|583156510|FG000|Overall Study|Lost to Follow-up|1|||
161481159|NCT00105469|583156511|FG001|Overall Study|Lost to Follow-up|0|||
161481160|NCT00105469|583156510|FG000|Overall Study|Lack of Efficacy|2|||
161481161|NCT00105469|583156511|FG001|Overall Study|Lack of Efficacy|0|||
161481162|NCT00105469|583156510|FG000|Overall Study|Other Reason|4|||
161481163|NCT00105469|583156511|FG001|Overall Study|Other Reason|0|||
161481164|NCT02820753|583156512|FG000|2 Month|Withdrawal by Subject|3|||
161481165|NCT02820753|583156513|FG001|2 Month|Withdrawal by Subject|3|||
161481166|NCT02820753|583156512|FG000|2 Month|Lost to Follow-up|24|||
161481167|NCT02820753|583156513|FG001|2 Month|Lost to Follow-up|26|||
161481168|NCT02820753|583156512|FG000|2 Month|Stopped per NIH Hold|51|||
161481169|NCT02820753|583156513|FG001|2 Month|Stopped per NIH Hold|13|||
161481170|NCT02820753|583156512|FG000|6 Month|Withdrawal by Subject|2|||
161481171|NCT02820753|583156513|FG001|6 Month|Withdrawal by Subject|2|||
161481172|NCT02820753|583156512|FG000|6 Month|Lost to Follow-up|20|||
161481173|NCT02820753|583156513|FG001|6 Month|Lost to Follow-up|27|||
161481174|NCT02820753|583156512|FG000|6 Month|Stopped per NIH Hold|81|||
161481175|NCT02820753|583156513|FG001|6 Month|Stopped per NIH Hold|81|||
161580036|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161580037|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161580038|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161580039|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
161580040|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161580041|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161580042|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161580043|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161580044|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
161580045|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161580046|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161580047|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161580048|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161580049|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161580050|NCT04043455|583513805|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161580051|NCT04043455|583513806|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
161580052|NCT04043455|583513807|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161580053|NCT04043455|583513808|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161580054|NCT04043455|583513809|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161580055|NCT04043455|583513810|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161580056|NCT04043455|583513805|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
161481176|NCT02820753|583156512|FG000|6 Month|Death|0|||
161481177|NCT02820753|583156513|FG001|6 Month|Death|1|||
161481178|NCT00790023|583156514|FG000|Overall Study|Adverse Event|2|||
161481179|NCT00790023|583156515|FG001|Overall Study|Adverse Event|1|||
161481180|NCT00790023|583156516|FG002|Overall Study|Adverse Event|4|||
161481181|NCT00790023|583156514|FG000|Overall Study|Protocol Violation|2|||
161481182|NCT00790023|583156515|FG001|Overall Study|Protocol Violation|4|||
161481183|NCT00790023|583156516|FG002|Overall Study|Protocol Violation|2|||
161481184|NCT00790023|583156514|FG000|Overall Study|Withdrawal by Subject|2|||
161481185|NCT00790023|583156515|FG001|Overall Study|Withdrawal by Subject|0|||
161481186|NCT00790023|583156516|FG002|Overall Study|Withdrawal by Subject|6|||
161481187|NCT00790023|583156514|FG000|Overall Study|Lost to Follow-up|0|||
161481188|NCT00790023|583156515|FG001|Overall Study|Lost to Follow-up|0|||
161481189|NCT00790023|583156516|FG002|Overall Study|Lost to Follow-up|1|||
161481190|NCT00790023|583156514|FG000|Overall Study|Other|5|||
161481191|NCT00790023|583156515|FG001|Overall Study|Other|5|||
161481192|NCT00790023|583156516|FG002|Overall Study|Other|8|||
161481193|NCT01338792|583156517|FG000|Overall Study|Adverse Event|2|||
161481194|NCT01338792|583156517|FG000|Overall Study|Death|1|||
161481195|NCT01338792|583156517|FG000|Overall Study|Withdrawal by Subject|1|||
161481196|NCT02468414|583156518|FG000|Overall Study|Early Study Termination by Sponsor|1|||
161481197|NCT02468414|583156519|FG001|Overall Study|Early Study Termination by Sponsor|0|||
161481198|NCT02468414|583156518|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
161481199|NCT02468414|583156519|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
161481200|NCT02468414|583156518|FG000|Overall Study|Screen Failure|1|||
161481201|NCT02468414|583156519|FG001|Overall Study|Screen Failure|0|||
161481202|NCT01652703|583156520|FG000|Overall Study|Withdrawal by Subject|0|||
161481203|NCT01652703|583156521|FG001|Overall Study|Withdrawal by Subject|1|||
161481204|NCT01652703|583156522|FG002|Overall Study|Withdrawal by Subject|3|||
161481205|NCT01652703|583156523|FG003|Overall Study|Withdrawal by Subject|1|||
161481206|NCT01652703|583156524|FG004|Overall Study|Withdrawal by Subject|0|||
161481207|NCT01652703|583156525|FG005|Overall Study|Withdrawal by Subject|1|||
161481208|NCT01652703|583156520|FG000|Overall Study|Other|0|||
161481209|NCT01652703|583156521|FG001|Overall Study|Other|0|||
161481210|NCT01652703|583156522|FG002|Overall Study|Other|0|||
161481211|NCT01652703|583156523|FG003|Overall Study|Other|1|||
161481212|NCT01652703|583156524|FG004|Overall Study|Other|1|||
161481213|NCT01652703|583156525|FG005|Overall Study|Other|1|||
161481214|NCT00062374|583156526|FG000|Overall Study|Not treated|12|||
161580057|NCT04043455|583513806|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
161481215|NCT03555591|583156527|FG000|Overall Study|Protocol Violation|77|||
161481216|NCT02380677|583156535|FG000|Overall Study|Adverse Event|0|||
161481217|NCT02380677|583156536|FG001|Overall Study|Adverse Event|0|||
161481218|NCT02380677|583156537|FG002|Overall Study|Adverse Event|0|||
161481219|NCT02380677|583156538|FG003|Overall Study|Adverse Event|1|||
161481220|NCT02380677|583156539|FG004|Overall Study|Adverse Event|1|||
161481221|NCT02380677|583156540|FG005|Overall Study|Adverse Event|4|||
161481222|NCT02380677|583156541|FG006|Overall Study|Adverse Event|2|||
161481223|NCT02380677|583156542|FG007|Overall Study|Adverse Event|2|||
161481224|NCT02380677|583156543|FG008|Overall Study|Adverse Event|2|||
161481225|NCT02380677|583156544|FG009|Overall Study|Adverse Event|1|||
161481226|NCT02380677|583156545|FG010|Overall Study|Adverse Event|2|||
161481227|NCT02380677|583156546|FG011|Overall Study|Adverse Event|1|||
161481228|NCT02380677|583156535|FG000|Overall Study|Physician Decision|1|||
161481229|NCT02380677|583156536|FG001|Overall Study|Physician Decision|0|||
161481230|NCT02380677|583156537|FG002|Overall Study|Physician Decision|1|||
161481231|NCT02380677|583156538|FG003|Overall Study|Physician Decision|1|||
161481232|NCT02380677|583156539|FG004|Overall Study|Physician Decision|0|||
161481233|NCT02380677|583156540|FG005|Overall Study|Physician Decision|0|||
161481234|NCT02380677|583156541|FG006|Overall Study|Physician Decision|0|||
161481235|NCT02380677|583156542|FG007|Overall Study|Physician Decision|0|||
161481236|NCT02380677|583156543|FG008|Overall Study|Physician Decision|0|||
161481237|NCT02380677|583156544|FG009|Overall Study|Physician Decision|0|||
161481238|NCT02380677|583156545|FG010|Overall Study|Physician Decision|0|||
161481239|NCT02380677|583156546|FG011|Overall Study|Physician Decision|0|||
161481240|NCT02380677|583156535|FG000|Overall Study|Lack of Efficacy|0|||
161481241|NCT02380677|583156536|FG001|Overall Study|Lack of Efficacy|1|||
161481242|NCT02380677|583156537|FG002|Overall Study|Lack of Efficacy|2|||
161481243|NCT02380677|583156538|FG003|Overall Study|Lack of Efficacy|0|||
161481244|NCT02380677|583156539|FG004|Overall Study|Lack of Efficacy|4|||
161481245|NCT02380677|583156540|FG005|Overall Study|Lack of Efficacy|1|||
161481246|NCT02380677|583156541|FG006|Overall Study|Lack of Efficacy|1|||
161481247|NCT02380677|583156542|FG007|Overall Study|Lack of Efficacy|2|||
161481248|NCT02380677|583156543|FG008|Overall Study|Lack of Efficacy|2|||
161481249|NCT02380677|583156544|FG009|Overall Study|Lack of Efficacy|0|||
161481250|NCT02380677|583156545|FG010|Overall Study|Lack of Efficacy|2|||
161481251|NCT02380677|583156546|FG011|Overall Study|Lack of Efficacy|1|||
161481252|NCT02380677|583156535|FG000|Overall Study|Withdrawal by Subject|0|||
161481253|NCT02380677|583156536|FG001|Overall Study|Withdrawal by Subject|0|||
161481254|NCT02380677|583156537|FG002|Overall Study|Withdrawal by Subject|0|||
161481255|NCT02380677|583156538|FG003|Overall Study|Withdrawal by Subject|0|||
161481256|NCT02380677|583156539|FG004|Overall Study|Withdrawal by Subject|0|||
161481257|NCT02380677|583156540|FG005|Overall Study|Withdrawal by Subject|0|||
161481258|NCT02380677|583156541|FG006|Overall Study|Withdrawal by Subject|0|||
161481259|NCT02380677|583156542|FG007|Overall Study|Withdrawal by Subject|0|||
161481260|NCT02380677|583156543|FG008|Overall Study|Withdrawal by Subject|0|||
161481261|NCT02380677|583156544|FG009|Overall Study|Withdrawal by Subject|1|||
161481262|NCT02380677|583156545|FG010|Overall Study|Withdrawal by Subject|0|||
161481263|NCT02380677|583156546|FG011|Overall Study|Withdrawal by Subject|3|||
161481264|NCT02380677|583156535|FG000|Overall Study|Other|0|||
161481265|NCT02380677|583156536|FG001|Overall Study|Other|0|||
161481266|NCT02380677|583156537|FG002|Overall Study|Other|0|||
161481267|NCT02380677|583156538|FG003|Overall Study|Other|1|||
161481268|NCT02380677|583156539|FG004|Overall Study|Other|1|||
161481269|NCT02380677|583156540|FG005|Overall Study|Other|1|||
161481270|NCT02380677|583156541|FG006|Overall Study|Other|0|||
161481271|NCT02380677|583156542|FG007|Overall Study|Other|0|||
161481272|NCT02380677|583156543|FG008|Overall Study|Other|0|||
161481273|NCT02380677|583156544|FG009|Overall Study|Other|0|||
161481274|NCT02380677|583156545|FG010|Overall Study|Other|0|||
161481275|NCT02380677|583156546|FG011|Overall Study|Other|0|||
161481276|NCT05035550|583156554|FG000|Overall Study|Withdrawal by Subject|3|||
161481277|NCT05035550|583156555|FG001|Overall Study|Withdrawal by Subject|0|||
161481278|NCT00617123|583156558|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
161481279|NCT00617123|583156559|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
161481280|NCT00617123|583156558|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
161481281|NCT00617123|583156559|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
161481282|NCT00617123|583156558|FG000|Referral Screening Period|Adverse Event|0|||
161481283|NCT00617123|583156559|FG001|Referral Screening Period|Adverse Event|1|||
161481284|NCT00617123|583156558|FG000|Study Treatment Period|Withdrawal by Subject|8|||
161481285|NCT00617123|583156559|FG001|Study Treatment Period|Withdrawal by Subject|12|||
161481286|NCT00617123|583156558|FG000|Study Treatment Period|Adverse Event|7|||
161481287|NCT00617123|583156559|FG001|Study Treatment Period|Adverse Event|3|||
161481288|NCT00617123|583156558|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
161481289|NCT00617123|583156559|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
161481290|NCT00617123|583156558|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
161481291|NCT00617123|583156559|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
161481292|NCT04213079|583156560|FG000|Overall Study|Lost to Follow-up|0|||
161481293|NCT04213079|583156561|FG001|Overall Study|Lost to Follow-up|2|||
161481294|NCT01061177|583156565|FG000|Overall Study|Adverse Event|117|||
161481295|NCT01061177|583156565|FG000|Overall Study|Withdrawal by Subject|27|||
161481296|NCT01061177|583156565|FG000|Overall Study|Disease progression|17|||
161481297|NCT01061177|583156565|FG000|Overall Study|Protocol Violation|11|||
161481298|NCT01061177|583156565|FG000|Overall Study|Lost to Follow-up|9|||
161481299|NCT01061177|583156565|FG000|Overall Study|New cancer therapy|9|||
161481300|NCT01061177|583156565|FG000|Overall Study|Abnormal laboratory values|6|||
161481301|NCT01061177|583156565|FG000|Overall Study|Abnormal test procedure results|4|||
161481302|NCT01061177|583156565|FG000|Overall Study|Administratie problems|4|||
161481303|NCT01061177|583156565|FG000|Overall Study|Death|4|||
161481304|NCT03616600|583156566|FG000|Overall Study|Withdrawal by Subject|1|||
161481305|NCT03616600|583156567|FG001|Overall Study|Withdrawal by Subject|0|||
161481306|NCT00587054|583156568|FG000|Overall Study|Patient not treated|9|||
161481307|NCT03984994|583156569|FG000|Overall Study|Withdrawal by Subject|2|||
161481308|NCT03984994|583156570|FG001|Overall Study|Withdrawal by Subject|1|||
161481309|NCT03010176|583156572|FG000|Overall Study|Death|21|||
161481310|NCT03010176|583156573|FG001|Overall Study|Death|35|||
161481311|NCT03010176|583156574|FG002|Overall Study|Death|19|||
161481312|NCT03010176|583156575|FG003|Overall Study|Death|19|||
161481313|NCT03010176|583156576|FG004|Overall Study|Death|14|||
161481314|NCT03010176|583156577|FG005|Overall Study|Death|0|||
161481315|NCT03010176|583156572|FG000|Overall Study|Lost to Follow-up|0|||
161481316|NCT03010176|583156573|FG001|Overall Study|Lost to Follow-up|0|||
161481317|NCT03010176|583156574|FG002|Overall Study|Lost to Follow-up|0|||
161481318|NCT03010176|583156575|FG003|Overall Study|Lost to Follow-up|0|||
161481319|NCT03010176|583156576|FG004|Overall Study|Lost to Follow-up|1|||
161481320|NCT03010176|583156577|FG005|Overall Study|Lost to Follow-up|0|||
161481321|NCT03010176|583156572|FG000|Overall Study|Physician Decision|0|||
161481322|NCT03010176|583156573|FG001|Overall Study|Physician Decision|4|||
161481323|NCT03010176|583156574|FG002|Overall Study|Physician Decision|0|||
161481324|NCT03010176|583156575|FG003|Overall Study|Physician Decision|1|||
161481325|NCT03010176|583156576|FG004|Overall Study|Physician Decision|0|||
161481326|NCT03010176|583156577|FG005|Overall Study|Physician Decision|0|||
161481327|NCT03010176|583156572|FG000|Overall Study|Sponsor Decision|0|||
161481328|NCT03010176|583156573|FG001|Overall Study|Sponsor Decision|4|||
161481329|NCT03010176|583156574|FG002|Overall Study|Sponsor Decision|4|||
161481330|NCT03010176|583156575|FG003|Overall Study|Sponsor Decision|1|||
161481331|NCT03010176|583156576|FG004|Overall Study|Sponsor Decision|6|||
161481332|NCT03010176|583156577|FG005|Overall Study|Sponsor Decision|0|||
161481333|NCT03010176|583156572|FG000|Overall Study|Withdrawal by Subject|11|||
161481334|NCT03010176|583156573|FG001|Overall Study|Withdrawal by Subject|9|||
161481335|NCT03010176|583156574|FG002|Overall Study|Withdrawal by Subject|3|||
161481336|NCT03010176|583156575|FG003|Overall Study|Withdrawal by Subject|0|||
161481337|NCT03010176|583156576|FG004|Overall Study|Withdrawal by Subject|4|||
161481338|NCT03010176|583156577|FG005|Overall Study|Withdrawal by Subject|0|||
161481339|NCT04220866|583156578|FG000|Overall Study|Death|4|||
161481340|NCT04220866|583156579|FG001|Overall Study|Death|5|||
161481341|NCT04220866|583156578|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
161481342|NCT04220866|583156579|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
161481343|NCT04220866|583156578|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
161481344|NCT04220866|583156579|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
161481345|NCT04220866|583156578|FG000|Overall Study|Withdrawal by Subject|0|||
161481346|NCT04220866|583156579|FG001|Overall Study|Withdrawal by Subject|1|||
161481347|NCT03858309|583156580|FG000|Overall Study|Withdrawal by Subject|2|||
161481348|NCT03858309|583156581|FG001|Overall Study|Withdrawal by Subject|3|||
161481349|NCT00709761|583156582|FG000|Overall Study|Withdrawal by Subject|8|||
161481350|NCT00709761|583156582|FG000|Overall Study|study closed/terminated|17|||
161481351|NCT00709761|583156582|FG000|Overall Study|Lost to Follow-up|2|||
161481352|NCT03478930|583156583|FG000|Overall Study|Adverse Event|0|||
161481353|NCT03478930|583156584|FG001|Overall Study|Adverse Event|1|||
161481354|NCT03478930|583156583|FG000|Overall Study|Lack of Efficacy|3|||
161481355|NCT03478930|583156584|FG001|Overall Study|Lack of Efficacy|3|||
161481356|NCT03478930|583156583|FG000|Overall Study|Withdrawal by Subject|6|||
161481357|NCT03478930|583156584|FG001|Overall Study|Withdrawal by Subject|5|||
161481358|NCT01812174|583156585|FG000|Overall Study|Death|1|||
161481359|NCT01812174|583156586|FG001|Overall Study|Death|0|||
161481360|NCT01812174|583156585|FG000|Overall Study|Protocol Violation|2|||
161481361|NCT01812174|583156586|FG001|Overall Study|Protocol Violation|0|||
161481362|NCT00553644|583156589|FG000|Overall Study|Adverse Event|17|||
161481363|NCT00553644|583156589|FG000|Overall Study|Withdrawal by Subject|4|||
161481364|NCT00553644|583156589|FG000|Overall Study|Physician Decision|1|||
161481365|NCT00553644|583156589|FG000|Overall Study|Alternative therapy|6|||
161481366|NCT01336764|583156592|FG000|Overall Study|Withdrawal by Subject|5|||
161481367|NCT01336764|583156593|FG001|Overall Study|Withdrawal by Subject|5|||
161481368|NCT01051323|583156594|FG000|Overall Study|Discontinuation of treatment|103|||
161481369|NCT01051323|583156594|FG000|Overall Study|Transplantation|28|||
161481370|NCT01051323|583156594|FG000|Overall Study|Dialysis dependency|22|||
161481371|NCT01051323|583156594|FG000|Overall Study|Withdrawal by Subject|13|||
161481372|NCT01051323|583156594|FG000|Overall Study|Lost to Follow-up|31|||
161481373|NCT01051323|583156594|FG000|Overall Study|Death|129|||
161481374|NCT01051323|583156594|FG000|Overall Study|Hospitalization|28|||
161481375|NCT01051323|583156594|FG000|Overall Study|Other|148|||
161481376|NCT01051323|583156594|FG000|Overall Study|Missing|37|||
161481377|NCT00555971|583156595|FG000|Overall Study|Adverse Event|1|||
161481378|NCT00555971|583156596|FG001|Overall Study|Adverse Event|1|||
161481379|NCT01626391|583156597|FG000|Overall Study|Physician Decision|1|||
161481380|NCT01626391|583156598|FG001|Overall Study|Physician Decision|0|||
161481381|NCT01626391|583156597|FG000|Overall Study|Withdrawal by Subject|1|||
161481382|NCT01626391|583156598|FG001|Overall Study|Withdrawal by Subject|0|||
161481383|NCT05469178|583156599|FG000|Overall Study|Death|1|||
161481384|NCT05469178|583156600|FG001|Overall Study|Death|1|||
161481385|NCT05469178|583156601|FG002|Overall Study|Death|3|||
161481386|NCT05469178|583156602|FG003|Overall Study|Death|6|||
161481387|NCT05469178|583156599|FG000|Overall Study|Lack of Efficacy|2|||
161481388|NCT05469178|583156600|FG001|Overall Study|Lack of Efficacy|2|||
161481389|NCT05469178|583156601|FG002|Overall Study|Lack of Efficacy|1|||
161481390|NCT05469178|583156602|FG003|Overall Study|Lack of Efficacy|10|||
161481391|NCT00968513|583156603|FG000|Overall Study|Death|4|||
161481392|NCT00968513|583156604|FG001|Overall Study|Death|10|||
161481393|NCT00968513|583156605|FG002|Overall Study|Death|15|||
161481394|NCT05466682|583156608|FG000|Overall Study|Withdrawal by Subject|0|||
161481395|NCT05466682|583156609|FG001|Overall Study|Withdrawal by Subject|2|||
161481396|NCT05466682|583156608|FG000|Overall Study|Lost to Follow-up|2|||
161481397|NCT05466682|583156609|FG001|Overall Study|Lost to Follow-up|1|||
161481398|NCT02801396|583156610|FG000|Period 1|Withdrawal by Subject|0|||
161481399|NCT02801396|583156611|FG001|Period 1|Withdrawal by Subject|0|||
161481400|NCT02801396|583156612|FG002|Period 1|Withdrawal by Subject|0|||
161481401|NCT02801396|583156613|FG003|Period 1|Withdrawal by Subject|0|||
161481402|NCT02801396|583156614|FG004|Period 1|Withdrawal by Subject|1|||
161580058|NCT04043455|583513807|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
161580059|NCT04043455|583513808|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
161580060|NCT04043455|583513809|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
161580061|NCT04043455|583513810|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
161580062|NCT04043455|583513805|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161580063|NCT04043455|583513806|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161580064|NCT04043455|583513807|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161580065|NCT04043455|583513808|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161580066|NCT04043455|583513809|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
161580067|NCT04043455|583513810|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
161580068|NCT04043455|583513805|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161580069|NCT04043455|583513806|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161580070|NCT04043455|583513807|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161580071|NCT04043455|583513808|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161580072|NCT04043455|583513809|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
161580073|NCT04043455|583513810|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161580074|NCT04043455|583513805|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161580075|NCT04043455|583513806|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161580076|NCT04043455|583513807|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161580077|NCT04043455|583513808|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161580078|NCT04043455|583513809|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
161580079|NCT04043455|583513810|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
161580080|NCT02652260|583513811|FG000|Base Study|Pregnancy|0|||
161580081|NCT02652260|583513812|FG001|Base Study|Pregnancy|1|||
161580082|NCT02652260|583513811|FG000|Base Study|Withdrawal by Subject|0|||
161580083|NCT02652260|583513812|FG001|Base Study|Withdrawal by Subject|1|||
161580084|NCT02652260|583513811|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
161669544|NCT01794520|583843109|FG002|Overall Study|Adverse events- related to progression|1|||
161669545|NCT01794520|583843110|FG003|Overall Study|Adverse events- related to progression|2|||
161669546|NCT01794520|583843111|FG004|Overall Study|Adverse events- related to progression|0|||
161669547|NCT01794520|583843112|FG005|Overall Study|Adverse events- related to progression|1|||
161816395|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161921289|NCT02903914|584757195|FG002|Overall Study|Adverse Event|1|||
161481403|NCT02801396|583156615|FG005|Period 1|Withdrawal by Subject|0|||
161481404|NCT03087643|583156622|FG000|Overall Study|Withdrawal by Subject|2|||
161481405|NCT03087643|583156623|FG001|Overall Study|Withdrawal by Subject|4|||
161481406|NCT03087643|583156622|FG000|Overall Study|Death|2|||
161481407|NCT03087643|583156623|FG001|Overall Study|Death|2|||
161481408|NCT02083783|583156624|FG000|Overall Study|Withdrawal by Subject|1|||
161481409|NCT02083783|583156625|FG001|Overall Study|Withdrawal by Subject|0|||
161481410|NCT04528732|583156626|FG000|Overall Study|Death|1|||
161481411|NCT04528732|583156627|FG001|Overall Study|Death|0|||
161481412|NCT04528732|583156628|FG002|Overall Study|Death|1|||
161481413|NCT04528732|583156626|FG000|Overall Study|Lost to Follow-up|0|||
161580085|NCT02652260|583513812|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
161481414|NCT04528732|583156627|FG001|Overall Study|Lost to Follow-up|1|||
161481415|NCT04528732|583156628|FG002|Overall Study|Lost to Follow-up|2|||
161481416|NCT02405780|583156640|FG000|Period I|Adverse Event|8|||
161481417|NCT02405780|583156641|FG001|Period I|Adverse Event|0|||
161481418|NCT02405780|583156642|FG002|Period I|Adverse Event|3|||
161481419|NCT02405780|583156643|FG003|Period I|Adverse Event|7|||
161580086|NCT02652260|583513811|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
161580087|NCT02652260|583513812|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
161481420|NCT02405780|583156640|FG000|Period I|Medical reasons|1|||
161481421|NCT02405780|583156641|FG001|Period I|Medical reasons|1|||
161481422|NCT02405780|583156642|FG002|Period I|Medical reasons|0|||
161481423|NCT02405780|583156643|FG003|Period I|Medical reasons|1|||
161481424|NCT02405780|583156640|FG000|Period I|Screening Failure|1|||
161481425|NCT02405780|583156641|FG001|Period I|Screening Failure|0|||
161481426|NCT02405780|583156642|FG002|Period I|Screening Failure|1|||
161481427|NCT02405780|583156643|FG003|Period I|Screening Failure|0|||
161481428|NCT02405780|583156640|FG000|Period I|Withdrawal by Subject|9|||
161481429|NCT02405780|583156641|FG001|Period I|Withdrawal by Subject|1|||
161481430|NCT02405780|583156642|FG002|Period I|Withdrawal by Subject|3|||
161481431|NCT02405780|583156643|FG003|Period I|Withdrawal by Subject|4|||
161481432|NCT02405780|583156640|FG000|Period I|Non-compliance with study procedures|8|||
161481433|NCT02405780|583156641|FG001|Period I|Non-compliance with study procedures|6|||
161481434|NCT02405780|583156642|FG002|Period I|Non-compliance with study procedures|8|||
161481435|NCT02405780|583156643|FG003|Period I|Non-compliance with study procedures|11|||
161481436|NCT02405780|583156640|FG000|Period II|Adverse Event|3|||
161481437|NCT02405780|583156641|FG001|Period II|Adverse Event|5|||
161481438|NCT02405780|583156642|FG002|Period II|Adverse Event|4|||
161481439|NCT02405780|583156643|FG003|Period II|Adverse Event|11|||
161481440|NCT02405780|583156640|FG000|Period II|Medical reason|0|||
161481441|NCT02405780|583156641|FG001|Period II|Medical reason|1|||
161481442|NCT02405780|583156642|FG002|Period II|Medical reason|0|||
161481443|NCT02405780|583156643|FG003|Period II|Medical reason|0|||
161481444|NCT02405780|583156640|FG000|Period II|Pregnancy|0|||
161481445|NCT02405780|583156641|FG001|Period II|Pregnancy|0|||
161481446|NCT02405780|583156642|FG002|Period II|Pregnancy|1|||
161481447|NCT02405780|583156643|FG003|Period II|Pregnancy|0|||
161481448|NCT02405780|583156640|FG000|Period II|Withdrawal by Subject|7|||
161481449|NCT02405780|583156641|FG001|Period II|Withdrawal by Subject|4|||
161481450|NCT02405780|583156642|FG002|Period II|Withdrawal by Subject|0|||
161481451|NCT02405780|583156643|FG003|Period II|Withdrawal by Subject|3|||
161481452|NCT02405780|583156640|FG000|Period II|Non-compliance with study procedures|5|||
161481453|NCT02405780|583156641|FG001|Period II|Non-compliance with study procedures|2|||
161481454|NCT02405780|583156642|FG002|Period II|Non-compliance with study procedures|7|||
161481455|NCT02405780|583156643|FG003|Period II|Non-compliance with study procedures|4|||
161481456|NCT01654536|583156644|FG000|Overall Study|Lost to Follow-up|5|||
161481457|NCT01654536|583156645|FG001|Overall Study|Lost to Follow-up|5|||
161481458|NCT01654536|583156644|FG000|Overall Study|Physician Decision|12|||
161481459|NCT01654536|583156645|FG001|Overall Study|Physician Decision|8|||
161481460|NCT01654536|583156644|FG000|Overall Study|Withdrawal by Subject|27|||
161481461|NCT01654536|583156645|FG001|Overall Study|Withdrawal by Subject|25|||
161481462|NCT00668707|583156646|FG000|Overall Study|Cancer Recurrence|58|||
161481463|NCT00668707|583156647|FG001|Overall Study|Cancer Recurrence|58|||
161481464|NCT00668707|583156646|FG000|Overall Study|Withdrawal by Subject|117|||
161481465|NCT00668707|583156647|FG001|Overall Study|Withdrawal by Subject|100|||
161481466|NCT00668707|583156646|FG000|Overall Study|Lost to Follow-up|3|||
161481467|NCT00668707|583156647|FG001|Overall Study|Lost to Follow-up|6|||
161481468|NCT00668707|583156646|FG000|Overall Study|Protocol Violation|10|||
161580088|NCT02652260|583513811|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
161580089|NCT02652260|583513812|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
161816396|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161481469|NCT00668707|583156647|FG001|Overall Study|Protocol Violation|12|||
161580090|NCT02652260|583513811|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
161816397|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816398|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816399|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816400|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816401|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816402|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161481470|NCT00668707|583156646|FG000|Overall Study|Death|11|||
161481471|NCT00668707|583156647|FG001|Overall Study|Death|4|||
161481472|NCT03846804|583156652|FG000|Overall Study|Refused blood draw|1|||
161481473|NCT03846804|583156652|FG000|Overall Study|Protocol Violation|1|||
161481474|NCT02784431|583156653|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
161481475|NCT02784431|583156653|FG000|Overall Study|Early Study Termination|19|||
161481476|NCT01273597|583156656|FG000|Overall Study|Adverse Event|5|||
161580091|NCT02652260|583513812|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
161481477|NCT01273597|583156656|FG000|Overall Study|Underwent Kidney Transplantation|2|||
161481478|NCT01273597|583156656|FG000|Overall Study|Reason Not Reported|1|||
161481479|NCT03547583|583156657|FG000|Overall Study|Adverse Event|16|||
161481480|NCT03547583|583156658|FG001|Overall Study|Adverse Event|11|||
161481481|NCT03547583|583156659|FG002|Overall Study|Adverse Event|10|||
161481482|NCT03547583|583156657|FG000|Overall Study|Death|11|||
161580092|NCT02652260|583513811|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
161481483|NCT03547583|583156658|FG001|Overall Study|Death|7|||
161481484|NCT03547583|583156659|FG002|Overall Study|Death|4|||
161816403|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816404|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816405|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816406|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816407|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161481485|NCT03547583|583156657|FG000|Overall Study|Lost to Follow-up|1|||
161481486|NCT03547583|583156658|FG001|Overall Study|Lost to Follow-up|0|||
161481487|NCT03547583|583156659|FG002|Overall Study|Lost to Follow-up|0|||
161481488|NCT03547583|583156657|FG000|Overall Study|Non-compliance with study drug|0|||
161481489|NCT03547583|583156658|FG001|Overall Study|Non-compliance with study drug|0|||
161481490|NCT03547583|583156659|FG002|Overall Study|Non-compliance with study drug|1|||
161481491|NCT03547583|583156657|FG000|Overall Study|Physician Decision|1|||
161481492|NCT03547583|583156658|FG001|Overall Study|Physician Decision|0|||
161481493|NCT03547583|583156659|FG002|Overall Study|Physician Decision|3|||
161481494|NCT03547583|583156657|FG000|Overall Study|Protocol Violation|2|||
161481495|NCT03547583|583156658|FG001|Overall Study|Protocol Violation|1|||
161481496|NCT03547583|583156659|FG002|Overall Study|Protocol Violation|1|||
161481497|NCT03547583|583156657|FG000|Overall Study|Withdrawal by Subject|12|||
161481498|NCT03547583|583156658|FG001|Overall Study|Withdrawal by Subject|19|||
161481499|NCT03547583|583156659|FG002|Overall Study|Withdrawal by Subject|10|||
161481500|NCT03547583|583156657|FG000|Overall Study|Other|2|||
161481501|NCT03547583|583156658|FG001|Overall Study|Other|2|||
161481502|NCT03547583|583156659|FG002|Overall Study|Other|3|||
161481503|NCT01949506|583156665|FG000|Overall Study|Physician Decision|1|||
161481504|NCT01446289|583156666|FG000|Overall Study|Withdrawal by Subject|1|||
161481505|NCT01446289|583156667|FG001|Overall Study|Withdrawal by Subject|0|||
161481506|NCT01446289|583156668|FG002|Overall Study|Withdrawal by Subject|1|||
161481507|NCT01446289|583156669|FG003|Overall Study|Withdrawal by Subject|0|||
161481508|NCT02513394|583156675|FG000|Overall Study|Withdrawal by Subject|11|||
161481509|NCT02513394|583156676|FG001|Overall Study|Withdrawal by Subject|23|||
161481510|NCT02513394|583156675|FG000|Overall Study|Ineligible|1|||
161481511|NCT02513394|583156676|FG001|Overall Study|Ineligible|0|||
161816408|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161481512|NCT01664533|583158487|FG000|Overall Study|Death|42|||
161481513|NCT01664533|583158487|FG000|Overall Study|Lost to Follow-up|3|||
161481514|NCT01664533|583158487|FG000|Overall Study|Study termination|9|||
161481515|NCT01664533|583158487|FG000|Overall Study|Protocol Violation|3|||
161481516|NCT00844831|583158489|FG000|Overall Study|Withdrawal by Subject|4|||
161481517|NCT00844831|583158489|FG000|Overall Study|Adverse Event|1|||
161481518|NCT00844831|583158489|FG000|Overall Study|Physician Decision|1|||
161481519|NCT05255068|583158490|FG000|Overall Study|Lost to Follow-up|0|||
161481520|NCT05255068|583158491|FG001|Overall Study|Lost to Follow-up|1|||
161481521|NCT03156543|583158493|FG000|Overall Study|Withdrawal by Subject|1|||
161481522|NCT03156543|583158494|FG001|Overall Study|Withdrawal by Subject|0|||
161481523|NCT02397278|583158495|FG000|Overall Study|Withdrawal by Subject|0|||
161481524|NCT02397278|583158496|FG001|Overall Study|Withdrawal by Subject|2|||
161481525|NCT02397278|583158495|FG000|Overall Study|Deemed ineligible following surgery|1|||
161481526|NCT02397278|583158496|FG001|Overall Study|Deemed ineligible following surgery|1|||
161481527|NCT02601469|583158498|FG000|Overall Study|Enrolled in Error|1|||
161481528|NCT02601469|583158499|FG001|Overall Study|Enrolled in Error|0|||
161481529|NCT00056316|583158500|FG000|Overall Study|Withdrawal by Subject|2|||
161481530|NCT00056316|583158501|FG001|Overall Study|Withdrawal by Subject|2|||
161481531|NCT00056316|583158500|FG000|Overall Study|Death/NH placement of pt|1|||
161481532|NCT00056316|583158501|FG001|Overall Study|Death/NH placement of pt|1|||
161481533|NCT02161731|583158502|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
161481534|NCT02161731|583158503|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
161481535|NCT02161731|583158502|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
161481536|NCT02161731|583158503|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
161481537|NCT01315678|583158508|FG000|Overall Study|Withdrawal by Subject|7|||
161481538|NCT01315678|583158509|FG001|Overall Study|Withdrawal by Subject|3|||
161481539|NCT01315678|583158508|FG000|Overall Study|Adverse Event|3|||
161816409|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816410|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161921290|NCT02903914|584757196|FG003|Overall Study|Adverse Event|0|||
161481540|NCT01315678|583158509|FG001|Overall Study|Adverse Event|1|||
161481541|NCT01315678|583158508|FG000|Overall Study|Lost to Follow-up|1|||
161481542|NCT01315678|583158509|FG001|Overall Study|Lost to Follow-up|0|||
161481543|NCT01315678|583158508|FG000|Overall Study|similar reason to those listed above|3|||
161481544|NCT01315678|583158509|FG001|Overall Study|similar reason to those listed above|2|||
161481545|NCT00573469|583158513|FG000|Overall Study|Adverse Event|1|||
161481546|NCT00573469|583158514|FG001|Overall Study|Adverse Event|1|||
161481547|NCT00573469|583158515|FG002|Overall Study|Adverse Event|1|||
161481548|NCT00573469|583158513|FG000|Overall Study|Withdrawal by Subject|0|||
161481549|NCT00573469|583158514|FG001|Overall Study|Withdrawal by Subject|2|||
161481550|NCT00573469|583158515|FG002|Overall Study|Withdrawal by Subject|0|||
161481551|NCT00573469|583158513|FG000|Overall Study|Other|5|||
161481552|NCT00573469|583158514|FG001|Overall Study|Other|1|||
161580093|NCT02652260|583513812|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
161580094|NCT02652260|583513811|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
161580095|NCT02652260|583513812|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
161580096|NCT02652260|583513811|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
161580097|NCT02652260|583513812|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
161580098|NCT02652260|583513811|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
161580099|NCT02652260|583513812|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
161580100|NCT02652260|583513811|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
161669548|NCT01794520|583843113|FG006|Overall Study|Adverse events- related to progression|0|||
161669549|NCT01794520|583843107|FG000|Overall Study|Adverse event- not related to progression|1|||
161669550|NCT01794520|583843108|FG001|Overall Study|Adverse event- not related to progression|1|||
161669551|NCT01794520|583843109|FG002|Overall Study|Adverse event- not related to progression|0|||
161669552|NCT01794520|583843110|FG003|Overall Study|Adverse event- not related to progression|0|||
161580101|NCT02652260|583513812|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
161669553|NCT01794520|583843111|FG004|Overall Study|Adverse event- not related to progression|2|||
161669554|NCT01794520|583843112|FG005|Overall Study|Adverse event- not related to progression|0|||
161669555|NCT01794520|583843113|FG006|Overall Study|Adverse event- not related to progression|0|||
161669556|NCT01794520|583843107|FG000|Overall Study|Progressive disease|5|||
161669557|NCT01794520|583843108|FG001|Overall Study|Progressive disease|6|||
161669558|NCT01794520|583843109|FG002|Overall Study|Progressive disease|2|||
161669559|NCT01794520|583843110|FG003|Overall Study|Progressive disease|5|||
161669560|NCT01794520|583843111|FG004|Overall Study|Progressive disease|27|||
161669561|NCT01794520|583843112|FG005|Overall Study|Progressive disease|18|||
161669562|NCT01794520|583843113|FG006|Overall Study|Progressive disease|0|||
161669563|NCT01794520|583843107|FG000|Overall Study|Withdrew consent|0|||
161669564|NCT01794520|583843108|FG001|Overall Study|Withdrew consent|0|||
161669565|NCT01794520|583843109|FG002|Overall Study|Withdrew consent|1|||
161669566|NCT01794520|583843110|FG003|Overall Study|Withdrew consent|1|||
161669567|NCT01794520|583843111|FG004|Overall Study|Withdrew consent|0|||
161921291|NCT02903914|584757197|FG004|Overall Study|Adverse Event|0|||
161921292|NCT02903914|584757198|FG005|Overall Study|Adverse Event|0|||
161921293|NCT02903914|584757199|FG006|Overall Study|Adverse Event|2|||
161921294|NCT02903914|584757200|FG007|Overall Study|Adverse Event|0|||
161921295|NCT02903914|584757193|FG000|Overall Study|Withdrawal by Subject|3|||
161921296|NCT02903914|584757194|FG001|Overall Study|Withdrawal by Subject|1|||
161921297|NCT02903914|584757195|FG002|Overall Study|Withdrawal by Subject|28|||
161580102|NCT02652260|583513811|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
161580103|NCT02652260|583513812|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
161669568|NCT01794520|583843112|FG005|Overall Study|Withdrew consent|0|||
161669569|NCT01794520|583843113|FG006|Overall Study|Withdrew consent|0|||
161669570|NCT01794520|583843107|FG000|Overall Study|Lost to Follow-up|0|||
161669571|NCT01794520|583843108|FG001|Overall Study|Lost to Follow-up|0|||
161921298|NCT02903914|584757196|FG003|Overall Study|Withdrawal by Subject|0|||
161921299|NCT02903914|584757197|FG004|Overall Study|Withdrawal by Subject|1|||
161481553|NCT00573469|583158515|FG002|Overall Study|Other|3|||
161481554|NCT00004978|583158516|FG000|Overall Study|Death|107|||
161481555|NCT00004978|583158517|FG001|Overall Study|Death|116|||
161481556|NCT00004978|583158516|FG000|Overall Study|Lost to Follow-up|101|||
161669572|NCT01794520|583843109|FG002|Overall Study|Lost to Follow-up|0|||
161669573|NCT01794520|583843110|FG003|Overall Study|Lost to Follow-up|0|||
161669574|NCT01794520|583843111|FG004|Overall Study|Lost to Follow-up|1|||
161669575|NCT01794520|583843112|FG005|Overall Study|Lost to Follow-up|0|||
161669576|NCT01794520|583843113|FG006|Overall Study|Lost to Follow-up|0|||
161669577|NCT01794520|583843107|FG000|Overall Study|Toxicity|0|||
161669578|NCT01794520|583843108|FG001|Overall Study|Toxicity|2|||
161669579|NCT01794520|583843109|FG002|Overall Study|Toxicity|0|||
161669580|NCT01794520|583843110|FG003|Overall Study|Toxicity|0|||
161669581|NCT01794520|583843111|FG004|Overall Study|Toxicity|0|||
161669582|NCT01794520|583843112|FG005|Overall Study|Toxicity|0|||
161669583|NCT01794520|583843113|FG006|Overall Study|Toxicity|0|||
161669584|NCT01794520|583843107|FG000|Overall Study|Study terminated by sponsor|0|||
161669585|NCT01794520|583843108|FG001|Overall Study|Study terminated by sponsor|0|||
161669586|NCT01794520|583843109|FG002|Overall Study|Study terminated by sponsor|1|||
161669587|NCT01794520|583843110|FG003|Overall Study|Study terminated by sponsor|0|||
161669588|NCT01794520|583843111|FG004|Overall Study|Study terminated by sponsor|1|||
161669589|NCT01794520|583843112|FG005|Overall Study|Study terminated by sponsor|0|||
161669590|NCT01794520|583843113|FG006|Overall Study|Study terminated by sponsor|7|||
161669591|NCT01794520|583843107|FG000|Overall Study|Death|0|||
161669592|NCT01794520|583843108|FG001|Overall Study|Death|0|||
161669593|NCT01794520|583843109|FG002|Overall Study|Death|0|||
161669594|NCT01794520|583843110|FG003|Overall Study|Death|0|||
161669595|NCT01794520|583843111|FG004|Overall Study|Death|1|||
161669596|NCT01794520|583843112|FG005|Overall Study|Death|0|||
161481557|NCT00004978|583158517|FG001|Overall Study|Lost to Follow-up|108|||
161481558|NCT00004978|583158516|FG000|Overall Study|Withdrawal by Subject|17|||
161481559|NCT00004978|583158517|FG001|Overall Study|Withdrawal by Subject|26|||
161481560|NCT00004978|583158516|FG000|Overall Study|site closure - not in analysis cohort|19|||
161481561|NCT00004978|583158517|FG001|Overall Study|site closure - not in analysis cohort|20|||
161481562|NCT02155608|583158524|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
161481563|NCT02155608|583158525|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
161481564|NCT02155608|583158524|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
161481565|NCT02155608|583158525|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
161481566|NCT01532414|583158526|FG000|Overall Study|Lost to Follow-up|3|||
161669597|NCT01794520|583843113|FG006|Overall Study|Death|22|||
161669598|NCT01794520|583843107|FG000|Overall Study|Other, not specified|0|||
161669599|NCT01794520|583843108|FG001|Overall Study|Other, not specified|0|||
161669600|NCT01794520|583843109|FG002|Overall Study|Other, not specified|1|||
161669601|NCT01794520|583843110|FG003|Overall Study|Other, not specified|1|||
161669602|NCT01794520|583843111|FG004|Overall Study|Other, not specified|4|||
161669603|NCT01794520|583843112|FG005|Overall Study|Other, not specified|1|||
161816411|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816412|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161481567|NCT01532414|583158527|FG001|Overall Study|Lost to Follow-up|0|||
161481568|NCT01532414|583158528|FG002|Overall Study|Lost to Follow-up|1|||
161481569|NCT01532414|583158526|FG000|Overall Study|Withdrawal by Subject|3|||
161481570|NCT01532414|583158527|FG001|Overall Study|Withdrawal by Subject|0|||
161481571|NCT01532414|583158528|FG002|Overall Study|Withdrawal by Subject|0|||
161481572|NCT01532414|583158526|FG000|Overall Study|No V6 semen sample|0|||
161481573|NCT01532414|583158527|FG001|Overall Study|No V6 semen sample|1|||
161481574|NCT01532414|583158528|FG002|Overall Study|No V6 semen sample|0|||
161481575|NCT01532414|583158526|FG000|Overall Study|Adverse Event|0|||
161481576|NCT01532414|583158527|FG001|Overall Study|Adverse Event|1|||
161481577|NCT01532414|583158528|FG002|Overall Study|Adverse Event|1|||
161481578|NCT01532414|583158526|FG000|Overall Study|Unable to complete 24 hour PK|0|||
161481579|NCT01532414|583158527|FG001|Overall Study|Unable to complete 24 hour PK|0|||
161481580|NCT01532414|583158528|FG002|Overall Study|Unable to complete 24 hour PK|1|||
161481581|NCT01532414|583158526|FG000|Overall Study|Withdrawn by sponsor|1|||
161816413|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161481582|NCT01532414|583158527|FG001|Overall Study|Withdrawn by sponsor|0|||
161481583|NCT01532414|583158528|FG002|Overall Study|Withdrawn by sponsor|0|||
161669604|NCT01794520|583843113|FG006|Overall Study|Other, not specified|2|||
161669605|NCT04796896|583843114|FG000|Overall Study|Adverse Event|1|||
161669606|NCT04796896|583843115|FG001|Overall Study|Adverse Event|0|||
161669607|NCT04796896|583843116|FG002|Overall Study|Adverse Event|0|||
161669608|NCT04796896|583843117|FG003|Overall Study|Adverse Event|0|||
161669609|NCT04796896|583843118|FG004|Overall Study|Adverse Event|0|||
161669610|NCT04796896|583843119|FG005|Overall Study|Adverse Event|1|||
161481584|NCT03633695|583158529|FG000|Overall Study|Lost to Follow-up|4|||
161481585|NCT03633695|583158530|FG001|Overall Study|Lost to Follow-up|5|||
161669611|NCT04796896|583843120|FG006|Overall Study|Adverse Event|1|||
161481586|NCT03633695|583158529|FG000|Overall Study|Discontinued|8|||
161669612|NCT04796896|583843121|FG007|Overall Study|Adverse Event|0|||
161481587|NCT03633695|583158530|FG001|Overall Study|Discontinued|4|||
161481588|NCT00684593|583158533|FG000|Overall Study|Adverse Event|0|||
161481589|NCT00684593|583158534|FG001|Overall Study|Adverse Event|2|||
161481590|NCT02599129|583158535|FG000|Overall Study|Lack of Efficacy|2|||
161481591|NCT02599129|583158536|FG001|Overall Study|Lack of Efficacy|2|||
161481592|NCT02599129|583158535|FG000|Overall Study|Lost to Follow-up|1|||
161481593|NCT02599129|583158536|FG001|Overall Study|Lost to Follow-up|0|||
161481594|NCT02599129|583158535|FG000|Overall Study|Withdrawal by Subject|2|||
161481595|NCT02599129|583158536|FG001|Overall Study|Withdrawal by Subject|1|||
161481596|NCT00617773|583158537|FG000|Overall Study|Physician Decision|1|||
161481597|NCT00617773|583158537|FG000|Overall Study|Lack of compliance with the protocol|1|||
161481598|NCT00617773|583158537|FG000|Overall Study|Withdrawal by Subject|1|||
161481599|NCT00617773|583158537|FG000|Overall Study|Death|1|||
161481600|NCT00617773|583158537|FG000|Overall Study|Progressive disease|19|||
161481601|NCT00617773|583158537|FG000|Overall Study|Protocol Violation|1|||
161481602|NCT01029795|583158538|FG000|Overall Study|Entry Criteria Not Met|2|||
161481603|NCT01029795|583158539|FG001|Overall Study|Entry Criteria Not Met|1|||
161481604|NCT01029795|583158538|FG000|Overall Study|Physician Decision|2|||
161481605|NCT01029795|583158539|FG001|Overall Study|Physician Decision|1|||
161481606|NCT01029795|583158538|FG000|Overall Study|Sponsor Decision|11|||
161481607|NCT01029795|583158539|FG001|Overall Study|Sponsor Decision|17|||
161481608|NCT01029795|583158538|FG000|Overall Study|Withdrawal by Subject|1|||
161481609|NCT01029795|583158539|FG001|Overall Study|Withdrawal by Subject|3|||
161481610|NCT02573311|583158549|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
161481611|NCT02573311|583158550|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
161481612|NCT02573311|583158549|FG000|Disposition for Part 2|Physician Decision|25|||
161481613|NCT02573311|583158550|FG001|Disposition for Part 2|Physician Decision|7|||
161481614|NCT02573311|583158549|FG000|Disposition for Part 2|Adverse Event|36|||
161481615|NCT02573311|583158550|FG001|Disposition for Part 2|Adverse Event|5|||
161481616|NCT02573311|583158549|FG000|Disposition for Part 2|Lost to Follow-up|76|||
161481617|NCT02573311|583158550|FG001|Disposition for Part 2|Lost to Follow-up|7|||
161481618|NCT02573311|583158549|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
161481619|NCT02573311|583158550|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
161481620|NCT02573311|583158549|FG000|Disposition for Part 2|Investigator decision|0|||
161481621|NCT02573311|583158550|FG001|Disposition for Part 2|Investigator decision|1|||
161481622|NCT02573311|583158549|FG000|Disposition for Part 2|Other than specified above|13|||
161481623|NCT02573311|583158550|FG001|Disposition for Part 2|Other than specified above|3|||
161481624|NCT05683249|583158551|FG000|Overall Study|Adverse Event|3|||
161481625|NCT05683249|583158552|FG001|Overall Study|Adverse Event|1|||
161481626|NCT05683249|583158551|FG000|Overall Study|Lack of Efficacy|0|||
161481627|NCT05683249|583158552|FG001|Overall Study|Lack of Efficacy|2|||
161580104|NCT02652260|583513811|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
161580105|NCT02652260|583513812|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
161580106|NCT02652260|583513811|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
161580107|NCT02652260|583513812|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
161580108|NCT05056246|583513813|FG000|Overall Study|Adverse Event|0|||
161580109|NCT05056246|583513814|FG001|Overall Study|Adverse Event|0|||
161580110|NCT05056246|583513815|FG002|Overall Study|Adverse Event|0|||
161580111|NCT05056246|583513816|FG003|Overall Study|Adverse Event|0|||
161580112|NCT05056246|583513817|FG004|Overall Study|Adverse Event|1|||
161580113|NCT05056246|583513813|FG000|Overall Study|Lost to Follow-up|0|||
161580114|NCT05056246|583513814|FG001|Overall Study|Lost to Follow-up|0|||
161816414|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816415|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816416|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816417|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816418|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816419|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
161816420|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
161481628|NCT05683249|583158551|FG000|Overall Study|Lost to Follow-up|6|||
161481629|NCT05683249|583158552|FG001|Overall Study|Lost to Follow-up|5|||
161481630|NCT05683249|583158551|FG000|Overall Study|Non-compliance with Study Drug|2|||
161481631|NCT05683249|583158552|FG001|Overall Study|Non-compliance with Study Drug|0|||
161481632|NCT05683249|583158551|FG000|Overall Study|Protocol Violation|6|||
161481633|NCT05683249|583158552|FG001|Overall Study|Protocol Violation|3|||
161481634|NCT05683249|583158551|FG000|Overall Study|Withdrawal by Subject|9|||
161481635|NCT05683249|583158552|FG001|Overall Study|Withdrawal by Subject|8|||
161481636|NCT05683249|583158551|FG000|Overall Study|Other|0|||
161481637|NCT05683249|583158552|FG001|Overall Study|Other|2|||
161481638|NCT01328431|583158553|FG000|Baseline|Protocol Violation|0|||
161481639|NCT01328431|583158554|FG001|Baseline|Protocol Violation|2|||
161481640|NCT01328431|583158553|FG000|1 Month (1M)|Lost to Follow-up|55|||
161481641|NCT01328431|583158554|FG001|1 Month (1M)|Lost to Follow-up|58|||
161481642|NCT01328431|583158553|FG000|3 Month (3M)|Death|2|||
161481643|NCT01328431|583158554|FG001|3 Month (3M)|Death|2|||
161580115|NCT05056246|583513815|FG002|Overall Study|Lost to Follow-up|0|||
161580116|NCT05056246|583513816|FG003|Overall Study|Lost to Follow-up|2|||
161481644|NCT01328431|583158553|FG000|3 Month (3M)|Lost to Follow-up|75|||
161481645|NCT01328431|583158554|FG001|3 Month (3M)|Lost to Follow-up|70|||
161481646|NCT01328431|583158553|FG000|12 Month (12M)|Death|2|||
161481647|NCT01328431|583158554|FG001|12 Month (12M)|Death|6|||
161481648|NCT01328431|583158553|FG000|12 Month (12M)|Lost to Follow-up|82|||
161481649|NCT01328431|583158554|FG001|12 Month (12M)|Lost to Follow-up|91|||
161481650|NCT02256631|583158557|FG000|Overall Study|Lost to Follow-up|1|||
161481651|NCT02256631|583158558|FG001|Overall Study|Lost to Follow-up|1|||
161481652|NCT02256631|583158559|FG002|Overall Study|Lost to Follow-up|0|||
161481653|NCT02256631|583158560|FG003|Overall Study|Lost to Follow-up|2|||
161481654|NCT02256631|583158561|FG004|Overall Study|Lost to Follow-up|0|||
161481655|NCT02256631|583158562|FG005|Overall Study|Lost to Follow-up|4|||
161481656|NCT02256631|583158563|FG006|Overall Study|Lost to Follow-up|1|||
161481657|NCT02256631|583158557|FG000|Overall Study|Withdrawal by Subject|0|||
161481658|NCT02256631|583158558|FG001|Overall Study|Withdrawal by Subject|0|||
161481659|NCT02256631|583158559|FG002|Overall Study|Withdrawal by Subject|0|||
161481660|NCT02256631|583158560|FG003|Overall Study|Withdrawal by Subject|1|||
161481661|NCT02256631|583158561|FG004|Overall Study|Withdrawal by Subject|1|||
161481662|NCT02256631|583158562|FG005|Overall Study|Withdrawal by Subject|0|||
161481663|NCT02256631|583158563|FG006|Overall Study|Withdrawal by Subject|1|||
161481664|NCT02256631|583158557|FG000|Overall Study|Unable to get to clinic|0|||
161481665|NCT02256631|583158558|FG001|Overall Study|Unable to get to clinic|2|||
161481666|NCT02256631|583158559|FG002|Overall Study|Unable to get to clinic|0|||
161481667|NCT02256631|583158560|FG003|Overall Study|Unable to get to clinic|1|||
161481668|NCT02256631|583158561|FG004|Overall Study|Unable to get to clinic|0|||
161481669|NCT02256631|583158562|FG005|Overall Study|Unable to get to clinic|1|||
161481670|NCT02256631|583158563|FG006|Overall Study|Unable to get to clinic|2|||
161481671|NCT01427972|583158564|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481672|NCT01427972|583158565|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481673|NCT01427972|583158566|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481674|NCT01427972|583158567|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481675|NCT01427972|583158568|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481676|NCT01427972|583158569|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481677|NCT01427972|583158570|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481678|NCT01427972|583158571|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
161481679|NCT01427972|583158572|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481680|NCT01427972|583158573|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481681|NCT01427972|583158574|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481682|NCT01427972|583158575|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161481683|NCT01427972|583158564|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481684|NCT01427972|583158565|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481685|NCT01427972|583158566|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481686|NCT01427972|583158567|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481687|NCT01427972|583158568|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481688|NCT01427972|583158569|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
161481689|NCT01427972|583158570|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481690|NCT01427972|583158571|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481691|NCT01427972|583158572|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481692|NCT01427972|583158573|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481693|NCT01427972|583158574|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481694|NCT01427972|583158575|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161481695|NCT01427972|583158564|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481696|NCT01427972|583158565|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
161481697|NCT01427972|583158566|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481698|NCT01427972|583158567|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481699|NCT01427972|583158568|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481700|NCT01427972|583158569|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481701|NCT01427972|583158570|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481702|NCT01427972|583158571|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481703|NCT01427972|583158572|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481704|NCT01427972|583158573|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481705|NCT01427972|583158574|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481706|NCT01427972|583158575|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
161481707|NCT02094677|583158576|FG000|Overall Study|Screening|3|||
161481708|NCT02094677|583158577|FG001|Overall Study|Screening|1|||
161481709|NCT04967443|583158581|FG000|Open Label Treatment|Death|1|||
161481710|NCT04967443|583158582|FG001|Open Label Treatment|Death|0|||
161481711|NCT04967443|583158583|FG002|Open Label Treatment|Death|0|||
161481712|NCT04967443|583158584|FG003|Open Label Treatment|Death|0|||
161481713|NCT04967443|583158585|FG004|Open Label Treatment|Death|0|||
161481714|NCT04967443|583158586|FG005|Open Label Treatment|Death|0|||
161481715|NCT04967443|583158587|FG006|Open Label Treatment|Death|0|||
161669613|NCT04796896|583843122|FG008|Overall Study|Adverse Event|1|||
161481716|NCT04967443|583158588|FG007|Open Label Treatment|Death|0|||
161816421|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816422|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161921300|NCT02903914|584757198|FG005|Overall Study|Withdrawal by Subject|2|||
161921301|NCT02903914|584757199|FG006|Overall Study|Withdrawal by Subject|12|||
161921302|NCT02903914|584757200|FG007|Overall Study|Withdrawal by Subject|0|||
161921303|NCT02903914|584757193|FG000|Overall Study|Progressive Disease|1|||
161921304|NCT02903914|584757194|FG001|Overall Study|Progressive Disease|0|||
161921305|NCT02903914|584757195|FG002|Overall Study|Progressive Disease|4|||
161921306|NCT02903914|584757196|FG003|Overall Study|Progressive Disease|0|||
161921307|NCT02903914|584757197|FG004|Overall Study|Progressive Disease|0|||
161921308|NCT02903914|584757198|FG005|Overall Study|Progressive Disease|0|||
161921309|NCT02903914|584757199|FG006|Overall Study|Progressive Disease|2|||
161816423|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161921310|NCT02903914|584757200|FG007|Overall Study|Progressive Disease|0|||
161580117|NCT05056246|583513817|FG004|Overall Study|Lost to Follow-up|0|||
161580118|NCT05056246|583513813|FG000|Overall Study|Withdrawal by Subject|0|||
161580119|NCT05056246|583513814|FG001|Overall Study|Withdrawal by Subject|1|||
161580120|NCT05056246|583513815|FG002|Overall Study|Withdrawal by Subject|0|||
161580121|NCT05056246|583513816|FG003|Overall Study|Withdrawal by Subject|0|||
161580122|NCT05056246|583513817|FG004|Overall Study|Withdrawal by Subject|0|||
161580123|NCT01631214|583513821|FG000|Overall Study|Withdrawal by Subject|276|||
161580124|NCT01631214|583513822|FG001|Overall Study|Withdrawal by Subject|290|||
161580125|NCT01631214|583513821|FG000|Overall Study|Death|113|||
161580126|NCT01631214|583513822|FG001|Overall Study|Death|106|||
161580127|NCT01631214|583513821|FG000|Overall Study|Lost to Follow-up|54|||
161580128|NCT01631214|583513822|FG001|Overall Study|Lost to Follow-up|40|||
161580129|NCT01631214|583513821|FG000|Overall Study|Adverse Event|45|||
161816424|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816425|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816426|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816427|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816428|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816429|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816430|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816431|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816432|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816433|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816434|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816435|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816436|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816437|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816438|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816439|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816440|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816441|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816442|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816443|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816444|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816445|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
161816446|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816447|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816448|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816449|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816450|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816451|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816452|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816453|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816454|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816455|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816456|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816457|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816458|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816459|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816460|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816461|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161921311|NCT02903914|584757193|FG000|Overall Study|Death|0|||
161921312|NCT02903914|584757194|FG001|Overall Study|Death|0|||
161921313|NCT02903914|584757195|FG002|Overall Study|Death|9|||
161921314|NCT02903914|584757196|FG003|Overall Study|Death|0|||
161580130|NCT01631214|583513822|FG001|Overall Study|Adverse Event|45|||
161481717|NCT04967443|583158581|FG000|Open Label Treatment|Lost to Follow-up|0|||
161481718|NCT04967443|583158582|FG001|Open Label Treatment|Lost to Follow-up|0|||
161481719|NCT04967443|583158583|FG002|Open Label Treatment|Lost to Follow-up|1|||
161481720|NCT04967443|583158584|FG003|Open Label Treatment|Lost to Follow-up|0|||
161481721|NCT04967443|583158585|FG004|Open Label Treatment|Lost to Follow-up|0|||
161481722|NCT04967443|583158586|FG005|Open Label Treatment|Lost to Follow-up|0|||
161580131|NCT01631214|583513821|FG000|Overall Study|Other|22|||
161580132|NCT01631214|583513822|FG001|Overall Study|Other|19|||
161580133|NCT01631214|583513821|FG000|Overall Study|Noncompliance|16|||
161580134|NCT01631214|583513822|FG001|Overall Study|Noncompliance|15|||
161580135|NCT01631214|583513821|FG000|Overall Study|Requirement for Alternative Therapy|8|||
161580136|NCT01631214|583513822|FG001|Overall Study|Requirement for Alternative Therapy|3|||
161580137|NCT01631214|583513821|FG000|Overall Study|Protocol Deviation|4|||
161580138|NCT01631214|583513822|FG001|Overall Study|Protocol Deviation|3|||
161580139|NCT01631214|583513821|FG000|Overall Study|Ineligibility determined|5|||
161580140|NCT01631214|583513822|FG001|Overall Study|Ineligibility determined|2|||
161580141|NCT01631214|583513821|FG000|Overall Study|Administrative Decision|1|||
161580142|NCT01631214|583513822|FG001|Overall Study|Administrative Decision|0|||
161580143|NCT03575052|583513823|FG000|Overall Study|Adverse Event|6|||
161580144|NCT03575052|583513824|FG001|Overall Study|Adverse Event|10|||
161580145|NCT03575052|583513823|FG000|Overall Study|Not further specified|5|||
161580146|NCT03575052|583513824|FG001|Overall Study|Not further specified|7|||
161580147|NCT03575052|583513823|FG000|Overall Study|Withdrawal by Subject|5|||
161580148|NCT03575052|583513824|FG001|Overall Study|Withdrawal by Subject|6|||
161580149|NCT03575052|583513823|FG000|Overall Study|Lost to Follow-up|3|||
161580150|NCT03575052|583513824|FG001|Overall Study|Lost to Follow-up|0|||
161580151|NCT03575052|583513823|FG000|Overall Study|Death|2|||
161580152|NCT03575052|583513824|FG001|Overall Study|Death|1|||
161580153|NCT03575052|583513823|FG000|Overall Study|Lack of Efficacy|2|||
161580154|NCT03575052|583513824|FG001|Overall Study|Lack of Efficacy|1|||
161580155|NCT03575052|583513823|FG000|Overall Study|Study drug noncompliance|1|||
161580156|NCT03575052|583513824|FG001|Overall Study|Study drug noncompliance|2|||
161580157|NCT03575052|583513823|FG000|Overall Study|Protocol Violation|0|||
161580158|NCT03575052|583513824|FG001|Overall Study|Protocol Violation|2|||
161580159|NCT03575052|583513823|FG000|Overall Study|Physician Decision|1|||
161580160|NCT03575052|583513824|FG001|Overall Study|Physician Decision|0|||
161580161|NCT03624972|583513834|FG000|Overall Study|Lost to Follow-up|2|||
161580162|NCT03624972|583513835|FG001|Overall Study|Lost to Follow-up|0|||
161580163|NCT03624972|583513836|FG002|Overall Study|Lost to Follow-up|0|||
161580164|NCT03624972|583513834|FG000|Overall Study|Withdrawal by Subject|0|||
161580165|NCT03624972|583513835|FG001|Overall Study|Withdrawal by Subject|2|||
161580166|NCT03624972|583513836|FG002|Overall Study|Withdrawal by Subject|0|||
161580167|NCT03112174|583513837|FG000|Overall Study|Withdrawal by Subject|3|||
161580168|NCT03112174|583513838|FG001|Overall Study|Withdrawal by Subject|0|||
161580169|NCT03112174|583513839|FG002|Overall Study|Withdrawal by Subject|11|||
161580170|NCT03112174|583513840|FG003|Overall Study|Withdrawal by Subject|9|||
161580171|NCT03112174|583513841|FG004|Overall Study|Withdrawal by Subject|7|||
161580172|NCT03112174|583513837|FG000|Overall Study|Lost to Follow-up|1|||
161580173|NCT03112174|583513838|FG001|Overall Study|Lost to Follow-up|1|||
161580174|NCT03112174|583513839|FG002|Overall Study|Lost to Follow-up|2|||
161580175|NCT03112174|583513840|FG003|Overall Study|Lost to Follow-up|3|||
161580176|NCT03112174|583513841|FG004|Overall Study|Lost to Follow-up|2|||
161580177|NCT03112174|583513837|FG000|Overall Study|Death|8|||
161580178|NCT03112174|583513838|FG001|Overall Study|Death|3|||
161580179|NCT03112174|583513839|FG002|Overall Study|Death|67|||
161580180|NCT03112174|583513840|FG003|Overall Study|Death|73|||
161580181|NCT03112174|583513841|FG004|Overall Study|Death|18|||
161580182|NCT03112174|583513837|FG000|Overall Study|Other, Not Specified|1|||
161580183|NCT03112174|583513838|FG001|Overall Study|Other, Not Specified|0|||
161816462|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816463|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161481723|NCT04967443|583158587|FG006|Open Label Treatment|Lost to Follow-up|0|||
161481724|NCT04967443|583158588|FG007|Open Label Treatment|Lost to Follow-up|0|||
161481725|NCT04967443|583158581|FG000|Open Label Treatment|Withdrawal by Subject|0|||
161481726|NCT04967443|583158582|FG001|Open Label Treatment|Withdrawal by Subject|1|||
161481727|NCT04967443|583158583|FG002|Open Label Treatment|Withdrawal by Subject|0|||
161481728|NCT04967443|583158584|FG003|Open Label Treatment|Withdrawal by Subject|1|||
161580184|NCT03112174|583513839|FG002|Overall Study|Other, Not Specified|1|||
161580185|NCT03112174|583513840|FG003|Overall Study|Other, Not Specified|2|||
161580186|NCT03112174|583513841|FG004|Overall Study|Other, Not Specified|0|||
161580187|NCT04512482|583513844|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
161580188|NCT04512482|583513845|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
161580189|NCT05119855|583513846|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
161580190|NCT05119855|583513847|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
161580191|NCT05119855|583513846|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
161580192|NCT05119855|583513847|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
161580193|NCT05119855|583513846|FG000|Overall Study|Lost to Follow-up|6|||
161481729|NCT04967443|583158585|FG004|Open Label Treatment|Withdrawal by Subject|0|||
161481730|NCT04967443|583158586|FG005|Open Label Treatment|Withdrawal by Subject|1|||
161481731|NCT04967443|583158587|FG006|Open Label Treatment|Withdrawal by Subject|2|||
161481732|NCT04967443|583158588|FG007|Open Label Treatment|Withdrawal by Subject|3|||
161481733|NCT04967443|583158581|FG000|Follow-Up|Death|1|||
161481734|NCT04967443|583158582|FG001|Follow-Up|Death|0|||
161481735|NCT04967443|583158583|FG002|Follow-Up|Death|0|||
161481736|NCT04967443|583158584|FG003|Follow-Up|Death|0|||
161481737|NCT04967443|583158585|FG004|Follow-Up|Death|0|||
161481738|NCT04967443|583158586|FG005|Follow-Up|Death|0|||
161481739|NCT04967443|583158587|FG006|Follow-Up|Death|0|||
161481740|NCT04967443|583158588|FG007|Follow-Up|Death|0|||
161481741|NCT04967443|583158581|FG000|Follow-Up|Lost to Follow-up|0|||
161481742|NCT04967443|583158582|FG001|Follow-Up|Lost to Follow-up|0|||
161481743|NCT04967443|583158583|FG002|Follow-Up|Lost to Follow-up|1|||
161481744|NCT04967443|583158584|FG003|Follow-Up|Lost to Follow-up|1|||
161481745|NCT04967443|583158585|FG004|Follow-Up|Lost to Follow-up|0|||
161481746|NCT04967443|583158586|FG005|Follow-Up|Lost to Follow-up|0|||
161481747|NCT04967443|583158587|FG006|Follow-Up|Lost to Follow-up|0|||
161481748|NCT04967443|583158588|FG007|Follow-Up|Lost to Follow-up|0|||
161481749|NCT04967443|583158581|FG000|Follow-Up|Withdrawal by Subject|0|||
161481750|NCT04967443|583158582|FG001|Follow-Up|Withdrawal by Subject|1|||
161481751|NCT04967443|583158583|FG002|Follow-Up|Withdrawal by Subject|0|||
161481752|NCT04967443|583158584|FG003|Follow-Up|Withdrawal by Subject|1|||
161481753|NCT04967443|583158585|FG004|Follow-Up|Withdrawal by Subject|0|||
161481754|NCT04967443|583158586|FG005|Follow-Up|Withdrawal by Subject|1|||
161481755|NCT04967443|583158587|FG006|Follow-Up|Withdrawal by Subject|2|||
161481756|NCT04967443|583158588|FG007|Follow-Up|Withdrawal by Subject|3|||
161481757|NCT00602797|583158589|FG000|Overall Study|Adverse Event|1|||
161481758|NCT04502693|583158590|FG000|Overall Study|Adverse Event|7|||
161481759|NCT04502693|583158591|FG001|Overall Study|Adverse Event|6|||
161481760|NCT04502693|583158592|FG002|Overall Study|Adverse Event|11|||
161481761|NCT04502693|583158593|FG003|Overall Study|Adverse Event|1|||
161481762|NCT04502693|583158590|FG000|Overall Study|Lost to Follow-up|32|||
161481763|NCT04502693|583158591|FG001|Overall Study|Lost to Follow-up|36|||
161481764|NCT04502693|583158592|FG002|Overall Study|Lost to Follow-up|69|||
161481765|NCT04502693|583158593|FG003|Overall Study|Lost to Follow-up|4|||
161481766|NCT04502693|583158590|FG000|Overall Study|Protocol Violation|8|||
161481767|NCT04502693|583158591|FG001|Overall Study|Protocol Violation|8|||
161481768|NCT04502693|583158592|FG002|Overall Study|Protocol Violation|16|||
161481769|NCT04502693|583158593|FG003|Overall Study|Protocol Violation|1|||
161481770|NCT04502693|583158590|FG000|Overall Study|Withdrawal by Subject|46|||
161481771|NCT04502693|583158591|FG001|Overall Study|Withdrawal by Subject|38|||
161481772|NCT04502693|583158592|FG002|Overall Study|Withdrawal by Subject|54|||
161481773|NCT04502693|583158593|FG003|Overall Study|Withdrawal by Subject|7|||
161481774|NCT04502693|583158590|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
161481775|NCT04502693|583158591|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
161481776|NCT04502693|583158592|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
161481777|NCT04502693|583158593|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161481778|NCT04502693|583158590|FG000|Overall Study|Other|1|||
161481779|NCT04502693|583158591|FG001|Overall Study|Other|0|||
161481780|NCT04502693|583158592|FG002|Overall Study|Other|1|||
161481781|NCT04502693|583158593|FG003|Overall Study|Other|1|||
161481782|NCT00393029|583158594|FG000|Overall Study|Not treated|0|||
161481783|NCT00393029|583158595|FG001|Overall Study|Not treated|1|||
161481784|NCT00279305|583158596|FG000|Overall Study|Pregnancy|1|||
161481785|NCT00279305|583158597|FG001|Overall Study|Pregnancy|0|||
161481786|NCT00279305|583158596|FG000|Overall Study|Withdrawal by Subject|2|||
161481787|NCT00279305|583158597|FG001|Overall Study|Withdrawal by Subject|0|||
161481788|NCT00279305|583158596|FG000|Overall Study|Dificulting establishing IV|1|||
161481789|NCT00279305|583158597|FG001|Overall Study|Dificulting establishing IV|0|||
161481790|NCT00279305|583158596|FG000|Overall Study|FDA Safety Alert|4|||
161481791|NCT00279305|583158597|FG001|Overall Study|FDA Safety Alert|1|||
161481792|NCT04404361|583158598|FG000|Overall Study|Death|12|||
161481793|NCT04404361|583158599|FG001|Overall Study|Death|12|||
161481794|NCT04404361|583158598|FG000|Overall Study|Withdrawal by Subject|13|||
161481795|NCT04404361|583158599|FG001|Overall Study|Withdrawal by Subject|5|||
161481796|NCT04404361|583158598|FG000|Overall Study|Lost to Follow-up|6|||
161481797|NCT04404361|583158599|FG001|Overall Study|Lost to Follow-up|3|||
161481798|NCT04404361|583158598|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
161481799|NCT04404361|583158599|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
161481800|NCT01063868|583158601|FG000|Overall Study|Adverse Event|9|||
161481801|NCT01063868|583158602|FG001|Overall Study|Adverse Event|7|||
161481802|NCT01063868|583158601|FG000|Overall Study|Withdrawal by Subject|3|||
161481803|NCT01063868|583158602|FG001|Overall Study|Withdrawal by Subject|1|||
161481804|NCT01063868|583158601|FG000|Overall Study|Study Terminated By Sponsor|23|||
161481805|NCT01063868|583158602|FG001|Overall Study|Study Terminated By Sponsor|4|||
161481806|NCT03307967|583158603|FG000|Overall Study|Lost to Follow-up|4|||
161481807|NCT02915016|583158604|FG000|Overall Study|Lost to Follow-up|4|||
161481808|NCT02915016|583158605|FG001|Overall Study|Lost to Follow-up|2|||
161481809|NCT02915016|583158606|FG002|Overall Study|Lost to Follow-up|5|||
161481810|NCT02915016|583158607|FG003|Overall Study|Lost to Follow-up|3|||
161481811|NCT02915016|583158608|FG004|Overall Study|Lost to Follow-up|5|||
161481812|NCT02915016|583158609|FG005|Overall Study|Lost to Follow-up|2|||
161481813|NCT02915016|583158610|FG006|Overall Study|Lost to Follow-up|8|||
161481814|NCT02915016|583158611|FG007|Overall Study|Lost to Follow-up|2|||
161481815|NCT02915016|583158604|FG000|Overall Study|Physician Decision|0|||
161481816|NCT02915016|583158605|FG001|Overall Study|Physician Decision|0|||
161481817|NCT02915016|583158606|FG002|Overall Study|Physician Decision|1|||
161481818|NCT02915016|583158607|FG003|Overall Study|Physician Decision|0|||
161481819|NCT02915016|583158608|FG004|Overall Study|Physician Decision|0|||
161481820|NCT02915016|583158609|FG005|Overall Study|Physician Decision|1|||
161481821|NCT02915016|583158610|FG006|Overall Study|Physician Decision|2|||
161481822|NCT02915016|583158611|FG007|Overall Study|Physician Decision|0|||
161481823|NCT02915016|583158604|FG000|Overall Study|Withdrawal by Subject|2|||
161481824|NCT02915016|583158605|FG001|Overall Study|Withdrawal by Subject|0|||
161481825|NCT02915016|583158606|FG002|Overall Study|Withdrawal by Subject|1|||
161481826|NCT02915016|583158607|FG003|Overall Study|Withdrawal by Subject|0|||
161481827|NCT02915016|583158608|FG004|Overall Study|Withdrawal by Subject|1|||
161481828|NCT02915016|583158609|FG005|Overall Study|Withdrawal by Subject|3|||
161481829|NCT02915016|583158610|FG006|Overall Study|Withdrawal by Subject|1|||
161481830|NCT02915016|583158611|FG007|Overall Study|Withdrawal by Subject|1|||
161481831|NCT02915016|583158604|FG000|Overall Study|Elected not to continue|0|||
161481832|NCT02915016|583158605|FG001|Overall Study|Elected not to continue|0|||
161481833|NCT02915016|583158606|FG002|Overall Study|Elected not to continue|0|||
161481834|NCT02915016|583158607|FG003|Overall Study|Elected not to continue|1|||
161481835|NCT02915016|583158608|FG004|Overall Study|Elected not to continue|0|||
161481836|NCT02915016|583158609|FG005|Overall Study|Elected not to continue|0|||
161481837|NCT02915016|583158610|FG006|Overall Study|Elected not to continue|1|||
161481838|NCT02915016|583158611|FG007|Overall Study|Elected not to continue|0|||
161481839|NCT02915016|583158604|FG000|Overall Study|HIV infection|1|||
161481840|NCT02915016|583158605|FG001|Overall Study|HIV infection|1|||
161481841|NCT02915016|583158606|FG002|Overall Study|HIV infection|1|||
161481842|NCT02915016|583158607|FG003|Overall Study|HIV infection|0|||
161481843|NCT02915016|583158608|FG004|Overall Study|HIV infection|1|||
161481844|NCT02915016|583158609|FG005|Overall Study|HIV infection|0|||
161481845|NCT02915016|583158610|FG006|Overall Study|HIV infection|0|||
161481846|NCT02915016|583158611|FG007|Overall Study|HIV infection|0|||
161481847|NCT02915016|583158604|FG000|Overall Study|Participant unable to adhere|0|||
161481848|NCT02915016|583158605|FG001|Overall Study|Participant unable to adhere|0|||
161481849|NCT02915016|583158606|FG002|Overall Study|Participant unable to adhere|0|||
161580194|NCT05119855|583513847|FG001|Overall Study|Lost to Follow-up|8|||
161580195|NCT00391898|583513852|FG000|Overall Study|Adverse Event|3|||
161921315|NCT02903914|584757197|FG004|Overall Study|Death|1|||
161921316|NCT02903914|584757198|FG005|Overall Study|Death|3|||
161921317|NCT02903914|584757199|FG006|Overall Study|Death|24|||
161921318|NCT02903914|584757200|FG007|Overall Study|Death|2|||
161580196|NCT00391898|583513853|FG001|Overall Study|Adverse Event|0|||
161921319|NCT02903914|584757193|FG000|Overall Study|Lost to Follow-up|0|||
161921320|NCT02903914|584757194|FG001|Overall Study|Lost to Follow-up|1|||
161481850|NCT02915016|583158607|FG003|Overall Study|Participant unable to adhere|0|||
161481851|NCT02915016|583158608|FG004|Overall Study|Participant unable to adhere|0|||
161481852|NCT02915016|583158609|FG005|Overall Study|Participant unable to adhere|0|||
161481853|NCT02915016|583158610|FG006|Overall Study|Participant unable to adhere|0|||
161481854|NCT02915016|583158611|FG007|Overall Study|Participant unable to adhere|1|||
161481855|NCT02578316|583158612|FG000|Extension Phase|Progression of disease|6|||
161481856|NCT02166905|583158613|FG000|Overall Study|Withdrawal by Subject|1|||
161481857|NCT02166905|583158614|FG001|Overall Study|Withdrawal by Subject|0|||
161481858|NCT02166905|583158615|FG002|Overall Study|Withdrawal by Subject|0|||
161481859|NCT02166905|583158616|FG003|Overall Study|Withdrawal by Subject|0|||
161481860|NCT02617628|583158617|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
161580197|NCT00391898|583513852|FG000|Overall Study|Other|8|||
161921321|NCT02903914|584757195|FG002|Overall Study|Lost to Follow-up|0|||
161921322|NCT02903914|584757196|FG003|Overall Study|Lost to Follow-up|0|||
161481861|NCT02617628|583158618|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
161481862|NCT03278873|583158620|FG000|Overall Study|Withdrawal by Subject|0|||
161481863|NCT03278873|583158621|FG001|Overall Study|Withdrawal by Subject|1|||
161481864|NCT03278873|583158622|FG002|Overall Study|Withdrawal by Subject|0|||
161481865|NCT03278873|583158623|FG003|Overall Study|Withdrawal by Subject|0|||
161481866|NCT03278873|583158620|FG000|Overall Study|Sponsor's decision|0|||
161481867|NCT03278873|583158621|FG001|Overall Study|Sponsor's decision|1|||
161481868|NCT03278873|583158622|FG002|Overall Study|Sponsor's decision|0|||
161481869|NCT03278873|583158623|FG003|Overall Study|Sponsor's decision|0|||
161481870|NCT03278873|583158620|FG000|Overall Study|Early Termination|2|||
161481871|NCT03278873|583158621|FG001|Overall Study|Early Termination|6|||
161481872|NCT03278873|583158622|FG002|Overall Study|Early Termination|0|||
161481873|NCT03278873|583158623|FG003|Overall Study|Early Termination|4|||
161481874|NCT03278873|583158620|FG000|Overall Study|Lost to Follow-up|0|||
161481875|NCT03278873|583158621|FG001|Overall Study|Lost to Follow-up|0|||
161481876|NCT03278873|583158622|FG002|Overall Study|Lost to Follow-up|2|||
161481877|NCT03278873|583158623|FG003|Overall Study|Lost to Follow-up|0|||
161481878|NCT03278873|583158620|FG000|Overall Study|The patient decided to withdraw via email|1|||
161481879|NCT03278873|583158621|FG001|Overall Study|The patient decided to withdraw via email|0|||
161481880|NCT03278873|583158622|FG002|Overall Study|The patient decided to withdraw via email|0|||
161481881|NCT03278873|583158623|FG003|Overall Study|The patient decided to withdraw via email|0|||
161481882|NCT03278873|583158620|FG000|Overall Study|The patient was unresponsive to contact|0|||
161481883|NCT03278873|583158621|FG001|Overall Study|The patient was unresponsive to contact|0|||
161481884|NCT03278873|583158622|FG002|Overall Study|The patient was unresponsive to contact|0|||
161481885|NCT03278873|583158623|FG003|Overall Study|The patient was unresponsive to contact|4|||
161481886|NCT03278873|583158620|FG000|Overall Study|The patient wished to participate no longer|0|||
161481887|NCT03278873|583158621|FG001|Overall Study|The patient wished to participate no longer|1|||
161481888|NCT03278873|583158622|FG002|Overall Study|The patient wished to participate no longer|0|||
161481889|NCT03278873|583158623|FG003|Overall Study|The patient wished to participate no longer|0|||
161481890|NCT03278873|583158620|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
161481891|NCT03278873|583158621|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
161481892|NCT03278873|583158622|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
161481893|NCT03278873|583158623|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
161481894|NCT05243641|583158624|FG000|Overall Study|Adverse Event|3|||
161481895|NCT05243641|583158625|FG001|Overall Study|Adverse Event|0|||
161481896|NCT05243641|583158626|FG002|Overall Study|Adverse Event|0|||
161481897|NCT05243641|583158627|FG003|Overall Study|Adverse Event|1|||
161481898|NCT05243641|583158628|FG004|Overall Study|Adverse Event|0|||
161481899|NCT05243641|583158629|FG005|Overall Study|Adverse Event|0|||
161481900|NCT05243641|583158624|FG000|Overall Study|Disease progression|4|||
161481901|NCT05243641|583158625|FG001|Overall Study|Disease progression|0|||
161481902|NCT05243641|583158626|FG002|Overall Study|Disease progression|0|||
161481903|NCT05243641|583158627|FG003|Overall Study|Disease progression|2|||
161481904|NCT05243641|583158628|FG004|Overall Study|Disease progression|0|||
161481905|NCT05243641|583158629|FG005|Overall Study|Disease progression|0|||
161481906|NCT04518306|583158636|FG000|Double-Blind Period|Run in failure|0|||
161481907|NCT04518306|583158637|FG001|Double-Blind Period|Run in failure|0|||
161481908|NCT04518306|583158638|FG002|Double-Blind Period|Run in failure|1|||
161481909|NCT04518306|583158636|FG000|Double-Blind Period|Adverse Event|0|||
161481910|NCT04518306|583158637|FG001|Double-Blind Period|Adverse Event|2|||
161481911|NCT04518306|583158638|FG002|Double-Blind Period|Adverse Event|2|||
161481912|NCT04518306|583158636|FG000|Double-Blind Period|Lost to Follow-up|1|||
161481913|NCT04518306|583158637|FG001|Double-Blind Period|Lost to Follow-up|2|||
161481914|NCT04518306|583158638|FG002|Double-Blind Period|Lost to Follow-up|2|||
161481915|NCT04518306|583158636|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
161481916|NCT04518306|583158637|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
161481917|NCT04518306|583158638|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
161481918|NCT04518306|583158636|FG000|Double-Blind Period|Other|0|||
161481919|NCT04518306|583158637|FG001|Double-Blind Period|Other|2|||
161481920|NCT04518306|583158638|FG002|Double-Blind Period|Other|0|||
161481921|NCT04518306|583158636|FG000|Double-Blind Period|Missing|0|||
161481922|NCT04518306|583158637|FG001|Double-Blind Period|Missing|1|||
161481923|NCT04518306|583158638|FG002|Double-Blind Period|Missing|0|||
161481924|NCT03268954|583158642|FG000|Overall Study|Withdrawal by Subject|27|||
161481925|NCT03268954|583158643|FG001|Overall Study|Withdrawal by Subject|17|||
161481926|NCT03268954|583158642|FG000|Overall Study|Lost to Follow-up|2|||
161481927|NCT03268954|583158643|FG001|Overall Study|Lost to Follow-up|3|||
161481928|NCT03268954|583158642|FG000|Overall Study|Reason Not Specified|3|||
161481929|NCT03268954|583158643|FG001|Overall Study|Reason Not Specified|8|||
161481930|NCT05372419|583158646|FG000|Overall Study|Protocol Deviation|1|||
161481931|NCT05372419|583158646|FG000|Overall Study|Withdrawal by Subject|5|||
161481932|NCT05372419|583158646|FG000|Overall Study|Lost to Follow-up|7|||
161481933|NCT05358444|583158647|FG000|Overall Study|Withdrawal by Subject|0|||
161481934|NCT05358444|583158648|FG001|Overall Study|Withdrawal by Subject|1|||
161481935|NCT05358444|583158647|FG000|Overall Study|Lost to Follow-up|0|||
161481936|NCT05358444|583158648|FG001|Overall Study|Lost to Follow-up|3|||
161481937|NCT02801331|583158649|FG000|Overall Study|Transferred to another hospital|8|||
161481938|NCT02801331|583158650|FG001|Overall Study|Transferred to another hospital|7|||
161481939|NCT02801331|583158649|FG000|Overall Study|Withdrawal by Subject|0|||
161481940|NCT02801331|583158650|FG001|Overall Study|Withdrawal by Subject|4|||
161481941|NCT02801331|583158649|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
161481942|NCT02801331|583158650|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
161481943|NCT02443987|583158651|FG000|Overall Study|Bladder injury|1|||
161481944|NCT02443987|583158652|FG001|Overall Study|Bladder injury|1|||
161481945|NCT02443987|583158651|FG000|Overall Study|Other|0|||
161481946|NCT02443987|583158652|FG001|Overall Study|Other|1|||
161481947|NCT03820986|583158655|FG000|Overall Study|Death|201|||
161481948|NCT03820986|583158656|FG001|Overall Study|Death|175|||
161481949|NCT03820986|583158655|FG000|Overall Study|Lost to Follow-up|1|||
161481950|NCT03820986|583158656|FG001|Overall Study|Lost to Follow-up|1|||
161481951|NCT03820986|583158655|FG000|Overall Study|Physician Decision|1|||
161481952|NCT03820986|583158656|FG001|Overall Study|Physician Decision|0|||
161481953|NCT03820986|583158655|FG000|Overall Study|Sponsor Decision|122|||
161481954|NCT03820986|583158656|FG001|Overall Study|Sponsor Decision|160|||
161481955|NCT03820986|583158655|FG000|Overall Study|Withdrawal by Subject|9|||
161481956|NCT03820986|583158656|FG001|Overall Study|Withdrawal by Subject|4|||
161481957|NCT05766423|583158663|FG000|Overall Study|Withdrawal by Subject|1|||
161481958|NCT05766423|583158664|FG001|Overall Study|Withdrawal by Subject|0|||
161481959|NCT05766423|583158663|FG000|Overall Study|Consented, not scheduled|3|||
161481960|NCT05766423|583158664|FG001|Overall Study|Consented, not scheduled|5|||
161481961|NCT03217175|583160634|FG000|Overall Study|Physician Decision|4|||
161481962|NCT03217175|583160635|FG001|Overall Study|Physician Decision|1|||
161481963|NCT00429273|583160636|FG000|Overall Study|Lost to Follow-up|1|||
161481964|NCT00429273|583160637|FG001|Overall Study|Lost to Follow-up|2|||
161481965|NCT00429273|583160638|FG002|Overall Study|Lost to Follow-up|2|||
161481966|NCT00429273|583160636|FG000|Overall Study|Physician Decision|6|||
161481967|NCT00429273|583160637|FG001|Overall Study|Physician Decision|5|||
161481968|NCT00429273|583160638|FG002|Overall Study|Physician Decision|5|||
161481969|NCT00429273|583160636|FG000|Overall Study|Adverse Event|1|||
161481970|NCT00429273|583160637|FG001|Overall Study|Adverse Event|1|||
161481971|NCT00429273|583160638|FG002|Overall Study|Adverse Event|2|||
161481972|NCT01218204|583160643|FG000|Part B Washout|Adverse Event|0|||
161481973|NCT01218204|583160644|FG001|Part B Washout|Adverse Event|1|||
161481974|NCT01218204|583160645|FG002|Part B Washout|Adverse Event|0|||
161481975|NCT01218204|583160646|FG003|Part B Washout|Adverse Event|0|||
161481976|NCT01218204|583160643|FG000|Part B Washout|Lost to Follow-up|0|||
161481977|NCT01218204|583160644|FG001|Part B Washout|Lost to Follow-up|2|||
161481978|NCT01218204|583160645|FG002|Part B Washout|Lost to Follow-up|0|||
161481979|NCT01218204|583160646|FG003|Part B Washout|Lost to Follow-up|0|||
161481980|NCT01218204|583160643|FG000|Part B Washout|Physician Decision|0|||
161481981|NCT01218204|583160644|FG001|Part B Washout|Physician Decision|14|||
161580198|NCT00391898|583513853|FG001|Overall Study|Other|10|||
161580199|NCT05489484|583513854|FG000|Overall Study|withdrawn|1|||
161580200|NCT02529995|583513855|FG000|Part A|Ongoing Study at Data Cut-off|14|||
161580201|NCT02529995|583513856|FG001|Part A|Ongoing Study at Data Cut-off|16|||
161580202|NCT02529995|583513855|FG000|Part A|Discontinued Study|1|||
161580203|NCT02529995|583513856|FG001|Part A|Discontinued Study|0|||
161816464|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816465|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816466|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816467|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816468|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816469|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816470|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816471|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816472|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
161481982|NCT01218204|583160645|FG002|Part B Washout|Physician Decision|0|||
161481983|NCT01218204|583160646|FG003|Part B Washout|Physician Decision|0|||
161481984|NCT01218204|583160643|FG000|Part B Washout|Withdrawal by Subject|0|||
161481985|NCT01218204|583160644|FG001|Part B Washout|Withdrawal by Subject|14|||
161481986|NCT01218204|583160645|FG002|Part B Washout|Withdrawal by Subject|0|||
161580204|NCT02529995|583513855|FG000|Part B|Ongoing Study at Data Cut-off|0|||
161669614|NCT04796896|583843123|FG009|Overall Study|Adverse Event|1|||
161481987|NCT01218204|583160646|FG003|Part B Washout|Withdrawal by Subject|0|||
161481988|NCT01218204|583160643|FG000|Part B Washout|Reached defined stopping criteria|0|||
161580205|NCT02529995|583513856|FG001|Part B|Ongoing Study at Data Cut-off|7|||
161669615|NCT04796896|583843124|FG010|Overall Study|Adverse Event|1|||
161481989|NCT01218204|583160644|FG001|Part B Washout|Reached defined stopping criteria|2|||
161481990|NCT01218204|583160645|FG002|Part B Washout|Reached defined stopping criteria|0|||
161580206|NCT02529995|583513855|FG000|Part B|Discontinued Study|6|||
161816473|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161481991|NCT01218204|583160646|FG003|Part B Washout|Reached defined stopping criteria|0|||
161481992|NCT01218204|583160643|FG000|Part B Washout|Did not meet continuation criteria|0|||
161481993|NCT01218204|583160644|FG001|Part B Washout|Did not meet continuation criteria|112|||
161481994|NCT01218204|583160645|FG002|Part B Washout|Did not meet continuation criteria|0|||
161481995|NCT01218204|583160646|FG003|Part B Washout|Did not meet continuation criteria|0|||
161481996|NCT01218204|583160643|FG000|Part B Run-in|Adverse Event|0|||
161481997|NCT01218204|583160644|FG001|Part B Run-in|Adverse Event|0|||
161481998|NCT01218204|583160645|FG002|Part B Run-in|Adverse Event|1|||
161481999|NCT01218204|583160646|FG003|Part B Run-in|Adverse Event|0|||
161482000|NCT01218204|583160643|FG000|Part B Run-in|Protocol Violation|0|||
161482001|NCT01218204|583160644|FG001|Part B Run-in|Protocol Violation|0|||
161482002|NCT01218204|583160645|FG002|Part B Run-in|Protocol Violation|2|||
161482003|NCT01218204|583160646|FG003|Part B Run-in|Protocol Violation|0|||
161482004|NCT01218204|583160643|FG000|Part B Run-in|Withdrawal by Subject|0|||
161482005|NCT01218204|583160644|FG001|Part B Run-in|Withdrawal by Subject|0|||
161482006|NCT01218204|583160645|FG002|Part B Run-in|Withdrawal by Subject|3|||
161482007|NCT01218204|583160646|FG003|Part B Run-in|Withdrawal by Subject|0|||
161482008|NCT01218204|583160643|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
161482009|NCT01218204|583160644|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
161482010|NCT01218204|583160645|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
161482011|NCT01218204|583160646|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
161482012|NCT01218204|583160643|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
161482013|NCT01218204|583160644|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
161482014|NCT01218204|583160645|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
161482015|NCT01218204|583160646|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
161482016|NCT00407797|583160654|FG000|Overall Study|Lost to Follow-up|2|||
161482017|NCT00407797|583160654|FG000|Overall Study|Adverse Event|6|||
161482018|NCT00407797|583160654|FG000|Overall Study|Other|7|||
161482019|NCT00407797|583160654|FG000|Overall Study|Withdrawal by Subject|3|||
161482020|NCT01402492|583160658|FG000|Overall Study|Withdrawal by Subject|17|||
161482021|NCT01402492|583160659|FG001|Overall Study|Withdrawal by Subject|11|||
161482022|NCT01402492|583160660|FG002|Overall Study|Withdrawal by Subject|11|||
161482023|NCT01402492|583160658|FG000|Overall Study|Adverse Event|2|||
161482024|NCT01402492|583160659|FG001|Overall Study|Adverse Event|3|||
161482025|NCT01402492|583160660|FG002|Overall Study|Adverse Event|4|||
161580207|NCT02529995|583513856|FG001|Part B|Discontinued Study|5|||
161580208|NCT00444600|583513857|FG000|Overall Study|Death|7|||
161580209|NCT00444600|583513858|FG001|Overall Study|Death|5|||
161580210|NCT00444600|583513859|FG002|Overall Study|Death|3|||
161580211|NCT00444600|583513860|FG003|Overall Study|Death|2|||
161580212|NCT00444600|583513857|FG000|Overall Study|Dropped|11|||
161580213|NCT00444600|583513858|FG001|Overall Study|Dropped|11|||
161580214|NCT00444600|583513859|FG002|Overall Study|Dropped|7|||
161580215|NCT00444600|583513860|FG003|Overall Study|Dropped|7|||
161580216|NCT00444600|583513857|FG000|Overall Study|Missed visit|1|||
161580217|NCT00444600|583513858|FG001|Overall Study|Missed visit|0|||
161580218|NCT00444600|583513859|FG002|Overall Study|Missed visit|0|||
161580219|NCT00444600|583513860|FG003|Overall Study|Missed visit|1|||
161580220|NCT05132478|583513861|FG000|Overall Study|did not complete survey after consent|1|||
161580221|NCT05132478|583513862|FG001|Overall Study|did not complete survey after consent|1|||
161580222|NCT05132478|583513861|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
161580223|NCT05132478|583513862|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
161580224|NCT02549170|583513863|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
161580225|NCT02549170|583513864|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
161580226|NCT02549170|583513865|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161580227|NCT02549170|583513866|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161580228|NCT02549170|583513867|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161921323|NCT02903914|584757197|FG004|Overall Study|Lost to Follow-up|2|||
161921324|NCT02903914|584757198|FG005|Overall Study|Lost to Follow-up|0|||
161580229|NCT02549170|583513863|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
161580230|NCT02549170|583513864|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
161482026|NCT01402492|583160658|FG000|Overall Study|Physician Decision|0|||
161482027|NCT01402492|583160659|FG001|Overall Study|Physician Decision|3|||
161580231|NCT02549170|583513865|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161580232|NCT02549170|583513866|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161580233|NCT02549170|583513867|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161580234|NCT02549170|583513863|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
161580235|NCT02549170|583513864|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
161482028|NCT01402492|583160660|FG002|Overall Study|Physician Decision|0|||
161482029|NCT01402492|583160658|FG000|Overall Study|Incarcerated (N=3)|2|||
161482030|NCT01402492|583160659|FG001|Overall Study|Incarcerated (N=3)|0|||
161482031|NCT01402492|583160660|FG002|Overall Study|Incarcerated (N=3)|1|||
161669616|NCT04796896|583843125|FG011|Overall Study|Adverse Event|0|||
161669617|NCT04796896|583843114|FG000|Overall Study|Lost to Follow-up|24|||
161669618|NCT04796896|583843115|FG001|Overall Study|Lost to Follow-up|15|||
161669619|NCT04796896|583843116|FG002|Overall Study|Lost to Follow-up|6|||
161669620|NCT04796896|583843117|FG003|Overall Study|Lost to Follow-up|4|||
161669621|NCT04796896|583843118|FG004|Overall Study|Lost to Follow-up|21|||
161669622|NCT04796896|583843119|FG005|Overall Study|Lost to Follow-up|55|||
161669623|NCT04796896|583843120|FG006|Overall Study|Lost to Follow-up|237|||
161669624|NCT04796896|583843121|FG007|Overall Study|Lost to Follow-up|52|||
161669625|NCT04796896|583843122|FG008|Overall Study|Lost to Follow-up|221|||
161669626|NCT04796896|583843123|FG009|Overall Study|Lost to Follow-up|43|||
161669627|NCT04796896|583843124|FG010|Overall Study|Lost to Follow-up|142|||
161669628|NCT04796896|583843125|FG011|Overall Study|Lost to Follow-up|18|||
161669629|NCT04796896|583843114|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
161669630|NCT04796896|583843115|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
161669631|NCT04796896|583843116|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
161669632|NCT04796896|583843117|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
161669633|NCT04796896|583843118|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
161669634|NCT04796896|583843119|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
161669635|NCT04796896|583843120|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
161669636|NCT04796896|583843121|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
161669637|NCT04796896|583843122|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
161669638|NCT04796896|583843123|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
161669639|NCT04796896|583843124|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
161669640|NCT04796896|583843125|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
161669641|NCT04796896|583843114|FG000|Overall Study|Physician Decision|1|||
161669642|NCT04796896|583843115|FG001|Overall Study|Physician Decision|0|||
161669643|NCT04796896|583843116|FG002|Overall Study|Physician Decision|0|||
161669644|NCT04796896|583843117|FG003|Overall Study|Physician Decision|0|||
161669645|NCT04796896|583843118|FG004|Overall Study|Physician Decision|0|||
161669646|NCT04796896|583843119|FG005|Overall Study|Physician Decision|3|||
161669647|NCT04796896|583843120|FG006|Overall Study|Physician Decision|18|||
161669648|NCT04796896|583843121|FG007|Overall Study|Physician Decision|1|||
161669649|NCT04796896|583843122|FG008|Overall Study|Physician Decision|7|||
161669650|NCT04796896|583843123|FG009|Overall Study|Physician Decision|0|||
161669651|NCT04796896|583843124|FG010|Overall Study|Physician Decision|5|||
161669652|NCT04796896|583843125|FG011|Overall Study|Physician Decision|0|||
161669653|NCT04796896|583843114|FG000|Overall Study|Withdrawal by Subject|36|||
161669654|NCT04796896|583843115|FG001|Overall Study|Withdrawal by Subject|31|||
161669655|NCT04796896|583843116|FG002|Overall Study|Withdrawal by Subject|11|||
161669656|NCT04796896|583843117|FG003|Overall Study|Withdrawal by Subject|8|||
161669657|NCT04796896|583843118|FG004|Overall Study|Withdrawal by Subject|16|||
161669658|NCT04796896|583843119|FG005|Overall Study|Withdrawal by Subject|162|||
161669659|NCT04796896|583843120|FG006|Overall Study|Withdrawal by Subject|299|||
161669660|NCT04796896|583843121|FG007|Overall Study|Withdrawal by Subject|149|||
161669661|NCT04796896|583843122|FG008|Overall Study|Withdrawal by Subject|303|||
161669662|NCT04796896|583843123|FG009|Overall Study|Withdrawal by Subject|94|||
161669663|NCT04796896|583843124|FG010|Overall Study|Withdrawal by Subject|192|||
161669664|NCT04796896|583843125|FG011|Overall Study|Withdrawal by Subject|16|||
161669665|NCT04796896|583843114|FG000|Overall Study|Other Than Specified|6|||
161669666|NCT04796896|583843115|FG001|Overall Study|Other Than Specified|5|||
161669667|NCT04796896|583843116|FG002|Overall Study|Other Than Specified|3|||
161669668|NCT04796896|583843117|FG003|Overall Study|Other Than Specified|2|||
161669669|NCT04796896|583843118|FG004|Overall Study|Other Than Specified|6|||
161669670|NCT04796896|583843119|FG005|Overall Study|Other Than Specified|31|||
161669671|NCT04796896|583843120|FG006|Overall Study|Other Than Specified|86|||
161669672|NCT04796896|583843121|FG007|Overall Study|Other Than Specified|66|||
161669673|NCT04796896|583843122|FG008|Overall Study|Other Than Specified|388|||
161669674|NCT04796896|583843123|FG009|Overall Study|Other Than Specified|48|||
161669675|NCT04796896|583843124|FG010|Overall Study|Other Than Specified|258|||
161669676|NCT04796896|583843125|FG011|Overall Study|Other Than Specified|4|||
161669677|NCT04796896|583843114|FG000|Overall Study|Protocol Deviation|0|||
161669678|NCT04796896|583843115|FG001|Overall Study|Protocol Deviation|0|||
161669679|NCT04796896|583843116|FG002|Overall Study|Protocol Deviation|0|||
161669680|NCT04796896|583843117|FG003|Overall Study|Protocol Deviation|1|||
161669681|NCT04796896|583843118|FG004|Overall Study|Protocol Deviation|1|||
161669682|NCT04796896|583843119|FG005|Overall Study|Protocol Deviation|2|||
161669683|NCT04796896|583843120|FG006|Overall Study|Protocol Deviation|2|||
161669684|NCT04796896|583843121|FG007|Overall Study|Protocol Deviation|2|||
161669685|NCT04796896|583843122|FG008|Overall Study|Protocol Deviation|2|||
161669686|NCT04796896|583843123|FG009|Overall Study|Protocol Deviation|1|||
161921325|NCT02903914|584757199|FG006|Overall Study|Lost to Follow-up|1|||
161669687|NCT04796896|583843124|FG010|Overall Study|Protocol Deviation|0|||
161669688|NCT04796896|583843125|FG011|Overall Study|Protocol Deviation|0|||
161669689|NCT04796896|583843114|FG000|Overall Study|Missing|0|||
161669690|NCT04796896|583843115|FG001|Overall Study|Missing|0|||
161482032|NCT01854710|583160672|FG000|Overall Study|Withdrawal by Subject|2|||
161482033|NCT01854710|583160673|FG001|Overall Study|Withdrawal by Subject|1|||
161482034|NCT01854710|583160674|FG002|Overall Study|Withdrawal by Subject|0|||
161482035|NCT01854710|583160675|FG003|Overall Study|Withdrawal by Subject|0|||
161482036|NCT01854710|583160676|FG004|Overall Study|Withdrawal by Subject|0|||
161482037|NCT01854710|583160677|FG005|Overall Study|Withdrawal by Subject|0|||
161482038|NCT01854710|583160672|FG000|Overall Study|CRI procedural error|2|||
161482039|NCT01854710|583160673|FG001|Overall Study|CRI procedural error|2|||
161482040|NCT01854710|583160674|FG002|Overall Study|CRI procedural error|2|||
161482041|NCT01854710|583160675|FG003|Overall Study|CRI procedural error|2|||
161482042|NCT01854710|583160676|FG004|Overall Study|CRI procedural error|2|||
161482043|NCT01854710|583160677|FG005|Overall Study|CRI procedural error|2|||
161482044|NCT03132220|583160682|FG000|Overall Study|Lost to Follow-up|17|||
161580236|NCT02549170|583513865|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161580237|NCT02549170|583513866|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161580238|NCT02549170|583513867|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161580239|NCT02988817|583513868|FG000|Overall Study|Withdrawal by Subject|1|||
161580240|NCT02988817|583513869|FG001|Overall Study|Withdrawal by Subject|0|||
161580241|NCT02988817|583513870|FG002|Overall Study|Withdrawal by Subject|0|||
161580242|NCT02988817|583513871|FG003|Overall Study|Withdrawal by Subject|1|||
161580243|NCT02988817|583513872|FG004|Overall Study|Withdrawal by Subject|3|||
161580244|NCT02988817|583513873|FG005|Overall Study|Withdrawal by Subject|1|||
161580245|NCT02988817|583513874|FG006|Overall Study|Withdrawal by Subject|2|||
161580246|NCT02988817|583513875|FG007|Overall Study|Withdrawal by Subject|1|||
161580247|NCT02988817|583513876|FG008|Overall Study|Withdrawal by Subject|1|||
161580248|NCT02988817|583513877|FG009|Overall Study|Withdrawal by Subject|1|||
161580249|NCT02988817|583513878|FG010|Overall Study|Withdrawal by Subject|1|||
161580250|NCT02988817|583513879|FG011|Overall Study|Withdrawal by Subject|12|||
161580251|NCT02988817|583513880|FG012|Overall Study|Withdrawal by Subject|6|||
161580252|NCT02988817|583513881|FG013|Overall Study|Withdrawal by Subject|6|||
161580253|NCT02988817|583513882|FG014|Overall Study|Withdrawal by Subject|4|||
161580254|NCT02988817|583513883|FG015|Overall Study|Withdrawal by Subject|5|||
161580255|NCT02988817|583513884|FG016|Overall Study|Withdrawal by Subject|4|||
161580256|NCT02988817|583513885|FG017|Overall Study|Withdrawal by Subject|11|||
161580257|NCT02988817|583513886|FG018|Overall Study|Withdrawal by Subject|4|||
161580258|NCT02988817|583513887|FG019|Overall Study|Withdrawal by Subject|2|||
161580259|NCT02988817|583513868|FG000|Overall Study|Death|0|||
161580260|NCT02988817|583513869|FG001|Overall Study|Death|1|||
161580261|NCT02988817|583513870|FG002|Overall Study|Death|3|||
161580262|NCT02988817|583513871|FG003|Overall Study|Death|1|||
161580263|NCT02988817|583513872|FG004|Overall Study|Death|6|||
161580264|NCT02988817|583513873|FG005|Overall Study|Death|10|||
161580265|NCT02988817|583513874|FG006|Overall Study|Death|1|||
161580266|NCT02988817|583513875|FG007|Overall Study|Death|2|||
161580267|NCT02988817|583513876|FG008|Overall Study|Death|1|||
161580268|NCT02988817|583513877|FG009|Overall Study|Death|5|||
161580269|NCT02988817|583513878|FG010|Overall Study|Death|1|||
161580270|NCT02988817|583513879|FG011|Overall Study|Death|8|||
161580271|NCT02988817|583513880|FG012|Overall Study|Death|9|||
161816474|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816475|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816476|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816477|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
161580272|NCT02988817|583513881|FG013|Overall Study|Death|17|||
161580273|NCT02988817|583513882|FG014|Overall Study|Death|18|||
161921326|NCT02903914|584757200|FG007|Overall Study|Lost to Follow-up|0|||
161580274|NCT02988817|583513883|FG015|Overall Study|Death|30|||
161580275|NCT02988817|583513884|FG016|Overall Study|Death|17|||
161921327|NCT02903914|584757193|FG000|Overall Study|Physician Decision|0|||
161921328|NCT02903914|584757194|FG001|Overall Study|Physician Decision|0|||
161921329|NCT02903914|584757195|FG002|Overall Study|Physician Decision|1|||
161921330|NCT02903914|584757196|FG003|Overall Study|Physician Decision|0|||
161921331|NCT02903914|584757197|FG004|Overall Study|Physician Decision|0|||
161921332|NCT02903914|584757198|FG005|Overall Study|Physician Decision|0|||
161921333|NCT02903914|584757199|FG006|Overall Study|Physician Decision|1|||
161921334|NCT02903914|584757200|FG007|Overall Study|Physician Decision|0|||
161921335|NCT02903914|584757193|FG000|Overall Study|Symptomatic Deterioration|0|||
161921336|NCT02903914|584757194|FG001|Overall Study|Symptomatic Deterioration|0|||
161921337|NCT02903914|584757195|FG002|Overall Study|Symptomatic Deterioration|1|||
161921338|NCT02903914|584757196|FG003|Overall Study|Symptomatic Deterioration|0|||
161921339|NCT02903914|584757197|FG004|Overall Study|Symptomatic Deterioration|0|||
161921340|NCT02903914|584757198|FG005|Overall Study|Symptomatic Deterioration|0|||
161921341|NCT02903914|584757199|FG006|Overall Study|Symptomatic Deterioration|0|||
161921342|NCT02903914|584757200|FG007|Overall Study|Symptomatic Deterioration|0|||
161921343|NCT02903914|584757193|FG000|Overall Study|New Cancer Therapy|2|||
161921344|NCT02903914|584757194|FG001|Overall Study|New Cancer Therapy|2|||
161482045|NCT03132220|583160683|FG001|Overall Study|Lost to Follow-up|8|||
161482046|NCT03132220|583160682|FG000|Overall Study|Withdrawal by Subject|1|||
161482047|NCT03132220|583160683|FG001|Overall Study|Withdrawal by Subject|4|||
161482048|NCT00601458|583160685|FG000|Overall Study|Dosing Error|1|||
161482049|NCT00601458|583160686|FG001|Overall Study|Dosing Error|0|||
161482050|NCT00601458|583160687|FG002|Overall Study|Dosing Error|0|||
161482051|NCT00601458|583160685|FG000|Overall Study|Incomplete Data|0|||
161482052|NCT00601458|583160686|FG001|Overall Study|Incomplete Data|2|||
161482053|NCT00601458|583160687|FG002|Overall Study|Incomplete Data|0|||
161482054|NCT00601458|583160685|FG000|Overall Study|Protocol Violation|3|||
161482055|NCT00601458|583160686|FG001|Overall Study|Protocol Violation|2|||
161482056|NCT00601458|583160687|FG002|Overall Study|Protocol Violation|1|||
161482057|NCT00601458|583160685|FG000|Overall Study|Early Termination|0|||
161482058|NCT00601458|583160686|FG001|Overall Study|Early Termination|1|||
161482059|NCT00601458|583160687|FG002|Overall Study|Early Termination|1|||
161482060|NCT00518986|583160688|FG000|Overall Study|Adverse Event|12|||
161482061|NCT00518986|583160689|FG001|Overall Study|Adverse Event|7|||
161482062|NCT00518986|583160688|FG000|Overall Study|Lack of Efficacy|0|||
161482063|NCT00518986|583160689|FG001|Overall Study|Lack of Efficacy|2|||
161482064|NCT00518986|583160688|FG000|Overall Study|Lost to Follow-up|3|||
161482065|NCT00518986|583160689|FG001|Overall Study|Lost to Follow-up|2|||
161482066|NCT00518986|583160688|FG000|Overall Study|Physician Decision|0|||
161482067|NCT00518986|583160689|FG001|Overall Study|Physician Decision|3|||
161482068|NCT00518986|583160688|FG000|Overall Study|Protocol Violation|5|||
161482069|NCT00518986|583160689|FG001|Overall Study|Protocol Violation|7|||
161482070|NCT00518986|583160688|FG000|Overall Study|Withdrawal by Subject|4|||
161482071|NCT00518986|583160689|FG001|Overall Study|Withdrawal by Subject|4|||
161482072|NCT00518986|583160688|FG000|Overall Study|Non-Specific|2|||
161482073|NCT00518986|583160689|FG001|Overall Study|Non-Specific|1|||
161482074|NCT04862585|583160692|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
161482075|NCT04862585|583160693|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
161482076|NCT04862585|583160692|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
161482077|NCT04862585|583160693|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
161482078|NCT04862585|583160692|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
161482079|NCT04862585|583160693|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
161482080|NCT04862585|583160692|FG000|Overall Study|one withdrew without providing a reason|0|||
161482081|NCT04862585|583160693|FG001|Overall Study|one withdrew without providing a reason|1|||
161482082|NCT02099708|583160695|FG000|Overall Study|Data Not Available|30|||
161482083|NCT02099708|583160695|FG000|Overall Study|Lost to Follow-up|141|||
161482084|NCT02099708|583160695|FG000|Overall Study|Other|29|||
161482085|NCT05229406|583160696|FG000|Overall Study|Withdrawal by Subject|1|||
161482086|NCT05229406|583160697|FG001|Overall Study|Withdrawal by Subject|2|||
161482087|NCT01930123|583160698|FG000|Overall Study|Adverse Event|1|||
161482088|NCT01930123|583160699|FG001|Overall Study|Adverse Event|0|||
161482089|NCT01930123|583160698|FG000|Overall Study|Physician Decision|21|||
161921345|NCT02903914|584757195|FG002|Overall Study|New Cancer Therapy|21|||
161921346|NCT02903914|584757196|FG003|Overall Study|New Cancer Therapy|4|||
161921347|NCT02903914|584757197|FG004|Overall Study|New Cancer Therapy|3|||
161921348|NCT02903914|584757198|FG005|Overall Study|New Cancer Therapy|6|||
161921349|NCT02903914|584757199|FG006|Overall Study|New Cancer Therapy|56|||
161921350|NCT02903914|584757200|FG007|Overall Study|New Cancer Therapy|3|||
161921351|NCT02903914|584757193|FG000|Overall Study|Didn't Return to Site|1|||
161482090|NCT01930123|583160699|FG001|Overall Study|Physician Decision|8|||
161482091|NCT01930123|583160698|FG000|Overall Study|Withdrawal by Subject|1|||
161482092|NCT01930123|583160699|FG001|Overall Study|Withdrawal by Subject|0|||
161482093|NCT03310021|583160702|FG000|Overall Study|Withdrawal by Subject|0|||
161482094|NCT03310021|583160703|FG001|Overall Study|Withdrawal by Subject|0|||
161921352|NCT02903914|584757194|FG001|Overall Study|Didn't Return to Site|0|||
161921353|NCT02903914|584757195|FG002|Overall Study|Didn't Return to Site|1|||
161921354|NCT02903914|584757196|FG003|Overall Study|Didn't Return to Site|1|||
161921355|NCT02903914|584757197|FG004|Overall Study|Didn't Return to Site|0|||
161921356|NCT02903914|584757198|FG005|Overall Study|Didn't Return to Site|0|||
161921357|NCT02903914|584757199|FG006|Overall Study|Didn't Return to Site|2|||
161921358|NCT02903914|584757200|FG007|Overall Study|Didn't Return to Site|0|||
161921359|NCT02903914|584757193|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
161921360|NCT02903914|584757194|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
161921361|NCT02903914|584757195|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
161921362|NCT02903914|584757196|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
161482095|NCT03310021|583160704|FG002|Overall Study|Withdrawal by Subject|0|||
161482096|NCT03310021|583160705|FG003|Overall Study|Withdrawal by Subject|0|||
161482097|NCT03310021|583160706|FG004|Overall Study|Withdrawal by Subject|0|||
161921363|NCT02903914|584757197|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
161921364|NCT02903914|584757198|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
161921365|NCT02903914|584757199|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
161482098|NCT03310021|583160707|FG005|Overall Study|Withdrawal by Subject|0|||
161482099|NCT03310021|583160708|FG006|Overall Study|Withdrawal by Subject|1|||
161482100|NCT03310021|583160709|FG007|Overall Study|Withdrawal by Subject|0|||
161482101|NCT03310021|583160710|FG008|Overall Study|Withdrawal by Subject|0|||
161482102|NCT03310021|583160711|FG009|Overall Study|Withdrawal by Subject|0|||
161482103|NCT03310021|583160712|FG010|Overall Study|Withdrawal by Subject|0|||
161482104|NCT03310021|583160713|FG011|Overall Study|Withdrawal by Subject|0|||
161482105|NCT03310021|583160714|FG012|Overall Study|Withdrawal by Subject|0|||
161482106|NCT03310021|583160715|FG013|Overall Study|Withdrawal by Subject|0|||
161482107|NCT03310021|583160716|FG014|Overall Study|Withdrawal by Subject|0|||
161482108|NCT03310021|583160717|FG015|Overall Study|Withdrawal by Subject|0|||
161482109|NCT03310021|583160718|FG016|Overall Study|Withdrawal by Subject|0|||
161482110|NCT03310021|583160719|FG017|Overall Study|Withdrawal by Subject|0|||
161482111|NCT03310021|583160720|FG018|Overall Study|Withdrawal by Subject|0|||
161482112|NCT03310021|583160721|FG019|Overall Study|Withdrawal by Subject|0|||
161482113|NCT03310021|583160702|FG000|Overall Study|Lost to Follow-up|0|||
161482114|NCT03310021|583160703|FG001|Overall Study|Lost to Follow-up|0|||
161482115|NCT03310021|583160704|FG002|Overall Study|Lost to Follow-up|0|||
161482116|NCT03310021|583160705|FG003|Overall Study|Lost to Follow-up|0|||
161482117|NCT03310021|583160706|FG004|Overall Study|Lost to Follow-up|0|||
161482118|NCT03310021|583160707|FG005|Overall Study|Lost to Follow-up|0|||
161482119|NCT03310021|583160708|FG006|Overall Study|Lost to Follow-up|0|||
161482120|NCT03310021|583160709|FG007|Overall Study|Lost to Follow-up|0|||
161482121|NCT03310021|583160710|FG008|Overall Study|Lost to Follow-up|0|||
161482122|NCT03310021|583160711|FG009|Overall Study|Lost to Follow-up|0|||
161482123|NCT03310021|583160712|FG010|Overall Study|Lost to Follow-up|1|||
161482124|NCT03310021|583160713|FG011|Overall Study|Lost to Follow-up|0|||
161482125|NCT03310021|583160714|FG012|Overall Study|Lost to Follow-up|0|||
161482126|NCT03310021|583160715|FG013|Overall Study|Lost to Follow-up|0|||
161482127|NCT03310021|583160716|FG014|Overall Study|Lost to Follow-up|0|||
161482128|NCT03310021|583160717|FG015|Overall Study|Lost to Follow-up|0|||
161482129|NCT03310021|583160718|FG016|Overall Study|Lost to Follow-up|0|||
161482130|NCT03310021|583160719|FG017|Overall Study|Lost to Follow-up|0|||
161482131|NCT03310021|583160720|FG018|Overall Study|Lost to Follow-up|0|||
161482132|NCT03310021|583160721|FG019|Overall Study|Lost to Follow-up|0|||
161482133|NCT00702923|583160724|FG000|Overall Study|Adverse Event|1|||
161482134|NCT02002091|583160725|FG000|Screening|Lost to Follow-up|10|||
161482135|NCT02002091|583160726|FG001|Screening|Lost to Follow-up|12|||
161482136|NCT02002091|583160725|FG000|Screening|Death|3|||
161482137|NCT02002091|583160726|FG001|Screening|Death|2|||
161482138|NCT03953820|583160727|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
161482139|NCT03953820|583160728|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
161482140|NCT03953820|583160729|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
161482141|NCT03953820|583160727|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
161482142|NCT03953820|583160728|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
161482143|NCT03953820|583160729|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
161482144|NCT01233258|583160732|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
161482145|NCT01233258|583160733|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
161482146|NCT01233258|583160734|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
161482147|NCT01233258|583160735|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
161482148|NCT01233258|583160736|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
161482149|NCT01233258|583160737|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
161482150|NCT01233258|583160732|FG000|First Intervention (6 Months)|Protocol Violation|0|||
161482151|NCT01233258|583160733|FG001|First Intervention (6 Months)|Protocol Violation|0|||
161580276|NCT02988817|583513885|FG017|Overall Study|Death|38|||
161580277|NCT02988817|583513886|FG018|Overall Study|Death|14|||
161580278|NCT02988817|583513887|FG019|Overall Study|Death|16|||
161580279|NCT02988817|583513868|FG000|Overall Study|Other|0|||
161580280|NCT02988817|583513869|FG001|Overall Study|Other|0|||
161580281|NCT02988817|583513870|FG002|Overall Study|Other|0|||
161580282|NCT02988817|583513871|FG003|Overall Study|Other|1|||
161580283|NCT02988817|583513872|FG004|Overall Study|Other|1|||
161580284|NCT02988817|583513873|FG005|Overall Study|Other|0|||
161580285|NCT02988817|583513874|FG006|Overall Study|Other|0|||
161482152|NCT01233258|583160734|FG002|First Intervention (6 Months)|Protocol Violation|1|||
161482153|NCT01233258|583160735|FG003|First Intervention (6 Months)|Protocol Violation|0|||
161482154|NCT01233258|583160736|FG004|First Intervention (6 Months)|Protocol Violation|0|||
161482155|NCT01233258|583160737|FG005|First Intervention (6 Months)|Protocol Violation|0|||
161482156|NCT01233258|583160732|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
161482157|NCT01233258|583160733|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
161482158|NCT01233258|583160734|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
161482159|NCT01233258|583160735|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
161580286|NCT02988817|583513875|FG007|Overall Study|Other|0|||
161669691|NCT04796896|583843116|FG002|Overall Study|Missing|0|||
161580287|NCT02988817|583513876|FG008|Overall Study|Other|0|||
161580288|NCT02988817|583513877|FG009|Overall Study|Other|0|||
161921366|NCT02903914|584757200|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
161921367|NCT02903914|584757193|FG000|Overall Study|Follow-up Did Not Occur|0|||
161921368|NCT02903914|584757194|FG001|Overall Study|Follow-up Did Not Occur|1|||
161921369|NCT02903914|584757195|FG002|Overall Study|Follow-up Did Not Occur|1|||
161921370|NCT02903914|584757196|FG003|Overall Study|Follow-up Did Not Occur|0|||
161921371|NCT02903914|584757197|FG004|Overall Study|Follow-up Did Not Occur|2|||
161921372|NCT02903914|584757198|FG005|Overall Study|Follow-up Did Not Occur|0|||
161921373|NCT02903914|584757199|FG006|Overall Study|Follow-up Did Not Occur|8|||
161921374|NCT02903914|584757200|FG007|Overall Study|Follow-up Did Not Occur|0|||
161921375|NCT02903914|584757193|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
161921376|NCT02903914|584757194|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
161921377|NCT02903914|584757195|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
161921378|NCT02903914|584757196|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
161921379|NCT02903914|584757197|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
161921380|NCT02903914|584757198|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
161921381|NCT02903914|584757199|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
161921382|NCT02903914|584757200|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
161921383|NCT02903914|584757193|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921384|NCT02903914|584757194|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921385|NCT02903914|584757195|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
161921386|NCT02903914|584757196|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921387|NCT02903914|584757197|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921388|NCT02903914|584757198|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
161921389|NCT02903914|584757199|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921390|NCT02903914|584757200|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921391|NCT02903914|584757193|FG000|Overall Study|Clinical Disease Progression|0|||
161921392|NCT02903914|584757194|FG001|Overall Study|Clinical Disease Progression|0|||
161921393|NCT02903914|584757195|FG002|Overall Study|Clinical Disease Progression|2|||
161921394|NCT02903914|584757196|FG003|Overall Study|Clinical Disease Progression|0|||
161921395|NCT02903914|584757197|FG004|Overall Study|Clinical Disease Progression|0|||
161921396|NCT02903914|584757198|FG005|Overall Study|Clinical Disease Progression|0|||
161921397|NCT02903914|584757199|FG006|Overall Study|Clinical Disease Progression|0|||
161921398|NCT02903914|584757200|FG007|Overall Study|Clinical Disease Progression|0|||
161921399|NCT02903914|584757193|FG000|Overall Study|Completed Follow-up Period|0|||
161921400|NCT02903914|584757194|FG001|Overall Study|Completed Follow-up Period|0|||
161921401|NCT02903914|584757195|FG002|Overall Study|Completed Follow-up Period|6|||
161921402|NCT02903914|584757196|FG003|Overall Study|Completed Follow-up Period|2|||
161921403|NCT02903914|584757197|FG004|Overall Study|Completed Follow-up Period|1|||
161921404|NCT02903914|584757198|FG005|Overall Study|Completed Follow-up Period|0|||
161921405|NCT02903914|584757199|FG006|Overall Study|Completed Follow-up Period|9|||
161921406|NCT02903914|584757200|FG007|Overall Study|Completed Follow-up Period|1|||
161921407|NCT02903914|584757193|FG000|Overall Study|Taken off Treatment per Protocol|0|||
161921408|NCT02903914|584757194|FG001|Overall Study|Taken off Treatment per Protocol|0|||
161921409|NCT02903914|584757195|FG002|Overall Study|Taken off Treatment per Protocol|0|||
161921410|NCT02903914|584757196|FG003|Overall Study|Taken off Treatment per Protocol|0|||
161921411|NCT02903914|584757197|FG004|Overall Study|Taken off Treatment per Protocol|0|||
161921412|NCT02903914|584757198|FG005|Overall Study|Taken off Treatment per Protocol|1|||
161580289|NCT02988817|583513878|FG010|Overall Study|Other|0|||
161580290|NCT02988817|583513879|FG011|Overall Study|Other|0|||
161580291|NCT02988817|583513880|FG012|Overall Study|Other|0|||
161580292|NCT02988817|583513881|FG013|Overall Study|Other|0|||
161580293|NCT02988817|583513882|FG014|Overall Study|Other|0|||
161921413|NCT02903914|584757199|FG006|Overall Study|Taken off Treatment per Protocol|0|||
161921414|NCT02903914|584757200|FG007|Overall Study|Taken off Treatment per Protocol|0|||
161921415|NCT02903914|584757193|FG000|Overall Study|Refused Further Treatment/Contact|0|||
161921416|NCT02903914|584757194|FG001|Overall Study|Refused Further Treatment/Contact|0|||
161921417|NCT02903914|584757195|FG002|Overall Study|Refused Further Treatment/Contact|0|||
161580294|NCT02988817|583513883|FG015|Overall Study|Other|1|||
161580295|NCT02988817|583513884|FG016|Overall Study|Other|0|||
161580296|NCT02988817|583513885|FG017|Overall Study|Other|0|||
161580297|NCT02988817|583513886|FG018|Overall Study|Other|0|||
161580298|NCT02988817|583513887|FG019|Overall Study|Other|0|||
161580299|NCT02988817|583513868|FG000|Overall Study|Lost to Follow-up|0|||
161580300|NCT02988817|583513869|FG001|Overall Study|Lost to Follow-up|0|||
161580301|NCT02988817|583513870|FG002|Overall Study|Lost to Follow-up|0|||
161580302|NCT02988817|583513871|FG003|Overall Study|Lost to Follow-up|0|||
161580303|NCT02988817|583513872|FG004|Overall Study|Lost to Follow-up|0|||
161921418|NCT02903914|584757196|FG003|Overall Study|Refused Further Treatment/Contact|0|||
161921419|NCT02903914|584757197|FG004|Overall Study|Refused Further Treatment/Contact|0|||
161921420|NCT02903914|584757198|FG005|Overall Study|Refused Further Treatment/Contact|0|||
161921421|NCT02903914|584757199|FG006|Overall Study|Refused Further Treatment/Contact|1|||
161921422|NCT02903914|584757200|FG007|Overall Study|Refused Further Treatment/Contact|0|||
161580304|NCT02988817|583513873|FG005|Overall Study|Lost to Follow-up|0|||
161580305|NCT02988817|583513874|FG006|Overall Study|Lost to Follow-up|0|||
161580306|NCT02988817|583513875|FG007|Overall Study|Lost to Follow-up|0|||
161580307|NCT02988817|583513876|FG008|Overall Study|Lost to Follow-up|1|||
161580308|NCT02988817|583513877|FG009|Overall Study|Lost to Follow-up|0|||
161580309|NCT02988817|583513878|FG010|Overall Study|Lost to Follow-up|1|||
161580310|NCT02988817|583513879|FG011|Overall Study|Lost to Follow-up|1|||
161580311|NCT02988817|583513880|FG012|Overall Study|Lost to Follow-up|0|||
161580312|NCT02988817|583513881|FG013|Overall Study|Lost to Follow-up|0|||
161580313|NCT02988817|583513882|FG014|Overall Study|Lost to Follow-up|1|||
161580314|NCT02988817|583513883|FG015|Overall Study|Lost to Follow-up|1|||
161580315|NCT02988817|583513884|FG016|Overall Study|Lost to Follow-up|2|||
161580316|NCT02988817|583513885|FG017|Overall Study|Lost to Follow-up|3|||
161580317|NCT02988817|583513886|FG018|Overall Study|Lost to Follow-up|0|||
161580318|NCT02988817|583513887|FG019|Overall Study|Lost to Follow-up|0|||
161580319|NCT02988817|583513868|FG000|Overall Study|Sponsor decision|0|||
161580320|NCT02988817|583513869|FG001|Overall Study|Sponsor decision|0|||
161580321|NCT02988817|583513870|FG002|Overall Study|Sponsor decision|0|||
161580322|NCT02988817|583513871|FG003|Overall Study|Sponsor decision|0|||
161580323|NCT02988817|583513872|FG004|Overall Study|Sponsor decision|0|||
161580324|NCT02988817|583513873|FG005|Overall Study|Sponsor decision|0|||
161580325|NCT02988817|583513874|FG006|Overall Study|Sponsor decision|0|||
161580326|NCT02988817|583513875|FG007|Overall Study|Sponsor decision|0|||
161580327|NCT02988817|583513876|FG008|Overall Study|Sponsor decision|0|||
161580328|NCT02988817|583513877|FG009|Overall Study|Sponsor decision|0|||
161921423|NCT02903914|584757193|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161580329|NCT02988817|583513878|FG010|Overall Study|Sponsor decision|0|||
161921424|NCT02903914|584757194|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921425|NCT02903914|584757195|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921426|NCT02903914|584757196|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921427|NCT02903914|584757197|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921428|NCT02903914|584757198|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921429|NCT02903914|584757199|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
161921430|NCT02903914|584757200|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921431|NCT03487445|584757204|FG000|Randomization|Not treated for administrative reasons|1|||
161921432|NCT03487445|584757205|FG001|Randomization|Not treated for administrative reasons|0|||
161921433|NCT04225039|584757208|FG000|Overall Study|Withdrawal by Subject|1|||
161921434|NCT04225039|584757209|FG001|Overall Study|Withdrawal by Subject|0|||
161921435|NCT04225039|584757210|FG002|Overall Study|Withdrawal by Subject|0|||
161921436|NCT04225039|584757211|FG003|Overall Study|Withdrawal by Subject|1|||
161921437|NCT04225039|584757208|FG000|Overall Study|Currently active on study treatment|0|||
161921438|NCT04225039|584757209|FG001|Overall Study|Currently active on study treatment|1|||
161921439|NCT04225039|584757210|FG002|Overall Study|Currently active on study treatment|0|||
161921440|NCT04225039|584757211|FG003|Overall Study|Currently active on study treatment|0|||
161921441|NCT04225039|584757208|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
161921442|NCT04225039|584757209|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161921443|NCT04225039|584757210|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161921444|NCT04225039|584757211|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161921445|NCT04225039|584757208|FG000|Overall Study|Ineligible for treatment|0|||
161921446|NCT04225039|584757209|FG001|Overall Study|Ineligible for treatment|0|||
161921447|NCT04225039|584757210|FG002|Overall Study|Ineligible for treatment|0|||
161921448|NCT04225039|584757211|FG003|Overall Study|Ineligible for treatment|4|||
161921449|NCT00975923|584757212|FG000|Overall Study|Withdrawal by Subject|0|||
161921450|NCT00975923|584757213|FG001|Overall Study|Withdrawal by Subject|1|||
161921451|NCT01964404|584757214|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
161921452|NCT01964404|584757215|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
161921453|NCT01964404|584757216|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
161921454|NCT01964404|584757217|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
161921455|NCT01964404|584757218|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
161921456|NCT01964404|584757219|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
161921457|NCT01964404|584757220|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
161921458|NCT01964404|584757221|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
161921459|NCT01964404|584757222|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
161921460|NCT01964404|584757223|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
161580330|NCT02988817|583513879|FG011|Overall Study|Sponsor decision|1|||
161580331|NCT02988817|583513880|FG012|Overall Study|Sponsor decision|1|||
161580332|NCT02988817|583513881|FG013|Overall Study|Sponsor decision|2|||
161580333|NCT02988817|583513882|FG014|Overall Study|Sponsor decision|2|||
161580334|NCT02988817|583513883|FG015|Overall Study|Sponsor decision|6|||
161580335|NCT02988817|583513884|FG016|Overall Study|Sponsor decision|2|||
161580336|NCT02988817|583513885|FG017|Overall Study|Sponsor decision|3|||
161580337|NCT02988817|583513886|FG018|Overall Study|Sponsor decision|2|||
161921461|NCT01964404|584757214|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
161921462|NCT01964404|584757215|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
161482160|NCT01233258|583160736|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
161482161|NCT01233258|583160737|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
161482162|NCT00530946|583160741|FG000|Overall Study|Adverse Event|1|||
161482163|NCT00530946|583160742|FG001|Overall Study|Adverse Event|2|||
161482164|NCT00530946|583160743|FG002|Overall Study|Adverse Event|1|||
161482165|NCT00530946|583160744|FG003|Overall Study|Adverse Event|1|||
161482166|NCT00530946|583160741|FG000|Overall Study|Protocol Violation|0|||
161482167|NCT00530946|583160742|FG001|Overall Study|Protocol Violation|0|||
161482168|NCT00530946|583160743|FG002|Overall Study|Protocol Violation|0|||
161482169|NCT00530946|583160744|FG003|Overall Study|Protocol Violation|1|||
161482170|NCT00530946|583160741|FG000|Overall Study|Noncompliance|1|||
161482171|NCT00530946|583160742|FG001|Overall Study|Noncompliance|0|||
161482172|NCT00530946|583160743|FG002|Overall Study|Noncompliance|0|||
161482173|NCT00530946|583160744|FG003|Overall Study|Noncompliance|0|||
161482174|NCT01534962|583160745|FG000|Overall Study|Randomized but did not start treatment|2|||
161482175|NCT01534962|583160746|FG001|Overall Study|Randomized but did not start treatment|0|||
161482176|NCT01534962|583160747|FG002|Overall Study|Randomized but did not start treatment|0|||
161482177|NCT01534962|583160748|FG003|Overall Study|Randomized but did not start treatment|1|||
161482178|NCT01534962|583160745|FG000|Overall Study|Discontinued at AF recurrence|35|||
161482179|NCT01534962|583160746|FG001|Overall Study|Discontinued at AF recurrence|26|||
161482180|NCT01534962|583160747|FG002|Overall Study|Discontinued at AF recurrence|24|||
161482181|NCT01534962|583160748|FG003|Overall Study|Discontinued at AF recurrence|31|||
161482182|NCT00880009|583160753|FG000|Overall Study|Study terminated by sponsor|14|||
161482183|NCT00880009|583160753|FG000|Overall Study|Withdrawal by Subject|1|||
161482184|NCT00880009|583160753|FG000|Overall Study|Protocol Violation|1|||
161482185|NCT04545385|583160754|FG000|Overall Study|Withdrawal by Subject|2|||
161482186|NCT04545385|583160755|FG001|Overall Study|Withdrawal by Subject|0|||
161482187|NCT04545385|583160754|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
161482188|NCT04545385|583160755|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
161482189|NCT04545385|583160754|FG000|Overall Study|Study termination|10|||
161482190|NCT04545385|583160755|FG001|Overall Study|Study termination|10|||
161482191|NCT04545385|583160754|FG000|Overall Study|Sponsor decision|2|||
161482192|NCT04545385|583160755|FG001|Overall Study|Sponsor decision|2|||
161482193|NCT04545385|583160754|FG000|Overall Study|Other than specified|1|||
161482194|NCT04545385|583160755|FG001|Overall Study|Other than specified|0|||
161482195|NCT01128842|583160760|FG000|Overall Study|Adverse Event|1|||
161482196|NCT01128842|583160760|FG000|Overall Study|Disease Progression|6|||
161482197|NCT03322631|583160761|FG000|Overall Study|Withdrawal by Subject|0|||
161482198|NCT03322631|583160762|FG001|Overall Study|Withdrawal by Subject|1|||
161482199|NCT03322631|583160763|FG002|Overall Study|Withdrawal by Subject|0|||
161482200|NCT03322631|583160764|FG003|Overall Study|Withdrawal by Subject|0|||
161482201|NCT03322631|583160761|FG000|Overall Study|Adverse Event|0|||
161482202|NCT03322631|583160762|FG001|Overall Study|Adverse Event|0|||
161482203|NCT03322631|583160763|FG002|Overall Study|Adverse Event|1|||
161482204|NCT03322631|583160764|FG003|Overall Study|Adverse Event|0|||
161482205|NCT02378961|583160765|FG000|Overall Study|Lack of Efficacy|4|||
161482206|NCT02378961|583160766|FG001|Overall Study|Lack of Efficacy|2|||
161482207|NCT02378961|583160767|FG002|Overall Study|Lack of Efficacy|0|||
161816478|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816479|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816480|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816481|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816482|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816483|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816484|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816485|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816486|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816487|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816488|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816489|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816490|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816491|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816492|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816493|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816494|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816495|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816496|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816497|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816498|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
161816499|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816500|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816501|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816502|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
161482208|NCT02378961|583160768|FG003|Overall Study|Lack of Efficacy|1|||
161921463|NCT01964404|584757216|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161921464|NCT01964404|584757217|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161921465|NCT01964404|584757218|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921466|NCT01964404|584757219|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921467|NCT01964404|584757220|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921468|NCT01964404|584757221|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921469|NCT01964404|584757222|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921470|NCT01964404|584757223|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921471|NCT01964404|584757214|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161921472|NCT01964404|584757215|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
161921473|NCT01964404|584757216|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921474|NCT01964404|584757217|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
161921475|NCT01964404|584757218|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921476|NCT01964404|584757219|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921477|NCT01964404|584757220|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921478|NCT01964404|584757221|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161669692|NCT04796896|583843117|FG003|Overall Study|Missing|0|||
161669693|NCT04796896|583843118|FG004|Overall Study|Missing|0|||
161669694|NCT04796896|583843119|FG005|Overall Study|Missing|0|||
161669695|NCT04796896|583843120|FG006|Overall Study|Missing|2|||
161669696|NCT04796896|583843121|FG007|Overall Study|Missing|1|||
161669697|NCT04796896|583843122|FG008|Overall Study|Missing|2|||
161669698|NCT04796896|583843123|FG009|Overall Study|Missing|1|||
161669699|NCT04796896|583843124|FG010|Overall Study|Missing|1|||
161669700|NCT04796896|583843125|FG011|Overall Study|Missing|0|||
161669701|NCT04796896|583843114|FG000|Overall Study|Death|0|||
161669702|NCT04796896|583843115|FG001|Overall Study|Death|0|||
161669703|NCT04796896|583843116|FG002|Overall Study|Death|0|||
161669704|NCT04796896|583843117|FG003|Overall Study|Death|0|||
161669705|NCT04796896|583843118|FG004|Overall Study|Death|0|||
161669706|NCT04796896|583843119|FG005|Overall Study|Death|0|||
161669707|NCT04796896|583843120|FG006|Overall Study|Death|0|||
161669708|NCT04796896|583843121|FG007|Overall Study|Death|0|||
161669709|NCT04796896|583843122|FG008|Overall Study|Death|1|||
161669710|NCT04796896|583843123|FG009|Overall Study|Death|0|||
161669711|NCT04796896|583843124|FG010|Overall Study|Death|0|||
161921479|NCT01964404|584757222|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921480|NCT01964404|584757223|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921481|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
161669712|NCT04796896|583843125|FG011|Overall Study|Death|0|||
161669713|NCT02021292|583843126|FG000|Overall Study|Physician Decision|0|||
161669714|NCT02021292|583843127|FG001|Overall Study|Physician Decision|1|||
161669715|NCT02021292|583843126|FG000|Overall Study|Lost to Follow-up|0|||
161669716|NCT02021292|583843127|FG001|Overall Study|Lost to Follow-up|1|||
161669717|NCT02021292|583843126|FG000|Overall Study|Death|0|||
161669718|NCT02021292|583843127|FG001|Overall Study|Death|1|||
161669719|NCT04356183|583843128|FG000|Overall Study|Lost to Follow-up|1|||
161669720|NCT04356183|583843129|FG001|Overall Study|Lost to Follow-up|0|||
161669721|NCT04356183|583843128|FG000|Overall Study|Withdrawal by Subject|1|||
161669722|NCT04356183|583843129|FG001|Overall Study|Withdrawal by Subject|1|||
161669723|NCT05972733|583843132|FG000|Overall Study|Lost to Follow-up|2|||
161669724|NCT05972733|583843132|FG000|Overall Study|Withdrawal by Subject|1|||
161669725|NCT01177787|583843133|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
161669726|NCT01177787|583843133|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
161669727|NCT01177787|583843133|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
161669728|NCT01637623|583843134|FG000|Overall Study|Lost to Follow-up|0|||
161669729|NCT01637623|583843135|FG001|Overall Study|Lost to Follow-up|0|||
161669730|NCT01637623|583843136|FG002|Overall Study|Lost to Follow-up|2|||
161669731|NCT01637623|583843134|FG000|Overall Study|Physician Decision|1|||
161669732|NCT01637623|583843135|FG001|Overall Study|Physician Decision|0|||
161669733|NCT01637623|583843136|FG002|Overall Study|Physician Decision|1|||
161669734|NCT02824263|583843141|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
161669735|NCT02824263|583843142|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
161669736|NCT02824263|583843141|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
161669737|NCT02824263|583843142|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
161669738|NCT00568321|583843143|FG000|Overall Study|Adverse Event|1|||
161669739|NCT00568321|583843144|FG001|Overall Study|Adverse Event|0|||
161921482|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
161921483|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
161921484|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
161921485|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
161921486|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
161482209|NCT02378961|583160765|FG000|Overall Study|Death|0|||
161482210|NCT02378961|583160766|FG001|Overall Study|Death|0|||
161482211|NCT02378961|583160767|FG002|Overall Study|Death|1|||
161669740|NCT00568321|583843145|FG002|Overall Study|Adverse Event|0|||
161669741|NCT00568321|583843143|FG000|Overall Study|Lack of Efficacy|8|||
161669742|NCT00568321|583843144|FG001|Overall Study|Lack of Efficacy|5|||
161669743|NCT00568321|583843145|FG002|Overall Study|Lack of Efficacy|6|||
161669744|NCT00568321|583843143|FG000|Overall Study|Lost to Follow-up|0|||
161669745|NCT00568321|583843144|FG001|Overall Study|Lost to Follow-up|0|||
161669746|NCT00568321|583843145|FG002|Overall Study|Lost to Follow-up|1|||
161669747|NCT00568321|583843143|FG000|Overall Study|Withdrawal by Subject|2|||
161669748|NCT00568321|583843144|FG001|Overall Study|Withdrawal by Subject|0|||
161669749|NCT00568321|583843145|FG002|Overall Study|Withdrawal by Subject|0|||
161669750|NCT00568321|583843143|FG000|Overall Study|Protocol Violation|0|||
161669751|NCT00568321|583843144|FG001|Overall Study|Protocol Violation|0|||
161669752|NCT00568321|583843145|FG002|Overall Study|Protocol Violation|1|||
161669753|NCT00568321|583843143|FG000|Overall Study|Randomized, not treated|2|||
161921487|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
161669754|NCT00568321|583843144|FG001|Overall Study|Randomized, not treated|0|||
161669755|NCT00568321|583843145|FG002|Overall Study|Randomized, not treated|1|||
161669756|NCT01676909|583843147|FG000|Overall Study|Withdrawal by Subject|3|||
161669757|NCT01676909|583843148|FG001|Overall Study|Withdrawal by Subject|5|||
161669758|NCT01676909|583843147|FG000|Overall Study|Lost to Follow-up|15|||
161669759|NCT01676909|583843148|FG001|Overall Study|Lost to Follow-up|9|||
161669760|NCT04615247|583843149|FG000|Overall Study|Adverse Event|0|||
161669761|NCT04615247|583843150|FG001|Overall Study|Adverse Event|2|||
161669762|NCT04615247|583843149|FG000|Overall Study|Withdrawal by Subject|1|||
161669763|NCT04615247|583843150|FG001|Overall Study|Withdrawal by Subject|1|||
161669764|NCT00823901|583843153|FG000|Overall Study|Adverse Event|1|||
161669765|NCT00823901|583843154|FG001|Overall Study|Adverse Event|1|||
161669766|NCT00823901|583843153|FG000|Overall Study|Lack of Efficacy|1|||
161669767|NCT00823901|583843154|FG001|Overall Study|Lack of Efficacy|0|||
161669768|NCT00823901|583843153|FG000|Overall Study|Lost to Follow-up|2|||
161669769|NCT00823901|583843154|FG001|Overall Study|Lost to Follow-up|1|||
161669770|NCT01369511|583843155|FG000|Overall Study|Adverse Event|1|||
161669771|NCT01369511|583843156|FG001|Overall Study|Adverse Event|1|||
161669772|NCT01369511|583843157|FG002|Overall Study|Adverse Event|5|||
161669773|NCT01369511|583843158|FG003|Overall Study|Adverse Event|0|||
161669774|NCT01369511|583843155|FG000|Overall Study|Entry criteria not met|2|||
161669775|NCT01369511|583843156|FG001|Overall Study|Entry criteria not met|0|||
161669776|NCT01369511|583843157|FG002|Overall Study|Entry criteria not met|0|||
161669777|NCT01369511|583843158|FG003|Overall Study|Entry criteria not met|1|||
161669778|NCT01369511|583843155|FG000|Overall Study|Lost to Follow-up|0|||
161669779|NCT01369511|583843156|FG001|Overall Study|Lost to Follow-up|1|||
161669780|NCT01369511|583843157|FG002|Overall Study|Lost to Follow-up|1|||
161669781|NCT01369511|583843158|FG003|Overall Study|Lost to Follow-up|2|||
161669782|NCT01369511|583843155|FG000|Overall Study|Protocol Violation|0|||
161669783|NCT01369511|583843156|FG001|Overall Study|Protocol Violation|1|||
161669784|NCT01369511|583843157|FG002|Overall Study|Protocol Violation|0|||
161669785|NCT01369511|583843158|FG003|Overall Study|Protocol Violation|2|||
161669786|NCT01369511|583843155|FG000|Overall Study|Physician Decision|3|||
161669787|NCT01369511|583843156|FG001|Overall Study|Physician Decision|4|||
161669788|NCT01369511|583843157|FG002|Overall Study|Physician Decision|0|||
161669789|NCT01369511|583843158|FG003|Overall Study|Physician Decision|0|||
161669790|NCT01369511|583843155|FG000|Overall Study|Sponsor decision|2|||
161669791|NCT01369511|583843156|FG001|Overall Study|Sponsor decision|0|||
161669792|NCT01369511|583843157|FG002|Overall Study|Sponsor decision|1|||
161669793|NCT01369511|583843158|FG003|Overall Study|Sponsor decision|0|||
161669794|NCT01369511|583843155|FG000|Overall Study|Withdrawal by Subject|5|||
161669795|NCT01369511|583843156|FG001|Overall Study|Withdrawal by Subject|6|||
161669796|NCT01369511|583843157|FG002|Overall Study|Withdrawal by Subject|4|||
161669797|NCT01369511|583843158|FG003|Overall Study|Withdrawal by Subject|6|||
161669798|NCT01376349|583843159|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
161669799|NCT01376349|583843160|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
161669800|NCT01376349|583843161|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
161669801|NCT01376349|583843159|FG000|Raondomized Treatment|Adverse Event|13|||
161669802|NCT01376349|583843160|FG001|Raondomized Treatment|Adverse Event|17|||
161669803|NCT01376349|583843161|FG002|Raondomized Treatment|Adverse Event|14|||
161669804|NCT01376349|583843159|FG000|Raondomized Treatment|Unkown|1|||
161669805|NCT01376349|583843160|FG001|Raondomized Treatment|Unkown|2|||
161669806|NCT01376349|583843161|FG002|Raondomized Treatment|Unkown|1|||
161669807|NCT01376349|583843159|FG000|Raondomized Treatment|Alternative Treatment|0|||
161669808|NCT01376349|583843160|FG001|Raondomized Treatment|Alternative Treatment|0|||
161669809|NCT01376349|583843161|FG002|Raondomized Treatment|Alternative Treatment|1|||
161669810|NCT00718640|583843162|FG000|Overall Study|Adverse Event|4|||
161669811|NCT00718640|583843162|FG000|Overall Study|Death|1|||
161921488|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
161921489|NCT00325416|584757226|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
161921490|NCT00325416|584757227|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
161921491|NCT00325416|584757226|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
161921492|NCT00325416|584757227|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
161921493|NCT06239610|584757228|FG000|Overall Study|no usable migration data for minimum of one day|11|||
161669812|NCT00718640|583843162|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
161669813|NCT00818389|583843163|FG000|Overall Study|Death|1|||
161669814|NCT00818389|583843164|FG001|Overall Study|Death|3|||
161669815|NCT00818389|583843163|FG000|Overall Study|ALS Disease Progression|1|||
161921494|NCT02830087|584757231|FG000|Overall Study|No study staff to follow-up patients|4|||
161921495|NCT02830087|584757232|FG001|Overall Study|No study staff to follow-up patients|4|||
161669816|NCT00818389|583843164|FG001|Overall Study|ALS Disease Progression|0|||
161669817|NCT00818389|583843163|FG000|Overall Study|Withdrawal by Subject|2|||
161669818|NCT00818389|583843164|FG001|Overall Study|Withdrawal by Subject|2|||
161669819|NCT00818389|583843163|FG000|Overall Study|Adverse Event|0|||
161669820|NCT00818389|583843164|FG001|Overall Study|Adverse Event|1|||
161669821|NCT05193500|583843167|FG000|Overall Study|Withdrawal by Subject|7|||
161669822|NCT05193500|583843168|FG001|Overall Study|Withdrawal by Subject|4|||
161482212|NCT02378961|583160768|FG003|Overall Study|Death|0|||
161482213|NCT05399641|583160776|FG000|Overall Study|Adverse Event|0|||
161482214|NCT05399641|583160777|FG001|Overall Study|Adverse Event|1|||
161482215|NCT05399641|583160778|FG002|Overall Study|Adverse Event|1|||
161482216|NCT05399641|583160776|FG000|Overall Study|Lost to Follow-up|1|||
161482217|NCT05399641|583160777|FG001|Overall Study|Lost to Follow-up|2|||
161482218|NCT05399641|583160778|FG002|Overall Study|Lost to Follow-up|2|||
161482219|NCT05399641|583160776|FG000|Overall Study|Physician Decision|1|||
161482220|NCT05399641|583160777|FG001|Overall Study|Physician Decision|3|||
161482221|NCT05399641|583160778|FG002|Overall Study|Physician Decision|3|||
161482222|NCT05399641|583160776|FG000|Overall Study|Withdrawal by Subject|4|||
161482223|NCT05399641|583160777|FG001|Overall Study|Withdrawal by Subject|11|||
161482224|NCT05399641|583160778|FG002|Overall Study|Withdrawal by Subject|7|||
161482225|NCT05399641|583160776|FG000|Overall Study|Reason not defined|3|||
161482226|NCT05399641|583160777|FG001|Overall Study|Reason not defined|5|||
161482227|NCT05399641|583160778|FG002|Overall Study|Reason not defined|6|||
161482228|NCT01300650|583160779|FG000|Overall Study|Adverse Event|1|||
161482229|NCT03943147|583160780|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
161482230|NCT03943147|583160781|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
161482231|NCT03943147|583160780|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
161482232|NCT03943147|583160781|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
161482233|NCT03943147|583160780|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
161482234|NCT03943147|583160781|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
161482235|NCT03943147|583160780|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
161482236|NCT03943147|583160781|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
161482237|NCT03943147|583160780|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
161482238|NCT03943147|583160781|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
161482239|NCT03943147|583160780|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
161482240|NCT03943147|583160781|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
161482241|NCT01318993|583160782|FG000|Overall Study|Adverse Event|53|||
161482242|NCT01318993|583160782|FG000|Overall Study|Lack of Efficacy|121|||
161482243|NCT01318993|583160782|FG000|Overall Study|Protocol Violation|3|||
161482244|NCT01318993|583160782|FG000|Overall Study|Protocol based stopping criteria|6|||
161482245|NCT01318993|583160782|FG000|Overall Study|Study closed or terminated|174|||
161482246|NCT01318993|583160782|FG000|Overall Study|Lost to Follow-up|4|||
161482247|NCT01318993|583160782|FG000|Overall Study|Physician Decision|13|||
161482248|NCT01318993|583160782|FG000|Overall Study|Withdrawal by Subject|24|||
161482249|NCT03736447|583160786|FG000|Overall Study|Adverse Event|5|||
161482250|NCT03736447|583160787|FG001|Overall Study|Adverse Event|1|||
161482251|NCT03736447|583160786|FG000|Overall Study|Withdrawal by Subject|5|||
161482252|NCT03736447|583160787|FG001|Overall Study|Withdrawal by Subject|1|||
161482253|NCT03736447|583160786|FG000|Overall Study|Lost to Follow-up|1|||
161482254|NCT03736447|583160787|FG001|Overall Study|Lost to Follow-up|0|||
161482255|NCT03736447|583160786|FG000|Overall Study|Physician Decision|1|||
161482256|NCT03736447|583160787|FG001|Overall Study|Physician Decision|0|||
161482257|NCT03736447|583160786|FG000|Overall Study|Continued commitment to study treatment|3|||
161482258|NCT03736447|583160787|FG001|Overall Study|Continued commitment to study treatment|0|||
161482259|NCT03736447|583160786|FG000|Overall Study|Taste aversion to study product|0|||
161482260|NCT03736447|583160787|FG001|Overall Study|Taste aversion to study product|1|||
161482261|NCT02619175|583160789|FG000|Overall Study|Withdrawal by Subject|1|||
161482262|NCT02619175|583160790|FG001|Overall Study|Withdrawal by Subject|0|||
161482263|NCT02619175|583160789|FG000|Overall Study|foot pain|1|||
161482264|NCT02619175|583160790|FG001|Overall Study|foot pain|0|||
161482265|NCT02795832|583160794|FG000|Overall Study|Adverse Event|0|||
161482266|NCT02795832|583160795|FG001|Overall Study|Adverse Event|0|||
161482267|NCT02795832|583160796|FG002|Overall Study|Adverse Event|0|||
161482268|NCT02795832|583160797|FG003|Overall Study|Adverse Event|0|||
161482269|NCT02795832|583160798|FG004|Overall Study|Adverse Event|0|||
161482270|NCT02795832|583160799|FG005|Overall Study|Adverse Event|3|||
161482271|NCT02695329|583160800|FG000|Overall Study|Adverse Event|1|||
161482272|NCT02695329|583160801|FG001|Overall Study|Adverse Event|0|||
161580338|NCT02988817|583513887|FG019|Overall Study|Sponsor decision|7|||
161580339|NCT02988817|583513868|FG000|Overall Study|Physician Decision|0|||
161580340|NCT02988817|583513869|FG001|Overall Study|Physician Decision|0|||
161580341|NCT02988817|583513870|FG002|Overall Study|Physician Decision|0|||
161482273|NCT02695329|583160800|FG000|Overall Study|Poor X-ray quality for measurement|4|||
161482274|NCT02695329|583160801|FG001|Overall Study|Poor X-ray quality for measurement|5|||
161482275|NCT01382212|583160802|FG000|Overall Study|Kidney transplant|1|||
161482276|NCT01382212|583160802|FG000|Overall Study|Withdrew consent|1|||
161482277|NCT01846416|583160804|FG000|Treatment Phase|Death|2|||
161482278|NCT01846416|583160805|FG001|Treatment Phase|Death|9|||
161482279|NCT01846416|583160806|FG002|Treatment Phase|Death|1|||
161482280|NCT01846416|583160804|FG000|Treatment Phase|Withdrawal by Subject|2|||
161482281|NCT01846416|583160805|FG001|Treatment Phase|Withdrawal by Subject|4|||
161482282|NCT01846416|583160806|FG002|Treatment Phase|Withdrawal by Subject|2|||
161580342|NCT02988817|583513871|FG003|Overall Study|Physician Decision|0|||
161482283|NCT01846416|583160804|FG000|Treatment Phase|Other|1|||
161482284|NCT01846416|583160805|FG001|Treatment Phase|Other|5|||
161482285|NCT01846416|583160806|FG002|Treatment Phase|Other|1|||
161482286|NCT01846416|583160804|FG000|Treatment Phase|Physician Decision|1|||
161580343|NCT02988817|583513872|FG004|Overall Study|Physician Decision|0|||
161580344|NCT02988817|583513873|FG005|Overall Study|Physician Decision|0|||
161580345|NCT02988817|583513874|FG006|Overall Study|Physician Decision|0|||
161580346|NCT02988817|583513875|FG007|Overall Study|Physician Decision|0|||
161580347|NCT02988817|583513876|FG008|Overall Study|Physician Decision|0|||
161580348|NCT02988817|583513877|FG009|Overall Study|Physician Decision|0|||
161580349|NCT02988817|583513878|FG010|Overall Study|Physician Decision|0|||
161580350|NCT02988817|583513879|FG011|Overall Study|Physician Decision|0|||
161580351|NCT02988817|583513880|FG012|Overall Study|Physician Decision|0|||
161580352|NCT02988817|583513881|FG013|Overall Study|Physician Decision|0|||
161580353|NCT02988817|583513882|FG014|Overall Study|Physician Decision|0|||
161580354|NCT02988817|583513883|FG015|Overall Study|Physician Decision|1|||
161580355|NCT02988817|583513884|FG016|Overall Study|Physician Decision|0|||
161580356|NCT02988817|583513885|FG017|Overall Study|Physician Decision|0|||
161580357|NCT02988817|583513886|FG018|Overall Study|Physician Decision|1|||
161580358|NCT02988817|583513887|FG019|Overall Study|Physician Decision|1|||
161580359|NCT00421889|583513888|FG000|Overall Study|Adverse Event|1|||
161580360|NCT00421889|583513889|FG001|Overall Study|Adverse Event|0|||
161580361|NCT00421889|583513890|FG002|Overall Study|Adverse Event|1|||
161580362|NCT00421889|583513891|FG003|Overall Study|Adverse Event|1|||
161669823|NCT05193500|583843169|FG002|Overall Study|Withdrawal by Subject|3|||
161669824|NCT05193500|583843170|FG003|Overall Study|Withdrawal by Subject|5|||
161669825|NCT05458479|583843171|FG000|Overall Study|Lost to Follow-up|1|||
161482287|NCT01846416|583160805|FG001|Treatment Phase|Physician Decision|2|||
161482288|NCT01846416|583160806|FG002|Treatment Phase|Physician Decision|0|||
161482289|NCT01846416|583160804|FG000|Treatment Phase|Adverse Event|3|||
161482290|NCT01846416|583160805|FG001|Treatment Phase|Adverse Event|4|||
161482291|NCT01846416|583160806|FG002|Treatment Phase|Adverse Event|0|||
161482292|NCT01846416|583160804|FG000|Treatment Phase|Non-compliance|0|||
161482293|NCT01846416|583160805|FG001|Treatment Phase|Non-compliance|2|||
161482294|NCT01846416|583160806|FG002|Treatment Phase|Non-compliance|0|||
161482295|NCT01846416|583160804|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
161482296|NCT01846416|583160805|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
161482297|NCT01846416|583160806|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
161482298|NCT01846416|583160804|FG000|Treatment Phase|Progressive Disease|21|||
161482299|NCT01846416|583160805|FG001|Treatment Phase|Progressive Disease|63|||
161482300|NCT01846416|583160806|FG002|Treatment Phase|Progressive Disease|9|||
161482301|NCT01846416|583160804|FG000|Survival Follow-up|Death|21|||
161482302|NCT01846416|583160805|FG001|Survival Follow-up|Death|62|||
161482303|NCT01846416|583160806|FG002|Survival Follow-up|Death|9|||
161482304|NCT01846416|583160804|FG000|Survival Follow-up|Lost to Follow-up|0|||
161482305|NCT01846416|583160805|FG001|Survival Follow-up|Lost to Follow-up|2|||
161482306|NCT01846416|583160806|FG002|Survival Follow-up|Lost to Follow-up|2|||
161482307|NCT01846416|583160804|FG000|Survival Follow-up|Withdrawal by Subject|2|||
161482308|NCT01846416|583160805|FG001|Survival Follow-up|Withdrawal by Subject|7|||
161482309|NCT01846416|583160806|FG002|Survival Follow-up|Withdrawal by Subject|0|||
161482310|NCT01846416|583160804|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
161482311|NCT01846416|583160805|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
161482312|NCT01846416|583160806|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
161482313|NCT01846416|583160804|FG000|Survival Follow-up|Other|3|||
161482314|NCT01846416|583160805|FG001|Survival Follow-up|Other|1|||
161482315|NCT01846416|583160806|FG002|Survival Follow-up|Other|1|||
161482316|NCT00382252|583160807|FG000|Overall Study|Death|4|||
161482317|NCT00382252|583160807|FG000|Overall Study|Protocol Violation|8|||
161482318|NCT00382252|583160807|FG000|Overall Study|Not treated by RFA|1|||
161482319|NCT00833794|583160808|FG000|Open-label Phase|Adverse Event|225|||
161482320|NCT00833794|583160809|FG001|Open-label Phase|Adverse Event|0|||
161482321|NCT00833794|583160808|FG000|Open-label Phase|Lack of Efficacy|28|||
161482322|NCT00833794|583160809|FG001|Open-label Phase|Lack of Efficacy|0|||
161482323|NCT00833794|583160808|FG000|Open-label Phase|Withdrawal by Subject|48|||
161580363|NCT00421889|583513892|FG004|Overall Study|Adverse Event|1|||
161669826|NCT01978262|583843172|FG000|Overall Study|Withdrawal by Subject|9|||
161482324|NCT00833794|583160809|FG001|Open-label Phase|Withdrawal by Subject|0|||
161482325|NCT00833794|583160808|FG000|Open-label Phase|Physician Decision|20|||
161482326|NCT00833794|583160809|FG001|Open-label Phase|Physician Decision|0|||
161482327|NCT00833794|583160808|FG000|Open-label Phase|Administrative reason|1|||
161482328|NCT00833794|583160809|FG001|Open-label Phase|Administrative reason|0|||
161482329|NCT00833794|583160808|FG000|Open-label Phase|Protocol Violation|47|||
161482330|NCT00833794|583160809|FG001|Open-label Phase|Protocol Violation|0|||
161482331|NCT00833794|583160808|FG000|Open-label Phase|Did not complete wash-out period|12|||
161482332|NCT00833794|583160809|FG001|Open-label Phase|Did not complete wash-out period|0|||
161580364|NCT00421889|583513893|FG005|Overall Study|Adverse Event|4|||
161580365|NCT00421889|583513894|FG006|Overall Study|Adverse Event|1|||
161580366|NCT00421889|583513895|FG007|Overall Study|Adverse Event|0|||
161669827|NCT01978262|583843172|FG000|Overall Study|Lost to Follow-up|2|||
161482333|NCT00833794|583160808|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
161482334|NCT00833794|583160809|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
161921496|NCT02830087|584757233|FG002|Overall Study|No study staff to follow-up patients|4|||
161921497|NCT02830087|584757234|FG003|Overall Study|No study staff to follow-up patients|3|||
161921498|NCT02830087|584757235|FG004|Overall Study|No study staff to follow-up patients|3|||
161921499|NCT02830087|584757236|FG005|Overall Study|No study staff to follow-up patients|3|||
161921500|NCT02916771|584757237|FG000|Overall Study|Withdrawal by Subject|9|||
161482335|NCT00833794|583160808|FG000|Double-blind Phase|Adverse Event|44|||
161482336|NCT00833794|583160809|FG001|Double-blind Phase|Adverse Event|11|||
161482337|NCT00833794|583160808|FG000|Double-blind Phase|Lack of Efficacy|34|||
161482338|NCT00833794|583160809|FG001|Double-blind Phase|Lack of Efficacy|22|||
161482339|NCT00833794|583160808|FG000|Double-blind Phase|Withdrawal by Subject|23|||
161482340|NCT00833794|583160809|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161482341|NCT00833794|583160808|FG000|Double-blind Phase|Physician Decision|4|||
161482342|NCT00833794|583160809|FG001|Double-blind Phase|Physician Decision|7|||
161482343|NCT00833794|583160808|FG000|Double-blind Phase|Administrative reason|1|||
161482344|NCT00833794|583160809|FG001|Double-blind Phase|Administrative reason|3|||
161482345|NCT00039130|583160812|FG000|Overall Study|Adverse Event|11|||
161482346|NCT00039130|583160812|FG000|Overall Study|Death|9|||
161482347|NCT00039130|583160812|FG000|Overall Study|Withdrawal by Subject|3|||
161482348|NCT00039130|583160812|FG000|Overall Study|Progression|2|||
161482349|NCT00039130|583160812|FG000|Overall Study|Subsequent treatment|2|||
161482350|NCT00039130|583160812|FG000|Overall Study|Physician Decision|3|||
161482351|NCT01269463|583160813|FG000|First Intervention|Withdrawal by Subject|1|||
161482352|NCT01269463|583160814|FG001|First Intervention|Withdrawal by Subject|0|||
161482353|NCT01269463|583160813|FG000|First Intervention|Adverse Event|1|||
161482354|NCT01269463|583160814|FG001|First Intervention|Adverse Event|0|||
161482355|NCT01269463|583160813|FG000|First Intervention|Lack of Efficacy|0|||
161482356|NCT01269463|583160814|FG001|First Intervention|Lack of Efficacy|1|||
161482357|NCT01269463|583160813|FG000|First Intervention|Physician Decision|0|||
161482358|NCT01269463|583160814|FG001|First Intervention|Physician Decision|1|||
161482359|NCT02612727|583160816|FG000|Overall Study|Parent request|4|||
161482360|NCT02612727|583160817|FG001|Overall Study|Parent request|1|||
161482361|NCT02612727|583160816|FG000|Overall Study|Needed treatment incompatible with PT|1|||
161482362|NCT02612727|583160817|FG001|Overall Study|Needed treatment incompatible with PT|1|||
161482363|NCT02612727|583160816|FG000|Overall Study|Direct hyperbilirubinemia|0|||
161482364|NCT02612727|583160817|FG001|Overall Study|Direct hyperbilirubinemia|2|||
161482365|NCT01638546|583160828|FG000|Overall Study|Adverse Event|1|||
161482366|NCT01638546|583160829|FG001|Overall Study|Adverse Event|3|||
161482367|NCT00540514|583162448|FG000|Overall Study|Still on treatment|3|||
161482368|NCT00540514|583162449|FG001|Overall Study|Still on treatment|0|||
161482369|NCT00540514|583162448|FG000|Overall Study|Unacceptable Toxicity|61|||
161482370|NCT00540514|583162449|FG001|Overall Study|Unacceptable Toxicity|62|||
161482371|NCT00540514|583162448|FG000|Overall Study|Adverse Event|20|||
161482372|NCT00540514|583162449|FG001|Overall Study|Adverse Event|24|||
161482373|NCT00540514|583162448|FG000|Overall Study|Physician Decision|86|||
161482374|NCT00540514|583162449|FG001|Overall Study|Physician Decision|99|||
161482375|NCT00540514|583162448|FG000|Overall Study|Protocol Deviation|3|||
161482376|NCT00540514|583162449|FG001|Overall Study|Protocol Deviation|4|||
161482377|NCT00540514|583162448|FG000|Overall Study|Lost to Follow-up|1|||
161482378|NCT00540514|583162449|FG001|Overall Study|Lost to Follow-up|1|||
161482379|NCT00540514|583162448|FG000|Overall Study|Withdrawal by Subject|65|||
161482380|NCT00540514|583162449|FG001|Overall Study|Withdrawal by Subject|67|||
161482381|NCT00540514|583162448|FG000|Overall Study|Excluded prior to treatment|7|||
161482382|NCT00540514|583162449|FG001|Overall Study|Excluded prior to treatment|7|||
161482383|NCT00540514|583162448|FG000|Overall Study|Paclitaxel not available|0|||
161482384|NCT00540514|583162449|FG001|Overall Study|Paclitaxel not available|2|||
161482385|NCT01892293|583162460|FG000|Overall Study|Apheresed but not treated|4|||
161482386|NCT03602482|583162463|FG000|Overall Study|Withdrawal by Subject|6|||
161482387|NCT03602482|583162464|FG001|Overall Study|Withdrawal by Subject|7|||
161482388|NCT03602482|583162465|FG002|Overall Study|Withdrawal by Subject|0|||
161482389|NCT03602482|583162466|FG003|Overall Study|Withdrawal by Subject|0|||
161482390|NCT03808545|583162478|FG000|Overall Study|Withdrawal by Subject|1|||
161482391|NCT03808545|583162479|FG001|Overall Study|Withdrawal by Subject|1|||
161482392|NCT00618072|583162488|FG000|Overall Study|Lost to Follow-up|2|||
161482393|NCT00618072|583162489|FG001|Overall Study|Lost to Follow-up|0|||
161482394|NCT00618072|583162490|FG002|Overall Study|Lost to Follow-up|3|||
161482395|NCT00618072|583162488|FG000|Overall Study|Physician Decision|0|||
161482396|NCT00618072|583162489|FG001|Overall Study|Physician Decision|1|||
161482397|NCT00618072|583162490|FG002|Overall Study|Physician Decision|1|||
161921501|NCT02916771|584757237|FG000|Overall Study|Physician Decision|1|||
161482398|NCT00684307|583162491|FG000|Overall Study|Adverse Event|11|||
161482399|NCT00684307|583162492|FG001|Overall Study|Adverse Event|6|||
161482400|NCT00684307|583162493|FG002|Overall Study|Adverse Event|15|||
161482401|NCT00684307|583162494|FG003|Overall Study|Adverse Event|16|||
161482402|NCT00684307|583162495|FG004|Overall Study|Adverse Event|8|||
161669828|NCT02202551|583843173|FG000|Overall Study|Adverse Event|8|||
161669829|NCT02202551|583843174|FG001|Overall Study|Adverse Event|19|||
161669830|NCT02202551|583843175|FG002|Overall Study|Adverse Event|5|||
161669831|NCT02202551|583843176|FG003|Overall Study|Adverse Event|9|||
161669832|NCT02202551|583843173|FG000|Overall Study|Death|3|||
161669833|NCT02202551|583843174|FG001|Overall Study|Death|2|||
161669834|NCT02202551|583843175|FG002|Overall Study|Death|1|||
161669835|NCT02202551|583843176|FG003|Overall Study|Death|1|||
161669836|NCT02202551|583843173|FG000|Overall Study|Lost to Follow-up|0|||
161669837|NCT02202551|583843174|FG001|Overall Study|Lost to Follow-up|1|||
161669838|NCT02202551|583843175|FG002|Overall Study|Lost to Follow-up|0|||
161669839|NCT02202551|583843176|FG003|Overall Study|Lost to Follow-up|1|||
161669840|NCT02202551|583843173|FG000|Overall Study|Needed to take excluded medication|0|||
161669841|NCT02202551|583843174|FG001|Overall Study|Needed to take excluded medication|2|||
161669842|NCT02202551|583843175|FG002|Overall Study|Needed to take excluded medication|0|||
161669843|NCT02202551|583843176|FG003|Overall Study|Needed to take excluded medication|1|||
161669844|NCT02202551|583843173|FG000|Overall Study|Subject moved away|0|||
161669845|NCT02202551|583843174|FG001|Overall Study|Subject moved away|1|||
161669846|NCT02202551|583843175|FG002|Overall Study|Subject moved away|0|||
161669847|NCT02202551|583843176|FG003|Overall Study|Subject moved away|0|||
161669848|NCT02202551|583843173|FG000|Overall Study|DBS surgery|3|||
161669849|NCT02202551|583843174|FG001|Overall Study|DBS surgery|0|||
161669850|NCT02202551|583843175|FG002|Overall Study|DBS surgery|0|||
161669851|NCT02202551|583843176|FG003|Overall Study|DBS surgery|0|||
161669852|NCT02202551|583843173|FG000|Overall Study|Dyskinesia upon taper|1|||
161669853|NCT02202551|583843174|FG001|Overall Study|Dyskinesia upon taper|0|||
161669854|NCT02202551|583843175|FG002|Overall Study|Dyskinesia upon taper|0|||
161669855|NCT02202551|583843176|FG003|Overall Study|Dyskinesia upon taper|0|||
161669856|NCT02202551|583843173|FG000|Overall Study|Lack of Efficacy|0|||
161669857|NCT02202551|583843174|FG001|Overall Study|Lack of Efficacy|1|||
161669858|NCT02202551|583843175|FG002|Overall Study|Lack of Efficacy|0|||
161669859|NCT02202551|583843176|FG003|Overall Study|Lack of Efficacy|0|||
161669860|NCT02202551|583843173|FG000|Overall Study|Physician Decision|1|||
161669861|NCT02202551|583843174|FG001|Overall Study|Physician Decision|0|||
161669862|NCT02202551|583843175|FG002|Overall Study|Physician Decision|0|||
161669863|NCT02202551|583843176|FG003|Overall Study|Physician Decision|0|||
161669864|NCT02202551|583843173|FG000|Overall Study|Site closure|3|||
161669865|NCT02202551|583843174|FG001|Overall Study|Site closure|0|||
161669866|NCT02202551|583843175|FG002|Overall Study|Site closure|0|||
161669867|NCT02202551|583843176|FG003|Overall Study|Site closure|1|||
161669868|NCT02202551|583843173|FG000|Overall Study|Unable to complete visits per protocol|1|||
161669869|NCT02202551|583843174|FG001|Overall Study|Unable to complete visits per protocol|0|||
161669870|NCT02202551|583843175|FG002|Overall Study|Unable to complete visits per protocol|0|||
161669871|NCT02202551|583843176|FG003|Overall Study|Unable to complete visits per protocol|0|||
161669872|NCT02202551|583843173|FG000|Overall Study|Worsening Dyskinesia|0|||
161669873|NCT02202551|583843174|FG001|Overall Study|Worsening Dyskinesia|0|||
161669874|NCT02202551|583843175|FG002|Overall Study|Worsening Dyskinesia|0|||
161669875|NCT02202551|583843176|FG003|Overall Study|Worsening Dyskinesia|1|||
161669876|NCT02202551|583843173|FG000|Overall Study|Protocol Violation|0|||
161669877|NCT02202551|583843174|FG001|Overall Study|Protocol Violation|1|||
161669878|NCT02202551|583843175|FG002|Overall Study|Protocol Violation|0|||
161669879|NCT02202551|583843176|FG003|Overall Study|Protocol Violation|0|||
161669880|NCT02202551|583843173|FG000|Overall Study|Sponsor's decision|2|||
161669881|NCT02202551|583843174|FG001|Overall Study|Sponsor's decision|0|||
161669882|NCT02202551|583843175|FG002|Overall Study|Sponsor's decision|0|||
161669883|NCT02202551|583843176|FG003|Overall Study|Sponsor's decision|0|||
161669884|NCT02202551|583843173|FG000|Overall Study|Subject unwilling to proceed|1|||
161669885|NCT02202551|583843174|FG001|Overall Study|Subject unwilling to proceed|5|||
161669886|NCT02202551|583843175|FG002|Overall Study|Subject unwilling to proceed|3|||
161669887|NCT02202551|583843176|FG003|Overall Study|Subject unwilling to proceed|5|||
161669888|NCT02202551|583843173|FG000|Overall Study|Subject consent withdrawn|0|||
161669889|NCT02202551|583843174|FG001|Overall Study|Subject consent withdrawn|3|||
161669890|NCT02202551|583843175|FG002|Overall Study|Subject consent withdrawn|1|||
161669891|NCT02202551|583843176|FG003|Overall Study|Subject consent withdrawn|2|||
161669892|NCT02202551|583843173|FG000|Overall Study|eGFR<50mL/min/m2|2|||
161669893|NCT02202551|583843174|FG001|Overall Study|eGFR<50mL/min/m2|2|||
161816503|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161669894|NCT02202551|583843175|FG002|Overall Study|eGFR<50mL/min/m2|0|||
161669895|NCT02202551|583843176|FG003|Overall Study|eGFR<50mL/min/m2|1|||
161669896|NCT02121834|583843177|FG000|Overall Study|Protocol Violation|0|||
161669897|NCT02121834|583843178|FG001|Overall Study|Protocol Violation|1|||
161669898|NCT02121834|583843179|FG002|Overall Study|Protocol Violation|0|||
161669899|NCT02121834|583843180|FG003|Overall Study|Protocol Violation|0|||
161669900|NCT02121834|583843181|FG004|Overall Study|Protocol Violation|0|||
161669901|NCT02121834|583843182|FG005|Overall Study|Protocol Violation|0|||
161669902|NCT02121834|583843183|FG006|Overall Study|Protocol Violation|0|||
161669903|NCT02121834|583843177|FG000|Overall Study|Withdrawal by Subject|0|||
161482403|NCT00684307|583162491|FG000|Overall Study|Development of increasing Liver Function|0|||
161482404|NCT00684307|583162492|FG001|Overall Study|Development of increasing Liver Function|2|||
161482405|NCT00684307|583162493|FG002|Overall Study|Development of increasing Liver Function|0|||
161482406|NCT00684307|583162494|FG003|Overall Study|Development of increasing Liver Function|1|||
161482407|NCT00684307|583162495|FG004|Overall Study|Development of increasing Liver Function|0|||
161482408|NCT00684307|583162491|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
161482409|NCT00684307|583162492|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
161482410|NCT00684307|583162493|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
161482411|NCT00684307|583162494|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
161482412|NCT00684307|583162495|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
161482413|NCT00684307|583162491|FG000|Overall Study|Incorrect enrolment or randomization|4|||
161482414|NCT00684307|583162492|FG001|Overall Study|Incorrect enrolment or randomization|0|||
161482415|NCT00684307|583162493|FG002|Overall Study|Incorrect enrolment or randomization|0|||
161482416|NCT00684307|583162494|FG003|Overall Study|Incorrect enrolment or randomization|0|||
161482417|NCT00684307|583162495|FG004|Overall Study|Incorrect enrolment or randomization|0|||
161482418|NCT00684307|583162491|FG000|Overall Study|Interupted IP for more than 7 days|0|||
161482419|NCT00684307|583162492|FG001|Overall Study|Interupted IP for more than 7 days|4|||
161482420|NCT00684307|583162493|FG002|Overall Study|Interupted IP for more than 7 days|1|||
161482421|NCT00684307|583162494|FG003|Overall Study|Interupted IP for more than 7 days|3|||
161482422|NCT00684307|583162495|FG004|Overall Study|Interupted IP for more than 7 days|3|||
161482423|NCT00684307|583162491|FG000|Overall Study|Severe non compliance to protocol|1|||
161482424|NCT00684307|583162492|FG001|Overall Study|Severe non compliance to protocol|0|||
161482425|NCT00684307|583162493|FG002|Overall Study|Severe non compliance to protocol|0|||
161482426|NCT00684307|583162494|FG003|Overall Study|Severe non compliance to protocol|1|||
161482427|NCT00684307|583162495|FG004|Overall Study|Severe non compliance to protocol|2|||
161482428|NCT00684307|583162491|FG000|Overall Study|Participant not willing to continue|7|||
161482429|NCT00684307|583162492|FG001|Overall Study|Participant not willing to continue|10|||
161482430|NCT00684307|583162493|FG002|Overall Study|Participant not willing to continue|11|||
161482431|NCT00684307|583162494|FG003|Overall Study|Participant not willing to continue|5|||
161482432|NCT00684307|583162495|FG004|Overall Study|Participant not willing to continue|8|||
161482433|NCT00684307|583162491|FG000|Overall Study|Criteria from the CSR|0|||
161482434|NCT00684307|583162492|FG001|Overall Study|Criteria from the CSR|0|||
161482435|NCT00684307|583162493|FG002|Overall Study|Criteria from the CSR|1|||
161482436|NCT00684307|583162494|FG003|Overall Study|Criteria from the CSR|3|||
161482437|NCT00684307|583162495|FG004|Overall Study|Criteria from the CSR|3|||
161482438|NCT00133952|583162497|FG000|Overall Study|Adverse Event|1|||
161482439|NCT00133952|583162498|FG001|Overall Study|Adverse Event|2|||
161482440|NCT00133952|583162497|FG000|Overall Study|Death|3|||
161482441|NCT00133952|583162498|FG001|Overall Study|Death|2|||
161482442|NCT00133952|583162497|FG000|Overall Study|Lost to Follow-up|9|||
161482443|NCT00133952|583162498|FG001|Overall Study|Lost to Follow-up|14|||
161482444|NCT00133952|583162497|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
161482445|NCT00133952|583162498|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
161482446|NCT00133952|583162497|FG000|Overall Study|Protocol Violation|1|||
161482447|NCT00133952|583162498|FG001|Overall Study|Protocol Violation|1|||
161482448|NCT00133952|583162497|FG000|Overall Study|Withdrawal by Subject|20|||
161482449|NCT00133952|583162498|FG001|Overall Study|Withdrawal by Subject|4|||
161482450|NCT00133952|583162497|FG000|Overall Study|Physician Decision|4|||
161482451|NCT00133952|583162498|FG001|Overall Study|Physician Decision|3|||
161482452|NCT00133952|583162497|FG000|Overall Study|Sponsor Decision|0|||
161482453|NCT00133952|583162498|FG001|Overall Study|Sponsor Decision|1|||
161482454|NCT02170298|583162501|FG000|Overall Study|Withdrawal by Subject|0|||
161482455|NCT02170298|583162502|FG001|Overall Study|Withdrawal by Subject|1|||
161482456|NCT02170298|583162501|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
161482457|NCT02170298|583162502|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
161482458|NCT05048784|583162505|FG000|Period 1|Adverse Event|3|||
161482459|NCT05048784|583162506|FG001|Period 1|Adverse Event|1|||
161482460|NCT05048784|583162507|FG002|Period 1|Adverse Event|0|||
161482461|NCT05048784|583162508|FG003|Period 1|Adverse Event|0|||
161482462|NCT05048784|583162505|FG000|Period 2|Lost to Follow-up|0|||
161482463|NCT05048784|583162506|FG001|Period 2|Lost to Follow-up|1|||
161482464|NCT05048784|583162507|FG002|Period 2|Lost to Follow-up|0|||
161482465|NCT05048784|583162508|FG003|Period 2|Lost to Follow-up|0|||
161482466|NCT02853604|583162513|FG000|Overall Study|Withdrawal by Subject|12|||
161482467|NCT02853604|583162514|FG001|Overall Study|Withdrawal by Subject|35|||
161482468|NCT02853604|583162513|FG000|Overall Study|Lost to Follow-up|4|||
161482469|NCT02853604|583162514|FG001|Overall Study|Lost to Follow-up|8|||
161482470|NCT02853604|583162513|FG000|Overall Study|Death|1|||
161482471|NCT02853604|583162514|FG001|Overall Study|Death|5|||
161482472|NCT02853604|583162513|FG000|Overall Study|Miscellaneous|11|||
161482473|NCT02853604|583162514|FG001|Overall Study|Miscellaneous|2|||
161482474|NCT02853604|583162513|FG000|Overall Study|Progressive Disease|0|||
161482475|NCT02853604|583162514|FG001|Overall Study|Progressive Disease|2|||
161482476|NCT00727025|583162515|FG000|Overall Study|Physician Decision|23|||
161482477|NCT02269241|583162516|FG000|Overall Study|Lost to Follow-up|269|||
161482478|NCT02269241|583162516|FG000|Overall Study|Withdrawal by Subject|155|||
161482479|NCT02269241|583162516|FG000|Overall Study|Protocol Violation|1|||
161482480|NCT02269241|583162516|FG000|Overall Study|Physician Decision|7|||
161482481|NCT02269241|583162516|FG000|Overall Study|Pregnancy|15|||
161482482|NCT02269241|583162516|FG000|Overall Study|Wish for pregnancy|5|||
161482483|NCT02269241|583162516|FG000|Overall Study|Development of an exclusion criteria|16|||
161482484|NCT02269241|583162516|FG000|Overall Study|Adverse Event|113|||
161482485|NCT02269241|583162516|FG000|Overall Study|At the specific request of the sponsor|20|||
161482486|NCT02269241|583162516|FG000|Overall Study|Several reasons not classified|53|||
161482487|NCT02269241|583162516|FG000|Overall Study|Screening failures|546|||
161482488|NCT03020160|583162517|FG000|Overall Study|Withdrawal by Subject|1|||
161482489|NCT03020160|583162518|FG001|Overall Study|Withdrawal by Subject|0|||
161482490|NCT02270957|583162519|FG000|Overall Study|Lack of Efficacy|2|||
161482491|NCT02270957|583162520|FG001|Overall Study|Lack of Efficacy|4|||
161482492|NCT02270957|583162519|FG000|Overall Study|Adverse Event|2|||
161482493|NCT02270957|583162520|FG001|Overall Study|Adverse Event|0|||
161482494|NCT01539538|583162528|FG000|Overall Study|Adverse Event|13|||
161482495|NCT01539538|583162529|FG001|Overall Study|Adverse Event|18|||
161482496|NCT01539538|583162528|FG000|Overall Study|Lack of Efficacy|13|||
161482497|NCT01539538|583162529|FG001|Overall Study|Lack of Efficacy|16|||
161482498|NCT01539538|583162528|FG000|Overall Study|Withdrawal by Subject|2|||
161482499|NCT01539538|583162529|FG001|Overall Study|Withdrawal by Subject|3|||
161482500|NCT01539538|583162528|FG000|Overall Study|PCA no longer required or PCA problem|3|||
161482501|NCT01539538|583162529|FG001|Overall Study|PCA no longer required or PCA problem|7|||
161482502|NCT03897465|583162530|FG000|Overall Study|Lost to Follow-up|2|||
161482503|NCT03897465|583162531|FG001|Overall Study|Lost to Follow-up|1|||
161482504|NCT03897465|583162530|FG000|Overall Study|Adverse Event|2|||
161482505|NCT03897465|583162531|FG001|Overall Study|Adverse Event|0|||
161482506|NCT03897465|583162530|FG000|Overall Study|complete healing by V2|1|||
161482507|NCT03897465|583162531|FG001|Overall Study|complete healing by V2|0|||
161482508|NCT03897465|583162530|FG000|Overall Study|occurence of exclusion criterion|1|||
161482509|NCT03897465|583162531|FG001|Overall Study|occurence of exclusion criterion|1|||
161482510|NCT03897465|583162530|FG000|Overall Study|Other|1|||
161482511|NCT03897465|583162531|FG001|Overall Study|Other|0|||
161482512|NCT00847379|583162532|FG000|Overall Study|Study terminated by Sponsor|59|||
161482513|NCT00847379|583162533|FG001|Overall Study|Study terminated by Sponsor|57|||
161482514|NCT00847379|583162534|FG002|Overall Study|Study terminated by Sponsor|57|||
161482515|NCT00521014|583162535|FG000|Overall Study|Inevaluable, not treated|1|||
161482516|NCT04390191|583162536|FG000|Overall Study|Withdrawal by Subject|1|||
161482517|NCT04390191|583162537|FG001|Overall Study|Withdrawal by Subject|0|||
161482518|NCT03978832|583162540|FG000|Overall Study|Adverse Event|1|||
161482519|NCT03978832|583162540|FG000|Overall Study|Lost to Follow-up|1|||
161482520|NCT03978832|583162540|FG000|Overall Study|Withdrawal by Subject|6|||
161482521|NCT03978832|583162540|FG000|Overall Study|Physician Decision|2|||
161482522|NCT03978832|583162540|FG000|Overall Study|did not pass screening criteria|44|||
161482523|NCT00003499|583162541|FG000|Overall Study|Not evaluable|8|||
161482524|NCT02042183|583162546|FG000|Overall Study|Physician Decision|7|||
161482525|NCT02042183|583162547|FG001|Overall Study|Physician Decision|2|||
161482526|NCT02042183|583162546|FG000|Overall Study|Lack of Efficacy|4|||
161482527|NCT02042183|583162547|FG001|Overall Study|Lack of Efficacy|3|||
161482528|NCT02042183|583162546|FG000|Overall Study|Non-compliance with Study Drug|2|||
161482529|NCT02042183|583162547|FG001|Overall Study|Non-compliance with Study Drug|3|||
161482530|NCT02042183|583162546|FG000|Overall Study|Adverse Event|17|||
161482531|NCT02042183|583162547|FG001|Overall Study|Adverse Event|6|||
161482532|NCT02042183|583162546|FG000|Overall Study|Other|3|||
161482533|NCT02042183|583162547|FG001|Overall Study|Other|3|||
161482534|NCT02042183|583162546|FG000|Overall Study|Withdrawal by Subject|21|||
161482535|NCT02042183|583162547|FG001|Overall Study|Withdrawal by Subject|16|||
161482536|NCT02042183|583162546|FG000|Overall Study|Site Terminated by Sponsor|2|||
161482537|NCT02042183|583162547|FG001|Overall Study|Site Terminated by Sponsor|1|||
161482538|NCT02042183|583162546|FG000|Overall Study|Lost to Follow-up|9|||
161482539|NCT02042183|583162547|FG001|Overall Study|Lost to Follow-up|2|||
161482540|NCT01256008|583162548|FG000|Overall Study|Lost to Follow-up|6|||
161482541|NCT01256008|583162549|FG001|Overall Study|Lost to Follow-up|4|||
161482542|NCT01256008|583162550|FG002|Overall Study|Lost to Follow-up|11|||
161482543|NCT01256008|583162548|FG000|Overall Study|Withdrawal by Subject|2|||
161482544|NCT01256008|583162549|FG001|Overall Study|Withdrawal by Subject|3|||
161482545|NCT01256008|583162550|FG002|Overall Study|Withdrawal by Subject|10|||
161482546|NCT00378378|583162553|FG000|Overall Study|Withdrawal by Subject|0|||
161482547|NCT00378378|583162554|FG001|Overall Study|Withdrawal by Subject|1|||
161482548|NCT00378378|583162555|FG002|Overall Study|Withdrawal by Subject|0|||
161482549|NCT00378378|583162553|FG000|Overall Study|Treatment Failure|0|||
161482550|NCT00378378|583162554|FG001|Overall Study|Treatment Failure|0|||
161482551|NCT00378378|583162555|FG002|Overall Study|Treatment Failure|1|||
161482552|NCT00378378|583162553|FG000|Overall Study|Non-compliance with protocol|0|||
161482553|NCT00378378|583162554|FG001|Overall Study|Non-compliance with protocol|0|||
161482554|NCT00378378|583162555|FG002|Overall Study|Non-compliance with protocol|1|||
161482555|NCT04171531|583162559|FG000|Overall Study|Lost to Follow-up|4|||
161482556|NCT04171531|583162560|FG001|Overall Study|Lost to Follow-up|5|||
161482557|NCT04171531|583162559|FG000|Overall Study|Consent only through 6 months|1|||
161482558|NCT04171531|583162560|FG001|Overall Study|Consent only through 6 months|1|||
161482559|NCT04171531|583162559|FG000|Overall Study|Insurance did not cover procedure|0|||
161482560|NCT04171531|583162560|FG001|Overall Study|Insurance did not cover procedure|1|||
161482561|NCT04171531|583162559|FG000|Overall Study|Physician Decision|0|||
161482562|NCT04171531|583162560|FG001|Overall Study|Physician Decision|3|||
161482563|NCT04171531|583162559|FG000|Overall Study|Withdrawal by Subject|1|||
161482564|NCT04171531|583162560|FG001|Overall Study|Withdrawal by Subject|5|||
161482565|NCT05537883|583162563|FG000|Overall Study|revisional surgery|4|||
161482566|NCT05537883|583162564|FG001|Overall Study|revisional surgery|2|||
161482567|NCT05537883|583162563|FG000|Overall Study|surgeries were cancelled|0|||
161482568|NCT05537883|583162564|FG001|Overall Study|surgeries were cancelled|2|||
161482569|NCT05537883|583162563|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
161482570|NCT05537883|583162564|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
161482571|NCT05288062|583162565|FG000|Overall Study|Ineligible|0|||
161482572|NCT05288062|583162566|FG001|Overall Study|Ineligible|0|||
161482573|NCT05288062|583162567|FG002|Overall Study|Ineligible|1|||
161482574|NCT05288062|583162568|FG003|Overall Study|Ineligible|0|||
161482575|NCT05288062|583162565|FG000|Overall Study|Withdrawal by Subject|0|||
161482576|NCT05288062|583162566|FG001|Overall Study|Withdrawal by Subject|0|||
161482577|NCT05288062|583162567|FG002|Overall Study|Withdrawal by Subject|1|||
161482578|NCT05288062|583162568|FG003|Overall Study|Withdrawal by Subject|0|||
161482579|NCT02296320|583162570|FG000|Overall Study|Withdrawal by Subject|4|||
161482580|NCT02296320|583162571|FG001|Overall Study|Withdrawal by Subject|0|||
161482581|NCT02296320|583162572|FG002|Overall Study|Withdrawal by Subject|2|||
161482582|NCT02296320|583162570|FG000|Overall Study|Death|24|||
161482583|NCT02296320|583162571|FG001|Overall Study|Death|3|||
161482584|NCT02296320|583162572|FG002|Overall Study|Death|27|||
161482585|NCT02296320|583162570|FG000|Overall Study|Lost to Follow-up|5|||
161482586|NCT02296320|583162571|FG001|Overall Study|Lost to Follow-up|2|||
161482587|NCT02296320|583162572|FG002|Overall Study|Lost to Follow-up|7|||
161482588|NCT02296320|583162570|FG000|Overall Study|Not treated|2|||
161482589|NCT02296320|583162571|FG001|Overall Study|Not treated|0|||
161482590|NCT02296320|583162572|FG002|Overall Study|Not treated|0|||
161482591|NCT02296320|583162570|FG000|Overall Study|Not - specified|0|||
161482592|NCT02296320|583162571|FG001|Overall Study|Not - specified|0|||
161482593|NCT02296320|583162572|FG002|Overall Study|Not - specified|1|||
161482594|NCT00729651|583162575|FG000|Overall Study|Withdrawal by Subject|5|||
161482595|NCT00729651|583162576|FG001|Overall Study|Withdrawal by Subject|6|||
161482596|NCT00729651|583162575|FG000|Overall Study|Lost to Follow-up|5|||
161482597|NCT00729651|583162576|FG001|Overall Study|Lost to Follow-up|4|||
161482598|NCT00729651|583162575|FG000|Overall Study|Protocol Violation|0|||
161482599|NCT00729651|583162576|FG001|Overall Study|Protocol Violation|1|||
161482600|NCT00729651|583162575|FG000|Overall Study|Adverse Event|7|||
161482601|NCT00729651|583162576|FG001|Overall Study|Adverse Event|3|||
161482602|NCT00729651|583162575|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
161482603|NCT00729651|583162576|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
161482604|NCT00729651|583162575|FG000|Overall Study|Subject's private reason|2|||
161482605|NCT00729651|583162576|FG001|Overall Study|Subject's private reason|0|||
161482606|NCT01874054|583162577|FG000|Overall Study|Withdrawal by Subject|3|||
161482607|NCT01874054|583162577|FG000|Overall Study|Study Termination by Sponsor|42|||
161482608|NCT01874054|583162577|FG000|Overall Study|Lost to Follow-up|5|||
161482609|NCT01874054|583162577|FG000|Overall Study|Death|5|||
161482610|NCT00390468|583162578|FG000|Overall Study|Protocol Violation|2|||
161580367|NCT00421889|583513896|FG008|Overall Study|Adverse Event|2|||
161580368|NCT00421889|583513888|FG000|Overall Study|Withdrawal by Subject|1|||
161580369|NCT00421889|583513889|FG001|Overall Study|Withdrawal by Subject|3|||
161580370|NCT00421889|583513890|FG002|Overall Study|Withdrawal by Subject|0|||
161580371|NCT00421889|583513891|FG003|Overall Study|Withdrawal by Subject|0|||
161482611|NCT00390468|583162578|FG000|Overall Study|Lack of Efficacy|1|||
161482612|NCT01049308|583162579|FG000|Pill Counts|Withdrawal by Subject|83|||
161482613|NCT01348165|583162580|FG000|Overall Study|Adverse Event|0|||
161482614|NCT01348165|583162581|FG001|Overall Study|Adverse Event|0|||
161482615|NCT01348165|583162582|FG002|Overall Study|Adverse Event|0|||
161482616|NCT01348165|583162583|FG003|Overall Study|Adverse Event|0|||
161482617|NCT01348165|583162584|FG004|Overall Study|Adverse Event|0|||
161580372|NCT00421889|583513892|FG004|Overall Study|Withdrawal by Subject|2|||
161482618|NCT01348165|583162585|FG005|Overall Study|Adverse Event|0|||
161482619|NCT01348165|583162586|FG006|Overall Study|Adverse Event|1|||
161482620|NCT02439138|583162591|FG000|Overall Study|Adverse Event|1|||
161482621|NCT02439138|583162591|FG000|Overall Study|PI decision to terminate the study|2|||
161482622|NCT04659161|583162592|FG000|Overall Study|Adverse Event|10|||
161482623|NCT04659161|583162593|FG001|Overall Study|Adverse Event|6|||
161482624|NCT04659161|583162592|FG000|Overall Study|Withdrawal by Subject|13|||
161482625|NCT04659161|583162593|FG001|Overall Study|Withdrawal by Subject|12|||
161482626|NCT04659161|583162592|FG000|Overall Study|Other|9|||
161482627|NCT04659161|583162593|FG001|Overall Study|Other|8|||
161482628|NCT01929343|583162594|FG000|Overall Study|Physician Decision|0|||
161482629|NCT01929343|583162595|FG001|Overall Study|Physician Decision|2|||
161482630|NCT01929343|583162596|FG002|Overall Study|Physician Decision|0|||
161482631|NCT01929343|583162594|FG000|Overall Study|Withdrawal by Subject|1|||
161482632|NCT01929343|583162595|FG001|Overall Study|Withdrawal by Subject|0|||
161482633|NCT01929343|583162596|FG002|Overall Study|Withdrawal by Subject|0|||
161482634|NCT02197130|583162599|FG000|Overall Study|Adverse Event|13|||
161482635|NCT02197130|583162600|FG001|Overall Study|Adverse Event|4|||
161482636|NCT02197130|583162601|FG002|Overall Study|Adverse Event|23|||
161482637|NCT02197130|583162599|FG000|Overall Study|Death|0|||
161482638|NCT02197130|583162600|FG001|Overall Study|Death|1|||
161482639|NCT02197130|583162601|FG002|Overall Study|Death|0|||
161580373|NCT00421889|583513893|FG005|Overall Study|Withdrawal by Subject|0|||
161580374|NCT00421889|583513894|FG006|Overall Study|Withdrawal by Subject|0|||
161816504|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816505|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816506|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816507|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816508|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816509|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816510|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816511|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816512|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816513|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816514|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816515|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816516|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816517|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816518|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816519|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816520|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816521|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816522|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816523|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
161816524|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
161816525|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816526|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816527|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816528|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816529|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816530|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816531|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816532|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816533|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816534|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816535|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816536|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816537|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816538|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816539|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816540|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816541|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816542|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816543|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816544|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816545|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816546|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816547|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816548|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816549|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816550|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816551|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
161816552|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
161482640|NCT02197130|583162599|FG000|Overall Study|Lost to Follow-up|2|||
161482641|NCT02197130|583162600|FG001|Overall Study|Lost to Follow-up|0|||
161482642|NCT02197130|583162601|FG002|Overall Study|Lost to Follow-up|1|||
161482643|NCT02197130|583162599|FG000|Overall Study|Does not meet entrance criteria|0|||
161482644|NCT02197130|583162600|FG001|Overall Study|Does not meet entrance criteria|0|||
161482645|NCT02197130|583162601|FG002|Overall Study|Does not meet entrance criteria|1|||
161482646|NCT02197130|583162599|FG000|Overall Study|Withdrawal by Subject|0|||
161482647|NCT02197130|583162600|FG001|Overall Study|Withdrawal by Subject|3|||
161482648|NCT02197130|583162601|FG002|Overall Study|Withdrawal by Subject|4|||
161482649|NCT02197130|583162599|FG000|Overall Study|Other|1|||
161482650|NCT02197130|583162600|FG001|Overall Study|Other|0|||
161482651|NCT02197130|583162601|FG002|Overall Study|Other|3|||
161580375|NCT00421889|583513895|FG007|Overall Study|Withdrawal by Subject|0|||
161580376|NCT00421889|583513896|FG008|Overall Study|Withdrawal by Subject|0|||
161580377|NCT00421889|583513888|FG000|Overall Study|Death|0|||
161580378|NCT00421889|583513889|FG001|Overall Study|Death|0|||
161580379|NCT00421889|583513890|FG002|Overall Study|Death|0|||
161580380|NCT00421889|583513891|FG003|Overall Study|Death|0|||
161580381|NCT00421889|583513892|FG004|Overall Study|Death|1|||
161580382|NCT00421889|583513893|FG005|Overall Study|Death|1|||
161580383|NCT00421889|583513894|FG006|Overall Study|Death|0|||
161482652|NCT02615145|583162602|FG000|Overall Study|Did Not Start Treatment|0|||
161482653|NCT02615145|583162603|FG001|Overall Study|Did Not Start Treatment|0|||
161482654|NCT02615145|583162604|FG002|Overall Study|Did Not Start Treatment|1|||
161482655|NCT02615145|583162605|FG003|Overall Study|Did Not Start Treatment|1|||
161580384|NCT00421889|583513895|FG007|Overall Study|Death|0|||
161580385|NCT00421889|583513896|FG008|Overall Study|Death|0|||
161482656|NCT02615145|583162602|FG000|Overall Study|Failure to Return|20|||
161482657|NCT02615145|583162603|FG001|Overall Study|Failure to Return|10|||
161482658|NCT02615145|583162604|FG002|Overall Study|Failure to Return|7|||
161482659|NCT02615145|583162605|FG003|Overall Study|Failure to Return|0|||
161482660|NCT02615145|583162602|FG000|Overall Study|Death|2|||
161482661|NCT02615145|583162603|FG001|Overall Study|Death|3|||
161482662|NCT02615145|583162604|FG002|Overall Study|Death|0|||
161482663|NCT02615145|583162605|FG003|Overall Study|Death|0|||
161482664|NCT02615145|583162602|FG000|Overall Study|Other, Not Specified|5|||
161482665|NCT02615145|583162603|FG001|Overall Study|Other, Not Specified|2|||
161482666|NCT02615145|583162604|FG002|Overall Study|Other, Not Specified|0|||
161482667|NCT02615145|583162605|FG003|Overall Study|Other, Not Specified|0|||
161482668|NCT00006237|583162608|FG000|Overall Study|Adverse Event|39|||
161482669|NCT00006237|583162609|FG001|Overall Study|Adverse Event|29|||
161482670|NCT00006237|583162608|FG000|Overall Study|Death|1|||
161482671|NCT00006237|583162609|FG001|Overall Study|Death|0|||
161482672|NCT00006237|583162608|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
161482673|NCT00006237|583162609|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
161482674|NCT00006237|583162608|FG000|Overall Study|Progression/relapse|54|||
161482675|NCT00006237|583162609|FG001|Overall Study|Progression/relapse|2|||
161482676|NCT00006237|583162608|FG000|Overall Study|Not eligible|9|||
161482677|NCT00006237|583162609|FG001|Overall Study|Not eligible|20|||
161482678|NCT00006237|583162608|FG000|Overall Study|Withdrawal by Subject|0|||
161482679|NCT00006237|583162609|FG001|Overall Study|Withdrawal by Subject|1|||
161482680|NCT00006237|583162608|FG000|Overall Study|Not protocol specified|14|||
161482681|NCT00006237|583162609|FG001|Overall Study|Not protocol specified|5|||
161482682|NCT03648983|583162616|FG000|Overall Study|Study was terminated due to PI departure|95|||
161482683|NCT00911820|583164883|FG000|Overall Study|RECIST progression|12|||
161482684|NCT00911820|583164884|FG001|Overall Study|RECIST progression|8|||
161482685|NCT00911820|583164883|FG000|Overall Study|Adverse Event|8|||
161482686|NCT00911820|583164884|FG001|Overall Study|Adverse Event|8|||
161482687|NCT00911820|583164883|FG000|Overall Study|Clinical Progression|7|||
161482688|NCT00911820|583164884|FG001|Overall Study|Clinical Progression|5|||
161482689|NCT00911820|583164883|FG000|Overall Study|Physician Decision|5|||
161482690|NCT00911820|583164884|FG001|Overall Study|Physician Decision|9|||
161482691|NCT00911820|583164883|FG000|Overall Study|Decline in Performance Status|4|||
161482692|NCT00911820|583164884|FG001|Overall Study|Decline in Performance Status|2|||
161482693|NCT00911820|583164883|FG000|Overall Study|Withdrawal by Subject|3|||
161482694|NCT00911820|583164884|FG001|Overall Study|Withdrawal by Subject|4|||
161482695|NCT00911820|583164883|FG000|Overall Study|Death|1|||
161482696|NCT00911820|583164884|FG001|Overall Study|Death|2|||
161482697|NCT00911820|583164883|FG000|Overall Study|Pursue surgery|1|||
161482698|NCT00911820|583164884|FG001|Overall Study|Pursue surgery|1|||
161482699|NCT00911820|583164883|FG000|Overall Study|Pursue Radiation|1|||
161482700|NCT00911820|583164884|FG001|Overall Study|Pursue Radiation|0|||
161482701|NCT00911820|583164883|FG000|Overall Study|Still on Therapy|2|||
161482702|NCT00911820|583164884|FG001|Overall Study|Still on Therapy|2|||
161482703|NCT00911820|583164883|FG000|Overall Study|Pathology Not Confirmed|1|||
161482704|NCT00911820|583164884|FG001|Overall Study|Pathology Not Confirmed|0|||
161482705|NCT00911820|583164883|FG000|Overall Study|Withdraw before Receive Treatment|0|||
161482706|NCT00911820|583164884|FG001|Overall Study|Withdraw before Receive Treatment|2|||
161482707|NCT00996216|583164885|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
161482708|NCT00996216|583164885|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
161482709|NCT00996216|583164885|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
161482710|NCT01411774|583164886|FG000|Overall Study|Withdrawal by Subject|0|||
161482711|NCT01411774|583164887|FG001|Overall Study|Withdrawal by Subject|3|||
161482712|NCT03292588|583164888|FG000|Overall Study|Death|1|||
161482713|NCT03292588|583164889|FG001|Overall Study|Death|0|||
161482714|NCT03292588|583164888|FG000|Overall Study|Lost to Follow-up|12|||
161482715|NCT03292588|583164889|FG001|Overall Study|Lost to Follow-up|16|||
161482716|NCT03292588|583164888|FG000|Overall Study|Physician Decision|0|||
161482717|NCT03292588|583164889|FG001|Overall Study|Physician Decision|1|||
161482718|NCT03292588|583164888|FG000|Overall Study|Withdrawal by Subject|4|||
161482719|NCT03292588|583164889|FG001|Overall Study|Withdrawal by Subject|4|||
161482720|NCT03292588|583164888|FG000|Overall Study|Move out of town|1|||
161482721|NCT03292588|583164889|FG001|Overall Study|Move out of town|0|||
161482722|NCT03292588|583164888|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
161482723|NCT03292588|583164889|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
161482724|NCT05526716|583164895|FG000|Overall Study|Death|1|||
161482725|NCT05526716|583164896|FG001|Overall Study|Death|2|||
161482726|NCT05526716|583164895|FG000|Overall Study|Lost to Follow-up|17|||
161482727|NCT05526716|583164896|FG001|Overall Study|Lost to Follow-up|15|||
161482728|NCT05526716|583164895|FG000|Overall Study|Physician Decision|0|||
161580386|NCT00421889|583513888|FG000|Overall Study|Progressive disease|3|||
161580387|NCT00421889|583513889|FG001|Overall Study|Progressive disease|2|||
161482729|NCT05526716|583164896|FG001|Overall Study|Physician Decision|1|||
161482730|NCT05526716|583164895|FG000|Overall Study|Randomized by mistake without study treatment|0|||
161580388|NCT00421889|583513890|FG002|Overall Study|Progressive disease|2|||
161482731|NCT05526716|583164896|FG001|Overall Study|Randomized by mistake without study treatment|1|||
161482732|NCT05526716|583164895|FG000|Overall Study|Withdrawal by Subject|12|||
161482733|NCT05526716|583164896|FG001|Overall Study|Withdrawal by Subject|12|||
161482734|NCT05526716|583164895|FG000|Overall Study|Not reported|0|||
161482735|NCT05526716|583164896|FG001|Overall Study|Not reported|2|||
161482736|NCT04932096|583164899|FG000|Overall Study|Withdrawal by Subject|1|||
161482737|NCT04932096|583164900|FG001|Overall Study|Withdrawal by Subject|1|||
161482738|NCT04932096|583164899|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
161482739|NCT04932096|583164900|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
161482740|NCT01438957|583164901|FG000|Overall Study|Physician Decision|1|||
161482741|NCT01438957|583164902|FG001|Overall Study|Physician Decision|1|||
161482742|NCT01438957|583164903|FG002|Overall Study|Physician Decision|0|||
161482743|NCT01438957|583164904|FG003|Overall Study|Physician Decision|1|||
161482744|NCT01438957|583164905|FG004|Overall Study|Physician Decision|0|||
161482745|NCT03902574|583164907|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
161482746|NCT03902574|583164908|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
161482747|NCT03902574|583164909|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
161482748|NCT02101060|583164915|FG000|Overall Study|Adverse Event|1|||
161482749|NCT02101060|583164916|FG001|Overall Study|Adverse Event|0|||
161482750|NCT02101060|583164915|FG000|Overall Study|Withdrawal by Subject|1|||
161482751|NCT02101060|583164916|FG001|Overall Study|Withdrawal by Subject|1|||
161482752|NCT02101060|583164915|FG000|Overall Study|Lost to Follow-up|3|||
161482753|NCT02101060|583164916|FG001|Overall Study|Lost to Follow-up|3|||
161482754|NCT00545168|583164923|FG000|Overall Study|Lost to Follow-up|5|||
161482755|NCT00545168|583164924|FG001|Overall Study|Lost to Follow-up|5|||
161482756|NCT00545168|583164925|FG002|Overall Study|Lost to Follow-up|5|||
161482757|NCT00545168|583164923|FG000|Overall Study|Withdrawal by Subject|9|||
161482758|NCT00545168|583164924|FG001|Overall Study|Withdrawal by Subject|0|||
161482759|NCT00545168|583164925|FG002|Overall Study|Withdrawal by Subject|13|||
161482760|NCT00545168|583164923|FG000|Overall Study|Protocol Violation|1|||
161482761|NCT00545168|583164924|FG001|Overall Study|Protocol Violation|0|||
161482762|NCT00545168|583164925|FG002|Overall Study|Protocol Violation|1|||
161482763|NCT00545168|583164923|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
161482764|NCT00545168|583164924|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
161482765|NCT00545168|583164925|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
161482766|NCT01833520|583164928|FG000|Overall Study|Lack of Efficacy|3|||
161482767|NCT01833520|583164929|FG001|Overall Study|Lack of Efficacy|3|||
161482768|NCT01833520|583164930|FG002|Overall Study|Lack of Efficacy|8|||
161482769|NCT01833520|583164931|FG003|Overall Study|Lack of Efficacy|3|||
161482770|NCT04182763|583164941|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
161482771|NCT04182763|583164942|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
161482772|NCT04182763|583164943|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
161482773|NCT04182763|583164944|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
161482774|NCT04182763|583164945|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
161482775|NCT04182763|583164941|FG000|Double-Blind Period, initial 6 months|Death|0|||
161482776|NCT04182763|583164942|FG001|Double-Blind Period, initial 6 months|Death|1|||
161482777|NCT04182763|583164943|FG002|Double-Blind Period, initial 6 months|Death|0|||
161482778|NCT04182763|583164944|FG003|Double-Blind Period, initial 6 months|Death|0|||
161482779|NCT04182763|583164945|FG004|Double-Blind Period, initial 6 months|Death|0|||
161482780|NCT04182763|583164941|FG000|Open-Label Period, subsequent 18 months|Death|3|||
161482781|NCT04182763|583164942|FG001|Open-Label Period, subsequent 18 months|Death|2|||
161482782|NCT04182763|583164943|FG002|Open-Label Period, subsequent 18 months|Death|2|||
161482783|NCT04182763|583164944|FG003|Open-Label Period, subsequent 18 months|Death|0|||
161482784|NCT04182763|583164945|FG004|Open-Label Period, subsequent 18 months|Death|1|||
161482785|NCT04182763|583164941|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
161482786|NCT04182763|583164942|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
161482787|NCT04182763|583164943|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
161482788|NCT04182763|583164944|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
161482789|NCT04182763|583164945|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
161482790|NCT04182763|583164941|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
161482791|NCT04182763|583164942|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
161482792|NCT04182763|583164943|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
161482793|NCT04182763|583164944|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
161580389|NCT00421889|583513891|FG003|Overall Study|Progressive disease|3|||
161580390|NCT00421889|583513892|FG004|Overall Study|Progressive disease|2|||
161580391|NCT00421889|583513893|FG005|Overall Study|Progressive disease|21|||
161580392|NCT00421889|583513894|FG006|Overall Study|Progressive disease|3|||
161580393|NCT00421889|583513895|FG007|Overall Study|Progressive disease|1|||
161580394|NCT00421889|583513896|FG008|Overall Study|Progressive disease|5|||
161580395|NCT00421889|583513888|FG000|Overall Study|Patient/Investigator request|0|||
161580396|NCT00421889|583513889|FG001|Overall Study|Patient/Investigator request|0|||
161482794|NCT04182763|583164945|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
161482795|NCT00003479|583164949|FG000|Overall Study|Not evaluable|3|||
161482796|NCT01484197|583164962|FG000|Treatment Period 1|Adverse Event|1|||
161482797|NCT01484197|583164963|FG001|Treatment Period 1|Adverse Event|0|||
161482798|NCT01484197|583164964|FG002|Treatment Period 1|Adverse Event|0|||
161482799|NCT01484197|583164965|FG003|Treatment Period 1|Adverse Event|0|||
161482800|NCT01484197|583164962|FG000|Treatment Period 2|Subject withdrew consent|0|||
161482801|NCT01484197|583164963|FG001|Treatment Period 2|Subject withdrew consent|0|||
161482802|NCT01484197|583164964|FG002|Treatment Period 2|Subject withdrew consent|0|||
161482803|NCT01484197|583164965|FG003|Treatment Period 2|Subject withdrew consent|1|||
161482804|NCT01727297|583164966|FG000|Overall Study|Death|13|||
161482805|NCT01727297|583164967|FG001|Overall Study|Death|0|||
161482806|NCT01727297|583164966|FG000|Overall Study|Protocol Violation|1|||
161482807|NCT01727297|583164967|FG001|Overall Study|Protocol Violation|10|||
161482808|NCT01727297|583164966|FG000|Overall Study|Adverse Event|3|||
161482809|NCT01727297|583164967|FG001|Overall Study|Adverse Event|1|||
161482810|NCT01727297|583164966|FG000|Overall Study|Lost to Follow-up|11|||
161482811|NCT01727297|583164967|FG001|Overall Study|Lost to Follow-up|0|||
161482812|NCT01727297|583164966|FG000|Overall Study|Withdrawal by Subject|26|||
161482813|NCT01727297|583164967|FG001|Overall Study|Withdrawal by Subject|27|||
161482814|NCT01727297|583164966|FG000|Overall Study|Physician Decision|19|||
161482815|NCT01727297|583164967|FG001|Overall Study|Physician Decision|5|||
161482816|NCT01727297|583164966|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
161482817|NCT01727297|583164967|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
161482818|NCT02244606|583164968|FG000|Overall Study|Adverse Event|0|||
161482819|NCT02244606|583164969|FG001|Overall Study|Adverse Event|1|||
161482820|NCT02244606|583164970|FG002|Overall Study|Adverse Event|1|||
161482821|NCT02244606|583164971|FG003|Overall Study|Adverse Event|0|||
161482822|NCT02244606|583164968|FG000|Overall Study|Lost to Follow-up|2|||
161482823|NCT02244606|583164969|FG001|Overall Study|Lost to Follow-up|2|||
161482824|NCT02244606|583164970|FG002|Overall Study|Lost to Follow-up|1|||
161482825|NCT02244606|583164971|FG003|Overall Study|Lost to Follow-up|0|||
161482826|NCT02244606|583164968|FG000|Overall Study|Protocol Violation|0|||
161482827|NCT02244606|583164969|FG001|Overall Study|Protocol Violation|0|||
161482828|NCT02244606|583164970|FG002|Overall Study|Protocol Violation|0|||
161482829|NCT02244606|583164971|FG003|Overall Study|Protocol Violation|1|||
161482830|NCT02244606|583164968|FG000|Overall Study|Withdrawal by Subject|1|||
161482831|NCT02244606|583164969|FG001|Overall Study|Withdrawal by Subject|1|||
161482832|NCT02244606|583164970|FG002|Overall Study|Withdrawal by Subject|0|||
161482833|NCT02244606|583164971|FG003|Overall Study|Withdrawal by Subject|0|||
161482834|NCT02244606|583164968|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
161482835|NCT02244606|583164969|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
161482836|NCT02244606|583164970|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
161482837|NCT02244606|583164971|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
161482838|NCT02321800|583164977|FG000|Overall Study|Withdrawal by Subject|3|||
161482839|NCT02321800|583164978|FG001|Overall Study|Withdrawal by Subject|3|||
161482840|NCT02321800|583164977|FG000|Overall Study|Death|1|||
161482841|NCT02321800|583164978|FG001|Overall Study|Death|0|||
161482842|NCT02321800|583164977|FG000|Overall Study|Protocol Violation|1|||
161482843|NCT02321800|583164978|FG001|Overall Study|Protocol Violation|0|||
161482844|NCT02321800|583164977|FG000|Overall Study|Lost to Follow-up|10|||
161482845|NCT02321800|583164978|FG001|Overall Study|Lost to Follow-up|4|||
161482846|NCT02321800|583164977|FG000|Overall Study|Adverse Event|2|||
161482847|NCT02321800|583164978|FG001|Overall Study|Adverse Event|3|||
161482848|NCT02321800|583164977|FG000|Overall Study|Other, Miscellaneous|3|||
161482849|NCT02321800|583164978|FG001|Overall Study|Other, Miscellaneous|1|||
161482850|NCT00982878|583164982|FG000|Overall Study|Physician Decision|1|||
161482851|NCT00642460|583164988|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
161482852|NCT00642460|583164989|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
161482853|NCT00642460|583164990|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
161482854|NCT00642460|583164991|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
161482855|NCT00642460|583164992|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
161482856|NCT00642460|583164993|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
161482857|NCT00642460|583164988|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
161580397|NCT00421889|583513890|FG002|Overall Study|Patient/Investigator request|0|||
161482858|NCT00642460|583164989|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
161482859|NCT00642460|583164990|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
161482860|NCT00642460|583164991|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
161482861|NCT00642460|583164992|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
161580398|NCT00421889|583513891|FG003|Overall Study|Patient/Investigator request|0|||
161482862|NCT00642460|583164993|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
161482863|NCT00642460|583164988|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
161482864|NCT00642460|583164989|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
161482865|NCT00642460|583164990|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
161816553|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816554|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
161580399|NCT00421889|583513892|FG004|Overall Study|Patient/Investigator request|0|||
161580400|NCT00421889|583513893|FG005|Overall Study|Patient/Investigator request|9|||
161580401|NCT00421889|583513894|FG006|Overall Study|Patient/Investigator request|0|||
161580402|NCT00421889|583513895|FG007|Overall Study|Patient/Investigator request|1|||
161580403|NCT00421889|583513896|FG008|Overall Study|Patient/Investigator request|3|||
161580404|NCT00421889|583513888|FG000|Overall Study|Lost to Follow-up|0|||
161580405|NCT00421889|583513889|FG001|Overall Study|Lost to Follow-up|0|||
161816555|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Death|0|||
161921502|NCT02916771|584757237|FG000|Overall Study|Began treatment for another active malignancy|1|||
161921503|NCT00479232|584758121|FG000|Overall Study|Adverse Event|0|||
161921504|NCT00479232|584758122|FG001|Overall Study|Adverse Event|0|||
161921505|NCT00479232|584758123|FG002|Overall Study|Adverse Event|5|||
161482866|NCT00642460|583164991|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
161921506|NCT00479232|584758124|FG003|Overall Study|Adverse Event|0|||
161921507|NCT00479232|584758125|FG004|Overall Study|Adverse Event|0|||
161921508|NCT00479232|584758126|FG005|Overall Study|Adverse Event|10|||
161921509|NCT00479232|584758121|FG000|Overall Study|Deviation from Protocol|0|||
161921510|NCT00479232|584758122|FG001|Overall Study|Deviation from Protocol|0|||
161921511|NCT00479232|584758123|FG002|Overall Study|Deviation from Protocol|1|||
161921512|NCT00479232|584758124|FG003|Overall Study|Deviation from Protocol|0|||
161921513|NCT00479232|584758125|FG004|Overall Study|Deviation from Protocol|0|||
161921514|NCT00479232|584758126|FG005|Overall Study|Deviation from Protocol|0|||
161921515|NCT00479232|584758121|FG000|Overall Study|Lack of Efficacy|0|||
161921516|NCT00479232|584758122|FG001|Overall Study|Lack of Efficacy|0|||
161921517|NCT00479232|584758123|FG002|Overall Study|Lack of Efficacy|2|||
161921518|NCT00479232|584758124|FG003|Overall Study|Lack of Efficacy|0|||
161921519|NCT00479232|584758125|FG004|Overall Study|Lack of Efficacy|0|||
161921520|NCT00479232|584758126|FG005|Overall Study|Lack of Efficacy|4|||
161921521|NCT00479232|584758121|FG000|Overall Study|Physician Decision|0|||
161921522|NCT00479232|584758122|FG001|Overall Study|Physician Decision|0|||
161921523|NCT00479232|584758123|FG002|Overall Study|Physician Decision|2|||
161921524|NCT00479232|584758124|FG003|Overall Study|Physician Decision|0|||
161921525|NCT00479232|584758125|FG004|Overall Study|Physician Decision|0|||
161921526|NCT00479232|584758126|FG005|Overall Study|Physician Decision|1|||
161921527|NCT00479232|584758121|FG000|Overall Study|Progressive Disease|3|||
161921528|NCT00479232|584758122|FG001|Overall Study|Progressive Disease|1|||
161921529|NCT00479232|584758123|FG002|Overall Study|Progressive Disease|12|||
161921530|NCT00479232|584758124|FG003|Overall Study|Progressive Disease|3|||
161921531|NCT00479232|584758125|FG004|Overall Study|Progressive Disease|3|||
161921532|NCT00479232|584758126|FG005|Overall Study|Progressive Disease|12|||
161921533|NCT00479232|584758121|FG000|Overall Study|Withdrew Consent|0|||
161921534|NCT00479232|584758122|FG001|Overall Study|Withdrew Consent|2|||
161921535|NCT00479232|584758123|FG002|Overall Study|Withdrew Consent|6|||
161921536|NCT00479232|584758124|FG003|Overall Study|Withdrew Consent|0|||
161921537|NCT00479232|584758125|FG004|Overall Study|Withdrew Consent|1|||
161921538|NCT00479232|584758126|FG005|Overall Study|Withdrew Consent|3|||
161921539|NCT02260986|584758127|FG000|Overall Study|Adverse Event|24|||
161921540|NCT02260986|584758128|FG001|Overall Study|Adverse Event|0|||
161921541|NCT02260986|584758129|FG002|Overall Study|Adverse Event|11|||
161921542|NCT02260986|584758127|FG000|Overall Study|Lack of Efficacy|27|||
161921543|NCT02260986|584758128|FG001|Overall Study|Lack of Efficacy|3|||
161921544|NCT02260986|584758129|FG002|Overall Study|Lack of Efficacy|0|||
161921545|NCT02260986|584758127|FG000|Overall Study|Protocol Violation|14|||
161921546|NCT02260986|584758128|FG001|Overall Study|Protocol Violation|5|||
161921547|NCT02260986|584758129|FG002|Overall Study|Protocol Violation|16|||
161921548|NCT02260986|584758127|FG000|Overall Study|Car accident|0|||
161921549|NCT02260986|584758128|FG001|Overall Study|Car accident|0|||
161921550|NCT02260986|584758129|FG002|Overall Study|Car accident|1|||
161921551|NCT02260986|584758127|FG000|Overall Study|Withdrawal by Subject|17|||
161921552|NCT02260986|584758128|FG001|Overall Study|Withdrawal by Subject|4|||
161921553|NCT02260986|584758129|FG002|Overall Study|Withdrawal by Subject|9|||
161921554|NCT02260986|584758127|FG000|Overall Study|Incorrect randomization|0|||
161921555|NCT02260986|584758128|FG001|Overall Study|Incorrect randomization|1|||
161921556|NCT02260986|584758129|FG002|Overall Study|Incorrect randomization|0|||
161921557|NCT02260986|584758127|FG000|Overall Study|Lack of investigation product supply|2|||
161921558|NCT02260986|584758128|FG001|Overall Study|Lack of investigation product supply|0|||
161921559|NCT02260986|584758129|FG002|Overall Study|Lack of investigation product supply|1|||
161921560|NCT02260986|584758127|FG000|Overall Study|Lost to Follow-up|4|||
161921561|NCT02260986|584758128|FG001|Overall Study|Lost to Follow-up|0|||
161921562|NCT02260986|584758129|FG002|Overall Study|Lost to Follow-up|3|||
161921563|NCT02260986|584758127|FG000|Overall Study|Pregnancy|2|||
161482867|NCT00642460|583164992|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
161921564|NCT02260986|584758128|FG001|Overall Study|Pregnancy|0|||
161921565|NCT02260986|584758129|FG002|Overall Study|Pregnancy|0|||
161921566|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Adverse Event|2|||
161921567|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
161921568|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
161921569|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
161921570|NCT02536794|584758131|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
161921571|NCT02536794|584758131|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
161921572|NCT00313170|584758132|FG000|Overall Study|Death|2|||
161921573|NCT00313170|584758133|FG001|Overall Study|Death|4|||
161921574|NCT00313170|584758134|FG002|Overall Study|Death|2|||
161921575|NCT00313170|584758132|FG000|Overall Study|Adverse Event|1|||
161921576|NCT00313170|584758133|FG001|Overall Study|Adverse Event|2|||
161921577|NCT00313170|584758134|FG002|Overall Study|Adverse Event|0|||
161482868|NCT00642460|583164993|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
161482869|NCT00642460|583164988|FG000|Part II: Open-Label Up to Week 92|Death|0|||
161482870|NCT00642460|583164989|FG001|Part II: Open-Label Up to Week 92|Death|1|||
161482871|NCT00642460|583164990|FG002|Part II: Open-Label Up to Week 92|Death|0|||
161482872|NCT00642460|583164991|FG003|Part II: Open-Label Up to Week 92|Death|2|||
161482873|NCT00642460|583164992|FG004|Part II: Open-Label Up to Week 92|Death|0|||
161482874|NCT00642460|583164993|FG005|Part II: Open-Label Up to Week 92|Death|0|||
161482875|NCT00642460|583164988|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
161482876|NCT00642460|583164989|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
161482877|NCT00642460|583164990|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
161482878|NCT00642460|583164991|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
161482879|NCT00642460|583164992|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
161482880|NCT00642460|583164993|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
161482881|NCT00642460|583164988|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
161482882|NCT00642460|583164989|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
161482883|NCT00642460|583164990|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
161482884|NCT00642460|583164991|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
161482885|NCT00642460|583164992|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
161482886|NCT00642460|583164993|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
161482887|NCT00642460|583164988|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
161482888|NCT00642460|583164989|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
161482889|NCT00642460|583164990|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
161482890|NCT00642460|583164991|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
161482891|NCT00642460|583164992|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
161482892|NCT00642460|583164993|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
161482893|NCT00642460|583164988|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
161482894|NCT00642460|583164989|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
161482895|NCT00642460|583164990|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
161482896|NCT00642460|583164991|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
161482897|NCT00642460|583164992|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
161482898|NCT00642460|583164993|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
161482899|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
161482900|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
161482901|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
161482902|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
161482903|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
161482904|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
161482905|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
161482906|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
161580406|NCT00421889|583513890|FG002|Overall Study|Lost to Follow-up|0|||
161580407|NCT00421889|583513891|FG003|Overall Study|Lost to Follow-up|0|||
161580408|NCT00421889|583513892|FG004|Overall Study|Lost to Follow-up|0|||
161580409|NCT00421889|583513893|FG005|Overall Study|Lost to Follow-up|0|||
161580410|NCT00421889|583513894|FG006|Overall Study|Lost to Follow-up|0|||
161580411|NCT00421889|583513895|FG007|Overall Study|Lost to Follow-up|0|||
161580412|NCT00421889|583513896|FG008|Overall Study|Lost to Follow-up|1|||
161580413|NCT03051165|583513900|FG000|Overall Study|Withdrawal by Subject|1|||
161580414|NCT03051165|583513900|FG000|Overall Study|Early termination of study|12|||
161580415|NCT03684044|583513905|FG000|Overall Study|Adverse Event|3|||
161580416|NCT03684044|583513906|FG001|Overall Study|Adverse Event|0|||
161580417|NCT03684044|583513905|FG000|Overall Study|Death|4|||
161580418|NCT03684044|583513906|FG001|Overall Study|Death|7|||
161580419|NCT03684044|583513905|FG000|Overall Study|Lost to Follow-up|3|||
161580420|NCT03684044|583513906|FG001|Overall Study|Lost to Follow-up|2|||
161580421|NCT03684044|583513905|FG000|Overall Study|Patient Not Available|0|||
161580422|NCT03684044|583513906|FG001|Overall Study|Patient Not Available|2|||
161580423|NCT03684044|583513905|FG000|Overall Study|Physician Decision|1|||
161580424|NCT03684044|583513906|FG001|Overall Study|Physician Decision|0|||
161580425|NCT03684044|583513905|FG000|Overall Study|Withdrawal by Subject|11|||
161580426|NCT03684044|583513906|FG001|Overall Study|Withdrawal by Subject|9|||
161580427|NCT03703336|583513907|FG000|Overall Study|Parent withdrew consent|29|||
161580428|NCT03703336|583513908|FG001|Overall Study|Parent withdrew consent|8|||
161580429|NCT03703336|583513907|FG000|Overall Study|Migration|3|||
161669904|NCT02121834|583843178|FG001|Overall Study|Withdrawal by Subject|1|||
161669905|NCT02121834|583843179|FG002|Overall Study|Withdrawal by Subject|1|||
161669906|NCT02121834|583843180|FG003|Overall Study|Withdrawal by Subject|0|||
161921578|NCT00313170|584758132|FG000|Overall Study|Disease progression|31|||
161580430|NCT03703336|583513908|FG001|Overall Study|Migration|3|||
161580431|NCT03703336|583513907|FG000|Overall Study|Protocol Violation|3|||
161580432|NCT03703336|583513908|FG001|Overall Study|Protocol Violation|1|||
161580433|NCT03703336|583513907|FG000|Overall Study|Physician Decision|2|||
161921579|NCT00313170|584758133|FG001|Overall Study|Disease progression|26|||
161580434|NCT03703336|583513908|FG001|Overall Study|Physician Decision|0|||
161580435|NCT03703336|583513907|FG000|Overall Study|Adverse Event|0|||
161580436|NCT03703336|583513908|FG001|Overall Study|Adverse Event|2|||
161580437|NCT03703336|583513907|FG000|Overall Study|Lost to Follow-up|1|||
161580438|NCT03703336|583513908|FG001|Overall Study|Lost to Follow-up|0|||
161580439|NCT00595413|583513909|FG000|Overall Study|Adverse Event|0|||
161580440|NCT00595413|583513910|FG001|Overall Study|Adverse Event|2|||
161580441|NCT00595413|583513911|FG002|Overall Study|Adverse Event|1|||
161580442|NCT00595413|583513912|FG003|Overall Study|Adverse Event|1|||
161580443|NCT00595413|583513909|FG000|Overall Study|Lost to Follow-up|2|||
161580444|NCT00595413|583513910|FG001|Overall Study|Lost to Follow-up|2|||
161580445|NCT00595413|583513911|FG002|Overall Study|Lost to Follow-up|1|||
161580446|NCT00595413|583513912|FG003|Overall Study|Lost to Follow-up|3|||
161580447|NCT00595413|583513909|FG000|Overall Study|Death|0|||
161580448|NCT00595413|583513910|FG001|Overall Study|Death|0|||
161580449|NCT00595413|583513911|FG002|Overall Study|Death|1|||
161580450|NCT00595413|583513912|FG003|Overall Study|Death|0|||
161580451|NCT00595413|583513909|FG000|Overall Study|Other|5|||
161580452|NCT00595413|583513910|FG001|Overall Study|Other|1|||
161580453|NCT00595413|583513911|FG002|Overall Study|Other|5|||
161580454|NCT00595413|583513912|FG003|Overall Study|Other|0|||
161580455|NCT00807937|583513913|FG000|Overall Study|Adverse Event|12|||
161580456|NCT00807937|583513914|FG001|Overall Study|Adverse Event|12|||
161580457|NCT00807937|583513915|FG002|Overall Study|Adverse Event|5|||
161580458|NCT00807937|583513916|FG003|Overall Study|Adverse Event|4|||
161580459|NCT00807937|583513913|FG000|Overall Study|Protocol Violation|4|||
161580460|NCT00807937|583513914|FG001|Overall Study|Protocol Violation|5|||
161580461|NCT00807937|583513915|FG002|Overall Study|Protocol Violation|3|||
161580462|NCT00807937|583513916|FG003|Overall Study|Protocol Violation|3|||
161580463|NCT00807937|583513913|FG000|Overall Study|Withdrawal by Subject|5|||
161580464|NCT00807937|583513914|FG001|Overall Study|Withdrawal by Subject|4|||
161580465|NCT00807937|583513915|FG002|Overall Study|Withdrawal by Subject|1|||
161580466|NCT00807937|583513916|FG003|Overall Study|Withdrawal by Subject|4|||
161580467|NCT00807937|583513913|FG000|Overall Study|Lost to Follow-up|4|||
161580468|NCT00807937|583513914|FG001|Overall Study|Lost to Follow-up|0|||
161580469|NCT00807937|583513915|FG002|Overall Study|Lost to Follow-up|2|||
161580470|NCT00807937|583513916|FG003|Overall Study|Lost to Follow-up|1|||
161580471|NCT00807937|583513913|FG000|Overall Study|Lack of Efficacy|0|||
161580472|NCT00807937|583513914|FG001|Overall Study|Lack of Efficacy|0|||
161816556|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Death|0|||
161816557|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Death|0|||
161816558|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Death|0|||
161816559|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Death|0|||
161816560|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Death|0|||
161816561|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Death|0|||
161816562|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Death|0|||
161816563|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Death|0|||
161816564|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Death|0|||
161816565|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Death|0|||
161921580|NCT00313170|584758134|FG002|Overall Study|Disease progression|27|||
161921581|NCT00313170|584758132|FG000|Overall Study|Withdrawal by Subject|1|||
161921582|NCT00313170|584758133|FG001|Overall Study|Withdrawal by Subject|0|||
161921583|NCT00313170|584758134|FG002|Overall Study|Withdrawal by Subject|1|||
161921584|NCT00313170|584758132|FG000|Overall Study|Incorrect enrollment|0|||
161921585|NCT00313170|584758133|FG001|Overall Study|Incorrect enrollment|2|||
161921586|NCT00313170|584758134|FG002|Overall Study|Incorrect enrollment|1|||
161921587|NCT00313170|584758132|FG000|Overall Study|Lost to Follow-up|0|||
161921588|NCT00313170|584758133|FG001|Overall Study|Lost to Follow-up|0|||
161921589|NCT00313170|584758134|FG002|Overall Study|Lost to Follow-up|1|||
161921590|NCT00313170|584758132|FG000|Overall Study|Progression (investigators opinion)|1|||
161921591|NCT00313170|584758133|FG001|Overall Study|Progression (investigators opinion)|0|||
161921592|NCT00313170|584758134|FG002|Overall Study|Progression (investigators opinion)|0|||
161921593|NCT01521364|584758140|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
161921594|NCT01521364|584758140|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
161921595|NCT02447029|584758144|FG000|Overall Study|Withdrawal by Subject|3|||
161921596|NCT02447029|584758145|FG001|Overall Study|Withdrawal by Subject|2|||
161921597|NCT04132050|584758151|FG000|Period I (Double-blind Period)|Adverse Event|3|||
161921598|NCT04132050|584758152|FG001|Period I (Double-blind Period)|Adverse Event|0|||
161921599|NCT04132050|584758151|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
161921600|NCT04132050|584758152|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
161921601|NCT04132050|584758151|FG000|R788 Treatment Period|Adverse Event|5|||
161580473|NCT00807937|583513915|FG002|Overall Study|Lack of Efficacy|1|||
161580474|NCT00807937|583513916|FG003|Overall Study|Lack of Efficacy|2|||
161580475|NCT00807937|583513913|FG000|Overall Study|Intake of prohibited medicine|0|||
161580476|NCT00807937|583513914|FG001|Overall Study|Intake of prohibited medicine|0|||
161921602|NCT04132050|584758152|FG001|R788 Treatment Period|Adverse Event|0|||
161921603|NCT04132050|584758151|FG000|R788 Treatment Period|Lack of Efficacy|5|||
161921604|NCT04132050|584758152|FG001|R788 Treatment Period|Lack of Efficacy|0|||
161482907|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
161482908|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
161482909|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
161482910|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
161482911|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
161482912|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
161482913|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
161482914|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
161482915|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
161580477|NCT00807937|583513915|FG002|Overall Study|Intake of prohibited medicine|2|||
161580478|NCT00807937|583513916|FG003|Overall Study|Intake of prohibited medicine|0|||
161580479|NCT00807937|583513913|FG000|Overall Study|All other reasons (not provided)|2|||
161580480|NCT00807937|583513914|FG001|Overall Study|All other reasons (not provided)|4|||
161580481|NCT00807937|583513915|FG002|Overall Study|All other reasons (not provided)|0|||
161580482|NCT00807937|583513916|FG003|Overall Study|All other reasons (not provided)|1|||
161580483|NCT04629950|583513919|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
161580484|NCT04629950|583513920|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
161921605|NCT04132050|584758151|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
161921606|NCT04132050|584758152|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
161921607|NCT02406612|584758163|FG000|Overall Study|Screening Failure|3|||
161921608|NCT02406612|584758164|FG001|Overall Study|Screening Failure|0|||
161921609|NCT02406612|584758163|FG000|Overall Study|Intra-procedural Exclusion|1|||
161921610|NCT02406612|584758164|FG001|Overall Study|Intra-procedural Exclusion|3|||
161921611|NCT02406612|584758163|FG000|Overall Study|Guidewire Failure|0|||
161921612|NCT02406612|584758164|FG001|Overall Study|Guidewire Failure|1|||
161921613|NCT03483012|584758168|FG000|Overall Study|Lack of Efficacy|6|||
161921614|NCT02900976|584758169|FG000|Overall Study|Adverse Event|0|||
161921615|NCT02900976|584758170|FG001|Overall Study|Adverse Event|1|||
161921616|NCT02900976|584758169|FG000|Overall Study|Physician Decision|0|||
161921617|NCT02900976|584758170|FG001|Overall Study|Physician Decision|2|||
161921618|NCT02900976|584758169|FG000|Overall Study|Progressive disease|0|||
161921619|NCT02900976|584758170|FG001|Overall Study|Progressive disease|6|||
161921620|NCT03611946|584758177|FG000|Overall Study|Withdrawal by Subject|0|||
161921621|NCT03611946|584758178|FG001|Overall Study|Withdrawal by Subject|0|||
161921622|NCT03611946|584758179|FG002|Overall Study|Withdrawal by Subject|1|||
161921623|NCT03611946|584758180|FG003|Overall Study|Withdrawal by Subject|0|||
161921624|NCT03069989|584758185|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
161921625|NCT03069989|584758186|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
161921626|NCT02872714|584758187|FG000|Overall Study|Progressive Disease|1|||
161921627|NCT02872714|584758188|FG001|Overall Study|Progressive Disease|2|||
161921628|NCT02872714|584758189|FG002|Overall Study|Progressive Disease|0|||
161921629|NCT02872714|584758190|FG003|Overall Study|Progressive Disease|0|||
161921630|NCT02872714|584758191|FG004|Overall Study|Progressive Disease|0|||
161921631|NCT02872714|584758187|FG000|Overall Study|Death|87|||
161921632|NCT02872714|584758188|FG001|Overall Study|Death|36|||
161921633|NCT02872714|584758189|FG002|Overall Study|Death|8|||
161921634|NCT02872714|584758190|FG003|Overall Study|Death|81|||
161921635|NCT02872714|584758191|FG004|Overall Study|Death|2|||
161921636|NCT02872714|584758187|FG000|Overall Study|Lost to Follow-up|2|||
161921637|NCT02872714|584758188|FG001|Overall Study|Lost to Follow-up|1|||
161921638|NCT02872714|584758189|FG002|Overall Study|Lost to Follow-up|0|||
161921639|NCT02872714|584758190|FG003|Overall Study|Lost to Follow-up|3|||
161921640|NCT02872714|584758191|FG004|Overall Study|Lost to Follow-up|0|||
161921641|NCT02872714|584758187|FG000|Overall Study|Physician Decision|0|||
161921642|NCT02872714|584758188|FG001|Overall Study|Physician Decision|0|||
161921643|NCT02872714|584758189|FG002|Overall Study|Physician Decision|0|||
161921644|NCT02872714|584758190|FG003|Overall Study|Physician Decision|1|||
161921645|NCT02872714|584758191|FG004|Overall Study|Physician Decision|0|||
161921646|NCT02872714|584758187|FG000|Overall Study|Withdrawal by Subject|1|||
161921647|NCT02872714|584758188|FG001|Overall Study|Withdrawal by Subject|3|||
161482916|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
161482917|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
161921648|NCT02872714|584758189|FG002|Overall Study|Withdrawal by Subject|0|||
161921649|NCT02872714|584758190|FG003|Overall Study|Withdrawal by Subject|2|||
161921650|NCT02872714|584758191|FG004|Overall Study|Withdrawal by Subject|0|||
161921651|NCT02872714|584758187|FG000|Overall Study|Captured as Other|2|||
161921652|NCT02872714|584758188|FG001|Overall Study|Captured as Other|0|||
161921653|NCT02872714|584758189|FG002|Overall Study|Captured as Other|0|||
161921654|NCT02872714|584758190|FG003|Overall Study|Captured as Other|1|||
161921655|NCT02872714|584758191|FG004|Overall Study|Captured as Other|0|||
161921656|NCT06717399|584758192|FG000|Overall Study|Death|1|||
161921657|NCT03043573|584758195|FG000|Overall Study|Lost to Follow-up|3|||
161921658|NCT03043573|584758196|FG001|Overall Study|Lost to Follow-up|3|||
161921659|NCT03043573|584758195|FG000|Overall Study|Physician Decision|0|||
161482918|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
161482919|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
161482920|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
161482921|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
161482922|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
161482923|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Other|0|||
161482924|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Other|0|||
161482925|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Other|0|||
161482926|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Other|0|||
161482927|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Other|2|||
161482928|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Other|2|||
161482929|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Death|0|||
161482930|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Death|0|||
161921660|NCT03043573|584758196|FG001|Overall Study|Physician Decision|5|||
161482931|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Death|0|||
161482932|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Death|0|||
161482933|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Death|0|||
161482934|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Death|3|||
161482935|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
161482936|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
161482937|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
161482938|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
161482939|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
161482940|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
161482941|NCT00642460|583164988|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
161482942|NCT00642460|583164989|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
161482943|NCT00642460|583164990|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
161482944|NCT00642460|583164991|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
161482945|NCT00642460|583164992|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
161482946|NCT00642460|583164993|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
161482947|NCT04605484|583164996|FG000|Overall Study|Lost to Follow-up|0|||
161482948|NCT04605484|583164997|FG001|Overall Study|Lost to Follow-up|1|||
161482949|NCT04605484|583164998|FG002|Overall Study|Lost to Follow-up|1|||
161482950|NCT04605484|583164996|FG000|Overall Study|Other|0|||
161482951|NCT04605484|583164997|FG001|Overall Study|Other|1|||
161482952|NCT04605484|583164998|FG002|Overall Study|Other|0|||
161482953|NCT03366337|583164999|FG000|Overall Study|Lost to Follow-up|1|||
161482954|NCT03366337|583165000|FG001|Overall Study|Lost to Follow-up|0|||
161482955|NCT03366337|583165001|FG002|Overall Study|Lost to Follow-up|1|||
161482956|NCT03366337|583165002|FG003|Overall Study|Lost to Follow-up|0|||
161482957|NCT03366337|583164999|FG000|Overall Study|Withdrawal by Subject|2|||
161482958|NCT03366337|583165000|FG001|Overall Study|Withdrawal by Subject|0|||
161482959|NCT03366337|583165001|FG002|Overall Study|Withdrawal by Subject|1|||
161482960|NCT03366337|583165002|FG003|Overall Study|Withdrawal by Subject|1|||
161482961|NCT01697566|583165011|FG000|Overall Study|Withdrawal by Subject|0|||
161482962|NCT01697566|583165012|FG001|Overall Study|Withdrawal by Subject|0|||
161482963|NCT01697566|583165013|FG002|Overall Study|Withdrawal by Subject|1|||
161482964|NCT01697566|583165014|FG003|Overall Study|Withdrawal by Subject|1|||
161482965|NCT01697566|583165011|FG000|Overall Study|Final biopsy not obtained|0|||
161482966|NCT01697566|583165012|FG001|Overall Study|Final biopsy not obtained|0|||
161482967|NCT01697566|583165013|FG002|Overall Study|Final biopsy not obtained|1|||
161482968|NCT01697566|583165014|FG003|Overall Study|Final biopsy not obtained|0|||
161482969|NCT01447433|583165015|FG000|Overall Study|Lost to Follow-up|0|||
161482970|NCT01447433|583165016|FG001|Overall Study|Lost to Follow-up|2|||
161482971|NCT01447433|583165015|FG000|Overall Study|Withdrawal by Subject|3|||
161921661|NCT03043573|584758195|FG000|Overall Study|Withdrawal by Subject|0|||
161482972|NCT01447433|583165016|FG001|Overall Study|Withdrawal by Subject|3|||
161482973|NCT01447433|583165015|FG000|Overall Study|Protocol Violation|1|||
161482974|NCT01447433|583165016|FG001|Overall Study|Protocol Violation|1|||
161482975|NCT01578187|583165017|FG000|Usability Phase|Withdrawal by Subject|1|||
161482976|NCT02516163|583165022|FG000|Overall Study|Withdrawal by Subject|1|||
161482977|NCT02516163|583165022|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
161482978|NCT02516163|583165022|FG000|Overall Study|Unfit/delay in surgery|3|||
161482979|NCT02516163|583165022|FG000|Overall Study|Use of incorrect measurement technique|5|||
161482980|NCT02516163|583165022|FG000|Overall Study|Data not recorded|2|||
161482981|NCT02516163|583165022|FG000|Overall Study|MRI contraindication exclusion|6|||
161921662|NCT03043573|584758196|FG001|Overall Study|Withdrawal by Subject|4|||
161482982|NCT01217814|583165023|FG000|Overall Study|Adverse Event|1|||
161482983|NCT01217814|583165024|FG001|Overall Study|Adverse Event|1|||
161580485|NCT04629950|583513921|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
161580486|NCT04629950|583513922|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
161482984|NCT01217814|583165025|FG002|Overall Study|Adverse Event|0|||
161580487|NCT04629950|583513919|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161921663|NCT03580928|584758197|FG000|Overall Study|Death|0|||
161482985|NCT01217814|583165023|FG000|Overall Study|Lack of Efficacy|0|||
161482986|NCT01217814|583165024|FG001|Overall Study|Lack of Efficacy|0|||
161482987|NCT01217814|583165025|FG002|Overall Study|Lack of Efficacy|1|||
161482988|NCT01658072|583165026|FG000|Overall Study|Protocol Violation|4|||
161482989|NCT01658072|583165027|FG001|Overall Study|Protocol Violation|2|||
161482990|NCT00040664|583165028|FG000|Overall Study|Adverse Event|12|||
161482991|NCT00040664|583165029|FG001|Overall Study|Adverse Event|3|||
161482992|NCT00040664|583165030|FG002|Overall Study|Adverse Event|2|||
161482993|NCT00040664|583165031|FG003|Overall Study|Adverse Event|7|||
161482994|NCT00040664|583165028|FG000|Overall Study|Lack of Efficacy|9|||
161482995|NCT00040664|583165029|FG001|Overall Study|Lack of Efficacy|2|||
161482996|NCT00040664|583165030|FG002|Overall Study|Lack of Efficacy|3|||
161482997|NCT00040664|583165031|FG003|Overall Study|Lack of Efficacy|4|||
161482998|NCT00040664|583165028|FG000|Overall Study|Insufficient CD4 response|1|||
161482999|NCT00040664|583165029|FG001|Overall Study|Insufficient CD4 response|0|||
161483000|NCT00040664|583165030|FG002|Overall Study|Insufficient CD4 response|1|||
161483001|NCT00040664|583165031|FG003|Overall Study|Insufficient CD4 response|0|||
161483002|NCT00040664|583165028|FG000|Overall Study|Lost to Follow-up|4|||
161483003|NCT00040664|583165029|FG001|Overall Study|Lost to Follow-up|2|||
161483004|NCT00040664|583165030|FG002|Overall Study|Lost to Follow-up|0|||
161483005|NCT00040664|583165031|FG003|Overall Study|Lost to Follow-up|2|||
161483006|NCT00040664|583165028|FG000|Overall Study|Protocol Violation|2|||
161483007|NCT00040664|583165029|FG001|Overall Study|Protocol Violation|1|||
161483008|NCT00040664|583165030|FG002|Overall Study|Protocol Violation|0|||
161483009|NCT00040664|583165031|FG003|Overall Study|Protocol Violation|1|||
161483010|NCT00040664|583165028|FG000|Overall Study|Withdrawal by Subject|7|||
161483011|NCT00040664|583165029|FG001|Overall Study|Withdrawal by Subject|0|||
161483012|NCT00040664|583165030|FG002|Overall Study|Withdrawal by Subject|3|||
161483013|NCT00040664|583165031|FG003|Overall Study|Withdrawal by Subject|4|||
161483014|NCT00040664|583165028|FG000|Overall Study|Pregnancy|3|||
161483015|NCT00040664|583165029|FG001|Overall Study|Pregnancy|0|||
161483016|NCT00040664|583165030|FG002|Overall Study|Pregnancy|0|||
161483017|NCT00040664|583165031|FG003|Overall Study|Pregnancy|3|||
161483018|NCT00040664|583165028|FG000|Overall Study|Medication adherence/compliance problems|8|||
161483019|NCT00040664|583165029|FG001|Overall Study|Medication adherence/compliance problems|2|||
161483020|NCT00040664|583165030|FG002|Overall Study|Medication adherence/compliance problems|1|||
161483021|NCT00040664|583165031|FG003|Overall Study|Medication adherence/compliance problems|5|||
161483022|NCT00040664|583165028|FG000|Overall Study|Poor taste|2|||
161483023|NCT00040664|583165029|FG001|Overall Study|Poor taste|0|||
161483024|NCT00040664|583165030|FG002|Overall Study|Poor taste|2|||
161483025|NCT00040664|583165031|FG003|Overall Study|Poor taste|0|||
161483026|NCT00040664|583165028|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
161483027|NCT00040664|583165029|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
161483028|NCT00040664|583165030|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
161483029|NCT00040664|583165031|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
161483030|NCT00040664|583165028|FG000|Overall Study|Change of formulation|2|||
161483031|NCT00040664|583165029|FG001|Overall Study|Change of formulation|2|||
161483032|NCT00040664|583165030|FG002|Overall Study|Change of formulation|0|||
161483033|NCT00040664|583165031|FG003|Overall Study|Change of formulation|0|||
161483034|NCT00040664|583165028|FG000|Overall Study|Non-viability of oral suspension|1|||
161483035|NCT00040664|583165029|FG001|Overall Study|Non-viability of oral suspension|0|||
161483036|NCT00040664|583165030|FG002|Overall Study|Non-viability of oral suspension|1|||
161483037|NCT00040664|583165031|FG003|Overall Study|Non-viability of oral suspension|0|||
161483038|NCT01709162|583165032|FG000|Overall Study|Disease progression|3|||
161483039|NCT01709162|583165033|FG001|Overall Study|Disease progression|3|||
161483040|NCT01709162|583165032|FG000|Overall Study|Study drug toxicity|2|||
161816566|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Death|0|||
161483041|NCT01709162|583165033|FG001|Overall Study|Study drug toxicity|0|||
161483042|NCT01709162|583165032|FG000|Overall Study|Administrative reason by sponsor|0|||
161483043|NCT01709162|583165033|FG001|Overall Study|Administrative reason by sponsor|1|||
161483044|NCT01709162|583165032|FG000|Overall Study|Other|1|||
161816567|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Death|0|||
161816568|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Death|0|||
161816569|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Death|0|||
161816570|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Death|0|||
161483045|NCT01709162|583165033|FG001|Overall Study|Other|0|||
161816571|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Death|0|||
161483046|NCT01709162|583165032|FG000|Overall Study|Withdrawal by Subject|0|||
161483047|NCT01709162|583165033|FG001|Overall Study|Withdrawal by Subject|1|||
161483048|NCT01637272|583165037|FG000|Overall Study|Adverse Event|6|||
161483049|NCT01637272|583165037|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161483050|NCT01637272|583165037|FG000|Overall Study|Withdrawal by Subject|3|||
161483051|NCT01637272|583165037|FG000|Overall Study|Lost to Follow-up|2|||
161483052|NCT01637272|583165037|FG000|Overall Study|completed core, did not enter ext. phase|4|||
161483053|NCT01637272|583165037|FG000|Overall Study|Administrative problems|1|||
161483054|NCT01637272|583165037|FG000|Overall Study|Protocol Violation|2|||
161483055|NCT01844518|583165038|FG000|Overall Study|Adverse Event|7|||
161483056|NCT01844518|583165039|FG001|Overall Study|Adverse Event|1|||
161483057|NCT01844518|583165038|FG000|Overall Study|Lack of Efficacy|17|||
161483058|NCT01844518|583165039|FG001|Overall Study|Lack of Efficacy|5|||
161483059|NCT01844518|583165038|FG000|Overall Study|Participant's request to discontinue|4|||
161483060|NCT01844518|583165039|FG001|Overall Study|Participant's request to discontinue|1|||
161483061|NCT01844518|583165038|FG000|Overall Study|Poor/Non-compliance|1|||
161483062|NCT01844518|583165039|FG001|Overall Study|Poor/Non-compliance|0|||
161483063|NCT01844518|583165038|FG000|Overall Study|No Longer Met Study Criteria|2|||
161483064|NCT01844518|583165039|FG001|Overall Study|No Longer Met Study Criteria|0|||
161483065|NCT01844518|583165038|FG000|Overall Study|Withdrawal by Subject|9|||
161483066|NCT01844518|583165039|FG001|Overall Study|Withdrawal by Subject|0|||
161483067|NCT01844518|583165038|FG000|Overall Study|Pregnancy|1|||
161483068|NCT01844518|583165039|FG001|Overall Study|Pregnancy|0|||
161483069|NCT03334539|583165044|FG000|Overall Study|Adverse Event|3|||
161483070|NCT03334539|583165045|FG001|Overall Study|Adverse Event|5|||
161483071|NCT03334539|583165046|FG002|Overall Study|Adverse Event|0|||
161483072|NCT03334539|583165044|FG000|Overall Study|Withdrawal by Subject|0|||
161483073|NCT03334539|583165045|FG001|Overall Study|Withdrawal by Subject|1|||
161483074|NCT03334539|583165046|FG002|Overall Study|Withdrawal by Subject|1|||
161483075|NCT03334539|583165044|FG000|Overall Study|Administrative Reasons|1|||
161483076|NCT03334539|583165045|FG001|Overall Study|Administrative Reasons|0|||
161483077|NCT03334539|583165046|FG002|Overall Study|Administrative Reasons|0|||
161483078|NCT03334539|583165044|FG000|Overall Study|Hypertension Not Controlled|0|||
161483079|NCT03334539|583165045|FG001|Overall Study|Hypertension Not Controlled|1|||
161483080|NCT03334539|583165046|FG002|Overall Study|Hypertension Not Controlled|0|||
161483081|NCT03706456|583165050|FG000|Overall Study|Adverse Event|1|||
161483082|NCT03706456|583165050|FG000|Overall Study|Lack of Efficacy|2|||
161483083|NCT04523220|583165051|FG000|Main Treatment Period|Physician Decision|1|||
161483084|NCT04523220|583165052|FG001|Main Treatment Period|Physician Decision|1|||
161483085|NCT04523220|583165053|FG002|Main Treatment Period|Physician Decision|0|||
161483086|NCT04523220|583165051|FG000|Main Treatment Period|Other|5|||
161483087|NCT04523220|583165052|FG001|Main Treatment Period|Other|2|||
161483088|NCT04523220|583165053|FG002|Main Treatment Period|Other|4|||
161483089|NCT04523220|583165051|FG000|Main Treatment Period|Subject Decision|5|||
161483090|NCT04523220|583165052|FG001|Main Treatment Period|Subject Decision|7|||
161483091|NCT04523220|583165053|FG002|Main Treatment Period|Subject Decision|3|||
161483092|NCT04523220|583165051|FG000|Main Treatment Period|Death|5|||
161483093|NCT04523220|583165052|FG001|Main Treatment Period|Death|11|||
161483094|NCT04523220|583165053|FG002|Main Treatment Period|Death|4|||
161483095|NCT04523220|583165051|FG000|Main Treatment Period|Adverse Event|11|||
161483096|NCT04523220|583165052|FG001|Main Treatment Period|Adverse Event|9|||
161483097|NCT04523220|583165053|FG002|Main Treatment Period|Adverse Event|9|||
161483098|NCT04523220|583165051|FG000|Main Treatment Period|Withdrawal by Subject|3|||
161483099|NCT04523220|583165052|FG001|Main Treatment Period|Withdrawal by Subject|3|||
161483100|NCT04523220|583165053|FG002|Main Treatment Period|Withdrawal by Subject|4|||
161483101|NCT04523220|583165051|FG000|Main Treatment Period|Study drug never adminstered|10|||
161483102|NCT04523220|583165052|FG001|Main Treatment Period|Study drug never adminstered|3|||
161483103|NCT04523220|583165053|FG002|Main Treatment Period|Study drug never adminstered|5|||
161483104|NCT04523220|583165051|FG000|Extension Treatment Period|Physician Decision|1|||
161483105|NCT04523220|583165052|FG001|Extension Treatment Period|Physician Decision|0|||
161483106|NCT04523220|583165053|FG002|Extension Treatment Period|Physician Decision|3|||
161483107|NCT04523220|583165051|FG000|Extension Treatment Period|Other|2|||
161483108|NCT04523220|583165052|FG001|Extension Treatment Period|Other|6|||
161483109|NCT04523220|583165053|FG002|Extension Treatment Period|Other|6|||
161483110|NCT04523220|583165051|FG000|Extension Treatment Period|Subject Decision|5|||
161483111|NCT04523220|583165052|FG001|Extension Treatment Period|Subject Decision|2|||
161483112|NCT04523220|583165053|FG002|Extension Treatment Period|Subject Decision|4|||
161669907|NCT02121834|583843181|FG004|Overall Study|Withdrawal by Subject|0|||
161669908|NCT02121834|583843182|FG005|Overall Study|Withdrawal by Subject|0|||
161669909|NCT02121834|583843183|FG006|Overall Study|Withdrawal by Subject|0|||
161483113|NCT04523220|583165051|FG000|Extension Treatment Period|Death|6|||
161483114|NCT04523220|583165052|FG001|Extension Treatment Period|Death|4|||
161483115|NCT04523220|583165053|FG002|Extension Treatment Period|Death|7|||
161483116|NCT04523220|583165051|FG000|Extension Treatment Period|Adverse Event|6|||
161483117|NCT04523220|583165052|FG001|Extension Treatment Period|Adverse Event|7|||
161483118|NCT04523220|583165053|FG002|Extension Treatment Period|Adverse Event|9|||
161483119|NCT04523220|583165051|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
161483120|NCT04523220|583165052|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
161483121|NCT04523220|583165053|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
161483122|NCT04523220|583165051|FG000|Extension Treatment Period|Study drug never administered|0|||
161669910|NCT02121834|583843177|FG000|Overall Study|Lost to Follow-up|0|||
161483123|NCT04523220|583165052|FG001|Extension Treatment Period|Study drug never administered|1|||
161483124|NCT04523220|583165053|FG002|Extension Treatment Period|Study drug never administered|0|||
161483125|NCT00256750|583165055|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
161483126|NCT00256750|583165056|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
161483127|NCT00256750|583165057|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
161483128|NCT00256750|583165055|FG000|Transplanted Pre-Treatment|Other|2|||
161483129|NCT00256750|583165056|FG001|Transplanted Pre-Treatment|Other|0|||
161483130|NCT00256750|583165057|FG002|Transplanted Pre-Treatment|Other|0|||
161483131|NCT00256750|583165055|FG000|Transplanted Pre-Treatment|Death|1|||
161483132|NCT00256750|583165056|FG001|Transplanted Pre-Treatment|Death|0|||
161483133|NCT00256750|583165057|FG002|Transplanted Pre-Treatment|Death|0|||
161483134|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
161483135|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
161483136|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
161483137|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Death|3|||
161483138|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Death|2|||
161483139|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Death|4|||
161483140|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
161483141|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
161483142|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
161483143|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
161580488|NCT04629950|583513920|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
161580489|NCT04629950|583513921|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161580490|NCT04629950|583513922|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161580491|NCT04629950|583513919|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161580492|NCT04629950|583513920|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
161580493|NCT04629950|583513921|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161580494|NCT04629950|583513922|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161580495|NCT04629950|583513919|FG000|Extension Study|Withdrawal by Subject|0|||
161580496|NCT04629950|583513920|FG001|Extension Study|Withdrawal by Subject|0|||
161580497|NCT04629950|583513921|FG002|Extension Study|Withdrawal by Subject|1|||
161580498|NCT04629950|583513922|FG003|Extension Study|Withdrawal by Subject|0|||
161580499|NCT04629950|583513919|FG000|Extension Study|Adverse Event|0|||
161580500|NCT04629950|583513920|FG001|Extension Study|Adverse Event|0|||
161580501|NCT04629950|583513921|FG002|Extension Study|Adverse Event|0|||
161580502|NCT04629950|583513922|FG003|Extension Study|Adverse Event|1|||
161580503|NCT03233633|583513923|FG000|Overall Study|Adverse Event|2|||
161580504|NCT03233633|583513923|FG000|Overall Study|Less Than 3 Days of Data|6|||
161580505|NCT02708108|583513924|FG000|Overall Study|Death|1|||
161580506|NCT02708108|583513925|FG001|Overall Study|Death|2|||
161580507|NCT02708108|583513924|FG000|Overall Study|Regimen change|1|||
161580508|NCT02708108|583513925|FG001|Overall Study|Regimen change|0|||
161580509|NCT02708108|583513924|FG000|Overall Study|No MRD and no imaging available|0|||
161580510|NCT02708108|583513925|FG001|Overall Study|No MRD and no imaging available|1|||
161580511|NCT02568683|583513927|FG000|Overall Study|Death|0|||
161580512|NCT02568683|583513928|FG001|Overall Study|Death|2|||
161580513|NCT02568683|583513927|FG000|Overall Study|Withdrew Consent|1|||
161580514|NCT02568683|583513928|FG001|Overall Study|Withdrew Consent|0|||
161580515|NCT02568683|583513927|FG000|Overall Study|Study Terminated By Sponsor|5|||
161580516|NCT02568683|583513928|FG001|Overall Study|Study Terminated By Sponsor|2|||
161580517|NCT01561989|583513931|FG000|Overall Study|accural target not met.|5|||
161580518|NCT01561989|583513932|FG001|Overall Study|accural target not met.|6|||
161580519|NCT03485950|583513933|FG000|Overall Study|Adverse Event|1|||
161580520|NCT03485950|583513934|FG001|Overall Study|Adverse Event|0|||
161580521|NCT03485950|583513933|FG000|Overall Study|Death|3|||
161580522|NCT03485950|583513934|FG001|Overall Study|Death|2|||
161580523|NCT03485950|583513933|FG000|Overall Study|Withdrawal by Subject|3|||
161580524|NCT03485950|583513934|FG001|Overall Study|Withdrawal by Subject|0|||
161580525|NCT01388361|583513943|FG000|Overall Study|Adverse Event|0|||
161580526|NCT01388361|583513944|FG001|Overall Study|Adverse Event|5|||
161580527|NCT01388361|583513945|FG002|Overall Study|Adverse Event|1|||
161580528|NCT01388361|583513943|FG000|Overall Study|Protocol Violation|0|||
161816572|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Death|0|||
161816573|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Death|0|||
161483144|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
161483145|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
161483146|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Other|5|||
161483147|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Other|4|||
161483148|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Other|2|||
161483149|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
161483150|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
161580529|NCT01388361|583513944|FG001|Overall Study|Protocol Violation|0|||
161580530|NCT01388361|583513945|FG002|Overall Study|Protocol Violation|2|||
161580531|NCT01388361|583513943|FG000|Overall Study|Withdrawal criteria|12|||
161580532|NCT01388361|583513944|FG001|Overall Study|Withdrawal criteria|7|||
161580533|NCT01388361|583513945|FG002|Overall Study|Withdrawal criteria|10|||
161580534|NCT01388361|583513943|FG000|Overall Study|Unclassified|0|||
161580535|NCT01388361|583513944|FG001|Overall Study|Unclassified|0|||
161580536|NCT01388361|583513945|FG002|Overall Study|Unclassified|1|||
161483151|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
161483152|NCT00256750|583165055|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
161483153|NCT00256750|583165056|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
161483154|NCT00256750|583165057|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
161483155|NCT00256750|583165055|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
161483156|NCT00256750|583165056|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
161483157|NCT00256750|583165057|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
161483158|NCT00256750|583165055|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
161483159|NCT00256750|583165056|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
161483160|NCT00256750|583165057|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
161483161|NCT00256750|583165055|FG000|Post-Transplant Treated (24 Months)|Death|3|||
161483162|NCT00256750|583165056|FG001|Post-Transplant Treated (24 Months)|Death|0|||
161483163|NCT00256750|583165057|FG002|Post-Transplant Treated (24 Months)|Death|0|||
161483164|NCT00256750|583165055|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
161483165|NCT00256750|583165056|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
161483166|NCT00256750|583165057|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
161483167|NCT00256750|583165055|FG000|Post-Transplant Treated (24 Months)|Other|2|||
161483168|NCT00256750|583165056|FG001|Post-Transplant Treated (24 Months)|Other|0|||
161483169|NCT00256750|583165057|FG002|Post-Transplant Treated (24 Months)|Other|1|||
161483170|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
161483171|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
161483172|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
161483173|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
161483174|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
161483175|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
161483176|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Death|0|||
161483177|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Death|2|||
161483178|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Death|1|||
161483179|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
161483180|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
161483181|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
161483182|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
161483183|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
161483184|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
161483185|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
161483186|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
161483187|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
161483188|NCT00256750|583165055|FG000|Post-Transplant Treated (36 Months)|Other|0|||
161483189|NCT00256750|583165056|FG001|Post-Transplant Treated (36 Months)|Other|1|||
161483190|NCT00256750|583165057|FG002|Post-Transplant Treated (36 Months)|Other|1|||
161483191|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
161483192|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
161483193|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
161483194|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
161483195|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
161669911|NCT02121834|583843178|FG001|Overall Study|Lost to Follow-up|0|||
161669912|NCT02121834|583843179|FG002|Overall Study|Lost to Follow-up|1|||
161669913|NCT02121834|583843180|FG003|Overall Study|Lost to Follow-up|0|||
161669914|NCT02121834|583843181|FG004|Overall Study|Lost to Follow-up|0|||
161669915|NCT02121834|583843182|FG005|Overall Study|Lost to Follow-up|0|||
161669916|NCT02121834|583843183|FG006|Overall Study|Lost to Follow-up|0|||
161669917|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
161669918|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
161669919|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
161669920|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
161669921|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
161669922|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
161669923|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
161669924|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
161669925|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
161669926|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
161816574|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Death|0|||
161669927|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
161816575|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Death|0|||
161816576|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Death|0|||
161483196|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
161816577|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Death|0|||
161816578|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Death|2|||
161483197|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
161483198|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
161483199|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
161483200|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
161483201|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
161483202|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
161483203|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
161483204|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
161483205|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
161483206|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
161483207|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
161483208|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
161483209|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
161483210|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
161483211|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
161483212|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
161483213|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
161483214|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
161483215|NCT00256750|583165055|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
161483216|NCT00256750|583165056|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
161483217|NCT00256750|583165057|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
161483218|NCT00558558|583165061|FG000|Overall Study|Unable to swallow|1|||
161483219|NCT00558558|583165061|FG000|Overall Study|Withdrawal by Subject|1|||
161483220|NCT00558558|583165061|FG000|Overall Study|Lack of Efficacy|4|||
161483221|NCT02549937|583165063|FG000|Overall Study|Death|0|||
161483222|NCT02549937|583165064|FG001|Overall Study|Death|1|||
161483223|NCT02549937|583165065|FG002|Overall Study|Death|0|||
161483224|NCT02549937|583165066|FG003|Overall Study|Death|1|||
161483225|NCT02549937|583165067|FG004|Overall Study|Death|0|||
161483226|NCT02549937|583165068|FG005|Overall Study|Death|8|||
161483227|NCT02549937|583165069|FG006|Overall Study|Death|0|||
161483228|NCT02549937|583165070|FG007|Overall Study|Death|0|||
161483229|NCT02549937|583165071|FG008|Overall Study|Death|19|||
161483230|NCT02549937|583165063|FG000|Overall Study|No follow up required|3|||
161483231|NCT02549937|583165064|FG001|Overall Study|No follow up required|6|||
161483232|NCT02549937|583165065|FG002|Overall Study|No follow up required|3|||
161483233|NCT02549937|583165066|FG003|Overall Study|No follow up required|8|||
161483234|NCT02549937|583165067|FG004|Overall Study|No follow up required|12|||
161483235|NCT02549937|583165068|FG005|Overall Study|No follow up required|21|||
161483236|NCT02549937|583165069|FG006|Overall Study|No follow up required|9|||
161483237|NCT02549937|583165070|FG007|Overall Study|No follow up required|11|||
161483238|NCT02549937|583165071|FG008|Overall Study|No follow up required|0|||
161483239|NCT02549937|583165063|FG000|Overall Study|Other|0|||
161483240|NCT02549937|583165064|FG001|Overall Study|Other|0|||
161483241|NCT02549937|583165065|FG002|Overall Study|Other|0|||
161483242|NCT02549937|583165066|FG003|Overall Study|Other|0|||
161483243|NCT02549937|583165067|FG004|Overall Study|Other|1|||
161483244|NCT02549937|583165068|FG005|Overall Study|Other|0|||
161483245|NCT02549937|583165069|FG006|Overall Study|Other|3|||
161483246|NCT02549937|583165070|FG007|Overall Study|Other|2|||
161483247|NCT02549937|583165071|FG008|Overall Study|Other|3|||
161483248|NCT02549937|583165063|FG000|Overall Study|Lost to Follow-up|0|||
161483249|NCT02549937|583165064|FG001|Overall Study|Lost to Follow-up|0|||
161483250|NCT02549937|583165065|FG002|Overall Study|Lost to Follow-up|0|||
161483251|NCT02549937|583165066|FG003|Overall Study|Lost to Follow-up|0|||
161483252|NCT02549937|583165067|FG004|Overall Study|Lost to Follow-up|0|||
161483253|NCT02549937|583165068|FG005|Overall Study|Lost to Follow-up|0|||
161483254|NCT02549937|583165069|FG006|Overall Study|Lost to Follow-up|0|||
161483255|NCT02549937|583165070|FG007|Overall Study|Lost to Follow-up|0|||
161483256|NCT02549937|583165071|FG008|Overall Study|Lost to Follow-up|3|||
161483257|NCT02549937|583165063|FG000|Overall Study|Withdrawal by Subject|0|||
161483258|NCT02549937|583165064|FG001|Overall Study|Withdrawal by Subject|0|||
161669928|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
161483259|NCT02549937|583165065|FG002|Overall Study|Withdrawal by Subject|0|||
161483260|NCT02549937|583165066|FG003|Overall Study|Withdrawal by Subject|0|||
161483261|NCT02549937|583165067|FG004|Overall Study|Withdrawal by Subject|0|||
161483262|NCT02549937|583165068|FG005|Overall Study|Withdrawal by Subject|1|||
161483263|NCT02549937|583165069|FG006|Overall Study|Withdrawal by Subject|4|||
161483264|NCT02549937|583165070|FG007|Overall Study|Withdrawal by Subject|3|||
161483265|NCT02549937|583165071|FG008|Overall Study|Withdrawal by Subject|2|||
161483266|NCT02549937|583165063|FG000|Overall Study|Sponsor Decision|0|||
161483267|NCT02549937|583165064|FG001|Overall Study|Sponsor Decision|0|||
161483268|NCT02549937|583165065|FG002|Overall Study|Sponsor Decision|0|||
161483269|NCT02549937|583165066|FG003|Overall Study|Sponsor Decision|0|||
161483270|NCT02549937|583165067|FG004|Overall Study|Sponsor Decision|0|||
161483271|NCT02549937|583165068|FG005|Overall Study|Sponsor Decision|0|||
161483272|NCT02549937|583165069|FG006|Overall Study|Sponsor Decision|0|||
161483273|NCT02549937|583165070|FG007|Overall Study|Sponsor Decision|0|||
161483274|NCT02549937|583165071|FG008|Overall Study|Sponsor Decision|6|||
161483275|NCT02144012|583165072|FG000|Overall Study|Adverse Event|1|||
161483276|NCT02144012|583165073|FG001|Overall Study|Adverse Event|0|||
161483277|NCT02144012|583165072|FG000|Overall Study|Death|1|||
161483278|NCT02144012|583165073|FG001|Overall Study|Death|0|||
161483279|NCT02144012|583165072|FG000|Overall Study|Withdrawal by Subject|11|||
161483280|NCT02144012|583165073|FG001|Overall Study|Withdrawal by Subject|3|||
161483281|NCT02144012|583165072|FG000|Overall Study|Study Terminated by Sponsor|18|||
161483282|NCT02144012|583165073|FG001|Overall Study|Study Terminated by Sponsor|12|||
161483283|NCT02144012|583165072|FG000|Overall Study|Other|3|||
161483284|NCT02144012|583165073|FG001|Overall Study|Other|0|||
161483285|NCT00317356|583165074|FG000|Overall Study|Adverse Event|0|||
161483286|NCT00317356|583165075|FG001|Overall Study|Adverse Event|0|||
161483287|NCT00317356|583165076|FG002|Overall Study|Adverse Event|1|||
161483288|NCT00317356|583165077|FG003|Overall Study|Adverse Event|0|||
161483289|NCT00317356|583165074|FG000|Overall Study|Lack of Efficacy|1|||
161483290|NCT00317356|583165075|FG001|Overall Study|Lack of Efficacy|1|||
161483291|NCT00317356|583165076|FG002|Overall Study|Lack of Efficacy|0|||
161483292|NCT00317356|583165077|FG003|Overall Study|Lack of Efficacy|3|||
161483293|NCT00317356|583165074|FG000|Overall Study|Physician Decision|0|||
161483294|NCT00317356|583165075|FG001|Overall Study|Physician Decision|1|||
161483295|NCT00317356|583165076|FG002|Overall Study|Physician Decision|0|||
161483296|NCT00317356|583165077|FG003|Overall Study|Physician Decision|0|||
161483297|NCT03727347|583165078|FG000|Overall Study|Withdrawal by Subject|2|||
161483298|NCT03727347|583165078|FG000|Overall Study|Lost to Follow-up|1|||
161483299|NCT04292743|583165079|FG000|Overall Study|Physician Decision|1|||
161483300|NCT04292743|583165080|FG001|Overall Study|Physician Decision|3|||
161483301|NCT04292743|583165081|FG002|Overall Study|Physician Decision|0|||
161483302|NCT04292743|583165082|FG003|Overall Study|Physician Decision|0|||
161483303|NCT04292743|583165079|FG000|Overall Study|Withdrawal by Subject|0|||
161483304|NCT04292743|583165080|FG001|Overall Study|Withdrawal by Subject|5|||
161483305|NCT04292743|583165081|FG002|Overall Study|Withdrawal by Subject|0|||
161483306|NCT04292743|583165082|FG003|Overall Study|Withdrawal by Subject|0|||
161483307|NCT04292743|583165079|FG000|Overall Study|Death|0|||
161483308|NCT04292743|583165080|FG001|Overall Study|Death|1|||
161483309|NCT04292743|583165081|FG002|Overall Study|Death|0|||
161483310|NCT04292743|583165082|FG003|Overall Study|Death|0|||
161483311|NCT04292743|583165079|FG000|Overall Study|Progression of Disease|2|||
161483312|NCT04292743|583165080|FG001|Overall Study|Progression of Disease|5|||
161483313|NCT04292743|583165081|FG002|Overall Study|Progression of Disease|0|||
161483314|NCT04292743|583165082|FG003|Overall Study|Progression of Disease|0|||
161483315|NCT04292743|583165079|FG000|Overall Study|No Treatment per protocol|0|||
161483316|NCT04292743|583165080|FG001|Overall Study|No Treatment per protocol|2|||
161483317|NCT04292743|583165081|FG002|Overall Study|No Treatment per protocol|0|||
161483318|NCT04292743|583165082|FG003|Overall Study|No Treatment per protocol|0|||
161483319|NCT05330702|583165083|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
161483320|NCT05330702|583165084|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
161483321|NCT05330702|583165085|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
161816579|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Death|0|||
161483322|NCT01943292|583166395|FG000|Overall Study|Withdrawal by Subject|1|||
161483323|NCT01943292|583166396|FG001|Overall Study|Withdrawal by Subject|0|||
161483324|NCT01943292|583166397|FG002|Overall Study|Withdrawal by Subject|0|||
161483325|NCT00187486|583166404|FG000|Overall Study|Protocol Violation|1|||
161483326|NCT02483520|583166405|FG000|Overall Study|Lost to Follow-up|3|||
161483327|NCT02483520|583166406|FG001|Overall Study|Lost to Follow-up|4|||
161483328|NCT02483520|583166405|FG000|Overall Study|Withdrawal by Subject|4|||
161483329|NCT02483520|583166406|FG001|Overall Study|Withdrawal by Subject|14|||
161483330|NCT02483520|583166405|FG000|Overall Study|Hospitalized|2|||
161816580|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Death|0|||
161816581|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816582|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816583|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161483331|NCT02483520|583166406|FG001|Overall Study|Hospitalized|3|||
161483332|NCT02483520|583166405|FG000|Overall Study|Moved to LTC|2|||
161483333|NCT02483520|583166406|FG001|Overall Study|Moved to LTC|3|||
161483334|NCT01104493|583166409|FG000|Overall Study|Lost to Follow-up|0|||
161483335|NCT01104493|583166410|FG001|Overall Study|Lost to Follow-up|2|||
161483336|NCT03489720|583166412|FG000|Overall Study|Withdrawal by Subject|2|||
161483337|NCT03489720|583166413|FG001|Overall Study|Withdrawal by Subject|0|||
161483338|NCT02511184|583166414|FG000|Overall Study|Death|1|||
161816584|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816585|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161483339|NCT02511184|583166415|FG001|Overall Study|Death|0|||
161483340|NCT02511184|583166414|FG000|Overall Study|Lost to Follow-up|0|||
161483341|NCT02511184|583166415|FG001|Overall Study|Lost to Follow-up|1|||
161483342|NCT02511184|583166414|FG000|Overall Study|Study terminated by sponsor|1|||
161483343|NCT02511184|583166415|FG001|Overall Study|Study terminated by sponsor|5|||
161483344|NCT02511184|583166414|FG000|Overall Study|Withdrawal by Subject|0|||
161483345|NCT02511184|583166415|FG001|Overall Study|Withdrawal by Subject|1|||
161483346|NCT01806545|583166416|FG000|Overall Study|Adverse Event|2|||
161483347|NCT01806545|583166417|FG001|Overall Study|Adverse Event|3|||
161483348|NCT01806545|583166416|FG000|Overall Study|Lost to Follow-up|1|||
161483349|NCT01806545|583166417|FG001|Overall Study|Lost to Follow-up|0|||
161483350|NCT01806545|583166416|FG000|Overall Study|Withdrawal by Subject|3|||
161483351|NCT01806545|583166417|FG001|Overall Study|Withdrawal by Subject|2|||
161483352|NCT00884312|583166418|FG000|Overall Study|Non-fatal Progressive Disease|0|||
161483353|NCT00884312|583166419|FG001|Overall Study|Non-fatal Progressive Disease|8|||
161483354|NCT00884312|583166418|FG000|Overall Study|Fatal Progressive Disease|0|||
161483355|NCT00884312|583166419|FG001|Overall Study|Fatal Progressive Disease|1|||
161483356|NCT00884312|583166418|FG000|Overall Study|Non-fatal Adverse Event|1|||
161483357|NCT00884312|583166419|FG001|Overall Study|Non-fatal Adverse Event|0|||
161483358|NCT00884312|583166418|FG000|Overall Study|Fatal Adverse Event|1|||
161483359|NCT00884312|583166419|FG001|Overall Study|Fatal Adverse Event|4|||
161483360|NCT00884312|583166418|FG000|Overall Study|Withdrawal by Subject|0|||
161483361|NCT00884312|583166419|FG001|Overall Study|Withdrawal by Subject|6|||
161483362|NCT00884312|583166418|FG000|Overall Study|Physician Decision|0|||
161483363|NCT00884312|583166419|FG001|Overall Study|Physician Decision|1|||
161483364|NCT00884312|583166418|FG000|Overall Study|Other|0|||
161483365|NCT00884312|583166419|FG001|Overall Study|Other|4|||
161483366|NCT00884312|583166418|FG000|Overall Study|Did Not Receive Study Drug|0|||
161483367|NCT00884312|583166419|FG001|Overall Study|Did Not Receive Study Drug|1|||
161483368|NCT03521934|583166429|FG000|Overall Study|Death|65|||
161483369|NCT03521934|583166430|FG001|Overall Study|Death|73|||
161483370|NCT03521934|583166429|FG000|Overall Study|Withdrawal by Subject|18|||
161483371|NCT03521934|583166430|FG001|Overall Study|Withdrawal by Subject|23|||
161483372|NCT03521934|583166429|FG000|Overall Study|Site Terminated by Sponsor|39|||
161483373|NCT03521934|583166430|FG001|Overall Study|Site Terminated by Sponsor|35|||
161483374|NCT03521934|583166429|FG000|Overall Study|Study Terminated by Sponsor|483|||
161483375|NCT03521934|583166430|FG001|Overall Study|Study Terminated by Sponsor|477|||
161483376|NCT03521934|583166429|FG000|Overall Study|Reason not Specified|3|||
161483377|NCT03521934|583166430|FG001|Overall Study|Reason not Specified|6|||
161483378|NCT00284050|583166431|FG000|Overall Study|Adverse Event|1|||
161483379|NCT00284050|583166432|FG001|Overall Study|Adverse Event|1|||
161483380|NCT00284050|583166433|FG002|Overall Study|Adverse Event|1|||
161483381|NCT00284050|583166431|FG000|Overall Study|Lack of Efficacy|0|||
161483382|NCT00284050|583166432|FG001|Overall Study|Lack of Efficacy|1|||
161483383|NCT00284050|583166433|FG002|Overall Study|Lack of Efficacy|3|||
161483384|NCT00284050|583166431|FG000|Overall Study|Protocol Violation|0|||
161483385|NCT00284050|583166432|FG001|Overall Study|Protocol Violation|1|||
161483386|NCT00284050|583166433|FG002|Overall Study|Protocol Violation|2|||
161483387|NCT00284050|583166431|FG000|Overall Study|Withdrawal by Subject|2|||
161483388|NCT00284050|583166432|FG001|Overall Study|Withdrawal by Subject|2|||
161483389|NCT00284050|583166433|FG002|Overall Study|Withdrawal by Subject|2|||
161483390|NCT00284050|583166431|FG000|Overall Study|Lost to Follow-up|1|||
161483391|NCT00284050|583166432|FG001|Overall Study|Lost to Follow-up|0|||
161483392|NCT00284050|583166433|FG002|Overall Study|Lost to Follow-up|1|||
161580537|NCT05368831|583513948|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
161816586|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816587|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161483393|NCT00284050|583166431|FG000|Overall Study|Death|1|||
161483394|NCT00284050|583166432|FG001|Overall Study|Death|0|||
161483395|NCT00284050|583166433|FG002|Overall Study|Death|0|||
161483396|NCT00489541|583166438|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
161483397|NCT00489541|583166439|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
161483398|NCT00489541|583166438|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
161483399|NCT00489541|583166439|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
161483400|NCT00489541|583166438|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
161483401|NCT00489541|583166439|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
161483402|NCT00489541|583166438|FG000|12-Month Clinical Follow-up|Death|3|||
161483403|NCT00489541|583166439|FG001|12-Month Clinical Follow-up|Death|2|||
161483404|NCT00489541|583166438|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
161483405|NCT00489541|583166439|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
161483406|NCT00489541|583166438|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
161483407|NCT00489541|583166439|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
161483408|NCT02551731|583166440|FG000|Overall Study|Withdrawal by Subject|2|||
161483409|NCT01192516|583166442|FG000|Overall Study|Lost to Follow-up|7|||
161483410|NCT01192516|583166443|FG001|Overall Study|Lost to Follow-up|10|||
161483411|NCT01192516|583166444|FG002|Overall Study|Lost to Follow-up|7|||
161483412|NCT01192516|583166442|FG000|Overall Study|Withdrawal by Subject|4|||
161483413|NCT01192516|583166443|FG001|Overall Study|Withdrawal by Subject|4|||
161483414|NCT01192516|583166444|FG002|Overall Study|Withdrawal by Subject|1|||
161483415|NCT01192516|583166442|FG000|Overall Study|started new treatment|5|||
161483416|NCT01192516|583166443|FG001|Overall Study|started new treatment|1|||
161483417|NCT01192516|583166444|FG002|Overall Study|started new treatment|0|||
161483418|NCT01192516|583166442|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
161483419|NCT01192516|583166443|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
161483420|NCT01192516|583166444|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
161483421|NCT05228132|583166449|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
161483422|NCT05228132|583166449|FG000|Overall Study|Adverse Event|3|||
161483423|NCT05228132|583166449|FG000|Overall Study|Lost to Follow-up|1|||
161483424|NCT05228132|583166449|FG000|Overall Study|Arteriovenous-fistula mature|1|||
161483425|NCT02627144|583166450|FG000|Overall Study|Serious adverse event|32|||
161483426|NCT02627144|583166450|FG000|Overall Study|Cancer progression|171|||
161483427|NCT02627144|583166450|FG000|Overall Study|Death from cancer|20|||
161483428|NCT02627144|583166450|FG000|Overall Study|Death from other cause|8|||
161483429|NCT02627144|583166450|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
161483430|NCT02627144|583166450|FG000|Overall Study|Administrative reasons|65|||
161483431|NCT02627144|583166450|FG000|Overall Study|Lost to Follow-up|8|||
161483432|NCT02627144|583166450|FG000|Overall Study|Enrolled, not treated|6|||
161483433|NCT02627144|583166450|FG000|Overall Study|Other|17|||
161483434|NCT00496470|583166457|FG000|Overall Study|Adverse Event|8|||
161483435|NCT00496470|583166458|FG001|Overall Study|Adverse Event|10|||
161483436|NCT00496470|583166457|FG000|Overall Study|Withdrawal by Subject|5|||
161483437|NCT00496470|583166458|FG001|Overall Study|Withdrawal by Subject|12|||
161483438|NCT00496470|583166457|FG000|Overall Study|Incorrectly enrolled|13|||
161483439|NCT00496470|583166458|FG001|Overall Study|Incorrectly enrolled|5|||
161483440|NCT00496470|583166457|FG000|Overall Study|Other reason|0|||
161483441|NCT00496470|583166458|FG001|Overall Study|Other reason|2|||
161483442|NCT01217801|583166464|FG000|Period 1|Protocol Violation|1|||
161483443|NCT01217801|583166465|FG001|Period 1|Protocol Violation|1|||
161483444|NCT01217801|583166464|FG000|Period 1|Withdrawal by Subject|0|||
161483445|NCT01217801|583166465|FG001|Period 1|Withdrawal by Subject|1|||
161483446|NCT00291577|583166467|FG000|Overall Study|Adverse Event|1|||
161483447|NCT00291577|583166467|FG000|Overall Study|Other|4|||
161483448|NCT00291577|583166467|FG000|Overall Study|Withdrawal by Subject|2|||
161483449|NCT00291577|583166467|FG000|Overall Study|Lack of Efficacy|14|||
161483450|NCT04584645|583166468|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
161483451|NCT04584645|583166469|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
161483452|NCT03845985|583166476|FG000|Overall Study|Lost to Follow-up|2|||
161483453|NCT03845985|583166477|FG001|Overall Study|Lost to Follow-up|1|||
161816588|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816589|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816590|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816591|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816592|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816593|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816594|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816595|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816596|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816597|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816598|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161483454|NCT03845985|583166476|FG000|Overall Study|Physician Decision|1|||
161483455|NCT03845985|583166477|FG001|Overall Study|Physician Decision|0|||
161483456|NCT03845985|583166476|FG000|Overall Study|Withdrawal by Subject|4|||
161483457|NCT03845985|583166477|FG001|Overall Study|Withdrawal by Subject|1|||
161483458|NCT02756013|583166478|FG000|Overall Study|Adverse Event|1|||
161483459|NCT02756013|583166478|FG000|Overall Study|Hypersensitivity|1|||
161483460|NCT03926169|583166479|FG000|Period A|Adverse Event|2|||
161483461|NCT03926169|583166480|FG001|Period A|Adverse Event|2|||
161483462|NCT03926169|583166481|FG002|Period A|Adverse Event|1|||
161483463|NCT03926169|583166479|FG000|Period A|Withdrawal by Subject|2|||
161483464|NCT03926169|583166480|FG001|Period A|Withdrawal by Subject|2|||
161483465|NCT03926169|583166481|FG002|Period A|Withdrawal by Subject|2|||
161483466|NCT03926169|583166479|FG000|Period A|Lost to Follow-up|3|||
161483467|NCT03926169|583166480|FG001|Period A|Lost to Follow-up|1|||
161483468|NCT03926169|583166481|FG002|Period A|Lost to Follow-up|0|||
161483469|NCT03926169|583166479|FG000|Period A|Lack of Efficacy|0|||
161483470|NCT03926169|583166480|FG001|Period A|Lack of Efficacy|2|||
161483471|NCT03926169|583166481|FG002|Period A|Lack of Efficacy|2|||
161483472|NCT03926169|583166479|FG000|Period A|COVID-19 Infection|0|||
161483473|NCT03926169|583166480|FG001|Period A|COVID-19 Infection|1|||
161483474|NCT03926169|583166481|FG002|Period A|COVID-19 Infection|0|||
161483475|NCT03926169|583166479|FG000|Period A|COVID-19 Logistical Restrictions|0|||
161483476|NCT03926169|583166480|FG001|Period A|COVID-19 Logistical Restrictions|2|||
161483477|NCT03926169|583166481|FG002|Period A|COVID-19 Logistical Restrictions|1|||
161483478|NCT03926169|583166479|FG000|Period A|Other, Not Specified|1|||
161483479|NCT03926169|583166480|FG001|Period A|Other, Not Specified|0|||
161483480|NCT03926169|583166481|FG002|Period A|Other, Not Specified|0|||
161483481|NCT03926169|583166479|FG000|Period B|Adverse Event|3|||
161483482|NCT03926169|583166480|FG001|Period B|Adverse Event|1|||
161483483|NCT03926169|583166481|FG002|Period B|Adverse Event|1|||
161483484|NCT03926169|583166479|FG000|Period B|Withdrawal by Subject|1|||
161483485|NCT03926169|583166480|FG001|Period B|Withdrawal by Subject|3|||
161483486|NCT03926169|583166481|FG002|Period B|Withdrawal by Subject|0|||
161483487|NCT03926169|583166479|FG000|Period B|Lack of Efficacy|3|||
161483488|NCT03926169|583166480|FG001|Period B|Lack of Efficacy|1|||
161483489|NCT03926169|583166481|FG002|Period B|Lack of Efficacy|1|||
161483490|NCT03926169|583166479|FG000|Period B|Lost to Follow-up|1|||
161483491|NCT03926169|583166480|FG001|Period B|Lost to Follow-up|1|||
161483492|NCT03926169|583166481|FG002|Period B|Lost to Follow-up|4|||
161483493|NCT03926169|583166479|FG000|Period B|Other, Not Specified|62|||
161483494|NCT03926169|583166480|FG001|Period B|Other, Not Specified|57|||
161483495|NCT03926169|583166481|FG002|Period B|Other, Not Specified|65|||
161483496|NCT00968201|583166482|FG000|Base Study - (Period II)|Adverse Event|8|||
161483497|NCT00968201|583166483|FG001|Base Study - (Period II)|Adverse Event|0|||
161483498|NCT00968201|583166484|FG002|Base Study - (Period II)|Adverse Event|16|||
161483499|NCT00968201|583166482|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
161483500|NCT00968201|583166483|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
161483501|NCT00968201|583166484|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
161483502|NCT00968201|583166482|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
161483503|NCT00968201|583166483|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
161483504|NCT00968201|583166484|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
161483505|NCT00968201|583166482|FG000|Base Study - (Period II)|Protocol Violation|12|||
161483506|NCT00968201|583166483|FG001|Base Study - (Period II)|Protocol Violation|0|||
161816599|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161483507|NCT00968201|583166484|FG002|Base Study - (Period II)|Protocol Violation|12|||
161483508|NCT00968201|583166482|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
161483509|NCT00968201|583166483|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
161483510|NCT00968201|583166484|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
161483511|NCT00968201|583166482|FG000|Base Study - (Period II)|Site Error|0|||
161483512|NCT00968201|583166483|FG001|Base Study - (Period II)|Site Error|0|||
161483513|NCT00968201|583166484|FG002|Base Study - (Period II)|Site Error|1|||
161483514|NCT00968201|583166482|FG000|Extension Study - (Period III)|Adverse Event|0|||
161816600|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816601|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816602|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816603|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816604|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816605|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816606|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
161816607|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Other|0|||
161816608|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Other|0|||
161816609|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Other|0|||
161816610|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Other|0|||
161816611|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Other|0|||
161816612|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Other|0|||
161816613|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Other|0|||
161483515|NCT00968201|583166483|FG001|Extension Study - (Period III)|Adverse Event|5|||
161483516|NCT00968201|583166484|FG002|Extension Study - (Period III)|Adverse Event|22|||
161483517|NCT00968201|583166482|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
161483518|NCT00968201|583166483|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
161483519|NCT00968201|583166484|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
161483520|NCT00968201|583166482|FG000|Extension Study - (Period III)|Protocol Violation|0|||
161483521|NCT00968201|583166483|FG001|Extension Study - (Period III)|Protocol Violation|17|||
161483522|NCT00968201|583166484|FG002|Extension Study - (Period III)|Protocol Violation|14|||
161483523|NCT00968201|583166482|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
161483524|NCT00968201|583166483|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
161669929|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
161483525|NCT00968201|583166484|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
161483526|NCT00968201|583166482|FG000|Extension Study - (Period III)|Patient Relocated|0|||
161483527|NCT00968201|583166483|FG001|Extension Study - (Period III)|Patient Relocated|1|||
161483528|NCT00968201|583166484|FG002|Extension Study - (Period III)|Patient Relocated|1|||
161483529|NCT00968201|583166482|FG000|Extension Study - (Period III)|Noncompliance|0|||
161483530|NCT00968201|583166483|FG001|Extension Study - (Period III)|Noncompliance|0|||
161483531|NCT00968201|583166484|FG002|Extension Study - (Period III)|Noncompliance|3|||
161483532|NCT00968201|583166482|FG000|Extension Study - (Period III)|Other|0|||
161483533|NCT00968201|583166483|FG001|Extension Study - (Period III)|Other|0|||
161483534|NCT00968201|583166484|FG002|Extension Study - (Period III)|Other|2|||
161483535|NCT00968201|583166482|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
161483536|NCT00968201|583166483|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
161483537|NCT00968201|583166484|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
161483538|NCT04974697|583166485|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
161483539|NCT04974697|583166485|FG000|Overall Study|Lens discomfort|1|||
161483540|NCT03302234|583166486|FG000|Overall Study|Death|191|||
161483541|NCT03302234|583166487|FG001|Overall Study|Death|192|||
161483542|NCT03302234|583166486|FG000|Overall Study|Withdrawal by Subject|2|||
161483543|NCT03302234|583166487|FG001|Overall Study|Withdrawal by Subject|2|||
161483544|NCT03302234|583166486|FG000|Overall Study|Sponsor Decision|90|||
161483545|NCT03302234|583166487|FG001|Overall Study|Sponsor Decision|89|||
161483546|NCT03302234|583166486|FG000|Overall Study|Laryngeal carcinoma|0|||
161483547|NCT03302234|583166487|FG001|Overall Study|Laryngeal carcinoma|1|||
161483548|NCT03302234|583166486|FG000|Overall Study|Not Reported|1|||
161483549|NCT03302234|583166487|FG001|Overall Study|Not Reported|0|||
161483550|NCT04112784|583166489|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
161483551|NCT04112784|583166489|FG000|Overall Study|Screen Failures|4|||
161483552|NCT00221403|583166490|FG000|Overall Study|Protocol Violation|1|||
161483553|NCT00221403|583166491|FG001|Overall Study|Protocol Violation|0|||
161483554|NCT00221403|583166492|FG002|Overall Study|Protocol Violation|0|||
161483555|NCT00221403|583166490|FG000|Overall Study|Physician Decision|1|||
161483556|NCT00221403|583166491|FG001|Overall Study|Physician Decision|0|||
161483557|NCT00221403|583166492|FG002|Overall Study|Physician Decision|0|||
161483558|NCT00221403|583166490|FG000|Overall Study|Withdrawal by Subject|0|||
161483559|NCT00221403|583166491|FG001|Overall Study|Withdrawal by Subject|3|||
161483560|NCT00221403|583166492|FG002|Overall Study|Withdrawal by Subject|0|||
161483561|NCT00221403|583166490|FG000|Overall Study|Lack of Efficacy|0|||
161483562|NCT00221403|583166491|FG001|Overall Study|Lack of Efficacy|1|||
161483563|NCT00221403|583166492|FG002|Overall Study|Lack of Efficacy|0|||
161483564|NCT00221403|583166490|FG000|Overall Study|Adverse Event|0|||
161483565|NCT00221403|583166491|FG001|Overall Study|Adverse Event|1|||
161483566|NCT00221403|583166492|FG002|Overall Study|Adverse Event|0|||
161483567|NCT00496054|583166498|FG000|Overall Study|Adverse Event|1|||
161483568|NCT00496054|583166498|FG000|Overall Study|Lost to Follow-up|7|||
161483569|NCT01737697|583166499|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483570|NCT01737697|583166500|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
161483571|NCT01737697|583166501|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483572|NCT01737697|583166502|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
161483573|NCT01737697|583166503|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
161483574|NCT01737697|583166504|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483575|NCT01737697|583166505|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483576|NCT01737697|583166506|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483577|NCT01737697|583166507|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483578|NCT01737697|583166508|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161816614|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Other|0|||
161816615|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Other|0|||
161816616|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Other|0|||
161816617|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Other|0|||
161816618|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Other|0|||
161816619|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Other|0|||
161816620|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Other|0|||
161816621|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Other|0|||
161816622|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Other|0|||
161816623|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Other|0|||
161483579|NCT01737697|583166509|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483580|NCT01737697|583166510|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483581|NCT01737697|583166511|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483582|NCT01737697|583166512|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483583|NCT01737697|583166513|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
161483584|NCT01737697|583166499|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
161483585|NCT01737697|583166500|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
161483586|NCT01737697|583166501|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
161483587|NCT01737697|583166502|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483588|NCT01737697|583166503|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483589|NCT01737697|583166504|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483590|NCT01737697|583166505|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483591|NCT01737697|583166506|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483592|NCT01737697|583166507|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483593|NCT01737697|583166508|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483594|NCT01737697|583166509|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483595|NCT01737697|583166510|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483596|NCT01737697|583166511|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483597|NCT01737697|583166512|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483598|NCT01737697|583166513|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
161483599|NCT01737697|583166499|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483600|NCT01737697|583166500|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483601|NCT01737697|583166501|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483602|NCT01737697|583166502|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
161483603|NCT01737697|583166503|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483604|NCT01737697|583166504|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483605|NCT01737697|583166505|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483606|NCT01737697|583166506|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483607|NCT01737697|583166507|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483608|NCT01737697|583166508|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483609|NCT01737697|583166509|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483610|NCT01737697|583166510|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483611|NCT01737697|583166511|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483612|NCT01737697|583166512|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483613|NCT01737697|583166513|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
161483614|NCT01737697|583166499|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483615|NCT01737697|583166500|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
161483616|NCT01737697|583166501|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161921664|NCT03580928|584758198|FG001|Overall Study|Death|3|||
161483617|NCT01737697|583166502|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483618|NCT01737697|583166503|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161921665|NCT03580928|584758197|FG000|Overall Study|Withdrawal by Subject|2|||
161921666|NCT03580928|584758198|FG001|Overall Study|Withdrawal by Subject|1|||
161483619|NCT01737697|583166504|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483620|NCT01737697|583166505|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483621|NCT01737697|583166506|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483622|NCT01737697|583166507|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483623|NCT01737697|583166508|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161921667|NCT03580928|584758197|FG000|Overall Study|Lost to Follow-up|2|||
161921668|NCT03580928|584758198|FG001|Overall Study|Lost to Follow-up|0|||
161921669|NCT03580928|584758197|FG000|Overall Study|Progressive Disease|0|||
161921670|NCT03580928|584758198|FG001|Overall Study|Progressive Disease|1|||
161921671|NCT00484159|584759968|FG000|Overall Study|Lost to Follow-up|1|||
161483624|NCT01737697|583166509|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483625|NCT01737697|583166510|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483626|NCT01737697|583166511|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483627|NCT01737697|583166512|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483628|NCT01737697|583166513|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
161483629|NCT01737697|583166499|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483630|NCT01737697|583166500|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483631|NCT01737697|583166501|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161921672|NCT00484159|584759969|FG001|Overall Study|Lost to Follow-up|1|||
161483632|NCT01737697|583166502|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483633|NCT01737697|583166503|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
161483634|NCT01737697|583166504|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483635|NCT01737697|583166505|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483636|NCT01737697|583166506|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483637|NCT01737697|583166507|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483638|NCT01737697|583166508|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483639|NCT01737697|583166509|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483640|NCT01737697|583166510|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483641|NCT01737697|583166511|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483642|NCT01737697|583166512|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161921673|NCT00484159|584759970|FG002|Overall Study|Lost to Follow-up|0|||
161921674|NCT03234881|584759971|FG000|Overall Study|Lost to Follow-up|9|||
161921675|NCT03234881|584759972|FG001|Overall Study|Lost to Follow-up|3|||
161483643|NCT01737697|583166513|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
161483644|NCT01737697|583166499|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483645|NCT01737697|583166500|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
161483646|NCT01737697|583166501|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
161483647|NCT01737697|583166502|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
161483648|NCT01737697|583166503|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
161483649|NCT01737697|583166504|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483650|NCT01737697|583166505|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483651|NCT01737697|583166506|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483652|NCT01737697|583166507|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483653|NCT01737697|583166508|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483654|NCT01737697|583166509|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483655|NCT01737697|583166510|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483656|NCT01737697|583166511|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483657|NCT01737697|583166512|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483658|NCT01737697|583166513|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
161483659|NCT01737697|583166499|FG000|Subacute Phase|Adverse Event|0|||
161483660|NCT01737697|583166500|FG001|Subacute Phase|Adverse Event|0|||
161669930|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
161483661|NCT01737697|583166501|FG002|Subacute Phase|Adverse Event|0|||
161483662|NCT01737697|583166502|FG003|Subacute Phase|Adverse Event|0|||
161483663|NCT01737697|583166503|FG004|Subacute Phase|Adverse Event|0|||
161483664|NCT01737697|583166504|FG005|Subacute Phase|Adverse Event|1|||
161669931|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
161669932|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
161669933|NCT01294683|583843186|FG000|Post Crossover (Period III)|Adverse Event|6|||
161669934|NCT01294683|583843187|FG001|Post Crossover (Period III)|Adverse Event|6|||
161669935|NCT01294683|583843186|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
161669936|NCT01294683|583843187|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
161669937|NCT01294683|583843186|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
161669938|NCT01294683|583843187|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
161921676|NCT03807843|584759973|FG000|Overall Study|Lost to Follow-up|1|||
161483665|NCT01737697|583166505|FG006|Subacute Phase|Adverse Event|1|||
161483666|NCT01737697|583166506|FG007|Subacute Phase|Adverse Event|1|||
161483667|NCT01737697|583166507|FG008|Subacute Phase|Adverse Event|1|||
161483668|NCT01737697|583166508|FG009|Subacute Phase|Adverse Event|1|||
161483669|NCT01737697|583166509|FG010|Subacute Phase|Adverse Event|4|||
161483670|NCT01737697|583166510|FG011|Subacute Phase|Adverse Event|1|||
161483671|NCT01737697|583166511|FG012|Subacute Phase|Adverse Event|1|||
161483672|NCT01737697|583166512|FG013|Subacute Phase|Adverse Event|0|||
161483673|NCT01737697|583166513|FG014|Subacute Phase|Adverse Event|0|||
161483674|NCT01737697|583166499|FG000|Subacute Phase|Withdrawal by Subject|0|||
161483675|NCT01737697|583166500|FG001|Subacute Phase|Withdrawal by Subject|0|||
161483676|NCT01737697|583166501|FG002|Subacute Phase|Withdrawal by Subject|0|||
161483677|NCT01737697|583166502|FG003|Subacute Phase|Withdrawal by Subject|0|||
161483678|NCT01737697|583166503|FG004|Subacute Phase|Withdrawal by Subject|0|||
161483679|NCT01737697|583166504|FG005|Subacute Phase|Withdrawal by Subject|1|||
161483680|NCT01737697|583166505|FG006|Subacute Phase|Withdrawal by Subject|0|||
161483681|NCT01737697|583166506|FG007|Subacute Phase|Withdrawal by Subject|2|||
161483682|NCT01737697|583166507|FG008|Subacute Phase|Withdrawal by Subject|0|||
161483683|NCT01737697|583166508|FG009|Subacute Phase|Withdrawal by Subject|1|||
161483684|NCT01737697|583166509|FG010|Subacute Phase|Withdrawal by Subject|0|||
161483685|NCT01737697|583166510|FG011|Subacute Phase|Withdrawal by Subject|1|||
161483686|NCT01737697|583166511|FG012|Subacute Phase|Withdrawal by Subject|1|||
161483687|NCT01737697|583166512|FG013|Subacute Phase|Withdrawal by Subject|1|||
161669939|NCT01294683|583843186|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
161669940|NCT01294683|583843187|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
161669941|NCT01794923|583843188|FG000|Overall Study|Adverse Event|0|||
161921677|NCT03807843|584759974|FG001|Overall Study|Lost to Follow-up|0|||
161921678|NCT01239680|584759979|FG000|Overall Study|Withdrawal by Subject|2|||
161921679|NCT01239680|584759980|FG001|Overall Study|Withdrawal by Subject|0|||
161921680|NCT00639379|584759981|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
161921681|NCT00639379|584759982|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
161921682|NCT00639379|584759981|FG000|Period 1 - 2 Weeks|lens issue|3|||
161483688|NCT01737697|583166513|FG014|Subacute Phase|Withdrawal by Subject|0|||
161669942|NCT01794923|583843189|FG001|Overall Study|Adverse Event|0|||
161669943|NCT01794923|583843190|FG002|Overall Study|Adverse Event|1|||
161921683|NCT00639379|584759982|FG001|Period 1 - 2 Weeks|lens issue|0|||
161483689|NCT01737697|583166499|FG000|Subacute Phase|Lost to Follow-up|0|||
161483690|NCT01737697|583166500|FG001|Subacute Phase|Lost to Follow-up|0|||
161483691|NCT01737697|583166501|FG002|Subacute Phase|Lost to Follow-up|0|||
161483692|NCT01737697|583166502|FG003|Subacute Phase|Lost to Follow-up|0|||
161483693|NCT01737697|583166503|FG004|Subacute Phase|Lost to Follow-up|0|||
161921684|NCT01797185|584759983|FG000|Overall Study|Adverse Event|5|||
161483694|NCT01737697|583166504|FG005|Subacute Phase|Lost to Follow-up|0|||
161483695|NCT01737697|583166505|FG006|Subacute Phase|Lost to Follow-up|0|||
161483696|NCT01737697|583166506|FG007|Subacute Phase|Lost to Follow-up|0|||
161483697|NCT01737697|583166507|FG008|Subacute Phase|Lost to Follow-up|0|||
161483698|NCT01737697|583166508|FG009|Subacute Phase|Lost to Follow-up|0|||
161483699|NCT01737697|583166509|FG010|Subacute Phase|Lost to Follow-up|0|||
161483700|NCT01737697|583166510|FG011|Subacute Phase|Lost to Follow-up|0|||
161483701|NCT01737697|583166511|FG012|Subacute Phase|Lost to Follow-up|0|||
161483702|NCT01737697|583166512|FG013|Subacute Phase|Lost to Follow-up|0|||
161483703|NCT01737697|583166513|FG014|Subacute Phase|Lost to Follow-up|1|||
161483704|NCT01737697|583166499|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
161483705|NCT01737697|583166500|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
161483706|NCT01737697|583166501|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
161483707|NCT01737697|583166502|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
161483708|NCT01737697|583166503|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
161483709|NCT01737697|583166504|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
161483710|NCT01737697|583166505|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
161483711|NCT01737697|583166506|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
161483712|NCT01737697|583166507|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
161483713|NCT01737697|583166508|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
161483714|NCT01737697|583166509|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
161483715|NCT01737697|583166510|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
161483716|NCT01737697|583166511|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
161483717|NCT01737697|583166512|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
161483718|NCT01737697|583166513|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
161483719|NCT01737697|583166499|FG000|Subacute Phase|Protocol Violation|0|||
161483720|NCT01737697|583166500|FG001|Subacute Phase|Protocol Violation|0|||
161483721|NCT01737697|583166501|FG002|Subacute Phase|Protocol Violation|0|||
161483722|NCT01737697|583166502|FG003|Subacute Phase|Protocol Violation|0|||
161483723|NCT01737697|583166503|FG004|Subacute Phase|Protocol Violation|0|||
161483724|NCT01737697|583166504|FG005|Subacute Phase|Protocol Violation|1|||
161483725|NCT01737697|583166505|FG006|Subacute Phase|Protocol Violation|0|||
161483726|NCT01737697|583166506|FG007|Subacute Phase|Protocol Violation|0|||
161483727|NCT01737697|583166507|FG008|Subacute Phase|Protocol Violation|0|||
161483728|NCT01737697|583166508|FG009|Subacute Phase|Protocol Violation|0|||
161483729|NCT01737697|583166509|FG010|Subacute Phase|Protocol Violation|1|||
161483730|NCT01737697|583166510|FG011|Subacute Phase|Protocol Violation|0|||
161483731|NCT01737697|583166511|FG012|Subacute Phase|Protocol Violation|0|||
161483732|NCT01737697|583166512|FG013|Subacute Phase|Protocol Violation|0|||
161483733|NCT01737697|583166513|FG014|Subacute Phase|Protocol Violation|0|||
161483734|NCT01737697|583166499|FG000|Subacute Phase|Physician Decision|0|||
161483735|NCT01737697|583166500|FG001|Subacute Phase|Physician Decision|0|||
161483736|NCT01737697|583166501|FG002|Subacute Phase|Physician Decision|0|||
161483737|NCT01737697|583166502|FG003|Subacute Phase|Physician Decision|0|||
161483738|NCT01737697|583166503|FG004|Subacute Phase|Physician Decision|0|||
161483739|NCT01737697|583166504|FG005|Subacute Phase|Physician Decision|0|||
161483740|NCT01737697|583166505|FG006|Subacute Phase|Physician Decision|0|||
161483741|NCT01737697|583166506|FG007|Subacute Phase|Physician Decision|0|||
161483742|NCT01737697|583166507|FG008|Subacute Phase|Physician Decision|1|||
161483743|NCT01737697|583166508|FG009|Subacute Phase|Physician Decision|0|||
161483744|NCT01737697|583166509|FG010|Subacute Phase|Physician Decision|0|||
161483745|NCT01737697|583166510|FG011|Subacute Phase|Physician Decision|0|||
161483746|NCT01737697|583166511|FG012|Subacute Phase|Physician Decision|0|||
161483747|NCT01737697|583166512|FG013|Subacute Phase|Physician Decision|0|||
161483748|NCT01737697|583166513|FG014|Subacute Phase|Physician Decision|0|||
161483749|NCT01737697|583166499|FG000|Subacute Phase|Death|0|||
161483750|NCT01737697|583166500|FG001|Subacute Phase|Death|0|||
161483751|NCT01737697|583166501|FG002|Subacute Phase|Death|0|||
161483752|NCT01737697|583166502|FG003|Subacute Phase|Death|0|||
161483753|NCT01737697|583166503|FG004|Subacute Phase|Death|0|||
161816624|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Other|0|||
161816625|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Other|0|||
161816626|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Other|0|||
161483754|NCT01737697|583166504|FG005|Subacute Phase|Death|0|||
161483755|NCT01737697|583166505|FG006|Subacute Phase|Death|0|||
161483756|NCT01737697|583166506|FG007|Subacute Phase|Death|0|||
161483757|NCT01737697|583166507|FG008|Subacute Phase|Death|0|||
161483758|NCT01737697|583166508|FG009|Subacute Phase|Death|0|||
161483759|NCT01737697|583166509|FG010|Subacute Phase|Death|1|||
161816627|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Other|0|||
161483760|NCT01737697|583166510|FG011|Subacute Phase|Death|0|||
161483761|NCT01737697|583166511|FG012|Subacute Phase|Death|0|||
161483762|NCT01737697|583166512|FG013|Subacute Phase|Death|0|||
161483763|NCT01737697|583166513|FG014|Subacute Phase|Death|0|||
161483764|NCT02216591|583166514|FG000|Overall Study|Lost to Follow-up|0|||
161483765|NCT02216591|583166515|FG001|Overall Study|Lost to Follow-up|1|||
161483766|NCT01950741|583166517|FG000|Overall Study|Lost to Follow-up|1|||
161483767|NCT01950741|583166517|FG000|Overall Study|Death|1|||
161483768|NCT01950741|583166517|FG000|Overall Study|Withdrawal by Subject|1|||
161483769|NCT04342897|583166520|FG000|Overall Study|Death|7|||
161483770|NCT04342897|583166521|FG001|Overall Study|Death|4|||
161483771|NCT04342897|583166520|FG000|Overall Study|Lost to Follow-up|6|||
161483772|NCT04342897|583166521|FG001|Overall Study|Lost to Follow-up|6|||
161483773|NCT04342897|583166520|FG000|Overall Study|Withdrawal by Subject|1|||
161483774|NCT04342897|583166521|FG001|Overall Study|Withdrawal by Subject|2|||
161483775|NCT00621153|583166523|FG000|Overall Study|Safety Reason|8|||
161483776|NCT00621153|583166524|FG001|Overall Study|Safety Reason|7|||
161483777|NCT00621153|583166523|FG000|Overall Study|Adverse Event|3|||
161483778|NCT00621153|583166524|FG001|Overall Study|Adverse Event|2|||
161483779|NCT00621153|583166523|FG000|Overall Study|Lost to Follow-up|5|||
161483780|NCT00621153|583166524|FG001|Overall Study|Lost to Follow-up|1|||
161483781|NCT00621153|583166523|FG000|Overall Study|Withdrawal by Subject|4|||
161483782|NCT00621153|583166524|FG001|Overall Study|Withdrawal by Subject|5|||
161483783|NCT00753415|583166525|FG000|Part A|Disease progression|1|||
161483784|NCT00753415|583166526|FG001|Part A|Disease progression|0|||
161483785|NCT00753415|583166527|FG002|Part A|Disease progression|1|||
161483786|NCT00753415|583166528|FG003|Part A|Disease progression|2|||
161483787|NCT00753415|583166529|FG004|Part A|Disease progression|0|||
161483788|NCT00753415|583166530|FG005|Part A|Disease progression|0|||
161483789|NCT00753415|583166531|FG006|Part A|Disease progression|0|||
161483790|NCT00753415|583166532|FG007|Part A|Disease progression|0|||
161483791|NCT00753415|583166533|FG008|Part A|Disease progression|0|||
161483792|NCT00753415|583166534|FG009|Part A|Disease progression|0|||
161483793|NCT00753415|583166525|FG000|Part A|Withdrawal by Subject|0|||
161483794|NCT00753415|583166526|FG001|Part A|Withdrawal by Subject|0|||
161483795|NCT00753415|583166527|FG002|Part A|Withdrawal by Subject|1|||
161483796|NCT00753415|583166528|FG003|Part A|Withdrawal by Subject|0|||
161483797|NCT00753415|583166529|FG004|Part A|Withdrawal by Subject|0|||
161483798|NCT00753415|583166530|FG005|Part A|Withdrawal by Subject|0|||
161483799|NCT00753415|583166531|FG006|Part A|Withdrawal by Subject|0|||
161483800|NCT00753415|583166532|FG007|Part A|Withdrawal by Subject|0|||
161483801|NCT00753415|583166533|FG008|Part A|Withdrawal by Subject|0|||
161483802|NCT00753415|583166534|FG009|Part A|Withdrawal by Subject|0|||
161483803|NCT00753415|583166525|FG000|Part B|Lost to Follow-up|0|||
161483804|NCT00753415|583166526|FG001|Part B|Lost to Follow-up|0|||
161483805|NCT00753415|583166527|FG002|Part B|Lost to Follow-up|0|||
161483806|NCT00753415|583166528|FG003|Part B|Lost to Follow-up|0|||
161483807|NCT00753415|583166529|FG004|Part B|Lost to Follow-up|0|||
161483808|NCT00753415|583166530|FG005|Part B|Lost to Follow-up|0|||
161483809|NCT00753415|583166531|FG006|Part B|Lost to Follow-up|0|||
161483810|NCT00753415|583166532|FG007|Part B|Lost to Follow-up|1|||
161483811|NCT00753415|583166533|FG008|Part B|Lost to Follow-up|1|||
161483812|NCT00753415|583166534|FG009|Part B|Lost to Follow-up|0|||
161483813|NCT00753415|583166525|FG000|Part B|Disease progression|0|||
161483814|NCT00753415|583166526|FG001|Part B|Disease progression|0|||
161483815|NCT00753415|583166527|FG002|Part B|Disease progression|0|||
161483816|NCT00753415|583166528|FG003|Part B|Disease progression|0|||
161483817|NCT00753415|583166529|FG004|Part B|Disease progression|0|||
161483818|NCT00753415|583166530|FG005|Part B|Disease progression|0|||
161483819|NCT00753415|583166531|FG006|Part B|Disease progression|0|||
161483820|NCT00753415|583166532|FG007|Part B|Disease progression|0|||
161483821|NCT00753415|583166533|FG008|Part B|Disease progression|2|||
161483822|NCT00753415|583166534|FG009|Part B|Disease progression|1|||
161483823|NCT02881554|583166543|FG000|Overall Study|Withdrawal by Subject|2|||
161483824|NCT02881554|583166544|FG001|Overall Study|Withdrawal by Subject|0|||
161483825|NCT02674529|583168873|FG000|Overall Study|Lost to Follow-up|1|||
161483826|NCT02674529|583168874|FG001|Overall Study|Lost to Follow-up|2|||
161483827|NCT02674529|583168873|FG000|Overall Study|Withdrawal by Subject|2|||
161483828|NCT02674529|583168874|FG001|Overall Study|Withdrawal by Subject|1|||
161483829|NCT02674529|583168873|FG000|Overall Study|Physician Decision|0|||
161483830|NCT02674529|583168874|FG001|Overall Study|Physician Decision|1|||
161483831|NCT02674529|583168873|FG000|Overall Study|Protocol Violation|0|||
161483832|NCT02674529|583168874|FG001|Overall Study|Protocol Violation|1|||
161483833|NCT02141282|583168876|FG000|Overall Study|Adverse event, not related to progression|8|||
161483834|NCT02141282|583168877|FG001|Overall Study|Adverse event, not related to progression|1|||
161483835|NCT02141282|583168878|FG002|Overall Study|Adverse event, not related to progression|3|||
161483836|NCT02141282|583168879|FG003|Overall Study|Adverse event, not related to progression|1|||
161483837|NCT02141282|583168876|FG000|Overall Study|Adverse event, related to progression|1|||
161483838|NCT02141282|583168877|FG001|Overall Study|Adverse event, related to progression|0|||
161483839|NCT02141282|583168878|FG002|Overall Study|Adverse event, related to progression|2|||
161483840|NCT02141282|583168879|FG003|Overall Study|Adverse event, related to progression|0|||
161483841|NCT02141282|583168876|FG000|Overall Study|COVID-19 infection|1|||
161483842|NCT02141282|583168877|FG001|Overall Study|COVID-19 infection|0|||
161483843|NCT02141282|583168878|FG002|Overall Study|COVID-19 infection|0|||
161483844|NCT02141282|583168879|FG003|Overall Study|COVID-19 infection|0|||
161483845|NCT02141282|583168876|FG000|Overall Study|Lost to Follow-up|0|||
161483846|NCT02141282|583168877|FG001|Overall Study|Lost to Follow-up|0|||
161483847|NCT02141282|583168878|FG002|Overall Study|Lost to Follow-up|4|||
161483848|NCT02141282|583168879|FG003|Overall Study|Lost to Follow-up|2|||
161483849|NCT02141282|583168876|FG000|Overall Study|Other, not specified|14|||
161483850|NCT02141282|583168877|FG001|Overall Study|Other, not specified|11|||
161483851|NCT02141282|583168878|FG002|Overall Study|Other, not specified|23|||
161483852|NCT02141282|583168879|FG003|Overall Study|Other, not specified|9|||
161483853|NCT02141282|583168876|FG000|Overall Study|Progressive disease, Richter's|4|||
161483854|NCT02141282|583168877|FG001|Overall Study|Progressive disease, Richter's|1|||
161483855|NCT02141282|583168878|FG002|Overall Study|Progressive disease, Richter's|1|||
161483856|NCT02141282|583168879|FG003|Overall Study|Progressive disease, Richter's|1|||
161483857|NCT02141282|583168876|FG000|Overall Study|Progressive disease per protocol|12|||
161483858|NCT02141282|583168877|FG001|Overall Study|Progressive disease per protocol|7|||
161483859|NCT02141282|583168878|FG002|Overall Study|Progressive disease per protocol|9|||
161483860|NCT02141282|583168879|FG003|Overall Study|Progressive disease per protocol|2|||
161483861|NCT02141282|583168876|FG000|Overall Study|Stem cell transplant|1|||
161483862|NCT02141282|583168877|FG001|Overall Study|Stem cell transplant|0|||
161483863|NCT02141282|583168878|FG002|Overall Study|Stem cell transplant|1|||
161483864|NCT02141282|583168879|FG003|Overall Study|Stem cell transplant|0|||
161483865|NCT02141282|583168876|FG000|Overall Study|Study terminated by Sponsor|0|||
161483866|NCT02141282|583168877|FG001|Overall Study|Study terminated by Sponsor|1|||
161483867|NCT02141282|583168878|FG002|Overall Study|Study terminated by Sponsor|0|||
161483868|NCT02141282|583168879|FG003|Overall Study|Study terminated by Sponsor|0|||
161483869|NCT02141282|583168876|FG000|Overall Study|Subject non-compliance|0|||
161483870|NCT02141282|583168877|FG001|Overall Study|Subject non-compliance|0|||
161483871|NCT02141282|583168878|FG002|Overall Study|Subject non-compliance|1|||
161483872|NCT02141282|583168879|FG003|Overall Study|Subject non-compliance|0|||
161483873|NCT02141282|583168876|FG000|Overall Study|Withdrew consent|2|||
161921685|NCT01797185|584759984|FG001|Overall Study|Adverse Event|15|||
161921686|NCT01797185|584759985|FG002|Overall Study|Adverse Event|6|||
161921687|NCT01797185|584759983|FG000|Overall Study|Withdrawal by Subject|6|||
161921688|NCT01797185|584759984|FG001|Overall Study|Withdrawal by Subject|9|||
161921689|NCT01797185|584759985|FG002|Overall Study|Withdrawal by Subject|5|||
161921690|NCT01797185|584759983|FG000|Overall Study|Site terminated|8|||
161921691|NCT01797185|584759984|FG001|Overall Study|Site terminated|4|||
161921692|NCT01797185|584759985|FG002|Overall Study|Site terminated|0|||
161921693|NCT01797185|584759983|FG000|Overall Study|Lost to Follow-up|2|||
161483874|NCT02141282|583168877|FG001|Overall Study|Withdrew consent|0|||
161483875|NCT02141282|583168878|FG002|Overall Study|Withdrew consent|4|||
161483876|NCT02141282|583168879|FG003|Overall Study|Withdrew consent|0|||
161483877|NCT00963547|583168882|FG000|Overall Study|Adverse Event|0|||
161483878|NCT00963547|583168883|FG001|Overall Study|Adverse Event|1|||
161483879|NCT00963547|583168884|FG002|Overall Study|Adverse Event|0|||
161483880|NCT00963547|583168885|FG003|Overall Study|Adverse Event|1|||
161483881|NCT00963547|583168886|FG004|Overall Study|Adverse Event|0|||
161483882|NCT00963547|583168887|FG005|Overall Study|Adverse Event|0|||
161483883|NCT00963547|583168888|FG006|Overall Study|Adverse Event|0|||
161483884|NCT00963547|583168882|FG000|Overall Study|Physician Decision|1|||
161483885|NCT00963547|583168883|FG001|Overall Study|Physician Decision|1|||
161483886|NCT00963547|583168884|FG002|Overall Study|Physician Decision|0|||
161483887|NCT00963547|583168885|FG003|Overall Study|Physician Decision|0|||
161483888|NCT00963547|583168886|FG004|Overall Study|Physician Decision|0|||
161483889|NCT00963547|583168887|FG005|Overall Study|Physician Decision|0|||
161483890|NCT00963547|583168888|FG006|Overall Study|Physician Decision|0|||
161483891|NCT00963547|583168882|FG000|Overall Study|Progressive Disease|3|||
161483892|NCT00963547|583168883|FG001|Overall Study|Progressive Disease|8|||
161483893|NCT00963547|583168884|FG002|Overall Study|Progressive Disease|9|||
161483894|NCT00963547|583168885|FG003|Overall Study|Progressive Disease|5|||
161483895|NCT00963547|583168886|FG004|Overall Study|Progressive Disease|0|||
161483896|NCT00963547|583168887|FG005|Overall Study|Progressive Disease|0|||
161483897|NCT00963547|583168888|FG006|Overall Study|Progressive Disease|0|||
161483898|NCT00963547|583168882|FG000|Overall Study|Withdrawal by Subject|0|||
161483899|NCT00963547|583168883|FG001|Overall Study|Withdrawal by Subject|0|||
161483900|NCT00963547|583168884|FG002|Overall Study|Withdrawal by Subject|3|||
161483901|NCT00963547|583168885|FG003|Overall Study|Withdrawal by Subject|0|||
161483902|NCT00963547|583168886|FG004|Overall Study|Withdrawal by Subject|0|||
161483903|NCT00963547|583168887|FG005|Overall Study|Withdrawal by Subject|0|||
161483904|NCT00963547|583168888|FG006|Overall Study|Withdrawal by Subject|0|||
161921694|NCT01797185|584759984|FG001|Overall Study|Lost to Follow-up|6|||
161921695|NCT01797185|584759985|FG002|Overall Study|Lost to Follow-up|1|||
161921696|NCT01797185|584759983|FG000|Overall Study|Withdrawn per sponsor|5|||
161483905|NCT00963547|583168882|FG000|Overall Study|Reason Unknown|0|||
161483906|NCT00963547|583168883|FG001|Overall Study|Reason Unknown|1|||
161483907|NCT00963547|583168884|FG002|Overall Study|Reason Unknown|0|||
161483908|NCT00963547|583168885|FG003|Overall Study|Reason Unknown|0|||
161483909|NCT00963547|583168886|FG004|Overall Study|Reason Unknown|0|||
161483910|NCT00963547|583168887|FG005|Overall Study|Reason Unknown|0|||
161483911|NCT00963547|583168888|FG006|Overall Study|Reason Unknown|0|||
161483912|NCT00331682|583168889|FG000|Overall Study|Adverse Event|1|||
161483913|NCT03761277|583168890|FG000|Enrollment to Implant|Screen Failure|17|||
161483914|NCT03761277|583168890|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
161483915|NCT03761277|583168890|FG000|Enrollment to Implant|Physician Decision|2|||
161483916|NCT03761277|583168890|FG000|Enrollment to Implant|Site Closure|3|||
161483917|NCT03761277|583168890|FG000|Enrollment to Implant|Sponsor Request|2|||
161483918|NCT03761277|583168890|FG000|Post-Implant to 6 Months|Adverse Event|2|||
161483919|NCT03761277|583168890|FG000|Post-Implant to 6 Months|Death|1|||
161483920|NCT03761277|583168890|FG000|Post-Implant to 6 Months|Site Closure|2|||
161483921|NCT03761277|583168890|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
161483922|NCT03761277|583168890|FG000|6 Months to 12 Months|Physician Decision|2|||
161483923|NCT03761277|583168890|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
161483924|NCT00759031|583168891|FG000|First Intervention (1 Day)|Physician Decision|1|||
161483925|NCT00759031|583168892|FG001|First Intervention (1 Day)|Physician Decision|0|||
161483926|NCT00759031|583168891|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161483927|NCT00759031|583168892|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161483928|NCT00759031|583168891|FG000|First Intervention (1 Day)|Screening failure|1|||
161483929|NCT00759031|583168892|FG001|First Intervention (1 Day)|Screening failure|0|||
161483930|NCT00543140|583168893|FG000|Overall Study|Lost to Follow-up|33|||
161483931|NCT00543140|583168893|FG000|Overall Study|Withdrawal by Subject|13|||
161483932|NCT00543140|583168893|FG000|Overall Study|Protocol Violation|10|||
161483933|NCT00543140|583168893|FG000|Overall Study|Insufficient weight loss|10|||
161483934|NCT00543140|583168893|FG000|Overall Study|SAE leading to explant of SAGB|3|||
161483935|NCT00543140|583168893|FG000|Overall Study|Death|1|||
161483936|NCT00543140|583168893|FG000|Overall Study|Subject moved|1|||
161580538|NCT03565315|583513950|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161580539|NCT03565315|583513951|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161816628|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Other|0|||
161816629|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Other|0|||
161816630|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Other|0|||
161816631|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Other|1|||
161816632|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Other|0|||
161816633|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816634|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816635|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816636|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816637|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816638|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816639|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816640|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816641|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816642|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816643|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816644|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816645|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816646|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816647|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816648|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816649|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816650|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816651|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816652|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816653|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816654|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816655|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816656|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
161816657|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816658|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816659|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816660|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161483937|NCT00543140|583168893|FG000|Overall Study|Conversion to different procedure|1|||
161483938|NCT04532164|583168894|FG000|Overall Study|Adverse Event|1|||
161483939|NCT04532164|583168894|FG000|Overall Study|Protocol Violation|5|||
161483940|NCT04532164|583168894|FG000|Overall Study|Lost to Follow-up|1|||
161483941|NCT04532164|583168894|FG000|Overall Study|Found to be Ineligible|3|||
161483942|NCT04532164|583168894|FG000|Overall Study|Withdrawal by Subject|14|||
161483943|NCT01599234|583168895|FG000|Overall Study|Adverse Event|9|||
161483944|NCT01599234|583168896|FG001|Overall Study|Adverse Event|5|||
161483945|NCT01599234|583168895|FG000|Overall Study|Withdrawal by Subject|2|||
161483946|NCT01599234|583168896|FG001|Overall Study|Withdrawal by Subject|1|||
161483947|NCT01599234|583168895|FG000|Overall Study|Lost to Follow-up|1|||
161483948|NCT01599234|583168896|FG001|Overall Study|Lost to Follow-up|2|||
161483949|NCT01599234|583168895|FG000|Overall Study|Lack of Efficacy|2|||
161483950|NCT01599234|583168896|FG001|Overall Study|Lack of Efficacy|4|||
161483951|NCT01599234|583168895|FG000|Overall Study|Unable to operate spray|1|||
161483952|NCT01599234|583168896|FG001|Overall Study|Unable to operate spray|0|||
161483953|NCT01599234|583168895|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
161483954|NCT01599234|583168896|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
161483955|NCT01599234|583168895|FG000|Overall Study|Death|1|||
161483956|NCT01599234|583168896|FG001|Overall Study|Death|0|||
161483957|NCT01599234|583168895|FG000|Overall Study|Patient would not stop driving|1|||
161483958|NCT01599234|583168896|FG001|Overall Study|Patient would not stop driving|0|||
161483959|NCT01599234|583168895|FG000|Overall Study|Contra-indication discovered|0|||
161483960|NCT01599234|583168896|FG001|Overall Study|Contra-indication discovered|1|||
161483961|NCT01599234|583168895|FG000|Overall Study|Pregnancy|0|||
161483962|NCT01599234|583168896|FG001|Overall Study|Pregnancy|1|||
161483963|NCT00743340|583168901|FG000|Overall Study|Study medication non-compliance|1|||
161483964|NCT00743340|583168901|FG000|Overall Study|Lost to Follow-up|1|||
161483965|NCT00743340|583168901|FG000|Overall Study|Withdrawal from the Study|5|||
161483966|NCT00743340|583168901|FG000|Overall Study|Protocol Violation|1|||
161483967|NCT00743340|583168901|FG000|Overall Study|Virologic failure|8|||
161483968|NCT00743340|583168901|FG000|Overall Study|Pregnancy|1|||
161483969|NCT00743340|583168901|FG000|Overall Study|Rolled over to other Gilead Study|23|||
161483970|NCT00743340|583168901|FG000|Overall Study|Participant Relocated|1|||
161483971|NCT02708121|583168902|FG000|Overall Study|Withdrawn by Study Team|1|||
161483972|NCT02708121|583168903|FG001|Overall Study|Withdrawn by Study Team|1|||
161483973|NCT02708121|583168902|FG000|Overall Study|Withdrawal by Subject|0|||
161483974|NCT02708121|583168903|FG001|Overall Study|Withdrawal by Subject|4|||
161483975|NCT00127660|583168906|FG000|Overall Study|Protocol Violation|3|||
161483976|NCT00127660|583168907|FG001|Overall Study|Protocol Violation|3|||
161483977|NCT00127660|583168908|FG002|Overall Study|Protocol Violation|5|||
161483978|NCT00127660|583168909|FG003|Overall Study|Protocol Violation|0|||
161483979|NCT01425281|583168910|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
161483980|NCT01425281|583168911|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
161483981|NCT01425281|583168910|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
161483982|NCT01425281|583168911|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
161483983|NCT01425281|583168910|FG000|At 180-day Clinical Follow-up|Death|0|||
161483984|NCT01425281|583168911|FG001|At 180-day Clinical Follow-up|Death|1|||
161483985|NCT01425281|583168910|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
161483986|NCT01425281|583168911|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
161580540|NCT03565315|583513952|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161580541|NCT03565315|583513953|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
161580542|NCT01170962|583513954|FG000|Treatment Period|Lack of Efficacy|96|||
161816661|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816662|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816663|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816664|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816665|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816666|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816667|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816668|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816669|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816670|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816671|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816672|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816673|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816674|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816675|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816676|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816677|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816678|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816679|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161483987|NCT01425281|583168910|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
161483988|NCT01425281|583168911|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
161921697|NCT01797185|584759984|FG001|Overall Study|Withdrawn per sponsor|0|||
161921698|NCT01797185|584759985|FG002|Overall Study|Withdrawn per sponsor|0|||
161580543|NCT01170962|583513955|FG001|Treatment Period|Lack of Efficacy|91|||
161580544|NCT01170962|583513956|FG002|Treatment Period|Lack of Efficacy|7|||
161580545|NCT01170962|583513954|FG000|Treatment Period|Adverse Event|11|||
161580546|NCT01170962|583513955|FG001|Treatment Period|Adverse Event|12|||
161580547|NCT01170962|583513956|FG002|Treatment Period|Adverse Event|3|||
161580548|NCT01170962|583513954|FG000|Treatment Period|Withdrawal by Subject|2|||
161580549|NCT01170962|583513955|FG001|Treatment Period|Withdrawal by Subject|1|||
161580550|NCT01170962|583513956|FG002|Treatment Period|Withdrawal by Subject|0|||
161580551|NCT01170962|583513954|FG000|Treatment Period|Lost to Follow-up|1|||
161580552|NCT01170962|583513955|FG001|Treatment Period|Lost to Follow-up|1|||
161580553|NCT01170962|583513956|FG002|Treatment Period|Lost to Follow-up|1|||
161580554|NCT01170962|583513954|FG000|Treatment Period|Participant no longer meets criteria|0|||
161580555|NCT01170962|583513955|FG001|Treatment Period|Participant no longer meets criteria|1|||
161580556|NCT01170962|583513956|FG002|Treatment Period|Participant no longer meets criteria|0|||
161580557|NCT01170962|583513954|FG000|Treatment Period|Request to discontinue treatment|7|||
161580558|NCT01170962|583513955|FG001|Treatment Period|Request to discontinue treatment|3|||
161580559|NCT01170962|583513956|FG002|Treatment Period|Request to discontinue treatment|1|||
161580560|NCT01170962|583513954|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
161580561|NCT01170962|583513955|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
161580562|NCT01170962|583513956|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
161580563|NCT01170962|583513954|FG000|Follow up Period|Withdrawal by Subject|14|||
161580564|NCT01170962|583513955|FG001|Follow up Period|Withdrawal by Subject|10|||
161580565|NCT01170962|583513956|FG002|Follow up Period|Withdrawal by Subject|2|||
161580566|NCT01170962|583513954|FG000|Follow up Period|Lost to Follow-up|13|||
161580567|NCT01170962|583513955|FG001|Follow up Period|Lost to Follow-up|8|||
161580568|NCT01170962|583513956|FG002|Follow up Period|Lost to Follow-up|1|||
161580569|NCT01170962|583513954|FG000|Follow up Period|Death|2|||
161580570|NCT01170962|583513955|FG001|Follow up Period|Death|2|||
161580571|NCT01170962|583513956|FG002|Follow up Period|Death|0|||
161580572|NCT01170962|583513954|FG000|Follow up Period|Others|10|||
161580573|NCT01170962|583513955|FG001|Follow up Period|Others|7|||
161580574|NCT01170962|583513956|FG002|Follow up Period|Others|3|||
161580575|NCT03887650|583513957|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
161580576|NCT03887650|583513958|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
161580577|NCT03887650|583513957|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
161580578|NCT03887650|583513958|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
161580579|NCT03887650|583513957|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
161580580|NCT03887650|583513958|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
161580581|NCT01083316|583513959|FG000|Overall Study|Adverse Event|2|||
161580582|NCT01083316|583513959|FG000|Overall Study|Withdrawal by Subject|1|||
161580583|NCT04200365|583513960|FG000|Overall Study|Adverse Event|2|||
161580584|NCT04200365|583513960|FG000|Overall Study|Progressive Disease|4|||
161580585|NCT04200365|583513960|FG000|Overall Study|Lack of Efficacy|1|||
161580586|NCT04200365|583513960|FG000|Overall Study|Study Closure|4|||
161580587|NCT03942042|583513961|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
161580588|NCT03942042|583513962|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
161580589|NCT03942042|583513961|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
161580590|NCT03942042|583513962|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
161580591|NCT01199705|583513965|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
161580592|NCT01199575|583513966|FG000|Overall Study|Withdrawal by Subject|5|||
161921699|NCT01797185|584759983|FG000|Overall Study|Physician Decision|1|||
161921700|NCT01797185|584759984|FG001|Overall Study|Physician Decision|3|||
161921701|NCT01797185|584759985|FG002|Overall Study|Physician Decision|0|||
161921702|NCT01797185|584759983|FG000|Overall Study|Protocol Violation|1|||
161921703|NCT01797185|584759984|FG001|Overall Study|Protocol Violation|1|||
161921704|NCT01797185|584759985|FG002|Overall Study|Protocol Violation|0|||
161921705|NCT01033942|584759986|FG000|Overall Study|Withdrawal by Subject|1|||
161921706|NCT01033942|584759987|FG001|Overall Study|Withdrawal by Subject|1|||
161921707|NCT01033942|584759988|FG002|Overall Study|Withdrawal by Subject|1|||
161921708|NCT01033942|584759986|FG000|Overall Study|Lost to Follow-up|1|||
161921709|NCT01033942|584759987|FG001|Overall Study|Lost to Follow-up|0|||
161921710|NCT01033942|584759988|FG002|Overall Study|Lost to Follow-up|0|||
161921711|NCT01033942|584759986|FG000|Overall Study|Enrolled in Extension Study|0|||
161921712|NCT01033942|584759987|FG001|Overall Study|Enrolled in Extension Study|3|||
161580593|NCT00704184|583513971|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
161580594|NCT00704184|583513972|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
161580595|NCT00704184|583513973|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
161921713|NCT01033942|584759988|FG002|Overall Study|Enrolled in Extension Study|0|||
161921714|NCT05276804|584759996|FG000|Overall Study|screen failure|23|||
161921715|NCT05276804|584759997|FG001|Overall Study|screen failure|0|||
161921716|NCT02827708|584759998|FG000|Overall Study|Lost to Follow-up|3|||
161921717|NCT02827708|584759999|FG001|Overall Study|Lost to Follow-up|1|||
161580596|NCT00704184|583513974|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
161580597|NCT00704184|583513975|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
161580598|NCT00704184|583513971|FG000|Open-Label Treatment|Adverse Event|0|||
161580599|NCT00704184|583513972|FG001|Open-Label Treatment|Adverse Event|0|||
161580600|NCT00704184|583513973|FG002|Open-Label Treatment|Adverse Event|2|||
161580601|NCT00704184|583513974|FG003|Open-Label Treatment|Adverse Event|0|||
161580602|NCT00704184|583513975|FG004|Open-Label Treatment|Adverse Event|1|||
161580603|NCT00704184|583513971|FG000|Open-Label Treatment|Lack of Efficacy|0|||
161580604|NCT00704184|583513972|FG001|Open-Label Treatment|Lack of Efficacy|2|||
161580605|NCT00704184|583513973|FG002|Open-Label Treatment|Lack of Efficacy|2|||
161580606|NCT00704184|583513974|FG003|Open-Label Treatment|Lack of Efficacy|2|||
161580607|NCT00704184|583513975|FG004|Open-Label Treatment|Lack of Efficacy|1|||
161580608|NCT00704184|583513971|FG000|Open-Label Treatment|Physician Decision|0|||
161580609|NCT00704184|583513972|FG001|Open-Label Treatment|Physician Decision|0|||
161580610|NCT00704184|583513973|FG002|Open-Label Treatment|Physician Decision|0|||
161580611|NCT00704184|583513974|FG003|Open-Label Treatment|Physician Decision|0|||
161483989|NCT01425281|583168910|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
161483990|NCT01425281|583168911|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
161483991|NCT01425281|583168910|FG000|At 2-year Clinical Follow-up|Death|2|||
161483992|NCT01425281|583168911|FG001|At 2-year Clinical Follow-up|Death|0|||
161483993|NCT01425281|583168910|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
161483994|NCT01425281|583168911|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
161483995|NCT01425281|583168910|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
161483996|NCT01425281|583168911|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
161483997|NCT01425281|583168910|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
161483998|NCT01425281|583168911|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
161483999|NCT01425281|583168910|FG000|At 3-year Clinical Follow-up|Death|2|||
161484000|NCT01425281|583168911|FG001|At 3-year Clinical Follow-up|Death|3|||
161484001|NCT01425281|583168910|FG000|At 4-year Clinical Follow-up|Death|7|||
161484002|NCT01425281|583168911|FG001|At 4-year Clinical Follow-up|Death|3|||
161484003|NCT01425281|583168910|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
161484004|NCT01425281|583168911|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
161484005|NCT01425281|583168910|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
161484006|NCT01425281|583168911|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
161484007|NCT01425281|583168910|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
161484008|NCT01425281|583168911|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
161484009|NCT01425281|583168910|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
161484010|NCT01425281|583168911|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
161484011|NCT01425281|583168910|FG000|At 5-year Clinical Follow-up|Death|2|||
161484012|NCT01425281|583168911|FG001|At 5-year Clinical Follow-up|Death|0|||
161484013|NCT01425281|583168910|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
161484014|NCT01425281|583168911|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
161484015|NCT01425281|583168910|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
161484016|NCT01425281|583168911|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
161484017|NCT01425281|583168910|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
161484018|NCT01425281|583168911|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
161484019|NCT01987505|583168912|FG000|Overall Study|Other|9|||
161484020|NCT01987505|583168912|FG000|Overall Study|Withdrawal by Subject|2|||
161484021|NCT01987505|583168912|FG000|Overall Study|Other Reason|2|||
161484022|NCT01987505|583168912|FG000|Overall Study|Lost to Follow-up|15|||
161484023|NCT01987505|583168912|FG000|Overall Study|Investigator Decision|2|||
161484024|NCT01987505|583168912|FG000|Overall Study|Death|4|||
161484025|NCT01749514|583168913|FG000|Overall Study|Lost to Follow-up|0|||
161484026|NCT01749514|583168914|FG001|Overall Study|Lost to Follow-up|0|||
161484027|NCT01749514|583168915|FG002|Overall Study|Lost to Follow-up|0|||
161484028|NCT01749514|583168916|FG003|Overall Study|Lost to Follow-up|0|||
161484029|NCT01749514|583168917|FG004|Overall Study|Lost to Follow-up|0|||
161484030|NCT01749514|583168918|FG005|Overall Study|Lost to Follow-up|0|||
161484031|NCT01749514|583168919|FG006|Overall Study|Lost to Follow-up|0|||
161484032|NCT01749514|583168920|FG007|Overall Study|Lost to Follow-up|1|||
161484033|NCT01749514|583168913|FG000|Overall Study|Withdrawal by Subject|0|||
161580612|NCT00704184|583513975|FG004|Open-Label Treatment|Physician Decision|1|||
161580613|NCT00704184|583513971|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
161580614|NCT00704184|583513972|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161580615|NCT00704184|583513973|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
161921718|NCT02827708|584759998|FG000|Overall Study|Withdrawal by Subject|1|||
161921719|NCT02827708|584759999|FG001|Overall Study|Withdrawal by Subject|2|||
161921720|NCT02827708|584759998|FG000|Overall Study|Death|1|||
161921721|NCT02827708|584759999|FG001|Overall Study|Death|2|||
161921722|NCT00407511|584760001|FG000|Overall Study|Adverse Event|9|||
161921723|NCT00407511|584760001|FG000|Overall Study|Lost to Follow-up|4|||
161921724|NCT00407511|584760001|FG000|Overall Study|Other|5|||
161921725|NCT00407511|584760001|FG000|Overall Study|Withdrawal by Subject|4|||
161580616|NCT00704184|583513974|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
161580617|NCT00704184|583513975|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
161580618|NCT00716859|583513978|FG000|Overall Study|Adverse Event|4|||
161580619|NCT00716859|583513979|FG001|Overall Study|Adverse Event|1|||
161580620|NCT00716859|583513978|FG000|Overall Study|Lack of Efficacy|3|||
161580621|NCT00716859|583513979|FG001|Overall Study|Lack of Efficacy|0|||
161580622|NCT00716859|583513978|FG000|Overall Study|Withdrawal by Subject|1|||
161580623|NCT00716859|583513979|FG001|Overall Study|Withdrawal by Subject|3|||
161580624|NCT00716859|583513978|FG000|Overall Study|Not treated|1|||
161580625|NCT00716859|583513979|FG001|Overall Study|Not treated|1|||
161580626|NCT02178098|583513980|FG000|Overall Study|Withdrawal by Subject|0|||
161580627|NCT02178098|583513981|FG001|Overall Study|Withdrawal by Subject|6|||
161580628|NCT02178098|583513980|FG000|Overall Study|Adverse Event|1|||
161580629|NCT02178098|583513981|FG001|Overall Study|Adverse Event|2|||
161580630|NCT02178098|583513980|FG000|Overall Study|Protocol Violation|1|||
161580631|NCT02178098|583513981|FG001|Overall Study|Protocol Violation|1|||
161580632|NCT02178098|583513980|FG000|Overall Study|Lost to Follow-up|0|||
161580633|NCT02178098|583513981|FG001|Overall Study|Lost to Follow-up|1|||
161580634|NCT02178098|583513980|FG000|Overall Study|Sponsor Request|1|||
161580635|NCT02178098|583513981|FG001|Overall Study|Sponsor Request|0|||
161580636|NCT02178098|583513980|FG000|Overall Study|Other|2|||
161580637|NCT02178098|583513981|FG001|Overall Study|Other|2|||
161580638|NCT01109524|583513987|FG000|Overall Study|Disease Progression|29|||
161580639|NCT01109524|583513987|FG000|Overall Study|Study Drug toxicity|6|||
161580640|NCT01109524|583513987|FG000|Overall Study|Adverse Event|4|||
161580641|NCT01109524|583513987|FG000|Overall Study|Withdrawal by Subject|2|||
161816680|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161580642|NCT01109524|583513987|FG000|Overall Study|Maximum clinical benefit|3|||
161580643|NCT01109524|583513987|FG000|Overall Study|Death|2|||
161580644|NCT01109524|583513987|FG000|Overall Study|No longer meets criteria|2|||
161580645|NCT01109524|583513987|FG000|Overall Study|Participant requested to end treatment|4|||
161580646|NCT01109524|583513987|FG000|Overall Study|Other|5|||
161921726|NCT02115386|584760002|FG000|Overall Study|Protocol Violation|1|||
161921727|NCT02115386|584760002|FG000|Overall Study|Administrative - trial was terminated|6|||
161921728|NCT02493855|584760003|FG000|Overall Study|Non-compliance|1|||
161921729|NCT02493855|584760004|FG001|Overall Study|Non-compliance|0|||
161921730|NCT02493855|584760005|FG002|Overall Study|Non-compliance|0|||
161921731|NCT02493855|584760003|FG000|Overall Study|Adverse Event|0|||
161921732|NCT02493855|584760004|FG001|Overall Study|Adverse Event|1|||
161921733|NCT02493855|584760005|FG002|Overall Study|Adverse Event|0|||
161921734|NCT02493855|584760003|FG000|Overall Study|Withdrawal by Subject|1|||
161921735|NCT02493855|584760004|FG001|Overall Study|Withdrawal by Subject|0|||
161921736|NCT02493855|584760005|FG002|Overall Study|Withdrawal by Subject|0|||
161921737|NCT05059080|584760006|FG000|Overall Study|Withdrawal by Subject|3|||
161921738|NCT05059080|584760006|FG000|Overall Study|Study Terminated by Sponsor|64|||
161921739|NCT02299167|584760007|FG000|Overall Study|patients were excluded from the study|11|||
161921740|NCT03600428|584760009|FG000|Overall Study|Not eligible|0|||
161921741|NCT03600428|584760010|FG001|Overall Study|Not eligible|1|||
161921742|NCT03600428|584760009|FG000|Overall Study|Lost to Follow-up|5|||
161921743|NCT03600428|584760010|FG001|Overall Study|Lost to Follow-up|4|||
161921744|NCT00549328|584760011|FG000|Overall Study|Adverse Event|2|||
161921745|NCT00549328|584760011|FG000|Overall Study|Disease Progression|10|||
161921746|NCT00549328|584760011|FG000|Overall Study|Death|1|||
161921747|NCT00549328|584760011|FG000|Overall Study|Use of Prohibited Medication|1|||
161921748|NCT00770484|584760012|FG000|Overall Study|Withdrawal by Subject|1|||
161921749|NCT00770484|584760013|FG001|Overall Study|Withdrawal by Subject|0|||
161921750|NCT04868682|584760019|FG000|Post-treatment|Lost to Follow-up|1|||
161921751|NCT04868682|584760020|FG001|Post-treatment|Lost to Follow-up|1|||
161921752|NCT04868682|584760019|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
161921753|NCT04868682|584760020|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
161921754|NCT04868682|584760019|FG000|Six-month Assessment|Lost to Follow-up|1|||
161921755|NCT04868682|584760020|FG001|Six-month Assessment|Lost to Follow-up|0|||
161921756|NCT04868682|584760019|FG000|Six-month Assessment|Death|1|||
161921757|NCT04868682|584760020|FG001|Six-month Assessment|Death|0|||
161921758|NCT04868682|584760019|FG000|Six-month Assessment|Refused|0|||
161921759|NCT04868682|584760020|FG001|Six-month Assessment|Refused|1|||
161921760|NCT04868682|584760019|FG000|12-month Assessment|Lost to Follow-up|2|||
161921761|NCT04868682|584760020|FG001|12-month Assessment|Lost to Follow-up|1|||
161921762|NCT04868682|584760019|FG000|12-month Assessment|Death|0|||
161921763|NCT04868682|584760020|FG001|12-month Assessment|Death|1|||
161921764|NCT03880565|584760024|FG000|Overall Study|Withdrawal by Subject|1|||
161921765|NCT03880565|584760025|FG001|Overall Study|Withdrawal by Subject|0|||
161921766|NCT02202616|584760026|FG000|Overall Study|Screen failed|24|||
161921767|NCT02202616|584760026|FG000|Overall Study|Adverse Event|32|||
161921768|NCT02202616|584760026|FG000|Overall Study|Protocol deviation|18|||
161921769|NCT02202616|584760026|FG000|Overall Study|Patient withdrew consent|12|||
161921770|NCT02202616|584760026|FG000|Overall Study|Lost to Follow-up|6|||
161921771|NCT02202616|584760026|FG000|Overall Study|Administrative problems|6|||
161921772|NCT02202616|584760026|FG000|Overall Study|Abnormal test procedure result|1|||
161921773|NCT02202616|584760026|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161921774|NCT04327271|584760030|FG000|Overall Study|Death|1|||
161921775|NCT04327271|584760031|FG001|Overall Study|Death|0|||
161921776|NCT04327271|584760030|FG000|Overall Study|Withdrawal by Subject|1|||
161921777|NCT04327271|584760031|FG001|Overall Study|Withdrawal by Subject|0|||
161921778|NCT04327271|584760030|FG000|Overall Study|randomization error (data capture)|4|||
161921779|NCT04327271|584760031|FG001|Overall Study|randomization error (data capture)|3|||
161921780|NCT05696847|584760032|FG000|Overall Study|Withdrawal by Subject|1|||
161921781|NCT05696847|584760033|FG001|Overall Study|Withdrawal by Subject|0|||
161921782|NCT05696847|584760034|FG002|Overall Study|Withdrawal by Subject|0|||
161921783|NCT05696847|584760035|FG003|Overall Study|Withdrawal by Subject|0|||
161921784|NCT05696847|584760036|FG004|Overall Study|Withdrawal by Subject|0|||
161921785|NCT05696847|584760037|FG005|Overall Study|Withdrawal by Subject|0|||
161921786|NCT05696847|584760032|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161921787|NCT05696847|584760033|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161921788|NCT05696847|584760034|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161921789|NCT05696847|584760035|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161921790|NCT05696847|584760036|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161921791|NCT05696847|584760037|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161921792|NCT05696847|584760032|FG000|Overall Study|Adverse Event|0|||
161921793|NCT05696847|584760033|FG001|Overall Study|Adverse Event|0|||
161921794|NCT05696847|584760034|FG002|Overall Study|Adverse Event|0|||
161921795|NCT05696847|584760035|FG003|Overall Study|Adverse Event|0|||
161921796|NCT05696847|584760036|FG004|Overall Study|Adverse Event|0|||
161921797|NCT05696847|584760037|FG005|Overall Study|Adverse Event|1|||
161921798|NCT05696847|584760032|FG000|Overall Study|Sponsor Decision|0|||
161921799|NCT05696847|584760033|FG001|Overall Study|Sponsor Decision|0|||
161921800|NCT05696847|584760034|FG002|Overall Study|Sponsor Decision|0|||
161921801|NCT05696847|584760035|FG003|Overall Study|Sponsor Decision|1|||
161921802|NCT05696847|584760036|FG004|Overall Study|Sponsor Decision|0|||
161921803|NCT05696847|584760037|FG005|Overall Study|Sponsor Decision|0|||
161921804|NCT01695746|584760041|FG000|Overall Study|Adverse Event|1|||
161921805|NCT01695746|584760041|FG000|Overall Study|Non-compliance by the participant|3|||
161921806|NCT01695746|584760041|FG000|Overall Study|Protocol Violation|5|||
161921807|NCT01695746|584760041|FG000|Overall Study|Participant not willing to participate|3|||
161921808|NCT03506477|584760044|FG000|Overall Study|Withdrawal by Subject|1|||
161921809|NCT03506477|584760045|FG001|Overall Study|Withdrawal by Subject|0|||
161921810|NCT03462680|584760046|FG000|Overall Study|Withdrawal by Subject|3|||
161921811|NCT03462680|584760047|FG001|Overall Study|Withdrawal by Subject|5|||
161921812|NCT02516241|584760048|FG000|Overall Study|Death|255|||
161921813|NCT02516241|584760049|FG001|Overall Study|Death|262|||
161921814|NCT02516241|584760050|FG002|Overall Study|Death|270|||
161921815|NCT02516241|584760048|FG000|Overall Study|Lost to Follow-up|1|||
161921816|NCT02516241|584760049|FG001|Overall Study|Lost to Follow-up|1|||
161921817|NCT02516241|584760050|FG002|Overall Study|Lost to Follow-up|3|||
161921818|NCT02516241|584760048|FG000|Overall Study|Withdrawal by Subject|2|||
161921819|NCT02516241|584760049|FG001|Overall Study|Withdrawal by Subject|7|||
161921820|NCT02516241|584760050|FG002|Overall Study|Withdrawal by Subject|12|||
161921821|NCT02516241|584760048|FG000|Overall Study|participants ongoing at data cut-off|84|||
161921822|NCT02516241|584760049|FG001|Overall Study|participants ongoing at data cut-off|76|||
161921823|NCT02516241|584760050|FG002|Overall Study|participants ongoing at data cut-off|59|||
161921824|NCT00462462|584760051|FG000|Overall Study|Physician Decision|0|||
161921825|NCT00462462|584760052|FG001|Overall Study|Physician Decision|1|||
161921826|NCT01163617|584760053|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921827|NCT01163617|584760054|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
161921828|NCT01163617|584760055|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921829|NCT01163617|584760056|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921830|NCT01163617|584760057|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921831|NCT01163617|584760058|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921832|NCT01163617|584760059|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921833|NCT01163617|584760060|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921834|NCT01163617|584760053|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921835|NCT01163617|584760054|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
161921836|NCT01163617|584760055|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921837|NCT01163617|584760056|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921838|NCT01163617|584760057|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921839|NCT01163617|584760058|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921840|NCT01163617|584760059|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921841|NCT01163617|584760060|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921842|NCT01163617|584760053|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921843|NCT01163617|584760054|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921844|NCT01163617|584760055|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
161921845|NCT01163617|584760056|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921846|NCT01163617|584760057|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921847|NCT01163617|584760058|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921848|NCT01163617|584760059|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921849|NCT01163617|584760060|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921850|NCT02875080|584760061|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
161921851|NCT02875080|584760062|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
161921852|NCT02875080|584760063|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
161921853|NCT02394756|584760064|FG000|Period 1|Lens Discomfort|0|||
161921854|NCT02394756|584760065|FG001|Period 1|Lens Discomfort|0|||
161921855|NCT02394756|584760066|FG002|Period 1|Lens Discomfort|0|||
161921856|NCT02394756|584760067|FG003|Period 1|Lens Discomfort|0|||
161484034|NCT01749514|583168914|FG001|Overall Study|Withdrawal by Subject|0|||
161484035|NCT01749514|583168915|FG002|Overall Study|Withdrawal by Subject|0|||
161484036|NCT01749514|583168916|FG003|Overall Study|Withdrawal by Subject|0|||
161484037|NCT01749514|583168917|FG004|Overall Study|Withdrawal by Subject|0|||
161484038|NCT01749514|583168918|FG005|Overall Study|Withdrawal by Subject|1|||
161484039|NCT01749514|583168919|FG006|Overall Study|Withdrawal by Subject|0|||
161484040|NCT01749514|583168920|FG007|Overall Study|Withdrawal by Subject|1|||
161484041|NCT01749514|583168913|FG000|Overall Study|Not Reported|0|||
161484042|NCT01749514|583168914|FG001|Overall Study|Not Reported|0|||
161484043|NCT01749514|583168915|FG002|Overall Study|Not Reported|0|||
161484044|NCT01749514|583168916|FG003|Overall Study|Not Reported|0|||
161484045|NCT01749514|583168917|FG004|Overall Study|Not Reported|0|||
161484046|NCT01749514|583168918|FG005|Overall Study|Not Reported|0|||
161484047|NCT01749514|583168919|FG006|Overall Study|Not Reported|0|||
161484048|NCT01749514|583168920|FG007|Overall Study|Not Reported|5|||
161484049|NCT02509156|583168921|FG000|Randomized Phase|Death|1|||
161484050|NCT02509156|583168922|FG001|Randomized Phase|Death|0|||
161484051|NCT02509156|583168921|FG000|Randomized Phase|Withdrawal by Subject|1|||
161484052|NCT02509156|583168922|FG001|Randomized Phase|Withdrawal by Subject|1|||
161484053|NCT05131646|583168923|FG000|Overall Study|Withdrawal by Subject|1|||
161484054|NCT05131646|583168924|FG001|Overall Study|Withdrawal by Subject|0|||
161921857|NCT02394756|584760068|FG004|Period 1|Lens Discomfort|0|||
161921858|NCT02394756|584760069|FG005|Period 1|Lens Discomfort|1|||
161921859|NCT02394756|584760064|FG000|Period 1|Withdrawal by Subject|0|||
161921860|NCT02394756|584760065|FG001|Period 1|Withdrawal by Subject|1|||
161484055|NCT05131646|583168925|FG002|Overall Study|Withdrawal by Subject|0|||
161484056|NCT02128113|583168926|FG000|Overall Study|Withdrawal by Subject|3|||
161484057|NCT02128113|583168927|FG001|Overall Study|Withdrawal by Subject|1|||
161484058|NCT02128113|583168928|FG002|Overall Study|Withdrawal by Subject|0|||
161484059|NCT02128113|583168926|FG000|Overall Study|Protocol Violation|0|||
161484060|NCT02128113|583168927|FG001|Overall Study|Protocol Violation|1|||
161484061|NCT02128113|583168928|FG002|Overall Study|Protocol Violation|0|||
161921861|NCT02394756|584760066|FG002|Period 1|Withdrawal by Subject|1|||
161484062|NCT02128113|583168926|FG000|Overall Study|Surgery cancelled|0|||
161484063|NCT02128113|583168927|FG001|Overall Study|Surgery cancelled|1|||
161484064|NCT02128113|583168928|FG002|Overall Study|Surgery cancelled|0|||
161484065|NCT02128113|583168926|FG000|Overall Study|Adverse Event|0|||
161484066|NCT02128113|583168927|FG001|Overall Study|Adverse Event|0|||
161484067|NCT02128113|583168928|FG002|Overall Study|Adverse Event|1|||
161484068|NCT01750242|583168929|FG000|Overall Study|Unreadable Images|3|||
161484069|NCT03765918|583168930|FG000|Overall Study|Death|109|||
161484070|NCT03765918|583168931|FG001|Overall Study|Death|127|||
161484071|NCT03765918|583168930|FG000|Overall Study|Lost to Follow-up|2|||
161484072|NCT03765918|583168931|FG001|Overall Study|Lost to Follow-up|3|||
161921862|NCT02394756|584760067|FG003|Period 1|Withdrawal by Subject|1|||
161484073|NCT03765918|583168930|FG000|Overall Study|Withdrawal by Subject|12|||
161484074|NCT03765918|583168931|FG001|Overall Study|Withdrawal by Subject|16|||
161484075|NCT03765918|583168930|FG000|Overall Study|Participants Ongoing|240|||
161921863|NCT02394756|584760068|FG004|Period 1|Withdrawal by Subject|0|||
161921864|NCT02394756|584760069|FG005|Period 1|Withdrawal by Subject|0|||
161921865|NCT02394756|584760064|FG000|Period 2|Unsatisfactory Visual Response|0|||
161921866|NCT02394756|584760065|FG001|Period 2|Unsatisfactory Visual Response|0|||
161921867|NCT02394756|584760066|FG002|Period 2|Unsatisfactory Visual Response|0|||
161921868|NCT02394756|584760067|FG003|Period 2|Unsatisfactory Visual Response|0|||
161484076|NCT03765918|583168931|FG001|Overall Study|Participants Ongoing|205|||
161484077|NCT04202965|583168932|FG000|Overall Study|Adverse Event|3|||
161484078|NCT04202965|583168932|FG000|Overall Study|Did not meet inclusion criteria|1|||
161484079|NCT02969369|583168933|FG000|Study|Adverse Event|1|||
161484080|NCT02969369|583168934|FG001|Study|Adverse Event|6|||
161484081|NCT02969369|583168933|FG000|Study|Lack of Efficacy|0|||
161484082|NCT02969369|583168934|FG001|Study|Lack of Efficacy|1|||
161484083|NCT02969369|583168933|FG000|Study|Lost to Follow-up|0|||
161484084|NCT02969369|583168934|FG001|Study|Lost to Follow-up|1|||
161484085|NCT02969369|583168933|FG000|Study|Withdrawal by Subject|3|||
161484086|NCT02969369|583168934|FG001|Study|Withdrawal by Subject|5|||
161484087|NCT02969369|583168933|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
161484088|NCT02969369|583168934|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
161484089|NCT02969369|583168933|FG000|Double-blind Period|Adverse Event|1|||
161484090|NCT02969369|583168934|FG001|Double-blind Period|Adverse Event|5|||
161484091|NCT02969369|583168933|FG000|Double-blind Period|Lost to Follow-up|0|||
161484092|NCT02969369|583168934|FG001|Double-blind Period|Lost to Follow-up|1|||
161484093|NCT02969369|583168933|FG000|Double-blind Period|Withdrawal by Subject|2|||
161484094|NCT02969369|583168934|FG001|Double-blind Period|Withdrawal by Subject|3|||
161484095|NCT02969369|583168933|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
161484096|NCT02969369|583168934|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
161484097|NCT02969369|583168933|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
161484098|NCT02969369|583168934|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
161484099|NCT02969369|583168933|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
161484100|NCT02969369|583168934|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
161580647|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
161580648|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161484101|NCT02969369|583168933|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
161484102|NCT02969369|583168934|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
161580649|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161921869|NCT02394756|584760068|FG004|Period 2|Unsatisfactory Visual Response|1|||
161921870|NCT02394756|584760069|FG005|Period 2|Unsatisfactory Visual Response|0|||
161921871|NCT03018938|584760070|FG000|Overall Study|Death|0|||
161921872|NCT03018938|584760071|FG001|Overall Study|Death|1|||
161921873|NCT03018938|584760070|FG000|Overall Study|Lost to Follow-up|21|||
161921874|NCT03018938|584760071|FG001|Overall Study|Lost to Follow-up|32|||
161921875|NCT03018938|584760070|FG000|Overall Study|Withdrawal by Subject|38|||
161921876|NCT03018938|584760071|FG001|Overall Study|Withdrawal by Subject|45|||
161921877|NCT03018938|584760070|FG000|Overall Study|Physician Decision|3|||
161921878|NCT03018938|584760071|FG001|Overall Study|Physician Decision|2|||
161921879|NCT03018938|584760070|FG000|Overall Study|Sponsor Decision|0|||
161921880|NCT03018938|584760071|FG001|Overall Study|Sponsor Decision|1|||
161921881|NCT03018938|584760070|FG000|Overall Study|Screen failure-After randomization|4|||
161921882|NCT03018938|584760071|FG001|Overall Study|Screen failure-After randomization|2|||
161921883|NCT03018938|584760070|FG000|Overall Study|Not recorded|0|||
161921884|NCT03018938|584760071|FG001|Overall Study|Not recorded|2|||
161921885|NCT00191100|584760074|FG000|Overall Study|Adverse Event|18|||
161921886|NCT00191100|584760075|FG001|Overall Study|Adverse Event|1|||
161921887|NCT00191100|584760074|FG000|Overall Study|Lost to Follow-up|2|||
161921888|NCT00191100|584760075|FG001|Overall Study|Lost to Follow-up|0|||
161921889|NCT00191100|584760074|FG000|Overall Study|Patient Moved|0|||
161921890|NCT00191100|584760075|FG001|Overall Study|Patient Moved|1|||
161921891|NCT00191100|584760074|FG000|Overall Study|Withdrawal by Subject|9|||
161921892|NCT00191100|584760075|FG001|Overall Study|Withdrawal by Subject|3|||
161921893|NCT00191100|584760074|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
161921894|NCT00191100|584760075|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
161921895|NCT00191100|584760074|FG000|Overall Study|Clinical Relapse|2|||
161921896|NCT00191100|584760075|FG001|Overall Study|Clinical Relapse|1|||
161921897|NCT00191100|584760074|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
161921898|NCT00191100|584760075|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
161921899|NCT00191100|584760074|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
161921900|NCT00191100|584760075|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
161921901|NCT00191100|584760074|FG000|Overall Study|Physician Decision|3|||
161921902|NCT00191100|584760075|FG001|Overall Study|Physician Decision|1|||
161921903|NCT00191100|584760074|FG000|Overall Study|Death from Study Drug Toxicity|2|||
161921904|NCT00191100|584760075|FG001|Overall Study|Death from Study Drug Toxicity|0|||
161921905|NCT00191100|584760074|FG000|Overall Study|Protocol Violation|1|||
161921906|NCT00191100|584760075|FG001|Overall Study|Protocol Violation|1|||
161921907|NCT00191100|584760074|FG000|Overall Study|Death from Other Cause|1|||
161921908|NCT00191100|584760075|FG001|Overall Study|Death from Other Cause|0|||
161580650|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161580651|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161921909|NCT00191100|584760074|FG000|Overall Study|Reason Not Specified|0|||
161921910|NCT00191100|584760075|FG001|Overall Study|Reason Not Specified|1|||
161921911|NCT04766333|584760994|FG000|Overall Study|Lost to Follow-up|40|||
161921912|NCT04766333|584760995|FG001|Overall Study|Lost to Follow-up|826|||
161921913|NCT05177094|584760998|FG000|Overall Study|Adverse Event|5|||
161921914|NCT05177094|584760999|FG001|Overall Study|Adverse Event|5|||
161921915|NCT05177094|584760998|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
161484103|NCT01980992|583168937|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
161484104|NCT01980992|583168938|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
161484105|NCT01980992|583168937|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
161484106|NCT01980992|583168938|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
161484107|NCT01980992|583168937|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
161484108|NCT01980992|583168938|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
161484109|NCT01980992|583168937|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
161484110|NCT01980992|583168938|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
161669944|NCT01881750|583843191|FG000|Overall Study|Changes in concomitant therapies|2|||
161669945|NCT01881750|583843192|FG001|Overall Study|Changes in concomitant therapies|3|||
161669946|NCT01881750|583843191|FG000|Overall Study|Lost to Follow-up|0|||
161669947|NCT01881750|583843192|FG001|Overall Study|Lost to Follow-up|1|||
161669948|NCT00051363|583843193|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
161669949|NCT00051363|583843194|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
161669950|NCT00051363|583843193|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
161669951|NCT00051363|583843194|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
161669952|NCT00051363|583843193|FG000|Overall Study|Death|2|||
161669953|NCT00051363|583843194|FG001|Overall Study|Death|2|||
161669954|NCT00051363|583843193|FG000|Overall Study|Excluded Pre-Randomization|2|||
161669955|NCT00051363|583843194|FG001|Overall Study|Excluded Pre-Randomization|5|||
161669956|NCT00026208|583843199|FG000|Overall Study|Complications of auto accident|1|||
161669957|NCT00026208|583843200|FG001|Overall Study|Complications of auto accident|0|||
161669958|NCT03282240|583843201|FG000|Overall Study|Adverse Event|2|||
161669959|NCT03282240|583843202|FG001|Overall Study|Adverse Event|2|||
161669960|NCT03282240|583843203|FG002|Overall Study|Adverse Event|0|||
161669961|NCT03282240|583843201|FG000|Overall Study|Lost to Follow-up|3|||
161669962|NCT03282240|583843202|FG001|Overall Study|Lost to Follow-up|0|||
161669963|NCT03282240|583843203|FG002|Overall Study|Lost to Follow-up|0|||
161669964|NCT03282240|583843201|FG000|Overall Study|Protocol Deviation|4|||
161669965|NCT03282240|583843202|FG001|Overall Study|Protocol Deviation|1|||
161669966|NCT03282240|583843203|FG002|Overall Study|Protocol Deviation|2|||
161669967|NCT03282240|583843201|FG000|Overall Study|Withdrawal by Subject|1|||
161669968|NCT03282240|583843202|FG001|Overall Study|Withdrawal by Subject|0|||
161669969|NCT03282240|583843203|FG002|Overall Study|Withdrawal by Subject|1|||
161669970|NCT01675479|583843204|FG000|Overall Study|Lost to Follow-up|11|||
161669971|NCT02910739|583843205|FG000|Overall Study|Adverse Event|1|||
161669972|NCT02910739|583843206|FG001|Overall Study|Adverse Event|0|||
161669973|NCT02910739|583843207|FG002|Overall Study|Adverse Event|0|||
161669974|NCT02910739|583843208|FG003|Overall Study|Adverse Event|0|||
161669975|NCT01572922|583843211|FG000|Overall Study|Adverse Event|1|||
161669976|NCT01572922|583843211|FG000|Overall Study|Protocol Violation|1|||
161669977|NCT01572922|583843211|FG000|Overall Study|Death|1|||
161669978|NCT01103245|583845285|FG000|Overall Study|Withdrawal by Subject|1|||
161669979|NCT01103245|583845286|FG001|Overall Study|Withdrawal by Subject|0|||
161669980|NCT01103245|583845287|FG002|Overall Study|Withdrawal by Subject|3|||
161669981|NCT01103245|583845288|FG003|Overall Study|Withdrawal by Subject|0|||
161669982|NCT01103245|583845285|FG000|Overall Study|Inadequate IV access|1|||
161669983|NCT01103245|583845286|FG001|Overall Study|Inadequate IV access|0|||
161669984|NCT01103245|583845287|FG002|Overall Study|Inadequate IV access|0|||
161669985|NCT01103245|583845288|FG003|Overall Study|Inadequate IV access|0|||
161484111|NCT01980992|583168937|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
161484112|NCT01980992|583168938|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
161484113|NCT01980992|583168937|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
161484114|NCT01980992|583168938|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
161484115|NCT00299975|583168939|FG000|Overall Study|Adverse Event|1|||
161484116|NCT00299975|583168940|FG001|Overall Study|Adverse Event|0|||
161669986|NCT01103245|583845285|FG000|Overall Study|Adverse Event|0|||
161669987|NCT01103245|583845286|FG001|Overall Study|Adverse Event|2|||
161669988|NCT01103245|583845287|FG002|Overall Study|Adverse Event|1|||
161669989|NCT01103245|583845288|FG003|Overall Study|Adverse Event|0|||
161669990|NCT01103245|583845285|FG000|Overall Study|Physician Decision|1|||
161669991|NCT01103245|583845286|FG001|Overall Study|Physician Decision|0|||
161669992|NCT01103245|583845287|FG002|Overall Study|Physician Decision|0|||
161580652|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
161580653|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161580654|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161580655|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161580656|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161580657|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
161580658|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161580659|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161580660|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161580661|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161580662|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
161580663|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161580664|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161580665|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161580666|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161580667|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
161580668|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161580669|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161580670|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161580671|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161580672|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
161580673|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161580674|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161580675|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161921916|NCT05177094|584760999|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
161921917|NCT05177094|584760998|FG000|Overall Study|Protocol Deviation|3|||
161921918|NCT05177094|584760999|FG001|Overall Study|Protocol Deviation|0|||
161921919|NCT05177094|584760998|FG000|Overall Study|Withdrawal by Subject|6|||
161921920|NCT05177094|584760999|FG001|Overall Study|Withdrawal by Subject|3|||
161921921|NCT05177094|584760998|FG000|Overall Study|Participant could not tolerate long study visits|1|||
161921922|NCT05177094|584760999|FG001|Overall Study|Participant could not tolerate long study visits|0|||
161921923|NCT02737618|584761000|FG000|Overall Study|Withdrawal by Subject|9|||
161921924|NCT01047501|584761003|FG000|Overall Study|Adverse Event|7|||
161921925|NCT01047501|584761004|FG001|Overall Study|Adverse Event|8|||
161921926|NCT01047501|584761005|FG002|Overall Study|Adverse Event|5|||
161921927|NCT01047501|584761003|FG000|Overall Study|Withdrew Consent|6|||
161921928|NCT01047501|584761004|FG001|Overall Study|Withdrew Consent|2|||
161921929|NCT01047501|584761005|FG002|Overall Study|Withdrew Consent|4|||
161921930|NCT01047501|584761003|FG000|Overall Study|Lost to Follow-up|0|||
161921931|NCT01047501|584761004|FG001|Overall Study|Lost to Follow-up|1|||
161921932|NCT01047501|584761005|FG002|Overall Study|Lost to Follow-up|1|||
161921933|NCT01047501|584761003|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
161921934|NCT01047501|584761004|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
161921935|NCT01047501|584761005|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
161921936|NCT01047501|584761003|FG000|Overall Study|Death|1|||
161921937|NCT01047501|584761004|FG001|Overall Study|Death|0|||
161921938|NCT01047501|584761005|FG002|Overall Study|Death|0|||
161921939|NCT01047501|584761003|FG000|Overall Study|Other discontinuation|1|||
161921940|NCT01047501|584761004|FG001|Overall Study|Other discontinuation|0|||
161921941|NCT01047501|584761005|FG002|Overall Study|Other discontinuation|1|||
161921942|NCT01047501|584761003|FG000|Overall Study|Investigator judgement|0|||
161921943|NCT01047501|584761004|FG001|Overall Study|Investigator judgement|0|||
161921944|NCT01047501|584761005|FG002|Overall Study|Investigator judgement|1|||
161921945|NCT01257542|584761006|FG000|Overall Study|Protocol Violation|3|||
161921946|NCT01257542|584761007|FG001|Overall Study|Protocol Violation|5|||
161921947|NCT01257542|584761006|FG000|Overall Study|Withdrawal by Subject|0|||
161921948|NCT01257542|584761007|FG001|Overall Study|Withdrawal by Subject|2|||
161921949|NCT03097315|584761013|FG000|Overall Study|Withdrawal by Subject|1|||
161921950|NCT03384966|584761014|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
161921951|NCT03384966|584761015|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
161921952|NCT03384966|584761016|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
161921953|NCT03384966|584761014|FG000|Follow-up Period|Adverse Event|1|||
161921954|NCT03384966|584761015|FG001|Follow-up Period|Adverse Event|0|||
161921955|NCT03384966|584761016|FG002|Follow-up Period|Adverse Event|0|||
161921956|NCT02948400|584761018|FG000|Overall Study|Withdrawal by Subject|17|||
161921957|NCT02948400|584761019|FG001|Overall Study|Withdrawal by Subject|10|||
161921958|NCT02948400|584761018|FG000|Overall Study|failed to attend appointments|47|||
161921959|NCT02948400|584761019|FG001|Overall Study|failed to attend appointments|34|||
161921960|NCT02948400|584761018|FG000|Overall Study|COVID-related closure|6|||
161921961|NCT02948400|584761019|FG001|Overall Study|COVID-related closure|2|||
161484117|NCT00299975|583168941|FG002|Overall Study|Adverse Event|2|||
161484118|NCT00299975|583168939|FG000|Overall Study|Pregnancy|0|||
161580676|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161580677|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
161580678|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161580679|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161580680|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161580681|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161580682|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
161580683|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161580684|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161580685|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161580686|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161484119|NCT00299975|583168940|FG001|Overall Study|Pregnancy|0|||
161484120|NCT00299975|583168941|FG002|Overall Study|Pregnancy|1|||
161484121|NCT00299975|583168939|FG000|Overall Study|Lack of Efficacy|1|||
161484122|NCT00299975|583168940|FG001|Overall Study|Lack of Efficacy|0|||
161484123|NCT00299975|583168941|FG002|Overall Study|Lack of Efficacy|1|||
161484124|NCT00299975|583168939|FG000|Overall Study|Lost to Follow-up|1|||
161484125|NCT00299975|583168940|FG001|Overall Study|Lost to Follow-up|0|||
161484126|NCT00299975|583168941|FG002|Overall Study|Lost to Follow-up|0|||
161580687|NCT02409667|583513988|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
161580688|NCT02409667|583513989|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161580689|NCT02409667|583513990|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161580690|NCT02409667|583513991|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161580691|NCT02409667|583513992|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161580692|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
161921962|NCT02948400|584761018|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
161484127|NCT00299975|583168939|FG000|Overall Study|Withdrawal by Subject|0|||
161484128|NCT00299975|583168940|FG001|Overall Study|Withdrawal by Subject|1|||
161484129|NCT00299975|583168941|FG002|Overall Study|Withdrawal by Subject|3|||
161484130|NCT00299975|583168939|FG000|Overall Study|Physician Decision|0|||
161484131|NCT00299975|583168940|FG001|Overall Study|Physician Decision|0|||
161484132|NCT00299975|583168941|FG002|Overall Study|Physician Decision|1|||
161484133|NCT01169493|583168945|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
161484134|NCT01169493|583168946|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
161484135|NCT01169493|583168947|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
161484136|NCT01169493|583168948|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
161484137|NCT01169493|583168949|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
161484138|NCT01169493|583168950|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
161484139|NCT01169493|583168945|FG000|Period 3 (6 Months)|Adverse Event|0|||
161484140|NCT01169493|583168946|FG001|Period 3 (6 Months)|Adverse Event|1|||
161484141|NCT01169493|583168947|FG002|Period 3 (6 Months)|Adverse Event|0|||
161484142|NCT01169493|583168948|FG003|Period 3 (6 Months)|Adverse Event|0|||
161484143|NCT01169493|583168949|FG004|Period 3 (6 Months)|Adverse Event|0|||
161484144|NCT01169493|583168950|FG005|Period 3 (6 Months)|Adverse Event|0|||
161484145|NCT01169493|583168945|FG000|Period 3 (6 Months)|Physician Decision|0|||
161484146|NCT01169493|583168946|FG001|Period 3 (6 Months)|Physician Decision|1|||
161484147|NCT01169493|583168947|FG002|Period 3 (6 Months)|Physician Decision|1|||
161484148|NCT01169493|583168948|FG003|Period 3 (6 Months)|Physician Decision|0|||
161484149|NCT01169493|583168949|FG004|Period 3 (6 Months)|Physician Decision|0|||
161484150|NCT01169493|583168950|FG005|Period 3 (6 Months)|Physician Decision|0|||
161484151|NCT00211809|583168957|FG000|Overall Study|Lack of Efficacy|1|||
161484152|NCT00211809|583168957|FG000|Overall Study|Lost to Follow-up|2|||
161484153|NCT00211809|583168957|FG000|Overall Study|Pregnancy|1|||
161484154|NCT00211809|583168957|FG000|Overall Study|side effects|2|||
161484155|NCT00036270|583168959|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
161484156|NCT00036270|583168960|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
161484157|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
161580693|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
161669993|NCT01103245|583845288|FG003|Overall Study|Physician Decision|0|||
161921963|NCT02948400|584761019|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
161921964|NCT02948400|584761018|FG000|Overall Study|motion sickness in virtual reality|2|||
161921965|NCT02948400|584761019|FG001|Overall Study|motion sickness in virtual reality|0|||
161921966|NCT01716156|584761020|FG000|Overall Study|Protocol Violation|1|||
161921967|NCT01716156|584761021|FG001|Overall Study|Protocol Violation|0|||
161921968|NCT01716156|584761022|FG002|Overall Study|Protocol Violation|0|||
161484158|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
161484159|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
161484160|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
161484161|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
161484162|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
161484163|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Other|277|||
161580694|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
161580695|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
161580696|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
161580697|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161580698|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161669994|NCT03078907|583845293|FG000|Overall Study|Adverse Event|2|||
161484164|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Other|288|||
161484165|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
161484166|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
161484167|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
161484168|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
161484169|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
161484170|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
161484171|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
161484172|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
161484173|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
161484174|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
161484175|NCT00036270|583168959|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
161484176|NCT00036270|583168960|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
161484177|NCT01370356|583168961|FG000|Overall Study|Death|1|||
161484178|NCT01370356|583168962|FG001|Overall Study|Death|0|||
161484179|NCT01370356|583168961|FG000|Overall Study|Lack of Efficacy|6|||
161484180|NCT01370356|583168962|FG001|Overall Study|Lack of Efficacy|28|||
161484181|NCT01370356|583168961|FG000|Overall Study|Lost to Follow-up|76|||
161484182|NCT01370356|583168962|FG001|Overall Study|Lost to Follow-up|81|||
161921969|NCT01716156|584761020|FG000|Overall Study|Withdrawal by Subject|0|||
161921970|NCT01716156|584761021|FG001|Overall Study|Withdrawal by Subject|1|||
161921971|NCT01716156|584761022|FG002|Overall Study|Withdrawal by Subject|2|||
161921972|NCT01716156|584761020|FG000|Overall Study|Lost to Follow-up|1|||
161921973|NCT01716156|584761021|FG001|Overall Study|Lost to Follow-up|0|||
161921974|NCT01716156|584761022|FG002|Overall Study|Lost to Follow-up|0|||
161921975|NCT05513950|584761025|FG000|Overall Study|Not treated due to technical reasons|0|||
161921976|NCT05513950|584761026|FG001|Overall Study|Not treated due to technical reasons|0|||
161921977|NCT05513950|584761027|FG002|Overall Study|Not treated due to technical reasons|1|||
161921978|NCT05513950|584761028|FG003|Overall Study|Not treated due to technical reasons|0|||
161921979|NCT05221866|584761029|FG000|Overall Study|Withdrawal by Subject|5|||
161921980|NCT05221866|584761030|FG001|Overall Study|Withdrawal by Subject|7|||
161921981|NCT05221866|584761031|FG002|Overall Study|Withdrawal by Subject|6|||
161921982|NCT05221866|584761032|FG003|Overall Study|Withdrawal by Subject|4|||
161921983|NCT05221866|584761029|FG000|Overall Study|Physician Decision|3|||
161921984|NCT05221866|584761030|FG001|Overall Study|Physician Decision|2|||
161921985|NCT05221866|584761031|FG002|Overall Study|Physician Decision|1|||
161921986|NCT05221866|584761032|FG003|Overall Study|Physician Decision|4|||
161921987|NCT05221866|584761029|FG000|Overall Study|Lost to Follow-up|12|||
161921988|NCT05221866|584761030|FG001|Overall Study|Lost to Follow-up|17|||
161921989|NCT05221866|584761031|FG002|Overall Study|Lost to Follow-up|14|||
161921990|NCT05221866|584761032|FG003|Overall Study|Lost to Follow-up|14|||
161921991|NCT05221866|584761029|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
161921992|NCT05221866|584761030|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
161921993|NCT05221866|584761031|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
161921994|NCT05221866|584761032|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
161921995|NCT05561140|584761033|FG000|Randomized Treatment Period|Adverse Event|1|||
161921996|NCT05561140|584761034|FG001|Randomized Treatment Period|Adverse Event|0|||
161921997|NCT05561140|584761033|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
161921998|NCT05561140|584761034|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
161921999|NCT05561140|584761033|FG000|Open Label Treatment Period|Adverse Event|6|||
161922000|NCT05561140|584761034|FG001|Open Label Treatment Period|Adverse Event|4|||
161922001|NCT05561140|584761033|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
161922002|NCT05561140|584761034|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
161922003|NCT05561140|584761033|FG000|Open Label Treatment Period|Physician Decision|0|||
161922004|NCT05561140|584761034|FG001|Open Label Treatment Period|Physician Decision|1|||
161922005|NCT05561140|584761033|FG000|Open Label Treatment Period|Pregnancy|1|||
161922006|NCT05561140|584761034|FG001|Open Label Treatment Period|Pregnancy|0|||
161922007|NCT05561140|584761033|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
161922008|NCT05561140|584761034|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
161922009|NCT05561140|584761033|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
161580699|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161580700|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
161580701|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161580702|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
161580703|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
161580704|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
161580705|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
161580706|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
161922010|NCT05561140|584761034|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
161922011|NCT05561140|584761033|FG000|Open Label Treatment Period|Other|1|||
161922012|NCT05561140|584761034|FG001|Open Label Treatment Period|Other|0|||
161922013|NCT00221104|584761037|FG000|Overall Study|Adverse Event|1|||
161922014|NCT00221104|584761038|FG001|Overall Study|Adverse Event|0|||
161922015|NCT00221104|584761037|FG000|Overall Study|Physician Decision|1|||
161922016|NCT00221104|584761038|FG001|Overall Study|Physician Decision|0|||
161922017|NCT00221104|584761037|FG000|Overall Study|Protocol Violation|2|||
161922018|NCT00221104|584761038|FG001|Overall Study|Protocol Violation|0|||
161922019|NCT00221104|584761037|FG000|Overall Study|Withdrawal by Subject|42|||
161922020|NCT00221104|584761038|FG001|Overall Study|Withdrawal by Subject|29|||
161922021|NCT00221104|584761037|FG000|Overall Study|Others|37|||
161922022|NCT00221104|584761038|FG001|Overall Study|Others|47|||
161922023|NCT02989389|584761039|FG000|Period 1|Lost to Follow-up|0|||
161922024|NCT02989389|584761040|FG001|Period 1|Lost to Follow-up|1|||
161922025|NCT02989389|584761041|FG002|Period 1|Lost to Follow-up|0|||
161922026|NCT02989389|584761042|FG003|Period 1|Lost to Follow-up|0|||
161922027|NCT02989389|584761043|FG004|Period 1|Lost to Follow-up|0|||
161922028|NCT02989389|584761044|FG005|Period 1|Lost to Follow-up|0|||
161922029|NCT02989389|584761045|FG006|Period 1|Lost to Follow-up|0|||
161922030|NCT02989389|584761046|FG007|Period 1|Lost to Follow-up|0|||
161922031|NCT02989389|584761047|FG008|Period 1|Lost to Follow-up|0|||
161922032|NCT02989389|584761048|FG009|Period 1|Lost to Follow-up|0|||
161816681|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
161580707|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161580708|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
161580709|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
161580710|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161580711|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161580712|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
161580713|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
161580714|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
161580715|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
161580716|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
161580717|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161580718|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161580719|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
161580720|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161580721|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
161580722|NCT02409667|583513988|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161580723|NCT02409667|583513989|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161580724|NCT02409667|583513990|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
161580725|NCT02409667|583513991|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161580726|NCT02409667|583513992|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161580727|NCT01925339|583513993|FG000|Overall Study|Adverse Event|2|||
161580728|NCT01925339|583513994|FG001|Overall Study|Adverse Event|0|||
161580729|NCT02769858|583514003|FG000|Overall Study|Withdrawal by Subject|2|||
161580730|NCT04939246|583514004|FG000|After Treatment|Death|4|||
161580731|NCT04939246|583514004|FG000|After Treatment|Lost to Follow-up|1|||
161580732|NCT04939246|583514004|FG000|After Treatment|Discharged to hospice|2|||
161580733|NCT03783026|583515981|FG000|Treatment Phase|Adverse Event|15|||
161580734|NCT03783026|583515981|FG000|Treatment Phase|Lack of Efficacy|11|||
161580735|NCT03783026|583515981|FG000|Treatment Phase|Withdrawal by Subject|6|||
161580736|NCT03783026|583515981|FG000|Treatment Phase|Lost to Follow-up|2|||
161580737|NCT03783026|583515981|FG000|Treatment Phase|Protocol Deviation|8|||
161580738|NCT03783026|583515981|FG000|Treatment Phase|Did Not Receive Treatment|1|||
161580739|NCT03783026|583515981|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
161580740|NCT04814186|583515982|FG000|Treatment Phase|Adverse Event|1|||
161580741|NCT04814186|583515982|FG000|Treatment Phase|Death|6|||
161580742|NCT04814186|583515982|FG000|Treatment Phase|Withdrawal by Subject|2|||
161580743|NCT04814186|583515982|FG000|Treatment Phase|Other|1|||
161580744|NCT04814186|583515982|FG000|Follow-Up Phase|Adverse Event|1|||
161580745|NCT04814186|583515982|FG000|Follow-Up Phase|Death|6|||
161580746|NCT04814186|583515982|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
161580747|NCT04814186|583515982|FG000|Follow-Up Phase|Other|1|||
161580748|NCT05505045|583515987|FG000|Overall Study|Withdrawal by Subject|2|||
161580749|NCT05505045|583515988|FG001|Overall Study|Withdrawal by Subject|1|||
161580750|NCT01643070|583515989|FG000|Overall Study|Withdrawal by Subject|3|||
161580751|NCT01643070|583515990|FG001|Overall Study|Withdrawal by Subject|1|||
161580752|NCT01643070|583515989|FG000|Overall Study|Death|1|||
161580753|NCT01643070|583515990|FG001|Overall Study|Death|0|||
161580754|NCT01643070|583515989|FG000|Overall Study|Pregressive disease|0|||
161580755|NCT01643070|583515990|FG001|Overall Study|Pregressive disease|2|||
161580756|NCT04201834|583515994|FG000|Overall Study|Screen fail|1|||
161580757|NCT04104321|583515998|FG000|Overall Study|didn't take the study drug|3|||
161580758|NCT04842500|583515999|FG000|Overall Study|Withdrawal by Subject|4|||
161580759|NCT04842500|583516000|FG001|Overall Study|Withdrawal by Subject|1|||
161580760|NCT04842500|583516001|FG002|Overall Study|Withdrawal by Subject|2|||
161580761|NCT04842500|583516002|FG003|Overall Study|Withdrawal by Subject|3|||
161580762|NCT04842500|583515999|FG000|Overall Study|Protocol Violation|1|||
161816682|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
161816683|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816684|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
161816685|NCT03218787|584368831|FG000|Overall Study|Lost to Follow-up|12|||
161816686|NCT03218787|584368831|FG000|Overall Study|Withdrawal by Subject|72|||
161816687|NCT03218787|584368831|FG000|Overall Study|Physician Decision|11|||
161816688|NCT03218787|584368831|FG000|Overall Study|Death|111|||
161580763|NCT04842500|583516000|FG001|Overall Study|Protocol Violation|0|||
161580764|NCT04842500|583516001|FG002|Overall Study|Protocol Violation|0|||
161580765|NCT04842500|583516002|FG003|Overall Study|Protocol Violation|1|||
161580766|NCT02980276|583516003|FG000|Overall Study|Withdrawal by Subject|4|||
161580767|NCT02980276|583516004|FG001|Overall Study|Withdrawal by Subject|4|||
161669995|NCT03078907|583845294|FG001|Overall Study|Adverse Event|0|||
161669996|NCT03078907|583845293|FG000|Overall Study|Other|1|||
161669997|NCT03078907|583845294|FG001|Overall Study|Other|0|||
161816689|NCT02896296|584368832|FG000|Overall Study|Adverse Event|1|||
161816690|NCT02896296|584368832|FG000|Overall Study|Lost to Follow-up|19|||
161816691|NCT02896296|584368832|FG000|Overall Study|Pregnancy|1|||
161484183|NCT01370356|583168961|FG000|Overall Study|Withdrawal by Subject|54|||
161484184|NCT01370356|583168962|FG001|Overall Study|Withdrawal by Subject|59|||
161484185|NCT01370356|583168961|FG000|Overall Study|Reason not specified|39|||
161484186|NCT01370356|583168962|FG001|Overall Study|Reason not specified|43|||
161484187|NCT01370356|583168961|FG000|Overall Study|Protocol Violation|3|||
161484188|NCT01370356|583168962|FG001|Overall Study|Protocol Violation|3|||
161484189|NCT01370356|583168961|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
161484190|NCT01370356|583168962|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
161484191|NCT01370356|583168961|FG000|Overall Study|AE Not Related to Study Drug|1|||
161484192|NCT01370356|583168962|FG001|Overall Study|AE Not Related to Study Drug|4|||
161484193|NCT01218243|583168964|FG000|Overall Study|Lack of Efficacy|1|||
161484194|NCT01218243|583168965|FG001|Overall Study|Lack of Efficacy|1|||
161484195|NCT01218243|583168964|FG000|Overall Study|Lost to Follow-up|3|||
161484196|NCT01218243|583168965|FG001|Overall Study|Lost to Follow-up|3|||
161484197|NCT01218243|583168964|FG000|Overall Study|Protocol Violation|5|||
161484198|NCT01218243|583168965|FG001|Overall Study|Protocol Violation|10|||
161484199|NCT00799422|583168969|FG000|First Week of Wear|Lost to Follow-up|0|||
161484200|NCT00799422|583168970|FG001|First Week of Wear|Lost to Follow-up|0|||
161484201|NCT00799422|583168971|FG002|First Week of Wear|Lost to Follow-up|1|||
161484202|NCT00799422|583168972|FG003|First Week of Wear|Lost to Follow-up|0|||
161484203|NCT00799422|583168973|FG004|First Week of Wear|Lost to Follow-up|0|||
161484204|NCT00799422|583168974|FG005|First Week of Wear|Lost to Follow-up|0|||
161484205|NCT00799422|583168969|FG000|First Week of Wear|Adverse Event|0|||
161484206|NCT00799422|583168970|FG001|First Week of Wear|Adverse Event|0|||
161484207|NCT00799422|583168971|FG002|First Week of Wear|Adverse Event|0|||
161484208|NCT00799422|583168972|FG003|First Week of Wear|Adverse Event|1|||
161484209|NCT00799422|583168973|FG004|First Week of Wear|Adverse Event|0|||
161484210|NCT00799422|583168974|FG005|First Week of Wear|Adverse Event|0|||
161484211|NCT01496612|583168975|FG000|1st Intervention|Adverse Event|1|||
161484212|NCT01496612|583168976|FG001|1st Intervention|Adverse Event|0|||
161484213|NCT01496612|583168975|FG000|1st Intervention|Withdrawal by Subject|1|||
161484214|NCT01496612|583168976|FG001|1st Intervention|Withdrawal by Subject|0|||
161484215|NCT03129100|583168978|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
161484216|NCT03129100|583168979|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
161484217|NCT03129100|583168980|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
161484218|NCT03129100|583168981|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
161484219|NCT03129100|583168982|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
161484220|NCT03129100|583168983|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
161484221|NCT03129100|583168984|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
161484222|NCT03129100|583168985|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
161484223|NCT03129100|583168986|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
161484224|NCT03129100|583168987|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
161484225|NCT03129100|583168988|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
161484226|NCT03129100|583168989|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
161484227|NCT03129100|583168990|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
161484228|NCT03129100|583168991|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
161484229|NCT03129100|583168992|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
161484230|NCT03129100|583168993|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
161484231|NCT03129100|583168994|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
161484232|NCT03129100|583168995|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
161484233|NCT03129100|583168996|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
161484234|NCT03129100|583168997|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
161484235|NCT03129100|583168998|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
161484236|NCT03129100|583168999|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
161484237|NCT03129100|583169000|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
161484238|NCT03129100|583169001|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
161484239|NCT03129100|583169002|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
161484240|NCT03129100|583169003|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
161484241|NCT03129100|583168978|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
161484242|NCT03129100|583168979|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484243|NCT03129100|583168980|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484244|NCT03129100|583168981|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484245|NCT03129100|583168982|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484246|NCT03129100|583168983|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484247|NCT03129100|583168984|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484248|NCT03129100|583168985|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161922033|NCT02989389|584761039|FG000|Period 1|Physician Decision|0|||
161484249|NCT03129100|583168986|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484250|NCT03129100|583168987|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484251|NCT03129100|583168988|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484252|NCT03129100|583168989|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484253|NCT03129100|583168990|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484254|NCT03129100|583168991|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161580768|NCT02980276|583516003|FG000|Overall Study|Physician Decision|0|||
161580769|NCT02980276|583516004|FG001|Overall Study|Physician Decision|1|||
161580770|NCT02980276|583516003|FG000|Overall Study|Lost to Follow-up|18|||
161580771|NCT02980276|583516004|FG001|Overall Study|Lost to Follow-up|18|||
161580772|NCT02980276|583516003|FG000|Overall Study|Death|1|||
161580773|NCT02980276|583516004|FG001|Overall Study|Death|0|||
161580774|NCT02980276|583516003|FG000|Overall Study|Miscellaneous other|10|||
161580775|NCT02980276|583516004|FG001|Overall Study|Miscellaneous other|4|||
161580776|NCT04139668|583516006|FG000|Overall Study|Withdrawal by Subject|1|||
161580777|NCT03025789|583516007|FG000|Overall Study|Lack of Efficacy|6|||
161580778|NCT03025789|583516008|FG001|Overall Study|Lack of Efficacy|1|||
161580779|NCT03025789|583516007|FG000|Overall Study|Death|1|||
161580780|NCT03025789|583516008|FG001|Overall Study|Death|0|||
161580781|NCT03025789|583516007|FG000|Overall Study|Withdrawal by Subject|0|||
161580782|NCT03025789|583516008|FG001|Overall Study|Withdrawal by Subject|2|||
161580783|NCT03554265|583516009|FG000|Overall Study|Withdrawal by Subject|2|||
161580784|NCT03554265|583516010|FG001|Overall Study|Withdrawal by Subject|2|||
161580785|NCT03554265|583516011|FG002|Overall Study|Withdrawal by Subject|3|||
161580786|NCT03554265|583516009|FG000|Overall Study|Physician Decision|0|||
161580787|NCT03554265|583516010|FG001|Overall Study|Physician Decision|0|||
161580788|NCT03554265|583516011|FG002|Overall Study|Physician Decision|1|||
161580789|NCT04999085|583516014|FG000|Overall Study|Death|1|||
161580790|NCT05057897|583516015|FG000|Overall Study|Site closure|2|||
161580791|NCT05057897|583516016|FG001|Overall Study|Site closure|2|||
161580792|NCT05057897|583516015|FG000|Overall Study|Death|1|||
161580793|NCT05057897|583516016|FG001|Overall Study|Death|0|||
161580794|NCT02824029|583516021|FG000|Overall Study|Didn't receive treatment|2|||
161580795|NCT02824029|583516021|FG000|Overall Study|Patient decision to discontinue treatment|3|||
161580796|NCT02824029|583516021|FG000|Overall Study|Non-compliant|5|||
161580797|NCT02824029|583516021|FG000|Overall Study|Progression of disease|15|||
161580798|NCT02824029|583516021|FG000|Overall Study|Inadequate response to therapy|2|||
161580799|NCT02824029|583516021|FG000|Overall Study|Possible progression per treating physician|1|||
161580800|NCT04440176|583516023|FG000|Overall Study|Withdrawal by Subject|5|||
161580801|NCT04440176|583516024|FG001|Overall Study|Withdrawal by Subject|3|||
161580802|NCT04440176|583516023|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161580803|NCT04440176|583516024|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161580804|NCT04440176|583516023|FG000|Overall Study|Adverse Event|2|||
161580805|NCT04440176|583516024|FG001|Overall Study|Adverse Event|6|||
161580806|NCT04440176|583516023|FG000|Overall Study|Lost to Follow-up|22|||
161580807|NCT04440176|583516024|FG001|Overall Study|Lost to Follow-up|23|||
161580808|NCT04440176|583516023|FG000|Overall Study|Medication error without associated adverse event|0|||
161580809|NCT04440176|583516024|FG001|Overall Study|Medication error without associated adverse event|1|||
161580810|NCT04440176|583516023|FG000|Overall Study|No longer met eligibility criteria|7|||
161580811|NCT04440176|583516024|FG001|Overall Study|No longer met eligibility criteria|1|||
161580812|NCT04440176|583516023|FG000|Overall Study|Other|1|||
161580813|NCT04440176|583516024|FG001|Overall Study|Other|2|||
161580814|NCT04440176|583516023|FG000|Overall Study|Protocol deviation|6|||
161580815|NCT04440176|583516024|FG001|Overall Study|Protocol deviation|8|||
161580816|NCT04440176|583516023|FG000|Overall Study|Randomized but not vaccinated|6|||
161580817|NCT04440176|583516024|FG001|Overall Study|Randomized but not vaccinated|3|||
161580818|NCT04188379|583516025|FG000|Overall Study|Withdrawal by Subject|10|||
161580819|NCT04188379|583516026|FG001|Overall Study|Withdrawal by Subject|3|||
161580820|NCT04188379|583516025|FG000|Overall Study|Physician Decision|0|||
161580821|NCT04188379|583516026|FG001|Overall Study|Physician Decision|1|||
161922034|NCT02989389|584761040|FG001|Period 1|Physician Decision|0|||
161922035|NCT02989389|584761041|FG002|Period 1|Physician Decision|0|||
161922036|NCT02989389|584761042|FG003|Period 1|Physician Decision|0|||
161922037|NCT02989389|584761043|FG004|Period 1|Physician Decision|0|||
161922038|NCT02989389|584761044|FG005|Period 1|Physician Decision|0|||
161922039|NCT02989389|584761045|FG006|Period 1|Physician Decision|0|||
161922040|NCT02989389|584761046|FG007|Period 1|Physician Decision|0|||
161922041|NCT02989389|584761047|FG008|Period 1|Physician Decision|1|||
161922042|NCT02989389|584761048|FG009|Period 1|Physician Decision|0|||
161922043|NCT01666652|584761049|FG000|Overall Study|Serious Adverse Event|0|||
161922044|NCT01666652|584761050|FG001|Overall Study|Serious Adverse Event|0|||
161922045|NCT01666652|584761051|FG002|Overall Study|Serious Adverse Event|0|||
161922046|NCT01666652|584761052|FG003|Overall Study|Serious Adverse Event|1|||
161922047|NCT01666652|584761053|FG004|Overall Study|Serious Adverse Event|0|||
161922048|NCT01666652|584761049|FG000|Overall Study|Withdrawal by Subject|0|||
161580822|NCT04188379|583516025|FG000|Overall Study|Adverse Event|3|||
161580823|NCT04188379|583516026|FG001|Overall Study|Adverse Event|1|||
161580824|NCT04188379|583516025|FG000|Overall Study|Pregnancy|1|||
161580825|NCT04188379|583516026|FG001|Overall Study|Pregnancy|0|||
161580826|NCT04188379|583516025|FG000|Overall Study|Lack of Efficacy|8|||
161580827|NCT04188379|583516026|FG001|Overall Study|Lack of Efficacy|5|||
161580828|NCT04188379|583516025|FG000|Overall Study|Other|0|||
161580829|NCT04188379|583516026|FG001|Overall Study|Other|3|||
161580830|NCT00111813|583516029|FG000|Overall Study|Adverse Event|1|||
161922049|NCT01666652|584761050|FG001|Overall Study|Withdrawal by Subject|0|||
161922050|NCT01666652|584761051|FG002|Overall Study|Withdrawal by Subject|0|||
161922051|NCT01666652|584761052|FG003|Overall Study|Withdrawal by Subject|0|||
161922052|NCT01666652|584761053|FG004|Overall Study|Withdrawal by Subject|1|||
161922053|NCT01666652|584761049|FG000|Overall Study|Moved from study area|1|||
161922054|NCT01666652|584761050|FG001|Overall Study|Moved from study area|0|||
161922055|NCT01666652|584761051|FG002|Overall Study|Moved from study area|0|||
161922056|NCT01666652|584761052|FG003|Overall Study|Moved from study area|2|||
161922057|NCT01666652|584761053|FG004|Overall Study|Moved from study area|0|||
161922058|NCT01666652|584761049|FG000|Overall Study|Lost to Follow-up|1|||
161922059|NCT01666652|584761050|FG001|Overall Study|Lost to Follow-up|1|||
161922060|NCT01666652|584761051|FG002|Overall Study|Lost to Follow-up|1|||
161922061|NCT01666652|584761052|FG003|Overall Study|Lost to Follow-up|1|||
161922062|NCT01666652|584761053|FG004|Overall Study|Lost to Follow-up|0|||
161922063|NCT01018979|584761054|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
161922064|NCT01018979|584761055|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
161922065|NCT01018979|584761054|FG000|Overall Study|Not received at least one dose|0|||
161922066|NCT01018979|584761055|FG001|Overall Study|Not received at least one dose|1|||
161922067|NCT00088153|584761056|FG000|Overall Study|Physician Decision|3|||
161922068|NCT00088153|584761057|FG001|Overall Study|Physician Decision|3|||
161922069|NCT00088153|584761056|FG000|Overall Study|Withdrawal by Subject|10|||
161484255|NCT03129100|583168992|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484256|NCT03129100|583168993|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484257|NCT03129100|583168994|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484258|NCT03129100|583168995|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484259|NCT03129100|583168996|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484260|NCT03129100|583168997|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484261|NCT03129100|583168998|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484262|NCT03129100|583168999|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484263|NCT03129100|583169000|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484264|NCT03129100|583169001|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484265|NCT03129100|583169002|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484266|NCT03129100|583169003|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161484267|NCT03129100|583168978|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
161484268|NCT03129100|583168979|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
161484269|NCT03129100|583168980|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484270|NCT03129100|583168981|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484271|NCT03129100|583168982|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484272|NCT03129100|583168983|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484273|NCT03129100|583168984|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484274|NCT03129100|583168985|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484275|NCT03129100|583168986|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484276|NCT03129100|583168987|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484277|NCT03129100|583168988|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484278|NCT03129100|583168989|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484279|NCT03129100|583168990|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484280|NCT03129100|583168991|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484281|NCT03129100|583168992|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484282|NCT03129100|583168993|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484283|NCT03129100|583168994|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484284|NCT03129100|583168995|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484285|NCT03129100|583168996|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484286|NCT03129100|583168997|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484287|NCT03129100|583168998|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484288|NCT03129100|583168999|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484289|NCT03129100|583169000|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484290|NCT03129100|583169001|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484291|NCT03129100|583169002|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484292|NCT03129100|583169003|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
161484293|NCT03129100|583168978|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
161484294|NCT03129100|583168979|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
161484295|NCT03129100|583168980|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484296|NCT03129100|583168981|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484297|NCT03129100|583168982|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484298|NCT03129100|583168983|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484299|NCT03129100|583168984|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484300|NCT03129100|583168985|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484301|NCT03129100|583168986|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484302|NCT03129100|583168987|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161580831|NCT00111813|583516030|FG001|Overall Study|Adverse Event|2|||
161580832|NCT00111813|583516031|FG002|Overall Study|Adverse Event|4|||
161580833|NCT00111813|583516032|FG003|Overall Study|Adverse Event|2|||
161669998|NCT03078907|583845293|FG000|Overall Study|Protocol Violation|0|||
161669999|NCT03078907|583845294|FG001|Overall Study|Protocol Violation|1|||
161670000|NCT01955122|583845295|FG000|Overall Study|Physician Decision|5|||
161670001|NCT01955122|583845296|FG001|Overall Study|Physician Decision|5|||
161670002|NCT01672788|583845297|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
161670003|NCT01672788|583845298|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
161670004|NCT01672788|583845299|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
161670005|NCT01672788|583845300|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
161670006|NCT01128361|583845303|FG000|Overall Study|Lost to Follow-up|0|||
161670007|NCT01128361|583845304|FG001|Overall Study|Lost to Follow-up|1|||
161670008|NCT01128361|583845303|FG000|Overall Study|Withdrawal by Subject|5|||
161670009|NCT01128361|583845304|FG001|Overall Study|Withdrawal by Subject|2|||
161670010|NCT02464228|583845305|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
161670011|NCT02464228|583845306|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
161670012|NCT02464228|583845307|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
161670013|NCT02464228|583845308|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
161670014|NCT02464228|583845305|FG000|Overall Study|Physician Decision|2|||
161670015|NCT02464228|583845306|FG001|Overall Study|Physician Decision|0|||
161670016|NCT02464228|583845307|FG002|Overall Study|Physician Decision|1|||
161670017|NCT02464228|583845308|FG003|Overall Study|Physician Decision|0|||
161670018|NCT02464228|583845305|FG000|Overall Study|Miscellaneous|1|||
161670019|NCT02464228|583845306|FG001|Overall Study|Miscellaneous|0|||
161670020|NCT02464228|583845307|FG002|Overall Study|Miscellaneous|1|||
161670021|NCT02464228|583845308|FG003|Overall Study|Miscellaneous|0|||
161670022|NCT02464228|583845305|FG000|Overall Study|Adverse Event|9|||
161670023|NCT02464228|583845306|FG001|Overall Study|Adverse Event|0|||
161670024|NCT02464228|583845307|FG002|Overall Study|Adverse Event|3|||
161670025|NCT02464228|583845308|FG003|Overall Study|Adverse Event|0|||
161670026|NCT02464228|583845305|FG000|Overall Study|Withdrawal by Subject|1|||
161670027|NCT02464228|583845306|FG001|Overall Study|Withdrawal by Subject|1|||
161670028|NCT02464228|583845307|FG002|Overall Study|Withdrawal by Subject|1|||
161670029|NCT02464228|583845308|FG003|Overall Study|Withdrawal by Subject|0|||
161670030|NCT02464228|583845305|FG000|Overall Study|Disease Progression|22|||
161670031|NCT02464228|583845306|FG001|Overall Study|Disease Progression|12|||
161670032|NCT02464228|583845307|FG002|Overall Study|Disease Progression|5|||
161670033|NCT02464228|583845308|FG003|Overall Study|Disease Progression|2|||
161670034|NCT04658186|583845324|FG000|Overall Study|Adverse Event|4|||
161670035|NCT04658186|583845325|FG001|Overall Study|Adverse Event|18|||
161670036|NCT04658186|583845326|FG002|Overall Study|Adverse Event|15|||
161670037|NCT04658186|583845324|FG000|Overall Study|Lack of Efficacy|1|||
161670038|NCT04658186|583845325|FG001|Overall Study|Lack of Efficacy|1|||
161670039|NCT04658186|583845326|FG002|Overall Study|Lack of Efficacy|0|||
161670040|NCT04658186|583845324|FG000|Overall Study|Protocol Violation|0|||
161670041|NCT04658186|583845325|FG001|Overall Study|Protocol Violation|0|||
161670042|NCT04658186|583845326|FG002|Overall Study|Protocol Violation|1|||
161670043|NCT04658186|583845324|FG000|Overall Study|Lost to Follow-up|0|||
161670044|NCT04658186|583845325|FG001|Overall Study|Lost to Follow-up|0|||
161670045|NCT04658186|583845326|FG002|Overall Study|Lost to Follow-up|2|||
161670046|NCT04658186|583845324|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
161670047|NCT04658186|583845325|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
161670048|NCT04658186|583845326|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
161670049|NCT04658186|583845324|FG000|Overall Study|Participant is Moving in Another Province|0|||
161670050|NCT04658186|583845325|FG001|Overall Study|Participant is Moving in Another Province|1|||
161670051|NCT04658186|583845326|FG002|Overall Study|Participant is Moving in Another Province|0|||
161670052|NCT04658186|583845324|FG000|Overall Study|Non-Compliance|0|||
161670053|NCT04658186|583845325|FG001|Overall Study|Non-Compliance|1|||
161670054|NCT04658186|583845326|FG002|Overall Study|Non-Compliance|1|||
161670055|NCT04658186|583845324|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
161670056|NCT04658186|583845325|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
161922070|NCT00088153|584761057|FG001|Overall Study|Withdrawal by Subject|10|||
161922071|NCT00088153|584761056|FG000|Overall Study|Lost to Follow-up|11|||
161922072|NCT00088153|584761057|FG001|Overall Study|Lost to Follow-up|12|||
161922073|NCT01132755|584761058|FG000|Overall Study|Procedure not done due to medical reason|23|||
161922074|NCT01132755|584761058|FG000|Overall Study|Protocol Violation|15|||
161922075|NCT01132755|584761058|FG000|Overall Study|Withdrawal by Subject|4|||
161670057|NCT04658186|583845326|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
161922076|NCT01757847|584761059|FG000|Overall Study|Withdrawal by Subject|3|||
161922077|NCT01757847|584761060|FG001|Overall Study|Withdrawal by Subject|4|||
161670058|NCT04658186|583845324|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
161922078|NCT04057365|584761061|FG000|Overall Study|Withdrawal by Subject|2|||
161670059|NCT04658186|583845325|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
161670060|NCT04658186|583845326|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
161670061|NCT04658186|583845324|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
161670062|NCT04658186|583845325|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
161670063|NCT04658186|583845326|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
161484303|NCT03129100|583168988|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484304|NCT03129100|583168989|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484305|NCT03129100|583168990|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484306|NCT03129100|583168991|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484307|NCT03129100|583168992|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484308|NCT03129100|583168993|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484309|NCT03129100|583168994|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484310|NCT03129100|583168995|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484311|NCT03129100|583168996|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484312|NCT03129100|583168997|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484313|NCT03129100|583168998|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484314|NCT03129100|583168999|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484315|NCT03129100|583169000|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484316|NCT03129100|583169001|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484317|NCT03129100|583169002|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484318|NCT03129100|583169003|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
161484319|NCT03129100|583168978|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484320|NCT03129100|583168979|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
161484321|NCT03129100|583168980|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484322|NCT03129100|583168981|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484323|NCT03129100|583168982|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484324|NCT03129100|583168983|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484325|NCT03129100|583168984|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484326|NCT03129100|583168985|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484327|NCT03129100|583168986|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484328|NCT03129100|583168987|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484329|NCT03129100|583168988|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484330|NCT03129100|583168989|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484331|NCT03129100|583168990|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484332|NCT03129100|583168991|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484333|NCT03129100|583168992|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484334|NCT03129100|583168993|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484335|NCT03129100|583168994|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484336|NCT03129100|583168995|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484337|NCT03129100|583168996|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484338|NCT03129100|583168997|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484339|NCT03129100|583168998|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484340|NCT03129100|583168999|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484341|NCT03129100|583169000|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484342|NCT03129100|583169001|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484343|NCT03129100|583169002|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484344|NCT03129100|583169003|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
161484345|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484346|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484347|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
161484348|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
161484349|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484350|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
161484351|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484352|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484353|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484354|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484355|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484356|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484357|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484358|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484359|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484360|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484361|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484362|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484363|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484364|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484365|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484366|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484367|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484368|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484369|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484370|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
161484371|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Death|0|||
161484372|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Death|0|||
161484373|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Death|1|||
161484374|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Death|0|||
161484375|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Death|0|||
161484376|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Death|0|||
161484377|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Death|0|||
161484378|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Death|0|||
161484379|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Death|0|||
161484380|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Death|0|||
161484381|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Death|0|||
161484382|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Death|0|||
161484383|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Death|0|||
161484384|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Death|0|||
161484385|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Death|0|||
161484386|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Death|0|||
161484387|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Death|0|||
161484388|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Death|0|||
161484389|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Death|0|||
161484390|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Death|0|||
161484391|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Death|0|||
161484392|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Death|0|||
161484393|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Death|0|||
161484394|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Death|0|||
161484395|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Death|0|||
161484396|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Death|0|||
161484397|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484398|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484399|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
161484400|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
161484401|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
161484402|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
161484403|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
161484404|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484405|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484406|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484407|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484408|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484409|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484410|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484411|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484412|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484413|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484414|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484415|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484416|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484417|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484418|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484419|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484420|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484421|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484422|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161484423|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484424|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484425|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
161484426|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484427|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161580834|NCT00111813|583516033|FG004|Overall Study|Adverse Event|2|||
161580835|NCT00111813|583516034|FG005|Overall Study|Adverse Event|2|||
161580836|NCT00111813|583516029|FG000|Overall Study|Progressive disease|2|||
161580837|NCT00111813|583516030|FG001|Overall Study|Progressive disease|1|||
161580838|NCT00111813|583516031|FG002|Overall Study|Progressive disease|5|||
161580839|NCT00111813|583516032|FG003|Overall Study|Progressive disease|3|||
161580840|NCT00111813|583516033|FG004|Overall Study|Progressive disease|4|||
161816692|NCT02896296|584368832|FG000|Overall Study|Physician Decision|2|||
161816693|NCT02896296|584368832|FG000|Overall Study|Withdrawal by Subject|10|||
161816694|NCT02896296|584368832|FG000|Overall Study|Site closing|7|||
161816695|NCT02896296|584368832|FG000|Overall Study|Incarceration|1|||
161816696|NCT02896296|584368832|FG000|Overall Study|Relocation|1|||
161580841|NCT00111813|583516034|FG005|Overall Study|Progressive disease|3|||
161580842|NCT00111813|583516029|FG000|Overall Study|Lack of Efficacy|0|||
161816697|NCT04633564|584368833|FG000|Period 1|Adverse Event|28|||
161580843|NCT00111813|583516030|FG001|Overall Study|Lack of Efficacy|0|||
161580844|NCT00111813|583516031|FG002|Overall Study|Lack of Efficacy|0|||
161580845|NCT00111813|583516032|FG003|Overall Study|Lack of Efficacy|0|||
161580846|NCT00111813|583516033|FG004|Overall Study|Lack of Efficacy|0|||
161580847|NCT00111813|583516034|FG005|Overall Study|Lack of Efficacy|1|||
161580848|NCT00111813|583516029|FG000|Overall Study|Other|0|||
161580849|NCT00111813|583516030|FG001|Overall Study|Other|0|||
161580850|NCT00111813|583516031|FG002|Overall Study|Other|1|||
161580851|NCT00111813|583516032|FG003|Overall Study|Other|0|||
161580852|NCT00111813|583516033|FG004|Overall Study|Other|0|||
161580853|NCT00111813|583516034|FG005|Overall Study|Other|0|||
161580854|NCT01610297|583516035|FG000|Overall Study|Lost to Follow-up|1|||
161580855|NCT00818246|583516036|FG000|Overall Study|Impossible to match pictures|5|||
161580856|NCT02121002|583516037|FG000|Overall Study|Physician Decision|2|||
161580857|NCT02121002|583516038|FG001|Overall Study|Physician Decision|0|||
161580858|NCT02121002|583516039|FG002|Overall Study|Physician Decision|0|||
161580859|NCT02121002|583516037|FG000|Overall Study|Withdrawal by Subject|3|||
161580860|NCT02121002|583516038|FG001|Overall Study|Withdrawal by Subject|1|||
161580861|NCT02121002|583516039|FG002|Overall Study|Withdrawal by Subject|4|||
161580862|NCT02121002|583516037|FG000|Overall Study|Protocol Violation|1|||
161580863|NCT02121002|583516038|FG001|Overall Study|Protocol Violation|2|||
161580864|NCT02121002|583516039|FG002|Overall Study|Protocol Violation|4|||
161580865|NCT02121002|583516037|FG000|Overall Study|Concomitant therapy|0|||
161580866|NCT02121002|583516038|FG001|Overall Study|Concomitant therapy|1|||
161580867|NCT02121002|583516039|FG002|Overall Study|Concomitant therapy|1|||
161580868|NCT02121002|583516037|FG000|Overall Study|Others|1|||
161580869|NCT02121002|583516038|FG001|Overall Study|Others|0|||
161580870|NCT02121002|583516039|FG002|Overall Study|Others|1|||
161580871|NCT02590432|583516040|FG000|Open-label Treatment Period|Adverse Event|97|||
161816698|NCT04633564|584368834|FG001|Period 1|Adverse Event|19|||
161816699|NCT04633564|584368833|FG000|Period 1|Death|8|||
161816700|NCT04633564|584368834|FG001|Period 1|Death|7|||
161816701|NCT04633564|584368833|FG000|Period 1|Lost to Follow-up|3|||
161816702|NCT04633564|584368834|FG001|Period 1|Lost to Follow-up|5|||
161816703|NCT04633564|584368833|FG000|Period 1|Physician Decision|4|||
161816704|NCT04633564|584368834|FG001|Period 1|Physician Decision|12|||
161816705|NCT04633564|584368833|FG000|Period 1|Protocol Violation|0|||
161816706|NCT04633564|584368834|FG001|Period 1|Protocol Violation|1|||
161816707|NCT04633564|584368833|FG000|Period 1|Withdrawal by Subject|10|||
161816708|NCT04633564|584368834|FG001|Period 1|Withdrawal by Subject|8|||
161816709|NCT04633564|584368833|FG000|Period 1|Progressive disease|47|||
161816710|NCT04633564|584368834|FG001|Period 1|Progressive disease|51|||
161816711|NCT04633564|584368833|FG000|Period 1|Terminated by Sponsor|8|||
161922079|NCT04057365|584761062|FG001|Overall Study|Withdrawal by Subject|0|||
161922080|NCT01063114|584761063|FG000|Overall Study|Lost to Follow-up|1|||
161922081|NCT04598828|584761066|FG000|Overall Study|Physician Decision|1|||
161922082|NCT04598828|584761067|FG001|Overall Study|Physician Decision|0|||
161922083|NCT04598828|584761066|FG000|Overall Study|Withdrawal by Subject|0|||
161922084|NCT04598828|584761067|FG001|Overall Study|Withdrawal by Subject|1|||
161922085|NCT04598828|584761066|FG000|Overall Study|Withdrawal by Subject|0|||
161922086|NCT04598828|584761067|FG001|Overall Study|Withdrawal by Subject|1|||
161922087|NCT02676973|584761068|FG000|Overall Study|Withdrawal by Subject|9|||
161922088|NCT02676973|584761069|FG001|Overall Study|Withdrawal by Subject|8|||
161922089|NCT02676973|584761070|FG002|Overall Study|Withdrawal by Subject|11|||
161922090|NCT02676973|584761068|FG000|Overall Study|Lost to Follow-up|8|||
161922091|NCT02676973|584761069|FG001|Overall Study|Lost to Follow-up|12|||
161922092|NCT02676973|584761070|FG002|Overall Study|Lost to Follow-up|8|||
161922093|NCT02676973|584761068|FG000|Overall Study|Death|2|||
161922094|NCT02676973|584761069|FG001|Overall Study|Death|1|||
161922095|NCT02676973|584761070|FG002|Overall Study|Death|5|||
161922096|NCT01078662|584761072|FG000|Overall Study|Death|41|||
161922097|NCT01078662|584761073|FG001|Overall Study|Death|103|||
161922098|NCT01078662|584761074|FG002|Overall Study|Death|18|||
161922099|NCT01078662|584761075|FG003|Overall Study|Death|5|||
161922100|NCT01078662|584761076|FG004|Overall Study|Death|8|||
161922101|NCT01078662|584761072|FG000|Overall Study|Patients reached data cut-off|12|||
161922102|NCT01078662|584761073|FG001|Overall Study|Patients reached data cut-off|53|||
161922103|NCT01078662|584761074|FG002|Overall Study|Patients reached data cut-off|2|||
161922104|NCT01078662|584761075|FG003|Overall Study|Patients reached data cut-off|2|||
161922105|NCT01078662|584761076|FG004|Overall Study|Patients reached data cut-off|3|||
161922106|NCT01078662|584761072|FG000|Overall Study|Withdrawal by Subject|4|||
161922107|NCT01078662|584761073|FG001|Overall Study|Withdrawal by Subject|11|||
161922108|NCT01078662|584761074|FG002|Overall Study|Withdrawal by Subject|1|||
161922109|NCT01078662|584761075|FG003|Overall Study|Withdrawal by Subject|0|||
161922110|NCT01078662|584761076|FG004|Overall Study|Withdrawal by Subject|0|||
161922111|NCT01078662|584761072|FG000|Overall Study|Protocol Violation|0|||
161922112|NCT01078662|584761073|FG001|Overall Study|Protocol Violation|1|||
161922113|NCT01078662|584761074|FG002|Overall Study|Protocol Violation|0|||
161922114|NCT01078662|584761075|FG003|Overall Study|Protocol Violation|0|||
161922115|NCT01078662|584761076|FG004|Overall Study|Protocol Violation|0|||
161580872|NCT02590432|583516041|FG001|Open-label Treatment Period|Adverse Event|79|||
161580873|NCT02590432|583516042|FG002|Open-label Treatment Period|Adverse Event|0|||
161580874|NCT02590432|583516043|FG003|Open-label Treatment Period|Adverse Event|0|||
161580875|NCT02590432|583516044|FG004|Open-label Treatment Period|Adverse Event|0|||
161580876|NCT02590432|583516045|FG005|Open-label Treatment Period|Adverse Event|0|||
161580877|NCT02590432|583516046|FG006|Open-label Treatment Period|Adverse Event|0|||
161580878|NCT02590432|583516047|FG007|Open-label Treatment Period|Adverse Event|0|||
161580879|NCT02590432|583516048|FG008|Open-label Treatment Period|Adverse Event|0|||
161580880|NCT02590432|583516040|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
161580881|NCT02590432|583516041|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
161580882|NCT02590432|583516042|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
161580883|NCT02590432|583516043|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
161580884|NCT02590432|583516044|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
161580885|NCT02590432|583516045|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
161580886|NCT02590432|583516046|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
161580887|NCT02590432|583516047|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
161580888|NCT02590432|583516048|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
161580889|NCT02590432|583516040|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
161580890|NCT02590432|583516041|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
161580891|NCT02590432|583516042|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
161580892|NCT02590432|583516043|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
161580893|NCT02590432|583516044|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
161580894|NCT02590432|583516045|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
161580895|NCT02590432|583516046|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
161580896|NCT02590432|583516047|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
161580897|NCT02590432|583516048|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
161580898|NCT02590432|583516040|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
161580899|NCT02590432|583516041|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
161580900|NCT02590432|583516042|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161580901|NCT02590432|583516043|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161580902|NCT02590432|583516044|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
161580903|NCT02590432|583516045|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
161580904|NCT02590432|583516046|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
161922116|NCT01078662|584761072|FG000|Overall Study|Lost to Follow-up|1|||
161922117|NCT01078662|584761073|FG001|Overall Study|Lost to Follow-up|0|||
161922118|NCT01078662|584761074|FG002|Overall Study|Lost to Follow-up|0|||
161922119|NCT01078662|584761075|FG003|Overall Study|Lost to Follow-up|0|||
161922120|NCT01078662|584761076|FG004|Overall Study|Lost to Follow-up|0|||
161922121|NCT01127061|584762232|FG000|Overall Study|Lost to Follow-up|7|||
161922122|NCT01127061|584762233|FG001|Overall Study|Lost to Follow-up|10|||
161922123|NCT01127061|584762232|FG000|Overall Study|Physician Decision|3|||
161922124|NCT01127061|584762233|FG001|Overall Study|Physician Decision|3|||
161922125|NCT03921541|584762238|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
161922126|NCT03921541|584762239|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161922127|NCT00182637|584762240|FG000|Overall Study|Adverse Event|2|||
161922128|NCT00182637|584762240|FG000|Overall Study|Disease Progression|1|||
161922129|NCT00003456|584762241|FG000|Overall Study|Not evaluable|8|||
161922130|NCT00420407|584762243|FG000|Overall Study|Lost to Follow-up|0|||
161922131|NCT00420407|584762244|FG001|Overall Study|Lost to Follow-up|3|||
161922132|NCT00420407|584762243|FG000|Overall Study|Physician Decision|2|||
161922133|NCT00420407|584762244|FG001|Overall Study|Physician Decision|1|||
161922134|NCT00420407|584762243|FG000|Overall Study|subject identified as detainee|1|||
161922135|NCT00420407|584762244|FG001|Overall Study|subject identified as detainee|0|||
161922136|NCT00420407|584762243|FG000|Overall Study|subject identified as Jehovah's witness|1|||
161922137|NCT00420407|584762244|FG001|Overall Study|subject identified as Jehovah's witness|0|||
161922138|NCT00420407|584762243|FG000|Overall Study|Withdrawal by Subject|0|||
161922139|NCT00420407|584762244|FG001|Overall Study|Withdrawal by Subject|2|||
161922140|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
161922141|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
161922142|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
161922143|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
161922144|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
161922145|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
161922146|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
161580905|NCT02590432|583516047|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
161580906|NCT02590432|583516048|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
161580907|NCT02590432|583516040|FG000|Open-label Treatment Period|Protocol Violation|10|||
161580908|NCT02590432|583516041|FG001|Open-label Treatment Period|Protocol Violation|4|||
161580909|NCT02590432|583516042|FG002|Open-label Treatment Period|Protocol Violation|0|||
161580910|NCT02590432|583516043|FG003|Open-label Treatment Period|Protocol Violation|0|||
161580911|NCT02590432|583516044|FG004|Open-label Treatment Period|Protocol Violation|0|||
161580912|NCT02590432|583516045|FG005|Open-label Treatment Period|Protocol Violation|0|||
161580913|NCT02590432|583516046|FG006|Open-label Treatment Period|Protocol Violation|0|||
161580914|NCT02590432|583516047|FG007|Open-label Treatment Period|Protocol Violation|0|||
161580915|NCT02590432|583516048|FG008|Open-label Treatment Period|Protocol Violation|0|||
161580916|NCT02590432|583516040|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
161580917|NCT02590432|583516041|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
161580918|NCT02590432|583516042|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580919|NCT02590432|583516043|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580920|NCT02590432|583516044|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580921|NCT02590432|583516045|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580922|NCT02590432|583516046|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580923|NCT02590432|583516047|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580924|NCT02590432|583516048|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161580925|NCT02590432|583516040|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
161580926|NCT02590432|583516041|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
161580927|NCT02590432|583516042|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580928|NCT02590432|583516043|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580929|NCT02590432|583516044|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580930|NCT02590432|583516045|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580931|NCT02590432|583516046|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580932|NCT02590432|583516047|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580933|NCT02590432|583516048|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161580934|NCT02590432|583516040|FG000|Double-blind Treatment Period|Adverse Event|0|||
161580935|NCT02590432|583516041|FG001|Double-blind Treatment Period|Adverse Event|0|||
161580936|NCT02590432|583516042|FG002|Double-blind Treatment Period|Adverse Event|14|||
161580937|NCT02590432|583516043|FG003|Double-blind Treatment Period|Adverse Event|12|||
161580938|NCT02590432|583516044|FG004|Double-blind Treatment Period|Adverse Event|6|||
161580939|NCT02590432|583516045|FG005|Double-blind Treatment Period|Adverse Event|22|||
161580940|NCT02590432|583516046|FG006|Double-blind Treatment Period|Adverse Event|20|||
161580941|NCT02590432|583516047|FG007|Double-blind Treatment Period|Adverse Event|0|||
161580942|NCT02590432|583516048|FG008|Double-blind Treatment Period|Adverse Event|0|||
161580943|NCT02590432|583516040|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161580944|NCT02590432|583516041|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161580945|NCT02590432|583516042|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161580946|NCT02590432|583516043|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161670064|NCT04658186|583845324|FG000|Overall Study|PI Decision due to Participant Safety|0|||
161670065|NCT04658186|583845325|FG001|Overall Study|PI Decision due to Participant Safety|0|||
161816712|NCT04633564|584368834|FG001|Period 1|Terminated by Sponsor|6|||
161816713|NCT04633564|584368833|FG000|Period 2|Adverse Event|3|||
161580947|NCT02590432|583516044|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
161580948|NCT02590432|583516045|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
161580949|NCT02590432|583516046|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
161580950|NCT02590432|583516047|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
161580951|NCT02590432|583516048|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
161580952|NCT02590432|583516040|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
161580953|NCT02590432|583516041|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
161580954|NCT02590432|583516042|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
161580955|NCT02590432|583516043|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
161580956|NCT02590432|583516044|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
161580957|NCT02590432|583516045|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
161580958|NCT02590432|583516046|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
161580959|NCT02590432|583516047|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
161580960|NCT02590432|583516048|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
161580961|NCT02590432|583516040|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161580962|NCT02590432|583516041|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161580963|NCT02590432|583516042|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161580964|NCT02590432|583516043|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161580965|NCT02590432|583516044|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
161816714|NCT04633564|584368834|FG001|Period 2|Adverse Event|4|||
161816715|NCT04633564|584368833|FG000|Period 2|Death|0|||
161816716|NCT04633564|584368834|FG001|Period 2|Death|2|||
161816717|NCT04633564|584368833|FG000|Period 2|Lost to Follow-up|0|||
161484428|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484429|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484430|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484431|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484432|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484433|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484434|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484435|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484436|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484437|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484438|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484439|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484440|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484441|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484442|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484443|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484444|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484445|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484446|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484447|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484448|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
161484449|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484450|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484451|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
161484452|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484453|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484454|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484455|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484456|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484457|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484458|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484459|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484460|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484461|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484462|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484463|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484464|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484465|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484466|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484467|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484468|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484469|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161580966|NCT02590432|583516045|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
161580967|NCT02590432|583516046|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
161580968|NCT02590432|583516047|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
161580969|NCT02590432|583516048|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
161580970|NCT02590432|583516040|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580971|NCT02590432|583516041|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580972|NCT02590432|583516042|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580973|NCT02590432|583516043|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580974|NCT02590432|583516044|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580975|NCT02590432|583516045|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
161484470|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484471|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161580976|NCT02590432|583516046|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580977|NCT02590432|583516047|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580978|NCT02590432|583516048|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161580979|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161484472|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484473|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484474|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161484475|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484476|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484477|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
161484478|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484479|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484480|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484481|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484482|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484483|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484484|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484485|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484486|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484487|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484488|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484489|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484490|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484491|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484492|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484493|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484494|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484495|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484496|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484497|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484498|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484499|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484500|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
161484501|NCT03129100|583168978|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484502|NCT03129100|583168979|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484503|NCT03129100|583168980|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484504|NCT03129100|583168981|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484505|NCT03129100|583168982|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
161484506|NCT03129100|583168983|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
161484507|NCT03129100|583168984|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
161484508|NCT03129100|583168985|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484509|NCT03129100|583168986|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484510|NCT03129100|583168987|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161922147|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
161484511|NCT03129100|583168988|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484512|NCT03129100|583168989|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484513|NCT03129100|583168990|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484514|NCT03129100|583168991|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484515|NCT03129100|583168992|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484516|NCT03129100|583168993|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484517|NCT03129100|583168994|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484518|NCT03129100|583168995|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484519|NCT03129100|583168996|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484520|NCT03129100|583168997|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484521|NCT03129100|583168998|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484522|NCT03129100|583168999|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484523|NCT03129100|583169000|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484524|NCT03129100|583169001|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484525|NCT03129100|583169002|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484526|NCT03129100|583169003|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161484527|NCT03129100|583168978|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484528|NCT03129100|583168979|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161580980|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161580981|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161922148|NCT04633447|584762247|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
161922149|NCT04633447|584762248|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
161922150|NCT04633447|584762247|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
161484529|NCT03129100|583168980|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484530|NCT03129100|583168981|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484531|NCT03129100|583168982|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484532|NCT03129100|583168983|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484533|NCT03129100|583168984|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484534|NCT03129100|583168985|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484535|NCT03129100|583168986|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484536|NCT03129100|583168987|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
161484537|NCT03129100|583168988|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484538|NCT03129100|583168989|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484539|NCT03129100|583168990|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484540|NCT03129100|583168991|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484541|NCT03129100|583168992|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484542|NCT03129100|583168993|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484543|NCT03129100|583168994|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484544|NCT03129100|583168995|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484545|NCT03129100|583168996|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161922151|NCT04633447|584762248|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
161484546|NCT03129100|583168997|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484547|NCT03129100|583168998|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484548|NCT03129100|583168999|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484549|NCT03129100|583169000|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484550|NCT03129100|583169001|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484551|NCT03129100|583169002|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484552|NCT03129100|583169003|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
161484553|NCT03129100|583168978|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484554|NCT03129100|583168979|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484555|NCT03129100|583168980|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484556|NCT03129100|583168981|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484557|NCT03129100|583168982|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484558|NCT03129100|583168983|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484559|NCT03129100|583168984|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484560|NCT03129100|583168985|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484561|NCT03129100|583168986|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484562|NCT03129100|583168987|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484563|NCT03129100|583168988|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484564|NCT03129100|583168989|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
161484565|NCT03129100|583168990|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484566|NCT03129100|583168991|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484567|NCT03129100|583168992|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484568|NCT03129100|583168993|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484569|NCT03129100|583168994|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484570|NCT03129100|583168995|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484571|NCT03129100|583168996|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484572|NCT03129100|583168997|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484573|NCT03129100|583168998|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484574|NCT03129100|583168999|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484575|NCT03129100|583169000|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484576|NCT03129100|583169001|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484577|NCT03129100|583169002|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484578|NCT03129100|583169003|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
161484579|NCT03129100|583168978|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484580|NCT03129100|583168979|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484581|NCT03129100|583168980|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484582|NCT03129100|583168981|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484583|NCT03129100|583168982|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484584|NCT03129100|583168983|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484585|NCT03129100|583168984|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484586|NCT03129100|583168985|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484587|NCT03129100|583168986|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484588|NCT03129100|583168987|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484589|NCT03129100|583168988|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161922152|NCT04333498|584762249|FG000|Overall Study|Lost to Follow-up|1|||
161922153|NCT04333498|584762250|FG001|Overall Study|Lost to Follow-up|0|||
161670066|NCT04658186|583845326|FG002|Overall Study|PI Decision due to Participant Safety|1|||
161670067|NCT04658186|583845324|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
161670068|NCT04658186|583845325|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
161670069|NCT04658186|583845326|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
161670070|NCT04098068|583845327|FG000|Overall Study|Disease Progression|7|||
161670071|NCT04098068|583845327|FG000|Overall Study|Withdrawal by Subject|2|||
161670072|NCT04098068|583845327|FG000|Overall Study|New Cancer Diagnosis|1|||
161670073|NCT03871829|583845328|FG000|Overall Study|Lost to Follow-up|0|||
161670074|NCT03871829|583845329|FG001|Overall Study|Lost to Follow-up|1|||
161670075|NCT03871829|583845328|FG000|Overall Study|Withdrawal by Subject|1|||
161670076|NCT03871829|583845329|FG001|Overall Study|Withdrawal by Subject|1|||
161670077|NCT03871829|583845328|FG000|Overall Study|Death|12|||
161670078|NCT03871829|583845329|FG001|Overall Study|Death|8|||
161670079|NCT03871829|583845328|FG000|Overall Study|Study terminated by sponsor|31|||
161670080|NCT03871829|583845329|FG001|Overall Study|Study terminated by sponsor|34|||
161670081|NCT02993523|583845330|FG000|Overall Study|Withdrew Consent|0|||
161670082|NCT02993523|583845331|FG001|Overall Study|Withdrew Consent|0|||
161670083|NCT02993523|583845332|FG002|Overall Study|Withdrew Consent|2|||
161670084|NCT02993523|583845333|FG003|Overall Study|Withdrew Consent|9|||
161670085|NCT02993523|583845334|FG004|Overall Study|Withdrew Consent|0|||
161670086|NCT02993523|583845330|FG000|Overall Study|Lost to Follow-up|0|||
161670087|NCT02993523|583845331|FG001|Overall Study|Lost to Follow-up|0|||
161670088|NCT02993523|583845332|FG002|Overall Study|Lost to Follow-up|3|||
161670089|NCT02993523|583845333|FG003|Overall Study|Lost to Follow-up|6|||
161670090|NCT02993523|583845334|FG004|Overall Study|Lost to Follow-up|0|||
161670091|NCT02993523|583845330|FG000|Overall Study|Death|1|||
161670092|NCT02993523|583845331|FG001|Overall Study|Death|1|||
161670093|NCT02993523|583845332|FG002|Overall Study|Death|138|||
161670094|NCT02993523|583845333|FG003|Overall Study|Death|222|||
161670095|NCT02993523|583845334|FG004|Overall Study|Death|6|||
161670096|NCT02993523|583845330|FG000|Overall Study|Reason not Specified|0|||
161670097|NCT02993523|583845331|FG001|Overall Study|Reason not Specified|0|||
161670098|NCT02993523|583845332|FG002|Overall Study|Reason not Specified|1|||
161670099|NCT02993523|583845333|FG003|Overall Study|Reason not Specified|1|||
161670100|NCT02993523|583845334|FG004|Overall Study|Reason not Specified|0|||
161670101|NCT03694418|583845335|FG000|Overall Study|Lost to Follow-up|115|||
161670102|NCT03694418|583845336|FG001|Overall Study|Lost to Follow-up|23|||
161670103|NCT03694418|583845337|FG002|Overall Study|Lost to Follow-up|12|||
161670104|NCT03694418|583845338|FG003|Overall Study|Lost to Follow-up|12|||
161484590|NCT03129100|583168989|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
161484591|NCT03129100|583168990|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
161484592|NCT03129100|583168991|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
161484593|NCT03129100|583168992|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
161484594|NCT03129100|583168993|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161580982|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161580983|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161580984|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161670105|NCT03694418|583845339|FG004|Overall Study|Lost to Follow-up|13|||
161670106|NCT04288778|583845342|FG000|Overall Study|Withdrawal by Subject|2|||
161670107|NCT04288778|583845342|FG000|Overall Study|Adverse Event|5|||
161484595|NCT03129100|583168994|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484596|NCT03129100|583168995|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484597|NCT03129100|583168996|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161580985|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161580986|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
161580987|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
161580988|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161580989|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161670108|NCT04288778|583845342|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161670109|NCT04288778|583845342|FG000|Overall Study|Other|1|||
161580990|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161670110|NCT04288778|583845342|FG000|Overall Study|Started but not treated|2|||
161670111|NCT04442737|583845343|FG000|Overall Study|Lost to Follow-up|1|||
161670112|NCT04442737|583845344|FG001|Overall Study|Lost to Follow-up|3|||
161580991|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161580992|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161580993|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161580994|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161670113|NCT04442737|583845343|FG000|Overall Study|Withdrawal by Subject|3|||
161670114|NCT04442737|583845344|FG001|Overall Study|Withdrawal by Subject|2|||
161670115|NCT04442737|583845343|FG000|Overall Study|Adverse Event|3|||
161670116|NCT04442737|583845344|FG001|Overall Study|Adverse Event|2|||
161670117|NCT04442737|583845343|FG000|Overall Study|Death|0|||
161670118|NCT04442737|583845344|FG001|Overall Study|Death|1|||
161484598|NCT03129100|583168997|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484599|NCT03129100|583168998|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484600|NCT03129100|583168999|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484601|NCT03129100|583169000|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484602|NCT03129100|583169001|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484603|NCT03129100|583169002|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484604|NCT03129100|583169003|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
161484605|NCT03129100|583168978|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484606|NCT03129100|583168979|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484607|NCT03129100|583168980|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484608|NCT03129100|583168981|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484609|NCT03129100|583168982|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484610|NCT03129100|583168983|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484611|NCT03129100|583168984|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484612|NCT03129100|583168985|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484613|NCT03129100|583168986|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484614|NCT03129100|583168987|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484615|NCT03129100|583168988|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484616|NCT03129100|583168989|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
161484617|NCT03129100|583168990|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484618|NCT03129100|583168991|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
161484619|NCT03129100|583168992|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
161484620|NCT03129100|583168993|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484621|NCT03129100|583168994|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484622|NCT03129100|583168995|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484623|NCT03129100|583168996|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484624|NCT03129100|583168997|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484625|NCT03129100|583168998|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484626|NCT03129100|583168999|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484627|NCT03129100|583169000|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484628|NCT03129100|583169001|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484629|NCT03129100|583169002|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484630|NCT03129100|583169003|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
161484631|NCT03129100|583168978|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484632|NCT03129100|583168979|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484633|NCT03129100|583168980|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484634|NCT03129100|583168981|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484635|NCT03129100|583168982|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484636|NCT03129100|583168983|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484637|NCT03129100|583168984|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484638|NCT03129100|583168985|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484639|NCT03129100|583168986|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484640|NCT03129100|583168987|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484641|NCT03129100|583168988|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484642|NCT03129100|583168989|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484643|NCT03129100|583168990|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484644|NCT03129100|583168991|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484645|NCT03129100|583168992|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484646|NCT03129100|583168993|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
161484647|NCT03129100|583168994|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161922154|NCT04333498|584762249|FG000|Overall Study|Lost to Follow-up|0|||
161922155|NCT04333498|584762250|FG001|Overall Study|Lost to Follow-up|1|||
161484648|NCT03129100|583168995|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484649|NCT03129100|583168996|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484650|NCT03129100|583168997|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484651|NCT03129100|583168998|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484652|NCT03129100|583168999|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484653|NCT03129100|583169000|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484654|NCT03129100|583169001|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484655|NCT03129100|583169002|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484656|NCT03129100|583169003|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
161484657|NCT03129100|583168978|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484658|NCT03129100|583168979|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161922156|NCT01565694|584762251|FG000|Dose-Titration Period|Adverse Event|4|||
161922157|NCT01565694|584762251|FG000|Dose-Titration Period|Protocol Violation|10|||
161922158|NCT01565694|584762251|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
161922159|NCT05399771|584762253|FG000|Overall Study|Physician Decision|3|||
161922160|NCT05399771|584762253|FG000|Overall Study|Adverse Event|1|||
161922161|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
161922162|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
161922163|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
161922164|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
161922165|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
161922166|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
161922167|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161484659|NCT03129100|583168980|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484660|NCT03129100|583168981|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484661|NCT03129100|583168982|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484662|NCT03129100|583168983|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484663|NCT03129100|583168984|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484664|NCT03129100|583168985|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484665|NCT03129100|583168986|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484666|NCT03129100|583168987|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484667|NCT03129100|583168988|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484668|NCT03129100|583168989|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484669|NCT03129100|583168990|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
161484670|NCT03129100|583168991|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484671|NCT03129100|583168992|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
161484672|NCT03129100|583168993|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
161484673|NCT03129100|583168994|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484674|NCT03129100|583168995|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484675|NCT03129100|583168996|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484676|NCT03129100|583168997|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484677|NCT03129100|583168998|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484678|NCT03129100|583168999|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484679|NCT03129100|583169000|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484680|NCT03129100|583169001|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484681|NCT03129100|583169002|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484682|NCT03129100|583169003|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
161484683|NCT03129100|583168978|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484684|NCT03129100|583168979|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484685|NCT03129100|583168980|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484686|NCT03129100|583168981|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484687|NCT03129100|583168982|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484688|NCT03129100|583168983|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484689|NCT03129100|583168984|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484690|NCT03129100|583168985|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484691|NCT03129100|583168986|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484692|NCT03129100|583168987|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484693|NCT03129100|583168988|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484694|NCT03129100|583168989|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484695|NCT03129100|583168990|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484696|NCT03129100|583168991|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484697|NCT03129100|583168992|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484698|NCT03129100|583168993|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484699|NCT03129100|583168994|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484700|NCT03129100|583168995|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
161484701|NCT03129100|583168996|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484702|NCT03129100|583168997|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
161484703|NCT03129100|583168998|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484704|NCT03129100|583168999|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484705|NCT03129100|583169000|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484706|NCT03129100|583169001|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484707|NCT03129100|583169002|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484708|NCT03129100|583169003|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
161484709|NCT03129100|583168978|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484710|NCT03129100|583168979|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484711|NCT03129100|583168980|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484712|NCT03129100|583168981|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484713|NCT03129100|583168982|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484714|NCT03129100|583168983|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161922168|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161922169|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161484715|NCT03129100|583168984|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484716|NCT03129100|583168985|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484717|NCT03129100|583168986|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484718|NCT03129100|583168987|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484719|NCT03129100|583168988|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484720|NCT03129100|583168989|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484721|NCT03129100|583168990|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484722|NCT03129100|583168991|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484723|NCT03129100|583168992|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484724|NCT03129100|583168993|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484725|NCT03129100|583168994|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484726|NCT03129100|583168995|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484727|NCT03129100|583168996|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484728|NCT03129100|583168997|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484729|NCT03129100|583168998|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
161484730|NCT03129100|583168999|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484731|NCT03129100|583169000|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484732|NCT03129100|583169001|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484733|NCT03129100|583169002|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484734|NCT03129100|583169003|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
161484735|NCT03129100|583168978|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
161484736|NCT03129100|583168979|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
161484737|NCT03129100|583168980|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
161484738|NCT03129100|583168981|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
161484739|NCT03129100|583168982|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
161484740|NCT03129100|583168983|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
161580995|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
161580996|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161580997|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161580998|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161580999|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161484741|NCT03129100|583168984|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
161484742|NCT03129100|583168985|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
161484743|NCT03129100|583168986|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
161484744|NCT03129100|583168987|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
161484745|NCT03129100|583168988|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
161484746|NCT03129100|583168989|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
161484747|NCT03129100|583168990|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
161484748|NCT03129100|583168991|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
161484749|NCT03129100|583168992|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
161484750|NCT03129100|583168993|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
161484751|NCT03129100|583168994|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
161484752|NCT03129100|583168995|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
161484753|NCT03129100|583168996|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
161484754|NCT03129100|583168997|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
161484755|NCT03129100|583168998|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
161484756|NCT03129100|583168999|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
161484757|NCT03129100|583169000|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
161484758|NCT03129100|583169001|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
161484759|NCT03129100|583169002|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
161484760|NCT03129100|583169003|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
161484761|NCT03129100|583168978|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484762|NCT03129100|583168979|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484763|NCT03129100|583168980|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484764|NCT03129100|583168981|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484765|NCT03129100|583168982|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484766|NCT03129100|583168983|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484767|NCT03129100|583168984|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484768|NCT03129100|583168985|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484769|NCT03129100|583168986|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484770|NCT03129100|583168987|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484771|NCT03129100|583168988|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484772|NCT03129100|583168989|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484773|NCT03129100|583168990|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161581000|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161581001|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161581002|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161670119|NCT04442737|583845343|FG000|Overall Study|Protocol Violation|0|||
161484774|NCT03129100|583168991|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484775|NCT03129100|583168992|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484776|NCT03129100|583168993|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484777|NCT03129100|583168994|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484778|NCT03129100|583168995|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484779|NCT03129100|583168996|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484780|NCT03129100|583168997|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484781|NCT03129100|583168998|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
161484782|NCT03129100|583168999|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484783|NCT03129100|583169000|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484784|NCT03129100|583169001|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484785|NCT03129100|583169002|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484786|NCT03129100|583169003|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161484787|NCT03129100|583168978|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
161484788|NCT03129100|583168979|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
161484789|NCT03129100|583168980|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
161484790|NCT03129100|583168981|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
161484791|NCT03129100|583168982|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
161484792|NCT03129100|583168983|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
161484793|NCT03129100|583168984|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
161484794|NCT03129100|583168985|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
161484795|NCT03129100|583168986|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
161484796|NCT03129100|583168987|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
161484797|NCT03129100|583168988|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
161484798|NCT03129100|583168989|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
161484799|NCT03129100|583168990|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
161484800|NCT03129100|583168991|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
161484801|NCT03129100|583168992|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
161484802|NCT03129100|583168993|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
161484803|NCT03129100|583168994|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
161484804|NCT03129100|583168995|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
161484805|NCT03129100|583168996|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
161484806|NCT03129100|583168997|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
161484807|NCT03129100|583168998|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
161484808|NCT03129100|583168999|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
161484809|NCT03129100|583169000|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
161484810|NCT03129100|583169001|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
161484811|NCT03129100|583169002|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
161484812|NCT03129100|583169003|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
161484813|NCT03129100|583168978|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484814|NCT03129100|583168979|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484815|NCT03129100|583168980|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484816|NCT03129100|583168981|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484817|NCT03129100|583168982|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484818|NCT03129100|583168983|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484819|NCT03129100|583168984|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484820|NCT03129100|583168985|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484821|NCT03129100|583168986|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484822|NCT03129100|583168987|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484823|NCT03129100|583168988|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484824|NCT03129100|583168989|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484825|NCT03129100|583168990|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484826|NCT03129100|583168991|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484827|NCT03129100|583168992|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484828|NCT03129100|583168993|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484829|NCT03129100|583168994|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484830|NCT03129100|583168995|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484831|NCT03129100|583168996|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484832|NCT03129100|583168997|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161922170|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161922171|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161922172|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
161922173|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161922174|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161484833|NCT03129100|583168998|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484834|NCT03129100|583168999|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484835|NCT03129100|583169000|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484836|NCT03129100|583169001|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
161484837|NCT03129100|583169002|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
161484838|NCT03129100|583169003|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
161922175|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161484839|NCT03129100|583168978|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484840|NCT03129100|583168979|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484841|NCT03129100|583168980|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484842|NCT03129100|583168981|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484843|NCT03129100|583168982|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484844|NCT03129100|583168983|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484845|NCT03129100|583168984|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484846|NCT03129100|583168985|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484847|NCT03129100|583168986|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484848|NCT03129100|583168987|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484849|NCT03129100|583168988|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484850|NCT03129100|583168989|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484851|NCT03129100|583168990|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484852|NCT03129100|583168991|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484853|NCT03129100|583168992|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484854|NCT03129100|583168993|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484855|NCT03129100|583168994|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484856|NCT03129100|583168995|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484857|NCT03129100|583168996|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484858|NCT03129100|583168997|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484859|NCT03129100|583168998|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484860|NCT03129100|583168999|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484861|NCT03129100|583169000|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
161484862|NCT03129100|583169001|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
161484863|NCT03129100|583169002|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
161484864|NCT03129100|583169003|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
161484865|NCT03129100|583168978|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484866|NCT03129100|583168979|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484867|NCT03129100|583168980|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484868|NCT03129100|583168981|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484869|NCT03129100|583168982|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484870|NCT03129100|583168983|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484871|NCT03129100|583168984|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484872|NCT03129100|583168985|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484873|NCT03129100|583168986|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484874|NCT03129100|583168987|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484875|NCT03129100|583168988|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484876|NCT03129100|583168989|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484877|NCT03129100|583168990|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484878|NCT03129100|583168991|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484879|NCT03129100|583168992|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484880|NCT03129100|583168993|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484881|NCT03129100|583168994|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484882|NCT03129100|583168995|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484883|NCT03129100|583168996|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484884|NCT03129100|583168997|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484885|NCT03129100|583168998|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484886|NCT03129100|583168999|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484887|NCT03129100|583169000|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484888|NCT03129100|583169001|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484889|NCT03129100|583169002|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
161484890|NCT03129100|583169003|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
161484891|NCT03129100|583168978|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484892|NCT03129100|583168979|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484893|NCT03129100|583168980|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484894|NCT03129100|583168981|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484895|NCT03129100|583168982|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484896|NCT03129100|583168983|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484897|NCT03129100|583168984|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484898|NCT03129100|583168985|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484899|NCT03129100|583168986|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484900|NCT03129100|583168987|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484901|NCT03129100|583168988|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484902|NCT03129100|583168989|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161670120|NCT04442737|583845344|FG001|Overall Study|Protocol Violation|2|||
161484903|NCT03129100|583168990|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484904|NCT03129100|583168991|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484905|NCT03129100|583168992|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484906|NCT03129100|583168993|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484907|NCT03129100|583168994|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484908|NCT03129100|583168995|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484909|NCT03129100|583168996|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484910|NCT03129100|583168997|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484911|NCT03129100|583168998|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484912|NCT03129100|583168999|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484913|NCT03129100|583169000|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484914|NCT03129100|583169001|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484915|NCT03129100|583169002|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
161484916|NCT03129100|583169003|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
161484917|NCT03129100|583168978|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
161484918|NCT03129100|583168979|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
161484919|NCT03129100|583168980|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
161484920|NCT03129100|583168981|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
161484921|NCT03129100|583168982|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
161484922|NCT03129100|583168983|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
161922176|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161922177|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161922178|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
161922179|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
161922180|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
161922181|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
161922182|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
161922183|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
161922184|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
161922185|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
161922186|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
161922187|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
161922188|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
161922189|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
161922190|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
161922191|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
161484923|NCT03129100|583168984|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
161484924|NCT03129100|583168985|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
161484925|NCT03129100|583168986|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
161484926|NCT03129100|583168987|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
161484927|NCT03129100|583168988|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
161484928|NCT03129100|583168989|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
161484929|NCT03129100|583168990|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
161484930|NCT03129100|583168991|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
161484931|NCT03129100|583168992|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
161484932|NCT03129100|583168993|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
161484933|NCT03129100|583168994|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
161484934|NCT03129100|583168995|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
161581003|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161581004|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
161581005|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
161581006|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581007|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581008|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581009|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581010|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581011|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581012|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581013|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161581014|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
161581015|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581016|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581017|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581018|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581019|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161922192|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
161922193|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
161922194|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
161922195|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
161922196|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
161922197|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922198|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922199|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922200|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922201|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922202|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
161922203|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
161922204|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
161922205|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
161922206|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
161922207|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
161922208|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
161922209|NCT00541229|584762256|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
161922210|NCT00541229|584762257|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
161922211|NCT00541229|584762258|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
161922212|NCT00541229|584762259|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
161922213|NCT00541229|584762260|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
161922214|NCT00541229|584762261|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
161922215|NCT00541229|584762256|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
161922216|NCT00541229|584762257|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922217|NCT00541229|584762258|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922218|NCT00541229|584762259|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922219|NCT00541229|584762260|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922220|NCT00541229|584762261|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
161922221|NCT00541229|584762256|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
161922222|NCT00541229|584762257|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922223|NCT00541229|584762258|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
161581020|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581021|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581022|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161581023|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
161581024|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581025|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581026|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581027|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581028|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581029|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581030|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581031|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
161581032|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161581033|NCT02590432|583516040|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581034|NCT02590432|583516041|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581035|NCT02590432|583516042|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581036|NCT02590432|583516043|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581037|NCT02590432|583516044|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581038|NCT02590432|583516045|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581039|NCT02590432|583516046|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581040|NCT02590432|583516047|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
161581041|NCT02590432|583516048|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161581042|NCT00409838|583516049|FG000|Short-term Period|Adverse Event|0|||
161581043|NCT00409838|583516050|FG001|Short-term Period|Adverse Event|1|||
161581044|NCT00409838|583516049|FG000|Short-term Period|Lost to Follow-up|0|||
161581045|NCT00409838|583516050|FG001|Short-term Period|Lost to Follow-up|1|||
161581046|NCT00409838|583516049|FG000|Short-term Period|Withdrawal by Subject|2|||
161581047|NCT00409838|583516050|FG001|Short-term Period|Withdrawal by Subject|3|||
161581048|NCT00409838|583516049|FG000|Short-term Period|Never Treated|1|||
161581049|NCT00409838|583516050|FG001|Short-term Period|Never Treated|0|||
161581050|NCT00409838|583516049|FG000|Long-term Extension Period|Adverse Event|10|||
161581051|NCT00409838|583516050|FG001|Long-term Extension Period|Adverse Event|0|||
161922224|NCT00541229|584762259|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922225|NCT00541229|584762260|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922226|NCT00541229|584762261|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922227|NCT00541229|584762256|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922228|NCT00541229|584762257|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922229|NCT00541229|584762258|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922230|NCT00541229|584762259|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922231|NCT00541229|584762260|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
161922232|NCT00541229|584762261|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922233|NCT00541229|584762256|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
161922234|NCT00541229|584762257|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
161922235|NCT00541229|584762258|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
161922236|NCT00541229|584762259|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
161922237|NCT00541229|584762260|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
161922238|NCT00541229|584762261|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
161922239|NCT00541229|584762256|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
161922240|NCT00541229|584762257|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
161922241|NCT00541229|584762258|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
161922242|NCT00541229|584762259|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
161922243|NCT00541229|584762260|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
161922244|NCT00541229|584762261|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
161922245|NCT00541229|584762256|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922246|NCT00541229|584762257|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922247|NCT00541229|584762258|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922248|NCT00541229|584762259|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922249|NCT00541229|584762260|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922250|NCT00541229|584762261|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
161922251|NCT00541229|584762256|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922252|NCT00541229|584762257|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922253|NCT00541229|584762258|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
161922254|NCT00541229|584762259|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161484935|NCT03129100|583168996|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
161484936|NCT03129100|583168997|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
161484937|NCT03129100|583168998|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
161484938|NCT03129100|583168999|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
161484939|NCT03129100|583169000|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
161484940|NCT03129100|583169001|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
161484941|NCT03129100|583169002|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
161484942|NCT03129100|583169003|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
161484943|NCT03708328|583169006|FG000|Overall Study|Death|3|||
161484944|NCT03708328|583169007|FG001|Overall Study|Death|3|||
161484945|NCT03708328|583169008|FG002|Overall Study|Death|4|||
161484946|NCT03708328|583169009|FG003|Overall Study|Death|2|||
161816718|NCT04633564|584368834|FG001|Period 2|Lost to Follow-up|1|||
161484947|NCT03708328|583169010|FG004|Overall Study|Death|2|||
161484948|NCT03708328|583169011|FG005|Overall Study|Death|13|||
161484949|NCT03708328|583169012|FG006|Overall Study|Death|26|||
161484950|NCT03708328|583169013|FG007|Overall Study|Death|18|||
161484951|NCT03708328|583169014|FG008|Overall Study|Death|13|||
161816719|NCT04633564|584368833|FG000|Period 2|Physician Decision|2|||
161816720|NCT04633564|584368834|FG001|Period 2|Physician Decision|4|||
161816721|NCT04633564|584368833|FG000|Period 2|Withdrawal by Subject|5|||
161816722|NCT04633564|584368834|FG001|Period 2|Withdrawal by Subject|1|||
161816723|NCT04633564|584368833|FG000|Period 2|Progressive Disease|74|||
161816724|NCT04633564|584368834|FG001|Period 2|Progressive Disease|82|||
161816725|NCT04633564|584368833|FG000|Period 2|Terminated by Sponsor|9|||
161816726|NCT04633564|584368834|FG001|Period 2|Terminated by Sponsor|3|||
161816727|NCT04198363|584368835|FG000|Overall Study|Adverse Event|1|||
161816728|NCT04198363|584368836|FG001|Overall Study|Adverse Event|1|||
161816729|NCT04198363|584368835|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
161816730|NCT04198363|584368836|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
161816731|NCT04198363|584368835|FG000|Overall Study|Reason not Specified|1|||
161484952|NCT03708328|583169015|FG009|Overall Study|Death|8|||
161581052|NCT00409838|583516049|FG000|Long-term Extension Period|Death|1|||
161581053|NCT00409838|583516050|FG001|Long-term Extension Period|Death|0|||
161581054|NCT00409838|583516049|FG000|Long-term Extension Period|Lack of Efficacy|2|||
161581055|NCT00409838|583516050|FG001|Long-term Extension Period|Lack of Efficacy|0|||
161484953|NCT03708328|583169006|FG000|Overall Study|Lost to Follow-up|0|||
161484954|NCT03708328|583169007|FG001|Overall Study|Lost to Follow-up|1|||
161484955|NCT03708328|583169008|FG002|Overall Study|Lost to Follow-up|0|||
161484956|NCT03708328|583169009|FG003|Overall Study|Lost to Follow-up|1|||
161581056|NCT00409838|583516049|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
161816732|NCT04198363|584368836|FG001|Overall Study|Reason not Specified|0|||
161816733|NCT03500094|584368842|FG000|Overall Study|Withdrawal by Subject|1|||
161816734|NCT03500094|584368842|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
161922255|NCT00541229|584762260|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922256|NCT00541229|584762261|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922257|NCT01312129|584762262|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
161922258|NCT01312129|584762263|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
161922259|NCT02397837|584762266|FG000|Overall Study|Withdrawal by Subject|6|||
161922260|NCT02397837|584762267|FG001|Overall Study|Withdrawal by Subject|5|||
161922261|NCT02397837|584762266|FG000|Overall Study|Physician Decision|1|||
161922262|NCT02397837|584762267|FG001|Overall Study|Physician Decision|1|||
161922263|NCT01482221|584762275|FG000|Overall Study|Lack of Efficacy|1|||
161922264|NCT01482221|584762276|FG001|Overall Study|Lack of Efficacy|0|||
161922265|NCT01482221|584762277|FG002|Overall Study|Lack of Efficacy|1|||
161922266|NCT01482221|584762275|FG000|Overall Study|Lost to Follow-up|3|||
161922267|NCT01482221|584762276|FG001|Overall Study|Lost to Follow-up|2|||
161922268|NCT01482221|584762277|FG002|Overall Study|Lost to Follow-up|1|||
161922269|NCT01482221|584762275|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
161922270|NCT01482221|584762276|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
161922271|NCT01482221|584762277|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
161922272|NCT01482221|584762275|FG000|Overall Study|Condition under Investigation Worsened|3|||
161922273|NCT01482221|584762276|FG001|Overall Study|Condition under Investigation Worsened|2|||
161922274|NCT01482221|584762277|FG002|Overall Study|Condition under Investigation Worsened|4|||
161670121|NCT04442737|583845343|FG000|Overall Study|Other|1|||
161484957|NCT03708328|583169010|FG004|Overall Study|Lost to Follow-up|0|||
161484958|NCT03708328|583169011|FG005|Overall Study|Lost to Follow-up|3|||
161484959|NCT03708328|583169012|FG006|Overall Study|Lost to Follow-up|3|||
161484960|NCT03708328|583169013|FG007|Overall Study|Lost to Follow-up|0|||
161484961|NCT03708328|583169014|FG008|Overall Study|Lost to Follow-up|0|||
161484962|NCT03708328|583169015|FG009|Overall Study|Lost to Follow-up|1|||
161484963|NCT03708328|583169006|FG000|Overall Study|Physician Decision|0|||
161484964|NCT03708328|583169007|FG001|Overall Study|Physician Decision|0|||
161484965|NCT03708328|583169008|FG002|Overall Study|Physician Decision|0|||
161484966|NCT03708328|583169009|FG003|Overall Study|Physician Decision|0|||
161484967|NCT03708328|583169010|FG004|Overall Study|Physician Decision|0|||
161484968|NCT03708328|583169011|FG005|Overall Study|Physician Decision|1|||
161484969|NCT03708328|583169012|FG006|Overall Study|Physician Decision|0|||
161484970|NCT03708328|583169013|FG007|Overall Study|Physician Decision|0|||
161484971|NCT03708328|583169014|FG008|Overall Study|Physician Decision|0|||
161922275|NCT01482221|584762275|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
161922276|NCT01482221|584762276|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
161922277|NCT01482221|584762277|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161816735|NCT03500094|584368842|FG000|Overall Study|Lost to Follow-up|1|||
161581057|NCT00409838|583516050|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
161581058|NCT00409838|583516049|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
161581059|NCT00409838|583516050|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
161581060|NCT00409838|583516049|FG000|Long-term Extension Period|Pregnancy|1|||
161816736|NCT00640341|584370829|FG000|Overall Study|Adverse Event|0|||
161581061|NCT00409838|583516050|FG001|Long-term Extension Period|Pregnancy|0|||
161581062|NCT04788641|583516052|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161581063|NCT04788641|583516053|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161581064|NCT04788641|583516054|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
161581065|NCT04788641|583516055|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161581066|NCT04788641|583516052|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
161581067|NCT04788641|583516053|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161816737|NCT00640341|584370830|FG001|Overall Study|Adverse Event|0|||
161816738|NCT00640341|584370831|FG002|Overall Study|Adverse Event|1|||
161816739|NCT00640341|584370829|FG000|Overall Study|Positive Slit Lamp Findings|0|||
161816740|NCT00640341|584370830|FG001|Overall Study|Positive Slit Lamp Findings|0|||
161816741|NCT00640341|584370831|FG002|Overall Study|Positive Slit Lamp Findings|1|||
161816742|NCT00640341|584370829|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
161816743|NCT00640341|584370830|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
161816744|NCT00640341|584370831|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
161816745|NCT00640341|584370829|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
161816746|NCT00640341|584370830|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
161816747|NCT00640341|584370831|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
161816748|NCT00640341|584370829|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
161816749|NCT00640341|584370830|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
161816750|NCT00640341|584370831|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
161816751|NCT00640341|584370829|FG000|Overall Study|Lost to Follow-up|2|||
161816752|NCT00640341|584370830|FG001|Overall Study|Lost to Follow-up|0|||
161816753|NCT00640341|584370831|FG002|Overall Study|Lost to Follow-up|0|||
161816754|NCT00640341|584370829|FG000|Overall Study|Withdrawal by Subject|4|||
161816755|NCT00640341|584370830|FG001|Overall Study|Withdrawal by Subject|0|||
161816756|NCT00640341|584370831|FG002|Overall Study|Withdrawal by Subject|1|||
161816757|NCT00640341|584370829|FG000|Overall Study|Unacceptable Lens Movement|1|||
161816758|NCT00640341|584370830|FG001|Overall Study|Unacceptable Lens Movement|0|||
161816759|NCT00640341|584370831|FG002|Overall Study|Unacceptable Lens Movement|0|||
161816760|NCT00640341|584370829|FG000|Overall Study|Poor fit/Uncomfortable|4|||
161816761|NCT00640341|584370830|FG001|Overall Study|Poor fit/Uncomfortable|0|||
161816762|NCT00640341|584370831|FG002|Overall Study|Poor fit/Uncomfortable|0|||
161816763|NCT00640341|584370829|FG000|Overall Study|Ineligable at Baseline|5|||
161816764|NCT00640341|584370830|FG001|Overall Study|Ineligable at Baseline|3|||
161816765|NCT00640341|584370831|FG002|Overall Study|Ineligable at Baseline|2|||
161816766|NCT00640341|584370829|FG000|Overall Study|Adverse event and positive slit lamp|1|||
161816767|NCT00640341|584370830|FG001|Overall Study|Adverse event and positive slit lamp|0|||
161816768|NCT00640341|584370831|FG002|Overall Study|Adverse event and positive slit lamp|0|||
161816769|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
161816770|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
161816771|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
161816772|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
161816773|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
161816774|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
161816775|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
161816776|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
161816777|NCT01541215|584370834|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
161816778|NCT01541215|584370835|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
161816779|NCT01541215|584370834|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
161816780|NCT01541215|584370835|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
161816781|NCT02316223|584370839|FG000|Overall Study|Lack of Efficacy|0|||
161816782|NCT02316223|584370840|FG001|Overall Study|Lack of Efficacy|1|||
161816783|NCT02316223|584370841|FG002|Overall Study|Lack of Efficacy|1|||
161816784|NCT02316223|584370839|FG000|Overall Study|Lost to Follow-up|27|||
161816785|NCT02316223|584370840|FG001|Overall Study|Lost to Follow-up|34|||
161816786|NCT02316223|584370841|FG002|Overall Study|Lost to Follow-up|36|||
161922278|NCT01482221|584762275|FG000|Overall Study|Adverse Event|1|||
161816787|NCT02316223|584370839|FG000|Overall Study|COPD Diagnosis|3|||
161816788|NCT02316223|584370840|FG001|Overall Study|COPD Diagnosis|2|||
161816789|NCT02316223|584370841|FG002|Overall Study|COPD Diagnosis|3|||
161816790|NCT02316223|584370839|FG000|Overall Study|Reside outside study area|1|||
161816791|NCT02316223|584370840|FG001|Overall Study|Reside outside study area|1|||
161816792|NCT02316223|584370841|FG002|Overall Study|Reside outside study area|1|||
161816793|NCT02316223|584370839|FG000|Overall Study|No asthma|2|||
161816794|NCT02316223|584370840|FG001|Overall Study|No asthma|0|||
161816795|NCT02316223|584370841|FG002|Overall Study|No asthma|0|||
161922279|NCT01482221|584762276|FG001|Overall Study|Adverse Event|7|||
161922280|NCT01482221|584762277|FG002|Overall Study|Adverse Event|3|||
161922281|NCT01482221|584762275|FG000|Overall Study|Withdrawal by Subject|10|||
161922282|NCT01482221|584762276|FG001|Overall Study|Withdrawal by Subject|7|||
161922283|NCT01482221|584762277|FG002|Overall Study|Withdrawal by Subject|12|||
161922284|NCT01482221|584762275|FG000|Overall Study|Incorrect randomization|0|||
161922285|NCT01482221|584762276|FG001|Overall Study|Incorrect randomization|1|||
161922286|NCT01482221|584762277|FG002|Overall Study|Incorrect randomization|0|||
161922287|NCT01482221|584762275|FG000|Overall Study|Physician Decision|0|||
161922288|NCT01482221|584762276|FG001|Overall Study|Physician Decision|1|||
161484972|NCT03708328|583169015|FG009|Overall Study|Physician Decision|0|||
161484973|NCT03708328|583169006|FG000|Overall Study|Withdrawal by Subject|0|||
161484974|NCT03708328|583169007|FG001|Overall Study|Withdrawal by Subject|0|||
161484975|NCT03708328|583169008|FG002|Overall Study|Withdrawal by Subject|0|||
161581068|NCT04788641|583516054|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161581069|NCT04788641|583516055|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161581070|NCT04788641|583516052|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
161581071|NCT04788641|583516053|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
161581072|NCT04788641|583516054|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
161581073|NCT04788641|583516055|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
161581074|NCT01250769|583516056|FG000|Overall Study|Withdrawal by Subject|0|||
161581075|NCT01250769|583516057|FG001|Overall Study|Withdrawal by Subject|1|||
161581076|NCT01250769|583516058|FG002|Overall Study|Withdrawal by Subject|1|||
161581077|NCT01250769|583516059|FG003|Overall Study|Withdrawal by Subject|0|||
161581078|NCT01250769|583516056|FG000|Overall Study|Adverse Event|0|||
161581079|NCT01250769|583516057|FG001|Overall Study|Adverse Event|0|||
161581080|NCT01250769|583516058|FG002|Overall Study|Adverse Event|1|||
161581081|NCT01250769|583516059|FG003|Overall Study|Adverse Event|0|||
161581082|NCT01985334|583516060|FG000|Overall Study|Administrative problems|1|||
161581083|NCT01985334|583516061|FG001|Overall Study|Administrative problems|1|||
161581084|NCT01985334|583516062|FG002|Overall Study|Administrative problems|0|||
161581085|NCT01985334|583516063|FG003|Overall Study|Administrative problems|2|||
161581086|NCT01985334|583516064|FG004|Overall Study|Administrative problems|0|||
161581087|NCT01985334|583516065|FG005|Overall Study|Administrative problems|1|||
161581088|NCT01985334|583516066|FG006|Overall Study|Administrative problems|1|||
161581089|NCT01985334|583516067|FG007|Overall Study|Administrative problems|3|||
161581090|NCT01985334|583516060|FG000|Overall Study|Death|1|||
161581091|NCT01985334|583516061|FG001|Overall Study|Death|0|||
161581092|NCT01985334|583516062|FG002|Overall Study|Death|0|||
161581093|NCT01985334|583516063|FG003|Overall Study|Death|3|||
161581094|NCT01985334|583516064|FG004|Overall Study|Death|0|||
161581095|NCT01985334|583516065|FG005|Overall Study|Death|0|||
161484976|NCT03708328|583169009|FG003|Overall Study|Withdrawal by Subject|0|||
161484977|NCT03708328|583169010|FG004|Overall Study|Withdrawal by Subject|1|||
161484978|NCT03708328|583169011|FG005|Overall Study|Withdrawal by Subject|0|||
161484979|NCT03708328|583169012|FG006|Overall Study|Withdrawal by Subject|2|||
161484980|NCT03708328|583169013|FG007|Overall Study|Withdrawal by Subject|4|||
161484981|NCT03708328|583169014|FG008|Overall Study|Withdrawal by Subject|1|||
161484982|NCT03708328|583169015|FG009|Overall Study|Withdrawal by Subject|5|||
161484983|NCT03708328|583169006|FG000|Overall Study|Study Closed Locally|0|||
161484984|NCT03708328|583169007|FG001|Overall Study|Study Closed Locally|0|||
161484985|NCT03708328|583169008|FG002|Overall Study|Study Closed Locally|0|||
161484986|NCT03708328|583169009|FG003|Overall Study|Study Closed Locally|0|||
161484987|NCT03708328|583169010|FG004|Overall Study|Study Closed Locally|0|||
161484988|NCT03708328|583169011|FG005|Overall Study|Study Closed Locally|0|||
161484989|NCT03708328|583169012|FG006|Overall Study|Study Closed Locally|0|||
161484990|NCT03708328|583169013|FG007|Overall Study|Study Closed Locally|1|||
161484991|NCT03708328|583169014|FG008|Overall Study|Study Closed Locally|0|||
161484992|NCT03708328|583169015|FG009|Overall Study|Study Closed Locally|0|||
161484993|NCT03708328|583169006|FG000|Overall Study|Study Ended By Sponsor|0|||
161484994|NCT03708328|583169007|FG001|Overall Study|Study Ended By Sponsor|0|||
161484995|NCT03708328|583169008|FG002|Overall Study|Study Ended By Sponsor|0|||
161581096|NCT01985334|583516066|FG006|Overall Study|Death|1|||
161484996|NCT03708328|583169009|FG003|Overall Study|Study Ended By Sponsor|0|||
161484997|NCT03708328|583169010|FG004|Overall Study|Study Ended By Sponsor|0|||
161484998|NCT03708328|583169011|FG005|Overall Study|Study Ended By Sponsor|1|||
161484999|NCT03708328|583169012|FG006|Overall Study|Study Ended By Sponsor|0|||
161581097|NCT01985334|583516067|FG007|Overall Study|Death|2|||
161581098|NCT01985334|583516060|FG000|Overall Study|Worsening of disease|0|||
161581099|NCT01985334|583516061|FG001|Overall Study|Worsening of disease|0|||
161581100|NCT01985334|583516062|FG002|Overall Study|Worsening of disease|0|||
161581101|NCT01985334|583516063|FG003|Overall Study|Worsening of disease|1|||
161581102|NCT01985334|583516064|FG004|Overall Study|Worsening of disease|0|||
161581103|NCT01985334|583516065|FG005|Overall Study|Worsening of disease|3|||
161922289|NCT01482221|584762277|FG002|Overall Study|Physician Decision|0|||
161922290|NCT00263562|584762278|FG000|Overall Study|Protocol Violation|3|||
161922291|NCT00263562|584762279|FG001|Overall Study|Protocol Violation|0|||
161922292|NCT04602000|584762280|FG000|Overall Study|Withdrawal by Subject|3|||
161922293|NCT04602000|584762281|FG001|Overall Study|Withdrawal by Subject|6|||
161922294|NCT04602000|584762282|FG002|Overall Study|Withdrawal by Subject|3|||
161922295|NCT04602000|584762283|FG003|Overall Study|Withdrawal by Subject|27|||
161922296|NCT04602000|584762284|FG004|Overall Study|Withdrawal by Subject|39|||
161922297|NCT04602000|584762280|FG000|Overall Study|Physician Decision|1|||
161922298|NCT04602000|584762281|FG001|Overall Study|Physician Decision|0|||
161922299|NCT04602000|584762282|FG002|Overall Study|Physician Decision|0|||
161922300|NCT04602000|584762283|FG003|Overall Study|Physician Decision|2|||
161922301|NCT04602000|584762284|FG004|Overall Study|Physician Decision|2|||
161922302|NCT04602000|584762280|FG000|Overall Study|Death|0|||
161922303|NCT04602000|584762281|FG001|Overall Study|Death|1|||
161922304|NCT04602000|584762282|FG002|Overall Study|Death|0|||
161922305|NCT04602000|584762283|FG003|Overall Study|Death|1|||
161922306|NCT04602000|584762284|FG004|Overall Study|Death|2|||
161922307|NCT04602000|584762280|FG000|Overall Study|Lost to Follow-up|0|||
161922308|NCT04602000|584762281|FG001|Overall Study|Lost to Follow-up|0|||
161922309|NCT04602000|584762282|FG002|Overall Study|Lost to Follow-up|0|||
161922310|NCT04602000|584762283|FG003|Overall Study|Lost to Follow-up|3|||
161922311|NCT04602000|584762284|FG004|Overall Study|Lost to Follow-up|4|||
161922312|NCT04602000|584762280|FG000|Overall Study|Other|4|||
161922313|NCT04602000|584762281|FG001|Overall Study|Other|1|||
161922314|NCT04602000|584762282|FG002|Overall Study|Other|2|||
161922315|NCT04602000|584762283|FG003|Overall Study|Other|5|||
161922316|NCT04602000|584762284|FG004|Overall Study|Other|4|||
161922317|NCT04602000|584762280|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922318|NCT04602000|584762281|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922319|NCT04602000|584762282|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
161922320|NCT04602000|584762283|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922321|NCT04602000|584762284|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922322|NCT05607043|584762285|FG000|Overall Study|Lost to Follow-up|2|||
161922323|NCT00081458|584762289|FG000|Overall Study|Adverse Event|1|||
161922324|NCT00081458|584762290|FG001|Overall Study|Adverse Event|5|||
161922325|NCT00081458|584762291|FG002|Overall Study|Adverse Event|2|||
161922326|NCT00081458|584762289|FG000|Overall Study|Withdrawal by Subject|0|||
161922327|NCT00081458|584762290|FG001|Overall Study|Withdrawal by Subject|3|||
161922328|NCT00081458|584762291|FG002|Overall Study|Withdrawal by Subject|1|||
161922329|NCT00081458|584762289|FG000|Overall Study|Randomized but not dosed|0|||
161922330|NCT00081458|584762290|FG001|Overall Study|Randomized but not dosed|0|||
161922331|NCT00081458|584762291|FG002|Overall Study|Randomized but not dosed|1|||
161922332|NCT00195429|584762292|FG000|Overall Study|Adverse Event|2|||
161922333|NCT00195429|584762293|FG001|Overall Study|Adverse Event|4|||
161922334|NCT00195429|584762292|FG000|Overall Study|Lack of Efficacy|2|||
161922335|NCT00195429|584762293|FG001|Overall Study|Lack of Efficacy|1|||
161922336|NCT00195429|584762292|FG000|Overall Study|Lost to Follow-up|1|||
161485000|NCT03708328|583169013|FG007|Overall Study|Study Ended By Sponsor|1|||
161485001|NCT03708328|583169014|FG008|Overall Study|Study Ended By Sponsor|0|||
161485002|NCT03708328|583169015|FG009|Overall Study|Study Ended By Sponsor|0|||
161485003|NCT03708328|583169006|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485004|NCT03708328|583169007|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485005|NCT03708328|583169008|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485006|NCT03708328|583169009|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485007|NCT03708328|583169010|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485008|NCT03708328|583169011|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485009|NCT03708328|583169012|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485010|NCT03708328|583169013|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485011|NCT03708328|583169014|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
161485012|NCT03708328|583169015|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
161485013|NCT00571948|583169016|FG000|Overall Study|Lost to Follow-up|2|||
161485014|NCT00571948|583169017|FG001|Overall Study|Lost to Follow-up|0|||
161485015|NCT00571948|583169016|FG000|Overall Study|Withdrawal by Subject|1|||
161485016|NCT00571948|583169017|FG001|Overall Study|Withdrawal by Subject|2|||
161485017|NCT00571948|583169016|FG000|Overall Study|Protocol Violation|3|||
161485018|NCT00571948|583169017|FG001|Overall Study|Protocol Violation|3|||
161485019|NCT00571948|583169016|FG000|Overall Study|infant refused study meal|3|||
161485020|NCT00571948|583169017|FG001|Overall Study|infant refused study meal|4|||
161485021|NCT00571948|583169016|FG000|Overall Study|Parent were afraid of blood colection|2|||
161670122|NCT04442737|583845344|FG001|Overall Study|Other|1|||
161922337|NCT00195429|584762293|FG001|Overall Study|Lost to Follow-up|0|||
161922338|NCT00367458|584762294|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
161922339|NCT00367458|584762295|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
161922340|NCT01334515|584762298|FG000|Overall Study|Adverse Event|1|||
161922341|NCT01334515|584762299|FG001|Overall Study|Adverse Event|6|||
161922342|NCT01334515|584762298|FG000|Overall Study|Death|1|||
161922343|NCT01334515|584762299|FG001|Overall Study|Death|0|||
161485022|NCT00571948|583169017|FG001|Overall Study|Parent were afraid of blood colection|5|||
161485023|NCT01845831|583169018|FG000|Inpatient Phase|Withdrawal by Subject|1|||
161670123|NCT01139021|583845345|FG000|Overall Study|Adverse Event|0|||
161670124|NCT01139021|583845346|FG001|Overall Study|Adverse Event|0|||
161670125|NCT01139021|583845347|FG002|Overall Study|Adverse Event|0|||
161670126|NCT01139021|583845348|FG003|Overall Study|Adverse Event|0|||
161670127|NCT01139021|583845349|FG004|Overall Study|Adverse Event|1|||
161670128|NCT01139021|583845350|FG005|Overall Study|Adverse Event|0|||
161670129|NCT01139021|583845345|FG000|Overall Study|Lost to Follow-up|0|||
161670130|NCT01139021|583845346|FG001|Overall Study|Lost to Follow-up|0|||
161670131|NCT01139021|583845347|FG002|Overall Study|Lost to Follow-up|0|||
161670132|NCT01139021|583845348|FG003|Overall Study|Lost to Follow-up|0|||
161670133|NCT01139021|583845349|FG004|Overall Study|Lost to Follow-up|2|||
161485024|NCT01845831|583169019|FG001|Inpatient Phase|Withdrawal by Subject|1|||
161485025|NCT01845831|583169020|FG002|Inpatient Phase|Withdrawal by Subject|0|||
161485026|NCT01845831|583169021|FG003|Inpatient Phase|Withdrawal by Subject|0|||
161670134|NCT01139021|583845350|FG005|Overall Study|Lost to Follow-up|0|||
161670135|NCT01139021|583845345|FG000|Overall Study|Protocol Violation|1|||
161922344|NCT01334515|584762298|FG000|Overall Study|Lack of Efficacy|8|||
161922345|NCT01334515|584762299|FG001|Overall Study|Lack of Efficacy|21|||
161922346|NCT01334515|584762298|FG000|Overall Study|Physician Decision|1|||
161922347|NCT01334515|584762299|FG001|Overall Study|Physician Decision|1|||
161922348|NCT01334515|584762298|FG000|Overall Study|Withdrawal by Subject|1|||
161922349|NCT01334515|584762299|FG001|Overall Study|Withdrawal by Subject|1|||
161922350|NCT05774977|584762304|FG000|Overall Study|Withdrawal by Subject|2|||
161922351|NCT00374868|584762306|FG000|Overall Study|Adverse Event|12|||
161922352|NCT00374868|584762306|FG000|Overall Study|Progressive Disease|7|||
161922353|NCT00374868|584762306|FG000|Overall Study|Physician Decision|13|||
161922354|NCT00374868|584762306|FG000|Overall Study|Lost to Follow-up|1|||
161922355|NCT00374868|584762306|FG000|Overall Study|Death|2|||
161922356|NCT00374868|584762306|FG000|Overall Study|Other - Not Specified|1|||
161922357|NCT04470427|584762307|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
161922358|NCT04470427|584762308|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
161922359|NCT04470427|584762309|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
161922360|NCT04470427|584762310|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
161922361|NCT04470427|584762311|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
161922362|NCT04470427|584762312|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
161922363|NCT04470427|584762307|FG000|Part B :Open-label|Other than specified|0|||
161922364|NCT04470427|584762308|FG001|Part B :Open-label|Other than specified|0|||
161922365|NCT04470427|584762309|FG002|Part B :Open-label|Other than specified|788|||
161922366|NCT04470427|584762310|FG003|Part B :Open-label|Other than specified|0|||
161922367|NCT04470427|584762311|FG004|Part B :Open-label|Other than specified|523|||
161922368|NCT04470427|584762312|FG005|Part B :Open-label|Other than specified|0|||
161922369|NCT04470427|584762307|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
161922370|NCT04470427|584762308|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
161922371|NCT04470427|584762309|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
161922372|NCT04470427|584762310|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
161922373|NCT04470427|584762311|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
161922374|NCT04470427|584762312|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
161922375|NCT04470427|584762307|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
161922376|NCT04470427|584762308|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
161922377|NCT04470427|584762309|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
161922378|NCT04470427|584762310|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
161922379|NCT04470427|584762311|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
161922380|NCT04470427|584762312|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
161922381|NCT03188185|584762313|FG000|Stage 1|Adverse Event|4|||
161922382|NCT03188185|584762314|FG001|Stage 1|Adverse Event|12|||
161922383|NCT03188185|584762315|FG002|Stage 1|Adverse Event|0|||
161922384|NCT03188185|584762316|FG003|Stage 1|Adverse Event|0|||
161922385|NCT03188185|584762313|FG000|Stage 1|Lack of Efficacy|0|||
161922386|NCT03188185|584762314|FG001|Stage 1|Lack of Efficacy|2|||
161922387|NCT03188185|584762315|FG002|Stage 1|Lack of Efficacy|0|||
161922388|NCT03188185|584762316|FG003|Stage 1|Lack of Efficacy|0|||
161922389|NCT03188185|584762313|FG000|Stage 1|Lost to Follow-up|6|||
161922390|NCT03188185|584762314|FG001|Stage 1|Lost to Follow-up|1|||
161922391|NCT03188185|584762315|FG002|Stage 1|Lost to Follow-up|0|||
161922392|NCT03188185|584762316|FG003|Stage 1|Lost to Follow-up|0|||
161670136|NCT01139021|583845346|FG001|Overall Study|Protocol Violation|0|||
161670137|NCT01139021|583845347|FG002|Overall Study|Protocol Violation|0|||
161922393|NCT03188185|584762313|FG000|Stage 1|Withdrawal by Subject|9|||
161922394|NCT03188185|584762314|FG001|Stage 1|Withdrawal by Subject|0|||
161922395|NCT03188185|584762315|FG002|Stage 1|Withdrawal by Subject|0|||
161922396|NCT03188185|584762316|FG003|Stage 1|Withdrawal by Subject|0|||
161922397|NCT03188185|584762313|FG000|Stage 1|Identified as a professional patient|0|||
161922398|NCT03188185|584762314|FG001|Stage 1|Identified as a professional patient|1|||
161922399|NCT03188185|584762315|FG002|Stage 1|Identified as a professional patient|0|||
161922400|NCT03188185|584762316|FG003|Stage 1|Identified as a professional patient|0|||
161922401|NCT03188185|584762313|FG000|Stage 2|Adverse Event|0|||
161922402|NCT03188185|584762314|FG001|Stage 2|Adverse Event|0|||
161922403|NCT03188185|584762315|FG002|Stage 2|Adverse Event|2|||
161922404|NCT03188185|584762316|FG003|Stage 2|Adverse Event|4|||
161922405|NCT03188185|584762313|FG000|Stage 2|Lack of Efficacy|0|||
161922406|NCT03188185|584762314|FG001|Stage 2|Lack of Efficacy|0|||
161922407|NCT03188185|584762315|FG002|Stage 2|Lack of Efficacy|3|||
161922408|NCT03188185|584762316|FG003|Stage 2|Lack of Efficacy|0|||
161922409|NCT03188185|584762313|FG000|Stage 2|Lost to Follow-up|0|||
161922410|NCT03188185|584762314|FG001|Stage 2|Lost to Follow-up|0|||
161922411|NCT03188185|584762315|FG002|Stage 2|Lost to Follow-up|1|||
161922412|NCT03188185|584762316|FG003|Stage 2|Lost to Follow-up|0|||
161922413|NCT03188185|584762313|FG000|Stage 2|Physician Decision|0|||
161922414|NCT03188185|584762314|FG001|Stage 2|Physician Decision|0|||
161922415|NCT03188185|584762315|FG002|Stage 2|Physician Decision|0|||
161922416|NCT03188185|584762316|FG003|Stage 2|Physician Decision|1|||
161922417|NCT03188185|584762313|FG000|Stage 2|Withdrawal by Subject|0|||
161922418|NCT03188185|584762314|FG001|Stage 2|Withdrawal by Subject|0|||
161922419|NCT03188185|584762315|FG002|Stage 2|Withdrawal by Subject|3|||
161922420|NCT03188185|584762316|FG003|Stage 2|Withdrawal by Subject|1|||
161922421|NCT02324153|584762319|FG000|Overall Study|Withdrawal by Subject|4|||
161922422|NCT02324153|584762320|FG001|Overall Study|Withdrawal by Subject|1|||
161922423|NCT02324153|584762319|FG000|Overall Study|Surgery postponed after randomization|3|||
161922424|NCT02324153|584762320|FG001|Overall Study|Surgery postponed after randomization|0|||
161922425|NCT02324153|584762319|FG000|Overall Study|Developed delirium preoperatively|1|||
161922426|NCT02324153|584762320|FG001|Overall Study|Developed delirium preoperatively|0|||
161485027|NCT01845831|583169022|FG004|Inpatient Phase|Withdrawal by Subject|0|||
161485028|NCT02010775|583169024|FG000|Overall Study|Adverse Event|0|||
161485029|NCT02010775|583169025|FG001|Overall Study|Adverse Event|0|||
161485030|NCT02010775|583169026|FG002|Overall Study|Adverse Event|0|||
161485031|NCT02010775|583169027|FG003|Overall Study|Adverse Event|0|||
161922427|NCT01937299|584762321|FG000|Overall Study|Adverse Event|13|||
161922428|NCT01937299|584762322|FG001|Overall Study|Adverse Event|0|||
161922429|NCT01937299|584762321|FG000|Overall Study|Lack of Efficacy|0|||
161922430|NCT01937299|584762322|FG001|Overall Study|Lack of Efficacy|4|||
161922431|NCT01937299|584762321|FG000|Overall Study|Withdrawal by Subject|1|||
161922432|NCT01937299|584762322|FG001|Overall Study|Withdrawal by Subject|0|||
161922433|NCT01913353|584762323|FG000|Overall Study|Adverse Event|2|||
161922434|NCT01913353|584762324|FG001|Overall Study|Adverse Event|0|||
161922435|NCT01913353|584762323|FG000|Overall Study|Physician Decision|0|||
161922436|NCT01913353|584762324|FG001|Overall Study|Physician Decision|2|||
161922437|NCT01913353|584762323|FG000|Overall Study|Withdrawal by Subject|20|||
161922438|NCT01913353|584762324|FG001|Overall Study|Withdrawal by Subject|6|||
161922439|NCT01913353|584762323|FG000|Overall Study|multiple reasons|10|||
161922440|NCT01913353|584762324|FG001|Overall Study|multiple reasons|7|||
161922441|NCT00385840|584762325|FG000|Overall Study|Adverse Event|1|||
161922442|NCT00385840|584762326|FG001|Overall Study|Adverse Event|1|||
161922443|NCT00385840|584762325|FG000|Overall Study|Lost to Follow-up|3|||
161922444|NCT00385840|584762326|FG001|Overall Study|Lost to Follow-up|13|||
161922445|NCT04017962|584762327|FG000|Overall Study|Death|2|||
161922446|NCT04017962|584762328|FG001|Overall Study|Death|0|||
161922447|NCT04017962|584762327|FG000|Overall Study|Lost to Follow-up|2|||
161922448|NCT04017962|584762328|FG001|Overall Study|Lost to Follow-up|0|||
161922449|NCT04017962|584762327|FG000|Overall Study|Physician Decision|1|||
161922450|NCT04017962|584762328|FG001|Overall Study|Physician Decision|0|||
161922451|NCT04017962|584762327|FG000|Overall Study|Discontinued LTV|5|||
161922452|NCT04017962|584762328|FG001|Overall Study|Discontinued LTV|0|||
161922453|NCT00700635|584762329|FG000|Overall Study|Adverse Event|1|||
161922454|NCT00700635|584762330|FG001|Overall Study|Adverse Event|0|||
161922455|NCT00700635|584762331|FG002|Overall Study|Adverse Event|0|||
161922456|NCT00700635|584762329|FG000|Overall Study|Lost to Follow-up|1|||
161922457|NCT00700635|584762330|FG001|Overall Study|Lost to Follow-up|3|||
161922458|NCT00700635|584762331|FG002|Overall Study|Lost to Follow-up|0|||
161922459|NCT00700635|584762329|FG000|Overall Study|Protocol Violation|2|||
161922460|NCT00700635|584762330|FG001|Overall Study|Protocol Violation|2|||
161922461|NCT00700635|584762331|FG002|Overall Study|Protocol Violation|0|||
161922462|NCT00700635|584762329|FG000|Overall Study|Withdrawal by Subject|7|||
161922463|NCT00700635|584762330|FG001|Overall Study|Withdrawal by Subject|3|||
161922464|NCT00700635|584762331|FG002|Overall Study|Withdrawal by Subject|1|||
161922465|NCT05172570|584762332|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
161922466|NCT05172570|584762333|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
161922467|NCT05172570|584762334|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
161922468|NCT05172570|584762332|FG000|Overall Study|PI Decision due to equipment shortages|0|||
161922469|NCT05172570|584762333|FG001|Overall Study|PI Decision due to equipment shortages|0|||
161922470|NCT05172570|584762334|FG002|Overall Study|PI Decision due to equipment shortages|1|||
161922471|NCT01260948|584762335|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
161922472|NCT01260948|584762336|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
161922473|NCT01260948|584762335|FG000|Second Intervention|Emesis|0|||
161922474|NCT01260948|584762336|FG001|Second Intervention|Emesis|1|||
161922475|NCT00768053|584762337|FG000|Overall Study|Adverse Event|10|||
161922476|NCT00768053|584762337|FG000|Overall Study|Lost to Follow-up|1|||
161922477|NCT01202591|584762338|FG000|Overall Study|Adverse Event|2|||
161922478|NCT01202591|584762339|FG001|Overall Study|Adverse Event|1|||
161922479|NCT01202591|584762340|FG002|Overall Study|Adverse Event|4|||
161922480|NCT01202591|584762341|FG003|Overall Study|Adverse Event|4|||
161922481|NCT01202591|584762342|FG004|Overall Study|Adverse Event|0|||
161922482|NCT01202591|584762343|FG005|Overall Study|Adverse Event|0|||
161922483|NCT01202591|584762338|FG000|Overall Study|Other reason as per investigator|3|||
161922484|NCT01202591|584762339|FG001|Overall Study|Other reason as per investigator|4|||
161922485|NCT01202591|584762340|FG002|Overall Study|Other reason as per investigator|7|||
161922486|NCT01202591|584762341|FG003|Overall Study|Other reason as per investigator|3|||
161922487|NCT01202591|584762342|FG004|Overall Study|Other reason as per investigator|1|||
161922488|NCT01202591|584762343|FG005|Overall Study|Other reason as per investigator|3|||
161922489|NCT01202591|584762338|FG000|Overall Study|Withdrawal by Subject|0|||
161922490|NCT01202591|584762339|FG001|Overall Study|Withdrawal by Subject|0|||
161922491|NCT01202591|584762340|FG002|Overall Study|Withdrawal by Subject|0|||
161485032|NCT02010775|583169028|FG004|Overall Study|Adverse Event|1|||
161922492|NCT01202591|584762341|FG003|Overall Study|Withdrawal by Subject|0|||
161485033|NCT02010775|583169024|FG000|Overall Study|Pregnancy|0|||
161485034|NCT02010775|583169025|FG001|Overall Study|Pregnancy|0|||
161922493|NCT01202591|584762342|FG004|Overall Study|Withdrawal by Subject|2|||
161922494|NCT01202591|584762343|FG005|Overall Study|Withdrawal by Subject|1|||
161922495|NCT01202591|584762338|FG000|Overall Study|Objective Disease Progression|0|||
161922496|NCT01202591|584762339|FG001|Overall Study|Objective Disease Progression|0|||
161922497|NCT01202591|584762340|FG002|Overall Study|Objective Disease Progression|0|||
161922498|NCT01202591|584762341|FG003|Overall Study|Objective Disease Progression|0|||
161922499|NCT01202591|584762342|FG004|Overall Study|Objective Disease Progression|2|||
161922500|NCT01202591|584762343|FG005|Overall Study|Objective Disease Progression|0|||
161485035|NCT02010775|583169026|FG002|Overall Study|Pregnancy|2|||
161485036|NCT02010775|583169027|FG003|Overall Study|Pregnancy|0|||
161485037|NCT02010775|583169028|FG004|Overall Study|Pregnancy|0|||
161485038|NCT02010775|583169024|FG000|Overall Study|Lost to Follow-up|2|||
161485039|NCT02010775|583169025|FG001|Overall Study|Lost to Follow-up|0|||
161485040|NCT02010775|583169026|FG002|Overall Study|Lost to Follow-up|0|||
161485041|NCT02010775|583169027|FG003|Overall Study|Lost to Follow-up|1|||
161485042|NCT02010775|583169028|FG004|Overall Study|Lost to Follow-up|1|||
161485043|NCT02010775|583169024|FG000|Overall Study|Personal Reasons|3|||
161485044|NCT02010775|583169025|FG001|Overall Study|Personal Reasons|3|||
161485045|NCT02010775|583169026|FG002|Overall Study|Personal Reasons|1|||
161485046|NCT02010775|583169027|FG003|Overall Study|Personal Reasons|2|||
161485047|NCT02010775|583169028|FG004|Overall Study|Personal Reasons|4|||
161485048|NCT02030041|583169029|FG000|Overall Study|Withdrawal by Subject|2|||
161485049|NCT02030041|583169030|FG001|Overall Study|Withdrawal by Subject|2|||
161485050|NCT02030041|583169031|FG002|Overall Study|Withdrawal by Subject|1|||
161485051|NCT02006719|583169033|FG000|Overall Study|Withdrawal by Subject|10|||
161485052|NCT02006719|583169034|FG001|Overall Study|Withdrawal by Subject|2|||
161485053|NCT02006719|583169033|FG000|Overall Study|Lost to Follow-up|5|||
161485054|NCT02006719|583169034|FG001|Overall Study|Lost to Follow-up|1|||
161485055|NCT02006719|583169033|FG000|Overall Study|Protocol Violation|2|||
161485056|NCT02006719|583169034|FG001|Overall Study|Protocol Violation|0|||
161485057|NCT02006719|583169033|FG000|Overall Study|Adverse Event|1|||
161485058|NCT02006719|583169034|FG001|Overall Study|Adverse Event|1|||
161485059|NCT02006719|583169033|FG000|Overall Study|Other/Unknown|0|||
161485060|NCT02006719|583169034|FG001|Overall Study|Other/Unknown|1|||
161485061|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
161485062|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
161581104|NCT01985334|583516066|FG006|Overall Study|Worsening of disease|0|||
161581105|NCT01985334|583516067|FG007|Overall Study|Worsening of disease|1|||
161581106|NCT01985334|583516060|FG000|Overall Study|Other|2|||
161581107|NCT01985334|583516061|FG001|Overall Study|Other|9|||
161581108|NCT01985334|583516062|FG002|Overall Study|Other|7|||
161581109|NCT01985334|583516063|FG003|Overall Study|Other|17|||
161581110|NCT01985334|583516064|FG004|Overall Study|Other|4|||
161581111|NCT01985334|583516065|FG005|Overall Study|Other|8|||
161485063|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
161581112|NCT01985334|583516066|FG006|Overall Study|Other|4|||
161581113|NCT01985334|583516067|FG007|Overall Study|Other|7|||
161581114|NCT01985334|583516060|FG000|Overall Study|Protocol deviation|6|||
161485064|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161485065|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161485066|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161581115|NCT01985334|583516061|FG001|Overall Study|Protocol deviation|31|||
161581116|NCT01985334|583516062|FG002|Overall Study|Protocol deviation|25|||
161581117|NCT01985334|583516063|FG003|Overall Study|Protocol deviation|84|||
161485067|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161485068|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161485069|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161922501|NCT04941898|584763156|FG000|Overall Study|Protocol Violation|1|||
161922502|NCT03641924|584763157|FG000|Overall Study|Withdrawal by Subject|26|||
161922503|NCT03641924|584763157|FG000|Overall Study|Lost to Follow-up|16|||
161922504|NCT03641924|584763157|FG000|Overall Study|Protocol Violation|10|||
161922505|NCT02068794|584763158|FG000|Overall Study|Withdrawal by Subject|0|||
161922506|NCT02068794|584763159|FG001|Overall Study|Withdrawal by Subject|1|||
161922507|NCT02068794|584763160|FG002|Overall Study|Withdrawal by Subject|2|||
161922508|NCT02068794|584763158|FG000|Overall Study|Early Progression|1|||
161922509|NCT02068794|584763159|FG001|Overall Study|Early Progression|0|||
161922510|NCT02068794|584763160|FG002|Overall Study|Early Progression|1|||
161485070|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161922511|NCT02068794|584763158|FG000|Overall Study|Ineligible|0|||
161922512|NCT02068794|584763159|FG001|Overall Study|Ineligible|0|||
161485071|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
161485072|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
161485073|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485074|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
161485075|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485076|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485077|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161922513|NCT02068794|584763160|FG002|Overall Study|Ineligible|1|||
161922514|NCT03720847|584763161|FG000|Washout|Physician Decision|1|||
161922515|NCT03720847|584763162|FG001|Washout|Physician Decision|2|||
161922516|NCT01500096|584763163|FG000|Overall Study|Lost to Follow-up|1|||
161922517|NCT01500096|584763164|FG001|Overall Study|Lost to Follow-up|0|||
161922518|NCT01500096|584763165|FG002|Overall Study|Lost to Follow-up|0|||
161485078|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161581118|NCT01985334|583516064|FG004|Overall Study|Protocol deviation|17|||
161581119|NCT01985334|583516065|FG005|Overall Study|Protocol deviation|47|||
161581120|NCT01985334|583516066|FG006|Overall Study|Protocol deviation|15|||
161581121|NCT01985334|583516067|FG007|Overall Study|Protocol deviation|42|||
161581122|NCT01985334|583516060|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
161581123|NCT01985334|583516061|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
161581124|NCT01985334|583516062|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
161581125|NCT01985334|583516063|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
161581126|NCT01985334|583516064|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
161581127|NCT01985334|583516065|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
161581128|NCT01985334|583516066|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
161581129|NCT01985334|583516067|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
161922519|NCT01500096|584763166|FG003|Overall Study|Lost to Follow-up|2|||
161922520|NCT02506036|584763168|FG000|First Intervention (4-6 Weeks)|Death|1|||
161922521|NCT02506036|584763169|FG001|First Intervention (4-6 Weeks)|Death|0|||
161581130|NCT01985334|583516060|FG000|Overall Study|Subject withdrawal of consent|3|||
161581131|NCT01985334|583516061|FG001|Overall Study|Subject withdrawal of consent|6|||
161922522|NCT02506036|584763168|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
161922523|NCT02506036|584763169|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
161922524|NCT02506036|584763168|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
161581132|NCT01985334|583516062|FG002|Overall Study|Subject withdrawal of consent|2|||
161922525|NCT02506036|584763169|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
161581133|NCT01985334|583516063|FG003|Overall Study|Subject withdrawal of consent|28|||
161670138|NCT01139021|583845348|FG003|Overall Study|Protocol Violation|0|||
161485079|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485080|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485081|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485082|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
161485083|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
161485084|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
161485085|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
161485086|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485087|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485088|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485089|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161581134|NCT01985334|583516064|FG004|Overall Study|Subject withdrawal of consent|4|||
161581135|NCT01985334|583516065|FG005|Overall Study|Subject withdrawal of consent|19|||
161581136|NCT01985334|583516066|FG006|Overall Study|Subject withdrawal of consent|0|||
161581137|NCT01985334|583516067|FG007|Overall Study|Subject withdrawal of consent|20|||
161581138|NCT01985334|583516060|FG000|Overall Study|Adverse Event|0|||
161581139|NCT01985334|583516061|FG001|Overall Study|Adverse Event|8|||
161581140|NCT01985334|583516062|FG002|Overall Study|Adverse Event|2|||
161581141|NCT01985334|583516063|FG003|Overall Study|Adverse Event|26|||
161581142|NCT01985334|583516064|FG004|Overall Study|Adverse Event|3|||
161581143|NCT01985334|583516065|FG005|Overall Study|Adverse Event|18|||
161922526|NCT00898807|584763170|FG000|Overall Study|Withdrawal by Subject|5|||
161922527|NCT00898807|584763171|FG001|Overall Study|Withdrawal by Subject|3|||
161922528|NCT00898807|584763170|FG000|Overall Study|Family pressure to discontinue|2|||
161922529|NCT00898807|584763171|FG001|Overall Study|Family pressure to discontinue|2|||
161922530|NCT00898807|584763170|FG000|Overall Study|Lost to Follow-up|1|||
161922531|NCT00898807|584763171|FG001|Overall Study|Lost to Follow-up|3|||
161922532|NCT00898807|584763170|FG000|Overall Study|Death|0|||
161922533|NCT00898807|584763171|FG001|Overall Study|Death|1|||
161922534|NCT05427916|584763177|FG000|Overall Study|Adverse Event|3|||
161922535|NCT05427916|584763178|FG001|Overall Study|Adverse Event|0|||
161922536|NCT05427916|584763177|FG000|Overall Study|Lack of Efficacy|6|||
161922537|NCT05427916|584763178|FG001|Overall Study|Lack of Efficacy|0|||
161922538|NCT05427916|584763177|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
161581144|NCT01985334|583516066|FG006|Overall Study|Adverse Event|3|||
161581145|NCT01985334|583516067|FG007|Overall Study|Adverse Event|15|||
161581146|NCT01985334|583516060|FG000|Overall Study|Other|4|||
161581147|NCT01985334|583516061|FG001|Overall Study|Other|2|||
161581148|NCT01985334|583516062|FG002|Overall Study|Other|3|||
161581149|NCT01985334|583516063|FG003|Overall Study|Other|10|||
161581150|NCT01985334|583516064|FG004|Overall Study|Other|1|||
161581151|NCT01985334|583516065|FG005|Overall Study|Other|6|||
161581152|NCT01985334|583516066|FG006|Overall Study|Other|2|||
161581153|NCT01985334|583516067|FG007|Overall Study|Other|2|||
161581154|NCT01985334|583516060|FG000|Overall Study|Medication non-compliance|0|||
161581155|NCT01985334|583516061|FG001|Overall Study|Medication non-compliance|4|||
161581156|NCT01985334|583516062|FG002|Overall Study|Medication non-compliance|1|||
161581157|NCT01985334|583516063|FG003|Overall Study|Medication non-compliance|6|||
161581158|NCT01985334|583516064|FG004|Overall Study|Medication non-compliance|2|||
161922539|NCT05427916|584763178|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
161922540|NCT00429299|584763181|FG000|Overall Study|Disease Progression|1|||
161922541|NCT00429299|584763182|FG001|Overall Study|Disease Progression|1|||
161922542|NCT00429299|584763183|FG002|Overall Study|Disease Progression|0|||
161922543|NCT00429299|584763181|FG000|Overall Study|Adverse Event|2|||
161922544|NCT00429299|584763182|FG001|Overall Study|Adverse Event|5|||
161922545|NCT00429299|584763183|FG002|Overall Study|Adverse Event|1|||
161922546|NCT00429299|584763181|FG000|Overall Study|Protocol Violation|1|||
161922547|NCT00429299|584763182|FG001|Overall Study|Protocol Violation|0|||
161581159|NCT01985334|583516065|FG005|Overall Study|Medication non-compliance|3|||
161581160|NCT01985334|583516066|FG006|Overall Study|Medication non-compliance|1|||
161581161|NCT01985334|583516067|FG007|Overall Study|Medication non-compliance|3|||
161581162|NCT01985334|583516060|FG000|Overall Study|Use of prohibited treatment|1|||
161581163|NCT01985334|583516061|FG001|Overall Study|Use of prohibited treatment|4|||
161581164|NCT01985334|583516062|FG002|Overall Study|Use of prohibited treatment|1|||
161581165|NCT01985334|583516063|FG003|Overall Study|Use of prohibited treatment|2|||
161581166|NCT01985334|583516064|FG004|Overall Study|Use of prohibited treatment|1|||
161581167|NCT01985334|583516065|FG005|Overall Study|Use of prohibited treatment|6|||
161581168|NCT01985334|583516066|FG006|Overall Study|Use of prohibited treatment|2|||
161581169|NCT01985334|583516067|FG007|Overall Study|Use of prohibited treatment|0|||
161922548|NCT00429299|584763183|FG002|Overall Study|Protocol Violation|0|||
161922549|NCT00429299|584763181|FG000|Overall Study|Withdrawal by Subject|0|||
161581170|NCT01985334|583516060|FG000|Overall Study|Investigator decision|0|||
161581171|NCT01985334|583516061|FG001|Overall Study|Investigator decision|3|||
161922550|NCT00429299|584763182|FG001|Overall Study|Withdrawal by Subject|1|||
161670139|NCT01139021|583845349|FG004|Overall Study|Protocol Violation|2|||
161670140|NCT01139021|583845350|FG005|Overall Study|Protocol Violation|0|||
161922551|NCT00429299|584763183|FG002|Overall Study|Withdrawal by Subject|3|||
161922552|NCT04871113|584763184|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922553|NCT04871113|584763185|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922554|NCT04871113|584763186|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922555|NCT04871113|584763187|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922556|NCT04871113|584763188|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922557|NCT04871113|584763189|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
161922558|NCT04871113|584763190|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922559|NCT04871113|584763191|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922560|NCT04871113|584763192|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922561|NCT04871113|584763193|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922562|NCT04871113|584763184|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922563|NCT04871113|584763185|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922564|NCT04871113|584763186|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922565|NCT04871113|584763187|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922566|NCT04871113|584763188|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922567|NCT04871113|584763189|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922568|NCT04871113|584763190|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
161922569|NCT04871113|584763191|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
161922570|NCT04871113|584763192|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161670141|NCT01139021|583845345|FG000|Overall Study|Withdrawal by Subject|0|||
161922571|NCT04871113|584763193|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922572|NCT02143778|584763194|FG000|Overall Study|Withdrawal by Subject|2|||
161922573|NCT02143778|584763194|FG000|Overall Study|Device malfunction|1|||
161922574|NCT05630755|584763195|FG000|Overall Study|Lost to Follow-up|7|||
161922575|NCT05630755|584763196|FG001|Overall Study|Lost to Follow-up|0|||
161922576|NCT05630755|584763195|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
161922577|NCT05630755|584763196|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
161922578|NCT05630755|584763195|FG000|Overall Study|Withdrawal by Subject|9|||
161485090|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485091|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485092|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485093|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
161485094|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
161485095|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
161485096|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485097|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485098|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485099|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485100|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485101|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485102|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485103|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485104|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
161485105|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
161485106|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
161485107|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
161485108|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485109|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485110|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485111|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485112|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485113|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485114|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485115|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
161485116|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485117|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
161485118|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
161485119|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485120|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485121|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485122|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485123|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485124|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485125|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485126|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
161485127|NCT02207244|583169037|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485128|NCT02207244|583169038|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
161485129|NCT02207244|583169039|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485130|NCT02207244|583169040|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485131|NCT02207244|583169041|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485132|NCT02207244|583169042|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485133|NCT02207244|583169043|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485134|NCT02207244|583169044|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485135|NCT02207244|583169045|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485136|NCT02207244|583169046|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485137|NCT02207244|583169047|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
161485138|NCT02207244|583169037|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485139|NCT02207244|583169038|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485140|NCT02207244|583169039|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485141|NCT02207244|583169040|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485142|NCT02207244|583169041|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
161485143|NCT02207244|583169042|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
161485144|NCT02207244|583169043|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161922579|NCT05630755|584763196|FG001|Overall Study|Withdrawal by Subject|3|||
161485145|NCT02207244|583169044|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485146|NCT02207244|583169045|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485147|NCT02207244|583169046|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485148|NCT02207244|583169047|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
161485149|NCT02207244|583169037|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485150|NCT02207244|583169038|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485151|NCT02207244|583169039|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485152|NCT02207244|583169040|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485153|NCT02207244|583169041|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485154|NCT02207244|583169042|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
161485155|NCT02207244|583169043|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485156|NCT02207244|583169044|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485157|NCT02207244|583169045|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485158|NCT02207244|583169046|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485159|NCT02207244|583169047|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
161485160|NCT02207244|583169037|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485161|NCT02207244|583169038|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485162|NCT02207244|583169039|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485163|NCT02207244|583169040|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
161485164|NCT02207244|583169041|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
161485165|NCT02207244|583169042|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
161485166|NCT02207244|583169043|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485167|NCT02207244|583169044|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485168|NCT02207244|583169045|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485169|NCT02207244|583169046|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485170|NCT02207244|583169047|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161485171|NCT02207244|583169037|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485172|NCT02207244|583169038|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485173|NCT02207244|583169039|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485174|NCT02207244|583169040|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
161485175|NCT02207244|583169041|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
161485176|NCT02207244|583169042|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
161485177|NCT02207244|583169043|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485178|NCT02207244|583169044|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485179|NCT02207244|583169045|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485180|NCT02207244|583169046|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485181|NCT02207244|583169047|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
161485182|NCT02207244|583169037|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485183|NCT02207244|583169038|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485184|NCT02207244|583169039|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485185|NCT02207244|583169040|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
161485186|NCT02207244|583169041|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485187|NCT02207244|583169042|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
161485188|NCT02207244|583169043|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485189|NCT02207244|583169044|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485190|NCT02207244|583169045|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485191|NCT02207244|583169046|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485192|NCT02207244|583169047|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
161485193|NCT02207244|583169037|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485194|NCT02207244|583169038|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485195|NCT02207244|583169039|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485196|NCT02207244|583169040|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
161485197|NCT02207244|583169041|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485198|NCT02207244|583169042|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485199|NCT02207244|583169043|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
161816796|NCT02316223|584370839|FG000|Overall Study|Discontinued by PI|11|||
161816797|NCT02316223|584370840|FG001|Overall Study|Discontinued by PI|19|||
161816798|NCT02316223|584370841|FG002|Overall Study|Discontinued by PI|3|||
161816799|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
161816800|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
161816801|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816802|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816803|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816804|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816805|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
161816806|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
161816807|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816808|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816809|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816810|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816811|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
161816812|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816813|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816814|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816815|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816816|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816817|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
161816818|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
161816819|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816820|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816821|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816822|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816823|NCT03234907|584370843|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161816824|NCT03234907|584370844|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161816825|NCT03234907|584370845|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161816826|NCT03234907|584370846|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
161816827|NCT03234907|584370847|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
161816828|NCT03234907|584370848|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
161816829|NCT03234907|584370843|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
161816830|NCT03234907|584370844|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
161816831|NCT03234907|584370845|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
161816832|NCT03234907|584370846|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
161816833|NCT03234907|584370847|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
161816834|NCT03234907|584370848|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
161816835|NCT03234907|584370843|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161816836|NCT03234907|584370844|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161816837|NCT03234907|584370845|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161816838|NCT03234907|584370846|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
161816839|NCT03234907|584370847|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
161816840|NCT03234907|584370848|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
161816841|NCT02986139|584370851|FG000|Overall Study|Sponsor Decision|1|||
161816842|NCT02986139|584370852|FG001|Overall Study|Sponsor Decision|2|||
161816843|NCT02986139|584370851|FG000|Overall Study|Withdrawal by Subject|0|||
161816844|NCT02986139|584370852|FG001|Overall Study|Withdrawal by Subject|1|||
161816845|NCT02986139|584370851|FG000|Overall Study|Lost to Follow-up|0|||
161816846|NCT02986139|584370852|FG001|Overall Study|Lost to Follow-up|1|||
161816847|NCT02583048|584370853|FG000|Overall Study|Withdrawal by Subject|0|||
161816848|NCT02583048|584370854|FG001|Overall Study|Withdrawal by Subject|1|||
161816849|NCT02583048|584370855|FG002|Overall Study|Withdrawal by Subject|0|||
161816850|NCT02583048|584370853|FG000|Overall Study|Failed to meet eligibility criterion|0|||
161816851|NCT02583048|584370854|FG001|Overall Study|Failed to meet eligibility criterion|0|||
161816852|NCT02583048|584370855|FG002|Overall Study|Failed to meet eligibility criterion|1|||
161816853|NCT00414726|584370859|FG000|Overall Study|Withdrawal by Subject|0|||
161816854|NCT00414726|584370860|FG001|Overall Study|Withdrawal by Subject|1|||
161816855|NCT02107196|584370861|FG000|12-week Treatment Period|Adverse Event|6|||
161816856|NCT02107196|584370862|FG001|12-week Treatment Period|Adverse Event|3|||
161816857|NCT02107196|584370861|FG000|12-week Treatment Period|Lack of Efficacy|2|||
161485200|NCT02207244|583169044|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485201|NCT02207244|583169045|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485202|NCT02207244|583169046|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485203|NCT02207244|583169047|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
161485204|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485205|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485206|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485207|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485208|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485209|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485210|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
161485211|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
161485212|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
161485213|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
161485214|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
161485215|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485216|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485217|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485218|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485219|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485220|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485221|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485222|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
161485223|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485224|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485225|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
161485226|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485227|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485228|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485229|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485230|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485231|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485232|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
161485233|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
161581172|NCT01985334|583516062|FG002|Overall Study|Investigator decision|0|||
161581173|NCT01985334|583516063|FG003|Overall Study|Investigator decision|7|||
161581174|NCT01985334|583516064|FG004|Overall Study|Investigator decision|1|||
161581175|NCT01985334|583516065|FG005|Overall Study|Investigator decision|1|||
161581176|NCT01985334|583516066|FG006|Overall Study|Investigator decision|0|||
161581177|NCT01985334|583516067|FG007|Overall Study|Investigator decision|4|||
161816858|NCT02107196|584370862|FG001|12-week Treatment Period|Lack of Efficacy|1|||
161816859|NCT02107196|584370861|FG000|12-week Treatment Period|Lost to Follow-up|3|||
161816860|NCT02107196|584370862|FG001|12-week Treatment Period|Lost to Follow-up|6|||
161816861|NCT02107196|584370861|FG000|12-week Treatment Period|Physician Decision|0|||
161816862|NCT02107196|584370862|FG001|12-week Treatment Period|Physician Decision|1|||
161816863|NCT02107196|584370861|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
161816864|NCT02107196|584370862|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
161816865|NCT02107196|584370861|FG000|12-week Treatment Period|Protocol Violation|7|||
161816866|NCT02107196|584370862|FG001|12-week Treatment Period|Protocol Violation|8|||
161816867|NCT02107196|584370861|FG000|12-week Treatment Period|Reason Missing|11|||
161816868|NCT02107196|584370862|FG001|12-week Treatment Period|Reason Missing|8|||
161816869|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
161816870|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
161816871|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
161816872|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161816873|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
161816874|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
161816875|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
161816876|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
161816877|NCT00691704|584370865|FG000|Induction Therapy|Disease Progression|1|||
161816878|NCT00691704|584370865|FG000|Induction Therapy|Active Hepatitis|1|||
161816879|NCT00691704|584370865|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
161922580|NCT05630755|584763195|FG000|Overall Study|Participant moved away from trial site|0|||
161485234|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
161581178|NCT01985334|583516060|FG000|Overall Study|Lost to Follow-up|0|||
161581179|NCT01985334|583516061|FG001|Overall Study|Lost to Follow-up|2|||
161581180|NCT01985334|583516062|FG002|Overall Study|Lost to Follow-up|0|||
161581181|NCT01985334|583516063|FG003|Overall Study|Lost to Follow-up|3|||
161922581|NCT05630755|584763196|FG001|Overall Study|Participant moved away from trial site|1|||
161485235|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
161485236|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
161485237|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485238|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485239|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485240|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485241|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485242|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485243|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
161485244|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
161485245|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485246|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
161485247|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
161485248|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485249|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485250|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485251|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485252|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485253|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485254|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
161485255|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
161485256|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
161485257|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
161485258|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
161485259|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485260|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485261|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485262|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485263|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485264|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485265|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485266|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
161485267|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
161485268|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485269|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
161485270|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485271|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485272|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485273|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485274|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485275|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485276|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485277|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485278|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
161485279|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485280|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
161485281|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485282|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485283|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485284|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485285|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485286|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485287|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485288|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
161485289|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485290|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485291|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
161485292|NCT02207244|583169037|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485293|NCT02207244|583169038|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485294|NCT02207244|583169039|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485295|NCT02207244|583169040|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485296|NCT02207244|583169041|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161922582|NCT05630755|584763195|FG000|Overall Study|Status not Recorded|316|||
161922583|NCT05630755|584763196|FG001|Overall Study|Status not Recorded|161|||
161485297|NCT02207244|583169042|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485298|NCT02207244|583169043|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
161485299|NCT02207244|583169044|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485300|NCT02207244|583169045|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485301|NCT02207244|583169046|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485302|NCT02207244|583169047|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
161485303|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485304|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485305|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485306|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485307|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485308|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485309|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485310|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485311|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
161485312|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
161485313|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
161485314|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485315|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485316|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485317|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485318|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485319|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485320|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485321|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485322|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
161485323|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
161485324|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
161485325|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485326|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161581182|NCT01985334|583516064|FG004|Overall Study|Lost to Follow-up|1|||
161581183|NCT01985334|583516065|FG005|Overall Study|Lost to Follow-up|4|||
161581184|NCT01985334|583516066|FG006|Overall Study|Lost to Follow-up|0|||
161581185|NCT01985334|583516067|FG007|Overall Study|Lost to Follow-up|3|||
161581186|NCT00093015|583516068|FG000|Overall Study|Withdrawal by Subject|194|||
161581187|NCT00093015|583516069|FG001|Overall Study|Withdrawal by Subject|171|||
161581188|NCT00093015|583516068|FG000|Overall Study|Lost to Follow-up|96|||
161581189|NCT00093015|583516069|FG001|Overall Study|Lost to Follow-up|108|||
161581190|NCT00093015|583516068|FG000|Overall Study|Death|375|||
161581191|NCT00093015|583516069|FG001|Overall Study|Death|385|||
161581192|NCT03951805|583516074|FG000|Overall Study|Adverse Event|1|||
161581193|NCT03951805|583516075|FG001|Overall Study|Adverse Event|0|||
161581194|NCT03951805|583516076|FG002|Overall Study|Adverse Event|0|||
161581195|NCT03951805|583516077|FG003|Overall Study|Adverse Event|0|||
161581196|NCT01198145|583516080|FG000|Overall Study|Withdrawal by Subject|1|||
161581197|NCT01198145|583516081|FG001|Overall Study|Withdrawal by Subject|1|||
161581198|NCT00603954|583516082|FG000|Overall Study|Protocol Violation|1|||
161581199|NCT00603954|583516083|FG001|Overall Study|Protocol Violation|2|||
161581200|NCT02528188|583516084|FG000|Overall Study|Adverse Event|23|||
161581201|NCT02528188|583516085|FG001|Overall Study|Adverse Event|22|||
161581202|NCT02528188|583516086|FG002|Overall Study|Adverse Event|8|||
161581203|NCT02528188|583516084|FG000|Overall Study|Protocol Violation|4|||
161581204|NCT02528188|583516085|FG001|Overall Study|Protocol Violation|6|||
161581205|NCT02528188|583516086|FG002|Overall Study|Protocol Violation|4|||
161581206|NCT02528188|583516084|FG000|Overall Study|Lack of Efficacy|19|||
161581207|NCT02528188|583516085|FG001|Overall Study|Lack of Efficacy|21|||
161581208|NCT02528188|583516086|FG002|Overall Study|Lack of Efficacy|22|||
161581209|NCT02528188|583516084|FG000|Overall Study|Withdrawal by Subject|97|||
161922584|NCT04790201|584763199|FG000|Overall Study|Lost to Follow-up|0|||
161922585|NCT04790201|584763200|FG001|Overall Study|Lost to Follow-up|0|||
161922586|NCT04790201|584763201|FG002|Overall Study|Lost to Follow-up|2|||
161485327|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485328|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161581210|NCT02528188|583516085|FG001|Overall Study|Withdrawal by Subject|104|||
161581211|NCT02528188|583516086|FG002|Overall Study|Withdrawal by Subject|100|||
161581212|NCT02528188|583516084|FG000|Overall Study|Lost to Follow-up|25|||
161581213|NCT02528188|583516085|FG001|Overall Study|Lost to Follow-up|21|||
161581214|NCT02528188|583516086|FG002|Overall Study|Lost to Follow-up|31|||
161581215|NCT02528188|583516084|FG000|Overall Study|Death|4|||
161581216|NCT02528188|583516085|FG001|Overall Study|Death|4|||
161922587|NCT04790201|584763199|FG000|Overall Study|Death|0|||
161922588|NCT04790201|584763200|FG001|Overall Study|Death|1|||
161485329|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485330|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485331|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485332|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485333|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
161485334|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
161485335|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
161485336|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485337|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485338|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485339|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161922589|NCT04790201|584763201|FG002|Overall Study|Death|0|||
161922590|NCT04790201|584763199|FG000|Overall Study|Protocol Violation|1|||
161922591|NCT04790201|584763200|FG001|Overall Study|Protocol Violation|0|||
161922592|NCT04790201|584763201|FG002|Overall Study|Protocol Violation|1|||
161922593|NCT03637374|584763202|FG000|Overall Study|Death|2|||
161922594|NCT03637374|584763203|FG001|Overall Study|Death|0|||
161922595|NCT02836769|584763207|FG000|Overall Study|Lost to Follow-up|10|||
161922596|NCT02836769|584763207|FG000|Overall Study|Medical withdrawal|2|||
161922597|NCT02836769|584763207|FG000|Overall Study|Withdrawal by Subject|3|||
161922598|NCT04339972|584763208|FG000|Overall Study|Scheduling Issues|3|||
161922599|NCT04339972|584763209|FG001|Overall Study|Scheduling Issues|3|||
161922600|NCT04339972|584763208|FG000|Overall Study|dropout|1|||
161922601|NCT04339972|584763209|FG001|Overall Study|dropout|1|||
161922602|NCT04339972|584763208|FG000|Overall Study|Technical issues|1|||
161922603|NCT04339972|584763209|FG001|Overall Study|Technical issues|0|||
161922604|NCT04339972|584763208|FG000|Overall Study|Claustraphobia|0|||
161485340|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485341|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485342|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485343|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485344|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
161922605|NCT04339972|584763209|FG001|Overall Study|Claustraphobia|1|||
161922606|NCT00776997|584763211|FG000|Overall Study|Adverse Event|2|||
161922607|NCT00933166|584763212|FG000|Overall Study|Lost to Follow-up|4|||
161922608|NCT00933166|584763212|FG000|Overall Study|Lack of Efficacy|9|||
161922609|NCT00933166|584763212|FG000|Overall Study|Unavailable|4|||
161922610|NCT00933166|584763212|FG000|Overall Study|Withdrawal by Subject|1|||
161922611|NCT02403271|584763213|FG000|Period 1|Other varied reasons|1|||
161922612|NCT02403271|584763214|FG001|Period 1|Other varied reasons|0|||
161922613|NCT02403271|584763213|FG000|Period 2|Withdrawal by Subject|0|||
161922614|NCT02403271|584763214|FG001|Period 2|Withdrawal by Subject|14|||
161922615|NCT02403271|584763213|FG000|Period 2|Death|0|||
161922616|NCT02403271|584763214|FG001|Period 2|Death|84|||
161922617|NCT02403271|584763213|FG000|Period 2|Lost to Follow-up|0|||
161922618|NCT02403271|584763214|FG001|Period 2|Lost to Follow-up|2|||
161922619|NCT02403271|584763213|FG000|Period 2|Study Terminated by Sponsor|0|||
161922620|NCT02403271|584763214|FG001|Period 2|Study Terminated by Sponsor|14|||
161922621|NCT02403271|584763213|FG000|Period 2|Other varied reasons|0|||
161922622|NCT02403271|584763214|FG001|Period 2|Other varied reasons|10|||
161922623|NCT03925220|584763215|FG000|Overall Study|Withdrawal by Subject|4|||
161922624|NCT03925220|584763216|FG001|Overall Study|Withdrawal by Subject|4|||
161922625|NCT03925220|584763217|FG002|Overall Study|Withdrawal by Subject|4|||
161485345|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
161485346|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
161581217|NCT02528188|583516086|FG002|Overall Study|Death|0|||
161581218|NCT02528188|583516084|FG000|Overall Study|Other|89|||
161581219|NCT02528188|583516085|FG001|Overall Study|Other|91|||
161581220|NCT02528188|583516086|FG002|Overall Study|Other|74|||
161581221|NCT02528188|583516084|FG000|Overall Study|Randomized but not treated|6|||
161581222|NCT02528188|583516085|FG001|Overall Study|Randomized but not treated|7|||
161581223|NCT02528188|583516086|FG002|Overall Study|Randomized but not treated|12|||
161581224|NCT01239316|583516097|FG000|Overall Study|Progression/Relapse|11|||
161581225|NCT01239316|583516097|FG000|Overall Study|Adverse Event|1|||
161581226|NCT02299375|583516101|FG000|Overall Study|Adverse Event, serious fatal|1|||
161581227|NCT02299375|583516102|FG001|Overall Study|Adverse Event, serious fatal|3|||
161922626|NCT03925220|584763218|FG003|Overall Study|Withdrawal by Subject|4|||
161922627|NCT03925220|584763215|FG000|Overall Study|Lost to Follow-up|40|||
161922628|NCT03925220|584763216|FG001|Overall Study|Lost to Follow-up|46|||
161922629|NCT03925220|584763217|FG002|Overall Study|Lost to Follow-up|37|||
161922630|NCT03925220|584763218|FG003|Overall Study|Lost to Follow-up|38|||
161922631|NCT03301714|584763219|FG000|Overall Study|Lost to Follow-up|10|||
161922632|NCT03301714|584763220|FG001|Overall Study|Lost to Follow-up|4|||
161922633|NCT03301714|584763221|FG002|Overall Study|Lost to Follow-up|4|||
161485347|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
161922634|NCT03301714|584763219|FG000|Overall Study|Did not receive allocated intervention|0|||
161922635|NCT03301714|584763220|FG001|Overall Study|Did not receive allocated intervention|2|||
161485348|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
161485349|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
161485350|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
161485351|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
161485352|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
161485353|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
161485354|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
161485355|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
161485356|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
161485357|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
161485358|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
161485359|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
161485360|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
161485361|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
161485362|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
161485363|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
161485364|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
161485365|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
161485366|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
161485367|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
161485368|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
161581228|NCT02299375|583516101|FG000|Overall Study|Adverse Event, non-fatal|8|||
161581229|NCT02299375|583516102|FG001|Overall Study|Adverse Event, non-fatal|9|||
161581230|NCT02299375|583516101|FG000|Overall Study|Lack of Efficacy|1|||
161581231|NCT02299375|583516102|FG001|Overall Study|Lack of Efficacy|3|||
161581232|NCT02299375|583516101|FG000|Overall Study|Protocol Violation|1|||
161581233|NCT02299375|583516102|FG001|Overall Study|Protocol Violation|3|||
161816880|NCT00691704|584370865|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
161816881|NCT00691704|584370865|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
161816882|NCT01993186|584370866|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
161816883|NCT01993186|584370867|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
161816884|NCT01993186|584370866|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
161816885|NCT01993186|584370867|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161816886|NCT01993186|584370866|FG000|Open-Label Extension Period|Other, Not Specified|0|||
161816887|NCT01993186|584370867|FG001|Open-Label Extension Period|Other, Not Specified|1|||
161816888|NCT01993186|584370866|FG000|Open-Label Extension Period|Adverse Event|1|||
161816889|NCT01993186|584370867|FG001|Open-Label Extension Period|Adverse Event|0|||
161816890|NCT01993186|584370866|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
161816891|NCT01993186|584370867|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
161816892|NCT01993186|584370866|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
161816893|NCT01993186|584370867|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
161816894|NCT01993186|584370866|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
161816895|NCT01993186|584370867|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
161816896|NCT02451696|584370868|FG000|Overall Study|Surgery postponed|1|||
161816897|NCT02451696|584370869|FG001|Overall Study|Surgery postponed|0|||
161816898|NCT00198133|584370870|FG000|Overall Study|Disease progression|2|||
161816899|NCT00198133|584370871|FG001|Overall Study|Disease progression|5|||
161816900|NCT00198133|584370870|FG000|Overall Study|Adverse Event|1|||
161816901|NCT00198133|584370871|FG001|Overall Study|Adverse Event|3|||
161816902|NCT00198133|584370870|FG000|Overall Study|Withdrawal by Subject|1|||
161816903|NCT00198133|584370871|FG001|Overall Study|Withdrawal by Subject|0|||
161816904|NCT00198133|584370870|FG000|Overall Study|Physician Decision|1|||
161816905|NCT00198133|584370871|FG001|Overall Study|Physician Decision|0|||
161816906|NCT01557751|584370872|FG000|Overall Study|Physician Decision|3|||
161816907|NCT02752074|584370873|FG000|Overall Study|Lost to Follow-up|1|||
161816908|NCT02752074|584370874|FG001|Overall Study|Lost to Follow-up|4|||
161816909|NCT02752074|584370873|FG000|Overall Study|Death|146|||
161816910|NCT02752074|584370874|FG001|Overall Study|Death|129|||
161816911|NCT02752074|584370873|FG000|Overall Study|Withdrawal by Subject|9|||
161816912|NCT02752074|584370874|FG001|Overall Study|Withdrawal by Subject|10|||
161816913|NCT00840216|584370875|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161816914|NCT00840216|584370876|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161816915|NCT01380782|584370877|FG000|Overall Study|Adverse Event|0|||
161816916|NCT01380782|584370878|FG001|Overall Study|Adverse Event|1|||
161816917|NCT01380782|584370879|FG002|Overall Study|Adverse Event|0|||
161485369|NCT02207244|583169037|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485370|NCT02207244|583169038|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485371|NCT02207244|583169039|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485372|NCT02207244|583169040|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161816918|NCT01380782|584370880|FG003|Overall Study|Adverse Event|0|||
161816919|NCT01380782|584370877|FG000|Overall Study|Death|1|||
161816920|NCT01380782|584370878|FG001|Overall Study|Death|0|||
161816921|NCT01380782|584370879|FG002|Overall Study|Death|0|||
161816922|NCT01380782|584370880|FG003|Overall Study|Death|0|||
161816923|NCT01380782|584370877|FG000|Overall Study|Lack of Efficacy|10|||
161922636|NCT03301714|584763221|FG002|Overall Study|Did not receive allocated intervention|3|||
161922637|NCT04465955|584763222|FG000|Overall Study|Withdrew consent|6|||
161922638|NCT04465955|584763223|FG001|Overall Study|Withdrew consent|10|||
161922639|NCT04465955|584763224|FG002|Overall Study|Withdrew consent|7|||
161922640|NCT04465955|584763222|FG000|Overall Study|Adverse Event|6|||
161922641|NCT04465955|584763223|FG001|Overall Study|Adverse Event|5|||
161922642|NCT04465955|584763224|FG002|Overall Study|Adverse Event|1|||
161922643|NCT04465955|584763222|FG000|Overall Study|Lost to Follow-up|2|||
161922644|NCT04465955|584763223|FG001|Overall Study|Lost to Follow-up|0|||
161922645|NCT04465955|584763224|FG002|Overall Study|Lost to Follow-up|3|||
161922646|NCT04465955|584763222|FG000|Overall Study|Other|1|||
161922647|NCT04465955|584763223|FG001|Overall Study|Other|1|||
161922648|NCT04465955|584763224|FG002|Overall Study|Other|3|||
161922649|NCT04738487|584763225|FG000|Overall Study|Participant Ongoing in Study|298|||
161922650|NCT04738487|584763226|FG001|Overall Study|Participant Ongoing in Study|297|||
161922651|NCT04738487|584763225|FG000|Overall Study|Withdrawal by Subject|7|||
161922652|NCT04738487|584763226|FG001|Overall Study|Withdrawal by Subject|9|||
161922653|NCT04738487|584763225|FG000|Overall Study|Lost to Follow-up|2|||
161922654|NCT04738487|584763226|FG001|Overall Study|Lost to Follow-up|0|||
161922655|NCT04738487|584763225|FG000|Overall Study|Death|287|||
161922656|NCT04738487|584763226|FG001|Overall Study|Death|306|||
161922657|NCT00632359|584763227|FG000|Overall Study|Withdrawal by Subject|2|||
161922658|NCT03599713|584763232|FG000|Overall Study|Death|38|||
161922659|NCT03599713|584763233|FG001|Overall Study|Death|3|||
161922660|NCT03599713|584763232|FG000|Overall Study|Withdrawal by Subject|17|||
161922661|NCT03599713|584763233|FG001|Overall Study|Withdrawal by Subject|0|||
161922662|NCT03599713|584763232|FG000|Overall Study|Lost to Follow-up|4|||
161922663|NCT03599713|584763233|FG001|Overall Study|Lost to Follow-up|0|||
161922664|NCT03599713|584763232|FG000|Overall Study|Discontinued Due to End of Study|42|||
161922665|NCT03599713|584763233|FG001|Overall Study|Discontinued Due to End of Study|3|||
161922666|NCT05578872|584763236|FG000|Overall Study|Withdrawal by Subject|2|||
161922667|NCT05578872|584763237|FG001|Overall Study|Withdrawal by Subject|1|||
161922668|NCT05578872|584763236|FG000|Overall Study|Adverse Event|1|||
161922669|NCT05578872|584763237|FG001|Overall Study|Adverse Event|1|||
161922670|NCT05578872|584763236|FG000|Overall Study|Physician Decision|1|||
161922671|NCT05578872|584763237|FG001|Overall Study|Physician Decision|2|||
161922672|NCT05578872|584763236|FG000|Overall Study|Progressive disease|10|||
161922673|NCT05578872|584763237|FG001|Overall Study|Progressive disease|9|||
161922674|NCT05578872|584763236|FG000|Overall Study|Sponsor decision|0|||
161922675|NCT05578872|584763237|FG001|Overall Study|Sponsor decision|1|||
161485373|NCT02207244|583169041|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485374|NCT02207244|583169042|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485375|NCT02207244|583169043|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485376|NCT02207244|583169044|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485377|NCT02207244|583169045|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485378|NCT02207244|583169046|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
161485379|NCT02207244|583169047|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
161485380|NCT01866930|583169049|FG000|Treatment Period|Other|1|||
161485381|NCT01866930|583169050|FG001|Treatment Period|Other|0|||
161485382|NCT01866930|583169049|FG000|Treatment Period|Death|0|||
161485383|NCT01866930|583169050|FG001|Treatment Period|Death|2|||
161485384|NCT01866930|583169049|FG000|Treatment Period|Poor/non compliance|0|||
161485385|NCT01866930|583169050|FG001|Treatment Period|Poor/non compliance|2|||
161485386|NCT01866930|583169049|FG000|Treatment Period|No longer meets study criteria|0|||
161485387|NCT01866930|583169050|FG001|Treatment Period|No longer meets study criteria|1|||
161485388|NCT01866930|583169049|FG000|Treatment Period|Withdrawal by Subject|2|||
161485389|NCT01866930|583169050|FG001|Treatment Period|Withdrawal by Subject|8|||
161485390|NCT01866930|583169049|FG000|Treatment Period|Lack of Efficacy|1|||
161485391|NCT01866930|583169050|FG001|Treatment Period|Lack of Efficacy|9|||
161581234|NCT02299375|583516101|FG000|Overall Study|Other: Met stopping criteria|1|||
161922676|NCT05578872|584763236|FG000|Overall Study|Toxicity and Patient's decision|0|||
161922677|NCT05578872|584763237|FG001|Overall Study|Toxicity and Patient's decision|1|||
161485392|NCT01866930|583169049|FG000|Treatment Period|Adverse Event|4|||
161485393|NCT01866930|583169050|FG001|Treatment Period|Adverse Event|12|||
161485394|NCT01866930|583169049|FG000|Treatment Period|Lost to Follow-up|1|||
161581235|NCT02299375|583516102|FG001|Overall Study|Other: Met stopping criteria|0|||
161485395|NCT01866930|583169050|FG001|Treatment Period|Lost to Follow-up|1|||
161485396|NCT01866930|583169049|FG000|Follow-up Period|Lost to Follow-up|1|||
161581236|NCT02299375|583516101|FG000|Overall Study|Other: Study closed/terminated|66|||
161922678|NCT01022580|584764826|FG000|Overall Study|Death|18|||
161922679|NCT01022580|584764827|FG001|Overall Study|Death|22|||
161922680|NCT03439839|584764828|FG000|Overall Study|Death|3|||
161922681|NCT03439839|584764829|FG001|Overall Study|Death|0|||
161922682|NCT03033901|584764833|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
161922683|NCT03033901|584764833|FG000|Overall Study|Refused PSG|23|||
161922684|NCT03033901|584764833|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
161922685|NCT03033901|584764833|FG000|Overall Study|Missing Oximetry Data|3|||
161922686|NCT00924651|584764836|FG000|Overall Study|Chemo started too soon|2|||
161581237|NCT02299375|583516102|FG001|Overall Study|Other: Study closed/terminated|55|||
161581238|NCT02299375|583516101|FG000|Overall Study|Lost to Follow-up|0|||
161581239|NCT02299375|583516102|FG001|Overall Study|Lost to Follow-up|2|||
161581240|NCT02299375|583516101|FG000|Overall Study|Physician Decision|1|||
161581241|NCT02299375|583516102|FG001|Overall Study|Physician Decision|1|||
161581242|NCT02299375|583516101|FG000|Overall Study|Withdrawal by Subject|1|||
161581243|NCT02299375|583516102|FG001|Overall Study|Withdrawal by Subject|4|||
161581244|NCT00411216|583516103|FG000|Overall Study|Ten participants were entered into the c|0|||
161581245|NCT00411216|583516104|FG001|Overall Study|Ten participants were entered into the c|2|||
161581246|NCT01205048|583516105|FG000|Overall Study|Withdrawal by Subject|14|||
161581247|NCT01205048|583516105|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
161581248|NCT01205048|583516105|FG000|Overall Study|Lost to Follow-up|4|||
161581249|NCT01205048|583516105|FG000|Overall Study|Other|2|||
161581250|NCT00823472|583516106|FG000|Overall Study|Physician Decision|24|||
161816924|NCT01380782|584370878|FG001|Overall Study|Lack of Efficacy|9|||
161816925|NCT01380782|584370879|FG002|Overall Study|Lack of Efficacy|10|||
161816926|NCT01380782|584370880|FG003|Overall Study|Lack of Efficacy|3|||
161816927|NCT01380782|584370877|FG000|Overall Study|Physician Decision|1|||
161816928|NCT01380782|584370878|FG001|Overall Study|Physician Decision|0|||
161816929|NCT01380782|584370879|FG002|Overall Study|Physician Decision|0|||
161816930|NCT01380782|584370880|FG003|Overall Study|Physician Decision|0|||
161816931|NCT01380782|584370877|FG000|Overall Study|Withdrawal by Subject|0|||
161816932|NCT01380782|584370878|FG001|Overall Study|Withdrawal by Subject|0|||
161816933|NCT01380782|584370879|FG002|Overall Study|Withdrawal by Subject|1|||
161816934|NCT01380782|584370880|FG003|Overall Study|Withdrawal by Subject|1|||
161816935|NCT01403194|584370884|FG000|Overall Study|Screen Failure|2|||
161816936|NCT01403194|584370884|FG000|Overall Study|Lost to Follow-up|8|||
161816937|NCT03428750|584370885|FG000|Overall Study|Withdrawal by Subject|11|||
161816938|NCT03428750|584370886|FG001|Overall Study|Withdrawal by Subject|10|||
161816939|NCT03428750|584370885|FG000|Overall Study|Lost to Follow-up|3|||
161816940|NCT03428750|584370886|FG001|Overall Study|Lost to Follow-up|9|||
161816941|NCT03428750|584370885|FG000|Overall Study|Adverse Event|9|||
161816942|NCT03428750|584370886|FG001|Overall Study|Adverse Event|1|||
161816943|NCT03428750|584370885|FG000|Overall Study|Protocol Violation|1|||
161816944|NCT03428750|584370886|FG001|Overall Study|Protocol Violation|0|||
161816945|NCT03428750|584370885|FG000|Overall Study|Administrative|0|||
161816946|NCT03428750|584370886|FG001|Overall Study|Administrative|1|||
161816947|NCT04474405|584370889|FG000|Overall Study|Withdrawal by Subject|0|||
161816948|NCT04474405|584370890|FG001|Overall Study|Withdrawal by Subject|0|||
161816949|NCT04474405|584370891|FG002|Overall Study|Withdrawal by Subject|1|||
161816950|NCT04474405|584370892|FG003|Overall Study|Withdrawal by Subject|0|||
161816951|NCT04474405|584370893|FG004|Overall Study|Withdrawal by Subject|1|||
161816952|NCT04474405|584370894|FG005|Overall Study|Withdrawal by Subject|0|||
161816953|NCT04474405|584370889|FG000|Overall Study|Other|0|||
161816954|NCT04474405|584370890|FG001|Overall Study|Other|0|||
161816955|NCT04474405|584370891|FG002|Overall Study|Other|0|||
161816956|NCT04474405|584370892|FG003|Overall Study|Other|0|||
161816957|NCT04474405|584370893|FG004|Overall Study|Other|3|||
161816958|NCT04474405|584370894|FG005|Overall Study|Other|0|||
161816959|NCT00274651|584370895|FG000|Overall Study|Adverse Event|6|||
161581251|NCT00823472|583516107|FG001|Overall Study|Physician Decision|28|||
161581252|NCT01251354|583516112|FG000|Overall Study|Adverse Event|1|||
161581253|NCT01251354|583516112|FG000|Overall Study|Investigator's Decision|1|||
161581254|NCT01251354|583516112|FG000|Overall Study|Disease Progression|4|||
161816960|NCT00274651|584370896|FG001|Overall Study|Adverse Event|3|||
161816961|NCT00274651|584370895|FG000|Overall Study|Lack of Efficacy|13|||
161816962|NCT00274651|584370896|FG001|Overall Study|Lack of Efficacy|6|||
161816963|NCT00274651|584370895|FG000|Overall Study|Death|1|||
161816964|NCT00274651|584370896|FG001|Overall Study|Death|3|||
161816965|NCT00274651|584370895|FG000|Overall Study|Withdrawal by Subject|0|||
161816966|NCT00274651|584370896|FG001|Overall Study|Withdrawal by Subject|1|||
161816967|NCT00274651|584370895|FG000|Overall Study|Physician Decision|8|||
161922687|NCT00924651|584764837|FG001|Overall Study|Chemo started too soon|3|||
161922688|NCT00924651|584764836|FG000|Overall Study|No Reason|3|||
161922689|NCT00924651|584764837|FG001|Overall Study|No Reason|7|||
161922690|NCT00924651|584764836|FG000|Overall Study|Overwhelmed|6|||
161485397|NCT01866930|583169050|FG001|Follow-up Period|Lost to Follow-up|1|||
161485398|NCT01866930|583169049|FG000|Follow-up Period|Other|1|||
161485399|NCT01866930|583169050|FG001|Follow-up Period|Other|5|||
161485400|NCT01866930|583169049|FG000|Follow-up Period|No longer required per protocol|1|||
161485401|NCT01866930|583169050|FG001|Follow-up Period|No longer required per protocol|0|||
161485402|NCT01866930|583169049|FG000|Follow-up Period|Withdrawal by Subject|3|||
161485403|NCT01866930|583169050|FG001|Follow-up Period|Withdrawal by Subject|3|||
161485404|NCT02521870|583169057|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485405|NCT02521870|583169058|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
161485406|NCT02521870|583169059|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485407|NCT02521870|583169060|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485408|NCT02521870|583169061|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161581255|NCT04992390|583516119|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
161581256|NCT04992390|583516120|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
161581257|NCT04992390|583516121|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
161581258|NCT04992390|583516119|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
161581259|NCT04992390|583516120|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
161670142|NCT01139021|583845346|FG001|Overall Study|Withdrawal by Subject|0|||
161670143|NCT01139021|583845347|FG002|Overall Study|Withdrawal by Subject|0|||
161670144|NCT01139021|583845348|FG003|Overall Study|Withdrawal by Subject|1|||
161670145|NCT01139021|583845349|FG004|Overall Study|Withdrawal by Subject|4|||
161670146|NCT01139021|583845350|FG005|Overall Study|Withdrawal by Subject|0|||
161670147|NCT00784693|583845355|FG000|Overall Study|Lost to Follow-up|0|||
161670148|NCT00784693|583845356|FG001|Overall Study|Lost to Follow-up|1|||
161670149|NCT00784693|583845355|FG000|Overall Study|Lack of Efficacy|1|||
161670150|NCT00784693|583845356|FG001|Overall Study|Lack of Efficacy|1|||
161670151|NCT00784693|583845355|FG000|Overall Study|Withdrawal by Subject|0|||
161670152|NCT00784693|583845356|FG001|Overall Study|Withdrawal by Subject|4|||
161670153|NCT00784693|583845355|FG000|Overall Study|Randomized but not Treated|1|||
161670154|NCT00784693|583845356|FG001|Overall Study|Randomized but not Treated|0|||
161670155|NCT00784693|583845355|FG000|Overall Study|Other|1|||
161816968|NCT00274651|584370896|FG001|Overall Study|Physician Decision|7|||
161816969|NCT03446768|584370897|FG000|Overall Study|Withdrawal by Subject|0|||
161816970|NCT03446768|584370898|FG001|Overall Study|Withdrawal by Subject|1|||
161816971|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
161581260|NCT04992390|583516121|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
161581261|NCT04992390|583516119|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
161581262|NCT04992390|583516120|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
161581263|NCT04992390|583516121|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
161581264|NCT04992390|583516119|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
161581265|NCT04992390|583516120|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
161581266|NCT04992390|583516121|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
161581267|NCT04992390|583516119|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
161581268|NCT04992390|583516120|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
161581269|NCT04992390|583516121|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
161581270|NCT04992390|583516119|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
161581271|NCT04992390|583516120|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
161581272|NCT04992390|583516121|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
161581273|NCT04992390|583516119|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
161581274|NCT04992390|583516120|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
161581275|NCT04992390|583516121|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
161670156|NCT00784693|583845356|FG001|Overall Study|Other|0|||
161670157|NCT02982187|583845357|FG000|Overall Study|Withdrawal by Subject|0|||
161816972|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
161816973|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
161816974|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
161816975|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
161816976|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
161816977|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
161816978|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
161816979|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
161816980|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
161816981|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
161816982|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
161816983|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
161816984|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
161816985|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
161922691|NCT00924651|584764837|FG001|Overall Study|Overwhelmed|6|||
161485409|NCT02521870|583169062|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485410|NCT02521870|583169063|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485411|NCT02521870|583169064|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485412|NCT02521870|583169065|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485413|NCT02521870|583169066|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485414|NCT02521870|583169067|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485415|NCT02521870|583169068|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161485416|NCT02521870|583169057|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
161485417|NCT02521870|583169058|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
161485418|NCT02521870|583169059|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
161485419|NCT02521870|583169060|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
161581276|NCT04992390|583516119|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
161581277|NCT04992390|583516120|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
161581278|NCT04992390|583516121|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
161581279|NCT04992390|583516119|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
161581280|NCT04992390|583516120|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
161581281|NCT04992390|583516121|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
161581282|NCT04992390|583516119|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
161581283|NCT04992390|583516120|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
161581284|NCT04992390|583516121|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
161581285|NCT04992390|583516119|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
161581286|NCT04992390|583516120|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
161581287|NCT04992390|583516121|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
161581288|NCT04992390|583516119|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
161581289|NCT04992390|583516120|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
161581290|NCT04992390|583516121|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
161581291|NCT04992390|583516119|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
161581292|NCT04992390|583516120|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
161581293|NCT04992390|583516121|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
161581294|NCT04992390|583516119|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
161581295|NCT04992390|583516120|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
161581296|NCT04992390|583516121|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
161581297|NCT04992390|583516119|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
161581298|NCT04992390|583516120|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
161581299|NCT04992390|583516121|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
161581300|NCT04992390|583516119|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
161581301|NCT04992390|583516120|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
161581302|NCT04992390|583516121|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
161581303|NCT01853748|583518223|FG000|Allocation|Withdrawal by Subject|1|||
161581304|NCT01853748|583518224|FG001|Allocation|Withdrawal by Subject|13|||
161581305|NCT01853748|583518223|FG000|Allocation|not sufficient to receive intervention|0|||
161581306|NCT01853748|583518224|FG001|Allocation|not sufficient to receive intervention|1|||
161581307|NCT01853748|583518223|FG000|Follow-Up|Withdrawal by Subject|7|||
161581308|NCT01853748|583518224|FG001|Follow-Up|Withdrawal by Subject|6|||
161581309|NCT01853748|583518223|FG000|Follow-Up|Adverse Event|67|||
161581310|NCT01853748|583518224|FG001|Follow-Up|Adverse Event|7|||
161581311|NCT01853748|583518223|FG000|Follow-Up|not available for data collection|16|||
161581312|NCT01853748|583518224|FG001|Follow-Up|not available for data collection|4|||
161581313|NCT00780416|583518229|FG000|Overall Study|Physician Decision|3|||
161581314|NCT00780416|583518230|FG001|Overall Study|Physician Decision|3|||
161581315|NCT00780416|583518229|FG000|Overall Study|Protocol Violation|1|||
161581316|NCT00780416|583518230|FG001|Overall Study|Protocol Violation|0|||
161581317|NCT00780416|583518229|FG000|Overall Study|Withdrawal by Subject|8|||
161581318|NCT00780416|583518230|FG001|Overall Study|Withdrawal by Subject|6|||
161581319|NCT02916706|583518231|FG000|Overall Study|Adverse Event|0|||
161581320|NCT02916706|583518232|FG001|Overall Study|Adverse Event|1|||
161581321|NCT02916706|583518231|FG000|Overall Study|Lost to Follow-up|0|||
161581322|NCT02916706|583518232|FG001|Overall Study|Lost to Follow-up|1|||
161581323|NCT02916706|583518231|FG000|Overall Study|Physician Decision|1|||
161581324|NCT02916706|583518232|FG001|Overall Study|Physician Decision|0|||
161581325|NCT02916706|583518231|FG000|Overall Study|Protocol Violation|3|||
161581326|NCT02916706|583518232|FG001|Overall Study|Protocol Violation|1|||
161581327|NCT02916706|583518231|FG000|Overall Study|Withdrawal by Subject|6|||
161581328|NCT02916706|583518232|FG001|Overall Study|Withdrawal by Subject|9|||
161581329|NCT02916706|583518231|FG000|Overall Study|Other|5|||
161581330|NCT02916706|583518232|FG001|Overall Study|Other|19|||
161581331|NCT02723955|583518233|FG000|Escalation Phase|Death|1|||
161581332|NCT02723955|583518234|FG001|Escalation Phase|Death|1|||
161581333|NCT02723955|583518235|FG002|Escalation Phase|Death|2|||
161485420|NCT02521870|583169061|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
161485421|NCT02521870|583169062|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
161816986|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
161816987|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
161816988|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
161670158|NCT02982187|583845358|FG001|Overall Study|Withdrawal by Subject|0|||
161670159|NCT02982187|583845359|FG002|Overall Study|Withdrawal by Subject|0|||
161485422|NCT02521870|583169063|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
161485423|NCT02521870|583169064|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
161485424|NCT02521870|583169065|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
161485425|NCT02521870|583169066|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
161485426|NCT02521870|583169067|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
161485427|NCT02521870|583169068|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
161485428|NCT02521870|583169057|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
161485429|NCT02521870|583169058|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
161485430|NCT02521870|583169059|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
161485431|NCT02521870|583169060|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
161485432|NCT02521870|583169061|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
161485433|NCT02521870|583169062|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
161485434|NCT02521870|583169063|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
161485435|NCT02521870|583169064|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
161485436|NCT02521870|583169065|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
161485437|NCT02521870|583169066|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
161485438|NCT02521870|583169067|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
161485439|NCT02521870|583169068|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
161485440|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161485441|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161485442|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161485443|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161485444|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
161485445|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
161670160|NCT02982187|583845360|FG003|Overall Study|Withdrawal by Subject|0|||
161670161|NCT02982187|583845361|FG004|Overall Study|Withdrawal by Subject|0|||
161670162|NCT02982187|583845362|FG005|Overall Study|Withdrawal by Subject|0|||
161670163|NCT02982187|583845363|FG006|Overall Study|Withdrawal by Subject|1|||
161670164|NCT02982187|583845364|FG007|Overall Study|Withdrawal by Subject|0|||
161670165|NCT02349451|583845368|FG000|Overall Study|Withdrawal by Subject|0|||
161670166|NCT02349451|583845369|FG001|Overall Study|Withdrawal by Subject|1|||
161670167|NCT02349451|583845370|FG002|Overall Study|Withdrawal by Subject|2|||
161670168|NCT02349451|583845371|FG003|Overall Study|Withdrawal by Subject|1|||
161670169|NCT02168842|583845372|FG000|Overall Study|Withdrawal by Subject|5|||
161670170|NCT02168842|583845373|FG001|Overall Study|Withdrawal by Subject|3|||
161670171|NCT02168842|583845372|FG000|Overall Study|Lost to Follow-up|0|||
161670172|NCT02168842|583845373|FG001|Overall Study|Lost to Follow-up|2|||
161670173|NCT02168842|583845372|FG000|Overall Study|Death|2|||
161670174|NCT02168842|583845373|FG001|Overall Study|Death|1|||
161670175|NCT02168842|583845372|FG000|Overall Study|Physician Decision|1|||
161670176|NCT02168842|583845373|FG001|Overall Study|Physician Decision|2|||
161670177|NCT02147353|583845374|FG000|Overall Study|Lost to Follow-up|2|||
161485446|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
161485447|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161485448|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
161485449|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
161485450|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
161485451|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161485452|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
161485453|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
161485454|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
161485455|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
161670178|NCT02147353|583845375|FG001|Overall Study|Lost to Follow-up|0|||
161670179|NCT02147353|583845374|FG000|Overall Study|unable to make visits|4|||
161485456|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
161670180|NCT02147353|583845375|FG001|Overall Study|unable to make visits|0|||
161670181|NCT02147353|583845374|FG000|Overall Study|medication noncompliance|3|||
161485457|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
161485458|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
161485459|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
161485460|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
161485461|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
161670182|NCT02147353|583845375|FG001|Overall Study|medication noncompliance|0|||
161816989|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
161485462|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
161485463|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
161670183|NCT02578862|583845383|FG000|Overall Study|Withdrawal by Subject|0|||
161670184|NCT02578862|583845384|FG001|Overall Study|Withdrawal by Subject|1|||
161816990|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
161581334|NCT02723955|583518236|FG003|Escalation Phase|Death|7|||
161581335|NCT02723955|583518237|FG004|Escalation Phase|Death|18|||
161581336|NCT02723955|583518238|FG005|Escalation Phase|Death|17|||
161581337|NCT02723955|583518239|FG006|Escalation Phase|Death|11|||
161581338|NCT02723955|583518240|FG007|Escalation Phase|Death|21|||
161581339|NCT02723955|583518241|FG008|Escalation Phase|Death|3|||
161581340|NCT02723955|583518242|FG009|Escalation Phase|Death|0|||
161581341|NCT02723955|583518243|FG010|Escalation Phase|Death|0|||
161581342|NCT02723955|583518244|FG011|Escalation Phase|Death|0|||
161581343|NCT02723955|583518245|FG012|Escalation Phase|Death|2|||
161581344|NCT02723955|583518246|FG013|Escalation Phase|Death|4|||
161581345|NCT02723955|583518247|FG014|Escalation Phase|Death|5|||
161581346|NCT02723955|583518248|FG015|Escalation Phase|Death|6|||
161581347|NCT02723955|583518249|FG016|Escalation Phase|Death|6|||
161581348|NCT02723955|583518250|FG017|Escalation Phase|Death|7|||
161581349|NCT02723955|583518251|FG018|Escalation Phase|Death|1|||
161581350|NCT02723955|583518252|FG019|Escalation Phase|Death|3|||
161581351|NCT02723955|583518253|FG020|Escalation Phase|Death|13|||
161581352|NCT02723955|583518254|FG021|Escalation Phase|Death|3|||
161581353|NCT02723955|583518255|FG022|Escalation Phase|Death|2|||
161581354|NCT02723955|583518256|FG023|Escalation Phase|Death|4|||
161581355|NCT02723955|583518257|FG024|Escalation Phase|Death|31|||
161581356|NCT02723955|583518258|FG025|Escalation Phase|Death|7|||
161581357|NCT02723955|583518259|FG026|Escalation Phase|Death|13|||
161581358|NCT02723955|583518260|FG027|Escalation Phase|Death|0|||
161581359|NCT02723955|583518261|FG028|Escalation Phase|Death|1|||
161581360|NCT02723955|583518262|FG029|Escalation Phase|Death|0|||
161581361|NCT02723955|583518263|FG030|Escalation Phase|Death|0|||
161581362|NCT02723955|583518264|FG031|Escalation Phase|Death|0|||
161581363|NCT02723955|583518265|FG032|Escalation Phase|Death|0|||
161581364|NCT02723955|583518266|FG033|Escalation Phase|Death|0|||
161581365|NCT02723955|583518267|FG034|Escalation Phase|Death|0|||
161581366|NCT02723955|583518268|FG035|Escalation Phase|Death|0|||
161581367|NCT02723955|583518269|FG036|Escalation Phase|Death|0|||
161581368|NCT02723955|583518270|FG037|Escalation Phase|Death|0|||
161581369|NCT02723955|583518271|FG038|Escalation Phase|Death|0|||
161581370|NCT02723955|583518272|FG039|Escalation Phase|Death|0|||
161581371|NCT02723955|583518273|FG040|Escalation Phase|Death|0|||
161581372|NCT02723955|583518274|FG041|Escalation Phase|Death|0|||
161581373|NCT02723955|583518275|FG042|Escalation Phase|Death|0|||
161581374|NCT02723955|583518233|FG000|Escalation Phase|Lost to Follow-up|0|||
161581375|NCT02723955|583518234|FG001|Escalation Phase|Lost to Follow-up|0|||
161581376|NCT02723955|583518235|FG002|Escalation Phase|Lost to Follow-up|0|||
161581377|NCT02723955|583518236|FG003|Escalation Phase|Lost to Follow-up|0|||
161581378|NCT02723955|583518237|FG004|Escalation Phase|Lost to Follow-up|0|||
161581379|NCT02723955|583518238|FG005|Escalation Phase|Lost to Follow-up|2|||
161581380|NCT02723955|583518239|FG006|Escalation Phase|Lost to Follow-up|1|||
161581381|NCT02723955|583518240|FG007|Escalation Phase|Lost to Follow-up|1|||
161581382|NCT02723955|583518241|FG008|Escalation Phase|Lost to Follow-up|1|||
161581383|NCT02723955|583518242|FG009|Escalation Phase|Lost to Follow-up|0|||
161581384|NCT02723955|583518243|FG010|Escalation Phase|Lost to Follow-up|0|||
161581385|NCT02723955|583518244|FG011|Escalation Phase|Lost to Follow-up|0|||
161581386|NCT02723955|583518245|FG012|Escalation Phase|Lost to Follow-up|1|||
161581387|NCT02723955|583518246|FG013|Escalation Phase|Lost to Follow-up|0|||
161581388|NCT02723955|583518247|FG014|Escalation Phase|Lost to Follow-up|0|||
161581389|NCT02723955|583518248|FG015|Escalation Phase|Lost to Follow-up|0|||
161581390|NCT02723955|583518249|FG016|Escalation Phase|Lost to Follow-up|1|||
161581391|NCT02723955|583518250|FG017|Escalation Phase|Lost to Follow-up|2|||
161581392|NCT02723955|583518251|FG018|Escalation Phase|Lost to Follow-up|0|||
161581393|NCT02723955|583518252|FG019|Escalation Phase|Lost to Follow-up|1|||
161581394|NCT02723955|583518253|FG020|Escalation Phase|Lost to Follow-up|2|||
161581395|NCT02723955|583518254|FG021|Escalation Phase|Lost to Follow-up|1|||
161581396|NCT02723955|583518255|FG022|Escalation Phase|Lost to Follow-up|0|||
161581397|NCT02723955|583518256|FG023|Escalation Phase|Lost to Follow-up|0|||
161581398|NCT02723955|583518257|FG024|Escalation Phase|Lost to Follow-up|1|||
161581399|NCT02723955|583518258|FG025|Escalation Phase|Lost to Follow-up|1|||
161581400|NCT02723955|583518259|FG026|Escalation Phase|Lost to Follow-up|3|||
161581401|NCT02723955|583518260|FG027|Escalation Phase|Lost to Follow-up|0|||
161581402|NCT02723955|583518261|FG028|Escalation Phase|Lost to Follow-up|1|||
161581403|NCT02723955|583518262|FG029|Escalation Phase|Lost to Follow-up|0|||
161581404|NCT02723955|583518263|FG030|Escalation Phase|Lost to Follow-up|0|||
161581405|NCT02723955|583518264|FG031|Escalation Phase|Lost to Follow-up|0|||
161581406|NCT02723955|583518265|FG032|Escalation Phase|Lost to Follow-up|0|||
161581407|NCT02723955|583518266|FG033|Escalation Phase|Lost to Follow-up|0|||
161581408|NCT02723955|583518267|FG034|Escalation Phase|Lost to Follow-up|0|||
161581409|NCT02723955|583518268|FG035|Escalation Phase|Lost to Follow-up|0|||
161581410|NCT02723955|583518269|FG036|Escalation Phase|Lost to Follow-up|0|||
161581411|NCT02723955|583518270|FG037|Escalation Phase|Lost to Follow-up|0|||
161581412|NCT02723955|583518271|FG038|Escalation Phase|Lost to Follow-up|0|||
161581413|NCT02723955|583518272|FG039|Escalation Phase|Lost to Follow-up|0|||
161581414|NCT02723955|583518273|FG040|Escalation Phase|Lost to Follow-up|0|||
161485464|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
161485465|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
161485466|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
161485467|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
161670185|NCT02578862|583845383|FG000|Overall Study|Unplanned unilateral procedure|0|||
161670186|NCT02578862|583845384|FG001|Overall Study|Unplanned unilateral procedure|1|||
161670187|NCT01230788|583845393|FG000|Overall Study|Prescribed exclusion drug|1|||
161670188|NCT01142596|583845394|FG000|Overall Study|Withdrawal by Subject|9|||
161670189|NCT01142596|583845395|FG001|Overall Study|Withdrawal by Subject|35|||
161670190|NCT01142596|583845394|FG000|Overall Study|Adverse Event|8|||
161670191|NCT01142596|583845395|FG001|Overall Study|Adverse Event|35|||
161670192|NCT01142596|583845394|FG000|Overall Study|Lack of Efficacy|5|||
161670193|NCT01142596|583845395|FG001|Overall Study|Lack of Efficacy|9|||
161670194|NCT01142596|583845394|FG000|Overall Study|Lost to Follow-up|2|||
161670195|NCT01142596|583845395|FG001|Overall Study|Lost to Follow-up|3|||
161670196|NCT01142596|583845394|FG000|Overall Study|Other reason (not specified)|5|||
161670197|NCT01142596|583845395|FG001|Overall Study|Other reason (not specified)|4|||
161670198|NCT01423253|583845396|FG000|Overall Study|Adverse Event|2|||
161670199|NCT01423253|583845396|FG000|Overall Study|Lack of Efficacy|2|||
161670200|NCT01423253|583845396|FG000|Overall Study|Lost to Follow-up|1|||
161670201|NCT01423253|583845396|FG000|Overall Study|Protocol Violation|2|||
161670202|NCT01423253|583845396|FG000|Overall Study|Withdrawal by Subject|2|||
161670203|NCT01290601|583845399|FG000|Overall Study|Adverse Event|0|||
161670204|NCT01290601|583845400|FG001|Overall Study|Adverse Event|2|||
161670205|NCT01290601|583845401|FG002|Overall Study|Adverse Event|0|||
161670206|NCT01290601|583845402|FG003|Overall Study|Adverse Event|0|||
161670207|NCT01290601|583845399|FG000|Overall Study|Lack of Efficacy|2|||
161670208|NCT01290601|583845400|FG001|Overall Study|Lack of Efficacy|1|||
161670209|NCT01290601|583845401|FG002|Overall Study|Lack of Efficacy|0|||
161670210|NCT01290601|583845402|FG003|Overall Study|Lack of Efficacy|0|||
161670211|NCT01290601|583845399|FG000|Overall Study|Lost to Follow-up|7|||
161670212|NCT01290601|583845400|FG001|Overall Study|Lost to Follow-up|2|||
161670213|NCT01290601|583845401|FG002|Overall Study|Lost to Follow-up|0|||
161670214|NCT01290601|583845402|FG003|Overall Study|Lost to Follow-up|0|||
161670215|NCT01290601|583845399|FG000|Overall Study|Other|1|||
161670216|NCT01290601|583845400|FG001|Overall Study|Other|0|||
161670217|NCT01290601|583845401|FG002|Overall Study|Other|0|||
161670218|NCT01290601|583845402|FG003|Overall Study|Other|0|||
161670219|NCT01290601|583845399|FG000|Overall Study|Protocol Violation|1|||
161670220|NCT01290601|583845400|FG001|Overall Study|Protocol Violation|0|||
161670221|NCT01290601|583845401|FG002|Overall Study|Protocol Violation|0|||
161670222|NCT01290601|583845402|FG003|Overall Study|Protocol Violation|0|||
161670223|NCT00775450|583845403|FG000|Overall Study|Serious Adverse Event|2|||
161670224|NCT00775450|583845404|FG001|Overall Study|Serious Adverse Event|0|||
161670225|NCT00775450|583845405|FG002|Overall Study|Serious Adverse Event|0|||
161670226|NCT00775450|583845406|FG003|Overall Study|Serious Adverse Event|0|||
161670227|NCT00775450|583845407|FG004|Overall Study|Serious Adverse Event|0|||
161670228|NCT00775450|583845403|FG000|Overall Study|Protocol Violation|0|||
161670229|NCT00775450|583845404|FG001|Overall Study|Protocol Violation|0|||
161670230|NCT00775450|583845405|FG002|Overall Study|Protocol Violation|0|||
161670231|NCT00775450|583845406|FG003|Overall Study|Protocol Violation|0|||
161670232|NCT00775450|583845407|FG004|Overall Study|Protocol Violation|1|||
161670233|NCT00775450|583845403|FG000|Overall Study|Withdrawal by Subject|1|||
161670234|NCT00775450|583845404|FG001|Overall Study|Withdrawal by Subject|0|||
161816991|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
161485468|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
161485469|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
161485470|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
161485471|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
161485472|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
161485473|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
161485474|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
161485475|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
161485476|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Death|0|||
161485477|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Death|0|||
161485478|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Death|0|||
161670235|NCT00775450|583845405|FG002|Overall Study|Withdrawal by Subject|0|||
161670236|NCT00775450|583845406|FG003|Overall Study|Withdrawal by Subject|0|||
161670237|NCT00775450|583845407|FG004|Overall Study|Withdrawal by Subject|1|||
161670238|NCT01749540|583845415|FG000|Overall Study|Protocol Violation|0|||
161670239|NCT01749540|583845416|FG001|Overall Study|Protocol Violation|0|||
161670240|NCT01749540|583845417|FG002|Overall Study|Protocol Violation|0|||
161670241|NCT01749540|583845418|FG003|Overall Study|Protocol Violation|0|||
161670242|NCT01749540|583845419|FG004|Overall Study|Protocol Violation|0|||
161670243|NCT01749540|583845420|FG005|Overall Study|Protocol Violation|1|||
161816992|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
161670244|NCT01749540|583845421|FG006|Overall Study|Protocol Violation|1|||
161581415|NCT02723955|583518274|FG041|Escalation Phase|Lost to Follow-up|0|||
161581416|NCT02723955|583518275|FG042|Escalation Phase|Lost to Follow-up|0|||
161581417|NCT02723955|583518233|FG000|Escalation Phase|Physician Decision|0|||
161581418|NCT02723955|583518234|FG001|Escalation Phase|Physician Decision|0|||
161581419|NCT02723955|583518235|FG002|Escalation Phase|Physician Decision|0|||
161581420|NCT02723955|583518236|FG003|Escalation Phase|Physician Decision|0|||
161581421|NCT02723955|583518237|FG004|Escalation Phase|Physician Decision|0|||
161581422|NCT02723955|583518238|FG005|Escalation Phase|Physician Decision|2|||
161581423|NCT02723955|583518239|FG006|Escalation Phase|Physician Decision|0|||
161581424|NCT02723955|583518240|FG007|Escalation Phase|Physician Decision|0|||
161581425|NCT02723955|583518241|FG008|Escalation Phase|Physician Decision|0|||
161581426|NCT02723955|583518242|FG009|Escalation Phase|Physician Decision|0|||
161581427|NCT02723955|583518243|FG010|Escalation Phase|Physician Decision|0|||
161581428|NCT02723955|583518244|FG011|Escalation Phase|Physician Decision|0|||
161581429|NCT02723955|583518245|FG012|Escalation Phase|Physician Decision|0|||
161581430|NCT02723955|583518246|FG013|Escalation Phase|Physician Decision|0|||
161581431|NCT02723955|583518247|FG014|Escalation Phase|Physician Decision|0|||
161581432|NCT02723955|583518248|FG015|Escalation Phase|Physician Decision|0|||
161581433|NCT02723955|583518249|FG016|Escalation Phase|Physician Decision|0|||
161581434|NCT02723955|583518250|FG017|Escalation Phase|Physician Decision|0|||
161581435|NCT02723955|583518251|FG018|Escalation Phase|Physician Decision|0|||
161922692|NCT00924651|584764836|FG000|Overall Study|Noncompliant|1|||
161581436|NCT02723955|583518252|FG019|Escalation Phase|Physician Decision|0|||
161581437|NCT02723955|583518253|FG020|Escalation Phase|Physician Decision|0|||
161581438|NCT02723955|583518254|FG021|Escalation Phase|Physician Decision|0|||
161922693|NCT00924651|584764837|FG001|Overall Study|Noncompliant|4|||
161922694|NCT00924651|584764836|FG000|Overall Study|Medical|1|||
161922695|NCT00924651|584764837|FG001|Overall Study|Medical|3|||
161922696|NCT00924651|584764836|FG000|Overall Study|Changed Mind|10|||
161922697|NCT00924651|584764837|FG001|Overall Study|Changed Mind|1|||
161922698|NCT00924651|584764836|FG000|Overall Study|Incomplete Form|2|||
161922699|NCT00924651|584764837|FG001|Overall Study|Incomplete Form|1|||
161922700|NCT00723944|584764838|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
161922701|NCT00723944|584764839|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
161922702|NCT00723944|584764838|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
161922703|NCT00723944|584764839|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
161922704|NCT00723944|584764838|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
161922705|NCT00723944|584764839|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
161922706|NCT00835978|584764840|FG000|Overall Study|Death|33|||
161922707|NCT00835978|584764841|FG001|Overall Study|Death|40|||
161922708|NCT00835978|584764842|FG002|Overall Study|Death|49|||
161816993|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
161485479|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Death|0|||
161485480|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Death|1|||
161485481|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Death|1|||
161485482|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Death|3|||
161485483|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Death|1|||
161485484|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Death|1|||
161485485|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Death|5|||
161485486|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Death|2|||
161485487|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Death|2|||
161485488|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Other|0|||
161816994|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
161816995|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
161485489|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Other|0|||
161485490|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Other|0|||
161485491|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Other|0|||
161485492|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Other|10|||
161485493|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Other|3|||
161485494|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Other|2|||
161485495|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Other|0|||
161485496|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Other|10|||
161485497|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Other|5|||
161485498|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Other|1|||
161485499|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Other|7|||
161485500|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485501|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485502|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485503|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485504|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
161485505|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485506|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485507|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485508|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485509|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485510|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485511|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161485512|NCT02521870|583169057|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485513|NCT02521870|583169058|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485514|NCT02521870|583169059|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485515|NCT02521870|583169060|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485516|NCT02521870|583169061|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
161485517|NCT02521870|583169062|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485518|NCT02521870|583169063|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485519|NCT02521870|583169064|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485520|NCT02521870|583169065|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485521|NCT02521870|583169066|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485522|NCT02521870|583169067|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485523|NCT02521870|583169068|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
161485524|NCT00519831|583169069|FG000|Overall Study|Adverse Event|3|||
161485525|NCT00471328|583169070|FG000|Core Phase|Adverse Event|18|||
161485526|NCT00471328|583169071|FG001|Core Phase|Adverse Event|6|||
161485527|NCT00471328|583169070|FG000|Core Phase|Death|8|||
161485528|NCT00471328|583169071|FG001|Core Phase|Death|4|||
161485529|NCT00471328|583169070|FG000|Core Phase|Withdrawal by Subject|2|||
161485530|NCT00471328|583169071|FG001|Core Phase|Withdrawal by Subject|2|||
161485531|NCT00471328|583169070|FG000|Core Phase|Abnormal laboratory value|1|||
161485532|NCT00471328|583169071|FG001|Core Phase|Abnormal laboratory value|0|||
161485533|NCT00471328|583169070|FG000|Core Phase|Disease Progression|78|||
161485534|NCT00471328|583169071|FG001|Core Phase|Disease Progression|53|||
161485535|NCT00471328|583169070|FG000|Core Phase|Administrative Problem|0|||
161485536|NCT00471328|583169071|FG001|Core Phase|Administrative Problem|1|||
161485537|NCT00471328|583169070|FG000|Core Phase|Protocol Deviation|0|||
161485538|NCT00471328|583169071|FG001|Core Phase|Protocol Deviation|1|||
161485539|NCT00471328|583169070|FG000|Extension Phase|Adverse Event|3|||
161485540|NCT00471328|583169071|FG001|Extension Phase|Adverse Event|12|||
161485541|NCT00471328|583169070|FG000|Extension Phase|Withdrawal by Subject|0|||
161485542|NCT00471328|583169071|FG001|Extension Phase|Withdrawal by Subject|2|||
161485543|NCT00471328|583169070|FG000|Extension Phase|Death|1|||
161485544|NCT00471328|583169071|FG001|Extension Phase|Death|7|||
161485545|NCT00471328|583169070|FG000|Extension Phase|Protocol Deviation|3|||
161485546|NCT00471328|583169071|FG001|Extension Phase|Protocol Deviation|1|||
161485547|NCT00471328|583169070|FG000|Extension Phase|Treatment duration as per protocol|0|||
161485548|NCT00471328|583169071|FG001|Extension Phase|Treatment duration as per protocol|1|||
161485549|NCT00471328|583169070|FG000|Extension Phase|Disease Progression|32|||
161485550|NCT00471328|583169071|FG001|Extension Phase|Disease Progression|44|||
161485551|NCT00471328|583169070|FG000|Extension Phase|New cancer Therapy|1|||
161670245|NCT01749540|583845415|FG000|Overall Study|Withdrawal by Subject|0|||
161670246|NCT01749540|583845416|FG001|Overall Study|Withdrawal by Subject|0|||
161670247|NCT01749540|583845417|FG002|Overall Study|Withdrawal by Subject|0|||
161670248|NCT01749540|583845418|FG003|Overall Study|Withdrawal by Subject|1|||
161670249|NCT01749540|583845419|FG004|Overall Study|Withdrawal by Subject|0|||
161670250|NCT01749540|583845420|FG005|Overall Study|Withdrawal by Subject|0|||
161670251|NCT01749540|583845421|FG006|Overall Study|Withdrawal by Subject|0|||
161670252|NCT01749540|583845415|FG000|Overall Study|Initiated into extension study A536-06|0|||
161670253|NCT01749540|583845416|FG001|Overall Study|Initiated into extension study A536-06|0|||
161670254|NCT01749540|583845417|FG002|Overall Study|Initiated into extension study A536-06|0|||
161670255|NCT01749540|583845418|FG003|Overall Study|Initiated into extension study A536-06|0|||
161670256|NCT01749540|583845419|FG004|Overall Study|Initiated into extension study A536-06|0|||
161670257|NCT01749540|583845420|FG005|Overall Study|Initiated into extension study A536-06|2|||
161670258|NCT01749540|583845421|FG006|Overall Study|Initiated into extension study A536-06|24|||
161670259|NCT00752622|583845433|FG000|Induction Phase|Adverse Event|3|||
161670260|NCT00752622|583845433|FG000|Induction Phase|Other|3|||
161670261|NCT00752622|583845433|FG000|Induction Phase|Non-responder|14|||
161485552|NCT00471328|583169071|FG001|Extension Phase|New cancer Therapy|0|||
161670262|NCT00752622|583845433|FG000|Induction Phase|Withdrawal by Subject|1|||
161670263|NCT00752622|583845433|FG000|Induction Phase|Premature study termination|14|||
161670264|NCT00752622|583845433|FG000|Observational Phase|Premature Study Termination|36|||
161670265|NCT00752622|583845433|FG000|Observational Phase|Non-responder|2|||
161670266|NCT00752622|583845433|FG000|Observational Phase|Withdrawal by Subject|2|||
161670267|NCT00752622|583845433|FG000|Observational Phase|Adverse Event|1|||
161485553|NCT00471328|583169070|FG000|Extension Phase|Administrative Problem|1|||
161485554|NCT00471328|583169071|FG001|Extension Phase|Administrative Problem|0|||
161485555|NCT02854631|583169072|FG000|Overall Study|Adverse Event|1|||
161485556|NCT02854631|583169073|FG001|Overall Study|Adverse Event|2|||
161485557|NCT02854631|583169072|FG000|Overall Study|Withdrew Consent|3|||
161485558|NCT02854631|583169073|FG001|Overall Study|Withdrew Consent|2|||
161485559|NCT02854631|583169072|FG000|Overall Study|Investigator's Discretion|2|||
161485560|NCT02854631|583169073|FG001|Overall Study|Investigator's Discretion|0|||
161485561|NCT02854631|583169072|FG000|Overall Study|Death|12|||
161485562|NCT02854631|583169073|FG001|Overall Study|Death|8|||
161485563|NCT02854631|583169072|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
161485564|NCT02854631|583169073|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
161485565|NCT02854631|583169072|FG000|Overall Study|Protocol Violation|0|||
161485566|NCT02854631|583169073|FG001|Overall Study|Protocol Violation|1|||
161485567|NCT02854631|583169072|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
161485568|NCT02854631|583169073|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
161485569|NCT02854631|583169072|FG000|Overall Study|Lost to Follow-up|4|||
161485570|NCT02854631|583169073|FG001|Overall Study|Lost to Follow-up|2|||
161485571|NCT03930797|583169074|FG000|Overall Study|Lost to Follow-up|3|||
161485572|NCT03930797|583169075|FG001|Overall Study|Lost to Follow-up|10|||
161485573|NCT01962896|583169076|FG000|Overall Study|Lack of Efficacy|4|||
161485574|NCT00662012|583169077|FG000|Overall Study|Lost to Follow-up|85|||
161485575|NCT00662012|583169077|FG000|Overall Study|Death|1|||
161485576|NCT00662012|583169077|FG000|Overall Study|Withdrawal by Subject|1|||
161485577|NCT04212650|583169078|FG000|Overall Study|Withdrawal by Subject|1|||
161485578|NCT04212650|583169079|FG001|Overall Study|Withdrawal by Subject|0|||
161485579|NCT00598832|583169080|FG000|Overall Study|Lack of Efficacy|3|||
161485580|NCT00598832|583169081|FG001|Overall Study|Lack of Efficacy|7|||
161485581|NCT00598832|583169080|FG000|Overall Study|Adverse Event|6|||
161485582|NCT00598832|583169081|FG001|Overall Study|Adverse Event|2|||
161485583|NCT00598832|583169080|FG000|Overall Study|Withdrawal by Subject|25|||
161485584|NCT00598832|583169081|FG001|Overall Study|Withdrawal by Subject|36|||
161485585|NCT00598832|583169080|FG000|Overall Study|Protocol Violation|0|||
161485586|NCT00598832|583169081|FG001|Overall Study|Protocol Violation|2|||
161485587|NCT00598832|583169080|FG000|Overall Study|Lost to Follow-up|24|||
161485588|NCT00598832|583169081|FG001|Overall Study|Lost to Follow-up|29|||
161485589|NCT00598832|583169080|FG000|Overall Study|Pregnancy|2|||
161485590|NCT00598832|583169081|FG001|Overall Study|Pregnancy|2|||
161485591|NCT00598832|583169080|FG000|Overall Study|Physician Decision|1|||
161485592|NCT00598832|583169081|FG001|Overall Study|Physician Decision|4|||
161485593|NCT00598832|583169080|FG000|Overall Study|Non compliance|1|||
161485594|NCT00598832|583169081|FG001|Overall Study|Non compliance|0|||
161485595|NCT02142959|583169082|FG000|Overall Study|Adverse Event|1|||
161485596|NCT02142959|583169083|FG001|Overall Study|Adverse Event|0|||
161485597|NCT02142959|583169084|FG002|Overall Study|Adverse Event|0|||
161485598|NCT02142959|583169082|FG000|Overall Study|Death|0|||
161485599|NCT02142959|583169083|FG001|Overall Study|Death|1|||
161485600|NCT02142959|583169084|FG002|Overall Study|Death|0|||
161485601|NCT02142959|583169082|FG000|Overall Study|Withdrawal by Subject|3|||
161485602|NCT02142959|583169083|FG001|Overall Study|Withdrawal by Subject|1|||
161485603|NCT02142959|583169084|FG002|Overall Study|Withdrawal by Subject|3|||
161485604|NCT02142959|583169082|FG000|Overall Study|Administrative Reasons|1|||
161485605|NCT02142959|583169083|FG001|Overall Study|Administrative Reasons|0|||
161670268|NCT00752622|583845433|FG000|Observational Phase|Other|2|||
161670269|NCT00752622|583845433|FG000|Interventional Phase|Non-responder|2|||
161670270|NCT00752622|583845433|FG000|Interventional Phase|Physician Decision|1|||
161670271|NCT00752622|583845433|FG000|Interventional Phase|Premature Study Termination|5|||
161670272|NCT00576836|583845434|FG000|Overall Study|Death|0|||
161670273|NCT00576836|583845435|FG001|Overall Study|Death|1|||
161670274|NCT00576836|583845434|FG000|Overall Study|Physician Decision|0|||
161670275|NCT00576836|583845435|FG001|Overall Study|Physician Decision|1|||
161670276|NCT00392327|583845438|FG000|Overall Study|Death|1|||
161670277|NCT00392327|583845439|FG001|Overall Study|Death|0|||
161670278|NCT00392327|583845440|FG002|Overall Study|Death|1|||
161670279|NCT00392327|583845441|FG003|Overall Study|Death|0|||
161670280|NCT00392327|583845442|FG004|Overall Study|Death|0|||
161670281|NCT00392327|583845443|FG005|Overall Study|Death|0|||
161670282|NCT00392327|583845444|FG006|Overall Study|Death|0|||
161670283|NCT00392327|583845445|FG007|Overall Study|Death|0|||
161670284|NCT00392327|583845438|FG000|Overall Study|Lack of Efficacy|8|||
161670285|NCT00392327|583845439|FG001|Overall Study|Lack of Efficacy|8|||
161670286|NCT00392327|583845440|FG002|Overall Study|Lack of Efficacy|9|||
161670287|NCT00392327|583845441|FG003|Overall Study|Lack of Efficacy|6|||
161670288|NCT00392327|583845442|FG004|Overall Study|Lack of Efficacy|3|||
161670289|NCT00392327|583845443|FG005|Overall Study|Lack of Efficacy|3|||
161670290|NCT00392327|583845444|FG006|Overall Study|Lack of Efficacy|3|||
161670291|NCT00392327|583845445|FG007|Overall Study|Lack of Efficacy|3|||
161670292|NCT00392327|583845438|FG000|Overall Study|Physician Decision|3|||
161670293|NCT00392327|583845439|FG001|Overall Study|Physician Decision|5|||
161670294|NCT00392327|583845440|FG002|Overall Study|Physician Decision|2|||
161670295|NCT00392327|583845441|FG003|Overall Study|Physician Decision|2|||
161670296|NCT00392327|583845442|FG004|Overall Study|Physician Decision|0|||
161670297|NCT00392327|583845443|FG005|Overall Study|Physician Decision|1|||
161670298|NCT00392327|583845444|FG006|Overall Study|Physician Decision|5|||
161670299|NCT00392327|583845445|FG007|Overall Study|Physician Decision|3|||
161670300|NCT00392327|583845438|FG000|Overall Study|Protocol Violation|0|||
161670301|NCT00392327|583845439|FG001|Overall Study|Protocol Violation|0|||
161670302|NCT00392327|583845440|FG002|Overall Study|Protocol Violation|1|||
161670303|NCT00392327|583845441|FG003|Overall Study|Protocol Violation|0|||
161670304|NCT00392327|583845442|FG004|Overall Study|Protocol Violation|0|||
161670305|NCT00392327|583845443|FG005|Overall Study|Protocol Violation|0|||
161670306|NCT00392327|583845444|FG006|Overall Study|Protocol Violation|0|||
161670307|NCT00392327|583845445|FG007|Overall Study|Protocol Violation|0|||
161670308|NCT00392327|583845438|FG000|Overall Study|Withdrawal by Subject|3|||
161670309|NCT00392327|583845439|FG001|Overall Study|Withdrawal by Subject|2|||
161670310|NCT00392327|583845440|FG002|Overall Study|Withdrawal by Subject|4|||
161670311|NCT00392327|583845441|FG003|Overall Study|Withdrawal by Subject|6|||
161670312|NCT00392327|583845442|FG004|Overall Study|Withdrawal by Subject|0|||
161670313|NCT00392327|583845443|FG005|Overall Study|Withdrawal by Subject|1|||
161670314|NCT00392327|583845444|FG006|Overall Study|Withdrawal by Subject|1|||
161670315|NCT00392327|583845445|FG007|Overall Study|Withdrawal by Subject|5|||
161670316|NCT00392327|583845438|FG000|Overall Study|Ineligible|0|||
161670317|NCT00392327|583845439|FG001|Overall Study|Ineligible|4|||
161670318|NCT00392327|583845440|FG002|Overall Study|Ineligible|3|||
161670319|NCT00392327|583845441|FG003|Overall Study|Ineligible|2|||
161670320|NCT00392327|583845442|FG004|Overall Study|Ineligible|0|||
161670321|NCT00392327|583845443|FG005|Overall Study|Ineligible|0|||
161670322|NCT00392327|583845444|FG006|Overall Study|Ineligible|0|||
161670323|NCT00392327|583845445|FG007|Overall Study|Ineligible|0|||
161670324|NCT00894686|583845446|FG000|Overall Study|Withdrawal by Subject|50|||
161670325|NCT00894686|583845446|FG000|Overall Study|Physician Decision|1|||
161670326|NCT00894686|583845446|FG000|Overall Study|Other|5|||
161670327|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
161670328|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
161816996|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
161670329|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670330|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670331|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670332|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670333|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670334|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
161670335|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670336|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670337|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670338|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670339|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670340|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
161670341|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161922709|NCT00835978|584764843|FG003|Overall Study|Death|4|||
161670342|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670343|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670344|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670345|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
161670346|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
161670347|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670348|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670349|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670350|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670351|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670352|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670353|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670354|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
161670355|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
161670356|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670357|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161670358|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161670359|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
161670360|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
161670361|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
161670362|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161670363|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
161670364|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
161670365|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
161670366|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161670367|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161670368|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161670369|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
161670370|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
161670371|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
161670372|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
161670373|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
161670374|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
161670375|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161670376|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161670377|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
161670378|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
161485606|NCT02142959|583169084|FG002|Overall Study|Administrative Reasons|1|||
161485607|NCT02142959|583169082|FG000|Overall Study|Missing|0|||
161485608|NCT02142959|583169083|FG001|Overall Study|Missing|1|||
161485609|NCT02142959|583169084|FG002|Overall Study|Missing|0|||
161485610|NCT02142959|583169082|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
161485611|NCT02142959|583169083|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
161485612|NCT02142959|583169084|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
161485613|NCT02142959|583169082|FG000|Overall Study|Patient didn't complete end of study visit|0|||
161485614|NCT02142959|583169083|FG001|Overall Study|Patient didn't complete end of study visit|0|||
161485615|NCT02142959|583169084|FG002|Overall Study|Patient didn't complete end of study visit|1|||
161485616|NCT01753856|583169089|FG000|Overall Study|Adverse Event|1|||
161485617|NCT01753856|583169090|FG001|Overall Study|Adverse Event|0|||
161485618|NCT01753856|583169089|FG000|Overall Study|Withdrawal by Subject|0|||
161485619|NCT01753856|583169090|FG001|Overall Study|Withdrawal by Subject|2|||
161485620|NCT01753856|583169089|FG000|Overall Study|Sponsor Decision|2|||
161485621|NCT01753856|583169090|FG001|Overall Study|Sponsor Decision|0|||
161485622|NCT05980182|583169091|FG000|Overall Study|Lost to Follow-up|10|||
161485623|NCT01852110|583171001|FG000|Overall Study|Adverse Event|12|||
161485624|NCT01852110|583171002|FG001|Overall Study|Adverse Event|5|||
161485625|NCT01852110|583171003|FG002|Overall Study|Adverse Event|0|||
161485626|NCT01852110|583171004|FG003|Overall Study|Adverse Event|0|||
161485627|NCT01852110|583171005|FG004|Overall Study|Adverse Event|0|||
161485628|NCT01852110|583171006|FG005|Overall Study|Adverse Event|0|||
161485629|NCT01852110|583171001|FG000|Overall Study|Lost to Follow-up|1|||
161485630|NCT01852110|583171002|FG001|Overall Study|Lost to Follow-up|3|||
161485631|NCT01852110|583171003|FG002|Overall Study|Lost to Follow-up|0|||
161485632|NCT01852110|583171004|FG003|Overall Study|Lost to Follow-up|0|||
161485633|NCT01852110|583171005|FG004|Overall Study|Lost to Follow-up|0|||
161485634|NCT01852110|583171006|FG005|Overall Study|Lost to Follow-up|0|||
161485635|NCT01852110|583171001|FG000|Overall Study|Non-compliance with Study Drug|2|||
161485636|NCT01852110|583171002|FG001|Overall Study|Non-compliance with Study Drug|1|||
161670379|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161670380|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
161670381|NCT00178126|583845459|FG000|Overall Study|Lost to Follow-up|21|||
161670382|NCT00178126|583845460|FG001|Overall Study|Lost to Follow-up|21|||
161670383|NCT00178126|583845459|FG000|Overall Study|did not receive intervention|4|||
161670384|NCT00178126|583845460|FG001|Overall Study|did not receive intervention|6|||
161670385|NCT01074216|583845461|FG000|Overall Study|Physician Decision|1|||
161670386|NCT01074216|583845461|FG000|Overall Study|Not Treated|12|||
161670387|NCT01323634|583845462|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
161670388|NCT01323634|583845463|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
161670389|NCT01323634|583845464|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
161670390|NCT01323634|583845462|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
161670391|NCT01323634|583845463|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
161670392|NCT01323634|583845464|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
161670393|NCT01323634|583845462|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
161670394|NCT01323634|583845463|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161670395|NCT01323634|583845464|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161670396|NCT01323634|583845462|FG000|2-week Run-in Period|Physician Decision|5|||
161670397|NCT01323634|583845463|FG001|2-week Run-in Period|Physician Decision|0|||
161670398|NCT01323634|583845464|FG002|2-week Run-in Period|Physician Decision|0|||
161670399|NCT01323634|583845462|FG000|2-week Run-in Period|Protocol Violation|1|||
161670400|NCT01323634|583845463|FG001|2-week Run-in Period|Protocol Violation|0|||
161670401|NCT01323634|583845464|FG002|2-week Run-in Period|Protocol Violation|0|||
161670402|NCT01323634|583845462|FG000|2-week Run-in Period|Adverse Event|1|||
161670403|NCT01323634|583845463|FG001|2-week Run-in Period|Adverse Event|0|||
161670404|NCT01323634|583845464|FG002|2-week Run-in Period|Adverse Event|0|||
161670405|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161670406|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
161670407|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
161670408|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161670409|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161670410|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
161670411|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161670412|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
161670413|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
161670414|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161670415|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161670416|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161670417|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
161670418|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
161670419|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
161670420|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161670421|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
161670422|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
161670423|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
161670424|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
161670425|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
161670426|NCT05056987|583845465|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
161670427|NCT05056987|583845466|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
161670428|NCT05056987|583845465|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
161670429|NCT05056987|583845466|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
161670430|NCT01182194|583845467|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
161670431|NCT01182194|583845468|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
161670432|NCT01948908|583845469|FG000|Overall Study|Protocol Violation|1|||
161670433|NCT01948908|583845470|FG001|Overall Study|Protocol Violation|0|||
161670434|NCT01948908|583845471|FG002|Overall Study|Protocol Violation|2|||
161670435|NCT01585987|583845472|FG000|Randomized|Withdrawal by Subject|0|||
161670436|NCT01585987|583845473|FG001|Randomized|Withdrawal by Subject|4|||
161670437|NCT01585987|583845472|FG000|Randomized|No longer met criteria|0|||
161670438|NCT01585987|583845473|FG001|Randomized|No longer met criteria|2|||
161670439|NCT01585987|583845472|FG000|Treated|Disease Progression|39|||
161670440|NCT01585987|583845473|FG001|Treated|Disease Progression|36|||
161670441|NCT01585987|583845472|FG000|Treated|Study Drug Toxicity|9|||
161670442|NCT01585987|583845473|FG001|Treated|Study Drug Toxicity|5|||
161816997|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
161816998|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
161816999|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
161670443|NCT01585987|583845472|FG000|Treated|Adverse Event|3|||
161670444|NCT01585987|583845473|FG001|Treated|Adverse Event|0|||
161670445|NCT01585987|583845472|FG000|Treated|Withdrawal by Subject|1|||
161817000|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
161485637|NCT01852110|583171003|FG002|Overall Study|Non-compliance with Study Drug|0|||
161485638|NCT01852110|583171004|FG003|Overall Study|Non-compliance with Study Drug|0|||
161485639|NCT01852110|583171005|FG004|Overall Study|Non-compliance with Study Drug|0|||
161485640|NCT01852110|583171006|FG005|Overall Study|Non-compliance with Study Drug|0|||
161485641|NCT01852110|583171001|FG000|Overall Study|Physician Decision|1|||
161485642|NCT01852110|583171002|FG001|Overall Study|Physician Decision|0|||
161485643|NCT01852110|583171003|FG002|Overall Study|Physician Decision|0|||
161485644|NCT01852110|583171004|FG003|Overall Study|Physician Decision|0|||
161485645|NCT01852110|583171005|FG004|Overall Study|Physician Decision|0|||
161485646|NCT01852110|583171006|FG005|Overall Study|Physician Decision|0|||
161485647|NCT01852110|583171001|FG000|Overall Study|Protocol Violation|0|||
161485648|NCT01852110|583171002|FG001|Overall Study|Protocol Violation|1|||
161485649|NCT01852110|583171003|FG002|Overall Study|Protocol Violation|0|||
161485650|NCT01852110|583171004|FG003|Overall Study|Protocol Violation|0|||
161485651|NCT01852110|583171005|FG004|Overall Study|Protocol Violation|0|||
161485652|NCT01852110|583171006|FG005|Overall Study|Protocol Violation|0|||
161485653|NCT01852110|583171001|FG000|Overall Study|Study Terminated by Sponsor|30|||
161485654|NCT01852110|583171002|FG001|Overall Study|Study Terminated by Sponsor|32|||
161670446|NCT01585987|583845473|FG001|Treated|Withdrawal by Subject|2|||
161485655|NCT01852110|583171003|FG002|Overall Study|Study Terminated by Sponsor|0|||
161485656|NCT01852110|583171004|FG003|Overall Study|Study Terminated by Sponsor|0|||
161485657|NCT01852110|583171005|FG004|Overall Study|Study Terminated by Sponsor|0|||
161485658|NCT01852110|583171006|FG005|Overall Study|Study Terminated by Sponsor|0|||
161485659|NCT01852110|583171001|FG000|Overall Study|Withdrawal by Subject|4|||
161485660|NCT01852110|583171002|FG001|Overall Study|Withdrawal by Subject|4|||
161485661|NCT01852110|583171003|FG002|Overall Study|Withdrawal by Subject|0|||
161485662|NCT01852110|583171004|FG003|Overall Study|Withdrawal by Subject|0|||
161485663|NCT01852110|583171005|FG004|Overall Study|Withdrawal by Subject|0|||
161485664|NCT01852110|583171006|FG005|Overall Study|Withdrawal by Subject|0|||
161485665|NCT02961751|583171017|FG000|Overall Study|Lost to Follow-up|11|||
161485666|NCT02961751|583171017|FG000|Overall Study|Physician Decision|2|||
161485667|NCT02961751|583171017|FG000|Overall Study|Not Eligible at Enrollment|1|||
161485668|NCT02961751|583171017|FG000|Overall Study|Protocol Violation|1|||
161485669|NCT00842712|583171018|FG000|Safety Run-in Part|Adverse Event|0|||
161485670|NCT00842712|583171019|FG001|Safety Run-in Part|Adverse Event|1|||
161485671|NCT00842712|583171020|FG002|Safety Run-in Part|Adverse Event|0|||
161485672|NCT00842712|583171021|FG003|Safety Run-in Part|Adverse Event|0|||
161485673|NCT00842712|583171022|FG004|Safety Run-in Part|Adverse Event|0|||
161485674|NCT00842712|583171023|FG005|Safety Run-in Part|Adverse Event|0|||
161485675|NCT00842712|583171024|FG006|Safety Run-in Part|Adverse Event|0|||
161485676|NCT00842712|583171018|FG000|Safety Run-in Part|Progressive disease|3|||
161485677|NCT00842712|583171019|FG001|Safety Run-in Part|Progressive disease|1|||
161485678|NCT00842712|583171020|FG002|Safety Run-in Part|Progressive disease|0|||
161485679|NCT00842712|583171021|FG003|Safety Run-in Part|Progressive disease|1|||
161485680|NCT00842712|583171022|FG004|Safety Run-in Part|Progressive disease|0|||
161485681|NCT00842712|583171023|FG005|Safety Run-in Part|Progressive disease|0|||
161485682|NCT00842712|583171024|FG006|Safety Run-in Part|Progressive disease|0|||
161485683|NCT00842712|583171018|FG000|Randomized Part|Randomized but not treated|0|||
161485684|NCT00842712|583171019|FG001|Randomized Part|Randomized but not treated|0|||
161485685|NCT00842712|583171020|FG002|Randomized Part|Randomized but not treated|0|||
161485686|NCT00842712|583171021|FG003|Randomized Part|Randomized but not treated|0|||
161485687|NCT00842712|583171022|FG004|Randomized Part|Randomized but not treated|0|||
161485688|NCT00842712|583171023|FG005|Randomized Part|Randomized but not treated|1|||
161485689|NCT00842712|583171024|FG006|Randomized Part|Randomized but not treated|4|||
161485690|NCT00842712|583171018|FG000|Randomized Part|Ongoing at cut-off date|0|||
161485691|NCT00842712|583171019|FG001|Randomized Part|Ongoing at cut-off date|0|||
161485692|NCT00842712|583171020|FG002|Randomized Part|Ongoing at cut-off date|0|||
161485693|NCT00842712|583171021|FG003|Randomized Part|Ongoing at cut-off date|0|||
161485694|NCT00842712|583171022|FG004|Randomized Part|Ongoing at cut-off date|0|||
161485695|NCT00842712|583171023|FG005|Randomized Part|Ongoing at cut-off date|0|||
161485696|NCT00842712|583171024|FG006|Randomized Part|Ongoing at cut-off date|2|||
161485697|NCT01384760|583171031|FG000|Overall Study|Lost to Follow-up|0|||
161485698|NCT01384760|583171032|FG001|Overall Study|Lost to Follow-up|6|||
161485699|NCT01384760|583171031|FG000|Overall Study|Protocol Violation|16|||
161485700|NCT01384760|583171032|FG001|Overall Study|Protocol Violation|0|||
161485701|NCT00903695|583171036|FG000|Overall Study|medical exclusion after 1st testing|1|||
161485702|NCT00903695|583171037|FG001|Overall Study|medical exclusion after 1st testing|0|||
161485703|NCT00903695|583171036|FG000|Overall Study|lung cancer|1|||
161485704|NCT00903695|583171037|FG001|Overall Study|lung cancer|0|||
161485705|NCT01549860|583171038|FG000|Overall Study|Withdrawal by Subject|1|||
161485706|NCT01549860|583171039|FG001|Overall Study|Withdrawal by Subject|0|||
161485707|NCT01549860|583171038|FG000|Overall Study|Physician Decision|1|||
161670447|NCT01585987|583845472|FG000|Treated|Death|1|||
161485708|NCT01549860|583171039|FG001|Overall Study|Physician Decision|1|||
161485709|NCT01366521|583171041|FG000|Overall Study|Adverse Event|1|||
161485710|NCT01366521|583171042|FG001|Overall Study|Adverse Event|0|||
161485711|NCT01366521|583171043|FG002|Overall Study|Adverse Event|0|||
161670448|NCT01585987|583845473|FG001|Treated|Death|0|||
161670449|NCT01585987|583845472|FG000|Treated|Lost to Follow-up|0|||
161670450|NCT01585987|583845473|FG001|Treated|Lost to Follow-up|1|||
161670451|NCT01585987|583845472|FG000|Treated|Maximum Clinical Benefit|0|||
161670452|NCT01585987|583845473|FG001|Treated|Maximum Clinical Benefit|1|||
161670453|NCT01585987|583845472|FG000|Treated|Non-Specified|1|||
161670454|NCT01585987|583845473|FG001|Treated|Non-Specified|2|||
161670455|NCT01585987|583845472|FG000|Treated|Subject Request|0|||
161670456|NCT01585987|583845473|FG001|Treated|Subject Request|1|||
161670457|NCT01585987|583845472|FG000|Treated|Poor/Non-Compliance|0|||
161670458|NCT01585987|583845473|FG001|Treated|Poor/Non-Compliance|1|||
161670459|NCT03291587|583845474|FG000|Overall Study|Lost to Follow-up|62|||
161670460|NCT03291587|583845475|FG001|Overall Study|Lost to Follow-up|43|||
161670461|NCT03291587|583845474|FG000|Overall Study|Refused to Answer|5|||
161670462|NCT03291587|583845475|FG001|Overall Study|Refused to Answer|2|||
161670463|NCT03291587|583845474|FG000|Overall Study|Death|2|||
161670464|NCT03291587|583845475|FG001|Overall Study|Death|4|||
161670465|NCT03291587|583845474|FG000|Overall Study|Not interested in participating|8|||
161670466|NCT03291587|583845475|FG001|Overall Study|Not interested in participating|6|||
161670467|NCT03291587|583845474|FG000|Overall Study|Too busy to participate|4|||
161670468|NCT03291587|583845475|FG001|Overall Study|Too busy to participate|2|||
161670469|NCT00796120|583845476|FG000|Overall Study|Death|3|||
161670470|NCT00796120|583845477|FG001|Overall Study|Death|0|||
161670471|NCT00796120|583845476|FG000|Overall Study|Adverse Event|11|||
161670472|NCT00796120|583845477|FG001|Overall Study|Adverse Event|6|||
161670473|NCT00796120|583845476|FG000|Overall Study|Progressive disease|22|||
161670474|NCT00796120|583845477|FG001|Overall Study|Progressive disease|13|||
161670475|NCT00796120|583845476|FG000|Overall Study|Participant refusal|3|||
161670476|NCT00796120|583845477|FG001|Overall Study|Participant refusal|4|||
161670477|NCT00796120|583845476|FG000|Overall Study|Other|6|||
161670478|NCT00796120|583845477|FG001|Overall Study|Other|17|||
161670479|NCT00796120|583845476|FG000|Overall Study|Physician Decision|16|||
161670480|NCT00796120|583845477|FG001|Overall Study|Physician Decision|17|||
161670481|NCT00796120|583845476|FG000|Overall Study|Randomized but not treated|0|||
161670482|NCT00796120|583845477|FG001|Overall Study|Randomized but not treated|3|||
161670483|NCT01411839|583845482|FG000|Overall Study|Lost to Follow-up|4|||
161670484|NCT01411839|583845483|FG001|Overall Study|Lost to Follow-up|3|||
161670485|NCT04641299|583847204|FG000|Overall Study|Adverse Event|0|||
161670486|NCT04641299|583847205|FG001|Overall Study|Adverse Event|0|||
161670487|NCT04641299|583847206|FG002|Overall Study|Adverse Event|2|||
161670488|NCT04641299|583847207|FG003|Overall Study|Adverse Event|0|||
161670489|NCT04641299|583847204|FG000|Overall Study|Lost to Follow-up|0|||
161670490|NCT04641299|583847205|FG001|Overall Study|Lost to Follow-up|1|||
161670491|NCT04641299|583847206|FG002|Overall Study|Lost to Follow-up|0|||
161670492|NCT04641299|583847207|FG003|Overall Study|Lost to Follow-up|0|||
161670493|NCT04641299|583847204|FG000|Overall Study|Withdrawal by Subject|1|||
161670494|NCT04641299|583847205|FG001|Overall Study|Withdrawal by Subject|0|||
161670495|NCT04641299|583847206|FG002|Overall Study|Withdrawal by Subject|0|||
161670496|NCT04641299|583847207|FG003|Overall Study|Withdrawal by Subject|0|||
161670497|NCT04641299|583847204|FG000|Overall Study|Reason not given|1|||
161670498|NCT04641299|583847205|FG001|Overall Study|Reason not given|0|||
161581439|NCT02723955|583518255|FG022|Escalation Phase|Physician Decision|0|||
161581440|NCT02723955|583518256|FG023|Escalation Phase|Physician Decision|0|||
161581441|NCT02723955|583518257|FG024|Escalation Phase|Physician Decision|0|||
161581442|NCT02723955|583518258|FG025|Escalation Phase|Physician Decision|0|||
161581443|NCT02723955|583518259|FG026|Escalation Phase|Physician Decision|2|||
161581444|NCT02723955|583518260|FG027|Escalation Phase|Physician Decision|0|||
161581445|NCT02723955|583518261|FG028|Escalation Phase|Physician Decision|0|||
161581446|NCT02723955|583518262|FG029|Escalation Phase|Physician Decision|0|||
161581447|NCT02723955|583518263|FG030|Escalation Phase|Physician Decision|0|||
161581448|NCT02723955|583518264|FG031|Escalation Phase|Physician Decision|0|||
161581449|NCT02723955|583518265|FG032|Escalation Phase|Physician Decision|0|||
161581450|NCT02723955|583518266|FG033|Escalation Phase|Physician Decision|0|||
161581451|NCT02723955|583518267|FG034|Escalation Phase|Physician Decision|0|||
161581452|NCT02723955|583518268|FG035|Escalation Phase|Physician Decision|0|||
161581453|NCT02723955|583518269|FG036|Escalation Phase|Physician Decision|0|||
161581454|NCT02723955|583518270|FG037|Escalation Phase|Physician Decision|0|||
161581455|NCT02723955|583518271|FG038|Escalation Phase|Physician Decision|0|||
161581456|NCT02723955|583518272|FG039|Escalation Phase|Physician Decision|0|||
161581457|NCT02723955|583518273|FG040|Escalation Phase|Physician Decision|0|||
161581458|NCT02723955|583518274|FG041|Escalation Phase|Physician Decision|0|||
161581459|NCT02723955|583518275|FG042|Escalation Phase|Physician Decision|0|||
161581460|NCT02723955|583518233|FG000|Escalation Phase|Withdrawal by Subject|0|||
161581461|NCT02723955|583518234|FG001|Escalation Phase|Withdrawal by Subject|0|||
161581462|NCT02723955|583518235|FG002|Escalation Phase|Withdrawal by Subject|0|||
161581463|NCT02723955|583518236|FG003|Escalation Phase|Withdrawal by Subject|0|||
161581464|NCT02723955|583518237|FG004|Escalation Phase|Withdrawal by Subject|1|||
161581465|NCT02723955|583518238|FG005|Escalation Phase|Withdrawal by Subject|1|||
161581466|NCT02723955|583518239|FG006|Escalation Phase|Withdrawal by Subject|1|||
161581467|NCT02723955|583518240|FG007|Escalation Phase|Withdrawal by Subject|1|||
161581468|NCT02723955|583518241|FG008|Escalation Phase|Withdrawal by Subject|0|||
161581469|NCT02723955|583518242|FG009|Escalation Phase|Withdrawal by Subject|0|||
161581470|NCT02723955|583518243|FG010|Escalation Phase|Withdrawal by Subject|0|||
161581471|NCT02723955|583518244|FG011|Escalation Phase|Withdrawal by Subject|0|||
161581472|NCT02723955|583518245|FG012|Escalation Phase|Withdrawal by Subject|1|||
161581473|NCT02723955|583518246|FG013|Escalation Phase|Withdrawal by Subject|0|||
161581474|NCT02723955|583518247|FG014|Escalation Phase|Withdrawal by Subject|0|||
161581475|NCT02723955|583518248|FG015|Escalation Phase|Withdrawal by Subject|0|||
161581476|NCT02723955|583518249|FG016|Escalation Phase|Withdrawal by Subject|1|||
161581477|NCT02723955|583518250|FG017|Escalation Phase|Withdrawal by Subject|0|||
161581478|NCT02723955|583518251|FG018|Escalation Phase|Withdrawal by Subject|0|||
161581479|NCT02723955|583518252|FG019|Escalation Phase|Withdrawal by Subject|0|||
161581480|NCT02723955|583518253|FG020|Escalation Phase|Withdrawal by Subject|0|||
161581481|NCT02723955|583518254|FG021|Escalation Phase|Withdrawal by Subject|0|||
161581482|NCT02723955|583518255|FG022|Escalation Phase|Withdrawal by Subject|0|||
161581483|NCT02723955|583518256|FG023|Escalation Phase|Withdrawal by Subject|2|||
161581484|NCT02723955|583518257|FG024|Escalation Phase|Withdrawal by Subject|0|||
161581485|NCT02723955|583518258|FG025|Escalation Phase|Withdrawal by Subject|1|||
161581486|NCT02723955|583518259|FG026|Escalation Phase|Withdrawal by Subject|0|||
161581487|NCT02723955|583518260|FG027|Escalation Phase|Withdrawal by Subject|0|||
161581488|NCT02723955|583518261|FG028|Escalation Phase|Withdrawal by Subject|1|||
161581489|NCT02723955|583518262|FG029|Escalation Phase|Withdrawal by Subject|0|||
161581490|NCT02723955|583518263|FG030|Escalation Phase|Withdrawal by Subject|0|||
161581491|NCT02723955|583518264|FG031|Escalation Phase|Withdrawal by Subject|0|||
161581492|NCT02723955|583518265|FG032|Escalation Phase|Withdrawal by Subject|0|||
161581493|NCT02723955|583518266|FG033|Escalation Phase|Withdrawal by Subject|0|||
161581494|NCT02723955|583518267|FG034|Escalation Phase|Withdrawal by Subject|0|||
161581495|NCT02723955|583518268|FG035|Escalation Phase|Withdrawal by Subject|0|||
161581496|NCT02723955|583518269|FG036|Escalation Phase|Withdrawal by Subject|0|||
161581497|NCT02723955|583518270|FG037|Escalation Phase|Withdrawal by Subject|0|||
161581498|NCT02723955|583518271|FG038|Escalation Phase|Withdrawal by Subject|0|||
161581499|NCT02723955|583518272|FG039|Escalation Phase|Withdrawal by Subject|0|||
161581500|NCT02723955|583518273|FG040|Escalation Phase|Withdrawal by Subject|0|||
161581501|NCT02723955|583518274|FG041|Escalation Phase|Withdrawal by Subject|0|||
161831518|NCT03135899|584424793|FG001|Overall Study|Withdrawal by Subject|0|||
161581502|NCT02723955|583518275|FG042|Escalation Phase|Withdrawal by Subject|0|||
161581503|NCT02723955|583518233|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581504|NCT02723955|583518234|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581505|NCT02723955|583518235|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581506|NCT02723955|583518236|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581507|NCT02723955|583518237|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
161670499|NCT04641299|583847206|FG002|Overall Study|Reason not given|0|||
161831519|NCT03135899|584424794|FG002|Overall Study|Withdrawal by Subject|0|||
161831520|NCT03135899|584424795|FG003|Overall Study|Withdrawal by Subject|0|||
161670500|NCT04641299|583847207|FG003|Overall Study|Reason not given|0|||
161670501|NCT01890148|583847211|FG000|Overall Study|Adverse Event|1|||
161670502|NCT05736211|583847216|FG000|Overall Study|Lost to Follow-up|6|||
161670503|NCT05736211|583847217|FG001|Overall Study|Lost to Follow-up|0|||
161670504|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
161670505|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
161670506|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Death|0|||
161670507|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Death|1|||
161670508|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
161670509|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
161670510|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
161670511|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
161670512|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
161670513|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
161670514|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
161670515|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
161670516|NCT00323297|583847233|FG000|Part B (Open-label)|Death|0|||
161670517|NCT00323297|583847234|FG001|Part B (Open-label)|Death|1|||
161670518|NCT00323297|583847233|FG000|Part B (Open-label)|Reason unspecified|0|||
161670519|NCT00323297|583847234|FG001|Part B (Open-label)|Reason unspecified|1|||
161670520|NCT00323297|583847233|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
161670521|NCT00323297|583847234|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
161670522|NCT00323297|583847233|FG000|Part B (Open-label)|Lack of Efficacy|3|||
161670523|NCT00323297|583847234|FG001|Part B (Open-label)|Lack of Efficacy|1|||
161670524|NCT00323297|583847233|FG000|Part B (Open-label)|Adverse Event|5|||
161670525|NCT00323297|583847234|FG001|Part B (Open-label)|Adverse Event|5|||
161670526|NCT00323297|583847233|FG000|Part B (Open-label)|Protocol Violation|0|||
161670527|NCT00323297|583847234|FG001|Part B (Open-label)|Protocol Violation|1|||
161670528|NCT01176773|583847235|FG000|Overall Study|Screen Failure|2|||
161670529|NCT01176773|583847235|FG000|Overall Study|Withdrew consent|1|||
161670530|NCT01498289|583847240|FG000|Overall Study|Adverse Event|16|||
161485712|NCT01366521|583171044|FG003|Overall Study|Adverse Event|0|||
161485713|NCT01366521|583171041|FG000|Overall Study|Protocol Violation|0|||
161485714|NCT01366521|583171042|FG001|Overall Study|Protocol Violation|0|||
161485715|NCT01366521|583171043|FG002|Overall Study|Protocol Violation|1|||
161485716|NCT01366521|583171044|FG003|Overall Study|Protocol Violation|0|||
161485717|NCT01366521|583171041|FG000|Overall Study|Physician Decision|0|||
161485718|NCT01366521|583171042|FG001|Overall Study|Physician Decision|0|||
161485719|NCT01366521|583171043|FG002|Overall Study|Physician Decision|1|||
161485720|NCT01366521|583171044|FG003|Overall Study|Physician Decision|0|||
161485721|NCT01366521|583171041|FG000|Overall Study|Withdrawal by Subject|0|||
161485722|NCT01366521|583171042|FG001|Overall Study|Withdrawal by Subject|1|||
161485723|NCT01366521|583171043|FG002|Overall Study|Withdrawal by Subject|0|||
161485724|NCT01366521|583171044|FG003|Overall Study|Withdrawal by Subject|0|||
161485725|NCT02430311|583171045|FG000|Part A|Adverse Event|0|||
161485726|NCT02430311|583171046|FG001|Part A|Adverse Event|1|||
161485727|NCT02430311|583171045|FG000|Part A|Withdrawal by Subject|1|||
161485728|NCT02430311|583171046|FG001|Part A|Withdrawal by Subject|0|||
161485729|NCT02430311|583171045|FG000|Part B|Meet study-specific withdrawal criteria|6|||
161485730|NCT02430311|583171046|FG001|Part B|Meet study-specific withdrawal criteria|6|||
161485731|NCT02430311|583171045|FG000|Part B|Withdrawal by Subject|2|||
161485732|NCT02430311|583171046|FG001|Part B|Withdrawal by Subject|2|||
161485733|NCT02430311|583171045|FG000|Part B|Adverse Event|1|||
161485734|NCT02430311|583171046|FG001|Part B|Adverse Event|0|||
161485735|NCT02430311|583171045|FG000|Part B|Death|1|||
161485736|NCT02430311|583171046|FG001|Part B|Death|0|||
161485737|NCT00578812|583171047|FG000|Overall Study|Not treated|6|||
161485738|NCT00578812|583171048|FG001|Overall Study|Not treated|7|||
161485739|NCT02041286|583171064|FG000|Overall Study|Adverse Event|1|||
161485740|NCT00085631|583171073|FG000|Overall Study|Missing Data|4|||
161485741|NCT00085631|583171074|FG001|Overall Study|Missing Data|11|||
161485742|NCT00085631|583171075|FG002|Overall Study|Missing Data|7|||
161485743|NCT00411645|583171076|FG000|Overall Study|Consent Withdrawn|13|||
161485744|NCT00411645|583171077|FG001|Overall Study|Consent Withdrawn|22|||
161670531|NCT01498289|583847241|FG001|Overall Study|Adverse Event|18|||
161670532|NCT01498289|583847240|FG000|Overall Study|Death|6|||
161670533|NCT01498289|583847241|FG001|Overall Study|Death|8|||
161670534|NCT01498289|583847240|FG000|Overall Study|Withdrawal unrelated to AE|16|||
161670535|NCT01498289|583847241|FG001|Overall Study|Withdrawal unrelated to AE|16|||
161922710|NCT00835978|584764840|FG000|Overall Study|Lost to Follow-up|3|||
161922711|NCT00835978|584764841|FG001|Overall Study|Lost to Follow-up|4|||
161485745|NCT00411645|583171076|FG000|Overall Study|Death|56|||
161485746|NCT00411645|583171077|FG001|Overall Study|Death|135|||
161485747|NCT00411645|583171076|FG000|Overall Study|Investigator/Sponsor Decision|10|||
161485748|NCT00411645|583171077|FG001|Overall Study|Investigator/Sponsor Decision|7|||
161485749|NCT00411645|583171076|FG000|Overall Study|Lost to Follow-up|2|||
161485750|NCT00411645|583171077|FG001|Overall Study|Lost to Follow-up|0|||
161670536|NCT01498289|583847240|FG000|Overall Study|Progression/relapse|53|||
161485751|NCT01349790|583171078|FG000|Overall Study|Investigator Judgement|3|||
161485752|NCT01349790|583171078|FG000|Overall Study|Death|2|||
161485753|NCT01349790|583171078|FG000|Overall Study|Withdrawal by Patient|2|||
161485754|NCT01349790|583171078|FG000|Overall Study|Adverse Event|1|||
161485755|NCT01349790|583171078|FG000|Overall Study|Lost to Follow-up|1|||
161485756|NCT01513473|583171079|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
161485757|NCT01513473|583171080|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
161485758|NCT01513473|583171079|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
161485759|NCT01513473|583171080|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
161485760|NCT01513473|583171079|FG000|Main Trial (26 Weeks)|Unclassified|0|||
161485761|NCT01513473|583171080|FG001|Main Trial (26 Weeks)|Unclassified|2|||
161485762|NCT01513473|583171079|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
161485763|NCT01513473|583171080|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
161485764|NCT01513473|583171079|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
161485765|NCT01513473|583171080|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
161485766|NCT04016285|583171081|FG000|Overall Study|Did not progress to surgery|2|||
161485767|NCT04016285|583171082|FG001|Overall Study|Did not progress to surgery|5|||
161485768|NCT04016285|583171081|FG000|Overall Study|Failed to collect outcome data|5|||
161485769|NCT04016285|583171082|FG001|Overall Study|Failed to collect outcome data|3|||
161485770|NCT04166435|583171083|FG000|Overall Study|2 patients ineligible for response|2|||
161485771|NCT03462082|583171084|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161485772|NCT03462082|583171085|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161485773|NCT03462082|583171086|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161485774|NCT03462082|583171087|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161485775|NCT03462082|583171088|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161485776|NCT03462082|583171089|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161485777|NCT03462082|583171090|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
161485778|NCT03462082|583171091|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
161485779|NCT00166114|583171094|FG000|Overall Study|Protocol Violation|2|||
161485780|NCT00166114|583171095|FG001|Overall Study|Protocol Violation|1|||
161485781|NCT00166114|583171094|FG000|Overall Study|Withdrawal by Subject|10|||
161485782|NCT00166114|583171095|FG001|Overall Study|Withdrawal by Subject|4|||
161485783|NCT00166114|583171094|FG000|Overall Study|Adverse Event|2|||
161485784|NCT00166114|583171095|FG001|Overall Study|Adverse Event|1|||
161485785|NCT03042533|583171100|FG000|Overall Study|MD left program|1|||
161485786|NCT03042533|583171101|FG001|Overall Study|MD left program|4|||
161485787|NCT03042533|583171102|FG002|Overall Study|MD left program|1|||
161485788|NCT03266107|583171103|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
161485789|NCT03266107|583171103|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
161485790|NCT03266107|583171103|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
161485791|NCT03266107|583171103|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
161485792|NCT02548650|583171106|FG000|Triple Therapy|Adverse Event|1|||
161485793|NCT02548650|583171107|FG001|Triple Therapy|Adverse Event|0|||
161485794|NCT02548650|583171106|FG000|Triple Therapy|Withdrawal by Subject|0|||
161485795|NCT02548650|583171107|FG001|Triple Therapy|Withdrawal by Subject|4|||
161485796|NCT02548650|583171106|FG000|Double Therapy|Adverse Event|1|||
161485797|NCT02548650|583171107|FG001|Double Therapy|Adverse Event|1|||
161485798|NCT02548650|583171106|FG000|Double Therapy|Withdrawal by Subject|0|||
161485799|NCT02548650|583171107|FG001|Double Therapy|Withdrawal by Subject|1|||
161485800|NCT01191801|583171108|FG000|Overall Study|Death|36|||
161485801|NCT01191801|583171109|FG001|Overall Study|Death|12|||
161485802|NCT01191801|583171108|FG000|Overall Study|Lack of Efficacy|176|||
161485803|NCT01191801|583171109|FG001|Overall Study|Lack of Efficacy|258|||
161485804|NCT01191801|583171108|FG000|Overall Study|Adverse Event|9|||
161485805|NCT01191801|583171109|FG001|Overall Study|Adverse Event|8|||
161485806|NCT01191801|583171108|FG000|Overall Study|Protocol Violation|2|||
161485807|NCT01191801|583171109|FG001|Overall Study|Protocol Violation|4|||
161485808|NCT01191801|583171108|FG000|Overall Study|Physician Decision|47|||
161485809|NCT01191801|583171109|FG001|Overall Study|Physician Decision|24|||
161485810|NCT01191801|583171108|FG000|Overall Study|Withdrawal by Subject|1|||
161485811|NCT01191801|583171109|FG001|Overall Study|Withdrawal by Subject|4|||
161485812|NCT01191801|583171108|FG000|Overall Study|Not Provided|45|||
161485813|NCT01191801|583171109|FG001|Overall Study|Not Provided|27|||
161485814|NCT00299104|583171110|FG000|Treatment Period|Adverse Event|14|||
161485815|NCT00299104|583171111|FG001|Treatment Period|Adverse Event|9|||
161485816|NCT00299104|583171112|FG002|Treatment Period|Adverse Event|7|||
161485817|NCT00299104|583171110|FG000|Treatment Period|Death|1|||
161485818|NCT00299104|583171111|FG001|Treatment Period|Death|1|||
161485819|NCT00299104|583171112|FG002|Treatment Period|Death|1|||
161485820|NCT00299104|583171110|FG000|Treatment Period|Insufficient therapeutic response|34|||
161485821|NCT00299104|583171111|FG001|Treatment Period|Insufficient therapeutic response|13|||
161485822|NCT00299104|583171112|FG002|Treatment Period|Insufficient therapeutic response|8|||
161485823|NCT00299104|583171110|FG000|Treatment Period|Failure to return|9|||
161485824|NCT00299104|583171111|FG001|Treatment Period|Failure to return|8|||
161485825|NCT00299104|583171112|FG002|Treatment Period|Failure to return|8|||
161485826|NCT00299104|583171110|FG000|Treatment Period|Violation of selection criteria|1|||
161485827|NCT00299104|583171111|FG001|Treatment Period|Violation of selection criteria|2|||
161485828|NCT00299104|583171112|FG002|Treatment Period|Violation of selection criteria|0|||
161670537|NCT01498289|583847241|FG001|Overall Study|Progression/relapse|59|||
161670538|NCT01498289|583847240|FG000|Overall Study|Not protocol specified|7|||
161670539|NCT01498289|583847241|FG001|Overall Study|Not protocol specified|2|||
161670540|NCT01498289|583847240|FG000|Overall Study|Reason under review|0|||
161670541|NCT01498289|583847241|FG001|Overall Study|Reason under review|1|||
161670542|NCT01575028|583847242|FG000|Overall Study|Physician Decision|0|||
161670543|NCT01575028|583847243|FG001|Overall Study|Physician Decision|1|||
161670544|NCT01759407|583847246|FG000|Overall Study|Protocol Violation|0|||
161670545|NCT01759407|583847247|FG001|Overall Study|Protocol Violation|2|||
161670546|NCT02520284|583847248|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
161670547|NCT02520284|583847249|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
161670548|NCT02520284|583847250|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
161670549|NCT02520284|583847248|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161670550|NCT02520284|583847249|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161670551|NCT02520284|583847250|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161670552|NCT02520284|583847248|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
161670553|NCT02520284|583847249|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
161670554|NCT02520284|583847250|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
161670555|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
161670556|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
161670557|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
161670558|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
161485829|NCT00299104|583171110|FG000|Treatment Period|Protocol Violation|1|||
161485830|NCT00299104|583171111|FG001|Treatment Period|Protocol Violation|1|||
161485831|NCT00299104|583171112|FG002|Treatment Period|Protocol Violation|0|||
161485832|NCT00299104|583171110|FG000|Treatment Period|Refused treatment|9|||
161485833|NCT00299104|583171111|FG001|Treatment Period|Refused treatment|2|||
161485834|NCT00299104|583171112|FG002|Treatment Period|Refused treatment|2|||
161485835|NCT00299104|583171110|FG000|Treatment Period|Withdrew consent|14|||
161485836|NCT00299104|583171111|FG001|Treatment Period|Withdrew consent|19|||
161485837|NCT00299104|583171112|FG002|Treatment Period|Withdrew consent|9|||
161485838|NCT00299104|583171110|FG000|Treatment Period|Administrative reasons|106|||
161485839|NCT00299104|583171111|FG001|Treatment Period|Administrative reasons|120|||
161485840|NCT00299104|583171112|FG002|Treatment Period|Administrative reasons|137|||
161485841|NCT00299104|583171110|FG000|Safety Follow-Up (SFU) Period|Death|3|||
161485842|NCT00299104|583171111|FG001|Safety Follow-Up (SFU) Period|Death|2|||
161485843|NCT00299104|583171112|FG002|Safety Follow-Up (SFU) Period|Death|1|||
161485844|NCT00299104|583171110|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
161485845|NCT00299104|583171111|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
161485846|NCT00299104|583171112|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
161485847|NCT00299104|583171110|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
161485848|NCT00299104|583171111|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
161485849|NCT00299104|583171112|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
161485850|NCT00299104|583171110|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
161485851|NCT00299104|583171111|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
161485852|NCT00299104|583171112|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
161485853|NCT00299104|583171110|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
161485854|NCT00299104|583171111|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
161485855|NCT00299104|583171112|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
161485856|NCT00299104|583171110|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
161485857|NCT00299104|583171111|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
161485858|NCT00299104|583171112|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
161485859|NCT00299104|583171110|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
161485860|NCT00299104|583171111|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
161485861|NCT00299104|583171112|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
161485862|NCT00299104|583171110|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
161485863|NCT00299104|583171111|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
161485864|NCT00299104|583171112|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
161485865|NCT00814164|583171116|FG000|Overall Study|Progression|7|||
161485866|NCT00814164|583171116|FG000|Overall Study|not stated|7|||
161485867|NCT00814164|583171116|FG000|Overall Study|Death|5|||
161485868|NCT02651922|583171117|FG000|Overall Study|due to exclusion criteria|2|||
161485869|NCT01366209|583171118|FG000|Overall Study|Adverse Event|6|||
161670559|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
161485870|NCT01366209|583171119|FG001|Overall Study|Adverse Event|7|||
161670560|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
161670561|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
161670562|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
161670563|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
161670564|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
161670565|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
161670566|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
161670567|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
161670568|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
161670569|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
161670570|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
161670571|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
161670572|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
161670573|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
161670574|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
161670575|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
161670576|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
161670577|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
161670578|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
161670579|NCT03737474|583847251|FG000|Overall Study|Adverse Event|18|||
161670580|NCT03737474|583847252|FG001|Overall Study|Adverse Event|48|||
161670581|NCT03737474|583847251|FG000|Overall Study|Lack of Efficacy|1|||
161670582|NCT03737474|583847252|FG001|Overall Study|Lack of Efficacy|3|||
161670583|NCT03737474|583847251|FG000|Overall Study|Protocol Violation|0|||
161670584|NCT03737474|583847252|FG001|Overall Study|Protocol Violation|8|||
161670585|NCT03737474|583847251|FG000|Overall Study|Withdrawal by Subject|5|||
161670586|NCT03737474|583847252|FG001|Overall Study|Withdrawal by Subject|20|||
161670587|NCT03737474|583847251|FG000|Overall Study|Non-compliance With Study Drug|0|||
161670588|NCT03737474|583847252|FG001|Overall Study|Non-compliance With Study Drug|1|||
161670589|NCT03737474|583847251|FG000|Overall Study|Physician Decision|1|||
161670590|NCT03737474|583847252|FG001|Overall Study|Physician Decision|4|||
161670591|NCT02513745|583847255|FG000|Overall Study|Criteria at time of surgery not met.|3|||
161670592|NCT02513745|583847256|FG001|Overall Study|Criteria at time of surgery not met.|3|||
161670593|NCT04526197|583847257|FG000|Period 1|Adverse Event|0|||
161670594|NCT04526197|583847258|FG001|Period 1|Adverse Event|1|||
161670595|NCT04526197|583847257|FG000|Period 1|Withdrawal by Subject|1|||
161670596|NCT04526197|583847258|FG001|Period 1|Withdrawal by Subject|0|||
161670597|NCT04526197|583847257|FG000|Period 2|Adverse Event|0|||
161670598|NCT04526197|583847258|FG001|Period 2|Adverse Event|1|||
161670599|NCT04526197|583847257|FG000|Period 2|Withdrawal by Subject|0|||
161670600|NCT04526197|583847258|FG001|Period 2|Withdrawal by Subject|1|||
161670601|NCT01209143|583847259|FG000|Overall Study|Adverse Event|2|||
161670602|NCT01209143|583847260|FG001|Overall Study|Adverse Event|1|||
161670603|NCT01209143|583847259|FG000|Overall Study|Death|0|||
161670604|NCT01209143|583847260|FG001|Overall Study|Death|1|||
161670605|NCT01209143|583847259|FG000|Overall Study|Physician Decision|3|||
161670606|NCT01209143|583847260|FG001|Overall Study|Physician Decision|1|||
161670607|NCT01209143|583847259|FG000|Overall Study|Lost to Follow-up|1|||
161581508|NCT02723955|583518238|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
161581509|NCT02723955|583518239|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
161581510|NCT02723955|583518240|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
161581511|NCT02723955|583518241|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
161581512|NCT02723955|583518242|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581513|NCT02723955|583518243|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581514|NCT02723955|583518244|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581515|NCT02723955|583518245|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581516|NCT02723955|583518246|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581517|NCT02723955|583518247|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581518|NCT02723955|583518248|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581519|NCT02723955|583518249|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581520|NCT02723955|583518250|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581521|NCT02723955|583518251|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581522|NCT02723955|583518252|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581523|NCT02723955|583518253|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161670608|NCT01209143|583847260|FG001|Overall Study|Lost to Follow-up|0|||
161670609|NCT01209143|583847259|FG000|Overall Study|Withdrawal by Subject|2|||
161670610|NCT01209143|583847260|FG001|Overall Study|Withdrawal by Subject|1|||
161670611|NCT01209143|583847259|FG000|Overall Study|Disease progression|11|||
161670612|NCT01209143|583847260|FG001|Overall Study|Disease progression|16|||
161670613|NCT00381303|583847261|FG000|Overall Study|Lost to Follow-up|25|||
161581524|NCT02723955|583518254|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581525|NCT02723955|583518255|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581526|NCT02723955|583518256|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581527|NCT02723955|583518257|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581528|NCT02723955|583518258|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581529|NCT02723955|583518259|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581530|NCT02723955|583518260|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581531|NCT02723955|583518261|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581532|NCT02723955|583518262|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581533|NCT02723955|583518263|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581534|NCT02723955|583518264|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581535|NCT02723955|583518265|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581536|NCT02723955|583518266|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581537|NCT02723955|583518267|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581538|NCT02723955|583518268|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581539|NCT02723955|583518269|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581540|NCT02723955|583518270|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581541|NCT02723955|583518271|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581542|NCT02723955|583518272|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581543|NCT02723955|583518273|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581544|NCT02723955|583518274|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581545|NCT02723955|583518275|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161581546|NCT02723955|583518233|FG000|Escalation Phase|Site Closed|0|||
161581547|NCT02723955|583518234|FG001|Escalation Phase|Site Closed|0|||
161581548|NCT02723955|583518235|FG002|Escalation Phase|Site Closed|0|||
161581549|NCT02723955|583518236|FG003|Escalation Phase|Site Closed|0|||
161581550|NCT02723955|583518237|FG004|Escalation Phase|Site Closed|0|||
161581551|NCT02723955|583518238|FG005|Escalation Phase|Site Closed|0|||
161581552|NCT02723955|583518239|FG006|Escalation Phase|Site Closed|0|||
161581553|NCT02723955|583518240|FG007|Escalation Phase|Site Closed|0|||
161581554|NCT02723955|583518241|FG008|Escalation Phase|Site Closed|0|||
161581555|NCT02723955|583518242|FG009|Escalation Phase|Site Closed|0|||
161581556|NCT02723955|583518243|FG010|Escalation Phase|Site Closed|0|||
161581557|NCT02723955|583518244|FG011|Escalation Phase|Site Closed|0|||
161581558|NCT02723955|583518245|FG012|Escalation Phase|Site Closed|0|||
161581559|NCT02723955|583518246|FG013|Escalation Phase|Site Closed|0|||
161581560|NCT02723955|583518247|FG014|Escalation Phase|Site Closed|0|||
161581561|NCT02723955|583518248|FG015|Escalation Phase|Site Closed|1|||
161581562|NCT02723955|583518249|FG016|Escalation Phase|Site Closed|0|||
161581563|NCT02723955|583518250|FG017|Escalation Phase|Site Closed|2|||
161581564|NCT02723955|583518251|FG018|Escalation Phase|Site Closed|0|||
161581565|NCT02723955|583518252|FG019|Escalation Phase|Site Closed|0|||
161581566|NCT02723955|583518253|FG020|Escalation Phase|Site Closed|1|||
161581567|NCT02723955|583518254|FG021|Escalation Phase|Site Closed|0|||
161581568|NCT02723955|583518255|FG022|Escalation Phase|Site Closed|0|||
161581569|NCT02723955|583518256|FG023|Escalation Phase|Site Closed|0|||
161581570|NCT02723955|583518257|FG024|Escalation Phase|Site Closed|3|||
161581571|NCT02723955|583518258|FG025|Escalation Phase|Site Closed|1|||
161581572|NCT02723955|583518259|FG026|Escalation Phase|Site Closed|3|||
161581573|NCT02723955|583518260|FG027|Escalation Phase|Site Closed|1|||
161581574|NCT02723955|583518261|FG028|Escalation Phase|Site Closed|1|||
161581575|NCT02723955|583518262|FG029|Escalation Phase|Site Closed|0|||
161581576|NCT02723955|583518263|FG030|Escalation Phase|Site Closed|0|||
161581577|NCT02723955|583518264|FG031|Escalation Phase|Site Closed|0|||
161581578|NCT02723955|583518265|FG032|Escalation Phase|Site Closed|0|||
161581579|NCT02723955|583518266|FG033|Escalation Phase|Site Closed|0|||
161581580|NCT02723955|583518267|FG034|Escalation Phase|Site Closed|0|||
161581581|NCT02723955|583518268|FG035|Escalation Phase|Site Closed|0|||
161581582|NCT02723955|583518269|FG036|Escalation Phase|Site Closed|0|||
161581583|NCT02723955|583518270|FG037|Escalation Phase|Site Closed|0|||
161670614|NCT00381303|583847262|FG001|Overall Study|Lost to Follow-up|9|||
161581584|NCT02723955|583518271|FG038|Escalation Phase|Site Closed|0|||
161581585|NCT02723955|583518272|FG039|Escalation Phase|Site Closed|0|||
161581586|NCT02723955|583518273|FG040|Escalation Phase|Site Closed|0|||
161581587|NCT02723955|583518274|FG041|Escalation Phase|Site Closed|0|||
161581588|NCT02723955|583518275|FG042|Escalation Phase|Site Closed|0|||
161581589|NCT02723955|583518233|FG000|Expansion Phase|Death|0|||
161581590|NCT02723955|583518234|FG001|Expansion Phase|Death|0|||
161581591|NCT02723955|583518235|FG002|Expansion Phase|Death|0|||
161581592|NCT02723955|583518236|FG003|Expansion Phase|Death|0|||
161581593|NCT02723955|583518237|FG004|Expansion Phase|Death|0|||
161581594|NCT02723955|583518238|FG005|Expansion Phase|Death|0|||
161581595|NCT02723955|583518239|FG006|Expansion Phase|Death|0|||
161581596|NCT02723955|583518240|FG007|Expansion Phase|Death|0|||
161581597|NCT02723955|583518241|FG008|Expansion Phase|Death|0|||
161581598|NCT02723955|583518242|FG009|Expansion Phase|Death|25|||
161581599|NCT02723955|583518243|FG010|Expansion Phase|Death|69|||
161581600|NCT02723955|583518244|FG011|Expansion Phase|Death|48|||
161581601|NCT02723955|583518245|FG012|Expansion Phase|Death|0|||
161581602|NCT02723955|583518246|FG013|Expansion Phase|Death|0|||
161581603|NCT02723955|583518247|FG014|Expansion Phase|Death|0|||
161581604|NCT02723955|583518248|FG015|Expansion Phase|Death|0|||
161581605|NCT02723955|583518249|FG016|Expansion Phase|Death|0|||
161581606|NCT02723955|583518250|FG017|Expansion Phase|Death|0|||
161581607|NCT02723955|583518251|FG018|Expansion Phase|Death|0|||
161581608|NCT02723955|583518252|FG019|Expansion Phase|Death|0|||
161581609|NCT02723955|583518253|FG020|Expansion Phase|Death|0|||
161581610|NCT02723955|583518254|FG021|Expansion Phase|Death|0|||
161581611|NCT02723955|583518255|FG022|Expansion Phase|Death|0|||
161581612|NCT02723955|583518256|FG023|Expansion Phase|Death|0|||
161581613|NCT02723955|583518257|FG024|Expansion Phase|Death|0|||
161581614|NCT02723955|583518258|FG025|Expansion Phase|Death|0|||
161581615|NCT02723955|583518259|FG026|Expansion Phase|Death|0|||
161581616|NCT02723955|583518260|FG027|Expansion Phase|Death|0|||
161581617|NCT02723955|583518261|FG028|Expansion Phase|Death|0|||
161581618|NCT02723955|583518262|FG029|Expansion Phase|Death|12|||
161581619|NCT02723955|583518263|FG030|Expansion Phase|Death|202|||
161581620|NCT02723955|583518264|FG031|Expansion Phase|Death|31|||
161581621|NCT02723955|583518265|FG032|Expansion Phase|Death|17|||
161581622|NCT02723955|583518266|FG033|Expansion Phase|Death|2|||
161581623|NCT02723955|583518267|FG034|Expansion Phase|Death|3|||
161581624|NCT02723955|583518268|FG035|Expansion Phase|Death|3|||
161581625|NCT02723955|583518269|FG036|Expansion Phase|Death|1|||
161581626|NCT02723955|583518270|FG037|Expansion Phase|Death|0|||
161581627|NCT02723955|583518271|FG038|Expansion Phase|Death|0|||
161581628|NCT02723955|583518272|FG039|Expansion Phase|Death|0|||
161581629|NCT02723955|583518273|FG040|Expansion Phase|Death|0|||
161581630|NCT02723955|583518274|FG041|Expansion Phase|Death|0|||
161581631|NCT02723955|583518275|FG042|Expansion Phase|Death|0|||
161581632|NCT02723955|583518233|FG000|Expansion Phase|Lost to Follow-up|0|||
161581633|NCT02723955|583518234|FG001|Expansion Phase|Lost to Follow-up|0|||
161581634|NCT02723955|583518235|FG002|Expansion Phase|Lost to Follow-up|0|||
161581635|NCT02723955|583518236|FG003|Expansion Phase|Lost to Follow-up|0|||
161581636|NCT02723955|583518237|FG004|Expansion Phase|Lost to Follow-up|0|||
161581637|NCT02723955|583518238|FG005|Expansion Phase|Lost to Follow-up|0|||
161581638|NCT02723955|583518239|FG006|Expansion Phase|Lost to Follow-up|0|||
161581639|NCT02723955|583518240|FG007|Expansion Phase|Lost to Follow-up|0|||
161581640|NCT02723955|583518241|FG008|Expansion Phase|Lost to Follow-up|0|||
161581641|NCT02723955|583518242|FG009|Expansion Phase|Lost to Follow-up|0|||
161581642|NCT02723955|583518243|FG010|Expansion Phase|Lost to Follow-up|4|||
161581643|NCT02723955|583518244|FG011|Expansion Phase|Lost to Follow-up|1|||
161581644|NCT02723955|583518245|FG012|Expansion Phase|Lost to Follow-up|0|||
161581645|NCT02723955|583518246|FG013|Expansion Phase|Lost to Follow-up|0|||
161581646|NCT02723955|583518247|FG014|Expansion Phase|Lost to Follow-up|0|||
161581647|NCT02723955|583518248|FG015|Expansion Phase|Lost to Follow-up|0|||
161581648|NCT02723955|583518249|FG016|Expansion Phase|Lost to Follow-up|0|||
161581649|NCT02723955|583518250|FG017|Expansion Phase|Lost to Follow-up|0|||
161581650|NCT02723955|583518251|FG018|Expansion Phase|Lost to Follow-up|0|||
161581651|NCT02723955|583518252|FG019|Expansion Phase|Lost to Follow-up|0|||
161581652|NCT02723955|583518253|FG020|Expansion Phase|Lost to Follow-up|0|||
161581653|NCT02723955|583518254|FG021|Expansion Phase|Lost to Follow-up|0|||
161581654|NCT02723955|583518255|FG022|Expansion Phase|Lost to Follow-up|0|||
161581655|NCT02723955|583518256|FG023|Expansion Phase|Lost to Follow-up|0|||
161581656|NCT02723955|583518257|FG024|Expansion Phase|Lost to Follow-up|0|||
161581657|NCT02723955|583518258|FG025|Expansion Phase|Lost to Follow-up|0|||
161581658|NCT02723955|583518259|FG026|Expansion Phase|Lost to Follow-up|0|||
161581659|NCT02723955|583518260|FG027|Expansion Phase|Lost to Follow-up|0|||
161581660|NCT02723955|583518261|FG028|Expansion Phase|Lost to Follow-up|0|||
161581661|NCT02723955|583518262|FG029|Expansion Phase|Lost to Follow-up|1|||
161581662|NCT02723955|583518263|FG030|Expansion Phase|Lost to Follow-up|19|||
161581663|NCT02723955|583518264|FG031|Expansion Phase|Lost to Follow-up|2|||
161581664|NCT02723955|583518265|FG032|Expansion Phase|Lost to Follow-up|1|||
161581665|NCT02723955|583518266|FG033|Expansion Phase|Lost to Follow-up|0|||
161581666|NCT02723955|583518267|FG034|Expansion Phase|Lost to Follow-up|0|||
161581667|NCT02723955|583518268|FG035|Expansion Phase|Lost to Follow-up|0|||
161581668|NCT02723955|583518269|FG036|Expansion Phase|Lost to Follow-up|0|||
161581669|NCT02723955|583518270|FG037|Expansion Phase|Lost to Follow-up|0|||
161581670|NCT02723955|583518271|FG038|Expansion Phase|Lost to Follow-up|0|||
161581671|NCT02723955|583518272|FG039|Expansion Phase|Lost to Follow-up|0|||
161581672|NCT02723955|583518273|FG040|Expansion Phase|Lost to Follow-up|0|||
161581673|NCT02723955|583518274|FG041|Expansion Phase|Lost to Follow-up|0|||
161581674|NCT02723955|583518275|FG042|Expansion Phase|Lost to Follow-up|0|||
161581675|NCT02723955|583518233|FG000|Expansion Phase|Physician Decision|0|||
161670615|NCT00381303|583847261|FG000|Overall Study|AE/HIV-related event|22|||
161670616|NCT00381303|583847262|FG001|Overall Study|AE/HIV-related event|6|||
161670617|NCT00381303|583847261|FG000|Overall Study|Non-Adherence|13|||
161670618|NCT00381303|583847262|FG001|Overall Study|Non-Adherence|6|||
161670619|NCT00381303|583847261|FG000|Overall Study|Withdrawal by Subject|13|||
161670620|NCT00381303|583847262|FG001|Overall Study|Withdrawal by Subject|6|||
161670621|NCT00381303|583847261|FG000|Overall Study|Virologic failure|6|||
161670622|NCT00381303|583847262|FG001|Overall Study|Virologic failure|4|||
161670623|NCT00381303|583847261|FG000|Overall Study|Ineligible to continue the trial|2|||
161670624|NCT00381303|583847262|FG001|Overall Study|Ineligible to continue the trial|1|||
161670625|NCT00381303|583847261|FG000|Overall Study|Pregnancy|2|||
161670626|NCT00381303|583847262|FG001|Overall Study|Pregnancy|0|||
161670627|NCT00381303|583847261|FG000|Overall Study|Physician Decision|1|||
161670628|NCT00381303|583847262|FG001|Overall Study|Physician Decision|0|||
161670629|NCT00381303|583847261|FG000|Overall Study|Physician's decision to close the site|3|||
161670630|NCT00381303|583847262|FG001|Overall Study|Physician's decision to close the site|1|||
161670631|NCT00381303|583847261|FG000|Overall Study|Subject moved out of state|2|||
161670632|NCT00381303|583847262|FG001|Overall Study|Subject moved out of state|0|||
161670633|NCT00381303|583847261|FG000|Overall Study|Subject taking too many different meds|1|||
161670634|NCT00381303|583847262|FG001|Overall Study|Subject taking too many different meds|0|||
161670635|NCT00381303|583847261|FG000|Overall Study|No virologic response by week 12|1|||
161670636|NCT00381303|583847262|FG001|Overall Study|No virologic response by week 12|0|||
161670637|NCT00381303|583847261|FG000|Overall Study|Subject was too busy for appointments|1|||
161670638|NCT00381303|583847262|FG001|Overall Study|Subject was too busy for appointments|0|||
161670639|NCT00381303|583847261|FG000|Overall Study|Subject did not continue visits|1|||
161670640|NCT00381303|583847262|FG001|Overall Study|Subject did not continue visits|0|||
161670641|NCT00381303|583847261|FG000|Overall Study|Subject primary physician's decision|1|||
161670642|NCT00381303|583847262|FG001|Overall Study|Subject primary physician's decision|0|||
161670643|NCT01136811|583847263|FG000|Overall Study|Physician Decision|11|||
161670644|NCT01211522|583847265|FG000|Overall Study|Withdrawal by Subject|3|||
161670645|NCT01211522|583847266|FG001|Overall Study|Withdrawal by Subject|7|||
161670646|NCT01211522|583847267|FG002|Overall Study|Withdrawal by Subject|5|||
161670647|NCT01116882|583847273|FG000|30-day|Lost to Follow-up|50|||
161670648|NCT01116882|583847274|FG001|30-day|Lost to Follow-up|21|||
161670649|NCT01116882|583847273|FG000|30-day|Withdrawal by Subject|2|||
161670650|NCT01116882|583847274|FG001|30-day|Withdrawal by Subject|4|||
161670651|NCT01116882|583847273|FG000|30-day|Other Reasons|16|||
161670652|NCT01116882|583847274|FG001|30-day|Other Reasons|6|||
161670653|NCT01116882|583847273|FG000|12-month|Lost to Follow-up|111|||
161670654|NCT01116882|583847274|FG001|12-month|Lost to Follow-up|42|||
161670655|NCT01116882|583847273|FG000|12-month|Other Reasons|151|||
161670656|NCT01116882|583847274|FG001|12-month|Other Reasons|49|||
161670657|NCT01116882|583847273|FG000|12-month|Withdrawal by Subject|5|||
161670658|NCT01116882|583847274|FG001|12-month|Withdrawal by Subject|8|||
161670659|NCT00547365|583847275|FG000|Overall Study|Physician Decision|1|||
161670660|NCT00547365|583847275|FG000|Overall Study|Lost to Follow-up|1|||
161670661|NCT00547365|583847275|FG000|Overall Study|Protocol Violation|2|||
161670662|NCT00547365|583847275|FG000|Overall Study|death (not related to study)|4|||
161670663|NCT01139658|583847278|FG000|Overall Study|Adverse Event|10|||
161670664|NCT01139658|583847279|FG001|Overall Study|Adverse Event|27|||
161670665|NCT01139658|583847278|FG000|Overall Study|Lack of Efficacy|15|||
161670666|NCT01139658|583847279|FG001|Overall Study|Lack of Efficacy|7|||
161670667|NCT01139658|583847278|FG000|Overall Study|Withdrawal by Subject|2|||
161670668|NCT01139658|583847279|FG001|Overall Study|Withdrawal by Subject|4|||
161670669|NCT01139658|583847278|FG000|Overall Study|No documentation of treatment|1|||
161670670|NCT01139658|583847279|FG001|Overall Study|No documentation of treatment|0|||
161670671|NCT01139658|583847278|FG000|Overall Study|Other|28|||
161670672|NCT01139658|583847279|FG001|Overall Study|Other|75|||
161670673|NCT01777269|583847280|FG000|Overall Study|Adverse Event|24|||
161670674|NCT01777269|583847281|FG001|Overall Study|Adverse Event|33|||
161670675|NCT01777269|583847280|FG000|Overall Study|Lack of Efficacy|8|||
161670676|NCT01777269|583847281|FG001|Overall Study|Lack of Efficacy|10|||
161670677|NCT01777269|583847280|FG000|Overall Study|Protocol Violation|4|||
161670678|NCT01777269|583847281|FG001|Overall Study|Protocol Violation|4|||
161670679|NCT01777269|583847280|FG000|Overall Study|Participants reached stopping criteria|1|||
161670680|NCT01777269|583847281|FG001|Overall Study|Participants reached stopping criteria|1|||
161670681|NCT01777269|583847280|FG000|Overall Study|Lost to Follow-up|4|||
161670682|NCT01777269|583847281|FG001|Overall Study|Lost to Follow-up|0|||
161670683|NCT01777269|583847280|FG000|Overall Study|Physician Decision|5|||
161670684|NCT01777269|583847281|FG001|Overall Study|Physician Decision|2|||
161670685|NCT01777269|583847280|FG000|Overall Study|Withdrawal by Subject|9|||
161670686|NCT01777269|583847281|FG001|Overall Study|Withdrawal by Subject|9|||
161670687|NCT00504881|583847282|FG000|Overall Study|Lack of Efficacy|1|||
161670688|NCT00504881|583847283|FG001|Overall Study|Lack of Efficacy|5|||
161670689|NCT00504881|583847282|FG000|Overall Study|Lost to Follow-up|0|||
161670690|NCT00504881|583847283|FG001|Overall Study|Lost to Follow-up|2|||
161670691|NCT00504881|583847282|FG000|Overall Study|Withdrawal by Subject|1|||
161581676|NCT02723955|583518234|FG001|Expansion Phase|Physician Decision|0|||
161581677|NCT02723955|583518235|FG002|Expansion Phase|Physician Decision|0|||
161581678|NCT02723955|583518236|FG003|Expansion Phase|Physician Decision|0|||
161581679|NCT02723955|583518237|FG004|Expansion Phase|Physician Decision|0|||
161581680|NCT02723955|583518238|FG005|Expansion Phase|Physician Decision|0|||
161581681|NCT02723955|583518239|FG006|Expansion Phase|Physician Decision|0|||
161581682|NCT02723955|583518240|FG007|Expansion Phase|Physician Decision|0|||
161581683|NCT02723955|583518241|FG008|Expansion Phase|Physician Decision|0|||
161581684|NCT02723955|583518242|FG009|Expansion Phase|Physician Decision|0|||
161581685|NCT02723955|583518243|FG010|Expansion Phase|Physician Decision|0|||
161581686|NCT02723955|583518244|FG011|Expansion Phase|Physician Decision|0|||
161581687|NCT02723955|583518245|FG012|Expansion Phase|Physician Decision|0|||
161581688|NCT02723955|583518246|FG013|Expansion Phase|Physician Decision|0|||
161581689|NCT02723955|583518247|FG014|Expansion Phase|Physician Decision|0|||
161581690|NCT02723955|583518248|FG015|Expansion Phase|Physician Decision|0|||
161581691|NCT02723955|583518249|FG016|Expansion Phase|Physician Decision|0|||
161581692|NCT02723955|583518250|FG017|Expansion Phase|Physician Decision|0|||
161581693|NCT02723955|583518251|FG018|Expansion Phase|Physician Decision|0|||
161581694|NCT02723955|583518252|FG019|Expansion Phase|Physician Decision|0|||
161581695|NCT02723955|583518253|FG020|Expansion Phase|Physician Decision|0|||
161581696|NCT02723955|583518254|FG021|Expansion Phase|Physician Decision|0|||
161581697|NCT02723955|583518255|FG022|Expansion Phase|Physician Decision|0|||
161581698|NCT02723955|583518256|FG023|Expansion Phase|Physician Decision|0|||
161581699|NCT02723955|583518257|FG024|Expansion Phase|Physician Decision|0|||
161581700|NCT02723955|583518258|FG025|Expansion Phase|Physician Decision|0|||
161581701|NCT02723955|583518259|FG026|Expansion Phase|Physician Decision|0|||
161581702|NCT02723955|583518260|FG027|Expansion Phase|Physician Decision|0|||
161581703|NCT02723955|583518261|FG028|Expansion Phase|Physician Decision|0|||
161581704|NCT02723955|583518262|FG029|Expansion Phase|Physician Decision|0|||
161581705|NCT02723955|583518263|FG030|Expansion Phase|Physician Decision|1|||
161581706|NCT02723955|583518264|FG031|Expansion Phase|Physician Decision|1|||
161581707|NCT02723955|583518265|FG032|Expansion Phase|Physician Decision|0|||
161581708|NCT02723955|583518266|FG033|Expansion Phase|Physician Decision|0|||
161581709|NCT02723955|583518267|FG034|Expansion Phase|Physician Decision|0|||
161581710|NCT02723955|583518268|FG035|Expansion Phase|Physician Decision|0|||
161581711|NCT02723955|583518269|FG036|Expansion Phase|Physician Decision|0|||
161581712|NCT02723955|583518270|FG037|Expansion Phase|Physician Decision|0|||
161581713|NCT02723955|583518271|FG038|Expansion Phase|Physician Decision|0|||
161581714|NCT02723955|583518272|FG039|Expansion Phase|Physician Decision|0|||
161581715|NCT02723955|583518273|FG040|Expansion Phase|Physician Decision|0|||
161581716|NCT02723955|583518274|FG041|Expansion Phase|Physician Decision|0|||
161581717|NCT02723955|583518275|FG042|Expansion Phase|Physician Decision|0|||
161581718|NCT02723955|583518233|FG000|Expansion Phase|Withdrawal by Subject|0|||
161581719|NCT02723955|583518234|FG001|Expansion Phase|Withdrawal by Subject|0|||
161581720|NCT02723955|583518235|FG002|Expansion Phase|Withdrawal by Subject|0|||
161581721|NCT02723955|583518236|FG003|Expansion Phase|Withdrawal by Subject|0|||
161581722|NCT02723955|583518237|FG004|Expansion Phase|Withdrawal by Subject|0|||
161581723|NCT02723955|583518238|FG005|Expansion Phase|Withdrawal by Subject|0|||
161581724|NCT02723955|583518239|FG006|Expansion Phase|Withdrawal by Subject|0|||
161581725|NCT02723955|583518240|FG007|Expansion Phase|Withdrawal by Subject|0|||
161581726|NCT02723955|583518241|FG008|Expansion Phase|Withdrawal by Subject|0|||
161581727|NCT02723955|583518242|FG009|Expansion Phase|Withdrawal by Subject|2|||
161581728|NCT02723955|583518243|FG010|Expansion Phase|Withdrawal by Subject|1|||
161581729|NCT02723955|583518244|FG011|Expansion Phase|Withdrawal by Subject|0|||
161581730|NCT02723955|583518245|FG012|Expansion Phase|Withdrawal by Subject|0|||
161581731|NCT02723955|583518246|FG013|Expansion Phase|Withdrawal by Subject|0|||
161581732|NCT02723955|583518247|FG014|Expansion Phase|Withdrawal by Subject|0|||
161581733|NCT02723955|583518248|FG015|Expansion Phase|Withdrawal by Subject|0|||
161581734|NCT02723955|583518249|FG016|Expansion Phase|Withdrawal by Subject|0|||
161581735|NCT02723955|583518250|FG017|Expansion Phase|Withdrawal by Subject|0|||
161581736|NCT02723955|583518251|FG018|Expansion Phase|Withdrawal by Subject|0|||
161581737|NCT02723955|583518252|FG019|Expansion Phase|Withdrawal by Subject|0|||
161581738|NCT02723955|583518253|FG020|Expansion Phase|Withdrawal by Subject|0|||
161581739|NCT02723955|583518254|FG021|Expansion Phase|Withdrawal by Subject|0|||
161581740|NCT02723955|583518255|FG022|Expansion Phase|Withdrawal by Subject|0|||
161581741|NCT02723955|583518256|FG023|Expansion Phase|Withdrawal by Subject|0|||
161581742|NCT02723955|583518257|FG024|Expansion Phase|Withdrawal by Subject|0|||
161581743|NCT02723955|583518258|FG025|Expansion Phase|Withdrawal by Subject|0|||
161581744|NCT02723955|583518259|FG026|Expansion Phase|Withdrawal by Subject|0|||
161581745|NCT02723955|583518260|FG027|Expansion Phase|Withdrawal by Subject|0|||
161581746|NCT02723955|583518261|FG028|Expansion Phase|Withdrawal by Subject|0|||
161581747|NCT02723955|583518262|FG029|Expansion Phase|Withdrawal by Subject|0|||
161581748|NCT02723955|583518263|FG030|Expansion Phase|Withdrawal by Subject|8|||
161581749|NCT02723955|583518264|FG031|Expansion Phase|Withdrawal by Subject|4|||
161581750|NCT02723955|583518265|FG032|Expansion Phase|Withdrawal by Subject|0|||
161485871|NCT01366209|583171118|FG000|Overall Study|Withdrawal by Subject|4|||
161485872|NCT01366209|583171119|FG001|Overall Study|Withdrawal by Subject|4|||
161485873|NCT01366209|583171118|FG000|Overall Study|Death|12|||
161485874|NCT01366209|583171119|FG001|Overall Study|Death|19|||
161485875|NCT01366209|583171118|FG000|Overall Study|Lung transplantation|6|||
161485876|NCT01366209|583171119|FG001|Overall Study|Lung transplantation|1|||
161485877|NCT01366209|583171118|FG000|Overall Study|Lost to Follow-up|2|||
161485878|NCT01366209|583171119|FG001|Overall Study|Lost to Follow-up|1|||
161485879|NCT01366209|583171118|FG000|Overall Study|Physician Decision|1|||
161485880|NCT01366209|583171119|FG001|Overall Study|Physician Decision|0|||
161485881|NCT01366209|583171118|FG000|Overall Study|Sponsors decision|0|||
161485882|NCT01366209|583171119|FG001|Overall Study|Sponsors decision|1|||
161485883|NCT01366209|583171118|FG000|Overall Study|Withdrew consent|4|||
161485884|NCT01366209|583171119|FG001|Overall Study|Withdrew consent|3|||
161485885|NCT01053221|583171120|FG000|Overall Study|The study was closed prematurely|5|||
161485886|NCT01053221|583171121|FG001|Overall Study|The study was closed prematurely|9|||
161485887|NCT03018704|583171122|FG000|Overall Study|Lost to Follow-up|1|||
161485888|NCT03018704|583171123|FG001|Overall Study|Lost to Follow-up|1|||
161485889|NCT00320411|583171124|FG000|Overall Study|No investigational product admin.|4|||
161485890|NCT02088047|583171127|FG000|Overall Study|Withdrawal by Subject|1|||
161485891|NCT02088047|583171128|FG001|Overall Study|Withdrawal by Subject|0|||
161485892|NCT01025752|583171129|FG000|Overall Study|Lost to Follow-up|7|||
161485893|NCT01025752|583171130|FG001|Overall Study|Lost to Follow-up|10|||
161485894|NCT01025752|583171129|FG000|Overall Study|Physician Decision|1|||
161485895|NCT01025752|583171130|FG001|Overall Study|Physician Decision|3|||
161485896|NCT01417234|583171131|FG000|Overall Study|Subject non-compliant|3|||
161485897|NCT00023764|583171132|FG000|Overall Study|Other|1|||
161485898|NCT00023764|583171132|FG000|Overall Study|Adverse Event|4|||
161581751|NCT02723955|583518266|FG033|Expansion Phase|Withdrawal by Subject|0|||
161581752|NCT02723955|583518267|FG034|Expansion Phase|Withdrawal by Subject|0|||
161581753|NCT02723955|583518268|FG035|Expansion Phase|Withdrawal by Subject|1|||
161581754|NCT02723955|583518269|FG036|Expansion Phase|Withdrawal by Subject|0|||
161581755|NCT02723955|583518270|FG037|Expansion Phase|Withdrawal by Subject|0|||
161581756|NCT02723955|583518271|FG038|Expansion Phase|Withdrawal by Subject|0|||
161581757|NCT02723955|583518272|FG039|Expansion Phase|Withdrawal by Subject|0|||
161581758|NCT02723955|583518273|FG040|Expansion Phase|Withdrawal by Subject|0|||
161581759|NCT02723955|583518274|FG041|Expansion Phase|Withdrawal by Subject|0|||
161581760|NCT02723955|583518275|FG042|Expansion Phase|Withdrawal by Subject|0|||
161581761|NCT02723955|583518233|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581762|NCT02723955|583518234|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581763|NCT02723955|583518235|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581764|NCT02723955|583518236|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581765|NCT02723955|583518237|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581766|NCT02723955|583518238|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581767|NCT02723955|583518239|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581768|NCT02723955|583518240|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581769|NCT02723955|583518241|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581770|NCT02723955|583518242|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
161581771|NCT02723955|583518243|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
161581772|NCT02723955|583518244|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
161581773|NCT02723955|583518245|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581774|NCT02723955|583518246|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581775|NCT02723955|583518247|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581776|NCT02723955|583518248|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581777|NCT02723955|583518249|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581778|NCT02723955|583518250|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581779|NCT02723955|583518251|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581780|NCT02723955|583518252|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581781|NCT02723955|583518253|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581782|NCT02723955|583518254|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581783|NCT02723955|583518255|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161603634|NCT05412004|583603299|FG000|Overall Study|Withdrawal by Subject|4|||
161485899|NCT00023764|583171132|FG000|Overall Study|Withdrawal by Subject|1|||
161485900|NCT00023764|583171132|FG000|Overall Study|Progression of disease|6|||
161485901|NCT00023764|583171132|FG000|Overall Study|patient received other treatment|1|||
161485902|NCT00023764|583171132|FG000|Overall Study|delay in obtaining staging images|1|||
161670692|NCT00504881|583847283|FG001|Overall Study|Withdrawal by Subject|4|||
161670693|NCT00504881|583847282|FG000|Overall Study|Non-Compliance|1|||
161670694|NCT00504881|583847283|FG001|Overall Study|Non-Compliance|0|||
161670695|NCT00504881|583847282|FG000|Overall Study|No Birth Control|0|||
161670696|NCT00504881|583847283|FG001|Overall Study|No Birth Control|1|||
161670697|NCT00504881|583847282|FG000|Overall Study|Safety Visit not performed|0|||
161670698|NCT00504881|583847283|FG001|Overall Study|Safety Visit not performed|1|||
161670699|NCT00504881|583847282|FG000|Overall Study|AE, serious fatal|0|||
161670700|NCT00504881|583847283|FG001|Overall Study|AE, serious fatal|1|||
161670701|NCT00504881|583847282|FG000|Overall Study|SAE, non-fatal|2|||
161670702|NCT00504881|583847283|FG001|Overall Study|SAE, non-fatal|6|||
161670703|NCT00504881|583847282|FG000|Overall Study|AE, non-serious non-fatal|4|||
161670704|NCT00504881|583847283|FG001|Overall Study|AE, non-serious non-fatal|14|||
161670705|NCT00504881|583847282|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161670706|NCT00504881|583847283|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
161670707|NCT00504881|583847282|FG000|Overall Study|AE of unknown type|1|||
161670708|NCT00504881|583847283|FG001|Overall Study|AE of unknown type|0|||
161670709|NCT00753272|583847291|FG000|Overall Study|Adverse Event|878|||
161670710|NCT00753272|583847292|FG001|Overall Study|Adverse Event|869|||
161670711|NCT00753272|583847291|FG000|Overall Study|Protocol Violation|28|||
161670712|NCT00753272|583847292|FG001|Overall Study|Protocol Violation|46|||
161670713|NCT00753272|583847291|FG000|Overall Study|Withdrawal by Subject|2481|||
161670714|NCT00753272|583847292|FG001|Overall Study|Withdrawal by Subject|2407|||
161670715|NCT00753272|583847291|FG000|Overall Study|Lost to Follow-up|491|||
161670716|NCT00753272|583847292|FG001|Overall Study|Lost to Follow-up|497|||
161670717|NCT00753272|583847291|FG000|Overall Study|Other|1104|||
161670718|NCT00753272|583847292|FG001|Overall Study|Other|1088|||
161670719|NCT00803270|583847293|FG000|Overall Study|Lost to Follow-up|1|||
161670720|NCT00803270|583847294|FG001|Overall Study|Lost to Follow-up|2|||
161670721|NCT01966471|583847295|FG000|Overall Study|Death|44|||
161670722|NCT01966471|583847296|FG001|Overall Study|Death|56|||
161817001|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
161817002|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
161922712|NCT00835978|584764842|FG002|Overall Study|Lost to Follow-up|2|||
161581784|NCT02723955|583518256|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581785|NCT02723955|583518257|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581786|NCT02723955|583518258|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581787|NCT02723955|583518259|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581788|NCT02723955|583518260|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581789|NCT02723955|583518261|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581790|NCT02723955|583518262|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581791|NCT02723955|583518263|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
161581792|NCT02723955|583518264|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581793|NCT02723955|583518265|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161670723|NCT01966471|583847295|FG000|Overall Study|Lost to Follow-up|46|||
161670724|NCT01966471|583847296|FG001|Overall Study|Lost to Follow-up|39|||
161670725|NCT01966471|583847295|FG000|Overall Study|Various reasons|4|||
161922713|NCT00835978|584764843|FG003|Overall Study|Lost to Follow-up|1|||
161922714|NCT00835978|584764840|FG000|Overall Study|Other|5|||
161922715|NCT00835978|584764841|FG001|Overall Study|Other|1|||
161922716|NCT00835978|584764842|FG002|Overall Study|Other|8|||
161922717|NCT00835978|584764843|FG003|Overall Study|Other|0|||
161922718|NCT00835978|584764840|FG000|Overall Study|Objective progression or relapse|2|||
161922719|NCT00835978|584764841|FG001|Overall Study|Objective progression or relapse|0|||
161922720|NCT00835978|584764842|FG002|Overall Study|Objective progression or relapse|1|||
161922721|NCT00835978|584764843|FG003|Overall Study|Objective progression or relapse|0|||
161922722|NCT00835978|584764840|FG000|Overall Study|Adverse Event|1|||
161922723|NCT00835978|584764841|FG001|Overall Study|Adverse Event|0|||
161922724|NCT00835978|584764842|FG002|Overall Study|Adverse Event|1|||
161922725|NCT00835978|584764843|FG003|Overall Study|Adverse Event|0|||
161922726|NCT00835978|584764840|FG000|Overall Study|Withdrawal by Subject|0|||
161922727|NCT00835978|584764841|FG001|Overall Study|Withdrawal by Subject|3|||
161922728|NCT00835978|584764842|FG002|Overall Study|Withdrawal by Subject|0|||
161922729|NCT00835978|584764843|FG003|Overall Study|Withdrawal by Subject|5|||
161922730|NCT00835978|584764840|FG000|Overall Study|Study terminated by sponsor|12|||
161922731|NCT00835978|584764841|FG001|Overall Study|Study terminated by sponsor|8|||
161922732|NCT00835978|584764842|FG002|Overall Study|Study terminated by sponsor|30|||
161922733|NCT00835978|584764843|FG003|Overall Study|Study terminated by sponsor|0|||
161922734|NCT01410604|584764844|FG000|Overall Study|Adverse Event|2|||
161922735|NCT01410604|584764845|FG001|Overall Study|Adverse Event|1|||
161922736|NCT01410604|584764844|FG000|Overall Study|Lost to Follow-up|1|||
161922737|NCT01410604|584764845|FG001|Overall Study|Lost to Follow-up|0|||
161670726|NCT01966471|583847296|FG001|Overall Study|Various reasons|4|||
161670727|NCT01966471|583847295|FG000|Overall Study|Physician Decision|7|||
161670728|NCT01966471|583847296|FG001|Overall Study|Physician Decision|5|||
161670729|NCT01966471|583847295|FG000|Overall Study|Study Terminated By Sponsor|758|||
161670730|NCT01966471|583847296|FG001|Overall Study|Study Terminated By Sponsor|773|||
161670731|NCT01966471|583847295|FG000|Overall Study|Withdrawal by Subject|59|||
161670732|NCT01966471|583847296|FG001|Overall Study|Withdrawal by Subject|51|||
161670733|NCT02092220|583847301|FG000|Period 1|Unrelated Illness|0|||
161670734|NCT02092220|583847302|FG001|Period 1|Unrelated Illness|2|||
161670735|NCT02092220|583847301|FG000|Period 2|Severe Hypoglycaemia|1|||
161670736|NCT02092220|583847302|FG001|Period 2|Severe Hypoglycaemia|0|||
161670737|NCT02092220|583847301|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
161670738|NCT02092220|583847302|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
161670739|NCT00960531|583847303|FG000|Overall Study|Lack of Efficacy|1|||
161670740|NCT00960531|583847304|FG001|Overall Study|Lack of Efficacy|0|||
161670741|NCT00960531|583847305|FG002|Overall Study|Lack of Efficacy|0|||
161670742|NCT00960531|583847306|FG003|Overall Study|Lack of Efficacy|0|||
161670743|NCT00960531|583847307|FG004|Overall Study|Lack of Efficacy|0|||
161670744|NCT00960531|583847308|FG005|Overall Study|Lack of Efficacy|0|||
161670745|NCT00960531|583847309|FG006|Overall Study|Lack of Efficacy|0|||
161670746|NCT00960531|583847310|FG007|Overall Study|Lack of Efficacy|0|||
161670747|NCT00960531|583847311|FG008|Overall Study|Lack of Efficacy|0|||
161670748|NCT00960531|583847312|FG009|Overall Study|Lack of Efficacy|0|||
161670749|NCT00960531|583847303|FG000|Overall Study|Withdrawal by Subject|1|||
161670750|NCT00960531|583847304|FG001|Overall Study|Withdrawal by Subject|0|||
161670751|NCT00960531|583847305|FG002|Overall Study|Withdrawal by Subject|5|||
161670752|NCT00960531|583847306|FG003|Overall Study|Withdrawal by Subject|2|||
161670753|NCT00960531|583847307|FG004|Overall Study|Withdrawal by Subject|0|||
161670754|NCT00960531|583847308|FG005|Overall Study|Withdrawal by Subject|0|||
161670755|NCT00960531|583847309|FG006|Overall Study|Withdrawal by Subject|2|||
161670756|NCT00960531|583847310|FG007|Overall Study|Withdrawal by Subject|0|||
161670757|NCT00960531|583847311|FG008|Overall Study|Withdrawal by Subject|1|||
161670758|NCT00960531|583847312|FG009|Overall Study|Withdrawal by Subject|0|||
161670759|NCT00960531|583847303|FG000|Overall Study|Caregiver Request|2|||
161485903|NCT01537393|583171133|FG000|Overall Study|Exclude prior to study|32|||
161485904|NCT01537393|583171134|FG001|Overall Study|Exclude prior to study|44|||
161485905|NCT01537393|583171133|FG000|Overall Study|Death|20|||
161485906|NCT01537393|583171134|FG001|Overall Study|Death|32|||
161485907|NCT01537393|583171133|FG000|Overall Study|Withdrawal by Subject|18|||
161485908|NCT01537393|583171134|FG001|Overall Study|Withdrawal by Subject|17|||
161485909|NCT01537393|583171133|FG000|Overall Study|Lost to Follow-up|53|||
161485910|NCT01537393|583171134|FG001|Overall Study|Lost to Follow-up|48|||
161485911|NCT01537393|583171133|FG000|Overall Study|Failure - Regrafted|28|||
161485912|NCT01537393|583171134|FG001|Overall Study|Failure - Regrafted|43|||
161485913|NCT01537393|583171133|FG000|Overall Study|Failure - Not regrafted|2|||
161485914|NCT01537393|583171134|FG001|Overall Study|Failure - Not regrafted|6|||
161485915|NCT01537393|583171133|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
161485916|NCT01537393|583171134|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
161485917|NCT00459953|583171135|FG000|Overall Study|not analyzed-household member in study|1|||
161485918|NCT00459953|583171136|FG001|Overall Study|not analyzed-household member in study|1|||
161485919|NCT01197560|583171137|FG000|Overall Study|Adverse Event|6|||
161485920|NCT01197560|583171138|FG001|Overall Study|Adverse Event|8|||
161485921|NCT01197560|583171137|FG000|Overall Study|Death|3|||
161485922|NCT01197560|583171138|FG001|Overall Study|Death|5|||
161485923|NCT01197560|583171137|FG000|Overall Study|Withdrawal by Subject|1|||
161485924|NCT01197560|583171138|FG001|Overall Study|Withdrawal by Subject|1|||
161485925|NCT01197560|583171137|FG000|Overall Study|Disease progression|40|||
161485926|NCT01197560|583171138|FG001|Overall Study|Disease progression|35|||
161485927|NCT01197560|583171137|FG000|Overall Study|Miscellaneous|4|||
161670760|NCT00960531|583847304|FG001|Overall Study|Caregiver Request|0|||
161670761|NCT00960531|583847305|FG002|Overall Study|Caregiver Request|6|||
161670762|NCT00960531|583847306|FG003|Overall Study|Caregiver Request|5|||
161670763|NCT00960531|583847307|FG004|Overall Study|Caregiver Request|0|||
161670764|NCT00960531|583847308|FG005|Overall Study|Caregiver Request|2|||
161922738|NCT01410604|584764844|FG000|Overall Study|Physician Decision|0|||
161485928|NCT01197560|583171138|FG001|Overall Study|Miscellaneous|3|||
161485929|NCT01197560|583171137|FG000|Overall Study|Missing|0|||
161670765|NCT00960531|583847309|FG006|Overall Study|Caregiver Request|3|||
161670766|NCT00960531|583847310|FG007|Overall Study|Caregiver Request|1|||
161670767|NCT00960531|583847311|FG008|Overall Study|Caregiver Request|3|||
161485930|NCT01197560|583171138|FG001|Overall Study|Missing|1|||
161485931|NCT00211510|583171141|FG000|Overall Study|Physician Decision|3|||
161485932|NCT00211510|583171142|FG001|Overall Study|Physician Decision|1|||
161485933|NCT00211510|583171141|FG000|Overall Study|Withdrawal by Subject|3|||
161670768|NCT00960531|583847312|FG009|Overall Study|Caregiver Request|0|||
161670769|NCT00960531|583847303|FG000|Overall Study|Investigator Request|0|||
161670770|NCT00960531|583847304|FG001|Overall Study|Investigator Request|0|||
161670771|NCT00960531|583847305|FG002|Overall Study|Investigator Request|1|||
161581794|NCT02723955|583518266|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581795|NCT02723955|583518267|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581796|NCT02723955|583518268|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581797|NCT02723955|583518269|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581798|NCT02723955|583518270|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581799|NCT02723955|583518271|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581800|NCT02723955|583518272|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161817003|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
161581801|NCT02723955|583518273|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581802|NCT02723955|583518274|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581803|NCT02723955|583518275|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161581804|NCT02723955|583518233|FG000|Expansion Phase|Site Closed|0|||
161581805|NCT02723955|583518234|FG001|Expansion Phase|Site Closed|0|||
161581806|NCT02723955|583518235|FG002|Expansion Phase|Site Closed|0|||
161581807|NCT02723955|583518236|FG003|Expansion Phase|Site Closed|0|||
161581808|NCT02723955|583518237|FG004|Expansion Phase|Site Closed|0|||
161581809|NCT02723955|583518238|FG005|Expansion Phase|Site Closed|0|||
161581810|NCT02723955|583518239|FG006|Expansion Phase|Site Closed|0|||
161581811|NCT02723955|583518240|FG007|Expansion Phase|Site Closed|0|||
161581812|NCT02723955|583518241|FG008|Expansion Phase|Site Closed|0|||
161581813|NCT02723955|583518242|FG009|Expansion Phase|Site Closed|1|||
161581814|NCT02723955|583518243|FG010|Expansion Phase|Site Closed|2|||
161581815|NCT02723955|583518244|FG011|Expansion Phase|Site Closed|6|||
161581816|NCT02723955|583518245|FG012|Expansion Phase|Site Closed|0|||
161581817|NCT02723955|583518246|FG013|Expansion Phase|Site Closed|0|||
161581818|NCT02723955|583518247|FG014|Expansion Phase|Site Closed|0|||
161581819|NCT02723955|583518248|FG015|Expansion Phase|Site Closed|0|||
161581820|NCT02723955|583518249|FG016|Expansion Phase|Site Closed|0|||
161581821|NCT02723955|583518250|FG017|Expansion Phase|Site Closed|0|||
161581822|NCT02723955|583518251|FG018|Expansion Phase|Site Closed|0|||
161581823|NCT02723955|583518252|FG019|Expansion Phase|Site Closed|0|||
161581824|NCT02723955|583518253|FG020|Expansion Phase|Site Closed|0|||
161581825|NCT02723955|583518254|FG021|Expansion Phase|Site Closed|0|||
161581826|NCT02723955|583518255|FG022|Expansion Phase|Site Closed|0|||
161581827|NCT02723955|583518256|FG023|Expansion Phase|Site Closed|0|||
161581828|NCT02723955|583518257|FG024|Expansion Phase|Site Closed|0|||
161581829|NCT02723955|583518258|FG025|Expansion Phase|Site Closed|0|||
161581830|NCT02723955|583518259|FG026|Expansion Phase|Site Closed|0|||
161581831|NCT02723955|583518260|FG027|Expansion Phase|Site Closed|0|||
161581832|NCT02723955|583518261|FG028|Expansion Phase|Site Closed|0|||
161581833|NCT02723955|583518262|FG029|Expansion Phase|Site Closed|0|||
161581834|NCT02723955|583518263|FG030|Expansion Phase|Site Closed|8|||
161581835|NCT02723955|583518264|FG031|Expansion Phase|Site Closed|4|||
161581836|NCT02723955|583518265|FG032|Expansion Phase|Site Closed|2|||
161581837|NCT02723955|583518266|FG033|Expansion Phase|Site Closed|2|||
161581838|NCT02723955|583518267|FG034|Expansion Phase|Site Closed|0|||
161581839|NCT02723955|583518268|FG035|Expansion Phase|Site Closed|0|||
161581840|NCT02723955|583518269|FG036|Expansion Phase|Site Closed|0|||
161581841|NCT02723955|583518270|FG037|Expansion Phase|Site Closed|0|||
161581842|NCT02723955|583518271|FG038|Expansion Phase|Site Closed|0|||
161581843|NCT02723955|583518272|FG039|Expansion Phase|Site Closed|0|||
161581844|NCT02723955|583518273|FG040|Expansion Phase|Site Closed|0|||
161581845|NCT02723955|583518274|FG041|Expansion Phase|Site Closed|0|||
161581846|NCT02723955|583518275|FG042|Expansion Phase|Site Closed|0|||
161581847|NCT02723955|583518233|FG000|Crossover/ Re-treatment Phase|Death|0|||
161581848|NCT02723955|583518234|FG001|Crossover/ Re-treatment Phase|Death|0|||
161581849|NCT02723955|583518235|FG002|Crossover/ Re-treatment Phase|Death|0|||
161581850|NCT02723955|583518236|FG003|Crossover/ Re-treatment Phase|Death|0|||
161581851|NCT02723955|583518237|FG004|Crossover/ Re-treatment Phase|Death|0|||
161581852|NCT02723955|583518238|FG005|Crossover/ Re-treatment Phase|Death|0|||
161581853|NCT02723955|583518239|FG006|Crossover/ Re-treatment Phase|Death|0|||
161581854|NCT02723955|583518240|FG007|Crossover/ Re-treatment Phase|Death|0|||
161581855|NCT02723955|583518241|FG008|Crossover/ Re-treatment Phase|Death|0|||
161581856|NCT02723955|583518242|FG009|Crossover/ Re-treatment Phase|Death|0|||
161581857|NCT02723955|583518243|FG010|Crossover/ Re-treatment Phase|Death|0|||
161581858|NCT02723955|583518244|FG011|Crossover/ Re-treatment Phase|Death|0|||
161581859|NCT02723955|583518245|FG012|Crossover/ Re-treatment Phase|Death|0|||
161581860|NCT02723955|583518246|FG013|Crossover/ Re-treatment Phase|Death|0|||
161581861|NCT02723955|583518247|FG014|Crossover/ Re-treatment Phase|Death|0|||
161581862|NCT02723955|583518248|FG015|Crossover/ Re-treatment Phase|Death|0|||
161581863|NCT02723955|583518249|FG016|Crossover/ Re-treatment Phase|Death|0|||
161581864|NCT02723955|583518250|FG017|Crossover/ Re-treatment Phase|Death|0|||
161581865|NCT02723955|583518251|FG018|Crossover/ Re-treatment Phase|Death|0|||
161817004|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
161817005|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
161817006|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
161485934|NCT00211510|583171142|FG001|Overall Study|Withdrawal by Subject|1|||
161485935|NCT01487200|583171143|FG000|Overall Study|Withdrawal by Subject|0|||
161485936|NCT01487200|583171144|FG001|Overall Study|Withdrawal by Subject|1|||
161485937|NCT01487200|583171145|FG002|Overall Study|Withdrawal by Subject|0|||
161485938|NCT01487200|583171146|FG003|Overall Study|Withdrawal by Subject|0|||
161485939|NCT04051008|583171151|FG000|Overall Study|Withdrawal by Subject|2|||
161485940|NCT04051008|583171152|FG001|Overall Study|Withdrawal by Subject|0|||
161485941|NCT04051008|583171153|FG002|Overall Study|Withdrawal by Subject|1|||
161485942|NCT02862171|583171154|FG000|Overall Study|Death|1|||
161485943|NCT02862171|583171154|FG000|Overall Study|Lost to Follow-up|13|||
161485944|NCT02862171|583171154|FG000|Overall Study|Withdrawal by Subject|57|||
161485945|NCT02862171|583171154|FG000|Overall Study|Non-compliance|4|||
161485946|NCT02862171|583171154|FG000|Overall Study|HIV-1 seroconversion|18|||
161485947|NCT00838578|583171158|FG000|Overall Study|Protocol Violation|2|||
161485948|NCT00357968|583171163|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
161485949|NCT00357968|583171164|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
161485950|NCT00357968|583171163|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
161485951|NCT00357968|583171164|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
161485952|NCT03919799|583171165|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
161485953|NCT03919799|583171166|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
161485954|NCT03919799|583171167|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
161485955|NCT03919799|583171168|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
161485956|NCT03919799|583171169|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
161485957|NCT03919799|583171165|FG000|DB Period (28 Weeks)|Adverse Event|1|||
161485958|NCT03919799|583171166|FG001|DB Period (28 Weeks)|Adverse Event|1|||
161485959|NCT03919799|583171167|FG002|DB Period (28 Weeks)|Adverse Event|1|||
161485960|NCT03919799|583171168|FG003|DB Period (28 Weeks)|Adverse Event|0|||
161485961|NCT03919799|583171169|FG004|DB Period (28 Weeks)|Adverse Event|0|||
161485962|NCT03919799|583171165|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
161485963|NCT03919799|583171166|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
161581866|NCT02723955|583518252|FG019|Crossover/ Re-treatment Phase|Death|0|||
161581867|NCT02723955|583518253|FG020|Crossover/ Re-treatment Phase|Death|0|||
161581868|NCT02723955|583518254|FG021|Crossover/ Re-treatment Phase|Death|0|||
161581869|NCT02723955|583518255|FG022|Crossover/ Re-treatment Phase|Death|0|||
161581870|NCT02723955|583518256|FG023|Crossover/ Re-treatment Phase|Death|0|||
161581871|NCT02723955|583518257|FG024|Crossover/ Re-treatment Phase|Death|0|||
161581872|NCT02723955|583518258|FG025|Crossover/ Re-treatment Phase|Death|0|||
161581873|NCT02723955|583518259|FG026|Crossover/ Re-treatment Phase|Death|0|||
161581874|NCT02723955|583518260|FG027|Crossover/ Re-treatment Phase|Death|0|||
161581875|NCT02723955|583518261|FG028|Crossover/ Re-treatment Phase|Death|0|||
161581876|NCT02723955|583518262|FG029|Crossover/ Re-treatment Phase|Death|0|||
161581877|NCT02723955|583518263|FG030|Crossover/ Re-treatment Phase|Death|0|||
161581878|NCT02723955|583518264|FG031|Crossover/ Re-treatment Phase|Death|0|||
161581879|NCT02723955|583518265|FG032|Crossover/ Re-treatment Phase|Death|0|||
161581880|NCT02723955|583518266|FG033|Crossover/ Re-treatment Phase|Death|0|||
161581881|NCT02723955|583518267|FG034|Crossover/ Re-treatment Phase|Death|0|||
161581882|NCT02723955|583518268|FG035|Crossover/ Re-treatment Phase|Death|0|||
161581883|NCT02723955|583518269|FG036|Crossover/ Re-treatment Phase|Death|0|||
161581884|NCT02723955|583518270|FG037|Crossover/ Re-treatment Phase|Death|1|||
161581885|NCT02723955|583518271|FG038|Crossover/ Re-treatment Phase|Death|14|||
161581886|NCT02723955|583518272|FG039|Crossover/ Re-treatment Phase|Death|32|||
161581887|NCT02723955|583518273|FG040|Crossover/ Re-treatment Phase|Death|2|||
161581888|NCT02723955|583518274|FG041|Crossover/ Re-treatment Phase|Death|1|||
161581889|NCT02723955|583518275|FG042|Crossover/ Re-treatment Phase|Death|0|||
161581890|NCT02723955|583518233|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581891|NCT02723955|583518234|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581892|NCT02723955|583518235|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581893|NCT02723955|583518236|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581894|NCT02723955|583518237|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581895|NCT02723955|583518238|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581896|NCT02723955|583518239|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581897|NCT02723955|583518240|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581898|NCT02723955|583518241|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581899|NCT02723955|583518242|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581900|NCT02723955|583518243|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581901|NCT02723955|583518244|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581902|NCT02723955|583518245|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581903|NCT02723955|583518246|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581904|NCT02723955|583518247|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581905|NCT02723955|583518248|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161670772|NCT00960531|583847306|FG003|Overall Study|Investigator Request|0|||
161670773|NCT00960531|583847307|FG004|Overall Study|Investigator Request|0|||
161670774|NCT00960531|583847308|FG005|Overall Study|Investigator Request|0|||
161670775|NCT00960531|583847309|FG006|Overall Study|Investigator Request|0|||
161670776|NCT00960531|583847310|FG007|Overall Study|Investigator Request|0|||
161670777|NCT00960531|583847311|FG008|Overall Study|Investigator Request|0|||
161670778|NCT00960531|583847312|FG009|Overall Study|Investigator Request|0|||
161670779|NCT00960531|583847303|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161670780|NCT00960531|583847304|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161670781|NCT00960531|583847305|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161670782|NCT00960531|583847306|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161670783|NCT00960531|583847307|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161670784|NCT00960531|583847308|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161670785|NCT00960531|583847309|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
161670786|NCT00960531|583847310|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
161670787|NCT00960531|583847311|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
161670788|NCT00960531|583847312|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
161670789|NCT00960531|583847303|FG000|Overall Study|Lost to Follow-up|0|||
161670790|NCT00960531|583847304|FG001|Overall Study|Lost to Follow-up|0|||
161670791|NCT00960531|583847305|FG002|Overall Study|Lost to Follow-up|1|||
161670792|NCT00960531|583847306|FG003|Overall Study|Lost to Follow-up|0|||
161670793|NCT00960531|583847307|FG004|Overall Study|Lost to Follow-up|0|||
161670794|NCT00960531|583847308|FG005|Overall Study|Lost to Follow-up|0|||
161670795|NCT00960531|583847309|FG006|Overall Study|Lost to Follow-up|1|||
161670796|NCT00960531|583847310|FG007|Overall Study|Lost to Follow-up|0|||
161670797|NCT00960531|583847311|FG008|Overall Study|Lost to Follow-up|0|||
161670798|NCT00960531|583847312|FG009|Overall Study|Lost to Follow-up|0|||
161670799|NCT00960531|583847303|FG000|Overall Study|Failed to Return|2|||
161670800|NCT00960531|583847304|FG001|Overall Study|Failed to Return|0|||
161670801|NCT00960531|583847305|FG002|Overall Study|Failed to Return|0|||
161670802|NCT00960531|583847306|FG003|Overall Study|Failed to Return|0|||
161670803|NCT00960531|583847307|FG004|Overall Study|Failed to Return|0|||
161670804|NCT00960531|583847308|FG005|Overall Study|Failed to Return|0|||
161670805|NCT00960531|583847309|FG006|Overall Study|Failed to Return|0|||
161670806|NCT00960531|583847310|FG007|Overall Study|Failed to Return|2|||
161670807|NCT00960531|583847311|FG008|Overall Study|Failed to Return|0|||
161670808|NCT00960531|583847312|FG009|Overall Study|Failed to Return|0|||
161670809|NCT00960531|583847303|FG000|Overall Study|Adverse Event (AE)|2|||
161670810|NCT00960531|583847304|FG001|Overall Study|Adverse Event (AE)|0|||
161670811|NCT00960531|583847305|FG002|Overall Study|Adverse Event (AE)|0|||
161670812|NCT00960531|583847306|FG003|Overall Study|Adverse Event (AE)|0|||
161670813|NCT00960531|583847307|FG004|Overall Study|Adverse Event (AE)|0|||
161670814|NCT00960531|583847308|FG005|Overall Study|Adverse Event (AE)|1|||
161670815|NCT00960531|583847309|FG006|Overall Study|Adverse Event (AE)|2|||
161670816|NCT00960531|583847310|FG007|Overall Study|Adverse Event (AE)|0|||
161670817|NCT00960531|583847311|FG008|Overall Study|Adverse Event (AE)|2|||
161670818|NCT00960531|583847312|FG009|Overall Study|Adverse Event (AE)|0|||
161670819|NCT00960531|583847303|FG000|Overall Study|Reason not Specified|2|||
161670820|NCT00960531|583847304|FG001|Overall Study|Reason not Specified|1|||
161670821|NCT00960531|583847305|FG002|Overall Study|Reason not Specified|13|||
161670822|NCT00960531|583847306|FG003|Overall Study|Reason not Specified|1|||
161670823|NCT00960531|583847307|FG004|Overall Study|Reason not Specified|2|||
161670824|NCT00960531|583847308|FG005|Overall Study|Reason not Specified|0|||
161670825|NCT00960531|583847309|FG006|Overall Study|Reason not Specified|16|||
161670826|NCT00960531|583847310|FG007|Overall Study|Reason not Specified|0|||
161670827|NCT00960531|583847311|FG008|Overall Study|Reason not Specified|8|||
161670828|NCT00960531|583847312|FG009|Overall Study|Reason not Specified|1|||
161670829|NCT00593957|583847313|FG000|Overall Study|Physician Decision|0|||
161670830|NCT00593957|583847314|FG001|Overall Study|Physician Decision|1|||
161817007|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
161670831|NCT00593957|583847315|FG002|Overall Study|Physician Decision|2|||
161670832|NCT02411578|583847318|FG000|Crossover Trial Phase|Pregnancy|0|||
161670833|NCT02411578|583847319|FG001|Crossover Trial Phase|Pregnancy|1|||
161670834|NCT00494481|583847320|FG000|Overall Study|Condition under investigation worsened|11|||
161670835|NCT00494481|583847321|FG001|Overall Study|Condition under investigation worsened|13|||
161670836|NCT00494481|583847320|FG000|Overall Study|Adverse Event|15|||
161670837|NCT00494481|583847321|FG001|Overall Study|Adverse Event|11|||
161670838|NCT00494481|583847320|FG000|Overall Study|Other|1|||
161670839|NCT00494481|583847321|FG001|Overall Study|Other|0|||
161670840|NCT00494481|583847320|FG000|Overall Study|Never received IP|2|||
161670841|NCT00494481|583847321|FG001|Overall Study|Never received IP|0|||
161670842|NCT01030198|583847322|FG000|Overall Study|Could not measure efficacy accurately|0|||
161670843|NCT01030198|583847323|FG001|Overall Study|Could not measure efficacy accurately|7|||
161817008|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
161670844|NCT00332189|583847324|FG000|Overall Study|Adverse Event|3|||
161670845|NCT00332189|583847324|FG000|Overall Study|Uncooperative/Noncompliant|3|||
161670846|NCT00332189|583847324|FG000|Overall Study|Withdrawal by Subject|9|||
161581906|NCT02723955|583518249|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581907|NCT02723955|583518250|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581908|NCT02723955|583518251|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581909|NCT02723955|583518252|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581910|NCT02723955|583518253|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581911|NCT02723955|583518254|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581912|NCT02723955|583518255|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581913|NCT02723955|583518256|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581914|NCT02723955|583518257|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581915|NCT02723955|583518258|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581916|NCT02723955|583518259|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581917|NCT02723955|583518260|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581918|NCT02723955|583518261|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581919|NCT02723955|583518262|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581920|NCT02723955|583518263|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581921|NCT02723955|583518264|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581922|NCT02723955|583518265|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581923|NCT02723955|583518266|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581924|NCT02723955|583518267|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581925|NCT02723955|583518268|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581926|NCT02723955|583518269|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581927|NCT02723955|583518270|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581928|NCT02723955|583518271|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581929|NCT02723955|583518272|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
161581930|NCT02723955|583518273|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581931|NCT02723955|583518274|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581932|NCT02723955|583518275|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161581933|NCT02723955|583518233|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581934|NCT02723955|583518234|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581935|NCT02723955|583518235|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581936|NCT02723955|583518236|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581937|NCT02723955|583518237|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581938|NCT02723955|583518238|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581939|NCT02723955|583518239|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581940|NCT02723955|583518240|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581941|NCT02723955|583518241|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581942|NCT02723955|583518242|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581943|NCT02723955|583518243|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581944|NCT02723955|583518244|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581945|NCT02723955|583518245|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581946|NCT02723955|583518246|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581947|NCT02723955|583518247|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581948|NCT02723955|583518248|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581949|NCT02723955|583518249|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581950|NCT02723955|583518250|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581951|NCT02723955|583518251|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581952|NCT02723955|583518252|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581953|NCT02723955|583518253|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581954|NCT02723955|583518254|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581955|NCT02723955|583518255|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581956|NCT02723955|583518256|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581957|NCT02723955|583518257|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581958|NCT02723955|583518258|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581959|NCT02723955|583518259|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581960|NCT02723955|583518260|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581961|NCT02723955|583518261|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581962|NCT02723955|583518262|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581963|NCT02723955|583518263|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581964|NCT02723955|583518264|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581965|NCT02723955|583518265|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581966|NCT02723955|583518266|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
161817009|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
161581967|NCT02723955|583518267|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581968|NCT02723955|583518268|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
161817010|NCT04194801|584370899|FG000|Part Ib/II End of Study|Death|2|||
161817011|NCT04194801|584370900|FG001|Part Ib/II End of Study|Death|3|||
161581969|NCT02723955|583518269|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581970|NCT02723955|583518270|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581971|NCT02723955|583518271|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
161581972|NCT02723955|583518272|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
161581973|NCT02723955|583518273|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581974|NCT02723955|583518274|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
161581975|NCT02723955|583518275|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
161581976|NCT02723955|583518233|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
161581977|NCT02723955|583518234|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
161581978|NCT02723955|583518235|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
161581979|NCT02723955|583518236|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
161581980|NCT02723955|583518237|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
161581981|NCT02723955|583518238|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
161581982|NCT02723955|583518239|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
161581983|NCT02723955|583518240|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
161581984|NCT02723955|583518241|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
161581985|NCT02723955|583518242|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
161581986|NCT02723955|583518243|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
161581987|NCT02723955|583518244|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
161581988|NCT02723955|583518245|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
161581989|NCT02723955|583518246|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
161581990|NCT02723955|583518247|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
161581991|NCT02723955|583518248|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
161581992|NCT02723955|583518249|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
161581993|NCT02723955|583518250|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
161581994|NCT02723955|583518251|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
161581995|NCT02723955|583518252|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
161581996|NCT02723955|583518253|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
161581997|NCT02723955|583518254|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
161581998|NCT02723955|583518255|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
161581999|NCT02723955|583518256|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
161582000|NCT02723955|583518257|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
161582001|NCT02723955|583518258|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
161582002|NCT02723955|583518259|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
161582003|NCT02723955|583518260|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
161582004|NCT02723955|583518261|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
161582005|NCT02723955|583518262|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
161582006|NCT02723955|583518263|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
161582007|NCT02723955|583518264|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
161582008|NCT02723955|583518265|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
161582009|NCT02723955|583518266|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
161582010|NCT02723955|583518267|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
161582011|NCT02723955|583518268|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
161582012|NCT02723955|583518269|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
161582013|NCT02723955|583518270|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
161582014|NCT02723955|583518271|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
161582015|NCT02723955|583518272|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
161582016|NCT02723955|583518273|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
161582017|NCT02723955|583518274|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
161582018|NCT02723955|583518275|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
161582019|NCT03088813|583518278|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161582020|NCT03088813|583518279|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
161582021|NCT03088813|583518280|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161582022|NCT03088813|583518281|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161582023|NCT03088813|583518278|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161582024|NCT03088813|583518279|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161582025|NCT03088813|583518280|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
161582026|NCT03088813|583518281|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161582027|NCT03088813|583518278|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
161582028|NCT03088813|583518279|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
161582029|NCT03088813|583518280|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
161582030|NCT03088813|583518281|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
161582031|NCT03088813|583518278|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
161582032|NCT03088813|583518279|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
161582033|NCT03088813|583518280|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
161582034|NCT03088813|583518281|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
161582035|NCT03088813|583518278|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
161582036|NCT03088813|583518279|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
161582037|NCT03088813|583518280|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
161582038|NCT03088813|583518281|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
161817012|NCT04194801|584370901|FG002|Part Ib/II End of Study|Death|3|||
161582039|NCT03088813|583518278|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161582040|NCT03088813|583518279|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161582041|NCT03088813|583518280|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161485964|NCT03919799|583171167|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
161485965|NCT03919799|583171168|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
161485966|NCT03919799|583171169|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
161485967|NCT03919799|583171165|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
161485968|NCT03919799|583171166|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
161485969|NCT03919799|583171167|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
161485970|NCT03919799|583171168|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
161485971|NCT03919799|583171169|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
161485972|NCT03919799|583171165|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
161485973|NCT03919799|583171166|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
161485974|NCT03919799|583171167|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
161485975|NCT03919799|583171168|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
161485976|NCT03919799|583171169|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
161485977|NCT03547687|583171171|FG000|Overall Study|Withdrawal by Subject|1|||
161485978|NCT03547687|583171171|FG000|Overall Study|Death|1|||
161485979|NCT00646776|583171172|FG000|Overall Study|Adverse Event|1|||
161485980|NCT00646776|583171173|FG001|Overall Study|Adverse Event|9|||
161485981|NCT00646776|583171172|FG000|Overall Study|Investigator discretion|0|||
161485982|NCT00646776|583171173|FG001|Overall Study|Investigator discretion|4|||
161485983|NCT04600921|583171174|FG000|Overall Study|Withdrawal by Subject|3|||
161485984|NCT04600921|583171175|FG001|Overall Study|Withdrawal by Subject|5|||
161485985|NCT04600921|583171174|FG000|Overall Study|Death|0|||
161485986|NCT04600921|583171175|FG001|Overall Study|Death|1|||
161485987|NCT04419714|583171176|FG000|Overall Study|Technical Fault|5|||
161485988|NCT04419714|583171176|FG000|Overall Study|Protocol Deviation|2|||
161485989|NCT04419714|583171176|FG000|Overall Study|Withdrawal by Subject|1|||
161485990|NCT02700815|583172809|FG000|Overall Study|Adverse Event|0|||
161485991|NCT02700815|583172810|FG001|Overall Study|Adverse Event|6|||
161485992|NCT02700815|583172811|FG002|Overall Study|Adverse Event|2|||
161485993|NCT02700815|583172812|FG003|Overall Study|Adverse Event|3|||
161485994|NCT02700815|583172809|FG000|Overall Study|Lack of Efficacy|0|||
161485995|NCT02700815|583172810|FG001|Overall Study|Lack of Efficacy|0|||
161485996|NCT02700815|583172811|FG002|Overall Study|Lack of Efficacy|1|||
161485997|NCT02700815|583172812|FG003|Overall Study|Lack of Efficacy|2|||
161485998|NCT02700815|583172809|FG000|Overall Study|Lost to Follow-up|1|||
161485999|NCT02700815|583172810|FG001|Overall Study|Lost to Follow-up|0|||
161486000|NCT02700815|583172811|FG002|Overall Study|Lost to Follow-up|0|||
161486001|NCT02700815|583172812|FG003|Overall Study|Lost to Follow-up|1|||
161486002|NCT02700815|583172809|FG000|Overall Study|Refusal to continue medication|0|||
161486003|NCT02700815|583172810|FG001|Overall Study|Refusal to continue medication|1|||
161486004|NCT02700815|583172811|FG002|Overall Study|Refusal to continue medication|0|||
161486005|NCT02700815|583172812|FG003|Overall Study|Refusal to continue medication|1|||
161486006|NCT02700815|583172809|FG000|Overall Study|Withdrawal by Subject|0|||
161486007|NCT02700815|583172810|FG001|Overall Study|Withdrawal by Subject|0|||
161486008|NCT02700815|583172811|FG002|Overall Study|Withdrawal by Subject|1|||
161486009|NCT02700815|583172812|FG003|Overall Study|Withdrawal by Subject|0|||
161486010|NCT04023526|583172813|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
161486011|NCT04023526|583172814|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
161486012|NCT04023526|583172813|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
161486013|NCT04023526|583172814|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
161486014|NCT01955733|583172818|FG000|Period 1|Lost to Follow-up|1|||
161486015|NCT01955733|583172819|FG001|Period 1|Lost to Follow-up|0|||
161486016|NCT01955733|583172820|FG002|Period 1|Lost to Follow-up|0|||
161486017|NCT01955733|583172818|FG000|Period 2|Adverse Event|1|||
161486018|NCT01955733|583172819|FG001|Period 2|Adverse Event|0|||
161486019|NCT01955733|583172820|FG002|Period 2|Adverse Event|0|||
161486020|NCT01955733|583172818|FG000|Period 2|Physician Decision|0|||
161486021|NCT01955733|583172819|FG001|Period 2|Physician Decision|0|||
161486022|NCT01955733|583172820|FG002|Period 2|Physician Decision|1|||
161486023|NCT01955733|583172818|FG000|Period 2|Withdrawal by Subject|1|||
161486024|NCT01955733|583172819|FG001|Period 2|Withdrawal by Subject|3|||
161486025|NCT01955733|583172820|FG002|Period 2|Withdrawal by Subject|2|||
161486026|NCT01955733|583172818|FG000|Period 2|Study terminated by sponsor|8|||
161486027|NCT01955733|583172819|FG001|Period 2|Study terminated by sponsor|14|||
161486028|NCT01955733|583172820|FG002|Period 2|Study terminated by sponsor|16|||
161486029|NCT01955733|583172818|FG000|Period 2|Lost to Follow-up|2|||
161486030|NCT01955733|583172819|FG001|Period 2|Lost to Follow-up|0|||
161486031|NCT01955733|583172820|FG002|Period 2|Lost to Follow-up|0|||
161486032|NCT01955733|583172818|FG000|Period 2|Other not defined above|0|||
161486033|NCT01955733|583172819|FG001|Period 2|Other not defined above|2|||
161582042|NCT03088813|583518281|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
161670847|NCT00332189|583847324|FG000|Overall Study|Lack of Efficacy|4|||
161486034|NCT01955733|583172820|FG002|Period 2|Other not defined above|2|||
161486035|NCT02239978|583172823|FG000|Overall Study|Withdrawal by Subject|2|||
161486036|NCT02239978|583172824|FG001|Overall Study|Withdrawal by Subject|0|||
161486037|NCT02324569|583172835|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161486038|NCT02324569|583172836|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
161670848|NCT00332189|583847324|FG000|Overall Study|Moved out of country|2|||
161670849|NCT02370043|583847325|FG000|Overall Study|Withdrawal by Subject|0|||
161670850|NCT02370043|583847326|FG001|Overall Study|Withdrawal by Subject|0|||
161670851|NCT02370043|583847327|FG002|Overall Study|Withdrawal by Subject|0|||
161670852|NCT02370043|583847328|FG003|Overall Study|Withdrawal by Subject|0|||
161670853|NCT02370043|583847329|FG004|Overall Study|Withdrawal by Subject|1|||
161670854|NCT02370043|583847330|FG005|Overall Study|Withdrawal by Subject|1|||
161670855|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
161670856|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
161670857|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
161670858|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
161670859|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
161670860|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
161922739|NCT01410604|584764845|FG001|Overall Study|Physician Decision|1|||
161922740|NCT02383173|584764850|FG000|Overall Study|Palliative Care Team withdrew|0|||
161922741|NCT02383173|584764851|FG001|Overall Study|Palliative Care Team withdrew|2|||
161922742|NCT00800540|584764852|FG000|Period One: 6 Weeks|Noncompliance|1|||
161922743|NCT00800540|584764853|FG001|Period One: 6 Weeks|Noncompliance|0|||
161922744|NCT00800540|584764852|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
161922745|NCT00800540|584764853|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
161922746|NCT00800540|584764852|FG000|Period 2: 6 Weeks|Adverse Event|0|||
161922747|NCT00800540|584764853|FG001|Period 2: 6 Weeks|Adverse Event|1|||
161922748|NCT00153920|584764854|FG000|Overall Study|Adverse Event|9|||
161922749|NCT00153920|584764854|FG000|Overall Study|Progressive Disease|9|||
161922750|NCT00153920|584764854|FG000|Overall Study|Physician Decision|3|||
161922751|NCT00153920|584764854|FG000|Overall Study|Lack of Response|3|||
161922752|NCT00153920|584764854|FG000|Overall Study|Death|2|||
161922753|NCT00153920|584764854|FG000|Overall Study|Withdrawal by Subject|1|||
161922754|NCT00153920|584764854|FG000|Overall Study|Non-Protocol Therapy|1|||
161922755|NCT00153920|584764854|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
161922756|NCT00153920|584764854|FG000|Overall Study|Progressive Disease before Trt|1|||
161922757|NCT04795323|584764855|FG000|Overall Study|Did not interact with TARA|1|||
161922758|NCT04795323|584764856|FG001|Overall Study|Did not interact with TARA|0|||
161922759|NCT00376506|584764857|FG000|Overall Study|Death|0|||
161922760|NCT00376506|584764858|FG001|Overall Study|Death|2|||
161922761|NCT01944774|584764860|FG000|Overall Study|Withdrawal by Subject|2|||
161922762|NCT01944774|584764861|FG001|Overall Study|Withdrawal by Subject|3|||
161922763|NCT01944774|584764862|FG002|Overall Study|Withdrawal by Subject|3|||
161922764|NCT01944774|584764860|FG000|Overall Study|Adverse Event|3|||
161922765|NCT01944774|584764861|FG001|Overall Study|Adverse Event|2|||
161922766|NCT01944774|584764862|FG002|Overall Study|Adverse Event|3|||
161922767|NCT01944774|584764860|FG000|Overall Study|Lack of Efficacy|1|||
161922768|NCT01944774|584764861|FG001|Overall Study|Lack of Efficacy|2|||
161922769|NCT01944774|584764862|FG002|Overall Study|Lack of Efficacy|2|||
161922770|NCT01944774|584764860|FG000|Overall Study|Lost to Follow-up|0|||
161922771|NCT01944774|584764861|FG001|Overall Study|Lost to Follow-up|1|||
161922772|NCT01944774|584764862|FG002|Overall Study|Lost to Follow-up|0|||
161922773|NCT02112552|584764865|FG000|Overall Study|Withdrawal by Subject|1|||
161922774|NCT02112552|584764865|FG000|Overall Study|Adverse Event|1|||
161922775|NCT00774748|584764866|FG000|Overall Study|Lost to Follow-up|3|||
161922776|NCT03349515|584764870|FG000|Overall Study|Lack of Efficacy|2|||
161922777|NCT03349515|584764871|FG001|Overall Study|Lack of Efficacy|0|||
161922778|NCT03349515|584764870|FG000|Overall Study|Physician Decision|3|||
161922779|NCT03349515|584764871|FG001|Overall Study|Physician Decision|1|||
161922780|NCT02965456|584764876|FG000|Overall Study|Lost to Follow-up|40|||
161922781|NCT02965456|584764877|FG001|Overall Study|Lost to Follow-up|18|||
161922782|NCT02965456|584764876|FG000|Overall Study|Subject Request|22|||
161922783|NCT02965456|584764877|FG001|Overall Study|Subject Request|13|||
161922784|NCT02965456|584764876|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
161922785|NCT02965456|584764877|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
161922786|NCT02965456|584764876|FG000|Overall Study|Adverse Event|3|||
161922787|NCT02965456|584764877|FG001|Overall Study|Adverse Event|0|||
161922788|NCT02965456|584764876|FG000|Overall Study|Noncompliance with Study Drug|1|||
161922789|NCT02965456|584764877|FG001|Overall Study|Noncompliance with Study Drug|1|||
161922790|NCT02965456|584764876|FG000|Overall Study|Worsening Condition|0|||
161922791|NCT02965456|584764877|FG001|Overall Study|Worsening Condition|2|||
161922792|NCT02965456|584764876|FG000|Overall Study|Lack of Efficacy|1|||
161922793|NCT02965456|584764877|FG001|Overall Study|Lack of Efficacy|0|||
161922794|NCT02965456|584764876|FG000|Overall Study|Physician Decision|0|||
161922795|NCT02965456|584764877|FG001|Overall Study|Physician Decision|1|||
161922796|NCT02965456|584764876|FG000|Overall Study|Pregnancy|1|||
161922797|NCT02965456|584764877|FG001|Overall Study|Pregnancy|0|||
161922798|NCT02965456|584764876|FG000|Overall Study|Protocol Violation|0|||
161922799|NCT02965456|584764877|FG001|Overall Study|Protocol Violation|1|||
161486039|NCT02324569|583172835|FG000|Overall Study|Voluntary Withdrawal|3|||
161486040|NCT02324569|583172836|FG001|Overall Study|Voluntary Withdrawal|6|||
161486041|NCT02324569|583172835|FG000|Overall Study|Lack of Efficacy|2|||
161486042|NCT02324569|583172836|FG001|Overall Study|Lack of Efficacy|3|||
161486043|NCT02324569|583172835|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
161486044|NCT02324569|583172836|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
161486045|NCT02324569|583172835|FG000|Overall Study|Inconvenient Schedule|2|||
161486046|NCT02324569|583172836|FG001|Overall Study|Inconvenient Schedule|0|||
161486047|NCT00793403|583172845|FG000|Overall Study|Other|73|||
161486048|NCT00309387|583172857|FG000|Overall Study|Death|72|||
161486049|NCT00309387|583172858|FG001|Overall Study|Death|73|||
161486050|NCT00309387|583172857|FG000|Overall Study|Lost to Follow-up|70|||
161486051|NCT00309387|583172858|FG001|Overall Study|Lost to Follow-up|86|||
161486052|NCT00381095|583172860|FG000|Overall Study|Death|3|||
161486053|NCT00381095|583172861|FG001|Overall Study|Death|4|||
161486054|NCT00381095|583172860|FG000|Overall Study|Lack of Efficacy|2|||
161486055|NCT00381095|583172861|FG001|Overall Study|Lack of Efficacy|4|||
161486056|NCT00381095|583172860|FG000|Overall Study|Other|2|||
161486057|NCT00381095|583172861|FG001|Overall Study|Other|2|||
161486058|NCT00381095|583172860|FG000|Overall Study|Protocol Violation|1|||
161486059|NCT00381095|583172861|FG001|Overall Study|Protocol Violation|1|||
161486060|NCT00381095|583172860|FG000|Overall Study|Withdrawal by Subject|3|||
161486061|NCT00381095|583172861|FG001|Overall Study|Withdrawal by Subject|3|||
161486062|NCT00381095|583172860|FG000|Overall Study|Adverse Event|2|||
161486063|NCT00381095|583172861|FG001|Overall Study|Adverse Event|7|||
161486064|NCT02899988|583172862|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
161486065|NCT02899988|583172863|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
161486066|NCT02899988|583172864|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486067|NCT02899988|583172865|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486068|NCT02899988|583172866|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486069|NCT02899988|583172867|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486070|NCT02899988|583172868|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486071|NCT02899988|583172869|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486072|NCT02899988|583172870|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486073|NCT02899988|583172871|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486074|NCT02899988|583172872|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161486075|NCT02899988|583172862|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
161486076|NCT02899988|583172863|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
161486077|NCT02899988|583172864|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161486078|NCT02899988|583172865|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
161486079|NCT02899988|583172866|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161486080|NCT02899988|583172867|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161486081|NCT02899988|583172868|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
161486082|NCT02899988|583172869|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
161486083|NCT02899988|583172870|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
161486084|NCT02899988|583172871|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
161486085|NCT02899988|583172872|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
161486086|NCT02899988|583172862|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
161486087|NCT02899988|583172863|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
161486088|NCT02899988|583172864|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
161486089|NCT02899988|583172865|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
161486090|NCT02899988|583172866|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
161486091|NCT02899988|583172867|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
161486092|NCT02899988|583172868|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
161486093|NCT02899988|583172869|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
161486094|NCT02899988|583172870|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
161486095|NCT02899988|583172871|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
161486096|NCT02899988|583172872|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
161486097|NCT02899988|583172862|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
161486098|NCT02899988|583172863|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
161486099|NCT02899988|583172864|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
161486100|NCT02899988|583172865|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
161486101|NCT02899988|583172866|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
161486102|NCT02899988|583172867|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
161582043|NCT03088813|583518278|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161582044|NCT03088813|583518279|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161486103|NCT02899988|583172868|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
161582045|NCT03088813|583518280|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
161582046|NCT03088813|583518281|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161582047|NCT04878354|583518282|FG000|Overall Study|Adverse Event|4|||
161486104|NCT02899988|583172869|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
161486105|NCT02899988|583172870|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
161486106|NCT02899988|583172871|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
161582048|NCT04878354|583518283|FG001|Overall Study|Adverse Event|13|||
161486107|NCT02899988|583172872|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
161486108|NCT02899988|583172862|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486109|NCT02899988|583172863|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486110|NCT02899988|583172864|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486111|NCT02899988|583172865|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486112|NCT02899988|583172866|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486113|NCT02899988|583172867|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
161486114|NCT02899988|583172868|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486115|NCT02899988|583172869|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
161486116|NCT02899988|583172870|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486117|NCT02899988|583172871|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486118|NCT02899988|583172872|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
161486119|NCT02899988|583172862|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
161486120|NCT02899988|583172863|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
161486121|NCT02899988|583172864|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
161486122|NCT02899988|583172865|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
161486123|NCT02899988|583172866|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
161486124|NCT02899988|583172867|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
161486125|NCT02899988|583172868|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
161486126|NCT02899988|583172869|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
161486127|NCT02899988|583172870|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
161486128|NCT02899988|583172871|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
161486129|NCT02899988|583172872|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
161486130|NCT04492618|583172873|FG000|Overall Study|Withdrawal by Subject|1|||
161486131|NCT03562481|583172874|FG000|First Intervention|Lost to Follow-up|1|||
161486132|NCT03562481|583172875|FG001|First Intervention|Lost to Follow-up|0|||
161486133|NCT00856284|583172881|FG000|Overall Study|Hyperglycemic rescue|231|||
161486134|NCT00856284|583172882|FG001|Overall Study|Hyperglycemic rescue|201|||
161486135|NCT00856284|583172883|FG002|Overall Study|Hyperglycemic rescue|235|||
161486136|NCT00856284|583172881|FG000|Overall Study|Adverse Event|60|||
161486137|NCT00856284|583172882|FG001|Overall Study|Adverse Event|74|||
161486138|NCT00856284|583172883|FG002|Overall Study|Adverse Event|82|||
161486139|NCT00856284|583172881|FG000|Overall Study|Major protocol deviation|24|||
161486140|NCT00856284|583172882|FG001|Overall Study|Major protocol deviation|16|||
161486141|NCT00856284|583172883|FG002|Overall Study|Major protocol deviation|15|||
161486142|NCT00856284|583172881|FG000|Overall Study|Lost to Follow-up|20|||
161486143|NCT00856284|583172882|FG001|Overall Study|Lost to Follow-up|22|||
161486144|NCT00856284|583172883|FG002|Overall Study|Lost to Follow-up|28|||
161486145|NCT00856284|583172881|FG000|Overall Study|Voluntary withdrawal|48|||
161582049|NCT04878354|583518282|FG000|Overall Study|Withdrawal by Subject|14|||
161582050|NCT04878354|583518283|FG001|Overall Study|Withdrawal by Subject|12|||
161582051|NCT04878354|583518282|FG000|Overall Study|Lost to Follow-up|4|||
161582052|NCT04878354|583518283|FG001|Overall Study|Lost to Follow-up|1|||
161582053|NCT04878354|583518282|FG000|Overall Study|Lack of Efficacy|1|||
161582054|NCT04878354|583518283|FG001|Overall Study|Lack of Efficacy|0|||
161582055|NCT04878354|583518282|FG000|Overall Study|Protocol Violation|0|||
161582056|NCT04878354|583518283|FG001|Overall Study|Protocol Violation|1|||
161582057|NCT04878354|583518282|FG000|Overall Study|"Reason stated as other in CRF"|2|||
161582058|NCT04878354|583518283|FG001|Overall Study|"Reason stated as other in CRF"|3|||
161582059|NCT01903811|583518291|FG000|Overall Study|No measurable disease|1|||
161582060|NCT01903811|583518292|FG001|Overall Study|No measurable disease|1|||
161582061|NCT01903811|583518291|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
161582062|NCT01903811|583518292|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
161582063|NCT01903811|583518291|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
161582064|NCT01903811|583518292|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
161582065|NCT01903811|583518291|FG000|Overall Study|Withdrawal by Subject|0|||
161582066|NCT01903811|583518292|FG001|Overall Study|Withdrawal by Subject|1|||
161582067|NCT04540913|583518293|FG000|Overall Study|Withdrawal by Subject|14|||
161582068|NCT04540913|583518294|FG001|Overall Study|Withdrawal by Subject|3|||
161582069|NCT02118961|583518295|FG000|Overall Study|Withdrawal by Subject|1|||
161582070|NCT02118961|583518296|FG001|Overall Study|Withdrawal by Subject|0|||
161582071|NCT05288283|583518297|FG000|Overall Study|Study Terminated Early|1|||
161486146|NCT00856284|583172882|FG001|Overall Study|Voluntary withdrawal|52|||
161486147|NCT00856284|583172883|FG002|Overall Study|Voluntary withdrawal|62|||
161486148|NCT00856284|583172881|FG000|Overall Study|Pregnancy|1|||
161486149|NCT00856284|583172882|FG001|Overall Study|Pregnancy|2|||
161486150|NCT00856284|583172883|FG002|Overall Study|Pregnancy|0|||
161582072|NCT05288283|583518298|FG001|Overall Study|Study Terminated Early|1|||
161582073|NCT02992925|583518301|FG000|Cohort 2|Physician Decision|0|||
161582074|NCT02992925|583518302|FG001|Cohort 2|Physician Decision|0|||
161582075|NCT02992925|583518303|FG002|Cohort 2|Physician Decision|1|||
161582076|NCT02992925|583518304|FG003|Cohort 2|Physician Decision|0|||
161582077|NCT02992925|583518301|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
161582078|NCT02992925|583518302|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
161670861|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
161670862|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
161670863|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
161670864|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
161670865|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
161670866|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
161670867|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
161670868|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
161670869|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
161670870|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
161670871|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
161670872|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
161670873|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
161670874|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
161670875|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
161670876|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
161670877|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
161670878|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
161670879|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
161670880|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
161670881|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
161670882|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
161670883|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
161670884|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
161670885|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
161670886|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
161670887|NCT05266586|583847335|FG000|Overall Study|Adverse Event|2|||
161670888|NCT05266586|583847336|FG001|Overall Study|Adverse Event|2|||
161670889|NCT05266586|583847337|FG002|Overall Study|Adverse Event|1|||
161670890|NCT05266586|583847335|FG000|Overall Study|Withdrawal by Subject|1|||
161670891|NCT05266586|583847336|FG001|Overall Study|Withdrawal by Subject|0|||
161670892|NCT05266586|583847337|FG002|Overall Study|Withdrawal by Subject|1|||
161670893|NCT05266586|583847335|FG000|Overall Study|Non-compliance with study drug|0|||
161670894|NCT05266586|583847336|FG001|Overall Study|Non-compliance with study drug|1|||
161670895|NCT05266586|583847337|FG002|Overall Study|Non-compliance with study drug|0|||
161670896|NCT05266586|583847335|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
161670897|NCT05266586|583847336|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
161670898|NCT05266586|583847337|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
161670899|NCT02225353|583847338|FG000|Overall Study|Lost to Follow-up|0|||
161670900|NCT02225353|583847339|FG001|Overall Study|Lost to Follow-up|1|||
161670901|NCT02225353|583847340|FG002|Overall Study|Lost to Follow-up|3|||
161670902|NCT02225353|583847338|FG000|Overall Study|Protocol Violation|4|||
161670903|NCT02225353|583847339|FG001|Overall Study|Protocol Violation|5|||
161670904|NCT02225353|583847340|FG002|Overall Study|Protocol Violation|12|||
161670905|NCT03707925|583847341|FG000|Overall Study|Inevaluable|1|||
161670906|NCT01193920|583847342|FG000|Overall Study|Withdrawal by Subject|1|||
161670907|NCT01193920|583847343|FG001|Overall Study|Withdrawal by Subject|0|||
161670908|NCT01193920|583847344|FG002|Overall Study|Withdrawal by Subject|5|||
161670909|NCT01193920|583847345|FG003|Overall Study|Withdrawal by Subject|1|||
161670910|NCT01193920|583847346|FG004|Overall Study|Withdrawal by Subject|3|||
161670911|NCT01193920|583847347|FG005|Overall Study|Withdrawal by Subject|1|||
161670912|NCT01193920|583847348|FG006|Overall Study|Withdrawal by Subject|3|||
161670913|NCT01193920|583847349|FG007|Overall Study|Withdrawal by Subject|0|||
161670914|NCT01193920|583847350|FG008|Overall Study|Withdrawal by Subject|1|||
161670915|NCT01193920|583847351|FG009|Overall Study|Withdrawal by Subject|0|||
161670916|NCT01193920|583847342|FG000|Overall Study|Lost to Follow-up|1|||
161670917|NCT01193920|583847343|FG001|Overall Study|Lost to Follow-up|0|||
161670918|NCT01193920|583847344|FG002|Overall Study|Lost to Follow-up|1|||
161670919|NCT01193920|583847345|FG003|Overall Study|Lost to Follow-up|1|||
161670920|NCT01193920|583847346|FG004|Overall Study|Lost to Follow-up|3|||
161670921|NCT01193920|583847347|FG005|Overall Study|Lost to Follow-up|3|||
161670922|NCT01193920|583847348|FG006|Overall Study|Lost to Follow-up|1|||
161670923|NCT01193920|583847349|FG007|Overall Study|Lost to Follow-up|0|||
161670924|NCT01193920|583847350|FG008|Overall Study|Lost to Follow-up|2|||
161670925|NCT01193920|583847351|FG009|Overall Study|Lost to Follow-up|3|||
161670926|NCT01193920|583847342|FG000|Overall Study|Protocol Violation|1|||
161670927|NCT01193920|583847343|FG001|Overall Study|Protocol Violation|0|||
161670928|NCT01193920|583847344|FG002|Overall Study|Protocol Violation|0|||
161670929|NCT01193920|583847345|FG003|Overall Study|Protocol Violation|0|||
161670930|NCT01193920|583847346|FG004|Overall Study|Protocol Violation|0|||
161486151|NCT00856284|583172881|FG000|Overall Study|Investigator discretion|9|||
161486152|NCT00856284|583172882|FG001|Overall Study|Investigator discretion|8|||
161486153|NCT00856284|583172883|FG002|Overall Study|Investigator discretion|10|||
161486154|NCT00856284|583172881|FG000|Overall Study|Other|15|||
161486155|NCT00856284|583172882|FG001|Overall Study|Other|17|||
161486156|NCT00856284|583172883|FG002|Overall Study|Other|14|||
161486157|NCT00856284|583172881|FG000|Overall Study|Randomized in error|0|||
161486158|NCT00856284|583172882|FG001|Overall Study|Randomized in error|0|||
161486159|NCT00856284|583172883|FG002|Overall Study|Randomized in error|1|||
161486160|NCT01327885|583172884|FG000|Overall Study|Disease progression-according to RECIST|173|||
161486161|NCT01327885|583172885|FG001|Overall Study|Disease progression-according to RECIST|165|||
161486162|NCT01327885|583172884|FG000|Overall Study|Clinical progression|24|||
161486163|NCT01327885|583172885|FG001|Overall Study|Clinical progression|27|||
161486164|NCT01327885|583172884|FG000|Overall Study|Adverse Event|14|||
161486165|NCT01327885|583172885|FG001|Overall Study|Adverse Event|10|||
161486166|NCT01327885|583172884|FG000|Overall Study|Subject choice|5|||
161486167|NCT01327885|583172885|FG001|Overall Study|Subject choice|10|||
161486168|NCT01327885|583172884|FG000|Overall Study|Other|8|||
161486169|NCT01327885|583172885|FG001|Overall Study|Other|6|||
161486170|NCT01327885|583172884|FG000|Overall Study|Withdrawal of consent from study|3|||
161486171|NCT01327885|583172885|FG001|Overall Study|Withdrawal of consent from study|4|||
161486172|NCT01327885|583172884|FG000|Overall Study|Not treated|1|||
161486173|NCT01327885|583172885|FG001|Overall Study|Not treated|1|||
161486174|NCT01327885|583172884|FG000|Overall Study|Administrative decision|0|||
161486175|NCT01327885|583172885|FG001|Overall Study|Administrative decision|1|||
161486176|NCT02485301|583172886|FG000|Overall Study|Serious Adverse Events|2|||
161486177|NCT02485301|583172887|FG001|Overall Study|Serious Adverse Events|1|||
161486178|NCT02485301|583172886|FG000|Overall Study|Protocol Violation|0|||
161486179|NCT02485301|583172887|FG001|Overall Study|Protocol Violation|1|||
161486180|NCT02485301|583172886|FG000|Overall Study|Withdrawal by Subject|6|||
161486181|NCT02485301|583172887|FG001|Overall Study|Withdrawal by Subject|7|||
161486182|NCT02485301|583172886|FG000|Overall Study|Migrated/moved from study area|10|||
161486183|NCT02485301|583172887|FG001|Overall Study|Migrated/moved from study area|19|||
161486184|NCT02485301|583172886|FG000|Overall Study|Lost to Follow-up|17|||
161486185|NCT02485301|583172887|FG001|Overall Study|Lost to Follow-up|17|||
161486186|NCT02485301|583172886|FG000|Overall Study|Other|3|||
161486187|NCT02485301|583172887|FG001|Overall Study|Other|4|||
161486188|NCT01059825|583172888|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
161486189|NCT01059825|583172889|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
161486190|NCT01059825|583172890|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
161486191|NCT01059825|583172891|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
161486192|NCT01059825|583172892|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
161486193|NCT01059825|583172893|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
161486194|NCT01059825|583172894|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
161486195|NCT01059825|583172888|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
161486196|NCT01059825|583172889|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
161486197|NCT01059825|583172890|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
161486198|NCT01059825|583172891|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
161486199|NCT01059825|583172892|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
161486200|NCT01059825|583172893|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
161486201|NCT01059825|583172894|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
161486202|NCT01059825|583172888|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
161486203|NCT01059825|583172889|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
161486204|NCT01059825|583172890|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
161486205|NCT01059825|583172891|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
161486206|NCT01059825|583172892|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
161486207|NCT01059825|583172893|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
161486208|NCT01059825|583172894|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
161486209|NCT01059825|583172888|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
161486210|NCT01059825|583172889|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
161486211|NCT01059825|583172890|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
161486212|NCT01059825|583172891|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
161486213|NCT01059825|583172892|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
161486214|NCT01059825|583172893|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
161486215|NCT01059825|583172894|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
161486216|NCT01059825|583172888|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
161582079|NCT02992925|583518303|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
161922800|NCT02965456|584764876|FG000|Overall Study|Participant ran out of study drug|0|||
161486217|NCT01059825|583172889|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
161486218|NCT01059825|583172890|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
161486219|NCT01059825|583172891|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
161582080|NCT02992925|583518304|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
161922801|NCT02965456|584764877|FG001|Overall Study|Participant ran out of study drug|1|||
161486220|NCT01059825|583172892|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
161486221|NCT01059825|583172893|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
161486222|NCT01059825|583172894|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
161486223|NCT01059825|583172888|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
161486224|NCT01059825|583172889|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
161486225|NCT01059825|583172890|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
161486226|NCT01059825|583172891|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
161486227|NCT01059825|583172892|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
161486228|NCT01059825|583172893|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
161486229|NCT01059825|583172894|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
161486230|NCT01059825|583172888|FG000|Treatment Period|Lost to Follow-up|2|||
161486231|NCT01059825|583172889|FG001|Treatment Period|Lost to Follow-up|1|||
161486232|NCT01059825|583172890|FG002|Treatment Period|Lost to Follow-up|0|||
161486233|NCT01059825|583172891|FG003|Treatment Period|Lost to Follow-up|1|||
161486234|NCT01059825|583172892|FG004|Treatment Period|Lost to Follow-up|2|||
161486235|NCT01059825|583172893|FG005|Treatment Period|Lost to Follow-up|0|||
161486236|NCT01059825|583172894|FG006|Treatment Period|Lost to Follow-up|0|||
161486237|NCT01059825|583172888|FG000|Treatment Period|Withdrawal by Subject|3|||
161486238|NCT01059825|583172889|FG001|Treatment Period|Withdrawal by Subject|0|||
161486239|NCT01059825|583172890|FG002|Treatment Period|Withdrawal by Subject|1|||
161486240|NCT01059825|583172891|FG003|Treatment Period|Withdrawal by Subject|5|||
161486241|NCT01059825|583172892|FG004|Treatment Period|Withdrawal by Subject|4|||
161486242|NCT01059825|583172893|FG005|Treatment Period|Withdrawal by Subject|1|||
161486243|NCT01059825|583172894|FG006|Treatment Period|Withdrawal by Subject|0|||
161486244|NCT01059825|583172888|FG000|Treatment Period|Other reason not specified|1|||
161486245|NCT01059825|583172889|FG001|Treatment Period|Other reason not specified|2|||
161486246|NCT01059825|583172890|FG002|Treatment Period|Other reason not specified|1|||
161486247|NCT01059825|583172891|FG003|Treatment Period|Other reason not specified|2|||
161486248|NCT01059825|583172892|FG004|Treatment Period|Other reason not specified|0|||
161486249|NCT01059825|583172893|FG005|Treatment Period|Other reason not specified|0|||
161486250|NCT01059825|583172894|FG006|Treatment Period|Other reason not specified|0|||
161486251|NCT01059825|583172888|FG000|Treatment Period|Protocol Violation|0|||
161486252|NCT01059825|583172889|FG001|Treatment Period|Protocol Violation|0|||
161486253|NCT01059825|583172890|FG002|Treatment Period|Protocol Violation|1|||
161486254|NCT01059825|583172891|FG003|Treatment Period|Protocol Violation|1|||
161486255|NCT01059825|583172892|FG004|Treatment Period|Protocol Violation|1|||
161486256|NCT01059825|583172893|FG005|Treatment Period|Protocol Violation|1|||
161486257|NCT01059825|583172894|FG006|Treatment Period|Protocol Violation|0|||
161486258|NCT01059825|583172888|FG000|Treatment Period|Adverse event related to study drug|1|||
161486259|NCT01059825|583172889|FG001|Treatment Period|Adverse event related to study drug|0|||
161486260|NCT01059825|583172890|FG002|Treatment Period|Adverse event related to study drug|1|||
161486261|NCT01059825|583172891|FG003|Treatment Period|Adverse event related to study drug|1|||
161486262|NCT01059825|583172892|FG004|Treatment Period|Adverse event related to study drug|0|||
161486263|NCT01059825|583172893|FG005|Treatment Period|Adverse event related to study drug|0|||
161486264|NCT01059825|583172894|FG006|Treatment Period|Adverse event related to study drug|0|||
161486265|NCT01059825|583172888|FG000|Treatment Period|Insufficient clinical response|3|||
161486266|NCT01059825|583172889|FG001|Treatment Period|Insufficient clinical response|0|||
161486267|NCT01059825|583172890|FG002|Treatment Period|Insufficient clinical response|0|||
161486268|NCT01059825|583172891|FG003|Treatment Period|Insufficient clinical response|0|||
161486269|NCT01059825|583172892|FG004|Treatment Period|Insufficient clinical response|0|||
161486270|NCT01059825|583172893|FG005|Treatment Period|Insufficient clinical response|0|||
161486271|NCT01059825|583172894|FG006|Treatment Period|Insufficient clinical response|0|||
161486272|NCT01059825|583172888|FG000|Treatment Period|Adverse event not related to study drug|0|||
161486273|NCT01059825|583172889|FG001|Treatment Period|Adverse event not related to study drug|1|||
161486274|NCT01059825|583172890|FG002|Treatment Period|Adverse event not related to study drug|2|||
161486275|NCT01059825|583172891|FG003|Treatment Period|Adverse event not related to study drug|1|||
161486276|NCT01059825|583172892|FG004|Treatment Period|Adverse event not related to study drug|1|||
161486277|NCT01059825|583172893|FG005|Treatment Period|Adverse event not related to study drug|1|||
161486278|NCT01059825|583172894|FG006|Treatment Period|Adverse event not related to study drug|0|||
161486279|NCT03342690|583172895|FG000|Overall Study|Missing Information|9|||
161486280|NCT03342690|583172895|FG000|Overall Study|Protocol Violation|16|||
161486281|NCT03138889|583172899|FG000|Overall Study|Withdrawal by Subject|5|||
161486282|NCT03138889|583172900|FG001|Overall Study|Withdrawal by Subject|5|||
161486283|NCT03138889|583172901|FG002|Overall Study|Withdrawal by Subject|0|||
161486284|NCT03138889|583172902|FG003|Overall Study|Withdrawal by Subject|2|||
161486285|NCT03138889|583172903|FG004|Overall Study|Withdrawal by Subject|1|||
161486286|NCT03138889|583172904|FG005|Overall Study|Withdrawal by Subject|3|||
161486287|NCT03138889|583172905|FG006|Overall Study|Withdrawal by Subject|0|||
161486288|NCT03138889|583172906|FG007|Overall Study|Withdrawal by Subject|1|||
161486289|NCT02289690|583172907|FG000|Overall Study|Adverse Event Related to Progression|0|||
161486290|NCT02289690|583172908|FG001|Overall Study|Adverse Event Related to Progression|1|||
161582081|NCT05678998|583518305|FG000|Overall Study|Withdrawal by Subject|1|||
161582082|NCT05678998|583518306|FG001|Overall Study|Withdrawal by Subject|1|||
161582083|NCT05678998|583518307|FG002|Overall Study|Withdrawal by Subject|3|||
161582084|NCT05678998|583518308|FG003|Overall Study|Withdrawal by Subject|0|||
161582085|NCT05678998|583518309|FG004|Overall Study|Withdrawal by Subject|1|||
161922802|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
161922803|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
161922804|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
161922805|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Death|1|||
161922806|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Death|0|||
161922807|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Death|0|||
161922808|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
161922809|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
161922810|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
161922811|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
161922812|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
161922813|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
161922814|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
161922815|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
161922816|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
161922817|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
161922818|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
161922819|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
161922820|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
161922821|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
161922822|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
161922823|NCT05073315|584764878|FG000|Period 2|Adverse Event|0|||
161922824|NCT05073315|584764879|FG001|Period 2|Adverse Event|3|||
161922825|NCT05073315|584764880|FG002|Period 2|Adverse Event|6|||
161922826|NCT05073315|584764878|FG000|Period 2|Lost to Follow-up|0|||
161922827|NCT05073315|584764879|FG001|Period 2|Lost to Follow-up|5|||
161922828|NCT05073315|584764880|FG002|Period 2|Lost to Follow-up|5|||
161922829|NCT05073315|584764878|FG000|Period 2|Withdrawal by Subject|0|||
161922830|NCT05073315|584764879|FG001|Period 2|Withdrawal by Subject|4|||
161922831|NCT05073315|584764880|FG002|Period 2|Withdrawal by Subject|9|||
161922832|NCT05073315|584764878|FG000|Period 2|Protocol Violation|0|||
161922833|NCT05073315|584764879|FG001|Period 2|Protocol Violation|0|||
161922834|NCT05073315|584764880|FG002|Period 2|Protocol Violation|1|||
161922835|NCT01529268|584764881|FG000|Overall Study|Lost to Follow-up|9|||
161922836|NCT01529268|584764882|FG001|Overall Study|Lost to Follow-up|3|||
161922837|NCT01529268|584764881|FG000|Overall Study|Moved|3|||
161922838|NCT01529268|584764882|FG001|Overall Study|Moved|0|||
161582086|NCT05678998|583518305|FG000|Overall Study|Lost to Follow-up|0|||
161922839|NCT00303953|584764883|FG000|Overall Study|Ineligible|1|||
161486291|NCT02289690|583172909|FG002|Overall Study|Adverse Event Related to Progression|1|||
161486292|NCT02289690|583172910|FG003|Overall Study|Adverse Event Related to Progression|0|||
161486293|NCT02289690|583172911|FG004|Overall Study|Adverse Event Related to Progression|1|||
161486294|NCT02289690|583172912|FG005|Overall Study|Adverse Event Related to Progression|0|||
161486295|NCT02289690|583172913|FG006|Overall Study|Adverse Event Related to Progression|1|||
161486296|NCT02289690|583172914|FG007|Overall Study|Adverse Event Related to Progression|0|||
161486297|NCT02289690|583172915|FG008|Overall Study|Adverse Event Related to Progression|0|||
161486298|NCT02289690|583172916|FG009|Overall Study|Adverse Event Related to Progression|0|||
161486299|NCT02289690|583172907|FG000|Overall Study|Withdrawal by Subject|1|||
161486300|NCT02289690|583172908|FG001|Overall Study|Withdrawal by Subject|0|||
161486301|NCT02289690|583172909|FG002|Overall Study|Withdrawal by Subject|0|||
161486302|NCT02289690|583172910|FG003|Overall Study|Withdrawal by Subject|0|||
161582087|NCT05678998|583518306|FG001|Overall Study|Lost to Follow-up|0|||
161582088|NCT05678998|583518307|FG002|Overall Study|Lost to Follow-up|0|||
161582089|NCT05678998|583518308|FG003|Overall Study|Lost to Follow-up|0|||
161582090|NCT05678998|583518309|FG004|Overall Study|Lost to Follow-up|1|||
161582091|NCT05678998|583518305|FG000|Overall Study|Death|0|||
161582092|NCT05678998|583518306|FG001|Overall Study|Death|0|||
161582093|NCT05678998|583518307|FG002|Overall Study|Death|0|||
161582094|NCT05678998|583518308|FG003|Overall Study|Death|3|||
161486303|NCT02289690|583172911|FG004|Overall Study|Withdrawal by Subject|1|||
161486304|NCT02289690|583172912|FG005|Overall Study|Withdrawal by Subject|1|||
161486305|NCT02289690|583172913|FG006|Overall Study|Withdrawal by Subject|0|||
161486306|NCT02289690|583172914|FG007|Overall Study|Withdrawal by Subject|0|||
161486307|NCT02289690|583172915|FG008|Overall Study|Withdrawal by Subject|4|||
161486308|NCT02289690|583172916|FG009|Overall Study|Withdrawal by Subject|2|||
161486309|NCT02289690|583172907|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
161486310|NCT02289690|583172908|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
161486311|NCT02289690|583172909|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
161486312|NCT02289690|583172910|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
161486313|NCT02289690|583172911|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
161486314|NCT02289690|583172912|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
161486315|NCT02289690|583172913|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
161486316|NCT02289690|583172914|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
161486317|NCT02289690|583172915|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
161486318|NCT02289690|583172916|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
161486319|NCT02289690|583172907|FG000|Overall Study|Lost to Follow-up|0|||
161486320|NCT02289690|583172908|FG001|Overall Study|Lost to Follow-up|0|||
161486321|NCT02289690|583172909|FG002|Overall Study|Lost to Follow-up|0|||
161486322|NCT02289690|583172910|FG003|Overall Study|Lost to Follow-up|0|||
161486323|NCT02289690|583172911|FG004|Overall Study|Lost to Follow-up|0|||
161486324|NCT02289690|583172912|FG005|Overall Study|Lost to Follow-up|0|||
161486325|NCT02289690|583172913|FG006|Overall Study|Lost to Follow-up|0|||
161486326|NCT02289690|583172914|FG007|Overall Study|Lost to Follow-up|1|||
161486327|NCT02289690|583172915|FG008|Overall Study|Lost to Follow-up|0|||
161582095|NCT05678998|583518309|FG004|Overall Study|Death|4|||
161582096|NCT05678998|583518305|FG000|Overall Study|Other|0|||
161582097|NCT05678998|583518306|FG001|Overall Study|Other|0|||
161582098|NCT05678998|583518307|FG002|Overall Study|Other|0|||
161582099|NCT05678998|583518308|FG003|Overall Study|Other|2|||
161582100|NCT05678998|583518309|FG004|Overall Study|Other|1|||
161582101|NCT03990649|583518312|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
161582102|NCT03990649|583518313|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
161582103|NCT03990649|583518314|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
161582104|NCT03990649|583518312|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
161582105|NCT03990649|583518313|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
161582106|NCT03990649|583518314|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
161582107|NCT03990649|583518312|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
161486328|NCT02289690|583172916|FG009|Overall Study|Lost to Follow-up|2|||
161486329|NCT02289690|583172907|FG000|Overall Study|Death|0|||
161486330|NCT02289690|583172908|FG001|Overall Study|Death|0|||
161486331|NCT02289690|583172909|FG002|Overall Study|Death|0|||
161486332|NCT02289690|583172910|FG003|Overall Study|Death|0|||
161582108|NCT03990649|583518313|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
161582109|NCT03990649|583518314|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
161582110|NCT03990649|583518312|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
161582111|NCT03990649|583518313|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
161582112|NCT03990649|583518314|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
161582113|NCT03990649|583518312|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
161582114|NCT03990649|583518313|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
161582115|NCT03990649|583518314|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
161582116|NCT03990649|583518312|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
161582117|NCT03990649|583518313|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
161582118|NCT03990649|583518314|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
161582119|NCT03990649|583518312|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
161582120|NCT03990649|583518313|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
161582121|NCT03990649|583518314|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
161582122|NCT05773313|583518315|FG000|Overall Study|Lost to Follow-up|3|||
161582123|NCT03050814|583518316|FG000|Overall Study|Screen failures|0|||
161582124|NCT03050814|583518317|FG001|Overall Study|Screen failures|0|||
161582125|NCT03050814|583518318|FG002|Overall Study|Screen failures|4|||
161670931|NCT01193920|583847347|FG005|Overall Study|Protocol Violation|0|||
161670932|NCT01193920|583847348|FG006|Overall Study|Protocol Violation|0|||
161670933|NCT01193920|583847349|FG007|Overall Study|Protocol Violation|0|||
161670934|NCT01193920|583847350|FG008|Overall Study|Protocol Violation|0|||
161670935|NCT01193920|583847351|FG009|Overall Study|Protocol Violation|0|||
161670936|NCT01193920|583847342|FG000|Overall Study|Death|0|||
161670937|NCT01193920|583847343|FG001|Overall Study|Death|0|||
161670938|NCT01193920|583847344|FG002|Overall Study|Death|0|||
161670939|NCT01193920|583847345|FG003|Overall Study|Death|1|||
161670940|NCT01193920|583847346|FG004|Overall Study|Death|0|||
161670941|NCT01193920|583847347|FG005|Overall Study|Death|0|||
161582126|NCT05137236|583518319|FG000|Part A|Other than Specified|1|||
161582127|NCT05137236|583518320|FG001|Part A|Other than Specified|0|||
161582128|NCT05137236|583518321|FG002|Part A|Other than Specified|0|||
161582129|NCT05137236|583518322|FG003|Part A|Other than Specified|0|||
161582130|NCT05137236|583518323|FG004|Part A|Other than Specified|0|||
161582131|NCT05137236|583518324|FG005|Part A|Other than Specified|0|||
161582132|NCT05137236|583518325|FG006|Part A|Other than Specified|0|||
161582133|NCT05137236|583518326|FG007|Part A|Other than Specified|0|||
161582134|NCT05137236|583518319|FG000|Part A|Withdrawal by Subject|0|||
161582135|NCT05137236|583518320|FG001|Part A|Withdrawal by Subject|4|||
161582136|NCT05137236|583518321|FG002|Part A|Withdrawal by Subject|1|||
161582137|NCT05137236|583518322|FG003|Part A|Withdrawal by Subject|1|||
161582138|NCT05137236|583518323|FG004|Part A|Withdrawal by Subject|3|||
161582139|NCT05137236|583518324|FG005|Part A|Withdrawal by Subject|2|||
161582140|NCT05137236|583518325|FG006|Part A|Withdrawal by Subject|0|||
161582141|NCT05137236|583518326|FG007|Part A|Withdrawal by Subject|0|||
161582142|NCT05137236|583518319|FG000|Part A|Lost to Follow-up|5|||
161582143|NCT05137236|583518320|FG001|Part A|Lost to Follow-up|7|||
161582144|NCT05137236|583518321|FG002|Part A|Lost to Follow-up|1|||
161582145|NCT05137236|583518322|FG003|Part A|Lost to Follow-up|3|||
161582146|NCT05137236|583518323|FG004|Part A|Lost to Follow-up|3|||
161582147|NCT05137236|583518324|FG005|Part A|Lost to Follow-up|8|||
161582148|NCT05137236|583518325|FG006|Part A|Lost to Follow-up|0|||
161582149|NCT05137236|583518326|FG007|Part A|Lost to Follow-up|0|||
161582150|NCT05137236|583518319|FG000|Part B|Withdrawal by Subject|0|||
161582151|NCT05137236|583518320|FG001|Part B|Withdrawal by Subject|0|||
161582152|NCT05137236|583518321|FG002|Part B|Withdrawal by Subject|0|||
161582153|NCT05137236|583518322|FG003|Part B|Withdrawal by Subject|0|||
161582154|NCT05137236|583518323|FG004|Part B|Withdrawal by Subject|0|||
161582155|NCT05137236|583518324|FG005|Part B|Withdrawal by Subject|0|||
161582156|NCT05137236|583518325|FG006|Part B|Withdrawal by Subject|0|||
161582157|NCT05137236|583518326|FG007|Part B|Withdrawal by Subject|2|||
161582158|NCT05137236|583518319|FG000|Part B|Lost to Follow-up|0|||
161582159|NCT05137236|583518320|FG001|Part B|Lost to Follow-up|0|||
161582160|NCT05137236|583518321|FG002|Part B|Lost to Follow-up|0|||
161582161|NCT05137236|583518322|FG003|Part B|Lost to Follow-up|0|||
161582162|NCT05137236|583518323|FG004|Part B|Lost to Follow-up|0|||
161582163|NCT05137236|583518324|FG005|Part B|Lost to Follow-up|0|||
161582164|NCT05137236|583518325|FG006|Part B|Lost to Follow-up|5|||
161582165|NCT05137236|583518326|FG007|Part B|Lost to Follow-up|5|||
161582166|NCT05137236|583518319|FG000|Part B|Death|0|||
161582167|NCT05137236|583518320|FG001|Part B|Death|0|||
161582168|NCT05137236|583518321|FG002|Part B|Death|0|||
161582169|NCT05137236|583518322|FG003|Part B|Death|0|||
161582170|NCT05137236|583518323|FG004|Part B|Death|0|||
161582171|NCT05137236|583518324|FG005|Part B|Death|0|||
161582172|NCT05137236|583518325|FG006|Part B|Death|0|||
161582173|NCT05137236|583518326|FG007|Part B|Death|2|||
161582174|NCT01534494|583518327|FG000|Overall Study|Withdrawal by Subject|1|||
161582175|NCT00802464|583518328|FG000|Month 0 - Month 8|Adverse Event|0|||
161582176|NCT00802464|583518329|FG001|Month 0 - Month 8|Adverse Event|1|||
161582177|NCT00802464|583518330|FG002|Month 0 - Month 8|Adverse Event|1|||
161582178|NCT00802464|583518331|FG003|Month 0 - Month 8|Adverse Event|2|||
161582179|NCT00802464|583518328|FG000|Month 0 - Month 8|Protocol Violation|0|||
161582180|NCT00802464|583518329|FG001|Month 0 - Month 8|Protocol Violation|0|||
161582181|NCT00802464|583518330|FG002|Month 0 - Month 8|Protocol Violation|1|||
161582182|NCT00802464|583518331|FG003|Month 0 - Month 8|Protocol Violation|0|||
161582183|NCT00802464|583518328|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
161582184|NCT00802464|583518329|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
161582185|NCT00802464|583518330|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
161922840|NCT00303953|584764883|FG000|Overall Study|Death|1|||
161922841|NCT00303953|584764883|FG000|Overall Study|Adverse Event|4|||
161922842|NCT00303953|584764883|FG000|Overall Study|Lack of Efficacy|12|||
161582186|NCT00802464|583518331|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
161582187|NCT00802464|583518328|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
161582188|NCT00802464|583518329|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
161582189|NCT00802464|583518330|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
161582190|NCT00802464|583518331|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
161582191|NCT00802464|583518328|FG000|Month 0 - Month 8|Other|0|||
161670942|NCT01193920|583847348|FG006|Overall Study|Death|2|||
161670943|NCT01193920|583847349|FG007|Overall Study|Death|3|||
161670944|NCT01193920|583847350|FG008|Overall Study|Death|2|||
161670945|NCT01193920|583847351|FG009|Overall Study|Death|4|||
161486333|NCT02289690|583172911|FG004|Overall Study|Death|0|||
161486334|NCT02289690|583172912|FG005|Overall Study|Death|0|||
161486335|NCT02289690|583172913|FG006|Overall Study|Death|0|||
161486336|NCT02289690|583172914|FG007|Overall Study|Death|49|||
161486337|NCT02289690|583172915|FG008|Overall Study|Death|45|||
161486338|NCT02289690|583172916|FG009|Overall Study|Death|41|||
161486339|NCT02289690|583172907|FG000|Overall Study|Sponsor Discontinued Study|0|||
161486340|NCT02289690|583172908|FG001|Overall Study|Sponsor Discontinued Study|0|||
161486341|NCT02289690|583172909|FG002|Overall Study|Sponsor Discontinued Study|0|||
161486342|NCT02289690|583172910|FG003|Overall Study|Sponsor Discontinued Study|0|||
161486343|NCT02289690|583172911|FG004|Overall Study|Sponsor Discontinued Study|0|||
161486344|NCT02289690|583172912|FG005|Overall Study|Sponsor Discontinued Study|0|||
161486345|NCT02289690|583172913|FG006|Overall Study|Sponsor Discontinued Study|0|||
161486346|NCT02289690|583172914|FG007|Overall Study|Sponsor Discontinued Study|9|||
161486347|NCT02289690|583172915|FG008|Overall Study|Sponsor Discontinued Study|7|||
161486348|NCT02289690|583172916|FG009|Overall Study|Sponsor Discontinued Study|15|||
161486349|NCT02289690|583172907|FG000|Overall Study|Other|0|||
161486350|NCT02289690|583172908|FG001|Overall Study|Other|0|||
161486351|NCT02289690|583172909|FG002|Overall Study|Other|0|||
161486352|NCT02289690|583172910|FG003|Overall Study|Other|1|||
161486353|NCT02289690|583172911|FG004|Overall Study|Other|1|||
161486354|NCT02289690|583172912|FG005|Overall Study|Other|0|||
161486355|NCT02289690|583172913|FG006|Overall Study|Other|1|||
161486356|NCT02289690|583172914|FG007|Overall Study|Other|2|||
161486357|NCT02289690|583172915|FG008|Overall Study|Other|3|||
161486358|NCT02289690|583172916|FG009|Overall Study|Other|1|||
161486359|NCT02495168|583172917|FG000|Overall Study|Other than Specified|18|||
161486360|NCT02495168|583172918|FG001|Overall Study|Other than Specified|22|||
161486361|NCT02495168|583172919|FG002|Overall Study|Other than Specified|5|||
161486362|NCT02495168|583172917|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
161486363|NCT02495168|583172918|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
161486364|NCT02495168|583172919|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
161486365|NCT02495168|583172917|FG000|Overall Study|Physician Decision|1|||
161486366|NCT02495168|583172918|FG001|Overall Study|Physician Decision|1|||
161486367|NCT02495168|583172919|FG002|Overall Study|Physician Decision|0|||
161486368|NCT02495168|583172917|FG000|Overall Study|Lost to Follow-up|10|||
161486369|NCT02495168|583172918|FG001|Overall Study|Lost to Follow-up|6|||
161486370|NCT02495168|583172919|FG002|Overall Study|Lost to Follow-up|1|||
161582192|NCT00802464|583518329|FG001|Month 0 - Month 8|Other|0|||
161582193|NCT00802464|583518330|FG002|Month 0 - Month 8|Other|1|||
161582194|NCT00802464|583518331|FG003|Month 0 - Month 8|Other|0|||
161582195|NCT00802464|583518328|FG000|Month 8 - Month 14|Adverse Event|0|||
161582196|NCT00802464|583518329|FG001|Month 8 - Month 14|Adverse Event|1|||
161582197|NCT00802464|583518330|FG002|Month 8 - Month 14|Adverse Event|0|||
161582198|NCT00802464|583518331|FG003|Month 8 - Month 14|Adverse Event|0|||
161582199|NCT00802464|583518328|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
161582200|NCT00802464|583518329|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
161582201|NCT00802464|583518330|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
161582202|NCT00802464|583518331|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
161582203|NCT00802464|583518328|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
161582204|NCT00802464|583518329|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
161582205|NCT00802464|583518330|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
161582206|NCT00802464|583518331|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
161582207|NCT00402246|583518332|FG000|Overall Study|Death|62|||
161582208|NCT00402246|583518333|FG001|Overall Study|Death|58|||
161582209|NCT00402246|583518332|FG000|Overall Study|Lost to Follow-up|20|||
161582210|NCT00402246|583518333|FG001|Overall Study|Lost to Follow-up|28|||
161582211|NCT00402246|583518332|FG000|Overall Study|Withdrawal by Subject|72|||
161582212|NCT00402246|583518333|FG001|Overall Study|Withdrawal by Subject|87|||
161582213|NCT00402246|583518332|FG000|Overall Study|Physician Decision|24|||
161582214|NCT00402246|583518333|FG001|Overall Study|Physician Decision|26|||
161582215|NCT00402246|583518332|FG000|Overall Study|Protocol Violation|25|||
161582216|NCT00402246|583518333|FG001|Overall Study|Protocol Violation|24|||
161582217|NCT00402246|583518332|FG000|Overall Study|Missed Final Visit|1|||
161582218|NCT00402246|583518333|FG001|Overall Study|Missed Final Visit|2|||
161486371|NCT02495168|583172917|FG000|Overall Study|Withdrawal by Subject|1|||
161582219|NCT00402246|583518332|FG000|Overall Study|Insurance Issues|2|||
161582220|NCT00402246|583518333|FG001|Overall Study|Insurance Issues|1|||
161582221|NCT00402246|583518332|FG000|Overall Study|Heart Transplant|0|||
161582222|NCT00402246|583518333|FG001|Overall Study|Heart Transplant|1|||
161582223|NCT00402246|583518332|FG000|Overall Study|Patient's device explanted|6|||
161582224|NCT00402246|583518333|FG001|Overall Study|Patient's device explanted|2|||
161582225|NCT00402246|583518332|FG000|Overall Study|Center Closure|5|||
161582226|NCT00402246|583518333|FG001|Overall Study|Center Closure|3|||
161486372|NCT02495168|583172918|FG001|Overall Study|Withdrawal by Subject|4|||
161486373|NCT02495168|583172919|FG002|Overall Study|Withdrawal by Subject|2|||
161486374|NCT02495168|583172917|FG000|Overall Study|Protocol Violation|0|||
161486375|NCT02495168|583172918|FG001|Overall Study|Protocol Violation|10|||
161486376|NCT02495168|583172919|FG002|Overall Study|Protocol Violation|1|||
161486377|NCT02495168|583172917|FG000|Overall Study|Adverse Event|4|||
161486378|NCT02495168|583172918|FG001|Overall Study|Adverse Event|8|||
161486379|NCT02495168|583172919|FG002|Overall Study|Adverse Event|3|||
161486380|NCT02495168|583172917|FG000|Overall Study|Lack of Efficacy|0|||
161486381|NCT02495168|583172918|FG001|Overall Study|Lack of Efficacy|0|||
161486382|NCT02495168|583172919|FG002|Overall Study|Lack of Efficacy|3|||
161486383|NCT03167411|583172925|FG000|Overall Study|Adverse Event|0|||
161486384|NCT03167411|583172926|FG001|Overall Study|Adverse Event|1|||
161486385|NCT00420927|583172927|FG000|Period 1|Adverse Event|19|||
161486386|NCT00420927|583172928|FG001|Period 1|Adverse Event|15|||
161486387|NCT00420927|583172929|FG002|Period 1|Adverse Event|0|||
161486388|NCT00420927|583172930|FG003|Period 1|Adverse Event|0|||
161486389|NCT00420927|583172931|FG004|Period 1|Adverse Event|0|||
161486390|NCT00420927|583172932|FG005|Period 1|Adverse Event|0|||
161486391|NCT00420927|583172933|FG006|Period 1|Adverse Event|0|||
161486392|NCT00420927|583172927|FG000|Period 1|Withdrawal by Subject|7|||
161486393|NCT00420927|583172928|FG001|Period 1|Withdrawal by Subject|12|||
161486394|NCT00420927|583172929|FG002|Period 1|Withdrawal by Subject|0|||
161486395|NCT00420927|583172930|FG003|Period 1|Withdrawal by Subject|0|||
161486396|NCT00420927|583172931|FG004|Period 1|Withdrawal by Subject|0|||
161486397|NCT00420927|583172932|FG005|Period 1|Withdrawal by Subject|0|||
161486398|NCT00420927|583172933|FG006|Period 1|Withdrawal by Subject|0|||
161486399|NCT00420927|583172927|FG000|Period 1|Lost to Follow-up|8|||
161486400|NCT00420927|583172928|FG001|Period 1|Lost to Follow-up|6|||
161486401|NCT00420927|583172929|FG002|Period 1|Lost to Follow-up|0|||
161486402|NCT00420927|583172930|FG003|Period 1|Lost to Follow-up|0|||
161486403|NCT00420927|583172931|FG004|Period 1|Lost to Follow-up|0|||
161486404|NCT00420927|583172932|FG005|Period 1|Lost to Follow-up|0|||
161486405|NCT00420927|583172933|FG006|Period 1|Lost to Follow-up|0|||
161486406|NCT00420927|583172927|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
161486407|NCT00420927|583172928|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
161486408|NCT00420927|583172929|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
161486409|NCT00420927|583172930|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
161486410|NCT00420927|583172931|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
161582227|NCT00402246|583518332|FG000|Overall Study|Deterioriating Condition|3|||
161582228|NCT00402246|583518333|FG001|Overall Study|Deterioriating Condition|2|||
161582229|NCT02622568|583518343|FG000|Overall Study|Lost to Follow-up|5|||
161582230|NCT02622568|583518344|FG001|Overall Study|Lost to Follow-up|5|||
161582231|NCT01939899|583518345|FG000|Lead-in Dose Finding Phase|Death|0|||
161582232|NCT01939899|583518346|FG001|Lead-in Dose Finding Phase|Death|3|||
161582233|NCT01939899|583518347|FG002|Lead-in Dose Finding Phase|Death|1|||
161817013|NCT04194801|584370899|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
161817014|NCT04194801|584370900|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
161486411|NCT00420927|583172932|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
161486412|NCT00420927|583172933|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
161486413|NCT00420927|583172927|FG000|Period 1|Death|2|||
161486414|NCT00420927|583172928|FG001|Period 1|Death|0|||
161486415|NCT00420927|583172929|FG002|Period 1|Death|0|||
161486416|NCT00420927|583172930|FG003|Period 1|Death|0|||
161486417|NCT00420927|583172931|FG004|Period 1|Death|0|||
161486418|NCT00420927|583172932|FG005|Period 1|Death|0|||
161486419|NCT00420927|583172933|FG006|Period 1|Death|0|||
161486420|NCT00420927|583172927|FG000|Period 1|Subject moved/relocated|0|||
161486421|NCT00420927|583172928|FG001|Period 1|Subject moved/relocated|2|||
161486422|NCT00420927|583172929|FG002|Period 1|Subject moved/relocated|0|||
161486423|NCT00420927|583172930|FG003|Period 1|Subject moved/relocated|0|||
161486424|NCT00420927|583172931|FG004|Period 1|Subject moved/relocated|0|||
161486425|NCT00420927|583172932|FG005|Period 1|Subject moved/relocated|0|||
161582234|NCT01939899|583518348|FG003|Lead-in Dose Finding Phase|Death|0|||
161582235|NCT01939899|583518349|FG004|Lead-in Dose Finding Phase|Death|0|||
161582236|NCT01939899|583518345|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
161582237|NCT01939899|583518346|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
161582238|NCT01939899|583518347|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
161582239|NCT01939899|583518348|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
161582240|NCT01939899|583518349|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
161582241|NCT01939899|583518345|FG000|Lead-in Dose Finding Phase|Other|0|||
161582242|NCT01939899|583518346|FG001|Lead-in Dose Finding Phase|Other|0|||
161582243|NCT01939899|583518347|FG002|Lead-in Dose Finding Phase|Other|1|||
161582244|NCT01939899|583518348|FG003|Lead-in Dose Finding Phase|Other|0|||
161582245|NCT01939899|583518349|FG004|Lead-in Dose Finding Phase|Other|0|||
161582246|NCT01939899|583518345|FG000|Phase 2|Withdrawal by Subject|0|||
161582247|NCT01939899|583518346|FG001|Phase 2|Withdrawal by Subject|0|||
161582248|NCT01939899|583518347|FG002|Phase 2|Withdrawal by Subject|0|||
161582249|NCT01939899|583518348|FG003|Phase 2|Withdrawal by Subject|2|||
161582250|NCT01939899|583518349|FG004|Phase 2|Withdrawal by Subject|0|||
161582251|NCT01939899|583518345|FG000|Phase 2|Disease Progression|0|||
161582252|NCT01939899|583518346|FG001|Phase 2|Disease Progression|0|||
161582253|NCT01939899|583518347|FG002|Phase 2|Disease Progression|0|||
161582254|NCT01939899|583518348|FG003|Phase 2|Disease Progression|9|||
161582255|NCT01939899|583518349|FG004|Phase 2|Disease Progression|1|||
161582256|NCT02015520|583518354|FG000|Overall Study|Lack of Efficacy|1|||
161486426|NCT00420927|583172933|FG006|Period 1|Subject moved/relocated|0|||
161486427|NCT00420927|583172927|FG000|Period 1|Noncompliant with study drug|1|||
161486428|NCT00420927|583172928|FG001|Period 1|Noncompliant with study drug|1|||
161486429|NCT00420927|583172929|FG002|Period 1|Noncompliant with study drug|0|||
161486430|NCT00420927|583172930|FG003|Period 1|Noncompliant with study drug|0|||
161486431|NCT00420927|583172931|FG004|Period 1|Noncompliant with study drug|0|||
161486432|NCT00420927|583172932|FG005|Period 1|Noncompliant with study drug|0|||
161486433|NCT00420927|583172933|FG006|Period 1|Noncompliant with study drug|0|||
161486434|NCT00420927|583172927|FG000|Period 1|Randomization error|1|||
161486435|NCT00420927|583172928|FG001|Period 1|Randomization error|0|||
161582257|NCT02015520|583518355|FG001|Overall Study|Lack of Efficacy|0|||
161582258|NCT02015520|583518356|FG002|Overall Study|Lack of Efficacy|3|||
161582259|NCT02015520|583518357|FG003|Overall Study|Lack of Efficacy|2|||
161582260|NCT02015520|583518354|FG000|Overall Study|Adverse Event|0|||
161582261|NCT02015520|583518355|FG001|Overall Study|Adverse Event|0|||
161582262|NCT02015520|583518356|FG002|Overall Study|Adverse Event|0|||
161582263|NCT02015520|583518357|FG003|Overall Study|Adverse Event|1|||
161582264|NCT02015520|583518354|FG000|Overall Study|Withdrawal by Subject|2|||
161582265|NCT02015520|583518355|FG001|Overall Study|Withdrawal by Subject|2|||
161582266|NCT02015520|583518356|FG002|Overall Study|Withdrawal by Subject|1|||
161582267|NCT02015520|583518357|FG003|Overall Study|Withdrawal by Subject|0|||
161582268|NCT02015520|583518354|FG000|Overall Study|Death|1|||
161582269|NCT02015520|583518355|FG001|Overall Study|Death|0|||
161582270|NCT02015520|583518356|FG002|Overall Study|Death|0|||
161582271|NCT02015520|583518357|FG003|Overall Study|Death|0|||
161582272|NCT02015520|583518354|FG000|Overall Study|Lost to Follow-up|0|||
161582273|NCT02015520|583518355|FG001|Overall Study|Lost to Follow-up|0|||
161582274|NCT02015520|583518356|FG002|Overall Study|Lost to Follow-up|1|||
161582275|NCT02015520|583518357|FG003|Overall Study|Lost to Follow-up|0|||
161582276|NCT02015520|583518354|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161582277|NCT02015520|583518355|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161582278|NCT02015520|583518356|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
161582279|NCT02015520|583518357|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161582280|NCT02015520|583518354|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
161582281|NCT02015520|583518355|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
161582282|NCT02015520|583518356|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
161582283|NCT02015520|583518357|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
161582284|NCT01854385|583518361|FG000|Pre-Treatment|Withdrawal by Subject|4|||
161582285|NCT01854385|583518361|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
161582286|NCT01854385|583518361|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
161582287|NCT01854385|583518361|FG000|Pre-Treatment|Unable to come for study visits|1|||
161582288|NCT01854385|583518361|FG000|Treatment|Lost to Follow-up|1|||
161582289|NCT02932579|583518362|FG000|Overall Study|Withdrawal by Subject|4|||
161582290|NCT02932579|583518363|FG001|Overall Study|Withdrawal by Subject|1|||
161582291|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
161582292|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
161582293|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
161582294|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
161582295|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
161582296|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161582297|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161582298|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
161582299|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161582300|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161582301|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
161582302|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
161582303|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
161582304|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
161582305|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
161582306|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161582307|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
161582308|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
161582309|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161582310|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161582311|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
161582312|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
161486436|NCT00420927|583172929|FG002|Period 1|Randomization error|0|||
161486437|NCT00420927|583172930|FG003|Period 1|Randomization error|0|||
161582313|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
161603635|NCT05412004|583603300|FG001|Overall Study|Withdrawal by Subject|19|||
161486438|NCT00420927|583172931|FG004|Period 1|Randomization error|0|||
161486439|NCT00420927|583172932|FG005|Period 1|Randomization error|0|||
161486440|NCT00420927|583172933|FG006|Period 1|Randomization error|0|||
161486441|NCT00420927|583172927|FG000|Period 1|Suspected tuberculosis/positive test|1|||
161486442|NCT00420927|583172928|FG001|Period 1|Suspected tuberculosis/positive test|1|||
161486443|NCT00420927|583172929|FG002|Period 1|Suspected tuberculosis/positive test|0|||
161486444|NCT00420927|583172930|FG003|Period 1|Suspected tuberculosis/positive test|0|||
161486445|NCT00420927|583172931|FG004|Period 1|Suspected tuberculosis/positive test|0|||
161486446|NCT00420927|583172932|FG005|Period 1|Suspected tuberculosis/positive test|0|||
161486447|NCT00420927|583172933|FG006|Period 1|Suspected tuberculosis/positive test|0|||
161486448|NCT00420927|583172927|FG000|Period 1|Study site closure|0|||
161486449|NCT00420927|583172928|FG001|Period 1|Study site closure|1|||
161486450|NCT00420927|583172929|FG002|Period 1|Study site closure|0|||
161486451|NCT00420927|583172930|FG003|Period 1|Study site closure|0|||
161486452|NCT00420927|583172931|FG004|Period 1|Study site closure|0|||
161486453|NCT00420927|583172932|FG005|Period 1|Study site closure|0|||
161486454|NCT00420927|583172933|FG006|Period 1|Study site closure|0|||
161486455|NCT00420927|583172927|FG000|Period 1|Subject received new diagnosis|0|||
161486456|NCT00420927|583172928|FG001|Period 1|Subject received new diagnosis|2|||
161486457|NCT00420927|583172929|FG002|Period 1|Subject received new diagnosis|0|||
161486458|NCT00420927|583172930|FG003|Period 1|Subject received new diagnosis|0|||
161486459|NCT00420927|583172931|FG004|Period 1|Subject received new diagnosis|0|||
161486460|NCT00420927|583172932|FG005|Period 1|Subject received new diagnosis|0|||
161486461|NCT00420927|583172933|FG006|Period 1|Subject received new diagnosis|0|||
161486462|NCT00420927|583172927|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
161486463|NCT00420927|583172928|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
161486464|NCT00420927|583172929|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
161486465|NCT00420927|583172930|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
161486466|NCT00420927|583172931|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
161486467|NCT00420927|583172932|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
161486468|NCT00420927|583172933|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
161486469|NCT00420927|583172927|FG000|Period 1|Failed to meet entry criteria|8|||
161486470|NCT00420927|583172928|FG001|Period 1|Failed to meet entry criteria|7|||
161486471|NCT00420927|583172929|FG002|Period 1|Failed to meet entry criteria|0|||
161486472|NCT00420927|583172930|FG003|Period 1|Failed to meet entry criteria|0|||
161670946|NCT01193920|583847342|FG000|Overall Study|Unable to classify|0|||
161670947|NCT01193920|583847343|FG001|Overall Study|Unable to classify|0|||
161670948|NCT01193920|583847344|FG002|Overall Study|Unable to classify|0|||
161670949|NCT01193920|583847345|FG003|Overall Study|Unable to classify|1|||
161670950|NCT01193920|583847346|FG004|Overall Study|Unable to classify|0|||
161670951|NCT01193920|583847347|FG005|Overall Study|Unable to classify|0|||
161670952|NCT01193920|583847348|FG006|Overall Study|Unable to classify|0|||
161670953|NCT01193920|583847349|FG007|Overall Study|Unable to classify|1|||
161670954|NCT01193920|583847350|FG008|Overall Study|Unable to classify|0|||
161670955|NCT01193920|583847351|FG009|Overall Study|Unable to classify|0|||
161670956|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
161670957|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
161670958|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
161670959|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
161670960|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
161670961|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
161670962|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
161670963|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
161670964|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
161670965|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
161670966|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
161670967|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
161670968|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
161670969|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
161670970|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
161670971|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
161670972|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
161670973|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
161817015|NCT04194801|584370901|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
161817016|NCT04194801|584370899|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
161817017|NCT04194801|584370900|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
161486473|NCT00420927|583172931|FG004|Period 1|Failed to meet entry criteria|0|||
161486474|NCT00420927|583172932|FG005|Period 1|Failed to meet entry criteria|0|||
161486475|NCT00420927|583172933|FG006|Period 1|Failed to meet entry criteria|0|||
161486476|NCT00420927|583172927|FG000|Period 1|Took prohibited medication|1|||
161486477|NCT00420927|583172928|FG001|Period 1|Took prohibited medication|3|||
161486478|NCT00420927|583172929|FG002|Period 1|Took prohibited medication|0|||
161486479|NCT00420927|583172930|FG003|Period 1|Took prohibited medication|0|||
161486480|NCT00420927|583172931|FG004|Period 1|Took prohibited medication|0|||
161486481|NCT00420927|583172932|FG005|Period 1|Took prohibited medication|0|||
161486482|NCT00420927|583172933|FG006|Period 1|Took prohibited medication|0|||
161486483|NCT00420927|583172927|FG000|Period 2|Adverse Event|0|||
161486484|NCT00420927|583172928|FG001|Period 2|Adverse Event|0|||
161486485|NCT00420927|583172929|FG002|Period 2|Adverse Event|7|||
161486486|NCT00420927|583172930|FG003|Period 2|Adverse Event|3|||
161486487|NCT00420927|583172931|FG004|Period 2|Adverse Event|17|||
161486488|NCT00420927|583172932|FG005|Period 2|Adverse Event|6|||
161486489|NCT00420927|583172933|FG006|Period 2|Adverse Event|20|||
161486490|NCT00420927|583172927|FG000|Period 2|Withdrawal by Subject|0|||
161486491|NCT00420927|583172928|FG001|Period 2|Withdrawal by Subject|0|||
161486492|NCT00420927|583172929|FG002|Period 2|Withdrawal by Subject|1|||
161486493|NCT00420927|583172930|FG003|Period 2|Withdrawal by Subject|3|||
161486494|NCT00420927|583172931|FG004|Period 2|Withdrawal by Subject|11|||
161486495|NCT00420927|583172932|FG005|Period 2|Withdrawal by Subject|2|||
161486496|NCT00420927|583172933|FG006|Period 2|Withdrawal by Subject|12|||
161486497|NCT00420927|583172927|FG000|Period 2|Lost to Follow-up|0|||
161486498|NCT00420927|583172928|FG001|Period 2|Lost to Follow-up|0|||
161486499|NCT00420927|583172929|FG002|Period 2|Lost to Follow-up|2|||
161486500|NCT00420927|583172930|FG003|Period 2|Lost to Follow-up|2|||
161486501|NCT00420927|583172931|FG004|Period 2|Lost to Follow-up|6|||
161486502|NCT00420927|583172932|FG005|Period 2|Lost to Follow-up|3|||
161486503|NCT00420927|583172933|FG006|Period 2|Lost to Follow-up|9|||
161486504|NCT00420927|583172927|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
161486505|NCT00420927|583172928|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
161486506|NCT00420927|583172929|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
161486507|NCT00420927|583172930|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
161486508|NCT00420927|583172931|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
161486509|NCT00420927|583172932|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
161486510|NCT00420927|583172933|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
161486511|NCT00420927|583172927|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
161486512|NCT00420927|583172928|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
161486513|NCT00420927|583172929|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
161486514|NCT00420927|583172930|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
161486515|NCT00420927|583172931|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
161486516|NCT00420927|583172932|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
161486517|NCT00420927|583172933|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
161486518|NCT00420927|583172927|FG000|Period 2|Subject unable to find transportation|0|||
161486519|NCT00420927|583172928|FG001|Period 2|Subject unable to find transportation|0|||
161486520|NCT00420927|583172929|FG002|Period 2|Subject unable to find transportation|0|||
161486521|NCT00420927|583172930|FG003|Period 2|Subject unable to find transportation|0|||
161486522|NCT00420927|583172931|FG004|Period 2|Subject unable to find transportation|0|||
161486523|NCT00420927|583172932|FG005|Period 2|Subject unable to find transportation|0|||
161486524|NCT00420927|583172933|FG006|Period 2|Subject unable to find transportation|1|||
161486525|NCT00420927|583172927|FG000|Period 2|Physician Decision|0|||
161486526|NCT00420927|583172928|FG001|Period 2|Physician Decision|0|||
161486527|NCT00420927|583172929|FG002|Period 2|Physician Decision|0|||
161486528|NCT00420927|583172930|FG003|Period 2|Physician Decision|0|||
161486529|NCT00420927|583172931|FG004|Period 2|Physician Decision|1|||
161486530|NCT00420927|583172932|FG005|Period 2|Physician Decision|1|||
161486531|NCT00420927|583172933|FG006|Period 2|Physician Decision|0|||
161486532|NCT00420927|583172927|FG000|Period 2|Sponsor decision|0|||
161486533|NCT00420927|583172928|FG001|Period 2|Sponsor decision|0|||
161486534|NCT00420927|583172929|FG002|Period 2|Sponsor decision|1|||
161486535|NCT00420927|583172930|FG003|Period 2|Sponsor decision|0|||
161582314|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
161582315|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
161582316|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161582317|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161582318|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
161582319|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161582320|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161922843|NCT00303953|584764883|FG000|Overall Study|Physician Decision|1|||
161486536|NCT00420927|583172931|FG004|Period 2|Sponsor decision|0|||
161486537|NCT00420927|583172932|FG005|Period 2|Sponsor decision|0|||
161486538|NCT00420927|583172933|FG006|Period 2|Sponsor decision|1|||
161486539|NCT00420927|583172927|FG000|Period 2|Randomization error|0|||
161486540|NCT00420927|583172928|FG001|Period 2|Randomization error|0|||
161486541|NCT00420927|583172929|FG002|Period 2|Randomization error|0|||
161486542|NCT00420927|583172930|FG003|Period 2|Randomization error|0|||
161486543|NCT00420927|583172931|FG004|Period 2|Randomization error|1|||
161486544|NCT00420927|583172932|FG005|Period 2|Randomization error|1|||
161486545|NCT00420927|583172933|FG006|Period 2|Randomization error|0|||
161486546|NCT00420927|583172927|FG000|Period 2|Noncompliant with study drug|0|||
161486547|NCT00420927|583172928|FG001|Period 2|Noncompliant with study drug|0|||
161486548|NCT00420927|583172929|FG002|Period 2|Noncompliant with study drug|0|||
161486549|NCT00420927|583172930|FG003|Period 2|Noncompliant with study drug|1|||
161486550|NCT00420927|583172931|FG004|Period 2|Noncompliant with study drug|0|||
161486551|NCT00420927|583172932|FG005|Period 2|Noncompliant with study drug|0|||
161486552|NCT00420927|583172933|FG006|Period 2|Noncompliant with study drug|2|||
161486553|NCT00420927|583172927|FG000|Period 2|Methotrexate intolerance|0|||
161486554|NCT00420927|583172928|FG001|Period 2|Methotrexate intolerance|0|||
161486555|NCT00420927|583172929|FG002|Period 2|Methotrexate intolerance|0|||
161486556|NCT00420927|583172930|FG003|Period 2|Methotrexate intolerance|0|||
161486557|NCT00420927|583172931|FG004|Period 2|Methotrexate intolerance|0|||
161486558|NCT00420927|583172932|FG005|Period 2|Methotrexate intolerance|0|||
161922844|NCT00021255|584764884|FG000|Overall Study|Death|1|||
161486559|NCT00420927|583172933|FG006|Period 2|Methotrexate intolerance|1|||
161486560|NCT00420927|583172927|FG000|Period 2|Took prohibited medication|0|||
161486561|NCT00420927|583172928|FG001|Period 2|Took prohibited medication|0|||
161582321|NCT04759833|583518366|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161582322|NCT04759833|583518367|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
161582323|NCT04759833|583518368|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161582324|NCT04759833|583518369|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161582325|NCT04759833|583518370|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161582326|NCT04759833|583518366|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161582327|NCT04759833|583518367|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161582328|NCT04759833|583518368|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161582329|NCT04759833|583518369|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
161582330|NCT04759833|583518370|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
161582331|NCT04759833|583518366|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161582332|NCT04759833|583518367|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161582333|NCT04759833|583518368|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161582334|NCT04759833|583518369|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161582335|NCT04759833|583518370|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
161582336|NCT04759833|583518366|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161582337|NCT04759833|583518367|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161582338|NCT04759833|583518368|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161582339|NCT04759833|583518369|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
161582340|NCT04759833|583518370|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
161582341|NCT04759833|583518366|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161582342|NCT04759833|583518367|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161582343|NCT04759833|583518368|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161582344|NCT04759833|583518369|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
161582345|NCT04759833|583518370|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
161582346|NCT04759833|583518366|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161582347|NCT04759833|583518367|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161582348|NCT04759833|583518368|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161582349|NCT04759833|583518369|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
161582350|NCT04759833|583518370|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
161582351|NCT04759833|583518366|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161582352|NCT04759833|583518367|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161582353|NCT04759833|583518368|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161582354|NCT04759833|583518369|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
161582355|NCT04759833|583518370|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
161582356|NCT00508924|583518371|FG000|Overall Study|Protocol Violation|0|||
161582357|NCT00508924|583518372|FG001|Overall Study|Protocol Violation|0|||
161582358|NCT00508924|583518373|FG002|Overall Study|Protocol Violation|1|||
161582359|NCT00508924|583518374|FG003|Overall Study|Protocol Violation|1|||
161582360|NCT00630058|583518375|FG000|Overall Study|Adverse Event|1|||
161582361|NCT00630058|583518376|FG001|Overall Study|Adverse Event|1|||
161582362|NCT00630058|583518375|FG000|Overall Study|Withdrawal by Subject|0|||
161582363|NCT00630058|583518376|FG001|Overall Study|Withdrawal by Subject|1|||
161582364|NCT00630058|583518375|FG000|Overall Study|stopping criteria|3|||
161582365|NCT00630058|583518376|FG001|Overall Study|stopping criteria|2|||
161582366|NCT00415519|583518381|FG000|Overall Study|Adverse Event|1|||
161486562|NCT00420927|583172929|FG002|Period 2|Took prohibited medication|0|||
161486563|NCT00420927|583172930|FG003|Period 2|Took prohibited medication|0|||
161486564|NCT00420927|583172931|FG004|Period 2|Took prohibited medication|1|||
161486565|NCT00420927|583172932|FG005|Period 2|Took prohibited medication|0|||
161486566|NCT00420927|583172933|FG006|Period 2|Took prohibited medication|0|||
161486567|NCT04448171|583172934|FG000|Overall Study|Procedure Cancelled|1|||
161670974|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
161670975|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
161670976|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
161670977|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161670978|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
161670979|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
161670980|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
161670981|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
161670982|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
161670983|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161670984|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161670985|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161670986|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
161670987|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
161670988|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
161670989|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161670990|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
161670991|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
161670992|NCT00954421|583847355|FG000|Screening|screen failures|3|||
161670993|NCT00954421|583847355|FG000|6 Months of DBS|Withdrawal by Subject|1|||
161670994|NCT00954421|583847355|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
161670995|NCT04683731|583847358|FG000|Overall Study|Withdrawal by Subject|1|||
161670996|NCT04683731|583847359|FG001|Overall Study|Withdrawal by Subject|0|||
161670997|NCT04683731|583847360|FG002|Overall Study|Withdrawal by Subject|3|||
161670998|NCT04683731|583847361|FG003|Overall Study|Withdrawal by Subject|2|||
161670999|NCT04683731|583847358|FG000|Overall Study|Determined patient was not eligible|3|||
161671000|NCT04683731|583847359|FG001|Overall Study|Determined patient was not eligible|3|||
161671001|NCT04683731|583847360|FG002|Overall Study|Determined patient was not eligible|12|||
161671002|NCT04683731|583847361|FG003|Overall Study|Determined patient was not eligible|3|||
161671003|NCT00883051|583847362|FG000|Overall Study|Lost to Follow-up|0|||
161671004|NCT00883051|583847363|FG001|Overall Study|Lost to Follow-up|0|||
161671005|NCT00883051|583847364|FG002|Overall Study|Lost to Follow-up|0|||
161671006|NCT00883051|583847365|FG003|Overall Study|Lost to Follow-up|0|||
161671007|NCT00883051|583847366|FG004|Overall Study|Lost to Follow-up|1|||
161671008|NCT00883051|583847362|FG000|Overall Study|Did not use study medication|24|||
161671009|NCT00883051|583847363|FG001|Overall Study|Did not use study medication|22|||
161671010|NCT00883051|583847364|FG002|Overall Study|Did not use study medication|29|||
161671011|NCT00883051|583847365|FG003|Overall Study|Did not use study medication|29|||
161671012|NCT00883051|583847366|FG004|Overall Study|Did not use study medication|17|||
161671013|NCT03144804|583847367|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
161671014|NCT00959647|583847368|FG000|Overall Study|Adverse Event|2|||
161671015|NCT00959647|583847368|FG000|Overall Study|Progressive disease|6|||
161671016|NCT00959647|583847368|FG000|Overall Study|Study terminated by sponsor|4|||
161671017|NCT00959647|583847368|FG000|Overall Study|Withdrawal by Subject|7|||
161671018|NCT04223856|583847369|FG000|Overall Study|Progressive disease|153|||
161671019|NCT04223856|583847370|FG001|Overall Study|Progressive disease|73|||
161671020|NCT04223856|583847369|FG000|Overall Study|Adverse Event|97|||
161671021|NCT04223856|583847370|FG001|Overall Study|Adverse Event|62|||
161671022|NCT04223856|583847369|FG000|Overall Study|Physician Decision|9|||
161671023|NCT04223856|583847370|FG001|Overall Study|Physician Decision|28|||
161671024|NCT04223856|583847369|FG000|Overall Study|Withdrawal by Subject|22|||
161671025|NCT04223856|583847370|FG001|Overall Study|Withdrawal by Subject|24|||
161671026|NCT04223856|583847369|FG000|Overall Study|Other|7|||
161671027|NCT04223856|583847370|FG001|Overall Study|Other|2|||
161671028|NCT04223856|583847369|FG000|Overall Study|Randomized but not treated|2|||
161671029|NCT04223856|583847370|FG001|Overall Study|Randomized but not treated|11|||
161671030|NCT04223856|583847369|FG000|Overall Study|On-treatment|144|||
161486568|NCT04448171|583172935|FG001|Overall Study|Procedure Cancelled|0|||
161486569|NCT04448171|583172934|FG000|Overall Study|Protocol Violation|1|||
161486570|NCT04448171|583172935|FG001|Overall Study|Protocol Violation|0|||
161486571|NCT00855920|583172936|FG000|Overall Study|Protocol Violation|0|||
161486572|NCT00855920|583172937|FG001|Overall Study|Protocol Violation|0|||
161486573|NCT00855920|583172938|FG002|Overall Study|Protocol Violation|2|||
161486574|NCT00855920|583172936|FG000|Overall Study|Adverse Event|2|||
161486575|NCT00855920|583172937|FG001|Overall Study|Adverse Event|1|||
161671031|NCT04223856|583847370|FG001|Overall Study|On-treatment|0|||
161486576|NCT00855920|583172938|FG002|Overall Study|Adverse Event|1|||
161486577|NCT00855920|583172936|FG000|Overall Study|Lack of Efficacy|2|||
161671032|NCT06515483|583847373|FG000|Overall Study|Subject withdraw due to family issues|1|||
161671033|NCT06515483|583847374|FG001|Overall Study|Subject withdraw due to family issues|0|||
161671034|NCT05104476|583849022|FG000|Overall Study|Randomized But Not Treated|1|||
161671035|NCT05104476|583849023|FG001|Overall Study|Randomized But Not Treated|2|||
161486578|NCT00855920|583172937|FG001|Overall Study|Lack of Efficacy|2|||
161486579|NCT00855920|583172938|FG002|Overall Study|Lack of Efficacy|2|||
161486580|NCT00855920|583172936|FG000|Overall Study|Withdrawal by Subject|2|||
161486581|NCT00855920|583172937|FG001|Overall Study|Withdrawal by Subject|3|||
161486582|NCT00855920|583172938|FG002|Overall Study|Withdrawal by Subject|2|||
161486583|NCT00855920|583172936|FG000|Overall Study|Lost to Follow-up|1|||
161486584|NCT00855920|583172937|FG001|Overall Study|Lost to Follow-up|0|||
161486585|NCT00855920|583172938|FG002|Overall Study|Lost to Follow-up|2|||
161486586|NCT00855920|583172936|FG000|Overall Study|Death|0|||
161486587|NCT00855920|583172937|FG001|Overall Study|Death|1|||
161582367|NCT00415519|583518382|FG001|Overall Study|Adverse Event|0|||
161582368|NCT00415519|583518381|FG000|Overall Study|Withdrawal by Subject|2|||
161582369|NCT00415519|583518382|FG001|Overall Study|Withdrawal by Subject|0|||
161582370|NCT00415519|583518381|FG000|Overall Study|Patient's convenience|1|||
161582371|NCT00415519|583518382|FG001|Overall Study|Patient's convenience|0|||
161582372|NCT04163718|583518383|FG000|Overall Study|Study terminated|12|||
161582373|NCT02706717|583518384|FG000|Overall Study|Withdrawal by Subject|1|||
161582374|NCT02706717|583518385|FG001|Overall Study|Withdrawal by Subject|8|||
161582375|NCT02706717|583518384|FG000|Overall Study|Lost to Follow-up|0|||
161582376|NCT02706717|583518385|FG001|Overall Study|Lost to Follow-up|1|||
161582377|NCT02706717|583518384|FG000|Overall Study|Physician Decision|0|||
161582378|NCT02706717|583518385|FG001|Overall Study|Physician Decision|1|||
161582379|NCT02706717|583518384|FG000|Overall Study|Death|0|||
161582380|NCT02706717|583518385|FG001|Overall Study|Death|1|||
161582381|NCT00978042|583518390|FG000|Initial Treatment Period|Treated in Error|0|||
161582382|NCT00978042|583518391|FG001|Initial Treatment Period|Treated in Error|3|||
161582383|NCT00978042|583518390|FG000|Initial Treatment Period|Ineligibility|1|||
161582384|NCT00978042|583518391|FG001|Initial Treatment Period|Ineligibility|0|||
161582385|NCT00978042|583518390|FG000|Initial Treatment Period|Lost to Follow-up|21|||
161582386|NCT00978042|583518391|FG001|Initial Treatment Period|Lost to Follow-up|3|||
161582387|NCT00978042|583518390|FG000|Initial Treatment Period|Adverse Event|2|||
161582388|NCT00978042|583518391|FG001|Initial Treatment Period|Adverse Event|0|||
161582389|NCT00978042|583518390|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
161582390|NCT00978042|583518391|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
161582391|NCT00978042|583518390|FG000|Initial Treatment Period|Consent withdrawn|22|||
161582392|NCT00978042|583518391|FG001|Initial Treatment Period|Consent withdrawn|9|||
161582393|NCT00978042|583518390|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
161582394|NCT00978042|583518391|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
161582395|NCT04872738|583518392|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
161582396|NCT04872738|583518393|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
161582397|NCT03997916|583518394|FG000|Overall Study|Protocol Violation|35|||
161582398|NCT03103321|583519620|FG000|Overall Study|Protocol Violation|1|||
161582399|NCT03103321|583519621|FG001|Overall Study|Protocol Violation|1|||
161582400|NCT03103321|583519622|FG002|Overall Study|Protocol Violation|1|||
161582401|NCT03103321|583519623|FG003|Overall Study|Protocol Violation|0|||
161582402|NCT06375421|583519625|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
161582403|NCT06375421|583519626|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
161582404|NCT06375421|583519627|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
161582405|NCT06375421|583519628|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
161582406|NCT05760313|583519634|FG000|Overall Study|Withdrawal by Subject|0|||
161582407|NCT05760313|583519635|FG001|Overall Study|Withdrawal by Subject|0|||
161582408|NCT05760313|583519636|FG002|Overall Study|Withdrawal by Subject|1|||
161582409|NCT05760313|583519634|FG000|Overall Study|Other|1|||
161582410|NCT05760313|583519635|FG001|Overall Study|Other|0|||
161582411|NCT05760313|583519636|FG002|Overall Study|Other|0|||
161582412|NCT00956007|583519637|FG000|Overall Study|Protocol Violation|27|||
161582413|NCT00956007|583519638|FG001|Overall Study|Protocol Violation|23|||
161582414|NCT05228470|583519639|FG000|Overall Study|Death|6|||
161582415|NCT05228470|583519640|FG001|Overall Study|Death|11|||
161582416|NCT05228470|583519639|FG000|Overall Study|Withdrawal by Subject|1|||
161582417|NCT05228470|583519640|FG001|Overall Study|Withdrawal by Subject|8|||
161582418|NCT05228470|583519639|FG000|Overall Study|Ongoing|1|||
161582419|NCT05228470|583519640|FG001|Overall Study|Ongoing|11|||
161486588|NCT00855920|583172938|FG002|Overall Study|Death|0|||
161582420|NCT03885037|583519641|FG000|Overall Study|Protocol Violation|16|||
161582421|NCT01492686|583519642|FG000|Double-blind Phase|Adverse Event|0|||
161486589|NCT00855920|583172936|FG000|Overall Study|Decision by the sponsor|0|||
161582422|NCT01492686|583519643|FG001|Double-blind Phase|Adverse Event|2|||
161582423|NCT01492686|583519642|FG000|Double-blind Phase|Physician Decision|0|||
161671036|NCT05104476|583849022|FG000|Overall Study|Adverse Event|2|||
161486590|NCT00855920|583172937|FG001|Overall Study|Decision by the sponsor|1|||
161582424|NCT01492686|583519643|FG001|Double-blind Phase|Physician Decision|1|||
161582425|NCT01492686|583519642|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161582426|NCT01492686|583519643|FG001|Double-blind Phase|Withdrawal by Subject|2|||
161671037|NCT05104476|583849023|FG001|Overall Study|Adverse Event|2|||
161671038|NCT05104476|583849022|FG000|Overall Study|Withdrawal by Subject|3|||
161817018|NCT04194801|584370901|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
161486591|NCT00855920|583172938|FG002|Overall Study|Decision by the sponsor|1|||
161486592|NCT00855920|583172936|FG000|Overall Study|Other than specified above|1|||
161486593|NCT00855920|583172937|FG001|Overall Study|Other than specified above|1|||
161486594|NCT00855920|583172938|FG002|Overall Study|Other than specified above|1|||
161486595|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
161486596|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
161486597|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
161486598|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
161486599|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
161486600|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
161486601|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
161486602|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
161486603|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
161486604|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
161486605|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
161486606|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
161486607|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
161486608|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
161486609|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
161486610|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
161486611|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
161486612|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
161486613|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
161486614|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
161486615|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
161486616|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
161486617|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
161486618|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
161486619|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
161582427|NCT01492686|583519642|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
161582428|NCT01492686|583519643|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
161582429|NCT01492686|583519642|FG000|Open-label Phase|Adverse Event|1|||
161582430|NCT01492686|583519643|FG001|Open-label Phase|Adverse Event|2|||
161582431|NCT01492686|583519642|FG000|Open-label Phase|Physician Decision|1|||
161582432|NCT01492686|583519643|FG001|Open-label Phase|Physician Decision|0|||
161582433|NCT01492686|583519642|FG000|Open-label Phase|Withdrawal by Subject|6|||
161582434|NCT01492686|583519643|FG001|Open-label Phase|Withdrawal by Subject|7|||
161582435|NCT01492686|583519642|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
161582436|NCT01492686|583519643|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
161582437|NCT03314987|583519646|FG000|Overall Study|Lost to Follow-up|13|||
161582438|NCT03314987|583519647|FG001|Overall Study|Lost to Follow-up|13|||
161582439|NCT05552963|583519648|FG000|Overall Study|Lost to Follow-up|1|||
161582440|NCT05552963|583519648|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
161582441|NCT00431834|583519651|FG000|Overall Study|Withdrawal by Subject|7|||
161582442|NCT00431834|583519651|FG000|Overall Study|Death|3|||
161582443|NCT00431834|583519651|FG000|Overall Study|Missed Endpoint Visit|2|||
161582444|NCT00431834|583519651|FG000|Overall Study|Lost to Follow-up|1|||
161582445|NCT05529979|583519654|FG000|Overall Study|Lost to Follow-up|6|||
161582446|NCT05529979|583519654|FG000|Overall Study|Physician Decision|1|||
161582447|NCT05529979|583519654|FG000|Overall Study|non-feasibility cases|4|||
161582448|NCT05529979|583519654|FG000|Overall Study|Lack of Efficacy|3|||
161582449|NCT05529979|583519654|FG000|Overall Study|ablation not performed|1|||
161582450|NCT04191499|583519655|FG000|Overall Study|Adverse Event|1|||
161582451|NCT04191499|583519656|FG001|Overall Study|Adverse Event|0|||
161582452|NCT04191499|583519655|FG000|Overall Study|Death|42|||
161582453|NCT04191499|583519656|FG001|Overall Study|Death|55|||
161486620|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
161486621|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
161486622|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
161582454|NCT04191499|583519655|FG000|Overall Study|Lost to Follow-up|4|||
161582455|NCT04191499|583519656|FG001|Overall Study|Lost to Follow-up|1|||
161817019|NCT04194801|584370899|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
161817020|NCT04194801|584370900|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
161582456|NCT04191499|583519655|FG000|Overall Study|Physician Decision|1|||
161582457|NCT04191499|583519656|FG001|Overall Study|Physician Decision|0|||
161582458|NCT04191499|583519655|FG000|Overall Study|Progressive Disease|1|||
161582459|NCT04191499|583519656|FG001|Overall Study|Progressive Disease|0|||
161582460|NCT04191499|583519655|FG000|Overall Study|Symptomatic Deterioration|1|||
161817021|NCT04194801|584370901|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
161486623|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
161486624|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
161486625|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
161486626|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
161486627|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
161486628|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
161486629|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
161486630|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
161486631|NCT00843024|583172941|FG000|Single-blind Placebo Run-In Phase|Other|0|||
161486632|NCT00843024|583172942|FG001|Single-blind Placebo Run-In Phase|Other|1|||
161486633|NCT00843024|583172943|FG002|Single-blind Placebo Run-In Phase|Other|0|||
161486634|NCT00843024|583172944|FG003|Single-blind Placebo Run-In Phase|Other|0|||
161486635|NCT00843024|583172945|FG004|Single-blind Placebo Run-In Phase|Other|0|||
161486636|NCT00843024|583172946|FG005|Single-blind Placebo Run-In Phase|Other|0|||
161486637|NCT00843024|583172941|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
161486638|NCT00843024|583172942|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
161486639|NCT00843024|583172943|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
161486640|NCT00843024|583172944|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
161486641|NCT00843024|583172945|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
161486642|NCT00843024|583172946|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
161486643|NCT00843024|583172941|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161486644|NCT00843024|583172942|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
161486645|NCT00843024|583172943|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
161486646|NCT00843024|583172944|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
161486647|NCT00843024|583172945|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
161486648|NCT00843024|583172946|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
161486649|NCT00843024|583172941|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161486650|NCT00843024|583172942|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161486651|NCT00843024|583172943|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161486652|NCT00843024|583172944|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
161486653|NCT00843024|583172945|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161486654|NCT00843024|583172946|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
161486655|NCT00843024|583172941|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
161486656|NCT00843024|583172942|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
161486657|NCT00843024|583172943|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
161486658|NCT00843024|583172944|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
161486659|NCT00843024|583172945|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
161486660|NCT00843024|583172946|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
161486661|NCT00843024|583172941|FG000|Double-blind Treatment Phase|Physician Decision|0|||
161486662|NCT00843024|583172942|FG001|Double-blind Treatment Phase|Physician Decision|0|||
161486663|NCT00843024|583172943|FG002|Double-blind Treatment Phase|Physician Decision|0|||
161486664|NCT00843024|583172944|FG003|Double-blind Treatment Phase|Physician Decision|3|||
161486665|NCT00843024|583172945|FG004|Double-blind Treatment Phase|Physician Decision|1|||
161486666|NCT00843024|583172946|FG005|Double-blind Treatment Phase|Physician Decision|1|||
161486667|NCT00843024|583172941|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161486668|NCT00843024|583172942|FG001|Double-blind Treatment Phase|Adverse Event|0|||
161486669|NCT00843024|583172943|FG002|Double-blind Treatment Phase|Adverse Event|0|||
161486670|NCT00843024|583172944|FG003|Double-blind Treatment Phase|Adverse Event|0|||
161486671|NCT00843024|583172945|FG004|Double-blind Treatment Phase|Adverse Event|1|||
161486672|NCT00843024|583172946|FG005|Double-blind Treatment Phase|Adverse Event|1|||
161486673|NCT00843024|583172941|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
161486674|NCT00843024|583172942|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
161486675|NCT00843024|583172943|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
161486676|NCT00843024|583172944|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
161486677|NCT00843024|583172945|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
161486678|NCT00843024|583172946|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
161486679|NCT01032837|583172947|FG000|Overall Study|Adverse event/internal illness|0|||
161486680|NCT01032837|583172948|FG001|Overall Study|Adverse event/internal illness|1|||
161486681|NCT01032837|583172949|FG002|Overall Study|Adverse event/internal illness|0|||
161486682|NCT01032837|583172950|FG003|Overall Study|Adverse event/internal illness|1|||
161486683|NCT01032837|583172947|FG000|Overall Study|Withdrew consent|0|||
161486684|NCT01032837|583172948|FG001|Overall Study|Withdrew consent|2|||
161582461|NCT04191499|583519656|FG001|Overall Study|Symptomatic Deterioration|0|||
161582462|NCT04191499|583519655|FG000|Overall Study|Withdrawal by Subject|7|||
161582463|NCT04191499|583519656|FG001|Overall Study|Withdrawal by Subject|11|||
161582464|NCT04191499|583519655|FG000|Overall Study|Ongoing in the study|104|||
161582465|NCT04191499|583519656|FG001|Overall Study|Ongoing in the study|97|||
161582466|NCT03403413|583519659|FG000|Overall Study|Lack of Efficacy|2|||
161582467|NCT02924064|583519660|FG000|Overall Study|Adverse Event|2|||
161582468|NCT02924064|583519661|FG001|Overall Study|Adverse Event|2|||
161486685|NCT01032837|583172949|FG002|Overall Study|Withdrew consent|0|||
161486686|NCT01032837|583172950|FG003|Overall Study|Withdrew consent|1|||
161486687|NCT01032837|583172947|FG000|Overall Study|Failed to return|0|||
161486688|NCT01032837|583172948|FG001|Overall Study|Failed to return|0|||
161486689|NCT01032837|583172949|FG002|Overall Study|Failed to return|1|||
161486690|NCT01032837|583172950|FG003|Overall Study|Failed to return|0|||
161671039|NCT05104476|583849023|FG001|Overall Study|Withdrawal by Subject|3|||
161671040|NCT05104476|583849022|FG000|Overall Study|Other Than Specified|0|||
161671041|NCT05104476|583849023|FG001|Overall Study|Other Than Specified|3|||
161671042|NCT00992511|583849026|FG000|Overall Study|Migrated/moved from study area|1|||
161671043|NCT00992511|583849027|FG001|Overall Study|Migrated/moved from study area|0|||
161671044|NCT00992511|583849028|FG002|Overall Study|Migrated/moved from study area|1|||
161486691|NCT01032837|583172947|FG000|Overall Study|Refused treatment|0|||
161486692|NCT01032837|583172948|FG001|Overall Study|Refused treatment|0|||
161486693|NCT01032837|583172949|FG002|Overall Study|Refused treatment|0|||
161486694|NCT01032837|583172950|FG003|Overall Study|Refused treatment|1|||
161486695|NCT05201703|583172951|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
161486696|NCT05201703|583172952|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
161486697|NCT05201703|583172951|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
161486698|NCT05201703|583172952|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
161486699|NCT00844896|583172953|FG000|Overall Study|Lost to Follow-up|12|||
161486700|NCT00844896|583172954|FG001|Overall Study|Lost to Follow-up|16|||
161486701|NCT00844896|583172953|FG000|Overall Study|Parents did not have time to complete|0|||
161486702|NCT00844896|583172954|FG001|Overall Study|Parents did not have time to complete|1|||
161486703|NCT02233647|583172955|FG000|Overall Study|Adverse Event|1|||
161486704|NCT00458211|583172956|FG000|Overall Study|Lack of Efficacy|12|||
161582469|NCT02924064|583519660|FG000|Overall Study|Lost to Follow-up|0|||
161582470|NCT02924064|583519661|FG001|Overall Study|Lost to Follow-up|2|||
161582471|NCT02924064|583519660|FG000|Overall Study|Physician Decision|0|||
161582472|NCT02924064|583519661|FG001|Overall Study|Physician Decision|2|||
161582473|NCT02924064|583519660|FG000|Overall Study|Protocol Violation|1|||
161582474|NCT02924064|583519661|FG001|Overall Study|Protocol Violation|3|||
161582475|NCT02924064|583519660|FG000|Overall Study|Withdrawal by Subject|4|||
161582476|NCT02924064|583519661|FG001|Overall Study|Withdrawal by Subject|5|||
161582477|NCT02924064|583519660|FG000|Overall Study|Other|17|||
161582478|NCT02924064|583519661|FG001|Overall Study|Other|29|||
161582479|NCT00529100|583519664|FG000|Overall Study|Adverse Event|0|||
161582480|NCT00529100|583519665|FG001|Overall Study|Adverse Event|5|||
161582481|NCT00529100|583519664|FG000|Overall Study|Protocol Violation|0|||
161582482|NCT00529100|583519665|FG001|Overall Study|Protocol Violation|1|||
161582483|NCT00529100|583519664|FG000|Overall Study|Progressive Disease|0|||
161582484|NCT00529100|583519665|FG001|Overall Study|Progressive Disease|1|||
161582485|NCT00529100|583519664|FG000|Overall Study|Withdrawal by Subject|0|||
161582486|NCT00529100|583519665|FG001|Overall Study|Withdrawal by Subject|1|||
161582487|NCT00529100|583519664|FG000|Overall Study|Participant Ineligibility|0|||
161582488|NCT00529100|583519665|FG001|Overall Study|Participant Ineligibility|1|||
161582489|NCT05524454|583519667|FG000|Overall Study|Withdrawal by Subject|1|||
161582490|NCT05999435|583519668|FG000|Overall Study|Adverse Event|1|||
161582491|NCT05999435|583519669|FG001|Overall Study|Adverse Event|0|||
161582492|NCT05999435|583519670|FG002|Overall Study|Adverse Event|0|||
161582493|NCT05999435|583519668|FG000|Overall Study|Withdrawal by Subject|2|||
161582494|NCT05999435|583519669|FG001|Overall Study|Withdrawal by Subject|1|||
161582495|NCT05999435|583519670|FG002|Overall Study|Withdrawal by Subject|0|||
161582496|NCT05054725|583519674|FG000|Overall Study|Withdrawal by Subject|3|||
161582497|NCT05054725|583519675|FG001|Overall Study|Withdrawal by Subject|4|||
161582498|NCT05054725|583519674|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
161582499|NCT05054725|583519675|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
161582500|NCT05054725|583519674|FG000|Overall Study|Death|1|||
161582501|NCT05054725|583519675|FG001|Overall Study|Death|21|||
161582502|NCT05054725|583519674|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
161582503|NCT05054725|583519675|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
161582504|NCT05054725|583519674|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
161671045|NCT00992511|583849029|FG003|Overall Study|Migrated/moved from study area|2|||
161582505|NCT05054725|583519675|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
161582506|NCT05054725|583519674|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
161582507|NCT05054725|583519675|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
161582508|NCT05054725|583519674|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
161582509|NCT05054725|583519675|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
161486705|NCT00458211|583172956|FG000|Overall Study|Withdrawal by Subject|2|||
161486706|NCT00458211|583172956|FG000|Overall Study|Protocol Violation|2|||
161486707|NCT02132130|583172957|FG000|Overall Study|Lost to Follow-up|0|||
161486708|NCT02132130|583172958|FG001|Overall Study|Lost to Follow-up|2|||
161486709|NCT02132130|583172959|FG002|Overall Study|Lost to Follow-up|0|||
161486710|NCT02132130|583172960|FG003|Overall Study|Lost to Follow-up|0|||
161486711|NCT02132130|583172957|FG000|Overall Study|Withdrawal by Subject|0|||
161486712|NCT02132130|583172958|FG001|Overall Study|Withdrawal by Subject|0|||
161486713|NCT02132130|583172959|FG002|Overall Study|Withdrawal by Subject|0|||
161486714|NCT02132130|583172960|FG003|Overall Study|Withdrawal by Subject|1|||
161486715|NCT00679302|583172961|FG000|Overall Study|Lost to Follow-up|8|||
161486716|NCT00679302|583172962|FG001|Overall Study|Lost to Follow-up|4|||
161486717|NCT04656691|583172963|FG000|Overall Study|Adverse Event|1|||
161486718|NCT00439244|583172966|FG000|Overall Study|Adverse Event|5|||
161486719|NCT00439244|583172967|FG001|Overall Study|Adverse Event|2|||
161486720|NCT00439244|583172968|FG002|Overall Study|Adverse Event|3|||
161486721|NCT00439244|583172966|FG000|Overall Study|Withdrawal by Subject|3|||
161486722|NCT00439244|583172967|FG001|Overall Study|Withdrawal by Subject|1|||
161486723|NCT00439244|583172968|FG002|Overall Study|Withdrawal by Subject|2|||
161486724|NCT00439244|583172966|FG000|Overall Study|Lost to Follow-up|2|||
161486725|NCT00439244|583172967|FG001|Overall Study|Lost to Follow-up|1|||
161486726|NCT00439244|583172968|FG002|Overall Study|Lost to Follow-up|2|||
161486727|NCT00439244|583172966|FG000|Overall Study|Death|0|||
161486728|NCT00439244|583172967|FG001|Overall Study|Death|1|||
161486729|NCT00439244|583172968|FG002|Overall Study|Death|0|||
161486730|NCT00439244|583172966|FG000|Overall Study|Protocol Violation|0|||
161486731|NCT00439244|583172967|FG001|Overall Study|Protocol Violation|1|||
161486732|NCT00439244|583172968|FG002|Overall Study|Protocol Violation|0|||
161486733|NCT00439244|583172966|FG000|Overall Study|Administrative problems|1|||
161486734|NCT00439244|583172967|FG001|Overall Study|Administrative problems|0|||
161486735|NCT00439244|583172968|FG002|Overall Study|Administrative problems|0|||
161486736|NCT05425745|583172972|FG000|Overall Study|Withdrawal of Consent|3|||
161486737|NCT05425745|583172973|FG001|Overall Study|Withdrawal of Consent|3|||
161486738|NCT05425745|583172972|FG000|Overall Study|Death|2|||
161486739|NCT05425745|583172973|FG001|Overall Study|Death|3|||
161486740|NCT05425745|583172972|FG000|Overall Study|Lost to Follow-up|1|||
161486741|NCT05425745|583172973|FG001|Overall Study|Lost to Follow-up|2|||
161486742|NCT05425745|583172972|FG000|Overall Study|Adverse Event|0|||
161486743|NCT05425745|583172973|FG001|Overall Study|Adverse Event|1|||
161486744|NCT05425745|583172972|FG000|Overall Study|Did not return for end of study visit|0|||
161486745|NCT05425745|583172973|FG001|Overall Study|Did not return for end of study visit|1|||
161486746|NCT05425745|583172972|FG000|Overall Study|End of study visit completed by phone|1|||
161486747|NCT05425745|583172973|FG001|Overall Study|End of study visit completed by phone|0|||
161486748|NCT05425745|583172972|FG000|Overall Study|Subject decision|1|||
161486749|NCT05425745|583172973|FG001|Overall Study|Subject decision|0|||
161486750|NCT00524368|583174380|FG000|Overall Study|Adverse Event|10|||
161486751|NCT00524368|583174381|FG001|Overall Study|Adverse Event|12|||
161486752|NCT00524368|583174380|FG000|Overall Study|Lost to Follow-up|9|||
161486753|NCT00524368|583174381|FG001|Overall Study|Lost to Follow-up|13|||
161486754|NCT00524368|583174380|FG000|Overall Study|Withdrawal by Subject|4|||
161486755|NCT00524368|583174381|FG001|Overall Study|Withdrawal by Subject|5|||
161486756|NCT00524368|583174380|FG000|Overall Study|Non-compliant|8|||
161486757|NCT00524368|583174381|FG001|Overall Study|Non-compliant|9|||
161486758|NCT00524368|583174380|FG000|Overall Study|Reached a Virologic Endpoint|3|||
161486759|NCT00524368|583174381|FG001|Overall Study|Reached a Virologic Endpoint|2|||
161486760|NCT00524368|583174380|FG000|Overall Study|Sponsor's Decision|2|||
161486761|NCT00524368|583174381|FG001|Overall Study|Sponsor's Decision|0|||
161486762|NCT00524368|583174380|FG000|Overall Study|Ineligible to Continue the study|2|||
161486763|NCT00524368|583174381|FG001|Overall Study|Ineligible to Continue the study|5|||
161486764|NCT00524368|583174380|FG000|Overall Study|Other|3|||
161486765|NCT00524368|583174381|FG001|Overall Study|Other|2|||
161486766|NCT04221009|583174383|FG000|Overall Study|Withdrawal by Subject|4|||
161486767|NCT00793598|583174384|FG000|Overall Study|Patient Request|0|||
161486768|NCT00793598|583174385|FG001|Overall Study|Patient Request|1|||
161486769|NCT00793598|583174386|FG002|Overall Study|Patient Request|0|||
161486770|NCT00793598|583174387|FG003|Overall Study|Patient Request|0|||
161486771|NCT00793598|583174388|FG004|Overall Study|Patient Request|0|||
161486772|NCT00793598|583174389|FG005|Overall Study|Patient Request|0|||
161486773|NCT00793598|583174390|FG006|Overall Study|Patient Request|0|||
161486774|NCT00793598|583174391|FG007|Overall Study|Patient Request|0|||
161486775|NCT00793598|583174384|FG000|Overall Study|Protocol Violation|0|||
161486776|NCT00793598|583174385|FG001|Overall Study|Protocol Violation|0|||
161486777|NCT00793598|583174386|FG002|Overall Study|Protocol Violation|0|||
161486778|NCT00793598|583174387|FG003|Overall Study|Protocol Violation|0|||
161486779|NCT00793598|583174388|FG004|Overall Study|Protocol Violation|0|||
161486780|NCT00793598|583174389|FG005|Overall Study|Protocol Violation|0|||
161486781|NCT00793598|583174390|FG006|Overall Study|Protocol Violation|0|||
161486782|NCT00793598|583174391|FG007|Overall Study|Protocol Violation|1|||
161486783|NCT00793598|583174384|FG000|Overall Study|Subject not dosed|0|||
161486784|NCT00793598|583174385|FG001|Overall Study|Subject not dosed|0|||
161486785|NCT00793598|583174386|FG002|Overall Study|Subject not dosed|0|||
161486786|NCT00793598|583174387|FG003|Overall Study|Subject not dosed|0|||
161486787|NCT00793598|583174388|FG004|Overall Study|Subject not dosed|0|||
161486788|NCT00793598|583174389|FG005|Overall Study|Subject not dosed|1|||
161486789|NCT00793598|583174390|FG006|Overall Study|Subject not dosed|0|||
161582510|NCT05054725|583519674|FG000|Overall Study|Physician discretion due to subject progression|0|||
161582511|NCT05054725|583519675|FG001|Overall Study|Physician discretion due to subject progression|1|||
161582512|NCT03674411|583519676|FG000|Overall Study|Non-treatment|4|||
161486790|NCT00793598|583174391|FG007|Overall Study|Subject not dosed|0|||
161486791|NCT02762266|583174392|FG000|Overall Study|Physician Decision|2|||
161486792|NCT02762266|583174393|FG001|Overall Study|Physician Decision|0|||
161486793|NCT02373202|583174396|FG000|Overall Study|Adverse Event|2|||
161486794|NCT02373202|583174397|FG001|Overall Study|Adverse Event|5|||
161486795|NCT02373202|583174398|FG002|Overall Study|Adverse Event|2|||
161486796|NCT02373202|583174399|FG003|Overall Study|Adverse Event|1|||
161486797|NCT02373202|583174396|FG000|Overall Study|Lack of Efficacy|0|||
161486798|NCT02373202|583174397|FG001|Overall Study|Lack of Efficacy|0|||
161486799|NCT02373202|583174398|FG002|Overall Study|Lack of Efficacy|1|||
161486800|NCT02373202|583174399|FG003|Overall Study|Lack of Efficacy|0|||
161486801|NCT02373202|583174396|FG000|Overall Study|Other|0|||
161486802|NCT02373202|583174397|FG001|Overall Study|Other|1|||
161486803|NCT02373202|583174398|FG002|Overall Study|Other|0|||
161486804|NCT02373202|583174399|FG003|Overall Study|Other|0|||
161486805|NCT03010254|583174400|FG000|Overall Study|Adverse Event|0|||
161486806|NCT03010254|583174401|FG001|Overall Study|Adverse Event|1|||
161486807|NCT03010254|583174400|FG000|Overall Study|Lost to Follow-up|4|||
161486808|NCT03010254|583174401|FG001|Overall Study|Lost to Follow-up|0|||
161486809|NCT03010254|583174400|FG000|Overall Study|Withdrawal by Subject|1|||
161486810|NCT03010254|583174401|FG001|Overall Study|Withdrawal by Subject|1|||
161486811|NCT03010254|583174400|FG000|Overall Study|Other|2|||
161486812|NCT03010254|583174401|FG001|Overall Study|Other|3|||
161486813|NCT01404325|583174408|FG000|Overall Study|Lost to Follow-up|1|||
161486814|NCT01404325|583174409|FG001|Overall Study|Lost to Follow-up|0|||
161486815|NCT01404325|583174408|FG000|Overall Study|Death|2|||
161486816|NCT01404325|583174409|FG001|Overall Study|Death|0|||
161486817|NCT01404325|583174408|FG000|Overall Study|Graft loss/Retransplantation|1|||
161486818|NCT01404325|583174409|FG001|Overall Study|Graft loss/Retransplantation|0|||
161486819|NCT01404325|583174408|FG000|Overall Study|non-specified reason|0|||
161486820|NCT01404325|583174409|FG001|Overall Study|non-specified reason|2|||
161486821|NCT03909295|583174413|FG000|Overall Study|Adverse Event|2|||
161486822|NCT03909295|583174413|FG000|Overall Study|Study terminated by sponsor|50|||
161486823|NCT03312933|583174417|FG000|Overall Study|Protocol Violation|15|||
161486824|NCT03312933|583174417|FG000|Overall Study|Lost to Follow-up|36|||
161486825|NCT03312933|583174417|FG000|Overall Study|Withdrawal by Subject|3|||
161486826|NCT00848081|583174418|FG000|Overall Study|Adverse Event|6|||
161486827|NCT00848081|583174419|FG001|Overall Study|Adverse Event|7|||
161486828|NCT00848081|583174418|FG000|Overall Study|Protocol Violation|8|||
161486829|NCT00848081|583174419|FG001|Overall Study|Protocol Violation|5|||
161486830|NCT00848081|583174418|FG000|Overall Study|Lost to Follow-up|1|||
161486831|NCT00848081|583174419|FG001|Overall Study|Lost to Follow-up|0|||
161486832|NCT00848081|583174418|FG000|Overall Study|Physician Decision|0|||
161486833|NCT00848081|583174419|FG001|Overall Study|Physician Decision|3|||
161486834|NCT00848081|583174418|FG000|Overall Study|Withdrawal by Subject|5|||
161486835|NCT00848081|583174419|FG001|Overall Study|Withdrawal by Subject|3|||
161486836|NCT01752907|583174421|FG000|Overall Study|Withdrawal by Subject|4|||
161486837|NCT01752907|583174422|FG001|Overall Study|Withdrawal by Subject|10|||
161486838|NCT01752907|583174421|FG000|Overall Study|Lost to Follow-up|2|||
161486839|NCT01752907|583174422|FG001|Overall Study|Lost to Follow-up|1|||
161486840|NCT01752907|583174421|FG000|Overall Study|Decision by Sponsor|6|||
161486841|NCT01752907|583174422|FG001|Overall Study|Decision by Sponsor|9|||
161486842|NCT03098550|583174423|FG000|Overall Study|Disease Progression|30|||
161486843|NCT03098550|583174424|FG001|Overall Study|Disease Progression|19|||
161486844|NCT03098550|583174425|FG002|Overall Study|Disease Progression|41|||
161486845|NCT03098550|583174423|FG000|Overall Study|Study Drug Toxicity|2|||
161486846|NCT03098550|583174424|FG001|Overall Study|Study Drug Toxicity|1|||
161486847|NCT03098550|583174425|FG002|Overall Study|Study Drug Toxicity|0|||
161486848|NCT03098550|583174423|FG000|Overall Study|Death|1|||
161486849|NCT03098550|583174424|FG001|Overall Study|Death|0|||
161486850|NCT03098550|583174425|FG002|Overall Study|Death|0|||
161486851|NCT03098550|583174423|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
161486852|NCT03098550|583174424|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
161486853|NCT03098550|583174425|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
161486854|NCT03098550|583174423|FG000|Overall Study|Administrative reason by sponsor|0|||
161486855|NCT03098550|583174424|FG001|Overall Study|Administrative reason by sponsor|0|||
161486856|NCT03098550|583174425|FG002|Overall Study|Administrative reason by sponsor|1|||
161486857|NCT03098550|583174423|FG000|Overall Study|Other reasons|2|||
161486858|NCT03098550|583174424|FG001|Overall Study|Other reasons|0|||
161486859|NCT03098550|583174425|FG002|Overall Study|Other reasons|0|||
161486860|NCT00630396|583174429|FG000|Overall Study|Death|4|||
161582513|NCT03674411|583519677|FG001|Overall Study|Non-treatment|0|||
161582514|NCT04982315|583519678|FG000|Overall Study|Death|1|||
161582515|NCT04982315|583519679|FG001|Overall Study|Death|0|||
161582516|NCT04982315|583519680|FG002|Overall Study|Death|1|||
161582517|NCT04982315|583519678|FG000|Overall Study|Lack of Efficacy|0|||
161582518|NCT04982315|583519679|FG001|Overall Study|Lack of Efficacy|0|||
161582519|NCT04982315|583519680|FG002|Overall Study|Lack of Efficacy|2|||
161582520|NCT04982315|583519678|FG000|Overall Study|Withdrawal by Subject|24|||
161582521|NCT04982315|583519679|FG001|Overall Study|Withdrawal by Subject|1|||
161582522|NCT04982315|583519680|FG002|Overall Study|Withdrawal by Subject|2|||
161582523|NCT04982315|583519678|FG000|Overall Study|Dealing with health/life issues|3|||
161582524|NCT04982315|583519679|FG001|Overall Study|Dealing with health/life issues|4|||
161582525|NCT04982315|583519680|FG002|Overall Study|Dealing with health/life issues|7|||
161582526|NCT04982315|583519678|FG000|Overall Study|Privacy concerns|1|||
161582527|NCT04982315|583519679|FG001|Overall Study|Privacy concerns|0|||
161582528|NCT04982315|583519680|FG002|Overall Study|Privacy concerns|0|||
161582529|NCT04982315|583519678|FG000|Overall Study|Withdrawal by research team|0|||
161582530|NCT04982315|583519679|FG001|Overall Study|Withdrawal by research team|0|||
161582531|NCT04982315|583519680|FG002|Overall Study|Withdrawal by research team|1|||
161582532|NCT00780910|583519681|FG000|Overall Study|Adverse Event|2|||
161582533|NCT00781274|583519687|FG000|Overall Study|Withdrawal by Subject|2|||
161582534|NCT04705480|583519689|FG000|Overall Study|Withdrawal by Subject|1|||
161582535|NCT04705480|583519690|FG001|Overall Study|Withdrawal by Subject|0|||
161582536|NCT04705480|583519691|FG002|Overall Study|Withdrawal by Subject|1|||
161582537|NCT04705480|583519689|FG000|Overall Study|Protocol Violation|2|||
161582538|NCT04705480|583519690|FG001|Overall Study|Protocol Violation|0|||
161582539|NCT04705480|583519691|FG002|Overall Study|Protocol Violation|2|||
161582540|NCT04705480|583519689|FG000|Overall Study|Decision to discharge before intervention|2|||
161582541|NCT04705480|583519690|FG001|Overall Study|Decision to discharge before intervention|0|||
161582542|NCT04705480|583519691|FG002|Overall Study|Decision to discharge before intervention|0|||
161582543|NCT00861692|583519692|FG000|Overall Study|Death|6|||
161582544|NCT06429163|583519693|FG000|Overall Study|uterine fibroid type 7|1|||
161582545|NCT06429163|583519694|FG001|Overall Study|uterine fibroid type 7|1|||
161582546|NCT06429163|583519695|FG002|Overall Study|uterine fibroid type 7|1|||
161582547|NCT06429163|583519693|FG000|Overall Study|severe adhesions|1|||
161582548|NCT06429163|583519694|FG001|Overall Study|severe adhesions|2|||
161582549|NCT06429163|583519695|FG002|Overall Study|severe adhesions|1|||
161582550|NCT06429163|583519693|FG000|Overall Study|conversion to laparotomy|0|||
161582551|NCT06429163|583519694|FG001|Overall Study|conversion to laparotomy|1|||
161582552|NCT06429163|583519695|FG002|Overall Study|conversion to laparotomy|0|||
161582553|NCT06429163|583519693|FG000|Overall Study|concomitant procedure|1|||
161582554|NCT06429163|583519694|FG001|Overall Study|concomitant procedure|0|||
161582555|NCT06429163|583519695|FG002|Overall Study|concomitant procedure|0|||
161582556|NCT04970654|583519696|FG000|Overall Study|Withdrawal by parents/guardian|1|||
161582557|NCT04970654|583519697|FG001|Overall Study|Withdrawal by parents/guardian|2|||
161582558|NCT04970654|583519696|FG000|Overall Study|Unclassified|2|||
161582559|NCT04970654|583519697|FG001|Overall Study|Unclassified|1|||
161582560|NCT04970654|583519696|FG000|Overall Study|Lost to Follow-up|1|||
161582561|NCT04970654|583519697|FG001|Overall Study|Lost to Follow-up|0|||
161582562|NCT04929483|583519698|FG000|Main Study (24 Weeks)|Adverse Event|1|||
161582563|NCT04929483|583519699|FG001|Main Study (24 Weeks)|Adverse Event|6|||
161582564|NCT04929483|583519700|FG002|Main Study (24 Weeks)|Adverse Event|2|||
161582565|NCT04929483|583519701|FG003|Main Study (24 Weeks)|Adverse Event|1|||
161582566|NCT04929483|583519702|FG004|Main Study (24 Weeks)|Adverse Event|0|||
161582567|NCT04929483|583519703|FG005|Main Study (24 Weeks)|Adverse Event|0|||
161582568|NCT04929483|583519698|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161582569|NCT04929483|583519699|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161582570|NCT04929483|583519700|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161582571|NCT04929483|583519701|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161582572|NCT04929483|583519702|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161582573|NCT04929483|583519703|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161582574|NCT04929483|583519698|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
161582575|NCT04929483|583519699|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
161582576|NCT04929483|583519700|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
161582577|NCT04929483|583519701|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
161582578|NCT04929483|583519702|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
161582579|NCT04929483|583519703|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
161582580|NCT04929483|583519698|FG000|Main Study (24 Weeks)|Physician Decision|0|||
161671046|NCT00992511|583849026|FG000|Overall Study|Lost to Follow-up|1|||
161671047|NCT00992511|583849027|FG001|Overall Study|Lost to Follow-up|0|||
161582581|NCT04929483|583519699|FG001|Main Study (24 Weeks)|Physician Decision|2|||
161582582|NCT04929483|583519700|FG002|Main Study (24 Weeks)|Physician Decision|0|||
161582583|NCT04929483|583519701|FG003|Main Study (24 Weeks)|Physician Decision|0|||
161582584|NCT04929483|583519702|FG004|Main Study (24 Weeks)|Physician Decision|0|||
161582585|NCT04929483|583519703|FG005|Main Study (24 Weeks)|Physician Decision|0|||
161671048|NCT00992511|583849028|FG002|Overall Study|Lost to Follow-up|0|||
161671049|NCT00992511|583849029|FG003|Overall Study|Lost to Follow-up|2|||
161671050|NCT00992511|583849026|FG000|Overall Study|Withdrawal by Subject|0|||
161671051|NCT00992511|583849027|FG001|Overall Study|Withdrawal by Subject|0|||
161671052|NCT00992511|583849028|FG002|Overall Study|Withdrawal by Subject|1|||
161671053|NCT00992511|583849029|FG003|Overall Study|Withdrawal by Subject|1|||
161671054|NCT01180998|583849030|FG000|Overall Study|Poor Vision|0|||
161671055|NCT01180998|583849031|FG001|Overall Study|Poor Vision|2|||
161671056|NCT01180998|583849032|FG002|Overall Study|Poor Vision|2|||
161671057|NCT01180998|583849030|FG000|Overall Study|Lost to Follow-up|0|||
161671058|NCT01180998|583849031|FG001|Overall Study|Lost to Follow-up|0|||
161671059|NCT01180998|583849032|FG002|Overall Study|Lost to Follow-up|1|||
161671060|NCT01180998|583849030|FG000|Overall Study|Protocol Violation|1|||
161671061|NCT01180998|583849031|FG001|Overall Study|Protocol Violation|2|||
161671062|NCT01180998|583849032|FG002|Overall Study|Protocol Violation|0|||
161671063|NCT01180998|583849030|FG000|Overall Study|Withdrawal by Subject|0|||
161671064|NCT01180998|583849031|FG001|Overall Study|Withdrawal by Subject|0|||
161671065|NCT01180998|583849032|FG002|Overall Study|Withdrawal by Subject|1|||
161671066|NCT01180998|583849030|FG000|Overall Study|Poor comfort|3|||
161671067|NCT01180998|583849031|FG001|Overall Study|Poor comfort|0|||
161671068|NCT01180998|583849032|FG002|Overall Study|Poor comfort|4|||
161671069|NCT01180998|583849030|FG000|Overall Study|Poor lens handling|0|||
161671070|NCT01180998|583849031|FG001|Overall Study|Poor lens handling|0|||
161671071|NCT01180998|583849032|FG002|Overall Study|Poor lens handling|2|||
161671072|NCT01176968|583849033|FG000|Overall Study|Adverse Event|10|||
161671073|NCT01176968|583849034|FG001|Overall Study|Adverse Event|11|||
161671074|NCT01176968|583849033|FG000|Overall Study|Death|2|||
161671075|NCT01176968|583849034|FG001|Overall Study|Death|3|||
161671076|NCT01176968|583849033|FG000|Overall Study|Lack of Efficacy|0|||
161671077|NCT01176968|583849034|FG001|Overall Study|Lack of Efficacy|1|||
161671078|NCT01176968|583849033|FG000|Overall Study|Lost to Follow-up|16|||
161671079|NCT01176968|583849034|FG001|Overall Study|Lost to Follow-up|14|||
161671080|NCT01176968|583849033|FG000|Overall Study|Withdrawal by Subject|48|||
161671081|NCT01176968|583849034|FG001|Overall Study|Withdrawal by Subject|48|||
161671082|NCT01176968|583849033|FG000|Overall Study|Protocol Violation|2|||
161671083|NCT01176968|583849034|FG001|Overall Study|Protocol Violation|1|||
161671084|NCT01176968|583849033|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161671085|NCT01176968|583849034|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161671086|NCT01176968|583849033|FG000|Overall Study|Study terminated by sponsor|0|||
161671087|NCT01176968|583849034|FG001|Overall Study|Study terminated by sponsor|1|||
161671088|NCT01176968|583849033|FG000|Overall Study|Reason not defined|5|||
161671089|NCT01176968|583849034|FG001|Overall Study|Reason not defined|3|||
161671090|NCT04485104|583849035|FG000|Overall Study|Physician Decision|2|||
161671091|NCT04485104|583849036|FG001|Overall Study|Physician Decision|0|||
161671092|NCT04485104|583849035|FG000|Overall Study|Decision by sponsor|0|||
161671093|NCT04485104|583849036|FG001|Overall Study|Decision by sponsor|1|||
161671094|NCT00744523|583849037|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
161671095|NCT00744523|583849038|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
161671096|NCT05057247|583849039|FG000|Overall Study|Death|4|||
161671097|NCT05057247|583849039|FG000|Overall Study|Physician Decision|3|||
161671098|NCT05057247|583849039|FG000|Overall Study|Progressive Disease|7|||
161671099|NCT05057247|583849039|FG000|Overall Study|Withdrawal by Subject|3|||
161671100|NCT05057247|583849039|FG000|Overall Study|Adverse Event|6|||
161671101|NCT05057247|583849039|FG000|Overall Study|Subject Non-Compliance|1|||
161671102|NCT05057247|583849039|FG000|Overall Study|On treatment|2|||
161671103|NCT03588728|583849043|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
161671104|NCT03588728|583849044|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
161671105|NCT03588728|583849045|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
161671106|NCT03588728|583849046|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
161671107|NCT03588728|583849043|FG000|Overall Study|Lab shut down due to COVID-19|0|||
161671108|NCT03588728|583849044|FG001|Overall Study|Lab shut down due to COVID-19|0|||
161671109|NCT03588728|583849045|FG002|Overall Study|Lab shut down due to COVID-19|0|||
161671110|NCT03588728|583849046|FG003|Overall Study|Lab shut down due to COVID-19|1|||
161671111|NCT03588728|583849043|FG000|Overall Study|multiple technical issues|1|||
161671112|NCT03588728|583849044|FG001|Overall Study|multiple technical issues|0|||
161817022|NCT04194801|584370899|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
161817023|NCT04194801|584370900|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
161671113|NCT03588728|583849045|FG002|Overall Study|multiple technical issues|0|||
161671114|NCT03588728|583849046|FG003|Overall Study|multiple technical issues|0|||
161671115|NCT03588728|583849043|FG000|Overall Study|Hospitalized for COVID|1|||
161671116|NCT03588728|583849044|FG001|Overall Study|Hospitalized for COVID|0|||
161671117|NCT03588728|583849045|FG002|Overall Study|Hospitalized for COVID|0|||
161671118|NCT03588728|583849046|FG003|Overall Study|Hospitalized for COVID|0|||
161671119|NCT03588728|583849043|FG000|Overall Study|Schedule change unable to attend sessions|1|||
161671120|NCT03588728|583849044|FG001|Overall Study|Schedule change unable to attend sessions|0|||
161817024|NCT04194801|584370901|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
161486861|NCT00630396|583174429|FG000|Overall Study|Lost to Follow-up|3|||
161817025|NCT01604941|584370905|FG000|Overall Study|Adverse Event|1|||
161486862|NCT02990910|583174433|FG000|Overall Study|Lack of Efficacy|6|||
161486863|NCT02990910|583174434|FG001|Overall Study|Lack of Efficacy|10|||
161486864|NCT02064868|583174436|FG000|Overall Study|Lost to Follow-up|14|||
161486865|NCT02064868|583174437|FG001|Overall Study|Lost to Follow-up|8|||
161486866|NCT02064868|583174436|FG000|Overall Study|Physician Decision|1|||
161486867|NCT02064868|583174437|FG001|Overall Study|Physician Decision|0|||
161486868|NCT02064868|583174436|FG000|Overall Study|Withdrawal by Subject|14|||
161486869|NCT02064868|583174437|FG001|Overall Study|Withdrawal by Subject|3|||
161486870|NCT02064868|583174436|FG000|Overall Study|Technical Problems or Missing|5|||
161486871|NCT02064868|583174437|FG001|Overall Study|Technical Problems or Missing|2|||
161486872|NCT00482612|583174438|FG000|In-treatment Period|No study medication administered|0|||
161486873|NCT00482612|583174439|FG001|In-treatment Period|No study medication administered|0|||
161486874|NCT00482612|583174440|FG002|In-treatment Period|No study medication administered|1|||
161486875|NCT00482612|583174441|FG003|In-treatment Period|No study medication administered|0|||
161486876|NCT00482612|583174438|FG000|Follow-up Period|Other|4|||
161486877|NCT00482612|583174439|FG001|Follow-up Period|Other|2|||
161486878|NCT00482612|583174440|FG002|Follow-up Period|Other|1|||
161486879|NCT00482612|583174441|FG003|Follow-up Period|Other|2|||
161486880|NCT00482612|583174438|FG000|Follow-up Period|Lack of compliance|0|||
161486881|NCT00482612|583174439|FG001|Follow-up Period|Lack of compliance|0|||
161486882|NCT00482612|583174440|FG002|Follow-up Period|Lack of compliance|1|||
161486883|NCT00482612|583174441|FG003|Follow-up Period|Lack of compliance|0|||
161486884|NCT00482612|583174438|FG000|Follow-up Period|Lost to Follow-up|0|||
161486885|NCT00482612|583174439|FG001|Follow-up Period|Lost to Follow-up|4|||
161486886|NCT00482612|583174440|FG002|Follow-up Period|Lost to Follow-up|2|||
161486887|NCT00482612|583174441|FG003|Follow-up Period|Lost to Follow-up|1|||
161486888|NCT00482612|583174438|FG000|Follow-up Period|Adverse Event|4|||
161486889|NCT00482612|583174439|FG001|Follow-up Period|Adverse Event|7|||
161486890|NCT00482612|583174440|FG002|Follow-up Period|Adverse Event|9|||
161486891|NCT00482612|583174441|FG003|Follow-up Period|Adverse Event|0|||
161486892|NCT00482612|583174438|FG000|Follow-up Period|Lack of Efficacy|2|||
161486893|NCT00482612|583174439|FG001|Follow-up Period|Lack of Efficacy|0|||
161486894|NCT00482612|583174440|FG002|Follow-up Period|Lack of Efficacy|1|||
161486895|NCT00482612|583174441|FG003|Follow-up Period|Lack of Efficacy|0|||
161486896|NCT00482612|583174438|FG000|Follow-up Period|Withdrawal by Subject|3|||
161486897|NCT00482612|583174439|FG001|Follow-up Period|Withdrawal by Subject|5|||
161486898|NCT00482612|583174440|FG002|Follow-up Period|Withdrawal by Subject|7|||
161486899|NCT00482612|583174441|FG003|Follow-up Period|Withdrawal by Subject|2|||
161486900|NCT00482612|583174438|FG000|Follow-up Period|Reasons not related to trial|1|||
161486901|NCT00482612|583174439|FG001|Follow-up Period|Reasons not related to trial|0|||
161486902|NCT00482612|583174440|FG002|Follow-up Period|Reasons not related to trial|1|||
161486903|NCT00482612|583174441|FG003|Follow-up Period|Reasons not related to trial|3|||
161486904|NCT00660023|583174442|FG000|Overall Study|Adverse Event|2|||
161486905|NCT00660023|583174442|FG000|Overall Study|Death|8|||
161486906|NCT00660023|583174442|FG000|Overall Study|Blood Transfusion|5|||
161486907|NCT00660023|583174442|FG000|Overall Study|Renal Transplantation|3|||
161486908|NCT00660023|583174442|FG000|Overall Study|Withdrawal by Subject|1|||
161486909|NCT00660023|583174442|FG000|Overall Study|Missed Pregnancy Test|1|||
161486910|NCT00660023|583174442|FG000|Overall Study|Other Screening Failure|9|||
161486911|NCT04180488|583174444|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
161486912|NCT04180488|583174445|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
161486913|NCT04180488|583174446|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
161486914|NCT04180488|583174447|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
161486915|NCT04180488|583174448|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
161486916|NCT04180488|583174449|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
161486917|NCT04180488|583174444|FG000|Overall Study|Withdrawal by Subject|8|||
161486918|NCT04180488|583174445|FG001|Overall Study|Withdrawal by Subject|4|||
161486919|NCT04180488|583174446|FG002|Overall Study|Withdrawal by Subject|5|||
161486920|NCT04180488|583174447|FG003|Overall Study|Withdrawal by Subject|2|||
161486921|NCT04180488|583174448|FG004|Overall Study|Withdrawal by Subject|8|||
161486922|NCT04180488|583174449|FG005|Overall Study|Withdrawal by Subject|6|||
161486923|NCT04180488|583174444|FG000|Overall Study|Adverse Event|3|||
161486924|NCT04180488|583174445|FG001|Overall Study|Adverse Event|2|||
161486925|NCT04180488|583174446|FG002|Overall Study|Adverse Event|0|||
161486926|NCT04180488|583174447|FG003|Overall Study|Adverse Event|0|||
161486927|NCT04180488|583174448|FG004|Overall Study|Adverse Event|0|||
161486928|NCT04180488|583174449|FG005|Overall Study|Adverse Event|0|||
161486929|NCT04180488|583174444|FG000|Overall Study|Poor compliance to protocol|0|||
161486930|NCT04180488|583174445|FG001|Overall Study|Poor compliance to protocol|0|||
161486931|NCT04180488|583174446|FG002|Overall Study|Poor compliance to protocol|1|||
161486932|NCT04180488|583174447|FG003|Overall Study|Poor compliance to protocol|0|||
161671121|NCT03588728|583849045|FG002|Overall Study|Schedule change unable to attend sessions|0|||
161671122|NCT03588728|583849046|FG003|Overall Study|Schedule change unable to attend sessions|0|||
161671123|NCT01388790|583849047|FG000|Overall Study|Ongoing at data cut-off date|8|||
161671124|NCT03153137|583849048|FG000|Overall Study|Lost to Follow-up|1|||
161486933|NCT04180488|583174448|FG004|Overall Study|Poor compliance to protocol|0|||
161486934|NCT04180488|583174449|FG005|Overall Study|Poor compliance to protocol|0|||
161486935|NCT03506815|583174450|FG000|Overall Study|Adverse Event|8|||
161486936|NCT03506815|583174451|FG001|Overall Study|Adverse Event|0|||
161486937|NCT03506815|583174450|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
161486938|NCT03506815|583174451|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
161671125|NCT03153137|583849049|FG001|Overall Study|Lost to Follow-up|0|||
161671126|NCT03153137|583849048|FG000|Overall Study|Withdrawal by Subject|2|||
161486939|NCT03506815|583174450|FG000|Overall Study|Protocol Violation|1|||
161486940|NCT03506815|583174451|FG001|Overall Study|Protocol Violation|0|||
161486941|NCT03506815|583174450|FG000|Overall Study|Elective Surgery|1|||
161486942|NCT03506815|583174451|FG001|Overall Study|Elective Surgery|0|||
161486943|NCT01401283|583174454|FG000|Overall Study|surgery cancelled|5|||
161486944|NCT01401283|583174455|FG001|Overall Study|surgery cancelled|8|||
161486945|NCT01401283|583174454|FG000|Overall Study|preoperative arrhythmia|5|||
161671127|NCT03153137|583849049|FG001|Overall Study|Withdrawal by Subject|1|||
161671128|NCT03153137|583849048|FG000|Overall Study|Physician Decision|0|||
161671129|NCT03153137|583849049|FG001|Overall Study|Physician Decision|3|||
161671130|NCT00195507|583849050|FG000|Overall Study|Adverse Event|24|||
161671131|NCT00195507|583849051|FG001|Overall Study|Adverse Event|13|||
161671132|NCT00195507|583849050|FG000|Overall Study|Death|0|||
161671133|NCT00195507|583849051|FG001|Overall Study|Death|1|||
161671134|NCT00195507|583849050|FG000|Overall Study|Failed to Return|4|||
161671135|NCT00195507|583849051|FG001|Overall Study|Failed to Return|3|||
161671136|NCT00195507|583849050|FG000|Overall Study|Physician Decision|1|||
161671137|NCT00195507|583849051|FG001|Overall Study|Physician Decision|2|||
161671138|NCT00195507|583849050|FG000|Overall Study|Lost to Follow-up|3|||
161671139|NCT00195507|583849051|FG001|Overall Study|Lost to Follow-up|2|||
161671140|NCT00195507|583849050|FG000|Overall Study|Protocol Violation|5|||
161817026|NCT01604941|584370906|FG001|Overall Study|Adverse Event|2|||
161817027|NCT01604941|584370907|FG002|Overall Study|Adverse Event|0|||
161486946|NCT01401283|583174455|FG001|Overall Study|preoperative arrhythmia|0|||
161486947|NCT01401283|583174454|FG000|Overall Study|no central venous access|0|||
161486948|NCT01401283|583174455|FG001|Overall Study|no central venous access|1|||
161486949|NCT01401283|583174454|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
161486950|NCT01401283|583174455|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
161486951|NCT03824912|583174461|FG000|Overall Study|Lost to Follow-up|18|||
161486952|NCT03824912|583174462|FG001|Overall Study|Lost to Follow-up|15|||
161486953|NCT03824912|583174463|FG002|Overall Study|Lost to Follow-up|8|||
161582586|NCT04929483|583519698|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
161582587|NCT04929483|583519699|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
161582588|NCT04929483|583519700|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
161582589|NCT04929483|583519701|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
161582590|NCT04929483|583519702|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
161582591|NCT04929483|583519703|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
161582592|NCT04929483|583519698|FG000|Main Study (24 Weeks)|Randomized in error|0|||
161582593|NCT04929483|583519699|FG001|Main Study (24 Weeks)|Randomized in error|1|||
161582594|NCT04929483|583519700|FG002|Main Study (24 Weeks)|Randomized in error|0|||
161582595|NCT04929483|583519701|FG003|Main Study (24 Weeks)|Randomized in error|2|||
161582596|NCT04929483|583519702|FG004|Main Study (24 Weeks)|Randomized in error|0|||
161582597|NCT04929483|583519703|FG005|Main Study (24 Weeks)|Randomized in error|0|||
161582598|NCT04929483|583519698|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161582599|NCT04929483|583519699|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161582600|NCT04929483|583519700|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
161582601|NCT04929483|583519701|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161582602|NCT04929483|583519702|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
161582603|NCT04929483|583519703|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161582604|NCT04929483|583519698|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161582605|NCT04929483|583519699|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161582606|NCT04929483|583519700|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161582607|NCT04929483|583519701|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161582608|NCT04929483|583519702|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161582609|NCT04929483|583519703|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161582610|NCT04929483|583519698|FG000|Extension Study (24 Weeks)|Other than specified|1|||
161582611|NCT04929483|583519699|FG001|Extension Study (24 Weeks)|Other than specified|0|||
161582612|NCT04929483|583519700|FG002|Extension Study (24 Weeks)|Other than specified|1|||
161582613|NCT04929483|583519701|FG003|Extension Study (24 Weeks)|Other than specified|0|||
161582614|NCT04929483|583519702|FG004|Extension Study (24 Weeks)|Other than specified|1|||
161671141|NCT00195507|583849051|FG001|Overall Study|Protocol Violation|4|||
161671142|NCT00195507|583849050|FG000|Overall Study|Lack of Efficacy|40|||
161817028|NCT01604941|584370908|FG003|Overall Study|Adverse Event|0|||
161486954|NCT03824912|583174461|FG000|Overall Study|Negative Baseline Culture Result|118|||
161486955|NCT03824912|583174462|FG001|Overall Study|Negative Baseline Culture Result|112|||
161486956|NCT03824912|583174463|FG002|Overall Study|Negative Baseline Culture Result|57|||
161486957|NCT03824912|583174461|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161486958|NCT03824912|583174462|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161486959|NCT03824912|583174463|FG002|Overall Study|Non-Compliance with Study Drug|1|||
161486960|NCT03824912|583174461|FG000|Overall Study|Protocol Violation|1|||
161486961|NCT03824912|583174462|FG001|Overall Study|Protocol Violation|4|||
161486962|NCT03824912|583174463|FG002|Overall Study|Protocol Violation|1|||
161486963|NCT03824912|583174461|FG000|Overall Study|Withdrawal by Subject|3|||
161486964|NCT03824912|583174462|FG001|Overall Study|Withdrawal by Subject|2|||
161486965|NCT03824912|583174463|FG002|Overall Study|Withdrawal by Subject|1|||
161486966|NCT03824912|583174461|FG000|Overall Study|Participation in another study|0|||
161486967|NCT03824912|583174462|FG001|Overall Study|Participation in another study|1|||
161486968|NCT03824912|583174463|FG002|Overall Study|Participation in another study|0|||
161486969|NCT04271605|583174464|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
161486970|NCT00105482|583174479|FG000|Overall Study|Adverse Event|1|||
161486971|NCT00105482|583174480|FG001|Overall Study|Adverse Event|1|||
161486972|NCT00105482|583174479|FG000|Overall Study|Lost to Follow-up|26|||
161486973|NCT00105482|583174480|FG001|Overall Study|Lost to Follow-up|17|||
161486974|NCT00105482|583174479|FG000|Overall Study|Withdrawal by Subject|0|||
161486975|NCT00105482|583174480|FG001|Overall Study|Withdrawal by Subject|1|||
161486976|NCT00105482|583174479|FG000|Overall Study|Lost Interest|29|||
161486977|NCT00105482|583174480|FG001|Overall Study|Lost Interest|32|||
161486978|NCT00105482|583174479|FG000|Overall Study|Scheduling Conflict|2|||
161486979|NCT00105482|583174480|FG001|Overall Study|Scheduling Conflict|3|||
161486980|NCT00105482|583174479|FG000|Overall Study|Withdrawn by PI|1|||
161486981|NCT00105482|583174480|FG001|Overall Study|Withdrawn by PI|1|||
161486982|NCT00644995|583174486|FG000|Overall Study|Lost to Follow-up|1|||
161486983|NCT00644995|583174487|FG001|Overall Study|Lost to Follow-up|4|||
161486984|NCT00644995|583174486|FG000|Overall Study|Refused|1|||
161486985|NCT00644995|583174487|FG001|Overall Study|Refused|0|||
161486986|NCT03247530|583174488|FG000|Overall Study|Withdrawal by caregiver|19|||
161486987|NCT03247530|583174489|FG001|Overall Study|Withdrawal by caregiver|8|||
161486988|NCT03247530|583174490|FG002|Overall Study|Withdrawal by caregiver|10|||
161486989|NCT03247530|583174488|FG000|Overall Study|Lost to Follow-up|3|||
161486990|NCT03247530|583174489|FG001|Overall Study|Lost to Follow-up|9|||
161486991|NCT03247530|583174490|FG002|Overall Study|Lost to Follow-up|6|||
161486992|NCT03247530|583174488|FG000|Overall Study|Adverse Event|2|||
161486993|NCT03247530|583174489|FG001|Overall Study|Adverse Event|5|||
161486994|NCT03247530|583174490|FG002|Overall Study|Adverse Event|2|||
161671143|NCT00195507|583849051|FG001|Overall Study|Lack of Efficacy|67|||
161671144|NCT00195507|583849050|FG000|Overall Study|Withdrawal by Subject|16|||
161486995|NCT03247530|583174488|FG000|Overall Study|Failure to follow procedure|1|||
161486996|NCT03247530|583174489|FG001|Overall Study|Failure to follow procedure|1|||
161486997|NCT03247530|583174490|FG002|Overall Study|Failure to follow procedure|1|||
161486998|NCT03247530|583174488|FG000|Overall Study|Withdrawal by Subject|1|||
161486999|NCT03247530|583174489|FG001|Overall Study|Withdrawal by Subject|1|||
161487000|NCT03247530|583174490|FG002|Overall Study|Withdrawal by Subject|0|||
161487001|NCT03247530|583174488|FG000|Overall Study|Study medication misuse|0|||
161487002|NCT03247530|583174489|FG001|Overall Study|Study medication misuse|1|||
161487003|NCT03247530|583174490|FG002|Overall Study|Study medication misuse|0|||
161487004|NCT03247530|583174488|FG000|Overall Study|Other, multiple categories|1|||
161487005|NCT03247530|583174489|FG001|Overall Study|Other, multiple categories|3|||
161487006|NCT03247530|583174490|FG002|Overall Study|Other, multiple categories|1|||
161487007|NCT01587001|583174491|FG000|Overall Study|Lost to Follow-up|2|||
161487008|NCT01587001|583174492|FG001|Overall Study|Lost to Follow-up|0|||
161487009|NCT01587001|583174491|FG000|Overall Study|Insufficient samples to complete testing|4|||
161487010|NCT01587001|583174492|FG001|Overall Study|Insufficient samples to complete testing|1|||
161487011|NCT04786990|583174493|FG000|Overall Study|Withdrawal by Subject|1|||
161487012|NCT04786990|583174493|FG000|Overall Study|Adverse Event|1|||
161487013|NCT04786990|583174493|FG000|Overall Study|Lost to Follow-up|1|||
161487014|NCT04786990|583174493|FG000|Overall Study|Noncompliance|1|||
161487015|NCT04786990|583174493|FG000|Overall Study|Unable to complete site visits|1|||
161487016|NCT04786990|583174493|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161487017|NCT02846779|583174497|FG000|Overall Study|Lost Enrollment|83|||
161487018|NCT02846779|583174498|FG001|Overall Study|Lost Enrollment|82|||
161487019|NCT02846779|583174499|FG002|Overall Study|Lost Enrollment|86|||
161487020|NCT02846779|583174497|FG000|Overall Study|Less than 31 days of follow-up|56|||
161487021|NCT02846779|583174498|FG001|Overall Study|Less than 31 days of follow-up|45|||
161487022|NCT02846779|583174499|FG002|Overall Study|Less than 31 days of follow-up|52|||
161487023|NCT00887978|583174502|FG000|Overall Study|Adverse Event|18|||
161817029|NCT01604941|584370909|FG004|Overall Study|Adverse Event|1|||
161487024|NCT00887978|583174503|FG001|Overall Study|Adverse Event|5|||
161487025|NCT00887978|583174502|FG000|Overall Study|Clinical Worsening|4|||
161487026|NCT00887978|583174503|FG001|Overall Study|Clinical Worsening|4|||
161671145|NCT00195507|583849051|FG001|Overall Study|Withdrawal by Subject|23|||
161671146|NCT00195507|583849050|FG000|Overall Study|Protocol Deviation|6|||
161671147|NCT00195507|583849051|FG001|Overall Study|Protocol Deviation|3|||
161671148|NCT00528866|583849052|FG000|Overall Study|Protocol Violation|6|||
161671149|NCT00993915|583849053|FG000|Overall Study|Insufficient clinical response|3|||
161671150|NCT00993915|583849053|FG000|Overall Study|Withdrawal by Subject|2|||
161671151|NCT00993915|583849053|FG000|Overall Study|Other|1|||
161671152|NCT00993915|583849053|FG000|Overall Study|Ongoing|3|||
161671153|NCT01386658|583849054|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
161671154|NCT01386658|583849055|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
161671155|NCT01386658|583849054|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
161671156|NCT01386658|583849055|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
161671157|NCT02465463|583849056|FG000|Overall Study|Lost to Follow-up|2|||
161671158|NCT02465463|583849057|FG001|Overall Study|Lost to Follow-up|1|||
161671159|NCT02465463|583849056|FG000|Overall Study|Death|1|||
161671160|NCT02465463|583849057|FG001|Overall Study|Death|0|||
161487027|NCT00887978|583174502|FG000|Overall Study|Death|2|||
161487028|NCT00887978|583174503|FG001|Overall Study|Death|3|||
161487029|NCT00887978|583174502|FG000|Overall Study|Withdrawal by Subject|1|||
161487030|NCT00887978|583174503|FG001|Overall Study|Withdrawal by Subject|2|||
161487031|NCT00887978|583174502|FG000|Overall Study|Lost to Follow-up|0|||
161487032|NCT00887978|583174503|FG001|Overall Study|Lost to Follow-up|1|||
161487033|NCT05353985|583174506|FG000|Overall Study|Adverse Event|5|||
161487034|NCT05353985|583174507|FG001|Overall Study|Adverse Event|7|||
161487035|NCT05353985|583174506|FG000|Overall Study|Lost to Follow-up|1|||
161487036|NCT05353985|583174507|FG001|Overall Study|Lost to Follow-up|1|||
161487037|NCT05353985|583174506|FG000|Overall Study|Protocol Violation|1|||
161487038|NCT05353985|583174507|FG001|Overall Study|Protocol Violation|0|||
161487039|NCT05353985|583174506|FG000|Overall Study|Withdrawal by Subject|13|||
161487040|NCT05353985|583174507|FG001|Overall Study|Withdrawal by Subject|17|||
161487041|NCT05353985|583174506|FG000|Overall Study|Reason Not Specified|1|||
161487042|NCT05353985|583174507|FG001|Overall Study|Reason Not Specified|0|||
161487043|NCT05353985|583174506|FG000|Overall Study|Randomized in Error & Not Treated|0|||
161487044|NCT05353985|583174507|FG001|Overall Study|Randomized in Error & Not Treated|1|||
161487045|NCT00410046|583175865|FG000|Overall Study|Adverse Event|3|||
161487046|NCT00410046|583175865|FG000|Overall Study|Withdrawal by Subject|1|||
161487047|NCT00410046|583175865|FG000|Overall Study|Lost to Follow-up|1|||
161487048|NCT02310568|583175868|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
161487049|NCT02310568|583175869|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
161487050|NCT02310568|583175870|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
161487051|NCT02310568|583175871|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
161487052|NCT02310568|583175872|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
161487053|NCT02310568|583175868|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
161487054|NCT02310568|583175869|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
161487055|NCT02310568|583175870|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
161487056|NCT02310568|583175871|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
161487057|NCT02310568|583175872|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
161487058|NCT02310568|583175868|FG000|Stage 1 ( 4 Weeks)|Other|1|||
161671161|NCT02465463|583849056|FG000|Overall Study|Protocol Violation|1|||
161671162|NCT02465463|583849057|FG001|Overall Study|Protocol Violation|0|||
161671163|NCT01067326|583849062|FG000|Overall Study|Adverse Event|0|||
161671164|NCT01067326|583849063|FG001|Overall Study|Adverse Event|2|||
161487059|NCT02310568|583175869|FG001|Stage 1 ( 4 Weeks)|Other|1|||
161487060|NCT02310568|583175870|FG002|Stage 1 ( 4 Weeks)|Other|0|||
161487061|NCT02310568|583175871|FG003|Stage 1 ( 4 Weeks)|Other|0|||
161487062|NCT02310568|583175872|FG004|Stage 1 ( 4 Weeks)|Other|0|||
161487063|NCT02310568|583175868|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
161487064|NCT02310568|583175869|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
161487065|NCT02310568|583175870|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
161487066|NCT02310568|583175871|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
161487067|NCT02310568|583175872|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
161487068|NCT02310568|583175868|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
161671165|NCT01067326|583849062|FG000|Overall Study|Withdrawal by Subject|1|||
161671166|NCT01067326|583849063|FG001|Overall Study|Withdrawal by Subject|0|||
161671167|NCT01067326|583849062|FG000|Overall Study|Early Study Termination|1|||
161487069|NCT02310568|583175869|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
161487070|NCT02310568|583175870|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
161487071|NCT02310568|583175871|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
161487072|NCT02310568|583175872|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
161671168|NCT01067326|583849063|FG001|Overall Study|Early Study Termination|1|||
161487073|NCT02310568|583175868|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
161487074|NCT02310568|583175869|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
161487075|NCT02310568|583175870|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
161487076|NCT02310568|583175871|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
161671169|NCT03026127|583849072|FG000|CRISP R61|Adverse Event|5|||
161671170|NCT03026127|583849073|FG001|CRISP R61|Adverse Event|0|||
161671171|NCT03026127|583849074|FG002|CRISP R61|Adverse Event|0|||
161487077|NCT02310568|583175872|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
161487078|NCT02310568|583175868|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
161487079|NCT02310568|583175869|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
161487080|NCT02310568|583175870|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
161487081|NCT02310568|583175871|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
161487082|NCT02310568|583175872|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
161487083|NCT02310568|583175868|FG000|Stage 2 (4 Weeks)|Other|0|||
161487084|NCT02310568|583175869|FG001|Stage 2 (4 Weeks)|Other|1|||
161487085|NCT02310568|583175870|FG002|Stage 2 (4 Weeks)|Other|1|||
161487086|NCT02310568|583175871|FG003|Stage 2 (4 Weeks)|Other|0|||
161487087|NCT02310568|583175872|FG004|Stage 2 (4 Weeks)|Other|0|||
161487088|NCT02310568|583175868|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
161487089|NCT02310568|583175869|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
161487090|NCT02310568|583175870|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
161487091|NCT02310568|583175871|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
161487092|NCT02310568|583175872|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
161487093|NCT02310568|583175868|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
161487094|NCT02310568|583175869|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
161487095|NCT02310568|583175870|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
161487096|NCT02310568|583175871|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
161487097|NCT02310568|583175872|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
161487098|NCT02310568|583175868|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
161487099|NCT02310568|583175869|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
161487100|NCT02310568|583175870|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
161487101|NCT02310568|583175871|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
161487102|NCT02310568|583175872|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
161487103|NCT02989194|583175877|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
161487104|NCT02989194|583175878|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
161487105|NCT02989194|583175879|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
161487106|NCT02989194|583175877|FG000|Overall Study|Lost to Follow-up|0|||
161487107|NCT02989194|583175878|FG001|Overall Study|Lost to Follow-up|1|||
161487108|NCT02989194|583175879|FG002|Overall Study|Lost to Follow-up|0|||
161487109|NCT02989194|583175877|FG000|Overall Study|Withdrawal by Subject|0|||
161487110|NCT02989194|583175878|FG001|Overall Study|Withdrawal by Subject|1|||
161487111|NCT02989194|583175879|FG002|Overall Study|Withdrawal by Subject|0|||
161487112|NCT04160091|583175882|FG000|Overall Study|Terminated by Sponsor|7|||
161487113|NCT04160091|583175883|FG001|Overall Study|Terminated by Sponsor|3|||
161487114|NCT04160091|583175884|FG002|Overall Study|Terminated by Sponsor|5|||
161487115|NCT04160091|583175885|FG003|Overall Study|Terminated by Sponsor|2|||
161487116|NCT04160091|583175882|FG000|Overall Study|Noncompliance|0|||
161487117|NCT04160091|583175883|FG001|Overall Study|Noncompliance|0|||
161487118|NCT04160091|583175884|FG002|Overall Study|Noncompliance|0|||
161487119|NCT04160091|583175885|FG003|Overall Study|Noncompliance|1|||
161487120|NCT04160091|583175882|FG000|Overall Study|Withdrawal by Subject|0|||
161487121|NCT04160091|583175883|FG001|Overall Study|Withdrawal by Subject|0|||
161487122|NCT04160091|583175884|FG002|Overall Study|Withdrawal by Subject|0|||
161487123|NCT04160091|583175885|FG003|Overall Study|Withdrawal by Subject|1|||
161487124|NCT00609492|583175888|FG000|Overall Study|Withdrawal by Subject|0|||
161487125|NCT00609492|583175889|FG001|Overall Study|Withdrawal by Subject|2|||
161487126|NCT00609492|583175890|FG002|Overall Study|Withdrawal by Subject|3|||
161487127|NCT00609492|583175888|FG000|Overall Study|Lost to Follow-up|1|||
161487128|NCT00609492|583175889|FG001|Overall Study|Lost to Follow-up|1|||
161487129|NCT00609492|583175890|FG002|Overall Study|Lost to Follow-up|4|||
161487130|NCT02057406|583175891|FG000|Overall Study|Physician Decision|0|||
161487131|NCT02057406|583175892|FG001|Overall Study|Physician Decision|0|||
161487132|NCT02057406|583175893|FG002|Overall Study|Physician Decision|2|||
161487133|NCT02057406|583175891|FG000|Overall Study|Withdrawal by Subject|0|||
161487134|NCT02057406|583175892|FG001|Overall Study|Withdrawal by Subject|2|||
161487135|NCT02057406|583175893|FG002|Overall Study|Withdrawal by Subject|0|||
161487136|NCT02057406|583175891|FG000|Overall Study|Lost to Follow-up|0|||
161487137|NCT02057406|583175892|FG001|Overall Study|Lost to Follow-up|0|||
161487138|NCT02057406|583175893|FG002|Overall Study|Lost to Follow-up|1|||
161487139|NCT02057406|583175891|FG000|Overall Study|Death|1|||
161487140|NCT02057406|583175892|FG001|Overall Study|Death|0|||
161487141|NCT02057406|583175893|FG002|Overall Study|Death|0|||
161487142|NCT02057406|583175891|FG000|Overall Study|Protocol Violation|0|||
161487143|NCT02057406|583175892|FG001|Overall Study|Protocol Violation|1|||
161487144|NCT02057406|583175893|FG002|Overall Study|Protocol Violation|0|||
161487145|NCT02057406|583175891|FG000|Overall Study|Patient transportation issues|0|||
161487146|NCT02057406|583175892|FG001|Overall Study|Patient transportation issues|0|||
161487147|NCT02057406|583175893|FG002|Overall Study|Patient transportation issues|1|||
161487148|NCT01224431|583175894|FG000|Overall Study|not randomized|0|||
161582615|NCT04929483|583519703|FG005|Extension Study (24 Weeks)|Other than specified|0|||
161582616|NCT04929483|583519698|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
161582617|NCT04929483|583519699|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
161582618|NCT04929483|583519700|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
161582619|NCT04929483|583519701|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
161487149|NCT01224431|583175895|FG001|Overall Study|not randomized|4|||
161487150|NCT01224431|583175894|FG000|Overall Study|no video record|0|||
161487151|NCT01224431|583175895|FG001|Overall Study|no video record|1|||
161487152|NCT02433483|583175896|FG000|Overall Study|Unacceptable toxicity|1|||
161487153|NCT02433483|583175896|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
161487154|NCT00549302|583175905|FG000|Double-Blind|Death|2|||
161487155|NCT00549302|583175906|FG001|Double-Blind|Death|9|||
161487156|NCT00549302|583175907|FG002|Double-Blind|Death|0|||
161487157|NCT00549302|583175905|FG000|Double-Blind|Adverse Event|3|||
161487158|NCT00549302|583175906|FG001|Double-Blind|Adverse Event|16|||
161487159|NCT00549302|583175907|FG002|Double-Blind|Adverse Event|0|||
161487160|NCT00549302|583175905|FG000|Double-Blind|Withdrawal by Subject|3|||
161487161|NCT00549302|583175906|FG001|Double-Blind|Withdrawal by Subject|8|||
161487162|NCT00549302|583175907|FG002|Double-Blind|Withdrawal by Subject|0|||
161487163|NCT00549302|583175905|FG000|Double-Blind|Investigator Decision|1|||
161487164|NCT00549302|583175906|FG001|Double-Blind|Investigator Decision|5|||
161487165|NCT00549302|583175907|FG002|Double-Blind|Investigator Decision|0|||
161487166|NCT00549302|583175905|FG000|Double-Blind|Sponsor Decision|0|||
161487167|NCT00549302|583175906|FG001|Double-Blind|Sponsor Decision|1|||
161487168|NCT00549302|583175907|FG002|Double-Blind|Sponsor Decision|0|||
161487169|NCT00549302|583175905|FG000|Double-Blind|Lost to Follow-up|1|||
161487170|NCT00549302|583175906|FG001|Double-Blind|Lost to Follow-up|2|||
161487171|NCT00549302|583175907|FG002|Double-Blind|Lost to Follow-up|0|||
161487172|NCT00549302|583175905|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
161487173|NCT00549302|583175906|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
161487174|NCT00549302|583175907|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
161487175|NCT00549302|583175905|FG000|Double-Blind|New condition or starts new therapy|0|||
161487176|NCT00549302|583175906|FG001|Double-Blind|New condition or starts new therapy|2|||
161487177|NCT00549302|583175907|FG002|Double-Blind|New condition or starts new therapy|0|||
161487178|NCT00549302|583175905|FG000|Open-Label|Adverse Event|0|||
161487179|NCT00549302|583175906|FG001|Open-Label|Adverse Event|0|||
161487180|NCT00549302|583175907|FG002|Open-Label|Adverse Event|11|||
161671172|NCT03026127|583849072|FG000|CRISP R61|Lost to Follow-up|2|||
161487181|NCT00549302|583175905|FG000|Open-Label|Death|0|||
161487182|NCT00549302|583175906|FG001|Open-Label|Death|0|||
161487183|NCT00549302|583175907|FG002|Open-Label|Death|40|||
161487184|NCT00549302|583175905|FG000|Open-Label|Investigator Decision|0|||
161487185|NCT00549302|583175906|FG001|Open-Label|Investigator Decision|0|||
161487186|NCT00549302|583175907|FG002|Open-Label|Investigator Decision|5|||
161487187|NCT00549302|583175905|FG000|Open-Label|Lost to Follow-up|0|||
161487188|NCT00549302|583175906|FG001|Open-Label|Lost to Follow-up|0|||
161487189|NCT00549302|583175907|FG002|Open-Label|Lost to Follow-up|2|||
161487190|NCT00549302|583175905|FG000|Open-Label|Other|0|||
161487191|NCT00549302|583175906|FG001|Open-Label|Other|0|||
161487192|NCT00549302|583175907|FG002|Open-Label|Other|3|||
161487193|NCT00549302|583175905|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
161487194|NCT00549302|583175906|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
161487195|NCT00549302|583175907|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
161487196|NCT00549302|583175905|FG000|Open-Label|Withdrawal by Subject|0|||
161487197|NCT00549302|583175906|FG001|Open-Label|Withdrawal by Subject|0|||
161487198|NCT00549302|583175907|FG002|Open-Label|Withdrawal by Subject|6|||
161487199|NCT01414114|583175908|FG000|Overall Study|Adverse Event|2|||
161487200|NCT01414114|583175908|FG000|Overall Study|Withdrawal by Subject|1|||
161487201|NCT01414114|583175908|FG000|Overall Study|Other|2|||
161487202|NCT05620563|583175909|FG000|Overall Study|Adverse Event|3|||
161487203|NCT05620563|583175910|FG001|Overall Study|Adverse Event|1|||
161487204|NCT05620563|583175909|FG000|Overall Study|Lost to Follow-up|0|||
161487205|NCT05620563|583175910|FG001|Overall Study|Lost to Follow-up|2|||
161487206|NCT05620563|583175909|FG000|Overall Study|Protocol Deviation|1|||
161487207|NCT05620563|583175910|FG001|Overall Study|Protocol Deviation|2|||
161487208|NCT05620563|583175909|FG000|Overall Study|Withdrawal by Subject|3|||
161487209|NCT05620563|583175910|FG001|Overall Study|Withdrawal by Subject|3|||
161487210|NCT05620563|583175909|FG000|Overall Study|Physician Decision|0|||
161487211|NCT05620563|583175910|FG001|Overall Study|Physician Decision|1|||
161487212|NCT00865124|583175911|FG000|Overall Study|Physician Decision|2|||
161487213|NCT00865124|583175912|FG001|Overall Study|Physician Decision|1|||
161487214|NCT00865124|583175913|FG002|Overall Study|Physician Decision|0|||
161487215|NCT00865124|583175911|FG000|Overall Study|Withdrawn consent|2|||
161487216|NCT00865124|583175912|FG001|Overall Study|Withdrawn consent|0|||
161487217|NCT00865124|583175913|FG002|Overall Study|Withdrawn consent|0|||
161487218|NCT02743520|583175914|FG000|Overall Study|Withdrawal by Subject|1|||
161487219|NCT02547649|583175918|FG000|Overall Study|Lost to Follow-up|3|||
161487220|NCT02547649|583175919|FG001|Overall Study|Lost to Follow-up|1|||
161671173|NCT03026127|583849073|FG001|CRISP R61|Lost to Follow-up|0|||
161487221|NCT02547649|583175920|FG002|Overall Study|Lost to Follow-up|1|||
161487222|NCT02547649|583175918|FG000|Overall Study|Not vaccinated|0|||
161487223|NCT02547649|583175919|FG001|Overall Study|Not vaccinated|0|||
161487224|NCT02547649|583175920|FG002|Overall Study|Not vaccinated|1|||
161487225|NCT02547649|583175918|FG000|Overall Study|Withdrawal by Subject|0|||
161487226|NCT02547649|583175919|FG001|Overall Study|Withdrawal by Subject|4|||
161487227|NCT02547649|583175920|FG002|Overall Study|Withdrawal by Subject|2|||
161487228|NCT03454997|583175921|FG000|Overall Study|Staff Coach - Left Oranization|1|||
161487229|NCT03454997|583175922|FG001|Overall Study|Staff Coach - Left Oranization|1|||
161487230|NCT03454997|583175921|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
161487231|NCT03454997|583175922|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
161487232|NCT03454997|583175921|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
161487233|NCT03454997|583175922|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
161487234|NCT03454997|583175921|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
161487235|NCT03454997|583175922|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
161487236|NCT03454997|583175921|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
161487237|NCT03454997|583175922|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
161487238|NCT03454997|583175921|FG000|Overall Study|Client with SMI - Left organization|0|||
161487239|NCT03454997|583175922|FG001|Overall Study|Client with SMI - Left organization|1|||
161487240|NCT03454997|583175921|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
161487241|NCT03454997|583175922|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
161487242|NCT01111149|583175927|FG000|Overall Study|Protocol Violation|1|||
161487243|NCT01111149|583175928|FG001|Overall Study|Protocol Violation|1|||
161487244|NCT01111149|583175929|FG002|Overall Study|Protocol Violation|2|||
161487245|NCT01111149|583175927|FG000|Overall Study|Withdrawal by Subject|1|||
161487246|NCT01111149|583175928|FG001|Overall Study|Withdrawal by Subject|0|||
161487247|NCT01111149|583175929|FG002|Overall Study|Withdrawal by Subject|2|||
161487248|NCT00006903|583175934|FG000|Overall Study|Still receiving treatment|0|||
161487249|NCT00006903|583175935|FG001|Overall Study|Still receiving treatment|0|||
161487250|NCT00006903|583175936|FG002|Overall Study|Still receiving treatment|1|||
161487251|NCT00006903|583175934|FG000|Overall Study|Refused further treatment|0|||
161487252|NCT00006903|583175935|FG001|Overall Study|Refused further treatment|2|||
161487253|NCT00006903|583175936|FG002|Overall Study|Refused further treatment|1|||
161487254|NCT00006903|583175934|FG000|Overall Study|Adverse Event|0|||
161487255|NCT00006903|583175935|FG001|Overall Study|Adverse Event|0|||
161487256|NCT00006903|583175936|FG002|Overall Study|Adverse Event|1|||
161487257|NCT00006903|583175934|FG000|Overall Study|Death|0|||
161487258|NCT00006903|583175935|FG001|Overall Study|Death|1|||
161487259|NCT00006903|583175936|FG002|Overall Study|Death|0|||
161487260|NCT00006903|583175934|FG000|Overall Study|Patient never treated|0|||
161487261|NCT00006903|583175935|FG001|Overall Study|Patient never treated|0|||
161487262|NCT00006903|583175936|FG002|Overall Study|Patient never treated|1|||
161487263|NCT00006903|583175934|FG000|Overall Study|Ineligible|10|||
161487264|NCT00006903|583175935|FG001|Overall Study|Ineligible|1|||
161487265|NCT00006903|583175936|FG002|Overall Study|Ineligible|2|||
161487266|NCT01909674|583175937|FG000|Overall Study|Withdrawal by Subject|5|||
161487267|NCT01909674|583175938|FG001|Overall Study|Withdrawal by Subject|2|||
161487268|NCT02794883|583175939|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
161487269|NCT02794883|583175940|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
161487270|NCT02794883|583175941|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
161487271|NCT02794883|583175939|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
161487272|NCT02794883|583175940|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
161487273|NCT02794883|583175941|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
161487274|NCT02794883|583175939|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
161487275|NCT02794883|583175940|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
161487276|NCT02794883|583175941|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
161487277|NCT02794883|583175939|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
161487278|NCT02794883|583175940|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
161487279|NCT02794883|583175941|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
161487280|NCT02794883|583175939|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
161487281|NCT02794883|583175940|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
161487282|NCT02794883|583175941|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
161487283|NCT02794883|583175939|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
161487284|NCT02794883|583175940|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
161487285|NCT02794883|583175941|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
161487286|NCT02794883|583175939|FG000|Follow-up Period (up to 2 Years)|Death|12|||
161487287|NCT02794883|583175940|FG001|Follow-up Period (up to 2 Years)|Death|10|||
161487288|NCT02794883|583175941|FG002|Follow-up Period (up to 2 Years)|Death|10|||
161487289|NCT01678911|583175945|FG000|Second Intervention|Lost to Follow-up|2|||
161487290|NCT01678911|583175946|FG001|Second Intervention|Lost to Follow-up|0|||
161487291|NCT01906008|583175947|FG000|Overall Study|Lost to Follow-up|2|||
161487292|NCT01906008|583175948|FG001|Overall Study|Lost to Follow-up|0|||
161487293|NCT01906008|583175947|FG000|Overall Study|Oxaliplatin toxicity|2|||
161487294|NCT01906008|583175948|FG001|Overall Study|Oxaliplatin toxicity|0|||
161487295|NCT01906008|583175947|FG000|Overall Study|Protocol Violation|0|||
161487296|NCT01906008|583175948|FG001|Overall Study|Protocol Violation|1|||
161487297|NCT01906008|583175947|FG000|Overall Study|Withdrawal by Subject|1|||
161487298|NCT01906008|583175948|FG001|Overall Study|Withdrawal by Subject|5|||
161487299|NCT01906008|583175947|FG000|Overall Study|Did not start study med|3|||
161487300|NCT01906008|583175948|FG001|Overall Study|Did not start study med|4|||
161487301|NCT01906008|583175947|FG000|Overall Study|Oxaliplatin stops|10|||
161487302|NCT01906008|583175948|FG001|Overall Study|Oxaliplatin stops|8|||
161487303|NCT01906008|583175947|FG000|Overall Study|Hospice|1|||
161582620|NCT04929483|583519702|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
161582621|NCT04929483|583519703|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
161582622|NCT01626885|583519704|FG000|Overall Study|Adverse Event|8|||
161582623|NCT01626885|583519704|FG000|Overall Study|Withdrawal by Subject|4|||
161582624|NCT04083781|583519711|FG000|Main Part|Physician Decision|0|||
161582625|NCT04083781|583519712|FG001|Main Part|Physician Decision|1|||
161582626|NCT04083781|583519713|FG002|Main Part|Physician Decision|2|||
161582627|NCT04083781|583519714|FG003|Main Part|Physician Decision|0|||
161582628|NCT04083781|583519711|FG000|Main Part|Death|1|||
161582629|NCT04083781|583519712|FG001|Main Part|Death|3|||
161582630|NCT04083781|583519713|FG002|Main Part|Death|1|||
161582631|NCT04083781|583519714|FG003|Main Part|Death|0|||
161582632|NCT04083781|583519711|FG000|Main Part|Withdrawal by Subject|5|||
161582633|NCT04083781|583519712|FG001|Main Part|Withdrawal by Subject|2|||
161582634|NCT04083781|583519713|FG002|Main Part|Withdrawal by Subject|3|||
161582635|NCT04083781|583519714|FG003|Main Part|Withdrawal by Subject|7|||
161582636|NCT04083781|583519711|FG000|Extension Part|Physician Decision|0|||
161582637|NCT04083781|583519712|FG001|Extension Part|Physician Decision|0|||
161582638|NCT04083781|583519713|FG002|Extension Part|Physician Decision|0|||
161582639|NCT04083781|583519714|FG003|Extension Part|Physician Decision|1|||
161582640|NCT04083781|583519711|FG000|Extension Part|Death|0|||
161582641|NCT04083781|583519712|FG001|Extension Part|Death|1|||
161582642|NCT04083781|583519713|FG002|Extension Part|Death|0|||
161582643|NCT04083781|583519714|FG003|Extension Part|Death|1|||
161582644|NCT04083781|583519711|FG000|Extension Part|Withdrawal by Subject|0|||
161582645|NCT04083781|583519712|FG001|Extension Part|Withdrawal by Subject|1|||
161582646|NCT04083781|583519713|FG002|Extension Part|Withdrawal by Subject|0|||
161582647|NCT04083781|583519714|FG003|Extension Part|Withdrawal by Subject|0|||
161582648|NCT04083781|583519711|FG000|Extension Part|Ongoing|13|||
161582649|NCT04083781|583519712|FG001|Extension Part|Ongoing|25|||
161582650|NCT04083781|583519713|FG002|Extension Part|Ongoing|15|||
161582651|NCT04083781|583519714|FG003|Extension Part|Ongoing|51|||
161582652|NCT01143337|583519715|FG000|Overall Study|Adverse Event|3|||
161582653|NCT01143337|583519716|FG001|Overall Study|Adverse Event|9|||
161582654|NCT01143337|583519717|FG002|Overall Study|Adverse Event|5|||
161582655|NCT01143337|583519715|FG000|Overall Study|Lack of Efficacy|6|||
161582656|NCT01143337|583519716|FG001|Overall Study|Lack of Efficacy|2|||
161582657|NCT01143337|583519717|FG002|Overall Study|Lack of Efficacy|1|||
161582658|NCT01143337|583519715|FG000|Overall Study|Protocol Violation|1|||
161582659|NCT01143337|583519716|FG001|Overall Study|Protocol Violation|0|||
161582660|NCT01143337|583519717|FG002|Overall Study|Protocol Violation|0|||
161582661|NCT01143337|583519715|FG000|Overall Study|Withdrawal by Subject|0|||
161582662|NCT01143337|583519716|FG001|Overall Study|Withdrawal by Subject|0|||
161582663|NCT01143337|583519717|FG002|Overall Study|Withdrawal by Subject|1|||
161582664|NCT01143337|583519715|FG000|Overall Study|Other reason|0|||
161582665|NCT01143337|583519716|FG001|Overall Study|Other reason|0|||
161582666|NCT01143337|583519717|FG002|Overall Study|Other reason|5|||
161582667|NCT01466192|583519718|FG000|Overall Study|Physician Decision|1|||
161582668|NCT01466192|583519718|FG000|Overall Study|Withdrawal by Subject|3|||
161582669|NCT05600283|583519719|FG000|Overall Study|Withdrawal by Subject|3|||
161487304|NCT01906008|583175948|FG001|Overall Study|Hospice|0|||
161487305|NCT01906008|583175947|FG000|Overall Study|Physician Decision|3|||
161487306|NCT01906008|583175948|FG001|Overall Study|Physician Decision|3|||
161487307|NCT01906008|583175947|FG000|Overall Study|Lack of compliance of study med|5|||
161487308|NCT01906008|583175948|FG001|Overall Study|Lack of compliance of study med|3|||
161487309|NCT01906008|583175947|FG000|Overall Study|Adverse Event|0|||
161487310|NCT01906008|583175948|FG001|Overall Study|Adverse Event|3|||
161487311|NCT02117648|583175949|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
161487312|NCT02117648|583175949|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
161487313|NCT02117648|583175949|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
161487314|NCT02117648|583175949|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
161487315|NCT02117648|583175949|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
161487316|NCT02117648|583175949|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
161487317|NCT02117648|583175949|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
161487318|NCT02117648|583175949|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
161487319|NCT02117648|583175949|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
161487320|NCT02117648|583175949|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
161487321|NCT02117648|583175949|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
161487322|NCT05025241|583175951|FG000|Screening|Failed Screening|5|||
161487323|NCT05025241|583175951|FG000|Treatment and Follow Up|Adverse Event|3|||
161487324|NCT02670837|583175952|FG000|Overall Study|Death|2|||
161487325|NCT02670837|583175953|FG001|Overall Study|Death|0|||
161487326|NCT02670837|583175954|FG002|Overall Study|Death|0|||
161487327|NCT02220205|583175955|FG000|Overall Study|Withdrawal by Subject|1|||
161487328|NCT02220205|583175956|FG001|Overall Study|Withdrawal by Subject|0|||
161487329|NCT02266225|583175957|FG000|Overall Study|Lost to Follow-up|2|||
161487330|NCT02266225|583175957|FG000|Overall Study|Death|1|||
161487331|NCT02266225|583175957|FG000|Overall Study|Withdrawal by Subject|13|||
161487332|NCT01574326|583175958|FG000|Overall Study|Randomized but not treated|0|||
161487333|NCT01574326|583175959|FG001|Overall Study|Randomized but not treated|1|||
161487334|NCT01574326|583175958|FG000|Overall Study|Withdrawal by Participant|2|||
161487335|NCT01574326|583175959|FG001|Overall Study|Withdrawal by Participant|4|||
161487336|NCT01574326|583175958|FG000|Overall Study|Physician Decision|5|||
161487337|NCT01574326|583175959|FG001|Overall Study|Physician Decision|3|||
161487338|NCT01574326|583175958|FG000|Overall Study|Adverse Event|1|||
161487339|NCT01574326|583175959|FG001|Overall Study|Adverse Event|3|||
161487340|NCT01574326|583175958|FG000|Overall Study|Other: Mainly kidney transplant|8|||
161487341|NCT01574326|583175959|FG001|Overall Study|Other: Mainly kidney transplant|8|||
161487342|NCT00137046|583175960|FG000|Overall Study|Death|2|||
161487343|NCT00137046|583175961|FG001|Overall Study|Death|1|||
161487344|NCT00137046|583175960|FG000|Overall Study|Adverse Event|16|||
161582670|NCT05600283|583519720|FG001|Overall Study|Withdrawal by Subject|8|||
161582671|NCT05600283|583519719|FG000|Overall Study|Invalid Vaginal Swab|2|||
161582672|NCT05600283|583519720|FG001|Overall Study|Invalid Vaginal Swab|2|||
161582673|NCT05600283|583519719|FG000|Overall Study|Missing Clinician Collection|3|||
161582674|NCT05600283|583519720|FG001|Overall Study|Missing Clinician Collection|6|||
161582675|NCT05600283|583519719|FG000|Overall Study|Screen Failure|1|||
161582676|NCT05600283|583519720|FG001|Overall Study|Screen Failure|2|||
161582677|NCT05600283|583519719|FG000|Overall Study|Sample Lost in Transit|1|||
161582678|NCT05600283|583519720|FG001|Overall Study|Sample Lost in Transit|0|||
161582679|NCT00068601|583519721|FG000|Overall Study|Ineligible|11|||
161582680|NCT00068601|583519722|FG001|Overall Study|Ineligible|13|||
161582681|NCT00068601|583519721|FG000|Overall Study|Not evaluable: withdrew consent|5|||
161582682|NCT00068601|583519722|FG001|Overall Study|Not evaluable: withdrew consent|4|||
161582683|NCT00068601|583519721|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
161582684|NCT00068601|583519722|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
161582685|NCT00068601|583519721|FG000|Overall Study|Death|11|||
161582686|NCT00068601|583519722|FG001|Overall Study|Death|3|||
161582687|NCT00068601|583519721|FG000|Overall Study|Lost to Follow-up|3|||
161582688|NCT00068601|583519722|FG001|Overall Study|Lost to Follow-up|2|||
161922845|NCT00021255|584764885|FG001|Overall Study|Death|0|||
161487345|NCT00137046|583175961|FG001|Overall Study|Adverse Event|5|||
161487346|NCT00137046|583175960|FG000|Overall Study|Laboratory Abnormality|2|||
161487347|NCT00137046|583175961|FG001|Overall Study|Laboratory Abnormality|0|||
161487348|NCT00137046|583175960|FG000|Overall Study|Lack of Efficacy|13|||
161487349|NCT00137046|583175961|FG001|Overall Study|Lack of Efficacy|1|||
161487350|NCT00137046|583175960|FG000|Overall Study|Lost to Follow-up|8|||
161582689|NCT00068601|583519721|FG000|Overall Study|Missing primary outcome data|30|||
161582690|NCT00068601|583519722|FG001|Overall Study|Missing primary outcome data|34|||
161582691|NCT02468128|583519723|FG000|Overall Study|Protocol Violation|6|||
161922846|NCT00021255|584764886|FG002|Overall Study|Death|2|||
161487351|NCT00137046|583175961|FG001|Overall Study|Lost to Follow-up|24|||
161487352|NCT00137046|583175960|FG000|Overall Study|Other|23|||
161487353|NCT00137046|583175961|FG001|Overall Study|Other|19|||
161582692|NCT02468128|583519724|FG001|Overall Study|Protocol Violation|6|||
161582693|NCT00440011|583519725|FG000|Overall Study|Adverse Event|2|||
161582694|NCT00440011|583519726|FG001|Overall Study|Adverse Event|0|||
161487354|NCT00137046|583175960|FG000|Overall Study|Withdrawal by Subject|33|||
161487355|NCT00137046|583175961|FG001|Overall Study|Withdrawal by Subject|42|||
161487356|NCT00137046|583175960|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
161487357|NCT00137046|583175961|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
161487358|NCT00137046|583175960|FG000|Overall Study|Withdrew prior to study treatment|1|||
161487359|NCT00137046|583175961|FG001|Overall Study|Withdrew prior to study treatment|1|||
161487360|NCT02268084|583175968|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
161487361|NCT02268084|583175969|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
161487362|NCT02268084|583175968|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
161487363|NCT02268084|583175969|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
161487364|NCT05227027|583175970|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
161487365|NCT05227027|583175971|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
161487366|NCT06149247|583175972|FG000|Overall Study|Adverse Event|0|||
161487367|NCT06149247|583175973|FG001|Overall Study|Adverse Event|1|||
161487368|NCT00371137|583175978|FG000|Overall Study|Adverse Event|20|||
161487369|NCT00371137|583175979|FG001|Overall Study|Adverse Event|35|||
161487370|NCT00371137|583175980|FG002|Overall Study|Adverse Event|42|||
161487371|NCT00371137|583175978|FG000|Overall Study|Withdrawal by Subject|11|||
161487372|NCT00371137|583175979|FG001|Overall Study|Withdrawal by Subject|10|||
161487373|NCT00371137|583175980|FG002|Overall Study|Withdrawal by Subject|15|||
161487374|NCT00371137|583175978|FG000|Overall Study|Lost to Follow-up|6|||
161487375|NCT00371137|583175979|FG001|Overall Study|Lost to Follow-up|3|||
161487376|NCT00371137|583175980|FG002|Overall Study|Lost to Follow-up|5|||
161487377|NCT00371137|583175978|FG000|Overall Study|Lack of Efficacy|30|||
161487378|NCT00371137|583175979|FG001|Overall Study|Lack of Efficacy|12|||
161487379|NCT00371137|583175980|FG002|Overall Study|Lack of Efficacy|13|||
161487380|NCT00371137|583175978|FG000|Overall Study|Sponsor Decision|2|||
161487381|NCT00371137|583175979|FG001|Overall Study|Sponsor Decision|1|||
161487382|NCT00371137|583175980|FG002|Overall Study|Sponsor Decision|2|||
161487383|NCT00371137|583175978|FG000|Overall Study|Physician Decision|1|||
161487384|NCT00371137|583175979|FG001|Overall Study|Physician Decision|1|||
161487385|NCT00371137|583175980|FG002|Overall Study|Physician Decision|1|||
161487386|NCT00371137|583175978|FG000|Overall Study|Protocol Violation|2|||
161487387|NCT00371137|583175979|FG001|Overall Study|Protocol Violation|1|||
161487388|NCT00371137|583175980|FG002|Overall Study|Protocol Violation|1|||
161487389|NCT01756898|583175983|FG000|Overall Study|Adverse Event|7|||
161487390|NCT01756898|583175984|FG001|Overall Study|Adverse Event|1|||
161487391|NCT01756898|583175985|FG002|Overall Study|Adverse Event|0|||
161487392|NCT01756898|583175986|FG003|Overall Study|Adverse Event|0|||
161487393|NCT01756898|583175983|FG000|Overall Study|Lack of Efficacy|4|||
161487394|NCT01756898|583175984|FG001|Overall Study|Lack of Efficacy|7|||
161487395|NCT01756898|583175985|FG002|Overall Study|Lack of Efficacy|6|||
161487396|NCT01756898|583175986|FG003|Overall Study|Lack of Efficacy|6|||
161487397|NCT01756898|583175983|FG000|Overall Study|Lost to Follow-up|2|||
161487398|NCT01756898|583175984|FG001|Overall Study|Lost to Follow-up|4|||
161487399|NCT01756898|583175985|FG002|Overall Study|Lost to Follow-up|2|||
161487400|NCT01756898|583175986|FG003|Overall Study|Lost to Follow-up|3|||
161487401|NCT01756898|583175983|FG000|Overall Study|Protocol Violation|1|||
161487402|NCT01756898|583175984|FG001|Overall Study|Protocol Violation|2|||
161487403|NCT01756898|583175985|FG002|Overall Study|Protocol Violation|2|||
161487404|NCT01756898|583175986|FG003|Overall Study|Protocol Violation|1|||
161487405|NCT01756898|583175983|FG000|Overall Study|Withdrew Consent|5|||
161487406|NCT01756898|583175984|FG001|Overall Study|Withdrew Consent|3|||
161487407|NCT01756898|583175985|FG002|Overall Study|Withdrew Consent|5|||
161487408|NCT01756898|583175986|FG003|Overall Study|Withdrew Consent|6|||
161487409|NCT01756898|583175983|FG000|Overall Study|Other|0|||
161487410|NCT01756898|583175984|FG001|Overall Study|Other|2|||
161487411|NCT01756898|583175985|FG002|Overall Study|Other|2|||
161487412|NCT01756898|583175986|FG003|Overall Study|Other|0|||
161487413|NCT01500694|583175987|FG000|Overall Study|Adverse Event|4|||
161487414|NCT01500694|583175988|FG001|Overall Study|Adverse Event|3|||
161487415|NCT01500694|583175987|FG000|Overall Study|Protocol Violation|0|||
161487416|NCT01500694|583175988|FG001|Overall Study|Protocol Violation|1|||
161487417|NCT01500694|583175987|FG000|Overall Study|Withdrawal by Subject|23|||
161487418|NCT01500694|583175988|FG001|Overall Study|Withdrawal by Subject|14|||
161487419|NCT01500694|583175987|FG000|Overall Study|Lost to Follow-up|2|||
161487420|NCT01500694|583175988|FG001|Overall Study|Lost to Follow-up|3|||
161487421|NCT01500694|583175987|FG000|Overall Study|Lack of Efficacy|14|||
161487422|NCT01500694|583175988|FG001|Overall Study|Lack of Efficacy|5|||
161487423|NCT01500694|583175987|FG000|Overall Study|Other|9|||
161487424|NCT01500694|583175988|FG001|Overall Study|Other|3|||
161487425|NCT02837783|583175989|FG000|Overall Study|Adverse Event|1|||
161487426|NCT02837783|583175990|FG001|Overall Study|Adverse Event|0|||
161487427|NCT02837783|583175989|FG000|Overall Study|Other, Not Specified|1|||
161582695|NCT00440011|583519725|FG000|Overall Study|Lost to Follow-up|0|||
161582696|NCT00440011|583519726|FG001|Overall Study|Lost to Follow-up|2|||
161487428|NCT02837783|583175990|FG001|Overall Study|Other, Not Specified|2|||
161487429|NCT03694821|583176010|FG000|Overall Study|Study terminated|4|||
161487430|NCT03694821|583176011|FG001|Overall Study|Study terminated|8|||
161487431|NCT03694821|583176012|FG002|Overall Study|Study terminated|4|||
161487432|NCT01438424|583178134|FG000|Overall Study|Continuing treatment|29|||
161487433|NCT01438424|583178134|FG000|Overall Study|Minimal virologic response|95|||
161487434|NCT01438424|583178134|FG000|Overall Study|Not identified|55|||
161487435|NCT01438424|583178134|FG000|Overall Study|Withdrawal by Subject|104|||
161487436|NCT01438424|583178134|FG000|Overall Study|Progression of chronic hepatitis B|22|||
161487437|NCT01438424|583178134|FG000|Overall Study|Death|22|||
161487438|NCT01438424|583178134|FG000|Overall Study|Adverse Event|17|||
161487439|NCT01438424|583178134|FG000|Overall Study|Lost to Follow-up|17|||
161487440|NCT01438424|583178134|FG000|Overall Study|Abnormal laboratory test result|14|||
161487441|NCT01438424|583178134|FG000|Overall Study|Need for drug prohibited by protocol|14|||
161487442|NCT01438424|583178134|FG000|Overall Study|Pregnancy|7|||
161487443|NCT01438424|583178134|FG000|Overall Study|No longer met inclusion criteria|1|||
161487444|NCT01438424|583178134|FG000|Overall Study|Participant noncompliance|20|||
161487445|NCT02927080|583178135|FG000|Overall Study|Withdrawal by Subject|0|||
161487446|NCT02927080|583178136|FG001|Overall Study|Withdrawal by Subject|0|||
161487447|NCT02927080|583178137|FG002|Overall Study|Withdrawal by Subject|0|||
161487448|NCT02927080|583178138|FG003|Overall Study|Withdrawal by Subject|0|||
161487449|NCT02927080|583178139|FG004|Overall Study|Withdrawal by Subject|1|||
161487450|NCT02927080|583178140|FG005|Overall Study|Withdrawal by Subject|0|||
161487451|NCT02927080|583178141|FG006|Overall Study|Withdrawal by Subject|1|||
161487452|NCT02927080|583178142|FG007|Overall Study|Withdrawal by Subject|1|||
161487453|NCT02927080|583178143|FG008|Overall Study|Withdrawal by Subject|0|||
161487454|NCT02927080|583178144|FG009|Overall Study|Withdrawal by Subject|2|||
161487455|NCT02927080|583178135|FG000|Overall Study|Willingness to comply with protocol|0|||
161487456|NCT02927080|583178136|FG001|Overall Study|Willingness to comply with protocol|0|||
161487457|NCT02927080|583178137|FG002|Overall Study|Willingness to comply with protocol|0|||
161487458|NCT02927080|583178138|FG003|Overall Study|Willingness to comply with protocol|0|||
161487459|NCT02927080|583178139|FG004|Overall Study|Willingness to comply with protocol|0|||
161487460|NCT02927080|583178140|FG005|Overall Study|Willingness to comply with protocol|0|||
161487461|NCT02927080|583178141|FG006|Overall Study|Willingness to comply with protocol|0|||
161487462|NCT02927080|583178142|FG007|Overall Study|Willingness to comply with protocol|0|||
161487463|NCT02927080|583178143|FG008|Overall Study|Willingness to comply with protocol|0|||
161487464|NCT02927080|583178144|FG009|Overall Study|Willingness to comply with protocol|1|||
161487465|NCT02927080|583178135|FG000|Overall Study|Study terminated by Sponsor|0|||
161487466|NCT02927080|583178136|FG001|Overall Study|Study terminated by Sponsor|0|||
161487467|NCT02927080|583178137|FG002|Overall Study|Study terminated by Sponsor|0|||
161487468|NCT02927080|583178138|FG003|Overall Study|Study terminated by Sponsor|0|||
161487469|NCT02927080|583178139|FG004|Overall Study|Study terminated by Sponsor|0|||
161487470|NCT02927080|583178140|FG005|Overall Study|Study terminated by Sponsor|0|||
161487471|NCT02927080|583178141|FG006|Overall Study|Study terminated by Sponsor|6|||
161487472|NCT02927080|583178142|FG007|Overall Study|Study terminated by Sponsor|7|||
161487473|NCT02927080|583178143|FG008|Overall Study|Study terminated by Sponsor|2|||
161487474|NCT02927080|583178144|FG009|Overall Study|Study terminated by Sponsor|3|||
161487475|NCT02927080|583178135|FG000|Overall Study|Adverse Event|0|||
161487476|NCT02927080|583178136|FG001|Overall Study|Adverse Event|1|||
161487477|NCT02927080|583178137|FG002|Overall Study|Adverse Event|0|||
161487478|NCT02927080|583178138|FG003|Overall Study|Adverse Event|0|||
161487479|NCT02927080|583178139|FG004|Overall Study|Adverse Event|0|||
161487480|NCT02927080|583178140|FG005|Overall Study|Adverse Event|0|||
161487481|NCT02927080|583178141|FG006|Overall Study|Adverse Event|0|||
161487482|NCT02927080|583178142|FG007|Overall Study|Adverse Event|1|||
161487483|NCT02927080|583178143|FG008|Overall Study|Adverse Event|0|||
161487484|NCT02927080|583178144|FG009|Overall Study|Adverse Event|1|||
161487485|NCT02927080|583178135|FG000|Overall Study|Other|0|||
161487486|NCT02927080|583178136|FG001|Overall Study|Other|0|||
161487487|NCT02927080|583178137|FG002|Overall Study|Other|0|||
161487488|NCT02927080|583178138|FG003|Overall Study|Other|0|||
161487489|NCT02927080|583178139|FG004|Overall Study|Other|0|||
161487490|NCT02927080|583178140|FG005|Overall Study|Other|0|||
161487491|NCT02927080|583178141|FG006|Overall Study|Other|1|||
161487492|NCT02927080|583178142|FG007|Overall Study|Other|0|||
161487493|NCT02927080|583178143|FG008|Overall Study|Other|1|||
161487494|NCT02927080|583178144|FG009|Overall Study|Other|0|||
161487495|NCT01411228|583178146|FG000|Overall Study|Lost to Follow-up|0|||
161487496|NCT01411228|583178147|FG001|Overall Study|Lost to Follow-up|0|||
161487497|NCT01411228|583178148|FG002|Overall Study|Lost to Follow-up|1|||
161487498|NCT01411228|583178146|FG000|Overall Study|Withdrawal by Subject|1|||
161487499|NCT01411228|583178147|FG001|Overall Study|Withdrawal by Subject|0|||
161487500|NCT01411228|583178148|FG002|Overall Study|Withdrawal by Subject|0|||
161487501|NCT00664742|583178149|FG000|Overall Study|Withdrawn due to adverse events|3|||
161487502|NCT00664742|583178149|FG000|Overall Study|Withdrawal by Subject|31|||
161487503|NCT00664742|583178149|FG000|Overall Study|Lost to Follow-up|92|||
161487504|NCT02670083|583178150|FG000|Overall Study|Adverse Event|16|||
161487505|NCT02670083|583178151|FG001|Overall Study|Adverse Event|13|||
161487506|NCT02670083|583178150|FG000|Overall Study|Death|4|||
161487507|NCT02670083|583178151|FG001|Overall Study|Death|6|||
161487508|NCT02670083|583178150|FG000|Overall Study|Lost to Follow-up|2|||
161487509|NCT02670083|583178151|FG001|Overall Study|Lost to Follow-up|2|||
161487510|NCT02670083|583178150|FG000|Overall Study|Multiple Reasons|9|||
161487511|NCT02670083|583178151|FG001|Overall Study|Multiple Reasons|9|||
161487512|NCT02670083|583178150|FG000|Overall Study|Physician Decision|0|||
161487513|NCT02670083|583178151|FG001|Overall Study|Physician Decision|2|||
161487514|NCT02670083|583178150|FG000|Overall Study|Study Terminated By Sponsor|257|||
161487515|NCT02670083|583178151|FG001|Overall Study|Study Terminated By Sponsor|254|||
161487516|NCT02670083|583178150|FG000|Overall Study|Symptomatic Deterioration|0|||
161487517|NCT02670083|583178151|FG001|Overall Study|Symptomatic Deterioration|2|||
161487518|NCT02670083|583178150|FG000|Overall Study|Withdrawal by Subject|32|||
161487519|NCT02670083|583178151|FG001|Overall Study|Withdrawal by Subject|31|||
161487520|NCT02670083|583178150|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161487521|NCT02670083|583178151|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161487522|NCT02825992|583178152|FG000|Overall Study|Withdrawal by Subject|4|||
161487523|NCT02825992|583178152|FG000|Overall Study|Lost to Follow-up|2|||
161487524|NCT02825992|583178152|FG000|Overall Study|Procedure terminated|2|||
161487525|NCT02692716|583178154|FG000|Overall Study|Lost to Follow-up|2|||
161487526|NCT02692716|583178155|FG001|Overall Study|Lost to Follow-up|5|||
161487527|NCT02692716|583178154|FG000|Overall Study|Withdrawal by Subject|3|||
161487528|NCT02692716|583178155|FG001|Overall Study|Withdrawal by Subject|1|||
161487529|NCT02904512|583178162|FG000|Overall Study|Withdrawal by Subject|1|||
161487530|NCT02904512|583178163|FG001|Overall Study|Withdrawal by Subject|0|||
161487531|NCT02904512|583178162|FG000|Overall Study|Transferred to ICU|1|||
161487532|NCT02904512|583178163|FG001|Overall Study|Transferred to ICU|0|||
161487533|NCT02904512|583178162|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
161487534|NCT02904512|583178163|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
161487535|NCT01963403|583178170|FG000|Overall Study|Lost to Follow-up|2|||
161487536|NCT01963403|583178171|FG001|Overall Study|Lost to Follow-up|3|||
161487537|NCT01963403|583178170|FG000|Overall Study|Implant removal|0|||
161487538|NCT01963403|583178171|FG001|Overall Study|Implant removal|1|||
161487539|NCT02743806|583178172|FG000|Overall Study|Adverse Event|9|||
161487540|NCT02743806|583178172|FG000|Overall Study|Lost to Follow-up|8|||
161487541|NCT02743806|583178172|FG000|Overall Study|Voluntary Withdrawal|54|||
161487542|NCT02743806|583178172|FG000|Overall Study|Study Termination|65|||
161487543|NCT02743806|583178172|FG000|Overall Study|Pregnancy|6|||
161487544|NCT02743806|583178172|FG000|Overall Study|No Longer Clinically Benefiting|27|||
161487545|NCT02743806|583178172|FG000|Overall Study|Reason Not Specified|12|||
161487546|NCT02085785|583178175|FG000|Overall Study|Withdrawal by Subject|2|||
161487547|NCT02085785|583178176|FG001|Overall Study|Withdrawal by Subject|1|||
161487548|NCT02085785|583178175|FG000|Overall Study|Lost to Follow-up|0|||
161487549|NCT02085785|583178176|FG001|Overall Study|Lost to Follow-up|1|||
161487550|NCT00779467|583178177|FG000|Overall Study|Lack of Efficacy|11|||
161487551|NCT00779467|583178178|FG001|Overall Study|Lack of Efficacy|2|||
161487552|NCT00779467|583178179|FG002|Overall Study|Lack of Efficacy|6|||
161487553|NCT00779467|583178180|FG003|Overall Study|Lack of Efficacy|11|||
161487554|NCT00779467|583178177|FG000|Overall Study|failed inclusion criteria|3|||
161487555|NCT00779467|583178178|FG001|Overall Study|failed inclusion criteria|3|||
161487556|NCT00779467|583178179|FG002|Overall Study|failed inclusion criteria|1|||
161487557|NCT00779467|583178180|FG003|Overall Study|failed inclusion criteria|2|||
161487558|NCT00779467|583178177|FG000|Overall Study|missing data|1|||
161487559|NCT00779467|583178178|FG001|Overall Study|missing data|0|||
161487560|NCT00779467|583178179|FG002|Overall Study|missing data|1|||
161487561|NCT00779467|583178180|FG003|Overall Study|missing data|4|||
161487562|NCT00779467|583178177|FG000|Overall Study|technical issue|0|||
161487563|NCT00779467|583178178|FG001|Overall Study|technical issue|0|||
161487564|NCT00779467|583178179|FG002|Overall Study|technical issue|2|||
161487565|NCT00779467|583178180|FG003|Overall Study|technical issue|1|||
161487566|NCT00779467|583178177|FG000|Overall Study|unavailable research staff|0|||
161487567|NCT00779467|583178178|FG001|Overall Study|unavailable research staff|0|||
161487568|NCT00779467|583178179|FG002|Overall Study|unavailable research staff|0|||
161487569|NCT00779467|583178180|FG003|Overall Study|unavailable research staff|1|||
161487570|NCT03590041|583178181|FG000|Overall Study|Protocol Violation|4|||
161487571|NCT03590041|583178182|FG001|Overall Study|Protocol Violation|3|||
161487572|NCT03590041|583178181|FG000|Overall Study|No session data recorded|14|||
161487573|NCT03590041|583178182|FG001|Overall Study|No session data recorded|2|||
161487574|NCT00267046|583178189|FG000|Overall Study|Disease progression|4|||
161487575|NCT00267046|583178190|FG001|Overall Study|Disease progression|2|||
161487576|NCT00267046|583178189|FG000|Overall Study|Chemotoxicity|2|||
161487577|NCT00267046|583178190|FG001|Overall Study|Chemotoxicity|0|||
161487578|NCT00267046|583178189|FG000|Overall Study|Open-label palifermin|2|||
161487579|NCT00267046|583178190|FG001|Overall Study|Open-label palifermin|7|||
161487580|NCT00267046|583178189|FG000|Overall Study|Surgery|3|||
161487581|NCT00267046|583178190|FG001|Overall Study|Surgery|1|||
161487582|NCT00267046|583178189|FG000|Overall Study|Withdrawal by Subject|1|||
161487583|NCT00267046|583178190|FG001|Overall Study|Withdrawal by Subject|0|||
161487584|NCT00267046|583178189|FG000|Overall Study|Radiation|0|||
161487585|NCT00267046|583178190|FG001|Overall Study|Radiation|1|||
161487586|NCT00460408|583178191|FG000|Overall Study|Adverse Event|1|||
161487587|NCT00460408|583178192|FG001|Overall Study|Adverse Event|0|||
161487588|NCT00460408|583178193|FG002|Overall Study|Adverse Event|0|||
161487589|NCT00460408|583178194|FG003|Overall Study|Adverse Event|0|||
161487590|NCT00460408|583178191|FG000|Overall Study|Death|7|||
161487591|NCT00460408|583178192|FG001|Overall Study|Death|0|||
161487592|NCT00460408|583178193|FG002|Overall Study|Death|0|||
161487593|NCT00460408|583178194|FG003|Overall Study|Death|0|||
161487594|NCT00460408|583178191|FG000|Overall Study|Lost to Follow-up|11|||
161487595|NCT00460408|583178192|FG001|Overall Study|Lost to Follow-up|0|||
161487596|NCT00460408|583178193|FG002|Overall Study|Lost to Follow-up|1|||
161671174|NCT03026127|583849074|FG002|CRISP R61|Lost to Follow-up|0|||
161671175|NCT03026127|583849072|FG000|CRISP R61|Dropped before therapy|5|||
161671176|NCT03026127|583849073|FG001|CRISP R61|Dropped before therapy|0|||
161671177|NCT03026127|583849074|FG002|CRISP R61|Dropped before therapy|0|||
161671178|NCT03026127|583849072|FG000|CRISP R33|Lost to Follow-up|0|||
161671179|NCT03026127|583849073|FG001|CRISP R33|Lost to Follow-up|5|||
161671180|NCT03026127|583849074|FG002|CRISP R33|Lost to Follow-up|4|||
161671181|NCT03026127|583849072|FG000|CRISP R33|Adverse Event|0|||
161671182|NCT03026127|583849073|FG001|CRISP R33|Adverse Event|9|||
161671183|NCT03026127|583849074|FG002|CRISP R33|Adverse Event|5|||
161487597|NCT00460408|583178194|FG003|Overall Study|Lost to Follow-up|0|||
161487598|NCT00460408|583178191|FG000|Overall Study|Withdrawal by Subject|31|||
161671184|NCT03026127|583849072|FG000|CRISP R33|Withdrawal by Subject|0|||
161671185|NCT03026127|583849073|FG001|CRISP R33|Withdrawal by Subject|9|||
161671186|NCT03026127|583849074|FG002|CRISP R33|Withdrawal by Subject|1|||
161671187|NCT03026127|583849072|FG000|CRISP R33|Lack of Efficacy|0|||
161671188|NCT03026127|583849073|FG001|CRISP R33|Lack of Efficacy|3|||
161671189|NCT03026127|583849074|FG002|CRISP R33|Lack of Efficacy|2|||
161487599|NCT00460408|583178192|FG001|Overall Study|Withdrawal by Subject|0|||
161487600|NCT00460408|583178193|FG002|Overall Study|Withdrawal by Subject|0|||
161487601|NCT00460408|583178194|FG003|Overall Study|Withdrawal by Subject|0|||
161487602|NCT00460408|583178191|FG000|Overall Study|Insufficient clinical response|5|||
161487603|NCT00460408|583178192|FG001|Overall Study|Insufficient clinical response|1|||
161487604|NCT00460408|583178193|FG002|Overall Study|Insufficient clinical response|5|||
161487605|NCT00460408|583178194|FG003|Overall Study|Insufficient clinical response|0|||
161671190|NCT03026127|583849072|FG000|CRISP R33|Physician Decision|0|||
161671191|NCT03026127|583849073|FG001|CRISP R33|Physician Decision|3|||
161817030|NCT01604941|584370910|FG005|Overall Study|Adverse Event|5|||
161817031|NCT01604941|584370905|FG000|Overall Study|Non-compliance|1|||
161817032|NCT01604941|584370906|FG001|Overall Study|Non-compliance|0|||
161487606|NCT00460408|583178191|FG000|Overall Study|Other|12|||
161671192|NCT03026127|583849074|FG002|CRISP R33|Physician Decision|1|||
161487607|NCT00460408|583178192|FG001|Overall Study|Other|2|||
161487608|NCT00460408|583178193|FG002|Overall Study|Other|0|||
161487609|NCT00460408|583178194|FG003|Overall Study|Other|0|||
161487610|NCT02573350|583178195|FG000|Overall Study|Lost to Follow-up|2|||
161487611|NCT02573350|583178196|FG001|Overall Study|Lost to Follow-up|1|||
161487612|NCT02573350|583178195|FG000|Overall Study|Adverse Event|3|||
161487613|NCT02573350|583178196|FG001|Overall Study|Adverse Event|4|||
161487614|NCT02573350|583178195|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
161487615|NCT02573350|583178196|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
161671193|NCT03026127|583849072|FG000|CRISP R33|Transportation|0|||
161671194|NCT03026127|583849073|FG001|CRISP R33|Transportation|2|||
161671195|NCT03026127|583849074|FG002|CRISP R33|Transportation|1|||
161671196|NCT00132496|583849077|FG000|Overall Study|Withdrawal by Subject|1|||
161487616|NCT02573350|583178195|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
161487617|NCT02573350|583178196|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
161487618|NCT02573350|583178195|FG000|Overall Study|Subject withdrew consent to participate|6|||
161487619|NCT02573350|583178196|FG001|Overall Study|Subject withdrew consent to participate|1|||
161487620|NCT02573350|583178195|FG000|Overall Study|Protocol Deviation|1|||
161487621|NCT02573350|583178196|FG001|Overall Study|Protocol Deviation|1|||
161487622|NCT01442493|583178197|FG000|Overall Study|withdrawn from study|3|||
161487623|NCT01442493|583178198|FG001|Overall Study|withdrawn from study|2|||
161487624|NCT00938639|583178199|FG000|Overall Study|Moved away from study area|0|||
161487625|NCT00938639|583178200|FG001|Overall Study|Moved away from study area|1|||
161671197|NCT00132496|583849078|FG001|Overall Study|Withdrawal by Subject|2|||
161671198|NCT00132496|583849077|FG000|Overall Study|Physician Decision|1|||
161671199|NCT00132496|583849078|FG001|Overall Study|Physician Decision|0|||
161671200|NCT00564018|583849081|FG000|Overall Study|Withdrawal by Subject|2|||
161671201|NCT00564018|583849082|FG001|Overall Study|Withdrawal by Subject|3|||
161671202|NCT00564018|583849083|FG002|Overall Study|Withdrawal by Subject|1|||
161671203|NCT00986440|583849084|FG000|Overall Study|Progressive disease|27|||
161671204|NCT00986440|583849085|FG001|Overall Study|Progressive disease|37|||
161671205|NCT00986440|583849084|FG000|Overall Study|Serious adverse event or adverse event|9|||
161671206|NCT00986440|583849085|FG001|Overall Study|Serious adverse event or adverse event|2|||
161671207|NCT00986440|583849084|FG000|Overall Study|Withdrawal by Subject|1|||
161671208|NCT00986440|583849085|FG001|Overall Study|Withdrawal by Subject|2|||
161671209|NCT00986440|583849084|FG000|Overall Study|Screen failure (not dosed)|4|||
161671210|NCT00986440|583849085|FG001|Overall Study|Screen failure (not dosed)|2|||
161671211|NCT00388154|583849086|FG000|Overall Study|Withdrawal by Subject|1|||
161671212|NCT03431857|583849095|FG000|Overall Study|Death|6|||
161671213|NCT03431857|583849095|FG000|Overall Study|Lost to Follow-up|41|||
161671214|NCT03431857|583849095|FG000|Overall Study|Adverse Event|6|||
161671215|NCT03431857|583849095|FG000|Overall Study|Withdrawal by Subject|1|||
161487626|NCT00938639|583178199|FG000|Overall Study|Lost to Follow-up|1|||
161487627|NCT00938639|583178200|FG001|Overall Study|Lost to Follow-up|2|||
161487628|NCT00938639|583178199|FG000|Overall Study|Family issues|1|||
161487629|NCT00938639|583178200|FG001|Overall Study|Family issues|1|||
161487630|NCT00938639|583178199|FG000|Overall Study|Participant noncompliance|1|||
161487631|NCT00938639|583178200|FG001|Overall Study|Participant noncompliance|0|||
161487632|NCT04326231|583178204|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
161487633|NCT03303079|583178205|FG000|Overall Study|Adverse Event|0|||
161487634|NCT03303079|583178206|FG001|Overall Study|Adverse Event|1|||
161487635|NCT03303079|583178207|FG002|Overall Study|Adverse Event|3|||
161487636|NCT03303079|583178205|FG000|Overall Study|Protocol Violation|5|||
161487637|NCT03303079|583178206|FG001|Overall Study|Protocol Violation|4|||
161487638|NCT03303079|583178207|FG002|Overall Study|Protocol Violation|7|||
161487639|NCT03303079|583178205|FG000|Overall Study|Withdrawal by Subject|2|||
161487640|NCT03303079|583178206|FG001|Overall Study|Withdrawal by Subject|4|||
161487641|NCT03303079|583178207|FG002|Overall Study|Withdrawal by Subject|2|||
161487642|NCT03303079|583178205|FG000|Overall Study|Other than specified|0|||
161487643|NCT03303079|583178206|FG001|Overall Study|Other than specified|2|||
161487644|NCT03303079|583178207|FG002|Overall Study|Other than specified|0|||
161487645|NCT01741701|583178214|FG000|Overall Study|Adverse Event|5|||
161487646|NCT01741701|583178215|FG001|Overall Study|Adverse Event|1|||
161487647|NCT01741701|583178214|FG000|Overall Study|Withdrawal by Subject|0|||
161487648|NCT01741701|583178215|FG001|Overall Study|Withdrawal by Subject|1|||
161487649|NCT01830972|583178224|FG000|Part II|Withdrawal by Subject|2|||
161487650|NCT01830972|583178225|FG001|Part II|Withdrawal by Subject|2|||
161487651|NCT01830972|583178224|FG000|Part III|Withdrawal by Subject|1|||
161487652|NCT01830972|583178225|FG001|Part III|Withdrawal by Subject|0|||
161487653|NCT01830972|583178224|FG000|Part III|Noncompliance|1|||
161487654|NCT01830972|583178225|FG001|Part III|Noncompliance|0|||
161487655|NCT01830972|583178224|FG000|Part IV|Withdrawal by Subject|2|||
161487656|NCT01830972|583178225|FG001|Part IV|Withdrawal by Subject|1|||
161487657|NCT01830972|583178224|FG000|Part IV|Non-Compliance|1|||
161487658|NCT01830972|583178225|FG001|Part IV|Non-Compliance|0|||
161487659|NCT00726661|583178226|FG000|Overall Study|Lost to Follow-up|36|||
161487660|NCT00726661|583178227|FG001|Overall Study|Lost to Follow-up|11|||
161487661|NCT00726661|583178226|FG000|Overall Study|Withdrawal by Subject|17|||
161487662|NCT00726661|583178227|FG001|Overall Study|Withdrawal by Subject|13|||
161487663|NCT00726661|583178226|FG000|Overall Study|Trial terminated by sponsor|214|||
161671216|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Other|1|||
161671217|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Other|0|||
161671218|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
161487664|NCT00726661|583178227|FG001|Overall Study|Trial terminated by sponsor|187|||
161487665|NCT00726661|583178226|FG000|Overall Study|Death|475|||
161487666|NCT00726661|583178227|FG001|Overall Study|Death|159|||
161487667|NCT00726661|583178226|FG000|Overall Study|Physician Decision|25|||
161487668|NCT00726661|583178227|FG001|Overall Study|Physician Decision|13|||
161487669|NCT00726661|583178226|FG000|Overall Study|Other|47|||
161487670|NCT00726661|583178227|FG001|Overall Study|Other|35|||
161487671|NCT02557646|583178230|FG000|Overall Study|Adverse Event|40|||
161487672|NCT02557646|583178230|FG000|Overall Study|Death|1|||
161487673|NCT02557646|583178230|FG000|Overall Study|Lack of Efficacy|186|||
161487674|NCT02557646|583178230|FG000|Overall Study|Withdrawal by Subject|18|||
161487675|NCT02557646|583178230|FG000|Overall Study|Lost to Follow-up|17|||
161487676|NCT02557646|583178230|FG000|Overall Study|Other|14|||
161487677|NCT00660309|583178233|FG000|Overall Study|Adverse Event|2|||
161487678|NCT00660309|583178234|FG001|Overall Study|Adverse Event|0|||
161487679|NCT00660309|583178233|FG000|Overall Study|Withdrawal by Subject|0|||
161487680|NCT00660309|583178234|FG001|Overall Study|Withdrawal by Subject|3|||
161487681|NCT02532972|583178238|FG000|Overall Study|Withdrawal by Subject|1|||
161487682|NCT00110149|583178239|FG000|Overall Study|Physician Decision|3|||
161487683|NCT00748033|583178240|FG000|Overall Study|Adverse Event|0|||
161487684|NCT00748033|583178241|FG001|Overall Study|Adverse Event|1|||
161487685|NCT01018186|583178242|FG000|2-week Run-in Period|Protocol Violation|1|||
161487686|NCT01018186|583178243|FG001|2-week Run-in Period|Protocol Violation|0|||
161487687|NCT01018186|583178244|FG002|2-week Run-in Period|Protocol Violation|0|||
161487688|NCT01018186|583178245|FG003|2-week Run-in Period|Protocol Violation|0|||
161487689|NCT01018186|583178242|FG000|2-week Run-in Period|Lost to Follow-up|2|||
161487690|NCT01018186|583178243|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161487691|NCT01018186|583178244|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161487692|NCT01018186|583178245|FG003|2-week Run-in Period|Lost to Follow-up|0|||
161487693|NCT01018186|583178242|FG000|2-week Run-in Period|Physician Decision|3|||
161487694|NCT01018186|583178243|FG001|2-week Run-in Period|Physician Decision|0|||
161487695|NCT01018186|583178244|FG002|2-week Run-in Period|Physician Decision|0|||
161487696|NCT01018186|583178245|FG003|2-week Run-in Period|Physician Decision|0|||
161487697|NCT01018186|583178242|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
161487698|NCT01018186|583178243|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161487699|NCT01018186|583178244|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161487700|NCT01018186|583178245|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
161487701|NCT01018186|583178242|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
161487702|NCT01018186|583178243|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161487703|NCT01018186|583178244|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161487704|NCT01018186|583178245|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161487705|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
161487706|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
161487707|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
161487708|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
161487709|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161487710|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
161487711|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
161487712|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
161487713|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
161487714|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
161487715|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
161487716|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
161487717|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
161487718|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
161487719|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
161487720|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
161487721|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
161487722|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
161487723|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
161487724|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
161487725|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
161487726|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
161487727|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
161487728|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
161487729|NCT01018186|583178242|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161582697|NCT00440011|583519725|FG000|Overall Study|Protocol Violation|1|||
161582698|NCT00440011|583519726|FG001|Overall Study|Protocol Violation|1|||
161582699|NCT00440011|583519725|FG000|Overall Study|Withdrawal by Subject|1|||
161582700|NCT00440011|583519726|FG001|Overall Study|Withdrawal by Subject|0|||
161487730|NCT01018186|583178243|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
161487731|NCT01018186|583178244|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
161487732|NCT01018186|583178245|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
161487733|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
161487734|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
161487735|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
161582701|NCT00621296|583519730|FG000|Overall Study|Adverse Event|2|||
161487736|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
161487737|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
161487738|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
161487739|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
161487740|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
161487741|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
161487742|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
161487743|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
161487744|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
161487745|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
161487746|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
161487747|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
161487748|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
161487749|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
161487750|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
161487751|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
161487752|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
161487753|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
161487754|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
161487755|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
161487756|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
161487757|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
161487758|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
161487759|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
161487760|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
161487761|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
161487762|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
161487763|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
161487764|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
161487765|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
161487766|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
161487767|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
161487768|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
161487769|NCT02603419|583178246|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
161582702|NCT00621296|583519730|FG000|Overall Study|Lack of Efficacy|1|||
161582703|NCT00621296|583519730|FG000|Overall Study|Physician Decision|7|||
161582704|NCT00621296|583519730|FG000|Overall Study|Unmatch Criteria|1|||
161487770|NCT02603419|583178247|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
161487771|NCT02603419|583178248|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
161487772|NCT02603419|583178249|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
161487773|NCT02603419|583178250|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
161487774|NCT02603419|583178251|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
161487775|NCT02603419|583178246|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
161487776|NCT02603419|583178247|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
161582705|NCT00621296|583519730|FG000|Overall Study|Stopping Criteria|3|||
161582706|NCT04166058|583519731|FG000|Overall Study|Adverse Event|1|||
161487777|NCT02603419|583178248|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
161487778|NCT02603419|583178249|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
161487779|NCT02603419|583178250|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
161487780|NCT02603419|583178251|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
161582707|NCT04166058|583519732|FG001|Overall Study|Adverse Event|1|||
161582708|NCT04166058|583519733|FG002|Overall Study|Adverse Event|0|||
161582709|NCT04166058|583519734|FG003|Overall Study|Adverse Event|0|||
161582710|NCT04166058|583519731|FG000|Overall Study|Withdrawal by Subject|4|||
161582711|NCT04166058|583519732|FG001|Overall Study|Withdrawal by Subject|4|||
161582712|NCT04166058|583519733|FG002|Overall Study|Withdrawal by Subject|1|||
161582713|NCT04166058|583519734|FG003|Overall Study|Withdrawal by Subject|10|||
161582714|NCT04166058|583519731|FG000|Overall Study|Lost to Follow-up|9|||
161582715|NCT04166058|583519732|FG001|Overall Study|Lost to Follow-up|2|||
161582716|NCT04166058|583519733|FG002|Overall Study|Lost to Follow-up|1|||
161582717|NCT04166058|583519734|FG003|Overall Study|Lost to Follow-up|1|||
161582718|NCT04166058|583519731|FG000|Overall Study|Pregnancy|1|||
161582719|NCT04166058|583519732|FG001|Overall Study|Pregnancy|0|||
161582720|NCT04166058|583519733|FG002|Overall Study|Pregnancy|0|||
161582721|NCT04166058|583519734|FG003|Overall Study|Pregnancy|0|||
161582722|NCT04166058|583519731|FG000|Overall Study|Physician Decision|2|||
161582723|NCT04166058|583519732|FG001|Overall Study|Physician Decision|0|||
161582724|NCT04166058|583519733|FG002|Overall Study|Physician Decision|0|||
161487781|NCT02603419|583178246|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
161487782|NCT02603419|583178247|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
161487783|NCT02603419|583178248|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
161487784|NCT02603419|583178249|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
161487785|NCT02603419|583178250|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
161487786|NCT02603419|583178251|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
161487787|NCT02603419|583178246|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
161487788|NCT02603419|583178247|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
161487789|NCT02603419|583178248|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
161487790|NCT02603419|583178249|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
161487791|NCT02603419|583178250|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
161487792|NCT02603419|583178251|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
161487793|NCT03552198|583178252|FG000|Overall Study|Lost to Follow-up|42|||
161487794|NCT03552198|583178253|FG001|Overall Study|Lost to Follow-up|48|||
161487795|NCT03552198|583178254|FG002|Overall Study|Lost to Follow-up|15|||
161487796|NCT03552198|583178255|FG003|Overall Study|Lost to Follow-up|19|||
161487797|NCT03552198|583178252|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
161487798|NCT03552198|583178253|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
161487799|NCT03552198|583178254|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
161487800|NCT03552198|583178255|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
161487801|NCT03552198|583178252|FG000|Overall Study|Did not receive air alerts|1|||
161487802|NCT03552198|583178253|FG001|Overall Study|Did not receive air alerts|0|||
161487803|NCT03552198|583178254|FG002|Overall Study|Did not receive air alerts|0|||
161487804|NCT03552198|583178255|FG003|Overall Study|Did not receive air alerts|1|||
161487805|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
161582725|NCT04166058|583519734|FG003|Overall Study|Physician Decision|2|||
161582726|NCT04166058|583519731|FG000|Overall Study|Protocol Violation|1|||
161582727|NCT04166058|583519732|FG001|Overall Study|Protocol Violation|0|||
161582728|NCT04166058|583519733|FG002|Overall Study|Protocol Violation|0|||
161582729|NCT04166058|583519734|FG003|Overall Study|Protocol Violation|0|||
161582730|NCT04166058|583519731|FG000|Overall Study|Lack of Efficacy|2|||
161582731|NCT04166058|583519732|FG001|Overall Study|Lack of Efficacy|0|||
161582732|NCT04166058|583519733|FG002|Overall Study|Lack of Efficacy|0|||
161582733|NCT04166058|583519734|FG003|Overall Study|Lack of Efficacy|0|||
161582734|NCT04166058|583519731|FG000|Overall Study|Other|1|||
161582735|NCT04166058|583519732|FG001|Overall Study|Other|0|||
161582736|NCT04166058|583519733|FG002|Overall Study|Other|0|||
161582737|NCT04166058|583519734|FG003|Overall Study|Other|1|||
161582738|NCT04166058|583519731|FG000|Overall Study|Non-compliance with study drug|0|||
161582739|NCT04166058|583519732|FG001|Overall Study|Non-compliance with study drug|0|||
161582740|NCT04166058|583519733|FG002|Overall Study|Non-compliance with study drug|0|||
161582741|NCT04166058|583519734|FG003|Overall Study|Non-compliance with study drug|2|||
161582742|NCT02998528|583519735|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
161582743|NCT02998528|583519736|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
161582744|NCT02998528|583519737|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
161582745|NCT02998528|583519735|FG000|Randomization Period|Participant withdrew consent|0|||
161582746|NCT02998528|583519736|FG001|Randomization Period|Participant withdrew consent|3|||
161582747|NCT02998528|583519737|FG002|Randomization Period|Participant withdrew consent|0|||
161582748|NCT02998528|583519735|FG000|Randomization Period|Participant no longer meets study criteria|1|||
161582749|NCT02998528|583519736|FG001|Randomization Period|Participant no longer meets study criteria|3|||
161582750|NCT02998528|583519737|FG002|Randomization Period|Participant no longer meets study criteria|2|||
161582751|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
161582752|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
161582753|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
161582754|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
161582755|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
161582756|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
161582757|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
161582758|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
161582759|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
161582760|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
161582761|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
161487806|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
161582762|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
161582763|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
161582764|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
161671219|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
161671220|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
161487807|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
161671221|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
161671222|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
161671223|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
161671224|NCT01117857|583849100|FG000|Overall Study|Lost to Follow-up|4|||
161671225|NCT01117857|583849100|FG000|Overall Study|Withdrawal by Subject|4|||
161671226|NCT01117857|583849100|FG000|Overall Study|Physician Decision|1|||
161671227|NCT01119001|583849101|FG000|Overall Study|Withdrawal by Subject|2|||
161671228|NCT05245097|583849102|FG000|Overall Study|Adverse Event|13|||
161671229|NCT05245097|583849103|FG001|Overall Study|Adverse Event|2|||
161671230|NCT05245097|583849102|FG000|Overall Study|Protocol Violation|8|||
161671231|NCT05245097|583849103|FG001|Overall Study|Protocol Violation|6|||
161671232|NCT05245097|583849102|FG000|Overall Study|Withdrawal by Subject|18|||
161487808|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
161487809|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161487810|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161487811|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
161487812|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
161487813|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Other|1|||
161487814|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Other|4|||
161487815|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Other|3|||
161487816|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Other|6|||
161487817|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
161487818|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
161487819|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
161487820|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
161487821|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
161487822|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
161487823|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
161487824|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
161487825|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161487826|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161487827|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
161487828|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
161487829|NCT02925494|583178256|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
161487830|NCT02925494|583178257|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
161487831|NCT02925494|583178258|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
161671233|NCT05245097|583849103|FG001|Overall Study|Withdrawal by Subject|0|||
161671234|NCT05245097|583849102|FG000|Overall Study|Death|6|||
161671235|NCT05245097|583849103|FG001|Overall Study|Death|7|||
161487832|NCT02925494|583178259|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
161487833|NCT01666782|583178265|FG000|Overall Study|Received 2 doses of vaccine|0|||
161487834|NCT01666782|583178266|FG001|Overall Study|Received 2 doses of vaccine|1|||
161487835|NCT01666782|583178265|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
161487836|NCT01666782|583178266|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
161487837|NCT02007109|583178269|FG000|Overall Study|Diary not returned or excluded|102|||
161487838|NCT02007109|583178269|FG000|Overall Study|Excluded - Age<7yo|9|||
161487839|NCT03572062|583178270|FG000|Overall Study|Adverse Event|0|||
161487840|NCT03572062|583178271|FG001|Overall Study|Adverse Event|0|||
161487841|NCT03572062|583178272|FG002|Overall Study|Adverse Event|0|||
161487842|NCT03572062|583178273|FG003|Overall Study|Adverse Event|0|||
161487843|NCT03572062|583178274|FG004|Overall Study|Adverse Event|0|||
161487844|NCT03572062|583178275|FG005|Overall Study|Adverse Event|0|||
161487845|NCT03572062|583178276|FG006|Overall Study|Adverse Event|0|||
161487846|NCT03572062|583178277|FG007|Overall Study|Adverse Event|0|||
161487847|NCT03572062|583178278|FG008|Overall Study|Adverse Event|1|||
161487848|NCT03572062|583178279|FG009|Overall Study|Adverse Event|3|||
161487849|NCT03572062|583178270|FG000|Overall Study|Death|0|||
161487850|NCT03572062|583178271|FG001|Overall Study|Death|0|||
161487851|NCT03572062|583178272|FG002|Overall Study|Death|0|||
161487852|NCT03572062|583178273|FG003|Overall Study|Death|0|||
161487853|NCT03572062|583178274|FG004|Overall Study|Death|0|||
161487854|NCT03572062|583178275|FG005|Overall Study|Death|1|||
161487855|NCT03572062|583178276|FG006|Overall Study|Death|0|||
161487856|NCT03572062|583178277|FG007|Overall Study|Death|0|||
161487857|NCT03572062|583178278|FG008|Overall Study|Death|0|||
161487858|NCT03572062|583178279|FG009|Overall Study|Death|0|||
161487859|NCT03572062|583178270|FG000|Overall Study|Lost to Follow-up|0|||
161487860|NCT03572062|583178271|FG001|Overall Study|Lost to Follow-up|0|||
161671236|NCT05245097|583849102|FG000|Overall Study|Physician Decision|6|||
161487861|NCT03572062|583178272|FG002|Overall Study|Lost to Follow-up|0|||
161487862|NCT03572062|583178273|FG003|Overall Study|Lost to Follow-up|0|||
161487863|NCT03572062|583178274|FG004|Overall Study|Lost to Follow-up|0|||
161487864|NCT03572062|583178275|FG005|Overall Study|Lost to Follow-up|1|||
161487865|NCT03572062|583178276|FG006|Overall Study|Lost to Follow-up|1|||
161487866|NCT03572062|583178277|FG007|Overall Study|Lost to Follow-up|0|||
161671237|NCT05245097|583849103|FG001|Overall Study|Physician Decision|0|||
161582765|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
161582766|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Death|1|||
161582767|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Death|0|||
161582768|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Death|0|||
161582769|NCT02998528|583519735|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
161582770|NCT02998528|583519736|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
161582771|NCT02998528|583519737|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
161582772|NCT02998528|583519735|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
161582773|NCT02998528|583519736|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
161582774|NCT02998528|583519737|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
161582775|NCT02998528|583519735|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
161582776|NCT02998528|583519736|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
161582777|NCT02998528|583519737|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
161582778|NCT02998528|583519735|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
161582779|NCT02998528|583519736|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
161582780|NCT02998528|583519737|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
161582781|NCT02998528|583519735|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
161582782|NCT02998528|583519736|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
161582783|NCT02998528|583519737|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
161582784|NCT02998528|583519735|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
161582785|NCT02998528|583519736|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
161582786|NCT02998528|583519737|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
161582787|NCT00591214|583519738|FG000|Overall Study|Physician Decision|7|||
161582788|NCT00591214|583519738|FG000|Overall Study|Withdrawal by Subject|1|||
161582789|NCT01753570|583519739|FG000|Overall Study|Adverse Event|1|||
161582790|NCT01753570|583519740|FG001|Overall Study|Adverse Event|0|||
161582791|NCT01753570|583519741|FG002|Overall Study|Adverse Event|1|||
161582792|NCT01753570|583519739|FG000|Overall Study|Physician Decision|0|||
161582793|NCT01753570|583519740|FG001|Overall Study|Physician Decision|1|||
161582794|NCT01753570|583519741|FG002|Overall Study|Physician Decision|0|||
161582795|NCT01753570|583519739|FG000|Overall Study|Withdrawal by Subject|1|||
161582796|NCT01753570|583519740|FG001|Overall Study|Withdrawal by Subject|4|||
161582797|NCT01753570|583519741|FG002|Overall Study|Withdrawal by Subject|0|||
161582798|NCT05308316|583519742|FG000|Overall Study|Withdrawal by Subject|2|||
161582799|NCT05308316|583519742|FG000|Overall Study|Physician Decision|1|||
161582800|NCT03671811|583519744|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
161582801|NCT03671811|583519745|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
161582802|NCT02152137|583521095|FG000|Overall Study|Withdrawal by Subject|1|||
161582803|NCT02152137|583521095|FG000|Overall Study|Originally assigned to Arm B|3|||
161582804|NCT03358875|583521096|FG000|Overall Study|Death|409|||
161582805|NCT03358875|583521097|FG001|Overall Study|Death|223|||
161582806|NCT03358875|583521096|FG000|Overall Study|Study Closed by Sponsor|66|||
161582807|NCT03358875|583521097|FG001|Overall Study|Study Closed by Sponsor|29|||
161582808|NCT03358875|583521096|FG000|Overall Study|Withdrawal by Subject|13|||
161582809|NCT03358875|583521097|FG001|Overall Study|Withdrawal by Subject|16|||
161582810|NCT03358875|583521096|FG000|Overall Study|Lost to Follow-up|13|||
161582811|NCT03358875|583521097|FG001|Overall Study|Lost to Follow-up|2|||
161582812|NCT03358875|583521096|FG000|Overall Study|Miscellaneous|33|||
161582813|NCT03358875|583521097|FG001|Overall Study|Miscellaneous|0|||
161582814|NCT03358875|583521096|FG000|Overall Study|Remained on Study|1|||
161582815|NCT03358875|583521097|FG001|Overall Study|Remained on Study|0|||
161582816|NCT05613205|583521112|FG000|Overall Study|Lost to Follow-up|0|||
161582817|NCT05613205|583521113|FG001|Overall Study|Lost to Follow-up|0|||
161582818|NCT05613205|583521114|FG002|Overall Study|Lost to Follow-up|1|||
161582819|NCT05613205|583521115|FG003|Overall Study|Lost to Follow-up|1|||
161582820|NCT05613205|583521116|FG004|Overall Study|Lost to Follow-up|0|||
161582821|NCT05613205|583521112|FG000|Overall Study|Withdrawal by Subject|0|||
161582822|NCT05613205|583521113|FG001|Overall Study|Withdrawal by Subject|0|||
161671238|NCT05245097|583849102|FG000|Overall Study|Relocation|4|||
161671239|NCT05245097|583849103|FG001|Overall Study|Relocation|3|||
161671240|NCT03604523|583849108|FG000|Overall Study|Physician Decision|1|||
161582823|NCT05613205|583521114|FG002|Overall Study|Withdrawal by Subject|1|||
161582824|NCT05613205|583521115|FG003|Overall Study|Withdrawal by Subject|1|||
161582825|NCT05613205|583521116|FG004|Overall Study|Withdrawal by Subject|0|||
161582826|NCT03602014|583521121|FG000|Overall Study|Lost to Follow-up|2|||
161582827|NCT03602014|583521122|FG001|Overall Study|Lost to Follow-up|0|||
161582828|NCT03602014|583521123|FG002|Overall Study|Lost to Follow-up|0|||
161582829|NCT05846646|583521129|FG000|Overall Study|Physician Decision|1|||
161582830|NCT05846646|583521130|FG001|Overall Study|Physician Decision|0|||
161671241|NCT03604523|583849109|FG001|Overall Study|Physician Decision|0|||
161582831|NCT05846646|583521131|FG002|Overall Study|Physician Decision|0|||
161582832|NCT05846646|583521129|FG000|Overall Study|Lack of Efficacy|1|||
161671242|NCT00458341|583849110|FG000|Cycle 1|Adverse Event|1|||
161487867|NCT03572062|583178278|FG008|Overall Study|Lost to Follow-up|0|||
161487868|NCT03572062|583178279|FG009|Overall Study|Lost to Follow-up|0|||
161487869|NCT03572062|583178270|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487870|NCT03572062|583178271|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487871|NCT03572062|583178272|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487872|NCT03572062|583178273|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487873|NCT03572062|583178274|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487874|NCT03572062|583178275|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487875|NCT03572062|583178276|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487876|NCT03572062|583178277|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487877|NCT03572062|583178278|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
161487878|NCT03572062|583178279|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
161487879|NCT03572062|583178270|FG000|Overall Study|Study Terminated By Sponsor|0|||
161487880|NCT03572062|583178271|FG001|Overall Study|Study Terminated By Sponsor|0|||
161487881|NCT03572062|583178272|FG002|Overall Study|Study Terminated By Sponsor|0|||
161487882|NCT03572062|583178273|FG003|Overall Study|Study Terminated By Sponsor|0|||
161487883|NCT03572062|583178274|FG004|Overall Study|Study Terminated By Sponsor|0|||
161487884|NCT03572062|583178275|FG005|Overall Study|Study Terminated By Sponsor|0|||
161487885|NCT03572062|583178276|FG006|Overall Study|Study Terminated By Sponsor|0|||
161487886|NCT03572062|583178277|FG007|Overall Study|Study Terminated By Sponsor|0|||
161487887|NCT03572062|583178278|FG008|Overall Study|Study Terminated By Sponsor|29|||
161487888|NCT03572062|583178279|FG009|Overall Study|Study Terminated By Sponsor|27|||
161817033|NCT01604941|584370907|FG002|Overall Study|Non-compliance|0|||
161487889|NCT03572062|583178270|FG000|Overall Study|Physician Decision|0|||
161487890|NCT03572062|583178271|FG001|Overall Study|Physician Decision|0|||
161487891|NCT03572062|583178272|FG002|Overall Study|Physician Decision|0|||
161487892|NCT03572062|583178273|FG003|Overall Study|Physician Decision|0|||
161487893|NCT03572062|583178274|FG004|Overall Study|Physician Decision|0|||
161487894|NCT03572062|583178275|FG005|Overall Study|Physician Decision|0|||
161487895|NCT03572062|583178276|FG006|Overall Study|Physician Decision|0|||
161487896|NCT03572062|583178277|FG007|Overall Study|Physician Decision|0|||
161487897|NCT03572062|583178278|FG008|Overall Study|Physician Decision|1|||
161487898|NCT03572062|583178279|FG009|Overall Study|Physician Decision|0|||
161487899|NCT03572062|583178270|FG000|Overall Study|Withdrawal by Subject|0|||
161487900|NCT03572062|583178271|FG001|Overall Study|Withdrawal by Subject|0|||
161487901|NCT03572062|583178272|FG002|Overall Study|Withdrawal by Subject|0|||
161487902|NCT03572062|583178273|FG003|Overall Study|Withdrawal by Subject|0|||
161487903|NCT03572062|583178274|FG004|Overall Study|Withdrawal by Subject|0|||
161487904|NCT03572062|583178275|FG005|Overall Study|Withdrawal by Subject|0|||
161487905|NCT03572062|583178276|FG006|Overall Study|Withdrawal by Subject|0|||
161487906|NCT03572062|583178277|FG007|Overall Study|Withdrawal by Subject|0|||
161487907|NCT03572062|583178278|FG008|Overall Study|Withdrawal by Subject|0|||
161487908|NCT03572062|583178279|FG009|Overall Study|Withdrawal by Subject|1|||
161487909|NCT03572062|583178270|FG000|Overall Study|Randomized But Not Treated|0|||
161487910|NCT03572062|583178271|FG001|Overall Study|Randomized But Not Treated|0|||
161487911|NCT03572062|583178272|FG002|Overall Study|Randomized But Not Treated|0|||
161487912|NCT03572062|583178273|FG003|Overall Study|Randomized But Not Treated|0|||
161487913|NCT03572062|583178274|FG004|Overall Study|Randomized But Not Treated|1|||
161487914|NCT03572062|583178275|FG005|Overall Study|Randomized But Not Treated|2|||
161487915|NCT03572062|583178276|FG006|Overall Study|Randomized But Not Treated|0|||
161582833|NCT05846646|583521130|FG001|Overall Study|Lack of Efficacy|1|||
161582834|NCT05846646|583521131|FG002|Overall Study|Lack of Efficacy|0|||
161582835|NCT05846646|583521129|FG000|Overall Study|Early Study Termination|1|||
161582836|NCT05846646|583521130|FG001|Overall Study|Early Study Termination|2|||
161582837|NCT05846646|583521131|FG002|Overall Study|Early Study Termination|0|||
161582838|NCT02088853|583521132|FG000|Overall Study|Pregnancy|1|||
161582839|NCT02088853|583521133|FG001|Overall Study|Pregnancy|0|||
161582840|NCT04704284|583521134|FG000|Overall Study|Withdrawal by Subject|1|||
161582841|NCT01061671|583521142|FG000|Overall Study|Withdrawal by Subject|16|||
161582842|NCT01061671|583521143|FG001|Overall Study|Withdrawal by Subject|20|||
161582843|NCT01061671|583521142|FG000|Overall Study|Lost to Follow-up|3|||
161582844|NCT01061671|583521143|FG001|Overall Study|Lost to Follow-up|5|||
161582845|NCT01061671|583521142|FG000|Overall Study|Death|28|||
161582846|NCT01061671|583521143|FG001|Overall Study|Death|30|||
161582847|NCT00331136|583521154|FG000|Overall Study|Adverse Event|3|||
161582848|NCT00331136|583521155|FG001|Overall Study|Adverse Event|5|||
161582849|NCT00331136|583521156|FG002|Overall Study|Adverse Event|0|||
161817034|NCT01604941|584370908|FG003|Overall Study|Non-compliance|0|||
161487916|NCT03572062|583178277|FG007|Overall Study|Randomized But Not Treated|1|||
161487917|NCT03572062|583178278|FG008|Overall Study|Randomized But Not Treated|0|||
161487918|NCT03572062|583178279|FG009|Overall Study|Randomized But Not Treated|0|||
161487919|NCT01858389|583178280|FG000|Overall Study|Death|1|||
161487920|NCT01858389|583178281|FG001|Overall Study|Death|3|||
161487921|NCT01858389|583178280|FG000|Overall Study|Study terminated by sponsor|0|||
161582850|NCT00331136|583521157|FG003|Overall Study|Adverse Event|1|||
161582851|NCT00331136|583521154|FG000|Overall Study|Withdrawal by Subject|0|||
161487922|NCT01858389|583178281|FG001|Overall Study|Study terminated by sponsor|2|||
161487923|NCT01858389|583178280|FG000|Overall Study|Withdrawal by Subject|0|||
161487924|NCT01858389|583178281|FG001|Overall Study|Withdrawal by Subject|1|||
161487925|NCT01858389|583178280|FG000|Overall Study|Progressive disease|10|||
161487926|NCT01858389|583178281|FG001|Overall Study|Progressive disease|11|||
161487927|NCT01858389|583178280|FG000|Overall Study|Other|2|||
161487928|NCT01858389|583178281|FG001|Overall Study|Other|4|||
161487929|NCT01858389|583178280|FG000|Overall Study|Adverse Event|3|||
161487930|NCT01858389|583178281|FG001|Overall Study|Adverse Event|1|||
161487931|NCT01858389|583178280|FG000|Overall Study|Did not receive treatment|0|||
161487932|NCT01858389|583178281|FG001|Overall Study|Did not receive treatment|3|||
161487933|NCT01691781|583178282|FG000|Overall Study|Withdrawal by Subject|4|||
161487934|NCT01691781|583178283|FG001|Overall Study|Withdrawal by Subject|3|||
161487935|NCT01691781|583178282|FG000|Overall Study|Physician Decision|1|||
161487936|NCT01691781|583178283|FG001|Overall Study|Physician Decision|1|||
161487937|NCT01691781|583178282|FG000|Overall Study|Protocol Violation|2|||
161487938|NCT01691781|583178283|FG001|Overall Study|Protocol Violation|2|||
161487939|NCT01691781|583178282|FG000|Overall Study|Adverse Event|0|||
161487940|NCT01691781|583178283|FG001|Overall Study|Adverse Event|1|||
161487941|NCT03978520|583178284|FG000|Overall Study|Adverse Event|2|||
161487942|NCT03978520|583178285|FG001|Overall Study|Adverse Event|5|||
161487943|NCT03978520|583178286|FG002|Overall Study|Adverse Event|3|||
161487944|NCT03978520|583178287|FG003|Overall Study|Adverse Event|5|||
161487945|NCT03978520|583178288|FG004|Overall Study|Adverse Event|6|||
161487946|NCT03978520|583178284|FG000|Overall Study|Withdrawal by Subject|10|||
161487947|NCT03978520|583178285|FG001|Overall Study|Withdrawal by Subject|4|||
161487948|NCT03978520|583178286|FG002|Overall Study|Withdrawal by Subject|5|||
161487949|NCT03978520|583178287|FG003|Overall Study|Withdrawal by Subject|6|||
161487950|NCT03978520|583178288|FG004|Overall Study|Withdrawal by Subject|5|||
161487951|NCT03978520|583178284|FG000|Overall Study|Lost to Follow-up|2|||
161487952|NCT03978520|583178285|FG001|Overall Study|Lost to Follow-up|2|||
161487953|NCT03978520|583178286|FG002|Overall Study|Lost to Follow-up|2|||
161487954|NCT03978520|583178287|FG003|Overall Study|Lost to Follow-up|0|||
161487955|NCT03978520|583178288|FG004|Overall Study|Lost to Follow-up|1|||
161487956|NCT03978520|583178284|FG000|Overall Study|COVID-19 infection|0|||
161487957|NCT03978520|583178285|FG001|Overall Study|COVID-19 infection|1|||
161487958|NCT03978520|583178286|FG002|Overall Study|COVID-19 infection|0|||
161487959|NCT03978520|583178287|FG003|Overall Study|COVID-19 infection|0|||
161487960|NCT03978520|583178288|FG004|Overall Study|COVID-19 infection|0|||
161487961|NCT03978520|583178284|FG000|Overall Study|Other, not specified|9|||
161487962|NCT03978520|583178285|FG001|Overall Study|Other, not specified|4|||
161487963|NCT03978520|583178286|FG002|Overall Study|Other, not specified|1|||
161487964|NCT03978520|583178287|FG003|Overall Study|Other, not specified|1|||
161487965|NCT03978520|583178288|FG004|Overall Study|Other, not specified|2|||
161487966|NCT03978520|583178284|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
161487967|NCT03978520|583178285|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
161487968|NCT03978520|583178286|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
161487969|NCT03978520|583178287|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
161487970|NCT03978520|583178288|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
161487971|NCT03200860|583178289|FG000|Overall Study|Withdrawal by Subject|1|||
161487972|NCT03200860|583178290|FG001|Overall Study|Withdrawal by Subject|0|||
161487973|NCT02634320|583178296|FG000|Overall Study|Adverse Event|2|||
161487974|NCT02634320|583178296|FG000|Overall Study|Lost to Follow-up|3|||
161487975|NCT02634320|583178296|FG000|Overall Study|Moved out of area|2|||
161487976|NCT02634320|583178296|FG000|Overall Study|Out of window for study visits|1|||
161487977|NCT02634320|583178296|FG000|Overall Study|Protocol Violation|1|||
161487978|NCT02634320|583178296|FG000|Overall Study|Withdrawal by Subject|5|||
161487979|NCT02634320|583178296|FG000|Overall Study|Lack of Efficacy|2|||
161487980|NCT02760069|583178297|FG000|Overall Study|Withdrawal by Subject|0|||
161487981|NCT02760069|583178298|FG001|Overall Study|Withdrawal by Subject|1|||
161487982|NCT02760069|583178299|FG002|Overall Study|Withdrawal by Subject|1|||
161487983|NCT00600483|583178304|FG000|Overall Study|Lost to Follow-up|26|||
161487984|NCT00600483|583178305|FG001|Overall Study|Lost to Follow-up|47|||
161487985|NCT00600483|583178304|FG000|Overall Study|Randomized but not treated|10|||
161487986|NCT00600483|583178305|FG001|Overall Study|Randomized but not treated|0|||
161487987|NCT03031678|583178306|FG000|Overall Study|Study closed prior to completion|1|||
161487988|NCT05109442|583178311|FG000|Overall Study|Withdrawal by Subject|0|||
161671243|NCT00458341|583849111|FG001|Cycle 1|Adverse Event|0|||
161487989|NCT05109442|583178312|FG001|Overall Study|Withdrawal by Subject|0|||
161487990|NCT05109442|583178313|FG002|Overall Study|Withdrawal by Subject|1|||
161487991|NCT05109442|583178314|FG003|Overall Study|Withdrawal by Subject|0|||
161487992|NCT05109442|583178315|FG004|Overall Study|Withdrawal by Subject|0|||
161487993|NCT05109442|583178316|FG005|Overall Study|Withdrawal by Subject|0|||
161487994|NCT05109442|583178311|FG000|Overall Study|Adverse Event|0|||
161487995|NCT05109442|583178312|FG001|Overall Study|Adverse Event|1|||
161487996|NCT05109442|583178313|FG002|Overall Study|Adverse Event|5|||
161671244|NCT05461794|583849112|FG000|Overall Study|Withdrawal by Subject|1|||
161487997|NCT05109442|583178314|FG003|Overall Study|Adverse Event|0|||
161487998|NCT05109442|583178315|FG004|Overall Study|Adverse Event|0|||
161487999|NCT05109442|583178316|FG005|Overall Study|Adverse Event|2|||
161488000|NCT05109442|583178311|FG000|Overall Study|Death|0|||
161488001|NCT05109442|583178312|FG001|Overall Study|Death|0|||
161488002|NCT05109442|583178313|FG002|Overall Study|Death|4|||
161488003|NCT05109442|583178314|FG003|Overall Study|Death|0|||
161488004|NCT05109442|583178315|FG004|Overall Study|Death|0|||
161488005|NCT05109442|583178316|FG005|Overall Study|Death|1|||
161488006|NCT05109442|583178311|FG000|Overall Study|Physician Decision|1|||
161488007|NCT05109442|583178312|FG001|Overall Study|Physician Decision|0|||
161488008|NCT05109442|583178313|FG002|Overall Study|Physician Decision|1|||
161488009|NCT05109442|583178314|FG003|Overall Study|Physician Decision|0|||
161488010|NCT05109442|583178315|FG004|Overall Study|Physician Decision|0|||
161488011|NCT05109442|583178316|FG005|Overall Study|Physician Decision|2|||
161488012|NCT05109442|583178311|FG000|Overall Study|Other than listed|0|||
161488013|NCT05109442|583178312|FG001|Overall Study|Other than listed|0|||
161488014|NCT05109442|583178313|FG002|Overall Study|Other than listed|9|||
161488015|NCT05109442|583178314|FG003|Overall Study|Other than listed|2|||
161488016|NCT05109442|583178315|FG004|Overall Study|Other than listed|0|||
161488017|NCT05109442|583178316|FG005|Overall Study|Other than listed|8|||
161488018|NCT05109442|583178311|FG000|Overall Study|Lack of Efficacy|3|||
161488019|NCT05109442|583178312|FG001|Overall Study|Lack of Efficacy|5|||
161488020|NCT05109442|583178313|FG002|Overall Study|Lack of Efficacy|29|||
161488021|NCT05109442|583178314|FG003|Overall Study|Lack of Efficacy|10|||
161488022|NCT05109442|583178315|FG004|Overall Study|Lack of Efficacy|11|||
161488023|NCT05109442|583178316|FG005|Overall Study|Lack of Efficacy|17|||
161488024|NCT03278613|583178326|FG000|Overall Study|Lost to Follow-up|3|||
161488025|NCT03278613|583178327|FG001|Overall Study|Lost to Follow-up|1|||
161488026|NCT01405456|583178328|FG000|Overall Study|Lost to Follow-up|2|||
161488027|NCT01405456|583178329|FG001|Overall Study|Lost to Follow-up|1|||
161488028|NCT01405456|583178328|FG000|Overall Study|Physician Decision|1|||
161488029|NCT01405456|583178329|FG001|Overall Study|Physician Decision|0|||
161488030|NCT05475236|583178331|FG000|Overall Study|Withdrawal by Subject|0|||
161488031|NCT05475236|583178332|FG001|Overall Study|Withdrawal by Subject|1|||
161488032|NCT02154490|583180397|FG000|Overall Study|No tissue submitted|23|||
161488033|NCT02154490|583180397|FG000|Overall Study|No biomarker results|167|||
161488034|NCT02154490|583180397|FG000|Overall Study|Not assigned to a sub-study|270|||
161488035|NCT02154490|583180397|FG000|Overall Study|Did not register to a sub-study|749|||
161488036|NCT00418314|583180398|FG000|Overall Study|Withdrawal by Subject|1|||
161488037|NCT00418314|583180399|FG001|Overall Study|Withdrawal by Subject|2|||
161488038|NCT00589914|583180409|FG000|Overall Study|Adverse Event|19|||
161488039|NCT00589914|583180410|FG001|Overall Study|Adverse Event|10|||
161488040|NCT00589914|583180409|FG000|Overall Study|Death|2|||
161488041|NCT00589914|583180410|FG001|Overall Study|Death|0|||
161488042|NCT00589914|583180409|FG000|Overall Study|Lack of Efficacy|40|||
161488043|NCT00589914|583180410|FG001|Overall Study|Lack of Efficacy|43|||
161488044|NCT00589914|583180409|FG000|Overall Study|Lost to Follow-up|11|||
161488045|NCT00589914|583180410|FG001|Overall Study|Lost to Follow-up|18|||
161488046|NCT00589914|583180409|FG000|Overall Study|Pregnancy|1|||
161488047|NCT00589914|583180410|FG001|Overall Study|Pregnancy|0|||
161488048|NCT00589914|583180409|FG000|Overall Study|Withdrawal by Subject|55|||
161488049|NCT00589914|583180410|FG001|Overall Study|Withdrawal by Subject|49|||
161488050|NCT00589914|583180409|FG000|Overall Study|Other|22|||
161488051|NCT00589914|583180410|FG001|Overall Study|Other|17|||
161488052|NCT03585504|583180411|FG000|Overall Study|Lost to Follow-up|26|||
161488053|NCT03585504|583180412|FG001|Overall Study|Lost to Follow-up|29|||
161488054|NCT02564042|583180413|FG000|Overall Study|Adverse Event|4|||
161488055|NCT02564042|583180414|FG001|Overall Study|Adverse Event|4|||
161488056|NCT02564042|583180415|FG002|Overall Study|Adverse Event|3|||
161488057|NCT02564042|583180416|FG003|Overall Study|Adverse Event|0|||
161488058|NCT02564042|583180417|FG004|Overall Study|Adverse Event|0|||
161488059|NCT02564042|583180418|FG005|Overall Study|Adverse Event|1|||
161488060|NCT02564042|583180413|FG000|Overall Study|Lost to Follow-up|1|||
161488061|NCT02564042|583180414|FG001|Overall Study|Lost to Follow-up|1|||
161488062|NCT02564042|583180415|FG002|Overall Study|Lost to Follow-up|1|||
161488063|NCT02564042|583180416|FG003|Overall Study|Lost to Follow-up|0|||
161488064|NCT02564042|583180417|FG004|Overall Study|Lost to Follow-up|1|||
161488065|NCT02564042|583180418|FG005|Overall Study|Lost to Follow-up|1|||
161488066|NCT02564042|583180413|FG000|Overall Study|Physician Decision|1|||
161488067|NCT02564042|583180414|FG001|Overall Study|Physician Decision|0|||
161488068|NCT02564042|583180415|FG002|Overall Study|Physician Decision|0|||
161488069|NCT02564042|583180416|FG003|Overall Study|Physician Decision|1|||
161488070|NCT02564042|583180417|FG004|Overall Study|Physician Decision|0|||
161488071|NCT02564042|583180418|FG005|Overall Study|Physician Decision|0|||
161488072|NCT02564042|583180413|FG000|Overall Study|Withdrawal by Subject|5|||
161488073|NCT02564042|583180414|FG001|Overall Study|Withdrawal by Subject|3|||
161488074|NCT02564042|583180415|FG002|Overall Study|Withdrawal by Subject|2|||
161488075|NCT02564042|583180416|FG003|Overall Study|Withdrawal by Subject|2|||
161488076|NCT02564042|583180417|FG004|Overall Study|Withdrawal by Subject|10|||
161488077|NCT02564042|583180418|FG005|Overall Study|Withdrawal by Subject|12|||
161488078|NCT01356966|583180419|FG000|Overall Study|Withdrawal by Subject|1|||
161488079|NCT01356966|583180420|FG001|Overall Study|Withdrawal by Subject|2|||
161488080|NCT01356966|583180419|FG000|Overall Study|Physician Decision|1|||
161488081|NCT01356966|583180420|FG001|Overall Study|Physician Decision|0|||
161488082|NCT00849381|583180422|FG000|Overall Study|Adverse Event|1|||
161488083|NCT00849381|583180422|FG000|Overall Study|Lost to Follow-up|129|||
161488084|NCT00849381|583180422|FG000|Overall Study|Protocol Violation|5|||
161488085|NCT00849381|583180422|FG000|Overall Study|Withdrawal by Subject|6|||
161488086|NCT00849381|583180422|FG000|Overall Study|Other|4|||
161488087|NCT02692703|583180428|FG000|Overall Study|Lost to Follow-up|1|||
161488088|NCT02692703|583180428|FG000|Overall Study|Other|1|||
161488089|NCT02289898|583180429|FG000|Overall Study|Death|5|||
161488090|NCT02289898|583180430|FG001|Overall Study|Death|4|||
161488091|NCT02289898|583180431|FG002|Overall Study|Death|3|||
161488092|NCT02289898|583180429|FG000|Overall Study|Physician Decision|2|||
161488093|NCT02289898|583180430|FG001|Overall Study|Physician Decision|5|||
161488094|NCT02289898|583180431|FG002|Overall Study|Physician Decision|2|||
161488095|NCT02289898|583180429|FG000|Overall Study|Withdrawal by Subject|0|||
161488096|NCT02289898|583180430|FG001|Overall Study|Withdrawal by Subject|4|||
161488097|NCT02289898|583180431|FG002|Overall Study|Withdrawal by Subject|1|||
161488098|NCT02289898|583180429|FG000|Overall Study|Adverse Event|3|||
161488099|NCT02289898|583180430|FG001|Overall Study|Adverse Event|5|||
161488100|NCT02289898|583180431|FG002|Overall Study|Adverse Event|5|||
161488101|NCT02289898|583180429|FG000|Overall Study|Disease progression|34|||
161488102|NCT02289898|583180430|FG001|Overall Study|Disease progression|28|||
161488103|NCT02289898|583180431|FG002|Overall Study|Disease progression|34|||
161488104|NCT02289898|583180429|FG000|Overall Study|Use of another anticancer therapy|0|||
161488105|NCT02289898|583180430|FG001|Overall Study|Use of another anticancer therapy|0|||
161488106|NCT02289898|583180431|FG002|Overall Study|Use of another anticancer therapy|1|||
161488107|NCT02289898|583180429|FG000|Overall Study|Other|8|||
161488108|NCT02289898|583180430|FG001|Overall Study|Other|7|||
161488109|NCT02289898|583180431|FG002|Overall Study|Other|10|||
161488110|NCT04118166|583180432|FG000|Overall Study|Adverse Event|1|||
161488111|NCT03519932|583180435|FG000|First Intervention|Adverse Event|1|||
161488112|NCT03519932|583180436|FG001|First Intervention|Adverse Event|3|||
161488113|NCT02254486|583180437|FG000|Overall Study|Adverse Event|1|||
161488114|NCT02254486|583180438|FG001|Overall Study|Adverse Event|1|||
161488115|NCT02254486|583180437|FG000|Overall Study|Lack of Efficacy|1|||
161488116|NCT02254486|583180438|FG001|Overall Study|Lack of Efficacy|0|||
161488117|NCT02254486|583180437|FG000|Overall Study|Lost to Follow-up|2|||
161488118|NCT02254486|583180438|FG001|Overall Study|Lost to Follow-up|4|||
161488119|NCT02254486|583180437|FG000|Overall Study|Protocol Violation|1|||
161488120|NCT02254486|583180438|FG001|Overall Study|Protocol Violation|2|||
161488121|NCT02254486|583180437|FG000|Overall Study|Withdrawal by Subject|17|||
161488122|NCT02254486|583180438|FG001|Overall Study|Withdrawal by Subject|15|||
161488123|NCT02254486|583180437|FG000|Overall Study|GFR<60mL/min|16|||
161488124|NCT02254486|583180438|FG001|Overall Study|GFR<60mL/min|21|||
161488125|NCT02254486|583180437|FG000|Overall Study|Various|12|||
161488126|NCT02254486|583180438|FG001|Overall Study|Various|12|||
161488127|NCT00103142|583180444|FG000|Overall Study|Adverse Event|1|||
161488128|NCT00103142|583180445|FG001|Overall Study|Adverse Event|0|||
161488129|NCT00103142|583180444|FG000|Overall Study|Progression of disease|2|||
161488130|NCT00103142|583180445|FG001|Overall Study|Progression of disease|1|||
161488131|NCT02772081|583180446|FG000|Overall Study|Physician Decision|1|||
161488132|NCT02772081|583180447|FG001|Overall Study|Physician Decision|1|||
161488133|NCT02772081|583180446|FG000|Overall Study|Death|1|||
161488134|NCT02772081|583180447|FG001|Overall Study|Death|1|||
161488135|NCT01979016|583180457|FG000|Overall Study|Withdrawal by Subject|2|||
161488136|NCT01979016|583180458|FG001|Overall Study|Withdrawal by Subject|0|||
161488137|NCT01979016|583180457|FG000|Overall Study|Adverse Event|0|||
161671245|NCT05461794|583849113|FG001|Overall Study|Withdrawal by Subject|1|||
161671246|NCT05461794|583849114|FG002|Overall Study|Withdrawal by Subject|3|||
161488138|NCT01979016|583180458|FG001|Overall Study|Adverse Event|1|||
161488139|NCT00372112|583180460|FG000|Overall Study|Adverse Event|0|||
161488140|NCT00372112|583180461|FG001|Overall Study|Adverse Event|1|||
161488141|NCT00372112|583180462|FG002|Overall Study|Adverse Event|1|||
161488142|NCT00372112|583180463|FG003|Overall Study|Adverse Event|1|||
161488143|NCT00372112|583180460|FG000|Overall Study|Withdrawal by Subject|0|||
161488144|NCT00372112|583180461|FG001|Overall Study|Withdrawal by Subject|0|||
161488145|NCT00372112|583180462|FG002|Overall Study|Withdrawal by Subject|2|||
161488146|NCT00372112|583180463|FG003|Overall Study|Withdrawal by Subject|1|||
161488147|NCT00372112|583180460|FG000|Overall Study|Exacerbation|0|||
161488148|NCT00372112|583180461|FG001|Overall Study|Exacerbation|0|||
161488149|NCT00372112|583180462|FG002|Overall Study|Exacerbation|0|||
161488150|NCT00372112|583180463|FG003|Overall Study|Exacerbation|1|||
161488151|NCT00372112|583180460|FG000|Overall Study|PR >240 at Visit 3|0|||
161488152|NCT00372112|583180461|FG001|Overall Study|PR >240 at Visit 3|0|||
161488153|NCT00372112|583180462|FG002|Overall Study|PR >240 at Visit 3|0|||
161488154|NCT00372112|583180463|FG003|Overall Study|PR >240 at Visit 3|1|||
161488155|NCT00372112|583180460|FG000|Overall Study|Hepatitis B|1|||
161671247|NCT05461794|583849112|FG000|Overall Study|Study Terminated By Sponsor|18|||
161671248|NCT05461794|583849113|FG001|Overall Study|Study Terminated By Sponsor|13|||
161671249|NCT05461794|583849114|FG002|Overall Study|Study Terminated By Sponsor|16|||
161671250|NCT05461794|583849112|FG000|Overall Study|Death|20|||
161671251|NCT05461794|583849113|FG001|Overall Study|Death|5|||
161671252|NCT05461794|583849114|FG002|Overall Study|Death|19|||
161671253|NCT02730598|583849117|FG000|Overall Study|Withdrawal by Subject|3|||
161671254|NCT02730598|583849118|FG001|Overall Study|Withdrawal by Subject|3|||
161671255|NCT02730598|583849117|FG000|Overall Study|Protocol Violation|0|||
161671256|NCT02730598|583849118|FG001|Overall Study|Protocol Violation|1|||
161671257|NCT02730598|583849117|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
161671258|NCT02730598|583849118|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
161671259|NCT00810394|583849119|FG000|Overall Study|Withdrawal by Subject|3|||
161671260|NCT00467285|583849122|FG000|Overall Study|Lost to Follow-up|4|||
161671261|NCT00467285|583849123|FG001|Overall Study|Lost to Follow-up|4|||
161671262|NCT03891524|583849124|FG000|Overall Study|Death|0|||
161671263|NCT03891524|583849125|FG001|Overall Study|Death|0|||
161671264|NCT03891524|583849126|FG002|Overall Study|Death|0|||
161671265|NCT03891524|583849127|FG003|Overall Study|Death|0|||
161671266|NCT03891524|583849128|FG004|Overall Study|Death|0|||
161671267|NCT03891524|583849129|FG005|Overall Study|Death|0|||
161671268|NCT03891524|583849130|FG006|Overall Study|Death|0|||
161671269|NCT03891524|583849131|FG007|Overall Study|Death|1|||
161671270|NCT03891524|583849124|FG000|Overall Study|Withdrawal by Subject|0|||
161671271|NCT03891524|583849125|FG001|Overall Study|Withdrawal by Subject|1|||
161488156|NCT00372112|583180461|FG001|Overall Study|Hepatitis B|0|||
161488157|NCT00372112|583180462|FG002|Overall Study|Hepatitis B|0|||
161488158|NCT00372112|583180463|FG003|Overall Study|Hepatitis B|0|||
161488159|NCT00372112|583180460|FG000|Overall Study|Other-protocol violation|0|||
161488160|NCT00372112|583180461|FG001|Overall Study|Other-protocol violation|0|||
161488161|NCT00372112|583180462|FG002|Overall Study|Other-protocol violation|1|||
161488162|NCT00372112|583180463|FG003|Overall Study|Other-protocol violation|0|||
161488163|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
161488164|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
161488165|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
161488166|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
161488167|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
161488168|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
161488169|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
161488170|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
161488171|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Patient Request|1|||
161488172|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Patient Request|0|||
161488173|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
161488174|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
161488175|NCT04649060|583180464|FG000|Arm A/Arm B Treatment|Other|1|||
161488176|NCT04649060|583180465|FG001|Arm A/Arm B Treatment|Other|0|||
161488177|NCT04649060|583180464|FG000|Crossover (Arm B)|Adverse Event|0|||
161488178|NCT04649060|583180465|FG001|Crossover (Arm B)|Adverse Event|1|||
161488179|NCT04649060|583180464|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
161488180|NCT04649060|583180465|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
161488181|NCT02706691|583180466|FG000|Overall Study|Adverse Event|1|||
161488182|NCT00171730|583180469|FG000|Overall Study|Adverse Event|3|||
161488183|NCT00171730|583180469|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161488184|NCT00171730|583180469|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
161488185|NCT00171730|583180469|FG000|Overall Study|Withdrawal by Subject|3|||
161488186|NCT01985867|583180470|FG000|Overall Study|Lost to Follow-up|3|||
161488187|NCT01985867|583180471|FG001|Overall Study|Lost to Follow-up|4|||
161488188|NCT01985867|583180470|FG000|Overall Study|Adverse Event|3|||
161488189|NCT01985867|583180471|FG001|Overall Study|Adverse Event|2|||
161488190|NCT01985867|583180470|FG000|Overall Study|Lack of Efficacy|1|||
161488191|NCT01985867|583180471|FG001|Overall Study|Lack of Efficacy|0|||
161488192|NCT01829191|583180472|FG000|Overall Study|Relocation|0|||
161488193|NCT01829191|583180473|FG001|Overall Study|Relocation|1|||
161488194|NCT01829191|583180472|FG000|Overall Study|Lens discomfort|0|||
161488195|NCT01829191|583180473|FG001|Overall Study|Lens discomfort|3|||
161488196|NCT01829191|583180472|FG000|Overall Study|Lens handling difficulty|1|||
161488197|NCT01829191|583180473|FG001|Overall Study|Lens handling difficulty|4|||
161488198|NCT01829191|583180472|FG000|Overall Study|Protocol Violation|4|||
161488199|NCT01829191|583180473|FG001|Overall Study|Protocol Violation|1|||
161488200|NCT01829191|583180472|FG000|Overall Study|Withdrawal by Subject|2|||
161488201|NCT01829191|583180473|FG001|Overall Study|Withdrawal by Subject|3|||
161488202|NCT01829191|583180472|FG000|Overall Study|Lost to Follow-up|0|||
161488203|NCT01829191|583180473|FG001|Overall Study|Lost to Follow-up|1|||
161488204|NCT01829191|583180472|FG000|Overall Study|Subject was fit for ortho - k|0|||
161488205|NCT01829191|583180473|FG001|Overall Study|Subject was fit for ortho - k|1|||
161582852|NCT00331136|583521155|FG001|Overall Study|Withdrawal by Subject|1|||
161582853|NCT00331136|583521156|FG002|Overall Study|Withdrawal by Subject|0|||
161582854|NCT00331136|583521157|FG003|Overall Study|Withdrawal by Subject|0|||
161582855|NCT00331136|583521154|FG000|Overall Study|Lost to Follow-up|0|||
161582856|NCT00331136|583521155|FG001|Overall Study|Lost to Follow-up|1|||
161488206|NCT01276353|583180474|FG000|Double-blind|Adverse Event|2|||
161488207|NCT01276353|583180475|FG001|Double-blind|Adverse Event|0|||
161488208|NCT01276353|583180474|FG000|Double-blind|Withdrawal by Subject|1|||
161488209|NCT01276353|583180475|FG001|Double-blind|Withdrawal by Subject|0|||
161582857|NCT00331136|583521156|FG002|Overall Study|Lost to Follow-up|0|||
161582858|NCT00331136|583521157|FG003|Overall Study|Lost to Follow-up|0|||
161582859|NCT00331136|583521154|FG000|Overall Study|Protocol Violation|1|||
161671272|NCT03891524|583849126|FG002|Overall Study|Withdrawal by Subject|2|||
161488210|NCT01276353|583180474|FG000|Extension|Adverse Event|2|||
161488211|NCT01276353|583180475|FG001|Extension|Adverse Event|5|||
161488212|NCT01276353|583180474|FG000|Extension|Withdrawal by Subject|1|||
161488213|NCT01276353|583180475|FG001|Extension|Withdrawal by Subject|2|||
161488214|NCT01276353|583180474|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
161488215|NCT01276353|583180475|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
161488216|NCT01276353|583180474|FG000|Extension|Physician Decision|1|||
161488217|NCT01276353|583180475|FG001|Extension|Physician Decision|0|||
161488218|NCT01276353|583180474|FG000|Extension|Prohibited concomitant medications|0|||
161488219|NCT01276353|583180475|FG001|Extension|Prohibited concomitant medications|1|||
161488220|NCT00553514|583180481|FG000|Overall Study|Protocol deviation|0|||
161488221|NCT00553514|583180482|FG001|Overall Study|Protocol deviation|0|||
161488222|NCT00553514|583180483|FG002|Overall Study|Protocol deviation|0|||
161582860|NCT00331136|583521155|FG001|Overall Study|Protocol Violation|0|||
161488223|NCT00553514|583180484|FG003|Overall Study|Protocol deviation|1|||
161488224|NCT00553514|583180485|FG004|Overall Study|Protocol deviation|0|||
161671273|NCT03891524|583849127|FG003|Overall Study|Withdrawal by Subject|1|||
161671274|NCT03891524|583849128|FG004|Overall Study|Withdrawal by Subject|2|||
161488225|NCT00553514|583180481|FG000|Overall Study|Lack of ovarian response|4|||
161488226|NCT00553514|583180482|FG001|Overall Study|Lack of ovarian response|5|||
161488227|NCT00553514|583180483|FG002|Overall Study|Lack of ovarian response|5|||
161671275|NCT03891524|583849129|FG005|Overall Study|Withdrawal by Subject|2|||
161671276|NCT03891524|583849130|FG006|Overall Study|Withdrawal by Subject|2|||
161671277|NCT03891524|583849131|FG007|Overall Study|Withdrawal by Subject|1|||
161671278|NCT01210118|583849133|FG000|Overall Study|Lost to Follow-up|1|||
161671279|NCT01210118|583849134|FG001|Overall Study|Lost to Follow-up|1|||
161671280|NCT01210118|583849133|FG000|Overall Study|Protocol Violation|1|||
161671281|NCT01210118|583849134|FG001|Overall Study|Protocol Violation|1|||
161671282|NCT01210118|583849133|FG000|Overall Study|Spontaneous abortion|1|||
161671283|NCT01210118|583849134|FG001|Overall Study|Spontaneous abortion|3|||
161671284|NCT02958267|583849135|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
161671285|NCT02958267|583849136|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
161671286|NCT02958267|583849135|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
161488228|NCT00553514|583180484|FG003|Overall Study|Lack of ovarian response|5|||
161488229|NCT00553514|583180485|FG004|Overall Study|Lack of ovarian response|6|||
161488230|NCT00553514|583180481|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161488231|NCT00553514|583180482|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
161488232|NCT00553514|583180483|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161488233|NCT00553514|583180484|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
161488234|NCT00553514|583180485|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
161488235|NCT00553514|583180481|FG000|Overall Study|Risk of multiple pregnancy|0|||
161488236|NCT00553514|583180482|FG001|Overall Study|Risk of multiple pregnancy|2|||
161488237|NCT00553514|583180483|FG002|Overall Study|Risk of multiple pregnancy|0|||
161488238|NCT00553514|583180484|FG003|Overall Study|Risk of multiple pregnancy|1|||
161488239|NCT00553514|583180485|FG004|Overall Study|Risk of multiple pregnancy|0|||
161488240|NCT00553514|583180481|FG000|Overall Study|Other|1|||
161488241|NCT00553514|583180482|FG001|Overall Study|Other|1|||
161488242|NCT00553514|583180483|FG002|Overall Study|Other|0|||
161671287|NCT02958267|583849136|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
161671288|NCT02958267|583849135|FG000|Follow-up Visits|Additional treatment pursued|2|||
161671289|NCT02958267|583849136|FG001|Follow-up Visits|Additional treatment pursued|1|||
161671290|NCT01079130|583849137|FG000|Overall Study|Adverse Event|1|||
161671291|NCT01079130|583849138|FG001|Overall Study|Adverse Event|1|||
161671292|NCT01079130|583849139|FG002|Overall Study|Adverse Event|0|||
161671293|NCT01079130|583849140|FG003|Overall Study|Adverse Event|1|||
161671294|NCT01079130|583849141|FG004|Overall Study|Adverse Event|5|||
161671295|NCT01079130|583849142|FG005|Overall Study|Adverse Event|1|||
161671296|NCT01079130|583849137|FG000|Overall Study|Administrative problems|1|||
161488243|NCT00553514|583180484|FG003|Overall Study|Other|0|||
161488244|NCT00553514|583180485|FG004|Overall Study|Other|1|||
161488245|NCT01465997|583180486|FG000|Overall Study|Adverse Event|12|||
161488246|NCT01465997|583180487|FG001|Overall Study|Adverse Event|22|||
161488247|NCT01465997|583180486|FG000|Overall Study|Lack of Efficacy|13|||
161488248|NCT01465997|583180487|FG001|Overall Study|Lack of Efficacy|1|||
161488249|NCT01465997|583180486|FG000|Overall Study|Protocol Violation|1|||
161488250|NCT01465997|583180487|FG001|Overall Study|Protocol Violation|4|||
161488251|NCT01465997|583180486|FG000|Overall Study|Lost to Follow-up|6|||
161488252|NCT01465997|583180487|FG001|Overall Study|Lost to Follow-up|9|||
161488253|NCT01465997|583180486|FG000|Overall Study|Withdrawal by Subject|32|||
161488254|NCT01465997|583180487|FG001|Overall Study|Withdrawal by Subject|35|||
161488255|NCT01465997|583180486|FG000|Overall Study|investigator's decision|1|||
161488256|NCT01465997|583180487|FG001|Overall Study|investigator's decision|1|||
161488257|NCT01465997|583180486|FG000|Overall Study|Death|0|||
161488258|NCT01465997|583180487|FG001|Overall Study|Death|1|||
161488259|NCT01465997|583180486|FG000|Overall Study|sponsor's decision|1|||
161671297|NCT01079130|583849138|FG001|Overall Study|Administrative problems|3|||
161671298|NCT01079130|583849139|FG002|Overall Study|Administrative problems|0|||
161671299|NCT01079130|583849140|FG003|Overall Study|Administrative problems|0|||
161671300|NCT01079130|583849141|FG004|Overall Study|Administrative problems|0|||
161671301|NCT01079130|583849142|FG005|Overall Study|Administrative problems|1|||
161817035|NCT01604941|584370909|FG004|Overall Study|Non-compliance|0|||
161488260|NCT01465997|583180487|FG001|Overall Study|sponsor's decision|1|||
161488261|NCT01465997|583180486|FG000|Overall Study|subject withdrew consent|1|||
161488262|NCT01465997|583180487|FG001|Overall Study|subject withdrew consent|0|||
161671302|NCT01079130|583849137|FG000|Overall Study|Withdrawal by Subject|0|||
161671303|NCT01079130|583849138|FG001|Overall Study|Withdrawal by Subject|1|||
161817036|NCT01604941|584370910|FG005|Overall Study|Non-compliance|0|||
161488263|NCT01465997|583180486|FG000|Overall Study|local lab unblinded site|1|||
161488264|NCT01465997|583180487|FG001|Overall Study|local lab unblinded site|0|||
161488265|NCT01465997|583180486|FG000|Overall Study|withdrew before follow-up|0|||
161488266|NCT01465997|583180487|FG001|Overall Study|withdrew before follow-up|13|||
161488267|NCT01465997|583180486|FG000|Overall Study|decision by site staff|0|||
161488268|NCT01465997|583180487|FG001|Overall Study|decision by site staff|1|||
161488269|NCT01465997|583180486|FG000|Overall Study|subject left participation SP0993|0|||
161488270|NCT01465997|583180487|FG001|Overall Study|subject left participation SP0993|1|||
161488271|NCT02205814|583180488|FG000|Overall Study|Lost to Follow-up|0|||
161488272|NCT02205814|583180489|FG001|Overall Study|Lost to Follow-up|0|||
161488273|NCT02205814|583180490|FG002|Overall Study|Lost to Follow-up|0|||
161488274|NCT02205814|583180491|FG003|Overall Study|Lost to Follow-up|1|||
161488275|NCT02205814|583180488|FG000|Overall Study|Lack of Efficacy|1|||
161488276|NCT02205814|583180489|FG001|Overall Study|Lack of Efficacy|0|||
161488277|NCT02205814|583180490|FG002|Overall Study|Lack of Efficacy|1|||
161488278|NCT02205814|583180491|FG003|Overall Study|Lack of Efficacy|1|||
161488279|NCT02205814|583180488|FG000|Overall Study|Physician Decision|0|||
161488280|NCT02205814|583180489|FG001|Overall Study|Physician Decision|0|||
161488281|NCT02205814|583180490|FG002|Overall Study|Physician Decision|1|||
161488282|NCT02205814|583180491|FG003|Overall Study|Physician Decision|0|||
161488283|NCT02205814|583180488|FG000|Overall Study|Protocol Violation|1|||
161488284|NCT02205814|583180489|FG001|Overall Study|Protocol Violation|0|||
161488285|NCT02205814|583180490|FG002|Overall Study|Protocol Violation|0|||
161488286|NCT02205814|583180491|FG003|Overall Study|Protocol Violation|1|||
161488287|NCT02205814|583180488|FG000|Overall Study|Withdrawal by Subject|0|||
161582861|NCT00331136|583521156|FG002|Overall Study|Protocol Violation|0|||
161582862|NCT00331136|583521157|FG003|Overall Study|Protocol Violation|0|||
161582863|NCT00331136|583521154|FG000|Overall Study|Not treated|1|||
161582864|NCT00331136|583521155|FG001|Overall Study|Not treated|0|||
161582865|NCT00331136|583521156|FG002|Overall Study|Not treated|0|||
161582866|NCT00331136|583521157|FG003|Overall Study|Not treated|0|||
161582867|NCT00419341|583521158|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
161582868|NCT00419341|583521158|FG000|Wash in/Wash Out Period|Adverse Event|2|||
161582869|NCT00419341|583521158|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
161582870|NCT00419341|583521158|FG000|Efficacy Period|Withdrawal by Subject|6|||
161488288|NCT02205814|583180489|FG001|Overall Study|Withdrawal by Subject|1|||
161488289|NCT02205814|583180490|FG002|Overall Study|Withdrawal by Subject|2|||
161488290|NCT02205814|583180491|FG003|Overall Study|Withdrawal by Subject|1|||
161488291|NCT02205814|583180488|FG000|Overall Study|not compliant with study procedures|0|||
161488292|NCT02205814|583180489|FG001|Overall Study|not compliant with study procedures|0|||
161488293|NCT02205814|583180490|FG002|Overall Study|not compliant with study procedures|1|||
161488294|NCT02205814|583180491|FG003|Overall Study|not compliant with study procedures|0|||
161488295|NCT01426373|583180492|FG000|Overall Study|Adverse Event|6|||
161488296|NCT01426373|583180492|FG000|Overall Study|Lost to Follow-up|14|||
161488297|NCT01426373|583180492|FG000|Overall Study|Participant Convenience|10|||
161488298|NCT01426373|583180492|FG000|Overall Study|Miscellaneous Reasons|4|||
161488299|NCT00005937|583180500|FG000|Overall Study|Lack of Efficacy|5|||
161488300|NCT00160251|583180501|FG000|Prior to Amendment 2|Adverse Event|2|||
161488301|NCT00160251|583180502|FG001|Prior to Amendment 2|Adverse Event|1|||
161582871|NCT00419341|583521158|FG000|Efficacy Period|Protocol Violation|1|||
161582872|NCT00419341|583521158|FG000|Efficacy Period|Lost to Follow-up|1|||
161582873|NCT00419341|583521158|FG000|Efficacy Period|Non-compliance|1|||
161582874|NCT00419341|583521158|FG000|Efficacy Period|Termination of study site|1|||
161488302|NCT00160251|583180503|FG002|Prior to Amendment 2|Adverse Event|3|||
161488303|NCT00160251|583180504|FG003|Prior to Amendment 2|Adverse Event|1|||
161488304|NCT00160251|583180505|FG004|Prior to Amendment 2|Adverse Event|1|||
161488305|NCT00160251|583180506|FG005|Prior to Amendment 2|Adverse Event|1|||
161488306|NCT00160251|583180507|FG006|Prior to Amendment 2|Adverse Event|1|||
161582875|NCT02321514|583521159|FG000|Overall Study|Death|15|||
161671304|NCT01079130|583849139|FG002|Overall Study|Withdrawal by Subject|0|||
161671305|NCT01079130|583849140|FG003|Overall Study|Withdrawal by Subject|0|||
161671306|NCT01079130|583849141|FG004|Overall Study|Withdrawal by Subject|1|||
161671307|NCT01079130|583849142|FG005|Overall Study|Withdrawal by Subject|3|||
161488307|NCT00160251|583180508|FG007|Prior to Amendment 2|Adverse Event|0|||
161488308|NCT00160251|583180501|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
161488309|NCT00160251|583180502|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
161582876|NCT02321514|583521159|FG000|Overall Study|Missed Visit|7|||
161582877|NCT02321514|583521159|FG000|Overall Study|Study Exit|3|||
161582878|NCT04578106|583521169|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
161671308|NCT01079130|583849137|FG000|Overall Study|Protocol deviation|0|||
161488310|NCT00160251|583180503|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
161488311|NCT00160251|583180504|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
161488312|NCT00160251|583180505|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
161488313|NCT00160251|583180506|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
161488314|NCT00160251|583180507|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
161488315|NCT00160251|583180508|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
161488316|NCT00160251|583180501|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
161582879|NCT00424463|583521172|FG000|Overall Study|Adverse Event|2|||
161582880|NCT00424463|583521173|FG001|Overall Study|Adverse Event|3|||
161582881|NCT00424463|583521174|FG002|Overall Study|Adverse Event|2|||
161671309|NCT01079130|583849138|FG001|Overall Study|Protocol deviation|2|||
161488317|NCT00160251|583180502|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
161488318|NCT00160251|583180503|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
161488319|NCT00160251|583180504|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
161488320|NCT00160251|583180505|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
161488321|NCT00160251|583180506|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
161488322|NCT00160251|583180507|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
161488323|NCT00160251|583180508|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
161488324|NCT00160251|583180501|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
161488325|NCT00160251|583180502|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
161488326|NCT00160251|583180503|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
161488327|NCT00160251|583180504|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
161488328|NCT00160251|583180505|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
161488329|NCT00160251|583180506|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
161488330|NCT00160251|583180507|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
161488331|NCT00160251|583180508|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
161488332|NCT00160251|583180501|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
161488333|NCT00160251|583180502|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
161488334|NCT00160251|583180503|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
161488335|NCT00160251|583180504|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
161488336|NCT00160251|583180505|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
161488337|NCT00160251|583180506|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
161488338|NCT00160251|583180507|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
161488339|NCT00160251|583180508|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
161488340|NCT00160251|583180501|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
161488341|NCT00160251|583180502|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
161488342|NCT00160251|583180503|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
161488343|NCT00160251|583180504|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
161488344|NCT00160251|583180505|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
161488345|NCT00160251|583180506|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
161488346|NCT00160251|583180507|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
161488347|NCT00160251|583180508|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
161488348|NCT00160251|583180501|FG000|Post-amendment 2|Adverse Event|0|||
161488349|NCT00160251|583180502|FG001|Post-amendment 2|Adverse Event|0|||
161488350|NCT00160251|583180503|FG002|Post-amendment 2|Adverse Event|0|||
161488351|NCT00160251|583180504|FG003|Post-amendment 2|Adverse Event|0|||
161488352|NCT00160251|583180505|FG004|Post-amendment 2|Adverse Event|0|||
161488353|NCT00160251|583180506|FG005|Post-amendment 2|Adverse Event|0|||
161488354|NCT00160251|583180507|FG006|Post-amendment 2|Adverse Event|0|||
161488355|NCT00160251|583180508|FG007|Post-amendment 2|Adverse Event|20|||
161488356|NCT00160251|583180501|FG000|Post-amendment 2|Lack of Efficacy|0|||
161488357|NCT00160251|583180502|FG001|Post-amendment 2|Lack of Efficacy|0|||
161488358|NCT00160251|583180503|FG002|Post-amendment 2|Lack of Efficacy|0|||
161488359|NCT00160251|583180504|FG003|Post-amendment 2|Lack of Efficacy|0|||
161488360|NCT00160251|583180505|FG004|Post-amendment 2|Lack of Efficacy|0|||
161488361|NCT00160251|583180506|FG005|Post-amendment 2|Lack of Efficacy|0|||
161488362|NCT00160251|583180507|FG006|Post-amendment 2|Lack of Efficacy|0|||
161488363|NCT00160251|583180508|FG007|Post-amendment 2|Lack of Efficacy|24|||
161488364|NCT00160251|583180501|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488365|NCT00160251|583180502|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488366|NCT00160251|583180503|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488367|NCT00160251|583180504|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488368|NCT00160251|583180505|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488369|NCT00160251|583180506|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488370|NCT00160251|583180507|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
161488371|NCT00160251|583180508|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
161488372|NCT01288469|583180509|FG000|Overall Study|Adverse Event|4|||
161488373|NCT01288469|583180510|FG001|Overall Study|Adverse Event|1|||
161488374|NCT01288469|583180511|FG002|Overall Study|Adverse Event|1|||
161488375|NCT01288469|583180509|FG000|Overall Study|Poor compliance to protocol|0|||
161582882|NCT00424463|583521172|FG000|Overall Study|Physician Decision|0|||
161582883|NCT00424463|583521173|FG001|Overall Study|Physician Decision|2|||
161582884|NCT00424463|583521174|FG002|Overall Study|Physician Decision|2|||
161582885|NCT00424463|583521172|FG000|Overall Study|Withdrawal by Subject|4|||
161582886|NCT00424463|583521173|FG001|Overall Study|Withdrawal by Subject|2|||
161488376|NCT01288469|583180510|FG001|Overall Study|Poor compliance to protocol|1|||
161488377|NCT01288469|583180511|FG002|Overall Study|Poor compliance to protocol|0|||
161582887|NCT00424463|583521174|FG002|Overall Study|Withdrawal by Subject|5|||
161582888|NCT00424463|583521172|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
161582889|NCT00424463|583521173|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
161488378|NCT01288469|583180509|FG000|Overall Study|Participant Moved|1|||
161582890|NCT00424463|583521174|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
161488379|NCT01288469|583180510|FG001|Overall Study|Participant Moved|0|||
161488380|NCT01288469|583180511|FG002|Overall Study|Participant Moved|0|||
161488381|NCT01288469|583180509|FG000|Overall Study|Consent withdrawn by subject|1|||
161488382|NCT01288469|583180510|FG001|Overall Study|Consent withdrawn by subject|1|||
161488383|NCT01288469|583180511|FG002|Overall Study|Consent withdrawn by subject|1|||
161488384|NCT01288469|583180509|FG000|Overall Study|Exclusion criteria finally met|1|||
161488385|NCT01288469|583180510|FG001|Overall Study|Exclusion criteria finally met|0|||
161488386|NCT01288469|583180511|FG002|Overall Study|Exclusion criteria finally met|0|||
161488387|NCT01574612|583180512|FG000|Overall Study|Adverse Event|3|||
161488388|NCT01574612|583180512|FG000|Overall Study|non compliant with drug|2|||
161488389|NCT01574612|583180512|FG000|Overall Study|Withdrawal by Subject|1|||
161488390|NCT01574612|583180512|FG000|Overall Study|Lost to Follow-up|2|||
161488391|NCT00582166|583180513|FG000|Overall Study|Death|1|||
161488392|NCT00582166|583180513|FG000|Overall Study|Ineligible pathology|1|||
161488393|NCT01606436|583180514|FG000|Overall Study|Withdrawal by Subject|0|||
161488394|NCT01606436|583180515|FG001|Overall Study|Withdrawal by Subject|0|||
161488395|NCT01606436|583180516|FG002|Overall Study|Withdrawal by Subject|1|||
161488396|NCT01606436|583180517|FG003|Overall Study|Withdrawal by Subject|1|||
161488397|NCT01606436|583180518|FG004|Overall Study|Withdrawal by Subject|1|||
161488398|NCT01606436|583180519|FG005|Overall Study|Withdrawal by Subject|0|||
161488399|NCT01606436|583180514|FG000|Overall Study|Adverse Event|0|||
161488400|NCT01606436|583180515|FG001|Overall Study|Adverse Event|0|||
161488401|NCT01606436|583180516|FG002|Overall Study|Adverse Event|1|||
161488402|NCT01606436|583180517|FG003|Overall Study|Adverse Event|0|||
161488403|NCT01606436|583180518|FG004|Overall Study|Adverse Event|0|||
161488404|NCT01606436|583180519|FG005|Overall Study|Adverse Event|0|||
161488405|NCT01606436|583180514|FG000|Overall Study|Sponsor Decision|0|||
161488406|NCT01606436|583180515|FG001|Overall Study|Sponsor Decision|0|||
161488407|NCT01606436|583180516|FG002|Overall Study|Sponsor Decision|0|||
161488408|NCT01606436|583180517|FG003|Overall Study|Sponsor Decision|1|||
161488409|NCT01606436|583180518|FG004|Overall Study|Sponsor Decision|0|||
161488410|NCT01606436|583180519|FG005|Overall Study|Sponsor Decision|0|||
161488411|NCT02859454|583180522|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
161488412|NCT02452398|583180527|FG000|Overall Study|Adverse Event|1|||
161488413|NCT02452398|583180527|FG000|Overall Study|Lost to Follow-up|28|||
161488414|NCT02452398|583180527|FG000|Overall Study|Physician Decision|2|||
161488415|NCT02452398|583180527|FG000|Overall Study|Withdrawal by Subject|6|||
161488416|NCT02452398|583180527|FG000|Overall Study|Moved away|4|||
161488417|NCT03334448|583180528|FG000|Washout|Personal Reason|0|||
161488418|NCT03334448|583180529|FG001|Washout|Personal Reason|1|||
161488419|NCT03334448|583180530|FG002|Washout|Personal Reason|0|||
161488420|NCT03334448|583180531|FG003|Washout|Personal Reason|0|||
161671310|NCT01079130|583849139|FG002|Overall Study|Protocol deviation|1|||
161671311|NCT01079130|583849140|FG003|Overall Study|Protocol deviation|2|||
161671312|NCT01079130|583849141|FG004|Overall Study|Protocol deviation|0|||
161671313|NCT01079130|583849142|FG005|Overall Study|Protocol deviation|0|||
161671314|NCT01079130|583849137|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161488421|NCT03334448|583180528|FG000|Washout|Protocol Violation|0|||
161488422|NCT03334448|583180529|FG001|Washout|Protocol Violation|0|||
161488423|NCT03334448|583180530|FG002|Washout|Protocol Violation|0|||
161488424|NCT03334448|583180531|FG003|Washout|Protocol Violation|1|||
161488425|NCT02326025|583180532|FG000|Overall Study|Adverse Event|3|||
161488426|NCT02326025|583180533|FG001|Overall Study|Adverse Event|0|||
161488427|NCT02326025|583180532|FG000|Overall Study|Physician Decision|1|||
161488428|NCT02326025|583180533|FG001|Overall Study|Physician Decision|2|||
161488429|NCT02326025|583180532|FG000|Overall Study|Physician and Participant Decision|1|||
161488430|NCT02326025|583180533|FG001|Overall Study|Physician and Participant Decision|0|||
161488431|NCT02326025|583180532|FG000|Overall Study|Withdrawal by Subject|0|||
161488432|NCT02326025|583180533|FG001|Overall Study|Withdrawal by Subject|2|||
161488433|NCT02326025|583180532|FG000|Overall Study|Protocol Violation|0|||
161488434|NCT02326025|583180533|FG001|Overall Study|Protocol Violation|1|||
161488435|NCT01365910|583180534|FG000|Overall Study|Withdrawal by Subject|7|||
161488436|NCT01365910|583180534|FG000|Overall Study|disease progression|18|||
161488437|NCT01365910|583180534|FG000|Overall Study|Adverse Event|3|||
161488438|NCT01365910|583180534|FG000|Overall Study|other complicating disease|1|||
161488439|NCT01365910|583180534|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
161488440|NCT02013791|583180535|FG000|Period 1|Lost to Follow-up|0|||
161488441|NCT02013791|583180536|FG001|Period 1|Lost to Follow-up|0|||
161488442|NCT02013791|583180537|FG002|Period 1|Lost to Follow-up|0|||
161488443|NCT02013791|583180538|FG003|Period 1|Lost to Follow-up|1|||
161488444|NCT02013791|583180539|FG004|Period 1|Lost to Follow-up|0|||
161488445|NCT02013791|583180540|FG005|Period 1|Lost to Follow-up|0|||
161488446|NCT02013791|583180541|FG006|Period 1|Lost to Follow-up|1|||
161488447|NCT02013791|583180542|FG007|Period 1|Lost to Follow-up|1|||
161488448|NCT02013791|583180543|FG008|Period 1|Lost to Follow-up|0|||
161488449|NCT02013791|583180535|FG000|Period 1|Other Miscellaneous Reasons|0|||
161488450|NCT02013791|583180536|FG001|Period 1|Other Miscellaneous Reasons|2|||
161488451|NCT02013791|583180537|FG002|Period 1|Other Miscellaneous Reasons|0|||
161488452|NCT02013791|583180538|FG003|Period 1|Other Miscellaneous Reasons|0|||
161488453|NCT02013791|583180539|FG004|Period 1|Other Miscellaneous Reasons|0|||
161488454|NCT02013791|583180540|FG005|Period 1|Other Miscellaneous Reasons|0|||
161488455|NCT02013791|583180541|FG006|Period 1|Other Miscellaneous Reasons|0|||
161488456|NCT02013791|583180542|FG007|Period 1|Other Miscellaneous Reasons|0|||
161488457|NCT02013791|583180543|FG008|Period 1|Other Miscellaneous Reasons|0|||
161488458|NCT03798483|583180544|FG000|Overall Study|Lost to Follow-up|2|||
161488459|NCT02643082|583180545|FG000|Period 1|Adverse Event|1|||
161488460|NCT02643082|583180546|FG001|Period 1|Adverse Event|0|||
161488461|NCT02289417|583180547|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
161488462|NCT02289417|583180548|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488463|NCT02289417|583180549|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
161488464|NCT02289417|583180550|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488465|NCT02289417|583180551|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488466|NCT02289417|583180552|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488467|NCT02289417|583180553|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488468|NCT02289417|583180554|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488469|NCT02289417|583180555|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161488470|NCT02289417|583180547|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
161488471|NCT02289417|583180548|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
161488472|NCT02289417|583180549|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
161488473|NCT02289417|583180550|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
161488474|NCT02289417|583180551|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
161488475|NCT02289417|583180552|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
161488476|NCT02289417|583180553|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
161488477|NCT02289417|583180554|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
161488478|NCT02289417|583180555|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
161488479|NCT02289417|583180547|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488480|NCT02289417|583180548|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
161488481|NCT02289417|583180549|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488482|NCT02289417|583180550|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488483|NCT02289417|583180551|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488484|NCT02289417|583180552|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488485|NCT02289417|583180553|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488486|NCT02289417|583180554|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488487|NCT02289417|583180555|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
161488488|NCT02289417|583180547|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
161488489|NCT02289417|583180548|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488490|NCT02289417|583180549|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488491|NCT02289417|583180550|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488492|NCT02289417|583180551|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488493|NCT02289417|583180552|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488494|NCT02289417|583180553|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488495|NCT02289417|583180554|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488496|NCT02289417|583180555|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
161488497|NCT02289417|583180547|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
161488498|NCT02289417|583180548|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
161488499|NCT02289417|583180549|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
161488500|NCT02289417|583180550|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
161488501|NCT02289417|583180551|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
161488502|NCT02289417|583180552|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
161488503|NCT02289417|583180553|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
161488504|NCT02289417|583180554|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
161488505|NCT02289417|583180555|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
161488506|NCT02289417|583180547|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161488507|NCT02289417|583180548|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161488508|NCT02289417|583180549|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
161488509|NCT02289417|583180550|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161488510|NCT02289417|583180551|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161488511|NCT02289417|583180552|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161488512|NCT02289417|583180553|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161582891|NCT00424463|583521172|FG000|Overall Study|Patient's convenience|0|||
161582892|NCT00424463|583521173|FG001|Overall Study|Patient's convenience|0|||
161582893|NCT00424463|583521174|FG002|Overall Study|Patient's convenience|1|||
161582894|NCT03570892|583521175|FG000|Overall Study|Death|51|||
161582895|NCT03570892|583521176|FG001|Overall Study|Death|45|||
161582896|NCT03570892|583521175|FG000|Overall Study|Subject decision|5|||
161922847|NCT00021255|584764884|FG000|Overall Study|Breast cancer relapse|5|||
161488513|NCT02289417|583180554|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161488514|NCT02289417|583180555|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
161582897|NCT03570892|583521176|FG001|Overall Study|Subject decision|3|||
161582898|NCT03570892|583521175|FG000|Overall Study|Protocol Violation|1|||
161488515|NCT02289417|583180547|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
161488516|NCT02289417|583180548|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
161488517|NCT02289417|583180549|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
161488518|NCT02289417|583180550|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
161488519|NCT02289417|583180551|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
161488520|NCT02289417|583180552|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
161488521|NCT02289417|583180553|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
161488522|NCT02289417|583180554|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
161488523|NCT02289417|583180555|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
161488524|NCT02289417|583180547|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
161488525|NCT02289417|583180548|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
161488526|NCT02289417|583180549|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
161488527|NCT02289417|583180550|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
161488528|NCT02289417|583180551|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
161488529|NCT02289417|583180552|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
161488530|NCT02289417|583180553|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
161488531|NCT02289417|583180554|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
161488532|NCT02289417|583180555|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
161488533|NCT02289417|583180547|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488534|NCT02289417|583180548|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488535|NCT02289417|583180549|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488536|NCT02289417|583180550|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488537|NCT02289417|583180551|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488538|NCT02289417|583180552|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488539|NCT02289417|583180553|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
161488540|NCT02289417|583180554|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488541|NCT02289417|583180555|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
161488542|NCT02289417|583180547|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488543|NCT02289417|583180548|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488544|NCT02289417|583180549|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488545|NCT02289417|583180550|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
161488546|NCT02289417|583180551|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488547|NCT02289417|583180552|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488548|NCT02289417|583180553|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
161488549|NCT02289417|583180554|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488550|NCT02289417|583180555|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
161488551|NCT02289417|583180547|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
161488552|NCT02289417|583180548|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
161488553|NCT02289417|583180549|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
161488554|NCT02289417|583180550|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
161488555|NCT02289417|583180551|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
161488556|NCT02289417|583180552|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
161488557|NCT02289417|583180553|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
161488558|NCT02289417|583180554|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
161488559|NCT02289417|583180555|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
161817037|NCT01604941|584370905|FG000|Overall Study|Participant Decision|0|||
161488560|NCT02289417|583180547|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488561|NCT02289417|583180548|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488562|NCT02289417|583180549|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488563|NCT02289417|583180550|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488564|NCT02289417|583180551|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488565|NCT02289417|583180552|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488566|NCT02289417|583180553|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
161488567|NCT02289417|583180554|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
161488568|NCT02289417|583180555|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
161488569|NCT02289417|583180547|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488570|NCT02289417|583180548|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488571|NCT02289417|583180549|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488572|NCT02289417|583180550|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488573|NCT02289417|583180551|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488574|NCT02289417|583180552|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488575|NCT02289417|583180553|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
161488576|NCT02289417|583180554|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
161488577|NCT02289417|583180555|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
161488578|NCT02289417|583180547|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488579|NCT02289417|583180548|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
161671315|NCT01079130|583849138|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161817038|NCT01604941|584370906|FG001|Overall Study|Participant Decision|0|||
161488580|NCT02289417|583180549|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488581|NCT02289417|583180550|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488582|NCT02289417|583180551|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488583|NCT02289417|583180552|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488584|NCT02289417|583180553|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488585|NCT02289417|583180554|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
161488586|NCT02289417|583180555|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
161488587|NCT02725710|583180556|FG000|Overall Study|Lost to Follow-up|1|||
161488588|NCT02725710|583180557|FG001|Overall Study|Lost to Follow-up|0|||
161488589|NCT02505867|583180558|FG000|Overall Study|Lack of Efficacy|6|||
161488590|NCT02505867|583180559|FG001|Overall Study|Lack of Efficacy|6|||
161488591|NCT01782222|583180560|FG000|Overall Study|Adverse Event|4|||
161488592|NCT01782222|583180561|FG001|Overall Study|Adverse Event|5|||
161488593|NCT01782222|583180562|FG002|Overall Study|Adverse Event|3|||
161488594|NCT01782222|583180560|FG000|Overall Study|Lack of Efficacy|2|||
161488595|NCT01782222|583180561|FG001|Overall Study|Lack of Efficacy|1|||
161488596|NCT01782222|583180562|FG002|Overall Study|Lack of Efficacy|0|||
161488597|NCT01782222|583180560|FG000|Overall Study|Protocol Violation|1|||
161488598|NCT01782222|583180561|FG001|Overall Study|Protocol Violation|0|||
161488599|NCT01782222|583180562|FG002|Overall Study|Protocol Violation|0|||
161488600|NCT01782222|583180560|FG000|Overall Study|Withdrawal by Subject|1|||
161488601|NCT01782222|583180561|FG001|Overall Study|Withdrawal by Subject|4|||
161488602|NCT01782222|583180562|FG002|Overall Study|Withdrawal by Subject|1|||
161488603|NCT01782222|583180560|FG000|Overall Study|Moved to other state|0|||
161488604|NCT01782222|583180561|FG001|Overall Study|Moved to other state|1|||
161488605|NCT01782222|583180562|FG002|Overall Study|Moved to other state|0|||
161488606|NCT01605877|583180563|FG000|Overall Study|Withdrawal by Subject|1|||
161488607|NCT01918085|583180566|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
161488608|NCT01918085|583180567|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
161488609|NCT00687323|583180568|FG000|Overall Study|Death|25|||
161488610|NCT00687323|583180568|FG000|Overall Study|Withdrawal by Subject|1|||
161488611|NCT00687323|583180568|FG000|Overall Study|Excluded from efficacy evaluations|6|||
161488612|NCT00687323|583180568|FG000|Overall Study|Screen failure|148|||
161488613|NCT03655691|583180574|FG000|Overall Study|Adverse Event|0|||
161488614|NCT03655691|583180575|FG001|Overall Study|Adverse Event|0|||
161488615|NCT03655691|583180576|FG002|Overall Study|Adverse Event|1|||
161488616|NCT03655691|583180574|FG000|Overall Study|Lost to Follow-up|1|||
161488617|NCT03655691|583180575|FG001|Overall Study|Lost to Follow-up|1|||
161488618|NCT03655691|583180576|FG002|Overall Study|Lost to Follow-up|2|||
161488619|NCT03655691|583180574|FG000|Overall Study|Protocol Violation|0|||
161488620|NCT03655691|583180575|FG001|Overall Study|Protocol Violation|1|||
161488621|NCT03655691|583180576|FG002|Overall Study|Protocol Violation|0|||
161488622|NCT03655691|583180574|FG000|Overall Study|Withdrawal by Subject|1|||
161488623|NCT03655691|583180575|FG001|Overall Study|Withdrawal by Subject|1|||
161488624|NCT03655691|583180576|FG002|Overall Study|Withdrawal by Subject|0|||
161488625|NCT04557371|583180577|FG000|Overall Study|Covid-19-related|0|||
161488626|NCT04557371|583180578|FG001|Overall Study|Covid-19-related|1|||
161488627|NCT04557371|583180579|FG002|Overall Study|Covid-19-related|0|||
161488628|NCT04557371|583180577|FG000|Overall Study|Withdrawal by Subject|0|||
161488629|NCT04557371|583180578|FG001|Overall Study|Withdrawal by Subject|1|||
161488630|NCT04557371|583180579|FG002|Overall Study|Withdrawal by Subject|0|||
161488631|NCT04557371|583180577|FG000|Overall Study|Adverse Event|1|||
161488632|NCT04557371|583180578|FG001|Overall Study|Adverse Event|0|||
161488633|NCT04557371|583180579|FG002|Overall Study|Adverse Event|0|||
161488634|NCT01428453|583180582|FG000|Overall Study|Adverse Event|2|||
161488635|NCT01428453|583180583|FG001|Overall Study|Adverse Event|7|||
161488636|NCT01428453|583180582|FG000|Overall Study|Protocol Violation|1|||
161488637|NCT01428453|583180583|FG001|Overall Study|Protocol Violation|0|||
161488638|NCT01428453|583180582|FG000|Overall Study|Lost to Follow-up|0|||
161488639|NCT01428453|583180583|FG001|Overall Study|Lost to Follow-up|1|||
161488640|NCT01428453|583180582|FG000|Overall Study|Withdrawal by Subject|3|||
161488641|NCT01428453|583180583|FG001|Overall Study|Withdrawal by Subject|1|||
161488642|NCT01996709|583180584|FG000|Overall Study|Withdrawal by Subject|1|||
161488643|NCT01996709|583180585|FG001|Overall Study|Withdrawal by Subject|0|||
161488644|NCT01996709|583180584|FG000|Overall Study|Lost to Follow-up|3|||
161488645|NCT01996709|583180585|FG001|Overall Study|Lost to Follow-up|0|||
161488646|NCT01996709|583180584|FG000|Overall Study|Subject Non-Compliant|1|||
161488647|NCT01996709|583180585|FG001|Overall Study|Subject Non-Compliant|0|||
161488648|NCT01996709|583180584|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161488649|NCT01996709|583180585|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
161488650|NCT03918447|583180586|FG000|Overall Study|Death|1|||
161488651|NCT03918447|583180587|FG001|Overall Study|Death|0|||
161488652|NCT03918447|583180586|FG000|Overall Study|Lost to Follow-up|13|||
161488653|NCT03918447|583180587|FG001|Overall Study|Lost to Follow-up|6|||
161488654|NCT03918447|583180586|FG000|Overall Study|Withdrawal by Subject|19|||
161488655|NCT03918447|583180587|FG001|Overall Study|Withdrawal by Subject|17|||
161488656|NCT03918447|583180586|FG000|Overall Study|Study Terminated by Sponsor|195|||
161671316|NCT01079130|583849139|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161671317|NCT01079130|583849140|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161671318|NCT01079130|583849141|FG004|Overall Study|Abnormal test procedure result(s)|1|||
161671319|NCT01079130|583849142|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161671320|NCT01079130|583849137|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161671321|NCT01079130|583849138|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161671322|NCT01079130|583849139|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161671323|NCT01079130|583849140|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161671324|NCT01079130|583849141|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161671325|NCT01079130|583849142|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161671326|NCT01079130|583849137|FG000|Overall Study|Lost to Follow-up|0|||
161671327|NCT01079130|583849138|FG001|Overall Study|Lost to Follow-up|0|||
161671328|NCT01079130|583849139|FG002|Overall Study|Lost to Follow-up|0|||
161671329|NCT01079130|583849140|FG003|Overall Study|Lost to Follow-up|0|||
161671330|NCT01079130|583849141|FG004|Overall Study|Lost to Follow-up|1|||
161671331|NCT01079130|583849142|FG005|Overall Study|Lost to Follow-up|0|||
161671332|NCT00475033|583849147|FG000|Infant Series|Failed to return|3|||
161671333|NCT00475033|583849148|FG001|Infant Series|Failed to return|4|||
161671334|NCT00475033|583849147|FG000|Infant Series|Parent or legal guardian request|1|||
161671335|NCT00475033|583849148|FG001|Infant Series|Parent or legal guardian request|5|||
161671336|NCT00475033|583849147|FG000|Infant Series|Protocol Violation|1|||
161671337|NCT00475033|583849148|FG001|Infant Series|Protocol Violation|2|||
161671338|NCT00475033|583849147|FG000|Infant Series|Lost to Follow-up|2|||
161671339|NCT00475033|583849148|FG001|Infant Series|Lost to Follow-up|0|||
161671340|NCT00475033|583849147|FG000|Infant Series|Adverse Event|0|||
161671341|NCT00475033|583849148|FG001|Infant Series|Adverse Event|2|||
161671342|NCT00475033|583849147|FG000|After the Infant Series|Adverse Event|0|||
161671343|NCT00475033|583849148|FG001|After the Infant Series|Adverse Event|4|||
161671344|NCT00475033|583849147|FG000|After the Infant Series|Parent or legal guardian request|2|||
161671345|NCT00475033|583849148|FG001|After the Infant Series|Parent or legal guardian request|2|||
161671346|NCT00475033|583849147|FG000|After the Infant Series|Failed to return|2|||
161671347|NCT00475033|583849148|FG001|After the Infant Series|Failed to return|1|||
161671348|NCT00475033|583849147|FG000|After the Infant Series|Protocol Violation|1|||
161671349|NCT00475033|583849148|FG001|After the Infant Series|Protocol Violation|0|||
161671350|NCT00475033|583849147|FG000|After the Infant Series|Lost to Follow-up|1|||
161671351|NCT00475033|583849148|FG001|After the Infant Series|Lost to Follow-up|0|||
161671352|NCT00475033|583849147|FG000|After the Infant Series|Other|0|||
161671353|NCT00475033|583849148|FG001|After the Infant Series|Other|1|||
161671354|NCT00475033|583849147|FG000|Toddler Dose|Parent or legal guardian request|2|||
161671355|NCT00475033|583849148|FG001|Toddler Dose|Parent or legal guardian request|0|||
161671356|NCT00475033|583849147|FG000|Toddler Dose|Failed to return|1|||
161671357|NCT00475033|583849148|FG001|Toddler Dose|Failed to return|0|||
161671358|NCT00475033|583849147|FG000|Toddler Dose|Lost to Follow-up|1|||
161671359|NCT00475033|583849148|FG001|Toddler Dose|Lost to Follow-up|0|||
161671360|NCT01696942|583849153|FG000|Overall Study|Withdrawal by Subject|1|||
161671361|NCT01696942|583849154|FG001|Overall Study|Withdrawal by Subject|0|||
161671362|NCT01696942|583849153|FG000|Overall Study|Protocol Violation|1|||
161671363|NCT01696942|583849154|FG001|Overall Study|Protocol Violation|2|||
161671364|NCT01696942|583849153|FG000|Overall Study|screen failure|0|||
161671365|NCT01696942|583849154|FG001|Overall Study|screen failure|1|||
161671366|NCT01335009|583849155|FG000|Overall Study|Too ill to travel to study sites|1|||
161671367|NCT01335009|583849156|FG001|Overall Study|Too ill to travel to study sites|0|||
161671368|NCT01335009|583849155|FG000|Overall Study|Death|28|||
161671369|NCT01335009|583849156|FG001|Overall Study|Death|32|||
161671370|NCT01335009|583849155|FG000|Overall Study|Withdrawal by Subject|1|||
161671371|NCT01335009|583849156|FG001|Overall Study|Withdrawal by Subject|1|||
161671372|NCT01335009|583849155|FG000|Overall Study|Lost to Follow-up|1|||
161671373|NCT01335009|583849156|FG001|Overall Study|Lost to Follow-up|0|||
161671374|NCT04824521|583849157|FG000|Overall Study|Lost to Follow-up|1|||
161671375|NCT01598311|583849158|FG000|Overall Study|Physician Decision|4|||
161671376|NCT01598311|583849159|FG001|Overall Study|Physician Decision|5|||
161671377|NCT01598311|583849158|FG000|Overall Study|Adverse Event|9|||
161671378|NCT01598311|583849159|FG001|Overall Study|Adverse Event|13|||
161671379|NCT01598311|583849158|FG000|Overall Study|Lost to Follow-up|7|||
161671380|NCT01598311|583849159|FG001|Overall Study|Lost to Follow-up|12|||
161671381|NCT01598311|583849158|FG000|Overall Study|Withdrawal by Subject|9|||
161671382|NCT01598311|583849159|FG001|Overall Study|Withdrawal by Subject|13|||
161671383|NCT01598311|583849158|FG000|Overall Study|No reason provided.|0|||
161671384|NCT01598311|583849159|FG001|Overall Study|No reason provided.|5|||
161671385|NCT01598311|583849158|FG000|Overall Study|Randomized but never treated|8|||
161671386|NCT01598311|583849159|FG001|Overall Study|Randomized but never treated|5|||
161671387|NCT01598311|583849158|FG000|Overall Study|Treated but no confirmed CDAD|9|||
161671388|NCT01598311|583849159|FG001|Overall Study|Treated but no confirmed CDAD|8|||
161671389|NCT01598311|583849158|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
161488657|NCT03918447|583180587|FG001|Overall Study|Study Terminated by Sponsor|197|||
161488658|NCT03918447|583180586|FG000|Overall Study|Reason not Specified|0|||
161488659|NCT03918447|583180587|FG001|Overall Study|Reason not Specified|1|||
161488660|NCT00477971|583180588|FG000|Overall Study|Disease progression|6|||
161488661|NCT00477971|583180589|FG001|Overall Study|Disease progression|0|||
161488662|NCT00477971|583180588|FG000|Overall Study|Withdrawal by Subject|3|||
161488663|NCT00477971|583180589|FG001|Overall Study|Withdrawal by Subject|1|||
161488664|NCT00477971|583180588|FG000|Overall Study|Adverse Event|3|||
161488665|NCT00477971|583180589|FG001|Overall Study|Adverse Event|0|||
161488666|NCT00477971|583180588|FG000|Overall Study|Death|2|||
161488667|NCT00477971|583180589|FG001|Overall Study|Death|4|||
161488668|NCT00477971|583180588|FG000|Overall Study|Alternative treatment|3|||
161488669|NCT00477971|583180589|FG001|Overall Study|Alternative treatment|1|||
161488670|NCT01774968|583180590|FG000|Overall Study|Adverse Event|4|||
161488671|NCT01774968|583180591|FG001|Overall Study|Adverse Event|4|||
161488672|NCT01774968|583180590|FG000|Overall Study|Death|0|||
161488673|NCT01774968|583180591|FG001|Overall Study|Death|1|||
161488674|NCT01774968|583180590|FG000|Overall Study|Lost to Follow-up|1|||
161488675|NCT01774968|583180591|FG001|Overall Study|Lost to Follow-up|3|||
161488676|NCT01774968|583180590|FG000|Overall Study|Physician Decision|5|||
161488677|NCT01774968|583180591|FG001|Overall Study|Physician Decision|1|||
161488678|NCT01774968|583180590|FG000|Overall Study|Protocol Violation|14|||
161488679|NCT01774968|583180591|FG001|Overall Study|Protocol Violation|13|||
161488680|NCT01774968|583180590|FG000|Overall Study|Sponsor Decision|0|||
161488681|NCT01774968|583180591|FG001|Overall Study|Sponsor Decision|2|||
161488682|NCT01774968|583180590|FG000|Overall Study|Withdrawal by Subject|6|||
161488683|NCT01774968|583180591|FG001|Overall Study|Withdrawal by Subject|11|||
161488684|NCT05355805|583180592|FG000|Overall Study|Lost to Follow-up|6|||
161488685|NCT05355805|583180593|FG001|Overall Study|Lost to Follow-up|11|||
161488686|NCT05355805|583180594|FG002|Overall Study|Lost to Follow-up|10|||
161488687|NCT05355805|583180595|FG003|Overall Study|Lost to Follow-up|6|||
161488688|NCT05355805|583180592|FG000|Overall Study|Decision by Sponsor|0|||
161488689|NCT05355805|583180593|FG001|Overall Study|Decision by Sponsor|0|||
161488690|NCT05355805|583180594|FG002|Overall Study|Decision by Sponsor|1|||
161488691|NCT05355805|583180595|FG003|Overall Study|Decision by Sponsor|0|||
161488692|NCT05355805|583180592|FG000|Overall Study|Withdrawal by Subject|7|||
161488693|NCT05355805|583180593|FG001|Overall Study|Withdrawal by Subject|14|||
161488694|NCT05355805|583180594|FG002|Overall Study|Withdrawal by Subject|15|||
161488695|NCT05355805|583180595|FG003|Overall Study|Withdrawal by Subject|13|||
161488696|NCT04232124|583181978|FG000|Overall Study|Lost to Follow-up|3|||
161488697|NCT01986855|583181981|FG000|Overall Study|Adverse Event|1|||
161488698|NCT01986855|583181982|FG001|Overall Study|Adverse Event|0|||
161488699|NCT01986855|583181983|FG002|Overall Study|Adverse Event|0|||
161488700|NCT01986855|583181981|FG000|Overall Study|Death|3|||
161488701|NCT01986855|583181982|FG001|Overall Study|Death|4|||
161488702|NCT01986855|583181983|FG002|Overall Study|Death|4|||
161488703|NCT01986855|583181981|FG000|Overall Study|Lost to Follow-up|2|||
161488704|NCT01986855|583181982|FG001|Overall Study|Lost to Follow-up|1|||
161488705|NCT01986855|583181983|FG002|Overall Study|Lost to Follow-up|0|||
161488706|NCT01986855|583181981|FG000|Overall Study|Screen Failure|0|||
161488707|NCT01986855|583181982|FG001|Overall Study|Screen Failure|1|||
161488708|NCT01986855|583181983|FG002|Overall Study|Screen Failure|0|||
161582899|NCT03570892|583521176|FG001|Overall Study|Protocol Violation|4|||
161582900|NCT03570892|583521175|FG000|Overall Study|Physician Decision|0|||
161582901|NCT03570892|583521176|FG001|Overall Study|Physician Decision|2|||
161582902|NCT03891758|583521177|FG000|Overall Study|Adverse Event|2|||
161582903|NCT03891758|583521178|FG001|Overall Study|Adverse Event|0|||
161582904|NCT03891758|583521177|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161582905|NCT03891758|583521178|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161488709|NCT01986855|583181981|FG000|Overall Study|Participant Moved|0|||
161582906|NCT04434729|583521181|FG000|Overall Study|Adverse Event|1|||
161582907|NCT04434729|583521181|FG000|Overall Study|Physician Decision|1|||
161582908|NCT00975819|583521182|FG000|Overall Study|Lack of Efficacy|8|||
161582909|NCT00975819|583521182|FG000|Overall Study|Adverse Event|2|||
161582910|NCT00975819|583521182|FG000|Overall Study|Physician Decision|2|||
161582911|NCT00975819|583521182|FG000|Overall Study|Withdrawal by Subject|2|||
161582912|NCT00975819|583521182|FG000|Overall Study|Protocol Violation|1|||
161582913|NCT01968109|583521183|FG000|Overall Study|DISEASE PROGRESSION|4|||
161582914|NCT01968109|583521184|FG001|Overall Study|DISEASE PROGRESSION|4|||
161488710|NCT01986855|583181982|FG001|Overall Study|Participant Moved|0|||
161488711|NCT01986855|583181983|FG002|Overall Study|Participant Moved|2|||
161488712|NCT01986855|583181981|FG000|Overall Study|Withdrawal by Subject|7|||
161488713|NCT01986855|583181982|FG001|Overall Study|Withdrawal by Subject|8|||
161582915|NCT01968109|583521185|FG002|Overall Study|DISEASE PROGRESSION|3|||
161488714|NCT01986855|583181983|FG002|Overall Study|Withdrawal by Subject|5|||
161488715|NCT04317066|583181984|FG000|Overall Study|Sponsor decision|5|||
161488716|NCT04317066|583181984|FG000|Overall Study|Death|2|||
161488717|NCT02014597|583181988|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
161488718|NCT02014597|583181989|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
161582916|NCT01968109|583521186|FG003|Overall Study|DISEASE PROGRESSION|9|||
161488719|NCT02279173|583181991|FG000|Overall Study|Protocol-specified Criteria|67|||
161488720|NCT02279173|583181991|FG000|Overall Study|Withdrawal by Subject|20|||
161488721|NCT02279173|583181991|FG000|Overall Study|Decision by Sponsor|4|||
161488722|NCT02279173|583181991|FG000|Overall Study|Lost to Follow-up|3|||
161488723|NCT00464087|583181993|FG000|Overall Study|No PCI per inclusion criteria|0|||
161488724|NCT00464087|583181994|FG001|Overall Study|No PCI per inclusion criteria|0|||
161488725|NCT00464087|583181995|FG002|Overall Study|No PCI per inclusion criteria|29|||
161488726|NCT01164956|583181996|FG000|Overall Study|Side Effects|1|||
161488727|NCT01164956|583181997|FG001|Overall Study|Side Effects|0|||
161488728|NCT01164956|583181998|FG002|Overall Study|Side Effects|1|||
161488729|NCT00754624|583181999|FG000|Overall Study|Adverse Event|16|||
161488730|NCT00754624|583181999|FG000|Overall Study|Death|1|||
161488731|NCT00754624|583181999|FG000|Overall Study|Physician Decision|8|||
161488732|NCT00754624|583181999|FG000|Overall Study|Protocol Violation|1|||
161488733|NCT00754624|583181999|FG000|Overall Study|Withdrawal by Subject|28|||
161488734|NCT00754624|583181999|FG000|Overall Study|Various|12|||
161488735|NCT00754624|583181999|FG000|Overall Study|Lost to Follow-up|3|||
161488736|NCT00720434|583182000|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
161488737|NCT00720434|583182001|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
161488738|NCT00720434|583182002|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
161488739|NCT00720434|583182003|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
161488740|NCT00720434|583182000|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
161488741|NCT00720434|583182001|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
161488742|NCT00720434|583182002|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
161488743|NCT00720434|583182003|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
161488744|NCT00720434|583182000|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
161488745|NCT00720434|583182001|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
161488746|NCT00720434|583182002|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
161488747|NCT00720434|583182003|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
161488748|NCT00720434|583182000|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
161488749|NCT00720434|583182001|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
161488750|NCT00720434|583182002|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
161488751|NCT00720434|583182003|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
161488752|NCT00720434|583182000|FG000|Open-Label Period (Week 5-72)|Other|4|||
161488753|NCT00720434|583182001|FG001|Open-Label Period (Week 5-72)|Other|3|||
161488754|NCT00720434|583182002|FG002|Open-Label Period (Week 5-72)|Other|3|||
161488755|NCT00720434|583182003|FG003|Open-Label Period (Week 5-72)|Other|2|||
161488756|NCT00967798|583182004|FG000|Overall Study|Withdrawal by Subject|5|||
161488757|NCT00967798|583182005|FG001|Overall Study|Withdrawal by Subject|2|||
161488758|NCT00967798|583182004|FG000|Overall Study|Lost to Follow-up|4|||
161488759|NCT00967798|583182005|FG001|Overall Study|Lost to Follow-up|1|||
161488760|NCT02425046|583182006|FG000|Overall Study|Lost to Follow-up|52|||
161488761|NCT02425046|583182007|FG001|Overall Study|Lost to Follow-up|50|||
161488762|NCT02425046|583182008|FG002|Overall Study|Lost to Follow-up|56|||
161488763|NCT02425046|583182006|FG000|Overall Study|Withdrawal by Subject|16|||
161488764|NCT02425046|583182007|FG001|Overall Study|Withdrawal by Subject|12|||
161488765|NCT02425046|583182008|FG002|Overall Study|Withdrawal by Subject|0|||
161488766|NCT02782780|583182009|FG000|Overall Study|dropped out after randomization.|7|||
161488767|NCT02782780|583182010|FG001|Overall Study|dropped out after randomization.|5|||
161488768|NCT02782780|583182009|FG000|Overall Study|Protocol Violation|0|||
161488769|NCT02782780|583182010|FG001|Overall Study|Protocol Violation|2|||
161671390|NCT01598311|583849159|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
161671391|NCT00523718|583851252|FG000|Overall Study|Withdrawal by Subject|1|||
161488770|NCT01413191|583182011|FG000|Overall Study|Lost to Follow-up|5|||
161488771|NCT01413191|583182011|FG000|Overall Study|Disease Progression|5|||
161488772|NCT01413191|583182011|FG000|Overall Study|Death|1|||
161488773|NCT03654651|583182012|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161488774|NCT03654651|583182013|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
161488775|NCT03045328|583182014|FG000|Overall Study|Withdrawal by Subject|2|||
161488776|NCT04429061|583182015|FG000|Overall Study|Lost to Follow-up|62|||
161488777|NCT04429061|583182016|FG001|Overall Study|Lost to Follow-up|87|||
161488778|NCT04429061|583182015|FG000|Overall Study|Withdrawal by Subject|3|||
161488779|NCT04429061|583182016|FG001|Overall Study|Withdrawal by Subject|4|||
161488780|NCT00885105|583182021|FG000|Overall Study|Withdrawal by Subject|0|||
161488781|NCT00885105|583182022|FG001|Overall Study|Withdrawal by Subject|8|||
161488782|NCT00885105|583182021|FG000|Overall Study|Adverse Event|1|||
161488783|NCT00885105|583182022|FG001|Overall Study|Adverse Event|0|||
161488784|NCT00885105|583182021|FG000|Overall Study|Protocol Violation|0|||
161488785|NCT00885105|583182022|FG001|Overall Study|Protocol Violation|2|||
161488786|NCT01350414|583182023|FG000|Overall Study|Lost to Follow-up|13|||
161488787|NCT01350414|583182023|FG000|Overall Study|Withdrawal by Subject|4|||
161488788|NCT01350414|583182023|FG000|Overall Study|Physician Decision|2|||
161488789|NCT00759954|583182024|FG000|Overall Study|Personal reason|1|||
161488790|NCT00759954|583182025|FG001|Overall Study|Personal reason|0|||
161488791|NCT00759954|583182024|FG000|Overall Study|Adverse Event|1|||
161488792|NCT00759954|583182025|FG001|Overall Study|Adverse Event|2|||
161488793|NCT00022633|583182029|FG000|Overall Study|Adverse Event|11|||
161488794|NCT00022633|583182030|FG001|Overall Study|Adverse Event|1|||
161488795|NCT00022633|583182029|FG000|Overall Study|Refusal unrelated to adverse event|1|||
161488796|NCT00022633|583182030|FG001|Overall Study|Refusal unrelated to adverse event|0|||
161488797|NCT00022633|583182029|FG000|Overall Study|Progression/relapse|9|||
161488798|NCT00022633|583182030|FG001|Overall Study|Progression/relapse|2|||
161488799|NCT00022633|583182029|FG000|Overall Study|Death|4|||
161488800|NCT00022633|583182030|FG001|Overall Study|Death|0|||
161488801|NCT00022633|583182029|FG000|Overall Study|Other - not protocol specified|3|||
161488802|NCT00022633|583182030|FG001|Overall Study|Other - not protocol specified|2|||
161488803|NCT00022633|583182029|FG000|Overall Study|Ineligible|4|||
161488804|NCT00022633|583182030|FG001|Overall Study|Ineligible|0|||
161488805|NCT03033394|583182035|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
161488806|NCT03033394|583182035|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
161582917|NCT01968109|583521187|FG004|Overall Study|DISEASE PROGRESSION|5|||
161582918|NCT01968109|583521188|FG005|Overall Study|DISEASE PROGRESSION|6|||
161582919|NCT01968109|583521189|FG006|Overall Study|DISEASE PROGRESSION|6|||
161582920|NCT01968109|583521190|FG007|Overall Study|DISEASE PROGRESSION|6|||
161582921|NCT01968109|583521191|FG008|Overall Study|DISEASE PROGRESSION|4|||
161582922|NCT01968109|583521192|FG009|Overall Study|DISEASE PROGRESSION|5|||
161582923|NCT01968109|583521193|FG010|Overall Study|DISEASE PROGRESSION|8|||
161582924|NCT01968109|583521194|FG011|Overall Study|DISEASE PROGRESSION|4|||
161582925|NCT01968109|583521195|FG012|Overall Study|DISEASE PROGRESSION|7|||
161582926|NCT01968109|583521196|FG013|Overall Study|DISEASE PROGRESSION|14|||
161582927|NCT01968109|583521197|FG014|Overall Study|DISEASE PROGRESSION|14|||
161582928|NCT01968109|583521198|FG015|Overall Study|DISEASE PROGRESSION|13|||
161582929|NCT01968109|583521199|FG016|Overall Study|DISEASE PROGRESSION|34|||
161582930|NCT01968109|583521200|FG017|Overall Study|DISEASE PROGRESSION|20|||
161582931|NCT01968109|583521201|FG018|Overall Study|DISEASE PROGRESSION|54|||
161582932|NCT01968109|583521202|FG019|Overall Study|DISEASE PROGRESSION|46|||
161582933|NCT01968109|583521203|FG020|Overall Study|DISEASE PROGRESSION|77|||
161582934|NCT01968109|583521204|FG021|Overall Study|DISEASE PROGRESSION|25|||
161582935|NCT01968109|583521205|FG022|Overall Study|DISEASE PROGRESSION|47|||
161582936|NCT01968109|583521206|FG023|Overall Study|DISEASE PROGRESSION|125|||
161582937|NCT01968109|583521207|FG024|Overall Study|DISEASE PROGRESSION|155|||
161582938|NCT01968109|583521208|FG025|Overall Study|DISEASE PROGRESSION|63|||
161582939|NCT01968109|583521209|FG026|Overall Study|DISEASE PROGRESSION|65|||
161582940|NCT01968109|583521210|FG027|Overall Study|DISEASE PROGRESSION|137|||
161582941|NCT01968109|583521211|FG028|Overall Study|DISEASE PROGRESSION|35|||
161582942|NCT01968109|583521212|FG029|Overall Study|DISEASE PROGRESSION|23|||
161582943|NCT01968109|583521213|FG030|Overall Study|DISEASE PROGRESSION|71|||
161582944|NCT01968109|583521183|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582945|NCT01968109|583521184|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582946|NCT01968109|583521185|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582947|NCT01968109|583521186|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582948|NCT01968109|583521187|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582949|NCT01968109|583521188|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582950|NCT01968109|583521189|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582951|NCT01968109|583521190|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582952|NCT01968109|583521191|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582953|NCT01968109|583521192|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582954|NCT01968109|583521193|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582955|NCT01968109|583521194|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582956|NCT01968109|583521195|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582957|NCT01968109|583521196|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582958|NCT01968109|583521197|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582959|NCT01968109|583521198|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582960|NCT01968109|583521199|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582961|NCT01968109|583521200|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582962|NCT01968109|583521201|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161582963|NCT01968109|583521202|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161582964|NCT01968109|583521203|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161582965|NCT01968109|583521204|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161817039|NCT01604941|584370907|FG002|Overall Study|Participant Decision|0|||
161817040|NCT01604941|584370908|FG003|Overall Study|Participant Decision|0|||
161817041|NCT01604941|584370909|FG004|Overall Study|Participant Decision|0|||
161817042|NCT01604941|584370910|FG005|Overall Study|Participant Decision|2|||
161582966|NCT01968109|583521205|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161488807|NCT03033394|583182035|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
161488808|NCT03033394|583182035|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
161488809|NCT03033394|583182035|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
161488810|NCT02927431|583182036|FG000|Overall Study|Withdrawal by Subject|0|||
161488811|NCT02927431|583182037|FG001|Overall Study|Withdrawal by Subject|0|||
161488812|NCT02927431|583182038|FG002|Overall Study|Withdrawal by Subject|1|||
161488813|NCT02246660|583182039|FG000|Overall Study|Withdrawal by Subject|0|||
161488814|NCT02246660|583182040|FG001|Overall Study|Withdrawal by Subject|1|||
161922848|NCT00021255|584764885|FG001|Overall Study|Breast cancer relapse|18|||
161488815|NCT02246660|583182041|FG002|Overall Study|Withdrawal by Subject|0|||
161488816|NCT02246660|583182039|FG000|Overall Study|Death|0|||
161488817|NCT02246660|583182040|FG001|Overall Study|Death|0|||
161488818|NCT02246660|583182041|FG002|Overall Study|Death|1|||
161488819|NCT04952402|583182042|FG000|Overall Study|Lost to Follow-up|1|||
161488820|NCT04952402|583182043|FG001|Overall Study|Lost to Follow-up|3|||
161488821|NCT04952402|583182042|FG000|Overall Study|Lack Of Venous Access|0|||
161488822|NCT04952402|583182043|FG001|Overall Study|Lack Of Venous Access|1|||
161488823|NCT00143403|583182044|FG000|Overall Study|Adverse Event|3|||
161488824|NCT00143403|583182045|FG001|Overall Study|Adverse Event|8|||
161488825|NCT00143403|583182044|FG000|Overall Study|Death|1|||
161488826|NCT00143403|583182045|FG001|Overall Study|Death|0|||
161488827|NCT00143403|583182044|FG000|Overall Study|Withdrawal by Subject|3|||
161488828|NCT00143403|583182045|FG001|Overall Study|Withdrawal by Subject|12|||
161488829|NCT00143403|583182044|FG000|Overall Study|Relapse|15|||
161488830|NCT00143403|583182045|FG001|Overall Study|Relapse|7|||
161488831|NCT00143403|583182044|FG000|Overall Study|Protocol Violation|2|||
161488832|NCT00143403|583182045|FG001|Overall Study|Protocol Violation|2|||
161488833|NCT00143403|583182044|FG000|Overall Study|specified by site|4|||
161488834|NCT00143403|583182045|FG001|Overall Study|specified by site|9|||
161488835|NCT00143403|583182044|FG000|Overall Study|Randomized Not Treated|7|||
161488836|NCT00143403|583182045|FG001|Overall Study|Randomized Not Treated|8|||
161488837|NCT00587639|583182046|FG000|Overall Study|Withdrawal by Subject|1|||
161488838|NCT01442675|583182047|FG000|Overall Study|Protocol Violation|6|||
161488839|NCT01442675|583182047|FG000|Overall Study|Lost to Follow-up|2|||
161488840|NCT01442675|583182047|FG000|Overall Study|Withdrawal by Subject|4|||
161488841|NCT03944954|583182052|FG000|Overall Study|Withdrawal by Subject|22|||
161488842|NCT03944954|583182053|FG001|Overall Study|Withdrawal by Subject|4|||
161488843|NCT03944954|583182052|FG000|Overall Study|Lost to Follow-up|18|||
161488844|NCT03944954|583182053|FG001|Overall Study|Lost to Follow-up|0|||
161488845|NCT03944954|583182052|FG000|Overall Study|Failed Medical Screening|7|||
161488846|NCT03944954|583182053|FG001|Overall Study|Failed Medical Screening|0|||
161488847|NCT03235154|583182057|FG000|Overall Study|Withdrawal by Subject|1|||
161488848|NCT03235154|583182057|FG000|Overall Study|Adverse Event|1|||
161488849|NCT03235154|583182057|FG000|Overall Study|Lost to Follow-up|2|||
161488850|NCT00536198|583182058|FG000|Overall Study|Lost to Follow-up|15|||
161488851|NCT00536198|583182059|FG001|Overall Study|Lost to Follow-up|14|||
161488852|NCT00536198|583182058|FG000|Overall Study|Withdrawal by Subject|16|||
161488853|NCT00536198|583182059|FG001|Overall Study|Withdrawal by Subject|12|||
161488854|NCT00536198|583182058|FG000|Overall Study|Adverse Event|2|||
161488855|NCT00536198|583182059|FG001|Overall Study|Adverse Event|2|||
161488856|NCT00536198|583182058|FG000|Overall Study|Rescue|3|||
161488857|NCT00536198|583182059|FG001|Overall Study|Rescue|9|||
161488858|NCT00536198|583182058|FG000|Overall Study|Pregnancy|1|||
161488859|NCT00536198|583182059|FG001|Overall Study|Pregnancy|1|||
161488860|NCT00536198|583182058|FG000|Overall Study|Protocol Violation|0|||
161488861|NCT00536198|583182059|FG001|Overall Study|Protocol Violation|1|||
161488862|NCT00881712|583182060|FG000|Overall Study|Death|1|||
161488863|NCT00881712|583182061|FG001|Overall Study|Death|0|||
161488864|NCT00881712|583182062|FG002|Overall Study|Death|0|||
161582967|NCT01968109|583521206|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
161582968|NCT01968109|583521207|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
161582969|NCT01968109|583521208|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161582970|NCT01968109|583521209|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161582971|NCT01968109|583521210|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161582972|NCT01968109|583521211|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
161582973|NCT01968109|583521212|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
161582974|NCT01968109|583521213|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161922849|NCT00021255|584764886|FG002|Overall Study|Breast cancer relapse|11|||
161922850|NCT00021255|584764884|FG000|Overall Study|Second primary malignancy|0|||
161488865|NCT00881712|583182060|FG000|Overall Study|Withdrawal by Subject|1|||
161488866|NCT00881712|583182061|FG001|Overall Study|Withdrawal by Subject|0|||
161488867|NCT00881712|583182062|FG002|Overall Study|Withdrawal by Subject|0|||
161488868|NCT00276744|583182063|FG000|PART A|Reason unknown|98|||
161488869|NCT00965718|583182082|FG000|Overall Study|Withdrawal by Subject|4|||
161488870|NCT03667924|583182083|FG000|Baseline Completed|Lost to Follow-up|0|||
161488871|NCT03667924|583182084|FG001|Baseline Completed|Lost to Follow-up|2|||
161488872|NCT03667924|583182085|FG002|Baseline Completed|Lost to Follow-up|0|||
161488873|NCT03667924|583182083|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
161488874|NCT03667924|583182084|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
161488875|NCT03667924|583182085|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
161488876|NCT03667924|583182083|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
161488877|NCT03667924|583182084|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
161488878|NCT03667924|583182085|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
161488879|NCT03667924|583182083|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
161488880|NCT03667924|583182084|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
161488881|NCT03667924|583182085|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
161488882|NCT03667924|583182083|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
161488883|NCT03667924|583182084|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
161488884|NCT03667924|583182085|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
161488885|NCT03667924|583182083|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
161488886|NCT03667924|583182084|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
161488887|NCT03667924|583182085|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
161488888|NCT03667924|583182083|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
161488889|NCT03667924|583182084|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
161488890|NCT03667924|583182085|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
161488891|NCT00126568|583182086|FG000|Overall Study|Death|2|||
161488892|NCT01244425|583182087|FG000|Overall Study|Withdrawal by Subject|2|||
161488893|NCT01244425|583182088|FG001|Overall Study|Withdrawal by Subject|2|||
161488894|NCT01244425|583182087|FG000|Overall Study|Adverse Event|1|||
161488895|NCT01244425|583182088|FG001|Overall Study|Adverse Event|1|||
161488896|NCT02547454|583182089|FG000|Overall Study|Due to hemodialysis|53|||
161488897|NCT02547454|583182089|FG000|Overall Study|Due to transplantation|1|||
161488898|NCT02547454|583182089|FG000|Overall Study|Due to no further need to treat|4|||
161488899|NCT02547454|583182089|FG000|Overall Study|Death|38|||
161488900|NCT02547454|583182089|FG000|Overall Study|Lost to Follow-up|26|||
161488901|NCT02547454|583182089|FG000|Overall Study|Other|39|||
161488902|NCT02547454|583182089|FG000|Overall Study|No data|11|||
161488903|NCT01482884|583182090|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
161488904|NCT01482884|583182091|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
161488905|NCT01482884|583182090|FG000|Overall Study|Protocol Violation|1|||
161488906|NCT01482884|583182091|FG001|Overall Study|Protocol Violation|0|||
161488907|NCT01482884|583182090|FG000|Overall Study|Lost to Follow-up|2|||
161488908|NCT01482884|583182091|FG001|Overall Study|Lost to Follow-up|2|||
161488909|NCT01482884|583182090|FG000|Overall Study|Lack of Efficacy|0|||
161488910|NCT01482884|583182091|FG001|Overall Study|Lack of Efficacy|1|||
161488911|NCT01482884|583182090|FG000|Overall Study|Adverse Event|2|||
161488912|NCT01482884|583182091|FG001|Overall Study|Adverse Event|1|||
161488913|NCT01482884|583182090|FG000|Overall Study|Withdrawal by Subject|8|||
161488914|NCT01482884|583182091|FG001|Overall Study|Withdrawal by Subject|13|||
161488915|NCT04102020|583182092|FG000|Overall Study|Adverse Event|1|||
161488916|NCT04102020|583182093|FG001|Overall Study|Adverse Event|0|||
161488917|NCT04102020|583182094|FG002|Overall Study|Adverse Event|0|||
161488918|NCT04102020|583182095|FG003|Overall Study|Adverse Event|1|||
161488919|NCT04102020|583182096|FG004|Overall Study|Adverse Event|0|||
161488920|NCT04102020|583182092|FG000|Overall Study|Withdrawal by Subject|0|||
161488921|NCT04102020|583182093|FG001|Overall Study|Withdrawal by Subject|1|||
161488922|NCT04102020|583182094|FG002|Overall Study|Withdrawal by Subject|1|||
161488923|NCT04102020|583182095|FG003|Overall Study|Withdrawal by Subject|1|||
161488924|NCT04102020|583182096|FG004|Overall Study|Withdrawal by Subject|1|||
161488925|NCT04102020|583182092|FG000|Overall Study|Death|1|||
161488926|NCT04102020|583182093|FG001|Overall Study|Death|4|||
161488927|NCT04102020|583182094|FG002|Overall Study|Death|1|||
161488928|NCT04102020|583182095|FG003|Overall Study|Death|1|||
161488929|NCT04102020|583182096|FG004|Overall Study|Death|0|||
161488930|NCT04102020|583182092|FG000|Overall Study|Physician Decision|1|||
161488931|NCT04102020|583182093|FG001|Overall Study|Physician Decision|2|||
161488932|NCT04102020|583182094|FG002|Overall Study|Physician Decision|2|||
161488933|NCT04102020|583182095|FG003|Overall Study|Physician Decision|0|||
161488934|NCT04102020|583182096|FG004|Overall Study|Physician Decision|1|||
161488935|NCT04102020|583182092|FG000|Overall Study|COVID-19 Infection|1|||
161488936|NCT04102020|583182093|FG001|Overall Study|COVID-19 Infection|0|||
161488937|NCT04102020|583182094|FG002|Overall Study|COVID-19 Infection|0|||
161488938|NCT04102020|583182095|FG003|Overall Study|COVID-19 Infection|0|||
161488939|NCT04102020|583182096|FG004|Overall Study|COVID-19 Infection|0|||
161488940|NCT04102020|583182092|FG000|Overall Study|Not disclosed|5|||
161488941|NCT04102020|583182093|FG001|Overall Study|Not disclosed|3|||
161488942|NCT04102020|583182094|FG002|Overall Study|Not disclosed|8|||
161488943|NCT04102020|583182095|FG003|Overall Study|Not disclosed|0|||
161488944|NCT04102020|583182096|FG004|Overall Study|Not disclosed|1|||
161488945|NCT04102020|583182092|FG000|Overall Study|MIssing|1|||
161488946|NCT04102020|583182093|FG001|Overall Study|MIssing|0|||
161488947|NCT04102020|583182094|FG002|Overall Study|MIssing|1|||
161488948|NCT04102020|583182095|FG003|Overall Study|MIssing|1|||
161488949|NCT04102020|583182096|FG004|Overall Study|MIssing|1|||
161488950|NCT04102020|583182092|FG000|Overall Study|Continuing in ongoing study|13|||
161488951|NCT04102020|583182093|FG001|Overall Study|Continuing in ongoing study|13|||
161488952|NCT04102020|583182094|FG002|Overall Study|Continuing in ongoing study|7|||
161488953|NCT04102020|583182095|FG003|Overall Study|Continuing in ongoing study|26|||
161488954|NCT04102020|583182096|FG004|Overall Study|Continuing in ongoing study|12|||
161488955|NCT04853225|583182097|FG000|Overall Study|Withdrawal by Subject|81|||
161488956|NCT04853225|583182098|FG001|Overall Study|Withdrawal by Subject|4|||
161488957|NCT04853225|583182099|FG002|Overall Study|Withdrawal by Subject|1|||
161488958|NCT04853225|583182097|FG000|Overall Study|Physician Decision|12|||
161488959|NCT04853225|583182098|FG001|Overall Study|Physician Decision|4|||
161488960|NCT04853225|583182099|FG002|Overall Study|Physician Decision|1|||
161488961|NCT04853225|583182097|FG000|Overall Study|Lost to Follow-up|50|||
161488962|NCT04853225|583182098|FG001|Overall Study|Lost to Follow-up|0|||
161488963|NCT04853225|583182099|FG002|Overall Study|Lost to Follow-up|0|||
161488964|NCT04853225|583182097|FG000|Overall Study|Other|102|||
161488965|NCT04853225|583182098|FG001|Overall Study|Other|11|||
161488966|NCT04853225|583182099|FG002|Overall Study|Other|5|||
161488967|NCT04853225|583182097|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
161488968|NCT04853225|583182098|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
161488969|NCT04853225|583182099|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
161488970|NCT04853225|583182097|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
161488971|NCT04853225|583182098|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
161488972|NCT04853225|583182099|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
161488973|NCT03789318|583182100|FG000|Overall Study|Adverse Event|0|||
161488974|NCT03789318|583182101|FG001|Overall Study|Adverse Event|0|||
161488975|NCT03789318|583182102|FG002|Overall Study|Adverse Event|1|||
161488976|NCT03789318|583182103|FG003|Overall Study|Adverse Event|1|||
161488977|NCT03789318|583182104|FG004|Overall Study|Adverse Event|0|||
161488978|NCT03789318|583182100|FG000|Overall Study|Lost to Follow-up|0|||
161488979|NCT03789318|583182101|FG001|Overall Study|Lost to Follow-up|0|||
161488980|NCT03789318|583182102|FG002|Overall Study|Lost to Follow-up|1|||
161488981|NCT03789318|583182103|FG003|Overall Study|Lost to Follow-up|0|||
161488982|NCT03789318|583182104|FG004|Overall Study|Lost to Follow-up|0|||
161488983|NCT03789318|583182100|FG000|Overall Study|Withdrawal by Subject|0|||
161488984|NCT03789318|583182101|FG001|Overall Study|Withdrawal by Subject|0|||
161488985|NCT03789318|583182102|FG002|Overall Study|Withdrawal by Subject|1|||
161488986|NCT03789318|583182103|FG003|Overall Study|Withdrawal by Subject|0|||
161488987|NCT03789318|583182104|FG004|Overall Study|Withdrawal by Subject|0|||
161488988|NCT02167893|583182105|FG000|Overall Study|Investigator transferred|85|||
161488989|NCT02167893|583182105|FG000|Overall Study|Investigator health reasons|10|||
161488990|NCT02167893|583182105|FG000|Overall Study|Case report forms not collected|68|||
161488991|NCT01325584|583182106|FG000|Overall Study|Death|1|||
161488992|NCT00407563|583183455|FG000|Overall Study|Patient continues on treatment|1|||
161488993|NCT01409564|583183456|FG000|Overall Study|low medication compliance|4|||
161488994|NCT01409564|583183457|FG001|Overall Study|low medication compliance|3|||
161488995|NCT01409564|583183456|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
161488996|NCT01409564|583183457|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
161488997|NCT05040386|583183458|FG000|Overall Study|Withdrawal by Subject|1|||
161488998|NCT05040386|583183459|FG001|Overall Study|Withdrawal by Subject|0|||
161488999|NCT05040386|583183460|FG002|Overall Study|Withdrawal by Subject|1|||
161489000|NCT05040386|583183461|FG003|Overall Study|Withdrawal by Subject|0|||
161489001|NCT05040386|583183458|FG000|Overall Study|Lost to Follow-up|0|||
161489002|NCT05040386|583183459|FG001|Overall Study|Lost to Follow-up|0|||
161489003|NCT05040386|583183460|FG002|Overall Study|Lost to Follow-up|1|||
161489004|NCT05040386|583183461|FG003|Overall Study|Lost to Follow-up|0|||
161489005|NCT02618434|583183464|FG000|Overall Study|Withdrawal by Subject|0|||
161489006|NCT02618434|583183465|FG001|Overall Study|Withdrawal by Subject|2|||
161489007|NCT02618434|583183466|FG002|Overall Study|Withdrawal by Subject|3|||
161489008|NCT02618434|583183464|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
161489009|NCT02618434|583183465|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
161489010|NCT02618434|583183466|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
161489011|NCT02618434|583183464|FG000|Overall Study|Lost to Follow-up|3|||
161489012|NCT02618434|583183465|FG001|Overall Study|Lost to Follow-up|1|||
161489013|NCT02618434|583183466|FG002|Overall Study|Lost to Follow-up|3|||
161489014|NCT02618434|583183464|FG000|Overall Study|Adverse Event|1|||
161489015|NCT02618434|583183465|FG001|Overall Study|Adverse Event|0|||
161489016|NCT02618434|583183466|FG002|Overall Study|Adverse Event|12|||
161489017|NCT02618434|583183464|FG000|Overall Study|Physician Decision|0|||
161489018|NCT02618434|583183465|FG001|Overall Study|Physician Decision|1|||
161489019|NCT02618434|583183466|FG002|Overall Study|Physician Decision|0|||
161489020|NCT02618434|583183464|FG000|Overall Study|Protocol Violation|0|||
161489021|NCT02618434|583183465|FG001|Overall Study|Protocol Violation|0|||
161489022|NCT02618434|583183466|FG002|Overall Study|Protocol Violation|1|||
161489023|NCT02618434|583183464|FG000|Overall Study|Other, Multiple categories|1|||
161582975|NCT01968109|583521183|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
161922851|NCT00021255|584764885|FG001|Overall Study|Second primary malignancy|4|||
161922852|NCT00021255|584764886|FG002|Overall Study|Second primary malignancy|1|||
161922853|NCT00021255|584764884|FG000|Overall Study|Withdrawal by Subject|41|||
161922854|NCT00021255|584764885|FG001|Overall Study|Withdrawal by Subject|64|||
161922855|NCT00021255|584764886|FG002|Overall Study|Withdrawal by Subject|26|||
161922856|NCT00021255|584764884|FG000|Overall Study|Lost to Follow-up|0|||
161922857|NCT00021255|584764885|FG001|Overall Study|Lost to Follow-up|2|||
161922858|NCT00021255|584764886|FG002|Overall Study|Lost to Follow-up|3|||
161922859|NCT00021255|584764884|FG000|Overall Study|Cardiac toxicity|0|||
161922860|NCT00021255|584764885|FG001|Overall Study|Cardiac toxicity|61|||
161922861|NCT00021255|584764886|FG002|Overall Study|Cardiac toxicity|32|||
161922862|NCT00021255|584764884|FG000|Overall Study|Herceptin toxicity|0|||
161922863|NCT00021255|584764885|FG001|Overall Study|Herceptin toxicity|22|||
161922864|NCT00021255|584764886|FG002|Overall Study|Herceptin toxicity|6|||
161922865|NCT00021255|584764884|FG000|Overall Study|Adverse Event|46|||
161922866|NCT00021255|584764885|FG001|Overall Study|Adverse Event|30|||
161922867|NCT00021255|584764886|FG002|Overall Study|Adverse Event|18|||
161922868|NCT00021255|584764884|FG000|Overall Study|Protocol Violation|0|||
161922869|NCT00021255|584764885|FG001|Overall Study|Protocol Violation|2|||
161922870|NCT00021255|584764886|FG002|Overall Study|Protocol Violation|0|||
161922871|NCT00021255|584764884|FG000|Overall Study|Other than specified above|0|||
161922872|NCT00021255|584764885|FG001|Overall Study|Other than specified above|38|||
161922873|NCT00021255|584764886|FG002|Overall Study|Other than specified above|19|||
161922874|NCT00021255|584764884|FG000|Overall Study|Missing|0|||
161922875|NCT00021255|584764885|FG001|Overall Study|Missing|27|||
161922876|NCT00021255|584764886|FG002|Overall Study|Missing|13|||
161922877|NCT00021255|584764884|FG000|Overall Study|Randomized but not treated|28|||
161922878|NCT00021255|584764885|FG001|Overall Study|Randomized but not treated|2|||
161922879|NCT00021255|584764886|FG002|Overall Study|Randomized but not treated|18|||
161922880|NCT02232698|584764887|FG000|Overall Study|Pregnancy|1|||
161922881|NCT02232698|584764888|FG001|Overall Study|Pregnancy|1|||
161922882|NCT02232698|584764887|FG000|Overall Study|Met exclusion criteria|1|||
161489024|NCT02618434|583183465|FG001|Overall Study|Other, Multiple categories|1|||
161489025|NCT02618434|583183466|FG002|Overall Study|Other, Multiple categories|1|||
161489026|NCT04626297|583183470|FG000|Overall Study|Adverse Event|5|||
161489027|NCT04626297|583183471|FG001|Overall Study|Adverse Event|3|||
161489028|NCT04626297|583183470|FG000|Overall Study|Lost to Follow-up|7|||
161489029|NCT04626297|583183471|FG001|Overall Study|Lost to Follow-up|3|||
161489030|NCT04626297|583183470|FG000|Overall Study|Protocol Violation|5|||
161489031|NCT04626297|583183471|FG001|Overall Study|Protocol Violation|1|||
161489032|NCT04626297|583183470|FG000|Overall Study|Withdrawal by Subject|20|||
161489033|NCT04626297|583183471|FG001|Overall Study|Withdrawal by Subject|6|||
161489034|NCT04626297|583183470|FG000|Overall Study|Sponsor decision|2|||
161489035|NCT04626297|583183471|FG001|Overall Study|Sponsor decision|1|||
161489036|NCT02066233|583183472|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
161489037|NCT02066233|583183473|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
161489038|NCT02598076|583183474|FG000|Overall Study|Lost to Follow-up|2|||
161489039|NCT02598076|583183475|FG001|Overall Study|Lost to Follow-up|3|||
161489040|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Death|3|||
161489041|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Death|3|||
161489042|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Death|0|||
161489043|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Death|0|||
161489044|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
161489045|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
161489046|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
161489047|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
161489048|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
161489049|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
161489050|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
161489051|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
161489052|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
161489053|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
161489054|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
161489055|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
161489056|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
161489057|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
161489058|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
161489059|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
161489060|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
161489061|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
161489062|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
161489063|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
161489064|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
161489065|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
161489066|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
161489067|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
161489068|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Other|6|||
161489069|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Other|3|||
161489070|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Other|0|||
161489071|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Other|0|||
161489072|NCT02051608|583183478|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
161489073|NCT02051608|583183479|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
161489074|NCT02051608|583183480|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
161489075|NCT02051608|583183481|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
161489076|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Adverse Event|0|||
161489077|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Adverse Event|0|||
161489078|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Adverse Event|6|||
161489079|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Adverse Event|8|||
161489080|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Death|0|||
161582976|NCT01968109|583521184|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
161582977|NCT01968109|583521185|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
161582978|NCT01968109|583521186|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
161582979|NCT01968109|583521187|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
161582980|NCT01968109|583521188|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
161582981|NCT01968109|583521189|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
161582982|NCT01968109|583521190|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
161582983|NCT01968109|583521191|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
161489081|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Death|0|||
161489082|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Death|7|||
161489083|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Death|4|||
161489084|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
161582984|NCT01968109|583521192|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
161582985|NCT01968109|583521193|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
161489085|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
161489086|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
161489087|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
161489088|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
161489089|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
161489090|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
161489091|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
161489092|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161489093|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161489094|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
161489095|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
161489096|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
161489097|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
161489098|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
161489099|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
161489100|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Physician Decision|0|||
161489101|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Physician Decision|0|||
161489102|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Physician Decision|8|||
161489103|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Physician Decision|5|||
161489104|NCT02051608|583183478|FG000|Part 2: Open-label Extension|Other|0|||
161489105|NCT02051608|583183479|FG001|Part 2: Open-label Extension|Other|0|||
161489106|NCT02051608|583183480|FG002|Part 2: Open-label Extension|Other|9|||
161489107|NCT02051608|583183481|FG003|Part 2: Open-label Extension|Other|9|||
161489108|NCT02005445|583183482|FG000|Overall Study|Dual study enrollment|0|||
161489109|NCT02005445|583183483|FG001|Overall Study|Dual study enrollment|1|||
161489110|NCT00449540|583183484|FG000|Pretreatment Phase|No migraine experienced|66|||
161489111|NCT00449540|583183485|FG001|Pretreatment Phase|No migraine experienced|0|||
161489112|NCT00449540|583183486|FG002|Pretreatment Phase|No migraine experienced|0|||
161489113|NCT00449540|583183484|FG000|Treatment Phase|did not experience or treat migraine|0|||
161489114|NCT00449540|583183485|FG001|Treatment Phase|did not experience or treat migraine|20|||
161489115|NCT00449540|583183486|FG002|Treatment Phase|did not experience or treat migraine|17|||
161489116|NCT00010374|583183487|FG000|Overall Study|False positive phrenic nerve test|1|||
161489117|NCT00533845|583183496|FG000|Overall Study|Physician Decision|1|||
161489118|NCT00533845|583183497|FG001|Overall Study|Physician Decision|0|||
161489119|NCT01919723|583183498|FG000|Overall Study|Blood Samples Hemolyzed|2|||
161489120|NCT01919723|583183499|FG001|Overall Study|Blood Samples Hemolyzed|2|||
161489121|NCT04294472|583183507|FG000|Overall Study|Adverse Event|0|||
161489122|NCT04294472|583183508|FG001|Overall Study|Adverse Event|1|||
161489123|NCT04294472|583183509|FG002|Overall Study|Adverse Event|1|||
161489124|NCT04294472|583183507|FG000|Overall Study|Randomized but not treated|0|||
161489125|NCT04294472|583183508|FG001|Overall Study|Randomized but not treated|1|||
161489126|NCT04294472|583183509|FG002|Overall Study|Randomized but not treated|1|||
161489127|NCT00563381|583183511|FG000|Overall Study|Adverse Event|264|||
161489128|NCT00563381|583183512|FG001|Overall Study|Adverse Event|292|||
161489129|NCT00563381|583183511|FG000|Overall Study|Protocol Violation|66|||
161489130|NCT00563381|583183512|FG001|Overall Study|Protocol Violation|74|||
161489131|NCT00563381|583183511|FG000|Overall Study|Lost to Follow-up|7|||
161489132|NCT00563381|583183512|FG001|Overall Study|Lost to Follow-up|15|||
161489133|NCT00563381|583183511|FG000|Overall Study|Withdrawal by Subject|192|||
161489134|NCT00563381|583183512|FG001|Overall Study|Withdrawal by Subject|209|||
161489135|NCT00563381|583183511|FG000|Overall Study|Lack of Efficacy|32|||
161489136|NCT00563381|583183512|FG001|Overall Study|Lack of Efficacy|24|||
161489137|NCT00563381|583183511|FG000|Overall Study|Individual different reasons|24|||
161489138|NCT00563381|583183512|FG001|Overall Study|Individual different reasons|34|||
161489139|NCT00667368|583183513|FG000|Overall Study|Lost to Follow-up|176|||
161489140|NCT00667368|583183514|FG001|Overall Study|Lost to Follow-up|155|||
161489141|NCT00667368|583183513|FG000|Overall Study|Discontinued early|24|||
161489142|NCT00667368|583183514|FG001|Overall Study|Discontinued early|17|||
161489143|NCT02407704|583183515|FG000|Overall Study|Lost to Follow-up|0|||
161489144|NCT02407704|583183516|FG001|Overall Study|Lost to Follow-up|0|||
161489145|NCT02407704|583183517|FG002|Overall Study|Lost to Follow-up|0|||
161489146|NCT02407704|583183518|FG003|Overall Study|Lost to Follow-up|2|||
161489147|NCT02407704|583183515|FG000|Overall Study|Protocol Violation|0|||
161489148|NCT02407704|583183516|FG001|Overall Study|Protocol Violation|0|||
161489149|NCT02407704|583183517|FG002|Overall Study|Protocol Violation|0|||
161671392|NCT00523718|583851253|FG001|Overall Study|Withdrawal by Subject|0|||
161489150|NCT02407704|583183518|FG003|Overall Study|Protocol Violation|1|||
161489151|NCT02407704|583183515|FG000|Overall Study|Withdrawal by Subject|0|||
161489152|NCT02407704|583183516|FG001|Overall Study|Withdrawal by Subject|0|||
161489153|NCT02407704|583183517|FG002|Overall Study|Withdrawal by Subject|1|||
161489154|NCT02407704|583183518|FG003|Overall Study|Withdrawal by Subject|0|||
161489155|NCT01957644|583183519|FG000|Overall Study|Adverse Event|4|||
161489156|NCT01957644|583183520|FG001|Overall Study|Adverse Event|2|||
161489157|NCT01957644|583183521|FG002|Overall Study|Adverse Event|0|||
161671393|NCT00523718|583851252|FG000|Overall Study|Protocol Violation|2|||
161489158|NCT01957644|583183522|FG003|Overall Study|Adverse Event|0|||
161489159|NCT01957644|583183523|FG004|Overall Study|Adverse Event|1|||
161922883|NCT02232698|584764888|FG001|Overall Study|Met exclusion criteria|1|||
161922884|NCT02232698|584764887|FG000|Overall Study|Had device-associated symptoms|7|||
161922885|NCT02232698|584764888|FG001|Overall Study|Had device-associated symptoms|0|||
161922886|NCT02232698|584764887|FG000|Overall Study|Non-compliance with study device|1|||
161922887|NCT02232698|584764888|FG001|Overall Study|Non-compliance with study device|4|||
161922888|NCT02232698|584764887|FG000|Overall Study|Allocated to control group|0|||
161922889|NCT02232698|584764888|FG001|Overall Study|Allocated to control group|3|||
161922890|NCT02232698|584764887|FG000|Overall Study|Withdrawal by Subject|0|||
161922891|NCT02232698|584764888|FG001|Overall Study|Withdrawal by Subject|11|||
161922892|NCT02393755|584764889|FG000|Overall Study|Withdrawal by Subject|0|||
161922893|NCT02393755|584764890|FG001|Overall Study|Withdrawal by Subject|3|||
161922894|NCT02393755|584764889|FG000|Overall Study|Adverse Event|0|||
161922895|NCT02393755|584764890|FG001|Overall Study|Adverse Event|2|||
161922896|NCT02393755|584764889|FG000|Overall Study|Physician Decision|0|||
161922897|NCT02393755|584764890|FG001|Overall Study|Physician Decision|2|||
161922898|NCT01327703|584764891|FG000|Second Treatment Period|Adverse Event|1|||
161922899|NCT01327703|584764892|FG001|Second Treatment Period|Adverse Event|1|||
161922900|NCT01327703|584764891|FG000|Second Treatment Period|Protocol Violation|0|||
161922901|NCT01327703|584764892|FG001|Second Treatment Period|Protocol Violation|1|||
161922902|NCT05324371|584764893|FG000|Overall Study|Withdrawal by Subject|1|||
161922903|NCT05324371|584764893|FG000|Overall Study|Death|1|||
161922904|NCT00812097|584764894|FG000|Overall Study|Death|3|||
161922905|NCT00812097|584764895|FG001|Overall Study|Death|10|||
161582986|NCT01968109|583521194|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
161582987|NCT01968109|583521195|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
161582988|NCT01968109|583521196|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
161582989|NCT01968109|583521197|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
161582990|NCT01968109|583521198|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
161582991|NCT01968109|583521199|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
161582992|NCT01968109|583521200|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
161582993|NCT01968109|583521201|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
161582994|NCT01968109|583521202|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
161582995|NCT01968109|583521203|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
161582996|NCT01968109|583521204|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
161582997|NCT01968109|583521205|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
161582998|NCT01968109|583521206|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
161582999|NCT01968109|583521207|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
161583000|NCT01968109|583521208|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
161583001|NCT01968109|583521209|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
161583002|NCT01968109|583521210|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
161583003|NCT01968109|583521211|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
161583004|NCT01968109|583521212|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
161583005|NCT01968109|583521213|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
161583006|NCT01968109|583521183|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583007|NCT01968109|583521184|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583008|NCT01968109|583521185|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583009|NCT01968109|583521186|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583010|NCT01968109|583521187|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161489160|NCT01957644|583183519|FG000|Overall Study|Progressive disease / relapse|0|||
161489161|NCT01957644|583183520|FG001|Overall Study|Progressive disease / relapse|1|||
161489162|NCT01957644|583183521|FG002|Overall Study|Progressive disease / relapse|0|||
161489163|NCT01957644|583183522|FG003|Overall Study|Progressive disease / relapse|1|||
161489164|NCT01957644|583183523|FG004|Overall Study|Progressive disease / relapse|0|||
161489165|NCT01957644|583183519|FG000|Overall Study|Other reason|1|||
161489166|NCT01957644|583183520|FG001|Overall Study|Other reason|2|||
161489167|NCT01957644|583183521|FG002|Overall Study|Other reason|1|||
161489168|NCT01957644|583183522|FG003|Overall Study|Other reason|1|||
161489169|NCT01957644|583183523|FG004|Overall Study|Other reason|0|||
161489170|NCT01957644|583183519|FG000|Overall Study|Withdrawal by Subject|1|||
161489171|NCT01957644|583183520|FG001|Overall Study|Withdrawal by Subject|0|||
161489172|NCT01957644|583183521|FG002|Overall Study|Withdrawal by Subject|0|||
161489173|NCT01957644|583183522|FG003|Overall Study|Withdrawal by Subject|0|||
161489174|NCT01957644|583183523|FG004|Overall Study|Withdrawal by Subject|0|||
161489175|NCT01957644|583183519|FG000|Overall Study|Protocol Violation|0|||
161489176|NCT01957644|583183520|FG001|Overall Study|Protocol Violation|1|||
161489177|NCT01957644|583183521|FG002|Overall Study|Protocol Violation|0|||
161489178|NCT01957644|583183522|FG003|Overall Study|Protocol Violation|0|||
161489179|NCT01957644|583183523|FG004|Overall Study|Protocol Violation|0|||
161489180|NCT01957553|583183524|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
161489181|NCT01957553|583183525|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
161489182|NCT01957553|583183524|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
161489183|NCT01957553|583183525|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
161489184|NCT01957553|583183524|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
161489185|NCT01957553|583183525|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
161489186|NCT01957553|583183524|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
161489187|NCT01957553|583183525|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
161489188|NCT01957553|583183524|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
161489189|NCT01957553|583183525|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
161583011|NCT01968109|583521188|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583012|NCT01968109|583521189|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583013|NCT01968109|583521190|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161583014|NCT01968109|583521191|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583015|NCT01968109|583521192|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583016|NCT01968109|583521193|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583017|NCT01968109|583521194|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161489190|NCT01957553|583183524|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
161489191|NCT01957553|583183525|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
161489192|NCT01957553|583183524|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
161489193|NCT01957553|583183525|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
161489194|NCT01957553|583183524|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
161489195|NCT01957553|583183525|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
161583018|NCT01968109|583521195|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583019|NCT01968109|583521196|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583020|NCT01968109|583521197|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583021|NCT01968109|583521198|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583022|NCT01968109|583521199|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583023|NCT01968109|583521200|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583024|NCT01968109|583521201|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161671394|NCT00523718|583851253|FG001|Overall Study|Protocol Violation|0|||
161489196|NCT01957553|583183524|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
161489197|NCT01957553|583183525|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
161489198|NCT04044716|583183526|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
161489199|NCT04044716|583183527|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
161489200|NCT04044716|583183528|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
161489201|NCT04044716|583183526|FG000|Overall Study|Lost to Follow-up|2|||
161489202|NCT04044716|583183527|FG001|Overall Study|Lost to Follow-up|3|||
161489203|NCT04044716|583183528|FG002|Overall Study|Lost to Follow-up|0|||
161489204|NCT01683383|583183533|FG000|Overall Study|Infant was not transported|1|||
161489205|NCT01683383|583183534|FG001|Overall Study|Infant was not transported|0|||
161489206|NCT02496611|583183535|FG000|Overall Study|Lost to Follow-up|2|||
161489207|NCT02496611|583183536|FG001|Overall Study|Lost to Follow-up|1|||
161489208|NCT02496611|583183535|FG000|Overall Study|Withdrawal by Subject|5|||
161489209|NCT02496611|583183536|FG001|Overall Study|Withdrawal by Subject|2|||
161489210|NCT02850965|583183537|FG000|Overall Study|Other than listed|3|||
161489211|NCT02850965|583183538|FG001|Overall Study|Other than listed|4|||
161489212|NCT02850965|583183537|FG000|Overall Study|Protocol Violation|0|||
161489213|NCT02850965|583183538|FG001|Overall Study|Protocol Violation|2|||
161489214|NCT02850965|583183537|FG000|Overall Study|Lost to Follow-up|5|||
161489215|NCT02850965|583183538|FG001|Overall Study|Lost to Follow-up|3|||
161489216|NCT02850965|583183537|FG000|Overall Study|Lack of Efficacy|4|||
161489217|NCT02850965|583183538|FG001|Overall Study|Lack of Efficacy|8|||
161489218|NCT02850965|583183537|FG000|Overall Study|Adverse Event|3|||
161489219|NCT02850965|583183538|FG001|Overall Study|Adverse Event|2|||
161489220|NCT02850965|583183537|FG000|Overall Study|Withdrawal by Subject|3|||
161489221|NCT02850965|583183538|FG001|Overall Study|Withdrawal by Subject|4|||
161489222|NCT02850965|583183537|FG000|Overall Study|Physician Decision|0|||
161489223|NCT02850965|583183538|FG001|Overall Study|Physician Decision|1|||
161489224|NCT02850965|583183537|FG000|Overall Study|Randomized but not treated|0|||
161489225|NCT02850965|583183538|FG001|Overall Study|Randomized but not treated|1|||
161489226|NCT00230607|583183547|FG000|Overall Study|Other|3|||
161489227|NCT03672747|583183548|FG000|Overall Study|Lost to Follow-up|1|||
161489228|NCT03672747|583183549|FG001|Overall Study|Lost to Follow-up|1|||
161489229|NCT03672747|583183550|FG002|Overall Study|Lost to Follow-up|2|||
161489230|NCT03672747|583183551|FG003|Overall Study|Lost to Follow-up|2|||
161583025|NCT01968109|583521202|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161583026|NCT01968109|583521203|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161583027|NCT01968109|583521204|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161583028|NCT01968109|583521205|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583029|NCT01968109|583521206|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583030|NCT01968109|583521207|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
161583031|NCT01968109|583521208|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
161583032|NCT01968109|583521209|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161583033|NCT01968109|583521210|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
161489231|NCT03672747|583183552|FG004|Overall Study|Lost to Follow-up|2|||
161489232|NCT03672747|583183553|FG005|Overall Study|Lost to Follow-up|1|||
161583034|NCT01968109|583521211|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161583035|NCT01968109|583521212|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161817043|NCT01604941|584370905|FG000|Overall Study|Early Study Termination|9|||
161489233|NCT03228537|583183556|FG000|Neoadjuvant|Adverse Event|2|||
161922906|NCT00812097|584764896|FG002|Overall Study|Death|3|||
161489234|NCT03228537|583183556|FG000|Neoadjuvant|Progression/Relapse|4|||
161489235|NCT03228537|583183556|FG000|Neoadjuvant|Death|1|||
161922907|NCT00812097|584764897|FG003|Overall Study|Death|3|||
161922908|NCT00812097|584764894|FG000|Overall Study|Withdrawal by Subject|14|||
161922909|NCT00812097|584764895|FG001|Overall Study|Withdrawal by Subject|12|||
161922910|NCT00812097|584764896|FG002|Overall Study|Withdrawal by Subject|8|||
161922911|NCT00812097|584764897|FG003|Overall Study|Withdrawal by Subject|2|||
161922912|NCT00812097|584764894|FG000|Overall Study|Lost to Follow-up|90|||
161922913|NCT00812097|584764895|FG001|Overall Study|Lost to Follow-up|14|||
161922914|NCT00812097|584764896|FG002|Overall Study|Lost to Follow-up|17|||
161922915|NCT00812097|584764897|FG003|Overall Study|Lost to Follow-up|5|||
161922916|NCT00812097|584764894|FG000|Overall Study|Explantation of study device(s)|27|||
161922917|NCT00812097|584764895|FG001|Overall Study|Explantation of study device(s)|29|||
161922918|NCT00812097|584764896|FG002|Overall Study|Explantation of study device(s)|14|||
161922919|NCT00812097|584764897|FG003|Overall Study|Explantation of study device(s)|20|||
161922920|NCT00812097|584764894|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
161922921|NCT00812097|584764895|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
161922922|NCT00812097|584764896|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
161922923|NCT00812097|584764897|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
161922924|NCT01786109|584764898|FG000|Overall Study|fail manometry barostat tube placement|1|||
161922925|NCT01786109|584764899|FG001|Overall Study|fail manometry barostat tube placement|0|||
161922926|NCT01786109|584764900|FG002|Overall Study|fail manometry barostat tube placement|0|||
161922927|NCT01786109|584764898|FG000|Overall Study|unrelated illness|0|||
161922928|NCT01786109|584764899|FG001|Overall Study|unrelated illness|0|||
161489236|NCT03228537|583183556|FG000|Surgery|Death|1|||
161489237|NCT03228537|583183556|FG000|Surgery|Other - Not Protocol Specified|2|||
161489238|NCT03228537|583183556|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
161489239|NCT03228537|583183556|FG000|Maintenance|Progression/Relapse|10|||
161489240|NCT01648205|583183559|FG000|Placebo|Pregnancy|1|||
161489241|NCT01648205|583183559|FG000|Placebo|Withdrawal by Subject|1|||
161489242|NCT01648205|583183559|FG000|Placebo|Protocol Violation|2|||
161489243|NCT01648205|583183559|FG000|Ranolazine|Death|1|||
161489244|NCT01648205|583183559|FG000|Ranolazine|Withdrawal by Subject|1|||
161489245|NCT01648205|583183559|FG000|Ranolazine|Protocol Violation|3|||
161489246|NCT00580606|583183570|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
161489247|NCT00580606|583183571|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
161489248|NCT00580606|583183570|FG000|Open Label (OL)|Withdrawal by Subject|4|||
161489249|NCT00580606|583183571|FG001|Open Label (OL)|Withdrawal by Subject|6|||
161489250|NCT00580606|583183570|FG000|Open Label (OL)|Dosing Symptoms|0|||
161489251|NCT00580606|583183571|FG001|Open Label (OL)|Dosing Symptoms|1|||
161489252|NCT00580606|583183570|FG000|Open Label (OL)|Lost to Follow-up|0|||
161489253|NCT00580606|583183571|FG001|Open Label (OL)|Lost to Follow-up|1|||
161489254|NCT00580606|583183570|FG000|Open Label (OL)|Pregnancy|0|||
161489255|NCT00580606|583183571|FG001|Open Label (OL)|Pregnancy|1|||
161489256|NCT00580606|583183570|FG000|Open Label (OL)|Non-compliance|2|||
161489257|NCT00580606|583183571|FG001|Open Label (OL)|Non-compliance|0|||
161489258|NCT00580606|583183570|FG000|Open Label (OL)|Physician Decision|1|||
161489259|NCT00580606|583183571|FG001|Open Label (OL)|Physician Decision|1|||
161489260|NCT00580606|583183570|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
161489261|NCT00580606|583183571|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
161489262|NCT03358290|583183573|FG000|Overall Study|Study discontinued by Sponsor|0|||
161489263|NCT03358290|583183574|FG001|Overall Study|Study discontinued by Sponsor|1|||
161489264|NCT03358290|583183575|FG002|Overall Study|Study discontinued by Sponsor|1|||
161489265|NCT03358290|583183576|FG003|Overall Study|Study discontinued by Sponsor|0|||
161489266|NCT03358290|583183577|FG004|Overall Study|Study discontinued by Sponsor|0|||
161489267|NCT03358290|583183573|FG000|Overall Study|Adverse Event|0|||
161489268|NCT03358290|583183574|FG001|Overall Study|Adverse Event|0|||
161489269|NCT03358290|583183575|FG002|Overall Study|Adverse Event|1|||
161489270|NCT03358290|583183576|FG003|Overall Study|Adverse Event|2|||
161489271|NCT03358290|583183577|FG004|Overall Study|Adverse Event|0|||
161489272|NCT03358290|583183573|FG000|Overall Study|Withdrawal by Subject|0|||
161489273|NCT03358290|583183574|FG001|Overall Study|Withdrawal by Subject|0|||
161489274|NCT03358290|583183575|FG002|Overall Study|Withdrawal by Subject|0|||
161489275|NCT03358290|583183576|FG003|Overall Study|Withdrawal by Subject|0|||
161489276|NCT03358290|583183577|FG004|Overall Study|Withdrawal by Subject|1|||
161489277|NCT04847557|583183578|FG000|Overall Study|Adverse Event|1|||
161489278|NCT04847557|583183579|FG001|Overall Study|Adverse Event|0|||
161489279|NCT04847557|583183578|FG000|Overall Study|Death|19|||
161489280|NCT04847557|583183579|FG001|Overall Study|Death|15|||
161489281|NCT04847557|583183578|FG000|Overall Study|Lost to Follow-up|3|||
161489282|NCT04847557|583183579|FG001|Overall Study|Lost to Follow-up|6|||
161489283|NCT04847557|583183578|FG000|Overall Study|Physician Decision|1|||
161489284|NCT04847557|583183579|FG001|Overall Study|Physician Decision|0|||
161489285|NCT04847557|583183578|FG000|Overall Study|Protocol Violation|0|||
161489286|NCT04847557|583183579|FG001|Overall Study|Protocol Violation|1|||
161489287|NCT04847557|583183578|FG000|Overall Study|Withdrawal by Subject|8|||
161489288|NCT04847557|583183579|FG001|Overall Study|Withdrawal by Subject|14|||
161489289|NCT00733408|583185767|FG000|Overall Study|Adverse Event|4|||
161489290|NCT01134783|583185769|FG000|Overall Study|Pregnancy|16|||
161489291|NCT01134783|583185770|FG001|Overall Study|Pregnancy|8|||
161489292|NCT01134783|583185769|FG000|Overall Study|Withdrawal by Subject|15|||
161489293|NCT01134783|583185770|FG001|Overall Study|Withdrawal by Subject|9|||
161489294|NCT01134783|583185769|FG000|Overall Study|Lost to Follow-up|5|||
161489295|NCT01134783|583185770|FG001|Overall Study|Lost to Follow-up|20|||
161489296|NCT00531232|583185772|FG000|Overall Study|Investigator decision|0|||
161489297|NCT00531232|583185773|FG001|Overall Study|Investigator decision|0|||
161489298|NCT00531232|583185774|FG002|Overall Study|Investigator decision|4|||
161489299|NCT00531232|583185772|FG000|Overall Study|Participants refused further treatment|0|||
161489300|NCT00531232|583185773|FG001|Overall Study|Participants refused further treatment|1|||
161489301|NCT00531232|583185774|FG002|Overall Study|Participants refused further treatment|2|||
161489302|NCT00531232|583185772|FG000|Overall Study|Adverse events (AEs)|1|||
161489303|NCT00531232|583185773|FG001|Overall Study|Adverse events (AEs)|2|||
161489304|NCT00531232|583185774|FG002|Overall Study|Adverse events (AEs)|2|||
161489305|NCT00531232|583185772|FG000|Overall Study|Treatment failure|1|||
161489306|NCT00531232|583185773|FG001|Overall Study|Treatment failure|3|||
161489307|NCT00531232|583185774|FG002|Overall Study|Treatment failure|7|||
161489308|NCT00531232|583185772|FG000|Overall Study|Disease recurrence|0|||
161489309|NCT00531232|583185773|FG001|Overall Study|Disease recurrence|0|||
161489310|NCT00531232|583185774|FG002|Overall Study|Disease recurrence|1|||
161489311|NCT00531232|583185772|FG000|Overall Study|Deceased|2|||
161489312|NCT00531232|583185773|FG001|Overall Study|Deceased|2|||
161489313|NCT00531232|583185774|FG002|Overall Study|Deceased|2|||
161489314|NCT00531232|583185772|FG000|Overall Study|Withdrawal by Subject|0|||
161489315|NCT00531232|583185773|FG001|Overall Study|Withdrawal by Subject|1|||
161489316|NCT00531232|583185774|FG002|Overall Study|Withdrawal by Subject|2|||
161489317|NCT00531232|583185772|FG000|Overall Study|Other|0|||
161489318|NCT00531232|583185773|FG001|Overall Study|Other|0|||
161489319|NCT00531232|583185774|FG002|Overall Study|Other|5|||
161489320|NCT00397982|583185775|FG000|Overall Study|Withdrawal by Subject|1|||
161489321|NCT00397982|583185775|FG000|Overall Study|Adverse Event|1|||
161489322|NCT00397982|583185775|FG000|Overall Study|noncompliance|1|||
161489323|NCT00397982|583185775|FG000|Overall Study|Unrelated health issues|1|||
161489324|NCT02329730|583185776|FG000|Overall Study|Protocol Violation|0|||
161489325|NCT02329730|583185777|FG001|Overall Study|Protocol Violation|0|||
161489326|NCT02329730|583185778|FG002|Overall Study|Protocol Violation|0|||
161489327|NCT02329730|583185779|FG003|Overall Study|Protocol Violation|0|||
161489328|NCT02329730|583185780|FG004|Overall Study|Protocol Violation|2|||
161489329|NCT02329730|583185781|FG005|Overall Study|Protocol Violation|2|||
161489330|NCT02329730|583185782|FG006|Overall Study|Protocol Violation|0|||
161489331|NCT02329730|583185783|FG007|Overall Study|Protocol Violation|0|||
161489332|NCT02329730|583185784|FG008|Overall Study|Protocol Violation|0|||
161489333|NCT02329730|583185785|FG009|Overall Study|Protocol Violation|0|||
161489334|NCT02329730|583185786|FG010|Overall Study|Protocol Violation|0|||
161489335|NCT02329730|583185787|FG011|Overall Study|Protocol Violation|0|||
161489336|NCT02329730|583185776|FG000|Overall Study|Withdrawal by Subject|0|||
161489337|NCT02329730|583185777|FG001|Overall Study|Withdrawal by Subject|0|||
161489338|NCT02329730|583185778|FG002|Overall Study|Withdrawal by Subject|0|||
161489339|NCT02329730|583185779|FG003|Overall Study|Withdrawal by Subject|0|||
161489340|NCT02329730|583185780|FG004|Overall Study|Withdrawal by Subject|1|||
161489341|NCT02329730|583185781|FG005|Overall Study|Withdrawal by Subject|0|||
161489342|NCT02329730|583185782|FG006|Overall Study|Withdrawal by Subject|1|||
161489343|NCT02329730|583185783|FG007|Overall Study|Withdrawal by Subject|1|||
161489344|NCT02329730|583185784|FG008|Overall Study|Withdrawal by Subject|1|||
161489345|NCT02329730|583185785|FG009|Overall Study|Withdrawal by Subject|1|||
161489346|NCT02329730|583185786|FG010|Overall Study|Withdrawal by Subject|0|||
161489347|NCT02329730|583185787|FG011|Overall Study|Withdrawal by Subject|0|||
161489348|NCT02345850|583185788|FG000|Overall Study|Not transplanted|10|||
161489349|NCT02345850|583185789|FG001|Overall Study|Not transplanted|5|||
161489350|NCT02345850|583185790|FG002|Overall Study|Not transplanted|4|||
161489351|NCT02345850|583185788|FG000|Overall Study|Lost to Follow-up|2|||
161489352|NCT02345850|583185789|FG001|Overall Study|Lost to Follow-up|3|||
161489353|NCT02345850|583185790|FG002|Overall Study|Lost to Follow-up|2|||
161489354|NCT02345850|583185788|FG000|Overall Study|Withdrawal by Subject|1|||
161489355|NCT02345850|583185789|FG001|Overall Study|Withdrawal by Subject|0|||
161489356|NCT02345850|583185790|FG002|Overall Study|Withdrawal by Subject|0|||
161489357|NCT00463346|583185792|FG000|Overall Study|Withdrawal by Subject|3|||
161489358|NCT00463346|583185793|FG001|Overall Study|Withdrawal by Subject|3|||
161489359|NCT02392247|583185794|FG000|Overall Study|Withdrawal by Subject|1|||
161671395|NCT01306890|583851254|FG000|Overall Study|Adverse Event|2|||
161671396|NCT01306890|583851254|FG000|Overall Study|Death|1223|||
161671397|NCT01306890|583851254|FG000|Overall Study|Lost to Follow-up|58|||
161671398|NCT01306890|583851254|FG000|Overall Study|Withdrawal by Subject|88|||
161489360|NCT02392247|583185794|FG000|Overall Study|Surgery cancelled; no data|1|||
161489361|NCT03641651|583185795|FG000|Overall Study|organizational issues at one study site|1|||
161489362|NCT01991067|583185797|FG000|Overall Study|Lost to Follow-up|6|||
161489363|NCT01991067|583185798|FG001|Overall Study|Lost to Follow-up|5|||
161489364|NCT00951665|583185800|FG000|Phase 1b|Adverse Event|2|||
161489365|NCT00951665|583185801|FG001|Phase 1b|Adverse Event|1|||
161489366|NCT00951665|583185802|FG002|Phase 1b|Adverse Event|0|||
161489367|NCT00951665|583185803|FG003|Phase 1b|Adverse Event|1|||
161671399|NCT01306890|583851254|FG000|Overall Study|Unspecified reasons|104|||
161671400|NCT01306890|583851254|FG000|Overall Study|Study Termination|3|||
161671401|NCT01306890|583851254|FG000|Overall Study|No discontinuation documentation|41|||
161671402|NCT02217436|583851255|FG000|Overall Study|Protocol Violation|1|||
161671403|NCT02217436|583851256|FG001|Overall Study|Protocol Violation|1|||
161671404|NCT02217436|583851255|FG000|Overall Study|Incomplete data|0|||
161489368|NCT00951665|583185804|FG004|Phase 1b|Adverse Event|0|||
161489369|NCT00951665|583185805|FG005|Phase 1b|Adverse Event|0|||
161489370|NCT00951665|583185800|FG000|Phase 1b|Death|1|||
161489371|NCT00951665|583185801|FG001|Phase 1b|Death|0|||
161489372|NCT00951665|583185802|FG002|Phase 1b|Death|2|||
161489373|NCT00951665|583185803|FG003|Phase 1b|Death|0|||
161489374|NCT00951665|583185804|FG004|Phase 1b|Death|0|||
161489375|NCT00951665|583185805|FG005|Phase 1b|Death|0|||
161489376|NCT00951665|583185800|FG000|Phase 1b|Physician Decision|4|||
161489377|NCT00951665|583185801|FG001|Phase 1b|Physician Decision|0|||
161489378|NCT00951665|583185802|FG002|Phase 1b|Physician Decision|1|||
161489379|NCT00951665|583185803|FG003|Phase 1b|Physician Decision|0|||
161489380|NCT00951665|583185804|FG004|Phase 1b|Physician Decision|0|||
161489381|NCT00951665|583185805|FG005|Phase 1b|Physician Decision|0|||
161489382|NCT00951665|583185800|FG000|Phase 1b|Withdrawal by Subject|0|||
161489383|NCT00951665|583185801|FG001|Phase 1b|Withdrawal by Subject|1|||
161489384|NCT00951665|583185802|FG002|Phase 1b|Withdrawal by Subject|0|||
161489385|NCT00951665|583185803|FG003|Phase 1b|Withdrawal by Subject|0|||
161489386|NCT00951665|583185804|FG004|Phase 1b|Withdrawal by Subject|0|||
161489387|NCT00951665|583185805|FG005|Phase 1b|Withdrawal by Subject|0|||
161489388|NCT00951665|583185800|FG000|Phase 1b|Disease Progression|13|||
161489389|NCT00951665|583185801|FG001|Phase 1b|Disease Progression|2|||
161489390|NCT00951665|583185802|FG002|Phase 1b|Disease Progression|14|||
161489391|NCT00951665|583185803|FG003|Phase 1b|Disease Progression|0|||
161489392|NCT00951665|583185804|FG004|Phase 1b|Disease Progression|0|||
161489393|NCT00951665|583185805|FG005|Phase 1b|Disease Progression|0|||
161489394|NCT00951665|583185800|FG000|Phase 1b|Protocol Violation|2|||
161817044|NCT01604941|584370906|FG001|Overall Study|Early Study Termination|2|||
161817045|NCT01604941|584370907|FG002|Overall Study|Early Study Termination|3|||
161489395|NCT00951665|583185801|FG001|Phase 1b|Protocol Violation|0|||
161489396|NCT00951665|583185802|FG002|Phase 1b|Protocol Violation|0|||
161489397|NCT00951665|583185803|FG003|Phase 1b|Protocol Violation|0|||
161489398|NCT00951665|583185804|FG004|Phase 1b|Protocol Violation|0|||
161489399|NCT00951665|583185805|FG005|Phase 1b|Protocol Violation|0|||
161489400|NCT00951665|583185800|FG000|Phase 2a|Adverse Event|0|||
161489401|NCT00951665|583185801|FG001|Phase 2a|Adverse Event|0|||
161489402|NCT00951665|583185802|FG002|Phase 2a|Adverse Event|0|||
161489403|NCT00951665|583185803|FG003|Phase 2a|Adverse Event|0|||
161489404|NCT00951665|583185804|FG004|Phase 2a|Adverse Event|2|||
161489405|NCT00951665|583185805|FG005|Phase 2a|Adverse Event|0|||
161489406|NCT00951665|583185800|FG000|Phase 2a|Death|0|||
161489407|NCT00951665|583185801|FG001|Phase 2a|Death|0|||
161489408|NCT00951665|583185802|FG002|Phase 2a|Death|0|||
161489409|NCT00951665|583185803|FG003|Phase 2a|Death|0|||
161489410|NCT00951665|583185804|FG004|Phase 2a|Death|1|||
161489411|NCT00951665|583185805|FG005|Phase 2a|Death|1|||
161489412|NCT00951665|583185800|FG000|Phase 2a|Lost to Follow-up|0|||
161489413|NCT00951665|583185801|FG001|Phase 2a|Lost to Follow-up|0|||
161489414|NCT00951665|583185802|FG002|Phase 2a|Lost to Follow-up|0|||
161489415|NCT00951665|583185803|FG003|Phase 2a|Lost to Follow-up|0|||
161489416|NCT00951665|583185804|FG004|Phase 2a|Lost to Follow-up|1|||
161489417|NCT00951665|583185805|FG005|Phase 2a|Lost to Follow-up|0|||
161489418|NCT00951665|583185800|FG000|Phase 2a|Physician Decision|0|||
161489419|NCT00951665|583185801|FG001|Phase 2a|Physician Decision|0|||
161489420|NCT00951665|583185802|FG002|Phase 2a|Physician Decision|0|||
161489421|NCT00951665|583185803|FG003|Phase 2a|Physician Decision|0|||
161489422|NCT00951665|583185804|FG004|Phase 2a|Physician Decision|0|||
161489423|NCT00951665|583185805|FG005|Phase 2a|Physician Decision|1|||
161489424|NCT00951665|583185800|FG000|Phase 2a|Withdrawal by Subject|0|||
161489425|NCT00951665|583185801|FG001|Phase 2a|Withdrawal by Subject|0|||
161489426|NCT00951665|583185802|FG002|Phase 2a|Withdrawal by Subject|0|||
161489427|NCT00951665|583185803|FG003|Phase 2a|Withdrawal by Subject|0|||
161489428|NCT00951665|583185804|FG004|Phase 2a|Withdrawal by Subject|2|||
161489429|NCT00951665|583185805|FG005|Phase 2a|Withdrawal by Subject|0|||
161489430|NCT00951665|583185800|FG000|Phase 2a|Disease Progression|0|||
161489431|NCT00951665|583185801|FG001|Phase 2a|Disease Progression|0|||
161489432|NCT00951665|583185802|FG002|Phase 2a|Disease Progression|0|||
161489433|NCT00951665|583185803|FG003|Phase 2a|Disease Progression|0|||
161489434|NCT00951665|583185804|FG004|Phase 2a|Disease Progression|6|||
161489435|NCT00951665|583185805|FG005|Phase 2a|Disease Progression|5|||
161489436|NCT00224055|583185806|FG000|Overall Study|Adverse Event|9|||
161489437|NCT00224055|583185807|FG001|Overall Study|Adverse Event|3|||
161489438|NCT00224055|583185806|FG000|Overall Study|Lost to Follow-up|1|||
161489439|NCT00224055|583185807|FG001|Overall Study|Lost to Follow-up|2|||
161489440|NCT00224055|583185806|FG000|Overall Study|Protocol Violation|1|||
161489441|NCT00224055|583185807|FG001|Overall Study|Protocol Violation|1|||
161489442|NCT00224055|583185806|FG000|Overall Study|Inclusion Violation|3|||
161489443|NCT00224055|583185807|FG001|Overall Study|Inclusion Violation|6|||
161489444|NCT00224055|583185806|FG000|Overall Study|Withdrawal by Subject|0|||
161489445|NCT00224055|583185807|FG001|Overall Study|Withdrawal by Subject|2|||
161489446|NCT00224055|583185806|FG000|Overall Study|Other|1|||
161489447|NCT00224055|583185807|FG001|Overall Study|Other|0|||
161489448|NCT00127712|583185808|FG000|Overall Study|Adverse Event|3|||
161489449|NCT00127712|583185809|FG001|Overall Study|Adverse Event|0|||
161489450|NCT00127712|583185808|FG000|Overall Study|Lack of GI access to continue|2|||
161489451|NCT00127712|583185809|FG001|Overall Study|Lack of GI access to continue|0|||
161489452|NCT03055260|583185812|FG000|Overall Study|Withdrawal by Subject|1|||
161489453|NCT03055260|583185813|FG001|Overall Study|Withdrawal by Subject|0|||
161489454|NCT02450903|583185814|FG000|Overall Study|Adverse Event|3|||
161817046|NCT01604941|584370908|FG003|Overall Study|Early Study Termination|3|||
161489455|NCT02450903|583185814|FG000|Overall Study|Progressive disease|15|||
161489456|NCT02450903|583185814|FG000|Overall Study|Switched to commercial drug|1|||
161489457|NCT02450903|583185814|FG000|Overall Study|Subject/guardian decision|1|||
161489458|NCT00592839|583185815|FG000|Overall Study|Withdrawal by Subject|1|||
161489459|NCT00592839|583185816|FG001|Overall Study|Withdrawal by Subject|1|||
161489460|NCT00592839|583185817|FG002|Overall Study|Withdrawal by Subject|3|||
161489461|NCT00592839|583185815|FG000|Overall Study|Protocol Violation|1|||
161922929|NCT01786109|584764900|FG002|Overall Study|unrelated illness|1|||
161489462|NCT00592839|583185816|FG001|Overall Study|Protocol Violation|1|||
161489463|NCT00592839|583185817|FG002|Overall Study|Protocol Violation|2|||
161489464|NCT00592839|583185815|FG000|Overall Study|Adverse Event|0|||
161489465|NCT00592839|583185816|FG001|Overall Study|Adverse Event|1|||
161489466|NCT00592839|583185817|FG002|Overall Study|Adverse Event|0|||
161489467|NCT00592839|583185815|FG000|Overall Study|Lost to Follow-up|0|||
161489468|NCT00592839|583185816|FG001|Overall Study|Lost to Follow-up|1|||
161489469|NCT00592839|583185817|FG002|Overall Study|Lost to Follow-up|1|||
161489470|NCT00799487|583185819|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
161489471|NCT00799487|583185820|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
161489472|NCT00799487|583185821|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
161489473|NCT00799487|583185819|FG000|Dose Adjustment Period|Adverse Event|2|||
161489474|NCT00799487|583185820|FG001|Dose Adjustment Period|Adverse Event|0|||
161489475|NCT00799487|583185821|FG002|Dose Adjustment Period|Adverse Event|0|||
161489476|NCT00799487|583185819|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
161489477|NCT00799487|583185820|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
161489478|NCT00799487|583185821|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
161489479|NCT00799487|583185819|FG000|Dose Adjustment Period|Investigator Discretion|2|||
161489480|NCT00799487|583185820|FG001|Dose Adjustment Period|Investigator Discretion|0|||
161489481|NCT00799487|583185821|FG002|Dose Adjustment Period|Investigator Discretion|0|||
161489482|NCT00799487|583185819|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
161489483|NCT00799487|583185820|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
161489484|NCT00799487|583185821|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
161489485|NCT00799487|583185819|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
161489486|NCT00799487|583185820|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
161489487|NCT00799487|583185821|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
161489488|NCT00799487|583185819|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
161489489|NCT00799487|583185820|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
161489490|NCT00799487|583185821|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
161489491|NCT00799487|583185819|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
161489492|NCT00799487|583185820|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
161489493|NCT00799487|583185821|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
161489494|NCT00799487|583185819|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
161489495|NCT00799487|583185820|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
161489496|NCT00799487|583185821|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
161489497|NCT00799487|583185819|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
161489498|NCT00799487|583185820|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
161489499|NCT00799487|583185821|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
161489500|NCT00799487|583185819|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
161489501|NCT00799487|583185820|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
161489502|NCT00799487|583185821|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
161489503|NCT00799487|583185819|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
161489504|NCT00799487|583185820|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
161489505|NCT00799487|583185821|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
161489506|NCT01463878|583185822|FG000|Overall Study|no longer met criteria for tube feed|2|||
161817047|NCT01604941|584370909|FG004|Overall Study|Early Study Termination|0|||
161489507|NCT01463878|583185823|FG001|Overall Study|no longer met criteria for tube feed|2|||
161489508|NCT03454893|583185826|FG000|Overall Study|Study Terminated by the Sponsor|5|||
161489509|NCT03454893|583185826|FG000|Overall Study|Did not pass screening|4|||
161489510|NCT04876274|583185827|FG000|Overall Study|Lost to Follow-up|9|||
161489511|NCT04876274|583185828|FG001|Overall Study|Lost to Follow-up|12|||
161489512|NCT00142584|583185829|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
161489513|NCT00142584|583185830|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
161489514|NCT00142584|583185829|FG000|Overall Study|Withdrawal by Subject|30|||
161489515|NCT00142584|583185830|FG001|Overall Study|Withdrawal by Subject|16|||
161489516|NCT00142584|583185829|FG000|Overall Study|Lost to Follow-up|22|||
161489517|NCT00142584|583185830|FG001|Overall Study|Lost to Follow-up|12|||
161489518|NCT00142584|583185829|FG000|Overall Study|Adverse Event|14|||
161489519|NCT00142584|583185830|FG001|Overall Study|Adverse Event|5|||
161489520|NCT00142584|583185829|FG000|Overall Study|Protocol Violation|4|||
161489521|NCT00142584|583185830|FG001|Overall Study|Protocol Violation|7|||
161489522|NCT00142584|583185829|FG000|Overall Study|Treatment Failure|2|||
161489523|NCT00142584|583185830|FG001|Overall Study|Treatment Failure|0|||
161489524|NCT03070782|583185833|FG000|Overall Study|Adverse Event|3|||
161489525|NCT03070782|583185834|FG001|Overall Study|Adverse Event|0|||
161489526|NCT03070782|583185835|FG002|Overall Study|Adverse Event|3|||
161489527|NCT03070782|583185836|FG003|Overall Study|Adverse Event|1|||
161817048|NCT01604941|584370910|FG005|Overall Study|Early Study Termination|0|||
161671405|NCT02217436|583851256|FG001|Overall Study|Incomplete data|1|||
161671406|NCT00234494|583851261|FG000|Overall Study|Protocol Violation|2|||
161489528|NCT03070782|583185837|FG004|Overall Study|Adverse Event|6|||
161489529|NCT03070782|583185838|FG005|Overall Study|Adverse Event|2|||
161489530|NCT03070782|583185833|FG000|Overall Study|Withdrawal by Subject|2|||
161489531|NCT03070782|583185834|FG001|Overall Study|Withdrawal by Subject|1|||
161489532|NCT03070782|583185835|FG002|Overall Study|Withdrawal by Subject|1|||
161489533|NCT03070782|583185836|FG003|Overall Study|Withdrawal by Subject|0|||
161489534|NCT03070782|583185837|FG004|Overall Study|Withdrawal by Subject|4|||
161489535|NCT03070782|583185838|FG005|Overall Study|Withdrawal by Subject|3|||
161489536|NCT03070782|583185833|FG000|Overall Study|Reason Not Specified|2|||
161489537|NCT03070782|583185834|FG001|Overall Study|Reason Not Specified|0|||
161489538|NCT03070782|583185835|FG002|Overall Study|Reason Not Specified|0|||
161489539|NCT03070782|583185836|FG003|Overall Study|Reason Not Specified|1|||
161489540|NCT03070782|583185837|FG004|Overall Study|Reason Not Specified|2|||
161489541|NCT03070782|583185838|FG005|Overall Study|Reason Not Specified|1|||
161489542|NCT03070782|583185833|FG000|Overall Study|Ineligibility|0|||
161489543|NCT03070782|583185834|FG001|Overall Study|Ineligibility|0|||
161489544|NCT03070782|583185835|FG002|Overall Study|Ineligibility|0|||
161489545|NCT03070782|583185836|FG003|Overall Study|Ineligibility|1|||
161489546|NCT03070782|583185837|FG004|Overall Study|Ineligibility|0|||
161489547|NCT03070782|583185838|FG005|Overall Study|Ineligibility|1|||
161489548|NCT03070782|583185833|FG000|Overall Study|Pregnancy|0|||
161489549|NCT03070782|583185834|FG001|Overall Study|Pregnancy|0|||
161489550|NCT03070782|583185835|FG002|Overall Study|Pregnancy|0|||
161489551|NCT03070782|583185836|FG003|Overall Study|Pregnancy|1|||
161489552|NCT03070782|583185837|FG004|Overall Study|Pregnancy|0|||
161489553|NCT03070782|583185838|FG005|Overall Study|Pregnancy|0|||
161489554|NCT03070782|583185833|FG000|Overall Study|Investigator Judgement|0|||
161489555|NCT03070782|583185834|FG001|Overall Study|Investigator Judgement|0|||
161489556|NCT03070782|583185835|FG002|Overall Study|Investigator Judgement|0|||
161489557|NCT03070782|583185836|FG003|Overall Study|Investigator Judgement|1|||
161489558|NCT03070782|583185837|FG004|Overall Study|Investigator Judgement|0|||
161489559|NCT03070782|583185838|FG005|Overall Study|Investigator Judgement|0|||
161489560|NCT01986985|583185843|FG000|Overall Study|Withdrawal by Subject|4|||
161489561|NCT01986985|583185843|FG000|Overall Study|Scan not completed due to malfunction|3|||
161489562|NCT01083576|583185844|FG000|Overall Study|Treatment Failure|6|||
161489563|NCT01083576|583185845|FG001|Overall Study|Treatment Failure|1|||
161489564|NCT03527966|583185846|FG000|Overall Study|Lost to Follow-up|3|||
161489565|NCT03527966|583185847|FG001|Overall Study|Lost to Follow-up|0|||
161489566|NCT01948050|583185848|FG000|Overall Study|Withdrawal by Subject|0|||
161489567|NCT01948050|583185849|FG001|Overall Study|Withdrawal by Subject|1|||
161489568|NCT02288559|583185850|FG000|Overall Study|Adverse Event|1|||
161489569|NCT02288559|583185851|FG001|Overall Study|Adverse Event|1|||
161489570|NCT02288559|583185852|FG002|Overall Study|Adverse Event|5|||
161489571|NCT02288559|583185853|FG003|Overall Study|Adverse Event|0|||
161489572|NCT02288559|583185850|FG000|Overall Study|Death|0|||
161489573|NCT02288559|583185851|FG001|Overall Study|Death|0|||
161489574|NCT02288559|583185852|FG002|Overall Study|Death|1|||
161489575|NCT02288559|583185853|FG003|Overall Study|Death|0|||
161489576|NCT02288559|583185850|FG000|Overall Study|Lost to Follow-up|0|||
161489577|NCT02288559|583185851|FG001|Overall Study|Lost to Follow-up|0|||
161489578|NCT02288559|583185852|FG002|Overall Study|Lost to Follow-up|0|||
161583036|NCT01968109|583521213|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161583037|NCT01968109|583521183|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583038|NCT01968109|583521184|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583039|NCT01968109|583521185|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583040|NCT01968109|583521186|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583041|NCT01968109|583521187|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583042|NCT01968109|583521188|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161671407|NCT02634346|583851265|FG000|Overall Study|Withdrawal by Subject|8|||
161671408|NCT02634346|583851266|FG001|Overall Study|Withdrawal by Subject|9|||
161817049|NCT02213263|584370915|FG000|Overall Study|Insufficient clinical response|4|||
161817050|NCT02213263|584370916|FG001|Overall Study|Insufficient clinical response|3|||
161489579|NCT02288559|583185853|FG003|Overall Study|Lost to Follow-up|1|||
161489580|NCT02288559|583185850|FG000|Overall Study|Withdrawal by Subject|0|||
161489581|NCT02288559|583185851|FG001|Overall Study|Withdrawal by Subject|0|||
161489582|NCT02288559|583185852|FG002|Overall Study|Withdrawal by Subject|2|||
161489583|NCT02288559|583185853|FG003|Overall Study|Withdrawal by Subject|1|||
161489584|NCT02288559|583185850|FG000|Overall Study|Reason Not Specified|0|||
161489585|NCT02288559|583185851|FG001|Overall Study|Reason Not Specified|0|||
161489586|NCT02288559|583185852|FG002|Overall Study|Reason Not Specified|3|||
161489587|NCT02288559|583185853|FG003|Overall Study|Reason Not Specified|0|||
161583043|NCT01968109|583521189|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583044|NCT01968109|583521190|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583045|NCT01968109|583521191|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161817051|NCT02213263|584370915|FG000|Overall Study|Lost to Follow-up|0|||
161489588|NCT00558025|583185854|FG000|Overall Study|Adverse Event|1|||
161489589|NCT00558025|583185855|FG001|Overall Study|Adverse Event|1|||
161671409|NCT02634346|583851267|FG002|Overall Study|Withdrawal by Subject|8|||
161671410|NCT02634346|583851265|FG000|Overall Study|Adverse Event|2|||
161671411|NCT02634346|583851266|FG001|Overall Study|Adverse Event|2|||
161671412|NCT02634346|583851267|FG002|Overall Study|Adverse Event|7|||
161671413|NCT02634346|583851265|FG000|Overall Study|Lack of Efficacy|1|||
161671414|NCT02634346|583851266|FG001|Overall Study|Lack of Efficacy|2|||
161671415|NCT02634346|583851267|FG002|Overall Study|Lack of Efficacy|8|||
161671416|NCT02634346|583851265|FG000|Overall Study|Lost to Follow-up|1|||
161671417|NCT02634346|583851266|FG001|Overall Study|Lost to Follow-up|0|||
161671418|NCT02634346|583851267|FG002|Overall Study|Lost to Follow-up|0|||
161671419|NCT02634346|583851265|FG000|Overall Study|Protocol Violation|0|||
161671420|NCT02634346|583851266|FG001|Overall Study|Protocol Violation|1|||
161671421|NCT02634346|583851267|FG002|Overall Study|Protocol Violation|0|||
161671422|NCT02170389|583851268|FG000|Overall Study|Study terminated prior to start of treat|1|||
161671423|NCT00908232|583851274|FG000|Cycle 1 to 4|Death|5|||
161671424|NCT00908232|583851275|FG001|Cycle 1 to 4|Death|0|||
161671425|NCT00908232|583851276|FG002|Cycle 1 to 4|Death|0|||
161671426|NCT00908232|583851277|FG003|Cycle 1 to 4|Death|0|||
161671427|NCT00908232|583851274|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
161671428|NCT00908232|583851275|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
161671429|NCT00908232|583851276|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
161671430|NCT00908232|583851277|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
161671431|NCT00908232|583851274|FG000|Cycle 1 to 4|Progressive Disease|6|||
161671432|NCT00908232|583851275|FG001|Cycle 1 to 4|Progressive Disease|0|||
161671433|NCT00908232|583851276|FG002|Cycle 1 to 4|Progressive Disease|0|||
161671434|NCT00908232|583851277|FG003|Cycle 1 to 4|Progressive Disease|0|||
161671435|NCT00908232|583851274|FG000|Cycle 1 to 4|Adverse Event|12|||
161671436|NCT00908232|583851275|FG001|Cycle 1 to 4|Adverse Event|0|||
161671437|NCT00908232|583851276|FG002|Cycle 1 to 4|Adverse Event|0|||
161671438|NCT00908232|583851277|FG003|Cycle 1 to 4|Adverse Event|0|||
161671439|NCT00908232|583851274|FG000|Cycle 1 to 4|Other|1|||
161671440|NCT00908232|583851275|FG001|Cycle 1 to 4|Other|0|||
161671441|NCT00908232|583851276|FG002|Cycle 1 to 4|Other|0|||
161671442|NCT00908232|583851277|FG003|Cycle 1 to 4|Other|0|||
161671443|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
161671444|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161671445|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161671446|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161671447|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
161671448|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161671449|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161671450|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161671451|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
161671452|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
161671453|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
161671454|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
161671455|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
161671456|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
161671457|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
161671458|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
161671459|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
161671460|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
161671461|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
161671462|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
161671463|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
161671464|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161671465|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161671466|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161671467|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
161671468|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
161671469|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
161671470|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
161671471|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
161817052|NCT02213263|584370916|FG001|Overall Study|Lost to Follow-up|1|||
161817053|NCT02213263|584370915|FG000|Overall Study|No longer willing to participate|3|||
161817054|NCT02213263|584370916|FG001|Overall Study|No longer willing to participate|4|||
161671472|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161671473|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161671474|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161671475|NCT00769860|583851286|FG000|Overall Study|Withdrawal by Subject|2|||
161671476|NCT00769860|583851287|FG001|Overall Study|Withdrawal by Subject|0|||
161671477|NCT00448435|583851290|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
161817055|NCT02213263|584370915|FG000|Overall Study|Progressive disease|20|||
161817056|NCT02213263|584370916|FG001|Overall Study|Progressive disease|14|||
161489590|NCT00558025|583185854|FG000|Overall Study|Withdrawal by Subject|2|||
161489591|NCT00558025|583185855|FG001|Overall Study|Withdrawal by Subject|2|||
161489592|NCT00558025|583185854|FG000|Overall Study|Protocol Violation|1|||
161489593|NCT00558025|583185855|FG001|Overall Study|Protocol Violation|0|||
161489594|NCT04577118|583185856|FG000|Overall Study|Withdrawal by Subject|4|||
161489595|NCT00356369|583185861|FG000|Active Phase|Withdrawal by Subject|2|||
161583046|NCT01968109|583521192|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161583047|NCT01968109|583521193|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583048|NCT01968109|583521194|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161583049|NCT01968109|583521195|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583050|NCT01968109|583521196|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161583051|NCT01968109|583521197|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161583052|NCT01968109|583521198|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161583053|NCT01968109|583521199|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161583054|NCT01968109|583521200|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161489596|NCT00356369|583185862|FG001|Active Phase|Withdrawal by Subject|1|||
161489597|NCT00673465|583185863|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489598|NCT00673465|583185864|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489599|NCT00673465|583185865|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489600|NCT00673465|583185866|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489601|NCT00673465|583185867|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
161489602|NCT00673465|583185868|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
161489603|NCT00673465|583185869|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489604|NCT00673465|583185870|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489605|NCT00673465|583185871|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489606|NCT00673465|583185872|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489607|NCT00673465|583185873|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489608|NCT00673465|583185874|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
161489609|NCT00673465|583185863|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489610|NCT00673465|583185864|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489611|NCT00673465|583185865|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
161583055|NCT01968109|583521201|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161583056|NCT01968109|583521202|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161583057|NCT01968109|583521203|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161583058|NCT01968109|583521204|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161583059|NCT01968109|583521205|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161583060|NCT01968109|583521206|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161583061|NCT01968109|583521207|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
161583062|NCT01968109|583521208|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
161583063|NCT01968109|583521209|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161583064|NCT01968109|583521210|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161583065|NCT01968109|583521211|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161583066|NCT01968109|583521212|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161583067|NCT01968109|583521213|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161583068|NCT01968109|583521183|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583069|NCT01968109|583521184|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583070|NCT01968109|583521185|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583071|NCT01968109|583521186|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583072|NCT01968109|583521187|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583073|NCT01968109|583521188|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161583074|NCT01968109|583521189|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583075|NCT01968109|583521190|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583076|NCT01968109|583521191|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161583077|NCT01968109|583521192|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583078|NCT01968109|583521193|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583079|NCT01968109|583521194|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583080|NCT01968109|583521195|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583081|NCT01968109|583521196|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583082|NCT01968109|583521197|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583083|NCT01968109|583521198|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
161583084|NCT01968109|583521199|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
161583085|NCT01968109|583521200|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161583086|NCT01968109|583521201|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161489612|NCT00673465|583185866|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489613|NCT00673465|583185867|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
161583087|NCT01968109|583521202|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161583088|NCT01968109|583521203|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
161583089|NCT01968109|583521204|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161489614|NCT00673465|583185868|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489615|NCT00673465|583185869|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489616|NCT00673465|583185870|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489617|NCT00673465|583185871|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489618|NCT00673465|583185872|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489619|NCT00673465|583185873|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489620|NCT00673465|583185874|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
161489621|NCT01996982|583185875|FG000|Overall Study|PI/team left institution|7|||
161489622|NCT01195415|583185894|FG000|Overall Study|No repeat biopsy due to progression|2|||
161489623|NCT00996307|583185897|FG000|Overall Study|Adverse Event|0|||
161489624|NCT00996307|583185898|FG001|Overall Study|Adverse Event|1|||
161489625|NCT00996307|583185899|FG002|Overall Study|Adverse Event|0|||
161489626|NCT00996307|583185900|FG003|Overall Study|Adverse Event|0|||
161489627|NCT00996307|583185897|FG000|Overall Study|Withdrawal by Subject|3|||
161489628|NCT00996307|583185898|FG001|Overall Study|Withdrawal by Subject|2|||
161489629|NCT00996307|583185899|FG002|Overall Study|Withdrawal by Subject|5|||
161489630|NCT00996307|583185900|FG003|Overall Study|Withdrawal by Subject|5|||
161489631|NCT00996307|583185897|FG000|Overall Study|Lost to Follow-up|13|||
161489632|NCT00996307|583185898|FG001|Overall Study|Lost to Follow-up|13|||
161489633|NCT00996307|583185899|FG002|Overall Study|Lost to Follow-up|7|||
161489634|NCT00996307|583185900|FG003|Overall Study|Lost to Follow-up|15|||
161489635|NCT00996307|583185897|FG000|Overall Study|Administrative reason|0|||
161489636|NCT00996307|583185898|FG001|Overall Study|Administrative reason|1|||
161489637|NCT00996307|583185899|FG002|Overall Study|Administrative reason|0|||
161489638|NCT00996307|583185900|FG003|Overall Study|Administrative reason|0|||
161489639|NCT00996307|583185897|FG000|Overall Study|Unable to classify|4|||
161489640|NCT00996307|583185898|FG001|Overall Study|Unable to classify|0|||
161489641|NCT00996307|583185899|FG002|Overall Study|Unable to classify|2|||
161489642|NCT00996307|583185900|FG003|Overall Study|Unable to classify|1|||
161489643|NCT02788357|583185901|FG000|Overall Study|Lost to Follow-up|3|||
161489644|NCT02788357|583185902|FG001|Overall Study|Lost to Follow-up|0|||
161489645|NCT00640601|583185903|FG000|Overall Study|Adverse Event|43|||
161489646|NCT00640601|583185903|FG000|Overall Study|Withdrawal by Subject|20|||
161489647|NCT00640601|583185903|FG000|Overall Study|Protocol Violation|6|||
161489648|NCT00640601|583185903|FG000|Overall Study|Lack of Efficacy|16|||
161489649|NCT00640601|583185903|FG000|Overall Study|Lost to Follow-up|9|||
161489650|NCT00640601|583185903|FG000|Overall Study|Physician Decision|8|||
161489651|NCT00640601|583185903|FG000|Overall Study|treatment naive, combination therapy|10|||
161489652|NCT03198234|583185904|FG000|Overall Study|Relapse of primary disease|0|||
161489653|NCT03198234|583185905|FG001|Overall Study|Relapse of primary disease|1|||
161489654|NCT03198234|583185906|FG002|Overall Study|Relapse of primary disease|0|||
161489655|NCT00165776|583185907|FG000|Overall Study|Lack of Efficacy|0|||
161489656|NCT00165776|583185908|FG001|Overall Study|Lack of Efficacy|0|||
161489657|NCT00165776|583185909|FG002|Overall Study|Lack of Efficacy|0|||
161489658|NCT00165776|583185910|FG003|Overall Study|Lack of Efficacy|1|||
161489659|NCT00165776|583185907|FG000|Overall Study|Withdrawal by Subject|4|||
161489660|NCT00165776|583185908|FG001|Overall Study|Withdrawal by Subject|1|||
161489661|NCT00165776|583185909|FG002|Overall Study|Withdrawal by Subject|2|||
161489662|NCT00165776|583185910|FG003|Overall Study|Withdrawal by Subject|0|||
161489663|NCT00165776|583185907|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
161489664|NCT00165776|583185908|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
161489665|NCT00165776|583185909|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
161489666|NCT00165776|583185910|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
161489667|NCT04285879|583185912|FG000|Overall Study|Lost to Follow-up|1|||
161489668|NCT04285879|583185913|FG001|Overall Study|Lost to Follow-up|8|||
161489669|NCT04285879|583185912|FG000|Overall Study|medical/surgical exclusion|16|||
161489670|NCT04285879|583185913|FG001|Overall Study|medical/surgical exclusion|0|||
161489671|NCT01835587|583185916|FG000|Overall Study|Disease Recurrence or Relapse|0|||
161489672|NCT01835587|583185917|FG001|Overall Study|Disease Recurrence or Relapse|3|||
161489673|NCT01835587|583185918|FG002|Overall Study|Disease Recurrence or Relapse|0|||
161489674|NCT01835587|583185919|FG003|Overall Study|Disease Recurrence or Relapse|3|||
161489675|NCT01835587|583185916|FG000|Overall Study|Withdrawal by Subject|2|||
161489676|NCT01835587|583185917|FG001|Overall Study|Withdrawal by Subject|0|||
161583090|NCT01968109|583521205|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161489677|NCT01835587|583185918|FG002|Overall Study|Withdrawal by Subject|0|||
161489678|NCT01835587|583185919|FG003|Overall Study|Withdrawal by Subject|3|||
161489679|NCT01835587|583185916|FG000|Overall Study|Adverse Event|0|||
161489680|NCT01835587|583185917|FG001|Overall Study|Adverse Event|0|||
161489681|NCT01835587|583185918|FG002|Overall Study|Adverse Event|2|||
161489682|NCT01835587|583185919|FG003|Overall Study|Adverse Event|2|||
161489683|NCT01835587|583185916|FG000|Overall Study|Death|0|||
161489684|NCT01835587|583185917|FG001|Overall Study|Death|0|||
161489685|NCT01835587|583185918|FG002|Overall Study|Death|0|||
161489686|NCT01835587|583185919|FG003|Overall Study|Death|1|||
161489687|NCT01835587|583185916|FG000|Overall Study|Miscellaneous|0|||
161489688|NCT01835587|583185917|FG001|Overall Study|Miscellaneous|1|||
161489689|NCT01835587|583185918|FG002|Overall Study|Miscellaneous|0|||
161489690|NCT01835587|583185919|FG003|Overall Study|Miscellaneous|0|||
161489691|NCT03310775|583185926|FG000|Overall Study|Lost to Follow-up|2|||
161489692|NCT03310775|583185927|FG001|Overall Study|Lost to Follow-up|3|||
161489693|NCT03310775|583185926|FG000|Overall Study|aggravation of depression|0|||
161489694|NCT03310775|583185927|FG001|Overall Study|aggravation of depression|1|||
161489695|NCT02260921|583185935|FG000|Overall Study|Adverse Event|1|||
161489696|NCT02260921|583185936|FG001|Overall Study|Adverse Event|0|||
161489697|NCT02260921|583185935|FG000|Overall Study|Lost to Follow-up|4|||
161489698|NCT02260921|583185936|FG001|Overall Study|Lost to Follow-up|3|||
161489699|NCT02260921|583185935|FG000|Overall Study|Withdraw Consent|4|||
161489700|NCT02260921|583185936|FG001|Overall Study|Withdraw Consent|1|||
161489701|NCT02260921|583185935|FG000|Overall Study|Death|1|||
161489702|NCT02260921|583185936|FG001|Overall Study|Death|0|||
161489703|NCT02260921|583185935|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
161489704|NCT02260921|583185936|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
161489705|NCT02999854|583185937|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
161489706|NCT02999854|583185938|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
161489707|NCT02999854|583185937|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
161489708|NCT02999854|583185938|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
161489709|NCT02999854|583185937|FG000|Active Study Phase (up to 18 Months)|Death|7|||
161489710|NCT02999854|583185938|FG001|Active Study Phase (up to 18 Months)|Death|5|||
161489711|NCT02999854|583185937|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
161489712|NCT02999854|583185938|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
161489713|NCT02999854|583185937|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
161489714|NCT02999854|583185938|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
161489715|NCT02999854|583185937|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
161489716|NCT02999854|583185938|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
161489717|NCT02999854|583185937|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
161489718|NCT02999854|583185938|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
161489719|NCT02999854|583185937|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
161489720|NCT02999854|583185938|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
161489721|NCT00203996|583185939|FG000|Overall Study|Lost to Follow-up|0|||
161489722|NCT00203996|583185940|FG001|Overall Study|Lost to Follow-up|0|||
161489723|NCT00203996|583185941|FG002|Overall Study|Lost to Follow-up|0|||
161489724|NCT00203996|583185942|FG003|Overall Study|Lost to Follow-up|1|||
161489725|NCT00203996|583185943|FG004|Overall Study|Lost to Follow-up|0|||
161489726|NCT00203996|583185944|FG005|Overall Study|Lost to Follow-up|0|||
161489727|NCT00203996|583185945|FG006|Overall Study|Lost to Follow-up|0|||
161489728|NCT00203996|583185946|FG007|Overall Study|Lost to Follow-up|0|||
161489729|NCT00203996|583185947|FG008|Overall Study|Lost to Follow-up|0|||
161489730|NCT00203996|583185948|FG009|Overall Study|Lost to Follow-up|0|||
161489731|NCT00203996|583185939|FG000|Overall Study|Protocol Violation|0|||
161489732|NCT00203996|583185940|FG001|Overall Study|Protocol Violation|0|||
161489733|NCT00203996|583185941|FG002|Overall Study|Protocol Violation|0|||
161489734|NCT00203996|583185942|FG003|Overall Study|Protocol Violation|6|||
161489735|NCT00203996|583185943|FG004|Overall Study|Protocol Violation|1|||
161489736|NCT00203996|583185944|FG005|Overall Study|Protocol Violation|0|||
161489737|NCT00203996|583185945|FG006|Overall Study|Protocol Violation|0|||
161489738|NCT00203996|583185946|FG007|Overall Study|Protocol Violation|0|||
161489739|NCT00203996|583185947|FG008|Overall Study|Protocol Violation|0|||
161489740|NCT00203996|583185948|FG009|Overall Study|Protocol Violation|0|||
161489741|NCT00203996|583185939|FG000|Overall Study|Physician Decision|0|||
161489742|NCT00203996|583185940|FG001|Overall Study|Physician Decision|0|||
161489743|NCT00203996|583185941|FG002|Overall Study|Physician Decision|0|||
161489744|NCT00203996|583185942|FG003|Overall Study|Physician Decision|2|||
161489745|NCT00203996|583185943|FG004|Overall Study|Physician Decision|0|||
161489746|NCT00203996|583185944|FG005|Overall Study|Physician Decision|0|||
161489747|NCT00203996|583185945|FG006|Overall Study|Physician Decision|0|||
161489748|NCT00203996|583185946|FG007|Overall Study|Physician Decision|0|||
161489749|NCT00203996|583185947|FG008|Overall Study|Physician Decision|0|||
161489750|NCT00203996|583185948|FG009|Overall Study|Physician Decision|1|||
161489751|NCT00203996|583185939|FG000|Overall Study|CPAP machine malfunction|0|||
161489752|NCT00203996|583185940|FG001|Overall Study|CPAP machine malfunction|0|||
161489753|NCT00203996|583185941|FG002|Overall Study|CPAP machine malfunction|0|||
161489754|NCT00203996|583185942|FG003|Overall Study|CPAP machine malfunction|1|||
161489755|NCT00203996|583185943|FG004|Overall Study|CPAP machine malfunction|0|||
161489756|NCT00203996|583185944|FG005|Overall Study|CPAP machine malfunction|0|||
161489757|NCT00203996|583185945|FG006|Overall Study|CPAP machine malfunction|0|||
161489758|NCT00203996|583185946|FG007|Overall Study|CPAP machine malfunction|0|||
161489759|NCT00203996|583185947|FG008|Overall Study|CPAP machine malfunction|0|||
161489760|NCT00203996|583185948|FG009|Overall Study|CPAP machine malfunction|0|||
161489761|NCT00203996|583185939|FG000|Overall Study|Scheduling issue|0|||
161489762|NCT00203996|583185940|FG001|Overall Study|Scheduling issue|0|||
161489763|NCT00203996|583185941|FG002|Overall Study|Scheduling issue|0|||
161489764|NCT00203996|583185942|FG003|Overall Study|Scheduling issue|0|||
161583091|NCT01968109|583521206|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
161583092|NCT01968109|583521207|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
161583093|NCT01968109|583521208|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583094|NCT01968109|583521209|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161583095|NCT01968109|583521210|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
161583096|NCT01968109|583521211|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583097|NCT01968109|583521212|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161583098|NCT01968109|583521213|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161583099|NCT01968109|583521183|FG000|Overall Study|OTHER REASONS|0|||
161583100|NCT01968109|583521184|FG001|Overall Study|OTHER REASONS|0|||
161583101|NCT01968109|583521185|FG002|Overall Study|OTHER REASONS|0|||
161583102|NCT01968109|583521186|FG003|Overall Study|OTHER REASONS|1|||
161583103|NCT01968109|583521187|FG004|Overall Study|OTHER REASONS|0|||
161583104|NCT01968109|583521188|FG005|Overall Study|OTHER REASONS|0|||
161583105|NCT01968109|583521189|FG006|Overall Study|OTHER REASONS|0|||
161583106|NCT01968109|583521190|FG007|Overall Study|OTHER REASONS|0|||
161583107|NCT01968109|583521191|FG008|Overall Study|OTHER REASONS|0|||
161583108|NCT01968109|583521192|FG009|Overall Study|OTHER REASONS|0|||
161583109|NCT01968109|583521193|FG010|Overall Study|OTHER REASONS|0|||
161583110|NCT01968109|583521194|FG011|Overall Study|OTHER REASONS|1|||
161583111|NCT01968109|583521195|FG012|Overall Study|OTHER REASONS|0|||
161583112|NCT01968109|583521196|FG013|Overall Study|OTHER REASONS|0|||
161583113|NCT01968109|583521197|FG014|Overall Study|OTHER REASONS|1|||
161583114|NCT01968109|583521198|FG015|Overall Study|OTHER REASONS|1|||
161583115|NCT01968109|583521199|FG016|Overall Study|OTHER REASONS|1|||
161583116|NCT01968109|583521200|FG017|Overall Study|OTHER REASONS|0|||
161583117|NCT01968109|583521201|FG018|Overall Study|OTHER REASONS|0|||
161583118|NCT01968109|583521202|FG019|Overall Study|OTHER REASONS|0|||
161583119|NCT01968109|583521203|FG020|Overall Study|OTHER REASONS|0|||
161583120|NCT01968109|583521204|FG021|Overall Study|OTHER REASONS|2|||
161583121|NCT01968109|583521205|FG022|Overall Study|OTHER REASONS|0|||
161583122|NCT01968109|583521206|FG023|Overall Study|OTHER REASONS|0|||
161583123|NCT01968109|583521207|FG024|Overall Study|OTHER REASONS|3|||
161583124|NCT01968109|583521208|FG025|Overall Study|OTHER REASONS|0|||
161583125|NCT01968109|583521209|FG026|Overall Study|OTHER REASONS|3|||
161583126|NCT01968109|583521210|FG027|Overall Study|OTHER REASONS|3|||
161583127|NCT01968109|583521211|FG028|Overall Study|OTHER REASONS|6|||
161583128|NCT01968109|583521212|FG029|Overall Study|OTHER REASONS|7|||
161583129|NCT01968109|583521213|FG030|Overall Study|OTHER REASONS|3|||
161583130|NCT01968109|583521183|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583131|NCT01968109|583521184|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583132|NCT01968109|583521185|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583133|NCT01968109|583521186|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583134|NCT01968109|583521187|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583135|NCT01968109|583521188|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583136|NCT01968109|583521189|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583137|NCT01968109|583521190|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583138|NCT01968109|583521191|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583139|NCT01968109|583521192|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583140|NCT01968109|583521193|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583141|NCT01968109|583521194|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583142|NCT01968109|583521195|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583143|NCT01968109|583521196|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583144|NCT01968109|583521197|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583145|NCT01968109|583521198|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583146|NCT01968109|583521199|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
161583147|NCT01968109|583521200|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161583148|NCT01968109|583521201|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583149|NCT01968109|583521202|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161583150|NCT01968109|583521203|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161583151|NCT01968109|583521204|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583152|NCT01968109|583521205|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583153|NCT01968109|583521206|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583154|NCT01968109|583521207|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161671478|NCT00448435|583851291|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161583155|NCT01968109|583521208|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161583156|NCT01968109|583521209|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161583157|NCT01968109|583521210|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161583158|NCT01968109|583521211|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
161583159|NCT01968109|583521212|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
161583160|NCT01968109|583521213|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161583161|NCT01968109|583521183|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583162|NCT01968109|583521184|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583163|NCT01968109|583521185|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583164|NCT01968109|583521186|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583165|NCT01968109|583521187|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161489765|NCT00203996|583185943|FG004|Overall Study|Scheduling issue|0|||
161489766|NCT00203996|583185944|FG005|Overall Study|Scheduling issue|0|||
161489767|NCT00203996|583185945|FG006|Overall Study|Scheduling issue|0|||
161671479|NCT02804178|583851296|FG000|Overall Study|Adverse Event|1|||
161671480|NCT00412971|583851297|FG000|Overall Study|Lost to Follow-up|17|||
161489768|NCT00203996|583185946|FG007|Overall Study|Scheduling issue|2|||
161671481|NCT00412971|583851298|FG001|Overall Study|Lost to Follow-up|9|||
161489769|NCT00203996|583185947|FG008|Overall Study|Scheduling issue|0|||
161489770|NCT00203996|583185948|FG009|Overall Study|Scheduling issue|0|||
161489771|NCT03064451|583185949|FG000|Overall Study|Lost to Follow-up|1|||
161489772|NCT03064451|583185949|FG000|Overall Study|Mapping Failure|4|||
161489773|NCT03064451|583185949|FG000|Overall Study|Exited prior to procedure|8|||
161489774|NCT03064451|583185949|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
161583166|NCT01968109|583521188|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583167|NCT01968109|583521189|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583168|NCT01968109|583521190|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583169|NCT01968109|583521191|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583170|NCT01968109|583521192|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583171|NCT01968109|583521193|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583172|NCT01968109|583521194|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583173|NCT01968109|583521195|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583174|NCT01968109|583521196|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583175|NCT01968109|583521197|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583176|NCT01968109|583521198|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583177|NCT01968109|583521199|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583178|NCT01968109|583521200|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583179|NCT01968109|583521201|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583180|NCT01968109|583521202|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583181|NCT01968109|583521203|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
161583182|NCT01968109|583521204|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583183|NCT01968109|583521205|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583184|NCT01968109|583521206|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
161583185|NCT01968109|583521207|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583186|NCT01968109|583521208|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583187|NCT01968109|583521209|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583188|NCT01968109|583521210|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583189|NCT01968109|583521211|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583190|NCT01968109|583521212|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583191|NCT01968109|583521213|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161583192|NCT01968109|583521183|FG000|Overall Study|Death|0|||
161583193|NCT01968109|583521184|FG001|Overall Study|Death|0|||
161583194|NCT01968109|583521185|FG002|Overall Study|Death|0|||
161583195|NCT01968109|583521186|FG003|Overall Study|Death|0|||
161583196|NCT01968109|583521187|FG004|Overall Study|Death|0|||
161583197|NCT01968109|583521188|FG005|Overall Study|Death|0|||
161583198|NCT01968109|583521189|FG006|Overall Study|Death|0|||
161583199|NCT01968109|583521190|FG007|Overall Study|Death|0|||
161583200|NCT01968109|583521191|FG008|Overall Study|Death|0|||
161583201|NCT01968109|583521192|FG009|Overall Study|Death|0|||
161583202|NCT01968109|583521193|FG010|Overall Study|Death|0|||
161671482|NCT00412971|583851297|FG000|Overall Study|Protocol Violation|13|||
161671483|NCT00412971|583851298|FG001|Overall Study|Protocol Violation|1|||
161583203|NCT01968109|583521194|FG011|Overall Study|Death|0|||
161583204|NCT01968109|583521195|FG012|Overall Study|Death|0|||
161583205|NCT01968109|583521196|FG013|Overall Study|Death|0|||
161583206|NCT01968109|583521197|FG014|Overall Study|Death|0|||
161583207|NCT01968109|583521198|FG015|Overall Study|Death|0|||
161583208|NCT01968109|583521199|FG016|Overall Study|Death|0|||
161583209|NCT01968109|583521200|FG017|Overall Study|Death|0|||
161583210|NCT01968109|583521201|FG018|Overall Study|Death|0|||
161583211|NCT01968109|583521202|FG019|Overall Study|Death|0|||
161671484|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
161489775|NCT00897104|583185950|FG000|Overall Study|Lost to Follow-up|12|||
161583212|NCT01968109|583521203|FG020|Overall Study|Death|0|||
161583213|NCT01968109|583521204|FG021|Overall Study|Death|1|||
161583214|NCT01968109|583521205|FG022|Overall Study|Death|0|||
161583215|NCT01968109|583521206|FG023|Overall Study|Death|0|||
161583216|NCT01968109|583521207|FG024|Overall Study|Death|0|||
161489776|NCT00897104|583185951|FG001|Overall Study|Lost to Follow-up|17|||
161583217|NCT01968109|583521208|FG025|Overall Study|Death|0|||
161583218|NCT01968109|583521209|FG026|Overall Study|Death|0|||
161583219|NCT01968109|583521210|FG027|Overall Study|Death|0|||
161583220|NCT01968109|583521211|FG028|Overall Study|Death|0|||
161583221|NCT01968109|583521212|FG029|Overall Study|Death|0|||
161583222|NCT01968109|583521213|FG030|Overall Study|Death|1|||
161583223|NCT06938230|583521217|FG000|Overall Study|Lost to Follow-up|56|||
161671485|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
161489777|NCT00897104|583185952|FG002|Overall Study|Lost to Follow-up|2|||
161489778|NCT00897104|583185950|FG000|Overall Study|Pregnancy|0|||
161489779|NCT00897104|583185951|FG001|Overall Study|Pregnancy|1|||
161489780|NCT00897104|583185952|FG002|Overall Study|Pregnancy|0|||
161489781|NCT00897104|583185950|FG000|Overall Study|Protocol Violation|0|||
161489782|NCT00897104|583185951|FG001|Overall Study|Protocol Violation|1|||
161489783|NCT00897104|583185952|FG002|Overall Study|Protocol Violation|0|||
161489784|NCT00897104|583185950|FG000|Overall Study|Withdrawal by Subject|23|||
161489785|NCT00897104|583185951|FG001|Overall Study|Withdrawal by Subject|27|||
161489786|NCT00897104|583185952|FG002|Overall Study|Withdrawal by Subject|3|||
161489787|NCT00897104|583185950|FG000|Overall Study|Abnormal Prestudy Labs|2|||
161489788|NCT00897104|583185951|FG001|Overall Study|Abnormal Prestudy Labs|0|||
161489789|NCT00897104|583185952|FG002|Overall Study|Abnormal Prestudy Labs|0|||
161489790|NCT00897104|583185950|FG000|Overall Study|Abnormal Baseline ECG|2|||
161489791|NCT00897104|583185951|FG001|Overall Study|Abnormal Baseline ECG|2|||
161489792|NCT00897104|583185952|FG002|Overall Study|Abnormal Baseline ECG|0|||
161489793|NCT00897104|583185950|FG000|Overall Study|Need for Concom. Med.|0|||
161489794|NCT00897104|583185951|FG001|Overall Study|Need for Concom. Med.|1|||
161489795|NCT00897104|583185952|FG002|Overall Study|Need for Concom. Med.|1|||
161489796|NCT00897104|583185950|FG000|Overall Study|Lack of Migraine Attack|20|||
161489797|NCT00897104|583185951|FG001|Overall Study|Lack of Migraine Attack|22|||
161489798|NCT00897104|583185952|FG002|Overall Study|Lack of Migraine Attack|1|||
161489799|NCT00897104|583185950|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161489800|NCT00897104|583185951|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161489801|NCT00897104|583185952|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161489802|NCT00897104|583185950|FG000|Overall Study|Other|3|||
161489803|NCT00897104|583185951|FG001|Overall Study|Other|0|||
161489804|NCT00897104|583185952|FG002|Overall Study|Other|0|||
161489805|NCT00897104|583185950|FG000|Overall Study|Protocol Violation|1|||
161489806|NCT00897104|583185951|FG001|Overall Study|Protocol Violation|0|||
161489807|NCT00897104|583185952|FG002|Overall Study|Protocol Violation|0|||
161489808|NCT00897104|583185950|FG000|Overall Study|Withdrawal by Subject|0|||
161489809|NCT00897104|583185951|FG001|Overall Study|Withdrawal by Subject|0|||
161489810|NCT00897104|583185952|FG002|Overall Study|Withdrawal by Subject|1|||
161489811|NCT00750204|583185953|FG000|Overall Study|study halted prematurely|1|||
161489812|NCT00750204|583185954|FG001|Overall Study|study halted prematurely|1|||
161489813|NCT00434330|583185955|FG000|Overall Study|Adverse Event|0|||
161489814|NCT00434330|583185956|FG001|Overall Study|Adverse Event|0|||
161489815|NCT00434330|583185957|FG002|Overall Study|Adverse Event|1|||
161489816|NCT00434330|583185958|FG003|Overall Study|Adverse Event|0|||
161489817|NCT00434330|583185959|FG004|Overall Study|Adverse Event|0|||
161489818|NCT00434330|583185960|FG005|Overall Study|Adverse Event|0|||
161489819|NCT00434330|583185955|FG000|Overall Study|Death|1|||
161489820|NCT00434330|583185956|FG001|Overall Study|Death|0|||
161489821|NCT00434330|583185957|FG002|Overall Study|Death|0|||
161489822|NCT00434330|583185958|FG003|Overall Study|Death|0|||
161489823|NCT00434330|583185959|FG004|Overall Study|Death|1|||
161489824|NCT00434330|583185960|FG005|Overall Study|Death|1|||
161489825|NCT00434330|583185955|FG000|Overall Study|Withdrawal by Subject|0|||
161489826|NCT00434330|583185956|FG001|Overall Study|Withdrawal by Subject|0|||
161489827|NCT00434330|583185957|FG002|Overall Study|Withdrawal by Subject|1|||
161489828|NCT00434330|583185958|FG003|Overall Study|Withdrawal by Subject|1|||
161489829|NCT00434330|583185959|FG004|Overall Study|Withdrawal by Subject|0|||
161489830|NCT00434330|583185960|FG005|Overall Study|Withdrawal by Subject|0|||
161489831|NCT00434330|583185955|FG000|Overall Study|Renal transplant|0|||
161489832|NCT00434330|583185956|FG001|Overall Study|Renal transplant|0|||
161489833|NCT00434330|583185957|FG002|Overall Study|Renal transplant|0|||
161489834|NCT00434330|583185958|FG003|Overall Study|Renal transplant|1|||
161489835|NCT00434330|583185959|FG004|Overall Study|Renal transplant|0|||
161489836|NCT00434330|583185960|FG005|Overall Study|Renal transplant|0|||
161489837|NCT00434330|583185955|FG000|Overall Study|Subject Not Compliant With Study|0|||
161489838|NCT00434330|583185956|FG001|Overall Study|Subject Not Compliant With Study|0|||
161489839|NCT00434330|583185957|FG002|Overall Study|Subject Not Compliant With Study|1|||
161489840|NCT00434330|583185958|FG003|Overall Study|Subject Not Compliant With Study|0|||
161489841|NCT00434330|583185959|FG004|Overall Study|Subject Not Compliant With Study|0|||
161489842|NCT00434330|583185960|FG005|Overall Study|Subject Not Compliant With Study|0|||
161489843|NCT00850564|583185963|FG000|Overall Study|Withdrawal by Subject|2|||
161489844|NCT03032705|583185964|FG000|Overall Study|Lost to Follow-up|16|||
161489845|NCT03032705|583185965|FG001|Overall Study|Lost to Follow-up|17|||
161489846|NCT03032705|583185964|FG000|Overall Study|did not quality|6|||
161489847|NCT03032705|583185965|FG001|Overall Study|did not quality|6|||
161489848|NCT01937559|583185968|FG000|Overall Study|Physician Decision|3|||
161489849|NCT01937559|583185969|FG001|Overall Study|Physician Decision|3|||
161489850|NCT01937559|583185970|FG002|Overall Study|Physician Decision|0|||
161489851|NCT01937559|583185968|FG000|Overall Study|Withdrawal by Subject|6|||
161489852|NCT01937559|583185969|FG001|Overall Study|Withdrawal by Subject|4|||
161489853|NCT01937559|583185970|FG002|Overall Study|Withdrawal by Subject|0|||
161489854|NCT01937559|583185968|FG000|Overall Study|screen fail|2|||
161671486|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
161489855|NCT01937559|583185969|FG001|Overall Study|screen fail|4|||
161489856|NCT01937559|583185970|FG002|Overall Study|screen fail|0|||
161489857|NCT04818840|583185971|FG000|Overall Study|Lost to Follow-up|0|||
161489858|NCT04818840|583185972|FG001|Overall Study|Lost to Follow-up|5|||
161489859|NCT04818840|583185971|FG000|Overall Study|Physician Decision|1|||
161489860|NCT04818840|583185972|FG001|Overall Study|Physician Decision|0|||
161489861|NCT04818840|583185971|FG000|Overall Study|Site Terminated by Sponsor|0|||
161489862|NCT04818840|583185972|FG001|Overall Study|Site Terminated by Sponsor|3|||
161489863|NCT04818840|583185971|FG000|Overall Study|Study Terminated by Sponsor|43|||
161671487|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
161489864|NCT04818840|583185972|FG001|Overall Study|Study Terminated by Sponsor|7|||
161489865|NCT04818840|583185971|FG000|Overall Study|Withdrawal by Subject|0|||
161489866|NCT04818840|583185972|FG001|Overall Study|Withdrawal by Subject|1|||
161489867|NCT00254540|583188230|FG000|Overall Study|Adverse Event|6|||
161489868|NCT00254540|583188231|FG001|Overall Study|Adverse Event|7|||
161489869|NCT00254540|583188230|FG000|Overall Study|Lack of Efficacy|13|||
161489870|NCT00254540|583188231|FG001|Overall Study|Lack of Efficacy|13|||
161489871|NCT00254540|583188230|FG000|Overall Study|Death|0|||
161489872|NCT00254540|583188231|FG001|Overall Study|Death|1|||
161489873|NCT00254540|583188230|FG000|Overall Study|Laboratory Test Abnormality|0|||
161489874|NCT00254540|583188231|FG001|Overall Study|Laboratory Test Abnormality|1|||
161489875|NCT01313767|583188232|FG000|Overall Study|Adverse Event|1|||
161489876|NCT01313767|583188233|FG001|Overall Study|Adverse Event|0|||
161489877|NCT01313767|583188232|FG000|Overall Study|Lost to Follow-up|1|||
161489878|NCT01313767|583188233|FG001|Overall Study|Lost to Follow-up|0|||
161489879|NCT01313767|583188232|FG000|Overall Study|Withdrawal by Subject|2|||
161489880|NCT01313767|583188233|FG001|Overall Study|Withdrawal by Subject|1|||
161489881|NCT01313767|583188232|FG000|Overall Study|Protocol Violation|3|||
161489882|NCT01313767|583188233|FG001|Overall Study|Protocol Violation|1|||
161489883|NCT00249444|583188234|FG000|Overall Study|Lost to Follow-up|2|||
161489884|NCT00249444|583188235|FG001|Overall Study|Lost to Follow-up|2|||
161489885|NCT00249444|583188234|FG000|Overall Study|non-compliant|9|||
161489886|NCT00249444|583188235|FG001|Overall Study|non-compliant|11|||
161489887|NCT00249444|583188234|FG000|Overall Study|Adverse Event|1|||
161489888|NCT00249444|583188235|FG001|Overall Study|Adverse Event|1|||
161489889|NCT00249444|583188234|FG000|Overall Study|life event|0|||
161489890|NCT00249444|583188235|FG001|Overall Study|life event|1|||
161489891|NCT00232817|583188236|FG000|Overall Study|Protocol Violation|2|||
161489892|NCT00232817|583188237|FG001|Overall Study|Protocol Violation|1|||
161489893|NCT01084174|583188241|FG000|Overall Study|gastrointestinal symptoms|1|||
161489894|NCT01084174|583188242|FG001|Overall Study|gastrointestinal symptoms|1|||
161489895|NCT01084174|583188241|FG000|Overall Study|Eosinophilic esophagitis|0|||
161489896|NCT01084174|583188242|FG001|Overall Study|Eosinophilic esophagitis|1|||
161489897|NCT01084174|583188241|FG000|Overall Study|Anaphylaxis|0|||
161489898|NCT01084174|583188242|FG001|Overall Study|Anaphylaxis|1|||
161489899|NCT01084174|583188241|FG000|Overall Study|Participant noncompliance|0|||
161489900|NCT01084174|583188242|FG001|Overall Study|Participant noncompliance|1|||
161489901|NCT04273217|583188243|FG000|Overall Study|Lost to Follow-up|0|||
161489902|NCT04273217|583188244|FG001|Overall Study|Lost to Follow-up|0|||
161489903|NCT04273217|583188245|FG002|Overall Study|Lost to Follow-up|0|||
161489904|NCT04273217|583188246|FG003|Overall Study|Lost to Follow-up|0|||
161489905|NCT04273217|583188247|FG004|Overall Study|Lost to Follow-up|0|||
161583224|NCT06938230|583521218|FG001|Overall Study|Lost to Follow-up|18|||
161583225|NCT03899792|583521222|FG000|Phase 2|Ongoing Treatment|0|||
161583226|NCT03899792|583521223|FG001|Phase 2|Ongoing Treatment|13|||
161583227|NCT03899792|583521224|FG002|Phase 2|Ongoing Treatment|14|||
161583228|NCT03899792|583521225|FG003|Phase 2|Ongoing Treatment|2|||
161583229|NCT03899792|583521222|FG000|Phase 2|Death|0|||
161583230|NCT03899792|583521223|FG001|Phase 2|Death|0|||
161583231|NCT03899792|583521224|FG002|Phase 2|Death|0|||
161583232|NCT03899792|583521225|FG003|Phase 2|Death|4|||
161583233|NCT03899792|583521222|FG000|Phase 2|Lost to Follow-up|0|||
161583234|NCT03899792|583521223|FG001|Phase 2|Lost to Follow-up|1|||
161583235|NCT03899792|583521224|FG002|Phase 2|Lost to Follow-up|1|||
161583236|NCT03899792|583521225|FG003|Phase 2|Lost to Follow-up|0|||
161489906|NCT04273217|583188248|FG005|Overall Study|Lost to Follow-up|1|||
161583237|NCT03899792|583521222|FG000|Phase 2|Withdrawal by Subject|0|||
161489907|NCT04273217|583188243|FG000|Overall Study|Participant non-compliance|0|||
161489908|NCT04273217|583188244|FG001|Overall Study|Participant non-compliance|0|||
161489909|NCT04273217|583188245|FG002|Overall Study|Participant non-compliance|0|||
161489910|NCT04273217|583188246|FG003|Overall Study|Participant non-compliance|0|||
161489911|NCT04273217|583188247|FG004|Overall Study|Participant non-compliance|1|||
161489912|NCT04273217|583188248|FG005|Overall Study|Participant non-compliance|0|||
161489913|NCT04273217|583188243|FG000|Overall Study|Positive urine drug screen|1|||
161489914|NCT04273217|583188244|FG001|Overall Study|Positive urine drug screen|0|||
161489915|NCT04273217|583188245|FG002|Overall Study|Positive urine drug screen|1|||
161489916|NCT04273217|583188246|FG003|Overall Study|Positive urine drug screen|0|||
161489917|NCT04273217|583188247|FG004|Overall Study|Positive urine drug screen|0|||
161583238|NCT03899792|583521223|FG001|Phase 2|Withdrawal by Subject|1|||
161817057|NCT02213263|584370915|FG000|Overall Study|Protocol Violation|0|||
161489918|NCT04273217|583188248|FG005|Overall Study|Positive urine drug screen|1|||
161489919|NCT04532099|583188249|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
161489920|NCT04532099|583188250|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
161489921|NCT04532099|583188251|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
161489922|NCT05492942|583188252|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
161489923|NCT05492942|583188253|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
161489924|NCT05492942|583188254|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
161489925|NCT05492942|583188255|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
161489926|NCT02506153|583188256|FG000|Overall Study|Adverse Event|359|||
161489927|NCT02506153|583188257|FG001|Overall Study|Adverse Event|114|||
161489928|NCT02506153|583188256|FG000|Overall Study|Refused unrelated to adverse event|127|||
161489929|NCT02506153|583188257|FG001|Overall Study|Refused unrelated to adverse event|18|||
161489930|NCT02506153|583188256|FG000|Overall Study|Progression/relapse|91|||
161489931|NCT02506153|583188257|FG001|Overall Study|Progression/relapse|136|||
161489932|NCT02506153|583188256|FG000|Overall Study|Death|2|||
161489933|NCT02506153|583188257|FG001|Overall Study|Death|1|||
161489934|NCT02506153|583188256|FG000|Overall Study|Other - not protocol specified|23|||
161489935|NCT02506153|583188257|FG001|Overall Study|Other - not protocol specified|12|||
161489936|NCT00311623|583188258|FG000|Overall Study|Physician Decision|0|||
161489937|NCT00311623|583188259|FG001|Overall Study|Physician Decision|0|||
161489938|NCT00311623|583188260|FG002|Overall Study|Physician Decision|2|||
161489939|NCT03103919|583188261|FG000|Overall Study|Adverse Event|2|||
161489940|NCT03103919|583188262|FG001|Overall Study|Adverse Event|2|||
161489941|NCT03998189|583188263|FG000|Overall Study|Lack of Efficacy|0|||
161489942|NCT03998189|583188264|FG001|Overall Study|Lack of Efficacy|1|||
161489943|NCT04983264|583188265|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
161489944|NCT04983264|583188266|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
161489945|NCT04983264|583188267|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
161489946|NCT04983264|583188265|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
161489947|NCT04983264|583188266|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
161489948|NCT04983264|583188267|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
161489949|NCT01124422|583188268|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
161489950|NCT01124422|583188269|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
161489951|NCT01124422|583188270|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
161489952|NCT01124422|583188268|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
161489953|NCT01124422|583188269|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
161489954|NCT01124422|583188270|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
161489955|NCT01124422|583188268|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
161489956|NCT01124422|583188269|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
161489957|NCT01124422|583188270|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
161489958|NCT01124422|583188268|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
161489959|NCT01124422|583188269|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
161489960|NCT01124422|583188270|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
161489961|NCT01124422|583188268|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
161489962|NCT01124422|583188269|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
161489963|NCT01124422|583188270|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
161489964|NCT01124422|583188268|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
161489965|NCT01124422|583188269|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
161489966|NCT01124422|583188270|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
161489967|NCT01124422|583188268|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
161489968|NCT01124422|583188269|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
161489969|NCT01124422|583188270|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
161489970|NCT01124422|583188268|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
161489971|NCT01124422|583188269|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
161489972|NCT01124422|583188270|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
161489973|NCT01124422|583188268|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
161489974|NCT01124422|583188269|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
161489975|NCT01124422|583188270|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
161489976|NCT01124422|583188268|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
161489977|NCT01124422|583188269|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
161489978|NCT01124422|583188270|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
161489979|NCT01828281|583188271|FG000|Overall Study|Withdrawal by Subject|1|||
161489980|NCT01828281|583188272|FG001|Overall Study|Withdrawal by Subject|0|||
161489981|NCT02709785|583188275|FG000|Overall Study|Withdrawal by Subject|1|||
161489982|NCT02709785|583188276|FG001|Overall Study|Withdrawal by Subject|2|||
161489983|NCT02709785|583188277|FG002|Overall Study|Withdrawal by Subject|1|||
161489984|NCT01961323|583188280|FG000|Overall Study|Withdrawal by Subject|7|||
161489985|NCT01961323|583188280|FG000|Overall Study|Lost to Follow-up|8|||
161489986|NCT01961323|583188280|FG000|Overall Study|screen failure|34|||
161489987|NCT00810407|583188281|FG000|Overall Study|Protocol Violation|3|||
161489988|NCT00810407|583188281|FG000|Overall Study|No Visit After First Day of Treatment|3|||
161489989|NCT03315208|583188282|FG000|Overall Study|Lost to Follow-up|11|||
161489990|NCT03315208|583188283|FG001|Overall Study|Lost to Follow-up|6|||
161489991|NCT03315208|583188282|FG000|Overall Study|Withdrawal by Subject|2|||
161489992|NCT03315208|583188283|FG001|Overall Study|Withdrawal by Subject|0|||
161489993|NCT02320149|583188285|FG000|Overall Study|Adverse Event|3|||
161489994|NCT02320149|583188286|FG001|Overall Study|Adverse Event|7|||
161489995|NCT02320149|583188285|FG000|Overall Study|Withdrawal of Consent|28|||
161489996|NCT02320149|583188286|FG001|Overall Study|Withdrawal of Consent|32|||
161489997|NCT02320149|583188285|FG000|Overall Study|Lost to Follow-up|21|||
161583239|NCT03899792|583521224|FG002|Phase 2|Withdrawal by Subject|0|||
161671488|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
161671489|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
161583240|NCT03899792|583521225|FG003|Phase 2|Withdrawal by Subject|0|||
161583241|NCT00330681|583521226|FG000|Overall Study|Adverse Event|3|||
161583242|NCT00330681|583521227|FG001|Overall Study|Adverse Event|6|||
161583243|NCT00330681|583521226|FG000|Overall Study|Protocol Violation|0|||
161922930|NCT01786109|584764898|FG000|Overall Study|adverse effects colon preparation|0|||
161922931|NCT01786109|584764899|FG001|Overall Study|adverse effects colon preparation|0|||
161583244|NCT00330681|583521227|FG001|Overall Study|Protocol Violation|1|||
161583245|NCT00330681|583521226|FG000|Overall Study|Withdrawal by Subject|5|||
161583246|NCT00330681|583521227|FG001|Overall Study|Withdrawal by Subject|5|||
161583247|NCT00330681|583521226|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
161583248|NCT00330681|583521227|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
161583249|NCT04310735|583522643|FG000|Overall Study|Withdrawal by Subject|1|||
161583250|NCT04310735|583522644|FG001|Overall Study|Withdrawal by Subject|3|||
161583251|NCT04310735|583522645|FG002|Overall Study|Withdrawal by Subject|8|||
161583252|NCT04310735|583522643|FG000|Overall Study|Equipment malfunction|0|||
161583253|NCT04310735|583522644|FG001|Overall Study|Equipment malfunction|1|||
161583254|NCT04310735|583522645|FG002|Overall Study|Equipment malfunction|0|||
161583255|NCT03012841|583522646|FG000|Overall Study|Protocol Violation|0|||
161583256|NCT03012841|583522647|FG001|Overall Study|Protocol Violation|10|||
161583257|NCT03012841|583522646|FG000|Overall Study|Lost to Follow-up|6|||
161583258|NCT03012841|583522647|FG001|Overall Study|Lost to Follow-up|1|||
161583259|NCT03012841|583522646|FG000|Overall Study|Withdrawal by Subject|6|||
161583260|NCT03012841|583522647|FG001|Overall Study|Withdrawal by Subject|0|||
161583261|NCT03012841|583522646|FG000|Overall Study|Unable to complete 12 month visit|6|||
161583262|NCT03012841|583522647|FG001|Overall Study|Unable to complete 12 month visit|0|||
161583263|NCT03012841|583522646|FG000|Overall Study|Subject relocation|1|||
161583264|NCT03012841|583522647|FG001|Overall Study|Subject relocation|0|||
161583265|NCT03012841|583522646|FG000|Overall Study|Seasonal winter travel|1|||
161583266|NCT03012841|583522647|FG001|Overall Study|Seasonal winter travel|0|||
161583267|NCT03012841|583522646|FG000|Overall Study|Physician Decision|0|||
161583268|NCT03012841|583522647|FG001|Overall Study|Physician Decision|2|||
161583269|NCT03012841|583522646|FG000|Overall Study|No ablation performed|0|||
161583270|NCT03012841|583522647|FG001|Overall Study|No ablation performed|2|||
161583271|NCT03012841|583522646|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
161583272|NCT03012841|583522647|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
161583273|NCT03012841|583522646|FG000|Overall Study|Insurance change|0|||
161583274|NCT03012841|583522647|FG001|Overall Study|Insurance change|1|||
161583275|NCT05696080|583522648|FG000|Overall Study|Lost to Follow-up|2|||
161583276|NCT05696080|583522649|FG001|Overall Study|Lost to Follow-up|1|||
161583277|NCT05696080|583522648|FG000|Overall Study|Physician Decision|1|||
161583278|NCT05696080|583522649|FG001|Overall Study|Physician Decision|0|||
161583279|NCT05696080|583522648|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161583280|NCT05696080|583522649|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161583281|NCT05696080|583522648|FG000|Overall Study|Withdrawal by Subject|12|||
161583282|NCT05696080|583522649|FG001|Overall Study|Withdrawal by Subject|0|||
161583283|NCT03398200|583522650|FG000|Overall Study|Withdrawal by Subject|0|||
161583284|NCT03398200|583522651|FG001|Overall Study|Withdrawal by Subject|1|||
161583285|NCT04065048|583522652|FG000|Overall Study|Withdrawal by Subject|1|||
161583286|NCT04065048|583522653|FG001|Overall Study|Withdrawal by Subject|2|||
161583287|NCT04065048|583522654|FG002|Overall Study|Withdrawal by Subject|1|||
161583288|NCT04065048|583522655|FG003|Overall Study|Withdrawal by Subject|1|||
161583289|NCT04065048|583522652|FG000|Overall Study|Adverse Event|1|||
161583290|NCT04065048|583522653|FG001|Overall Study|Adverse Event|0|||
161583291|NCT04065048|583522654|FG002|Overall Study|Adverse Event|1|||
161583292|NCT04065048|583522655|FG003|Overall Study|Adverse Event|0|||
161922932|NCT01786109|584764900|FG002|Overall Study|adverse effects colon preparation|1|||
161583293|NCT03397108|583522656|FG000|Overall Study|Lost to Follow-up|15|||
161583294|NCT03397108|583522657|FG001|Overall Study|Lost to Follow-up|0|||
161922933|NCT02513563|584764903|FG000|Overall Study|Death|4|||
161922934|NCT02513563|584764903|FG000|Overall Study|Withdrawal by Subject|4|||
161583295|NCT03397108|583522656|FG000|Overall Study|Insufficient milk production|3|||
161489998|NCT02320149|583188286|FG001|Overall Study|Lost to Follow-up|34|||
161489999|NCT02320149|583188285|FG000|Overall Study|Protocol Violation|2|||
161490000|NCT02320149|583188286|FG001|Overall Study|Protocol Violation|1|||
161922935|NCT02513563|584764903|FG000|Overall Study|Physician Decision|1|||
161922936|NCT00317369|584764904|FG000|Overall Study|Adverse Event|2|||
161922937|NCT00317369|584764905|FG001|Overall Study|Adverse Event|1|||
161922938|NCT00317369|584764906|FG002|Overall Study|Adverse Event|0|||
161922939|NCT00317369|584764904|FG000|Overall Study|Lack of Efficacy|0|||
161922940|NCT00317369|584764905|FG001|Overall Study|Lack of Efficacy|1|||
161922941|NCT00317369|584764906|FG002|Overall Study|Lack of Efficacy|1|||
161922942|NCT00317369|584764904|FG000|Overall Study|Withdrawal by Subject|0|||
161922943|NCT00317369|584764905|FG001|Overall Study|Withdrawal by Subject|0|||
161922944|NCT00317369|584764906|FG002|Overall Study|Withdrawal by Subject|1|||
161922945|NCT04069520|584764907|FG000|Overall Study|Lost to Follow-up|0|||
161922946|NCT04069520|584764908|FG001|Overall Study|Lost to Follow-up|2|||
161922947|NCT04069520|584764907|FG000|Overall Study|Withdrawal by Subject|0|||
161922948|NCT04069520|584764908|FG001|Overall Study|Withdrawal by Subject|1|||
161922949|NCT04069520|584764907|FG000|Overall Study|Prior Injury|1|||
161922950|NCT04069520|584764908|FG001|Overall Study|Prior Injury|0|||
161922951|NCT04069520|584764907|FG000|Overall Study|Orthodontia|1|||
161922952|NCT04069520|584764908|FG001|Overall Study|Orthodontia|0|||
161922953|NCT04069520|584764907|FG000|Overall Study|Cut from team|0|||
161922954|NCT04069520|584764908|FG001|Overall Study|Cut from team|2|||
161922955|NCT01068912|584764909|FG000|Overall Study|Adverse Event|2|||
161922956|NCT01068912|584764910|FG001|Overall Study|Adverse Event|3|||
161922957|NCT01068912|584764911|FG002|Overall Study|Adverse Event|2|||
161922958|NCT01068912|584764909|FG000|Overall Study|Withdrawal by Subject|5|||
161922959|NCT01068912|584764910|FG001|Overall Study|Withdrawal by Subject|6|||
161922960|NCT01068912|584764911|FG002|Overall Study|Withdrawal by Subject|6|||
161922961|NCT01068912|584764909|FG000|Overall Study|Lost to Follow-up|3|||
161922962|NCT01068912|584764910|FG001|Overall Study|Lost to Follow-up|7|||
161922963|NCT01068912|584764911|FG002|Overall Study|Lost to Follow-up|3|||
161922964|NCT01068912|584764909|FG000|Overall Study|Protocol Violation|0|||
161922965|NCT01068912|584764910|FG001|Overall Study|Protocol Violation|2|||
161922966|NCT01068912|584764911|FG002|Overall Study|Protocol Violation|0|||
161922967|NCT01068912|584764909|FG000|Overall Study|aggravation influenza|1|||
161922968|NCT01068912|584764910|FG001|Overall Study|aggravation influenza|1|||
161922969|NCT01068912|584764911|FG002|Overall Study|aggravation influenza|1|||
161922970|NCT01068912|584764909|FG000|Overall Study|other underlying illness|0|||
161922971|NCT01068912|584764910|FG001|Overall Study|other underlying illness|3|||
161922972|NCT01068912|584764911|FG002|Overall Study|other underlying illness|3|||
161922973|NCT03998462|584764913|FG000|Overall Study|Withdrawal by Subject|10|||
161922974|NCT03998462|584764914|FG001|Overall Study|Withdrawal by Subject|4|||
161922975|NCT03998462|584764913|FG000|Overall Study|Lost to Follow-up|1|||
161922976|NCT03998462|584764914|FG001|Overall Study|Lost to Follow-up|0|||
161922977|NCT03998462|584764913|FG000|Overall Study|Technical Difficulties|1|||
161922978|NCT03998462|584764914|FG001|Overall Study|Technical Difficulties|2|||
161922979|NCT05710224|584764915|FG000|Overall Study|Death|1|||
161922980|NCT05710224|584764916|FG001|Overall Study|Death|0|||
161922981|NCT05710224|584764915|FG000|Overall Study|Lost to Follow-up|16|||
161922982|NCT05710224|584764916|FG001|Overall Study|Lost to Follow-up|7|||
161922983|NCT05710224|584764915|FG000|Overall Study|Withdrawal by Subject|4|||
161922984|NCT05710224|584764916|FG001|Overall Study|Withdrawal by Subject|6|||
161922985|NCT05710224|584764915|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161922986|NCT05710224|584764916|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161922987|NCT05710224|584764915|FG000|Overall Study|Participants Left The City|0|||
161922988|NCT05710224|584764916|FG001|Overall Study|Participants Left The City|2|||
161922989|NCT04822194|584764919|FG000|Overall Study|Withdrawal by Subject|5|||
161922990|NCT04822194|584764920|FG001|Overall Study|Withdrawal by Subject|4|||
161922991|NCT04822194|584764919|FG000|Overall Study|Technical issues with MR scanner|1|||
161922992|NCT04822194|584764920|FG001|Overall Study|Technical issues with MR scanner|0|||
161922993|NCT04822194|584764919|FG000|Overall Study|Lost to Follow-up|5|||
161922994|NCT04822194|584764920|FG001|Overall Study|Lost to Follow-up|7|||
161922995|NCT03369223|584764921|FG000|Overall Study|Lost to Follow-up|0|||
161922996|NCT03369223|584764922|FG001|Overall Study|Lost to Follow-up|0|||
161922997|NCT03369223|584764923|FG002|Overall Study|Lost to Follow-up|0|||
161922998|NCT03369223|584764924|FG003|Overall Study|Lost to Follow-up|0|||
161922999|NCT03369223|584764925|FG004|Overall Study|Lost to Follow-up|0|||
161923000|NCT03369223|584764926|FG005|Overall Study|Lost to Follow-up|0|||
161923001|NCT03369223|584764927|FG006|Overall Study|Lost to Follow-up|0|||
161923002|NCT03369223|584764928|FG007|Overall Study|Lost to Follow-up|0|||
161923003|NCT03369223|584764929|FG008|Overall Study|Lost to Follow-up|0|||
161923004|NCT03369223|584764930|FG009|Overall Study|Lost to Follow-up|0|||
161923005|NCT03369223|584764931|FG010|Overall Study|Lost to Follow-up|0|||
161923006|NCT03369223|584764932|FG011|Overall Study|Lost to Follow-up|0|||
161923007|NCT03369223|584764933|FG012|Overall Study|Lost to Follow-up|0|||
161923008|NCT03369223|584764934|FG013|Overall Study|Lost to Follow-up|0|||
161923009|NCT03369223|584764935|FG014|Overall Study|Lost to Follow-up|0|||
161923010|NCT03369223|584764936|FG015|Overall Study|Lost to Follow-up|0|||
161923011|NCT03369223|584764937|FG016|Overall Study|Lost to Follow-up|0|||
161671490|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
161671491|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
161671492|NCT01774084|583851301|FG000|Overall Study|Personal reasons|1|||
161490001|NCT02320149|583188285|FG000|Overall Study|Noncompliance with Study Treatment|7|||
161490002|NCT02320149|583188286|FG001|Overall Study|Noncompliance with Study Treatment|2|||
161490003|NCT02320149|583188285|FG000|Overall Study|Lack of Efficacy|0|||
161490004|NCT02320149|583188286|FG001|Overall Study|Lack of Efficacy|1|||
161490005|NCT02320149|583188285|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161490006|NCT02320149|583188286|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161490007|NCT06133348|583188287|FG000|Overall Study|Death|3|||
161490008|NCT06133348|583188287|FG000|Overall Study|Lost to Follow-up|1|||
161490009|NCT06133348|583188287|FG000|Overall Study|Physician Decision|1|||
161490010|NCT06133348|583188287|FG000|Overall Study|Withdrawal by Subject|5|||
161490011|NCT00276159|583188288|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
161490012|NCT00333866|583188291|FG000|Overall Study|Adverse Event|23|||
161490013|NCT00333866|583188292|FG001|Overall Study|Adverse Event|37|||
161490014|NCT00333866|583188293|FG002|Overall Study|Adverse Event|38|||
161490015|NCT00333866|583188294|FG003|Overall Study|Adverse Event|47|||
161490016|NCT00333866|583188291|FG000|Overall Study|Other|3|||
161490017|NCT00333866|583188292|FG001|Overall Study|Other|2|||
161490018|NCT00333866|583188293|FG002|Overall Study|Other|2|||
161490019|NCT00333866|583188294|FG003|Overall Study|Other|2|||
161490020|NCT00333866|583188291|FG000|Overall Study|Lack of Efficacy|8|||
161490021|NCT00333866|583188292|FG001|Overall Study|Lack of Efficacy|6|||
161490022|NCT00333866|583188293|FG002|Overall Study|Lack of Efficacy|3|||
161490023|NCT00333866|583188294|FG003|Overall Study|Lack of Efficacy|5|||
161490024|NCT00333866|583188291|FG000|Overall Study|Lost to Follow-up|1|||
161583296|NCT03397108|583522657|FG001|Overall Study|Insufficient milk production|2|||
161583297|NCT03397108|583522656|FG000|Overall Study|Withdrawal by Subject|2|||
161583298|NCT03397108|583522657|FG001|Overall Study|Withdrawal by Subject|0|||
161583299|NCT05096819|583522660|FG000|Overall Study|Withdrawal by Subject|3|||
161583300|NCT05096819|583522661|FG001|Overall Study|Withdrawal by Subject|0|||
161671493|NCT01774084|583851302|FG001|Overall Study|Personal reasons|0|||
161671494|NCT01387230|583851303|FG000|Overall Study|Adverse Event|0|||
161671495|NCT01387230|583851304|FG001|Overall Study|Adverse Event|1|||
161671496|NCT01387230|583851305|FG002|Overall Study|Adverse Event|3|||
161671497|NCT01387230|583851303|FG000|Overall Study|Lack of Efficacy|8|||
161671498|NCT01387230|583851304|FG001|Overall Study|Lack of Efficacy|5|||
161671499|NCT01387230|583851305|FG002|Overall Study|Lack of Efficacy|4|||
161671500|NCT01387230|583851303|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
161671501|NCT01387230|583851304|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161671502|NCT01387230|583851305|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
161671503|NCT01387230|583851303|FG000|Overall Study|Lost to Follow-up|0|||
161671504|NCT01387230|583851304|FG001|Overall Study|Lost to Follow-up|0|||
161671505|NCT01387230|583851305|FG002|Overall Study|Lost to Follow-up|1|||
161671506|NCT01387230|583851303|FG000|Overall Study|Withdrawal by Subject|4|||
161671507|NCT01387230|583851304|FG001|Overall Study|Withdrawal by Subject|1|||
161671508|NCT01387230|583851305|FG002|Overall Study|Withdrawal by Subject|0|||
161671509|NCT01182766|583851309|FG000|Overall Study|Lost to Follow-up|32|||
161671510|NCT01182766|583851310|FG001|Overall Study|Lost to Follow-up|36|||
161671511|NCT01182766|583851311|FG002|Overall Study|Lost to Follow-up|29|||
161671512|NCT01182766|583851309|FG000|Overall Study|Withdrawal by Subject|14|||
161671513|NCT01182766|583851310|FG001|Overall Study|Withdrawal by Subject|3|||
161490025|NCT00333866|583188292|FG001|Overall Study|Lost to Follow-up|2|||
161490026|NCT00333866|583188293|FG002|Overall Study|Lost to Follow-up|2|||
161490027|NCT00333866|583188294|FG003|Overall Study|Lost to Follow-up|2|||
161490028|NCT00333866|583188291|FG000|Overall Study|Withdrawal by Subject|8|||
161583301|NCT03324984|583522662|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
161583302|NCT03324984|583522663|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
161583303|NCT04607044|583522664|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
161583304|NCT04607044|583522664|FG000|Overall Study|Adverse Event|1|||
161490029|NCT00333866|583188292|FG001|Overall Study|Withdrawal by Subject|14|||
161490030|NCT00333866|583188293|FG002|Overall Study|Withdrawal by Subject|4|||
161583305|NCT04607044|583522664|FG000|Overall Study|Did not receive study device|3|||
161583306|NCT04607044|583522664|FG000|Overall Study|Death|1|||
161583307|NCT04337372|583522668|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
161583308|NCT04337372|583522669|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
161583309|NCT04337372|583522670|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
161583310|NCT04337372|583522671|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
161671514|NCT01182766|583851311|FG002|Overall Study|Withdrawal by Subject|6|||
161923012|NCT03369223|584764938|FG017|Overall Study|Lost to Follow-up|0|||
161490031|NCT00333866|583188294|FG003|Overall Study|Withdrawal by Subject|9|||
161490032|NCT00333866|583188291|FG000|Overall Study|Randomized but not Treated|5|||
161490033|NCT00333866|583188292|FG001|Overall Study|Randomized but not Treated|3|||
161583311|NCT04337372|583522668|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
161671515|NCT01182766|583851309|FG000|Overall Study|Physician Decision|1|||
161671516|NCT01182766|583851310|FG001|Overall Study|Physician Decision|0|||
161490034|NCT00333866|583188293|FG002|Overall Study|Randomized but not Treated|2|||
161490035|NCT00333866|583188294|FG003|Overall Study|Randomized but not Treated|1|||
161490036|NCT06073119|583188295|FG000|Overall Study|Adverse Event|1|||
161490037|NCT06073119|583188296|FG001|Overall Study|Adverse Event|3|||
161490038|NCT06073119|583188297|FG002|Overall Study|Adverse Event|0|||
161490039|NCT06073119|583188298|FG003|Overall Study|Adverse Event|0|||
161490040|NCT06073119|583188299|FG004|Overall Study|Adverse Event|1|||
161490041|NCT06073119|583188300|FG005|Overall Study|Adverse Event|0|||
161490042|NCT06073119|583188295|FG000|Overall Study|Non-compliance with study schedule|1|||
161490043|NCT06073119|583188296|FG001|Overall Study|Non-compliance with study schedule|0|||
161490044|NCT06073119|583188297|FG002|Overall Study|Non-compliance with study schedule|0|||
161490045|NCT06073119|583188298|FG003|Overall Study|Non-compliance with study schedule|0|||
161490046|NCT06073119|583188299|FG004|Overall Study|Non-compliance with study schedule|1|||
161490047|NCT06073119|583188300|FG005|Overall Study|Non-compliance with study schedule|0|||
161490048|NCT06073119|583188295|FG000|Overall Study|Withdrawal by Subject|4|||
161490049|NCT06073119|583188296|FG001|Overall Study|Withdrawal by Subject|4|||
161490050|NCT06073119|583188297|FG002|Overall Study|Withdrawal by Subject|3|||
161490051|NCT06073119|583188298|FG003|Overall Study|Withdrawal by Subject|5|||
161490052|NCT06073119|583188299|FG004|Overall Study|Withdrawal by Subject|3|||
161490053|NCT06073119|583188300|FG005|Overall Study|Withdrawal by Subject|1|||
161490054|NCT06073119|583188295|FG000|Overall Study|Other|2|||
161490055|NCT06073119|583188296|FG001|Overall Study|Other|4|||
161490056|NCT06073119|583188297|FG002|Overall Study|Other|1|||
161490057|NCT06073119|583188298|FG003|Overall Study|Other|0|||
161490058|NCT06073119|583188299|FG004|Overall Study|Other|1|||
161490059|NCT06073119|583188300|FG005|Overall Study|Other|0|||
161490060|NCT01359449|583188301|FG000|Overall Study|Lost to Follow-up|1|||
161490061|NCT01359449|583188302|FG001|Overall Study|Lost to Follow-up|0|||
161490062|NCT01359449|583188301|FG000|Overall Study|Protocol Violation|0|||
161490063|NCT01359449|583188302|FG001|Overall Study|Protocol Violation|2|||
161490064|NCT01359449|583188301|FG000|Overall Study|Withdrawal by Subject|3|||
161490065|NCT01359449|583188302|FG001|Overall Study|Withdrawal by Subject|2|||
161490066|NCT02036294|583188306|FG000|Overall Study|Death|7|||
161490067|NCT02036294|583188307|FG001|Overall Study|Death|8|||
161490068|NCT02036294|583188306|FG000|Overall Study|Withdrawal by Subject|2|||
161490069|NCT02036294|583188307|FG001|Overall Study|Withdrawal by Subject|3|||
161490070|NCT00429104|583188312|FG000|Overall Study|Protocol Violation|1|||
161490071|NCT01907815|583188313|FG000|Overall Study|Withdrawal by Subject|1|||
161490072|NCT01907815|583188314|FG001|Overall Study|Withdrawal by Subject|0|||
161490073|NCT01285310|583188315|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
161490074|NCT01285310|583188316|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
161490075|NCT01285310|583188317|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
161490076|NCT01285310|583188318|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
161490077|NCT01285310|583188319|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
161490078|NCT01285310|583188315|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
161490079|NCT01285310|583188316|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
161490080|NCT01285310|583188317|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
161490081|NCT01285310|583188318|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
161490082|NCT01285310|583188319|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
161490083|NCT01285310|583188315|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
161490084|NCT01285310|583188316|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
161490085|NCT01285310|583188317|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
161490086|NCT01285310|583188318|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
161490087|NCT01285310|583188319|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
161490088|NCT01285310|583188315|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
161490089|NCT01285310|583188316|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
161490090|NCT01285310|583188317|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
161490091|NCT01285310|583188318|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
161490092|NCT01285310|583188319|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
161490093|NCT01285310|583188315|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
161490094|NCT01285310|583188316|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
161490095|NCT01285310|583188317|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
161490096|NCT01285310|583188318|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
161490097|NCT01285310|583188319|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
161490098|NCT01285310|583188315|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
161490099|NCT01285310|583188316|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
161490100|NCT01285310|583188317|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
161490101|NCT01285310|583188318|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
161490102|NCT01285310|583188319|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
161490103|NCT01285310|583188315|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
161490104|NCT01285310|583188316|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
161490105|NCT01285310|583188317|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
161490106|NCT01285310|583188318|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
161490107|NCT01285310|583188319|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
161490108|NCT01285310|583188315|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
161490109|NCT01285310|583188316|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
161490110|NCT01285310|583188317|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
161490111|NCT01285310|583188318|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
161490112|NCT01285310|583188319|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
161583312|NCT04337372|583522669|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
161583313|NCT04337372|583522670|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
161583314|NCT04337372|583522671|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
161583315|NCT04337372|583522668|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
161583316|NCT04337372|583522669|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
161583317|NCT04337372|583522670|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
161583318|NCT04337372|583522671|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
161583319|NCT04337372|583522668|FG000|Day 2: EEG Measures|Protocol Violation|6|||
161583320|NCT04337372|583522669|FG001|Day 2: EEG Measures|Protocol Violation|6|||
161583321|NCT04337372|583522670|FG002|Day 2: EEG Measures|Protocol Violation|5|||
161583322|NCT04337372|583522671|FG003|Day 2: EEG Measures|Protocol Violation|17|||
161583323|NCT05307783|583522672|FG000|Overall Study|Death|7|||
161583324|NCT05307783|583522672|FG000|Overall Study|Lost to Follow-up|4|||
161583325|NCT04883645|583522673|FG000|Overall Study|Death|1|||
161583326|NCT03460236|583522675|FG000|Overall Study|failed radiographic screening|16|||
161583327|NCT03460236|583522675|FG000|Overall Study|Withdrawal by Subject|11|||
161583328|NCT06194214|583522676|FG000|Overall Study|Adverse Event|1|||
161583329|NCT04869982|583522680|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
161583330|NCT04869982|583522681|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
161583331|NCT04869982|583522680|FG000|Overall Study|Migrated / moved from the study area|1|||
161583332|NCT04869982|583522681|FG001|Overall Study|Migrated / moved from the study area|1|||
161583333|NCT04869982|583522680|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
161583334|NCT04869982|583522681|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
161583335|NCT04869982|583522680|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
161583336|NCT04869982|583522681|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
161583337|NCT04869982|583522680|FG000|Overall Study|Solicited adverse event|2|||
161583338|NCT04869982|583522681|FG001|Overall Study|Solicited adverse event|1|||
161583339|NCT04608045|583522682|FG000|Overall Study|Physician Decision|1|||
161583340|NCT02473250|583522684|FG000|Overall Study|Lost to Follow-up|10|||
161583341|NCT02473250|583522684|FG000|Overall Study|Physician Decision|5|||
161583342|NCT02473250|583522684|FG000|Overall Study|Did not tolerate medication washout|3|||
161583343|NCT02473250|583522684|FG000|Overall Study|Antidepressant effect of divalproex|2|||
161583344|NCT04847999|583522685|FG000|Overall Study|Lost to Follow-up|0|||
161583345|NCT04847999|583522686|FG001|Overall Study|Lost to Follow-up|1|||
161583346|NCT01704079|583522690|FG000|Overall Study|Withdrawal by Subject|5|||
161583347|NCT01704079|583522691|FG001|Overall Study|Withdrawal by Subject|7|||
161923013|NCT03369223|584764939|FG018|Overall Study|Lost to Follow-up|2|||
161923014|NCT03369223|584764940|FG019|Overall Study|Lost to Follow-up|1|||
161923015|NCT03369223|584764921|FG000|Overall Study|Participant no longer meets study criteria|0|||
161923016|NCT03369223|584764922|FG001|Overall Study|Participant no longer meets study criteria|0|||
161923017|NCT03369223|584764923|FG002|Overall Study|Participant no longer meets study criteria|0|||
161923018|NCT03369223|584764924|FG003|Overall Study|Participant no longer meets study criteria|0|||
161583348|NCT01704079|583522690|FG000|Overall Study|Lost to Follow-up|2|||
161923019|NCT03369223|584764925|FG004|Overall Study|Participant no longer meets study criteria|0|||
161923020|NCT03369223|584764926|FG005|Overall Study|Participant no longer meets study criteria|0|||
161923021|NCT03369223|584764927|FG006|Overall Study|Participant no longer meets study criteria|0|||
161583349|NCT01704079|583522691|FG001|Overall Study|Lost to Follow-up|5|||
161583350|NCT01704079|583522690|FG000|Overall Study|Adverse Event|4|||
161923022|NCT03369223|584764928|FG007|Overall Study|Participant no longer meets study criteria|0|||
161923023|NCT03369223|584764929|FG008|Overall Study|Participant no longer meets study criteria|0|||
161490113|NCT01285310|583188315|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
161490114|NCT01285310|583188316|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
161490115|NCT01285310|583188317|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
161490116|NCT01285310|583188318|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
161490117|NCT01285310|583188319|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
161490118|NCT01285310|583188315|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
161583351|NCT01704079|583522691|FG001|Overall Study|Adverse Event|7|||
161583352|NCT01704079|583522690|FG000|Overall Study|Protocol Violation|1|||
161583353|NCT01704079|583522691|FG001|Overall Study|Protocol Violation|0|||
161583354|NCT01704079|583522690|FG000|Overall Study|Subject noncompliance|2|||
161583355|NCT01704079|583522691|FG001|Overall Study|Subject noncompliance|3|||
161583356|NCT01704079|583522690|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
161583357|NCT01704079|583522691|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
161583358|NCT04300231|583522692|FG000|Overall Study|Protocol Violation|4|||
161583359|NCT04300231|583522693|FG001|Overall Study|Protocol Violation|3|||
161490119|NCT01285310|583188316|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
161490120|NCT01285310|583188317|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
161490121|NCT01285310|583188318|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
161490122|NCT01285310|583188319|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
161490123|NCT01285310|583188315|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
161490124|NCT01285310|583188316|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
161490125|NCT01285310|583188317|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
161490126|NCT01285310|583188318|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
161490127|NCT01285310|583188319|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
161490128|NCT01285310|583188315|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
161490129|NCT01285310|583188316|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
161490130|NCT01285310|583188317|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
161490131|NCT01285310|583188318|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
161490132|NCT01285310|583188319|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
161490133|NCT00514540|583188320|FG000|First-Line Chemo|Withdrawal by Subject|1|||
161490134|NCT00514540|583188320|FG000|First-Line Chemo|Protocol Violation|7|||
161490135|NCT00514540|583188320|FG000|Second-Line|Physician/Patient Decision|31|||
161490136|NCT00555321|583188327|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
161490137|NCT00555321|583188328|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
161490138|NCT00555321|583188329|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
161490139|NCT00555321|583188330|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
161490140|NCT00555321|583188331|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
161490141|NCT00555321|583188327|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
161490142|NCT00555321|583188328|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
161490143|NCT00555321|583188329|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
161490144|NCT00555321|583188330|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
161490145|NCT00555321|583188331|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
161490146|NCT00555321|583188327|FG000|Treatment Phase up to 12-months|Death|2|||
161490147|NCT00555321|583188328|FG001|Treatment Phase up to 12-months|Death|1|||
161490148|NCT00555321|583188329|FG002|Treatment Phase up to 12-months|Death|4|||
161490149|NCT00555321|583188330|FG003|Treatment Phase up to 12-months|Death|0|||
161490150|NCT00555321|583188331|FG004|Treatment Phase up to 12-months|Death|0|||
161490151|NCT00555321|583188327|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
161490152|NCT00555321|583188328|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
161490153|NCT00555321|583188329|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
161490154|NCT00555321|583188330|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
161490155|NCT00555321|583188331|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
161490156|NCT00555321|583188327|FG000|Treatment Phase up to 12-months|Other Reason|1|||
161490157|NCT00555321|583188328|FG001|Treatment Phase up to 12-months|Other Reason|3|||
161490158|NCT00555321|583188329|FG002|Treatment Phase up to 12-months|Other Reason|2|||
161490159|NCT00555321|583188330|FG003|Treatment Phase up to 12-months|Other Reason|0|||
161490160|NCT00555321|583188331|FG004|Treatment Phase up to 12-months|Other Reason|0|||
161490161|NCT00555321|583188327|FG000|Treatment Phase up to 12-months|Never treated|2|||
161490162|NCT00555321|583188328|FG001|Treatment Phase up to 12-months|Never treated|3|||
161490163|NCT00555321|583188329|FG002|Treatment Phase up to 12-months|Never treated|1|||
161490164|NCT00555321|583188330|FG003|Treatment Phase up to 12-months|Never treated|0|||
161490165|NCT00555321|583188331|FG004|Treatment Phase up to 12-months|Never treated|4|||
161490166|NCT00555321|583188327|FG000|Long-term Extension Phase|Adverse Event|2|||
161490167|NCT00555321|583188328|FG001|Long-term Extension Phase|Adverse Event|5|||
161490168|NCT00555321|583188329|FG002|Long-term Extension Phase|Adverse Event|2|||
161490169|NCT00555321|583188330|FG003|Long-term Extension Phase|Adverse Event|1|||
161490170|NCT00555321|583188331|FG004|Long-term Extension Phase|Adverse Event|0|||
161490171|NCT00555321|583188327|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
161490172|NCT00555321|583188328|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
161490173|NCT00555321|583188329|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
161490174|NCT00555321|583188330|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
161490175|NCT00555321|583188331|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
161490176|NCT00555321|583188327|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
161490177|NCT00555321|583188328|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
161490178|NCT00555321|583188329|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
161490179|NCT00555321|583188330|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
161490180|NCT00555321|583188331|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
161490181|NCT00555321|583188327|FG000|Long-term Extension Phase|Death|2|||
161490182|NCT00555321|583188328|FG001|Long-term Extension Phase|Death|0|||
161490183|NCT00555321|583188329|FG002|Long-term Extension Phase|Death|0|||
161490184|NCT00555321|583188330|FG003|Long-term Extension Phase|Death|3|||
161490185|NCT00555321|583188331|FG004|Long-term Extension Phase|Death|0|||
161671517|NCT01182766|583851311|FG002|Overall Study|Physician Decision|0|||
161671518|NCT01182766|583851309|FG000|Overall Study|Non-compliance|1|||
161490186|NCT00555321|583188327|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
161490187|NCT00555321|583188328|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
161490188|NCT00555321|583188329|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
161490189|NCT00555321|583188330|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
161490190|NCT00555321|583188331|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
161490191|NCT00555321|583188327|FG000|Long-term Extension Phase|Other Reason|1|||
161490192|NCT00555321|583188328|FG001|Long-term Extension Phase|Other Reason|0|||
161490193|NCT00555321|583188329|FG002|Long-term Extension Phase|Other Reason|2|||
161490194|NCT00555321|583188330|FG003|Long-term Extension Phase|Other Reason|0|||
161490195|NCT00555321|583188331|FG004|Long-term Extension Phase|Other Reason|0|||
161490196|NCT02733367|583188332|FG000|Overall Study|Withdrawal by Subject|6|||
161490197|NCT01348347|583188333|FG000|Overall Study|Withdrawal by Subject|1|||
161490198|NCT01348347|583188334|FG001|Overall Study|Withdrawal by Subject|1|||
161490199|NCT01348347|583188335|FG002|Overall Study|Withdrawal by Subject|1|||
161490200|NCT01348347|583188333|FG000|Overall Study|Progressive disease|2|||
161490201|NCT01348347|583188334|FG001|Overall Study|Progressive disease|5|||
161490202|NCT01348347|583188335|FG002|Overall Study|Progressive disease|5|||
161490203|NCT00191789|583188339|FG000|Overall Study|Adverse Event|5|||
161490204|NCT00191789|583188339|FG000|Overall Study|Patient: Satisfactory Response|5|||
161490205|NCT00191789|583188339|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
161490206|NCT00191789|583188339|FG000|Overall Study|Withdrawal by Subject|4|||
161490207|NCT00191789|583188339|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
161490208|NCT00191789|583188339|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
161490209|NCT00191789|583188339|FG000|Overall Study|Death - Not Study-Drug Related|1|||
161490210|NCT01922089|583188340|FG000|Overall Study|Adverse Event|18|||
161490211|NCT01922089|583188341|FG001|Overall Study|Adverse Event|13|||
161490212|NCT01922089|583188340|FG000|Overall Study|Protocol Deviation|10|||
161490213|NCT01922089|583188341|FG001|Overall Study|Protocol Deviation|7|||
161490214|NCT01922089|583188340|FG000|Overall Study|Withdrawal by Subject|3|||
161490215|NCT01922089|583188341|FG001|Overall Study|Withdrawal by Subject|4|||
161490216|NCT01922089|583188340|FG000|Overall Study|administrative problems|4|||
161490217|NCT01922089|583188341|FG001|Overall Study|administrative problems|1|||
161490218|NCT01922089|583188340|FG000|Overall Study|Physician Decision|2|||
161490219|NCT01922089|583188341|FG001|Overall Study|Physician Decision|3|||
161490220|NCT01922089|583188340|FG000|Overall Study|Death|2|||
161490221|NCT01922089|583188341|FG001|Overall Study|Death|1|||
161490222|NCT01922089|583188340|FG000|Overall Study|Lost to Follow-up|0|||
161490223|NCT01922089|583188341|FG001|Overall Study|Lost to Follow-up|1|||
161490224|NCT02170051|583188343|FG000|Overall Study|Withdrawal by Subject|10|||
161490225|NCT02170051|583188344|FG001|Overall Study|Withdrawal by Subject|10|||
161490226|NCT02170051|583188343|FG000|Overall Study|Lost to Follow-up|1|||
161490227|NCT02170051|583188344|FG001|Overall Study|Lost to Follow-up|3|||
161490228|NCT01712490|583188345|FG000|Overall Study|Ongoing|601|||
161490229|NCT01712490|583188346|FG001|Overall Study|Ongoing|586|||
161490230|NCT01712490|583188345|FG000|Overall Study|Other|11|||
161490231|NCT01712490|583188346|FG001|Overall Study|Other|11|||
161490232|NCT01712490|583188345|FG000|Overall Study|Withdrawal by Subject|36|||
161490233|NCT01712490|583188346|FG001|Overall Study|Withdrawal by Subject|44|||
161490234|NCT01712490|583188345|FG000|Overall Study|Lost to Follow-up|16|||
161490235|NCT01712490|583188346|FG001|Overall Study|Lost to Follow-up|29|||
161490236|NCT01129960|583188354|FG000|Overall Study|Withdrawal by Subject|3|||
161490237|NCT01129960|583188355|FG001|Overall Study|Withdrawal by Subject|0|||
161490238|NCT01129960|583188356|FG002|Overall Study|Withdrawal by Subject|3|||
161490239|NCT01129960|583188357|FG003|Overall Study|Withdrawal by Subject|2|||
161490240|NCT01129960|583188354|FG000|Overall Study|Lack of Efficacy|1|||
161490241|NCT01129960|583188355|FG001|Overall Study|Lack of Efficacy|1|||
161671519|NCT01182766|583851310|FG001|Overall Study|Non-compliance|1|||
161490242|NCT01129960|583188356|FG002|Overall Study|Lack of Efficacy|1|||
161490243|NCT01129960|583188357|FG003|Overall Study|Lack of Efficacy|1|||
161490244|NCT01129960|583188354|FG000|Overall Study|Adverse Event|23|||
161490245|NCT01129960|583188355|FG001|Overall Study|Adverse Event|16|||
161490246|NCT01129960|583188356|FG002|Overall Study|Adverse Event|16|||
161490247|NCT01129960|583188357|FG003|Overall Study|Adverse Event|7|||
161490248|NCT01129960|583188354|FG000|Overall Study|Protocol Violation|1|||
161490249|NCT01129960|583188355|FG001|Overall Study|Protocol Violation|2|||
161490250|NCT01129960|583188356|FG002|Overall Study|Protocol Violation|3|||
161490251|NCT01129960|583188357|FG003|Overall Study|Protocol Violation|0|||
161490252|NCT01129960|583188354|FG000|Overall Study|Lost to Follow-up|0|||
161490253|NCT01129960|583188355|FG001|Overall Study|Lost to Follow-up|2|||
161490254|NCT01129960|583188356|FG002|Overall Study|Lost to Follow-up|3|||
161490255|NCT01129960|583188357|FG003|Overall Study|Lost to Follow-up|3|||
161490256|NCT01129960|583188354|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
161490257|NCT01129960|583188355|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
161490258|NCT01129960|583188356|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
161490259|NCT01129960|583188357|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
161490260|NCT01129960|583188354|FG000|Overall Study|Physician Decision|1|||
161490261|NCT01129960|583188355|FG001|Overall Study|Physician Decision|0|||
161490262|NCT01129960|583188356|FG002|Overall Study|Physician Decision|0|||
161490263|NCT01129960|583188357|FG003|Overall Study|Physician Decision|0|||
161490264|NCT01129960|583188354|FG000|Overall Study|Pregnancy|1|||
161490265|NCT01129960|583188355|FG001|Overall Study|Pregnancy|0|||
161490266|NCT01129960|583188356|FG002|Overall Study|Pregnancy|0|||
161490267|NCT01129960|583188357|FG003|Overall Study|Pregnancy|0|||
161490268|NCT02860169|583188358|FG000|Part A|Withdrawal by Subject|1|||
161490269|NCT02860169|583188358|FG000|Part A|Other (Screening failure)|6|||
161490270|NCT02860169|583188358|FG000|Part A|Other (Survey not completed)|3|||
161490271|NCT02860169|583188358|FG000|Part A|Other (did not completed consent)|1|||
161490272|NCT02860169|583188358|FG000|Part B|Other (Screening failure)|10|||
161490273|NCT02860169|583188358|FG000|Part B|Withdrawal by Subject|1|||
161490274|NCT02860169|583188358|FG000|Part C|Other (Screening failure)|1|||
161490275|NCT01782495|583188361|FG000|Overall Study|Adverse Event|0|||
161490276|NCT01782495|583188362|FG001|Overall Study|Adverse Event|0|||
161490277|NCT01782495|583188363|FG002|Overall Study|Adverse Event|0|||
161490278|NCT01782495|583188364|FG003|Overall Study|Adverse Event|0|||
161490279|NCT01782495|583188365|FG004|Overall Study|Adverse Event|0|||
161490280|NCT01782495|583188366|FG005|Overall Study|Adverse Event|0|||
161490281|NCT01782495|583188367|FG006|Overall Study|Adverse Event|0|||
161490282|NCT01782495|583188368|FG007|Overall Study|Adverse Event|2|||
161490283|NCT01782495|583188369|FG008|Overall Study|Adverse Event|0|||
161490284|NCT01782495|583188370|FG009|Overall Study|Adverse Event|0|||
161490285|NCT01782495|583188371|FG010|Overall Study|Adverse Event|0|||
161490286|NCT01782495|583188361|FG000|Overall Study|Withdrew Consent|0|||
161490287|NCT01782495|583188362|FG001|Overall Study|Withdrew Consent|1|||
161490288|NCT01782495|583188363|FG002|Overall Study|Withdrew Consent|0|||
161490289|NCT01782495|583188364|FG003|Overall Study|Withdrew Consent|0|||
161490290|NCT01782495|583188365|FG004|Overall Study|Withdrew Consent|0|||
161490291|NCT01782495|583188366|FG005|Overall Study|Withdrew Consent|0|||
161490292|NCT01782495|583188367|FG006|Overall Study|Withdrew Consent|0|||
161490293|NCT01782495|583188368|FG007|Overall Study|Withdrew Consent|1|||
161490294|NCT01782495|583188369|FG008|Overall Study|Withdrew Consent|0|||
161490295|NCT01782495|583188370|FG009|Overall Study|Withdrew Consent|0|||
161490296|NCT01782495|583188371|FG010|Overall Study|Withdrew Consent|0|||
161490297|NCT01927367|583188372|FG000|Overall Study|Withdrawal by Subject|7|||
161490298|NCT01927367|583188373|FG001|Overall Study|Withdrawal by Subject|4|||
161490299|NCT01927367|583188372|FG000|Overall Study|No baseline data|0|||
161490300|NCT01927367|583188373|FG001|Overall Study|No baseline data|1|||
161490301|NCT00071513|583188376|FG000|Intervention Component|Withdrawal by Subject|2|||
161490302|NCT00071513|583188377|FG001|Intervention Component|Withdrawal by Subject|3|||
161490303|NCT00071513|583188376|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
161490304|NCT00071513|583188377|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
161490305|NCT02622321|583188378|FG000|Overall Study|Withdrawal by Subject|2|||
161490306|NCT02622321|583188379|FG001|Overall Study|Withdrawal by Subject|0|||
161490307|NCT02622321|583188380|FG002|Overall Study|Withdrawal by Subject|0|||
161490308|NCT02622321|583188381|FG003|Overall Study|Withdrawal by Subject|0|||
161490309|NCT02622321|583188378|FG000|Overall Study|Death|0|||
161490310|NCT02622321|583188379|FG001|Overall Study|Death|0|||
161583360|NCT04300231|583522694|FG002|Overall Study|Protocol Violation|0|||
161490311|NCT02622321|583188380|FG002|Overall Study|Death|1|||
161490312|NCT02622321|583188381|FG003|Overall Study|Death|0|||
161583361|NCT04300231|583522695|FG003|Overall Study|Protocol Violation|2|||
161583362|NCT03584516|583522696|FG000|Part 1|Death|2|||
161583363|NCT03584516|583522697|FG001|Part 1|Death|3|||
161583364|NCT03584516|583522698|FG002|Part 1|Death|0|||
161583365|NCT03584516|583522699|FG003|Part 1|Death|0|||
161583366|NCT03584516|583522700|FG004|Part 1|Death|0|||
161583367|NCT03584516|583522701|FG005|Part 1|Death|0|||
161583368|NCT03584516|583522696|FG000|Part 1|Withdrawal by Subject|2|||
161583369|NCT03584516|583522697|FG001|Part 1|Withdrawal by Subject|0|||
161583370|NCT03584516|583522698|FG002|Part 1|Withdrawal by Subject|0|||
161583371|NCT03584516|583522699|FG003|Part 1|Withdrawal by Subject|0|||
161583372|NCT03584516|583522700|FG004|Part 1|Withdrawal by Subject|0|||
161583373|NCT03584516|583522701|FG005|Part 1|Withdrawal by Subject|0|||
161923024|NCT03369223|584764930|FG009|Overall Study|Participant no longer meets study criteria|0|||
161923025|NCT03369223|584764931|FG010|Overall Study|Participant no longer meets study criteria|0|||
161490313|NCT02622321|583188378|FG000|Overall Study|Physician Decision|1|||
161490314|NCT02622321|583188379|FG001|Overall Study|Physician Decision|0|||
161490315|NCT02622321|583188380|FG002|Overall Study|Physician Decision|0|||
161490316|NCT02622321|583188381|FG003|Overall Study|Physician Decision|0|||
161490317|NCT00241280|583188382|FG000|Overall Study|Adverse Event|2|||
161490318|NCT00241280|583188383|FG001|Overall Study|Adverse Event|6|||
161490319|NCT00241280|583188382|FG000|Overall Study|Discomfort|11|||
161490320|NCT00241280|583188383|FG001|Overall Study|Discomfort|16|||
161583374|NCT03584516|583522696|FG000|Part 1|Lost to Follow-up|1|||
161583375|NCT03584516|583522697|FG001|Part 1|Lost to Follow-up|0|||
161583376|NCT03584516|583522698|FG002|Part 1|Lost to Follow-up|0|||
161490321|NCT00241280|583188382|FG000|Overall Study|Pregnancy|1|||
161490322|NCT00241280|583188383|FG001|Overall Study|Pregnancy|5|||
161583377|NCT03584516|583522699|FG003|Part 1|Lost to Follow-up|0|||
161583378|NCT03584516|583522700|FG004|Part 1|Lost to Follow-up|0|||
161583379|NCT03584516|583522701|FG005|Part 1|Lost to Follow-up|0|||
161490323|NCT00241280|583188382|FG000|Overall Study|Lost to Follow-up|5|||
161490324|NCT00241280|583188383|FG001|Overall Study|Lost to Follow-up|8|||
161490325|NCT00241280|583188382|FG000|Overall Study|Withdrawal by Subject|7|||
161490326|NCT00241280|583188383|FG001|Overall Study|Withdrawal by Subject|4|||
161490327|NCT00241280|583188382|FG000|Overall Study|Protocol Violation|4|||
161490328|NCT00241280|583188383|FG001|Overall Study|Protocol Violation|10|||
161490329|NCT00241280|583188382|FG000|Overall Study|Relocation|4|||
161490330|NCT00241280|583188383|FG001|Overall Study|Relocation|4|||
161490331|NCT00241280|583188382|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
161490332|NCT00241280|583188383|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
161490333|NCT00241280|583188382|FG000|Overall Study|Unsatisfactory Visual Response|1|||
161490334|NCT00241280|583188383|FG001|Overall Study|Unsatisfactory Visual Response|1|||
161490335|NCT00241280|583188382|FG000|Overall Study|Diabetic|1|||
161490336|NCT00241280|583188383|FG001|Overall Study|Diabetic|0|||
161490337|NCT00241280|583188382|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
161490338|NCT00241280|583188383|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
161490339|NCT00241280|583188382|FG000|Overall Study|Dispensed incorrect test article|1|||
161490340|NCT00241280|583188383|FG001|Overall Study|Dispensed incorrect test article|2|||
161490341|NCT00241280|583188382|FG000|Overall Study|Unacceptable Fit|0|||
161490342|NCT00241280|583188383|FG001|Overall Study|Unacceptable Fit|1|||
161490343|NCT00241280|583188382|FG000|Overall Study|Scheduling Conflict|0|||
161490344|NCT00241280|583188383|FG001|Overall Study|Scheduling Conflict|2|||
161490345|NCT00241280|583188382|FG000|Overall Study|History of Ocular Surgery|0|||
161490346|NCT00241280|583188383|FG001|Overall Study|History of Ocular Surgery|1|||
161490347|NCT00241280|583188382|FG000|Overall Study|Coating on Lens|1|||
161490348|NCT00241280|583188383|FG001|Overall Study|Coating on Lens|0|||
161490349|NCT00241280|583188382|FG000|Overall Study|Excessive Dryness|0|||
161490350|NCT00241280|583188383|FG001|Overall Study|Excessive Dryness|1|||
161490351|NCT01958008|583188384|FG000|Overall Study|Worsening of disease under study|0|||
161490352|NCT01958008|583188385|FG001|Overall Study|Worsening of disease under study|0|||
161490353|NCT01958008|583188386|FG002|Overall Study|Worsening of disease under study|1|||
161490354|NCT01958008|583188387|FG003|Overall Study|Worsening of disease under study|0|||
161490355|NCT01958008|583188384|FG000|Overall Study|Other adverse event|1|||
161490356|NCT01958008|583188385|FG001|Overall Study|Other adverse event|0|||
161490357|NCT01958008|583188386|FG002|Overall Study|Other adverse event|0|||
161490358|NCT01958008|583188387|FG003|Overall Study|Other adverse event|0|||
161490359|NCT01634360|583188388|FG000|Overall Study|Adverse Event|10|||
161490360|NCT01634360|583188389|FG001|Overall Study|Adverse Event|34|||
161490361|NCT01634360|583188388|FG000|Overall Study|subject withdrew consent|13|||
161490362|NCT01634360|583188389|FG001|Overall Study|subject withdrew consent|23|||
161490363|NCT01634360|583188388|FG000|Overall Study|Protocol Violation|1|||
161490364|NCT01634360|583188389|FG001|Overall Study|Protocol Violation|1|||
161490365|NCT01634360|583188388|FG000|Overall Study|Lack of Efficacy|4|||
161490366|NCT01634360|583188389|FG001|Overall Study|Lack of Efficacy|14|||
161490367|NCT01634360|583188388|FG000|Overall Study|Other|3|||
161490368|NCT01634360|583188389|FG001|Overall Study|Other|20|||
161490369|NCT01634360|583188388|FG000|Overall Study|Study termination by sponsor|18|||
161490370|NCT01634360|583188389|FG001|Overall Study|Study termination by sponsor|44|||
161490371|NCT01414855|583188390|FG000|Overall Study|Death|17|||
161490372|NCT01414855|583188390|FG000|Overall Study|Lost to Follow-up|5|||
161490373|NCT01414855|583188390|FG000|Overall Study|Withdrawal by Subject|7|||
161490374|NCT02743871|583188391|FG000|Overall Study|Lost to Follow-up|0|||
161583380|NCT03584516|583522696|FG000|Part 1|Study Terminated by Sponsor|0|||
161583381|NCT03584516|583522697|FG001|Part 1|Study Terminated by Sponsor|2|||
161583382|NCT03584516|583522698|FG002|Part 1|Study Terminated by Sponsor|0|||
161583383|NCT03584516|583522699|FG003|Part 1|Study Terminated by Sponsor|0|||
161583384|NCT03584516|583522700|FG004|Part 1|Study Terminated by Sponsor|0|||
161583385|NCT03584516|583522701|FG005|Part 1|Study Terminated by Sponsor|0|||
161583386|NCT03584516|583522696|FG000|Part 1 Expansion|Death|0|||
161583387|NCT03584516|583522697|FG001|Part 1 Expansion|Death|0|||
161583388|NCT03584516|583522698|FG002|Part 1 Expansion|Death|9|||
161583389|NCT03584516|583522699|FG003|Part 1 Expansion|Death|8|||
161671520|NCT01182766|583851311|FG002|Overall Study|Non-compliance|1|||
161671521|NCT03027557|583851312|FG000|Overall Study|Adverse Event|1|||
161671522|NCT03027557|583851313|FG001|Overall Study|Adverse Event|0|||
161490375|NCT02743871|583188392|FG001|Overall Study|Lost to Follow-up|0|||
161490376|NCT02743871|583188393|FG002|Overall Study|Lost to Follow-up|0|||
161490377|NCT02743871|583188394|FG003|Overall Study|Lost to Follow-up|1|||
161490378|NCT02743871|583188395|FG004|Overall Study|Lost to Follow-up|0|||
161490379|NCT02743871|583188396|FG005|Overall Study|Lost to Follow-up|0|||
161490380|NCT02743871|583188397|FG006|Overall Study|Lost to Follow-up|1|||
161490381|NCT02743871|583188398|FG007|Overall Study|Lost to Follow-up|0|||
161490382|NCT02743871|583188399|FG008|Overall Study|Lost to Follow-up|0|||
161490383|NCT02743871|583188400|FG009|Overall Study|Lost to Follow-up|0|||
161490384|NCT02743871|583188401|FG010|Overall Study|Lost to Follow-up|0|||
161490385|NCT02743871|583188402|FG011|Overall Study|Lost to Follow-up|2|||
161490386|NCT02743871|583188403|FG012|Overall Study|Lost to Follow-up|0|||
161490387|NCT02743871|583188404|FG013|Overall Study|Lost to Follow-up|0|||
161583390|NCT03584516|583522700|FG004|Part 1 Expansion|Death|4|||
161490388|NCT02743871|583188391|FG000|Overall Study|Withdrawal by Subject|0|||
161490389|NCT02743871|583188392|FG001|Overall Study|Withdrawal by Subject|0|||
161490390|NCT02743871|583188393|FG002|Overall Study|Withdrawal by Subject|0|||
161490391|NCT02743871|583188394|FG003|Overall Study|Withdrawal by Subject|0|||
161490392|NCT02743871|583188395|FG004|Overall Study|Withdrawal by Subject|0|||
161490393|NCT02743871|583188396|FG005|Overall Study|Withdrawal by Subject|0|||
161490394|NCT02743871|583188397|FG006|Overall Study|Withdrawal by Subject|0|||
161490395|NCT02743871|583188398|FG007|Overall Study|Withdrawal by Subject|0|||
161490396|NCT02743871|583188399|FG008|Overall Study|Withdrawal by Subject|0|||
161490397|NCT02743871|583188400|FG009|Overall Study|Withdrawal by Subject|0|||
161490398|NCT02743871|583188401|FG010|Overall Study|Withdrawal by Subject|1|||
161490399|NCT02743871|583188402|FG011|Overall Study|Withdrawal by Subject|0|||
161490400|NCT02743871|583188403|FG012|Overall Study|Withdrawal by Subject|12|||
161490401|NCT02743871|583188404|FG013|Overall Study|Withdrawal by Subject|6|||
161490402|NCT02743871|583188391|FG000|Overall Study|Adverse Event|1|||
161490403|NCT02743871|583188392|FG001|Overall Study|Adverse Event|0|||
161490404|NCT02743871|583188393|FG002|Overall Study|Adverse Event|0|||
161490405|NCT02743871|583188394|FG003|Overall Study|Adverse Event|0|||
161490406|NCT02743871|583188395|FG004|Overall Study|Adverse Event|0|||
161490407|NCT02743871|583188396|FG005|Overall Study|Adverse Event|0|||
161490408|NCT02743871|583188397|FG006|Overall Study|Adverse Event|0|||
161490409|NCT02743871|583188398|FG007|Overall Study|Adverse Event|0|||
161490410|NCT02743871|583188399|FG008|Overall Study|Adverse Event|0|||
161490411|NCT02743871|583188400|FG009|Overall Study|Adverse Event|0|||
161490412|NCT02743871|583188401|FG010|Overall Study|Adverse Event|0|||
161490413|NCT02743871|583188402|FG011|Overall Study|Adverse Event|0|||
161490414|NCT02743871|583188403|FG012|Overall Study|Adverse Event|0|||
161490415|NCT02743871|583188404|FG013|Overall Study|Adverse Event|0|||
161490416|NCT02743871|583188391|FG000|Overall Study|Other|0|||
161490417|NCT02743871|583188392|FG001|Overall Study|Other|0|||
161490418|NCT02743871|583188393|FG002|Overall Study|Other|0|||
161490419|NCT02743871|583188394|FG003|Overall Study|Other|0|||
161490420|NCT02743871|583188395|FG004|Overall Study|Other|0|||
161490421|NCT02743871|583188396|FG005|Overall Study|Other|0|||
161490422|NCT02743871|583188397|FG006|Overall Study|Other|0|||
161490423|NCT02743871|583188398|FG007|Overall Study|Other|0|||
161490424|NCT02743871|583188399|FG008|Overall Study|Other|0|||
161490425|NCT02743871|583188400|FG009|Overall Study|Other|0|||
161490426|NCT02743871|583188401|FG010|Overall Study|Other|0|||
161490427|NCT02743871|583188402|FG011|Overall Study|Other|1|||
161490428|NCT02743871|583188403|FG012|Overall Study|Other|1|||
161490429|NCT02743871|583188404|FG013|Overall Study|Other|1|||
161490430|NCT02743871|583188391|FG000|Overall Study|Protocol Violation|0|||
161490431|NCT02743871|583188392|FG001|Overall Study|Protocol Violation|0|||
161490432|NCT02743871|583188393|FG002|Overall Study|Protocol Violation|0|||
161490433|NCT02743871|583188394|FG003|Overall Study|Protocol Violation|0|||
161490434|NCT02743871|583188395|FG004|Overall Study|Protocol Violation|0|||
161490435|NCT02743871|583188396|FG005|Overall Study|Protocol Violation|0|||
161490436|NCT02743871|583188397|FG006|Overall Study|Protocol Violation|0|||
161490437|NCT02743871|583188398|FG007|Overall Study|Protocol Violation|0|||
161490438|NCT02743871|583188399|FG008|Overall Study|Protocol Violation|0|||
161490439|NCT02743871|583188400|FG009|Overall Study|Protocol Violation|0|||
161490440|NCT02743871|583188401|FG010|Overall Study|Protocol Violation|0|||
161490441|NCT02743871|583188402|FG011|Overall Study|Protocol Violation|0|||
161490442|NCT02743871|583188403|FG012|Overall Study|Protocol Violation|2|||
161817058|NCT02213263|584370916|FG001|Overall Study|Protocol Violation|1|||
161817059|NCT02213263|584370915|FG000|Overall Study|Adverse Event|1|||
161490443|NCT02743871|583188404|FG013|Overall Study|Protocol Violation|0|||
161490444|NCT01853826|583190270|FG000|Overall Study|Patients who switched to commercial drug|11|||
161490445|NCT01853826|583190270|FG000|Overall Study|Patient refused to continue medication|21|||
161490446|NCT01853826|583190270|FG000|Overall Study|Lost to Follow-up|2|||
161490447|NCT01853826|583190270|FG000|Overall Study|Non-compliant with protocol|4|||
161490448|NCT01853826|583190270|FG000|Overall Study|Other adverse events (AE)|62|||
161490449|NCT01853826|583190270|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
161817060|NCT02213263|584370916|FG001|Overall Study|Adverse Event|3|||
161817061|NCT05752721|584370917|FG000|Overall Study|Lost to Follow-up|22|||
161817062|NCT05752721|584370918|FG001|Overall Study|Lost to Follow-up|20|||
161817063|NCT05752721|584370917|FG000|Overall Study|Withdrawal by Subject|15|||
161817064|NCT05752721|584370918|FG001|Overall Study|Withdrawal by Subject|12|||
161490450|NCT01853826|583190270|FG000|Overall Study|Progressive disease|342|||
161490451|NCT01853826|583190270|FG000|Overall Study|Other than listed|13|||
161490452|NCT01853826|583190270|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
161490453|NCT04779489|583190281|FG000|Overall Study|Physician Decision|1|||
161490454|NCT02068443|583190282|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161490455|NCT02068443|583190283|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
161490456|NCT02068443|583190284|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
161490457|NCT02068443|583190282|FG000|Overall Study|Voluntary Withdrawal|4|||
161490458|NCT02068443|583190283|FG001|Overall Study|Voluntary Withdrawal|0|||
161817065|NCT00263588|584370919|FG000|Overall Study|Death|54|||
161490459|NCT02068443|583190284|FG002|Overall Study|Voluntary Withdrawal|1|||
161490460|NCT02068443|583190282|FG000|Overall Study|Lack of Efficacy|2|||
161490461|NCT02068443|583190283|FG001|Overall Study|Lack of Efficacy|1|||
161490462|NCT02068443|583190284|FG002|Overall Study|Lack of Efficacy|0|||
161490463|NCT02068443|583190282|FG000|Overall Study|Other Reason Not Specified|1|||
161490464|NCT02068443|583190283|FG001|Overall Study|Other Reason Not Specified|0|||
161490465|NCT02068443|583190284|FG002|Overall Study|Other Reason Not Specified|0|||
161490466|NCT02723084|583190286|FG000|Overall Study|Withdrawal by Subject|1|||
161490467|NCT02723084|583190287|FG001|Overall Study|Withdrawal by Subject|1|||
161490468|NCT02723084|583190286|FG000|Overall Study|Lost to Follow-up|3|||
161490469|NCT02723084|583190287|FG001|Overall Study|Lost to Follow-up|0|||
161490470|NCT05126901|583190292|FG000|Overall Study|Withdrawal by Subject|1|||
161490471|NCT05126901|583190293|FG001|Overall Study|Withdrawal by Subject|1|||
161490472|NCT05126901|583190294|FG002|Overall Study|Withdrawal by Subject|4|||
161490473|NCT05126901|583190292|FG000|Overall Study|Adverse Event|0|||
161490474|NCT05126901|583190293|FG001|Overall Study|Adverse Event|0|||
161490475|NCT05126901|583190294|FG002|Overall Study|Adverse Event|1|||
161490476|NCT05126901|583190292|FG000|Overall Study|Lost to Follow-up|0|||
161490477|NCT05126901|583190293|FG001|Overall Study|Lost to Follow-up|2|||
161490478|NCT05126901|583190294|FG002|Overall Study|Lost to Follow-up|0|||
161490479|NCT04067544|583190295|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
161490480|NCT01320085|583190296|FG000|Overall Study|Disease Progression|26|||
161490481|NCT01320085|583190297|FG001|Overall Study|Disease Progression|93|||
161490482|NCT01320085|583190298|FG002|Overall Study|Disease Progression|17|||
161490483|NCT01320085|583190296|FG000|Overall Study|Adverse Event|12|||
161490484|NCT01320085|583190297|FG001|Overall Study|Adverse Event|20|||
161490485|NCT01320085|583190298|FG002|Overall Study|Adverse Event|5|||
161490486|NCT01320085|583190296|FG000|Overall Study|Withdrawal by Subject|2|||
161490487|NCT01320085|583190297|FG001|Overall Study|Withdrawal by Subject|4|||
161490488|NCT01320085|583190298|FG002|Overall Study|Withdrawal by Subject|1|||
161490489|NCT01320085|583190296|FG000|Overall Study|Protocol Deviation|1|||
161490490|NCT01320085|583190297|FG001|Overall Study|Protocol Deviation|0|||
161490491|NCT01320085|583190298|FG002|Overall Study|Protocol Deviation|1|||
161490492|NCT01320085|583190296|FG000|Overall Study|Administrative problems|0|||
161490493|NCT01320085|583190297|FG001|Overall Study|Administrative problems|0|||
161490494|NCT01320085|583190298|FG002|Overall Study|Administrative problems|1|||
161490495|NCT00225251|583190301|FG000|Overall Study|Withdrawal by Subject|1|||
161490496|NCT00225251|583190302|FG001|Overall Study|Withdrawal by Subject|1|||
161490497|NCT00710710|583190303|FG000|Overall Study|Consent withdrawn|2|||
161490498|NCT00710710|583190304|FG001|Overall Study|Consent withdrawn|2|||
161490499|NCT00710710|583190303|FG000|Overall Study|Protocol Violation|0|||
161490500|NCT00710710|583190304|FG001|Overall Study|Protocol Violation|1|||
161490501|NCT00710710|583190303|FG000|Overall Study|Adverse Event|3|||
161490502|NCT00710710|583190304|FG001|Overall Study|Adverse Event|3|||
161490503|NCT00710710|583190303|FG000|Overall Study|Progressive disease|40|||
161490504|NCT00710710|583190304|FG001|Overall Study|Progressive disease|38|||
161490505|NCT00715078|583190305|FG000|Overall Study|Death|29|||
161490506|NCT00715078|583190306|FG001|Overall Study|Death|36|||
161490507|NCT00715078|583190307|FG002|Overall Study|Death|36|||
161490508|NCT00715078|583190305|FG000|Overall Study|Withdrawal by Subject|1|||
161490509|NCT00715078|583190306|FG001|Overall Study|Withdrawal by Subject|0|||
161490510|NCT00715078|583190307|FG002|Overall Study|Withdrawal by Subject|1|||
161490511|NCT00715078|583190305|FG000|Overall Study|Unable to start due to disease prog.|0|||
161490512|NCT00715078|583190306|FG001|Overall Study|Unable to start due to disease prog.|0|||
161490513|NCT00715078|583190307|FG002|Overall Study|Unable to start due to disease prog.|1|||
161490514|NCT01529346|583190308|FG000|Overall Study|Lost to Follow-up|2|||
161490515|NCT01529346|583190309|FG001|Overall Study|Lost to Follow-up|0|||
161490516|NCT01529346|583190310|FG002|Overall Study|Lost to Follow-up|1|||
161490517|NCT01529346|583190311|FG003|Overall Study|Lost to Follow-up|0|||
161490518|NCT01529346|583190312|FG004|Overall Study|Lost to Follow-up|0|||
161490519|NCT01529346|583190308|FG000|Overall Study|Other|0|||
161490520|NCT01529346|583190309|FG001|Overall Study|Other|1|||
161490521|NCT01529346|583190310|FG002|Overall Study|Other|1|||
161490522|NCT01529346|583190311|FG003|Overall Study|Other|0|||
161490523|NCT01529346|583190312|FG004|Overall Study|Other|0|||
161490524|NCT01287897|583190313|FG000|Overall Study|Adverse Event|5|||
161490525|NCT01287897|583190314|FG001|Overall Study|Adverse Event|3|||
161490526|NCT01287897|583190315|FG002|Overall Study|Adverse Event|6|||
161490527|NCT01287897|583190316|FG003|Overall Study|Adverse Event|4|||
161490528|NCT01287897|583190313|FG000|Overall Study|Lack of Efficacy|2|||
161490529|NCT01287897|583190314|FG001|Overall Study|Lack of Efficacy|0|||
161490530|NCT01287897|583190315|FG002|Overall Study|Lack of Efficacy|0|||
161490531|NCT01287897|583190316|FG003|Overall Study|Lack of Efficacy|0|||
161490532|NCT01287897|583190313|FG000|Overall Study|Protocol Violation|1|||
161490533|NCT01287897|583190314|FG001|Overall Study|Protocol Violation|1|||
161490534|NCT01287897|583190315|FG002|Overall Study|Protocol Violation|0|||
161490535|NCT01287897|583190316|FG003|Overall Study|Protocol Violation|1|||
161490536|NCT01287897|583190313|FG000|Overall Study|Lost to Follow-up|0|||
161490537|NCT01287897|583190314|FG001|Overall Study|Lost to Follow-up|0|||
161490538|NCT01287897|583190315|FG002|Overall Study|Lost to Follow-up|2|||
161490539|NCT01287897|583190316|FG003|Overall Study|Lost to Follow-up|0|||
161490540|NCT01287897|583190313|FG000|Overall Study|Withdrawal by Subject|1|||
161490541|NCT01287897|583190314|FG001|Overall Study|Withdrawal by Subject|5|||
161490542|NCT01287897|583190315|FG002|Overall Study|Withdrawal by Subject|3|||
161490543|NCT01287897|583190316|FG003|Overall Study|Withdrawal by Subject|2|||
161490544|NCT01287897|583190313|FG000|Overall Study|Not consented properly|0|||
161490545|NCT01287897|583190314|FG001|Overall Study|Not consented properly|1|||
161490546|NCT01287897|583190315|FG002|Overall Study|Not consented properly|0|||
161490547|NCT01287897|583190316|FG003|Overall Study|Not consented properly|0|||
161490548|NCT01287897|583190313|FG000|Overall Study|Not meeting entrance criteria|1|||
161490549|NCT01287897|583190314|FG001|Overall Study|Not meeting entrance criteria|1|||
161490550|NCT01287897|583190315|FG002|Overall Study|Not meeting entrance criteria|0|||
161490551|NCT01287897|583190316|FG003|Overall Study|Not meeting entrance criteria|0|||
161490552|NCT01287897|583190313|FG000|Overall Study|Other|1|||
161490553|NCT01287897|583190314|FG001|Overall Study|Other|0|||
161490554|NCT01287897|583190315|FG002|Overall Study|Other|1|||
161490555|NCT01287897|583190316|FG003|Overall Study|Other|0|||
161490556|NCT00386776|583190323|FG000|Overall Study|Withdrawal by Subject|8|||
161490557|NCT02282020|583190324|FG000|Overall Study|Objective Disease Progression|128|||
161490558|NCT02282020|583190325|FG001|Overall Study|Objective Disease Progression|30|||
161490559|NCT02282020|583190324|FG000|Overall Study|Adverse Event|18|||
161490560|NCT02282020|583190325|FG001|Overall Study|Adverse Event|15|||
161490561|NCT02282020|583190324|FG000|Overall Study|Withdrawal by Subject|7|||
161490562|NCT02282020|583190325|FG001|Overall Study|Withdrawal by Subject|10|||
161490563|NCT02282020|583190324|FG000|Overall Study|Miscellaneous|5|||
161490564|NCT02282020|583190325|FG001|Overall Study|Miscellaneous|19|||
161490565|NCT02282020|583190324|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
161490566|NCT02282020|583190325|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
161490567|NCT02282020|583190324|FG000|Overall Study|Developed Discontinuation Criteria|0|||
161490568|NCT02282020|583190325|FG001|Overall Study|Developed Discontinuation Criteria|2|||
161490569|NCT02282020|583190324|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
161490570|NCT02282020|583190325|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
161490571|NCT00588848|583190326|FG000|Overall Study|Physician Decision|0|||
161490572|NCT00588848|583190327|FG001|Overall Study|Physician Decision|3|||
161490573|NCT01499667|583190328|FG000|Overall Study|administrative problems|4|||
161490574|NCT01499667|583190329|FG001|Overall Study|administrative problems|5|||
161490575|NCT01499667|583190330|FG002|Overall Study|administrative problems|5|||
161490576|NCT01499667|583190328|FG000|Overall Study|Protocol Violation|1|||
161490577|NCT01499667|583190329|FG001|Overall Study|Protocol Violation|3|||
161490578|NCT01499667|583190330|FG002|Overall Study|Protocol Violation|2|||
161490579|NCT01499667|583190328|FG000|Overall Study|Adverse Event|0|||
161490580|NCT01499667|583190329|FG001|Overall Study|Adverse Event|2|||
161490581|NCT01499667|583190330|FG002|Overall Study|Adverse Event|2|||
161490582|NCT01499667|583190328|FG000|Overall Study|Withdrawal by Subject|2|||
161490583|NCT01499667|583190329|FG001|Overall Study|Withdrawal by Subject|1|||
161490584|NCT01499667|583190330|FG002|Overall Study|Withdrawal by Subject|1|||
161490585|NCT01499667|583190328|FG000|Overall Study|Lack of Efficacy|2|||
161490586|NCT01499667|583190329|FG001|Overall Study|Lack of Efficacy|0|||
161490587|NCT01499667|583190330|FG002|Overall Study|Lack of Efficacy|0|||
161490588|NCT02902965|583190331|FG000|Overall Study|Withdrawal by Subject|10|||
161490589|NCT02673489|583190332|FG000|Treatment Period|Lost to Follow-up|3|||
161490590|NCT02673489|583190333|FG001|Treatment Period|Lost to Follow-up|0|||
161490591|NCT02673489|583190332|FG000|Treatment Period|Participant request to discontinue|1|||
161490592|NCT02673489|583190333|FG001|Treatment Period|Participant request to discontinue|1|||
161583391|NCT03584516|583522701|FG005|Part 1 Expansion|Death|5|||
161583392|NCT03584516|583522696|FG000|Part 1 Expansion|Lost to Follow-up|0|||
161490593|NCT02673489|583190332|FG000|Treatment Period|Participant moved to another province|1|||
161490594|NCT02673489|583190333|FG001|Treatment Period|Participant moved to another province|0|||
161490595|NCT02673489|583190332|FG000|Treatment Period|Participant was incarcerated|0|||
161583393|NCT03584516|583522697|FG001|Part 1 Expansion|Lost to Follow-up|0|||
161583394|NCT03584516|583522698|FG002|Part 1 Expansion|Lost to Follow-up|0|||
161583395|NCT03584516|583522699|FG003|Part 1 Expansion|Lost to Follow-up|1|||
161583396|NCT03584516|583522700|FG004|Part 1 Expansion|Lost to Follow-up|0|||
161583397|NCT03584516|583522701|FG005|Part 1 Expansion|Lost to Follow-up|0|||
161583398|NCT03584516|583522696|FG000|Part 1 Expansion|Physician Decision|0|||
161583399|NCT03584516|583522697|FG001|Part 1 Expansion|Physician Decision|0|||
161671523|NCT03027557|583851314|FG002|Overall Study|Adverse Event|0|||
161490596|NCT02673489|583190333|FG001|Treatment Period|Participant was incarcerated|1|||
161490597|NCT02673489|583190332|FG000|Treatment Period|Adverse Event|0|||
161490598|NCT02673489|583190333|FG001|Treatment Period|Adverse Event|1|||
161490599|NCT02673489|583190332|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
161490600|NCT02673489|583190333|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
161583400|NCT03584516|583522698|FG002|Part 1 Expansion|Physician Decision|4|||
161583401|NCT03584516|583522699|FG003|Part 1 Expansion|Physician Decision|3|||
161817066|NCT00263588|584370920|FG001|Overall Study|Death|90|||
161671524|NCT02430051|583851317|FG000|Overall Study|Withdrawal by Subject|6|||
161671525|NCT02430051|583851318|FG001|Overall Study|Withdrawal by Subject|3|||
161671526|NCT02430051|583851317|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
161671527|NCT02430051|583851318|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
161671528|NCT02430051|583851317|FG000|Overall Study|Protocol Violation|1|||
161671529|NCT02430051|583851318|FG001|Overall Study|Protocol Violation|0|||
161671530|NCT02030405|583851322|FG000|Overall Study|Withdrawal by Subject|1|||
161671531|NCT02030405|583851322|FG000|Overall Study|Lost to Follow-up|1|||
161671532|NCT01145755|583851325|FG000|Overall Study|Adverse Event|2|||
161671533|NCT01145755|583851326|FG001|Overall Study|Adverse Event|4|||
161923026|NCT03369223|584764932|FG011|Overall Study|Participant no longer meets study criteria|0|||
161923027|NCT03369223|584764933|FG012|Overall Study|Participant no longer meets study criteria|0|||
161923028|NCT03369223|584764934|FG013|Overall Study|Participant no longer meets study criteria|0|||
161671534|NCT01145755|583851327|FG002|Overall Study|Adverse Event|2|||
161923029|NCT03369223|584764935|FG014|Overall Study|Participant no longer meets study criteria|2|||
161923030|NCT03369223|584764936|FG015|Overall Study|Participant no longer meets study criteria|0|||
161923031|NCT03369223|584764937|FG016|Overall Study|Participant no longer meets study criteria|2|||
161923032|NCT03369223|584764938|FG017|Overall Study|Participant no longer meets study criteria|0|||
161923033|NCT03369223|584764939|FG018|Overall Study|Participant no longer meets study criteria|0|||
161923034|NCT03369223|584764940|FG019|Overall Study|Participant no longer meets study criteria|0|||
161923035|NCT03369223|584764921|FG000|Overall Study|Other reasons|0|||
161923036|NCT03369223|584764922|FG001|Overall Study|Other reasons|0|||
161923037|NCT03369223|584764923|FG002|Overall Study|Other reasons|0|||
161923038|NCT03369223|584764924|FG003|Overall Study|Other reasons|0|||
161923039|NCT03369223|584764925|FG004|Overall Study|Other reasons|0|||
161923040|NCT03369223|584764926|FG005|Overall Study|Other reasons|0|||
161923041|NCT03369223|584764927|FG006|Overall Study|Other reasons|0|||
161923042|NCT03369223|584764928|FG007|Overall Study|Other reasons|0|||
161923043|NCT03369223|584764929|FG008|Overall Study|Other reasons|0|||
161923044|NCT03369223|584764930|FG009|Overall Study|Other reasons|0|||
161923045|NCT03369223|584764931|FG010|Overall Study|Other reasons|0|||
161923046|NCT03369223|584764932|FG011|Overall Study|Other reasons|0|||
161923047|NCT03369223|584764933|FG012|Overall Study|Other reasons|0|||
161923048|NCT03369223|584764934|FG013|Overall Study|Other reasons|1|||
161923049|NCT03369223|584764935|FG014|Overall Study|Other reasons|2|||
161923050|NCT03369223|584764936|FG015|Overall Study|Other reasons|0|||
161923051|NCT03369223|584764937|FG016|Overall Study|Other reasons|1|||
161923052|NCT03369223|584764938|FG017|Overall Study|Other reasons|0|||
161923053|NCT03369223|584764939|FG018|Overall Study|Other reasons|0|||
161923054|NCT03369223|584764940|FG019|Overall Study|Other reasons|2|||
161923055|NCT03369223|584764921|FG000|Overall Study|Death|0|||
161923056|NCT03369223|584764922|FG001|Overall Study|Death|0|||
161923057|NCT03369223|584764923|FG002|Overall Study|Death|0|||
161923058|NCT03369223|584764924|FG003|Overall Study|Death|0|||
161923059|NCT03369223|584764925|FG004|Overall Study|Death|0|||
161923060|NCT03369223|584764926|FG005|Overall Study|Death|0|||
161923061|NCT03369223|584764927|FG006|Overall Study|Death|0|||
161923062|NCT03369223|584764928|FG007|Overall Study|Death|0|||
161923063|NCT03369223|584764929|FG008|Overall Study|Death|0|||
161923064|NCT03369223|584764930|FG009|Overall Study|Death|0|||
161923065|NCT03369223|584764931|FG010|Overall Study|Death|0|||
161923066|NCT03369223|584764932|FG011|Overall Study|Death|0|||
161923067|NCT03369223|584764933|FG012|Overall Study|Death|0|||
161923068|NCT03369223|584764934|FG013|Overall Study|Death|1|||
161923069|NCT03369223|584764935|FG014|Overall Study|Death|0|||
161923070|NCT03369223|584764936|FG015|Overall Study|Death|0|||
161923071|NCT03369223|584764937|FG016|Overall Study|Death|0|||
161923072|NCT03369223|584764938|FG017|Overall Study|Death|0|||
161923073|NCT03369223|584764939|FG018|Overall Study|Death|1|||
161923074|NCT03369223|584764940|FG019|Overall Study|Death|0|||
161923075|NCT03369223|584764921|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161923076|NCT03369223|584764922|FG001|Overall Study|Adverse event unrelated to study drug|0|||
161923077|NCT03369223|584764923|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161923078|NCT03369223|584764924|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161923079|NCT03369223|584764925|FG004|Overall Study|Adverse event unrelated to study drug|0|||
161923080|NCT03369223|584764926|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161923081|NCT03369223|584764927|FG006|Overall Study|Adverse event unrelated to study drug|1|||
161923082|NCT03369223|584764928|FG007|Overall Study|Adverse event unrelated to study drug|0|||
161923083|NCT03369223|584764929|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161923084|NCT03369223|584764930|FG009|Overall Study|Adverse event unrelated to study drug|1|||
161923085|NCT03369223|584764931|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161923086|NCT03369223|584764932|FG011|Overall Study|Adverse event unrelated to study drug|0|||
161923087|NCT03369223|584764933|FG012|Overall Study|Adverse event unrelated to study drug|0|||
161923088|NCT03369223|584764934|FG013|Overall Study|Adverse event unrelated to study drug|4|||
161923089|NCT03369223|584764935|FG014|Overall Study|Adverse event unrelated to study drug|2|||
161923090|NCT03369223|584764936|FG015|Overall Study|Adverse event unrelated to study drug|0|||
161490601|NCT02673489|583190332|FG000|Follow Up Period|Unable to return for follow-up|0|||
161490602|NCT02673489|583190333|FG001|Follow Up Period|Unable to return for follow-up|1|||
161490603|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
161490604|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
161490605|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
161490606|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
161490607|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
161490608|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
161490609|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
161490610|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
161490611|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
161490612|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
161490613|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
161490614|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
161923091|NCT03369223|584764937|FG016|Overall Study|Adverse event unrelated to study drug|2|||
161923092|NCT03369223|584764938|FG017|Overall Study|Adverse event unrelated to study drug|1|||
161923093|NCT03369223|584764939|FG018|Overall Study|Adverse event unrelated to study drug|3|||
161923094|NCT03369223|584764940|FG019|Overall Study|Adverse event unrelated to study drug|2|||
161923095|NCT03369223|584764921|FG000|Overall Study|Disease progression|6|||
161923096|NCT03369223|584764922|FG001|Overall Study|Disease progression|8|||
161923097|NCT03369223|584764923|FG002|Overall Study|Disease progression|5|||
161923098|NCT03369223|584764924|FG003|Overall Study|Disease progression|1|||
161923099|NCT03369223|584764925|FG004|Overall Study|Disease progression|9|||
161923100|NCT03369223|584764926|FG005|Overall Study|Disease progression|9|||
161923101|NCT03369223|584764927|FG006|Overall Study|Disease progression|4|||
161490615|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
161490616|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
161490617|NCT00293254|583190334|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
161583402|NCT03584516|583522700|FG004|Part 1 Expansion|Physician Decision|2|||
161583403|NCT03584516|583522701|FG005|Part 1 Expansion|Physician Decision|3|||
161583404|NCT03584516|583522696|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
161583405|NCT03584516|583522697|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
161583406|NCT03584516|583522698|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
161583407|NCT03584516|583522699|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
161583408|NCT03584516|583522700|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
161583409|NCT03584516|583522701|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
161583410|NCT03584516|583522696|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
161583411|NCT03584516|583522697|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
161583412|NCT03584516|583522698|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
161583413|NCT03584516|583522699|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
161583414|NCT03584516|583522700|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
161583415|NCT03584516|583522701|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
161583416|NCT03584516|583522696|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161583417|NCT03584516|583522697|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161583418|NCT03584516|583522698|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161583419|NCT03584516|583522699|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
161583420|NCT03584516|583522700|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161583421|NCT03584516|583522701|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161583422|NCT03584516|583522696|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161583423|NCT03584516|583522697|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161583424|NCT03584516|583522698|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161583425|NCT03584516|583522699|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161583426|NCT03584516|583522700|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161583427|NCT03584516|583522701|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
161583428|NCT01443845|583522707|FG000|Overall Study|Protocol Violation|43|||
161583429|NCT01443845|583522708|FG001|Overall Study|Protocol Violation|45|||
161583430|NCT01443845|583522707|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
161583431|NCT01443845|583522708|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
161583432|NCT01443845|583522707|FG000|Overall Study|Deterioration in pulmonary function|1|||
161583433|NCT01443845|583522708|FG001|Overall Study|Deterioration in pulmonary function|4|||
161583434|NCT01443845|583522707|FG000|Overall Study|Lack of Efficacy|10|||
161583435|NCT01443845|583522708|FG001|Overall Study|Lack of Efficacy|5|||
161923102|NCT03369223|584764928|FG007|Overall Study|Disease progression|6|||
161923103|NCT03369223|584764929|FG008|Overall Study|Disease progression|10|||
161490618|NCT00293254|583190335|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
161583436|NCT01443845|583522707|FG000|Overall Study|Adverse Event|64|||
161583437|NCT01443845|583522708|FG001|Overall Study|Adverse Event|138|||
161583438|NCT01443845|583522707|FG000|Overall Study|Withdrawal by Subject|63|||
161923104|NCT03369223|584764930|FG009|Overall Study|Disease progression|7|||
161923105|NCT03369223|584764931|FG010|Overall Study|Disease progression|4|||
161490619|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
161490620|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
161490621|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Death|4|||
161490622|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Death|1|||
161490623|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
161490624|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
161490625|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
161490626|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
161490627|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
161490628|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
161490629|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
161490630|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
161490631|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
161490632|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
161490633|NCT00293254|583190334|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
161490634|NCT00293254|583190335|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
161490635|NCT00293254|583190334|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
161490636|NCT00293254|583190335|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
161490637|NCT00293254|583190334|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
161490638|NCT00293254|583190335|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
161490639|NCT00293254|583190334|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
161490640|NCT00293254|583190335|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
161490641|NCT00293254|583190334|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
161490642|NCT00293254|583190335|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
161490643|NCT00293254|583190334|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
161490644|NCT00293254|583190335|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
161490645|NCT00293254|583190334|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
161490646|NCT00293254|583190335|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
161490647|NCT00293254|583190334|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
161490648|NCT00293254|583190335|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
161490649|NCT00293254|583190334|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
161490650|NCT00293254|583190335|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
161490651|NCT00293254|583190334|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
161490652|NCT00293254|583190335|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
161490653|NCT00293254|583190334|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
161490654|NCT00293254|583190335|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
161490655|NCT00293254|583190334|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
161490656|NCT00293254|583190335|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
161490657|NCT00082355|583190336|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
161490658|NCT00082355|583190336|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
161490659|NCT00082355|583190336|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
161490660|NCT00531050|583190338|FG000|Part 1: Period 1|Adverse Event|0|||
161490661|NCT00531050|583190339|FG001|Part 1: Period 1|Adverse Event|1|||
161490662|NCT00531050|583190340|FG002|Part 1: Period 1|Adverse Event|0|||
161490663|NCT00531050|583190341|FG003|Part 1: Period 1|Adverse Event|0|||
161490664|NCT00531050|583190342|FG004|Part 1: Period 1|Adverse Event|0|||
161671535|NCT01145755|583851325|FG000|Overall Study|Withdrawal by Subject|2|||
161671536|NCT01145755|583851326|FG001|Overall Study|Withdrawal by Subject|2|||
161671537|NCT01145755|583851327|FG002|Overall Study|Withdrawal by Subject|2|||
161671538|NCT01145755|583851325|FG000|Overall Study|Lost to Follow-up|2|||
161671539|NCT01145755|583851326|FG001|Overall Study|Lost to Follow-up|3|||
161671540|NCT01145755|583851327|FG002|Overall Study|Lost to Follow-up|1|||
161671541|NCT01145755|583851325|FG000|Overall Study|Protocol Violation|0|||
161671542|NCT01145755|583851326|FG001|Overall Study|Protocol Violation|3|||
161671543|NCT01145755|583851327|FG002|Overall Study|Protocol Violation|1|||
161671544|NCT01145755|583851325|FG000|Overall Study|Study Closure|14|||
161671545|NCT01145755|583851326|FG001|Overall Study|Study Closure|14|||
161671546|NCT01145755|583851327|FG002|Overall Study|Study Closure|17|||
161671547|NCT01145755|583851325|FG000|Overall Study|Lack of Efficacy|0|||
161671548|NCT01145755|583851326|FG001|Overall Study|Lack of Efficacy|1|||
161490665|NCT00531050|583190343|FG005|Part 1: Period 1|Adverse Event|0|||
161490666|NCT00531050|583190338|FG000|Part 1: Period 1|Protocol Deviation|0|||
161490667|NCT00531050|583190339|FG001|Part 1: Period 1|Protocol Deviation|0|||
161490668|NCT00531050|583190340|FG002|Part 1: Period 1|Protocol Deviation|0|||
161671549|NCT01145755|583851327|FG002|Overall Study|Lack of Efficacy|0|||
161671550|NCT01145755|583851325|FG000|Overall Study|Patient could not swollow medication|0|||
161671551|NCT01145755|583851326|FG001|Overall Study|Patient could not swollow medication|0|||
161671552|NCT01145755|583851327|FG002|Overall Study|Patient could not swollow medication|1|||
161671553|NCT01145755|583851325|FG000|Overall Study|Withdrawal by Subject|0|||
161490669|NCT00531050|583190341|FG003|Part 1: Period 1|Protocol Deviation|1|||
161490670|NCT00531050|583190342|FG004|Part 1: Period 1|Protocol Deviation|0|||
161490671|NCT00531050|583190343|FG005|Part 1: Period 1|Protocol Deviation|0|||
161490672|NCT00531050|583190338|FG000|Part 1: Period 3|Adverse Event|1|||
161490673|NCT00531050|583190339|FG001|Part 1: Period 3|Adverse Event|0|||
161490674|NCT00531050|583190340|FG002|Part 1: Period 3|Adverse Event|0|||
161490675|NCT00531050|583190341|FG003|Part 1: Period 3|Adverse Event|0|||
161490676|NCT00531050|583190342|FG004|Part 1: Period 3|Adverse Event|0|||
161490677|NCT00531050|583190343|FG005|Part 1: Period 3|Adverse Event|0|||
161490678|NCT00531050|583190338|FG000|Part 2: Period 1|Adverse Event|0|||
161490679|NCT00531050|583190339|FG001|Part 2: Period 1|Adverse Event|0|||
161490680|NCT00531050|583190340|FG002|Part 2: Period 1|Adverse Event|0|||
161490681|NCT00531050|583190341|FG003|Part 2: Period 1|Adverse Event|0|||
161490682|NCT00531050|583190342|FG004|Part 2: Period 1|Adverse Event|0|||
161490683|NCT00531050|583190343|FG005|Part 2: Period 1|Adverse Event|1|||
161490684|NCT00531050|583190338|FG000|Part 2: Period 3|Abnormal test procedure|1|||
161490685|NCT00531050|583190339|FG001|Part 2: Period 3|Abnormal test procedure|0|||
161490686|NCT00531050|583190340|FG002|Part 2: Period 3|Abnormal test procedure|0|||
161490687|NCT00531050|583190341|FG003|Part 2: Period 3|Abnormal test procedure|0|||
161490688|NCT00531050|583190342|FG004|Part 2: Period 3|Abnormal test procedure|0|||
161490689|NCT00531050|583190343|FG005|Part 2: Period 3|Abnormal test procedure|1|||
161490690|NCT02233309|583190344|FG000|Overall Study|Physician Decision|5|||
161490691|NCT01506479|583190348|FG000|Overall Study|Lost to Follow-up|1|||
161490692|NCT01506479|583190349|FG001|Overall Study|Lost to Follow-up|2|||
161490693|NCT01506479|583190350|FG002|Overall Study|Lost to Follow-up|2|||
161490694|NCT01506479|583190348|FG000|Overall Study|Withdrawal by Subject|1|||
161490695|NCT01506479|583190349|FG001|Overall Study|Withdrawal by Subject|2|||
161490696|NCT01506479|583190350|FG002|Overall Study|Withdrawal by Subject|1|||
161490697|NCT01506479|583190348|FG000|Overall Study|Missing assessment|1|||
161490698|NCT01506479|583190349|FG001|Overall Study|Missing assessment|0|||
161490699|NCT01506479|583190350|FG002|Overall Study|Missing assessment|0|||
161490700|NCT01506479|583190348|FG000|Overall Study|Adverse Event|0|||
161490701|NCT01506479|583190349|FG001|Overall Study|Adverse Event|1|||
161490702|NCT01506479|583190350|FG002|Overall Study|Adverse Event|0|||
161490703|NCT01314443|583190351|FG000|Overall Study|Withdrawal by Subject|2|||
161490704|NCT01314443|583190352|FG001|Overall Study|Withdrawal by Subject|1|||
161490705|NCT01314443|583190353|FG002|Overall Study|Withdrawal by Subject|1|||
161490706|NCT01314443|583190354|FG003|Overall Study|Withdrawal by Subject|1|||
161490707|NCT01314443|583190351|FG000|Overall Study|Protocol Violation|2|||
161490708|NCT01314443|583190352|FG001|Overall Study|Protocol Violation|2|||
161490709|NCT01314443|583190353|FG002|Overall Study|Protocol Violation|1|||
161490710|NCT01314443|583190354|FG003|Overall Study|Protocol Violation|1|||
161490711|NCT05247866|583190356|FG000|Overall Study|Adverse Event|2|||
161490712|NCT05247866|583190356|FG000|Overall Study|Lack of Efficacy|1|||
161490713|NCT05247866|583190356|FG000|Overall Study|Protocol Violation|1|||
161490714|NCT05247866|583190356|FG000|Overall Study|Withdrawal by Subject|3|||
161490715|NCT04463719|583190361|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
161490716|NCT04463719|583190362|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
161490717|NCT04463719|583190363|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
161490718|NCT02875860|583190364|FG000|Overall Study|Withdrawal by Subject|0|||
161490719|NCT02875860|583190365|FG001|Overall Study|Withdrawal by Subject|1|||
161490720|NCT02746874|583190366|FG000|Overall Study|Withdrawal by Subject|0|||
161490721|NCT02746874|583190367|FG001|Overall Study|Withdrawal by Subject|1|||
161490722|NCT02746874|583190366|FG000|Overall Study|Surgery Date Changed|0|||
161490723|NCT02746874|583190367|FG001|Overall Study|Surgery Date Changed|2|||
161490724|NCT01881776|583190368|FG000|Overall Study|Lost to Follow-up|1|||
161490725|NCT01881776|583190369|FG001|Overall Study|Lost to Follow-up|2|||
161490726|NCT01881776|583190370|FG002|Overall Study|Lost to Follow-up|1|||
161490727|NCT01881776|583190368|FG000|Overall Study|Protocol Violation|0|||
161490728|NCT01881776|583190369|FG001|Overall Study|Protocol Violation|2|||
161583439|NCT01443845|583522708|FG001|Overall Study|Withdrawal by Subject|67|||
161583440|NCT01443845|583522707|FG000|Overall Study|Military Conflict - Site Terminated|20|||
161583441|NCT01443845|583522708|FG001|Overall Study|Military Conflict - Site Terminated|21|||
161583442|NCT01443845|583522707|FG000|Overall Study|Lost to Follow-up|9|||
161583443|NCT01443845|583522708|FG001|Overall Study|Lost to Follow-up|13|||
161583444|NCT01471691|583522714|FG000|Overall Study|Lack of Efficacy|0|||
161583445|NCT01471691|583522715|FG001|Overall Study|Lack of Efficacy|1|||
161490729|NCT01881776|583190370|FG002|Overall Study|Protocol Violation|1|||
161490730|NCT01156311|583190374|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
161490731|NCT01156311|583190375|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
161490732|NCT01156311|583190376|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
161490733|NCT01156311|583190377|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
161490734|NCT01156311|583190374|FG000|2-Month Monotherapy Period|Physician Decision|0|||
161490735|NCT01156311|583190375|FG001|2-Month Monotherapy Period|Physician Decision|1|||
161490736|NCT01156311|583190376|FG002|2-Month Monotherapy Period|Physician Decision|0|||
161603636|NCT05412004|583603301|FG002|Overall Study|Withdrawal by Subject|4|||
161603637|NCT05412004|583603302|FG003|Overall Study|Withdrawal by Subject|14|||
161671554|NCT01145755|583851326|FG001|Overall Study|Withdrawal by Subject|0|||
161671555|NCT01145755|583851327|FG002|Overall Study|Withdrawal by Subject|1|||
161671556|NCT01145755|583851325|FG000|Overall Study|Positive urine ethanol|0|||
161671557|NCT01145755|583851326|FG001|Overall Study|Positive urine ethanol|1|||
161671558|NCT01145755|583851327|FG002|Overall Study|Positive urine ethanol|0|||
161671559|NCT01009554|583851330|FG000|Overall Study|Adverse Event|1|||
161671560|NCT01009554|583851331|FG001|Overall Study|Adverse Event|1|||
161490737|NCT01156311|583190377|FG003|2-Month Monotherapy Period|Physician Decision|0|||
161490738|NCT01156311|583190374|FG000|2-Month Monotherapy Period|Other|1|||
161490739|NCT01156311|583190375|FG001|2-Month Monotherapy Period|Other|0|||
161490740|NCT01156311|583190376|FG002|2-Month Monotherapy Period|Other|0|||
161490741|NCT01156311|583190377|FG003|2-Month Monotherapy Period|Other|0|||
161490742|NCT01156311|583190374|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
161490743|NCT01156311|583190375|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
161490744|NCT01156311|583190376|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
161490745|NCT01156311|583190377|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
161490746|NCT01156311|583190374|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
161490747|NCT01156311|583190375|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
161490748|NCT01156311|583190376|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
161490749|NCT01156311|583190377|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
161490750|NCT01156311|583190374|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
161490751|NCT01156311|583190375|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
161490752|NCT01156311|583190376|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
161490753|NCT01156311|583190377|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
161490754|NCT01156311|583190374|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
161490755|NCT01156311|583190375|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
161490756|NCT01156311|583190376|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
161490757|NCT01156311|583190377|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
161490758|NCT01156311|583190374|FG000|6-month Add-on Therapy Period|Other|0|||
161490759|NCT01156311|583190375|FG001|6-month Add-on Therapy Period|Other|0|||
161490760|NCT01156311|583190376|FG002|6-month Add-on Therapy Period|Other|1|||
161490761|NCT01156311|583190377|FG003|6-month Add-on Therapy Period|Other|2|||
161490762|NCT02393547|583190394|FG000|Overall Study|Adverse Event|2|||
161490763|NCT02393547|583190394|FG000|Overall Study|Withdrawal by Subject|3|||
161490764|NCT02393547|583190394|FG000|Overall Study|Lost to Follow-up|1|||
161490765|NCT05185089|583190400|FG000|First Intervention (4 weeks)|Adverse Event|0|||
161490766|NCT05185089|583190401|FG001|First Intervention (4 weeks)|Adverse Event|0|||
161490767|NCT05185089|583190402|FG002|First Intervention (4 weeks)|Adverse Event|0|||
161671561|NCT01009554|583851330|FG000|Overall Study|Withdrawal by Subject|1|||
161671562|NCT01009554|583851331|FG001|Overall Study|Withdrawal by Subject|3|||
161671563|NCT01009554|583851330|FG000|Overall Study|Noncompliant with Study Product|0|||
161671564|NCT01009554|583851331|FG001|Overall Study|Noncompliant with Study Product|3|||
161671565|NCT01605253|583851332|FG000|Overall Study|Physician Decision|3|||
161671566|NCT01605253|583851333|FG001|Overall Study|Physician Decision|2|||
161671567|NCT01605253|583851332|FG000|Overall Study|Lost to Follow-up|3|||
161671568|NCT01605253|583851333|FG001|Overall Study|Lost to Follow-up|1|||
161671569|NCT02973048|583851334|FG000|Overall Study|Epidural catheter insertion failure|1|||
161671570|NCT02973048|583851335|FG001|Overall Study|Epidural catheter insertion failure|0|||
161671571|NCT02973048|583851334|FG000|Overall Study|Withdrawal by Subject|0|||
161671572|NCT02973048|583851335|FG001|Overall Study|Withdrawal by Subject|3|||
161671573|NCT04427501|583851336|FG000|Overall Study|Death|0|||
161671574|NCT04427501|583851337|FG001|Overall Study|Death|0|||
161671575|NCT04427501|583851338|FG002|Overall Study|Death|0|||
161671576|NCT04427501|583851339|FG003|Overall Study|Death|0|||
161671577|NCT04427501|583851340|FG004|Overall Study|Death|0|||
161671578|NCT04427501|583851341|FG005|Overall Study|Death|15|||
161671579|NCT04427501|583851342|FG006|Overall Study|Death|0|||
161671580|NCT04427501|583851343|FG007|Overall Study|Death|0|||
161671581|NCT04427501|583851344|FG008|Overall Study|Death|0|||
161671582|NCT04427501|583851345|FG009|Overall Study|Death|0|||
161671583|NCT04427501|583851346|FG010|Overall Study|Death|0|||
161817067|NCT00263588|584370919|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
161490768|NCT05185089|583190403|FG003|First Intervention (4 weeks)|Adverse Event|1|||
161490769|NCT05185089|583190400|FG000|Second Intervention (4 weeks)|Death|0|||
161490770|NCT05185089|583190401|FG001|Second Intervention (4 weeks)|Death|1|||
161671584|NCT04427501|583851347|FG011|Overall Study|Death|0|||
161490771|NCT05185089|583190402|FG002|Second Intervention (4 weeks)|Death|0|||
161490772|NCT05185089|583190403|FG003|Second Intervention (4 weeks)|Death|0|||
161490773|NCT05185089|583190400|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
161671585|NCT04427501|583851336|FG000|Overall Study|Lost to Follow-up|5|||
161671586|NCT04427501|583851337|FG001|Overall Study|Lost to Follow-up|1|||
161671587|NCT04427501|583851338|FG002|Overall Study|Lost to Follow-up|2|||
161671588|NCT04427501|583851339|FG003|Overall Study|Lost to Follow-up|0|||
161671589|NCT04427501|583851340|FG004|Overall Study|Lost to Follow-up|2|||
161671590|NCT04427501|583851341|FG005|Overall Study|Lost to Follow-up|11|||
161671591|NCT04427501|583851342|FG006|Overall Study|Lost to Follow-up|10|||
161817068|NCT00263588|584370920|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
161490774|NCT05185089|583190401|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
161490775|NCT05185089|583190402|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
161490776|NCT05185089|583190403|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
161490777|NCT04997161|583190416|FG000|Overall Study|Study terminated by sponsor|3|||
161490778|NCT00752232|583190417|FG000|Overall Study|Protocol Violation|0|||
161490779|NCT00752232|583190418|FG001|Overall Study|Protocol Violation|0|||
161490780|NCT00752232|583190419|FG002|Overall Study|Protocol Violation|0|||
161490781|NCT00752232|583190420|FG003|Overall Study|Protocol Violation|0|||
161490782|NCT00752232|583190421|FG004|Overall Study|Protocol Violation|0|||
161490783|NCT00752232|583190422|FG005|Overall Study|Protocol Violation|1|||
161490784|NCT00752232|583190423|FG006|Overall Study|Protocol Violation|0|||
161490785|NCT00752232|583190417|FG000|Overall Study|Caregiver request|2|||
161490786|NCT00752232|583190418|FG001|Overall Study|Caregiver request|0|||
161490787|NCT00752232|583190419|FG002|Overall Study|Caregiver request|0|||
161490788|NCT00752232|583190420|FG003|Overall Study|Caregiver request|0|||
161490789|NCT00752232|583190421|FG004|Overall Study|Caregiver request|1|||
161490790|NCT00752232|583190422|FG005|Overall Study|Caregiver request|0|||
161490791|NCT00752232|583190423|FG006|Overall Study|Caregiver request|0|||
161490792|NCT00752232|583190417|FG000|Overall Study|Investigator request|0|||
161490793|NCT00752232|583190418|FG001|Overall Study|Investigator request|0|||
161817069|NCT00263588|584370919|FG000|Overall Study|Lost to Follow-up|7|||
161817070|NCT00263588|584370920|FG001|Overall Study|Lost to Follow-up|10|||
161817071|NCT00263588|584370919|FG000|Overall Study|Withdrawal by Subject|3|||
161817072|NCT00263588|584370920|FG001|Overall Study|Withdrawal by Subject|4|||
161817073|NCT00263588|584370919|FG000|Overall Study|Protocol Violation|0|||
161817074|NCT00263588|584370920|FG001|Overall Study|Protocol Violation|1|||
161817075|NCT00263588|584370919|FG000|Overall Study|Investigator decision|7|||
161817076|NCT00263588|584370920|FG001|Overall Study|Investigator decision|15|||
161817077|NCT00263588|584370919|FG000|Overall Study|Sponsor terminated study|0|||
161817078|NCT00263588|584370920|FG001|Overall Study|Sponsor terminated study|1|||
161817079|NCT00463684|584370932|FG000|Overall Study|Withdrawal by Subject|1|||
161817080|NCT00463684|584370932|FG000|Overall Study|Lost to Follow-up|3|||
161817081|NCT01906372|584370933|FG000|Overall Study|Withdrawal by Subject|2|||
161817082|NCT03629054|584370934|FG000|Period 2 (4 Days)|Not treated|0|||
161817083|NCT03629054|584370935|FG001|Period 2 (4 Days)|Not treated|1|||
161817084|NCT02462837|584370936|FG000|Overall Study|pt developed hives|1|||
161923106|NCT03369223|584764932|FG011|Overall Study|Disease progression|1|||
161923107|NCT03369223|584764933|FG012|Overall Study|Disease progression|1|||
161490794|NCT00752232|583190419|FG002|Overall Study|Investigator request|0|||
161923108|NCT03369223|584764934|FG013|Overall Study|Disease progression|25|||
161923109|NCT03369223|584764935|FG014|Overall Study|Disease progression|22|||
161923110|NCT03369223|584764936|FG015|Overall Study|Disease progression|2|||
161923111|NCT03369223|584764937|FG016|Overall Study|Disease progression|10|||
161923112|NCT03369223|584764938|FG017|Overall Study|Disease progression|1|||
161923113|NCT03369223|584764939|FG018|Overall Study|Disease progression|18|||
161923114|NCT03369223|584764940|FG019|Overall Study|Disease progression|28|||
161923115|NCT03369223|584764921|FG000|Overall Study|Study drug toxicity|0|||
161923116|NCT03369223|584764922|FG001|Overall Study|Study drug toxicity|1|||
161923117|NCT03369223|584764923|FG002|Overall Study|Study drug toxicity|4|||
161923118|NCT03369223|584764924|FG003|Overall Study|Study drug toxicity|0|||
161923119|NCT03369223|584764925|FG004|Overall Study|Study drug toxicity|1|||
161923120|NCT03369223|584764926|FG005|Overall Study|Study drug toxicity|2|||
161923121|NCT03369223|584764927|FG006|Overall Study|Study drug toxicity|4|||
161923122|NCT03369223|584764928|FG007|Overall Study|Study drug toxicity|2|||
161923123|NCT03369223|584764929|FG008|Overall Study|Study drug toxicity|2|||
161923124|NCT03369223|584764930|FG009|Overall Study|Study drug toxicity|0|||
161923125|NCT03369223|584764931|FG010|Overall Study|Study drug toxicity|6|||
161923126|NCT03369223|584764932|FG011|Overall Study|Study drug toxicity|1|||
161490795|NCT00752232|583190420|FG003|Overall Study|Investigator request|0|||
161490796|NCT00752232|583190421|FG004|Overall Study|Investigator request|1|||
161817085|NCT02462837|584370937|FG001|Overall Study|pt developed hives|0|||
161817086|NCT02462837|584370936|FG000|Overall Study|Withdrawal by Subject|1|||
161817087|NCT02462837|584370937|FG001|Overall Study|Withdrawal by Subject|0|||
161923127|NCT03369223|584764933|FG012|Overall Study|Study drug toxicity|2|||
161923128|NCT03369223|584764934|FG013|Overall Study|Study drug toxicity|19|||
161923129|NCT03369223|584764935|FG014|Overall Study|Study drug toxicity|19|||
161490797|NCT00752232|583190422|FG005|Overall Study|Investigator request|0|||
161490798|NCT00752232|583190423|FG006|Overall Study|Investigator request|0|||
161817088|NCT00924638|584370941|FG000|Overall Study|Death|3|||
161817089|NCT00924638|584370942|FG001|Overall Study|Death|2|||
161490799|NCT00752232|583190417|FG000|Overall Study|Subject request|0|||
161490800|NCT00752232|583190418|FG001|Overall Study|Subject request|0|||
161817090|NCT00924638|584370941|FG000|Overall Study|Lost to Follow-up|1|||
161817091|NCT00924638|584370942|FG001|Overall Study|Lost to Follow-up|1|||
161923130|NCT03369223|584764936|FG015|Overall Study|Study drug toxicity|0|||
161923131|NCT03369223|584764937|FG016|Overall Study|Study drug toxicity|18|||
161923132|NCT03369223|584764938|FG017|Overall Study|Study drug toxicity|3|||
161923133|NCT03369223|584764939|FG018|Overall Study|Study drug toxicity|11|||
161490801|NCT00752232|583190419|FG002|Overall Study|Subject request|1|||
161490802|NCT00752232|583190420|FG003|Overall Study|Subject request|0|||
161490803|NCT00752232|583190421|FG004|Overall Study|Subject request|0|||
161490804|NCT00752232|583190422|FG005|Overall Study|Subject request|0|||
161490805|NCT00752232|583190423|FG006|Overall Study|Subject request|0|||
161490806|NCT00752232|583190417|FG000|Overall Study|Group home admission|0|||
161490807|NCT00752232|583190418|FG001|Overall Study|Group home admission|0|||
161490808|NCT00752232|583190419|FG002|Overall Study|Group home admission|0|||
161490809|NCT00752232|583190420|FG003|Overall Study|Group home admission|1|||
161490810|NCT00752232|583190421|FG004|Overall Study|Group home admission|0|||
161490811|NCT00752232|583190422|FG005|Overall Study|Group home admission|0|||
161490812|NCT00752232|583190423|FG006|Overall Study|Group home admission|0|||
161490813|NCT00752232|583190417|FG000|Overall Study|Caregiver could not attend the subject|0|||
161490814|NCT00752232|583190418|FG001|Overall Study|Caregiver could not attend the subject|0|||
161490815|NCT00752232|583190419|FG002|Overall Study|Caregiver could not attend the subject|0|||
161490816|NCT00752232|583190420|FG003|Overall Study|Caregiver could not attend the subject|0|||
161490817|NCT00752232|583190421|FG004|Overall Study|Caregiver could not attend the subject|1|||
161490818|NCT00752232|583190422|FG005|Overall Study|Caregiver could not attend the subject|0|||
161490819|NCT00752232|583190423|FG006|Overall Study|Caregiver could not attend the subject|0|||
161490820|NCT04502589|583190424|FG000|Overall Study|Physician Decision|1|||
161490821|NCT04502589|583190425|FG001|Overall Study|Physician Decision|0|||
161490822|NCT02730455|583190427|FG000|Overall Study|Death|5|||
161490823|NCT02730455|583190428|FG001|Overall Study|Death|6|||
161490824|NCT02730455|583190429|FG002|Overall Study|Death|4|||
161490825|NCT02730455|583190427|FG000|Overall Study|Consent withdrawn|2|||
161490826|NCT02730455|583190428|FG001|Overall Study|Consent withdrawn|4|||
161490827|NCT02730455|583190429|FG002|Overall Study|Consent withdrawn|1|||
161490828|NCT02730455|583190427|FG000|Overall Study|Lost to Follow-up|3|||
161490829|NCT02730455|583190428|FG001|Overall Study|Lost to Follow-up|1|||
161490830|NCT02730455|583190429|FG002|Overall Study|Lost to Follow-up|4|||
161490831|NCT02730455|583190427|FG000|Overall Study|Other|1|||
161490832|NCT02730455|583190428|FG001|Overall Study|Other|1|||
161490833|NCT02730455|583190429|FG002|Overall Study|Other|2|||
161490834|NCT02730455|583190427|FG000|Overall Study|Other|2|||
161490835|NCT02730455|583190428|FG001|Overall Study|Other|2|||
161490836|NCT02730455|583190429|FG002|Overall Study|Other|0|||
161490837|NCT05582889|583190432|FG000|Overall Study|Health event|3|||
161490838|NCT05582889|583190433|FG001|Overall Study|Health event|2|||
161490839|NCT05582889|583190432|FG000|Overall Study|Lost to Follow-up|2|||
161490840|NCT05582889|583190433|FG001|Overall Study|Lost to Follow-up|4|||
161490841|NCT00001723|583190434|FG000|Overall Study|Lack of Efficacy|6|||
161490842|NCT00001723|583190435|FG001|Overall Study|Lack of Efficacy|7|||
161490843|NCT00001723|583190434|FG000|Overall Study|Lack of family interest|4|||
161490844|NCT00001723|583190435|FG001|Overall Study|Lack of family interest|5|||
161490845|NCT00001723|583190434|FG000|Overall Study|Lost to Follow-up|2|||
161490846|NCT00001723|583190435|FG001|Overall Study|Lost to Follow-up|2|||
161490847|NCT00001723|583190434|FG000|Overall Study|medication intolerance|1|||
161490848|NCT00001723|583190435|FG001|Overall Study|medication intolerance|2|||
161490849|NCT04551092|583190436|FG000|Overall Study|Lost to Follow-up|7|||
161490850|NCT04551092|583190436|FG000|Overall Study|Withdrawal by Subject|4|||
161490851|NCT01324999|583190437|FG000|Overall Study|Adverse Event|3|||
161490852|NCT01324999|583190437|FG000|Overall Study|Withdrawal by Subject|2|||
161490853|NCT01714635|583190443|FG000|Overall Study|Discontinued|1|||
161490854|NCT01714635|583190444|FG001|Overall Study|Discontinued|0|||
161490855|NCT01714635|583190445|FG002|Overall Study|Discontinued|2|||
161490856|NCT01714635|583190443|FG000|Overall Study|Missed 6-month exam|1|||
161490857|NCT01714635|583190444|FG001|Overall Study|Missed 6-month exam|0|||
161490858|NCT01714635|583190445|FG002|Overall Study|Missed 6-month exam|0|||
161490859|NCT02848651|583190447|FG000|Overall Study|Death|85|||
161490860|NCT02848651|583190447|FG000|Overall Study|Lost to Follow-up|1|||
161490861|NCT02848651|583190447|FG000|Overall Study|Non-Compliance|1|||
161490862|NCT02848651|583190447|FG000|Overall Study|Symptomatic Deterioration|1|||
161490863|NCT02848651|583190447|FG000|Overall Study|Physician Decision|4|||
161490864|NCT02848651|583190447|FG000|Overall Study|Withdrawal by Subject|14|||
161490865|NCT00396591|583190452|FG000|Overall Study|Disease Progression|13|||
161490866|NCT00396591|583190452|FG000|Overall Study|Adverse Event|2|||
161490867|NCT00396591|583190452|FG000|Overall Study|Participant request|1|||
161490868|NCT01535053|583190455|FG000|Overall Study|Ineligible|1|||
161490869|NCT01535053|583190456|FG001|Overall Study|Ineligible|2|||
161490870|NCT00512707|583190457|FG000|Overall Study|Lost to Follow-up|5|||
161490871|NCT00512707|583190458|FG001|Overall Study|Lost to Follow-up|11|||
161490872|NCT00512707|583190457|FG000|Overall Study|Developed skin irritation|2|||
161490873|NCT00512707|583190458|FG001|Overall Study|Developed skin irritation|1|||
161490874|NCT00512707|583190457|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
161490875|NCT00512707|583190458|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
161490876|NCT00512707|583190457|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
161490877|NCT00512707|583190458|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
161490878|NCT03653637|583192892|FG000|Overall Study|Death|1|||
161490879|NCT03653637|583192893|FG001|Overall Study|Death|3|||
161490880|NCT03653637|583192892|FG000|Overall Study|Lost to Follow-up|29|||
161490881|NCT03653637|583192893|FG001|Overall Study|Lost to Follow-up|30|||
161490882|NCT03653637|583192892|FG000|Overall Study|Physician Decision|1|||
161490883|NCT03653637|583192893|FG001|Overall Study|Physician Decision|1|||
161490884|NCT03653637|583192892|FG000|Overall Study|Withdrawal by Subject|7|||
161490885|NCT03653637|583192893|FG001|Overall Study|Withdrawal by Subject|4|||
161490886|NCT01702454|583192896|FG000|Overall Study|Consent withdrawal|0|||
161490887|NCT01702454|583192897|FG001|Overall Study|Consent withdrawal|1|||
161490888|NCT01702454|583192896|FG000|Overall Study|Migrated/moved from study area|0|||
161490889|NCT01702454|583192897|FG001|Overall Study|Migrated/moved from study area|1|||
161490890|NCT01702454|583192896|FG000|Overall Study|Lost to Follow-up|3|||
161490891|NCT01702454|583192897|FG001|Overall Study|Lost to Follow-up|6|||
161490892|NCT03510884|583192898|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
161490893|NCT03510884|583192899|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
161490894|NCT03510884|583192900|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
161490895|NCT03510884|583192901|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
161490896|NCT03510884|583192898|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
161490897|NCT03510884|583192899|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
161490898|NCT03510884|583192900|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
161490899|NCT03510884|583192901|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
161490900|NCT03510884|583192898|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
161490901|NCT03510884|583192899|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
161490902|NCT03510884|583192900|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
161490903|NCT03510884|583192901|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
161490904|NCT03510884|583192898|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
161490905|NCT03510884|583192899|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
161490906|NCT03510884|583192900|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
161490907|NCT03510884|583192901|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
161583446|NCT01808339|583522716|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583447|NCT01808339|583522717|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583448|NCT01808339|583522718|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583449|NCT01808339|583522719|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161583450|NCT01808339|583522720|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
161583451|NCT01808339|583522721|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161583452|NCT01808339|583522716|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161583453|NCT01808339|583522717|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161583454|NCT01808339|583522718|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161583455|NCT01808339|583522719|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161583456|NCT01808339|583522720|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161583457|NCT01808339|583522721|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161583458|NCT01808339|583522716|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583459|NCT01808339|583522717|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583460|NCT01808339|583522718|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161583461|NCT01808339|583522719|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583462|NCT01808339|583522720|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583463|NCT01808339|583522721|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161583464|NCT02461628|583522722|FG000|Overall Study|Refused to complete survey|4|||
161583465|NCT02461628|583522723|FG001|Overall Study|Refused to complete survey|7|||
161583466|NCT02462759|583522726|FG000|Part 1: Double Blind|Death|1|||
161583467|NCT02462759|583522727|FG001|Part 1: Double Blind|Death|0|||
161583468|NCT02462759|583522728|FG002|Part 1: Double Blind|Death|0|||
161583469|NCT00243503|583522729|FG000|Overall Study|Adverse Event|11|||
161583470|NCT00243503|583522729|FG000|Overall Study|Withdrawal by Subject|1|||
161583471|NCT00243503|583522729|FG000|Overall Study|Lack of Efficacy|44|||
161583472|NCT00243503|583522729|FG000|Overall Study|Death|1|||
161583473|NCT00243503|583522729|FG000|Overall Study|Other|1|||
161583474|NCT00520546|583522733|FG000|Overall Study|Withdrawal by Subject|1|||
161583475|NCT00520546|583522733|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
161583476|NCT03988023|583522735|FG000|Overall Study|Non-compliance|3|||
161583477|NCT03988023|583522736|FG001|Overall Study|Non-compliance|0|||
161490908|NCT03510884|583192898|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
161490909|NCT03510884|583192899|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
161490910|NCT03510884|583192900|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
161490911|NCT03510884|583192901|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
161490912|NCT03510884|583192898|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
161490913|NCT03510884|583192899|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
161490914|NCT03510884|583192900|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
161490915|NCT03510884|583192901|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
161490916|NCT03510884|583192898|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
161490917|NCT03510884|583192899|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
161490918|NCT03510884|583192900|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
161490919|NCT03510884|583192901|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
161490920|NCT03510884|583192898|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
161490921|NCT03510884|583192899|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
161490922|NCT03510884|583192900|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
161490923|NCT03510884|583192901|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
161490924|NCT03510884|583192898|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
161490925|NCT03510884|583192899|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
161583478|NCT03988023|583522735|FG000|Overall Study|Withdrawal by Subject|39|||
161583479|NCT03988023|583522736|FG001|Overall Study|Withdrawal by Subject|37|||
161583480|NCT03988023|583522735|FG000|Overall Study|Adverse Event|0|||
161490926|NCT03510884|583192900|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
161490927|NCT03510884|583192901|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
161490928|NCT03510884|583192898|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
161490929|NCT03510884|583192899|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
161490930|NCT03510884|583192900|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
161490931|NCT03510884|583192901|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
161490932|NCT00157950|583192902|FG000|Overall Study|Death|1|||
161490933|NCT00157950|583192903|FG001|Overall Study|Death|0|||
161490934|NCT02892760|583192907|FG000|Overall Study|Withdrawal by Subject|3|||
161490935|NCT01500629|583192908|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
161490936|NCT01500629|583192909|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
161490937|NCT00475176|583192912|FG000|Overall Study|Adverse Event|2|||
161490938|NCT00475176|583192912|FG000|Overall Study|Withdrawal by Subject|1|||
161490939|NCT00475176|583192912|FG000|Overall Study|Protocol Violation|1|||
161490940|NCT01484873|583192913|FG000|Overall Study|Withdrawal by Subject|2|||
161490941|NCT01549392|583192914|FG000|Overall Study|Withdrawal by Subject|1|||
161490942|NCT01549392|583192915|FG001|Overall Study|Withdrawal by Subject|0|||
161490943|NCT00227903|583192916|FG000|Overall Study|Withdrawal by Subject|2|||
161490944|NCT00227903|583192917|FG001|Overall Study|Withdrawal by Subject|5|||
161490945|NCT00227903|583192916|FG000|Overall Study|Subject moved out of area|1|||
161490946|NCT00227903|583192917|FG001|Overall Study|Subject moved out of area|2|||
161490947|NCT00227903|583192916|FG000|Overall Study|Lost to Follow-up|1|||
161490948|NCT00227903|583192917|FG001|Overall Study|Lost to Follow-up|3|||
161490949|NCT00227903|583192916|FG000|Overall Study|Miscarriage|1|||
161490950|NCT00227903|583192917|FG001|Overall Study|Miscarriage|0|||
161490951|NCT01475331|583192918|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
161490952|NCT01475331|583192919|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
161490953|NCT01475331|583192918|FG000|Overall Study|excessive main duct communication|1|||
161490954|NCT01475331|583192919|FG001|Overall Study|excessive main duct communication|1|||
161490955|NCT01475331|583192918|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
161490956|NCT01475331|583192919|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
161490957|NCT01475331|583192918|FG000|Overall Study|Sign of malignancy during the procedure|2|||
161490958|NCT01475331|583192919|FG001|Overall Study|Sign of malignancy during the procedure|0|||
161490959|NCT01475331|583192918|FG000|Overall Study|cyst found to be prohibitively small|0|||
161490960|NCT01475331|583192919|FG001|Overall Study|cyst found to be prohibitively small|1|||
161490961|NCT00462761|583192920|FG000|Overall Study|Adverse Event|6|||
161490962|NCT00462761|583192920|FG000|Overall Study|Withdrawal by Subject|9|||
161490963|NCT00462761|583192920|FG000|Overall Study|Physician Decision|5|||
161490964|NCT00462761|583192920|FG000|Overall Study|Disease progression|43|||
161490965|NCT00462761|583192920|FG000|Overall Study|Death|12|||
161490966|NCT00462761|583192920|FG000|Overall Study|Other|1|||
161490967|NCT02877082|583192921|FG000|Overall Study|Trial was closed early|5|||
161490968|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
161490969|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
161490970|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
161490971|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
161583481|NCT03988023|583522736|FG001|Overall Study|Adverse Event|2|||
161583482|NCT03988023|583522735|FG000|Overall Study|Physician Decision|0|||
161490972|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
161490973|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
161490974|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
161490975|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
161490976|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
161490977|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
161490978|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
161583483|NCT03988023|583522736|FG001|Overall Study|Physician Decision|1|||
161923134|NCT03369223|584764940|FG019|Overall Study|Study drug toxicity|7|||
161923135|NCT03369223|584764921|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161923136|NCT03369223|584764922|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161923137|NCT03369223|584764923|FG002|Overall Study|Participant request to discontinue study treatment|0|||
161923138|NCT03369223|584764924|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161490979|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
161490980|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
161490981|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
161490982|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
161490983|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
161490984|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
161490985|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
161490986|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
161490987|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
161490988|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
161490989|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
161490990|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
161490991|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
161490992|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
161490993|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
161490994|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
161490995|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
161490996|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
161490997|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
161490998|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
161490999|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
161491000|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
161491001|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
161491002|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
161491003|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
161491004|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
161491005|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
161491006|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
161491007|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
161491008|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
161491009|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
161491010|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
161491011|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
161491012|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
161491013|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
161491014|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
161491015|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
161491016|NCT03720470|583192926|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
161491017|NCT03720470|583192927|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
161491018|NCT03720470|583192928|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
161491019|NCT03720470|583192929|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
161491020|NCT03720470|583192930|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
161491021|NCT03720470|583192931|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
161491022|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
161491023|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
161491024|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
161491025|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
161491026|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
161491027|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
161491028|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
161491029|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
161491030|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
161491031|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
161491032|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
161491033|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
161491034|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
161491035|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
161491036|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
161491037|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
161491038|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
161491039|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
161491040|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
161491041|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
161491042|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
161491043|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
161491044|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
161491045|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
161491046|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
161491047|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
161491048|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
161491049|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
161491050|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
161491051|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
161491052|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
161491053|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
161491054|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
161491055|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
161491056|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
161491057|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
161491058|NCT03720470|583192926|FG000|Treatment Period: Final 4 Weeks|Other|0|||
161491059|NCT03720470|583192927|FG001|Treatment Period: Final 4 Weeks|Other|1|||
161491060|NCT03720470|583192928|FG002|Treatment Period: Final 4 Weeks|Other|0|||
161491061|NCT03720470|583192929|FG003|Treatment Period: Final 4 Weeks|Other|2|||
161491062|NCT03720470|583192930|FG004|Treatment Period: Final 4 Weeks|Other|1|||
161491063|NCT03720470|583192931|FG005|Treatment Period: Final 4 Weeks|Other|0|||
161491064|NCT00460031|583192932|FG000|Overall Study|Adverse Event|5|||
161491065|NCT00460031|583192932|FG000|Overall Study|Withdrawal by Subject|5|||
161491066|NCT00460031|583192932|FG000|Overall Study|Death|1|||
161491067|NCT01988103|583192937|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
161491068|NCT01988103|583192938|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
161491069|NCT01988103|583192939|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
161491070|NCT01988103|583192940|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
161491071|NCT01988103|583192941|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
161491072|NCT01988103|583192937|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
161491073|NCT01988103|583192938|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
161491074|NCT01988103|583192939|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
161491075|NCT01988103|583192940|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
161491076|NCT01988103|583192941|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
161491077|NCT01988103|583192937|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
161491078|NCT01988103|583192938|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
161491079|NCT01988103|583192939|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
161491080|NCT01988103|583192940|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161491081|NCT01988103|583192941|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161491082|NCT01988103|583192937|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
161491083|NCT01988103|583192938|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
161491084|NCT01988103|583192939|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
161491085|NCT01988103|583192940|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
161491086|NCT01988103|583192941|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
161491087|NCT01988103|583192937|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
161491088|NCT01988103|583192938|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
161491089|NCT01988103|583192939|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
161491090|NCT01988103|583192940|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
161491091|NCT01988103|583192941|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
161491092|NCT01988103|583192937|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
161491093|NCT01988103|583192938|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
161491094|NCT01988103|583192939|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
161491095|NCT01988103|583192940|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
161583484|NCT03988023|583522735|FG000|Overall Study|Lost to Follow-up|5|||
161817092|NCT00924638|584370941|FG000|Overall Study|Withdrawal by Subject|5|||
161817093|NCT00924638|584370942|FG001|Overall Study|Withdrawal by Subject|7|||
161817094|NCT00924638|584370941|FG000|Overall Study|Physician Decision|3|||
161817095|NCT00924638|584370942|FG001|Overall Study|Physician Decision|3|||
161817096|NCT01316055|584370943|FG000|Overall Study|Lost to Follow-up|1|||
161817097|NCT01316055|584370944|FG001|Overall Study|Lost to Follow-up|0|||
161817098|NCT01316055|584370945|FG002|Overall Study|Lost to Follow-up|0|||
161817099|NCT00989950|584370947|FG000|Randomized Phase|Protocol Violation|1|||
161817100|NCT00989950|584370948|FG001|Randomized Phase|Protocol Violation|0|||
161817101|NCT00989950|584370949|FG002|Randomized Phase|Protocol Violation|0|||
161817102|NCT00989950|584370950|FG003|Randomized Phase|Protocol Violation|0|||
161817103|NCT00989950|584370947|FG000|Randomized Phase|Adverse Event|0|||
161817104|NCT00989950|584370948|FG001|Randomized Phase|Adverse Event|1|||
161817105|NCT00989950|584370949|FG002|Randomized Phase|Adverse Event|0|||
161817106|NCT00989950|584370950|FG003|Randomized Phase|Adverse Event|0|||
161817107|NCT02845336|584370954|FG000|Overall Study|Lost to Follow-up|3|||
161817108|NCT02845336|584370955|FG001|Overall Study|Lost to Follow-up|1|||
161817109|NCT02845336|584370954|FG000|Overall Study|Inability to get medication|2|||
161817110|NCT02845336|584370955|FG001|Overall Study|Inability to get medication|0|||
161817111|NCT03488108|584370956|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161817112|NCT03488108|584370957|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161817113|NCT03488108|584370956|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
161817114|NCT03488108|584370957|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
161817115|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Refused|1|||
161817116|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Refused|3|||
161817117|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Medical|0|||
161817118|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Medical|1|||
161817119|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
161817120|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
161817121|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
161817122|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
161817123|NCT02054715|584370959|FG000|Baseline/Follow-up 1|No Reason|0|||
161817124|NCT02054715|584370960|FG001|Baseline/Follow-up 1|No Reason|1|||
161817125|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
161817126|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
161817127|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Ineligible|3|||
161817128|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Ineligible|0|||
161817129|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Hospitalization|1|||
161817130|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Hospitalization|0|||
161817131|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Changed Mind|1|||
161817132|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Changed Mind|0|||
161817133|NCT02054715|584370959|FG000|Follow-up 2|Lost to Followup|3|||
161817134|NCT02054715|584370960|FG001|Follow-up 2|Lost to Followup|1|||
161817135|NCT02054715|584370959|FG000|Follow-up 2|Refused|3|||
161817136|NCT02054715|584370960|FG001|Follow-up 2|Refused|2|||
161817137|NCT02054715|584370959|FG000|Follow-up 2|Followup Not Completed|3|||
161817138|NCT02054715|584370960|FG001|Follow-up 2|Followup Not Completed|4|||
161817139|NCT02054715|584370959|FG000|Follow-up 2|Ineligible|4|||
161817140|NCT02054715|584370960|FG001|Follow-up 2|Ineligible|5|||
161817141|NCT02054715|584370959|FG000|Follow-up 2|Death|3|||
161817142|NCT02054715|584370960|FG001|Follow-up 2|Death|3|||
161817143|NCT02054715|584370959|FG000|Follow-up 2|Hospitalization|0|||
161817144|NCT02054715|584370960|FG001|Follow-up 2|Hospitalization|2|||
161817145|NCT02054715|584370959|FG000|Follow-up 2|Changed MD/Facility|0|||
161817146|NCT02054715|584370960|FG001|Follow-up 2|Changed MD/Facility|1|||
161817147|NCT02054715|584370959|FG000|Follow-up 2|Changed Mind|0|||
161817148|NCT02054715|584370960|FG001|Follow-up 2|Changed Mind|1|||
161817149|NCT02054715|584370959|FG000|Follow-up 2|No Reason|2|||
161817150|NCT02054715|584370960|FG001|Follow-up 2|No Reason|0|||
161491096|NCT01988103|583192941|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
161817151|NCT02054715|584370959|FG000|Follow-up 2|Treatment Change or Delay|1|||
161817152|NCT02054715|584370960|FG001|Follow-up 2|Treatment Change or Delay|0|||
161817153|NCT00674128|584370961|FG000|Overall Study|Withdrawal by Subject|25|||
161817154|NCT00674128|584370962|FG001|Overall Study|Withdrawal by Subject|23|||
161817155|NCT01825798|584370965|FG000|Overall Study|Adverse Event|1|||
161817156|NCT01825798|584370966|FG001|Overall Study|Adverse Event|5|||
161817157|NCT01825798|584370965|FG000|Overall Study|Lost to Follow-up|1|||
161583485|NCT03988023|583522736|FG001|Overall Study|Lost to Follow-up|8|||
161817158|NCT01825798|584370966|FG001|Overall Study|Lost to Follow-up|0|||
161817159|NCT02471807|584370976|FG000|Overall Study|Death|14|||
161817160|NCT02471807|584370976|FG000|Overall Study|Withdrawal by Subject|2|||
161817161|NCT02471807|584370976|FG000|Overall Study|Explant|5|||
161817162|NCT02471807|584370976|FG000|Overall Study|Lost to Follow-up|1|||
161817163|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
161817164|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
161817165|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
161817166|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161817167|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161817168|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161817169|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
161817170|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817171|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817172|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817173|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817174|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817175|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
161817176|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
161817177|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817178|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817179|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817180|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817181|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
161817182|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817183|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
161817184|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817185|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817186|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817187|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817188|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
161817189|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817190|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817191|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817192|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161491097|NCT01988103|583192937|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
161491098|NCT01988103|583192938|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
161491099|NCT01988103|583192939|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
161491100|NCT01988103|583192940|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
161491101|NCT01988103|583192941|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
161491102|NCT01946425|583192945|FG000|Overall Study|Protocol Violation|1|||
161491103|NCT01946425|583192946|FG001|Overall Study|Protocol Violation|0|||
161491104|NCT01946425|583192945|FG000|Overall Study|Withdrawal by Subject|1|||
161491105|NCT01946425|583192946|FG001|Overall Study|Withdrawal by Subject|0|||
161671592|NCT04427501|583851343|FG007|Overall Study|Lost to Follow-up|10|||
161671593|NCT04427501|583851344|FG008|Overall Study|Lost to Follow-up|2|||
161671594|NCT04427501|583851345|FG009|Overall Study|Lost to Follow-up|5|||
161671595|NCT04427501|583851346|FG010|Overall Study|Lost to Follow-up|2|||
161671596|NCT04427501|583851347|FG011|Overall Study|Lost to Follow-up|0|||
161671597|NCT04427501|583851336|FG000|Overall Study|Physician Decision|0|||
161671598|NCT04427501|583851337|FG001|Overall Study|Physician Decision|3|||
161671599|NCT04427501|583851338|FG002|Overall Study|Physician Decision|0|||
161491108|NCT05682326|583192953|FG000|Overall Study|Withdrawal by Subject|1|||
161491109|NCT05682326|583192954|FG001|Overall Study|Withdrawal by Subject|0|||
161491110|NCT01402544|583192955|FG000|Overall Study|Withdrawal by Subject|6|||
161491111|NCT01113801|583192956|FG000|Overall Study|Adverse Event|4|||
161491112|NCT01113801|583192957|FG001|Overall Study|Adverse Event|0|||
161491113|NCT01113801|583192958|FG002|Overall Study|Adverse Event|2|||
161491114|NCT01113801|583192959|FG003|Overall Study|Adverse Event|6|||
161491115|NCT01113801|583192956|FG000|Overall Study|Death|4|||
161491116|NCT01113801|583192957|FG001|Overall Study|Death|5|||
161491117|NCT01113801|583192958|FG002|Overall Study|Death|3|||
161491118|NCT01113801|583192959|FG003|Overall Study|Death|4|||
161491119|NCT01113801|583192956|FG000|Overall Study|Protocol Violation|0|||
161491120|NCT01113801|583192957|FG001|Overall Study|Protocol Violation|1|||
161491121|NCT01113801|583192958|FG002|Overall Study|Protocol Violation|0|||
161491122|NCT01113801|583192959|FG003|Overall Study|Protocol Violation|0|||
161491123|NCT01113801|583192956|FG000|Overall Study|Withdrawal by Subject|9|||
161671600|NCT04427501|583851339|FG003|Overall Study|Physician Decision|0|||
161671601|NCT04427501|583851340|FG004|Overall Study|Physician Decision|0|||
161671602|NCT04427501|583851341|FG005|Overall Study|Physician Decision|0|||
161671603|NCT04427501|583851342|FG006|Overall Study|Physician Decision|2|||
161671604|NCT04427501|583851343|FG007|Overall Study|Physician Decision|0|||
161671605|NCT04427501|583851344|FG008|Overall Study|Physician Decision|0|||
161817193|NCT01559363|584370977|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817194|NCT01559363|584370978|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817195|NCT01559363|584370979|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817196|NCT01559363|584370980|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
161817197|NCT01559363|584370981|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
161817198|NCT01559363|584370982|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817199|NCT01559363|584370977|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161491124|NCT01113801|583192957|FG001|Overall Study|Withdrawal by Subject|7|||
161491125|NCT01113801|583192958|FG002|Overall Study|Withdrawal by Subject|7|||
161491126|NCT01113801|583192959|FG003|Overall Study|Withdrawal by Subject|8|||
161491127|NCT01113801|583192956|FG000|Overall Study|Physician Decision|2|||
161491128|NCT01113801|583192957|FG001|Overall Study|Physician Decision|2|||
161491129|NCT01113801|583192958|FG002|Overall Study|Physician Decision|3|||
161491130|NCT01113801|583192959|FG003|Overall Study|Physician Decision|3|||
161491131|NCT01113801|583192956|FG000|Overall Study|Sponsor Decision|15|||
161491132|NCT01113801|583192957|FG001|Overall Study|Sponsor Decision|21|||
161491133|NCT01113801|583192958|FG002|Overall Study|Sponsor Decision|20|||
161491134|NCT01113801|583192959|FG003|Overall Study|Sponsor Decision|15|||
161491135|NCT01113801|583192956|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
161491136|NCT01113801|583192957|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
161491137|NCT01113801|583192958|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
161583486|NCT03988023|583522735|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
161583487|NCT03988023|583522736|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
161583488|NCT03988023|583522735|FG000|Overall Study|Lack of Efficacy|3|||
161583489|NCT03988023|583522736|FG001|Overall Study|Lack of Efficacy|1|||
161583490|NCT03988023|583522735|FG000|Overall Study|COVID-19 pandemic|225|||
161583491|NCT03988023|583522736|FG001|Overall Study|COVID-19 pandemic|227|||
161583492|NCT02101281|583522737|FG000|Overall Study|Adverse Event|0|||
161583493|NCT02101281|583522738|FG001|Overall Study|Adverse Event|1|||
161583494|NCT03733119|583522739|FG000|Overall Study|Physician Decision|2|||
161583495|NCT03733119|583522740|FG001|Overall Study|Physician Decision|1|||
161583496|NCT03733119|583522739|FG000|Overall Study|ineligible to treat per protocol|0|||
161583497|NCT03733119|583522740|FG001|Overall Study|ineligible to treat per protocol|1|||
161583498|NCT02554786|583522743|FG000|Overall Study|Subject/guardian decision|29|||
161583499|NCT02554786|583522744|FG001|Overall Study|Subject/guardian decision|17|||
161583500|NCT02554786|583522745|FG002|Overall Study|Subject/guardian decision|18|||
161583501|NCT02554786|583522746|FG003|Overall Study|Subject/guardian decision|30|||
161583502|NCT02554786|583522747|FG004|Overall Study|Subject/guardian decision|20|||
161583503|NCT02554786|583522743|FG000|Overall Study|Lost to Follow-up|4|||
161583504|NCT02554786|583522744|FG001|Overall Study|Lost to Follow-up|3|||
161583505|NCT02554786|583522745|FG002|Overall Study|Lost to Follow-up|4|||
161583506|NCT02554786|583522746|FG003|Overall Study|Lost to Follow-up|2|||
161583507|NCT02554786|583522747|FG004|Overall Study|Lost to Follow-up|2|||
161583508|NCT02554786|583522743|FG000|Overall Study|Protocol deviation|1|||
161583509|NCT02554786|583522744|FG001|Overall Study|Protocol deviation|3|||
161583510|NCT02554786|583522745|FG002|Overall Study|Protocol deviation|3|||
161583511|NCT02554786|583522746|FG003|Overall Study|Protocol deviation|4|||
161583512|NCT02554786|583522747|FG004|Overall Study|Protocol deviation|2|||
161583513|NCT02554786|583522743|FG000|Overall Study|Technical problems|1|||
161583514|NCT02554786|583522744|FG001|Overall Study|Technical problems|1|||
161583515|NCT02554786|583522745|FG002|Overall Study|Technical problems|0|||
161583516|NCT02554786|583522746|FG003|Overall Study|Technical problems|2|||
161583517|NCT02554786|583522747|FG004|Overall Study|Technical problems|1|||
161583518|NCT02554786|583522743|FG000|Overall Study|Adverse Event|0|||
161583519|NCT02554786|583522744|FG001|Overall Study|Adverse Event|0|||
161583520|NCT02554786|583522745|FG002|Overall Study|Adverse Event|0|||
161583521|NCT02554786|583522746|FG003|Overall Study|Adverse Event|0|||
161583522|NCT02554786|583522747|FG004|Overall Study|Adverse Event|2|||
161583523|NCT02554786|583522743|FG000|Overall Study|Death|0|||
161583524|NCT02554786|583522744|FG001|Overall Study|Death|0|||
161583525|NCT02554786|583522745|FG002|Overall Study|Death|0|||
161583526|NCT02554786|583522746|FG003|Overall Study|Death|1|||
161583527|NCT02554786|583522747|FG004|Overall Study|Death|0|||
161583528|NCT02554786|583522743|FG000|Overall Study|Non-compliance with study treatment|0|||
161583529|NCT02554786|583522744|FG001|Overall Study|Non-compliance with study treatment|1|||
161583530|NCT02554786|583522745|FG002|Overall Study|Non-compliance with study treatment|1|||
161583531|NCT02554786|583522746|FG003|Overall Study|Non-compliance with study treatment|0|||
161583532|NCT02554786|583522747|FG004|Overall Study|Non-compliance with study treatment|1|||
161583533|NCT02554786|583522743|FG000|Overall Study|Physician Decision|0|||
161817200|NCT01559363|584370978|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161817201|NCT01559363|584370979|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161491138|NCT01113801|583192959|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
161491139|NCT01949051|583192963|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
161583534|NCT02554786|583522744|FG001|Overall Study|Physician Decision|1|||
161583535|NCT02554786|583522745|FG002|Overall Study|Physician Decision|4|||
161583536|NCT02554786|583522746|FG003|Overall Study|Physician Decision|1|||
161583537|NCT02554786|583522747|FG004|Overall Study|Physician Decision|1|||
161583538|NCT02554786|583522743|FG000|Overall Study|Pregnancy|0|||
161491140|NCT01949051|583192964|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
161583539|NCT02554786|583522744|FG001|Overall Study|Pregnancy|0|||
161583540|NCT02554786|583522745|FG002|Overall Study|Pregnancy|0|||
161583541|NCT02554786|583522746|FG003|Overall Study|Pregnancy|1|||
161583542|NCT02554786|583522747|FG004|Overall Study|Pregnancy|1|||
161491141|NCT01949051|583192965|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
161491142|NCT01949051|583192966|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
161491143|NCT01949051|583192967|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
161491144|NCT01949051|583192968|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
161491145|NCT01949051|583192963|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
161491146|NCT01949051|583192964|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161491147|NCT01949051|583192965|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161491148|NCT01949051|583192966|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161491149|NCT01949051|583192967|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161491150|NCT01949051|583192968|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161491151|NCT01949051|583192963|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
161491152|NCT01949051|583192964|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
161491153|NCT01949051|583192965|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
161491154|NCT01949051|583192966|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
161491155|NCT01949051|583192967|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
161491156|NCT01949051|583192968|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
161491157|NCT01949051|583192963|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
161491158|NCT01949051|583192964|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
161491159|NCT01949051|583192965|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
161491160|NCT01949051|583192966|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
161491161|NCT01949051|583192967|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
161491162|NCT01949051|583192968|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
161491163|NCT01949051|583192963|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
161491164|NCT01949051|583192964|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
161491165|NCT01949051|583192965|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
161491166|NCT01949051|583192966|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
161491167|NCT01949051|583192967|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
161491168|NCT01949051|583192968|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
161491169|NCT01846507|583192970|FG000|Overall Study|Lost to Follow-up|4|||
161491170|NCT01846507|583192970|FG000|Overall Study|Protocol Violation|1|||
161491171|NCT01846507|583192970|FG000|Overall Study|Missing data|2|||
161491172|NCT01782859|583192971|FG000|Overall Study|Protocol Violation|6|||
161491173|NCT01782859|583192972|FG001|Overall Study|Protocol Violation|6|||
161491174|NCT01782859|583192971|FG000|Overall Study|Withdrawal by Subject|0|||
161491175|NCT01782859|583192972|FG001|Overall Study|Withdrawal by Subject|1|||
161491176|NCT04545866|583192973|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
161491177|NCT04545866|583192974|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
161491178|NCT04545866|583192973|FG000|Overall Study|Withdrawal by Physician|1|||
161491179|NCT04545866|583192974|FG001|Overall Study|Withdrawal by Physician|0|||
161491180|NCT02436356|583192975|FG000|Overall Study|Excluded by MRI Screening|0|||
161491181|NCT02436356|583192976|FG001|Overall Study|Excluded by MRI Screening|0|||
161491182|NCT02436356|583192977|FG002|Overall Study|Excluded by MRI Screening|2|||
161491183|NCT02436356|583192975|FG000|Overall Study|Lost to Follow-up|0|||
161491184|NCT02436356|583192976|FG001|Overall Study|Lost to Follow-up|1|||
161491185|NCT02436356|583192977|FG002|Overall Study|Lost to Follow-up|0|||
161491186|NCT02436356|583192975|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
161491187|NCT02436356|583192976|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
161491188|NCT02436356|583192977|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
161491189|NCT02436356|583192975|FG000|Overall Study|Excluded due to other medical conditions|3|||
161491190|NCT02436356|583192976|FG001|Overall Study|Excluded due to other medical conditions|0|||
161491191|NCT02436356|583192977|FG002|Overall Study|Excluded due to other medical conditions|0|||
161491192|NCT02436356|583192975|FG000|Overall Study|Withdrawal by Subject|1|||
161491193|NCT02436356|583192976|FG001|Overall Study|Withdrawal by Subject|0|||
161491194|NCT02436356|583192977|FG002|Overall Study|Withdrawal by Subject|0|||
161491195|NCT03287804|583192978|FG000|Overall Study|Death|1|||
161491196|NCT03287804|583192978|FG000|Overall Study|Physician Decision|2|||
161491197|NCT03287804|583192978|FG000|Overall Study|Progressive disease|8|||
161491198|NCT00487747|583192979|FG000|Overall Study|Adverse Event|1|||
161491199|NCT00487747|583192979|FG000|Overall Study|Lost to Follow-up|9|||
161491200|NCT00487747|583192979|FG000|Overall Study|Lack of Efficacy|1|||
161491201|NCT04483011|583192980|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161491202|NCT04483011|583192981|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161583543|NCT05052996|583522748|FG000|Overall Study|Still on study|0|||
161583544|NCT05052996|583522749|FG001|Overall Study|Still on study|0|||
161583545|NCT05052996|583522750|FG002|Overall Study|Still on study|47|||
161583546|NCT05052996|583522751|FG003|Overall Study|Still on study|44|||
161583547|NCT05052996|583522748|FG000|Overall Study|Cohort terminated by sponsor|21|||
161583548|NCT05052996|583522749|FG001|Overall Study|Cohort terminated by sponsor|12|||
161491203|NCT02979522|583192993|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
161583549|NCT05052996|583522750|FG002|Overall Study|Cohort terminated by sponsor|0|||
161583550|NCT05052996|583522751|FG003|Overall Study|Cohort terminated by sponsor|0|||
161491204|NCT02979522|583192994|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
161491205|NCT02979522|583192993|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
161491206|NCT02979522|583192994|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
161491207|NCT01896531|583192995|FG000|Overall Study|Death|57|||
161491208|NCT01896531|583192996|FG001|Overall Study|Death|59|||
161491209|NCT01896531|583192995|FG000|Overall Study|Lost to Follow-up|3|||
161491210|NCT01896531|583192996|FG001|Overall Study|Lost to Follow-up|0|||
161491211|NCT01896531|583192995|FG000|Overall Study|Non-compliance|0|||
161491212|NCT01896531|583192996|FG001|Overall Study|Non-compliance|1|||
161491213|NCT01896531|583192995|FG000|Overall Study|Study Ended by Sponsor|7|||
161491214|NCT01896531|583192996|FG001|Overall Study|Study Ended by Sponsor|20|||
161491215|NCT01896531|583192995|FG000|Overall Study|Withdrawal by Subject|3|||
161491216|NCT01896531|583192996|FG001|Overall Study|Withdrawal by Subject|2|||
161491217|NCT01896531|583192995|FG000|Overall Study|Death Prior to Treatment|1|||
161491218|NCT01896531|583192996|FG001|Overall Study|Death Prior to Treatment|0|||
161491219|NCT00770289|583192997|FG000|Overall Study|Other|6|||
161491220|NCT02733991|583192998|FG000|Overall Study|Adverse Event|1|||
161491221|NCT02733991|583192999|FG001|Overall Study|Adverse Event|0|||
161491222|NCT02733991|583192998|FG000|Overall Study|Withdrawal by Subject|0|||
161491223|NCT02733991|583192999|FG001|Overall Study|Withdrawal by Subject|5|||
161491224|NCT02956486|583193000|FG000|Core Phase|Adverse Event|51|||
161491225|NCT02956486|583193001|FG001|Core Phase|Adverse Event|88|||
161491226|NCT02956486|583193002|FG002|Core Phase|Adverse Event|0|||
161491227|NCT02956486|583193000|FG000|Core Phase|Lost to Follow-up|8|||
161491228|NCT02956486|583193001|FG001|Core Phase|Lost to Follow-up|6|||
161491229|NCT02956486|583193002|FG002|Core Phase|Lost to Follow-up|0|||
161491230|NCT02956486|583193000|FG000|Core Phase|Inadequate therapeutic effect|4|||
161491231|NCT02956486|583193001|FG001|Core Phase|Inadequate therapeutic effect|5|||
161491232|NCT02956486|583193002|FG002|Core Phase|Inadequate therapeutic effect|0|||
161491233|NCT02956486|583193000|FG000|Core Phase|Withdrawal by Subject|101|||
161491234|NCT02956486|583193001|FG001|Core Phase|Withdrawal by Subject|104|||
161491235|NCT02956486|583193002|FG002|Core Phase|Withdrawal by Subject|0|||
161491236|NCT02956486|583193000|FG000|Core Phase|Study terminated by sponsor|888|||
161491237|NCT02956486|583193001|FG001|Core Phase|Study terminated by sponsor|848|||
161491238|NCT02956486|583193002|FG002|Core Phase|Study terminated by sponsor|0|||
161491239|NCT02956486|583193000|FG000|Core Phase|Other|27|||
161491240|NCT02956486|583193001|FG001|Core Phase|Other|18|||
161491241|NCT02956486|583193002|FG002|Core Phase|Other|0|||
161491242|NCT02956486|583193000|FG000|Core Phase|Not treated|0|||
161491243|NCT02956486|583193001|FG001|Core Phase|Not treated|3|||
161491244|NCT02956486|583193002|FG002|Core Phase|Not treated|0|||
161491245|NCT02956486|583193000|FG000|Extension Phase|Adverse Event|0|||
161491246|NCT02956486|583193001|FG001|Extension Phase|Adverse Event|0|||
161491247|NCT02956486|583193002|FG002|Extension Phase|Adverse Event|2|||
161491248|NCT02956486|583193000|FG000|Extension Phase|Study terminated by sponsor|0|||
161491249|NCT02956486|583193001|FG001|Extension Phase|Study terminated by sponsor|0|||
161583551|NCT05052996|583522748|FG000|Overall Study|Withdrew consent|1|||
161583552|NCT05052996|583522749|FG001|Overall Study|Withdrew consent|0|||
161583553|NCT05052996|583522750|FG002|Overall Study|Withdrew consent|1|||
161583554|NCT05052996|583522751|FG003|Overall Study|Withdrew consent|2|||
161583555|NCT05052996|583522748|FG000|Overall Study|Lost to Follow-up|1|||
161583556|NCT05052996|583522749|FG001|Overall Study|Lost to Follow-up|0|||
161583557|NCT05052996|583522750|FG002|Overall Study|Lost to Follow-up|0|||
161583558|NCT05052996|583522751|FG003|Overall Study|Lost to Follow-up|2|||
161583559|NCT05052996|583522748|FG000|Overall Study|Adverse Event|0|||
161583560|NCT05052996|583522749|FG001|Overall Study|Adverse Event|0|||
161583561|NCT05052996|583522750|FG002|Overall Study|Adverse Event|2|||
161583562|NCT05052996|583522751|FG003|Overall Study|Adverse Event|0|||
161583563|NCT05052996|583522748|FG000|Overall Study|Randomized but never treated|0|||
161583564|NCT05052996|583522749|FG001|Overall Study|Randomized but never treated|0|||
161583565|NCT05052996|583522750|FG002|Overall Study|Randomized but never treated|1|||
161583566|NCT05052996|583522751|FG003|Overall Study|Randomized but never treated|1|||
161583567|NCT05052996|583522748|FG000|Overall Study|Protocol Violation|1|||
161583568|NCT05052996|583522749|FG001|Overall Study|Protocol Violation|0|||
161583569|NCT05052996|583522750|FG002|Overall Study|Protocol Violation|0|||
161583570|NCT05052996|583522751|FG003|Overall Study|Protocol Violation|0|||
161583571|NCT01695954|583522752|FG000|Overall Study|Withdrawal by Subject|4|||
161583572|NCT01695954|583522753|FG001|Overall Study|Withdrawal by Subject|0|||
161583573|NCT01695954|583522752|FG000|Overall Study|Adverse Event|0|||
161491250|NCT02956486|583193002|FG002|Extension Phase|Study terminated by sponsor|16|||
161491251|NCT02956486|583193000|FG000|Extension Phase|Not Treated|0|||
161491252|NCT02956486|583193001|FG001|Extension Phase|Not Treated|0|||
161491253|NCT02956486|583193002|FG002|Extension Phase|Not Treated|1|||
161491254|NCT00680745|583193005|FG000|Overall Study|Withdrawal by Subject|8|||
161491255|NCT00680745|583193006|FG001|Overall Study|Withdrawal by Subject|3|||
161491256|NCT00680745|583193007|FG002|Overall Study|Withdrawal by Subject|2|||
161491257|NCT00680745|583193008|FG003|Overall Study|Withdrawal by Subject|8|||
161491258|NCT00680745|583193005|FG000|Overall Study|Lost to Follow-up|0|||
161491259|NCT00680745|583193006|FG001|Overall Study|Lost to Follow-up|1|||
161491260|NCT00680745|583193007|FG002|Overall Study|Lost to Follow-up|1|||
161491261|NCT00680745|583193008|FG003|Overall Study|Lost to Follow-up|0|||
161491262|NCT00680745|583193005|FG000|Overall Study|Death|1|||
161491263|NCT00680745|583193006|FG001|Overall Study|Death|0|||
161491264|NCT00680745|583193007|FG002|Overall Study|Death|1|||
161491265|NCT00680745|583193008|FG003|Overall Study|Death|0|||
161491266|NCT00680745|583193005|FG000|Overall Study|Adverse Event|5|||
161491267|NCT00680745|583193006|FG001|Overall Study|Adverse Event|3|||
161491268|NCT00680745|583193007|FG002|Overall Study|Adverse Event|3|||
161923139|NCT03369223|584764925|FG004|Overall Study|Participant request to discontinue study treatment|1|||
161923140|NCT03369223|584764926|FG005|Overall Study|Participant request to discontinue study treatment|1|||
161923141|NCT03369223|584764927|FG006|Overall Study|Participant request to discontinue study treatment|1|||
161491269|NCT00680745|583193008|FG003|Overall Study|Adverse Event|3|||
161491270|NCT00680745|583193005|FG000|Overall Study|Poor/Non-compliance|0|||
161491271|NCT00680745|583193006|FG001|Overall Study|Poor/Non-compliance|3|||
161491272|NCT00680745|583193007|FG002|Overall Study|Poor/Non-compliance|0|||
161491273|NCT00680745|583193008|FG003|Overall Study|Poor/Non-compliance|0|||
161491274|NCT00680745|583193005|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161583574|NCT01695954|583522753|FG001|Overall Study|Adverse Event|2|||
161583575|NCT01248936|583522764|FG000|Overall Study|Sponsor Decision|259|||
161491275|NCT00680745|583193006|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
161583576|NCT01248936|583522764|FG000|Overall Study|Progression of Disease|50|||
161583577|NCT01248936|583522764|FG000|Overall Study|Death|26|||
161583578|NCT01248936|583522764|FG000|Overall Study|Withdrawal of Consent|20|||
161583579|NCT01248936|583522764|FG000|Overall Study|Adverse Event|8|||
161583580|NCT01248936|583522764|FG000|Overall Study|Lost to Follow-up|7|||
161583581|NCT01248936|583522764|FG000|Overall Study|Refused Treatment|1|||
161583582|NCT01248936|583522764|FG000|Overall Study|Other reason|3|||
161583583|NCT03930420|583522765|FG000|Overall Study|Withdrawal by Subject|7|||
161583584|NCT03930420|583522766|FG001|Overall Study|Withdrawal by Subject|9|||
161583585|NCT05609032|583522767|FG000|Overall Study|Lost to Follow-up|3|||
161583586|NCT05609032|583522768|FG001|Overall Study|Lost to Follow-up|1|||
161583587|NCT05609032|583522767|FG000|Overall Study|Withdrawal by Subject|1|||
161583588|NCT05609032|583522768|FG001|Overall Study|Withdrawal by Subject|0|||
161583589|NCT00609336|583522769|FG000|Overall Study|Protocol Violation|3|||
161583590|NCT00609336|583522769|FG000|Overall Study|Death|1|||
161583591|NCT00609336|583522769|FG000|Overall Study|LA or Met at Surgery|9|||
161583592|NCT00567489|583522770|FG000|Overall Study|Adverse Event|6|||
161583593|NCT00567489|583522771|FG001|Overall Study|Adverse Event|14|||
161583594|NCT00567489|583522770|FG000|Overall Study|Physician Decision|0|||
161583595|NCT00567489|583522771|FG001|Overall Study|Physician Decision|4|||
161583596|NCT00567489|583522770|FG000|Overall Study|Withdrawal by Subject|0|||
161583597|NCT00567489|583522771|FG001|Overall Study|Withdrawal by Subject|2|||
161583598|NCT00567489|583522770|FG000|Overall Study|Renal Transplantation|0|||
161583599|NCT00567489|583522771|FG001|Overall Study|Renal Transplantation|3|||
161583600|NCT00567489|583522770|FG000|Overall Study|Other|1|||
161583601|NCT00567489|583522771|FG001|Overall Study|Other|0|||
161583602|NCT02692417|583522774|FG000|Overall Study|Withdrawal by Subject|5|||
161583603|NCT02692417|583522775|FG001|Overall Study|Withdrawal by Subject|1|||
161583604|NCT02692417|583522774|FG000|Overall Study|Adverse Event|1|||
161583605|NCT02692417|583522775|FG001|Overall Study|Adverse Event|0|||
161583606|NCT01207492|583522782|FG000|Overall Study|Still on study|1|||
161583607|NCT01207492|583522782|FG000|Overall Study|Withdrawal by Subject|9|||
161583608|NCT01207492|583522782|FG000|Overall Study|Physician Decision|1|||
161583609|NCT01207492|583522782|FG000|Overall Study|Progressive disease|3|||
161583610|NCT01207492|583522782|FG000|Overall Study|Toxicity|1|||
161583611|NCT04690556|583522783|FG000|Overall Study|Adverse Event|6|||
161583612|NCT04690556|583522784|FG001|Overall Study|Adverse Event|4|||
161583613|NCT04690556|583522783|FG000|Overall Study|Death|3|||
161491276|NCT00680745|583193007|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
161491277|NCT00680745|583193008|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
161583614|NCT04690556|583522784|FG001|Overall Study|Death|4|||
161583615|NCT04690556|583522783|FG000|Overall Study|Lost to Follow-up|3|||
161583616|NCT04690556|583522784|FG001|Overall Study|Lost to Follow-up|2|||
161583617|NCT04690556|583522783|FG000|Overall Study|Protocol Violation|1|||
161583618|NCT04690556|583522784|FG001|Overall Study|Protocol Violation|4|||
161583619|NCT04690556|583522783|FG000|Overall Study|Physician Decision|2|||
161583620|NCT04690556|583522784|FG001|Overall Study|Physician Decision|0|||
161583621|NCT04690556|583522783|FG000|Overall Study|Withdrawal by Subject|25|||
161583622|NCT04690556|583522784|FG001|Overall Study|Withdrawal by Subject|17|||
161583623|NCT04690556|583522783|FG000|Overall Study|Prohibited medications and other reasons|3|||
161491278|NCT00680745|583193005|FG000|Overall Study|False Treatment|0|||
161491279|NCT00680745|583193006|FG001|Overall Study|False Treatment|1|||
161491280|NCT00680745|583193007|FG002|Overall Study|False Treatment|3|||
161491281|NCT00680745|583193008|FG003|Overall Study|False Treatment|0|||
161583624|NCT04690556|583522784|FG001|Overall Study|Prohibited medications and other reasons|1|||
161583625|NCT00497198|583522785|FG000|Overall Study|Adverse Event|4|||
161583626|NCT00497198|583522786|FG001|Overall Study|Adverse Event|2|||
161491282|NCT02485574|583193013|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
161491283|NCT00255047|583193015|FG000|Overall Study|Serious Adverse Events|2|||
161491284|NCT00255047|583193016|FG001|Overall Study|Serious Adverse Events|1|||
161491285|NCT00255047|583193017|FG002|Overall Study|Serious Adverse Events|2|||
161491286|NCT00255047|583193018|FG003|Overall Study|Serious Adverse Events|1|||
161491287|NCT00255047|583193015|FG000|Overall Study|Adverse Event|0|||
161491288|NCT00255047|583193016|FG001|Overall Study|Adverse Event|3|||
161491289|NCT00255047|583193017|FG002|Overall Study|Adverse Event|2|||
161491290|NCT00255047|583193018|FG003|Overall Study|Adverse Event|1|||
161491291|NCT00255047|583193015|FG000|Overall Study|Protocol Violation|13|||
161491292|NCT00255047|583193016|FG001|Overall Study|Protocol Violation|13|||
161491293|NCT00255047|583193017|FG002|Overall Study|Protocol Violation|16|||
161491294|NCT00255047|583193018|FG003|Overall Study|Protocol Violation|20|||
161491295|NCT00255047|583193015|FG000|Overall Study|Lost to Follow-up|9|||
161491296|NCT00255047|583193016|FG001|Overall Study|Lost to Follow-up|8|||
161491297|NCT00255047|583193017|FG002|Overall Study|Lost to Follow-up|5|||
161491298|NCT00255047|583193018|FG003|Overall Study|Lost to Follow-up|6|||
161491299|NCT00255047|583193015|FG000|Overall Study|Withdrawal by Subject|24|||
161491300|NCT00255047|583193016|FG001|Overall Study|Withdrawal by Subject|23|||
161491301|NCT00255047|583193017|FG002|Overall Study|Withdrawal by Subject|25|||
161491302|NCT00255047|583193018|FG003|Overall Study|Withdrawal by Subject|18|||
161491303|NCT00003492|583193025|FG000|Overall Study|Not evaluable|6|||
161491304|NCT03049280|583193031|FG000|Overall Study|Physician Decision|1|||
161491305|NCT01867021|583193032|FG000|Overall Study|Adverse Event|0|||
161491306|NCT01867021|583193033|FG001|Overall Study|Adverse Event|1|||
161491307|NCT01867021|583193032|FG000|Overall Study|Not Eligible|0|||
161491308|NCT01867021|583193033|FG001|Overall Study|Not Eligible|1|||
161491309|NCT01867021|583193032|FG000|Overall Study|Death|1|||
161491310|NCT01867021|583193033|FG001|Overall Study|Death|0|||
161491311|NCT01867021|583193032|FG000|Overall Study|Lost to Follow-up|0|||
161491312|NCT01867021|583193033|FG001|Overall Study|Lost to Follow-up|2|||
161491313|NCT01867021|583193032|FG000|Overall Study|Withdrawal by Subject|1|||
161491314|NCT01867021|583193033|FG001|Overall Study|Withdrawal by Subject|6|||
161491315|NCT03171415|583193037|FG000|Overall Study|Lost to Follow-up|0|||
161491316|NCT03171415|583193038|FG001|Overall Study|Lost to Follow-up|0|||
161491317|NCT03171415|583193039|FG002|Overall Study|Lost to Follow-up|0|||
161491318|NCT03171415|583193040|FG003|Overall Study|Lost to Follow-up|0|||
161491319|NCT03171415|583193041|FG004|Overall Study|Lost to Follow-up|2|||
161491320|NCT04140292|583193042|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
161491321|NCT04140292|583193043|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
161491322|NCT01962207|583193045|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
161491323|NCT01962207|583193046|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
161491324|NCT01962207|583193047|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
161491325|NCT01962207|583193048|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
161491326|NCT01962207|583193045|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
161491327|NCT01962207|583193046|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
161491328|NCT01962207|583193047|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
161491329|NCT01962207|583193048|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
161491330|NCT01962207|583193045|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
161491331|NCT01962207|583193046|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
161491332|NCT01962207|583193047|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
161491333|NCT01962207|583193048|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
161491334|NCT01962207|583193045|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
161491335|NCT01962207|583193046|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
161491336|NCT01962207|583193047|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
161491337|NCT01962207|583193048|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
161491338|NCT01962207|583193045|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
161491339|NCT01962207|583193046|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
161491340|NCT01962207|583193047|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
161491341|NCT01962207|583193048|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
161491342|NCT01962207|583193045|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
161491343|NCT01962207|583193046|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
161491344|NCT01962207|583193047|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
161491345|NCT01962207|583193048|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
161491346|NCT03036072|583193049|FG000|Overall Study|Death|0|||
161491347|NCT03036072|583193050|FG001|Overall Study|Death|1|||
161491348|NCT03036072|583193049|FG000|Overall Study|Withdrawal by Subject|0|||
161491349|NCT03036072|583193050|FG001|Overall Study|Withdrawal by Subject|1|||
161491350|NCT03036072|583193049|FG000|Overall Study|Physician Decision|0|||
161491351|NCT03036072|583193050|FG001|Overall Study|Physician Decision|1|||
161491352|NCT00680043|583193051|FG000|Overall Study|Withdrawal by Subject|1|||
161491353|NCT00680043|583193052|FG001|Overall Study|Withdrawal by Subject|0|||
161491354|NCT00680043|583193053|FG002|Overall Study|Withdrawal by Subject|0|||
161583627|NCT00497198|583522785|FG000|Overall Study|Physician Decision|1|||
161491355|NCT00680043|583193051|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
161491356|NCT00680043|583193052|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
161491357|NCT00680043|583193053|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
161491358|NCT00680043|583193051|FG000|Overall Study|Renal Transplant|1|||
161491359|NCT00680043|583193052|FG001|Overall Study|Renal Transplant|0|||
161491360|NCT00680043|583193053|FG002|Overall Study|Renal Transplant|4|||
161491361|NCT02484729|583193054|FG000|Overall Study|Failure of IntelliCap Error|0|||
161491362|NCT02484729|583193055|FG001|Overall Study|Failure of IntelliCap Error|0|||
161491363|NCT02484729|583193056|FG002|Overall Study|Failure of IntelliCap Error|0|||
161491364|NCT02484729|583193057|FG003|Overall Study|Failure of IntelliCap Error|0|||
161491365|NCT02484729|583193058|FG004|Overall Study|Failure of IntelliCap Error|0|||
161491366|NCT02484729|583193059|FG005|Overall Study|Failure of IntelliCap Error|0|||
161491367|NCT02484729|583193060|FG006|Overall Study|Failure of IntelliCap Error|0|||
161491368|NCT02484729|583193061|FG007|Overall Study|Failure of IntelliCap Error|0|||
161491369|NCT02484729|583193062|FG008|Overall Study|Failure of IntelliCap Error|0|||
161491370|NCT02484729|583193063|FG009|Overall Study|Failure of IntelliCap Error|1|||
161491371|NCT02480114|583193064|FG000|Overall Study|Not completing surveys|3|||
161491372|NCT02480114|583193065|FG001|Overall Study|Not completing surveys|2|||
161491373|NCT02480114|583193064|FG000|Overall Study|Withdrawal by Subject|2|||
161491374|NCT02480114|583193065|FG001|Overall Study|Withdrawal by Subject|4|||
161491375|NCT02480114|583193064|FG000|Overall Study|Disease progression|3|||
161491376|NCT02480114|583193065|FG001|Overall Study|Disease progression|0|||
161491377|NCT02480114|583193064|FG000|Overall Study|Improper completion of survey|1|||
161491378|NCT02480114|583193065|FG001|Overall Study|Improper completion of survey|1|||
161491379|NCT02480114|583193064|FG000|Overall Study|Not eligible|0|||
161491380|NCT02480114|583193065|FG001|Overall Study|Not eligible|1|||
161491381|NCT01031069|583193066|FG000|Overall Study|Serious Adverse Event|0|||
161491382|NCT01031069|583193067|FG001|Overall Study|Serious Adverse Event|1|||
161491383|NCT01031069|583193068|FG002|Overall Study|Serious Adverse Event|0|||
161491384|NCT01031069|583193069|FG003|Overall Study|Serious Adverse Event|0|||
161491385|NCT01031069|583193066|FG000|Overall Study|Withdrawal by Subject|2|||
161491386|NCT01031069|583193067|FG001|Overall Study|Withdrawal by Subject|3|||
161491387|NCT01031069|583193068|FG002|Overall Study|Withdrawal by Subject|18|||
161491388|NCT01031069|583193069|FG003|Overall Study|Withdrawal by Subject|18|||
161491389|NCT01031069|583193066|FG000|Overall Study|Migrated/moved from study area|1|||
161491390|NCT01031069|583193067|FG001|Overall Study|Migrated/moved from study area|2|||
161491391|NCT01031069|583193068|FG002|Overall Study|Migrated/moved from study area|1|||
161491392|NCT01031069|583193069|FG003|Overall Study|Migrated/moved from study area|1|||
161491393|NCT01031069|583193066|FG000|Overall Study|Lost to Follow-up|9|||
161491394|NCT01031069|583193067|FG001|Overall Study|Lost to Follow-up|5|||
161491395|NCT01031069|583193068|FG002|Overall Study|Lost to Follow-up|21|||
161491396|NCT01031069|583193069|FG003|Overall Study|Lost to Follow-up|15|||
161491397|NCT01031069|583193066|FG000|Overall Study|Other|0|||
161491398|NCT01031069|583193067|FG001|Overall Study|Other|0|||
161491399|NCT01031069|583193068|FG002|Overall Study|Other|1|||
161491400|NCT01031069|583193069|FG003|Overall Study|Other|0|||
161491401|NCT01317160|583193070|FG000|Overall Study|Incorrect inclusion|1|||
161491402|NCT01317160|583193071|FG001|Overall Study|Incorrect inclusion|1|||
161491403|NCT01317160|583193070|FG000|Overall Study|Lost to Follow-up|3|||
161491404|NCT01317160|583193071|FG001|Overall Study|Lost to Follow-up|3|||
161491405|NCT01317160|583193070|FG000|Overall Study|Withdrawal by Subject|0|||
161491406|NCT01317160|583193071|FG001|Overall Study|Withdrawal by Subject|2|||
161491407|NCT03578367|583193073|FG000|Overall Study|Adverse Event|0|||
161817202|NCT01559363|584370980|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
161491408|NCT03578367|583193074|FG001|Overall Study|Adverse Event|3|||
161491409|NCT03578367|583193075|FG002|Overall Study|Adverse Event|0|||
161491410|NCT03578367|583193076|FG003|Overall Study|Adverse Event|5|||
161491411|NCT03578367|583193073|FG000|Overall Study|Withdrawal by Subject|2|||
161491412|NCT03578367|583193074|FG001|Overall Study|Withdrawal by Subject|2|||
161491413|NCT03578367|583193075|FG002|Overall Study|Withdrawal by Subject|1|||
161491414|NCT03578367|583193076|FG003|Overall Study|Withdrawal by Subject|3|||
161491415|NCT03578367|583193073|FG000|Overall Study|Physician Decision|0|||
161491416|NCT03578367|583193074|FG001|Overall Study|Physician Decision|0|||
161491417|NCT03578367|583193075|FG002|Overall Study|Physician Decision|14|||
161491418|NCT03578367|583193076|FG003|Overall Study|Physician Decision|0|||
161491419|NCT03578367|583193073|FG000|Overall Study|Death|1|||
161491420|NCT03578367|583193074|FG001|Overall Study|Death|0|||
161491421|NCT03578367|583193075|FG002|Overall Study|Death|0|||
161491422|NCT03578367|583193076|FG003|Overall Study|Death|0|||
161491423|NCT03578367|583193073|FG000|Overall Study|Not treated|0|||
161491424|NCT03578367|583193074|FG001|Overall Study|Not treated|0|||
161491425|NCT03578367|583193075|FG002|Overall Study|Not treated|1|||
161491426|NCT03578367|583193076|FG003|Overall Study|Not treated|0|||
161491427|NCT02081690|583194533|FG000|Overall Study|Death|3|||
161491428|NCT02081690|583194533|FG000|Overall Study|Physician Decision|3|||
161491429|NCT02081690|583194533|FG000|Overall Study|Withdrawal by Subject|1|||
161491430|NCT03204981|583194535|FG000|Overall Study|Physician Decision|2|||
161671606|NCT04427501|583851345|FG009|Overall Study|Physician Decision|0|||
161491431|NCT03204981|583194535|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
161491432|NCT00982488|583194536|FG000|Overall Study|Administrative reason by sponsor|81|||
161491433|NCT00982488|583194537|FG001|Overall Study|Administrative reason by sponsor|3|||
161491434|NCT00982488|583194538|FG002|Overall Study|Administrative reason by sponsor|11|||
161491435|NCT00982488|583194539|FG003|Overall Study|Administrative reason by sponsor|0|||
161491436|NCT00982488|583194540|FG004|Overall Study|Administrative reason by sponsor|0|||
161491437|NCT00982488|583194536|FG000|Overall Study|Adverse event unrelated to study drug|5|||
161491438|NCT00982488|583194537|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161491439|NCT00982488|583194538|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161491440|NCT00982488|583194539|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161491441|NCT00982488|583194540|FG004|Overall Study|Adverse event unrelated to study drug|0|||
161491442|NCT00982488|583194536|FG000|Overall Study|Death|11|||
161491443|NCT00982488|583194537|FG001|Overall Study|Death|0|||
161491444|NCT00982488|583194538|FG002|Overall Study|Death|2|||
161491445|NCT00982488|583194539|FG003|Overall Study|Death|0|||
161491446|NCT00982488|583194540|FG004|Overall Study|Death|0|||
161491447|NCT00982488|583194536|FG000|Overall Study|Disease progression|30|||
161491448|NCT00982488|583194537|FG001|Overall Study|Disease progression|5|||
161491449|NCT00982488|583194538|FG002|Overall Study|Disease progression|10|||
161491450|NCT00982488|583194539|FG003|Overall Study|Disease progression|1|||
161491451|NCT00982488|583194540|FG004|Overall Study|Disease progression|1|||
161491452|NCT00982488|583194536|FG000|Overall Study|Lost to Follow-up|1|||
161491453|NCT00982488|583194537|FG001|Overall Study|Lost to Follow-up|0|||
161491454|NCT00982488|583194538|FG002|Overall Study|Lost to Follow-up|0|||
161491455|NCT00982488|583194539|FG003|Overall Study|Lost to Follow-up|0|||
161491456|NCT00982488|583194540|FG004|Overall Study|Lost to Follow-up|0|||
161491457|NCT00982488|583194536|FG000|Overall Study|Maximum clinical benefit|1|||
161491458|NCT00982488|583194537|FG001|Overall Study|Maximum clinical benefit|1|||
161491459|NCT00982488|583194538|FG002|Overall Study|Maximum clinical benefit|1|||
161491460|NCT00982488|583194539|FG003|Overall Study|Maximum clinical benefit|0|||
161491461|NCT00982488|583194540|FG004|Overall Study|Maximum clinical benefit|0|||
161491462|NCT00982488|583194536|FG000|Overall Study|Other|15|||
161491463|NCT00982488|583194537|FG001|Overall Study|Other|1|||
161491464|NCT00982488|583194538|FG002|Overall Study|Other|3|||
161491465|NCT00982488|583194539|FG003|Overall Study|Other|1|||
161491466|NCT00982488|583194540|FG004|Overall Study|Other|0|||
161491467|NCT00982488|583194536|FG000|Overall Study|Poor compliance/noncompliance|0|||
161491468|NCT00982488|583194537|FG001|Overall Study|Poor compliance/noncompliance|1|||
161491469|NCT00982488|583194538|FG002|Overall Study|Poor compliance/noncompliance|0|||
161491470|NCT00982488|583194539|FG003|Overall Study|Poor compliance/noncompliance|0|||
161491471|NCT00982488|583194540|FG004|Overall Study|Poor compliance/noncompliance|0|||
161491472|NCT00982488|583194536|FG000|Overall Study|Stem cell transplant|2|||
161491473|NCT00982488|583194537|FG001|Overall Study|Stem cell transplant|0|||
161491474|NCT00982488|583194538|FG002|Overall Study|Stem cell transplant|0|||
161491475|NCT00982488|583194539|FG003|Overall Study|Stem cell transplant|1|||
161491476|NCT00982488|583194540|FG004|Overall Study|Stem cell transplant|0|||
161491477|NCT00982488|583194536|FG000|Overall Study|Study drug toxicity|34|||
161491478|NCT00982488|583194537|FG001|Overall Study|Study drug toxicity|1|||
161491479|NCT00982488|583194538|FG002|Overall Study|Study drug toxicity|6|||
161491480|NCT00982488|583194539|FG003|Overall Study|Study drug toxicity|0|||
161491481|NCT00982488|583194540|FG004|Overall Study|Study drug toxicity|0|||
161491482|NCT00982488|583194536|FG000|Overall Study|Withdrawal by Subject|5|||
161491483|NCT00982488|583194537|FG001|Overall Study|Withdrawal by Subject|1|||
161583628|NCT00497198|583522786|FG001|Overall Study|Physician Decision|2|||
161583629|NCT00497198|583522785|FG000|Overall Study|Withdrawal by Subject|0|||
161583630|NCT00497198|583522786|FG001|Overall Study|Withdrawal by Subject|1|||
161583631|NCT05028582|583522788|FG000|Overall Study|Lost to Follow-up|11|||
161583632|NCT05028582|583522789|FG001|Overall Study|Lost to Follow-up|9|||
161583633|NCT05028582|583522788|FG000|Overall Study|Withdrawal by Subject|9|||
161583634|NCT05028582|583522789|FG001|Overall Study|Withdrawal by Subject|10|||
161583635|NCT05028582|583522788|FG000|Overall Study|Adverse Event|5|||
161583636|NCT05028582|583522789|FG001|Overall Study|Adverse Event|2|||
161491484|NCT00982488|583194538|FG002|Overall Study|Withdrawal by Subject|1|||
161491485|NCT00982488|583194539|FG003|Overall Study|Withdrawal by Subject|0|||
161491486|NCT00982488|583194540|FG004|Overall Study|Withdrawal by Subject|0|||
161491487|NCT04203238|583194541|FG000|Overall Study|Withdrawal by Subject|1|||
161491488|NCT04203238|583194542|FG001|Overall Study|Withdrawal by Subject|1|||
161491489|NCT04203238|583194541|FG000|Overall Study|Covid-19|3|||
161491490|NCT04203238|583194542|FG001|Overall Study|Covid-19|0|||
161583637|NCT05028582|583522788|FG000|Overall Study|Miscellaneous|3|||
161583638|NCT05028582|583522789|FG001|Overall Study|Miscellaneous|2|||
161583639|NCT05028582|583522788|FG000|Overall Study|Lack of Efficacy|3|||
161491491|NCT04244786|583194545|FG000|Overall Study|Adverse Event|0|||
161491492|NCT04244786|583194546|FG001|Overall Study|Adverse Event|0|||
161491493|NCT04244786|583194547|FG002|Overall Study|Adverse Event|2|||
161491494|NCT04244786|583194545|FG000|Overall Study|Withdrawal by Subject|0|||
161491495|NCT04244786|583194546|FG001|Overall Study|Withdrawal by Subject|0|||
161491496|NCT04244786|583194547|FG002|Overall Study|Withdrawal by Subject|5|||
161491497|NCT00415909|583194548|FG000|Overall Study|Withdrawal by Subject|2|||
161491498|NCT00415909|583194548|FG000|Overall Study|Death|1|||
161491499|NCT05024058|583194549|FG000|Treatment|Study terminated by sponsor|5|||
161491500|NCT05024058|583194550|FG001|Treatment|Study terminated by sponsor|6|||
161491501|NCT05024058|583194551|FG002|Treatment|Study terminated by sponsor|4|||
161491502|NCT05024058|583194552|FG003|Treatment|Study terminated by sponsor|2|||
161491503|NCT05024058|583194553|FG004|Treatment|Study terminated by sponsor|3|||
161491504|NCT05024058|583194554|FG005|Treatment|Study terminated by sponsor|3|||
161491505|NCT05024058|583194555|FG006|Treatment|Study terminated by sponsor|1|||
161491506|NCT05024058|583194556|FG007|Treatment|Study terminated by sponsor|3|||
161491507|NCT05024058|583194557|FG008|Treatment|Study terminated by sponsor|6|||
161491508|NCT05024058|583194558|FG009|Treatment|Study terminated by sponsor|6|||
161491509|NCT05024058|583194549|FG000|Follow-up|Withdrawal by Subject|1|||
161491510|NCT05024058|583194550|FG001|Follow-up|Withdrawal by Subject|0|||
161491511|NCT05024058|583194551|FG002|Follow-up|Withdrawal by Subject|1|||
161491512|NCT05024058|583194552|FG003|Follow-up|Withdrawal by Subject|0|||
161491513|NCT05024058|583194553|FG004|Follow-up|Withdrawal by Subject|0|||
161491514|NCT05024058|583194554|FG005|Follow-up|Withdrawal by Subject|0|||
161491515|NCT05024058|583194555|FG006|Follow-up|Withdrawal by Subject|0|||
161491516|NCT05024058|583194556|FG007|Follow-up|Withdrawal by Subject|1|||
161491517|NCT05024058|583194557|FG008|Follow-up|Withdrawal by Subject|0|||
161491518|NCT05024058|583194558|FG009|Follow-up|Withdrawal by Subject|1|||
161491519|NCT02734810|583194559|FG000|Overall Study|Adverse Event|1|||
161491520|NCT02734810|583194560|FG001|Overall Study|Adverse Event|0|||
161491521|NCT02734810|583194559|FG000|Overall Study|Lack of Efficacy|1|||
161491522|NCT02734810|583194560|FG001|Overall Study|Lack of Efficacy|0|||
161491523|NCT02507505|583194561|FG000|Overall Study|Withdrawal by Subject|13|||
161491524|NCT02507505|583194562|FG001|Overall Study|Withdrawal by Subject|11|||
161491525|NCT02507505|583194561|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
161491526|NCT02507505|583194562|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
161491527|NCT02507505|583194561|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
161491528|NCT02507505|583194562|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
161491529|NCT02507505|583194561|FG000|Overall Study|Death before receipt of anesthesia|0|||
161491530|NCT02507505|583194562|FG001|Overall Study|Death before receipt of anesthesia|1|||
161491531|NCT00931762|583194563|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
161491532|NCT00931762|583194563|FG000|Overall Study|Administrative Problems|5|||
161491533|NCT00931762|583194563|FG000|Overall Study|Death|1|||
161491534|NCT00931762|583194563|FG000|Overall Study|Disease Progression|3|||
161491535|NCT00931762|583194563|FG000|Overall Study|Adverse Event (s)|11|||
161491536|NCT00931762|583194563|FG000|Overall Study|Subject withdrew consent|13|||
161491537|NCT03182829|583194564|FG000|Overall Study|Protocol Violation|12|||
161491538|NCT03182829|583194565|FG001|Overall Study|Protocol Violation|12|||
161491539|NCT03182829|583194564|FG000|Overall Study|Other|4|||
161491540|NCT03182829|583194565|FG001|Overall Study|Other|3|||
161491541|NCT02664441|583194566|FG000|Randomization|Withdrawal by Subject|0|||
161491542|NCT02664441|583194567|FG001|Randomization|Withdrawal by Subject|1|||
161491543|NCT02664441|583194566|FG000|36-week Randomized Trial|Adverse Event|2|||
161491544|NCT02664441|583194567|FG001|36-week Randomized Trial|Adverse Event|0|||
161491545|NCT02664441|583194566|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
161583640|NCT05028582|583522789|FG001|Overall Study|Lack of Efficacy|1|||
161583641|NCT05028582|583522788|FG000|Overall Study|Physician Decision|0|||
161583642|NCT05028582|583522789|FG001|Overall Study|Physician Decision|1|||
161583643|NCT04278586|583524102|FG000|Overall Study|Withdrawal by Subject|13|||
161583644|NCT04278586|583524103|FG001|Overall Study|Withdrawal by Subject|6|||
161583645|NCT04278586|583524102|FG000|Overall Study|Lost to Follow-up|37|||
161583646|NCT04278586|583524103|FG001|Overall Study|Lost to Follow-up|24|||
161583647|NCT03954184|583524110|FG000|Overall Study|Lost to Follow-up|500|||
161583648|NCT03954184|583524111|FG001|Overall Study|Lost to Follow-up|0|||
161583649|NCT05403801|583524114|FG000|Overall Study|Withdrawal by Subject|2|||
161583650|NCT02819843|583524115|FG000|Overall Study|Disease progression before RT|0|||
161583651|NCT02819843|583524116|FG001|Overall Study|Disease progression before RT|1|||
161583652|NCT02728557|583524117|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
161583653|NCT02728557|583524118|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
161583654|NCT02728557|583524117|FG000|Overall Study|Dissatisfaction with research tasks|0|||
161583655|NCT02728557|583524118|FG001|Overall Study|Dissatisfaction with research tasks|1|||
161603638|NCT05412004|583603299|FG000|Overall Study|Screen Failure|0|||
161491546|NCT02664441|583194567|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
161491547|NCT02664441|583194566|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
161491548|NCT02664441|583194567|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
161491549|NCT02664441|583194566|FG000|18-week Open Label Extension|Adverse Event|1|||
161671607|NCT04427501|583851346|FG010|Overall Study|Physician Decision|0|||
161671608|NCT04427501|583851347|FG011|Overall Study|Physician Decision|0|||
161671609|NCT04427501|583851336|FG000|Overall Study|Withdrawal by Subject|9|||
161671610|NCT04427501|583851337|FG001|Overall Study|Withdrawal by Subject|2|||
161817203|NCT01559363|584370981|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161817204|NCT01559363|584370982|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161817205|NCT00834873|584370983|FG000|First Intervention|Adverse Event|0|||
161817206|NCT00834873|584370984|FG001|First Intervention|Adverse Event|1|||
161817207|NCT02055547|584370989|FG000|Overall Study|Protocol Violation|0|||
161817208|NCT02055547|584370990|FG001|Overall Study|Protocol Violation|0|||
161817209|NCT02055547|584370991|FG002|Overall Study|Protocol Violation|1|||
161491550|NCT02664441|583194567|FG001|18-week Open Label Extension|Adverse Event|0|||
161491551|NCT02664441|583194566|FG000|18-week Open Label Extension|Physician Decision|1|||
161491552|NCT02664441|583194567|FG001|18-week Open Label Extension|Physician Decision|0|||
161491553|NCT02664441|583194566|FG000|18-week Open Label Extension|Death|1|||
161491554|NCT02664441|583194567|FG001|18-week Open Label Extension|Death|0|||
161491555|NCT02664441|583194566|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
161491556|NCT02664441|583194567|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
161491557|NCT02335489|583194572|FG000|Overall Study|Sponsor terminated study|4|||
161491558|NCT02335489|583194572|FG000|Overall Study|Lost to Follow-up|1|||
161491559|NCT02335489|583194572|FG000|Overall Study|Withdrawal by Subject|2|||
161491560|NCT02335489|583194572|FG000|Overall Study|Physician Decision|2|||
161491561|NCT02335489|583194572|FG000|Overall Study|Lack of Efficacy|1|||
161491562|NCT02259582|583194573|FG000|Overall Study|Physician Decision|0|||
161491563|NCT02259582|583194574|FG001|Overall Study|Physician Decision|1|||
161491564|NCT02259582|583194575|FG002|Overall Study|Physician Decision|0|||
161491565|NCT02259582|583194573|FG000|Overall Study|Death|0|||
161491566|NCT02259582|583194574|FG001|Overall Study|Death|0|||
161491567|NCT02259582|583194575|FG002|Overall Study|Death|1|||
161491568|NCT02259582|583194573|FG000|Overall Study|Adverse Event|1|||
161491569|NCT02259582|583194574|FG001|Overall Study|Adverse Event|0|||
161491570|NCT02259582|583194575|FG002|Overall Study|Adverse Event|1|||
161491571|NCT02259582|583194573|FG000|Overall Study|Withdrawal by Subject|0|||
161491572|NCT02259582|583194574|FG001|Overall Study|Withdrawal by Subject|0|||
161491573|NCT02259582|583194575|FG002|Overall Study|Withdrawal by Subject|1|||
161491574|NCT02259582|583194573|FG000|Overall Study|Disease progression|14|||
161491575|NCT02259582|583194574|FG001|Overall Study|Disease progression|15|||
161491576|NCT02259582|583194575|FG002|Overall Study|Disease progression|17|||
161491577|NCT02259582|583194573|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
161491578|NCT02259582|583194574|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
161491579|NCT02259582|583194575|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
161491580|NCT00759863|583194578|FG000|Overall Study|Death, moved, or lost contact|20|||
161491581|NCT00759863|583194579|FG001|Overall Study|Death, moved, or lost contact|18|||
161491582|NCT00412854|583194583|FG000|Overall Study|Withdrawn due to adverse events|1|||
161491583|NCT00412854|583194584|FG001|Overall Study|Withdrawn due to adverse events|5|||
161491584|NCT00412854|583194583|FG000|Overall Study|Withdrawn for other reasons|13|||
161491585|NCT00412854|583194584|FG001|Overall Study|Withdrawn for other reasons|11|||
161491586|NCT00503308|583194585|FG000|Overall Study|Protocol Violation|2|||
161491587|NCT00503308|583194586|FG001|Overall Study|Protocol Violation|1|||
161491588|NCT03263442|583194588|FG000|Inpatient Phase|Death|1|||
161491589|NCT03263442|583194589|FG001|Inpatient Phase|Death|0|||
161491590|NCT03263442|583194588|FG000|Inpatient Phase|Withdrawal by Subject|1|||
161491591|NCT03263442|583194589|FG001|Inpatient Phase|Withdrawal by Subject|0|||
161491592|NCT03263442|583194588|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
161491593|NCT03263442|583194589|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
161491594|NCT03263442|583194588|FG000|1-month Follow-Up|Lost to Follow-up|1|||
161491595|NCT03263442|583194589|FG001|1-month Follow-Up|Lost to Follow-up|0|||
161491596|NCT03263442|583194588|FG000|3-month Follow-Up|Lost to Follow-up|1|||
161491597|NCT03263442|583194589|FG001|3-month Follow-Up|Lost to Follow-up|3|||
161491598|NCT03263442|583194588|FG000|6-month Follow-Up|Lost to Follow-up|2|||
161491599|NCT03263442|583194589|FG001|6-month Follow-Up|Lost to Follow-up|2|||
161491600|NCT03804879|583194590|FG000|Overall Study|Adverse Event|3|||
161491601|NCT03804879|583194591|FG001|Overall Study|Adverse Event|0|||
161491602|NCT03804879|583194590|FG000|Overall Study|Study Terminated By Sponsor|10|||
161491603|NCT03804879|583194591|FG001|Overall Study|Study Terminated By Sponsor|12|||
161491604|NCT03804879|583194590|FG000|Overall Study|Withdrawal by Subject|3|||
161491605|NCT03804879|583194591|FG001|Overall Study|Withdrawal by Subject|1|||
161491606|NCT02436889|583194592|FG000|Overall Study|No improvement in symptoms|1|||
161603639|NCT05412004|583603300|FG001|Overall Study|Screen Failure|0|||
161603640|NCT05412004|583603301|FG002|Overall Study|Screen Failure|0|||
161603641|NCT05412004|583603302|FG003|Overall Study|Screen Failure|1|||
161603642|NCT05412004|583603299|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
161603643|NCT05412004|583603300|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
161603644|NCT05412004|583603301|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
161817210|NCT02055547|584370992|FG003|Overall Study|Protocol Violation|0|||
161817211|NCT02055547|584370993|FG004|Overall Study|Protocol Violation|0|||
161817212|NCT02055547|584370994|FG005|Overall Study|Protocol Violation|0|||
161817213|NCT02055547|584370995|FG006|Overall Study|Protocol Violation|1|||
161817214|NCT02055547|584370996|FG007|Overall Study|Protocol Violation|0|||
161817215|NCT02055547|584370997|FG008|Overall Study|Protocol Violation|0|||
161491607|NCT02436889|583194593|FG001|Overall Study|No improvement in symptoms|0|||
161491608|NCT02436889|583194592|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
161491609|NCT02436889|583194593|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
161491610|NCT01034462|583194594|FG000|Overall Study|Adverse Event|7|||
161491611|NCT01034462|583194595|FG001|Overall Study|Adverse Event|17|||
161491612|NCT01034462|583194594|FG000|Overall Study|Lack of Efficacy|4|||
161491613|NCT01034462|583194595|FG001|Overall Study|Lack of Efficacy|4|||
161491614|NCT01034462|583194594|FG000|Overall Study|Protocol Violation|10|||
161491615|NCT01034462|583194595|FG001|Overall Study|Protocol Violation|7|||
161491616|NCT01034462|583194594|FG000|Overall Study|Withdrawal by Subject|9|||
161491617|NCT01034462|583194595|FG001|Overall Study|Withdrawal by Subject|8|||
161491618|NCT01034462|583194594|FG000|Overall Study|Lost to Follow-up|14|||
161491619|NCT01034462|583194595|FG001|Overall Study|Lost to Follow-up|16|||
161491620|NCT01034462|583194594|FG000|Overall Study|Other reasons|1|||
161491621|NCT01034462|583194595|FG001|Overall Study|Other reasons|2|||
161491622|NCT01594125|583194596|FG000|Overall Study|Withdrawal by Subject|1|||
161491623|NCT01594125|583194597|FG001|Overall Study|Withdrawal by Subject|0|||
161491624|NCT01594125|583194598|FG002|Overall Study|Withdrawal by Subject|0|||
161491625|NCT01594125|583194599|FG003|Overall Study|Withdrawal by Subject|1|||
161491626|NCT01594125|583194600|FG004|Overall Study|Withdrawal by Subject|0|||
161491627|NCT01594125|583194596|FG000|Overall Study|Progressive Disease|3|||
161491628|NCT01594125|583194597|FG001|Overall Study|Progressive Disease|12|||
161491629|NCT01594125|583194598|FG002|Overall Study|Progressive Disease|3|||
161491630|NCT01594125|583194599|FG003|Overall Study|Progressive Disease|3|||
161491631|NCT01594125|583194600|FG004|Overall Study|Progressive Disease|7|||
161491632|NCT00708643|583194601|FG000|Overall Study|Adverse Event|0|||
161491633|NCT00708643|583194602|FG001|Overall Study|Adverse Event|1|||
161491634|NCT03635957|583194605|FG000|Run-In Period|Lost to Follow-up|1|||
161491635|NCT03635957|583194605|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
161491636|NCT01710033|583194606|FG000|Stage 2|Adverse Event|0|||
161491637|NCT01710033|583194607|FG001|Stage 2|Adverse Event|0|||
161491638|NCT01710033|583194608|FG002|Stage 2|Adverse Event|0|||
161491639|NCT01710033|583194609|FG003|Stage 2|Adverse Event|0|||
161491640|NCT01710033|583194610|FG004|Stage 2|Adverse Event|1|||
161491641|NCT01525550|583194612|FG000|Overall Study|Lost to Follow-up|8|||
161491642|NCT01525550|583194613|FG001|Overall Study|Lost to Follow-up|2|||
161491643|NCT01525550|583194612|FG000|Overall Study|Death|19|||
161491644|NCT01525550|583194613|FG001|Overall Study|Death|28|||
161491645|NCT01525550|583194612|FG000|Overall Study|Other|0|||
161491646|NCT01525550|583194613|FG001|Overall Study|Other|4|||
161491647|NCT01525550|583194612|FG000|Overall Study|Sponsor's Decision|30|||
161491648|NCT01525550|583194613|FG001|Overall Study|Sponsor's Decision|11|||
161491649|NCT01525550|583194612|FG000|Overall Study|Withdrawal by Subject|4|||
161491650|NCT01525550|583194613|FG001|Overall Study|Withdrawal by Subject|0|||
161491651|NCT03045887|583194616|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
161491652|NCT03045887|583194617|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491653|NCT03045887|583194618|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491654|NCT03045887|583194619|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491655|NCT03045887|583194620|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161817216|NCT02055547|584370998|FG009|Overall Study|Protocol Violation|0|||
161817217|NCT02055547|584370999|FG010|Overall Study|Protocol Violation|0|||
161817218|NCT02055547|584371000|FG011|Overall Study|Protocol Violation|0|||
161817219|NCT02055547|584371001|FG012|Overall Study|Protocol Violation|0|||
161817220|NCT02055547|584371002|FG013|Overall Study|Protocol Violation|0|||
161491656|NCT03045887|583194621|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491657|NCT03045887|583194622|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161671611|NCT04427501|583851338|FG002|Overall Study|Withdrawal by Subject|2|||
161817221|NCT02055547|584371003|FG014|Overall Study|Protocol Violation|0|||
161491658|NCT03045887|583194623|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491659|NCT03045887|583194624|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491660|NCT03045887|583194625|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
161491661|NCT03045887|583194616|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491662|NCT03045887|583194617|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161817222|NCT02055547|584371004|FG015|Overall Study|Protocol Violation|0|||
161817223|NCT02055547|584371005|FG016|Overall Study|Protocol Violation|0|||
161817224|NCT02055547|584371006|FG017|Overall Study|Protocol Violation|0|||
161817225|NCT02055547|584371007|FG018|Overall Study|Protocol Violation|0|||
161817226|NCT02055547|584370989|FG000|Overall Study|Physician Decision|0|||
161817227|NCT02055547|584370990|FG001|Overall Study|Physician Decision|1|||
161817228|NCT02055547|584370991|FG002|Overall Study|Physician Decision|1|||
161817229|NCT02055547|584370992|FG003|Overall Study|Physician Decision|0|||
161491663|NCT03045887|583194618|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491664|NCT03045887|583194619|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
161491665|NCT03045887|583194620|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491666|NCT03045887|583194621|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161923142|NCT03369223|584764928|FG007|Overall Study|Participant request to discontinue study treatment|0|||
161491667|NCT03045887|583194622|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491668|NCT03045887|583194623|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491669|NCT03045887|583194624|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491670|NCT03045887|583194625|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161491671|NCT03045887|583194616|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
161491672|NCT03045887|583194617|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491673|NCT03045887|583194618|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491674|NCT03045887|583194619|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491675|NCT03045887|583194620|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491676|NCT03045887|583194621|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491677|NCT03045887|583194622|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491678|NCT03045887|583194623|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491679|NCT03045887|583194624|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491680|NCT03045887|583194625|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
161491681|NCT03045887|583194616|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491682|NCT03045887|583194617|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491683|NCT03045887|583194618|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
161491684|NCT03045887|583194619|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
161491685|NCT03045887|583194620|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491686|NCT03045887|583194621|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491687|NCT03045887|583194622|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491688|NCT03045887|583194623|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491689|NCT03045887|583194624|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491690|NCT03045887|583194625|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
161491691|NCT03045887|583194616|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491692|NCT03045887|583194617|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491693|NCT03045887|583194618|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491694|NCT03045887|583194619|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
161491695|NCT03045887|583194620|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491696|NCT03045887|583194621|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491697|NCT03045887|583194622|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491698|NCT03045887|583194623|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491699|NCT03045887|583194624|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491700|NCT03045887|583194625|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161491701|NCT03414424|583194626|FG000|Overall Study|Screened out after consent|0|||
161491702|NCT03414424|583194627|FG001|Overall Study|Screened out after consent|2|||
161491703|NCT03414424|583194626|FG000|Overall Study|Lost to Follow-up|0|||
161491704|NCT03414424|583194627|FG001|Overall Study|Lost to Follow-up|1|||
161491705|NCT01408914|583194628|FG000|Overall Study|Could not complete tx in protocol period|5|||
161491706|NCT01408914|583194629|FG001|Overall Study|Could not complete tx in protocol period|5|||
161491707|NCT01408914|583194630|FG002|Overall Study|Could not complete tx in protocol period|6|||
161491708|NCT01408914|583194628|FG000|Overall Study|Lost to Follow-up|4|||
161491709|NCT01408914|583194629|FG001|Overall Study|Lost to Follow-up|1|||
161491710|NCT01408914|583194630|FG002|Overall Study|Lost to Follow-up|2|||
161491711|NCT01408914|583194628|FG000|Overall Study|Physician Decision|1|||
161491712|NCT01408914|583194629|FG001|Overall Study|Physician Decision|1|||
161491713|NCT01408914|583194630|FG002|Overall Study|Physician Decision|0|||
161491714|NCT01408914|583194628|FG000|Overall Study|Withdrawal by Subject|1|||
161491715|NCT01408914|583194629|FG001|Overall Study|Withdrawal by Subject|0|||
161491716|NCT01408914|583194630|FG002|Overall Study|Withdrawal by Subject|1|||
161491717|NCT01408914|583194628|FG000|Overall Study|Moved out of study jurisdiction|1|||
161491718|NCT01408914|583194629|FG001|Overall Study|Moved out of study jurisdiction|1|||
161491719|NCT01408914|583194630|FG002|Overall Study|Moved out of study jurisdiction|0|||
161491720|NCT01408914|583194628|FG000|Overall Study|Late exclusion|0|||
161491721|NCT01408914|583194629|FG001|Overall Study|Late exclusion|3|||
161491722|NCT01408914|583194630|FG002|Overall Study|Late exclusion|3|||
161491723|NCT01408914|583194628|FG000|Overall Study|Change in local TB/HIV norms|0|||
161491724|NCT01408914|583194629|FG001|Overall Study|Change in local TB/HIV norms|1|||
161491725|NCT01408914|583194630|FG002|Overall Study|Change in local TB/HIV norms|1|||
161491726|NCT01585194|583194631|FG000|Overall Study|Withdrawal by Subject|1|||
161491727|NCT01585194|583194631|FG000|Overall Study|Physician Decision|2|||
161491728|NCT01585194|583194631|FG000|Overall Study|Lack of insurance|1|||
161491729|NCT00993291|583194632|FG000|Overall Study|Withdrawal by Subject|1|||
161491730|NCT04446377|583194634|FG000|Overall Study|Withdrawal by Subject|6|||
161491731|NCT04446377|583194635|FG001|Overall Study|Withdrawal by Subject|1|||
161491732|NCT04446377|583194634|FG000|Overall Study|Physician Decision|1|||
161491733|NCT04446377|583194635|FG001|Overall Study|Physician Decision|1|||
161491734|NCT04446377|583194634|FG000|Overall Study|Lost to Follow-up|0|||
161491735|NCT04446377|583194635|FG001|Overall Study|Lost to Follow-up|2|||
161491736|NCT04446377|583194634|FG000|Overall Study|Not eligible|0|||
161491737|NCT04446377|583194635|FG001|Overall Study|Not eligible|1|||
161491738|NCT01414075|583194640|FG000|Overall Study|Adverse Event|1|||
161491739|NCT01414075|583194641|FG001|Overall Study|Adverse Event|0|||
161491740|NCT01414075|583194642|FG002|Overall Study|Adverse Event|1|||
161491741|NCT01414075|583194643|FG003|Overall Study|Adverse Event|0|||
161491742|NCT01414075|583194640|FG000|Overall Study|Death|1|||
161491743|NCT01414075|583194641|FG001|Overall Study|Death|0|||
161491744|NCT01414075|583194642|FG002|Overall Study|Death|0|||
161491745|NCT01414075|583194643|FG003|Overall Study|Death|1|||
161491746|NCT01414075|583194640|FG000|Overall Study|Withdrawal by Subject|0|||
161491747|NCT01414075|583194641|FG001|Overall Study|Withdrawal by Subject|0|||
161491748|NCT01414075|583194642|FG002|Overall Study|Withdrawal by Subject|0|||
161491749|NCT01414075|583194643|FG003|Overall Study|Withdrawal by Subject|1|||
161491750|NCT01414075|583194640|FG000|Overall Study|Other than specified|1|||
161491751|NCT01414075|583194641|FG001|Overall Study|Other than specified|0|||
161583656|NCT02728557|583524117|FG000|Overall Study|Scheduling or change in availability|1|||
161583657|NCT02728557|583524118|FG001|Overall Study|Scheduling or change in availability|1|||
161583658|NCT03416010|583524119|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
161583659|NCT03416010|583524120|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
161583660|NCT03416010|583524119|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
161583661|NCT03416010|583524120|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
161583662|NCT03416010|583524119|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
161583663|NCT03416010|583524120|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
161583664|NCT03416010|583524119|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
161583665|NCT03416010|583524120|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
161583666|NCT03416010|583524119|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
161583667|NCT03416010|583524120|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
161583668|NCT03416010|583524119|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
161583669|NCT03416010|583524120|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
161583670|NCT03416010|583524119|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
161583671|NCT03416010|583524120|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
161583672|NCT03948763|583524121|FG000|Overall Study|Sponsor's decision|0|||
161583673|NCT03948763|583524122|FG001|Overall Study|Sponsor's decision|2|||
161583674|NCT03948763|583524123|FG002|Overall Study|Sponsor's decision|6|||
161583675|NCT03948763|583524124|FG003|Overall Study|Sponsor's decision|4|||
161583676|NCT03948763|583524125|FG004|Overall Study|Sponsor's decision|0|||
161583677|NCT03948763|583524121|FG000|Overall Study|Physician Decision|0|||
161583678|NCT03948763|583524122|FG001|Overall Study|Physician Decision|0|||
161583679|NCT03948763|583524123|FG002|Overall Study|Physician Decision|1|||
161583680|NCT03948763|583524124|FG003|Overall Study|Physician Decision|0|||
161583681|NCT03948763|583524125|FG004|Overall Study|Physician Decision|0|||
161583682|NCT03948763|583524121|FG000|Overall Study|Lost to Follow-up|0|||
161583683|NCT03948763|583524122|FG001|Overall Study|Lost to Follow-up|0|||
161583684|NCT03948763|583524123|FG002|Overall Study|Lost to Follow-up|0|||
161583685|NCT03948763|583524124|FG003|Overall Study|Lost to Follow-up|0|||
161583686|NCT03948763|583524125|FG004|Overall Study|Lost to Follow-up|1|||
161583687|NCT03948763|583524121|FG000|Overall Study|Death|2|||
161583688|NCT03948763|583524122|FG001|Overall Study|Death|12|||
161583689|NCT03948763|583524123|FG002|Overall Study|Death|13|||
161583690|NCT03948763|583524124|FG003|Overall Study|Death|10|||
161583691|NCT03948763|583524125|FG004|Overall Study|Death|11|||
161583692|NCT03948763|583524121|FG000|Overall Study|Withdrawal by Subject|1|||
161583693|NCT03948763|583524122|FG001|Overall Study|Withdrawal by Subject|1|||
161583694|NCT03948763|583524123|FG002|Overall Study|Withdrawal by Subject|0|||
161583695|NCT03948763|583524124|FG003|Overall Study|Withdrawal by Subject|2|||
161583696|NCT03948763|583524125|FG004|Overall Study|Withdrawal by Subject|4|||
161583697|NCT06629454|583524129|FG000|Overall Study|Withdraw by Clinician Decision|1|||
161583698|NCT06023082|583524130|FG000|Overall Study|Withdrawal by Subject|2|||
161583699|NCT06023082|583524130|FG000|Overall Study|Lost to Follow-up|15|||
161583700|NCT06023082|583524130|FG000|Overall Study|Side effects|5|||
161583701|NCT05986565|583524131|FG000|Overall Study|Lost to Follow-up|8|||
161583702|NCT05986565|583524132|FG001|Overall Study|Lost to Follow-up|3|||
161583703|NCT05986565|583524131|FG000|Overall Study|Withdrawal by Subject|0|||
161491752|NCT01414075|583194642|FG002|Overall Study|Other than specified|1|||
161491753|NCT01414075|583194643|FG003|Overall Study|Other than specified|0|||
161583704|NCT05986565|583524132|FG001|Overall Study|Withdrawal by Subject|1|||
161583705|NCT00670046|583524133|FG000|Overall Study|Lost to Follow-up|1|||
161583706|NCT00670046|583524134|FG001|Overall Study|Lost to Follow-up|1|||
161583707|NCT00670046|583524133|FG000|Overall Study|Withdrawal by Subject|0|||
161491754|NCT04903626|583194645|FG000|Overall Study|Lost to Follow-up|6|||
161491755|NCT04903626|583194645|FG000|Overall Study|Withdrawal by Subject|1|||
161583708|NCT00670046|583524134|FG001|Overall Study|Withdrawal by Subject|1|||
161491756|NCT04903626|583194645|FG000|Overall Study|Other, Not Specified|1|||
161491757|NCT06112756|583194648|FG000|Overall Study|Withdrawal by Subject|0|||
161491758|NCT06112756|583194649|FG001|Overall Study|Withdrawal by Subject|2|||
161491759|NCT06112756|583194648|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
161491760|NCT06112756|583194649|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
161491761|NCT06112756|583194648|FG000|Overall Study|Adverse Event|2|||
161491762|NCT06112756|583194649|FG001|Overall Study|Adverse Event|2|||
161491763|NCT03060629|583194650|FG000|Overall Study|Death|4|||
161491764|NCT03060629|583194651|FG001|Overall Study|Death|5|||
161491765|NCT03060629|583194650|FG000|Overall Study|Withdrawal by Subject|50|||
161491766|NCT03060629|583194651|FG001|Overall Study|Withdrawal by Subject|35|||
161491767|NCT03060629|583194650|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
161491768|NCT03060629|583194651|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
161491769|NCT03060629|583194650|FG000|Overall Study|Participant Relocate|15|||
161491770|NCT03060629|583194651|FG001|Overall Study|Participant Relocate|15|||
161491771|NCT03060629|583194650|FG000|Overall Study|Unable to Contact Participant|34|||
161491772|NCT03060629|583194651|FG001|Overall Study|Unable to Contact Participant|23|||
161491773|NCT03060629|583194650|FG000|Overall Study|Investigator Decision|7|||
161491774|NCT03060629|583194651|FG001|Overall Study|Investigator Decision|7|||
161671612|NCT04427501|583851339|FG003|Overall Study|Withdrawal by Subject|3|||
161671613|NCT04427501|583851340|FG004|Overall Study|Withdrawal by Subject|7|||
161671614|NCT04427501|583851341|FG005|Overall Study|Withdrawal by Subject|25|||
161491775|NCT03060629|583194650|FG000|Overall Study|Study Terminated by Sponsor|1100|||
161491776|NCT03060629|583194651|FG001|Overall Study|Study Terminated by Sponsor|1123|||
161583709|NCT02006758|583524148|FG000|Overall Study|Protocol Violation|1|||
161583710|NCT02006758|583524148|FG000|Overall Study|Death|1|||
161583711|NCT02006758|583524148|FG000|Overall Study|Lost to Follow-up|4|||
161583712|NCT02006758|583524148|FG000|Overall Study|Withdrawal by Subject|4|||
161583713|NCT02006758|583524148|FG000|Overall Study|Procedurally excluded|1|||
161583714|NCT02006758|583524148|FG000|Overall Study|Other|2|||
161583715|NCT02740231|583524149|FG000|Overall Study|Withdrawal by Subject|1|||
161583716|NCT02740231|583524150|FG001|Overall Study|Withdrawal by Subject|1|||
161583717|NCT02740231|583524151|FG002|Overall Study|Withdrawal by Subject|1|||
161583718|NCT02740231|583524152|FG003|Overall Study|Withdrawal by Subject|0|||
161583719|NCT02740231|583524149|FG000|Overall Study|Lack of Efficacy|0|||
161583720|NCT02740231|583524150|FG001|Overall Study|Lack of Efficacy|1|||
161583721|NCT02740231|583524151|FG002|Overall Study|Lack of Efficacy|0|||
161583722|NCT02740231|583524152|FG003|Overall Study|Lack of Efficacy|4|||
161583723|NCT02740231|583524149|FG000|Overall Study|Lost to Follow-up|1|||
161583724|NCT02740231|583524150|FG001|Overall Study|Lost to Follow-up|3|||
161583725|NCT02740231|583524151|FG002|Overall Study|Lost to Follow-up|0|||
161583726|NCT02740231|583524152|FG003|Overall Study|Lost to Follow-up|3|||
161583727|NCT02740231|583524149|FG000|Overall Study|Adverse Event|0|||
161583728|NCT02740231|583524150|FG001|Overall Study|Adverse Event|1|||
161583729|NCT02740231|583524151|FG002|Overall Study|Adverse Event|0|||
161583730|NCT02740231|583524152|FG003|Overall Study|Adverse Event|1|||
161583731|NCT00914589|583524153|FG000|Overall Study|Adverse Event|1|||
161583732|NCT00914589|583524154|FG001|Overall Study|Adverse Event|0|||
161583733|NCT00914589|583524155|FG002|Overall Study|Adverse Event|1|||
161583734|NCT00914589|583524153|FG000|Overall Study|Protocol Violation|8|||
161583735|NCT00914589|583524154|FG001|Overall Study|Protocol Violation|6|||
161583736|NCT00914589|583524155|FG002|Overall Study|Protocol Violation|3|||
161583737|NCT00914589|583524153|FG000|Overall Study|unclassified|16|||
161583738|NCT00914589|583524154|FG001|Overall Study|unclassified|9|||
161583739|NCT00914589|583524155|FG002|Overall Study|unclassified|7|||
161583740|NCT00914589|583524153|FG000|Overall Study|Death|0|||
161583741|NCT00914589|583524154|FG001|Overall Study|Death|1|||
161583742|NCT00914589|583524155|FG002|Overall Study|Death|1|||
161583743|NCT01736215|583524157|FG000|Overall Study|Early termination of erythropoietin use|1|||
161583744|NCT01736215|583524157|FG000|Overall Study|Adverse Event|4|||
161583745|NCT01736215|583524157|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
161583746|NCT01736215|583524157|FG000|Overall Study|Insufficient data to perform analysis|8|||
161491777|NCT03060629|583194650|FG000|Overall Study|Other|4|||
161491778|NCT03060629|583194651|FG001|Overall Study|Other|4|||
161491779|NCT01862874|583194652|FG000|Overall Study|Randomized not treated|1|||
161583747|NCT03447249|583524160|FG000|Overall Study|Adverse Event|1|||
161583748|NCT03447249|583524161|FG001|Overall Study|Adverse Event|0|||
161583749|NCT03447249|583524160|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161583750|NCT03447249|583524161|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161491780|NCT01862874|583194653|FG001|Overall Study|Randomized not treated|0|||
161671615|NCT04427501|583851342|FG006|Overall Study|Withdrawal by Subject|15|||
161671616|NCT04427501|583851343|FG007|Overall Study|Withdrawal by Subject|7|||
161583751|NCT03447249|583524160|FG000|Overall Study|Other|3|||
161583752|NCT03447249|583524161|FG001|Overall Study|Other|0|||
161583753|NCT02372253|583524165|FG000|Overall Study|Non Compliance|2|||
161583754|NCT02372253|583524166|FG001|Overall Study|Non Compliance|0|||
161583755|NCT03201562|583524167|FG000|Overall Study|Physician Decision|0|||
161491781|NCT01862874|583194652|FG000|Overall Study|Adverse Event|0|||
161491782|NCT01862874|583194653|FG001|Overall Study|Adverse Event|3|||
161491783|NCT01862874|583194652|FG000|Overall Study|Lost to Follow-up|26|||
161491784|NCT01862874|583194653|FG001|Overall Study|Lost to Follow-up|29|||
161491785|NCT01862874|583194652|FG000|Overall Study|Physician Decision|5|||
161491786|NCT01862874|583194653|FG001|Overall Study|Physician Decision|3|||
161491787|NCT01862874|583194652|FG000|Overall Study|Withdrawn by parent/guardian|1|||
161491788|NCT01862874|583194653|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161491789|NCT01862874|583194652|FG000|Overall Study|Withdrawal by Subject|46|||
161491790|NCT01862874|583194653|FG001|Overall Study|Withdrawal by Subject|40|||
161491791|NCT01862874|583194652|FG000|Overall Study|Death|0|||
161491792|NCT01862874|583194653|FG001|Overall Study|Death|1|||
161491793|NCT03681405|583194654|FG000|Overall Study|Found to be ineligible after randomized|1|||
161491794|NCT03681405|583194655|FG001|Overall Study|Found to be ineligible after randomized|0|||
161491795|NCT02056340|583194657|FG000|Overall Study|Lost to Follow-up|5|||
161491796|NCT02056340|583194658|FG001|Overall Study|Lost to Follow-up|5|||
161491797|NCT02056340|583194657|FG000|Overall Study|Withdrawal by Subject|2|||
161491798|NCT02056340|583194658|FG001|Overall Study|Withdrawal by Subject|6|||
161491799|NCT04851314|583194663|FG000|Overall Study|Unable to complete research set-up procedures|0|||
161491800|NCT04851314|583194664|FG001|Overall Study|Unable to complete research set-up procedures|2|||
161491801|NCT04851314|583194663|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
161583756|NCT03201562|583524168|FG001|Overall Study|Physician Decision|0|||
161583757|NCT03201562|583524169|FG002|Overall Study|Physician Decision|1|||
161583758|NCT03201562|583524167|FG000|Overall Study|Adverse Event|0|||
161583759|NCT03201562|583524168|FG001|Overall Study|Adverse Event|0|||
161583760|NCT03201562|583524169|FG002|Overall Study|Adverse Event|1|||
161583761|NCT03201562|583524167|FG000|Overall Study|Lost to Follow-up|0|||
161583762|NCT03201562|583524168|FG001|Overall Study|Lost to Follow-up|1|||
161583763|NCT03201562|583524169|FG002|Overall Study|Lost to Follow-up|2|||
161583764|NCT00393484|583524170|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
161583765|NCT00393484|583524171|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
161583766|NCT00393484|583524170|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
161583767|NCT00393484|583524171|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
161583768|NCT00393484|583524170|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
161583769|NCT00393484|583524171|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
161583770|NCT00393484|583524170|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
161583771|NCT00393484|583524171|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
161583772|NCT00393484|583524170|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
161583773|NCT00393484|583524171|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
161583774|NCT00393484|583524170|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
161583775|NCT00393484|583524171|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
161583776|NCT00393484|583524170|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
161583777|NCT00393484|583524171|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
161583778|NCT00393484|583524170|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
161583779|NCT00393484|583524171|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
161583780|NCT00393484|583524170|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
161583781|NCT00393484|583524171|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
161583782|NCT00393484|583524170|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
161583783|NCT00393484|583524171|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
161583784|NCT01803555|583524172|FG000|Overall Study|Adverse Event|3|||
161583785|NCT01803555|583524173|FG001|Overall Study|Adverse Event|2|||
161583786|NCT01803555|583524172|FG000|Overall Study|Withdrawal by Subject|3|||
161583787|NCT01803555|583524173|FG001|Overall Study|Withdrawal by Subject|3|||
161491802|NCT04851314|583194664|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
161491803|NCT00867009|583194665|FG000|Induction Period|Nonserious Adverse Event|5|||
161491804|NCT00867009|583194665|FG000|Induction Period|Serious Adverse Event|10|||
161491805|NCT00867009|583194665|FG000|Induction Period|Death due to serious adverse event|6|||
161491806|NCT00867009|583194665|FG000|Induction Period|Death due to Study Disease|4|||
161583788|NCT01803555|583524172|FG000|Overall Study|Non-compliance|1|||
161583789|NCT01803555|583524173|FG001|Overall Study|Non-compliance|1|||
161583790|NCT01803555|583524172|FG000|Overall Study|Protocol Violation|3|||
161583791|NCT01803555|583524173|FG001|Overall Study|Protocol Violation|5|||
161583792|NCT01803555|583524172|FG000|Overall Study|Lost to Follow-up|0|||
161583793|NCT01803555|583524173|FG001|Overall Study|Lost to Follow-up|2|||
161491807|NCT00867009|583194665|FG000|Induction Period|Protocol Violation|1|||
161491808|NCT00867009|583194665|FG000|Induction Period|Withdrawal by Subject|8|||
161491809|NCT00867009|583194665|FG000|Induction Period|Physician Decision|3|||
161491810|NCT00867009|583194665|FG000|Induction Period|Progressive Disease (PD)|25|||
161491811|NCT00867009|583194665|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
161583794|NCT01803555|583524172|FG000|Overall Study|Other than specified|3|||
161583795|NCT01803555|583524173|FG001|Overall Study|Other than specified|5|||
161583796|NCT01551355|583524190|FG000|Overall Study|Lost to Follow-up|51|||
161817230|NCT02055547|584370993|FG004|Overall Study|Physician Decision|1|||
161817231|NCT02055547|584370994|FG005|Overall Study|Physician Decision|0|||
161817232|NCT02055547|584370995|FG006|Overall Study|Physician Decision|0|||
161817233|NCT02055547|584370996|FG007|Overall Study|Physician Decision|0|||
161491812|NCT03266094|583194668|FG000|Overall Study|Lost to Follow-up|1|||
161491813|NCT03266094|583194668|FG000|Overall Study|Withdrawal by Subject|1|||
161491814|NCT00883116|583194671|FG000|Overall Study|Adverse event unrelated to study drug|5|||
161491815|NCT00883116|583194672|FG001|Overall Study|Adverse event unrelated to study drug|10|||
161491816|NCT00883116|583194671|FG000|Overall Study|Death|6|||
161491817|NCT00883116|583194672|FG001|Overall Study|Death|2|||
161817234|NCT02055547|584370997|FG008|Overall Study|Physician Decision|0|||
161817235|NCT02055547|584370998|FG009|Overall Study|Physician Decision|1|||
161817236|NCT02055547|584370999|FG010|Overall Study|Physician Decision|1|||
161817237|NCT02055547|584371000|FG011|Overall Study|Physician Decision|0|||
161817238|NCT02055547|584371001|FG012|Overall Study|Physician Decision|0|||
161817239|NCT02055547|584371002|FG013|Overall Study|Physician Decision|0|||
161817240|NCT02055547|584371003|FG014|Overall Study|Physician Decision|0|||
161817241|NCT02055547|584371004|FG015|Overall Study|Physician Decision|0|||
161817242|NCT02055547|584371005|FG016|Overall Study|Physician Decision|0|||
161817243|NCT02055547|584371006|FG017|Overall Study|Physician Decision|0|||
161817244|NCT02055547|584371007|FG018|Overall Study|Physician Decision|0|||
161817245|NCT02055547|584370989|FG000|Overall Study|Adverse Event|0|||
161817246|NCT02055547|584370990|FG001|Overall Study|Adverse Event|0|||
161817247|NCT02055547|584370991|FG002|Overall Study|Adverse Event|0|||
161817248|NCT02055547|584370992|FG003|Overall Study|Adverse Event|0|||
161817249|NCT02055547|584370993|FG004|Overall Study|Adverse Event|0|||
161817250|NCT02055547|584370994|FG005|Overall Study|Adverse Event|0|||
161817251|NCT02055547|584370995|FG006|Overall Study|Adverse Event|1|||
161491818|NCT00883116|583194671|FG000|Overall Study|Disease progression|130|||
161491819|NCT00883116|583194672|FG001|Overall Study|Disease progression|128|||
161491820|NCT00883116|583194671|FG000|Overall Study|Lost to Follow-up|0|||
161491821|NCT00883116|583194672|FG001|Overall Study|Lost to Follow-up|1|||
161491822|NCT00883116|583194671|FG000|Overall Study|Maximum clinical benefit|13|||
161491823|NCT00883116|583194672|FG001|Overall Study|Maximum clinical benefit|46|||
161491824|NCT00883116|583194671|FG000|Overall Study|Not identified|3|||
161491825|NCT00883116|583194672|FG001|Overall Study|Not identified|6|||
161491826|NCT00883116|583194671|FG000|Overall Study|Study drug toxicity|36|||
161491827|NCT00883116|583194672|FG001|Overall Study|Study drug toxicity|16|||
161491828|NCT00883116|583194671|FG000|Overall Study|Withdrawal by Subject|14|||
161491829|NCT00883116|583194672|FG001|Overall Study|Withdrawal by Subject|8|||
161491830|NCT00883116|583194671|FG000|Overall Study|No longer meets study criteria|2|||
161491831|NCT00883116|583194672|FG001|Overall Study|No longer meets study criteria|2|||
161491832|NCT03241342|583194675|FG000|Overall Study|Adverse Event|5|||
161671617|NCT04427501|583851344|FG008|Overall Study|Withdrawal by Subject|4|||
161817252|NCT02055547|584370996|FG007|Overall Study|Adverse Event|0|||
161817253|NCT02055547|584370997|FG008|Overall Study|Adverse Event|1|||
161817254|NCT02055547|584370998|FG009|Overall Study|Adverse Event|0|||
161817255|NCT02055547|584370999|FG010|Overall Study|Adverse Event|0|||
161817256|NCT02055547|584371000|FG011|Overall Study|Adverse Event|0|||
161817257|NCT02055547|584371001|FG012|Overall Study|Adverse Event|0|||
161817258|NCT02055547|584371002|FG013|Overall Study|Adverse Event|0|||
161817259|NCT02055547|584371003|FG014|Overall Study|Adverse Event|0|||
161817260|NCT02055547|584371004|FG015|Overall Study|Adverse Event|0|||
161817261|NCT02055547|584371005|FG016|Overall Study|Adverse Event|0|||
161817262|NCT02055547|584371006|FG017|Overall Study|Adverse Event|0|||
161817263|NCT02055547|584371007|FG018|Overall Study|Adverse Event|0|||
161817264|NCT02055547|584370989|FG000|Overall Study|Withdrawal by Subject|0|||
161817265|NCT02055547|584370990|FG001|Overall Study|Withdrawal by Subject|0|||
161817266|NCT02055547|584370991|FG002|Overall Study|Withdrawal by Subject|0|||
161491833|NCT03241342|583194676|FG001|Overall Study|Adverse Event|8|||
161491834|NCT03241342|583194677|FG002|Overall Study|Adverse Event|4|||
161491835|NCT03241342|583194675|FG000|Overall Study|Lack of Efficacy|0|||
161491836|NCT03241342|583194676|FG001|Overall Study|Lack of Efficacy|0|||
161491837|NCT03241342|583194677|FG002|Overall Study|Lack of Efficacy|1|||
161491838|NCT03241342|583194675|FG000|Overall Study|noncompliance with study drug|2|||
161491839|NCT03241342|583194676|FG001|Overall Study|noncompliance with study drug|1|||
161491840|NCT03241342|583194677|FG002|Overall Study|noncompliance with study drug|1|||
161491841|NCT03241342|583194675|FG000|Overall Study|sponsor decision|0|||
161491842|NCT03241342|583194676|FG001|Overall Study|sponsor decision|1|||
161491843|NCT03241342|583194677|FG002|Overall Study|sponsor decision|2|||
161491844|NCT03241342|583194675|FG000|Overall Study|not reported|15|||
161491845|NCT03241342|583194676|FG001|Overall Study|not reported|21|||
161491846|NCT03241342|583194677|FG002|Overall Study|not reported|19|||
161491847|NCT03334903|583194681|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
161491848|NCT03334903|583194682|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
161817267|NCT02055547|584370992|FG003|Overall Study|Withdrawal by Subject|0|||
161817268|NCT02055547|584370993|FG004|Overall Study|Withdrawal by Subject|0|||
161817269|NCT02055547|584370994|FG005|Overall Study|Withdrawal by Subject|1|||
161491849|NCT03334903|583194681|FG000|Overall Study|Protocol Violation|1|||
161491850|NCT03334903|583194682|FG001|Overall Study|Protocol Violation|3|||
161491851|NCT03334903|583194681|FG000|Overall Study|Surgery postponed|1|||
161491852|NCT03334903|583194682|FG001|Overall Study|Surgery postponed|0|||
161491853|NCT03334903|583194681|FG000|Overall Study|Adverse Event|1|||
161491854|NCT03334903|583194682|FG001|Overall Study|Adverse Event|1|||
161491855|NCT03334903|583194681|FG000|Overall Study|Withdrawal by Subject|0|||
161491856|NCT03334903|583194682|FG001|Overall Study|Withdrawal by Subject|1|||
161491857|NCT00670800|583196572|FG000|Overall Study|2 controls were insulin resistant|0|||
161491858|NCT00670800|583196573|FG001|Overall Study|2 controls were insulin resistant|2|||
161491859|NCT00587561|583196574|FG000|Overall Study|Lost to Follow-up|6|||
161491860|NCT00587561|583196575|FG001|Overall Study|Lost to Follow-up|4|||
161491861|NCT05661942|583196576|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
161491862|NCT05661942|583196577|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
161491863|NCT00001596|583196588|FG000|Overall Study|Death|1|||
161491864|NCT00001596|583196589|FG001|Overall Study|Death|0|||
161491865|NCT00001596|583196588|FG000|Overall Study|Withdrawal by Subject|3|||
161491866|NCT00001596|583196589|FG001|Overall Study|Withdrawal by Subject|1|||
161491867|NCT00001596|583196588|FG000|Overall Study|Study Termination|12|||
161491868|NCT00001596|583196589|FG001|Overall Study|Study Termination|9|||
161491869|NCT00001596|583196588|FG000|Overall Study|Adverse Event|1|||
161491870|NCT00001596|583196589|FG001|Overall Study|Adverse Event|0|||
161491871|NCT03274687|583196590|FG000|Overall Study|Protocol Violation|1|||
161491872|NCT03274687|583196591|FG001|Overall Study|Protocol Violation|1|||
161491873|NCT01572909|583196594|FG000|Overall Study|Adverse Event|7|||
161491874|NCT01572909|583196595|FG001|Overall Study|Adverse Event|2|||
161491875|NCT01572909|583196594|FG000|Overall Study|Death|3|||
161491876|NCT01572909|583196595|FG001|Overall Study|Death|1|||
161491877|NCT01572909|583196594|FG000|Overall Study|Lost to Follow-up|8|||
161491878|NCT01572909|583196595|FG001|Overall Study|Lost to Follow-up|7|||
161491879|NCT01572909|583196594|FG000|Overall Study|Physician Decision|1|||
161491880|NCT01572909|583196595|FG001|Overall Study|Physician Decision|1|||
161491881|NCT01572909|583196594|FG000|Overall Study|Technical Issues|1|||
161491882|NCT01572909|583196595|FG001|Overall Study|Technical Issues|0|||
161491883|NCT01572909|583196594|FG000|Overall Study|Withdrawal by Subject|12|||
161491884|NCT01572909|583196595|FG001|Overall Study|Withdrawal by Subject|11|||
161491885|NCT01572909|583196594|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
161491886|NCT01572909|583196595|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
161491887|NCT01199289|583196596|FG000|Overall Study|Ineligibility determined|2|||
161491888|NCT01199289|583196597|FG001|Overall Study|Ineligibility determined|1|||
161491889|NCT01199289|583196598|FG002|Overall Study|Ineligibility determined|0|||
161491890|NCT01199289|583196599|FG003|Overall Study|Ineligibility determined|0|||
161491891|NCT01199289|583196596|FG000|Overall Study|Protocol Violation|1|||
161491892|NCT01199289|583196597|FG001|Overall Study|Protocol Violation|0|||
161491893|NCT01199289|583196598|FG002|Overall Study|Protocol Violation|0|||
161491894|NCT01199289|583196599|FG003|Overall Study|Protocol Violation|1|||
161491895|NCT01199289|583196596|FG000|Overall Study|Noncompliance|1|||
161491896|NCT01199289|583196597|FG001|Overall Study|Noncompliance|0|||
161491897|NCT01199289|583196598|FG002|Overall Study|Noncompliance|2|||
161491898|NCT01199289|583196599|FG003|Overall Study|Noncompliance|0|||
161491899|NCT01199289|583196596|FG000|Overall Study|Adverse Event|0|||
161491900|NCT01199289|583196597|FG001|Overall Study|Adverse Event|3|||
161491901|NCT01199289|583196598|FG002|Overall Study|Adverse Event|1|||
161491902|NCT01199289|583196599|FG003|Overall Study|Adverse Event|4|||
161491903|NCT01199289|583196596|FG000|Overall Study|Full consent withdrawn|2|||
161491904|NCT01199289|583196597|FG001|Overall Study|Full consent withdrawn|2|||
161491905|NCT01199289|583196598|FG002|Overall Study|Full consent withdrawn|2|||
161491906|NCT01199289|583196599|FG003|Overall Study|Full consent withdrawn|3|||
161491907|NCT01199289|583196596|FG000|Overall Study|Administrative decision|0|||
161491908|NCT01199289|583196597|FG001|Overall Study|Administrative decision|0|||
161491909|NCT01199289|583196598|FG002|Overall Study|Administrative decision|0|||
161491910|NCT01199289|583196599|FG003|Overall Study|Administrative decision|1|||
161491911|NCT01199289|583196596|FG000|Overall Study|Lost to Follow-up|0|||
161491912|NCT01199289|583196597|FG001|Overall Study|Lost to Follow-up|0|||
161491913|NCT01199289|583196598|FG002|Overall Study|Lost to Follow-up|0|||
161491914|NCT01199289|583196599|FG003|Overall Study|Lost to Follow-up|1|||
161491915|NCT01199289|583196596|FG000|Overall Study|Protocol-specified criteria|3|||
161491916|NCT01199289|583196597|FG001|Overall Study|Protocol-specified criteria|0|||
161491917|NCT01199289|583196598|FG002|Overall Study|Protocol-specified criteria|0|||
161491918|NCT01199289|583196599|FG003|Overall Study|Protocol-specified criteria|1|||
161491919|NCT01199289|583196596|FG000|Overall Study|Pregnancy|0|||
161491920|NCT01199289|583196597|FG001|Overall Study|Pregnancy|1|||
161491921|NCT01199289|583196598|FG002|Overall Study|Pregnancy|0|||
161491922|NCT01199289|583196599|FG003|Overall Study|Pregnancy|1|||
161491923|NCT02636868|583196600|FG000|Overall Study|Death|0|||
161491924|NCT02636868|583196601|FG001|Overall Study|Death|1|||
161491925|NCT02636868|583196602|FG002|Overall Study|Death|2|||
161491926|NCT00903617|583196608|FG000|Overall Study|Adverse Event|0|||
161491927|NCT00903617|583196609|FG001|Overall Study|Adverse Event|1|||
161491928|NCT00903617|583196610|FG002|Overall Study|Adverse Event|1|||
161491929|NCT00903617|583196611|FG003|Overall Study|Adverse Event|0|||
161491930|NCT00903617|583196608|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161491931|NCT00903617|583196609|FG001|Overall Study|Protocol-defined stopping criteria|2|||
161491932|NCT00903617|583196610|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161491933|NCT00903617|583196611|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161491934|NCT00903617|583196608|FG000|Overall Study|Lost to Follow-up|2|||
161491935|NCT00903617|583196609|FG001|Overall Study|Lost to Follow-up|0|||
161491936|NCT00903617|583196610|FG002|Overall Study|Lost to Follow-up|1|||
161491937|NCT00903617|583196611|FG003|Overall Study|Lost to Follow-up|1|||
161491938|NCT00903617|583196608|FG000|Overall Study|Withdrawal by Subject|1|||
161491939|NCT00903617|583196609|FG001|Overall Study|Withdrawal by Subject|2|||
161491940|NCT00903617|583196610|FG002|Overall Study|Withdrawal by Subject|3|||
161491941|NCT00903617|583196611|FG003|Overall Study|Withdrawal by Subject|0|||
161491942|NCT01104636|583196612|FG000|Overall Study|Lack of Efficacy|43|||
161491943|NCT01104636|583196612|FG000|Overall Study|Lost to Follow-up|24|||
161491944|NCT01104636|583196612|FG000|Overall Study|Withdrawal by Subject|4|||
161491945|NCT01104636|583196612|FG000|Overall Study|Other|43|||
161491946|NCT01104636|583196612|FG000|Overall Study|Study terminated by sponsor|1|||
161491947|NCT01104636|583196612|FG000|Overall Study|Pregnancy|2|||
161491948|NCT01104636|583196612|FG000|Overall Study|Adverse Event|40|||
161491949|NCT01104636|583196612|FG000|Overall Study|Ongoing|21|||
161491950|NCT01706003|583196613|FG000|Overall Study|Withdrawal by Subject|2|||
161491951|NCT01706003|583196614|FG001|Overall Study|Withdrawal by Subject|0|||
161491952|NCT01706003|583196613|FG000|Overall Study|Not scheduled|3|||
161491953|NCT01706003|583196614|FG001|Overall Study|Not scheduled|0|||
161491954|NCT01706003|583196613|FG000|Overall Study|Lost to Follow-up|6|||
161491955|NCT01706003|583196614|FG001|Overall Study|Lost to Follow-up|4|||
161491956|NCT03316131|583196615|FG000|Treatment Period 2|Protocol deviation|1|||
161491957|NCT03316131|583196616|FG001|Treatment Period 2|Protocol deviation|0|||
161491958|NCT05608005|583196618|FG000|Overall Study|Adverse Event|2|||
161491959|NCT05608005|583196619|FG001|Overall Study|Adverse Event|1|||
161491960|NCT05608005|583196620|FG002|Overall Study|Adverse Event|3|||
161491961|NCT05608005|583196618|FG000|Overall Study|Protocol Violation|2|||
161491962|NCT05608005|583196619|FG001|Overall Study|Protocol Violation|3|||
161491963|NCT05608005|583196620|FG002|Overall Study|Protocol Violation|0|||
161491964|NCT05608005|583196618|FG000|Overall Study|Withdrawal by Subject|10|||
161491965|NCT05608005|583196619|FG001|Overall Study|Withdrawal by Subject|12|||
161491966|NCT05608005|583196620|FG002|Overall Study|Withdrawal by Subject|4|||
161491967|NCT05608005|583196618|FG000|Overall Study|Lost to Follow-up|25|||
161491968|NCT05608005|583196619|FG001|Overall Study|Lost to Follow-up|27|||
161491969|NCT05608005|583196620|FG002|Overall Study|Lost to Follow-up|15|||
161491970|NCT05608005|583196618|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
161491971|NCT05608005|583196619|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
161491972|NCT05608005|583196620|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
161491973|NCT03518073|583196621|FG000|Overall Study|Adverse Event|2|||
161817270|NCT02055547|584370995|FG006|Overall Study|Withdrawal by Subject|0|||
161817271|NCT02055547|584370996|FG007|Overall Study|Withdrawal by Subject|0|||
161491974|NCT03518073|583196622|FG001|Overall Study|Adverse Event|4|||
161491975|NCT03518073|583196623|FG002|Overall Study|Adverse Event|2|||
161491976|NCT03518073|583196621|FG000|Overall Study|Death|2|||
161491977|NCT03518073|583196622|FG001|Overall Study|Death|1|||
161491978|NCT03518073|583196623|FG002|Overall Study|Death|3|||
161491979|NCT03518073|583196621|FG000|Overall Study|Lost to Follow-up|1|||
161491980|NCT03518073|583196622|FG001|Overall Study|Lost to Follow-up|0|||
161491981|NCT03518073|583196623|FG002|Overall Study|Lost to Follow-up|1|||
161491982|NCT03518073|583196621|FG000|Overall Study|Physician Decision|5|||
161491983|NCT03518073|583196622|FG001|Overall Study|Physician Decision|0|||
161491984|NCT03518073|583196623|FG002|Overall Study|Physician Decision|2|||
161491985|NCT03518073|583196621|FG000|Overall Study|Progressive disease|1|||
161491986|NCT03518073|583196622|FG001|Overall Study|Progressive disease|1|||
161491987|NCT03518073|583196623|FG002|Overall Study|Progressive disease|1|||
161491988|NCT03518073|583196621|FG000|Overall Study|Protocol Violation|1|||
161491989|NCT03518073|583196622|FG001|Overall Study|Protocol Violation|0|||
161817272|NCT02055547|584370997|FG008|Overall Study|Withdrawal by Subject|1|||
161817273|NCT02055547|584370998|FG009|Overall Study|Withdrawal by Subject|0|||
161491990|NCT03518073|583196623|FG002|Overall Study|Protocol Violation|0|||
161817274|NCT02055547|584370999|FG010|Overall Study|Withdrawal by Subject|0|||
161817275|NCT02055547|584371000|FG011|Overall Study|Withdrawal by Subject|0|||
161817276|NCT02055547|584371001|FG012|Overall Study|Withdrawal by Subject|0|||
161491991|NCT03518073|583196621|FG000|Overall Study|Withdrawal by Subject|30|||
161491992|NCT03518073|583196622|FG001|Overall Study|Withdrawal by Subject|34|||
161491993|NCT03518073|583196623|FG002|Overall Study|Withdrawal by Subject|29|||
161491994|NCT03518073|583196621|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
161491995|NCT03518073|583196622|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
161583797|NCT01551355|583524191|FG001|Overall Study|Lost to Follow-up|49|||
161491996|NCT03518073|583196623|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
161491997|NCT03518073|583196621|FG000|Overall Study|Covid-19|1|||
161491998|NCT03518073|583196622|FG001|Overall Study|Covid-19|2|||
161491999|NCT03518073|583196623|FG002|Overall Study|Covid-19|1|||
161492000|NCT03045081|583196624|FG000|Overall Study|Withdrawal by Subject|6|||
161492001|NCT03045081|583196625|FG001|Overall Study|Withdrawal by Subject|11|||
161492002|NCT02169739|583196627|FG000|Overall Study|Lost to Follow-up|0|||
161492003|NCT02169739|583196628|FG001|Overall Study|Lost to Follow-up|4|||
161492004|NCT01244906|583196630|FG000|Overall Study|Death|2|||
161492005|NCT01244906|583196630|FG000|Overall Study|Progression of disease post treatment|6|||
161492006|NCT03480750|583196631|FG000|Overall Study|Withdrawal by Subject|0|||
161492007|NCT03480750|583196632|FG001|Overall Study|Withdrawal by Subject|1|||
161492008|NCT03480750|583196633|FG002|Overall Study|Withdrawal by Subject|0|||
161492009|NCT03480750|583196634|FG003|Overall Study|Withdrawal by Subject|0|||
161492010|NCT03480750|583196635|FG004|Overall Study|Withdrawal by Subject|0|||
161492011|NCT03480750|583196636|FG005|Overall Study|Withdrawal by Subject|0|||
161492012|NCT03480750|583196631|FG000|Overall Study|The interruption in Trientine shippment|0|||
161492013|NCT03480750|583196632|FG001|Overall Study|The interruption in Trientine shippment|0|||
161492014|NCT03480750|583196633|FG002|Overall Study|The interruption in Trientine shippment|0|||
161492015|NCT03480750|583196634|FG003|Overall Study|The interruption in Trientine shippment|0|||
161492016|NCT03480750|583196635|FG004|Overall Study|The interruption in Trientine shippment|0|||
161492017|NCT03480750|583196636|FG005|Overall Study|The interruption in Trientine shippment|1|||
161492018|NCT03683758|583196641|FG000|Overall Study|Non-study commitment conflict|1|||
161492019|NCT03683758|583196642|FG001|Overall Study|Non-study commitment conflict|3|||
161492020|NCT03683758|583196641|FG000|Overall Study|Illness preventing participation|1|||
161492021|NCT03683758|583196642|FG001|Overall Study|Illness preventing participation|0|||
161492022|NCT03683758|583196641|FG000|Overall Study|Adverse Event|1|||
161492023|NCT03683758|583196642|FG001|Overall Study|Adverse Event|0|||
161492024|NCT00723892|583196645|FG000|Overall Study|Participant not tracked|33|||
161492025|NCT00723892|583196646|FG001|Overall Study|Participant not tracked|35|||
161492026|NCT00723892|583196645|FG000|Overall Study|Virological criterion|24|||
161492027|NCT00723892|583196646|FG001|Overall Study|Virological criterion|9|||
161492028|NCT00723892|583196645|FG000|Overall Study|Withdrawal by Subject|6|||
161492029|NCT00723892|583196646|FG001|Overall Study|Withdrawal by Subject|9|||
161492030|NCT00723892|583196645|FG000|Overall Study|End planned|11|||
161492031|NCT00723892|583196646|FG001|Overall Study|End planned|7|||
161492032|NCT00723892|583196645|FG000|Overall Study|Bad tolerance|5|||
161492033|NCT00723892|583196646|FG001|Overall Study|Bad tolerance|5|||
161492034|NCT00723892|583196645|FG000|Overall Study|Multiple reasons|17|||
161492035|NCT00723892|583196646|FG001|Overall Study|Multiple reasons|12|||
161492036|NCT00723892|583196645|FG000|Overall Study|Other|6|||
161492037|NCT00723892|583196646|FG001|Overall Study|Other|3|||
161492038|NCT00723892|583196645|FG000|Overall Study|Study end|1|||
161492039|NCT00723892|583196646|FG001|Overall Study|Study end|3|||
161492040|NCT00723892|583196645|FG000|Overall Study|Weight loss|1|||
161583798|NCT01551355|583524192|FG002|Overall Study|Lost to Follow-up|34|||
161583799|NCT01551355|583524193|FG003|Overall Study|Lost to Follow-up|24|||
161583800|NCT01551355|583524194|FG004|Overall Study|Lost to Follow-up|9|||
161583801|NCT01551355|583524195|FG005|Overall Study|Lost to Follow-up|6|||
161583802|NCT00031694|583524196|FG000|Overall Study|Adverse Event|12|||
161583803|NCT00031694|583524196|FG000|Overall Study|Death|2|||
161583804|NCT00031694|583524196|FG000|Overall Study|Withdrawal by Subject|5|||
161583805|NCT01538719|583524201|FG000|Overall Study|Lost to Follow-up|2|||
161583806|NCT01538719|583524202|FG001|Overall Study|Lost to Follow-up|0|||
161583807|NCT01255670|583524205|FG000|Overall Study|Adverse Event|10|||
161583808|NCT01255670|583524206|FG001|Overall Study|Adverse Event|10|||
161583809|NCT01255670|583524205|FG000|Overall Study|Lost to Follow-up|16|||
161583810|NCT01255670|583524206|FG001|Overall Study|Lost to Follow-up|10|||
161583811|NCT03892564|583524207|FG000|Overall Study|Withdrawal by Subject|2|||
161583812|NCT03664960|583524208|FG000|Overall Study|Adverse Event|0|||
161583813|NCT03664960|583524209|FG001|Overall Study|Adverse Event|3|||
161583814|NCT03664960|583524208|FG000|Overall Study|Lost to Follow-up|3|||
161583815|NCT03664960|583524209|FG001|Overall Study|Lost to Follow-up|2|||
161492041|NCT00723892|583196646|FG001|Overall Study|Weight loss|3|||
161492042|NCT00723892|583196645|FG000|Overall Study|Alcohol abuse|0|||
161492043|NCT00723892|583196646|FG001|Overall Study|Alcohol abuse|1|||
161492044|NCT00723892|583196645|FG000|Overall Study|Intercurrent infection|2|||
161583816|NCT03664960|583524208|FG000|Overall Study|Physician Decision|1|||
161583817|NCT03664960|583524209|FG001|Overall Study|Physician Decision|0|||
161583818|NCT03664960|583524208|FG000|Overall Study|Withdrawal by Subject|3|||
161583819|NCT03664960|583524209|FG001|Overall Study|Withdrawal by Subject|14|||
161492045|NCT00723892|583196646|FG001|Overall Study|Intercurrent infection|0|||
161492046|NCT00723892|583196645|FG000|Overall Study|Drug addiction|1|||
161492047|NCT00723892|583196646|FG001|Overall Study|Drug addiction|0|||
161492048|NCT02411292|583196647|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
161492049|NCT02411292|583196647|FG000|Overall Study|Death|2|||
161492050|NCT02411292|583196647|FG000|Overall Study|Lost to Follow-up|3|||
161492051|NCT00453921|583196648|FG000|Overall Study|Withdrawal by Subject|1|||
161492052|NCT00453921|583196649|FG001|Overall Study|Withdrawal by Subject|1|||
161492053|NCT00453921|583196650|FG002|Overall Study|Withdrawal by Subject|1|||
161492054|NCT00453921|583196651|FG003|Overall Study|Withdrawal by Subject|1|||
161492055|NCT00453921|583196648|FG000|Overall Study|Lost to Follow-up|0|||
161492056|NCT00453921|583196649|FG001|Overall Study|Lost to Follow-up|0|||
161492057|NCT00453921|583196650|FG002|Overall Study|Lost to Follow-up|1|||
161492058|NCT00453921|583196651|FG003|Overall Study|Lost to Follow-up|0|||
161492059|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
161492060|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
161492061|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
161492062|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
161492063|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
161492064|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
161492065|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
161492066|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
161492067|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Other|4|||
161492068|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Other|1|||
161492069|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
161492070|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
161492071|NCT00303498|583196652|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
161492072|NCT00303498|583196653|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
161492073|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
161492074|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
161492075|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Death|1|||
161492076|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Death|0|||
161492077|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
161492078|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
161492079|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
161492080|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
161492081|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
161492082|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
161492083|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
161492084|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
161492085|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Other|1|||
161492086|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Other|0|||
161492087|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
161492088|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
161492089|NCT00303498|583196652|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
161492090|NCT00303498|583196653|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
161492091|NCT00174915|583196654|FG000|Overall Study|Lost to Follow-up|19|||
161492092|NCT00174915|583196655|FG001|Overall Study|Lost to Follow-up|17|||
161492093|NCT00174915|583196656|FG002|Overall Study|Lost to Follow-up|9|||
161492094|NCT00174915|583196657|FG003|Overall Study|Lost to Follow-up|17|||
161492095|NCT00174915|583196658|FG004|Overall Study|Lost to Follow-up|10|||
161492096|NCT00174915|583196654|FG000|Overall Study|Adverse Event|18|||
161492097|NCT00174915|583196655|FG001|Overall Study|Adverse Event|16|||
161492098|NCT00174915|583196656|FG002|Overall Study|Adverse Event|11|||
161492099|NCT00174915|583196657|FG003|Overall Study|Adverse Event|18|||
161492100|NCT00174915|583196658|FG004|Overall Study|Adverse Event|5|||
161492101|NCT00174915|583196654|FG000|Overall Study|Personal Reason(s)|16|||
161492102|NCT00174915|583196655|FG001|Overall Study|Personal Reason(s)|16|||
161492103|NCT00174915|583196656|FG002|Overall Study|Personal Reason(s)|9|||
161492104|NCT00174915|583196657|FG003|Overall Study|Personal Reason(s)|9|||
161492105|NCT00174915|583196658|FG004|Overall Study|Personal Reason(s)|9|||
161492106|NCT00174915|583196654|FG000|Overall Study|Other|15|||
161492107|NCT00174915|583196655|FG001|Overall Study|Other|8|||
161492108|NCT00174915|583196656|FG002|Overall Study|Other|6|||
161492109|NCT00174915|583196657|FG003|Overall Study|Other|5|||
161492110|NCT00174915|583196658|FG004|Overall Study|Other|3|||
161492111|NCT00174915|583196654|FG000|Overall Study|Gout Flare|13|||
161492112|NCT00174915|583196655|FG001|Overall Study|Gout Flare|6|||
161492113|NCT00174915|583196656|FG002|Overall Study|Gout Flare|8|||
161492114|NCT00174915|583196657|FG003|Overall Study|Gout Flare|1|||
161492115|NCT00174915|583196658|FG004|Overall Study|Gout Flare|0|||
161492116|NCT00174915|583196654|FG000|Overall Study|Protocol Violation|6|||
161492117|NCT00174915|583196655|FG001|Overall Study|Protocol Violation|3|||
161492118|NCT00174915|583196656|FG002|Overall Study|Protocol Violation|3|||
161492119|NCT00174915|583196657|FG003|Overall Study|Protocol Violation|6|||
161492120|NCT00174915|583196658|FG004|Overall Study|Protocol Violation|3|||
161492121|NCT00174915|583196654|FG000|Overall Study|Therapeutic Failure|6|||
161492122|NCT00174915|583196655|FG001|Overall Study|Therapeutic Failure|3|||
161492123|NCT00174915|583196656|FG002|Overall Study|Therapeutic Failure|2|||
161492124|NCT00174915|583196657|FG003|Overall Study|Therapeutic Failure|1|||
161492125|NCT00174915|583196658|FG004|Overall Study|Therapeutic Failure|3|||
161492126|NCT03060447|583196659|FG000|Overall Study|Withdrawal by Subject|2|||
161492127|NCT03060447|583196660|FG001|Overall Study|Withdrawal by Subject|0|||
161492128|NCT02232425|583196661|FG000|Overall Study|Lost to Follow-up|6|||
161492129|NCT02232425|583196662|FG001|Overall Study|Lost to Follow-up|2|||
161492130|NCT02232425|583196661|FG000|Overall Study|Adverse Event|2|||
161492131|NCT02232425|583196662|FG001|Overall Study|Adverse Event|0|||
161492132|NCT02232425|583196661|FG000|Overall Study|Withdrawal by Subject|5|||
161492133|NCT02232425|583196662|FG001|Overall Study|Withdrawal by Subject|6|||
161492134|NCT02232425|583196661|FG000|Overall Study|Lack of Efficacy|1|||
161492135|NCT02232425|583196662|FG001|Overall Study|Lack of Efficacy|0|||
161492136|NCT01601626|583196665|FG000|Overall Study|Death|1|||
161492137|NCT01601626|583196666|FG001|Overall Study|Death|1|||
161492138|NCT01601626|583196667|FG002|Overall Study|Death|1|||
161492139|NCT01601626|583196665|FG000|Overall Study|Lost to Follow-up|1|||
161492140|NCT01601626|583196666|FG001|Overall Study|Lost to Follow-up|2|||
161492141|NCT01601626|583196667|FG002|Overall Study|Lost to Follow-up|0|||
161492142|NCT01601626|583196665|FG000|Overall Study|Unable to Get to Clinic|0|||
161492143|NCT01601626|583196666|FG001|Overall Study|Unable to Get to Clinic|1|||
161492144|NCT01601626|583196667|FG002|Overall Study|Unable to Get to Clinic|0|||
161492145|NCT01601626|583196665|FG000|Overall Study|Withdrawal by Subject|0|||
161492146|NCT01601626|583196666|FG001|Overall Study|Withdrawal by Subject|1|||
161492147|NCT01601626|583196667|FG002|Overall Study|Withdrawal by Subject|1|||
161492148|NCT01601626|583196665|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
161492149|NCT01601626|583196666|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
161492150|NCT01601626|583196667|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
161492151|NCT00546637|583196668|FG000|Overall Study|Adverse Event|46|||
161492152|NCT00546637|583196669|FG001|Overall Study|Adverse Event|20|||
161492153|NCT00546637|583196668|FG000|Overall Study|Lack of Efficacy|5|||
161492154|NCT00546637|583196669|FG001|Overall Study|Lack of Efficacy|5|||
161492155|NCT00546637|583196668|FG000|Overall Study|Lost to Follow-up|2|||
161492156|NCT00546637|583196669|FG001|Overall Study|Lost to Follow-up|2|||
161492157|NCT00546637|583196668|FG000|Overall Study|Other|10|||
161492158|NCT00546637|583196669|FG001|Overall Study|Other|12|||
161492159|NCT00546637|583196668|FG000|Overall Study|Withdrawal by Subject|7|||
161492160|NCT00546637|583196669|FG001|Overall Study|Withdrawal by Subject|9|||
161492161|NCT00546637|583196668|FG000|Overall Study|Randomized, but not treated|3|||
161492162|NCT00546637|583196669|FG001|Overall Study|Randomized, but not treated|1|||
161492163|NCT04984993|583196673|FG000|Overall Study|Withdrawal by Subject|8|||
161492164|NCT04984993|583196674|FG001|Overall Study|Withdrawal by Subject|2|||
161492165|NCT04984993|583196673|FG000|Overall Study|Lost to Follow-up|2|||
161492166|NCT04984993|583196674|FG001|Overall Study|Lost to Follow-up|2|||
161492167|NCT04984993|583196673|FG000|Overall Study|Both patients moved to another country|4|||
161492168|NCT04984993|583196674|FG001|Overall Study|Both patients moved to another country|0|||
161492169|NCT01110707|583196675|FG000|Overall Study|Protocol Violation|0|||
161492170|NCT01110707|583196676|FG001|Overall Study|Protocol Violation|3|||
161492171|NCT03108027|583196681|FG000|Period 1|Subject/Guardian Decision|0|||
161492172|NCT03108027|583196682|FG001|Period 1|Subject/Guardian Decision|0|||
161492173|NCT03108027|583196683|FG002|Period 1|Subject/Guardian Decision|0|||
161492174|NCT03108027|583196684|FG003|Period 1|Subject/Guardian Decision|2|||
161492175|NCT03108027|583196685|FG004|Period 1|Subject/Guardian Decision|0|||
161492176|NCT03108027|583196686|FG005|Period 1|Subject/Guardian Decision|0|||
161492177|NCT03108027|583196681|FG000|Period 3|Adverse Event|0|||
161492178|NCT03108027|583196682|FG001|Period 3|Adverse Event|1|||
161492179|NCT03108027|583196683|FG002|Period 3|Adverse Event|0|||
161492180|NCT03108027|583196684|FG003|Period 3|Adverse Event|0|||
161492181|NCT03108027|583196685|FG004|Period 3|Adverse Event|0|||
161492182|NCT03108027|583196686|FG005|Period 3|Adverse Event|0|||
161671618|NCT04427501|583851345|FG009|Overall Study|Withdrawal by Subject|1|||
161671619|NCT04427501|583851346|FG010|Overall Study|Withdrawal by Subject|4|||
161671620|NCT04427501|583851347|FG011|Overall Study|Withdrawal by Subject|0|||
161671621|NCT04427501|583851336|FG000|Overall Study|Other - as reported by the investigator|1|||
161817277|NCT02055547|584371002|FG013|Overall Study|Withdrawal by Subject|1|||
161492183|NCT02426892|583196687|FG000|Overall Study|Adverse Event|2|||
161817278|NCT02055547|584371003|FG014|Overall Study|Withdrawal by Subject|0|||
161492184|NCT02426892|583196687|FG000|Overall Study|Lack of Efficacy|17|||
161492185|NCT02426892|583196687|FG000|Overall Study|Withdrawal by Subject|1|||
161492186|NCT03178773|583196688|FG000|Overall Study|Death|0|||
161492187|NCT03178773|583196689|FG001|Overall Study|Death|1|||
161492188|NCT03178773|583196688|FG000|Overall Study|Lost to Follow-up|29|||
161492189|NCT03178773|583196689|FG001|Overall Study|Lost to Follow-up|25|||
161492190|NCT03178773|583196688|FG000|Overall Study|Withdrawal by Subject|10|||
161492191|NCT03178773|583196689|FG001|Overall Study|Withdrawal by Subject|14|||
161492192|NCT01382446|583196690|FG000|Overall Study|Withdrawal by Subject|0|||
161492193|NCT01382446|583196691|FG001|Overall Study|Withdrawal by Subject|1|||
161671622|NCT04427501|583851337|FG001|Overall Study|Other - as reported by the investigator|0|||
161492194|NCT01382446|583196690|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
161492195|NCT01382446|583196691|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
161671623|NCT04427501|583851338|FG002|Overall Study|Other - as reported by the investigator|0|||
161492196|NCT00003901|583196692|FG000|Overall Study|Adverse Event|1|||
161817279|NCT02055547|584371004|FG015|Overall Study|Withdrawal by Subject|1|||
161817280|NCT02055547|584371005|FG016|Overall Study|Withdrawal by Subject|0|||
161817281|NCT02055547|584371006|FG017|Overall Study|Withdrawal by Subject|0|||
161817282|NCT02055547|584371007|FG018|Overall Study|Withdrawal by Subject|0|||
161817283|NCT02055547|584370989|FG000|Overall Study|Lost to Follow-up|0|||
161817284|NCT02055547|584370990|FG001|Overall Study|Lost to Follow-up|0|||
161817285|NCT02055547|584370991|FG002|Overall Study|Lost to Follow-up|1|||
161817286|NCT02055547|584370992|FG003|Overall Study|Lost to Follow-up|0|||
161817287|NCT02055547|584370993|FG004|Overall Study|Lost to Follow-up|0|||
161817288|NCT02055547|584370994|FG005|Overall Study|Lost to Follow-up|0|||
161817289|NCT02055547|584370995|FG006|Overall Study|Lost to Follow-up|0|||
161817290|NCT02055547|584370996|FG007|Overall Study|Lost to Follow-up|0|||
161817291|NCT02055547|584370997|FG008|Overall Study|Lost to Follow-up|0|||
161817292|NCT02055547|584370998|FG009|Overall Study|Lost to Follow-up|0|||
161817293|NCT02055547|584370999|FG010|Overall Study|Lost to Follow-up|0|||
161817294|NCT02055547|584371000|FG011|Overall Study|Lost to Follow-up|0|||
161817295|NCT02055547|584371001|FG012|Overall Study|Lost to Follow-up|0|||
161817296|NCT02055547|584371002|FG013|Overall Study|Lost to Follow-up|0|||
161817297|NCT02055547|584371003|FG014|Overall Study|Lost to Follow-up|0|||
161817298|NCT02055547|584371004|FG015|Overall Study|Lost to Follow-up|0|||
161817299|NCT02055547|584371005|FG016|Overall Study|Lost to Follow-up|0|||
161817300|NCT02055547|584371006|FG017|Overall Study|Lost to Follow-up|0|||
161817301|NCT02055547|584371007|FG018|Overall Study|Lost to Follow-up|0|||
161817302|NCT01653704|584371008|FG000|Overall Study|Technical failure during recording|1|||
161817303|NCT01653704|584371009|FG001|Overall Study|Technical failure during recording|1|||
161817304|NCT01653704|584371008|FG000|Overall Study|Performance not reflective of training|1|||
161817305|NCT01653704|584371009|FG001|Overall Study|Performance not reflective of training|0|||
161817306|NCT03966911|584371010|FG000|Overall Study|Adverse Event|1|||
161817307|NCT03966911|584371011|FG001|Overall Study|Adverse Event|1|||
161817308|NCT03966911|584371010|FG000|Overall Study|Withdrawal by Subject|8|||
161817309|NCT03966911|584371011|FG001|Overall Study|Withdrawal by Subject|2|||
161492197|NCT00003901|583196692|FG000|Overall Study|Withdrawal by Subject|1|||
161492198|NCT00003901|583196692|FG000|Overall Study|Ineligible|6|||
161492199|NCT00003901|583196692|FG000|Overall Study|CT Scan not within protocol requirement|2|||
161492200|NCT00003901|583196692|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
161492201|NCT00003901|583196692|FG000|Overall Study|Medical problems|6|||
161492202|NCT00268996|583196695|FG000|Overall Study|Adverse Event|11|||
161492203|NCT00268996|583196696|FG001|Overall Study|Adverse Event|7|||
161492204|NCT00268996|583196695|FG000|Overall Study|Lost to Follow-up|3|||
161492205|NCT00268996|583196696|FG001|Overall Study|Lost to Follow-up|1|||
161492206|NCT00268996|583196695|FG000|Overall Study|Withdrawal by Subject|5|||
161492207|NCT00268996|583196696|FG001|Overall Study|Withdrawal by Subject|11|||
161492208|NCT00268996|583196695|FG000|Overall Study|Non-compliance|1|||
161492209|NCT00268996|583196696|FG001|Overall Study|Non-compliance|0|||
161492210|NCT00268996|583196695|FG000|Overall Study|Other|1|||
161492211|NCT00268996|583196696|FG001|Overall Study|Other|1|||
161492212|NCT03325075|583196699|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
161492213|NCT03325075|583196700|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
161492214|NCT03325075|583196701|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
161492215|NCT03325075|583196702|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
161492216|NCT03325075|583196699|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
161492217|NCT03325075|583196700|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
161492218|NCT03325075|583196701|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
161492219|NCT03325075|583196702|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
161492220|NCT03325075|583196699|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
161492221|NCT03325075|583196700|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
161492222|NCT03325075|583196701|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
161492223|NCT03325075|583196702|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
161492224|NCT00422591|583196703|FG000|Overall Study|Physician Decision|4|||
161492225|NCT00422591|583196703|FG000|Overall Study|Withdrawal by Subject|2|||
161492226|NCT00541034|583196706|FG000|Overall Study|Non-Compliance|3|||
161492227|NCT00847704|583196707|FG000|Overall Study|Withdrawal by Subject|1|||
161492228|NCT05838742|583196711|FG000|Overall Study|Adverse Event|2|||
161492229|NCT05838742|583196712|FG001|Overall Study|Adverse Event|0|||
161492230|NCT05838742|583196713|FG002|Overall Study|Adverse Event|1|||
161492231|NCT05838742|583196714|FG003|Overall Study|Adverse Event|0|||
161492232|NCT05838742|583196715|FG004|Overall Study|Adverse Event|1|||
161492233|NCT05838742|583196711|FG000|Overall Study|Lost to Follow-up|1|||
161492234|NCT05838742|583196712|FG001|Overall Study|Lost to Follow-up|1|||
161492235|NCT05838742|583196713|FG002|Overall Study|Lost to Follow-up|1|||
161492236|NCT05838742|583196714|FG003|Overall Study|Lost to Follow-up|0|||
161492237|NCT05838742|583196715|FG004|Overall Study|Lost to Follow-up|0|||
161492238|NCT05838742|583196711|FG000|Overall Study|Physician Decision|0|||
161492239|NCT05838742|583196712|FG001|Overall Study|Physician Decision|0|||
161817310|NCT03966911|584371010|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
161492240|NCT05838742|583196713|FG002|Overall Study|Physician Decision|0|||
161583820|NCT03664960|583524208|FG000|Overall Study|Sponsor Decision|1|||
161583821|NCT03664960|583524209|FG001|Overall Study|Sponsor Decision|1|||
161583822|NCT03664960|583524208|FG000|Overall Study|Other|1|||
161583823|NCT03664960|583524209|FG001|Overall Study|Other|2|||
161583824|NCT04019444|583524210|FG000|Overall Study|Withdrawal by Subject|0|||
161583825|NCT04019444|583524211|FG001|Overall Study|Withdrawal by Subject|1|||
161583826|NCT04019444|583524212|FG002|Overall Study|Withdrawal by Subject|0|||
161583827|NCT04019444|583524213|FG003|Overall Study|Withdrawal by Subject|1|||
161583828|NCT04019444|583524210|FG000|Overall Study|Solicited Event|0|||
161583829|NCT04019444|583524211|FG001|Overall Study|Solicited Event|0|||
161583830|NCT04019444|583524212|FG002|Overall Study|Solicited Event|2|||
161583831|NCT04019444|583524213|FG003|Overall Study|Solicited Event|0|||
161583832|NCT03807778|583524214|FG000|Overall Study|Adverse Event|0|||
161583833|NCT03807778|583524215|FG001|Overall Study|Adverse Event|0|||
161583834|NCT03807778|583524216|FG002|Overall Study|Adverse Event|3|||
161583835|NCT03807778|583524217|FG003|Overall Study|Adverse Event|5|||
161583836|NCT03807778|583524214|FG000|Overall Study|Progressive Disease|4|||
161583837|NCT03807778|583524215|FG001|Overall Study|Progressive Disease|2|||
161583838|NCT03807778|583524216|FG002|Overall Study|Progressive Disease|8|||
161583839|NCT03807778|583524217|FG003|Overall Study|Progressive Disease|15|||
161583840|NCT03807778|583524214|FG000|Overall Study|Symptomatic Deterioration|0|||
161583841|NCT03807778|583524215|FG001|Overall Study|Symptomatic Deterioration|1|||
161583842|NCT03807778|583524216|FG002|Overall Study|Symptomatic Deterioration|0|||
161923143|NCT03369223|584764929|FG008|Overall Study|Participant request to discontinue study treatment|0|||
161923144|NCT03369223|584764930|FG009|Overall Study|Participant request to discontinue study treatment|0|||
161492241|NCT05838742|583196714|FG003|Overall Study|Physician Decision|0|||
161492242|NCT05838742|583196715|FG004|Overall Study|Physician Decision|1|||
161492243|NCT05838742|583196711|FG000|Overall Study|Withdrawal by Subject|8|||
161492244|NCT05838742|583196712|FG001|Overall Study|Withdrawal by Subject|3|||
161492245|NCT05838742|583196713|FG002|Overall Study|Withdrawal by Subject|3|||
161492246|NCT05838742|583196714|FG003|Overall Study|Withdrawal by Subject|1|||
161492247|NCT05838742|583196715|FG004|Overall Study|Withdrawal by Subject|4|||
161492248|NCT05838742|583196711|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
161492249|NCT05838742|583196712|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
161492250|NCT05838742|583196713|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
161492251|NCT05838742|583196714|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
161492252|NCT05838742|583196715|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
161492253|NCT05838742|583196711|FG000|Overall Study|Lack of Efficacy|0|||
161492254|NCT05838742|583196712|FG001|Overall Study|Lack of Efficacy|0|||
161492255|NCT05838742|583196713|FG002|Overall Study|Lack of Efficacy|0|||
161492256|NCT05838742|583196714|FG003|Overall Study|Lack of Efficacy|1|||
161492257|NCT05838742|583196715|FG004|Overall Study|Lack of Efficacy|0|||
161492258|NCT05838742|583196711|FG000|Overall Study|Randomized, not treated|2|||
161492259|NCT05838742|583196712|FG001|Overall Study|Randomized, not treated|1|||
161492260|NCT05838742|583196713|FG002|Overall Study|Randomized, not treated|0|||
161492261|NCT05838742|583196714|FG003|Overall Study|Randomized, not treated|1|||
161492262|NCT05838742|583196715|FG004|Overall Study|Randomized, not treated|0|||
161492263|NCT02045797|583196716|FG000|Overall Study|Adverse Event|3|||
161492264|NCT02045797|583196717|FG001|Overall Study|Adverse Event|1|||
161492265|NCT02045797|583196718|FG002|Overall Study|Adverse Event|0|||
161492266|NCT02045797|583196716|FG000|Overall Study|Lack of Efficacy|1|||
161492267|NCT02045797|583196717|FG001|Overall Study|Lack of Efficacy|0|||
161492268|NCT02045797|583196718|FG002|Overall Study|Lack of Efficacy|0|||
161492269|NCT02045797|583196716|FG000|Overall Study|Lost to Follow-up|2|||
161492270|NCT02045797|583196717|FG001|Overall Study|Lost to Follow-up|3|||
161492271|NCT02045797|583196718|FG002|Overall Study|Lost to Follow-up|1|||
161492272|NCT02045797|583196716|FG000|Overall Study|Physician Decision|0|||
161492273|NCT02045797|583196717|FG001|Overall Study|Physician Decision|1|||
161492274|NCT02045797|583196718|FG002|Overall Study|Physician Decision|0|||
161492275|NCT02045797|583196716|FG000|Overall Study|Withdrawal by Subject|1|||
161492276|NCT02045797|583196717|FG001|Overall Study|Withdrawal by Subject|2|||
161492277|NCT02045797|583196718|FG002|Overall Study|Withdrawal by Subject|0|||
161492278|NCT03851302|583196719|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
161492279|NCT03851302|583196720|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
161583843|NCT03807778|583524217|FG003|Overall Study|Symptomatic Deterioration|1|||
161583844|NCT03807778|583524214|FG000|Overall Study|Withdrawal by Subject|0|||
161583845|NCT03807778|583524215|FG001|Overall Study|Withdrawal by Subject|1|||
161583846|NCT03807778|583524216|FG002|Overall Study|Withdrawal by Subject|0|||
161492280|NCT03851302|583196721|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
161583847|NCT03807778|583524217|FG003|Overall Study|Withdrawal by Subject|1|||
161583848|NCT03807778|583524214|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
161671624|NCT04427501|583851339|FG003|Overall Study|Other - as reported by the investigator|0|||
161583849|NCT03807778|583524215|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
161583850|NCT03807778|583524216|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
161583851|NCT03807778|583524217|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
161492281|NCT03851302|583196722|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
161492282|NCT03851302|583196723|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
161492283|NCT03851302|583196724|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
161492284|NCT03851302|583196719|FG000|Screening (1 Day)|Screened out|0|||
161492285|NCT03851302|583196720|FG001|Screening (1 Day)|Screened out|0|||
161492286|NCT03851302|583196721|FG002|Screening (1 Day)|Screened out|1|||
161492287|NCT03851302|583196722|FG003|Screening (1 Day)|Screened out|1|||
161492288|NCT03851302|583196723|FG004|Screening (1 Day)|Screened out|0|||
161492289|NCT03851302|583196724|FG005|Screening (1 Day)|Screened out|0|||
161492290|NCT03851302|583196719|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
161492291|NCT03851302|583196720|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
161492292|NCT03851302|583196721|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
161492293|NCT03851302|583196722|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
161492294|NCT03851302|583196723|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
161492295|NCT03851302|583196724|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
161492296|NCT04405037|583196725|FG000|Overall Study|Withdrawal by Subject|1|||
161492297|NCT04405037|583196726|FG001|Overall Study|Withdrawal by Subject|0|||
161492298|NCT04405037|583196725|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
161492299|NCT04405037|583196726|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
161492300|NCT00501293|583198003|FG000|Optimization Period|Enrolled in error|1|||
161492301|NCT00501293|583198004|FG001|Optimization Period|Enrolled in error|0|||
161492302|NCT00501293|583198003|FG000|Maintenance Period|Withdrawal by Subject|14|||
161492303|NCT00501293|583198004|FG001|Maintenance Period|Withdrawal by Subject|13|||
161492304|NCT00501293|583198003|FG000|Maintenance Period|Lost to Follow-up|12|||
161492305|NCT00501293|583198004|FG001|Maintenance Period|Lost to Follow-up|7|||
161492306|NCT00501293|583198003|FG000|Maintenance Period|Adverse Event|6|||
161492307|NCT00501293|583198004|FG001|Maintenance Period|Adverse Event|6|||
161492308|NCT00501293|583198003|FG000|Maintenance Period|Protocol Violation|2|||
161492309|NCT00501293|583198004|FG001|Maintenance Period|Protocol Violation|1|||
161492310|NCT00501293|583198003|FG000|Maintenance Period|Lack of Efficacy|4|||
161492311|NCT00501293|583198004|FG001|Maintenance Period|Lack of Efficacy|1|||
161492312|NCT00501293|583198003|FG000|Maintenance Period|Noncompliant with study medication|5|||
161492313|NCT00501293|583198004|FG001|Maintenance Period|Noncompliant with study medication|0|||
161492314|NCT00501293|583198003|FG000|Maintenance Period|Went into rehabilitation|1|||
161492315|NCT00501293|583198004|FG001|Maintenance Period|Went into rehabilitation|0|||
161492316|NCT00501293|583198003|FG000|Maintenance Period|Would not wear patch|1|||
161492317|NCT00501293|583198004|FG001|Maintenance Period|Would not wear patch|0|||
161492318|NCT00501293|583198003|FG000|Maintenance Period|Application site reaction|1|||
161492319|NCT00501293|583198004|FG001|Maintenance Period|Application site reaction|0|||
161492320|NCT00498602|583198009|FG000|Overall Study|Death|0|||
161492321|NCT00498602|583198010|FG001|Overall Study|Death|0|||
161492322|NCT00498602|583198011|FG002|Overall Study|Death|0|||
161492323|NCT00498602|583198012|FG003|Overall Study|Death|0|||
161492324|NCT00498602|583198013|FG004|Overall Study|Death|0|||
161492325|NCT00498602|583198014|FG005|Overall Study|Death|1|||
161492326|NCT00498602|583198015|FG006|Overall Study|Death|0|||
161492327|NCT00498602|583198009|FG000|Overall Study|Lack of Efficacy|1|||
161492328|NCT00498602|583198010|FG001|Overall Study|Lack of Efficacy|0|||
161492329|NCT00498602|583198011|FG002|Overall Study|Lack of Efficacy|0|||
161492330|NCT00498602|583198012|FG003|Overall Study|Lack of Efficacy|0|||
161492331|NCT00498602|583198013|FG004|Overall Study|Lack of Efficacy|0|||
161492332|NCT00498602|583198014|FG005|Overall Study|Lack of Efficacy|0|||
161492333|NCT00498602|583198015|FG006|Overall Study|Lack of Efficacy|0|||
161671625|NCT04427501|583851340|FG004|Overall Study|Other - as reported by the investigator|0|||
161671626|NCT04427501|583851341|FG005|Overall Study|Other - as reported by the investigator|6|||
161671627|NCT04427501|583851342|FG006|Overall Study|Other - as reported by the investigator|6|||
161671628|NCT04427501|583851343|FG007|Overall Study|Other - as reported by the investigator|0|||
161671629|NCT04427501|583851344|FG008|Overall Study|Other - as reported by the investigator|0|||
161671630|NCT04427501|583851345|FG009|Overall Study|Other - as reported by the investigator|0|||
161671631|NCT04427501|583851346|FG010|Overall Study|Other - as reported by the investigator|0|||
161671632|NCT04427501|583851347|FG011|Overall Study|Other - as reported by the investigator|0|||
161671633|NCT04427501|583851336|FG000|Overall Study|Other|0|||
161671634|NCT04427501|583851337|FG001|Overall Study|Other|0|||
161671635|NCT04427501|583851338|FG002|Overall Study|Other|0|||
161817311|NCT03966911|584371011|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
161817312|NCT00985751|584371012|FG000|Overall Study|Adverse Event|0|||
161492334|NCT00498602|583198009|FG000|Overall Study|Lost to Follow-up|0|||
161492335|NCT00498602|583198010|FG001|Overall Study|Lost to Follow-up|2|||
161492336|NCT00498602|583198011|FG002|Overall Study|Lost to Follow-up|0|||
161492337|NCT00498602|583198012|FG003|Overall Study|Lost to Follow-up|2|||
161492338|NCT00498602|583198013|FG004|Overall Study|Lost to Follow-up|0|||
161492339|NCT00498602|583198014|FG005|Overall Study|Lost to Follow-up|0|||
161492340|NCT00498602|583198015|FG006|Overall Study|Lost to Follow-up|0|||
161492341|NCT00498602|583198009|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161492342|NCT00498602|583198010|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161671636|NCT04427501|583851339|FG003|Overall Study|Other|0|||
161492343|NCT00498602|583198011|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
161492344|NCT00498602|583198012|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
161492345|NCT00498602|583198013|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161492346|NCT00498602|583198014|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161492347|NCT00498602|583198015|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161492348|NCT00498602|583198009|FG000|Overall Study|AE not related to Study Drug|1|||
161492349|NCT00498602|583198010|FG001|Overall Study|AE not related to Study Drug|3|||
161492350|NCT00498602|583198011|FG002|Overall Study|AE not related to Study Drug|0|||
161492351|NCT00498602|583198012|FG003|Overall Study|AE not related to Study Drug|0|||
161492352|NCT00498602|583198013|FG004|Overall Study|AE not related to Study Drug|2|||
161492353|NCT00498602|583198014|FG005|Overall Study|AE not related to Study Drug|2|||
161492354|NCT00498602|583198015|FG006|Overall Study|AE not related to Study Drug|1|||
161492355|NCT00498602|583198009|FG000|Overall Study|Caregiver Request|2|||
161492356|NCT00498602|583198010|FG001|Overall Study|Caregiver Request|2|||
161492357|NCT00498602|583198011|FG002|Overall Study|Caregiver Request|2|||
161492358|NCT00498602|583198012|FG003|Overall Study|Caregiver Request|0|||
161492359|NCT00498602|583198013|FG004|Overall Study|Caregiver Request|1|||
161492360|NCT00498602|583198014|FG005|Overall Study|Caregiver Request|2|||
161492361|NCT00498602|583198015|FG006|Overall Study|Caregiver Request|0|||
161492362|NCT00498602|583198009|FG000|Overall Study|Investigator Request|0|||
161492363|NCT00498602|583198010|FG001|Overall Study|Investigator Request|0|||
161492364|NCT00498602|583198011|FG002|Overall Study|Investigator Request|1|||
161492365|NCT00498602|583198012|FG003|Overall Study|Investigator Request|0|||
161492366|NCT00498602|583198013|FG004|Overall Study|Investigator Request|0|||
161492367|NCT00498602|583198014|FG005|Overall Study|Investigator Request|0|||
161492368|NCT00498602|583198015|FG006|Overall Study|Investigator Request|0|||
161492369|NCT00498602|583198009|FG000|Overall Study|Subject Request|3|||
161492370|NCT00498602|583198010|FG001|Overall Study|Subject Request|0|||
161492371|NCT00498602|583198011|FG002|Overall Study|Subject Request|1|||
161492372|NCT00498602|583198012|FG003|Overall Study|Subject Request|1|||
161492373|NCT00498602|583198013|FG004|Overall Study|Subject Request|1|||
161492374|NCT00498602|583198014|FG005|Overall Study|Subject Request|4|||
161492375|NCT00498602|583198015|FG006|Overall Study|Subject Request|1|||
161492376|NCT00498602|583198009|FG000|Overall Study|Other|2|||
161492377|NCT00498602|583198010|FG001|Overall Study|Other|3|||
161492378|NCT00498602|583198011|FG002|Overall Study|Other|1|||
161492379|NCT00498602|583198012|FG003|Overall Study|Other|0|||
161583852|NCT03582722|583524218|FG000|Overall Study|Lost to Follow-up|1|||
161583853|NCT03582722|583524219|FG001|Overall Study|Lost to Follow-up|4|||
161583854|NCT03582722|583524218|FG000|Overall Study|Withdrawal by Subject|3|||
161583855|NCT03582722|583524219|FG001|Overall Study|Withdrawal by Subject|3|||
161583856|NCT01216176|583525929|FG000|Overall Study|Adverse Event|0|||
161583857|NCT01216176|583525930|FG001|Overall Study|Adverse Event|8|||
161583858|NCT01216176|583525931|FG002|Overall Study|Adverse Event|0|||
161583859|NCT01216176|583525929|FG000|Overall Study|Physician Decision|0|||
161583860|NCT01216176|583525930|FG001|Overall Study|Physician Decision|0|||
161583861|NCT01216176|583525931|FG002|Overall Study|Physician Decision|1|||
161583862|NCT03481660|583525934|FG000|Overall Study|Adverse Event|5|||
161583863|NCT03481660|583525935|FG001|Overall Study|Adverse Event|4|||
161583864|NCT03481660|583525934|FG000|Overall Study|Death|13|||
161583865|NCT03481660|583525935|FG001|Overall Study|Death|9|||
161583866|NCT03481660|583525934|FG000|Overall Study|Lost to Follow-up|2|||
161583867|NCT03481660|583525935|FG001|Overall Study|Lost to Follow-up|2|||
161583868|NCT03481660|583525934|FG000|Overall Study|Physician Decision|2|||
161583869|NCT03481660|583525935|FG001|Overall Study|Physician Decision|3|||
161583870|NCT03481660|583525934|FG000|Overall Study|Withdrawal by Subject|14|||
161583871|NCT03481660|583525935|FG001|Overall Study|Withdrawal by Subject|7|||
161671637|NCT04427501|583851340|FG004|Overall Study|Other|0|||
161671638|NCT04427501|583851341|FG005|Overall Study|Other|0|||
161671639|NCT04427501|583851342|FG006|Overall Study|Other|0|||
161923145|NCT03369223|584764931|FG010|Overall Study|Participant request to discontinue study treatment|0|||
161923146|NCT03369223|584764932|FG011|Overall Study|Participant request to discontinue study treatment|0|||
161492380|NCT00498602|583198013|FG004|Overall Study|Other|0|||
161492381|NCT00498602|583198014|FG005|Overall Study|Other|3|||
161492382|NCT00498602|583198015|FG006|Overall Study|Other|0|||
161492383|NCT03318315|583198019|FG000|Overall Study|Lost to Follow-up|3|||
161492384|NCT03318315|583198020|FG001|Overall Study|Lost to Follow-up|2|||
161492385|NCT03318315|583198021|FG002|Overall Study|Lost to Follow-up|1|||
161492386|NCT03318315|583198019|FG000|Overall Study|Protocol Violation|1|||
161583872|NCT05215847|583525938|FG000|Overall Study|Lost to Follow-up|1|||
161583873|NCT02879448|583525939|FG000|Overall Study|Death|251|||
161492387|NCT03318315|583198020|FG001|Overall Study|Protocol Violation|1|||
161492388|NCT03318315|583198021|FG002|Overall Study|Protocol Violation|1|||
161492389|NCT03318315|583198019|FG000|Overall Study|Withdrawal by Subject|0|||
161583874|NCT02879448|583525940|FG001|Overall Study|Death|263|||
161583875|NCT02879448|583525939|FG000|Overall Study|Lost to Follow-up|23|||
161671640|NCT04427501|583851343|FG007|Overall Study|Other|0|||
161671641|NCT04427501|583851344|FG008|Overall Study|Other|0|||
161923147|NCT03369223|584764933|FG012|Overall Study|Participant request to discontinue study treatment|0|||
161923148|NCT03369223|584764934|FG013|Overall Study|Participant request to discontinue study treatment|1|||
161923149|NCT03369223|584764935|FG014|Overall Study|Participant request to discontinue study treatment|1|||
161923150|NCT03369223|584764936|FG015|Overall Study|Participant request to discontinue study treatment|0|||
161923151|NCT03369223|584764937|FG016|Overall Study|Participant request to discontinue study treatment|0|||
161923152|NCT03369223|584764938|FG017|Overall Study|Participant request to discontinue study treatment|0|||
161923153|NCT03369223|584764939|FG018|Overall Study|Participant request to discontinue study treatment|1|||
161923154|NCT03369223|584764940|FG019|Overall Study|Participant request to discontinue study treatment|0|||
161923155|NCT03369223|584764921|FG000|Overall Study|Participant withdrew consent|0|||
161923156|NCT03369223|584764922|FG001|Overall Study|Participant withdrew consent|1|||
161923157|NCT03369223|584764923|FG002|Overall Study|Participant withdrew consent|1|||
161923158|NCT03369223|584764924|FG003|Overall Study|Participant withdrew consent|0|||
161923159|NCT03369223|584764925|FG004|Overall Study|Participant withdrew consent|0|||
161923160|NCT03369223|584764926|FG005|Overall Study|Participant withdrew consent|0|||
161923161|NCT03369223|584764927|FG006|Overall Study|Participant withdrew consent|1|||
161923162|NCT03369223|584764928|FG007|Overall Study|Participant withdrew consent|1|||
161923163|NCT03369223|584764929|FG008|Overall Study|Participant withdrew consent|1|||
161923164|NCT03369223|584764930|FG009|Overall Study|Participant withdrew consent|0|||
161923165|NCT03369223|584764931|FG010|Overall Study|Participant withdrew consent|0|||
161923166|NCT03369223|584764932|FG011|Overall Study|Participant withdrew consent|1|||
161923167|NCT03369223|584764933|FG012|Overall Study|Participant withdrew consent|0|||
161923168|NCT03369223|584764934|FG013|Overall Study|Participant withdrew consent|0|||
161923169|NCT03369223|584764935|FG014|Overall Study|Participant withdrew consent|3|||
161923170|NCT03369223|584764936|FG015|Overall Study|Participant withdrew consent|0|||
161923171|NCT03369223|584764937|FG016|Overall Study|Participant withdrew consent|1|||
161923172|NCT03369223|584764938|FG017|Overall Study|Participant withdrew consent|0|||
161923173|NCT03369223|584764939|FG018|Overall Study|Participant withdrew consent|4|||
161923174|NCT03369223|584764940|FG019|Overall Study|Participant withdrew consent|2|||
161923175|NCT03369223|584764921|FG000|Overall Study|Randomized but not treated|0|||
161923176|NCT03369223|584764922|FG001|Overall Study|Randomized but not treated|0|||
161923177|NCT03369223|584764923|FG002|Overall Study|Randomized but not treated|0|||
161923178|NCT03369223|584764924|FG003|Overall Study|Randomized but not treated|0|||
161923179|NCT03369223|584764925|FG004|Overall Study|Randomized but not treated|0|||
161923180|NCT03369223|584764926|FG005|Overall Study|Randomized but not treated|0|||
161923181|NCT03369223|584764927|FG006|Overall Study|Randomized but not treated|0|||
161923182|NCT03369223|584764928|FG007|Overall Study|Randomized but not treated|0|||
161923183|NCT03369223|584764929|FG008|Overall Study|Randomized but not treated|0|||
161923184|NCT03369223|584764930|FG009|Overall Study|Randomized but not treated|0|||
161923185|NCT03369223|584764931|FG010|Overall Study|Randomized but not treated|0|||
161923186|NCT03369223|584764932|FG011|Overall Study|Randomized but not treated|0|||
161923187|NCT03369223|584764933|FG012|Overall Study|Randomized but not treated|0|||
161923188|NCT03369223|584764934|FG013|Overall Study|Randomized but not treated|1|||
161923189|NCT03369223|584764935|FG014|Overall Study|Randomized but not treated|1|||
161923190|NCT03369223|584764936|FG015|Overall Study|Randomized but not treated|0|||
161923191|NCT03369223|584764937|FG016|Overall Study|Randomized but not treated|0|||
161923192|NCT03369223|584764938|FG017|Overall Study|Randomized but not treated|0|||
161923193|NCT03369223|584764939|FG018|Overall Study|Randomized but not treated|0|||
161923194|NCT03369223|584764940|FG019|Overall Study|Randomized but not treated|0|||
161923195|NCT05182125|584764941|FG000|Overall Study|Withdrawal by Subject|0|||
161923196|NCT05182125|584764942|FG001|Overall Study|Withdrawal by Subject|0|||
161923197|NCT05182125|584764943|FG002|Overall Study|Withdrawal by Subject|0|||
161923198|NCT05182125|584764944|FG003|Overall Study|Withdrawal by Subject|0|||
161923199|NCT05182125|584764945|FG004|Overall Study|Withdrawal by Subject|2|||
161923200|NCT05182125|584764946|FG005|Overall Study|Withdrawal by Subject|0|||
161923201|NCT05182125|584764941|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923202|NCT05182125|584764942|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923203|NCT05182125|584764943|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923204|NCT05182125|584764944|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
161923205|NCT05182125|584764945|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923206|NCT05182125|584764946|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923207|NCT05182125|584764941|FG000|Overall Study|Death|0|||
161923208|NCT05182125|584764942|FG001|Overall Study|Death|0|||
161923209|NCT05182125|584764943|FG002|Overall Study|Death|0|||
161923210|NCT05182125|584764944|FG003|Overall Study|Death|0|||
161923211|NCT05182125|584764945|FG004|Overall Study|Death|1|||
161923212|NCT05182125|584764946|FG005|Overall Study|Death|0|||
161923213|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
161923214|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
161923215|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
161923216|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
161923217|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
161923218|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
161923219|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
161923220|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
161923221|NCT02965833|584764951|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
161923222|NCT02965833|584764952|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
161923223|NCT03370302|584764953|FG000|Dose Escalation Phase|Other|0|||
161923224|NCT03370302|584764954|FG001|Dose Escalation Phase|Other|1|||
161923225|NCT03370302|584764955|FG002|Dose Escalation Phase|Other|1|||
161923226|NCT03370302|584764956|FG003|Dose Escalation Phase|Other|0|||
161583876|NCT02879448|583525940|FG001|Overall Study|Lost to Follow-up|28|||
161583877|NCT02879448|583525939|FG000|Overall Study|Withdrawal by Subject|42|||
161817313|NCT00985751|584371013|FG001|Overall Study|Adverse Event|0|||
161817314|NCT00985751|584371014|FG002|Overall Study|Adverse Event|0|||
161817315|NCT00985751|584371015|FG003|Overall Study|Adverse Event|0|||
161817316|NCT00985751|584371016|FG004|Overall Study|Adverse Event|1|||
161817317|NCT01899053|584371017|FG000|Overall Study|Progressive Disease|4|||
161817318|NCT01899053|584371018|FG001|Overall Study|Progressive Disease|0|||
161817319|NCT01899053|584371019|FG002|Overall Study|Progressive Disease|3|||
161817320|NCT01899053|584371020|FG003|Overall Study|Progressive Disease|0|||
161817321|NCT01899053|584371021|FG004|Overall Study|Progressive Disease|3|||
161817322|NCT01899053|584371022|FG005|Overall Study|Progressive Disease|1|||
161817323|NCT01899053|584371023|FG006|Overall Study|Progressive Disease|1|||
161817324|NCT01899053|584371024|FG007|Overall Study|Progressive Disease|1|||
161817325|NCT01899053|584371025|FG008|Overall Study|Progressive Disease|4|||
161817326|NCT01899053|584371026|FG009|Overall Study|Progressive Disease|3|||
161817327|NCT01899053|584371027|FG010|Overall Study|Progressive Disease|12|||
161817328|NCT01899053|584371028|FG011|Overall Study|Progressive Disease|5|||
161817329|NCT01899053|584371029|FG012|Overall Study|Progressive Disease|8|||
161817330|NCT01899053|584371030|FG013|Overall Study|Progressive Disease|17|||
161817331|NCT01899053|584371017|FG000|Overall Study|Adverse Event|1|||
161817332|NCT01899053|584371018|FG001|Overall Study|Adverse Event|1|||
161817333|NCT01899053|584371019|FG002|Overall Study|Adverse Event|1|||
161817334|NCT01899053|584371020|FG003|Overall Study|Adverse Event|3|||
161817335|NCT01899053|584371021|FG004|Overall Study|Adverse Event|1|||
161817336|NCT01899053|584371022|FG005|Overall Study|Adverse Event|1|||
161817337|NCT01899053|584371023|FG006|Overall Study|Adverse Event|1|||
161817338|NCT01899053|584371024|FG007|Overall Study|Adverse Event|0|||
161817339|NCT01899053|584371025|FG008|Overall Study|Adverse Event|2|||
161817340|NCT01899053|584371026|FG009|Overall Study|Adverse Event|0|||
161817341|NCT01899053|584371027|FG010|Overall Study|Adverse Event|3|||
161817342|NCT01899053|584371028|FG011|Overall Study|Adverse Event|1|||
161817343|NCT01899053|584371029|FG012|Overall Study|Adverse Event|2|||
161817344|NCT01899053|584371030|FG013|Overall Study|Adverse Event|2|||
161817345|NCT01899053|584371017|FG000|Overall Study|Reason Not Specified|0|||
161817346|NCT01899053|584371018|FG001|Overall Study|Reason Not Specified|0|||
161817347|NCT01899053|584371019|FG002|Overall Study|Reason Not Specified|0|||
161817348|NCT01899053|584371020|FG003|Overall Study|Reason Not Specified|0|||
161817349|NCT01899053|584371021|FG004|Overall Study|Reason Not Specified|0|||
161817350|NCT01899053|584371022|FG005|Overall Study|Reason Not Specified|0|||
161817351|NCT01899053|584371023|FG006|Overall Study|Reason Not Specified|1|||
161817352|NCT01899053|584371024|FG007|Overall Study|Reason Not Specified|0|||
161817353|NCT01899053|584371025|FG008|Overall Study|Reason Not Specified|0|||
161817354|NCT01899053|584371026|FG009|Overall Study|Reason Not Specified|0|||
161817355|NCT01899053|584371027|FG010|Overall Study|Reason Not Specified|0|||
161817356|NCT01899053|584371028|FG011|Overall Study|Reason Not Specified|0|||
161817357|NCT01899053|584371029|FG012|Overall Study|Reason Not Specified|1|||
161583878|NCT02879448|583525940|FG001|Overall Study|Withdrawal by Subject|79|||
161583879|NCT02879448|583525939|FG000|Overall Study|Other Reasons|8|||
161583880|NCT02879448|583525940|FG001|Overall Study|Other Reasons|12|||
161817358|NCT01899053|584371030|FG013|Overall Study|Reason Not Specified|0|||
161817359|NCT01899053|584371017|FG000|Overall Study|Withdrawal by Subject|1|||
161817360|NCT01899053|584371018|FG001|Overall Study|Withdrawal by Subject|1|||
161817361|NCT01899053|584371019|FG002|Overall Study|Withdrawal by Subject|2|||
161817362|NCT01899053|584371020|FG003|Overall Study|Withdrawal by Subject|0|||
161817363|NCT01899053|584371021|FG004|Overall Study|Withdrawal by Subject|2|||
161817364|NCT01899053|584371022|FG005|Overall Study|Withdrawal by Subject|0|||
161817365|NCT01899053|584371023|FG006|Overall Study|Withdrawal by Subject|0|||
161817366|NCT01899053|584371024|FG007|Overall Study|Withdrawal by Subject|1|||
161817367|NCT01899053|584371025|FG008|Overall Study|Withdrawal by Subject|0|||
161817368|NCT01899053|584371026|FG009|Overall Study|Withdrawal by Subject|0|||
161817369|NCT01899053|584371027|FG010|Overall Study|Withdrawal by Subject|0|||
161583881|NCT04732494|583525950|FG000|Overall Study|Death|39|||
161583882|NCT04732494|583525951|FG001|Overall Study|Death|36|||
161583883|NCT04732494|583525950|FG000|Overall Study|Study Closed by Sponsor|20|||
161583884|NCT04732494|583525951|FG001|Overall Study|Study Closed by Sponsor|15|||
161583885|NCT04732494|583525950|FG000|Overall Study|Withdrawal by Subject|2|||
161583886|NCT04732494|583525951|FG001|Overall Study|Withdrawal by Subject|7|||
161583887|NCT04732494|583525950|FG000|Overall Study|Lost to Follow-up|1|||
161583888|NCT04732494|583525951|FG001|Overall Study|Lost to Follow-up|5|||
161583889|NCT03055858|583525952|FG000|Overall Study|Death|9|||
161817370|NCT01899053|584371028|FG011|Overall Study|Withdrawal by Subject|0|||
161583890|NCT03055858|583525952|FG000|Overall Study|Withdrawal by Subject|11|||
161583891|NCT03055858|583525952|FG000|Overall Study|Lost to Follow-up|6|||
161583892|NCT03055858|583525952|FG000|Overall Study|Missed Follow-Up Visits|18|||
161583893|NCT01718743|583525953|FG000|Overall Study|Physician Decision|7|||
161583894|NCT01718743|583525953|FG000|Overall Study|Withdrawal by Subject|14|||
161583895|NCT01718743|583525953|FG000|Overall Study|Progressive Disease|22|||
161583896|NCT01718743|583525953|FG000|Overall Study|Toxicity|1|||
161583897|NCT01718743|583525953|FG000|Overall Study|Malignancy|1|||
161583898|NCT05136404|583525954|FG000|Period 1|Adverse Event|0|||
161583899|NCT05136404|583525955|FG001|Period 1|Adverse Event|1|||
161583900|NCT05136404|583525956|FG002|Period 1|Adverse Event|1|||
161583901|NCT05136404|583525954|FG000|Period 2|Inappropriate Behavior|0|||
161817371|NCT01899053|584371029|FG012|Overall Study|Withdrawal by Subject|1|||
161817372|NCT01899053|584371030|FG013|Overall Study|Withdrawal by Subject|1|||
161817373|NCT01899053|584371017|FG000|Overall Study|Protocol Violation|0|||
161817374|NCT01899053|584371018|FG001|Overall Study|Protocol Violation|0|||
161817375|NCT01899053|584371019|FG002|Overall Study|Protocol Violation|1|||
161817376|NCT01899053|584371020|FG003|Overall Study|Protocol Violation|0|||
161817377|NCT01899053|584371021|FG004|Overall Study|Protocol Violation|0|||
161817378|NCT01899053|584371022|FG005|Overall Study|Protocol Violation|0|||
161817379|NCT01899053|584371023|FG006|Overall Study|Protocol Violation|0|||
161817380|NCT01899053|584371024|FG007|Overall Study|Protocol Violation|0|||
161817381|NCT01899053|584371025|FG008|Overall Study|Protocol Violation|0|||
161817382|NCT01899053|584371026|FG009|Overall Study|Protocol Violation|0|||
161817383|NCT01899053|584371027|FG010|Overall Study|Protocol Violation|0|||
161817384|NCT01899053|584371028|FG011|Overall Study|Protocol Violation|0|||
161817385|NCT01899053|584371029|FG012|Overall Study|Protocol Violation|0|||
161817386|NCT01899053|584371030|FG013|Overall Study|Protocol Violation|0|||
161817387|NCT01899053|584371017|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161817388|NCT01899053|584371018|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
161817389|NCT01899053|584371019|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817390|NCT01899053|584371020|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817391|NCT01899053|584371021|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817392|NCT01899053|584371022|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817393|NCT01899053|584371023|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817394|NCT01899053|584371024|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817395|NCT01899053|584371025|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817396|NCT01899053|584371026|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817397|NCT01899053|584371027|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
161817398|NCT01899053|584371028|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817399|NCT01899053|584371029|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817400|NCT01899053|584371030|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817401|NCT01899053|584371017|FG000|Overall Study|Symptomatic Deterioration|0|||
161817402|NCT01899053|584371018|FG001|Overall Study|Symptomatic Deterioration|0|||
161817403|NCT01899053|584371019|FG002|Overall Study|Symptomatic Deterioration|0|||
161817404|NCT01899053|584371020|FG003|Overall Study|Symptomatic Deterioration|0|||
161817405|NCT01899053|584371021|FG004|Overall Study|Symptomatic Deterioration|0|||
161817406|NCT01899053|584371022|FG005|Overall Study|Symptomatic Deterioration|1|||
161817407|NCT01899053|584371023|FG006|Overall Study|Symptomatic Deterioration|0|||
161817408|NCT01899053|584371024|FG007|Overall Study|Symptomatic Deterioration|1|||
161817409|NCT01899053|584371025|FG008|Overall Study|Symptomatic Deterioration|0|||
161583902|NCT05136404|583525955|FG001|Period 2|Inappropriate Behavior|0|||
161583903|NCT05136404|583525956|FG002|Period 2|Inappropriate Behavior|1|||
161583904|NCT05136404|583525954|FG000|Period 3|Adverse Event|0|||
161817410|NCT01899053|584371026|FG009|Overall Study|Symptomatic Deterioration|0|||
161817411|NCT01899053|584371027|FG010|Overall Study|Symptomatic Deterioration|0|||
161817412|NCT01899053|584371028|FG011|Overall Study|Symptomatic Deterioration|1|||
161817413|NCT01899053|584371029|FG012|Overall Study|Symptomatic Deterioration|2|||
161817414|NCT01899053|584371030|FG013|Overall Study|Symptomatic Deterioration|0|||
161817415|NCT01891357|584371031|FG000|Overall Study|Protocol Violation|3|||
161583905|NCT05136404|583525955|FG001|Period 3|Adverse Event|0|||
161583906|NCT05136404|583525956|FG002|Period 3|Adverse Event|1|||
161583907|NCT02553642|583525962|FG000|Overall Study|Withdrawal by Subject|0|||
161583908|NCT02553642|583525963|FG001|Overall Study|Withdrawal by Subject|3|||
161583909|NCT02553642|583525962|FG000|Overall Study|Physician Decision|0|||
161583910|NCT02553642|583525963|FG001|Overall Study|Physician Decision|1|||
161583911|NCT02553642|583525962|FG000|Overall Study|Additional cancer dx|0|||
161671642|NCT04427501|583851345|FG009|Overall Study|Other|0|||
161923227|NCT03370302|584764957|FG004|Dose Escalation Phase|Other|0|||
161923228|NCT03370302|584764958|FG005|Dose Escalation Phase|Other|0|||
161923229|NCT03370302|584764953|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161923230|NCT03370302|584764954|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
161923231|NCT03370302|584764955|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
161923232|NCT03370302|584764956|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161923233|NCT03370302|584764957|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
161923234|NCT03370302|584764958|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
161923235|NCT03370302|584764953|FG000|Dose Escalation Phase|Adverse Event|1|||
161923236|NCT03370302|584764954|FG001|Dose Escalation Phase|Adverse Event|0|||
161923237|NCT03370302|584764955|FG002|Dose Escalation Phase|Adverse Event|2|||
161923238|NCT03370302|584764956|FG003|Dose Escalation Phase|Adverse Event|0|||
161923239|NCT03370302|584764957|FG004|Dose Escalation Phase|Adverse Event|0|||
161923240|NCT03370302|584764958|FG005|Dose Escalation Phase|Adverse Event|0|||
161923241|NCT03370302|584764953|FG000|Dose Escalation Phase|Progressive Disease|2|||
161923242|NCT03370302|584764954|FG001|Dose Escalation Phase|Progressive Disease|4|||
161923243|NCT03370302|584764955|FG002|Dose Escalation Phase|Progressive Disease|2|||
161583912|NCT02553642|583525963|FG001|Overall Study|Additional cancer dx|1|||
161583913|NCT02553642|583525962|FG000|Overall Study|Never started treatment|0|||
161583914|NCT02553642|583525963|FG001|Overall Study|Never started treatment|1|||
161583915|NCT01820260|583525969|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583916|NCT01820260|583525970|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583917|NCT01820260|583525971|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583918|NCT01820260|583525972|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583919|NCT01820260|583525973|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161923244|NCT03370302|584764956|FG003|Dose Escalation Phase|Progressive Disease|0|||
161923245|NCT03370302|584764957|FG004|Dose Escalation Phase|Progressive Disease|3|||
161923246|NCT03370302|584764958|FG005|Dose Escalation Phase|Progressive Disease|1|||
161923247|NCT03370302|584764953|FG000|Dose Expansion Phase|Progressive Disease|0|||
161923248|NCT03370302|584764954|FG001|Dose Expansion Phase|Progressive Disease|0|||
161923249|NCT03370302|584764955|FG002|Dose Expansion Phase|Progressive Disease|0|||
161923250|NCT03370302|584764956|FG003|Dose Expansion Phase|Progressive Disease|6|||
161923251|NCT03370302|584764957|FG004|Dose Expansion Phase|Progressive Disease|0|||
161923252|NCT03370302|584764958|FG005|Dose Expansion Phase|Progressive Disease|0|||
161492390|NCT03318315|583198020|FG001|Overall Study|Withdrawal by Subject|0|||
161492391|NCT03318315|583198021|FG002|Overall Study|Withdrawal by Subject|2|||
161492392|NCT02617511|583198032|FG000|Overall Study|Withdrawal by Subject|1|||
161492393|NCT02617511|583198033|FG001|Overall Study|Withdrawal by Subject|0|||
161492394|NCT00811473|583198034|FG000|Overall Study|Adverse Event|3|||
161492395|NCT00811473|583198035|FG001|Overall Study|Adverse Event|12|||
161492396|NCT00811473|583198034|FG000|Overall Study|Lost to Follow-up|5|||
161492397|NCT00811473|583198035|FG001|Overall Study|Lost to Follow-up|1|||
161492398|NCT00811473|583198034|FG000|Overall Study|Withdrawal by Subject|2|||
161492399|NCT00811473|583198035|FG001|Overall Study|Withdrawal by Subject|4|||
161492400|NCT00811473|583198034|FG000|Overall Study|Severe non-compliance to protocol|2|||
161492401|NCT00811473|583198035|FG001|Overall Study|Severe non-compliance to protocol|4|||
161492402|NCT00811473|583198034|FG000|Overall Study|Lack of therapeutic response|4|||
161492403|NCT00811473|583198035|FG001|Overall Study|Lack of therapeutic response|1|||
161492404|NCT00811473|583198034|FG000|Overall Study|Condition under investigation worsened|1|||
161583920|NCT01820260|583525974|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583921|NCT01820260|583525975|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
161583922|NCT01820260|583525976|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583923|NCT01820260|583525977|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583924|NCT01820260|583525978|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583925|NCT01820260|583525979|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583926|NCT01820260|583525980|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583927|NCT01820260|583525981|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583928|NCT01820260|583525982|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161583929|NCT01820260|583525969|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583930|NCT01820260|583525970|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583931|NCT01820260|583525971|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583932|NCT01820260|583525972|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583933|NCT01820260|583525973|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583934|NCT01820260|583525974|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583935|NCT01820260|583525975|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583936|NCT01820260|583525976|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583937|NCT01820260|583525977|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161923253|NCT00118287|584764959|FG000|Overall Study|Intracranial haemorrhage|1|||
161923254|NCT00118287|584764959|FG000|Overall Study|Muscle pain|1|||
161923255|NCT03976375|584764960|FG000|Overall Study|Death|158|||
161923256|NCT03976375|584764961|FG001|Overall Study|Death|160|||
161923257|NCT03976375|584764962|FG002|Overall Study|Death|42|||
161923258|NCT03976375|584764960|FG000|Overall Study|Lost to Follow-up|2|||
161923259|NCT03976375|584764961|FG001|Overall Study|Lost to Follow-up|1|||
161923260|NCT03976375|584764962|FG002|Overall Study|Lost to Follow-up|1|||
161923261|NCT03976375|584764960|FG000|Overall Study|Withdrawal by Subject|5|||
161923262|NCT03976375|584764961|FG001|Overall Study|Withdrawal by Subject|9|||
161923263|NCT03976375|584764962|FG002|Overall Study|Withdrawal by Subject|4|||
161923264|NCT03976375|584764960|FG000|Overall Study|Sponsor decision|20|||
161923265|NCT03976375|584764961|FG001|Overall Study|Sponsor decision|19|||
161923266|NCT03976375|584764962|FG002|Overall Study|Sponsor decision|1|||
161923267|NCT04818112|584764963|FG000|Overall Study|Withdrawal by Subject|54|||
161923268|NCT04818112|584764964|FG001|Overall Study|Withdrawal by Subject|12|||
161923269|NCT04818112|584764963|FG000|Overall Study|Lost to Follow-up|38|||
161923270|NCT04818112|584764964|FG001|Overall Study|Lost to Follow-up|10|||
161923271|NCT03091439|584764965|FG000|Overall Study|Study Terminated by the Sponsor|1|||
161923272|NCT03091439|584764966|FG001|Overall Study|Study Terminated by the Sponsor|0|||
161923273|NCT03122106|584764967|FG000|Overall Study|Not enough tissue|1|||
161923274|NCT03122106|584764967|FG000|Overall Study|Disease progression during screening|2|||
161923275|NCT03122106|584764967|FG000|Overall Study|Poor RNA quality for vaccine|1|||
161923276|NCT00640289|584764968|FG000|Overall Study|Death|3|||
161923277|NCT00640289|584764968|FG000|Overall Study|Withdrawal by Subject|1|||
161923278|NCT00640289|584764968|FG000|Overall Study|Lost to Follow-up|1|||
161923279|NCT00640289|584764968|FG000|Overall Study|Data collected under different amendment|2|||
161923280|NCT00640289|584764968|FG000|Overall Study|Transferred to another center|1|||
161923281|NCT00640289|584764968|FG000|Overall Study|Missing status|5|||
161923282|NCT03550209|584764970|FG000|Overall Study|Lost to Follow-up|1|||
161923283|NCT03550209|584764971|FG001|Overall Study|Lost to Follow-up|0|||
161923284|NCT03550209|584764972|FG002|Overall Study|Lost to Follow-up|1|||
161923285|NCT03550209|584764973|FG003|Overall Study|Lost to Follow-up|0|||
161923286|NCT03550209|584764970|FG000|Overall Study|Withdrawal by Subject|0|||
161923287|NCT03550209|584764971|FG001|Overall Study|Withdrawal by Subject|3|||
161923288|NCT03550209|584764972|FG002|Overall Study|Withdrawal by Subject|1|||
161923289|NCT03550209|584764973|FG003|Overall Study|Withdrawal by Subject|2|||
161923290|NCT03550209|584764970|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
161923291|NCT03550209|584764971|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
161923292|NCT03550209|584764972|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
161923293|NCT03550209|584764973|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
161923294|NCT06170827|584764976|FG000|Overall Study|Withdrawal by Subject|1|||
161923295|NCT06170827|584764977|FG001|Overall Study|Withdrawal by Subject|1|||
161923296|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923297|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923298|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923299|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
161923300|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923301|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923302|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923303|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923304|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923305|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923306|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
161923307|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
161923308|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923309|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923310|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923311|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923312|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923313|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923314|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
161923315|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161583938|NCT01820260|583525978|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
161583939|NCT01820260|583525979|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583940|NCT01820260|583525980|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583941|NCT01820260|583525981|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583942|NCT01820260|583525982|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161583943|NCT05444192|583525983|FG000|Overall Study|Lost to Follow-up|1|||
161583944|NCT05444192|583525984|FG001|Overall Study|Lost to Follow-up|0|||
161583945|NCT04424927|583525988|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
161583946|NCT04424927|583525989|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
161583947|NCT04424927|583525990|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
161583948|NCT04424927|583525991|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
161583949|NCT04424927|583525992|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
161583950|NCT04424927|583525988|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
161671643|NCT04427501|583851346|FG010|Overall Study|Other|0|||
161923316|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923317|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923318|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923319|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923320|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
161923321|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
161923322|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
161923323|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
161923324|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
161923325|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
161923326|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
161923327|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
161923328|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923329|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923330|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923331|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923332|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
161923333|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
161923334|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923335|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923336|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923337|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923338|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923339|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923340|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
161923341|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
161923342|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923343|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923344|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923345|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923346|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923347|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923348|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
161923349|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923350|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923351|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923352|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Other|0|||
161923353|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Other|0|||
161923354|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Other|0|||
161923355|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Other|0|||
161923356|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Other|1|||
161923357|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Other|3|||
161923358|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Other|0|||
161923359|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Other|0|||
161923360|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923361|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923362|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923363|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923364|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923365|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923366|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
161923367|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923368|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923369|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923370|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923371|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923372|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923373|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161583951|NCT04424927|583525989|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
161583952|NCT04424927|583525990|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
161583953|NCT04424927|583525991|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
161583954|NCT04424927|583525992|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
161583955|NCT04424927|583525988|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
161923374|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923375|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
161923376|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923377|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923378|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
161583956|NCT04424927|583525989|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161671644|NCT04427501|583851347|FG011|Overall Study|Other|1|||
161923379|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923380|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923381|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923382|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
161923383|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
161923384|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Other|0|||
161923385|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Other|0|||
161923386|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Other|0|||
161923387|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Other|0|||
161923388|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Other|0|||
161923389|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Other|0|||
161923390|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Other|0|||
161923391|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Other|1|||
161923392|NCT05643794|584766481|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
161923393|NCT05643794|584766482|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161923394|NCT05643794|584766483|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
161923395|NCT05643794|584766481|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161923396|NCT05643794|584766482|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161923397|NCT05643794|584766483|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161923398|NCT05643794|584766481|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923399|NCT05643794|584766482|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
161923400|NCT05643794|584766483|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923401|NCT05643794|584766481|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161923402|NCT05643794|584766482|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161923403|NCT05643794|584766483|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161923404|NCT05643794|584766481|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
161923405|NCT05643794|584766482|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923406|NCT05643794|584766483|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923407|NCT05643794|584766481|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
161923408|NCT05643794|584766482|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
161923409|NCT05643794|584766483|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
161923410|NCT04167670|584766486|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
161923411|NCT04167670|584766487|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
161923412|NCT04167670|584766488|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
161923413|NCT04167670|584766486|FG000|Overall Study|Significant protocol deviation|3|||
161923414|NCT04167670|584766487|FG001|Overall Study|Significant protocol deviation|1|||
161923415|NCT04167670|584766488|FG002|Overall Study|Significant protocol deviation|0|||
161923416|NCT04167670|584766486|FG000|Overall Study|Lost to Follow-up|0|||
161923417|NCT04167670|584766487|FG001|Overall Study|Lost to Follow-up|3|||
161923418|NCT04167670|584766488|FG002|Overall Study|Lost to Follow-up|3|||
161923419|NCT04167670|584766486|FG000|Overall Study|Voluntary Withdrawal|0|||
161923420|NCT04167670|584766487|FG001|Overall Study|Voluntary Withdrawal|1|||
161923421|NCT04167670|584766488|FG002|Overall Study|Voluntary Withdrawal|1|||
161923422|NCT04167670|584766486|FG000|Overall Study|Withdrawal of Consent|4|||
161923423|NCT04167670|584766487|FG001|Overall Study|Withdrawal of Consent|1|||
161923424|NCT04167670|584766488|FG002|Overall Study|Withdrawal of Consent|3|||
161923425|NCT04167670|584766486|FG000|Overall Study|Miscellaneous|7|||
161923426|NCT04167670|584766487|FG001|Overall Study|Miscellaneous|5|||
161923427|NCT04167670|584766488|FG002|Overall Study|Miscellaneous|3|||
161923428|NCT04706403|584766489|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
161923429|NCT04706403|584766490|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
161923430|NCT04706403|584766491|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
161923431|NCT04706403|584766492|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
161923432|NCT04706403|584766493|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
161923433|NCT01653262|584766494|FG000|Overall Study|Lack of Efficacy|1|||
161923434|NCT01653262|584766494|FG000|Overall Study|SAE, non-fatal|1|||
161923435|NCT01653262|584766494|FG000|Overall Study|AE, non-serious non-fatal|1|||
161923436|NCT01112267|584766496|FG000|Overall Study|Adverse Event|24|||
161923437|NCT01112267|584766497|FG001|Overall Study|Adverse Event|6|||
161923438|NCT01112267|584766496|FG000|Overall Study|Withdrawal by Subject|3|||
161923439|NCT01112267|584766497|FG001|Overall Study|Withdrawal by Subject|5|||
161923440|NCT01112267|584766496|FG000|Overall Study|Protocol Violation|5|||
161923441|NCT01112267|584766497|FG001|Overall Study|Protocol Violation|3|||
161583957|NCT04424927|583525990|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161923442|NCT01112267|584766496|FG000|Overall Study|Participants not compliant|1|||
161923443|NCT01112267|584766497|FG001|Overall Study|Participants not compliant|2|||
161923444|NCT01112267|584766496|FG000|Overall Study|Participants not receive any study drug|1|||
161923445|NCT01112267|584766497|FG001|Overall Study|Participants not receive any study drug|2|||
161923446|NCT01373229|584766498|FG000|Overall Study|Death|3|||
161583958|NCT04424927|583525991|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161583959|NCT04424927|583525992|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161671645|NCT03170154|583851348|FG000|Overall Study|Lost to Follow-up|4|||
161923447|NCT01373229|584766498|FG000|Overall Study|Physician Decision|3|||
161923448|NCT00587457|584766499|FG000|Overall Study|Adverse Event|1|||
161923449|NCT00587457|584766500|FG001|Overall Study|Adverse Event|2|||
161923450|NCT00587457|584766501|FG002|Overall Study|Adverse Event|1|||
161923451|NCT00587457|584766499|FG000|Overall Study|Disease progression|2|||
161923452|NCT00587457|584766500|FG001|Overall Study|Disease progression|0|||
161923453|NCT00587457|584766501|FG002|Overall Study|Disease progression|2|||
161923454|NCT00587457|584766499|FG000|Overall Study|Initiation of alternative therapy|0|||
161923455|NCT00587457|584766500|FG001|Overall Study|Initiation of alternative therapy|1|||
161923456|NCT00587457|584766501|FG002|Overall Study|Initiation of alternative therapy|0|||
161923457|NCT00587457|584766499|FG000|Overall Study|Undefined|0|||
161923458|NCT00587457|584766500|FG001|Overall Study|Undefined|0|||
161923459|NCT00587457|584766501|FG002|Overall Study|Undefined|1|||
161923460|NCT00587457|584766499|FG000|Overall Study|Development of neutralizing Abs|0|||
161923461|NCT00587457|584766500|FG001|Overall Study|Development of neutralizing Abs|0|||
161923462|NCT00587457|584766501|FG002|Overall Study|Development of neutralizing Abs|1|||
161923463|NCT04439175|584766502|FG000|Overall Study|Never started treatment|4|||
161923464|NCT04439175|584766502|FG000|Overall Study|Ineligible|5|||
161923465|NCT04439175|584766502|FG000|Overall Study|Adverse Event|6|||
161923466|NCT04439175|584766502|FG000|Overall Study|Death|4|||
161923467|NCT04439175|584766502|FG000|Overall Study|Disease progression|44|||
161923468|NCT04439175|584766502|FG000|Overall Study|Withdrawal by Subject|4|||
161923469|NCT04439175|584766502|FG000|Overall Study|Alternative Therapy|1|||
161923470|NCT04439175|584766502|FG000|Overall Study|Other|2|||
161923471|NCT05417113|584766505|FG000|Overall Study|Lost to Follow-up|2|||
161923472|NCT05417113|584766506|FG001|Overall Study|Lost to Follow-up|2|||
161923473|NCT01847209|584766507|FG000|Overall Study|Withdrawal by Subject|1|||
161923474|NCT01847209|584766507|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
161923475|NCT00729586|584766508|FG000|Overall Study|Ineligible|0|||
161923476|NCT00729586|584766509|FG001|Overall Study|Ineligible|1|||
161492405|NCT00811473|583198035|FG001|Overall Study|Condition under investigation worsened|3|||
161492406|NCT00811473|583198034|FG000|Overall Study|Other 2|4|||
161492407|NCT00811473|583198035|FG001|Overall Study|Other 2|1|||
161492408|NCT00811473|583198034|FG000|Overall Study|Incorrect Enrollment|1|||
161492409|NCT00811473|583198035|FG001|Overall Study|Incorrect Enrollment|0|||
161923477|NCT00729586|584766508|FG000|Overall Study|never treated|1|||
161492410|NCT00811473|583198034|FG000|Overall Study|Safety Reasons|1|||
161492411|NCT00811473|583198035|FG001|Overall Study|Safety Reasons|0|||
161923478|NCT00729586|584766509|FG001|Overall Study|never treated|0|||
161923479|NCT02513199|584766512|FG000|Treatment|Death|1|||
161492412|NCT01119131|583198039|FG000|Overall Study|Adverse Event|1|||
161492413|NCT01119131|583198040|FG001|Overall Study|Adverse Event|1|||
161492414|NCT01119131|583198041|FG002|Overall Study|Adverse Event|1|||
161492415|NCT01119131|583198039|FG000|Overall Study|Non-Compliance|1|||
161492416|NCT01119131|583198040|FG001|Overall Study|Non-Compliance|0|||
161923480|NCT02513199|584766512|FG000|Treatment|Lost to Follow-up|1|||
161923481|NCT02513199|584766512|FG000|Follow-Up|Death|11|||
161923482|NCT02927145|584766516|FG000|Initial Recruitment|Withdrawal by Subject|0|||
161923483|NCT02927145|584766517|FG001|Initial Recruitment|Withdrawal by Subject|1|||
161923484|NCT02927145|584766518|FG002|Initial Recruitment|Withdrawal by Subject|1|||
161923485|NCT02927145|584766519|FG003|Initial Recruitment|Withdrawal by Subject|4|||
161923486|NCT02927145|584766520|FG004|Initial Recruitment|Withdrawal by Subject|1|||
161923487|NCT02927145|584766521|FG005|Initial Recruitment|Withdrawal by Subject|1|||
161923488|NCT02927145|584766522|FG006|Initial Recruitment|Withdrawal by Subject|0|||
161923489|NCT02927145|584766523|FG007|Initial Recruitment|Withdrawal by Subject|0|||
161923490|NCT02927145|584766524|FG008|Initial Recruitment|Withdrawal by Subject|2|||
161923491|NCT02927145|584766516|FG000|Initial Recruitment|Adverse Event|0|||
161923492|NCT02927145|584766517|FG001|Initial Recruitment|Adverse Event|0|||
161923493|NCT02927145|584766518|FG002|Initial Recruitment|Adverse Event|0|||
161923494|NCT02927145|584766519|FG003|Initial Recruitment|Adverse Event|0|||
161923495|NCT02927145|584766520|FG004|Initial Recruitment|Adverse Event|2|||
161923496|NCT02927145|584766521|FG005|Initial Recruitment|Adverse Event|0|||
161923497|NCT02927145|584766522|FG006|Initial Recruitment|Adverse Event|0|||
161923498|NCT02927145|584766523|FG007|Initial Recruitment|Adverse Event|0|||
161923499|NCT02927145|584766524|FG008|Initial Recruitment|Adverse Event|0|||
161923500|NCT02927145|584766516|FG000|Invitation for Additional Challenge|Pregnancy|0|||
161923501|NCT02927145|584766517|FG001|Invitation for Additional Challenge|Pregnancy|0|||
161923502|NCT02927145|584766518|FG002|Invitation for Additional Challenge|Pregnancy|0|||
161923503|NCT02927145|584766519|FG003|Invitation for Additional Challenge|Pregnancy|0|||
161923504|NCT02927145|584766520|FG004|Invitation for Additional Challenge|Pregnancy|0|||
161923505|NCT02927145|584766521|FG005|Invitation for Additional Challenge|Pregnancy|0|||
161923506|NCT02927145|584766522|FG006|Invitation for Additional Challenge|Pregnancy|1|||
161492417|NCT01119131|583198041|FG002|Overall Study|Non-Compliance|4|||
161492418|NCT01119131|583198039|FG000|Overall Study|Physician Decision|0|||
161492419|NCT01119131|583198040|FG001|Overall Study|Physician Decision|0|||
161492420|NCT01119131|583198041|FG002|Overall Study|Physician Decision|1|||
161492421|NCT01187043|583198043|FG000|Overall Study|Adverse Event|0|||
161492422|NCT01187043|583198044|FG001|Overall Study|Adverse Event|0|||
161492423|NCT01187043|583198045|FG002|Overall Study|Adverse Event|0|||
161492424|NCT01187043|583198046|FG003|Overall Study|Adverse Event|0|||
161492425|NCT01187043|583198047|FG004|Overall Study|Adverse Event|1|||
161492426|NCT01187043|583198043|FG000|Overall Study|Unable to make scheduled visits|1|||
161492427|NCT01187043|583198044|FG001|Overall Study|Unable to make scheduled visits|0|||
161492428|NCT01187043|583198045|FG002|Overall Study|Unable to make scheduled visits|4|||
161492429|NCT01187043|583198046|FG003|Overall Study|Unable to make scheduled visits|0|||
161492430|NCT01187043|583198047|FG004|Overall Study|Unable to make scheduled visits|1|||
161492431|NCT00573534|583198048|FG000|Overall Study|oppositional behavior|3|||
161492432|NCT03035409|583198049|FG000|Overall Study|Adverse Event|5|||
161492433|NCT03035409|583198049|FG000|Overall Study|Death|2|||
161492434|NCT03035409|583198049|FG000|Overall Study|Withdrawal by Subject|2|||
161492435|NCT03035409|583198049|FG000|Overall Study|Non compliance|4|||
161492436|NCT03035409|583198049|FG000|Overall Study|Patient was jittery|1|||
161492437|NCT03035409|583198049|FG000|Overall Study|Did not like Questionnaire|1|||
161492438|NCT03035409|583198049|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
161492439|NCT03035409|583198049|FG000|Overall Study|Did not like taking drugs|1|||
161492440|NCT00927784|583198052|FG000|Overall Study|Death|1|||
161492441|NCT00927784|583198053|FG001|Overall Study|Death|0|||
161492442|NCT00927784|583198052|FG000|Overall Study|Withdrawal by Subject|1|||
161492443|NCT00927784|583198053|FG001|Overall Study|Withdrawal by Subject|0|||
161492444|NCT02457910|583198054|FG000|Overall Study|Withdrawal by Subject|0|||
161492445|NCT02457910|583198055|FG001|Overall Study|Withdrawal by Subject|0|||
161492446|NCT02457910|583198056|FG002|Overall Study|Withdrawal by Subject|0|||
161492447|NCT02457910|583198057|FG003|Overall Study|Withdrawal by Subject|0|||
161492448|NCT02457910|583198058|FG004|Overall Study|Withdrawal by Subject|0|||
161492449|NCT02457910|583198059|FG005|Overall Study|Withdrawal by Subject|1|||
161492450|NCT02457910|583198054|FG000|Overall Study|Adverse Event|0|||
161492451|NCT02457910|583198055|FG001|Overall Study|Adverse Event|2|||
161492452|NCT02457910|583198056|FG002|Overall Study|Adverse Event|1|||
161492453|NCT02457910|583198057|FG003|Overall Study|Adverse Event|1|||
161492454|NCT02457910|583198058|FG004|Overall Study|Adverse Event|1|||
161492455|NCT02457910|583198059|FG005|Overall Study|Adverse Event|3|||
161583960|NCT04424927|583525988|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
161923507|NCT02927145|584766523|FG007|Invitation for Additional Challenge|Pregnancy|0|||
161923508|NCT02927145|584766524|FG008|Invitation for Additional Challenge|Pregnancy|0|||
161923509|NCT03298061|584766525|FG000|Overall Study|Adverse Event|3|||
161923510|NCT03298061|584766525|FG000|Overall Study|Lack of Efficacy|6|||
161923511|NCT03298061|584766525|FG000|Overall Study|Protocol Violation|1|||
161923512|NCT03298061|584766525|FG000|Overall Study|Physician Decision|7|||
161923513|NCT03298061|584766525|FG000|Overall Study|Withdrawal by Subject|10|||
161923514|NCT04307394|584766527|FG000|Overall Study|Lost to Follow-up|3|||
161923515|NCT04307394|584766527|FG000|Overall Study|Withdrawal by Subject|2|||
161923516|NCT01166945|584766530|FG000|Randomized|diagnosed with Group A strep|4|||
161923517|NCT01166945|584766531|FG001|Randomized|diagnosed with Group A strep|4|||
161923518|NCT01166945|584766530|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
161923519|NCT01166945|584766531|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
161923520|NCT01166945|584766530|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
161923521|NCT01166945|584766531|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
161923522|NCT01166945|584766530|FG000|Day 30|Lost to Follow-up|4|||
161923523|NCT01166945|584766531|FG001|Day 30|Lost to Follow-up|3|||
161923524|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
161923525|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
161923526|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
161923527|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
161923528|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
161923529|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
161923530|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
161923531|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
161923532|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
161923533|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
161923534|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
161923535|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
161923536|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
161923537|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
161923538|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
161923539|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
161923540|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
161923541|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
161923542|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
161923543|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
161923544|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
161923545|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
161923546|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
161923547|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
161923548|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
161923549|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
161923550|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
161923551|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
161923552|NCT01239745|584766540|FG000|Overall Study|Study terminated by sponsor|45|||
161923553|NCT01239745|584766540|FG000|Overall Study|Adverse Event|1|||
161923554|NCT06262607|584766547|FG000|Overall Study|Physician Decision|0|||
161923555|NCT06262607|584766548|FG001|Overall Study|Physician Decision|1|||
161923556|NCT06262607|584766547|FG000|Overall Study|Withdrawal by Subject|2|||
161923557|NCT06262607|584766548|FG001|Overall Study|Withdrawal by Subject|0|||
161923558|NCT01946802|584766549|FG000|Overall Study|Death|1|||
161923559|NCT01946802|584766549|FG000|Overall Study|Withdrawal by Subject|2|||
161923560|NCT01946802|584766549|FG000|Overall Study|Combined septic shock|1|||
161923561|NCT01946802|584766549|FG000|Overall Study|Protocol Violation|1|||
161923562|NCT02541903|584766550|FG000|Overall Study|Death|1|||
161923563|NCT02969018|584766555|FG000|Overall Study|Adverse Event|2|||
161923564|NCT02969018|584766556|FG001|Overall Study|Adverse Event|4|||
161923565|NCT02969018|584766557|FG002|Overall Study|Adverse Event|1|||
161923566|NCT02969018|584766558|FG003|Overall Study|Adverse Event|2|||
161923567|NCT02969018|584766559|FG004|Overall Study|Adverse Event|0|||
161923568|NCT02969018|584766560|FG005|Overall Study|Adverse Event|1|||
161923569|NCT02969018|584766561|FG006|Overall Study|Adverse Event|2|||
161492456|NCT02457910|583198054|FG000|Overall Study|Disease progression|3|||
161492457|NCT02457910|583198055|FG001|Overall Study|Disease progression|3|||
161492458|NCT02457910|583198056|FG002|Overall Study|Disease progression|1|||
161492459|NCT02457910|583198057|FG003|Overall Study|Disease progression|1|||
161492460|NCT02457910|583198058|FG004|Overall Study|Disease progression|4|||
161923570|NCT02969018|584766562|FG007|Overall Study|Adverse Event|0|||
161923571|NCT02969018|584766555|FG000|Overall Study|Lack of Efficacy|0|||
161923572|NCT02969018|584766556|FG001|Overall Study|Lack of Efficacy|1|||
161923573|NCT02969018|584766557|FG002|Overall Study|Lack of Efficacy|0|||
161923574|NCT02969018|584766558|FG003|Overall Study|Lack of Efficacy|0|||
161923575|NCT02969018|584766559|FG004|Overall Study|Lack of Efficacy|1|||
161492461|NCT02457910|583198059|FG005|Overall Study|Disease progression|6|||
161492462|NCT02457910|583198054|FG000|Overall Study|Other complicating illness|0|||
161492463|NCT02457910|583198055|FG001|Overall Study|Other complicating illness|0|||
161492464|NCT02457910|583198056|FG002|Overall Study|Other complicating illness|0|||
161492465|NCT02457910|583198057|FG003|Overall Study|Other complicating illness|0|||
161492466|NCT02457910|583198058|FG004|Overall Study|Other complicating illness|0|||
161492467|NCT02457910|583198059|FG005|Overall Study|Other complicating illness|1|||
161492468|NCT02457910|583198054|FG000|Overall Study|Death|0|||
161492469|NCT02457910|583198055|FG001|Overall Study|Death|0|||
161492470|NCT02457910|583198056|FG002|Overall Study|Death|1|||
161492471|NCT02457910|583198057|FG003|Overall Study|Death|0|||
161492472|NCT02457910|583198058|FG004|Overall Study|Death|0|||
161492473|NCT02457910|583198059|FG005|Overall Study|Death|0|||
161583961|NCT04424927|583525989|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161583962|NCT04424927|583525990|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161583963|NCT04424927|583525991|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161583964|NCT04424927|583525992|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161583965|NCT04424927|583525988|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161583966|NCT04424927|583525989|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
161817416|NCT00829764|584371032|FG000|First Intervention|Adverse Event|1|||
161817417|NCT00829764|584371033|FG001|First Intervention|Adverse Event|0|||
161817418|NCT00829764|584371032|FG000|First Intervention|Withdrawal by Subject|1|||
161817419|NCT00829764|584371033|FG001|First Intervention|Withdrawal by Subject|1|||
161817420|NCT00258856|584372808|FG000|Overall Study|Lost to Follow-up|1|||
161817421|NCT00258856|584372809|FG001|Overall Study|Lost to Follow-up|0|||
161817422|NCT00258856|584372810|FG002|Overall Study|Lost to Follow-up|2|||
161817423|NCT00258856|584372811|FG003|Overall Study|Lost to Follow-up|0|||
161817424|NCT00258856|584372808|FG000|Overall Study|Non-compliance|2|||
161817425|NCT00258856|584372809|FG001|Overall Study|Non-compliance|0|||
161817426|NCT00258856|584372810|FG002|Overall Study|Non-compliance|0|||
161817427|NCT00258856|584372811|FG003|Overall Study|Non-compliance|1|||
161817428|NCT02488109|584372817|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
161817429|NCT02488109|584372818|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
161817430|NCT02488109|584372817|FG000|12-month Follow-Up|Lost to Follow-up|4|||
161817431|NCT02488109|584372818|FG001|12-month Follow-Up|Lost to Follow-up|7|||
161817432|NCT03969641|584372819|FG000|Overall Study|Lost to Follow-up|5|||
161817433|NCT03969641|584372820|FG001|Overall Study|Lost to Follow-up|3|||
161817434|NCT03969641|584372819|FG000|Overall Study|Withdrawal by Subject|1|||
161817435|NCT03969641|584372820|FG001|Overall Study|Withdrawal by Subject|2|||
161817436|NCT03969641|584372819|FG000|Overall Study|Found to be ineligible|1|||
161817437|NCT03969641|584372820|FG001|Overall Study|Found to be ineligible|1|||
161817438|NCT03969641|584372819|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
161817439|NCT03969641|584372820|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
161817440|NCT03969641|584372819|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
161817441|NCT03969641|584372820|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
161817442|NCT03969641|584372819|FG000|Overall Study|Elective termination|0|||
161817443|NCT03969641|584372820|FG001|Overall Study|Elective termination|1|||
161817444|NCT02658019|584372836|FG000|Overall Study|Adverse Event|1|||
161817445|NCT00660660|584372837|FG000|Overall Study|Adverse Event|1|||
161817446|NCT00660660|584372838|FG001|Overall Study|Adverse Event|0|||
161817447|NCT00660660|584372837|FG000|Overall Study|Lost to Follow-up|0|||
161817448|NCT00660660|584372838|FG001|Overall Study|Lost to Follow-up|6|||
161817449|NCT00660660|584372837|FG000|Overall Study|Lack of Efficacy|0|||
161817450|NCT00660660|584372838|FG001|Overall Study|Lack of Efficacy|2|||
161817451|NCT00660660|584372837|FG000|Overall Study|Withdrawal by Subject|3|||
161817452|NCT00660660|584372838|FG001|Overall Study|Withdrawal by Subject|0|||
161817453|NCT00660660|584372837|FG000|Overall Study|Incorrect enrollment and other|0|||
161817454|NCT00660660|584372838|FG001|Overall Study|Incorrect enrollment and other|1|||
161817455|NCT00660660|584372837|FG000|Overall Study|New medication after randomization|1|||
161817456|NCT00660660|584372838|FG001|Overall Study|New medication after randomization|0|||
161671646|NCT03170154|583851348|FG000|Overall Study|Death|2|||
161817457|NCT01630616|584372839|FG000|Overall Study|Adverse Event|0|||
161817458|NCT01630616|584372840|FG001|Overall Study|Adverse Event|0|||
161817459|NCT01630616|584372841|FG002|Overall Study|Adverse Event|0|||
161817460|NCT01630616|584372842|FG003|Overall Study|Adverse Event|1|||
161817461|NCT01630616|584372843|FG004|Overall Study|Adverse Event|0|||
161817462|NCT01630616|584372844|FG005|Overall Study|Adverse Event|0|||
161817463|NCT01630616|584372839|FG000|Overall Study|Withdrawal by Subject|0|||
161817464|NCT01630616|584372840|FG001|Overall Study|Withdrawal by Subject|0|||
161817465|NCT01630616|584372841|FG002|Overall Study|Withdrawal by Subject|0|||
161817466|NCT01630616|584372842|FG003|Overall Study|Withdrawal by Subject|2|||
161817467|NCT01630616|584372843|FG004|Overall Study|Withdrawal by Subject|0|||
161817468|NCT01630616|584372844|FG005|Overall Study|Withdrawal by Subject|0|||
161817469|NCT00640393|584372846|FG000|Part 1|Lost to Follow-up|2|||
161492474|NCT00467259|583198060|FG000|Overall Study|Adverse Event|24|||
161492475|NCT00467259|583198061|FG001|Overall Study|Adverse Event|90|||
161492476|NCT00467259|583198060|FG000|Overall Study|Protocol Violation|1|||
161492477|NCT00467259|583198061|FG001|Overall Study|Protocol Violation|7|||
161492478|NCT00467259|583198060|FG000|Overall Study|Withdrawal by Subject|34|||
161492479|NCT00467259|583198061|FG001|Overall Study|Withdrawal by Subject|108|||
161492480|NCT00467259|583198060|FG000|Overall Study|Physician Decision|0|||
161492481|NCT00467259|583198061|FG001|Overall Study|Physician Decision|2|||
161492482|NCT00467259|583198060|FG000|Overall Study|Lost to Follow-up|14|||
161492483|NCT00467259|583198061|FG001|Overall Study|Lost to Follow-up|34|||
161492484|NCT00467259|583198060|FG000|Overall Study|Site Closed|2|||
161492485|NCT00467259|583198061|FG001|Overall Study|Site Closed|1|||
161492486|NCT01339429|583198062|FG000|Overall Study|Withdrawal by Subject|1|||
161492487|NCT01339429|583198062|FG000|Overall Study|Physician Decision|3|||
161492488|NCT00459667|583198065|FG000|Overall Study|Adverse Event|9|||
161492489|NCT00459667|583198066|FG001|Overall Study|Adverse Event|12|||
161492490|NCT00459667|583198067|FG002|Overall Study|Adverse Event|8|||
161492491|NCT00459667|583198065|FG000|Overall Study|Lost to Follow-up|5|||
161492492|NCT00459667|583198066|FG001|Overall Study|Lost to Follow-up|9|||
161492493|NCT00459667|583198067|FG002|Overall Study|Lost to Follow-up|3|||
161817470|NCT00640393|584372847|FG001|Part 1|Lost to Follow-up|0|||
161817471|NCT00640393|584372848|FG002|Part 1|Lost to Follow-up|0|||
161817472|NCT00640393|584372846|FG000|Part 1|Withdrawal by Subject|3|||
161817473|NCT00640393|584372847|FG001|Part 1|Withdrawal by Subject|0|||
161817474|NCT00640393|584372848|FG002|Part 1|Withdrawal by Subject|0|||
161817475|NCT00640393|584372846|FG000|Randomization|Withdrawn per protocol|17|||
161817476|NCT00640393|584372847|FG001|Randomization|Withdrawn per protocol|0|||
161817477|NCT00640393|584372848|FG002|Randomization|Withdrawn per protocol|0|||
161817478|NCT00640393|584372846|FG000|Randomization|Never randomized by site|2|||
161817479|NCT00640393|584372847|FG001|Randomization|Never randomized by site|0|||
161817480|NCT00640393|584372848|FG002|Randomization|Never randomized by site|0|||
161817481|NCT00640393|584372846|FG000|Part 2|Lost to Follow-up|0|||
161817482|NCT00640393|584372847|FG001|Part 2|Lost to Follow-up|2|||
161817483|NCT00640393|584372848|FG002|Part 2|Lost to Follow-up|2|||
161817484|NCT00640393|584372846|FG000|Part 2|Withdrawal by Subject|0|||
161817485|NCT00640393|584372847|FG001|Part 2|Withdrawal by Subject|6|||
161817486|NCT00640393|584372848|FG002|Part 2|Withdrawal by Subject|1|||
161817487|NCT00640393|584372846|FG000|Part 2|Non-adherence|0|||
161817488|NCT00640393|584372847|FG001|Part 2|Non-adherence|1|||
161817489|NCT00640393|584372848|FG002|Part 2|Non-adherence|0|||
161817490|NCT00640393|584372846|FG000|Part 2|Adverse Event|0|||
161817491|NCT00640393|584372847|FG001|Part 2|Adverse Event|1|||
161817492|NCT00640393|584372848|FG002|Part 2|Adverse Event|0|||
161817493|NCT00294047|584372850|FG000|Month 48|Adverse Event|28|||
161817494|NCT00294047|584372851|FG001|Month 48|Adverse Event|13|||
161817495|NCT00294047|584372850|FG000|Month 48|Protocol Violation|4|||
161817496|NCT00294047|584372851|FG001|Month 48|Protocol Violation|4|||
161817497|NCT00294047|584372850|FG000|Month 48|Withdrawal by Subject|111|||
161817498|NCT00294047|584372851|FG001|Month 48|Withdrawal by Subject|115|||
161817499|NCT00294047|584372850|FG000|Month 48|Lost to Follow-up|272|||
161817500|NCT00294047|584372851|FG001|Month 48|Lost to Follow-up|287|||
161817501|NCT00294047|584372850|FG000|Month 48|Other|10|||
161817502|NCT00294047|584372851|FG001|Month 48|Other|14|||
161817503|NCT00294047|584372850|FG000|Month 84|Adverse Event|4|||
161817504|NCT00294047|584372851|FG001|Month 84|Adverse Event|2|||
161817505|NCT00294047|584372850|FG000|Month 84|Protocol Violation|1|||
161817506|NCT00294047|584372851|FG001|Month 84|Protocol Violation|1|||
161817507|NCT00294047|584372850|FG000|Month 84|Withdrawal by Subject|33|||
161817508|NCT00294047|584372851|FG001|Month 84|Withdrawal by Subject|31|||
161817509|NCT00294047|584372850|FG000|Month 84|Lost to Follow-up|187|||
161817510|NCT00294047|584372851|FG001|Month 84|Lost to Follow-up|190|||
161817511|NCT00294047|584372850|FG000|Month 84|Absent Cervix|2|||
161817512|NCT00294047|584372851|FG001|Month 84|Absent Cervix|0|||
161817513|NCT00294047|584372850|FG000|Month 84|Work related reasons|4|||
161817514|NCT00294047|584372851|FG001|Month 84|Work related reasons|2|||
161817515|NCT00294047|584372850|FG000|Month 84|Center closed, subject did not transfer|1|||
161817516|NCT00294047|584372851|FG001|Month 84|Center closed, subject did not transfer|0|||
161817517|NCT00294047|584372850|FG000|Month 84|Family problems|2|||
161817518|NCT00294047|584372851|FG001|Month 84|Family problems|2|||
161583967|NCT04424927|583525990|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
161817519|NCT00294047|584372850|FG000|Month 84|Lack of time|3|||
161817520|NCT00294047|584372851|FG001|Month 84|Lack of time|1|||
161817521|NCT00294047|584372850|FG000|Month 84|Personal reason|2|||
161817522|NCT00294047|584372851|FG001|Month 84|Personal reason|4|||
161492494|NCT00459667|583198065|FG000|Overall Study|Pregnancy|1|||
161492495|NCT00459667|583198066|FG001|Overall Study|Pregnancy|1|||
161583968|NCT04424927|583525991|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161817523|NCT00294047|584372850|FG000|Month 84|Subject does not want male physician|1|||
161817524|NCT00294047|584372851|FG001|Month 84|Subject does not want male physician|0|||
161817525|NCT00294047|584372850|FG000|Month 84|Transport reimbursement delayed|0|||
161817526|NCT00294047|584372851|FG001|Month 84|Transport reimbursement delayed|1|||
161817527|NCT00294047|584372850|FG000|Month 84|Unable to reach study site|1|||
161817528|NCT00294047|584372851|FG001|Month 84|Unable to reach study site|0|||
161817529|NCT00294047|584372850|FG000|Month 84|Under investigation locally|1|||
161817530|NCT00294047|584372851|FG001|Month 84|Under investigation locally|0|||
161817531|NCT00294047|584372850|FG000|Month 84|Visit missed|0|||
161671647|NCT03170154|583851348|FG000|Overall Study|Withdrawal by Subject|2|||
161671648|NCT01906346|583851351|FG000|Overall Study|AEs|1|||
161671649|NCT04936841|583851352|FG000|Overall Study|Death|1|||
161671650|NCT02279862|583851353|FG000|Overall Study|Study drug toxicity|3|||
161671651|NCT02279862|583851354|FG001|Overall Study|Study drug toxicity|6|||
161923576|NCT02969018|584766560|FG005|Overall Study|Lack of Efficacy|1|||
161923577|NCT02969018|584766561|FG006|Overall Study|Lack of Efficacy|1|||
161923578|NCT02969018|584766562|FG007|Overall Study|Lack of Efficacy|1|||
161923579|NCT02969018|584766555|FG000|Overall Study|Lost to Follow-up|1|||
161923580|NCT02969018|584766556|FG001|Overall Study|Lost to Follow-up|2|||
161923581|NCT02969018|584766557|FG002|Overall Study|Lost to Follow-up|2|||
161923582|NCT02969018|584766558|FG003|Overall Study|Lost to Follow-up|0|||
161923583|NCT02969018|584766559|FG004|Overall Study|Lost to Follow-up|1|||
161923584|NCT02969018|584766560|FG005|Overall Study|Lost to Follow-up|1|||
161923585|NCT02969018|584766561|FG006|Overall Study|Lost to Follow-up|0|||
161923586|NCT02969018|584766562|FG007|Overall Study|Lost to Follow-up|1|||
161923587|NCT02969018|584766555|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923588|NCT02969018|584766556|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923589|NCT02969018|584766557|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923590|NCT02969018|584766558|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923591|NCT02969018|584766559|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923592|NCT02969018|584766560|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923593|NCT02969018|584766561|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
161923594|NCT02969018|584766562|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923595|NCT02969018|584766555|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161923596|NCT02969018|584766556|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161923597|NCT02969018|584766557|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161923598|NCT02969018|584766558|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161923599|NCT02969018|584766559|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161671652|NCT02279862|583851353|FG000|Overall Study|No longer meets criteria|0|||
161923600|NCT02969018|584766560|FG005|Overall Study|Non-Compliance With Study Drug|0|||
161923601|NCT02969018|584766561|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161923602|NCT02969018|584766562|FG007|Overall Study|Non-Compliance With Study Drug|0|||
161923603|NCT02969018|584766555|FG000|Overall Study|Other|0|||
161923604|NCT02969018|584766556|FG001|Overall Study|Other|0|||
161923605|NCT02969018|584766557|FG002|Overall Study|Other|0|||
161492496|NCT00459667|583198067|FG002|Overall Study|Pregnancy|1|||
161492497|NCT00459667|583198065|FG000|Overall Study|Protocol Violation|1|||
161492498|NCT00459667|583198066|FG001|Overall Study|Protocol Violation|0|||
161492499|NCT00459667|583198067|FG002|Overall Study|Protocol Violation|0|||
161492500|NCT00459667|583198065|FG000|Overall Study|Withdrawal by Subject|3|||
161492501|NCT00459667|583198066|FG001|Overall Study|Withdrawal by Subject|5|||
161492502|NCT00459667|583198067|FG002|Overall Study|Withdrawal by Subject|5|||
161492503|NCT00459667|583198065|FG000|Overall Study|Other disease modifying treatment|1|||
161492504|NCT00459667|583198066|FG001|Overall Study|Other disease modifying treatment|2|||
161492505|NCT00459667|583198067|FG002|Overall Study|Other disease modifying treatment|1|||
161492506|NCT00459667|583198065|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
161492507|NCT00459667|583198066|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
161492508|NCT00459667|583198067|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
161492509|NCT00459667|583198065|FG000|Overall Study|No treatment administered|6|||
161492510|NCT00459667|583198066|FG001|Overall Study|No treatment administered|3|||
161492511|NCT00459667|583198067|FG002|Overall Study|No treatment administered|1|||
161492512|NCT01013701|583198068|FG000|Overall Study|study prematurely terminated|7|||
161492513|NCT00556712|583198072|FG000|Overall Study|Adverse Event|7|||
161492514|NCT00556712|583198073|FG001|Overall Study|Adverse Event|19|||
161492515|NCT00556712|583198072|FG000|Overall Study|Death|5|||
161492516|NCT00556712|583198073|FG001|Overall Study|Death|10|||
161492517|NCT00556712|583198072|FG000|Overall Study|Progressive Disease|383|||
161492518|NCT00556712|583198073|FG001|Overall Study|Progressive Disease|320|||
161492519|NCT00556712|583198072|FG000|Overall Study|Protocol Violation|3|||
161492520|NCT00556712|583198073|FG001|Overall Study|Protocol Violation|2|||
161492521|NCT00556712|583198072|FG000|Overall Study|Refused Treatment|17|||
161492522|NCT00556712|583198073|FG001|Overall Study|Refused Treatment|16|||
161492523|NCT00556712|583198072|FG000|Overall Study|Failure to Return|2|||
161492524|NCT00556712|583198073|FG001|Overall Study|Failure to Return|3|||
161923606|NCT02969018|584766558|FG003|Overall Study|Other|1|||
161923607|NCT02969018|584766559|FG004|Overall Study|Other|0|||
161923608|NCT02969018|584766560|FG005|Overall Study|Other|0|||
161923609|NCT02969018|584766561|FG006|Overall Study|Other|0|||
161923610|NCT02969018|584766562|FG007|Overall Study|Other|2|||
161492525|NCT00556712|583198072|FG000|Overall Study|Other|2|||
161492526|NCT00556712|583198073|FG001|Overall Study|Other|2|||
161492527|NCT00556712|583198072|FG000|Overall Study|Ongoing at Data Cutoff|32|||
161492528|NCT00556712|583198073|FG001|Overall Study|Ongoing at Data Cutoff|66|||
161671653|NCT02279862|583851354|FG001|Overall Study|No longer meets criteria|1|||
161671654|NCT02279862|583851353|FG000|Overall Study|Administrative reason by sponsor|0|||
161923611|NCT02969018|584766555|FG000|Overall Study|Pregnancy|0|||
161923612|NCT02969018|584766556|FG001|Overall Study|Pregnancy|0|||
161923613|NCT02969018|584766557|FG002|Overall Study|Pregnancy|0|||
161923614|NCT02969018|584766558|FG003|Overall Study|Pregnancy|0|||
161923615|NCT02969018|584766559|FG004|Overall Study|Pregnancy|0|||
161923616|NCT02969018|584766560|FG005|Overall Study|Pregnancy|1|||
161923617|NCT02969018|584766561|FG006|Overall Study|Pregnancy|0|||
161923618|NCT02969018|584766562|FG007|Overall Study|Pregnancy|0|||
161923619|NCT02969018|584766555|FG000|Overall Study|Protocol Violation|0|||
161923620|NCT02969018|584766556|FG001|Overall Study|Protocol Violation|0|||
161923621|NCT02969018|584766557|FG002|Overall Study|Protocol Violation|1|||
161923622|NCT02969018|584766558|FG003|Overall Study|Protocol Violation|1|||
161923623|NCT02969018|584766559|FG004|Overall Study|Protocol Violation|0|||
161923624|NCT02969018|584766560|FG005|Overall Study|Protocol Violation|0|||
161923625|NCT02969018|584766561|FG006|Overall Study|Protocol Violation|0|||
161923626|NCT02969018|584766562|FG007|Overall Study|Protocol Violation|0|||
161923627|NCT02969018|584766555|FG000|Overall Study|Withdrawal by Subject|0|||
161923628|NCT02969018|584766556|FG001|Overall Study|Withdrawal by Subject|1|||
161923629|NCT02969018|584766557|FG002|Overall Study|Withdrawal by Subject|2|||
161923630|NCT02969018|584766558|FG003|Overall Study|Withdrawal by Subject|1|||
161923631|NCT02969018|584766559|FG004|Overall Study|Withdrawal by Subject|0|||
161923632|NCT02969018|584766560|FG005|Overall Study|Withdrawal by Subject|4|||
161923633|NCT02969018|584766561|FG006|Overall Study|Withdrawal by Subject|4|||
161923634|NCT02969018|584766562|FG007|Overall Study|Withdrawal by Subject|3|||
161923635|NCT00827242|584766564|FG000|Overall Study|Withdrawal by Subject|2|||
161923636|NCT00827242|584766565|FG001|Overall Study|Withdrawal by Subject|4|||
161923637|NCT00827242|584766564|FG000|Overall Study|Protocol Violation|1|||
161923638|NCT00827242|584766565|FG001|Overall Study|Protocol Violation|3|||
161923639|NCT00827242|584766564|FG000|Overall Study|Lost to Follow-up|0|||
161923640|NCT00827242|584766565|FG001|Overall Study|Lost to Follow-up|3|||
161923641|NCT00827242|584766564|FG000|Overall Study|Adverse Event Excluding Death|2|||
161923642|NCT00827242|584766565|FG001|Overall Study|Adverse Event Excluding Death|1|||
161923643|NCT00827242|584766564|FG000|Overall Study|Entry Criteria Not Met|4|||
161923644|NCT00827242|584766565|FG001|Overall Study|Entry Criteria Not Met|1|||
161923645|NCT00827242|584766564|FG000|Overall Study|Physician Decision|2|||
161923646|NCT00827242|584766565|FG001|Overall Study|Physician Decision|0|||
161923647|NCT00827242|584766564|FG000|Overall Study|Death|1|||
161923648|NCT00827242|584766565|FG001|Overall Study|Death|0|||
161923649|NCT00827242|584766564|FG000|Overall Study|Lack of Efficacy|1|||
161923650|NCT00827242|584766565|FG001|Overall Study|Lack of Efficacy|0|||
161923651|NCT05762679|584766566|FG000|Overall Study|Withdrawal by Subject|1|||
161923652|NCT05762679|584766566|FG000|Overall Study|No analyzable imaging data|1|||
161923653|NCT01479530|584766571|FG000|Overall Study|Adverse Event|5|||
161923654|NCT01479530|584766572|FG001|Overall Study|Adverse Event|6|||
161923655|NCT01479530|584766571|FG000|Overall Study|Lack of Efficacy|0|||
161923656|NCT01479530|584766572|FG001|Overall Study|Lack of Efficacy|1|||
161923657|NCT01479530|584766571|FG000|Overall Study|Protocol Violation|2|||
161923658|NCT01479530|584766572|FG001|Overall Study|Protocol Violation|3|||
161923659|NCT01479530|584766571|FG000|Overall Study|Withdrawal of Consent|3|||
161923660|NCT01479530|584766572|FG001|Overall Study|Withdrawal of Consent|2|||
161923661|NCT00927082|584766580|FG000|Overall Study|Lost to Follow-up|9|||
161923662|NCT00927082|584766581|FG001|Overall Study|Lost to Follow-up|8|||
161923663|NCT00927082|584766582|FG002|Overall Study|Lost to Follow-up|12|||
161923664|NCT00927082|584766583|FG003|Overall Study|Lost to Follow-up|16|||
161923665|NCT00927082|584766580|FG000|Overall Study|Withdrawal by Subject|3|||
161923666|NCT00927082|584766581|FG001|Overall Study|Withdrawal by Subject|2|||
161923667|NCT00927082|584766582|FG002|Overall Study|Withdrawal by Subject|7|||
161923668|NCT00927082|584766583|FG003|Overall Study|Withdrawal by Subject|2|||
161923669|NCT00927082|584766580|FG000|Overall Study|Death|0|||
161923670|NCT00927082|584766581|FG001|Overall Study|Death|0|||
161492529|NCT01059799|583198075|FG000|Overall Study|Adverse Event|2|||
161492530|NCT01059799|583198076|FG001|Overall Study|Adverse Event|3|||
161492531|NCT01059799|583198075|FG000|Overall Study|Lack of Efficacy|1|||
161492532|NCT01059799|583198076|FG001|Overall Study|Lack of Efficacy|0|||
161492533|NCT01059799|583198075|FG000|Overall Study|Protocol Violation|3|||
161492534|NCT01059799|583198076|FG001|Overall Study|Protocol Violation|2|||
161923671|NCT00927082|584766582|FG002|Overall Study|Death|1|||
161923672|NCT00927082|584766583|FG003|Overall Study|Death|0|||
161923673|NCT00927082|584766580|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
161923674|NCT00927082|584766581|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
161923675|NCT00927082|584766582|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
161923676|NCT00927082|584766583|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
161923677|NCT00825175|584766589|FG000|Overall Study|Withdrawal by Subject|0|||
161923678|NCT00825175|584766590|FG001|Overall Study|Withdrawal by Subject|5|||
161923679|NCT04615507|584766593|FG000|Period 1|Covid-19 exposure|2|||
161923680|NCT04615507|584766594|FG001|Period 1|Covid-19 exposure|1|||
161923681|NCT04615507|584766593|FG000|Period 2|Covid-19 exposure|0|||
161923682|NCT04615507|584766594|FG001|Period 2|Covid-19 exposure|1|||
161923683|NCT04615507|584766593|FG000|Period 2|Protocol Violation|1|||
161583969|NCT04424927|583525992|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161583970|NCT04424927|583525988|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
161583971|NCT04424927|583525989|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
161583972|NCT04424927|583525990|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
161583973|NCT04424927|583525991|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
161583974|NCT04424927|583525992|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
161583975|NCT04424927|583525988|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161817532|NCT00294047|584372851|FG001|Month 84|Visit missed|1|||
161817533|NCT00294047|584372850|FG000|Month 84|No consent for Month 84 Follow-up|731|||
161817534|NCT00294047|584372851|FG001|Month 84|No consent for Month 84 Follow-up|754|||
161817535|NCT00506831|584372852|FG000|Overall Study|Death|1|||
161817536|NCT00506831|584372852|FG000|Overall Study|Withdrawal by Subject|1|||
161817537|NCT01410227|584372856|FG000|Overall Study|Adverse Event|1|||
161817538|NCT01410227|584372857|FG001|Overall Study|Adverse Event|0|||
161817539|NCT01410227|584372858|FG002|Overall Study|Adverse Event|0|||
161817540|NCT01410227|584372859|FG003|Overall Study|Adverse Event|0|||
161817541|NCT01410227|584372856|FG000|Overall Study|Withdrawal by Subject|3|||
161817542|NCT01410227|584372857|FG001|Overall Study|Withdrawal by Subject|0|||
161817543|NCT01410227|584372858|FG002|Overall Study|Withdrawal by Subject|1|||
161817544|NCT01410227|584372859|FG003|Overall Study|Withdrawal by Subject|0|||
161817545|NCT01410227|584372856|FG000|Overall Study|Pregnancy|0|||
161817546|NCT01410227|584372857|FG001|Overall Study|Pregnancy|0|||
161817547|NCT01410227|584372858|FG002|Overall Study|Pregnancy|0|||
161817548|NCT01410227|584372859|FG003|Overall Study|Pregnancy|1|||
161817549|NCT01410227|584372856|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
161817550|NCT01410227|584372857|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
161817551|NCT01410227|584372858|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
161817552|NCT01410227|584372859|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
161817553|NCT00608322|584372862|FG000|Overall Study|Death|2|||
161817554|NCT00608322|584372863|FG001|Overall Study|Death|1|||
161817555|NCT04002648|584372864|FG000|Overall Study|Lost to Follow-up|2|||
161817556|NCT04002648|584372865|FG001|Overall Study|Lost to Follow-up|0|||
161817557|NCT00606281|584372869|FG000|Overall Study|Adverse Event|11|||
161817558|NCT00606281|584372870|FG001|Overall Study|Adverse Event|12|||
161817559|NCT00606281|584372869|FG000|Overall Study|Death|1|||
161817560|NCT00606281|584372870|FG001|Overall Study|Death|0|||
161817561|NCT00606281|584372869|FG000|Overall Study|Lack of Efficacy|28|||
161817562|NCT00606281|584372870|FG001|Overall Study|Lack of Efficacy|35|||
161817563|NCT00606281|584372869|FG000|Overall Study|Physician Decision|0|||
161817564|NCT00606281|584372870|FG001|Overall Study|Physician Decision|1|||
161817565|NCT00606281|584372869|FG000|Overall Study|Protocol Violation|3|||
161817566|NCT00606281|584372870|FG001|Overall Study|Protocol Violation|3|||
161817567|NCT00606281|584372869|FG000|Overall Study|Withdrawal by Subject|11|||
161817568|NCT00606281|584372870|FG001|Overall Study|Withdrawal by Subject|13|||
161817569|NCT00606281|584372869|FG000|Overall Study|Progression to depressive phase|1|||
161817570|NCT00606281|584372870|FG001|Overall Study|Progression to depressive phase|1|||
161817571|NCT00606281|584372869|FG000|Overall Study|Change of residence or other commitments|1|||
161817572|NCT00606281|584372870|FG001|Overall Study|Change of residence or other commitments|1|||
161817573|NCT00540423|584372872|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161817574|NCT00540423|584372873|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161817575|NCT00540423|584372874|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161817576|NCT00540423|584372872|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
161817577|NCT00540423|584372873|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161817578|NCT00540423|584372874|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
161817579|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
161817580|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
161817581|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
161817582|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
161817583|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161817584|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
161817585|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
161817586|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
161817587|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161817588|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
161817589|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161817590|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161817591|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Other|0|||
161817592|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Other|0|||
161817593|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Other|2|||
161817594|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Other|0|||
161923684|NCT04615507|584766594|FG001|Period 2|Protocol Violation|0|||
161923685|NCT04615507|584766593|FG000|Period 2|Withdrawal by Subject|1|||
161923686|NCT04615507|584766594|FG001|Period 2|Withdrawal by Subject|0|||
161923687|NCT04615507|584766593|FG000|Period 2|Adverse Event|0|||
161492535|NCT01059799|583198075|FG000|Overall Study|Withdrawal criteria|13|||
161492536|NCT01059799|583198076|FG001|Overall Study|Withdrawal criteria|2|||
161492537|NCT01059799|583198075|FG000|Overall Study|Other|12|||
161492538|NCT01059799|583198076|FG001|Overall Study|Other|3|||
161492539|NCT01361464|583198077|FG000|Overall Study|Death|1|||
161492540|NCT01361464|583198077|FG000|Overall Study|Withdrawal by Subject|2|||
161492541|NCT00818662|583198082|FG000|Overall Study|Adverse Event|5|||
161492542|NCT00818662|583198083|FG001|Overall Study|Adverse Event|14|||
161492543|NCT00818662|583198084|FG002|Overall Study|Adverse Event|4|||
161492544|NCT00818662|583198085|FG003|Overall Study|Adverse Event|3|||
161492545|NCT00818662|583198082|FG000|Overall Study|Withdrawal by Subject|5|||
161492546|NCT00818662|583198083|FG001|Overall Study|Withdrawal by Subject|4|||
161492547|NCT00818662|583198084|FG002|Overall Study|Withdrawal by Subject|2|||
161492548|NCT00818662|583198085|FG003|Overall Study|Withdrawal by Subject|2|||
161492549|NCT00818662|583198082|FG000|Overall Study|Death|1|||
161492550|NCT00818662|583198083|FG001|Overall Study|Death|3|||
161492551|NCT00818662|583198084|FG002|Overall Study|Death|0|||
161492552|NCT00818662|583198085|FG003|Overall Study|Death|0|||
161492553|NCT00818662|583198082|FG000|Overall Study|Physician Decision|1|||
161492554|NCT00818662|583198083|FG001|Overall Study|Physician Decision|0|||
161492555|NCT00818662|583198084|FG002|Overall Study|Physician Decision|0|||
161492556|NCT00818662|583198085|FG003|Overall Study|Physician Decision|0|||
161492557|NCT00818662|583198082|FG000|Overall Study|Lost to Follow-up|0|||
161492558|NCT00818662|583198083|FG001|Overall Study|Lost to Follow-up|0|||
161492559|NCT00818662|583198084|FG002|Overall Study|Lost to Follow-up|0|||
161817595|NCT03131895|584372875|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161817596|NCT03131895|584372876|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
161817597|NCT03131895|584372877|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161817598|NCT03131895|584372878|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161817599|NCT03131895|584372875|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
161492560|NCT00818662|583198085|FG003|Overall Study|Lost to Follow-up|1|||
161492561|NCT00818662|583198082|FG000|Overall Study|Unwilling or Unable to Participate|4|||
161492562|NCT00818662|583198083|FG001|Overall Study|Unwilling or Unable to Participate|6|||
161817600|NCT03131895|584372876|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161817601|NCT03131895|584372877|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161817602|NCT03131895|584372878|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161817603|NCT00731939|584372884|FG000|Overall Study|Adverse Event|6|||
161817604|NCT00731939|584372884|FG000|Overall Study|Lost to Follow-up|15|||
161817605|NCT00731939|584372884|FG000|Overall Study|Not implanted with study device|9|||
161817606|NCT00731939|584372884|FG000|Overall Study|Withdrawal by Subject|2|||
161817607|NCT00731939|584372884|FG000|Overall Study|Did not meet enrollment criteria|2|||
161817608|NCT02280863|584372885|FG000|Integrated Platform|Met stopping criteria|0|||
161817609|NCT02280863|584372886|FG001|Integrated Platform|Met stopping criteria|1|||
161817610|NCT02622386|584372887|FG000|First Assignment|Withdrawal by Subject|3|||
161817611|NCT02622386|584372888|FG001|First Assignment|Withdrawal by Subject|2|||
161817612|NCT02622386|584372887|FG000|Washout|Withdrawal by Subject|4|||
161817613|NCT02622386|584372888|FG001|Washout|Withdrawal by Subject|4|||
161817614|NCT02622386|584372887|FG000|Second Assignment|Withdrawal by Subject|0|||
161817615|NCT02622386|584372888|FG001|Second Assignment|Withdrawal by Subject|2|||
161817616|NCT05274763|584372889|FG000|Overall Study|Lost to Follow-up|1|||
161817617|NCT01174186|584372890|FG000|Overall Study|Lost to Follow-up|0|||
161817618|NCT01174186|584372891|FG001|Overall Study|Lost to Follow-up|1|||
161817619|NCT01174186|584372890|FG000|Overall Study|Withdrawal by Subject|0|||
161817620|NCT01174186|584372891|FG001|Overall Study|Withdrawal by Subject|2|||
161817621|NCT00918684|584372892|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
161817622|NCT00918684|584372892|FG000|Treatment Phase|Lack of Efficacy|6|||
161817623|NCT00918684|584372892|FG000|Treatment Phase|Lost to Follow-up|2|||
161492563|NCT00818662|583198084|FG002|Overall Study|Unwilling or Unable to Participate|2|||
161492564|NCT00818662|583198085|FG003|Overall Study|Unwilling or Unable to Participate|4|||
161492565|NCT00818662|583198082|FG000|Overall Study|Protocol Violation|1|||
161492566|NCT00818662|583198083|FG001|Overall Study|Protocol Violation|1|||
161492567|NCT00818662|583198084|FG002|Overall Study|Protocol Violation|0|||
161492568|NCT00818662|583198085|FG003|Overall Study|Protocol Violation|0|||
161492569|NCT00818662|583198082|FG000|Overall Study|Requires a Prohibited Medication|1|||
161492570|NCT00818662|583198083|FG001|Overall Study|Requires a Prohibited Medication|0|||
161492571|NCT00818662|583198084|FG002|Overall Study|Requires a Prohibited Medication|0|||
161492572|NCT00818662|583198085|FG003|Overall Study|Requires a Prohibited Medication|0|||
161492573|NCT00818662|583198082|FG000|Overall Study|Safety Risk|1|||
161492574|NCT00818662|583198083|FG001|Overall Study|Safety Risk|1|||
161583976|NCT04424927|583525989|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
161817624|NCT00918684|584372892|FG000|Treatment Phase|Physician Decision|8|||
161817625|NCT00918684|584372892|FG000|Treatment Phase|Protocol Violation|1|||
161817626|NCT00918684|584372892|FG000|Treatment Phase|Withdrawal by Subject|8|||
161817627|NCT00402103|584372893|FG000|Overall Study|Adverse Event|60|||
161492575|NCT00818662|583198084|FG002|Overall Study|Safety Risk|0|||
161671655|NCT02279862|583851354|FG001|Overall Study|Administrative reason by sponsor|1|||
161671656|NCT02279862|583851353|FG000|Overall Study|Disease progression|5|||
161671657|NCT02279862|583851354|FG001|Overall Study|Disease progression|2|||
161671658|NCT02279862|583851353|FG000|Overall Study|Study closed by sponsor|16|||
161671659|NCT02279862|583851354|FG001|Overall Study|Study closed by sponsor|13|||
161492576|NCT00818662|583198085|FG003|Overall Study|Safety Risk|1|||
161492577|NCT00818662|583198082|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
161492578|NCT00818662|583198083|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
161492579|NCT00818662|583198084|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
161492580|NCT00818662|583198085|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
161492581|NCT00818662|583198082|FG000|Overall Study|Participant's health declined|0|||
161671660|NCT02279862|583851353|FG000|Overall Study|Other|1|||
161492582|NCT00818662|583198083|FG001|Overall Study|Participant's health declined|0|||
161492583|NCT00818662|583198084|FG002|Overall Study|Participant's health declined|0|||
161492584|NCT00818662|583198085|FG003|Overall Study|Participant's health declined|1|||
161492585|NCT00818662|583198082|FG000|Overall Study|Caregiver to pursue other treatment|0|||
161492586|NCT00818662|583198083|FG001|Overall Study|Caregiver to pursue other treatment|1|||
161492587|NCT00818662|583198084|FG002|Overall Study|Caregiver to pursue other treatment|0|||
161492588|NCT00818662|583198085|FG003|Overall Study|Caregiver to pursue other treatment|0|||
161492589|NCT00818662|583198082|FG000|Overall Study|Moving out of state|0|||
161492590|NCT00818662|583198083|FG001|Overall Study|Moving out of state|0|||
161583977|NCT04424927|583525990|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161583978|NCT04424927|583525991|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161583979|NCT04424927|583525992|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
161583980|NCT04424927|583525988|FG000|Double-blind Period (24 Weeks)|Other|0|||
161583981|NCT04424927|583525989|FG001|Double-blind Period (24 Weeks)|Other|1|||
161583982|NCT04424927|583525990|FG002|Double-blind Period (24 Weeks)|Other|3|||
161583983|NCT04424927|583525991|FG003|Double-blind Period (24 Weeks)|Other|1|||
161583984|NCT04424927|583525992|FG004|Double-blind Period (24 Weeks)|Other|0|||
161583985|NCT01121991|583525995|FG000|Overall Study|Lack of Ovarian Response|2|||
161583986|NCT01121991|583525995|FG000|Overall Study|No Oocytes Retrieved|3|||
161671661|NCT02279862|583851354|FG001|Overall Study|Other|2|||
161671662|NCT02279862|583851353|FG000|Overall Study|Withdrawal by Subject|1|||
161671663|NCT02279862|583851354|FG001|Overall Study|Withdrawal by Subject|0|||
161671664|NCT04226833|583851357|FG000|Overall Study|Death|0|||
161671665|NCT04226833|583851358|FG001|Overall Study|Death|0|||
161671666|NCT04226833|583851359|FG002|Overall Study|Death|1|||
161671667|NCT04226833|583851360|FG003|Overall Study|Death|0|||
161671668|NCT00403754|583851363|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
161671669|NCT00403754|583851364|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
161671670|NCT00403754|583851365|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
161671671|NCT00403754|583851366|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
161671672|NCT00403754|583851363|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
161671673|NCT00403754|583851364|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
161671674|NCT00403754|583851365|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
161671675|NCT00403754|583851366|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
161817628|NCT00402103|584372894|FG001|Overall Study|Adverse Event|7|||
161817629|NCT00402103|584372893|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161817630|NCT00402103|584372894|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161817631|NCT00402103|584372893|FG000|Overall Study|Condition no longer requires study drug|2|||
161817632|NCT00402103|584372894|FG001|Overall Study|Condition no longer requires study drug|0|||
161817633|NCT00402103|584372893|FG000|Overall Study|Protocol Deviation|8|||
161817634|NCT00402103|584372894|FG001|Overall Study|Protocol Deviation|0|||
161817635|NCT00402103|584372893|FG000|Overall Study|Patient withdrew consent|12|||
161817636|NCT00402103|584372894|FG001|Overall Study|Patient withdrew consent|1|||
161817637|NCT00402103|584372893|FG000|Overall Study|Lost to Follow-up|6|||
161817638|NCT00402103|584372894|FG001|Overall Study|Lost to Follow-up|3|||
161817639|NCT00402103|584372893|FG000|Overall Study|Administrative problems|2|||
161817640|NCT00402103|584372894|FG001|Overall Study|Administrative problems|0|||
161817641|NCT00484679|584372895|FG000|Overall Study|Withdrawal by Subject|3|||
161817642|NCT00418145|584372898|FG000|Overall Study|study terminated|6|||
161492591|NCT00818662|583198084|FG002|Overall Study|Moving out of state|0|||
161492592|NCT00818662|583198085|FG003|Overall Study|Moving out of state|1|||
161583987|NCT01121991|583525995|FG000|Overall Study|No Fertilization|1|||
161583988|NCT04110054|583525996|FG000|Overall Study|COVID-19 reason other than AE|0|||
161583989|NCT04110054|583525997|FG001|Overall Study|COVID-19 reason other than AE|0|||
161817643|NCT00472212|584372899|FG000|Overall Study|Lost to Follow-up|6|||
161492593|NCT00818662|583198082|FG000|Overall Study|Declined move to another study site|1|||
161583990|NCT04110054|583525998|FG002|Overall Study|COVID-19 reason other than AE|2|||
161671676|NCT04343248|583851367|FG000|Overall Study|Withdrawal by Subject|5|||
161817644|NCT00472212|584372900|FG001|Overall Study|Lost to Follow-up|4|||
161492594|NCT00818662|583198083|FG001|Overall Study|Declined move to another study site|0|||
161671677|NCT04343248|583851368|FG001|Overall Study|Withdrawal by Subject|6|||
161817645|NCT00425308|584372901|FG000|Overall Study|Adverse Event|2|||
161671678|NCT04343248|583851367|FG000|Overall Study|Death|1|||
161671679|NCT04343248|583851368|FG001|Overall Study|Death|2|||
161671680|NCT04343248|583851367|FG000|Overall Study|Lost to Follow-up|9|||
161671681|NCT04343248|583851368|FG001|Overall Study|Lost to Follow-up|6|||
161671682|NCT04343248|583851367|FG000|Overall Study|Physician Decision|0|||
161671683|NCT04343248|583851368|FG001|Overall Study|Physician Decision|1|||
161923688|NCT04615507|584766594|FG001|Period 2|Adverse Event|1|||
161923689|NCT04615507|584766593|FG000|Period 3|Covid-19 exposure|0|||
161923690|NCT04615507|584766594|FG001|Period 3|Covid-19 exposure|1|||
161923691|NCT03407482|584766595|FG000|Overall Study|Adverse Event|12|||
161923692|NCT03407482|584766595|FG000|Overall Study|Disease Relapse|1|||
161923693|NCT03407482|584766595|FG000|Overall Study|Lost to Follow-up|1|||
161923694|NCT03407482|584766595|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161923695|NCT03407482|584766595|FG000|Overall Study|Pregnancy|2|||
161923696|NCT03407482|584766595|FG000|Overall Study|Protocol Violation|1|||
161923697|NCT03407482|584766595|FG000|Overall Study|Study Terminated By Sponsor|106|||
161923698|NCT03407482|584766595|FG000|Overall Study|Withdrawal by Subject|6|||
161923699|NCT03407482|584766595|FG000|Overall Study|Data Entry Error|1|||
161923700|NCT05887401|584766599|FG000|Overall Study|Withdrawal by Subject|0|||
161923701|NCT05887401|584766600|FG001|Overall Study|Withdrawal by Subject|0|||
161923702|NCT05887401|584766601|FG002|Overall Study|Withdrawal by Subject|0|||
161923703|NCT05887401|584766602|FG003|Overall Study|Withdrawal by Subject|0|||
161923704|NCT05887401|584766603|FG004|Overall Study|Withdrawal by Subject|0|||
161923705|NCT05887401|584766604|FG005|Overall Study|Withdrawal by Subject|0|||
161923706|NCT05887401|584766605|FG006|Overall Study|Withdrawal by Subject|0|||
161923707|NCT05887401|584766606|FG007|Overall Study|Withdrawal by Subject|0|||
161923708|NCT05887401|584766607|FG008|Overall Study|Withdrawal by Subject|0|||
161923709|NCT05887401|584766608|FG009|Overall Study|Withdrawal by Subject|1|||
161923710|NCT05887401|584766609|FG010|Overall Study|Withdrawal by Subject|0|||
161923711|NCT05887401|584766610|FG011|Overall Study|Withdrawal by Subject|0|||
161923712|NCT05887401|584766611|FG012|Overall Study|Withdrawal by Subject|0|||
161923713|NCT05887401|584766612|FG013|Overall Study|Withdrawal by Subject|0|||
161923714|NCT05887401|584766613|FG014|Overall Study|Withdrawal by Subject|0|||
161923715|NCT05887401|584766614|FG015|Overall Study|Withdrawal by Subject|1|||
161923716|NCT05887401|584766599|FG000|Overall Study|Lost to Follow-up|0|||
161923717|NCT05887401|584766600|FG001|Overall Study|Lost to Follow-up|1|||
161923718|NCT05887401|584766601|FG002|Overall Study|Lost to Follow-up|1|||
161923719|NCT05887401|584766602|FG003|Overall Study|Lost to Follow-up|2|||
161923720|NCT05887401|584766603|FG004|Overall Study|Lost to Follow-up|0|||
161923721|NCT05887401|584766604|FG005|Overall Study|Lost to Follow-up|0|||
161923722|NCT05887401|584766605|FG006|Overall Study|Lost to Follow-up|0|||
161923723|NCT05887401|584766606|FG007|Overall Study|Lost to Follow-up|0|||
161923724|NCT05887401|584766607|FG008|Overall Study|Lost to Follow-up|1|||
161923725|NCT05887401|584766608|FG009|Overall Study|Lost to Follow-up|1|||
161923726|NCT05887401|584766609|FG010|Overall Study|Lost to Follow-up|2|||
161923727|NCT05887401|584766610|FG011|Overall Study|Lost to Follow-up|1|||
161923728|NCT05887401|584766611|FG012|Overall Study|Lost to Follow-up|0|||
161923729|NCT05887401|584766612|FG013|Overall Study|Lost to Follow-up|0|||
161923730|NCT05887401|584766613|FG014|Overall Study|Lost to Follow-up|0|||
161923731|NCT05887401|584766614|FG015|Overall Study|Lost to Follow-up|0|||
161923732|NCT03010501|584766618|FG000|Study Week 1|Withdrawal by Subject|2|||
161923733|NCT03010501|584766619|FG001|Study Week 1|Withdrawal by Subject|1|||
161923734|NCT03010501|584766620|FG002|Study Week 1|Withdrawal by Subject|0|||
161923735|NCT03010501|584766621|FG003|Study Week 1|Withdrawal by Subject|2|||
161923736|NCT03010501|584766622|FG004|Study Week 1|Withdrawal by Subject|0|||
161923737|NCT03010501|584766623|FG005|Study Week 1|Withdrawal by Subject|0|||
161923738|NCT03010501|584766618|FG000|Study Week 3|Withdrawal by Subject|0|||
161923739|NCT03010501|584766619|FG001|Study Week 3|Withdrawal by Subject|0|||
161923740|NCT03010501|584766620|FG002|Study Week 3|Withdrawal by Subject|0|||
161923741|NCT03010501|584766621|FG003|Study Week 3|Withdrawal by Subject|1|||
161923742|NCT03010501|584766622|FG004|Study Week 3|Withdrawal by Subject|0|||
161923743|NCT03010501|584766623|FG005|Study Week 3|Withdrawal by Subject|0|||
161923744|NCT02347787|584766626|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
161923745|NCT02347787|584766627|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
161923746|NCT02347787|584766626|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
161923747|NCT02347787|584766627|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
161923748|NCT02347787|584766626|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
161923749|NCT02347787|584766627|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
161923750|NCT02347787|584766626|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
161923751|NCT02347787|584766627|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
161671684|NCT04343248|583851367|FG000|Overall Study|Adverse Event|1|||
161671685|NCT04343248|583851368|FG001|Overall Study|Adverse Event|0|||
161923752|NCT02369458|584766630|FG000|Overall Study|Determined to be not eligible|1|||
161923753|NCT02369458|584766631|FG001|Overall Study|Determined to be not eligible|0|||
161923754|NCT03853798|584766632|FG000|Overall Study|Death|0|||
161923755|NCT03853798|584766633|FG001|Overall Study|Death|0|||
161923756|NCT03853798|584766634|FG002|Overall Study|Death|0|||
161492595|NCT00818662|583198084|FG002|Overall Study|Declined move to another study site|0|||
161492596|NCT00818662|583198085|FG003|Overall Study|Declined move to another study site|0|||
161492597|NCT00818662|583198082|FG000|Overall Study|Change in living situation|0|||
161492598|NCT00818662|583198083|FG001|Overall Study|Change in living situation|0|||
161492599|NCT00818662|583198084|FG002|Overall Study|Change in living situation|0|||
161492600|NCT00818662|583198085|FG003|Overall Study|Change in living situation|1|||
161492601|NCT00818662|583198082|FG000|Overall Study|Study partner decision|0|||
161492602|NCT00818662|583198083|FG001|Overall Study|Study partner decision|0|||
161492603|NCT00818662|583198084|FG002|Overall Study|Study partner decision|0|||
161492604|NCT00818662|583198085|FG003|Overall Study|Study partner decision|1|||
161492605|NCT00818662|583198082|FG000|Overall Study|Admitted to long term nursing care|0|||
161492606|NCT00818662|583198083|FG001|Overall Study|Admitted to long term nursing care|1|||
161492607|NCT00818662|583198084|FG002|Overall Study|Admitted to long term nursing care|0|||
161492608|NCT00818662|583198085|FG003|Overall Study|Admitted to long term nursing care|0|||
161492609|NCT01106898|583198086|FG000|Overall Study|Adverse Event|6|||
161492610|NCT03021265|583198087|FG000|Overall Study|Adverse Event|29|||
161492611|NCT03021265|583198087|FG000|Overall Study|Lack of Efficacy|3|||
161492612|NCT03021265|583198087|FG000|Overall Study|Improved|17|||
161492613|NCT03021265|583198087|FG000|Overall Study|Lost to Follow-up|67|||
161492614|NCT03021265|583198087|FG000|Overall Study|No reason given|2|||
161492615|NCT03021265|583198087|FG000|Overall Study|No visit since the first visit|4|||
161492616|NCT01722071|583198088|FG000|Overall Study|Protocol Violation|1|||
161492617|NCT01722071|583198089|FG001|Overall Study|Protocol Violation|0|||
161492618|NCT01338493|583198090|FG000|Enrolled|Withdrawal by Subject|1|||
161492619|NCT01338493|583198090|FG000|Enrolled|Patient not implanted|4|||
161492620|NCT01338493|583198090|FG000|Discharge|Death|1|||
161492621|NCT01338493|583198090|FG000|Discharge|Missed visit|1|||
161492622|NCT01338493|583198090|FG000|6 Months Follow up|Lost to Follow-up|11|||
161492623|NCT01338493|583198090|FG000|6 Months Follow up|Missed visit|8|||
161492624|NCT01338493|583198090|FG000|12 Months Follow up|Lost to Follow-up|9|||
161492625|NCT01846611|583198091|FG000|Overall Study|Lost to Follow-up|4|||
161492626|NCT01846611|583198092|FG001|Overall Study|Lost to Follow-up|6|||
161492627|NCT01846611|583198091|FG000|Overall Study|Withdrawal by Subject|15|||
161492628|NCT01846611|583198092|FG001|Overall Study|Withdrawal by Subject|19|||
161492629|NCT01846611|583198091|FG000|Overall Study|Other|19|||
161492630|NCT01846611|583198092|FG001|Overall Study|Other|18|||
161492631|NCT01614067|583198093|FG000|Overall Study|Pregnancy|1|||
161492632|NCT01614067|583198094|FG001|Overall Study|Pregnancy|0|||
161492633|NCT01614067|583198093|FG000|Overall Study|Physician Decision|6|||
161492634|NCT01614067|583198094|FG001|Overall Study|Physician Decision|5|||
161492635|NCT01614067|583198093|FG000|Overall Study|Withdrawal by Subject|0|||
161492636|NCT01614067|583198094|FG001|Overall Study|Withdrawal by Subject|1|||
161492637|NCT01614067|583198093|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
161492638|NCT01614067|583198094|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
161492639|NCT02289079|583198097|FG000|Overall Study|Physician Decision|2|||
161492640|NCT02289079|583198098|FG001|Overall Study|Physician Decision|0|||
161492641|NCT02289079|583198097|FG000|Overall Study|Lost to Follow-up|0|||
161492642|NCT02289079|583198098|FG001|Overall Study|Lost to Follow-up|1|||
161492643|NCT02671422|583198099|FG000|Overall Study|Lost to Follow-up|1|||
161492644|NCT02671422|583198099|FG000|Overall Study|Adverse Event|68|||
161492645|NCT02671422|583198099|FG000|Overall Study|Lack of Efficacy|1|||
161492646|NCT02671422|583198099|FG000|Overall Study|Lost to Follow-up|4|||
161492647|NCT02671422|583198099|FG000|Overall Study|Withdrawal by Subject|7|||
161492648|NCT02671422|583198099|FG000|Overall Study|Progressive Disease|156|||
161492649|NCT02671422|583198099|FG000|Overall Study|Worsening of Disease|4|||
161492650|NCT02671422|583198099|FG000|Overall Study|Sponsor decision|5|||
161492651|NCT02671422|583198099|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
161492652|NCT02671422|583198099|FG000|Overall Study|Not treated with Vargatef®|3|||
161492653|NCT02671422|583198099|FG000|Overall Study|Other not defined above|3|||
161492654|NCT02111850|583198100|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492655|NCT02111850|583198101|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492656|NCT02111850|583198102|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492657|NCT02111850|583198103|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161583991|NCT04110054|583525999|FG003|Overall Study|COVID-19 reason other than AE|0|||
161583992|NCT04110054|583525996|FG000|Overall Study|Withdrawal by Subject|0|||
161583993|NCT04110054|583525997|FG001|Overall Study|Withdrawal by Subject|3|||
161492658|NCT02111850|583198104|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
161492659|NCT02111850|583198105|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492660|NCT02111850|583198106|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492661|NCT02111850|583198107|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492662|NCT02111850|583198108|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492663|NCT02111850|583198109|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161583994|NCT04110054|583525998|FG002|Overall Study|Withdrawal by Subject|2|||
161492664|NCT02111850|583198110|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
161492665|NCT03061331|583198111|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
161492666|NCT03061331|583198112|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
161492667|NCT01980875|583198113|FG000|Overall Study|Withdrew Consent|1|||
161492668|NCT01980875|583198114|FG001|Overall Study|Withdrew Consent|1|||
161492669|NCT01980875|583198115|FG002|Overall Study|Withdrew Consent|1|||
161492670|NCT01980875|583198113|FG000|Overall Study|Study Terminated by Sponsor|7|||
161492671|NCT01980875|583198114|FG001|Overall Study|Study Terminated by Sponsor|24|||
161492672|NCT01980875|583198115|FG002|Overall Study|Study Terminated by Sponsor|22|||
161492673|NCT01980875|583198113|FG000|Overall Study|Lost to Follow-up|0|||
161492674|NCT01980875|583198114|FG001|Overall Study|Lost to Follow-up|0|||
161492675|NCT01980875|583198115|FG002|Overall Study|Lost to Follow-up|1|||
161492676|NCT02625259|583198116|FG000|First Intervention (Day 1)|Other|0|||
161492677|NCT02625259|583198117|FG001|First Intervention (Day 1)|Other|0|||
161492678|NCT02625259|583198118|FG002|First Intervention (Day 1)|Other|1|||
161492679|NCT02625259|583198119|FG003|First Intervention (Day 1)|Other|0|||
161492680|NCT02625259|583198120|FG004|First Intervention (Day 1)|Other|0|||
161492681|NCT02625259|583198116|FG000|First Intervention (Day 1)|Adverse Event|2|||
161492682|NCT02625259|583198117|FG001|First Intervention (Day 1)|Adverse Event|1|||
161492683|NCT02625259|583198118|FG002|First Intervention (Day 1)|Adverse Event|0|||
161492684|NCT02625259|583198119|FG003|First Intervention (Day 1)|Adverse Event|0|||
161492685|NCT02625259|583198120|FG004|First Intervention (Day 1)|Adverse Event|0|||
161492686|NCT02625259|583198116|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
161492687|NCT02625259|583198117|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
161492688|NCT02625259|583198118|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161492689|NCT02625259|583198119|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
161492690|NCT02625259|583198120|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
161492691|NCT00513474|583198121|FG000|Overall Study|Death|6|||
161492692|NCT00513474|583198122|FG001|Overall Study|Death|9|||
161492693|NCT00513474|583198121|FG000|Overall Study|Participant Withdrew Consent|1|||
161492694|NCT00513474|583198122|FG001|Overall Study|Participant Withdrew Consent|0|||
161492695|NCT04772755|583198123|FG000|Overall Study|Withdrawal by Subject|1|||
161492696|NCT04772755|583198124|FG001|Overall Study|Withdrawal by Subject|0|||
161492697|NCT04772755|583198123|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
161492698|NCT04772755|583198124|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
161492699|NCT00662363|583198126|FG000|Overall Study|Withdrawal by Subject|6|||
161492700|NCT00662363|583198127|FG001|Overall Study|Withdrawal by Subject|5|||
161492701|NCT00662363|583198126|FG000|Overall Study|Adverse Event|0|||
161492702|NCT00662363|583198127|FG001|Overall Study|Adverse Event|3|||
161492703|NCT00662363|583198126|FG000|Overall Study|Discharged early from rehab|4|||
161492704|NCT00662363|583198127|FG001|Overall Study|Discharged early from rehab|1|||
161492705|NCT00662363|583198126|FG000|Overall Study|Protocol Violation|1|||
161492706|NCT00662363|583198127|FG001|Overall Study|Protocol Violation|1|||
161583995|NCT04110054|583525999|FG003|Overall Study|Withdrawal by Subject|0|||
161583996|NCT04110054|583525996|FG000|Overall Study|Adverse Event|1|||
161583997|NCT04110054|583525997|FG001|Overall Study|Adverse Event|1|||
161583998|NCT04110054|583525998|FG002|Overall Study|Adverse Event|4|||
161583999|NCT04110054|583525999|FG003|Overall Study|Adverse Event|3|||
161584000|NCT01000480|583526001|FG000|Induction Phase|Adverse Event|2|||
161584001|NCT01000480|583526001|FG000|Induction Phase|Lost to Follow-up|1|||
161584002|NCT01000480|583526001|FG000|Induction Phase|Physician Decision|1|||
161584003|NCT01000480|583526001|FG000|Induction Phase|Entry Criteria Not Met|3|||
161584004|NCT01000480|583526001|FG000|Concurrent Therapy Phase|Adverse Event|4|||
161584005|NCT01000480|583526001|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
161584006|NCT01000480|583526001|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
161584007|NCT01000480|583526001|FG000|Concurrent Therapy Phase|Physician Decision|1|||
161584008|NCT03655262|583526006|FG000|Overall Study|Withdrawal by Subject|0|||
161671686|NCT03951220|583851373|FG000|Overall Study|Withdrawal by Subject|9|||
161923757|NCT03853798|584766635|FG003|Overall Study|Death|0|||
161923758|NCT03853798|584766636|FG004|Overall Study|Death|0|||
161923759|NCT03853798|584766637|FG005|Overall Study|Death|1|||
161923760|NCT03853798|584766638|FG006|Overall Study|Death|0|||
161923761|NCT03853798|584766639|FG007|Overall Study|Death|0|||
161492707|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Adverse Event|82|||
161492708|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Death|6|||
161492709|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
161492710|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
161584009|NCT03655262|583526007|FG001|Overall Study|Withdrawal by Subject|0|||
161671687|NCT03951220|583851374|FG001|Overall Study|Withdrawal by Subject|2|||
161492711|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
161671688|NCT03951220|583851375|FG002|Overall Study|Withdrawal by Subject|0|||
161492712|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
161492713|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
161923762|NCT03853798|584766640|FG008|Overall Study|Death|0|||
161923763|NCT03853798|584766632|FG000|Overall Study|Adverse Event|0|||
161923764|NCT03853798|584766633|FG001|Overall Study|Adverse Event|0|||
161492714|NCT00195676|583198128|FG000|Period O - Open-label Treatment|Other reasons|68|||
161492715|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
161492716|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
161492717|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
161492718|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
161492719|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
161492720|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
161492721|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
161492722|NCT00195676|583198128|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
161492723|NCT00195676|583198128|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
161492724|NCT00195676|583198128|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
161492725|NCT00195676|583198128|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
161492726|NCT00195676|583198128|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
161492727|NCT00195676|583198128|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
161492728|NCT01905657|583198129|FG000|Overall Study|Adverse Event|23|||
161492729|NCT01905657|583198130|FG001|Overall Study|Adverse Event|17|||
161492730|NCT01905657|583198131|FG002|Overall Study|Adverse Event|18|||
161492731|NCT01905657|583198129|FG000|Overall Study|Clinical Progression|103|||
161492732|NCT01905657|583198130|FG001|Overall Study|Clinical Progression|78|||
161492733|NCT01905657|583198131|FG002|Overall Study|Clinical Progression|59|||
161492734|NCT01905657|583198129|FG000|Overall Study|Death|40|||
161492735|NCT01905657|583198130|FG001|Overall Study|Death|43|||
161492736|NCT01905657|583198131|FG002|Overall Study|Death|47|||
161492737|NCT01905657|583198129|FG000|Overall Study|Excluded Medication|13|||
161492738|NCT01905657|583198130|FG001|Overall Study|Excluded Medication|16|||
161492739|NCT01905657|583198131|FG002|Overall Study|Excluded Medication|9|||
161492740|NCT01905657|583198129|FG000|Overall Study|Lost to Follow-up|1|||
161492741|NCT01905657|583198130|FG001|Overall Study|Lost to Follow-up|2|||
161492742|NCT01905657|583198131|FG002|Overall Study|Lost to Follow-up|1|||
161492743|NCT01905657|583198129|FG000|Overall Study|Physician Decision|5|||
161492744|NCT01905657|583198130|FG001|Overall Study|Physician Decision|8|||
161492745|NCT01905657|583198131|FG002|Overall Study|Physician Decision|12|||
161492746|NCT01905657|583198129|FG000|Overall Study|Protocol Violation|2|||
161492747|NCT01905657|583198130|FG001|Overall Study|Protocol Violation|1|||
161492748|NCT01905657|583198131|FG002|Overall Study|Protocol Violation|1|||
161492749|NCT01905657|583198129|FG000|Overall Study|Screen Failure|0|||
161492750|NCT01905657|583198130|FG001|Overall Study|Screen Failure|1|||
161492751|NCT01905657|583198131|FG002|Overall Study|Screen Failure|0|||
161492752|NCT01905657|583198129|FG000|Overall Study|Withdrawal by Subject|15|||
161492753|NCT01905657|583198130|FG001|Overall Study|Withdrawal by Subject|21|||
161492754|NCT01905657|583198131|FG002|Overall Study|Withdrawal by Subject|53|||
161492755|NCT01905657|583198129|FG000|Overall Study|Sponsor Decision|1|||
161492756|NCT01905657|583198130|FG001|Overall Study|Sponsor Decision|0|||
161817646|NCT00425308|584372902|FG001|Overall Study|Adverse Event|1|||
161817647|NCT00425308|584372901|FG000|Overall Study|Withdrawal by Subject|1|||
161817648|NCT00425308|584372902|FG001|Overall Study|Withdrawal by Subject|0|||
161817649|NCT00425308|584372901|FG000|Overall Study|Death|1|||
161817650|NCT00425308|584372902|FG001|Overall Study|Death|0|||
161817651|NCT01075282|584372903|FG000|Overall Study|Withdrawal by Subject|11|||
161817652|NCT01075282|584372904|FG001|Overall Study|Withdrawal by Subject|7|||
161817653|NCT01075282|584372905|FG002|Overall Study|Withdrawal by Subject|11|||
161817654|NCT01075282|584372903|FG000|Overall Study|Adverse Event|9|||
161817655|NCT01075282|584372904|FG001|Overall Study|Adverse Event|8|||
161817656|NCT01075282|584372905|FG002|Overall Study|Adverse Event|5|||
161817657|NCT01075282|584372903|FG000|Overall Study|Entry Criteria Not Met|3|||
161817658|NCT01075282|584372904|FG001|Overall Study|Entry Criteria Not Met|2|||
161817659|NCT01075282|584372905|FG002|Overall Study|Entry Criteria Not Met|0|||
161817660|NCT01075282|584372903|FG000|Overall Study|Lost to Follow-up|3|||
161817661|NCT01075282|584372904|FG001|Overall Study|Lost to Follow-up|3|||
161817662|NCT01075282|584372905|FG002|Overall Study|Lost to Follow-up|3|||
161817663|NCT01075282|584372903|FG000|Overall Study|Physician Decision|3|||
161817664|NCT01075282|584372904|FG001|Overall Study|Physician Decision|3|||
161817665|NCT01075282|584372905|FG002|Overall Study|Physician Decision|3|||
161817666|NCT01075282|584372903|FG000|Overall Study|Lack of Efficacy|1|||
161817667|NCT01075282|584372904|FG001|Overall Study|Lack of Efficacy|1|||
161492757|NCT01905657|583198131|FG002|Overall Study|Sponsor Decision|0|||
161492758|NCT01189812|583198132|FG000|Overall Study|Withdrawal by Subject|2|||
161492759|NCT01189812|583198133|FG001|Overall Study|Withdrawal by Subject|3|||
161492760|NCT01189812|583198132|FG000|Overall Study|Adverse Event|1|||
161492761|NCT01189812|583198133|FG001|Overall Study|Adverse Event|0|||
161492762|NCT01189812|583198132|FG000|Overall Study|Out of Window|4|||
161492763|NCT01189812|583198133|FG001|Overall Study|Out of Window|3|||
161923765|NCT03853798|584766634|FG002|Overall Study|Adverse Event|2|||
161923766|NCT03853798|584766635|FG003|Overall Study|Adverse Event|0|||
161492764|NCT01189812|583198132|FG000|Overall Study|Moved out of State|1|||
161492765|NCT01189812|583198133|FG001|Overall Study|Moved out of State|2|||
161817668|NCT01075282|584372905|FG002|Overall Study|Lack of Efficacy|0|||
161492766|NCT03761147|583198135|FG000|Overall Study|Withdrawal by Subject|6|||
161492767|NCT03761147|583198136|FG001|Overall Study|Withdrawal by Subject|1|||
161492768|NCT03761147|583198135|FG000|Overall Study|Adverse Event|1|||
161492769|NCT03761147|583198136|FG001|Overall Study|Adverse Event|3|||
161492770|NCT04080297|583198137|FG000|Overall Study|Adverse Event|1|||
161492771|NCT04080297|583198138|FG001|Overall Study|Adverse Event|3|||
161492772|NCT04080297|583198137|FG000|Overall Study|concurrent illness|1|||
161492773|NCT04080297|583198138|FG001|Overall Study|concurrent illness|0|||
161492774|NCT02744391|583198139|FG000|Overall Study|Lost to Follow-up|9|||
161492775|NCT02744391|583198139|FG000|Overall Study|Physician Decision|2|||
161492776|NCT02744391|583198139|FG000|Overall Study|Withdrawal by Subject|3|||
161492777|NCT05119569|583198140|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
161492778|NCT05119569|583198141|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
161492779|NCT05119569|583198142|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161492780|NCT05119569|583198143|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161492781|NCT05119569|583198140|FG000|Double Blind Treatment Phase|Adverse Event|6|||
161492782|NCT05119569|583198141|FG001|Double Blind Treatment Phase|Adverse Event|0|||
161492783|NCT05119569|583198142|FG002|Double Blind Treatment Phase|Adverse Event|0|||
161492784|NCT05119569|583198143|FG003|Double Blind Treatment Phase|Adverse Event|0|||
161492785|NCT05119569|583198140|FG000|Open Label Extension Phase|Ongoing in the study|0|||
161492786|NCT05119569|583198141|FG001|Open Label Extension Phase|Ongoing in the study|0|||
161492787|NCT05119569|583198142|FG002|Open Label Extension Phase|Ongoing in the study|65|||
161492788|NCT05119569|583198143|FG003|Open Label Extension Phase|Ongoing in the study|34|||
161492789|NCT02623439|583198144|FG000|Overall Study|Withdrawal by Subject|1|||
161492790|NCT02623439|583198144|FG000|Overall Study|Screen Failure|1|||
161492791|NCT02200445|583198148|FG000|Overall Study|Lack of Efficacy|1|||
161492792|NCT02200445|583198149|FG001|Overall Study|Lack of Efficacy|2|||
161492793|NCT02200445|583198150|FG002|Overall Study|Lack of Efficacy|2|||
161492794|NCT02200445|583198148|FG000|Overall Study|Adverse Event|0|||
161492795|NCT02200445|583198149|FG001|Overall Study|Adverse Event|2|||
161492796|NCT02200445|583198150|FG002|Overall Study|Adverse Event|0|||
161492797|NCT03700671|583198151|FG000|Overall Study|Lack of Efficacy|1|||
161492798|NCT03700671|583198152|FG001|Overall Study|Lack of Efficacy|2|||
161492799|NCT04434092|583198159|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
161492800|NCT04434092|583198160|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
161492801|NCT04434092|583198161|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
161492802|NCT04434092|583198159|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
161492803|NCT04434092|583198160|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
161492804|NCT04434092|583198161|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
161492805|NCT04434092|583198159|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
161817669|NCT01075282|584372903|FG000|Overall Study|Treatment Non-compliance|1|||
161817670|NCT01075282|584372904|FG001|Overall Study|Treatment Non-compliance|2|||
161817671|NCT01075282|584372905|FG002|Overall Study|Treatment Non-compliance|2|||
161817672|NCT01075282|584372903|FG000|Overall Study|Protocol Violation|0|||
161817673|NCT01075282|584372904|FG001|Overall Study|Protocol Violation|2|||
161817674|NCT01075282|584372905|FG002|Overall Study|Protocol Violation|1|||
161817675|NCT01075282|584372903|FG000|Overall Study|Death|0|||
161817676|NCT01075282|584372904|FG001|Overall Study|Death|1|||
161817677|NCT01075282|584372905|FG002|Overall Study|Death|2|||
161817678|NCT00367133|584372906|FG000|2 Years|Death|20|||
161817679|NCT00367133|584372907|FG001|2 Years|Death|12|||
161817680|NCT00367133|584372908|FG002|2 Years|Death|12|||
161817681|NCT00367133|584372906|FG000|2 Years|Dropped|34|||
161817682|NCT00367133|584372907|FG001|2 Years|Dropped|19|||
161817683|NCT00367133|584372908|FG002|2 Years|Dropped|33|||
161817684|NCT00367133|584372906|FG000|2 Years|Missed visit|4|||
161817685|NCT00367133|584372907|FG001|2 Years|Missed visit|5|||
161817686|NCT00367133|584372908|FG002|2 Years|Missed visit|4|||
161817687|NCT00847535|584372909|FG000|Overall Study|Withdrawal by Subject|2|||
161817688|NCT00847535|584372910|FG001|Overall Study|Withdrawal by Subject|1|||
161817689|NCT00847535|584372911|FG002|Overall Study|Withdrawal by Subject|1|||
161817690|NCT00847535|584372909|FG000|Overall Study|Lost to Follow-up|0|||
161817691|NCT00847535|584372910|FG001|Overall Study|Lost to Follow-up|1|||
161817692|NCT00847535|584372911|FG002|Overall Study|Lost to Follow-up|0|||
161817693|NCT01252953|584372912|FG000|Overall Study|Withdrawal by Subject|16|||
161671689|NCT04484831|583851382|FG000|Overall Study|Withdrawal by Subject|1|||
161671690|NCT04484831|583851383|FG001|Overall Study|Withdrawal by Subject|0|||
161817694|NCT01252953|584372913|FG001|Overall Study|Withdrawal by Subject|17|||
161817695|NCT01252953|584372912|FG000|Overall Study|Lost to Follow-up|22|||
161817696|NCT01252953|584372913|FG001|Overall Study|Lost to Follow-up|21|||
161817697|NCT00906399|584372916|FG000|Year 1|Randomized But Not Treated|0|||
161817698|NCT00906399|584372917|FG001|Year 1|Randomized But Not Treated|1|||
161817699|NCT00906399|584372918|FG002|Year 1|Randomized But Not Treated|3|||
161817700|NCT00906399|584372919|FG003|Year 1|Randomized But Not Treated|0|||
161817701|NCT00906399|584372920|FG004|Year 1|Randomized But Not Treated|0|||
161817702|NCT00906399|584372921|FG005|Year 1|Randomized But Not Treated|0|||
161817703|NCT00906399|584372922|FG006|Year 1|Randomized But Not Treated|0|||
161492806|NCT04434092|583198160|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
161492807|NCT04434092|583198161|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
161492808|NCT04434092|583198159|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
161492809|NCT04434092|583198160|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
161492810|NCT04434092|583198161|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
161492811|NCT04434092|583198159|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
161492812|NCT04434092|583198160|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
161492813|NCT04434092|583198161|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
161492814|NCT04434092|583198159|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
161492815|NCT04434092|583198160|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
161492816|NCT04434092|583198161|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
161492817|NCT04434092|583198159|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
161492818|NCT04434092|583198160|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
161492819|NCT04434092|583198161|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
161492820|NCT03220217|583200032|FG000|Overall Study|Withdrawal by Subject|0|||
161923767|NCT03853798|584766636|FG004|Overall Study|Adverse Event|0|||
161923768|NCT03853798|584766637|FG005|Overall Study|Adverse Event|0|||
161923769|NCT03853798|584766638|FG006|Overall Study|Adverse Event|0|||
161923770|NCT03853798|584766639|FG007|Overall Study|Adverse Event|0|||
161923771|NCT03853798|584766640|FG008|Overall Study|Adverse Event|0|||
161923772|NCT03853798|584766632|FG000|Overall Study|Withdrawal by Subject|0|||
161923773|NCT03853798|584766633|FG001|Overall Study|Withdrawal by Subject|1|||
161923774|NCT03853798|584766634|FG002|Overall Study|Withdrawal by Subject|4|||
161923775|NCT03853798|584766635|FG003|Overall Study|Withdrawal by Subject|0|||
161923776|NCT03853798|584766636|FG004|Overall Study|Withdrawal by Subject|0|||
161923777|NCT03853798|584766637|FG005|Overall Study|Withdrawal by Subject|5|||
161923778|NCT03853798|584766638|FG006|Overall Study|Withdrawal by Subject|0|||
161923779|NCT03853798|584766639|FG007|Overall Study|Withdrawal by Subject|0|||
161923780|NCT03853798|584766640|FG008|Overall Study|Withdrawal by Subject|4|||
161923781|NCT03853798|584766632|FG000|Overall Study|Physician Decision|1|||
161923782|NCT03853798|584766633|FG001|Overall Study|Physician Decision|0|||
161923783|NCT03853798|584766634|FG002|Overall Study|Physician Decision|0|||
161923784|NCT03853798|584766635|FG003|Overall Study|Physician Decision|0|||
161923785|NCT03853798|584766636|FG004|Overall Study|Physician Decision|0|||
161923786|NCT03853798|584766637|FG005|Overall Study|Physician Decision|0|||
161923787|NCT03853798|584766638|FG006|Overall Study|Physician Decision|0|||
161923788|NCT03853798|584766639|FG007|Overall Study|Physician Decision|0|||
161923789|NCT03853798|584766640|FG008|Overall Study|Physician Decision|1|||
161923790|NCT03853798|584766632|FG000|Overall Study|Lack of Efficacy|0|||
161923791|NCT03853798|584766633|FG001|Overall Study|Lack of Efficacy|0|||
161923792|NCT03853798|584766634|FG002|Overall Study|Lack of Efficacy|2|||
161923793|NCT03853798|584766635|FG003|Overall Study|Lack of Efficacy|0|||
161923794|NCT03853798|584766636|FG004|Overall Study|Lack of Efficacy|0|||
161923795|NCT03853798|584766637|FG005|Overall Study|Lack of Efficacy|0|||
161923796|NCT03853798|584766638|FG006|Overall Study|Lack of Efficacy|0|||
161923797|NCT03853798|584766639|FG007|Overall Study|Lack of Efficacy|0|||
161923798|NCT03853798|584766640|FG008|Overall Study|Lack of Efficacy|1|||
161923799|NCT03853798|584766632|FG000|Overall Study|Approved Drug Available for Indication|0|||
161923800|NCT03853798|584766633|FG001|Overall Study|Approved Drug Available for Indication|0|||
161923801|NCT03853798|584766634|FG002|Overall Study|Approved Drug Available for Indication|1|||
161923802|NCT03853798|584766635|FG003|Overall Study|Approved Drug Available for Indication|0|||
161923803|NCT03853798|584766636|FG004|Overall Study|Approved Drug Available for Indication|0|||
161923804|NCT03853798|584766637|FG005|Overall Study|Approved Drug Available for Indication|1|||
161923805|NCT03853798|584766638|FG006|Overall Study|Approved Drug Available for Indication|0|||
161923806|NCT03853798|584766639|FG007|Overall Study|Approved Drug Available for Indication|0|||
161923807|NCT03853798|584766640|FG008|Overall Study|Approved Drug Available for Indication|0|||
161923808|NCT03853798|584766632|FG000|Overall Study|Other un-specified|0|||
161923809|NCT03853798|584766633|FG001|Overall Study|Other un-specified|0|||
161492821|NCT03220217|583200033|FG001|Overall Study|Withdrawal by Subject|1|||
161492822|NCT03220217|583200034|FG002|Overall Study|Withdrawal by Subject|0|||
161492823|NCT03220217|583200032|FG000|Overall Study|Subject Missed Procedure|0|||
161492824|NCT03220217|583200033|FG001|Overall Study|Subject Missed Procedure|0|||
161492825|NCT03220217|583200034|FG002|Overall Study|Subject Missed Procedure|1|||
161492826|NCT00312494|583200035|FG000|Overall Study|Randomized; not treated with study drug|9|||
161923810|NCT03853798|584766634|FG002|Overall Study|Other un-specified|2|||
161923811|NCT03853798|584766635|FG003|Overall Study|Other un-specified|0|||
161923812|NCT03853798|584766636|FG004|Overall Study|Other un-specified|0|||
161923813|NCT03853798|584766637|FG005|Overall Study|Other un-specified|1|||
161923814|NCT03853798|584766638|FG006|Overall Study|Other un-specified|0|||
161923815|NCT03853798|584766639|FG007|Overall Study|Other un-specified|0|||
161923816|NCT03853798|584766640|FG008|Overall Study|Other un-specified|0|||
161923817|NCT02743494|584766641|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
161923818|NCT02743494|584766642|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
161923819|NCT02743494|584766641|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
161923820|NCT02743494|584766642|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
161923821|NCT02743494|584766641|FG000|Treatment Period|Disease recurrence|152|||
161923822|NCT02743494|584766642|FG001|Treatment Period|Disease recurrence|115|||
161923823|NCT02743494|584766641|FG000|Treatment Period|Study drug toxicity|56|||
161923824|NCT02743494|584766642|FG001|Treatment Period|Study drug toxicity|8|||
161923825|NCT02743494|584766641|FG000|Treatment Period|Death|1|||
161923826|NCT02743494|584766642|FG001|Treatment Period|Death|1|||
161492827|NCT00312494|583200036|FG001|Overall Study|Randomized; not treated with study drug|10|||
161492828|NCT00312494|583200037|FG002|Overall Study|Randomized; not treated with study drug|5|||
161492829|NCT00312494|583200035|FG000|Overall Study|Adverse Event|33|||
161492830|NCT00312494|583200036|FG001|Overall Study|Adverse Event|15|||
161492831|NCT00312494|583200037|FG002|Overall Study|Adverse Event|11|||
161492832|NCT00312494|583200035|FG000|Overall Study|Lack of Efficacy|4|||
161492833|NCT00312494|583200036|FG001|Overall Study|Lack of Efficacy|6|||
161492834|NCT00312494|583200037|FG002|Overall Study|Lack of Efficacy|8|||
161492835|NCT00312494|583200035|FG000|Overall Study|Laboratory abnormality|1|||
161492836|NCT00312494|583200036|FG001|Overall Study|Laboratory abnormality|0|||
161492837|NCT00312494|583200037|FG002|Overall Study|Laboratory abnormality|0|||
161492838|NCT00312494|583200035|FG000|Overall Study|Lost to Follow-up|8|||
161492839|NCT00312494|583200036|FG001|Overall Study|Lost to Follow-up|8|||
161492840|NCT00312494|583200037|FG002|Overall Study|Lost to Follow-up|8|||
161492841|NCT00312494|583200035|FG000|Overall Study|Withdrawal by Subject|6|||
161492842|NCT00312494|583200036|FG001|Overall Study|Withdrawal by Subject|9|||
161492843|NCT00312494|583200037|FG002|Overall Study|Withdrawal by Subject|10|||
161492844|NCT00312494|583200035|FG000|Overall Study|Other|10|||
161492845|NCT00312494|583200036|FG001|Overall Study|Other|10|||
161492846|NCT00312494|583200037|FG002|Overall Study|Other|1|||
161492847|NCT02355691|583200038|FG000|Overall Study|Loss of Research Personnel|7|||
161492848|NCT02355691|583200039|FG001|Overall Study|Loss of Research Personnel|9|||
161492849|NCT00065507|583200040|FG000|Overall Study|Death|16|||
161492850|NCT00065507|583200041|FG001|Overall Study|Death|17|||
161492851|NCT00065507|583200040|FG000|Overall Study|Adverse Event|4|||
161492852|NCT00065507|583200041|FG001|Overall Study|Adverse Event|3|||
161492853|NCT00065507|583200040|FG000|Overall Study|Lack of Efficacy|0|||
161492854|NCT00065507|583200041|FG001|Overall Study|Lack of Efficacy|6|||
161492855|NCT00065507|583200040|FG000|Overall Study|Poor/Non-compliance|3|||
161492856|NCT00065507|583200041|FG001|Overall Study|Poor/Non-compliance|2|||
161492857|NCT00065507|583200040|FG000|Overall Study|Lost to Follow-up|3|||
161492858|NCT00065507|583200041|FG001|Overall Study|Lost to Follow-up|0|||
161584010|NCT03655262|583526008|FG002|Overall Study|Withdrawal by Subject|1|||
161584011|NCT04149002|583526018|FG000|Overall Study|Lost to Follow-up|1|||
161584012|NCT04149002|583526019|FG001|Overall Study|Lost to Follow-up|0|||
161817704|NCT00906399|584372916|FG000|Year 1|Adverse Event|4|||
161817705|NCT00906399|584372917|FG001|Year 1|Adverse Event|22|||
161817706|NCT00906399|584372918|FG002|Year 1|Adverse Event|24|||
161817707|NCT00906399|584372919|FG003|Year 1|Adverse Event|0|||
161817708|NCT00906399|584372920|FG004|Year 1|Adverse Event|0|||
161817709|NCT00906399|584372921|FG005|Year 1|Adverse Event|0|||
161817710|NCT00906399|584372922|FG006|Year 1|Adverse Event|0|||
161817711|NCT00906399|584372916|FG000|Year 1|Lost to Follow-up|4|||
161817712|NCT00906399|584372917|FG001|Year 1|Lost to Follow-up|4|||
161817713|NCT00906399|584372918|FG002|Year 1|Lost to Follow-up|2|||
161817714|NCT00906399|584372919|FG003|Year 1|Lost to Follow-up|0|||
161817715|NCT00906399|584372920|FG004|Year 1|Lost to Follow-up|0|||
161817716|NCT00906399|584372921|FG005|Year 1|Lost to Follow-up|0|||
161817717|NCT00906399|584372922|FG006|Year 1|Lost to Follow-up|0|||
161817718|NCT00906399|584372916|FG000|Year 1|Withdrawal by Subject|30|||
161817719|NCT00906399|584372917|FG001|Year 1|Withdrawal by Subject|32|||
161817720|NCT00906399|584372918|FG002|Year 1|Withdrawal by Subject|36|||
161817721|NCT00906399|584372919|FG003|Year 1|Withdrawal by Subject|0|||
161817722|NCT00906399|584372920|FG004|Year 1|Withdrawal by Subject|0|||
161817723|NCT00906399|584372921|FG005|Year 1|Withdrawal by Subject|0|||
161817724|NCT00906399|584372922|FG006|Year 1|Withdrawal by Subject|0|||
161817725|NCT00906399|584372916|FG000|Year 1|Physician Decision|0|||
161817726|NCT00906399|584372917|FG001|Year 1|Physician Decision|1|||
161817727|NCT00906399|584372918|FG002|Year 1|Physician Decision|3|||
161817728|NCT00906399|584372919|FG003|Year 1|Physician Decision|0|||
161817729|NCT00906399|584372920|FG004|Year 1|Physician Decision|0|||
161492859|NCT00065507|583200040|FG000|Overall Study|Subject Withdrew Consent|2|||
161492860|NCT00065507|583200041|FG001|Overall Study|Subject Withdrew Consent|1|||
161492861|NCT00065507|583200040|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
161492862|NCT00065507|583200041|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
161492863|NCT00350636|583200042|FG000|Overall Study|Adverse Event|19|||
161492864|NCT00350636|583200043|FG001|Overall Study|Adverse Event|13|||
161492865|NCT00350636|583200042|FG000|Overall Study|Protocol Violation|1|||
161492866|NCT00350636|583200043|FG001|Overall Study|Protocol Violation|3|||
161492867|NCT00350636|583200042|FG000|Overall Study|Withdrawal by Subject|13|||
161817730|NCT00906399|584372921|FG005|Year 1|Physician Decision|0|||
161817731|NCT00906399|584372922|FG006|Year 1|Physician Decision|0|||
161492868|NCT00350636|583200043|FG001|Overall Study|Withdrawal by Subject|17|||
161492869|NCT00350636|583200042|FG000|Overall Study|Lost to Follow-up|9|||
161492870|NCT00350636|583200043|FG001|Overall Study|Lost to Follow-up|8|||
161492871|NCT00350636|583200042|FG000|Overall Study|Physician Decision|0|||
161492872|NCT00350636|583200043|FG001|Overall Study|Physician Decision|2|||
161492873|NCT00350636|583200042|FG000|Overall Study|Other|1|||
161492874|NCT00350636|583200043|FG001|Overall Study|Other|2|||
161492875|NCT00100815|583200044|FG000|Overall Study|Progression|24|||
161492876|NCT00100815|583200044|FG000|Overall Study|Adverse Event|18|||
161492877|NCT00100815|583200044|FG000|Overall Study|Death|4|||
161492878|NCT00100815|583200044|FG000|Overall Study|Other|3|||
161492879|NCT01647282|583200050|FG000|Overall Study|Physician Decision|7|||
161492880|NCT01647282|583200051|FG001|Overall Study|Physician Decision|5|||
161492881|NCT01042236|583200052|FG000|Treatment Period 1|Adverse Event|0|||
161492882|NCT01042236|583200053|FG001|Treatment Period 1|Adverse Event|1|||
161492883|NCT01042236|583200054|FG002|Treatment Period 1|Adverse Event|0|||
161492884|NCT01042236|583200055|FG003|Treatment Period 1|Adverse Event|0|||
161492885|NCT01042236|583200056|FG004|Treatment Period 1|Adverse Event|1|||
161492886|NCT01042236|583200057|FG005|Treatment Period 1|Adverse Event|0|||
161492887|NCT01042236|583200052|FG000|Treatment Period 3|Adverse Event|0|||
161492888|NCT01042236|583200053|FG001|Treatment Period 3|Adverse Event|0|||
161492889|NCT01042236|583200054|FG002|Treatment Period 3|Adverse Event|0|||
161492890|NCT01042236|583200055|FG003|Treatment Period 3|Adverse Event|1|||
161492891|NCT01042236|583200056|FG004|Treatment Period 3|Adverse Event|0|||
161492892|NCT01042236|583200057|FG005|Treatment Period 3|Adverse Event|0|||
161492893|NCT01042236|583200052|FG000|Treatment Period 3|Protocol Violation|0|||
161492894|NCT01042236|583200053|FG001|Treatment Period 3|Protocol Violation|0|||
161492895|NCT01042236|583200054|FG002|Treatment Period 3|Protocol Violation|0|||
161492896|NCT01042236|583200055|FG003|Treatment Period 3|Protocol Violation|1|||
161492897|NCT01042236|583200056|FG004|Treatment Period 3|Protocol Violation|0|||
161492898|NCT01042236|583200057|FG005|Treatment Period 3|Protocol Violation|0|||
161492899|NCT01172847|583200060|FG000|Overall Study|Withdrawal by Subject|3|||
161492900|NCT00665353|583200065|FG000|Study Step 1|Adverse Event|1|||
161492901|NCT00665353|583200065|FG000|Study Step 1|Withdrawal by Subject|2|||
161492902|NCT00665353|583200065|FG000|Study Step 2|Lost to Follow-up|2|||
161492903|NCT00665353|583200065|FG000|Study Step 2|Lack of Efficacy|12|||
161492904|NCT01851720|583200066|FG000|Overall Study|Lost to Follow-up|0|||
161492905|NCT01851720|583200067|FG001|Overall Study|Lost to Follow-up|1|||
161492906|NCT02132767|583200072|FG000|Overall Study|Death|3|||
161492907|NCT02132767|583200073|FG001|Overall Study|Death|2|||
161492908|NCT02132767|583200072|FG000|Overall Study|Withdrawal by Subject|10|||
161492909|NCT02132767|583200073|FG001|Overall Study|Withdrawal by Subject|9|||
161492910|NCT02132767|583200072|FG000|Overall Study|Lost to Follow-up|4|||
161492911|NCT02132767|583200073|FG001|Overall Study|Lost to Follow-up|4|||
161492912|NCT00390858|583200074|FG000|Overall Study|Adverse Event|6|||
161492913|NCT00390858|583200075|FG001|Overall Study|Adverse Event|2|||
161492914|NCT00390858|583200074|FG000|Overall Study|Lack of Efficacy|0|||
161492915|NCT00390858|583200075|FG001|Overall Study|Lack of Efficacy|1|||
161492916|NCT00390858|583200074|FG000|Overall Study|Withdrawal by Subject|3|||
161492917|NCT00390858|583200075|FG001|Overall Study|Withdrawal by Subject|4|||
161492918|NCT00937157|583200076|FG000|Overall Study|Pregnancy|1|||
161492919|NCT00937157|583200076|FG000|Overall Study|Lost to Follow-up|3|||
161492920|NCT02865187|583200077|FG000|Overall Study|Lost to Follow-up|12|||
161492921|NCT02865187|583200078|FG001|Overall Study|Lost to Follow-up|7|||
161492922|NCT02865187|583200077|FG000|Overall Study|Adverse Event|1|||
161492923|NCT02865187|583200078|FG001|Overall Study|Adverse Event|0|||
161492924|NCT04267133|583200079|FG000|Overall Study|Withdrawal by Subject|1|||
161492925|NCT04267133|583200079|FG000|Overall Study|Adverse Event|4|||
161492926|NCT02968563|583200080|FG000|Overall Study|Adverse Event|0|||
161492927|NCT02968563|583200081|FG001|Overall Study|Adverse Event|6|||
161492928|NCT02968563|583200080|FG000|Overall Study|Death|1|||
161492929|NCT02968563|583200081|FG001|Overall Study|Death|1|||
161492930|NCT02968563|583200080|FG000|Overall Study|Lost to Follow-up|0|||
161492931|NCT02968563|583200081|FG001|Overall Study|Lost to Follow-up|1|||
161492932|NCT00674661|583200082|FG000|Overall Study|Other|5|||
161492933|NCT00674661|583200083|FG001|Overall Study|Other|7|||
161492934|NCT00674661|583200082|FG000|Overall Study|Lost to Follow-up|6|||
161492935|NCT00674661|583200083|FG001|Overall Study|Lost to Follow-up|3|||
161492936|NCT00674661|583200082|FG000|Overall Study|Withdrawal by Subject|0|||
161492937|NCT00674661|583200083|FG001|Overall Study|Withdrawal by Subject|5|||
161492938|NCT02377466|583200088|FG000|Overall Study|Other: Randomized and not treated|0|||
161492939|NCT02377466|583200089|FG001|Overall Study|Other: Randomized and not treated|2|||
161492940|NCT04210310|583200090|FG000|Overall Study|Lost to Follow-up|32|||
161492941|NCT04210310|583200091|FG001|Overall Study|Lost to Follow-up|1|||
161492942|NCT03566823|583200093|FG000|Overall Study|Lack of Efficacy|0|||
161492943|NCT03566823|583200094|FG001|Overall Study|Lack of Efficacy|1|||
161492944|NCT03566823|583200095|FG002|Overall Study|Lack of Efficacy|0|||
161492945|NCT03566823|583200093|FG000|Overall Study|Withdrawal by Subject|1|||
161492946|NCT03566823|583200094|FG001|Overall Study|Withdrawal by Subject|2|||
161492947|NCT03566823|583200095|FG002|Overall Study|Withdrawal by Subject|0|||
161492948|NCT03566823|583200093|FG000|Overall Study|Adverse Event|1|||
161492949|NCT03566823|583200094|FG001|Overall Study|Adverse Event|0|||
161492950|NCT03566823|583200095|FG002|Overall Study|Adverse Event|2|||
161492951|NCT01909479|583200096|FG000|From Baseline to Week 26|Adverse Event|3|||
161492952|NCT01909479|583200097|FG001|From Baseline to Week 26|Adverse Event|2|||
161923827|NCT02743494|584766641|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
161923828|NCT02743494|584766642|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
161923829|NCT02743494|584766641|FG000|Treatment Period|Participant request to discontinue treatment|31|||
161923830|NCT02743494|584766642|FG001|Treatment Period|Participant request to discontinue treatment|5|||
161923831|NCT02743494|584766641|FG000|Treatment Period|Participant withdrew consent|11|||
161923832|NCT02743494|584766642|FG001|Treatment Period|Participant withdrew consent|4|||
161923833|NCT02743494|584766641|FG000|Treatment Period|Lost to Follow-up|0|||
161923834|NCT02743494|584766642|FG001|Treatment Period|Lost to Follow-up|1|||
161923835|NCT02743494|584766641|FG000|Treatment Period|Poor/Non-compliance|2|||
161923836|NCT02743494|584766642|FG001|Treatment Period|Poor/Non-compliance|0|||
161923837|NCT02743494|584766641|FG000|Treatment Period|Other reasons|4|||
161923838|NCT02743494|584766642|FG001|Treatment Period|Other reasons|1|||
161923839|NCT02207608|584766643|FG000|Overall Study|Adverse Event|1|||
161923840|NCT02207608|584766644|FG001|Overall Study|Adverse Event|0|||
161923841|NCT05399485|584768055|FG000|DBT Phase|Other|6|||
161923842|NCT05399485|584768056|FG001|DBT Phase|Other|5|||
161923843|NCT05399485|584768055|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
161923844|NCT05399485|584768056|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
161923845|NCT05399485|584768055|FG000|DBT Phase|Withdrawal by Subject|3|||
161923846|NCT05399485|584768056|FG001|DBT Phase|Withdrawal by Subject|2|||
161923847|NCT05399485|584768055|FG000|DBT Phase|Protocol Violation|2|||
161923848|NCT05399485|584768056|FG001|DBT Phase|Protocol Violation|1|||
161923849|NCT05399485|584768055|FG000|DBT Phase|Physician Decision|0|||
161923850|NCT05399485|584768056|FG001|DBT Phase|Physician Decision|1|||
161923851|NCT05399485|584768055|FG000|DBT Phase|Adverse Event|2|||
161923852|NCT05399485|584768056|FG001|DBT Phase|Adverse Event|1|||
161923853|NCT05399485|584768055|FG000|OLE Phase|Protocol deviation|1|||
161923854|NCT05399485|584768056|FG001|OLE Phase|Protocol deviation|0|||
161923855|NCT05399485|584768055|FG000|OLE Phase|Other|5|||
161923856|NCT05399485|584768056|FG001|OLE Phase|Other|5|||
161923857|NCT05399485|584768055|FG000|OLE Phase|Withdrawal by Subject|12|||
161923858|NCT05399485|584768056|FG001|OLE Phase|Withdrawal by Subject|7|||
161923859|NCT05399485|584768055|FG000|OLE Phase|Pregnancy|0|||
161923860|NCT05399485|584768056|FG001|OLE Phase|Pregnancy|2|||
161923861|NCT05399485|584768055|FG000|OLE Phase|Physician Decision|3|||
161923862|NCT05399485|584768056|FG001|OLE Phase|Physician Decision|0|||
161923863|NCT05399485|584768055|FG000|OLE Phase|Adverse Event|2|||
161923864|NCT05399485|584768056|FG001|OLE Phase|Adverse Event|2|||
161923865|NCT03554473|584768059|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
161492953|NCT01909479|583200096|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
161492954|NCT01909479|583200097|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
161492955|NCT01909479|583200096|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
161492956|NCT01909479|583200097|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
161492957|NCT01909479|583200096|FG000|26 - 52 Weeks|Adverse Event|0|||
161492958|NCT01909479|583200097|FG001|26 - 52 Weeks|Adverse Event|1|||
161492959|NCT01909479|583200096|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
161492960|NCT01909479|583200097|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
161492961|NCT01909479|583200096|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
161492962|NCT01909479|583200097|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
161492963|NCT01909479|583200096|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
161492964|NCT01909479|583200097|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
161492965|NCT01909479|583200096|FG000|52 Weeks to End of Study|Adverse Event|2|||
161492966|NCT01909479|583200097|FG001|52 Weeks to End of Study|Adverse Event|1|||
161492967|NCT01909479|583200096|FG000|52 Weeks to End of Study|Death|0|||
161492968|NCT01909479|583200097|FG001|52 Weeks to End of Study|Death|1|||
161492969|NCT01909479|583200096|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
161492970|NCT01909479|583200097|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
161492971|NCT01909479|583200096|FG000|52 Weeks to End of Study|Protocol Violation|1|||
161492972|NCT01909479|583200097|FG001|52 Weeks to End of Study|Protocol Violation|0|||
161492973|NCT01909479|583200096|FG000|52 Weeks to End of Study|Progressive disease|1|||
161492974|NCT01909479|583200097|FG001|52 Weeks to End of Study|Progressive disease|1|||
161492975|NCT01909479|583200096|FG000|52 Weeks to End of Study|Personal reasons|2|||
161492976|NCT01909479|583200097|FG001|52 Weeks to End of Study|Personal reasons|1|||
161492977|NCT01909479|583200096|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
161492978|NCT01909479|583200097|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
161584013|NCT04149002|583526018|FG000|Overall Study|Withdrawal by Subject|1|||
161923866|NCT03554473|584768060|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
161923867|NCT03554473|584768061|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
161923868|NCT03554473|584768059|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
161923869|NCT03554473|584768060|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
161923870|NCT03554473|584768061|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
161923871|NCT03554473|584768059|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
161923872|NCT03554473|584768060|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
161923873|NCT03554473|584768061|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
161923874|NCT01363076|584768062|FG000|Overall Study|Withdrawal by Subject|0|||
161923875|NCT01363076|584768063|FG001|Overall Study|Withdrawal by Subject|1|||
161923876|NCT02642679|584768064|FG000|Overall Study|Withdrawal by Subject|1|||
161923877|NCT02642679|584768064|FG000|Overall Study|Physician Decision|1|||
161923878|NCT02642679|584768064|FG000|Overall Study|Physician Decision|1|||
161923879|NCT05206604|584768065|FG000|Overall Study|Non-compliance with study drug|0|||
161923880|NCT05206604|584768066|FG001|Overall Study|Non-compliance with study drug|0|||
161923881|NCT05206604|584768067|FG002|Overall Study|Non-compliance with study drug|0|||
161923882|NCT05206604|584768068|FG003|Overall Study|Non-compliance with study drug|0|||
161923883|NCT05206604|584768069|FG004|Overall Study|Non-compliance with study drug|0|||
161923884|NCT05206604|584768070|FG005|Overall Study|Non-compliance with study drug|1|||
161923885|NCT05206604|584768071|FG006|Overall Study|Non-compliance with study drug|0|||
161923886|NCT05206604|584768072|FG007|Overall Study|Non-compliance with study drug|0|||
161923887|NCT02014103|584768073|FG000|Overall Study|Protocol Violation|7|||
161923888|NCT02014103|584768074|FG001|Overall Study|Protocol Violation|7|||
161923889|NCT02014103|584768073|FG000|Overall Study|Adverse Event|1|||
161923890|NCT02014103|584768074|FG001|Overall Study|Adverse Event|0|||
161923891|NCT02014103|584768073|FG000|Overall Study|Lost venous access|1|||
161923892|NCT02014103|584768074|FG001|Overall Study|Lost venous access|0|||
161923893|NCT02014103|584768073|FG000|Overall Study|Withdrawal by Subject|0|||
161923894|NCT02014103|584768074|FG001|Overall Study|Withdrawal by Subject|2|||
161923895|NCT05638737|584768075|FG000|Overall Study|Withdrawal by Subject|4|||
161923896|NCT05638737|584768076|FG001|Overall Study|Withdrawal by Subject|7|||
161923897|NCT01617967|584768087|FG000|Overall Study|Protocol Violation|0|||
161923898|NCT01617967|584768088|FG001|Overall Study|Protocol Violation|0|||
161923899|NCT01617967|584768089|FG002|Overall Study|Protocol Violation|0|||
161923900|NCT01617967|584768090|FG003|Overall Study|Protocol Violation|1|||
161923901|NCT01617967|584768091|FG004|Overall Study|Protocol Violation|0|||
161923902|NCT01617967|584768092|FG005|Overall Study|Protocol Violation|0|||
161923903|NCT01617967|584768087|FG000|Overall Study|Withdrawal by Subject|0|||
161923904|NCT01617967|584768088|FG001|Overall Study|Withdrawal by Subject|0|||
161923905|NCT01617967|584768089|FG002|Overall Study|Withdrawal by Subject|0|||
161584014|NCT04149002|583526019|FG001|Overall Study|Withdrawal by Subject|0|||
161671691|NCT00174265|583851384|FG000|Overall Study|Adverse Event|7|||
161671692|NCT00174265|583851385|FG001|Overall Study|Adverse Event|4|||
161671693|NCT00174265|583851384|FG000|Overall Study|Lack of Efficacy|2|||
161671694|NCT00174265|583851385|FG001|Overall Study|Lack of Efficacy|2|||
161671695|NCT00174265|583851384|FG000|Overall Study|Withdrawal by Subject|3|||
161671696|NCT00174265|583851385|FG001|Overall Study|Withdrawal by Subject|5|||
161671697|NCT00174265|583851384|FG000|Overall Study|Lost to Follow-up|1|||
161671698|NCT00174265|583851385|FG001|Overall Study|Lost to Follow-up|0|||
161671699|NCT00174265|583851384|FG000|Overall Study|Other (Not specified)|16|||
161671700|NCT00174265|583851385|FG001|Overall Study|Other (Not specified)|10|||
161671701|NCT03231943|583851386|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161584015|NCT04583423|583526024|FG000|Overall Study|Lost to Follow-up|0|||
161584016|NCT04583423|583526025|FG001|Overall Study|Lost to Follow-up|1|||
161584017|NCT04583423|583526026|FG002|Overall Study|Lost to Follow-up|0|||
161584018|NCT04583423|583526027|FG003|Overall Study|Lost to Follow-up|2|||
161584019|NCT04583423|583526024|FG000|Overall Study|Study Terminated by Sponsor|32|||
161584020|NCT04583423|583526025|FG001|Overall Study|Study Terminated by Sponsor|35|||
161584021|NCT04583423|583526026|FG002|Overall Study|Study Terminated by Sponsor|36|||
161584022|NCT04583423|583526027|FG003|Overall Study|Study Terminated by Sponsor|33|||
161584023|NCT04583423|583526024|FG000|Overall Study|Withdrawal by Subject|3|||
161584024|NCT04583423|583526025|FG001|Overall Study|Withdrawal by Subject|1|||
161584025|NCT04583423|583526026|FG002|Overall Study|Withdrawal by Subject|2|||
161584026|NCT04583423|583526027|FG003|Overall Study|Withdrawal by Subject|1|||
161584027|NCT06061081|583526028|FG000|Overall Study|Withdrawal by Subject|1|||
161584028|NCT06061081|583526029|FG001|Overall Study|Withdrawal by Subject|0|||
161584029|NCT06061081|583526030|FG002|Overall Study|Withdrawal by Subject|0|||
161584030|NCT06061081|583526031|FG003|Overall Study|Withdrawal by Subject|0|||
161584031|NCT06061081|583526032|FG004|Overall Study|Withdrawal by Subject|0|||
161584032|NCT03330795|583526033|FG000|Overall Study|Death|3|||
161671702|NCT03231943|583851387|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
161671703|NCT03231943|583851388|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
161671704|NCT03231943|583851389|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671705|NCT03231943|583851390|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671706|NCT03231943|583851391|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671707|NCT03231943|583851392|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161817732|NCT00906399|584372916|FG000|Year 1|Death|2|||
161817733|NCT00906399|584372917|FG001|Year 1|Death|1|||
161817734|NCT00906399|584372918|FG002|Year 1|Death|1|||
161817735|NCT00906399|584372919|FG003|Year 1|Death|0|||
161817736|NCT00906399|584372920|FG004|Year 1|Death|0|||
161817737|NCT00906399|584372921|FG005|Year 1|Death|0|||
161817738|NCT00906399|584372922|FG006|Year 1|Death|0|||
161817739|NCT00906399|584372916|FG000|Year 1|Other|4|||
161817740|NCT00906399|584372917|FG001|Year 1|Other|2|||
161817741|NCT00906399|584372918|FG002|Year 1|Other|7|||
161817742|NCT00906399|584372919|FG003|Year 1|Other|0|||
161817743|NCT00906399|584372920|FG004|Year 1|Other|0|||
161817744|NCT00906399|584372921|FG005|Year 1|Other|0|||
161817745|NCT00906399|584372922|FG006|Year 1|Other|0|||
161817746|NCT00906399|584372916|FG000|Year 2|Adverse Event|0|||
161817747|NCT00906399|584372917|FG001|Year 2|Adverse Event|0|||
161817748|NCT00906399|584372918|FG002|Year 2|Adverse Event|0|||
161817749|NCT00906399|584372919|FG003|Year 2|Adverse Event|9|||
161817750|NCT00906399|584372920|FG004|Year 2|Adverse Event|8|||
161817751|NCT00906399|584372921|FG005|Year 2|Adverse Event|11|||
161817752|NCT00906399|584372922|FG006|Year 2|Adverse Event|6|||
161817753|NCT00906399|584372916|FG000|Year 2|Lost to Follow-up|0|||
161817754|NCT00906399|584372917|FG001|Year 2|Lost to Follow-up|0|||
161817755|NCT00906399|584372918|FG002|Year 2|Lost to Follow-up|0|||
161817756|NCT00906399|584372919|FG003|Year 2|Lost to Follow-up|1|||
161817757|NCT00906399|584372920|FG004|Year 2|Lost to Follow-up|4|||
161817758|NCT00906399|584372921|FG005|Year 2|Lost to Follow-up|2|||
161817759|NCT00906399|584372922|FG006|Year 2|Lost to Follow-up|4|||
161817760|NCT00906399|584372916|FG000|Year 2|Withdrawal by Subject|0|||
161817761|NCT00906399|584372917|FG001|Year 2|Withdrawal by Subject|0|||
161817762|NCT00906399|584372918|FG002|Year 2|Withdrawal by Subject|0|||
161817763|NCT00906399|584372919|FG003|Year 2|Withdrawal by Subject|17|||
161817764|NCT00906399|584372920|FG004|Year 2|Withdrawal by Subject|18|||
161817765|NCT00906399|584372921|FG005|Year 2|Withdrawal by Subject|27|||
161817766|NCT00906399|584372922|FG006|Year 2|Withdrawal by Subject|13|||
161817767|NCT00906399|584372916|FG000|Year 2|Physician Decision|0|||
161817768|NCT00906399|584372917|FG001|Year 2|Physician Decision|0|||
161817769|NCT00906399|584372918|FG002|Year 2|Physician Decision|0|||
161817770|NCT00906399|584372919|FG003|Year 2|Physician Decision|0|||
161817771|NCT00906399|584372920|FG004|Year 2|Physician Decision|2|||
161817772|NCT00906399|584372921|FG005|Year 2|Physician Decision|6|||
161817773|NCT00906399|584372922|FG006|Year 2|Physician Decision|3|||
161817774|NCT00906399|584372916|FG000|Year 2|Death|0|||
161817775|NCT00906399|584372917|FG001|Year 2|Death|0|||
161817776|NCT00906399|584372918|FG002|Year 2|Death|0|||
161817777|NCT00906399|584372919|FG003|Year 2|Death|1|||
161817778|NCT00906399|584372920|FG004|Year 2|Death|0|||
161817779|NCT00906399|584372921|FG005|Year 2|Death|0|||
161817780|NCT00906399|584372922|FG006|Year 2|Death|3|||
161817781|NCT00906399|584372916|FG000|Year 2|Other|0|||
161817782|NCT00906399|584372917|FG001|Year 2|Other|0|||
161817783|NCT00906399|584372918|FG002|Year 2|Other|0|||
161817784|NCT00906399|584372919|FG003|Year 2|Other|2|||
161817785|NCT00906399|584372920|FG004|Year 2|Other|3|||
161817786|NCT00906399|584372921|FG005|Year 2|Other|1|||
161817787|NCT00906399|584372922|FG006|Year 2|Other|0|||
161817788|NCT01456221|584372925|FG000|Overall Study|Withdrawal by Subject|56|||
161817789|NCT01456221|584372926|FG001|Overall Study|Withdrawal by Subject|49|||
161817790|NCT01456221|584372925|FG000|Overall Study|Lost to Follow-up|1|||
161817791|NCT01456221|584372926|FG001|Overall Study|Lost to Follow-up|4|||
161817792|NCT01456221|584372925|FG000|Overall Study|Received medication|3|||
161817793|NCT01456221|584372926|FG001|Overall Study|Received medication|2|||
161817794|NCT01456221|584372925|FG000|Overall Study|Incomplete data|4|||
161817795|NCT01456221|584372926|FG001|Overall Study|Incomplete data|2|||
161817796|NCT01986647|584372928|FG000|Overall Study|Lost to Follow-up|4|||
161817797|NCT01986647|584372929|FG001|Overall Study|Lost to Follow-up|1|||
161923906|NCT01617967|584768090|FG003|Overall Study|Withdrawal by Subject|0|||
161817798|NCT01986647|584372930|FG002|Overall Study|Lost to Follow-up|4|||
161817799|NCT01986647|584372931|FG003|Overall Study|Lost to Follow-up|4|||
161817800|NCT01986647|584372928|FG000|Overall Study|Withdrawal by Subject|1|||
161817801|NCT01986647|584372929|FG001|Overall Study|Withdrawal by Subject|3|||
161817802|NCT01986647|584372930|FG002|Overall Study|Withdrawal by Subject|2|||
161817803|NCT01986647|584372931|FG003|Overall Study|Withdrawal by Subject|3|||
161817804|NCT01986647|584372928|FG000|Overall Study|Health|5|||
161817805|NCT01986647|584372929|FG001|Overall Study|Health|3|||
161817806|NCT01986647|584372930|FG002|Overall Study|Health|6|||
161817807|NCT01986647|584372931|FG003|Overall Study|Health|4|||
161817808|NCT01960296|584372932|FG000|Overall Study|Postponed surgery|1|||
161817809|NCT01960296|584372933|FG001|Overall Study|Postponed surgery|0|||
161817810|NCT01960296|584372932|FG000|Overall Study|Received different procedure|1|||
161817811|NCT01960296|584372933|FG001|Overall Study|Received different procedure|3|||
161817812|NCT02003391|584372934|FG000|Overall Study|Withdrawal by Subject|2|||
161817813|NCT02003391|584372935|FG001|Overall Study|Withdrawal by Subject|1|||
161492979|NCT01909479|583200096|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
161492980|NCT01909479|583200097|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
161492981|NCT01909479|583200096|FG000|52 Weeks to End of Study|Lack of contact|1|||
161492982|NCT01909479|583200097|FG001|52 Weeks to End of Study|Lack of contact|0|||
161492983|NCT01909479|583200096|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
161492984|NCT01909479|583200097|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
161492985|NCT01909479|583200096|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
161492986|NCT01909479|583200097|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
161492987|NCT03557151|583200099|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
161492988|NCT03557151|583200100|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
161492989|NCT03557151|583200099|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
161492990|NCT03557151|583200100|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
161492991|NCT03557151|583200099|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
161584033|NCT03330795|583526033|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
161584034|NCT05575076|583526034|FG000|Overall Study|Adverse Event|24|||
161584035|NCT05575076|583526034|FG000|Overall Study|Death|7|||
161584036|NCT05575076|583526034|FG000|Overall Study|Lost to Follow-up|16|||
161584037|NCT05575076|583526034|FG000|Overall Study|Non-Compliance|3|||
161584038|NCT05575076|583526034|FG000|Overall Study|Physician Decision|6|||
161584039|NCT05575076|583526034|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
161584040|NCT05575076|583526034|FG000|Overall Study|Withdrawal by Subject|71|||
161584041|NCT05575076|583526034|FG000|Overall Study|Study Terminated by Sponsor|630|||
161584042|NCT05575076|583526034|FG000|Overall Study|Other|17|||
161584043|NCT00510887|583526035|FG000|Overall Study|Lost to Follow-up|1|||
161584044|NCT02376790|583526045|FG000|Overall Study|Withdrawal by Subject|43|||
161584045|NCT02376790|583526046|FG001|Overall Study|Withdrawal by Subject|36|||
161584046|NCT02376790|583526047|FG002|Overall Study|Withdrawal by Subject|37|||
161584047|NCT02376790|583526045|FG000|Overall Study|Decision by Sponsor|2|||
161584048|NCT02376790|583526046|FG001|Overall Study|Decision by Sponsor|1|||
161584049|NCT02376790|583526047|FG002|Overall Study|Decision by Sponsor|4|||
161584050|NCT02376790|583526045|FG000|Overall Study|Lost to Follow-up|15|||
161584051|NCT02376790|583526046|FG001|Overall Study|Lost to Follow-up|10|||
161584052|NCT02376790|583526047|FG002|Overall Study|Lost to Follow-up|12|||
161584053|NCT00988858|583526048|FG000|Overall Study|Adverse Event|7|||
161584054|NCT00988858|583526048|FG000|Overall Study|Death|1|||
161584055|NCT00988858|583526048|FG000|Overall Study|Physician Decision|1|||
161584056|NCT00988858|583526048|FG000|Overall Study|Sponsor Decision|1|||
161584057|NCT03014453|583526049|FG000|Overall Study|Lost to Follow-up|12|||
161584058|NCT03014453|583526049|FG000|Overall Study|Discontinued GER|3|||
161584059|NCT03014453|583526049|FG000|Overall Study|Excluded|19|||
161584060|NCT03014453|583526049|FG000|Overall Study|Refused to take part in|37|||
161584061|NCT02238483|583526050|FG000|Overall Study|Withdrawal by Subject|2|||
161584062|NCT02238483|583526051|FG001|Overall Study|Withdrawal by Subject|7|||
161584063|NCT02238483|583526050|FG000|Overall Study|Lost to Follow-up|1|||
161584064|NCT02238483|583526051|FG001|Overall Study|Lost to Follow-up|1|||
161584065|NCT02238483|583526050|FG000|Overall Study|Protocol Violation|1|||
161584066|NCT02238483|583526051|FG001|Overall Study|Protocol Violation|2|||
161584067|NCT02238483|583526050|FG000|Overall Study|Death|1|||
161584068|NCT02238483|583526051|FG001|Overall Study|Death|0|||
161584069|NCT02238483|583526050|FG000|Overall Study|Adverse Event|7|||
161584070|NCT02238483|583526051|FG001|Overall Study|Adverse Event|3|||
161584071|NCT02238483|583526050|FG000|Overall Study|Withdrawn due to physician decision|1|||
161584072|NCT02238483|583526051|FG001|Overall Study|Withdrawn due to physician decision|0|||
161584073|NCT02238483|583526050|FG000|Overall Study|Completion status not recorded|1|||
161584074|NCT02238483|583526051|FG001|Overall Study|Completion status not recorded|1|||
161584075|NCT02238483|583526050|FG000|Overall Study|Illness in family member|1|||
161584076|NCT02238483|583526051|FG001|Overall Study|Illness in family member|0|||
161584077|NCT02538341|583526059|FG000|Overall Study|Lost to Follow-up|51|||
161584078|NCT02538341|583526060|FG001|Overall Study|Lost to Follow-up|46|||
161584079|NCT02538341|583526059|FG000|Overall Study|Withdrawal by Subject|3|||
161584080|NCT02538341|583526060|FG001|Overall Study|Withdrawal by Subject|1|||
161584081|NCT02538341|583526059|FG000|Overall Study|Death|2|||
161584082|NCT02538341|583526060|FG001|Overall Study|Death|0|||
161584083|NCT03750968|583526061|FG000|Overall Study|Adverse Event|2|||
161584084|NCT03750968|583526062|FG001|Overall Study|Adverse Event|0|||
161584085|NCT03750968|583526061|FG000|Overall Study|Lost to Follow-up|1|||
161584086|NCT03750968|583526062|FG001|Overall Study|Lost to Follow-up|3|||
161584087|NCT02539225|583526065|FG000|Part A|Adverse Event|13|||
161584088|NCT02539225|583526066|FG001|Part A|Adverse Event|4|||
161584089|NCT02539225|583526065|FG000|Part A|Withdrawal by Subject|2|||
161584090|NCT02539225|583526066|FG001|Part A|Withdrawal by Subject|4|||
161584091|NCT02539225|583526065|FG000|Part A|Physician Decision|4|||
161584092|NCT02539225|583526066|FG001|Part A|Physician Decision|7|||
161584093|NCT02539225|583526065|FG000|Part A|Did Not Receive study Drug|1|||
161584094|NCT02539225|583526066|FG001|Part A|Did Not Receive study Drug|1|||
161584095|NCT02539225|583526065|FG000|Pre Treatment for Part B|Progressive disease|1|||
161584096|NCT02539225|583526066|FG001|Pre Treatment for Part B|Progressive disease|1|||
161671708|NCT03231943|583851393|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671709|NCT03231943|583851394|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671710|NCT03231943|583851395|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671711|NCT03231943|583851396|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671712|NCT03231943|583851397|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671713|NCT03231943|583851398|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671714|NCT03231943|583851386|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671715|NCT03231943|583851387|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
161671716|NCT03231943|583851388|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671717|NCT03231943|583851389|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671718|NCT03231943|583851390|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161923907|NCT01617967|584768091|FG004|Overall Study|Withdrawal by Subject|0|||
161923908|NCT01617967|584768092|FG005|Overall Study|Withdrawal by Subject|1|||
161923909|NCT01617967|584768087|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
161923910|NCT01617967|584768088|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
161923911|NCT01617967|584768089|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
161923912|NCT01617967|584768090|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
161923913|NCT01617967|584768091|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
161923914|NCT01617967|584768092|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
161923915|NCT00530075|584768093|FG000|Overall Study|Adverse Event|1|||
161923916|NCT00530075|584768093|FG000|Overall Study|Death|1|||
161923917|NCT00530075|584768093|FG000|Overall Study|Lack of Efficacy|3|||
161923918|NCT00530075|584768093|FG000|Overall Study|Protocol Violation|1|||
161923919|NCT00530075|584768093|FG000|Overall Study|Withdrawal by Subject|1|||
161923920|NCT03520569|584768098|FG000|Overall Study|Withdrawal by Subject|1|||
161923921|NCT01178411|584768099|FG000|Overall Study|Adverse Event|5|||
161923922|NCT01178411|584768099|FG000|Overall Study|Withdrawal by Subject|4|||
161923923|NCT01178411|584768099|FG000|Overall Study|Protocol Violation|1|||
161923924|NCT01178411|584768099|FG000|Overall Study|Progressive disease per RECIST|32|||
161923925|NCT01178411|584768099|FG000|Overall Study|Progressive disease per clinician|9|||
161923926|NCT01178411|584768099|FG000|Overall Study|Physician Decision|6|||
161923927|NCT01178411|584768099|FG000|Overall Study|Death|1|||
161923928|NCT01178411|584768099|FG000|Overall Study|No reason provided|1|||
161923929|NCT01178411|584768099|FG000|Overall Study|Drug manufacturing ended|1|||
161923930|NCT00784927|584768100|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
161923931|NCT00784927|584768100|FG000|Overall Study|Protocol Violation|1|||
161923932|NCT00784927|584768100|FG000|Overall Study|Ineligible|1|||
161923933|NCT02453048|584768103|FG000|Overall Study|Only part of initial 6 mo. study|0|||
161923934|NCT02453048|584768104|FG001|Overall Study|Only part of initial 6 mo. study|0|||
161923935|NCT02453048|584768105|FG002|Overall Study|Only part of initial 6 mo. study|0|||
161923936|NCT02453048|584768106|FG003|Overall Study|Only part of initial 6 mo. study|0|||
161923937|NCT02453048|584768107|FG004|Overall Study|Only part of initial 6 mo. study|6|||
161923938|NCT02453048|584768103|FG000|Overall Study|Lost to Follow-up|0|||
161923939|NCT02453048|584768104|FG001|Overall Study|Lost to Follow-up|1|||
161923940|NCT02453048|584768105|FG002|Overall Study|Lost to Follow-up|2|||
161923941|NCT02453048|584768106|FG003|Overall Study|Lost to Follow-up|0|||
161923942|NCT02453048|584768107|FG004|Overall Study|Lost to Follow-up|0|||
161923943|NCT03677401|584768110|FG000|Overall Study|Adverse Event|4|||
161923944|NCT03677401|584768111|FG001|Overall Study|Adverse Event|14|||
161923945|NCT03677401|584768110|FG000|Overall Study|Lack of Efficacy|3|||
161923946|NCT03677401|584768111|FG001|Overall Study|Lack of Efficacy|1|||
161923947|NCT03677401|584768110|FG000|Overall Study|Withdrawal by Subject|2|||
161923948|NCT03677401|584768111|FG001|Overall Study|Withdrawal by Subject|2|||
161923949|NCT03677401|584768110|FG000|Overall Study|Sponsor decision|0|||
161923950|NCT03677401|584768111|FG001|Overall Study|Sponsor decision|1|||
161923951|NCT03677401|584768110|FG000|Overall Study|Reason Unspecified|1|||
161923952|NCT03677401|584768111|FG001|Overall Study|Reason Unspecified|0|||
161923953|NCT00726557|584768112|FG000|Overall Study|Screening failure|4|||
161923954|NCT00726557|584768112|FG000|Overall Study|No end of treatment documentation|37|||
161923955|NCT00726557|584768112|FG000|Overall Study|No follow-up documentation available|55|||
161923956|NCT00726557|584768112|FG000|Overall Study|Treatment less than 3 months|17|||
161923957|NCT00726557|584768112|FG000|Overall Study|Inclusion criteria not met|15|||
161671719|NCT03231943|583851391|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671720|NCT03231943|583851392|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671721|NCT03231943|583851393|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671722|NCT03231943|583851394|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161923958|NCT00574951|584768113|FG000|Overall Study|Ineligible - improper prior treatment|1|||
161923959|NCT05161936|584768114|FG000|Overall Study|Study terminated by Sponsor|1|||
161923960|NCT05161936|584768115|FG001|Overall Study|Study terminated by Sponsor|0|||
161923961|NCT05161936|584768116|FG002|Overall Study|Study terminated by Sponsor|0|||
161923962|NCT05161936|584768114|FG000|Overall Study|Withdrawal by Subject|0|||
161923963|NCT05161936|584768115|FG001|Overall Study|Withdrawal by Subject|0|||
161923964|NCT05161936|584768116|FG002|Overall Study|Withdrawal by Subject|1|||
161671723|NCT03231943|583851395|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671724|NCT03231943|583851396|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671725|NCT03231943|583851397|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671726|NCT03231943|583851398|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671727|NCT03231943|583851386|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
161671728|NCT03231943|583851387|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671729|NCT03231943|583851388|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671730|NCT03231943|583851389|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671731|NCT03231943|583851390|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671732|NCT03231943|583851391|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671733|NCT03231943|583851392|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671734|NCT03231943|583851393|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671735|NCT03231943|583851394|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671736|NCT03231943|583851395|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671737|NCT03231943|583851396|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671738|NCT03231943|583851397|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671739|NCT03231943|583851398|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671740|NCT03231943|583851386|FG000|Part 2|Adverse Event|0|||
161671741|NCT03231943|583851387|FG001|Part 2|Adverse Event|0|||
161671742|NCT03231943|583851388|FG002|Part 2|Adverse Event|0|||
161671743|NCT03231943|583851389|FG003|Part 2|Adverse Event|0|||
161671744|NCT03231943|583851390|FG004|Part 2|Adverse Event|0|||
161671745|NCT03231943|583851391|FG005|Part 2|Adverse Event|0|||
161671746|NCT03231943|583851392|FG006|Part 2|Adverse Event|0|||
161671747|NCT03231943|583851393|FG007|Part 2|Adverse Event|0|||
161671748|NCT03231943|583851394|FG008|Part 2|Adverse Event|0|||
161671749|NCT03231943|583851395|FG009|Part 2|Adverse Event|0|||
161671750|NCT03231943|583851396|FG010|Part 2|Adverse Event|1|||
161671751|NCT03231943|583851397|FG011|Part 2|Adverse Event|0|||
161671752|NCT03231943|583851398|FG012|Part 2|Adverse Event|0|||
161671753|NCT03231943|583851386|FG000|Part 2|Withdrawal by Subject|0|||
161671754|NCT03231943|583851387|FG001|Part 2|Withdrawal by Subject|0|||
161671755|NCT03231943|583851388|FG002|Part 2|Withdrawal by Subject|0|||
161671756|NCT03231943|583851389|FG003|Part 2|Withdrawal by Subject|0|||
161671757|NCT03231943|583851390|FG004|Part 2|Withdrawal by Subject|0|||
161671758|NCT03231943|583851391|FG005|Part 2|Withdrawal by Subject|0|||
161671759|NCT03231943|583851392|FG006|Part 2|Withdrawal by Subject|0|||
161671760|NCT03231943|583851393|FG007|Part 2|Withdrawal by Subject|0|||
161671761|NCT03231943|583851394|FG008|Part 2|Withdrawal by Subject|0|||
161671762|NCT03231943|583851395|FG009|Part 2|Withdrawal by Subject|0|||
161671763|NCT03231943|583851396|FG010|Part 2|Withdrawal by Subject|0|||
161671764|NCT03231943|583851397|FG011|Part 2|Withdrawal by Subject|1|||
161671765|NCT03231943|583851398|FG012|Part 2|Withdrawal by Subject|0|||
161671766|NCT00047320|583851399|FG000|Overall Study|Lack of Efficacy|8|||
161671767|NCT00047320|583851399|FG000|Overall Study|Lost to Follow-up|1|||
161671768|NCT00047320|583851399|FG000|Overall Study|Physician Decision|8|||
161671769|NCT00047320|583851399|FG000|Overall Study|Withdrawal by Subject|9|||
161671770|NCT00047320|583851399|FG000|Overall Study|Ineligible|2|||
161671771|NCT03471871|583851400|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161671772|NCT03471871|583851401|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161671773|NCT03471871|583851402|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
161671774|NCT03471871|583851403|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161671775|NCT03471871|583851404|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161492992|NCT03557151|583200100|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
161492993|NCT02810392|583200101|FG000|Overall Study|Subject too ill to continue|1|||
161492994|NCT02810392|583200102|FG001|Overall Study|Subject too ill to continue|0|||
161492995|NCT02810392|583200101|FG000|Overall Study|COVID 19 research restrictions|0|||
161492996|NCT02810392|583200102|FG001|Overall Study|COVID 19 research restrictions|1|||
161492997|NCT06079320|583200105|FG000|Follow up Phase|Lost to Follow-up|1|||
161492998|NCT06079320|583200106|FG001|Follow up Phase|Lost to Follow-up|0|||
161492999|NCT01405742|583200107|FG000|Overall Study|Lost to Follow-up|1|||
161493000|NCT01405742|583200108|FG001|Overall Study|Lost to Follow-up|0|||
161493001|NCT04900220|583200109|FG000|Overall Study|Lost to Follow-up|1|||
161493002|NCT04900220|583200110|FG001|Overall Study|Lost to Follow-up|1|||
161493003|NCT02196558|583200111|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
161493004|NCT02196558|583200112|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
161671776|NCT03471871|583851400|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161671777|NCT03471871|583851401|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161671778|NCT03471871|583851402|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161671779|NCT03471871|583851403|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
161671780|NCT03471871|583851404|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
161671781|NCT03471871|583851400|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671782|NCT03471871|583851401|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671783|NCT03471871|583851402|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671784|NCT03471871|583851403|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671785|NCT03471871|583851404|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
161671786|NCT03471871|583851400|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671787|NCT03471871|583851401|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671788|NCT03471871|583851402|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671789|NCT03471871|583851403|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671790|NCT03471871|583851404|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
161671791|NCT03471871|583851400|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671792|NCT03471871|583851401|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671793|NCT03471871|583851402|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671794|NCT03471871|583851403|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
161671795|NCT03471871|583851404|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671796|NCT03040622|583851405|FG000|Overall Study|unable to implant device|3|||
161671797|NCT02818920|583851406|FG000|Overall Study|Unresectable|4|||
161671798|NCT02818920|583851406|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
161671799|NCT02818920|583851406|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
161671800|NCT02818920|583851406|FG000|Overall Study|Adverse Event|3|||
161671801|NCT02818920|583851406|FG000|Overall Study|Developed Other Disease|1|||
161671802|NCT02818920|583851406|FG000|Overall Study|Refused Further Treatment|1|||
161671803|NCT00445068|583851407|FG000|Overall Study|Disease progression|26|||
161671804|NCT00445068|583851407|FG000|Overall Study|Adverse Event|5|||
161671805|NCT00445068|583851407|FG000|Overall Study|Abnormal laboratory value|2|||
161671806|NCT00445068|583851407|FG000|Overall Study|Withdrawal by Subject|2|||
161671807|NCT00445068|583851407|FG000|Overall Study|Death|1|||
161671808|NCT02673619|583851408|FG000|Overall Study|Lost to Follow-up|1|||
161671809|NCT02673619|583851409|FG001|Overall Study|Lost to Follow-up|0|||
161671810|NCT02673619|583851410|FG002|Overall Study|Lost to Follow-up|0|||
161671811|NCT02673619|583851411|FG003|Overall Study|Lost to Follow-up|0|||
161671812|NCT02673619|583851408|FG000|Overall Study|Withdrawal by Subject|1|||
161671813|NCT02673619|583851409|FG001|Overall Study|Withdrawal by Subject|1|||
161671814|NCT02673619|583851410|FG002|Overall Study|Withdrawal by Subject|1|||
161671815|NCT02673619|583851411|FG003|Overall Study|Withdrawal by Subject|0|||
161671816|NCT02673619|583851408|FG000|Overall Study|Adverse Event|0|||
161671817|NCT02673619|583851409|FG001|Overall Study|Adverse Event|0|||
161671818|NCT02673619|583851410|FG002|Overall Study|Adverse Event|1|||
161671819|NCT02673619|583851411|FG003|Overall Study|Adverse Event|0|||
161671820|NCT02673619|583851408|FG000|Overall Study|Lack of Efficacy|0|||
161671821|NCT02673619|583851409|FG001|Overall Study|Lack of Efficacy|0|||
161671822|NCT02673619|583851410|FG002|Overall Study|Lack of Efficacy|1|||
161671823|NCT02673619|583851411|FG003|Overall Study|Lack of Efficacy|0|||
161671824|NCT03444324|583851412|FG000|Overall Study|Withdrawal by Subject|0|||
161671825|NCT03444324|583851413|FG001|Overall Study|Withdrawal by Subject|1|||
161671826|NCT03444324|583851412|FG000|Overall Study|Lost to Follow-up|4|||
161671827|NCT03444324|583851413|FG001|Overall Study|Lost to Follow-up|2|||
161671828|NCT03444324|583851412|FG000|Overall Study|Protocol Violation|0|||
161671829|NCT03444324|583851413|FG001|Overall Study|Protocol Violation|1|||
161671830|NCT03444324|583851412|FG000|Overall Study|Lack of Trial Compliance|1|||
161671831|NCT03444324|583851413|FG001|Overall Study|Lack of Trial Compliance|1|||
161671832|NCT03444324|583851412|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
161671833|NCT03444324|583851413|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
161671834|NCT00658684|583851415|FG000|Overall Study|Adverse Event|10|||
161671835|NCT00658684|583851416|FG001|Overall Study|Adverse Event|8|||
161671836|NCT00658684|583851417|FG002|Overall Study|Adverse Event|2|||
161671837|NCT00658684|583851418|FG003|Overall Study|Adverse Event|0|||
161671838|NCT00658684|583851415|FG000|Overall Study|Withdrawal by Subject|6|||
161671839|NCT00658684|583851416|FG001|Overall Study|Withdrawal by Subject|4|||
161671840|NCT00658684|583851417|FG002|Overall Study|Withdrawal by Subject|1|||
161671841|NCT00658684|583851418|FG003|Overall Study|Withdrawal by Subject|1|||
161671842|NCT00658684|583851415|FG000|Overall Study|Lack of Efficacy|1|||
161671843|NCT00658684|583851416|FG001|Overall Study|Lack of Efficacy|1|||
161671844|NCT00658684|583851417|FG002|Overall Study|Lack of Efficacy|0|||
161671845|NCT00658684|583851418|FG003|Overall Study|Lack of Efficacy|0|||
161671846|NCT00658684|583851415|FG000|Overall Study|Protocol Violation|1|||
161671847|NCT00658684|583851416|FG001|Overall Study|Protocol Violation|1|||
161671848|NCT00658684|583851417|FG002|Overall Study|Protocol Violation|0|||
161671849|NCT00658684|583851418|FG003|Overall Study|Protocol Violation|0|||
161671850|NCT00658684|583851415|FG000|Overall Study|Pregnancy|1|||
161671851|NCT00658684|583851416|FG001|Overall Study|Pregnancy|1|||
161671852|NCT00658684|583851417|FG002|Overall Study|Pregnancy|0|||
161671853|NCT00658684|583851418|FG003|Overall Study|Pregnancy|0|||
161671854|NCT00688103|583851419|FG000|Overall Study|Adverse Event|4|||
161671855|NCT00688103|583851420|FG001|Overall Study|Adverse Event|1|||
161671856|NCT00688103|583851419|FG000|Overall Study|Lack of Efficacy|11|||
161671857|NCT00688103|583851420|FG001|Overall Study|Lack of Efficacy|1|||
161671858|NCT00688103|583851419|FG000|Overall Study|Withdrawal by Subject|4|||
161493005|NCT02196558|583200113|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
161493006|NCT02196558|583200111|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
161493007|NCT02196558|583200112|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
161493008|NCT02196558|583200113|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
161493009|NCT02196558|583200111|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
161493010|NCT02196558|583200112|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
161493011|NCT02196558|583200113|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
161493012|NCT02196558|583200111|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
161493013|NCT02196558|583200112|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
161493014|NCT02196558|583200113|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
161493015|NCT02196558|583200111|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
161493016|NCT02196558|583200112|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
161493017|NCT02196558|583200113|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
161493018|NCT03428360|583200115|FG000|Overall Study|Informed consent withdrawn|5|||
161493019|NCT03428360|583200115|FG000|Overall Study|Withdrawal by Subject|4|||
161493020|NCT03428360|583200115|FG000|Overall Study|Lost to Follow-up|5|||
161493021|NCT03428360|583200115|FG000|Overall Study|Physician Decision|2|||
161493022|NCT03428360|583200115|FG000|Overall Study|Informed consent withdrawn|5|||
161493023|NCT03428360|583200115|FG000|Overall Study|Study terminated by sponsor|10|||
161584097|NCT02539225|583526065|FG000|Pre Treatment for Part B|Adverse Event|1|||
161584098|NCT02539225|583526066|FG001|Pre Treatment for Part B|Adverse Event|1|||
161584099|NCT02539225|583526065|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
161584100|NCT02539225|583526066|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
161584101|NCT02539225|583526065|FG000|Pre Treatment for Part B|Physician Decision|2|||
161584102|NCT02539225|583526066|FG001|Pre Treatment for Part B|Physician Decision|0|||
161584103|NCT02539225|583526065|FG000|Part B|Adverse Event|4|||
161584104|NCT02539225|583526066|FG001|Part B|Adverse Event|4|||
161584105|NCT02539225|583526065|FG000|Part B|Withdrawal by Subject|0|||
161584106|NCT02539225|583526066|FG001|Part B|Withdrawal by Subject|3|||
161584107|NCT02539225|583526065|FG000|Part B|Physician Decision|0|||
161584108|NCT02539225|583526066|FG001|Part B|Physician Decision|9|||
161584109|NCT03101371|583526072|FG000|Overall Study|Physician Decision|0|||
161584110|NCT03101371|583526073|FG001|Overall Study|Physician Decision|1|||
161584111|NCT03101371|583526072|FG000|Overall Study|Lost to Follow-up|1|||
161584112|NCT03101371|583526073|FG001|Overall Study|Lost to Follow-up|4|||
161584113|NCT03101371|583526072|FG000|Overall Study|Did not meet eligibility criteria|2|||
161584114|NCT03101371|583526073|FG001|Overall Study|Did not meet eligibility criteria|1|||
161584115|NCT01094184|583526074|FG000|Overall Study|Death|35|||
161584116|NCT01094184|583526075|FG001|Overall Study|Death|11|||
161584117|NCT02318134|583526076|FG000|Overall Study|Withdrawal by Subject|2|||
161584118|NCT02318134|583526077|FG001|Overall Study|Withdrawal by Subject|1|||
161584119|NCT03988842|583526078|FG000|Overall Study|Death|1|||
161584120|NCT04766034|583526079|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161584121|NCT04766034|583526080|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161584122|NCT04766034|583526081|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161584123|NCT04766034|583526082|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161584124|NCT04766034|583526083|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
161584125|NCT04766034|583526079|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161584126|NCT04766034|583526080|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161584127|NCT04766034|583526081|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161584128|NCT04766034|583526082|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161584129|NCT04766034|583526083|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
161584130|NCT04766034|583526079|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
161584131|NCT04766034|583526080|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
161584132|NCT04766034|583526081|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
161584133|NCT04766034|583526082|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
161584134|NCT04766034|583526083|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
161584135|NCT04766034|583526079|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
161584136|NCT04766034|583526080|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
161584137|NCT04766034|583526081|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
161584138|NCT04766034|583526082|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
161584139|NCT04766034|583526083|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
161584140|NCT01976312|583526084|FG000|Overall Study|Pregnancy|0|||
161584141|NCT01976312|583526085|FG001|Overall Study|Pregnancy|1|||
161584142|NCT01976312|583526084|FG000|Overall Study|Lost to Follow-up|2|||
161584143|NCT01976312|583526085|FG001|Overall Study|Lost to Follow-up|0|||
161493024|NCT03428360|583200115|FG000|Overall Study|Non-compliant with study|1|||
161493025|NCT03428360|583200115|FG000|Overall Study|Non-compliant with study drug|3|||
161493026|NCT03428360|583200115|FG000|Overall Study|Death|3|||
161493027|NCT03428360|583200115|FG000|Overall Study|Adverse Event|1|||
161493028|NCT03428360|583200115|FG000|Overall Study|Not on antiepileptic drug|1|||
161493029|NCT02028065|583200116|FG000|Randomization Through Start Treatment|Not treated|1|||
161493030|NCT02028065|583200117|FG001|Randomization Through Start Treatment|Not treated|3|||
161493031|NCT02028065|583200118|FG002|Randomization Through Start Treatment|Not treated|3|||
161493032|NCT02028065|583200116|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
161493033|NCT02028065|583200117|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
161493034|NCT02028065|583200118|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
161493035|NCT02028065|583200116|FG000|Treatment Through Study Completion|Physician Decision|1|||
161493036|NCT02028065|583200117|FG001|Treatment Through Study Completion|Physician Decision|0|||
161493037|NCT02028065|583200118|FG002|Treatment Through Study Completion|Physician Decision|0|||
161671859|NCT00688103|583851420|FG001|Overall Study|Withdrawal by Subject|2|||
161671860|NCT00688103|583851419|FG000|Overall Study|complex reasons|11|||
161671861|NCT00688103|583851420|FG001|Overall Study|complex reasons|9|||
161671862|NCT05959629|583851424|FG000|Overall Study|partially necrotic/technical issues|2|||
161671863|NCT05959629|583851425|FG001|Overall Study|partially necrotic/technical issues|2|||
161671864|NCT02076113|583852977|FG000|Overall Study|Lost to Follow-up|4|||
161671865|NCT02076113|583852978|FG001|Overall Study|Lost to Follow-up|1|||
161671866|NCT02076113|583852977|FG000|Overall Study|Withdrawal by Subject|2|||
161671867|NCT02076113|583852978|FG001|Overall Study|Withdrawal by Subject|3|||
161671868|NCT02076113|583852977|FG000|Overall Study|Death|1|||
161671869|NCT02076113|583852978|FG001|Overall Study|Death|3|||
161671870|NCT00833911|583852979|FG000|Titration|Adverse Event|18|||
161671871|NCT00833911|583852979|FG000|Titration|Withdrawal by Subject|3|||
161671872|NCT00833911|583852979|FG000|Maintenance Phase I|Adverse Event|73|||
161671873|NCT00833911|583852979|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
161671874|NCT00833911|583852979|FG000|Maintenance Phase I|Physician Decision|10|||
161671875|NCT00833911|583852979|FG000|Maintenance Phase I|Lack of Efficacy|4|||
161493038|NCT02028065|583200116|FG000|Treatment Through Study Completion|Protocol Violation|1|||
161493039|NCT02028065|583200117|FG001|Treatment Through Study Completion|Protocol Violation|4|||
161493040|NCT02028065|583200118|FG002|Treatment Through Study Completion|Protocol Violation|0|||
161671876|NCT00833911|583852979|FG000|Maintenance Phase II|Adverse Event|6|||
161493041|NCT02028065|583200116|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
161493042|NCT02028065|583200117|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
161493043|NCT02028065|583200118|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
161493044|NCT02028065|583200116|FG000|Treatment Through Study Completion|Adverse Event|3|||
161493045|NCT02028065|583200117|FG001|Treatment Through Study Completion|Adverse Event|3|||
161493046|NCT02028065|583200118|FG002|Treatment Through Study Completion|Adverse Event|5|||
161493047|NCT02107482|583200124|FG000|Overall Study|inconveinence|2|||
161493048|NCT02107482|583200124|FG000|Overall Study|Lost to Follow-up|1|||
161493049|NCT02107482|583200124|FG000|Overall Study|Lack of Efficacy|1|||
161493050|NCT00576927|583200127|FG000|Clinical Assessment|Lack of Efficacy|24|||
161493051|NCT00576927|583200127|FG000|Clinical Assessment|Death|1|||
161493052|NCT00576927|583200127|FG000|Clinical Assessment|Withdrawal by Subject|10|||
161493053|NCT00576927|583200127|FG000|Clinical Assessment|Physician Decision|1|||
161493054|NCT00576927|583200127|FG000|Baseline|Physician Decision|9|||
161493055|NCT00576927|583200127|FG000|Baseline|Medication Change by PCP of subject|1|||
161493056|NCT00576927|583200127|FG000|Baseline|Withdrawal by Subject|3|||
161493057|NCT00576927|583200127|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
161493058|NCT00576927|583200127|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
161493059|NCT00576927|583200127|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
161493060|NCT00576927|583200127|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
161493061|NCT00576927|583200127|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
161493062|NCT03128892|583200128|FG000|Overall Study|Withdrawal by Subject|2|||
161493063|NCT03128892|583200128|FG000|Overall Study|Physician Decision|1|||
161493064|NCT01850524|583200130|FG000|Overall Study|Lost to Follow-up|5|||
161493065|NCT01850524|583200131|FG001|Overall Study|Lost to Follow-up|10|||
161493066|NCT01850524|583200130|FG000|Overall Study|Withdrawal by Subject|24|||
161493067|NCT01850524|583200131|FG001|Overall Study|Withdrawal by Subject|22|||
161493068|NCT01850524|583200130|FG000|Overall Study|Reason not Specified|142|||
161493069|NCT01850524|583200131|FG001|Overall Study|Reason not Specified|141|||
161493070|NCT00368355|583200133|FG000|Overall Study|Adverse Event|1|||
161493071|NCT00368355|583200134|FG001|Overall Study|Adverse Event|0|||
161493072|NCT00368355|583200133|FG000|Overall Study|Death|2|||
161493073|NCT00368355|583200134|FG001|Overall Study|Death|4|||
161493074|NCT00368355|583200133|FG000|Overall Study|Relapse|6|||
161493075|NCT00368355|583200134|FG001|Overall Study|Relapse|10|||
161493076|NCT00368355|583200133|FG000|Overall Study|Subsequent transplant|0|||
161671877|NCT00833911|583852979|FG000|Maintenance Phase II|Physician Decision|2|||
161671878|NCT00833911|583852979|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
161584144|NCT01976312|583526084|FG000|Overall Study|Withdrawal by Subject|7|||
161584145|NCT01976312|583526085|FG001|Overall Study|Withdrawal by Subject|2|||
161584146|NCT01976312|583526084|FG000|Overall Study|Adverse Event|6|||
161584147|NCT01976312|583526085|FG001|Overall Study|Adverse Event|6|||
161584148|NCT01976312|583526084|FG000|Overall Study|Protocol Violation|2|||
161584149|NCT01976312|583526085|FG001|Overall Study|Protocol Violation|0|||
161584150|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
161584151|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
161584152|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
161584153|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
161584154|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
161584155|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
161584156|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
161584157|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
161584158|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
161584159|NCT03939312|583526086|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
161817814|NCT02003391|584372934|FG000|Overall Study|Protocol Violation|0|||
161817815|NCT02003391|584372935|FG001|Overall Study|Protocol Violation|1|||
161817816|NCT02003391|584372934|FG000|Overall Study|Adverse Event|1|||
161817817|NCT02003391|584372935|FG001|Overall Study|Adverse Event|0|||
161817818|NCT02272803|584372936|FG000|Overall Study|Disease progression|16|||
161817819|NCT02272803|584372937|FG001|Overall Study|Disease progression|8|||
161817820|NCT02272803|584372936|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
161817821|NCT02272803|584372937|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
161817822|NCT02272803|584372936|FG000|Overall Study|Study drug toxicity|4|||
161817823|NCT02272803|584372937|FG001|Overall Study|Study drug toxicity|9|||
161817824|NCT02272803|584372936|FG000|Overall Study|Participant request to discontinue study treatment|3|||
161817825|NCT02272803|584372937|FG001|Overall Study|Participant request to discontinue study treatment|7|||
161817826|NCT02272803|584372936|FG000|Overall Study|Maximum clinical benefit|4|||
161817827|NCT02272803|584372937|FG001|Overall Study|Maximum clinical benefit|2|||
161817828|NCT02272803|584372936|FG000|Overall Study|Poor/non-compliance|2|||
161817829|NCT02272803|584372937|FG001|Overall Study|Poor/non-compliance|2|||
161817830|NCT02272803|584372936|FG000|Overall Study|Withdrawal by Subject|2|||
161817831|NCT02272803|584372937|FG001|Overall Study|Withdrawal by Subject|1|||
161817832|NCT02272803|584372936|FG000|Overall Study|Death|0|||
161817833|NCT02272803|584372937|FG001|Overall Study|Death|1|||
161817834|NCT02272803|584372936|FG000|Overall Study|Other reasons|1|||
161817835|NCT02272803|584372937|FG001|Overall Study|Other reasons|3|||
161817836|NCT02272803|584372936|FG000|Overall Study|Administrative reason by sponsor|5|||
161817837|NCT02272803|584372937|FG001|Overall Study|Administrative reason by sponsor|4|||
161817838|NCT02611323|584372938|FG000|Overall Study|Death|3|||
161817839|NCT02611323|584372939|FG001|Overall Study|Death|1|||
161817840|NCT02611323|584372940|FG002|Overall Study|Death|0|||
161817841|NCT02611323|584372941|FG003|Overall Study|Death|0|||
161817842|NCT02611323|584372942|FG004|Overall Study|Death|1|||
161817843|NCT02611323|584372943|FG005|Overall Study|Death|1|||
161817844|NCT02611323|584372944|FG006|Overall Study|Death|8|||
161817845|NCT02611323|584372945|FG007|Overall Study|Death|0|||
161817846|NCT02611323|584372946|FG008|Overall Study|Death|4|||
161817847|NCT02611323|584372947|FG009|Overall Study|Death|6|||
161817848|NCT02611323|584372948|FG010|Overall Study|Death|26|||
161817849|NCT02611323|584372938|FG000|Overall Study|Lost to Follow-up|1|||
161817850|NCT02611323|584372939|FG001|Overall Study|Lost to Follow-up|0|||
161817851|NCT02611323|584372940|FG002|Overall Study|Lost to Follow-up|0|||
161817852|NCT02611323|584372941|FG003|Overall Study|Lost to Follow-up|0|||
161817853|NCT02611323|584372942|FG004|Overall Study|Lost to Follow-up|0|||
161817854|NCT02611323|584372943|FG005|Overall Study|Lost to Follow-up|0|||
161817855|NCT02611323|584372944|FG006|Overall Study|Lost to Follow-up|3|||
161817856|NCT02611323|584372945|FG007|Overall Study|Lost to Follow-up|0|||
161817857|NCT02611323|584372946|FG008|Overall Study|Lost to Follow-up|0|||
161817858|NCT02611323|584372947|FG009|Overall Study|Lost to Follow-up|0|||
161817859|NCT02611323|584372948|FG010|Overall Study|Lost to Follow-up|2|||
161817860|NCT02611323|584372938|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
161584160|NCT03939312|583526086|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
161817861|NCT02611323|584372939|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817862|NCT02611323|584372940|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817863|NCT02611323|584372941|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817864|NCT02611323|584372942|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817865|NCT02611323|584372943|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817866|NCT02611323|584372944|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817867|NCT02611323|584372945|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817868|NCT02611323|584372946|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817869|NCT02611323|584372947|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
161923965|NCT04925934|584768117|FG000|Overall Study|Adverse Event|1|||
161923966|NCT04925934|584768118|FG001|Overall Study|Adverse Event|0|||
161671879|NCT00833911|583852979|FG000|Maintenance Phase II|Lack of Efficacy|1|||
161671880|NCT03942406|583852982|FG000|Overall Study|Lost to Follow-up|4|||
161671881|NCT03942406|583852983|FG001|Overall Study|Lost to Follow-up|5|||
161671882|NCT03942406|583852984|FG002|Overall Study|Lost to Follow-up|3|||
161671883|NCT03942406|583852985|FG003|Overall Study|Lost to Follow-up|7|||
161671884|NCT03942406|583852986|FG004|Overall Study|Lost to Follow-up|1|||
161671885|NCT03942406|583852987|FG005|Overall Study|Lost to Follow-up|0|||
161671886|NCT03942406|583852988|FG006|Overall Study|Lost to Follow-up|0|||
161671887|NCT03942406|583852982|FG000|Overall Study|Withdrawal by Subject|3|||
161671888|NCT03942406|583852983|FG001|Overall Study|Withdrawal by Subject|1|||
161671889|NCT03942406|583852984|FG002|Overall Study|Withdrawal by Subject|1|||
161671890|NCT03942406|583852985|FG003|Overall Study|Withdrawal by Subject|3|||
161671891|NCT03942406|583852986|FG004|Overall Study|Withdrawal by Subject|0|||
161671892|NCT03942406|583852987|FG005|Overall Study|Withdrawal by Subject|0|||
161671893|NCT03942406|583852988|FG006|Overall Study|Withdrawal by Subject|0|||
161671894|NCT03942406|583852982|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
161671895|NCT03942406|583852983|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
161671896|NCT03942406|583852984|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
161671897|NCT03942406|583852985|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
161671898|NCT03942406|583852986|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
161671899|NCT03942406|583852987|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
161671900|NCT03942406|583852988|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
161671901|NCT02616614|583852989|FG000|Overall Study|Withdrawal by Subject|10|||
161671902|NCT02616614|583852990|FG001|Overall Study|Withdrawal by Subject|5|||
161671903|NCT02616614|583852991|FG002|Overall Study|Withdrawal by Subject|6|||
161671904|NCT02616614|583852989|FG000|Overall Study|Physician Decision|2|||
161671905|NCT02616614|583852990|FG001|Overall Study|Physician Decision|1|||
161671906|NCT02616614|583852991|FG002|Overall Study|Physician Decision|0|||
161671907|NCT02616614|583852989|FG000|Overall Study|Adverse Event|1|||
161671908|NCT02616614|583852990|FG001|Overall Study|Adverse Event|4|||
161671909|NCT02616614|583852991|FG002|Overall Study|Adverse Event|1|||
161671910|NCT02616614|583852989|FG000|Overall Study|Protocol Violation|0|||
161671911|NCT02616614|583852990|FG001|Overall Study|Protocol Violation|3|||
161671912|NCT02616614|583852991|FG002|Overall Study|Protocol Violation|1|||
161671913|NCT02616614|583852989|FG000|Overall Study|Prohibited Medication|12|||
161671914|NCT02616614|583852990|FG001|Overall Study|Prohibited Medication|9|||
161671915|NCT02616614|583852991|FG002|Overall Study|Prohibited Medication|5|||
161671916|NCT02616614|583852989|FG000|Overall Study|More than 3 applications missed|6|||
161671917|NCT02616614|583852990|FG001|Overall Study|More than 3 applications missed|8|||
161671918|NCT02616614|583852991|FG002|Overall Study|More than 3 applications missed|1|||
161671919|NCT02616614|583852989|FG000|Overall Study|Lost to Follow-up|31|||
161671920|NCT02616614|583852990|FG001|Overall Study|Lost to Follow-up|28|||
161671921|NCT02616614|583852991|FG002|Overall Study|Lost to Follow-up|13|||
161671922|NCT02616614|583852989|FG000|Overall Study|Pregnancy|2|||
161671923|NCT02616614|583852990|FG001|Overall Study|Pregnancy|0|||
161493077|NCT00368355|583200134|FG001|Overall Study|Subsequent transplant|3|||
161493078|NCT00368355|583200133|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
161493079|NCT00368355|583200134|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
161493080|NCT03473808|583200143|FG000|Overall Study|Withdrawal by Subject|1|||
161493081|NCT02157298|583200146|FG000|Overall Study|Adverse Event|1|||
161493082|NCT02157298|583200147|FG001|Overall Study|Adverse Event|0|||
161493083|NCT02157298|583200146|FG000|Overall Study|Subject no longer meets study criteria|1|||
161493084|NCT02157298|583200147|FG001|Overall Study|Subject no longer meets study criteria|2|||
161493085|NCT02157298|583200146|FG000|Overall Study|Poor/Non-compliance|1|||
161493086|NCT02157298|583200147|FG001|Overall Study|Poor/Non-compliance|0|||
161493087|NCT02157298|583200146|FG000|Overall Study|Withdrawal by Subject|1|||
161493088|NCT02157298|583200147|FG001|Overall Study|Withdrawal by Subject|0|||
161493089|NCT04059094|583200148|FG000|Overall Study|Adverse Event|0|||
161493090|NCT04059094|583200149|FG001|Overall Study|Adverse Event|0|||
161493091|NCT04059094|583200150|FG002|Overall Study|Adverse Event|0|||
161493092|NCT04059094|583200151|FG003|Overall Study|Adverse Event|0|||
161493093|NCT04059094|583200152|FG004|Overall Study|Adverse Event|1|||
161493094|NCT04059094|583200148|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
161671924|NCT02616614|583852991|FG002|Overall Study|Pregnancy|1|||
161671925|NCT02616614|583852989|FG000|Overall Study|Other|1|||
161671926|NCT02616614|583852990|FG001|Overall Study|Other|2|||
161671927|NCT02616614|583852991|FG002|Overall Study|Other|1|||
161671928|NCT02748018|583852992|FG000|Study Period|Adverse Event|1|||
161493095|NCT04059094|583200149|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
161493096|NCT04059094|583200150|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
161671929|NCT02748018|583852993|FG001|Study Period|Adverse Event|3|||
161671930|NCT02748018|583852994|FG002|Study Period|Adverse Event|4|||
161671931|NCT02748018|583852995|FG003|Study Period|Adverse Event|0|||
161671932|NCT02748018|583852996|FG004|Study Period|Adverse Event|3|||
161671933|NCT02748018|583852997|FG005|Study Period|Adverse Event|3|||
161671934|NCT02748018|583852992|FG000|Study Period|Withdrawal by Subject|7|||
161493097|NCT04059094|583200151|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
161493098|NCT04059094|583200152|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
161493099|NCT01085591|583200153|FG000|Overall Study|Adverse Event|0|||
161493100|NCT01085591|583200154|FG001|Overall Study|Adverse Event|1|||
161493101|NCT01085591|583200155|FG002|Overall Study|Adverse Event|3|||
161493102|NCT01085591|583200153|FG000|Overall Study|Physician Decision|1|||
161493103|NCT01085591|583200154|FG001|Overall Study|Physician Decision|0|||
161493104|NCT01085591|583200155|FG002|Overall Study|Physician Decision|1|||
161493105|NCT01085591|583200153|FG000|Overall Study|Withdrawal by Subject|0|||
161493106|NCT01085591|583200154|FG001|Overall Study|Withdrawal by Subject|2|||
161493107|NCT01085591|583200155|FG002|Overall Study|Withdrawal by Subject|1|||
161493108|NCT01085591|583200153|FG000|Overall Study|Lost to Follow-up|0|||
161671935|NCT02748018|583852993|FG001|Study Period|Withdrawal by Subject|4|||
161671936|NCT02748018|583852994|FG002|Study Period|Withdrawal by Subject|4|||
161671937|NCT02748018|583852995|FG003|Study Period|Withdrawal by Subject|11|||
161671938|NCT02748018|583852996|FG004|Study Period|Withdrawal by Subject|12|||
161671939|NCT02748018|583852997|FG005|Study Period|Withdrawal by Subject|10|||
161671940|NCT02748018|583852992|FG000|Study Period|Pregnancy|0|||
161671941|NCT02748018|583852993|FG001|Study Period|Pregnancy|1|||
161671942|NCT02748018|583852994|FG002|Study Period|Pregnancy|0|||
161671943|NCT02748018|583852995|FG003|Study Period|Pregnancy|0|||
161671944|NCT02748018|583852996|FG004|Study Period|Pregnancy|1|||
161671945|NCT02748018|583852997|FG005|Study Period|Pregnancy|0|||
161671946|NCT02748018|583852992|FG000|Study Period|Physician Decision|2|||
161671947|NCT02748018|583852993|FG001|Study Period|Physician Decision|2|||
161671948|NCT02748018|583852994|FG002|Study Period|Physician Decision|1|||
161671949|NCT02748018|583852995|FG003|Study Period|Physician Decision|0|||
161671950|NCT02748018|583852996|FG004|Study Period|Physician Decision|2|||
161671951|NCT02748018|583852997|FG005|Study Period|Physician Decision|0|||
161671952|NCT02748018|583852992|FG000|Study Period|Lost to Follow-up|0|||
161671953|NCT02748018|583852993|FG001|Study Period|Lost to Follow-up|0|||
161671954|NCT02748018|583852994|FG002|Study Period|Lost to Follow-up|0|||
161671955|NCT02748018|583852995|FG003|Study Period|Lost to Follow-up|2|||
161671956|NCT02748018|583852996|FG004|Study Period|Lost to Follow-up|0|||
161671957|NCT02748018|583852997|FG005|Study Period|Lost to Follow-up|1|||
161671958|NCT02748018|583852992|FG000|Continuation Period|Adverse Event|2|||
161671959|NCT02748018|583852993|FG001|Continuation Period|Adverse Event|0|||
161671960|NCT02748018|583852994|FG002|Continuation Period|Adverse Event|1|||
161671961|NCT02748018|583852995|FG003|Continuation Period|Adverse Event|1|||
161671962|NCT02748018|583852996|FG004|Continuation Period|Adverse Event|1|||
161671963|NCT02748018|583852997|FG005|Continuation Period|Adverse Event|4|||
161671964|NCT02748018|583852992|FG000|Continuation Period|Withdrawal by Subject|3|||
161671965|NCT02748018|583852993|FG001|Continuation Period|Withdrawal by Subject|5|||
161671966|NCT02748018|583852994|FG002|Continuation Period|Withdrawal by Subject|3|||
161493109|NCT01085591|583200154|FG001|Overall Study|Lost to Follow-up|1|||
161493110|NCT01085591|583200155|FG002|Overall Study|Lost to Follow-up|1|||
161493111|NCT01085591|583200153|FG000|Overall Study|Protocol Violation|1|||
161493112|NCT01085591|583200154|FG001|Overall Study|Protocol Violation|1|||
161493113|NCT01085591|583200155|FG002|Overall Study|Protocol Violation|1|||
161671967|NCT02748018|583852995|FG003|Continuation Period|Withdrawal by Subject|9|||
161671968|NCT02748018|583852996|FG004|Continuation Period|Withdrawal by Subject|11|||
161671969|NCT02748018|583852997|FG005|Continuation Period|Withdrawal by Subject|1|||
161671970|NCT02748018|583852992|FG000|Continuation Period|Lost to Follow-up|0|||
161671971|NCT02748018|583852993|FG001|Continuation Period|Lost to Follow-up|2|||
161671972|NCT02748018|583852994|FG002|Continuation Period|Lost to Follow-up|1|||
161671973|NCT02748018|583852995|FG003|Continuation Period|Lost to Follow-up|0|||
161671974|NCT02748018|583852996|FG004|Continuation Period|Lost to Follow-up|1|||
161671975|NCT02748018|583852997|FG005|Continuation Period|Lost to Follow-up|0|||
161671976|NCT02748018|583852992|FG000|Continuation Period|Pregnancy|1|||
161671977|NCT02748018|583852993|FG001|Continuation Period|Pregnancy|2|||
161671978|NCT02748018|583852994|FG002|Continuation Period|Pregnancy|0|||
161671979|NCT02748018|583852995|FG003|Continuation Period|Pregnancy|0|||
161493114|NCT01085591|583200153|FG000|Overall Study|Other|0|||
161493115|NCT01085591|583200154|FG001|Overall Study|Other|1|||
161493116|NCT01085591|583200155|FG002|Overall Study|Other|0|||
161493117|NCT01085591|583200153|FG000|Overall Study|Not Properly Consented|1|||
161671980|NCT02748018|583852996|FG004|Continuation Period|Pregnancy|0|||
161671981|NCT02748018|583852997|FG005|Continuation Period|Pregnancy|0|||
161671982|NCT02748018|583852992|FG000|Continuation Period|Physician Decision|0|||
161671983|NCT02748018|583852993|FG001|Continuation Period|Physician Decision|1|||
161493118|NCT01085591|583200154|FG001|Overall Study|Not Properly Consented|0|||
161493119|NCT01085591|583200155|FG002|Overall Study|Not Properly Consented|0|||
161671984|NCT02748018|583852994|FG002|Continuation Period|Physician Decision|2|||
161671985|NCT02748018|583852995|FG003|Continuation Period|Physician Decision|0|||
161671986|NCT02748018|583852996|FG004|Continuation Period|Physician Decision|2|||
161671987|NCT02748018|583852997|FG005|Continuation Period|Physician Decision|1|||
161671988|NCT02748018|583852992|FG000|Continuation Period|Protocol Violation|0|||
161493120|NCT03715764|583200160|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
161493121|NCT03715764|583200161|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
161493122|NCT03715764|583200160|FG000|3 Month Follow-up|Lost to Follow-up|2|||
161493123|NCT03715764|583200161|FG001|3 Month Follow-up|Lost to Follow-up|2|||
161493124|NCT03715764|583200160|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
161493125|NCT03715764|583200161|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
161493126|NCT03715764|583200160|FG000|6 Month Follow-up|Lost to Follow-up|3|||
161493127|NCT03715764|583200161|FG001|6 Month Follow-up|Lost to Follow-up|0|||
161493128|NCT03715764|583200160|FG000|12 Month Follow-up|Lost to Follow-up|2|||
161493129|NCT03715764|583200161|FG001|12 Month Follow-up|Lost to Follow-up|3|||
161493130|NCT03715764|583200160|FG000|12 Month Follow-up|Pregnancy|0|||
161493131|NCT03715764|583200161|FG001|12 Month Follow-up|Pregnancy|1|||
161493132|NCT03715764|583200160|FG000|12 Month Follow-up|Surgery|2|||
161493133|NCT03715764|583200161|FG001|12 Month Follow-up|Surgery|0|||
161493134|NCT03715764|583200160|FG000|12 Month Follow-up|Wrong address|1|||
161493135|NCT03715764|583200161|FG001|12 Month Follow-up|Wrong address|0|||
161493136|NCT03715764|583200160|FG000|12 Month Follow-up|No symptoms|1|||
161493137|NCT03715764|583200161|FG001|12 Month Follow-up|No symptoms|0|||
161493138|NCT03715764|583200160|FG000|12 Month Follow-up|Changed primary care centre|0|||
161493139|NCT03715764|583200161|FG001|12 Month Follow-up|Changed primary care centre|1|||
161493140|NCT04484142|583200167|FG000|Overall Study|Adverse Event|13|||
161493141|NCT04484142|583200167|FG000|Overall Study|Progressive Disease|87|||
161493142|NCT04484142|583200167|FG000|Overall Study|Clinical Progression|10|||
161493143|NCT04484142|583200167|FG000|Overall Study|Withdrawal by Subject|6|||
161817870|NCT02611323|584372948|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817871|NCT02611323|584372938|FG000|Overall Study|Progressive Disease|0|||
161817872|NCT02611323|584372939|FG001|Overall Study|Progressive Disease|0|||
161817873|NCT02611323|584372940|FG002|Overall Study|Progressive Disease|0|||
161817874|NCT02611323|584372941|FG003|Overall Study|Progressive Disease|0|||
161817875|NCT02611323|584372942|FG004|Overall Study|Progressive Disease|0|||
161817876|NCT02611323|584372943|FG005|Overall Study|Progressive Disease|0|||
161817877|NCT02611323|584372944|FG006|Overall Study|Progressive Disease|0|||
161817878|NCT02611323|584372945|FG007|Overall Study|Progressive Disease|0|||
161817879|NCT02611323|584372946|FG008|Overall Study|Progressive Disease|0|||
161817880|NCT02611323|584372947|FG009|Overall Study|Progressive Disease|0|||
161817881|NCT02611323|584372948|FG010|Overall Study|Progressive Disease|1|||
161817882|NCT02611323|584372938|FG000|Overall Study|Withdrawal by Subject|1|||
161817883|NCT02611323|584372939|FG001|Overall Study|Withdrawal by Subject|0|||
161817884|NCT02611323|584372940|FG002|Overall Study|Withdrawal by Subject|0|||
161817885|NCT02611323|584372941|FG003|Overall Study|Withdrawal by Subject|0|||
161817886|NCT02611323|584372942|FG004|Overall Study|Withdrawal by Subject|0|||
161817887|NCT02611323|584372943|FG005|Overall Study|Withdrawal by Subject|0|||
161817888|NCT02611323|584372944|FG006|Overall Study|Withdrawal by Subject|0|||
161817889|NCT02611323|584372945|FG007|Overall Study|Withdrawal by Subject|1|||
161817890|NCT02611323|584372946|FG008|Overall Study|Withdrawal by Subject|0|||
161817891|NCT02611323|584372947|FG009|Overall Study|Withdrawal by Subject|1|||
161817892|NCT02611323|584372948|FG010|Overall Study|Withdrawal by Subject|0|||
161817893|NCT00243347|584372949|FG000|Overall Study|Lack of Efficacy|4|||
161817894|NCT00243347|584372949|FG000|Overall Study|Adverse Event|2|||
161817895|NCT00243347|584372949|FG000|Overall Study|Death|1|||
161817896|NCT00243347|584372949|FG000|Overall Study|Withdrawal by Subject|5|||
161817897|NCT00243347|584372949|FG000|Overall Study|Condition worsened|7|||
161817898|NCT02011945|584372956|FG000|Overall Study|Participant requested to Discontinue|0|||
161817899|NCT02011945|584372957|FG001|Overall Study|Participant requested to Discontinue|1|||
161817900|NCT02011945|584372958|FG002|Overall Study|Participant requested to Discontinue|1|||
161817901|NCT02011945|584372956|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
161817902|NCT02011945|584372957|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
161817903|NCT02011945|584372958|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
161817904|NCT02011945|584372956|FG000|Overall Study|Study Drug Toxicity|0|||
161817905|NCT02011945|584372957|FG001|Overall Study|Study Drug Toxicity|0|||
161817906|NCT02011945|584372958|FG002|Overall Study|Study Drug Toxicity|1|||
161817907|NCT02011945|584372956|FG000|Overall Study|Treatment Failure|0|||
161817908|NCT02011945|584372957|FG001|Overall Study|Treatment Failure|7|||
161493144|NCT04484142|583200167|FG000|Overall Study|Physician Decision|1|||
161493145|NCT05371509|583200168|FG000|Overall Study|Physician Decision|1|||
161493146|NCT05371509|583200169|FG001|Overall Study|Physician Decision|0|||
161493147|NCT02554812|583200170|FG000|Overall Study|Adverse Event|2|||
161493148|NCT02554812|583200171|FG001|Overall Study|Adverse Event|5|||
161493149|NCT02554812|583200172|FG002|Overall Study|Adverse Event|3|||
161493150|NCT02554812|583200173|FG003|Overall Study|Adverse Event|0|||
161817909|NCT02011945|584372958|FG002|Overall Study|Treatment Failure|6|||
161817910|NCT02011945|584372956|FG000|Overall Study|No Longer Meets Study Criteria|1|||
161817911|NCT02011945|584372957|FG001|Overall Study|No Longer Meets Study Criteria|0|||
161817912|NCT02011945|584372958|FG002|Overall Study|No Longer Meets Study Criteria|0|||
161817913|NCT02011945|584372956|FG000|Overall Study|Proceeded to stem cell transplant|0|||
161817914|NCT02011945|584372957|FG001|Overall Study|Proceeded to stem cell transplant|0|||
161493151|NCT02554812|583200174|FG004|Overall Study|Adverse Event|5|||
161493152|NCT02554812|583200175|FG005|Overall Study|Adverse Event|0|||
161493153|NCT02554812|583200176|FG006|Overall Study|Adverse Event|1|||
161493154|NCT02554812|583200177|FG007|Overall Study|Adverse Event|6|||
161493155|NCT02554812|583200178|FG008|Overall Study|Adverse Event|2|||
161493156|NCT02554812|583200179|FG009|Overall Study|Adverse Event|2|||
161493157|NCT02554812|583200180|FG010|Overall Study|Adverse Event|1|||
161493158|NCT02554812|583200181|FG011|Overall Study|Adverse Event|2|||
161493159|NCT02554812|583200182|FG012|Overall Study|Adverse Event|0|||
161493160|NCT02554812|583200183|FG013|Overall Study|Adverse Event|3|||
161493161|NCT02554812|583200184|FG014|Overall Study|Adverse Event|2|||
161493162|NCT02554812|583200185|FG015|Overall Study|Adverse Event|1|||
161493163|NCT02554812|583200186|FG016|Overall Study|Adverse Event|0|||
161493164|NCT02554812|583200187|FG017|Overall Study|Adverse Event|1|||
161493165|NCT02554812|583200188|FG018|Overall Study|Adverse Event|0|||
161493166|NCT02554812|583200189|FG019|Overall Study|Adverse Event|0|||
161493167|NCT02554812|583200190|FG020|Overall Study|Adverse Event|0|||
161493168|NCT02554812|583200191|FG021|Overall Study|Adverse Event|2|||
161493169|NCT02554812|583200192|FG022|Overall Study|Adverse Event|1|||
161493170|NCT02554812|583200193|FG023|Overall Study|Adverse Event|1|||
161493171|NCT02554812|583200194|FG024|Overall Study|Adverse Event|1|||
161493172|NCT02554812|583200195|FG025|Overall Study|Adverse Event|2|||
161493173|NCT02554812|583200196|FG026|Overall Study|Adverse Event|1|||
161493174|NCT02554812|583200170|FG000|Overall Study|Death|1|||
161671989|NCT02748018|583852993|FG001|Continuation Period|Protocol Violation|1|||
161671990|NCT02748018|583852994|FG002|Continuation Period|Protocol Violation|0|||
161671991|NCT02748018|583852995|FG003|Continuation Period|Protocol Violation|0|||
161671992|NCT02748018|583852996|FG004|Continuation Period|Protocol Violation|0|||
161671993|NCT02748018|583852997|FG005|Continuation Period|Protocol Violation|0|||
161671994|NCT06069778|583852998|FG000|Overall Study|Withdrawal by Subject|1|||
161671995|NCT03801902|583852999|FG000|Overall Study|Did not receive protocol treatment.|1|||
161671996|NCT03801902|583853000|FG001|Overall Study|Did not receive protocol treatment.|0|||
161671997|NCT03801902|583853001|FG002|Overall Study|Did not receive protocol treatment.|0|||
161671998|NCT03801902|583853002|FG003|Overall Study|Did not receive protocol treatment.|0|||
161671999|NCT04704336|583853008|FG000|Overall Study|Death|2|||
161672000|NCT04704336|583853009|FG001|Overall Study|Death|2|||
161672001|NCT04704336|583853008|FG000|Overall Study|Lost to Follow-up|33|||
161672002|NCT04704336|583853009|FG001|Overall Study|Lost to Follow-up|40|||
161672003|NCT02260882|583853010|FG000|Overall Study|Protocol Violation|0|||
161672004|NCT02260882|583853011|FG001|Overall Study|Protocol Violation|1|||
161672005|NCT02119325|583853012|FG000|Washout Period 1|Adverse Event|0|||
161672006|NCT02119325|583853013|FG001|Washout Period 1|Adverse Event|1|||
161672007|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
161672008|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
161672009|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
161672010|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
161672011|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
161672012|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
161672013|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
161672014|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
161672015|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Death|1|||
161672016|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Death|1|||
161672017|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
161672018|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
161672019|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
161672020|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
161672021|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
161672022|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
161672023|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
161672024|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
161672025|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
161672026|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
161817915|NCT02011945|584372958|FG002|Overall Study|Proceeded to stem cell transplant|1|||
161817916|NCT02011945|584372956|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
161672027|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
161672028|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
161817917|NCT02011945|584372957|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
161817918|NCT02011945|584372958|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
161817919|NCT03531827|584372959|FG000|Overall Study|Adverse Event|2|||
161493175|NCT02554812|583200171|FG001|Overall Study|Death|2|||
161493176|NCT02554812|583200172|FG002|Overall Study|Death|2|||
161493177|NCT02554812|583200173|FG003|Overall Study|Death|2|||
161493178|NCT02554812|583200174|FG004|Overall Study|Death|0|||
161493179|NCT02554812|583200175|FG005|Overall Study|Death|1|||
161493180|NCT02554812|583200176|FG006|Overall Study|Death|1|||
161493181|NCT02554812|583200177|FG007|Overall Study|Death|1|||
161493182|NCT02554812|583200178|FG008|Overall Study|Death|0|||
161493183|NCT02554812|583200179|FG009|Overall Study|Death|0|||
161493184|NCT02554812|583200180|FG010|Overall Study|Death|0|||
161493185|NCT02554812|583200181|FG011|Overall Study|Death|0|||
161493186|NCT02554812|583200182|FG012|Overall Study|Death|0|||
161493187|NCT02554812|583200183|FG013|Overall Study|Death|0|||
161493188|NCT02554812|583200184|FG014|Overall Study|Death|1|||
161493189|NCT02554812|583200185|FG015|Overall Study|Death|1|||
161493190|NCT02554812|583200186|FG016|Overall Study|Death|1|||
161493191|NCT02554812|583200187|FG017|Overall Study|Death|0|||
161493192|NCT02554812|583200188|FG018|Overall Study|Death|1|||
161493193|NCT02554812|583200189|FG019|Overall Study|Death|2|||
161493194|NCT02554812|583200190|FG020|Overall Study|Death|0|||
161493195|NCT02554812|583200191|FG021|Overall Study|Death|1|||
161493196|NCT02554812|583200192|FG022|Overall Study|Death|1|||
161493197|NCT02554812|583200193|FG023|Overall Study|Death|0|||
161493198|NCT02554812|583200194|FG024|Overall Study|Death|0|||
161493199|NCT02554812|583200195|FG025|Overall Study|Death|0|||
161493200|NCT02554812|583200196|FG026|Overall Study|Death|0|||
161493201|NCT02554812|583200170|FG000|Overall Study|Lost to Follow-up|0|||
161493202|NCT02554812|583200171|FG001|Overall Study|Lost to Follow-up|1|||
161493203|NCT02554812|583200172|FG002|Overall Study|Lost to Follow-up|0|||
161493204|NCT02554812|583200173|FG003|Overall Study|Lost to Follow-up|0|||
161493205|NCT02554812|583200174|FG004|Overall Study|Lost to Follow-up|0|||
161493206|NCT02554812|583200175|FG005|Overall Study|Lost to Follow-up|0|||
161493207|NCT02554812|583200176|FG006|Overall Study|Lost to Follow-up|0|||
161493208|NCT02554812|583200177|FG007|Overall Study|Lost to Follow-up|0|||
161493209|NCT02554812|583200178|FG008|Overall Study|Lost to Follow-up|0|||
161493210|NCT02554812|583200179|FG009|Overall Study|Lost to Follow-up|0|||
161493211|NCT02554812|583200180|FG010|Overall Study|Lost to Follow-up|0|||
161493212|NCT02554812|583200181|FG011|Overall Study|Lost to Follow-up|0|||
161493213|NCT02554812|583200182|FG012|Overall Study|Lost to Follow-up|0|||
161493214|NCT02554812|583200183|FG013|Overall Study|Lost to Follow-up|0|||
161493215|NCT02554812|583200184|FG014|Overall Study|Lost to Follow-up|0|||
161493216|NCT02554812|583200185|FG015|Overall Study|Lost to Follow-up|0|||
161493217|NCT02554812|583200186|FG016|Overall Study|Lost to Follow-up|0|||
161493218|NCT02554812|583200187|FG017|Overall Study|Lost to Follow-up|0|||
161493219|NCT02554812|583200188|FG018|Overall Study|Lost to Follow-up|0|||
161493220|NCT02554812|583200189|FG019|Overall Study|Lost to Follow-up|0|||
161493221|NCT02554812|583200190|FG020|Overall Study|Lost to Follow-up|0|||
161493222|NCT02554812|583200191|FG021|Overall Study|Lost to Follow-up|0|||
161493223|NCT02554812|583200192|FG022|Overall Study|Lost to Follow-up|0|||
161493224|NCT02554812|583200193|FG023|Overall Study|Lost to Follow-up|0|||
161493225|NCT02554812|583200194|FG024|Overall Study|Lost to Follow-up|0|||
161493226|NCT02554812|583200195|FG025|Overall Study|Lost to Follow-up|0|||
161493227|NCT02554812|583200196|FG026|Overall Study|Lost to Follow-up|0|||
161493228|NCT02554812|583200170|FG000|Overall Study|Global deterioration of health status|4|||
161493229|NCT02554812|583200171|FG001|Overall Study|Global deterioration of health status|3|||
161493230|NCT02554812|583200172|FG002|Overall Study|Global deterioration of health status|3|||
161493231|NCT02554812|583200173|FG003|Overall Study|Global deterioration of health status|2|||
161493232|NCT02554812|583200174|FG004|Overall Study|Global deterioration of health status|5|||
161493233|NCT02554812|583200175|FG005|Overall Study|Global deterioration of health status|0|||
161493234|NCT02554812|583200176|FG006|Overall Study|Global deterioration of health status|2|||
161493235|NCT02554812|583200177|FG007|Overall Study|Global deterioration of health status|1|||
161493236|NCT02554812|583200178|FG008|Overall Study|Global deterioration of health status|1|||
161493237|NCT02554812|583200179|FG009|Overall Study|Global deterioration of health status|1|||
161493238|NCT02554812|583200180|FG010|Overall Study|Global deterioration of health status|2|||
161584161|NCT03939312|583526086|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
161584162|NCT01609218|583526087|FG000|Period 1|Adverse Event|3|||
161584163|NCT01609218|583526088|FG001|Period 1|Adverse Event|5|||
161584164|NCT01609218|583526087|FG000|Period 1|Sponsor Decision|0|||
161584165|NCT01609218|583526088|FG001|Period 1|Sponsor Decision|1|||
161584166|NCT01609218|583526087|FG000|Period 2|Adverse Event|1|||
161584167|NCT01609218|583526088|FG001|Period 2|Adverse Event|0|||
161584168|NCT02807779|583526089|FG000|Overall Study|Lost to Follow-up|1|||
161584169|NCT02807779|583526090|FG001|Overall Study|Lost to Follow-up|0|||
161493239|NCT02554812|583200181|FG011|Overall Study|Global deterioration of health status|1|||
161493240|NCT02554812|583200182|FG012|Overall Study|Global deterioration of health status|0|||
161493241|NCT02554812|583200183|FG013|Overall Study|Global deterioration of health status|0|||
161493242|NCT02554812|583200184|FG014|Overall Study|Global deterioration of health status|0|||
161493243|NCT02554812|583200185|FG015|Overall Study|Global deterioration of health status|1|||
161493244|NCT02554812|583200186|FG016|Overall Study|Global deterioration of health status|0|||
161493245|NCT02554812|583200187|FG017|Overall Study|Global deterioration of health status|0|||
161493246|NCT02554812|583200188|FG018|Overall Study|Global deterioration of health status|0|||
161493247|NCT02554812|583200189|FG019|Overall Study|Global deterioration of health status|0|||
161584170|NCT02807779|583526091|FG002|Overall Study|Lost to Follow-up|0|||
161584171|NCT02807779|583526089|FG000|Overall Study|Physician Decision|2|||
161493248|NCT02554812|583200190|FG020|Overall Study|Global deterioration of health status|0|||
161493249|NCT02554812|583200191|FG021|Overall Study|Global deterioration of health status|0|||
161493250|NCT02554812|583200192|FG022|Overall Study|Global deterioration of health status|0|||
161493251|NCT02554812|583200193|FG023|Overall Study|Global deterioration of health status|0|||
161493252|NCT02554812|583200194|FG024|Overall Study|Global deterioration of health status|0|||
161493253|NCT02554812|583200195|FG025|Overall Study|Global deterioration of health status|0|||
161493254|NCT02554812|583200196|FG026|Overall Study|Global deterioration of health status|0|||
161493255|NCT02554812|583200170|FG000|Overall Study|Progressive disease|20|||
161493256|NCT02554812|583200171|FG001|Overall Study|Progressive disease|16|||
161493257|NCT02554812|583200172|FG002|Overall Study|Progressive disease|19|||
161493258|NCT02554812|583200173|FG003|Overall Study|Progressive disease|18|||
161493259|NCT02554812|583200174|FG004|Overall Study|Progressive disease|21|||
161493260|NCT02554812|583200175|FG005|Overall Study|Progressive disease|15|||
161493261|NCT02554812|583200176|FG006|Overall Study|Progressive disease|6|||
161493262|NCT02554812|583200177|FG007|Overall Study|Progressive disease|13|||
161493263|NCT02554812|583200178|FG008|Overall Study|Progressive disease|6|||
161493264|NCT02554812|583200179|FG009|Overall Study|Progressive disease|6|||
161493265|NCT02554812|583200180|FG010|Overall Study|Progressive disease|8|||
161493266|NCT02554812|583200181|FG011|Overall Study|Progressive disease|8|||
161493267|NCT02554812|583200182|FG012|Overall Study|Progressive disease|6|||
161493268|NCT02554812|583200183|FG013|Overall Study|Progressive disease|10|||
161493269|NCT02554812|583200184|FG014|Overall Study|Progressive disease|20|||
161493270|NCT02554812|583200185|FG015|Overall Study|Progressive disease|6|||
161493271|NCT02554812|583200186|FG016|Overall Study|Progressive disease|3|||
161493272|NCT02554812|583200187|FG017|Overall Study|Progressive disease|3|||
161493273|NCT02554812|583200188|FG018|Overall Study|Progressive disease|11|||
161493274|NCT02554812|583200189|FG019|Overall Study|Progressive disease|7|||
161672029|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
161493275|NCT02554812|583200190|FG020|Overall Study|Progressive disease|11|||
161493276|NCT02554812|583200191|FG021|Overall Study|Progressive disease|6|||
161493277|NCT02554812|583200192|FG022|Overall Study|Progressive disease|9|||
161493278|NCT02554812|583200193|FG023|Overall Study|Progressive disease|9|||
161493279|NCT02554812|583200194|FG024|Overall Study|Progressive disease|4|||
161493280|NCT02554812|583200195|FG025|Overall Study|Progressive disease|5|||
161493281|NCT02554812|583200196|FG026|Overall Study|Progressive disease|5|||
161493282|NCT02554812|583200170|FG000|Overall Study|Other|0|||
161493283|NCT02554812|583200171|FG001|Overall Study|Other|0|||
161493284|NCT02554812|583200172|FG002|Overall Study|Other|2|||
161493285|NCT02554812|583200173|FG003|Overall Study|Other|3|||
161493286|NCT02554812|583200174|FG004|Overall Study|Other|2|||
161493287|NCT02554812|583200175|FG005|Overall Study|Other|1|||
161493288|NCT02554812|583200176|FG006|Overall Study|Other|0|||
161493289|NCT02554812|583200177|FG007|Overall Study|Other|0|||
161493290|NCT02554812|583200178|FG008|Overall Study|Other|1|||
161493291|NCT02554812|583200179|FG009|Overall Study|Other|1|||
161493292|NCT02554812|583200180|FG010|Overall Study|Other|0|||
161493293|NCT02554812|583200181|FG011|Overall Study|Other|0|||
161493294|NCT02554812|583200182|FG012|Overall Study|Other|1|||
161493295|NCT02554812|583200183|FG013|Overall Study|Other|0|||
161493296|NCT02554812|583200184|FG014|Overall Study|Other|1|||
161493297|NCT02554812|583200185|FG015|Overall Study|Other|0|||
161584172|NCT02807779|583526090|FG001|Overall Study|Physician Decision|0|||
161584173|NCT02807779|583526091|FG002|Overall Study|Physician Decision|1|||
161584174|NCT02807779|583526089|FG000|Overall Study|Death|1|||
161584175|NCT02807779|583526090|FG001|Overall Study|Death|1|||
161584176|NCT02807779|583526091|FG002|Overall Study|Death|0|||
161584177|NCT02576509|583527932|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
161584178|NCT02576509|583527933|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
161584179|NCT02576509|583527932|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161584180|NCT02576509|583527933|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
161584181|NCT02576509|583527932|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
161584182|NCT02576509|583527933|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
161584183|NCT02576509|583527932|FG000|Treatment Period|Disease progression|263|||
161584184|NCT02576509|583527933|FG001|Treatment Period|Disease progression|244|||
161584185|NCT02576509|583527932|FG000|Treatment Period|Study drug toxicity|37|||
161493298|NCT02554812|583200186|FG016|Overall Study|Other|0|||
161493299|NCT02554812|583200187|FG017|Overall Study|Other|0|||
161493300|NCT02554812|583200188|FG018|Overall Study|Other|0|||
161493301|NCT02554812|583200189|FG019|Overall Study|Other|0|||
161493302|NCT02554812|583200190|FG020|Overall Study|Other|0|||
161493303|NCT02554812|583200191|FG021|Overall Study|Other|2|||
161584186|NCT02576509|583527933|FG001|Treatment Period|Study drug toxicity|41|||
161493304|NCT02554812|583200192|FG022|Overall Study|Other|0|||
161493305|NCT02554812|583200193|FG023|Overall Study|Other|0|||
161493306|NCT02554812|583200194|FG024|Overall Study|Other|0|||
161493307|NCT02554812|583200195|FG025|Overall Study|Other|0|||
161493308|NCT02554812|583200196|FG026|Overall Study|Other|0|||
161493309|NCT02554812|583200170|FG000|Overall Study|Withdrawal by Subject|1|||
161493310|NCT02554812|583200171|FG001|Overall Study|Withdrawal by Subject|0|||
161584187|NCT02576509|583527932|FG000|Treatment Period|Death|1|||
161672030|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
161672031|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
161672032|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
161672033|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
161672034|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
161672035|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
161672036|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
161672037|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
161672038|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
161672039|NCT00559585|583853016|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
161672040|NCT00559585|583853017|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
161672041|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
161672042|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
161672043|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
161672044|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
161672045|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
161672046|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
161672047|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
161672048|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
161672049|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
161672050|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
161672051|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
161672052|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
161672053|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
161672054|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
161672055|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
161672056|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
161672057|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
161672058|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
161672059|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
161672060|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
161672061|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
161672062|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
161672063|NCT04209621|583853018|FG000|Overall Study|Death|1|||
161672064|NCT04209621|583853018|FG000|Overall Study|Study Terminated Early|2|||
161672065|NCT02249767|583853019|FG000|Overall Study|Did not use medication|8|||
161672066|NCT02249767|583853020|FG001|Overall Study|Did not use medication|9|||
161672067|NCT02249767|583853021|FG002|Overall Study|Did not use medication|8|||
161672068|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161672069|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161672070|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672071|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672072|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161672073|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161923967|NCT04925934|584768119|FG002|Overall Study|Adverse Event|0|||
161672074|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672075|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672076|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672077|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
161672078|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672079|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672080|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
161923968|NCT04925934|584768117|FG000|Overall Study|Lost to Follow-up|2|||
161923969|NCT04925934|584768118|FG001|Overall Study|Lost to Follow-up|0|||
161923970|NCT04925934|584768119|FG002|Overall Study|Lost to Follow-up|1|||
161923971|NCT04925934|584768117|FG000|Overall Study|Death|0|||
161923972|NCT04925934|584768118|FG001|Overall Study|Death|1|||
161923973|NCT04925934|584768119|FG002|Overall Study|Death|0|||
161923974|NCT04925934|584768117|FG000|Overall Study|Withdrawal by Subject|8|||
161923975|NCT04925934|584768118|FG001|Overall Study|Withdrawal by Subject|5|||
161923976|NCT04925934|584768119|FG002|Overall Study|Withdrawal by Subject|9|||
161923977|NCT04925934|584768117|FG000|Overall Study|Other|2|||
161923978|NCT04925934|584768118|FG001|Overall Study|Other|2|||
161923979|NCT04925934|584768119|FG002|Overall Study|Other|2|||
161923980|NCT04925934|584768117|FG000|Overall Study|Eastern European Conflict|7|||
161923981|NCT04925934|584768118|FG001|Overall Study|Eastern European Conflict|3|||
161923982|NCT04925934|584768119|FG002|Overall Study|Eastern European Conflict|2|||
161923983|NCT04425018|584768120|FG000|Overall Study|Withdrawal by Subject|1|||
161672081|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672082|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
161672083|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672084|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161672085|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161923984|NCT04425018|584768121|FG001|Overall Study|Withdrawal by Subject|2|||
161923985|NCT02503865|584768122|FG000|Overall Study|Moved out of area|1|||
161923986|NCT02503865|584768123|FG001|Overall Study|Moved out of area|8|||
161923987|NCT02503865|584768124|FG002|Overall Study|Moved out of area|0|||
161923988|NCT02503865|584768122|FG000|Overall Study|Refused treatment|4|||
161923989|NCT02503865|584768123|FG001|Overall Study|Refused treatment|39|||
161923990|NCT02503865|584768124|FG002|Overall Study|Refused treatment|2|||
161923991|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
161923992|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
161923993|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
161923994|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
161923995|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
161923996|NCT00849472|584768133|FG000|Weekly Paclitaxel|Disease Progression|1|||
161923997|NCT00849472|584768133|FG000|Weekly Paclitaxel|Adverse Event|11|||
161923998|NCT00849472|584768133|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
161923999|NCT00849472|584768133|FG000|Weekly Paclitaxel|Physician Decision|3|||
161924000|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
161924001|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
161924002|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
161924003|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
161924004|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
161924005|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
161924006|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
161924007|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
161924008|NCT05128942|584768134|FG000|Overall Study|Withdrawal by Subject|1|||
161924009|NCT05128942|584768135|FG001|Overall Study|Withdrawal by Subject|0|||
161924010|NCT05128942|584768136|FG002|Overall Study|Withdrawal by Subject|1|||
161924011|NCT05128942|584768137|FG003|Overall Study|Withdrawal by Subject|0|||
161924012|NCT05128942|584768138|FG004|Overall Study|Withdrawal by Subject|0|||
161924013|NCT05128942|584768139|FG005|Overall Study|Withdrawal by Subject|0|||
161924014|NCT05128942|584768140|FG006|Overall Study|Withdrawal by Subject|0|||
161924015|NCT05128942|584768141|FG007|Overall Study|Withdrawal by Subject|0|||
161924016|NCT05128942|584768142|FG008|Overall Study|Withdrawal by Subject|0|||
161924017|NCT05128942|584768134|FG000|Overall Study|Other|2|||
161924018|NCT05128942|584768135|FG001|Overall Study|Other|0|||
161924019|NCT05128942|584768136|FG002|Overall Study|Other|2|||
161924020|NCT05128942|584768137|FG003|Overall Study|Other|0|||
161924021|NCT05128942|584768138|FG004|Overall Study|Other|0|||
161924022|NCT05128942|584768139|FG005|Overall Study|Other|0|||
161924023|NCT05128942|584768140|FG006|Overall Study|Other|0|||
161924024|NCT05128942|584768141|FG007|Overall Study|Other|0|||
161924025|NCT05128942|584768142|FG008|Overall Study|Other|0|||
161924026|NCT05128942|584768134|FG000|Overall Study|Termination by Sponsor|2|||
161924027|NCT05128942|584768135|FG001|Overall Study|Termination by Sponsor|6|||
161924028|NCT05128942|584768136|FG002|Overall Study|Termination by Sponsor|14|||
161924029|NCT05128942|584768137|FG003|Overall Study|Termination by Sponsor|2|||
161924030|NCT05128942|584768138|FG004|Overall Study|Termination by Sponsor|4|||
161924031|NCT05128942|584768139|FG005|Overall Study|Termination by Sponsor|8|||
161924032|NCT05128942|584768140|FG006|Overall Study|Termination by Sponsor|11|||
161924033|NCT05128942|584768141|FG007|Overall Study|Termination by Sponsor|6|||
161924034|NCT05128942|584768142|FG008|Overall Study|Termination by Sponsor|0|||
161924035|NCT05128942|584768134|FG000|Overall Study|Adverse Event|0|||
161924036|NCT05128942|584768135|FG001|Overall Study|Adverse Event|0|||
161924037|NCT05128942|584768136|FG002|Overall Study|Adverse Event|0|||
161924038|NCT05128942|584768137|FG003|Overall Study|Adverse Event|0|||
161924039|NCT05128942|584768138|FG004|Overall Study|Adverse Event|0|||
161924040|NCT05128942|584768139|FG005|Overall Study|Adverse Event|0|||
161924041|NCT05128942|584768140|FG006|Overall Study|Adverse Event|1|||
161924042|NCT05128942|584768141|FG007|Overall Study|Adverse Event|1|||
161924043|NCT05128942|584768142|FG008|Overall Study|Adverse Event|0|||
161924044|NCT05128942|584768134|FG000|Overall Study|Lost to Follow-up|0|||
161924045|NCT05128942|584768135|FG001|Overall Study|Lost to Follow-up|0|||
161924046|NCT05128942|584768136|FG002|Overall Study|Lost to Follow-up|0|||
161924047|NCT05128942|584768137|FG003|Overall Study|Lost to Follow-up|0|||
161924048|NCT05128942|584768138|FG004|Overall Study|Lost to Follow-up|1|||
161924049|NCT05128942|584768139|FG005|Overall Study|Lost to Follow-up|0|||
161924050|NCT05128942|584768140|FG006|Overall Study|Lost to Follow-up|0|||
161493311|NCT02554812|583200172|FG002|Overall Study|Withdrawal by Subject|0|||
161493312|NCT02554812|583200173|FG003|Overall Study|Withdrawal by Subject|2|||
161493313|NCT02554812|583200174|FG004|Overall Study|Withdrawal by Subject|2|||
161493314|NCT02554812|583200175|FG005|Overall Study|Withdrawal by Subject|3|||
161493315|NCT02554812|583200176|FG006|Overall Study|Withdrawal by Subject|0|||
161493316|NCT02554812|583200177|FG007|Overall Study|Withdrawal by Subject|0|||
161493317|NCT02554812|583200178|FG008|Overall Study|Withdrawal by Subject|1|||
161493318|NCT02554812|583200179|FG009|Overall Study|Withdrawal by Subject|1|||
161493319|NCT02554812|583200180|FG010|Overall Study|Withdrawal by Subject|0|||
161493320|NCT02554812|583200181|FG011|Overall Study|Withdrawal by Subject|1|||
161493321|NCT02554812|583200182|FG012|Overall Study|Withdrawal by Subject|1|||
161493322|NCT02554812|583200183|FG013|Overall Study|Withdrawal by Subject|1|||
161493323|NCT02554812|583200184|FG014|Overall Study|Withdrawal by Subject|1|||
161493324|NCT02554812|583200185|FG015|Overall Study|Withdrawal by Subject|1|||
161493325|NCT02554812|583200186|FG016|Overall Study|Withdrawal by Subject|3|||
161493326|NCT02554812|583200187|FG017|Overall Study|Withdrawal by Subject|1|||
161493327|NCT02554812|583200188|FG018|Overall Study|Withdrawal by Subject|0|||
161493328|NCT02554812|583200189|FG019|Overall Study|Withdrawal by Subject|2|||
161493329|NCT02554812|583200190|FG020|Overall Study|Withdrawal by Subject|0|||
161493330|NCT02554812|583200191|FG021|Overall Study|Withdrawal by Subject|1|||
161493331|NCT02554812|583200192|FG022|Overall Study|Withdrawal by Subject|0|||
161493332|NCT02554812|583200193|FG023|Overall Study|Withdrawal by Subject|1|||
161493333|NCT02554812|583200194|FG024|Overall Study|Withdrawal by Subject|0|||
161493334|NCT02554812|583200195|FG025|Overall Study|Withdrawal by Subject|0|||
161493335|NCT02554812|583200196|FG026|Overall Study|Withdrawal by Subject|1|||
161493336|NCT02554812|583200170|FG000|Overall Study|Physician Decision|1|||
161493337|NCT02554812|583200171|FG001|Overall Study|Physician Decision|0|||
161493338|NCT02554812|583200172|FG002|Overall Study|Physician Decision|0|||
161493339|NCT02554812|583200173|FG003|Overall Study|Physician Decision|1|||
161493340|NCT02554812|583200174|FG004|Overall Study|Physician Decision|0|||
161493341|NCT02554812|583200175|FG005|Overall Study|Physician Decision|1|||
161493342|NCT02554812|583200176|FG006|Overall Study|Physician Decision|0|||
161493343|NCT02554812|583200177|FG007|Overall Study|Physician Decision|0|||
161493344|NCT02554812|583200178|FG008|Overall Study|Physician Decision|0|||
161493345|NCT02554812|583200179|FG009|Overall Study|Physician Decision|0|||
161493346|NCT02554812|583200180|FG010|Overall Study|Physician Decision|1|||
161493347|NCT02554812|583200181|FG011|Overall Study|Physician Decision|0|||
161493348|NCT02554812|583200182|FG012|Overall Study|Physician Decision|0|||
161493349|NCT02554812|583200183|FG013|Overall Study|Physician Decision|0|||
161493350|NCT02554812|583200184|FG014|Overall Study|Physician Decision|0|||
161493351|NCT02554812|583200185|FG015|Overall Study|Physician Decision|0|||
161493352|NCT02554812|583200186|FG016|Overall Study|Physician Decision|1|||
161493353|NCT02554812|583200187|FG017|Overall Study|Physician Decision|1|||
161493354|NCT02554812|583200188|FG018|Overall Study|Physician Decision|0|||
161493355|NCT02554812|583200189|FG019|Overall Study|Physician Decision|1|||
161493356|NCT02554812|583200190|FG020|Overall Study|Physician Decision|1|||
161493357|NCT02554812|583200191|FG021|Overall Study|Physician Decision|0|||
161493358|NCT02554812|583200192|FG022|Overall Study|Physician Decision|1|||
161493359|NCT02554812|583200193|FG023|Overall Study|Physician Decision|0|||
161493360|NCT02554812|583200194|FG024|Overall Study|Physician Decision|0|||
161493361|NCT02554812|583200195|FG025|Overall Study|Physician Decision|0|||
161493362|NCT02554812|583200196|FG026|Overall Study|Physician Decision|0|||
161493363|NCT02554812|583200170|FG000|Overall Study|Study terminated by sponsor|0|||
161493364|NCT02554812|583200171|FG001|Overall Study|Study terminated by sponsor|0|||
161493365|NCT02554812|583200172|FG002|Overall Study|Study terminated by sponsor|0|||
161493366|NCT02554812|583200173|FG003|Overall Study|Study terminated by sponsor|0|||
161493367|NCT02554812|583200174|FG004|Overall Study|Study terminated by sponsor|0|||
161493368|NCT02554812|583200175|FG005|Overall Study|Study terminated by sponsor|0|||
161493369|NCT02554812|583200176|FG006|Overall Study|Study terminated by sponsor|0|||
161493370|NCT02554812|583200177|FG007|Overall Study|Study terminated by sponsor|0|||
161493371|NCT02554812|583200178|FG008|Overall Study|Study terminated by sponsor|0|||
161493372|NCT02554812|583200179|FG009|Overall Study|Study terminated by sponsor|0|||
161493373|NCT02554812|583200180|FG010|Overall Study|Study terminated by sponsor|0|||
161493374|NCT02554812|583200181|FG011|Overall Study|Study terminated by sponsor|0|||
161493375|NCT02554812|583200182|FG012|Overall Study|Study terminated by sponsor|0|||
161493376|NCT02554812|583200183|FG013|Overall Study|Study terminated by sponsor|0|||
161493377|NCT02554812|583200184|FG014|Overall Study|Study terminated by sponsor|0|||
161493378|NCT02554812|583200185|FG015|Overall Study|Study terminated by sponsor|0|||
161493379|NCT02554812|583200186|FG016|Overall Study|Study terminated by sponsor|0|||
161493380|NCT02554812|583200187|FG017|Overall Study|Study terminated by sponsor|0|||
161672086|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161493381|NCT02554812|583200188|FG018|Overall Study|Study terminated by sponsor|0|||
161493382|NCT02554812|583200189|FG019|Overall Study|Study terminated by sponsor|0|||
161493383|NCT02554812|583200190|FG020|Overall Study|Study terminated by sponsor|0|||
161493384|NCT02554812|583200191|FG021|Overall Study|Study terminated by sponsor|0|||
161493385|NCT02554812|583200192|FG022|Overall Study|Study terminated by sponsor|0|||
161493386|NCT02554812|583200193|FG023|Overall Study|Study terminated by sponsor|0|||
161493387|NCT02554812|583200194|FG024|Overall Study|Study terminated by sponsor|1|||
161493388|NCT02554812|583200195|FG025|Overall Study|Study terminated by sponsor|0|||
161493389|NCT02554812|583200196|FG026|Overall Study|Study terminated by sponsor|0|||
161493390|NCT02554812|583200170|FG000|Overall Study|No longer meets eligibility criteria|0|||
161493391|NCT02554812|583200171|FG001|Overall Study|No longer meets eligibility criteria|1|||
161493392|NCT02554812|583200172|FG002|Overall Study|No longer meets eligibility criteria|0|||
161493393|NCT02554812|583200173|FG003|Overall Study|No longer meets eligibility criteria|0|||
161493394|NCT02554812|583200174|FG004|Overall Study|No longer meets eligibility criteria|0|||
161493395|NCT02554812|583200175|FG005|Overall Study|No longer meets eligibility criteria|0|||
161493396|NCT02554812|583200176|FG006|Overall Study|No longer meets eligibility criteria|0|||
161493397|NCT02554812|583200177|FG007|Overall Study|No longer meets eligibility criteria|0|||
161493398|NCT02554812|583200178|FG008|Overall Study|No longer meets eligibility criteria|0|||
161493399|NCT02554812|583200179|FG009|Overall Study|No longer meets eligibility criteria|0|||
161493400|NCT02554812|583200180|FG010|Overall Study|No longer meets eligibility criteria|0|||
161493401|NCT02554812|583200181|FG011|Overall Study|No longer meets eligibility criteria|0|||
161493402|NCT02554812|583200182|FG012|Overall Study|No longer meets eligibility criteria|0|||
161493403|NCT02554812|583200183|FG013|Overall Study|No longer meets eligibility criteria|0|||
161493404|NCT02554812|583200184|FG014|Overall Study|No longer meets eligibility criteria|0|||
161493405|NCT02554812|583200185|FG015|Overall Study|No longer meets eligibility criteria|0|||
161493406|NCT02554812|583200186|FG016|Overall Study|No longer meets eligibility criteria|0|||
161493407|NCT02554812|583200187|FG017|Overall Study|No longer meets eligibility criteria|0|||
161493408|NCT02554812|583200188|FG018|Overall Study|No longer meets eligibility criteria|0|||
161493409|NCT02554812|583200189|FG019|Overall Study|No longer meets eligibility criteria|0|||
161493410|NCT02554812|583200190|FG020|Overall Study|No longer meets eligibility criteria|0|||
161493411|NCT02554812|583200191|FG021|Overall Study|No longer meets eligibility criteria|0|||
161493412|NCT02554812|583200192|FG022|Overall Study|No longer meets eligibility criteria|0|||
161493413|NCT02554812|583200193|FG023|Overall Study|No longer meets eligibility criteria|0|||
161493414|NCT02554812|583200194|FG024|Overall Study|No longer meets eligibility criteria|0|||
161493415|NCT02554812|583200195|FG025|Overall Study|No longer meets eligibility criteria|0|||
161493416|NCT02554812|583200196|FG026|Overall Study|No longer meets eligibility criteria|0|||
161493417|NCT02879305|583200197|FG000|Overall Study|Investigator Site Closed|55|||
161493418|NCT02879305|583200198|FG001|Overall Study|Investigator Site Closed|57|||
161493419|NCT02879305|583200197|FG000|Overall Study|Withdrawal by Subject|44|||
161493420|NCT02879305|583200198|FG001|Overall Study|Withdrawal by Subject|42|||
161493421|NCT02879305|583200197|FG000|Overall Study|Lost to Follow-up|17|||
161493422|NCT02879305|583200198|FG001|Overall Study|Lost to Follow-up|12|||
161817920|NCT03531827|584372960|FG001|Overall Study|Adverse Event|0|||
161817921|NCT03531827|584372959|FG000|Overall Study|Progressive disease|1|||
161493423|NCT02879305|583200197|FG000|Overall Study|Other|1|||
161493424|NCT02879305|583200198|FG001|Overall Study|Other|0|||
161493425|NCT01786629|583202235|FG000|Overall Study|Lack of Efficacy|0|||
161493426|NCT01786629|583202236|FG001|Overall Study|Lack of Efficacy|4|||
161493427|NCT01786629|583202235|FG000|Overall Study|Adverse Event|0|||
161493428|NCT01786629|583202236|FG001|Overall Study|Adverse Event|1|||
161493429|NCT00180414|583202237|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
161493430|NCT00180414|583202238|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
161493431|NCT00613938|583202239|FG000|Overall Study|Withdrawal by Subject|2|||
161493432|NCT00613938|583202240|FG001|Overall Study|Withdrawal by Subject|4|||
161493433|NCT00613938|583202241|FG002|Overall Study|Withdrawal by Subject|9|||
161493434|NCT00613938|583202242|FG003|Overall Study|Withdrawal by Subject|9|||
161493435|NCT00613938|583202239|FG000|Overall Study|Adverse Event|1|||
161493436|NCT00613938|583202240|FG001|Overall Study|Adverse Event|4|||
161493437|NCT00613938|583202241|FG002|Overall Study|Adverse Event|8|||
161493438|NCT00613938|583202242|FG003|Overall Study|Adverse Event|5|||
161493439|NCT00613938|583202239|FG000|Overall Study|Lack of Efficacy|16|||
161493440|NCT00613938|583202240|FG001|Overall Study|Lack of Efficacy|18|||
161493441|NCT00613938|583202241|FG002|Overall Study|Lack of Efficacy|5|||
161493442|NCT00613938|583202242|FG003|Overall Study|Lack of Efficacy|9|||
161493443|NCT00613938|583202239|FG000|Overall Study|Other|1|||
161493444|NCT00613938|583202240|FG001|Overall Study|Other|2|||
161493445|NCT00613938|583202241|FG002|Overall Study|Other|1|||
161493446|NCT00613938|583202242|FG003|Overall Study|Other|3|||
161493447|NCT03025542|583202243|FG000|Overall Study|Adverse Event|0|||
161493448|NCT03025542|583202244|FG001|Overall Study|Adverse Event|2|||
161493449|NCT03025542|583202243|FG000|Overall Study|Lost to Follow-up|1|||
161493450|NCT03025542|583202244|FG001|Overall Study|Lost to Follow-up|0|||
161493451|NCT03025542|583202243|FG000|Overall Study|Withdrawal by Subject|1|||
161493452|NCT03025542|583202244|FG001|Overall Study|Withdrawal by Subject|0|||
161493453|NCT00488345|583202245|FG000|Overall Study|Adverse Event|0|||
161493454|NCT00488345|583202246|FG001|Overall Study|Adverse Event|1|||
161493455|NCT00488345|583202247|FG002|Overall Study|Adverse Event|1|||
161584188|NCT02576509|583527933|FG001|Treatment Period|Death|1|||
161584189|NCT02576509|583527932|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
161817922|NCT03531827|584372960|FG001|Overall Study|Progressive disease|0|||
161817923|NCT03067987|584372961|FG000|Overall Study|Lost to Follow-up|7|||
161493456|NCT00488345|583202245|FG000|Overall Study|Unable to administer antibiotics at home|0|||
161493457|NCT00488345|583202246|FG001|Overall Study|Unable to administer antibiotics at home|1|||
161493458|NCT00488345|583202247|FG002|Overall Study|Unable to administer antibiotics at home|0|||
161493459|NCT00488345|583202245|FG000|Overall Study|Institutional Review Board review|0|||
161493460|NCT00488345|583202246|FG001|Overall Study|Institutional Review Board review|0|||
161493461|NCT00488345|583202247|FG002|Overall Study|Institutional Review Board review|1|||
161493462|NCT00488345|583202245|FG000|Overall Study|Surgical team recommendation|0|||
161493463|NCT00488345|583202246|FG001|Overall Study|Surgical team recommendation|1|||
161493464|NCT00488345|583202247|FG002|Overall Study|Surgical team recommendation|0|||
161493465|NCT00488345|583202245|FG000|Overall Study|Parent/legal guardian request|0|||
161493466|NCT00488345|583202246|FG001|Overall Study|Parent/legal guardian request|1|||
161493467|NCT00488345|583202247|FG002|Overall Study|Parent/legal guardian request|1|||
161493468|NCT04708886|583202253|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
161493469|NCT04708886|583202253|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
161493470|NCT01853046|583202254|FG000|Overall Study|Withdrawal by Subject|1|||
161493471|NCT01853046|583202255|FG001|Overall Study|Withdrawal by Subject|1|||
161493472|NCT01853046|583202254|FG000|Overall Study|Adverse Event|4|||
161493473|NCT01853046|583202255|FG001|Overall Study|Adverse Event|2|||
161493474|NCT01853046|583202254|FG000|Overall Study|Disease progression|13|||
161493475|NCT01853046|583202255|FG001|Overall Study|Disease progression|3|||
161493476|NCT03020407|583202257|FG000|Overall Study|Withdrawal by Subject|2|||
161493477|NCT03020407|583202258|FG001|Overall Study|Withdrawal by Subject|1|||
161493478|NCT03020407|583202257|FG000|Overall Study|Lost to Follow-up|2|||
161493479|NCT03020407|583202258|FG001|Overall Study|Lost to Follow-up|3|||
161493480|NCT03020407|583202257|FG000|Overall Study|Protocol Violation|0|||
161493481|NCT03020407|583202258|FG001|Overall Study|Protocol Violation|1|||
161493482|NCT01585428|583202259|FG000|Overall Study|Death during treatment|1|||
161493483|NCT01585428|583202260|FG001|Overall Study|Death during treatment|0|||
161493484|NCT00708162|583202261|FG000|Randomized Phase|Randomized but Not Treated|7|||
161493485|NCT00708162|583202262|FG001|Randomized Phase|Randomized but Not Treated|5|||
161493486|NCT00708162|583202261|FG000|Randomized Phase|Participant Noncompliance|40|||
161493487|NCT00708162|583202262|FG001|Randomized Phase|Participant Noncompliance|32|||
161493488|NCT00708162|583202261|FG000|Randomized Phase|Lost to Follow-up|34|||
161493489|NCT00708162|583202262|FG001|Randomized Phase|Lost to Follow-up|34|||
161493490|NCT00708162|583202261|FG000|Randomized Phase|Withdrew Consent|31|||
161493491|NCT00708162|583202262|FG001|Randomized Phase|Withdrew Consent|22|||
161493492|NCT00708162|583202261|FG000|Randomized Phase|Lack of Efficacy|14|||
161493493|NCT00708162|583202262|FG001|Randomized Phase|Lack of Efficacy|19|||
161493494|NCT00708162|583202261|FG000|Randomized Phase|Protocol Violation|10|||
161493495|NCT00708162|583202262|FG001|Randomized Phase|Protocol Violation|11|||
161493496|NCT00708162|583202261|FG000|Randomized Phase|Adverse Event|8|||
161493497|NCT00708162|583202262|FG001|Randomized Phase|Adverse Event|12|||
161493498|NCT00708162|583202261|FG000|Randomized Phase|Investigator's Discretion|7|||
161493499|NCT00708162|583202262|FG001|Randomized Phase|Investigator's Discretion|10|||
161493500|NCT00708162|583202261|FG000|Randomized Phase|Death|2|||
161493501|NCT00708162|583202262|FG001|Randomized Phase|Death|9|||
161493502|NCT00708162|583202261|FG000|Randomized Phase|Pregnancy|3|||
161493503|NCT00708162|583202262|FG001|Randomized Phase|Pregnancy|0|||
161493504|NCT00708162|583202261|FG000|Open-Label Phase|Lost to Follow-up|10|||
161493505|NCT00708162|583202262|FG001|Open-Label Phase|Lost to Follow-up|8|||
161493506|NCT00708162|583202261|FG000|Open-Label Phase|Withdrew Consent|12|||
161493507|NCT00708162|583202262|FG001|Open-Label Phase|Withdrew Consent|6|||
161493508|NCT00708162|583202261|FG000|Open-Label Phase|Participant Noncompliance|7|||
161493509|NCT00708162|583202262|FG001|Open-Label Phase|Participant Noncompliance|7|||
161817924|NCT03067987|584372962|FG001|Overall Study|Lost to Follow-up|10|||
161493510|NCT00708162|583202261|FG000|Open-Label Phase|Lack of Efficacy|7|||
161493511|NCT00708162|583202262|FG001|Open-Label Phase|Lack of Efficacy|4|||
161493512|NCT00708162|583202261|FG000|Open-Label Phase|Investigator's Discretion|3|||
161493513|NCT00708162|583202262|FG001|Open-Label Phase|Investigator's Discretion|2|||
161584190|NCT02576509|583527933|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
161584191|NCT02576509|583527932|FG000|Treatment Period|Participant request to stop treatment|8|||
161584192|NCT02576509|583527933|FG001|Treatment Period|Participant request to stop treatment|18|||
161817925|NCT03067987|584372961|FG000|Overall Study|Protocol Violation|1|||
161493514|NCT00708162|583202261|FG000|Open-Label Phase|Death|3|||
161493515|NCT00708162|583202262|FG001|Open-Label Phase|Death|1|||
161493516|NCT00708162|583202261|FG000|Open-Label Phase|Adverse Event|1|||
161493517|NCT00708162|583202262|FG001|Open-Label Phase|Adverse Event|2|||
161493518|NCT00708162|583202261|FG000|Open-Label Phase|Other|1|||
161493519|NCT00708162|583202262|FG001|Open-Label Phase|Other|0|||
161493520|NCT02699554|583202263|FG000|Overall Study|Lost to Follow-up|9|||
161493521|NCT00788151|583202264|FG000|Overall Study|Other adverse event|0|||
161493522|NCT00788151|583202265|FG001|Overall Study|Other adverse event|2|||
161493523|NCT00788151|583202264|FG000|Overall Study|Protocol Violation|0|||
161493524|NCT00788151|583202265|FG001|Overall Study|Protocol Violation|1|||
161493525|NCT00788151|583202264|FG000|Overall Study|Withdrawal by Subject|13|||
161493526|NCT00788151|583202265|FG001|Overall Study|Withdrawal by Subject|6|||
161493527|NCT00788151|583202264|FG000|Overall Study|Enrolled but not treated|1|||
161493528|NCT00788151|583202265|FG001|Overall Study|Enrolled but not treated|1|||
161493529|NCT02057198|583202266|FG000|Overall Study|Death|0|||
161493530|NCT02057198|583202267|FG001|Overall Study|Death|0|||
161493531|NCT02057198|583202268|FG002|Overall Study|Death|1|||
161493532|NCT02057198|583202266|FG000|Overall Study|Discharged early; lost to followup|0|||
161493533|NCT02057198|583202267|FG001|Overall Study|Discharged early; lost to followup|1|||
161493534|NCT02057198|583202268|FG002|Overall Study|Discharged early; lost to followup|0|||
161493535|NCT00503009|583202271|FG000|Overall Study|Protocol Violation|1|||
161493536|NCT00503009|583202272|FG001|Overall Study|Protocol Violation|0|||
161493537|NCT00503009|583202273|FG002|Overall Study|Protocol Violation|1|||
161493538|NCT00503009|583202271|FG000|Overall Study|Withdrawal by Subject|0|||
161493539|NCT00503009|583202272|FG001|Overall Study|Withdrawal by Subject|1|||
161493540|NCT00503009|583202273|FG002|Overall Study|Withdrawal by Subject|1|||
161493541|NCT00503009|583202271|FG000|Overall Study|Physician Decision|0|||
161493542|NCT00503009|583202272|FG001|Overall Study|Physician Decision|1|||
161493543|NCT00503009|583202273|FG002|Overall Study|Physician Decision|1|||
161493544|NCT02632552|583202277|FG000|Overall Study|Lost to Follow-up|14|||
161493545|NCT02632552|583202278|FG001|Overall Study|Lost to Follow-up|8|||
161493546|NCT02632552|583202277|FG000|Overall Study|Withdrawal by Subject|2|||
161493547|NCT02632552|583202278|FG001|Overall Study|Withdrawal by Subject|0|||
161493548|NCT02632552|583202277|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
161493549|NCT02632552|583202278|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
161493550|NCT02611778|583202285|FG000|Overall Study|Withdrawal by Subject|2|||
161493551|NCT02611778|583202286|FG001|Overall Study|Withdrawal by Subject|8|||
161493552|NCT02611778|583202285|FG000|Overall Study|Adverse Event|1|||
161493553|NCT02611778|583202286|FG001|Overall Study|Adverse Event|2|||
161493554|NCT02611778|583202285|FG000|Overall Study|Death|2|||
161493555|NCT02611778|583202286|FG001|Overall Study|Death|1|||
161493556|NCT02611778|583202285|FG000|Overall Study|Protocol Violation|1|||
161493557|NCT02611778|583202286|FG001|Overall Study|Protocol Violation|0|||
161493558|NCT02611778|583202285|FG000|Overall Study|Lost to Follow-up|3|||
161493559|NCT02611778|583202286|FG001|Overall Study|Lost to Follow-up|1|||
161493560|NCT02611778|583202285|FG000|Overall Study|Need for alternative treatment|1|||
161493561|NCT02611778|583202286|FG001|Overall Study|Need for alternative treatment|0|||
161493562|NCT02611778|583202285|FG000|Overall Study|Other Reason|2|||
161493563|NCT02611778|583202286|FG001|Overall Study|Other Reason|1|||
161493564|NCT04008030|583202287|FG000|Pre-Treatment|Withdrawal by Subject|0|||
161493565|NCT04008030|583202288|FG001|Pre-Treatment|Withdrawal by Subject|0|||
161584193|NCT02576509|583527932|FG000|Treatment Period|Participant withdrew consent|3|||
161584194|NCT02576509|583527933|FG001|Treatment Period|Participant withdrew consent|7|||
161493566|NCT04008030|583202289|FG002|Pre-Treatment|Withdrawal by Subject|9|||
161584195|NCT02576509|583527932|FG000|Treatment Period|Lost to Follow-up|0|||
161584196|NCT02576509|583527933|FG001|Treatment Period|Lost to Follow-up|1|||
161584197|NCT02576509|583527932|FG000|Treatment Period|Maximum clinical benefit|1|||
161584198|NCT02576509|583527933|FG001|Treatment Period|Maximum clinical benefit|0|||
161584199|NCT02576509|583527932|FG000|Treatment Period|Poor/non-compliance|1|||
161584200|NCT02576509|583527933|FG001|Treatment Period|Poor/non-compliance|1|||
161584201|NCT02576509|583527932|FG000|Treatment Period|Participant no longer meets criteria|1|||
161584202|NCT02576509|583527933|FG001|Treatment Period|Participant no longer meets criteria|0|||
161584203|NCT02576509|583527932|FG000|Treatment Period|Other reason|12|||
161584204|NCT02576509|583527933|FG001|Treatment Period|Other reason|8|||
161584205|NCT02576509|583527932|FG000|Treatment Period|NOT REPORTED|1|||
161584206|NCT02576509|583527933|FG001|Treatment Period|NOT REPORTED|0|||
161584207|NCT02576509|583527932|FG000|Treatment Period|Administrative reason by sponsor|0|||
161817926|NCT03067987|584372962|FG001|Overall Study|Protocol Violation|2|||
161817927|NCT03067987|584372961|FG000|Overall Study|Withdrawal by Subject|2|||
161817928|NCT03067987|584372962|FG001|Overall Study|Withdrawal by Subject|1|||
161817929|NCT03733145|584372963|FG000|Overall Study|screenfail|3|||
161817930|NCT03733145|584372964|FG001|Overall Study|screenfail|3|||
161817931|NCT03733145|584372965|FG002|Overall Study|screenfail|2|||
161493567|NCT04008030|583202287|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
161493568|NCT04008030|583202288|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
161493569|NCT04008030|583202289|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
161493570|NCT04008030|583202287|FG000|Pre-Treatment|Other reasons|0|||
161493571|NCT04008030|583202288|FG001|Pre-Treatment|Other reasons|1|||
161584208|NCT02576509|583527933|FG001|Treatment Period|Administrative reason by sponsor|1|||
161817932|NCT00754052|584374292|FG000|Overall Study|Study terminated by Sponsor|5|||
161817933|NCT00754052|584374293|FG001|Overall Study|Study terminated by Sponsor|3|||
161493572|NCT04008030|583202289|FG002|Pre-Treatment|Other reasons|6|||
161493573|NCT04008030|583202287|FG000|Treatment|Withdrawal by Subject|1|||
161493574|NCT04008030|583202288|FG001|Treatment|Withdrawal by Subject|1|||
161493575|NCT04008030|583202289|FG002|Treatment|Withdrawal by Subject|1|||
161493576|NCT04008030|583202287|FG000|Treatment|Death|2|||
161493577|NCT04008030|583202288|FG001|Treatment|Death|4|||
161493578|NCT04008030|583202289|FG002|Treatment|Death|0|||
161493579|NCT04008030|583202287|FG000|Treatment|Pregnancy|0|||
161493580|NCT04008030|583202288|FG001|Treatment|Pregnancy|1|||
161493581|NCT04008030|583202289|FG002|Treatment|Pregnancy|0|||
161493582|NCT04008030|583202287|FG000|Treatment|Participant no longer meets study criteria|0|||
161493583|NCT04008030|583202288|FG001|Treatment|Participant no longer meets study criteria|1|||
161493584|NCT04008030|583202289|FG002|Treatment|Participant no longer meets study criteria|0|||
161493585|NCT04008030|583202287|FG000|Treatment|Other reasons|5|||
161493586|NCT04008030|583202288|FG001|Treatment|Other reasons|13|||
161493587|NCT04008030|583202289|FG002|Treatment|Other reasons|6|||
161584209|NCT00212355|583527934|FG000|Overall Study|Adverse Event|1|||
161584210|NCT00212355|583527934|FG000|Overall Study|Withdrawal by Subject|1|||
161584211|NCT00212355|583527934|FG000|Overall Study|A change of address|1|||
161584212|NCT00186992|583527940|FG000|Overall Study|Withdrawal by Subject|5|||
161584213|NCT00186992|583527940|FG000|Overall Study|Physician's discretion|13|||
161584214|NCT00186992|583527940|FG000|Overall Study|PI Discretion|4|||
161584215|NCT00186992|583527940|FG000|Overall Study|Ineligible|2|||
161584216|NCT00186992|583527940|FG000|Overall Study|Lost to Follow-up|2|||
161584217|NCT00186992|583527940|FG000|Overall Study|Still on Study|9|||
161584218|NCT05104697|583527941|FG000|Overall Study|Withdrawal by Subject|0|||
161584219|NCT05104697|583527942|FG001|Overall Study|Withdrawal by Subject|1|||
161584220|NCT03913195|583527943|FG000|Overall Study|Adverse Event|0|||
161584221|NCT03913195|583527944|FG001|Overall Study|Adverse Event|0|||
161584222|NCT03913195|583527945|FG002|Overall Study|Adverse Event|1|||
161584223|NCT03913195|583527946|FG003|Overall Study|Adverse Event|1|||
161584224|NCT03913195|583527947|FG004|Overall Study|Adverse Event|0|||
161584225|NCT03913195|583527943|FG000|Overall Study|Withdrawal by Subject|0|||
161584226|NCT03913195|583527944|FG001|Overall Study|Withdrawal by Subject|0|||
161584227|NCT03913195|583527945|FG002|Overall Study|Withdrawal by Subject|1|||
161584228|NCT03913195|583527946|FG003|Overall Study|Withdrawal by Subject|0|||
161584229|NCT03913195|583527947|FG004|Overall Study|Withdrawal by Subject|1|||
161584230|NCT03913195|583527943|FG000|Overall Study|non adherence to study|0|||
161584231|NCT03913195|583527944|FG001|Overall Study|non adherence to study|0|||
161584232|NCT03913195|583527945|FG002|Overall Study|non adherence to study|1|||
161584233|NCT03913195|583527946|FG003|Overall Study|non adherence to study|0|||
161584234|NCT03913195|583527947|FG004|Overall Study|non adherence to study|0|||
161584235|NCT05307978|583527948|FG000|Overall Study|Lost to Follow-up|0|||
161584236|NCT05307978|583527949|FG001|Overall Study|Lost to Follow-up|1|||
161584237|NCT05307978|583527950|FG002|Overall Study|Lost to Follow-up|0|||
161584238|NCT05307978|583527951|FG003|Overall Study|Lost to Follow-up|4|||
161584239|NCT05307978|583527952|FG004|Overall Study|Lost to Follow-up|0|||
161584240|NCT05307978|583527953|FG005|Overall Study|Lost to Follow-up|0|||
161584241|NCT05307978|583527954|FG006|Overall Study|Lost to Follow-up|1|||
161584242|NCT03416023|583527955|FG000|Overall Study|Exclusion criteria failure|1|||
161584243|NCT03416023|583527955|FG000|Overall Study|Withdrawal by Subject|6|||
161584244|NCT03416023|583527955|FG000|Overall Study|Explanted|7|||
161584245|NCT03416023|583527955|FG000|Overall Study|Physician Decision|1|||
161584246|NCT03416023|583527955|FG000|Overall Study|Lost to Follow-up|1|||
161584247|NCT03416023|583527955|FG000|Overall Study|Death|1|||
161584248|NCT03651895|583527956|FG000|First Drug Assignment|Adverse Event|4|||
161584249|NCT03651895|583527957|FG001|First Drug Assignment|Adverse Event|5|||
161584250|NCT03651895|583527956|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
161672087|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161672088|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
161672089|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161672090|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161584251|NCT03651895|583527957|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
161584252|NCT02837510|583527958|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161584253|NCT02837510|583527959|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161584254|NCT02837510|583527958|FG000|Washout (2 Weeks)|Adverse Event|0|||
161584255|NCT02837510|583527959|FG001|Washout (2 Weeks)|Adverse Event|1|||
161584256|NCT02837510|583527958|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161584257|NCT02837510|583527959|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
161584258|NCT02837510|583527958|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
161584259|NCT02837510|583527959|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
161584260|NCT02837510|583527958|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
161584261|NCT02837510|583527959|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
161817934|NCT00557245|584374294|FG000|Overall Study|Lost to Follow-up|7|||
161493588|NCT04008030|583202287|FG000|Treatment|Disease Progression|137|||
161493589|NCT04008030|583202288|FG001|Treatment|Disease Progression|82|||
161493590|NCT04008030|583202289|FG002|Treatment|Disease Progression|85|||
161493591|NCT04008030|583202287|FG000|Treatment|Study drug toxicity|28|||
161493592|NCT04008030|583202288|FG001|Treatment|Study drug toxicity|48|||
161493593|NCT04008030|583202289|FG002|Treatment|Study drug toxicity|8|||
161584262|NCT02837510|583527958|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
161493594|NCT04008030|583202287|FG000|Treatment|Adverse Event unrelated to study drug|28|||
161493595|NCT04008030|583202288|FG001|Treatment|Adverse Event unrelated to study drug|22|||
161493596|NCT04008030|583202289|FG002|Treatment|Adverse Event unrelated to study drug|6|||
161493597|NCT04008030|583202287|FG000|Treatment|Maximum Clinical Benefit|0|||
161493598|NCT04008030|583202288|FG001|Treatment|Maximum Clinical Benefit|1|||
161493599|NCT04008030|583202289|FG002|Treatment|Maximum Clinical Benefit|9|||
161493600|NCT04008030|583202287|FG000|Treatment|On-going treatment|13|||
161493601|NCT04008030|583202288|FG001|Treatment|On-going treatment|20|||
161493602|NCT04008030|583202289|FG002|Treatment|On-going treatment|0|||
161493603|NCT02659631|583202292|FG000|Overall Study|Lost to Follow-up|0|||
161493604|NCT02659631|583202293|FG001|Overall Study|Lost to Follow-up|0|||
161493605|NCT02659631|583202294|FG002|Overall Study|Lost to Follow-up|2|||
161493606|NCT02659631|583202295|FG003|Overall Study|Lost to Follow-up|0|||
161493607|NCT02659631|583202296|FG004|Overall Study|Lost to Follow-up|0|||
161493608|NCT02659631|583202297|FG005|Overall Study|Lost to Follow-up|1|||
161493609|NCT02659631|583202298|FG006|Overall Study|Lost to Follow-up|0|||
161493610|NCT02659631|583202299|FG007|Overall Study|Lost to Follow-up|0|||
161493611|NCT02659631|583202300|FG008|Overall Study|Lost to Follow-up|0|||
161493612|NCT02659631|583202301|FG009|Overall Study|Lost to Follow-up|0|||
161493613|NCT02659631|583202292|FG000|Overall Study|Withdrawal prior to treatment|0|||
161493614|NCT02659631|583202293|FG001|Overall Study|Withdrawal prior to treatment|0|||
161493615|NCT02659631|583202294|FG002|Overall Study|Withdrawal prior to treatment|0|||
161493616|NCT02659631|583202295|FG003|Overall Study|Withdrawal prior to treatment|0|||
161493617|NCT02659631|583202296|FG004|Overall Study|Withdrawal prior to treatment|1|||
161493618|NCT02659631|583202297|FG005|Overall Study|Withdrawal prior to treatment|0|||
161493619|NCT02659631|583202298|FG006|Overall Study|Withdrawal prior to treatment|0|||
161493620|NCT02659631|583202299|FG007|Overall Study|Withdrawal prior to treatment|0|||
161493621|NCT02659631|583202300|FG008|Overall Study|Withdrawal prior to treatment|0|||
161493622|NCT02659631|583202301|FG009|Overall Study|Withdrawal prior to treatment|0|||
161493623|NCT02659631|583202292|FG000|Overall Study|Participant refused further follow-up|0|||
161493624|NCT02659631|583202293|FG001|Overall Study|Participant refused further follow-up|0|||
161493625|NCT02659631|583202294|FG002|Overall Study|Participant refused further follow-up|0|||
161493626|NCT02659631|583202295|FG003|Overall Study|Participant refused further follow-up|1|||
161493627|NCT02659631|583202296|FG004|Overall Study|Participant refused further follow-up|0|||
161493628|NCT02659631|583202297|FG005|Overall Study|Participant refused further follow-up|0|||
161493629|NCT02659631|583202298|FG006|Overall Study|Participant refused further follow-up|0|||
161493630|NCT02659631|583202299|FG007|Overall Study|Participant refused further follow-up|0|||
161493631|NCT02659631|583202300|FG008|Overall Study|Participant refused further follow-up|1|||
161493632|NCT02659631|583202301|FG009|Overall Study|Participant refused further follow-up|0|||
161493633|NCT02659631|583202292|FG000|Overall Study|Death (follow-up phase)|1|||
161493634|NCT02659631|583202293|FG001|Overall Study|Death (follow-up phase)|2|||
161493635|NCT02659631|583202294|FG002|Overall Study|Death (follow-up phase)|1|||
161493636|NCT02659631|583202295|FG003|Overall Study|Death (follow-up phase)|1|||
161493637|NCT02659631|583202296|FG004|Overall Study|Death (follow-up phase)|3|||
161493638|NCT02659631|583202297|FG005|Overall Study|Death (follow-up phase)|2|||
161493639|NCT02659631|583202298|FG006|Overall Study|Death (follow-up phase)|0|||
161493640|NCT02659631|583202299|FG007|Overall Study|Death (follow-up phase)|3|||
161493641|NCT02659631|583202300|FG008|Overall Study|Death (follow-up phase)|1|||
161493642|NCT02659631|583202301|FG009|Overall Study|Death (follow-up phase)|0|||
161493643|NCT02659631|583202292|FG000|Overall Study|Death (treatment phase)|0|||
161584263|NCT02837510|583527959|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
161584264|NCT05510232|583527960|FG000|Overall Study|Withdrawal by Subject|2|||
161584265|NCT05510232|583527961|FG001|Overall Study|Withdrawal by Subject|7|||
161584266|NCT05510232|583527962|FG002|Overall Study|Withdrawal by Subject|6|||
161584267|NCT05687903|583527966|FG000|Overall Study|Protocol Deviation|1|||
161584268|NCT05687903|583527967|FG001|Overall Study|Protocol Deviation|1|||
161584269|NCT05687903|583527968|FG002|Overall Study|Protocol Deviation|0|||
161584270|NCT05687903|583527969|FG003|Overall Study|Protocol Deviation|1|||
161584271|NCT05687903|583527970|FG004|Overall Study|Protocol Deviation|0|||
161584272|NCT04118452|583527971|FG000|Overall Study|Lost to Follow-up|5|||
161584273|NCT04118452|583527972|FG001|Overall Study|Lost to Follow-up|5|||
161584274|NCT04118452|583527971|FG000|Overall Study|Withdrawal by Subject|17|||
161493644|NCT02659631|583202293|FG001|Overall Study|Death (treatment phase)|0|||
161493645|NCT02659631|583202294|FG002|Overall Study|Death (treatment phase)|0|||
161493646|NCT02659631|583202295|FG003|Overall Study|Death (treatment phase)|0|||
161493647|NCT02659631|583202296|FG004|Overall Study|Death (treatment phase)|1|||
161493648|NCT02659631|583202297|FG005|Overall Study|Death (treatment phase)|0|||
161493649|NCT02659631|583202298|FG006|Overall Study|Death (treatment phase)|1|||
161493650|NCT02659631|583202299|FG007|Overall Study|Death (treatment phase)|0|||
161493651|NCT02659631|583202300|FG008|Overall Study|Death (treatment phase)|0|||
161493652|NCT02659631|583202301|FG009|Overall Study|Death (treatment phase)|0|||
161493653|NCT00495170|583202302|FG000|Overall Study|Lost to Follow-up|9|||
161493654|NCT00495170|583202302|FG000|Overall Study|Withdrawal by Subject|3|||
161493655|NCT00495170|583202302|FG000|Overall Study|Inappropriate staging|8|||
161817935|NCT00557245|584374295|FG001|Overall Study|Lost to Follow-up|8|||
161817936|NCT00557245|584374296|FG002|Overall Study|Lost to Follow-up|10|||
161493656|NCT01928329|583202303|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
161493657|NCT01928329|583202304|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
161493658|NCT01928329|583202303|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
161493659|NCT01928329|583202304|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
161493660|NCT01928329|583202303|FG000|Overall Study|Adverse Event|5|||
161493661|NCT01928329|583202304|FG001|Overall Study|Adverse Event|3|||
161817937|NCT00557245|584374294|FG000|Overall Study|Ineligible|5|||
161817938|NCT00557245|584374295|FG001|Overall Study|Ineligible|4|||
161493662|NCT01928329|583202303|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
161493663|NCT01928329|583202304|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
161493664|NCT01928329|583202303|FG000|Overall Study|Withdrawal by Subject|1|||
161493665|NCT01928329|583202304|FG001|Overall Study|Withdrawal by Subject|5|||
161493666|NCT01928329|583202303|FG000|Overall Study|Physician Decision|1|||
161493667|NCT01928329|583202304|FG001|Overall Study|Physician Decision|1|||
161493668|NCT00330616|583202305|FG000|Overall Study|Adverse Event|13|||
161493669|NCT00330616|583202305|FG000|Overall Study|Lack of Efficacy|1|||
161493670|NCT00330616|583202305|FG000|Overall Study|Lost to Follow-up|2|||
161493671|NCT00330616|583202305|FG000|Overall Study|Withdrawal by Subject|4|||
161493672|NCT00330616|583202305|FG000|Overall Study|Other|1|||
161493673|NCT02141997|583202310|FG000|Overall Study|Adverse Event|0|||
161493674|NCT02141997|583202311|FG001|Overall Study|Adverse Event|2|||
161493675|NCT02141997|583202312|FG002|Overall Study|Adverse Event|0|||
161493676|NCT02141997|583202313|FG003|Overall Study|Adverse Event|1|||
161493677|NCT02141997|583202310|FG000|Overall Study|Participant noncompliance|1|||
161493678|NCT02141997|583202311|FG001|Overall Study|Participant noncompliance|0|||
161493679|NCT02141997|583202312|FG002|Overall Study|Participant noncompliance|0|||
161493680|NCT02141997|583202313|FG003|Overall Study|Participant noncompliance|0|||
161493681|NCT02141997|583202310|FG000|Overall Study|Withdrew consent|1|||
161493682|NCT02141997|583202311|FG001|Overall Study|Withdrew consent|0|||
161493683|NCT02141997|583202312|FG002|Overall Study|Withdrew consent|3|||
161493684|NCT02141997|583202313|FG003|Overall Study|Withdrew consent|0|||
161493685|NCT02141997|583202310|FG000|Overall Study|Other|1|||
161493686|NCT02141997|583202311|FG001|Overall Study|Other|4|||
161493687|NCT02141997|583202312|FG002|Overall Study|Other|0|||
161493688|NCT02141997|583202313|FG003|Overall Study|Other|0|||
161493689|NCT00171223|583202319|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
161493690|NCT00171223|583202320|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
161493691|NCT00171223|583202321|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
161493692|NCT00171223|583202319|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
161493693|NCT00171223|583202320|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
161493694|NCT00171223|583202321|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
161493695|NCT00171223|583202319|FG000|Overall Study|Abnormal Procedure|1|||
161493696|NCT00171223|583202320|FG001|Overall Study|Abnormal Procedure|0|||
161584275|NCT04118452|583527972|FG001|Overall Study|Withdrawal by Subject|17|||
161584276|NCT03433339|583527973|FG000|Overall Study|Lost to Follow-up|2|||
161584277|NCT03433339|583527974|FG001|Overall Study|Lost to Follow-up|0|||
161584278|NCT03433339|583527973|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
161817939|NCT00557245|584374296|FG002|Overall Study|Ineligible|2|||
161817940|NCT00516295|584374300|FG000|Overall Study|Lack of Efficacy|2|||
161817941|NCT00516295|584374301|FG001|Overall Study|Lack of Efficacy|0|||
161817942|NCT00516295|584374302|FG002|Overall Study|Lack of Efficacy|0|||
161817943|NCT00516295|584374300|FG000|Overall Study|Ineligible|1|||
161817944|NCT00516295|584374301|FG001|Overall Study|Ineligible|0|||
161817945|NCT00516295|584374302|FG002|Overall Study|Ineligible|0|||
161817946|NCT02651987|584374305|FG000|Overall Study|Adverse Event|2|||
161817947|NCT02651987|584374306|FG001|Overall Study|Adverse Event|2|||
161817948|NCT02651987|584374305|FG000|Overall Study|Consent Withdrawn|2|||
161817949|NCT02651987|584374306|FG001|Overall Study|Consent Withdrawn|0|||
161493697|NCT00171223|583202321|FG002|Overall Study|Abnormal Procedure|0|||
161493698|NCT00171223|583202319|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
161493699|NCT00171223|583202320|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
161493700|NCT00171223|583202321|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
161493701|NCT00171223|583202319|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
161493702|NCT00171223|583202320|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
161493703|NCT00171223|583202321|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
161493704|NCT00171223|583202319|FG000|Overall Study|Protocol Violation|2|||
161493705|NCT00171223|583202320|FG001|Overall Study|Protocol Violation|2|||
161493706|NCT00171223|583202321|FG002|Overall Study|Protocol Violation|3|||
161817950|NCT02651987|584374305|FG000|Overall Study|Local PD|0|||
161817951|NCT02651987|584374306|FG001|Overall Study|Local PD|2|||
161817952|NCT02651987|584374305|FG000|Overall Study|Investigator Decision|1|||
161817953|NCT02651987|584374306|FG001|Overall Study|Investigator Decision|1|||
161493707|NCT00171223|583202319|FG000|Overall Study|Participant Withdrew Consent|12|||
161493708|NCT00171223|583202320|FG001|Overall Study|Participant Withdrew Consent|21|||
161493709|NCT00171223|583202321|FG002|Overall Study|Participant Withdrew Consent|15|||
161493710|NCT00171223|583202319|FG000|Overall Study|Lost to Follow-up|5|||
161493711|NCT00171223|583202320|FG001|Overall Study|Lost to Follow-up|2|||
161493712|NCT00171223|583202321|FG002|Overall Study|Lost to Follow-up|3|||
161493713|NCT00171223|583202319|FG000|Overall Study|Administrative Problems|4|||
161493714|NCT00171223|583202320|FG001|Overall Study|Administrative Problems|7|||
161493715|NCT00171223|583202321|FG002|Overall Study|Administrative Problems|6|||
161493716|NCT00171223|583202319|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
161493717|NCT00171223|583202320|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
161493718|NCT00171223|583202321|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
161493719|NCT00171223|583202319|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
161493720|NCT00171223|583202320|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
161493721|NCT00171223|583202321|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
161493722|NCT00451321|583202322|FG000|Overall Study|Lost to Follow-up|3|||
161493723|NCT00451321|583202323|FG001|Overall Study|Lost to Follow-up|3|||
161493724|NCT00451321|583202324|FG002|Overall Study|Lost to Follow-up|1|||
161493725|NCT00451321|583202325|FG003|Overall Study|Lost to Follow-up|3|||
161493726|NCT00451321|583202326|FG004|Overall Study|Lost to Follow-up|0|||
161493727|NCT00451321|583202327|FG005|Overall Study|Lost to Follow-up|1|||
161493728|NCT00451321|583202328|FG006|Overall Study|Lost to Follow-up|0|||
161493729|NCT00451321|583202329|FG007|Overall Study|Lost to Follow-up|0|||
161493730|NCT00451321|583202322|FG000|Overall Study|Withdrawal by Subject|3|||
161493731|NCT00451321|583202323|FG001|Overall Study|Withdrawal by Subject|1|||
161493732|NCT00451321|583202324|FG002|Overall Study|Withdrawal by Subject|0|||
161493733|NCT00451321|583202325|FG003|Overall Study|Withdrawal by Subject|4|||
161493734|NCT00451321|583202326|FG004|Overall Study|Withdrawal by Subject|0|||
161493735|NCT00451321|583202327|FG005|Overall Study|Withdrawal by Subject|0|||
161493736|NCT00451321|583202328|FG006|Overall Study|Withdrawal by Subject|0|||
161493737|NCT00451321|583202329|FG007|Overall Study|Withdrawal by Subject|0|||
161493738|NCT00451321|583202322|FG000|Overall Study|Study closed/terminated|1|||
161493739|NCT00451321|583202323|FG001|Overall Study|Study closed/terminated|1|||
161493740|NCT00451321|583202324|FG002|Overall Study|Study closed/terminated|17|||
161493741|NCT00451321|583202325|FG003|Overall Study|Study closed/terminated|5|||
161493742|NCT00451321|583202326|FG004|Overall Study|Study closed/terminated|7|||
161493743|NCT00451321|583202327|FG005|Overall Study|Study closed/terminated|7|||
161493744|NCT00451321|583202328|FG006|Overall Study|Study closed/terminated|5|||
161493745|NCT00451321|583202329|FG007|Overall Study|Study closed/terminated|3|||
161493746|NCT00451321|583202322|FG000|Overall Study|Sponsor decision to amend protocol|0|||
161493747|NCT00451321|583202323|FG001|Overall Study|Sponsor decision to amend protocol|0|||
161493748|NCT00451321|583202324|FG002|Overall Study|Sponsor decision to amend protocol|0|||
161493749|NCT00451321|583202325|FG003|Overall Study|Sponsor decision to amend protocol|0|||
161493750|NCT00451321|583202326|FG004|Overall Study|Sponsor decision to amend protocol|0|||
161493751|NCT00451321|583202327|FG005|Overall Study|Sponsor decision to amend protocol|1|||
161493752|NCT00451321|583202328|FG006|Overall Study|Sponsor decision to amend protocol|1|||
161493753|NCT00451321|583202329|FG007|Overall Study|Sponsor decision to amend protocol|3|||
161493754|NCT02064166|583202330|FG000|Overall Study|Adverse Event|1|||
161493755|NCT02064166|583202331|FG001|Overall Study|Adverse Event|0|||
161493756|NCT00732615|583202338|FG000|Overall Study|Withdrawal by Subject|3|||
161493757|NCT00732615|583202339|FG001|Overall Study|Withdrawal by Subject|1|||
161493758|NCT00732615|583202338|FG000|Overall Study|Lost to Follow-up|0|||
161493759|NCT00732615|583202339|FG001|Overall Study|Lost to Follow-up|1|||
161493760|NCT00732615|583202338|FG000|Overall Study|Adverse Event|0|||
161493761|NCT00732615|583202339|FG001|Overall Study|Adverse Event|2|||
161493762|NCT00732615|583202338|FG000|Overall Study|Physician Decision|3|||
161493763|NCT00732615|583202339|FG001|Overall Study|Physician Decision|0|||
161493764|NCT00732615|583202338|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
161493765|NCT00732615|583202339|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
161493766|NCT00909389|583202343|FG000|Overall Study|Adverse Event|6|||
161493767|NCT00909389|583202343|FG000|Overall Study|Death|4|||
161493768|NCT00909389|583202343|FG000|Overall Study|Poor Compliance|16|||
161493769|NCT00909389|583202343|FG000|Overall Study|Lost to Follow-up|4|||
161493770|NCT00909389|583202343|FG000|Overall Study|No Information|103|||
161493771|NCT00597766|583202346|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
161493772|NCT00597766|583202347|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
161493773|NCT00597766|583202348|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
161493774|NCT00597766|583202346|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
161493775|NCT00597766|583202347|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
161493776|NCT00597766|583202348|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
161672091|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161493777|NCT01333059|583202349|FG000|Overall Study|Physician Decision|3|||
161493778|NCT01333059|583202350|FG001|Overall Study|Physician Decision|3|||
161493779|NCT01333059|583202349|FG000|Overall Study|Protocol Violation|3|||
161493780|NCT01333059|583202350|FG001|Overall Study|Protocol Violation|0|||
161817954|NCT02725515|584374307|FG000|Overall Study|Refused infusion (no study treatment)|1|||
161817955|NCT02725515|584374308|FG001|Overall Study|Refused infusion (no study treatment)|0|||
161817956|NCT02725515|584374307|FG000|Overall Study|Loss of Improvement per Protocol|14|||
161817957|NCT02725515|584374308|FG001|Overall Study|Loss of Improvement per Protocol|25|||
161817958|NCT02725515|584374307|FG000|Overall Study|Withdrawal by Subject|2|||
161817959|NCT02725515|584374308|FG001|Overall Study|Withdrawal by Subject|1|||
161817960|NCT02725515|584374307|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161817961|NCT02725515|584374308|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161817962|NCT02725515|584374307|FG000|Overall Study|Lost to Follow-up|1|||
161817963|NCT02725515|584374308|FG001|Overall Study|Lost to Follow-up|1|||
161817964|NCT02725515|584374307|FG000|Overall Study|Adverse Event|7|||
161817965|NCT02725515|584374308|FG001|Overall Study|Adverse Event|2|||
161817966|NCT02725515|584374307|FG000|Overall Study|No Documented Disease Improvement|0|||
161817967|NCT02725515|584374308|FG001|Overall Study|No Documented Disease Improvement|1|||
161817968|NCT02725515|584374307|FG000|Overall Study|Completed Study Under Original Protocol|0|||
161817969|NCT02725515|584374308|FG001|Overall Study|Completed Study Under Original Protocol|1|||
161817970|NCT02725515|584374307|FG000|Overall Study|Lack of Response|0|||
161817971|NCT02725515|584374308|FG001|Overall Study|Lack of Response|1|||
161817972|NCT00183196|584374314|FG000|Overall Study|Withdrawal by Subject|18|||
161817973|NCT00183196|584374315|FG001|Overall Study|Withdrawal by Subject|11|||
161817974|NCT00183196|584374316|FG002|Overall Study|Withdrawal by Subject|13|||
161817975|NCT00183196|584374314|FG000|Overall Study|Adverse Event|1|||
161817976|NCT00183196|584374315|FG001|Overall Study|Adverse Event|2|||
161817977|NCT00183196|584374316|FG002|Overall Study|Adverse Event|2|||
161817978|NCT00183196|584374314|FG000|Overall Study|Legal event|1|||
161817979|NCT00183196|584374315|FG001|Overall Study|Legal event|1|||
161817980|NCT00183196|584374316|FG002|Overall Study|Legal event|1|||
161817981|NCT00183196|584374314|FG000|Overall Study|Required more intensive care|0|||
161817982|NCT00183196|584374315|FG001|Overall Study|Required more intensive care|1|||
161817983|NCT00183196|584374316|FG002|Overall Study|Required more intensive care|2|||
161817984|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
161817985|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
161817986|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
161817987|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
161817988|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
161817989|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
161817990|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
161817991|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
161817992|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
161817993|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
161817994|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
161817995|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
161817996|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
161817997|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
161817998|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
161817999|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Other|0|||
161818000|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Other|0|||
161493781|NCT01166763|583202351|FG000|Overall Study|Withdrawal by Subject|3|||
161493782|NCT00737282|583202352|FG000|Overall Study|Study prematurely terminated|175|||
161493783|NCT02763189|583202353|FG000|Overall Study|Device failure|0|||
161493784|NCT02763189|583202354|FG001|Overall Study|Device failure|2|||
161493785|NCT02049957|583202359|FG000|Overall Study|Progressive Disease|5|||
161493786|NCT02049957|583202360|FG001|Overall Study|Progressive Disease|4|||
161493787|NCT02049957|583202361|FG002|Overall Study|Progressive Disease|2|||
161493788|NCT02049957|583202362|FG003|Overall Study|Progressive Disease|2|||
161493789|NCT02049957|583202363|FG004|Overall Study|Progressive Disease|6|||
161493790|NCT02049957|583202364|FG005|Overall Study|Progressive Disease|35|||
161493791|NCT02049957|583202365|FG006|Overall Study|Progressive Disease|7|||
161493792|NCT02049957|583202366|FG007|Overall Study|Progressive Disease|26|||
161493793|NCT02049957|583202367|FG008|Overall Study|Progressive Disease|6|||
161493794|NCT02049957|583202359|FG000|Overall Study|Adverse Event|1|||
161493795|NCT02049957|583202360|FG001|Overall Study|Adverse Event|1|||
161493796|NCT02049957|583202361|FG002|Overall Study|Adverse Event|1|||
161493797|NCT02049957|583202362|FG003|Overall Study|Adverse Event|0|||
161493798|NCT02049957|583202363|FG004|Overall Study|Adverse Event|0|||
161493799|NCT02049957|583202364|FG005|Overall Study|Adverse Event|5|||
161493800|NCT02049957|583202365|FG006|Overall Study|Adverse Event|0|||
161818001|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Other|1|||
161818002|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
161818003|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
161818004|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
161818005|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
161818006|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
161818007|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
161818008|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
161818009|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
161818010|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
161818011|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
161818012|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
161818013|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
161818014|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
161818015|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
161818016|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
161818017|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
161818018|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
161818019|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
161818020|NCT00385736|584374317|FG000|Safety Analysis Set|Adverse Event|23|||
161818021|NCT00385736|584374318|FG001|Safety Analysis Set|Adverse Event|15|||
161818022|NCT00385736|584374319|FG002|Safety Analysis Set|Adverse Event|23|||
161818023|NCT00385736|584374317|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
161818024|NCT00385736|584374318|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
161818025|NCT00385736|584374319|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
161818026|NCT00385736|584374317|FG000|Safety Analysis Set|Lost to Follow-up|0|||
161818027|NCT00385736|584374318|FG001|Safety Analysis Set|Lost to Follow-up|2|||
161818028|NCT00385736|584374319|FG002|Safety Analysis Set|Lost to Follow-up|2|||
161818029|NCT00385736|584374317|FG000|Safety Analysis Set|Lack of Efficacy|38|||
161818030|NCT00385736|584374318|FG001|Safety Analysis Set|Lack of Efficacy|16|||
161818031|NCT00385736|584374319|FG002|Safety Analysis Set|Lack of Efficacy|31|||
161818032|NCT00385736|584374317|FG000|Safety Analysis Set|Protocol Violation|2|||
161818033|NCT00385736|584374318|FG001|Safety Analysis Set|Protocol Violation|1|||
161818034|NCT00385736|584374319|FG002|Safety Analysis Set|Protocol Violation|6|||
161818035|NCT00385736|584374317|FG000|Safety Analysis Set|Other|1|||
161818036|NCT00385736|584374318|FG001|Safety Analysis Set|Other|4|||
161818037|NCT00385736|584374319|FG002|Safety Analysis Set|Other|4|||
161818038|NCT01701063|584374326|FG000|Overall Study|Lost to Follow-up|0|||
161818039|NCT01701063|584374327|FG001|Overall Study|Lost to Follow-up|1|||
161818040|NCT01701063|584374328|FG002|Overall Study|Lost to Follow-up|0|||
161818041|NCT01701063|584374326|FG000|Overall Study|Withdrawal by Subject|0|||
161818042|NCT01701063|584374327|FG001|Overall Study|Withdrawal by Subject|0|||
161818043|NCT01701063|584374328|FG002|Overall Study|Withdrawal by Subject|1|||
161818044|NCT01701063|584374326|FG000|Overall Study|Other|0|||
161818045|NCT01701063|584374327|FG001|Overall Study|Other|0|||
161818046|NCT01701063|584374328|FG002|Overall Study|Other|1|||
161818047|NCT01919112|584374329|FG000|Secondary Analysis-day 30|Death|1|||
161818048|NCT01919112|584374330|FG001|Secondary Analysis-day 30|Death|1|||
161818049|NCT01919112|584374331|FG002|Secondary Analysis-day 30|Death|1|||
161818050|NCT01919112|584374329|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
161818051|NCT01919112|584374330|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
161818052|NCT01919112|584374331|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
161818053|NCT00835666|584374332|FG000|Washout|Protocol Violation|1|||
161818054|NCT00835666|584374333|FG001|Washout|Protocol Violation|0|||
161818055|NCT00835666|584374332|FG000|Washout|Withdrawal by Subject|1|||
161818056|NCT00835666|584374333|FG001|Washout|Withdrawal by Subject|0|||
161818057|NCT00635648|584374334|FG000|Overall Study|Adverse Event|12|||
161818058|NCT00635648|584374334|FG000|Overall Study|Withdrawal by Subject|9|||
161818059|NCT00635648|584374334|FG000|Overall Study|Physician Decision|4|||
161818060|NCT00635648|584374334|FG000|Overall Study|Rapid progression of baseline disease|4|||
161818061|NCT00635648|584374334|FG000|Overall Study|Use of other antifungal agent needed|1|||
161818062|NCT00635648|584374334|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
161818063|NCT00635648|584374334|FG000|Overall Study|Noncompliance with protocol|1|||
161818064|NCT00635648|584374334|FG000|Overall Study|Other reason|2|||
161818065|NCT03158727|584374339|FG000|Overall Study|Withdrawal by Subject|2|||
161818066|NCT03158727|584374340|FG001|Overall Study|Withdrawal by Subject|6|||
161818067|NCT03158727|584374339|FG000|Overall Study|Death|11|||
161818068|NCT03158727|584374340|FG001|Overall Study|Death|12|||
161818069|NCT03158727|584374339|FG000|Overall Study|Lost to Follow-up|1|||
161818070|NCT03158727|584374340|FG001|Overall Study|Lost to Follow-up|0|||
161818071|NCT03158727|584374339|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
161818072|NCT03158727|584374340|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
161924051|NCT05128942|584768141|FG007|Overall Study|Lost to Follow-up|0|||
161924052|NCT05128942|584768142|FG008|Overall Study|Lost to Follow-up|0|||
161924053|NCT05942040|584768143|FG000|Overall Study|No longer employed at study site.|0|||
161924054|NCT05942040|584768144|FG001|Overall Study|No longer employed at study site.|0|||
161924055|NCT05942040|584768145|FG002|Overall Study|No longer employed at study site.|3|||
161924056|NCT03442569|584768146|FG000|Overall Study|Subject was ineligible after enrollment|1|||
161924057|NCT06461455|584768147|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
161924058|NCT06461455|584768148|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
161924059|NCT06461455|584768147|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
161493801|NCT02049957|583202366|FG007|Overall Study|Adverse Event|6|||
161493802|NCT02049957|583202367|FG008|Overall Study|Adverse Event|1|||
161493803|NCT02049957|583202359|FG000|Overall Study|Study Terminated by Sponsor|0|||
161493804|NCT02049957|583202360|FG001|Overall Study|Study Terminated by Sponsor|1|||
161493805|NCT02049957|583202361|FG002|Overall Study|Study Terminated by Sponsor|0|||
161493806|NCT02049957|583202362|FG003|Overall Study|Study Terminated by Sponsor|0|||
161493807|NCT02049957|583202363|FG004|Overall Study|Study Terminated by Sponsor|0|||
161493808|NCT02049957|583202364|FG005|Overall Study|Study Terminated by Sponsor|0|||
161493809|NCT02049957|583202365|FG006|Overall Study|Study Terminated by Sponsor|1|||
161493810|NCT02049957|583202366|FG007|Overall Study|Study Terminated by Sponsor|0|||
161493811|NCT02049957|583202367|FG008|Overall Study|Study Terminated by Sponsor|0|||
161493812|NCT02049957|583202359|FG000|Overall Study|Withdrawal by Subject|0|||
161493813|NCT02049957|583202360|FG001|Overall Study|Withdrawal by Subject|0|||
161493814|NCT02049957|583202361|FG002|Overall Study|Withdrawal by Subject|0|||
161493815|NCT02049957|583202362|FG003|Overall Study|Withdrawal by Subject|1|||
161493816|NCT02049957|583202363|FG004|Overall Study|Withdrawal by Subject|0|||
161493817|NCT02049957|583202364|FG005|Overall Study|Withdrawal by Subject|2|||
161493818|NCT02049957|583202365|FG006|Overall Study|Withdrawal by Subject|0|||
161493819|NCT02049957|583202366|FG007|Overall Study|Withdrawal by Subject|3|||
161493820|NCT02049957|583202367|FG008|Overall Study|Withdrawal by Subject|1|||
161493821|NCT02049957|583202359|FG000|Overall Study|Physician Decision|0|||
161493822|NCT02049957|583202360|FG001|Overall Study|Physician Decision|0|||
161493823|NCT02049957|583202361|FG002|Overall Study|Physician Decision|0|||
161493824|NCT02049957|583202362|FG003|Overall Study|Physician Decision|0|||
161924060|NCT06461455|584768148|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
161924061|NCT06461455|584768147|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
161924062|NCT06461455|584768148|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
161924063|NCT06142383|584768149|FG000|Overall Study|Mis-randomized|0|||
161924064|NCT06142383|584768150|FG001|Overall Study|Mis-randomized|0|||
161924065|NCT06142383|584768151|FG002|Overall Study|Mis-randomized|1|||
161924066|NCT06142383|584768152|FG003|Overall Study|Mis-randomized|0|||
161493825|NCT02049957|583202363|FG004|Overall Study|Physician Decision|0|||
161493826|NCT02049957|583202364|FG005|Overall Study|Physician Decision|1|||
161493827|NCT02049957|583202365|FG006|Overall Study|Physician Decision|0|||
161493828|NCT02049957|583202366|FG007|Overall Study|Physician Decision|0|||
161493829|NCT02049957|583202367|FG008|Overall Study|Physician Decision|0|||
161493830|NCT04447755|583202368|FG000|Overall Study|Death|9|||
161493831|NCT04447755|583202369|FG001|Overall Study|Death|16|||
161493832|NCT04447755|583202370|FG002|Overall Study|Death|8|||
161493833|NCT04447755|583202371|FG003|Overall Study|Death|9|||
161493834|NCT04447755|583202372|FG004|Overall Study|Death|8|||
161493835|NCT04447755|583202373|FG005|Overall Study|Death|9|||
161493836|NCT04447755|583202374|FG006|Overall Study|Death|55|||
161493837|NCT04447755|583202368|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161493838|NCT04447755|583202369|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161493839|NCT04447755|583202370|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161493840|NCT04447755|583202371|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161493841|NCT04447755|583202372|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161493842|NCT04447755|583202373|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161493843|NCT04447755|583202374|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161493844|NCT04447755|583202368|FG000|Overall Study|Sponsor Decision|0|||
161493845|NCT04447755|583202369|FG001|Overall Study|Sponsor Decision|0|||
161493846|NCT04447755|583202370|FG002|Overall Study|Sponsor Decision|0|||
161493847|NCT04447755|583202371|FG003|Overall Study|Sponsor Decision|0|||
161493848|NCT04447755|583202372|FG004|Overall Study|Sponsor Decision|1|||
161493849|NCT04447755|583202373|FG005|Overall Study|Sponsor Decision|0|||
161493850|NCT04447755|583202374|FG006|Overall Study|Sponsor Decision|10|||
161493851|NCT04447755|583202368|FG000|Overall Study|Lost to Follow-up|0|||
161493852|NCT04447755|583202369|FG001|Overall Study|Lost to Follow-up|0|||
161493853|NCT04447755|583202370|FG002|Overall Study|Lost to Follow-up|0|||
161493854|NCT04447755|583202371|FG003|Overall Study|Lost to Follow-up|0|||
161493855|NCT04447755|583202372|FG004|Overall Study|Lost to Follow-up|0|||
161493856|NCT04447755|583202373|FG005|Overall Study|Lost to Follow-up|0|||
161493857|NCT04447755|583202374|FG006|Overall Study|Lost to Follow-up|1|||
161493858|NCT00840294|583202375|FG000|Overall Study|Withdrawal by Subject|2|||
161493859|NCT00840294|583202376|FG001|Overall Study|Withdrawal by Subject|1|||
161584279|NCT03433339|583527974|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
161584280|NCT03433339|583527973|FG000|Overall Study|Withdrawal by Subject|0|||
161584281|NCT03433339|583527974|FG001|Overall Study|Withdrawal by Subject|2|||
161493860|NCT00840294|583202375|FG000|Overall Study|Protocol Violation|1|||
161584282|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161493861|NCT00840294|583202376|FG001|Overall Study|Protocol Violation|3|||
161493862|NCT00840294|583202375|FG000|Overall Study|Illness|0|||
161924067|NCT06142383|584768153|FG004|Overall Study|Mis-randomized|0|||
161493863|NCT00840294|583202376|FG001|Overall Study|Illness|1|||
161493864|NCT00383149|583202378|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
161493865|NCT00383149|583202378|FG000|Overall Study|Death|2|||
161493866|NCT00383149|583202378|FG000|Overall Study|Disease Progression|38|||
161493867|NCT00383149|583202378|FG000|Overall Study|Lost to Follow-up|1|||
161493868|NCT00383149|583202378|FG000|Overall Study|Other|1|||
161493869|NCT00383149|583202378|FG000|Overall Study|Study Drug Toxicity|4|||
161493870|NCT00383149|583202378|FG000|Overall Study|Request to Discontinue Treatment|4|||
161493871|NCT00383149|583202378|FG000|Overall Study|Participant Withdrew Consent|1|||
161493872|NCT03721276|583202379|FG000|Overall Study|Lost to Follow-up|5|||
161493873|NCT03721276|583202380|FG001|Overall Study|Lost to Follow-up|3|||
161493874|NCT03721276|583202379|FG000|Overall Study|Adverse Event|0|||
161493875|NCT03721276|583202380|FG001|Overall Study|Adverse Event|1|||
161493876|NCT01340898|583202385|FG000|Primary Phase|Serious Adverse Events|0|||
161493877|NCT01340898|583202386|FG001|Primary Phase|Serious Adverse Events|0|||
161493878|NCT01340898|583202387|FG002|Primary Phase|Serious Adverse Events|1|||
161493879|NCT01340898|583202385|FG000|Primary Phase|Withdrawal by Subject|8|||
161493880|NCT01340898|583202386|FG001|Primary Phase|Withdrawal by Subject|7|||
161493881|NCT01340898|583202387|FG002|Primary Phase|Withdrawal by Subject|5|||
161493882|NCT01340898|583202385|FG000|Primary Phase|Migrated/moved from study area|4|||
161493883|NCT01340898|583202386|FG001|Primary Phase|Migrated/moved from study area|1|||
161493884|NCT01340898|583202387|FG002|Primary Phase|Migrated/moved from study area|0|||
161493885|NCT01340898|583202385|FG000|Primary Phase|Lost to Follow-up|4|||
161493886|NCT01340898|583202386|FG001|Primary Phase|Lost to Follow-up|1|||
161493887|NCT01340898|583202387|FG002|Primary Phase|Lost to Follow-up|0|||
161493888|NCT01340898|583202385|FG000|Booster Phase|Withdrawal by Subject|3|||
161493889|NCT01340898|583202386|FG001|Booster Phase|Withdrawal by Subject|0|||
161493890|NCT01340898|583202387|FG002|Booster Phase|Withdrawal by Subject|4|||
161493891|NCT01340898|583202385|FG000|Booster Phase|Migrated/moved from study area|3|||
161493892|NCT01340898|583202386|FG001|Booster Phase|Migrated/moved from study area|0|||
161493893|NCT01340898|583202387|FG002|Booster Phase|Migrated/moved from study area|0|||
161493894|NCT01340898|583202385|FG000|Booster Phase|Lost to Follow-up|4|||
161493895|NCT01340898|583202386|FG001|Booster Phase|Lost to Follow-up|2|||
161493896|NCT01340898|583202387|FG002|Booster Phase|Lost to Follow-up|3|||
161493897|NCT04868890|583202388|FG000|Overall Study|Death|2|||
161493898|NCT04868890|583202389|FG001|Overall Study|Death|1|||
161493899|NCT04868890|583202388|FG000|Overall Study|Withdrawal by Subject|1|||
161493900|NCT04868890|583202389|FG001|Overall Study|Withdrawal by Subject|5|||
161493901|NCT02669433|583202392|FG000|Overall Study|Protocol Violation|0|||
161493902|NCT02669433|583202393|FG001|Overall Study|Protocol Violation|4|||
161493903|NCT02669433|583202394|FG002|Overall Study|Protocol Violation|1|||
161493904|NCT02669433|583202392|FG000|Overall Study|Disease Progression|1|||
161493905|NCT02669433|583202393|FG001|Overall Study|Disease Progression|0|||
161493906|NCT02669433|583202394|FG002|Overall Study|Disease Progression|0|||
161493907|NCT02669433|583202392|FG000|Overall Study|Physician Decision|1|||
161493908|NCT02669433|583202393|FG001|Overall Study|Physician Decision|1|||
161493909|NCT02669433|583202394|FG002|Overall Study|Physician Decision|0|||
161493910|NCT02669433|583202392|FG000|Overall Study|Adverse Event|6|||
161493911|NCT02669433|583202393|FG001|Overall Study|Adverse Event|7|||
161493912|NCT02669433|583202394|FG002|Overall Study|Adverse Event|10|||
161493913|NCT02669433|583202392|FG000|Overall Study|Sponsor Termination|1|||
161493914|NCT02669433|583202393|FG001|Overall Study|Sponsor Termination|0|||
161493915|NCT02669433|583202394|FG002|Overall Study|Sponsor Termination|1|||
161493916|NCT02669433|583202392|FG000|Overall Study|Withdrawal by Subject|5|||
161493917|NCT02669433|583202393|FG001|Overall Study|Withdrawal by Subject|1|||
161493918|NCT02669433|583202394|FG002|Overall Study|Withdrawal by Subject|0|||
161493919|NCT02669433|583202392|FG000|Overall Study|Withdrawal by Caregiver|1|||
161493920|NCT02669433|583202393|FG001|Overall Study|Withdrawal by Caregiver|0|||
161493921|NCT02669433|583202394|FG002|Overall Study|Withdrawal by Caregiver|2|||
161493922|NCT02669433|583202392|FG000|Overall Study|Death|0|||
161493923|NCT02669433|583202393|FG001|Overall Study|Death|1|||
161493924|NCT02669433|583202394|FG002|Overall Study|Death|1|||
161493925|NCT01698801|583202397|FG000|Treatment Phase|Adverse Event|4|||
161493926|NCT01698801|583202397|FG000|Treatment Phase|Protocol Violation|1|||
161493927|NCT01698801|583202397|FG000|Treatment Phase|Other|4|||
161493928|NCT01698801|583202397|FG000|Treatment Phase|Withdrawal by Subject|1|||
161493929|NCT01698801|583202397|FG000|Treatment Phase|Disease progression|1|||
161493930|NCT01698801|583202397|FG000|Follow Up Phase|Withdrawal by Subject|1|||
161493931|NCT01698801|583202397|FG000|Follow Up Phase|Death|4|||
161672092|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672093|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161493932|NCT00656474|583202398|FG000|Overall Study|Other Reason|1|||
161493933|NCT02062879|583202399|FG000|Overall Study|Withdrawal by Subject|4|||
161493934|NCT02062879|583202400|FG001|Overall Study|Withdrawal by Subject|1|||
161493935|NCT02998840|583202401|FG000|Overall Study|Lost to Follow-up|1|||
161493936|NCT02998840|583202402|FG001|Overall Study|Lost to Follow-up|1|||
161493937|NCT02998840|583202403|FG002|Overall Study|Lost to Follow-up|2|||
161493938|NCT02998840|583202404|FG003|Overall Study|Lost to Follow-up|3|||
161493939|NCT02998840|583202401|FG000|Overall Study|Withdrawal by Subject|1|||
161493940|NCT02998840|583202402|FG001|Overall Study|Withdrawal by Subject|1|||
161493941|NCT02998840|583202403|FG002|Overall Study|Withdrawal by Subject|0|||
161493942|NCT02998840|583202404|FG003|Overall Study|Withdrawal by Subject|1|||
161818073|NCT03158727|584374339|FG000|Overall Study|Visit 11 not done by mistake|0|||
161818074|NCT03158727|584374340|FG001|Overall Study|Visit 11 not done by mistake|1|||
161818075|NCT03158727|584374339|FG000|Overall Study|Enrolled, not treated|1|||
161818076|NCT03158727|584374340|FG001|Overall Study|Enrolled, not treated|0|||
161818077|NCT00985439|584374341|FG000|Overall Study|Adverse Event|0|||
161818078|NCT00985439|584374342|FG001|Overall Study|Adverse Event|0|||
161818079|NCT00985439|584374343|FG002|Overall Study|Adverse Event|1|||
161818080|NCT00985439|584374344|FG003|Overall Study|Adverse Event|0|||
161818081|NCT00101439|584374348|FG000|Period 2|Withdrawal by Subject|0|||
161818082|NCT00101439|584374349|FG001|Period 2|Withdrawal by Subject|2|||
161818083|NCT00863330|584374355|FG000|Overall Study|study terminated early due to administra|6|||
161818084|NCT02615249|584374356|FG000|Overall Study|Withdrawal by Subject|1|||
161818085|NCT05098743|584374357|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
161818086|NCT05098743|584374358|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
161818087|NCT05098743|584374357|FG000|Overall Study|Lost to Follow-up|1|||
161818088|NCT05098743|584374358|FG001|Overall Study|Lost to Follow-up|2|||
161818089|NCT00868998|584374359|FG000|Overall Study|Screen Failure|1|||
161818090|NCT00868998|584374359|FG000|Overall Study|Withdrawal by Subject|1|||
161493943|NCT02998840|583202401|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
161493944|NCT02998840|583202402|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
161493945|NCT02998840|583202403|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
161493946|NCT02998840|583202404|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
161493947|NCT00665847|583202408|FG000|Overall Study|Adverse Event|8|||
161493948|NCT00665847|583202408|FG000|Overall Study|Withdrawal by Subject|2|||
161493949|NCT00665847|583202408|FG000|Overall Study|Subject non-compliant|8|||
161493950|NCT00665847|583202408|FG000|Overall Study|Subject reached a virologic endpoint|4|||
161493951|NCT00665847|583202408|FG000|Overall Study|Resistance to TMC125|1|||
161493952|NCT00665847|583202408|FG000|Overall Study|Subject ineligible to continue the trial|1|||
161493953|NCT00665847|583202408|FG000|Overall Study|Switch to Commercial Medication|1|||
161493954|NCT01686633|583202409|FG000|Overall Study|Lack of Efficacy|33|||
161493955|NCT01686633|583202410|FG001|Overall Study|Lack of Efficacy|13|||
161493956|NCT01686633|583202411|FG002|Overall Study|Lack of Efficacy|11|||
161493957|NCT01686633|583202409|FG000|Overall Study|Withdrawal by Subject|8|||
161493958|NCT01686633|583202410|FG001|Overall Study|Withdrawal by Subject|8|||
161493959|NCT01686633|583202411|FG002|Overall Study|Withdrawal by Subject|5|||
161493960|NCT01686633|583202409|FG000|Overall Study|Physician Decision|3|||
161493961|NCT01686633|583202410|FG001|Overall Study|Physician Decision|4|||
161493962|NCT01686633|583202411|FG002|Overall Study|Physician Decision|4|||
161493963|NCT01686633|583202409|FG000|Overall Study|Adverse Event|4|||
161493964|NCT01686633|583202410|FG001|Overall Study|Adverse Event|3|||
161493965|NCT01686633|583202411|FG002|Overall Study|Adverse Event|3|||
161493966|NCT01686633|583202409|FG000|Overall Study|Protocol Violation|2|||
161493967|NCT01686633|583202410|FG001|Overall Study|Protocol Violation|3|||
161493968|NCT01686633|583202411|FG002|Overall Study|Protocol Violation|0|||
161493969|NCT01686633|583202409|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
161493970|NCT01686633|583202410|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161493971|NCT01686633|583202411|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
161493972|NCT01686633|583202409|FG000|Overall Study|Lost to Follow-up|0|||
161493973|NCT01686633|583202410|FG001|Overall Study|Lost to Follow-up|1|||
161493974|NCT01686633|583202411|FG002|Overall Study|Lost to Follow-up|1|||
161493975|NCT00511667|583202416|FG000|Overall Study|Adverse Event|1|||
161493976|NCT00511667|583202417|FG001|Overall Study|Adverse Event|0|||
161493977|NCT00511667|583202416|FG000|Overall Study|Protocol Violation|1|||
161493978|NCT00511667|583202417|FG001|Overall Study|Protocol Violation|1|||
161493979|NCT00511667|583202416|FG000|Overall Study|Withdrawal by Subject|2|||
161493980|NCT00511667|583202417|FG001|Overall Study|Withdrawal by Subject|0|||
161493981|NCT00511667|583202416|FG000|Overall Study|Site terminated|6|||
161493982|NCT00511667|583202417|FG001|Overall Study|Site terminated|1|||
161493983|NCT00511667|583202416|FG000|Overall Study|Other|2|||
161493984|NCT00511667|583202417|FG001|Overall Study|Other|1|||
161493985|NCT00623727|583203822|FG000|Double Blind (DB)|Adverse Event|1|||
161493986|NCT00623727|583203823|FG001|Double Blind (DB)|Adverse Event|3|||
161493987|NCT00623727|583203822|FG000|Double Blind (DB)|Physician Decision|0|||
161818091|NCT00868998|584374359|FG000|Overall Study|Progression of disease|2|||
161818092|NCT00868998|584374359|FG000|Overall Study|Death|1|||
161818093|NCT01483820|584374361|FG000|Overall Study|Lack of Efficacy|6|||
161818094|NCT01483820|584374361|FG000|Overall Study|Adverse Event|1|||
161818095|NCT01483820|584374361|FG000|Overall Study|Death|1|||
161493988|NCT00623727|583203823|FG001|Double Blind (DB)|Physician Decision|1|||
161493989|NCT00623727|583203822|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
161818096|NCT00474188|584374365|FG000|Overall Study|Withdrawal by Subject|1|||
161493990|NCT00623727|583203823|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
161818097|NCT00474188|584374365|FG000|Overall Study|Study discontinued by sponsor|5|||
161818098|NCT05412121|584374366|FG000|Overall Study|Withdrawal by Subject|4|||
161818099|NCT05412121|584374366|FG000|Overall Study|Physician Decision|1|||
161493991|NCT00623727|583203822|FG000|Double Blind (DB)|Lack of Efficacy|2|||
161493992|NCT00623727|583203823|FG001|Double Blind (DB)|Lack of Efficacy|2|||
161493993|NCT00623727|583203822|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
161493994|NCT00623727|583203823|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
161493995|NCT00623727|583203822|FG000|Double Blind (DB)|Lost to Follow-up|1|||
161493996|NCT00623727|583203823|FG001|Double Blind (DB)|Lost to Follow-up|1|||
161493997|NCT00623727|583203822|FG000|Double Blind (DB)|Protocol Violation|2|||
161924068|NCT06142383|584768149|FG000|Overall Study|Adverse Event|0|||
161924069|NCT06142383|584768150|FG001|Overall Study|Adverse Event|1|||
161493998|NCT00623727|583203823|FG001|Double Blind (DB)|Protocol Violation|2|||
161493999|NCT00623727|583203822|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
161494000|NCT00623727|583203823|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
161494001|NCT00623727|583203822|FG000|Open Label Follow-up|Study termination|0|||
161494002|NCT00623727|583203823|FG001|Open Label Follow-up|Study termination|6|||
161494003|NCT00623727|583203822|FG000|Open Label Follow-up|Participant convenience|0|||
161494004|NCT00623727|583203823|FG001|Open Label Follow-up|Participant convenience|1|||
161494005|NCT01852942|583203824|FG000|Overall Study|Physician Decision|1|||
161494006|NCT01852942|583203825|FG001|Overall Study|Physician Decision|0|||
161494007|NCT01852942|583203824|FG000|Overall Study|Death|1|||
161494008|NCT01852942|583203825|FG001|Overall Study|Death|1|||
161494009|NCT01852942|583203824|FG000|Overall Study|Withdrawal by Subject|2|||
161494010|NCT01852942|583203825|FG001|Overall Study|Withdrawal by Subject|3|||
161494011|NCT01852942|583203824|FG000|Overall Study|Lost to Follow-up|1|||
161494012|NCT01852942|583203825|FG001|Overall Study|Lost to Follow-up|2|||
161494013|NCT00696696|583203829|FG000|Overall Study|Adverse Event|5|||
161494014|NCT00696696|583203829|FG000|Overall Study|Withdrawal by Subject|8|||
161924070|NCT06142383|584768151|FG002|Overall Study|Adverse Event|1|||
161924071|NCT06142383|584768152|FG003|Overall Study|Adverse Event|0|||
161924072|NCT06142383|584768153|FG004|Overall Study|Adverse Event|0|||
161924073|NCT06142383|584768149|FG000|Overall Study|Death|0|||
161924074|NCT06142383|584768150|FG001|Overall Study|Death|1|||
161924075|NCT06142383|584768151|FG002|Overall Study|Death|3|||
161924076|NCT06142383|584768152|FG003|Overall Study|Death|0|||
161924077|NCT06142383|584768153|FG004|Overall Study|Death|1|||
161924078|NCT06142383|584768149|FG000|Overall Study|Study Terminated by Sponsor|20|||
161924079|NCT06142383|584768150|FG001|Overall Study|Study Terminated by Sponsor|17|||
161924080|NCT06142383|584768151|FG002|Overall Study|Study Terminated by Sponsor|33|||
161494015|NCT00696696|583203829|FG000|Overall Study|Physician Decision|2|||
161494016|NCT00696696|583203829|FG000|Overall Study|Death|3|||
161584283|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161584284|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161584285|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161584286|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
161584287|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161584288|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161584289|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161584290|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161584291|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
161584292|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161584293|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161584294|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161584295|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161584296|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
161584297|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161584298|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161584299|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161584300|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161584301|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
161584302|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161584303|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161584304|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161584305|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161584306|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
161584307|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161584308|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161924081|NCT06142383|584768152|FG003|Overall Study|Study Terminated by Sponsor|0|||
161924082|NCT06142383|584768153|FG004|Overall Study|Study Terminated by Sponsor|21|||
161924083|NCT06142383|584768149|FG000|Overall Study|Subject Decision|0|||
161924084|NCT06142383|584768150|FG001|Overall Study|Subject Decision|1|||
161494017|NCT02642614|583203830|FG000|Overall Study|Adverse Event|1|||
161494018|NCT02642614|583203831|FG001|Overall Study|Adverse Event|1|||
161494019|NCT02642614|583203832|FG002|Overall Study|Adverse Event|2|||
161494020|NCT02642614|583203833|FG003|Overall Study|Adverse Event|2|||
161494021|NCT02642614|583203830|FG000|Overall Study|Lost to Follow-up|1|||
161494022|NCT02642614|583203831|FG001|Overall Study|Lost to Follow-up|0|||
161494023|NCT02642614|583203832|FG002|Overall Study|Lost to Follow-up|0|||
161494024|NCT02642614|583203833|FG003|Overall Study|Lost to Follow-up|0|||
161494025|NCT02642614|583203830|FG000|Overall Study|Withdrawal by Subject|1|||
161494026|NCT02642614|583203831|FG001|Overall Study|Withdrawal by Subject|1|||
161494027|NCT02642614|583203832|FG002|Overall Study|Withdrawal by Subject|0|||
161494028|NCT02642614|583203833|FG003|Overall Study|Withdrawal by Subject|0|||
161494029|NCT01729754|583203836|FG000|Part 1|Adverse Event|2|||
161494030|NCT01729754|583203837|FG001|Part 1|Adverse Event|0|||
161494031|NCT01729754|583203838|FG002|Part 1|Adverse Event|0|||
161494032|NCT01729754|583203839|FG003|Part 1|Adverse Event|1|||
161494033|NCT01729754|583203840|FG004|Part 1|Adverse Event|0|||
161494034|NCT01729754|583203841|FG005|Part 1|Adverse Event|0|||
161494035|NCT01729754|583203842|FG006|Part 1|Adverse Event|2|||
161494036|NCT01729754|583203843|FG007|Part 1|Adverse Event|0|||
161494037|NCT01729754|583203844|FG008|Part 1|Adverse Event|0|||
161494038|NCT01729754|583203845|FG009|Part 1|Adverse Event|5|||
161494039|NCT01729754|583203836|FG000|Part 1|Lack of Efficacy|1|||
161494040|NCT01729754|583203837|FG001|Part 1|Lack of Efficacy|0|||
161494041|NCT01729754|583203838|FG002|Part 1|Lack of Efficacy|0|||
161494042|NCT01729754|583203839|FG003|Part 1|Lack of Efficacy|0|||
161494043|NCT01729754|583203840|FG004|Part 1|Lack of Efficacy|0|||
161494044|NCT01729754|583203841|FG005|Part 1|Lack of Efficacy|0|||
161494045|NCT01729754|583203842|FG006|Part 1|Lack of Efficacy|2|||
161494046|NCT01729754|583203843|FG007|Part 1|Lack of Efficacy|0|||
161494047|NCT01729754|583203844|FG008|Part 1|Lack of Efficacy|0|||
161494048|NCT01729754|583203845|FG009|Part 1|Lack of Efficacy|0|||
161494049|NCT01729754|583203836|FG000|Part 1|Lost to Follow-up|1|||
161494050|NCT01729754|583203837|FG001|Part 1|Lost to Follow-up|0|||
161494051|NCT01729754|583203838|FG002|Part 1|Lost to Follow-up|0|||
161494052|NCT01729754|583203839|FG003|Part 1|Lost to Follow-up|2|||
161494053|NCT01729754|583203840|FG004|Part 1|Lost to Follow-up|0|||
161494054|NCT01729754|583203841|FG005|Part 1|Lost to Follow-up|0|||
161494055|NCT01729754|583203842|FG006|Part 1|Lost to Follow-up|3|||
161494056|NCT01729754|583203843|FG007|Part 1|Lost to Follow-up|0|||
161494057|NCT01729754|583203844|FG008|Part 1|Lost to Follow-up|0|||
161494058|NCT01729754|583203845|FG009|Part 1|Lost to Follow-up|3|||
161494059|NCT01729754|583203836|FG000|Part 1|Non-compliance with Study Drug|1|||
161494060|NCT01729754|583203837|FG001|Part 1|Non-compliance with Study Drug|0|||
161494061|NCT01729754|583203838|FG002|Part 1|Non-compliance with Study Drug|0|||
161494062|NCT01729754|583203839|FG003|Part 1|Non-compliance with Study Drug|0|||
161494063|NCT01729754|583203840|FG004|Part 1|Non-compliance with Study Drug|0|||
161494064|NCT01729754|583203841|FG005|Part 1|Non-compliance with Study Drug|0|||
161494065|NCT01729754|583203842|FG006|Part 1|Non-compliance with Study Drug|0|||
161494066|NCT01729754|583203843|FG007|Part 1|Non-compliance with Study Drug|0|||
161494067|NCT01729754|583203844|FG008|Part 1|Non-compliance with Study Drug|0|||
161494068|NCT01729754|583203845|FG009|Part 1|Non-compliance with Study Drug|0|||
161494069|NCT01729754|583203836|FG000|Part 1|Physician Decision|0|||
161494070|NCT01729754|583203837|FG001|Part 1|Physician Decision|0|||
161494071|NCT01729754|583203838|FG002|Part 1|Physician Decision|0|||
161494072|NCT01729754|583203839|FG003|Part 1|Physician Decision|0|||
161494073|NCT01729754|583203840|FG004|Part 1|Physician Decision|0|||
161494074|NCT01729754|583203841|FG005|Part 1|Physician Decision|0|||
161494075|NCT01729754|583203842|FG006|Part 1|Physician Decision|0|||
161494076|NCT01729754|583203843|FG007|Part 1|Physician Decision|0|||
161494077|NCT01729754|583203844|FG008|Part 1|Physician Decision|0|||
161494078|NCT01729754|583203845|FG009|Part 1|Physician Decision|4|||
161494079|NCT01729754|583203836|FG000|Part 1|Pregnancy|0|||
161494080|NCT01729754|583203837|FG001|Part 1|Pregnancy|0|||
161494081|NCT01729754|583203838|FG002|Part 1|Pregnancy|0|||
161584309|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161584310|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161494082|NCT01729754|583203839|FG003|Part 1|Pregnancy|1|||
161584311|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
161584312|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161494083|NCT01729754|583203840|FG004|Part 1|Pregnancy|0|||
161494084|NCT01729754|583203841|FG005|Part 1|Pregnancy|0|||
161494085|NCT01729754|583203842|FG006|Part 1|Pregnancy|0|||
161494086|NCT01729754|583203843|FG007|Part 1|Pregnancy|0|||
161494087|NCT01729754|583203844|FG008|Part 1|Pregnancy|0|||
161494088|NCT01729754|583203845|FG009|Part 1|Pregnancy|1|||
161494089|NCT01729754|583203836|FG000|Part 1|Progressive Disease|0|||
161494090|NCT01729754|583203837|FG001|Part 1|Progressive Disease|0|||
161494091|NCT01729754|583203838|FG002|Part 1|Progressive Disease|0|||
161494092|NCT01729754|583203839|FG003|Part 1|Progressive Disease|0|||
161494093|NCT01729754|583203840|FG004|Part 1|Progressive Disease|0|||
161494094|NCT01729754|583203841|FG005|Part 1|Progressive Disease|0|||
161494095|NCT01729754|583203842|FG006|Part 1|Progressive Disease|0|||
161494096|NCT01729754|583203843|FG007|Part 1|Progressive Disease|0|||
161494097|NCT01729754|583203844|FG008|Part 1|Progressive Disease|0|||
161494098|NCT01729754|583203845|FG009|Part 1|Progressive Disease|1|||
161494099|NCT01729754|583203836|FG000|Part 1|Protocol Violation|2|||
161494100|NCT01729754|583203837|FG001|Part 1|Protocol Violation|0|||
161494101|NCT01729754|583203838|FG002|Part 1|Protocol Violation|0|||
161494102|NCT01729754|583203839|FG003|Part 1|Protocol Violation|1|||
161494103|NCT01729754|583203840|FG004|Part 1|Protocol Violation|0|||
161494104|NCT01729754|583203841|FG005|Part 1|Protocol Violation|0|||
161494105|NCT01729754|583203842|FG006|Part 1|Protocol Violation|1|||
161494106|NCT01729754|583203843|FG007|Part 1|Protocol Violation|0|||
161494107|NCT01729754|583203844|FG008|Part 1|Protocol Violation|0|||
161494108|NCT01729754|583203845|FG009|Part 1|Protocol Violation|0|||
161494109|NCT01729754|583203836|FG000|Part 1|Withdrawal by Subject|5|||
161494110|NCT01729754|583203837|FG001|Part 1|Withdrawal by Subject|0|||
161494111|NCT01729754|583203838|FG002|Part 1|Withdrawal by Subject|0|||
161494112|NCT01729754|583203839|FG003|Part 1|Withdrawal by Subject|7|||
161494113|NCT01729754|583203840|FG004|Part 1|Withdrawal by Subject|0|||
161494114|NCT01729754|583203841|FG005|Part 1|Withdrawal by Subject|0|||
161494115|NCT01729754|583203842|FG006|Part 1|Withdrawal by Subject|5|||
161494116|NCT01729754|583203843|FG007|Part 1|Withdrawal by Subject|0|||
161494117|NCT01729754|583203844|FG008|Part 1|Withdrawal by Subject|0|||
161494118|NCT01729754|583203845|FG009|Part 1|Withdrawal by Subject|6|||
161494119|NCT01729754|583203836|FG000|Part 1|Other Protocol Specified Criteria|2|||
161494120|NCT01729754|583203837|FG001|Part 1|Other Protocol Specified Criteria|0|||
161494121|NCT01729754|583203838|FG002|Part 1|Other Protocol Specified Criteria|0|||
161494122|NCT01729754|583203839|FG003|Part 1|Other Protocol Specified Criteria|0|||
161494123|NCT01729754|583203840|FG004|Part 1|Other Protocol Specified Criteria|0|||
161494124|NCT01729754|583203841|FG005|Part 1|Other Protocol Specified Criteria|0|||
161494125|NCT01729754|583203842|FG006|Part 1|Other Protocol Specified Criteria|1|||
161494126|NCT01729754|583203843|FG007|Part 1|Other Protocol Specified Criteria|0|||
161494127|NCT01729754|583203844|FG008|Part 1|Other Protocol Specified Criteria|0|||
161494128|NCT01729754|583203845|FG009|Part 1|Other Protocol Specified Criteria|4|||
161494129|NCT01729754|583203836|FG000|Part 2|Adverse Event|2|||
161494130|NCT01729754|583203837|FG001|Part 2|Adverse Event|0|||
161494131|NCT01729754|583203838|FG002|Part 2|Adverse Event|0|||
161494132|NCT01729754|583203839|FG003|Part 2|Adverse Event|0|||
161494133|NCT01729754|583203840|FG004|Part 2|Adverse Event|0|||
161494134|NCT01729754|583203841|FG005|Part 2|Adverse Event|0|||
161494135|NCT01729754|583203842|FG006|Part 2|Adverse Event|0|||
161494136|NCT01729754|583203843|FG007|Part 2|Adverse Event|0|||
161494137|NCT01729754|583203844|FG008|Part 2|Adverse Event|1|||
161494138|NCT01729754|583203845|FG009|Part 2|Adverse Event|2|||
161494139|NCT01729754|583203836|FG000|Part 2|Lack of Efficacy|0|||
161494140|NCT01729754|583203837|FG001|Part 2|Lack of Efficacy|0|||
161494141|NCT01729754|583203838|FG002|Part 2|Lack of Efficacy|0|||
161494142|NCT01729754|583203839|FG003|Part 2|Lack of Efficacy|0|||
161494143|NCT01729754|583203840|FG004|Part 2|Lack of Efficacy|0|||
161494144|NCT01729754|583203841|FG005|Part 2|Lack of Efficacy|0|||
161494145|NCT01729754|583203842|FG006|Part 2|Lack of Efficacy|0|||
161494146|NCT01729754|583203843|FG007|Part 2|Lack of Efficacy|0|||
161494147|NCT01729754|583203844|FG008|Part 2|Lack of Efficacy|2|||
161494148|NCT01729754|583203845|FG009|Part 2|Lack of Efficacy|2|||
161494149|NCT01729754|583203836|FG000|Part 2|Lost to Follow-up|0|||
161494150|NCT01729754|583203837|FG001|Part 2|Lost to Follow-up|0|||
161494151|NCT01729754|583203838|FG002|Part 2|Lost to Follow-up|0|||
161494152|NCT01729754|583203839|FG003|Part 2|Lost to Follow-up|2|||
161494153|NCT01729754|583203840|FG004|Part 2|Lost to Follow-up|0|||
161494154|NCT01729754|583203841|FG005|Part 2|Lost to Follow-up|0|||
161494155|NCT01729754|583203842|FG006|Part 2|Lost to Follow-up|0|||
161494156|NCT01729754|583203843|FG007|Part 2|Lost to Follow-up|1|||
161494157|NCT01729754|583203844|FG008|Part 2|Lost to Follow-up|0|||
161494158|NCT01729754|583203845|FG009|Part 2|Lost to Follow-up|2|||
161494159|NCT01729754|583203836|FG000|Part 2|Non-Compliance with Study Drug|0|||
161494160|NCT01729754|583203837|FG001|Part 2|Non-Compliance with Study Drug|0|||
161494161|NCT01729754|583203838|FG002|Part 2|Non-Compliance with Study Drug|0|||
161494162|NCT01729754|583203839|FG003|Part 2|Non-Compliance with Study Drug|0|||
161494163|NCT01729754|583203840|FG004|Part 2|Non-Compliance with Study Drug|0|||
161494164|NCT01729754|583203841|FG005|Part 2|Non-Compliance with Study Drug|0|||
161494165|NCT01729754|583203842|FG006|Part 2|Non-Compliance with Study Drug|0|||
161494166|NCT01729754|583203843|FG007|Part 2|Non-Compliance with Study Drug|0|||
161494167|NCT01729754|583203844|FG008|Part 2|Non-Compliance with Study Drug|0|||
161494168|NCT01729754|583203845|FG009|Part 2|Non-Compliance with Study Drug|1|||
161494169|NCT01729754|583203836|FG000|Part 2|Pregnancy|0|||
161494170|NCT01729754|583203837|FG001|Part 2|Pregnancy|0|||
161494171|NCT01729754|583203838|FG002|Part 2|Pregnancy|0|||
161494172|NCT01729754|583203839|FG003|Part 2|Pregnancy|1|||
161494173|NCT01729754|583203840|FG004|Part 2|Pregnancy|0|||
161494174|NCT01729754|583203841|FG005|Part 2|Pregnancy|0|||
161494175|NCT01729754|583203842|FG006|Part 2|Pregnancy|0|||
161494176|NCT01729754|583203843|FG007|Part 2|Pregnancy|0|||
161494177|NCT01729754|583203844|FG008|Part 2|Pregnancy|0|||
161494178|NCT01729754|583203845|FG009|Part 2|Pregnancy|1|||
161494179|NCT01729754|583203836|FG000|Part 2|Withdrawal by Subject|3|||
161494180|NCT01729754|583203837|FG001|Part 2|Withdrawal by Subject|0|||
161494181|NCT01729754|583203838|FG002|Part 2|Withdrawal by Subject|0|||
161494182|NCT01729754|583203839|FG003|Part 2|Withdrawal by Subject|2|||
161494183|NCT01729754|583203840|FG004|Part 2|Withdrawal by Subject|0|||
161494184|NCT01729754|583203841|FG005|Part 2|Withdrawal by Subject|0|||
161494185|NCT01729754|583203842|FG006|Part 2|Withdrawal by Subject|0|||
161924085|NCT06142383|584768151|FG002|Overall Study|Subject Decision|2|||
161924086|NCT06142383|584768152|FG003|Overall Study|Subject Decision|0|||
161924087|NCT06142383|584768153|FG004|Overall Study|Subject Decision|0|||
161924088|NCT00544882|584768157|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
161924089|NCT00544882|584768158|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
161924090|NCT00544882|584768159|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
161924091|NCT00544882|584768157|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
161924092|NCT00544882|584768158|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
161494186|NCT01729754|583203843|FG007|Part 2|Withdrawal by Subject|1|||
161494187|NCT01729754|583203844|FG008|Part 2|Withdrawal by Subject|1|||
161494188|NCT01729754|583203845|FG009|Part 2|Withdrawal by Subject|4|||
161494189|NCT01729754|583203836|FG000|Part 2|Other Protocol Specified Criteria|1|||
161494190|NCT01729754|583203837|FG001|Part 2|Other Protocol Specified Criteria|0|||
161494191|NCT01729754|583203838|FG002|Part 2|Other Protocol Specified Criteria|0|||
161494192|NCT01729754|583203839|FG003|Part 2|Other Protocol Specified Criteria|0|||
161494193|NCT01729754|583203840|FG004|Part 2|Other Protocol Specified Criteria|0|||
161494194|NCT01729754|583203841|FG005|Part 2|Other Protocol Specified Criteria|0|||
161494195|NCT01729754|583203842|FG006|Part 2|Other Protocol Specified Criteria|0|||
161494196|NCT01729754|583203843|FG007|Part 2|Other Protocol Specified Criteria|1|||
161494197|NCT01729754|583203844|FG008|Part 2|Other Protocol Specified Criteria|0|||
161494198|NCT01729754|583203845|FG009|Part 2|Other Protocol Specified Criteria|0|||
161494199|NCT01729754|583203836|FG000|Part 3|Adverse Event|0|||
161494200|NCT01729754|583203837|FG001|Part 3|Adverse Event|0|||
161494201|NCT01729754|583203838|FG002|Part 3|Adverse Event|1|||
161494202|NCT01729754|583203839|FG003|Part 3|Adverse Event|0|||
161494203|NCT01729754|583203840|FG004|Part 3|Adverse Event|0|||
161494204|NCT01729754|583203841|FG005|Part 3|Adverse Event|5|||
161494205|NCT01729754|583203842|FG006|Part 3|Adverse Event|0|||
161494206|NCT01729754|583203843|FG007|Part 3|Adverse Event|0|||
161494207|NCT01729754|583203844|FG008|Part 3|Adverse Event|0|||
161494208|NCT01729754|583203845|FG009|Part 3|Adverse Event|3|||
161494209|NCT01729754|583203836|FG000|Part 3|Death|0|||
161494210|NCT01729754|583203837|FG001|Part 3|Death|0|||
161494211|NCT01729754|583203838|FG002|Part 3|Death|0|||
161494212|NCT01729754|583203839|FG003|Part 3|Death|0|||
161494213|NCT01729754|583203840|FG004|Part 3|Death|0|||
161494214|NCT01729754|583203841|FG005|Part 3|Death|2|||
161494215|NCT01729754|583203842|FG006|Part 3|Death|0|||
161494216|NCT01729754|583203843|FG007|Part 3|Death|0|||
161494217|NCT01729754|583203844|FG008|Part 3|Death|0|||
161494218|NCT01729754|583203845|FG009|Part 3|Death|0|||
161494219|NCT01729754|583203836|FG000|Part 3|Lack of Efficacy|0|||
161494220|NCT01729754|583203837|FG001|Part 3|Lack of Efficacy|0|||
161494221|NCT01729754|583203838|FG002|Part 3|Lack of Efficacy|0|||
161494222|NCT01729754|583203839|FG003|Part 3|Lack of Efficacy|0|||
161924093|NCT00544882|584768159|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
161494223|NCT01729754|583203840|FG004|Part 3|Lack of Efficacy|2|||
161494224|NCT01729754|583203841|FG005|Part 3|Lack of Efficacy|0|||
161494225|NCT01729754|583203842|FG006|Part 3|Lack of Efficacy|0|||
161494226|NCT01729754|583203843|FG007|Part 3|Lack of Efficacy|0|||
161494227|NCT01729754|583203844|FG008|Part 3|Lack of Efficacy|0|||
161494228|NCT01729754|583203845|FG009|Part 3|Lack of Efficacy|4|||
161494229|NCT01729754|583203836|FG000|Part 3|Lost to Follow-up|0|||
161494230|NCT01729754|583203837|FG001|Part 3|Lost to Follow-up|1|||
161494231|NCT01729754|583203838|FG002|Part 3|Lost to Follow-up|2|||
161494232|NCT01729754|583203839|FG003|Part 3|Lost to Follow-up|0|||
161494233|NCT01729754|583203840|FG004|Part 3|Lost to Follow-up|0|||
161494234|NCT01729754|583203841|FG005|Part 3|Lost to Follow-up|3|||
161494235|NCT01729754|583203842|FG006|Part 3|Lost to Follow-up|0|||
161494236|NCT01729754|583203843|FG007|Part 3|Lost to Follow-up|0|||
161494237|NCT01729754|583203844|FG008|Part 3|Lost to Follow-up|1|||
161494238|NCT01729754|583203845|FG009|Part 3|Lost to Follow-up|0|||
161494239|NCT01729754|583203836|FG000|Part 3|Physician Decision|0|||
161494240|NCT01729754|583203837|FG001|Part 3|Physician Decision|0|||
161494241|NCT01729754|583203838|FG002|Part 3|Physician Decision|1|||
161494242|NCT01729754|583203839|FG003|Part 3|Physician Decision|0|||
161494243|NCT01729754|583203840|FG004|Part 3|Physician Decision|0|||
161494244|NCT01729754|583203841|FG005|Part 3|Physician Decision|0|||
161494245|NCT01729754|583203842|FG006|Part 3|Physician Decision|0|||
161494246|NCT01729754|583203843|FG007|Part 3|Physician Decision|0|||
161494247|NCT01729754|583203844|FG008|Part 3|Physician Decision|0|||
161494248|NCT01729754|583203845|FG009|Part 3|Physician Decision|0|||
161494249|NCT01729754|583203836|FG000|Part 3|Withdrawal by Subject|0|||
161494250|NCT01729754|583203837|FG001|Part 3|Withdrawal by Subject|4|||
161494251|NCT01729754|583203838|FG002|Part 3|Withdrawal by Subject|1|||
161494252|NCT01729754|583203839|FG003|Part 3|Withdrawal by Subject|0|||
161494253|NCT01729754|583203840|FG004|Part 3|Withdrawal by Subject|2|||
161494254|NCT01729754|583203841|FG005|Part 3|Withdrawal by Subject|1|||
161494255|NCT01729754|583203842|FG006|Part 3|Withdrawal by Subject|0|||
161494256|NCT01729754|583203843|FG007|Part 3|Withdrawal by Subject|2|||
161494257|NCT01729754|583203844|FG008|Part 3|Withdrawal by Subject|0|||
161494258|NCT01729754|583203845|FG009|Part 3|Withdrawal by Subject|0|||
161494259|NCT01729754|583203836|FG000|Part 3|Other Protocol Specified Criteria|0|||
161494260|NCT01729754|583203837|FG001|Part 3|Other Protocol Specified Criteria|0|||
161494261|NCT01729754|583203838|FG002|Part 3|Other Protocol Specified Criteria|0|||
161494262|NCT01729754|583203839|FG003|Part 3|Other Protocol Specified Criteria|0|||
161494263|NCT01729754|583203840|FG004|Part 3|Other Protocol Specified Criteria|0|||
161494264|NCT01729754|583203841|FG005|Part 3|Other Protocol Specified Criteria|2|||
161494265|NCT01729754|583203842|FG006|Part 3|Other Protocol Specified Criteria|0|||
161494266|NCT01729754|583203843|FG007|Part 3|Other Protocol Specified Criteria|1|||
161494267|NCT01729754|583203844|FG008|Part 3|Other Protocol Specified Criteria|0|||
161494268|NCT01729754|583203845|FG009|Part 3|Other Protocol Specified Criteria|0|||
161494269|NCT00936910|583203846|FG000|Overall Study|Lack of Efficacy|3|||
161494270|NCT01349803|583203848|FG000|Overall Study|Adverse Event|0|||
161494271|NCT01349803|583203849|FG001|Overall Study|Adverse Event|0|||
161494272|NCT01349803|583203850|FG002|Overall Study|Adverse Event|0|||
161494273|NCT01349803|583203851|FG003|Overall Study|Adverse Event|2|||
161494274|NCT01349803|583203848|FG000|Overall Study|Withdrawal by Subject|1|||
161494275|NCT01349803|583203849|FG001|Overall Study|Withdrawal by Subject|0|||
161494276|NCT01349803|583203850|FG002|Overall Study|Withdrawal by Subject|0|||
161494277|NCT01349803|583203851|FG003|Overall Study|Withdrawal by Subject|0|||
161494278|NCT01349803|583203848|FG000|Overall Study|Protocol-specified criteria|0|||
161494279|NCT01349803|583203849|FG001|Overall Study|Protocol-specified criteria|1|||
161494280|NCT01349803|583203850|FG002|Overall Study|Protocol-specified criteria|3|||
161494281|NCT01349803|583203851|FG003|Overall Study|Protocol-specified criteria|0|||
161494282|NCT02345811|583203852|FG000|First Intervention|Withdrawal by Subject|1|||
161494283|NCT02345811|583203853|FG001|First Intervention|Withdrawal by Subject|1|||
161494284|NCT02522286|583203854|FG000|Overall Study|Withdrawal by Subject|3|||
161494285|NCT02522286|583203855|FG001|Overall Study|Withdrawal by Subject|0|||
161494286|NCT02522286|583203856|FG002|Overall Study|Withdrawal by Subject|0|||
161494287|NCT02522286|583203857|FG003|Overall Study|Withdrawal by Subject|3|||
161494288|NCT00605813|583203859|FG000|Overall Study|Protocol Violation|25|||
161494289|NCT01163279|583203861|FG000|Overall Study|Withdrawal by Subject|2|||
161494290|NCT01163279|583203862|FG001|Overall Study|Withdrawal by Subject|0|||
161494291|NCT01870583|583203863|FG000|Overall Study|Protocol Violation|0|||
161494292|NCT01870583|583203864|FG001|Overall Study|Protocol Violation|5|||
161494293|NCT01870583|583203865|FG002|Overall Study|Protocol Violation|3|||
161494294|NCT01870583|583203863|FG000|Overall Study|Lost to Follow-up|11|||
161494295|NCT01870583|583203864|FG001|Overall Study|Lost to Follow-up|13|||
161494296|NCT01870583|583203865|FG002|Overall Study|Lost to Follow-up|5|||
161494297|NCT01394523|583203866|FG000|Overall Study|Unable to place block|1|||
161494298|NCT01394523|583203867|FG001|Overall Study|Unable to place block|0|||
161494299|NCT01394523|583203868|FG002|Overall Study|Unable to place block|0|||
161494300|NCT02389998|583203872|FG000|Overall Study|car accident|1|||
161494301|NCT02389998|583203873|FG001|Overall Study|car accident|0|||
161494302|NCT04741074|583203874|FG000|Overall Study|Withdrawal by Subject|1|||
161494303|NCT04741074|583203875|FG001|Overall Study|Withdrawal by Subject|1|||
161494304|NCT04741074|583203874|FG000|Overall Study|Study terminated prematurely|1|||
161494305|NCT04741074|583203875|FG001|Overall Study|Study terminated prematurely|0|||
161494306|NCT01770379|583203877|FG000|Overall Study|Technical issues|1|||
161494307|NCT01770379|583203878|FG001|Overall Study|Technical issues|0|||
161494308|NCT01770379|583203879|FG002|Overall Study|Technical issues|0|||
161494309|NCT01770379|583203877|FG000|Overall Study|Withdrawal by Subject|7|||
161494310|NCT01770379|583203878|FG001|Overall Study|Withdrawal by Subject|10|||
161494311|NCT01770379|583203879|FG002|Overall Study|Withdrawal by Subject|7|||
161494312|NCT01770379|583203877|FG000|Overall Study|study terminated by sponsor|22|||
161494313|NCT01770379|583203878|FG001|Overall Study|study terminated by sponsor|23|||
161494314|NCT01770379|583203879|FG002|Overall Study|study terminated by sponsor|22|||
161494315|NCT01770379|583203877|FG000|Overall Study|Protocol Violation|0|||
161494316|NCT01770379|583203878|FG001|Overall Study|Protocol Violation|1|||
161494317|NCT01770379|583203879|FG002|Overall Study|Protocol Violation|1|||
161494318|NCT01770379|583203877|FG000|Overall Study|Physician Decision|0|||
161494319|NCT01770379|583203878|FG001|Overall Study|Physician Decision|1|||
161494320|NCT01770379|583203879|FG002|Overall Study|Physician Decision|2|||
161494321|NCT01770379|583203877|FG000|Overall Study|Lost to Follow-up|0|||
161494322|NCT01770379|583203878|FG001|Overall Study|Lost to Follow-up|0|||
161494323|NCT01770379|583203879|FG002|Overall Study|Lost to Follow-up|2|||
161494324|NCT01770379|583203877|FG000|Overall Study|Lack of Efficacy|8|||
161494325|NCT01770379|583203878|FG001|Overall Study|Lack of Efficacy|6|||
161494326|NCT01770379|583203879|FG002|Overall Study|Lack of Efficacy|6|||
161494327|NCT01770379|583203877|FG000|Overall Study|Adverse Event|1|||
161494328|NCT01770379|583203878|FG001|Overall Study|Adverse Event|3|||
161494329|NCT01770379|583203879|FG002|Overall Study|Adverse Event|2|||
161494330|NCT00778700|583203880|FG000|Overall Study|Adverse Event|6|||
161494331|NCT00778700|583203881|FG001|Overall Study|Adverse Event|1|||
161494332|NCT00778700|583203882|FG002|Overall Study|Adverse Event|3|||
161494333|NCT00778700|583203883|FG003|Overall Study|Adverse Event|5|||
161494334|NCT00778700|583203880|FG000|Overall Study|Protocol Violation|1|||
161494335|NCT00778700|583203881|FG001|Overall Study|Protocol Violation|1|||
161494336|NCT00778700|583203882|FG002|Overall Study|Protocol Violation|0|||
161494337|NCT00778700|583203883|FG003|Overall Study|Protocol Violation|0|||
161494338|NCT00778700|583203880|FG000|Overall Study|Subject Withdrew Consent|6|||
161494339|NCT00778700|583203881|FG001|Overall Study|Subject Withdrew Consent|4|||
161494340|NCT00778700|583203882|FG002|Overall Study|Subject Withdrew Consent|1|||
161494341|NCT00778700|583203883|FG003|Overall Study|Subject Withdrew Consent|4|||
161494342|NCT00778700|583203880|FG000|Overall Study|Lost to Follow-up|3|||
161494343|NCT00778700|583203881|FG001|Overall Study|Lost to Follow-up|1|||
161494344|NCT00778700|583203882|FG002|Overall Study|Lost to Follow-up|0|||
161494345|NCT00778700|583203883|FG003|Overall Study|Lost to Follow-up|1|||
161494346|NCT00778700|583203880|FG000|Overall Study|Reason not Specified|2|||
161494347|NCT00778700|583203881|FG001|Overall Study|Reason not Specified|0|||
161494348|NCT00778700|583203882|FG002|Overall Study|Reason not Specified|1|||
161494349|NCT00778700|583203883|FG003|Overall Study|Reason not Specified|3|||
161494350|NCT00778700|583203880|FG000|Overall Study|Other|0|||
161494351|NCT00778700|583203881|FG001|Overall Study|Other|0|||
161494352|NCT00778700|583203882|FG002|Overall Study|Other|1|||
161494353|NCT00778700|583203883|FG003|Overall Study|Other|0|||
161494354|NCT03274440|583203886|FG000|Overall Study|Time commitment too great|1|||
161494355|NCT03274440|583203887|FG001|Overall Study|Time commitment too great|0|||
161494356|NCT03274440|583203888|FG002|Overall Study|Time commitment too great|0|||
161494357|NCT03274440|583203889|FG003|Overall Study|Time commitment too great|1|||
161494358|NCT03274440|583203890|FG004|Overall Study|Time commitment too great|0|||
161494359|NCT03274440|583203891|FG005|Overall Study|Time commitment too great|0|||
161494360|NCT00450450|583203892|FG000|Overall Study|Death|1|||
161494361|NCT00450450|583203893|FG001|Overall Study|Death|3|||
161494362|NCT00450450|583203892|FG000|Overall Study|Relapse|2|||
161494363|NCT00450450|583203893|FG001|Overall Study|Relapse|0|||
161494364|NCT00450450|583203892|FG000|Overall Study|Missing Data|2|||
161494365|NCT00450450|583203893|FG001|Overall Study|Missing Data|0|||
161494366|NCT02150954|583203896|FG000|Overall Study|Protocol Violation|1|||
161494367|NCT02150954|583203897|FG001|Overall Study|Protocol Violation|0|||
161494368|NCT02369341|583203903|FG000|Overall Study|Migrated/moved from study area|1|||
161494369|NCT02369341|583203904|FG001|Overall Study|Migrated/moved from study area|0|||
161494370|NCT02574247|583203912|FG000|Overall Study|Withdrawal by Subject|1|||
161494371|NCT02574247|583203913|FG001|Overall Study|Withdrawal by Subject|0|||
161494372|NCT02574247|583203914|FG002|Overall Study|Withdrawal by Subject|0|||
161494373|NCT02574247|583203912|FG000|Overall Study|Did not meet inclusion criteria|4|||
161494374|NCT02574247|583203913|FG001|Overall Study|Did not meet inclusion criteria|3|||
161494375|NCT02574247|583203914|FG002|Overall Study|Did not meet inclusion criteria|5|||
161494376|NCT02707991|583203915|FG000|Overall Study|Protocol Violation|1|||
161494377|NCT02707991|583203916|FG001|Overall Study|Protocol Violation|0|||
161494378|NCT02707991|583203915|FG000|Overall Study|Became ineligible|0|||
161494379|NCT02707991|583203916|FG001|Overall Study|Became ineligible|1|||
161494380|NCT02268864|583203917|FG000|Overall Study|Withdrawal by Subject|2|||
161494381|NCT02268864|583203918|FG001|Overall Study|Withdrawal by Subject|0|||
161494382|NCT02268864|583203919|FG002|Overall Study|Withdrawal by Subject|0|||
161494383|NCT02268864|583203917|FG000|Overall Study|Death|0|||
161494384|NCT02268864|583203918|FG001|Overall Study|Death|1|||
161494385|NCT02268864|583203919|FG002|Overall Study|Death|0|||
161494386|NCT01496313|583203922|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
161494387|NCT01496313|583203923|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
161494388|NCT01496313|583203924|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
161494389|NCT01496313|583203925|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
161494390|NCT01496313|583203926|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
161494391|NCT01496313|583203927|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
161494392|NCT01496313|583203922|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
161494393|NCT01496313|583203923|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
161818100|NCT05412121|584374366|FG000|Overall Study|Lost to Follow-up|5|||
161494394|NCT01496313|583203924|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
161494395|NCT01496313|583203925|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
161494396|NCT01496313|583203926|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
161494397|NCT01496313|583203927|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
161494398|NCT01496313|583203922|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
161494399|NCT01496313|583203923|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
161494400|NCT01496313|583203924|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
161494401|NCT01496313|583203925|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
161494402|NCT01496313|583203926|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
161494403|NCT01496313|583203927|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
161494404|NCT01496313|583203922|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
161494405|NCT01496313|583203923|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
161584313|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161584314|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161584315|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161584316|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
161584317|NCT01898494|583527978|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161584318|NCT01898494|583527979|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161584319|NCT01898494|583527980|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161584320|NCT01898494|583527981|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161584321|NCT01898494|583527982|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
161584322|NCT01898494|583527978|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161584323|NCT01898494|583527979|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161584324|NCT01898494|583527980|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
161584325|NCT01898494|583527981|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
161584326|NCT01898494|583527982|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161584327|NCT01898494|583527978|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161584328|NCT01898494|583527979|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161584329|NCT01898494|583527980|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
161584330|NCT01898494|583527981|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
161584331|NCT01898494|583527982|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161584332|NCT01898494|583527978|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
161584333|NCT01898494|583527979|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
161584334|NCT01898494|583527980|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
161584335|NCT01898494|583527981|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
161584336|NCT01898494|583527982|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
161584337|NCT01898494|583527978|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161584338|NCT01898494|583527979|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
161584339|NCT01898494|583527980|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161584340|NCT01898494|583527981|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161584341|NCT01898494|583527982|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161584342|NCT01898494|583527978|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161584343|NCT01898494|583527979|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161584344|NCT01898494|583527980|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
161584345|NCT01898494|583527981|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161584346|NCT01898494|583527982|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161584347|NCT01898494|583527978|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
161584348|NCT01898494|583527979|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
161584349|NCT01898494|583527980|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
161584350|NCT01898494|583527981|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
161584351|NCT01898494|583527982|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
161584352|NCT04868110|583527991|FG000|Overall Study|Withdrawal by Subject|3|||
161584353|NCT04868110|583527992|FG001|Overall Study|Withdrawal by Subject|4|||
161584354|NCT00505934|583527995|FG000|Overall Study|Adverse Event|1|||
161584355|NCT00505934|583527995|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
161584356|NCT00505934|583527995|FG000|Overall Study|Other: IV dose needed to be changed|1|||
161584357|NCT01046136|583527998|FG000|Overall Study|Withdrawal by Subject|0|||
161584358|NCT01046136|583527999|FG001|Overall Study|Withdrawal by Subject|4|||
161584359|NCT01046136|583527998|FG000|Overall Study|Physician Decision|1|||
161584360|NCT01046136|583527999|FG001|Overall Study|Physician Decision|1|||
161584361|NCT01046136|583527998|FG000|Overall Study|Lost to Follow-up|3|||
161584362|NCT01046136|583527999|FG001|Overall Study|Lost to Follow-up|3|||
161584363|NCT02058108|583528000|FG000|Overall Study|Abnormal Laboratory Values|0|||
161584364|NCT02058108|583528001|FG001|Overall Study|Abnormal Laboratory Values|1|||
161584365|NCT02058108|583528000|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
161584366|NCT02058108|583528001|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161494406|NCT01496313|583203924|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
161584367|NCT02058108|583528000|FG000|Overall Study|No longer requires study drug|0|||
161584368|NCT02058108|583528001|FG001|Overall Study|No longer requires study drug|1|||
161584369|NCT02058108|583528000|FG000|Overall Study|Withdrawal by Subject|1|||
161584370|NCT02058108|583528001|FG001|Overall Study|Withdrawal by Subject|0|||
161584371|NCT02058108|583528000|FG000|Overall Study|Administrative problems|3|||
161584372|NCT02058108|583528001|FG001|Overall Study|Administrative problems|3|||
161584373|NCT02058108|583528000|FG000|Overall Study|Protocol Violation|0|||
161584374|NCT02058108|583528001|FG001|Overall Study|Protocol Violation|1|||
161584375|NCT01376700|583528005|FG000|Overall Study|Sponsor terminated study early|8|||
161584376|NCT01376700|583528005|FG000|Overall Study|Low or high titer inhibitor|8|||
161584377|NCT00727909|583528006|FG000|Overall Study|Withdrawal by Subject|5|||
161584378|NCT00727909|583528007|FG001|Overall Study|Withdrawal by Subject|11|||
161584379|NCT00727909|583528008|FG002|Overall Study|Withdrawal by Subject|8|||
161584380|NCT00727909|583528009|FG003|Overall Study|Withdrawal by Subject|5|||
161584381|NCT00727909|583528006|FG000|Overall Study|Death|0|||
161584382|NCT00727909|583528007|FG001|Overall Study|Death|0|||
161584383|NCT00727909|583528008|FG002|Overall Study|Death|1|||
161584384|NCT00727909|583528009|FG003|Overall Study|Death|0|||
161584385|NCT01696773|583528010|FG000|Days 15-27, Washout|Adverse Event|1|||
161584386|NCT01696773|583528011|FG001|Days 15-27, Washout|Adverse Event|0|||
161584387|NCT03446157|583528012|FG000|Overall Study|Death|11|||
161584388|NCT03446157|583528013|FG001|Overall Study|Death|9|||
161584389|NCT03446157|583528012|FG000|Overall Study|Lost to Follow-up|0|||
161584390|NCT03446157|583528013|FG001|Overall Study|Lost to Follow-up|1|||
161584391|NCT03446157|583528012|FG000|Overall Study|Withdrawal by Subject|2|||
161584392|NCT03446157|583528013|FG001|Overall Study|Withdrawal by Subject|1|||
161584393|NCT02386553|583528014|FG000|Overall Study|Reason Not Specified|1|||
161584394|NCT02386553|583528015|FG001|Overall Study|Reason Not Specified|1|||
161584395|NCT02386553|583528014|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
161584396|NCT02386553|583528015|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
161584397|NCT05623345|583528024|FG000|Overall Study|Withdrawal by Subject|14|||
161584398|NCT05623345|583528025|FG001|Overall Study|Withdrawal by Subject|0|||
161584399|NCT05623345|583528026|FG002|Overall Study|Withdrawal by Subject|9|||
161584400|NCT05623345|583528027|FG003|Overall Study|Withdrawal by Subject|20|||
161584401|NCT05623345|583528024|FG000|Overall Study|Lost to Follow-up|3|||
161584402|NCT05623345|583528025|FG001|Overall Study|Lost to Follow-up|0|||
161584403|NCT05623345|583528026|FG002|Overall Study|Lost to Follow-up|7|||
161584404|NCT05623345|583528027|FG003|Overall Study|Lost to Follow-up|2|||
161584405|NCT05623345|583528024|FG000|Overall Study|Termination of Study By Sponsor|37|||
161584406|NCT05623345|583528025|FG001|Overall Study|Termination of Study By Sponsor|4|||
161584407|NCT05623345|583528026|FG002|Overall Study|Termination of Study By Sponsor|40|||
161584408|NCT05623345|583528027|FG003|Overall Study|Termination of Study By Sponsor|38|||
161584409|NCT05384730|583528028|FG000|Overall Study|Adverse Event|1|||
161584410|NCT05384730|583528029|FG001|Overall Study|Adverse Event|0|||
161584411|NCT05384730|583528028|FG000|Overall Study|Lack of social support|2|||
161584412|NCT05384730|583528029|FG001|Overall Study|Lack of social support|0|||
161584413|NCT05384730|583528028|FG000|Overall Study|Hospital readmission|2|||
161584414|NCT05384730|583528029|FG001|Overall Study|Hospital readmission|0|||
161584415|NCT05384730|583528028|FG000|Overall Study|Disease progression|5|||
161584416|NCT05384730|583528029|FG001|Overall Study|Disease progression|0|||
161584417|NCT05384730|583528028|FG000|Overall Study|Overwhelmed with College commitments|0|||
161584418|NCT05384730|583528029|FG001|Overall Study|Overwhelmed with College commitments|2|||
161584419|NCT01619410|583528032|FG000|Overall Study|Lost to Follow-up|7|||
161584420|NCT01619410|583528033|FG001|Overall Study|Lost to Follow-up|4|||
161584421|NCT05782231|583528041|FG000|Overall Study|Withdrawal by Subject|1|||
161584422|NCT02252172|583528042|FG000|Overall Study|Lost to Follow-up|9|||
161584423|NCT02252172|583528043|FG001|Overall Study|Lost to Follow-up|6|||
161584424|NCT02252172|583528042|FG000|Overall Study|Death|218|||
161584425|NCT02252172|583528043|FG001|Overall Study|Death|175|||
161584426|NCT02252172|583528042|FG000|Overall Study|Withdrawal by Subject|20|||
161584427|NCT02252172|583528043|FG001|Overall Study|Withdrawal by Subject|15|||
161818101|NCT03541252|584374367|FG000|Overall Study|Withdrawal by Subject|1|||
161584428|NCT02252172|583528042|FG000|Overall Study|Physician Decision|0|||
161584429|NCT02252172|583528043|FG001|Overall Study|Physician Decision|1|||
161584430|NCT02252172|583528042|FG000|Overall Study|End of data collection|122|||
161818102|NCT01576705|584374368|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
161818103|NCT01576705|584374369|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
161818104|NCT01576705|584374370|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
161584431|NCT02252172|583528043|FG001|Overall Study|End of data collection|170|||
161584432|NCT02252172|583528042|FG000|Overall Study|Site closure|0|||
161584433|NCT02252172|583528043|FG001|Overall Study|Site closure|1|||
161584434|NCT03830866|583528044|FG000|Overall Study|Death|90|||
161584435|NCT03830866|583528045|FG001|Overall Study|Death|111|||
161584436|NCT03830866|583528044|FG000|Overall Study|Lost to Follow-up|7|||
161584437|NCT03830866|583528045|FG001|Overall Study|Lost to Follow-up|7|||
161584438|NCT03830866|583528044|FG000|Overall Study|Withdrawal by Subject|19|||
161584439|NCT03830866|583528045|FG001|Overall Study|Withdrawal by Subject|16|||
161672094|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672095|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672096|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672097|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672098|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
161672099|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672100|NCT01372410|583853022|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
161672101|NCT01372410|583853023|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672102|NCT01372410|583853024|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672103|NCT01372410|583853025|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672104|NCT01372410|583853026|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672105|NCT01372410|583853027|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672106|NCT01372410|583853028|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672107|NCT01372410|583853029|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
161672108|NCT01372410|583853022|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672109|NCT01372410|583853023|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672110|NCT01372410|583853024|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672111|NCT01372410|583853025|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672112|NCT01372410|583853026|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
161672113|NCT01372410|583853027|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672114|NCT01372410|583853028|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672115|NCT01372410|583853029|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672116|NCT01372410|583853022|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672117|NCT01372410|583853023|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672118|NCT01372410|583853024|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672119|NCT01372410|583853025|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672120|NCT01372410|583853026|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161672121|NCT01372410|583853027|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672122|NCT01372410|583853028|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161672123|NCT01372410|583853029|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161672124|NCT01372410|583853022|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672125|NCT01372410|583853023|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672126|NCT01372410|583853024|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672127|NCT01372410|583853025|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672128|NCT01372410|583853026|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672129|NCT01372410|583853027|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672130|NCT01372410|583853028|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672131|NCT01372410|583853029|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
161672132|NCT01372410|583853022|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672133|NCT01372410|583853023|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672134|NCT01372410|583853024|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
161672135|NCT01372410|583853025|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672136|NCT01372410|583853026|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672137|NCT01372410|583853027|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672138|NCT01372410|583853028|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672139|NCT01372410|583853029|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672140|NCT01372410|583853022|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672141|NCT01372410|583853023|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672142|NCT01372410|583853024|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672143|NCT01372410|583853025|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672144|NCT01372410|583853026|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672145|NCT01372410|583853027|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
161672146|NCT01372410|583853028|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672147|NCT01372410|583853029|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672148|NCT04585646|583853030|FG000|First Intervention|Physician Decision|1|||
161672149|NCT04585646|583853031|FG001|First Intervention|Physician Decision|0|||
161672150|NCT04585646|583853030|FG000|First Intervention|Lost to Follow-up|0|||
161672151|NCT04585646|583853031|FG001|First Intervention|Lost to Follow-up|3|||
161672152|NCT04585646|583853030|FG000|First Intervention|Withdrawal by Subject|0|||
161672153|NCT04585646|583853031|FG001|First Intervention|Withdrawal by Subject|1|||
161672154|NCT04614662|583853034|FG000|Overall Study|Withdrawal by Subject|0|||
161672155|NCT04614662|583853035|FG001|Overall Study|Withdrawal by Subject|1|||
161672156|NCT01862640|583853043|FG000|Overall Study|Adverse Event|4|||
161672157|NCT01862640|583853044|FG001|Overall Study|Adverse Event|10|||
161672158|NCT01862640|583853045|FG002|Overall Study|Adverse Event|6|||
161672159|NCT01862640|583853046|FG003|Overall Study|Adverse Event|8|||
161672160|NCT01862640|583853043|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161672161|NCT01862640|583853044|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161924094|NCT00544882|584768157|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
161584440|NCT03830866|583528044|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
161584441|NCT03830866|583528045|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
161584442|NCT03830866|583528044|FG000|Overall Study|Other|1|||
161584443|NCT03830866|583528045|FG001|Overall Study|Other|1|||
161584444|NCT01426412|583528046|FG000|Overall Study|Withdrawal by Subject|1|||
161584445|NCT01426412|583528047|FG001|Overall Study|Withdrawal by Subject|0|||
161584446|NCT01426412|583528048|FG002|Overall Study|Withdrawal by Subject|0|||
161584447|NCT01426412|583528049|FG003|Overall Study|Withdrawal by Subject|0|||
161584448|NCT01426412|583528050|FG004|Overall Study|Withdrawal by Subject|1|||
161584449|NCT01426412|583528051|FG005|Overall Study|Withdrawal by Subject|0|||
161584450|NCT01426412|583528052|FG006|Overall Study|Withdrawal by Subject|0|||
161584451|NCT01426412|583528053|FG007|Overall Study|Withdrawal by Subject|3|||
161584452|NCT01426412|583528054|FG008|Overall Study|Withdrawal by Subject|1|||
161584453|NCT00262301|583528057|FG000|Double-blind Phase|Lost to Follow-up|1|||
161584454|NCT00262301|583528058|FG001|Double-blind Phase|Lost to Follow-up|0|||
161584455|NCT00262301|583528059|FG002|Double-blind Phase|Lost to Follow-up|0|||
161584456|NCT00262301|583528057|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
161584457|NCT00262301|583528058|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
161584458|NCT00262301|583528059|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
161584459|NCT00976495|583528060|FG000|Overall Study|Withdrawal by Subject|0|||
161584460|NCT00976495|583528061|FG001|Overall Study|Withdrawal by Subject|1|||
161584461|NCT00976495|583528062|FG002|Overall Study|Withdrawal by Subject|0|||
161584462|NCT04154384|583528063|FG000|Overall Study|Lost to Follow-up|24|||
161584463|NCT04154384|583528064|FG001|Overall Study|Lost to Follow-up|33|||
161584464|NCT04154384|583528065|FG002|Overall Study|Lost to Follow-up|0|||
161584465|NCT04154384|583528063|FG000|Overall Study|Withdrawal by Subject|7|||
161584466|NCT04154384|583528064|FG001|Overall Study|Withdrawal by Subject|18|||
161584467|NCT04154384|583528065|FG002|Overall Study|Withdrawal by Subject|0|||
161584468|NCT04154384|583528063|FG000|Overall Study|Missing outcome data|1|||
161584469|NCT04154384|583528064|FG001|Overall Study|Missing outcome data|0|||
161584470|NCT04154384|583528065|FG002|Overall Study|Missing outcome data|0|||
161584471|NCT04732338|583528070|FG000|Overall Study|Lost to Follow-up|3|||
161584472|NCT04732338|583528071|FG001|Overall Study|Lost to Follow-up|3|||
161584473|NCT04484935|583528072|FG000|Overall Study|Other|0|||
161584474|NCT04484935|583528073|FG001|Overall Study|Other|1|||
161584475|NCT04484935|583528072|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161584476|NCT04484935|583528073|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161584477|NCT04484935|583528072|FG000|Overall Study|Lost to Follow-up|1|||
161584478|NCT04484935|583528073|FG001|Overall Study|Lost to Follow-up|0|||
161584479|NCT04484935|583528072|FG000|Overall Study|Death|2|||
161584480|NCT04484935|583528073|FG001|Overall Study|Death|1|||
161584481|NCT02759016|583528077|FG000|Overall Study|Not treated with BI 836826|1|||
161584482|NCT02759016|583528078|FG001|Overall Study|Not treated with BI 836826|0|||
161584483|NCT02759016|583528077|FG000|Overall Study|Progressive disease|1|||
161584484|NCT02759016|583528078|FG001|Overall Study|Progressive disease|0|||
161584485|NCT02759016|583528077|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
161584486|NCT02759016|583528078|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
161584487|NCT02759016|583528077|FG000|Overall Study|Other not defined above|2|||
161584488|NCT02759016|583528078|FG001|Overall Study|Other not defined above|1|||
161584489|NCT02891915|583528083|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161584490|NCT02891915|583528084|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
161584491|NCT02891915|583528083|FG000|Overall Study|Withdrawal by Subject|3|||
161584492|NCT02891915|583528084|FG001|Overall Study|Withdrawal by Subject|3|||
161584493|NCT02891915|583528083|FG000|Overall Study|Became Ineligible After Enrollment|2|||
161584494|NCT02891915|583528084|FG001|Overall Study|Became Ineligible After Enrollment|1|||
161584495|NCT02891915|583528083|FG000|Overall Study|Lost to Follow-up|1|||
161584496|NCT02891915|583528084|FG001|Overall Study|Lost to Follow-up|4|||
161584497|NCT02891915|583528083|FG000|Overall Study|Physician Decision|1|||
161672162|NCT01862640|583853045|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
161672163|NCT01862640|583853046|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161672164|NCT01862640|583853043|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
161672165|NCT01862640|583853044|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
161672166|NCT01862640|583853045|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
161672167|NCT01862640|583853046|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
161672168|NCT01862640|583853043|FG000|Overall Study|Withdrawal by Subject|2|||
161672169|NCT01862640|583853044|FG001|Overall Study|Withdrawal by Subject|4|||
161672170|NCT01862640|583853045|FG002|Overall Study|Withdrawal by Subject|8|||
161584498|NCT02891915|583528084|FG001|Overall Study|Physician Decision|0|||
161584499|NCT02556138|583528085|FG000|Overall Study|Withdrawal by Subject|1|||
161584500|NCT05094141|583528092|FG000|Overall Study|Death|0|||
161584501|NCT05094141|583528093|FG001|Overall Study|Death|0|||
161672171|NCT01862640|583853046|FG003|Overall Study|Withdrawal by Subject|5|||
161672172|NCT01862640|583853043|FG000|Overall Study|Protocol Deviation|0|||
161584502|NCT05094141|583528094|FG002|Overall Study|Death|1|||
161584503|NCT05094141|583528092|FG000|Overall Study|Withdrawal by Subject|0|||
161924095|NCT00544882|584768158|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
161924096|NCT00544882|584768159|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
161924097|NCT00544882|584768157|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
161924098|NCT00544882|584768158|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
161924099|NCT00544882|584768159|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
161924100|NCT00544882|584768157|FG000|Cycle 3: Follow-up|Noncompliance|0|||
161494407|NCT01496313|583203925|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
161494408|NCT01496313|583203926|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
161494409|NCT01496313|583203927|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
161494410|NCT01496313|583203922|FG000|Randomized Period (up to 14 Months)|Other|1|||
161494411|NCT01496313|583203923|FG001|Randomized Period (up to 14 Months)|Other|2|||
161494412|NCT01496313|583203924|FG002|Randomized Period (up to 14 Months)|Other|0|||
161494413|NCT01496313|583203925|FG003|Randomized Period (up to 14 Months)|Other|0|||
161494414|NCT01496313|583203926|FG004|Randomized Period (up to 14 Months)|Other|0|||
161494415|NCT01496313|583203927|FG005|Randomized Period (up to 14 Months)|Other|0|||
161494416|NCT01496313|583203922|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
161494417|NCT01496313|583203923|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
161494418|NCT01496313|583203924|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
161494419|NCT01496313|583203925|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
161494420|NCT01496313|583203926|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
161494421|NCT01496313|583203927|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
161494422|NCT01496313|583203922|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
161494423|NCT01496313|583203923|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
161494424|NCT01496313|583203924|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
161494425|NCT01496313|583203925|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
161494426|NCT01496313|583203926|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
161494427|NCT01496313|583203927|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
161584504|NCT05094141|583528093|FG001|Overall Study|Withdrawal by Subject|0|||
161584505|NCT05094141|583528094|FG002|Overall Study|Withdrawal by Subject|1|||
161584506|NCT05094141|583528092|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
161584507|NCT05094141|583528093|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
161584508|NCT05094141|583528094|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
161584509|NCT05094141|583528092|FG000|Overall Study|Did not participate in randomization|0|||
161584510|NCT05094141|583528093|FG001|Overall Study|Did not participate in randomization|0|||
161584511|NCT05094141|583528094|FG002|Overall Study|Did not participate in randomization|33|||
161584512|NCT03725722|583529757|FG000|Overall Study|Lack of Efficacy|2|||
161584513|NCT03725722|583529758|FG001|Overall Study|Lack of Efficacy|1|||
161584514|NCT03725722|583529759|FG002|Overall Study|Lack of Efficacy|2|||
161584515|NCT03725722|583529760|FG003|Overall Study|Lack of Efficacy|0|||
161584516|NCT03725722|583529761|FG004|Overall Study|Lack of Efficacy|2|||
161584517|NCT03725722|583529757|FG000|Overall Study|Adverse Event|2|||
161584518|NCT03725722|583529758|FG001|Overall Study|Adverse Event|2|||
161584519|NCT03725722|583529759|FG002|Overall Study|Adverse Event|1|||
161584520|NCT03725722|583529760|FG003|Overall Study|Adverse Event|0|||
161584521|NCT03725722|583529761|FG004|Overall Study|Adverse Event|6|||
161584522|NCT03725722|583529757|FG000|Overall Study|Withdrawal by Subject|4|||
161584523|NCT03725722|583529758|FG001|Overall Study|Withdrawal by Subject|1|||
161584524|NCT03725722|583529759|FG002|Overall Study|Withdrawal by Subject|0|||
161584525|NCT03725722|583529760|FG003|Overall Study|Withdrawal by Subject|4|||
161672173|NCT01862640|583853044|FG001|Overall Study|Protocol Deviation|0|||
161494428|NCT01496313|583203922|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
161494429|NCT01496313|583203923|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
161494430|NCT01496313|583203924|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
161494431|NCT01496313|583203925|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
161494432|NCT01496313|583203926|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
161494433|NCT01496313|583203927|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
161494434|NCT01528254|583203930|FG000|Overall Study|Administrative problems|96|||
161494435|NCT01528254|583203931|FG001|Overall Study|Administrative problems|94|||
161494436|NCT01528254|583203930|FG000|Overall Study|Adverse Event|28|||
161494437|NCT01528254|583203931|FG001|Overall Study|Adverse Event|44|||
161494438|NCT01528254|583203930|FG000|Overall Study|Lost to Follow-up|17|||
161584526|NCT03725722|583529761|FG004|Overall Study|Withdrawal by Subject|4|||
161584527|NCT03725722|583529757|FG000|Overall Study|Lost to Follow-up|3|||
161584528|NCT03725722|583529758|FG001|Overall Study|Lost to Follow-up|1|||
161584529|NCT03725722|583529759|FG002|Overall Study|Lost to Follow-up|2|||
161672174|NCT01862640|583853045|FG002|Overall Study|Protocol Deviation|1|||
161584530|NCT03725722|583529760|FG003|Overall Study|Lost to Follow-up|2|||
161584531|NCT03725722|583529761|FG004|Overall Study|Lost to Follow-up|1|||
161584532|NCT03725722|583529757|FG000|Overall Study|Personal reasons|0|||
161672175|NCT01862640|583853046|FG003|Overall Study|Protocol Deviation|0|||
161924101|NCT00544882|584768158|FG001|Cycle 3: Follow-up|Noncompliance|1|||
161672176|NCT02178553|583853049|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
161672177|NCT02178553|583853050|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
161818105|NCT01576705|584374371|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
161494439|NCT01528254|583203931|FG001|Overall Study|Lost to Follow-up|24|||
161494440|NCT01528254|583203930|FG000|Overall Study|Death|13|||
161494441|NCT01528254|583203931|FG001|Overall Study|Death|9|||
161494442|NCT01528254|583203930|FG000|Overall Study|Protocol deviation|9|||
161494443|NCT01528254|583203931|FG001|Overall Study|Protocol deviation|19|||
161494444|NCT01528254|583203930|FG000|Overall Study|New therapy for study indication|8|||
161494445|NCT01528254|583203931|FG001|Overall Study|New therapy for study indication|6|||
161494446|NCT01528254|583203930|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161494447|NCT01528254|583203931|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161494448|NCT01528254|583203930|FG000|Overall Study|Withdrawal by Subject|5|||
161494449|NCT01528254|583203931|FG001|Overall Study|Withdrawal by Subject|4|||
161494450|NCT01528254|583203930|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161494451|NCT01528254|583203931|FG001|Overall Study|Abnormal laboratory value(s)|7|||
161494452|NCT01528254|583203930|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161494453|NCT01528254|583203931|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161494454|NCT01528254|583203930|FG000|Overall Study|No longer requires study drug|1|||
161494455|NCT01528254|583203931|FG001|Overall Study|No longer requires study drug|1|||
161494456|NCT00416078|583203934|FG000|Overall Study|Death|3|||
161494457|NCT00416078|583203935|FG001|Overall Study|Death|4|||
161494458|NCT00416078|583203934|FG000|Overall Study|Withdrawal by Subject|3|||
161494459|NCT00416078|583203935|FG001|Overall Study|Withdrawal by Subject|2|||
161494460|NCT00416078|583203934|FG000|Overall Study|Physician Decision|1|||
161494461|NCT00416078|583203935|FG001|Overall Study|Physician Decision|0|||
161494462|NCT00416078|583203934|FG000|Overall Study|Lost to Follow-up|4|||
161494463|NCT00416078|583203935|FG001|Overall Study|Lost to Follow-up|2|||
161494464|NCT03564145|583203944|FG000|Overall Study|Adverse Event|4|||
161494465|NCT03564145|583203944|FG000|Overall Study|Lost to Follow-up|21|||
161494466|NCT03564145|583203944|FG000|Overall Study|Protocol Violation|2|||
161494467|NCT03564145|583203944|FG000|Overall Study|Withdrawal by Subject|48|||
161494468|NCT03564145|583203944|FG000|Overall Study|Study Terminated by Sponsor|146|||
161494469|NCT03564145|583203944|FG000|Overall Study|Physician Decision|1|||
161494470|NCT03564145|583203944|FG000|Overall Study|Other Than Specified|1|||
161494471|NCT03564145|583203944|FG000|Overall Study|Pregnancy|1|||
161494472|NCT04219891|583203947|FG000|Overall Study|Lost to Follow-up|3|||
161494473|NCT04219891|583203947|FG000|Overall Study|Withdrawal by Subject|2|||
161549215|NCT02291289|583401016|FG007|Induction Treatment|Reason Not Specified|0|||
161549216|NCT02291289|583401017|FG008|Induction Treatment|Reason Not Specified|0|||
161549217|NCT02291289|583401018|FG009|Induction Treatment|Reason Not Specified|7|||
161549218|NCT02291289|583401019|FG010|Induction Treatment|Reason Not Specified|0|||
161549219|NCT02291289|583401020|FG011|Induction Treatment|Reason Not Specified|0|||
161549220|NCT02291289|583401021|FG012|Induction Treatment|Reason Not Specified|0|||
161549221|NCT02291289|583401009|FG000|Induction Treatment|Physician Decision|0|||
161549222|NCT02291289|583401010|FG001|Induction Treatment|Physician Decision|0|||
161549223|NCT02291289|583401011|FG002|Induction Treatment|Physician Decision|0|||
161549224|NCT02291289|583401012|FG003|Induction Treatment|Physician Decision|3|||
161549225|NCT02291289|583401013|FG004|Induction Treatment|Physician Decision|0|||
161549226|NCT02291289|583401014|FG005|Induction Treatment|Physician Decision|0|||
161549227|NCT02291289|583401015|FG006|Induction Treatment|Physician Decision|0|||
161549228|NCT02291289|583401016|FG007|Induction Treatment|Physician Decision|0|||
161549229|NCT02291289|583401017|FG008|Induction Treatment|Physician Decision|0|||
161549230|NCT02291289|583401018|FG009|Induction Treatment|Physician Decision|1|||
161549231|NCT02291289|583401019|FG010|Induction Treatment|Physician Decision|0|||
161549232|NCT02291289|583401020|FG011|Induction Treatment|Physician Decision|0|||
161549233|NCT02291289|583401021|FG012|Induction Treatment|Physician Decision|0|||
161549234|NCT02291289|583401009|FG000|Induction Treatment|Protocol Violation|0|||
161549235|NCT02291289|583401010|FG001|Induction Treatment|Protocol Violation|0|||
161549236|NCT02291289|583401011|FG002|Induction Treatment|Protocol Violation|0|||
161549237|NCT02291289|583401012|FG003|Induction Treatment|Protocol Violation|3|||
161549238|NCT02291289|583401013|FG004|Induction Treatment|Protocol Violation|0|||
161549239|NCT02291289|583401014|FG005|Induction Treatment|Protocol Violation|0|||
161549240|NCT02291289|583401015|FG006|Induction Treatment|Protocol Violation|0|||
161549241|NCT02291289|583401016|FG007|Induction Treatment|Protocol Violation|0|||
161549242|NCT02291289|583401017|FG008|Induction Treatment|Protocol Violation|0|||
161672178|NCT02178553|583853049|FG000|Overall Study|Physician Decision|0|||
161584533|NCT03725722|583529758|FG001|Overall Study|Personal reasons|0|||
161584534|NCT03725722|583529759|FG002|Overall Study|Personal reasons|1|||
161584535|NCT03725722|583529760|FG003|Overall Study|Personal reasons|0|||
161584536|NCT03725722|583529761|FG004|Overall Study|Personal reasons|1|||
161584537|NCT03725722|583529757|FG000|Overall Study|COVID-19 situation|0|||
161584538|NCT03725722|583529758|FG001|Overall Study|COVID-19 situation|1|||
161584539|NCT03725722|583529759|FG002|Overall Study|COVID-19 situation|0|||
161584540|NCT03725722|583529760|FG003|Overall Study|COVID-19 situation|0|||
161584541|NCT03725722|583529761|FG004|Overall Study|COVID-19 situation|0|||
161584542|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
161584543|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
161584544|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
161584545|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
161584546|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
161584547|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
161584548|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
161584549|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
161584550|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
161584551|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
161584552|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
161584553|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
161584554|NCT01600014|583529762|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
161584555|NCT01600014|583529763|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
161584556|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
161584557|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
161584558|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
161584559|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
161584560|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
161584561|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
161584562|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
161584563|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
161584564|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
161584565|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
161584566|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
161584567|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
161584568|NCT01600014|583529762|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
161584569|NCT01600014|583529763|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
161584570|NCT01600014|583529762|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
161584571|NCT01600014|583529763|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
161584572|NCT01600014|583529762|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
161584573|NCT01600014|583529763|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
161584574|NCT01600014|583529762|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
161584575|NCT01600014|583529763|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
161584576|NCT03398148|583529767|FG000|Substudy 1 Period 1|Adverse Event|5|||
161584577|NCT03398148|583529768|FG001|Substudy 1 Period 1|Adverse Event|2|||
161584578|NCT03398148|583529769|FG002|Substudy 1 Period 1|Adverse Event|2|||
161584579|NCT03398148|583529770|FG003|Substudy 1 Period 1|Adverse Event|0|||
161584580|NCT03398148|583529771|FG004|Substudy 1 Period 1|Adverse Event|8|||
161584581|NCT03398148|583529772|FG005|Substudy 1 Period 1|Adverse Event|0|||
161584582|NCT03398148|583529773|FG006|Substudy 1 Period 1|Adverse Event|0|||
161584583|NCT03398148|583529774|FG007|Substudy 1 Period 1|Adverse Event|0|||
161584584|NCT03398148|583529775|FG008|Substudy 1 Period 1|Adverse Event|0|||
161584585|NCT03398148|583529776|FG009|Substudy 1 Period 1|Adverse Event|0|||
161584586|NCT03398148|583529777|FG010|Substudy 1 Period 1|Adverse Event|0|||
161584587|NCT03398148|583529778|FG011|Substudy 1 Period 1|Adverse Event|0|||
161584588|NCT03398148|583529779|FG012|Substudy 1 Period 1|Adverse Event|0|||
161584589|NCT03398148|583529780|FG013|Substudy 1 Period 1|Adverse Event|0|||
161584590|NCT03398148|583529781|FG014|Substudy 1 Period 1|Adverse Event|0|||
161584591|NCT03398148|583529767|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
161584592|NCT03398148|583529768|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
161584593|NCT03398148|583529769|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584594|NCT03398148|583529770|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
161584595|NCT03398148|583529771|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
161672179|NCT02178553|583853050|FG001|Overall Study|Physician Decision|4|||
161584596|NCT03398148|583529772|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584597|NCT03398148|583529773|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584598|NCT03398148|583529774|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584599|NCT03398148|583529775|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584600|NCT03398148|583529776|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584601|NCT03398148|583529777|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584602|NCT03398148|583529778|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584603|NCT03398148|583529779|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584604|NCT03398148|583529780|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584605|NCT03398148|583529781|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161584606|NCT03398148|583529767|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
161584607|NCT03398148|583529768|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
161584608|NCT03398148|583529769|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
161584609|NCT03398148|583529770|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
161584610|NCT03398148|583529771|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
161584611|NCT03398148|583529772|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
161584612|NCT03398148|583529773|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
161584613|NCT03398148|583529774|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
161584614|NCT03398148|583529775|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
161584615|NCT03398148|583529776|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
161584616|NCT03398148|583529777|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
161584617|NCT03398148|583529778|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
161584618|NCT03398148|583529779|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
161584619|NCT03398148|583529780|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
161584620|NCT03398148|583529781|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
161584621|NCT03398148|583529767|FG000|Substudy 1 Period 1|Other|0|||
161584622|NCT03398148|583529768|FG001|Substudy 1 Period 1|Other|1|||
161584623|NCT03398148|583529769|FG002|Substudy 1 Period 1|Other|0|||
161584624|NCT03398148|583529770|FG003|Substudy 1 Period 1|Other|0|||
161584625|NCT03398148|583529771|FG004|Substudy 1 Period 1|Other|3|||
161584626|NCT03398148|583529772|FG005|Substudy 1 Period 1|Other|0|||
161584627|NCT03398148|583529773|FG006|Substudy 1 Period 1|Other|0|||
161584628|NCT03398148|583529774|FG007|Substudy 1 Period 1|Other|0|||
161584629|NCT03398148|583529775|FG008|Substudy 1 Period 1|Other|0|||
161584630|NCT03398148|583529776|FG009|Substudy 1 Period 1|Other|0|||
161584631|NCT03398148|583529777|FG010|Substudy 1 Period 1|Other|0|||
161584632|NCT03398148|583529778|FG011|Substudy 1 Period 1|Other|0|||
161584633|NCT03398148|583529779|FG012|Substudy 1 Period 1|Other|0|||
161584634|NCT03398148|583529780|FG013|Substudy 1 Period 1|Other|0|||
161584635|NCT03398148|583529781|FG014|Substudy 1 Period 1|Other|0|||
161584636|NCT03398148|583529767|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584637|NCT03398148|583529768|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584638|NCT03398148|583529769|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584639|NCT03398148|583529770|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584640|NCT03398148|583529771|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
161584641|NCT03398148|583529772|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584642|NCT03398148|583529773|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584643|NCT03398148|583529774|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584644|NCT03398148|583529775|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584645|NCT03398148|583529776|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584646|NCT03398148|583529777|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584647|NCT03398148|583529778|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584648|NCT03398148|583529779|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584649|NCT03398148|583529780|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584650|NCT03398148|583529781|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
161584651|NCT03398148|583529767|FG000|Substudy 1 Period 2|Adverse Event|0|||
161584652|NCT03398148|583529768|FG001|Substudy 1 Period 2|Adverse Event|0|||
161584653|NCT03398148|583529769|FG002|Substudy 1 Period 2|Adverse Event|0|||
161584654|NCT03398148|583529770|FG003|Substudy 1 Period 2|Adverse Event|0|||
161584655|NCT03398148|583529771|FG004|Substudy 1 Period 2|Adverse Event|0|||
161584656|NCT03398148|583529772|FG005|Substudy 1 Period 2|Adverse Event|2|||
161584657|NCT03398148|583529773|FG006|Substudy 1 Period 2|Adverse Event|4|||
161584658|NCT03398148|583529774|FG007|Substudy 1 Period 2|Adverse Event|0|||
161584659|NCT03398148|583529775|FG008|Substudy 1 Period 2|Adverse Event|0|||
161584660|NCT03398148|583529776|FG009|Substudy 1 Period 2|Adverse Event|0|||
161584661|NCT03398148|583529777|FG010|Substudy 1 Period 2|Adverse Event|0|||
161584662|NCT03398148|583529778|FG011|Substudy 1 Period 2|Adverse Event|0|||
161584663|NCT03398148|583529779|FG012|Substudy 1 Period 2|Adverse Event|0|||
161584664|NCT03398148|583529780|FG013|Substudy 1 Period 2|Adverse Event|0|||
161584665|NCT03398148|583529781|FG014|Substudy 1 Period 2|Adverse Event|0|||
161584666|NCT03398148|583529767|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584667|NCT03398148|583529768|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584668|NCT03398148|583529769|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584669|NCT03398148|583529770|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584670|NCT03398148|583529771|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584671|NCT03398148|583529772|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584672|NCT03398148|583529773|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
161584673|NCT03398148|583529774|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
161584674|NCT03398148|583529775|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584675|NCT03398148|583529776|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584676|NCT03398148|583529777|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584677|NCT03398148|583529778|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584678|NCT03398148|583529779|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584679|NCT03398148|583529780|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584680|NCT03398148|583529781|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161584681|NCT03398148|583529767|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
161584682|NCT03398148|583529768|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
161584683|NCT03398148|583529769|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
161584684|NCT03398148|583529770|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
161584685|NCT03398148|583529771|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
161584686|NCT03398148|583529772|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
161584687|NCT03398148|583529773|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
161584688|NCT03398148|583529774|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
161584689|NCT03398148|583529775|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
161584690|NCT03398148|583529776|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
161584691|NCT03398148|583529777|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
161584692|NCT03398148|583529778|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
161584693|NCT03398148|583529779|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
161584694|NCT03398148|583529780|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
161584695|NCT03398148|583529781|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
161584696|NCT03398148|583529767|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584697|NCT03398148|583529768|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584698|NCT03398148|583529769|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584699|NCT03398148|583529770|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584700|NCT03398148|583529771|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584701|NCT03398148|583529772|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584702|NCT03398148|583529773|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
161584703|NCT03398148|583529774|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584704|NCT03398148|583529775|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584705|NCT03398148|583529776|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584706|NCT03398148|583529777|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584707|NCT03398148|583529778|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584708|NCT03398148|583529779|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584709|NCT03398148|583529780|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584710|NCT03398148|583529781|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584711|NCT03398148|583529767|FG000|Substudy 1 Period 2|Other|0|||
161584712|NCT03398148|583529768|FG001|Substudy 1 Period 2|Other|0|||
161584713|NCT03398148|583529769|FG002|Substudy 1 Period 2|Other|0|||
161584714|NCT03398148|583529770|FG003|Substudy 1 Period 2|Other|0|||
161584715|NCT03398148|583529771|FG004|Substudy 1 Period 2|Other|0|||
161584716|NCT03398148|583529772|FG005|Substudy 1 Period 2|Other|0|||
161584717|NCT03398148|583529773|FG006|Substudy 1 Period 2|Other|1|||
161584718|NCT03398148|583529774|FG007|Substudy 1 Period 2|Other|0|||
161584719|NCT03398148|583529775|FG008|Substudy 1 Period 2|Other|0|||
161584720|NCT03398148|583529776|FG009|Substudy 1 Period 2|Other|0|||
161584721|NCT03398148|583529777|FG010|Substudy 1 Period 2|Other|0|||
161584722|NCT03398148|583529778|FG011|Substudy 1 Period 2|Other|0|||
161584723|NCT03398148|583529779|FG012|Substudy 1 Period 2|Other|0|||
161584724|NCT03398148|583529780|FG013|Substudy 1 Period 2|Other|0|||
161584725|NCT03398148|583529781|FG014|Substudy 1 Period 2|Other|0|||
161584726|NCT03398148|583529767|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584727|NCT03398148|583529768|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584728|NCT03398148|583529769|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584729|NCT03398148|583529770|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584730|NCT03398148|583529771|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584731|NCT03398148|583529772|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584732|NCT03398148|583529773|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
161584733|NCT03398148|583529774|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584734|NCT03398148|583529775|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584735|NCT03398148|583529776|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584736|NCT03398148|583529777|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584737|NCT03398148|583529778|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584738|NCT03398148|583529779|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584739|NCT03398148|583529780|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584740|NCT03398148|583529781|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
161584741|NCT03398148|583529767|FG000|Substudy 2 Period 1|Adverse Event|0|||
161672180|NCT02178553|583853049|FG000|Overall Study|Technical problem with injection|1|||
161818106|NCT01576705|584374368|FG000|Overall Study|invalid ICF|0|||
161584742|NCT03398148|583529768|FG001|Substudy 2 Period 1|Adverse Event|0|||
161584743|NCT03398148|583529769|FG002|Substudy 2 Period 1|Adverse Event|0|||
161672181|NCT02178553|583853050|FG001|Overall Study|Technical problem with injection|3|||
161584744|NCT03398148|583529770|FG003|Substudy 2 Period 1|Adverse Event|0|||
161584745|NCT03398148|583529771|FG004|Substudy 2 Period 1|Adverse Event|0|||
161584746|NCT03398148|583529772|FG005|Substudy 2 Period 1|Adverse Event|0|||
161584747|NCT03398148|583529773|FG006|Substudy 2 Period 1|Adverse Event|0|||
161584748|NCT03398148|583529774|FG007|Substudy 2 Period 1|Adverse Event|0|||
161584749|NCT03398148|583529775|FG008|Substudy 2 Period 1|Adverse Event|0|||
161818107|NCT01576705|584374369|FG001|Overall Study|invalid ICF|1|||
161818108|NCT01576705|584374370|FG002|Overall Study|invalid ICF|0|||
161818109|NCT01576705|584374371|FG003|Overall Study|invalid ICF|0|||
161818110|NCT00858403|584374372|FG000|Overall Study|Withdrawal by Subject|1|||
161818111|NCT00858403|584374372|FG000|Overall Study|Death|3|||
161818112|NCT00858403|584374372|FG000|Overall Study|Disease Progression|1|||
161818113|NCT00227370|584374376|FG000|Overall Study|Withdrawal by Subject|1|||
161584750|NCT03398148|583529776|FG009|Substudy 2 Period 1|Adverse Event|12|||
161584751|NCT03398148|583529777|FG010|Substudy 2 Period 1|Adverse Event|2|||
161818114|NCT00227370|584374377|FG001|Overall Study|Withdrawal by Subject|2|||
161584752|NCT03398148|583529778|FG011|Substudy 2 Period 1|Adverse Event|0|||
161584753|NCT03398148|583529779|FG012|Substudy 2 Period 1|Adverse Event|0|||
161584754|NCT03398148|583529780|FG013|Substudy 2 Period 1|Adverse Event|0|||
161584755|NCT03398148|583529781|FG014|Substudy 2 Period 1|Adverse Event|0|||
161584756|NCT03398148|583529767|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584757|NCT03398148|583529768|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584758|NCT03398148|583529769|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584759|NCT03398148|583529770|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584760|NCT03398148|583529771|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584761|NCT03398148|583529772|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584762|NCT03398148|583529773|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584763|NCT03398148|583529774|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584764|NCT03398148|583529775|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584765|NCT03398148|583529776|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
161584766|NCT03398148|583529777|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
161584767|NCT03398148|583529778|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584768|NCT03398148|583529779|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584769|NCT03398148|583529780|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584770|NCT03398148|583529781|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161584771|NCT03398148|583529767|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
161584772|NCT03398148|583529768|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
161584773|NCT03398148|583529769|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
161584774|NCT03398148|583529770|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
161584775|NCT03398148|583529771|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
161584776|NCT03398148|583529772|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
161584777|NCT03398148|583529773|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
161584778|NCT03398148|583529774|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
161584779|NCT03398148|583529775|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
161584780|NCT03398148|583529776|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
161584781|NCT03398148|583529777|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
161584782|NCT03398148|583529778|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
161584783|NCT03398148|583529779|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
161584784|NCT03398148|583529780|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
161584785|NCT03398148|583529781|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
161584786|NCT03398148|583529767|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584787|NCT03398148|583529768|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584788|NCT03398148|583529769|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584789|NCT03398148|583529770|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584790|NCT03398148|583529771|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584791|NCT03398148|583529772|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584792|NCT03398148|583529773|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584793|NCT03398148|583529774|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584794|NCT03398148|583529775|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584795|NCT03398148|583529776|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584796|NCT03398148|583529777|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
161584797|NCT03398148|583529778|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584798|NCT03398148|583529779|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584799|NCT03398148|583529780|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584800|NCT03398148|583529781|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161584801|NCT03398148|583529767|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584802|NCT03398148|583529768|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584803|NCT03398148|583529769|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584804|NCT03398148|583529770|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161818115|NCT00227370|584374376|FG000|Overall Study|Death|3|||
161818116|NCT00227370|584374377|FG001|Overall Study|Death|4|||
161584805|NCT03398148|583529771|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584806|NCT03398148|583529772|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584807|NCT03398148|583529773|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584808|NCT03398148|583529774|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584809|NCT03398148|583529775|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584810|NCT03398148|583529776|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584811|NCT03398148|583529777|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
161584812|NCT03398148|583529778|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161818117|NCT00227370|584374376|FG000|Overall Study|Adverse Event|6|||
161818118|NCT00227370|584374377|FG001|Overall Study|Adverse Event|11|||
161818119|NCT00227370|584374376|FG000|Overall Study|Physician Decision|9|||
161584813|NCT03398148|583529779|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584814|NCT03398148|583529780|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584815|NCT03398148|583529781|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161584816|NCT03398148|583529767|FG000|Substudy 2 Period 1|Other|0|||
161584817|NCT03398148|583529768|FG001|Substudy 2 Period 1|Other|0|||
161584818|NCT03398148|583529769|FG002|Substudy 2 Period 1|Other|0|||
161584819|NCT03398148|583529770|FG003|Substudy 2 Period 1|Other|0|||
161584820|NCT03398148|583529771|FG004|Substudy 2 Period 1|Other|0|||
161584821|NCT03398148|583529772|FG005|Substudy 2 Period 1|Other|0|||
161584822|NCT03398148|583529773|FG006|Substudy 2 Period 1|Other|0|||
161584823|NCT03398148|583529774|FG007|Substudy 2 Period 1|Other|0|||
161584824|NCT03398148|583529775|FG008|Substudy 2 Period 1|Other|0|||
161584825|NCT03398148|583529776|FG009|Substudy 2 Period 1|Other|4|||
161584826|NCT03398148|583529777|FG010|Substudy 2 Period 1|Other|4|||
161584827|NCT03398148|583529778|FG011|Substudy 2 Period 1|Other|0|||
161584828|NCT03398148|583529779|FG012|Substudy 2 Period 1|Other|0|||
161584829|NCT03398148|583529780|FG013|Substudy 2 Period 1|Other|0|||
161584830|NCT03398148|583529781|FG014|Substudy 2 Period 1|Other|0|||
161584831|NCT03398148|583529767|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584832|NCT03398148|583529768|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584833|NCT03398148|583529769|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584834|NCT03398148|583529770|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584835|NCT03398148|583529771|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584836|NCT03398148|583529772|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
161494474|NCT00410761|583205789|FG000|Randomized Treatment Period|Adverse Event|34|||
161494475|NCT00410761|583205790|FG001|Randomized Treatment Period|Adverse Event|3|||
161494476|NCT00410761|583205789|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
161494477|NCT00410761|583205790|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
161494478|NCT00410761|583205789|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
161494479|NCT00410761|583205790|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
161494480|NCT00410761|583205789|FG000|Randomized Treatment Period|Other|69|||
161494481|NCT00410761|583205790|FG001|Randomized Treatment Period|Other|21|||
161494482|NCT00410761|583205789|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
161494483|NCT00410761|583205790|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
161494484|NCT00410761|583205789|FG000|Open-Label Treatment Period|Adverse Event|13|||
161494485|NCT00410761|583205790|FG001|Open-Label Treatment Period|Adverse Event|15|||
161584837|NCT03398148|583529773|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584838|NCT03398148|583529774|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584839|NCT03398148|583529775|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584840|NCT03398148|583529776|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584841|NCT03398148|583529777|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
161584842|NCT03398148|583529778|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584843|NCT03398148|583529779|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584844|NCT03398148|583529780|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
161584845|NCT03398148|583529781|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
161494486|NCT00410761|583205789|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
161494487|NCT00410761|583205790|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
161494488|NCT00410761|583205789|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
161584846|NCT03398148|583529767|FG000|Substudy 2 Period 2|Adverse Event|0|||
161584847|NCT03398148|583529768|FG001|Substudy 2 Period 2|Adverse Event|0|||
161584848|NCT03398148|583529769|FG002|Substudy 2 Period 2|Adverse Event|0|||
161584849|NCT03398148|583529770|FG003|Substudy 2 Period 2|Adverse Event|0|||
161584850|NCT03398148|583529771|FG004|Substudy 2 Period 2|Adverse Event|0|||
161584851|NCT03398148|583529772|FG005|Substudy 2 Period 2|Adverse Event|0|||
161584852|NCT03398148|583529773|FG006|Substudy 2 Period 2|Adverse Event|0|||
161584853|NCT03398148|583529774|FG007|Substudy 2 Period 2|Adverse Event|0|||
161584854|NCT03398148|583529775|FG008|Substudy 2 Period 2|Adverse Event|0|||
161584855|NCT03398148|583529776|FG009|Substudy 2 Period 2|Adverse Event|0|||
161584856|NCT03398148|583529777|FG010|Substudy 2 Period 2|Adverse Event|0|||
161584857|NCT03398148|583529778|FG011|Substudy 2 Period 2|Adverse Event|0|||
161584858|NCT03398148|583529779|FG012|Substudy 2 Period 2|Adverse Event|0|||
161584859|NCT03398148|583529780|FG013|Substudy 2 Period 2|Adverse Event|1|||
161584860|NCT03398148|583529781|FG014|Substudy 2 Period 2|Adverse Event|3|||
161818120|NCT00227370|584374377|FG001|Overall Study|Physician Decision|6|||
161818121|NCT00227370|584374376|FG000|Overall Study|Other reasons|2|||
161494489|NCT00410761|583205790|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
161584861|NCT03398148|583529767|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
161584862|NCT03398148|583529768|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
161584863|NCT03398148|583529769|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
161494490|NCT00410761|583205789|FG000|Open-Label Treatment Period|Other|18|||
161584864|NCT03398148|583529770|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
161584865|NCT03398148|583529771|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
161584866|NCT03398148|583529772|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
161584867|NCT03398148|583529773|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
161584868|NCT03398148|583529774|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
161818122|NCT00227370|584374377|FG001|Overall Study|Other reasons|1|||
161494491|NCT00410761|583205790|FG001|Open-Label Treatment Period|Other|9|||
161494492|NCT03745937|583205791|FG000|Overall Study|Withdrawal by Subject|0|||
161494493|NCT03745937|583205792|FG001|Overall Study|Withdrawal by Subject|0|||
161494494|NCT03745937|583205793|FG002|Overall Study|Withdrawal by Subject|0|||
161494495|NCT03745937|583205794|FG003|Overall Study|Withdrawal by Subject|1|||
161494496|NCT03745937|583205791|FG000|Overall Study|Not-specifed|0|||
161494497|NCT03745937|583205792|FG001|Overall Study|Not-specifed|1|||
161494498|NCT03745937|583205793|FG002|Overall Study|Not-specifed|0|||
161494499|NCT03745937|583205794|FG003|Overall Study|Not-specifed|1|||
161494500|NCT00773292|583205798|FG000|Treatment 48 Weeks|Adverse Event|1|||
161494501|NCT00773292|583205798|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
161494502|NCT00573755|583205799|FG000|Overall Study|Still receiving treatment|1|||
161494503|NCT00573755|583205800|FG001|Overall Study|Still receiving treatment|0|||
161494504|NCT03724812|583205801|FG000|Overall Study|Missed Visit|1|||
161818123|NCT03846193|584374378|FG000|Overall Study|Physician Decision|0|||
161494505|NCT03724812|583205801|FG000|Overall Study|Death|2|||
161494506|NCT03724812|583205801|FG000|Overall Study|Withdrawal by Subject|1|||
161494507|NCT03525574|583205805|FG000|Overall Study|Adverse Event|15|||
161818124|NCT03846193|584374379|FG001|Overall Study|Physician Decision|0|||
161818125|NCT03846193|584374380|FG002|Overall Study|Physician Decision|1|||
161818126|NCT03846193|584374381|FG003|Overall Study|Physician Decision|0|||
161494508|NCT03525574|583205806|FG001|Overall Study|Adverse Event|0|||
161494509|NCT03525574|583205805|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
161494510|NCT03525574|583205806|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161494511|NCT03525574|583205805|FG000|Overall Study|Lost to Follow-up|4|||
161494512|NCT03525574|583205806|FG001|Overall Study|Lost to Follow-up|0|||
161494513|NCT03525574|583205805|FG000|Overall Study|Commercial drug is Available for participant|48|||
161494514|NCT03525574|583205806|FG001|Overall Study|Commercial drug is Available for participant|0|||
161494515|NCT03525574|583205805|FG000|Overall Study|Death|1|||
161494516|NCT03525574|583205806|FG001|Overall Study|Death|0|||
161494517|NCT03525574|583205805|FG000|Overall Study|Other non-compliance|2|||
161494518|NCT03525574|583205806|FG001|Overall Study|Other non-compliance|0|||
161494519|NCT03525574|583205805|FG000|Overall Study|Physician Decision|6|||
161494520|NCT03525574|583205806|FG001|Overall Study|Physician Decision|0|||
161494521|NCT03525574|583205805|FG000|Overall Study|Other|58|||
161494522|NCT03525574|583205806|FG001|Overall Study|Other|0|||
161494523|NCT03525574|583205805|FG000|Overall Study|Enrolled but never dosed|1|||
161494524|NCT03525574|583205806|FG001|Overall Study|Enrolled but never dosed|0|||
161494525|NCT03525574|583205805|FG000|Overall Study|Not enrolled in 105 study|0|||
161494526|NCT03525574|583205806|FG001|Overall Study|Not enrolled in 105 study|3|||
161494527|NCT03227029|583205812|FG000|Overall Study|Child Wheezed (no treatment)|0|||
161494528|NCT03227029|583205813|FG001|Overall Study|Child Wheezed (no treatment)|1|||
161494529|NCT03227029|583205814|FG002|Overall Study|Child Wheezed (no treatment)|0|||
161494530|NCT03227029|583205812|FG000|Overall Study|No post RSV season visit due to COVID|3|||
161494531|NCT03227029|583205813|FG001|Overall Study|No post RSV season visit due to COVID|3|||
161494532|NCT03227029|583205814|FG002|Overall Study|No post RSV season visit due to COVID|2|||
161494533|NCT03227029|583205812|FG000|Overall Study|Not able to get to clinic|0|||
161494534|NCT03227029|583205813|FG001|Overall Study|Not able to get to clinic|0|||
161494535|NCT03227029|583205814|FG002|Overall Study|Not able to get to clinic|1|||
161494536|NCT03227029|583205812|FG000|Overall Study|Withdrawal by Subject|1|||
161494537|NCT03227029|583205813|FG001|Overall Study|Withdrawal by Subject|0|||
161494538|NCT03227029|583205814|FG002|Overall Study|Withdrawal by Subject|0|||
161494539|NCT03227029|583205812|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
161494540|NCT03227029|583205813|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
161584869|NCT03398148|583529775|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
161584870|NCT03398148|583529776|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
161584871|NCT03398148|583529777|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
161584872|NCT03398148|583529778|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
161818127|NCT03846193|584374382|FG004|Overall Study|Physician Decision|0|||
161818128|NCT03846193|584374378|FG000|Overall Study|Lost to Follow-up|0|||
161818129|NCT03846193|584374379|FG001|Overall Study|Lost to Follow-up|0|||
161818130|NCT03846193|584374380|FG002|Overall Study|Lost to Follow-up|0|||
161818131|NCT03846193|584374381|FG003|Overall Study|Lost to Follow-up|0|||
161818132|NCT03846193|584374382|FG004|Overall Study|Lost to Follow-up|1|||
161818133|NCT03846193|584374378|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161818134|NCT03846193|584374379|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161818135|NCT03846193|584374380|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161818136|NCT03846193|584374381|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
161494541|NCT03227029|583205814|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
161494542|NCT01291173|583205815|FG000|Overall Study|Adverse Event|0|||
161494543|NCT01291173|583205816|FG001|Overall Study|Adverse Event|3|||
161494544|NCT01291173|583205817|FG002|Overall Study|Adverse Event|1|||
161584873|NCT03398148|583529779|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
161818137|NCT03846193|584374382|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161494545|NCT01291173|583205818|FG003|Overall Study|Adverse Event|3|||
161494546|NCT01291173|583205815|FG000|Overall Study|Protocol Violation|7|||
161494547|NCT01291173|583205816|FG001|Overall Study|Protocol Violation|2|||
161494548|NCT01291173|583205817|FG002|Overall Study|Protocol Violation|2|||
161494549|NCT01291173|583205818|FG003|Overall Study|Protocol Violation|5|||
161494550|NCT01291173|583205815|FG000|Overall Study|Withdrawal by Subject|6|||
161494551|NCT01291173|583205816|FG001|Overall Study|Withdrawal by Subject|4|||
161494552|NCT01291173|583205817|FG002|Overall Study|Withdrawal by Subject|4|||
161494553|NCT01291173|583205818|FG003|Overall Study|Withdrawal by Subject|2|||
161494554|NCT01291173|583205815|FG000|Overall Study|Lost to Follow-up|4|||
161494555|NCT01291173|583205816|FG001|Overall Study|Lost to Follow-up|6|||
161494556|NCT01291173|583205817|FG002|Overall Study|Lost to Follow-up|3|||
161494557|NCT01291173|583205818|FG003|Overall Study|Lost to Follow-up|2|||
161494558|NCT01291173|583205815|FG000|Overall Study|Unable to meet visit schedule|0|||
161494559|NCT01291173|583205816|FG001|Overall Study|Unable to meet visit schedule|0|||
161494560|NCT01291173|583205817|FG002|Overall Study|Unable to meet visit schedule|1|||
161494561|NCT01291173|583205818|FG003|Overall Study|Unable to meet visit schedule|0|||
161494562|NCT01291173|583205815|FG000|Overall Study|Lack of compliance|0|||
161494563|NCT01291173|583205816|FG001|Overall Study|Lack of compliance|0|||
161494564|NCT01291173|583205817|FG002|Overall Study|Lack of compliance|0|||
161494565|NCT01291173|583205818|FG003|Overall Study|Lack of compliance|1|||
161494566|NCT01291173|583205815|FG000|Overall Study|Subject was unblinded|0|||
161494567|NCT01291173|583205816|FG001|Overall Study|Subject was unblinded|0|||
161494568|NCT01291173|583205817|FG002|Overall Study|Subject was unblinded|1|||
161494569|NCT01291173|583205818|FG003|Overall Study|Subject was unblinded|0|||
161494570|NCT01291173|583205815|FG000|Overall Study|Excluded therapy|0|||
161494571|NCT01291173|583205816|FG001|Overall Study|Excluded therapy|0|||
161494572|NCT01291173|583205817|FG002|Overall Study|Excluded therapy|1|||
161494573|NCT01291173|583205818|FG003|Overall Study|Excluded therapy|0|||
161494574|NCT01074450|583205824|FG000|First Intervention|Emesis in Dosing Interval|0|||
161494575|NCT01074450|583205825|FG001|First Intervention|Emesis in Dosing Interval|2|||
161494576|NCT01074450|583205824|FG000|Second Intervention|Protocol Violation|1|||
161494577|NCT01074450|583205825|FG001|Second Intervention|Protocol Violation|0|||
161494578|NCT01074450|583205824|FG000|Second Intervention|Physician Decision|0|||
161494579|NCT01074450|583205825|FG001|Second Intervention|Physician Decision|1|||
161494580|NCT02728895|583205826|FG000|Overall Study|Other|1|||
161494581|NCT02728895|583205827|FG001|Overall Study|Other|2|||
161494582|NCT02728895|583205826|FG000|Overall Study|Withdrawal by Subject|0|||
161494583|NCT02728895|583205827|FG001|Overall Study|Withdrawal by Subject|3|||
161494584|NCT02769247|583205828|FG000|Overall Study|Withdrawal by Subject|1|||
161494585|NCT02769247|583205829|FG001|Overall Study|Withdrawal by Subject|0|||
161494586|NCT02769247|583205830|FG002|Overall Study|Withdrawal by Subject|0|||
161494587|NCT02769247|583205831|FG003|Overall Study|Withdrawal by Subject|1|||
161494588|NCT02769247|583205828|FG000|Overall Study|Protocol Violation|0|||
161494589|NCT02769247|583205829|FG001|Overall Study|Protocol Violation|0|||
161494590|NCT02769247|583205830|FG002|Overall Study|Protocol Violation|1|||
161494591|NCT02769247|583205831|FG003|Overall Study|Protocol Violation|0|||
161494592|NCT02769247|583205828|FG000|Overall Study|Physician Decision|1|||
161494593|NCT02769247|583205829|FG001|Overall Study|Physician Decision|0|||
161494594|NCT02769247|583205830|FG002|Overall Study|Physician Decision|0|||
161494595|NCT02769247|583205831|FG003|Overall Study|Physician Decision|0|||
161494596|NCT04788953|583205832|FG000|Overall Study|Adverse Event|1|||
161494597|NCT04788953|583205833|FG001|Overall Study|Adverse Event|1|||
161494598|NCT04788953|583205832|FG000|Overall Study|Withdrawal by Subject|1|||
161494599|NCT04788953|583205833|FG001|Overall Study|Withdrawal by Subject|0|||
161494600|NCT04788953|583205832|FG000|Overall Study|Protocol Violation|0|||
161494601|NCT04788953|583205833|FG001|Overall Study|Protocol Violation|1|||
161494602|NCT00469092|583205834|FG000|Overall Study|Adverse Event|5|||
161494603|NCT00469092|583205835|FG001|Overall Study|Adverse Event|4|||
161494604|NCT00469092|583205834|FG000|Overall Study|Lack of Efficacy|1|||
161494605|NCT00469092|583205835|FG001|Overall Study|Lack of Efficacy|0|||
161494606|NCT00469092|583205834|FG000|Overall Study|Lost to Follow-up|1|||
161494607|NCT00469092|583205835|FG001|Overall Study|Lost to Follow-up|2|||
161584874|NCT03398148|583529780|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
161494608|NCT00469092|583205834|FG000|Overall Study|Protocol Violation|3|||
161494609|NCT00469092|583205835|FG001|Overall Study|Protocol Violation|3|||
161494610|NCT00469092|583205834|FG000|Overall Study|Withdrawal by Subject|4|||
161584875|NCT03398148|583529781|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
161924102|NCT00544882|584768159|FG002|Cycle 3: Follow-up|Noncompliance|0|||
161924103|NCT00544882|584768157|FG000|Cycle 3: Follow-up|Pregnancy|0|||
161494611|NCT00469092|583205835|FG001|Overall Study|Withdrawal by Subject|4|||
161494612|NCT00469092|583205834|FG000|Overall Study|Withdrawal Criteria|3|||
161494613|NCT00469092|583205835|FG001|Overall Study|Withdrawal Criteria|4|||
161494614|NCT00469092|583205834|FG000|Overall Study|Incorrectly Randomised|4|||
161494615|NCT00469092|583205835|FG001|Overall Study|Incorrectly Randomised|3|||
161494616|NCT00469092|583205834|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
161584876|NCT03398148|583529767|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161924104|NCT00544882|584768158|FG001|Cycle 3: Follow-up|Pregnancy|1|||
161494617|NCT00469092|583205835|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
161494618|NCT00469092|583205834|FG000|Overall Study|Use of lipid lowering drug|1|||
161494619|NCT00469092|583205835|FG001|Overall Study|Use of lipid lowering drug|0|||
161494620|NCT00469092|583205834|FG000|Overall Study|Hypoglycaemic Episodes|1|||
161494621|NCT00469092|583205835|FG001|Overall Study|Hypoglycaemic Episodes|1|||
161494622|NCT00469092|583205834|FG000|Overall Study|Abnormal lab value|1|||
161494623|NCT00469092|583205835|FG001|Overall Study|Abnormal lab value|0|||
161494624|NCT00469092|583205834|FG000|Overall Study|Use of Corticosteroid|1|||
161494625|NCT00469092|583205835|FG001|Overall Study|Use of Corticosteroid|0|||
161494626|NCT02024867|583205836|FG000|Overall Study|Protocol Violation|3|||
161494627|NCT02024867|583205837|FG001|Overall Study|Protocol Violation|3|||
161494628|NCT02024867|583205836|FG000|Overall Study|Lost to Follow-up|6|||
161494629|NCT02024867|583205837|FG001|Overall Study|Lost to Follow-up|4|||
161494630|NCT01086540|583205840|FG000|Overall Study|Death|3|||
161494631|NCT01086540|583205841|FG001|Overall Study|Death|1|||
161494632|NCT01086540|583205840|FG000|Overall Study|Physician Decision|2|||
161494633|NCT01086540|583205841|FG001|Overall Study|Physician Decision|1|||
161494634|NCT01086540|583205840|FG000|Overall Study|Addition of new therapy for PAH|1|||
161494635|NCT01086540|583205841|FG001|Overall Study|Addition of new therapy for PAH|0|||
161494636|NCT01998737|583205844|FG000|Overall Study|Corrupted database|23|||
161494637|NCT01998737|583205845|FG001|Overall Study|Corrupted database|0|||
161494638|NCT05407675|583205848|FG000|Overall Study|Withdrawal by Subject|0|||
161494639|NCT05407675|583205849|FG001|Overall Study|Withdrawal by Subject|2|||
161494640|NCT05407675|583205850|FG002|Overall Study|Withdrawal by Subject|3|||
161494641|NCT05407675|583205851|FG003|Overall Study|Withdrawal by Subject|5|||
161494642|NCT05407675|583205852|FG004|Overall Study|Withdrawal by Subject|0|||
161494643|NCT05407675|583205853|FG005|Overall Study|Withdrawal by Subject|2|||
161494644|NCT05407675|583205854|FG006|Overall Study|Withdrawal by Subject|0|||
161494645|NCT05407675|583205855|FG007|Overall Study|Withdrawal by Subject|0|||
161494646|NCT05407675|583205856|FG008|Overall Study|Withdrawal by Subject|2|||
161494647|NCT05407675|583205857|FG009|Overall Study|Withdrawal by Subject|0|||
161494648|NCT05407675|583205858|FG010|Overall Study|Withdrawal by Subject|1|||
161494649|NCT05407675|583205859|FG011|Overall Study|Withdrawal by Subject|0|||
161494650|NCT05407675|583205860|FG012|Overall Study|Withdrawal by Subject|0|||
161494651|NCT05407675|583205848|FG000|Overall Study|Site terminated by sponsor|0|||
161494652|NCT05407675|583205849|FG001|Overall Study|Site terminated by sponsor|0|||
161494653|NCT05407675|583205850|FG002|Overall Study|Site terminated by sponsor|1|||
161494654|NCT05407675|583205851|FG003|Overall Study|Site terminated by sponsor|0|||
161494655|NCT05407675|583205852|FG004|Overall Study|Site terminated by sponsor|2|||
161494656|NCT05407675|583205853|FG005|Overall Study|Site terminated by sponsor|0|||
161494657|NCT05407675|583205854|FG006|Overall Study|Site terminated by sponsor|1|||
161494658|NCT05407675|583205855|FG007|Overall Study|Site terminated by sponsor|0|||
161494659|NCT05407675|583205856|FG008|Overall Study|Site terminated by sponsor|0|||
161494660|NCT05407675|583205857|FG009|Overall Study|Site terminated by sponsor|2|||
161494661|NCT05407675|583205858|FG010|Overall Study|Site terminated by sponsor|2|||
161494662|NCT05407675|583205859|FG011|Overall Study|Site terminated by sponsor|2|||
161494663|NCT05407675|583205860|FG012|Overall Study|Site terminated by sponsor|1|||
161494664|NCT05407675|583205848|FG000|Overall Study|Disease Progression|0|||
161494665|NCT05407675|583205849|FG001|Overall Study|Disease Progression|0|||
161494666|NCT05407675|583205850|FG002|Overall Study|Disease Progression|0|||
161494667|NCT05407675|583205851|FG003|Overall Study|Disease Progression|0|||
161494668|NCT05407675|583205852|FG004|Overall Study|Disease Progression|0|||
161494669|NCT05407675|583205853|FG005|Overall Study|Disease Progression|0|||
161494670|NCT05407675|583205854|FG006|Overall Study|Disease Progression|0|||
161494671|NCT05407675|583205855|FG007|Overall Study|Disease Progression|0|||
161494672|NCT05407675|583205856|FG008|Overall Study|Disease Progression|0|||
161494673|NCT05407675|583205857|FG009|Overall Study|Disease Progression|0|||
161494674|NCT05407675|583205858|FG010|Overall Study|Disease Progression|1|||
161494675|NCT05407675|583205859|FG011|Overall Study|Disease Progression|0|||
161494676|NCT05407675|583205860|FG012|Overall Study|Disease Progression|0|||
161494677|NCT05407675|583205848|FG000|Overall Study|Physician Decision|0|||
161584877|NCT03398148|583529768|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584878|NCT03398148|583529769|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161494678|NCT05407675|583205849|FG001|Overall Study|Physician Decision|0|||
161494679|NCT05407675|583205850|FG002|Overall Study|Physician Decision|0|||
161494680|NCT05407675|583205851|FG003|Overall Study|Physician Decision|0|||
161494681|NCT05407675|583205852|FG004|Overall Study|Physician Decision|0|||
161494682|NCT05407675|583205853|FG005|Overall Study|Physician Decision|0|||
161494683|NCT05407675|583205854|FG006|Overall Study|Physician Decision|0|||
161494684|NCT05407675|583205855|FG007|Overall Study|Physician Decision|0|||
161494685|NCT05407675|583205856|FG008|Overall Study|Physician Decision|0|||
161584879|NCT03398148|583529770|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161494686|NCT05407675|583205857|FG009|Overall Study|Physician Decision|0|||
161494687|NCT05407675|583205858|FG010|Overall Study|Physician Decision|1|||
161494688|NCT05407675|583205859|FG011|Overall Study|Physician Decision|0|||
161494689|NCT05407675|583205860|FG012|Overall Study|Physician Decision|0|||
161494690|NCT05407675|583205848|FG000|Overall Study|Other reasons|0|||
161584880|NCT03398148|583529771|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161494691|NCT05407675|583205849|FG001|Overall Study|Other reasons|0|||
161494692|NCT05407675|583205850|FG002|Overall Study|Other reasons|0|||
161494693|NCT05407675|583205851|FG003|Overall Study|Other reasons|0|||
161494694|NCT05407675|583205852|FG004|Overall Study|Other reasons|0|||
161494695|NCT05407675|583205853|FG005|Overall Study|Other reasons|0|||
161924105|NCT00544882|584768159|FG002|Cycle 3: Follow-up|Pregnancy|0|||
161924106|NCT00308685|584768160|FG000|Overall Study|Lost to Follow-up|1|||
161924107|NCT00308685|584768161|FG001|Overall Study|Lost to Follow-up|0|||
161924108|NCT00308685|584768160|FG000|Overall Study|Need to administer prohibited medication|1|||
161924109|NCT00308685|584768161|FG001|Overall Study|Need to administer prohibited medication|2|||
161924110|NCT00308685|584768160|FG000|Overall Study|Other than specified|1|||
161924111|NCT00308685|584768161|FG001|Overall Study|Other than specified|3|||
161924112|NCT03770455|584768162|FG000|Overall Study|Screen failures|3|||
161924113|NCT01121575|584768163|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
161924114|NCT01121575|584768164|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
161924115|NCT01121575|584768165|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
161924116|NCT01121575|584768166|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
161924117|NCT01121575|584768167|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
161924118|NCT01121575|584768168|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
161924119|NCT01121575|584768163|FG000|Overall Study|Unspecified Reasons|8|||
161924120|NCT01121575|584768164|FG001|Overall Study|Unspecified Reasons|6|||
161924121|NCT01121575|584768165|FG002|Overall Study|Unspecified Reasons|7|||
161924122|NCT01121575|584768166|FG003|Overall Study|Unspecified Reasons|5|||
161924123|NCT01121575|584768167|FG004|Overall Study|Unspecified Reasons|13|||
161924124|NCT01121575|584768168|FG005|Overall Study|Unspecified Reasons|10|||
161924125|NCT01121575|584768163|FG000|Overall Study|Death|6|||
161924126|NCT01121575|584768164|FG001|Overall Study|Death|0|||
161924127|NCT01121575|584768165|FG002|Overall Study|Death|0|||
161924128|NCT01121575|584768166|FG003|Overall Study|Death|1|||
161924129|NCT01121575|584768167|FG004|Overall Study|Death|7|||
161924130|NCT01121575|584768168|FG005|Overall Study|Death|1|||
161924131|NCT02583269|584768169|FG000|Overall Study|Patient hospitalized prior to start|1|||
161924132|NCT02583269|584768170|FG001|Overall Study|Patient hospitalized prior to start|0|||
161924133|NCT02583269|584768171|FG002|Overall Study|Patient hospitalized prior to start|0|||
161924134|NCT02583269|584768172|FG003|Overall Study|Patient hospitalized prior to start|0|||
161924135|NCT02583269|584768173|FG004|Overall Study|Patient hospitalized prior to start|0|||
161924136|NCT03244189|584768175|FG000|Overall Study|Death|0|||
161924137|NCT03244189|584768176|FG001|Overall Study|Death|2|||
161924138|NCT03244189|584768175|FG000|Overall Study|Lost to Follow-up|92|||
161924139|NCT03244189|584768176|FG001|Overall Study|Lost to Follow-up|107|||
161924140|NCT03244189|584768175|FG000|Overall Study|Physician Decision|4|||
161924141|NCT03244189|584768176|FG001|Overall Study|Physician Decision|2|||
161924142|NCT03244189|584768175|FG000|Overall Study|Pregnancy|7|||
161924143|NCT03244189|584768176|FG001|Overall Study|Pregnancy|5|||
161924144|NCT03244189|584768175|FG000|Overall Study|Protocol Violation|0|||
161924145|NCT03244189|584768176|FG001|Overall Study|Protocol Violation|2|||
161924146|NCT03244189|584768175|FG000|Overall Study|Withdrawal by Subject|45|||
161924147|NCT03244189|584768176|FG001|Overall Study|Withdrawal by Subject|23|||
161924148|NCT03244189|584768175|FG000|Overall Study|Technical Problems|2|||
161924149|NCT03244189|584768176|FG001|Overall Study|Technical Problems|0|||
161924150|NCT03860584|584768184|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
161924151|NCT03860584|584768185|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
161924152|NCT03860584|584768184|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161924153|NCT03860584|584768185|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161924154|NCT03860584|584768184|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
161924155|NCT03860584|584768185|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
161924156|NCT03860584|584768184|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
161924157|NCT03860584|584768185|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
161924158|NCT05800145|584768186|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
161924159|NCT05800145|584768187|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924160|NCT05800145|584768188|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924161|NCT05800145|584768189|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
161924162|NCT05800145|584768190|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924163|NCT05800145|584768191|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924164|NCT05800145|584768186|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
161924165|NCT05800145|584768187|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924166|NCT05800145|584768188|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924167|NCT05800145|584768189|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
161924168|NCT05800145|584768190|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924169|NCT05800145|584768191|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924170|NCT05800145|584768186|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
161924171|NCT05800145|584768187|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
161924172|NCT05800145|584768188|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
161494696|NCT05407675|583205854|FG006|Overall Study|Other reasons|0|||
161494697|NCT05407675|583205855|FG007|Overall Study|Other reasons|0|||
161494698|NCT05407675|583205856|FG008|Overall Study|Other reasons|1|||
161494699|NCT05407675|583205857|FG009|Overall Study|Other reasons|1|||
161494700|NCT05407675|583205858|FG010|Overall Study|Other reasons|1|||
161494701|NCT05407675|583205859|FG011|Overall Study|Other reasons|1|||
161494702|NCT05407675|583205860|FG012|Overall Study|Other reasons|0|||
161494703|NCT05407675|583205848|FG000|Overall Study|Death|3|||
161494704|NCT05407675|583205849|FG001|Overall Study|Death|4|||
161494705|NCT05407675|583205850|FG002|Overall Study|Death|3|||
161494706|NCT05407675|583205851|FG003|Overall Study|Death|6|||
161494707|NCT05407675|583205852|FG004|Overall Study|Death|0|||
161494708|NCT05407675|583205853|FG005|Overall Study|Death|2|||
161494709|NCT05407675|583205854|FG006|Overall Study|Death|4|||
161494710|NCT05407675|583205855|FG007|Overall Study|Death|2|||
161494711|NCT05407675|583205856|FG008|Overall Study|Death|2|||
161494712|NCT05407675|583205857|FG009|Overall Study|Death|4|||
161494713|NCT05407675|583205858|FG010|Overall Study|Death|2|||
161494714|NCT05407675|583205859|FG011|Overall Study|Death|1|||
161494715|NCT05407675|583205860|FG012|Overall Study|Death|0|||
161494716|NCT05407675|583205848|FG000|Overall Study|Adverse Event|0|||
161494717|NCT05407675|583205849|FG001|Overall Study|Adverse Event|0|||
161494718|NCT05407675|583205850|FG002|Overall Study|Adverse Event|0|||
161494719|NCT05407675|583205851|FG003|Overall Study|Adverse Event|0|||
161494720|NCT05407675|583205852|FG004|Overall Study|Adverse Event|1|||
161494721|NCT05407675|583205853|FG005|Overall Study|Adverse Event|0|||
161494722|NCT05407675|583205854|FG006|Overall Study|Adverse Event|0|||
161494723|NCT05407675|583205855|FG007|Overall Study|Adverse Event|0|||
161584881|NCT03398148|583529772|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584882|NCT03398148|583529773|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584883|NCT03398148|583529774|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161672182|NCT05085665|583853051|FG000|Overall Study|Physician Decision|2|||
161672183|NCT03294109|583853052|FG000|Overall Study|Withdrawal by Subject|6|||
161672184|NCT03294109|583853053|FG001|Overall Study|Withdrawal by Subject|5|||
161672185|NCT01717768|583853054|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672186|NCT01717768|583853055|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
161672187|NCT01717768|583853056|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672188|NCT01717768|583853057|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672189|NCT01717768|583853058|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672190|NCT01717768|583853059|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672191|NCT01717768|583853060|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161584884|NCT03398148|583529775|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584885|NCT03398148|583529776|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584886|NCT03398148|583529777|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584887|NCT03398148|583529778|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
161584888|NCT03398148|583529779|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161584889|NCT03398148|583529780|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
161584890|NCT03398148|583529781|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
161584891|NCT03398148|583529767|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
161584892|NCT03398148|583529768|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
161584893|NCT03398148|583529769|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
161584894|NCT03398148|583529770|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
161584895|NCT03398148|583529771|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
161584896|NCT03398148|583529772|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
161584897|NCT03398148|583529773|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
161584898|NCT03398148|583529774|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
161584899|NCT03398148|583529775|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
161584900|NCT03398148|583529776|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
161584901|NCT03398148|583529777|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
161584902|NCT03398148|583529778|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
161584903|NCT03398148|583529779|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
161584904|NCT03398148|583529780|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
161584905|NCT03398148|583529781|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
161818138|NCT03961204|584374383|FG000|Overall Study|Withdrawal by Subject|2|||
161818139|NCT03961204|584374383|FG000|Overall Study|Lost to Follow-up|3|||
161818140|NCT03961204|584374383|FG000|Overall Study|Other|1|||
161584906|NCT03398148|583529767|FG000|Substudy 2 Period 2|Other|0|||
161818141|NCT03961204|584374383|FG000|Overall Study|Missing|1|||
161494724|NCT05407675|583205856|FG008|Overall Study|Adverse Event|0|||
161494725|NCT05407675|583205857|FG009|Overall Study|Adverse Event|0|||
161584907|NCT03398148|583529768|FG001|Substudy 2 Period 2|Other|0|||
161584908|NCT03398148|583529769|FG002|Substudy 2 Period 2|Other|0|||
161584909|NCT03398148|583529770|FG003|Substudy 2 Period 2|Other|0|||
161584910|NCT03398148|583529771|FG004|Substudy 2 Period 2|Other|0|||
161584911|NCT03398148|583529772|FG005|Substudy 2 Period 2|Other|0|||
161494726|NCT05407675|583205858|FG010|Overall Study|Adverse Event|0|||
161494727|NCT05407675|583205859|FG011|Overall Study|Adverse Event|1|||
161494728|NCT05407675|583205860|FG012|Overall Study|Adverse Event|0|||
161672192|NCT01717768|583853061|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161584912|NCT03398148|583529773|FG006|Substudy 2 Period 2|Other|0|||
161672193|NCT01717768|583853062|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672194|NCT01717768|583853063|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672195|NCT01717768|583853064|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672196|NCT01717768|583853065|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672197|NCT01717768|583853054|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672198|NCT01717768|583853055|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672199|NCT01717768|583853056|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672200|NCT01717768|583853057|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672201|NCT01717768|583853058|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672202|NCT01717768|583853059|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672203|NCT01717768|583853060|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672204|NCT01717768|583853061|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672205|NCT01717768|583853062|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672206|NCT01717768|583853063|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672207|NCT01717768|583853064|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672208|NCT01717768|583853065|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
161672209|NCT01717768|583853054|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672210|NCT01717768|583853055|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672211|NCT01717768|583853056|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672212|NCT01717768|583853057|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672213|NCT01717768|583853058|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672214|NCT01717768|583853059|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672215|NCT01717768|583853060|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672216|NCT01717768|583853061|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
161672217|NCT01717768|583853062|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672218|NCT01717768|583853063|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672219|NCT01717768|583853064|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672220|NCT01717768|583853065|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672221|NCT01717768|583853054|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672222|NCT01717768|583853055|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672223|NCT01717768|583853056|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672224|NCT01717768|583853057|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672225|NCT01717768|583853058|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672226|NCT01717768|583853059|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672227|NCT01717768|583853060|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672228|NCT01717768|583853061|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672229|NCT01717768|583853062|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672230|NCT01717768|583853063|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
161672231|NCT01717768|583853064|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672232|NCT01717768|583853065|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161924173|NCT05800145|584768189|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
161584913|NCT03398148|583529774|FG007|Substudy 2 Period 2|Other|0|||
161584914|NCT03398148|583529775|FG008|Substudy 2 Period 2|Other|0|||
161584915|NCT03398148|583529776|FG009|Substudy 2 Period 2|Other|0|||
161584916|NCT03398148|583529777|FG010|Substudy 2 Period 2|Other|0|||
161584917|NCT03398148|583529778|FG011|Substudy 2 Period 2|Other|0|||
161584918|NCT03398148|583529779|FG012|Substudy 2 Period 2|Other|0|||
161584919|NCT03398148|583529780|FG013|Substudy 2 Period 2|Other|1|||
161584920|NCT03398148|583529781|FG014|Substudy 2 Period 2|Other|1|||
161584921|NCT03398148|583529767|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584922|NCT03398148|583529768|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584923|NCT03398148|583529769|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584924|NCT03398148|583529770|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584925|NCT03398148|583529771|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584926|NCT03398148|583529772|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584927|NCT03398148|583529773|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584928|NCT03398148|583529774|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584929|NCT03398148|583529775|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
161924174|NCT05800145|584768190|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
161924175|NCT05800145|584768191|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
161924176|NCT04827446|584769599|FG000|Overall Study|Lost to Follow-up|1|||
161924177|NCT04827446|584769600|FG001|Overall Study|Lost to Follow-up|1|||
161924178|NCT04827446|584769599|FG000|Overall Study|Death|2|||
161584930|NCT03398148|583529776|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584931|NCT03398148|583529777|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584932|NCT03398148|583529778|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
161494729|NCT05407675|583205848|FG000|Overall Study|Ongoing Treatment|0|||
161494730|NCT05407675|583205849|FG001|Overall Study|Ongoing Treatment|0|||
161494731|NCT05407675|583205850|FG002|Overall Study|Ongoing Treatment|0|||
161494732|NCT05407675|583205851|FG003|Overall Study|Ongoing Treatment|0|||
161494733|NCT05407675|583205852|FG004|Overall Study|Ongoing Treatment|0|||
161494734|NCT05407675|583205853|FG005|Overall Study|Ongoing Treatment|0|||
161494735|NCT05407675|583205854|FG006|Overall Study|Ongoing Treatment|0|||
161494736|NCT05407675|583205855|FG007|Overall Study|Ongoing Treatment|0|||
161494737|NCT05407675|583205856|FG008|Overall Study|Ongoing Treatment|1|||
161494738|NCT05407675|583205857|FG009|Overall Study|Ongoing Treatment|0|||
161494739|NCT05407675|583205858|FG010|Overall Study|Ongoing Treatment|0|||
161494740|NCT05407675|583205859|FG011|Overall Study|Ongoing Treatment|0|||
161494741|NCT05407675|583205860|FG012|Overall Study|Ongoing Treatment|0|||
161494742|NCT00857220|583205861|FG000|Overall Study|Adverse Event|35|||
161494743|NCT00857220|583205861|FG000|Overall Study|Death|1|||
161494744|NCT00857220|583205861|FG000|Overall Study|Lack of Efficacy|11|||
161494745|NCT00857220|583205861|FG000|Overall Study|Lost to Follow-up|30|||
161494746|NCT00857220|583205861|FG000|Overall Study|Physician Decision|4|||
161494747|NCT00857220|583205861|FG000|Overall Study|Protocol Violation|16|||
161494748|NCT00857220|583205861|FG000|Overall Study|Withdrawal by Subject|67|||
161494749|NCT00857220|583205861|FG000|Overall Study|Clinical Hold|6|||
161494750|NCT00857220|583205861|FG000|Overall Study|Site Closed|5|||
161818142|NCT02218216|584374384|FG000|Overall Study|Study terminated before completed|6|||
161818143|NCT02218216|584374385|FG001|Overall Study|Study terminated before completed|0|||
161818144|NCT02218216|584374386|FG002|Overall Study|Study terminated before completed|0|||
161818145|NCT02452463|584374389|FG000|Overall Study|Death|1|||
161818146|NCT02452463|584374390|FG001|Overall Study|Death|0|||
161818147|NCT02452463|584374391|FG002|Overall Study|Death|0|||
161818148|NCT02452463|584374389|FG000|Overall Study|Study Suspended|1|||
161818149|NCT02452463|584374390|FG001|Overall Study|Study Suspended|0|||
161494751|NCT00857220|583205861|FG000|Overall Study|Miscellaneous|8|||
161494752|NCT02612428|583205862|FG000|VTL-308|Death|14|||
161494753|NCT02612428|583205863|FG001|VTL-308|Death|16|||
161494754|NCT02612428|583205862|FG000|VTL-308|Withdrawal by Subject|0|||
161494755|NCT02612428|583205863|FG001|VTL-308|Withdrawal by Subject|1|||
161494756|NCT02612428|583205862|FG000|VTL-308E|Death|9|||
161494757|NCT02612428|583205863|FG001|VTL-308E|Death|7|||
161494758|NCT02612428|583205862|FG000|VTL-308E|Lost to Follow-up|2|||
161494759|NCT02612428|583205863|FG001|VTL-308E|Lost to Follow-up|0|||
161494760|NCT00742001|583205864|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
161494761|NCT00742001|583205865|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
161494762|NCT00742001|583205866|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
161494763|NCT00137423|583205869|FG000|Overall Study|Adverse Event|7|||
161494764|NCT00137423|583205870|FG001|Overall Study|Adverse Event|9|||
161494765|NCT00137423|583205869|FG000|Overall Study|consent withdrawn|1|||
161494766|NCT00137423|583205870|FG001|Overall Study|consent withdrawn|1|||
161494767|NCT00137423|583205869|FG000|Overall Study|Lack of Efficacy|31|||
161494768|NCT00137423|583205870|FG001|Overall Study|Lack of Efficacy|33|||
161494769|NCT00137423|583205869|FG000|Overall Study|Death|0|||
161494770|NCT00137423|583205870|FG001|Overall Study|Death|1|||
161494771|NCT03187262|583205872|FG000|Induction|Lack of Efficacy|2|||
161494772|NCT03187262|583205872|FG000|Induction|Progressive Disease|4|||
161494773|NCT03187262|583205872|FG000|Consolidation|Progressive Disease|5|||
161494774|NCT01050257|583205874|FG000|Overall Study|Adverse Event|4|||
161494775|NCT01050257|583205875|FG001|Overall Study|Adverse Event|4|||
161494776|NCT01050257|583205876|FG002|Overall Study|Adverse Event|2|||
161494777|NCT01050257|583205874|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
161818150|NCT02452463|584374391|FG002|Overall Study|Study Suspended|0|||
161818151|NCT02452463|584374389|FG000|Overall Study|Recommended by DSMB|0|||
161818152|NCT02452463|584374390|FG001|Overall Study|Recommended by DSMB|1|||
161818153|NCT02452463|584374391|FG002|Overall Study|Recommended by DSMB|0|||
161818154|NCT02452463|584374389|FG000|Overall Study|Withdrawal by Subject|0|||
161494778|NCT01050257|583205875|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
161494779|NCT01050257|583205876|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
161494780|NCT01050257|583205874|FG000|Overall Study|Withdrawal by Subject|0|||
161494781|NCT01050257|583205875|FG001|Overall Study|Withdrawal by Subject|3|||
161494782|NCT01050257|583205876|FG002|Overall Study|Withdrawal by Subject|0|||
161494783|NCT01050257|583205874|FG000|Overall Study|No reason specified|0|||
161494784|NCT01050257|583205875|FG001|Overall Study|No reason specified|0|||
161494785|NCT01050257|583205876|FG002|Overall Study|No reason specified|2|||
161494786|NCT01050257|583205874|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
161494787|NCT01050257|583205875|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
161494788|NCT01050257|583205876|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
161494789|NCT01050257|583205874|FG000|Overall Study|Violation criteria|0|||
161494790|NCT01050257|583205875|FG001|Overall Study|Violation criteria|1|||
161494791|NCT01050257|583205876|FG002|Overall Study|Violation criteria|0|||
161494792|NCT01050257|583205874|FG000|Overall Study|Failure to return|0|||
161494793|NCT01050257|583205875|FG001|Overall Study|Failure to return|2|||
161818155|NCT02452463|584374390|FG001|Overall Study|Withdrawal by Subject|1|||
161924179|NCT04827446|584769600|FG001|Overall Study|Death|0|||
161494794|NCT01050257|583205876|FG002|Overall Study|Failure to return|0|||
161494795|NCT01050257|583205874|FG000|Overall Study|Death|0|||
161494796|NCT01050257|583205875|FG001|Overall Study|Death|0|||
161494797|NCT01050257|583205876|FG002|Overall Study|Death|1|||
161494798|NCT00278109|583205877|FG000|Overall Study|Adverse Event|3|||
161494799|NCT00278109|583205877|FG000|Overall Study|social circumstances|1|||
161494800|NCT02580357|583205878|FG000|Overall Study|Lost to Follow-up|2|||
161494801|NCT02580357|583205879|FG001|Overall Study|Lost to Follow-up|0|||
161494802|NCT02580357|583205880|FG002|Overall Study|Lost to Follow-up|0|||
161494803|NCT02580357|583205878|FG000|Overall Study|Protocol Violation|1|||
161494804|NCT02580357|583205879|FG001|Overall Study|Protocol Violation|0|||
161494805|NCT02580357|583205880|FG002|Overall Study|Protocol Violation|0|||
161494806|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
161494807|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
161494808|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
161494809|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
161494810|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
161494811|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
161494812|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
161494813|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
161494814|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
161494815|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
161494816|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
161494817|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
161494818|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
161494819|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
161494820|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
161494821|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
161494822|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
161494823|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
161494824|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
161494825|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
161494826|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
161494827|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
161494828|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
161494829|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
161494830|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
161584933|NCT03398148|583529779|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
161584934|NCT03398148|583529780|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
161584935|NCT03398148|583529781|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
161584936|NCT02791230|583529782|FG000|Overall Study|Adverse Event|10|||
161584937|NCT02791230|583529783|FG001|Overall Study|Adverse Event|9|||
161584938|NCT02791230|583529784|FG002|Overall Study|Adverse Event|66|||
161584939|NCT02791230|583529782|FG000|Overall Study|Death|38|||
161584940|NCT02791230|583529783|FG001|Overall Study|Death|25|||
161584941|NCT02791230|583529784|FG002|Overall Study|Death|184|||
161584942|NCT02791230|583529782|FG000|Overall Study|Lack of Efficacy|1|||
161584943|NCT02791230|583529783|FG001|Overall Study|Lack of Efficacy|0|||
161584944|NCT02791230|583529784|FG002|Overall Study|Lack of Efficacy|3|||
161584945|NCT02791230|583529782|FG000|Overall Study|Lost to Follow-up|0|||
161584946|NCT02791230|583529783|FG001|Overall Study|Lost to Follow-up|0|||
161584947|NCT02791230|583529784|FG002|Overall Study|Lost to Follow-up|10|||
161584948|NCT02791230|583529782|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
161584949|NCT02791230|583529783|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161584950|NCT02791230|583529784|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
161584951|NCT02791230|583529782|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
161584952|NCT02791230|583529783|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
161584953|NCT02791230|583529784|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
161584954|NCT02791230|583529782|FG000|Overall Study|Study sites terminated by sponsor|1|||
161584955|NCT02791230|583529783|FG001|Overall Study|Study sites terminated by sponsor|0|||
161584956|NCT02791230|583529784|FG002|Overall Study|Study sites terminated by sponsor|5|||
161584957|NCT02791230|583529782|FG000|Overall Study|Other|9|||
161584958|NCT02791230|583529783|FG001|Overall Study|Other|1|||
161584959|NCT02791230|583529784|FG002|Overall Study|Other|28|||
161584960|NCT02791230|583529782|FG000|Overall Study|Protocol Violation|0|||
161584961|NCT02791230|583529783|FG001|Overall Study|Protocol Violation|0|||
161584962|NCT02791230|583529784|FG002|Overall Study|Protocol Violation|4|||
161584963|NCT02791230|583529782|FG000|Overall Study|Withdrawal by Subject|24|||
161584964|NCT02791230|583529783|FG001|Overall Study|Withdrawal by Subject|13|||
161584965|NCT02791230|583529784|FG002|Overall Study|Withdrawal by Subject|172|||
161584966|NCT02791230|583529782|FG000|Overall Study|Enrolled but not treated|0|||
161672233|NCT00372385|583853066|FG000|Overall Study|Adverse Event|6|||
161818156|NCT02452463|584374391|FG002|Overall Study|Withdrawal by Subject|0|||
161924180|NCT04827446|584769599|FG000|Overall Study|Withdrawal by Subject|2|||
161494831|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
161494832|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
161494833|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
161494834|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
161494835|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
161494836|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
161494837|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
161494838|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
161494839|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
161494840|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
161494841|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161494842|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161494843|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161494844|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161494845|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161494846|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
161494847|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161494848|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
161494849|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
161494850|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
161494851|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
161494852|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
161494853|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
161494854|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
161494855|NCT03742037|583205882|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
161494856|NCT03742037|583205883|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
161494857|NCT03742037|583205884|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
161494858|NCT03742037|583205885|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
161494859|NCT03742037|583205886|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
161494860|NCT03742037|583205887|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
161494861|NCT03742037|583205888|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
161494862|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
161494863|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
161494864|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
161494865|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
161494866|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
161494867|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
161494868|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
161494869|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
161494870|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
161494871|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
161494872|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
161494873|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
161494874|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
161494875|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
161494876|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
161494877|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
161494878|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
161494879|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
161494880|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
161494881|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
161494882|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
161494883|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
161494884|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
161924181|NCT04827446|584769600|FG001|Overall Study|Withdrawal by Subject|2|||
161924182|NCT03735498|584769601|FG000|Overall Study|Withdrawal by Subject|3|||
161924183|NCT03735498|584769601|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
161924184|NCT00160615|584769602|FG000|Overall Study|Adverse Event|5|||
161924185|NCT00160615|584769603|FG001|Overall Study|Adverse Event|12|||
161924186|NCT00160615|584769602|FG000|Overall Study|Withdrawal by Subject|0|||
161924187|NCT00160615|584769603|FG001|Overall Study|Withdrawal by Subject|2|||
161924188|NCT00160615|584769602|FG000|Overall Study|Lack of Efficacy|11|||
161924189|NCT00160615|584769603|FG001|Overall Study|Lack of Efficacy|23|||
161924190|NCT00160615|584769602|FG000|Overall Study|Patient decision|1|||
161818157|NCT01073631|584374392|FG000|Overall Study|Death|82|||
161818158|NCT01073631|584374392|FG000|Overall Study|Adverse Event|24|||
161494885|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
161494886|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
161494887|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
161494888|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
161494889|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
161494890|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
161494891|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
161494892|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
161494893|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
161494894|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
161494895|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
161494896|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
161494897|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
161494898|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
161494899|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
161494900|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
161494901|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
161494902|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
161494903|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
161494904|NCT03742037|583205882|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
161494905|NCT03742037|583205883|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
161494906|NCT03742037|583205884|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
161494907|NCT03742037|583205885|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
161494908|NCT03742037|583205886|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
161494909|NCT03742037|583205887|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
161494910|NCT03742037|583205888|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
161494911|NCT04128267|583205891|FG000|Overall Study|Withdrawal by Subject|6|||
161494912|NCT04128267|583205891|FG000|Overall Study|Death|2|||
161494913|NCT04128267|583205891|FG000|Overall Study|Disease progression|1|||
161494914|NCT04128267|583205891|FG000|Overall Study|Participant had other medical issues|4|||
161494915|NCT04128267|583205891|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
161494916|NCT01705652|583205892|FG000|Overall Study|Adverse Event|1|||
161494917|NCT01705652|583205893|FG001|Overall Study|Adverse Event|0|||
161494918|NCT01705652|583205892|FG000|Overall Study|Withdrawal by Subject|1|||
161494919|NCT01705652|583205893|FG001|Overall Study|Withdrawal by Subject|2|||
161494920|NCT01705652|583205892|FG000|Overall Study|non-compliance|1|||
161494921|NCT01705652|583205893|FG001|Overall Study|non-compliance|1|||
161494922|NCT00056407|583205896|FG000|Overall Study|Adverse Event|282|||
161494923|NCT00056407|583205897|FG001|Overall Study|Adverse Event|364|||
161494924|NCT00056407|583205896|FG000|Overall Study|Withdrawal by Subject|377|||
161494925|NCT00056407|583205897|FG001|Overall Study|Withdrawal by Subject|361|||
161494926|NCT00056407|583205896|FG000|Overall Study|Lost to Follow-up|123|||
161494927|NCT00056407|583205897|FG001|Overall Study|Lost to Follow-up|113|||
161494928|NCT00056407|583205896|FG000|Overall Study|Protocol Violation|104|||
161494929|NCT00056407|583205897|FG001|Overall Study|Protocol Violation|95|||
161494930|NCT00056407|583205896|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
161494931|NCT00056407|583205897|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
161494932|NCT00056407|583205896|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
161494933|NCT00056407|583205897|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
161494934|NCT00056407|583205896|FG000|Overall Study|Missing|25|||
161494935|NCT00056407|583205897|FG001|Overall Study|Missing|34|||
161494936|NCT00616655|583205898|FG000|Overall Study|Adverse Event|10|||
161494937|NCT00616655|583205899|FG001|Overall Study|Adverse Event|7|||
161494938|NCT00616655|583205900|FG002|Overall Study|Adverse Event|12|||
161494939|NCT00616655|583205898|FG000|Overall Study|Lack of Efficacy|5|||
161494940|NCT00616655|583205899|FG001|Overall Study|Lack of Efficacy|5|||
161494941|NCT00616655|583205900|FG002|Overall Study|Lack of Efficacy|5|||
161818159|NCT01073631|584374392|FG000|Overall Study|Other|63|||
161818160|NCT01131260|584374393|FG000|Overall Study|Randomization error|5|||
161818161|NCT01131260|584374394|FG001|Overall Study|Randomization error|1|||
161818162|NCT01131260|584374393|FG000|Overall Study|Declined to continue participation|8|||
161818163|NCT01131260|584374394|FG001|Overall Study|Declined to continue participation|13|||
161818164|NCT01131260|584374393|FG000|Overall Study|Physician Decision|22|||
161818165|NCT01131260|584374394|FG001|Overall Study|Physician Decision|24|||
161818166|NCT01131260|584374393|FG000|Overall Study|Technical problems|7|||
161924191|NCT00160615|584769603|FG001|Overall Study|Patient decision|2|||
161818167|NCT01131260|584374394|FG001|Overall Study|Technical problems|6|||
161818168|NCT01131260|584374393|FG000|Overall Study|Staff error|2|||
161818169|NCT01131260|584374394|FG001|Overall Study|Staff error|1|||
161818170|NCT01131260|584374393|FG000|Overall Study|Ineligible|0|||
161818171|NCT01131260|584374394|FG001|Overall Study|Ineligible|2|||
161818172|NCT01494532|584374399|FG000|Overall Study|Adverse Event|4|||
161818173|NCT01494532|584374400|FG001|Overall Study|Adverse Event|1|||
161924192|NCT00160615|584769602|FG000|Overall Study|Investigator decision|1|||
161924193|NCT00160615|584769603|FG001|Overall Study|Investigator decision|1|||
161924194|NCT00160615|584769602|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
161924195|NCT00160615|584769603|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
161924196|NCT00160615|584769602|FG000|Overall Study|Switch to surgical treatment|0|||
161924197|NCT00160615|584769603|FG001|Overall Study|Switch to surgical treatment|2|||
161924198|NCT00160615|584769602|FG000|Overall Study|Non-compliance was suspected|0|||
161924199|NCT00160615|584769603|FG001|Overall Study|Non-compliance was suspected|1|||
161924200|NCT00160615|584769602|FG000|Overall Study|Poor compliance|0|||
161924201|NCT00160615|584769603|FG001|Overall Study|Poor compliance|1|||
161924202|NCT03971422|584769605|FG000|Overall Study|Lost to Follow-up|0|||
161924203|NCT03971422|584769606|FG001|Overall Study|Lost to Follow-up|1|||
161924204|NCT03971422|584769607|FG002|Overall Study|Lost to Follow-up|0|||
161924205|NCT03971422|584769605|FG000|Overall Study|Lack of Efficacy|5|||
161924206|NCT03971422|584769606|FG001|Overall Study|Lack of Efficacy|1|||
161924207|NCT03971422|584769607|FG002|Overall Study|Lack of Efficacy|1|||
161924208|NCT03971422|584769605|FG000|Overall Study|Adverse event, not fatal|2|||
161924209|NCT03971422|584769606|FG001|Overall Study|Adverse event, not fatal|2|||
161924210|NCT03971422|584769607|FG002|Overall Study|Adverse event, not fatal|5|||
161924211|NCT03971422|584769605|FG000|Overall Study|Worsening of MG Symptoms|1|||
161924212|NCT03971422|584769606|FG001|Overall Study|Worsening of MG Symptoms|4|||
161818174|NCT01494532|584374401|FG002|Overall Study|Adverse Event|8|||
161818175|NCT01494532|584374402|FG003|Overall Study|Adverse Event|6|||
161494942|NCT00616655|583205898|FG000|Overall Study|Lost to Follow-up|3|||
161494943|NCT00616655|583205899|FG001|Overall Study|Lost to Follow-up|12|||
161494944|NCT00616655|583205900|FG002|Overall Study|Lost to Follow-up|10|||
161494945|NCT00616655|583205898|FG000|Overall Study|Protocol Violation|2|||
161494946|NCT00616655|583205899|FG001|Overall Study|Protocol Violation|4|||
161494947|NCT00616655|583205900|FG002|Overall Study|Protocol Violation|3|||
161494948|NCT00616655|583205898|FG000|Overall Study|Withdrawal by Subject|9|||
161494949|NCT00616655|583205899|FG001|Overall Study|Withdrawal by Subject|7|||
161494950|NCT00616655|583205900|FG002|Overall Study|Withdrawal by Subject|11|||
161494951|NCT00616655|583205898|FG000|Overall Study|Does not meet in/ex criteria|0|||
161494952|NCT00616655|583205899|FG001|Overall Study|Does not meet in/ex criteria|0|||
161494953|NCT00616655|583205900|FG002|Overall Study|Does not meet in/ex criteria|2|||
161494954|NCT00616655|583205898|FG000|Overall Study|Other|6|||
161494955|NCT00616655|583205899|FG001|Overall Study|Other|6|||
161494956|NCT00616655|583205900|FG002|Overall Study|Other|5|||
161494957|NCT01026792|583205901|FG000|Overall Study|Protocol Violation|1|||
161494958|NCT00309842|583205902|FG000|Overall Study|Lost to Follow-up|1|||
161494959|NCT02335099|583205905|FG000|Treatment|Withdrawal by Subject|1|||
161494960|NCT02335099|583205906|FG001|Treatment|Withdrawal by Subject|3|||
161494961|NCT02335099|583205905|FG000|Treatment|Lost to Follow-up|2|||
161494962|NCT02335099|583205906|FG001|Treatment|Lost to Follow-up|0|||
161494963|NCT02335099|583205905|FG000|Treatment|Death|1|||
161494964|NCT02335099|583205906|FG001|Treatment|Death|0|||
161494965|NCT02335099|583205905|FG000|Treatment|Adverse Event|1|||
161494966|NCT02335099|583205906|FG001|Treatment|Adverse Event|2|||
161494967|NCT02335099|583205905|FG000|Follow-up|Death|0|||
161494968|NCT02335099|583205906|FG001|Follow-up|Death|1|||
161494969|NCT01472081|583205907|FG000|Overall Study|Continuing treatment at time of analysis|1|||
161494970|NCT01472081|583205908|FG001|Overall Study|Continuing treatment at time of analysis|4|||
161494971|NCT01472081|583205909|FG002|Overall Study|Continuing treatment at time of analysis|1|||
161494972|NCT01472081|583205910|FG003|Overall Study|Continuing treatment at time of analysis|8|||
161494973|NCT01472081|583205911|FG004|Overall Study|Continuing treatment at time of analysis|9|||
161494974|NCT01472081|583205912|FG005|Overall Study|Continuing treatment at time of analysis|0|||
161494975|NCT01472081|583205907|FG000|Overall Study|Disease Progression|4|||
161494976|NCT01472081|583205908|FG001|Overall Study|Disease Progression|10|||
161494977|NCT01472081|583205909|FG002|Overall Study|Disease Progression|12|||
161494978|NCT01472081|583205910|FG003|Overall Study|Disease Progression|31|||
161494979|NCT01472081|583205911|FG004|Overall Study|Disease Progression|22|||
161494980|NCT01472081|583205912|FG005|Overall Study|Disease Progression|3|||
161494981|NCT01472081|583205907|FG000|Overall Study|Study drug toxicity|2|||
161494982|NCT01472081|583205908|FG001|Overall Study|Study drug toxicity|9|||
161494983|NCT01472081|583205909|FG002|Overall Study|Study drug toxicity|4|||
161494984|NCT01472081|583205910|FG003|Overall Study|Study drug toxicity|6|||
161494985|NCT01472081|583205911|FG004|Overall Study|Study drug toxicity|13|||
161494986|NCT01472081|583205912|FG005|Overall Study|Study drug toxicity|2|||
161494987|NCT01472081|583205907|FG000|Overall Study|Death|0|||
161494988|NCT01472081|583205908|FG001|Overall Study|Death|0|||
161494989|NCT01472081|583205909|FG002|Overall Study|Death|0|||
161494990|NCT01472081|583205910|FG003|Overall Study|Death|0|||
161494991|NCT01472081|583205911|FG004|Overall Study|Death|1|||
161924213|NCT03971422|584769607|FG002|Overall Study|Worsening of MG Symptoms|2|||
161924214|NCT03971422|584769605|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
161924215|NCT03971422|584769606|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
161924216|NCT03971422|584769607|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
161924217|NCT03971422|584769605|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
161924218|NCT03971422|584769606|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
161494992|NCT01472081|583205912|FG005|Overall Study|Death|0|||
161494993|NCT01472081|583205907|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
161494994|NCT01472081|583205908|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
161494995|NCT01472081|583205909|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
161672234|NCT00372385|583853067|FG001|Overall Study|Adverse Event|11|||
161924219|NCT03971422|584769607|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
161494996|NCT01472081|583205910|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
161494997|NCT01472081|583205911|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
161494998|NCT01472081|583205912|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
161494999|NCT01472081|583205907|FG000|Overall Study|Withdrawal by Subject|0|||
161672235|NCT00372385|583853068|FG002|Overall Study|Adverse Event|9|||
161495000|NCT01472081|583205908|FG001|Overall Study|Withdrawal by Subject|0|||
161495001|NCT01472081|583205909|FG002|Overall Study|Withdrawal by Subject|0|||
161495002|NCT01472081|583205910|FG003|Overall Study|Withdrawal by Subject|0|||
161495003|NCT01472081|583205911|FG004|Overall Study|Withdrawal by Subject|0|||
161495004|NCT01472081|583205912|FG005|Overall Study|Withdrawal by Subject|1|||
161495005|NCT01472081|583205907|FG000|Overall Study|Poor/non-compliance|0|||
161495006|NCT01472081|583205908|FG001|Overall Study|Poor/non-compliance|0|||
161495007|NCT01472081|583205909|FG002|Overall Study|Poor/non-compliance|1|||
161495008|NCT01472081|583205910|FG003|Overall Study|Poor/non-compliance|0|||
161672236|NCT00372385|583853069|FG003|Overall Study|Adverse Event|7|||
161584967|NCT02791230|583529783|FG001|Overall Study|Enrolled but not treated|0|||
161584968|NCT02791230|583529784|FG002|Overall Study|Enrolled but not treated|5|||
161584969|NCT03683069|583529787|FG000|Overall Study|see limitations|12|||
161495009|NCT01472081|583205911|FG004|Overall Study|Poor/non-compliance|1|||
161495010|NCT01472081|583205912|FG005|Overall Study|Poor/non-compliance|0|||
161495011|NCT01472081|583205907|FG000|Overall Study|No longer meets study criteria|0|||
161495012|NCT01472081|583205908|FG001|Overall Study|No longer meets study criteria|0|||
161495013|NCT01472081|583205909|FG002|Overall Study|No longer meets study criteria|1|||
161495014|NCT01472081|583205910|FG003|Overall Study|No longer meets study criteria|0|||
161495015|NCT01472081|583205911|FG004|Overall Study|No longer meets study criteria|0|||
161495016|NCT01472081|583205912|FG005|Overall Study|No longer meets study criteria|0|||
161495017|NCT01472081|583205907|FG000|Overall Study|Subject request to discontinue treatment|0|||
161495018|NCT01472081|583205908|FG001|Overall Study|Subject request to discontinue treatment|3|||
161495019|NCT01472081|583205909|FG002|Overall Study|Subject request to discontinue treatment|1|||
161495020|NCT01472081|583205910|FG003|Overall Study|Subject request to discontinue treatment|1|||
161495021|NCT01472081|583205911|FG004|Overall Study|Subject request to discontinue treatment|0|||
161495022|NCT01472081|583205912|FG005|Overall Study|Subject request to discontinue treatment|0|||
161495023|NCT01367158|583205913|FG000|Overall Study|Withdrew consent|0|||
161495024|NCT01367158|583205914|FG001|Overall Study|Withdrew consent|2|||
161495025|NCT01367158|583205915|FG002|Overall Study|Withdrew consent|1|||
161495026|NCT01367158|583205916|FG003|Overall Study|Withdrew consent|0|||
161495027|NCT01367158|583205917|FG004|Overall Study|Withdrew consent|2|||
161495028|NCT01367158|583205918|FG005|Overall Study|Withdrew consent|0|||
161495029|NCT01367158|583205919|FG006|Overall Study|Withdrew consent|0|||
161495030|NCT01367158|583205920|FG007|Overall Study|Withdrew consent|1|||
161495031|NCT01367158|583205921|FG008|Overall Study|Withdrew consent|0|||
161495032|NCT01367158|583205922|FG009|Overall Study|Withdrew consent|0|||
161495033|NCT01367158|583205923|FG010|Overall Study|Withdrew consent|0|||
161495034|NCT01367158|583205913|FG000|Overall Study|Lost to Follow-up|0|||
161495035|NCT01367158|583205914|FG001|Overall Study|Lost to Follow-up|0|||
161495036|NCT01367158|583205915|FG002|Overall Study|Lost to Follow-up|0|||
161495037|NCT01367158|583205916|FG003|Overall Study|Lost to Follow-up|1|||
161495038|NCT01367158|583205917|FG004|Overall Study|Lost to Follow-up|0|||
161495039|NCT01367158|583205918|FG005|Overall Study|Lost to Follow-up|2|||
161495040|NCT01367158|583205919|FG006|Overall Study|Lost to Follow-up|0|||
161495041|NCT01367158|583205920|FG007|Overall Study|Lost to Follow-up|1|||
161495042|NCT01367158|583205921|FG008|Overall Study|Lost to Follow-up|0|||
161495043|NCT01367158|583205922|FG009|Overall Study|Lost to Follow-up|0|||
161495044|NCT01367158|583205923|FG010|Overall Study|Lost to Follow-up|1|||
161495045|NCT01367158|583205913|FG000|Overall Study|Protocol Violation|0|||
161495046|NCT01367158|583205914|FG001|Overall Study|Protocol Violation|1|||
161495047|NCT01367158|583205915|FG002|Overall Study|Protocol Violation|0|||
161495048|NCT01367158|583205916|FG003|Overall Study|Protocol Violation|0|||
161495049|NCT01367158|583205917|FG004|Overall Study|Protocol Violation|0|||
161495050|NCT01367158|583205918|FG005|Overall Study|Protocol Violation|0|||
161495051|NCT01367158|583205919|FG006|Overall Study|Protocol Violation|0|||
161495052|NCT01367158|583205920|FG007|Overall Study|Protocol Violation|0|||
161495053|NCT01367158|583205921|FG008|Overall Study|Protocol Violation|0|||
161495054|NCT01367158|583205922|FG009|Overall Study|Protocol Violation|0|||
161495055|NCT01367158|583205923|FG010|Overall Study|Protocol Violation|0|||
161495056|NCT01765153|583205924|FG000|Training Phase 1|Format of intervention differed|1|||
161495057|NCT01765153|583205925|FG001|Training Phase 1|Format of intervention differed|0|||
161495058|NCT01765153|583205924|FG000|Training Phase 1|Poor participation in intervention|0|||
161495059|NCT01765153|583205925|FG001|Training Phase 1|Poor participation in intervention|1|||
161495060|NCT01765153|583205924|FG000|Rest Phase 1|Withdrawal by Subject|0|||
161495061|NCT01765153|583205925|FG001|Rest Phase 1|Withdrawal by Subject|1|||
161495062|NCT01765153|583205924|FG000|Training Phase 2|Withdrawal by Subject|0|||
161495063|NCT01765153|583205925|FG001|Training Phase 2|Withdrawal by Subject|1|||
161495064|NCT01765153|583205924|FG000|Rest Phase 2|Lost to Follow-up|2|||
161495065|NCT01765153|583205925|FG001|Rest Phase 2|Lost to Follow-up|1|||
161495066|NCT04702997|583205926|FG000|Overall Study|Withdrawal by Subject|1|||
161495067|NCT04702997|583205927|FG001|Overall Study|Withdrawal by Subject|1|||
161924220|NCT03971422|584769605|FG000|Overall Study|Due to COVID-19 pandemic|0|||
161924221|NCT03971422|584769606|FG001|Overall Study|Due to COVID-19 pandemic|1|||
161924222|NCT03971422|584769607|FG002|Overall Study|Due to COVID-19 pandemic|1|||
161924223|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161495068|NCT03915496|583205928|FG000|Overall Study|Adverse Event|2|||
161495069|NCT03915496|583205929|FG001|Overall Study|Adverse Event|1|||
161495070|NCT03915496|583205930|FG002|Overall Study|Adverse Event|2|||
161495071|NCT02663674|583205931|FG000|Overall Study|Lost to Follow-up|5|||
161495072|NCT02663674|583205932|FG001|Overall Study|Lost to Follow-up|4|||
161495073|NCT02663674|583205931|FG000|Overall Study|Withdrawal by Subject|1|||
161495074|NCT02663674|583205932|FG001|Overall Study|Withdrawal by Subject|4|||
161495075|NCT02663674|583205931|FG000|Overall Study|Physician Decision|1|||
161495076|NCT02663674|583205932|FG001|Overall Study|Physician Decision|1|||
161495077|NCT02663674|583205931|FG000|Overall Study|Other Event (Health Related)|0|||
161495078|NCT02663674|583205932|FG001|Overall Study|Other Event (Health Related)|1|||
161495079|NCT01386554|583205935|FG000|Overall Study|Lost to Follow-up|0|||
161495080|NCT01386554|583205936|FG001|Overall Study|Lost to Follow-up|0|||
161924224|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
161924225|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924226|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924227|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924228|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924229|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
161924230|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924231|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924232|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924233|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924234|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924235|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
161924236|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924237|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924238|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924239|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924240|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924241|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
161924242|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
161924243|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924244|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924245|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924246|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924247|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924248|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924249|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
161495081|NCT01386554|583205937|FG002|Overall Study|Lost to Follow-up|1|||
161495082|NCT01386554|583205935|FG000|Overall Study|Adverse Event|2|||
161495083|NCT01386554|583205936|FG001|Overall Study|Adverse Event|5|||
161495084|NCT01386554|583205937|FG002|Overall Study|Adverse Event|2|||
161672237|NCT00372385|583853066|FG000|Overall Study|Noncompliance|0|||
161672238|NCT00372385|583853067|FG001|Overall Study|Noncompliance|1|||
161495085|NCT01386554|583205935|FG000|Overall Study|Progressive disease|1|||
161495086|NCT01386554|583205936|FG001|Overall Study|Progressive disease|2|||
161495087|NCT01386554|583205937|FG002|Overall Study|Progressive disease|2|||
161495088|NCT01386554|583205935|FG000|Overall Study|Administration of live vaccines|0|||
161495089|NCT01386554|583205936|FG001|Overall Study|Administration of live vaccines|1|||
161495090|NCT01386554|583205937|FG002|Overall Study|Administration of live vaccines|0|||
161495091|NCT01386554|583205935|FG000|Overall Study|Investigator discretion|0|||
161584970|NCT03683069|583529788|FG001|Overall Study|see limitations|13|||
161584971|NCT03821844|583529789|FG000|Overall Study|Death|37|||
161584972|NCT03821844|583529790|FG001|Overall Study|Death|31|||
161584973|NCT03821844|583529789|FG000|Overall Study|Discharged|10|||
161584974|NCT03821844|583529790|FG001|Overall Study|Discharged|14|||
161584975|NCT03821844|583529789|FG000|Overall Study|Not present in facility at followup|2|||
161584976|NCT03821844|583529790|FG001|Overall Study|Not present in facility at followup|3|||
161584977|NCT03899961|583529791|FG000|Overall Study|-delivery prior to|2|||
161584978|NCT03899961|583529792|FG001|Overall Study|-delivery prior to|7|||
161584979|NCT03899961|583529791|FG000|Overall Study|req general anesth|1|||
161584980|NCT03899961|583529792|FG001|Overall Study|req general anesth|2|||
161584981|NCT03899961|583529791|FG000|Overall Study|capacity|5|||
161584982|NCT03899961|583529792|FG001|Overall Study|capacity|6|||
161584983|NCT03899961|583529791|FG000|Overall Study|Withdrawal by Subject|1|||
161584984|NCT03899961|583529792|FG001|Overall Study|Withdrawal by Subject|1|||
161584985|NCT05075408|583529793|FG000|Overall Study|Withdrawal by Subject|5|||
161584986|NCT05075408|583529794|FG001|Overall Study|Withdrawal by Subject|3|||
161584987|NCT05075408|583529795|FG002|Overall Study|Withdrawal by Subject|4|||
161584988|NCT05075408|583529793|FG000|Overall Study|Adverse Event|5|||
161584989|NCT05075408|583529794|FG001|Overall Study|Adverse Event|7|||
161584990|NCT05075408|583529795|FG002|Overall Study|Adverse Event|8|||
161584991|NCT05075408|583529793|FG000|Overall Study|Protocol Violation|0|||
161584992|NCT05075408|583529794|FG001|Overall Study|Protocol Violation|1|||
161584993|NCT05075408|583529795|FG002|Overall Study|Protocol Violation|0|||
161584994|NCT05075408|583529793|FG000|Overall Study|Lost to Follow-up|2|||
161495092|NCT01386554|583205936|FG001|Overall Study|Investigator discretion|0|||
161495093|NCT01386554|583205937|FG002|Overall Study|Investigator discretion|1|||
161672239|NCT00372385|583853068|FG002|Overall Study|Noncompliance|1|||
161495094|NCT01386554|583205935|FG000|Overall Study|Reason not collected|0|||
161584995|NCT05075408|583529794|FG001|Overall Study|Lost to Follow-up|1|||
161584996|NCT05075408|583529795|FG002|Overall Study|Lost to Follow-up|1|||
161584997|NCT05075408|583529793|FG000|Overall Study|Physician Decision|1|||
161584998|NCT05075408|583529794|FG001|Overall Study|Physician Decision|0|||
161495095|NCT01386554|583205936|FG001|Overall Study|Reason not collected|1|||
161495096|NCT01386554|583205937|FG002|Overall Study|Reason not collected|0|||
161495097|NCT00353262|583205938|FG000|Overall Study|Adverse Event|8|||
161495098|NCT00353262|583205938|FG000|Overall Study|Withdrawal by Subject|2|||
161495099|NCT00353262|583205938|FG000|Overall Study|Insufficient Therapeutic Response|13|||
161495100|NCT00353262|583205938|FG000|Overall Study|Progression|1|||
161495101|NCT00353262|583205938|FG000|Overall Study|Surgery|4|||
161495102|NCT00353262|583205938|FG000|Overall Study|Break from Chemotherapy|1|||
161495103|NCT04166513|583205939|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
161495104|NCT04166513|583205940|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
161495105|NCT04166513|583205941|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
161495106|NCT04166513|583205942|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
161495107|NCT04166513|583205939|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
161495108|NCT04166513|583205940|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
161495109|NCT04166513|583205941|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
161495110|NCT04166513|583205942|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
161495111|NCT04166513|583205939|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
161495112|NCT04166513|583205940|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
161495113|NCT04166513|583205941|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
161495114|NCT04166513|583205942|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
161495115|NCT04166513|583205939|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
161495116|NCT04166513|583205940|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
161495117|NCT04166513|583205941|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
161495118|NCT04166513|583205942|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
161495119|NCT04166513|583205939|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
161495120|NCT04166513|583205940|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
161495121|NCT04166513|583205941|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
161495122|NCT04166513|583205942|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
161495123|NCT05286307|583205943|FG000|Overall Study|Incomplete outcome assessments|2|||
161495124|NCT05286307|583205944|FG001|Overall Study|Incomplete outcome assessments|1|||
161495125|NCT05286307|583205943|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
161495126|NCT05286307|583205944|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
161495127|NCT05286307|583205943|FG000|Overall Study|Lost to follow up at 6 months|25|||
161495128|NCT05286307|583205944|FG001|Overall Study|Lost to follow up at 6 months|35|||
161495129|NCT05286307|583205943|FG000|Overall Study|Study medication not available|1|||
161495130|NCT05286307|583205944|FG001|Overall Study|Study medication not available|1|||
161495131|NCT02759471|583205945|FG000|Overall Study|discomfort|2|||
161495132|NCT01103284|583205946|FG000|Overall Study|Death|2|||
161495133|NCT01103284|583205947|FG001|Overall Study|Death|0|||
161495134|NCT01103284|583205946|FG000|Overall Study|Lost to Follow-up|9|||
161495135|NCT01103284|583205947|FG001|Overall Study|Lost to Follow-up|10|||
161495136|NCT01103284|583205946|FG000|Overall Study|Pregnancy|3|||
161495137|NCT01103284|583205947|FG001|Overall Study|Pregnancy|1|||
161495138|NCT01103284|583205946|FG000|Overall Study|Protocol Violation|12|||
161495139|NCT01103284|583205947|FG001|Overall Study|Protocol Violation|5|||
161495140|NCT01103284|583205946|FG000|Overall Study|Adverse Event|0|||
161495141|NCT01103284|583205947|FG001|Overall Study|Adverse Event|5|||
161495142|NCT01103284|583205946|FG000|Overall Study|Withdrawal by Subject|14|||
161495143|NCT01103284|583205947|FG001|Overall Study|Withdrawal by Subject|18|||
161495144|NCT01103284|583205946|FG000|Overall Study|Dermal Hypersensitivity|0|||
161495145|NCT01103284|583205947|FG001|Overall Study|Dermal Hypersensitivity|1|||
161495146|NCT01103284|583205946|FG000|Overall Study|Termination by the Sponsor|0|||
161495147|NCT01103284|583205947|FG001|Overall Study|Termination by the Sponsor|1|||
161495148|NCT01103284|583205946|FG000|Overall Study|Not described|2|||
161495149|NCT01103284|583205947|FG001|Overall Study|Not described|1|||
161495150|NCT01103284|583205946|FG000|Overall Study|Missing CRF entries for study completion|0|||
161495151|NCT01103284|583205947|FG001|Overall Study|Missing CRF entries for study completion|2|||
161495152|NCT03712904|583206832|FG000|Overall Study|Death|0|||
161495153|NCT03712904|583206833|FG001|Overall Study|Death|1|||
161495154|NCT03712904|583206832|FG000|Overall Study|Withdrawal by Subject|0|||
161495155|NCT03712904|583206833|FG001|Overall Study|Withdrawal by Subject|1|||
161495156|NCT03712904|583206832|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
161495157|NCT03712904|583206833|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
161495158|NCT04568590|583206836|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
161495159|NCT01190254|583206839|FG000|Overall Study|Adverse Event|3|||
161495160|NCT01190254|583206840|FG001|Overall Study|Adverse Event|6|||
161495161|NCT01190254|583206841|FG002|Overall Study|Adverse Event|8|||
161495162|NCT01190254|583206839|FG000|Overall Study|Lack of Efficacy|7|||
161495163|NCT01190254|583206840|FG001|Overall Study|Lack of Efficacy|4|||
161495164|NCT01190254|583206841|FG002|Overall Study|Lack of Efficacy|5|||
161495165|NCT01190254|583206839|FG000|Overall Study|Lost to Follow-up|4|||
161495166|NCT01190254|583206840|FG001|Overall Study|Lost to Follow-up|2|||
161495167|NCT01190254|583206841|FG002|Overall Study|Lost to Follow-up|0|||
161495168|NCT01190254|583206839|FG000|Overall Study|Withdrawal by Subject|4|||
161495169|NCT01190254|583206840|FG001|Overall Study|Withdrawal by Subject|5|||
161495170|NCT01190254|583206841|FG002|Overall Study|Withdrawal by Subject|7|||
161495171|NCT01190254|583206839|FG000|Overall Study|Protocol Violation|2|||
161495172|NCT01190254|583206840|FG001|Overall Study|Protocol Violation|0|||
161495173|NCT01190254|583206841|FG002|Overall Study|Protocol Violation|2|||
161495174|NCT01190254|583206839|FG000|Overall Study|Did not meet protocol eligibility|1|||
161495175|NCT01190254|583206840|FG001|Overall Study|Did not meet protocol eligibility|0|||
161495176|NCT01190254|583206841|FG002|Overall Study|Did not meet protocol eligibility|0|||
161495177|NCT02356783|583206842|FG000|Overall Study|Lost to Follow-up|1|||
161495178|NCT02356783|583206843|FG001|Overall Study|Lost to Follow-up|3|||
161495179|NCT01485640|583206844|FG000|Overall Study|Adverse Event|10|||
161495180|NCT01485640|583206844|FG000|Overall Study|Lack of Efficacy|2|||
161495181|NCT01485640|583206844|FG000|Overall Study|Protocol Violation|1|||
161495182|NCT01485640|583206844|FG000|Overall Study|Withdrawal by Subject|14|||
161495183|NCT01485640|583206844|FG000|Overall Study|Terminated by Sponsor|95|||
161495184|NCT00202644|583206847|FG000|Overall Study|Adverse Event|12|||
161495185|NCT00202644|583206848|FG001|Overall Study|Adverse Event|13|||
161495186|NCT00202644|583206847|FG000|Overall Study|Withdrawal by Subject|8|||
161495187|NCT00202644|583206848|FG001|Overall Study|Withdrawal by Subject|6|||
161495188|NCT00202644|583206847|FG000|Overall Study|Lack of Efficacy|6|||
161495189|NCT00202644|583206848|FG001|Overall Study|Lack of Efficacy|6|||
161495190|NCT00202644|583206847|FG000|Overall Study|Lost to Follow-up|0|||
161495191|NCT00202644|583206848|FG001|Overall Study|Lost to Follow-up|1|||
161495192|NCT00202644|583206847|FG000|Overall Study|Other|9|||
161495193|NCT00202644|583206848|FG001|Overall Study|Other|1|||
161495194|NCT03232281|583206854|FG000|Overall Study|Adverse Event|1|||
161495195|NCT03232281|583206855|FG001|Overall Study|Adverse Event|1|||
161495196|NCT03232281|583206854|FG000|Overall Study|Withdrawal by Subject|5|||
161495197|NCT03232281|583206855|FG001|Overall Study|Withdrawal by Subject|4|||
161495198|NCT03232281|583206854|FG000|Overall Study|Protocol Deviation|1|||
161584999|NCT05075408|583529795|FG002|Overall Study|Physician Decision|0|||
161585000|NCT05075408|583529793|FG000|Overall Study|Other-unspecified|3|||
161585001|NCT05075408|583529794|FG001|Overall Study|Other-unspecified|2|||
161585002|NCT05075408|583529795|FG002|Overall Study|Other-unspecified|0|||
161495199|NCT03232281|583206855|FG001|Overall Study|Protocol Deviation|1|||
161495200|NCT01372501|583206859|FG000|Overall Study|Adverse Event|4|||
161585003|NCT05419505|583529797|FG000|Overall Study|Adverse Event|0|||
161495201|NCT01372501|583206859|FG000|Overall Study|Device migration|1|||
161495202|NCT02489344|583206860|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
161495203|NCT02489344|583206860|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
161495204|NCT02489344|583206860|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
161495205|NCT02489344|583206860|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
161672240|NCT00372385|583853069|FG003|Overall Study|Noncompliance|1|||
161672241|NCT00372385|583853066|FG000|Overall Study|Physician Decision|1|||
161672242|NCT00372385|583853067|FG001|Overall Study|Physician Decision|0|||
161672243|NCT00372385|583853068|FG002|Overall Study|Physician Decision|0|||
161672244|NCT00372385|583853069|FG003|Overall Study|Physician Decision|0|||
161672245|NCT00372385|583853066|FG000|Overall Study|Lost to Follow-up|2|||
161672246|NCT00372385|583853067|FG001|Overall Study|Lost to Follow-up|0|||
161672247|NCT00372385|583853068|FG002|Overall Study|Lost to Follow-up|0|||
161672248|NCT00372385|583853069|FG003|Overall Study|Lost to Follow-up|0|||
161672249|NCT00372385|583853066|FG000|Overall Study|Withdrawal by Subject|2|||
161672250|NCT00372385|583853067|FG001|Overall Study|Withdrawal by Subject|1|||
161672251|NCT00372385|583853068|FG002|Overall Study|Withdrawal by Subject|0|||
161672252|NCT00372385|583853069|FG003|Overall Study|Withdrawal by Subject|0|||
161672253|NCT00372385|583853066|FG000|Overall Study|Refusal of Treatment|3|||
161672254|NCT00372385|583853067|FG001|Overall Study|Refusal of Treatment|6|||
161672255|NCT00372385|583853068|FG002|Overall Study|Refusal of Treatment|0|||
161672256|NCT00372385|583853069|FG003|Overall Study|Refusal of Treatment|0|||
161672257|NCT00372385|583853066|FG000|Overall Study|No Response|1|||
161672258|NCT00372385|583853067|FG001|Overall Study|No Response|1|||
161672259|NCT00372385|583853068|FG002|Overall Study|No Response|0|||
161672260|NCT00372385|583853069|FG003|Overall Study|No Response|0|||
161672261|NCT00372385|583853066|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
161672262|NCT00372385|583853067|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161672263|NCT00372385|583853068|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161672264|NCT00372385|583853069|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161672265|NCT00372385|583853066|FG000|Overall Study|Virologic Stopping Rule|17|||
161672266|NCT00372385|583853067|FG001|Overall Study|Virologic Stopping Rule|0|||
161672267|NCT00372385|583853068|FG002|Overall Study|Virologic Stopping Rule|0|||
161672268|NCT00372385|583853069|FG003|Overall Study|Virologic Stopping Rule|0|||
161672269|NCT02554903|583853070|FG000|Overall Study|Death|1|||
161672270|NCT02554903|583853071|FG001|Overall Study|Death|1|||
161672271|NCT02554903|583853070|FG000|Overall Study|Physician Decision|2|||
161672272|NCT02554903|583853071|FG001|Overall Study|Physician Decision|2|||
161672273|NCT02554903|583853070|FG000|Overall Study|Heart Transplant|1|||
161672274|NCT02554903|583853071|FG001|Overall Study|Heart Transplant|2|||
161672275|NCT01163721|583853079|FG000|Overall Study|Adverse Event|5|||
161672276|NCT01163721|583853080|FG001|Overall Study|Adverse Event|6|||
161672277|NCT01163721|583853079|FG000|Overall Study|Withdrawal by Subject|3|||
161672278|NCT01163721|583853080|FG001|Overall Study|Withdrawal by Subject|4|||
161672279|NCT01163721|583853079|FG000|Overall Study|Lost to Follow-up|0|||
161672280|NCT01163721|583853080|FG001|Overall Study|Lost to Follow-up|1|||
161672281|NCT01163721|583853079|FG000|Overall Study|Physician Decision|0|||
161672282|NCT01163721|583853080|FG001|Overall Study|Physician Decision|1|||
161672283|NCT00364156|583853086|FG000|Overall Study|Withdrawal by Subject|73|||
161495206|NCT01132482|583206861|FG000|Overall Study|Adverse Event|1|||
161495207|NCT01132482|583206862|FG001|Overall Study|Adverse Event|0|||
161495208|NCT05333900|583206863|FG000|Overall Study|Protocol Violation|0|||
161495209|NCT05333900|583206864|FG001|Overall Study|Protocol Violation|1|||
161672284|NCT00364156|583853087|FG001|Overall Study|Withdrawal by Subject|80|||
161672285|NCT00364156|583853086|FG000|Overall Study|Protocol Violation|6|||
161672286|NCT00364156|583853087|FG001|Overall Study|Protocol Violation|1|||
161672287|NCT01050205|583853088|FG000|Overall Study|Lost to Follow-up|7|||
161672288|NCT01050205|583853089|FG001|Overall Study|Lost to Follow-up|1|||
161672289|NCT01050205|583853088|FG000|Overall Study|Withdrawal by Subject|1|||
161672290|NCT01050205|583853089|FG001|Overall Study|Withdrawal by Subject|1|||
161672291|NCT01050205|583853088|FG000|Overall Study|Relocated from area|1|||
161818176|NCT01494532|584374403|FG004|Overall Study|Adverse Event|5|||
161495210|NCT05333900|583206863|FG000|Overall Study|Withdrawal by Subject|0|||
161672292|NCT01050205|583853089|FG001|Overall Study|Relocated from area|2|||
161672293|NCT01050205|583853088|FG000|Overall Study|Discontinued Intervention|2|||
161672294|NCT01050205|583853089|FG001|Overall Study|Discontinued Intervention|0|||
161672295|NCT01472380|583853090|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
161818177|NCT01494532|584374404|FG005|Overall Study|Adverse Event|0|||
161818178|NCT01494532|584374399|FG000|Overall Study|Lack of Efficacy|0|||
161672296|NCT01472380|583853090|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
161672297|NCT02708095|583853091|FG000|Overall Study|Adverse Event|4|||
161672298|NCT02708095|583853092|FG001|Overall Study|Adverse Event|10|||
161672299|NCT02708095|583853093|FG002|Overall Study|Adverse Event|11|||
161672300|NCT02708095|583853091|FG000|Overall Study|Lack of Efficacy|9|||
161672301|NCT02708095|583853092|FG001|Overall Study|Lack of Efficacy|3|||
161672302|NCT02708095|583853093|FG002|Overall Study|Lack of Efficacy|0|||
161672303|NCT02708095|583853091|FG000|Overall Study|Lost to Follow-up|2|||
161672304|NCT02708095|583853092|FG001|Overall Study|Lost to Follow-up|0|||
161818179|NCT01494532|584374400|FG001|Overall Study|Lack of Efficacy|0|||
161818180|NCT01494532|584374401|FG002|Overall Study|Lack of Efficacy|0|||
161495211|NCT05333900|583206864|FG001|Overall Study|Withdrawal by Subject|1|||
161672305|NCT02708095|583853093|FG002|Overall Study|Lost to Follow-up|0|||
161672306|NCT02708095|583853091|FG000|Overall Study|Physician Decision|2|||
161818181|NCT01494532|584374402|FG003|Overall Study|Lack of Efficacy|0|||
161495212|NCT05333900|583206863|FG000|Overall Study|COVID-19 Pandemic|1|||
161495213|NCT05333900|583206864|FG001|Overall Study|COVID-19 Pandemic|1|||
161495214|NCT01462084|583206865|FG000|Overall Study|Withdrawal by Subject|1|||
161495215|NCT01462084|583206866|FG001|Overall Study|Withdrawal by Subject|0|||
161495216|NCT01462084|583206865|FG000|Overall Study|Protocol Violation|1|||
161495217|NCT01462084|583206866|FG001|Overall Study|Protocol Violation|1|||
161495218|NCT02278263|583206867|FG000|Overall Study|Protocol Violation|7|||
161495219|NCT02278263|583206868|FG001|Overall Study|Protocol Violation|0|||
161495220|NCT02278263|583206869|FG002|Overall Study|Protocol Violation|9|||
161495221|NCT02092662|583206871|FG000|Overall Study|Lost to Follow-up|13|||
161495222|NCT02092662|583206872|FG001|Overall Study|Lost to Follow-up|0|||
161495223|NCT00772707|583206873|FG000|Overall Study|Withdrawn|3|||
161495224|NCT01266460|583206875|FG000|Overall Study|Adverse Event|3|||
161495225|NCT01266460|583206875|FG000|Overall Study|Withdrawal by Subject|5|||
161495226|NCT01266460|583206875|FG000|Overall Study|Disease Progression|18|||
161495227|NCT01266460|583206875|FG000|Overall Study|Not otherwise specified|8|||
161495228|NCT01132547|583206876|FG000|Overall Study|Withdrawal by Subject|3|||
161495229|NCT01132547|583206877|FG001|Overall Study|Withdrawal by Subject|1|||
161495230|NCT01132547|583206876|FG000|Overall Study|Death|1|||
161495231|NCT01132547|583206877|FG001|Overall Study|Death|0|||
161495232|NCT05811234|583206878|FG000|Overall Study|Loss of Effectiveness|2|||
161495233|NCT05811234|583206878|FG000|Overall Study|Adverse Event|4|||
161495234|NCT05811234|583206878|FG000|Overall Study|Pregnancy|1|||
161495235|NCT05811234|583206878|FG000|Overall Study|Disease progression|1|||
161495236|NCT05811234|583206878|FG000|Overall Study|Withdrawal by Subject|4|||
161495237|NCT05811234|583206878|FG000|Overall Study|Lost to Follow-up|13|||
161495238|NCT05811234|583206878|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
161495239|NCT02710045|583206879|FG000|Overall Study|Death|1|||
161495240|NCT02710045|583206880|FG001|Overall Study|Death|2|||
161495241|NCT02710045|583206881|FG002|Overall Study|Death|0|||
161495242|NCT02710045|583206879|FG000|Overall Study|Withdrawal by Subject|6|||
161495243|NCT02710045|583206880|FG001|Overall Study|Withdrawal by Subject|6|||
161495244|NCT02710045|583206881|FG002|Overall Study|Withdrawal by Subject|2|||
161495245|NCT02710045|583206879|FG000|Overall Study|Protocol Violation|1|||
161495246|NCT02710045|583206880|FG001|Overall Study|Protocol Violation|2|||
161495247|NCT02710045|583206881|FG002|Overall Study|Protocol Violation|3|||
161495248|NCT02710045|583206879|FG000|Overall Study|Lost to Follow-up|3|||
161495249|NCT02710045|583206880|FG001|Overall Study|Lost to Follow-up|6|||
161495250|NCT02710045|583206881|FG002|Overall Study|Lost to Follow-up|7|||
161495251|NCT02710045|583206879|FG000|Overall Study|Physician Decision|0|||
161495252|NCT02710045|583206880|FG001|Overall Study|Physician Decision|0|||
161495253|NCT02710045|583206881|FG002|Overall Study|Physician Decision|1|||
161495254|NCT02710045|583206879|FG000|Overall Study|Poor Attendance|0|||
161495255|NCT02710045|583206880|FG001|Overall Study|Poor Attendance|1|||
161495256|NCT02710045|583206881|FG002|Overall Study|Poor Attendance|0|||
161495257|NCT04499781|583206882|FG000|Overall Study|Lost to Follow-up|2|||
161495258|NCT04499781|583206883|FG001|Overall Study|Lost to Follow-up|3|||
161495259|NCT04499781|583206882|FG000|Overall Study|Withdrawal by Subject|2|||
161495260|NCT04499781|583206883|FG001|Overall Study|Withdrawal by Subject|0|||
161495261|NCT00227305|583206888|FG000|Overall Study|Adverse Event|40|||
161495262|NCT00227305|583206888|FG000|Overall Study|Withdrawal by Subject|42|||
161495263|NCT00227305|583206888|FG000|Overall Study|Lost to Follow-up|33|||
161495264|NCT00227305|583206888|FG000|Overall Study|Study specific discontinuation|13|||
161495265|NCT00227305|583206888|FG000|Overall Study|MOVED OUT OF AREA|3|||
161495266|NCT00227305|583206888|FG000|Overall Study|Lack of Efficacy|7|||
161495267|NCT00227305|583206888|FG000|Overall Study|Physician Decision|3|||
161495268|NCT00227305|583206888|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
161495269|NCT00227305|583206888|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
161495270|NCT00227305|583206888|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
161495271|NCT04339296|583206895|FG000|Overall Study|Refuse to participate after allocation|1|||
161495272|NCT04339296|583206896|FG001|Overall Study|Refuse to participate after allocation|1|||
161495273|NCT04339296|583206895|FG000|Overall Study|Withdrew after completion of baseline|2|||
161495274|NCT04339296|583206896|FG001|Overall Study|Withdrew after completion of baseline|1|||
161495275|NCT04339296|583206895|FG000|Overall Study|Lost to Follow-up|0|||
161495276|NCT04339296|583206896|FG001|Overall Study|Lost to Follow-up|4|||
161495277|NCT04339296|583206895|FG000|Overall Study|Discontinued intervention|5|||
161495278|NCT04339296|583206896|FG001|Overall Study|Discontinued intervention|3|||
161495279|NCT03424265|583206897|FG000|Overall Study|screening failure|1|||
161495280|NCT03424265|583206898|FG001|Overall Study|screening failure|0|||
161495281|NCT03424265|583206897|FG000|Overall Study|Withdrawal by Subject|0|||
161495282|NCT03424265|583206898|FG001|Overall Study|Withdrawal by Subject|2|||
161495283|NCT00453544|583206899|FG000|Overall Study|Withdrawal by Subject|1|||
161495284|NCT00453544|583206900|FG001|Overall Study|Withdrawal by Subject|0|||
161495285|NCT00453544|583206901|FG002|Overall Study|Withdrawal by Subject|0|||
161495286|NCT00453544|583206902|FG003|Overall Study|Withdrawal by Subject|0|||
161495287|NCT00453544|583206899|FG000|Overall Study|Primary outcome measure not completed|1|||
161495288|NCT00453544|583206900|FG001|Overall Study|Primary outcome measure not completed|1|||
161495289|NCT00453544|583206901|FG002|Overall Study|Primary outcome measure not completed|0|||
161495290|NCT00453544|583206902|FG003|Overall Study|Primary outcome measure not completed|1|||
161495291|NCT01558752|583206903|FG000|Overall Study|Physician Decision|2|||
161495292|NCT01558752|583206904|FG001|Overall Study|Physician Decision|0|||
161495293|NCT01829230|583206905|FG000|Overall Study|Protocol Violation|0|||
161495294|NCT01829230|583206906|FG001|Overall Study|Protocol Violation|2|||
161495295|NCT01829230|583206905|FG000|Overall Study|Withdrawal by Subject|0|||
161495296|NCT01829230|583206906|FG001|Overall Study|Withdrawal by Subject|1|||
161495297|NCT01829230|583206905|FG000|Overall Study|Lost to Follow-up|1|||
161495298|NCT01829230|583206906|FG001|Overall Study|Lost to Follow-up|1|||
161495299|NCT00969150|583206907|FG000|Overall Study|Adverse Event|4|||
161495300|NCT00969150|583206908|FG001|Overall Study|Adverse Event|14|||
161495301|NCT00969150|583206907|FG000|Overall Study|Lack of Efficacy|1|||
161495302|NCT00969150|583206908|FG001|Overall Study|Lack of Efficacy|1|||
161495303|NCT00969150|583206907|FG000|Overall Study|Protocol Violation|9|||
161495304|NCT00969150|583206908|FG001|Overall Study|Protocol Violation|12|||
161495305|NCT00969150|583206907|FG000|Overall Study|Withdrawal by Subject|13|||
161495306|NCT00969150|583206908|FG001|Overall Study|Withdrawal by Subject|9|||
161495307|NCT00969150|583206907|FG000|Overall Study|Lost to Follow-up|5|||
161495308|NCT00969150|583206908|FG001|Overall Study|Lost to Follow-up|4|||
161495309|NCT00969150|583206907|FG000|Overall Study|Other reasons|1|||
161495310|NCT00969150|583206908|FG001|Overall Study|Other reasons|0|||
161495311|NCT00461682|583206909|FG000|Overall Study|Protocol Violation|1|||
161495312|NCT00597012|583206915|FG000|Overall Study|Death|1|||
161495313|NCT00597012|583206916|FG001|Overall Study|Death|1|||
161495314|NCT00597012|583206915|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
161495315|NCT00597012|583206916|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
161672307|NCT02708095|583853092|FG001|Overall Study|Physician Decision|3|||
161672308|NCT02708095|583853093|FG002|Overall Study|Physician Decision|2|||
161672309|NCT02708095|583853091|FG000|Overall Study|Protocol Violation|0|||
161672310|NCT02708095|583853092|FG001|Overall Study|Protocol Violation|0|||
161672311|NCT02708095|583853093|FG002|Overall Study|Protocol Violation|1|||
161672312|NCT02708095|583853091|FG000|Overall Study|Withdrawal by Subject|5|||
161672313|NCT02708095|583853092|FG001|Overall Study|Withdrawal by Subject|3|||
161672314|NCT02708095|583853093|FG002|Overall Study|Withdrawal by Subject|4|||
161672315|NCT03254485|583853106|FG000|Overall Study|Adverse Event|3|||
161672316|NCT03254485|583853107|FG001|Overall Study|Adverse Event|0|||
161672317|NCT03254485|583853108|FG002|Overall Study|Adverse Event|0|||
161672318|NCT03254485|583853109|FG003|Overall Study|Adverse Event|6|||
161672319|NCT03254485|583853106|FG000|Overall Study|Protocol Violation|6|||
161672320|NCT03254485|583853107|FG001|Overall Study|Protocol Violation|0|||
161672321|NCT03254485|583853108|FG002|Overall Study|Protocol Violation|0|||
161672322|NCT03254485|583853109|FG003|Overall Study|Protocol Violation|2|||
161672323|NCT03254485|583853106|FG000|Overall Study|Withdrawal by Subject|1|||
161672324|NCT03254485|583853107|FG001|Overall Study|Withdrawal by Subject|0|||
161672325|NCT03254485|583853108|FG002|Overall Study|Withdrawal by Subject|0|||
161672326|NCT03254485|583853109|FG003|Overall Study|Withdrawal by Subject|4|||
161672327|NCT03254485|583853106|FG000|Overall Study|Death|0|||
161672328|NCT03254485|583853107|FG001|Overall Study|Death|0|||
161672329|NCT03254485|583853108|FG002|Overall Study|Death|0|||
161672330|NCT03254485|583853109|FG003|Overall Study|Death|1|||
161672331|NCT03254485|583853106|FG000|Overall Study|Lost to Follow-up|1|||
161672332|NCT03254485|583853107|FG001|Overall Study|Lost to Follow-up|0|||
161495316|NCT00597012|583206915|FG000|Overall Study|Withdrawal by Subject|7|||
161924250|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924251|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924252|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924253|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924254|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924255|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
161924256|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161495317|NCT00597012|583206916|FG001|Overall Study|Withdrawal by Subject|4|||
161495318|NCT00597012|583206915|FG000|Overall Study|Ineligible|2|||
161495319|NCT00597012|583206916|FG001|Overall Study|Ineligible|0|||
161495320|NCT00597012|583206915|FG000|Overall Study|Lost to Follow-up|0|||
161672333|NCT03254485|583853108|FG002|Overall Study|Lost to Follow-up|0|||
161672334|NCT03254485|583853109|FG003|Overall Study|Lost to Follow-up|0|||
161672335|NCT03254485|583853106|FG000|Overall Study|Other|1|||
161672336|NCT03254485|583853107|FG001|Overall Study|Other|0|||
161672337|NCT03254485|583853108|FG002|Overall Study|Other|0|||
161672338|NCT03254485|583853109|FG003|Overall Study|Other|2|||
161495321|NCT00597012|583206916|FG001|Overall Study|Lost to Follow-up|2|||
161495322|NCT04105998|583208180|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
161672339|NCT03153111|583853110|FG000|Overall Study|Death|2|||
161672340|NCT03153111|583853111|FG001|Overall Study|Death|5|||
161672341|NCT03153111|583853110|FG000|Overall Study|Lost to Follow-up|1|||
161672342|NCT03153111|583853111|FG001|Overall Study|Lost to Follow-up|0|||
161818182|NCT01494532|584374403|FG004|Overall Study|Lack of Efficacy|2|||
161818183|NCT01494532|584374404|FG005|Overall Study|Lack of Efficacy|0|||
161818184|NCT01494532|584374399|FG000|Overall Study|Protocol deviation|2|||
161818185|NCT01494532|584374400|FG001|Overall Study|Protocol deviation|1|||
161818186|NCT01494532|584374401|FG002|Overall Study|Protocol deviation|3|||
161818187|NCT01494532|584374402|FG003|Overall Study|Protocol deviation|2|||
161818188|NCT01494532|584374403|FG004|Overall Study|Protocol deviation|3|||
161818189|NCT01494532|584374404|FG005|Overall Study|Protocol deviation|0|||
161818190|NCT01494532|584374399|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161818191|NCT01494532|584374400|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161818192|NCT01494532|584374401|FG002|Overall Study|Protocol-defined stopping criteria|1|||
161818193|NCT01494532|584374402|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161818194|NCT01494532|584374403|FG004|Overall Study|Protocol-defined stopping criteria|0|||
161818195|NCT01494532|584374404|FG005|Overall Study|Protocol-defined stopping criteria|0|||
161818196|NCT01494532|584374399|FG000|Overall Study|Lost to Follow-up|1|||
161818197|NCT01494532|584374400|FG001|Overall Study|Lost to Follow-up|0|||
161818198|NCT01494532|584374401|FG002|Overall Study|Lost to Follow-up|0|||
161818199|NCT01494532|584374402|FG003|Overall Study|Lost to Follow-up|2|||
161818200|NCT01494532|584374403|FG004|Overall Study|Lost to Follow-up|0|||
161818201|NCT01494532|584374404|FG005|Overall Study|Lost to Follow-up|0|||
161818202|NCT01494532|584374399|FG000|Overall Study|Physician Decision|0|||
161818203|NCT01494532|584374400|FG001|Overall Study|Physician Decision|1|||
161818204|NCT01494532|584374401|FG002|Overall Study|Physician Decision|1|||
161585004|NCT05419505|583529798|FG001|Overall Study|Adverse Event|0|||
161818205|NCT01494532|584374402|FG003|Overall Study|Physician Decision|2|||
161818206|NCT01494532|584374403|FG004|Overall Study|Physician Decision|0|||
161818207|NCT01494532|584374404|FG005|Overall Study|Physician Decision|0|||
161818208|NCT01494532|584374399|FG000|Overall Study|Withdrawal by Subject|3|||
161818209|NCT01494532|584374400|FG001|Overall Study|Withdrawal by Subject|1|||
161818210|NCT01494532|584374401|FG002|Overall Study|Withdrawal by Subject|4|||
161495323|NCT04105998|583208181|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
161495324|NCT00613015|583208183|FG000|Overall Study|Lost to Follow-up|0|||
161495325|NCT00613015|583208184|FG001|Overall Study|Lost to Follow-up|1|||
161495326|NCT00613015|583208185|FG002|Overall Study|Lost to Follow-up|3|||
161495327|NCT00613015|583208186|FG003|Overall Study|Lost to Follow-up|3|||
161495328|NCT00613015|583208187|FG004|Overall Study|Lost to Follow-up|2|||
161495329|NCT00613015|583208188|FG005|Overall Study|Lost to Follow-up|3|||
161495330|NCT00071760|583208191|FG000|Overall Study|Adverse Event|2|||
161495331|NCT00071760|583208192|FG001|Overall Study|Adverse Event|1|||
161495332|NCT00071760|583208191|FG000|Overall Study|Lost to Follow-up|0|||
161495333|NCT00071760|583208192|FG001|Overall Study|Lost to Follow-up|3|||
161495334|NCT00071760|583208191|FG000|Overall Study|Protocol Violation|1|||
161495335|NCT00071760|583208192|FG001|Overall Study|Protocol Violation|0|||
161495336|NCT00071760|583208191|FG000|Overall Study|Withdrawal by Subject|0|||
161495337|NCT00071760|583208192|FG001|Overall Study|Withdrawal by Subject|1|||
161495338|NCT00071760|583208191|FG000|Overall Study|Insufficient Viral Load Response|1|||
161495339|NCT00071760|583208192|FG001|Overall Study|Insufficient Viral Load Response|1|||
161495340|NCT00071760|583208191|FG000|Overall Study|Lack of availability of RTV|1|||
161495341|NCT00071760|583208192|FG001|Overall Study|Lack of availability of RTV|0|||
161495342|NCT00071760|583208191|FG000|Overall Study|Physician Decision|2|||
161495343|NCT00071760|583208192|FG001|Overall Study|Physician Decision|1|||
161495344|NCT00071760|583208191|FG000|Overall Study|Relocation|0|||
161495345|NCT00071760|583208192|FG001|Overall Study|Relocation|1|||
161495346|NCT02073279|583208193|FG000|Double-blind Period|Adverse Event|1|||
161495347|NCT02073279|583208194|FG001|Double-blind Period|Adverse Event|1|||
161495348|NCT02073279|583208193|FG000|Double-blind Period|Switched to another treatment|1|||
161495349|NCT02073279|583208194|FG001|Double-blind Period|Switched to another treatment|2|||
161495350|NCT02073279|583208193|FG000|Double-blind Period|Protocol Violation|0|||
161495351|NCT02073279|583208194|FG001|Double-blind Period|Protocol Violation|1|||
161495352|NCT02073279|583208193|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
161495353|NCT02073279|583208194|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
161495354|NCT02073279|583208193|FG000|Double-blind Period|Withdrawal by Subject|2|||
161495355|NCT02073279|583208194|FG001|Double-blind Period|Withdrawal by Subject|2|||
161495356|NCT02073279|583208193|FG000|Open-label Extension Period|Adverse Event|1|||
161495357|NCT02073279|583208194|FG001|Open-label Extension Period|Adverse Event|0|||
161495358|NCT02073279|583208193|FG000|Open-label Extension Period|Lack of Efficacy|1|||
161495359|NCT02073279|583208194|FG001|Open-label Extension Period|Lack of Efficacy|0|||
161495360|NCT02073279|583208193|FG000|Open-label Extension Period|Lost to Follow-up|0|||
161495361|NCT02073279|583208194|FG001|Open-label Extension Period|Lost to Follow-up|4|||
161495362|NCT02073279|583208193|FG000|Open-label Extension Period|Switched to another treatment|1|||
161495363|NCT02073279|583208194|FG001|Open-label Extension Period|Switched to another treatment|4|||
161495364|NCT02073279|583208193|FG000|Open-label Extension Period|Protocol Violation|0|||
161495365|NCT02073279|583208194|FG001|Open-label Extension Period|Protocol Violation|1|||
161495366|NCT02073279|583208193|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
161924257|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924258|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924259|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
161924260|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
161924261|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
161924262|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
161924263|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
161924264|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
161924265|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924266|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924267|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
161924268|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924269|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924270|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924271|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161495367|NCT02073279|583208194|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
161495368|NCT02073279|583208193|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
161495369|NCT02073279|583208194|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
161495370|NCT01994629|583208195|FG000|Overall Study|Withdrawal by Subject|1|||
161495371|NCT01994629|583208196|FG001|Overall Study|Withdrawal by Subject|0|||
161924272|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161495372|NCT01994629|583208195|FG000|Overall Study|Lost to Follow-up|0|||
161495373|NCT01994629|583208196|FG001|Overall Study|Lost to Follow-up|3|||
161495374|NCT03338062|583208199|FG000|Overall Study|Alternative Therapy|1|||
161495375|NCT03338062|583208200|FG001|Overall Study|Alternative Therapy|0|||
161495376|NCT04340362|583208201|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
161924273|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161924274|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161585005|NCT05419505|583529799|FG002|Overall Study|Adverse Event|0|||
161585006|NCT05419505|583529800|FG003|Overall Study|Adverse Event|1|||
161585007|NCT05419505|583529801|FG004|Overall Study|Adverse Event|0|||
161585008|NCT05419505|583529802|FG005|Overall Study|Adverse Event|0|||
161585009|NCT05419505|583529803|FG006|Overall Study|Adverse Event|0|||
161585010|NCT05419505|583529804|FG007|Overall Study|Adverse Event|0|||
161585011|NCT05419505|583529797|FG000|Overall Study|Withdrawal by Subject|1|||
161585012|NCT05419505|583529798|FG001|Overall Study|Withdrawal by Subject|2|||
161585013|NCT05419505|583529799|FG002|Overall Study|Withdrawal by Subject|0|||
161818211|NCT01494532|584374402|FG003|Overall Study|Withdrawal by Subject|3|||
161818212|NCT01494532|584374403|FG004|Overall Study|Withdrawal by Subject|2|||
161495377|NCT02375113|583208205|FG000|Overall Study|Undisclosed Reason(s).|1|||
161495378|NCT02375113|583208206|FG001|Overall Study|Undisclosed Reason(s).|1|||
161495379|NCT02375113|583208205|FG000|Overall Study|Poor adherence (<70%).|1|||
161495380|NCT02375113|583208206|FG001|Overall Study|Poor adherence (<70%).|0|||
161495381|NCT02375113|583208205|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
161495382|NCT02375113|583208206|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
161495383|NCT01214629|583208207|FG000|Overall Study|Progressive Disease|1|||
161495384|NCT01214629|583208208|FG001|Overall Study|Progressive Disease|1|||
161495385|NCT01214629|583208209|FG002|Overall Study|Progressive Disease|0|||
161495386|NCT01214629|583208210|FG003|Overall Study|Progressive Disease|1|||
161495387|NCT01214629|583208211|FG004|Overall Study|Progressive Disease|2|||
161495388|NCT01214629|583208212|FG005|Overall Study|Progressive Disease|3|||
161495389|NCT01214629|583208213|FG006|Overall Study|Progressive Disease|1|||
161495390|NCT01214629|583208214|FG007|Overall Study|Progressive Disease|1|||
161495391|NCT01214629|583208215|FG008|Overall Study|Progressive Disease|1|||
161495392|NCT01214629|583208216|FG009|Overall Study|Progressive Disease|5|||
161495393|NCT01214629|583208217|FG010|Overall Study|Progressive Disease|1|||
161495394|NCT01214629|583208207|FG000|Overall Study|Adverse Event|0|||
161495395|NCT01214629|583208208|FG001|Overall Study|Adverse Event|0|||
161495396|NCT01214629|583208209|FG002|Overall Study|Adverse Event|0|||
161495397|NCT01214629|583208210|FG003|Overall Study|Adverse Event|1|||
161495398|NCT01214629|583208211|FG004|Overall Study|Adverse Event|0|||
161495399|NCT01214629|583208212|FG005|Overall Study|Adverse Event|1|||
161495400|NCT01214629|583208213|FG006|Overall Study|Adverse Event|0|||
161495401|NCT01214629|583208214|FG007|Overall Study|Adverse Event|0|||
161818213|NCT01494532|584374404|FG005|Overall Study|Withdrawal by Subject|0|||
161672343|NCT03153111|583853110|FG000|Overall Study|Physician Decision|5|||
161672344|NCT03153111|583853111|FG001|Overall Study|Physician Decision|1|||
161672345|NCT03153111|583853110|FG000|Overall Study|Withdrawal by Subject|3|||
161672346|NCT03153111|583853111|FG001|Overall Study|Withdrawal by Subject|3|||
161818214|NCT00679081|584374405|FG000|Overall Study|Lost to Follow-up|1|||
161818215|NCT01404988|584374410|FG000|Overall Study|Death|2|||
161818216|NCT01404988|584374411|FG001|Overall Study|Death|0|||
161495402|NCT01214629|583208215|FG008|Overall Study|Adverse Event|0|||
161495403|NCT01214629|583208216|FG009|Overall Study|Adverse Event|1|||
161495404|NCT01214629|583208217|FG010|Overall Study|Adverse Event|0|||
161818217|NCT01404988|584374412|FG002|Overall Study|Death|2|||
161818218|NCT01404988|584374410|FG000|Overall Study|Adverse Event|1|||
161818219|NCT01404988|584374411|FG001|Overall Study|Adverse Event|0|||
161818220|NCT01404988|584374412|FG002|Overall Study|Adverse Event|0|||
161818221|NCT01404988|584374410|FG000|Overall Study|Withdrawal by Subject|2|||
161818222|NCT01404988|584374411|FG001|Overall Study|Withdrawal by Subject|2|||
161818223|NCT01404988|584374412|FG002|Overall Study|Withdrawal by Subject|0|||
161818224|NCT01404988|584374410|FG000|Overall Study|Lost to Follow-up|1|||
161818225|NCT01404988|584374411|FG001|Overall Study|Lost to Follow-up|2|||
161495405|NCT01214629|583208207|FG000|Overall Study|Physician Decision|0|||
161495406|NCT01214629|583208208|FG001|Overall Study|Physician Decision|0|||
161495407|NCT01214629|583208209|FG002|Overall Study|Physician Decision|0|||
161495408|NCT01214629|583208210|FG003|Overall Study|Physician Decision|0|||
161495409|NCT01214629|583208211|FG004|Overall Study|Physician Decision|0|||
161495410|NCT01214629|583208212|FG005|Overall Study|Physician Decision|0|||
161495411|NCT01214629|583208213|FG006|Overall Study|Physician Decision|0|||
161495412|NCT01214629|583208214|FG007|Overall Study|Physician Decision|0|||
161495413|NCT01214629|583208215|FG008|Overall Study|Physician Decision|0|||
161495414|NCT01214629|583208216|FG009|Overall Study|Physician Decision|0|||
161495415|NCT01214629|583208217|FG010|Overall Study|Physician Decision|1|||
161495416|NCT01214629|583208207|FG000|Overall Study|Withdrawal by Subject|0|||
161495417|NCT01214629|583208208|FG001|Overall Study|Withdrawal by Subject|0|||
161495418|NCT01214629|583208209|FG002|Overall Study|Withdrawal by Subject|0|||
161495419|NCT01214629|583208210|FG003|Overall Study|Withdrawal by Subject|0|||
161495420|NCT01214629|583208211|FG004|Overall Study|Withdrawal by Subject|0|||
161495421|NCT01214629|583208212|FG005|Overall Study|Withdrawal by Subject|0|||
161495422|NCT01214629|583208213|FG006|Overall Study|Withdrawal by Subject|0|||
161495423|NCT01214629|583208214|FG007|Overall Study|Withdrawal by Subject|0|||
161495424|NCT01214629|583208215|FG008|Overall Study|Withdrawal by Subject|0|||
161495425|NCT01214629|583208216|FG009|Overall Study|Withdrawal by Subject|1|||
161495426|NCT01214629|583208217|FG010|Overall Study|Withdrawal by Subject|0|||
161495427|NCT00877383|583208220|FG000|Overall Study|Adverse Event|13|||
161495428|NCT00877383|583208221|FG001|Overall Study|Adverse Event|14|||
161495429|NCT00877383|583208220|FG000|Overall Study|Lost to Follow-up|5|||
161495430|NCT00877383|583208221|FG001|Overall Study|Lost to Follow-up|3|||
161495431|NCT00877383|583208220|FG000|Overall Study|Subject withdrew consent|3|||
161495432|NCT00877383|583208221|FG001|Overall Study|Subject withdrew consent|12|||
161495433|NCT00877383|583208220|FG000|Overall Study|Subject no longer requires study drug|2|||
161495434|NCT00877383|583208221|FG001|Overall Study|Subject no longer requires study drug|0|||
161818226|NCT01404988|584374412|FG002|Overall Study|Lost to Follow-up|1|||
161818227|NCT04594252|584374413|FG000|Overall Study|Adverse Event|0|||
161818228|NCT04594252|584374414|FG001|Overall Study|Adverse Event|2|||
161672347|NCT02684357|583853112|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
161672348|NCT02684357|583853113|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
161672349|NCT02684357|583853114|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
161672350|NCT02684357|583853115|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
161672351|NCT02684357|583853116|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
161672352|NCT02684357|583853117|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
161672353|NCT02684357|583853112|FG000|Part A|Lost to Follow-up|0|||
161818229|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
161818230|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
161818231|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161818232|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161818233|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161818234|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
161818235|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818236|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818237|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818238|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818239|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
161818240|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
161818241|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161924275|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161924276|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
161924277|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924278|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924279|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924280|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924281|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924282|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
161818242|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161672354|NCT02684357|583853113|FG001|Part A|Lost to Follow-up|2|||
161924283|NCT01631188|584769616|FG000|Overall Study|Physician Decision|75|||
161924284|NCT04575324|584769620|FG000|Overall Study|Lost to Follow-up|29|||
161924285|NCT04575324|584769621|FG001|Overall Study|Lost to Follow-up|25|||
161924286|NCT04575324|584769620|FG000|Overall Study|Death|1|||
161924287|NCT04575324|584769621|FG001|Overall Study|Death|2|||
161924288|NCT04575324|584769620|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
161924289|NCT04575324|584769621|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
161924290|NCT01105130|584769622|FG000|Overall Study|Withdrawal by Subject|4|||
161924291|NCT01105130|584769623|FG001|Overall Study|Withdrawal by Subject|6|||
161924292|NCT01105130|584769624|FG002|Overall Study|Withdrawal by Subject|2|||
161924293|NCT01105130|584769622|FG000|Overall Study|Never Started|2|||
161924294|NCT01105130|584769623|FG001|Overall Study|Never Started|2|||
161924295|NCT01105130|584769624|FG002|Overall Study|Never Started|4|||
161924296|NCT01105130|584769622|FG000|Overall Study|Toxicity|1|||
161924297|NCT01105130|584769623|FG001|Overall Study|Toxicity|3|||
161924298|NCT01105130|584769624|FG002|Overall Study|Toxicity|2|||
161924299|NCT01105130|584769622|FG000|Overall Study|Multiple Reasons|3|||
161924300|NCT01105130|584769623|FG001|Overall Study|Multiple Reasons|0|||
161924301|NCT01105130|584769624|FG002|Overall Study|Multiple Reasons|2|||
161924302|NCT02582632|584769626|FG000|Overall Study|Other|1|||
161924303|NCT02323334|584769627|FG000|Period 3|Lost to Follow-up|0|||
161924304|NCT02323334|584769628|FG001|Period 3|Lost to Follow-up|0|||
161924305|NCT02323334|584769629|FG002|Period 3|Lost to Follow-up|1|||
161924306|NCT02323334|584769630|FG003|Period 3|Lost to Follow-up|0|||
161924307|NCT02323334|584769631|FG004|Period 3|Lost to Follow-up|0|||
161924308|NCT02323334|584769632|FG005|Period 3|Lost to Follow-up|0|||
161924309|NCT02323334|584769633|FG006|Period 3|Lost to Follow-up|0|||
161924310|NCT02323334|584769634|FG007|Period 3|Lost to Follow-up|0|||
161924311|NCT02323334|584769635|FG008|Period 3|Lost to Follow-up|0|||
161924312|NCT02323334|584769636|FG009|Period 3|Lost to Follow-up|0|||
161924313|NCT02323334|584769637|FG010|Period 3|Lost to Follow-up|0|||
161924314|NCT02323334|584769638|FG011|Period 3|Lost to Follow-up|0|||
161924315|NCT02323334|584769639|FG012|Period 3|Lost to Follow-up|0|||
161924316|NCT02323334|584769640|FG013|Period 3|Lost to Follow-up|0|||
161924317|NCT02323334|584769641|FG014|Period 3|Lost to Follow-up|0|||
161924318|NCT02323334|584769642|FG015|Period 3|Lost to Follow-up|0|||
161924319|NCT02323334|584769643|FG016|Period 3|Lost to Follow-up|0|||
161924320|NCT02323334|584769627|FG000|Period 3|Withdrawal by Subject|1|||
161924321|NCT02323334|584769628|FG001|Period 3|Withdrawal by Subject|0|||
161924322|NCT02323334|584769629|FG002|Period 3|Withdrawal by Subject|0|||
161924323|NCT02323334|584769630|FG003|Period 3|Withdrawal by Subject|0|||
161924324|NCT02323334|584769631|FG004|Period 3|Withdrawal by Subject|0|||
161924325|NCT02323334|584769632|FG005|Period 3|Withdrawal by Subject|0|||
161672355|NCT02684357|583853114|FG002|Part A|Lost to Follow-up|2|||
161672356|NCT02684357|583853115|FG003|Part A|Lost to Follow-up|0|||
161672357|NCT02684357|583853116|FG004|Part A|Lost to Follow-up|0|||
161672358|NCT02684357|583853117|FG005|Part A|Lost to Follow-up|0|||
161672359|NCT02684357|583853112|FG000|Part A|Withdrawal by Subject|3|||
161672360|NCT02684357|583853113|FG001|Part A|Withdrawal by Subject|0|||
161672361|NCT02684357|583853114|FG002|Part A|Withdrawal by Subject|0|||
161672362|NCT02684357|583853115|FG003|Part A|Withdrawal by Subject|0|||
161495435|NCT00877383|583208220|FG000|Overall Study|Administrative problems|2|||
161495436|NCT00877383|583208221|FG001|Overall Study|Administrative problems|0|||
161495437|NCT00877383|583208220|FG000|Overall Study|Protocol deviation|2|||
161495438|NCT00877383|583208221|FG001|Overall Study|Protocol deviation|6|||
161495439|NCT00877383|583208220|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161495440|NCT00877383|583208221|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161495441|NCT00877383|583208220|FG000|Overall Study|Death|1|||
161495442|NCT00877383|583208221|FG001|Overall Study|Death|2|||
161495443|NCT00459108|583208223|FG000|Overall Study|Withdrawal by Subject|5|||
161495444|NCT00459108|583208223|FG000|Overall Study|Adverse Event|3|||
161495445|NCT00459108|583208223|FG000|Overall Study|Death|2|||
161495446|NCT00459108|583208223|FG000|Overall Study|Progression|1|||
161495447|NCT04387435|583208232|FG000|Overall Study|Physician Decision|1|||
161495448|NCT00391274|583208236|FG000|Overall Study|Death Due to Study Disease|55|||
161495449|NCT00391274|583208237|FG001|Overall Study|Death Due to Study Disease|45|||
161495450|NCT00391274|583208236|FG000|Overall Study|Lost to Follow-up|0|||
161495451|NCT00391274|583208237|FG001|Overall Study|Lost to Follow-up|3|||
161495452|NCT00391274|583208236|FG000|Overall Study|Physician Decision|4|||
161495453|NCT00391274|583208237|FG001|Overall Study|Physician Decision|2|||
161495454|NCT00391274|583208236|FG000|Overall Study|Withdrawal by Subject|0|||
161495455|NCT00391274|583208237|FG001|Overall Study|Withdrawal by Subject|3|||
161495456|NCT00391274|583208236|FG000|Overall Study|Death Due to Adverse Event|1|||
161495457|NCT00391274|583208237|FG001|Overall Study|Death Due to Adverse Event|3|||
161495458|NCT00391274|583208236|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
161495459|NCT00391274|583208237|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
161495460|NCT00391274|583208236|FG000|Overall Study|Death Not Study Related|0|||
161495461|NCT00391274|583208237|FG001|Overall Study|Death Not Study Related|1|||
161495462|NCT04501666|583208239|FG000|Overall Study|Physician Decision|0|||
161495463|NCT04501666|583208240|FG001|Overall Study|Physician Decision|1|||
161495464|NCT04501666|583208239|FG000|Overall Study|Adverse Event|12|||
161495465|NCT04501666|583208240|FG001|Overall Study|Adverse Event|4|||
161495466|NCT04501666|583208239|FG000|Overall Study|Subject's request|10|||
161495467|NCT04501666|583208240|FG001|Overall Study|Subject's request|6|||
161495468|NCT04501666|583208239|FG000|Overall Study|Protocol Deviation|2|||
161495469|NCT04501666|583208240|FG001|Overall Study|Protocol Deviation|1|||
161495470|NCT04501666|583208239|FG000|Overall Study|Other-- site permanently closing|0|||
161495471|NCT04501666|583208240|FG001|Overall Study|Other-- site permanently closing|1|||
161495472|NCT00642941|583208241|FG000|Overall Study|Physician Decision|3|||
161495473|NCT00642941|583208242|FG001|Overall Study|Physician Decision|1|||
161495474|NCT00642941|583208243|FG002|Overall Study|Physician Decision|0|||
161495475|NCT00642941|583208244|FG003|Overall Study|Physician Decision|0|||
161495476|NCT00642941|583208245|FG004|Overall Study|Physician Decision|0|||
161495477|NCT00642941|583208246|FG005|Overall Study|Physician Decision|0|||
161495478|NCT00642941|583208247|FG006|Overall Study|Physician Decision|1|||
161495479|NCT00642941|583208248|FG007|Overall Study|Physician Decision|0|||
161495480|NCT00642941|583208249|FG008|Overall Study|Physician Decision|0|||
161495481|NCT00642941|583208250|FG009|Overall Study|Physician Decision|1|||
161495482|NCT00642941|583208251|FG010|Overall Study|Physician Decision|0|||
161495483|NCT00642941|583208252|FG011|Overall Study|Physician Decision|1|||
161495484|NCT00642941|583208241|FG000|Overall Study|Death|4|||
161495485|NCT00642941|583208242|FG001|Overall Study|Death|0|||
161495486|NCT00642941|583208243|FG002|Overall Study|Death|1|||
161495487|NCT00642941|583208244|FG003|Overall Study|Death|1|||
161495488|NCT00642941|583208245|FG004|Overall Study|Death|2|||
161495489|NCT00642941|583208246|FG005|Overall Study|Death|1|||
161495490|NCT00642941|583208247|FG006|Overall Study|Death|0|||
161495491|NCT00642941|583208248|FG007|Overall Study|Death|0|||
161495492|NCT00642941|583208249|FG008|Overall Study|Death|0|||
161495493|NCT00642941|583208250|FG009|Overall Study|Death|0|||
161495494|NCT00642941|583208251|FG010|Overall Study|Death|0|||
161495495|NCT00642941|583208252|FG011|Overall Study|Death|1|||
161495496|NCT00642941|583208241|FG000|Overall Study|Study closed by Sponsor|0|||
161818243|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161818244|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|move away|2|||
161818245|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|move away|7|||
161818246|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|move away|0|||
161495497|NCT00642941|583208242|FG001|Overall Study|Study closed by Sponsor|1|||
161495498|NCT00642941|583208243|FG002|Overall Study|Study closed by Sponsor|0|||
161495499|NCT00642941|583208244|FG003|Overall Study|Study closed by Sponsor|0|||
161495500|NCT00642941|583208245|FG004|Overall Study|Study closed by Sponsor|0|||
161495501|NCT00642941|583208246|FG005|Overall Study|Study closed by Sponsor|0|||
161495502|NCT00642941|583208247|FG006|Overall Study|Study closed by Sponsor|0|||
161495503|NCT00642941|583208248|FG007|Overall Study|Study closed by Sponsor|0|||
161495504|NCT00642941|583208249|FG008|Overall Study|Study closed by Sponsor|0|||
161818247|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|move away|0|||
161818248|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|move away|0|||
161495505|NCT00642941|583208250|FG009|Overall Study|Study closed by Sponsor|0|||
161495506|NCT00642941|583208251|FG010|Overall Study|Study closed by Sponsor|0|||
161495507|NCT00642941|583208252|FG011|Overall Study|Study closed by Sponsor|0|||
161495508|NCT00642941|583208241|FG000|Overall Study|Withdrawal by Subject|1|||
161495509|NCT00642941|583208242|FG001|Overall Study|Withdrawal by Subject|0|||
161495510|NCT00642941|583208243|FG002|Overall Study|Withdrawal by Subject|0|||
161495511|NCT00642941|583208244|FG003|Overall Study|Withdrawal by Subject|2|||
161495512|NCT00642941|583208245|FG004|Overall Study|Withdrawal by Subject|0|||
161495513|NCT00642941|583208246|FG005|Overall Study|Withdrawal by Subject|0|||
161495514|NCT00642941|583208247|FG006|Overall Study|Withdrawal by Subject|2|||
161495515|NCT00642941|583208248|FG007|Overall Study|Withdrawal by Subject|0|||
161495516|NCT00642941|583208249|FG008|Overall Study|Withdrawal by Subject|1|||
161495517|NCT00642941|583208250|FG009|Overall Study|Withdrawal by Subject|0|||
161495518|NCT00642941|583208251|FG010|Overall Study|Withdrawal by Subject|0|||
161495519|NCT00642941|583208252|FG011|Overall Study|Withdrawal by Subject|1|||
161495520|NCT00642941|583208241|FG000|Overall Study|Protocol Violation|0|||
161495521|NCT00642941|583208242|FG001|Overall Study|Protocol Violation|0|||
161495522|NCT00642941|583208243|FG002|Overall Study|Protocol Violation|0|||
161495523|NCT00642941|583208244|FG003|Overall Study|Protocol Violation|0|||
161495524|NCT00642941|583208245|FG004|Overall Study|Protocol Violation|0|||
161495525|NCT00642941|583208246|FG005|Overall Study|Protocol Violation|0|||
161495526|NCT00642941|583208247|FG006|Overall Study|Protocol Violation|1|||
161495527|NCT00642941|583208248|FG007|Overall Study|Protocol Violation|0|||
161495528|NCT00642941|583208249|FG008|Overall Study|Protocol Violation|0|||
161495529|NCT00642941|583208250|FG009|Overall Study|Protocol Violation|0|||
161495530|NCT00642941|583208251|FG010|Overall Study|Protocol Violation|0|||
161495531|NCT00642941|583208252|FG011|Overall Study|Protocol Violation|0|||
161495532|NCT00642941|583208241|FG000|Overall Study|Adverse Event|1|||
161495533|NCT00642941|583208242|FG001|Overall Study|Adverse Event|1|||
161495534|NCT00642941|583208243|FG002|Overall Study|Adverse Event|0|||
161495535|NCT00642941|583208244|FG003|Overall Study|Adverse Event|0|||
161495536|NCT00642941|583208245|FG004|Overall Study|Adverse Event|0|||
161495537|NCT00642941|583208246|FG005|Overall Study|Adverse Event|0|||
161495538|NCT00642941|583208247|FG006|Overall Study|Adverse Event|1|||
161495539|NCT00642941|583208248|FG007|Overall Study|Adverse Event|1|||
161495540|NCT00642941|583208249|FG008|Overall Study|Adverse Event|0|||
161495541|NCT00642941|583208250|FG009|Overall Study|Adverse Event|1|||
161495542|NCT00642941|583208251|FG010|Overall Study|Adverse Event|0|||
161495543|NCT00642941|583208252|FG011|Overall Study|Adverse Event|0|||
161495544|NCT00642941|583208241|FG000|Overall Study|Other|1|||
161495545|NCT00642941|583208242|FG001|Overall Study|Other|1|||
161495546|NCT00642941|583208243|FG002|Overall Study|Other|1|||
161495547|NCT00642941|583208244|FG003|Overall Study|Other|1|||
161495548|NCT00642941|583208245|FG004|Overall Study|Other|0|||
161495549|NCT00642941|583208246|FG005|Overall Study|Other|1|||
161495550|NCT00642941|583208247|FG006|Overall Study|Other|0|||
161495551|NCT00642941|583208248|FG007|Overall Study|Other|1|||
161495552|NCT00642941|583208249|FG008|Overall Study|Other|0|||
161495553|NCT00642941|583208250|FG009|Overall Study|Other|0|||
161585014|NCT05419505|583529800|FG003|Overall Study|Withdrawal by Subject|0|||
161585015|NCT05419505|583529801|FG004|Overall Study|Withdrawal by Subject|0|||
161585016|NCT05419505|583529802|FG005|Overall Study|Withdrawal by Subject|0|||
161585017|NCT05419505|583529803|FG006|Overall Study|Withdrawal by Subject|1|||
161585018|NCT05419505|583529804|FG007|Overall Study|Withdrawal by Subject|0|||
161585019|NCT05419505|583529797|FG000|Overall Study|Lost to Follow-up|2|||
161585020|NCT05419505|583529798|FG001|Overall Study|Lost to Follow-up|1|||
161585021|NCT05419505|583529799|FG002|Overall Study|Lost to Follow-up|0|||
161585022|NCT05419505|583529800|FG003|Overall Study|Lost to Follow-up|0|||
161585023|NCT05419505|583529801|FG004|Overall Study|Lost to Follow-up|1|||
161585024|NCT05419505|583529802|FG005|Overall Study|Lost to Follow-up|2|||
161585025|NCT05419505|583529803|FG006|Overall Study|Lost to Follow-up|0|||
161585026|NCT05419505|583529804|FG007|Overall Study|Lost to Follow-up|1|||
161585027|NCT02780388|583529807|FG000|Overall Study|Lost to Follow-up|0|||
161585028|NCT02780388|583529808|FG001|Overall Study|Lost to Follow-up|1|||
161585029|NCT02780388|583529809|FG002|Overall Study|Lost to Follow-up|0|||
161585030|NCT02780388|583529810|FG003|Overall Study|Lost to Follow-up|0|||
161585031|NCT02780388|583529811|FG004|Overall Study|Lost to Follow-up|0|||
161585032|NCT02780388|583529807|FG000|Overall Study|Withdrawal by Subject|1|||
161585033|NCT02780388|583529808|FG001|Overall Study|Withdrawal by Subject|1|||
161585034|NCT02780388|583529809|FG002|Overall Study|Withdrawal by Subject|0|||
161585035|NCT02780388|583529810|FG003|Overall Study|Withdrawal by Subject|0|||
161585036|NCT02780388|583529811|FG004|Overall Study|Withdrawal by Subject|0|||
161585037|NCT04527146|583529812|FG000|Overall Study|Withdrawal by Subject|12|||
161585038|NCT04527146|583529813|FG001|Overall Study|Withdrawal by Subject|15|||
161585039|NCT04527146|583529814|FG002|Overall Study|Withdrawal by Subject|7|||
161585040|NCT04527146|583529815|FG003|Overall Study|Withdrawal by Subject|16|||
161585041|NCT04527146|583529812|FG000|Overall Study|Lost to Follow-up|13|||
161495554|NCT00642941|583208251|FG010|Overall Study|Other|0|||
161495555|NCT00642941|583208252|FG011|Overall Study|Other|1|||
161495556|NCT00642941|583208241|FG000|Overall Study|Disease progression|60|||
161495557|NCT00642941|583208242|FG001|Overall Study|Disease progression|50|||
161495558|NCT00642941|583208243|FG002|Overall Study|Disease progression|5|||
161585042|NCT04527146|583529813|FG001|Overall Study|Lost to Follow-up|9|||
161818249|NCT01109849|584376003|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
161818250|NCT01109849|584376004|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
161818251|NCT01109849|584376005|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161818252|NCT01109849|584376006|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161495559|NCT00642941|583208244|FG003|Overall Study|Disease progression|36|||
161818253|NCT01109849|584376007|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161495560|NCT00642941|583208245|FG004|Overall Study|Disease progression|23|||
161495561|NCT00642941|583208246|FG005|Overall Study|Disease progression|39|||
161495562|NCT00642941|583208247|FG006|Overall Study|Disease progression|18|||
161495563|NCT00642941|583208248|FG007|Overall Study|Disease progression|12|||
161495564|NCT00642941|583208249|FG008|Overall Study|Disease progression|10|||
161495565|NCT00642941|583208250|FG009|Overall Study|Disease progression|7|||
161495566|NCT00642941|583208251|FG010|Overall Study|Disease progression|12|||
161495567|NCT00642941|583208252|FG011|Overall Study|Disease progression|7|||
161495568|NCT03051607|583208254|FG000|Overall Study|Adverse Event|66|||
161495569|NCT01505868|583208255|FG000|Overall Study|Withdrawal by Subject|1|||
161818254|NCT01109849|584376003|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
161818255|NCT01109849|584376004|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
161818256|NCT01109849|584376005|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
161818257|NCT01109849|584376006|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
161818258|NCT01109849|584376007|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
161818259|NCT02485158|584376011|FG000|Overall Study|Withdrawal by Subject|3|||
161818260|NCT02485158|584376011|FG000|Overall Study|expected drug side effect|1|||
161818261|NCT01098851|584376012|FG000|Overall Study|Equipment failure|1|||
161818262|NCT01098851|584376013|FG001|Overall Study|Equipment failure|0|||
161818263|NCT03087786|584376014|FG000|Overall Study|Withdrawal by Subject|2|||
161818264|NCT03087786|584376015|FG001|Overall Study|Withdrawal by Subject|0|||
161818265|NCT04661202|584376016|FG000|Overall Study|Withdrawal by Subject|1|||
161818266|NCT04661202|584376017|FG001|Overall Study|Withdrawal by Subject|1|||
161818267|NCT04661202|584376016|FG000|Overall Study|Lack of Efficacy|2|||
161818268|NCT04661202|584376017|FG001|Overall Study|Lack of Efficacy|0|||
161818269|NCT02313558|584376018|FG000|Overall Study|Withdrawal by Subject|2|||
161818270|NCT02313558|584376019|FG001|Overall Study|Withdrawal by Subject|0|||
161818271|NCT02313558|584376018|FG000|Overall Study|Lost to Follow-up|4|||
161924326|NCT02323334|584769633|FG006|Period 3|Withdrawal by Subject|0|||
161924327|NCT02323334|584769634|FG007|Period 3|Withdrawal by Subject|0|||
161924328|NCT02323334|584769635|FG008|Period 3|Withdrawal by Subject|0|||
161924329|NCT02323334|584769636|FG009|Period 3|Withdrawal by Subject|0|||
161924330|NCT02323334|584769637|FG010|Period 3|Withdrawal by Subject|0|||
161495570|NCT01505868|583208256|FG001|Overall Study|Withdrawal by Subject|0|||
161495571|NCT01505868|583208257|FG002|Overall Study|Withdrawal by Subject|0|||
161495572|NCT01505868|583208258|FG003|Overall Study|Withdrawal by Subject|0|||
161495573|NCT01505868|583208259|FG004|Overall Study|Withdrawal by Subject|0|||
161495574|NCT00894322|583208260|FG000|Overall Study|Withdrawal by Subject|1|||
161495575|NCT00894322|583208261|FG001|Overall Study|Withdrawal by Subject|0|||
161495576|NCT00894322|583208262|FG002|Overall Study|Withdrawal by Subject|0|||
161495577|NCT00553150|583208263|FG000|Overall Study|Withdrawal by Subject|0|||
161818272|NCT02313558|584376019|FG001|Overall Study|Lost to Follow-up|4|||
161818273|NCT04158687|584376022|FG000|Overall Study|Adverse Event|2|||
161818274|NCT04158687|584376023|FG001|Overall Study|Adverse Event|3|||
161818275|NCT04158687|584376024|FG002|Overall Study|Adverse Event|0|||
161818276|NCT04158687|584376025|FG003|Overall Study|Adverse Event|3|||
161818277|NCT04158687|584376022|FG000|Overall Study|Lost to Follow-up|5|||
161818278|NCT04158687|584376023|FG001|Overall Study|Lost to Follow-up|12|||
161818279|NCT04158687|584376024|FG002|Overall Study|Lost to Follow-up|4|||
161818280|NCT04158687|584376025|FG003|Overall Study|Lost to Follow-up|5|||
161818281|NCT04158687|584376022|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
161818282|NCT04158687|584376023|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
161924331|NCT02323334|584769638|FG011|Period 3|Withdrawal by Subject|0|||
161924332|NCT02323334|584769639|FG012|Period 3|Withdrawal by Subject|0|||
161924333|NCT02323334|584769640|FG013|Period 3|Withdrawal by Subject|0|||
161924334|NCT02323334|584769641|FG014|Period 3|Withdrawal by Subject|0|||
161924335|NCT02323334|584769642|FG015|Period 3|Withdrawal by Subject|0|||
161924336|NCT02323334|584769643|FG016|Period 3|Withdrawal by Subject|0|||
161924337|NCT00266812|584769645|FG000|Overall Study|Disease Progression|9|||
161924338|NCT00266812|584769646|FG001|Overall Study|Disease Progression|3|||
161924339|NCT00266812|584769645|FG000|Overall Study|Death|5|||
161924340|NCT00266812|584769646|FG001|Overall Study|Death|4|||
161495578|NCT00553150|583208264|FG001|Overall Study|Withdrawal by Subject|0|||
161818283|NCT04158687|584376024|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
161818284|NCT04158687|584376025|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
161818285|NCT04158687|584376022|FG000|Overall Study|Non-Compliance with Study Medication|2|||
161818286|NCT04158687|584376023|FG001|Overall Study|Non-Compliance with Study Medication|2|||
161818287|NCT04158687|584376024|FG002|Overall Study|Non-Compliance with Study Medication|3|||
161924341|NCT00266812|584769645|FG000|Overall Study|Adverse Event|3|||
161924342|NCT00266812|584769646|FG001|Overall Study|Adverse Event|1|||
161495579|NCT00553150|583208265|FG002|Overall Study|Withdrawal by Subject|0|||
161495580|NCT00553150|583208266|FG003|Overall Study|Withdrawal by Subject|2|||
161495581|NCT00553150|583208263|FG000|Overall Study|Protocol Violation|0|||
161495582|NCT00553150|583208264|FG001|Overall Study|Protocol Violation|0|||
161495583|NCT00553150|583208265|FG002|Overall Study|Protocol Violation|0|||
161495584|NCT00553150|583208266|FG003|Overall Study|Protocol Violation|1|||
161495585|NCT00553150|583208263|FG000|Overall Study|Ineligible|0|||
161495586|NCT00553150|583208264|FG001|Overall Study|Ineligible|0|||
161495587|NCT00553150|583208265|FG002|Overall Study|Ineligible|0|||
161495588|NCT00553150|583208266|FG003|Overall Study|Ineligible|1|||
161495589|NCT03338855|583208267|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
161495590|NCT03338855|583208268|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
161495591|NCT00975481|583208276|FG000|Second Intervention Period|Adverse Event|2|||
161495592|NCT00975481|583208277|FG001|Second Intervention Period|Adverse Event|1|||
161495593|NCT00975481|583208278|FG002|Second Intervention Period|Adverse Event|0|||
161495594|NCT00975481|583208279|FG003|Second Intervention Period|Adverse Event|0|||
161495595|NCT00975481|583208280|FG004|Second Intervention Period|Adverse Event|0|||
161495596|NCT00975481|583208281|FG005|Second Intervention Period|Adverse Event|0|||
161495597|NCT00975481|583208276|FG000|Second Intervention Period|Withdrawal by Subject|0|||
161495598|NCT00975481|583208277|FG001|Second Intervention Period|Withdrawal by Subject|0|||
161495599|NCT00975481|583208278|FG002|Second Intervention Period|Withdrawal by Subject|1|||
161495600|NCT00975481|583208279|FG003|Second Intervention Period|Withdrawal by Subject|0|||
161495601|NCT00975481|583208280|FG004|Second Intervention Period|Withdrawal by Subject|0|||
161495602|NCT00975481|583208281|FG005|Second Intervention Period|Withdrawal by Subject|0|||
161495603|NCT00975481|583208276|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
161495604|NCT00975481|583208277|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
161495605|NCT00975481|583208278|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
161495606|NCT00975481|583208279|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
161495607|NCT00975481|583208280|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
161495608|NCT00975481|583208281|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
161495609|NCT00975481|583208276|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
161495610|NCT00975481|583208277|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
161495611|NCT00975481|583208278|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
161495612|NCT00975481|583208279|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
161495613|NCT00975481|583208280|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
161495614|NCT00975481|583208281|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
161495615|NCT01387347|583208283|FG000|Overall Study|Lost to Follow-up|2|||
161495616|NCT01387347|583208284|FG001|Overall Study|Lost to Follow-up|1|||
161495617|NCT03251079|583208285|FG000|Overall Study|Withdrawal by Subject|1|||
161495618|NCT03605303|583208286|FG000|Period 1|Study Terminated|2|||
161495619|NCT03605303|583208287|FG001|Period 1|Study Terminated|1|||
161495620|NCT00399360|583208292|FG000|Overall Study|Lost to Follow-up|2|||
161495621|NCT00399360|583208293|FG001|Overall Study|Lost to Follow-up|1|||
161495622|NCT00399360|583208294|FG002|Overall Study|Lost to Follow-up|2|||
161495623|NCT00399360|583208295|FG003|Overall Study|Lost to Follow-up|4|||
161495624|NCT00399360|583208292|FG000|Overall Study|Adverse Event|0|||
161495625|NCT00399360|583208293|FG001|Overall Study|Adverse Event|0|||
161495626|NCT00399360|583208294|FG002|Overall Study|Adverse Event|1|||
161495627|NCT00399360|583208295|FG003|Overall Study|Adverse Event|0|||
161495628|NCT00399360|583208292|FG000|Overall Study|Withdrawal by Subject|0|||
161495629|NCT00399360|583208293|FG001|Overall Study|Withdrawal by Subject|2|||
161495630|NCT00399360|583208294|FG002|Overall Study|Withdrawal by Subject|0|||
161495631|NCT00399360|583208295|FG003|Overall Study|Withdrawal by Subject|2|||
161495632|NCT02626520|583208297|FG000|Overall Study|Physician Decision|1|||
161495633|NCT02626520|583208298|FG001|Overall Study|Physician Decision|1|||
161495634|NCT02626520|583208297|FG000|Overall Study|Adverse Event|0|||
161495635|NCT02626520|583208298|FG001|Overall Study|Adverse Event|4|||
161495636|NCT02626520|583208297|FG000|Overall Study|Lack of Efficacy|0|||
161495637|NCT02626520|583208298|FG001|Overall Study|Lack of Efficacy|2|||
161495638|NCT02626520|583208297|FG000|Overall Study|Did not start protocol therapy|0|||
161495639|NCT02626520|583208298|FG001|Overall Study|Did not start protocol therapy|2|||
161495640|NCT02626520|583208297|FG000|Overall Study|Study terminated|0|||
161495641|NCT02626520|583208298|FG001|Overall Study|Study terminated|1|||
161495642|NCT00492115|583208299|FG000|Overall Study|Withdrawal by Subject|3|||
161495643|NCT00492115|583208300|FG001|Overall Study|Withdrawal by Subject|4|||
161495644|NCT01288287|583208301|FG000|Overall Study|Lost to Follow-up|8|||
161495645|NCT01288287|583208301|FG000|Overall Study|Withdrawal by Subject|4|||
161495646|NCT01288287|583208301|FG000|Overall Study|Lack of Efficacy|13|||
161495647|NCT01288287|583208301|FG000|Overall Study|Other Reason|13|||
161495648|NCT01288287|583208301|FG000|Overall Study|Unknown Reason|1|||
161495649|NCT01288287|583208301|FG000|Overall Study|Unknown Status|7|||
161495650|NCT01523886|583208304|FG000|Overall Study|surgery cancelled|0|||
161495651|NCT01523886|583208305|FG001|Overall Study|surgery cancelled|1|||
161495652|NCT03839212|583208309|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
161495653|NCT00679263|583208310|FG000|Visit 2/Dose 1|Adverse Event|1|||
161585043|NCT04527146|583529814|FG002|Overall Study|Lost to Follow-up|16|||
161495654|NCT00679263|583208311|FG001|Visit 2/Dose 1|Adverse Event|0|||
161495655|NCT00679263|583208312|FG002|Visit 2/Dose 1|Adverse Event|0|||
161495656|NCT00679263|583208310|FG000|Visit 2/Dose 1|subject not compliance|1|||
161495657|NCT00679263|583208311|FG001|Visit 2/Dose 1|subject not compliance|1|||
161495658|NCT00679263|583208312|FG002|Visit 2/Dose 1|subject not compliance|0|||
161495659|NCT00733746|583208313|FG000|Overall Study|Ineligible|5|||
161495660|NCT02472795|583208316|FG000|Overall Study|Adverse Event|0|||
161495661|NCT02472795|583208317|FG001|Overall Study|Adverse Event|1|||
161495662|NCT02472795|583208318|FG002|Overall Study|Adverse Event|0|||
161495663|NCT02472795|583208319|FG003|Overall Study|Adverse Event|0|||
161495664|NCT02472795|583208320|FG004|Overall Study|Adverse Event|2|||
161495665|NCT02472795|583208316|FG000|Overall Study|Withdrawal by Subject|0|||
161495666|NCT02472795|583208317|FG001|Overall Study|Withdrawal by Subject|0|||
161495667|NCT02472795|583208318|FG002|Overall Study|Withdrawal by Subject|0|||
161495668|NCT02472795|583208319|FG003|Overall Study|Withdrawal by Subject|0|||
161495669|NCT02472795|583208320|FG004|Overall Study|Withdrawal by Subject|1|||
161495670|NCT04318080|583210859|FG000|Overall Study|Study closed by sponsor|10|||
161495671|NCT04318080|583210860|FG001|Overall Study|Study closed by sponsor|22|||
161495672|NCT04318080|583210859|FG000|Overall Study|Death|3|||
161495673|NCT04318080|583210860|FG001|Overall Study|Death|9|||
161495674|NCT04318080|583210859|FG000|Overall Study|Withdrawal by Subject|1|||
161495675|NCT04318080|583210860|FG001|Overall Study|Withdrawal by Subject|0|||
161495676|NCT04318080|583210859|FG000|Overall Study|Protocol Deviation|1|||
161495677|NCT04318080|583210860|FG001|Overall Study|Protocol Deviation|0|||
161495678|NCT06308822|583210861|FG000|Overall Study|Mutation Status Not Confirmed|17|||
161495679|NCT06308822|583210861|FG000|Overall Study|Adverse Event|1|||
161495680|NCT06308822|583210861|FG000|Overall Study|Death|5|||
161495681|NCT06308822|583210861|FG000|Overall Study|Disease progression|8|||
161495682|NCT06308822|583210861|FG000|Overall Study|Withdrawal by Subject|1|||
161495683|NCT06308822|583210861|FG000|Overall Study|Physician Decision|3|||
161495684|NCT01536379|583210862|FG000|Overall Study|Adverse Event|1|||
161495685|NCT01536379|583210863|FG001|Overall Study|Adverse Event|2|||
161585044|NCT04527146|583529815|FG003|Overall Study|Lost to Follow-up|13|||
161495686|NCT01536379|583210862|FG000|Overall Study|Withdrawal by Subject|1|||
161495687|NCT01536379|583210863|FG001|Overall Study|Withdrawal by Subject|1|||
161495688|NCT04734652|583210872|FG000|Overall Study|Withdrawal by Subject|2|||
161495689|NCT04734652|583210873|FG001|Overall Study|Withdrawal by Subject|0|||
161495690|NCT04734652|583210872|FG000|Overall Study|Death|0|||
161495691|NCT04734652|583210873|FG001|Overall Study|Death|1|||
161495692|NCT04729127|583210875|FG000|Overall Study|Suspended/Terminated EI Services|4|||
161495693|NCT04729127|583210876|FG001|Overall Study|Suspended/Terminated EI Services|0|||
161585045|NCT04527146|583529812|FG000|Overall Study|Death|0|||
161495694|NCT04729127|583210877|FG002|Overall Study|Suspended/Terminated EI Services|4|||
161495695|NCT04729127|583210878|FG003|Overall Study|Suspended/Terminated EI Services|6|||
161495696|NCT04729127|583210879|FG004|Overall Study|Suspended/Terminated EI Services|0|||
161495697|NCT04729127|583210880|FG005|Overall Study|Suspended/Terminated EI Services|6|||
161495698|NCT04729127|583210881|FG006|Overall Study|Suspended/Terminated EI Services|2|||
161495699|NCT04729127|583210882|FG007|Overall Study|Suspended/Terminated EI Services|0|||
161495700|NCT04729127|583210883|FG008|Overall Study|Suspended/Terminated EI Services|2|||
161495701|NCT04729127|583210875|FG000|Overall Study|Withdrawal by Subject|1|||
161495702|NCT04729127|583210876|FG001|Overall Study|Withdrawal by Subject|0|||
161495703|NCT04729127|583210877|FG002|Overall Study|Withdrawal by Subject|1|||
161495704|NCT04729127|583210878|FG003|Overall Study|Withdrawal by Subject|0|||
161495705|NCT04729127|583210879|FG004|Overall Study|Withdrawal by Subject|0|||
161495706|NCT04729127|583210880|FG005|Overall Study|Withdrawal by Subject|0|||
161495707|NCT04729127|583210881|FG006|Overall Study|Withdrawal by Subject|0|||
161495708|NCT04729127|583210882|FG007|Overall Study|Withdrawal by Subject|0|||
161495709|NCT04729127|583210883|FG008|Overall Study|Withdrawal by Subject|0|||
161495710|NCT04729127|583210875|FG000|Overall Study|Switched Agency/Setting|1|||
161495711|NCT04729127|583210876|FG001|Overall Study|Switched Agency/Setting|0|||
161495712|NCT04729127|583210877|FG002|Overall Study|Switched Agency/Setting|1|||
161495713|NCT04729127|583210878|FG003|Overall Study|Switched Agency/Setting|1|||
161495714|NCT04729127|583210879|FG004|Overall Study|Switched Agency/Setting|0|||
161495715|NCT04729127|583210880|FG005|Overall Study|Switched Agency/Setting|1|||
161495716|NCT04729127|583210881|FG006|Overall Study|Switched Agency/Setting|1|||
161495717|NCT04729127|583210882|FG007|Overall Study|Switched Agency/Setting|0|||
161495718|NCT04729127|583210883|FG008|Overall Study|Switched Agency/Setting|1|||
161495719|NCT03662542|583210886|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
161495720|NCT03662542|583210887|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495721|NCT03662542|583210888|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495722|NCT03662542|583210889|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495723|NCT03662542|583210890|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495724|NCT03662542|583210891|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495725|NCT03662542|583210892|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495726|NCT03662542|583210893|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495727|NCT03662542|583210894|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
161495728|NCT03662542|583210886|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495729|NCT03662542|583210887|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
161495730|NCT03662542|583210888|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495731|NCT03662542|583210889|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495732|NCT03662542|583210890|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161585046|NCT04527146|583529813|FG001|Overall Study|Death|1|||
161585047|NCT04527146|583529814|FG002|Overall Study|Death|1|||
161585048|NCT04527146|583529815|FG003|Overall Study|Death|0|||
161585049|NCT04527146|583529812|FG000|Overall Study|Adverse Event|0|||
161818288|NCT04158687|584376025|FG003|Overall Study|Non-Compliance with Study Medication|0|||
161818289|NCT04158687|584376022|FG000|Overall Study|Investigator Decision|0|||
161818290|NCT04158687|584376023|FG001|Overall Study|Investigator Decision|0|||
161818291|NCT04158687|584376024|FG002|Overall Study|Investigator Decision|2|||
161818292|NCT04158687|584376025|FG003|Overall Study|Investigator Decision|0|||
161818293|NCT04158687|584376022|FG000|Overall Study|Protocol Violation|0|||
161818294|NCT04158687|584376023|FG001|Overall Study|Protocol Violation|2|||
161818295|NCT04158687|584376024|FG002|Overall Study|Protocol Violation|1|||
161818296|NCT04158687|584376025|FG003|Overall Study|Protocol Violation|0|||
161818297|NCT04158687|584376022|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
161818298|NCT04158687|584376023|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
161818299|NCT04158687|584376024|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
161818300|NCT04158687|584376025|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
161818301|NCT04158687|584376022|FG000|Overall Study|Reason not Specified|3|||
161818302|NCT04158687|584376023|FG001|Overall Study|Reason not Specified|2|||
161495733|NCT03662542|583210891|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495734|NCT03662542|583210892|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495735|NCT03662542|583210893|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495736|NCT03662542|583210894|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
161495737|NCT03662542|583210886|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
161495738|NCT03662542|583210887|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
161495739|NCT03662542|583210888|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
161495740|NCT03662542|583210889|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
161585050|NCT04527146|583529813|FG001|Overall Study|Adverse Event|0|||
161585051|NCT04527146|583529814|FG002|Overall Study|Adverse Event|1|||
161818303|NCT04158687|584376024|FG002|Overall Study|Reason not Specified|4|||
161818304|NCT04158687|584376025|FG003|Overall Study|Reason not Specified|4|||
161818305|NCT02043132|584376033|FG000|Overall Study|Lost to Follow-up|1|||
161818306|NCT02043132|584376034|FG001|Overall Study|Lost to Follow-up|1|||
161495741|NCT03662542|583210890|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
161495742|NCT03662542|583210891|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
161495743|NCT03662542|583210892|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
161495744|NCT03662542|583210893|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
161495745|NCT03662542|583210894|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
161495746|NCT03662542|583210886|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
161495747|NCT03662542|583210887|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495748|NCT03662542|583210888|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495749|NCT03662542|583210889|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495750|NCT03662542|583210890|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495751|NCT03662542|583210891|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495752|NCT03662542|583210892|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495753|NCT03662542|583210893|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495754|NCT03662542|583210894|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161495755|NCT03662542|583210886|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495756|NCT03662542|583210887|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495757|NCT03662542|583210888|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495758|NCT03662542|583210889|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495759|NCT03662542|583210890|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495760|NCT03662542|583210891|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
161495761|NCT03662542|583210892|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495762|NCT03662542|583210893|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495763|NCT03662542|583210894|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
161495764|NCT03662542|583210886|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495765|NCT03662542|583210887|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495766|NCT03662542|583210888|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495767|NCT03662542|583210889|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
161495768|NCT03662542|583210890|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
161495769|NCT03662542|583210891|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495770|NCT03662542|583210892|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495771|NCT03662542|583210893|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495772|NCT03662542|583210894|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
161495773|NCT03662542|583210886|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
161495774|NCT03662542|583210887|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
161495775|NCT03662542|583210888|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
161495776|NCT03662542|583210889|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
161495777|NCT03662542|583210890|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
161495778|NCT03662542|583210891|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
161495779|NCT03662542|583210892|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
161495780|NCT03662542|583210893|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
161495781|NCT03662542|583210894|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
161585052|NCT04527146|583529815|FG003|Overall Study|Adverse Event|0|||
161495782|NCT03662542|583210886|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495783|NCT03662542|583210887|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495784|NCT03662542|583210888|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495785|NCT03662542|583210889|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495786|NCT03662542|583210890|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
161495787|NCT03662542|583210891|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
161495788|NCT03662542|583210892|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495789|NCT03662542|583210893|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495790|NCT03662542|583210894|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
161495791|NCT03662542|583210886|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495792|NCT03662542|583210887|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495793|NCT03662542|583210888|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495794|NCT03662542|583210889|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495795|NCT03662542|583210890|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161585053|NCT04527146|583529812|FG000|Overall Study|Ineligible after randomization|2|||
161585054|NCT04527146|583529813|FG001|Overall Study|Ineligible after randomization|0|||
161585055|NCT04527146|583529814|FG002|Overall Study|Ineligible after randomization|2|||
161585056|NCT04527146|583529815|FG003|Overall Study|Ineligible after randomization|2|||
161585057|NCT04527146|583529812|FG000|Overall Study|Moved to a different group|6|||
161585058|NCT04527146|583529813|FG001|Overall Study|Moved to a different group|3|||
161585059|NCT04527146|583529814|FG002|Overall Study|Moved to a different group|0|||
161585060|NCT04527146|583529815|FG003|Overall Study|Moved to a different group|2|||
161585061|NCT05107401|583529816|FG000|Overall Study|Lost to Follow-up|13|||
161585062|NCT05107401|583529817|FG001|Overall Study|Lost to Follow-up|12|||
161585063|NCT04468776|583529824|FG000|Overall Study|Lost to Follow-up|4|||
161585064|NCT04468776|583529825|FG001|Overall Study|Lost to Follow-up|3|||
161585065|NCT04468776|583529826|FG002|Overall Study|Lost to Follow-up|4|||
161585066|NCT04468776|583529824|FG000|Overall Study|Withdrawal by Subject|1|||
161585067|NCT04468776|583529825|FG001|Overall Study|Withdrawal by Subject|10|||
161585068|NCT04468776|583529826|FG002|Overall Study|Withdrawal by Subject|4|||
161585069|NCT04468776|583529824|FG000|Overall Study|Physician Decision|0|||
161585070|NCT04468776|583529825|FG001|Overall Study|Physician Decision|1|||
161585071|NCT04468776|583529826|FG002|Overall Study|Physician Decision|1|||
161585072|NCT04855760|583529827|FG000|Overall Study|Adverse Event|21|||
161585073|NCT04855760|583529827|FG000|Overall Study|Withdrawal by Subject|116|||
161585074|NCT04855760|583529827|FG000|Overall Study|Lack of Efficacy|21|||
161585075|NCT04855760|583529827|FG000|Overall Study|Lost to Follow-up|49|||
161585076|NCT04855760|583529827|FG000|Overall Study|Protocol Violation|2|||
161585077|NCT04855760|583529827|FG000|Overall Study|Physician Decision|5|||
161585078|NCT04855760|583529827|FG000|Overall Study|Pregnancy|1|||
161585079|NCT04855760|583529827|FG000|Overall Study|Non-Compliance with Study Drug|11|||
161585080|NCT04855760|583529827|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
161585081|NCT04855760|583529827|FG000|Overall Study|Study Completed by Sponsor|202|||
161585082|NCT04855760|583529827|FG000|Overall Study|Other|13|||
161585083|NCT04840199|583529832|FG000|Overall Study|Study Terminated by Sponsor|8|||
161585084|NCT04840199|583529833|FG001|Overall Study|Study Terminated by Sponsor|9|||
161585085|NCT04840199|583529832|FG000|Overall Study|Lost to Follow-up|0|||
161585086|NCT04840199|583529833|FG001|Overall Study|Lost to Follow-up|2|||
161585087|NCT04840199|583529832|FG000|Overall Study|Withdrawal by Subject|2|||
161585088|NCT04840199|583529833|FG001|Overall Study|Withdrawal by Subject|0|||
161585089|NCT04840199|583529832|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
161585090|NCT04840199|583529833|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
161585091|NCT03857620|583529835|FG000|Overall Study|Death|4|||
161585092|NCT03857620|583529836|FG001|Overall Study|Death|5|||
161585093|NCT03857620|583529837|FG002|Overall Study|Death|7|||
161585094|NCT03857620|583529835|FG000|Overall Study|Lost to Follow-up|2|||
161585095|NCT03857620|583529836|FG001|Overall Study|Lost to Follow-up|5|||
161585096|NCT03857620|583529837|FG002|Overall Study|Lost to Follow-up|3|||
161585097|NCT03857620|583529835|FG000|Overall Study|Disease progression or relapse after study registration|1|||
161585098|NCT03857620|583529836|FG001|Overall Study|Disease progression or relapse after study registration|5|||
161585099|NCT03857620|583529837|FG002|Overall Study|Disease progression or relapse after study registration|1|||
161585100|NCT03857620|583529835|FG000|Overall Study|Ineligible|5|||
161585101|NCT03857620|583529836|FG001|Overall Study|Ineligible|0|||
161585102|NCT03857620|583529837|FG002|Overall Study|Ineligible|2|||
161585103|NCT03857620|583529835|FG000|Overall Study|No malignancy|1|||
161585104|NCT03857620|583529836|FG001|Overall Study|No malignancy|0|||
161495796|NCT03662542|583210891|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
161585105|NCT03857620|583529837|FG002|Overall Study|No malignancy|1|||
161585106|NCT03857620|583529835|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
161585107|NCT03857620|583529836|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
161585108|NCT03857620|583529837|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
161585109|NCT03857620|583529835|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
161585110|NCT03857620|583529836|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
161585111|NCT03857620|583529837|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
161495797|NCT03662542|583210892|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495798|NCT03662542|583210893|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495799|NCT03662542|583210894|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161495800|NCT03662542|583210886|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495801|NCT03662542|583210887|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495802|NCT03662542|583210888|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495803|NCT03662542|583210889|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495804|NCT03662542|583210890|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495805|NCT03662542|583210891|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495806|NCT03662542|583210892|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495807|NCT03662542|583210893|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
161495808|NCT03662542|583210894|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
161495809|NCT03662542|583210886|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495810|NCT03662542|583210887|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495811|NCT03662542|583210888|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495812|NCT03662542|583210889|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495813|NCT03662542|583210890|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495814|NCT03662542|583210891|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495815|NCT03662542|583210892|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
161495816|NCT03662542|583210893|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
161495817|NCT03662542|583210894|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
161495818|NCT03662542|583210886|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495819|NCT03662542|583210887|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495820|NCT03662542|583210888|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495821|NCT03662542|583210889|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495822|NCT03662542|583210890|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495823|NCT03662542|583210891|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495824|NCT03662542|583210892|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
161495825|NCT03662542|583210893|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
161495826|NCT03662542|583210894|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
161495827|NCT03662542|583210886|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
161495828|NCT03662542|583210887|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
161495829|NCT03662542|583210888|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
161495830|NCT03662542|583210889|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
161495831|NCT03662542|583210890|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
161495832|NCT03662542|583210891|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
161495833|NCT03662542|583210892|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
161495834|NCT03662542|583210893|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
161495835|NCT03662542|583210894|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
161495836|NCT01217060|583210896|FG000|Overall Study|Withdrawal by Subject|1|||
161495837|NCT03388138|583210897|FG000|Overall Study|Protocol Violation|1|||
161495838|NCT03388138|583210898|FG001|Overall Study|Protocol Violation|0|||
161495839|NCT01528072|583210899|FG000|Overall Study|Withdrawal by Subject|5|||
161495840|NCT01528072|583210899|FG000|Overall Study|Physician Decision|1|||
161495841|NCT01528072|583210899|FG000|Overall Study|Determined not eligible by AEAC|1|||
161818307|NCT02043132|584376033|FG000|Overall Study|screen failures|4|||
161495842|NCT01528072|583210899|FG000|Overall Study|Missed Visit|2|||
161495843|NCT01528072|583210899|FG000|Overall Study|Lost to Follow-up|5|||
161818308|NCT02043132|584376034|FG001|Overall Study|screen failures|8|||
161495844|NCT01528072|583210899|FG000|Overall Study|Explanted|2|||
161495845|NCT01528072|583210899|FG000|Overall Study|Site Closure|4|||
161495846|NCT01528072|583210899|FG000|Overall Study|Death|2|||
161495847|NCT01528072|583210899|FG000|Overall Study|Early Termination of Study|52|||
161495848|NCT02436759|583210906|FG000|Overall Study|Adverse Event|3|||
161495849|NCT02436759|583210907|FG001|Overall Study|Adverse Event|0|||
161495850|NCT02436759|583210906|FG000|Overall Study|Protocol Violation|1|||
161495851|NCT02436759|583210907|FG001|Overall Study|Protocol Violation|0|||
161495852|NCT02436759|583210906|FG000|Overall Study|Withdrawal by Subject|0|||
161495853|NCT02436759|583210907|FG001|Overall Study|Withdrawal by Subject|1|||
161495854|NCT04014075|583210908|FG000|Overall Study|Progressive Disease|53|||
161495855|NCT04014075|583210908|FG000|Overall Study|Adverse Event|15|||
161495856|NCT04014075|583210908|FG000|Overall Study|Clinical Progression|4|||
161495857|NCT04014075|583210908|FG000|Overall Study|Death|2|||
161495858|NCT04014075|583210908|FG000|Overall Study|Withdrawal by Subject|2|||
161495859|NCT04014075|583210908|FG000|Overall Study|Miscellaneous|2|||
161495860|NCT04014075|583210908|FG000|Overall Study|Physician Decision|1|||
161495861|NCT01912287|583210909|FG000|Overall Study|Ineligible|1|||
161495862|NCT01912287|583210910|FG001|Overall Study|Ineligible|0|||
161495863|NCT01912287|583210911|FG002|Overall Study|Ineligible|1|||
161495864|NCT01912287|583210909|FG000|Overall Study|No-show|0|||
161495865|NCT01912287|583210910|FG001|Overall Study|No-show|0|||
161495866|NCT01912287|583210911|FG002|Overall Study|No-show|1|||
161495867|NCT01912287|583210909|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
161495868|NCT01912287|583210910|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
161495869|NCT01912287|583210911|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
161495870|NCT01912287|583210909|FG000|Overall Study|Felt treatment no longer needed|0|||
161495871|NCT01912287|583210910|FG001|Overall Study|Felt treatment no longer needed|1|||
161495872|NCT01912287|583210911|FG002|Overall Study|Felt treatment no longer needed|0|||
161495873|NCT01912287|583210909|FG000|Overall Study|Life circumstances|4|||
161495874|NCT01912287|583210910|FG001|Overall Study|Life circumstances|2|||
161495875|NCT01912287|583210911|FG002|Overall Study|Life circumstances|0|||
161495876|NCT01912287|583210909|FG000|Overall Study|Lost Interest|1|||
161495877|NCT01912287|583210910|FG001|Overall Study|Lost Interest|0|||
161495878|NCT01912287|583210911|FG002|Overall Study|Lost Interest|0|||
161495879|NCT01912287|583210909|FG000|Overall Study|Uknown reason - subject drop out|5|||
161495880|NCT01912287|583210910|FG001|Overall Study|Uknown reason - subject drop out|7|||
161495881|NCT01912287|583210911|FG002|Overall Study|Uknown reason - subject drop out|3|||
161495882|NCT01912287|583210909|FG000|Overall Study|Missed Assesment|1|||
161495883|NCT01912287|583210910|FG001|Overall Study|Missed Assesment|1|||
161495884|NCT01912287|583210911|FG002|Overall Study|Missed Assesment|1|||
161495885|NCT01912287|583210909|FG000|Overall Study|Scheduling/change in availability|17|||
161495886|NCT01912287|583210910|FG001|Overall Study|Scheduling/change in availability|10|||
161495887|NCT01912287|583210911|FG002|Overall Study|Scheduling/change in availability|8|||
161495888|NCT02631850|583210912|FG000|Treatment Period|Lost to Follow-up|0|||
161495889|NCT02631850|583210913|FG001|Treatment Period|Lost to Follow-up|1|||
161495890|NCT02631850|583210914|FG002|Treatment Period|Lost to Follow-up|0|||
161495891|NCT02631850|583210915|FG003|Treatment Period|Lost to Follow-up|0|||
161495892|NCT02631850|583210912|FG000|Treatment Period|Protocol Violation|1|||
161495893|NCT02631850|583210913|FG001|Treatment Period|Protocol Violation|0|||
161495894|NCT02631850|583210914|FG002|Treatment Period|Protocol Violation|0|||
161495895|NCT02631850|583210915|FG003|Treatment Period|Protocol Violation|0|||
161495896|NCT02631850|583210912|FG000|Treatment Period|Withdrawal by Subject|0|||
161495897|NCT02631850|583210913|FG001|Treatment Period|Withdrawal by Subject|5|||
161495898|NCT02631850|583210914|FG002|Treatment Period|Withdrawal by Subject|2|||
161495899|NCT02631850|583210915|FG003|Treatment Period|Withdrawal by Subject|2|||
161495900|NCT02631850|583210912|FG000|Treatment Period|Adverse Event|1|||
161495901|NCT02631850|583210913|FG001|Treatment Period|Adverse Event|0|||
161585112|NCT03857620|583529835|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161585113|NCT03857620|583529836|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161585114|NCT03857620|583529837|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
161585115|NCT03857620|583529835|FG000|Overall Study|Surgery not performed, patient decision|0|||
161495902|NCT02631850|583210914|FG002|Treatment Period|Adverse Event|2|||
161495903|NCT02631850|583210915|FG003|Treatment Period|Adverse Event|3|||
161495904|NCT02631850|583210912|FG000|Treatment Period|Family medical issue|1|||
161495905|NCT02631850|583210913|FG001|Treatment Period|Family medical issue|0|||
161495906|NCT02631850|583210914|FG002|Treatment Period|Family medical issue|0|||
161495907|NCT02631850|583210915|FG003|Treatment Period|Family medical issue|0|||
161495908|NCT02631850|583210912|FG000|6 Month Follow up|Lost to Follow-up|5|||
161495909|NCT02631850|583210913|FG001|6 Month Follow up|Lost to Follow-up|8|||
161495910|NCT02631850|583210914|FG002|6 Month Follow up|Lost to Follow-up|3|||
161495911|NCT02631850|583210915|FG003|6 Month Follow up|Lost to Follow-up|5|||
161495912|NCT02631850|583210912|FG000|6 Month Follow up|Withdrawal by Subject|1|||
161495913|NCT02631850|583210913|FG001|6 Month Follow up|Withdrawal by Subject|0|||
161495914|NCT02631850|583210914|FG002|6 Month Follow up|Withdrawal by Subject|0|||
161495915|NCT02631850|583210915|FG003|6 Month Follow up|Withdrawal by Subject|2|||
161495916|NCT02631850|583210912|FG000|6 Month Follow up|Adverse Event|1|||
161495917|NCT02631850|583210913|FG001|6 Month Follow up|Adverse Event|4|||
161495918|NCT02631850|583210914|FG002|6 Month Follow up|Adverse Event|1|||
161495919|NCT02631850|583210915|FG003|6 Month Follow up|Adverse Event|3|||
161495920|NCT02631850|583210912|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
161495921|NCT02631850|583210913|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
161495922|NCT02631850|583210914|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
161495923|NCT02631850|583210915|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
161495924|NCT00326950|583210917|FG000|Overall Study|Progressive Disease|1|||
161495925|NCT01514760|583210918|FG000|Overall Study|Lost to Follow-up|2|||
161495926|NCT00619801|583210939|FG000|Overall Study|Lack of Efficacy|0|||
161495927|NCT00619801|583210940|FG001|Overall Study|Lack of Efficacy|1|||
161495928|NCT00619801|583210939|FG000|Overall Study|Withdrawal by Subject|1|||
161495929|NCT00619801|583210940|FG001|Overall Study|Withdrawal by Subject|1|||
161495930|NCT00619801|583210939|FG000|Overall Study|Loss of efficacy|0|||
161495931|NCT00619801|583210940|FG001|Overall Study|Loss of efficacy|1|||
161495932|NCT03559257|583210951|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
161495933|NCT03559257|583210952|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
161495934|NCT03559257|583210951|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161495935|NCT03559257|583210952|FG001|Double Blind Treatment Period|Protocol Violation|4|||
161495936|NCT03559257|583210951|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
161495937|NCT03559257|583210952|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
161495938|NCT03559257|583210951|FG000|Double Blind Treatment Period|Adverse Event|0|||
161495939|NCT03559257|583210952|FG001|Double Blind Treatment Period|Adverse Event|1|||
161495940|NCT03559257|583210951|FG000|Double Blind Treatment Period|Screen Failure|0|||
161495941|NCT03559257|583210952|FG001|Double Blind Treatment Period|Screen Failure|1|||
161495942|NCT03559257|583210951|FG000|Open-label Treatment Period|Adverse Event|1|||
161495943|NCT03559257|583210952|FG001|Open-label Treatment Period|Adverse Event|4|||
161495944|NCT03559257|583210951|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
161495945|NCT03559257|583210952|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
161495946|NCT03559257|583210951|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
161495947|NCT03559257|583210952|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161495948|NCT03559257|583210951|FG000|Open-label Treatment Period|Protocol Violation|2|||
161495949|NCT03559257|583210952|FG001|Open-label Treatment Period|Protocol Violation|0|||
161495950|NCT03559257|583210951|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
161495951|NCT03559257|583210952|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161495952|NCT03559257|583210951|FG000|Open-label Treatment Period|Physician Decision|0|||
161495953|NCT03559257|583210952|FG001|Open-label Treatment Period|Physician Decision|1|||
161495954|NCT02738450|583210953|FG000|Overall Study|Withdrawal by Subject|0|||
161495955|NCT02738450|583210954|FG001|Overall Study|Withdrawal by Subject|2|||
161495956|NCT02738450|583210955|FG002|Overall Study|Withdrawal by Subject|0|||
161495957|NCT03630120|583210956|FG000|Overall Study|Disease progression|0|||
161495958|NCT03630120|583210957|FG001|Overall Study|Disease progression|1|||
161495959|NCT03630120|583210958|FG002|Overall Study|Disease progression|1|||
161495960|NCT03630120|583210959|FG003|Overall Study|Disease progression|1|||
161495961|NCT01519960|583210960|FG000|Overall Study|Withdrawal from the study|26|||
161495962|NCT01519960|583210961|FG001|Overall Study|Withdrawal from the study|22|||
161495963|NCT01519960|583210962|FG002|Overall Study|Withdrawal from the study|5|||
161495964|NCT03204305|583210971|FG000|Overall Study|Lost to Follow-up|6|||
161495965|NCT03204305|583210972|FG001|Overall Study|Lost to Follow-up|4|||
161495966|NCT03204305|583210973|FG002|Overall Study|Lost to Follow-up|0|||
161495967|NCT03204305|583210974|FG003|Overall Study|Lost to Follow-up|0|||
161495968|NCT03204305|583210971|FG000|Overall Study|Physician Decision|1|||
161495969|NCT03204305|583210972|FG001|Overall Study|Physician Decision|0|||
161495970|NCT03204305|583210973|FG002|Overall Study|Physician Decision|0|||
161495971|NCT03204305|583210974|FG003|Overall Study|Physician Decision|0|||
161495972|NCT03204305|583210971|FG000|Overall Study|failure to place arterial line|2|||
161495973|NCT03204305|583210972|FG001|Overall Study|failure to place arterial line|1|||
161495974|NCT03204305|583210973|FG002|Overall Study|failure to place arterial line|0|||
161495975|NCT03204305|583210974|FG003|Overall Study|failure to place arterial line|0|||
161495976|NCT03204305|583210971|FG000|Overall Study|Withdrawal by Subject|2|||
161495977|NCT03204305|583210972|FG001|Overall Study|Withdrawal by Subject|0|||
161495978|NCT03204305|583210973|FG002|Overall Study|Withdrawal by Subject|0|||
161495979|NCT03204305|583210974|FG003|Overall Study|Withdrawal by Subject|0|||
161495980|NCT01165554|583210981|FG000|Overall Study|Withdrawal by Subject|23|||
161495981|NCT02951156|583210982|FG000|Overall Study|Death|3|||
161495982|NCT02951156|583210983|FG001|Overall Study|Death|8|||
161495983|NCT02951156|583210984|FG002|Overall Study|Death|5|||
161495984|NCT02951156|583210982|FG000|Overall Study|Progressive disease|1|||
161495985|NCT02951156|583210983|FG001|Overall Study|Progressive disease|0|||
161495986|NCT02951156|583210984|FG002|Overall Study|Progressive disease|1|||
161495987|NCT02951156|583210982|FG000|Overall Study|Withdrawal by Subject|0|||
161495988|NCT02951156|583210983|FG001|Overall Study|Withdrawal by Subject|0|||
161495989|NCT02951156|583210984|FG002|Overall Study|Withdrawal by Subject|1|||
161495990|NCT02951156|583210982|FG000|Overall Study|Study terminated by sponsor|0|||
161495991|NCT02951156|583210983|FG001|Overall Study|Study terminated by sponsor|0|||
161495992|NCT02951156|583210984|FG002|Overall Study|Study terminated by sponsor|1|||
161495993|NCT02951156|583210982|FG000|Overall Study|Other|5|||
161495994|NCT02951156|583210983|FG001|Overall Study|Other|1|||
161495995|NCT02951156|583210984|FG002|Overall Study|Other|2|||
161495996|NCT01603459|583210985|FG000|Overall Study|Adverse Event|5|||
161495997|NCT01603459|583210985|FG000|Overall Study|Withdrawal by Subject|5|||
161495998|NCT01603459|583210985|FG000|Overall Study|Lost to Follow-up|3|||
161495999|NCT01603459|583210985|FG000|Overall Study|Predefined discontinuation criteria|3|||
161496000|NCT01603459|583210985|FG000|Overall Study|Non-compliance|1|||
161496001|NCT01603459|583210985|FG000|Overall Study|Administrative reason|1|||
161496002|NCT00535223|583210989|FG000|Overall Study|Withdrawal by Subject|4|||
161496003|NCT00535223|583210990|FG001|Overall Study|Withdrawal by Subject|1|||
161496004|NCT02953314|583210991|FG000|Overall Study|Adverse Event|0|||
161496005|NCT02953314|583210992|FG001|Overall Study|Adverse Event|1|||
161496006|NCT02953314|583210991|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161496007|NCT02953314|583210992|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161496008|NCT02515045|583211003|FG000|Overall Study|Adverse Event|0|||
161496009|NCT02515045|583211004|FG001|Overall Study|Adverse Event|3|||
161496010|NCT02515045|583211005|FG002|Overall Study|Adverse Event|3|||
161496011|NCT02515045|583211003|FG000|Overall Study|Lost to Follow-up|0|||
161496012|NCT02515045|583211004|FG001|Overall Study|Lost to Follow-up|1|||
161496013|NCT02515045|583211005|FG002|Overall Study|Lost to Follow-up|1|||
161496014|NCT00238121|583211006|FG000|Overall Study|Withdrawal by Subject|1|||
161496015|NCT00238121|583211007|FG001|Overall Study|Withdrawal by Subject|1|||
161496016|NCT00238121|583211006|FG000|Overall Study|Adverse Event|2|||
161496017|NCT00238121|583211007|FG001|Overall Study|Adverse Event|1|||
161496018|NCT03255382|583211008|FG000|Overall Study|Adverse Event|3|||
161496019|NCT03255382|583211009|FG001|Overall Study|Adverse Event|0|||
161496020|NCT03255382|583211008|FG000|Overall Study|Lost to Follow-up|2|||
161496021|NCT03255382|583211009|FG001|Overall Study|Lost to Follow-up|0|||
161496022|NCT03255382|583211008|FG000|Overall Study|Withdrawal by Subject|2|||
161496023|NCT03255382|583211009|FG001|Overall Study|Withdrawal by Subject|0|||
161496024|NCT03255382|583211008|FG000|Overall Study|Other|6|||
161496025|NCT03255382|583211009|FG001|Overall Study|Other|0|||
161496026|NCT02221284|583211010|FG000|Overall Study|Case Report Forms Uncollected|56|||
161496027|NCT02221284|583211010|FG000|Overall Study|Protocol Deviation|5|||
161496028|NCT01166178|583211011|FG000|Overall Study|Withdrawal by Subject|1|||
161496029|NCT01166178|583211012|FG001|Overall Study|Withdrawal by Subject|0|||
161496030|NCT01166178|583211011|FG000|Overall Study|Study was terminated|20|||
161496031|NCT01166178|583211012|FG001|Overall Study|Study was terminated|8|||
161496032|NCT04948450|583211013|FG000|Overall Study|Return home|1|||
161496033|NCT04948450|583211014|FG001|Overall Study|Return home|3|||
161496034|NCT00101907|583211018|FG000|Overall Study|Adverse Event|1|||
161496035|NCT00101907|583211019|FG001|Overall Study|Adverse Event|0|||
161496036|NCT00101907|583211020|FG002|Overall Study|Adverse Event|0|||
161496037|NCT00101907|583211021|FG003|Overall Study|Adverse Event|0|||
161496038|NCT00101907|583211022|FG004|Overall Study|Adverse Event|0|||
161496039|NCT00101907|583211023|FG005|Overall Study|Adverse Event|0|||
161496040|NCT00101907|583211018|FG000|Overall Study|Death|0|||
161496041|NCT00101907|583211019|FG001|Overall Study|Death|1|||
161496042|NCT00101907|583211020|FG002|Overall Study|Death|0|||
161496043|NCT00101907|583211021|FG003|Overall Study|Death|0|||
161496044|NCT00101907|583211022|FG004|Overall Study|Death|3|||
161672363|NCT02684357|583853116|FG004|Part A|Withdrawal by Subject|0|||
161672364|NCT02684357|583853117|FG005|Part A|Withdrawal by Subject|0|||
161672365|NCT02684357|583853112|FG000|Part A|Other|0|||
161672366|NCT02684357|583853113|FG001|Part A|Other|1|||
161672367|NCT02684357|583853114|FG002|Part A|Other|0|||
161672368|NCT02684357|583853115|FG003|Part A|Other|0|||
161672369|NCT02684357|583853116|FG004|Part A|Other|0|||
161672370|NCT02684357|583853117|FG005|Part A|Other|0|||
161672371|NCT02684357|583853112|FG000|Part B|Adverse Event (Other)|0|||
161818309|NCT03827395|584376035|FG000|Overall Study|Lost to Follow-up|1|||
161496045|NCT00101907|583211023|FG005|Overall Study|Death|0|||
161818310|NCT03827395|584376036|FG001|Overall Study|Lost to Follow-up|0|||
161496046|NCT00101907|583211018|FG000|Overall Study|Physician Decision|0|||
161496047|NCT00101907|583211019|FG001|Overall Study|Physician Decision|0|||
161496048|NCT00101907|583211020|FG002|Overall Study|Physician Decision|0|||
161496049|NCT00101907|583211021|FG003|Overall Study|Physician Decision|1|||
161496050|NCT00101907|583211022|FG004|Overall Study|Physician Decision|1|||
161496051|NCT00101907|583211023|FG005|Overall Study|Physician Decision|0|||
161496052|NCT00101907|583211018|FG000|Overall Study|Withdrawal by Subject|1|||
161496053|NCT00101907|583211019|FG001|Overall Study|Withdrawal by Subject|0|||
161496054|NCT00101907|583211020|FG002|Overall Study|Withdrawal by Subject|1|||
161672372|NCT02684357|583853113|FG001|Part B|Adverse Event (Other)|0|||
161672373|NCT02684357|583853114|FG002|Part B|Adverse Event (Other)|0|||
161672374|NCT02684357|583853115|FG003|Part B|Adverse Event (Other)|1|||
161672375|NCT02684357|583853116|FG004|Part B|Adverse Event (Other)|1|||
161496055|NCT00101907|583211021|FG003|Overall Study|Withdrawal by Subject|0|||
161496056|NCT00101907|583211022|FG004|Overall Study|Withdrawal by Subject|1|||
161496057|NCT00101907|583211023|FG005|Overall Study|Withdrawal by Subject|0|||
161496058|NCT00624052|583211024|FG000|Overall Study|Adverse Event|7|||
161496059|NCT00624052|583211025|FG001|Overall Study|Adverse Event|6|||
161496060|NCT00624052|583211026|FG002|Overall Study|Adverse Event|0|||
161496061|NCT00624052|583211027|FG003|Overall Study|Adverse Event|3|||
161496062|NCT00624052|583211024|FG000|Overall Study|Lack of Efficacy|1|||
161496063|NCT00624052|583211025|FG001|Overall Study|Lack of Efficacy|1|||
161496064|NCT00624052|583211026|FG002|Overall Study|Lack of Efficacy|0|||
161496065|NCT00624052|583211027|FG003|Overall Study|Lack of Efficacy|0|||
161496066|NCT00624052|583211024|FG000|Overall Study|Lost to Follow-up|2|||
161496067|NCT00624052|583211025|FG001|Overall Study|Lost to Follow-up|3|||
161496068|NCT00624052|583211026|FG002|Overall Study|Lost to Follow-up|1|||
161496069|NCT00624052|583211027|FG003|Overall Study|Lost to Follow-up|0|||
161496070|NCT00624052|583211024|FG000|Overall Study|Non compliant with the protocol|2|||
161496071|NCT00624052|583211025|FG001|Overall Study|Non compliant with the protocol|1|||
161496072|NCT00624052|583211026|FG002|Overall Study|Non compliant with the protocol|1|||
161496073|NCT00624052|583211027|FG003|Overall Study|Non compliant with the protocol|1|||
161496074|NCT00624052|583211024|FG000|Overall Study|Consent withdrawn|3|||
161496075|NCT00624052|583211025|FG001|Overall Study|Consent withdrawn|1|||
161496076|NCT00624052|583211026|FG002|Overall Study|Consent withdrawn|1|||
161496077|NCT00624052|583211027|FG003|Overall Study|Consent withdrawn|0|||
161496078|NCT00624052|583211024|FG000|Overall Study|Changed job/ran out if meds|0|||
161496079|NCT00624052|583211025|FG001|Overall Study|Changed job/ran out if meds|2|||
161496080|NCT00624052|583211026|FG002|Overall Study|Changed job/ran out if meds|0|||
161496081|NCT00624052|583211027|FG003|Overall Study|Changed job/ran out if meds|0|||
161496082|NCT01474876|583211034|FG000|Overall Study|Adverse Event|11|||
161496083|NCT01474876|583211035|FG001|Overall Study|Adverse Event|5|||
161496084|NCT01474876|583211036|FG002|Overall Study|Adverse Event|0|||
161496085|NCT01474876|583211034|FG000|Overall Study|Serious Adverse Event|2|||
161496086|NCT01474876|583211035|FG001|Overall Study|Serious Adverse Event|3|||
161496087|NCT01474876|583211036|FG002|Overall Study|Serious Adverse Event|0|||
161496088|NCT01474876|583211034|FG000|Overall Study|Lost to Follow-up|5|||
161496089|NCT01474876|583211035|FG001|Overall Study|Lost to Follow-up|4|||
161496090|NCT01474876|583211036|FG002|Overall Study|Lost to Follow-up|0|||
161496091|NCT01474876|583211034|FG000|Overall Study|Investigator's decision|28|||
161496092|NCT01474876|583211035|FG001|Overall Study|Investigator's decision|6|||
161496093|NCT01474876|583211036|FG002|Overall Study|Investigator's decision|0|||
161496094|NCT01474876|583211034|FG000|Overall Study|Patient's request|19|||
161496095|NCT01474876|583211035|FG001|Overall Study|Patient's request|5|||
161496096|NCT01474876|583211036|FG002|Overall Study|Patient's request|0|||
161496097|NCT01474876|583211034|FG000|Overall Study|Investigator's decision and pt request|1|||
161496098|NCT01474876|583211035|FG001|Overall Study|Investigator's decision and pt request|0|||
161496099|NCT01474876|583211036|FG002|Overall Study|Investigator's decision and pt request|0|||
161496100|NCT02291055|583211039|FG000|Overall Study|Death|2|||
161496101|NCT02291055|583211040|FG001|Overall Study|Death|2|||
161496102|NCT02291055|583211041|FG002|Overall Study|Death|5|||
161496103|NCT02291055|583211042|FG003|Overall Study|Death|8|||
161496104|NCT02291055|583211043|FG004|Overall Study|Death|12|||
161496105|NCT02291055|583211039|FG000|Overall Study|Lost to Follow-up|0|||
161496106|NCT02291055|583211040|FG001|Overall Study|Lost to Follow-up|0|||
161496107|NCT02291055|583211041|FG002|Overall Study|Lost to Follow-up|0|||
161496108|NCT02291055|583211042|FG003|Overall Study|Lost to Follow-up|1|||
161496109|NCT02291055|583211043|FG004|Overall Study|Lost to Follow-up|2|||
161496110|NCT02291055|583211039|FG000|Overall Study|Withdrawal by Subject|3|||
161496111|NCT02291055|583211040|FG001|Overall Study|Withdrawal by Subject|1|||
161496112|NCT02291055|583211041|FG002|Overall Study|Withdrawal by Subject|1|||
161496113|NCT02291055|583211042|FG003|Overall Study|Withdrawal by Subject|5|||
161496114|NCT02291055|583211043|FG004|Overall Study|Withdrawal by Subject|10|||
161496115|NCT02291055|583211039|FG000|Overall Study|Progressive Disease|0|||
161496116|NCT02291055|583211040|FG001|Overall Study|Progressive Disease|0|||
161496117|NCT02291055|583211041|FG002|Overall Study|Progressive Disease|1|||
161496118|NCT02291055|583211042|FG003|Overall Study|Progressive Disease|4|||
161496119|NCT02291055|583211043|FG004|Overall Study|Progressive Disease|2|||
161496120|NCT02291055|583211039|FG000|Overall Study|Study Terminated by Sponsor|0|||
161496121|NCT02291055|583211040|FG001|Overall Study|Study Terminated by Sponsor|0|||
161496122|NCT02291055|583211041|FG002|Overall Study|Study Terminated by Sponsor|0|||
161496123|NCT02291055|583211042|FG003|Overall Study|Study Terminated by Sponsor|5|||
161496124|NCT02291055|583211043|FG004|Overall Study|Study Terminated by Sponsor|1|||
161496125|NCT02291055|583211039|FG000|Overall Study|Other|0|||
161496126|NCT02291055|583211040|FG001|Overall Study|Other|2|||
161496127|NCT02291055|583211041|FG002|Overall Study|Other|1|||
161496128|NCT02291055|583211042|FG003|Overall Study|Other|4|||
161496129|NCT02291055|583211043|FG004|Overall Study|Other|0|||
161496130|NCT01173718|583211056|FG000|Overall Study|Death|17|||
161496131|NCT01173718|583211056|FG000|Overall Study|Abandonment of study graft|27|||
161496132|NCT02113956|583211057|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
161496133|NCT02113956|583211058|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
161496134|NCT02113956|583211057|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
161496135|NCT02113956|583211058|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
161496136|NCT02113956|583211057|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
161496137|NCT02113956|583211058|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
161496138|NCT01499563|583211061|FG000|Overall Study|Withdrawal by Subject|10|||
161496139|NCT01499563|583211062|FG001|Overall Study|Withdrawal by Subject|11|||
161496140|NCT01499563|583211063|FG002|Overall Study|Withdrawal by Subject|7|||
161496141|NCT01499563|583211064|FG003|Overall Study|Withdrawal by Subject|8|||
161496142|NCT01499563|583211061|FG000|Overall Study|Physician Decision|2|||
161496143|NCT01499563|583211062|FG001|Overall Study|Physician Decision|1|||
161496144|NCT01499563|583211063|FG002|Overall Study|Physician Decision|3|||
161496145|NCT01499563|583211064|FG003|Overall Study|Physician Decision|0|||
161496146|NCT01499563|583211061|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
161818311|NCT03827395|584376035|FG000|Overall Study|Protocol Violation|1|||
161818312|NCT03827395|584376036|FG001|Overall Study|Protocol Violation|0|||
161818313|NCT03827395|584376035|FG000|Overall Study|Became ineligible after enrollment|1|||
161818314|NCT03827395|584376036|FG001|Overall Study|Became ineligible after enrollment|2|||
161496147|NCT01499563|583211062|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
161496148|NCT01499563|583211063|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
161496149|NCT01499563|583211064|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
161496150|NCT01499563|583211061|FG000|Overall Study|Adverse Event|2|||
161818315|NCT01370083|584376037|FG000|Overall Study|Lost to Follow-up|2|||
161818316|NCT01370083|584376038|FG001|Overall Study|Lost to Follow-up|0|||
161818317|NCT01370083|584376037|FG000|Overall Study|Adverse Event|0|||
161818318|NCT01370083|584376038|FG001|Overall Study|Adverse Event|1|||
161818319|NCT02450539|584376041|FG000|Overall Study|Withdrawal by Subject|12|||
161818320|NCT02450539|584376042|FG001|Overall Study|Withdrawal by Subject|6|||
161818321|NCT02450539|584376041|FG000|Overall Study|Lost to Follow-up|4|||
161818322|NCT02450539|584376042|FG001|Overall Study|Lost to Follow-up|1|||
161818323|NCT00585286|584376043|FG000|Overall Study|Lost to Follow-up|1|||
161818324|NCT03358147|584376045|FG000|Overall Study|Withdrawal by Subject|13|||
161818325|NCT03358147|584376046|FG001|Overall Study|Withdrawal by Subject|19|||
161818326|NCT03358147|584376047|FG002|Overall Study|Withdrawal by Subject|16|||
161818327|NCT03358147|584376048|FG003|Overall Study|Withdrawal by Subject|10|||
161818328|NCT03358147|584376049|FG004|Overall Study|Withdrawal by Subject|5|||
161818329|NCT03358147|584376045|FG000|Overall Study|Adverse Event|3|||
161818330|NCT03358147|584376046|FG001|Overall Study|Adverse Event|9|||
161818331|NCT03358147|584376047|FG002|Overall Study|Adverse Event|7|||
161818332|NCT03358147|584376048|FG003|Overall Study|Adverse Event|5|||
161818333|NCT03358147|584376049|FG004|Overall Study|Adverse Event|2|||
161818334|NCT03358147|584376045|FG000|Overall Study|Lost to Follow-up|4|||
161818335|NCT03358147|584376046|FG001|Overall Study|Lost to Follow-up|3|||
161818336|NCT03358147|584376047|FG002|Overall Study|Lost to Follow-up|7|||
161818337|NCT03358147|584376048|FG003|Overall Study|Lost to Follow-up|6|||
161818338|NCT03358147|584376049|FG004|Overall Study|Lost to Follow-up|4|||
161818339|NCT03358147|584376045|FG000|Overall Study|Major Protocol Deviation|11|||
161818340|NCT03358147|584376046|FG001|Overall Study|Major Protocol Deviation|3|||
161818341|NCT03358147|584376047|FG002|Overall Study|Major Protocol Deviation|2|||
161818342|NCT03358147|584376048|FG003|Overall Study|Major Protocol Deviation|3|||
161818343|NCT03358147|584376049|FG004|Overall Study|Major Protocol Deviation|1|||
161818344|NCT03358147|584376045|FG000|Overall Study|Protocol specified criteria|2|||
161818345|NCT03358147|584376046|FG001|Overall Study|Protocol specified criteria|3|||
161818346|NCT03358147|584376047|FG002|Overall Study|Protocol specified criteria|0|||
161818347|NCT03358147|584376048|FG003|Overall Study|Protocol specified criteria|3|||
161818348|NCT03358147|584376049|FG004|Overall Study|Protocol specified criteria|1|||
161818349|NCT03358147|584376045|FG000|Overall Study|Physician Decision|1|||
161818350|NCT03358147|584376046|FG001|Overall Study|Physician Decision|0|||
161818351|NCT03358147|584376047|FG002|Overall Study|Physician Decision|1|||
161496151|NCT01499563|583211062|FG001|Overall Study|Adverse Event|0|||
161496152|NCT01499563|583211063|FG002|Overall Study|Adverse Event|1|||
161496153|NCT01499563|583211064|FG003|Overall Study|Adverse Event|3|||
161818352|NCT03358147|584376048|FG003|Overall Study|Physician Decision|6|||
161818353|NCT03358147|584376049|FG004|Overall Study|Physician Decision|1|||
161818354|NCT03358147|584376045|FG000|Overall Study|Administrative reasons|0|||
161818355|NCT03358147|584376046|FG001|Overall Study|Administrative reasons|1|||
161818356|NCT03358147|584376047|FG002|Overall Study|Administrative reasons|0|||
161496154|NCT01499563|583211061|FG000|Overall Study|Lack of Efficacy|0|||
161818357|NCT03358147|584376048|FG003|Overall Study|Administrative reasons|3|||
161818358|NCT03358147|584376049|FG004|Overall Study|Administrative reasons|0|||
161818359|NCT03358147|584376045|FG000|Overall Study|Lack of Efficacy|0|||
161818360|NCT03358147|584376046|FG001|Overall Study|Lack of Efficacy|1|||
161818361|NCT03358147|584376047|FG002|Overall Study|Lack of Efficacy|1|||
161818362|NCT03358147|584376048|FG003|Overall Study|Lack of Efficacy|0|||
161818363|NCT03358147|584376049|FG004|Overall Study|Lack of Efficacy|0|||
161818364|NCT03236311|584376050|FG000|Overall Study|Study terminated by sponsor|0|||
161496155|NCT01499563|583211062|FG001|Overall Study|Lack of Efficacy|1|||
161496156|NCT01499563|583211063|FG002|Overall Study|Lack of Efficacy|6|||
161496157|NCT01499563|583211064|FG003|Overall Study|Lack of Efficacy|3|||
161496158|NCT01499563|583211061|FG000|Overall Study|Other|8|||
161496159|NCT01499563|583211062|FG001|Overall Study|Other|6|||
161496160|NCT01499563|583211063|FG002|Overall Study|Other|6|||
161496161|NCT01499563|583211064|FG003|Overall Study|Other|4|||
161496162|NCT03658538|583211065|FG000|Overall Study|Death|2|||
161496163|NCT03658538|583211066|FG001|Overall Study|Death|1|||
161496164|NCT03658538|583211065|FG000|Overall Study|Cancer diagnosis|1|||
161496165|NCT03658538|583211066|FG001|Overall Study|Cancer diagnosis|0|||
161496166|NCT03658538|583211065|FG000|Overall Study|Change residence|1|||
161496167|NCT03658538|583211066|FG001|Overall Study|Change residence|2|||
161496168|NCT03658538|583211065|FG000|Overall Study|Lost to Follow-up|3|||
161496169|NCT03658538|583211066|FG001|Overall Study|Lost to Follow-up|3|||
161496170|NCT03658538|583211065|FG000|Overall Study|Unblinded|2|||
161496171|NCT03658538|583211066|FG001|Overall Study|Unblinded|3|||
161496172|NCT03658538|583211065|FG000|Overall Study|Physician Decision|0|||
161496173|NCT03658538|583211066|FG001|Overall Study|Physician Decision|1|||
161924343|NCT00266812|584769645|FG000|Overall Study|Protocol Violation|0|||
161924344|NCT00266812|584769646|FG001|Overall Study|Protocol Violation|1|||
161924345|NCT00266812|584769645|FG000|Overall Study|Withdrawal by Subject|0|||
161924346|NCT00266812|584769646|FG001|Overall Study|Withdrawal by Subject|2|||
161496174|NCT03658538|583211065|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
161496175|NCT03658538|583211066|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
161496176|NCT03658538|583211065|FG000|Overall Study|Evicted from home|1|||
161496177|NCT03658538|583211066|FG001|Overall Study|Evicted from home|0|||
161496178|NCT02738151|583211068|FG000|Overall Study|Randomized but not treated|4|||
161496179|NCT02738151|583211069|FG001|Overall Study|Randomized but not treated|1|||
161496180|NCT02738151|583211068|FG000|Overall Study|Adverse Event|4|||
161496181|NCT02738151|583211069|FG001|Overall Study|Adverse Event|5|||
161496182|NCT02738151|583211068|FG000|Overall Study|Hypoglycemia|0|||
161496183|NCT02738151|583211069|FG001|Overall Study|Hypoglycemia|1|||
161496184|NCT02738151|583211068|FG000|Overall Study|Poor Compliance to Protocol|4|||
161496185|NCT02738151|583211069|FG001|Overall Study|Poor Compliance to Protocol|3|||
161496186|NCT02738151|583211068|FG000|Overall Study|Other than specified above|11|||
161496187|NCT02738151|583211069|FG001|Overall Study|Other than specified above|21|||
161496188|NCT03333044|583211073|FG000|Overall Study|Pregnancy|1|||
161496189|NCT03333044|583211074|FG001|Overall Study|Pregnancy|0|||
161496190|NCT03333044|583211075|FG002|Overall Study|Pregnancy|0|||
161496191|NCT03333044|583211073|FG000|Overall Study|Lost to Follow-up|0|||
161496192|NCT03333044|583211074|FG001|Overall Study|Lost to Follow-up|14|||
161496193|NCT03333044|583211075|FG002|Overall Study|Lost to Follow-up|6|||
161496194|NCT04537234|583211079|FG000|Overall Study|Withdrawal by Subject|2|||
161496195|NCT04537234|583211080|FG001|Overall Study|Withdrawal by Subject|0|||
161496196|NCT02926924|583213972|FG000|Overall Study|withdrawal - reason unknown|0|||
161496197|NCT02926924|583213973|FG001|Overall Study|withdrawal - reason unknown|1|||
161496198|NCT00939809|583213978|FG000|Overall Study|Adverse Event|2|||
161496199|NCT00939809|583213978|FG000|Overall Study|Death|1|||
161496200|NCT01921179|583213979|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
161496201|NCT01921179|583213980|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
161496202|NCT01921179|583213979|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
161496203|NCT01921179|583213980|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
161496204|NCT02603809|583213982|FG000|Overall Study|Withdrawal by Subject|4|||
161496205|NCT02603809|583213983|FG001|Overall Study|Withdrawal by Subject|1|||
161496206|NCT02603809|583213984|FG002|Overall Study|Withdrawal by Subject|2|||
161496207|NCT02603809|583213985|FG003|Overall Study|Withdrawal by Subject|3|||
161496208|NCT02603809|583213986|FG004|Overall Study|Withdrawal by Subject|3|||
161496209|NCT02603809|583213987|FG005|Overall Study|Withdrawal by Subject|4|||
161496210|NCT02603809|583213982|FG000|Overall Study|Lost to Follow-up|2|||
161496211|NCT02603809|583213983|FG001|Overall Study|Lost to Follow-up|3|||
161496212|NCT02603809|583213984|FG002|Overall Study|Lost to Follow-up|1|||
161496213|NCT02603809|583213985|FG003|Overall Study|Lost to Follow-up|4|||
161496214|NCT02603809|583213986|FG004|Overall Study|Lost to Follow-up|2|||
161496215|NCT02603809|583213987|FG005|Overall Study|Lost to Follow-up|2|||
161496216|NCT02603809|583213982|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
161496217|NCT02603809|583213983|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
161496218|NCT02603809|583213984|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
161496219|NCT02603809|583213985|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
161496220|NCT02603809|583213986|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
161496221|NCT02603809|583213987|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
161924347|NCT00266812|584769645|FG000|Overall Study|Discontinued before starting study drug|4|||
161924348|NCT00266812|584769646|FG001|Overall Study|Discontinued before starting study drug|0|||
161496222|NCT02603809|583213982|FG000|Overall Study|Physician Decision|0|||
161496223|NCT02603809|583213983|FG001|Overall Study|Physician Decision|0|||
161496224|NCT02603809|583213984|FG002|Overall Study|Physician Decision|0|||
161496225|NCT02603809|583213985|FG003|Overall Study|Physician Decision|1|||
161818365|NCT03236311|584376051|FG001|Overall Study|Study terminated by sponsor|2|||
161818366|NCT03236311|584376050|FG000|Overall Study|Adverse Event|0|||
161818367|NCT03236311|584376051|FG001|Overall Study|Adverse Event|1|||
161818368|NCT00669162|584376052|FG000|Overall Study|Withdrawal by Subject|1|||
161818369|NCT02704091|584376053|FG000|Overall Study|Adverse Event|4|||
161818370|NCT02704091|584376054|FG001|Overall Study|Adverse Event|3|||
161818371|NCT02704091|584376053|FG000|Overall Study|Protocol Violation|5|||
161818372|NCT02704091|584376054|FG001|Overall Study|Protocol Violation|3|||
161818373|NCT02704091|584376053|FG000|Overall Study|Consent withdrawn|4|||
161818374|NCT02704091|584376054|FG001|Overall Study|Consent withdrawn|4|||
161924349|NCT00416949|584769647|FG000|Overall Study|Patients refused to participate|5|||
161924350|NCT01137812|584769648|FG000|Overall Study|Adverse Event|21|||
161496226|NCT02603809|583213986|FG004|Overall Study|Physician Decision|2|||
161496227|NCT02603809|583213987|FG005|Overall Study|Physician Decision|1|||
161496228|NCT02603809|583213982|FG000|Overall Study|Adverse Event|3|||
161496229|NCT02603809|583213983|FG001|Overall Study|Adverse Event|0|||
161496230|NCT02603809|583213984|FG002|Overall Study|Adverse Event|2|||
161496231|NCT02603809|583213985|FG003|Overall Study|Adverse Event|2|||
161496232|NCT02603809|583213986|FG004|Overall Study|Adverse Event|1|||
161496233|NCT02603809|583213987|FG005|Overall Study|Adverse Event|1|||
161496234|NCT02603809|583213982|FG000|Overall Study|Lack of Efficacy|0|||
161496235|NCT02603809|583213983|FG001|Overall Study|Lack of Efficacy|1|||
161496236|NCT02603809|583213984|FG002|Overall Study|Lack of Efficacy|0|||
161496237|NCT02603809|583213985|FG003|Overall Study|Lack of Efficacy|0|||
161496238|NCT02603809|583213986|FG004|Overall Study|Lack of Efficacy|0|||
161496239|NCT02603809|583213987|FG005|Overall Study|Lack of Efficacy|1|||
161496240|NCT00380978|583213988|FG000|Overall Study|Refused allocated intervention|0|||
161496241|NCT00380978|583213989|FG001|Overall Study|Refused allocated intervention|6|||
161496242|NCT00380978|583213988|FG000|Overall Study|Wrong study envelope|0|||
161496243|NCT00380978|583213989|FG001|Overall Study|Wrong study envelope|2|||
161496244|NCT00380978|583213988|FG000|Overall Study|Allocation prior to analgesia request|1|||
161496245|NCT00380978|583213989|FG001|Overall Study|Allocation prior to analgesia request|2|||
161496246|NCT00380978|583213988|FG000|Overall Study|Parous patient|1|||
161496247|NCT00380978|583213989|FG001|Overall Study|Parous patient|0|||
161496248|NCT04146545|583213990|FG000|Overall Study|deemed ineligible after randomization|1|||
161496249|NCT04146545|583213991|FG001|Overall Study|deemed ineligible after randomization|0|||
161496250|NCT01254227|583213992|FG000|Overall Study|Withdrawal by Subject|6|||
161496251|NCT01254227|583213992|FG000|Overall Study|Lost to Follow-up|6|||
161496252|NCT01254227|583213992|FG000|Overall Study|Adverse Event|5|||
161496253|NCT01254227|583213992|FG000|Overall Study|Abnormal test procedure result|5|||
161496254|NCT01254227|583213992|FG000|Overall Study|Administrative problems|2|||
161496255|NCT01254227|583213992|FG000|Overall Study|Death|1|||
161496256|NCT01254227|583213992|FG000|Overall Study|Protocol deviation|1|||
161496257|NCT02750592|583213993|FG000|Overall Study|Adverse Event|3|||
161496258|NCT02750592|583213993|FG000|Overall Study|Lack of Efficacy|2|||
161496259|NCT02981342|583213994|FG000|Overall Study|Adverse Event|0|||
161496260|NCT02981342|583213995|FG001|Overall Study|Adverse Event|0|||
161496261|NCT02981342|583213996|FG002|Overall Study|Adverse Event|0|||
161496262|NCT02981342|583213997|FG003|Overall Study|Adverse Event|1|||
161496263|NCT02981342|583213994|FG000|Overall Study|Death|0|||
161496264|NCT02981342|583213995|FG001|Overall Study|Death|9|||
161496265|NCT02981342|583213996|FG002|Overall Study|Death|9|||
161496266|NCT02981342|583213997|FG003|Overall Study|Death|4|||
161496267|NCT02981342|583213994|FG000|Overall Study|Withdrawal by Subject|0|||
161496268|NCT02981342|583213995|FG001|Overall Study|Withdrawal by Subject|0|||
161496269|NCT02981342|583213996|FG002|Overall Study|Withdrawal by Subject|3|||
161496270|NCT02981342|583213997|FG003|Overall Study|Withdrawal by Subject|1|||
161496271|NCT02981342|583213994|FG000|Overall Study|Study closed by sponsor|0|||
161818375|NCT02704091|584376053|FG000|Overall Study|Lost to Follow-up|13|||
161818376|NCT02704091|584376054|FG001|Overall Study|Lost to Follow-up|5|||
161818377|NCT02704091|584376053|FG000|Overall Study|Other|2|||
161924351|NCT01137812|584769649|FG001|Overall Study|Adverse Event|14|||
161924352|NCT01137812|584769648|FG000|Overall Study|Lost to Follow-up|6|||
161924353|NCT01137812|584769649|FG001|Overall Study|Lost to Follow-up|8|||
161924354|NCT01137812|584769648|FG000|Overall Study|Physician Decision|25|||
161496272|NCT02981342|583213995|FG001|Overall Study|Study closed by sponsor|0|||
161496273|NCT02981342|583213996|FG002|Overall Study|Study closed by sponsor|1|||
161496274|NCT02981342|583213997|FG003|Overall Study|Study closed by sponsor|1|||
161496275|NCT02981342|583213994|FG000|Overall Study|Randomized, Never Treated|0|||
161496276|NCT02981342|583213995|FG001|Overall Study|Randomized, Never Treated|1|||
161496277|NCT02981342|583213996|FG002|Overall Study|Randomized, Never Treated|0|||
161496278|NCT02981342|583213997|FG003|Overall Study|Randomized, Never Treated|7|||
161496279|NCT02981342|583213994|FG000|Overall Study|Lost to Follow-up|0|||
161496280|NCT02981342|583213995|FG001|Overall Study|Lost to Follow-up|1|||
161496281|NCT02981342|583213996|FG002|Overall Study|Lost to Follow-up|0|||
161496282|NCT02981342|583213997|FG003|Overall Study|Lost to Follow-up|0|||
161818378|NCT02704091|584376054|FG001|Overall Study|Other|8|||
161818379|NCT02412852|584376055|FG000|Overall Study|Withdrawal by Subject|0|||
161924355|NCT01137812|584769649|FG001|Overall Study|Physician Decision|17|||
161496283|NCT01277523|583214002|FG000|Overall Study|Adverse Event|1|||
161496284|NCT01277523|583214003|FG001|Overall Study|Adverse Event|0|||
161496285|NCT01277523|583214004|FG002|Overall Study|Adverse Event|0|||
161496286|NCT01277523|583214002|FG000|Overall Study|Protocol Violation|2|||
161496287|NCT01277523|583214003|FG001|Overall Study|Protocol Violation|0|||
161496288|NCT01277523|583214004|FG002|Overall Study|Protocol Violation|0|||
161496289|NCT01277523|583214002|FG000|Overall Study|Other Reason not Defined|0|||
161496290|NCT01277523|583214003|FG001|Overall Study|Other Reason not Defined|1|||
161496291|NCT01277523|583214004|FG002|Overall Study|Other Reason not Defined|0|||
161496292|NCT00112502|583214005|FG000|Overall Study|Withdrawal by Subject|0|||
161496293|NCT00112502|583214006|FG001|Overall Study|Withdrawal by Subject|1|||
161496294|NCT00112502|583214007|FG002|Overall Study|Withdrawal by Subject|1|||
161496295|NCT00112502|583214008|FG003|Overall Study|Withdrawal by Subject|4|||
161496296|NCT00112502|583214009|FG004|Overall Study|Withdrawal by Subject|2|||
161496297|NCT00112502|583214010|FG005|Overall Study|Withdrawal by Subject|5|||
161496298|NCT00112502|583214011|FG006|Overall Study|Withdrawal by Subject|3|||
161496299|NCT00112502|583214012|FG007|Overall Study|Withdrawal by Subject|7|||
161496300|NCT02608268|583214013|FG000|Overall Study|Adverse Event|0|||
161496301|NCT02608268|583214014|FG001|Overall Study|Adverse Event|0|||
161496302|NCT02608268|583214015|FG002|Overall Study|Adverse Event|1|||
161496303|NCT02608268|583214016|FG003|Overall Study|Adverse Event|0|||
161496304|NCT02608268|583214017|FG004|Overall Study|Adverse Event|0|||
161496305|NCT02608268|583214018|FG005|Overall Study|Adverse Event|0|||
161496306|NCT02608268|583214019|FG006|Overall Study|Adverse Event|0|||
161496307|NCT02608268|583214020|FG007|Overall Study|Adverse Event|0|||
161496308|NCT02608268|583214021|FG008|Overall Study|Adverse Event|0|||
161496309|NCT02608268|583214022|FG009|Overall Study|Adverse Event|0|||
161496310|NCT02608268|583214023|FG010|Overall Study|Adverse Event|0|||
161496311|NCT02608268|583214024|FG011|Overall Study|Adverse Event|0|||
161496312|NCT02608268|583214025|FG012|Overall Study|Adverse Event|2|||
161496313|NCT02608268|583214026|FG013|Overall Study|Adverse Event|0|||
161496314|NCT02608268|583214027|FG014|Overall Study|Adverse Event|0|||
161924356|NCT01137812|584769648|FG000|Overall Study|Protocol Violation|5|||
161924357|NCT01137812|584769649|FG001|Overall Study|Protocol Violation|4|||
161924358|NCT01137812|584769648|FG000|Overall Study|Withdrawal by Subject|5|||
161924359|NCT01137812|584769649|FG001|Overall Study|Withdrawal by Subject|13|||
161924360|NCT01137812|584769648|FG000|Overall Study|Death|2|||
161924361|NCT01137812|584769649|FG001|Overall Study|Death|0|||
161924362|NCT01137812|584769648|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
161924363|NCT01137812|584769649|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
161924364|NCT01137812|584769648|FG000|Overall Study|Other|19|||
161924365|NCT01137812|584769649|FG001|Overall Study|Other|27|||
161924366|NCT03927157|584769650|FG000|Overall Study|Adverse Event|1|||
161924367|NCT03927157|584769651|FG001|Overall Study|Adverse Event|3|||
161496315|NCT02608268|583214028|FG015|Overall Study|Adverse Event|0|||
161496316|NCT02608268|583214029|FG016|Overall Study|Adverse Event|0|||
161496317|NCT02608268|583214030|FG017|Overall Study|Adverse Event|0|||
161496318|NCT02608268|583214031|FG018|Overall Study|Adverse Event|0|||
161496319|NCT02608268|583214032|FG019|Overall Study|Adverse Event|0|||
161496320|NCT02608268|583214033|FG020|Overall Study|Adverse Event|1|||
161496321|NCT02608268|583214034|FG021|Overall Study|Adverse Event|1|||
161496322|NCT02608268|583214035|FG022|Overall Study|Adverse Event|0|||
161496323|NCT02608268|583214036|FG023|Overall Study|Adverse Event|0|||
161496324|NCT02608268|583214037|FG024|Overall Study|Adverse Event|1|||
161496325|NCT02608268|583214038|FG025|Overall Study|Adverse Event|0|||
161496326|NCT02608268|583214039|FG026|Overall Study|Adverse Event|0|||
161496327|NCT02608268|583214040|FG027|Overall Study|Adverse Event|0|||
161818380|NCT02412852|584376056|FG001|Overall Study|Withdrawal by Subject|1|||
161818381|NCT02412852|584376057|FG002|Overall Study|Withdrawal by Subject|0|||
161496328|NCT02608268|583214041|FG028|Overall Study|Adverse Event|1|||
161496329|NCT02608268|583214042|FG029|Overall Study|Adverse Event|0|||
161496330|NCT02608268|583214013|FG000|Overall Study|Death|1|||
161818382|NCT02412852|584376058|FG003|Overall Study|Withdrawal by Subject|0|||
161818383|NCT02412852|584376055|FG000|Overall Study|Physician Decision|0|||
161818384|NCT02412852|584376056|FG001|Overall Study|Physician Decision|0|||
161818385|NCT02412852|584376057|FG002|Overall Study|Physician Decision|0|||
161818386|NCT02412852|584376058|FG003|Overall Study|Physician Decision|1|||
161818387|NCT01051349|584376059|FG000|Overall Study|Adverse Event|88|||
161818388|NCT01051349|584376059|FG000|Overall Study|Consent Withdrawn|54|||
161818389|NCT01051349|584376059|FG000|Overall Study|Investigator Decision|6|||
161818390|NCT01051349|584376059|FG000|Overall Study|Lost to Follow-up|6|||
161818391|NCT01051349|584376059|FG000|Overall Study|Subject non-compliance|7|||
161818392|NCT01051349|584376059|FG000|Overall Study|Reason not Specified|12|||
161496331|NCT02608268|583214014|FG001|Overall Study|Death|0|||
161818393|NCT00840203|584376062|FG000|First Intervention|Protocol Violation|1|||
161924368|NCT03927157|584769650|FG000|Overall Study|Protocol Violation|1|||
161924369|NCT03927157|584769651|FG001|Overall Study|Protocol Violation|2|||
161924370|NCT03927157|584769650|FG000|Overall Study|Withdrawal by Subject|8|||
161496332|NCT02608268|583214015|FG002|Overall Study|Death|0|||
161496333|NCT02608268|583214016|FG003|Overall Study|Death|0|||
161496334|NCT02608268|583214017|FG004|Overall Study|Death|0|||
161496335|NCT02608268|583214018|FG005|Overall Study|Death|0|||
161496336|NCT02608268|583214019|FG006|Overall Study|Death|0|||
161496337|NCT02608268|583214020|FG007|Overall Study|Death|0|||
161496338|NCT02608268|583214021|FG008|Overall Study|Death|1|||
161496339|NCT02608268|583214022|FG009|Overall Study|Death|1|||
161496340|NCT02608268|583214023|FG010|Overall Study|Death|0|||
161496341|NCT02608268|583214024|FG011|Overall Study|Death|0|||
161496342|NCT02608268|583214025|FG012|Overall Study|Death|0|||
161496343|NCT02608268|583214026|FG013|Overall Study|Death|0|||
161496344|NCT02608268|583214027|FG014|Overall Study|Death|0|||
161496345|NCT02608268|583214028|FG015|Overall Study|Death|1|||
161496346|NCT02608268|583214029|FG016|Overall Study|Death|0|||
161496347|NCT02608268|583214030|FG017|Overall Study|Death|1|||
161496348|NCT02608268|583214031|FG018|Overall Study|Death|0|||
161496349|NCT02608268|583214032|FG019|Overall Study|Death|1|||
161496350|NCT02608268|583214033|FG020|Overall Study|Death|1|||
161496351|NCT02608268|583214034|FG021|Overall Study|Death|0|||
161496352|NCT02608268|583214035|FG022|Overall Study|Death|0|||
161496353|NCT02608268|583214036|FG023|Overall Study|Death|0|||
161672376|NCT02684357|583853117|FG005|Part B|Adverse Event (Other)|1|||
161924371|NCT03927157|584769651|FG001|Overall Study|Withdrawal by Subject|21|||
161924372|NCT03927157|584769650|FG000|Overall Study|Due to COVID-19 pandemic|5|||
161924373|NCT03927157|584769651|FG001|Overall Study|Due to COVID-19 pandemic|2|||
161924374|NCT03927157|584769650|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
161924375|NCT03927157|584769651|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
161924376|NCT03927157|584769650|FG000|Overall Study|Other than above|0|||
161924377|NCT03927157|584769651|FG001|Overall Study|Other than above|1|||
161924378|NCT05558410|584769652|FG000|Overall Study|Adverse Event|1|||
161924379|NCT05558410|584769653|FG001|Overall Study|Adverse Event|2|||
161924380|NCT05558410|584769654|FG002|Overall Study|Adverse Event|0|||
161924381|NCT05558410|584769652|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
161924382|NCT05558410|584769653|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161924383|NCT05558410|584769654|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
161672377|NCT02684357|583853112|FG000|Part B|Lost to Follow-up|0|||
161672378|NCT02684357|583853113|FG001|Part B|Lost to Follow-up|0|||
161672379|NCT02684357|583853114|FG002|Part B|Lost to Follow-up|0|||
161672380|NCT02684357|583853115|FG003|Part B|Lost to Follow-up|1|||
161672381|NCT02684357|583853116|FG004|Part B|Lost to Follow-up|1|||
161672382|NCT02684357|583853117|FG005|Part B|Lost to Follow-up|7|||
161672383|NCT02684357|583853112|FG000|Part B|Withdrawal by Subject|0|||
161672384|NCT02684357|583853113|FG001|Part B|Withdrawal by Subject|0|||
161672385|NCT02684357|583853114|FG002|Part B|Withdrawal by Subject|0|||
161672386|NCT02684357|583853115|FG003|Part B|Withdrawal by Subject|0|||
161672387|NCT02684357|583853116|FG004|Part B|Withdrawal by Subject|2|||
161672388|NCT02684357|583853117|FG005|Part B|Withdrawal by Subject|4|||
161672389|NCT02684357|583853112|FG000|Part B|Other|0|||
161672390|NCT02684357|583853113|FG001|Part B|Other|0|||
161672391|NCT02684357|583853114|FG002|Part B|Other|0|||
161672392|NCT02684357|583853115|FG003|Part B|Other|1|||
161672393|NCT02684357|583853116|FG004|Part B|Other|0|||
161672394|NCT02684357|583853117|FG005|Part B|Other|1|||
161672395|NCT01853982|583853118|FG000|Overall Study|Withdrawal by Subject|1|||
161672396|NCT01853982|583853119|FG001|Overall Study|Withdrawal by Subject|0|||
161672397|NCT01853982|583853118|FG000|Overall Study|Death|1|||
161672398|NCT01853982|583853119|FG001|Overall Study|Death|0|||
161672399|NCT01853982|583853118|FG000|Overall Study|Lost to Follow-up|0|||
161672400|NCT01853982|583853119|FG001|Overall Study|Lost to Follow-up|1|||
161672401|NCT00390910|583853120|FG000|Overall Study|Adverse Event|1|||
161924384|NCT05558410|584769652|FG000|Overall Study|Lost to Follow-up|10|||
161924385|NCT05558410|584769653|FG001|Overall Study|Lost to Follow-up|17|||
161496354|NCT02608268|583214037|FG024|Overall Study|Death|1|||
161496355|NCT02608268|583214038|FG025|Overall Study|Death|2|||
161496356|NCT02608268|583214039|FG026|Overall Study|Death|0|||
161496357|NCT02608268|583214040|FG027|Overall Study|Death|1|||
161496358|NCT02608268|583214041|FG028|Overall Study|Death|4|||
161496359|NCT02608268|583214042|FG029|Overall Study|Death|0|||
161496360|NCT02608268|583214013|FG000|Overall Study|Physician Decision|0|||
161496361|NCT02608268|583214014|FG001|Overall Study|Physician Decision|0|||
161496362|NCT02608268|583214015|FG002|Overall Study|Physician Decision|0|||
161496363|NCT02608268|583214016|FG003|Overall Study|Physician Decision|0|||
161672402|NCT00390910|583853121|FG001|Overall Study|Adverse Event|0|||
161496364|NCT02608268|583214017|FG004|Overall Study|Physician Decision|0|||
161496365|NCT02608268|583214018|FG005|Overall Study|Physician Decision|0|||
161496366|NCT02608268|583214019|FG006|Overall Study|Physician Decision|0|||
161672403|NCT00390910|583853122|FG002|Overall Study|Adverse Event|0|||
161672404|NCT00390910|583853120|FG000|Overall Study|Lost to Follow-up|0|||
161672405|NCT00390910|583853121|FG001|Overall Study|Lost to Follow-up|1|||
161672406|NCT00390910|583853122|FG002|Overall Study|Lost to Follow-up|5|||
161672407|NCT00390910|583853120|FG000|Overall Study|Withdrawal by Subject|1|||
161672408|NCT00390910|583853121|FG001|Overall Study|Withdrawal by Subject|3|||
161585116|NCT03857620|583529836|FG001|Overall Study|Surgery not performed, patient decision|3|||
161585117|NCT03857620|583529837|FG002|Overall Study|Surgery not performed, patient decision|1|||
161585118|NCT03857620|583529835|FG000|Overall Study|Surgery not performed, other reason|3|||
161585119|NCT03857620|583529836|FG001|Overall Study|Surgery not performed, other reason|1|||
161585120|NCT03857620|583529837|FG002|Overall Study|Surgery not performed, other reason|4|||
161585121|NCT03857620|583529835|FG000|Overall Study|Worsening performance status after surgery performed|0|||
161585122|NCT03857620|583529836|FG001|Overall Study|Worsening performance status after surgery performed|1|||
161585123|NCT03857620|583529837|FG002|Overall Study|Worsening performance status after surgery performed|1|||
161585124|NCT05952076|583529838|FG000|Overall Study|Death|1|||
161585125|NCT05952076|583529839|FG001|Overall Study|Death|1|||
161585126|NCT05952076|583529838|FG000|Overall Study|Lost to Follow-up|0|||
161585127|NCT05952076|583529839|FG001|Overall Study|Lost to Follow-up|1|||
161585128|NCT04905407|583529840|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
161585129|NCT04905407|583529841|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
161585130|NCT04905407|583529842|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
161585131|NCT04905407|583529843|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
161924386|NCT05558410|584769654|FG002|Overall Study|Lost to Follow-up|19|||
161924387|NCT05558410|584769652|FG000|Overall Study|Death|1|||
161924388|NCT05558410|584769653|FG001|Overall Study|Death|0|||
161924389|NCT05558410|584769654|FG002|Overall Study|Death|0|||
161924390|NCT05558410|584769652|FG000|Overall Study|Other non-compliance|0|||
161924391|NCT05558410|584769653|FG001|Overall Study|Other non-compliance|1|||
161924392|NCT05558410|584769654|FG002|Overall Study|Other non-compliance|2|||
161924393|NCT05558410|584769652|FG000|Overall Study|Sponsor Decision|1|||
161924394|NCT05558410|584769653|FG001|Overall Study|Sponsor Decision|0|||
161924395|NCT05558410|584769654|FG002|Overall Study|Sponsor Decision|0|||
161924396|NCT05558410|584769652|FG000|Overall Study|Other|1|||
161924397|NCT05558410|584769653|FG001|Overall Study|Other|0|||
161924398|NCT05558410|584769654|FG002|Overall Study|Other|1|||
161924399|NCT02265744|584769657|FG000|Overall Study|Poor/Non-compliance|1|||
161924400|NCT02265744|584769658|FG001|Overall Study|Poor/Non-compliance|1|||
161924401|NCT02265744|584769659|FG002|Overall Study|Poor/Non-compliance|0|||
161924402|NCT02265744|584769660|FG003|Overall Study|Poor/Non-compliance|0|||
161924403|NCT02265744|584769661|FG004|Overall Study|Poor/Non-compliance|2|||
161924404|NCT02265744|584769657|FG000|Overall Study|Lost to Follow-up|0|||
161924405|NCT02265744|584769658|FG001|Overall Study|Lost to Follow-up|0|||
161924406|NCT02265744|584769659|FG002|Overall Study|Lost to Follow-up|0|||
161924407|NCT02265744|584769660|FG003|Overall Study|Lost to Follow-up|1|||
161585132|NCT04905407|583529840|FG000|Part 1 and Part 2|Death|7|||
161585133|NCT04905407|583529841|FG001|Part 1 and Part 2|Death|7|||
161585134|NCT04905407|583529842|FG002|Part 1 and Part 2|Death|7|||
161672409|NCT00390910|583853122|FG002|Overall Study|Withdrawal by Subject|2|||
161672410|NCT00390910|583853120|FG000|Overall Study|Migrated/moved from study area|0|||
161672411|NCT00390910|583853121|FG001|Overall Study|Migrated/moved from study area|0|||
161672412|NCT00390910|583853122|FG002|Overall Study|Migrated/moved from study area|3|||
161672413|NCT05066724|583853124|FG000|Overall Study|Adverse Event|1|||
161672414|NCT05066724|583853124|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161672415|NCT05066724|583853124|FG000|Overall Study|Withdrawal by Subject|6|||
161672416|NCT05066724|583853124|FG000|Overall Study|Physician Decision|2|||
161672417|NCT01422850|583853125|FG000|Overall Study|Physician Decision|3|||
161585135|NCT04905407|583529843|FG003|Part 1 and Part 2|Death|0|||
161585136|NCT04905407|583529840|FG000|Part 1 and Part 2|Other than specified|0|||
161585137|NCT04905407|583529841|FG001|Part 1 and Part 2|Other than specified|0|||
161585138|NCT04905407|583529842|FG002|Part 1 and Part 2|Other than specified|1|||
161585139|NCT04905407|583529843|FG003|Part 1 and Part 2|Other than specified|0|||
161672418|NCT02244996|583853127|FG000|Overall Study|Lack of Efficacy|2|||
161672419|NCT02244996|583853128|FG001|Overall Study|Lack of Efficacy|6|||
161672420|NCT03602261|583853131|FG000|Overall Study|Adverse Event|5|||
161672421|NCT03602261|583853132|FG001|Overall Study|Adverse Event|1|||
161672422|NCT03602261|583853131|FG000|Overall Study|Physician Decision|1|||
161672423|NCT03602261|583853132|FG001|Overall Study|Physician Decision|0|||
161672424|NCT03602261|583853131|FG000|Overall Study|Withdrawal by Subject|1|||
161924408|NCT02265744|584769661|FG004|Overall Study|Lost to Follow-up|0|||
161924409|NCT02265744|584769657|FG000|Overall Study|Death|0|||
161585140|NCT04905407|583529840|FG000|Part 3|Death|0|||
161585141|NCT04905407|583529841|FG001|Part 3|Death|0|||
161585142|NCT04905407|583529842|FG002|Part 3|Death|0|||
161585143|NCT04905407|583529843|FG003|Part 3|Death|2|||
161585144|NCT00150813|583529846|FG000|Overall Study|Adverse Event|1|||
161672425|NCT03602261|583853132|FG001|Overall Study|Withdrawal by Subject|1|||
161672426|NCT03602261|583853131|FG000|Overall Study|Lack of Efficacy|0|||
161672427|NCT03602261|583853132|FG001|Overall Study|Lack of Efficacy|1|||
161924410|NCT02265744|584769658|FG001|Overall Study|Death|0|||
161924411|NCT02265744|584769659|FG002|Overall Study|Death|0|||
161924412|NCT02265744|584769660|FG003|Overall Study|Death|2|||
161585145|NCT00150813|583529846|FG000|Overall Study|Lack of Efficacy|1|||
161585146|NCT00150813|583529846|FG000|Overall Study|Lost to Follow-up|5|||
161924413|NCT02265744|584769661|FG004|Overall Study|Death|0|||
161496367|NCT02608268|583214020|FG007|Overall Study|Physician Decision|0|||
161496368|NCT02608268|583214021|FG008|Overall Study|Physician Decision|0|||
161496369|NCT02608268|583214022|FG009|Overall Study|Physician Decision|0|||
161496370|NCT02608268|583214023|FG010|Overall Study|Physician Decision|1|||
161496371|NCT02608268|583214024|FG011|Overall Study|Physician Decision|0|||
161496372|NCT02608268|583214025|FG012|Overall Study|Physician Decision|0|||
161496373|NCT02608268|583214026|FG013|Overall Study|Physician Decision|1|||
161496374|NCT02608268|583214027|FG014|Overall Study|Physician Decision|0|||
161496375|NCT02608268|583214028|FG015|Overall Study|Physician Decision|0|||
161496376|NCT02608268|583214029|FG016|Overall Study|Physician Decision|0|||
161818394|NCT00840203|584376063|FG001|First Intervention|Protocol Violation|1|||
161818395|NCT00840203|584376062|FG000|Washout|Protocol Violation|1|||
161818396|NCT00840203|584376063|FG001|Washout|Protocol Violation|0|||
161818397|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
161818398|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
161818399|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
161818400|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
161818401|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
161818402|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
161818403|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
161818404|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
161818405|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
161818406|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
161818407|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
161818408|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
161818409|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
161818410|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
161818411|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
161818412|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
161496377|NCT02608268|583214030|FG017|Overall Study|Physician Decision|0|||
161496378|NCT02608268|583214031|FG018|Overall Study|Physician Decision|0|||
161496379|NCT02608268|583214032|FG019|Overall Study|Physician Decision|0|||
161496380|NCT02608268|583214033|FG020|Overall Study|Physician Decision|0|||
161496381|NCT02608268|583214034|FG021|Overall Study|Physician Decision|0|||
161818413|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
161496382|NCT02608268|583214035|FG022|Overall Study|Physician Decision|1|||
161496383|NCT02608268|583214036|FG023|Overall Study|Physician Decision|1|||
161496384|NCT02608268|583214037|FG024|Overall Study|Physician Decision|1|||
161496385|NCT02608268|583214038|FG025|Overall Study|Physician Decision|0|||
161496386|NCT02608268|583214039|FG026|Overall Study|Physician Decision|0|||
161496387|NCT02608268|583214040|FG027|Overall Study|Physician Decision|2|||
161496388|NCT02608268|583214041|FG028|Overall Study|Physician Decision|1|||
161496389|NCT02608268|583214042|FG029|Overall Study|Physician Decision|1|||
161496390|NCT02608268|583214013|FG000|Overall Study|Progressive disease|12|||
161496391|NCT02608268|583214014|FG001|Overall Study|Progressive disease|8|||
161496392|NCT02608268|583214015|FG002|Overall Study|Progressive disease|13|||
161496393|NCT02608268|583214016|FG003|Overall Study|Progressive disease|5|||
161496394|NCT02608268|583214017|FG004|Overall Study|Progressive disease|2|||
161496395|NCT02608268|583214018|FG005|Overall Study|Progressive disease|4|||
161496396|NCT02608268|583214019|FG006|Overall Study|Progressive disease|6|||
161496397|NCT02608268|583214020|FG007|Overall Study|Progressive disease|2|||
161496398|NCT02608268|583214021|FG008|Overall Study|Progressive disease|5|||
161496399|NCT02608268|583214022|FG009|Overall Study|Progressive disease|6|||
161496400|NCT02608268|583214023|FG010|Overall Study|Progressive disease|5|||
161496401|NCT02608268|583214024|FG011|Overall Study|Progressive disease|5|||
161496402|NCT02608268|583214025|FG012|Overall Study|Progressive disease|4|||
161496403|NCT02608268|583214026|FG013|Overall Study|Progressive disease|11|||
161496404|NCT02608268|583214027|FG014|Overall Study|Progressive disease|6|||
161496405|NCT02608268|583214028|FG015|Overall Study|Progressive disease|3|||
161496406|NCT02608268|583214029|FG016|Overall Study|Progressive disease|5|||
161496407|NCT02608268|583214030|FG017|Overall Study|Progressive disease|5|||
161496408|NCT02608268|583214031|FG018|Overall Study|Progressive disease|5|||
161496409|NCT02608268|583214032|FG019|Overall Study|Progressive disease|2|||
161496410|NCT02608268|583214033|FG020|Overall Study|Progressive disease|10|||
161496411|NCT02608268|583214034|FG021|Overall Study|Progressive disease|4|||
161496412|NCT02608268|583214035|FG022|Overall Study|Progressive disease|5|||
161496413|NCT02608268|583214036|FG023|Overall Study|Progressive disease|5|||
161496414|NCT02608268|583214037|FG024|Overall Study|Progressive disease|3|||
161496415|NCT02608268|583214038|FG025|Overall Study|Progressive disease|11|||
161496416|NCT02608268|583214039|FG026|Overall Study|Progressive disease|16|||
161496417|NCT02608268|583214040|FG027|Overall Study|Progressive disease|11|||
161496418|NCT02608268|583214041|FG028|Overall Study|Progressive disease|10|||
161496419|NCT02608268|583214042|FG029|Overall Study|Progressive disease|15|||
161496420|NCT02608268|583214013|FG000|Overall Study|Subject/guardian decision|1|||
161496421|NCT02608268|583214014|FG001|Overall Study|Subject/guardian decision|1|||
161496422|NCT02608268|583214015|FG002|Overall Study|Subject/guardian decision|2|||
161496423|NCT02608268|583214016|FG003|Overall Study|Subject/guardian decision|0|||
161924414|NCT02265744|584769657|FG000|Overall Study|Withdrawal by Subject|2|||
161924415|NCT02265744|584769658|FG001|Overall Study|Withdrawal by Subject|0|||
161924416|NCT02265744|584769659|FG002|Overall Study|Withdrawal by Subject|0|||
161924417|NCT02265744|584769660|FG003|Overall Study|Withdrawal by Subject|2|||
161924418|NCT02265744|584769661|FG004|Overall Study|Withdrawal by Subject|0|||
161924419|NCT02265744|584769657|FG000|Overall Study|Participant request to discontinue|2|||
161924420|NCT02265744|584769658|FG001|Overall Study|Participant request to discontinue|2|||
161924421|NCT02265744|584769659|FG002|Overall Study|Participant request to discontinue|2|||
161924422|NCT02265744|584769660|FG003|Overall Study|Participant request to discontinue|0|||
161924423|NCT02265744|584769661|FG004|Overall Study|Participant request to discontinue|0|||
161924424|NCT02265744|584769657|FG000|Overall Study|Adverse Event|8|||
161924425|NCT02265744|584769658|FG001|Overall Study|Adverse Event|4|||
161924426|NCT02265744|584769659|FG002|Overall Study|Adverse Event|9|||
161924427|NCT02265744|584769660|FG003|Overall Study|Adverse Event|8|||
161924428|NCT02265744|584769661|FG004|Overall Study|Adverse Event|2|||
161924429|NCT02265744|584769657|FG000|Overall Study|Lack of Efficacy|2|||
161924430|NCT02265744|584769658|FG001|Overall Study|Lack of Efficacy|4|||
161924431|NCT02265744|584769659|FG002|Overall Study|Lack of Efficacy|3|||
161924432|NCT02265744|584769660|FG003|Overall Study|Lack of Efficacy|4|||
161924433|NCT02265744|584769661|FG004|Overall Study|Lack of Efficacy|5|||
161924434|NCT02265744|584769657|FG000|Overall Study|Reason not provided by Investigator|1|||
161924435|NCT02265744|584769658|FG001|Overall Study|Reason not provided by Investigator|0|||
161924436|NCT02265744|584769659|FG002|Overall Study|Reason not provided by Investigator|0|||
161924437|NCT02265744|584769660|FG003|Overall Study|Reason not provided by Investigator|2|||
161924438|NCT02265744|584769661|FG004|Overall Study|Reason not provided by Investigator|0|||
161924439|NCT02265744|584769657|FG000|Overall Study|Administrative reason by sponsor|3|||
161924440|NCT02265744|584769658|FG001|Overall Study|Administrative reason by sponsor|2|||
161924441|NCT02265744|584769659|FG002|Overall Study|Administrative reason by sponsor|2|||
161924442|NCT02265744|584769660|FG003|Overall Study|Administrative reason by sponsor|3|||
161924443|NCT02265744|584769661|FG004|Overall Study|Administrative reason by sponsor|3|||
161924444|NCT02265744|584769657|FG000|Overall Study|Subject no longer meets study criteria|0|||
161924445|NCT02265744|584769658|FG001|Overall Study|Subject no longer meets study criteria|0|||
161924446|NCT02265744|584769659|FG002|Overall Study|Subject no longer meets study criteria|0|||
161924447|NCT02265744|584769660|FG003|Overall Study|Subject no longer meets study criteria|0|||
161924448|NCT02265744|584769661|FG004|Overall Study|Subject no longer meets study criteria|1|||
161924449|NCT02265744|584769657|FG000|Overall Study|Pregnancy|1|||
161924450|NCT02265744|584769658|FG001|Overall Study|Pregnancy|2|||
161924451|NCT02265744|584769659|FG002|Overall Study|Pregnancy|1|||
161924452|NCT02265744|584769660|FG003|Overall Study|Pregnancy|1|||
161924453|NCT02265744|584769661|FG004|Overall Study|Pregnancy|0|||
161924454|NCT00923702|584769662|FG000|Overall Study|Ongoing enrollment|0|||
161924455|NCT00923702|584769663|FG001|Overall Study|Ongoing enrollment|0|||
161924456|NCT00923702|584769664|FG002|Overall Study|Ongoing enrollment|0|||
161924457|NCT00923702|584769665|FG003|Overall Study|Ongoing enrollment|0|||
161924458|NCT00923702|584769666|FG004|Overall Study|Ongoing enrollment|354|||
161924459|NCT05950906|584769670|FG000|Overall Study|Adverse Event|0|||
161924460|NCT05950906|584769671|FG001|Overall Study|Adverse Event|0|||
161924461|NCT05950906|584769672|FG002|Overall Study|Adverse Event|0|||
161924462|NCT05950906|584769673|FG003|Overall Study|Adverse Event|0|||
161924463|NCT05950906|584769674|FG004|Overall Study|Adverse Event|0|||
161924464|NCT05950906|584769675|FG005|Overall Study|Adverse Event|0|||
161924465|NCT05950906|584769676|FG006|Overall Study|Adverse Event|0|||
161924466|NCT05950906|584769677|FG007|Overall Study|Adverse Event|0|||
161924467|NCT05950906|584769678|FG008|Overall Study|Adverse Event|0|||
161924468|NCT05950906|584769679|FG009|Overall Study|Adverse Event|0|||
161924469|NCT05950906|584769680|FG010|Overall Study|Adverse Event|0|||
161924470|NCT05950906|584769681|FG011|Overall Study|Adverse Event|0|||
161924471|NCT05950906|584769682|FG012|Overall Study|Adverse Event|1|||
161924472|NCT05950906|584769683|FG013|Overall Study|Adverse Event|0|||
161924473|NCT05950906|584769670|FG000|Overall Study|Physician Decision|0|||
161924474|NCT05950906|584769671|FG001|Overall Study|Physician Decision|0|||
161924475|NCT05950906|584769672|FG002|Overall Study|Physician Decision|0|||
161924476|NCT05950906|584769673|FG003|Overall Study|Physician Decision|0|||
161924477|NCT05950906|584769674|FG004|Overall Study|Physician Decision|0|||
161924478|NCT05950906|584769675|FG005|Overall Study|Physician Decision|0|||
161924479|NCT05950906|584769676|FG006|Overall Study|Physician Decision|0|||
161924480|NCT05950906|584769677|FG007|Overall Study|Physician Decision|0|||
161924481|NCT05950906|584769678|FG008|Overall Study|Physician Decision|0|||
161924482|NCT05950906|584769679|FG009|Overall Study|Physician Decision|0|||
161924483|NCT05950906|584769680|FG010|Overall Study|Physician Decision|0|||
161924484|NCT05950906|584769681|FG011|Overall Study|Physician Decision|0|||
161924485|NCT05950906|584769682|FG012|Overall Study|Physician Decision|1|||
161924486|NCT05950906|584769683|FG013|Overall Study|Physician Decision|0|||
161924487|NCT02448043|584769684|FG000|Overall Study|Withdrawal by Subject|2|||
161924488|NCT02448043|584769685|FG001|Overall Study|Withdrawal by Subject|2|||
161924489|NCT02448043|584769684|FG000|Overall Study|Protocol Violation|1|||
161924490|NCT02448043|584769685|FG001|Overall Study|Protocol Violation|2|||
161496424|NCT02608268|583214017|FG004|Overall Study|Subject/guardian decision|0|||
161496425|NCT02608268|583214018|FG005|Overall Study|Subject/guardian decision|0|||
161496426|NCT02608268|583214019|FG006|Overall Study|Subject/guardian decision|0|||
161496427|NCT02608268|583214020|FG007|Overall Study|Subject/guardian decision|0|||
161496428|NCT02608268|583214021|FG008|Overall Study|Subject/guardian decision|2|||
161496429|NCT02608268|583214022|FG009|Overall Study|Subject/guardian decision|2|||
161924491|NCT03142750|584769686|FG000|Overall Study|Lost to Follow-up|4|||
161496430|NCT02608268|583214023|FG010|Overall Study|Subject/guardian decision|0|||
161496431|NCT02608268|583214024|FG011|Overall Study|Subject/guardian decision|1|||
161496432|NCT02608268|583214025|FG012|Overall Study|Subject/guardian decision|0|||
161496433|NCT02608268|583214026|FG013|Overall Study|Subject/guardian decision|1|||
161496434|NCT02608268|583214027|FG014|Overall Study|Subject/guardian decision|0|||
161496435|NCT02608268|583214028|FG015|Overall Study|Subject/guardian decision|1|||
161496436|NCT02608268|583214029|FG016|Overall Study|Subject/guardian decision|0|||
161496437|NCT02608268|583214030|FG017|Overall Study|Subject/guardian decision|0|||
161496438|NCT02608268|583214031|FG018|Overall Study|Subject/guardian decision|1|||
161496439|NCT02608268|583214032|FG019|Overall Study|Subject/guardian decision|0|||
161496440|NCT02608268|583214033|FG020|Overall Study|Subject/guardian decision|0|||
161496441|NCT02608268|583214034|FG021|Overall Study|Subject/guardian decision|0|||
161496442|NCT02608268|583214035|FG022|Overall Study|Subject/guardian decision|1|||
161496443|NCT02608268|583214036|FG023|Overall Study|Subject/guardian decision|0|||
161496444|NCT02608268|583214037|FG024|Overall Study|Subject/guardian decision|0|||
161496445|NCT02608268|583214038|FG025|Overall Study|Subject/guardian decision|1|||
161496446|NCT02608268|583214039|FG026|Overall Study|Subject/guardian decision|1|||
161496447|NCT02608268|583214040|FG027|Overall Study|Subject/guardian decision|1|||
161496448|NCT02608268|583214041|FG028|Overall Study|Subject/guardian decision|1|||
161496449|NCT02608268|583214042|FG029|Overall Study|Subject/guardian decision|0|||
161496450|NCT00265343|583214043|FG000|Overall Study|Adverse Event|10|||
161496451|NCT00265343|583214044|FG001|Overall Study|Adverse Event|7|||
161496452|NCT00265343|583214043|FG000|Overall Study|Withdrawal by Subject|3|||
161496453|NCT00265343|583214044|FG001|Overall Study|Withdrawal by Subject|9|||
161496454|NCT00265343|583214043|FG000|Overall Study|Other|8|||
161496455|NCT00265343|583214044|FG001|Overall Study|Other|3|||
161496456|NCT04762680|583214053|FG000|Phase 2|Adverse Event|0|||
161496457|NCT04762680|583214054|FG001|Phase 2|Adverse Event|1|||
161496458|NCT04762680|583214055|FG002|Phase 2|Adverse Event|0|||
161496459|NCT04762680|583214056|FG003|Phase 2|Adverse Event|0|||
161496460|NCT04762680|583214057|FG004|Phase 2|Adverse Event|0|||
161496461|NCT04762680|583214058|FG005|Phase 2|Adverse Event|0|||
161496462|NCT04762680|583214059|FG006|Phase 2|Adverse Event|0|||
161496463|NCT04762680|583214060|FG007|Phase 2|Adverse Event|0|||
161496464|NCT04762680|583214061|FG008|Phase 2|Adverse Event|0|||
161496465|NCT04762680|583214062|FG009|Phase 2|Adverse Event|0|||
161496466|NCT04762680|583214063|FG010|Phase 2|Adverse Event|0|||
161496467|NCT04762680|583214064|FG011|Phase 2|Adverse Event|0|||
161496468|NCT04762680|583214065|FG012|Phase 2|Adverse Event|0|||
161496469|NCT04762680|583214066|FG013|Phase 2|Adverse Event|0|||
161496470|NCT04762680|583214067|FG014|Phase 2|Adverse Event|0|||
161496471|NCT04762680|583214068|FG015|Phase 2|Adverse Event|0|||
161496472|NCT04762680|583214069|FG016|Phase 2|Adverse Event|0|||
161496473|NCT04762680|583214070|FG017|Phase 2|Adverse Event|0|||
161496474|NCT04762680|583214071|FG018|Phase 2|Adverse Event|0|||
161496475|NCT04762680|583214072|FG019|Phase 2|Adverse Event|0|||
161496476|NCT04762680|583214073|FG020|Phase 2|Adverse Event|0|||
161496477|NCT04762680|583214074|FG021|Phase 2|Adverse Event|0|||
161496478|NCT04762680|583214053|FG000|Phase 2|Protocol Violation|5|||
161496479|NCT04762680|583214054|FG001|Phase 2|Protocol Violation|5|||
161496480|NCT04762680|583214055|FG002|Phase 2|Protocol Violation|1|||
161496481|NCT04762680|583214056|FG003|Phase 2|Protocol Violation|0|||
161496482|NCT04762680|583214057|FG004|Phase 2|Protocol Violation|0|||
161496483|NCT04762680|583214058|FG005|Phase 2|Protocol Violation|0|||
161496484|NCT04762680|583214059|FG006|Phase 2|Protocol Violation|0|||
161496485|NCT04762680|583214060|FG007|Phase 2|Protocol Violation|0|||
161496486|NCT04762680|583214061|FG008|Phase 2|Protocol Violation|0|||
161496487|NCT04762680|583214062|FG009|Phase 2|Protocol Violation|0|||
161496488|NCT04762680|583214063|FG010|Phase 2|Protocol Violation|0|||
161496489|NCT04762680|583214064|FG011|Phase 2|Protocol Violation|0|||
161496490|NCT04762680|583214065|FG012|Phase 2|Protocol Violation|0|||
161496491|NCT04762680|583214066|FG013|Phase 2|Protocol Violation|0|||
161496492|NCT04762680|583214067|FG014|Phase 2|Protocol Violation|0|||
161496493|NCT04762680|583214068|FG015|Phase 2|Protocol Violation|0|||
161496494|NCT04762680|583214069|FG016|Phase 2|Protocol Violation|0|||
161496495|NCT04762680|583214070|FG017|Phase 2|Protocol Violation|0|||
161496496|NCT04762680|583214071|FG018|Phase 2|Protocol Violation|0|||
161496497|NCT04762680|583214072|FG019|Phase 2|Protocol Violation|0|||
161496498|NCT04762680|583214073|FG020|Phase 2|Protocol Violation|0|||
161496499|NCT04762680|583214074|FG021|Phase 2|Protocol Violation|0|||
161496500|NCT04762680|583214053|FG000|Phase 2|Withdrawal by Subject|23|||
161496501|NCT04762680|583214054|FG001|Phase 2|Withdrawal by Subject|21|||
161496502|NCT04762680|583214055|FG002|Phase 2|Withdrawal by Subject|28|||
161496503|NCT04762680|583214056|FG003|Phase 2|Withdrawal by Subject|0|||
161496504|NCT04762680|583214057|FG004|Phase 2|Withdrawal by Subject|0|||
161496505|NCT04762680|583214058|FG005|Phase 2|Withdrawal by Subject|0|||
161496506|NCT04762680|583214059|FG006|Phase 2|Withdrawal by Subject|0|||
161496507|NCT04762680|583214060|FG007|Phase 2|Withdrawal by Subject|0|||
161496508|NCT04762680|583214061|FG008|Phase 2|Withdrawal by Subject|0|||
161496509|NCT04762680|583214062|FG009|Phase 2|Withdrawal by Subject|0|||
161496510|NCT04762680|583214063|FG010|Phase 2|Withdrawal by Subject|0|||
161496511|NCT04762680|583214064|FG011|Phase 2|Withdrawal by Subject|0|||
161924492|NCT03142750|584769687|FG001|Overall Study|Lost to Follow-up|1|||
161924493|NCT03158688|584769692|FG000|Overall Study|Withdrawal by Subject|14|||
161924494|NCT03158688|584769693|FG001|Overall Study|Withdrawal by Subject|28|||
161924495|NCT03158688|584769692|FG000|Overall Study|Decision by sponsor|13|||
161924496|NCT03158688|584769693|FG001|Overall Study|Decision by sponsor|37|||
161924497|NCT03158688|584769692|FG000|Overall Study|Lost to Follow-up|4|||
161924498|NCT03158688|584769693|FG001|Overall Study|Lost to Follow-up|3|||
161924499|NCT03158688|584769692|FG000|Overall Study|Death|74|||
161924500|NCT03158688|584769693|FG001|Overall Study|Death|142|||
161924501|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
161924502|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
161924503|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
161924504|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
161924505|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
161924506|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
161924507|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
161924508|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
161924509|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
161924510|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
161924511|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
161924512|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
161924513|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
161924514|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
161924515|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
161924516|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
161924517|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
161924518|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
161924519|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
161924520|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
161924521|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
161924522|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
161924523|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
161924524|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
161924525|NCT02337946|584769700|FG000|In-between Period|Without Informed Consent|1|||
161924526|NCT02337946|584769701|FG001|In-between Period|Without Informed Consent|0|||
161924527|NCT02337946|584769702|FG002|In-between Period|Without Informed Consent|0|||
161924528|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
161924529|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
161924530|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
161924531|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
161924532|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
161924533|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
161924534|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
161924535|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
161924536|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
161924537|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
161924538|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
161924539|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
161924540|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
161924541|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
161924542|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
161924543|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
161924544|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
161496512|NCT04762680|583214065|FG012|Phase 2|Withdrawal by Subject|0|||
161496513|NCT04762680|583214066|FG013|Phase 2|Withdrawal by Subject|0|||
161496514|NCT04762680|583214067|FG014|Phase 2|Withdrawal by Subject|0|||
161496515|NCT04762680|583214068|FG015|Phase 2|Withdrawal by Subject|0|||
161496516|NCT04762680|583214069|FG016|Phase 2|Withdrawal by Subject|0|||
161496517|NCT04762680|583214070|FG017|Phase 2|Withdrawal by Subject|0|||
161496518|NCT04762680|583214071|FG018|Phase 2|Withdrawal by Subject|0|||
161496519|NCT04762680|583214072|FG019|Phase 2|Withdrawal by Subject|0|||
161496520|NCT04762680|583214073|FG020|Phase 2|Withdrawal by Subject|0|||
161924545|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
161924546|NCT01131585|584769703|FG000|Overall Study|Adverse Event|0|||
161496521|NCT04762680|583214074|FG021|Phase 2|Withdrawal by Subject|0|||
161496522|NCT04762680|583214053|FG000|Phase 2|Lost to Follow-up|14|||
161496523|NCT04762680|583214054|FG001|Phase 2|Lost to Follow-up|8|||
161496524|NCT04762680|583214055|FG002|Phase 2|Lost to Follow-up|9|||
161496525|NCT04762680|583214056|FG003|Phase 2|Lost to Follow-up|0|||
161496526|NCT04762680|583214057|FG004|Phase 2|Lost to Follow-up|0|||
161496527|NCT04762680|583214058|FG005|Phase 2|Lost to Follow-up|0|||
161496528|NCT04762680|583214059|FG006|Phase 2|Lost to Follow-up|0|||
161496529|NCT04762680|583214060|FG007|Phase 2|Lost to Follow-up|0|||
161496530|NCT04762680|583214061|FG008|Phase 2|Lost to Follow-up|0|||
161496531|NCT04762680|583214062|FG009|Phase 2|Lost to Follow-up|0|||
161496532|NCT04762680|583214063|FG010|Phase 2|Lost to Follow-up|0|||
161496533|NCT04762680|583214064|FG011|Phase 2|Lost to Follow-up|0|||
161496534|NCT04762680|583214065|FG012|Phase 2|Lost to Follow-up|0|||
161496535|NCT04762680|583214066|FG013|Phase 2|Lost to Follow-up|0|||
161496536|NCT04762680|583214067|FG014|Phase 2|Lost to Follow-up|0|||
161496537|NCT04762680|583214068|FG015|Phase 2|Lost to Follow-up|0|||
161496538|NCT04762680|583214069|FG016|Phase 2|Lost to Follow-up|0|||
161496539|NCT04762680|583214070|FG017|Phase 2|Lost to Follow-up|0|||
161496540|NCT04762680|583214071|FG018|Phase 2|Lost to Follow-up|0|||
161496541|NCT04762680|583214072|FG019|Phase 2|Lost to Follow-up|0|||
161496542|NCT04762680|583214073|FG020|Phase 2|Lost to Follow-up|0|||
161496543|NCT04762680|583214074|FG021|Phase 2|Lost to Follow-up|0|||
161496544|NCT04762680|583214053|FG000|Phase 3|Adverse Event|0|||
161496545|NCT04762680|583214054|FG001|Phase 3|Adverse Event|0|||
161496546|NCT04762680|583214055|FG002|Phase 3|Adverse Event|0|||
161496547|NCT04762680|583214056|FG003|Phase 3|Adverse Event|1|||
161496548|NCT04762680|583214057|FG004|Phase 3|Adverse Event|0|||
161496549|NCT04762680|583214058|FG005|Phase 3|Adverse Event|0|||
161496550|NCT04762680|583214059|FG006|Phase 3|Adverse Event|0|||
161496551|NCT04762680|583214060|FG007|Phase 3|Adverse Event|0|||
161496552|NCT04762680|583214061|FG008|Phase 3|Adverse Event|0|||
161496553|NCT04762680|583214062|FG009|Phase 3|Adverse Event|0|||
161496554|NCT04762680|583214063|FG010|Phase 3|Adverse Event|0|||
161496555|NCT04762680|583214064|FG011|Phase 3|Adverse Event|0|||
161496556|NCT04762680|583214065|FG012|Phase 3|Adverse Event|0|||
161496557|NCT04762680|583214066|FG013|Phase 3|Adverse Event|0|||
161496558|NCT04762680|583214067|FG014|Phase 3|Adverse Event|0|||
161496559|NCT04762680|583214068|FG015|Phase 3|Adverse Event|0|||
161496560|NCT04762680|583214069|FG016|Phase 3|Adverse Event|0|||
161496561|NCT04762680|583214070|FG017|Phase 3|Adverse Event|3|||
161496562|NCT04762680|583214071|FG018|Phase 3|Adverse Event|0|||
161496563|NCT04762680|583214072|FG019|Phase 3|Adverse Event|0|||
161496564|NCT04762680|583214073|FG020|Phase 3|Adverse Event|0|||
161496565|NCT04762680|583214074|FG021|Phase 3|Adverse Event|0|||
161496566|NCT04762680|583214053|FG000|Phase 3|Protocol Violation|0|||
161496567|NCT04762680|583214054|FG001|Phase 3|Protocol Violation|0|||
161496568|NCT04762680|583214055|FG002|Phase 3|Protocol Violation|0|||
161496569|NCT04762680|583214056|FG003|Phase 3|Protocol Violation|4|||
161496570|NCT04762680|583214057|FG004|Phase 3|Protocol Violation|1|||
161496571|NCT04762680|583214058|FG005|Phase 3|Protocol Violation|5|||
161496572|NCT04762680|583214059|FG006|Phase 3|Protocol Violation|1|||
161496573|NCT04762680|583214060|FG007|Phase 3|Protocol Violation|0|||
161496574|NCT04762680|583214061|FG008|Phase 3|Protocol Violation|0|||
161496575|NCT04762680|583214062|FG009|Phase 3|Protocol Violation|0|||
161496576|NCT04762680|583214063|FG010|Phase 3|Protocol Violation|0|||
161496577|NCT04762680|583214064|FG011|Phase 3|Protocol Violation|2|||
161496578|NCT04762680|583214065|FG012|Phase 3|Protocol Violation|3|||
161496579|NCT04762680|583214066|FG013|Phase 3|Protocol Violation|0|||
161496580|NCT04762680|583214067|FG014|Phase 3|Protocol Violation|0|||
161496581|NCT04762680|583214068|FG015|Phase 3|Protocol Violation|1|||
161496582|NCT04762680|583214069|FG016|Phase 3|Protocol Violation|0|||
161496583|NCT04762680|583214070|FG017|Phase 3|Protocol Violation|10|||
161496584|NCT04762680|583214071|FG018|Phase 3|Protocol Violation|0|||
161818414|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
161818415|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
161818416|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
161818417|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
161818418|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
161818419|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
161496585|NCT04762680|583214072|FG019|Phase 3|Protocol Violation|0|||
161496586|NCT04762680|583214073|FG020|Phase 3|Protocol Violation|0|||
161496587|NCT04762680|583214074|FG021|Phase 3|Protocol Violation|0|||
161496588|NCT04762680|583214053|FG000|Phase 3|Withdrawal by Subject|0|||
161496589|NCT04762680|583214054|FG001|Phase 3|Withdrawal by Subject|0|||
161496590|NCT04762680|583214055|FG002|Phase 3|Withdrawal by Subject|0|||
161496591|NCT04762680|583214056|FG003|Phase 3|Withdrawal by Subject|13|||
161496592|NCT04762680|583214057|FG004|Phase 3|Withdrawal by Subject|17|||
161496593|NCT04762680|583214058|FG005|Phase 3|Withdrawal by Subject|12|||
161496594|NCT04762680|583214059|FG006|Phase 3|Withdrawal by Subject|8|||
161496595|NCT04762680|583214060|FG007|Phase 3|Withdrawal by Subject|3|||
161496596|NCT04762680|583214061|FG008|Phase 3|Withdrawal by Subject|2|||
161496597|NCT04762680|583214062|FG009|Phase 3|Withdrawal by Subject|4|||
161496598|NCT04762680|583214063|FG010|Phase 3|Withdrawal by Subject|3|||
161496599|NCT04762680|583214064|FG011|Phase 3|Withdrawal by Subject|1|||
161496600|NCT04762680|583214065|FG012|Phase 3|Withdrawal by Subject|3|||
161496601|NCT04762680|583214066|FG013|Phase 3|Withdrawal by Subject|2|||
161496602|NCT04762680|583214067|FG014|Phase 3|Withdrawal by Subject|1|||
161496603|NCT04762680|583214068|FG015|Phase 3|Withdrawal by Subject|4|||
161496604|NCT04762680|583214069|FG016|Phase 3|Withdrawal by Subject|6|||
161924547|NCT01131585|584769704|FG001|Overall Study|Adverse Event|2|||
161924548|NCT01131585|584769703|FG000|Overall Study|Abnormal laboratory value|1|||
161924549|NCT01131585|584769704|FG001|Overall Study|Abnormal laboratory value|0|||
161924550|NCT01131585|584769703|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161924551|NCT01131585|584769704|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161924552|NCT01131585|584769703|FG000|Overall Study|Protocol Violation|2|||
161924553|NCT01131585|584769704|FG001|Overall Study|Protocol Violation|1|||
161924554|NCT01131585|584769703|FG000|Overall Study|Withdrawal by Subject|3|||
161924555|NCT01131585|584769704|FG001|Overall Study|Withdrawal by Subject|3|||
161924556|NCT01131585|584769703|FG000|Overall Study|Lost to Follow-up|0|||
161924557|NCT01131585|584769704|FG001|Overall Study|Lost to Follow-up|1|||
161924558|NCT01131585|584769703|FG000|Overall Study|Administrative problems|1|||
161924559|NCT01131585|584769704|FG001|Overall Study|Administrative problems|1|||
161924560|NCT01131585|584769703|FG000|Overall Study|Study termination|78|||
161924561|NCT01131585|584769704|FG001|Overall Study|Study termination|32|||
161496605|NCT04762680|583214070|FG017|Phase 3|Withdrawal by Subject|32|||
161924562|NCT02949934|584769705|FG000|Natural Drinking Period|Adverse Event|1|||
161924563|NCT02949934|584769706|FG001|Natural Drinking Period|Adverse Event|0|||
161924564|NCT02949934|584769707|FG002|Natural Drinking Period|Adverse Event|0|||
161924565|NCT02949934|584769708|FG003|Natural Drinking Period|Adverse Event|1|||
161496606|NCT04762680|583214071|FG018|Phase 3|Withdrawal by Subject|0|||
161585147|NCT00150813|583529846|FG000|Overall Study|Withdrawal by Subject|5|||
161585148|NCT00150813|583529846|FG000|Overall Study|Remission|3|||
161585149|NCT00150813|583529846|FG000|Overall Study|Planned pregancy|1|||
161585150|NCT00150813|583529846|FG000|Overall Study|Switch to commercially available LEV|2|||
161585151|NCT00894543|583529847|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
161585152|NCT00894543|583529848|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
161585153|NCT00894543|583529847|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
161585154|NCT00894543|583529848|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
161585155|NCT04579250|583529849|FG000|Overall Study|Withdrawal by Subject|1|||
161585156|NCT04579250|583529850|FG001|Overall Study|Withdrawal by Subject|1|||
161585157|NCT04579250|583529851|FG002|Overall Study|Withdrawal by Subject|0|||
161585158|NCT04579250|583529849|FG000|Overall Study|Lost to Follow-up|1|||
161585159|NCT04579250|583529850|FG001|Overall Study|Lost to Follow-up|1|||
161585160|NCT04579250|583529851|FG002|Overall Study|Lost to Follow-up|0|||
161585161|NCT04579250|583529849|FG000|Overall Study|Moved from area|0|||
161585162|NCT04579250|583529850|FG001|Overall Study|Moved from area|1|||
161585163|NCT04579250|583529851|FG002|Overall Study|Moved from area|2|||
161585164|NCT02919449|583529852|FG000|Overall Study|Withdrawal by Subject|1|||
161585165|NCT02919449|583529852|FG000|Overall Study|Investigator decision|1|||
161585166|NCT00411151|583529853|FG000|Overall Study|Death|38|||
161585167|NCT00411151|583529853|FG000|Overall Study|Withdrawal by Subject|2|||
161585168|NCT00411151|583529853|FG000|Overall Study|Lost to Follow-up|2|||
161585169|NCT00411151|583529853|FG000|Overall Study|Protocol Violation|1|||
161585170|NCT00411151|583529853|FG000|Overall Study|Trial prematurely closed|4|||
161585171|NCT04452318|583529857|FG000|Overall Study|Physician Decision|1|||
161585172|NCT04452318|583529858|FG001|Overall Study|Physician Decision|2|||
161585173|NCT04452318|583529859|FG002|Overall Study|Physician Decision|0|||
161585174|NCT04452318|583529860|FG003|Overall Study|Physician Decision|2|||
161585175|NCT04452318|583529861|FG004|Overall Study|Physician Decision|0|||
161585176|NCT04452318|583529862|FG005|Overall Study|Physician Decision|2|||
161585177|NCT04452318|583529863|FG006|Overall Study|Physician Decision|5|||
161585178|NCT04452318|583529857|FG000|Overall Study|Death|2|||
161496607|NCT04762680|583214072|FG019|Phase 3|Withdrawal by Subject|0|||
161496608|NCT04762680|583214073|FG020|Phase 3|Withdrawal by Subject|0|||
161496609|NCT04762680|583214074|FG021|Phase 3|Withdrawal by Subject|0|||
161585179|NCT04452318|583529858|FG001|Overall Study|Death|3|||
161585180|NCT04452318|583529859|FG002|Overall Study|Death|0|||
161585181|NCT04452318|583529860|FG003|Overall Study|Death|0|||
161585182|NCT04452318|583529861|FG004|Overall Study|Death|0|||
161924566|NCT02949934|584769709|FG004|Natural Drinking Period|Adverse Event|0|||
161924567|NCT02949934|584769710|FG005|Natural Drinking Period|Adverse Event|0|||
161924568|NCT02949934|584769705|FG000|Natural Drinking Period|Lost to Follow-up|0|||
161924569|NCT02949934|584769706|FG001|Natural Drinking Period|Lost to Follow-up|0|||
161585183|NCT04452318|583529862|FG005|Overall Study|Death|0|||
161585184|NCT04452318|583529863|FG006|Overall Study|Death|0|||
161585185|NCT04452318|583529857|FG000|Overall Study|Lost to Follow-up|38|||
161585186|NCT04452318|583529858|FG001|Overall Study|Lost to Follow-up|28|||
161585187|NCT04452318|583529859|FG002|Overall Study|Lost to Follow-up|0|||
161585188|NCT04452318|583529860|FG003|Overall Study|Lost to Follow-up|3|||
161585189|NCT04452318|583529861|FG004|Overall Study|Lost to Follow-up|3|||
161585190|NCT04452318|583529862|FG005|Overall Study|Lost to Follow-up|2|||
161585191|NCT04452318|583529863|FG006|Overall Study|Lost to Follow-up|1|||
161585192|NCT04452318|583529857|FG000|Overall Study|Withdrawal by Subject|46|||
161585193|NCT04452318|583529858|FG001|Overall Study|Withdrawal by Subject|40|||
161585194|NCT04452318|583529859|FG002|Overall Study|Withdrawal by Subject|0|||
161585195|NCT04452318|583529860|FG003|Overall Study|Withdrawal by Subject|18|||
161585196|NCT04452318|583529861|FG004|Overall Study|Withdrawal by Subject|6|||
161585197|NCT04452318|583529862|FG005|Overall Study|Withdrawal by Subject|8|||
161585198|NCT04452318|583529863|FG006|Overall Study|Withdrawal by Subject|6|||
161585199|NCT03380390|583529868|FG000|Overall Study|Adverse Event|3|||
161585200|NCT02886286|583529869|FG000|Overall Study|pump motor stall|0|||
161585201|NCT02886286|583529870|FG001|Overall Study|pump motor stall|1|||
161585202|NCT05494788|583529872|FG000|Initial Treatment Period|Adverse Event|2|||
161585203|NCT05494788|583529872|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161585204|NCT05494788|583529872|FG000|Extension Period|Adverse Event|1|||
161585205|NCT05494788|583529872|FG000|Extension Period|Withdrawal by Subject|1|||
161585206|NCT01017146|583529873|FG000|Overall Study|Adverse Event|11|||
161585207|NCT01017146|583529874|FG001|Overall Study|Adverse Event|1|||
161585208|NCT01017146|583529873|FG000|Overall Study|Lost to Follow-up|14|||
161585209|NCT01017146|583529874|FG001|Overall Study|Lost to Follow-up|14|||
161585210|NCT01017146|583529873|FG000|Overall Study|Noncompliance with Study Product|1|||
161585211|NCT01017146|583529874|FG001|Overall Study|Noncompliance with Study Product|1|||
161585212|NCT01017146|583529873|FG000|Overall Study|Withdrawal by Subject|32|||
161585213|NCT01017146|583529874|FG001|Overall Study|Withdrawal by Subject|16|||
161585214|NCT01017146|583529873|FG000|Overall Study|Relocation|0|||
161585215|NCT01017146|583529874|FG001|Overall Study|Relocation|4|||
161585216|NCT01017146|583529873|FG000|Overall Study|Pregnancy|2|||
161585217|NCT01017146|583529874|FG001|Overall Study|Pregnancy|1|||
161585218|NCT01017146|583529873|FG000|Overall Study|Protocol Violation|2|||
161585219|NCT01017146|583529874|FG001|Overall Study|Protocol Violation|0|||
161585220|NCT01017146|583529873|FG000|Overall Study|Took Excluded Medication|2|||
161585221|NCT01017146|583529874|FG001|Overall Study|Took Excluded Medication|0|||
161585222|NCT01017146|583529873|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161585223|NCT01017146|583529874|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
161585224|NCT01017146|583529873|FG000|Overall Study|Change in Work Situation|1|||
161585225|NCT01017146|583529874|FG001|Overall Study|Change in Work Situation|0|||
161585226|NCT00073749|583529875|FG000|Overall Study|Disease Progression|2|||
161585227|NCT00073749|583529876|FG001|Overall Study|Disease Progression|0|||
161585228|NCT00073749|583529877|FG002|Overall Study|Disease Progression|3|||
161585229|NCT00073749|583529878|FG003|Overall Study|Disease Progression|2|||
161585230|NCT00073749|583529879|FG004|Overall Study|Disease Progression|3|||
161585231|NCT00073749|583529880|FG005|Overall Study|Disease Progression|1|||
161585232|NCT00073749|583529881|FG006|Overall Study|Disease Progression|3|||
161585233|NCT00073749|583529875|FG000|Overall Study|Death|0|||
161585234|NCT00073749|583529876|FG001|Overall Study|Death|1|||
161585235|NCT00073749|583529877|FG002|Overall Study|Death|1|||
161585236|NCT00073749|583529878|FG003|Overall Study|Death|0|||
161585237|NCT00073749|583529879|FG004|Overall Study|Death|0|||
161585238|NCT00073749|583529880|FG005|Overall Study|Death|0|||
161585239|NCT00073749|583529881|FG006|Overall Study|Death|29|||
161585240|NCT00073749|583529875|FG000|Overall Study|Adverse Event|0|||
161585241|NCT00073749|583529876|FG001|Overall Study|Adverse Event|3|||
161585242|NCT00073749|583529877|FG002|Overall Study|Adverse Event|6|||
161585243|NCT00073749|583529878|FG003|Overall Study|Adverse Event|4|||
161585244|NCT00073749|583529879|FG004|Overall Study|Adverse Event|2|||
161585245|NCT00073749|583529880|FG005|Overall Study|Adverse Event|1|||
161585246|NCT00073749|583529881|FG006|Overall Study|Adverse Event|0|||
161585247|NCT00073749|583529875|FG000|Overall Study|Physician Decision|0|||
161585248|NCT00073749|583529876|FG001|Overall Study|Physician Decision|0|||
161585249|NCT00073749|583529877|FG002|Overall Study|Physician Decision|1|||
161585250|NCT00073749|583529878|FG003|Overall Study|Physician Decision|0|||
161585251|NCT00073749|583529879|FG004|Overall Study|Physician Decision|0|||
161585252|NCT00073749|583529880|FG005|Overall Study|Physician Decision|2|||
161585253|NCT00073749|583529881|FG006|Overall Study|Physician Decision|0|||
161585254|NCT00073749|583529875|FG000|Overall Study|Withdrawal by Subject|0|||
161585255|NCT00073749|583529876|FG001|Overall Study|Withdrawal by Subject|1|||
161585256|NCT00073749|583529877|FG002|Overall Study|Withdrawal by Subject|0|||
161585257|NCT00073749|583529878|FG003|Overall Study|Withdrawal by Subject|0|||
161585258|NCT00073749|583529879|FG004|Overall Study|Withdrawal by Subject|1|||
161585259|NCT00073749|583529880|FG005|Overall Study|Withdrawal by Subject|0|||
161585260|NCT00073749|583529881|FG006|Overall Study|Withdrawal by Subject|2|||
161496610|NCT04762680|583214053|FG000|Phase 3|Lost to Follow-up|0|||
161496611|NCT04762680|583214054|FG001|Phase 3|Lost to Follow-up|0|||
161496612|NCT04762680|583214055|FG002|Phase 3|Lost to Follow-up|0|||
161496613|NCT04762680|583214056|FG003|Phase 3|Lost to Follow-up|9|||
161496614|NCT04762680|583214057|FG004|Phase 3|Lost to Follow-up|22|||
161496615|NCT04762680|583214058|FG005|Phase 3|Lost to Follow-up|24|||
161496616|NCT04762680|583214059|FG006|Phase 3|Lost to Follow-up|2|||
161496617|NCT04762680|583214060|FG007|Phase 3|Lost to Follow-up|4|||
161496618|NCT04762680|583214061|FG008|Phase 3|Lost to Follow-up|6|||
161496619|NCT04762680|583214062|FG009|Phase 3|Lost to Follow-up|4|||
161496620|NCT04762680|583214063|FG010|Phase 3|Lost to Follow-up|3|||
161496621|NCT04762680|583214064|FG011|Phase 3|Lost to Follow-up|0|||
161496622|NCT04762680|583214065|FG012|Phase 3|Lost to Follow-up|5|||
161496623|NCT04762680|583214066|FG013|Phase 3|Lost to Follow-up|4|||
161496624|NCT04762680|583214067|FG014|Phase 3|Lost to Follow-up|6|||
161496625|NCT04762680|583214068|FG015|Phase 3|Lost to Follow-up|1|||
161496626|NCT04762680|583214069|FG016|Phase 3|Lost to Follow-up|1|||
161496627|NCT04762680|583214070|FG017|Phase 3|Lost to Follow-up|66|||
161496628|NCT04762680|583214071|FG018|Phase 3|Lost to Follow-up|0|||
161496629|NCT04762680|583214072|FG019|Phase 3|Lost to Follow-up|0|||
161496630|NCT04762680|583214073|FG020|Phase 3|Lost to Follow-up|0|||
161496631|NCT04762680|583214074|FG021|Phase 3|Lost to Follow-up|0|||
161496632|NCT04762680|583214053|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496633|NCT04762680|583214054|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496634|NCT04762680|583214055|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496635|NCT04762680|583214056|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496636|NCT04762680|583214057|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496637|NCT04762680|583214058|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496638|NCT04762680|583214059|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496639|NCT04762680|583214060|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496640|NCT04762680|583214061|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496641|NCT04762680|583214062|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496642|NCT04762680|583214063|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496643|NCT04762680|583214064|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496644|NCT04762680|583214065|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496645|NCT04762680|583214066|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496646|NCT04762680|583214067|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496647|NCT04762680|583214068|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496648|NCT04762680|583214069|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496649|NCT04762680|583214070|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496650|NCT04762680|583214071|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496651|NCT04762680|583214072|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496652|NCT04762680|583214073|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161496653|NCT04762680|583214074|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
161496654|NCT04762680|583214053|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496655|NCT04762680|583214054|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496656|NCT04762680|583214055|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496657|NCT04762680|583214056|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496658|NCT04762680|583214057|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496659|NCT04762680|583214058|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496660|NCT04762680|583214059|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496661|NCT04762680|583214060|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496662|NCT04762680|583214061|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496663|NCT04762680|583214062|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496664|NCT04762680|583214063|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496665|NCT04762680|583214064|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496666|NCT04762680|583214065|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496667|NCT04762680|583214066|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496668|NCT04762680|583214067|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496669|NCT04762680|583214068|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496670|NCT04762680|583214069|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496671|NCT04762680|583214070|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496672|NCT04762680|583214071|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496673|NCT04762680|583214072|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
161496674|NCT04762680|583214073|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496675|NCT04762680|583214074|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
161496676|NCT02584504|583214077|FG000|Double-blind Treatment|Participant withdrew consent|0|||
161496677|NCT02584504|583214078|FG001|Double-blind Treatment|Participant withdrew consent|0|||
161496678|NCT02584504|583214079|FG002|Double-blind Treatment|Participant withdrew consent|1|||
161496679|NCT02584504|583214077|FG000|Double-blind Treatment|Adverse Event|0|||
161496680|NCT02584504|583214078|FG001|Double-blind Treatment|Adverse Event|1|||
161496681|NCT02584504|583214079|FG002|Double-blind Treatment|Adverse Event|0|||
161496682|NCT02584504|583214077|FG000|Double-blind Treatment|Family Matter|0|||
161496683|NCT02584504|583214078|FG001|Double-blind Treatment|Family Matter|1|||
161496684|NCT02584504|583214079|FG002|Double-blind Treatment|Family Matter|0|||
161496685|NCT02584504|583214077|FG000|Open-label Treatment|Participant withdrew consent|0|||
161672428|NCT03602261|583853131|FG000|Overall Study|Subject moving out of state|1|||
161672429|NCT03602261|583853132|FG001|Overall Study|Subject moving out of state|0|||
161672430|NCT06071754|583853133|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
161672431|NCT03226275|583853134|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161672432|NCT03226275|583853135|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161672433|NCT03226275|583853136|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
161672434|NCT03226275|583853137|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161672435|NCT03226275|583853134|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161672436|NCT03226275|583853135|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161672437|NCT03226275|583853136|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161672438|NCT03226275|583853137|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
161672439|NCT01436071|583854453|FG000|Overall Study|Adverse Event|1|||
161672440|NCT01436071|583854454|FG001|Overall Study|Adverse Event|0|||
161496686|NCT02584504|583214078|FG001|Open-label Treatment|Participant withdrew consent|0|||
161496687|NCT02584504|583214079|FG002|Open-label Treatment|Participant withdrew consent|4|||
161496688|NCT02584504|583214077|FG000|Open-label Treatment|Adverse Event|2|||
161496689|NCT02584504|583214078|FG001|Open-label Treatment|Adverse Event|2|||
161496690|NCT02584504|583214079|FG002|Open-label Treatment|Adverse Event|3|||
161496691|NCT02584504|583214077|FG000|Open-label Treatment|Physician Decision|0|||
161496692|NCT02584504|583214078|FG001|Open-label Treatment|Physician Decision|1|||
161496693|NCT02584504|583214079|FG002|Open-label Treatment|Physician Decision|0|||
161496694|NCT02584504|583214077|FG000|Open-label Treatment|Entered but not treated|0|||
161496695|NCT02584504|583214078|FG001|Open-label Treatment|Entered but not treated|1|||
161496696|NCT02584504|583214079|FG002|Open-label Treatment|Entered but not treated|1|||
161496697|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Death|3|||
161496698|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Death|2|||
161496699|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Death|4|||
161496700|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Death|3|||
161496701|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Death|0|||
161496702|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Death|0|||
161496703|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
161496704|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
161496705|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
161496706|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
161496707|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
161496708|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
161496709|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
161496710|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
161496711|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
161496712|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
161496713|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
161496714|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
161496715|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
161496716|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
161585261|NCT00073749|583529875|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161585262|NCT00073749|583529876|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161585263|NCT00073749|583529877|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161585264|NCT00073749|583529878|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161585265|NCT00073749|583529879|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161585266|NCT00073749|583529880|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161585267|NCT00073749|583529881|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
161585268|NCT00073749|583529875|FG000|Overall Study|Lost to Follow-up|0|||
161585269|NCT00073749|583529876|FG001|Overall Study|Lost to Follow-up|0|||
161585270|NCT00073749|583529877|FG002|Overall Study|Lost to Follow-up|0|||
161585271|NCT00073749|583529878|FG003|Overall Study|Lost to Follow-up|0|||
161585272|NCT00073749|583529879|FG004|Overall Study|Lost to Follow-up|0|||
161585273|NCT00073749|583529880|FG005|Overall Study|Lost to Follow-up|0|||
161672441|NCT01436071|583854453|FG000|Overall Study|Lack of Efficacy|16|||
161672442|NCT01436071|583854454|FG001|Overall Study|Lack of Efficacy|7|||
161672443|NCT01436071|583854453|FG000|Overall Study|Protocol Violation|0|||
161672444|NCT01436071|583854454|FG001|Overall Study|Protocol Violation|1|||
161672445|NCT01436071|583854453|FG000|Overall Study|Lost to Follow-up|3|||
161585274|NCT00073749|583529881|FG006|Overall Study|Lost to Follow-up|2|||
161585275|NCT00073749|583529875|FG000|Overall Study|Other|0|||
161585276|NCT00073749|583529876|FG001|Overall Study|Other|0|||
161672446|NCT01436071|583854454|FG001|Overall Study|Lost to Follow-up|1|||
161672447|NCT01436071|583854453|FG000|Overall Study|Physician Decision|1|||
161496717|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
161496718|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
161496719|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
161496720|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
161585277|NCT00073749|583529877|FG002|Overall Study|Other|0|||
161818420|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
161818421|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
161818422|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
161818423|NCT01438060|584376071|FG000|On Study Beyond Week 140|Adverse Event|0|||
161818424|NCT01438060|584376072|FG001|On Study Beyond Week 140|Adverse Event|2|||
161818425|NCT01438060|584376071|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
161818426|NCT01438060|584376072|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
161818427|NCT01438060|584376071|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
161818428|NCT01438060|584376072|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
161818429|NCT01438060|584376071|FG000|On Study Beyond Week 140|Death|0|||
161818430|NCT01438060|584376072|FG001|On Study Beyond Week 140|Death|1|||
161818431|NCT01438060|584376071|FG000|On Study Beyond Week 140|Other Reason|0|||
161818432|NCT01438060|584376072|FG001|On Study Beyond Week 140|Other Reason|3|||
161818433|NCT03602339|584376073|FG000|Overall Study|Withdrawal by Subject|9|||
161496721|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
161496722|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
161496723|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
161496724|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
161496725|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
161496726|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
161496727|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
161496728|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
161496729|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
161496730|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
161496731|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
161496732|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
161496733|NCT02432846|583214080|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
161496734|NCT02432846|583214081|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
161496735|NCT02432846|583214082|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
161496736|NCT02432846|583214083|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
161496737|NCT02432846|583214084|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
161496738|NCT02432846|583214085|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
161496739|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
161496740|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
161496741|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
161496742|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
161496743|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
161496744|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
161496745|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
161496746|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
161496747|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
161496748|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
161496749|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
161496750|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
161496751|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
161496752|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
161496753|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
161496754|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
161496755|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
161496756|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
161496757|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
161496758|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
161496759|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
161496760|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
161496761|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
161496762|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
161496763|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
161496764|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
161496765|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
161496766|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
161818434|NCT03602339|584376073|FG000|Overall Study|Physician Decision|2|||
161818435|NCT03602339|584376073|FG000|Overall Study|Other reason|4|||
161924570|NCT02949934|584769707|FG002|Natural Drinking Period|Lost to Follow-up|0|||
161924571|NCT02949934|584769708|FG003|Natural Drinking Period|Lost to Follow-up|0|||
161924572|NCT02949934|584769709|FG004|Natural Drinking Period|Lost to Follow-up|1|||
161924573|NCT02949934|584769710|FG005|Natural Drinking Period|Lost to Follow-up|0|||
161496767|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
161672448|NCT01436071|583854454|FG001|Overall Study|Physician Decision|0|||
161672449|NCT01436071|583854453|FG000|Overall Study|Withdrawal by Subject|2|||
161672450|NCT01436071|583854454|FG001|Overall Study|Withdrawal by Subject|2|||
161672451|NCT01436071|583854453|FG000|Overall Study|Did Not Receive Trial Medication|3|||
161672452|NCT01436071|583854454|FG001|Overall Study|Did Not Receive Trial Medication|3|||
161672453|NCT00352885|583854457|FG000|Overall Study|Withdrawal by Subject|0|||
161672454|NCT00352885|583854458|FG001|Overall Study|Withdrawal by Subject|3|||
161672455|NCT00352885|583854457|FG000|Overall Study|Development of major depression|0|||
161672456|NCT00352885|583854458|FG001|Overall Study|Development of major depression|1|||
161496768|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
161672457|NCT00352885|583854457|FG000|Overall Study|Progression of metastatic melanoma|5|||
161672458|NCT00352885|583854458|FG001|Overall Study|Progression of metastatic melanoma|3|||
161672459|NCT00352885|583854457|FG000|Overall Study|Side effects of IL-2 administration|1|||
161672460|NCT00352885|583854458|FG001|Overall Study|Side effects of IL-2 administration|0|||
161672461|NCT01920594|583854459|FG000|Overall Study|Adverse Event|4|||
161672462|NCT01920594|583854460|FG001|Overall Study|Adverse Event|2|||
161672463|NCT01920594|583854459|FG000|Overall Study|Lost to Follow-up|1|||
161672464|NCT01920594|583854460|FG001|Overall Study|Lost to Follow-up|0|||
161672465|NCT01920594|583854459|FG000|Overall Study|Recovery|2|||
161672466|NCT01920594|583854460|FG001|Overall Study|Recovery|0|||
161672467|NCT01920594|583854459|FG000|Overall Study|Investigator discretion|0|||
161672468|NCT01920594|583854460|FG001|Overall Study|Investigator discretion|1|||
161672469|NCT01096342|583854461|FG000|Overall Study|Protocol Violation|1|||
161672470|NCT04906616|583854462|FG000|Overall Study|Divorce|3|||
161672471|NCT04906616|583854463|FG001|Overall Study|Divorce|2|||
161672472|NCT01521897|583854464|FG000|Overall Study|Protocol Violation|18|||
161672473|NCT01521897|583854464|FG000|Overall Study|Lost to Follow-up|5|||
161672474|NCT00385203|583854465|FG000|Overall Study|Adverse Event|5|||
161672475|NCT00385203|583854466|FG001|Overall Study|Adverse Event|4|||
161672476|NCT00385203|583854465|FG000|Overall Study|Death|1|||
161672477|NCT00385203|583854466|FG001|Overall Study|Death|0|||
161672478|NCT00385203|583854465|FG000|Overall Study|Condition under investigation worsened|18|||
161672479|NCT00385203|583854466|FG001|Overall Study|Condition under investigation worsened|3|||
161672480|NCT00385203|583854465|FG000|Overall Study|Incorrect enrollment|2|||
161672481|NCT00385203|583854466|FG001|Overall Study|Incorrect enrollment|0|||
161672482|NCT02194062|583854467|FG000|Overall Study|Lost to Follow-up|2|||
161672483|NCT02194062|583854468|FG001|Overall Study|Lost to Follow-up|2|||
161672484|NCT02194062|583854469|FG002|Overall Study|Lost to Follow-up|5|||
161672485|NCT03422172|583854470|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
161672486|NCT03422172|583854470|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
161672487|NCT03422172|583854470|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
161672488|NCT04147234|583854471|FG000|Overall Study|Clinical deterioration|0|||
161672489|NCT04147234|583854472|FG001|Overall Study|Clinical deterioration|0|||
161672490|NCT04147234|583854473|FG002|Overall Study|Clinical deterioration|1|||
161672491|NCT04147234|583854474|FG003|Overall Study|Clinical deterioration|0|||
161672492|NCT04147234|583854475|FG004|Overall Study|Clinical deterioration|0|||
161496769|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
161496770|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
161496771|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
161496772|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
161496773|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
161496774|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
161496775|NCT02432846|583214080|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
161496776|NCT02432846|583214081|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
161496777|NCT02432846|583214082|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
161496778|NCT02432846|583214083|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
161672493|NCT04147234|583854476|FG005|Overall Study|Clinical deterioration|0|||
161496779|NCT02432846|583214084|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
161672494|NCT04147234|583854477|FG006|Overall Study|Clinical deterioration|0|||
161672495|NCT04147234|583854471|FG000|Overall Study|Withdrawal by Subject|0|||
161672496|NCT04147234|583854472|FG001|Overall Study|Withdrawal by Subject|1|||
161672497|NCT04147234|583854473|FG002|Overall Study|Withdrawal by Subject|1|||
161672498|NCT04147234|583854474|FG003|Overall Study|Withdrawal by Subject|0|||
161672499|NCT04147234|583854475|FG004|Overall Study|Withdrawal by Subject|0|||
161672500|NCT04147234|583854476|FG005|Overall Study|Withdrawal by Subject|0|||
161672501|NCT04147234|583854477|FG006|Overall Study|Withdrawal by Subject|0|||
161672502|NCT04147234|583854471|FG000|Overall Study|Clinical disease progression|1|||
161672503|NCT04147234|583854472|FG001|Overall Study|Clinical disease progression|3|||
161672504|NCT04147234|583854473|FG002|Overall Study|Clinical disease progression|1|||
161672505|NCT04147234|583854474|FG003|Overall Study|Clinical disease progression|1|||
161672506|NCT04147234|583854475|FG004|Overall Study|Clinical disease progression|0|||
161672507|NCT04147234|583854476|FG005|Overall Study|Clinical disease progression|1|||
161672508|NCT04147234|583854477|FG006|Overall Study|Clinical disease progression|0|||
161672509|NCT04147234|583854471|FG000|Overall Study|Objective disease progression|6|||
161672510|NCT04147234|583854472|FG001|Overall Study|Objective disease progression|4|||
161672511|NCT04147234|583854473|FG002|Overall Study|Objective disease progression|3|||
161672512|NCT04147234|583854474|FG003|Overall Study|Objective disease progression|3|||
161672513|NCT04147234|583854475|FG004|Overall Study|Objective disease progression|5|||
161672514|NCT04147234|583854476|FG005|Overall Study|Objective disease progression|2|||
161672515|NCT04147234|583854477|FG006|Overall Study|Objective disease progression|3|||
161672516|NCT04147234|583854471|FG000|Overall Study|Adverse Event|0|||
161672517|NCT04147234|583854472|FG001|Overall Study|Adverse Event|0|||
161672518|NCT04147234|583854473|FG002|Overall Study|Adverse Event|0|||
161672519|NCT04147234|583854474|FG003|Overall Study|Adverse Event|0|||
161672520|NCT04147234|583854475|FG004|Overall Study|Adverse Event|1|||
161672521|NCT04147234|583854476|FG005|Overall Study|Adverse Event|0|||
161672522|NCT04147234|583854477|FG006|Overall Study|Adverse Event|0|||
161672523|NCT00293722|583854486|FG000|Overall Study|Other|427|||
161672524|NCT04498169|583854489|FG000|Study Completion|Adverse Event|1|||
161672525|NCT04498169|583854490|FG001|Study Completion|Adverse Event|1|||
161672526|NCT01754857|583854491|FG000|Overall Study|Adverse Event|7|||
161672527|NCT01754857|583854491|FG000|Overall Study|Disease progression|3|||
161672528|NCT01754857|583854491|FG000|Overall Study|Physician Decision|2|||
161672529|NCT01754857|583854491|FG000|Overall Study|Withdrawal by Subject|3|||
161672530|NCT01754857|583854491|FG000|Overall Study|other complicating disease|1|||
161672531|NCT01754857|583854491|FG000|Overall Study|ineligible to continue onto maintenance|1|||
161672532|NCT01754857|583854491|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
161672533|NCT01754857|583854491|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
161672534|NCT04964960|583854492|FG000|Overall Study|Withdrawal by Subject|1|||
161672535|NCT04964960|583854492|FG000|Overall Study|Did not complete cycles|1|||
161672536|NCT02960854|583854495|FG000|Overall Study|Not Disclosed|2|||
161496780|NCT02432846|583214085|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
161496781|NCT00413192|583214086|FG000|Overall Study|Disease progression|26|||
161496782|NCT00413192|583214087|FG001|Overall Study|Disease progression|31|||
161496783|NCT00413192|583214088|FG002|Overall Study|Disease progression|16|||
161496784|NCT00413192|583214089|FG003|Overall Study|Disease progression|25|||
161496785|NCT00413192|583214086|FG000|Overall Study|Toxicity|3|||
161496786|NCT00413192|583214087|FG001|Overall Study|Toxicity|2|||
161496787|NCT00413192|583214088|FG002|Overall Study|Toxicity|2|||
161496788|NCT00413192|583214089|FG003|Overall Study|Toxicity|2|||
161496789|NCT00413192|583214086|FG000|Overall Study|Withdrawal by Subject|3|||
161496790|NCT00413192|583214087|FG001|Overall Study|Withdrawal by Subject|5|||
161496791|NCT00413192|583214088|FG002|Overall Study|Withdrawal by Subject|0|||
161496792|NCT00413192|583214089|FG003|Overall Study|Withdrawal by Subject|1|||
161496793|NCT00413192|583214086|FG000|Overall Study|Intercurrent illness|0|||
161496794|NCT00413192|583214087|FG001|Overall Study|Intercurrent illness|0|||
161496795|NCT00413192|583214088|FG002|Overall Study|Intercurrent illness|0|||
161496796|NCT00413192|583214089|FG003|Overall Study|Intercurrent illness|1|||
161672537|NCT02960854|583854496|FG001|Overall Study|Not Disclosed|2|||
161672538|NCT02960854|583854495|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
161672539|NCT02960854|583854496|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
161672540|NCT02960854|583854495|FG000|Overall Study|Subject Withdrew Consent|0|||
161672541|NCT02960854|583854496|FG001|Overall Study|Subject Withdrew Consent|1|||
161672542|NCT02960854|583854495|FG000|Overall Study|Death|4|||
161672543|NCT02960854|583854496|FG001|Overall Study|Death|6|||
161672544|NCT00221195|583854497|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
161672545|NCT00221195|583854498|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
161672546|NCT00221195|583854497|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
161672547|NCT00221195|583854498|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
161496797|NCT00413192|583214086|FG000|Overall Study|Intercurrent death|0|||
161496798|NCT00413192|583214087|FG001|Overall Study|Intercurrent death|1|||
161496799|NCT00413192|583214088|FG002|Overall Study|Intercurrent death|0|||
161496800|NCT00413192|583214089|FG003|Overall Study|Intercurrent death|0|||
161672548|NCT00221195|583854497|FG000|Washout Period (Months 7-9)|Death|0|||
161672549|NCT00221195|583854498|FG001|Washout Period (Months 7-9)|Death|1|||
161672550|NCT00221195|583854497|FG000|Therapy 2 (Months 10-15)|Death|1|||
161672551|NCT00221195|583854498|FG001|Therapy 2 (Months 10-15)|Death|0|||
161672552|NCT00221195|583854497|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
161672553|NCT00221195|583854498|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
161672554|NCT01383161|583854500|FG000|Overall Study|Adverse Event|5|||
161672555|NCT01383161|583854501|FG001|Overall Study|Adverse Event|1|||
161672556|NCT01383161|583854500|FG000|Overall Study|Withdrawal by Subject|0|||
161496801|NCT00413192|583214086|FG000|Overall Study|Other|5|||
161496802|NCT00413192|583214087|FG001|Overall Study|Other|1|||
161496803|NCT00413192|583214088|FG002|Overall Study|Other|1|||
161496804|NCT00413192|583214089|FG003|Overall Study|Other|2|||
161496805|NCT00413192|583214086|FG000|Overall Study|Not treated|0|||
161496806|NCT00413192|583214087|FG001|Overall Study|Not treated|0|||
161672557|NCT01383161|583854501|FG001|Overall Study|Withdrawal by Subject|2|||
161496807|NCT00413192|583214088|FG002|Overall Study|Not treated|0|||
161496808|NCT00413192|583214089|FG003|Overall Study|Not treated|1|||
161496809|NCT01998633|583214090|FG000|Overall Study|Death|1|||
161496810|NCT03814746|583214091|FG000|Overall Study|Participant decision|9|||
161496811|NCT03814746|583214092|FG001|Overall Study|Participant decision|6|||
161496812|NCT03814746|583214093|FG002|Overall Study|Participant decision|15|||
161496813|NCT03814746|583214091|FG000|Overall Study|Physician Decision|2|||
161496814|NCT03814746|583214092|FG001|Overall Study|Physician Decision|2|||
161496815|NCT03814746|583214093|FG002|Overall Study|Physician Decision|4|||
161496816|NCT03814746|583214091|FG000|Overall Study|Death|2|||
161496817|NCT03814746|583214092|FG001|Overall Study|Death|2|||
161496818|NCT03814746|583214093|FG002|Overall Study|Death|2|||
161496819|NCT03814746|583214091|FG000|Overall Study|Adverse Event|2|||
161496820|NCT03814746|583214092|FG001|Overall Study|Adverse Event|2|||
161496821|NCT03814746|583214093|FG002|Overall Study|Adverse Event|1|||
161496822|NCT03814746|583214091|FG000|Overall Study|Lost to Follow-up|2|||
161496823|NCT03814746|583214092|FG001|Overall Study|Lost to Follow-up|1|||
161496824|NCT03814746|583214093|FG002|Overall Study|Lost to Follow-up|2|||
161496825|NCT03814746|583214091|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161496826|NCT03814746|583214092|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161496827|NCT03814746|583214093|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161496828|NCT03814746|583214091|FG000|Overall Study|Pregnancy|0|||
161496829|NCT03814746|583214092|FG001|Overall Study|Pregnancy|1|||
161496830|NCT03814746|583214093|FG002|Overall Study|Pregnancy|1|||
161496831|NCT03814746|583214091|FG000|Overall Study|Protocol Violation|1|||
161496832|NCT03814746|583214092|FG001|Overall Study|Protocol Violation|0|||
161496833|NCT03814746|583214093|FG002|Overall Study|Protocol Violation|0|||
161496834|NCT03992781|583214094|FG000|Overall Study|Lost to Follow-up|5|||
161496835|NCT03992781|583214094|FG000|Overall Study|Adverse Event|1|||
161496836|NCT03992781|583214094|FG000|Overall Study|Lack of Efficacy|5|||
161496837|NCT01996826|583214095|FG000|Overall Study|Lost to Follow-up|6|||
161496838|NCT01996826|583214096|FG001|Overall Study|Lost to Follow-up|2|||
161496839|NCT01996826|583214095|FG000|Overall Study|Physician Decision|1|||
161496840|NCT01996826|583214096|FG001|Overall Study|Physician Decision|1|||
161496841|NCT00695396|583214097|FG000|Overall Study|Study Closed Prematurely|5|||
161496842|NCT00695396|583214098|FG001|Overall Study|Study Closed Prematurely|6|||
161496843|NCT00695396|583214099|FG002|Overall Study|Study Closed Prematurely|8|||
161496844|NCT00695396|583214097|FG000|Overall Study|Withdrawal by Subject|2|||
161496845|NCT00695396|583214098|FG001|Overall Study|Withdrawal by Subject|2|||
161496846|NCT00695396|583214099|FG002|Overall Study|Withdrawal by Subject|0|||
161496847|NCT00518323|583214101|FG000|Overall Study|Lack of Efficacy|14|||
161496848|NCT00518323|583214102|FG001|Overall Study|Lack of Efficacy|2|||
161496849|NCT00518323|583214103|FG002|Overall Study|Lack of Efficacy|4|||
161496850|NCT00518323|583214104|FG003|Overall Study|Lack of Efficacy|20|||
161496851|NCT00518323|583214101|FG000|Overall Study|Withdrawal by Subject|1|||
161496852|NCT00518323|583214102|FG001|Overall Study|Withdrawal by Subject|2|||
161496853|NCT00518323|583214103|FG002|Overall Study|Withdrawal by Subject|4|||
161496854|NCT00518323|583214104|FG003|Overall Study|Withdrawal by Subject|2|||
161496855|NCT00518323|583214101|FG000|Overall Study|Lost to Follow-up|0|||
161496856|NCT00518323|583214102|FG001|Overall Study|Lost to Follow-up|2|||
161496857|NCT00518323|583214103|FG002|Overall Study|Lost to Follow-up|1|||
161496858|NCT00518323|583214104|FG003|Overall Study|Lost to Follow-up|3|||
161496859|NCT00518323|583214101|FG000|Overall Study|Adverse Event|1|||
161496860|NCT00518323|583214102|FG001|Overall Study|Adverse Event|1|||
161585278|NCT00073749|583529878|FG003|Overall Study|Other|0|||
161585279|NCT00073749|583529879|FG004|Overall Study|Other|0|||
161585280|NCT00073749|583529880|FG005|Overall Study|Other|2|||
161585281|NCT00073749|583529881|FG006|Overall Study|Other|0|||
161585282|NCT02272816|583529882|FG000|Overall Study|Adverse Event|1|||
161585283|NCT00065260|583529886|FG000|Overall Study|Death|0|||
161585284|NCT00065260|583529887|FG001|Overall Study|Death|1|||
161585285|NCT00001277|583529888|FG000|Overall Study|Adverse Event|0|||
161585286|NCT00001277|583529889|FG001|Overall Study|Adverse Event|0|||
161496861|NCT00518323|583214103|FG002|Overall Study|Adverse Event|1|||
161496862|NCT00518323|583214104|FG003|Overall Study|Adverse Event|0|||
161496863|NCT00518323|583214101|FG000|Overall Study|Prohibited medication and others|3|||
161496864|NCT00518323|583214102|FG001|Overall Study|Prohibited medication and others|1|||
161496865|NCT00518323|583214103|FG002|Overall Study|Prohibited medication and others|1|||
161496866|NCT00518323|583214104|FG003|Overall Study|Prohibited medication and others|0|||
161496867|NCT03164928|583214105|FG000|Overall Study|Lost to Follow-up|1|||
161496868|NCT03164928|583214106|FG001|Overall Study|Lost to Follow-up|0|||
161496869|NCT01275833|583214110|FG000|Overall Study|Study terminated|1|||
161496870|NCT01275833|583214111|FG001|Overall Study|Study terminated|1|||
161496871|NCT02118012|583214113|FG000|Overall Study|Adverse Event|0|||
161496872|NCT02118012|583214114|FG001|Overall Study|Adverse Event|1|||
161496873|NCT02118012|583214113|FG000|Overall Study|Physician Decision|0|||
161496874|NCT02118012|583214114|FG001|Overall Study|Physician Decision|1|||
161496875|NCT00536107|583214115|FG000|Overall Study|Death|5|||
161496876|NCT00536107|583214116|FG001|Overall Study|Death|1|||
161496877|NCT00536107|583214115|FG000|Overall Study|Incorrect enrolment|1|||
161496878|NCT00536107|583214116|FG001|Overall Study|Incorrect enrolment|0|||
161496879|NCT00536107|583214115|FG000|Overall Study|Withdrawal by Subject|0|||
161496880|NCT00536107|583214116|FG001|Overall Study|Withdrawal by Subject|1|||
161496881|NCT00536107|583214115|FG000|Overall Study|Study Termination|2|||
161672558|NCT01383161|583854500|FG000|Overall Study|Lack of Efficacy|0|||
161672559|NCT01383161|583854501|FG001|Overall Study|Lack of Efficacy|1|||
161672560|NCT01423812|583854508|FG000|Overall Study|Lost to Follow-up|2|||
161672561|NCT01423812|583854509|FG001|Overall Study|Lost to Follow-up|2|||
161672562|NCT01423812|583854508|FG000|Overall Study|Withdrawal by Subject|1|||
161672563|NCT01423812|583854509|FG001|Overall Study|Withdrawal by Subject|2|||
161672564|NCT01699789|583854510|FG000|Overall Study|Withdrawal by Subject|18|||
161672565|NCT01699789|583854511|FG001|Overall Study|Withdrawal by Subject|23|||
161496882|NCT00536107|583214116|FG001|Overall Study|Study Termination|4|||
161496883|NCT03329690|583214117|FG000|Overall Study|Progressive disease per RECIST|85|||
161496884|NCT03329690|583214118|FG001|Overall Study|Progressive disease per RECIST|44|||
161496885|NCT03329690|583214119|FG002|Overall Study|Progressive disease per RECIST|6|||
161496886|NCT03329690|583214120|FG003|Overall Study|Progressive disease per RECIST|16|||
161496887|NCT03329690|583214121|FG004|Overall Study|Progressive disease per RECIST|20|||
161496888|NCT03329690|583214117|FG000|Overall Study|Clinical progression|7|||
161496889|NCT03329690|583214118|FG001|Overall Study|Clinical progression|4|||
161496890|NCT03329690|583214119|FG002|Overall Study|Clinical progression|1|||
161496891|NCT03329690|583214120|FG003|Overall Study|Clinical progression|1|||
161496892|NCT03329690|583214121|FG004|Overall Study|Clinical progression|1|||
161496893|NCT03329690|583214117|FG000|Overall Study|Adverse Event|22|||
161496894|NCT03329690|583214118|FG001|Overall Study|Adverse Event|4|||
161496895|NCT03329690|583214119|FG002|Overall Study|Adverse Event|0|||
161496896|NCT03329690|583214120|FG003|Overall Study|Adverse Event|1|||
161496897|NCT03329690|583214121|FG004|Overall Study|Adverse Event|2|||
161496898|NCT03329690|583214117|FG000|Overall Study|Death|2|||
161496899|NCT03329690|583214118|FG001|Overall Study|Death|0|||
161496900|NCT03329690|583214119|FG002|Overall Study|Death|0|||
161496901|NCT03329690|583214120|FG003|Overall Study|Death|1|||
161496902|NCT03329690|583214121|FG004|Overall Study|Death|0|||
161496903|NCT03329690|583214117|FG000|Overall Study|Withdrawal by Subject|2|||
161496904|NCT03329690|583214118|FG001|Overall Study|Withdrawal by Subject|3|||
161496905|NCT03329690|583214119|FG002|Overall Study|Withdrawal by Subject|0|||
161496906|NCT03329690|583214120|FG003|Overall Study|Withdrawal by Subject|1|||
161496907|NCT03329690|583214121|FG004|Overall Study|Withdrawal by Subject|0|||
161496908|NCT03329690|583214117|FG000|Overall Study|Physician Decision|1|||
161496909|NCT03329690|583214118|FG001|Overall Study|Physician Decision|0|||
161496910|NCT03329690|583214119|FG002|Overall Study|Physician Decision|0|||
161496911|NCT03329690|583214120|FG003|Overall Study|Physician Decision|0|||
161496912|NCT03329690|583214121|FG004|Overall Study|Physician Decision|1|||
161496913|NCT03329690|583214117|FG000|Overall Study|Miscellaneous|6|||
161496914|NCT03329690|583214118|FG001|Overall Study|Miscellaneous|0|||
161496915|NCT03329690|583214119|FG002|Overall Study|Miscellaneous|0|||
161585287|NCT00001277|583529890|FG002|Overall Study|Adverse Event|1|||
161585288|NCT00001277|583529888|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
161585289|NCT00001277|583529889|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
161585290|NCT00001277|583529890|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
161585291|NCT00088413|583529894|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161585292|NCT00088413|583529895|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161585293|NCT00088413|583529896|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
161585294|NCT00088413|583529897|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161585295|NCT00088413|583529894|FG000|Overall Study|Adverse Events/Side Effects|0|||
161672566|NCT01699789|583854510|FG000|Overall Study|Death|1|||
161672567|NCT01699789|583854511|FG001|Overall Study|Death|2|||
161672568|NCT01699789|583854510|FG000|Overall Study|Lost to Follow-up|83|||
161672569|NCT01699789|583854511|FG001|Overall Study|Lost to Follow-up|101|||
161672570|NCT00639223|583854512|FG000|Overall Study|Lost to Follow-up|0|||
161672571|NCT00639223|583854513|FG001|Overall Study|Lost to Follow-up|2|||
161496916|NCT03329690|583214120|FG003|Overall Study|Miscellaneous|0|||
161496917|NCT03329690|583214121|FG004|Overall Study|Miscellaneous|0|||
161496918|NCT03329690|583214117|FG000|Overall Study|Did not receive treatment|1|||
161496919|NCT03329690|583214118|FG001|Overall Study|Did not receive treatment|0|||
161496920|NCT03329690|583214119|FG002|Overall Study|Did not receive treatment|0|||
161585296|NCT00088413|583529895|FG001|Overall Study|Adverse Events/Side Effects|1|||
161672572|NCT02511678|583854514|FG000|Overall Study|Withdrawal by Subject|2|||
161672573|NCT02511678|583854514|FG000|Overall Study|Lost to Follow-up|4|||
161496921|NCT03329690|583214120|FG003|Overall Study|Did not receive treatment|1|||
161496922|NCT03329690|583214121|FG004|Overall Study|Did not receive treatment|0|||
161496923|NCT00099437|583214124|FG000|Overall Study|Lost to Follow-up|30|||
161496924|NCT00099437|583214125|FG001|Overall Study|Lost to Follow-up|33|||
161496925|NCT00099437|583214124|FG000|Overall Study|Death|293|||
161672574|NCT02511678|583854514|FG000|Overall Study|Death|19|||
161496926|NCT00099437|583214125|FG001|Overall Study|Death|261|||
161672575|NCT02511678|583854514|FG000|Overall Study|Adverse Event|1|||
161672576|NCT02511678|583854514|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
161672577|NCT02511678|583854514|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
161672578|NCT02511678|583854514|FG000|Overall Study|Required Radiofrequency Ablation|1|||
161818436|NCT01190865|584376079|FG000|Overall Study|Withdrawal by Subject|1|||
161818437|NCT01190865|584376079|FG000|Overall Study|Non-compliance|2|||
161818438|NCT00875524|584376081|FG000|Overall Study|Serious adverse event|0|||
161818439|NCT00875524|584376082|FG001|Overall Study|Serious adverse event|1|||
161818440|NCT00875524|584376081|FG000|Overall Study|Protocol Violation|4|||
161818441|NCT00875524|584376082|FG001|Overall Study|Protocol Violation|0|||
161818442|NCT00875524|584376081|FG000|Overall Study|Lost to Follow-up|1|||
161818443|NCT00875524|584376082|FG001|Overall Study|Lost to Follow-up|0|||
161818444|NCT00875524|584376081|FG000|Overall Study|Withdrawal by Subject|3|||
161818445|NCT00875524|584376082|FG001|Overall Study|Withdrawal by Subject|5|||
161818446|NCT00829452|584376083|FG000|First Intervention|Withdrawal by Subject|0|||
161818447|NCT00829452|584376084|FG001|First Intervention|Withdrawal by Subject|1|||
161818448|NCT00829452|584376083|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
161818449|NCT00829452|584376084|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
161818450|NCT00829452|584376083|FG000|Second Intervention|Physician Decision|0|||
161818451|NCT00829452|584376084|FG001|Second Intervention|Physician Decision|1|||
161818452|NCT00574847|584376093|FG000|Overall Study|Adverse Event|2|||
161818453|NCT00574847|584376094|FG001|Overall Study|Adverse Event|0|||
161818454|NCT00574847|584376093|FG000|Overall Study|Death|1|||
161818455|NCT00574847|584376094|FG001|Overall Study|Death|0|||
161818456|NCT00574847|584376093|FG000|Overall Study|Withdrawal by Subject|2|||
161496927|NCT00099437|583214124|FG000|Overall Study|Withdrawal by Subject|6|||
161672579|NCT02511678|583854514|FG000|Overall Study|Biopsy was Negative|1|||
161672580|NCT02511678|583854514|FG000|Overall Study|Protocol Violation|1|||
161672581|NCT02511678|583854514|FG000|Overall Study|Received Radiation Treatment|1|||
161672582|NCT01295281|583854517|FG000|First Intervention (7 Days)|Death|0|||
161672583|NCT01295281|583854518|FG001|First Intervention (7 Days)|Death|1|||
161672584|NCT00292461|583854519|FG000|Overall Study|Adverse Event|4|||
161672585|NCT00292461|583854520|FG001|Overall Study|Adverse Event|2|||
161672586|NCT00292461|583854519|FG000|Overall Study|Lack of Efficacy|1|||
161672587|NCT00292461|583854520|FG001|Overall Study|Lack of Efficacy|0|||
161672588|NCT00292461|583854519|FG000|Overall Study|Withdrawal by Subject|0|||
161672589|NCT00292461|583854520|FG001|Overall Study|Withdrawal by Subject|1|||
161672590|NCT00292461|583854519|FG000|Overall Study|Protocol Violation|4|||
161672591|NCT00292461|583854520|FG001|Overall Study|Protocol Violation|3|||
161672592|NCT00292461|583854519|FG000|Overall Study|Lost to Follow-up|1|||
161672593|NCT00292461|583854520|FG001|Overall Study|Lost to Follow-up|0|||
161672594|NCT00633061|583854528|FG000|Overall Study|Study closed|86|||
161672595|NCT00633061|583854529|FG001|Overall Study|Study closed|0|||
161672596|NCT02000427|583854530|FG000|Overall Study|Death|22|||
161672597|NCT05125679|583854533|FG000|Overall Study|Study Terminated by Sponsor|2|||
161672598|NCT05125679|583854534|FG001|Overall Study|Study Terminated by Sponsor|5|||
161672599|NCT06268288|583854539|FG000|Overall Study|Withdrawal by Subject|1|||
161672600|NCT06268288|583854540|FG001|Overall Study|Withdrawal by Subject|2|||
161672601|NCT03049735|583854543|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
161672602|NCT03049735|583854544|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
161672603|NCT03049735|583854545|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
161672604|NCT03049735|583854543|FG000|Overall Study|Other|5|||
161672605|NCT03049735|583854544|FG001|Overall Study|Other|3|||
161672606|NCT03049735|583854545|FG002|Overall Study|Other|1|||
161672607|NCT03049735|583854543|FG000|Overall Study|Lack of Efficacy|4|||
161672608|NCT03049735|583854544|FG001|Overall Study|Lack of Efficacy|0|||
161672609|NCT03049735|583854545|FG002|Overall Study|Lack of Efficacy|3|||
161672610|NCT03049735|583854543|FG000|Overall Study|Protocol deviation|1|||
161672611|NCT03049735|583854544|FG001|Overall Study|Protocol deviation|0|||
161672612|NCT03049735|583854545|FG002|Overall Study|Protocol deviation|0|||
161496928|NCT00099437|583214125|FG001|Overall Study|Withdrawal by Subject|10|||
161672613|NCT03049735|583854543|FG000|Overall Study|Pregnancy|0|||
161672614|NCT03049735|583854544|FG001|Overall Study|Pregnancy|0|||
161672615|NCT03049735|583854545|FG002|Overall Study|Pregnancy|1|||
161672616|NCT03049735|583854543|FG000|Overall Study|Adverse Event|7|||
161672617|NCT03049735|583854544|FG001|Overall Study|Adverse Event|18|||
161672618|NCT03049735|583854545|FG002|Overall Study|Adverse Event|5|||
161672619|NCT03049735|583854543|FG000|Overall Study|Withdrawal by Subject|10|||
161818457|NCT00574847|584376094|FG001|Overall Study|Withdrawal by Subject|2|||
161818458|NCT00574847|584376093|FG000|Overall Study|Physician Decision|1|||
161818459|NCT00574847|584376094|FG001|Overall Study|Physician Decision|0|||
161496929|NCT00099437|583214124|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
161672620|NCT03049735|583854544|FG001|Overall Study|Withdrawal by Subject|3|||
161672621|NCT03049735|583854545|FG002|Overall Study|Withdrawal by Subject|7|||
161672622|NCT03049735|583854543|FG000|Overall Study|Lost to Follow-up|1|||
161672623|NCT03049735|583854544|FG001|Overall Study|Lost to Follow-up|5|||
161818460|NCT00574847|584376093|FG000|Overall Study|Did not receive medication (declined)|2|||
161818461|NCT00574847|584376094|FG001|Overall Study|Did not receive medication (declined)|5|||
161818462|NCT00957021|584376097|FG000|Overall Study|Death|5|||
161818463|NCT00957021|584376097|FG000|Overall Study|Lost to Follow-up|8|||
161496930|NCT00099437|583214125|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
161496931|NCT00450333|583214129|FG000|Overall Study|Study terminated|47|||
161496932|NCT00450333|583214130|FG001|Overall Study|Study terminated|54|||
161496933|NCT00450333|583214131|FG002|Overall Study|Study terminated|16|||
161496934|NCT00450333|583214132|FG003|Overall Study|Study terminated|21|||
161496935|NCT00450333|583214129|FG000|Overall Study|Adverse Event|1|||
161496936|NCT00450333|583214130|FG001|Overall Study|Adverse Event|7|||
161496937|NCT00450333|583214131|FG002|Overall Study|Adverse Event|2|||
161496938|NCT00450333|583214132|FG003|Overall Study|Adverse Event|2|||
161496939|NCT00450333|583214129|FG000|Overall Study|Protocol Violation|1|||
161496940|NCT00450333|583214130|FG001|Overall Study|Protocol Violation|0|||
161496941|NCT00450333|583214131|FG002|Overall Study|Protocol Violation|1|||
161496942|NCT00450333|583214132|FG003|Overall Study|Protocol Violation|0|||
161496943|NCT00450333|583214129|FG000|Overall Study|Withdrawal by Subject|1|||
161496944|NCT00450333|583214130|FG001|Overall Study|Withdrawal by Subject|0|||
161496945|NCT00450333|583214131|FG002|Overall Study|Withdrawal by Subject|3|||
161496946|NCT00450333|583214132|FG003|Overall Study|Withdrawal by Subject|0|||
161496947|NCT00450333|583214129|FG000|Overall Study|Kidney transplant|1|||
161496948|NCT00450333|583214130|FG001|Overall Study|Kidney transplant|0|||
161496949|NCT00450333|583214131|FG002|Overall Study|Kidney transplant|1|||
161496950|NCT00450333|583214132|FG003|Overall Study|Kidney transplant|3|||
161496951|NCT00450333|583214129|FG000|Overall Study|Death|3|||
161496952|NCT00450333|583214130|FG001|Overall Study|Death|2|||
161496953|NCT00450333|583214131|FG002|Overall Study|Death|2|||
161496954|NCT00450333|583214132|FG003|Overall Study|Death|2|||
161496955|NCT03855280|583214139|FG000|Treatment Phase|Adverse Event|1|||
161496956|NCT03855280|583214139|FG000|Treatment Phase|Withdrawal by Subject|1|||
161496957|NCT03855280|583214139|FG000|Continuation Phase|Protocol Violation|1|||
161496958|NCT03855280|583214139|FG000|Continuation Phase|Adverse Event|1|||
161496959|NCT03855280|583214139|FG000|Continuation Phase|Sponsor Concluded Study|1|||
161585297|NCT00088413|583529896|FG002|Overall Study|Adverse Events/Side Effects|1|||
161585298|NCT00088413|583529897|FG003|Overall Study|Adverse Events/Side Effects|0|||
161585299|NCT00088413|583529894|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
161585300|NCT00088413|583529895|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
161585301|NCT00088413|583529896|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
161585302|NCT00088413|583529897|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
161585303|NCT00088413|583529894|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
161585304|NCT00088413|583529895|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
161585305|NCT00088413|583529896|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
161585306|NCT00088413|583529897|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
161585307|NCT00088413|583529894|FG000|Overall Study|Death|0|||
161585308|NCT00088413|583529895|FG001|Overall Study|Death|1|||
161585309|NCT00088413|583529896|FG002|Overall Study|Death|0|||
161585310|NCT00088413|583529897|FG003|Overall Study|Death|0|||
161585311|NCT00088413|583529894|FG000|Overall Study|Progressive disease|9|||
161585312|NCT00088413|583529895|FG001|Overall Study|Progressive disease|11|||
161585313|NCT00088413|583529896|FG002|Overall Study|Progressive disease|8|||
161585314|NCT00088413|583529897|FG003|Overall Study|Progressive disease|14|||
161585315|NCT00088413|583529894|FG000|Overall Study|Other|0|||
161585316|NCT00088413|583529895|FG001|Overall Study|Other|1|||
161585317|NCT00088413|583529896|FG002|Overall Study|Other|0|||
161585318|NCT00088413|583529897|FG003|Overall Study|Other|0|||
161585319|NCT00088413|583529894|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
161585320|NCT00088413|583529895|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
161585321|NCT00088413|583529896|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
161585322|NCT00088413|583529897|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
161585323|NCT04048382|583529898|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
161585324|NCT04048382|583529899|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
161585325|NCT04048382|583529898|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
161585326|NCT04048382|583529899|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
161585327|NCT04048382|583529898|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
161585328|NCT04048382|583529899|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
161585329|NCT02119650|583529904|FG000|Overall Study|Adverse Event|3|||
161585330|NCT02119650|583529905|FG001|Overall Study|Adverse Event|4|||
161496960|NCT00561080|583214142|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
161496961|NCT00561080|583214143|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
161496962|NCT00561080|583214144|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
161496963|NCT00561080|583214142|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
161496964|NCT00561080|583214143|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
161496965|NCT00561080|583214144|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
161496966|NCT00561080|583214142|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
161496967|NCT00561080|583214143|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
161585331|NCT02119650|583529904|FG000|Overall Study|Subject decision|2|||
161585332|NCT02119650|583529905|FG001|Overall Study|Subject decision|3|||
161818464|NCT00957021|584376097|FG000|Overall Study|Withdrawal by Subject|34|||
161818465|NCT00957021|584376097|FG000|Overall Study|No 2 yr ROM data|35|||
161818466|NCT00957021|584376097|FG000|Overall Study|Revised study component by 2 yr visit|8|||
161818467|NCT00957021|584376097|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
161818468|NCT00957021|584376097|FG000|Overall Study|Surgery Cancelled|9|||
161818469|NCT00957021|584376097|FG000|Overall Study|Termination due to language issue|2|||
161818470|NCT04060251|584376109|FG000|Overall Study|Study terminated due to low enrollment.|7|||
161818471|NCT04060251|584376110|FG001|Overall Study|Study terminated due to low enrollment.|5|||
161818472|NCT04060251|584376111|FG002|Overall Study|Study terminated due to low enrollment.|7|||
161818473|NCT04060251|584376109|FG000|Overall Study|Adverse Event|1|||
161818474|NCT04060251|584376110|FG001|Overall Study|Adverse Event|1|||
161924574|NCT02949934|584769705|FG000|Neuroimaging|Protocol Violation|2|||
161924575|NCT02949934|584769706|FG001|Neuroimaging|Protocol Violation|0|||
161924576|NCT02949934|584769707|FG002|Neuroimaging|Protocol Violation|0|||
161924577|NCT02949934|584769708|FG003|Neuroimaging|Protocol Violation|0|||
161818475|NCT04060251|584376111|FG002|Overall Study|Adverse Event|0|||
161818476|NCT00487435|584376112|FG000|Overall Study|Adverse Event|146|||
161818477|NCT00487435|584376112|FG000|Overall Study|Death|2|||
161818478|NCT00487435|584376112|FG000|Overall Study|Lack of Efficacy|33|||
161818479|NCT00487435|584376112|FG000|Overall Study|Lost to Follow-up|54|||
161818480|NCT00487435|584376112|FG000|Overall Study|Pregnancy|2|||
161818481|NCT00487435|584376112|FG000|Overall Study|Withdrawal by Subject|132|||
161818482|NCT00487435|584376112|FG000|Overall Study|Resolution Of Pain|1|||
161818483|NCT00487435|584376112|FG000|Overall Study|Study Medication Non-Compliant|32|||
161818484|NCT00487435|584376112|FG000|Overall Study|Other|83|||
161818485|NCT01155531|584376119|FG000|Overall Study|Adverse Event|0|||
161818486|NCT01155531|584376120|FG001|Overall Study|Adverse Event|0|||
161924578|NCT02949934|584769709|FG004|Neuroimaging|Protocol Violation|1|||
161924579|NCT02949934|584769710|FG005|Neuroimaging|Protocol Violation|0|||
161924580|NCT02949934|584769705|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
161924581|NCT02949934|584769706|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
161924582|NCT02949934|584769707|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
161924583|NCT02949934|584769708|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
161924584|NCT02949934|584769709|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
161924585|NCT02949934|584769710|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
161924586|NCT02949934|584769705|FG000|Neuroimaging|Not scanned|0|||
161924587|NCT02949934|584769706|FG001|Neuroimaging|Not scanned|0|||
161924588|NCT02949934|584769707|FG002|Neuroimaging|Not scanned|1|||
161924589|NCT02949934|584769708|FG003|Neuroimaging|Not scanned|0|||
161924590|NCT02949934|584769709|FG004|Neuroimaging|Not scanned|0|||
161924591|NCT02949934|584769710|FG005|Neuroimaging|Not scanned|2|||
161924592|NCT02949934|584769705|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
161924593|NCT02949934|584769706|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
161924594|NCT02949934|584769707|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
161924595|NCT02949934|584769708|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
161924596|NCT02949934|584769709|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
161924597|NCT02949934|584769710|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
161924598|NCT02949934|584769705|FG000|Bar Laboratory|Adverse Event|1|||
161924599|NCT02949934|584769706|FG001|Bar Laboratory|Adverse Event|0|||
161924600|NCT02949934|584769707|FG002|Bar Laboratory|Adverse Event|2|||
161924601|NCT02949934|584769708|FG003|Bar Laboratory|Adverse Event|0|||
161924602|NCT02949934|584769709|FG004|Bar Laboratory|Adverse Event|1|||
161924603|NCT02949934|584769710|FG005|Bar Laboratory|Adverse Event|0|||
161924604|NCT02949934|584769705|FG000|Bar Laboratory|Protocol Violation|0|||
161924605|NCT02949934|584769706|FG001|Bar Laboratory|Protocol Violation|0|||
161924606|NCT02949934|584769707|FG002|Bar Laboratory|Protocol Violation|0|||
161924607|NCT02949934|584769708|FG003|Bar Laboratory|Protocol Violation|1|||
161924608|NCT02949934|584769709|FG004|Bar Laboratory|Protocol Violation|0|||
161924609|NCT02949934|584769710|FG005|Bar Laboratory|Protocol Violation|0|||
161924610|NCT02762604|584769711|FG000|Overall Study|Lost to Follow-up|2|||
161924611|NCT02762604|584769712|FG001|Overall Study|Lost to Follow-up|7|||
161924612|NCT02762604|584769711|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
161924613|NCT02762604|584769712|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
161924614|NCT04530526|584769716|FG000|Overall Study|Withdrawal by Subject|6|||
161924615|NCT04937387|584769717|FG000|Overall Study|Adverse Event|1|||
161924616|NCT04937387|584769718|FG001|Overall Study|Adverse Event|0|||
161924617|NCT04937387|584769719|FG002|Overall Study|Adverse Event|2|||
161924618|NCT04937387|584769720|FG003|Overall Study|Adverse Event|0|||
161585333|NCT02119650|583529904|FG000|Overall Study|Disease progression|11|||
161818487|NCT01155531|584376121|FG002|Overall Study|Adverse Event|1|||
161818488|NCT01155531|584376122|FG003|Overall Study|Adverse Event|0|||
161818489|NCT01155531|584376119|FG000|Overall Study|Lost to Follow-up|0|||
161818490|NCT01155531|584376120|FG001|Overall Study|Lost to Follow-up|0|||
161818491|NCT01155531|584376121|FG002|Overall Study|Lost to Follow-up|0|||
161818492|NCT01155531|584376122|FG003|Overall Study|Lost to Follow-up|1|||
161924619|NCT04937387|584769717|FG000|Overall Study|Lack of Efficacy|1|||
161924620|NCT04937387|584769718|FG001|Overall Study|Lack of Efficacy|0|||
161672624|NCT03049735|583854545|FG002|Overall Study|Lost to Follow-up|5|||
161672625|NCT02146326|583854546|FG000|Overall Study|Lost to Follow-up|3|||
161672626|NCT02146326|583854547|FG001|Overall Study|Lost to Follow-up|3|||
161672627|NCT02146326|583854548|FG002|Overall Study|Lost to Follow-up|11|||
161672628|NCT02146326|583854549|FG003|Overall Study|Lost to Follow-up|19|||
161672629|NCT02146326|583854546|FG000|Overall Study|Withdrawal by Subject|2|||
161672630|NCT02146326|583854547|FG001|Overall Study|Withdrawal by Subject|1|||
161672631|NCT02146326|583854548|FG002|Overall Study|Withdrawal by Subject|15|||
161672632|NCT02146326|583854549|FG003|Overall Study|Withdrawal by Subject|11|||
161672633|NCT02146326|583854546|FG000|Overall Study|Separated from mental health center|23|||
161672634|NCT02146326|583854547|FG001|Overall Study|Separated from mental health center|33|||
161924621|NCT04937387|584769719|FG002|Overall Study|Lack of Efficacy|0|||
161924622|NCT04937387|584769720|FG003|Overall Study|Lack of Efficacy|1|||
161924623|NCT04937387|584769717|FG000|Overall Study|Withdrawal by Subject|1|||
161924624|NCT04937387|584769718|FG001|Overall Study|Withdrawal by Subject|0|||
161924625|NCT04937387|584769719|FG002|Overall Study|Withdrawal by Subject|1|||
161924626|NCT04937387|584769720|FG003|Overall Study|Withdrawal by Subject|1|||
161924627|NCT04937387|584769717|FG000|Overall Study|Randomized in error|0|||
161924628|NCT04937387|584769718|FG001|Overall Study|Randomized in error|0|||
161924629|NCT04937387|584769719|FG002|Overall Study|Randomized in error|0|||
161924630|NCT04937387|584769720|FG003|Overall Study|Randomized in error|1|||
161924631|NCT01658878|584770966|FG000|Treatment Period|Disease Progression|1|||
161924632|NCT01658878|584770967|FG001|Treatment Period|Disease Progression|3|||
161496968|NCT00561080|583214144|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
161496969|NCT00561080|583214142|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
161496970|NCT00561080|583214143|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
161496971|NCT00561080|583214144|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
161496972|NCT00561080|583214142|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
161496973|NCT00561080|583214143|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
161496974|NCT00561080|583214144|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
161496975|NCT00561080|583214142|FG000|Vaccination Period (up to Month 4)|Other|0|||
161496976|NCT00561080|583214143|FG001|Vaccination Period (up to Month 4)|Other|2|||
161496977|NCT00561080|583214144|FG002|Vaccination Period (up to Month 4)|Other|1|||
161496978|NCT00561080|583214142|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
161496979|NCT00561080|583214143|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
161496980|NCT00561080|583214144|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
161496981|NCT00561080|583214142|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
161496982|NCT00561080|583214143|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
161496983|NCT00561080|583214144|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
161496984|NCT00561080|583214142|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
161496985|NCT00561080|583214143|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
161496986|NCT00561080|583214144|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
161496987|NCT00561080|583214142|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
161496988|NCT00561080|583214143|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
161496989|NCT00561080|583214144|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
161496990|NCT00423150|583214145|FG000|Overall Study|Adverse Event|11|||
161585334|NCT02119650|583529905|FG001|Overall Study|Disease progression|14|||
161585335|NCT02119650|583529904|FG000|Overall Study|Death|5|||
161585336|NCT02119650|583529905|FG001|Overall Study|Death|1|||
161585337|NCT02119650|583529904|FG000|Overall Study|Noncompliance with study treatment|1|||
161585338|NCT02119650|583529905|FG001|Overall Study|Noncompliance with study treatment|1|||
161585339|NCT02119650|583529904|FG000|Overall Study|Study terminated by the sponsor|1|||
161585340|NCT02119650|583529905|FG001|Overall Study|Study terminated by the sponsor|0|||
161585341|NCT02119650|583529904|FG000|Overall Study|Physician Decision|0|||
161585342|NCT02119650|583529905|FG001|Overall Study|Physician Decision|2|||
161585343|NCT02119650|583529904|FG000|Overall Study|Multiple reasons for termination|2|||
161585344|NCT02119650|583529905|FG001|Overall Study|Multiple reasons for termination|1|||
161585345|NCT02269475|583529906|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
161585346|NCT02269475|583529907|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
161585347|NCT02269475|583529906|FG000|Overall Study|Withdrawal by Subject|0|||
161585348|NCT02269475|583529907|FG001|Overall Study|Withdrawal by Subject|1|||
161585349|NCT03481816|583529908|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
161585350|NCT03481816|583529909|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
161585351|NCT03481816|583529908|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
161585352|NCT03481816|583529909|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
161585353|NCT03481816|583529908|FG000|Dose Expansion|Withdrawal by Subject|0|||
161585354|NCT03481816|583529909|FG001|Dose Expansion|Withdrawal by Subject|2|||
161585355|NCT03481816|583529908|FG000|Dose Expansion|Physician Decision|0|||
161585356|NCT03481816|583529909|FG001|Dose Expansion|Physician Decision|5|||
161585357|NCT01037985|583529910|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
161585358|NCT01037985|583529911|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
161672635|NCT02146326|583854548|FG002|Overall Study|Separated from mental health center|0|||
161496991|NCT00423150|583214145|FG000|Overall Study|Progression of disease being studied|69|||
161496992|NCT00423150|583214145|FG000|Overall Study|Withdrawal by Subject|1|||
161496993|NCT00423150|583214145|FG000|Overall Study|Non-compliance with protocol|1|||
161496994|NCT00423150|583214145|FG000|Overall Study|Administrative|4|||
161496995|NCT01092182|583214146|FG000|Overall Study|Death|0|||
161496996|NCT01092182|583214147|FG001|Overall Study|Death|5|||
161585359|NCT01037985|583529910|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
161585360|NCT01037985|583529911|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
161585361|NCT01037985|583529910|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
161585362|NCT01037985|583529911|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
161496997|NCT01092182|583214148|FG002|Overall Study|Death|3|||
161585363|NCT01037985|583529910|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
161585364|NCT01037985|583529911|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
161585365|NCT02730871|583529914|FG000|Overall Study|Adverse Event|6|||
161496998|NCT01092182|583214146|FG000|Overall Study|participant safety|1|||
161496999|NCT01092182|583214147|FG001|Overall Study|participant safety|2|||
161497000|NCT01092182|583214148|FG002|Overall Study|participant safety|0|||
161497001|NCT01092182|583214146|FG000|Overall Study|Physician Decision|0|||
161497002|NCT01092182|583214147|FG001|Overall Study|Physician Decision|6|||
161497003|NCT01092182|583214148|FG002|Overall Study|Physician Decision|0|||
161497004|NCT01092182|583214146|FG000|Overall Study|Did not meet criteria|0|||
161497005|NCT01092182|583214147|FG001|Overall Study|Did not meet criteria|0|||
161497006|NCT01092182|583214148|FG002|Overall Study|Did not meet criteria|25|||
161497007|NCT01092182|583214146|FG000|Overall Study|Non-compliance|0|||
161497008|NCT01092182|583214147|FG001|Overall Study|Non-compliance|3|||
161497009|NCT01092182|583214148|FG002|Overall Study|Non-compliance|0|||
161497010|NCT01092182|583214146|FG000|Overall Study|Participant refused follow-up|0|||
161497011|NCT01092182|583214147|FG001|Overall Study|Participant refused follow-up|2|||
161497012|NCT01092182|583214148|FG002|Overall Study|Participant refused follow-up|0|||
161497013|NCT01641692|583214149|FG000|Treatment Period 1|Adverse Event|1|||
161497014|NCT01641692|583214150|FG001|Treatment Period 1|Adverse Event|0|||
161672636|NCT02146326|583854549|FG003|Overall Study|Separated from mental health center|0|||
161672637|NCT02146326|583854546|FG000|Overall Study|Incarcerated|0|||
161672638|NCT02146326|583854547|FG001|Overall Study|Incarcerated|0|||
161672639|NCT02146326|583854548|FG002|Overall Study|Incarcerated|3|||
161672640|NCT02146326|583854549|FG003|Overall Study|Incarcerated|8|||
161672641|NCT02146326|583854546|FG000|Overall Study|Death|0|||
161672642|NCT02146326|583854547|FG001|Overall Study|Death|0|||
161672643|NCT02146326|583854548|FG002|Overall Study|Death|4|||
161672644|NCT02146326|583854549|FG003|Overall Study|Death|4|||
161672645|NCT02146326|583854546|FG000|Overall Study|Unable to complete interview|0|||
161672646|NCT02146326|583854547|FG001|Overall Study|Unable to complete interview|0|||
161672647|NCT02146326|583854548|FG002|Overall Study|Unable to complete interview|10|||
161672648|NCT02146326|583854549|FG003|Overall Study|Unable to complete interview|6|||
161672649|NCT00777946|583854552|FG000|Overall Study|Adverse Event|11|||
161672650|NCT00777946|583854553|FG001|Overall Study|Adverse Event|1|||
161672651|NCT00777946|583854554|FG002|Overall Study|Adverse Event|3|||
161672652|NCT00777946|583854552|FG000|Overall Study|Lack of Efficacy|0|||
161672653|NCT00777946|583854553|FG001|Overall Study|Lack of Efficacy|0|||
161672654|NCT00777946|583854554|FG002|Overall Study|Lack of Efficacy|9|||
161672655|NCT00777946|583854552|FG000|Overall Study|Condition no longer required study drug|1|||
161672656|NCT00777946|583854553|FG001|Overall Study|Condition no longer required study drug|0|||
161672657|NCT00777946|583854554|FG002|Overall Study|Condition no longer required study drug|0|||
161672658|NCT00777946|583854552|FG000|Overall Study|Patient withdrew consent|3|||
161924633|NCT01658878|584770968|FG002|Treatment Period|Disease Progression|2|||
161585366|NCT02730871|583529915|FG001|Overall Study|Adverse Event|0|||
161585367|NCT05368558|583529917|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
161585368|NCT05368558|583529918|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
161585369|NCT05368558|583529919|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
161585370|NCT05368558|583529920|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585371|NCT05368558|583529921|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585372|NCT05368558|583529922|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585373|NCT05368558|583529923|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585374|NCT05368558|583529924|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585375|NCT05368558|583529925|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585376|NCT05368558|583529926|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585377|NCT05368558|583529927|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161672659|NCT00777946|583854553|FG001|Overall Study|Patient withdrew consent|2|||
161672660|NCT00777946|583854554|FG002|Overall Study|Patient withdrew consent|3|||
161497015|NCT01641692|583214151|FG002|Treatment Period 1|Adverse Event|0|||
161497016|NCT01641692|583214152|FG003|Treatment Period 1|Adverse Event|0|||
161497017|NCT01641692|583214153|FG004|Treatment Period 1|Adverse Event|0|||
161497018|NCT01641692|583214154|FG005|Treatment Period 1|Adverse Event|0|||
161497019|NCT01641692|583214155|FG006|Treatment Period 1|Adverse Event|0|||
161497020|NCT01641692|583214156|FG007|Treatment Period 1|Adverse Event|0|||
161497021|NCT01641692|583214149|FG000|Treatment Period 1|Lack of Efficacy|0|||
161497022|NCT01641692|583214150|FG001|Treatment Period 1|Lack of Efficacy|0|||
161497023|NCT01641692|583214151|FG002|Treatment Period 1|Lack of Efficacy|0|||
161497024|NCT01641692|583214152|FG003|Treatment Period 1|Lack of Efficacy|0|||
161497025|NCT01641692|583214153|FG004|Treatment Period 1|Lack of Efficacy|0|||
161497026|NCT01641692|583214154|FG005|Treatment Period 1|Lack of Efficacy|0|||
161497027|NCT01641692|583214155|FG006|Treatment Period 1|Lack of Efficacy|0|||
161497028|NCT01641692|583214156|FG007|Treatment Period 1|Lack of Efficacy|1|||
161497029|NCT01641692|583214149|FG000|Treatment Period 1|Protocol Violation|1|||
161497030|NCT01641692|583214150|FG001|Treatment Period 1|Protocol Violation|0|||
161497031|NCT01641692|583214151|FG002|Treatment Period 1|Protocol Violation|0|||
161497032|NCT01641692|583214152|FG003|Treatment Period 1|Protocol Violation|0|||
161497033|NCT01641692|583214153|FG004|Treatment Period 1|Protocol Violation|2|||
161497034|NCT01641692|583214154|FG005|Treatment Period 1|Protocol Violation|0|||
161497035|NCT01641692|583214155|FG006|Treatment Period 1|Protocol Violation|0|||
161497036|NCT01641692|583214156|FG007|Treatment Period 1|Protocol Violation|0|||
161497037|NCT01641692|583214149|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
161497038|NCT01641692|583214150|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
161497039|NCT01641692|583214151|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
161497040|NCT01641692|583214152|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
161497041|NCT01641692|583214153|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
161497042|NCT01641692|583214154|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
161497043|NCT01641692|583214155|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
161497044|NCT01641692|583214156|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
161497045|NCT01641692|583214149|FG000|Treatment Period 1|Lost to Follow-up|0|||
161497046|NCT01641692|583214150|FG001|Treatment Period 1|Lost to Follow-up|0|||
161497047|NCT01641692|583214151|FG002|Treatment Period 1|Lost to Follow-up|1|||
161497048|NCT01641692|583214152|FG003|Treatment Period 1|Lost to Follow-up|0|||
161497049|NCT01641692|583214153|FG004|Treatment Period 1|Lost to Follow-up|0|||
161497050|NCT01641692|583214154|FG005|Treatment Period 1|Lost to Follow-up|0|||
161497051|NCT01641692|583214155|FG006|Treatment Period 1|Lost to Follow-up|0|||
161497052|NCT01641692|583214156|FG007|Treatment Period 1|Lost to Follow-up|0|||
161497053|NCT01641692|583214149|FG000|Treatment Period 1|Physician Decision|0|||
161497054|NCT01641692|583214150|FG001|Treatment Period 1|Physician Decision|0|||
161497055|NCT01641692|583214151|FG002|Treatment Period 1|Physician Decision|0|||
161497056|NCT01641692|583214152|FG003|Treatment Period 1|Physician Decision|0|||
161497057|NCT01641692|583214153|FG004|Treatment Period 1|Physician Decision|1|||
161497058|NCT01641692|583214154|FG005|Treatment Period 1|Physician Decision|0|||
161497059|NCT01641692|583214155|FG006|Treatment Period 1|Physician Decision|0|||
161497060|NCT01641692|583214156|FG007|Treatment Period 1|Physician Decision|0|||
161497061|NCT01641692|583214149|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161497062|NCT01641692|583214150|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161497063|NCT01641692|583214151|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161497064|NCT01641692|583214152|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161497065|NCT01641692|583214153|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161497066|NCT01641692|583214154|FG005|Treatment Period 1|Withdrawal by Subject|2|||
161497067|NCT01641692|583214155|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161497068|NCT01641692|583214156|FG007|Treatment Period 1|Withdrawal by Subject|1|||
161497069|NCT01641692|583214149|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
161497070|NCT01641692|583214150|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497071|NCT01641692|583214151|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497072|NCT01641692|583214152|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497073|NCT01641692|583214153|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497074|NCT01641692|583214154|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497075|NCT01641692|583214155|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497076|NCT01641692|583214156|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
161497077|NCT01641692|583214149|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497078|NCT01641692|583214150|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497079|NCT01641692|583214151|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497080|NCT01641692|583214152|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497081|NCT01641692|583214153|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497082|NCT01641692|583214154|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497083|NCT01641692|583214155|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
161497084|NCT01641692|583214156|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161497085|NCT01641692|583214149|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
161497086|NCT01641692|583214150|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497087|NCT01641692|583214151|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
161497088|NCT01641692|583214152|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
161497089|NCT01641692|583214153|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
161497090|NCT01641692|583214154|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497091|NCT01641692|583214155|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497092|NCT01641692|583214156|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
161497093|NCT01641692|583214149|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
161497094|NCT01641692|583214150|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
161497095|NCT01641692|583214151|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161497096|NCT01641692|583214152|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
161497097|NCT01641692|583214153|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
161497098|NCT01641692|583214154|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161497099|NCT01641692|583214155|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
161818493|NCT01155531|584376119|FG000|Overall Study|Withdrawal by Subject|1|||
161818494|NCT01155531|584376120|FG001|Overall Study|Withdrawal by Subject|0|||
161497100|NCT01641692|583214156|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161497101|NCT01641692|583214149|FG000|Treatment Period 2|Lack of Efficacy|1|||
161497102|NCT01641692|583214150|FG001|Treatment Period 2|Lack of Efficacy|0|||
161497103|NCT01641692|583214151|FG002|Treatment Period 2|Lack of Efficacy|0|||
161497104|NCT01641692|583214152|FG003|Treatment Period 2|Lack of Efficacy|0|||
161497105|NCT01641692|583214153|FG004|Treatment Period 2|Lack of Efficacy|0|||
161497106|NCT01641692|583214154|FG005|Treatment Period 2|Lack of Efficacy|0|||
161497107|NCT01641692|583214155|FG006|Treatment Period 2|Lack of Efficacy|0|||
161497108|NCT01641692|583214156|FG007|Treatment Period 2|Lack of Efficacy|0|||
161497109|NCT01641692|583214149|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
161497110|NCT01641692|583214150|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497111|NCT01641692|583214151|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497112|NCT01641692|583214152|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497113|NCT01641692|583214153|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497114|NCT01641692|583214154|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497115|NCT01641692|583214155|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497116|NCT01641692|583214156|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161497117|NCT01641692|583214149|FG000|Treatment Period 2|Lost to Follow-up|0|||
161497118|NCT01641692|583214150|FG001|Treatment Period 2|Lost to Follow-up|0|||
161497119|NCT01641692|583214151|FG002|Treatment Period 2|Lost to Follow-up|0|||
161497120|NCT01641692|583214152|FG003|Treatment Period 2|Lost to Follow-up|0|||
161497121|NCT01641692|583214153|FG004|Treatment Period 2|Lost to Follow-up|0|||
161497122|NCT01641692|583214154|FG005|Treatment Period 2|Lost to Follow-up|1|||
161497123|NCT01641692|583214155|FG006|Treatment Period 2|Lost to Follow-up|0|||
161497124|NCT01641692|583214156|FG007|Treatment Period 2|Lost to Follow-up|0|||
161497125|NCT01641692|583214149|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161497126|NCT01641692|583214150|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161497127|NCT01641692|583214151|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161497128|NCT01641692|583214152|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161497129|NCT01641692|583214153|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161497130|NCT01641692|583214154|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161497131|NCT01641692|583214155|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161497132|NCT01641692|583214156|FG007|Treatment Period 2|Withdrawal by Subject|1|||
161497133|NCT01641692|583214149|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497134|NCT01641692|583214150|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497135|NCT01641692|583214151|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497136|NCT01641692|583214152|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497137|NCT01641692|583214153|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
161497138|NCT01641692|583214154|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497139|NCT01641692|583214155|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
161497140|NCT01641692|583214156|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
161497141|NCT01641692|583214149|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161497142|NCT01641692|583214150|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161497143|NCT01641692|583214151|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
161497144|NCT01641692|583214152|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161497145|NCT01641692|583214153|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161497146|NCT01641692|583214154|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
161497147|NCT01641692|583214155|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161497148|NCT01641692|583214156|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
161497149|NCT01641692|583214149|FG000|Treatment Period 3|Adverse Event|0|||
161497150|NCT01641692|583214150|FG001|Treatment Period 3|Adverse Event|0|||
161497151|NCT01641692|583214151|FG002|Treatment Period 3|Adverse Event|0|||
161497152|NCT01641692|583214152|FG003|Treatment Period 3|Adverse Event|0|||
161497153|NCT01641692|583214153|FG004|Treatment Period 3|Adverse Event|0|||
161497154|NCT01641692|583214154|FG005|Treatment Period 3|Adverse Event|0|||
161497155|NCT01641692|583214155|FG006|Treatment Period 3|Adverse Event|1|||
161497156|NCT01641692|583214156|FG007|Treatment Period 3|Adverse Event|0|||
161497157|NCT01641692|583214149|FG000|Treatment Period 3|Protocol Violation|0|||
161818495|NCT01155531|584376121|FG002|Overall Study|Withdrawal by Subject|1|||
161818496|NCT01155531|584376122|FG003|Overall Study|Withdrawal by Subject|0|||
161497158|NCT01641692|583214150|FG001|Treatment Period 3|Protocol Violation|0|||
161497159|NCT01641692|583214151|FG002|Treatment Period 3|Protocol Violation|1|||
161497160|NCT01641692|583214152|FG003|Treatment Period 3|Protocol Violation|0|||
161497161|NCT01641692|583214153|FG004|Treatment Period 3|Protocol Violation|0|||
161497162|NCT01641692|583214154|FG005|Treatment Period 3|Protocol Violation|0|||
161497163|NCT01641692|583214155|FG006|Treatment Period 3|Protocol Violation|0|||
161497164|NCT01641692|583214156|FG007|Treatment Period 3|Protocol Violation|0|||
161497165|NCT01641692|583214149|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161497166|NCT01641692|583214150|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161497167|NCT01641692|583214151|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161497168|NCT01641692|583214152|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161585378|NCT05368558|583529928|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161585379|NCT05368558|583529917|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585380|NCT05368558|583529918|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585381|NCT05368558|583529919|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585382|NCT05368558|583529920|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
161585383|NCT05368558|583529921|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585384|NCT05368558|583529922|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
161585385|NCT05368558|583529923|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585386|NCT05368558|583529924|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585387|NCT05368558|583529925|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585388|NCT05368558|583529926|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585389|NCT05368558|583529927|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585390|NCT05368558|583529928|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161585391|NCT05368558|583529917|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585392|NCT05368558|583529918|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585393|NCT05368558|583529919|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585394|NCT05368558|583529920|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
161585395|NCT05368558|583529921|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585396|NCT05368558|583529922|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585397|NCT05368558|583529923|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585398|NCT05368558|583529924|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585399|NCT05368558|583529925|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585400|NCT05368558|583529926|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585401|NCT05368558|583529927|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585402|NCT05368558|583529928|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161585403|NCT05368558|583529917|FG000|Blinded Extension Period (BEP)|other|0|||
161585404|NCT05368558|583529918|FG001|Blinded Extension Period (BEP)|other|0|||
161585405|NCT05368558|583529919|FG002|Blinded Extension Period (BEP)|other|0|||
161585406|NCT05368558|583529920|FG003|Blinded Extension Period (BEP)|other|0|||
161585407|NCT05368558|583529921|FG004|Blinded Extension Period (BEP)|other|0|||
161585408|NCT05368558|583529922|FG005|Blinded Extension Period (BEP)|other|1|||
161672661|NCT00777946|583854552|FG000|Overall Study|Lost to Follow-up|3|||
161672662|NCT00777946|583854553|FG001|Overall Study|Lost to Follow-up|1|||
161672663|NCT00777946|583854554|FG002|Overall Study|Lost to Follow-up|0|||
161672664|NCT00777946|583854552|FG000|Overall Study|Protocol deviation|2|||
161672665|NCT00777946|583854553|FG001|Overall Study|Protocol deviation|1|||
161672666|NCT00777946|583854554|FG002|Overall Study|Protocol deviation|1|||
161672667|NCT00777946|583854552|FG000|Overall Study|Randomized in error|1|||
161672668|NCT00777946|583854553|FG001|Overall Study|Randomized in error|1|||
161672669|NCT00777946|583854554|FG002|Overall Study|Randomized in error|0|||
161672670|NCT04821869|583854566|FG000|Overall Study|Adverse Event|4|||
161672671|NCT04821869|583854566|FG000|Overall Study|Withdrawal by Subject|2|||
161672672|NCT04821869|583854566|FG000|Overall Study|Did not meet FEV1 criteria|1|||
161672673|NCT01313117|583854569|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
161672674|NCT01313117|583854569|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
161672675|NCT03442114|583854574|FG000|Overall Study|Lost to Follow-up|13|||
161672676|NCT03442114|583854575|FG001|Overall Study|Lost to Follow-up|13|||
161672677|NCT03442114|583854574|FG000|Overall Study|Physician Decision|2|||
161818497|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
161818498|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
161818499|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
161818500|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
161818501|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
161818502|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
161818503|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
161818504|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
161818505|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
161818506|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
161497169|NCT01641692|583214153|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161497170|NCT01641692|583214154|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161497171|NCT01641692|583214155|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161497172|NCT01641692|583214156|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161497173|NCT01641692|583214149|FG000|Treatment Period 3|Lost to Follow-up|0|||
161497174|NCT01641692|583214150|FG001|Treatment Period 3|Lost to Follow-up|1|||
161497175|NCT01641692|583214151|FG002|Treatment Period 3|Lost to Follow-up|0|||
161497176|NCT01641692|583214152|FG003|Treatment Period 3|Lost to Follow-up|0|||
161497177|NCT01641692|583214153|FG004|Treatment Period 3|Lost to Follow-up|0|||
161497178|NCT01641692|583214154|FG005|Treatment Period 3|Lost to Follow-up|0|||
161497179|NCT01641692|583214155|FG006|Treatment Period 3|Lost to Follow-up|0|||
161497180|NCT01641692|583214156|FG007|Treatment Period 3|Lost to Follow-up|0|||
161497181|NCT01641692|583214149|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497182|NCT01641692|583214150|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497183|NCT01641692|583214151|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497184|NCT01641692|583214152|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497185|NCT01641692|583214153|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497186|NCT01641692|583214154|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
161497187|NCT01641692|583214155|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497188|NCT01641692|583214156|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
161497189|NCT01641692|583214149|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
161497190|NCT01641692|583214150|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
161497191|NCT01641692|583214151|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
161497192|NCT01641692|583214152|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
161497193|NCT01641692|583214153|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
161497194|NCT01641692|583214154|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
161497195|NCT01641692|583214155|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
161497196|NCT01641692|583214156|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
161497197|NCT04007094|583214161|FG000|Overall Study|Lost to Follow-up|1|||
161497198|NCT04007094|583214162|FG001|Overall Study|Lost to Follow-up|1|||
161497199|NCT02921776|583214163|FG000|Overall Study|patient deterioration, fatigue|2|||
161497200|NCT02921776|583214164|FG001|Overall Study|patient deterioration, fatigue|6|||
161497201|NCT02921776|583214165|FG002|Overall Study|patient deterioration, fatigue|0|||
161497202|NCT02921776|583214166|FG003|Overall Study|patient deterioration, fatigue|0|||
161497203|NCT02921776|583214167|FG004|Overall Study|patient deterioration, fatigue|0|||
161497204|NCT02921776|583214168|FG005|Overall Study|patient deterioration, fatigue|0|||
161497205|NCT02921776|583214169|FG006|Overall Study|patient deterioration, fatigue|0|||
161497206|NCT02921776|583214170|FG007|Overall Study|patient deterioration, fatigue|0|||
161497207|NCT02921776|583214163|FG000|Overall Study|Withdrawal by Subject|0|||
161497208|NCT02921776|583214164|FG001|Overall Study|Withdrawal by Subject|2|||
161497209|NCT02921776|583214165|FG002|Overall Study|Withdrawal by Subject|0|||
161497210|NCT02921776|583214166|FG003|Overall Study|Withdrawal by Subject|1|||
161497211|NCT02921776|583214167|FG004|Overall Study|Withdrawal by Subject|1|||
161497212|NCT02921776|583214168|FG005|Overall Study|Withdrawal by Subject|0|||
161497213|NCT02921776|583214169|FG006|Overall Study|Withdrawal by Subject|8|||
161497214|NCT02921776|583214170|FG007|Overall Study|Withdrawal by Subject|1|||
161672678|NCT03442114|583854575|FG001|Overall Study|Physician Decision|2|||
161672679|NCT03442114|583854574|FG000|Overall Study|Protocol Violation|0|||
161672680|NCT03442114|583854575|FG001|Overall Study|Protocol Violation|2|||
161672681|NCT03442114|583854574|FG000|Overall Study|Withdrawal by Subject|1|||
161672682|NCT03442114|583854575|FG001|Overall Study|Withdrawal by Subject|3|||
161672683|NCT03442114|583854574|FG000|Overall Study|Guardianship Change|0|||
161672684|NCT03442114|583854575|FG001|Overall Study|Guardianship Change|1|||
161672685|NCT03808688|583856402|FG000|Overall Study|Adverse Event|13|||
161672686|NCT03808688|583856403|FG001|Overall Study|Adverse Event|17|||
161672687|NCT03808688|583856402|FG000|Overall Study|Lack of Efficacy|2|||
161672688|NCT03808688|583856403|FG001|Overall Study|Lack of Efficacy|0|||
161672689|NCT03808688|583856402|FG000|Overall Study|Lost to Follow-up|0|||
161672690|NCT03808688|583856403|FG001|Overall Study|Lost to Follow-up|2|||
161672691|NCT03808688|583856402|FG000|Overall Study|Withdrawal by Subject|1|||
161672692|NCT03808688|583856403|FG001|Overall Study|Withdrawal by Subject|0|||
161672693|NCT03808688|583856402|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
161497215|NCT02921776|583214163|FG000|Overall Study|Death|0|||
161497216|NCT02921776|583214164|FG001|Overall Study|Death|0|||
161497217|NCT02921776|583214165|FG002|Overall Study|Death|0|||
161497218|NCT02921776|583214166|FG003|Overall Study|Death|2|||
161497219|NCT02921776|583214167|FG004|Overall Study|Death|0|||
161672694|NCT03808688|583856403|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
161672695|NCT03808688|583856402|FG000|Overall Study|IOP Too High|1|||
161672696|NCT03808688|583856403|FG001|Overall Study|IOP Too High|1|||
161672697|NCT03808688|583856402|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
161672698|NCT03808688|583856403|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
161672699|NCT03808688|583856402|FG000|Overall Study|Visit Out of Window|0|||
161497220|NCT02921776|583214168|FG005|Overall Study|Death|0|||
161497221|NCT02921776|583214169|FG006|Overall Study|Death|0|||
161497222|NCT02921776|583214170|FG007|Overall Study|Death|0|||
161497223|NCT02921776|583214163|FG000|Overall Study|extubation or early discharge|0|||
161497224|NCT02921776|583214164|FG001|Overall Study|extubation or early discharge|0|||
161497225|NCT02921776|583214165|FG002|Overall Study|extubation or early discharge|0|||
161497226|NCT02921776|583214166|FG003|Overall Study|extubation or early discharge|5|||
161497227|NCT02921776|583214167|FG004|Overall Study|extubation or early discharge|5|||
161497228|NCT02921776|583214168|FG005|Overall Study|extubation or early discharge|0|||
161497229|NCT02921776|583214169|FG006|Overall Study|extubation or early discharge|0|||
161497230|NCT02921776|583214170|FG007|Overall Study|extubation or early discharge|0|||
161497231|NCT02921776|583214163|FG000|Overall Study|Lost to Follow-up|0|||
161497232|NCT02921776|583214164|FG001|Overall Study|Lost to Follow-up|0|||
161497233|NCT02921776|583214165|FG002|Overall Study|Lost to Follow-up|0|||
161497234|NCT02921776|583214166|FG003|Overall Study|Lost to Follow-up|0|||
161497235|NCT02921776|583214167|FG004|Overall Study|Lost to Follow-up|0|||
161497236|NCT02921776|583214168|FG005|Overall Study|Lost to Follow-up|2|||
161497237|NCT02921776|583214169|FG006|Overall Study|Lost to Follow-up|3|||
161497238|NCT02921776|583214170|FG007|Overall Study|Lost to Follow-up|6|||
161497239|NCT01239368|583215353|FG000|Overall Study|Principal investigator discretion|1|||
161497240|NCT01239368|583215354|FG001|Overall Study|Principal investigator discretion|0|||
161497241|NCT01239368|583215355|FG002|Overall Study|Principal investigator discretion|0|||
161497242|NCT01239368|583215356|FG003|Overall Study|Principal investigator discretion|0|||
161497243|NCT01239368|583215357|FG004|Overall Study|Principal investigator discretion|1|||
161497244|NCT01239368|583215358|FG005|Overall Study|Principal investigator discretion|2|||
161497245|NCT01239368|583215359|FG006|Overall Study|Principal investigator discretion|0|||
161497246|NCT01239368|583215360|FG007|Overall Study|Principal investigator discretion|0|||
161497247|NCT01239368|583215361|FG008|Overall Study|Principal investigator discretion|0|||
161497248|NCT01239368|583215362|FG009|Overall Study|Principal investigator discretion|1|||
161497249|NCT01239368|583215353|FG000|Overall Study|Disease progression on study|1|||
161497250|NCT01239368|583215354|FG001|Overall Study|Disease progression on study|1|||
161497251|NCT01239368|583215355|FG002|Overall Study|Disease progression on study|1|||
161497252|NCT01239368|583215356|FG003|Overall Study|Disease progression on study|1|||
161497253|NCT01239368|583215357|FG004|Overall Study|Disease progression on study|4|||
161497254|NCT01239368|583215358|FG005|Overall Study|Disease progression on study|2|||
161497255|NCT01239368|583215359|FG006|Overall Study|Disease progression on study|5|||
161497256|NCT01239368|583215360|FG007|Overall Study|Disease progression on study|0|||
161497257|NCT01239368|583215361|FG008|Overall Study|Disease progression on study|0|||
161497258|NCT01239368|583215362|FG009|Overall Study|Disease progression on study|2|||
161497259|NCT01239368|583215353|FG000|Overall Study|Refused further treatment|0|||
161497260|NCT01239368|583215354|FG001|Overall Study|Refused further treatment|0|||
161497261|NCT01239368|583215355|FG002|Overall Study|Refused further treatment|0|||
161672700|NCT03808688|583856403|FG001|Overall Study|Visit Out of Window|1|||
161672701|NCT03808688|583856402|FG000|Overall Study|Medication Non-Compliance|0|||
161672702|NCT03808688|583856403|FG001|Overall Study|Medication Non-Compliance|1|||
161672703|NCT03335163|583856407|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
161672704|NCT03335163|583856407|FG000|Overall Study|Withdrawal by Subject|18|||
161672705|NCT01215175|583856409|FG000|Overall Study|Lost to Follow-up|0|||
161672706|NCT01215175|583856410|FG001|Overall Study|Lost to Follow-up|1|||
161672707|NCT01215175|583856411|FG002|Overall Study|Lost to Follow-up|0|||
161672708|NCT01215175|583856412|FG003|Overall Study|Lost to Follow-up|1|||
161672709|NCT01215175|583856413|FG004|Overall Study|Lost to Follow-up|0|||
161672710|NCT01016964|583856414|FG000|Overall Study|Lost to Follow-up|3|||
161672711|NCT01016964|583856415|FG001|Overall Study|Lost to Follow-up|3|||
161672712|NCT03872453|583856416|FG000|Overall Study|Adverse Event|1|||
161672713|NCT03872453|583856417|FG001|Overall Study|Adverse Event|1|||
161672714|NCT03872453|583856418|FG002|Overall Study|Adverse Event|0|||
161672715|NCT03872453|583856419|FG003|Overall Study|Adverse Event|0|||
161672716|NCT03872453|583856416|FG000|Overall Study|Lost to Follow-up|8|||
161672717|NCT03872453|583856417|FG001|Overall Study|Lost to Follow-up|7|||
161672718|NCT03872453|583856418|FG002|Overall Study|Lost to Follow-up|4|||
161672719|NCT03872453|583856419|FG003|Overall Study|Lost to Follow-up|4|||
161672720|NCT03872453|583856416|FG000|Overall Study|Never Treated Migraine|19|||
161672721|NCT03872453|583856417|FG001|Overall Study|Never Treated Migraine|17|||
161497262|NCT01239368|583215356|FG003|Overall Study|Refused further treatment|0|||
161497263|NCT01239368|583215357|FG004|Overall Study|Refused further treatment|0|||
161497264|NCT01239368|583215358|FG005|Overall Study|Refused further treatment|0|||
161497265|NCT01239368|583215359|FG006|Overall Study|Refused further treatment|0|||
161497266|NCT01239368|583215360|FG007|Overall Study|Refused further treatment|0|||
161497267|NCT01239368|583215361|FG008|Overall Study|Refused further treatment|0|||
161497268|NCT01239368|583215362|FG009|Overall Study|Refused further treatment|1|||
161672722|NCT03872453|583856418|FG002|Overall Study|Never Treated Migraine|13|||
161672723|NCT03872453|583856419|FG003|Overall Study|Never Treated Migraine|12|||
161672724|NCT03872453|583856416|FG000|Overall Study|Pregnancy|1|||
161672725|NCT03872453|583856417|FG001|Overall Study|Pregnancy|0|||
161672726|NCT03872453|583856418|FG002|Overall Study|Pregnancy|0|||
161497269|NCT01239368|583215353|FG000|Overall Study|Death|0|||
161497270|NCT01239368|583215354|FG001|Overall Study|Death|0|||
161497271|NCT01239368|583215355|FG002|Overall Study|Death|0|||
161497272|NCT01239368|583215356|FG003|Overall Study|Death|0|||
161497273|NCT01239368|583215357|FG004|Overall Study|Death|0|||
161497274|NCT01239368|583215358|FG005|Overall Study|Death|0|||
161497275|NCT01239368|583215359|FG006|Overall Study|Death|1|||
161497276|NCT01239368|583215360|FG007|Overall Study|Death|0|||
161497277|NCT01239368|583215361|FG008|Overall Study|Death|0|||
161497278|NCT01239368|583215362|FG009|Overall Study|Death|0|||
161497279|NCT04709575|583215363|FG000|Overall Study|Withdrawal by Subject|6|||
161497280|NCT04709575|583215364|FG001|Overall Study|Withdrawal by Subject|2|||
161497281|NCT04709575|583215363|FG000|Overall Study|Lost to Follow-up|2|||
161497282|NCT04709575|583215364|FG001|Overall Study|Lost to Follow-up|2|||
161497283|NCT04709575|583215363|FG000|Overall Study|Adverse Event|1|||
161497284|NCT04709575|583215364|FG001|Overall Study|Adverse Event|0|||
161497285|NCT04709575|583215363|FG000|Overall Study|Protocol Violation|1|||
161497286|NCT04709575|583215364|FG001|Overall Study|Protocol Violation|1|||
161497287|NCT03181399|583215366|FG000|6 Months on Treatment|Protocol non-compliance|7|||
161497288|NCT03181399|583215366|FG000|6 Months on Treatment|Adverse Event|4|||
161497289|NCT03181399|583215366|FG000|6 Months on Treatment|Tried alternative treatment|2|||
161497290|NCT03181399|583215366|FG000|6 Months on Treatment|Lost to Follow-up|2|||
161497291|NCT03181399|583215366|FG000|6 Months on Treatment|Personal reasons|1|||
161497292|NCT03181399|583215366|FG000|3 Months Off-treatment|Parent unable to travel|1|||
161497293|NCT00858442|583215369|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
161497294|NCT00858442|583215370|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
161497295|NCT02016625|583215371|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
161497296|NCT02016625|583215372|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
161497297|NCT02016625|583215371|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
161585409|NCT05368558|583529923|FG006|Blinded Extension Period (BEP)|other|0|||
161585410|NCT05368558|583529924|FG007|Blinded Extension Period (BEP)|other|0|||
161585411|NCT05368558|583529925|FG008|Blinded Extension Period (BEP)|other|0|||
161585412|NCT05368558|583529926|FG009|Blinded Extension Period (BEP)|other|0|||
161585413|NCT05368558|583529927|FG010|Blinded Extension Period (BEP)|other|0|||
161585414|NCT05368558|583529928|FG011|Blinded Extension Period (BEP)|other|0|||
161585415|NCT01303445|583529931|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
161585416|NCT01303445|583529932|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
161585417|NCT01303445|583529931|FG000|Second Intervention (7 Days)|Adverse Event|0|||
161585418|NCT01303445|583529932|FG001|Second Intervention (7 Days)|Adverse Event|2|||
161585419|NCT01303445|583529931|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
161585420|NCT01303445|583529932|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
161585421|NCT01303445|583529931|FG000|Washout (14 Days)|Protocol Violation|1|||
161585422|NCT01303445|583529932|FG001|Washout (14 Days)|Protocol Violation|0|||
161585423|NCT01303445|583529931|FG000|Washout (14 Days)|Lost to Follow-up|0|||
161585424|NCT01303445|583529932|FG001|Washout (14 Days)|Lost to Follow-up|2|||
161585425|NCT01303445|583529931|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
161585426|NCT01303445|583529932|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
161585427|NCT01303445|583529931|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
161585428|NCT01303445|583529932|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
161585429|NCT04459416|583531736|FG000|Overall Study|Lost to Follow-up|2|||
161585430|NCT04459416|583531737|FG001|Overall Study|Lost to Follow-up|0|||
161585431|NCT04459416|583531736|FG000|Overall Study|Withdrawal by Subject|8|||
161585432|NCT04459416|583531737|FG001|Overall Study|Withdrawal by Subject|10|||
161585433|NCT04459416|583531736|FG000|Overall Study|Disease progression|0|||
161585434|NCT04459416|583531737|FG001|Overall Study|Disease progression|3|||
161585435|NCT03744312|583531738|FG000|Overall Study|Withdrawal by Subject|0|||
161585436|NCT03744312|583531739|FG001|Overall Study|Withdrawal by Subject|1|||
161585437|NCT03744312|583531738|FG000|Overall Study|Screen fail|0|||
161585438|NCT03744312|583531739|FG001|Overall Study|Screen fail|1|||
161585439|NCT05134337|583531740|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
161585440|NCT05134337|583531741|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
161585441|NCT04923347|583531742|FG000|Overall Study|Withdrawal by Subject|14|||
161585442|NCT01259401|583531743|FG000|4-month Follow-up|Death|0|||
161585443|NCT01259401|583531744|FG001|4-month Follow-up|Death|1|||
161497298|NCT02016625|583215372|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
161497299|NCT02016625|583215371|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
161497300|NCT02016625|583215372|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
161497301|NCT03970733|583215376|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
161497302|NCT03970733|583215377|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
161585444|NCT01259401|583531743|FG000|4-month Follow-up|Lost to Follow-up|0|||
161497303|NCT03970733|583215378|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
161497304|NCT03970733|583215379|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
161497305|NCT03970733|583215380|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
161585445|NCT01259401|583531744|FG001|4-month Follow-up|Lost to Follow-up|1|||
161497306|NCT03970733|583215376|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
161497307|NCT03970733|583215377|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
161497308|NCT03970733|583215378|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
161497309|NCT03970733|583215379|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
161497310|NCT03970733|583215380|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
161497311|NCT03970733|583215376|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
161497312|NCT03970733|583215377|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
161497313|NCT03970733|583215378|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
161497314|NCT03970733|583215379|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
161585446|NCT05478525|583531747|FG000|Overall Study|Withdrawal by Subject|0|||
161497315|NCT03970733|583215380|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
161585447|NCT05478525|583531748|FG001|Overall Study|Withdrawal by Subject|1|||
161585448|NCT05478525|583531749|FG002|Overall Study|Withdrawal by Subject|2|||
161585449|NCT05478525|583531750|FG003|Overall Study|Withdrawal by Subject|0|||
161585450|NCT05478525|583531747|FG000|Overall Study|COVID-19 Infection|2|||
161585451|NCT05478525|583531748|FG001|Overall Study|COVID-19 Infection|0|||
161585452|NCT05478525|583531749|FG002|Overall Study|COVID-19 Infection|1|||
161585453|NCT05478525|583531750|FG003|Overall Study|COVID-19 Infection|1|||
161585454|NCT01649271|583531751|FG000|Overall Study|Progressive disease|4|||
161585455|NCT01649271|583531752|FG001|Overall Study|Progressive disease|5|||
161585456|NCT01649271|583531751|FG000|Overall Study|Other Adverse Event|0|||
161585457|NCT01649271|583531752|FG001|Overall Study|Other Adverse Event|2|||
161585458|NCT01649271|583531751|FG000|Overall Study|Withdrawal by Subject|1|||
161585459|NCT01649271|583531752|FG001|Overall Study|Withdrawal by Subject|0|||
161585460|NCT01649271|583531751|FG000|Overall Study|Other than stated above|1|||
161585461|NCT01649271|583531752|FG001|Overall Study|Other than stated above|0|||
161585462|NCT05644002|583531755|FG000|Overall Study|Lost to Follow-up|1|||
161585463|NCT05644002|583531756|FG001|Overall Study|Lost to Follow-up|2|||
161585464|NCT05644002|583531755|FG000|Overall Study|Withdrawal by Subject|0|||
161585465|NCT05644002|583531756|FG001|Overall Study|Withdrawal by Subject|1|||
161585466|NCT05756075|583531761|FG000|Overall Study|Withdrawal by Subject|16|||
161585467|NCT05756075|583531762|FG001|Overall Study|Withdrawal by Subject|9|||
161585468|NCT01991977|583531763|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
161585469|NCT01991977|583531763|FG000|Overall Study|Withdrew after start of treatment|5|||
161585470|NCT04038957|583531765|FG000|Overall Study|Withdrawal by Subject|1|||
161585471|NCT04038957|583531765|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
161585472|NCT02605837|583531767|FG000|Overall Study|Adverse Event|3|||
161585473|NCT02605837|583531768|FG001|Overall Study|Adverse Event|1|||
161585474|NCT02605837|583531767|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161585475|NCT02605837|583531768|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161585476|NCT02605837|583531767|FG000|Overall Study|Withdrawal by Subject|8|||
161585477|NCT02605837|583531768|FG001|Overall Study|Withdrawal by Subject|8|||
161585478|NCT02605837|583531767|FG000|Overall Study|Physician Decision|0|||
161585479|NCT02605837|583531768|FG001|Overall Study|Physician Decision|1|||
161585480|NCT05656911|583531771|FG000|Treatment Phase|Physician Decision|2|||
161585481|NCT05656911|583531772|FG001|Treatment Phase|Physician Decision|0|||
161585482|NCT05656911|583531771|FG000|Treatment Phase|Lack of Efficacy|6|||
161585483|NCT05656911|583531772|FG001|Treatment Phase|Lack of Efficacy|3|||
161585484|NCT05656911|583531771|FG000|Treatment Phase|Subject Decision|4|||
161585485|NCT05656911|583531772|FG001|Treatment Phase|Subject Decision|2|||
161585486|NCT05656911|583531771|FG000|Treatment Phase|Other Reasons|1|||
161585487|NCT05656911|583531772|FG001|Treatment Phase|Other Reasons|0|||
161585488|NCT05656911|583531771|FG000|Treatment Phase|Adverse Event|3|||
161585489|NCT05656911|583531772|FG001|Treatment Phase|Adverse Event|1|||
161585490|NCT05656911|583531771|FG000|Follow-up Phase|Subject Decision|0|||
161585491|NCT05656911|583531772|FG001|Follow-up Phase|Subject Decision|1|||
161585492|NCT05656911|583531771|FG000|Follow-up Phase|Missing|1|||
161585493|NCT05656911|583531772|FG001|Follow-up Phase|Missing|0|||
161585494|NCT02201108|583531779|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
161585495|NCT02201108|583531780|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
161585496|NCT02201108|583531781|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
161497316|NCT03970733|583215376|FG000|Main Study Phase (18 Months)|Other|1|||
161497317|NCT03970733|583215377|FG001|Main Study Phase (18 Months)|Other|1|||
161585497|NCT02201108|583531779|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
161585498|NCT02201108|583531780|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
161585499|NCT02201108|583531781|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
161585500|NCT02201108|583531779|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
161585501|NCT02201108|583531780|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
161585502|NCT02201108|583531781|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
161585503|NCT02201108|583531779|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
161585504|NCT02201108|583531780|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
161585505|NCT02201108|583531781|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
161585506|NCT02201108|583531779|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
161585507|NCT02201108|583531780|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
161497318|NCT03970733|583215378|FG002|Main Study Phase (18 Months)|Other|0|||
161497319|NCT03970733|583215379|FG003|Main Study Phase (18 Months)|Other|0|||
161497320|NCT03970733|583215380|FG004|Main Study Phase (18 Months)|Other|0|||
161497321|NCT03970733|583215376|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
161497322|NCT03970733|583215377|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
161497323|NCT03970733|583215378|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
161497324|NCT03970733|583215379|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
161497325|NCT03970733|583215380|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
161497326|NCT02784821|583215384|FG000|Overall Study|Death|0|||
161497327|NCT02784821|583215385|FG001|Overall Study|Death|5|||
161497328|NCT02784821|583215386|FG002|Overall Study|Death|4|||
161497329|NCT02784821|583215387|FG003|Overall Study|Death|5|||
161497330|NCT02794103|583215388|FG000|Overall Study|Loss to follow up due to high sedation|3|||
161497331|NCT01139450|583215389|FG000|Overall Study|Withdrawal by Subject|7|||
161497332|NCT01139450|583215390|FG001|Overall Study|Withdrawal by Subject|10|||
161497333|NCT01139450|583215391|FG002|Overall Study|Withdrawal by Subject|13|||
161497334|NCT01139450|583215389|FG000|Overall Study|Lack of Efficacy|3|||
161497335|NCT01139450|583215390|FG001|Overall Study|Lack of Efficacy|1|||
161497336|NCT01139450|583215391|FG002|Overall Study|Lack of Efficacy|8|||
161497337|NCT01139450|583215389|FG000|Overall Study|Protocol Violation|6|||
161497338|NCT01139450|583215390|FG001|Overall Study|Protocol Violation|5|||
161497339|NCT01139450|583215391|FG002|Overall Study|Protocol Violation|2|||
161497340|NCT01139450|583215389|FG000|Overall Study|Lost to Follow-up|9|||
161497341|NCT01139450|583215390|FG001|Overall Study|Lost to Follow-up|7|||
161585508|NCT02201108|583531781|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
161585509|NCT02201108|583531779|FG000|Open Label Period (up to Week 192)|Other reason|4|||
161818507|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
161818508|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
161818509|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
161818510|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
161818511|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
161818512|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
161818513|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
161818514|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
161818515|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
161818516|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
161818517|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
161818518|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
161818519|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
161818520|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
161818521|NCT02705716|584376125|FG000|Overall Study|Adverse Event|0|||
161818522|NCT02705716|584376126|FG001|Overall Study|Adverse Event|1|||
161818523|NCT02705716|584376125|FG000|Overall Study|Protocol Violation|3|||
161818524|NCT02705716|584376126|FG001|Overall Study|Protocol Violation|0|||
161818525|NCT02705716|584376125|FG000|Overall Study|Withdrawal of Consent|1|||
161585510|NCT02201108|583531780|FG001|Open Label Period (up to Week 192)|Other reason|7|||
161585511|NCT02201108|583531781|FG002|Open Label Period (up to Week 192)|Other reason|0|||
161818526|NCT02705716|584376126|FG001|Overall Study|Withdrawal of Consent|1|||
161818527|NCT00562718|584376127|FG000|Overall Study|Death|1|||
161818528|NCT00562718|584376127|FG000|Overall Study|Withdrawal by Subject|3|||
161818529|NCT00562718|584376127|FG000|Overall Study|Adverse Event|4|||
161818530|NCT00562718|584376127|FG000|Overall Study|Lack of Efficacy|2|||
161818531|NCT00562718|584376127|FG000|Overall Study|not stated|1|||
161818532|NCT01151618|584376128|FG000|Overall Study|Adverse Event|2|||
161818533|NCT01151618|584376128|FG000|Overall Study|Withdrawal by Subject|7|||
161818534|NCT04025021|584376129|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
161818535|NCT04025021|584376130|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
161818536|NCT00842309|584376137|FG000|Overall Study|Withdrawal by Subject|3|||
161818537|NCT00842309|584376138|FG001|Overall Study|Withdrawal by Subject|1|||
161818538|NCT02670551|584376139|FG000|Overall Study|Adverse Event|4|||
161497342|NCT01139450|583215391|FG002|Overall Study|Lost to Follow-up|11|||
161497343|NCT01139450|583215389|FG000|Overall Study|Administrative|0|||
161497344|NCT01139450|583215390|FG001|Overall Study|Administrative|0|||
161497345|NCT01139450|583215391|FG002|Overall Study|Administrative|1|||
161497346|NCT01139450|583215389|FG000|Overall Study|Adverse Event|2|||
161497347|NCT01139450|583215390|FG001|Overall Study|Adverse Event|2|||
161585512|NCT02201108|583531779|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
161585513|NCT02201108|583531780|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
161585514|NCT02201108|583531781|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
161818539|NCT02670551|584376140|FG001|Overall Study|Adverse Event|7|||
161818540|NCT02670551|584376141|FG002|Overall Study|Adverse Event|9|||
161818541|NCT02670551|584376139|FG000|Overall Study|Lack of Efficacy|2|||
161818542|NCT02670551|584376140|FG001|Overall Study|Lack of Efficacy|0|||
161818543|NCT02670551|584376141|FG002|Overall Study|Lack of Efficacy|3|||
161497348|NCT01139450|583215391|FG002|Overall Study|Adverse Event|3|||
161497349|NCT02082210|583215397|FG000|Overall Study|Death|0|||
161497350|NCT02082210|583215398|FG001|Overall Study|Death|0|||
161497351|NCT02082210|583215399|FG002|Overall Study|Death|1|||
161497352|NCT02082210|583215400|FG003|Overall Study|Death|1|||
161497353|NCT02082210|583215401|FG004|Overall Study|Death|1|||
161497354|NCT02082210|583215402|FG005|Overall Study|Death|0|||
161497355|NCT02082210|583215397|FG000|Overall Study|Withdrawal by Subject|0|||
161497356|NCT02082210|583215398|FG001|Overall Study|Withdrawal by Subject|0|||
161497357|NCT02082210|583215399|FG002|Overall Study|Withdrawal by Subject|0|||
161497358|NCT02082210|583215400|FG003|Overall Study|Withdrawal by Subject|1|||
161497359|NCT02082210|583215401|FG004|Overall Study|Withdrawal by Subject|2|||
161497360|NCT02082210|583215402|FG005|Overall Study|Withdrawal by Subject|2|||
161497361|NCT02082210|583215397|FG000|Overall Study|Clinical Progression|0|||
161497362|NCT02082210|583215398|FG001|Overall Study|Clinical Progression|0|||
161497363|NCT02082210|583215399|FG002|Overall Study|Clinical Progression|0|||
161497364|NCT02082210|583215400|FG003|Overall Study|Clinical Progression|1|||
161497365|NCT02082210|583215401|FG004|Overall Study|Clinical Progression|0|||
161497366|NCT02082210|583215402|FG005|Overall Study|Clinical Progression|0|||
161497367|NCT02082210|583215397|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
161497368|NCT02082210|583215398|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
161497369|NCT02082210|583215399|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
161497370|NCT02082210|583215400|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
161497371|NCT02082210|583215401|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
161497372|NCT02082210|583215402|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
161497373|NCT02082210|583215397|FG000|Overall Study|Physician Decision|0|||
161497374|NCT02082210|583215398|FG001|Overall Study|Physician Decision|0|||
161497375|NCT02082210|583215399|FG002|Overall Study|Physician Decision|1|||
161497376|NCT02082210|583215400|FG003|Overall Study|Physician Decision|1|||
161497377|NCT02082210|583215401|FG004|Overall Study|Physician Decision|0|||
161497378|NCT02082210|583215402|FG005|Overall Study|Physician Decision|0|||
161497379|NCT01859494|583215413|FG000|Overall Study|Adverse Event|1|||
161497380|NCT01290666|583215419|FG000|Overall Study|Lost to Follow-up|11|||
161497381|NCT01290666|583215419|FG000|Overall Study|Withdrawal by Subject|23|||
161497382|NCT01290666|583215419|FG000|Overall Study|Early Termination of Study|4|||
161497383|NCT00297037|583215422|FG000|Overall Study|Withdrawal by Subject|2|||
161497384|NCT00297037|583215423|FG001|Overall Study|Withdrawal by Subject|0|||
161497385|NCT05089682|583215430|FG000|Overall Study|Withdrawal by Subject|2|||
161497386|NCT00483379|583215436|FG000|Treatment Period|Adverse Event|1|||
161497387|NCT00483379|583215437|FG001|Treatment Period|Adverse Event|0|||
161497388|NCT00483379|583215436|FG000|Treatment Period|Withdrawal by Subject|1|||
161672727|NCT03872453|583856419|FG003|Overall Study|Pregnancy|0|||
161672728|NCT03872453|583856416|FG000|Overall Study|Protocol Deviation|2|||
161672729|NCT03872453|583856417|FG001|Overall Study|Protocol Deviation|0|||
161672730|NCT03872453|583856418|FG002|Overall Study|Protocol Deviation|0|||
161672731|NCT03872453|583856419|FG003|Overall Study|Protocol Deviation|2|||
161672732|NCT03872453|583856416|FG000|Overall Study|Withdrawal by Subject|0|||
161672733|NCT03872453|583856417|FG001|Overall Study|Withdrawal by Subject|1|||
161672734|NCT03872453|583856418|FG002|Overall Study|Withdrawal by Subject|2|||
161497389|NCT00483379|583215437|FG001|Treatment Period|Withdrawal by Subject|0|||
161497390|NCT00371254|583215439|FG000|Overall Study|Disease progression|13|||
161497391|NCT00371254|583215440|FG001|Overall Study|Disease progression|13|||
161497392|NCT00371254|583215439|FG000|Overall Study|Study drug toxicity|3|||
161497393|NCT00371254|583215440|FG001|Overall Study|Study drug toxicity|5|||
161497394|NCT00371254|583215439|FG000|Overall Study|Subject request|5|||
161497395|NCT00371254|583215440|FG001|Overall Study|Subject request|0|||
161497396|NCT00371254|583215439|FG000|Overall Study|Investigator Decision|2|||
161497397|NCT00371254|583215440|FG001|Overall Study|Investigator Decision|0|||
161497398|NCT00371254|583215439|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161497399|NCT00371254|583215440|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161497400|NCT00371254|583215439|FG000|Overall Study|Lost to Follow-up|0|||
161497401|NCT00371254|583215440|FG001|Overall Study|Lost to Follow-up|1|||
161497402|NCT00371254|583215439|FG000|Overall Study|Withdrawal by Subject|0|||
161497403|NCT00371254|583215440|FG001|Overall Study|Withdrawal by Subject|1|||
161672735|NCT03872453|583856419|FG003|Overall Study|Withdrawal by Subject|0|||
161497404|NCT01817725|583215441|FG000|Overall Study|Withdrawal by Subject|1|||
161497405|NCT02418468|583215443|FG000|Overall Study|Adverse Event|1|||
161497406|NCT02418468|583215444|FG001|Overall Study|Adverse Event|0|||
161497407|NCT02418468|583215443|FG000|Overall Study|Withdrawal of informed consent|1|||
161497408|NCT02418468|583215444|FG001|Overall Study|Withdrawal of informed consent|1|||
161672736|NCT03872453|583856416|FG000|Overall Study|Other Than Specified|1|||
161497409|NCT02337907|583215445|FG000|Overall Study|Other than listed|1|||
161497410|NCT02337907|583215446|FG001|Overall Study|Other than listed|0|||
161497411|NCT02337907|583215447|FG002|Overall Study|Other than listed|0|||
161497412|NCT02337907|583215448|FG003|Overall Study|Other than listed|1|||
161672737|NCT03872453|583856417|FG001|Overall Study|Other Than Specified|0|||
161497413|NCT02337907|583215449|FG004|Overall Study|Other than listed|1|||
161497414|NCT02337907|583215450|FG005|Overall Study|Other than listed|0|||
161818544|NCT02670551|584376139|FG000|Overall Study|Withdrawal of Consent|6|||
161818545|NCT02670551|584376140|FG001|Overall Study|Withdrawal of Consent|3|||
161818546|NCT02670551|584376141|FG002|Overall Study|Withdrawal of Consent|8|||
161818547|NCT02670551|584376139|FG000|Overall Study|Lost to Follow-up|5|||
161818548|NCT02670551|584376140|FG001|Overall Study|Lost to Follow-up|7|||
161497415|NCT02337907|583215445|FG000|Overall Study|Withdrawal by Subject|2|||
161497416|NCT02337907|583215446|FG001|Overall Study|Withdrawal by Subject|3|||
161497417|NCT02337907|583215447|FG002|Overall Study|Withdrawal by Subject|0|||
161497418|NCT02337907|583215448|FG003|Overall Study|Withdrawal by Subject|2|||
161497419|NCT02337907|583215449|FG004|Overall Study|Withdrawal by Subject|5|||
161497420|NCT02337907|583215450|FG005|Overall Study|Withdrawal by Subject|0|||
161497421|NCT02337907|583215445|FG000|Overall Study|Lost to Follow-up|0|||
161497422|NCT02337907|583215446|FG001|Overall Study|Lost to Follow-up|0|||
161497423|NCT02337907|583215447|FG002|Overall Study|Lost to Follow-up|0|||
161497424|NCT02337907|583215448|FG003|Overall Study|Lost to Follow-up|0|||
161497425|NCT02337907|583215449|FG004|Overall Study|Lost to Follow-up|0|||
161818549|NCT02670551|584376141|FG002|Overall Study|Lost to Follow-up|6|||
161818550|NCT02670551|584376139|FG000|Overall Study|Protocol Violation|1|||
161497426|NCT02337907|583215450|FG005|Overall Study|Lost to Follow-up|1|||
161497427|NCT02337907|583215445|FG000|Overall Study|Adverse Event|1|||
161497428|NCT02337907|583215446|FG001|Overall Study|Adverse Event|1|||
161497429|NCT02337907|583215447|FG002|Overall Study|Adverse Event|1|||
161497430|NCT02337907|583215448|FG003|Overall Study|Adverse Event|1|||
161497431|NCT02337907|583215449|FG004|Overall Study|Adverse Event|4|||
161497432|NCT02337907|583215450|FG005|Overall Study|Adverse Event|0|||
161497433|NCT00909779|583215451|FG000|Overall Study|Adverse Event|53|||
161497434|NCT00909779|583215452|FG001|Overall Study|Adverse Event|55|||
161497435|NCT00909779|583215451|FG000|Overall Study|Lack of Efficacy|7|||
161497436|NCT00909779|583215452|FG001|Overall Study|Lack of Efficacy|4|||
161497437|NCT00909779|583215451|FG000|Overall Study|Lost to Follow-up|19|||
161497438|NCT00909779|583215452|FG001|Overall Study|Lost to Follow-up|15|||
161497439|NCT00909779|583215451|FG000|Overall Study|Physician Decision|8|||
161497440|NCT00909779|583215452|FG001|Overall Study|Physician Decision|2|||
161497441|NCT00909779|583215451|FG000|Overall Study|Protocol Violation|2|||
161497442|NCT00909779|583215452|FG001|Overall Study|Protocol Violation|5|||
161497443|NCT00909779|583215451|FG000|Overall Study|Withdrawal by Subject|116|||
161497444|NCT00909779|583215452|FG001|Overall Study|Withdrawal by Subject|80|||
161497445|NCT00909779|583215451|FG000|Overall Study|Site Ceasing Operation|2|||
161497446|NCT00909779|583215452|FG001|Overall Study|Site Ceasing Operation|2|||
161497447|NCT00909779|583215451|FG000|Overall Study|Medical Monitor Decision|1|||
161497448|NCT00909779|583215452|FG001|Overall Study|Medical Monitor Decision|0|||
161497449|NCT00909779|583215451|FG000|Overall Study|Noncompliance|1|||
161497450|NCT00909779|583215452|FG001|Overall Study|Noncompliance|1|||
161497451|NCT00909779|583215451|FG000|Overall Study|Randomized in error|1|||
161497452|NCT00909779|583215452|FG001|Overall Study|Randomized in error|1|||
161497453|NCT00949325|583215453|FG000|Overall Study|Adverse Event|0|||
161585515|NCT02201108|583531779|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
161585516|NCT02201108|583531780|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
161585517|NCT02201108|583531781|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
161585518|NCT02201108|583531779|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
161585519|NCT02201108|583531780|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
161585520|NCT02201108|583531781|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
161585521|NCT03055377|583531782|FG000|Treatment Phase|Lost to Follow-up|28|||
161585522|NCT03055377|583531783|FG001|Treatment Phase|Lost to Follow-up|24|||
161585523|NCT03055377|583531782|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
161585524|NCT03055377|583531783|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
161585525|NCT04143061|583531784|FG000|Overall Study|Protocol Deviation|0|||
161818551|NCT02670551|584376140|FG001|Overall Study|Protocol Violation|0|||
161585526|NCT04143061|583531785|FG001|Overall Study|Protocol Deviation|0|||
161585527|NCT04143061|583531786|FG002|Overall Study|Protocol Deviation|0|||
161585528|NCT04143061|583531787|FG003|Overall Study|Protocol Deviation|0|||
161818552|NCT02670551|584376141|FG002|Overall Study|Protocol Violation|0|||
161818553|NCT02670551|584376139|FG000|Overall Study|Noncompliance with study drug|3|||
161497454|NCT00949325|583215454|FG001|Overall Study|Adverse Event|2|||
161497455|NCT00949325|583215455|FG002|Overall Study|Adverse Event|0|||
161497456|NCT02809677|583215456|FG000|Overall Study|Withdrawal by Subject|8|||
161497457|NCT05172544|583215459|FG000|Overall Study|Withdrawal by Subject|1|||
161497458|NCT05172544|583215460|FG001|Overall Study|Withdrawal by Subject|0|||
161497459|NCT05172544|583215461|FG002|Overall Study|Withdrawal by Subject|0|||
161497460|NCT05172544|583215459|FG000|Overall Study|Physician Decision|0|||
161497461|NCT05172544|583215460|FG001|Overall Study|Physician Decision|0|||
161497462|NCT05172544|583215461|FG002|Overall Study|Physician Decision|1|||
161585529|NCT04143061|583531788|FG004|Overall Study|Protocol Deviation|0|||
161585530|NCT04143061|583531789|FG005|Overall Study|Protocol Deviation|0|||
161585531|NCT04143061|583531790|FG006|Overall Study|Protocol Deviation|5|||
161818554|NCT02670551|584376140|FG001|Overall Study|Noncompliance with study drug|3|||
161497463|NCT02295995|583215463|FG000|Overall Study|Lost to Follow-up|5|||
161497464|NCT02295995|583215464|FG001|Overall Study|Lost to Follow-up|1|||
161497465|NCT03649711|583215465|FG000|Overall Study|Adverse Event|0|||
161497466|NCT03649711|583215466|FG001|Overall Study|Adverse Event|1|||
161497467|NCT03649711|583215467|FG002|Overall Study|Adverse Event|0|||
161497468|NCT03649711|583215465|FG000|Overall Study|Kidney Transplant|1|||
161497469|NCT03649711|583215466|FG001|Overall Study|Kidney Transplant|0|||
161497470|NCT03649711|583215467|FG002|Overall Study|Kidney Transplant|0|||
161497471|NCT04350788|583215472|FG000|Overall Study|Lost to Follow-up|6|||
161497472|NCT04350788|583215473|FG001|Overall Study|Lost to Follow-up|2|||
161497473|NCT04350788|583215472|FG000|Overall Study|Withdrawal by Subject|2|||
161497474|NCT04350788|583215473|FG001|Overall Study|Withdrawal by Subject|4|||
161497475|NCT04350788|583215472|FG000|Overall Study|Protocol Violation|4|||
161497476|NCT04350788|583215473|FG001|Overall Study|Protocol Violation|0|||
161497477|NCT01581307|583215474|FG000|Overall Study|Withdrawal by Subject|1|||
161497478|NCT00378209|583215475|FG000|Overall Study|Progressive disease|11|||
161497479|NCT00378209|583215475|FG000|Overall Study|Adverse Event|3|||
161497480|NCT00378209|583215475|FG000|Overall Study|Initiation of non-protocol therapy|3|||
161497481|NCT00378209|583215475|FG000|Overall Study|Physician Decision|3|||
161497482|NCT00378209|583215475|FG000|Overall Study|Death|1|||
161497483|NCT00378209|583215475|FG000|Overall Study|Treatment delay|1|||
161497484|NCT02070744|583215476|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
161497485|NCT02070744|583215477|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
161497486|NCT02070744|583215478|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
161497487|NCT02070744|583215479|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
161497488|NCT02070744|583215480|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
161497489|NCT02070744|583215476|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
161497490|NCT02070744|583215477|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
161497491|NCT02070744|583215478|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
161497492|NCT02070744|583215479|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
161497493|NCT02070744|583215480|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
161497494|NCT02070744|583215476|FG000|OLE Phase (48 Weeks)|Other|0|||
161497495|NCT02070744|583215477|FG001|OLE Phase (48 Weeks)|Other|0|||
161497496|NCT02070744|583215478|FG002|OLE Phase (48 Weeks)|Other|0|||
161497497|NCT02070744|583215479|FG003|OLE Phase (48 Weeks)|Other|0|||
161497498|NCT02070744|583215480|FG004|OLE Phase (48 Weeks)|Other|1|||
161497499|NCT07114198|583215484|FG000|Overall Study|Protocol Violation|1|||
161497500|NCT07114198|583215485|FG001|Overall Study|Protocol Violation|1|||
161497501|NCT02967692|583217600|FG000|Overall Study|Progressive disease|3|||
161818555|NCT02670551|584376141|FG002|Overall Study|Noncompliance with study drug|2|||
161818556|NCT02670551|584376139|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161818557|NCT02670551|584376140|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161818558|NCT02670551|584376141|FG002|Overall Study|Other Miscellaneous Reasons|3|||
161818559|NCT02670551|584376139|FG000|Overall Study|Did Not Receive Treatment|5|||
161497502|NCT02967692|583217601|FG001|Overall Study|Progressive disease|15|||
161497503|NCT02967692|583217602|FG002|Overall Study|Progressive disease|114|||
161497504|NCT02967692|583217603|FG003|Overall Study|Progressive disease|151|||
161497505|NCT02967692|583217600|FG000|Overall Study|Subject/guardian decision|1|||
161497506|NCT02967692|583217601|FG001|Overall Study|Subject/guardian decision|1|||
161497507|NCT02967692|583217602|FG002|Overall Study|Subject/guardian decision|14|||
161497508|NCT02967692|583217603|FG003|Overall Study|Subject/guardian decision|22|||
161497509|NCT02967692|583217600|FG000|Overall Study|Death|0|||
161497510|NCT02967692|583217601|FG001|Overall Study|Death|1|||
161497511|NCT02967692|583217602|FG002|Overall Study|Death|13|||
161497512|NCT02967692|583217603|FG003|Overall Study|Death|13|||
161497513|NCT02967692|583217600|FG000|Overall Study|Protocol deviation|1|||
161497514|NCT02967692|583217601|FG001|Overall Study|Protocol deviation|0|||
161818560|NCT02670551|584376140|FG001|Overall Study|Did Not Receive Treatment|3|||
161818561|NCT02670551|584376141|FG002|Overall Study|Did Not Receive Treatment|0|||
161818562|NCT04476277|584376142|FG000|Overall Study|Withdrawal by Subject|0|||
161497515|NCT02967692|583217602|FG002|Overall Study|Protocol deviation|1|||
161497516|NCT02967692|583217603|FG003|Overall Study|Protocol deviation|1|||
161497517|NCT02967692|583217600|FG000|Overall Study|Lost to Follow-up|0|||
161818563|NCT04476277|584376143|FG001|Overall Study|Withdrawal by Subject|0|||
161818564|NCT04476277|584376144|FG002|Overall Study|Withdrawal by Subject|1|||
161497518|NCT02967692|583217601|FG001|Overall Study|Lost to Follow-up|0|||
161497519|NCT02967692|583217602|FG002|Overall Study|Lost to Follow-up|1|||
161497520|NCT02967692|583217603|FG003|Overall Study|Lost to Follow-up|0|||
161497521|NCT02967692|583217600|FG000|Overall Study|Physician Decision|0|||
161497522|NCT02967692|583217601|FG001|Overall Study|Physician Decision|0|||
161497523|NCT02967692|583217602|FG002|Overall Study|Physician Decision|22|||
161497524|NCT02967692|583217603|FG003|Overall Study|Physician Decision|13|||
161497525|NCT02967692|583217600|FG000|Overall Study|Adverse Event|2|||
161497526|NCT02967692|583217601|FG001|Overall Study|Adverse Event|9|||
161497527|NCT02967692|583217602|FG002|Overall Study|Adverse Event|60|||
161818565|NCT04476277|584376145|FG003|Overall Study|Withdrawal by Subject|0|||
161497528|NCT02967692|583217603|FG003|Overall Study|Adverse Event|28|||
161497529|NCT02967692|583217600|FG000|Overall Study|Study terminated by sponsor|2|||
161497530|NCT02967692|583217601|FG001|Overall Study|Study terminated by sponsor|1|||
161497531|NCT02967692|583217602|FG002|Overall Study|Study terminated by sponsor|42|||
161497532|NCT02967692|583217603|FG003|Overall Study|Study terminated by sponsor|37|||
161497533|NCT04439253|583217607|FG000|Overall Study|Adverse Event|1|||
161497534|NCT04439253|583217607|FG000|Overall Study|Disease progression|2|||
161497535|NCT04439253|583217607|FG000|Overall Study|Complicating disease|1|||
161497536|NCT04447417|583217608|FG000|Overall Study|Withdrawal by Subject|1|||
161497537|NCT04447417|583217609|FG001|Overall Study|Withdrawal by Subject|0|||
161497538|NCT04447417|583217608|FG000|Overall Study|Failure to meet inclusion criteria|1|||
161497539|NCT04447417|583217609|FG001|Overall Study|Failure to meet inclusion criteria|0|||
161497540|NCT04447417|583217608|FG000|Overall Study|Lost to Follow-up|1|||
161497541|NCT04447417|583217609|FG001|Overall Study|Lost to Follow-up|0|||
161497542|NCT00066066|583217610|FG000|Overall Study|Lost to Follow-up|6|||
161497543|NCT00066066|583217611|FG001|Overall Study|Lost to Follow-up|4|||
161497544|NCT00066066|583217612|FG002|Overall Study|Lost to Follow-up|7|||
161497545|NCT00066066|583217613|FG003|Overall Study|Lost to Follow-up|4|||
161497546|NCT00066066|583217614|FG004|Overall Study|Lost to Follow-up|3|||
161497547|NCT00066066|583217615|FG005|Overall Study|Lost to Follow-up|5|||
161497548|NCT02155738|583217618|FG000|Overall Study|Missing critical information|1|||
161497549|NCT02155738|583217619|FG001|Overall Study|Missing critical information|0|||
161497550|NCT02155738|583217620|FG002|Overall Study|Missing critical information|0|||
161497551|NCT02155738|583217621|FG003|Overall Study|Missing critical information|1|||
161497552|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
161497553|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
161497554|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
161497555|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
161497556|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
161497557|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
161497558|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
161497559|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
161497560|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
161497561|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
161497562|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
161497563|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
161497564|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
161497565|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
161497566|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
161497567|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
161497568|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
161497569|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
161497570|NCT00887354|583217624|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
161497571|NCT00887354|583217625|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
161672738|NCT03872453|583856418|FG002|Overall Study|Other Than Specified|0|||
161672739|NCT03872453|583856419|FG003|Overall Study|Other Than Specified|0|||
161672740|NCT01678209|583856420|FG000|Overall Study|could not scan twice|1|||
161672741|NCT01678209|583856421|FG001|Overall Study|could not scan twice|1|||
161672742|NCT01678209|583856422|FG002|Overall Study|could not scan twice|1|||
161924634|NCT01658878|584770969|FG003|Treatment Period|Disease Progression|1|||
161924635|NCT01658878|584770970|FG004|Treatment Period|Disease Progression|13|||
161924636|NCT01658878|584770971|FG005|Treatment Period|Disease Progression|3|||
161924637|NCT01658878|584770972|FG006|Treatment Period|Disease Progression|4|||
161497572|NCT00887354|583217624|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
161497573|NCT00887354|583217625|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
161497574|NCT00887354|583217624|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
161497575|NCT00887354|583217625|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
161497576|NCT00887354|583217624|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
161497577|NCT00887354|583217625|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
161497578|NCT00887354|583217624|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
161497579|NCT00887354|583217625|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
161497580|NCT00887354|583217624|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
161497581|NCT00887354|583217625|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
161497582|NCT01466348|583217626|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
161497583|NCT01466348|583217627|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
161924638|NCT01658878|584770973|FG007|Treatment Period|Disease Progression|3|||
161497584|NCT02189473|583217632|FG000|Overall Study|Death|22|||
161497585|NCT02189473|583217633|FG001|Overall Study|Death|23|||
161497586|NCT02189473|583217632|FG000|Overall Study|Lost to Follow-up|1|||
161672743|NCT01678209|583856420|FG000|Overall Study|scheduling conflicts|0|||
161924639|NCT01658878|584770974|FG008|Treatment Period|Disease Progression|5|||
161924640|NCT01658878|584770975|FG009|Treatment Period|Disease Progression|3|||
161924641|NCT01658878|584770976|FG010|Treatment Period|Disease Progression|3|||
161818566|NCT01962298|584376146|FG000|Overall Study|Protocol Violation|1|||
161818567|NCT01962298|584376147|FG001|Overall Study|Protocol Violation|0|||
161818568|NCT01962298|584376148|FG002|Overall Study|Protocol Violation|1|||
161818569|NCT01962298|584376149|FG003|Overall Study|Protocol Violation|1|||
161497587|NCT02189473|583217633|FG001|Overall Study|Lost to Follow-up|2|||
161497588|NCT01955161|583217634|FG000|Overall Study|Withdrawal before treatment|2|||
161497589|NCT01955161|583217635|FG001|Overall Study|Withdrawal before treatment|0|||
161818570|NCT01962298|584376150|FG004|Overall Study|Protocol Violation|0|||
161818571|NCT01962298|584376146|FG000|Overall Study|Data quality insufficient|2|||
161818572|NCT01962298|584376147|FG001|Overall Study|Data quality insufficient|0|||
161818573|NCT01962298|584376148|FG002|Overall Study|Data quality insufficient|3|||
161818574|NCT01962298|584376149|FG003|Overall Study|Data quality insufficient|1|||
161818575|NCT01962298|584376150|FG004|Overall Study|Data quality insufficient|4|||
161818576|NCT01962298|584376146|FG000|Overall Study|Insufficient data|0|||
161818577|NCT01962298|584376147|FG001|Overall Study|Insufficient data|2|||
161818578|NCT01962298|584376148|FG002|Overall Study|Insufficient data|1|||
161818579|NCT01962298|584376149|FG003|Overall Study|Insufficient data|0|||
161818580|NCT01962298|584376150|FG004|Overall Study|Insufficient data|1|||
161818581|NCT01962298|584376146|FG000|Overall Study|Incorrect data recorded|0|||
161818582|NCT01962298|584376147|FG001|Overall Study|Incorrect data recorded|1|||
161818583|NCT01962298|584376148|FG002|Overall Study|Incorrect data recorded|0|||
161818584|NCT01962298|584376149|FG003|Overall Study|Incorrect data recorded|0|||
161497590|NCT01955161|583217636|FG002|Overall Study|Withdrawal before treatment|1|||
161497591|NCT01955161|583217634|FG000|Overall Study|Adverse Event|10|||
161497592|NCT01955161|583217635|FG001|Overall Study|Adverse Event|14|||
161818585|NCT01962298|584376150|FG004|Overall Study|Incorrect data recorded|0|||
161818586|NCT01962298|584376146|FG000|Overall Study|Physician Decision|0|||
161818587|NCT01962298|584376147|FG001|Overall Study|Physician Decision|1|||
161818588|NCT01962298|584376148|FG002|Overall Study|Physician Decision|0|||
161818589|NCT01962298|584376149|FG003|Overall Study|Physician Decision|0|||
161818590|NCT01962298|584376150|FG004|Overall Study|Physician Decision|1|||
161818591|NCT03727139|584376151|FG000|Overall Study|Protocol Violation|60|||
161818592|NCT00566722|584376152|FG000|Overall Study|Adverse Event|0|||
161818593|NCT00566722|584376153|FG001|Overall Study|Adverse Event|1|||
161818594|NCT00566722|584376154|FG002|Overall Study|Adverse Event|0|||
161818595|NCT00566722|584376152|FG000|Overall Study|Withdrawal by Subject|0|||
161818596|NCT00566722|584376153|FG001|Overall Study|Withdrawal by Subject|0|||
161818597|NCT00566722|584376154|FG002|Overall Study|Withdrawal by Subject|1|||
161818598|NCT00566722|584376152|FG000|Overall Study|Lost to Follow-up|1|||
161818599|NCT00566722|584376153|FG001|Overall Study|Lost to Follow-up|1|||
161818600|NCT00566722|584376154|FG002|Overall Study|Lost to Follow-up|1|||
161818601|NCT00566722|584376152|FG000|Overall Study|Lack of Efficacy|1|||
161818602|NCT00566722|584376153|FG001|Overall Study|Lack of Efficacy|2|||
161818603|NCT00566722|584376154|FG002|Overall Study|Lack of Efficacy|4|||
161818604|NCT00566722|584376152|FG000|Overall Study|Did not meet exclusion criteria|0|||
161818605|NCT00566722|584376153|FG001|Overall Study|Did not meet exclusion criteria|0|||
161818606|NCT00566722|584376154|FG002|Overall Study|Did not meet exclusion criteria|2|||
161818607|NCT00566722|584376152|FG000|Overall Study|Serious adverse event|0|||
161818608|NCT00566722|584376153|FG001|Overall Study|Serious adverse event|1|||
161818609|NCT00566722|584376154|FG002|Overall Study|Serious adverse event|0|||
161818610|NCT00566722|584376152|FG000|Overall Study|Noncompliant with drug administration|0|||
161818611|NCT00566722|584376153|FG001|Overall Study|Noncompliant with drug administration|0|||
161818612|NCT00566722|584376154|FG002|Overall Study|Noncompliant with drug administration|1|||
161818613|NCT02264977|584376155|FG000|Overall Study|Death|3|||
161818614|NCT02264977|584376155|FG000|Overall Study|Physician Decision|1|||
161818615|NCT02264977|584376155|FG000|Overall Study|Refuse to return|1|||
161818616|NCT03573544|584376156|FG000|Overall Study|Adverse Event|0|||
161818617|NCT03573544|584376157|FG001|Overall Study|Adverse Event|0|||
161818618|NCT03573544|584376158|FG002|Overall Study|Adverse Event|0|||
161818619|NCT03573544|584376159|FG003|Overall Study|Adverse Event|3|||
161818620|NCT03573544|584376160|FG004|Overall Study|Adverse Event|1|||
161818621|NCT03573544|584376161|FG005|Overall Study|Adverse Event|0|||
161818622|NCT03573544|584376162|FG006|Overall Study|Adverse Event|2|||
161924642|NCT01658878|584770977|FG011|Treatment Period|Disease Progression|4|||
161818623|NCT03573544|584376163|FG007|Overall Study|Adverse Event|0|||
161818624|NCT03573544|584376156|FG000|Overall Study|Physician Decision|0|||
161818625|NCT03573544|584376157|FG001|Overall Study|Physician Decision|0|||
161924643|NCT01658878|584770978|FG012|Treatment Period|Disease Progression|43|||
161818626|NCT03573544|584376158|FG002|Overall Study|Physician Decision|0|||
161818627|NCT03573544|584376159|FG003|Overall Study|Physician Decision|0|||
161818628|NCT03573544|584376160|FG004|Overall Study|Physician Decision|0|||
161818629|NCT03573544|584376161|FG005|Overall Study|Physician Decision|0|||
161818630|NCT03573544|584376162|FG006|Overall Study|Physician Decision|1|||
161818631|NCT03573544|584376163|FG007|Overall Study|Physician Decision|0|||
161818632|NCT03573544|584376156|FG000|Overall Study|Withdrawal by Subject|2|||
161818633|NCT03573544|584376157|FG001|Overall Study|Withdrawal by Subject|0|||
161818634|NCT03573544|584376158|FG002|Overall Study|Withdrawal by Subject|0|||
161924644|NCT01658878|584770979|FG013|Treatment Period|Disease Progression|48|||
161497593|NCT01955161|583217636|FG002|Overall Study|Adverse Event|15|||
161497594|NCT01955161|583217634|FG000|Overall Study|Death|1|||
161497595|NCT01955161|583217635|FG001|Overall Study|Death|1|||
161497596|NCT01955161|583217636|FG002|Overall Study|Death|3|||
161497597|NCT01955161|583217634|FG000|Overall Study|Withdrawal by Subject|9|||
161672744|NCT01678209|583856421|FG001|Overall Study|scheduling conflicts|0|||
161672745|NCT01678209|583856422|FG002|Overall Study|scheduling conflicts|1|||
161924645|NCT01658878|584770980|FG014|Treatment Period|Disease Progression|33|||
161924646|NCT01658878|584770981|FG015|Treatment Period|Disease Progression|46|||
161924647|NCT01658878|584770982|FG016|Treatment Period|Disease Progression|41|||
161924648|NCT01658878|584770983|FG017|Treatment Period|Disease Progression|42|||
161924649|NCT01658878|584770984|FG018|Treatment Period|Disease Progression|28|||
161924650|NCT01658878|584770985|FG019|Treatment Period|Disease Progression|37|||
161924651|NCT01658878|584770986|FG020|Treatment Period|Disease Progression|37|||
161924652|NCT01658878|584770987|FG021|Treatment Period|Disease Progression|39|||
161924653|NCT01658878|584770988|FG022|Treatment Period|Disease Progression|27|||
161924654|NCT01658878|584770989|FG023|Treatment Period|Disease Progression|19|||
161924655|NCT01658878|584770966|FG000|Treatment Period|Study Drug Toxicity|0|||
161924656|NCT01658878|584770967|FG001|Treatment Period|Study Drug Toxicity|0|||
161672746|NCT01678209|583856420|FG000|Overall Study|screen fail|16|||
161672747|NCT01678209|583856421|FG001|Overall Study|screen fail|17|||
161672748|NCT01678209|583856422|FG002|Overall Study|screen fail|16|||
161672749|NCT03756350|583856427|FG000|Overall Study|Lost to Follow-up|1|||
161672750|NCT00702845|583856431|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
161672751|NCT00702845|583856432|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
161672752|NCT00702845|583856431|FG000|Overall Study|Too high ovarian response|5|||
161672753|NCT00702845|583856432|FG001|Overall Study|Too high ovarian response|1|||
161672754|NCT00702845|583856431|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
161672755|NCT00702845|583856432|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
161672756|NCT00702845|583856431|FG000|Overall Study|Insufficient ovarian response|1|||
161672757|NCT00702845|583856432|FG001|Overall Study|Insufficient ovarian response|0|||
161672758|NCT00702845|583856431|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
161672759|NCT00702845|583856432|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
161672760|NCT00702845|583856431|FG000|Overall Study|No or abnormal fertilization|4|||
161672761|NCT00702845|583856432|FG001|Overall Study|No or abnormal fertilization|2|||
161672762|NCT00702845|583856431|FG000|Overall Study|Patient's decision|2|||
161672763|NCT00702845|583856432|FG001|Overall Study|Patient's decision|1|||
161924657|NCT01658878|584770968|FG002|Treatment Period|Study Drug Toxicity|0|||
161924658|NCT01658878|584770969|FG003|Treatment Period|Study Drug Toxicity|1|||
161672764|NCT00702845|583856431|FG000|Overall Study|Not randomized|0|||
161672765|NCT00702845|583856432|FG001|Overall Study|Not randomized|1|||
161924659|NCT01658878|584770970|FG004|Treatment Period|Study Drug Toxicity|0|||
161924660|NCT01658878|584770971|FG005|Treatment Period|Study Drug Toxicity|0|||
161924661|NCT01658878|584770972|FG006|Treatment Period|Study Drug Toxicity|0|||
161924662|NCT01658878|584770973|FG007|Treatment Period|Study Drug Toxicity|0|||
161924663|NCT01658878|584770974|FG008|Treatment Period|Study Drug Toxicity|0|||
161924664|NCT01658878|584770975|FG009|Treatment Period|Study Drug Toxicity|0|||
161924665|NCT01658878|584770976|FG010|Treatment Period|Study Drug Toxicity|0|||
161924666|NCT01658878|584770977|FG011|Treatment Period|Study Drug Toxicity|0|||
161924667|NCT01658878|584770978|FG012|Treatment Period|Study Drug Toxicity|7|||
161924668|NCT01658878|584770979|FG013|Treatment Period|Study Drug Toxicity|1|||
161924669|NCT01658878|584770980|FG014|Treatment Period|Study Drug Toxicity|5|||
161924670|NCT01658878|584770981|FG015|Treatment Period|Study Drug Toxicity|0|||
161497598|NCT01955161|583217635|FG001|Overall Study|Withdrawal by Subject|8|||
161672766|NCT00440700|583856433|FG000|Overall Study|Withdrawal by Subject|8|||
161672767|NCT00440700|583856434|FG001|Overall Study|Withdrawal by Subject|8|||
161672768|NCT00440700|583856435|FG002|Overall Study|Withdrawal by Subject|4|||
161672769|NCT00928564|583856436|FG000|Overall Study|Lost to Follow-up|6|||
161672770|NCT00928564|583856437|FG001|Overall Study|Lost to Follow-up|0|||
161672771|NCT03434353|583856444|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
161672772|NCT03434353|583856445|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
161672773|NCT03434353|583856446|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
161672774|NCT03434353|583856447|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
161672775|NCT03434353|583856448|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
161497599|NCT01955161|583217636|FG002|Overall Study|Withdrawal by Subject|12|||
161497600|NCT01955161|583217634|FG000|Overall Study|Protocol Violation|2|||
161672776|NCT03434353|583856444|FG000|Overall Study|Withdrew consent|1|||
161672777|NCT03434353|583856445|FG001|Overall Study|Withdrew consent|0|||
161672778|NCT03434353|583856446|FG002|Overall Study|Withdrew consent|3|||
161672779|NCT03434353|583856447|FG003|Overall Study|Withdrew consent|0|||
161672780|NCT03434353|583856448|FG004|Overall Study|Withdrew consent|0|||
161924671|NCT01658878|584770982|FG016|Treatment Period|Study Drug Toxicity|5|||
161924672|NCT01658878|584770983|FG017|Treatment Period|Study Drug Toxicity|10|||
161924673|NCT01658878|584770984|FG018|Treatment Period|Study Drug Toxicity|12|||
161924674|NCT01658878|584770985|FG019|Treatment Period|Study Drug Toxicity|4|||
161585532|NCT04143061|583531791|FG007|Overall Study|Protocol Deviation|5|||
161585533|NCT04143061|583531784|FG000|Overall Study|Withdrawal by Subject|2|||
161585534|NCT04143061|583531785|FG001|Overall Study|Withdrawal by Subject|0|||
161585535|NCT04143061|583531786|FG002|Overall Study|Withdrawal by Subject|0|||
161585536|NCT04143061|583531787|FG003|Overall Study|Withdrawal by Subject|0|||
161585537|NCT04143061|583531788|FG004|Overall Study|Withdrawal by Subject|0|||
161585538|NCT04143061|583531789|FG005|Overall Study|Withdrawal by Subject|1|||
161585539|NCT04143061|583531790|FG006|Overall Study|Withdrawal by Subject|0|||
161585540|NCT04143061|583531791|FG007|Overall Study|Withdrawal by Subject|0|||
161818635|NCT03573544|584376159|FG003|Overall Study|Withdrawal by Subject|1|||
161818636|NCT03573544|584376160|FG004|Overall Study|Withdrawal by Subject|1|||
161818637|NCT03573544|584376161|FG005|Overall Study|Withdrawal by Subject|1|||
161818638|NCT03573544|584376162|FG006|Overall Study|Withdrawal by Subject|0|||
161585541|NCT04143061|583531784|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161585542|NCT04143061|583531785|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161585543|NCT04143061|583531786|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161585544|NCT04143061|583531787|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161585545|NCT04143061|583531788|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
161585546|NCT04143061|583531789|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
161585547|NCT04143061|583531790|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
161585548|NCT04143061|583531791|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
161818639|NCT03573544|584376163|FG007|Overall Study|Withdrawal by Subject|1|||
161818640|NCT03573544|584376156|FG000|Overall Study|Disease progression|3|||
161818641|NCT03573544|584376157|FG001|Overall Study|Disease progression|3|||
161818642|NCT03573544|584376158|FG002|Overall Study|Disease progression|6|||
161585549|NCT03289039|583531792|FG000|Overall Study|Withdrawal by Subject|0|||
161585550|NCT03289039|583531793|FG001|Overall Study|Withdrawal by Subject|1|||
161585551|NCT03289039|583531792|FG000|Overall Study|Became ineligible prior to treatment start|0|||
161585552|NCT03289039|583531793|FG001|Overall Study|Became ineligible prior to treatment start|1|||
161585553|NCT03289039|583531792|FG000|Overall Study|progressed before treatment start|1|||
161585554|NCT03289039|583531793|FG001|Overall Study|progressed before treatment start|0|||
161585555|NCT04586920|583531794|FG000|Overall Study|Lost to Follow-up|0|||
161585556|NCT04586920|583531795|FG001|Overall Study|Lost to Follow-up|0|||
161585557|NCT04586920|583531796|FG002|Overall Study|Lost to Follow-up|0|||
161818643|NCT03573544|584376159|FG003|Overall Study|Disease progression|4|||
161924675|NCT01658878|584770986|FG020|Treatment Period|Study Drug Toxicity|2|||
161924676|NCT01658878|584770987|FG021|Treatment Period|Study Drug Toxicity|3|||
161924677|NCT01658878|584770988|FG022|Treatment Period|Study Drug Toxicity|2|||
161924678|NCT01658878|584770989|FG023|Treatment Period|Study Drug Toxicity|6|||
161924679|NCT01658878|584770966|FG000|Treatment Period|Maximum Clinical Benefit|0|||
161924680|NCT01658878|584770967|FG001|Treatment Period|Maximum Clinical Benefit|0|||
161924681|NCT01658878|584770968|FG002|Treatment Period|Maximum Clinical Benefit|1|||
161924682|NCT01658878|584770969|FG003|Treatment Period|Maximum Clinical Benefit|0|||
161924683|NCT01658878|584770970|FG004|Treatment Period|Maximum Clinical Benefit|0|||
161585558|NCT04586920|583531797|FG003|Overall Study|Lost to Follow-up|0|||
161818644|NCT03573544|584376160|FG004|Overall Study|Disease progression|5|||
161818645|NCT03573544|584376161|FG005|Overall Study|Disease progression|7|||
161924684|NCT01658878|584770971|FG005|Treatment Period|Maximum Clinical Benefit|0|||
161585559|NCT04586920|583531798|FG004|Overall Study|Lost to Follow-up|0|||
161585560|NCT04586920|583531799|FG005|Overall Study|Lost to Follow-up|0|||
161585561|NCT04586920|583531800|FG006|Overall Study|Lost to Follow-up|1|||
161585562|NCT04586920|583531801|FG007|Overall Study|Lost to Follow-up|1|||
161585563|NCT04586920|583531802|FG008|Overall Study|Lost to Follow-up|0|||
161497601|NCT01955161|583217635|FG001|Overall Study|Protocol Violation|0|||
161497602|NCT01955161|583217636|FG002|Overall Study|Protocol Violation|0|||
161497603|NCT01955161|583217634|FG000|Overall Study|Other reason: physician decision|0|||
161497604|NCT01955161|583217635|FG001|Overall Study|Other reason: physician decision|1|||
161497605|NCT01955161|583217636|FG002|Overall Study|Other reason: physician decision|1|||
161497606|NCT01955161|583217634|FG000|Overall Study|Other reason: disallowed medication|1|||
161497607|NCT01955161|583217635|FG001|Overall Study|Other reason: disallowed medication|0|||
161497608|NCT01955161|583217636|FG002|Overall Study|Other reason: disallowed medication|1|||
161672781|NCT03434353|583856444|FG000|Overall Study|Adverse Event|1|||
161672782|NCT03434353|583856445|FG001|Overall Study|Adverse Event|0|||
161672783|NCT03434353|583856446|FG002|Overall Study|Adverse Event|0|||
161672784|NCT03434353|583856447|FG003|Overall Study|Adverse Event|0|||
161672785|NCT03434353|583856448|FG004|Overall Study|Adverse Event|1|||
161672786|NCT03434353|583856444|FG000|Overall Study|Lost to Follow-up|2|||
161672787|NCT03434353|583856445|FG001|Overall Study|Lost to Follow-up|0|||
161672788|NCT03434353|583856446|FG002|Overall Study|Lost to Follow-up|0|||
161672789|NCT03434353|583856447|FG003|Overall Study|Lost to Follow-up|0|||
161672790|NCT03434353|583856448|FG004|Overall Study|Lost to Follow-up|0|||
161672791|NCT03739762|583856449|FG000|Overall Study|Lost to Follow-up|1|||
161672792|NCT03739762|583856450|FG001|Overall Study|Lost to Follow-up|1|||
161672793|NCT03739762|583856449|FG000|Overall Study|Withdrawal by Subject|2|||
161672794|NCT03739762|583856450|FG001|Overall Study|Withdrawal by Subject|6|||
161672795|NCT00929656|583856451|FG000|Overall Study|Lost to Follow-up|0|||
161672796|NCT00929656|583856452|FG001|Overall Study|Lost to Follow-up|1|||
161672797|NCT00607880|583856453|FG000|Overall Study|Unable to place port due to occlusion|1|||
161672798|NCT00607880|583856454|FG001|Overall Study|Unable to place port due to occlusion|0|||
161672799|NCT04606771|583856455|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
161672800|NCT04606771|583856456|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
161672801|NCT04606771|583856455|FG000|Overall Study|Death|5|||
161672802|NCT04606771|583856456|FG001|Overall Study|Death|6|||
161672803|NCT04606771|583856455|FG000|Overall Study|Wrong randomisation|0|||
161672804|NCT04606771|583856456|FG001|Overall Study|Wrong randomisation|1|||
161672805|NCT01008696|583856458|FG000|Overall Study|Participant's evasion of hospital visit|5|||
161672806|NCT01008696|583856459|FG001|Overall Study|Participant's evasion of hospital visit|4|||
161672807|NCT01008696|583856458|FG000|Overall Study|Withdrawal by Subject|2|||
161818646|NCT03573544|584376162|FG006|Overall Study|Disease progression|6|||
161818647|NCT03573544|584376163|FG007|Overall Study|Disease progression|7|||
161818648|NCT03105297|584376164|FG000|Baseline Phase (Day 1)|Other|21|||
161818649|NCT03105297|584376164|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
161818650|NCT03105297|584376164|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
161818651|NCT00714051|584376165|FG000|Overall Study|Withdrawal by Subject|1|||
161818652|NCT00714051|584376166|FG001|Overall Study|Withdrawal by Subject|0|||
161818653|NCT00714051|584376165|FG000|Overall Study|Death|0|||
161818654|NCT00714051|584376166|FG001|Overall Study|Death|1|||
161818655|NCT01390948|584376167|FG000|Overall Study|End of Study|1|||
161818656|NCT01390948|584376168|FG001|Overall Study|End of Study|0|||
161818657|NCT01390948|584376169|FG002|Overall Study|End of Study|0|||
161818658|NCT01390948|584376167|FG000|Overall Study|Withdrew consent|2|||
161818659|NCT01390948|584376168|FG001|Overall Study|Withdrew consent|2|||
161818660|NCT01390948|584376169|FG002|Overall Study|Withdrew consent|0|||
161818661|NCT01390948|584376167|FG000|Overall Study|Progressive Disease|2|||
161818662|NCT01390948|584376168|FG001|Overall Study|Progressive Disease|5|||
161818663|NCT01390948|584376169|FG002|Overall Study|Progressive Disease|0|||
161818664|NCT01390948|584376167|FG000|Overall Study|Death during follow-up|10|||
161818665|NCT01390948|584376168|FG001|Overall Study|Death during follow-up|11|||
161818666|NCT01390948|584376169|FG002|Overall Study|Death during follow-up|1|||
161818667|NCT05740098|584376172|FG000|Overall Study|Lost to Follow-up|26|||
161818668|NCT05740098|584376173|FG001|Overall Study|Lost to Follow-up|17|||
161818669|NCT05740098|584376174|FG002|Overall Study|Lost to Follow-up|21|||
161818670|NCT00849797|584376179|FG000|First Intervention|bad veins|1|||
161818671|NCT00849797|584376180|FG001|First Intervention|bad veins|0|||
161818672|NCT00849797|584376179|FG000|First Intervention|Adverse Event|0|||
161818673|NCT00849797|584376180|FG001|First Intervention|Adverse Event|1|||
161818674|NCT00849797|584376179|FG000|Washout: One Week|Withdrawal by Subject|0|||
161818675|NCT00849797|584376180|FG001|Washout: One Week|Withdrawal by Subject|2|||
161818676|NCT01018862|584376188|FG000|Overall Study|Adverse Event|2|||
161818677|NCT01018862|584376189|FG001|Overall Study|Adverse Event|0|||
161818678|NCT01018862|584376190|FG002|Overall Study|Adverse Event|6|||
161818679|NCT01018862|584376188|FG000|Overall Study|Lack of Efficacy|1|||
161818680|NCT01018862|584376189|FG001|Overall Study|Lack of Efficacy|0|||
161672808|NCT01008696|583856459|FG001|Overall Study|Withdrawal by Subject|4|||
161672809|NCT01008696|583856458|FG000|Overall Study|Physician Decision|5|||
161672810|NCT01008696|583856459|FG001|Overall Study|Physician Decision|1|||
161672811|NCT01008696|583856458|FG000|Overall Study|Adverse Event|1|||
161672812|NCT01008696|583856459|FG001|Overall Study|Adverse Event|0|||
161672813|NCT01008696|583856458|FG000|Overall Study|Participants' non-cooperation|2|||
161672814|NCT01008696|583856459|FG001|Overall Study|Participants' non-cooperation|3|||
161818681|NCT01018862|584376190|FG002|Overall Study|Lack of Efficacy|2|||
161497609|NCT01955161|583217634|FG000|Overall Study|Other reason: caregiver unavailable|1|||
161497610|NCT01955161|583217635|FG001|Overall Study|Other reason: caregiver unavailable|0|||
161497611|NCT01955161|583217636|FG002|Overall Study|Other reason: caregiver unavailable|0|||
161497612|NCT01955161|583217634|FG000|Overall Study|Other reason: moved to nursing home|0|||
161497613|NCT01955161|583217635|FG001|Overall Study|Other reason: moved to nursing home|1|||
161497614|NCT01955161|583217636|FG002|Overall Study|Other reason: moved to nursing home|0|||
161497615|NCT01955161|583217634|FG000|Overall Study|Other reason: insufficient compliance|0|||
161497616|NCT01955161|583217635|FG001|Overall Study|Other reason: insufficient compliance|0|||
161497617|NCT01955161|583217636|FG002|Overall Study|Other reason: insufficient compliance|1|||
161497618|NCT01955161|583217634|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
161497619|NCT01955161|583217635|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
161672815|NCT01008696|583856458|FG000|Overall Study|Other|2|||
161672816|NCT01008696|583856459|FG001|Overall Study|Other|3|||
161672817|NCT01008696|583856458|FG000|Overall Study|Other|0|||
161672818|NCT01008696|583856459|FG001|Overall Study|Other|2|||
161672819|NCT01207596|583856460|FG000|Overall Study|Physician Decision|4|||
161672820|NCT01207596|583856460|FG000|Overall Study|Lack of Efficacy|1|||
161672821|NCT01207596|583856460|FG000|Overall Study|Adverse Event|3|||
161672822|NCT01207596|583856460|FG000|Overall Study|Withdrawal by Subject|1|||
161672823|NCT03083847|583856461|FG000|Main|Physician Decision|0|||
161672824|NCT03083847|583856462|FG001|Main|Physician Decision|0|||
161672825|NCT03083847|583856463|FG002|Main|Physician Decision|0|||
161672826|NCT03083847|583856464|FG003|Main|Physician Decision|0|||
161672827|NCT03083847|583856465|FG004|Main|Physician Decision|0|||
161672828|NCT03083847|583856466|FG005|Main|Physician Decision|1|||
161672829|NCT03083847|583856467|FG006|Main|Physician Decision|0|||
161672830|NCT03083847|583856468|FG007|Main|Physician Decision|0|||
161672831|NCT03083847|583856469|FG008|Main|Physician Decision|0|||
161672832|NCT03083847|583856470|FG009|Main|Physician Decision|0|||
161818682|NCT01018862|584376188|FG000|Overall Study|Lost to Follow-up|3|||
161818683|NCT01018862|584376189|FG001|Overall Study|Lost to Follow-up|1|||
161497620|NCT01955161|583217636|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
161497621|NCT01955161|583217634|FG000|Overall Study|Other reason: patient's will|0|||
161818684|NCT01018862|584376190|FG002|Overall Study|Lost to Follow-up|0|||
161818685|NCT01018862|584376188|FG000|Overall Study|Protocol Violation|1|||
161497622|NCT01955161|583217635|FG001|Overall Study|Other reason: patient's will|0|||
161497623|NCT01955161|583217636|FG002|Overall Study|Other reason: patient's will|1|||
161497624|NCT05123222|583217642|FG000|Overall Study|Lost to Follow-up|2|||
161497625|NCT05123222|583217643|FG001|Overall Study|Lost to Follow-up|0|||
161497626|NCT05123222|583217644|FG002|Overall Study|Lost to Follow-up|0|||
161497627|NCT05123222|583217645|FG003|Overall Study|Lost to Follow-up|0|||
161497628|NCT05123222|583217642|FG000|Overall Study|Protocol Violation|0|||
161497629|NCT05123222|583217643|FG001|Overall Study|Protocol Violation|0|||
161497630|NCT05123222|583217644|FG002|Overall Study|Protocol Violation|1|||
161497631|NCT05123222|583217645|FG003|Overall Study|Protocol Violation|0|||
161497632|NCT02385266|583217646|FG000|Overall Study|Withdrawal by Subject|1|||
161497633|NCT02385266|583217647|FG001|Overall Study|Withdrawal by Subject|3|||
161497634|NCT00914810|583217648|FG000|Overall Study|Withdrawal by Subject|1|||
161497635|NCT00914810|583217649|FG001|Overall Study|Withdrawal by Subject|0|||
161497636|NCT00914810|583217648|FG000|Overall Study|Relocated out of state|1|||
161497637|NCT00914810|583217649|FG001|Overall Study|Relocated out of state|0|||
161497638|NCT00914810|583217648|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
161497639|NCT00914810|583217649|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
161497640|NCT02535741|583217650|FG000|Overall Study|Adverse Event|3|||
161497641|NCT02535741|583217650|FG000|Overall Study|Withdrawal by Subject|9|||
161497642|NCT02535741|583217650|FG000|Overall Study|Lost to Follow-up|10|||
161497643|NCT02535741|583217650|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
161497644|NCT02535741|583217650|FG000|Overall Study|Missing data|6|||
161497645|NCT02731729|583217651|FG000|Overall Study|Death|2|||
161497646|NCT02731729|583217652|FG001|Overall Study|Death|2|||
161497647|NCT02731729|583217651|FG000|Overall Study|Study terminated by Sponsor|6|||
161497648|NCT02731729|583217652|FG001|Overall Study|Study terminated by Sponsor|6|||
161497649|NCT02731729|583217651|FG000|Overall Study|Withdrawal by Subject|1|||
161497650|NCT02731729|583217652|FG001|Overall Study|Withdrawal by Subject|0|||
161497651|NCT01344447|583217653|FG000|Overall Study|Adverse Event|1|||
161497652|NCT01344447|583217653|FG000|Overall Study|Protocol Violation|1|||
161497653|NCT01344447|583217653|FG000|Overall Study|Withdrawal by Subject|1|||
161497654|NCT01344447|583217653|FG000|Overall Study|The contrast was not seen|1|||
161672833|NCT03083847|583856461|FG000|Main|Pregnancy|0|||
161672834|NCT03083847|583856462|FG001|Main|Pregnancy|0|||
161672835|NCT03083847|583856463|FG002|Main|Pregnancy|0|||
161672836|NCT03083847|583856464|FG003|Main|Pregnancy|0|||
161672837|NCT03083847|583856465|FG004|Main|Pregnancy|0|||
161672838|NCT03083847|583856466|FG005|Main|Pregnancy|0|||
161672839|NCT03083847|583856467|FG006|Main|Pregnancy|0|||
161818686|NCT01018862|584376189|FG001|Overall Study|Protocol Violation|3|||
161818687|NCT01018862|584376190|FG002|Overall Study|Protocol Violation|3|||
161818688|NCT01018862|584376188|FG000|Overall Study|Withdrawal by Subject|1|||
161818689|NCT01018862|584376189|FG001|Overall Study|Withdrawal by Subject|2|||
161672840|NCT03083847|583856468|FG007|Main|Pregnancy|1|||
161672841|NCT03083847|583856469|FG008|Main|Pregnancy|0|||
161672842|NCT03083847|583856470|FG009|Main|Pregnancy|0|||
161672843|NCT03083847|583856461|FG000|Main|Adverse Event|0|||
161672844|NCT03083847|583856462|FG001|Main|Adverse Event|0|||
161672845|NCT03083847|583856463|FG002|Main|Adverse Event|0|||
161672846|NCT03083847|583856464|FG003|Main|Adverse Event|0|||
161672847|NCT03083847|583856465|FG004|Main|Adverse Event|0|||
161672848|NCT03083847|583856466|FG005|Main|Adverse Event|0|||
161672849|NCT03083847|583856467|FG006|Main|Adverse Event|0|||
161672850|NCT03083847|583856468|FG007|Main|Adverse Event|2|||
161672851|NCT03083847|583856469|FG008|Main|Adverse Event|0|||
161672852|NCT03083847|583856470|FG009|Main|Adverse Event|0|||
161672853|NCT03083847|583856461|FG000|Main|Withdrawal by Subject|0|||
161672854|NCT03083847|583856462|FG001|Main|Withdrawal by Subject|0|||
161672855|NCT03083847|583856463|FG002|Main|Withdrawal by Subject|0|||
161672856|NCT03083847|583856464|FG003|Main|Withdrawal by Subject|0|||
161672857|NCT03083847|583856465|FG004|Main|Withdrawal by Subject|0|||
161672858|NCT03083847|583856466|FG005|Main|Withdrawal by Subject|0|||
161672859|NCT03083847|583856467|FG006|Main|Withdrawal by Subject|1|||
161672860|NCT03083847|583856468|FG007|Main|Withdrawal by Subject|1|||
161672861|NCT03083847|583856469|FG008|Main|Withdrawal by Subject|0|||
161672862|NCT03083847|583856470|FG009|Main|Withdrawal by Subject|0|||
161672863|NCT00216203|583856471|FG000|Overall Study|Withdrawal by Subject|2|||
161497655|NCT01344447|583217653|FG000|Overall Study|Physician Decision|1|||
161497656|NCT01344447|583217653|FG000|Overall Study|MRA unsuccessful|1|||
161497657|NCT01344447|583217653|FG000|Overall Study|Bolus tracking failed|1|||
161497658|NCT01344447|583217653|FG000|Overall Study|Error of power injector|1|||
161497659|NCT01660711|583217654|FG000|Overall Study|Adverse Event|7|||
161497660|NCT01660711|583217654|FG000|Overall Study|Withdrawal by Subject|1|||
161497661|NCT00952341|583217656|FG000|Cycle 1|Adverse Event|4|||
161497662|NCT00952341|583217657|FG001|Cycle 1|Adverse Event|1|||
161497663|NCT00952341|583217656|FG000|Cycle 1|Withdrawal by Subject|3|||
161497664|NCT00952341|583217657|FG001|Cycle 1|Withdrawal by Subject|8|||
161497665|NCT00952341|583217656|FG000|Cycle 1|Protocol Violation|2|||
161497666|NCT00952341|583217657|FG001|Cycle 1|Protocol Violation|1|||
161497667|NCT00952341|583217656|FG000|Cycle 1|Lost to Follow-up|11|||
161497668|NCT00952341|583217657|FG001|Cycle 1|Lost to Follow-up|2|||
161497669|NCT00952341|583217656|FG000|Cycle 1|Physician Decision|0|||
161497670|NCT00952341|583217657|FG001|Cycle 1|Physician Decision|1|||
161497671|NCT00952341|583217656|FG000|Cycle 2|Withdrawal by Subject|1|||
161497672|NCT00952341|583217657|FG001|Cycle 2|Withdrawal by Subject|1|||
161497673|NCT00952341|583217656|FG000|Cycle 2|Protocol Violation|1|||
161497674|NCT00952341|583217657|FG001|Cycle 2|Protocol Violation|0|||
161497675|NCT00952341|583217656|FG000|Cycle 2|Lost to Follow-up|6|||
161497676|NCT00952341|583217657|FG001|Cycle 2|Lost to Follow-up|9|||
161585564|NCT04586920|583531803|FG009|Overall Study|Lost to Follow-up|1|||
161585565|NCT04586920|583531804|FG010|Overall Study|Lost to Follow-up|0|||
161585566|NCT04586920|583531805|FG011|Overall Study|Lost to Follow-up|0|||
161585567|NCT04586920|583531806|FG012|Overall Study|Lost to Follow-up|0|||
161585568|NCT04586920|583531807|FG013|Overall Study|Lost to Follow-up|1|||
161585569|NCT04586920|583531808|FG014|Overall Study|Lost to Follow-up|0|||
161672864|NCT02596620|583856474|FG000|Overall Study|Lost to Follow-up|1|||
161672865|NCT02596620|583856475|FG001|Overall Study|Lost to Follow-up|1|||
161924685|NCT01658878|584770972|FG006|Treatment Period|Maximum Clinical Benefit|0|||
161924686|NCT01658878|584770973|FG007|Treatment Period|Maximum Clinical Benefit|0|||
161585570|NCT04586920|583531809|FG015|Overall Study|Lost to Follow-up|0|||
161585571|NCT04586920|583531810|FG016|Overall Study|Lost to Follow-up|0|||
161585572|NCT04586920|583531811|FG017|Overall Study|Lost to Follow-up|0|||
161585573|NCT04586920|583531794|FG000|Overall Study|Withdrawal by Subject|0|||
161585574|NCT04586920|583531795|FG001|Overall Study|Withdrawal by Subject|0|||
161497677|NCT00952341|583217656|FG000|Cycle 2|Physician Decision|1|||
161497678|NCT00952341|583217657|FG001|Cycle 2|Physician Decision|1|||
161497679|NCT00952341|583217656|FG000|Cycle 2|Progressive Disease|0|||
161585575|NCT04586920|583531796|FG002|Overall Study|Withdrawal by Subject|0|||
161497680|NCT00952341|583217657|FG001|Cycle 2|Progressive Disease|1|||
161585576|NCT04586920|583531797|FG003|Overall Study|Withdrawal by Subject|0|||
161672866|NCT03155373|583856485|FG000|Overall Study|No longer required surgery|1|||
161672867|NCT03155373|583856485|FG000|Overall Study|Protocol Violation|1|||
161672868|NCT03155373|583856485|FG000|Overall Study|Death|2|||
161672869|NCT03155373|583856485|FG000|Overall Study|Withdrawal by Subject|3|||
161672870|NCT01054144|583856486|FG000|Overall Study|Death|2|||
161672871|NCT02856893|583856487|FG000|Overall Study|Lack of Efficacy|27|||
161672872|NCT02856893|583856488|FG001|Overall Study|Lack of Efficacy|15|||
161497681|NCT02066467|583217662|FG000|Overall Study|Did not undergo implant procedure|24|||
161497682|NCT02066467|583217662|FG000|Overall Study|Attempted to implant withoput success|43|||
161585577|NCT04586920|583531798|FG004|Overall Study|Withdrawal by Subject|0|||
161672873|NCT02856893|583856489|FG002|Overall Study|Lack of Efficacy|19|||
161672874|NCT02856893|583856487|FG000|Overall Study|Death|1|||
161672875|NCT02856893|583856488|FG001|Overall Study|Death|0|||
161672876|NCT02856893|583856489|FG002|Overall Study|Death|0|||
161672877|NCT02856893|583856487|FG000|Overall Study|Adverse Event|2|||
161672878|NCT02856893|583856488|FG001|Overall Study|Adverse Event|0|||
161672879|NCT02856893|583856489|FG002|Overall Study|Adverse Event|0|||
161672880|NCT02856893|583856487|FG000|Overall Study|Physician Decision|0|||
161672881|NCT02856893|583856488|FG001|Overall Study|Physician Decision|2|||
161672882|NCT02856893|583856489|FG002|Overall Study|Physician Decision|3|||
161672883|NCT02856893|583856487|FG000|Overall Study|Withdrawal by Subject|1|||
161672884|NCT02856893|583856488|FG001|Overall Study|Withdrawal by Subject|1|||
161672885|NCT02856893|583856489|FG002|Overall Study|Withdrawal by Subject|0|||
161672886|NCT02856893|583856487|FG000|Overall Study|Other reasons|2|||
161672887|NCT02856893|583856488|FG001|Overall Study|Other reasons|1|||
161672888|NCT02856893|583856489|FG002|Overall Study|Other reasons|2|||
161672889|NCT02310672|583856490|FG000|Overall Study|Death|1|||
161672890|NCT02310672|583856490|FG000|Overall Study|Lost to Follow-up|1|||
161672891|NCT02310672|583856490|FG000|Overall Study|Withdrawal by Subject|1|||
161672892|NCT02310672|583856490|FG000|Overall Study|Sponsor's decision|12|||
161672893|NCT01214187|583856494|FG000|Overall Study|Adverse Event|6|||
161672894|NCT01214187|583856495|FG001|Overall Study|Adverse Event|2|||
161672895|NCT01214187|583856494|FG000|Overall Study|Death|1|||
161672896|NCT01214187|583856495|FG001|Overall Study|Death|1|||
161672897|NCT01214187|583856494|FG000|Overall Study|Withdrawal by Subject|0|||
161672898|NCT01214187|583856495|FG001|Overall Study|Withdrawal by Subject|3|||
161672899|NCT02308007|583856504|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
161672900|NCT02308007|583856505|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
161672901|NCT02308007|583856506|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
161672902|NCT02308007|583856504|FG000|Overall Study|Positive for STD at Baseline|7|||
161672903|NCT02308007|583856505|FG001|Overall Study|Positive for STD at Baseline|11|||
161672904|NCT02308007|583856506|FG002|Overall Study|Positive for STD at Baseline|7|||
161672905|NCT02308007|583856504|FG000|Overall Study|Lost to Follow-up|3|||
161672906|NCT02308007|583856505|FG001|Overall Study|Lost to Follow-up|0|||
161672907|NCT02308007|583856506|FG002|Overall Study|Lost to Follow-up|1|||
161672908|NCT03118674|583856507|FG000|Overall Study|Lost to Follow-up|2|||
161672909|NCT03118674|583856507|FG000|Overall Study|Screen Faliure|8|||
161672910|NCT03118674|583856507|FG000|Overall Study|Withdrawal by Subject|5|||
161672911|NCT01233869|583856508|FG000|Initial Treatment Period (24 Months)|Death|1|||
161672912|NCT01233869|583856509|FG001|Initial Treatment Period (24 Months)|Death|0|||
161672913|NCT01233869|583856510|FG002|Initial Treatment Period (24 Months)|Death|0|||
161672914|NCT01233869|583856511|FG003|Initial Treatment Period (24 Months)|Death|0|||
161672915|NCT01233869|583856508|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
161672916|NCT01233869|583856509|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
161672917|NCT01233869|583856510|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
161672918|NCT01233869|583856511|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
161672919|NCT01233869|583856508|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
161672920|NCT01233869|583856509|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
161672921|NCT01233869|583856510|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
161672922|NCT01233869|583856511|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
161672923|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161672924|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161672925|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161672926|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
161672927|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
161672928|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
161672929|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
161672930|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
161585578|NCT04586920|583531799|FG005|Overall Study|Withdrawal by Subject|0|||
161585579|NCT04586920|583531800|FG006|Overall Study|Withdrawal by Subject|0|||
161585580|NCT04586920|583531801|FG007|Overall Study|Withdrawal by Subject|1|||
161585581|NCT04586920|583531802|FG008|Overall Study|Withdrawal by Subject|0|||
161585582|NCT04586920|583531803|FG009|Overall Study|Withdrawal by Subject|1|||
161585583|NCT04586920|583531804|FG010|Overall Study|Withdrawal by Subject|0|||
161585584|NCT04586920|583531805|FG011|Overall Study|Withdrawal by Subject|1|||
161585585|NCT04586920|583531806|FG012|Overall Study|Withdrawal by Subject|0|||
161585586|NCT04586920|583531807|FG013|Overall Study|Withdrawal by Subject|0|||
161585587|NCT04586920|583531808|FG014|Overall Study|Withdrawal by Subject|0|||
161585588|NCT04586920|583531809|FG015|Overall Study|Withdrawal by Subject|0|||
161585589|NCT04586920|583531810|FG016|Overall Study|Withdrawal by Subject|0|||
161585590|NCT04586920|583531811|FG017|Overall Study|Withdrawal by Subject|0|||
161585591|NCT02287311|583531812|FG000|Cohort 1: Dose Level 1|Death|2|||
161672931|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Other|3|||
161672932|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Other|0|||
161672933|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Other|0|||
161672934|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Other|3|||
161585592|NCT02287311|583531813|FG001|Cohort 1: Dose Level 1|Death|0|||
161497683|NCT02066467|583217662|FG000|Overall Study|Consent ineligible|1|||
161497684|NCT02066467|583217662|FG000|Overall Study|Death|54|||
161497685|NCT02066467|583217662|FG000|Overall Study|Lost to Follow-up|51|||
161497686|NCT02066467|583217662|FG000|Overall Study|Adverse Event|20|||
161497687|NCT02066467|583217662|FG000|Overall Study|Withdrawal by Subject|16|||
161497688|NCT02066467|583217662|FG000|Overall Study|Physician Decision|2|||
161924687|NCT01658878|584770974|FG008|Treatment Period|Maximum Clinical Benefit|0|||
161497689|NCT02066467|583217662|FG000|Overall Study|Not defined|4|||
161497690|NCT01652664|583217663|FG000|Overall Study|Treatment Failure|5|||
161497691|NCT01652664|583217664|FG001|Overall Study|Treatment Failure|1|||
161497692|NCT01652664|583217663|FG000|Overall Study|Inadequate IOP control|1|||
161497693|NCT01652664|583217664|FG001|Overall Study|Inadequate IOP control|0|||
161497694|NCT00491387|583217665|FG000|Overall Study|study terminated|20|||
161497695|NCT02914769|583217668|FG000|Overall Study|Protocol Violation|3|||
161497696|NCT02914769|583217669|FG001|Overall Study|Protocol Violation|2|||
161497697|NCT02914769|583217668|FG000|Overall Study|Withdrawal by Subject|0|||
161585593|NCT02287311|583531814|FG002|Cohort 1: Dose Level 1|Death|0|||
161585594|NCT02287311|583531815|FG003|Cohort 1: Dose Level 1|Death|3|||
161585595|NCT02287311|583531816|FG004|Cohort 1: Dose Level 1|Death|0|||
161585596|NCT02287311|583531817|FG005|Cohort 1: Dose Level 1|Death|0|||
161585597|NCT02287311|583531818|FG006|Cohort 1: Dose Level 1|Death|1|||
161585598|NCT02287311|583531819|FG007|Cohort 1: Dose Level 1|Death|0|||
161585599|NCT02287311|583531820|FG008|Cohort 1: Dose Level 1|Death|0|||
161585600|NCT02287311|583531812|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585601|NCT02287311|583531813|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585602|NCT02287311|583531814|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585603|NCT02287311|583531815|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
161585604|NCT02287311|583531816|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585605|NCT02287311|583531817|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585606|NCT02287311|583531818|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
161585607|NCT02287311|583531819|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585608|NCT02287311|583531820|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161585609|NCT02287311|583531812|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
161585610|NCT02287311|583531813|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
161585611|NCT02287311|583531814|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
161585612|NCT02287311|583531815|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
161585613|NCT02287311|583531816|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
161585614|NCT02287311|583531817|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
161585615|NCT02287311|583531818|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
161585616|NCT02287311|583531819|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
161585617|NCT02287311|583531820|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
161585618|NCT02287311|583531812|FG000|Cohort 2: Dose Level 2|Death|0|||
161585619|NCT02287311|583531813|FG001|Cohort 2: Dose Level 2|Death|2|||
161585620|NCT02287311|583531814|FG002|Cohort 2: Dose Level 2|Death|0|||
161585621|NCT02287311|583531815|FG003|Cohort 2: Dose Level 2|Death|0|||
161585622|NCT02287311|583531816|FG004|Cohort 2: Dose Level 2|Death|2|||
161585623|NCT02287311|583531817|FG005|Cohort 2: Dose Level 2|Death|0|||
161585624|NCT02287311|583531818|FG006|Cohort 2: Dose Level 2|Death|0|||
161585625|NCT02287311|583531819|FG007|Cohort 2: Dose Level 2|Death|2|||
161585626|NCT02287311|583531820|FG008|Cohort 2: Dose Level 2|Death|0|||
161585627|NCT02287311|583531812|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585628|NCT02287311|583531813|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585629|NCT02287311|583531814|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585630|NCT02287311|583531815|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585631|NCT02287311|583531816|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
161585632|NCT02287311|583531817|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585633|NCT02287311|583531818|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585634|NCT02287311|583531819|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585635|NCT02287311|583531820|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161585636|NCT02287311|583531812|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585637|NCT02287311|583531813|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
161585638|NCT02287311|583531814|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585639|NCT02287311|583531815|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585640|NCT02287311|583531816|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585641|NCT02287311|583531817|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585642|NCT02287311|583531818|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585643|NCT02287311|583531819|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585644|NCT02287311|583531820|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
161585645|NCT02287311|583531812|FG000|Cohort 3: Dose Level 3|Death|0|||
161585646|NCT02287311|583531813|FG001|Cohort 3: Dose Level 3|Death|0|||
161585647|NCT02287311|583531814|FG002|Cohort 3: Dose Level 3|Death|4|||
161585648|NCT02287311|583531815|FG003|Cohort 3: Dose Level 3|Death|0|||
161585649|NCT02287311|583531816|FG004|Cohort 3: Dose Level 3|Death|0|||
161585650|NCT02287311|583531817|FG005|Cohort 3: Dose Level 3|Death|4|||
161585651|NCT02287311|583531818|FG006|Cohort 3: Dose Level 3|Death|0|||
161924688|NCT01658878|584770975|FG009|Treatment Period|Maximum Clinical Benefit|0|||
161585652|NCT02287311|583531819|FG007|Cohort 3: Dose Level 3|Death|0|||
161585653|NCT02287311|583531820|FG008|Cohort 3: Dose Level 3|Death|2|||
161497698|NCT02914769|583217669|FG001|Overall Study|Withdrawal by Subject|1|||
161497699|NCT01592344|583217670|FG000|Overall Study|Adverse Event|1|||
161497700|NCT01592344|583217671|FG001|Overall Study|Adverse Event|1|||
161497701|NCT01592344|583217670|FG000|Overall Study|Lack of Efficacy|1|||
161497702|NCT01592344|583217671|FG001|Overall Study|Lack of Efficacy|0|||
161497703|NCT01592344|583217670|FG000|Overall Study|not available at primary outcome visit|2|||
161497704|NCT01592344|583217671|FG001|Overall Study|not available at primary outcome visit|4|||
161497705|NCT02738333|583217672|FG000|Overall Study|Death|1|||
161497706|NCT02738333|583217673|FG001|Overall Study|Death|0|||
161497707|NCT02738333|583217674|FG002|Overall Study|Death|0|||
161497708|NCT02738333|583217672|FG000|Overall Study|Lost to Follow-up|1|||
161672935|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
161672936|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
161672937|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
161672938|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
161672939|NCT01324323|583856512|FG000|Overall Study|Withdrawal by Subject|1|||
161672940|NCT00537485|583856513|FG000|Overall Study|Adverse Event|10|||
161672941|NCT00537485|583856514|FG001|Overall Study|Adverse Event|5|||
161672942|NCT00537485|583856513|FG000|Overall Study|Withdrawal by Subject|3|||
161672943|NCT00537485|583856514|FG001|Overall Study|Withdrawal by Subject|2|||
161672944|NCT00537485|583856513|FG000|Overall Study|Withdrawal by Subject|1|||
161672945|NCT00537485|583856514|FG001|Overall Study|Withdrawal by Subject|3|||
161672946|NCT00537485|583856513|FG000|Overall Study|Physician Decision|1|||
161672947|NCT00537485|583856514|FG001|Overall Study|Physician Decision|0|||
161672948|NCT01601847|583856523|FG000|Overall Study|Death|1|||
161672949|NCT01601847|583856524|FG001|Overall Study|Death|0|||
161672950|NCT01601847|583856523|FG000|Overall Study|Withdrawal by Subject|11|||
161497709|NCT02738333|583217673|FG001|Overall Study|Lost to Follow-up|0|||
161497710|NCT02738333|583217674|FG002|Overall Study|Lost to Follow-up|0|||
161497711|NCT03311659|583217681|FG000|Overall Study|Protocol Violation|1|||
161497712|NCT04327388|583217684|FG000|Overall Study|Adverse Event|17|||
161497713|NCT04327388|583217685|FG001|Overall Study|Adverse Event|18|||
161497714|NCT04327388|583217686|FG002|Overall Study|Adverse Event|9|||
161497715|NCT04327388|583217684|FG000|Overall Study|Other|1|||
161497716|NCT04327388|583217685|FG001|Overall Study|Other|2|||
161497717|NCT04327388|583217686|FG002|Overall Study|Other|0|||
161497718|NCT04327388|583217684|FG000|Overall Study|Randomized and not treated|2|||
161497719|NCT04327388|583217685|FG001|Overall Study|Randomized and not treated|0|||
161497720|NCT04327388|583217686|FG002|Overall Study|Randomized and not treated|2|||
161497721|NCT04829318|583217687|FG000|Overall Study|Adverse Event|6|||
161497722|NCT04829318|583217687|FG000|Overall Study|Death|1|||
161497723|NCT04829318|583217687|FG000|Overall Study|Lost to Follow-up|1|||
161497724|NCT04829318|583217687|FG000|Overall Study|Physician Decision|1|||
161497725|NCT04829318|583217687|FG000|Overall Study|Withdrawal by Subject|19|||
161497726|NCT04829318|583217687|FG000|Overall Study|Site terminated by sponsor|1|||
161497727|NCT04829318|583217687|FG000|Overall Study|Sponsor decision|5|||
161497728|NCT04829318|583217687|FG000|Overall Study|Other|1|||
161497729|NCT00728130|583217688|FG000|Overall Study|Withdrawal by Subject|1|||
161497730|NCT00728130|583217688|FG000|Overall Study|Paperwork not completed in time|1|||
161497731|NCT00728130|583217688|FG000|Overall Study|Physician Decision|1|||
161497732|NCT04053023|583217691|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
161497733|NCT04053023|583217692|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
161497734|NCT03447990|583217693|FG000|Overall Study|Withdrawal by Subject|0|||
161497735|NCT03447990|583217694|FG001|Overall Study|Withdrawal by Subject|0|||
161497736|NCT03447990|583217695|FG002|Overall Study|Withdrawal by Subject|0|||
161497737|NCT03447990|583217696|FG003|Overall Study|Withdrawal by Subject|0|||
161497738|NCT03447990|583217697|FG004|Overall Study|Withdrawal by Subject|0|||
161497739|NCT03447990|583217698|FG005|Overall Study|Withdrawal by Subject|0|||
161497740|NCT03447990|583217699|FG006|Overall Study|Withdrawal by Subject|1|||
161497741|NCT03755414|583217701|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
161497742|NCT03755414|583217702|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
161497743|NCT03755414|583217703|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
161497744|NCT03755414|583217701|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
161672951|NCT01601847|583856524|FG001|Overall Study|Withdrawal by Subject|7|||
161497745|NCT03755414|583217702|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
161497746|NCT03755414|583217703|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
161497747|NCT03755414|583217701|FG000|Overall Study|Non-compliance|0|||
161672952|NCT01601847|583856523|FG000|Overall Study|Lost to Follow-up|1|||
161672953|NCT01601847|583856524|FG001|Overall Study|Lost to Follow-up|3|||
161818690|NCT01018862|584376190|FG002|Overall Study|Withdrawal by Subject|1|||
161818691|NCT01018862|584376188|FG000|Overall Study|administrative problems|5|||
161497748|NCT03755414|583217702|FG001|Overall Study|Non-compliance|1|||
161497749|NCT03755414|583217703|FG002|Overall Study|Non-compliance|0|||
161497750|NCT02153112|583217704|FG000|Overall Study|Adverse Event|0|||
161497751|NCT02153112|583217705|FG001|Overall Study|Adverse Event|0|||
161497752|NCT02153112|583217706|FG002|Overall Study|Adverse Event|1|||
161497753|NCT02153112|583217707|FG003|Overall Study|Adverse Event|0|||
161497754|NCT02153112|583217708|FG004|Overall Study|Adverse Event|0|||
161497755|NCT02153112|583217709|FG005|Overall Study|Adverse Event|0|||
161497756|NCT02153112|583217710|FG006|Overall Study|Adverse Event|0|||
161497757|NCT02153112|583217711|FG007|Overall Study|Adverse Event|0|||
161497758|NCT02153112|583217712|FG008|Overall Study|Adverse Event|0|||
161497759|NCT02153112|583217713|FG009|Overall Study|Adverse Event|0|||
161497760|NCT02153112|583217704|FG000|Overall Study|Lost to Follow-up|1|||
161497761|NCT02153112|583217705|FG001|Overall Study|Lost to Follow-up|1|||
161497762|NCT02153112|583217706|FG002|Overall Study|Lost to Follow-up|0|||
161497763|NCT02153112|583217707|FG003|Overall Study|Lost to Follow-up|0|||
161497764|NCT02153112|583217708|FG004|Overall Study|Lost to Follow-up|2|||
161497765|NCT02153112|583217709|FG005|Overall Study|Lost to Follow-up|1|||
161497766|NCT02153112|583217710|FG006|Overall Study|Lost to Follow-up|1|||
161497767|NCT02153112|583217711|FG007|Overall Study|Lost to Follow-up|0|||
161497768|NCT02153112|583217712|FG008|Overall Study|Lost to Follow-up|1|||
161497769|NCT02153112|583217713|FG009|Overall Study|Lost to Follow-up|1|||
161497770|NCT02153112|583217704|FG000|Overall Study|Withdrawal by Subject|3|||
161497771|NCT02153112|583217705|FG001|Overall Study|Withdrawal by Subject|1|||
161497772|NCT02153112|583217706|FG002|Overall Study|Withdrawal by Subject|2|||
161497773|NCT02153112|583217707|FG003|Overall Study|Withdrawal by Subject|2|||
161497774|NCT02153112|583217708|FG004|Overall Study|Withdrawal by Subject|1|||
161497775|NCT02153112|583217709|FG005|Overall Study|Withdrawal by Subject|1|||
161497776|NCT02153112|583217710|FG006|Overall Study|Withdrawal by Subject|7|||
161497777|NCT02153112|583217711|FG007|Overall Study|Withdrawal by Subject|2|||
161497778|NCT02153112|583217712|FG008|Overall Study|Withdrawal by Subject|13|||
161497779|NCT02153112|583217713|FG009|Overall Study|Withdrawal by Subject|12|||
161497780|NCT02153112|583217704|FG000|Overall Study|Reason not Specified|0|||
161497781|NCT02153112|583217705|FG001|Overall Study|Reason not Specified|0|||
161497782|NCT02153112|583217706|FG002|Overall Study|Reason not Specified|0|||
161497783|NCT02153112|583217707|FG003|Overall Study|Reason not Specified|0|||
161497784|NCT02153112|583217708|FG004|Overall Study|Reason not Specified|0|||
161497785|NCT02153112|583217709|FG005|Overall Study|Reason not Specified|0|||
161497786|NCT02153112|583217710|FG006|Overall Study|Reason not Specified|0|||
161497787|NCT02153112|583217711|FG007|Overall Study|Reason not Specified|0|||
161497788|NCT02153112|583217712|FG008|Overall Study|Reason not Specified|1|||
161497789|NCT02153112|583217713|FG009|Overall Study|Reason not Specified|1|||
161497790|NCT05104567|583217714|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
161497791|NCT05104567|583217715|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
161497792|NCT05104567|583217716|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
161497793|NCT05104567|583217717|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
161497794|NCT05104567|583217718|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
161497795|NCT05104567|583217719|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
161497796|NCT05104567|583217720|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
161497797|NCT05104567|583217714|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
161497798|NCT05104567|583217715|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
161497799|NCT05104567|583217716|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
161497800|NCT05104567|583217717|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
161497801|NCT05104567|583217718|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
161497802|NCT05104567|583217719|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
161497803|NCT05104567|583217720|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
161497804|NCT05104567|583217714|FG000|Overall Study|Progressive disease|3|||
161497805|NCT05104567|583217715|FG001|Overall Study|Progressive disease|13|||
161497806|NCT05104567|583217716|FG002|Overall Study|Progressive disease|13|||
161497807|NCT05104567|583217717|FG003|Overall Study|Progressive disease|17|||
161497808|NCT05104567|583217718|FG004|Overall Study|Progressive disease|17|||
161497809|NCT05104567|583217719|FG005|Overall Study|Progressive disease|28|||
161497810|NCT05104567|583217720|FG006|Overall Study|Progressive disease|24|||
161497811|NCT05104567|583217714|FG000|Overall Study|Withdrawal by Subject|1|||
161497812|NCT05104567|583217715|FG001|Overall Study|Withdrawal by Subject|1|||
161497813|NCT05104567|583217716|FG002|Overall Study|Withdrawal by Subject|2|||
161818692|NCT01018862|584376189|FG001|Overall Study|administrative problems|4|||
161818693|NCT01018862|584376190|FG002|Overall Study|administrative problems|4|||
161497814|NCT05104567|583217717|FG003|Overall Study|Withdrawal by Subject|0|||
161497815|NCT05104567|583217718|FG004|Overall Study|Withdrawal by Subject|0|||
161497816|NCT05104567|583217719|FG005|Overall Study|Withdrawal by Subject|0|||
161497817|NCT05104567|583217720|FG006|Overall Study|Withdrawal by Subject|0|||
161497818|NCT05104567|583217714|FG000|Overall Study|Other|1|||
161497819|NCT05104567|583217715|FG001|Overall Study|Other|1|||
161497820|NCT05104567|583217716|FG002|Overall Study|Other|1|||
161818694|NCT01968031|584376194|FG000|Overall Study|Adverse Event|13|||
161672954|NCT00631189|583856525|FG000|Initial Phase|Protocol Violation|347|||
161672955|NCT00631189|583856526|FG001|Initial Phase|Protocol Violation|0|||
161672956|NCT00631189|583856527|FG002|Initial Phase|Protocol Violation|0|||
161672957|NCT00631189|583856528|FG003|Initial Phase|Protocol Violation|0|||
161672958|NCT00631189|583856525|FG000|Initial Phase|Withdrawal by Subject|4|||
161672959|NCT00631189|583856526|FG001|Initial Phase|Withdrawal by Subject|0|||
161672960|NCT00631189|583856527|FG002|Initial Phase|Withdrawal by Subject|0|||
161672961|NCT00631189|583856528|FG003|Initial Phase|Withdrawal by Subject|0|||
161672962|NCT00631189|583856525|FG000|Treatment Phase|Withdrawal by Subject|0|||
161672963|NCT00631189|583856526|FG001|Treatment Phase|Withdrawal by Subject|2|||
161672964|NCT00631189|583856527|FG002|Treatment Phase|Withdrawal by Subject|1|||
161497821|NCT05104567|583217717|FG003|Overall Study|Other|0|||
161497822|NCT05104567|583217718|FG004|Overall Study|Other|0|||
161497823|NCT05104567|583217719|FG005|Overall Study|Other|0|||
161497824|NCT05104567|583217720|FG006|Overall Study|Other|0|||
161497825|NCT01464346|583217721|FG000|Overall Study|Withdrawal by Subject|0|||
161497826|NCT01464346|583217722|FG001|Overall Study|Withdrawal by Subject|0|||
161497827|NCT01464346|583217723|FG002|Overall Study|Withdrawal by Subject|1|||
161497828|NCT03999892|583217724|FG000|Overall Study|Lost to Follow-up|1|||
161497829|NCT01848756|583217725|FG000|Overall Study|Adverse Event|1|||
161497830|NCT01848756|583217725|FG000|Overall Study|Withdrawal by Subject|1|||
161497831|NCT01848756|583217725|FG000|Overall Study|Enrolled in Error|1|||
161497832|NCT01286012|583217726|FG000|Overall Study|Adverse Event|3|||
161497833|NCT01286012|583217727|FG001|Overall Study|Adverse Event|3|||
161497834|NCT01286012|583217726|FG000|Overall Study|Death|2|||
161497835|NCT01286012|583217727|FG001|Overall Study|Death|3|||
161497836|NCT01286012|583217726|FG000|Overall Study|Protocol Violation|1|||
161497837|NCT01286012|583217727|FG001|Overall Study|Protocol Violation|1|||
161497838|NCT01286012|583217726|FG000|Overall Study|Withdrawal by Subject|4|||
161497839|NCT01286012|583217727|FG001|Overall Study|Withdrawal by Subject|4|||
161497840|NCT01286012|583217726|FG000|Overall Study|Physician Decision|2|||
161497841|NCT01286012|583217727|FG001|Overall Study|Physician Decision|0|||
161497842|NCT01286012|583217726|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
161497843|NCT01286012|583217727|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
161497844|NCT04056195|583217731|FG000|Overall Study|Adverse Event|1|||
161585654|NCT02287311|583531812|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585655|NCT02287311|583531813|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585656|NCT02287311|583531814|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
161585657|NCT02287311|583531815|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585658|NCT02287311|583531816|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585659|NCT02287311|583531817|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
161585660|NCT02287311|583531818|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585661|NCT02287311|583531819|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585662|NCT02287311|583531820|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161585663|NCT02287311|583531812|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585664|NCT02287311|583531813|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585665|NCT02287311|583531814|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585666|NCT02287311|583531815|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585667|NCT02287311|583531816|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585668|NCT02287311|583531817|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
161585669|NCT02287311|583531818|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585670|NCT02287311|583531819|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161585671|NCT02287311|583531820|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
161585672|NCT04048681|583531824|FG000|Overall Study|family emergency|0|||
161585673|NCT04048681|583531825|FG001|Overall Study|family emergency|0|||
161585674|NCT04048681|583531826|FG002|Overall Study|family emergency|0|||
161585675|NCT04048681|583531827|FG003|Overall Study|family emergency|1|||
161585676|NCT04048681|583531828|FG004|Overall Study|family emergency|0|||
161585677|NCT02374307|583531831|FG000|3-months Follow-up|Lost to Follow-up|1|||
161585678|NCT02374307|583531832|FG001|3-months Follow-up|Lost to Follow-up|2|||
161585679|NCT02374307|583531831|FG000|3-months Follow-up|Withdrawal by Subject|1|||
161585680|NCT02374307|583531832|FG001|3-months Follow-up|Withdrawal by Subject|4|||
161672965|NCT00631189|583856528|FG003|Treatment Phase|Withdrawal by Subject|1|||
161818695|NCT01968031|584376195|FG001|Overall Study|Adverse Event|10|||
161497845|NCT04056195|583217732|FG001|Overall Study|Adverse Event|0|||
161497846|NCT04056195|583217733|FG002|Overall Study|Adverse Event|0|||
161585681|NCT02374307|583531831|FG000|3-months Follow-up|Death|1|||
161672966|NCT00631189|583856525|FG000|Treatment Phase|Protocol Violation|0|||
161818696|NCT01968031|584376196|FG002|Overall Study|Adverse Event|22|||
161497847|NCT04056195|583217731|FG000|Overall Study|Withdrawal by Subject|0|||
161497848|NCT04056195|583217732|FG001|Overall Study|Withdrawal by Subject|1|||
161497849|NCT04056195|583217733|FG002|Overall Study|Withdrawal by Subject|1|||
161672967|NCT00631189|583856526|FG001|Treatment Phase|Protocol Violation|1|||
161672968|NCT00631189|583856527|FG002|Treatment Phase|Protocol Violation|6|||
161672969|NCT00631189|583856528|FG003|Treatment Phase|Protocol Violation|2|||
161497850|NCT04056195|583217731|FG000|Overall Study|Physician Decision|1|||
161497851|NCT04056195|583217732|FG001|Overall Study|Physician Decision|1|||
161497852|NCT04056195|583217733|FG002|Overall Study|Physician Decision|1|||
161497853|NCT01498458|583217734|FG000|Overall Study|Adverse Event|4|||
161497854|NCT01498458|583217734|FG000|Overall Study|Physician Decision|3|||
161497855|NCT02406651|583217735|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
161497856|NCT02226003|583217739|FG000|Overall Study|Lost to Follow-up|2|||
161497857|NCT02226003|583217740|FG001|Overall Study|Lost to Follow-up|1|||
161497858|NCT02226003|583217741|FG002|Overall Study|Lost to Follow-up|3|||
161497859|NCT02226003|583217739|FG000|Overall Study|Withdrawal by Subject|0|||
161497860|NCT02226003|583217740|FG001|Overall Study|Withdrawal by Subject|0|||
161497861|NCT02226003|583217741|FG002|Overall Study|Withdrawal by Subject|3|||
161497862|NCT00718328|583217742|FG000|Overall Study|Lost to Follow-up|1|||
161497863|NCT00718328|583217743|FG001|Overall Study|Lost to Follow-up|0|||
161497864|NCT02865915|583217744|FG000|Overall Study|Pregnancy|1|||
161672970|NCT00631189|583856525|FG000|Treatment Phase|Adverse Event|0|||
161497865|NCT02865915|583217745|FG001|Overall Study|Pregnancy|0|||
161497866|NCT02865915|583217744|FG000|Overall Study|Withdrawal by Subject|1|||
161497867|NCT02865915|583217745|FG001|Overall Study|Withdrawal by Subject|1|||
161497868|NCT02865915|583217744|FG000|Overall Study|Adverse Event|0|||
161497869|NCT02865915|583217745|FG001|Overall Study|Adverse Event|4|||
161497870|NCT02865915|583217744|FG000|Overall Study|Lost to Follow-up|0|||
161497871|NCT02865915|583217745|FG001|Overall Study|Lost to Follow-up|1|||
161497872|NCT02865915|583217744|FG000|Overall Study|Protocol Violation|0|||
161497873|NCT02865915|583217745|FG001|Overall Study|Protocol Violation|1|||
161497874|NCT02865915|583217744|FG000|Overall Study|Study terminated by sponsor|23|||
161497875|NCT02865915|583217745|FG001|Overall Study|Study terminated by sponsor|18|||
161497876|NCT02865915|583217744|FG000|Overall Study|Dosing group discontinued|0|||
161497877|NCT02865915|583217745|FG001|Overall Study|Dosing group discontinued|5|||
161497878|NCT00663052|583217748|FG000|Overall Study|Adverse Event|6|||
161497879|NCT00663052|583217749|FG001|Overall Study|Adverse Event|3|||
161497880|NCT00663052|583217748|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
161497881|NCT00663052|583217749|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161497882|NCT00663052|583217748|FG000|Overall Study|Protocol Violation|1|||
161497883|NCT00663052|583217749|FG001|Overall Study|Protocol Violation|0|||
161497884|NCT00663052|583217748|FG000|Overall Study|Withdrawal by Subject|2|||
161497885|NCT00663052|583217749|FG001|Overall Study|Withdrawal by Subject|5|||
161497886|NCT00663052|583217748|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
161497887|NCT00663052|583217749|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
161672971|NCT00631189|583856526|FG001|Treatment Phase|Adverse Event|3|||
161672972|NCT00631189|583856527|FG002|Treatment Phase|Adverse Event|2|||
161672973|NCT00631189|583856528|FG003|Treatment Phase|Adverse Event|4|||
161672974|NCT00631189|583856525|FG000|Treatment Phase|Lost to Follow-up|0|||
161672975|NCT00631189|583856526|FG001|Treatment Phase|Lost to Follow-up|1|||
161672976|NCT00631189|583856527|FG002|Treatment Phase|Lost to Follow-up|0|||
161672977|NCT00631189|583856528|FG003|Treatment Phase|Lost to Follow-up|0|||
161672978|NCT00631189|583856525|FG000|Treatment Phase|Pregnancy|0|||
161672979|NCT00631189|583856526|FG001|Treatment Phase|Pregnancy|0|||
161672980|NCT00631189|583856527|FG002|Treatment Phase|Pregnancy|1|||
161672981|NCT00631189|583856528|FG003|Treatment Phase|Pregnancy|0|||
161672982|NCT00631189|583856525|FG000|Treatment Phase|patient did not take pravastatin|0|||
161672983|NCT00631189|583856526|FG001|Treatment Phase|patient did not take pravastatin|0|||
161672984|NCT00631189|583856527|FG002|Treatment Phase|patient did not take pravastatin|1|||
161672985|NCT00631189|583856528|FG003|Treatment Phase|patient did not take pravastatin|0|||
161497888|NCT00663052|583217748|FG000|Overall Study|Other|0|||
161672986|NCT04464265|583856529|FG000|Overall Study|Physician Decision|2|||
161672987|NCT00954174|583856536|FG000|Overall Study|Adverse Event|28|||
161672988|NCT00954174|583856537|FG001|Overall Study|Adverse Event|23|||
161672989|NCT00954174|583856538|FG002|Overall Study|Adverse Event|4|||
161672990|NCT00954174|583856539|FG003|Overall Study|Adverse Event|9|||
161497889|NCT00663052|583217749|FG001|Overall Study|Other|1|||
161672991|NCT00954174|583856536|FG000|Overall Study|Death|4|||
161672992|NCT00954174|583856537|FG001|Overall Study|Death|2|||
161672993|NCT00954174|583856538|FG002|Overall Study|Death|0|||
161672994|NCT00954174|583856539|FG003|Overall Study|Death|0|||
161672995|NCT00954174|583856536|FG000|Overall Study|Lack of Efficacy|32|||
161497890|NCT05760300|583217758|FG000|Overall Study|Adverse Event|0|||
161497891|NCT05760300|583217759|FG001|Overall Study|Adverse Event|0|||
161497892|NCT05760300|583217760|FG002|Overall Study|Adverse Event|1|||
161497893|NCT05760300|583217761|FG003|Overall Study|Adverse Event|0|||
161497894|NCT05760300|583217758|FG000|Overall Study|Participant Decision|1|||
161497895|NCT05760300|583217759|FG001|Overall Study|Participant Decision|0|||
161497896|NCT05760300|583217760|FG002|Overall Study|Participant Decision|0|||
161497897|NCT05760300|583217761|FG003|Overall Study|Participant Decision|0|||
161672996|NCT00954174|583856537|FG001|Overall Study|Lack of Efficacy|22|||
161672997|NCT00954174|583856538|FG002|Overall Study|Lack of Efficacy|8|||
161672998|NCT00954174|583856539|FG003|Overall Study|Lack of Efficacy|6|||
161672999|NCT00954174|583856536|FG000|Overall Study|Withdrawal by Subject|14|||
161673000|NCT00954174|583856537|FG001|Overall Study|Withdrawal by Subject|10|||
161673001|NCT00954174|583856538|FG002|Overall Study|Withdrawal by Subject|4|||
161673002|NCT00954174|583856539|FG003|Overall Study|Withdrawal by Subject|3|||
161673003|NCT00954174|583856536|FG000|Overall Study|Medical Reason|4|||
161673004|NCT00954174|583856537|FG001|Overall Study|Medical Reason|2|||
161673005|NCT00954174|583856538|FG002|Overall Study|Medical Reason|1|||
161673006|NCT00954174|583856539|FG003|Overall Study|Medical Reason|0|||
161673007|NCT00954174|583856536|FG000|Overall Study|Ineligible|40|||
161497898|NCT03279692|583217762|FG000|Overall Study|Withdrawal by Subject|1|||
161497899|NCT02446990|583217765|FG000|Overall Study|Death|485|||
161497900|NCT02446990|583217766|FG001|Overall Study|Death|458|||
161497901|NCT02446990|583217765|FG000|Overall Study|Lost to Follow-up|3|||
161497902|NCT02446990|583217766|FG001|Overall Study|Lost to Follow-up|1|||
161497903|NCT02446990|583217765|FG000|Overall Study|Physician Decision|1|||
161497904|NCT02446990|583217766|FG001|Overall Study|Physician Decision|0|||
161497905|NCT02446990|583217765|FG000|Overall Study|Withdrawal by Subject|231|||
161497906|NCT02446990|583217766|FG001|Overall Study|Withdrawal by Subject|199|||
161497907|NCT01064401|583217767|FG000|Overall Study|Adverse Event|47|||
161497908|NCT01064401|583217768|FG001|Overall Study|Adverse Event|56|||
161497909|NCT01064401|583217767|FG000|Overall Study|Lack of Efficacy|46|||
161497910|NCT01064401|583217768|FG001|Overall Study|Lack of Efficacy|23|||
161497911|NCT01064401|583217767|FG000|Overall Study|Lost to Follow-up|12|||
161497912|NCT01064401|583217768|FG001|Overall Study|Lost to Follow-up|9|||
161497913|NCT01064401|583217767|FG000|Overall Study|Consent Withdrawn|98|||
161497914|NCT01064401|583217768|FG001|Overall Study|Consent Withdrawn|80|||
161497915|NCT01064401|583217767|FG000|Overall Study|Investigator Decision|4|||
161497916|NCT01064401|583217768|FG001|Overall Study|Investigator Decision|6|||
161497917|NCT01064401|583217767|FG000|Overall Study|Death|4|||
161497918|NCT01064401|583217768|FG001|Overall Study|Death|0|||
161497919|NCT01064401|583217767|FG000|Overall Study|Pregnancy|4|||
161497920|NCT01064401|583217768|FG001|Overall Study|Pregnancy|7|||
161497921|NCT01064401|583217767|FG000|Overall Study|Noncompliance|7|||
161497922|NCT01064401|583217768|FG001|Overall Study|Noncompliance|8|||
161497923|NCT01064401|583217767|FG000|Overall Study|Site Closure|4|||
161497924|NCT01064401|583217768|FG001|Overall Study|Site Closure|5|||
161497925|NCT01064401|583217767|FG000|Overall Study|Other|2|||
161497926|NCT01064401|583217768|FG001|Overall Study|Other|1|||
161497927|NCT03158051|583217769|FG000|Overall Study|Lost to Follow-up|41|||
161497928|NCT03158051|583217770|FG001|Overall Study|Lost to Follow-up|47|||
161497929|NCT03158051|583217769|FG000|Overall Study|Physician Decision|6|||
161497930|NCT03158051|583217770|FG001|Overall Study|Physician Decision|7|||
161497931|NCT03158051|583217769|FG000|Overall Study|Withdrawal by Subject|24|||
161497932|NCT03158051|583217770|FG001|Overall Study|Withdrawal by Subject|15|||
161673008|NCT00954174|583856537|FG001|Overall Study|Ineligible|47|||
161497933|NCT03158051|583217769|FG000|Overall Study|Death|0|||
161497934|NCT03158051|583217770|FG001|Overall Study|Death|1|||
161497935|NCT02588833|583217771|FG000|Part 1|Withdrawal by Subject|1|||
161497936|NCT02588833|583217772|FG001|Part 1|Withdrawal by Subject|0|||
161497937|NCT02588833|583217771|FG000|Part 2A|Physician Decision|0|||
161497938|NCT02588833|583217772|FG001|Part 2A|Physician Decision|1|||
161497939|NCT02588833|583217771|FG000|Part 2A|Withdrawal by Subject|0|||
161497940|NCT02588833|583217772|FG001|Part 2A|Withdrawal by Subject|1|||
161497941|NCT02588833|583217771|FG000|Part 2B|Adverse Event|0|||
161497942|NCT02588833|583217772|FG001|Part 2B|Adverse Event|1|||
161497943|NCT02588833|583217771|FG000|Part 2C|Adverse Event|0|||
161497944|NCT02588833|583217772|FG001|Part 2C|Adverse Event|1|||
161497945|NCT02588833|583217771|FG000|Part 2C|Withdrawal by Subject|0|||
161497946|NCT02588833|583217772|FG001|Part 2C|Withdrawal by Subject|1|||
161497947|NCT02588833|583217771|FG000|Part 3 (Safety Follow-up)|Other|0|||
161497948|NCT02588833|583217772|FG001|Part 3 (Safety Follow-up)|Other|2|||
161673009|NCT00954174|583856538|FG002|Overall Study|Ineligible|7|||
161673010|NCT00954174|583856539|FG003|Overall Study|Ineligible|4|||
161673011|NCT00954174|583856536|FG000|Overall Study|Never Treated|4|||
161818697|NCT01968031|584376194|FG000|Overall Study|Withdrawal by Subject|3|||
161673012|NCT00954174|583856537|FG001|Overall Study|Never Treated|17|||
161497949|NCT02005250|583217773|FG000|Overall Study|Lost to Follow-up|15|||
161497950|NCT02005250|583217774|FG001|Overall Study|Lost to Follow-up|5|||
161497951|NCT00702403|583219948|FG000|From Consent to Engraftment|Progressive leukemia|6|||
161497952|NCT00702403|583219948|FG000|From Consent to Engraftment|Critically ill|2|||
161497953|NCT00702403|583219948|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
161497954|NCT00702403|583219948|FG000|From Consent to Engraftment|Myocardial infarction|1|||
161497955|NCT00702403|583219948|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
161497956|NCT00702403|583219948|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
161497957|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
161497958|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
161497959|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Non-compliance|2|||
161497960|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
161497961|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
161497962|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Suicide|1|||
161497963|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
161497964|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
161497965|NCT00702403|583219948|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
161497966|NCT00192504|583219958|FG000|Overall Study|Lost to Follow-up|1|||
161497967|NCT00192504|583219959|FG001|Overall Study|Lost to Follow-up|0|||
161497968|NCT00192504|583219960|FG002|Overall Study|Lost to Follow-up|0|||
161497969|NCT00192504|583219961|FG003|Overall Study|Lost to Follow-up|0|||
161497970|NCT00192504|583219958|FG000|Overall Study|Dosing window missed|0|||
161497971|NCT00192504|583219959|FG001|Overall Study|Dosing window missed|0|||
161497972|NCT00192504|583219960|FG002|Overall Study|Dosing window missed|1|||
161497973|NCT00192504|583219961|FG003|Overall Study|Dosing window missed|0|||
161497974|NCT03989440|583219962|FG000|Overall Study|COVID-19 travel restrictions|0|||
161497975|NCT03989440|583219963|FG001|Overall Study|COVID-19 travel restrictions|0|||
161497976|NCT03989440|583219964|FG002|Overall Study|COVID-19 travel restrictions|1|||
161497977|NCT03989440|583219965|FG003|Overall Study|COVID-19 travel restrictions|0|||
161497978|NCT03989440|583219966|FG004|Overall Study|COVID-19 travel restrictions|0|||
161497979|NCT03989440|583219967|FG005|Overall Study|COVID-19 travel restrictions|0|||
161497980|NCT03989440|583219962|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
161497981|NCT03989440|583219963|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
161497982|NCT03989440|583219964|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
161497983|NCT03989440|583219965|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
161497984|NCT03989440|583219966|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
161497985|NCT03989440|583219967|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
161497986|NCT04608500|583219968|FG000|Overall Study|Adverse Event|2|||
161497987|NCT04608500|583219969|FG001|Overall Study|Adverse Event|0|||
161497988|NCT04608500|583219968|FG000|Overall Study|Lost to Follow-up|15|||
161497989|NCT04608500|583219969|FG001|Overall Study|Lost to Follow-up|9|||
161497990|NCT04608500|583219968|FG000|Overall Study|Participant request|11|||
161497991|NCT04608500|583219969|FG001|Overall Study|Participant request|7|||
161497992|NCT04608500|583219968|FG000|Overall Study|Protocol Violation|1|||
161497993|NCT04608500|583219969|FG001|Overall Study|Protocol Violation|0|||
161497994|NCT04608500|583219968|FG000|Overall Study|Other|6|||
161497995|NCT04608500|583219969|FG001|Overall Study|Other|2|||
161497996|NCT00542919|583219970|FG000|Overall Study|Adverse Event|1|||
161497997|NCT00542919|583219971|FG001|Overall Study|Adverse Event|5|||
161497998|NCT00542919|583219972|FG002|Overall Study|Adverse Event|1|||
161497999|NCT00542919|583219970|FG000|Overall Study|Withdrawal by Subject|1|||
161498000|NCT00542919|583219971|FG001|Overall Study|Withdrawal by Subject|0|||
161498001|NCT00542919|583219972|FG002|Overall Study|Withdrawal by Subject|3|||
161498002|NCT00542919|583219970|FG000|Overall Study|Physician Decision|2|||
161498003|NCT00542919|583219971|FG001|Overall Study|Physician Decision|2|||
161498004|NCT00542919|583219972|FG002|Overall Study|Physician Decision|1|||
161498005|NCT00542919|583219970|FG000|Overall Study|Sponsor Decision|1|||
161498006|NCT00542919|583219971|FG001|Overall Study|Sponsor Decision|0|||
161498007|NCT00542919|583219972|FG002|Overall Study|Sponsor Decision|0|||
161498008|NCT00542919|583219970|FG000|Overall Study|Lost to Follow-up|2|||
161498009|NCT00542919|583219971|FG001|Overall Study|Lost to Follow-up|0|||
161498010|NCT00542919|583219972|FG002|Overall Study|Lost to Follow-up|1|||
161498011|NCT03020823|583219981|FG000|Overall Study|Physician Decision|4|||
161498012|NCT03020823|583219981|FG000|Overall Study|Lack of Efficacy|4|||
161498013|NCT03020823|583219981|FG000|Overall Study|Adverse Event|2|||
161498014|NCT03739112|583219982|FG000|Overall Study|Adverse Event|2|||
161498015|NCT03739112|583219983|FG001|Overall Study|Adverse Event|2|||
161498016|NCT03739112|583219982|FG000|Overall Study|Withdrawal by Subject|38|||
161498017|NCT03739112|583219983|FG001|Overall Study|Withdrawal by Subject|19|||
161498018|NCT03739112|583219982|FG000|Overall Study|Lost to Follow-up|31|||
161498019|NCT03739112|583219983|FG001|Overall Study|Lost to Follow-up|33|||
161498020|NCT03739112|583219982|FG000|Overall Study|Protocol Deviation|12|||
161498021|NCT03739112|583219983|FG001|Overall Study|Protocol Deviation|9|||
161498022|NCT03739112|583219982|FG000|Overall Study|Physician Decision|1|||
161498023|NCT03739112|583219983|FG001|Overall Study|Physician Decision|0|||
161498024|NCT03739112|583219982|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
161498025|NCT03739112|583219983|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
161498026|NCT03739112|583219982|FG000|Overall Study|Site went on hold|65|||
161585682|NCT02374307|583531832|FG001|3-months Follow-up|Death|2|||
161498027|NCT03739112|583219983|FG001|Overall Study|Site went on hold|67|||
161498028|NCT03739112|583219982|FG000|Overall Study|Other than specified|8|||
161498029|NCT03739112|583219983|FG001|Overall Study|Other than specified|5|||
161498030|NCT03739112|583219982|FG000|Overall Study|Randomized but not vaccinated|31|||
161498031|NCT03739112|583219983|FG001|Overall Study|Randomized but not vaccinated|25|||
161498032|NCT00588822|583219985|FG000|Overall Study|progression of disease|8|||
161498033|NCT01727141|583219989|FG000|Overall Study|Physician Decision|0|||
161673013|NCT00954174|583856538|FG002|Overall Study|Never Treated|0|||
161498034|NCT01727141|583219990|FG001|Overall Study|Physician Decision|1|||
161498035|NCT01727141|583219991|FG002|Overall Study|Physician Decision|0|||
161673014|NCT00954174|583856539|FG003|Overall Study|Never Treated|3|||
161673015|NCT02234323|583856540|FG000|All Enrolled|Not Treated: Completed study in database|2|||
161673016|NCT02234323|583856540|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
161673017|NCT02234323|583856540|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
161673018|NCT02234323|583856540|FG000|All Treated|Death|1|||
161673019|NCT02234323|583856540|FG000|All Treated|Physician Decision|5|||
161673020|NCT02234323|583856540|FG000|All Treated|Lack of Efficacy|3|||
161673021|NCT02234323|583856540|FG000|All Treated|Exceeded lab value limit|2|||
161673022|NCT02234323|583856540|FG000|All Treated|Other|7|||
161673023|NCT02644941|583856541|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
161673024|NCT02644941|583856542|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
161673025|NCT00867113|583856543|FG000|Treatment Period|Adverse Event|15|||
161673026|NCT00867113|583856543|FG000|Treatment Period|Death|2|||
161673027|NCT00867113|583856543|FG000|Treatment Period|Withdrawal by Subject|19|||
161673028|NCT00867113|583856543|FG000|Treatment Period|Lost to Follow-up|3|||
161673029|NCT00867113|583856543|FG000|Treatment Period|Administrative problems|1|||
161498036|NCT01727141|583219992|FG003|Overall Study|Physician Decision|2|||
161498037|NCT01727141|583219989|FG000|Overall Study|Lost to Follow-up|0|||
161498038|NCT01727141|583219990|FG001|Overall Study|Lost to Follow-up|2|||
161498039|NCT01727141|583219991|FG002|Overall Study|Lost to Follow-up|0|||
161498040|NCT01727141|583219992|FG003|Overall Study|Lost to Follow-up|0|||
161498041|NCT01727141|583219989|FG000|Overall Study|Death|0|||
161498042|NCT01727141|583219990|FG001|Overall Study|Death|1|||
161498043|NCT01727141|583219991|FG002|Overall Study|Death|1|||
161498044|NCT01727141|583219992|FG003|Overall Study|Death|1|||
161498045|NCT01727141|583219989|FG000|Overall Study|Protocol deviation|1|||
161498046|NCT01727141|583219990|FG001|Overall Study|Protocol deviation|1|||
161498047|NCT01727141|583219991|FG002|Overall Study|Protocol deviation|0|||
161498048|NCT01727141|583219992|FG003|Overall Study|Protocol deviation|1|||
161498049|NCT01727141|583219989|FG000|Overall Study|Withdrawal by Subject|4|||
161498050|NCT01727141|583219990|FG001|Overall Study|Withdrawal by Subject|4|||
161498051|NCT01727141|583219991|FG002|Overall Study|Withdrawal by Subject|2|||
161498052|NCT01727141|583219992|FG003|Overall Study|Withdrawal by Subject|11|||
161498053|NCT02529137|583219993|FG000|Overall Study|Discontinuation for different reasons|8|||
161498054|NCT00581776|583219999|FG000|Overall Study|Disease progression or no response|3|||
161498055|NCT02357901|583220000|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
161498056|NCT02357901|583220001|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
161498057|NCT02357901|583220002|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
161498058|NCT02357901|583220003|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
161498059|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
161498060|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
161498061|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
161498062|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
161498063|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
161498064|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
161498065|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
161498066|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
161498067|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161673030|NCT00867113|583856543|FG000|Treatment Period|Disease progression/relapse|1|||
161673031|NCT00867113|583856543|FG000|Treatment Period|Protocol Violation|4|||
161673032|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Death|1|||
161673033|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
161498068|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
161498069|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
161498070|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
161498071|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
161498072|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
161673034|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
161673035|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
161673036|NCT01145495|583856544|FG000|Overall Study|Adverse Event|6|||
161673037|NCT01145495|583856544|FG000|Overall Study|Withdrawal by Subject|6|||
161673038|NCT01145495|583856544|FG000|Overall Study|Disease progression after respone|2|||
161818698|NCT01968031|584376195|FG001|Overall Study|Withdrawal by Subject|7|||
161818699|NCT01968031|584376196|FG002|Overall Study|Withdrawal by Subject|3|||
161818700|NCT01968031|584376194|FG000|Overall Study|Did not meet entry criteria|1|||
161498073|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
161498074|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
161498075|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
161498076|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
161498077|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
161498078|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
161498079|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
161498080|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
161498081|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
161498082|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
161498083|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
161498084|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
161498085|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
161498086|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
161498087|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
161498088|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
161498089|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
161498090|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
161498091|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
161498092|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
161498093|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
161498094|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
161498095|NCT02357901|583220000|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
161498096|NCT02357901|583220001|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
161498097|NCT02357901|583220002|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
161498098|NCT02357901|583220003|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
161498099|NCT02759120|583220006|FG000|Overall Study|Death|34|||
161498100|NCT02759120|583220007|FG001|Overall Study|Death|36|||
161498101|NCT02759120|583220006|FG000|Overall Study|Lost to Follow-up|4|||
161498102|NCT02759120|583220007|FG001|Overall Study|Lost to Follow-up|7|||
161498103|NCT02759120|583220006|FG000|Overall Study|Physician Decision|3|||
161498104|NCT02759120|583220007|FG001|Overall Study|Physician Decision|0|||
161498105|NCT02759120|583220006|FG000|Overall Study|Withdrawal by Subject|28|||
161498106|NCT02759120|583220007|FG001|Overall Study|Withdrawal by Subject|15|||
161498107|NCT02759120|583220006|FG000|Overall Study|Moved out of area|3|||
161498108|NCT02759120|583220007|FG001|Overall Study|Moved out of area|4|||
161498109|NCT02759120|583220006|FG000|Overall Study|Lung transplant|3|||
161498110|NCT02759120|583220007|FG001|Overall Study|Lung transplant|5|||
161498111|NCT02759120|583220006|FG000|Overall Study|Other reason not completed|10|||
161498112|NCT02759120|583220007|FG001|Overall Study|Other reason not completed|12|||
161498113|NCT04461015|583220011|FG000|Overall Study|IV access lost during the study|0|||
161498114|NCT04461015|583220012|FG001|Overall Study|IV access lost during the study|1|||
161498115|NCT04461015|583220011|FG000|Overall Study|Withdrawal by Subject|0|||
161818701|NCT01968031|584376195|FG001|Overall Study|Did not meet entry criteria|1|||
161818702|NCT01968031|584376196|FG002|Overall Study|Did not meet entry criteria|1|||
161673039|NCT01886313|583856547|FG000|Overall Study|Adverse Event|1|||
161673040|NCT01886313|583856548|FG001|Overall Study|Adverse Event|1|||
161498116|NCT04461015|583220012|FG001|Overall Study|Withdrawal by Subject|1|||
161498117|NCT02063854|583220020|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
161498118|NCT02063854|583220021|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
161498119|NCT02063854|583220022|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
161498120|NCT02063854|583220023|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
161498121|NCT02063854|583220024|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
161498122|NCT02063854|583220025|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
161498123|NCT02063854|583220026|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
161498124|NCT02063854|583220020|FG000|Overall Study|Major Protocol Deviation|0|||
161498125|NCT02063854|583220021|FG001|Overall Study|Major Protocol Deviation|0|||
161498126|NCT02063854|583220022|FG002|Overall Study|Major Protocol Deviation|3|||
161498127|NCT02063854|583220023|FG003|Overall Study|Major Protocol Deviation|0|||
161498128|NCT02063854|583220024|FG004|Overall Study|Major Protocol Deviation|0|||
161498129|NCT02063854|583220025|FG005|Overall Study|Major Protocol Deviation|0|||
161498130|NCT02063854|583220026|FG006|Overall Study|Major Protocol Deviation|0|||
161498131|NCT02063854|583220020|FG000|Overall Study|Voluntary Withdrawal|2|||
161498132|NCT02063854|583220021|FG001|Overall Study|Voluntary Withdrawal|0|||
161498133|NCT02063854|583220022|FG002|Overall Study|Voluntary Withdrawal|8|||
161673041|NCT01603082|583856553|FG000|Overall Study|Adverse Event|0|||
161673042|NCT01603082|583856554|FG001|Overall Study|Adverse Event|1|||
161673043|NCT01603082|583856553|FG000|Overall Study|Withdrawal by Subject|1|||
161818703|NCT01968031|584376194|FG000|Overall Study|Noncompliance|0|||
161818704|NCT01968031|584376195|FG001|Overall Study|Noncompliance|0|||
161818705|NCT01968031|584376196|FG002|Overall Study|Noncompliance|2|||
161818706|NCT01968031|584376194|FG000|Overall Study|Failed inclusion criteria|0|||
161498134|NCT02063854|583220023|FG003|Overall Study|Voluntary Withdrawal|1|||
161498135|NCT02063854|583220024|FG004|Overall Study|Voluntary Withdrawal|3|||
161498136|NCT02063854|583220025|FG005|Overall Study|Voluntary Withdrawal|6|||
161498137|NCT02063854|583220026|FG006|Overall Study|Voluntary Withdrawal|1|||
161498138|NCT02063854|583220020|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
161498139|NCT02063854|583220021|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
161498140|NCT02063854|583220022|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
161498141|NCT02063854|583220023|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
161498142|NCT02063854|583220024|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
161498143|NCT02063854|583220025|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
161498144|NCT02063854|583220026|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
161498145|NCT02063854|583220020|FG000|Overall Study|Reason Not Specified|1|||
161498146|NCT02063854|583220021|FG001|Overall Study|Reason Not Specified|0|||
161498147|NCT02063854|583220022|FG002|Overall Study|Reason Not Specified|0|||
161498148|NCT02063854|583220023|FG003|Overall Study|Reason Not Specified|0|||
161498149|NCT02063854|583220024|FG004|Overall Study|Reason Not Specified|0|||
161498150|NCT02063854|583220025|FG005|Overall Study|Reason Not Specified|0|||
161498151|NCT02063854|583220026|FG006|Overall Study|Reason Not Specified|0|||
161498152|NCT02063854|583220020|FG000|Overall Study|Did Not Receive Study Drug|0|||
161498153|NCT02063854|583220021|FG001|Overall Study|Did Not Receive Study Drug|0|||
161498154|NCT02063854|583220022|FG002|Overall Study|Did Not Receive Study Drug|0|||
161498155|NCT02063854|583220023|FG003|Overall Study|Did Not Receive Study Drug|0|||
161498156|NCT02063854|583220024|FG004|Overall Study|Did Not Receive Study Drug|0|||
161498157|NCT02063854|583220025|FG005|Overall Study|Did Not Receive Study Drug|1|||
161498158|NCT02063854|583220026|FG006|Overall Study|Did Not Receive Study Drug|0|||
161498159|NCT01413360|583220031|FG000|Overall Study|Lost to Follow-up|2|||
161498160|NCT01413360|583220031|FG000|Overall Study|Adverse Event|1|||
161498161|NCT02246673|583220035|FG000|Overall Study|Sponsor Decision|1|||
161498162|NCT02246673|583220036|FG001|Overall Study|Sponsor Decision|0|||
161498163|NCT02246673|583220037|FG002|Overall Study|Sponsor Decision|0|||
161498164|NCT02246673|583220038|FG003|Overall Study|Sponsor Decision|0|||
161498165|NCT02246673|583220039|FG004|Overall Study|Sponsor Decision|0|||
161498166|NCT02246673|583220035|FG000|Overall Study|Withdrawal by Subject|0|||
161498167|NCT02246673|583220036|FG001|Overall Study|Withdrawal by Subject|0|||
161498168|NCT02246673|583220037|FG002|Overall Study|Withdrawal by Subject|0|||
161498169|NCT02246673|583220038|FG003|Overall Study|Withdrawal by Subject|0|||
161498170|NCT02246673|583220039|FG004|Overall Study|Withdrawal by Subject|1|||
161498171|NCT02246673|583220035|FG000|Overall Study|Lost to Follow-up|0|||
161498172|NCT02246673|583220036|FG001|Overall Study|Lost to Follow-up|0|||
161498173|NCT02246673|583220037|FG002|Overall Study|Lost to Follow-up|0|||
161498174|NCT02246673|583220038|FG003|Overall Study|Lost to Follow-up|1|||
161498175|NCT02246673|583220039|FG004|Overall Study|Lost to Follow-up|0|||
161498176|NCT02246673|583220035|FG000|Overall Study|Protocol Violation|0|||
161498177|NCT02246673|583220036|FG001|Overall Study|Protocol Violation|0|||
161498178|NCT02246673|583220037|FG002|Overall Study|Protocol Violation|0|||
161498179|NCT02246673|583220038|FG003|Overall Study|Protocol Violation|1|||
161498180|NCT02246673|583220039|FG004|Overall Study|Protocol Violation|0|||
161498181|NCT05413369|583220040|FG000|Overall Study|Adverse Event|1|||
161498182|NCT05413369|583220041|FG001|Overall Study|Adverse Event|1|||
161498183|NCT05413369|583220040|FG000|Overall Study|Withdrawal by Subject|13|||
161498184|NCT05413369|583220041|FG001|Overall Study|Withdrawal by Subject|4|||
161498185|NCT05413369|583220040|FG000|Overall Study|Non-compliance with study schedule|2|||
161498186|NCT05413369|583220041|FG001|Overall Study|Non-compliance with study schedule|1|||
161498187|NCT05413369|583220040|FG000|Overall Study|Other|1|||
161498188|NCT05413369|583220041|FG001|Overall Study|Other|1|||
161498189|NCT04519645|583220046|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
161498190|NCT04519645|583220047|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
161498191|NCT04519645|583220048|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
161498192|NCT04519645|583220046|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
161498193|NCT04519645|583220047|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
161498194|NCT04519645|583220048|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
161498195|NCT04519645|583220046|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
161498196|NCT04519645|583220047|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
161498197|NCT04519645|583220048|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
161498198|NCT04519645|583220046|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
161673044|NCT01603082|583856554|FG001|Overall Study|Withdrawal by Subject|0|||
161498199|NCT04519645|583220047|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
161498200|NCT04519645|583220048|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
161498201|NCT01679002|583220049|FG000|Overall Study|Adverse Event|1|||
161498202|NCT01679002|583220050|FG001|Overall Study|Adverse Event|1|||
161498203|NCT01679002|583220051|FG002|Overall Study|Adverse Event|0|||
161498204|NCT00730912|583220054|FG000|Overall Study|Discontinued|0|||
161498205|NCT00730912|583220055|FG001|Overall Study|Discontinued|0|||
161498206|NCT00730912|583220056|FG002|Overall Study|Discontinued|1|||
161498207|NCT02205333|583220060|FG000|Overall Study|Death|5|||
161498208|NCT02205333|583220061|FG001|Overall Study|Death|6|||
161498209|NCT02205333|583220062|FG002|Overall Study|Death|2|||
161498210|NCT02205333|583220063|FG003|Overall Study|Death|6|||
161498211|NCT02205333|583220064|FG004|Overall Study|Death|5|||
161498212|NCT02205333|583220065|FG005|Overall Study|Death|3|||
161498213|NCT02205333|583220066|FG006|Overall Study|Death|3|||
161498214|NCT02205333|583220067|FG007|Overall Study|Death|2|||
161498215|NCT02205333|583220068|FG008|Overall Study|Death|0|||
161498216|NCT02205333|583220060|FG000|Overall Study|Withdrawal by Subject|1|||
161498217|NCT02205333|583220061|FG001|Overall Study|Withdrawal by Subject|0|||
161498218|NCT02205333|583220062|FG002|Overall Study|Withdrawal by Subject|0|||
161498219|NCT02205333|583220063|FG003|Overall Study|Withdrawal by Subject|1|||
161498220|NCT02205333|583220064|FG004|Overall Study|Withdrawal by Subject|0|||
161498221|NCT02205333|583220065|FG005|Overall Study|Withdrawal by Subject|0|||
161498222|NCT02205333|583220066|FG006|Overall Study|Withdrawal by Subject|2|||
161498223|NCT02205333|583220067|FG007|Overall Study|Withdrawal by Subject|0|||
161498224|NCT02205333|583220068|FG008|Overall Study|Withdrawal by Subject|0|||
161498225|NCT01176266|583220069|FG000|Overall Study|Death|6|||
161498226|NCT01176266|583220069|FG000|Overall Study|Withdrawal by Subject|3|||
161498227|NCT01179477|583220070|FG000|Overall Study|Death|542|||
161498228|NCT01179477|583220070|FG000|Overall Study|Unsuccessful implant|80|||
161498229|NCT01179477|583220070|FG000|Overall Study|Non-death withdrawal|438|||
161498230|NCT01179477|583220070|FG000|Overall Study|Did not complete final visit|27|||
161498231|NCT00455429|583220072|FG000|Overall Study|Study Terminated by Sponsor|0|||
161498232|NCT00455429|583220073|FG001|Overall Study|Study Terminated by Sponsor|0|||
161498233|NCT00455429|583220074|FG002|Overall Study|Study Terminated by Sponsor|0|||
161498234|NCT00455429|583220075|FG003|Overall Study|Study Terminated by Sponsor|3|||
161498235|NCT00455429|583220072|FG000|Overall Study|Lost to Follow-up|1|||
161498236|NCT00455429|583220073|FG001|Overall Study|Lost to Follow-up|0|||
161498237|NCT00455429|583220074|FG002|Overall Study|Lost to Follow-up|0|||
161498238|NCT00455429|583220075|FG003|Overall Study|Lost to Follow-up|3|||
161498239|NCT00455429|583220072|FG000|Overall Study|Withdrawal by Subject|0|||
161498240|NCT00455429|583220073|FG001|Overall Study|Withdrawal by Subject|1|||
161498241|NCT00455429|583220074|FG002|Overall Study|Withdrawal by Subject|1|||
161498242|NCT00455429|583220075|FG003|Overall Study|Withdrawal by Subject|0|||
161498243|NCT00455429|583220072|FG000|Overall Study|Lack of Efficacy|0|||
161498244|NCT00455429|583220073|FG001|Overall Study|Lack of Efficacy|1|||
161498245|NCT00455429|583220074|FG002|Overall Study|Lack of Efficacy|0|||
161498246|NCT00455429|583220075|FG003|Overall Study|Lack of Efficacy|1|||
161498247|NCT00455429|583220072|FG000|Overall Study|Adverse Event|0|||
161498248|NCT00455429|583220073|FG001|Overall Study|Adverse Event|1|||
161498249|NCT00455429|583220074|FG002|Overall Study|Adverse Event|0|||
161498250|NCT00455429|583220075|FG003|Overall Study|Adverse Event|3|||
161498251|NCT00455429|583220072|FG000|Overall Study|Randomly assigned but not treated|0|||
161498252|NCT00455429|583220073|FG001|Overall Study|Randomly assigned but not treated|0|||
161498253|NCT00455429|583220074|FG002|Overall Study|Randomly assigned but not treated|0|||
161498254|NCT00455429|583220075|FG003|Overall Study|Randomly assigned but not treated|2|||
161498255|NCT00455429|583220072|FG000|Overall Study|Personal Reason|1|||
161498256|NCT00455429|583220073|FG001|Overall Study|Personal Reason|0|||
161498257|NCT00455429|583220074|FG002|Overall Study|Personal Reason|0|||
161498258|NCT00455429|583220075|FG003|Overall Study|Personal Reason|0|||
161498259|NCT00455429|583220072|FG000|Overall Study|Non-compliance|0|||
161498260|NCT00455429|583220073|FG001|Overall Study|Non-compliance|0|||
161498261|NCT00455429|583220074|FG002|Overall Study|Non-compliance|0|||
161498262|NCT00455429|583220075|FG003|Overall Study|Non-compliance|1|||
161498263|NCT00455429|583220072|FG000|Overall Study|Other|0|||
161498264|NCT00455429|583220073|FG001|Overall Study|Other|2|||
161498265|NCT00455429|583220074|FG002|Overall Study|Other|0|||
161498266|NCT00455429|583220075|FG003|Overall Study|Other|1|||
161673045|NCT01603082|583856553|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
161673046|NCT01603082|583856554|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
161673047|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161673048|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161673049|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
161498267|NCT04351087|583220076|FG000|Overall Study|Lost to Follow-up|7|||
161673050|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161818707|NCT01968031|584376195|FG001|Overall Study|Failed inclusion criteria|2|||
161498268|NCT04351087|583220077|FG001|Overall Study|Lost to Follow-up|3|||
161498269|NCT04351087|583220076|FG000|Overall Study|Withdrawal by Subject|3|||
161498270|NCT04351087|583220077|FG001|Overall Study|Withdrawal by Subject|4|||
161498271|NCT04351087|583220076|FG000|Overall Study|Lack of Efficacy|3|||
161498272|NCT04351087|583220077|FG001|Overall Study|Lack of Efficacy|2|||
161498273|NCT03519347|583220078|FG000|Interventional Crossover Period 1|Death|0|||
161498274|NCT03519347|583220079|FG001|Interventional Crossover Period 1|Death|0|||
161498275|NCT03519347|583220080|FG002|Interventional Crossover Period 1|Death|0|||
161498276|NCT03519347|583220081|FG003|Interventional Crossover Period 1|Death|1|||
161498277|NCT01412021|583220082|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
161498278|NCT01412021|583220082|FG000|Overall Study|Treatment Prior to Approval|3|||
161498279|NCT01412021|583220082|FG000|Overall Study|Transferred to Other Hospital|9|||
161924689|NCT01658878|584770976|FG010|Treatment Period|Maximum Clinical Benefit|0|||
161924690|NCT01658878|584770977|FG011|Treatment Period|Maximum Clinical Benefit|0|||
161924691|NCT01658878|584770978|FG012|Treatment Period|Maximum Clinical Benefit|0|||
161924692|NCT01658878|584770979|FG013|Treatment Period|Maximum Clinical Benefit|0|||
161924693|NCT01658878|584770980|FG014|Treatment Period|Maximum Clinical Benefit|0|||
161924694|NCT01658878|584770981|FG015|Treatment Period|Maximum Clinical Benefit|0|||
161924695|NCT01658878|584770982|FG016|Treatment Period|Maximum Clinical Benefit|0|||
161924696|NCT01658878|584770983|FG017|Treatment Period|Maximum Clinical Benefit|0|||
161924697|NCT01658878|584770984|FG018|Treatment Period|Maximum Clinical Benefit|1|||
161924698|NCT01658878|584770985|FG019|Treatment Period|Maximum Clinical Benefit|1|||
161924699|NCT01658878|584770986|FG020|Treatment Period|Maximum Clinical Benefit|0|||
161498280|NCT00484939|583220085|FG000|Overall Study|Death|9|||
161498281|NCT00484939|583220086|FG001|Overall Study|Death|13|||
161498282|NCT00484939|583220085|FG000|Overall Study|Adverse Event|22|||
161498283|NCT00484939|583220086|FG001|Overall Study|Adverse Event|12|||
161498284|NCT00484939|583220085|FG000|Overall Study|Patient Withdrew Consent|19|||
161498285|NCT00484939|583220086|FG001|Overall Study|Patient Withdrew Consent|10|||
161498286|NCT00484939|583220085|FG000|Overall Study|Protocol Violation|3|||
161498287|NCT00484939|583220086|FG001|Overall Study|Protocol Violation|3|||
161498288|NCT00484939|583220085|FG000|Overall Study|Lost to Follow-up|0|||
161498289|NCT00484939|583220086|FG001|Overall Study|Lost to Follow-up|3|||
161498290|NCT00484939|583220085|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
161498291|NCT00484939|583220086|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
161498292|NCT00484939|583220085|FG000|Overall Study|Disease progression|67|||
161498293|NCT00484939|583220086|FG001|Overall Study|Disease progression|88|||
161498294|NCT00484939|583220085|FG000|Overall Study|Screen Failure|2|||
161498295|NCT00484939|583220086|FG001|Overall Study|Screen Failure|2|||
161498296|NCT00484939|583220085|FG000|Overall Study|Reason Not Specified|11|||
161498297|NCT00484939|583220086|FG001|Overall Study|Reason Not Specified|6|||
161498298|NCT01522365|583220087|FG000|Overall Study|Withdrawal by Subject|1|||
161498299|NCT01522365|583220088|FG001|Overall Study|Withdrawal by Subject|1|||
161498300|NCT01522365|583220087|FG000|Overall Study|Lost to Follow-up|1|||
161498301|NCT01522365|583220088|FG001|Overall Study|Lost to Follow-up|1|||
161498302|NCT02466555|583220091|FG000|Overall Study|Lost to Follow-up|2|||
161498303|NCT01120756|583220092|FG000|Overall Study|Withdrawal by Subject|1|||
161498304|NCT01120756|583220093|FG001|Overall Study|Withdrawal by Subject|1|||
161498305|NCT00698581|583220094|FG000|Overall Study|Lack of Efficacy|23|||
161498306|NCT00698581|583220095|FG001|Overall Study|Lack of Efficacy|11|||
161498307|NCT00698581|583220094|FG000|Overall Study|Withdrawal by Subject|6|||
161673051|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
161924700|NCT01658878|584770987|FG021|Treatment Period|Maximum Clinical Benefit|0|||
161924701|NCT01658878|584770988|FG022|Treatment Period|Maximum Clinical Benefit|0|||
161924702|NCT01658878|584770989|FG023|Treatment Period|Maximum Clinical Benefit|0|||
161924703|NCT01658878|584770966|FG000|Treatment Period|Other Reasons|0|||
161924704|NCT01658878|584770967|FG001|Treatment Period|Other Reasons|0|||
161924705|NCT01658878|584770968|FG002|Treatment Period|Other Reasons|0|||
161498308|NCT00698581|583220095|FG001|Overall Study|Withdrawal by Subject|0|||
161498309|NCT00698581|583220094|FG000|Overall Study|Other reason|9|||
161498310|NCT00698581|583220095|FG001|Overall Study|Other reason|1|||
161498311|NCT00698581|583220094|FG000|Overall Study|SAE, non-fatal|1|||
161498312|NCT00698581|583220095|FG001|Overall Study|SAE, non-fatal|0|||
161818708|NCT01968031|584376196|FG002|Overall Study|Failed inclusion criteria|0|||
161818709|NCT01968031|584376194|FG000|Overall Study|Death|0|||
161818710|NCT01968031|584376195|FG001|Overall Study|Death|0|||
161818711|NCT01968031|584376196|FG002|Overall Study|Death|1|||
161818712|NCT01968031|584376194|FG000|Overall Study|Prohibited concomitant medication|1|||
161818713|NCT01968031|584376195|FG001|Overall Study|Prohibited concomitant medication|0|||
161818714|NCT01968031|584376196|FG002|Overall Study|Prohibited concomitant medication|0|||
161818715|NCT00477594|584376197|FG000|Year 1 and Year 2|Adverse Event|4|||
161818716|NCT00477594|584376198|FG001|Year 1 and Year 2|Adverse Event|2|||
161818717|NCT00477594|584376197|FG000|Year 1 and Year 2|Physician Decision|2|||
161818718|NCT00477594|584376198|FG001|Year 1 and Year 2|Physician Decision|1|||
161818719|NCT00477594|584376197|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
161818720|NCT00477594|584376198|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
161818721|NCT00477594|584376197|FG000|Year 1 and Year 2|Other|1|||
161818722|NCT00477594|584376198|FG001|Year 1 and Year 2|Other|0|||
161818723|NCT00477594|584376197|FG000|Year 3|Adverse Event|1|||
161818724|NCT00477594|584376198|FG001|Year 3|Adverse Event|0|||
161818725|NCT00477594|584376197|FG000|Year 3|Withdrawal by Subject|1|||
161818726|NCT00477594|584376198|FG001|Year 3|Withdrawal by Subject|0|||
161818727|NCT00477594|584376197|FG000|Follow-up Period|Withdrawal by Subject|2|||
161818728|NCT00477594|584376198|FG001|Follow-up Period|Withdrawal by Subject|1|||
161818729|NCT00477594|584376197|FG000|Follow-up Period|Other|1|||
161818730|NCT00477594|584376198|FG001|Follow-up Period|Other|0|||
161818731|NCT04573309|584378103|FG000|Overall Study|Protocol Violation|1|||
161818732|NCT04573309|584378104|FG001|Overall Study|Protocol Violation|0|||
161818733|NCT01691430|584378105|FG000|Overall Study|Death|17|||
161818734|NCT01691430|584378106|FG001|Overall Study|Death|16|||
161818735|NCT01691430|584378105|FG000|Overall Study|Withdrawal by Subject|5|||
161818736|NCT01691430|584378106|FG001|Overall Study|Withdrawal by Subject|1|||
161818737|NCT01691430|584378105|FG000|Overall Study|Lost to Follow-up|0|||
161818738|NCT01691430|584378106|FG001|Overall Study|Lost to Follow-up|3|||
161818739|NCT02998541|584378108|FG000|Overall Study|Adverse Event|4|||
161818740|NCT02998541|584378109|FG001|Overall Study|Adverse Event|5|||
161818741|NCT02998541|584378110|FG002|Overall Study|Adverse Event|1|||
161818742|NCT02998541|584378108|FG000|Overall Study|Protocol Violation|1|||
161818743|NCT02998541|584378109|FG001|Overall Study|Protocol Violation|0|||
161818744|NCT02998541|584378110|FG002|Overall Study|Protocol Violation|0|||
161818745|NCT02998541|584378108|FG000|Overall Study|Withdrawal by Subject|3|||
161818746|NCT02998541|584378109|FG001|Overall Study|Withdrawal by Subject|1|||
161818747|NCT02998541|584378110|FG002|Overall Study|Withdrawal by Subject|0|||
161818748|NCT02998541|584378108|FG000|Overall Study|Lost to Follow-up|0|||
161818749|NCT02998541|584378109|FG001|Overall Study|Lost to Follow-up|3|||
161818750|NCT02998541|584378110|FG002|Overall Study|Lost to Follow-up|1|||
161818751|NCT02998541|584378108|FG000|Overall Study|Physician Decision|0|||
161818752|NCT02998541|584378109|FG001|Overall Study|Physician Decision|0|||
161818753|NCT02998541|584378110|FG002|Overall Study|Physician Decision|3|||
161818754|NCT02998541|584378108|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161818755|NCT02998541|584378109|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161818756|NCT02998541|584378110|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
161818757|NCT03540160|584378114|FG000|Overall Study|Protocol Violation|1|||
161818758|NCT03540160|584378114|FG000|Overall Study|Physician Decision|8|||
161818759|NCT03540160|584378114|FG000|Overall Study|Lack of Efficacy|60|||
161818760|NCT03540160|584378114|FG000|Overall Study|Pregnancy|1|||
161818761|NCT03540160|584378114|FG000|Overall Study|Adverse Event|20|||
161818762|NCT03540160|584378114|FG000|Overall Study|Withdrawal by Subject|68|||
161585683|NCT02374307|583531831|FG000|3-months Follow-up|Missed first follow-up|5|||
161585684|NCT02374307|583531832|FG001|3-months Follow-up|Missed first follow-up|1|||
161585685|NCT02374307|583531831|FG000|6-months Follow-up|Lost to Follow-up|1|||
161585686|NCT02374307|583531832|FG001|6-months Follow-up|Lost to Follow-up|2|||
161585687|NCT02374307|583531831|FG000|6-months Follow-up|Death|2|||
161585688|NCT02374307|583531832|FG001|6-months Follow-up|Death|1|||
161585689|NCT02374307|583531831|FG000|6-months Follow-up|Withdrawal by Subject|0|||
161585690|NCT02374307|583531832|FG001|6-months Follow-up|Withdrawal by Subject|3|||
161585691|NCT01989455|583531833|FG000|Overall Study|Adverse Event|0|||
161585692|NCT01989455|583531834|FG001|Overall Study|Adverse Event|1|||
161585693|NCT01989455|583531835|FG002|Overall Study|Adverse Event|0|||
161673052|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
161818763|NCT03540160|584378114|FG000|Overall Study|COVID-19|2|||
161818764|NCT03540160|584378114|FG000|Overall Study|Study Closure|10|||
161818765|NCT03540160|584378114|FG000|Overall Study|Lost to Follow-up|18|||
161818766|NCT03540160|584378114|FG000|Overall Study|Sponsor decision|191|||
161818767|NCT01944722|584378115|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
161585694|NCT01989455|583531836|FG003|Overall Study|Adverse Event|0|||
161818768|NCT01944722|584378115|FG000|Overall Study|Specimen Shipping Issues|34|||
161818769|NCT01944722|584378115|FG000|Overall Study|Improper Storage/Transport|5|||
161818770|NCT01944722|584378115|FG000|Overall Study|Insufficient Volume for Test|1|||
161818771|NCT01944722|584378115|FG000|Overall Study|Missing Specimens|3|||
161818772|NCT01944722|584378115|FG000|Overall Study|Specimens Mislabeled|2|||
161818773|NCT01944722|584378115|FG000|Overall Study|Withdrawal by Subject|8|||
161585695|NCT01989455|583531837|FG004|Overall Study|Adverse Event|0|||
161585696|NCT01989455|583531833|FG000|Overall Study|Withdrawal by Subject|0|||
161585697|NCT01989455|583531834|FG001|Overall Study|Withdrawal by Subject|1|||
161585698|NCT01989455|583531835|FG002|Overall Study|Withdrawal by Subject|0|||
161585699|NCT01989455|583531836|FG003|Overall Study|Withdrawal by Subject|0|||
161585700|NCT01989455|583531837|FG004|Overall Study|Withdrawal by Subject|0|||
161585701|NCT01989455|583531833|FG000|Overall Study|Technical problems with infusion|0|||
161585702|NCT01989455|583531834|FG001|Overall Study|Technical problems with infusion|0|||
161585703|NCT01989455|583531835|FG002|Overall Study|Technical problems with infusion|1|||
161585704|NCT01989455|583531836|FG003|Overall Study|Technical problems with infusion|0|||
161585705|NCT01989455|583531837|FG004|Overall Study|Technical problems with infusion|1|||
161585706|NCT00632203|583531838|FG000|Overall Study|Did not start study treatment|1|||
161585707|NCT00632203|583531839|FG001|Overall Study|Did not start study treatment|0|||
161585708|NCT00448669|583531845|FG000|Overall Study|Lost to Follow-up|52|||
161585709|NCT00448669|583531846|FG001|Overall Study|Lost to Follow-up|63|||
161585710|NCT00448669|583531845|FG000|Overall Study|Withdrawal by Subject|90|||
161585711|NCT00448669|583531846|FG001|Overall Study|Withdrawal by Subject|74|||
161585712|NCT00448669|583531845|FG000|Overall Study|Relocated|49|||
161585713|NCT00448669|583531846|FG001|Overall Study|Relocated|36|||
161585714|NCT00448669|583531845|FG000|Overall Study|Were withdrawn by investigator|10|||
161585715|NCT00448669|583531846|FG001|Overall Study|Were withdrawn by investigator|6|||
161585716|NCT00448669|583531845|FG000|Overall Study|Death|2|||
161585717|NCT00448669|583531846|FG001|Overall Study|Death|4|||
161585718|NCT00448669|583531845|FG000|Overall Study|Had other reasons|5|||
161585719|NCT00448669|583531846|FG001|Overall Study|Had other reasons|6|||
161585720|NCT00448669|583531845|FG000|Overall Study|HIV-infected at enrollment|1|||
161585721|NCT00448669|583531846|FG001|Overall Study|HIV-infected at enrollment|2|||
161585722|NCT00448669|583531845|FG000|Overall Study|Never started drug|9|||
161585723|NCT00448669|583531846|FG001|Overall Study|Never started drug|7|||
161585724|NCT04287985|583531847|FG000|Overall Study|Adverse Event|1|||
161585725|NCT04287985|583531848|FG001|Overall Study|Adverse Event|0|||
161585726|NCT04287985|583531849|FG002|Overall Study|Adverse Event|0|||
161585727|NCT04287985|583531850|FG003|Overall Study|Adverse Event|0|||
161585728|NCT04287985|583531847|FG000|Overall Study|Protocol Violation|0|||
161585729|NCT04287985|583531848|FG001|Overall Study|Protocol Violation|1|||
161585730|NCT04287985|583531849|FG002|Overall Study|Protocol Violation|0|||
161585731|NCT04287985|583531850|FG003|Overall Study|Protocol Violation|0|||
161585732|NCT04287985|583531847|FG000|Overall Study|Physician Decision|0|||
161585733|NCT04287985|583531848|FG001|Overall Study|Physician Decision|0|||
161585734|NCT04287985|583531849|FG002|Overall Study|Physician Decision|0|||
161585735|NCT04287985|583531850|FG003|Overall Study|Physician Decision|1|||
161585736|NCT04287985|583531847|FG000|Overall Study|Withdrawal by Subject|2|||
161585737|NCT04287985|583531848|FG001|Overall Study|Withdrawal by Subject|1|||
161585738|NCT04287985|583531849|FG002|Overall Study|Withdrawal by Subject|1|||
161585739|NCT04287985|583531850|FG003|Overall Study|Withdrawal by Subject|2|||
161585740|NCT02638337|583531851|FG000|Overall Study|Adverse Event|6|||
161585741|NCT02638337|583531852|FG001|Overall Study|Adverse Event|10|||
161585742|NCT02638337|583531851|FG000|Overall Study|Protocol Violation|3|||
161673053|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
161673054|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
161673055|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
161673056|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
161673057|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
161673058|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
161673059|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
161673060|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
161924706|NCT01658878|584770969|FG003|Treatment Period|Other Reasons|1|||
161924707|NCT01658878|584770970|FG004|Treatment Period|Other Reasons|0|||
161924708|NCT01658878|584770971|FG005|Treatment Period|Other Reasons|0|||
161924709|NCT01658878|584770972|FG006|Treatment Period|Other Reasons|0|||
161924710|NCT01658878|584770973|FG007|Treatment Period|Other Reasons|0|||
161924711|NCT01658878|584770974|FG008|Treatment Period|Other Reasons|0|||
161924712|NCT01658878|584770975|FG009|Treatment Period|Other Reasons|0|||
161924713|NCT01658878|584770976|FG010|Treatment Period|Other Reasons|0|||
161924714|NCT01658878|584770977|FG011|Treatment Period|Other Reasons|0|||
161924715|NCT01658878|584770978|FG012|Treatment Period|Other Reasons|2|||
161924716|NCT01658878|584770979|FG013|Treatment Period|Other Reasons|0|||
161924717|NCT01658878|584770980|FG014|Treatment Period|Other Reasons|0|||
161585743|NCT02638337|583531852|FG001|Overall Study|Protocol Violation|0|||
161585744|NCT02638337|583531851|FG000|Overall Study|Withdrawal by Subject|13|||
161585745|NCT02638337|583531852|FG001|Overall Study|Withdrawal by Subject|16|||
161585746|NCT02638337|583531851|FG000|Overall Study|Lost to Follow-up|7|||
161924718|NCT01658878|584770981|FG015|Treatment Period|Other Reasons|2|||
161924719|NCT01658878|584770982|FG016|Treatment Period|Other Reasons|1|||
161924720|NCT01658878|584770983|FG017|Treatment Period|Other Reasons|1|||
161924721|NCT01658878|584770984|FG018|Treatment Period|Other Reasons|3|||
161924722|NCT01658878|584770985|FG019|Treatment Period|Other Reasons|1|||
161673061|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
161924723|NCT01658878|584770986|FG020|Treatment Period|Other Reasons|4|||
161924724|NCT01658878|584770987|FG021|Treatment Period|Other Reasons|0|||
161924725|NCT01658878|584770988|FG022|Treatment Period|Other Reasons|0|||
161924726|NCT01658878|584770989|FG023|Treatment Period|Other Reasons|4|||
161924727|NCT01658878|584770966|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924728|NCT01658878|584770967|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161498313|NCT00698581|583220094|FG000|Overall Study|AE, non-serious non-fatal|4|||
161673062|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
161498314|NCT00698581|583220095|FG001|Overall Study|AE, non-serious non-fatal|0|||
161498315|NCT00698581|583220094|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161673063|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
161673064|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
161673065|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
161498316|NCT00698581|583220095|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161498317|NCT00698581|583220094|FG000|Overall Study|AE of unknown type|1|||
161498318|NCT00698581|583220095|FG001|Overall Study|AE of unknown type|0|||
161498319|NCT03760146|583220096|FG000|Overall Study|Adverse Event|11|||
161498320|NCT03760146|583220097|FG001|Overall Study|Adverse Event|8|||
161498321|NCT03760146|583220098|FG002|Overall Study|Adverse Event|0|||
161498322|NCT03760146|583220099|FG003|Overall Study|Adverse Event|0|||
161498323|NCT03760146|583220100|FG004|Overall Study|Adverse Event|0|||
161498324|NCT03760146|583220101|FG005|Overall Study|Adverse Event|0|||
161818774|NCT01944722|584378115|FG000|Overall Study|NILM Subjects <30 years old|8106|||
161818775|NCT01944722|584378115|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
161818776|NCT01944722|584378115|FG000|Overall Study|>ASCUS Cytology|1122|||
161818777|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
161818778|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
161818779|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
161818780|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
161818781|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
161818782|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
161818783|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
161818784|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
161818785|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
161818786|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
161818787|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
161818788|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
161818789|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
161818790|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
161818791|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
161818792|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
161818793|NCT00687739|584378120|FG000|Overall Study|Lost to Follow-up|2|||
161818794|NCT00687739|584378121|FG001|Overall Study|Lost to Follow-up|2|||
161818795|NCT00687739|584378122|FG002|Overall Study|Lost to Follow-up|1|||
161818796|NCT00687739|584378123|FG003|Overall Study|Lost to Follow-up|2|||
161818797|NCT00687739|584378120|FG000|Overall Study|Adverse Event|0|||
161818798|NCT00687739|584378121|FG001|Overall Study|Adverse Event|1|||
161498325|NCT03760146|583220096|FG000|Overall Study|Death|1|||
161498326|NCT03760146|583220097|FG001|Overall Study|Death|0|||
161498327|NCT03760146|583220098|FG002|Overall Study|Death|0|||
161673066|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
161673067|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
161498328|NCT03760146|583220099|FG003|Overall Study|Death|0|||
161673068|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
161673069|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
161673070|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
161818799|NCT00687739|584378122|FG002|Overall Study|Adverse Event|1|||
161818800|NCT00687739|584378123|FG003|Overall Study|Adverse Event|0|||
161818801|NCT02554877|584378124|FG000|Overall Study|Adverse Event|2|||
161818802|NCT02554877|584378125|FG001|Overall Study|Adverse Event|0|||
161818803|NCT02554877|584378126|FG002|Overall Study|Adverse Event|0|||
161818804|NCT02554877|584378127|FG003|Overall Study|Adverse Event|1|||
161818805|NCT02554877|584378124|FG000|Overall Study|Lost to Follow-up|1|||
161818806|NCT02554877|584378125|FG001|Overall Study|Lost to Follow-up|1|||
161818807|NCT02554877|584378126|FG002|Overall Study|Lost to Follow-up|1|||
161924729|NCT01658878|584770968|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924730|NCT01658878|584770969|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161498329|NCT03760146|583220100|FG004|Overall Study|Death|0|||
161498330|NCT03760146|583220101|FG005|Overall Study|Death|0|||
161498331|NCT03760146|583220096|FG000|Overall Study|Lost to Follow-up|41|||
161498332|NCT03760146|583220097|FG001|Overall Study|Lost to Follow-up|28|||
161498333|NCT03760146|583220098|FG002|Overall Study|Lost to Follow-up|9|||
161498334|NCT03760146|583220099|FG003|Overall Study|Lost to Follow-up|2|||
161498335|NCT03760146|583220100|FG004|Overall Study|Lost to Follow-up|14|||
161498336|NCT03760146|583220101|FG005|Overall Study|Lost to Follow-up|8|||
161498337|NCT03760146|583220096|FG000|Overall Study|No longer met eligibility criteria|3|||
161498338|NCT03760146|583220097|FG001|Overall Study|No longer met eligibility criteria|9|||
161498339|NCT03760146|583220098|FG002|Overall Study|No longer met eligibility criteria|0|||
161498340|NCT03760146|583220099|FG003|Overall Study|No longer met eligibility criteria|0|||
161498341|NCT03760146|583220100|FG004|Overall Study|No longer met eligibility criteria|1|||
161498342|NCT03760146|583220101|FG005|Overall Study|No longer met eligibility criteria|0|||
161498343|NCT03760146|583220096|FG000|Overall Study|Protocol Violation|21|||
161498344|NCT03760146|583220097|FG001|Overall Study|Protocol Violation|13|||
161498345|NCT03760146|583220098|FG002|Overall Study|Protocol Violation|1|||
161498346|NCT03760146|583220099|FG003|Overall Study|Protocol Violation|0|||
161498347|NCT03760146|583220100|FG004|Overall Study|Protocol Violation|1|||
161498348|NCT03760146|583220101|FG005|Overall Study|Protocol Violation|0|||
161498349|NCT03760146|583220096|FG000|Overall Study|Withdrawal by Subject|19|||
161498350|NCT03760146|583220097|FG001|Overall Study|Withdrawal by Subject|20|||
161498351|NCT03760146|583220098|FG002|Overall Study|Withdrawal by Subject|1|||
161673071|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
161673072|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
161673073|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
161673074|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
161673075|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161673076|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
161673077|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161673078|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161673079|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
161673080|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
161673081|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
161673082|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
161673083|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
161673084|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
161673085|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
161673086|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
161673087|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
161673088|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
161673089|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
161673090|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
161673091|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
161673092|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
161673093|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
161498352|NCT03760146|583220099|FG003|Overall Study|Withdrawal by Subject|0|||
161498353|NCT03760146|583220100|FG004|Overall Study|Withdrawal by Subject|1|||
161498354|NCT03760146|583220101|FG005|Overall Study|Withdrawal by Subject|0|||
161498355|NCT00449644|583220102|FG000|Overall Study|Adverse Event|0|||
161498356|NCT00449644|583220103|FG001|Overall Study|Adverse Event|0|||
161498357|NCT00449644|583220104|FG002|Overall Study|Adverse Event|3|||
161498358|NCT00449644|583220105|FG003|Overall Study|Adverse Event|5|||
161498359|NCT00449644|583220102|FG000|Overall Study|Death|1|||
161498360|NCT00449644|583220103|FG001|Overall Study|Death|0|||
161498361|NCT00449644|583220104|FG002|Overall Study|Death|6|||
161498362|NCT00449644|583220105|FG003|Overall Study|Death|1|||
161498363|NCT00449644|583220102|FG000|Overall Study|Lost to Follow-up|1|||
161498364|NCT00449644|583220103|FG001|Overall Study|Lost to Follow-up|1|||
161498365|NCT00449644|583220104|FG002|Overall Study|Lost to Follow-up|5|||
161498366|NCT00449644|583220105|FG003|Overall Study|Lost to Follow-up|3|||
161498367|NCT00449644|583220102|FG000|Overall Study|Pregnancy|0|||
161498368|NCT00449644|583220103|FG001|Overall Study|Pregnancy|0|||
161498369|NCT00449644|583220104|FG002|Overall Study|Pregnancy|3|||
161498370|NCT00449644|583220105|FG003|Overall Study|Pregnancy|2|||
161498371|NCT00449644|583220102|FG000|Overall Study|Protocol Violation|4|||
161673094|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
161818808|NCT02554877|584378127|FG003|Overall Study|Lost to Follow-up|2|||
161498372|NCT00449644|583220103|FG001|Overall Study|Protocol Violation|4|||
161498373|NCT00449644|583220104|FG002|Overall Study|Protocol Violation|3|||
161498374|NCT00449644|583220105|FG003|Overall Study|Protocol Violation|7|||
161498375|NCT00449644|583220102|FG000|Overall Study|Withdrawal by Subject|3|||
161498376|NCT00449644|583220103|FG001|Overall Study|Withdrawal by Subject|4|||
161498377|NCT00449644|583220104|FG002|Overall Study|Withdrawal by Subject|6|||
161498378|NCT00449644|583220105|FG003|Overall Study|Withdrawal by Subject|7|||
161498379|NCT00449644|583220102|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
161498380|NCT00449644|583220103|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
161498381|NCT00449644|583220104|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
161498382|NCT00449644|583220105|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
161498383|NCT00449644|583220102|FG000|Overall Study|Other|1|||
161498384|NCT00449644|583220103|FG001|Overall Study|Other|4|||
161498385|NCT00449644|583220104|FG002|Overall Study|Other|1|||
161498386|NCT00449644|583220105|FG003|Overall Study|Other|0|||
161498387|NCT00449644|583220102|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
161498388|NCT00449644|583220103|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
161498389|NCT00449644|583220104|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
161498390|NCT00449644|583220105|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
161498391|NCT00529542|583220106|FG000|Overall Study|Withdrawal by Subject|1|||
161498392|NCT00529542|583220107|FG001|Overall Study|Withdrawal by Subject|0|||
161498393|NCT00529542|583220106|FG000|Overall Study|Lost to Follow-up|0|||
161498394|NCT00529542|583220107|FG001|Overall Study|Lost to Follow-up|1|||
161498395|NCT00296374|583220119|FG000|Overall Study|Adverse Event|14|||
161498396|NCT00296374|583220120|FG001|Overall Study|Adverse Event|10|||
161498397|NCT00296374|583220121|FG002|Overall Study|Adverse Event|7|||
161498398|NCT00296374|583220119|FG000|Overall Study|Withdrawal by Subject|3|||
161498399|NCT00296374|583220120|FG001|Overall Study|Withdrawal by Subject|5|||
161498400|NCT00296374|583220121|FG002|Overall Study|Withdrawal by Subject|11|||
161498401|NCT00296374|583220119|FG000|Overall Study|Incorrect enrollment|3|||
161498402|NCT00296374|583220120|FG001|Overall Study|Incorrect enrollment|3|||
161498403|NCT00296374|583220121|FG002|Overall Study|Incorrect enrollment|4|||
161498404|NCT00296374|583220119|FG000|Overall Study|Protocol Violation|1|||
161498405|NCT00296374|583220120|FG001|Overall Study|Protocol Violation|2|||
161498406|NCT00296374|583220121|FG002|Overall Study|Protocol Violation|3|||
161498407|NCT00296374|583220119|FG000|Overall Study|Lost to Follow-up|3|||
161498408|NCT00296374|583220120|FG001|Overall Study|Lost to Follow-up|1|||
161498409|NCT00296374|583220121|FG002|Overall Study|Lost to Follow-up|1|||
161498410|NCT00296374|583220119|FG000|Overall Study|Relocated to another state|1|||
161498411|NCT00296374|583220120|FG001|Overall Study|Relocated to another state|0|||
161498412|NCT00296374|583220121|FG002|Overall Study|Relocated to another state|0|||
161498413|NCT00296374|583220119|FG000|Overall Study|Stopped drug before end of study visit|0|||
161498414|NCT00296374|583220120|FG001|Overall Study|Stopped drug before end of study visit|1|||
161498415|NCT00296374|583220121|FG002|Overall Study|Stopped drug before end of study visit|0|||
161498416|NCT00296374|583220119|FG000|Overall Study|Nephrologist introduced ACE|0|||
161498417|NCT00296374|583220120|FG001|Overall Study|Nephrologist introduced ACE|1|||
161498418|NCT00296374|583220121|FG002|Overall Study|Nephrologist introduced ACE|0|||
161498419|NCT00296374|583220119|FG000|Overall Study|Pregnancy|0|||
161498420|NCT00296374|583220120|FG001|Overall Study|Pregnancy|0|||
161498421|NCT00296374|583220121|FG002|Overall Study|Pregnancy|2|||
161498422|NCT00296374|583220119|FG000|Overall Study|Other|0|||
161498423|NCT00296374|583220120|FG001|Overall Study|Other|0|||
161498424|NCT00296374|583220121|FG002|Overall Study|Other|1|||
161498425|NCT01721330|583220122|FG000|Overall Study|Withdrawal by Subject|0|||
161498426|NCT01721330|583220123|FG001|Overall Study|Withdrawal by Subject|1|||
161498427|NCT01030523|583221303|FG000|Initial Study (5 Years)|Death|1|||
161498428|NCT01030523|583221304|FG001|Initial Study (5 Years)|Death|0|||
161498429|NCT01030523|583221303|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
161498430|NCT01030523|583221304|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
161498431|NCT01030523|583221303|FG000|Initial Study (5 Years)|Implant failure|1|||
161498432|NCT01030523|583221304|FG001|Initial Study (5 Years)|Implant failure|0|||
161498433|NCT01030523|583221303|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
161498434|NCT01030523|583221304|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
161498435|NCT01030523|583221303|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
161498436|NCT01030523|583221304|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
161498437|NCT01030523|583221303|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
161498438|NCT01030523|583221304|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
161498439|NCT01063764|583221307|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
161498440|NCT01063764|583221307|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
161498441|NCT01063764|583221307|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
161498442|NCT01063764|583221307|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
161498443|NCT01063764|583221307|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
161498444|NCT01063764|583221307|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
161498445|NCT01063764|583221307|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
161498446|NCT00697515|583221308|FG000|Dose Optimization Period|Adverse Event|4|||
161498447|NCT00697515|583221309|FG001|Dose Optimization Period|Adverse Event|0|||
161498448|NCT00697515|583221308|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
161498449|NCT00697515|583221309|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
161498450|NCT00697515|583221308|FG000|Dose Optimization Period|Lost to Follow-up|2|||
161498451|NCT00697515|583221309|FG001|Dose Optimization Period|Lost to Follow-up|0|||
161498452|NCT00697515|583221308|FG000|Dose Optimization Period|sponsor request|2|||
161498453|NCT00697515|583221309|FG001|Dose Optimization Period|sponsor request|0|||
161498454|NCT00697515|583221308|FG000|Dose Optimization Period|called to active duty|1|||
161498455|NCT00697515|583221309|FG001|Dose Optimization Period|called to active duty|0|||
161498456|NCT00697515|583221308|FG000|Dose Optimization Period|elevated QTc|1|||
161498457|NCT00697515|583221309|FG001|Dose Optimization Period|elevated QTc|0|||
161498458|NCT00697515|583221308|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
161498459|NCT00697515|583221309|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
161498460|NCT00697515|583221308|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
161498461|NCT00697515|583221309|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
161498462|NCT00697515|583221308|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
161498463|NCT00697515|583221309|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
161498464|NCT00697515|583221308|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
161498465|NCT00697515|583221309|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
161498466|NCT05954052|583221310|FG000|Overall Study|Adverse Event|1|||
161498467|NCT01957462|583221311|FG000|Test Period 1|Withdrawal by Subject|1|||
161498468|NCT01957462|583221312|FG001|Test Period 1|Withdrawal by Subject|0|||
161498469|NCT01957462|583221311|FG000|Test Period 1|Adverse Event|1|||
161498470|NCT01957462|583221312|FG001|Test Period 1|Adverse Event|0|||
161498471|NCT03102918|583221313|FG000|Overall Study|Protocol Violation|1|||
161498472|NCT03102918|583221314|FG001|Overall Study|Protocol Violation|0|||
161498473|NCT05517382|583221323|FG000|Overall Study|Lost to Follow-up|0|||
161498474|NCT05517382|583221324|FG001|Overall Study|Lost to Follow-up|1|||
161498475|NCT03886220|583221325|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
161498476|NCT03886220|583221326|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
161498477|NCT03886220|583221325|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
161498478|NCT03886220|583221326|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161498479|NCT03886220|583221325|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161498480|NCT03886220|583221326|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161498481|NCT01675128|583221333|FG000|Overall Study|Disease progression on study|1|||
161498482|NCT01675128|583221334|FG001|Overall Study|Disease progression on study|1|||
161498483|NCT01675128|583221335|FG002|Overall Study|Disease progression on study|1|||
161498484|NCT01675128|583221333|FG000|Overall Study|Refused further treatment|1|||
161498485|NCT01675128|583221334|FG001|Overall Study|Refused further treatment|0|||
161498486|NCT01675128|583221335|FG002|Overall Study|Refused further treatment|0|||
161498487|NCT01675128|583221333|FG000|Overall Study|Pulmonary complication; off study|0|||
161498488|NCT01675128|583221334|FG001|Overall Study|Pulmonary complication; off study|1|||
161498489|NCT01675128|583221335|FG002|Overall Study|Pulmonary complication; off study|0|||
161498490|NCT03526458|583221339|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
161498491|NCT03526458|583221340|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
161498492|NCT03526458|583221339|FG000|Overall Study|Stone passed, surgery cancelled|2|||
161498493|NCT03526458|583221340|FG001|Overall Study|Stone passed, surgery cancelled|1|||
161498494|NCT03526458|583221339|FG000|Overall Study|Withdrawal by Subject|1|||
161498495|NCT03526458|583221340|FG001|Overall Study|Withdrawal by Subject|0|||
161498496|NCT03526458|583221339|FG000|Overall Study|Physician Decision|2|||
161498497|NCT03526458|583221340|FG001|Overall Study|Physician Decision|1|||
161498498|NCT03526458|583221339|FG000|Overall Study|Lack of equipment|1|||
161498499|NCT03526458|583221340|FG001|Overall Study|Lack of equipment|1|||
161498500|NCT00271947|583221343|FG000|Overall Study|Lost to Follow-up|1|||
161498501|NCT04404855|583221344|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
161585747|NCT02638337|583531852|FG001|Overall Study|Lost to Follow-up|7|||
161585748|NCT02638337|583531851|FG000|Overall Study|Other - Miscellaneous|4|||
161585749|NCT02638337|583531852|FG001|Overall Study|Other - Miscellaneous|3|||
161585750|NCT03771352|583531853|FG000|Overall Study|Screen failure|2|||
161585751|NCT03771352|583531853|FG000|Overall Study|Withdrawal by Subject|2|||
161585752|NCT04315181|583531854|FG000|Overall Study|Non-responsive to drug conditions.|1|||
161585753|NCT01948661|583531855|FG000|Overall Study|Withdrawal by Subject|2|||
161585754|NCT01948661|583531856|FG001|Overall Study|Withdrawal by Subject|4|||
161585755|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Adverse Event|4|||
161585756|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Adverse Event|1|||
161585757|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
161585758|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
161585759|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
161585760|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
161585761|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
161498502|NCT04404855|583221345|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
161498503|NCT00735878|583221346|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
161498504|NCT00735878|583221347|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
161585762|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
161585763|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
161498505|NCT00735878|583221348|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
161498506|NCT00651755|583221351|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
161498507|NCT00651755|583221352|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
161924731|NCT01658878|584770970|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924732|NCT01658878|584770971|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924733|NCT01658878|584770972|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924734|NCT01658878|584770973|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924735|NCT01658878|584770974|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161498508|NCT00651755|583221351|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
161498509|NCT00651755|583221352|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
161498510|NCT03642717|583221357|FG000|Overall Study|Lost to Follow-up|2|||
161498511|NCT03642717|583221357|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
161498512|NCT03642717|583221357|FG000|Overall Study|Taken study drug prior to contract date|3|||
161498513|NCT02587065|583221358|FG000|Overall Study|Adverse Event|14|||
161498514|NCT02587065|583221358|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
161498515|NCT02587065|583221358|FG000|Overall Study|Non-adherence to the Protocol|3|||
161498516|NCT02587065|583221358|FG000|Overall Study|Discontinuation of Study Medication|2|||
161498517|NCT02587065|583221358|FG000|Overall Study|Reason not Specified|3|||
161498518|NCT01559012|583221359|FG000|Overall Study|Withdrawal by Subject|0|||
161498519|NCT01559012|583221360|FG001|Overall Study|Withdrawal by Subject|1|||
161498520|NCT00302458|583221363|FG000|Overall Study|Lost to Follow-up|1|||
161498521|NCT00302458|583221363|FG000|Overall Study|Ineligible after screening|1|||
161498522|NCT00302458|583221363|FG000|Overall Study|Withdrawal by Subject|1|||
161498523|NCT00946712|583221364|FG000|Overall Study|Adverse Event|118|||
161498524|NCT00946712|583221365|FG001|Overall Study|Adverse Event|124|||
161498525|NCT00946712|583221364|FG000|Overall Study|Disease progression|308|||
161498526|NCT00946712|583221365|FG001|Overall Study|Disease progression|404|||
161498527|NCT00946712|583221364|FG000|Overall Study|Death|21|||
161498528|NCT00946712|583221365|FG001|Overall Study|Death|22|||
161498529|NCT00946712|583221364|FG000|Overall Study|No treatment given|25|||
161498530|NCT00946712|583221365|FG001|Overall Study|No treatment given|29|||
161498531|NCT00946712|583221364|FG000|Overall Study|Other reasons|61|||
161498532|NCT00946712|583221365|FG001|Overall Study|Other reasons|73|||
161498533|NCT00946712|583221364|FG000|Overall Study|On Treatment|0|||
161498534|NCT00946712|583221365|FG001|Overall Study|On Treatment|4|||
161498535|NCT00946712|583221364|FG000|Overall Study|Ineligible|14|||
161498536|NCT00946712|583221365|FG001|Overall Study|Ineligible|6|||
161498537|NCT00853723|583221367|FG000|Overall Study|Adverse Event|3|||
161498538|NCT00853723|583221368|FG001|Overall Study|Adverse Event|4|||
161498539|NCT00853723|583221369|FG002|Overall Study|Adverse Event|1|||
161498540|NCT00853723|583221367|FG000|Overall Study|Withdrawal by Subject|2|||
161498541|NCT00853723|583221368|FG001|Overall Study|Withdrawal by Subject|1|||
161498542|NCT00853723|583221369|FG002|Overall Study|Withdrawal by Subject|0|||
161498543|NCT00853723|583221367|FG000|Overall Study|Protocol Violation|1|||
161498544|NCT00853723|583221368|FG001|Overall Study|Protocol Violation|2|||
161498545|NCT00853723|583221369|FG002|Overall Study|Protocol Violation|1|||
161498546|NCT04248933|583221370|FG000|Overall Study|Lost to Follow-up|9|||
161498547|NCT04248933|583221370|FG000|Overall Study|Withdrawal by Subject|2|||
161498548|NCT00445965|583221373|FG000|Overall Study|Adverse Event|2|||
161498549|NCT00445965|583221373|FG000|Overall Study|Physician Decision|1|||
161498550|NCT00445965|583221373|FG000|Overall Study|Enrolled but not treated|1|||
161498551|NCT00445965|583221373|FG000|Overall Study|Removed due to progressive disease|29|||
161498552|NCT02642432|583221374|FG000|Overall Study|Adverse Event|2|||
161498553|NCT02642432|583221374|FG000|Overall Study|Withdrew Consent|1|||
161498554|NCT02642432|583221374|FG000|Overall Study|Lost to Follow-up|2|||
161498555|NCT02642432|583221374|FG000|Overall Study|Other|3|||
161498556|NCT02447081|583221375|FG000|Overall Study|Death|161|||
161498557|NCT02447081|583221375|FG000|Overall Study|Lost to Follow-up|36|||
161498558|NCT02447081|583221375|FG000|Overall Study|Visit not completed|17|||
161585764|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
161585765|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Other|6|||
161585766|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Other|1|||
161585767|NCT03271489|583531857|FG000|Double-Blind (DB) Period|Missing|1|||
161585768|NCT03271489|583531858|FG001|Double-Blind (DB) Period|Missing|0|||
161585769|NCT03271489|583531857|FG000|Open-Label (OL) Period|Adverse Event|2|||
161585770|NCT03271489|583531858|FG001|Open-Label (OL) Period|Adverse Event|0|||
161924736|NCT01658878|584770975|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924737|NCT01658878|584770976|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924738|NCT01658878|584770977|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161498559|NCT02447081|583221375|FG000|Overall Study|unsuccessful implant procedure|10|||
161498560|NCT05778786|583221376|FG000|Period 1|COVID-19 Related|3|||
161498561|NCT05778786|583221377|FG001|Period 1|COVID-19 Related|3|||
161498562|NCT05778786|583221376|FG000|Period 1|Withdrew Consent during Study|1|||
161498563|NCT05778786|583221377|FG001|Period 1|Withdrew Consent during Study|0|||
161498564|NCT05778786|583221376|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
161585771|NCT03271489|583531857|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
161498565|NCT05778786|583221377|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
161498566|NCT05778786|583221376|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
161498567|NCT05778786|583221377|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
161498568|NCT02867709|583221380|FG000|Treatment Period|Adverse Event|1|||
161498569|NCT02867709|583221381|FG001|Treatment Period|Adverse Event|1|||
161498570|NCT02867709|583221382|FG002|Treatment Period|Adverse Event|2|||
161498571|NCT02867709|583221380|FG000|Treatment Period|Withdrawal of Consent|7|||
161673095|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
161924739|NCT01658878|584770978|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924740|NCT01658878|584770979|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924741|NCT01658878|584770980|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161924742|NCT01658878|584770981|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924743|NCT01658878|584770982|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924744|NCT01658878|584770983|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161924745|NCT01658878|584770984|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924746|NCT01658878|584770985|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924747|NCT01658878|584770986|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924748|NCT01658878|584770987|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161673096|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
161673097|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
161673098|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
161673099|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
161673100|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
161673101|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
161673102|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
161673103|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
161673104|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
161673105|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
161673106|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
161673107|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
161673108|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
161673109|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
161673110|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
161498572|NCT02867709|583221381|FG001|Treatment Period|Withdrawal of Consent|9|||
161498573|NCT02867709|583221382|FG002|Treatment Period|Withdrawal of Consent|8|||
161498574|NCT02867709|583221380|FG000|Treatment Period|Lost to Follow-up|17|||
161498575|NCT02867709|583221381|FG001|Treatment Period|Lost to Follow-up|20|||
161498576|NCT02867709|583221382|FG002|Treatment Period|Lost to Follow-up|20|||
161498577|NCT02867709|583221380|FG000|Treatment Period|Lack of Qualifying Event|42|||
161498578|NCT02867709|583221381|FG001|Treatment Period|Lack of Qualifying Event|55|||
161498579|NCT02867709|583221382|FG002|Treatment Period|Lack of Qualifying Event|42|||
161498580|NCT02867709|583221380|FG000|Treatment Period|Protocol Violation|3|||
161498581|NCT02867709|583221381|FG001|Treatment Period|Protocol Violation|2|||
161498582|NCT02867709|583221382|FG002|Treatment Period|Protocol Violation|3|||
161498583|NCT02867709|583221380|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
161498584|NCT02867709|583221381|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
161498585|NCT02867709|583221382|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
161498586|NCT02867709|583221380|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
161498587|NCT02867709|583221381|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
161498588|NCT02867709|583221382|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
161498589|NCT02867709|583221380|FG000|Safety Follow-up Period|Pregnancy|0|||
161498590|NCT02867709|583221381|FG001|Safety Follow-up Period|Pregnancy|1|||
161498591|NCT02867709|583221382|FG002|Safety Follow-up Period|Pregnancy|0|||
161498592|NCT02867709|583221380|FG000|Safety Follow-up Period|Protocol Violation|0|||
161498593|NCT02867709|583221381|FG001|Safety Follow-up Period|Protocol Violation|1|||
161673111|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
161673112|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
161673113|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
161924749|NCT01658878|584770988|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924750|NCT01658878|584770989|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161498594|NCT02867709|583221382|FG002|Safety Follow-up Period|Protocol Violation|1|||
161498595|NCT02075658|583221383|FG000|Overall Study|Physician Decision|2|||
161498596|NCT02075658|583221384|FG001|Overall Study|Physician Decision|2|||
161498597|NCT05198843|583221386|FG000|Overall Study|Lack of Efficacy|1|||
161673114|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
161924751|NCT01658878|584770966|FG000|Treatment Period|Poor/Non-compliance|0|||
161498598|NCT03188094|583221387|FG000|Overall Study|Screen failure|1|||
161673115|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
161673116|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
161924752|NCT01658878|584770967|FG001|Treatment Period|Poor/Non-compliance|0|||
161498599|NCT03188094|583221388|FG001|Overall Study|Screen failure|0|||
161498600|NCT03188094|583221389|FG002|Overall Study|Screen failure|0|||
161818809|NCT02554877|584378124|FG000|Overall Study|Did not meet entrance criteria|0|||
161818810|NCT02554877|584378125|FG001|Overall Study|Did not meet entrance criteria|0|||
161818811|NCT02554877|584378126|FG002|Overall Study|Did not meet entrance criteria|1|||
161498601|NCT03188094|583221387|FG000|Overall Study|Pregnancy|3|||
161498602|NCT03188094|583221388|FG001|Overall Study|Pregnancy|0|||
161498603|NCT03188094|583221389|FG002|Overall Study|Pregnancy|0|||
161498604|NCT03188094|583221387|FG000|Overall Study|Ineligible|1|||
161498605|NCT03188094|583221388|FG001|Overall Study|Ineligible|0|||
161498606|NCT03188094|583221389|FG002|Overall Study|Ineligible|0|||
161498607|NCT03188094|583221387|FG000|Overall Study|Lost to Follow-up|0|||
161498608|NCT03188094|583221388|FG001|Overall Study|Lost to Follow-up|0|||
161498609|NCT03188094|583221389|FG002|Overall Study|Lost to Follow-up|17|||
161498610|NCT02946047|583221390|FG000|Overall Study|Adverse Event|1|||
161498611|NCT02946047|583221391|FG001|Overall Study|Adverse Event|0|||
161498612|NCT02946047|583221392|FG002|Overall Study|Adverse Event|0|||
161498613|NCT02946047|583221393|FG003|Overall Study|Adverse Event|0|||
161498614|NCT03615105|583221394|FG000|Overall Study|Protocol Violation|1|||
161498615|NCT03615105|583221395|FG001|Overall Study|Protocol Violation|0|||
161498616|NCT03615105|583221396|FG002|Overall Study|Protocol Violation|0|||
161498617|NCT03615105|583221394|FG000|Overall Study|Death|0|||
161818812|NCT02554877|584378127|FG003|Overall Study|Did not meet entrance criteria|0|||
161818813|NCT02554877|584378124|FG000|Overall Study|No longer met eligibility criteria|1|||
161818814|NCT02554877|584378125|FG001|Overall Study|No longer met eligibility criteria|0|||
161498618|NCT03615105|583221395|FG001|Overall Study|Death|2|||
161498619|NCT03615105|583221396|FG002|Overall Study|Death|0|||
161498620|NCT05041322|583221397|FG000|Baseline|Withdrawal by Subject|1|||
161498621|NCT05041322|583221398|FG001|Baseline|Withdrawal by Subject|0|||
161498622|NCT05041322|583221397|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
161498623|NCT05041322|583221398|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
161498624|NCT05041322|583221397|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
161498625|NCT05041322|583221398|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
161498626|NCT01894581|583221399|FG000|Overall Study|Withdrawal by Subject|2|||
161498627|NCT01894581|583221400|FG001|Overall Study|Withdrawal by Subject|3|||
161498628|NCT01894581|583221399|FG000|Overall Study|Screen Failure|3|||
161498629|NCT01894581|583221400|FG001|Overall Study|Screen Failure|4|||
161498630|NCT03313804|583221401|FG000|Treatment|Death|5|||
161498631|NCT03313804|583221401|FG000|Treatment|still on treatment|2|||
161498632|NCT03313804|583221401|FG000|Follow Up|still on follow up|3|||
161498633|NCT03795298|583221402|FG000|Overall Study|Death|34|||
161498634|NCT03795298|583221403|FG001|Overall Study|Death|29|||
161498635|NCT03795298|583221402|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
161498636|NCT03795298|583221403|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
161498637|NCT03795298|583221402|FG000|Overall Study|Lost to Follow-up|28|||
161498638|NCT03795298|583221403|FG001|Overall Study|Lost to Follow-up|17|||
161498639|NCT03795298|583221402|FG000|Overall Study|Physician Decision|5|||
161498640|NCT03795298|583221403|FG001|Overall Study|Physician Decision|4|||
161498641|NCT03795298|583221402|FG000|Overall Study|Withdrawal by Subject|43|||
161498642|NCT03795298|583221403|FG001|Overall Study|Withdrawal by Subject|28|||
161498643|NCT03795298|583221402|FG000|Overall Study|Reason not reported|7|||
161498644|NCT03795298|583221403|FG001|Overall Study|Reason not reported|9|||
161498645|NCT01252940|583221404|FG000|Main Study Phase|Randomized but not treated|4|||
161498646|NCT01252940|583221405|FG001|Main Study Phase|Randomized but not treated|2|||
161585772|NCT03271489|583531858|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
161818815|NCT02554877|584378126|FG002|Overall Study|No longer met eligibility criteria|1|||
161818816|NCT02554877|584378127|FG003|Overall Study|No longer met eligibility criteria|1|||
161818817|NCT02554877|584378124|FG000|Overall Study|Protocol Violation|3|||
161818818|NCT02554877|584378125|FG001|Overall Study|Protocol Violation|1|||
161924753|NCT01658878|584770968|FG002|Treatment Period|Poor/Non-compliance|0|||
161924754|NCT01658878|584770969|FG003|Treatment Period|Poor/Non-compliance|0|||
161924755|NCT01658878|584770970|FG004|Treatment Period|Poor/Non-compliance|0|||
161924756|NCT01658878|584770971|FG005|Treatment Period|Poor/Non-compliance|0|||
161924757|NCT01658878|584770972|FG006|Treatment Period|Poor/Non-compliance|0|||
161924758|NCT01658878|584770973|FG007|Treatment Period|Poor/Non-compliance|0|||
161498647|NCT01252940|583221404|FG000|Main Study Phase|Adverse Event|3|||
161498648|NCT01252940|583221405|FG001|Main Study Phase|Adverse Event|1|||
161498649|NCT01252940|583221404|FG000|Main Study Phase|Lack of Efficacy|1|||
161498650|NCT01252940|583221405|FG001|Main Study Phase|Lack of Efficacy|0|||
161498651|NCT01252940|583221404|FG000|Main Study Phase|Lost to Follow-up|6|||
161498652|NCT01252940|583221405|FG001|Main Study Phase|Lost to Follow-up|1|||
161498653|NCT01252940|583221404|FG000|Main Study Phase|Physician Decision|1|||
161498654|NCT01252940|583221405|FG001|Main Study Phase|Physician Decision|0|||
161498655|NCT01252940|583221404|FG000|Main Study Phase|Protocol Violation|4|||
161585773|NCT03271489|583531857|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
161498656|NCT01252940|583221405|FG001|Main Study Phase|Protocol Violation|2|||
161498657|NCT01252940|583221404|FG000|Main Study Phase|Withdrawal by Subject|6|||
161585774|NCT03271489|583531858|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
161818819|NCT02554877|584378126|FG002|Overall Study|Protocol Violation|1|||
161498658|NCT01252940|583221405|FG001|Main Study Phase|Withdrawal by Subject|5|||
161498659|NCT01252940|583221404|FG000|Main Study Phase|Subject Non-compliance|1|||
161498660|NCT01252940|583221405|FG001|Main Study Phase|Subject Non-compliance|1|||
161498661|NCT01252940|583221404|FG000|Extension Phase|Adverse Event|2|||
161498662|NCT01252940|583221405|FG001|Extension Phase|Adverse Event|1|||
161498663|NCT01252940|583221404|FG000|Extension Phase|Lack of Efficacy|1|||
161498664|NCT01252940|583221405|FG001|Extension Phase|Lack of Efficacy|0|||
161498665|NCT01252940|583221404|FG000|Extension Phase|Lost to Follow-up|5|||
161498666|NCT01252940|583221405|FG001|Extension Phase|Lost to Follow-up|0|||
161498667|NCT01252940|583221404|FG000|Extension Phase|Physician Decision|0|||
161498668|NCT01252940|583221405|FG001|Extension Phase|Physician Decision|1|||
161498669|NCT01252940|583221404|FG000|Extension Phase|Subject Non-compliance|1|||
161498670|NCT01252940|583221405|FG001|Extension Phase|Subject Non-compliance|0|||
161498671|NCT01252940|583221404|FG000|Extension Phase|Withdrawal by Subject|1|||
161498672|NCT01252940|583221405|FG001|Extension Phase|Withdrawal by Subject|1|||
161498673|NCT01502423|583221406|FG000|Overall Study|Withdrawal by Subject|0|||
161498674|NCT01502423|583221407|FG001|Overall Study|Withdrawal by Subject|1|||
161498675|NCT04199117|583221408|FG000|Overall Study|Withdrawal by Subject|3|||
161498676|NCT04199117|583221409|FG001|Overall Study|Withdrawal by Subject|0|||
161498677|NCT04199117|583221410|FG002|Overall Study|Withdrawal by Subject|0|||
161498678|NCT04199117|583221411|FG003|Overall Study|Withdrawal by Subject|1|||
161498679|NCT04199117|583221412|FG004|Overall Study|Withdrawal by Subject|1|||
161498680|NCT04199117|583221413|FG005|Overall Study|Withdrawal by Subject|0|||
161498681|NCT04199117|583221414|FG006|Overall Study|Withdrawal by Subject|0|||
161498682|NCT04199117|583221415|FG007|Overall Study|Withdrawal by Subject|2|||
161498683|NCT04199117|583221416|FG008|Overall Study|Withdrawal by Subject|0|||
161498684|NCT04199117|583221417|FG009|Overall Study|Withdrawal by Subject|0|||
161498685|NCT04199117|583221418|FG010|Overall Study|Withdrawal by Subject|1|||
161498686|NCT04199117|583221419|FG011|Overall Study|Withdrawal by Subject|1|||
161498687|NCT04199117|583221420|FG012|Overall Study|Withdrawal by Subject|2|||
161498688|NCT04199117|583221421|FG013|Overall Study|Withdrawal by Subject|1|||
161498689|NCT04199117|583221422|FG014|Overall Study|Withdrawal by Subject|1|||
161498690|NCT04199117|583221423|FG015|Overall Study|Withdrawal by Subject|1|||
161498691|NCT04199117|583221408|FG000|Overall Study|Death|1|||
161498692|NCT04199117|583221409|FG001|Overall Study|Death|1|||
161498693|NCT04199117|583221410|FG002|Overall Study|Death|0|||
161498694|NCT04199117|583221411|FG003|Overall Study|Death|0|||
161498695|NCT04199117|583221412|FG004|Overall Study|Death|0|||
161498696|NCT04199117|583221413|FG005|Overall Study|Death|0|||
161498697|NCT04199117|583221414|FG006|Overall Study|Death|0|||
161498698|NCT04199117|583221415|FG007|Overall Study|Death|0|||
161498699|NCT04199117|583221416|FG008|Overall Study|Death|0|||
161498700|NCT04199117|583221417|FG009|Overall Study|Death|0|||
161818820|NCT02554877|584378127|FG003|Overall Study|Protocol Violation|0|||
161498701|NCT04199117|583221418|FG010|Overall Study|Death|0|||
161498702|NCT04199117|583221419|FG011|Overall Study|Death|1|||
161498703|NCT04199117|583221420|FG012|Overall Study|Death|0|||
161498704|NCT04199117|583221421|FG013|Overall Study|Death|1|||
161498705|NCT04199117|583221422|FG014|Overall Study|Death|0|||
161498706|NCT04199117|583221423|FG015|Overall Study|Death|0|||
161498707|NCT04199117|583221408|FG000|Overall Study|Withdrawal by PI|0|||
161498708|NCT04199117|583221409|FG001|Overall Study|Withdrawal by PI|0|||
161498709|NCT04199117|583221410|FG002|Overall Study|Withdrawal by PI|0|||
161498710|NCT04199117|583221411|FG003|Overall Study|Withdrawal by PI|0|||
161498711|NCT04199117|583221412|FG004|Overall Study|Withdrawal by PI|0|||
161498712|NCT04199117|583221413|FG005|Overall Study|Withdrawal by PI|0|||
161498713|NCT04199117|583221414|FG006|Overall Study|Withdrawal by PI|0|||
161498714|NCT04199117|583221415|FG007|Overall Study|Withdrawal by PI|0|||
161498715|NCT04199117|583221416|FG008|Overall Study|Withdrawal by PI|0|||
161498716|NCT04199117|583221417|FG009|Overall Study|Withdrawal by PI|0|||
161498717|NCT04199117|583221418|FG010|Overall Study|Withdrawal by PI|0|||
161498718|NCT04199117|583221419|FG011|Overall Study|Withdrawal by PI|0|||
161498719|NCT04199117|583221420|FG012|Overall Study|Withdrawal by PI|1|||
161498720|NCT04199117|583221421|FG013|Overall Study|Withdrawal by PI|0|||
161498721|NCT04199117|583221422|FG014|Overall Study|Withdrawal by PI|0|||
161498722|NCT04199117|583221423|FG015|Overall Study|Withdrawal by PI|0|||
161498723|NCT04383743|583221424|FG000|Overall Study|Withdrawal by Subject|1|||
161498724|NCT04383743|583221424|FG000|Overall Study|Adverse Event|1|||
161498725|NCT04814433|583221427|FG000|Overall Study|Survey not returned|4|||
161498726|NCT04814433|583221428|FG001|Overall Study|Survey not returned|8|||
161498727|NCT04814433|583221429|FG002|Overall Study|Survey not returned|4|||
161498728|NCT04814433|583221430|FG003|Overall Study|Survey not returned|5|||
161498729|NCT03482791|583221435|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
161498730|NCT03482791|583221436|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
161498731|NCT01816893|583221437|FG000|Washout Period|Withdrawal by Subject|2|||
161498732|NCT01816893|583221438|FG001|Washout Period|Withdrawal by Subject|0|||
161498733|NCT00699972|583223172|FG000|Overall Study|Adverse Event|7|||
161498734|NCT00699972|583223173|FG001|Overall Study|Adverse Event|9|||
161498735|NCT00699972|583223174|FG002|Overall Study|Adverse Event|24|||
161498736|NCT00699972|583223172|FG000|Overall Study|Lost to Follow-up|0|||
161498737|NCT00699972|583223173|FG001|Overall Study|Lost to Follow-up|2|||
161498738|NCT00699972|583223174|FG002|Overall Study|Lost to Follow-up|0|||
161498739|NCT00699972|583223172|FG000|Overall Study|Withdrawal by Subject|3|||
161498740|NCT00699972|583223173|FG001|Overall Study|Withdrawal by Subject|7|||
161498741|NCT00699972|583223174|FG002|Overall Study|Withdrawal by Subject|4|||
161498742|NCT00699972|583223172|FG000|Overall Study|Lack of Efficacy|2|||
161498743|NCT00699972|583223173|FG001|Overall Study|Lack of Efficacy|0|||
161498744|NCT00699972|583223174|FG002|Overall Study|Lack of Efficacy|2|||
161498745|NCT00699972|583223172|FG000|Overall Study|Administrative/Other|3|||
161498746|NCT00699972|583223173|FG001|Overall Study|Administrative/Other|1|||
161498747|NCT00699972|583223174|FG002|Overall Study|Administrative/Other|4|||
161498748|NCT00699972|583223172|FG000|Overall Study|Randomized, Not Treated|1|||
161498749|NCT00699972|583223173|FG001|Overall Study|Randomized, Not Treated|0|||
161498750|NCT00699972|583223174|FG002|Overall Study|Randomized, Not Treated|1|||
161498751|NCT01545817|583223175|FG000|Pazopanib|Disease progression|51|||
161498752|NCT01545817|583223176|FG001|Pazopanib|Disease progression|0|||
161498753|NCT01545817|583223175|FG000|Pazopanib|Adverse Event|19|||
161498754|NCT01545817|583223176|FG001|Pazopanib|Adverse Event|0|||
161498755|NCT01545817|583223175|FG000|Pazopanib|Other reason|4|||
161498756|NCT01545817|583223176|FG001|Pazopanib|Other reason|0|||
161498757|NCT01545817|583223175|FG000|Everolimus|Other reason|0|||
161498758|NCT01545817|583223176|FG001|Everolimus|Other reason|7|||
161498759|NCT01545817|583223175|FG000|Everolimus|Disease progression|0|||
161498760|NCT01545817|583223176|FG001|Everolimus|Disease progression|25|||
161498761|NCT01545817|583223175|FG000|Everolimus|Adverse Event|0|||
161498762|NCT01545817|583223176|FG001|Everolimus|Adverse Event|6|||
161498763|NCT03971695|583223180|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498764|NCT03971695|583223181|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498765|NCT03971695|583223182|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498766|NCT03971695|583223183|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
161498767|NCT03971695|583223184|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
161498768|NCT03971695|583223185|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498769|NCT03971695|583223186|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498770|NCT03971695|583223187|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498771|NCT03971695|583223188|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
161498772|NCT03971695|583223189|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
161498773|NCT03971695|583223190|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
161498774|NCT03971695|583223191|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
161498775|NCT03971695|583223192|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
161498776|NCT00156533|583223193|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
161498777|NCT00156533|583223194|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
161498778|NCT00156533|583223195|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
161498779|NCT00156533|583223196|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
161498780|NCT00156533|583223193|FG000|Overall Study|Withdrawal by Subject|1|||
161498781|NCT00156533|583223194|FG001|Overall Study|Withdrawal by Subject|0|||
161498782|NCT00156533|583223195|FG002|Overall Study|Withdrawal by Subject|0|||
161498783|NCT00156533|583223196|FG003|Overall Study|Withdrawal by Subject|1|||
161498784|NCT00156533|583223193|FG000|Overall Study|Failed Screening|1|||
161498785|NCT00156533|583223194|FG001|Overall Study|Failed Screening|0|||
161498786|NCT00156533|583223195|FG002|Overall Study|Failed Screening|1|||
161498787|NCT00156533|583223196|FG003|Overall Study|Failed Screening|1|||
161498788|NCT01881230|583223197|FG000|Overall Study|Death|2|||
161498789|NCT01881230|583223198|FG001|Overall Study|Death|0|||
161498790|NCT01881230|583223199|FG002|Overall Study|Death|1|||
161498791|NCT01881230|583223197|FG000|Overall Study|Adverse Event|9|||
161498792|NCT01881230|583223198|FG001|Overall Study|Adverse Event|13|||
161498793|NCT01881230|583223199|FG002|Overall Study|Adverse Event|12|||
161498794|NCT01881230|583223197|FG000|Overall Study|Progressive Disease|31|||
161498795|NCT01881230|583223198|FG001|Overall Study|Progressive Disease|35|||
161498796|NCT01881230|583223199|FG002|Overall Study|Progressive Disease|36|||
161498797|NCT01881230|583223197|FG000|Overall Study|Symptomatic Deterioration|3|||
161673117|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
161673118|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
161673119|NCT04195581|583856562|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
161498798|NCT01881230|583223198|FG001|Overall Study|Symptomatic Deterioration|3|||
161498799|NCT01881230|583223199|FG002|Overall Study|Symptomatic Deterioration|1|||
161498800|NCT01881230|583223197|FG000|Overall Study|Withdrawal by Subject|6|||
161498801|NCT01881230|583223198|FG001|Overall Study|Withdrawal by Subject|4|||
161498802|NCT01881230|583223199|FG002|Overall Study|Withdrawal by Subject|6|||
161498803|NCT01881230|583223197|FG000|Overall Study|Physician Decision|4|||
161498804|NCT01881230|583223198|FG001|Overall Study|Physician Decision|3|||
161498805|NCT01881230|583223199|FG002|Overall Study|Physician Decision|6|||
161498806|NCT01881230|583223197|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161498807|NCT01881230|583223198|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161498808|NCT01881230|583223199|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161498809|NCT01881230|583223197|FG000|Overall Study|Given Commercially Available Drug|0|||
161498810|NCT01881230|583223198|FG001|Overall Study|Given Commercially Available Drug|0|||
161498811|NCT01881230|583223199|FG002|Overall Study|Given Commercially Available Drug|2|||
161498812|NCT01881230|583223197|FG000|Overall Study|Protocol Violation|1|||
161673120|NCT04195581|583856562|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
161673121|NCT04195581|583856562|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
161673122|NCT04195581|583856562|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
161673123|NCT04195581|583856562|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
161673124|NCT04195581|583856562|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
161673125|NCT00821431|583856563|FG000|Overall Study|Adverse Event|6|||
161673126|NCT00821431|583856564|FG001|Overall Study|Adverse Event|3|||
161673127|NCT00821431|583856563|FG000|Overall Study|Withdrawal by Subject|5|||
161673128|NCT00821431|583856564|FG001|Overall Study|Withdrawal by Subject|0|||
161673129|NCT00821431|583856563|FG000|Overall Study|Lost to Follow-up|1|||
161673130|NCT00821431|583856564|FG001|Overall Study|Lost to Follow-up|0|||
161673131|NCT00821431|583856563|FG000|Overall Study|Protocol Violation|3|||
161673132|NCT00821431|583856564|FG001|Overall Study|Protocol Violation|1|||
161673133|NCT00821431|583856563|FG000|Overall Study|Physician Decision|0|||
161673134|NCT00821431|583856564|FG001|Overall Study|Physician Decision|1|||
161673135|NCT04890054|583857890|FG000|Overall Study|Lost to Follow-up|202|||
161673136|NCT04890054|583857891|FG001|Overall Study|Lost to Follow-up|219|||
161673137|NCT04313153|583857892|FG000|Overall Study|Adverse Event (includes Death)|14|||
161673138|NCT04313153|583857893|FG001|Overall Study|Adverse Event (includes Death)|19|||
161673139|NCT04313153|583857894|FG002|Overall Study|Adverse Event (includes Death)|10|||
161673140|NCT04313153|583857892|FG000|Overall Study|Physician Decision|4|||
161673141|NCT04313153|583857893|FG001|Overall Study|Physician Decision|2|||
161673142|NCT04313153|583857894|FG002|Overall Study|Physician Decision|1|||
161673143|NCT04313153|583857892|FG000|Overall Study|Withdrawal by Subject|7|||
161673144|NCT04313153|583857893|FG001|Overall Study|Withdrawal by Subject|6|||
161673145|NCT04313153|583857894|FG002|Overall Study|Withdrawal by Subject|2|||
161673146|NCT04313153|583857892|FG000|Overall Study|Lack of Efficacy|3|||
161673147|NCT04313153|583857893|FG001|Overall Study|Lack of Efficacy|3|||
161673148|NCT04313153|583857894|FG002|Overall Study|Lack of Efficacy|0|||
161673149|NCT04313153|583857892|FG000|Overall Study|Lost to Follow-up|1|||
161924759|NCT01658878|584770974|FG008|Treatment Period|Poor/Non-compliance|0|||
161924760|NCT01658878|584770975|FG009|Treatment Period|Poor/Non-compliance|0|||
161924761|NCT01658878|584770976|FG010|Treatment Period|Poor/Non-compliance|0|||
161924762|NCT01658878|584770977|FG011|Treatment Period|Poor/Non-compliance|0|||
161924763|NCT01658878|584770978|FG012|Treatment Period|Poor/Non-compliance|0|||
161924764|NCT01658878|584770979|FG013|Treatment Period|Poor/Non-compliance|0|||
161924765|NCT01658878|584770980|FG014|Treatment Period|Poor/Non-compliance|0|||
161924766|NCT01658878|584770981|FG015|Treatment Period|Poor/Non-compliance|1|||
161924767|NCT01658878|584770982|FG016|Treatment Period|Poor/Non-compliance|0|||
161924768|NCT01658878|584770983|FG017|Treatment Period|Poor/Non-compliance|0|||
161924769|NCT01658878|584770984|FG018|Treatment Period|Poor/Non-compliance|0|||
161924770|NCT01658878|584770985|FG019|Treatment Period|Poor/Non-compliance|0|||
161924771|NCT01658878|584770986|FG020|Treatment Period|Poor/Non-compliance|0|||
161924772|NCT01658878|584770987|FG021|Treatment Period|Poor/Non-compliance|0|||
161924773|NCT01658878|584770988|FG022|Treatment Period|Poor/Non-compliance|0|||
161924774|NCT01658878|584770989|FG023|Treatment Period|Poor/Non-compliance|0|||
161924775|NCT01658878|584770966|FG000|Treatment Period|Participant Withdrew Consent|0|||
161924776|NCT01658878|584770967|FG001|Treatment Period|Participant Withdrew Consent|0|||
161924777|NCT01658878|584770968|FG002|Treatment Period|Participant Withdrew Consent|0|||
161924778|NCT01658878|584770969|FG003|Treatment Period|Participant Withdrew Consent|0|||
161924779|NCT01658878|584770970|FG004|Treatment Period|Participant Withdrew Consent|0|||
161924780|NCT01658878|584770971|FG005|Treatment Period|Participant Withdrew Consent|0|||
161498813|NCT01881230|583223198|FG001|Overall Study|Protocol Violation|1|||
161498814|NCT01881230|583223199|FG002|Overall Study|Protocol Violation|0|||
161498815|NCT01881230|583223197|FG000|Overall Study|Miscellaneous|3|||
161498816|NCT01881230|583223198|FG001|Overall Study|Miscellaneous|3|||
161673150|NCT04313153|583857893|FG001|Overall Study|Lost to Follow-up|0|||
161673151|NCT04313153|583857894|FG002|Overall Study|Lost to Follow-up|2|||
161673152|NCT04313153|583857892|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
161673153|NCT04313153|583857893|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
161924781|NCT01658878|584770972|FG006|Treatment Period|Participant Withdrew Consent|0|||
161924782|NCT01658878|584770973|FG007|Treatment Period|Participant Withdrew Consent|0|||
161498817|NCT01881230|583223199|FG002|Overall Study|Miscellaneous|0|||
161498818|NCT01881230|583223197|FG000|Overall Study|Untreated: Other|0|||
161673154|NCT04313153|583857894|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
161924783|NCT01658878|584770974|FG008|Treatment Period|Participant Withdrew Consent|0|||
161924784|NCT01658878|584770975|FG009|Treatment Period|Participant Withdrew Consent|0|||
161924785|NCT01658878|584770976|FG010|Treatment Period|Participant Withdrew Consent|0|||
161924786|NCT01658878|584770977|FG011|Treatment Period|Participant Withdrew Consent|0|||
161924787|NCT01658878|584770978|FG012|Treatment Period|Participant Withdrew Consent|1|||
161498819|NCT01881230|583223198|FG001|Overall Study|Untreated: Other|0|||
161498820|NCT01881230|583223199|FG002|Overall Study|Untreated: Other|1|||
161498821|NCT01881230|583223197|FG000|Overall Study|Untreated: Death|0|||
161498822|NCT01881230|583223198|FG001|Overall Study|Untreated: Death|0|||
161498823|NCT01881230|583223199|FG002|Overall Study|Untreated: Death|1|||
161498824|NCT01881230|583223197|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
161498825|NCT01881230|583223198|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
161498826|NCT01881230|583223199|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
161498827|NCT02747420|583223200|FG000|Overall Study|Lost to Follow-up|4|||
161498828|NCT02747420|583223201|FG001|Overall Study|Lost to Follow-up|2|||
161498829|NCT02747420|583223200|FG000|Overall Study|Withdrawal by Subject|3|||
161498830|NCT02747420|583223201|FG001|Overall Study|Withdrawal by Subject|2|||
161498831|NCT05129488|583223202|FG000|Overall Study|Protocol Violation|3|||
161498832|NCT00706641|583223207|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
161498833|NCT00706641|583223207|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
161498834|NCT00706641|583223207|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
161498835|NCT04782856|583223208|FG000|Overall Study|Withdrawal by Subject|0|||
161498836|NCT04782856|583223209|FG001|Overall Study|Withdrawal by Subject|1|||
161498837|NCT00798369|583223210|FG000|Overall Study|Subject withdrew consent|0|||
161498838|NCT00798369|583223211|FG001|Overall Study|Subject withdrew consent|0|||
161498839|NCT00798369|583223212|FG002|Overall Study|Subject withdrew consent|1|||
161498840|NCT00798369|583223213|FG003|Overall Study|Subject withdrew consent|1|||
161498841|NCT00798369|583223214|FG004|Overall Study|Subject withdrew consent|0|||
161498842|NCT00798369|583223215|FG005|Overall Study|Subject withdrew consent|2|||
161498843|NCT00798369|583223210|FG000|Overall Study|Lost to Follow-up|1|||
161498844|NCT00798369|583223211|FG001|Overall Study|Lost to Follow-up|1|||
161498845|NCT00798369|583223212|FG002|Overall Study|Lost to Follow-up|1|||
161498846|NCT00798369|583223213|FG003|Overall Study|Lost to Follow-up|0|||
161498847|NCT00798369|583223214|FG004|Overall Study|Lost to Follow-up|1|||
161498848|NCT00798369|583223215|FG005|Overall Study|Lost to Follow-up|0|||
161498849|NCT00798369|583223210|FG000|Overall Study|Adminstrative problems|0|||
161498850|NCT00798369|583223211|FG001|Overall Study|Adminstrative problems|0|||
161498851|NCT00798369|583223212|FG002|Overall Study|Adminstrative problems|0|||
161498852|NCT00798369|583223213|FG003|Overall Study|Adminstrative problems|0|||
161498853|NCT00798369|583223214|FG004|Overall Study|Adminstrative problems|0|||
161498854|NCT00798369|583223215|FG005|Overall Study|Adminstrative problems|1|||
161498855|NCT04475588|583223216|FG000|Overall Study|Adverse Event|2|||
161498856|NCT04475588|583223217|FG001|Overall Study|Adverse Event|0|||
161498857|NCT01327300|583223218|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
161498858|NCT01327300|583223219|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
161498859|NCT02603432|583223220|FG000|Overall Study|Adverse Event|1|||
161924788|NCT01658878|584770979|FG013|Treatment Period|Participant Withdrew Consent|0|||
161924789|NCT01658878|584770980|FG014|Treatment Period|Participant Withdrew Consent|2|||
161924790|NCT01658878|584770981|FG015|Treatment Period|Participant Withdrew Consent|0|||
161924791|NCT01658878|584770982|FG016|Treatment Period|Participant Withdrew Consent|0|||
161924792|NCT01658878|584770983|FG017|Treatment Period|Participant Withdrew Consent|2|||
161924793|NCT01658878|584770984|FG018|Treatment Period|Participant Withdrew Consent|1|||
161498860|NCT02603432|583223221|FG001|Overall Study|Adverse Event|0|||
161498861|NCT02603432|583223220|FG000|Overall Study|Death|221|||
161498862|NCT02603432|583223221|FG001|Overall Study|Death|242|||
161585775|NCT03271489|583531857|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
161585776|NCT03271489|583531858|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
161585777|NCT03271489|583531857|FG000|Open-Label (OL) Period|No Specified|2|||
161585778|NCT03271489|583531858|FG001|Open-Label (OL) Period|No Specified|2|||
161585779|NCT03271489|583531857|FG000|Open-Label (OL) Period|Missing|2|||
161585780|NCT03271489|583531858|FG001|Open-Label (OL) Period|Missing|0|||
161924794|NCT01658878|584770985|FG019|Treatment Period|Participant Withdrew Consent|2|||
161498863|NCT02603432|583223220|FG000|Overall Study|Lost to Follow-up|3|||
161498864|NCT02603432|583223221|FG001|Overall Study|Lost to Follow-up|9|||
161498865|NCT02603432|583223220|FG000|Overall Study|Progressive Disease|7|||
161498866|NCT02603432|583223221|FG001|Overall Study|Progressive Disease|5|||
161498867|NCT02603432|583223220|FG000|Overall Study|Withdrawal by Subject|12|||
161498868|NCT02603432|583223221|FG001|Overall Study|Withdrawal by Subject|18|||
161498869|NCT02603432|583223220|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
161585781|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
161585782|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
161924795|NCT01658878|584770986|FG020|Treatment Period|Participant Withdrew Consent|1|||
161924796|NCT01658878|584770987|FG021|Treatment Period|Participant Withdrew Consent|0|||
161924797|NCT01658878|584770988|FG022|Treatment Period|Participant Withdrew Consent|2|||
161924798|NCT01658878|584770989|FG023|Treatment Period|Participant Withdrew Consent|2|||
161924799|NCT01658878|584770966|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924800|NCT01658878|584770967|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924801|NCT01658878|584770968|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924802|NCT01658878|584770969|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924803|NCT01658878|584770970|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924804|NCT01658878|584770971|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924805|NCT01658878|584770972|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924806|NCT01658878|584770973|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924807|NCT01658878|584770974|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924808|NCT01658878|584770975|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161498870|NCT02603432|583223221|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161498871|NCT02603432|583223220|FG000|Overall Study|Study terminated by sponsor|74|||
161498872|NCT02603432|583223221|FG001|Overall Study|Study terminated by sponsor|75|||
161498873|NCT02603432|583223220|FG000|Overall Study|Other|13|||
161498874|NCT02603432|583223221|FG001|Overall Study|Other|0|||
161498875|NCT00666757|583223225|FG000|Overall Study|Lost to Follow-up|39|||
161498876|NCT00666757|583223226|FG001|Overall Study|Lost to Follow-up|35|||
161498877|NCT00666757|583223225|FG000|Overall Study|Protocol Violation|23|||
161498878|NCT00666757|583223226|FG001|Overall Study|Protocol Violation|24|||
161498879|NCT00666757|583223225|FG000|Overall Study|Adverse Event|22|||
161498880|NCT00666757|583223226|FG001|Overall Study|Adverse Event|12|||
161498881|NCT00666757|583223225|FG000|Overall Study|Withdrawal by Subject|13|||
161498882|NCT00666757|583223226|FG001|Overall Study|Withdrawal by Subject|17|||
161498883|NCT00666757|583223225|FG000|Overall Study|Lack of Efficacy|3|||
161498884|NCT00666757|583223226|FG001|Overall Study|Lack of Efficacy|6|||
161498885|NCT00666757|583223225|FG000|Overall Study|Physician Decision|0|||
161924809|NCT01658878|584770976|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924810|NCT01658878|584770977|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161498886|NCT00666757|583223226|FG001|Overall Study|Physician Decision|2|||
161498887|NCT00666757|583223225|FG000|Overall Study|Sponsor decision|0|||
161498888|NCT00666757|583223226|FG001|Overall Study|Sponsor decision|1|||
161498889|NCT01231581|583223227|FG000|Overall Study|Lost to Follow-up|2|||
161498890|NCT01231581|583223228|FG001|Overall Study|Lost to Follow-up|2|||
161498891|NCT01231581|583223227|FG000|Overall Study|Withdrawal by Subject|6|||
161498892|NCT01231581|583223228|FG001|Overall Study|Withdrawal by Subject|9|||
161498893|NCT01231581|583223227|FG000|Overall Study|Study Closed/Terminated|6|||
161498894|NCT01231581|583223228|FG001|Overall Study|Study Closed/Terminated|5|||
161498895|NCT01231581|583223227|FG000|Overall Study|Death|65|||
161498896|NCT01231581|583223228|FG001|Overall Study|Death|64|||
161498897|NCT01231581|583223227|FG000|Overall Study|Ongoing|1|||
161498898|NCT01231581|583223228|FG001|Overall Study|Ongoing|0|||
161498899|NCT01723163|583223231|FG000|Treatment Phase|Withdrawal by Subject|14|||
161498900|NCT01723163|583223232|FG001|Treatment Phase|Withdrawal by Subject|6|||
161498901|NCT01723163|583223231|FG000|Treatment Phase|Withdrawal by PI|5|||
161498902|NCT01723163|583223232|FG001|Treatment Phase|Withdrawal by PI|1|||
161498903|NCT01723163|583223231|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
161498904|NCT01723163|583223232|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
161498905|NCT01723163|583223231|FG000|3-Month Follow-up|Unable to Contact|12|||
161498906|NCT01723163|583223232|FG001|3-Month Follow-up|Unable to Contact|19|||
161498907|NCT01723163|583223231|FG000|6-Month Follow-up|Death|1|||
161498908|NCT01723163|583223232|FG001|6-Month Follow-up|Death|0|||
161924811|NCT01658878|584770978|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161924812|NCT01658878|584770979|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
161924813|NCT01658878|584770980|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
161924814|NCT01658878|584770981|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161924815|NCT01658878|584770982|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
161498909|NCT01723163|583223231|FG000|6-Month Follow-up|Unable to Contact|17|||
161498910|NCT01723163|583223232|FG001|6-Month Follow-up|Unable to Contact|15|||
161498911|NCT01723163|583223231|FG000|12-Month Follow-up|Death|1|||
161498912|NCT01723163|583223232|FG001|12-Month Follow-up|Death|0|||
161498913|NCT01723163|583223231|FG000|12-Month Follow-up|Unable to Contact|23|||
161498914|NCT01723163|583223232|FG001|12-Month Follow-up|Unable to Contact|28|||
161498915|NCT02510794|583223233|FG000|Overall Study|Adverse Event|0|||
161498916|NCT02510794|583223234|FG001|Overall Study|Adverse Event|1|||
161498917|NCT02510794|583223235|FG002|Overall Study|Adverse Event|0|||
161498918|NCT02510794|583223236|FG003|Overall Study|Adverse Event|0|||
161498919|NCT02510794|583223233|FG000|Overall Study|Death|1|||
161498920|NCT02510794|583223234|FG001|Overall Study|Death|2|||
161498921|NCT02510794|583223235|FG002|Overall Study|Death|1|||
161498922|NCT02510794|583223236|FG003|Overall Study|Death|1|||
161498923|NCT02510794|583223233|FG000|Overall Study|Lack of Efficacy|3|||
161498924|NCT02510794|583223234|FG001|Overall Study|Lack of Efficacy|1|||
161498925|NCT02510794|583223235|FG002|Overall Study|Lack of Efficacy|1|||
161498926|NCT02510794|583223236|FG003|Overall Study|Lack of Efficacy|0|||
161498927|NCT02510794|583223233|FG000|Overall Study|Participant moved out of the area|0|||
161498928|NCT02510794|583223234|FG001|Overall Study|Participant moved out of the area|0|||
161498929|NCT02510794|583223235|FG002|Overall Study|Participant moved out of the area|0|||
161498930|NCT02510794|583223236|FG003|Overall Study|Participant moved out of the area|1|||
161498931|NCT02510794|583223233|FG000|Overall Study|Physician Decision|3|||
161498932|NCT02510794|583223234|FG001|Overall Study|Physician Decision|0|||
161498933|NCT02510794|583223235|FG002|Overall Study|Physician Decision|0|||
161498934|NCT02510794|583223236|FG003|Overall Study|Physician Decision|0|||
161498935|NCT02510794|583223233|FG000|Overall Study|Protocol Violation|0|||
161498936|NCT02510794|583223234|FG001|Overall Study|Protocol Violation|0|||
161498937|NCT02510794|583223235|FG002|Overall Study|Protocol Violation|1|||
161498938|NCT02510794|583223236|FG003|Overall Study|Protocol Violation|0|||
161498939|NCT02510794|583223233|FG000|Overall Study|Withdrawal by Subject|1|||
161498940|NCT02510794|583223234|FG001|Overall Study|Withdrawal by Subject|2|||
161498941|NCT02510794|583223235|FG002|Overall Study|Withdrawal by Subject|4|||
161498942|NCT02510794|583223236|FG003|Overall Study|Withdrawal by Subject|3|||
161498943|NCT01649375|583223237|FG000|Up to Week 16|Adverse Event|2|||
161498944|NCT01649375|583223238|FG001|Up to Week 16|Adverse Event|5|||
161498945|NCT01649375|583223239|FG002|Up to Week 16|Adverse Event|4|||
161498946|NCT01649375|583223240|FG003|Up to Week 16|Adverse Event|0|||
161498947|NCT01649375|583223241|FG004|Up to Week 16|Adverse Event|0|||
161498948|NCT01649375|583223237|FG000|Up to Week 16|Lack of Efficacy|0|||
161498949|NCT01649375|583223238|FG001|Up to Week 16|Lack of Efficacy|0|||
161498950|NCT01649375|583223239|FG002|Up to Week 16|Lack of Efficacy|1|||
161498951|NCT01649375|583223240|FG003|Up to Week 16|Lack of Efficacy|0|||
161498952|NCT01649375|583223241|FG004|Up to Week 16|Lack of Efficacy|0|||
161498953|NCT01649375|583223237|FG000|Up to Week 16|Physician Decision|0|||
161498954|NCT01649375|583223238|FG001|Up to Week 16|Physician Decision|0|||
161498955|NCT01649375|583223239|FG002|Up to Week 16|Physician Decision|1|||
161498956|NCT01649375|583223240|FG003|Up to Week 16|Physician Decision|0|||
161498957|NCT01649375|583223241|FG004|Up to Week 16|Physician Decision|0|||
161498958|NCT01649375|583223237|FG000|Up to Week 16|Withdrawal by Subject|2|||
161498959|NCT01649375|583223238|FG001|Up to Week 16|Withdrawal by Subject|1|||
161498960|NCT01649375|583223239|FG002|Up to Week 16|Withdrawal by Subject|2|||
161498961|NCT01649375|583223240|FG003|Up to Week 16|Withdrawal by Subject|0|||
161498962|NCT01649375|583223241|FG004|Up to Week 16|Withdrawal by Subject|0|||
161498963|NCT01649375|583223237|FG000|Up to Week 16|Death|1|||
161498964|NCT01649375|583223238|FG001|Up to Week 16|Death|0|||
161498965|NCT01649375|583223239|FG002|Up to Week 16|Death|0|||
161498966|NCT01649375|583223240|FG003|Up to Week 16|Death|0|||
161498967|NCT01649375|583223241|FG004|Up to Week 16|Death|0|||
161498968|NCT01649375|583223237|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
161498969|NCT01649375|583223238|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
161498970|NCT01649375|583223239|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
161498971|NCT01649375|583223240|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
161498972|NCT01649375|583223241|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
161818821|NCT02554877|584378124|FG000|Overall Study|Other|1|||
161818822|NCT02554877|584378125|FG001|Overall Study|Other|3|||
161818823|NCT02554877|584378126|FG002|Overall Study|Other|0|||
161818824|NCT02554877|584378127|FG003|Overall Study|Other|3|||
161818825|NCT02554877|584378124|FG000|Overall Study|Insufficient clinical response|4|||
161818826|NCT02554877|584378125|FG001|Overall Study|Insufficient clinical response|0|||
161818827|NCT02554877|584378126|FG002|Overall Study|Insufficient clinical response|0|||
161818828|NCT02554877|584378127|FG003|Overall Study|Insufficient clinical response|0|||
161818829|NCT02554877|584378124|FG000|Overall Study|No longer willing to participate|0|||
161818830|NCT02554877|584378125|FG001|Overall Study|No longer willing to participate|2|||
161498973|NCT01649375|583223237|FG000|Week 16 up to Week 260|Non-compliance|0|||
161498974|NCT01649375|583223238|FG001|Week 16 up to Week 260|Non-compliance|1|||
161498975|NCT01649375|583223239|FG002|Week 16 up to Week 260|Non-compliance|0|||
161498976|NCT01649375|583223240|FG003|Week 16 up to Week 260|Non-compliance|1|||
161498977|NCT01649375|583223241|FG004|Week 16 up to Week 260|Non-compliance|0|||
161498978|NCT01649375|583223237|FG000|Week 16 up to Week 260|Physician Decision|0|||
161585783|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
161818831|NCT02554877|584378126|FG002|Overall Study|No longer willing to participate|2|||
161498979|NCT01649375|583223238|FG001|Week 16 up to Week 260|Physician Decision|2|||
161498980|NCT01649375|583223239|FG002|Week 16 up to Week 260|Physician Decision|0|||
161498981|NCT01649375|583223240|FG003|Week 16 up to Week 260|Physician Decision|0|||
161498982|NCT01649375|583223241|FG004|Week 16 up to Week 260|Physician Decision|0|||
161498983|NCT01649375|583223237|FG000|Week 16 up to Week 260|Technical issues|0|||
161498984|NCT01649375|583223238|FG001|Week 16 up to Week 260|Technical issues|1|||
161498985|NCT01649375|583223239|FG002|Week 16 up to Week 260|Technical issues|0|||
161585784|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
161498986|NCT01649375|583223240|FG003|Week 16 up to Week 260|Technical issues|1|||
161498987|NCT01649375|583223241|FG004|Week 16 up to Week 260|Technical issues|0|||
161498988|NCT01649375|583223237|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
161498989|NCT01649375|583223238|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
161498990|NCT01649375|583223239|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
161498991|NCT01649375|583223240|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
161498992|NCT01649375|583223241|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
161498993|NCT01649375|583223237|FG000|Week 16 up to Week 260|Death|1|||
161498994|NCT01649375|583223238|FG001|Week 16 up to Week 260|Death|1|||
161924816|NCT01658878|584770983|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161498995|NCT01649375|583223239|FG002|Week 16 up to Week 260|Death|0|||
161498996|NCT01649375|583223240|FG003|Week 16 up to Week 260|Death|0|||
161498997|NCT01649375|583223241|FG004|Week 16 up to Week 260|Death|0|||
161498998|NCT01649375|583223237|FG000|Week 16 up to Week 260|Adverse Event|5|||
161498999|NCT01649375|583223238|FG001|Week 16 up to Week 260|Adverse Event|2|||
161499000|NCT01649375|583223239|FG002|Week 16 up to Week 260|Adverse Event|0|||
161499001|NCT01649375|583223240|FG003|Week 16 up to Week 260|Adverse Event|3|||
161499002|NCT01649375|583223241|FG004|Week 16 up to Week 260|Adverse Event|2|||
161499003|NCT01856790|583223242|FG000|Closed Loop Control|Withdrawal by Subject|2|||
161818832|NCT02554877|584378127|FG003|Overall Study|No longer willing to participate|0|||
161818833|NCT01537887|584378128|FG000|Period 1|Physician Decision|0|||
161818834|NCT01537887|584378129|FG001|Period 1|Physician Decision|0|||
161818835|NCT01537887|584378130|FG002|Period 1|Physician Decision|0|||
161924817|NCT01658878|584770984|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924818|NCT01658878|584770985|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
161924819|NCT01658878|584770986|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
161924820|NCT01658878|584770987|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161924821|NCT01658878|584770988|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924822|NCT01658878|584770989|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
161924823|NCT01658878|584770966|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
161924824|NCT01658878|584770967|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
161924825|NCT01658878|584770968|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
161924826|NCT01658878|584770969|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
161924827|NCT01658878|584770970|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
161924828|NCT01658878|584770971|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
161924829|NCT01658878|584770972|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
161924830|NCT01658878|584770973|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
161924831|NCT01658878|584770974|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
161924832|NCT01658878|584770975|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
161924833|NCT01658878|584770976|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
161924834|NCT01658878|584770977|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
161924835|NCT01658878|584770978|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
161499004|NCT01856790|583223242|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
161818836|NCT01537887|584378131|FG003|Period 1|Physician Decision|0|||
161818837|NCT01537887|584378132|FG004|Period 1|Physician Decision|1|||
161499005|NCT04091646|583223245|FG000|Overall Study|Adverse Event|2|||
161499006|NCT04091646|583223246|FG001|Overall Study|Adverse Event|1|||
161818838|NCT01537887|584378133|FG005|Period 1|Physician Decision|1|||
161818839|NCT01537887|584378128|FG000|Period 1|Did not receive treatment|0|||
161818840|NCT01537887|584378129|FG001|Period 1|Did not receive treatment|0|||
161818841|NCT01537887|584378130|FG002|Period 1|Did not receive treatment|1|||
161499007|NCT04091646|583223245|FG000|Overall Study|Lost to Follow-up|6|||
161585785|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
161924836|NCT01658878|584770979|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
161924837|NCT01658878|584770980|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
161924838|NCT01658878|584770981|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
161924839|NCT01658878|584770982|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
161924840|NCT01658878|584770983|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
161924841|NCT01658878|584770984|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
161924842|NCT01658878|584770985|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
161924843|NCT01658878|584770986|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
161924844|NCT01658878|584770987|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
161924845|NCT01658878|584770988|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
161924846|NCT01658878|584770989|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
161924847|NCT01658878|584770966|FG000|Treatment Period|Death|0|||
161924848|NCT01658878|584770967|FG001|Treatment Period|Death|0|||
161924849|NCT01658878|584770968|FG002|Treatment Period|Death|0|||
161924850|NCT01658878|584770969|FG003|Treatment Period|Death|0|||
161924851|NCT01658878|584770970|FG004|Treatment Period|Death|0|||
161924852|NCT01658878|584770971|FG005|Treatment Period|Death|0|||
161924853|NCT01658878|584770972|FG006|Treatment Period|Death|0|||
161924854|NCT01658878|584770973|FG007|Treatment Period|Death|0|||
161924855|NCT01658878|584770974|FG008|Treatment Period|Death|0|||
161924856|NCT01658878|584770975|FG009|Treatment Period|Death|0|||
161924857|NCT01658878|584770976|FG010|Treatment Period|Death|0|||
161924858|NCT01658878|584770977|FG011|Treatment Period|Death|0|||
161924859|NCT01658878|584770978|FG012|Treatment Period|Death|1|||
161924860|NCT01658878|584770979|FG013|Treatment Period|Death|0|||
161924861|NCT01658878|584770980|FG014|Treatment Period|Death|0|||
161924862|NCT01658878|584770981|FG015|Treatment Period|Death|0|||
161924863|NCT01658878|584770982|FG016|Treatment Period|Death|1|||
161924864|NCT01658878|584770983|FG017|Treatment Period|Death|1|||
161924865|NCT01658878|584770984|FG018|Treatment Period|Death|0|||
161924866|NCT01658878|584770985|FG019|Treatment Period|Death|0|||
161924867|NCT01658878|584770986|FG020|Treatment Period|Death|0|||
161924868|NCT01658878|584770987|FG021|Treatment Period|Death|2|||
161924869|NCT01658878|584770988|FG022|Treatment Period|Death|0|||
161924870|NCT01658878|584770989|FG023|Treatment Period|Death|0|||
161924871|NCT01658878|584770966|FG000|Treatment Period|Adverse Event|0|||
161924872|NCT01658878|584770967|FG001|Treatment Period|Adverse Event|0|||
161924873|NCT01658878|584770968|FG002|Treatment Period|Adverse Event|0|||
161924874|NCT01658878|584770969|FG003|Treatment Period|Adverse Event|0|||
161924875|NCT01658878|584770970|FG004|Treatment Period|Adverse Event|0|||
161924876|NCT01658878|584770971|FG005|Treatment Period|Adverse Event|0|||
161924877|NCT01658878|584770972|FG006|Treatment Period|Adverse Event|0|||
161924878|NCT01658878|584770973|FG007|Treatment Period|Adverse Event|0|||
161924879|NCT01658878|584770974|FG008|Treatment Period|Adverse Event|0|||
161924880|NCT01658878|584770975|FG009|Treatment Period|Adverse Event|0|||
161924881|NCT01658878|584770976|FG010|Treatment Period|Adverse Event|0|||
161924882|NCT01658878|584770977|FG011|Treatment Period|Adverse Event|0|||
161924883|NCT01658878|584770978|FG012|Treatment Period|Adverse Event|0|||
161924884|NCT01658878|584770979|FG013|Treatment Period|Adverse Event|0|||
161924885|NCT01658878|584770980|FG014|Treatment Period|Adverse Event|0|||
161924886|NCT01658878|584770981|FG015|Treatment Period|Adverse Event|0|||
161924887|NCT01658878|584770982|FG016|Treatment Period|Adverse Event|10|||
161924888|NCT01658878|584770983|FG017|Treatment Period|Adverse Event|3|||
161924889|NCT01658878|584770984|FG018|Treatment Period|Adverse Event|3|||
161924890|NCT01658878|584770985|FG019|Treatment Period|Adverse Event|2|||
161924891|NCT01658878|584770986|FG020|Treatment Period|Adverse Event|3|||
161924892|NCT01658878|584770987|FG021|Treatment Period|Adverse Event|3|||
161924893|NCT01658878|584770988|FG022|Treatment Period|Adverse Event|4|||
161924894|NCT01658878|584770989|FG023|Treatment Period|Adverse Event|3|||
161924895|NCT01658878|584770966|FG000|Treatment Period|Lost to Follow-up|0|||
161924896|NCT01658878|584770967|FG001|Treatment Period|Lost to Follow-up|0|||
161924897|NCT01658878|584770968|FG002|Treatment Period|Lost to Follow-up|0|||
161924898|NCT01658878|584770969|FG003|Treatment Period|Lost to Follow-up|0|||
161924899|NCT01658878|584770970|FG004|Treatment Period|Lost to Follow-up|0|||
161924900|NCT01658878|584770971|FG005|Treatment Period|Lost to Follow-up|0|||
161924901|NCT01658878|584770972|FG006|Treatment Period|Lost to Follow-up|0|||
161924902|NCT01658878|584770973|FG007|Treatment Period|Lost to Follow-up|0|||
161924903|NCT01658878|584770974|FG008|Treatment Period|Lost to Follow-up|0|||
161924904|NCT01658878|584770975|FG009|Treatment Period|Lost to Follow-up|0|||
161924905|NCT01658878|584770976|FG010|Treatment Period|Lost to Follow-up|0|||
161924906|NCT01658878|584770977|FG011|Treatment Period|Lost to Follow-up|0|||
161924907|NCT01658878|584770978|FG012|Treatment Period|Lost to Follow-up|0|||
161924908|NCT01658878|584770979|FG013|Treatment Period|Lost to Follow-up|0|||
161924909|NCT01658878|584770980|FG014|Treatment Period|Lost to Follow-up|0|||
161924910|NCT01658878|584770981|FG015|Treatment Period|Lost to Follow-up|0|||
161924911|NCT01658878|584770982|FG016|Treatment Period|Lost to Follow-up|1|||
161924912|NCT01658878|584770983|FG017|Treatment Period|Lost to Follow-up|0|||
161924913|NCT01658878|584770984|FG018|Treatment Period|Lost to Follow-up|1|||
161924914|NCT01658878|584770985|FG019|Treatment Period|Lost to Follow-up|1|||
161924915|NCT01658878|584770986|FG020|Treatment Period|Lost to Follow-up|0|||
161924916|NCT01658878|584770987|FG021|Treatment Period|Lost to Follow-up|0|||
161924917|NCT01658878|584770988|FG022|Treatment Period|Lost to Follow-up|1|||
161924918|NCT01658878|584770989|FG023|Treatment Period|Lost to Follow-up|0|||
161924919|NCT03600350|584770990|FG000|Overall Study|Death|1|||
161924920|NCT03600350|584770990|FG000|Overall Study|On Follow Up|18|||
161924921|NCT02400736|584770993|FG000|Overall Study|Lost to Follow-up|6|||
161924922|NCT02400736|584770994|FG001|Overall Study|Lost to Follow-up|6|||
161924923|NCT02400736|584770993|FG000|Overall Study|Withdrawal by Subject|2|||
161924924|NCT02400736|584770994|FG001|Overall Study|Withdrawal by Subject|1|||
161924925|NCT02400736|584770993|FG000|Overall Study|Moved from the area|3|||
161924926|NCT02400736|584770994|FG001|Overall Study|Moved from the area|1|||
161924927|NCT00327171|584770995|FG000|Overall Study|Did not receive study medication|3|||
161924928|NCT00327171|584770996|FG001|Overall Study|Did not receive study medication|0|||
161924929|NCT00327171|584770995|FG000|Overall Study|Adverse Event|23|||
161924930|NCT00327171|584770996|FG001|Overall Study|Adverse Event|23|||
161924931|NCT00327171|584770995|FG000|Overall Study|Disease progression/lack of efficacy|68|||
161924932|NCT00327171|584770996|FG001|Overall Study|Disease progression/lack of efficacy|69|||
161924933|NCT00327171|584770995|FG000|Overall Study|Investigator/participant request|1|||
161924934|NCT00327171|584770996|FG001|Overall Study|Investigator/participant request|8|||
161924935|NCT00327171|584770995|FG000|Overall Study|Clinical progression|12|||
161924936|NCT00327171|584770996|FG001|Overall Study|Clinical progression|8|||
161924937|NCT00327171|584770995|FG000|Overall Study|Undisclosed history of ischemia|0|||
161924938|NCT00327171|584770996|FG001|Overall Study|Undisclosed history of ischemia|1|||
161924939|NCT00327171|584770995|FG000|Overall Study|Other|1|||
161924940|NCT00327171|584770996|FG001|Overall Study|Other|0|||
161924941|NCT01363440|584770997|FG000|Overall Study|Adverse Event|5|||
161924942|NCT01363440|584770998|FG001|Overall Study|Adverse Event|4|||
161924943|NCT01363440|584770999|FG002|Overall Study|Adverse Event|4|||
161924944|NCT01363440|584770997|FG000|Overall Study|Death|3|||
161924945|NCT01363440|584770998|FG001|Overall Study|Death|7|||
161924946|NCT01363440|584770999|FG002|Overall Study|Death|5|||
161924947|NCT01363440|584770997|FG000|Overall Study|Withdrawal by Subject|9|||
161924948|NCT01363440|584770998|FG001|Overall Study|Withdrawal by Subject|11|||
161924949|NCT01363440|584770999|FG002|Overall Study|Withdrawal by Subject|11|||
161924950|NCT01363440|584770997|FG000|Overall Study|Lost to Follow-up|2|||
161924951|NCT01363440|584770998|FG001|Overall Study|Lost to Follow-up|4|||
161924952|NCT01363440|584770999|FG002|Overall Study|Lost to Follow-up|5|||
161924953|NCT01363440|584770997|FG000|Overall Study|Other|4|||
161924954|NCT01363440|584770998|FG001|Overall Study|Other|5|||
161924955|NCT01363440|584770999|FG002|Overall Study|Other|2|||
161924956|NCT01771913|584771000|FG000|Overall Study|Withdrawal by Subject|1|||
161924957|NCT01771913|584771001|FG001|Overall Study|Withdrawal by Subject|0|||
161924958|NCT00992836|584771002|FG000|Overall Study|Lost to Follow-up|1|||
161924959|NCT00992836|584771002|FG000|Overall Study|Withdrawal by Subject|2|||
161924960|NCT00992836|584771002|FG000|Overall Study|Protocol Violation|2|||
161924961|NCT03695094|584771003|FG000|Overall Study|Adverse Event|1|||
161924962|NCT03695094|584771004|FG001|Overall Study|Adverse Event|1|||
161924963|NCT03695094|584771003|FG000|Overall Study|Withdrawal by Subject|1|||
161924964|NCT03695094|584771004|FG001|Overall Study|Withdrawal by Subject|0|||
161924965|NCT01471574|584771009|FG000|Treatment Period|Lack of Efficacy|12|||
161924966|NCT01471574|584771010|FG001|Treatment Period|Lack of Efficacy|4|||
161924967|NCT01471574|584771011|FG002|Treatment Period|Lack of Efficacy|14|||
161924968|NCT01471574|584771012|FG003|Treatment Period|Lack of Efficacy|1|||
161924969|NCT01471574|584771009|FG000|Treatment Period|Adverse Event|7|||
161924970|NCT01471574|584771010|FG001|Treatment Period|Adverse Event|3|||
161924971|NCT01471574|584771011|FG002|Treatment Period|Adverse Event|6|||
161924972|NCT01471574|584771012|FG003|Treatment Period|Adverse Event|1|||
161924973|NCT01471574|584771009|FG000|Treatment Period|Withdrawal by Subject|5|||
161499008|NCT04091646|583223246|FG001|Overall Study|Lost to Follow-up|2|||
161683059|NCT02554019|583891223|FG002|Overall Study|Withdrawal by Subject|2|||
161924974|NCT01471574|584771010|FG001|Treatment Period|Withdrawal by Subject|1|||
161924975|NCT01471574|584771011|FG002|Treatment Period|Withdrawal by Subject|1|||
161924976|NCT01471574|584771012|FG003|Treatment Period|Withdrawal by Subject|0|||
161924977|NCT01471574|584771009|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
161924978|NCT01471574|584771010|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
161924979|NCT01471574|584771011|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
161924980|NCT01471574|584771012|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
161924981|NCT01471574|584771009|FG000|Treatment Period|Lost to Follow-up|1|||
161924982|NCT01471574|584771010|FG001|Treatment Period|Lost to Follow-up|2|||
161924983|NCT01471574|584771011|FG002|Treatment Period|Lost to Follow-up|2|||
161924984|NCT01471574|584771012|FG003|Treatment Period|Lost to Follow-up|0|||
161924985|NCT01471574|584771009|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
161924986|NCT01471574|584771010|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
161499009|NCT04091646|583223245|FG000|Overall Study|Protocol Violation|0|||
161499010|NCT04091646|583223246|FG001|Overall Study|Protocol Violation|1|||
161499011|NCT04091646|583223245|FG000|Overall Study|Withdrawal by Subject|4|||
161499012|NCT04091646|583223246|FG001|Overall Study|Withdrawal by Subject|1|||
161499013|NCT04091646|583223245|FG000|Overall Study|Participant Incarcerated|1|||
161499014|NCT04091646|583223246|FG001|Overall Study|Participant Incarcerated|0|||
161499015|NCT01921829|583223247|FG000|Overall Study|Withdrawal by Subject|0|||
161499016|NCT01921829|583223248|FG001|Overall Study|Withdrawal by Subject|1|||
161499017|NCT04765358|583223253|FG000|Overall Study|Withdrawal by Subject|1|||
161499018|NCT03446040|583223254|FG000|Overall Study|Disease progression|3|||
161499019|NCT03446040|583223255|FG001|Overall Study|Disease progression|3|||
161499020|NCT03446040|583223256|FG002|Overall Study|Disease progression|3|||
161499021|NCT03446040|583223257|FG003|Overall Study|Disease progression|4|||
161499022|NCT03446040|583223258|FG004|Overall Study|Disease progression|4|||
161499023|NCT03446040|583223259|FG005|Overall Study|Disease progression|6|||
161499024|NCT03446040|583223260|FG006|Overall Study|Disease progression|3|||
161499025|NCT03446040|583223261|FG007|Overall Study|Disease progression|4|||
161499026|NCT03446040|583223262|FG008|Overall Study|Disease progression|2|||
161499027|NCT03446040|583223263|FG009|Overall Study|Disease progression|4|||
161499028|NCT03446040|583223264|FG010|Overall Study|Disease progression|9|||
161499029|NCT03446040|583223265|FG011|Overall Study|Disease progression|3|||
161499030|NCT03446040|583223266|FG012|Overall Study|Disease progression|7|||
161499031|NCT03446040|583223267|FG013|Overall Study|Disease progression|7|||
161499032|NCT03446040|583223254|FG000|Overall Study|Study drug toxicity|0|||
161499033|NCT03446040|583223255|FG001|Overall Study|Study drug toxicity|0|||
161499034|NCT03446040|583223256|FG002|Overall Study|Study drug toxicity|0|||
161499035|NCT03446040|583223257|FG003|Overall Study|Study drug toxicity|0|||
161499036|NCT03446040|583223258|FG004|Overall Study|Study drug toxicity|0|||
161499037|NCT03446040|583223259|FG005|Overall Study|Study drug toxicity|0|||
161499038|NCT03446040|583223260|FG006|Overall Study|Study drug toxicity|0|||
161499039|NCT03446040|583223261|FG007|Overall Study|Study drug toxicity|0|||
161499040|NCT03446040|583223262|FG008|Overall Study|Study drug toxicity|1|||
161499041|NCT03446040|583223263|FG009|Overall Study|Study drug toxicity|0|||
161499042|NCT03446040|583223264|FG010|Overall Study|Study drug toxicity|0|||
161499043|NCT03446040|583223265|FG011|Overall Study|Study drug toxicity|0|||
161499044|NCT03446040|583223266|FG012|Overall Study|Study drug toxicity|0|||
161499045|NCT03446040|583223267|FG013|Overall Study|Study drug toxicity|0|||
161499046|NCT03446040|583223254|FG000|Overall Study|Adverse Event|0|||
161499047|NCT03446040|583223255|FG001|Overall Study|Adverse Event|0|||
161924987|NCT01471574|584771011|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
161924988|NCT01471574|584771012|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
161924989|NCT01471574|584771009|FG000|Treatment Period|Other|1|||
161924990|NCT01471574|584771010|FG001|Treatment Period|Other|0|||
161924991|NCT01471574|584771011|FG002|Treatment Period|Other|0|||
161924992|NCT01471574|584771012|FG003|Treatment Period|Other|0|||
161924993|NCT01471574|584771009|FG000|Follow-up Period|Withdrawal by Subject|3|||
161924994|NCT01471574|584771010|FG001|Follow-up Period|Withdrawal by Subject|0|||
161924995|NCT01471574|584771011|FG002|Follow-up Period|Withdrawal by Subject|3|||
161924996|NCT01471574|584771012|FG003|Follow-up Period|Withdrawal by Subject|1|||
161924997|NCT01471574|584771009|FG000|Follow-up Period|Lost to Follow-up|4|||
161924998|NCT01471574|584771010|FG001|Follow-up Period|Lost to Follow-up|1|||
161924999|NCT01471574|584771011|FG002|Follow-up Period|Lost to Follow-up|3|||
161925000|NCT01471574|584771012|FG003|Follow-up Period|Lost to Follow-up|2|||
161925001|NCT01471574|584771009|FG000|Follow-up Period|Death|0|||
161925002|NCT01471574|584771010|FG001|Follow-up Period|Death|0|||
161925003|NCT01471574|584771011|FG002|Follow-up Period|Death|1|||
161925004|NCT01471574|584771012|FG003|Follow-up Period|Death|0|||
161925005|NCT01471574|584771009|FG000|Follow-up Period|Follow-up no longer required|0|||
161925006|NCT01471574|584771010|FG001|Follow-up Period|Follow-up no longer required|1|||
161925007|NCT01471574|584771011|FG002|Follow-up Period|Follow-up no longer required|0|||
161925008|NCT01471574|584771012|FG003|Follow-up Period|Follow-up no longer required|0|||
161925009|NCT01795937|584771013|FG000|Overall Study|Withdrawal by Subject|1|||
161499048|NCT03446040|583223256|FG002|Overall Study|Adverse Event|0|||
161925010|NCT01795937|584771014|FG001|Overall Study|Withdrawal by Subject|0|||
161499049|NCT03446040|583223257|FG003|Overall Study|Adverse Event|0|||
161499050|NCT03446040|583223258|FG004|Overall Study|Adverse Event|0|||
161499051|NCT03446040|583223259|FG005|Overall Study|Adverse Event|2|||
161499052|NCT03446040|583223260|FG006|Overall Study|Adverse Event|0|||
161925011|NCT01795937|584771015|FG002|Overall Study|Withdrawal by Subject|0|||
161925012|NCT01795937|584771013|FG000|Overall Study|Physician Decision|0|||
161499053|NCT03446040|583223261|FG007|Overall Study|Adverse Event|0|||
161499054|NCT03446040|583223262|FG008|Overall Study|Adverse Event|1|||
161499055|NCT03446040|583223263|FG009|Overall Study|Adverse Event|0|||
161499056|NCT03446040|583223264|FG010|Overall Study|Adverse Event|0|||
161499057|NCT03446040|583223265|FG011|Overall Study|Adverse Event|0|||
161499058|NCT03446040|583223266|FG012|Overall Study|Adverse Event|0|||
161499059|NCT03446040|583223267|FG013|Overall Study|Adverse Event|0|||
161499060|NCT03446040|583223254|FG000|Overall Study|Death|0|||
161925013|NCT01795937|584771014|FG001|Overall Study|Physician Decision|1|||
161925014|NCT01795937|584771015|FG002|Overall Study|Physician Decision|0|||
161925015|NCT01177410|584771016|FG000|Overall Study|Adverse Event|0|||
161925016|NCT01177410|584771017|FG001|Overall Study|Adverse Event|2|||
161925017|NCT01177410|584771018|FG002|Overall Study|Adverse Event|2|||
161925018|NCT01177410|584771016|FG000|Overall Study|Withdrawal by Subject|1|||
161925019|NCT01177410|584771017|FG001|Overall Study|Withdrawal by Subject|4|||
161925020|NCT01177410|584771018|FG002|Overall Study|Withdrawal by Subject|3|||
161925021|NCT01177410|584771016|FG000|Overall Study|Lost to Follow-up|0|||
161925022|NCT01177410|584771017|FG001|Overall Study|Lost to Follow-up|1|||
161925023|NCT01177410|584771018|FG002|Overall Study|Lost to Follow-up|0|||
161925024|NCT02965716|584771020|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161925025|NCT02965716|584771021|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
161925026|NCT02965716|584771020|FG000|Overall Study|Progression/Relapse|8|||
161925027|NCT02965716|584771021|FG001|Overall Study|Progression/Relapse|16|||
161925028|NCT02965716|584771020|FG000|Overall Study|Death|1|||
161925029|NCT02965716|584771021|FG001|Overall Study|Death|0|||
161925030|NCT02965716|584771020|FG000|Overall Study|Not Protocol Specified|1|||
161925031|NCT02965716|584771021|FG001|Overall Study|Not Protocol Specified|3|||
161925032|NCT02691663|584771026|FG000|Overall Study|Screen failure after baseline|2|||
161925033|NCT02691663|584771027|FG001|Overall Study|Screen failure after baseline|2|||
161925034|NCT02691663|584771026|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
161925035|NCT02691663|584771027|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
161925036|NCT02691663|584771026|FG000|Overall Study|Withdrawn after Follow up 2|1|||
161925037|NCT02691663|584771027|FG001|Overall Study|Withdrawn after Follow up 2|1|||
161925038|NCT02691663|584771026|FG000|Overall Study|Lost to Follow-up|3|||
161925039|NCT02691663|584771027|FG001|Overall Study|Lost to Follow-up|2|||
161925040|NCT00303628|584771028|FG000|Overall Study|Disease progression|0|||
161925041|NCT00303628|584771029|FG001|Overall Study|Disease progression|1|||
161925042|NCT00303628|584771028|FG000|Overall Study|Adverse Event|26|||
161499061|NCT03446040|583223255|FG001|Overall Study|Death|0|||
161499062|NCT03446040|583223256|FG002|Overall Study|Death|0|||
161499063|NCT03446040|583223257|FG003|Overall Study|Death|0|||
161499064|NCT03446040|583223258|FG004|Overall Study|Death|0|||
161499065|NCT03446040|583223259|FG005|Overall Study|Death|0|||
161499066|NCT03446040|583223260|FG006|Overall Study|Death|0|||
161499067|NCT03446040|583223261|FG007|Overall Study|Death|0|||
161499068|NCT03446040|583223262|FG008|Overall Study|Death|0|||
161499069|NCT03446040|583223263|FG009|Overall Study|Death|0|||
161499070|NCT03446040|583223264|FG010|Overall Study|Death|1|||
161499071|NCT03446040|583223265|FG011|Overall Study|Death|0|||
161499072|NCT03446040|583223266|FG012|Overall Study|Death|0|||
161499073|NCT03446040|583223267|FG013|Overall Study|Death|2|||
161499074|NCT03446040|583223254|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
161499075|NCT03446040|583223255|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
161499076|NCT03446040|583223256|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
161499077|NCT03446040|583223257|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
161499078|NCT03446040|583223258|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
161925043|NCT00303628|584771029|FG001|Overall Study|Adverse Event|36|||
161925044|NCT00303628|584771028|FG000|Overall Study|Death|0|||
161925045|NCT00303628|584771029|FG001|Overall Study|Death|1|||
161925046|NCT00303628|584771028|FG000|Overall Study|Withdrawal by Subject|11|||
161925047|NCT00303628|584771029|FG001|Overall Study|Withdrawal by Subject|20|||
161925048|NCT00303628|584771028|FG000|Overall Study|Alternative therapy|2|||
161925049|NCT00303628|584771029|FG001|Overall Study|Alternative therapy|0|||
161925050|NCT00303628|584771028|FG000|Overall Study|Other complicating disease|0|||
161925051|NCT00303628|584771029|FG001|Overall Study|Other complicating disease|1|||
161925052|NCT00303628|584771028|FG000|Overall Study|Not start protocol therapy|3|||
161925053|NCT00303628|584771029|FG001|Overall Study|Not start protocol therapy|5|||
161925054|NCT00303628|584771028|FG000|Overall Study|Other|8|||
161925055|NCT00303628|584771029|FG001|Overall Study|Other|9|||
161925056|NCT02942407|584771030|FG000|Overall Study|Lost to Follow-up|3|||
161925057|NCT02942407|584771031|FG001|Overall Study|Lost to Follow-up|2|||
161925058|NCT02942407|584771030|FG000|Overall Study|Withdrawal by Subject|7|||
161925059|NCT02942407|584771031|FG001|Overall Study|Withdrawal by Subject|9|||
161925060|NCT02942407|584771030|FG000|Overall Study|Death|16|||
161925061|NCT02942407|584771031|FG001|Overall Study|Death|13|||
161499079|NCT03446040|583223259|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
161499080|NCT03446040|583223260|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
161925062|NCT05887908|584771032|FG000|Overall Study|Adverse Event|6|||
161925063|NCT05887908|584771033|FG001|Overall Study|Adverse Event|1|||
161925064|NCT05887908|584771034|FG002|Overall Study|Adverse Event|1|||
161925065|NCT05887908|584771032|FG000|Overall Study|Physician Decision|4|||
161925066|NCT05887908|584771033|FG001|Overall Study|Physician Decision|1|||
161925067|NCT05887908|584771034|FG002|Overall Study|Physician Decision|0|||
161925068|NCT05887908|584771032|FG000|Overall Study|Withdrawal by Subject|3|||
161499081|NCT03446040|583223261|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
161499082|NCT03446040|583223262|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
161499083|NCT03446040|583223263|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
161499084|NCT03446040|583223264|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
161499085|NCT03446040|583223265|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
161499086|NCT03446040|583223266|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
161499087|NCT03446040|583223267|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
161499088|NCT03446040|583223254|FG000|Overall Study|Participant withdrew consent|0|||
161499089|NCT03446040|583223255|FG001|Overall Study|Participant withdrew consent|0|||
161499090|NCT03446040|583223256|FG002|Overall Study|Participant withdrew consent|0|||
161499091|NCT03446040|583223257|FG003|Overall Study|Participant withdrew consent|0|||
161499092|NCT03446040|583223258|FG004|Overall Study|Participant withdrew consent|0|||
161499093|NCT03446040|583223259|FG005|Overall Study|Participant withdrew consent|1|||
161499094|NCT03446040|583223260|FG006|Overall Study|Participant withdrew consent|0|||
161499095|NCT03446040|583223261|FG007|Overall Study|Participant withdrew consent|1|||
161499096|NCT03446040|583223262|FG008|Overall Study|Participant withdrew consent|0|||
161499097|NCT03446040|583223263|FG009|Overall Study|Participant withdrew consent|0|||
161499098|NCT03446040|583223264|FG010|Overall Study|Participant withdrew consent|0|||
161499099|NCT03446040|583223265|FG011|Overall Study|Participant withdrew consent|0|||
161499100|NCT03446040|583223266|FG012|Overall Study|Participant withdrew consent|0|||
161499101|NCT03446040|583223267|FG013|Overall Study|Participant withdrew consent|0|||
161499102|NCT03446040|583223254|FG000|Overall Study|Not reported|0|||
161499103|NCT03446040|583223255|FG001|Overall Study|Not reported|0|||
161499104|NCT03446040|583223256|FG002|Overall Study|Not reported|1|||
161499105|NCT03446040|583223257|FG003|Overall Study|Not reported|0|||
161499106|NCT03446040|583223258|FG004|Overall Study|Not reported|0|||
161499107|NCT03446040|583223259|FG005|Overall Study|Not reported|0|||
161499108|NCT03446040|583223260|FG006|Overall Study|Not reported|0|||
161499109|NCT03446040|583223261|FG007|Overall Study|Not reported|0|||
161499110|NCT03446040|583223262|FG008|Overall Study|Not reported|0|||
161499111|NCT03446040|583223263|FG009|Overall Study|Not reported|0|||
161499112|NCT03446040|583223264|FG010|Overall Study|Not reported|0|||
161499113|NCT03446040|583223265|FG011|Overall Study|Not reported|0|||
161499114|NCT03446040|583223266|FG012|Overall Study|Not reported|0|||
161499115|NCT03446040|583223267|FG013|Overall Study|Not reported|0|||
161499116|NCT01316276|583223268|FG000|Overall Study|Death|1|||
161499117|NCT01316276|583223268|FG000|Overall Study|Adverse Event|19|||
161499118|NCT01316276|583223268|FG000|Overall Study|Withdrawal of consent|24|||
161818842|NCT01537887|584378131|FG003|Period 1|Did not receive treatment|0|||
161818843|NCT01537887|584378132|FG004|Period 1|Did not receive treatment|0|||
161499119|NCT01316276|583223268|FG000|Overall Study|Lost to Follow-up|1|||
161499120|NCT01316276|583223268|FG000|Overall Study|Other|22|||
161499121|NCT00605475|583223269|FG000|Overall Study|Abnormal Laboratory Values|0|||
161499122|NCT00605475|583223270|FG001|Overall Study|Abnormal Laboratory Values|0|||
161499123|NCT00605475|583223271|FG002|Overall Study|Abnormal Laboratory Values|0|||
161499124|NCT00605475|583223272|FG003|Overall Study|Abnormal Laboratory Values|0|||
161499125|NCT00605475|583223273|FG004|Overall Study|Abnormal Laboratory Values|0|||
161499126|NCT00605475|583223274|FG005|Overall Study|Abnormal Laboratory Values|0|||
161499127|NCT00605475|583223275|FG006|Overall Study|Abnormal Laboratory Values|0|||
161499128|NCT00605475|583223276|FG007|Overall Study|Abnormal Laboratory Values|0|||
161499129|NCT00605475|583223277|FG008|Overall Study|Abnormal Laboratory Values|1|||
161499130|NCT00605475|583223278|FG009|Overall Study|Abnormal Laboratory Values|0|||
161499131|NCT00605475|583223269|FG000|Overall Study|Administrative problems|0|||
161499132|NCT00605475|583223270|FG001|Overall Study|Administrative problems|0|||
161499133|NCT00605475|583223271|FG002|Overall Study|Administrative problems|0|||
161499134|NCT00605475|583223272|FG003|Overall Study|Administrative problems|0|||
161499135|NCT00605475|583223273|FG004|Overall Study|Administrative problems|0|||
161499136|NCT00605475|583223274|FG005|Overall Study|Administrative problems|0|||
161818844|NCT01537887|584378133|FG005|Period 1|Did not receive treatment|0|||
161818845|NCT01537887|584378128|FG000|Period 2|Withdrawal by Subject|0|||
161818846|NCT01537887|584378129|FG001|Period 2|Withdrawal by Subject|1|||
161818847|NCT01537887|584378130|FG002|Period 2|Withdrawal by Subject|0|||
161818848|NCT01537887|584378131|FG003|Period 2|Withdrawal by Subject|0|||
161818849|NCT01537887|584378132|FG004|Period 2|Withdrawal by Subject|0|||
161499137|NCT00605475|583223275|FG006|Overall Study|Administrative problems|1|||
161499138|NCT00605475|583223276|FG007|Overall Study|Administrative problems|0|||
161499139|NCT00605475|583223277|FG008|Overall Study|Administrative problems|0|||
161499140|NCT00605475|583223278|FG009|Overall Study|Administrative problems|0|||
161499141|NCT00605475|583223269|FG000|Overall Study|Lost to Follow-up|0|||
161499142|NCT00605475|583223270|FG001|Overall Study|Lost to Follow-up|0|||
161499143|NCT00605475|583223271|FG002|Overall Study|Lost to Follow-up|0|||
161499144|NCT00605475|583223272|FG003|Overall Study|Lost to Follow-up|0|||
161499145|NCT00605475|583223273|FG004|Overall Study|Lost to Follow-up|0|||
161499146|NCT00605475|583223274|FG005|Overall Study|Lost to Follow-up|0|||
161499147|NCT00605475|583223275|FG006|Overall Study|Lost to Follow-up|0|||
161499148|NCT00605475|583223276|FG007|Overall Study|Lost to Follow-up|0|||
161499149|NCT00605475|583223277|FG008|Overall Study|Lost to Follow-up|1|||
161499150|NCT00605475|583223278|FG009|Overall Study|Lost to Follow-up|1|||
161499151|NCT00605475|583223269|FG000|Overall Study|Protocol Violation|0|||
161499152|NCT00605475|583223270|FG001|Overall Study|Protocol Violation|0|||
161499153|NCT00605475|583223271|FG002|Overall Study|Protocol Violation|0|||
161499154|NCT00605475|583223272|FG003|Overall Study|Protocol Violation|0|||
161499155|NCT00605475|583223273|FG004|Overall Study|Protocol Violation|1|||
161499156|NCT00605475|583223274|FG005|Overall Study|Protocol Violation|0|||
161499157|NCT00605475|583223275|FG006|Overall Study|Protocol Violation|0|||
161499158|NCT00605475|583223276|FG007|Overall Study|Protocol Violation|0|||
161499159|NCT00605475|583223277|FG008|Overall Study|Protocol Violation|0|||
161499160|NCT00605475|583223278|FG009|Overall Study|Protocol Violation|0|||
161499161|NCT00605475|583223269|FG000|Overall Study|Withdrawal by Subject|0|||
161499162|NCT00605475|583223270|FG001|Overall Study|Withdrawal by Subject|0|||
161499163|NCT00605475|583223271|FG002|Overall Study|Withdrawal by Subject|0|||
161499164|NCT00605475|583223272|FG003|Overall Study|Withdrawal by Subject|0|||
161499165|NCT00605475|583223273|FG004|Overall Study|Withdrawal by Subject|0|||
161499166|NCT00605475|583223274|FG005|Overall Study|Withdrawal by Subject|2|||
161499167|NCT00605475|583223275|FG006|Overall Study|Withdrawal by Subject|0|||
161499168|NCT00605475|583223276|FG007|Overall Study|Withdrawal by Subject|0|||
161499169|NCT00605475|583223277|FG008|Overall Study|Withdrawal by Subject|0|||
161499170|NCT00605475|583223278|FG009|Overall Study|Withdrawal by Subject|1|||
161499171|NCT00464568|583223283|FG000|Overall Study|Adverse Event|2|||
161499172|NCT03538158|583223285|FG000|Overall Study|Lost to Follow-up|13|||
161499173|NCT03538158|583223286|FG001|Overall Study|Lost to Follow-up|7|||
161499174|NCT03538158|583223285|FG000|Overall Study|Withdrawal by Subject|2|||
161499175|NCT03538158|583223286|FG001|Overall Study|Withdrawal by Subject|1|||
161499176|NCT02419742|583223289|FG000|Overall Study|Adverse Event|2|||
161499177|NCT02419742|583223290|FG001|Overall Study|Adverse Event|0|||
161499178|NCT02419742|583223289|FG000|Overall Study|Disease Progression|0|||
161499179|NCT02419742|583223290|FG001|Overall Study|Disease Progression|1|||
161499180|NCT02419742|583223289|FG000|Overall Study|Withdrew Consent|2|||
161499181|NCT02419742|583223290|FG001|Overall Study|Withdrew Consent|1|||
161585786|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
161585787|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
161585788|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
161585789|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
161585790|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
161585791|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
161585792|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
161585793|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
161585794|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
161585795|NCT03271489|583531857|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
161585796|NCT03271489|583531858|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
161585797|NCT01127373|583531859|FG000|Overall Study|Not Treated|3|||
161585798|NCT01127373|583531859|FG000|Overall Study|Lost to Follow-up|7|||
161585799|NCT01127373|583531859|FG000|Overall Study|Withdrawal by Subject|1|||
161585800|NCT01127373|583531859|FG000|Overall Study|Disease progression|1|||
161585801|NCT00522951|583531862|FG000|Period 1|body motion|0|||
161585802|NCT00522951|583531863|FG001|Period 1|body motion|1|||
161585803|NCT00522951|583531862|FG000|Washout Period|Adverse Event|0|||
161585804|NCT00522951|583531863|FG001|Washout Period|Adverse Event|1|||
161585805|NCT00522951|583531862|FG000|Washout Period|Death|0|||
161585806|NCT00522951|583531863|FG001|Washout Period|Death|1|||
161585807|NCT00522951|583531862|FG000|Period 2|Withdrawal by Subject|1|||
161585808|NCT00522951|583531863|FG001|Period 2|Withdrawal by Subject|0|||
161925069|NCT05887908|584771033|FG001|Overall Study|Withdrawal by Subject|2|||
161925070|NCT05887908|584771034|FG002|Overall Study|Withdrawal by Subject|3|||
161585809|NCT00522951|583531862|FG000|Period 2|residual contrast medium|1|||
161925071|NCT05887908|584771032|FG000|Overall Study|Ineligibility after the start of the study|4|||
161925072|NCT05887908|584771033|FG001|Overall Study|Ineligibility after the start of the study|1|||
161925073|NCT05887908|584771034|FG002|Overall Study|Ineligibility after the start of the study|0|||
161499182|NCT02419742|583223289|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
161499183|NCT02419742|583223290|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
161499184|NCT02255981|583223293|FG000|Overall Study|Lost to Follow-up|3|||
161499185|NCT02255981|583223293|FG000|Overall Study|Withdrawal by Subject|1|||
161499186|NCT01454570|583223304|FG000|Overall Study|Withdrawal by Subject|2|||
161499187|NCT01454570|583223304|FG000|Overall Study|Screen Failure|7|||
161499188|NCT00885755|583223305|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
161499189|NCT00885755|583223306|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
161499190|NCT00885755|583223307|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
161673155|NCT04313153|583857892|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
161673156|NCT04313153|583857893|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
161818850|NCT01537887|584378133|FG005|Period 2|Withdrawal by Subject|0|||
161818851|NCT01537887|584378128|FG000|Period 3|Adverse Event|0|||
161818852|NCT01537887|584378129|FG001|Period 3|Adverse Event|0|||
161818853|NCT01537887|584378130|FG002|Period 3|Adverse Event|1|||
161818854|NCT01537887|584378131|FG003|Period 3|Adverse Event|0|||
161818855|NCT01537887|584378132|FG004|Period 3|Adverse Event|0|||
161818856|NCT01537887|584378133|FG005|Period 3|Adverse Event|0|||
161818857|NCT01537887|584378128|FG000|Period 3|Withdrawal by Subject|0|||
161818858|NCT01537887|584378129|FG001|Period 3|Withdrawal by Subject|1|||
161818859|NCT01537887|584378130|FG002|Period 3|Withdrawal by Subject|0|||
161818860|NCT01537887|584378131|FG003|Period 3|Withdrawal by Subject|0|||
161818861|NCT01537887|584378132|FG004|Period 3|Withdrawal by Subject|0|||
161818862|NCT01537887|584378133|FG005|Period 3|Withdrawal by Subject|0|||
161818863|NCT02072096|584378136|FG000|Overall Study|Lack of Efficacy|18|||
161818864|NCT02072096|584378137|FG001|Overall Study|Lack of Efficacy|29|||
161818865|NCT02072096|584378136|FG000|Overall Study|Protocol Violation|7|||
161818866|NCT02072096|584378137|FG001|Overall Study|Protocol Violation|7|||
161818867|NCT02072096|584378136|FG000|Overall Study|Withdrawal by Subject|5|||
161818868|NCT02072096|584378137|FG001|Overall Study|Withdrawal by Subject|7|||
161818869|NCT02072096|584378136|FG000|Overall Study|Adverse Event|5|||
161818870|NCT02072096|584378137|FG001|Overall Study|Adverse Event|2|||
161818871|NCT02072096|584378136|FG000|Overall Study|No Reason Provided|4|||
161818872|NCT02072096|584378137|FG001|Overall Study|No Reason Provided|2|||
161818873|NCT02072096|584378136|FG000|Overall Study|Death|2|||
161818874|NCT02072096|584378137|FG001|Overall Study|Death|0|||
161818875|NCT02072096|584378136|FG000|Overall Study|Physician Decision|0|||
161818876|NCT02072096|584378137|FG001|Overall Study|Physician Decision|1|||
161818877|NCT02072096|584378136|FG000|Overall Study|Study Terminated by Sponsor|43|||
161818878|NCT02072096|584378137|FG001|Overall Study|Study Terminated by Sponsor|30|||
161818879|NCT02072096|584378136|FG000|Overall Study|Lost to Follow-up|1|||
161818880|NCT02072096|584378137|FG001|Overall Study|Lost to Follow-up|0|||
161818881|NCT02336074|584378144|FG000|Overall Study|Adverse Event|0|||
161818882|NCT02336074|584378145|FG001|Overall Study|Adverse Event|2|||
161818883|NCT05604014|584378165|FG000|Overall Study|Lost to Follow-up|13|||
161818884|NCT01266902|584378167|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
161818885|NCT01266902|584378168|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
161818886|NCT01266902|584378169|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
161818887|NCT01266902|584378167|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
161818888|NCT01266902|584378168|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
161818889|NCT01266902|584378169|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
161818890|NCT01266902|584378167|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
161818891|NCT01266902|584378168|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
161818892|NCT01266902|584378169|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
161818893|NCT01266902|584378167|FG000|Period 1 (Main Study)|Adverse Event|3|||
161818894|NCT01266902|584378168|FG001|Period 1 (Main Study)|Adverse Event|11|||
161818895|NCT01266902|584378169|FG002|Period 1 (Main Study)|Adverse Event|0|||
161818896|NCT01266902|584378167|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
161818897|NCT01266902|584378168|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
161818898|NCT01266902|584378169|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
161818899|NCT01266902|584378167|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
161818900|NCT01266902|584378168|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
161818901|NCT01266902|584378169|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
161818902|NCT01266902|584378167|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
161818903|NCT01266902|584378168|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
161818904|NCT01266902|584378169|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
161818905|NCT01266902|584378167|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
161818906|NCT01266902|584378168|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
161818907|NCT01266902|584378169|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
161818908|NCT01266902|584378167|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
161818909|NCT01266902|584378168|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
161818910|NCT01266902|584378169|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
161818911|NCT01266902|584378167|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
161818912|NCT01266902|584378168|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
161818913|NCT01266902|584378169|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
161818914|NCT02121184|584378170|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
161818915|NCT02121184|584378171|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
161818916|NCT02121184|584378170|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
161818917|NCT02121184|584378171|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
161818918|NCT02121184|584378170|FG000|Overall Study|Emergency cesarean section required|0|||
161818919|NCT02121184|584378171|FG001|Overall Study|Emergency cesarean section required|2|||
161499191|NCT00885755|583223305|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
161499192|NCT00885755|583223306|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
161499193|NCT00885755|583223307|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
161499194|NCT00885755|583223305|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
161499195|NCT00885755|583223306|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
161499196|NCT00885755|583223307|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
161499197|NCT00885755|583223305|FG000|Part I: Trastuzumab+Taxane|Death|0|||
161499198|NCT00885755|583223306|FG001|Part I: Trastuzumab+Taxane|Death|0|||
161499199|NCT00885755|583223307|FG002|Part I: Trastuzumab+Taxane|Death|1|||
161499200|NCT00885755|583223305|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
161499201|NCT00885755|583223306|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
161499202|NCT00885755|583223307|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
161499203|NCT04649164|583223308|FG000|Overall Study|Withdrawal by Subject|1|||
161499204|NCT04649164|583223309|FG001|Overall Study|Withdrawal by Subject|1|||
161499205|NCT04649164|583223310|FG002|Overall Study|Withdrawal by Subject|2|||
161499206|NCT04649164|583223308|FG000|Overall Study|Participant's care recipient expired|0|||
161499207|NCT04649164|583223309|FG001|Overall Study|Participant's care recipient expired|0|||
161499208|NCT04649164|583223310|FG002|Overall Study|Participant's care recipient expired|2|||
161499209|NCT04356963|583223317|FG000|First Session|Withdrawal by Subject|1|||
161499210|NCT04356963|583223317|FG000|Second Session|Withdrawal by Subject|3|||
161499211|NCT04356963|583223317|FG000|Second Session|Lost to Follow-up|1|||
161499212|NCT04356963|583223317|FG000|Third Session|Lost to Follow-up|6|||
161499213|NCT04356963|583223317|FG000|Third Session|Withdrawal by Subject|1|||
161499214|NCT02410954|583223322|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
161499215|NCT02410954|583223323|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
161499216|NCT02410954|583223322|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
161499217|NCT02410954|583223323|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
161499218|NCT00791518|583223325|FG000|Overall Study|Protocol Violation|93|||
161499219|NCT02488681|583223326|FG000|Overall Study|Implant unsuccessful|7|||
161499220|NCT00720057|583223327|FG000|Overall Study|Lost to Follow-up|0|||
161499221|NCT00720057|583223328|FG001|Overall Study|Lost to Follow-up|2|||
161499222|NCT00720057|583223327|FG000|Overall Study|Protocol Violation|1|||
161499223|NCT00720057|583223328|FG001|Overall Study|Protocol Violation|0|||
161499224|NCT00720057|583223327|FG000|Overall Study|Withdrawal by Subject|0|||
161499225|NCT00720057|583223328|FG001|Overall Study|Withdrawal by Subject|1|||
161499226|NCT00271609|583223340|FG000|Overall Study|Adverse Event|11|||
161499227|NCT00271609|583223341|FG001|Overall Study|Adverse Event|3|||
161499228|NCT00271609|583223340|FG000|Overall Study|Withdrawal by Subject|2|||
161499229|NCT00271609|583223341|FG001|Overall Study|Withdrawal by Subject|0|||
161818920|NCT02121184|584378170|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
161818921|NCT02121184|584378171|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
161499230|NCT03341533|583223342|FG000|Overall Study|Withdrawal by Subject|1|||
161499231|NCT03341533|583223343|FG001|Overall Study|Withdrawal by Subject|1|||
161499232|NCT03341533|583223342|FG000|Overall Study|Not eligible after randomization|2|||
161499233|NCT03341533|583223343|FG001|Overall Study|Not eligible after randomization|1|||
161499234|NCT00643682|583223344|FG000|Overall Study|did not keep appointment|522|||
161499235|NCT00643682|583223345|FG001|Overall Study|did not keep appointment|509|||
161499236|NCT01782664|583223347|FG000|Overall Study|Adverse Event|2|||
161499237|NCT01782664|583223348|FG001|Overall Study|Adverse Event|2|||
161499238|NCT01782664|583223349|FG002|Overall Study|Adverse Event|2|||
161499239|NCT01782664|583223350|FG003|Overall Study|Adverse Event|2|||
161818922|NCT04567329|584378174|FG000|Overall Study|Withdrawal by Subject|5|||
161818923|NCT04567329|584378175|FG001|Overall Study|Withdrawal by Subject|6|||
161818924|NCT04567329|584378174|FG000|Overall Study|Protocol Violation|2|||
161818925|NCT04567329|584378175|FG001|Overall Study|Protocol Violation|3|||
161818926|NCT04567329|584378174|FG000|Overall Study|Discontinued|2|||
161818927|NCT04567329|584378175|FG001|Overall Study|Discontinued|2|||
161818928|NCT04567329|584378174|FG000|Overall Study|Lost to Follow-up|0|||
161818929|NCT04567329|584378175|FG001|Overall Study|Lost to Follow-up|1|||
161818930|NCT04567329|584378174|FG000|Overall Study|Lack of Efficacy|0|||
161818931|NCT04567329|584378175|FG001|Overall Study|Lack of Efficacy|1|||
161818932|NCT02933060|584378176|FG000|Overall Study|Withdrawal by Subject|0|||
161818933|NCT02933060|584378177|FG001|Overall Study|Withdrawal by Subject|1|||
161818934|NCT01945580|584378178|FG000|Overall Study|Withdrawal by Subject|13|||
161499240|NCT01782664|583223351|FG004|Overall Study|Adverse Event|0|||
161499241|NCT01782664|583223352|FG005|Overall Study|Adverse Event|0|||
161818935|NCT01945580|584378179|FG001|Overall Study|Withdrawal by Subject|35|||
161499242|NCT01782664|583223347|FG000|Overall Study|Lack of Efficacy|2|||
161499243|NCT01782664|583223348|FG001|Overall Study|Lack of Efficacy|0|||
161499244|NCT01782664|583223349|FG002|Overall Study|Lack of Efficacy|2|||
161499245|NCT01782664|583223350|FG003|Overall Study|Lack of Efficacy|2|||
161499246|NCT01782664|583223351|FG004|Overall Study|Lack of Efficacy|0|||
161499247|NCT01782664|583223352|FG005|Overall Study|Lack of Efficacy|0|||
161499248|NCT01782664|583223347|FG000|Overall Study|Protocol Violation|0|||
161499249|NCT01782664|583223348|FG001|Overall Study|Protocol Violation|1|||
161499250|NCT01782664|583223349|FG002|Overall Study|Protocol Violation|0|||
161499251|NCT01782664|583223350|FG003|Overall Study|Protocol Violation|1|||
161499252|NCT01782664|583223351|FG004|Overall Study|Protocol Violation|0|||
161499253|NCT01782664|583223352|FG005|Overall Study|Protocol Violation|0|||
161499254|NCT01782664|583223347|FG000|Overall Study|Withdrawal by Subject|2|||
161499255|NCT01782664|583223348|FG001|Overall Study|Withdrawal by Subject|2|||
161499256|NCT01782664|583223349|FG002|Overall Study|Withdrawal by Subject|0|||
161499257|NCT01782664|583223350|FG003|Overall Study|Withdrawal by Subject|0|||
161499258|NCT01782664|583223351|FG004|Overall Study|Withdrawal by Subject|0|||
161499259|NCT01782664|583223352|FG005|Overall Study|Withdrawal by Subject|0|||
161499260|NCT04170348|583223353|FG000|Overall Study|Lost to Follow-up|2|||
161499261|NCT04170348|583223354|FG001|Overall Study|Lost to Follow-up|2|||
161499262|NCT04170348|583223353|FG000|Overall Study|Withdrawal by Subject|1|||
161499263|NCT04170348|583223354|FG001|Overall Study|Withdrawal by Subject|5|||
161499264|NCT04170348|583223353|FG000|Overall Study|Non-adherence|1|||
161499265|NCT04170348|583223354|FG001|Overall Study|Non-adherence|1|||
161499266|NCT04170348|583223353|FG000|Overall Study|Adverse Event|1|||
161499267|NCT04170348|583223354|FG001|Overall Study|Adverse Event|0|||
161499268|NCT01082965|583223356|FG000|Overall Study|Protocol Violation|0|||
161499269|NCT01082965|583223357|FG001|Overall Study|Protocol Violation|1|||
161499270|NCT01082965|583223356|FG000|Overall Study|Other|1|||
161499271|NCT01082965|583223357|FG001|Overall Study|Other|1|||
161499272|NCT04307446|583225256|FG000|Overall Study|Lost to Follow-up|2|||
161499273|NCT04307446|583225257|FG001|Overall Study|Lost to Follow-up|0|||
161499274|NCT02515942|583225258|FG000|Overall Study|Adverse Event|5|||
161499275|NCT02515942|583225259|FG001|Overall Study|Adverse Event|0|||
161499276|NCT02515942|583225260|FG002|Overall Study|Adverse Event|0|||
161499277|NCT02515942|583225258|FG000|Overall Study|Death|0|||
161499278|NCT02515942|583225259|FG001|Overall Study|Death|0|||
161499279|NCT02515942|583225260|FG002|Overall Study|Death|1|||
161499280|NCT02515942|583225258|FG000|Overall Study|Lack of Efficacy|0|||
161499281|NCT02515942|583225259|FG001|Overall Study|Lack of Efficacy|0|||
161499282|NCT02515942|583225260|FG002|Overall Study|Lack of Efficacy|1|||
161499283|NCT02515942|583225258|FG000|Overall Study|Lost to Follow-up|2|||
161499284|NCT02515942|583225259|FG001|Overall Study|Lost to Follow-up|0|||
161499285|NCT02515942|583225260|FG002|Overall Study|Lost to Follow-up|0|||
161499286|NCT02515942|583225258|FG000|Overall Study|Withdrawal by Subject|0|||
161499287|NCT02515942|583225259|FG001|Overall Study|Withdrawal by Subject|3|||
161499288|NCT02515942|583225260|FG002|Overall Study|Withdrawal by Subject|2|||
161499289|NCT00902564|583225261|FG000|Overall Study|Withdrawal by Subject|2|||
161499290|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
161925074|NCT05887908|584771032|FG000|Overall Study|Subject non-compliance|4|||
161499291|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
161499292|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
161499293|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
161499294|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
161499295|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
161499296|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
161499297|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
161499298|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
161499299|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
161499300|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
161499301|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
161499302|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
161499303|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
161499304|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
161499305|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
161499306|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
161499307|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
161499308|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
161925075|NCT05887908|584771033|FG001|Overall Study|Subject non-compliance|0|||
161499309|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
161499310|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
161499311|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
161499312|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
161499313|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
161499314|NCT00277212|583225262|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
161499315|NCT00277212|583225263|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
161499316|NCT00277212|583225264|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
161499317|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
161499318|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
161499319|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
161499320|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
161499321|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
161499322|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
161499323|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
161499324|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
161499325|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
161499326|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
161499327|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
161499328|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
161499329|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
161499330|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
161925076|NCT05887908|584771034|FG002|Overall Study|Subject non-compliance|4|||
161925077|NCT05887908|584771032|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
161925078|NCT05887908|584771033|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
161925079|NCT05887908|584771034|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
161499331|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
161499332|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
161499333|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
161499334|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
161499335|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
161499336|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
161499337|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
161499338|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
161499339|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
161499340|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
161499341|NCT00277212|583225262|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
161499342|NCT00277212|583225263|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
161499343|NCT00277212|583225264|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
161499344|NCT05620576|583225265|FG000|Overall Study|Adverse Event|1|||
161499345|NCT05620576|583225266|FG001|Overall Study|Adverse Event|1|||
161499346|NCT05620576|583225265|FG000|Overall Study|Lost to Follow-up|3|||
161499347|NCT05620576|583225266|FG001|Overall Study|Lost to Follow-up|1|||
161499348|NCT05620576|583225265|FG000|Overall Study|Physician Decision|0|||
161499349|NCT05620576|583225266|FG001|Overall Study|Physician Decision|1|||
161499350|NCT05620576|583225265|FG000|Overall Study|Protocol Deviation|1|||
161499351|NCT05620576|583225266|FG001|Overall Study|Protocol Deviation|1|||
161499352|NCT05620576|583225265|FG000|Overall Study|Withdrawal by Subject|2|||
161499353|NCT05620576|583225266|FG001|Overall Study|Withdrawal by Subject|3|||
161499354|NCT03336216|583225267|FG000|Randomization|Not reported|2|||
161499355|NCT03336216|583225268|FG001|Randomization|Not reported|0|||
161499356|NCT03336216|583225269|FG002|Randomization|Not reported|1|||
161499357|NCT03336216|583225270|FG003|Randomization|Not reported|0|||
161499358|NCT03336216|583225267|FG000|Randomization|Other reasons|1|||
161499359|NCT03336216|583225268|FG001|Randomization|Other reasons|1|||
161499360|NCT03336216|583225269|FG002|Randomization|Other reasons|1|||
161499361|NCT03336216|583225270|FG003|Randomization|Other reasons|0|||
161499362|NCT03336216|583225267|FG000|Randomization|Participant no longer meets study criteria|0|||
161585810|NCT00522951|583531863|FG001|Period 2|residual contrast medium|1|||
161585811|NCT00136435|583531867|FG000|Overall Study|Ineligible|8|||
161585812|NCT00136435|583531867|FG000|Overall Study|Induction Death|1|||
161585813|NCT00136435|583531867|FG000|Overall Study|Induction Failure|10|||
161585814|NCT00136435|583531867|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
161585815|NCT00136435|583531867|FG000|Overall Study|Withdrawal by Subject|3|||
161585816|NCT00136435|583531867|FG000|Overall Study|Adverse Event|19|||
161585817|NCT00136435|583531867|FG000|Overall Study|Relapse|4|||
161499363|NCT03336216|583225268|FG001|Randomization|Participant no longer meets study criteria|2|||
161499364|NCT03336216|583225269|FG002|Randomization|Participant no longer meets study criteria|4|||
161499365|NCT03336216|583225270|FG003|Randomization|Participant no longer meets study criteria|1|||
161499366|NCT03336216|583225267|FG000|Randomization|Lost to Follow-up|1|||
161585818|NCT00136435|583531867|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
161585819|NCT00390299|583531868|FG000|Overall Study|Cancellation|1|||
161585820|NCT00390299|583531869|FG001|Overall Study|Cancellation|0|||
161585821|NCT00390299|583531870|FG002|Overall Study|Cancellation|0|||
161585822|NCT00390299|583531871|FG003|Overall Study|Cancellation|0|||
161585823|NCT00390299|583531872|FG004|Overall Study|Cancellation|0|||
161585824|NCT00539734|583531873|FG000|Overall Study|Protocol Violation|1|||
161499367|NCT03336216|583225268|FG001|Randomization|Lost to Follow-up|0|||
161499368|NCT03336216|583225269|FG002|Randomization|Lost to Follow-up|0|||
161499369|NCT03336216|583225270|FG003|Randomization|Lost to Follow-up|0|||
161499370|NCT03336216|583225267|FG000|Randomization|Participant withdrew consent|9|||
161499371|NCT03336216|583225268|FG001|Randomization|Participant withdrew consent|1|||
161499372|NCT03336216|583225269|FG002|Randomization|Participant withdrew consent|0|||
161499373|NCT03336216|583225270|FG003|Randomization|Participant withdrew consent|0|||
161499374|NCT03336216|583225267|FG000|Randomization|Adverse Event|1|||
161499375|NCT03336216|583225268|FG001|Randomization|Adverse Event|1|||
161499376|NCT03336216|583225269|FG002|Randomization|Adverse Event|0|||
161499377|NCT03336216|583225270|FG003|Randomization|Adverse Event|0|||
161499378|NCT03336216|583225267|FG000|Treatment|Adverse Event|2|||
161499379|NCT03336216|583225268|FG001|Treatment|Adverse Event|3|||
161499380|NCT03336216|583225269|FG002|Treatment|Adverse Event|4|||
161499381|NCT03336216|583225270|FG003|Treatment|Adverse Event|4|||
161499382|NCT03336216|583225267|FG000|Treatment|Participant request to discontinue treatment|2|||
161499383|NCT03336216|583225268|FG001|Treatment|Participant request to discontinue treatment|1|||
161499384|NCT03336216|583225269|FG002|Treatment|Participant request to discontinue treatment|2|||
161499385|NCT03336216|583225270|FG003|Treatment|Participant request to discontinue treatment|2|||
161499386|NCT03336216|583225267|FG000|Treatment|Participant withdrew consent|7|||
161499387|NCT03336216|583225268|FG001|Treatment|Participant withdrew consent|2|||
161499388|NCT03336216|583225269|FG002|Treatment|Participant withdrew consent|3|||
161499389|NCT03336216|583225270|FG003|Treatment|Participant withdrew consent|2|||
161499390|NCT03336216|583225267|FG000|Treatment|Death|2|||
161499391|NCT03336216|583225268|FG001|Treatment|Death|3|||
161499392|NCT03336216|583225269|FG002|Treatment|Death|3|||
161499393|NCT03336216|583225270|FG003|Treatment|Death|4|||
161499394|NCT03336216|583225267|FG000|Treatment|Participant no longer meets study criteria|0|||
161499395|NCT03336216|583225268|FG001|Treatment|Participant no longer meets study criteria|1|||
161499396|NCT03336216|583225269|FG002|Treatment|Participant no longer meets study criteria|0|||
161499397|NCT03336216|583225270|FG003|Treatment|Participant no longer meets study criteria|0|||
161499398|NCT03336216|583225267|FG000|Treatment|Other reasons|2|||
161499399|NCT03336216|583225268|FG001|Treatment|Other reasons|0|||
161499400|NCT03336216|583225269|FG002|Treatment|Other reasons|0|||
161499401|NCT03336216|583225270|FG003|Treatment|Other reasons|3|||
161499402|NCT03336216|583225267|FG000|Treatment|Disease progression|23|||
161499403|NCT03336216|583225268|FG001|Treatment|Disease progression|34|||
161499404|NCT03336216|583225269|FG002|Treatment|Disease progression|33|||
161499405|NCT03336216|583225270|FG003|Treatment|Disease progression|26|||
161499406|NCT03336216|583225267|FG000|Treatment|Study drug toxicity|0|||
161499407|NCT03336216|583225268|FG001|Treatment|Study drug toxicity|3|||
161499408|NCT03336216|583225269|FG002|Treatment|Study drug toxicity|2|||
161499409|NCT03336216|583225270|FG003|Treatment|Study drug toxicity|0|||
161499410|NCT03336216|583225267|FG000|Treatment|Adverse Event unrelated to study drug|1|||
161499411|NCT03336216|583225268|FG001|Treatment|Adverse Event unrelated to study drug|1|||
161499412|NCT03336216|583225269|FG002|Treatment|Adverse Event unrelated to study drug|1|||
161499413|NCT03336216|583225270|FG003|Treatment|Adverse Event unrelated to study drug|0|||
161499414|NCT03336216|583225267|FG000|Treatment|Disease Recurrence|1|||
161499415|NCT03336216|583225268|FG001|Treatment|Disease Recurrence|0|||
161499416|NCT03336216|583225269|FG002|Treatment|Disease Recurrence|0|||
161499417|NCT03336216|583225270|FG003|Treatment|Disease Recurrence|0|||
161499418|NCT00922766|583225273|FG000|Overall Study|Death|3|||
161499419|NCT00922766|583225273|FG000|Overall Study|Withdrawal by Subject|2|||
161499420|NCT00922766|583225273|FG000|Overall Study|Other|1|||
161499421|NCT00922766|583225273|FG000|Overall Study|Adverse Event|1|||
161499422|NCT02622828|583225274|FG000|Overall Study|participant withdrew|3|||
161499423|NCT03616912|583225275|FG000|Overall Study|Adverse Event|17|||
161499424|NCT03616912|583225276|FG001|Overall Study|Adverse Event|21|||
161499425|NCT03616912|583225277|FG002|Overall Study|Adverse Event|9|||
161499426|NCT03616912|583225278|FG003|Overall Study|Adverse Event|0|||
161499427|NCT03616912|583225279|FG004|Overall Study|Adverse Event|0|||
161499428|NCT03616912|583225280|FG005|Overall Study|Adverse Event|0|||
161499429|NCT03616912|583225275|FG000|Overall Study|Death|1|||
161499430|NCT03616912|583225276|FG001|Overall Study|Death|1|||
161499431|NCT03616912|583225277|FG002|Overall Study|Death|0|||
161499432|NCT03616912|583225278|FG003|Overall Study|Death|0|||
161499433|NCT03616912|583225279|FG004|Overall Study|Death|0|||
161499434|NCT03616912|583225280|FG005|Overall Study|Death|0|||
161499435|NCT03616912|583225275|FG000|Overall Study|Lack of Efficacy|13|||
161499436|NCT03616912|583225276|FG001|Overall Study|Lack of Efficacy|6|||
161499437|NCT03616912|583225277|FG002|Overall Study|Lack of Efficacy|8|||
161499438|NCT03616912|583225278|FG003|Overall Study|Lack of Efficacy|4|||
161499439|NCT03616912|583225279|FG004|Overall Study|Lack of Efficacy|5|||
161499440|NCT03616912|583225280|FG005|Overall Study|Lack of Efficacy|1|||
161499441|NCT03616912|583225275|FG000|Overall Study|Lost to Follow-up|1|||
161499442|NCT03616912|583225276|FG001|Overall Study|Lost to Follow-up|2|||
161585825|NCT03101930|583531874|FG000|Overall Study|Withdrawal by Subject|2|||
161585826|NCT03101930|583531875|FG001|Overall Study|Withdrawal by Subject|1|||
161585827|NCT03101930|583531876|FG002|Overall Study|Withdrawal by Subject|2|||
161585828|NCT02814838|583531877|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
161673157|NCT04313153|583857894|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
161673158|NCT04313153|583857892|FG000|Overall Study|Change in Dialysis Modality|0|||
161673159|NCT04313153|583857893|FG001|Overall Study|Change in Dialysis Modality|1|||
161673160|NCT04313153|583857894|FG002|Overall Study|Change in Dialysis Modality|2|||
161673161|NCT04313153|583857892|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
161673162|NCT04313153|583857893|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
161673163|NCT04313153|583857894|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
161673164|NCT04313153|583857892|FG000|Overall Study|Other|5|||
161673165|NCT04313153|583857893|FG001|Overall Study|Other|3|||
161585829|NCT02814838|583531878|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
161585830|NCT02814838|583531877|FG000|Overall Study|Consent withdrawal|1|||
161673166|NCT04313153|583857894|FG002|Overall Study|Other|2|||
161673167|NCT05586269|583857895|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
161673168|NCT05586269|583857896|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
161673169|NCT05586269|583857897|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
161673170|NCT05586269|583857898|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
161673171|NCT05586269|583857895|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
161673172|NCT05586269|583857896|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
161673173|NCT05586269|583857897|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
161673174|NCT05586269|583857898|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
161673175|NCT01990534|583857902|FG000|Overall Study|Death|22|||
161818936|NCT01945580|584378178|FG000|Overall Study|Physician Decision|3|||
161585831|NCT02814838|583531878|FG001|Overall Study|Consent withdrawal|1|||
161585832|NCT01771731|583531882|FG000|Overall Study|Physician Decision|1|||
161585833|NCT01771731|583531883|FG001|Overall Study|Physician Decision|0|||
161585834|NCT01771731|583531882|FG000|Overall Study|Protocol Violation|0|||
161585835|NCT01771731|583531883|FG001|Overall Study|Protocol Violation|1|||
161585836|NCT01771731|583531882|FG000|Overall Study|Adverse event: Pain Crisis|1|||
161585837|NCT01771731|583531883|FG001|Overall Study|Adverse event: Pain Crisis|1|||
161585838|NCT00087139|583531884|FG000|Overall Study|Adverse Event|18|||
161585839|NCT00087139|583531885|FG001|Overall Study|Adverse Event|17|||
161585840|NCT00087139|583531886|FG002|Overall Study|Adverse Event|13|||
161585841|NCT00087139|583531884|FG000|Overall Study|Death|2|||
161585842|NCT00087139|583531885|FG001|Overall Study|Death|1|||
161585843|NCT00087139|583531886|FG002|Overall Study|Death|0|||
161585844|NCT00087139|583531884|FG000|Overall Study|Withdrawal by Subject|3|||
161585845|NCT00087139|583531885|FG001|Overall Study|Withdrawal by Subject|2|||
161585846|NCT00087139|583531886|FG002|Overall Study|Withdrawal by Subject|2|||
161585847|NCT00087139|583531884|FG000|Overall Study|Physician Decision|1|||
161585848|NCT00087139|583531885|FG001|Overall Study|Physician Decision|1|||
161585849|NCT00087139|583531886|FG002|Overall Study|Physician Decision|1|||
161585850|NCT00087139|583531884|FG000|Overall Study|Disease progression|9|||
161818937|NCT01945580|584378179|FG001|Overall Study|Physician Decision|2|||
161818938|NCT01945580|584378178|FG000|Overall Study|Lost to Follow-up|26|||
161818939|NCT01945580|584378179|FG001|Overall Study|Lost to Follow-up|39|||
161818940|NCT01945580|584378178|FG000|Overall Study|Death|7|||
161818941|NCT01945580|584378179|FG001|Overall Study|Death|2|||
161818942|NCT01945580|584378178|FG000|Overall Study|Patient moved out of state|0|||
161818943|NCT01945580|584378179|FG001|Overall Study|Patient moved out of state|1|||
161818944|NCT01945580|584378178|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
161818945|NCT01945580|584378179|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
161818946|NCT01945580|584378178|FG000|Overall Study|Family illness - unable to return|0|||
161925080|NCT05887908|584771032|FG000|Overall Study|Pregnancy|0|||
161585851|NCT00087139|583531885|FG001|Overall Study|Disease progression|19|||
161585852|NCT00087139|583531886|FG002|Overall Study|Disease progression|12|||
161585853|NCT00087139|583531884|FG000|Overall Study|Ineligible|4|||
161585854|NCT00087139|583531885|FG001|Overall Study|Ineligible|7|||
161585855|NCT00087139|583531886|FG002|Overall Study|Ineligible|4|||
161585856|NCT00087139|583531884|FG000|Overall Study|Symptomatic deterioration|1|||
161585857|NCT00087139|583531885|FG001|Overall Study|Symptomatic deterioration|1|||
161585858|NCT00087139|583531886|FG002|Overall Study|Symptomatic deterioration|3|||
161585859|NCT00087139|583531884|FG000|Overall Study|Use of coumadin|1|||
161585860|NCT00087139|583531885|FG001|Overall Study|Use of coumadin|0|||
161585861|NCT00087139|583531886|FG002|Overall Study|Use of coumadin|0|||
161585862|NCT00087139|583531884|FG000|Overall Study|Response achieved|0|||
161585863|NCT00087139|583531885|FG001|Overall Study|Response achieved|1|||
161585864|NCT00087139|583531886|FG002|Overall Study|Response achieved|0|||
161585865|NCT00087139|583531884|FG000|Overall Study|Extradural disease|0|||
161585866|NCT00087139|583531885|FG001|Overall Study|Extradural disease|0|||
161585867|NCT00087139|583531886|FG002|Overall Study|Extradural disease|1|||
161585868|NCT04095104|583531894|FG000|Overall Study|Withdrawal by Subject|0|||
161673176|NCT01990534|583857902|FG000|Overall Study|Progressive disease|3|||
161673177|NCT01990534|583857902|FG000|Overall Study|Protocol Violation|1|||
161673178|NCT01990534|583857902|FG000|Overall Study|Withdrawal of Informed Consent|2|||
161673179|NCT01990534|583857902|FG000|Overall Study|Symptomatic Deterioration|1|||
161673180|NCT01990534|583857902|FG000|Overall Study|Withdrawal by Subject|3|||
161673181|NCT01990534|583857902|FG000|Overall Study|Reason not Specified|2|||
161673182|NCT01990534|583857902|FG000|Overall Study|Lost to Follow-up|1|||
161673183|NCT01831544|583857903|FG000|Overall Study|Death|1|||
161673184|NCT01831544|583857903|FG000|Overall Study|Still on original MVAD device|2|||
161673185|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
161673186|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
161673187|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
161673188|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
161673189|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
161673190|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
161673191|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
161673192|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
161673193|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
161673194|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
161673195|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673196|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
161673197|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673198|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673199|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673200|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
161673201|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
161673202|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161673203|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161673204|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161673205|NCT03308942|583857906|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673206|NCT03308942|583857907|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673207|NCT03308942|583857908|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673208|NCT03308942|583857909|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
161673209|NCT03308942|583857910|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673210|NCT03308942|583857906|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673211|NCT03308942|583857907|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673212|NCT03308942|583857908|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673213|NCT03308942|583857909|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
161673214|NCT03308942|583857910|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673215|NCT03308942|583857906|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673216|NCT03308942|583857907|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673217|NCT03308942|583857908|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673218|NCT03308942|583857909|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
161673219|NCT03308942|583857910|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673220|NCT01131351|583857911|FG000|Overall Study|Adverse Event|0|||
161673221|NCT01131351|583857912|FG001|Overall Study|Adverse Event|2|||
161673222|NCT01131351|583857911|FG000|Overall Study|Protocol Deviation|0|||
161673223|NCT01131351|583857912|FG001|Overall Study|Protocol Deviation|1|||
161673224|NCT01284062|583857919|FG000|Overall Study|Adverse Event|4|||
161673225|NCT01284062|583857920|FG001|Overall Study|Adverse Event|5|||
161673226|NCT01284062|583857921|FG002|Overall Study|Adverse Event|0|||
161673227|NCT01284062|583857922|FG003|Overall Study|Adverse Event|5|||
161673228|NCT01284062|583857919|FG000|Overall Study|Lack of Efficacy|3|||
161673229|NCT01284062|583857920|FG001|Overall Study|Lack of Efficacy|2|||
161673230|NCT01284062|583857921|FG002|Overall Study|Lack of Efficacy|2|||
161673231|NCT01284062|583857922|FG003|Overall Study|Lack of Efficacy|1|||
161673232|NCT01284062|583857919|FG000|Overall Study|Medication error without adverse event|0|||
161673233|NCT01284062|583857920|FG001|Overall Study|Medication error without adverse event|0|||
161673234|NCT01284062|583857921|FG002|Overall Study|Medication error without adverse event|1|||
161673235|NCT01284062|583857922|FG003|Overall Study|Medication error without adverse event|0|||
161673236|NCT01284062|583857919|FG000|Overall Study|Protocol Violation|1|||
161818947|NCT01945580|584378179|FG001|Overall Study|Family illness - unable to return|1|||
161818948|NCT01945580|584378178|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
161818949|NCT01945580|584378179|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
161818950|NCT01945580|584378178|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
161818951|NCT01945580|584378179|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
161818952|NCT01945580|584378178|FG000|Overall Study|Noncompliance with 36 month visit|1|||
161673237|NCT01284062|583857920|FG001|Overall Study|Protocol Violation|0|||
161673238|NCT01284062|583857921|FG002|Overall Study|Protocol Violation|0|||
161499443|NCT03616912|583225277|FG002|Overall Study|Lost to Follow-up|3|||
161499444|NCT03616912|583225278|FG003|Overall Study|Lost to Follow-up|0|||
161499445|NCT03616912|583225279|FG004|Overall Study|Lost to Follow-up|0|||
161499446|NCT03616912|583225280|FG005|Overall Study|Lost to Follow-up|0|||
161499447|NCT03616912|583225275|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
161499448|NCT03616912|583225276|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
161818953|NCT01945580|584378179|FG001|Overall Study|Noncompliance with 36 month visit|0|||
161818954|NCT01945580|584378178|FG000|Overall Study|The patient moved.|1|||
161499449|NCT03616912|583225277|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
161499450|NCT03616912|583225278|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
161499451|NCT03616912|583225279|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
161499452|NCT03616912|583225280|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
161499453|NCT03616912|583225275|FG000|Overall Study|Withdrawal by Subject|12|||
161499454|NCT03616912|583225276|FG001|Overall Study|Withdrawal by Subject|12|||
161499455|NCT03616912|583225277|FG002|Overall Study|Withdrawal by Subject|15|||
161499456|NCT03616912|583225278|FG003|Overall Study|Withdrawal by Subject|2|||
161499457|NCT03616912|583225279|FG004|Overall Study|Withdrawal by Subject|0|||
161499458|NCT03616912|583225280|FG005|Overall Study|Withdrawal by Subject|2|||
161499459|NCT03616912|583225275|FG000|Overall Study|Study Terminated by Sponsor|0|||
161499460|NCT03616912|583225276|FG001|Overall Study|Study Terminated by Sponsor|0|||
161499461|NCT03616912|583225277|FG002|Overall Study|Study Terminated by Sponsor|0|||
161499462|NCT03616912|583225278|FG003|Overall Study|Study Terminated by Sponsor|10|||
161499463|NCT03616912|583225279|FG004|Overall Study|Study Terminated by Sponsor|9|||
161499464|NCT03616912|583225280|FG005|Overall Study|Study Terminated by Sponsor|11|||
161499465|NCT03616912|583225275|FG000|Overall Study|Protocol Deviation|1|||
161499466|NCT03616912|583225276|FG001|Overall Study|Protocol Deviation|1|||
161499467|NCT03616912|583225277|FG002|Overall Study|Protocol Deviation|0|||
161499468|NCT03616912|583225278|FG003|Overall Study|Protocol Deviation|0|||
161499469|NCT03616912|583225279|FG004|Overall Study|Protocol Deviation|0|||
161499470|NCT03616912|583225280|FG005|Overall Study|Protocol Deviation|0|||
161499471|NCT03616912|583225275|FG000|Overall Study|Pregnancy|1|||
161499472|NCT03616912|583225276|FG001|Overall Study|Pregnancy|0|||
161499473|NCT03616912|583225277|FG002|Overall Study|Pregnancy|4|||
161499474|NCT03616912|583225278|FG003|Overall Study|Pregnancy|0|||
161499475|NCT03616912|583225279|FG004|Overall Study|Pregnancy|0|||
161499476|NCT03616912|583225280|FG005|Overall Study|Pregnancy|0|||
161499477|NCT03616912|583225275|FG000|Overall Study|Protocol Violation|1|||
161499478|NCT03616912|583225276|FG001|Overall Study|Protocol Violation|0|||
161499479|NCT03616912|583225277|FG002|Overall Study|Protocol Violation|2|||
161499480|NCT03616912|583225278|FG003|Overall Study|Protocol Violation|0|||
161499481|NCT03616912|583225279|FG004|Overall Study|Protocol Violation|0|||
161499482|NCT03616912|583225280|FG005|Overall Study|Protocol Violation|0|||
161499483|NCT03616912|583225275|FG000|Overall Study|Physician Decision|2|||
161499484|NCT03616912|583225276|FG001|Overall Study|Physician Decision|0|||
161499485|NCT03616912|583225277|FG002|Overall Study|Physician Decision|0|||
161499486|NCT03616912|583225278|FG003|Overall Study|Physician Decision|0|||
161499487|NCT03616912|583225279|FG004|Overall Study|Physician Decision|1|||
161499488|NCT03616912|583225280|FG005|Overall Study|Physician Decision|0|||
161499489|NCT03616912|583225275|FG000|Overall Study|Randomized But Never Treated|0|||
161499490|NCT03616912|583225276|FG001|Overall Study|Randomized But Never Treated|2|||
161499491|NCT03616912|583225277|FG002|Overall Study|Randomized But Never Treated|0|||
161499492|NCT03616912|583225278|FG003|Overall Study|Randomized But Never Treated|0|||
161499493|NCT03616912|583225279|FG004|Overall Study|Randomized But Never Treated|0|||
161499494|NCT03616912|583225280|FG005|Overall Study|Randomized But Never Treated|0|||
161499495|NCT01124604|583225281|FG000|Overall Study|Adverse Event|10|||
161499496|NCT01124604|583225282|FG001|Overall Study|Adverse Event|1|||
161499497|NCT01124604|583225281|FG000|Overall Study|Lack of Efficacy|1|||
161499498|NCT01124604|583225282|FG001|Overall Study|Lack of Efficacy|0|||
161499499|NCT01124604|583225281|FG000|Overall Study|Withdrawal by Subject|4|||
161818955|NCT01945580|584378179|FG001|Overall Study|The patient moved.|0|||
161499500|NCT01124604|583225282|FG001|Overall Study|Withdrawal by Subject|0|||
161499501|NCT01124604|583225281|FG000|Overall Study|Disease Progression|0|||
161499502|NCT01124604|583225282|FG001|Overall Study|Disease Progression|1|||
161499503|NCT01859507|583225283|FG000|Overall Study|left the country|4|||
161499504|NCT01762943|583225284|FG000|Overall Study|Physician Decision|1|||
161499505|NCT01762943|583225285|FG001|Overall Study|Physician Decision|1|||
161499506|NCT01762943|583225284|FG000|Overall Study|Protocol Violation|1|||
161499507|NCT01762943|583225285|FG001|Overall Study|Protocol Violation|0|||
161499508|NCT01762943|583225284|FG000|Overall Study|Withdrawal by Subject|2|||
161499509|NCT01762943|583225285|FG001|Overall Study|Withdrawal by Subject|1|||
161499510|NCT00539838|583225286|FG000|Overall Study|Fail to return|2|||
161499511|NCT00539838|583225287|FG001|Overall Study|Fail to return|0|||
161499512|NCT00539838|583225288|FG002|Overall Study|Fail to return|0|||
161499513|NCT00539838|583225286|FG000|Overall Study|Withdrawal by Subject|0|||
161499514|NCT00539838|583225287|FG001|Overall Study|Withdrawal by Subject|4|||
161499515|NCT00539838|583225288|FG002|Overall Study|Withdrawal by Subject|0|||
161499516|NCT00539838|583225286|FG000|Overall Study|Death|0|||
161499517|NCT00539838|583225287|FG001|Overall Study|Death|2|||
161499518|NCT00539838|583225288|FG002|Overall Study|Death|0|||
161499519|NCT00539838|583225286|FG000|Overall Study|Did not cooperate|1|||
161499520|NCT00539838|583225287|FG001|Overall Study|Did not cooperate|0|||
161499521|NCT00539838|583225288|FG002|Overall Study|Did not cooperate|1|||
161499522|NCT00539838|583225286|FG000|Overall Study|Administrative|4|||
161499523|NCT00539838|583225287|FG001|Overall Study|Administrative|0|||
161499524|NCT00539838|583225288|FG002|Overall Study|Administrative|8|||
161499525|NCT02474199|583225292|FG000|Overall Study|Lost to Follow-up|1|||
161499526|NCT02474199|583225293|FG001|Overall Study|Lost to Follow-up|0|||
161499527|NCT02474199|583225294|FG002|Overall Study|Lost to Follow-up|0|||
161499528|NCT02474199|583225295|FG003|Overall Study|Lost to Follow-up|0|||
161499529|NCT02474199|583225292|FG000|Overall Study|Withdrawal by Subject|1|||
161499530|NCT02474199|583225293|FG001|Overall Study|Withdrawal by Subject|2|||
161499531|NCT02474199|583225294|FG002|Overall Study|Withdrawal by Subject|0|||
161499532|NCT02474199|583225295|FG003|Overall Study|Withdrawal by Subject|1|||
161499533|NCT02474199|583225292|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
161499534|NCT02474199|583225293|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
161499535|NCT02474199|583225294|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
161499536|NCT02474199|583225295|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
161499537|NCT02474199|583225292|FG000|Overall Study|Did not meet eligibility criteria|0|||
161499538|NCT02474199|583225293|FG001|Overall Study|Did not meet eligibility criteria|0|||
161499539|NCT02474199|583225294|FG002|Overall Study|Did not meet eligibility criteria|2|||
161499540|NCT02474199|583225295|FG003|Overall Study|Did not meet eligibility criteria|2|||
161499541|NCT03090100|583225296|FG000|Overall Study|Adverse Event|9|||
161499542|NCT03090100|583225297|FG001|Overall Study|Adverse Event|11|||
161499543|NCT03090100|583225296|FG000|Overall Study|Pregnancy|1|||
161499544|NCT03090100|583225297|FG001|Overall Study|Pregnancy|1|||
161499545|NCT03090100|583225296|FG000|Overall Study|Lack of Efficacy|2|||
161499546|NCT03090100|583225297|FG001|Overall Study|Lack of Efficacy|7|||
161499547|NCT03090100|583225296|FG000|Overall Study|Lost to Follow-up|2|||
161499548|NCT03090100|583225297|FG001|Overall Study|Lost to Follow-up|2|||
161499549|NCT03090100|583225296|FG000|Overall Study|Withdrawal by Subject|7|||
161499550|NCT03090100|583225297|FG001|Overall Study|Withdrawal by Subject|19|||
161499551|NCT03090100|583225296|FG000|Overall Study|Protocol Violation|2|||
161499552|NCT03090100|583225297|FG001|Overall Study|Protocol Violation|6|||
161499553|NCT03090100|583225296|FG000|Overall Study|Non-compliance|2|||
161499554|NCT03090100|583225297|FG001|Overall Study|Non-compliance|0|||
161499555|NCT03090100|583225296|FG000|Overall Study|Other|2|||
161499556|NCT03090100|583225297|FG001|Overall Study|Other|2|||
161499557|NCT00159588|583225300|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
161499558|NCT00159588|583225301|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
161499559|NCT00159588|583225302|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
161499560|NCT00456521|583225303|FG000|Overall Study|Adverse Event|150|||
161925081|NCT05887908|584771033|FG001|Overall Study|Pregnancy|1|||
161499561|NCT00456521|583225304|FG001|Overall Study|Adverse Event|25|||
161499562|NCT00456521|583225303|FG000|Overall Study|Withdrawal by Subject|43|||
161499563|NCT00456521|583225304|FG001|Overall Study|Withdrawal by Subject|24|||
161499564|NCT00456521|583225303|FG000|Overall Study|Lost to Follow-up|22|||
161499565|NCT00456521|583225304|FG001|Overall Study|Lost to Follow-up|17|||
161499566|NCT00456521|583225303|FG000|Overall Study|Lack of Efficacy|3|||
161499567|NCT00456521|583225304|FG001|Overall Study|Lack of Efficacy|6|||
161499568|NCT00456521|583225303|FG000|Overall Study|Protocol Violation|4|||
161499569|NCT00456521|583225304|FG001|Overall Study|Protocol Violation|0|||
161499570|NCT00456521|583225303|FG000|Overall Study|Pregnancy|1|||
161499571|NCT00456521|583225304|FG001|Overall Study|Pregnancy|1|||
161499572|NCT00456521|583225303|FG000|Overall Study|Drug non-compliance, moved, other|26|||
161499573|NCT00456521|583225304|FG001|Overall Study|Drug non-compliance, moved, other|11|||
161925082|NCT05887908|584771034|FG002|Overall Study|Pregnancy|0|||
161925083|NCT05887908|584771032|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
161925084|NCT05887908|584771033|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
161925085|NCT05887908|584771034|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
161499574|NCT02596854|583225305|FG000|Overall Study|Withdrawn|8|||
161499575|NCT03406858|583225308|FG000|Overall Study|Failure to receive treatment drug.|1|||
161499576|NCT03406858|583225308|FG000|Overall Study|ineligible|1|||
161499577|NCT00405587|583225309|FG000|Overall Study|Death|0|||
161499578|NCT00405587|583225310|FG001|Overall Study|Death|0|||
161499579|NCT00405587|583225311|FG002|Overall Study|Death|0|||
161499580|NCT00405587|583225312|FG003|Overall Study|Death|1|||
161499581|NCT00405587|583225309|FG000|Overall Study|Disease Progression|22|||
161499582|NCT00405587|583225310|FG001|Overall Study|Disease Progression|23|||
161499583|NCT00405587|583225311|FG002|Overall Study|Disease Progression|21|||
161499584|NCT00405587|583225312|FG003|Overall Study|Disease Progression|17|||
161499585|NCT00405587|583225309|FG000|Overall Study|Physician Decision|3|||
161499586|NCT00405587|583225310|FG001|Overall Study|Physician Decision|2|||
161499587|NCT00405587|583225311|FG002|Overall Study|Physician Decision|0|||
161499588|NCT00405587|583225312|FG003|Overall Study|Physician Decision|0|||
161499589|NCT00405587|583225309|FG000|Overall Study|Adverse Event|1|||
161499590|NCT00405587|583225310|FG001|Overall Study|Adverse Event|0|||
161499591|NCT00405587|583225311|FG002|Overall Study|Adverse Event|0|||
161499592|NCT00405587|583225312|FG003|Overall Study|Adverse Event|0|||
161499593|NCT00405587|583225309|FG000|Overall Study|Lost to Follow-up|0|||
161499594|NCT00405587|583225310|FG001|Overall Study|Lost to Follow-up|1|||
161499595|NCT00405587|583225311|FG002|Overall Study|Lost to Follow-up|1|||
161499596|NCT00405587|583225312|FG003|Overall Study|Lost to Follow-up|0|||
161499597|NCT00405587|583225309|FG000|Overall Study|Radiation induced necrosis|0|||
161499598|NCT00405587|583225310|FG001|Overall Study|Radiation induced necrosis|1|||
161499599|NCT00405587|583225311|FG002|Overall Study|Radiation induced necrosis|0|||
161499600|NCT00405587|583225312|FG003|Overall Study|Radiation induced necrosis|0|||
161499601|NCT00405587|583225309|FG000|Overall Study|Withdrawal by Subject|0|||
161499602|NCT00405587|583225310|FG001|Overall Study|Withdrawal by Subject|0|||
161499603|NCT00405587|583225311|FG002|Overall Study|Withdrawal by Subject|0|||
161499604|NCT00405587|583225312|FG003|Overall Study|Withdrawal by Subject|2|||
161499605|NCT00405587|583225309|FG000|Overall Study|Participant not dosed|0|||
161499606|NCT00405587|583225310|FG001|Overall Study|Participant not dosed|1|||
161499607|NCT00405587|583225311|FG002|Overall Study|Participant not dosed|0|||
161499608|NCT00405587|583225312|FG003|Overall Study|Participant not dosed|0|||
161499609|NCT06027866|583225313|FG000|Overall Study|Withdrawal by Subject|2|||
161499610|NCT00507442|583225316|FG000|Overall Study|Adverse Event|8|||
161499611|NCT00507442|583225317|FG001|Overall Study|Adverse Event|11|||
161499612|NCT00507442|583225318|FG002|Overall Study|Adverse Event|4|||
161499613|NCT00507442|583225319|FG003|Overall Study|Adverse Event|1|||
161499614|NCT00507442|583225316|FG000|Overall Study|Protocol Violation|0|||
161499615|NCT00507442|583225317|FG001|Overall Study|Protocol Violation|1|||
161499616|NCT00507442|583225318|FG002|Overall Study|Protocol Violation|0|||
161499617|NCT00507442|583225319|FG003|Overall Study|Protocol Violation|0|||
161499618|NCT00507442|583225316|FG000|Overall Study|Lost to Follow-up|0|||
161499619|NCT00507442|583225317|FG001|Overall Study|Lost to Follow-up|0|||
161499620|NCT00507442|583225318|FG002|Overall Study|Lost to Follow-up|1|||
161499621|NCT00507442|583225319|FG003|Overall Study|Lost to Follow-up|0|||
161499622|NCT00507442|583225316|FG000|Overall Study|Physician Decision|0|||
161499623|NCT00507442|583225317|FG001|Overall Study|Physician Decision|2|||
161499624|NCT00507442|583225318|FG002|Overall Study|Physician Decision|4|||
161499625|NCT00507442|583225319|FG003|Overall Study|Physician Decision|1|||
161499626|NCT00507442|583225316|FG000|Overall Study|Progressive Disease|2|||
161499627|NCT00507442|583225317|FG001|Overall Study|Progressive Disease|4|||
161499628|NCT00507442|583225318|FG002|Overall Study|Progressive Disease|2|||
161499629|NCT00507442|583225319|FG003|Overall Study|Progressive Disease|0|||
161499630|NCT00507442|583225316|FG000|Overall Study|Withdrawal by Subject|4|||
161499631|NCT00507442|583225317|FG001|Overall Study|Withdrawal by Subject|4|||
161499632|NCT00507442|583225318|FG002|Overall Study|Withdrawal by Subject|2|||
161499633|NCT00507442|583225319|FG003|Overall Study|Withdrawal by Subject|1|||
161499634|NCT00507442|583225316|FG000|Overall Study|Other|2|||
161499635|NCT00507442|583225317|FG001|Overall Study|Other|5|||
161499636|NCT00507442|583225318|FG002|Overall Study|Other|2|||
161499637|NCT00507442|583225319|FG003|Overall Study|Other|2|||
161499638|NCT02672423|583225321|FG000|Period 1|Adverse Event|0|||
161499639|NCT02672423|583225322|FG001|Period 1|Adverse Event|0|||
161499640|NCT02672423|583225323|FG002|Period 1|Adverse Event|0|||
161499641|NCT02672423|583225324|FG003|Period 1|Adverse Event|0|||
161499642|NCT02672423|583225325|FG004|Period 1|Adverse Event|1|||
161499643|NCT02672423|583225326|FG005|Period 1|Adverse Event|0|||
161499644|NCT02672423|583225327|FG006|Period 1|Adverse Event|0|||
161499645|NCT02672423|583225328|FG007|Period 1|Adverse Event|0|||
161499646|NCT02672423|583225329|FG008|Period 1|Adverse Event|0|||
161499647|NCT02672423|583225330|FG009|Period 1|Adverse Event|0|||
161499648|NCT02672423|583225321|FG000|Period 2|Withdrawal by Subject|0|||
161499649|NCT02672423|583225322|FG001|Period 2|Withdrawal by Subject|0|||
161499650|NCT02672423|583225323|FG002|Period 2|Withdrawal by Subject|1|||
161499651|NCT02672423|583225324|FG003|Period 2|Withdrawal by Subject|0|||
161499652|NCT02672423|583225325|FG004|Period 2|Withdrawal by Subject|0|||
161499653|NCT02672423|583225326|FG005|Period 2|Withdrawal by Subject|0|||
161499654|NCT02672423|583225327|FG006|Period 2|Withdrawal by Subject|0|||
161499655|NCT02672423|583225328|FG007|Period 2|Withdrawal by Subject|0|||
161499656|NCT02672423|583225329|FG008|Period 2|Withdrawal by Subject|0|||
161499657|NCT02672423|583225330|FG009|Period 2|Withdrawal by Subject|0|||
161499658|NCT02672423|583225321|FG000|Period 3|Withdrawal by Subject|0|||
161818956|NCT01945580|584378178|FG000|Overall Study|No data available|0|||
161818957|NCT01945580|584378179|FG001|Overall Study|No data available|2|||
161818958|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
161818959|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
161499659|NCT02672423|583225322|FG001|Period 3|Withdrawal by Subject|0|||
161499660|NCT02672423|583225323|FG002|Period 3|Withdrawal by Subject|0|||
161499661|NCT02672423|583225324|FG003|Period 3|Withdrawal by Subject|0|||
161499662|NCT02672423|583225325|FG004|Period 3|Withdrawal by Subject|0|||
161499663|NCT02672423|583225326|FG005|Period 3|Withdrawal by Subject|0|||
161499664|NCT02672423|583225327|FG006|Period 3|Withdrawal by Subject|0|||
161499665|NCT02672423|583225328|FG007|Period 3|Withdrawal by Subject|1|||
161499666|NCT02672423|583225329|FG008|Period 3|Withdrawal by Subject|0|||
161499667|NCT02672423|583225330|FG009|Period 3|Withdrawal by Subject|0|||
161499668|NCT02672423|583225321|FG000|Period 3|Physician Decision|0|||
161499669|NCT02672423|583225322|FG001|Period 3|Physician Decision|0|||
161499670|NCT02672423|583225323|FG002|Period 3|Physician Decision|0|||
161499671|NCT02672423|583225324|FG003|Period 3|Physician Decision|0|||
161499672|NCT02672423|583225325|FG004|Period 3|Physician Decision|0|||
161499673|NCT02672423|583225326|FG005|Period 3|Physician Decision|1|||
161499674|NCT02672423|583225327|FG006|Period 3|Physician Decision|0|||
161499675|NCT02672423|583225328|FG007|Period 3|Physician Decision|0|||
161499676|NCT02672423|583225329|FG008|Period 3|Physician Decision|0|||
161499677|NCT02672423|583225330|FG009|Period 3|Physician Decision|0|||
161499678|NCT00325754|583225331|FG000|Overall Study|Adverse Event|4|||
161499679|NCT00325754|583225332|FG001|Overall Study|Adverse Event|1|||
161499680|NCT01852812|583225336|FG000|Overall Study|Adverse Event|0|||
161499681|NCT01852812|583225337|FG001|Overall Study|Adverse Event|0|||
161499682|NCT01852812|583225338|FG002|Overall Study|Adverse Event|1|||
161499683|NCT01852812|583225336|FG000|Overall Study|Non-compliance With Study Drug|0|||
161499684|NCT01852812|583225337|FG001|Overall Study|Non-compliance With Study Drug|1|||
161499685|NCT01852812|583225338|FG002|Overall Study|Non-compliance With Study Drug|0|||
161499686|NCT02625090|583225343|FG000|Overall Study|Participant wants to be pregnant|2|||
161499687|NCT02625090|583225343|FG000|Overall Study|For the Promoter|1|||
161499688|NCT02625090|583225343|FG000|Overall Study|Sponsor's Decision|9|||
161499689|NCT02625090|583225343|FG000|Overall Study|Somnolence|1|||
161499690|NCT02625090|583225343|FG000|Overall Study|Study terminated by Sponsor|7|||
161499691|NCT02625090|583225343|FG000|Overall Study|Negative Benefit/Risk|1|||
161499692|NCT02625090|583225343|FG000|Overall Study|Protocol Deviation|2|||
161499693|NCT02625090|583225343|FG000|Overall Study|Lack of Efficacy|16|||
161499694|NCT02625090|583225343|FG000|Overall Study|Adverse Event|3|||
161499695|NCT03168464|583225344|FG000|Overall Study|Death|9|||
161499696|NCT03168464|583225344|FG000|Overall Study|Progression of disease|6|||
161499697|NCT02250443|583225345|FG000|Overall Study|Administrative problems|7|||
161499698|NCT02250443|583225345|FG000|Overall Study|Adverse Event|3|||
161499699|NCT01549964|583225346|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
161499700|NCT01549964|583225347|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
161499701|NCT01549964|583225348|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
161499702|NCT01549964|583225349|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
161499703|NCT01549964|583225346|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
161499704|NCT01549964|583225347|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
161499705|NCT01549964|583225348|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
161499706|NCT01549964|583225349|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
161499707|NCT01549964|583225346|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
161499708|NCT01549964|583225347|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
161499709|NCT01549964|583225348|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
161499710|NCT01549964|583225349|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
161499711|NCT01549964|583225346|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
161499712|NCT01549964|583225347|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
161499713|NCT01549964|583225348|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
161499714|NCT01549964|583225349|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
161499715|NCT01549964|583225346|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
161499716|NCT01549964|583225347|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
161499717|NCT01549964|583225348|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
161499718|NCT01549964|583225349|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
161499719|NCT01549964|583225346|FG000|24-Week Treatment Period|Other|1|||
161499720|NCT01549964|583225347|FG001|24-Week Treatment Period|Other|0|||
161499721|NCT01549964|583225348|FG002|24-Week Treatment Period|Other|1|||
161499722|NCT01549964|583225349|FG003|24-Week Treatment Period|Other|0|||
161499723|NCT01549964|583225346|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
161499724|NCT01549964|583225347|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
161499725|NCT01549964|583225348|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
161499726|NCT01549964|583225349|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
161499727|NCT01549964|583225346|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
161499728|NCT01549964|583225347|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
161499729|NCT01549964|583225348|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
161499730|NCT01549964|583225349|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
161499731|NCT01549964|583225346|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
161499732|NCT01549964|583225347|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
161499733|NCT01549964|583225348|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
161499734|NCT01549964|583225349|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
161499735|NCT01549964|583225346|FG000|80-Week Extension Period|Pregnancy|0|||
161499736|NCT01549964|583225347|FG001|80-Week Extension Period|Pregnancy|0|||
161499737|NCT01549964|583225348|FG002|80-Week Extension Period|Pregnancy|1|||
161499738|NCT01549964|583225349|FG003|80-Week Extension Period|Pregnancy|0|||
161499739|NCT01549964|583225346|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
161499740|NCT01549964|583225347|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
161499741|NCT01549964|583225348|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
161499742|NCT01549964|583225349|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
161499743|NCT01549964|583225346|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
161499744|NCT01549964|583225347|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
161499745|NCT01549964|583225348|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
161499746|NCT01549964|583225349|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
161499747|NCT01549964|583225346|FG000|80-Week Extension Period|Lost to Follow-up|1|||
161499748|NCT01549964|583225347|FG001|80-Week Extension Period|Lost to Follow-up|0|||
161499749|NCT01549964|583225348|FG002|80-Week Extension Period|Lost to Follow-up|2|||
161499750|NCT01549964|583225349|FG003|80-Week Extension Period|Lost to Follow-up|1|||
161499751|NCT01549964|583225346|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
161499752|NCT01549964|583225347|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
161499753|NCT01549964|583225348|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
161499754|NCT01549964|583225349|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
161499755|NCT00634088|583225350|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
161499756|NCT00634088|583225351|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
161499757|NCT00634088|583225352|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
161499758|NCT00634088|583225353|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
161499759|NCT00634088|583225350|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
161499760|NCT00634088|583225351|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
161499761|NCT00634088|583225352|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
161499762|NCT00634088|583225353|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
161499763|NCT00634088|583225350|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
161499764|NCT00634088|583225351|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
161499765|NCT00634088|583225352|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
161499766|NCT00634088|583225353|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
161499767|NCT00634088|583225350|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
161499768|NCT00634088|583225351|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
161499769|NCT00634088|583225352|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
161499770|NCT00634088|583225353|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
161499771|NCT00634088|583225350|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
161499772|NCT00634088|583225351|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
161499773|NCT00634088|583225352|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
161499774|NCT00634088|583225353|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
161499775|NCT00634088|583225350|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
161499776|NCT00634088|583225351|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
161499777|NCT00634088|583225352|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
161499778|NCT00634088|583225353|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
161499779|NCT02290821|583225356|FG000|Overall Study|Withdrawal by Subject|1|||
161499780|NCT02290821|583225357|FG001|Overall Study|Withdrawal by Subject|1|||
161499781|NCT02290821|583225356|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
161499782|NCT02290821|583225357|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
161499783|NCT02290821|583225356|FG000|Overall Study|Lost to Follow-up|3|||
161499784|NCT02290821|583225357|FG001|Overall Study|Lost to Follow-up|2|||
161499785|NCT02438722|583225362|FG000|Overall Study|Adverse Event|12|||
161499786|NCT02438722|583225363|FG001|Overall Study|Adverse Event|9|||
161499787|NCT02438722|583225362|FG000|Overall Study|Refusal unrelated to AE|2|||
161499788|NCT02438722|583225363|FG001|Overall Study|Refusal unrelated to AE|5|||
161499789|NCT02438722|583225362|FG000|Overall Study|Disease progression/relapse|46|||
161499790|NCT02438722|583225363|FG001|Overall Study|Disease progression/relapse|51|||
161499791|NCT02438722|583225362|FG000|Overall Study|Death|0|||
161499792|NCT02438722|583225363|FG001|Overall Study|Death|3|||
161499793|NCT02438722|583225362|FG000|Overall Study|Physician Decision|2|||
161499794|NCT02438722|583225363|FG001|Overall Study|Physician Decision|2|||
161499795|NCT02438722|583225362|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
161499796|NCT02438722|583225363|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
161585869|NCT04095104|583531895|FG001|Overall Study|Withdrawal by Subject|1|||
161585870|NCT01136876|583531896|FG000|Overall Study|Lost to Follow-up|0|||
161499797|NCT02438722|583225362|FG000|Overall Study|Withdrawal by Subject|0|||
161499798|NCT02438722|583225363|FG001|Overall Study|Withdrawal by Subject|1|||
161499799|NCT02438722|583225362|FG000|Overall Study|On protocol treatment|15|||
161499800|NCT02438722|583225363|FG001|Overall Study|On protocol treatment|14|||
161499801|NCT02438722|583225362|FG000|Overall Study|Did not receive protocol treatment|5|||
161499802|NCT02438722|583225363|FG001|Overall Study|Did not receive protocol treatment|0|||
161499803|NCT03343483|583225364|FG000|Overall Study|Death|0|||
161499804|NCT03343483|583225365|FG001|Overall Study|Death|3|||
161499805|NCT03343483|583225364|FG000|Overall Study|Lost to Follow-up|9|||
161499806|NCT03343483|583225365|FG001|Overall Study|Lost to Follow-up|13|||
161499807|NCT03343483|583225364|FG000|Overall Study|Withdrawal by Subject|8|||
161585871|NCT01136876|583531897|FG001|Overall Study|Lost to Follow-up|1|||
161499808|NCT03343483|583225365|FG001|Overall Study|Withdrawal by Subject|17|||
161499809|NCT01488097|583225368|FG000|Overall Study|Lost to Follow-up|1|||
161499810|NCT01577758|583225369|FG000|Dose Escalation Phase|Adverse Event|0|||
161499811|NCT01577758|583225370|FG001|Dose Escalation Phase|Adverse Event|0|||
161499812|NCT01577758|583225371|FG002|Dose Escalation Phase|Adverse Event|0|||
161499813|NCT01577758|583225372|FG003|Dose Escalation Phase|Adverse Event|0|||
161499814|NCT01577758|583225373|FG004|Dose Escalation Phase|Adverse Event|0|||
161499815|NCT01577758|583225374|FG005|Dose Escalation Phase|Adverse Event|2|||
161499816|NCT01577758|583225375|FG006|Dose Escalation Phase|Adverse Event|1|||
161499817|NCT01577758|583225376|FG007|Dose Escalation Phase|Adverse Event|0|||
161499818|NCT01577758|583225369|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
161499819|NCT01577758|583225370|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
161499820|NCT01577758|583225371|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
161499821|NCT01577758|583225372|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
161499822|NCT01577758|583225373|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
161499823|NCT01577758|583225374|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
161499824|NCT01577758|583225375|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
161499825|NCT01577758|583225376|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
161499826|NCT01577758|583225369|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161499827|NCT01577758|583225370|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161499828|NCT01577758|583225371|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161499829|NCT01577758|583225372|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161499830|NCT01577758|583225373|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
161499831|NCT01577758|583225374|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
161499832|NCT01577758|583225375|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
161499833|NCT01577758|583225376|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
161499834|NCT01577758|583225369|FG000|Dose Escalation Phase|Progression Disease|2|||
161499835|NCT01577758|583225370|FG001|Dose Escalation Phase|Progression Disease|2|||
161499836|NCT01577758|583225371|FG002|Dose Escalation Phase|Progression Disease|1|||
161499837|NCT01577758|583225372|FG003|Dose Escalation Phase|Progression Disease|2|||
161499838|NCT01577758|583225373|FG004|Dose Escalation Phase|Progression Disease|5|||
161499839|NCT01577758|583225374|FG005|Dose Escalation Phase|Progression Disease|0|||
161499840|NCT01577758|583225375|FG006|Dose Escalation Phase|Progression Disease|0|||
161499841|NCT01577758|583225376|FG007|Dose Escalation Phase|Progression Disease|0|||
161499842|NCT01577758|583225369|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499843|NCT01577758|583225370|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499844|NCT01577758|583225371|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499845|NCT01577758|583225372|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499846|NCT01577758|583225373|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499847|NCT01577758|583225374|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499848|NCT01577758|583225375|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
161499849|NCT01577758|583225376|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
161499850|NCT01577758|583225369|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499851|NCT01577758|583225370|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499852|NCT01577758|583225371|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499853|NCT01577758|583225372|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499854|NCT01577758|583225373|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499855|NCT01577758|583225374|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499856|NCT01577758|583225375|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
161499857|NCT01577758|583225376|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
161499858|NCT01577758|583225369|FG000|mCRC Expansion Phase|Progression Disease|0|||
161499859|NCT01577758|583225370|FG001|mCRC Expansion Phase|Progression Disease|0|||
161499860|NCT01577758|583225371|FG002|mCRC Expansion Phase|Progression Disease|0|||
161499861|NCT01577758|583225372|FG003|mCRC Expansion Phase|Progression Disease|0|||
161499862|NCT01577758|583225373|FG004|mCRC Expansion Phase|Progression Disease|0|||
161499863|NCT01577758|583225374|FG005|mCRC Expansion Phase|Progression Disease|0|||
161499864|NCT01577758|583225375|FG006|mCRC Expansion Phase|Progression Disease|0|||
161499865|NCT01577758|583225376|FG007|mCRC Expansion Phase|Progression Disease|19|||
161499866|NCT04969224|583225381|FG000|Overall Study|Adverse Event|1|||
161499867|NCT04969224|583225381|FG000|Overall Study|Enrolled but never dosed|1|||
161499868|NCT03165110|583225385|FG000|Overall Study|Anroid phone software incompatibility|1|||
161499869|NCT02726074|583225386|FG000|Overall Study|Withdrawal by Subject|4|||
161499870|NCT02726074|583225386|FG000|Overall Study|Adverse Event|14|||
161499871|NCT02726074|583225386|FG000|Overall Study|Protocol Violation|3|||
161499872|NCT02726074|583225386|FG000|Overall Study|Lost to Follow-up|2|||
161499873|NCT02726074|583225386|FG000|Overall Study|Others|3|||
161499874|NCT05533632|583225387|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
161499875|NCT05533632|583225387|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
161673239|NCT01284062|583857922|FG003|Overall Study|Protocol Violation|2|||
161499876|NCT05533632|583225387|FG000|Overall Study|Lost to Follow-up|1|||
161499877|NCT05533632|583225387|FG000|Overall Study|Withdrawal by Subject|4|||
161499878|NCT05533632|583225387|FG000|Overall Study|Adverse Event|4|||
161499879|NCT00579826|583225388|FG000|Overall Study|Withdrawal by Subject|5|||
161499880|NCT00579826|583225389|FG001|Overall Study|Withdrawal by Subject|3|||
161499881|NCT04191382|583225390|FG000|Overall Study|Withdrawal by Subject|1|||
161499882|NCT04191382|583225391|FG001|Overall Study|Withdrawal by Subject|0|||
161499883|NCT04191382|583225392|FG002|Overall Study|Withdrawal by Subject|0|||
161499884|NCT00454987|583225395|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
161499885|NCT00454987|583225396|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
161499886|NCT00454987|583225397|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
161499887|NCT00454987|583225395|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
161499888|NCT00454987|583225396|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
161499889|NCT00454987|583225397|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
161499890|NCT00454987|583225395|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
161499891|NCT00454987|583225396|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
161499892|NCT00454987|583225397|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
161499893|NCT03054870|583225399|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
161499894|NCT03054870|583225399|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
161499895|NCT02009046|583225400|FG000|Overall Study|Lost to Follow-up|256|||
161499896|NCT02009046|583225401|FG001|Overall Study|Lost to Follow-up|206|||
161499897|NCT00973479|583225405|FG000|Overall Study|Lost to Follow-up|0|||
161499898|NCT00973479|583225406|FG001|Overall Study|Lost to Follow-up|3|||
161499899|NCT00973479|583225405|FG000|Overall Study|Death|2|||
161499900|NCT00973479|583225406|FG001|Overall Study|Death|2|||
161499901|NCT00973479|583225405|FG000|Overall Study|Withdrawal by Subject|15|||
161499902|NCT00973479|583225406|FG001|Overall Study|Withdrawal by Subject|16|||
161499903|NCT00973479|583225405|FG000|Overall Study|Lack of Efficacy|5|||
161499904|NCT00973479|583225406|FG001|Overall Study|Lack of Efficacy|7|||
161499905|NCT00973479|583225405|FG000|Overall Study|Adverse Event|12|||
161499906|NCT00973479|583225406|FG001|Overall Study|Adverse Event|32|||
161499907|NCT00973479|583225405|FG000|Overall Study|Protocol Violation|2|||
161499908|NCT00973479|583225406|FG001|Overall Study|Protocol Violation|2|||
161499909|NCT00973479|583225405|FG000|Overall Study|Other|1|||
161499910|NCT00973479|583225406|FG001|Overall Study|Other|7|||
161499911|NCT05075850|583225407|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
161499912|NCT04256785|583225408|FG000|Overall Study|Adverse Event|8|||
161499913|NCT04256785|583225409|FG001|Overall Study|Adverse Event|6|||
161499914|NCT04256785|583225408|FG000|Overall Study|Lack of Efficacy|3|||
161499915|NCT04256785|583225409|FG001|Overall Study|Lack of Efficacy|4|||
161925086|NCT05887908|584771032|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
161499916|NCT04256785|583225408|FG000|Overall Study|Lost to Follow-up|7|||
161499917|NCT04256785|583225409|FG001|Overall Study|Lost to Follow-up|7|||
161499918|NCT04256785|583225408|FG000|Overall Study|Protocol Violation|1|||
161499919|NCT04256785|583225409|FG001|Overall Study|Protocol Violation|0|||
161499920|NCT04256785|583225408|FG000|Overall Study|Withdrawal by Subject|4|||
161499921|NCT04256785|583225409|FG001|Overall Study|Withdrawal by Subject|1|||
161499922|NCT04256785|583225408|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
161499923|NCT04256785|583225409|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
161499924|NCT00362115|583225410|FG000|Overall Study|Adverse Event|0|||
161499925|NCT00362115|583225411|FG001|Overall Study|Adverse Event|1|||
161499926|NCT00362115|583225412|FG002|Overall Study|Adverse Event|1|||
161499927|NCT00362115|583225413|FG003|Overall Study|Adverse Event|1|||
161499928|NCT00362115|583225414|FG004|Overall Study|Adverse Event|2|||
161499929|NCT00362115|583225415|FG005|Overall Study|Adverse Event|2|||
161499930|NCT00362115|583225416|FG006|Overall Study|Adverse Event|1|||
161499931|NCT00362115|583225410|FG000|Overall Study|Protocol Violation|0|||
161499932|NCT00362115|583225411|FG001|Overall Study|Protocol Violation|0|||
161499933|NCT00362115|583225412|FG002|Overall Study|Protocol Violation|0|||
161499934|NCT00362115|583225413|FG003|Overall Study|Protocol Violation|0|||
161585872|NCT01136876|583531896|FG000|Overall Study|Physician Decision|3|||
161585873|NCT01136876|583531897|FG001|Overall Study|Physician Decision|5|||
161925087|NCT05887908|584771033|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
161925088|NCT05887908|584771034|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
161925089|NCT05887908|584771032|FG000|Overall Study|Other Reason|3|||
161925090|NCT05887908|584771033|FG001|Overall Study|Other Reason|3|||
161499935|NCT00362115|583225414|FG004|Overall Study|Protocol Violation|0|||
161499936|NCT00362115|583225415|FG005|Overall Study|Protocol Violation|1|||
161499937|NCT00362115|583225416|FG006|Overall Study|Protocol Violation|0|||
161499938|NCT00362115|583225410|FG000|Overall Study|Lost to Follow-up|0|||
161925091|NCT05887908|584771034|FG002|Overall Study|Other Reason|3|||
161925092|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
161499939|NCT00362115|583225411|FG001|Overall Study|Lost to Follow-up|1|||
161499940|NCT00362115|583225412|FG002|Overall Study|Lost to Follow-up|0|||
161499941|NCT00362115|583225413|FG003|Overall Study|Lost to Follow-up|0|||
161499942|NCT00362115|583225414|FG004|Overall Study|Lost to Follow-up|2|||
161499943|NCT00362115|583225415|FG005|Overall Study|Lost to Follow-up|0|||
161499944|NCT00362115|583225416|FG006|Overall Study|Lost to Follow-up|1|||
161499945|NCT00362115|583225410|FG000|Overall Study|Withdrawal by Subject|1|||
161499946|NCT00362115|583225411|FG001|Overall Study|Withdrawal by Subject|3|||
161499947|NCT00362115|583225412|FG002|Overall Study|Withdrawal by Subject|1|||
161499948|NCT00362115|583225413|FG003|Overall Study|Withdrawal by Subject|0|||
161499949|NCT00362115|583225414|FG004|Overall Study|Withdrawal by Subject|1|||
161499950|NCT00362115|583225415|FG005|Overall Study|Withdrawal by Subject|3|||
161499951|NCT00362115|583225416|FG006|Overall Study|Withdrawal by Subject|4|||
161499952|NCT00362115|583225410|FG000|Overall Study|Lack of Efficacy|1|||
161499953|NCT00362115|583225411|FG001|Overall Study|Lack of Efficacy|0|||
161499954|NCT00362115|583225412|FG002|Overall Study|Lack of Efficacy|5|||
161499955|NCT00362115|583225413|FG003|Overall Study|Lack of Efficacy|2|||
161499956|NCT00362115|583225414|FG004|Overall Study|Lack of Efficacy|2|||
161499957|NCT00362115|583225415|FG005|Overall Study|Lack of Efficacy|0|||
161499958|NCT00362115|583225416|FG006|Overall Study|Lack of Efficacy|3|||
161499959|NCT00362115|583225410|FG000|Overall Study|Physician Decision|0|||
161499960|NCT00362115|583225411|FG001|Overall Study|Physician Decision|0|||
161499961|NCT00362115|583225412|FG002|Overall Study|Physician Decision|0|||
161499962|NCT00362115|583225413|FG003|Overall Study|Physician Decision|0|||
161499963|NCT00362115|583225414|FG004|Overall Study|Physician Decision|0|||
161499964|NCT00362115|583225415|FG005|Overall Study|Physician Decision|0|||
161499965|NCT00362115|583225416|FG006|Overall Study|Physician Decision|3|||
161499966|NCT00362115|583225410|FG000|Overall Study|Other|0|||
161499967|NCT00362115|583225411|FG001|Overall Study|Other|1|||
161499968|NCT00362115|583225412|FG002|Overall Study|Other|0|||
161499969|NCT00362115|583225413|FG003|Overall Study|Other|1|||
161499970|NCT00362115|583225414|FG004|Overall Study|Other|0|||
161499971|NCT00362115|583225415|FG005|Overall Study|Other|1|||
161499972|NCT00362115|583225416|FG006|Overall Study|Other|0|||
161499973|NCT01170091|583225417|FG000|Overall Study|Missing efficacy evaluation|3|||
161499974|NCT01170091|583225417|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
161499975|NCT02188589|583225418|FG000|Overall Study|Withdrawal by Subject|5|||
161499976|NCT00003641|583225419|FG000|Overall Study|Withdrawal by Subject|0|||
161499977|NCT00003641|583225420|FG001|Overall Study|Withdrawal by Subject|100|||
161499978|NCT00003641|583225419|FG000|Overall Study|Adverse Event|0|||
161499979|NCT00003641|583225420|FG001|Overall Study|Adverse Event|38|||
161499980|NCT00003641|583225419|FG000|Overall Study|Disease progression|0|||
161499981|NCT00003641|583225420|FG001|Overall Study|Disease progression|2|||
161499982|NCT00003641|583225419|FG000|Overall Study|Unknown/missing|0|||
161499983|NCT00003641|583225420|FG001|Overall Study|Unknown/missing|22|||
161499984|NCT00003641|583225419|FG000|Overall Study|Should not receive interferon therapy|2|||
161499985|NCT00003641|583225420|FG001|Overall Study|Should not receive interferon therapy|0|||
161499986|NCT00003641|583225419|FG000|Overall Study|Never started interferon|567|||
161499987|NCT00003641|583225420|FG001|Overall Study|Never started interferon|12|||
161499988|NCT00741039|583225424|FG000|Overall Study|Patient non-compliance|2|||
161499989|NCT00741039|583225425|FG001|Overall Study|Patient non-compliance|0|||
161499990|NCT00878709|583225426|FG000|Overall Study|Withdrawal by Subject|197|||
161499991|NCT00878709|583225427|FG001|Overall Study|Withdrawal by Subject|120|||
161499992|NCT00878709|583225426|FG000|Overall Study|Lost to Follow-up|35|||
161499993|NCT00878709|583225427|FG001|Overall Study|Lost to Follow-up|33|||
161499994|NCT00878709|583225426|FG000|Overall Study|Other Reasons|93|||
161499995|NCT00878709|583225427|FG001|Overall Study|Other Reasons|84|||
161673240|NCT01284062|583857919|FG000|Overall Study|Withdrawal by Subject|3|||
161673241|NCT01284062|583857920|FG001|Overall Study|Withdrawal by Subject|1|||
161673242|NCT01284062|583857921|FG002|Overall Study|Withdrawal by Subject|2|||
161925093|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
161925094|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
161925095|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
161673243|NCT01284062|583857922|FG003|Overall Study|Withdrawal by Subject|5|||
161673244|NCT01284062|583857919|FG000|Overall Study|Other|0|||
161673245|NCT01284062|583857920|FG001|Overall Study|Other|0|||
161673246|NCT01284062|583857921|FG002|Overall Study|Other|0|||
161925096|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
161925097|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
161925098|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
161925099|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
161499996|NCT00768300|583225428|FG000|Overall Study|Randomized but not treated|1|||
161499997|NCT00768300|583225429|FG001|Overall Study|Randomized but not treated|1|||
161499998|NCT00768300|583225428|FG000|Overall Study|Adverse Event|10|||
161499999|NCT00768300|583225429|FG001|Overall Study|Adverse Event|2|||
161500000|NCT00768300|583225428|FG000|Overall Study|Protocol Violation|6|||
161500001|NCT00768300|583225429|FG001|Overall Study|Protocol Violation|1|||
161500002|NCT00768300|583225428|FG000|Overall Study|Withdrawal by Subject|13|||
161500003|NCT00768300|583225429|FG001|Overall Study|Withdrawal by Subject|7|||
161500004|NCT00768300|583225428|FG000|Overall Study|Physician Decision|2|||
161500005|NCT00768300|583225429|FG001|Overall Study|Physician Decision|3|||
161673247|NCT01284062|583857922|FG003|Overall Study|Other|1|||
161500006|NCT00768300|583225428|FG000|Overall Study|Study discontinued by Sponsor|271|||
161673248|NCT01284062|583857919|FG000|Overall Study|Site Closed|0|||
161585874|NCT01136876|583531896|FG000|Overall Study|Missing NGAL measurement|2|||
161585875|NCT01136876|583531897|FG001|Overall Study|Missing NGAL measurement|5|||
161818960|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
161818961|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
161818962|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
161818963|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
161818964|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
161818965|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
161818966|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
161818967|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
161818968|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
161818969|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
161818970|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
161818971|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
161818972|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
161818973|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
161818974|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
161818975|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
161818976|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
161818977|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
161818978|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
161818979|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
161818980|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
161818981|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
161818982|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
161818983|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
161818984|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
161818985|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
161818986|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
161818987|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
161818988|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
161818989|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
161818990|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
161818991|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
161818992|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
161818993|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
161818994|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
161818995|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
161818996|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
161818997|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
161818998|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
161818999|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
161819000|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
161819001|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
161819002|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
161819003|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
161819004|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
161500007|NCT00768300|583225429|FG001|Overall Study|Study discontinued by Sponsor|140|||
161500008|NCT00768300|583225428|FG000|Overall Study|Death|21|||
161925100|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
161500009|NCT00768300|583225429|FG001|Overall Study|Death|5|||
161500010|NCT00768300|583225428|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
161500011|NCT00768300|583225429|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
161500012|NCT00768300|583225428|FG000|Overall Study|Screen failure following randomization|1|||
161500013|NCT00768300|583225429|FG001|Overall Study|Screen failure following randomization|0|||
161500014|NCT00768300|583225428|FG000|Overall Study|Received lung transplant|1|||
161500015|NCT00768300|583225429|FG001|Overall Study|Received lung transplant|1|||
161500016|NCT00768300|583225428|FG000|Overall Study|Lost to Follow-up|0|||
161500017|NCT00768300|583225429|FG001|Overall Study|Lost to Follow-up|1|||
161500018|NCT00768300|583225428|FG000|Overall Study|Began prohibited concomitant medication|0|||
161500019|NCT00768300|583225429|FG001|Overall Study|Began prohibited concomitant medication|1|||
161500020|NCT00768300|583225428|FG000|Overall Study|Treated but never dosed with Study drug|1|||
161500021|NCT00768300|583225429|FG001|Overall Study|Treated but never dosed with Study drug|0|||
161500022|NCT00768300|583225428|FG000|Overall Study|Missing data|1|||
161500023|NCT00768300|583225429|FG001|Overall Study|Missing data|0|||
161500024|NCT02068222|583225430|FG000|Overall Study|Lost to Follow-up|1|||
161500025|NCT01374087|583225433|FG000|Overall Study|Adverse Event|1|||
161500026|NCT01374087|583225434|FG001|Overall Study|Adverse Event|0|||
161500027|NCT01374087|583225433|FG000|Overall Study|Disease progression|2|||
161500028|NCT01374087|583225434|FG001|Overall Study|Disease progression|2|||
161500029|NCT01374087|583225433|FG000|Overall Study|Study discontinued|13|||
161500030|NCT01374087|583225434|FG001|Overall Study|Study discontinued|13|||
161925101|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
161925102|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
161925103|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
161500031|NCT03011307|583225435|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
161500032|NCT03011307|583225436|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
161500033|NCT03011307|583225435|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
161500034|NCT03011307|583225436|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
161500035|NCT03011307|583225435|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
161500036|NCT03011307|583225436|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
161500037|NCT01365507|583226688|FG000|Overall Study|Withdrawal Criteria|8|||
161500038|NCT01365507|583226689|FG001|Overall Study|Withdrawal Criteria|5|||
161500039|NCT01365507|583226688|FG000|Overall Study|Unclassified|1|||
161500040|NCT01365507|583226689|FG001|Overall Study|Unclassified|4|||
161500041|NCT04254978|583226693|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
161500042|NCT04254978|583226693|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
161500043|NCT04254978|583226693|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
161500044|NCT04254978|583226693|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
161500045|NCT04254978|583226693|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
161500046|NCT04254978|583226693|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
161500047|NCT03257631|583226694|FG000|Overall Study|Death|1|||
161925104|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
161925105|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
161925106|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
161925107|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
161925108|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
161925109|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
161925110|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
161925111|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
161925112|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
161925113|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
161925114|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
161925115|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
161925116|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
161500048|NCT03257631|583226695|FG001|Overall Study|Death|0|||
161500049|NCT03257631|583226696|FG002|Overall Study|Death|1|||
161500050|NCT03257631|583226697|FG003|Overall Study|Death|1|||
161925117|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
161925118|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
161500051|NCT03257631|583226694|FG000|Overall Study|Progressive Disease|10|||
161500052|NCT03257631|583226695|FG001|Overall Study|Progressive Disease|9|||
161925119|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
161925120|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
161925121|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
161925122|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
161925123|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
161925124|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
161925125|NCT04828486|584771042|FG000|Overall Study|Adverse Event|2|||
161925126|NCT04828486|584771042|FG000|Overall Study|Death|1|||
161925127|NCT04828486|584771042|FG000|Overall Study|Disease Progression|8|||
161925128|NCT04828486|584771042|FG000|Overall Study|Other Complicating Disease|1|||
161925129|NCT04828486|584771042|FG000|Overall Study|Withdrawal by Subject|1|||
161925130|NCT03325439|584771043|FG000|Overall Study|Ineligibility|3|||
161925131|NCT02315625|584771044|FG000|First Intervention|Disease Progression|1|||
161925132|NCT02315625|584771045|FG001|First Intervention|Disease Progression|0|||
161925133|NCT02315625|584771044|FG000|Second Intervention|Physician Decision|2|||
161925134|NCT02315625|584771045|FG001|Second Intervention|Physician Decision|1|||
161925135|NCT02315625|584771044|FG000|Second Intervention|Study closure|1|||
161925136|NCT02315625|584771045|FG001|Second Intervention|Study closure|0|||
161925137|NCT02315625|584771044|FG000|Second Intervention|Disease Progression|1|||
161925138|NCT02315625|584771045|FG001|Second Intervention|Disease Progression|0|||
161500053|NCT03257631|583226696|FG002|Overall Study|Progressive Disease|17|||
161500054|NCT03257631|583226697|FG003|Overall Study|Progressive Disease|8|||
161500055|NCT03257631|583226694|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161500056|NCT03257631|583226695|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161500057|NCT03257631|583226696|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161500058|NCT03257631|583226697|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
161500059|NCT03257631|583226694|FG000|Overall Study|Adverse Event|0|||
161500060|NCT03257631|583226695|FG001|Overall Study|Adverse Event|0|||
161500061|NCT03257631|583226696|FG002|Overall Study|Adverse Event|2|||
161500062|NCT03257631|583226697|FG003|Overall Study|Adverse Event|0|||
161500063|NCT03509675|583226699|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
161500064|NCT03509675|583226700|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
161500065|NCT03509675|583226699|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
161500066|NCT03509675|583226700|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
161500067|NCT03509675|583226699|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
161500068|NCT03509675|583226700|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
161500069|NCT03509675|583226699|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
161500070|NCT03509675|583226700|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
161500071|NCT02404311|583226706|FG000|Part A: Month 0-18|Death|2|||
161500072|NCT02404311|583226707|FG001|Part A: Month 0-18|Death|0|||
161500073|NCT02404311|583226708|FG002|Part A: Month 0-18|Death|0|||
161500074|NCT02404311|583226709|FG003|Part A: Month 0-18|Death|0|||
161500075|NCT02404311|583226710|FG004|Part A: Month 0-18|Death|0|||
161500076|NCT02404311|583226706|FG000|Part A: Month 0-18|Physician Decision|1|||
161500077|NCT02404311|583226707|FG001|Part A: Month 0-18|Physician Decision|0|||
161500078|NCT02404311|583226708|FG002|Part A: Month 0-18|Physician Decision|0|||
161500079|NCT02404311|583226709|FG003|Part A: Month 0-18|Physician Decision|0|||
161500080|NCT02404311|583226710|FG004|Part A: Month 0-18|Physician Decision|0|||
161500081|NCT02404311|583226706|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
161500082|NCT02404311|583226707|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
161500083|NCT02404311|583226708|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
161925139|NCT06132386|584771049|FG000|Overall Study|ineligble laboratory|1|||
161925140|NCT06132386|584771050|FG001|Overall Study|ineligble laboratory|0|||
161925141|NCT06132386|584771051|FG002|Overall Study|ineligble laboratory|0|||
161925142|NCT06132386|584771052|FG003|Overall Study|ineligble laboratory|0|||
161500084|NCT02404311|583226709|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
161500085|NCT02404311|583226710|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
161500086|NCT02404311|583226706|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
161819005|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
161819006|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
161819007|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
161819008|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
161819009|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
161819010|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
161819011|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
161819012|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
161819013|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
161819014|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
161925143|NCT06132386|584771053|FG004|Overall Study|ineligble laboratory|1|||
161500087|NCT02404311|583226707|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
161500088|NCT02404311|583226708|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
161585876|NCT05321069|583531898|FG000|Overall Study|Adverse Event|52|||
161500089|NCT02404311|583226709|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
161500090|NCT02404311|583226710|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
161500091|NCT02404311|583226706|FG000|Part A: Month 0-18|HIV Infection|6|||
161500092|NCT02404311|583226707|FG001|Part A: Month 0-18|HIV Infection|2|||
161500093|NCT02404311|583226708|FG002|Part A: Month 0-18|HIV Infection|0|||
161500094|NCT02404311|583226709|FG003|Part A: Month 0-18|HIV Infection|0|||
161500095|NCT02404311|583226710|FG004|Part A: Month 0-18|HIV Infection|0|||
161500096|NCT02404311|583226706|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
161500097|NCT02404311|583226707|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
161500098|NCT02404311|583226708|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
161500099|NCT02404311|583226709|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
161500100|NCT02404311|583226710|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
161585877|NCT05321069|583531899|FG001|Overall Study|Adverse Event|52|||
161585878|NCT05321069|583531900|FG002|Overall Study|Adverse Event|64|||
161585879|NCT05321069|583531898|FG000|Overall Study|Protocol Violation|1|||
161585880|NCT05321069|583531899|FG001|Overall Study|Protocol Violation|1|||
161585881|NCT05321069|583531900|FG002|Overall Study|Protocol Violation|0|||
161585882|NCT05321069|583531898|FG000|Overall Study|Withdrawal by Subject|23|||
161585883|NCT05321069|583531899|FG001|Overall Study|Withdrawal by Subject|18|||
161585884|NCT05321069|583531900|FG002|Overall Study|Withdrawal by Subject|12|||
161585885|NCT05321069|583531898|FG000|Overall Study|Lost to Follow-up|1|||
161585886|NCT05321069|583531899|FG001|Overall Study|Lost to Follow-up|0|||
161585887|NCT05321069|583531900|FG002|Overall Study|Lost to Follow-up|1|||
161585888|NCT05321069|583531898|FG000|Overall Study|No reason stated by the participants|23|||
161585889|NCT05321069|583531899|FG001|Overall Study|No reason stated by the participants|22|||
161585890|NCT05321069|583531900|FG002|Overall Study|No reason stated by the participants|16|||
161585891|NCT05321069|583531898|FG000|Overall Study|Lack of Efficacy|1|||
161585892|NCT05321069|583531899|FG001|Overall Study|Lack of Efficacy|1|||
161585893|NCT05321069|583531900|FG002|Overall Study|Lack of Efficacy|0|||
161585894|NCT05048186|583531903|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
161585895|NCT05048186|583531904|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
161585896|NCT05048186|583531903|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
161673249|NCT01284062|583857920|FG001|Overall Study|Site Closed|0|||
161673250|NCT01284062|583857921|FG002|Overall Study|Site Closed|1|||
161819015|NCT00858780|584378190|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
161819016|NCT00858780|584378191|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819017|NCT00858780|584378192|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819018|NCT00858780|584378193|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819019|NCT00858780|584378194|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819020|NCT00858780|584378190|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819021|NCT00858780|584378191|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819022|NCT00858780|584378192|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
161819023|NCT00858780|584378193|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819024|NCT00858780|584378194|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819025|NCT00858780|584378190|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
161819026|NCT00858780|584378191|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161819027|NCT00858780|584378192|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161819028|NCT00858780|584378193|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161819029|NCT00858780|584378194|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
161819030|NCT00858780|584378190|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819031|NCT00858780|584378191|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
161819032|NCT00858780|584378192|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819033|NCT00858780|584378193|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819034|NCT00858780|584378194|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819035|NCT00858780|584378190|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819036|NCT00858780|584378191|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819037|NCT00858780|584378192|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819038|NCT00858780|584378193|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819039|NCT00858780|584378194|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
161819040|NCT00858780|584378190|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
161819041|NCT00858780|584378191|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
161925144|NCT06132386|584771054|FG005|Overall Study|ineligble laboratory|0|||
161925145|NCT06132386|584771049|FG000|Overall Study|ineligible vital signs|0|||
161925146|NCT06132386|584771050|FG001|Overall Study|ineligible vital signs|1|||
161500101|NCT03314584|583226717|FG000|Overall Study|Withdrawal by Subject|3|||
161500102|NCT03314584|583226718|FG001|Overall Study|Withdrawal by Subject|3|||
161500103|NCT03314584|583226717|FG000|Overall Study|Lost to Follow-up|4|||
161500104|NCT03314584|583226718|FG001|Overall Study|Lost to Follow-up|0|||
161500105|NCT06134817|583226719|FG000|Overall Study|Physician Departure - termination of study|1|||
161673251|NCT01284062|583857922|FG003|Overall Study|Site Closed|0|||
161500106|NCT00930579|583226726|FG000|Overall Study|Withdrawal by Subject|1|||
161500107|NCT00930579|583226726|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
161500108|NCT01046682|583226735|FG000|Overall Study|Adverse Event|2|||
161500109|NCT01046682|583226736|FG001|Overall Study|Adverse Event|0|||
161500110|NCT05071183|583226737|FG000|Overall Study|Death|1|||
161500111|NCT05071183|583226738|FG001|Overall Study|Death|2|||
161500112|NCT05071183|583226739|FG002|Overall Study|Death|0|||
161500113|NCT05071183|583226737|FG000|Overall Study|Other Reasons|1|||
161500114|NCT05071183|583226738|FG001|Overall Study|Other Reasons|3|||
161500115|NCT05071183|583226739|FG002|Overall Study|Other Reasons|2|||
161500116|NCT02046148|583226740|FG000|Overall Study|Lost to Follow-up|1|||
161819042|NCT00858780|584378192|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
161819043|NCT00858780|584378193|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
161819044|NCT00858780|584378194|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
161819045|NCT01964950|584378195|FG000|Overall Study|Protocol Violation|25|||
161819046|NCT00819169|584378203|FG000|Overall Study|Withdrawal by Subject|2|||
161819047|NCT00819169|584378204|FG001|Overall Study|Withdrawal by Subject|0|||
161819048|NCT00819169|584378205|FG002|Overall Study|Withdrawal by Subject|0|||
161819049|NCT00819169|584378206|FG003|Overall Study|Withdrawal by Subject|1|||
161819050|NCT00819169|584378207|FG004|Overall Study|Withdrawal by Subject|1|||
161819051|NCT00819169|584378208|FG005|Overall Study|Withdrawal by Subject|1|||
161819052|NCT00819169|584378209|FG006|Overall Study|Withdrawal by Subject|5|||
161500117|NCT02046148|583226741|FG001|Overall Study|Lost to Follow-up|1|||
161500118|NCT02046148|583226740|FG000|Overall Study|Withdrawal by Subject|0|||
161500119|NCT02046148|583226741|FG001|Overall Study|Withdrawal by Subject|2|||
161500120|NCT03506373|583226743|FG000|Overall Study|Adverse Event|6|||
161500121|NCT03506373|583226743|FG000|Overall Study|Withdrawal by Subject|2|||
161500122|NCT03506373|583226743|FG000|Overall Study|Disease progression|5|||
161500123|NCT03506373|583226743|FG000|Overall Study|Other|3|||
161500124|NCT02939560|583226753|FG000|Overall Study|Withdrawal by Subject|2|||
161500125|NCT02939560|583226753|FG000|Overall Study|Protocol Violation|1|||
161500126|NCT03340025|583226754|FG000|Overall Study|Lost to Follow-up|2|||
161500127|NCT03340025|583226755|FG001|Overall Study|Lost to Follow-up|2|||
161500128|NCT02420691|583226756|FG000|Overall Study|Adverse Event|3|||
161500129|NCT02420691|583226756|FG000|Overall Study|Withdrawal by Subject|3|||
161500130|NCT01293240|583226757|FG000|Overall Study|Noncompliance|2|||
161500131|NCT01520363|583226758|FG000|Overall Study|Withdrawal by Subject|2|||
161500132|NCT01520363|583226759|FG001|Overall Study|Withdrawal by Subject|0|||
161500133|NCT01498952|583226763|FG000|Overall Study|Death|2|||
161500134|NCT01498952|583226764|FG001|Overall Study|Death|2|||
161500135|NCT01498952|583226765|FG002|Overall Study|Death|0|||
161500136|NCT01498952|583226766|FG003|Overall Study|Death|0|||
161500137|NCT01498952|583226767|FG004|Overall Study|Death|0|||
161500138|NCT00304356|583226768|FG000|Nitazoxanide|Physician Decision|5|||
161500139|NCT00304356|583226768|FG000|Nitazoxanide|Physician Decision|1|||
161500140|NCT00304356|583226768|FG000|Nitazoxanide|number is 0|1|||
161500141|NCT00304356|583226768|FG000|Nitazoxanide|Physician Decision|1|||
161500142|NCT00304356|583226768|FG000|Nitazoxanide|Physician Decision|1|||
161500143|NCT00304356|583226768|FG000|Nitazoxanide|Physician Decision|1|||
161500144|NCT01265849|583226771|FG000|Overall Study|Randomized//Treatment not initiated|1|||
161500145|NCT01265849|583226772|FG001|Overall Study|Randomized//Treatment not initiated|4|||
161500146|NCT01265849|583226773|FG002|Overall Study|Randomized//Treatment not initiated|0|||
161500147|NCT01265849|583226771|FG000|Overall Study|Physician Decision|1|||
161500148|NCT01265849|583226772|FG001|Overall Study|Physician Decision|2|||
161500149|NCT01265849|583226773|FG002|Overall Study|Physician Decision|0|||
161500150|NCT01265849|583226771|FG000|Overall Study|Lost to Follow-up|18|||
161500151|NCT01265849|583226772|FG001|Overall Study|Lost to Follow-up|15|||
161500152|NCT01265849|583226773|FG002|Overall Study|Lost to Follow-up|5|||
161500153|NCT01265849|583226771|FG000|Overall Study|Not otherwise specified|1|||
161500154|NCT01265849|583226772|FG001|Overall Study|Not otherwise specified|6|||
161500155|NCT01265849|583226773|FG002|Overall Study|Not otherwise specified|1|||
161500156|NCT01265849|583226771|FG000|Overall Study|Withdrawal by Subject|25|||
161500157|NCT01265849|583226772|FG001|Overall Study|Withdrawal by Subject|34|||
161500158|NCT01265849|583226773|FG002|Overall Study|Withdrawal by Subject|13|||
161500159|NCT01154218|583226774|FG000|Third Intervention Period|Adverse Event|0|||
161500160|NCT01154218|583226775|FG001|Third Intervention Period|Adverse Event|1|||
161500161|NCT01154218|583226776|FG002|Third Intervention Period|Adverse Event|0|||
161500162|NCT01154218|583226777|FG003|Third Intervention Period|Adverse Event|0|||
161500163|NCT01154218|583226774|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161500164|NCT01154218|583226775|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161500165|NCT01154218|583226776|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161819053|NCT00819169|584378210|FG007|Overall Study|Withdrawal by Subject|1|||
161819054|NCT00819169|584378211|FG008|Overall Study|Withdrawal by Subject|4|||
161500166|NCT01154218|583226777|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
161500167|NCT01154218|583226774|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
161500168|NCT01154218|583226775|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
161500169|NCT01154218|583226776|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
161500170|NCT01154218|583226777|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
161500171|NCT03194321|583226778|FG000|Overall Study|Withdrawal by Subject|1|||
161500172|NCT03194321|583226778|FG000|Overall Study|Lost to Follow-up|1|||
161500173|NCT03194321|583226778|FG000|Overall Study|Travel for Follow-up|1|||
161500174|NCT00567892|583226789|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
161500175|NCT00567892|583226790|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
161500176|NCT00567892|583226791|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
161500177|NCT00567892|583226792|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
161500178|NCT00567892|583226789|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
161500179|NCT00567892|583226790|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
161500180|NCT00567892|583226791|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
161500181|NCT00567892|583226792|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
161500182|NCT01344161|583226794|FG000|Overall Study|Lost to Follow-up|4|||
161500183|NCT01344161|583226795|FG001|Overall Study|Lost to Follow-up|1|||
161500184|NCT01344161|583226794|FG000|Overall Study|Pregnancy|0|||
161500185|NCT01344161|583226795|FG001|Overall Study|Pregnancy|1|||
161500186|NCT01344161|583226794|FG000|Overall Study|Protocol Violation|1|||
161500187|NCT01344161|583226795|FG001|Overall Study|Protocol Violation|1|||
161500188|NCT04690751|583226796|FG000|Overall Study|Protocol Violation|0|||
161500189|NCT04690751|583226797|FG001|Overall Study|Protocol Violation|1|||
161500190|NCT04690751|583226798|FG002|Overall Study|Protocol Violation|0|||
161500191|NCT04690751|583226799|FG003|Overall Study|Protocol Violation|1|||
161500192|NCT04690751|583226800|FG004|Overall Study|Protocol Violation|2|||
161500193|NCT04690751|583226801|FG005|Overall Study|Protocol Violation|0|||
161500194|NCT04690751|583226796|FG000|Overall Study|Adverse Event|0|||
161500195|NCT04690751|583226797|FG001|Overall Study|Adverse Event|0|||
161500196|NCT04690751|583226798|FG002|Overall Study|Adverse Event|1|||
161500197|NCT04690751|583226799|FG003|Overall Study|Adverse Event|0|||
161500198|NCT04690751|583226800|FG004|Overall Study|Adverse Event|0|||
161500199|NCT04690751|583226801|FG005|Overall Study|Adverse Event|0|||
161500200|NCT04690751|583226796|FG000|Overall Study|Positive urine drug screen test|0|||
161500201|NCT04690751|583226797|FG001|Overall Study|Positive urine drug screen test|0|||
161500202|NCT04690751|583226798|FG002|Overall Study|Positive urine drug screen test|0|||
161500203|NCT04690751|583226799|FG003|Overall Study|Positive urine drug screen test|0|||
161500204|NCT04690751|583226800|FG004|Overall Study|Positive urine drug screen test|1|||
161500205|NCT04690751|583226801|FG005|Overall Study|Positive urine drug screen test|0|||
161500206|NCT04364620|583226802|FG000|Overall Study|Disease Progression|20|||
161500207|NCT04364620|583226802|FG000|Overall Study|Adverse Event|5|||
161500208|NCT04364620|583226802|FG000|Overall Study|Physician Decision|4|||
161500209|NCT04364620|583226802|FG000|Overall Study|Death|3|||
161500210|NCT04364620|583226802|FG000|Overall Study|Other|2|||
161500211|NCT04364620|583226802|FG000|Overall Study|Withdrawal by Subject|1|||
161500212|NCT01541969|583228487|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
161500213|NCT01541969|583228488|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
161500214|NCT01541969|583228487|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
161500215|NCT01541969|583228488|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
161673252|NCT03189862|583857923|FG000|Overall Study|Withdrawal by Subject|1|||
161673253|NCT03189862|583857924|FG001|Overall Study|Withdrawal by Subject|0|||
161673254|NCT03189862|583857923|FG000|Overall Study|Lost to Follow-up|54|||
161673255|NCT03189862|583857924|FG001|Overall Study|Lost to Follow-up|62|||
161500216|NCT01541969|583228487|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
161500217|NCT01541969|583228488|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
161500218|NCT01541969|583228487|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
161500219|NCT01541969|583228488|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
161500220|NCT01541969|583228487|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
161500221|NCT01541969|583228488|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
161500222|NCT01541969|583228487|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
161500223|NCT01541969|583228488|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
161500224|NCT01541969|583228487|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
161500225|NCT01541969|583228488|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
161500226|NCT01541969|583228487|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
161500227|NCT01541969|583228488|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
161500228|NCT01541969|583228487|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
161500229|NCT01541969|583228488|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
161500230|NCT01541969|583228487|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
161500231|NCT01541969|583228488|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
161500232|NCT01614990|583228489|FG000|Overall Study|Protocol Violation|1|||
161500233|NCT01614990|583228490|FG001|Overall Study|Protocol Violation|1|||
161673256|NCT00931944|583857926|FG000|Overall Study|Adverse Event|4|||
161500234|NCT02255500|583228495|FG000|Overall Study|Withdrawal by Subject|1|||
161500235|NCT02255500|583228496|FG001|Overall Study|Withdrawal by Subject|0|||
161500236|NCT02449239|583228499|FG000|Induction Phase|Lack of Efficacy|64|||
161500237|NCT02449239|583228499|FG000|Induction Phase|Adverse Event|1|||
161500238|NCT02449239|583228499|FG000|Induction Phase|Lost to Follow-up|1|||
161500239|NCT02449239|583228499|FG000|Induction Phase|Protocol Violation|1|||
161500240|NCT02449239|583228499|FG000|Induction Phase|Physician Decision|1|||
161500241|NCT02449239|583228499|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
161500242|NCT02449239|583228499|FG000|Induction Phase|Withdrawal by Subject|1|||
161500243|NCT02449239|583228499|FG000|Maintenance Month 3|Lack of Efficacy|14|||
161500244|NCT02449239|583228499|FG000|Maintenance Month 6|Lack of Efficacy|10|||
161500245|NCT02449239|583228499|FG000|Maintenance Month 6|Adverse Event|2|||
161500246|NCT02449239|583228499|FG000|Maintenance Month 6|Physician Decision|1|||
161500247|NCT02449239|583228499|FG000|Maintenance Month 9|Lack of Efficacy|2|||
161500248|NCT02449239|583228499|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
161500249|NCT02449239|583228499|FG000|Maintenance Month 12|Lack of Efficacy|5|||
161500250|NCT02449239|583228499|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
161500251|NCT02449239|583228499|FG000|Maintenance Month 12|Subject moved from area|1|||
161500252|NCT02449239|583228499|FG000|Maintenance Month 15|Lack of Efficacy|1|||
161500253|NCT02449239|583228499|FG000|Maintenance Month 21|Lack of Efficacy|1|||
161500254|NCT02449239|583228499|FG000|Maintenance Month 21|Sponsor decision|1|||
161500255|NCT03239470|583228502|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
161500256|NCT03239470|583228503|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
161500257|NCT01023581|583228504|FG000|Overall Study|Adverse Event|4|||
161500258|NCT01023581|583228505|FG001|Overall Study|Adverse Event|4|||
161500259|NCT01023581|583228506|FG002|Overall Study|Adverse Event|7|||
161500260|NCT01023581|583228507|FG003|Overall Study|Adverse Event|3|||
161500261|NCT01023581|583228508|FG004|Overall Study|Adverse Event|2|||
161500262|NCT01023581|583228509|FG005|Overall Study|Adverse Event|5|||
161500263|NCT01023581|583228510|FG006|Overall Study|Adverse Event|11|||
161500264|NCT01023581|583228504|FG000|Overall Study|Major protocol deviation|2|||
161500265|NCT01023581|583228505|FG001|Overall Study|Major protocol deviation|0|||
161500266|NCT01023581|583228506|FG002|Overall Study|Major protocol deviation|3|||
161500267|NCT01023581|583228507|FG003|Overall Study|Major protocol deviation|0|||
161500268|NCT01023581|583228508|FG004|Overall Study|Major protocol deviation|0|||
161500269|NCT01023581|583228509|FG005|Overall Study|Major protocol deviation|0|||
161500270|NCT01023581|583228510|FG006|Overall Study|Major protocol deviation|0|||
161500271|NCT01023581|583228504|FG000|Overall Study|Lost to Follow-up|4|||
161500272|NCT01023581|583228505|FG001|Overall Study|Lost to Follow-up|8|||
161500273|NCT01023581|583228506|FG002|Overall Study|Lost to Follow-up|7|||
161500274|NCT01023581|583228507|FG003|Overall Study|Lost to Follow-up|2|||
161500275|NCT01023581|583228508|FG004|Overall Study|Lost to Follow-up|5|||
161500276|NCT01023581|583228509|FG005|Overall Study|Lost to Follow-up|2|||
161500277|NCT01023581|583228510|FG006|Overall Study|Lost to Follow-up|2|||
161500278|NCT01023581|583228504|FG000|Overall Study|Withdrawal by Subject|13|||
161500279|NCT01023581|583228505|FG001|Overall Study|Withdrawal by Subject|8|||
161500280|NCT01023581|583228506|FG002|Overall Study|Withdrawal by Subject|16|||
161500281|NCT01023581|583228507|FG003|Overall Study|Withdrawal by Subject|10|||
161500282|NCT01023581|583228508|FG004|Overall Study|Withdrawal by Subject|6|||
161500283|NCT01023581|583228509|FG005|Overall Study|Withdrawal by Subject|8|||
161500284|NCT01023581|583228510|FG006|Overall Study|Withdrawal by Subject|5|||
161500285|NCT01023581|583228504|FG000|Overall Study|Pregnancy|0|||
161500286|NCT01023581|583228505|FG001|Overall Study|Pregnancy|0|||
161500287|NCT01023581|583228506|FG002|Overall Study|Pregnancy|0|||
161500288|NCT01023581|583228507|FG003|Overall Study|Pregnancy|2|||
161500289|NCT01023581|583228508|FG004|Overall Study|Pregnancy|0|||
161500290|NCT01023581|583228509|FG005|Overall Study|Pregnancy|1|||
161500291|NCT01023581|583228510|FG006|Overall Study|Pregnancy|0|||
161500292|NCT01023581|583228504|FG000|Overall Study|Lack of Efficacy|9|||
161500293|NCT01023581|583228505|FG001|Overall Study|Lack of Efficacy|3|||
161500294|NCT01023581|583228506|FG002|Overall Study|Lack of Efficacy|6|||
161500295|NCT01023581|583228507|FG003|Overall Study|Lack of Efficacy|2|||
161500296|NCT01023581|583228508|FG004|Overall Study|Lack of Efficacy|1|||
161500297|NCT01023581|583228509|FG005|Overall Study|Lack of Efficacy|2|||
161500298|NCT01023581|583228510|FG006|Overall Study|Lack of Efficacy|1|||
161500299|NCT01023581|583228504|FG000|Overall Study|Physician Decision|2|||
161500300|NCT01023581|583228505|FG001|Overall Study|Physician Decision|0|||
161500301|NCT01023581|583228506|FG002|Overall Study|Physician Decision|2|||
161500302|NCT01023581|583228507|FG003|Overall Study|Physician Decision|1|||
161500303|NCT01023581|583228508|FG004|Overall Study|Physician Decision|1|||
161500304|NCT01023581|583228509|FG005|Overall Study|Physician Decision|1|||
161500305|NCT01023581|583228510|FG006|Overall Study|Physician Decision|1|||
161500306|NCT01023581|583228504|FG000|Overall Study|Other|1|||
161500307|NCT01023581|583228505|FG001|Overall Study|Other|0|||
161500308|NCT01023581|583228506|FG002|Overall Study|Other|1|||
161500309|NCT01023581|583228507|FG003|Overall Study|Other|0|||
161500310|NCT01023581|583228508|FG004|Overall Study|Other|1|||
161500311|NCT01023581|583228509|FG005|Overall Study|Other|0|||
161500312|NCT01023581|583228510|FG006|Overall Study|Other|0|||
161500313|NCT02658890|583228516|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500314|NCT02658890|583228517|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500315|NCT02658890|583228518|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500316|NCT02658890|583228519|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500317|NCT02658890|583228520|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500318|NCT02658890|583228521|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500319|NCT02658890|583228522|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500320|NCT02658890|583228523|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500321|NCT02658890|583228524|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
161500322|NCT02658890|583228525|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500323|NCT02658890|583228526|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500324|NCT02658890|583228527|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500325|NCT02658890|583228528|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500326|NCT02658890|583228529|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500327|NCT02658890|583228530|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500328|NCT02658890|583228531|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500329|NCT02658890|583228532|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500330|NCT02658890|583228533|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500331|NCT02658890|583228534|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500332|NCT02658890|583228535|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500333|NCT02658890|583228536|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500334|NCT02658890|583228537|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500335|NCT02658890|583228538|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500336|NCT02658890|583228539|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500337|NCT02658890|583228540|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500338|NCT02658890|583228541|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500339|NCT02658890|583228542|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500340|NCT02658890|583228516|FG000|Treatment Phase|Adverse Event|0|||
161500341|NCT02658890|583228517|FG001|Treatment Phase|Adverse Event|1|||
161500342|NCT02658890|583228518|FG002|Treatment Phase|Adverse Event|2|||
161500343|NCT02658890|583228519|FG003|Treatment Phase|Adverse Event|2|||
161500344|NCT02658890|583228520|FG004|Treatment Phase|Adverse Event|1|||
161500345|NCT02658890|583228521|FG005|Treatment Phase|Adverse Event|0|||
161500346|NCT02658890|583228522|FG006|Treatment Phase|Adverse Event|0|||
161500347|NCT02658890|583228523|FG007|Treatment Phase|Adverse Event|2|||
161500348|NCT02658890|583228524|FG008|Treatment Phase|Adverse Event|1|||
161500349|NCT02658890|583228525|FG009|Treatment Phase|Adverse Event|2|||
161500350|NCT02658890|583228526|FG010|Treatment Phase|Adverse Event|3|||
161500351|NCT02658890|583228527|FG011|Treatment Phase|Adverse Event|0|||
161500352|NCT02658890|583228528|FG012|Treatment Phase|Adverse Event|1|||
161500353|NCT02658890|583228529|FG013|Treatment Phase|Adverse Event|4|||
161500354|NCT02658890|583228530|FG014|Treatment Phase|Adverse Event|0|||
161500355|NCT02658890|583228531|FG015|Treatment Phase|Adverse Event|0|||
161500356|NCT02658890|583228532|FG016|Treatment Phase|Adverse Event|0|||
161500357|NCT02658890|583228533|FG017|Treatment Phase|Adverse Event|0|||
161500358|NCT02658890|583228534|FG018|Treatment Phase|Adverse Event|5|||
161500359|NCT02658890|583228535|FG019|Treatment Phase|Adverse Event|1|||
161500360|NCT02658890|583228536|FG020|Treatment Phase|Adverse Event|3|||
161500361|NCT02658890|583228537|FG021|Treatment Phase|Adverse Event|0|||
161500362|NCT02658890|583228538|FG022|Treatment Phase|Adverse Event|5|||
161500363|NCT02658890|583228539|FG023|Treatment Phase|Adverse Event|0|||
161500364|NCT02658890|583228540|FG024|Treatment Phase|Adverse Event|0|||
161500365|NCT02658890|583228541|FG025|Treatment Phase|Adverse Event|2|||
161500366|NCT02658890|583228542|FG026|Treatment Phase|Adverse Event|1|||
161500367|NCT02658890|583228516|FG000|Treatment Phase|Death|0|||
161500368|NCT02658890|583228517|FG001|Treatment Phase|Death|0|||
161500369|NCT02658890|583228518|FG002|Treatment Phase|Death|0|||
161500370|NCT02658890|583228519|FG003|Treatment Phase|Death|0|||
161500371|NCT02658890|583228520|FG004|Treatment Phase|Death|0|||
161500372|NCT02658890|583228521|FG005|Treatment Phase|Death|0|||
161500373|NCT02658890|583228522|FG006|Treatment Phase|Death|0|||
161500374|NCT02658890|583228523|FG007|Treatment Phase|Death|0|||
161673257|NCT00931944|583857926|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
161819055|NCT00819169|584378203|FG000|Overall Study|Lost to Follow-up|0|||
161819056|NCT00819169|584378204|FG001|Overall Study|Lost to Follow-up|2|||
161819057|NCT00819169|584378205|FG002|Overall Study|Lost to Follow-up|0|||
161500375|NCT02658890|583228524|FG008|Treatment Phase|Death|0|||
161500376|NCT02658890|583228525|FG009|Treatment Phase|Death|0|||
161500377|NCT02658890|583228526|FG010|Treatment Phase|Death|0|||
161500378|NCT02658890|583228527|FG011|Treatment Phase|Death|0|||
161500379|NCT02658890|583228528|FG012|Treatment Phase|Death|0|||
161500380|NCT02658890|583228529|FG013|Treatment Phase|Death|0|||
161500381|NCT02658890|583228530|FG014|Treatment Phase|Death|0|||
161500382|NCT02658890|583228531|FG015|Treatment Phase|Death|0|||
161500383|NCT02658890|583228532|FG016|Treatment Phase|Death|0|||
161925147|NCT06132386|584771051|FG002|Overall Study|ineligible vital signs|0|||
161925148|NCT06132386|584771052|FG003|Overall Study|ineligible vital signs|0|||
161925149|NCT06132386|584771053|FG004|Overall Study|ineligible vital signs|0|||
161925150|NCT06132386|584771054|FG005|Overall Study|ineligible vital signs|0|||
161925151|NCT05179603|584771055|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161925152|NCT05179603|584771055|FG000|Overall Study|Withdrawal by Subject|1|||
161925153|NCT05179603|584771055|FG000|Overall Study|Progressive disease|4|||
161925154|NCT05179603|584771055|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
161925155|NCT05937373|584771056|FG000|Overall Study|Out of Window|2|||
161925156|NCT05937373|584771057|FG001|Overall Study|Out of Window|0|||
161925157|NCT05937373|584771056|FG000|Overall Study|Device fell off prior to date of surgery|0|||
161925158|NCT05937373|584771057|FG001|Overall Study|Device fell off prior to date of surgery|2|||
161925159|NCT06061952|584771059|FG000|Overall Study|Withdrawal by Subject|1|||
161925160|NCT06061952|584771060|FG001|Overall Study|Withdrawal by Subject|2|||
161925161|NCT06061952|584771059|FG000|Overall Study|Lost to Follow-up|2|||
161925162|NCT06061952|584771060|FG001|Overall Study|Lost to Follow-up|2|||
161925163|NCT01405911|584771061|FG000|Overall Study|Pre-treatment lab AE|0|||
161925164|NCT01405911|584771062|FG001|Overall Study|Pre-treatment lab AE|1|||
161925165|NCT01405911|584771063|FG002|Overall Study|Pre-treatment lab AE|0|||
161925166|NCT01405911|584771061|FG000|Overall Study|Lost to Follow-up|0|||
161925167|NCT01405911|584771062|FG001|Overall Study|Lost to Follow-up|1|||
161925168|NCT01405911|584771063|FG002|Overall Study|Lost to Follow-up|0|||
161925169|NCT01405911|584771061|FG000|Overall Study|Protocol Violation|1|||
161925170|NCT01405911|584771062|FG001|Overall Study|Protocol Violation|0|||
161925171|NCT01405911|584771063|FG002|Overall Study|Protocol Violation|0|||
161925172|NCT01405911|584771061|FG000|Overall Study|Withdrawal by Subject|3|||
161925173|NCT01405911|584771062|FG001|Overall Study|Withdrawal by Subject|1|||
161925174|NCT01405911|584771063|FG002|Overall Study|Withdrawal by Subject|1|||
161925175|NCT06375655|584771064|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
161925176|NCT06375655|584771065|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
161925177|NCT01685437|584771068|FG000|Overall Study|Withdrawal by Subject|22|||
161925178|NCT01685437|584771068|FG000|Overall Study|Lost to Follow-up|3|||
161925179|NCT01685437|584771068|FG000|Overall Study|Adverse Event|1|||
161925180|NCT01685437|584771068|FG000|Overall Study|Protocol Violation|4|||
161925181|NCT01685437|584771068|FG000|Overall Study|Unable to make visits due to work|1|||
161925182|NCT01039675|584771075|FG000|Overall Study|Adverse Event|0|||
161925183|NCT01039675|584771076|FG001|Overall Study|Adverse Event|2|||
161925184|NCT01039675|584771075|FG000|Overall Study|Lack of Efficacy|0|||
161925185|NCT01039675|584771076|FG001|Overall Study|Lack of Efficacy|2|||
161925186|NCT01039675|584771075|FG000|Overall Study|Withdrawal by Subject|0|||
161925187|NCT01039675|584771076|FG001|Overall Study|Withdrawal by Subject|1|||
161925188|NCT01039675|584771075|FG000|Overall Study|Lost to Follow-up|0|||
161925189|NCT01039675|584771076|FG001|Overall Study|Lost to Follow-up|1|||
161925190|NCT01039675|584771075|FG000|Overall Study|Physician Decision|0|||
161925191|NCT01039675|584771076|FG001|Overall Study|Physician Decision|1|||
161925192|NCT03514017|584771081|FG000|Overall Study|Death|1|||
161925193|NCT03514017|584771081|FG000|Overall Study|Adverse Event|1|||
161925194|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925195|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
161925196|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
161925197|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925198|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925199|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925200|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925201|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
161925202|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925203|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
161925204|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925205|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925206|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925207|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925208|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925209|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925210|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
161925211|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925212|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925213|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925214|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925215|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
161925216|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925217|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161500384|NCT02658890|583228533|FG017|Treatment Phase|Death|0|||
161500385|NCT02658890|583228534|FG018|Treatment Phase|Death|1|||
161500386|NCT02658890|583228535|FG019|Treatment Phase|Death|0|||
161500387|NCT02658890|583228536|FG020|Treatment Phase|Death|0|||
161500388|NCT02658890|583228537|FG021|Treatment Phase|Death|0|||
161500389|NCT02658890|583228538|FG022|Treatment Phase|Death|0|||
161500390|NCT02658890|583228539|FG023|Treatment Phase|Death|0|||
161500391|NCT02658890|583228540|FG024|Treatment Phase|Death|0|||
161500392|NCT02658890|583228541|FG025|Treatment Phase|Death|0|||
161500393|NCT02658890|583228542|FG026|Treatment Phase|Death|0|||
161500394|NCT02658890|583228516|FG000|Treatment Phase|Lost to Follow-up|0|||
161500395|NCT02658890|583228517|FG001|Treatment Phase|Lost to Follow-up|0|||
161500396|NCT02658890|583228518|FG002|Treatment Phase|Lost to Follow-up|0|||
161500397|NCT02658890|583228519|FG003|Treatment Phase|Lost to Follow-up|0|||
161500398|NCT02658890|583228520|FG004|Treatment Phase|Lost to Follow-up|0|||
161500399|NCT02658890|583228521|FG005|Treatment Phase|Lost to Follow-up|0|||
161500400|NCT02658890|583228522|FG006|Treatment Phase|Lost to Follow-up|1|||
161500401|NCT02658890|583228523|FG007|Treatment Phase|Lost to Follow-up|0|||
161500402|NCT02658890|583228524|FG008|Treatment Phase|Lost to Follow-up|0|||
161500403|NCT02658890|583228525|FG009|Treatment Phase|Lost to Follow-up|0|||
161819058|NCT00819169|584378206|FG003|Overall Study|Lost to Follow-up|1|||
161819059|NCT00819169|584378207|FG004|Overall Study|Lost to Follow-up|0|||
161819060|NCT00819169|584378208|FG005|Overall Study|Lost to Follow-up|6|||
161819061|NCT00819169|584378209|FG006|Overall Study|Lost to Follow-up|2|||
161819062|NCT00819169|584378210|FG007|Overall Study|Lost to Follow-up|2|||
161819063|NCT00819169|584378211|FG008|Overall Study|Lost to Follow-up|1|||
161819064|NCT00819169|584378203|FG000|Overall Study|Death|1|||
161819065|NCT00819169|584378204|FG001|Overall Study|Death|1|||
161819066|NCT00819169|584378205|FG002|Overall Study|Death|3|||
161819067|NCT00819169|584378206|FG003|Overall Study|Death|8|||
161819068|NCT00819169|584378207|FG004|Overall Study|Death|5|||
161819069|NCT00819169|584378208|FG005|Overall Study|Death|7|||
161819070|NCT00819169|584378209|FG006|Overall Study|Death|9|||
161819071|NCT00819169|584378210|FG007|Overall Study|Death|4|||
161819072|NCT00819169|584378211|FG008|Overall Study|Death|7|||
161819073|NCT00819169|584378203|FG000|Overall Study|Ineligibility determined|0|||
161819074|NCT00819169|584378204|FG001|Overall Study|Ineligibility determined|0|||
161819075|NCT00819169|584378205|FG002|Overall Study|Ineligibility determined|0|||
161819076|NCT00819169|584378206|FG003|Overall Study|Ineligibility determined|2|||
161819077|NCT00819169|584378207|FG004|Overall Study|Ineligibility determined|0|||
161819078|NCT00819169|584378208|FG005|Overall Study|Ineligibility determined|0|||
161819079|NCT00819169|584378209|FG006|Overall Study|Ineligibility determined|0|||
161819080|NCT00819169|584378210|FG007|Overall Study|Ineligibility determined|0|||
161819081|NCT00819169|584378211|FG008|Overall Study|Ineligibility determined|1|||
161819082|NCT00819169|584378203|FG000|Overall Study|Adverse Event|0|||
161819083|NCT00819169|584378204|FG001|Overall Study|Adverse Event|0|||
161819084|NCT00819169|584378205|FG002|Overall Study|Adverse Event|0|||
161819085|NCT00819169|584378206|FG003|Overall Study|Adverse Event|0|||
161819086|NCT00819169|584378207|FG004|Overall Study|Adverse Event|1|||
161819087|NCT00819169|584378208|FG005|Overall Study|Adverse Event|0|||
161819088|NCT00819169|584378209|FG006|Overall Study|Adverse Event|0|||
161819089|NCT00819169|584378210|FG007|Overall Study|Adverse Event|0|||
161819090|NCT00819169|584378211|FG008|Overall Study|Adverse Event|0|||
161819091|NCT00819169|584378203|FG000|Overall Study|Administrative Decision|0|||
161819092|NCT00819169|584378204|FG001|Overall Study|Administrative Decision|0|||
161819093|NCT00819169|584378205|FG002|Overall Study|Administrative Decision|0|||
161819094|NCT00819169|584378206|FG003|Overall Study|Administrative Decision|0|||
161819095|NCT00819169|584378207|FG004|Overall Study|Administrative Decision|1|||
161819096|NCT00819169|584378208|FG005|Overall Study|Administrative Decision|2|||
161819097|NCT00819169|584378209|FG006|Overall Study|Administrative Decision|0|||
161819098|NCT00819169|584378210|FG007|Overall Study|Administrative Decision|2|||
161819099|NCT00819169|584378211|FG008|Overall Study|Administrative Decision|0|||
161819100|NCT02637141|584378215|FG000|Overall Study|Adverse Event|1|||
161819101|NCT02637141|584378216|FG001|Overall Study|Adverse Event|1|||
161819102|NCT02637141|584378217|FG002|Overall Study|Adverse Event|0|||
161819103|NCT02637141|584378215|FG000|Overall Study|Withdrawal by Subject|1|||
161819104|NCT02637141|584378216|FG001|Overall Study|Withdrawal by Subject|1|||
161819105|NCT02637141|584378217|FG002|Overall Study|Withdrawal by Subject|1|||
161819106|NCT03885934|584378221|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161819107|NCT03885934|584378222|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
161819108|NCT03885934|584378223|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161500404|NCT02658890|583228526|FG010|Treatment Phase|Lost to Follow-up|0|||
161500405|NCT02658890|583228527|FG011|Treatment Phase|Lost to Follow-up|0|||
161500406|NCT02658890|583228528|FG012|Treatment Phase|Lost to Follow-up|0|||
161500407|NCT02658890|583228529|FG013|Treatment Phase|Lost to Follow-up|0|||
161819109|NCT03885934|584378224|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
161819110|NCT03885934|584378225|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
161819111|NCT03885934|584378226|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
161500408|NCT02658890|583228530|FG014|Treatment Phase|Lost to Follow-up|0|||
161500409|NCT02658890|583228531|FG015|Treatment Phase|Lost to Follow-up|0|||
161500410|NCT02658890|583228532|FG016|Treatment Phase|Lost to Follow-up|0|||
161500411|NCT02658890|583228533|FG017|Treatment Phase|Lost to Follow-up|0|||
161500412|NCT02658890|583228534|FG018|Treatment Phase|Lost to Follow-up|0|||
161500413|NCT02658890|583228535|FG019|Treatment Phase|Lost to Follow-up|0|||
161500414|NCT02658890|583228536|FG020|Treatment Phase|Lost to Follow-up|0|||
161500415|NCT02658890|583228537|FG021|Treatment Phase|Lost to Follow-up|0|||
161500416|NCT02658890|583228538|FG022|Treatment Phase|Lost to Follow-up|0|||
161500417|NCT02658890|583228539|FG023|Treatment Phase|Lost to Follow-up|0|||
161500418|NCT02658890|583228540|FG024|Treatment Phase|Lost to Follow-up|0|||
161500419|NCT02658890|583228541|FG025|Treatment Phase|Lost to Follow-up|0|||
161500420|NCT02658890|583228542|FG026|Treatment Phase|Lost to Follow-up|0|||
161500421|NCT02658890|583228516|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
161500422|NCT02658890|583228517|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
161500423|NCT02658890|583228518|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
161500424|NCT02658890|583228519|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
161500425|NCT02658890|583228520|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
161500426|NCT02658890|583228521|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
161500427|NCT02658890|583228522|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
161500428|NCT02658890|583228523|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
161500429|NCT02658890|583228524|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
161500430|NCT02658890|583228525|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
161500431|NCT02658890|583228526|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
161500432|NCT02658890|583228527|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
161500433|NCT02658890|583228528|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
161500434|NCT02658890|583228529|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
161500435|NCT02658890|583228530|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
161500436|NCT02658890|583228531|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
161500437|NCT02658890|583228532|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
161500438|NCT02658890|583228533|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
161500439|NCT02658890|583228534|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
161500440|NCT02658890|583228535|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
161500441|NCT02658890|583228536|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
161500442|NCT02658890|583228537|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
161500443|NCT02658890|583228538|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
161500444|NCT02658890|583228539|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
161500445|NCT02658890|583228540|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
161500446|NCT02658890|583228541|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
161500447|NCT02658890|583228542|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
161500448|NCT02658890|583228516|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
161500449|NCT02658890|583228517|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
161500450|NCT02658890|583228518|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
161500451|NCT02658890|583228519|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
161500452|NCT02658890|583228520|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
161500453|NCT02658890|583228521|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
161500454|NCT02658890|583228522|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
161500455|NCT02658890|583228523|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
161500456|NCT02658890|583228524|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
161500457|NCT02658890|583228525|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
161500458|NCT02658890|583228526|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
161500459|NCT02658890|583228527|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
161500460|NCT02658890|583228528|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
161500461|NCT02658890|583228529|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
161500462|NCT02658890|583228530|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
161500463|NCT02658890|583228531|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
161500464|NCT02658890|583228532|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
161500465|NCT02658890|583228533|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
161500466|NCT02658890|583228534|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
161500467|NCT02658890|583228535|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
161500468|NCT02658890|583228536|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
161500469|NCT02658890|583228537|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
161500470|NCT02658890|583228538|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
161500471|NCT02658890|583228539|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
161500472|NCT02658890|583228540|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
161500473|NCT02658890|583228541|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
161500474|NCT02658890|583228542|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
161500475|NCT02658890|583228516|FG000|Treatment Phase|Other Reasons|0|||
161500476|NCT02658890|583228517|FG001|Treatment Phase|Other Reasons|0|||
161500477|NCT02658890|583228518|FG002|Treatment Phase|Other Reasons|0|||
161500478|NCT02658890|583228519|FG003|Treatment Phase|Other Reasons|0|||
161500479|NCT02658890|583228520|FG004|Treatment Phase|Other Reasons|0|||
161500480|NCT02658890|583228521|FG005|Treatment Phase|Other Reasons|0|||
161500481|NCT02658890|583228522|FG006|Treatment Phase|Other Reasons|1|||
161500482|NCT02658890|583228523|FG007|Treatment Phase|Other Reasons|0|||
161500483|NCT02658890|583228524|FG008|Treatment Phase|Other Reasons|1|||
161500484|NCT02658890|583228525|FG009|Treatment Phase|Other Reasons|0|||
161500485|NCT02658890|583228526|FG010|Treatment Phase|Other Reasons|0|||
161500486|NCT02658890|583228527|FG011|Treatment Phase|Other Reasons|0|||
161500487|NCT02658890|583228528|FG012|Treatment Phase|Other Reasons|0|||
161500488|NCT02658890|583228529|FG013|Treatment Phase|Other Reasons|2|||
161500489|NCT02658890|583228530|FG014|Treatment Phase|Other Reasons|0|||
161500490|NCT02658890|583228531|FG015|Treatment Phase|Other Reasons|0|||
161500491|NCT02658890|583228532|FG016|Treatment Phase|Other Reasons|0|||
161500492|NCT02658890|583228533|FG017|Treatment Phase|Other Reasons|0|||
161500493|NCT02658890|583228534|FG018|Treatment Phase|Other Reasons|1|||
161500494|NCT02658890|583228535|FG019|Treatment Phase|Other Reasons|0|||
161500495|NCT02658890|583228536|FG020|Treatment Phase|Other Reasons|0|||
161500496|NCT02658890|583228537|FG021|Treatment Phase|Other Reasons|0|||
161500497|NCT02658890|583228538|FG022|Treatment Phase|Other Reasons|0|||
161500498|NCT02658890|583228539|FG023|Treatment Phase|Other Reasons|0|||
161500499|NCT02658890|583228540|FG024|Treatment Phase|Other Reasons|1|||
161500500|NCT02658890|583228541|FG025|Treatment Phase|Other Reasons|0|||
161500501|NCT02658890|583228542|FG026|Treatment Phase|Other Reasons|1|||
161500502|NCT02658890|583228516|FG000|Treatment Phase|Progressive Disease|6|||
161500503|NCT02658890|583228517|FG001|Treatment Phase|Progressive Disease|7|||
161500504|NCT02658890|583228518|FG002|Treatment Phase|Progressive Disease|6|||
161500505|NCT02658890|583228519|FG003|Treatment Phase|Progressive Disease|12|||
161500506|NCT02658890|583228520|FG004|Treatment Phase|Progressive Disease|6|||
161500507|NCT02658890|583228521|FG005|Treatment Phase|Progressive Disease|18|||
161500508|NCT02658890|583228522|FG006|Treatment Phase|Progressive Disease|12|||
161500509|NCT02658890|583228523|FG007|Treatment Phase|Progressive Disease|19|||
161500510|NCT02658890|583228524|FG008|Treatment Phase|Progressive Disease|26|||
161500511|NCT02658890|583228525|FG009|Treatment Phase|Progressive Disease|8|||
161500512|NCT02658890|583228526|FG010|Treatment Phase|Progressive Disease|7|||
161500513|NCT02658890|583228527|FG011|Treatment Phase|Progressive Disease|9|||
161500514|NCT02658890|583228528|FG012|Treatment Phase|Progressive Disease|8|||
161500515|NCT02658890|583228529|FG013|Treatment Phase|Progressive Disease|29|||
161500516|NCT02658890|583228530|FG014|Treatment Phase|Progressive Disease|6|||
161500517|NCT02658890|583228531|FG015|Treatment Phase|Progressive Disease|2|||
161500518|NCT02658890|583228532|FG016|Treatment Phase|Progressive Disease|32|||
161500519|NCT02658890|583228533|FG017|Treatment Phase|Progressive Disease|14|||
161500520|NCT02658890|583228534|FG018|Treatment Phase|Progressive Disease|40|||
161500521|NCT02658890|583228535|FG019|Treatment Phase|Progressive Disease|32|||
161500522|NCT02658890|583228536|FG020|Treatment Phase|Progressive Disease|19|||
161500523|NCT02658890|583228537|FG021|Treatment Phase|Progressive Disease|30|||
161500524|NCT02658890|583228538|FG022|Treatment Phase|Progressive Disease|15|||
161500525|NCT02658890|583228539|FG023|Treatment Phase|Progressive Disease|0|||
161500526|NCT02658890|583228540|FG024|Treatment Phase|Progressive Disease|0|||
161500527|NCT02658890|583228541|FG025|Treatment Phase|Progressive Disease|14|||
161500528|NCT02658890|583228542|FG026|Treatment Phase|Progressive Disease|11|||
161500529|NCT02658890|583228516|FG000|Treatment Phase|Study Drug Toxicity|0|||
161500530|NCT02658890|583228517|FG001|Treatment Phase|Study Drug Toxicity|0|||
161500531|NCT02658890|583228518|FG002|Treatment Phase|Study Drug Toxicity|2|||
161500532|NCT02658890|583228519|FG003|Treatment Phase|Study Drug Toxicity|0|||
161500533|NCT02658890|583228520|FG004|Treatment Phase|Study Drug Toxicity|0|||
161500534|NCT02658890|583228521|FG005|Treatment Phase|Study Drug Toxicity|0|||
161500535|NCT02658890|583228522|FG006|Treatment Phase|Study Drug Toxicity|0|||
161500536|NCT02658890|583228523|FG007|Treatment Phase|Study Drug Toxicity|0|||
161500537|NCT02658890|583228524|FG008|Treatment Phase|Study Drug Toxicity|3|||
161500538|NCT02658890|583228525|FG009|Treatment Phase|Study Drug Toxicity|0|||
161819112|NCT00406393|584378227|FG000|Overall Study|Did not undergo transplantation|2|||
161819113|NCT00406393|584378228|FG001|Overall Study|Did not undergo transplantation|1|||
161819114|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
161819115|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
161819116|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
161500539|NCT02658890|583228526|FG010|Treatment Phase|Study Drug Toxicity|1|||
161819117|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
161819118|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
161819119|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
161819120|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
161819121|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
161500540|NCT02658890|583228527|FG011|Treatment Phase|Study Drug Toxicity|1|||
161500541|NCT02658890|583228528|FG012|Treatment Phase|Study Drug Toxicity|2|||
161500542|NCT02658890|583228529|FG013|Treatment Phase|Study Drug Toxicity|9|||
161500543|NCT02658890|583228530|FG014|Treatment Phase|Study Drug Toxicity|0|||
161500544|NCT02658890|583228531|FG015|Treatment Phase|Study Drug Toxicity|1|||
161500545|NCT02658890|583228532|FG016|Treatment Phase|Study Drug Toxicity|1|||
161683060|NCT02554019|583891221|FG000|Overall Study|Adverse Event|1|||
161819122|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
161819123|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
161500546|NCT02658890|583228533|FG017|Treatment Phase|Study Drug Toxicity|0|||
161500547|NCT02658890|583228534|FG018|Treatment Phase|Study Drug Toxicity|8|||
161500548|NCT02658890|583228535|FG019|Treatment Phase|Study Drug Toxicity|3|||
161500549|NCT02658890|583228536|FG020|Treatment Phase|Study Drug Toxicity|2|||
161500550|NCT02658890|583228537|FG021|Treatment Phase|Study Drug Toxicity|0|||
161500551|NCT02658890|583228538|FG022|Treatment Phase|Study Drug Toxicity|8|||
161500552|NCT02658890|583228539|FG023|Treatment Phase|Study Drug Toxicity|0|||
161500553|NCT02658890|583228540|FG024|Treatment Phase|Study Drug Toxicity|0|||
161500554|NCT02658890|583228541|FG025|Treatment Phase|Study Drug Toxicity|2|||
161500555|NCT02658890|583228542|FG026|Treatment Phase|Study Drug Toxicity|0|||
161500556|NCT02658890|583228516|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500557|NCT02658890|583228517|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500558|NCT02658890|583228518|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500559|NCT02658890|583228519|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
161500560|NCT02658890|583228520|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500561|NCT02658890|583228521|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500562|NCT02658890|583228522|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500563|NCT02658890|583228523|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500564|NCT02658890|583228524|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500565|NCT02658890|583228525|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
161500566|NCT02658890|583228526|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500567|NCT02658890|583228527|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500568|NCT02658890|583228528|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500569|NCT02658890|583228529|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500570|NCT02658890|583228530|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500571|NCT02658890|583228531|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500572|NCT02658890|583228532|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500573|NCT02658890|583228533|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500574|NCT02658890|583228534|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
161500575|NCT02658890|583228535|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500576|NCT02658890|583228536|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500577|NCT02658890|583228537|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500578|NCT02658890|583228538|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
161500579|NCT02658890|583228539|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500580|NCT02658890|583228540|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500581|NCT02658890|583228541|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500582|NCT02658890|583228542|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
161500583|NCT02658890|583228516|FG000|Treatment Phase|Withdrawal by Subject|0|||
161500584|NCT02658890|583228517|FG001|Treatment Phase|Withdrawal by Subject|1|||
161500585|NCT02658890|583228518|FG002|Treatment Phase|Withdrawal by Subject|0|||
161500586|NCT02658890|583228519|FG003|Treatment Phase|Withdrawal by Subject|0|||
161500587|NCT02658890|583228520|FG004|Treatment Phase|Withdrawal by Subject|0|||
161500588|NCT02658890|583228521|FG005|Treatment Phase|Withdrawal by Subject|0|||
161500589|NCT02658890|583228522|FG006|Treatment Phase|Withdrawal by Subject|1|||
161500590|NCT02658890|583228523|FG007|Treatment Phase|Withdrawal by Subject|0|||
161500591|NCT02658890|583228524|FG008|Treatment Phase|Withdrawal by Subject|0|||
161500592|NCT02658890|583228525|FG009|Treatment Phase|Withdrawal by Subject|1|||
161500593|NCT02658890|583228526|FG010|Treatment Phase|Withdrawal by Subject|0|||
161500594|NCT02658890|583228527|FG011|Treatment Phase|Withdrawal by Subject|0|||
161500595|NCT02658890|583228528|FG012|Treatment Phase|Withdrawal by Subject|1|||
161500596|NCT02658890|583228529|FG013|Treatment Phase|Withdrawal by Subject|3|||
161500597|NCT02658890|583228530|FG014|Treatment Phase|Withdrawal by Subject|0|||
161500598|NCT02658890|583228531|FG015|Treatment Phase|Withdrawal by Subject|0|||
161500599|NCT02658890|583228532|FG016|Treatment Phase|Withdrawal by Subject|1|||
161500600|NCT02658890|583228533|FG017|Treatment Phase|Withdrawal by Subject|0|||
161500601|NCT02658890|583228534|FG018|Treatment Phase|Withdrawal by Subject|4|||
161500602|NCT02658890|583228535|FG019|Treatment Phase|Withdrawal by Subject|3|||
161500603|NCT02658890|583228536|FG020|Treatment Phase|Withdrawal by Subject|0|||
161500604|NCT02658890|583228537|FG021|Treatment Phase|Withdrawal by Subject|4|||
161500605|NCT02658890|583228538|FG022|Treatment Phase|Withdrawal by Subject|1|||
161500606|NCT02658890|583228539|FG023|Treatment Phase|Withdrawal by Subject|1|||
161500607|NCT02658890|583228540|FG024|Treatment Phase|Withdrawal by Subject|0|||
161500608|NCT02658890|583228541|FG025|Treatment Phase|Withdrawal by Subject|0|||
161819124|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
161819125|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
161500609|NCT02658890|583228542|FG026|Treatment Phase|Withdrawal by Subject|0|||
161500610|NCT00076011|583228545|FG000|Overall Study|Death|1|||
161819126|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
161819127|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
161500611|NCT00076011|583228545|FG000|Overall Study|Adverse Event|10|||
161500612|NCT00076011|583228545|FG000|Overall Study|Lack of Efficacy|25|||
161500613|NCT00076011|583228545|FG000|Overall Study|Withdrawal by Subject|1|||
161500614|NCT00076011|583228545|FG000|Overall Study|Study terminated by sponsor|3|||
161500615|NCT00076011|583228545|FG000|Overall Study|Other|11|||
161500616|NCT00076011|583228545|FG000|Overall Study|Ongoing|1|||
161500617|NCT02864251|583228552|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
161500618|NCT02864251|583228553|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
161500619|NCT02864251|583228554|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
161500620|NCT02864251|583228552|FG000|Pre-Treatment|Withdrawal by Participant|0|||
161500621|NCT02864251|583228553|FG001|Pre-Treatment|Withdrawal by Participant|0|||
161500622|NCT02864251|583228554|FG002|Pre-Treatment|Withdrawal by Participant|4|||
161500623|NCT02864251|583228552|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
161500624|NCT02864251|583228553|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
161500625|NCT02864251|583228554|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
161500626|NCT02864251|583228552|FG000|Pre-Treatment|Other Reasons|0|||
161500627|NCT02864251|583228553|FG001|Pre-Treatment|Other Reasons|1|||
161500628|NCT02864251|583228554|FG002|Pre-Treatment|Other Reasons|1|||
161500629|NCT02864251|583228552|FG000|Treatment|Disease Progression|109|||
161500630|NCT02864251|583228553|FG001|Treatment|Disease Progression|52|||
161500631|NCT02864251|583228554|FG002|Treatment|Disease Progression|101|||
161500632|NCT02864251|583228552|FG000|Treatment|Study Drug Toxicity|9|||
161500633|NCT02864251|583228553|FG001|Treatment|Study Drug Toxicity|4|||
161500634|NCT02864251|583228554|FG002|Treatment|Study Drug Toxicity|10|||
161500635|NCT02864251|583228552|FG000|Treatment|Death|0|||
161500636|NCT02864251|583228553|FG001|Treatment|Death|2|||
161500637|NCT02864251|583228554|FG002|Treatment|Death|3|||
161500638|NCT02864251|583228552|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
161500639|NCT02864251|583228553|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
161500640|NCT02864251|583228554|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
161500641|NCT02864251|583228552|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
161500642|NCT02864251|583228553|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
161500643|NCT02864251|583228554|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
161500644|NCT02864251|583228552|FG000|Treatment|Withdrawal by Participant|8|||
161500645|NCT02864251|583228553|FG001|Treatment|Withdrawal by Participant|5|||
161500646|NCT02864251|583228554|FG002|Treatment|Withdrawal by Participant|13|||
161500647|NCT02864251|583228552|FG000|Treatment|Maximum Clinical Benefit|1|||
161819128|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
161819129|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161819130|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
161819131|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161819132|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
161819133|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
161819134|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
161819135|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
161819136|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
161819137|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
161819138|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
161819139|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
161819140|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
161819141|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
161819142|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
161819143|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
161819144|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
161819145|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
161819146|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
161819147|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
161819148|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
161819149|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
161819150|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
161819151|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
161819152|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
161819153|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
161819154|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
161819155|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
161819156|NCT00380588|584378232|FG000|Overall Study|Unequivocal Disease Progression|25|||
161500648|NCT02864251|583228553|FG001|Treatment|Maximum Clinical Benefit|0|||
161500649|NCT02864251|583228554|FG002|Treatment|Maximum Clinical Benefit|1|||
161500650|NCT02864251|583228552|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
161500651|NCT02864251|583228553|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
161500652|NCT02864251|583228554|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
161500653|NCT02864251|583228552|FG000|Treatment|Other Reasons|1|||
161500654|NCT02864251|583228553|FG001|Treatment|Other Reasons|1|||
161500655|NCT02864251|583228554|FG002|Treatment|Other Reasons|4|||
161500656|NCT02864251|583228552|FG000|Treatment|Administrative Reason by Sponsor|1|||
161500657|NCT02864251|583228553|FG001|Treatment|Administrative Reason by Sponsor|0|||
161500658|NCT02864251|583228554|FG002|Treatment|Administrative Reason by Sponsor|0|||
161500659|NCT04343521|583228555|FG000|Overall Study|Adverse Event|0|||
161500660|NCT04343521|583228556|FG001|Overall Study|Adverse Event|2|||
161500661|NCT04343521|583228555|FG000|Overall Study|Death|1|||
161500662|NCT04343521|583228556|FG001|Overall Study|Death|2|||
161500663|NCT04343521|583228555|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
161500664|NCT04343521|583228556|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
161500665|NCT04343521|583228555|FG000|Overall Study|Withdrawal by Subject|70|||
161500666|NCT04343521|583228556|FG001|Overall Study|Withdrawal by Subject|95|||
161500667|NCT04343521|583228555|FG000|Overall Study|Withdrawal by study team|6|||
161500668|NCT04343521|583228556|FG001|Overall Study|Withdrawal by study team|12|||
161500669|NCT00107198|583228557|FG000|Overall Study|Lack of Efficacy|28|||
161500670|NCT00107198|583228557|FG000|Overall Study|Lost to Follow-up|12|||
161500671|NCT00107198|583228557|FG000|Overall Study|Protocol Violation|1|||
161500672|NCT00107198|583228557|FG000|Overall Study|Withdrawal by Subject|6|||
161500673|NCT00107198|583228557|FG000|Overall Study|Ineligible|5|||
161500674|NCT02532647|583228558|FG000|Overall Study|Did not receive trial medication|1|||
161500675|NCT02532647|583228559|FG001|Overall Study|Did not receive trial medication|0|||
161500676|NCT02532647|583228560|FG002|Overall Study|Did not receive trial medication|1|||
161500677|NCT03897179|583228570|FG000|Overall Study|Withdrawal by Subject|1|||
161500678|NCT01480076|583228571|FG000|Overall Study|Run-in Failure|52|||
161500679|NCT01480076|583228571|FG000|Overall Study|Adverse Event|39|||
161500680|NCT01480076|583228571|FG000|Overall Study|Death|2|||
161500681|NCT01480076|583228571|FG000|Overall Study|Disease Progression|5|||
161500682|NCT01480076|583228571|FG000|Overall Study|Non-compliance With Study Protocol|15|||
161500683|NCT01480076|583228571|FG000|Overall Study|Withdrawal by Subject|105|||
161500684|NCT01480076|583228571|FG000|Overall Study|Lost to Follow-up|7|||
161500685|NCT01480076|583228571|FG000|Overall Study|Investigator Decision|13|||
161500686|NCT01480076|583228571|FG000|Overall Study|Other|52|||
161500687|NCT02503332|583228572|FG000|Overall Study|Adverse Event|17|||
161500688|NCT02503332|583228573|FG001|Overall Study|Adverse Event|5|||
161500689|NCT02503332|583228574|FG002|Overall Study|Adverse Event|3|||
161819157|NCT00380588|584378233|FG001|Overall Study|Unequivocal Disease Progression|34|||
161819158|NCT00380588|584378232|FG000|Overall Study|Next Cycle Not Started|4|||
161925218|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925219|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925220|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925221|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925222|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161500690|NCT02503332|583228575|FG003|Overall Study|Adverse Event|1|||
161819159|NCT00380588|584378233|FG001|Overall Study|Next Cycle Not Started|0|||
161819160|NCT00380588|584378232|FG000|Overall Study|Adverse Event|7|||
161819161|NCT00380588|584378233|FG001|Overall Study|Adverse Event|3|||
161819162|NCT00380588|584378232|FG000|Overall Study|Withdrawal by Subject|1|||
161819163|NCT00380588|584378233|FG001|Overall Study|Withdrawal by Subject|3|||
161819164|NCT00380588|584378232|FG000|Overall Study|Physician Decision|2|||
161819165|NCT00380588|584378233|FG001|Overall Study|Physician Decision|0|||
161819166|NCT02096705|584378234|FG000|Treatment|Adverse Event|6|||
161819167|NCT02096705|584378235|FG001|Treatment|Adverse Event|3|||
161819168|NCT02096705|584378234|FG000|Treatment|Subject request to discontinue treatment|1|||
161819169|NCT02096705|584378235|FG001|Treatment|Subject request to discontinue treatment|1|||
161819170|NCT02096705|584378234|FG000|Treatment|Withdrawal by Subject|1|||
161500691|NCT02503332|583228572|FG000|Overall Study|Investigator's Decision|5|||
161500692|NCT02503332|583228573|FG001|Overall Study|Investigator's Decision|1|||
161500693|NCT02503332|583228574|FG002|Overall Study|Investigator's Decision|0|||
161500694|NCT02503332|583228575|FG003|Overall Study|Investigator's Decision|0|||
161500695|NCT02503332|583228572|FG000|Overall Study|Sponsor's Decision|1|||
161500696|NCT02503332|583228573|FG001|Overall Study|Sponsor's Decision|0|||
161819171|NCT02096705|584378235|FG001|Treatment|Withdrawal by Subject|0|||
161819172|NCT02096705|584378234|FG000|Treatment|Other|1|||
161500697|NCT02503332|583228574|FG002|Overall Study|Sponsor's Decision|0|||
161500698|NCT02503332|583228575|FG003|Overall Study|Sponsor's Decision|1|||
161500699|NCT02503332|583228572|FG000|Overall Study|Subject Request|6|||
161500700|NCT02503332|583228573|FG001|Overall Study|Subject Request|5|||
161500701|NCT02503332|583228574|FG002|Overall Study|Subject Request|2|||
161500702|NCT02503332|583228575|FG003|Overall Study|Subject Request|1|||
161500703|NCT02503332|583228572|FG000|Overall Study|Death|0|||
161500704|NCT02503332|583228573|FG001|Overall Study|Death|2|||
161819173|NCT02096705|584378235|FG001|Treatment|Other|1|||
161819174|NCT02096705|584378234|FG000|Follow-up|Withdrawal by Subject|1|||
161819175|NCT02096705|584378235|FG001|Follow-up|Withdrawal by Subject|0|||
161819176|NCT02096705|584378234|FG000|Follow-up|Adverse Event|2|||
161819177|NCT02096705|584378235|FG001|Follow-up|Adverse Event|2|||
161819178|NCT02096705|584378234|FG000|Follow-up|Subjects not reporting status|1|||
161819179|NCT02096705|584378235|FG001|Follow-up|Subjects not reporting status|2|||
161819180|NCT02905435|584378236|FG000|Overall Study|Death|2|||
161819181|NCT02905435|584378236|FG000|Overall Study|Physician Decision|1|||
161819182|NCT02905435|584378236|FG000|Overall Study|Lost to Follow-up|4|||
161819183|NCT02377349|584378240|FG000|Overall Study|Serious Adverse Event|1|||
161819184|NCT02377349|584378241|FG001|Overall Study|Serious Adverse Event|0|||
161819185|NCT02377349|584378240|FG000|Overall Study|Protocol Violation|3|||
161819186|NCT02377349|584378241|FG001|Overall Study|Protocol Violation|2|||
161819187|NCT02377349|584378240|FG000|Overall Study|Withdrawal by Subject|5|||
161819188|NCT02377349|584378241|FG001|Overall Study|Withdrawal by Subject|3|||
161819189|NCT02377349|584378240|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
161819190|NCT02377349|584378241|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
161819191|NCT02377349|584378240|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
161819192|NCT02377349|584378241|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
161819193|NCT02377349|584378240|FG000|Overall Study|Other|0|||
161819194|NCT02377349|584378241|FG001|Overall Study|Other|1|||
161819195|NCT01663896|584378254|FG000|Overall Study|Various reasons|43|||
161819196|NCT00999687|584378258|FG000|First Intervention|Withdrawal by Subject|1|||
161819197|NCT00999687|584378258|FG000|Second Intervention|Withdrawal by Subject|2|||
161819198|NCT00999687|584378258|FG000|Second Intervention|Lack of Efficacy|1|||
161819199|NCT03614728|584378261|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
161819200|NCT03614728|584378262|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161819201|NCT03614728|584378263|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161819202|NCT03614728|584378264|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161500705|NCT02503332|583228574|FG002|Overall Study|Death|2|||
161500706|NCT02503332|583228575|FG003|Overall Study|Death|0|||
161500707|NCT02503332|583228572|FG000|Overall Study|Other|5|||
161500708|NCT02503332|583228573|FG001|Overall Study|Other|6|||
161500709|NCT02503332|583228574|FG002|Overall Study|Other|1|||
161500710|NCT02503332|583228575|FG003|Overall Study|Other|1|||
161500711|NCT05694546|583228577|FG000|Overall Study|Lost to Follow-up|11|||
161500712|NCT02120950|583228578|FG000|Overall Study|Adverse Event|5|||
161500713|NCT02120950|583228579|FG001|Overall Study|Adverse Event|4|||
161500714|NCT02120950|583228580|FG002|Overall Study|Adverse Event|3|||
161500715|NCT02120950|583228578|FG000|Overall Study|Death|3|||
161500716|NCT02120950|583228579|FG001|Overall Study|Death|0|||
161500717|NCT02120950|583228580|FG002|Overall Study|Death|1|||
161500718|NCT02120950|583228578|FG000|Overall Study|Withdrawal by Subject|6|||
161500719|NCT02120950|583228579|FG001|Overall Study|Withdrawal by Subject|3|||
161500720|NCT02120950|583228580|FG002|Overall Study|Withdrawal by Subject|2|||
161500721|NCT02120950|583228578|FG000|Overall Study|Protocol Violation|1|||
161500722|NCT02120950|583228579|FG001|Overall Study|Protocol Violation|1|||
161500723|NCT02120950|583228580|FG002|Overall Study|Protocol Violation|7|||
161500724|NCT02120950|583228578|FG000|Overall Study|Other reasons|5|||
161500725|NCT02120950|583228579|FG001|Overall Study|Other reasons|4|||
161500726|NCT02120950|583228580|FG002|Overall Study|Other reasons|1|||
161500727|NCT02120950|583228578|FG000|Overall Study|Lost to Follow-up|0|||
161819203|NCT03614728|584378261|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161819204|NCT03614728|584378262|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
161819205|NCT03614728|584378263|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161819206|NCT03614728|584378264|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161819207|NCT01401062|584378269|FG000|Overall Study|Death|9|||
161819208|NCT01401062|584378270|FG001|Overall Study|Death|7|||
161819209|NCT01401062|584378269|FG000|Overall Study|Physician Decision|1|||
161819210|NCT01401062|584378270|FG001|Overall Study|Physician Decision|0|||
161819211|NCT01401062|584378269|FG000|Overall Study|Withdrawal by Subject|1|||
161819212|NCT01401062|584378270|FG001|Overall Study|Withdrawal by Subject|1|||
161819213|NCT03684928|584378273|FG000|First Intervention|Lost to Follow-up|0|||
161819214|NCT03684928|584378274|FG001|First Intervention|Lost to Follow-up|1|||
161819215|NCT03684928|584378273|FG000|First Intervention|Withdrawal by Subject|0|||
161819216|NCT03684928|584378274|FG001|First Intervention|Withdrawal by Subject|2|||
161819217|NCT03684928|584378273|FG000|Second Intervention|Soft Tissue Injury|1|||
161819218|NCT03684928|584378274|FG001|Second Intervention|Soft Tissue Injury|0|||
161819219|NCT03193021|584378275|FG000|Overall Study|Lost to Follow-up|1|||
161819220|NCT03193021|584378276|FG001|Overall Study|Lost to Follow-up|1|||
161819221|NCT02286466|584378277|FG000|Overall Study|Death|1|||
161819222|NCT02286466|584378278|FG001|Overall Study|Death|3|||
161819223|NCT02286466|584378277|FG000|Overall Study|Withdrawal by Subject|5|||
161819224|NCT02286466|584378278|FG001|Overall Study|Withdrawal by Subject|2|||
161819225|NCT02286466|584378277|FG000|Overall Study|Lost to Follow-up|1|||
161819226|NCT02286466|584378278|FG001|Overall Study|Lost to Follow-up|4|||
161819227|NCT02286466|584378277|FG000|Overall Study|Declined Clinician Assessment|0|||
161819228|NCT02286466|584378278|FG001|Overall Study|Declined Clinician Assessment|1|||
161819229|NCT00835081|584378279|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161819230|NCT00835081|584378280|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161819231|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
161819232|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
161819233|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
161819234|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
161819235|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
161819236|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
161819237|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
161819238|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
161819239|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
161819240|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
161819241|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
161819242|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
161819243|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
161819244|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
161819245|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
161819246|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
161500728|NCT02120950|583228579|FG001|Overall Study|Lost to Follow-up|2|||
161500729|NCT02120950|583228580|FG002|Overall Study|Lost to Follow-up|1|||
161500730|NCT02424383|583228581|FG000|Overall Study|Withdrawal by Subject|32|||
161500731|NCT02424383|583228581|FG000|Overall Study|Death|170|||
161500732|NCT02424383|583228581|FG000|Overall Study|Sponsor's decision|3|||
161500733|NCT02424383|583228581|FG000|Overall Study|Investigator's decision|44|||
161500734|NCT02424383|583228581|FG000|Overall Study|Lost to Follow-up|81|||
161500735|NCT02424383|583228581|FG000|Overall Study|Other|7|||
161683061|NCT02554019|583891222|FG001|Overall Study|Adverse Event|0|||
161500736|NCT02424383|583228581|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
161500737|NCT03412084|583228585|FG000|Overall Study|Withdrawal by Subject|2|||
161500738|NCT03412084|583228586|FG001|Overall Study|Withdrawal by Subject|0|||
161500739|NCT03412084|583228585|FG000|Overall Study|Participant moved|1|||
161500740|NCT03412084|583228586|FG001|Overall Study|Participant moved|0|||
161500741|NCT03412084|583228585|FG000|Overall Study|Lost to Follow-up|1|||
161500742|NCT03412084|583228586|FG001|Overall Study|Lost to Follow-up|1|||
161500743|NCT01928862|583228590|FG000|Overall Study|Lost to Follow-up|1|||
161500744|NCT01928862|583228591|FG001|Overall Study|Lost to Follow-up|0|||
161500745|NCT01928862|583228592|FG002|Overall Study|Lost to Follow-up|0|||
161500746|NCT01928862|583228593|FG003|Overall Study|Lost to Follow-up|0|||
161500747|NCT01928862|583228594|FG004|Overall Study|Lost to Follow-up|1|||
161500748|NCT01752855|583228598|FG000|Overall Study|Adverse Event|1|||
161500749|NCT01752855|583228599|FG001|Overall Study|Adverse Event|0|||
161500750|NCT01752855|583228598|FG000|Overall Study|Withdrew Consent|0|||
161500751|NCT01752855|583228599|FG001|Overall Study|Withdrew Consent|2|||
161500752|NCT01752855|583228598|FG000|Overall Study|Lack of Efficacy|0|||
161500753|NCT01752855|583228599|FG001|Overall Study|Lack of Efficacy|2|||
161500754|NCT01478321|583228601|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
161925223|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925224|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
161925225|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925226|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925227|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925228|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925229|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
161925230|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925231|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925232|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925233|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925234|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925235|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925236|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
161925237|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
161925238|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925239|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925240|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
161925241|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925242|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925243|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925244|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925245|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925246|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
161925247|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925248|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925249|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925250|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
161925251|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925252|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925253|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925254|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925255|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925256|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925257|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925258|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
161925259|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925260|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925261|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925262|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925263|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925264|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
161500755|NCT01478321|583228601|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
161500756|NCT01478321|583228601|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
161500757|NCT01478321|583228601|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
161500758|NCT01478321|583228601|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
161500759|NCT01478321|583228601|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
161925265|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925266|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161500760|NCT01478321|583228601|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
161500761|NCT01478321|583228601|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
161500762|NCT02053753|583228602|FG000|Overall Study|Withdrawal by Subject|2|||
161500763|NCT02053753|583228603|FG001|Overall Study|Withdrawal by Subject|4|||
161500764|NCT02053753|583228602|FG000|Overall Study|Decision by Sponsor|1|||
161500765|NCT02053753|583228603|FG001|Overall Study|Decision by Sponsor|1|||
161500766|NCT02053753|583228602|FG000|Overall Study|Lost to Follow-up|4|||
161500767|NCT02053753|583228603|FG001|Overall Study|Lost to Follow-up|3|||
161500768|NCT02439320|583228604|FG000|Overall Study|Adverse Event|0|||
161500769|NCT02439320|583228605|FG001|Overall Study|Adverse Event|2|||
161500770|NCT02439320|583228606|FG002|Overall Study|Adverse Event|0|||
161500771|NCT02439320|583228604|FG000|Overall Study|Lost to Follow-up|37|||
161500772|NCT02439320|583228605|FG001|Overall Study|Lost to Follow-up|34|||
161500773|NCT02439320|583228606|FG002|Overall Study|Lost to Follow-up|42|||
161500774|NCT02439320|583228604|FG000|Overall Study|Death|0|||
161500775|NCT02439320|583228605|FG001|Overall Study|Death|1|||
161500776|NCT02439320|583228606|FG002|Overall Study|Death|0|||
161500777|NCT02439320|583228604|FG000|Overall Study|Noncompliance with Protocol|10|||
161500778|NCT02439320|583228605|FG001|Overall Study|Noncompliance with Protocol|11|||
161500779|NCT02439320|583228606|FG002|Overall Study|Noncompliance with Protocol|7|||
161683062|NCT02554019|583891223|FG002|Overall Study|Adverse Event|0|||
161500780|NCT02439320|583228604|FG000|Overall Study|Pregnancy|0|||
161500781|NCT02439320|583228605|FG001|Overall Study|Pregnancy|1|||
161500782|NCT02439320|583228606|FG002|Overall Study|Pregnancy|1|||
161500783|NCT02439320|583228604|FG000|Overall Study|Withdrawal by Subject|12|||
161500784|NCT02439320|583228605|FG001|Overall Study|Withdrawal by Subject|16|||
161500785|NCT02439320|583228606|FG002|Overall Study|Withdrawal by Subject|14|||
161500786|NCT02439320|583228604|FG000|Overall Study|Physician Decision|2|||
161500787|NCT02439320|583228605|FG001|Overall Study|Physician Decision|1|||
161500788|NCT02439320|583228606|FG002|Overall Study|Physician Decision|0|||
161500789|NCT02439320|583228604|FG000|Overall Study|Sponsor Request|0|||
161500790|NCT02439320|583228605|FG001|Overall Study|Sponsor Request|2|||
161500791|NCT02439320|583228606|FG002|Overall Study|Sponsor Request|1|||
161500792|NCT02439320|583228604|FG000|Overall Study|Randomization Failure|35|||
161500793|NCT02439320|583228605|FG001|Overall Study|Randomization Failure|46|||
161500794|NCT02439320|583228606|FG002|Overall Study|Randomization Failure|34|||
161500795|NCT01505608|583228607|FG000|Phase I|Lack of Efficacy|0|||
161500796|NCT01505608|583228608|FG001|Phase I|Lack of Efficacy|4|||
161500797|NCT01505608|583228607|FG000|Phase I|Adverse Event|0|||
161500798|NCT01505608|583228608|FG001|Phase I|Adverse Event|1|||
161500799|NCT01505608|583228607|FG000|Phase I|Withdrawal by Subject|0|||
161500800|NCT01505608|583228608|FG001|Phase I|Withdrawal by Subject|1|||
161500801|NCT01505608|583228607|FG000|Phase II|Lack of Efficacy|2|||
161500802|NCT01505608|583228608|FG001|Phase II|Lack of Efficacy|1|||
161500803|NCT01505608|583228607|FG000|Phase II|Protocol Violation|0|||
161500804|NCT01505608|583228608|FG001|Phase II|Protocol Violation|1|||
161500805|NCT01251380|583228611|FG000|Overall Study|Other (Not otherwise specified)|12|||
161585897|NCT05048186|583531904|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
161585898|NCT02412748|583531905|FG000|Overall Study|Lost to Follow-up|38|||
161819247|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
161819248|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
161819249|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
161819250|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
161819251|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
161819252|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Death|0|||
161819253|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Death|1|||
161819254|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Death|1|||
161819255|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
161819256|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
161819257|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
161819258|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
161819259|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
161819260|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
161819261|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
161819262|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
161819263|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
161819264|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
161819265|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
161819266|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
161819267|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
161819268|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
161819269|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
161819270|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
161819271|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
161819272|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
161819273|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
161819274|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
161819275|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
161819276|NCT01675596|584378284|FG000|Overall Study|Death|6|||
161819277|NCT01675596|584378284|FG000|Overall Study|Exit with other reason|1|||
161819278|NCT01675596|584378284|FG000|Overall Study|Missed Visit|1|||
161819279|NCT00840879|584378285|FG000|Second Intervention|Withdrawal by Subject|1|||
161819280|NCT00840879|584378286|FG001|Second Intervention|Withdrawal by Subject|0|||
161819281|NCT01894230|584379599|FG000|Overall Study|Lost to Follow-up|2|||
161819282|NCT01894230|584379600|FG001|Overall Study|Lost to Follow-up|2|||
161819283|NCT01894230|584379599|FG000|Overall Study|Withdrawal by Subject|4|||
161819284|NCT01894230|584379600|FG001|Overall Study|Withdrawal by Subject|4|||
161819285|NCT01894230|584379599|FG000|Overall Study|Non-adherent|0|||
161819286|NCT01894230|584379600|FG001|Overall Study|Non-adherent|1|||
161819287|NCT01894230|584379599|FG000|Overall Study|Death|1|||
161819288|NCT01894230|584379600|FG001|Overall Study|Death|0|||
161819289|NCT02219009|584379601|FG000|Overall Study|Withdrawal by Subject|5|||
161819290|NCT02219009|584379602|FG001|Overall Study|Withdrawal by Subject|1|||
161500806|NCT01251380|583228611|FG000|Overall Study|Withdrawal by Subject|6|||
161500807|NCT01251380|583228611|FG000|Overall Study|Lack of Efficacy|1|||
161500808|NCT01251380|583228611|FG000|Overall Study|Adverse Event|1|||
161500809|NCT01251380|583228611|FG000|Overall Study|Lost to Follow-up|2|||
161500810|NCT02404350|583228615|FG000|Overall Study|Adverse Event|2|||
161500811|NCT02404350|583228616|FG001|Overall Study|Adverse Event|2|||
161500812|NCT02404350|583228617|FG002|Overall Study|Adverse Event|3|||
161500813|NCT02404350|583228618|FG003|Overall Study|Adverse Event|9|||
161500814|NCT02404350|583228615|FG000|Overall Study|Lack of Efficacy|3|||
161500815|NCT02404350|583228616|FG001|Overall Study|Lack of Efficacy|1|||
161500816|NCT02404350|583228617|FG002|Overall Study|Lack of Efficacy|0|||
161500817|NCT02404350|583228618|FG003|Overall Study|Lack of Efficacy|3|||
161500818|NCT02404350|583228615|FG000|Overall Study|Lost to Follow-up|2|||
161500819|NCT02404350|583228616|FG001|Overall Study|Lost to Follow-up|0|||
161925267|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
161925268|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925269|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925270|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925271|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
161925272|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
161925273|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925274|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925275|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
161925276|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925277|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925278|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
161925279|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
161925280|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925281|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
161925282|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925283|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925284|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925285|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
161925286|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
161925287|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
161925288|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
161925289|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
161925290|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
161500820|NCT02404350|583228617|FG002|Overall Study|Lost to Follow-up|0|||
161500821|NCT02404350|583228618|FG003|Overall Study|Lost to Follow-up|1|||
161500822|NCT02404350|583228615|FG000|Overall Study|Physician Decision|1|||
161500823|NCT02404350|583228616|FG001|Overall Study|Physician Decision|0|||
161500824|NCT02404350|583228617|FG002|Overall Study|Physician Decision|0|||
161500825|NCT02404350|583228618|FG003|Overall Study|Physician Decision|2|||
161500826|NCT02404350|583228615|FG000|Overall Study|Pregnancy|0|||
161500827|NCT02404350|583228616|FG001|Overall Study|Pregnancy|0|||
161500828|NCT02404350|583228617|FG002|Overall Study|Pregnancy|0|||
161500829|NCT02404350|583228618|FG003|Overall Study|Pregnancy|1|||
161500830|NCT02404350|583228615|FG000|Overall Study|Withdrawal by Subject|7|||
161500831|NCT02404350|583228616|FG001|Overall Study|Withdrawal by Subject|3|||
161500832|NCT02404350|583228617|FG002|Overall Study|Withdrawal by Subject|3|||
161500833|NCT02404350|583228618|FG003|Overall Study|Withdrawal by Subject|19|||
161500834|NCT02404350|583228615|FG000|Overall Study|Due to Non-compliance with treatment|0|||
161500835|NCT02404350|583228616|FG001|Overall Study|Due to Non-compliance with treatment|0|||
161500836|NCT02404350|583228617|FG002|Overall Study|Due to Non-compliance with treatment|0|||
161500837|NCT02404350|583228618|FG003|Overall Study|Due to Non-compliance with treatment|1|||
161500838|NCT02404350|583228615|FG000|Overall Study|Due to Technical problems|0|||
161500839|NCT02404350|583228616|FG001|Overall Study|Due to Technical problems|0|||
161500840|NCT02404350|583228617|FG002|Overall Study|Due to Technical problems|0|||
161500841|NCT02404350|583228618|FG003|Overall Study|Due to Technical problems|1|||
161500842|NCT05389657|583228619|FG000|Overall Study|Lost to Follow-up|7|||
161500843|NCT05389657|583228620|FG001|Overall Study|Lost to Follow-up|8|||
161500844|NCT05237206|583228622|FG000|Overall Study|screen failure-did not receive treatment|8|||
161925291|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
161925292|NCT01807520|584771803|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925293|NCT01807520|584771804|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161500845|NCT05237206|583228622|FG000|Overall Study|did not receive treatment|3|||
161925294|NCT01807520|584771805|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925295|NCT01807520|584771806|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925296|NCT01807520|584771807|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161500846|NCT03261947|583228623|FG000|Overall Study|Death|10|||
161500847|NCT03261947|583228624|FG001|Overall Study|Death|13|||
161500848|NCT03261947|583228625|FG002|Overall Study|Death|17|||
161500849|NCT03261947|583228626|FG003|Overall Study|Death|12|||
161500850|NCT03261947|583228627|FG004|Overall Study|Death|8|||
161500851|NCT03261947|583228623|FG000|Overall Study|Lost to Follow-up|0|||
161500852|NCT03261947|583228624|FG001|Overall Study|Lost to Follow-up|0|||
161500853|NCT03261947|583228625|FG002|Overall Study|Lost to Follow-up|2|||
161500854|NCT03261947|583228626|FG003|Overall Study|Lost to Follow-up|1|||
161500855|NCT03261947|583228627|FG004|Overall Study|Lost to Follow-up|0|||
161500856|NCT03261947|583228623|FG000|Overall Study|Withdrawal by Subject|0|||
161500857|NCT03261947|583228624|FG001|Overall Study|Withdrawal by Subject|0|||
161500858|NCT03261947|583228625|FG002|Overall Study|Withdrawal by Subject|3|||
161500859|NCT03261947|583228626|FG003|Overall Study|Withdrawal by Subject|0|||
161500860|NCT03261947|583228627|FG004|Overall Study|Withdrawal by Subject|1|||
161500861|NCT03261947|583228623|FG000|Overall Study|Site Terminated by Sponsor|0|||
161500862|NCT03261947|583228624|FG001|Overall Study|Site Terminated by Sponsor|0|||
161500863|NCT03261947|583228625|FG002|Overall Study|Site Terminated by Sponsor|4|||
161500864|NCT03261947|583228626|FG003|Overall Study|Site Terminated by Sponsor|7|||
161500865|NCT03261947|583228627|FG004|Overall Study|Site Terminated by Sponsor|5|||
161500866|NCT03261947|583228623|FG000|Overall Study|Reason not Specified|2|||
161500867|NCT03261947|583228624|FG001|Overall Study|Reason not Specified|0|||
161500868|NCT03261947|583228625|FG002|Overall Study|Reason not Specified|4|||
161500869|NCT03261947|583228626|FG003|Overall Study|Reason not Specified|1|||
161500870|NCT03261947|583228627|FG004|Overall Study|Reason not Specified|3|||
161500871|NCT03969992|583228628|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
161500872|NCT03969992|583228629|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
161500873|NCT03969992|583228630|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
161500874|NCT03969992|583228628|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
161500875|NCT03969992|583228629|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
161500876|NCT03969992|583228630|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
161500877|NCT03969992|583228628|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
161500878|NCT03969992|583228629|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
161500879|NCT03969992|583228630|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
161500880|NCT03969992|583228628|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
161500881|NCT03969992|583228629|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
161500882|NCT03969992|583228630|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
161500883|NCT03969992|583228628|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
161500884|NCT03969992|583228629|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
161500885|NCT03969992|583228630|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
161500886|NCT04120974|583228631|FG000|Overall Study|Death|1|||
161500887|NCT04120974|583228631|FG000|Overall Study|Physician Decision|1|||
161500888|NCT04120974|583228631|FG000|Overall Study|Lost to Follow-up|6|||
161500889|NCT02154581|583228635|FG000|Overall Study|Lost to Follow-up|7|||
161500890|NCT02154581|583228636|FG001|Overall Study|Lost to Follow-up|8|||
161500891|NCT03082599|583228641|FG000|Overall Study|Lost to Follow-up|1|||
161500892|NCT03082599|583228642|FG001|Overall Study|Lost to Follow-up|0|||
161500893|NCT00832585|583228646|FG000|Overall Study|Withdrawal by Subject|1|||
161500894|NCT00832585|583228646|FG000|Overall Study|Lost to Follow-up|1|||
161500895|NCT00314574|583230393|FG000|Overall Study|Death|3|||
161500896|NCT00314574|583230394|FG001|Overall Study|Death|0|||
161500897|NCT00314574|583230393|FG000|Overall Study|Adverse Event|11|||
161500898|NCT00314574|583230394|FG001|Overall Study|Adverse Event|16|||
161500899|NCT00314574|583230393|FG000|Overall Study|Lost to Follow-up|19|||
161500900|NCT00314574|583230394|FG001|Overall Study|Lost to Follow-up|25|||
161500901|NCT00314574|583230393|FG000|Overall Study|Withdrawal by Subject|33|||
161500902|NCT00314574|583230394|FG001|Overall Study|Withdrawal by Subject|22|||
161500903|NCT00314574|583230393|FG000|Overall Study|Physician Decision|22|||
161500904|NCT00314574|583230394|FG001|Overall Study|Physician Decision|15|||
161500905|NCT00314574|583230393|FG000|Overall Study|Pregnancy|6|||
161500906|NCT00314574|583230394|FG001|Overall Study|Pregnancy|4|||
161500907|NCT00314574|583230393|FG000|Overall Study|Data unknown at database lock|0|||
161819291|NCT02219009|584379601|FG000|Overall Study|Adverse Event|2|||
161819292|NCT02219009|584379602|FG001|Overall Study|Adverse Event|4|||
161819293|NCT02219009|584379601|FG000|Overall Study|Lost to Follow-up|2|||
161819294|NCT02219009|584379602|FG001|Overall Study|Lost to Follow-up|2|||
161819295|NCT02219009|584379601|FG000|Overall Study|Protocol deviation|1|||
161819296|NCT02219009|584379602|FG001|Overall Study|Protocol deviation|0|||
161585899|NCT02412748|583531906|FG001|Overall Study|Lost to Follow-up|39|||
161585900|NCT04218266|583531907|FG000|Overall Study|Death|1|||
161500908|NCT00314574|583230394|FG001|Overall Study|Data unknown at database lock|1|||
161500909|NCT02932904|583230399|FG000|Overall Study|Reason not Specified|1|||
161500910|NCT02932904|583230400|FG001|Overall Study|Reason not Specified|0|||
161500911|NCT02932904|583230401|FG002|Overall Study|Reason not Specified|2|||
161500912|NCT02932904|583230402|FG003|Overall Study|Reason not Specified|2|||
161500913|NCT02932904|583230399|FG000|Overall Study|Noncompliance with Study Drug|2|||
161500914|NCT02932904|583230400|FG001|Overall Study|Noncompliance with Study Drug|3|||
161500915|NCT02932904|583230401|FG002|Overall Study|Noncompliance with Study Drug|3|||
161500916|NCT02932904|583230402|FG003|Overall Study|Noncompliance with Study Drug|4|||
161500917|NCT02932904|583230399|FG000|Overall Study|Pregnancy|0|||
161819297|NCT02219009|584379601|FG000|Overall Study|Physician Decision|0|||
161819298|NCT02219009|584379602|FG001|Overall Study|Physician Decision|1|||
161585901|NCT04218266|583531908|FG001|Overall Study|Death|2|||
161500918|NCT02932904|583230400|FG001|Overall Study|Pregnancy|1|||
161500919|NCT02932904|583230401|FG002|Overall Study|Pregnancy|1|||
161500920|NCT02932904|583230402|FG003|Overall Study|Pregnancy|0|||
161500921|NCT02932904|583230399|FG000|Overall Study|Study Termination|0|||
161500922|NCT02932904|583230400|FG001|Overall Study|Study Termination|1|||
161500923|NCT02932904|583230401|FG002|Overall Study|Study Termination|0|||
161500924|NCT02932904|583230402|FG003|Overall Study|Study Termination|0|||
161500925|NCT02932904|583230399|FG000|Overall Study|Voluntary Withdrawal|2|||
161500926|NCT02932904|583230400|FG001|Overall Study|Voluntary Withdrawal|1|||
161500927|NCT02932904|583230401|FG002|Overall Study|Voluntary Withdrawal|4|||
161500928|NCT02932904|583230402|FG003|Overall Study|Voluntary Withdrawal|2|||
161500929|NCT02932904|583230399|FG000|Overall Study|Lost to Follow-up|5|||
161500930|NCT02932904|583230400|FG001|Overall Study|Lost to Follow-up|3|||
161500931|NCT02932904|583230401|FG002|Overall Study|Lost to Follow-up|6|||
161500932|NCT02932904|583230402|FG003|Overall Study|Lost to Follow-up|0|||
161500933|NCT02932904|583230399|FG000|Overall Study|Significant Protocol Deviation|2|||
161500934|NCT02932904|583230400|FG001|Overall Study|Significant Protocol Deviation|3|||
161500935|NCT02932904|583230401|FG002|Overall Study|Significant Protocol Deviation|6|||
161500936|NCT02932904|583230402|FG003|Overall Study|Significant Protocol Deviation|1|||
161500937|NCT02932904|583230399|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
161500938|NCT02932904|583230400|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
161500939|NCT02932904|583230401|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161500940|NCT02932904|583230402|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
161500941|NCT02932904|583230399|FG000|Overall Study|Randomized But Not Treated|1|||
161500942|NCT02932904|583230400|FG001|Overall Study|Randomized But Not Treated|1|||
161500943|NCT02932904|583230401|FG002|Overall Study|Randomized But Not Treated|0|||
161500944|NCT02932904|583230402|FG003|Overall Study|Randomized But Not Treated|2|||
161500945|NCT03144180|583230406|FG000|Overall Study|STAT Delivery|1|||
161500946|NCT03144180|583230407|FG001|Overall Study|STAT Delivery|1|||
161500947|NCT03144180|583230406|FG000|Overall Study|Provider forgot to fill out forms|1|||
161500948|NCT03144180|583230407|FG001|Overall Study|Provider forgot to fill out forms|3|||
161500949|NCT03144180|583230406|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
161500950|NCT03144180|583230407|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
161500951|NCT03144180|583230406|FG000|Overall Study|Scrub tech removed tube cap|0|||
161500952|NCT03144180|583230407|FG001|Overall Study|Scrub tech removed tube cap|1|||
161500953|NCT00751348|583230412|FG000|Overall Study|Withdrawal by Subject|5|||
161500954|NCT00751348|583230413|FG001|Overall Study|Withdrawal by Subject|2|||
161500955|NCT00751348|583230412|FG000|Overall Study|Migration from study area|1|||
161500956|NCT00751348|583230413|FG001|Overall Study|Migration from study area|0|||
161500957|NCT00743652|583230419|FG000|Overall Study|Parent/Legal Guardian Request|3|||
161819299|NCT02259348|584379603|FG000|Overall Study|Donors|6|||
161819300|NCT02259348|584379603|FG000|Overall Study|Death|4|||
161819301|NCT01622660|584379604|FG000|Overall Study|Adverse Event|1|||
161819302|NCT04211766|584379605|FG000|Overall Study|Withdrawal by Subject|5|||
161819303|NCT04211766|584379606|FG001|Overall Study|Withdrawal by Subject|1|||
161819304|NCT00642993|584379607|FG000|Overall Study|Adverse Event|85|||
161819305|NCT00642993|584379608|FG001|Overall Study|Adverse Event|4|||
161819306|NCT00642993|584379607|FG000|Overall Study|Lost to Follow-up|8|||
161819307|NCT00642993|584379608|FG001|Overall Study|Lost to Follow-up|4|||
161819308|NCT00642993|584379607|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
161819309|NCT00642993|584379608|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
161819310|NCT00642993|584379607|FG000|Overall Study|Protocol Violation|1|||
161819311|NCT00642993|584379608|FG001|Overall Study|Protocol Violation|4|||
161819312|NCT00642993|584379607|FG000|Overall Study|Did not meet protocol eligibility|0|||
161819313|NCT00642993|584379608|FG001|Overall Study|Did not meet protocol eligibility|1|||
161819314|NCT00642993|584379607|FG000|Overall Study|Administrative|1|||
161819315|NCT00642993|584379608|FG001|Overall Study|Administrative|0|||
161819316|NCT02664415|584379609|FG000|Overall Study|Adverse Event|1|||
161819317|NCT02664415|584379610|FG001|Overall Study|Adverse Event|0|||
161819318|NCT02034513|584379611|FG000|Overall Study|Adverse Event|11|||
161819319|NCT02034513|584379612|FG001|Overall Study|Adverse Event|10|||
161819320|NCT02034513|584379611|FG000|Overall Study|Lack of Efficacy|0|||
161500958|NCT00743652|583230420|FG001|Overall Study|Parent/Legal Guardian Request|2|||
161819321|NCT02034513|584379612|FG001|Overall Study|Lack of Efficacy|1|||
161500959|NCT00743652|583230421|FG002|Overall Study|Parent/Legal Guardian Request|2|||
161500960|NCT00743652|583230422|FG003|Overall Study|Parent/Legal Guardian Request|2|||
161500961|NCT00743652|583230423|FG004|Overall Study|Parent/Legal Guardian Request|0|||
161500962|NCT00743652|583230419|FG000|Overall Study|Adverse Event|3|||
161500963|NCT00743652|583230420|FG001|Overall Study|Adverse Event|0|||
161500964|NCT00743652|583230421|FG002|Overall Study|Adverse Event|0|||
161500965|NCT00743652|583230422|FG003|Overall Study|Adverse Event|0|||
161500966|NCT00743652|583230423|FG004|Overall Study|Adverse Event|0|||
161819322|NCT02034513|584379611|FG000|Overall Study|Lost to Follow-up|6|||
161819323|NCT02034513|584379612|FG001|Overall Study|Lost to Follow-up|7|||
161819324|NCT02034513|584379611|FG000|Overall Study|Pregnancy|0|||
161500967|NCT00743652|583230419|FG000|Overall Study|Death|2|||
161500968|NCT00743652|583230420|FG001|Overall Study|Death|0|||
161500969|NCT00743652|583230421|FG002|Overall Study|Death|0|||
161500970|NCT00743652|583230422|FG003|Overall Study|Death|0|||
161500971|NCT00743652|583230423|FG004|Overall Study|Death|0|||
161500972|NCT00743652|583230419|FG000|Overall Study|Investigator Request|0|||
161500973|NCT00743652|583230420|FG001|Overall Study|Investigator Request|0|||
161500974|NCT00743652|583230421|FG002|Overall Study|Investigator Request|0|||
161500975|NCT00743652|583230422|FG003|Overall Study|Investigator Request|2|||
161500976|NCT00743652|583230423|FG004|Overall Study|Investigator Request|0|||
161925297|NCT01807520|584771808|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
161925298|NCT01807520|584771809|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925299|NCT01807520|584771803|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925300|NCT01807520|584771804|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925301|NCT01807520|584771805|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925302|NCT01807520|584771806|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925303|NCT01807520|584771807|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925304|NCT01807520|584771808|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
161925305|NCT01807520|584771809|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925306|NCT01807520|584771803|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925307|NCT01807520|584771804|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925308|NCT01807520|584771805|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925309|NCT01807520|584771806|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925310|NCT01807520|584771807|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925311|NCT01807520|584771808|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
161925312|NCT01807520|584771809|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
161925313|NCT01002105|584771813|FG000|Overall Study|Lost to Follow-up|10|||
161925314|NCT01002105|584771814|FG001|Overall Study|Lost to Follow-up|16|||
161925315|NCT01002105|584771813|FG000|Overall Study|non compliance|5|||
161925316|NCT01002105|584771814|FG001|Overall Study|non compliance|3|||
161925317|NCT01002105|584771813|FG000|Overall Study|condition worsened|4|||
161925318|NCT01002105|584771814|FG001|Overall Study|condition worsened|2|||
161925319|NCT00552058|584771815|FG000|Overall Study|Adverse Event|8|||
161925320|NCT00552058|584771816|FG001|Overall Study|Adverse Event|7|||
161925321|NCT00552058|584771815|FG000|Overall Study|Lack of Efficacy|1|||
161925322|NCT00552058|584771816|FG001|Overall Study|Lack of Efficacy|5|||
161925323|NCT00552058|584771815|FG000|Overall Study|Lost to Follow-up|1|||
161925324|NCT00552058|584771816|FG001|Overall Study|Lost to Follow-up|0|||
161925325|NCT00552058|584771815|FG000|Overall Study|Withdrawal by Subject|4|||
161925326|NCT00552058|584771816|FG001|Overall Study|Withdrawal by Subject|4|||
161925327|NCT00552058|584771815|FG000|Overall Study|Other: Protocol Violation|0|||
161500977|NCT00743652|583230419|FG000|Overall Study|Other|1|||
161500978|NCT00743652|583230420|FG001|Overall Study|Other|1|||
161500979|NCT00743652|583230421|FG002|Overall Study|Other|0|||
161500980|NCT00743652|583230422|FG003|Overall Study|Other|0|||
161500981|NCT00743652|583230423|FG004|Overall Study|Other|0|||
161500982|NCT00743652|583230419|FG000|Overall Study|Lost to Follow-up|1|||
161925328|NCT00552058|584771816|FG001|Overall Study|Other: Protocol Violation|1|||
161925329|NCT00552058|584771815|FG000|Overall Study|Other: Non Compliance|1|||
161925330|NCT00552058|584771816|FG001|Overall Study|Other: Non Compliance|2|||
161500983|NCT00743652|583230420|FG001|Overall Study|Lost to Follow-up|0|||
161500984|NCT00743652|583230421|FG002|Overall Study|Lost to Follow-up|0|||
161500985|NCT00743652|583230422|FG003|Overall Study|Lost to Follow-up|0|||
161500986|NCT00743652|583230423|FG004|Overall Study|Lost to Follow-up|0|||
161500987|NCT00228917|583230424|FG000|Overall Study|Migrated/moved from study area|0|||
161500988|NCT00228917|583230425|FG001|Overall Study|Migrated/moved from study area|0|||
161500989|NCT00228917|583230426|FG002|Overall Study|Migrated/moved from study area|0|||
161925331|NCT00552058|584771815|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
161925332|NCT00552058|584771816|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
161925333|NCT00552058|584771815|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
161925334|NCT00552058|584771816|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
161925335|NCT00552058|584771815|FG000|Overall Study|Other: Positive Stool Result|0|||
161925336|NCT00552058|584771816|FG001|Overall Study|Other: Positive Stool Result|1|||
161925337|NCT00552058|584771815|FG000|Overall Study|Other: Randomized in error|0|||
161925338|NCT00552058|584771816|FG001|Overall Study|Other: Randomized in error|1|||
161925339|NCT00552058|584771815|FG000|Overall Study|Other: Sponsors Decision|0|||
161925340|NCT00552058|584771816|FG001|Overall Study|Other: Sponsors Decision|1|||
161925341|NCT00552058|584771815|FG000|Overall Study|Other: Early Roll Over|1|||
161925342|NCT00552058|584771816|FG001|Overall Study|Other: Early Roll Over|0|||
161925343|NCT01028053|584771819|FG000|Overall Study|Screen Failure|113|||
161925344|NCT01028053|584771819|FG000|Overall Study|Patient Request|11|||
161925345|NCT01028053|584771819|FG000|Overall Study|Protocol Violation|1|||
161925346|NCT01028053|584771819|FG000|Overall Study|Physician Decision|2|||
161925347|NCT01028053|584771819|FG000|Overall Study|Technical Problem|1|||
161925348|NCT01028053|584771819|FG000|Overall Study|Terminated by Sponsor|1|||
161925349|NCT01028053|584771819|FG000|Overall Study|Various reasons|4|||
161925350|NCT00471354|584771820|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
161925351|NCT00471354|584771820|FG000|Overall Study|Adverse Event|13|||
161925352|NCT00471354|584771820|FG000|Overall Study|Protocol Violation|12|||
161500990|NCT00228917|583230427|FG003|Overall Study|Migrated/moved from study area|0|||
161500991|NCT00228917|583230428|FG004|Overall Study|Migrated/moved from study area|0|||
161925353|NCT00471354|584771820|FG000|Overall Study|Withdrawal by Subject|1|||
161925354|NCT00471354|584771820|FG000|Overall Study|Physician Decision|4|||
161925355|NCT00471354|584771820|FG000|Overall Study|Sponsor Decision|1|||
161925356|NCT00471354|584771820|FG000|Overall Study|Lost to Follow-up|3|||
161925357|NCT00471354|584771820|FG000|Overall Study|Lack of Efficacy|5|||
161925358|NCT00471354|584771820|FG000|Overall Study|Patient/Caregiver Decision|12|||
161925359|NCT05141357|584771821|FG000|Overall Study|Adverse Event|3|||
161925360|NCT05141357|584771821|FG000|Overall Study|Lack of Efficacy|2|||
161925361|NCT01336972|584771825|FG000|Overall Study|Adverse Event|1|||
161925362|NCT01336972|584771826|FG001|Overall Study|Adverse Event|1|||
161500992|NCT00228917|583230429|FG005|Overall Study|Migrated/moved from study area|2|||
161500993|NCT00228917|583230430|FG006|Overall Study|Migrated/moved from study area|0|||
161500994|NCT00228917|583230431|FG007|Overall Study|Migrated/moved from study area|0|||
161500995|NCT01476696|583230434|FG000|Overall Study|Sponsor decision|2|||
161500996|NCT01476696|583230435|FG001|Overall Study|Sponsor decision|1|||
161500997|NCT01476696|583230436|FG002|Overall Study|Sponsor decision|0|||
161500998|NCT01476696|583230434|FG000|Overall Study|Withdrawal by Subject|1|||
161500999|NCT01476696|583230435|FG001|Overall Study|Withdrawal by Subject|0|||
161501000|NCT01476696|583230436|FG002|Overall Study|Withdrawal by Subject|0|||
161501001|NCT02063737|583230437|FG000|Overall Study|Lost to Follow-up|11|||
161501002|NCT02063737|583230438|FG001|Overall Study|Lost to Follow-up|4|||
161501003|NCT04372602|583230441|FG000|Overall Study|Withdrawal by Subject|1|||
161501004|NCT04372602|583230442|FG001|Overall Study|Withdrawal by Subject|1|||
161501005|NCT04372602|583230441|FG000|Overall Study|Adverse Event|0|||
161501006|NCT04372602|583230442|FG001|Overall Study|Adverse Event|1|||
161501007|NCT04372602|583230441|FG000|Overall Study|Transitioned to comfort care|0|||
161501008|NCT04372602|583230442|FG001|Overall Study|Transitioned to comfort care|1|||
161501009|NCT01085097|583230446|FG000|Overall Study|Adverse Event|0|||
161501010|NCT01085097|583230447|FG001|Overall Study|Adverse Event|0|||
161501011|NCT01085097|583230448|FG002|Overall Study|Adverse Event|2|||
161501012|NCT01085097|583230446|FG000|Overall Study|Treatment failure|2|||
161501013|NCT01085097|583230447|FG001|Overall Study|Treatment failure|0|||
161501014|NCT01085097|583230448|FG002|Overall Study|Treatment failure|0|||
161501015|NCT06049043|583230449|FG000|Overall Study|Lost to Follow-up|11|||
161501016|NCT06049043|583230450|FG001|Overall Study|Lost to Follow-up|9|||
161501017|NCT00129129|583230451|FG000|Primary Phase|Adverse Event|2|||
161501018|NCT00129129|583230452|FG001|Primary Phase|Adverse Event|1|||
161501019|NCT00129129|583230453|FG002|Primary Phase|Adverse Event|0|||
161501020|NCT00129129|583230454|FG003|Primary Phase|Adverse Event|0|||
161925363|NCT01336972|584771827|FG002|Overall Study|Adverse Event|0|||
161925364|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
161925365|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
161925366|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
161925367|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
161925368|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
161925369|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
161925370|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
161925371|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
161925372|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
161925373|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
161925374|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
161925375|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
161925376|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
161925377|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
161925378|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
161925379|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
161501021|NCT00129129|583230455|FG004|Primary Phase|Adverse Event|0|||
161501022|NCT00129129|583230451|FG000|Primary Phase|Withdrawal by Subject|12|||
161501023|NCT00129129|583230452|FG001|Primary Phase|Withdrawal by Subject|10|||
161501024|NCT00129129|583230453|FG002|Primary Phase|Withdrawal by Subject|0|||
161501025|NCT00129129|583230454|FG003|Primary Phase|Withdrawal by Subject|0|||
161501026|NCT00129129|583230455|FG004|Primary Phase|Withdrawal by Subject|0|||
161501027|NCT00129129|583230451|FG000|Primary Phase|Migration from study area|1|||
161501028|NCT00129129|583230452|FG001|Primary Phase|Migration from study area|3|||
161501029|NCT00129129|583230453|FG002|Primary Phase|Migration from study area|0|||
161501030|NCT00129129|583230454|FG003|Primary Phase|Migration from study area|0|||
161501031|NCT00129129|583230455|FG004|Primary Phase|Migration from study area|0|||
161501032|NCT00129129|583230451|FG000|Primary Phase|Lost to Follow-up|8|||
161501033|NCT00129129|583230452|FG001|Primary Phase|Lost to Follow-up|6|||
161501034|NCT00129129|583230453|FG002|Primary Phase|Lost to Follow-up|0|||
161501035|NCT00129129|583230454|FG003|Primary Phase|Lost to Follow-up|0|||
161501036|NCT00129129|583230455|FG004|Primary Phase|Lost to Follow-up|0|||
161501037|NCT00129129|583230451|FG000|Primary Phase|Other|2|||
161501038|NCT00129129|583230452|FG001|Primary Phase|Other|5|||
161501039|NCT00129129|583230453|FG002|Primary Phase|Other|0|||
161501040|NCT00129129|583230454|FG003|Primary Phase|Other|0|||
161501041|NCT00129129|583230455|FG004|Primary Phase|Other|0|||
161501042|NCT00129129|583230451|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
161501043|NCT00129129|583230452|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
161501044|NCT00129129|583230453|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
161925380|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
161925381|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
161925382|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
161925383|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
161925384|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
161925385|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
161925386|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
161925387|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
161925388|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
161925389|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
161925390|NCT02639559|584771830|FG000|Overall Study|Mobilization failure|0|||
161925391|NCT02639559|584771831|FG001|Overall Study|Mobilization failure|3|||
161925392|NCT02639559|584771830|FG000|Overall Study|Issues with vascular acess|1|||
161501045|NCT00129129|583230454|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
161501046|NCT00129129|583230455|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
161501047|NCT00129129|583230451|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
161501048|NCT00129129|583230452|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
161501049|NCT00129129|583230453|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
161501050|NCT00129129|583230454|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
161501051|NCT00129129|583230455|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
161501052|NCT00129129|583230451|FG000|Fourth Dose Phase|Migration from study area|0|||
161501053|NCT00129129|583230452|FG001|Fourth Dose Phase|Migration from study area|0|||
161501054|NCT00129129|583230453|FG002|Fourth Dose Phase|Migration from study area|0|||
161501055|NCT00129129|583230454|FG003|Fourth Dose Phase|Migration from study area|0|||
161501056|NCT00129129|583230455|FG004|Fourth Dose Phase|Migration from study area|2|||
161501057|NCT00129129|583230451|FG000|Fourth Dose Phase|Other|0|||
161925393|NCT02639559|584771831|FG001|Overall Study|Issues with vascular acess|0|||
161501058|NCT00129129|583230452|FG001|Fourth Dose Phase|Other|0|||
161501059|NCT00129129|583230453|FG002|Fourth Dose Phase|Other|0|||
161501060|NCT00129129|583230454|FG003|Fourth Dose Phase|Other|1|||
161501061|NCT00129129|583230455|FG004|Fourth Dose Phase|Other|1|||
161501062|NCT00129129|583230451|FG000|Fourth Dose Phase|Protocol Violation|0|||
161501063|NCT00129129|583230452|FG001|Fourth Dose Phase|Protocol Violation|0|||
161501064|NCT00129129|583230453|FG002|Fourth Dose Phase|Protocol Violation|0|||
161501065|NCT00129129|583230454|FG003|Fourth Dose Phase|Protocol Violation|1|||
161501066|NCT00129129|583230455|FG004|Fourth Dose Phase|Protocol Violation|0|||
161501067|NCT03089606|583230458|FG000|Overall Study|Progression after Cycle 1|1|||
161501068|NCT00335972|583230459|FG000|Overall Study|not given treatments|0|||
161585902|NCT04218266|583531909|FG002|Overall Study|Death|3|||
161585903|NCT04218266|583531907|FG000|Overall Study|Adverse Event|13|||
161925394|NCT00471107|584771834|FG000|Overall Study|Technical problems/data loss|3|||
161925395|NCT00471107|584771835|FG001|Overall Study|Technical problems/data loss|1|||
161925396|NCT00471107|584771836|FG002|Overall Study|Technical problems/data loss|3|||
161925397|NCT04740567|584771840|FG000|Overall Study|Death|31|||
161925398|NCT04740567|584771841|FG001|Overall Study|Death|43|||
161925399|NCT04740567|584771840|FG000|Overall Study|Lost to Follow-up|2|||
161925400|NCT04740567|584771841|FG001|Overall Study|Lost to Follow-up|11|||
161585904|NCT04218266|583531908|FG001|Overall Study|Adverse Event|14|||
161585905|NCT04218266|583531909|FG002|Overall Study|Adverse Event|11|||
161585906|NCT04218266|583531907|FG000|Overall Study|Other|7|||
161585907|NCT04218266|583531908|FG001|Overall Study|Other|5|||
161585908|NCT04218266|583531909|FG002|Overall Study|Other|14|||
161585909|NCT04218266|583531907|FG000|Overall Study|Physician Decision|1|||
161819325|NCT02034513|584379612|FG001|Overall Study|Pregnancy|3|||
161819326|NCT02034513|584379611|FG000|Overall Study|Protocol Violation|7|||
161819327|NCT02034513|584379612|FG001|Overall Study|Protocol Violation|10|||
161819328|NCT02034513|584379611|FG000|Overall Study|Withdrawal by Subject|25|||
161819329|NCT02034513|584379612|FG001|Overall Study|Withdrawal by Subject|25|||
161819330|NCT02034513|584379611|FG000|Overall Study|Unclassified|0|||
161819331|NCT02034513|584379612|FG001|Overall Study|Unclassified|1|||
161819332|NCT00960154|584379613|FG000|Overall Study|Study termination|25|||
161819333|NCT00960154|584379614|FG001|Overall Study|Study termination|25|||
161819334|NCT00757705|584379615|FG000|Overall Study|Adverse Event|19|||
161819335|NCT00757705|584379615|FG000|Overall Study|Lost to Follow-up|16|||
161819336|NCT00757705|584379615|FG000|Overall Study|Withdrawal by Subject|25|||
161819337|NCT00757705|584379615|FG000|Overall Study|Insufficient Response|26|||
161819338|NCT00757705|584379615|FG000|Overall Study|Ineligible to continue|8|||
161819339|NCT00757705|584379615|FG000|Overall Study|Non-compliant|9|||
161819340|NCT00757705|584379615|FG000|Overall Study|Other|18|||
161819341|NCT04408924|584379619|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
161819342|NCT04408924|584379619|FG000|Overall Study|Lost to Follow-up|3|||
161819343|NCT04408924|584379619|FG000|Overall Study|Withdrawal by Subject|5|||
161819344|NCT04408924|584379619|FG000|Overall Study|Sponsor Decision|2|||
161819345|NCT00486434|584379620|FG000|Overall Study|Withdrawal by Subject|34|||
161819346|NCT00486434|584379621|FG001|Overall Study|Withdrawal by Subject|39|||
161819347|NCT00486434|584379620|FG000|Overall Study|Adverse Event|118|||
161819348|NCT00486434|584379621|FG001|Overall Study|Adverse Event|44|||
161819349|NCT00486434|584379620|FG000|Overall Study|Protocol Violation|22|||
161819350|NCT00486434|584379621|FG001|Overall Study|Protocol Violation|21|||
161819351|NCT00486434|584379620|FG000|Overall Study|Lack of Efficacy|12|||
161819352|NCT00486434|584379621|FG001|Overall Study|Lack of Efficacy|19|||
161819353|NCT00486434|584379620|FG000|Overall Study|Lost to Follow-up|2|||
161819354|NCT00486434|584379621|FG001|Overall Study|Lost to Follow-up|3|||
161819355|NCT00486434|584379620|FG000|Overall Study|Death|1|||
161819356|NCT00486434|584379621|FG001|Overall Study|Death|2|||
161819357|NCT00486434|584379620|FG000|Overall Study|Personal reasons|5|||
161501069|NCT00335972|583230460|FG001|Overall Study|not given treatments|3|||
161501070|NCT03965962|583230462|FG000|Overall Study|Adverse Event|1|||
161501071|NCT03965962|583230463|FG001|Overall Study|Adverse Event|0|||
161585910|NCT04218266|583531908|FG001|Overall Study|Physician Decision|3|||
161585911|NCT04218266|583531909|FG002|Overall Study|Physician Decision|2|||
161585912|NCT04218266|583531907|FG000|Overall Study|Non-compliance with study drug|0|||
161819358|NCT00486434|584379621|FG001|Overall Study|Personal reasons|6|||
161819359|NCT02218541|584379622|FG000|Overall Study|Lost to Follow-up|2|||
161819360|NCT02218541|584379623|FG001|Overall Study|Lost to Follow-up|1|||
161819361|NCT02218541|584379622|FG000|Overall Study|Implant Failure|4|||
161819362|NCT02218541|584379623|FG001|Overall Study|Implant Failure|1|||
161925401|NCT04740567|584771840|FG000|Overall Study|Patient declined to participate|13|||
161501072|NCT03965962|583230464|FG002|Overall Study|Adverse Event|0|||
161501073|NCT03965962|583230465|FG003|Overall Study|Adverse Event|0|||
161501074|NCT03965962|583230462|FG000|Overall Study|Protocol Violation|21|||
161501075|NCT03965962|583230463|FG001|Overall Study|Protocol Violation|4|||
161501076|NCT03965962|583230464|FG002|Overall Study|Protocol Violation|10|||
161501077|NCT03965962|583230465|FG003|Overall Study|Protocol Violation|5|||
161501078|NCT03965962|583230462|FG000|Overall Study|Lost to Follow-up|0|||
161501079|NCT03965962|583230463|FG001|Overall Study|Lost to Follow-up|1|||
161501080|NCT03965962|583230464|FG002|Overall Study|Lost to Follow-up|0|||
161501081|NCT03965962|583230465|FG003|Overall Study|Lost to Follow-up|0|||
161501082|NCT03965962|583230462|FG000|Overall Study|Withdrawal by Subject|3|||
161501083|NCT03965962|583230463|FG001|Overall Study|Withdrawal by Subject|0|||
161501084|NCT03965962|583230464|FG002|Overall Study|Withdrawal by Subject|0|||
161501085|NCT03965962|583230465|FG003|Overall Study|Withdrawal by Subject|1|||
161501086|NCT03190889|583230470|FG000|Overall Study|Lost to Follow-up|7|||
161501087|NCT03190889|583230471|FG001|Overall Study|Lost to Follow-up|7|||
161501088|NCT03190889|583230472|FG002|Overall Study|Lost to Follow-up|3|||
161501089|NCT03190889|583230470|FG000|Overall Study|Withdrawal by Subject|1|||
161501090|NCT03190889|583230471|FG001|Overall Study|Withdrawal by Subject|1|||
161501091|NCT03190889|583230472|FG002|Overall Study|Withdrawal by Subject|2|||
161501092|NCT03190889|583230470|FG000|Overall Study|Did not complete protocol|4|||
161501093|NCT03190889|583230471|FG001|Overall Study|Did not complete protocol|9|||
161501094|NCT03190889|583230472|FG002|Overall Study|Did not complete protocol|0|||
161501095|NCT03190889|583230470|FG000|Overall Study|COVID-19|1|||
161501096|NCT03190889|583230471|FG001|Overall Study|COVID-19|0|||
161501097|NCT03190889|583230472|FG002|Overall Study|COVID-19|2|||
161501098|NCT02140567|583230474|FG000|Overall Study|Problems with recording equipment|6|||
161501099|NCT02882854|583230477|FG000|Overall Study|Lost to Follow-up|1|||
161501100|NCT02882854|583230478|FG001|Overall Study|Lost to Follow-up|2|||
161501101|NCT02882854|583230477|FG000|Overall Study|Physician Decision|0|||
161501102|NCT02882854|583230478|FG001|Overall Study|Physician Decision|1|||
161501103|NCT02039674|583230479|FG000|Overall Study|Adverse Event|0|||
161501104|NCT02039674|583230480|FG001|Overall Study|Adverse Event|0|||
161819363|NCT00856349|584379624|FG000|Overall Study|Death|418|||
161501105|NCT02039674|583230481|FG002|Overall Study|Adverse Event|0|||
161501106|NCT02039674|583230482|FG003|Overall Study|Adverse Event|1|||
161501107|NCT02039674|583230483|FG004|Overall Study|Adverse Event|0|||
161501108|NCT02039674|583230484|FG005|Overall Study|Adverse Event|0|||
161501109|NCT02039674|583230485|FG006|Overall Study|Adverse Event|0|||
161501110|NCT02039674|583230486|FG007|Overall Study|Adverse Event|0|||
161501111|NCT02039674|583230487|FG008|Overall Study|Adverse Event|2|||
161501112|NCT02039674|583230488|FG009|Overall Study|Adverse Event|1|||
161501113|NCT02039674|583230489|FG010|Overall Study|Adverse Event|0|||
161501114|NCT02039674|583230490|FG011|Overall Study|Adverse Event|2|||
161501115|NCT02039674|583230491|FG012|Overall Study|Adverse Event|3|||
161819364|NCT00856349|584379624|FG000|Overall Study|Withdrawal by Subject|116|||
161819365|NCT00856349|584379624|FG000|Overall Study|Lost to Follow-up|91|||
161819366|NCT00856349|584379624|FG000|Overall Study|Protocol Violation|38|||
161819367|NCT00856349|584379624|FG000|Overall Study|Physician Decision|13|||
161819368|NCT00856349|584379624|FG000|Overall Study|Subject relocation|104|||
161819369|NCT00856349|584379624|FG000|Overall Study|Device explant|33|||
161819370|NCT00856349|584379624|FG000|Overall Study|Site closure|78|||
161819371|NCT00856349|584379624|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
161819372|NCT01923740|584379627|FG000|Overall Study|Lost to Follow-up|4|||
161819373|NCT01923740|584379628|FG001|Overall Study|Lost to Follow-up|9|||
161819374|NCT01923740|584379627|FG000|Overall Study|Withdrawal by Subject|2|||
161819375|NCT01923740|584379628|FG001|Overall Study|Withdrawal by Subject|0|||
161819376|NCT03345420|584379631|FG000|Overall Study|Withdrawal by Subject|1|||
161819377|NCT00834444|584379632|FG000|First Intervention|Adverse Event|1|||
161819378|NCT00834444|584379633|FG001|First Intervention|Adverse Event|0|||
161819379|NCT00834444|584379632|FG000|First Intervention|Intolerance to Venopuncture|0|||
161819380|NCT00834444|584379633|FG001|First Intervention|Intolerance to Venopuncture|1|||
161819381|NCT00834444|584379632|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161819382|NCT00834444|584379633|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161819383|NCT00834444|584379632|FG000|Second Intervention|Adverse Event|1|||
161819384|NCT00834444|584379633|FG001|Second Intervention|Adverse Event|0|||
161819385|NCT02890992|584379637|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819386|NCT02890992|584379638|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
161819387|NCT02890992|584379639|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819388|NCT02890992|584379640|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819389|NCT02890992|584379641|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819390|NCT02890992|584379642|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819391|NCT02890992|584379643|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819392|NCT02890992|584379644|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819393|NCT02890992|584379637|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819394|NCT02890992|584379638|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161501116|NCT02039674|583230492|FG013|Overall Study|Adverse Event|1|||
161501117|NCT02039674|583230479|FG000|Overall Study|Death|2|||
161501118|NCT02039674|583230480|FG001|Overall Study|Death|0|||
161501119|NCT02039674|583230481|FG002|Overall Study|Death|2|||
161501120|NCT02039674|583230482|FG003|Overall Study|Death|3|||
161501121|NCT02039674|583230483|FG004|Overall Study|Death|0|||
161501122|NCT02039674|583230484|FG005|Overall Study|Death|0|||
161501123|NCT02039674|583230485|FG006|Overall Study|Death|1|||
161501124|NCT02039674|583230486|FG007|Overall Study|Death|0|||
161501125|NCT02039674|583230487|FG008|Overall Study|Death|2|||
161501126|NCT02039674|583230488|FG009|Overall Study|Death|0|||
161501127|NCT02039674|583230489|FG010|Overall Study|Death|1|||
161501128|NCT02039674|583230490|FG011|Overall Study|Death|3|||
161501129|NCT02039674|583230491|FG012|Overall Study|Death|2|||
161501130|NCT02039674|583230492|FG013|Overall Study|Death|8|||
161501131|NCT02039674|583230479|FG000|Overall Study|Excluded Medication|1|||
161501132|NCT02039674|583230480|FG001|Overall Study|Excluded Medication|1|||
161501133|NCT02039674|583230481|FG002|Overall Study|Excluded Medication|0|||
161501134|NCT02039674|583230482|FG003|Overall Study|Excluded Medication|1|||
161501135|NCT02039674|583230483|FG004|Overall Study|Excluded Medication|0|||
161501136|NCT02039674|583230484|FG005|Overall Study|Excluded Medication|1|||
161501137|NCT02039674|583230485|FG006|Overall Study|Excluded Medication|0|||
161501138|NCT02039674|583230486|FG007|Overall Study|Excluded Medication|0|||
161501139|NCT02039674|583230487|FG008|Overall Study|Excluded Medication|2|||
161501140|NCT02039674|583230488|FG009|Overall Study|Excluded Medication|3|||
161501141|NCT02039674|583230489|FG010|Overall Study|Excluded Medication|5|||
161501142|NCT02039674|583230490|FG011|Overall Study|Excluded Medication|6|||
161501143|NCT02039674|583230491|FG012|Overall Study|Excluded Medication|8|||
161501144|NCT02039674|583230492|FG013|Overall Study|Excluded Medication|3|||
161501145|NCT02039674|583230479|FG000|Overall Study|Lost to Follow-up|0|||
161501146|NCT02039674|583230480|FG001|Overall Study|Lost to Follow-up|0|||
161501147|NCT02039674|583230481|FG002|Overall Study|Lost to Follow-up|0|||
161501148|NCT02039674|583230482|FG003|Overall Study|Lost to Follow-up|0|||
161501149|NCT02039674|583230483|FG004|Overall Study|Lost to Follow-up|1|||
161501150|NCT02039674|583230484|FG005|Overall Study|Lost to Follow-up|1|||
161501151|NCT02039674|583230485|FG006|Overall Study|Lost to Follow-up|0|||
161501152|NCT02039674|583230486|FG007|Overall Study|Lost to Follow-up|0|||
161501153|NCT02039674|583230487|FG008|Overall Study|Lost to Follow-up|0|||
161501154|NCT02039674|583230488|FG009|Overall Study|Lost to Follow-up|0|||
161501155|NCT02039674|583230489|FG010|Overall Study|Lost to Follow-up|0|||
161501156|NCT02039674|583230490|FG011|Overall Study|Lost to Follow-up|2|||
161501157|NCT02039674|583230491|FG012|Overall Study|Lost to Follow-up|2|||
161501158|NCT02039674|583230492|FG013|Overall Study|Lost to Follow-up|1|||
161501159|NCT02039674|583230479|FG000|Overall Study|Physician Decision|0|||
161501160|NCT02039674|583230480|FG001|Overall Study|Physician Decision|0|||
161501161|NCT02039674|583230481|FG002|Overall Study|Physician Decision|0|||
161501162|NCT02039674|583230482|FG003|Overall Study|Physician Decision|0|||
161501163|NCT02039674|583230483|FG004|Overall Study|Physician Decision|0|||
161501164|NCT02039674|583230484|FG005|Overall Study|Physician Decision|0|||
161501165|NCT02039674|583230485|FG006|Overall Study|Physician Decision|0|||
161501166|NCT02039674|583230486|FG007|Overall Study|Physician Decision|0|||
161501167|NCT02039674|583230487|FG008|Overall Study|Physician Decision|0|||
161501168|NCT02039674|583230488|FG009|Overall Study|Physician Decision|0|||
161501169|NCT02039674|583230489|FG010|Overall Study|Physician Decision|0|||
161501170|NCT02039674|583230490|FG011|Overall Study|Physician Decision|1|||
161501171|NCT02039674|583230491|FG012|Overall Study|Physician Decision|1|||
161501172|NCT02039674|583230492|FG013|Overall Study|Physician Decision|0|||
161501173|NCT02039674|583230479|FG000|Overall Study|Progressive Disease|8|||
161501174|NCT02039674|583230480|FG001|Overall Study|Progressive Disease|8|||
161501175|NCT02039674|583230481|FG002|Overall Study|Progressive Disease|6|||
161501176|NCT02039674|583230482|FG003|Overall Study|Progressive Disease|7|||
161501177|NCT02039674|583230483|FG004|Overall Study|Progressive Disease|9|||
161501178|NCT02039674|583230484|FG005|Overall Study|Progressive Disease|10|||
161501179|NCT02039674|583230485|FG006|Overall Study|Progressive Disease|1|||
161501180|NCT02039674|583230486|FG007|Overall Study|Progressive Disease|3|||
161501181|NCT02039674|583230487|FG008|Overall Study|Progressive Disease|6|||
161501182|NCT02039674|583230488|FG009|Overall Study|Progressive Disease|4|||
161501183|NCT02039674|583230489|FG010|Overall Study|Progressive Disease|0|||
161501184|NCT02039674|583230490|FG011|Overall Study|Progressive Disease|34|||
161501185|NCT02039674|583230491|FG012|Overall Study|Progressive Disease|34|||
161501186|NCT02039674|583230492|FG013|Overall Study|Progressive Disease|18|||
161501187|NCT02039674|583230479|FG000|Overall Study|Withdrawal by Subject|1|||
161501188|NCT02039674|583230480|FG001|Overall Study|Withdrawal by Subject|2|||
161501189|NCT02039674|583230481|FG002|Overall Study|Withdrawal by Subject|3|||
161501190|NCT02039674|583230482|FG003|Overall Study|Withdrawal by Subject|0|||
161501191|NCT02039674|583230483|FG004|Overall Study|Withdrawal by Subject|1|||
161501192|NCT02039674|583230484|FG005|Overall Study|Withdrawal by Subject|0|||
161501193|NCT02039674|583230485|FG006|Overall Study|Withdrawal by Subject|0|||
161501194|NCT02039674|583230486|FG007|Overall Study|Withdrawal by Subject|0|||
161501195|NCT02039674|583230487|FG008|Overall Study|Withdrawal by Subject|0|||
161501196|NCT02039674|583230488|FG009|Overall Study|Withdrawal by Subject|1|||
161501197|NCT02039674|583230489|FG010|Overall Study|Withdrawal by Subject|1|||
161501198|NCT02039674|583230490|FG011|Overall Study|Withdrawal by Subject|4|||
161501199|NCT02039674|583230491|FG012|Overall Study|Withdrawal by Subject|6|||
161501200|NCT02039674|583230492|FG013|Overall Study|Withdrawal by Subject|2|||
161501201|NCT02039674|583230479|FG000|Overall Study|Clinical Progression|0|||
161501202|NCT02039674|583230480|FG001|Overall Study|Clinical Progression|0|||
161501203|NCT02039674|583230481|FG002|Overall Study|Clinical Progression|0|||
161501204|NCT02039674|583230482|FG003|Overall Study|Clinical Progression|0|||
161501205|NCT02039674|583230483|FG004|Overall Study|Clinical Progression|0|||
161501206|NCT02039674|583230484|FG005|Overall Study|Clinical Progression|0|||
161501207|NCT02039674|583230485|FG006|Overall Study|Clinical Progression|1|||
161501208|NCT02039674|583230486|FG007|Overall Study|Clinical Progression|0|||
161501209|NCT02039674|583230487|FG008|Overall Study|Clinical Progression|0|||
161501210|NCT02039674|583230488|FG009|Overall Study|Clinical Progression|0|||
161925402|NCT04740567|584771841|FG001|Overall Study|Patient declined to participate|26|||
161925403|NCT04740567|584771840|FG000|Overall Study|Patient was physically incapable|1|||
161925404|NCT04740567|584771841|FG001|Overall Study|Patient was physically incapable|3|||
161925405|NCT04740567|584771840|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
161925406|NCT04740567|584771841|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
161925407|NCT06204887|584771842|FG000|Overall Study|Lost to Follow-up|3|||
161925408|NCT06204887|584771843|FG001|Overall Study|Lost to Follow-up|4|||
161925409|NCT06204887|584771844|FG002|Overall Study|Lost to Follow-up|1|||
161925410|NCT06204887|584771845|FG003|Overall Study|Lost to Follow-up|6|||
161925411|NCT03833167|584771846|FG000|Overall Study|Withdrawal by Subject|4|||
161925412|NCT03833167|584771847|FG001|Overall Study|Withdrawal by Subject|6|||
161925413|NCT03833167|584771846|FG000|Overall Study|Ongoing|186|||
161925414|NCT03833167|584771847|FG001|Overall Study|Ongoing|194|||
161925415|NCT03833167|584771846|FG000|Overall Study|Lost to Follow-up|1|||
161925416|NCT03833167|584771847|FG001|Overall Study|Lost to Follow-up|1|||
161925417|NCT03833167|584771846|FG000|Overall Study|Physician Decision|0|||
161925418|NCT03833167|584771847|FG001|Overall Study|Physician Decision|2|||
161925419|NCT03833167|584771846|FG000|Overall Study|Death|34|||
161925420|NCT03833167|584771847|FG001|Overall Study|Death|22|||
161925421|NCT02227199|584771849|FG000|Overall Study|Physician Decision|0|||
161925422|NCT02227199|584771850|FG001|Overall Study|Physician Decision|0|||
161925423|NCT02227199|584771851|FG002|Overall Study|Physician Decision|1|||
161501211|NCT02039674|583230489|FG010|Overall Study|Clinical Progression|0|||
161501212|NCT02039674|583230490|FG011|Overall Study|Clinical Progression|0|||
161501213|NCT02039674|583230491|FG012|Overall Study|Clinical Progression|1|||
161501214|NCT02039674|583230492|FG013|Overall Study|Clinical Progression|0|||
161501215|NCT02039674|583230479|FG000|Overall Study|Sponsor Decision|1|||
161501216|NCT02039674|583230480|FG001|Overall Study|Sponsor Decision|1|||
161501217|NCT02039674|583230481|FG002|Overall Study|Sponsor Decision|1|||
161501218|NCT02039674|583230482|FG003|Overall Study|Sponsor Decision|1|||
161501219|NCT02039674|583230483|FG004|Overall Study|Sponsor Decision|1|||
161501220|NCT02039674|583230484|FG005|Overall Study|Sponsor Decision|0|||
161501221|NCT02039674|583230485|FG006|Overall Study|Sponsor Decision|0|||
161501222|NCT02039674|583230486|FG007|Overall Study|Sponsor Decision|0|||
161501223|NCT02039674|583230487|FG008|Overall Study|Sponsor Decision|0|||
161501224|NCT02039674|583230488|FG009|Overall Study|Sponsor Decision|3|||
161501225|NCT02039674|583230489|FG010|Overall Study|Sponsor Decision|0|||
161501226|NCT02039674|583230490|FG011|Overall Study|Sponsor Decision|8|||
161501227|NCT02039674|583230491|FG012|Overall Study|Sponsor Decision|5|||
161501228|NCT02039674|583230492|FG013|Overall Study|Sponsor Decision|0|||
161501229|NCT02039674|583230479|FG000|Overall Study|Other|0|||
161501230|NCT02039674|583230480|FG001|Overall Study|Other|0|||
161501231|NCT02039674|583230481|FG002|Overall Study|Other|0|||
161501232|NCT02039674|583230482|FG003|Overall Study|Other|0|||
161501233|NCT02039674|583230483|FG004|Overall Study|Other|0|||
161501234|NCT02039674|583230484|FG005|Overall Study|Other|0|||
161501235|NCT02039674|583230485|FG006|Overall Study|Other|0|||
161501236|NCT02039674|583230486|FG007|Overall Study|Other|0|||
161501237|NCT02039674|583230487|FG008|Overall Study|Other|0|||
161501238|NCT02039674|583230488|FG009|Overall Study|Other|0|||
161501239|NCT02039674|583230489|FG010|Overall Study|Other|0|||
161501240|NCT02039674|583230490|FG011|Overall Study|Other|0|||
161501241|NCT02039674|583230491|FG012|Overall Study|Other|1|||
161501242|NCT02039674|583230492|FG013|Overall Study|Other|0|||
161925424|NCT02227199|584771849|FG000|Overall Study|Adverse Event|0|||
161925425|NCT02227199|584771850|FG001|Overall Study|Adverse Event|0|||
161585913|NCT04218266|583531908|FG001|Overall Study|Non-compliance with study drug|0|||
161925426|NCT02227199|584771851|FG002|Overall Study|Adverse Event|3|||
161925427|NCT01428128|584771852|FG000|Overall Study|Withdrawal by Subject|4|||
161925428|NCT01428128|584771852|FG000|Overall Study|Screen failure by p53|10|||
161925429|NCT01428128|584771852|FG000|Overall Study|Received Neulasta in one cycle|2|||
161501243|NCT01358357|583230493|FG000|Open Label Phase|Adverse Event|0|||
161501244|NCT01358357|583230494|FG001|Open Label Phase|Adverse Event|0|||
161501245|NCT01358357|583230495|FG002|Open Label Phase|Adverse Event|59|||
161501246|NCT01358357|583230493|FG000|Open Label Phase|Lack of Efficacy|0|||
161819395|NCT02890992|584379639|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161501247|NCT01358357|583230494|FG001|Open Label Phase|Lack of Efficacy|0|||
161501248|NCT01358357|583230495|FG002|Open Label Phase|Lack of Efficacy|107|||
161501249|NCT01358357|583230493|FG000|Open Label Phase|Lost to Follow-up|0|||
161501250|NCT01358357|583230494|FG001|Open Label Phase|Lost to Follow-up|0|||
161501251|NCT01358357|583230495|FG002|Open Label Phase|Lost to Follow-up|76|||
161501252|NCT01358357|583230493|FG000|Open Label Phase|Protocol Violation|0|||
161501253|NCT01358357|583230494|FG001|Open Label Phase|Protocol Violation|0|||
161501254|NCT01358357|583230495|FG002|Open Label Phase|Protocol Violation|45|||
161501255|NCT01358357|583230493|FG000|Open Label Phase|Withdrawal by Subject|0|||
161501256|NCT01358357|583230494|FG001|Open Label Phase|Withdrawal by Subject|0|||
161501257|NCT01358357|583230495|FG002|Open Label Phase|Withdrawal by Subject|112|||
161585914|NCT04218266|583531909|FG002|Overall Study|Non-compliance with study drug|1|||
161585915|NCT04218266|583531907|FG000|Overall Study|Withdrawal by Subject|1|||
161585916|NCT04218266|583531908|FG001|Overall Study|Withdrawal by Subject|3|||
161585917|NCT04218266|583531909|FG002|Overall Study|Withdrawal by Subject|1|||
161585918|NCT04218266|583531907|FG000|Overall Study|Study drug never administered|2|||
161585919|NCT04218266|583531908|FG001|Overall Study|Study drug never administered|0|||
161585920|NCT04218266|583531909|FG002|Overall Study|Study drug never administered|0|||
161585921|NCT04820686|583531910|FG000|Overall Study|Withdrawal by Subject|5|||
161585922|NCT04820686|583531911|FG001|Overall Study|Withdrawal by Subject|2|||
161585923|NCT04820686|583531912|FG002|Overall Study|Withdrawal by Subject|3|||
161585924|NCT04820686|583531910|FG000|Overall Study|Study Termination|25|||
161585925|NCT04820686|583531911|FG001|Overall Study|Study Termination|13|||
161585926|NCT04820686|583531912|FG002|Overall Study|Study Termination|14|||
161585927|NCT04820686|583531910|FG000|Overall Study|Adverse Event|0|||
161585928|NCT04820686|583531911|FG001|Overall Study|Adverse Event|1|||
161585929|NCT04820686|583531912|FG002|Overall Study|Adverse Event|0|||
161585930|NCT01424670|583531913|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
161819396|NCT02890992|584379640|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819397|NCT02890992|584379641|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819398|NCT02890992|584379642|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819399|NCT02890992|584379643|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
161819400|NCT02890992|584379644|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
161819401|NCT02890992|584379637|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819402|NCT02890992|584379638|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
161819403|NCT02890992|584379639|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819404|NCT02890992|584379640|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819405|NCT02890992|584379641|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819406|NCT02890992|584379642|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819407|NCT02890992|584379643|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819408|NCT02890992|584379644|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819409|NCT00958724|584379647|FG000|Overall Study|Disease Progression|6|||
161819410|NCT01496118|584379648|FG000|Overall Study|Disease progression|3|||
161819411|NCT01496118|584379649|FG001|Overall Study|Disease progression|2|||
161819412|NCT01496118|584379650|FG002|Overall Study|Disease progression|3|||
161819413|NCT01496118|584379651|FG003|Overall Study|Disease progression|1|||
161819414|NCT01496118|584379652|FG004|Overall Study|Disease progression|2|||
161819415|NCT01496118|584379653|FG005|Overall Study|Disease progression|2|||
161819416|NCT01496118|584379654|FG006|Overall Study|Disease progression|14|||
161819417|NCT01496118|584379655|FG007|Overall Study|Disease progression|10|||
161819418|NCT01496118|584379648|FG000|Overall Study|Physician Decision|0|||
161819419|NCT01496118|584379649|FG001|Overall Study|Physician Decision|0|||
161819420|NCT01496118|584379650|FG002|Overall Study|Physician Decision|0|||
161819421|NCT01496118|584379651|FG003|Overall Study|Physician Decision|0|||
161819422|NCT01496118|584379652|FG004|Overall Study|Physician Decision|1|||
161819423|NCT01496118|584379653|FG005|Overall Study|Physician Decision|0|||
161819424|NCT01496118|584379654|FG006|Overall Study|Physician Decision|3|||
161819425|NCT01496118|584379655|FG007|Overall Study|Physician Decision|6|||
161925430|NCT01428128|584771852|FG000|Overall Study|Adverse Event|1|||
161501258|NCT01358357|583230493|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
161501259|NCT01358357|583230494|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
161501260|NCT01358357|583230495|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
161585931|NCT01424670|583531914|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
161585932|NCT01424670|583531913|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
161585933|NCT01424670|583531914|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
161585934|NCT01424670|583531913|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
161819426|NCT01496118|584379648|FG000|Overall Study|Adverse Event|1|||
161819427|NCT01496118|584379649|FG001|Overall Study|Adverse Event|1|||
161501261|NCT01358357|583230493|FG000|Open Label Phase|Terminated at study completion|0|||
161501262|NCT01358357|583230494|FG001|Open Label Phase|Terminated at study completion|0|||
161501263|NCT01358357|583230495|FG002|Open Label Phase|Terminated at study completion|5|||
161501264|NCT01358357|583230493|FG000|Open Label Phase|Mood episode|0|||
161501265|NCT01358357|583230494|FG001|Open Label Phase|Mood episode|0|||
161501266|NCT01358357|583230495|FG002|Open Label Phase|Mood episode|42|||
161925431|NCT03003962|584771853|FG000|Overall Study|Withdrawal by Subject|5|||
161925432|NCT03003962|584771854|FG001|Overall Study|Withdrawal by Subject|17|||
161501267|NCT01358357|583230493|FG000|Double-Blind Phase|Adverse Event|8|||
161501268|NCT01358357|583230494|FG001|Double-Blind Phase|Adverse Event|5|||
161501269|NCT01358357|583230495|FG002|Double-Blind Phase|Adverse Event|0|||
161501270|NCT01358357|583230493|FG000|Double-Blind Phase|Lost to Follow-up|5|||
161501271|NCT01358357|583230494|FG001|Double-Blind Phase|Lost to Follow-up|7|||
161501272|NCT01358357|583230495|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161501273|NCT01358357|583230493|FG000|Double-Blind Phase|Protocol Violation|1|||
161501274|NCT01358357|583230494|FG001|Double-Blind Phase|Protocol Violation|11|||
161501275|NCT01358357|583230495|FG002|Double-Blind Phase|Protocol Violation|0|||
161501276|NCT01358357|583230493|FG000|Double-Blind Phase|Protocol Violation|16|||
161501277|NCT01358357|583230494|FG001|Double-Blind Phase|Protocol Violation|12|||
161501278|NCT01358357|583230495|FG002|Double-Blind Phase|Protocol Violation|0|||
161501279|NCT01358357|583230493|FG000|Double-Blind Phase|Terminated at study completion|2|||
161501280|NCT01358357|583230494|FG001|Double-Blind Phase|Terminated at study completion|0|||
161501281|NCT01358357|583230495|FG002|Double-Blind Phase|Terminated at study completion|0|||
161819428|NCT01496118|584379650|FG002|Overall Study|Adverse Event|0|||
161819429|NCT01496118|584379651|FG003|Overall Study|Adverse Event|0|||
161819430|NCT01496118|584379652|FG004|Overall Study|Adverse Event|0|||
161819431|NCT01496118|584379653|FG005|Overall Study|Adverse Event|0|||
161819432|NCT01496118|584379654|FG006|Overall Study|Adverse Event|6|||
161819433|NCT01496118|584379655|FG007|Overall Study|Adverse Event|10|||
161819434|NCT01496118|584379648|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819435|NCT01496118|584379649|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819436|NCT01496118|584379650|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819437|NCT01496118|584379651|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819438|NCT01496118|584379652|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819439|NCT01496118|584379653|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819440|NCT01496118|584379654|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
161819441|NCT01496118|584379655|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819442|NCT01496118|584379648|FG000|Overall Study|Death|0|||
161819443|NCT01496118|584379649|FG001|Overall Study|Death|0|||
161819444|NCT01496118|584379650|FG002|Overall Study|Death|0|||
161819445|NCT01496118|584379651|FG003|Overall Study|Death|0|||
161819446|NCT01496118|584379652|FG004|Overall Study|Death|0|||
161925433|NCT03003962|584771853|FG000|Overall Study|Death|274|||
161925434|NCT03003962|584771854|FG001|Overall Study|Death|277|||
161925435|NCT03003962|584771853|FG000|Overall Study|Participants ongoing at DCO|55|||
161925436|NCT03003962|584771854|FG001|Overall Study|Participants ongoing at DCO|40|||
161925437|NCT04337021|584771855|FG000|Overall Study|Lost to Follow-up|54|||
161501282|NCT01358357|583230493|FG000|Double-Blind Phase|Recurrence of mood event|48|||
161501283|NCT01358357|583230494|FG001|Double-Blind Phase|Recurrence of mood event|64|||
161501284|NCT01358357|583230495|FG002|Double-Blind Phase|Recurrence of mood event|0|||
161501285|NCT01358357|583230493|FG000|Double-Blind Phase|Administrative|0|||
161501286|NCT01358357|583230494|FG001|Double-Blind Phase|Administrative|1|||
161501287|NCT01358357|583230495|FG002|Double-Blind Phase|Administrative|0|||
161501288|NCT02590939|583230496|FG000|Overall Study|Withdrawal by Subject|3|||
161501289|NCT02590939|583230497|FG001|Overall Study|Withdrawal by Subject|1|||
161501290|NCT02590939|583230496|FG000|Overall Study|Failed the nociceptive test|2|||
161501291|NCT02590939|583230497|FG001|Overall Study|Failed the nociceptive test|1|||
161501292|NCT03774433|583230498|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
161501293|NCT00108160|583230503|FG000|Overall Study|Lost to Follow-up|25|||
161501294|NCT00108160|583230504|FG001|Overall Study|Lost to Follow-up|12|||
161501295|NCT00108160|583230503|FG000|Overall Study|Death|1|||
161925438|NCT04337021|584771856|FG001|Overall Study|Lost to Follow-up|66|||
161501296|NCT00108160|583230504|FG001|Overall Study|Death|2|||
161501297|NCT00108160|583230503|FG000|Overall Study|Withdrawal by Subject|4|||
161501298|NCT00108160|583230504|FG001|Overall Study|Withdrawal by Subject|2|||
161673258|NCT00931944|583857926|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
161925439|NCT06394323|584771857|FG000|Overall Study|Death|0|||
161819447|NCT01496118|584379653|FG005|Overall Study|Death|0|||
161819448|NCT01496118|584379654|FG006|Overall Study|Death|1|||
161501299|NCT00108160|583230503|FG000|Overall Study|Protocol Violation|9|||
161501300|NCT00108160|583230504|FG001|Overall Study|Protocol Violation|5|||
161501301|NCT02081079|583230505|FG000|Overall Study|Lack of Efficacy|3|||
161925440|NCT06394323|584771858|FG001|Overall Study|Death|1|||
161925441|NCT06394323|584771859|FG002|Overall Study|Death|0|||
161925442|NCT06394323|584771860|FG003|Overall Study|Death|0|||
161501302|NCT02081079|583230506|FG001|Overall Study|Lack of Efficacy|2|||
161501303|NCT02081079|583230505|FG000|Overall Study|Lost to Follow-up|1|||
161501304|NCT02081079|583230506|FG001|Overall Study|Lost to Follow-up|0|||
161501305|NCT01712854|583230507|FG000|Overall Study|Physician Decision|1|||
161501306|NCT00768144|583230508|FG000|Overall Study|Adverse Event|13|||
161501307|NCT00768144|583230508|FG000|Overall Study|Progressive Disease|21|||
161501308|NCT00768144|583230508|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
161501309|NCT00768144|583230508|FG000|Overall Study|Pt Withdrew Consent|1|||
161501310|NCT01150123|583230509|FG000|Overall Study|Withdrawal by Subject|1|||
161501311|NCT01150123|583230510|FG001|Overall Study|Withdrawal by Subject|1|||
161501312|NCT01150123|583230511|FG002|Overall Study|Withdrawal by Subject|2|||
161501313|NCT01150123|583230512|FG003|Overall Study|Withdrawal by Subject|1|||
161501314|NCT01150123|583230513|FG004|Overall Study|Withdrawal by Subject|1|||
161501315|NCT01150123|583230514|FG005|Overall Study|Withdrawal by Subject|1|||
161501316|NCT01150123|583230515|FG006|Overall Study|Withdrawal by Subject|0|||
161501317|NCT01150123|583230516|FG007|Overall Study|Withdrawal by Subject|3|||
161501318|NCT01150123|583230517|FG008|Overall Study|Withdrawal by Subject|2|||
161501319|NCT01150123|583230518|FG009|Overall Study|Withdrawal by Subject|0|||
161501320|NCT01150123|583230519|FG010|Overall Study|Withdrawal by Subject|1|||
161501321|NCT01150123|583230520|FG011|Overall Study|Withdrawal by Subject|0|||
161501322|NCT01150123|583230521|FG012|Overall Study|Withdrawal by Subject|1|||
161501323|NCT01150123|583230522|FG013|Overall Study|Withdrawal by Subject|0|||
161501324|NCT01150123|583230523|FG014|Overall Study|Withdrawal by Subject|0|||
161501325|NCT01150123|583230524|FG015|Overall Study|Withdrawal by Subject|1|||
161501326|NCT01150123|583230525|FG016|Overall Study|Withdrawal by Subject|0|||
161501327|NCT01150123|583230526|FG017|Overall Study|Withdrawal by Subject|1|||
161501328|NCT01150123|583230509|FG000|Overall Study|Lost to Follow-up|2|||
161501329|NCT01150123|583230510|FG001|Overall Study|Lost to Follow-up|1|||
161501330|NCT01150123|583230511|FG002|Overall Study|Lost to Follow-up|2|||
161501331|NCT01150123|583230512|FG003|Overall Study|Lost to Follow-up|2|||
161501332|NCT01150123|583230513|FG004|Overall Study|Lost to Follow-up|2|||
161501333|NCT01150123|583230514|FG005|Overall Study|Lost to Follow-up|5|||
161501334|NCT01150123|583230515|FG006|Overall Study|Lost to Follow-up|0|||
161501335|NCT01150123|583230516|FG007|Overall Study|Lost to Follow-up|0|||
161501336|NCT01150123|583230517|FG008|Overall Study|Lost to Follow-up|3|||
161501337|NCT01150123|583230518|FG009|Overall Study|Lost to Follow-up|1|||
161501338|NCT01150123|583230519|FG010|Overall Study|Lost to Follow-up|1|||
161501339|NCT01150123|583230520|FG011|Overall Study|Lost to Follow-up|1|||
161501340|NCT01150123|583230521|FG012|Overall Study|Lost to Follow-up|2|||
161501341|NCT01150123|583230522|FG013|Overall Study|Lost to Follow-up|0|||
161501342|NCT01150123|583230523|FG014|Overall Study|Lost to Follow-up|0|||
161501343|NCT01150123|583230524|FG015|Overall Study|Lost to Follow-up|0|||
161501344|NCT01150123|583230525|FG016|Overall Study|Lost to Follow-up|0|||
161501345|NCT01150123|583230526|FG017|Overall Study|Lost to Follow-up|0|||
161501346|NCT02225743|583230527|FG000|Overall Study|Withdrawal by Subject|18|||
161501347|NCT02171260|583230528|FG000|Overall Study|Death|0|||
161501348|NCT02171260|583230529|FG001|Overall Study|Death|0|||
161501349|NCT02171260|583230530|FG002|Overall Study|Death|0|||
161501350|NCT02171260|583230531|FG003|Overall Study|Death|1|||
161501351|NCT02171260|583230528|FG000|Overall Study|Physician Decision|1|||
161501352|NCT02171260|583230529|FG001|Overall Study|Physician Decision|0|||
161501353|NCT02171260|583230530|FG002|Overall Study|Physician Decision|1|||
161501354|NCT02171260|583230531|FG003|Overall Study|Physician Decision|0|||
161501355|NCT02171260|583230528|FG000|Overall Study|Withdrawal by Subject|1|||
161501356|NCT02171260|583230529|FG001|Overall Study|Withdrawal by Subject|0|||
161501357|NCT02171260|583230530|FG002|Overall Study|Withdrawal by Subject|0|||
161585935|NCT01424670|583531914|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
161585936|NCT01424670|583531913|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
161585937|NCT01424670|583531914|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
161925443|NCT06394323|584771857|FG000|Overall Study|Physician Decision|0|||
161925444|NCT06394323|584771858|FG001|Overall Study|Physician Decision|2|||
161925445|NCT06394323|584771859|FG002|Overall Study|Physician Decision|0|||
161925446|NCT06394323|584771860|FG003|Overall Study|Physician Decision|0|||
161925447|NCT06394323|584771857|FG000|Overall Study|Withdrawal by Subject|4|||
161925448|NCT06394323|584771858|FG001|Overall Study|Withdrawal by Subject|4|||
161925449|NCT06394323|584771859|FG002|Overall Study|Withdrawal by Subject|0|||
161501358|NCT02171260|583230531|FG003|Overall Study|Withdrawal by Subject|0|||
161501359|NCT02171260|583230528|FG000|Overall Study|Evidence of progressive disease|4|||
161501360|NCT02171260|583230529|FG001|Overall Study|Evidence of progressive disease|6|||
161501361|NCT02171260|583230530|FG002|Overall Study|Evidence of progressive disease|4|||
161501362|NCT02171260|583230531|FG003|Overall Study|Evidence of progressive disease|4|||
161501363|NCT00322842|583230534|FG000|Overall Study|Withdrawal by Subject|0|||
161501364|NCT00322842|583230535|FG001|Overall Study|Withdrawal by Subject|1|||
161501365|NCT00322842|583230534|FG000|Overall Study|Lost to Follow-up|0|||
161925450|NCT06394323|584771860|FG003|Overall Study|Withdrawal by Subject|0|||
161501366|NCT00322842|583230535|FG001|Overall Study|Lost to Follow-up|1|||
161501367|NCT00322842|583230534|FG000|Overall Study|Refused transplant|1|||
161925451|NCT00567580|584773183|FG000|Overall Study|Protocol Violation|28|||
161925452|NCT00567580|584773184|FG001|Overall Study|Protocol Violation|24|||
161925453|NCT00567580|584773185|FG002|Overall Study|Protocol Violation|24|||
161925454|NCT00134719|584773186|FG000|Primary Vaccination Phase|Adverse Event|4|||
161925455|NCT00134719|584773187|FG001|Primary Vaccination Phase|Adverse Event|0|||
161925456|NCT00134719|584773188|FG002|Primary Vaccination Phase|Adverse Event|0|||
161925457|NCT00134719|584773186|FG000|Primary Vaccination Phase|Protocol Violation|1|||
161925458|NCT00134719|584773187|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161925459|NCT00134719|584773188|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161925460|NCT00134719|584773186|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
161925461|NCT00134719|584773187|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
161925462|NCT00134719|584773188|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
161925463|NCT00134719|584773186|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
161925464|NCT00134719|584773187|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
161925465|NCT00134719|584773188|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
161925466|NCT00134719|584773186|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
161925467|NCT00134719|584773187|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
161925468|NCT00134719|584773188|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
161925469|NCT00134719|584773186|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
161925470|NCT00134719|584773187|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
161925471|NCT00134719|584773188|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
161925472|NCT00620035|584773189|FG000|Overall Study|Adverse Event|106|||
161925473|NCT00620035|584773189|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161925474|NCT00620035|584773189|FG000|Overall Study|Other Reason|38|||
161925475|NCT00145327|584773190|FG000|Overall Study|Withdrawal by Subject|77|||
161925476|NCT00145327|584773191|FG001|Overall Study|Withdrawal by Subject|72|||
161925477|NCT00145327|584773192|FG002|Overall Study|Withdrawal by Subject|164|||
161925478|NCT00145327|584773190|FG000|Overall Study|Death|26|||
161925479|NCT00145327|584773191|FG001|Overall Study|Death|18|||
161925480|NCT00145327|584773192|FG002|Overall Study|Death|30|||
161925481|NCT00145327|584773190|FG000|Overall Study|Adverse Event|14|||
161501368|NCT00322842|583230535|FG001|Overall Study|Refused transplant|0|||
161501369|NCT00322842|583230534|FG000|Overall Study|Death|1|||
161501370|NCT00322842|583230535|FG001|Overall Study|Death|0|||
161501371|NCT00323492|583230536|FG000|Study Phase 1|Adverse Event|2|||
161501372|NCT00323492|583230537|FG001|Study Phase 1|Adverse Event|0|||
161501373|NCT00323492|583230538|FG002|Study Phase 1|Adverse Event|0|||
161501374|NCT00323492|583230536|FG000|Study Phase 2|Adverse Event|1|||
161501375|NCT00323492|583230537|FG001|Study Phase 2|Adverse Event|0|||
161501376|NCT00323492|583230538|FG002|Study Phase 2|Adverse Event|0|||
161501377|NCT00323492|583230536|FG000|Study Phase 2|Physician Decision|1|||
161501378|NCT00323492|583230537|FG001|Study Phase 2|Physician Decision|0|||
161501379|NCT00323492|583230538|FG002|Study Phase 2|Physician Decision|0|||
161501380|NCT00323492|583230536|FG000|Study Phase 2|Lost to Follow-up|1|||
161501381|NCT00323492|583230537|FG001|Study Phase 2|Lost to Follow-up|0|||
161501382|NCT00323492|583230538|FG002|Study Phase 2|Lost to Follow-up|0|||
161501383|NCT00323492|583230536|FG000|Study Phase 2|Withdrawal by Subject|0|||
161501384|NCT00323492|583230537|FG001|Study Phase 2|Withdrawal by Subject|1|||
161501385|NCT00323492|583230538|FG002|Study Phase 2|Withdrawal by Subject|0|||
161501386|NCT00323492|583230536|FG000|Study Phase 2|Noncompliance with study schedule|0|||
161501387|NCT00323492|583230537|FG001|Study Phase 2|Noncompliance with study schedule|0|||
161501388|NCT00323492|583230538|FG002|Study Phase 2|Noncompliance with study schedule|1|||
161501389|NCT00323492|583230536|FG000|Study Phase 2|Protocol Violation|1|||
161501390|NCT00323492|583230537|FG001|Study Phase 2|Protocol Violation|0|||
161501391|NCT00323492|583230538|FG002|Study Phase 2|Protocol Violation|0|||
161501392|NCT02486042|583230539|FG000|Overall Study|Physician Decision|1|||
161501393|NCT02486042|583230540|FG001|Overall Study|Physician Decision|7|||
161501394|NCT02486042|583230539|FG000|Overall Study|Hospital transfer|2|||
161501395|NCT02486042|583230540|FG001|Overall Study|Hospital transfer|2|||
161501396|NCT02486042|583230539|FG000|Overall Study|Withdrawal by Subject|0|||
161501397|NCT02486042|583230540|FG001|Overall Study|Withdrawal by Subject|2|||
161501398|NCT01466387|583230543|FG000|Overall Study|Adverse Event|0|||
161501399|NCT01466387|583230544|FG001|Overall Study|Adverse Event|0|||
161673259|NCT00931944|583857926|FG000|Overall Study|Death|28|||
161501400|NCT01466387|583230545|FG002|Overall Study|Adverse Event|1|||
161501401|NCT01466387|583230546|FG003|Overall Study|Adverse Event|1|||
161673260|NCT00931944|583857926|FG000|Overall Study|Other|2|||
161673261|NCT01026142|583857931|FG000|Overall Study|Death|136|||
161673262|NCT01026142|583857932|FG001|Overall Study|Death|134|||
161673263|NCT01026142|583857931|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
161673264|NCT01026142|583857932|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
161673265|NCT00634010|583857933|FG000|Overall Study|Adverse Event|2|||
161673266|NCT00634010|583857934|FG001|Overall Study|Adverse Event|5|||
161925482|NCT00145327|584773191|FG001|Overall Study|Adverse Event|11|||
161925483|NCT00145327|584773192|FG002|Overall Study|Adverse Event|22|||
161925484|NCT00145327|584773190|FG000|Overall Study|Lost to Follow-up|9|||
161925485|NCT00145327|584773191|FG001|Overall Study|Lost to Follow-up|14|||
161501402|NCT01466387|583230547|FG004|Overall Study|Adverse Event|0|||
161501403|NCT01466387|583230548|FG005|Overall Study|Adverse Event|0|||
161501404|NCT01466387|583230543|FG000|Overall Study|Lost to Follow-up|0|||
161501405|NCT01466387|583230544|FG001|Overall Study|Lost to Follow-up|0|||
161501406|NCT01466387|583230545|FG002|Overall Study|Lost to Follow-up|0|||
161501407|NCT01466387|583230546|FG003|Overall Study|Lost to Follow-up|0|||
161501408|NCT01466387|583230547|FG004|Overall Study|Lost to Follow-up|0|||
161501409|NCT01466387|583230548|FG005|Overall Study|Lost to Follow-up|1|||
161501410|NCT01466387|583230543|FG000|Overall Study|Protocol Violation|1|||
161501411|NCT01466387|583230544|FG001|Overall Study|Protocol Violation|0|||
161501412|NCT01466387|583230545|FG002|Overall Study|Protocol Violation|0|||
161501413|NCT01466387|583230546|FG003|Overall Study|Protocol Violation|1|||
161501414|NCT01466387|583230547|FG004|Overall Study|Protocol Violation|0|||
161501415|NCT01466387|583230548|FG005|Overall Study|Protocol Violation|0|||
161501416|NCT00673179|583230558|FG000|Overall Study|Toxicity/Complications|3|||
161501417|NCT00673179|583230559|FG001|Overall Study|Toxicity/Complications|0|||
161501418|NCT00352846|583230560|FG000|Overall Study|Disease progression|0|||
161501419|NCT00352846|583230561|FG001|Overall Study|Disease progression|2|||
161501420|NCT00352846|583230560|FG000|Overall Study|Withdrawal by Subject|3|||
161501421|NCT00352846|583230561|FG001|Overall Study|Withdrawal by Subject|8|||
161501422|NCT00352846|583230560|FG000|Overall Study|Ineligible|3|||
161501423|NCT00352846|583230561|FG001|Overall Study|Ineligible|2|||
161501424|NCT00352846|583230560|FG000|Overall Study|Non-compliance|2|||
161501425|NCT00352846|583230561|FG001|Overall Study|Non-compliance|0|||
161501426|NCT00352846|583230560|FG000|Overall Study|Death|0|||
161501427|NCT00352846|583230561|FG001|Overall Study|Death|1|||
161501428|NCT00281684|583230562|FG000|Overall Study|Lost to Follow-up|0|||
161501429|NCT00281684|583230563|FG001|Overall Study|Lost to Follow-up|0|||
161501430|NCT00281684|583230564|FG002|Overall Study|Lost to Follow-up|1|||
161501431|NCT00281684|583230565|FG003|Overall Study|Lost to Follow-up|0|||
161501432|NCT00281684|583230562|FG000|Overall Study|Withdrawal by Subject|1|||
161501433|NCT00281684|583230563|FG001|Overall Study|Withdrawal by Subject|0|||
161501434|NCT00281684|583230564|FG002|Overall Study|Withdrawal by Subject|0|||
161501435|NCT00281684|583230565|FG003|Overall Study|Withdrawal by Subject|0|||
161501436|NCT01527682|583230566|FG000|Overall Study|Protocol Violation|8|||
161501437|NCT04668950|583230568|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
161501438|NCT04668950|583230569|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
161501439|NCT04668950|583230568|FG000|Overall Study|Could not confirm started study medication|15|||
161501440|NCT04668950|583230569|FG001|Overall Study|Could not confirm started study medication|15|||
161501441|NCT04668950|583230568|FG000|Overall Study|Could not confirm baseline status|6|||
161501442|NCT04668950|583230569|FG001|Overall Study|Could not confirm baseline status|2|||
161501443|NCT04668950|583230568|FG000|Overall Study|Drop out and did not start medication|15|||
161501444|NCT04668950|583230569|FG001|Overall Study|Drop out and did not start medication|17|||
161501445|NCT04668950|583230568|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
161501446|NCT04668950|583230569|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
161501447|NCT04668950|583230568|FG000|Overall Study|Other|2|||
161501448|NCT04668950|583230569|FG001|Overall Study|Other|4|||
161501449|NCT03979638|583230572|FG000|Period 1|Physician Decision|1|||
161501450|NCT03979638|583230573|FG001|Period 1|Physician Decision|1|||
161501451|NCT03979638|583230572|FG000|Period 1|Withdrawal by Subject|4|||
161501452|NCT03979638|583230573|FG001|Period 1|Withdrawal by Subject|3|||
161501453|NCT03979638|583230572|FG000|Period 1|Study terminated by Sponsor|1|||
161501454|NCT03979638|583230573|FG001|Period 1|Study terminated by Sponsor|3|||
161501455|NCT03979638|583230572|FG000|Period 1|Protocol Violation|1|||
161501456|NCT03979638|583230573|FG001|Period 1|Protocol Violation|0|||
161501457|NCT03979638|583230572|FG000|Period 2|Study terminated by Sponsor|1|||
161501458|NCT03979638|583230573|FG001|Period 2|Study terminated by Sponsor|1|||
161501459|NCT01531387|583230574|FG000|Overall Study|Early termination of study|11|||
161501460|NCT01531387|583230575|FG001|Overall Study|Early termination of study|11|||
161501461|NCT00578942|583230576|FG000|Overall Study|Lost to Follow-up|1|||
161501462|NCT01124643|583230579|FG000|Overall Study|Death|1|||
161501463|NCT04220411|583230580|FG000|Overall Study|Adverse Event|0|||
161501464|NCT04220411|583230581|FG001|Overall Study|Adverse Event|0|||
161501465|NCT04220411|583230582|FG002|Overall Study|Adverse Event|0|||
161501466|NCT04220411|583230583|FG003|Overall Study|Adverse Event|1|||
161501467|NCT02678676|583230584|FG000|Overall Study|Death|619|||
161501468|NCT02678676|583230585|FG001|Overall Study|Death|649|||
161501469|NCT02678676|583230584|FG000|Overall Study|Withdrawal by Subject|13|||
161501470|NCT02678676|583230585|FG001|Overall Study|Withdrawal by Subject|5|||
161501471|NCT02678676|583230584|FG000|Overall Study|Lost to Follow-up|171|||
161501472|NCT02678676|583230585|FG001|Overall Study|Lost to Follow-up|151|||
161501473|NCT02678676|583230584|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
161501474|NCT02678676|583230585|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
161501475|NCT01400516|583230589|FG000|Primary Trial|Withdrawal by Subject|0|||
161501476|NCT01400516|583230590|FG001|Primary Trial|Withdrawal by Subject|2|||
161501477|NCT00549562|583230591|FG000|Overall Study|Adverse Event|1|||
161501478|NCT00549562|583230591|FG000|Overall Study|Lack of Efficacy|1|||
161501479|NCT00403273|583232080|FG000|Overall Study|Lost to Follow-up|3|||
161501480|NCT00403273|583232081|FG001|Overall Study|Lost to Follow-up|2|||
161501481|NCT00403273|583232080|FG000|Overall Study|Physician Decision|0|||
161501482|NCT00403273|583232081|FG001|Overall Study|Physician Decision|1|||
161501483|NCT00403273|583232080|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
161501484|NCT00403273|583232081|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
161501485|NCT00502697|583232087|FG000|Overall Study|Withdrawal by Subject|3|||
161501486|NCT00502697|583232088|FG001|Overall Study|Withdrawal by Subject|1|||
161501487|NCT00502697|583232087|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
161501488|NCT00502697|583232088|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
161501489|NCT00502697|583232087|FG000|Overall Study|found not to meet eligibility criteria|3|||
161501490|NCT00502697|583232088|FG001|Overall Study|found not to meet eligibility criteria|4|||
161501491|NCT00502697|583232087|FG000|Overall Study|did not meet assignment criteria|4|||
161501492|NCT00502697|583232088|FG001|Overall Study|did not meet assignment criteria|2|||
161501493|NCT03256552|583232093|FG000|Overall Study|Protocol Violation|1|||
161501494|NCT03256552|583232093|FG000|Overall Study|Physician Decision|1|||
161501495|NCT03256552|583232093|FG000|Overall Study|Adverse Event|1|||
161501496|NCT03256552|583232093|FG000|Overall Study|Withdrawal by Subject|2|||
161819449|NCT01496118|584379655|FG007|Overall Study|Death|1|||
161819450|NCT01496118|584379648|FG000|Overall Study|Withdrawal by Subject|0|||
161501497|NCT02268409|583232100|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
161501498|NCT02268409|583232100|FG000|Overall Study|Death|1|||
161501499|NCT02268409|583232100|FG000|Overall Study|Lost to Follow-up|1|||
161501500|NCT02268409|583232100|FG000|Overall Study|Protocol Violation|3|||
161501501|NCT02268409|583232100|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
161501502|NCT02268409|583232100|FG000|Overall Study|Withdrawal by Subject|5|||
161501503|NCT00489853|583232101|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
161501504|NCT00489853|583232102|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
161501505|NCT00489853|583232103|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
161501506|NCT00489853|583232101|FG000|Wash-out Period 1|Adverse Event|0|||
161501507|NCT00489853|583232102|FG001|Wash-out Period 1|Adverse Event|1|||
161501508|NCT00489853|583232103|FG002|Wash-out Period 1|Adverse Event|1|||
161501509|NCT00489853|583232101|FG000|Wash-out Period 1|Protocol Violation|0|||
161501510|NCT00489853|583232102|FG001|Wash-out Period 1|Protocol Violation|1|||
161501511|NCT00489853|583232103|FG002|Wash-out Period 1|Protocol Violation|1|||
161501512|NCT00489853|583232101|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
161501513|NCT00489853|583232102|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
161501514|NCT00489853|583232103|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
161501515|NCT00489853|583232101|FG000|Wash-out Period 2|Adverse Event|1|||
161501516|NCT00489853|583232102|FG001|Wash-out Period 2|Adverse Event|1|||
161585938|NCT01424670|583531913|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
161585939|NCT01424670|583531914|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
161585940|NCT01424670|583531913|FG000|Continuation Period|Adverse Event|13|||
161585941|NCT01424670|583531914|FG001|Continuation Period|Adverse Event|5|||
161585942|NCT01424670|583531913|FG000|Continuation Period|Lost to Follow-up|2|||
161585943|NCT01424670|583531914|FG001|Continuation Period|Lost to Follow-up|0|||
161585944|NCT01424670|583531913|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
161585945|NCT01424670|583531914|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
161585946|NCT01424670|583531913|FG000|Continuation Period|Physician Decision|5|||
161585947|NCT01424670|583531914|FG001|Continuation Period|Physician Decision|4|||
161585948|NCT01424670|583531913|FG000|Continuation Period|Withdrawal by Subject|13|||
161585949|NCT01424670|583531914|FG001|Continuation Period|Withdrawal by Subject|4|||
161585950|NCT00761189|583531915|FG000|Overall Study|Adverse Event|42|||
161585951|NCT00761189|583531915|FG000|Overall Study|Lack of Efficacy|45|||
161585952|NCT00761189|583531915|FG000|Overall Study|Lost to Follow-up|36|||
161585953|NCT00761189|583531915|FG000|Overall Study|Withdrawal by Subject|49|||
161585954|NCT00761189|583531915|FG000|Overall Study|Other|13|||
161585955|NCT04377308|583531916|FG000|Overall Study|Withdrawal by Subject|0|||
161585956|NCT04377308|583531917|FG001|Overall Study|Withdrawal by Subject|1|||
161673267|NCT00634010|583857933|FG000|Overall Study|Withdrawal by Subject|5|||
161673268|NCT00634010|583857934|FG001|Overall Study|Withdrawal by Subject|6|||
161819451|NCT01496118|584379649|FG001|Overall Study|Withdrawal by Subject|0|||
161819452|NCT01496118|584379650|FG002|Overall Study|Withdrawal by Subject|0|||
161501517|NCT00489853|583232103|FG002|Wash-out Period 2|Adverse Event|0|||
161501518|NCT00489853|583232101|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
161501519|NCT00489853|583232102|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
161501520|NCT00489853|583232103|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
161501521|NCT00489853|583232101|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
161501522|NCT00489853|583232102|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
161501523|NCT00489853|583232103|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
161585957|NCT01494922|583531918|FG000|Overall Study|Adverse Event|1|||
161585958|NCT00709098|583531926|FG000|Double-blind Period|Withdrawal of consent|3|||
161501524|NCT03265249|583232108|FG000|Overall Study|Withdrawal by Subject|0|||
161501525|NCT03265249|583232109|FG001|Overall Study|Withdrawal by Subject|1|||
161501526|NCT01012622|583232113|FG000|Overall Study|Withdrawal by Subject|6|||
161501527|NCT01012622|583232113|FG000|Overall Study|Lost to Follow-up|5|||
161501528|NCT01012622|583232113|FG000|Overall Study|Adverse Event|7|||
161501529|NCT01012622|583232113|FG000|Overall Study|non-compliance with the drug|9|||
161501530|NCT01012622|583232113|FG000|Overall Study|Other|1|||
161501531|NCT01012622|583232113|FG000|Overall Study|screening failure|1|||
161501532|NCT01012622|583232113|FG000|Overall Study|withdrawal of consent by a parent|2|||
161501533|NCT01176292|583232114|FG000|Overall Study|Lost to Follow-up|2|||
161501534|NCT01176292|583232115|FG001|Overall Study|Lost to Follow-up|4|||
161501535|NCT01176292|583232114|FG000|Overall Study|Adverse Event|1|||
161501536|NCT01176292|583232115|FG001|Overall Study|Adverse Event|1|||
161673269|NCT00634010|583857933|FG000|Overall Study|Physician Decision|1|||
161673270|NCT00634010|583857934|FG001|Overall Study|Physician Decision|1|||
161673271|NCT00634010|583857933|FG000|Overall Study|Disease Progression|1|||
161673272|NCT00634010|583857934|FG001|Overall Study|Disease Progression|1|||
161501537|NCT01176292|583232114|FG000|Overall Study|Physician Decision|0|||
161501538|NCT01176292|583232115|FG001|Overall Study|Physician Decision|2|||
161501539|NCT01176292|583232114|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
161501540|NCT01176292|583232115|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
161501541|NCT00380393|583232116|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
161501542|NCT00380393|583232117|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
161501543|NCT00380393|583232116|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
161501544|NCT00380393|583232117|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
161501545|NCT00380393|583232116|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
161501546|NCT00380393|583232117|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
161673273|NCT00634010|583857933|FG000|Overall Study|Non-Compliant|1|||
161673274|NCT00634010|583857934|FG001|Overall Study|Non-Compliant|1|||
161673275|NCT00882310|583857935|FG000|Overall Study|Screen Failure|10|||
161673276|NCT00882310|583857935|FG000|Overall Study|Never received treatment|1|||
161673277|NCT00882310|583857935|FG000|Overall Study|Death|6|||
161673278|NCT00882310|583857935|FG000|Overall Study|Progression of disease|4|||
161501547|NCT00380393|583232116|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
161501548|NCT00380393|583232117|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
161673279|NCT00882310|583857935|FG000|Overall Study|Adverse Event|1|||
161673280|NCT04233164|583857940|FG000|Overall Study|Unable to obtain specimen|0|||
161673281|NCT04233164|583857941|FG001|Overall Study|Unable to obtain specimen|1|||
161673282|NCT04201821|583857944|FG000|Overall Study|Withdrawal by Subject|2|||
161673283|NCT00651157|583857945|FG000|Overall Study|Death|1|||
161673284|NCT00651157|583857945|FG000|Overall Study|Protocol Violation|1|||
161673285|NCT00688181|583857947|FG000|Overall Study|Lost to Follow-up|17|||
161673286|NCT00688181|583857947|FG000|Overall Study|Unknown Reason|4|||
161673287|NCT00688181|583857947|FG000|Overall Study|Non-clinical Reason|2|||
161673288|NCT01891721|583857948|FG000|Overall Study|Lost to Follow-up|10|||
161673289|NCT01891721|583857949|FG001|Overall Study|Lost to Follow-up|5|||
161673290|NCT01891721|583857950|FG002|Overall Study|Lost to Follow-up|1|||
161673291|NCT03829319|583857951|FG000|Overall Study|Sponsor's Decision|4|||
161673292|NCT03829319|583857952|FG001|Overall Study|Sponsor's Decision|90|||
161673293|NCT03829319|583857953|FG002|Overall Study|Sponsor's Decision|102|||
161673294|NCT03829319|583857951|FG000|Overall Study|Withdrawal by Subject|1|||
161673295|NCT03829319|583857952|FG001|Overall Study|Withdrawal by Subject|5|||
161673296|NCT03829319|583857953|FG002|Overall Study|Withdrawal by Subject|4|||
161673297|NCT03829319|583857951|FG000|Overall Study|Physician Decision|0|||
161673298|NCT03829319|583857952|FG001|Overall Study|Physician Decision|3|||
161673299|NCT03829319|583857953|FG002|Overall Study|Physician Decision|0|||
161501549|NCT00380393|583232116|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
161501550|NCT00380393|583232117|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
161501551|NCT00380393|583232116|FG000|Month 14|Withdrawal by Subject|9|||
161501552|NCT00380393|583232117|FG001|Month 14|Withdrawal by Subject|7|||
161673300|NCT03829319|583857951|FG000|Overall Study|Lost to Follow-up|0|||
161673301|NCT03829319|583857952|FG001|Overall Study|Lost to Follow-up|0|||
161673302|NCT03829319|583857953|FG002|Overall Study|Lost to Follow-up|1|||
161673303|NCT03829319|583857951|FG000|Overall Study|Death|8|||
161673304|NCT03829319|583857952|FG001|Overall Study|Death|277|||
161673305|NCT03829319|583857953|FG002|Overall Study|Death|266|||
161673306|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161673307|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161673308|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161501553|NCT00380393|583232116|FG000|Month 14|Death|1|||
161501554|NCT00380393|583232117|FG001|Month 14|Death|0|||
161501555|NCT00380393|583232116|FG000|Month 14|Lost to Follow-up|0|||
161501556|NCT00380393|583232117|FG001|Month 14|Lost to Follow-up|1|||
161501557|NCT00380393|583232116|FG000|Month 14|Migrated/moved from study area|39|||
161673309|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
161673310|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161673311|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161501558|NCT00380393|583232117|FG001|Month 14|Migrated/moved from study area|42|||
161501559|NCT00380393|583232116|FG000|Month 14|Protocol Violation|2|||
161501560|NCT00380393|583232117|FG001|Month 14|Protocol Violation|0|||
161501561|NCT00380393|583232116|FG000|Month 14|Others|6|||
161501562|NCT00380393|583232117|FG001|Month 14|Others|6|||
161501563|NCT00278954|583232128|FG000|Overall Study|Adverse Event|3|||
161501564|NCT00278954|583232128|FG000|Overall Study|Lost to Follow-up|1|||
161501565|NCT00278954|583232128|FG000|Overall Study|Withdrawal by Subject|1|||
161501566|NCT02211131|583232132|FG000|Overall Study|Death|26|||
161501567|NCT02211131|583232133|FG001|Overall Study|Death|16|||
161501568|NCT02211131|583232132|FG000|Overall Study|Lost to Follow-up|4|||
161501569|NCT02211131|583232133|FG001|Overall Study|Lost to Follow-up|3|||
161501570|NCT02211131|583232132|FG000|Overall Study|Decision by Sponsor|1|||
161501571|NCT02211131|583232133|FG001|Overall Study|Decision by Sponsor|1|||
161501572|NCT02211131|583232132|FG000|Overall Study|Withdrawal by Subject|3|||
161501573|NCT02211131|583232133|FG001|Overall Study|Withdrawal by Subject|8|||
161501574|NCT05664490|583232134|FG000|Overall Study|Withdrawal by Subject|0|||
161501575|NCT05664490|583232135|FG001|Overall Study|Withdrawal by Subject|1|||
161501576|NCT05664490|583232134|FG000|Overall Study|Lost to Follow-up|14|||
161501577|NCT05664490|583232135|FG001|Overall Study|Lost to Follow-up|22|||
161501578|NCT00704535|583232136|FG000|Overall Study|Adverse Event|2|||
161501579|NCT00704535|583232136|FG000|Overall Study|Death|2|||
161501580|NCT00704535|583232136|FG000|Overall Study|Lost to Follow-up|8|||
161501581|NCT00704535|583232136|FG000|Overall Study|Protocol Violation|10|||
161501582|NCT00704535|583232136|FG000|Overall Study|Completed status not on Case Report Form|124|||
161501583|NCT01589445|583232139|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
161501584|NCT01589445|583232139|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
161501585|NCT01589445|583232139|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
161501586|NCT01589445|583232139|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
161501587|NCT01589445|583232139|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
161501588|NCT01589445|583232139|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
161501589|NCT01589445|583232139|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
161501590|NCT01589445|583232139|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
161501591|NCT01589445|583232139|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
161501592|NCT01589445|583232139|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
161501593|NCT04064294|583232148|FG000|Overall Study|Adverse Event|1|||
161501594|NCT04064294|583232149|FG001|Overall Study|Adverse Event|0|||
161501595|NCT04064294|583232150|FG002|Overall Study|Adverse Event|0|||
161501596|NCT00481195|583232151|FG000|Overall Study|Adverse Event|16|||
161501597|NCT00481195|583232152|FG001|Overall Study|Adverse Event|11|||
161501598|NCT00481195|583232151|FG000|Overall Study|Lack of Efficacy|1|||
161501599|NCT00481195|583232152|FG001|Overall Study|Lack of Efficacy|3|||
161501600|NCT00481195|583232151|FG000|Overall Study|Lost to Follow-up|4|||
161501601|NCT00481195|583232152|FG001|Overall Study|Lost to Follow-up|6|||
161501602|NCT00481195|583232151|FG000|Overall Study|Physician Decision|3|||
161501603|NCT00481195|583232152|FG001|Overall Study|Physician Decision|1|||
161501604|NCT00481195|583232151|FG000|Overall Study|Protocol Violation|10|||
161501605|NCT00481195|583232152|FG001|Overall Study|Protocol Violation|7|||
161501606|NCT00481195|583232151|FG000|Overall Study|Withdrawal by Subject|3|||
161501607|NCT00481195|583232152|FG001|Overall Study|Withdrawal by Subject|9|||
161501608|NCT00481195|583232151|FG000|Overall Study|Miscellaneous|2|||
161501609|NCT00481195|583232152|FG001|Overall Study|Miscellaneous|2|||
161501610|NCT01498640|583232153|FG000|Overall Study|Lost to Follow-up|1|||
161501611|NCT01498640|583232153|FG000|Overall Study|Death|1|||
161501612|NCT01498640|583232153|FG000|Overall Study|Other|3|||
161501613|NCT01319877|583232154|FG000|Overall Study|Lost to Follow-up|100|||
161501614|NCT01319877|583232155|FG001|Overall Study|Lost to Follow-up|37|||
161501615|NCT01319877|583232154|FG000|Overall Study|Physician Decision|2|||
161501616|NCT01319877|583232155|FG001|Overall Study|Physician Decision|0|||
161501617|NCT01319877|583232154|FG000|Overall Study|Disease Progression|2|||
161501618|NCT01319877|583232155|FG001|Overall Study|Disease Progression|2|||
161501619|NCT01319877|583232154|FG000|Overall Study|Withdrawal by Subject|0|||
161501620|NCT01319877|583232155|FG001|Overall Study|Withdrawal by Subject|1|||
161501621|NCT01319877|583232154|FG000|Overall Study|Reason Not Specified|4|||
161501622|NCT01319877|583232155|FG001|Overall Study|Reason Not Specified|5|||
161501623|NCT02347189|583232158|FG000|Overall Study|No implant attempted of study device|9|||
161501624|NCT02347189|583232158|FG000|Overall Study|No primary outcome data available|2|||
161501625|NCT02677987|583232159|FG000|Overall Study|Withdrawal by Subject|3|||
161585959|NCT00709098|583531927|FG001|Double-blind Period|Withdrawal of consent|3|||
161501626|NCT02677987|583232160|FG001|Overall Study|Withdrawal by Subject|0|||
161501627|NCT02677987|583232159|FG000|Overall Study|Lost to Follow-up|1|||
161501628|NCT02677987|583232160|FG001|Overall Study|Lost to Follow-up|0|||
161501629|NCT03320564|583232161|FG000|Overall Study|Protocol Violation|1|||
161585960|NCT00709098|583531928|FG002|Double-blind Period|Withdrawal of consent|0|||
161501630|NCT00600938|583232162|FG000|Core Study|Abnormal test procedure result(s)|3|||
161501631|NCT00600938|583232163|FG001|Core Study|Abnormal test procedure result(s)|2|||
161501632|NCT00600938|583232164|FG002|Core Study|Abnormal test procedure result(s)|0|||
161585961|NCT00709098|583531926|FG000|Double-blind Period|Administrative reason|1|||
161501633|NCT00600938|583232165|FG003|Core Study|Abnormal test procedure result(s)|0|||
161501634|NCT00600938|583232162|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
161501635|NCT00600938|583232163|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
161501636|NCT00600938|583232164|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
161501637|NCT00600938|583232165|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
161501638|NCT00600938|583232162|FG000|Core Study|Patient withdrew consent|7|||
161501639|NCT00600938|583232163|FG001|Core Study|Patient withdrew consent|12|||
161501640|NCT00600938|583232164|FG002|Core Study|Patient withdrew consent|0|||
161501641|NCT00600938|583232165|FG003|Core Study|Patient withdrew consent|0|||
161501642|NCT00600938|583232162|FG000|Core Study|Lost to Follow-up|3|||
161501643|NCT00600938|583232163|FG001|Core Study|Lost to Follow-up|2|||
161501644|NCT00600938|583232164|FG002|Core Study|Lost to Follow-up|0|||
161501645|NCT00600938|583232165|FG003|Core Study|Lost to Follow-up|0|||
161501646|NCT00600938|583232162|FG000|Core Study|Death|1|||
161501647|NCT00600938|583232163|FG001|Core Study|Death|1|||
161501648|NCT00600938|583232164|FG002|Core Study|Death|0|||
161501649|NCT00600938|583232165|FG003|Core Study|Death|0|||
161501650|NCT00600938|583232162|FG000|Core Study|Protocol Violation|1|||
161501651|NCT00600938|583232163|FG001|Core Study|Protocol Violation|2|||
161501652|NCT00600938|583232164|FG002|Core Study|Protocol Violation|0|||
161501653|NCT00600938|583232165|FG003|Core Study|Protocol Violation|0|||
161501654|NCT00600938|583232162|FG000|Extension Study|Adverse Event|1|||
161501655|NCT00600938|583232163|FG001|Extension Study|Adverse Event|0|||
161501656|NCT00600938|583232164|FG002|Extension Study|Adverse Event|2|||
161501657|NCT00600938|583232165|FG003|Extension Study|Adverse Event|0|||
161501658|NCT00600938|583232162|FG000|Extension Study|Abnormal test procedure results|0|||
161501659|NCT00600938|583232163|FG001|Extension Study|Abnormal test procedure results|1|||
161501660|NCT00600938|583232164|FG002|Extension Study|Abnormal test procedure results|1|||
161501661|NCT00600938|583232165|FG003|Extension Study|Abnormal test procedure results|1|||
161501662|NCT00600938|583232162|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
161501663|NCT00600938|583232163|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
161501664|NCT00600938|583232164|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
161501665|NCT00600938|583232165|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
161501666|NCT00600938|583232162|FG000|Extension Study|Withdrawal by Subject|2|||
161501667|NCT00600938|583232163|FG001|Extension Study|Withdrawal by Subject|2|||
161501668|NCT00600938|583232164|FG002|Extension Study|Withdrawal by Subject|3|||
161501669|NCT00600938|583232165|FG003|Extension Study|Withdrawal by Subject|0|||
161501670|NCT00600938|583232162|FG000|Extension Study|Lost to Follow-up|1|||
161501671|NCT00600938|583232163|FG001|Extension Study|Lost to Follow-up|1|||
161501672|NCT00600938|583232164|FG002|Extension Study|Lost to Follow-up|2|||
161501673|NCT00600938|583232165|FG003|Extension Study|Lost to Follow-up|0|||
161501674|NCT00600938|583232162|FG000|Extension Study|Death|1|||
161501675|NCT00600938|583232163|FG001|Extension Study|Death|0|||
161501676|NCT00600938|583232164|FG002|Extension Study|Death|0|||
161501677|NCT00600938|583232165|FG003|Extension Study|Death|0|||
161501678|NCT02680639|583232166|FG000|Screening Period|Screen Failure|7|||
161501679|NCT02680639|583232167|FG001|Screening Period|Screen Failure|0|||
161501680|NCT02680639|583232168|FG002|Screening Period|Screen Failure|0|||
161501681|NCT03200899|583232169|FG000|Overall Study|Lost to Follow-up|10|||
161501682|NCT03200899|583232170|FG001|Overall Study|Lost to Follow-up|23|||
161501683|NCT01342510|583232182|FG000|Overall Study|Protocol Violation|12|||
161501684|NCT01342510|583232183|FG001|Overall Study|Protocol Violation|6|||
161501685|NCT01342510|583232184|FG002|Overall Study|Protocol Violation|13|||
161501686|NCT01342510|583232185|FG003|Overall Study|Protocol Violation|11|||
161501687|NCT00323115|583232190|FG000|Vaccine Administration|Adverse Event|1|||
161501688|NCT00323115|583232190|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
161501689|NCT04837131|583232191|FG000|Overall Study|Death|1|||
161501690|NCT04837131|583232191|FG000|Overall Study|Withdrawal by Subject|1|||
161501691|NCT04837131|583232191|FG000|Overall Study|Adverse Event|1|||
161501692|NCT04837131|583232191|FG000|Overall Study|Protocol Violation|1|||
161501693|NCT02496533|583232192|FG000|Overall Study|Lack of data on outcome|3|||
161501694|NCT02496533|583232193|FG001|Overall Study|Lack of data on outcome|0|||
161501695|NCT02496533|583232192|FG000|Overall Study|Patient did not complete all measures|0|||
161501696|NCT02496533|583232193|FG001|Overall Study|Patient did not complete all measures|4|||
161501697|NCT02496533|583232192|FG000|Overall Study|Late for radiologic testing|0|||
161501698|NCT02496533|583232193|FG001|Overall Study|Late for radiologic testing|2|||
161501699|NCT05756790|583232194|FG000|Overall Study|Withdrawal by Subject|1|||
161501700|NCT05756790|583232195|FG001|Overall Study|Withdrawal by Subject|1|||
161501701|NCT05756790|583232196|FG002|Overall Study|Withdrawal by Subject|1|||
161501702|NCT05756790|583232197|FG003|Overall Study|Withdrawal by Subject|1|||
161501703|NCT05756790|583232198|FG004|Overall Study|Withdrawal by Subject|0|||
161501704|NCT05756790|583232199|FG005|Overall Study|Withdrawal by Subject|0|||
161501705|NCT05756790|583232194|FG000|Overall Study|Protocol Violation|0|||
161501706|NCT05756790|583232195|FG001|Overall Study|Protocol Violation|0|||
161585962|NCT00709098|583531927|FG001|Double-blind Period|Administrative reason|3|||
161585963|NCT00709098|583531928|FG002|Double-blind Period|Administrative reason|0|||
161501707|NCT05756790|583232196|FG002|Overall Study|Protocol Violation|1|||
161585964|NCT00709098|583531926|FG000|Double-blind Period|Death|1|||
161501708|NCT05756790|583232197|FG003|Overall Study|Protocol Violation|1|||
161501709|NCT05756790|583232198|FG004|Overall Study|Protocol Violation|0|||
161501710|NCT05756790|583232199|FG005|Overall Study|Protocol Violation|0|||
161501711|NCT05756790|583232194|FG000|Overall Study|Ineligible|0|||
161501712|NCT05756790|583232195|FG001|Overall Study|Ineligible|0|||
161501713|NCT05756790|583232196|FG002|Overall Study|Ineligible|0|||
161501714|NCT05756790|583232197|FG003|Overall Study|Ineligible|0|||
161501715|NCT05756790|583232198|FG004|Overall Study|Ineligible|2|||
161501716|NCT05756790|583232199|FG005|Overall Study|Ineligible|2|||
161501717|NCT00589108|583233468|FG000|Overall Study|Lost to Follow-up|1|||
161501718|NCT00589108|583233469|FG001|Overall Study|Lost to Follow-up|1|||
161501719|NCT00589108|583233470|FG002|Overall Study|Lost to Follow-up|1|||
161501720|NCT00589108|583233468|FG000|Overall Study|Death|3|||
161501721|NCT00589108|583233469|FG001|Overall Study|Death|3|||
161501722|NCT00589108|583233470|FG002|Overall Study|Death|4|||
161501723|NCT03026257|583233473|FG000|Overall Study|Adverse Event|3|||
161501724|NCT03026257|583233474|FG001|Overall Study|Adverse Event|0|||
161501725|NCT03026257|583233475|FG002|Overall Study|Adverse Event|0|||
161501726|NCT03026257|583233476|FG003|Overall Study|Adverse Event|0|||
161501727|NCT03026257|583233477|FG004|Overall Study|Adverse Event|0|||
161501728|NCT03026257|583233478|FG005|Overall Study|Adverse Event|0|||
161501729|NCT03026257|583233473|FG000|Overall Study|Lost to Follow-up|1|||
161501730|NCT03026257|583233474|FG001|Overall Study|Lost to Follow-up|0|||
161501731|NCT03026257|583233475|FG002|Overall Study|Lost to Follow-up|0|||
161501732|NCT03026257|583233476|FG003|Overall Study|Lost to Follow-up|0|||
161501733|NCT03026257|583233477|FG004|Overall Study|Lost to Follow-up|0|||
161501734|NCT03026257|583233478|FG005|Overall Study|Lost to Follow-up|0|||
161501735|NCT03026257|583233473|FG000|Overall Study|Protocol Violation|1|||
161501736|NCT03026257|583233474|FG001|Overall Study|Protocol Violation|0|||
161501737|NCT03026257|583233475|FG002|Overall Study|Protocol Violation|0|||
161501738|NCT03026257|583233476|FG003|Overall Study|Protocol Violation|1|||
161501739|NCT03026257|583233477|FG004|Overall Study|Protocol Violation|1|||
161501740|NCT03026257|583233478|FG005|Overall Study|Protocol Violation|0|||
161501741|NCT03026257|583233473|FG000|Overall Study|Withdrawal by Subject|1|||
161501742|NCT03026257|583233474|FG001|Overall Study|Withdrawal by Subject|1|||
161501743|NCT03026257|583233475|FG002|Overall Study|Withdrawal by Subject|0|||
161501744|NCT03026257|583233476|FG003|Overall Study|Withdrawal by Subject|0|||
161501745|NCT03026257|583233477|FG004|Overall Study|Withdrawal by Subject|0|||
161501746|NCT03026257|583233478|FG005|Overall Study|Withdrawal by Subject|0|||
161501747|NCT02181556|583233480|FG000|Overall Study|Withdrawal by Subject|1|||
161501748|NCT00427635|583233481|FG000|Treatment Phase|Withdrawal by Subject|1|||
161501749|NCT00427635|583233482|FG001|Treatment Phase|Withdrawal by Subject|0|||
161501750|NCT00427635|583233481|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
161501751|NCT00427635|583233482|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
161501752|NCT00838201|583233485|FG000|Overall Study|Investigator decision, or other reasons|2|||
161501753|NCT00838201|583233486|FG001|Overall Study|Investigator decision, or other reasons|3|||
161501754|NCT00838201|583233485|FG000|Overall Study|Noncompliance|0|||
161501755|NCT00838201|583233486|FG001|Overall Study|Noncompliance|1|||
161501756|NCT00838201|583233485|FG000|Overall Study|Administrative decision|1|||
161501757|NCT00838201|583233486|FG001|Overall Study|Administrative decision|2|||
161501758|NCT00838201|583233485|FG000|Overall Study|Disease progression|3|||
161501759|NCT00838201|583233486|FG001|Overall Study|Disease progression|3|||
161501760|NCT00838201|583233485|FG000|Overall Study|Consent withdrawn|16|||
161501761|NCT00838201|583233486|FG001|Overall Study|Consent withdrawn|19|||
161501762|NCT00838201|583233485|FG000|Overall Study|Lost to Follow-up|4|||
161501763|NCT00838201|583233486|FG001|Overall Study|Lost to Follow-up|3|||
161501764|NCT00838201|583233485|FG000|Overall Study|Adverse Event|5|||
161501765|NCT00838201|583233486|FG001|Overall Study|Adverse Event|9|||
161501766|NCT00838201|583233485|FG000|Overall Study|Death|11|||
161501767|NCT00838201|583233486|FG001|Overall Study|Death|13|||
161501768|NCT03873987|583233487|FG000|Overall Study|Adverse Event|1|||
161501769|NCT03873987|583233488|FG001|Overall Study|Adverse Event|0|||
161501770|NCT03873987|583233487|FG000|Overall Study|staff was unable to start a new IV line|1|||
161501771|NCT03873987|583233488|FG001|Overall Study|staff was unable to start a new IV line|0|||
161585965|NCT00709098|583531927|FG001|Double-blind Period|Death|1|||
161501772|NCT03873987|583233487|FG000|Overall Study|Lost to Follow-up|0|||
161501773|NCT03873987|583233488|FG001|Overall Study|Lost to Follow-up|1|||
161501774|NCT01465022|583233489|FG000|Overall Study|Lost to Follow-up|15|||
161501775|NCT01465022|583233490|FG001|Overall Study|Lost to Follow-up|14|||
161501776|NCT01465022|583233491|FG002|Overall Study|Lost to Follow-up|0|||
161501777|NCT01465022|583233489|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
161501778|NCT01465022|583233490|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
161585966|NCT00709098|583531928|FG002|Double-blind Period|Death|0|||
161501779|NCT01465022|583233491|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
161501780|NCT01465022|583233489|FG000|Overall Study|Not Randomized|0|||
161501781|NCT01465022|583233490|FG001|Overall Study|Not Randomized|0|||
161501782|NCT01465022|583233491|FG002|Overall Study|Not Randomized|70|||
161501783|NCT00004888|583233492|FG000|Overall Study|Adverse Event|5|||
161585967|NCT00709098|583531926|FG000|Double-blind Period|Lost to Follow-up|1|||
161501784|NCT00004888|583233493|FG001|Overall Study|Adverse Event|10|||
161501785|NCT00004888|583233492|FG000|Overall Study|Withdrawal by Subject|0|||
161501786|NCT00004888|583233493|FG001|Overall Study|Withdrawal by Subject|3|||
161501787|NCT00004888|583233492|FG000|Overall Study|Physician Decision|1|||
161501788|NCT00004888|583233493|FG001|Overall Study|Physician Decision|1|||
161501789|NCT00004888|583233492|FG000|Overall Study|Progressive Disease|4|||
161501790|NCT00004888|583233493|FG001|Overall Study|Progressive Disease|9|||
161501791|NCT00004888|583233492|FG000|Overall Study|Death without progressive disease|0|||
161501792|NCT00004888|583233493|FG001|Overall Study|Death without progressive disease|1|||
161501793|NCT00004888|583233492|FG000|Overall Study|Toxic death|1|||
161501794|NCT00004888|583233493|FG001|Overall Study|Toxic death|0|||
161501795|NCT00136084|583233494|FG000|Overall Study|Death|12|||
161501796|NCT00136084|583233495|FG001|Overall Study|Death|5|||
161501797|NCT00136084|583233494|FG000|Overall Study|Unacceptable toxicity|8|||
161501798|NCT00136084|583233495|FG001|Overall Study|Unacceptable toxicity|11|||
161501799|NCT00136084|583233494|FG000|Overall Study|Relapse|20|||
161501800|NCT00136084|583233495|FG001|Overall Study|Relapse|23|||
161501801|NCT00136084|583233494|FG000|Overall Study|Lost to Follow-up|2|||
161501802|NCT00136084|583233495|FG001|Overall Study|Lost to Follow-up|0|||
161501803|NCT00136084|583233494|FG000|Overall Study|No Response|1|||
161501804|NCT00136084|583233495|FG001|Overall Study|No Response|2|||
161501805|NCT00136084|583233494|FG000|Overall Study|Withdrawal by Subject|5|||
161501806|NCT00136084|583233495|FG001|Overall Study|Withdrawal by Subject|1|||
161501807|NCT02174848|583233496|FG000|Overall Study|Adverse Event|2|||
161501808|NCT02174848|583233497|FG001|Overall Study|Adverse Event|1|||
161501809|NCT02174848|583233496|FG000|Overall Study|Withdrawal by Subject|3|||
161501810|NCT02174848|583233497|FG001|Overall Study|Withdrawal by Subject|3|||
161501811|NCT02174848|583233496|FG000|Overall Study|Lost to Follow-up|0|||
161501812|NCT02174848|583233497|FG001|Overall Study|Lost to Follow-up|1|||
161501813|NCT02174848|583233496|FG000|Overall Study|Worsening of disease|1|||
161501814|NCT02174848|583233497|FG001|Overall Study|Worsening of disease|1|||
161501815|NCT02174848|583233496|FG000|Overall Study|Unable to comply with study requirements|1|||
161501816|NCT02174848|583233497|FG001|Overall Study|Unable to comply with study requirements|0|||
161501817|NCT02520011|583233499|FG000|Overall Study|Adverse Event|0|||
161501818|NCT02520011|583233500|FG001|Overall Study|Adverse Event|1|||
161501819|NCT02520011|583233501|FG002|Overall Study|Adverse Event|2|||
161501820|NCT02520011|583233499|FG000|Overall Study|Death|0|||
161501821|NCT02520011|583233500|FG001|Overall Study|Death|8|||
161501822|NCT02520011|583233501|FG002|Overall Study|Death|1|||
161673312|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161673313|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161673314|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
161673315|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161673316|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673317|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673318|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673319|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
161673320|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673321|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673322|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673323|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673324|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
161673325|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673326|NCT04484259|583857954|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161673327|NCT04484259|583857955|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161673328|NCT04484259|583857956|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161673329|NCT04484259|583857957|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161819453|NCT01496118|584379651|FG003|Overall Study|Withdrawal by Subject|2|||
161501823|NCT02520011|583233499|FG000|Overall Study|Lack of Efficacy|4|||
161501824|NCT02520011|583233500|FG001|Overall Study|Lack of Efficacy|26|||
161501825|NCT02520011|583233501|FG002|Overall Study|Lack of Efficacy|4|||
161501826|NCT02520011|583233499|FG000|Overall Study|Physician Decision|0|||
161501827|NCT02520011|583233500|FG001|Overall Study|Physician Decision|2|||
161501828|NCT02520011|583233501|FG002|Overall Study|Physician Decision|0|||
161501829|NCT02520011|583233499|FG000|Overall Study|Withdrawal by Subject|1|||
161501830|NCT02520011|583233500|FG001|Overall Study|Withdrawal by Subject|3|||
161501831|NCT02520011|583233501|FG002|Overall Study|Withdrawal by Subject|0|||
161501832|NCT02520011|583233499|FG000|Overall Study|Protocol Deviation|0|||
161501833|NCT02520011|583233500|FG001|Overall Study|Protocol Deviation|1|||
161501834|NCT02520011|583233501|FG002|Overall Study|Protocol Deviation|0|||
161501835|NCT02520011|583233499|FG000|Overall Study|Patient went to hospice|0|||
161501836|NCT02520011|583233500|FG001|Overall Study|Patient went to hospice|1|||
161501837|NCT02520011|583233501|FG002|Overall Study|Patient went to hospice|0|||
161501838|NCT02520011|583233499|FG000|Overall Study|Progressive disease following response|0|||
161501839|NCT02520011|583233500|FG001|Overall Study|Progressive disease following response|4|||
161501840|NCT02520011|583233501|FG002|Overall Study|Progressive disease following response|2|||
161501841|NCT00644969|583233502|FG000|Treatment Phase|Randomized, not treated|1|||
161501842|NCT00644969|583233503|FG001|Treatment Phase|Randomized, not treated|0|||
161501843|NCT00644969|583233502|FG000|Treatment Phase|Adverse Event|3|||
161501844|NCT00644969|583233503|FG001|Treatment Phase|Adverse Event|0|||
161501845|NCT00644969|583233502|FG000|Treatment Phase|Withdrawal by Subject|4|||
161501846|NCT00644969|583233503|FG001|Treatment Phase|Withdrawal by Subject|0|||
161673330|NCT04484259|583857958|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
161819454|NCT01496118|584379652|FG004|Overall Study|Withdrawal by Subject|0|||
161819455|NCT01496118|584379653|FG005|Overall Study|Withdrawal by Subject|1|||
161819456|NCT01496118|584379654|FG006|Overall Study|Withdrawal by Subject|6|||
161819457|NCT01496118|584379655|FG007|Overall Study|Withdrawal by Subject|3|||
161819458|NCT00841659|584379656|FG000|Washout: 2 Weeks|Protocol Violation|1|||
161819459|NCT00841659|584379657|FG001|Washout: 2 Weeks|Protocol Violation|0|||
161819460|NCT01149057|584379661|FG000|Overall Study|Lack of Efficacy|16|||
161819461|NCT01149057|584379661|FG000|Overall Study|Adverse Event|13|||
161819462|NCT01149057|584379661|FG000|Overall Study|Withdrawal by Subject|9|||
161819463|NCT01149057|584379661|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
161819464|NCT01149057|584379661|FG000|Overall Study|B Cell Depletion|4|||
161819465|NCT01149057|584379661|FG000|Overall Study|Participant Non-Compliance|2|||
161819466|NCT01149057|584379661|FG000|Overall Study|Lost to Follow-up|1|||
161819467|NCT01149057|584379661|FG000|Overall Study|High Parathyroid Hormone Value|1|||
161819468|NCT01149057|584379661|FG000|Overall Study|Other|6|||
161673331|NCT04484259|583857954|FG000|Randomized Treatment|Withdrawal by Subject|1|||
161673332|NCT04484259|583857955|FG001|Randomized Treatment|Withdrawal by Subject|0|||
161673333|NCT04484259|583857956|FG002|Randomized Treatment|Withdrawal by Subject|0|||
161673334|NCT04484259|583857957|FG003|Randomized Treatment|Withdrawal by Subject|0|||
161673335|NCT04484259|583857958|FG004|Randomized Treatment|Withdrawal by Subject|0|||
161673336|NCT04498832|583857959|FG000|Overall Study|Adverse Event|1|||
161673337|NCT04498832|583857960|FG001|Overall Study|Adverse Event|3|||
161673338|NCT04498832|583857959|FG000|Overall Study|Withdrawal by Subject|0|||
161673339|NCT04498832|583857960|FG001|Overall Study|Withdrawal by Subject|1|||
161673340|NCT01313650|583857962|FG000|Overall Study|Adverse Event|9|||
161673341|NCT01313650|583857963|FG001|Overall Study|Adverse Event|34|||
161673342|NCT01313650|583857964|FG002|Overall Study|Adverse Event|24|||
161673343|NCT01313650|583857965|FG003|Overall Study|Adverse Event|23|||
161673344|NCT01313650|583857962|FG000|Overall Study|Lack of Efficacy|37|||
161673345|NCT01313650|583857963|FG001|Overall Study|Lack of Efficacy|20|||
161673346|NCT01313650|583857964|FG002|Overall Study|Lack of Efficacy|32|||
161673347|NCT01313650|583857965|FG003|Overall Study|Lack of Efficacy|20|||
161673348|NCT01313650|583857962|FG000|Overall Study|Lost to Follow-up|1|||
161673349|NCT01313650|583857963|FG001|Overall Study|Lost to Follow-up|0|||
161673350|NCT01313650|583857964|FG002|Overall Study|Lost to Follow-up|3|||
161673351|NCT01313650|583857965|FG003|Overall Study|Lost to Follow-up|2|||
161673352|NCT01313650|583857962|FG000|Overall Study|Withdrawal by Subject|16|||
161673353|NCT01313650|583857963|FG001|Overall Study|Withdrawal by Subject|20|||
161673354|NCT01313650|583857964|FG002|Overall Study|Withdrawal by Subject|15|||
161673355|NCT01313650|583857965|FG003|Overall Study|Withdrawal by Subject|15|||
161673356|NCT01313650|583857962|FG000|Overall Study|Protocol Violation|4|||
161673357|NCT01313650|583857963|FG001|Overall Study|Protocol Violation|7|||
161673358|NCT01313650|583857964|FG002|Overall Study|Protocol Violation|5|||
161673359|NCT01313650|583857965|FG003|Overall Study|Protocol Violation|6|||
161673360|NCT01313650|583857962|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
161819469|NCT04608448|584379662|FG000|Overall Study|Withdrawal by Subject|1|||
161819470|NCT04608448|584379662|FG000|Overall Study|Adverse Event|1|||
161925486|NCT00145327|584773192|FG002|Overall Study|Lost to Follow-up|14|||
161925487|NCT00145327|584773190|FG000|Overall Study|Administrative problems|12|||
161925488|NCT00145327|584773191|FG001|Overall Study|Administrative problems|9|||
161925489|NCT00145327|584773192|FG002|Overall Study|Administrative problems|13|||
161925490|NCT00145327|584773190|FG000|Overall Study|Protocol Violation|2|||
161925491|NCT00145327|584773191|FG001|Overall Study|Protocol Violation|0|||
161925492|NCT00145327|584773192|FG002|Overall Study|Protocol Violation|2|||
161925493|NCT00145327|584773190|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161925494|NCT00145327|584773191|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161925495|NCT00145327|584773192|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161925496|NCT00145327|584773190|FG000|Overall Study|Missing - not stated|1|||
161925497|NCT00145327|584773191|FG001|Overall Study|Missing - not stated|0|||
161673361|NCT01313650|583857963|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
161819471|NCT03499873|584379663|FG000|Overall Study|Withdrawal by Subject|4|||
161925498|NCT00145327|584773192|FG002|Overall Study|Missing - not stated|1|||
161925499|NCT00845182|584773193|FG000|Overall Study|Lost to Follow-up|3|||
161673362|NCT01313650|583857964|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
161673363|NCT01313650|583857965|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
161673364|NCT04029480|583857966|FG000|Overall Study|Physician Decision|0|||
161673365|NCT04029480|583857967|FG001|Overall Study|Physician Decision|0|||
161925500|NCT00845182|584773194|FG001|Overall Study|Lost to Follow-up|3|||
161925501|NCT00845182|584773195|FG002|Overall Study|Lost to Follow-up|4|||
161925502|NCT00845182|584773193|FG000|Overall Study|Adverse Event|0|||
161925503|NCT00845182|584773194|FG001|Overall Study|Adverse Event|1|||
161673366|NCT04029480|583857968|FG002|Overall Study|Physician Decision|2|||
161673367|NCT04029480|583857969|FG003|Overall Study|Physician Decision|1|||
161673368|NCT04029480|583857966|FG000|Overall Study|Withdrawal by Subject|2|||
161673369|NCT04029480|583857967|FG001|Overall Study|Withdrawal by Subject|0|||
161673370|NCT04029480|583857968|FG002|Overall Study|Withdrawal by Subject|1|||
161673371|NCT04029480|583857969|FG003|Overall Study|Withdrawal by Subject|1|||
161673372|NCT02593786|583857970|FG000|Overall Study|Disease progression|12|||
161673373|NCT02593786|583857971|FG001|Overall Study|Disease progression|16|||
161673374|NCT02593786|583857972|FG002|Overall Study|Disease progression|10|||
161673375|NCT02593786|583857973|FG003|Overall Study|Disease progression|7|||
161673376|NCT02593786|583857970|FG000|Overall Study|Study drug toxicity|1|||
161673377|NCT02593786|583857971|FG001|Overall Study|Study drug toxicity|0|||
161673378|NCT02593786|583857972|FG002|Overall Study|Study drug toxicity|0|||
161501847|NCT00644969|583233502|FG000|Treatment Phase|Lost to Follow-up|2|||
161501848|NCT00644969|583233503|FG001|Treatment Phase|Lost to Follow-up|2|||
161501849|NCT00644969|583233502|FG000|Treatment Phase|Other|4|||
161501850|NCT00644969|583233503|FG001|Treatment Phase|Other|1|||
161673379|NCT02593786|583857973|FG003|Overall Study|Study drug toxicity|0|||
161819472|NCT03499873|584379664|FG001|Overall Study|Withdrawal by Subject|6|||
161819473|NCT03499873|584379665|FG002|Overall Study|Withdrawal by Subject|1|||
161819474|NCT03499873|584379663|FG000|Overall Study|Subjects condition worsened|0|||
161819475|NCT03499873|584379664|FG001|Overall Study|Subjects condition worsened|3|||
161819476|NCT03499873|584379665|FG002|Overall Study|Subjects condition worsened|11|||
161819477|NCT03499873|584379663|FG000|Overall Study|Adverse Event|8|||
161819478|NCT03499873|584379664|FG001|Overall Study|Adverse Event|3|||
161819479|NCT03499873|584379665|FG002|Overall Study|Adverse Event|6|||
161819480|NCT03499873|584379663|FG000|Overall Study|Physician Decision|1|||
161819481|NCT03499873|584379664|FG001|Overall Study|Physician Decision|0|||
161819482|NCT03499873|584379665|FG002|Overall Study|Physician Decision|0|||
161819483|NCT03499873|584379663|FG000|Overall Study|Administrative reasons|0|||
161819484|NCT03499873|584379664|FG001|Overall Study|Administrative reasons|1|||
161819485|NCT03499873|584379665|FG002|Overall Study|Administrative reasons|0|||
161819486|NCT03499873|584379663|FG000|Overall Study|Concomitant therapy|5|||
161819487|NCT03499873|584379664|FG001|Overall Study|Concomitant therapy|4|||
161819488|NCT03499873|584379665|FG002|Overall Study|Concomitant therapy|7|||
161819489|NCT03499873|584379663|FG000|Overall Study|Miscellaneous|1|||
161819490|NCT03499873|584379664|FG001|Overall Study|Miscellaneous|2|||
161819491|NCT03499873|584379665|FG002|Overall Study|Miscellaneous|2|||
161819492|NCT03499873|584379663|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
161819493|NCT03499873|584379664|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
161819494|NCT03499873|584379665|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
161819495|NCT01297504|584379666|FG000|Overall Study|Invalid Consent|1|||
161819496|NCT01297504|584379666|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
161819497|NCT01297504|584379666|FG000|Overall Study|No Study Visits|4|||
161819498|NCT01297504|584379666|FG000|Overall Study|Death|3|||
161819499|NCT01297504|584379666|FG000|Overall Study|Lost to Follow-up|43|||
161819500|NCT01297504|584379666|FG000|Overall Study|Withdrawal by Subject|9|||
161819501|NCT01297504|584379666|FG000|Overall Study|Site Closure|3|||
161819502|NCT01297504|584379666|FG000|Overall Study|Protocol Violation|3|||
161819503|NCT00654186|584379667|FG000|Overall Study|Withdrawal by Subject|5|||
161819504|NCT01024855|584379670|FG000|Overall Study|Inclusion/exclusion criteria|1|||
161819505|NCT00577655|584379671|FG000|Overall Study|Patient Request|0|||
161819506|NCT00577655|584379672|FG001|Overall Study|Patient Request|2|||
161819507|NCT00577655|584379671|FG000|Overall Study|Protocol Violation|0|||
161819508|NCT00577655|584379672|FG001|Overall Study|Protocol Violation|1|||
161819509|NCT00577655|584379671|FG000|Overall Study|Lost to Follow-up|1|||
161819510|NCT00577655|584379672|FG001|Overall Study|Lost to Follow-up|1|||
161819511|NCT03306277|584379676|FG000|Overall Study|Death|1|||
161819512|NCT03306277|584379676|FG000|Overall Study|Adverse Event|1|||
161819513|NCT03306277|584379676|FG000|Overall Study|Withdrawal by Subject|1|||
161501851|NCT00644969|583233502|FG000|Post Treatment Phase|Death|1|||
161501852|NCT00644969|583233503|FG001|Post Treatment Phase|Death|0|||
161819514|NCT01370863|584379680|FG000|Overall Study|Adverse Event|1|||
161819515|NCT01370863|584379681|FG001|Overall Study|Adverse Event|1|||
161819516|NCT01370863|584379680|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
161819517|NCT01370863|584379681|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
161819518|NCT01370863|584379680|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161819519|NCT01370863|584379681|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161673380|NCT02593786|583857970|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161819520|NCT00881751|584379682|FG000|Overall Study|Physician Decision|0|||
161819521|NCT00881751|584379683|FG001|Overall Study|Physician Decision|1|||
161673381|NCT02593786|583857971|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161673382|NCT02593786|583857972|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161501853|NCT00644969|583233502|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
161501854|NCT00644969|583233503|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
161501855|NCT00644969|583233502|FG000|Post Treatment Phase|Lost to Follow-up|4|||
161501856|NCT00644969|583233503|FG001|Post Treatment Phase|Lost to Follow-up|1|||
161501857|NCT00644969|583233502|FG000|Post Treatment Phase|Other|1|||
161501858|NCT00644969|583233503|FG001|Post Treatment Phase|Other|0|||
161501859|NCT00997503|583233509|FG000|Overall Study|Death|53|||
161501860|NCT00997503|583233509|FG000|Overall Study|Withdrawal by Subject|76|||
161501861|NCT00997503|583233509|FG000|Overall Study|Lost to Follow-up|33|||
161501862|NCT00997503|583233509|FG000|Overall Study|Adverse Event|3|||
161501863|NCT00997503|583233509|FG000|Overall Study|Physician Decision|10|||
161673383|NCT02593786|583857973|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161673384|NCT02593786|583857970|FG000|Overall Study|Participant request to discontinue study therapy|0|||
161673385|NCT02593786|583857971|FG001|Overall Study|Participant request to discontinue study therapy|2|||
161673386|NCT02593786|583857972|FG002|Overall Study|Participant request to discontinue study therapy|0|||
161501864|NCT00997503|583233509|FG000|Overall Study|Missed 12-month follow-up|85|||
161501865|NCT00997503|583233509|FG000|Overall Study|Other reason|13|||
161501866|NCT01933048|583233510|FG000|Overall Study|Lost to Follow-up|15|||
161501867|NCT01933048|583233511|FG001|Overall Study|Lost to Follow-up|18|||
161501868|NCT01933048|583233510|FG000|Overall Study|personal reasons|1|||
161501869|NCT01933048|583233511|FG001|Overall Study|personal reasons|1|||
161501870|NCT01933048|583233510|FG000|Overall Study|Protocol Violation|7|||
161501871|NCT01933048|583233511|FG001|Overall Study|Protocol Violation|8|||
161585968|NCT00709098|583531927|FG001|Double-blind Period|Lost to Follow-up|1|||
161585969|NCT00709098|583531928|FG002|Double-blind Period|Lost to Follow-up|0|||
161585970|NCT00709098|583531926|FG000|Open-label Period|Withdrawal of consent|0|||
161585971|NCT00709098|583531927|FG001|Open-label Period|Withdrawal of consent|0|||
161585972|NCT00709098|583531928|FG002|Open-label Period|Withdrawal of consent|7|||
161673387|NCT02593786|583857973|FG003|Overall Study|Participant request to discontinue study therapy|0|||
161673388|NCT02593786|583857970|FG000|Overall Study|Other reasons|1|||
161673389|NCT02593786|583857971|FG001|Overall Study|Other reasons|1|||
161673390|NCT02593786|583857972|FG002|Overall Study|Other reasons|0|||
161673391|NCT02593786|583857973|FG003|Overall Study|Other reasons|5|||
161673392|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
161673393|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673394|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673395|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673396|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673397|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673398|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
161673399|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
161673400|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673401|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673402|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673403|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673404|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673405|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
161673406|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673407|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673408|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673409|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673410|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
161673411|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673412|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673413|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673414|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673415|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673416|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
161673417|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
161673418|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
161925504|NCT00845182|584773195|FG002|Overall Study|Adverse Event|1|||
161925505|NCT00845182|584773193|FG000|Overall Study|Physician Decision|0|||
161501872|NCT01933048|583233510|FG000|Overall Study|Physician Decision|1|||
161501873|NCT01933048|583233511|FG001|Overall Study|Physician Decision|0|||
161501874|NCT01933048|583233510|FG000|Overall Study|unknown reasons|1|||
161501875|NCT01933048|583233511|FG001|Overall Study|unknown reasons|1|||
161501876|NCT02780804|583233512|FG000|Overall Study|Death|1|||
161585973|NCT00709098|583531926|FG000|Open-label Period|Administrative reason|0|||
161585974|NCT00709098|583531927|FG001|Open-label Period|Administrative reason|0|||
161585975|NCT00709098|583531928|FG002|Open-label Period|Administrative reason|5|||
161501877|NCT02780804|583233513|FG001|Overall Study|Death|0|||
161501878|NCT02780804|583233514|FG002|Overall Study|Death|0|||
161501879|NCT02780804|583233512|FG000|Overall Study|Lack of Efficacy|5|||
161501880|NCT02780804|583233513|FG001|Overall Study|Lack of Efficacy|8|||
161501881|NCT02780804|583233514|FG002|Overall Study|Lack of Efficacy|4|||
161501882|NCT02780804|583233512|FG000|Overall Study|Physician Decision|0|||
161501883|NCT02780804|583233513|FG001|Overall Study|Physician Decision|0|||
161501884|NCT02780804|583233514|FG002|Overall Study|Physician Decision|2|||
161501885|NCT02780804|583233512|FG000|Overall Study|Withdrawal by Subject|0|||
161501886|NCT02780804|583233513|FG001|Overall Study|Withdrawal by Subject|1|||
161501887|NCT02780804|583233514|FG002|Overall Study|Withdrawal by Subject|0|||
161501888|NCT02476968|583233515|FG000|Overall Study|Other|0|||
161501889|NCT02476968|583233516|FG001|Overall Study|Other|2|||
161501890|NCT02476968|583233517|FG002|Overall Study|Other|0|||
161501891|NCT02476968|583233515|FG000|Overall Study|Lost to Follow-up|10|||
161501892|NCT02476968|583233516|FG001|Overall Study|Lost to Follow-up|0|||
161501893|NCT02476968|583233517|FG002|Overall Study|Lost to Follow-up|1|||
161501894|NCT02476968|583233515|FG000|Overall Study|Death|48|||
161501895|NCT02476968|583233516|FG001|Overall Study|Death|8|||
161501896|NCT02476968|583233517|FG002|Overall Study|Death|1|||
161501897|NCT02476968|583233515|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161501898|NCT02476968|583233516|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161501899|NCT02476968|583233517|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161501900|NCT02476968|583233515|FG000|Overall Study|Patient decision|37|||
161501901|NCT02476968|583233516|FG001|Overall Study|Patient decision|8|||
161501902|NCT02476968|583233517|FG002|Overall Study|Patient decision|0|||
161501903|NCT04171414|583233522|FG000|Overall Study|Death|1|||
161501904|NCT04171414|583233522|FG000|Overall Study|Withdrawal by Subject|1|||
161501905|NCT01714310|583233523|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
161501906|NCT01714310|583233524|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
161501907|NCT01714310|583233525|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
161501908|NCT01714310|583233523|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
161501909|NCT01714310|583233524|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
161501910|NCT01714310|583233525|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
161501911|NCT01714310|583233523|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
161501912|NCT01714310|583233524|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
161501913|NCT01714310|583233525|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
161501914|NCT01714310|583233523|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
161501915|NCT01714310|583233524|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
161501916|NCT01714310|583233525|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
161501917|NCT02487394|583233526|FG000|Phase 1|Withdrawal by Subject|0|||
161501918|NCT02487394|583233527|FG001|Phase 1|Withdrawal by Subject|1|||
161501919|NCT01289847|583233528|FG000|Overall Study|Patient could not comply with visits|1|||
161501920|NCT00006478|583233539|FG000|Overall Study|Vaccine could not be produced|1|||
161501921|NCT00006478|583233539|FG000|Overall Study|Physician Decision|6|||
161501922|NCT03161483|583233540|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
161501923|NCT03161483|583233541|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
161501924|NCT03161483|583233542|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
161501925|NCT03161483|583233543|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
161501926|NCT03161483|583233540|FG000|Treatment Period|Death|1|||
161501927|NCT03161483|583233541|FG001|Treatment Period|Death|0|||
161501928|NCT03161483|583233542|FG002|Treatment Period|Death|0|||
161501929|NCT03161483|583233543|FG003|Treatment Period|Death|0|||
161673419|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
161673420|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
161673421|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
161673422|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
161673423|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
161673424|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
161673425|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
161673426|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
161673427|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
161673428|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673429|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673430|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
161673431|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673432|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
161673433|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673434|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161673435|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161673436|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161673437|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
161673438|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
161673439|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
161673440|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
161673441|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
161925506|NCT00845182|584773194|FG001|Overall Study|Physician Decision|0|||
161925507|NCT00845182|584773195|FG002|Overall Study|Physician Decision|1|||
161501930|NCT03161483|583233540|FG000|Treatment Period|Adverse Event|5|||
161501931|NCT03161483|583233541|FG001|Treatment Period|Adverse Event|2|||
161501932|NCT03161483|583233542|FG002|Treatment Period|Adverse Event|1|||
161501933|NCT03161483|583233543|FG003|Treatment Period|Adverse Event|11|||
161501934|NCT03161483|583233540|FG000|Treatment Period|Pregnancy|1|||
161501935|NCT03161483|583233541|FG001|Treatment Period|Pregnancy|0|||
161501936|NCT03161483|583233542|FG002|Treatment Period|Pregnancy|0|||
161501937|NCT03161483|583233543|FG003|Treatment Period|Pregnancy|0|||
161501938|NCT03161483|583233540|FG000|Treatment Period|Lack of Efficacy|0|||
161501939|NCT03161483|583233541|FG001|Treatment Period|Lack of Efficacy|0|||
161925508|NCT04621760|584773196|FG000|Overall Study|Lost to Follow-up|2|||
161501940|NCT03161483|583233542|FG002|Treatment Period|Lack of Efficacy|0|||
161501941|NCT03161483|583233543|FG003|Treatment Period|Lack of Efficacy|1|||
161501942|NCT03161483|583233540|FG000|Treatment Period|Withdrawal by Subject|2|||
161501943|NCT03161483|583233541|FG001|Treatment Period|Withdrawal by Subject|5|||
161501944|NCT03161483|583233542|FG002|Treatment Period|Withdrawal by Subject|2|||
161501945|NCT03161483|583233543|FG003|Treatment Period|Withdrawal by Subject|6|||
161501946|NCT03161483|583233540|FG000|Treatment Period|Lost to Follow-up|0|||
161501947|NCT03161483|583233541|FG001|Treatment Period|Lost to Follow-up|0|||
161501948|NCT03161483|583233542|FG002|Treatment Period|Lost to Follow-up|0|||
161501949|NCT03161483|583233543|FG003|Treatment Period|Lost to Follow-up|1|||
161501950|NCT03161483|583233540|FG000|Treatment Period|Protocol Violation|0|||
161501951|NCT03161483|583233541|FG001|Treatment Period|Protocol Violation|0|||
161501952|NCT03161483|583233542|FG002|Treatment Period|Protocol Violation|0|||
161501953|NCT03161483|583233543|FG003|Treatment Period|Protocol Violation|1|||
161501954|NCT03161483|583233540|FG000|Treatment Period|Other reasons|1|||
161501955|NCT03161483|583233541|FG001|Treatment Period|Other reasons|1|||
161501956|NCT03161483|583233542|FG002|Treatment Period|Other reasons|0|||
161501957|NCT03161483|583233543|FG003|Treatment Period|Other reasons|0|||
161501958|NCT00600756|583233546|FG000|Analysis After 6 Months|Adverse Event|43|||
161501959|NCT00600756|583233547|FG001|Analysis After 6 Months|Adverse Event|33|||
161501960|NCT00600756|583233546|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
161501961|NCT00600756|583233547|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
161501962|NCT00600756|583233546|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
161673442|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
161673443|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
161673444|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
161673445|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
161673446|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
161673447|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
161673448|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
161673449|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
161673450|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
161673451|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
161673452|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
161925509|NCT04621760|584773197|FG001|Overall Study|Lost to Follow-up|4|||
161501963|NCT00600756|583233547|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
161501964|NCT00600756|583233546|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
161501965|NCT00600756|583233547|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
161501966|NCT00600756|583233546|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
161501967|NCT00600756|583233547|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
161501968|NCT00600756|583233546|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
161501969|NCT00600756|583233547|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
161501970|NCT00600756|583233546|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
161501971|NCT00600756|583233547|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
161501972|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
161501973|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
161501974|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
161501975|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
161501976|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
161501977|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
161501978|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
161501979|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
161501980|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
161501981|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
161501982|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
161501983|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
161501984|NCT00600756|583233546|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
161501985|NCT00600756|583233547|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
161501986|NCT04753164|583233548|FG000|Overall Study|Adverse Event|0|||
161501987|NCT04753164|583233549|FG001|Overall Study|Adverse Event|2|||
161501988|NCT04753164|583233548|FG000|Overall Study|Withdrawal by Subject|9|||
161501989|NCT04753164|583233549|FG001|Overall Study|Withdrawal by Subject|7|||
161501990|NCT04753164|583233548|FG000|Overall Study|Lost to Follow-up|6|||
161501991|NCT04753164|583233549|FG001|Overall Study|Lost to Follow-up|6|||
161501992|NCT04753164|583233548|FG000|Overall Study|Other|12|||
161501993|NCT04753164|583233549|FG001|Overall Study|Other|5|||
161501994|NCT00694369|583233550|FG000|Overall Study|Adverse Event|0|||
161501995|NCT00694369|583233551|FG001|Overall Study|Adverse Event|1|||
161501996|NCT00694369|583233552|FG002|Overall Study|Adverse Event|0|||
161501997|NCT00694369|583233553|FG003|Overall Study|Adverse Event|1|||
161501998|NCT00694369|583233554|FG004|Overall Study|Adverse Event|3|||
161501999|NCT00694369|583233550|FG000|Overall Study|Lost to Follow-up|0|||
161502000|NCT00694369|583233551|FG001|Overall Study|Lost to Follow-up|0|||
161502001|NCT00694369|583233552|FG002|Overall Study|Lost to Follow-up|1|||
161502002|NCT00694369|583233553|FG003|Overall Study|Lost to Follow-up|1|||
161673453|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
161819522|NCT00881751|584379682|FG000|Overall Study|Adverse Event|0|||
161502003|NCT00694369|583233554|FG004|Overall Study|Lost to Follow-up|0|||
161502004|NCT00694369|583233550|FG000|Overall Study|Physician Decision|0|||
161502005|NCT00694369|583233551|FG001|Overall Study|Physician Decision|0|||
161502006|NCT00694369|583233552|FG002|Overall Study|Physician Decision|0|||
161502007|NCT00694369|583233553|FG003|Overall Study|Physician Decision|0|||
161673454|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
161819523|NCT00881751|584379683|FG001|Overall Study|Adverse Event|2|||
161819524|NCT00881751|584379682|FG000|Overall Study|Withdrawal by Subject|0|||
161819525|NCT00881751|584379683|FG001|Overall Study|Withdrawal by Subject|2|||
161819526|NCT01926119|584379684|FG000|Overall Study|Withdrawal by Subject|1|||
161819527|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
161819528|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
161819529|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
161819530|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
161819531|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
161819532|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
161819533|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
161819534|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
161819535|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
161819536|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
161819537|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
161819538|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
161819539|NCT01968551|584379685|FG000|Extension Phase|Adverse Event|0|||
161819540|NCT01968551|584379686|FG001|Extension Phase|Adverse Event|0|||
161819541|NCT01968551|584379687|FG002|Extension Phase|Adverse Event|2|||
161819542|NCT01968551|584379685|FG000|Extension Phase|Death|0|||
161819543|NCT01968551|584379686|FG001|Extension Phase|Death|1|||
161673455|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
161502008|NCT00694369|583233554|FG004|Overall Study|Physician Decision|1|||
161673456|NCT01658826|583857983|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
161673457|NCT01658826|583857984|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
161673458|NCT01658826|583857983|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
161673459|NCT01658826|583857984|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
161673460|NCT01658826|583857983|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
161673461|NCT01658826|583857984|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
161673462|NCT01658826|583857983|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
161673463|NCT01658826|583857984|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
161673464|NCT01019980|583857988|FG000|Overall Study|Drug not available.|2|||
161673465|NCT01019980|583857989|FG001|Overall Study|Drug not available.|0|||
161925510|NCT04621760|584773196|FG000|Overall Study|Withdrawal by Subject|1|||
161925511|NCT04621760|584773197|FG001|Overall Study|Withdrawal by Subject|0|||
161925512|NCT01028560|584773198|FG000|Overall Study|Lack of Efficacy|3|||
161925513|NCT01028560|584773199|FG001|Overall Study|Lack of Efficacy|6|||
161502009|NCT00694369|583233550|FG000|Overall Study|Protocol Violation|0|||
161502010|NCT00694369|583233551|FG001|Overall Study|Protocol Violation|1|||
161673466|NCT02038920|583857999|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
161673467|NCT02038920|583858000|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
161673468|NCT02038920|583858001|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673469|NCT02038920|583858002|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673470|NCT02038920|583858003|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673471|NCT02038920|583858004|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673472|NCT02038920|583857999|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
161673473|NCT02038920|583858000|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673474|NCT02038920|583858001|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673475|NCT02038920|583858002|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673476|NCT02038920|583858003|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673477|NCT02038920|583858004|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673478|NCT02038920|583857999|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
161673479|NCT02038920|583858000|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
161673480|NCT02038920|583858001|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161502011|NCT00694369|583233552|FG002|Overall Study|Protocol Violation|0|||
161502012|NCT00694369|583233553|FG003|Overall Study|Protocol Violation|0|||
161502013|NCT00694369|583233554|FG004|Overall Study|Protocol Violation|0|||
161502014|NCT00694369|583233550|FG000|Overall Study|Withdrawal by Subject|1|||
161502015|NCT00694369|583233551|FG001|Overall Study|Withdrawal by Subject|1|||
161502016|NCT00694369|583233552|FG002|Overall Study|Withdrawal by Subject|1|||
161502017|NCT00694369|583233553|FG003|Overall Study|Withdrawal by Subject|1|||
161502018|NCT00694369|583233554|FG004|Overall Study|Withdrawal by Subject|2|||
161502019|NCT02871739|583233555|FG000|Overall Study|Lost to Follow-up|3|||
161502020|NCT02871739|583233556|FG001|Overall Study|Lost to Follow-up|2|||
161502021|NCT02871739|583233557|FG002|Overall Study|Lost to Follow-up|0|||
161673481|NCT02038920|583858002|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161673482|NCT02038920|583858003|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161673483|NCT02038920|583858004|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161819544|NCT01968551|584379687|FG002|Extension Phase|Death|0|||
161819545|NCT01968551|584379685|FG000|Extension Phase|Withdrew Consent|0|||
161819546|NCT01968551|584379686|FG001|Extension Phase|Withdrew Consent|0|||
161819547|NCT01968551|584379687|FG002|Extension Phase|Withdrew Consent|1|||
161819548|NCT01968551|584379685|FG000|Extension Phase|Lost to Follow-up|1|||
161819549|NCT01968551|584379686|FG001|Extension Phase|Lost to Follow-up|0|||
161819550|NCT01968551|584379687|FG002|Extension Phase|Lost to Follow-up|1|||
161819551|NCT00645853|584379688|FG000|Overall Study|Adverse Event|18|||
161819552|NCT00645853|584379689|FG001|Overall Study|Adverse Event|7|||
161819553|NCT00645853|584379688|FG000|Overall Study|AZ study closure in Hungary|60|||
161819554|NCT00645853|584379689|FG001|Overall Study|AZ study closure in Hungary|40|||
161819555|NCT00645853|584379688|FG000|Overall Study|Withdrawal by Subject|5|||
161819556|NCT00645853|584379689|FG001|Overall Study|Withdrawal by Subject|2|||
161819557|NCT00645853|584379688|FG000|Overall Study|Protocol Violation|0|||
161819558|NCT00645853|584379689|FG001|Overall Study|Protocol Violation|2|||
161819559|NCT00645853|584379688|FG000|Overall Study|Discontinuation criteria|2|||
161673484|NCT02038920|583857999|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161673485|NCT02038920|583858000|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161673486|NCT02038920|583858001|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
161673487|NCT02038920|583858002|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
161819560|NCT00645853|584379689|FG001|Overall Study|Discontinuation criteria|2|||
161502022|NCT02871739|583233558|FG003|Overall Study|Lost to Follow-up|2|||
161502023|NCT00439556|583233559|FG000|Overall Study|Patient was taken off study for non-comp|0|||
161502024|NCT00439556|583233560|FG001|Overall Study|Patient was taken off study for non-comp|1|||
161673488|NCT02038920|583858003|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
161673489|NCT02038920|583858004|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161673490|NCT02038920|583857999|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673491|NCT02038920|583858000|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673492|NCT02038920|583858001|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
161673493|NCT02038920|583858002|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673494|NCT02038920|583858003|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673495|NCT02038920|583858004|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673496|NCT02038920|583857999|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161673497|NCT02038920|583858000|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161673498|NCT02038920|583858001|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
161673499|NCT02038920|583858002|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
161673500|NCT02038920|583858003|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
161673501|NCT02038920|583858004|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161673502|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161925514|NCT01028560|584773198|FG000|Overall Study|Withdrawal by Subject|7|||
161925515|NCT01028560|584773199|FG001|Overall Study|Withdrawal by Subject|12|||
161925516|NCT01960842|584773202|FG000|Overall Study|Adverse Event|1|||
161925517|NCT01960842|584773202|FG000|Overall Study|Withdrawal by Subject|2|||
161925518|NCT02029443|584773204|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
161925519|NCT02029443|584773205|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
161502025|NCT00439556|583233561|FG002|Overall Study|Patient was taken off study for non-comp|0|||
161502026|NCT01324388|583233564|FG000|Part 1 of Study|Adverse Event|2|||
161502027|NCT01324388|583233565|FG001|Part 1 of Study|Adverse Event|0|||
161502028|NCT01324388|583233566|FG002|Part 1 of Study|Adverse Event|0|||
161502029|NCT01324388|583233567|FG003|Part 1 of Study|Adverse Event|0|||
161502030|NCT01324388|583233564|FG000|Part 1 of Study|Protocol Violation|1|||
161502031|NCT01324388|583233565|FG001|Part 1 of Study|Protocol Violation|2|||
161502032|NCT01324388|583233566|FG002|Part 1 of Study|Protocol Violation|0|||
161502033|NCT01324388|583233567|FG003|Part 1 of Study|Protocol Violation|0|||
161502034|NCT01324388|583233564|FG000|Part 1 of Study|Physician Decision|1|||
161502035|NCT01324388|583233565|FG001|Part 1 of Study|Physician Decision|0|||
161502036|NCT01324388|583233566|FG002|Part 1 of Study|Physician Decision|0|||
161502037|NCT01324388|583233567|FG003|Part 1 of Study|Physician Decision|0|||
161502038|NCT01324388|583233564|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
161502039|NCT01324388|583233565|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
161502040|NCT01324388|583233566|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
161502041|NCT01324388|583233567|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
161502042|NCT01324388|583233564|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
161502043|NCT01324388|583233565|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
161502044|NCT01324388|583233566|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
161502045|NCT01324388|583233567|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
161502046|NCT01405963|583233568|FG000|Overall Study|Moved Away|2|||
161502047|NCT01405963|583233569|FG001|Overall Study|Moved Away|0|||
161502048|NCT01405963|583233568|FG000|Overall Study|Adverse Event|0|||
161502049|NCT01405963|583233569|FG001|Overall Study|Adverse Event|1|||
161502050|NCT01405963|583233568|FG000|Overall Study|Lost to Follow-up|0|||
161502051|NCT01405963|583233569|FG001|Overall Study|Lost to Follow-up|1|||
161502052|NCT00850395|583233576|FG000|Overall Study|Death|1|||
161502053|NCT00850395|583233576|FG000|Overall Study|Adverse Event|1|||
161502054|NCT00850395|583233576|FG000|Overall Study|Insufficient clinical response|3|||
161502055|NCT00850395|583233576|FG000|Overall Study|Other|5|||
161502056|NCT01737047|583233577|FG000|Overall Study|Death|10|||
161502057|NCT01737047|583233578|FG001|Overall Study|Death|0|||
161502058|NCT01737047|583233579|FG002|Overall Study|Death|1|||
161502059|NCT01737047|583233577|FG000|Overall Study|Withdrawal by Subject|17|||
161502060|NCT01737047|583233578|FG001|Overall Study|Withdrawal by Subject|11|||
161502061|NCT01737047|583233579|FG002|Overall Study|Withdrawal by Subject|4|||
161502062|NCT02802592|583233580|FG000|Overall Study|Study terminated due to loss of funding|4|||
161502063|NCT04007523|583233581|FG000|Overall Study|Withdrawal by Subject|0|||
161502064|NCT04007523|583233582|FG001|Overall Study|Withdrawal by Subject|1|||
161502065|NCT04007523|583233583|FG002|Overall Study|Withdrawal by Subject|1|||
161502066|NCT04007523|583233584|FG003|Overall Study|Withdrawal by Subject|0|||
161502067|NCT04007523|583233581|FG000|Overall Study|ICU Transfer|0|||
161502068|NCT04007523|583233582|FG001|Overall Study|ICU Transfer|1|||
161502069|NCT04007523|583233583|FG002|Overall Study|ICU Transfer|0|||
161502070|NCT04007523|583233584|FG003|Overall Study|ICU Transfer|0|||
161502071|NCT04007523|583233581|FG000|Overall Study|COVID hospital closure|0|||
161673503|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161673504|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161925520|NCT02029443|584773206|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
161502072|NCT04007523|583233582|FG001|Overall Study|COVID hospital closure|0|||
161502073|NCT04007523|583233583|FG002|Overall Study|COVID hospital closure|1|||
161502074|NCT04007523|583233584|FG003|Overall Study|COVID hospital closure|2|||
161502075|NCT04007523|583233581|FG000|Overall Study|Surgery cancelled|0|||
161502076|NCT04007523|583233582|FG001|Overall Study|Surgery cancelled|0|||
161502077|NCT04007523|583233583|FG002|Overall Study|Surgery cancelled|1|||
161502078|NCT04007523|583233584|FG003|Overall Study|Surgery cancelled|1|||
161502079|NCT01826487|583233585|FG000|Overall Study|Adverse Event|1|||
161502080|NCT01826487|583233586|FG001|Overall Study|Adverse Event|1|||
161502081|NCT01826487|583233585|FG000|Overall Study|Lost to Follow-up|1|||
161502082|NCT01826487|583233586|FG001|Overall Study|Lost to Follow-up|0|||
161502083|NCT01826487|583233585|FG000|Overall Study|Withdrawal by Subject|1|||
161502084|NCT01826487|583233586|FG001|Overall Study|Withdrawal by Subject|3|||
161502085|NCT01826487|583233585|FG000|Overall Study|Protocol Violation|1|||
161502086|NCT01826487|583233586|FG001|Overall Study|Protocol Violation|1|||
161502087|NCT01408030|583233587|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
161502088|NCT01408030|583233588|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
161502089|NCT01408030|583233589|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
161502090|NCT01408030|583233590|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
161502091|NCT01408030|583233587|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
161502092|NCT01408030|583233588|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
161502093|NCT01408030|583233589|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
161502094|NCT01408030|583233590|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
161502095|NCT01408030|583233587|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
161502096|NCT01408030|583233588|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
161502097|NCT01408030|583233589|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
161502098|NCT01408030|583233590|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
161502099|NCT01408030|583233587|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
161502100|NCT01408030|583233588|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
161502101|NCT01408030|583233589|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
161502102|NCT01408030|583233590|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
161502103|NCT01408030|583233587|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
161502104|NCT01408030|583233588|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
161502105|NCT01408030|583233589|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
161502106|NCT01408030|583233590|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
161502107|NCT01408030|583233587|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
161502108|NCT01408030|583233588|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
161502109|NCT01408030|583233589|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
161502110|NCT01408030|583233590|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
161502111|NCT01408030|583233587|FG000|Observation Phase (Off Drug)|Other|1|||
161502112|NCT01408030|583233588|FG001|Observation Phase (Off Drug)|Other|1|||
161502113|NCT01408030|583233589|FG002|Observation Phase (Off Drug)|Other|1|||
161502114|NCT01408030|583233590|FG003|Observation Phase (Off Drug)|Other|1|||
161502115|NCT02965703|583233591|FG000|Overall Study|Withdrawal by Subject|6|||
161502116|NCT02965703|583233592|FG001|Overall Study|Withdrawal by Subject|3|||
161502117|NCT02965703|583233593|FG002|Overall Study|Withdrawal by Subject|1|||
161502118|NCT02965703|583233591|FG000|Overall Study|Protocol Violation|1|||
161502119|NCT02965703|583233592|FG001|Overall Study|Protocol Violation|0|||
161502120|NCT02965703|583233593|FG002|Overall Study|Protocol Violation|0|||
161502121|NCT02965703|583233591|FG000|Overall Study|Adverse Event|1|||
161502122|NCT02965703|583233592|FG001|Overall Study|Adverse Event|1|||
161502123|NCT02965703|583233593|FG002|Overall Study|Adverse Event|0|||
161502124|NCT02965703|583233591|FG000|Overall Study|Lost to Follow-up|2|||
161502125|NCT02965703|583233592|FG001|Overall Study|Lost to Follow-up|1|||
161502126|NCT02965703|583233593|FG002|Overall Study|Lost to Follow-up|1|||
161502127|NCT00788827|583233599|FG000|Overall Study|Lack of Efficacy|2|||
161502128|NCT03608774|583233600|FG000|Overall Study|Lost to Follow-up|5|||
161502129|NCT03608774|583233601|FG001|Overall Study|Lost to Follow-up|5|||
161502130|NCT03608774|583233600|FG000|Overall Study|Withdrawal by Subject|1|||
161585976|NCT00709098|583531926|FG000|Open-label Period|Death|0|||
161585977|NCT00709098|583531927|FG001|Open-label Period|Death|0|||
161585978|NCT00709098|583531928|FG002|Open-label Period|Death|1|||
161585979|NCT00709098|583531926|FG000|Open-label Period|Lost to Follow-up|0|||
161585980|NCT00709098|583531927|FG001|Open-label Period|Lost to Follow-up|0|||
161585981|NCT00709098|583531928|FG002|Open-label Period|Lost to Follow-up|1|||
161585982|NCT00774852|583531929|FG000|Overall Study|Adverse Event|9|||
161585983|NCT00774852|583531930|FG001|Overall Study|Adverse Event|6|||
161585984|NCT00774852|583531929|FG000|Overall Study|Death|2|||
161585985|NCT00774852|583531930|FG001|Overall Study|Death|1|||
161585986|NCT00774852|583531929|FG000|Overall Study|Lack of Efficacy|3|||
161585987|NCT00774852|583531930|FG001|Overall Study|Lack of Efficacy|7|||
161585988|NCT00774852|583531929|FG000|Overall Study|Lost to Follow-up|9|||
161585989|NCT00774852|583531930|FG001|Overall Study|Lost to Follow-up|5|||
161585990|NCT00774852|583531929|FG000|Overall Study|Physician Decision|2|||
161585991|NCT00774852|583531930|FG001|Overall Study|Physician Decision|6|||
161585992|NCT00774852|583531929|FG000|Overall Study|Pregnancy|1|||
161502131|NCT03608774|583233601|FG001|Overall Study|Withdrawal by Subject|0|||
161502132|NCT03608774|583233600|FG000|Overall Study|Protocol Violation|1|||
161502133|NCT03608774|583233601|FG001|Overall Study|Protocol Violation|0|||
161502134|NCT03608774|583233600|FG000|Overall Study|Not eligible at enrollment|0|||
161502135|NCT03608774|583233601|FG001|Overall Study|Not eligible at enrollment|1|||
161819561|NCT00645853|584379688|FG000|Overall Study|recall of ICF, planned operation, death|7|||
161819562|NCT00645853|584379689|FG001|Overall Study|recall of ICF, planned operation, death|4|||
161502136|NCT03608774|583233600|FG000|Overall Study|Health related event|0|||
161502137|NCT03608774|583233601|FG001|Overall Study|Health related event|1|||
161585993|NCT00774852|583531930|FG001|Overall Study|Pregnancy|2|||
161585994|NCT00774852|583531929|FG000|Overall Study|Withdrawal by Subject|2|||
161585995|NCT00774852|583531930|FG001|Overall Study|Withdrawal by Subject|2|||
161585996|NCT00774852|583531929|FG000|Overall Study|Non-responder|15|||
161585997|NCT00774852|583531930|FG001|Overall Study|Non-responder|11|||
161585998|NCT00774852|583531929|FG000|Overall Study|Subject non-compliance|0|||
161585999|NCT00774852|583531930|FG001|Overall Study|Subject non-compliance|1|||
161586000|NCT00774852|583531929|FG000|Overall Study|Protocol Violation|1|||
161586001|NCT00774852|583531930|FG001|Overall Study|Protocol Violation|0|||
161586002|NCT00774852|583531929|FG000|Overall Study|Subject received prohibited medication|1|||
161586003|NCT00774852|583531930|FG001|Overall Study|Subject received prohibited medication|0|||
161586004|NCT04428112|583531931|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
161586005|NCT04428112|583531932|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
161586006|NCT04428112|583531931|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
161586007|NCT04428112|583531932|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
161586008|NCT04428112|583531931|FG000|Overall Study|Withdrawal by Subject|9|||
161586009|NCT04428112|583531932|FG001|Overall Study|Withdrawal by Subject|4|||
161586010|NCT04428112|583531931|FG000|Overall Study|Lost to Follow-up|27|||
161586011|NCT04428112|583531932|FG001|Overall Study|Lost to Follow-up|7|||
161586012|NCT04994509|583531934|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
161586013|NCT04994509|583531935|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
161673505|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161673506|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161673507|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
161673508|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673509|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673510|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673511|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161819563|NCT01507662|584379690|FG000|Overall Study|Death|26|||
161819564|NCT01507662|584379691|FG001|Overall Study|Death|18|||
161819565|NCT01507662|584379690|FG000|Overall Study|Withdrawal by Subject|290|||
161819566|NCT01507662|584379691|FG001|Overall Study|Withdrawal by Subject|287|||
161819567|NCT01507662|584379690|FG000|Overall Study|Lost to Follow-up|498|||
161819568|NCT01507662|584379691|FG001|Overall Study|Lost to Follow-up|523|||
161819569|NCT01507662|584379690|FG000|Overall Study|Proxy interview done|2|||
161819570|NCT01507662|584379691|FG001|Overall Study|Proxy interview done|3|||
161819571|NCT01395017|584379692|FG000|Overall Study|Lost to Follow-up|1|||
161819572|NCT01395017|584379693|FG001|Overall Study|Lost to Follow-up|0|||
161819573|NCT01395017|584379692|FG000|Overall Study|Adverse Event|26|||
161819574|NCT01395017|584379693|FG001|Overall Study|Adverse Event|12|||
161819575|NCT01395017|584379692|FG000|Overall Study|Physician Decision|11|||
161819576|NCT01395017|584379693|FG001|Overall Study|Physician Decision|15|||
161819577|NCT01395017|584379692|FG000|Overall Study|Withdrawal by Subject|14|||
161819578|NCT01395017|584379693|FG001|Overall Study|Withdrawal by Subject|8|||
161819579|NCT01395017|584379692|FG000|Overall Study|Protocol deviation|1|||
161819580|NCT01395017|584379693|FG001|Overall Study|Protocol deviation|2|||
161819581|NCT01395017|584379692|FG000|Overall Study|Death|4|||
161819582|NCT01395017|584379693|FG001|Overall Study|Death|3|||
161819583|NCT01395017|584379692|FG000|Overall Study|Disease progression|42|||
161819584|NCT01395017|584379693|FG001|Overall Study|Disease progression|58|||
161819585|NCT01395017|584379692|FG000|Overall Study|Sponsor discontinued study|1|||
161819586|NCT01395017|584379693|FG001|Overall Study|Sponsor discontinued study|4|||
161819587|NCT03366428|584379694|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
161819588|NCT03366428|584379694|FG000|Overall Study|Adverse Event|12|||
161819589|NCT03366428|584379694|FG000|Overall Study|Clinical progression|2|||
161819590|NCT03366428|584379694|FG000|Overall Study|Withdrawal by Subject|4|||
161819591|NCT01958476|584379695|FG000|Overall Study|Parent requested exclusion from analysis|1|||
161819592|NCT01958476|584379696|FG001|Overall Study|Parent requested exclusion from analysis|0|||
161819593|NCT02943096|584379699|FG000|Overall Study|Lack of Efficacy|0|||
161819594|NCT02943096|584379700|FG001|Overall Study|Lack of Efficacy|1|||
161819595|NCT03867760|584379706|FG000|Overall Study|Lost to Follow-up|2|||
161819596|NCT03867760|584379707|FG001|Overall Study|Lost to Follow-up|3|||
161819597|NCT03867760|584379706|FG000|Overall Study|Withdrawal by Subject|1|||
161819598|NCT03867760|584379707|FG001|Overall Study|Withdrawal by Subject|2|||
161819599|NCT03867760|584379706|FG000|Overall Study|subject could not meet study logistics|3|||
161819600|NCT03867760|584379707|FG001|Overall Study|subject could not meet study logistics|3|||
161819601|NCT04203823|584379708|FG000|Overall Study|Withdrawal by Subject|2|||
161819602|NCT04203823|584379709|FG001|Overall Study|Withdrawal by Subject|2|||
161819603|NCT04203823|584379708|FG000|Overall Study|Adverse Event|1|||
161819604|NCT04203823|584379709|FG001|Overall Study|Adverse Event|1|||
161819605|NCT04203823|584379708|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161819606|NCT04203823|584379709|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
161673512|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673513|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
161673514|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673515|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673516|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673517|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161502138|NCT01586819|583233602|FG000|Overall Study|Withdrawal by Subject|1|||
161502139|NCT01586819|583233603|FG001|Overall Study|Withdrawal by Subject|0|||
161502140|NCT01359254|583233604|FG000|Overall Study|Death|1|||
161502141|NCT01359254|583233605|FG001|Overall Study|Death|0|||
161673518|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673519|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
161673520|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673521|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673522|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673523|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673524|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673525|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
161673526|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673527|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673528|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673529|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673530|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673531|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
161673532|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673533|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673534|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673535|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673536|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673537|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
161673538|NCT02383589|583858006|FG000|Treatment Period|Adverse Event|1|||
161673539|NCT02383589|583858007|FG001|Treatment Period|Adverse Event|3|||
161673540|NCT02383589|583858006|FG000|Treatment Period|Lost to Follow-up|0|||
161673541|NCT02383589|583858007|FG001|Treatment Period|Lost to Follow-up|1|||
161673542|NCT02383589|583858006|FG000|Treatment Period|Withdrawal by Subject|0|||
161673543|NCT02383589|583858007|FG001|Treatment Period|Withdrawal by Subject|5|||
161673544|NCT02383589|583858006|FG000|Treatment Period|Non-compliance with study drug|0|||
161673545|NCT02383589|583858007|FG001|Treatment Period|Non-compliance with study drug|1|||
161673546|NCT02383589|583858006|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
161673547|NCT02383589|583858007|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
161673548|NCT02383589|583858006|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
161673549|NCT02383589|583858007|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
161673550|NCT02383589|583858006|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
161673551|NCT02383589|583858007|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
161673552|NCT00866697|583858008|FG000|Overall Study|Study closed/terminated|156|||
161673553|NCT00866697|583858009|FG001|Overall Study|Study closed/terminated|138|||
161673554|NCT00866697|583858008|FG000|Overall Study|Lost to Follow-up|22|||
161673555|NCT00866697|583858009|FG001|Overall Study|Lost to Follow-up|28|||
161925521|NCT02029443|584773207|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
161925522|NCT02029443|584773208|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
161925523|NCT02029443|584773204|FG000|Overall Study|Death|13|||
161925524|NCT02029443|584773205|FG001|Overall Study|Death|2|||
161925525|NCT02029443|584773206|FG002|Overall Study|Death|2|||
161925526|NCT02029443|584773207|FG003|Overall Study|Death|11|||
161925527|NCT02029443|584773208|FG004|Overall Study|Death|2|||
161925528|NCT02029443|584773204|FG000|Overall Study|Lost to Follow-up|1|||
161925529|NCT02029443|584773205|FG001|Overall Study|Lost to Follow-up|0|||
161925530|NCT02029443|584773206|FG002|Overall Study|Lost to Follow-up|1|||
161925531|NCT02029443|584773207|FG003|Overall Study|Lost to Follow-up|1|||
161925532|NCT02029443|584773208|FG004|Overall Study|Lost to Follow-up|0|||
161925533|NCT02029443|584773204|FG000|Overall Study|Started other anti-cancer therapy|17|||
161925534|NCT02029443|584773205|FG001|Overall Study|Started other anti-cancer therapy|4|||
161925535|NCT02029443|584773206|FG002|Overall Study|Started other anti-cancer therapy|7|||
161925536|NCT02029443|584773207|FG003|Overall Study|Started other anti-cancer therapy|9|||
161502142|NCT02028988|583233611|FG000|Overall Study|Withdrawal by Subject|2|||
161673556|NCT00866697|583858008|FG000|Overall Study|Physician Decision|3|||
161673557|NCT00866697|583858009|FG001|Overall Study|Physician Decision|5|||
161673558|NCT00866697|583858008|FG000|Overall Study|Withdrawal by Subject|33|||
161673559|NCT00866697|583858009|FG001|Overall Study|Withdrawal by Subject|57|||
161925537|NCT02029443|584773208|FG004|Overall Study|Started other anti-cancer therapy|3|||
161502143|NCT00851799|583233614|FG000|Overall Study|Death|1|||
161925538|NCT02029443|584773204|FG000|Overall Study|Withdrawal by Subject|3|||
161502144|NCT00851799|583233615|FG001|Overall Study|Death|0|||
161502145|NCT00851799|583233616|FG002|Overall Study|Death|1|||
161502146|NCT00851799|583233614|FG000|Overall Study|Lost to Follow-up|5|||
161502147|NCT00851799|583233615|FG001|Overall Study|Lost to Follow-up|3|||
161502148|NCT00851799|583233616|FG002|Overall Study|Lost to Follow-up|10|||
161502149|NCT00851799|583233614|FG000|Overall Study|Not able to get to clinic|8|||
161502150|NCT00851799|583233615|FG001|Overall Study|Not able to get to clinic|5|||
161502151|NCT00851799|583233616|FG002|Overall Study|Not able to get to clinic|9|||
161502152|NCT00851799|583233614|FG000|Overall Study|Not willing to adhere to requirements|1|||
161502153|NCT00851799|583233615|FG001|Overall Study|Not willing to adhere to requirements|2|||
161502154|NCT00851799|583233616|FG002|Overall Study|Not willing to adhere to requirements|2|||
161502155|NCT00851799|583233614|FG000|Overall Study|Withdrew consent prior study completion|1|||
161502156|NCT00851799|583233615|FG001|Overall Study|Withdrew consent prior study completion|2|||
161502157|NCT00851799|583233616|FG002|Overall Study|Withdrew consent prior study completion|1|||
161502158|NCT00851799|583233614|FG000|Overall Study|Severe Debilitation|0|||
161502159|NCT00851799|583233615|FG001|Overall Study|Severe Debilitation|1|||
161502160|NCT00851799|583233616|FG002|Overall Study|Severe Debilitation|0|||
161502161|NCT00851799|583233614|FG000|Overall Study|Completed protocol due to pregnancy|0|||
161502162|NCT00851799|583233615|FG001|Overall Study|Completed protocol due to pregnancy|0|||
161502163|NCT00851799|583233616|FG002|Overall Study|Completed protocol due to pregnancy|1|||
161502164|NCT04365556|583233619|FG000|Overall Study|No longer eligible due to treatment plan|1|||
161502165|NCT04365556|583233620|FG001|Overall Study|No longer eligible due to treatment plan|0|||
161502166|NCT04365556|583233619|FG000|Overall Study|Lost to Follow-up|3|||
161502167|NCT04365556|583233620|FG001|Overall Study|Lost to Follow-up|2|||
161502168|NCT04439318|583233621|FG000|Overall Study|Ineligible|1|||
161502169|NCT04439318|583233621|FG000|Overall Study|Never Started Treatment|3|||
161502170|NCT04439318|583233621|FG000|Overall Study|Adverse Event|10|||
161502171|NCT04439318|583233621|FG000|Overall Study|Death|2|||
161502172|NCT04439318|583233621|FG000|Overall Study|Disease Progression|25|||
161502173|NCT04439318|583233621|FG000|Overall Study|Other Complicating Disease|2|||
161502174|NCT04439318|583233621|FG000|Overall Study|Withdrawal by Subject|4|||
161502175|NCT04439318|583233621|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
161502176|NCT04439318|583233621|FG000|Overall Study|Non-Compliance|1|||
161502177|NCT04439318|583233621|FG000|Overall Study|Still on Treatment|1|||
161502178|NCT02579265|583235040|FG000|Overall Study|Weaned off earlier than 28 days|44|||
161502179|NCT02579265|583235041|FG001|Overall Study|Weaned off earlier than 28 days|43|||
161502180|NCT02579265|583235040|FG000|Overall Study|Adverse Event|2|||
161502181|NCT02579265|583235041|FG001|Overall Study|Adverse Event|0|||
161502182|NCT02579265|583235040|FG000|Overall Study|Any other reason not specified|0|||
161502183|NCT02579265|583235041|FG001|Overall Study|Any other reason not specified|2|||
161502184|NCT02579265|583235040|FG000|Overall Study|Withdrawal by Subject|2|||
161502185|NCT02579265|583235041|FG001|Overall Study|Withdrawal by Subject|0|||
161502186|NCT02579265|583235040|FG000|Overall Study|Physician Decision|1|||
161502187|NCT02579265|583235041|FG001|Overall Study|Physician Decision|0|||
161502188|NCT02579265|583235040|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
161502189|NCT02579265|583235041|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
161502190|NCT01641367|583235050|FG000|Cohorts|Death|18|||
161502191|NCT01641367|583235051|FG001|Cohorts|Death|1|||
161502192|NCT01641367|583235052|FG002|Cohorts|Death|2|||
161502193|NCT01641367|583235053|FG003|Cohorts|Death|0|||
161502194|NCT01641367|583235054|FG004|Cohorts|Death|1|||
161502195|NCT01641367|583235055|FG005|Cohorts|Death|1|||
161502196|NCT01641367|583235056|FG006|Cohorts|Death|0|||
161502197|NCT01641367|583235057|FG007|Cohorts|Death|0|||
161502198|NCT01641367|583235050|FG000|Cohorts|Lost to Follow-up|16|||
161502199|NCT01641367|583235051|FG001|Cohorts|Lost to Follow-up|0|||
161502200|NCT01641367|583235052|FG002|Cohorts|Lost to Follow-up|2|||
161502201|NCT01641367|583235053|FG003|Cohorts|Lost to Follow-up|0|||
161502202|NCT01641367|583235054|FG004|Cohorts|Lost to Follow-up|2|||
161502203|NCT01641367|583235055|FG005|Cohorts|Lost to Follow-up|0|||
161502204|NCT01641367|583235056|FG006|Cohorts|Lost to Follow-up|0|||
161502205|NCT01641367|583235057|FG007|Cohorts|Lost to Follow-up|0|||
161502206|NCT01641367|583235050|FG000|Randomized Adherence Intervention|Death|0|||
161502207|NCT01641367|583235051|FG001|Randomized Adherence Intervention|Death|0|||
161502208|NCT01641367|583235052|FG002|Randomized Adherence Intervention|Death|0|||
161502209|NCT01641367|583235053|FG003|Randomized Adherence Intervention|Death|0|||
161502210|NCT01641367|583235054|FG004|Randomized Adherence Intervention|Death|0|||
161502211|NCT01641367|583235055|FG005|Randomized Adherence Intervention|Death|0|||
161502212|NCT01641367|583235056|FG006|Randomized Adherence Intervention|Death|11|||
161502213|NCT01641367|583235057|FG007|Randomized Adherence Intervention|Death|12|||
161502214|NCT01641367|583235050|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
161502215|NCT01641367|583235051|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
161502216|NCT01641367|583235052|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
161502217|NCT01641367|583235053|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
161502218|NCT01641367|583235054|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
161502219|NCT01641367|583235055|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
161502220|NCT01641367|583235056|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
161502221|NCT01641367|583235057|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
161502222|NCT04920123|583235060|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161502223|NCT04920123|583235061|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161502224|NCT04920123|583235062|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161502225|NCT00218296|583235068|FG000|Overall Study|Lost to Follow-up|9|||
161502226|NCT00218296|583235069|FG001|Overall Study|Lost to Follow-up|7|||
161502227|NCT00218296|583235068|FG000|Overall Study|Withdrawal by Subject|36|||
161502228|NCT00218296|583235069|FG001|Overall Study|Withdrawal by Subject|47|||
161673560|NCT02906787|583858012|FG000|Overall Study|Withdrawal by Subject|12|||
161673561|NCT02906787|583858013|FG001|Overall Study|Withdrawal by Subject|10|||
161673562|NCT02906787|583858012|FG000|Overall Study|Missed|24|||
161673563|NCT02906787|583858013|FG001|Overall Study|Missed|22|||
161673564|NCT00447382|583858014|FG000|Overall Study|Adverse Event|1|||
161673565|NCT00447382|583858015|FG001|Overall Study|Adverse Event|1|||
161673566|NCT00447382|583858014|FG000|Overall Study|Lack of Efficacy|1|||
161673567|NCT00447382|583858015|FG001|Overall Study|Lack of Efficacy|0|||
161673568|NCT00447382|583858014|FG000|Overall Study|Protocol Violation|2|||
161925539|NCT02029443|584773205|FG001|Overall Study|Withdrawal by Subject|1|||
161925540|NCT02029443|584773206|FG002|Overall Study|Withdrawal by Subject|1|||
161673569|NCT00447382|583858015|FG001|Overall Study|Protocol Violation|0|||
161673570|NCT00447382|583858014|FG000|Overall Study|Unclassified|2|||
161673571|NCT00447382|583858015|FG001|Overall Study|Unclassified|5|||
161673572|NCT03901053|583858020|FG000|Overall Study|Lost to Follow-up|6|||
161673573|NCT03901053|583858021|FG001|Overall Study|Lost to Follow-up|2|||
161673574|NCT03901053|583858020|FG000|Overall Study|Withdrawal by Subject|4|||
161673575|NCT03901053|583858021|FG001|Overall Study|Withdrawal by Subject|3|||
161673576|NCT03901053|583858020|FG000|Overall Study|Unsatisfactory Device|1|||
161673577|NCT03901053|583858021|FG001|Overall Study|Unsatisfactory Device|2|||
161673578|NCT03901053|583858020|FG000|Overall Study|No longer meets study criteria|1|||
161925541|NCT02029443|584773207|FG003|Overall Study|Withdrawal by Subject|1|||
161925542|NCT02029443|584773208|FG004|Overall Study|Withdrawal by Subject|0|||
161502229|NCT00218296|583235068|FG000|Overall Study|Randomized but did not enter treatment|66|||
161502230|NCT00218296|583235069|FG001|Overall Study|Randomized but did not enter treatment|67|||
161502231|NCT02586493|583235073|FG000|Overall Study|Adverse Event|4|||
161502232|NCT02586493|583235073|FG000|Overall Study|Protocol Violation|6|||
161925543|NCT02029443|584773204|FG000|Overall Study|Other|6|||
161925544|NCT02029443|584773205|FG001|Overall Study|Other|6|||
161925545|NCT02029443|584773206|FG002|Overall Study|Other|4|||
161925546|NCT02029443|584773207|FG003|Overall Study|Other|2|||
161925547|NCT02029443|584773208|FG004|Overall Study|Other|0|||
161925548|NCT03123588|584773209|FG000|Overall Study|Study Terminated by Sponsor|2|||
161925549|NCT03123588|584773210|FG001|Overall Study|Study Terminated by Sponsor|5|||
161925550|NCT03123588|584773209|FG000|Overall Study|Withdrawal by Subject|1|||
161925551|NCT03123588|584773210|FG001|Overall Study|Withdrawal by Subject|0|||
161925552|NCT03123588|584773209|FG000|Overall Study|Adverse Event|1|||
161925553|NCT03123588|584773210|FG001|Overall Study|Adverse Event|0|||
161502233|NCT02586493|583235073|FG000|Overall Study|Lost to Follow-up|1|||
161502234|NCT02586493|583235073|FG000|Overall Study|Withdrawal by Subject|1|||
161502235|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
161502236|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
161502237|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
161502238|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
161502239|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
161502240|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
161502241|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
161502242|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
161502243|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
161502244|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
161502245|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
161925554|NCT03123588|584773209|FG000|Overall Study|Physician Decision|2|||
161502246|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
161502247|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
161502248|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
161502249|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
161502250|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Death|5|||
161502251|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Death|0|||
161502252|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Death|2|||
161502253|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Death|0|||
161502254|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Death|4|||
161502255|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
161502256|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
161502257|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
161502258|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
161502259|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
161502260|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
161502261|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
161502262|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
161502263|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
161502264|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
161502265|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
161502266|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
161502267|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
161502268|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
161502269|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
161502270|NCT01604343|583235087|FG000|Prior to W52 Administration(Through W52)|Other|15|||
161502271|NCT01604343|583235088|FG001|Prior to W52 Administration(Through W52)|Other|0|||
161502272|NCT01604343|583235089|FG002|Prior to W52 Administration(Through W52)|Other|10|||
161502273|NCT01604343|583235090|FG003|Prior to W52 Administration(Through W52)|Other|0|||
161502274|NCT01604343|583235091|FG004|Prior to W52 Administration(Through W52)|Other|6|||
161502275|NCT01604343|583235087|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
161502276|NCT01604343|583235088|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
161502277|NCT01604343|583235089|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
161502278|NCT01604343|583235090|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
161502279|NCT01604343|583235091|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
161586014|NCT04994509|583531936|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
161586015|NCT04994509|583531934|FG000|Overall Study|Withdrew Consent|73|||
161586016|NCT04994509|583531935|FG001|Overall Study|Withdrew Consent|72|||
161925555|NCT03123588|584773210|FG001|Overall Study|Physician Decision|1|||
161925556|NCT02063724|584773211|FG000|Overall Study|Disease progression|1|||
161502280|NCT01604343|583235087|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
161925557|NCT00896233|584773212|FG000|Overall Study|Claustrophobia during MRI|1|||
161925558|NCT02697422|584773216|FG000|Overall Study|Declined exit survey|9|||
161925559|NCT02697422|584773217|FG001|Overall Study|Declined exit survey|2|||
161925560|NCT02697422|584773216|FG000|Overall Study|Lost to Follow-up|13|||
161502281|NCT01604343|583235088|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
161502282|NCT01604343|583235089|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
161502283|NCT01604343|583235090|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
161502284|NCT01604343|583235091|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
161502285|NCT01604343|583235087|FG000|Week 52 to Week 104|Adverse Event|0|||
161502286|NCT01604343|583235088|FG001|Week 52 to Week 104|Adverse Event|12|||
161502287|NCT01604343|583235089|FG002|Week 52 to Week 104|Adverse Event|26|||
161502288|NCT01604343|583235090|FG003|Week 52 to Week 104|Adverse Event|21|||
161502289|NCT01604343|583235091|FG004|Week 52 to Week 104|Adverse Event|27|||
161502290|NCT01604343|583235087|FG000|Week 52 to Week 104|Death|0|||
161502291|NCT01604343|583235088|FG001|Week 52 to Week 104|Death|4|||
161502292|NCT01604343|583235089|FG002|Week 52 to Week 104|Death|2|||
161502293|NCT01604343|583235090|FG003|Week 52 to Week 104|Death|5|||
161502294|NCT01604343|583235091|FG004|Week 52 to Week 104|Death|0|||
161502295|NCT01604343|583235087|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
161502296|NCT01604343|583235088|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
161502297|NCT01604343|583235089|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
161502298|NCT01604343|583235090|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
161502299|NCT01604343|583235091|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
161502300|NCT01604343|583235087|FG000|Week 52 to Week 104|Physician Decision|0|||
161502301|NCT01604343|583235088|FG001|Week 52 to Week 104|Physician Decision|1|||
161502302|NCT01604343|583235089|FG002|Week 52 to Week 104|Physician Decision|0|||
161502303|NCT01604343|583235090|FG003|Week 52 to Week 104|Physician Decision|0|||
161502304|NCT01604343|583235091|FG004|Week 52 to Week 104|Physician Decision|2|||
161502305|NCT01604343|583235087|FG000|Week 52 to Week 104|Pregnancy|0|||
161502306|NCT01604343|583235088|FG001|Week 52 to Week 104|Pregnancy|0|||
161502307|NCT01604343|583235089|FG002|Week 52 to Week 104|Pregnancy|1|||
161502308|NCT01604343|583235090|FG003|Week 52 to Week 104|Pregnancy|2|||
161502309|NCT01604343|583235091|FG004|Week 52 to Week 104|Pregnancy|1|||
161502310|NCT01604343|583235087|FG000|Week 52 to Week 104|Other|0|||
161502311|NCT01604343|583235088|FG001|Week 52 to Week 104|Other|11|||
161502312|NCT01604343|583235089|FG002|Week 52 to Week 104|Other|11|||
161502313|NCT01604343|583235090|FG003|Week 52 to Week 104|Other|6|||
161502314|NCT01604343|583235091|FG004|Week 52 to Week 104|Other|3|||
161502315|NCT01604343|583235087|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
161502316|NCT01604343|583235088|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
161502317|NCT01604343|583235089|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
161502318|NCT01604343|583235090|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
161502319|NCT01604343|583235091|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
161502320|NCT01604343|583235087|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
161502321|NCT01604343|583235088|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
161502322|NCT01604343|583235089|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
161502323|NCT01604343|583235090|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
161502324|NCT01604343|583235091|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
161502325|NCT01604343|583235087|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
161586017|NCT04994509|583531936|FG002|Overall Study|Withdrew Consent|46|||
161586018|NCT04994509|583531934|FG000|Overall Study|Lost to Follow-up|39|||
161925561|NCT02697422|584773217|FG001|Overall Study|Lost to Follow-up|8|||
161925562|NCT02697422|584773216|FG000|Overall Study|Death|2|||
161925563|NCT02697422|584773217|FG001|Overall Study|Death|1|||
161925564|NCT02697422|584773216|FG000|Overall Study|Withdrawal by Subject|0|||
161925565|NCT02697422|584773217|FG001|Overall Study|Withdrawal by Subject|1|||
161925566|NCT02697422|584773216|FG000|Overall Study|Physician Decision|1|||
161502326|NCT01604343|583235088|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
161502327|NCT01604343|583235089|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
161502328|NCT01604343|583235090|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
161502329|NCT01604343|583235091|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
161502330|NCT02711800|583235093|FG000|Overall Study|Lost to Follow-up|1|||
161502331|NCT02711800|583235093|FG000|Overall Study|Withdrawal by Subject|1|||
161502332|NCT01990495|583235103|FG000|Overall Study|Physician Decision|5|||
161502333|NCT01990495|583235104|FG001|Overall Study|Physician Decision|4|||
161502334|NCT00449956|583235105|FG000|Overall Study|Adverse Event|7|||
161502335|NCT00449956|583235106|FG001|Overall Study|Adverse Event|1|||
161502336|NCT00449956|583235107|FG002|Overall Study|Adverse Event|6|||
161502337|NCT00449956|583235105|FG000|Overall Study|Lack of Efficacy|0|||
161502338|NCT00449956|583235106|FG001|Overall Study|Lack of Efficacy|0|||
161502339|NCT00449956|583235107|FG002|Overall Study|Lack of Efficacy|1|||
161502340|NCT00449956|583235105|FG000|Overall Study|Protocol Violation|1|||
161502341|NCT00449956|583235106|FG001|Overall Study|Protocol Violation|1|||
161586019|NCT04994509|583531935|FG001|Overall Study|Lost to Follow-up|36|||
161586020|NCT04994509|583531936|FG002|Overall Study|Lost to Follow-up|26|||
161586021|NCT04994509|583531934|FG000|Overall Study|HIV-1 Infection|4|||
161586022|NCT04994509|583531935|FG001|Overall Study|HIV-1 Infection|20|||
161586023|NCT04994509|583531936|FG002|Overall Study|HIV-1 Infection|12|||
161586024|NCT04994509|583531934|FG000|Overall Study|Investigator's Discretion|9|||
161586025|NCT04994509|583531935|FG001|Overall Study|Investigator's Discretion|8|||
161925567|NCT02697422|584773217|FG001|Overall Study|Physician Decision|1|||
161586026|NCT04994509|583531936|FG002|Overall Study|Investigator's Discretion|11|||
161586027|NCT04994509|583531934|FG000|Overall Study|Randomized but Never Treated|10|||
161586028|NCT04994509|583531935|FG001|Overall Study|Randomized but Never Treated|10|||
161586029|NCT04994509|583531936|FG002|Overall Study|Randomized but Never Treated|3|||
161586030|NCT04994509|583531934|FG000|Overall Study|Pregnancy|5|||
161586031|NCT04994509|583531935|FG001|Overall Study|Pregnancy|5|||
161586032|NCT04994509|583531936|FG002|Overall Study|Pregnancy|0|||
161586033|NCT04994509|583531934|FG000|Overall Study|Death|0|||
161586034|NCT04994509|583531935|FG001|Overall Study|Death|5|||
161586035|NCT04994509|583531936|FG002|Overall Study|Death|0|||
161586036|NCT04994509|583531934|FG000|Overall Study|Adverse Event|2|||
161586037|NCT04994509|583531935|FG001|Overall Study|Adverse Event|1|||
161586038|NCT04994509|583531936|FG002|Overall Study|Adverse Event|0|||
161586039|NCT04994509|583531934|FG000|Overall Study|Non-compliance With Study Drug|1|||
161586040|NCT04994509|583531935|FG001|Overall Study|Non-compliance With Study Drug|1|||
161586041|NCT04994509|583531936|FG002|Overall Study|Non-compliance With Study Drug|1|||
161586042|NCT04994509|583531934|FG000|Overall Study|Withdrew Assent|3|||
161586043|NCT04994509|583531935|FG001|Overall Study|Withdrew Assent|0|||
161586044|NCT04994509|583531936|FG002|Overall Study|Withdrew Assent|0|||
161586045|NCT04994509|583531934|FG000|Overall Study|Protocol Violation|1|||
161586046|NCT04994509|583531935|FG001|Overall Study|Protocol Violation|0|||
161586047|NCT04994509|583531936|FG002|Overall Study|Protocol Violation|0|||
161586048|NCT04402294|583531938|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
161586049|NCT04402294|583531939|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
161586050|NCT04402294|583531938|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
161586051|NCT04402294|583531939|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
161586052|NCT04924062|583534125|FG000|Overall Study|Death|49|||
161586053|NCT04924062|583534126|FG001|Overall Study|Death|63|||
161586054|NCT04924062|583534125|FG000|Overall Study|Participant On-going|26|||
161586055|NCT04924062|583534126|FG001|Overall Study|Participant On-going|20|||
161586056|NCT03845465|583534127|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
161586057|NCT03845465|583534128|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
161586058|NCT03845465|583534127|FG000|6-month Data Collection|Withdrawal by Subject|0|||
161586059|NCT03845465|583534128|FG001|6-month Data Collection|Withdrawal by Subject|2|||
161586060|NCT03845465|583534127|FG000|12-month Data Collection|Withdrawal by Subject|0|||
161586061|NCT03845465|583534128|FG001|12-month Data Collection|Withdrawal by Subject|2|||
161586062|NCT03547908|583534131|FG000|Blinded Phase|Lost to Follow-up|3|||
161586063|NCT03547908|583534132|FG001|Blinded Phase|Lost to Follow-up|3|||
161586064|NCT03547908|583534133|FG002|Blinded Phase|Lost to Follow-up|0|||
161586065|NCT03547908|583534134|FG003|Blinded Phase|Lost to Follow-up|0|||
161586066|NCT03547908|583534131|FG000|Blinded Phase|Withdrew Consent|2|||
161586067|NCT03547908|583534132|FG001|Blinded Phase|Withdrew Consent|3|||
161586068|NCT03547908|583534133|FG002|Blinded Phase|Withdrew Consent|0|||
161586069|NCT03547908|583534134|FG003|Blinded Phase|Withdrew Consent|0|||
161586070|NCT03547908|583534131|FG000|Blinded Phase|Investigator's Discretion|2|||
161586071|NCT03547908|583534132|FG001|Blinded Phase|Investigator's Discretion|1|||
161586072|NCT03547908|583534133|FG002|Blinded Phase|Investigator's Discretion|0|||
161586073|NCT03547908|583534134|FG003|Blinded Phase|Investigator's Discretion|0|||
161586074|NCT03547908|583534131|FG000|Blinded Phase|Death|2|||
161586075|NCT03547908|583534132|FG001|Blinded Phase|Death|0|||
161502342|NCT00449956|583235107|FG002|Overall Study|Protocol Violation|1|||
161502343|NCT00449956|583235105|FG000|Overall Study|Withdrawal by Subject|0|||
161502344|NCT00449956|583235106|FG001|Overall Study|Withdrawal by Subject|1|||
161502345|NCT00449956|583235107|FG002|Overall Study|Withdrawal by Subject|0|||
161502346|NCT00449956|583235105|FG000|Overall Study|Physician Decision|2|||
161502347|NCT00449956|583235106|FG001|Overall Study|Physician Decision|1|||
161502348|NCT00449956|583235107|FG002|Overall Study|Physician Decision|1|||
161502349|NCT01988571|583235112|FG000|Overall Study|Death|3|||
161502350|NCT01988571|583235113|FG001|Overall Study|Death|1|||
161502351|NCT01988571|583235112|FG000|Overall Study|Physician Decision|2|||
161502352|NCT01988571|583235113|FG001|Overall Study|Physician Decision|1|||
161502353|NCT01988571|583235112|FG000|Overall Study|Lost to Follow-up|3|||
161502354|NCT01988571|583235113|FG001|Overall Study|Lost to Follow-up|0|||
161502355|NCT01988571|583235112|FG000|Overall Study|Withdrawal by Subject|31|||
161502356|NCT01988571|583235113|FG001|Overall Study|Withdrawal by Subject|33|||
161502357|NCT00337103|583235115|FG000|Overall Study|Progressive Disease|414|||
161502358|NCT00337103|583235116|FG001|Overall Study|Progressive Disease|410|||
161502359|NCT00337103|583235115|FG000|Overall Study|Adverse Event|45|||
161502360|NCT00337103|583235116|FG001|Overall Study|Adverse Event|59|||
161502361|NCT00337103|583235115|FG000|Overall Study|Subject Choice|34|||
161502362|NCT00337103|583235116|FG001|Overall Study|Subject Choice|27|||
161502363|NCT00337103|583235115|FG000|Overall Study|Clinical Progression|27|||
161502364|NCT00337103|583235116|FG001|Overall Study|Clinical Progression|24|||
161502365|NCT00337103|583235115|FG000|Overall Study|Physician Decision|15|||
161502366|NCT00337103|583235116|FG001|Overall Study|Physician Decision|14|||
161502367|NCT00337103|583235115|FG000|Overall Study|Withdrawal by Subject|8|||
161502368|NCT00337103|583235116|FG001|Overall Study|Withdrawal by Subject|5|||
161502369|NCT00337103|583235115|FG000|Overall Study|Other|5|||
161502370|NCT00337103|583235116|FG001|Overall Study|Other|6|||
161502371|NCT00337103|583235115|FG000|Overall Study|Entry Criteria Not Met|4|||
161502372|NCT00337103|583235116|FG001|Overall Study|Entry Criteria Not Met|1|||
161502373|NCT00337103|583235115|FG000|Overall Study|Lost to Follow-up|1|||
161502374|NCT00337103|583235116|FG001|Overall Study|Lost to Follow-up|2|||
161502375|NCT00337103|583235115|FG000|Overall Study|Death|1|||
161673579|NCT03901053|583858021|FG001|Overall Study|No longer meets study criteria|3|||
161673580|NCT03901053|583858020|FG000|Overall Study|Subject's Medical Status|0|||
161673581|NCT03901053|583858021|FG001|Overall Study|Subject's Medical Status|1|||
161673582|NCT03901053|583858020|FG000|Overall Study|Screening Failure|1|||
161925568|NCT02697422|584773216|FG000|Overall Study|Exit survey data lost|1|||
161502376|NCT00337103|583235116|FG001|Overall Study|Death|0|||
161502377|NCT00409617|583235128|FG000|Overall Study|Adverse Event|57|||
161502378|NCT00409617|583235128|FG000|Overall Study|Lack of Efficacy|54|||
161502379|NCT00409617|583235128|FG000|Overall Study|Lost to Follow-up|2|||
161502380|NCT00409617|583235128|FG000|Overall Study|Protocol Violation|24|||
161502381|NCT00409617|583235128|FG000|Overall Study|Withdrawal by Subject|8|||
161502382|NCT00409617|583235128|FG000|Overall Study|Administrative reasons|1|||
161502383|NCT00409617|583235128|FG000|Overall Study|Not described|14|||
161502384|NCT02159521|583235129|FG000|Overall Study|Enrolled but not treated|3|||
161502385|NCT02159521|583235129|FG000|Overall Study|Withdrawal by Subject|7|||
161502386|NCT02159521|583235129|FG000|Overall Study|Lost to Follow-up|6|||
161502387|NCT02159521|583235129|FG000|Overall Study|Death|1|||
161502388|NCT02159521|583235129|FG000|Overall Study|Other than specified|1|||
161502389|NCT00907374|583235132|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
161502390|NCT00907374|583235133|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
161586076|NCT03547908|583534133|FG002|Blinded Phase|Death|0|||
161586077|NCT03547908|583534134|FG003|Blinded Phase|Death|0|||
161586078|NCT03547908|583534131|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
161586079|NCT03547908|583534132|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
161586080|NCT03547908|583534133|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
161586081|NCT03547908|583534134|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
161586082|NCT03547908|583534131|FG000|Blinded Phase|Adverse Event|1|||
161586083|NCT03547908|583534132|FG001|Blinded Phase|Adverse Event|0|||
161586084|NCT03547908|583534133|FG002|Blinded Phase|Adverse Event|0|||
161586085|NCT03547908|583534134|FG003|Blinded Phase|Adverse Event|0|||
161586086|NCT03547908|583534131|FG000|Blinded Phase|Randomized But Never Treated|1|||
161502391|NCT03818516|583235134|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
161502392|NCT03742141|583235140|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
161502393|NCT01524692|583235143|FG000|Overall Study|Withdrawal by Subject|3|||
161502394|NCT01709695|583235145|FG000|Overall Study|Withdrawal by Subject|1|||
161502395|NCT01709695|583235146|FG001|Overall Study|Withdrawal by Subject|1|||
161502396|NCT03065244|583235150|FG000|Overall Study|Lost to Follow-up|1|||
161502397|NCT03065244|583235151|FG001|Overall Study|Lost to Follow-up|1|||
161502398|NCT03065244|583235150|FG000|Overall Study|Diagnosed with a different disease|1|||
161502399|NCT03065244|583235151|FG001|Overall Study|Diagnosed with a different disease|1|||
161502400|NCT03065244|583235150|FG000|Overall Study|Protocol Violation|0|||
161586087|NCT03547908|583534132|FG001|Blinded Phase|Randomized But Never Treated|0|||
161586088|NCT03547908|583534133|FG002|Blinded Phase|Randomized But Never Treated|0|||
161586089|NCT03547908|583534134|FG003|Blinded Phase|Randomized But Never Treated|0|||
161586090|NCT03547908|583534131|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
161586091|NCT03547908|583534132|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
161502401|NCT03065244|583235151|FG001|Overall Study|Protocol Violation|1|||
161502402|NCT03065244|583235150|FG000|Overall Study|Withdrawal by Subject|1|||
161502403|NCT03065244|583235151|FG001|Overall Study|Withdrawal by Subject|1|||
161502404|NCT03717480|583235152|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
161502405|NCT01894152|583235153|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
161502406|NCT01774786|583235155|FG000|Overall Study|Death|300|||
161502407|NCT01774786|583235156|FG001|Overall Study|Death|319|||
161502408|NCT01774786|583235155|FG000|Overall Study|Lost to Follow-up|6|||
161502409|NCT01774786|583235156|FG001|Overall Study|Lost to Follow-up|7|||
161502410|NCT01774786|583235155|FG000|Overall Study|Withdrawal by Subject|18|||
161502411|NCT01774786|583235156|FG001|Overall Study|Withdrawal by Subject|14|||
161502412|NCT01774786|583235155|FG000|Overall Study|Physician Decision|2|||
161502413|NCT01774786|583235156|FG001|Overall Study|Physician Decision|0|||
161502414|NCT01774786|583235155|FG000|Overall Study|Non-compliance|0|||
161502415|NCT01774786|583235156|FG001|Overall Study|Non-compliance|1|||
161502416|NCT01774786|583235155|FG000|Overall Study|Reason Not Specified|2|||
161502417|NCT01774786|583235156|FG001|Overall Study|Reason Not Specified|5|||
161502418|NCT04544293|583235157|FG000|Double-blind|Adverse Event|2|||
161502419|NCT04544293|583235158|FG001|Double-blind|Adverse Event|1|||
161502420|NCT04544293|583235157|FG000|Double-blind|Pregnancy|0|||
161502421|NCT04544293|583235158|FG001|Double-blind|Pregnancy|1|||
161502422|NCT04544293|583235157|FG000|Double-blind|Lost to Follow-up|0|||
161502423|NCT04544293|583235158|FG001|Double-blind|Lost to Follow-up|1|||
161502424|NCT04544293|583235157|FG000|Open-Label Extension|Study ongoing|79|||
161502425|NCT04544293|583235158|FG001|Open-Label Extension|Study ongoing|81|||
161502426|NCT01062555|583235163|FG000|Phase 1|Death|10|||
161502427|NCT01062555|583235164|FG001|Phase 1|Death|17|||
161502428|NCT01062555|583235165|FG002|Phase 1|Death|0|||
161502429|NCT01062555|583235166|FG003|Phase 1|Death|0|||
161502430|NCT01062555|583235163|FG000|Phase 1|Graft Failure|12|||
161502431|NCT01062555|583235164|FG001|Phase 1|Graft Failure|8|||
161502432|NCT01062555|583235165|FG002|Phase 1|Graft Failure|0|||
161502433|NCT01062555|583235166|FG003|Phase 1|Graft Failure|0|||
161502434|NCT01062555|583235163|FG000|Phase 1|Withdrawal by Subject|1|||
161502435|NCT01062555|583235164|FG001|Phase 1|Withdrawal by Subject|1|||
161502436|NCT01062555|583235165|FG002|Phase 1|Withdrawal by Subject|0|||
161502437|NCT01062555|583235166|FG003|Phase 1|Withdrawal by Subject|0|||
161502438|NCT01062555|583235163|FG000|Phase 2|Death|0|||
161502439|NCT01062555|583235164|FG001|Phase 2|Death|0|||
161502440|NCT01062555|583235165|FG002|Phase 2|Death|8|||
161502441|NCT01062555|583235166|FG003|Phase 2|Death|3|||
161502442|NCT01062555|583235163|FG000|Phase 2|Graft failure|0|||
161502443|NCT01062555|583235164|FG001|Phase 2|Graft failure|0|||
161502444|NCT01062555|583235165|FG002|Phase 2|Graft failure|7|||
161502445|NCT01062555|583235166|FG003|Phase 2|Graft failure|4|||
161502446|NCT01062555|583235163|FG000|Phase 2|Withdrawal by Subject|0|||
161502447|NCT01062555|583235164|FG001|Phase 2|Withdrawal by Subject|0|||
161502448|NCT01062555|583235165|FG002|Phase 2|Withdrawal by Subject|0|||
161502449|NCT01062555|583235166|FG003|Phase 2|Withdrawal by Subject|7|||
161502450|NCT01062555|583235163|FG000|Phase 2|Protocol Violation|0|||
161502451|NCT01062555|583235164|FG001|Phase 2|Protocol Violation|0|||
161502452|NCT01062555|583235165|FG002|Phase 2|Protocol Violation|0|||
161502453|NCT01062555|583235166|FG003|Phase 2|Protocol Violation|3|||
161502454|NCT01062555|583235163|FG000|Phase 2|Physician Decision|0|||
161502455|NCT01062555|583235164|FG001|Phase 2|Physician Decision|0|||
161502456|NCT01062555|583235165|FG002|Phase 2|Physician Decision|0|||
161819607|NCT00874276|584379710|FG000|Overall Study|Withdrawal by Subject|1|||
161819608|NCT00874276|584379711|FG001|Overall Study|Withdrawal by Subject|1|||
161819609|NCT04236596|584379712|FG000|Overall Study|Withdrawal by Subject|1|||
161819610|NCT04236596|584379712|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
161819611|NCT04236596|584379712|FG000|Overall Study|Participants did not receive implant at all|4|||
161819612|NCT02588339|584379714|FG000|Overall Study|Withdrawal by Subject|1|||
161819613|NCT02588339|584379714|FG000|Overall Study|GVHD Progression prior to treatment|2|||
161502457|NCT01062555|583235166|FG003|Phase 2|Physician Decision|17|||
161502458|NCT02818777|583235173|FG000|Overall Study|Adverse Event|3|||
161502459|NCT00747435|583235174|FG000|Overall Study|Lost to Follow-up|2|||
161502460|NCT00747435|583235174|FG000|Overall Study|Withdrawal by Subject|3|||
161502461|NCT00747435|583235174|FG000|Overall Study|Still undergoing follow up|1|||
161502462|NCT01324349|583235175|FG000|Overall Study|Death|1|||
161502463|NCT01324349|583235176|FG001|Overall Study|Death|1|||
161502464|NCT01324349|583235175|FG000|Overall Study|Withdrawal by Subject|0|||
161502465|NCT01324349|583235176|FG001|Overall Study|Withdrawal by Subject|1|||
161502466|NCT02276612|583235177|FG000|Overall Study|Death|1|||
161502467|NCT02276612|583235178|FG001|Overall Study|Death|0|||
161502468|NCT02276612|583235177|FG000|Overall Study|Pregnancy|1|||
161819614|NCT02300987|584381114|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
161502469|NCT02276612|583235178|FG001|Overall Study|Pregnancy|0|||
161502470|NCT02276612|583235177|FG000|Overall Study|Withdrew Consent|1|||
161502471|NCT02276612|583235178|FG001|Overall Study|Withdrew Consent|0|||
161502472|NCT02276612|583235177|FG000|Overall Study|Lost to Follow-up|1|||
161502473|NCT02276612|583235178|FG001|Overall Study|Lost to Follow-up|0|||
161502474|NCT00826267|583236870|FG000|Overall Study|Other Adverse Event|1|||
161502475|NCT00826267|583236871|FG001|Overall Study|Other Adverse Event|0|||
161502476|NCT00826267|583236872|FG002|Overall Study|Other Adverse Event|0|||
161502477|NCT00436748|583236873|FG000|Overall Study|Ineligibility Determined|1|||
161502478|NCT00436748|583236874|FG001|Overall Study|Ineligibility Determined|1|||
161502479|NCT00436748|583236873|FG000|Overall Study|Adverse Event|0|||
161502480|NCT00436748|583236874|FG001|Overall Study|Adverse Event|2|||
161502481|NCT00436748|583236873|FG000|Overall Study|Consent Withdrawn|1|||
161502482|NCT00436748|583236874|FG001|Overall Study|Consent Withdrawn|4|||
161502483|NCT00436748|583236873|FG000|Overall Study|Administrative Decision|1|||
161502484|NCT00436748|583236874|FG001|Overall Study|Administrative Decision|0|||
161502485|NCT00436748|583236873|FG000|Overall Study|Lost to Follow-up|0|||
161502486|NCT00436748|583236874|FG001|Overall Study|Lost to Follow-up|1|||
161502487|NCT00436748|583236873|FG000|Overall Study|Protocol-specified Criteria|5|||
161502488|NCT00436748|583236874|FG001|Overall Study|Protocol-specified Criteria|4|||
161502489|NCT00436748|583236873|FG000|Overall Study|Other|3|||
161502490|NCT00436748|583236874|FG001|Overall Study|Other|0|||
161502491|NCT00850200|583236875|FG000|Overall Study|Physician Decision|2|||
161502492|NCT00850200|583236875|FG000|Overall Study|Did not recieve treatment|2|||
161502493|NCT00850200|583236875|FG000|Overall Study|Withdrawal by Subject|1|||
161502494|NCT05442554|583236876|FG000|Overall Study|Adverse Event|1|||
161502495|NCT00097721|583236884|FG000|Overall Study|Adverse Event|8|||
161502496|NCT00097721|583236885|FG001|Overall Study|Adverse Event|1|||
161502497|NCT00097721|583236884|FG000|Overall Study|Withdrawal by Subject|6|||
161502498|NCT00097721|583236885|FG001|Overall Study|Withdrawal by Subject|1|||
161502499|NCT00097721|583236884|FG000|Overall Study|Progressive Disease|55|||
161502500|NCT00097721|583236885|FG001|Overall Study|Progressive Disease|27|||
161502501|NCT00097721|583236884|FG000|Overall Study|Physician Decision|1|||
161502502|NCT00097721|583236885|FG001|Overall Study|Physician Decision|3|||
161502503|NCT00097721|583236884|FG000|Overall Study|Reason not given|1|||
161502504|NCT00097721|583236885|FG001|Overall Study|Reason not given|1|||
161502505|NCT02972632|583236891|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
161502506|NCT02972632|583236891|FG000|Overall Study|Lost to Follow-up|4|||
161502507|NCT02972632|583236891|FG000|Overall Study|Voluntary Withdrawal|10|||
161502508|NCT02126969|583236892|FG000|Overall Study|Withdrawal by Subject|1|||
161502509|NCT02126969|583236893|FG001|Overall Study|Withdrawal by Subject|2|||
161502510|NCT00354172|583236894|FG000|Overall Study|Did not receive transplant|1|||
161502511|NCT01828034|583236895|FG000|Overall Study|Withdrawal by Subject|0|||
161502512|NCT01828034|583236896|FG001|Overall Study|Withdrawal by Subject|0|||
161502513|NCT01828034|583236897|FG002|Overall Study|Withdrawal by Subject|0|||
161502514|NCT01828034|583236898|FG003|Overall Study|Withdrawal by Subject|1|||
161502515|NCT02023151|583236899|FG000|Overall Study|Lost to Follow-up|4|||
161502516|NCT03450707|583236900|FG000|Overall Study|Outside enrollment window|4|||
161502517|NCT03450707|583236901|FG001|Overall Study|Outside enrollment window|1|||
161502518|NCT03450707|583236900|FG000|Overall Study|Death|1|||
161502519|NCT03450707|583236901|FG001|Overall Study|Death|0|||
161502520|NCT03450707|583236900|FG000|Overall Study|Indication for thiamine|1|||
161502521|NCT03450707|583236901|FG001|Overall Study|Indication for thiamine|1|||
161502522|NCT03450707|583236900|FG000|Overall Study|Evidence of traumatic brain injury|1|||
161502523|NCT03450707|583236901|FG001|Overall Study|Evidence of traumatic brain injury|0|||
161502524|NCT03450707|583236900|FG000|Overall Study|Following commands|0|||
161586092|NCT03547908|583534133|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
161586093|NCT03547908|583534134|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
161586094|NCT03547908|583534131|FG000|Open-label Extension Phase|Death|0|||
161586095|NCT03547908|583534132|FG001|Open-label Extension Phase|Death|0|||
161586096|NCT03547908|583534133|FG002|Open-label Extension Phase|Death|1|||
161586097|NCT03547908|583534134|FG003|Open-label Extension Phase|Death|0|||
161586098|NCT04059354|583534137|FG000|Overall Study|COVID-19 pandemic|3|||
161586099|NCT02349412|583534139|FG000|Overall Study|Withdrawal by Subject|7|||
161819615|NCT02300987|584381115|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
161819616|NCT02300987|584381114|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
161819617|NCT02300987|584381115|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
161819618|NCT02300987|584381114|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
161819619|NCT02300987|584381115|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
161819620|NCT02300987|584381114|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
161502525|NCT03450707|583236901|FG001|Overall Study|Following commands|3|||
161502526|NCT03450707|583236900|FG000|Overall Study|Lactate < 3.5|0|||
161502527|NCT03450707|583236901|FG001|Overall Study|Lactate < 3.5|2|||
161502528|NCT03450707|583236900|FG000|Overall Study|Rearrest with ECMO|0|||
161502529|NCT03450707|583236901|FG001|Overall Study|Rearrest with ECMO|1|||
161502530|NCT03450707|583236900|FG000|Overall Study|Indication for thiamine + head CT results|0|||
161502531|NCT03450707|583236901|FG001|Overall Study|Indication for thiamine + head CT results|1|||
161502532|NCT03450707|583236900|FG000|Overall Study|Family/patient goals of care|0|||
161502533|NCT03450707|583236901|FG001|Overall Study|Family/patient goals of care|1|||
161586100|NCT02349412|583534140|FG001|Overall Study|Withdrawal by Subject|7|||
161502534|NCT02871375|583236902|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
161819621|NCT02300987|584381115|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
161819622|NCT02300987|584381114|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
161819623|NCT02300987|584381115|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
161819624|NCT05330975|584381116|FG000|Primary|Lost to Follow-up|12|||
161502535|NCT02871375|583236903|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
161819625|NCT05330975|584381117|FG001|Primary|Lost to Follow-up|21|||
161819626|NCT05330975|584381118|FG002|Primary|Lost to Follow-up|38|||
161819627|NCT05330975|584381119|FG003|Primary|Lost to Follow-up|30|||
161819628|NCT05330975|584381120|FG004|Primary|Lost to Follow-up|25|||
161819629|NCT05330975|584381121|FG005|Primary|Lost to Follow-up|28|||
161819630|NCT05330975|584381122|FG006|Primary|Lost to Follow-up|0|||
161819631|NCT05330975|584381116|FG000|Primary|Withdrawal by Subject|4|||
161819632|NCT05330975|584381117|FG001|Primary|Withdrawal by Subject|11|||
161819633|NCT05330975|584381118|FG002|Primary|Withdrawal by Subject|8|||
161819634|NCT05330975|584381119|FG003|Primary|Withdrawal by Subject|23|||
161819635|NCT05330975|584381120|FG004|Primary|Withdrawal by Subject|20|||
161819636|NCT05330975|584381121|FG005|Primary|Withdrawal by Subject|19|||
161819637|NCT05330975|584381122|FG006|Primary|Withdrawal by Subject|0|||
161819638|NCT05330975|584381116|FG000|Primary|Protocol Violation|0|||
161819639|NCT05330975|584381117|FG001|Primary|Protocol Violation|2|||
161819640|NCT05330975|584381118|FG002|Primary|Protocol Violation|0|||
161502536|NCT00004412|583236906|FG000|Randomized Period|Moved to Crossover Period|3|||
161502537|NCT00004412|583236907|FG001|Randomized Period|Moved to Crossover Period|0|||
161502538|NCT00004412|583236908|FG002|Randomized Period|Moved to Crossover Period|0|||
161502539|NCT00149747|583236921|FG000|Overall Study|Death|1|||
161502540|NCT00149747|583236922|FG001|Overall Study|Death|0|||
161502541|NCT00149747|583236921|FG000|Overall Study|Withdrawal by Subject|3|||
161502542|NCT00149747|583236922|FG001|Overall Study|Withdrawal by Subject|3|||
161502543|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
161502544|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
161502545|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
161502546|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
161502547|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
161502548|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
161502549|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
161502550|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
161502551|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
161502552|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
161502553|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
161502554|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
161502555|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
161502556|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
161502557|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
161502558|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
161502559|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
161502560|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
161502561|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
161502562|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
161502563|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
161502564|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
161502565|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
161502566|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
161502567|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
161502568|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
161502569|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
161502570|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
161502571|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
161502572|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
161502573|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
161502574|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
161502575|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
161502576|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
161502577|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
161502578|NCT03373383|583236923|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
161502579|NCT03373383|583236924|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
161502580|NCT03373383|583236925|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
161502581|NCT03373383|583236926|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
161502582|NCT03373383|583236927|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
161502583|NCT03373383|583236923|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
161502584|NCT03373383|583236924|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
161502585|NCT03373383|583236925|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
161502586|NCT03373383|583236926|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
161502587|NCT03373383|583236927|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
161502588|NCT02689258|583236928|FG000|Overall Study|Subject Non-Compliance|0|||
161502589|NCT02689258|583236929|FG001|Overall Study|Subject Non-Compliance|1|||
161502590|NCT02689258|583236930|FG002|Overall Study|Subject Non-Compliance|0|||
161673583|NCT03901053|583858021|FG001|Overall Study|Screening Failure|0|||
161673584|NCT02408861|583858022|FG000|Overall Study|Death|0|||
161673585|NCT02408861|583858023|FG001|Overall Study|Death|3|||
161673586|NCT02408861|583858024|FG002|Overall Study|Death|1|||
161502591|NCT02689258|583236931|FG003|Overall Study|Subject Non-Compliance|0|||
161502592|NCT02689258|583236932|FG004|Overall Study|Subject Non-Compliance|0|||
161673587|NCT02408861|583858025|FG003|Overall Study|Death|2|||
161673588|NCT02408861|583858026|FG004|Overall Study|Death|4|||
161502593|NCT02689258|583236933|FG005|Overall Study|Subject Non-Compliance|0|||
161502594|NCT02689258|583236934|FG006|Overall Study|Subject Non-Compliance|0|||
161502595|NCT02689258|583236935|FG007|Overall Study|Subject Non-Compliance|0|||
161502596|NCT02689258|583236936|FG008|Overall Study|Subject Non-Compliance|0|||
161502597|NCT02689258|583236937|FG009|Overall Study|Subject Non-Compliance|0|||
161502598|NCT02689258|583236938|FG010|Overall Study|Subject Non-Compliance|0|||
161673589|NCT02408861|583858027|FG005|Overall Study|Death|1|||
161673590|NCT02408861|583858028|FG006|Overall Study|Death|0|||
161502599|NCT02689258|583236939|FG011|Overall Study|Subject Non-Compliance|0|||
161502600|NCT02689258|583236928|FG000|Overall Study|Subject Refusal to Continue|0|||
161502601|NCT02689258|583236929|FG001|Overall Study|Subject Refusal to Continue|1|||
161502602|NCT02689258|583236930|FG002|Overall Study|Subject Refusal to Continue|0|||
161502603|NCT02689258|583236931|FG003|Overall Study|Subject Refusal to Continue|0|||
161502604|NCT02689258|583236932|FG004|Overall Study|Subject Refusal to Continue|0|||
161502605|NCT02689258|583236933|FG005|Overall Study|Subject Refusal to Continue|0|||
161502606|NCT02689258|583236934|FG006|Overall Study|Subject Refusal to Continue|0|||
161502607|NCT02689258|583236935|FG007|Overall Study|Subject Refusal to Continue|0|||
161502608|NCT02689258|583236936|FG008|Overall Study|Subject Refusal to Continue|1|||
161502609|NCT02689258|583236937|FG009|Overall Study|Subject Refusal to Continue|0|||
161502610|NCT02689258|583236938|FG010|Overall Study|Subject Refusal to Continue|0|||
161502611|NCT02689258|583236939|FG011|Overall Study|Subject Refusal to Continue|1|||
161502612|NCT02689258|583236928|FG000|Overall Study|Other|0|||
161502613|NCT02689258|583236929|FG001|Overall Study|Other|2|||
161502614|NCT02689258|583236930|FG002|Overall Study|Other|0|||
161502615|NCT02689258|583236931|FG003|Overall Study|Other|0|||
161502616|NCT02689258|583236932|FG004|Overall Study|Other|1|||
161502617|NCT02689258|583236933|FG005|Overall Study|Other|0|||
161502618|NCT02689258|583236934|FG006|Overall Study|Other|0|||
161502619|NCT02689258|583236935|FG007|Overall Study|Other|0|||
161502620|NCT02689258|583236936|FG008|Overall Study|Other|1|||
161502621|NCT02689258|583236937|FG009|Overall Study|Other|0|||
161502622|NCT02689258|583236938|FG010|Overall Study|Other|0|||
161502623|NCT02689258|583236939|FG011|Overall Study|Other|0|||
161502624|NCT00594464|583236941|FG000|Overall Study|Withdrawal by Subject|1|||
161502625|NCT00594464|583236941|FG000|Overall Study|Delay in operation|2|||
161502626|NCT00785486|583236942|FG000|Midazolam Alone|Withdrawal by Subject|1|||
161502627|NCT02907359|583236949|FG000|Overall Study|Death|234|||
161502628|NCT02907359|583236950|FG001|Overall Study|Death|117|||
161502629|NCT02907359|583236949|FG000|Overall Study|Withdrawal by Subject|6|||
161502630|NCT02907359|583236950|FG001|Overall Study|Withdrawal by Subject|11|||
161502631|NCT02907359|583236949|FG000|Overall Study|Lost to Follow-up|1|||
161502632|NCT02907359|583236950|FG001|Overall Study|Lost to Follow-up|0|||
161502633|NCT03131440|583236951|FG000|Overall Study|Withdrawal by Subject|1|||
161502634|NCT03131440|583236952|FG001|Overall Study|Withdrawal by Subject|3|||
161502635|NCT03131440|583236953|FG002|Overall Study|Withdrawal by Subject|0|||
161502636|NCT03131440|583236954|FG003|Overall Study|Withdrawal by Subject|0|||
161502637|NCT03131440|583236955|FG004|Overall Study|Withdrawal by Subject|1|||
161502638|NCT03131440|583236956|FG005|Overall Study|Withdrawal by Subject|0|||
161502639|NCT03131440|583236957|FG006|Overall Study|Withdrawal by Subject|0|||
161502640|NCT03131440|583236958|FG007|Overall Study|Withdrawal by Subject|1|||
161502641|NCT03131440|583236959|FG008|Overall Study|Withdrawal by Subject|1|||
161502642|NCT03131440|583236960|FG009|Overall Study|Withdrawal by Subject|1|||
161673591|NCT02408861|583858022|FG000|Overall Study|Lost to Follow-up|0|||
161673592|NCT02408861|583858023|FG001|Overall Study|Lost to Follow-up|0|||
161673593|NCT02408861|583858024|FG002|Overall Study|Lost to Follow-up|1|||
161673594|NCT02408861|583858025|FG003|Overall Study|Lost to Follow-up|1|||
161673595|NCT02408861|583858026|FG004|Overall Study|Lost to Follow-up|4|||
161673596|NCT02408861|583858027|FG005|Overall Study|Lost to Follow-up|2|||
161502643|NCT03131440|583236961|FG010|Overall Study|Withdrawal by Subject|0|||
161502644|NCT03131440|583236962|FG011|Overall Study|Withdrawal by Subject|1|||
161502645|NCT03131440|583236963|FG012|Overall Study|Withdrawal by Subject|1|||
161502646|NCT03131440|583236964|FG013|Overall Study|Withdrawal by Subject|0|||
161502647|NCT03131440|583236965|FG014|Overall Study|Withdrawal by Subject|1|||
161502648|NCT03131440|583236966|FG015|Overall Study|Withdrawal by Subject|0|||
161502649|NCT03131440|583236967|FG016|Overall Study|Withdrawal by Subject|0|||
161502650|NCT03131440|583236968|FG017|Overall Study|Withdrawal by Subject|0|||
161502651|NCT03131440|583236969|FG018|Overall Study|Withdrawal by Subject|1|||
161673597|NCT02408861|583858028|FG006|Overall Study|Lost to Follow-up|1|||
161673598|NCT02408861|583858022|FG000|Overall Study|Disease Progression|0|||
161673599|NCT02408861|583858023|FG001|Overall Study|Disease Progression|0|||
161502652|NCT03131440|583236970|FG019|Overall Study|Withdrawal by Subject|0|||
161502653|NCT03131440|583236971|FG020|Overall Study|Withdrawal by Subject|1|||
161502654|NCT03131440|583236972|FG021|Overall Study|Withdrawal by Subject|1|||
161502655|NCT03131440|583236973|FG022|Overall Study|Withdrawal by Subject|1|||
161502656|NCT03131440|583236974|FG023|Overall Study|Withdrawal by Subject|0|||
161502657|NCT03131440|583236975|FG024|Overall Study|Withdrawal by Subject|0|||
161673600|NCT02408861|583858024|FG002|Overall Study|Disease Progression|1|||
161673601|NCT02408861|583858025|FG003|Overall Study|Disease Progression|0|||
161673602|NCT02408861|583858026|FG004|Overall Study|Disease Progression|3|||
161502658|NCT03131440|583236976|FG025|Overall Study|Withdrawal by Subject|0|||
161502659|NCT03131440|583236977|FG026|Overall Study|Withdrawal by Subject|0|||
161502660|NCT03131440|583236978|FG027|Overall Study|Withdrawal by Subject|0|||
161502661|NCT03131440|583236979|FG028|Overall Study|Withdrawal by Subject|0|||
161502662|NCT03131440|583236980|FG029|Overall Study|Withdrawal by Subject|0|||
161502663|NCT03131440|583236981|FG030|Overall Study|Withdrawal by Subject|1|||
161673603|NCT02408861|583858027|FG005|Overall Study|Disease Progression|1|||
161502664|NCT03131440|583236982|FG031|Overall Study|Withdrawal by Subject|0|||
161502665|NCT03131440|583236951|FG000|Overall Study|Lost to Follow-up|0|||
161502666|NCT03131440|583236952|FG001|Overall Study|Lost to Follow-up|0|||
161502667|NCT03131440|583236953|FG002|Overall Study|Lost to Follow-up|0|||
161502668|NCT03131440|583236954|FG003|Overall Study|Lost to Follow-up|0|||
161502669|NCT03131440|583236955|FG004|Overall Study|Lost to Follow-up|0|||
161502670|NCT03131440|583236956|FG005|Overall Study|Lost to Follow-up|1|||
161502671|NCT03131440|583236957|FG006|Overall Study|Lost to Follow-up|0|||
161502672|NCT03131440|583236958|FG007|Overall Study|Lost to Follow-up|0|||
161502673|NCT03131440|583236959|FG008|Overall Study|Lost to Follow-up|0|||
161502674|NCT03131440|583236960|FG009|Overall Study|Lost to Follow-up|0|||
161502675|NCT03131440|583236961|FG010|Overall Study|Lost to Follow-up|0|||
161502676|NCT03131440|583236962|FG011|Overall Study|Lost to Follow-up|0|||
161502677|NCT03131440|583236963|FG012|Overall Study|Lost to Follow-up|0|||
161502678|NCT03131440|583236964|FG013|Overall Study|Lost to Follow-up|0|||
161502679|NCT03131440|583236965|FG014|Overall Study|Lost to Follow-up|0|||
161502680|NCT03131440|583236966|FG015|Overall Study|Lost to Follow-up|0|||
161502681|NCT03131440|583236967|FG016|Overall Study|Lost to Follow-up|0|||
161502682|NCT03131440|583236968|FG017|Overall Study|Lost to Follow-up|0|||
161502683|NCT03131440|583236969|FG018|Overall Study|Lost to Follow-up|0|||
161502684|NCT03131440|583236970|FG019|Overall Study|Lost to Follow-up|2|||
161502685|NCT03131440|583236971|FG020|Overall Study|Lost to Follow-up|1|||
161502686|NCT03131440|583236972|FG021|Overall Study|Lost to Follow-up|0|||
161502687|NCT03131440|583236973|FG022|Overall Study|Lost to Follow-up|1|||
161502688|NCT03131440|583236974|FG023|Overall Study|Lost to Follow-up|0|||
161502689|NCT03131440|583236975|FG024|Overall Study|Lost to Follow-up|1|||
161502690|NCT03131440|583236976|FG025|Overall Study|Lost to Follow-up|0|||
161502691|NCT03131440|583236977|FG026|Overall Study|Lost to Follow-up|0|||
161502692|NCT03131440|583236978|FG027|Overall Study|Lost to Follow-up|2|||
161502693|NCT03131440|583236979|FG028|Overall Study|Lost to Follow-up|0|||
161502694|NCT03131440|583236980|FG029|Overall Study|Lost to Follow-up|2|||
161502695|NCT03131440|583236981|FG030|Overall Study|Lost to Follow-up|0|||
161502696|NCT03131440|583236982|FG031|Overall Study|Lost to Follow-up|0|||
161502697|NCT03131440|583236951|FG000|Overall Study|Death|0|||
161502698|NCT03131440|583236952|FG001|Overall Study|Death|0|||
161502699|NCT03131440|583236953|FG002|Overall Study|Death|0|||
161502700|NCT03131440|583236954|FG003|Overall Study|Death|0|||
161502701|NCT03131440|583236955|FG004|Overall Study|Death|0|||
161502702|NCT03131440|583236956|FG005|Overall Study|Death|0|||
161502703|NCT03131440|583236957|FG006|Overall Study|Death|0|||
161502704|NCT03131440|583236958|FG007|Overall Study|Death|0|||
161502705|NCT03131440|583236959|FG008|Overall Study|Death|0|||
161502706|NCT03131440|583236960|FG009|Overall Study|Death|0|||
161502707|NCT03131440|583236961|FG010|Overall Study|Death|0|||
161502708|NCT03131440|583236962|FG011|Overall Study|Death|0|||
161502709|NCT03131440|583236963|FG012|Overall Study|Death|0|||
161502710|NCT03131440|583236964|FG013|Overall Study|Death|0|||
161502711|NCT03131440|583236965|FG014|Overall Study|Death|0|||
161502712|NCT03131440|583236966|FG015|Overall Study|Death|0|||
161502713|NCT03131440|583236967|FG016|Overall Study|Death|0|||
161502714|NCT03131440|583236968|FG017|Overall Study|Death|0|||
161502715|NCT03131440|583236969|FG018|Overall Study|Death|0|||
161502716|NCT03131440|583236970|FG019|Overall Study|Death|0|||
161502717|NCT03131440|583236971|FG020|Overall Study|Death|0|||
161502718|NCT03131440|583236972|FG021|Overall Study|Death|0|||
161502719|NCT03131440|583236973|FG022|Overall Study|Death|0|||
161586101|NCT05338086|583534143|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
161586102|NCT05338086|583534144|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161586103|NCT05338086|583534145|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161586104|NCT05338086|583534146|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161819641|NCT05330975|584381119|FG003|Primary|Protocol Violation|4|||
161819642|NCT05330975|584381120|FG004|Primary|Protocol Violation|0|||
161502720|NCT03131440|583236974|FG023|Overall Study|Death|0|||
161502721|NCT03131440|583236975|FG024|Overall Study|Death|0|||
161502722|NCT03131440|583236976|FG025|Overall Study|Death|1|||
161502723|NCT03131440|583236977|FG026|Overall Study|Death|0|||
161502724|NCT03131440|583236978|FG027|Overall Study|Death|0|||
161502725|NCT03131440|583236979|FG028|Overall Study|Death|0|||
161502726|NCT03131440|583236980|FG029|Overall Study|Death|0|||
161502727|NCT03131440|583236981|FG030|Overall Study|Death|0|||
161502728|NCT03131440|583236982|FG031|Overall Study|Death|0|||
161502729|NCT00746941|583236985|FG000|Overall Study|Death|2|||
161502730|NCT00746941|583236986|FG001|Overall Study|Death|0|||
161502731|NCT00746941|583236987|FG002|Overall Study|Death|0|||
161502732|NCT00746941|583236988|FG003|Overall Study|Death|6|||
161502733|NCT00746941|583236985|FG000|Overall Study|Physician Decision|0|||
161502734|NCT00746941|583236986|FG001|Overall Study|Physician Decision|0|||
161502735|NCT00746941|583236987|FG002|Overall Study|Physician Decision|2|||
161502736|NCT00746941|583236988|FG003|Overall Study|Physician Decision|0|||
161502737|NCT00746941|583236985|FG000|Overall Study|Withdrawal by Subject|3|||
161502738|NCT00746941|583236986|FG001|Overall Study|Withdrawal by Subject|0|||
161502739|NCT00746941|583236987|FG002|Overall Study|Withdrawal by Subject|0|||
161502740|NCT00746941|583236988|FG003|Overall Study|Withdrawal by Subject|2|||
161673604|NCT02408861|583858028|FG006|Overall Study|Disease Progression|1|||
161673605|NCT02408861|583858022|FG000|Overall Study|Adverse Event|1|||
161673606|NCT02408861|583858023|FG001|Overall Study|Adverse Event|0|||
161673607|NCT02408861|583858024|FG002|Overall Study|Adverse Event|1|||
161673608|NCT02408861|583858025|FG003|Overall Study|Adverse Event|0|||
161925569|NCT02697422|584773217|FG001|Overall Study|Exit survey data lost|0|||
161925570|NCT02068599|584773222|FG000|Overall Study|Adverse Event|4|||
161925571|NCT02068599|584773223|FG001|Overall Study|Adverse Event|1|||
161925572|NCT02068599|584773224|FG002|Overall Study|Adverse Event|1|||
161925573|NCT02068599|584773222|FG000|Overall Study|Withdrawal by Subject|2|||
161925574|NCT02068599|584773223|FG001|Overall Study|Withdrawal by Subject|7|||
161925575|NCT02068599|584773224|FG002|Overall Study|Withdrawal by Subject|5|||
161925576|NCT02068599|584773222|FG000|Overall Study|Protocol Violation|4|||
161673609|NCT02408861|583858026|FG004|Overall Study|Adverse Event|2|||
161673610|NCT02408861|583858027|FG005|Overall Study|Adverse Event|0|||
161673611|NCT02408861|583858028|FG006|Overall Study|Adverse Event|0|||
161673612|NCT02408861|583858022|FG000|Overall Study|Physician Decision|1|||
161673613|NCT02408861|583858023|FG001|Overall Study|Physician Decision|1|||
161673614|NCT02408861|583858024|FG002|Overall Study|Physician Decision|1|||
161673615|NCT02408861|583858025|FG003|Overall Study|Physician Decision|0|||
161673616|NCT02408861|583858026|FG004|Overall Study|Physician Decision|0|||
161673617|NCT02408861|583858027|FG005|Overall Study|Physician Decision|1|||
161673618|NCT02408861|583858028|FG006|Overall Study|Physician Decision|0|||
161673619|NCT02408861|583858022|FG000|Overall Study|Protocol Violation|1|||
161673620|NCT02408861|583858023|FG001|Overall Study|Protocol Violation|0|||
161673621|NCT02408861|583858024|FG002|Overall Study|Protocol Violation|0|||
161673622|NCT02408861|583858025|FG003|Overall Study|Protocol Violation|0|||
161673623|NCT02408861|583858026|FG004|Overall Study|Protocol Violation|0|||
161673624|NCT02408861|583858027|FG005|Overall Study|Protocol Violation|0|||
161673625|NCT02408861|583858028|FG006|Overall Study|Protocol Violation|0|||
161673626|NCT02408861|583858022|FG000|Overall Study|Withdrawal by Subject|0|||
161673627|NCT02408861|583858023|FG001|Overall Study|Withdrawal by Subject|0|||
161925577|NCT02068599|584773223|FG001|Overall Study|Protocol Violation|2|||
161925578|NCT02068599|584773224|FG002|Overall Study|Protocol Violation|3|||
161673628|NCT02408861|583858024|FG002|Overall Study|Withdrawal by Subject|0|||
161673629|NCT02408861|583858025|FG003|Overall Study|Withdrawal by Subject|0|||
161673630|NCT02408861|583858026|FG004|Overall Study|Withdrawal by Subject|1|||
161673631|NCT02408861|583858027|FG005|Overall Study|Withdrawal by Subject|1|||
161673632|NCT02408861|583858028|FG006|Overall Study|Withdrawal by Subject|0|||
161673633|NCT02408861|583858022|FG000|Overall Study|Other Treatment|0|||
161673634|NCT02408861|583858023|FG001|Overall Study|Other Treatment|0|||
161673635|NCT02408861|583858024|FG002|Overall Study|Other Treatment|0|||
161673636|NCT02408861|583858025|FG003|Overall Study|Other Treatment|0|||
161673637|NCT02408861|583858026|FG004|Overall Study|Other Treatment|0|||
161673638|NCT02408861|583858027|FG005|Overall Study|Other Treatment|1|||
161673639|NCT02408861|583858028|FG006|Overall Study|Other Treatment|1|||
161673640|NCT04752475|583859841|FG000|Overall Study|Withdrawal by Subject|1|||
161673641|NCT04752475|583859842|FG001|Overall Study|Withdrawal by Subject|1|||
161673642|NCT01310803|583859848|FG000|Overall Study|Subject terminated by Sponsor|1|||
161673643|NCT01310803|583859849|FG001|Overall Study|Subject terminated by Sponsor|0|||
161673644|NCT02113579|583859852|FG000|Overall Study|Adverse Event|1|||
161673645|NCT02113579|583859853|FG001|Overall Study|Adverse Event|0|||
161673646|NCT02113579|583859852|FG000|Overall Study|Withdrawal by Subject|3|||
161673647|NCT02113579|583859853|FG001|Overall Study|Withdrawal by Subject|2|||
161673648|NCT02113579|583859852|FG000|Overall Study|Lost to Follow-up|6|||
161673649|NCT02113579|583859853|FG001|Overall Study|Lost to Follow-up|2|||
161673650|NCT03047551|583859854|FG000|Overall Study|Did not receive TAS|1|||
161673651|NCT03047551|583859855|FG001|Overall Study|Did not receive TAS|0|||
161673652|NCT03047551|583859854|FG000|Overall Study|Physician Decision|1|||
161673653|NCT03047551|583859855|FG001|Overall Study|Physician Decision|0|||
161673654|NCT03047551|583859854|FG000|Overall Study|Withdrawal by Subject|0|||
161673655|NCT03047551|583859855|FG001|Overall Study|Withdrawal by Subject|1|||
161673656|NCT03047551|583859854|FG000|Overall Study|Probe malfunction|0|||
161673657|NCT03047551|583859855|FG001|Overall Study|Probe malfunction|1|||
161673658|NCT03047551|583859854|FG000|Overall Study|Ineligible|0|||
161673659|NCT03047551|583859855|FG001|Overall Study|Ineligible|1|||
161673660|NCT00726622|583859856|FG000|Overall Study|Withdrawal by Subject|16|||
161673661|NCT00726622|583859857|FG001|Overall Study|Withdrawal by Subject|2|||
161502741|NCT00746941|583236985|FG000|Overall Study|Other, reason not provided|2|||
161502742|NCT00746941|583236986|FG001|Overall Study|Other, reason not provided|4|||
161502743|NCT00746941|583236987|FG002|Overall Study|Other, reason not provided|0|||
161502744|NCT00746941|583236988|FG003|Overall Study|Other, reason not provided|4|||
161673662|NCT00726622|583859856|FG000|Overall Study|Physician Decision|0|||
161673663|NCT00726622|583859857|FG001|Overall Study|Physician Decision|1|||
161673664|NCT00726622|583859856|FG000|Overall Study|Metastasis|2|||
161673665|NCT00726622|583859857|FG001|Overall Study|Metastasis|0|||
161673666|NCT02462928|583859859|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161673667|NCT02462928|583859860|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161673668|NCT02462928|583859861|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
161673669|NCT02462928|583859859|FG000|Overall Study|Adverse Event|47|||
161673670|NCT02462928|583859860|FG001|Overall Study|Adverse Event|51|||
161502745|NCT00746941|583236985|FG000|Overall Study|Adverse Event|0|||
161502746|NCT00746941|583236986|FG001|Overall Study|Adverse Event|0|||
161673671|NCT02462928|583859861|FG002|Overall Study|Adverse Event|25|||
161673672|NCT02462928|583859859|FG000|Overall Study|Lack of Efficacy|3|||
161673673|NCT02462928|583859860|FG001|Overall Study|Lack of Efficacy|8|||
161673674|NCT02462928|583859861|FG002|Overall Study|Lack of Efficacy|3|||
161673675|NCT02462928|583859859|FG000|Overall Study|Lost to Follow-up|4|||
161673676|NCT02462928|583859860|FG001|Overall Study|Lost to Follow-up|4|||
161673677|NCT02462928|583859861|FG002|Overall Study|Lost to Follow-up|1|||
161673678|NCT02462928|583859859|FG000|Overall Study|Withdrawal by Patient|31|||
161673679|NCT02462928|583859860|FG001|Overall Study|Withdrawal by Patient|21|||
161673680|NCT02462928|583859861|FG002|Overall Study|Withdrawal by Patient|21|||
161673681|NCT02462928|583859859|FG000|Overall Study|Protocol Violation|0|||
161673682|NCT02462928|583859860|FG001|Overall Study|Protocol Violation|1|||
161673683|NCT02462928|583859861|FG002|Overall Study|Protocol Violation|0|||
161673684|NCT02462928|583859859|FG000|Overall Study|Reason not Specified|4|||
161673685|NCT02462928|583859860|FG001|Overall Study|Reason not Specified|6|||
161673686|NCT02462928|583859861|FG002|Overall Study|Reason not Specified|5|||
161673687|NCT00395863|583859862|FG000|Overall Study|Patients did not complete both exams|2|||
161673688|NCT00395863|583859863|FG001|Overall Study|Patients did not complete both exams|3|||
161673689|NCT01940354|583859864|FG000|Overall Study|Withdrawal by Subject|4|||
161673690|NCT01940354|583859865|FG001|Overall Study|Withdrawal by Subject|2|||
161673691|NCT02020863|583859866|FG000|Overall Study|Discovery of Metastatic disease|4|||
161673692|NCT02020863|583859866|FG000|Overall Study|Team chose not to place an a line|1|||
161673693|NCT03873493|583859867|FG000|Overall Study|Withdrawal by Subject|1|||
161673694|NCT03873493|583859867|FG000|Overall Study|Death|9|||
161673695|NCT03873493|583859867|FG000|Overall Study|Lost to Follow-up|1|||
161673696|NCT03873493|583859867|FG000|Overall Study|Study Terminated by Sponsor|1|||
161673697|NCT03873493|583859867|FG000|Overall Study|Other|2|||
161673698|NCT00909792|583859874|FG000|Period 1|Did not meet inclusion criteria|0|||
161925579|NCT02068599|584773222|FG000|Overall Study|Lost to Follow-up|1|||
161925580|NCT02068599|584773223|FG001|Overall Study|Lost to Follow-up|0|||
161925581|NCT02068599|584773224|FG002|Overall Study|Lost to Follow-up|0|||
161925582|NCT02068599|584773222|FG000|Overall Study|Lack of Efficacy|0|||
161925583|NCT02068599|584773223|FG001|Overall Study|Lack of Efficacy|0|||
161925584|NCT02068599|584773224|FG002|Overall Study|Lack of Efficacy|3|||
161925585|NCT02068599|584773222|FG000|Overall Study|Noncompliance|0|||
161673699|NCT00909792|583859875|FG001|Period 1|Did not meet inclusion criteria|1|||
161673700|NCT00909792|583859874|FG000|Period 2|Biomicroscopy|1|||
161673701|NCT00909792|583859875|FG001|Period 2|Biomicroscopy|0|||
161673702|NCT00909792|583859874|FG000|Period 2|Lost to Follow-up|0|||
161673703|NCT00909792|583859875|FG001|Period 2|Lost to Follow-up|1|||
161673704|NCT01448213|583859876|FG000|Overall Study|Lost to Follow-up|12|||
161673705|NCT01448213|583859877|FG001|Overall Study|Lost to Follow-up|10|||
161673706|NCT01448213|583859876|FG000|Overall Study|Adverse Event|4|||
161673707|NCT01448213|583859877|FG001|Overall Study|Adverse Event|10|||
161673708|NCT01448213|583859876|FG000|Overall Study|Protocol Violation|1|||
161673709|NCT01448213|583859877|FG001|Overall Study|Protocol Violation|2|||
161673710|NCT03503513|583859878|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
161673711|NCT03503513|583859878|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
161925586|NCT02068599|584773223|FG001|Overall Study|Noncompliance|0|||
161925587|NCT02068599|584773224|FG002|Overall Study|Noncompliance|1|||
161925588|NCT01263028|584773225|FG000|Overall Study|Withdrawal by Subject|1|||
161925589|NCT01263028|584773225|FG000|Overall Study|Adverse Event|1|||
161925590|NCT01263028|584773225|FG000|Overall Study|Study terminated due to low enrollment.|4|||
161925591|NCT03019588|584773226|FG000|Overall Study|Death|44|||
161925592|NCT03019588|584773227|FG001|Overall Study|Death|46|||
161925593|NCT03019588|584773226|FG000|Overall Study|Study terminated by Sponsor|3|||
161925594|NCT03019588|584773227|FG001|Overall Study|Study terminated by Sponsor|1|||
161925595|NCT00366535|584773228|FG000|First Phase: 12 Weeks|Adverse Event|1|||
161925596|NCT00366535|584773229|FG001|First Phase: 12 Weeks|Adverse Event|3|||
161925597|NCT00366535|584773228|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
161925598|NCT00366535|584773229|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
161925599|NCT00366535|584773228|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
161925600|NCT00366535|584773229|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
161925601|NCT00366535|584773228|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
161925602|NCT00366535|584773229|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
161925603|NCT02958527|584773234|FG000|Overall Study|Not collected CRFs|12|||
161925604|NCT06042855|584773237|FG000|Overall Study|No Receipt of Study Drug|48|||
161925605|NCT06042855|584773238|FG001|Overall Study|No Receipt of Study Drug|57|||
161925606|NCT06042855|584773237|FG000|Overall Study|Administratively Withdrawn|59|||
161925607|NCT06042855|584773238|FG001|Overall Study|Administratively Withdrawn|59|||
161925608|NCT02939781|584773244|FG000|Overall Study|Protocol Violation|8|||
161925609|NCT02939781|584773244|FG000|Overall Study|Withdrawal by Subject|1|||
161925610|NCT06100250|584773245|FG000|Overall Study|Lost to Follow-up|5|||
161925611|NCT05259033|584773248|FG000|Overall Study|Withdrawal by Subject|10|||
161925612|NCT05259033|584773249|FG001|Overall Study|Withdrawal by Subject|5|||
161673712|NCT03503513|583859878|FG000|Overall Study|Physician Decision|3|||
161673713|NCT03503513|583859878|FG000|Overall Study|Withdrawal by Subject|2|||
161673714|NCT03503513|583859878|FG000|Overall Study|Lost to Follow-up|1|||
161673715|NCT01170039|583859883|FG000|Overall Study|Withdrawal by Subject|5|||
161925613|NCT05259033|584773248|FG000|Overall Study|Lost to Follow-up|1|||
161673716|NCT01170039|583859884|FG001|Overall Study|Withdrawal by Subject|3|||
161673717|NCT01170039|583859883|FG000|Overall Study|Lack of funding, drug not available|3|||
161673718|NCT01170039|583859884|FG001|Overall Study|Lack of funding, drug not available|3|||
161673719|NCT01205438|583859885|FG000|Overall Study|Adverse Event|19|||
161673720|NCT01205438|583859886|FG001|Overall Study|Adverse Event|17|||
161673721|NCT01205438|583859887|FG002|Overall Study|Adverse Event|24|||
161673722|NCT01205438|583859885|FG000|Overall Study|Death|1|||
161673723|NCT01205438|583859886|FG001|Overall Study|Death|1|||
161673724|NCT01205438|583859887|FG002|Overall Study|Death|3|||
161673725|NCT01205438|583859885|FG000|Overall Study|Entry Criteria Not Met|16|||
161502747|NCT00746941|583236987|FG002|Overall Study|Adverse Event|0|||
161502748|NCT00746941|583236988|FG003|Overall Study|Adverse Event|1|||
161502749|NCT01354496|583236996|FG000|Period 1|Adverse Event|0|||
161502750|NCT01354496|583236997|FG001|Period 1|Adverse Event|0|||
161502751|NCT01354496|583236998|FG002|Period 1|Adverse Event|1|||
161502752|NCT01354496|583236999|FG003|Period 1|Adverse Event|0|||
161502753|NCT01354496|583237000|FG004|Period 1|Adverse Event|0|||
161502754|NCT01354496|583237001|FG005|Period 1|Adverse Event|0|||
161502755|NCT01354496|583236996|FG000|Period 1|Physician Decision|0|||
161502756|NCT01354496|583236997|FG001|Period 1|Physician Decision|0|||
161502757|NCT01354496|583236998|FG002|Period 1|Physician Decision|1|||
161502758|NCT01354496|583236999|FG003|Period 1|Physician Decision|0|||
161502759|NCT01354496|583237000|FG004|Period 1|Physician Decision|0|||
161502760|NCT01354496|583237001|FG005|Period 1|Physician Decision|0|||
161502761|NCT01354496|583236996|FG000|Period 2|Adverse Event|0|||
161502762|NCT01354496|583236997|FG001|Period 2|Adverse Event|0|||
161502763|NCT01354496|583236998|FG002|Period 2|Adverse Event|0|||
161502764|NCT01354496|583236999|FG003|Period 2|Adverse Event|1|||
161502765|NCT01354496|583237000|FG004|Period 2|Adverse Event|0|||
161502766|NCT01354496|583237001|FG005|Period 2|Adverse Event|0|||
161502767|NCT01354496|583236996|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
161502768|NCT01354496|583236997|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
161502769|NCT01354496|583236998|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
161502770|NCT01354496|583236999|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
161502771|NCT01354496|583237000|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
161502772|NCT01354496|583237001|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
161502773|NCT00500292|583237003|FG000|Overall Study|Adverse Event|3|||
161502774|NCT00500292|583237004|FG001|Overall Study|Adverse Event|6|||
161502775|NCT00500292|583237005|FG002|Overall Study|Adverse Event|4|||
161502776|NCT00500292|583237003|FG000|Overall Study|Condition under investigation worsened|21|||
161502777|NCT00500292|583237004|FG001|Overall Study|Condition under investigation worsened|23|||
161502778|NCT00500292|583237005|FG002|Overall Study|Condition under investigation worsened|19|||
161502779|NCT00500292|583237003|FG000|Overall Study|Withdrawal by Subject|0|||
161502780|NCT00500292|583237004|FG001|Overall Study|Withdrawal by Subject|1|||
161502781|NCT00500292|583237005|FG002|Overall Study|Withdrawal by Subject|0|||
161502782|NCT00500292|583237003|FG000|Overall Study|Other|1|||
161502783|NCT00500292|583237004|FG001|Overall Study|Other|1|||
161502784|NCT00500292|583237005|FG002|Overall Study|Other|4|||
161502785|NCT02741700|583237006|FG000|Overall Study|Lost to Follow-up|17|||
161502786|NCT02741700|583237007|FG001|Overall Study|Lost to Follow-up|8|||
161502787|NCT02741700|583237006|FG000|Overall Study|Withdrawal by Subject|2|||
161502788|NCT02741700|583237007|FG001|Overall Study|Withdrawal by Subject|5|||
161502789|NCT02741700|583237006|FG000|Overall Study|Physician Decision|3|||
161502790|NCT02741700|583237007|FG001|Overall Study|Physician Decision|0|||
161502791|NCT02741700|583237006|FG000|Overall Study|Moved out of State|0|||
161502792|NCT02741700|583237007|FG001|Overall Study|Moved out of State|1|||
161925614|NCT05259033|584773249|FG001|Overall Study|Lost to Follow-up|0|||
161925615|NCT05259033|584773248|FG000|Overall Study|Death|2|||
161925616|NCT05259033|584773249|FG001|Overall Study|Death|0|||
161925617|NCT05537571|584773250|FG000|Overall Study|Withdrawal by Subject|1|||
161925618|NCT05537571|584773251|FG001|Overall Study|Withdrawal by Subject|1|||
161673726|NCT01205438|583859886|FG001|Overall Study|Entry Criteria Not Met|15|||
161673727|NCT01205438|583859887|FG002|Overall Study|Entry Criteria Not Met|13|||
161925619|NCT05537571|584773252|FG002|Overall Study|Withdrawal by Subject|0|||
161925620|NCT05537571|584773253|FG003|Overall Study|Withdrawal by Subject|0|||
161925621|NCT05537571|584773254|FG004|Overall Study|Withdrawal by Subject|0|||
161925622|NCT05537571|584773250|FG000|Overall Study|Adverse Event|2|||
161925623|NCT05537571|584773251|FG001|Overall Study|Adverse Event|0|||
161925624|NCT05537571|584773252|FG002|Overall Study|Adverse Event|0|||
161925625|NCT05537571|584773253|FG003|Overall Study|Adverse Event|0|||
161502793|NCT02741700|583237006|FG000|Overall Study|Death|4|||
161502794|NCT02741700|583237007|FG001|Overall Study|Death|5|||
161502795|NCT00075582|583237008|FG000|Overall Study|Adverse Event|3|||
161502796|NCT00075582|583237009|FG001|Overall Study|Adverse Event|1|||
161502797|NCT00075582|583237008|FG000|Overall Study|Lack of Efficacy|4|||
161502798|NCT00075582|583237009|FG001|Overall Study|Lack of Efficacy|8|||
161925626|NCT05537571|584773254|FG004|Overall Study|Adverse Event|0|||
161925627|NCT05537571|584773250|FG000|Overall Study|Hepatitis A screening result|2|||
161502799|NCT00075582|583237008|FG000|Overall Study|Physician Decision|5|||
161502800|NCT00075582|583237009|FG001|Overall Study|Physician Decision|8|||
161502801|NCT00075582|583237008|FG000|Overall Study|Withdrawal by Subject|2|||
161502802|NCT00075582|583237009|FG001|Overall Study|Withdrawal by Subject|2|||
161502803|NCT00075582|583237008|FG000|Overall Study|Ineligible for study|36|||
161502804|NCT00075582|583237009|FG001|Overall Study|Ineligible for study|16|||
161502805|NCT05045144|583237010|FG000|Overall Study|Lost to Follow-up|3|||
161502806|NCT05045144|583237011|FG001|Overall Study|Lost to Follow-up|2|||
161502807|NCT05045144|583237012|FG002|Overall Study|Lost to Follow-up|3|||
161502808|NCT05045144|583237013|FG003|Overall Study|Lost to Follow-up|5|||
161502809|NCT05045144|583237014|FG004|Overall Study|Lost to Follow-up|13|||
161502810|NCT05045144|583237010|FG000|Overall Study|Withdrawal by Subject|0|||
161502811|NCT05045144|583237011|FG001|Overall Study|Withdrawal by Subject|1|||
161502812|NCT05045144|583237012|FG002|Overall Study|Withdrawal by Subject|0|||
161502813|NCT05045144|583237013|FG003|Overall Study|Withdrawal by Subject|0|||
161502814|NCT05045144|583237014|FG004|Overall Study|Withdrawal by Subject|0|||
161502815|NCT05045144|583237010|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161502816|NCT05045144|583237011|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161502817|NCT05045144|583237012|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161502818|NCT05045144|583237013|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161502819|NCT05045144|583237014|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161502820|NCT02385084|583237015|FG000|Period 2|Protocol Violation|0|||
161502821|NCT02385084|583237016|FG001|Period 2|Protocol Violation|0|||
161502822|NCT02385084|583237017|FG002|Period 2|Protocol Violation|1|||
161502823|NCT02385084|583237018|FG003|Period 2|Protocol Violation|0|||
161502824|NCT02385084|583237019|FG004|Period 2|Protocol Violation|0|||
161502825|NCT02385084|583237020|FG005|Period 2|Protocol Violation|0|||
161502826|NCT02268786|583237021|FG000|Overall Study|No Euploid Embryos available|42|||
161502827|NCT02268786|583237022|FG001|Overall Study|No Euploid Embryos available|0|||
161502828|NCT02268786|583237021|FG000|Overall Study|Withdrawal by Subject|7|||
161502829|NCT02268786|583237022|FG001|Overall Study|Withdrawal by Subject|14|||
161502830|NCT02268786|583237021|FG000|Overall Study|Thaw Failure|6|||
161502831|NCT02268786|583237022|FG001|Overall Study|Thaw Failure|4|||
161502832|NCT02268786|583237021|FG000|Overall Study|Protocol Violation|1|||
161502833|NCT02268786|583237022|FG001|Overall Study|Protocol Violation|0|||
161502834|NCT00744627|583237023|FG000|Overall Study|Adverse Event|6|||
161502835|NCT00744627|583237024|FG001|Overall Study|Adverse Event|9|||
161502836|NCT00744627|583237023|FG000|Overall Study|Lack of Efficacy|7|||
161502837|NCT00744627|583237024|FG001|Overall Study|Lack of Efficacy|3|||
161502838|NCT00744627|583237023|FG000|Overall Study|Noncompliance|0|||
161502839|NCT00744627|583237024|FG001|Overall Study|Noncompliance|1|||
161502840|NCT00744627|583237023|FG000|Overall Study|Protocol Deviations|0|||
161502841|NCT00744627|583237024|FG001|Overall Study|Protocol Deviations|2|||
161502842|NCT00744627|583237023|FG000|Overall Study|Voluntary Withdrawal|9|||
161502843|NCT00744627|583237024|FG001|Overall Study|Voluntary Withdrawal|6|||
161502844|NCT00744627|583237023|FG000|Overall Study|Lost to Follow-up|2|||
161502845|NCT00744627|583237024|FG001|Overall Study|Lost to Follow-up|1|||
161502846|NCT00744627|583237023|FG000|Overall Study|Other|1|||
161502847|NCT00744627|583237024|FG001|Overall Study|Other|0|||
161502848|NCT04809220|583237027|FG000|Overall Study|Adverse Event|4|||
161502849|NCT04809220|583237028|FG001|Overall Study|Adverse Event|0|||
161502850|NCT04809220|583237027|FG000|Overall Study|Death|1|||
161502851|NCT04809220|583237028|FG001|Overall Study|Death|0|||
161502852|NCT04809220|583237027|FG000|Overall Study|Lost to Follow-up|3|||
161502853|NCT04809220|583237028|FG001|Overall Study|Lost to Follow-up|0|||
161502854|NCT04809220|583237027|FG000|Overall Study|Physician Decision|0|||
161502855|NCT04809220|583237028|FG001|Overall Study|Physician Decision|1|||
161502856|NCT04809220|583237027|FG000|Overall Study|Withdrawal by Subject|9|||
161502857|NCT04809220|583237028|FG001|Overall Study|Withdrawal by Subject|5|||
161502858|NCT04809220|583237027|FG000|Overall Study|Due to long-term overseas business trips|1|||
161502859|NCT04809220|583237028|FG001|Overall Study|Due to long-term overseas business trips|0|||
161502860|NCT03560531|583237033|FG000|Overall Study|Death|4|||
161502861|NCT03560531|583237034|FG001|Overall Study|Death|1|||
161502862|NCT03560531|583237035|FG002|Overall Study|Death|1|||
161502863|NCT03560531|583237036|FG003|Overall Study|Death|2|||
161502864|NCT03560531|583237037|FG004|Overall Study|Death|6|||
161502865|NCT03560531|583237038|FG005|Overall Study|Death|1|||
161502866|NCT03560531|583237039|FG006|Overall Study|Death|4|||
161502867|NCT03560531|583237040|FG007|Overall Study|Death|8|||
161502868|NCT03560531|583237041|FG008|Overall Study|Death|1|||
161502869|NCT03560531|583237042|FG009|Overall Study|Death|3|||
161502870|NCT03560531|583237043|FG010|Overall Study|Death|2|||
161502871|NCT03560531|583237044|FG011|Overall Study|Death|0|||
161502872|NCT03560531|583237045|FG012|Overall Study|Death|4|||
161819643|NCT05330975|584381121|FG005|Primary|Protocol Violation|3|||
161502873|NCT03560531|583237046|FG013|Overall Study|Death|1|||
161502874|NCT03560531|583237033|FG000|Overall Study|Lost to Follow-up|1|||
161502875|NCT03560531|583237034|FG001|Overall Study|Lost to Follow-up|1|||
161502876|NCT03560531|583237035|FG002|Overall Study|Lost to Follow-up|0|||
161819644|NCT05330975|584381122|FG006|Primary|Protocol Violation|0|||
161502877|NCT03560531|583237036|FG003|Overall Study|Lost to Follow-up|0|||
161502878|NCT03560531|583237037|FG004|Overall Study|Lost to Follow-up|0|||
161502879|NCT03560531|583237038|FG005|Overall Study|Lost to Follow-up|0|||
161502880|NCT03560531|583237039|FG006|Overall Study|Lost to Follow-up|1|||
161502881|NCT03560531|583237040|FG007|Overall Study|Lost to Follow-up|0|||
161502882|NCT03560531|583237041|FG008|Overall Study|Lost to Follow-up|0|||
161502883|NCT03560531|583237042|FG009|Overall Study|Lost to Follow-up|0|||
161502884|NCT03560531|583237043|FG010|Overall Study|Lost to Follow-up|0|||
161502885|NCT03560531|583237044|FG011|Overall Study|Lost to Follow-up|0|||
161502886|NCT03560531|583237045|FG012|Overall Study|Lost to Follow-up|0|||
161502887|NCT03560531|583237046|FG013|Overall Study|Lost to Follow-up|0|||
161502888|NCT03560531|583237033|FG000|Overall Study|Withdrawal by Subject|1|||
161502889|NCT03560531|583237034|FG001|Overall Study|Withdrawal by Subject|0|||
161502890|NCT03560531|583237035|FG002|Overall Study|Withdrawal by Subject|0|||
161502891|NCT03560531|583237036|FG003|Overall Study|Withdrawal by Subject|0|||
161502892|NCT03560531|583237037|FG004|Overall Study|Withdrawal by Subject|0|||
161502893|NCT03560531|583237038|FG005|Overall Study|Withdrawal by Subject|0|||
161502894|NCT03560531|583237039|FG006|Overall Study|Withdrawal by Subject|0|||
161502895|NCT03560531|583237040|FG007|Overall Study|Withdrawal by Subject|3|||
161502896|NCT03560531|583237041|FG008|Overall Study|Withdrawal by Subject|2|||
161502897|NCT03560531|583237042|FG009|Overall Study|Withdrawal by Subject|0|||
161502898|NCT03560531|583237043|FG010|Overall Study|Withdrawal by Subject|0|||
161502899|NCT03560531|583237044|FG011|Overall Study|Withdrawal by Subject|0|||
161502900|NCT03560531|583237045|FG012|Overall Study|Withdrawal by Subject|2|||
161502901|NCT03560531|583237046|FG013|Overall Study|Withdrawal by Subject|0|||
161502902|NCT03560531|583237033|FG000|Overall Study|Study end per-protocol|1|||
161502903|NCT03560531|583237034|FG001|Overall Study|Study end per-protocol|1|||
161502904|NCT03560531|583237035|FG002|Overall Study|Study end per-protocol|2|||
161502905|NCT03560531|583237036|FG003|Overall Study|Study end per-protocol|0|||
161502906|NCT03560531|583237037|FG004|Overall Study|Study end per-protocol|1|||
161502907|NCT03560531|583237038|FG005|Overall Study|Study end per-protocol|0|||
161502908|NCT03560531|583237039|FG006|Overall Study|Study end per-protocol|0|||
161502909|NCT03560531|583237040|FG007|Overall Study|Study end per-protocol|0|||
161502910|NCT03560531|583237041|FG008|Overall Study|Study end per-protocol|0|||
161502911|NCT03560531|583237042|FG009|Overall Study|Study end per-protocol|0|||
161502912|NCT03560531|583237043|FG010|Overall Study|Study end per-protocol|0|||
161502913|NCT03560531|583237044|FG011|Overall Study|Study end per-protocol|0|||
161502914|NCT03560531|583237045|FG012|Overall Study|Study end per-protocol|0|||
161502915|NCT03560531|583237046|FG013|Overall Study|Study end per-protocol|0|||
161502916|NCT03560531|583237033|FG000|Overall Study|Early study termination by sponsor|9|||
161502917|NCT03560531|583237034|FG001|Overall Study|Early study termination by sponsor|0|||
161502918|NCT03560531|583237035|FG002|Overall Study|Early study termination by sponsor|0|||
161502919|NCT03560531|583237036|FG003|Overall Study|Early study termination by sponsor|4|||
161502920|NCT03560531|583237037|FG004|Overall Study|Early study termination by sponsor|8|||
161502921|NCT03560531|583237038|FG005|Overall Study|Early study termination by sponsor|2|||
161502922|NCT03560531|583237039|FG006|Overall Study|Early study termination by sponsor|5|||
161502923|NCT03560531|583237040|FG007|Overall Study|Early study termination by sponsor|64|||
161502924|NCT03560531|583237041|FG008|Overall Study|Early study termination by sponsor|7|||
161502925|NCT03560531|583237042|FG009|Overall Study|Early study termination by sponsor|2|||
161502926|NCT03560531|583237043|FG010|Overall Study|Early study termination by sponsor|16|||
161502927|NCT03560531|583237044|FG011|Overall Study|Early study termination by sponsor|2|||
161502928|NCT03560531|583237045|FG012|Overall Study|Early study termination by sponsor|6|||
161502929|NCT03560531|583237046|FG013|Overall Study|Early study termination by sponsor|2|||
161502930|NCT02968979|583237047|FG000|Overall Study|Protocol Violation|7|||
161502931|NCT02968979|583237047|FG000|Overall Study|Withdrawal by Subject|1|||
161502932|NCT01471379|583237048|FG000|Overall Study|Adverse Event|1|||
161502933|NCT01471379|583237049|FG001|Overall Study|Adverse Event|0|||
161502934|NCT01471379|583237050|FG002|Overall Study|Adverse Event|0|||
161502935|NCT01471379|583237048|FG000|Overall Study|Study terminated|0|||
161502936|NCT01471379|583237049|FG001|Overall Study|Study terminated|1|||
161502937|NCT01471379|583237050|FG002|Overall Study|Study terminated|0|||
161502938|NCT00729183|583237051|FG000|Overall Study|Adverse Event|11|||
161502939|NCT00729183|583237052|FG001|Overall Study|Adverse Event|5|||
161502940|NCT00729183|583237051|FG000|Overall Study|Lack of Efficacy|0|||
161502941|NCT00729183|583237052|FG001|Overall Study|Lack of Efficacy|1|||
161502942|NCT00729183|583237051|FG000|Overall Study|Lost to Follow-up|3|||
161502943|NCT00729183|583237052|FG001|Overall Study|Lost to Follow-up|1|||
161502944|NCT00729183|583237051|FG000|Overall Study|Physician Decision|1|||
161502945|NCT00729183|583237052|FG001|Overall Study|Physician Decision|1|||
161502946|NCT00729183|583237051|FG000|Overall Study|Protocol Violation|1|||
161502947|NCT00729183|583237052|FG001|Overall Study|Protocol Violation|0|||
161502948|NCT00729183|583237051|FG000|Overall Study|Withdrawal by Subject|9|||
161819645|NCT05330975|584381116|FG000|Primary|Death|0|||
161819646|NCT05330975|584381117|FG001|Primary|Death|3|||
161502949|NCT00729183|583237052|FG001|Overall Study|Withdrawal by Subject|7|||
161502950|NCT01200797|583237061|FG000|Overall Study|symptomatic deterioration|2|||
161502951|NCT01200797|583237061|FG000|Overall Study|Adverse Event|4|||
161502952|NCT01200797|583237061|FG000|Overall Study|Disease Progression|13|||
161502953|NCT03745144|583237064|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
161502954|NCT03745144|583237065|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
161502955|NCT03745144|583237066|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
161502956|NCT03745144|583237064|FG000|Period 1|Other|0|||
161502957|NCT03745144|583237065|FG001|Period 1|Other|0|||
161502958|NCT03745144|583237066|FG002|Period 1|Other|1|||
161502959|NCT00642668|583237071|FG000|Overall Study|Lost to Follow-up|1|||
161502960|NCT00642668|583237071|FG000|Overall Study|Adverse Event|2|||
161502961|NCT00642668|583237071|FG000|Overall Study|Death|2|||
161673728|NCT01205438|583859885|FG000|Overall Study|Lack of Efficacy|14|||
161502962|NCT00642668|583237071|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161502963|NCT00642668|583237071|FG000|Overall Study|Failure to Return|1|||
161502964|NCT00642668|583237071|FG000|Overall Study|Dialysis Initiation|5|||
161502965|NCT00642668|583237071|FG000|Overall Study|Blood Transfusion|2|||
161502966|NCT00896337|583237072|FG000|Overall Study|Death|7|||
161502967|NCT00896337|583237072|FG000|Overall Study|Withdrawal by Subject|7|||
161502968|NCT00896337|583237072|FG000|Overall Study|Lost to Follow-up|11|||
161502969|NCT04151290|583237077|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
161502970|NCT04380857|583238866|FG000|Overall Study|Lost to Follow-up|3|||
161502971|NCT04380857|583238867|FG001|Overall Study|Lost to Follow-up|3|||
161502972|NCT02558790|583238868|FG000|Overall Study|Lost to Follow-up|2|||
161819647|NCT05330975|584381118|FG002|Primary|Death|1|||
161819648|NCT05330975|584381119|FG003|Primary|Death|1|||
161819649|NCT05330975|584381120|FG004|Primary|Death|0|||
161819650|NCT05330975|584381121|FG005|Primary|Death|0|||
161819651|NCT05330975|584381122|FG006|Primary|Death|0|||
161819652|NCT05330975|584381116|FG000|Primary|Other Than Specified|0|||
161819653|NCT05330975|584381117|FG001|Primary|Other Than Specified|1|||
161819654|NCT05330975|584381118|FG002|Primary|Other Than Specified|2|||
161819655|NCT05330975|584381119|FG003|Primary|Other Than Specified|1|||
161819656|NCT05330975|584381120|FG004|Primary|Other Than Specified|2|||
161819657|NCT05330975|584381121|FG005|Primary|Other Than Specified|2|||
161819658|NCT05330975|584381122|FG006|Primary|Other Than Specified|0|||
161819659|NCT05330975|584381116|FG000|Primary|Adverse Event|0|||
161819660|NCT05330975|584381117|FG001|Primary|Adverse Event|0|||
161819661|NCT05330975|584381118|FG002|Primary|Adverse Event|0|||
161819662|NCT05330975|584381119|FG003|Primary|Adverse Event|1|||
161819663|NCT05330975|584381120|FG004|Primary|Adverse Event|0|||
161819664|NCT05330975|584381121|FG005|Primary|Adverse Event|0|||
161819665|NCT05330975|584381122|FG006|Primary|Adverse Event|0|||
161819666|NCT05330975|584381116|FG000|Primary|Physician Decision|0|||
161819667|NCT05330975|584381117|FG001|Primary|Physician Decision|0|||
161819668|NCT05330975|584381118|FG002|Primary|Physician Decision|0|||
161502973|NCT02558790|583238868|FG000|Overall Study|Physician Decision|1|||
161502974|NCT02558790|583238868|FG000|Overall Study|Withdrawal by Subject|1|||
161502975|NCT02558790|583238868|FG000|Overall Study|Screen Fail|3|||
161502976|NCT05083442|583238869|FG000|Overall Study|Lost to Follow-up|1|||
161502977|NCT05083442|583238870|FG001|Overall Study|Lost to Follow-up|0|||
161502978|NCT05083442|583238869|FG000|Overall Study|Lack of Efficacy|0|||
161502979|NCT05083442|583238870|FG001|Overall Study|Lack of Efficacy|1|||
161502980|NCT05083442|583238869|FG000|Overall Study|Withdrawal by Subject|1|||
161502981|NCT05083442|583238870|FG001|Overall Study|Withdrawal by Subject|3|||
161502982|NCT05083442|583238869|FG000|Overall Study|scheduling difficulties|1|||
161502983|NCT05083442|583238870|FG001|Overall Study|scheduling difficulties|2|||
161502984|NCT04865354|583238878|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
161502985|NCT04865354|583238879|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
161502986|NCT04865354|583238878|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
161502987|NCT04865354|583238879|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
161502988|NCT04865354|583238878|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
161502989|NCT04865354|583238879|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
161502990|NCT02945410|583238880|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
161502991|NCT02945410|583238881|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
161502992|NCT02945410|583238882|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
161673729|NCT01205438|583859886|FG001|Overall Study|Lack of Efficacy|11|||
161673730|NCT01205438|583859887|FG002|Overall Study|Lack of Efficacy|14|||
161673731|NCT01205438|583859885|FG000|Overall Study|Lost to Follow-up|6|||
161673732|NCT01205438|583859886|FG001|Overall Study|Lost to Follow-up|7|||
161673733|NCT01205438|583859887|FG002|Overall Study|Lost to Follow-up|8|||
161673734|NCT01205438|583859885|FG000|Overall Study|Withdrawal by Subject|19|||
161673735|NCT01205438|583859886|FG001|Overall Study|Withdrawal by Subject|25|||
161673736|NCT01205438|583859887|FG002|Overall Study|Withdrawal by Subject|19|||
161673737|NCT01205438|583859885|FG000|Overall Study|Physician Decision|0|||
161673738|NCT01205438|583859886|FG001|Overall Study|Physician Decision|3|||
161673739|NCT01205438|583859887|FG002|Overall Study|Physician Decision|2|||
161502993|NCT02945410|583238883|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
161502994|NCT02945410|583238884|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
161502995|NCT02945410|583238885|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
161502996|NCT02945410|583238880|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
161502997|NCT02945410|583238881|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
161502998|NCT02945410|583238882|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
161502999|NCT02945410|583238883|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
161503000|NCT02945410|583238884|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
161503001|NCT02945410|583238885|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
161503002|NCT02945410|583238880|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
161503003|NCT02945410|583238881|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
161503004|NCT02945410|583238882|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
161503005|NCT02945410|583238883|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
161503006|NCT02945410|583238884|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
161503007|NCT02945410|583238885|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
161503008|NCT00110812|583238886|FG000|Main Study|Death|0|||
161503009|NCT00110812|583238887|FG001|Main Study|Death|0|||
161503010|NCT00110812|583238888|FG002|Main Study|Death|2|||
161503011|NCT00110812|583238886|FG000|Main Study|Withdrawal by Subject|0|||
161503012|NCT00110812|583238887|FG001|Main Study|Withdrawal by Subject|0|||
161503013|NCT00110812|583238888|FG002|Main Study|Withdrawal by Subject|1|||
161503014|NCT00110812|583238886|FG000|Main Study|Lost to Follow-up|8|||
161503015|NCT00110812|583238887|FG001|Main Study|Lost to Follow-up|11|||
161503016|NCT00110812|583238888|FG002|Main Study|Lost to Follow-up|10|||
161503017|NCT00110812|583238886|FG000|Extended Follow-up|Death|1|||
161503018|NCT00110812|583238887|FG001|Extended Follow-up|Death|0|||
161503019|NCT00110812|583238888|FG002|Extended Follow-up|Death|3|||
161503020|NCT00110812|583238886|FG000|Extended Follow-up|Withdrawal by Subject|0|||
161503021|NCT00110812|583238887|FG001|Extended Follow-up|Withdrawal by Subject|1|||
161503022|NCT00110812|583238888|FG002|Extended Follow-up|Withdrawal by Subject|0|||
161503023|NCT00110812|583238886|FG000|Extended Follow-up|Lost to Follow-up|1|||
161503024|NCT00110812|583238887|FG001|Extended Follow-up|Lost to Follow-up|3|||
161503025|NCT00110812|583238888|FG002|Extended Follow-up|Lost to Follow-up|1|||
161503026|NCT01886833|583238889|FG000|Overall Study|IgA not available from both periods|204|||
161503027|NCT01454726|583238890|FG000|Overall Study|Withdrawal by Subject|0|||
161503028|NCT01454726|583238891|FG001|Overall Study|Withdrawal by Subject|1|||
161503029|NCT04200248|583238892|FG000|Overall Study|Personal reasons|0|||
161503030|NCT04200248|583238893|FG001|Overall Study|Personal reasons|0|||
161503031|NCT04200248|583238894|FG002|Overall Study|Personal reasons|1|||
161503032|NCT04200248|583238892|FG000|Overall Study|Discontinued prior to treatment|3|||
161503033|NCT04200248|583238893|FG001|Overall Study|Discontinued prior to treatment|3|||
161503034|NCT04200248|583238894|FG002|Overall Study|Discontinued prior to treatment|2|||
161503035|NCT04476030|583238895|FG000|Overall Study|Withdrawal by Subject|20|||
161503036|NCT04476030|583238896|FG001|Overall Study|Withdrawal by Subject|16|||
161503037|NCT04476030|583238895|FG000|Overall Study|Adverse Event|10|||
161503038|NCT04476030|583238896|FG001|Overall Study|Adverse Event|11|||
161503039|NCT04476030|583238895|FG000|Overall Study|Lost to Follow-up|7|||
161673740|NCT01205438|583859885|FG000|Overall Study|Protocol Violation|2|||
161673741|NCT01205438|583859886|FG001|Overall Study|Protocol Violation|7|||
161673742|NCT01205438|583859887|FG002|Overall Study|Protocol Violation|4|||
161819669|NCT05330975|584381119|FG003|Primary|Physician Decision|0|||
161819670|NCT05330975|584381120|FG004|Primary|Physician Decision|1|||
161503040|NCT04476030|583238896|FG001|Overall Study|Lost to Follow-up|4|||
161503041|NCT04476030|583238895|FG000|Overall Study|Physician Decision|1|||
161503042|NCT04476030|583238896|FG001|Overall Study|Physician Decision|1|||
161503043|NCT04476030|583238895|FG000|Overall Study|Protocol Deviation|2|||
161503044|NCT04476030|583238896|FG001|Overall Study|Protocol Deviation|0|||
161503045|NCT04476030|583238895|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
161503046|NCT04476030|583238896|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
161503047|NCT04476030|583238895|FG000|Overall Study|Randomized but not Dosed|2|||
161503048|NCT04476030|583238896|FG001|Overall Study|Randomized but not Dosed|8|||
161673743|NCT01205438|583859885|FG000|Overall Study|Sponsor Decision|0|||
161503049|NCT02342704|583238897|FG000|Overall Study|Physician Decision|0|||
161503050|NCT02342704|583238898|FG001|Overall Study|Physician Decision|3|||
161503051|NCT02342704|583238897|FG000|Overall Study|Sponsor Termination|49|||
161503052|NCT02342704|583238898|FG001|Overall Study|Sponsor Termination|43|||
161503053|NCT02342704|583238897|FG000|Overall Study|Other|0|||
161503054|NCT02342704|583238898|FG001|Overall Study|Other|1|||
161503055|NCT02342704|583238897|FG000|Overall Study|Withdrawal by Subject|1|||
161503056|NCT02342704|583238898|FG001|Overall Study|Withdrawal by Subject|0|||
161503057|NCT02342704|583238897|FG000|Overall Study|Lost to Follow-up|2|||
161503058|NCT02342704|583238898|FG001|Overall Study|Lost to Follow-up|1|||
161503059|NCT02342704|583238897|FG000|Overall Study|Adverse Event|1|||
161503060|NCT02342704|583238898|FG001|Overall Study|Adverse Event|3|||
161503061|NCT00302003|583238899|FG000|Overall Study|Lack of Efficacy|62|||
161503062|NCT00302003|583238899|FG000|Overall Study|Lost to Follow-up|1|||
161503063|NCT00302003|583238899|FG000|Overall Study|Physician Decision|2|||
161503064|NCT00302003|583238899|FG000|Overall Study|Withdrawal by Subject|5|||
161503065|NCT00302003|583238899|FG000|Overall Study|Ineligible|9|||
161503066|NCT00302003|583238899|FG000|Overall Study|Protocol Violation|1|||
161503067|NCT02042924|583238900|FG000|Overall Study|Early Death|1|||
161503068|NCT04033003|583238903|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
161503069|NCT04033003|583238904|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
161503070|NCT04033003|583238903|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
161503071|NCT04033003|583238904|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
161503072|NCT04033003|583238903|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
161503073|NCT04033003|583238904|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
161503074|NCT04033003|583238903|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
161503075|NCT04033003|583238904|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
161503076|NCT04033003|583238903|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
161503077|NCT04033003|583238904|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
161503078|NCT04033003|583238903|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
161503079|NCT04033003|583238904|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
161503080|NCT04033003|583238903|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
161503081|NCT04033003|583238904|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
161503082|NCT04033003|583238903|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
161503083|NCT04033003|583238904|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
161503084|NCT04033003|583238903|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
161503085|NCT04033003|583238904|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
161503086|NCT04033003|583238903|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
161503087|NCT04033003|583238904|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
161503088|NCT04033003|583238903|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
161503089|NCT04033003|583238904|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
161503090|NCT04033003|583238903|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
161503091|NCT04033003|583238904|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
161503092|NCT04033003|583238903|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
161503093|NCT04033003|583238904|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
161503094|NCT02919670|583238905|FG000|Overall Study|Only 17 participants met compliance|43|||
161503095|NCT02919670|583238906|FG001|Overall Study|Only 17 participants met compliance|39|||
161503096|NCT02256891|583238907|FG000|Overall Study|Death|0|||
161503097|NCT02256891|583238908|FG001|Overall Study|Death|2|||
161503098|NCT02256891|583238907|FG000|Overall Study|Lost to Follow-up|0|||
161503099|NCT02256891|583238908|FG001|Overall Study|Lost to Follow-up|3|||
161503100|NCT02256891|583238907|FG000|Overall Study|Physician Decision|7|||
161503101|NCT02256891|583238908|FG001|Overall Study|Physician Decision|3|||
161503102|NCT02256891|583238907|FG000|Overall Study|Screen Fail|5|||
161503103|NCT02256891|583238908|FG001|Overall Study|Screen Fail|4|||
161503104|NCT02256891|583238907|FG000|Overall Study|Equipment Malfunction|0|||
161819671|NCT05330975|584381121|FG005|Primary|Physician Decision|0|||
161819672|NCT05330975|584381122|FG006|Primary|Physician Decision|0|||
161819673|NCT05330975|584381116|FG000|Revaccination|Adverse Event|0|||
161819674|NCT05330975|584381117|FG001|Revaccination|Adverse Event|0|||
161819675|NCT05330975|584381118|FG002|Revaccination|Adverse Event|0|||
161819676|NCT05330975|584381119|FG003|Revaccination|Adverse Event|0|||
161819677|NCT05330975|584381120|FG004|Revaccination|Adverse Event|0|||
161503105|NCT02256891|583238908|FG001|Overall Study|Equipment Malfunction|1|||
161819678|NCT05330975|584381121|FG005|Revaccination|Adverse Event|0|||
161503106|NCT01675882|583238913|FG000|Overall Study|Adverse Event|0|||
161503107|NCT01675882|583238914|FG001|Overall Study|Adverse Event|2|||
161503108|NCT01675882|583238915|FG002|Overall Study|Adverse Event|1|||
161503109|NCT01675882|583238916|FG003|Overall Study|Adverse Event|0|||
161503110|NCT01675882|583238913|FG000|Overall Study|Participant unwilling to continue|2|||
161503111|NCT01675882|583238914|FG001|Overall Study|Participant unwilling to continue|4|||
161503112|NCT01675882|583238915|FG002|Overall Study|Participant unwilling to continue|2|||
161503113|NCT01675882|583238916|FG003|Overall Study|Participant unwilling to continue|1|||
161503114|NCT01675882|583238913|FG000|Overall Study|Lost to Follow-up|0|||
161503115|NCT01675882|583238914|FG001|Overall Study|Lost to Follow-up|1|||
161586105|NCT05338086|583534147|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161586106|NCT05338086|583534143|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
161586107|NCT05338086|583534144|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
161503116|NCT01675882|583238915|FG002|Overall Study|Lost to Follow-up|0|||
161503117|NCT01675882|583238916|FG003|Overall Study|Lost to Follow-up|0|||
161503118|NCT01675882|583238913|FG000|Overall Study|Non-compliance|0|||
161503119|NCT01675882|583238914|FG001|Overall Study|Non-compliance|0|||
161503120|NCT01675882|583238915|FG002|Overall Study|Non-compliance|0|||
161503121|NCT01675882|583238916|FG003|Overall Study|Non-compliance|1|||
161503122|NCT00735371|583238917|FG000|Overall Study|Adverse Event|3|||
161503123|NCT00735371|583238918|FG001|Overall Study|Adverse Event|3|||
161503124|NCT00735371|583238919|FG002|Overall Study|Adverse Event|4|||
161503125|NCT00735371|583238920|FG003|Overall Study|Adverse Event|1|||
161503126|NCT00735371|583238917|FG000|Overall Study|Protocol Violation|2|||
161503127|NCT00735371|583238918|FG001|Overall Study|Protocol Violation|2|||
161503128|NCT00735371|583238919|FG002|Overall Study|Protocol Violation|0|||
161503129|NCT00735371|583238920|FG003|Overall Study|Protocol Violation|3|||
161503130|NCT00735371|583238917|FG000|Overall Study|Withdrawal by Subject|0|||
161503131|NCT00735371|583238918|FG001|Overall Study|Withdrawal by Subject|2|||
161503132|NCT00735371|583238919|FG002|Overall Study|Withdrawal by Subject|2|||
161503133|NCT00735371|583238920|FG003|Overall Study|Withdrawal by Subject|0|||
161503134|NCT00735371|583238917|FG000|Overall Study|Lost to Follow-up|1|||
161503135|NCT00735371|583238918|FG001|Overall Study|Lost to Follow-up|1|||
161503136|NCT00735371|583238919|FG002|Overall Study|Lost to Follow-up|3|||
161503137|NCT00735371|583238920|FG003|Overall Study|Lost to Follow-up|1|||
161925628|NCT05537571|584773251|FG001|Overall Study|Hepatitis A screening result|0|||
161925629|NCT05537571|584773252|FG002|Overall Study|Hepatitis A screening result|0|||
161925630|NCT05537571|584773253|FG003|Overall Study|Hepatitis A screening result|0|||
161925631|NCT05537571|584773254|FG004|Overall Study|Hepatitis A screening result|0|||
161925632|NCT05537571|584773250|FG000|Overall Study|Lost to Follow-up|0|||
161925633|NCT05537571|584773251|FG001|Overall Study|Lost to Follow-up|0|||
161925634|NCT05537571|584773252|FG002|Overall Study|Lost to Follow-up|1|||
161925635|NCT05537571|584773253|FG003|Overall Study|Lost to Follow-up|0|||
161925636|NCT05537571|584773254|FG004|Overall Study|Lost to Follow-up|1|||
161925637|NCT00424008|584773255|FG000|Overall Study|Adverse Event|8|||
161925638|NCT00424008|584773256|FG001|Overall Study|Adverse Event|6|||
161925639|NCT00424008|584773255|FG000|Overall Study|Lack of Efficacy|40|||
161925640|NCT00424008|584773256|FG001|Overall Study|Lack of Efficacy|34|||
161925641|NCT00424008|584773255|FG000|Overall Study|Lost to Follow-up|1|||
161925642|NCT00424008|584773256|FG001|Overall Study|Lost to Follow-up|2|||
161925643|NCT00424008|584773255|FG000|Overall Study|Withdrawal by Subject|5|||
161925644|NCT00424008|584773256|FG001|Overall Study|Withdrawal by Subject|8|||
161925645|NCT00424008|584773255|FG000|Overall Study|Noncompliance with protocol|13|||
161925646|NCT00424008|584773256|FG001|Overall Study|Noncompliance with protocol|7|||
161925647|NCT00424008|584773255|FG000|Overall Study|Did not meet protocol eligibility|16|||
161503138|NCT00735371|583238917|FG000|Overall Study|Lack of Efficacy|4|||
161503139|NCT00735371|583238918|FG001|Overall Study|Lack of Efficacy|2|||
161503140|NCT00735371|583238919|FG002|Overall Study|Lack of Efficacy|0|||
161503141|NCT00735371|583238920|FG003|Overall Study|Lack of Efficacy|4|||
161503142|NCT00735371|583238917|FG000|Overall Study|Sponsor Decision|3|||
161503143|NCT00735371|583238918|FG001|Overall Study|Sponsor Decision|1|||
161503144|NCT00735371|583238919|FG002|Overall Study|Sponsor Decision|0|||
161503145|NCT00735371|583238920|FG003|Overall Study|Sponsor Decision|1|||
161503146|NCT00735371|583238917|FG000|Overall Study|Protocol Violation|0|||
161503147|NCT00735371|583238918|FG001|Overall Study|Protocol Violation|1|||
161503148|NCT00735371|583238919|FG002|Overall Study|Protocol Violation|2|||
161503149|NCT00735371|583238920|FG003|Overall Study|Protocol Violation|0|||
161503150|NCT00735371|583238917|FG000|Overall Study|Prior Vyvanse Exposure|1|||
161503151|NCT00735371|583238918|FG001|Overall Study|Prior Vyvanse Exposure|1|||
161503152|NCT00735371|583238919|FG002|Overall Study|Prior Vyvanse Exposure|0|||
161503153|NCT00735371|583238920|FG003|Overall Study|Prior Vyvanse Exposure|0|||
161503154|NCT00735371|583238917|FG000|Overall Study|Exclusion criteria|1|||
161503155|NCT00735371|583238918|FG001|Overall Study|Exclusion criteria|0|||
161586108|NCT05338086|583534145|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161586109|NCT05338086|583534146|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161586110|NCT05338086|583534147|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161586111|NCT05338086|583534143|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
161586112|NCT05338086|583534144|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
161586113|NCT05338086|583534145|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161586114|NCT05338086|583534146|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161586115|NCT05338086|583534147|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161586116|NCT05338086|583534143|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
161586117|NCT05338086|583534144|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161586118|NCT05338086|583534145|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161586119|NCT05338086|583534146|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161586120|NCT05338086|583534147|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161586121|NCT05338086|583534143|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
161673744|NCT01205438|583859886|FG001|Overall Study|Sponsor Decision|1|||
161673745|NCT01205438|583859887|FG002|Overall Study|Sponsor Decision|1|||
161673746|NCT00733304|583859891|FG000|Overall Study|Adverse Event|3|||
161673747|NCT00733304|583859892|FG001|Overall Study|Adverse Event|0|||
161673748|NCT00733304|583859893|FG002|Overall Study|Adverse Event|0|||
161673749|NCT00733304|583859891|FG000|Overall Study|Lack of Efficacy|0|||
161673750|NCT00733304|583859892|FG001|Overall Study|Lack of Efficacy|0|||
161673751|NCT00733304|583859893|FG002|Overall Study|Lack of Efficacy|2|||
161673752|NCT00733304|583859891|FG000|Overall Study|Lost to Follow-up|0|||
161673753|NCT00733304|583859892|FG001|Overall Study|Lost to Follow-up|1|||
161673754|NCT00733304|583859893|FG002|Overall Study|Lost to Follow-up|0|||
161673755|NCT00733304|583859891|FG000|Overall Study|Physician Decision|3|||
161503156|NCT00735371|583238919|FG002|Overall Study|Exclusion criteria|0|||
161503157|NCT00735371|583238920|FG003|Overall Study|Exclusion criteria|0|||
161503158|NCT01533246|583238925|FG000|Overall Study|Adverse Event|1|||
161503159|NCT01533246|583238925|FG000|Overall Study|Withdrawal by Subject|1|||
161503160|NCT01446965|583238926|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
161503161|NCT01446965|583238927|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
161503162|NCT01446965|583238926|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
161503163|NCT01446965|583238927|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
161503164|NCT02016482|583238937|FG000|Period A|Adverse Event|3|||
161503165|NCT02016482|583238938|FG001|Period A|Adverse Event|5|||
161503166|NCT02016482|583238937|FG000|Period A|Withdrawal by Subject|3|||
161503167|NCT02016482|583238938|FG001|Period A|Withdrawal by Subject|4|||
161503168|NCT02016482|583238937|FG000|Period A|Lost to Follow-up|3|||
161503169|NCT02016482|583238938|FG001|Period A|Lost to Follow-up|3|||
161503170|NCT02016482|583238937|FG000|Period A|Lack of Efficacy|2|||
161503171|NCT02016482|583238938|FG001|Period A|Lack of Efficacy|1|||
161503172|NCT02016482|583238937|FG000|Period A|Other|3|||
161503173|NCT02016482|583238938|FG001|Period A|Other|0|||
161503174|NCT02016482|583238937|FG000|Period A|Protocol Violation|0|||
161503175|NCT02016482|583238938|FG001|Period A|Protocol Violation|1|||
161503176|NCT02016482|583238937|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
161503177|NCT02016482|583238938|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
161503178|NCT02016482|583238937|FG000|Period B|Withdrawal by Subject|1|||
161503179|NCT02016482|583238938|FG001|Period B|Withdrawal by Subject|1|||
161503180|NCT02016482|583238937|FG000|Period B|Lost to Follow-up|2|||
161503181|NCT02016482|583238938|FG001|Period B|Lost to Follow-up|0|||
161503182|NCT02016482|583238937|FG000|Period B|Lack of Efficacy|6|||
161503183|NCT02016482|583238938|FG001|Period B|Lack of Efficacy|4|||
161673756|NCT00733304|583859892|FG001|Overall Study|Physician Decision|1|||
161673757|NCT00733304|583859893|FG002|Overall Study|Physician Decision|3|||
161503184|NCT02016482|583238937|FG000|Period B|Other|4|||
161503185|NCT02016482|583238938|FG001|Period B|Other|0|||
161503186|NCT02016482|583238937|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
161503187|NCT02016482|583238938|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
161503188|NCT03387813|583238939|FG000|Overall Study|Death|40|||
161503189|NCT03387813|583238940|FG001|Overall Study|Death|37|||
161503190|NCT03387813|583238941|FG002|Overall Study|Death|190|||
161503191|NCT03387813|583238939|FG000|Overall Study|Withdrawal by Subject|9|||
161503192|NCT03387813|583238940|FG001|Overall Study|Withdrawal by Subject|19|||
161503193|NCT03387813|583238941|FG002|Overall Study|Withdrawal by Subject|32|||
161503194|NCT03387813|583238939|FG000|Overall Study|Lost to Follow-up|3|||
161503195|NCT03387813|583238940|FG001|Overall Study|Lost to Follow-up|9|||
161503196|NCT03387813|583238941|FG002|Overall Study|Lost to Follow-up|15|||
161503197|NCT03387813|583238939|FG000|Overall Study|Non-Compliance|6|||
161503198|NCT03387813|583238940|FG001|Overall Study|Non-Compliance|6|||
161503199|NCT03387813|583238941|FG002|Overall Study|Non-Compliance|31|||
161503200|NCT03387813|583238939|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
161673758|NCT00733304|583859891|FG000|Overall Study|Withdrawal by Subject|1|||
161503201|NCT03387813|583238940|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
161503202|NCT03387813|583238941|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
161503203|NCT00606892|583238942|FG000|First Intervention|Protocol Violation|1|||
161503204|NCT00606892|583238943|FG001|First Intervention|Protocol Violation|4|||
161503205|NCT00855309|583238945|FG000|Overall Study|patient never recieved drug|1|||
161503206|NCT00855309|583238946|FG001|Overall Study|patient never recieved drug|0|||
161503207|NCT00829296|583238947|FG000|Overall Study|Adverse Event|5|||
161503208|NCT00829296|583238948|FG001|Overall Study|Adverse Event|4|||
161503209|NCT04960228|583238954|FG000|Overall Study|Withdrawal by Subject|216|||
161503210|NCT04960228|583238955|FG001|Overall Study|Withdrawal by Subject|35|||
161503211|NCT04960228|583238954|FG000|Overall Study|Failed attention check|69|||
161503212|NCT04960228|583238955|FG001|Overall Study|Failed attention check|148|||
161503213|NCT04960228|583238954|FG000|Overall Study|Flagged for response quality by Dynata|3|||
161503214|NCT04960228|583238955|FG001|Overall Study|Flagged for response quality by Dynata|3|||
161503215|NCT01987427|583238956|FG000|Overall Study|Adverse Event|4|||
161503216|NCT01987427|583238957|FG001|Overall Study|Adverse Event|2|||
161503217|NCT01987427|583238958|FG002|Overall Study|Adverse Event|8|||
161503218|NCT01987427|583238956|FG000|Overall Study|Lost to Follow-up|6|||
161503219|NCT01987427|583238957|FG001|Overall Study|Lost to Follow-up|6|||
161503220|NCT01987427|583238958|FG002|Overall Study|Lost to Follow-up|9|||
161503221|NCT01987427|583238956|FG000|Overall Study|Withdrawal by Subject|2|||
161503222|NCT01987427|583238957|FG001|Overall Study|Withdrawal by Subject|1|||
161503223|NCT01987427|583238958|FG002|Overall Study|Withdrawal by Subject|3|||
161503224|NCT01987427|583238956|FG000|Overall Study|Lack of Efficacy|1|||
161503225|NCT01987427|583238957|FG001|Overall Study|Lack of Efficacy|0|||
161503226|NCT01987427|583238958|FG002|Overall Study|Lack of Efficacy|0|||
161503227|NCT01987427|583238956|FG000|Overall Study|Other|1|||
161503228|NCT01987427|583238957|FG001|Overall Study|Other|1|||
161503229|NCT01987427|583238958|FG002|Overall Study|Other|0|||
161503230|NCT02547129|583238963|FG000|Overall Study|Difficulty with ongoing infection|1|||
161503231|NCT02547129|583238964|FG001|Overall Study|Difficulty with ongoing infection|0|||
161503232|NCT00794196|583238966|FG000|Overall Study|Lost to Follow-up|5|||
161503233|NCT00794196|583238967|FG001|Overall Study|Lost to Follow-up|23|||
161503234|NCT02129803|583238968|FG000|Overall Study|Protocol Violation|4|||
161503235|NCT02129803|583238969|FG001|Overall Study|Protocol Violation|0|||
161503236|NCT02129803|583238968|FG000|Overall Study|Physician Decision|0|||
161503237|NCT02129803|583238969|FG001|Overall Study|Physician Decision|1|||
161503238|NCT02129803|583238968|FG000|Overall Study|Difficulty sleeping|1|||
161503239|NCT02129803|583238969|FG001|Overall Study|Difficulty sleeping|0|||
161503240|NCT02129803|583238968|FG000|Overall Study|Morning headache|0|||
161503241|NCT02129803|583238969|FG001|Overall Study|Morning headache|1|||
161503242|NCT02129803|583238968|FG000|Overall Study|Withdrawal by Subject|1|||
161503243|NCT02129803|583238969|FG001|Overall Study|Withdrawal by Subject|1|||
161503244|NCT02319031|583238970|FG000|Treatment Period|Death|1|||
161503245|NCT02319031|583238971|FG001|Treatment Period|Death|0|||
161503246|NCT01640366|583238976|FG000|Overall Study|Withdrawal by Subject|1|||
161503247|NCT01640366|583238976|FG000|Overall Study|Protocol Violation|16|||
161503248|NCT01640366|583238976|FG000|Overall Study|Lost to Follow-up|5|||
161673759|NCT00733304|583859892|FG001|Overall Study|Withdrawal by Subject|1|||
161673760|NCT00733304|583859893|FG002|Overall Study|Withdrawal by Subject|0|||
161503249|NCT02739269|583238977|FG000|Overall Study|Protocol Violation|5|||
161503250|NCT02739269|583238978|FG001|Overall Study|Protocol Violation|0|||
161503251|NCT02739269|583238977|FG000|Overall Study|Cycle cancellation|2|||
161503252|NCT02739269|583238978|FG001|Overall Study|Cycle cancellation|2|||
161503253|NCT02739269|583238977|FG000|Overall Study|Withdrawal by Subject|0|||
161503254|NCT02739269|583238978|FG001|Overall Study|Withdrawal by Subject|2|||
161503255|NCT01070316|583238982|FG000|Extension Phase|Lack of Efficacy|3|||
161503256|NCT01070316|583238982|FG000|Extension Phase|Withdrawal by Subject|1|||
161503257|NCT02013167|583238983|FG000|Overall Study|Withdrawal by Subject|15|||
161673761|NCT00528567|583859894|FG000|Overall Study|Death|4|||
161673762|NCT00528567|583859895|FG001|Overall Study|Death|5|||
161673763|NCT00528567|583859894|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
161673764|NCT00528567|583859895|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
161673765|NCT00528567|583859894|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
161673766|NCT00528567|583859895|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
161673767|NCT00528567|583859894|FG000|Overall Study|Violation Criteria at Entry|3|||
161673768|NCT00528567|583859895|FG001|Overall Study|Violation Criteria at Entry|17|||
161673769|NCT00528567|583859894|FG000|Overall Study|Withdrew Consent|59|||
161673770|NCT00528567|583859895|FG001|Overall Study|Withdrew Consent|55|||
161673771|NCT00528567|583859894|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
161673772|NCT00528567|583859895|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
161673773|NCT00528567|583859894|FG000|Overall Study|Failure to Return|1|||
161673774|NCT00528567|583859895|FG001|Overall Study|Failure to Return|4|||
161673775|NCT00528567|583859894|FG000|Overall Study|Other Protocol Violation|5|||
161673776|NCT00528567|583859895|FG001|Overall Study|Other Protocol Violation|21|||
161673777|NCT00528567|583859894|FG000|Overall Study|Administrative/Other|22|||
161673778|NCT00528567|583859895|FG001|Overall Study|Administrative/Other|75|||
161925648|NCT00424008|584773256|FG001|Overall Study|Did not meet protocol eligibility|21|||
161925649|NCT00424008|584773255|FG000|Overall Study|Administrative|266|||
161925650|NCT00424008|584773256|FG001|Overall Study|Administrative|257|||
161925651|NCT02530242|584773260|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
161925652|NCT02530242|584773261|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
161925653|NCT00283959|584773262|FG000|Extension Period|Low Compliance|1|||
161925654|NCT02665455|584773265|FG000|Overall Study|Withdrawal by Subject|6|||
161673779|NCT01122576|583859898|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
161673780|NCT01122576|583859899|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
161673781|NCT01122576|583859900|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
161673782|NCT01122576|583859898|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
161673783|NCT01122576|583859899|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
161673784|NCT01122576|583859900|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
161503258|NCT02013167|583238984|FG001|Overall Study|Withdrawal by Subject|14|||
161503259|NCT02013167|583238983|FG000|Overall Study|Sponsor Decision|1|||
161673785|NCT01122576|583859898|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
161925655|NCT02665455|584773265|FG000|Overall Study|Lost to Follow-up|1|||
161925656|NCT02665455|584773265|FG000|Overall Study|Adverse Event|1|||
161925657|NCT02665455|584773265|FG000|Overall Study|Protocol Violation|1|||
161925658|NCT06991803|584773266|FG000|Overall Study|Lost to Follow-up|0|||
161925659|NCT06991803|584773267|FG001|Overall Study|Lost to Follow-up|4|||
161925660|NCT06991803|584773268|FG002|Overall Study|Lost to Follow-up|0|||
161925661|NCT06991803|584773269|FG003|Overall Study|Lost to Follow-up|3|||
161925662|NCT06991803|584773270|FG004|Overall Study|Lost to Follow-up|2|||
161925663|NCT06991803|584773271|FG005|Overall Study|Lost to Follow-up|5|||
161925664|NCT05865886|584773272|FG000|Overall Study|Serious adverse event|0|||
161925665|NCT05865886|584773273|FG001|Overall Study|Serious adverse event|1|||
161925666|NCT01671059|584773274|FG000|Overall Study|Adverse Event|4|||
161925667|NCT01671059|584773274|FG000|Overall Study|Lack of Efficacy|1|||
161925668|NCT02564978|584773277|FG000|Overall Study|Adverse Event|8|||
161925669|NCT02564978|584773277|FG000|Overall Study|Death|1|||
161925670|NCT02564978|584773277|FG000|Overall Study|Lost to Follow-up|1|||
161925671|NCT02564978|584773277|FG000|Overall Study|Withdrawal by Subject|15|||
161925672|NCT02564978|584773277|FG000|Overall Study|Early Study Closure|2|||
161925673|NCT02564978|584773277|FG000|Overall Study|Other Reason|5|||
161925674|NCT04971837|584774565|FG000|Overall Study|Long Term Illness|1|||
161925675|NCT04971837|584774565|FG000|Overall Study|BMI too low|9|||
161925676|NCT04971837|584774565|FG000|Overall Study|geographic location|1|||
161925677|NCT04971837|584774565|FG000|Overall Study|Discontinued scheduling conflict|1|||
161925678|NCT03166631|584774566|FG000|Overall Study|Progressive disease|2|||
161925679|NCT03166631|584774567|FG001|Overall Study|Progressive disease|1|||
161925680|NCT03166631|584774568|FG002|Overall Study|Progressive disease|3|||
161925681|NCT03166631|584774569|FG003|Overall Study|Progressive disease|4|||
161673786|NCT01122576|583859899|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
161673787|NCT01122576|583859900|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
161925682|NCT03166631|584774570|FG004|Overall Study|Progressive disease|2|||
161925683|NCT03166631|584774571|FG005|Overall Study|Progressive disease|2|||
161925684|NCT03166631|584774572|FG006|Overall Study|Progressive disease|5|||
161925685|NCT03166631|584774573|FG007|Overall Study|Progressive disease|6|||
161925686|NCT03166631|584774574|FG008|Overall Study|Progressive disease|11|||
161503260|NCT02013167|583238984|FG001|Overall Study|Sponsor Decision|3|||
161503261|NCT02013167|583238983|FG000|Overall Study|Lost to Follow-up|0|||
161503262|NCT02013167|583238984|FG001|Overall Study|Lost to Follow-up|1|||
161503263|NCT02013167|583238983|FG000|Overall Study|Death|85|||
161503264|NCT02013167|583238984|FG001|Overall Study|Death|160|||
161503265|NCT01113879|583238989|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
161503266|NCT01113879|583238990|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
161503267|NCT00082433|583238994|FG000|Overall Study|Adverse Event|12|||
161503268|NCT00082433|583238995|FG001|Overall Study|Adverse Event|17|||
161503269|NCT00082433|583238994|FG000|Overall Study|Death|8|||
161503270|NCT00082433|583238995|FG001|Overall Study|Death|18|||
161503271|NCT00082433|583238994|FG000|Overall Study|Disease Progression/Relapse|270|||
161503272|NCT00082433|583238995|FG001|Overall Study|Disease Progression/Relapse|388|||
161503273|NCT00082433|583238994|FG000|Overall Study|Physician Decision|50|||
161503274|NCT00082433|583238995|FG001|Overall Study|Physician Decision|61|||
161503275|NCT00082433|583238994|FG000|Overall Study|Lost to Follow-up|1|||
161503276|NCT00082433|583238995|FG001|Overall Study|Lost to Follow-up|2|||
161503277|NCT00082433|583238994|FG000|Overall Study|Study Drug Toxicity|179|||
161503278|NCT00082433|583238995|FG001|Overall Study|Study Drug Toxicity|66|||
161503279|NCT00082433|583238994|FG000|Overall Study|Withdrawal by Subject|55|||
161503280|NCT00082433|583238995|FG001|Overall Study|Withdrawal by Subject|30|||
161503281|NCT00082433|583238994|FG000|Overall Study|Still On Treatment|2|||
161503282|NCT00082433|583238995|FG001|Overall Study|Still On Treatment|1|||
161503283|NCT00082433|583238994|FG000|Overall Study|Not Treated|12|||
161503284|NCT00082433|583238995|FG001|Overall Study|Not Treated|11|||
161503285|NCT00082433|583238994|FG000|Overall Study|Ineligible|2|||
161503286|NCT00082433|583238995|FG001|Overall Study|Ineligible|1|||
161503287|NCT00082433|583238994|FG000|Overall Study|Noncompliance|2|||
161503288|NCT00082433|583238995|FG001|Overall Study|Noncompliance|1|||
161503289|NCT00082433|583238994|FG000|Overall Study|New primary cancer|1|||
161503290|NCT00082433|583238995|FG001|Overall Study|New primary cancer|0|||
161503291|NCT00082433|583238994|FG000|Overall Study|Impending surgery|0|||
161503292|NCT00082433|583238995|FG001|Overall Study|Impending surgery|1|||
161503293|NCT01796197|583238998|FG000|Overall Study|Lost to Follow-up|1|||
161503294|NCT01796197|583238998|FG000|Overall Study|Lack of Efficacy|1|||
161503295|NCT04097821|583238999|FG000|Overall Study|Subject Decision|0|||
161503296|NCT04097821|583239000|FG001|Overall Study|Subject Decision|0|||
161503297|NCT04097821|583239001|FG002|Overall Study|Subject Decision|0|||
161503298|NCT04097821|583239002|FG003|Overall Study|Subject Decision|1|||
161503299|NCT04097821|583239003|FG004|Overall Study|Subject Decision|2|||
161503300|NCT04097821|583239004|FG005|Overall Study|Subject Decision|2|||
161503301|NCT04097821|583239005|FG006|Overall Study|Subject Decision|0|||
161503302|NCT04097821|583239006|FG007|Overall Study|Subject Decision|1|||
161503303|NCT04097821|583238999|FG000|Overall Study|Death|0|||
161503304|NCT04097821|583239000|FG001|Overall Study|Death|0|||
161503305|NCT04097821|583239001|FG002|Overall Study|Death|3|||
161503306|NCT04097821|583239002|FG003|Overall Study|Death|1|||
161503307|NCT04097821|583239003|FG004|Overall Study|Death|0|||
161503308|NCT04097821|583239004|FG005|Overall Study|Death|0|||
161503309|NCT04097821|583239005|FG006|Overall Study|Death|0|||
161503310|NCT04097821|583239006|FG007|Overall Study|Death|0|||
161503311|NCT04097821|583238999|FG000|Overall Study|Physician Decision|1|||
161503312|NCT04097821|583239000|FG001|Overall Study|Physician Decision|2|||
161503313|NCT04097821|583239001|FG002|Overall Study|Physician Decision|0|||
161503314|NCT04097821|583239002|FG003|Overall Study|Physician Decision|0|||
161503315|NCT04097821|583239003|FG004|Overall Study|Physician Decision|0|||
161503316|NCT04097821|583239004|FG005|Overall Study|Physician Decision|0|||
161503317|NCT04097821|583239005|FG006|Overall Study|Physician Decision|0|||
161503318|NCT04097821|583239006|FG007|Overall Study|Physician Decision|0|||
161503319|NCT04097821|583238999|FG000|Overall Study|Adverse Event|0|||
161503320|NCT04097821|583239000|FG001|Overall Study|Adverse Event|0|||
161503321|NCT04097821|583239001|FG002|Overall Study|Adverse Event|1|||
161503322|NCT04097821|583239002|FG003|Overall Study|Adverse Event|1|||
161503323|NCT04097821|583239003|FG004|Overall Study|Adverse Event|0|||
161503324|NCT04097821|583239004|FG005|Overall Study|Adverse Event|0|||
161503325|NCT04097821|583239005|FG006|Overall Study|Adverse Event|0|||
161503326|NCT04097821|583239006|FG007|Overall Study|Adverse Event|0|||
161503327|NCT04097821|583238999|FG000|Overall Study|New Therapy For Study Indication|0|||
161503328|NCT04097821|583239000|FG001|Overall Study|New Therapy For Study Indication|0|||
161503329|NCT04097821|583239001|FG002|Overall Study|New Therapy For Study Indication|0|||
161503330|NCT04097821|583239002|FG003|Overall Study|New Therapy For Study Indication|0|||
161503331|NCT04097821|583239003|FG004|Overall Study|New Therapy For Study Indication|0|||
161503332|NCT04097821|583239004|FG005|Overall Study|New Therapy For Study Indication|0|||
161503333|NCT04097821|583239005|FG006|Overall Study|New Therapy For Study Indication|1|||
161503334|NCT04097821|583239006|FG007|Overall Study|New Therapy For Study Indication|0|||
161503335|NCT00244712|583239010|FG000|Overall Study|Adverse Event|20|||
161503336|NCT00244712|583239011|FG001|Overall Study|Adverse Event|21|||
161503337|NCT00244712|583239010|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
161503338|NCT00244712|583239011|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
161503339|NCT00244712|583239010|FG000|Overall Study|Lack of Compliance|10|||
161503340|NCT00244712|583239011|FG001|Overall Study|Lack of Compliance|11|||
161503341|NCT00244712|583239010|FG000|Overall Study|Lost to Follow-up|45|||
161503342|NCT00244712|583239011|FG001|Overall Study|Lost to Follow-up|52|||
161503343|NCT00244712|583239010|FG000|Overall Study|Withdrawal by Subject|13|||
161503344|NCT00244712|583239011|FG001|Overall Study|Withdrawal by Subject|23|||
161503345|NCT00244712|583239010|FG000|Overall Study|Protocol Violation, disease progression|13|||
161503346|NCT00244712|583239011|FG001|Overall Study|Protocol Violation, disease progression|11|||
161503347|NCT01077804|583239014|FG000|Overall Study|Unreachable|102|||
161503348|NCT01077804|583239014|FG000|Overall Study|Refused to continue|79|||
161503349|NCT01077804|583239014|FG000|Overall Study|Other|18|||
161503350|NCT02776917|583239015|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
161503351|NCT02620046|583239017|FG000|Overall Study|Adverse Event|22|||
161503352|NCT02620046|583239018|FG001|Overall Study|Adverse Event|42|||
161503353|NCT02620046|583239017|FG000|Overall Study|Lost to Follow-up|4|||
161503354|NCT02620046|583239018|FG001|Overall Study|Lost to Follow-up|10|||
161503355|NCT02620046|583239017|FG000|Overall Study|Withdrawal by Subject|36|||
161503356|NCT02620046|583239018|FG001|Overall Study|Withdrawal by Subject|66|||
161503357|NCT02620046|583239017|FG000|Overall Study|Site Termination|3|||
161503358|NCT02620046|583239018|FG001|Overall Study|Site Termination|3|||
161503359|NCT02620046|583239017|FG000|Overall Study|Pregnancy|3|||
161503360|NCT02620046|583239018|FG001|Overall Study|Pregnancy|7|||
161503361|NCT02620046|583239017|FG000|Overall Study|Lack of Efficacy|81|||
161503362|NCT02620046|583239018|FG001|Overall Study|Lack of Efficacy|146|||
161503363|NCT02620046|583239017|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
161503364|NCT02620046|583239018|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
161503365|NCT02620046|583239017|FG000|Overall Study|Reason Not Specified|13|||
161503366|NCT02620046|583239018|FG001|Overall Study|Reason Not Specified|21|||
161503367|NCT02620046|583239017|FG000|Overall Study|Significant Protocol Deviation|0|||
161503368|NCT02620046|583239018|FG001|Overall Study|Significant Protocol Deviation|1|||
161503369|NCT00560950|583239021|FG000|Overall Study|Lost to Follow-up|1|||
161503370|NCT00560950|583239022|FG001|Overall Study|Lost to Follow-up|0|||
161503371|NCT00574405|583240697|FG000|Overall Study|Withdrawal by Subject|3|||
161503372|NCT00574405|583240698|FG001|Overall Study|Withdrawal by Subject|2|||
161503373|NCT01336738|583240699|FG000|Overall Study|Adverse Event|0|||
161503374|NCT01336738|583240700|FG001|Overall Study|Adverse Event|3|||
161503375|NCT01336738|583240701|FG002|Overall Study|Adverse Event|2|||
161503376|NCT01336738|583240702|FG003|Overall Study|Adverse Event|1|||
161503377|NCT01336738|583240703|FG004|Overall Study|Adverse Event|3|||
161503378|NCT01336738|583240699|FG000|Overall Study|Lost to Follow-up|2|||
161503379|NCT01336738|583240700|FG001|Overall Study|Lost to Follow-up|1|||
161503380|NCT01336738|583240701|FG002|Overall Study|Lost to Follow-up|2|||
161503381|NCT01336738|583240702|FG003|Overall Study|Lost to Follow-up|2|||
161503382|NCT01336738|583240703|FG004|Overall Study|Lost to Follow-up|2|||
161503383|NCT01336738|583240699|FG000|Overall Study|Did not meet entrance criteria|0|||
161503384|NCT01336738|583240700|FG001|Overall Study|Did not meet entrance criteria|1|||
161503385|NCT01336738|583240701|FG002|Overall Study|Did not meet entrance criteria|0|||
161503386|NCT01336738|583240702|FG003|Overall Study|Did not meet entrance criteria|0|||
161503387|NCT01336738|583240703|FG004|Overall Study|Did not meet entrance criteria|0|||
161503388|NCT01336738|583240699|FG000|Overall Study|Protocol Violation|0|||
161503389|NCT01336738|583240700|FG001|Overall Study|Protocol Violation|1|||
161503390|NCT01336738|583240701|FG002|Overall Study|Protocol Violation|0|||
161503391|NCT01336738|583240702|FG003|Overall Study|Protocol Violation|0|||
161503392|NCT01336738|583240703|FG004|Overall Study|Protocol Violation|0|||
161503393|NCT01336738|583240699|FG000|Overall Study|Withdrawal by Subject|2|||
161503394|NCT01336738|583240700|FG001|Overall Study|Withdrawal by Subject|0|||
161503395|NCT01336738|583240701|FG002|Overall Study|Withdrawal by Subject|2|||
161503396|NCT01336738|583240702|FG003|Overall Study|Withdrawal by Subject|1|||
161503397|NCT01336738|583240703|FG004|Overall Study|Withdrawal by Subject|1|||
161673788|NCT05696236|583859901|FG000|Overall Study|Lost to Follow-up|1|||
161673789|NCT05696236|583859902|FG001|Overall Study|Lost to Follow-up|0|||
161673790|NCT05696236|583859901|FG000|Overall Study|Later determined to not be eligible for participation|0|||
161673791|NCT05696236|583859902|FG001|Overall Study|Later determined to not be eligible for participation|1|||
161503398|NCT01336738|583240699|FG000|Overall Study|Other|3|||
161503399|NCT01336738|583240700|FG001|Overall Study|Other|3|||
161503400|NCT01336738|583240701|FG002|Overall Study|Other|2|||
161503401|NCT01336738|583240702|FG003|Overall Study|Other|3|||
161673792|NCT05696236|583859901|FG000|Overall Study|Withdrawal by Subject|2|||
161673793|NCT05696236|583859902|FG001|Overall Study|Withdrawal by Subject|2|||
161503402|NCT01336738|583240703|FG004|Overall Study|Other|4|||
161503403|NCT01083433|583240704|FG000|Overall Study|Lost to Follow-up|2|||
161503404|NCT01083433|583240705|FG001|Overall Study|Lost to Follow-up|1|||
161503405|NCT01083433|583240706|FG002|Overall Study|Lost to Follow-up|1|||
161503406|NCT01083433|583240704|FG000|Overall Study|Withdrawal by Subject|0|||
161503407|NCT01083433|583240705|FG001|Overall Study|Withdrawal by Subject|5|||
161503408|NCT01083433|583240706|FG002|Overall Study|Withdrawal by Subject|3|||
161503409|NCT01083433|583240704|FG000|Overall Study|Pregnancy|0|||
161673794|NCT01829360|583859905|FG000|Overall Study|Protocol Violation|0|||
161503410|NCT01083433|583240705|FG001|Overall Study|Pregnancy|0|||
161503411|NCT01083433|583240706|FG002|Overall Study|Pregnancy|1|||
161503412|NCT02970968|583240708|FG000|Overall Study|Withdrawal by Subject|3|||
161503413|NCT02970968|583240709|FG001|Overall Study|Withdrawal by Subject|3|||
161503414|NCT02970968|583240708|FG000|Overall Study|Adverse Event|1|||
161503415|NCT02970968|583240709|FG001|Overall Study|Adverse Event|2|||
161503416|NCT02970968|583240708|FG000|Overall Study|Lost to Follow-up|1|||
161503417|NCT02970968|583240709|FG001|Overall Study|Lost to Follow-up|1|||
161503418|NCT02970968|583240708|FG000|Overall Study|Non-Compliance|0|||
161503419|NCT02970968|583240709|FG001|Overall Study|Non-Compliance|1|||
161503420|NCT03003520|583240710|FG000|Overall Study|Adverse Event|9|||
161503421|NCT03003520|583240711|FG001|Overall Study|Adverse Event|0|||
161503422|NCT03003520|583240710|FG000|Overall Study|Death|1|||
161503423|NCT03003520|583240711|FG001|Overall Study|Death|0|||
161503424|NCT03003520|583240710|FG000|Overall Study|Other reasons|4|||
161503425|NCT03003520|583240711|FG001|Overall Study|Other reasons|0|||
161503426|NCT03003520|583240710|FG000|Overall Study|Withdrawal by Subject|6|||
161503427|NCT03003520|583240711|FG001|Overall Study|Withdrawal by Subject|0|||
161503428|NCT03003520|583240710|FG000|Overall Study|Progressive disease|9|||
161503429|NCT03003520|583240711|FG001|Overall Study|Progressive disease|1|||
161503430|NCT01332149|583240712|FG000|Overall Study|Adverse Event|11|||
161503431|NCT01332149|583240713|FG001|Overall Study|Adverse Event|9|||
161503432|NCT01332149|583240712|FG000|Overall Study|Other unspecified|5|||
161503433|NCT01332149|583240713|FG001|Overall Study|Other unspecified|7|||
161503434|NCT01332149|583240712|FG000|Overall Study|Protocol Violation|1|||
161503435|NCT01332149|583240713|FG001|Overall Study|Protocol Violation|3|||
161503436|NCT01332149|583240712|FG000|Overall Study|Withdrawal by Subject|4|||
161503437|NCT01332149|583240713|FG001|Overall Study|Withdrawal by Subject|5|||
161503438|NCT01332149|583240712|FG000|Overall Study|Lost to Follow-up|1|||
161503439|NCT01332149|583240713|FG001|Overall Study|Lost to Follow-up|1|||
161503440|NCT01332149|583240712|FG000|Overall Study|Insufficient clinical response|4|||
161503441|NCT01332149|583240713|FG001|Overall Study|Insufficient clinical response|7|||
161503442|NCT01332149|583240712|FG000|Overall Study|Did not meet entrance criteria|3|||
161503443|NCT01332149|583240713|FG001|Overall Study|Did not meet entrance criteria|4|||
161503444|NCT01332149|583240712|FG000|Overall Study|Randomized but not treated|1|||
161503445|NCT01332149|583240713|FG001|Overall Study|Randomized but not treated|2|||
161503446|NCT04982029|583240714|FG000|Overall Study|Lost to Follow-up|2|||
161503447|NCT04982029|583240715|FG001|Overall Study|Lost to Follow-up|3|||
161503448|NCT03264404|583240716|FG000|Overall Study|Death|2|||
161503449|NCT03264404|583240716|FG000|Overall Study|Physician Decision|1|||
161503450|NCT03264404|583240716|FG000|Overall Study|Disease Progression|28|||
161503451|NCT03264404|583240716|FG000|Overall Study|Adverse Event|1|||
161503452|NCT03264404|583240716|FG000|Overall Study|Off study prior to treatment|2|||
161503453|NCT02565381|583240717|FG000|Overall Study|Lost to Follow-up|1|||
161503454|NCT02565381|583240718|FG001|Overall Study|Lost to Follow-up|0|||
161503455|NCT02565381|583240719|FG002|Overall Study|Lost to Follow-up|1|||
161503456|NCT04615949|583240722|FG000|Overall Study|Withdrawal by Subject|2|||
161503457|NCT04615949|583240723|FG001|Overall Study|Withdrawal by Subject|4|||
161503458|NCT04615949|583240722|FG000|Overall Study|Lost to Follow-up|2|||
161503459|NCT04615949|583240723|FG001|Overall Study|Lost to Follow-up|2|||
161503460|NCT04615949|583240722|FG000|Overall Study|Death|0|||
161503461|NCT04615949|583240723|FG001|Overall Study|Death|2|||
161673795|NCT01829360|583859906|FG001|Overall Study|Protocol Violation|0|||
161673796|NCT01829360|583859907|FG002|Overall Study|Protocol Violation|1|||
161673797|NCT01829360|583859908|FG003|Overall Study|Protocol Violation|0|||
161673798|NCT02545322|583859909|FG000|Overall Study|Withdrawal by Subject|3|||
161673799|NCT00041067|583859910|FG000|Overall Study|Adverse Event|20|||
161673800|NCT00041067|583859910|FG000|Overall Study|Progression|19|||
161673801|NCT00041067|583859910|FG000|Overall Study|Patient refusal|12|||
161673802|NCT00041067|583859910|FG000|Overall Study|Other reasons|23|||
161503462|NCT03036566|583240724|FG000|Overall Study|Lost to Follow-up|3|||
161503463|NCT05458856|583240725|FG000|Overall Study|Withdrawal by Subject|5|||
161503464|NCT05458856|583240725|FG000|Overall Study|Death|4|||
161503465|NCT05458856|583240725|FG000|Overall Study|Protocol Deviation|3|||
161673803|NCT00041067|583859910|FG000|Overall Study|Ineligible|2|||
161503466|NCT05458856|583240725|FG000|Overall Study|Physician Decision|1|||
161503467|NCT01852292|583240729|FG000|Overall Study|Untreated - did not receive study drug|3|||
161503468|NCT01852292|583240730|FG001|Overall Study|Untreated - did not receive study drug|1|||
161503469|NCT01852292|583240729|FG000|Overall Study|Death|9|||
161503470|NCT01852292|583240730|FG001|Overall Study|Death|8|||
161503471|NCT01852292|583240729|FG000|Overall Study|Patient/guardian decision|8|||
161503472|NCT01852292|583240730|FG001|Overall Study|Patient/guardian decision|4|||
161503473|NCT01852292|583240729|FG000|Overall Study|Adverse Event|8|||
161503474|NCT01852292|583240730|FG001|Overall Study|Adverse Event|11|||
161503475|NCT01852292|583240729|FG000|Overall Study|Physician Decision|6|||
161503476|NCT01852292|583240730|FG001|Overall Study|Physician Decision|2|||
161503477|NCT01852292|583240729|FG000|Overall Study|Protocol Violation|2|||
161673804|NCT00778622|583859911|FG000|Overall Study|Adverse Event|5|||
161673805|NCT00778622|583859912|FG001|Overall Study|Adverse Event|4|||
161673806|NCT00778622|583859913|FG002|Overall Study|Adverse Event|7|||
161503478|NCT01852292|583240730|FG001|Overall Study|Protocol Violation|0|||
161503479|NCT01852292|583240729|FG000|Overall Study|Non-compliance with study treatment|1|||
161503480|NCT01852292|583240730|FG001|Overall Study|Non-compliance with study treatment|0|||
161503481|NCT01852292|583240729|FG000|Overall Study|Study terminated by Sponsor|0|||
161503482|NCT01852292|583240730|FG001|Overall Study|Study terminated by Sponsor|1|||
161503483|NCT01852292|583240729|FG000|Overall Study|Progressive disease|42|||
161503484|NCT01852292|583240730|FG001|Overall Study|Progressive disease|52|||
161503485|NCT01914666|583240733|FG000|Treatment Period|Lack of Efficacy|0|||
161503486|NCT01914666|583240734|FG001|Treatment Period|Lack of Efficacy|0|||
161503487|NCT01914666|583240735|FG002|Treatment Period|Lack of Efficacy|2|||
161503488|NCT01914666|583240733|FG000|Treatment Period|Adverse Event|10|||
161503489|NCT01914666|583240734|FG001|Treatment Period|Adverse Event|4|||
161503490|NCT01914666|583240735|FG002|Treatment Period|Adverse Event|2|||
161503491|NCT01914666|583240733|FG000|Treatment Period|Withdrawal by Subject|3|||
161503492|NCT01914666|583240734|FG001|Treatment Period|Withdrawal by Subject|2|||
161503493|NCT01914666|583240735|FG002|Treatment Period|Withdrawal by Subject|2|||
161503494|NCT01914666|583240733|FG000|Treatment Period|Physician Decision|0|||
161503495|NCT01914666|583240734|FG001|Treatment Period|Physician Decision|0|||
161503496|NCT01914666|583240735|FG002|Treatment Period|Physician Decision|2|||
161503497|NCT02388737|583240737|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
161503498|NCT02388737|583240738|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
161503499|NCT02388737|583240739|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
161503500|NCT02388737|583240737|FG000|Overall Study|Major Protocol Deviation|18|||
161503501|NCT02388737|583240738|FG001|Overall Study|Major Protocol Deviation|25|||
161503502|NCT02388737|583240739|FG002|Overall Study|Major Protocol Deviation|22|||
161503503|NCT02388737|583240737|FG000|Overall Study|Lost to Follow-up|5|||
161503504|NCT02388737|583240738|FG001|Overall Study|Lost to Follow-up|1|||
161503505|NCT02388737|583240739|FG002|Overall Study|Lost to Follow-up|4|||
161503506|NCT02388737|583240737|FG000|Overall Study|Voluntary Withdrawal|10|||
161503507|NCT02388737|583240738|FG001|Overall Study|Voluntary Withdrawal|18|||
161503508|NCT02388737|583240739|FG002|Overall Study|Voluntary Withdrawal|17|||
161503509|NCT02388737|583240737|FG000|Overall Study|Lack of Efficacy|3|||
161503510|NCT02388737|583240738|FG001|Overall Study|Lack of Efficacy|0|||
161503511|NCT02388737|583240739|FG002|Overall Study|Lack of Efficacy|3|||
161503512|NCT02388737|583240737|FG000|Overall Study|Reason Not Specified|5|||
161503513|NCT02388737|583240738|FG001|Overall Study|Reason Not Specified|5|||
161503514|NCT02388737|583240739|FG002|Overall Study|Reason Not Specified|4|||
161503515|NCT03252522|583240740|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
161503516|NCT03252522|583240741|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
161503517|NCT03252522|583240742|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
161503518|NCT03252522|583240740|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
161503519|NCT03252522|583240741|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
161503520|NCT03252522|583240742|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
161503521|NCT03252522|583240740|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
161503522|NCT03252522|583240741|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
161503523|NCT03252522|583240742|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
161503524|NCT03252522|583240740|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
161503525|NCT03252522|583240741|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
161503526|NCT03252522|583240742|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
161503527|NCT03252522|583240740|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
161503528|NCT03252522|583240741|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
161503529|NCT03252522|583240742|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
161503530|NCT03252522|583240740|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
161503531|NCT03252522|583240741|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
161503532|NCT03252522|583240742|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
161503533|NCT03252522|583240740|FG000|Phase 2: Open Label|Adverse Event|0|||
161503534|NCT03252522|583240741|FG001|Phase 2: Open Label|Adverse Event|0|||
161503535|NCT03252522|583240742|FG002|Phase 2: Open Label|Adverse Event|2|||
161503536|NCT03252522|583240740|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
161503537|NCT03252522|583240741|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
161503538|NCT03252522|583240742|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
161503539|NCT03299842|583240744|FG000|Overall Study|Caregiver withdrew consent|2|||
161503540|NCT03299842|583240744|FG000|Overall Study|Child would not keep the watch on|3|||
161503541|NCT00071812|583240745|FG000|24-Week Double-Blind Period|Adverse Event|2|||
161819679|NCT05330975|584381122|FG006|Revaccination|Adverse Event|3|||
161819680|NCT05330975|584381116|FG000|Revaccination|Lost to Follow-up|0|||
161503542|NCT00071812|583240746|FG001|24-Week Double-Blind Period|Adverse Event|3|||
161503543|NCT00071812|583240747|FG002|24-Week Double-Blind Period|Adverse Event|4|||
161819681|NCT05330975|584381117|FG001|Revaccination|Lost to Follow-up|0|||
161503544|NCT00071812|583240748|FG003|24-Week Double-Blind Period|Adverse Event|4|||
161503545|NCT00071812|583240745|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
161503546|NCT00071812|583240746|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
161503547|NCT00071812|583240747|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
161503548|NCT00071812|583240748|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
161503549|NCT00071812|583240745|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
161503550|NCT00071812|583240746|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
161503551|NCT00071812|583240747|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
161503552|NCT00071812|583240748|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
161503553|NCT00071812|583240745|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
161503554|NCT00071812|583240746|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
161503555|NCT00071812|583240747|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
161503556|NCT00071812|583240748|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
161503557|NCT00071812|583240745|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
161503558|NCT00071812|583240746|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
161503559|NCT00071812|583240747|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
161503560|NCT00071812|583240748|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
161503561|NCT00071812|583240745|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
161503562|NCT00071812|583240746|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
161503563|NCT00071812|583240747|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
161503564|NCT00071812|583240748|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
161503565|NCT00071812|583240745|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
161503566|NCT00071812|583240746|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
161503567|NCT00071812|583240747|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
161503568|NCT00071812|583240748|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
161503569|NCT00071812|583240745|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
161503570|NCT00071812|583240746|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
161503571|NCT00071812|583240747|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
161503572|NCT00071812|583240748|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
161503573|NCT00071812|583240745|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161503574|NCT00071812|583240746|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161503575|NCT00071812|583240747|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161503576|NCT00071812|583240748|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
161503577|NCT00071812|583240745|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
161503578|NCT00071812|583240746|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
161503579|NCT00071812|583240747|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
161503580|NCT00071812|583240748|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
161503581|NCT01940120|583240751|FG000|Overall Study|Death|40|||
161503582|NCT01940120|583240751|FG000|Overall Study|Withdrawal by Subject|8|||
161503583|NCT03711162|583240753|FG000|Overall Study|Adverse Event|5|||
161503584|NCT03711162|583240754|FG001|Overall Study|Adverse Event|2|||
161503585|NCT03711162|583240755|FG002|Overall Study|Adverse Event|4|||
161503586|NCT03711162|583240753|FG000|Overall Study|Death|11|||
161503587|NCT03711162|583240754|FG001|Overall Study|Death|7|||
161503588|NCT03711162|583240755|FG002|Overall Study|Death|8|||
161503589|NCT03711162|583240753|FG000|Overall Study|Lost to Follow-up|1|||
161503590|NCT03711162|583240754|FG001|Overall Study|Lost to Follow-up|0|||
161503591|NCT03711162|583240755|FG002|Overall Study|Lost to Follow-up|1|||
161503592|NCT03711162|583240753|FG000|Overall Study|Study Terminated by Sponsor|139|||
161503593|NCT03711162|583240754|FG001|Overall Study|Study Terminated by Sponsor|152|||
161503594|NCT03711162|583240755|FG002|Overall Study|Study Terminated by Sponsor|146|||
161503595|NCT03711162|583240753|FG000|Overall Study|Withdrawal by Subject|17|||
161503596|NCT03711162|583240754|FG001|Overall Study|Withdrawal by Subject|10|||
161503597|NCT03711162|583240755|FG002|Overall Study|Withdrawal by Subject|10|||
161503598|NCT03711162|583240753|FG000|Overall Study|Miscellaneous|1|||
161503599|NCT03711162|583240754|FG001|Overall Study|Miscellaneous|2|||
161503600|NCT03711162|583240755|FG002|Overall Study|Miscellaneous|2|||
161503601|NCT03711162|583240753|FG000|Overall Study|Not Treated|1|||
161503602|NCT03711162|583240754|FG001|Overall Study|Not Treated|0|||
161586122|NCT05338086|583534144|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
161586123|NCT05338086|583534145|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161586124|NCT05338086|583534146|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161586125|NCT05338086|583534147|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161503603|NCT03711162|583240755|FG002|Overall Study|Not Treated|1|||
161503604|NCT03711162|583240753|FG000|Overall Study|Physician Decision|0|||
161503605|NCT03711162|583240754|FG001|Overall Study|Physician Decision|2|||
161503606|NCT03711162|583240755|FG002|Overall Study|Physician Decision|0|||
161503607|NCT03711162|583240753|FG000|Overall Study|Lack of Efficacy|0|||
161503608|NCT03711162|583240754|FG001|Overall Study|Lack of Efficacy|0|||
161586126|NCT05338086|583534143|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
161503609|NCT03711162|583240755|FG002|Overall Study|Lack of Efficacy|2|||
161503610|NCT03711162|583240753|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
161586127|NCT05338086|583534144|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
161586128|NCT05338086|583534145|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
161586129|NCT05338086|583534146|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
161586130|NCT05338086|583534147|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
161503611|NCT03711162|583240754|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
161503612|NCT03711162|583240755|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
161503613|NCT01275066|583240758|FG000|Overall Study|Withdrawal by Subject|0|||
161503614|NCT01275066|583240759|FG001|Overall Study|Withdrawal by Subject|0|||
161503615|NCT01275066|583240760|FG002|Overall Study|Withdrawal by Subject|1|||
161503616|NCT01275066|583240758|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
161503617|NCT01275066|583240759|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
161503618|NCT01275066|583240760|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
161503619|NCT03240133|583240761|FG000|Overall Study|Withdrawal by Subject|0|||
161503620|NCT03240133|583240762|FG001|Overall Study|Withdrawal by Subject|1|||
161503621|NCT03240133|583240763|FG002|Overall Study|Withdrawal by Subject|0|||
161503622|NCT03240133|583240761|FG000|Overall Study|Adverse Event|1|||
161503623|NCT03240133|583240762|FG001|Overall Study|Adverse Event|1|||
161503624|NCT03240133|583240763|FG002|Overall Study|Adverse Event|0|||
161503625|NCT03240133|583240761|FG000|Overall Study|Rash|1|||
161503626|NCT03240133|583240762|FG001|Overall Study|Rash|0|||
161503627|NCT03240133|583240763|FG002|Overall Study|Rash|0|||
161503628|NCT03240133|583240761|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
161503629|NCT03240133|583240762|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
161503630|NCT03240133|583240763|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
161503631|NCT03240133|583240761|FG000|Overall Study|Intercurrent illness.|0|||
161503632|NCT03240133|583240762|FG001|Overall Study|Intercurrent illness.|1|||
161503633|NCT03240133|583240763|FG002|Overall Study|Intercurrent illness.|0|||
161503634|NCT03240133|583240761|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
161503635|NCT03240133|583240762|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
161503636|NCT03240133|583240763|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
161673807|NCT00778622|583859911|FG000|Overall Study|Withdrawal by Subject|4|||
161503637|NCT00749463|583240764|FG000|Overall Study|Adverse Event|0|||
161503638|NCT00749463|583240765|FG001|Overall Study|Adverse Event|4|||
161503639|NCT00749463|583240766|FG002|Overall Study|Adverse Event|1|||
161503640|NCT00749463|583240764|FG000|Overall Study|Withdrawal by Subject|1|||
161503641|NCT00749463|583240765|FG001|Overall Study|Withdrawal by Subject|0|||
161503642|NCT00749463|583240766|FG002|Overall Study|Withdrawal by Subject|0|||
161503643|NCT00116831|583240767|FG000|Overall Study|Adverse Event|14|||
161503644|NCT00116831|583240768|FG001|Overall Study|Adverse Event|16|||
161503645|NCT00116831|583240767|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
161673808|NCT00778622|583859912|FG001|Overall Study|Withdrawal by Subject|5|||
161673809|NCT00778622|583859913|FG002|Overall Study|Withdrawal by Subject|5|||
161673810|NCT00778622|583859911|FG000|Overall Study|Lost to Follow-up|3|||
161673811|NCT00778622|583859912|FG001|Overall Study|Lost to Follow-up|3|||
161673812|NCT00778622|583859913|FG002|Overall Study|Lost to Follow-up|2|||
161673813|NCT00778622|583859911|FG000|Overall Study|Protocol Violation|0|||
161673814|NCT00778622|583859912|FG001|Overall Study|Protocol Violation|3|||
161673815|NCT00778622|583859913|FG002|Overall Study|Protocol Violation|0|||
161673816|NCT00778622|583859911|FG000|Overall Study|Lack of Efficacy|2|||
161673817|NCT00778622|583859912|FG001|Overall Study|Lack of Efficacy|0|||
161673818|NCT00778622|583859913|FG002|Overall Study|Lack of Efficacy|0|||
161673819|NCT00778622|583859911|FG000|Overall Study|immigration|1|||
161673820|NCT00778622|583859912|FG001|Overall Study|immigration|0|||
161673821|NCT00778622|583859913|FG002|Overall Study|immigration|0|||
161503646|NCT00116831|583240768|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
161503647|NCT00116831|583240767|FG000|Overall Study|Lost to Follow-up|8|||
161503648|NCT00116831|583240768|FG001|Overall Study|Lost to Follow-up|6|||
161503649|NCT00116831|583240767|FG000|Overall Study|Protocol Violation|3|||
161503650|NCT00116831|583240768|FG001|Overall Study|Protocol Violation|6|||
161673822|NCT00778622|583859911|FG000|Overall Study|Other|1|||
161673823|NCT00778622|583859912|FG001|Overall Study|Other|0|||
161673824|NCT00778622|583859913|FG002|Overall Study|Other|1|||
161503651|NCT00116831|583240767|FG000|Overall Study|Hypoglycaemic events|1|||
161503652|NCT00116831|583240768|FG001|Overall Study|Hypoglycaemic events|0|||
161503653|NCT00116831|583240767|FG000|Overall Study|Low haemoglobin on screening|1|||
161503654|NCT00116831|583240768|FG001|Overall Study|Low haemoglobin on screening|0|||
161503655|NCT00116831|583240767|FG000|Overall Study|Withdrawn investigational product|1|||
161503656|NCT00116831|583240768|FG001|Overall Study|Withdrawn investigational product|0|||
161503657|NCT00116831|583240767|FG000|Overall Study|Withdrawal by Subject|32|||
161673825|NCT01251120|583859915|FG000|Overall Study|Lack of Efficacy|0|||
161673826|NCT01251120|583859916|FG001|Overall Study|Lack of Efficacy|1|||
161503658|NCT00116831|583240768|FG001|Overall Study|Withdrawal by Subject|32|||
161503659|NCT00116831|583240767|FG000|Overall Study|Insufficient therapeutic effect|0|||
161503660|NCT00116831|583240768|FG001|Overall Study|Insufficient therapeutic effect|1|||
161503661|NCT00116831|583240767|FG000|Overall Study|Missing data for participant|1|||
161673827|NCT01968070|583859917|FG000|Period 1|Withdrawal by Subject|0|||
161673828|NCT01968070|583859918|FG001|Period 1|Withdrawal by Subject|1|||
161673829|NCT01968070|583859919|FG002|Period 1|Withdrawal by Subject|0|||
161673830|NCT01968070|583859920|FG003|Period 1|Withdrawal by Subject|0|||
161673831|NCT01968070|583859921|FG004|Period 1|Withdrawal by Subject|0|||
161673832|NCT01968070|583859922|FG005|Period 1|Withdrawal by Subject|0|||
161673833|NCT01968070|583859923|FG006|Period 1|Withdrawal by Subject|1|||
161673834|NCT01968070|583859924|FG007|Period 1|Withdrawal by Subject|0|||
161673835|NCT01968070|583859925|FG008|Period 1|Withdrawal by Subject|0|||
161673836|NCT01968070|583859926|FG009|Period 1|Withdrawal by Subject|0|||
161503662|NCT00116831|583240768|FG001|Overall Study|Missing data for participant|0|||
161503663|NCT04904185|583240769|FG000|Overall Study|Expansion failure|1|||
161673837|NCT01968070|583859927|FG010|Period 1|Withdrawal by Subject|0|||
161673838|NCT01968070|583859928|FG011|Period 1|Withdrawal by Subject|0|||
161673839|NCT01968070|583859929|FG012|Period 1|Withdrawal by Subject|0|||
161673840|NCT01968070|583859930|FG013|Period 1|Withdrawal by Subject|0|||
161673841|NCT01968070|583859931|FG014|Period 1|Withdrawal by Subject|0|||
161673842|NCT01968070|583859932|FG015|Period 1|Withdrawal by Subject|1|||
161673843|NCT01968070|583859933|FG016|Period 1|Withdrawal by Subject|0|||
161673844|NCT01968070|583859934|FG017|Period 1|Withdrawal by Subject|0|||
161503664|NCT04904185|583240770|FG001|Overall Study|Expansion failure|0|||
161503665|NCT04904185|583240769|FG000|Overall Study|Late response on prior treatment|1|||
161503666|NCT04904185|583240770|FG001|Overall Study|Late response on prior treatment|0|||
161503667|NCT01344369|583240773|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
161503668|NCT01344369|583240774|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
161503669|NCT01344369|583240773|FG000|Washout of 28 Days|Physician Decision|0|||
161503670|NCT01344369|583240774|FG001|Washout of 28 Days|Physician Decision|1|||
161503671|NCT01344369|583240773|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
161503672|NCT01344369|583240774|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
161503673|NCT01465464|583240795|FG000|Overall Study|Adverse Event|96|||
161503674|NCT01465464|583240796|FG001|Overall Study|Adverse Event|49|||
161503675|NCT01465464|583240795|FG000|Overall Study|Lack of Efficacy|139|||
161503676|NCT01465464|583240796|FG001|Overall Study|Lack of Efficacy|190|||
161503677|NCT01465464|583240795|FG000|Overall Study|Physician Decision|13|||
161503678|NCT01465464|583240796|FG001|Overall Study|Physician Decision|5|||
161503679|NCT01465464|583240795|FG000|Overall Study|Protocol Violation|1|||
161503680|NCT01465464|583240796|FG001|Overall Study|Protocol Violation|1|||
161503681|NCT01465464|583240795|FG000|Overall Study|Withdrawal by Subject|46|||
161503682|NCT01465464|583240796|FG001|Overall Study|Withdrawal by Subject|30|||
161503683|NCT01465464|583240795|FG000|Overall Study|Other|9|||
161503684|NCT01465464|583240796|FG001|Overall Study|Other|3|||
161503685|NCT01465464|583240795|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
161503686|NCT01465464|583240796|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
161503687|NCT01183975|583240799|FG000|Overall Study|Lost to Follow-up|73|||
161503688|NCT02244580|583240807|FG000|Overall Study|No cancer tissues available|241|||
161503689|NCT02136576|583240809|FG000|Overall Study|Lost to Follow-up|2|||
161503690|NCT02136576|583240810|FG001|Overall Study|Lost to Follow-up|0|||
161503691|NCT02136576|583240811|FG002|Overall Study|Lost to Follow-up|0|||
161503692|NCT02197806|583240812|FG000|Overall Study|Adverse Event|0|||
161503693|NCT02197806|583240813|FG001|Overall Study|Adverse Event|1|||
161503694|NCT02197806|583240814|FG002|Overall Study|Adverse Event|0|||
161503695|NCT02197806|583240815|FG003|Overall Study|Adverse Event|1|||
161503696|NCT00680901|583240816|FG000|Overall Study|Ongoing: On Study Treatment|1|||
161503697|NCT00680901|583240817|FG001|Overall Study|Ongoing: On Study Treatment|0|||
161503698|NCT00680901|583240816|FG000|Overall Study|Ongoing: In Follow Up|1|||
161503699|NCT00680901|583240817|FG001|Overall Study|Ongoing: In Follow Up|0|||
161503700|NCT00680901|583240816|FG000|Overall Study|Adverse Event|1|||
161673845|NCT01968070|583859917|FG000|Period 1|Protocol Violation|0|||
161503701|NCT00680901|583240817|FG001|Overall Study|Adverse Event|1|||
161673846|NCT01968070|583859918|FG001|Period 1|Protocol Violation|0|||
161673847|NCT01968070|583859919|FG002|Period 1|Protocol Violation|0|||
161673848|NCT01968070|583859920|FG003|Period 1|Protocol Violation|1|||
161503702|NCT00680901|583240816|FG000|Overall Study|Lost to Follow-up|3|||
161503703|NCT00680901|583240817|FG001|Overall Study|Lost to Follow-up|5|||
161503704|NCT00680901|583240816|FG000|Overall Study|Subject decided to withdraw from the study|4|||
161503705|NCT00680901|583240817|FG001|Overall Study|Subject decided to withdraw from the study|15|||
161503706|NCT00680901|583240816|FG000|Overall Study|Sponsor decision|1|||
161503707|NCT00680901|583240817|FG001|Overall Study|Sponsor decision|0|||
161503708|NCT00680901|583240816|FG000|Overall Study|Physician Decision|0|||
161503709|NCT00680901|583240817|FG001|Overall Study|Physician Decision|2|||
161503710|NCT00680901|583240816|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
161503711|NCT00680901|583240817|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
161673849|NCT01968070|583859921|FG004|Period 1|Protocol Violation|1|||
161673850|NCT01968070|583859922|FG005|Period 1|Protocol Violation|0|||
161819682|NCT05330975|584381118|FG002|Revaccination|Lost to Follow-up|0|||
161503712|NCT00680901|583240816|FG000|Overall Study|Other protocol defined stopping criteria|17|||
161673851|NCT01968070|583859923|FG006|Period 1|Protocol Violation|0|||
161503713|NCT00680901|583240817|FG001|Overall Study|Other protocol defined stopping criteria|17|||
161503714|NCT00537381|583240818|FG000|Overall Study|Adverse Event|13|||
161503715|NCT00537381|583240819|FG001|Overall Study|Adverse Event|9|||
161503716|NCT00537381|583240818|FG000|Overall Study|Death|3|||
161503717|NCT00537381|583240819|FG001|Overall Study|Death|3|||
161503718|NCT00537381|583240818|FG000|Overall Study|Withdrawal by Subject|5|||
161503719|NCT00537381|583240819|FG001|Overall Study|Withdrawal by Subject|14|||
161503720|NCT00537381|583240818|FG000|Overall Study|Physician Decision|7|||
161503721|NCT00537381|583240819|FG001|Overall Study|Physician Decision|6|||
161503722|NCT00537381|583240818|FG000|Overall Study|Disease Progression|9|||
161503723|NCT00537381|583240819|FG001|Overall Study|Disease Progression|18|||
161503724|NCT00537381|583240818|FG000|Overall Study|Sponsor decision|14|||
161503725|NCT00537381|583240819|FG001|Overall Study|Sponsor decision|9|||
161503726|NCT00537381|583240818|FG000|Overall Study|Other|5|||
161503727|NCT00537381|583240819|FG001|Overall Study|Other|3|||
161503728|NCT01708174|583240820|FG000|Treatment Period|Withdrawal by Subject|1|||
161503729|NCT01708174|583240821|FG001|Treatment Period|Withdrawal by Subject|0|||
161503730|NCT01708174|583240822|FG002|Treatment Period|Withdrawal by Subject|0|||
161503731|NCT01708174|583240820|FG000|Treatment Period|Progressive disease|0|||
161503732|NCT01708174|583240821|FG001|Treatment Period|Progressive disease|1|||
161503733|NCT01708174|583240822|FG002|Treatment Period|Progressive disease|0|||
161503734|NCT01708174|583240820|FG000|Treatment Period|Death|0|||
161503735|NCT01708174|583240821|FG001|Treatment Period|Death|0|||
161503736|NCT01708174|583240822|FG002|Treatment Period|Death|1|||
161673852|NCT01968070|583859924|FG007|Period 1|Protocol Violation|0|||
161673853|NCT01968070|583859925|FG008|Period 1|Protocol Violation|0|||
161673854|NCT01968070|583859926|FG009|Period 1|Protocol Violation|0|||
161503737|NCT01708174|583240820|FG000|Treatment Period|Adverse Event|0|||
161503738|NCT01708174|583240821|FG001|Treatment Period|Adverse Event|1|||
161503739|NCT01708174|583240822|FG002|Treatment Period|Adverse Event|0|||
161503740|NCT00923559|583240823|FG000|Overall Study|Lost to Follow-up|2|||
161503741|NCT00923559|583240824|FG001|Overall Study|Lost to Follow-up|3|||
161503742|NCT02268812|583240825|FG000|Overall Study|Adverse Event|8|||
161503743|NCT02268812|583240826|FG001|Overall Study|Adverse Event|26|||
161503744|NCT02268812|583240827|FG002|Overall Study|Adverse Event|7|||
161503745|NCT02268812|583240828|FG003|Overall Study|Adverse Event|10|||
161503746|NCT02268812|583240825|FG000|Overall Study|Protocol deviation|0|||
161503747|NCT02268812|583240826|FG001|Overall Study|Protocol deviation|0|||
161503748|NCT02268812|583240827|FG002|Overall Study|Protocol deviation|1|||
161503749|NCT02268812|583240828|FG003|Overall Study|Protocol deviation|0|||
161503750|NCT02268812|583240825|FG000|Overall Study|Withdrawal by Subject|0|||
161503751|NCT02268812|583240826|FG001|Overall Study|Withdrawal by Subject|1|||
161503752|NCT02268812|583240827|FG002|Overall Study|Withdrawal by Subject|0|||
161503753|NCT02268812|583240828|FG003|Overall Study|Withdrawal by Subject|0|||
161503754|NCT02268812|583240825|FG000|Overall Study|Physician Decision|3|||
161503755|NCT02268812|583240826|FG001|Overall Study|Physician Decision|1|||
161503756|NCT02268812|583240827|FG002|Overall Study|Physician Decision|0|||
161503757|NCT02268812|583240828|FG003|Overall Study|Physician Decision|1|||
161503758|NCT02268812|583240825|FG000|Overall Study|Other|5|||
161503759|NCT02268812|583240826|FG001|Overall Study|Other|4|||
161503760|NCT02268812|583240827|FG002|Overall Study|Other|1|||
161503761|NCT02268812|583240828|FG003|Overall Study|Other|3|||
161503762|NCT01951157|583240830|FG000|Overall Study|Progressive Disease|12|||
161503763|NCT01951157|583240831|FG001|Overall Study|Progressive Disease|13|||
161673855|NCT01968070|583859927|FG010|Period 1|Protocol Violation|0|||
161503764|NCT01951157|583240832|FG002|Overall Study|Progressive Disease|10|||
161503765|NCT01951157|583240830|FG000|Overall Study|Treatment-unrelated AE|1|||
161503766|NCT01951157|583240831|FG001|Overall Study|Treatment-unrelated AE|0|||
161503767|NCT01951157|583240832|FG002|Overall Study|Treatment-unrelated AE|3|||
161503768|NCT01951157|583240830|FG000|Overall Study|Study Termination|0|||
161503769|NCT01951157|583240831|FG001|Overall Study|Study Termination|0|||
161503770|NCT01951157|583240832|FG002|Overall Study|Study Termination|1|||
161503771|NCT01951157|583240830|FG000|Overall Study|Physician Decision|5|||
161673856|NCT01968070|583859928|FG011|Period 1|Protocol Violation|0|||
161673857|NCT01968070|583859929|FG012|Period 1|Protocol Violation|0|||
161503772|NCT01951157|583240831|FG001|Overall Study|Physician Decision|3|||
161503773|NCT01951157|583240832|FG002|Overall Study|Physician Decision|2|||
161503774|NCT01951157|583240830|FG000|Overall Study|Non-treatmentrelated death|2|||
161503775|NCT01951157|583240831|FG001|Overall Study|Non-treatmentrelated death|2|||
161503776|NCT01951157|583240832|FG002|Overall Study|Non-treatmentrelated death|2|||
161503777|NCT01951157|583240830|FG000|Overall Study|No treated|0|||
161503778|NCT01951157|583240831|FG001|Overall Study|No treated|1|||
161503779|NCT01951157|583240832|FG002|Overall Study|No treated|0|||
161503780|NCT01951157|583240830|FG000|Overall Study|Treatment-related AE|2|||
161503781|NCT01951157|583240831|FG001|Overall Study|Treatment-related AE|0|||
161503782|NCT01951157|583240832|FG002|Overall Study|Treatment-related AE|4|||
161673858|NCT01968070|583859930|FG013|Period 1|Protocol Violation|0|||
161673859|NCT01968070|583859931|FG014|Period 1|Protocol Violation|0|||
161503783|NCT01951157|583240830|FG000|Overall Study|Consent withdrawn by subject|0|||
161503784|NCT01951157|583240831|FG001|Overall Study|Consent withdrawn by subject|1|||
161503785|NCT01951157|583240832|FG002|Overall Study|Consent withdrawn by subject|3|||
161503786|NCT01951157|583240830|FG000|Overall Study|Treatment-related death|0|||
161503787|NCT01951157|583240831|FG001|Overall Study|Treatment-related death|2|||
161503788|NCT01951157|583240832|FG002|Overall Study|Treatment-related death|0|||
161503789|NCT04964128|583240837|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
161503790|NCT04964128|583240837|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
161503791|NCT00994240|583240839|FG000|Overall Study|Lost to Follow-up|3|||
161503792|NCT00994240|583240840|FG001|Overall Study|Lost to Follow-up|2|||
161503793|NCT00994240|583240839|FG000|Overall Study|Withdrawal by Subject|1|||
161503794|NCT00994240|583240840|FG001|Overall Study|Withdrawal by Subject|0|||
161503795|NCT00994240|583240839|FG000|Overall Study|study termination|2|||
161503796|NCT00994240|583240840|FG001|Overall Study|study termination|3|||
161503797|NCT01177540|583240841|FG000|Overall Study|Adverse Event|1|||
161503798|NCT01177540|583240842|FG001|Overall Study|Adverse Event|0|||
161503799|NCT00748215|583240859|FG000|Overall Study|Withdrawal by Subject|7|||
161503800|NCT00748215|583240860|FG001|Overall Study|Withdrawal by Subject|7|||
161503801|NCT00748215|583240859|FG000|Overall Study|Treatment change|2|||
161503802|NCT00748215|583240860|FG001|Overall Study|Treatment change|1|||
161503803|NCT00748215|583240859|FG000|Overall Study|Change in patient condition|0|||
161503804|NCT00748215|583240860|FG001|Overall Study|Change in patient condition|3|||
161503805|NCT00748215|583240859|FG000|Overall Study|Non-compliant|0|||
161503806|NCT00748215|583240860|FG001|Overall Study|Non-compliant|2|||
161503807|NCT00748215|583240859|FG000|Overall Study|Adverse Event|0|||
161503808|NCT00748215|583240860|FG001|Overall Study|Adverse Event|5|||
161503809|NCT01572038|583242804|FG000|Overall Study|Death|648|||
161503810|NCT01572038|583242804|FG000|Overall Study|Withdrawal by Subject|204|||
161503811|NCT01572038|583242804|FG000|Overall Study|Lost to Follow-up|81|||
161503812|NCT01572038|583242804|FG000|Overall Study|Physician Decision|20|||
161503813|NCT01572038|583242804|FG000|Overall Study|Patient Decision|14|||
161503814|NCT01572038|583242804|FG000|Overall Study|Progressive Disease|8|||
161503815|NCT01572038|583242804|FG000|Overall Study|Site Closed Before Completing Form|6|||
161503816|NCT01572038|583242804|FG000|Overall Study|Enrolled into Another Trial|3|||
161503817|NCT01572038|583242804|FG000|Overall Study|Participated in Another Trial|3|||
161503818|NCT01572038|583242804|FG000|Overall Study|Termination by Sponsor|2|||
161503819|NCT01572038|583242804|FG000|Overall Study|Patient Deterioration|1|||
161503820|NCT01572038|583242804|FG000|Overall Study|Sponsor Decision|1|||
161503821|NCT04152447|583242805|FG000|Overall Study|Lost to Follow-up|1|||
161503822|NCT04152447|583242806|FG001|Overall Study|Lost to Follow-up|0|||
161503823|NCT04152447|583242805|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
161503824|NCT04152447|583242806|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
161503825|NCT04152447|583242805|FG000|Overall Study|Withdrawal by Subject|0|||
161503826|NCT04152447|583242806|FG001|Overall Study|Withdrawal by Subject|1|||
161503827|NCT04152447|583242805|FG000|Overall Study|Found ineligible after enrolling|1|||
161503828|NCT04152447|583242806|FG001|Overall Study|Found ineligible after enrolling|1|||
161503829|NCT04152447|583242805|FG000|Overall Study|Did not receive VR headset in time.|0|||
161503830|NCT04152447|583242806|FG001|Overall Study|Did not receive VR headset in time.|2|||
161503831|NCT03240575|583242807|FG000|Overall Study|Adverse Event|0|||
161503832|NCT03240575|583242808|FG001|Overall Study|Adverse Event|2|||
161503833|NCT03240575|583242809|FG002|Overall Study|Adverse Event|0|||
161503834|NCT03240575|583242810|FG003|Overall Study|Adverse Event|1|||
161503835|NCT03240575|583242807|FG000|Overall Study|Withdrawal by Subject|2|||
161503836|NCT03240575|583242808|FG001|Overall Study|Withdrawal by Subject|11|||
161503837|NCT03240575|583242809|FG002|Overall Study|Withdrawal by Subject|0|||
161503838|NCT03240575|583242810|FG003|Overall Study|Withdrawal by Subject|1|||
161503839|NCT03240575|583242807|FG000|Overall Study|Other|0|||
161503840|NCT03240575|583242808|FG001|Overall Study|Other|1|||
161503841|NCT03240575|583242809|FG002|Overall Study|Other|0|||
161503842|NCT03240575|583242810|FG003|Overall Study|Other|0|||
161503843|NCT04482179|583242811|FG000|Overall Study|Death|1|||
161503844|NCT04482179|583242812|FG001|Overall Study|Death|0|||
161503845|NCT04482179|583242811|FG000|Overall Study|Withdrawal by Subject|1|||
161503846|NCT04482179|583242812|FG001|Overall Study|Withdrawal by Subject|0|||
161819683|NCT05330975|584381119|FG003|Revaccination|Lost to Follow-up|0|||
161819684|NCT05330975|584381120|FG004|Revaccination|Lost to Follow-up|0|||
161819685|NCT05330975|584381121|FG005|Revaccination|Lost to Follow-up|0|||
161819686|NCT05330975|584381122|FG006|Revaccination|Lost to Follow-up|10|||
161819687|NCT05330975|584381116|FG000|Revaccination|Withdrawal by Subject|0|||
161819688|NCT05330975|584381117|FG001|Revaccination|Withdrawal by Subject|0|||
161819689|NCT05330975|584381118|FG002|Revaccination|Withdrawal by Subject|0|||
161503847|NCT03034954|583242813|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
161503848|NCT03034954|583242814|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
161503849|NCT03568942|583242819|FG000|Overall Study|Family emergency|1|||
161503850|NCT03568942|583242819|FG000|Overall Study|Lost to Follow-up|1|||
161503851|NCT04145895|583242825|FG000|Overall Study|Physician Decision|2|||
161819690|NCT05330975|584381119|FG003|Revaccination|Withdrawal by Subject|0|||
161503852|NCT04145895|583242826|FG001|Overall Study|Physician Decision|0|||
161503853|NCT04145895|583242825|FG000|Overall Study|Withdrawal by Subject|0|||
161503854|NCT04145895|583242826|FG001|Overall Study|Withdrawal by Subject|2|||
161503855|NCT00913744|583242827|FG000|Overall Study|Adverse Event|2|||
161503856|NCT00913744|583242828|FG001|Overall Study|Adverse Event|0|||
161503857|NCT00913744|583242827|FG000|Overall Study|Withdrawal by Subject|2|||
161503858|NCT00913744|583242828|FG001|Overall Study|Withdrawal by Subject|1|||
161503859|NCT00913744|583242827|FG000|Overall Study|Death|1|||
161503860|NCT00913744|583242828|FG001|Overall Study|Death|0|||
161503861|NCT00805935|583242829|FG000|Overall Study|Stimulation Failure|1|||
161503862|NCT00805935|583242830|FG001|Overall Study|Stimulation Failure|5|||
161503863|NCT00805935|583242831|FG002|Overall Study|Stimulation Failure|2|||
161503864|NCT00805935|583242832|FG003|Overall Study|Stimulation Failure|2|||
161503865|NCT00805935|583242829|FG000|Overall Study|Cycle cancelled|0|||
161503866|NCT00805935|583242830|FG001|Overall Study|Cycle cancelled|0|||
161503867|NCT00805935|583242831|FG002|Overall Study|Cycle cancelled|2|||
161503868|NCT00805935|583242832|FG003|Overall Study|Cycle cancelled|0|||
161503869|NCT00805935|583242829|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
161503870|NCT00805935|583242830|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
161503871|NCT00805935|583242831|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
161503872|NCT00805935|583242832|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
161503873|NCT00805935|583242829|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
161503874|NCT00805935|583242830|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
161503875|NCT00805935|583242831|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
161503876|NCT00805935|583242832|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
161503877|NCT00805935|583242829|FG000|Overall Study|Lost to Follow-up|1|||
161503878|NCT00805935|583242830|FG001|Overall Study|Lost to Follow-up|0|||
161503879|NCT00805935|583242831|FG002|Overall Study|Lost to Follow-up|0|||
161503880|NCT00805935|583242832|FG003|Overall Study|Lost to Follow-up|0|||
161503881|NCT00805935|583242829|FG000|Overall Study|No positive serum pregnancy|8|||
161503882|NCT00805935|583242830|FG001|Overall Study|No positive serum pregnancy|7|||
161503883|NCT00805935|583242831|FG002|Overall Study|No positive serum pregnancy|6|||
161503884|NCT00805935|583242832|FG003|Overall Study|No positive serum pregnancy|5|||
161503885|NCT00805935|583242829|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161503886|NCT00805935|583242830|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161503887|NCT00805935|583242831|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161503888|NCT00805935|583242832|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161819691|NCT05330975|584381120|FG004|Revaccination|Withdrawal by Subject|0|||
161819692|NCT05330975|584381121|FG005|Revaccination|Withdrawal by Subject|0|||
161503889|NCT00805935|583242829|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
161503890|NCT00805935|583242830|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
161503891|NCT00805935|583242831|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
161503892|NCT00805935|583242832|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
161503893|NCT00805935|583242829|FG000|Overall Study|Biochemical pregnancy|0|||
161819693|NCT05330975|584381122|FG006|Revaccination|Withdrawal by Subject|2|||
161819694|NCT05330975|584381116|FG000|Revaccination|Death|0|||
161819695|NCT05330975|584381117|FG001|Revaccination|Death|0|||
161819696|NCT05330975|584381118|FG002|Revaccination|Death|0|||
161819697|NCT05330975|584381119|FG003|Revaccination|Death|0|||
161819698|NCT05330975|584381120|FG004|Revaccination|Death|0|||
161819699|NCT05330975|584381121|FG005|Revaccination|Death|0|||
161819700|NCT05330975|584381122|FG006|Revaccination|Death|3|||
161819701|NCT05267106|584381123|FG000|Overall Study|Death|50|||
161819702|NCT05267106|584381124|FG001|Overall Study|Death|2|||
161819703|NCT05267106|584381123|FG000|Overall Study|Study terminated by Sponsor|24|||
161819704|NCT05267106|584381124|FG001|Overall Study|Study terminated by Sponsor|6|||
161819705|NCT05267106|584381123|FG000|Overall Study|Withdrawal by Subject|0|||
161819706|NCT05267106|584381124|FG001|Overall Study|Withdrawal by Subject|1|||
161819707|NCT04165824|584381125|FG000|Overall Study|Adverse Event|23|||
161819708|NCT04165824|584381125|FG000|Overall Study|Physician Decision|1|||
161819709|NCT04165824|584381125|FG000|Overall Study|Withdrawal by Subject|17|||
161819710|NCT04165824|584381125|FG000|Overall Study|Other|5|||
161819711|NCT03036930|584381128|FG000|Overall Study|Lost to Follow-up|7|||
161819712|NCT03036930|584381128|FG000|Overall Study|Withdrawal by Subject|3|||
161819713|NCT03036930|584381128|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
161503894|NCT00805935|583242830|FG001|Overall Study|Biochemical pregnancy|1|||
161503895|NCT00805935|583242831|FG002|Overall Study|Biochemical pregnancy|0|||
161819714|NCT01513239|584381133|FG000|Period 1: Main Phase|Adverse Event|1|||
161819715|NCT01513239|584381134|FG001|Period 1: Main Phase|Adverse Event|1|||
161819716|NCT01513239|584381135|FG002|Period 1: Main Phase|Adverse Event|2|||
161819717|NCT01513239|584381136|FG003|Period 1: Main Phase|Adverse Event|0|||
161819718|NCT01513239|584381137|FG004|Period 1: Main Phase|Adverse Event|0|||
161819719|NCT01513239|584381138|FG005|Period 1: Main Phase|Adverse Event|0|||
161503896|NCT00805935|583242832|FG003|Overall Study|Biochemical pregnancy|0|||
161819720|NCT01513239|584381133|FG000|Period 1: Main Phase|Death|29|||
161503897|NCT00805935|583242829|FG000|Overall Study|Chemical pregnancy|0|||
161819721|NCT01513239|584381134|FG001|Period 1: Main Phase|Death|22|||
161503898|NCT00805935|583242830|FG001|Overall Study|Chemical pregnancy|5|||
161503899|NCT00805935|583242831|FG002|Overall Study|Chemical pregnancy|3|||
161503900|NCT00805935|583242832|FG003|Overall Study|Chemical pregnancy|2|||
161503901|NCT00805935|583242829|FG000|Overall Study|Ectopic pregnancy|0|||
161503902|NCT00805935|583242830|FG001|Overall Study|Ectopic pregnancy|0|||
161503903|NCT00805935|583242831|FG002|Overall Study|Ectopic pregnancy|1|||
161503904|NCT00805935|583242832|FG003|Overall Study|Ectopic pregnancy|0|||
161503905|NCT00805935|583242829|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
161503906|NCT00805935|583242830|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
161503907|NCT00805935|583242831|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
161503908|NCT00805935|583242832|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
161503909|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
161503910|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
161503911|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
161503912|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
161503913|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
161503914|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
161503915|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
161503916|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
161503917|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
161503918|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
161503919|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
161503920|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
161503921|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
161503922|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
161503923|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
161503924|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
161503925|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
161503926|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
161503927|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
161503928|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
161503929|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
161503930|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
161503931|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
161503932|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
161503933|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
161503934|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
161503935|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
161503936|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
161503937|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
161503938|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
161503939|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
161503940|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
161503941|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
161503942|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
161503943|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
161503944|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
161503945|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
161673860|NCT01968070|583859932|FG015|Period 1|Protocol Violation|0|||
161503946|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
161503947|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
161503948|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
161503949|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
161503950|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
161503951|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
161503952|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
161503953|NCT01218516|583242833|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
161673861|NCT01968070|583859933|FG016|Period 1|Protocol Violation|0|||
161673862|NCT01968070|583859934|FG017|Period 1|Protocol Violation|0|||
161673863|NCT01968070|583859917|FG000|Period 1|Lost to Follow-up|0|||
161673864|NCT01968070|583859918|FG001|Period 1|Lost to Follow-up|0|||
161673865|NCT01968070|583859919|FG002|Period 1|Lost to Follow-up|0|||
161673866|NCT01968070|583859920|FG003|Period 1|Lost to Follow-up|1|||
161673867|NCT01968070|583859921|FG004|Period 1|Lost to Follow-up|0|||
161673868|NCT01968070|583859922|FG005|Period 1|Lost to Follow-up|0|||
161673869|NCT01968070|583859923|FG006|Period 1|Lost to Follow-up|0|||
161503954|NCT01218516|583242834|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
161503955|NCT01218516|583242835|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
161503956|NCT01218516|583242836|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
161503957|NCT01539226|583242837|FG000|Overall Study|Withdrawal by Subject|24|||
161503958|NCT01539226|583242838|FG001|Overall Study|Withdrawal by Subject|54|||
161503959|NCT01539226|583242837|FG000|Overall Study|Lost to Follow-up|20|||
161503960|NCT01539226|583242838|FG001|Overall Study|Lost to Follow-up|54|||
161503961|NCT01539226|583242837|FG000|Overall Study|Death|1|||
161503962|NCT01539226|583242838|FG001|Overall Study|Death|2|||
161503963|NCT01539226|583242837|FG000|Overall Study|Adverse Event|2|||
161503964|NCT01539226|583242838|FG001|Overall Study|Adverse Event|0|||
161503965|NCT01539226|583242837|FG000|Overall Study|Pregnancy|13|||
161503966|NCT01539226|583242838|FG001|Overall Study|Pregnancy|29|||
161503967|NCT01539226|583242837|FG000|Overall Study|inappropriate enrollment|0|||
161503968|NCT01539226|583242838|FG001|Overall Study|inappropriate enrollment|1|||
161503969|NCT01539226|583242837|FG000|Overall Study|Multiple Reasons|3|||
161503970|NCT01539226|583242838|FG001|Overall Study|Multiple Reasons|1|||
161503971|NCT01539226|583242837|FG000|Overall Study|not HIV seroconversion-related|93|||
161503972|NCT01539226|583242838|FG001|Overall Study|not HIV seroconversion-related|176|||
161503973|NCT01539226|583242837|FG000|Overall Study|HIV seroconversion-related|55|||
161503974|NCT01539226|583242838|FG001|Overall Study|HIV seroconversion-related|80|||
161503975|NCT01539226|583242837|FG000|Overall Study|Non-compliance|6|||
161503976|NCT01539226|583242838|FG001|Overall Study|Non-compliance|8|||
161503977|NCT00283439|583242839|FG000|Overall Study|Adverse Event|0|||
161503978|NCT00283439|583242840|FG001|Overall Study|Adverse Event|0|||
161503979|NCT00283439|583242841|FG002|Overall Study|Adverse Event|0|||
161503980|NCT00283439|583242842|FG003|Overall Study|Adverse Event|1|||
161503981|NCT00283439|583242839|FG000|Overall Study|Death|0|||
161503982|NCT00283439|583242840|FG001|Overall Study|Death|0|||
161503983|NCT00283439|583242841|FG002|Overall Study|Death|1|||
161503984|NCT00283439|583242842|FG003|Overall Study|Death|0|||
161503985|NCT00283439|583242839|FG000|Overall Study|Disease progression|0|||
161503986|NCT00283439|583242840|FG001|Overall Study|Disease progression|1|||
161503987|NCT00283439|583242841|FG002|Overall Study|Disease progression|0|||
161503988|NCT00283439|583242842|FG003|Overall Study|Disease progression|0|||
161503989|NCT00283439|583242839|FG000|Overall Study|Requirement for alternative therapy|1|||
161503990|NCT00283439|583242840|FG001|Overall Study|Requirement for alternative therapy|2|||
161503991|NCT00283439|583242841|FG002|Overall Study|Requirement for alternative therapy|5|||
161503992|NCT00283439|583242842|FG003|Overall Study|Requirement for alternative therapy|2|||
161819722|NCT01513239|584381135|FG002|Period 1: Main Phase|Death|32|||
161819723|NCT01513239|584381136|FG003|Period 1: Main Phase|Death|0|||
161819724|NCT01513239|584381137|FG004|Period 1: Main Phase|Death|0|||
161819725|NCT01513239|584381138|FG005|Period 1: Main Phase|Death|0|||
161819726|NCT01513239|584381133|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
161819727|NCT01513239|584381134|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
161819728|NCT01513239|584381135|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
161819729|NCT01513239|584381136|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
161819730|NCT01513239|584381137|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
161819731|NCT01513239|584381138|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
161819732|NCT01513239|584381133|FG000|Period 1: Main Phase|Physician Decision|4|||
161819733|NCT01513239|584381134|FG001|Period 1: Main Phase|Physician Decision|4|||
161819734|NCT01513239|584381135|FG002|Period 1: Main Phase|Physician Decision|4|||
161819735|NCT01513239|584381136|FG003|Period 1: Main Phase|Physician Decision|0|||
161819736|NCT01513239|584381137|FG004|Period 1: Main Phase|Physician Decision|0|||
161819737|NCT01513239|584381138|FG005|Period 1: Main Phase|Physician Decision|0|||
161819738|NCT01513239|584381133|FG000|Period 1: Main Phase|Protocol Violation|2|||
161819739|NCT01513239|584381134|FG001|Period 1: Main Phase|Protocol Violation|2|||
161819740|NCT01513239|584381135|FG002|Period 1: Main Phase|Protocol Violation|2|||
161819741|NCT01513239|584381136|FG003|Period 1: Main Phase|Protocol Violation|0|||
161819742|NCT01513239|584381137|FG004|Period 1: Main Phase|Protocol Violation|0|||
161819743|NCT01513239|584381138|FG005|Period 1: Main Phase|Protocol Violation|0|||
161819744|NCT01513239|584381133|FG000|Period 1: Main Phase|Technical Problems|1|||
161819745|NCT01513239|584381134|FG001|Period 1: Main Phase|Technical Problems|2|||
161819746|NCT01513239|584381135|FG002|Period 1: Main Phase|Technical Problems|0|||
161819747|NCT01513239|584381136|FG003|Period 1: Main Phase|Technical Problems|0|||
161819748|NCT01513239|584381137|FG004|Period 1: Main Phase|Technical Problems|0|||
161819749|NCT01513239|584381138|FG005|Period 1: Main Phase|Technical Problems|0|||
161819750|NCT01513239|584381133|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
161819751|NCT01513239|584381134|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
161503993|NCT00283439|583242839|FG000|Overall Study|Stem cell transplant|6|||
161503994|NCT00283439|583242840|FG001|Overall Study|Stem cell transplant|6|||
161503995|NCT00283439|583242841|FG002|Overall Study|Stem cell transplant|4|||
161503996|NCT00283439|583242842|FG003|Overall Study|Stem cell transplant|3|||
161503997|NCT00283439|583242839|FG000|Overall Study|Treatment discontinued|0|||
161503998|NCT00283439|583242840|FG001|Overall Study|Treatment discontinued|2|||
161503999|NCT00283439|583242841|FG002|Overall Study|Treatment discontinued|1|||
161504000|NCT00283439|583242842|FG003|Overall Study|Treatment discontinued|3|||
161504001|NCT00283439|583242839|FG000|Overall Study|Other|1|||
161504002|NCT00283439|583242840|FG001|Overall Study|Other|0|||
161504003|NCT00283439|583242841|FG002|Overall Study|Other|0|||
161504004|NCT00283439|583242842|FG003|Overall Study|Other|0|||
161504005|NCT01632891|583242843|FG000|Overall Study|Lost to Follow-up|0|||
161504006|NCT01632891|583242844|FG001|Overall Study|Lost to Follow-up|1|||
161504007|NCT01632891|583242843|FG000|Overall Study|Withdrawal by Subject|1|||
161504008|NCT01632891|583242844|FG001|Overall Study|Withdrawal by Subject|0|||
161504009|NCT00333229|583242845|FG000|Overall Study|Lack of Efficacy|0|||
161504010|NCT00333229|583242846|FG001|Overall Study|Lack of Efficacy|1|||
161504011|NCT00240071|583242848|FG000|Overall Study|Withdrawal by Subject|3|||
161504012|NCT02821962|583242849|FG000|Overall Study|Lost to Follow-up|2|||
161504013|NCT02821962|583242850|FG001|Overall Study|Lost to Follow-up|0|||
161504014|NCT04206293|583242863|FG000|Overall Study|Consent withdrawal|1|||
161504015|NCT01610791|583242872|FG000|Overall Study|Lost to Follow-up|7|||
161504016|NCT01610791|583242872|FG000|Overall Study|Adverse Event|6|||
161504017|NCT01610791|583242872|FG000|Overall Study|Physician Decision|1|||
161504018|NCT01610791|583242872|FG000|Overall Study|Adverse event and Investigator decision|1|||
161504019|NCT01610791|583242872|FG000|Overall Study|Death|1|||
161504020|NCT01610791|583242872|FG000|Overall Study|Not determined|5|||
161504021|NCT04304001|583242873|FG000|Overall Study|Lost to Follow-up|13|||
161504022|NCT04304001|583242874|FG001|Overall Study|Lost to Follow-up|9|||
161504023|NCT04164901|583242875|FG000|Overall Study|Withdrawal by Subject|4|||
161504024|NCT04164901|583242876|FG001|Overall Study|Withdrawal by Subject|4|||
161504025|NCT02465528|583242877|FG000|Overall Study|Progressive disease|0|||
161504026|NCT02465528|583242878|FG001|Overall Study|Progressive disease|2|||
161504027|NCT02465528|583242879|FG002|Overall Study|Progressive disease|9|||
161504028|NCT02465528|583242880|FG003|Overall Study|Progressive disease|4|||
161504029|NCT02465528|583242877|FG000|Overall Study|Study terminated by sponsor|1|||
161504030|NCT02465528|583242878|FG001|Overall Study|Study terminated by sponsor|2|||
161504031|NCT02465528|583242879|FG002|Overall Study|Study terminated by sponsor|0|||
161504032|NCT02465528|583242880|FG003|Overall Study|Study terminated by sponsor|0|||
161504033|NCT02465528|583242877|FG000|Overall Study|Withdrawal by Subject|0|||
161504034|NCT02465528|583242878|FG001|Overall Study|Withdrawal by Subject|0|||
161504035|NCT02465528|583242879|FG002|Overall Study|Withdrawal by Subject|2|||
161504036|NCT02465528|583242880|FG003|Overall Study|Withdrawal by Subject|0|||
161504037|NCT02465528|583242877|FG000|Overall Study|Adverse Event|0|||
161504038|NCT02465528|583242878|FG001|Overall Study|Adverse Event|0|||
161504039|NCT02465528|583242879|FG002|Overall Study|Adverse Event|0|||
161504040|NCT02465528|583242880|FG003|Overall Study|Adverse Event|1|||
161504041|NCT02465528|583242877|FG000|Overall Study|Physician Decision|0|||
161504042|NCT02465528|583242878|FG001|Overall Study|Physician Decision|0|||
161504043|NCT02465528|583242879|FG002|Overall Study|Physician Decision|1|||
161504044|NCT02465528|583242880|FG003|Overall Study|Physician Decision|0|||
161504045|NCT05358821|583242881|FG000|Overall Study|Withdrawal by Subject|0|||
161504046|NCT05358821|583242882|FG001|Overall Study|Withdrawal by Subject|1|||
161504047|NCT05358821|583242883|FG002|Overall Study|Withdrawal by Subject|0|||
161504048|NCT05358821|583242881|FG000|Overall Study|Withdrawal of Consent|0|||
161504049|NCT05358821|583242882|FG001|Overall Study|Withdrawal of Consent|0|||
161504050|NCT05358821|583242883|FG002|Overall Study|Withdrawal of Consent|1|||
161504051|NCT04627064|583242887|FG000|Overall Study|Progressive disease|8|||
161504052|NCT04627064|583242888|FG001|Overall Study|Progressive disease|0|||
161504053|NCT04627064|583242887|FG000|Overall Study|Withdrawal by Subject|2|||
161504054|NCT04627064|583242888|FG001|Overall Study|Withdrawal by Subject|0|||
161673870|NCT01968070|583859924|FG007|Period 1|Lost to Follow-up|0|||
161673871|NCT01968070|583859925|FG008|Period 1|Lost to Follow-up|0|||
161504055|NCT04627064|583242887|FG000|Overall Study|Physician Decision|1|||
161504056|NCT04627064|583242888|FG001|Overall Study|Physician Decision|0|||
161504057|NCT02086110|583242894|FG000|Overall Study|Withdrawal by Subject|1|||
161504058|NCT02086110|583242895|FG001|Overall Study|Withdrawal by Subject|1|||
161504059|NCT01869192|583242896|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
161673872|NCT01968070|583859926|FG009|Period 1|Lost to Follow-up|0|||
161504060|NCT01869192|583242897|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
161504061|NCT01869192|583242896|FG000|Postoperative Chemotherapy|Physician Decision|0|||
161819752|NCT01513239|584381135|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
161673873|NCT01968070|583859927|FG010|Period 1|Lost to Follow-up|0|||
161819753|NCT01513239|584381136|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
161819754|NCT01513239|584381137|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
161504062|NCT01869192|583242897|FG001|Postoperative Chemotherapy|Physician Decision|2|||
161504063|NCT02272413|583242901|FG000|Randomized Through Treatment Start|Not treated|3|||
161673874|NCT01968070|583859928|FG011|Period 1|Lost to Follow-up|0|||
161504064|NCT02272413|583242902|FG001|Randomized Through Treatment Start|Not treated|5|||
161504065|NCT02272413|583242901|FG000|Pre-switch Period|Adverse Event|38|||
161504066|NCT02272413|583242902|FG001|Pre-switch Period|Adverse Event|37|||
161504067|NCT02272413|583242901|FG000|Pre-switch Period|Death|26|||
161504068|NCT02272413|583242902|FG001|Pre-switch Period|Death|26|||
161504069|NCT02272413|583242901|FG000|Pre-switch Period|Withdrawal by Subject|27|||
161504070|NCT02272413|583242902|FG001|Pre-switch Period|Withdrawal by Subject|15|||
161504071|NCT02272413|583242901|FG000|Pre-switch Period|Physician Decision|6|||
161504072|NCT02272413|583242902|FG001|Pre-switch Period|Physician Decision|18|||
161504073|NCT02272413|583242901|FG000|Pre-switch Period|Progressive disease|185|||
161504074|NCT02272413|583242902|FG001|Pre-switch Period|Progressive disease|173|||
161504075|NCT02272413|583242901|FG000|Pre-switch Period|Lost to Follow-up|0|||
161819755|NCT01513239|584381138|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
161819756|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161819757|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161819758|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161819759|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
161819760|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
161819761|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
161819762|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Death|0|||
161819763|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Death|0|||
161819764|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Death|0|||
161819765|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Death|2|||
161819766|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Death|5|||
161504076|NCT02272413|583242902|FG001|Pre-switch Period|Lost to Follow-up|2|||
161504077|NCT02272413|583242901|FG000|Pre-switch Period|Protocol Violation|1|||
161504078|NCT02272413|583242902|FG001|Pre-switch Period|Protocol Violation|0|||
161504079|NCT02272413|583242901|FG000|Pre-switch Period|Other than listed|10|||
161504080|NCT02272413|583242902|FG001|Pre-switch Period|Other than listed|11|||
161504081|NCT02272413|583242901|FG000|Post-switch Period|Adverse Event|4|||
161504082|NCT02272413|583242902|FG001|Post-switch Period|Adverse Event|4|||
161504083|NCT02272413|583242901|FG000|Post-switch Period|Death|3|||
161504084|NCT02272413|583242902|FG001|Post-switch Period|Death|2|||
161504085|NCT02272413|583242901|FG000|Post-switch Period|Withdrawal by Subject|1|||
161504086|NCT02272413|583242902|FG001|Post-switch Period|Withdrawal by Subject|2|||
161504087|NCT02272413|583242901|FG000|Post-switch Period|Physician Decision|1|||
161504088|NCT02272413|583242902|FG001|Post-switch Period|Physician Decision|1|||
161504089|NCT02272413|583242901|FG000|Post-switch Period|Progressive disease|21|||
161504090|NCT02272413|583242902|FG001|Post-switch Period|Progressive disease|21|||
161504091|NCT02272413|583242901|FG000|Post-switch Period|Study terminated by sponsor|8|||
161504092|NCT02272413|583242902|FG001|Post-switch Period|Study terminated by sponsor|11|||
161504093|NCT02272413|583242901|FG000|Post-switch Period|Other than listed|4|||
161504094|NCT02272413|583242902|FG001|Post-switch Period|Other than listed|5|||
161504095|NCT02286193|583242905|FG000|Overall Study|Referred: CRS unable to make contact|62|||
161504096|NCT02286193|583242905|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
161504097|NCT02286193|583242905|FG000|Overall Study|Referred: Declined service|38|||
161504098|NCT00423891|583242906|FG000|Enrolled|Withdrawal by Subject|0|||
161504099|NCT00423891|583242907|FG001|Enrolled|Withdrawal by Subject|0|||
161504100|NCT00423891|583242908|FG002|Enrolled|Withdrawal by Subject|1|||
161504101|NCT00423891|583242906|FG000|Enrolled|Lost to Follow-up|0|||
161504102|NCT00423891|583242907|FG001|Enrolled|Lost to Follow-up|0|||
161504103|NCT00423891|583242908|FG002|Enrolled|Lost to Follow-up|1|||
161504104|NCT00423891|583242906|FG000|Enrolled|No longer met criteria|11|||
161504105|NCT00423891|583242907|FG001|Enrolled|No longer met criteria|2|||
161504106|NCT00423891|583242908|FG002|Enrolled|No longer met criteria|1|||
161504107|NCT00423891|583242906|FG000|Treatment|Withdrawal by Subject|1|||
161504108|NCT00423891|583242907|FG001|Treatment|Withdrawal by Subject|0|||
161504109|NCT00423891|583242908|FG002|Treatment|Withdrawal by Subject|0|||
161504110|NCT00423891|583242906|FG000|Treatment|Lost to Follow-up|1|||
161504111|NCT00423891|583242907|FG001|Treatment|Lost to Follow-up|0|||
161504112|NCT00423891|583242908|FG002|Treatment|Lost to Follow-up|0|||
161504113|NCT00423891|583242906|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
161673875|NCT01968070|583859929|FG012|Period 1|Lost to Follow-up|0|||
161819767|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Death|2|||
161819768|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819769|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819770|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819771|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
161819772|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
161819773|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819774|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161819775|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161819776|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161504114|NCT00423891|583242907|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
161504115|NCT00423891|583242908|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
161504116|NCT00423891|583242906|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
161504117|NCT00423891|583242907|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
161504118|NCT00423891|583242908|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
161504119|NCT04327999|583242911|FG000|Overall Study|Protocol Violation|1|||
161504120|NCT02872116|583242916|FG000|Pre-Treatment|Disease Progression|0|||
161504121|NCT02872116|583242917|FG001|Pre-Treatment|Disease Progression|1|||
161504122|NCT02872116|583242918|FG002|Pre-Treatment|Disease Progression|0|||
161673876|NCT01968070|583859930|FG013|Period 1|Lost to Follow-up|0|||
161504123|NCT02872116|583242916|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
161504124|NCT02872116|583242917|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
161504125|NCT02872116|583242918|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
161504126|NCT02872116|583242916|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
161504127|NCT02872116|583242917|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
161504128|NCT02872116|583242918|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
161504129|NCT02872116|583242916|FG000|Pre-Treatment|Participant withdrew consent|2|||
161504130|NCT02872116|583242917|FG001|Pre-Treatment|Participant withdrew consent|20|||
161504131|NCT02872116|583242918|FG002|Pre-Treatment|Participant withdrew consent|3|||
161504132|NCT02872116|583242916|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
161504133|NCT02872116|583242917|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
161504134|NCT02872116|583242918|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
161504135|NCT02872116|583242916|FG000|Pre-Treatment|Other reasons|1|||
161504136|NCT02872116|583242917|FG001|Pre-Treatment|Other reasons|2|||
161504137|NCT02872116|583242918|FG002|Pre-Treatment|Other reasons|2|||
161504138|NCT02872116|583242916|FG000|Treatment|Death|121|||
161504139|NCT02872116|583242917|FG001|Treatment|Death|94|||
161504140|NCT02872116|583242918|FG002|Treatment|Death|68|||
161504141|NCT02872116|583242916|FG000|Treatment|Lost to Follow-up|5|||
161504142|NCT02872116|583242917|FG001|Treatment|Lost to Follow-up|7|||
161504143|NCT02872116|583242918|FG002|Treatment|Lost to Follow-up|3|||
161504144|NCT02872116|583242916|FG000|Treatment|Participant withdrew consent|20|||
161504145|NCT02872116|583242917|FG001|Treatment|Participant withdrew consent|40|||
161504146|NCT02872116|583242918|FG002|Treatment|Participant withdrew consent|8|||
161504147|NCT02872116|583242916|FG000|Treatment|Other reasons|13|||
161504148|NCT02872116|583242917|FG001|Treatment|Other reasons|12|||
161504149|NCT02872116|583242918|FG002|Treatment|Other reasons|5|||
161504150|NCT03792672|583242927|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
161504151|NCT03792672|583242928|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
161504152|NCT03792672|583242929|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
161504153|NCT03792672|583242930|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
161504154|NCT03792672|583242931|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
161504155|NCT03792672|583242932|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
161504156|NCT03792672|583242927|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
161504157|NCT03792672|583242928|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
161504158|NCT03792672|583242929|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
161504159|NCT03792672|583242930|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
161504160|NCT03792672|583242931|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
161504161|NCT03792672|583242932|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
161504162|NCT03792672|583242927|FG000|Treatment Period 4 (2 Days)|Other|1|||
161504163|NCT03792672|583242928|FG001|Treatment Period 4 (2 Days)|Other|0|||
161504164|NCT03792672|583242929|FG002|Treatment Period 4 (2 Days)|Other|0|||
161504165|NCT03792672|583242930|FG003|Treatment Period 4 (2 Days)|Other|0|||
161504166|NCT03792672|583242931|FG004|Treatment Period 4 (2 Days)|Other|0|||
161504167|NCT03792672|583242932|FG005|Treatment Period 4 (2 Days)|Other|0|||
161673877|NCT01968070|583859931|FG014|Period 1|Lost to Follow-up|0|||
161673878|NCT01968070|583859932|FG015|Period 1|Lost to Follow-up|0|||
161673879|NCT01968070|583859933|FG016|Period 1|Lost to Follow-up|0|||
161673880|NCT01968070|583859934|FG017|Period 1|Lost to Follow-up|0|||
161673881|NCT01968070|583859917|FG000|Period 1|Adverse Event|0|||
161673882|NCT01968070|583859918|FG001|Period 1|Adverse Event|0|||
161673883|NCT01968070|583859919|FG002|Period 1|Adverse Event|0|||
161673884|NCT01968070|583859920|FG003|Period 1|Adverse Event|0|||
161673885|NCT01968070|583859921|FG004|Period 1|Adverse Event|0|||
161673886|NCT01968070|583859922|FG005|Period 1|Adverse Event|0|||
161673887|NCT01968070|583859923|FG006|Period 1|Adverse Event|1|||
161504168|NCT01364428|583242941|FG000|Overall Study|Adverse Event|1|||
161504169|NCT01364428|583242942|FG001|Overall Study|Adverse Event|2|||
161504170|NCT01364428|583242941|FG000|Overall Study|Protocol Violation|2|||
161504171|NCT01364428|583242942|FG001|Overall Study|Protocol Violation|0|||
161504172|NCT01364428|583242941|FG000|Overall Study|Withdrawal Criteria|14|||
161504173|NCT01364428|583242942|FG001|Overall Study|Withdrawal Criteria|10|||
161504174|NCT01364428|583242941|FG000|Overall Study|Other|3|||
161504175|NCT01364428|583242942|FG001|Overall Study|Other|3|||
161504176|NCT01585766|583242943|FG000|Overall Study|Withdrawal by Subject|0|||
161504177|NCT01585766|583242944|FG001|Overall Study|Withdrawal by Subject|1|||
161504178|NCT01585766|583242945|FG002|Overall Study|Withdrawal by Subject|1|||
161504179|NCT01585766|583242946|FG003|Overall Study|Withdrawal by Subject|0|||
161925687|NCT03166631|584774575|FG009|Overall Study|Progressive disease|5|||
161673888|NCT01968070|583859924|FG007|Period 1|Adverse Event|0|||
161673889|NCT01968070|583859925|FG008|Period 1|Adverse Event|0|||
161673890|NCT01968070|583859926|FG009|Period 1|Adverse Event|0|||
161673891|NCT01968070|583859927|FG010|Period 1|Adverse Event|0|||
161673892|NCT01968070|583859928|FG011|Period 1|Adverse Event|0|||
161504180|NCT01585766|583242947|FG004|Overall Study|Withdrawal by Subject|0|||
161504181|NCT01585766|583242948|FG005|Overall Study|Withdrawal by Subject|0|||
161504182|NCT01585766|583242943|FG000|Overall Study|Death|0|||
161504183|NCT01585766|583242944|FG001|Overall Study|Death|1|||
161504184|NCT01585766|583242945|FG002|Overall Study|Death|0|||
161504185|NCT01585766|583242946|FG003|Overall Study|Death|0|||
161504186|NCT01585766|583242947|FG004|Overall Study|Death|0|||
161504187|NCT01585766|583242948|FG005|Overall Study|Death|0|||
161819777|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
161504188|NCT01585766|583242943|FG000|Overall Study|Physician Decision|0|||
161504189|NCT01585766|583242944|FG001|Overall Study|Physician Decision|0|||
161504190|NCT01585766|583242945|FG002|Overall Study|Physician Decision|1|||
161504191|NCT01585766|583242946|FG003|Overall Study|Physician Decision|0|||
161504192|NCT01585766|583242947|FG004|Overall Study|Physician Decision|0|||
161504193|NCT01585766|583242948|FG005|Overall Study|Physician Decision|0|||
161504194|NCT01073865|583242949|FG000|Overall Study|Reasons other than below|19|||
161504195|NCT01073865|583242950|FG001|Overall Study|Reasons other than below|31|||
161504196|NCT01073865|583242949|FG000|Overall Study|Lost to Follow-up|1|||
161504197|NCT01073865|583242950|FG001|Overall Study|Lost to Follow-up|1|||
161504198|NCT01073865|583242949|FG000|Overall Study|Death|3|||
161504199|NCT01073865|583242950|FG001|Overall Study|Death|2|||
161504200|NCT01073865|583242949|FG000|Overall Study|Withdrawal by Subject|5|||
161504201|NCT01073865|583242950|FG001|Overall Study|Withdrawal by Subject|5|||
161504202|NCT03925324|583242951|FG000|Overall Study|Death|1|||
161504203|NCT03925324|583242952|FG001|Overall Study|Death|1|||
161504204|NCT04414553|583242953|FG000|Overall Study|Lost to Follow-up|20|||
161504205|NCT00696137|583242957|FG000|Overall Study|Withdrawal by Subject|2|||
161504206|NCT04371380|583242961|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
161504207|NCT04371380|583242962|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
161504208|NCT04371380|583242963|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
161504209|NCT02376166|583242964|FG000|Overall Study|Adverse Event|1|||
161504210|NCT02376166|583242964|FG000|Overall Study|Discontinued metformin early|2|||
161504211|NCT04251221|583242975|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
161504212|NCT04251221|583242976|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
161504213|NCT02120794|583242977|FG000|Overall Study|Withdrawal by Subject|43|||
161504214|NCT02120794|583242977|FG000|Overall Study|Adverse Event|10|||
161504215|NCT02120794|583242977|FG000|Overall Study|Physician Decision|4|||
161504216|NCT02120794|583242977|FG000|Overall Study|Due to insurance coverage|1|||
161504217|NCT01148511|583242978|FG000|Exposed to Study Drug|Protocol Violation|2|||
161504218|NCT01148511|583242979|FG001|Exposed to Study Drug|Protocol Violation|0|||
161504219|NCT01148511|583242980|FG002|Exposed to Study Drug|Protocol Violation|0|||
161504220|NCT01148511|583242978|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
161504221|NCT01148511|583242979|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
161504222|NCT01148511|583242980|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
161504223|NCT01148511|583242978|FG000|Randomized|Adverse Event|0|||
161504224|NCT01148511|583242979|FG001|Randomized|Adverse Event|1|||
161504225|NCT01148511|583242980|FG002|Randomized|Adverse Event|0|||
161504226|NCT01148511|583242978|FG000|Randomized|Protocol Violation|0|||
161504227|NCT01148511|583242979|FG001|Randomized|Protocol Violation|2|||
161504228|NCT01148511|583242980|FG002|Randomized|Protocol Violation|1|||
161504229|NCT01148511|583242978|FG000|Randomized|Lost to Follow-up|0|||
161504230|NCT01148511|583242979|FG001|Randomized|Lost to Follow-up|1|||
161504231|NCT01148511|583242980|FG002|Randomized|Lost to Follow-up|1|||
161504232|NCT01148511|583242978|FG000|Randomized|Consent withdrawal|0|||
161504233|NCT01148511|583242979|FG001|Randomized|Consent withdrawal|5|||
161504234|NCT01148511|583242980|FG002|Randomized|Consent withdrawal|3|||
161504235|NCT01148511|583242978|FG000|Randomized|Other|0|||
161504236|NCT01148511|583242979|FG001|Randomized|Other|1|||
161586131|NCT05338086|583534143|FG000|Transition Period (M12 to M18)|Death|0|||
161586132|NCT05338086|583534144|FG001|Transition Period (M12 to M18)|Death|0|||
161819778|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161819779|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161586133|NCT05338086|583534145|FG002|Transition Period (M12 to M18)|Death|1|||
161586134|NCT05338086|583534146|FG003|Transition Period (M12 to M18)|Death|0|||
161925688|NCT03166631|584774576|FG010|Overall Study|Progressive disease|7|||
161504237|NCT01148511|583242980|FG002|Randomized|Other|1|||
161504238|NCT00969553|583242981|FG000|Overall Study|Progressive disease (PD)|2|||
161504239|NCT00969553|583242982|FG001|Overall Study|Progressive disease (PD)|2|||
161504240|NCT00969553|583242983|FG002|Overall Study|Progressive disease (PD)|6|||
161504241|NCT00969553|583242984|FG003|Overall Study|Progressive disease (PD)|9|||
161504242|NCT00969553|583242985|FG004|Overall Study|Progressive disease (PD)|2|||
161504243|NCT00969553|583242986|FG005|Overall Study|Progressive disease (PD)|4|||
161504244|NCT00969553|583242987|FG006|Overall Study|Progressive disease (PD)|2|||
161504245|NCT00969553|583242988|FG007|Overall Study|Progressive disease (PD)|12|||
161504246|NCT00969553|583242989|FG008|Overall Study|Progressive disease (PD)|3|||
161504247|NCT00969553|583242981|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504248|NCT00969553|583242982|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504249|NCT00969553|583242983|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504250|NCT00969553|583242984|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504251|NCT00969553|583242985|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
161504252|NCT00969553|583242986|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504253|NCT00969553|583242987|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504254|NCT00969553|583242988|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504255|NCT00969553|583242989|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
161504256|NCT00969553|583242981|FG000|Overall Study|Other Adverse Event|0|||
161504257|NCT00969553|583242982|FG001|Overall Study|Other Adverse Event|0|||
161504258|NCT00969553|583242983|FG002|Overall Study|Other Adverse Event|0|||
161504259|NCT00969553|583242984|FG003|Overall Study|Other Adverse Event|1|||
161504260|NCT00969553|583242985|FG004|Overall Study|Other Adverse Event|0|||
161504261|NCT00969553|583242986|FG005|Overall Study|Other Adverse Event|0|||
161504262|NCT00969553|583242987|FG006|Overall Study|Other Adverse Event|1|||
161504263|NCT00969553|583242988|FG007|Overall Study|Other Adverse Event|0|||
161504264|NCT00969553|583242989|FG008|Overall Study|Other Adverse Event|0|||
161504265|NCT00969553|583242981|FG000|Overall Study|Refused cont. medication|1|||
161504266|NCT00969553|583242982|FG001|Overall Study|Refused cont. medication|1|||
161504267|NCT00969553|583242983|FG002|Overall Study|Refused cont. medication|0|||
161504268|NCT00969553|583242984|FG003|Overall Study|Refused cont. medication|2|||
161504269|NCT00969553|583242985|FG004|Overall Study|Refused cont. medication|0|||
161504270|NCT00969553|583242986|FG005|Overall Study|Refused cont. medication|0|||
161504271|NCT00969553|583242987|FG006|Overall Study|Refused cont. medication|0|||
161504272|NCT00969553|583242988|FG007|Overall Study|Refused cont. medication|1|||
161504273|NCT00969553|583242989|FG008|Overall Study|Refused cont. medication|0|||
161504274|NCT00969553|583242981|FG000|Overall Study|Not specified above|0|||
161504275|NCT00969553|583242982|FG001|Overall Study|Not specified above|0|||
161504276|NCT00969553|583242983|FG002|Overall Study|Not specified above|0|||
161504277|NCT00969553|583242984|FG003|Overall Study|Not specified above|4|||
161504278|NCT00969553|583242985|FG004|Overall Study|Not specified above|0|||
161504279|NCT00969553|583242986|FG005|Overall Study|Not specified above|0|||
161504280|NCT00969553|583242987|FG006|Overall Study|Not specified above|1|||
161504281|NCT00969553|583242988|FG007|Overall Study|Not specified above|1|||
161504282|NCT00969553|583242989|FG008|Overall Study|Not specified above|0|||
161504283|NCT04243538|583242990|FG000|Overall Study|Withdrawal by Subject|0|||
161504284|NCT04243538|583242991|FG001|Overall Study|Withdrawal by Subject|2|||
161504285|NCT04243538|583242990|FG000|Overall Study|Lost to Follow-up|0|||
161504286|NCT04243538|583242991|FG001|Overall Study|Lost to Follow-up|3|||
161504287|NCT04536727|583242992|FG000|Overall Study|Lost to Follow-up|1|||
161504288|NCT04536727|583242993|FG001|Overall Study|Lost to Follow-up|1|||
161504289|NCT04536727|583242992|FG000|Overall Study|Death|0|||
161504290|NCT04536727|583242993|FG001|Overall Study|Death|1|||
161504291|NCT00500370|583242994|FG000|Overall Study|Adverse Event|9|||
161504292|NCT00500370|583242995|FG001|Overall Study|Adverse Event|3|||
161504293|NCT00500370|583242994|FG000|Overall Study|Lost to Follow-up|10|||
161504294|NCT00500370|583242995|FG001|Overall Study|Lost to Follow-up|10|||
161504295|NCT00500370|583242994|FG000|Overall Study|Protocol Violation|2|||
161504296|NCT00500370|583242995|FG001|Overall Study|Protocol Violation|4|||
161504297|NCT00500370|583242994|FG000|Overall Study|Sponsor Decision|2|||
161504298|NCT00500370|583242995|FG001|Overall Study|Sponsor Decision|0|||
161504299|NCT00500370|583242994|FG000|Overall Study|Subject Decision|10|||
161504300|NCT00500370|583242995|FG001|Overall Study|Subject Decision|17|||
161504301|NCT05308901|583244450|FG000|Overall Study|Death|6|||
161504302|NCT02586012|583244451|FG000|Overall Study|Withdrawal by Subject|1|||
161504303|NCT02586012|583244452|FG001|Overall Study|Withdrawal by Subject|1|||
161504304|NCT02586012|583244453|FG002|Overall Study|Withdrawal by Subject|0|||
161504305|NCT02586012|583244454|FG003|Overall Study|Withdrawal by Subject|1|||
161504306|NCT02586012|583244455|FG004|Overall Study|Withdrawal by Subject|0|||
161504307|NCT02586012|583244456|FG005|Overall Study|Withdrawal by Subject|2|||
161504308|NCT02586012|583244451|FG000|Overall Study|Protocol Violation|0|||
161504309|NCT02586012|583244452|FG001|Overall Study|Protocol Violation|0|||
161504310|NCT02586012|583244453|FG002|Overall Study|Protocol Violation|0|||
161504311|NCT02586012|583244454|FG003|Overall Study|Protocol Violation|0|||
161504312|NCT02586012|583244455|FG004|Overall Study|Protocol Violation|0|||
161504313|NCT02586012|583244456|FG005|Overall Study|Protocol Violation|1|||
161504314|NCT02586012|583244451|FG000|Overall Study|study terminated|0|||
161504315|NCT02586012|583244452|FG001|Overall Study|study terminated|2|||
161504316|NCT02586012|583244453|FG002|Overall Study|study terminated|1|||
161504317|NCT02586012|583244454|FG003|Overall Study|study terminated|1|||
161504318|NCT02586012|583244455|FG004|Overall Study|study terminated|1|||
161504319|NCT02586012|583244456|FG005|Overall Study|study terminated|0|||
161504320|NCT01816139|583244457|FG000|Overall Study|Adverse Event|6|||
161504321|NCT01816139|583244458|FG001|Overall Study|Adverse Event|8|||
161504322|NCT01816139|583244457|FG000|Overall Study|Lack of Efficacy|1|||
161504323|NCT01816139|583244458|FG001|Overall Study|Lack of Efficacy|2|||
161504324|NCT01816139|583244457|FG000|Overall Study|Lost to Follow-up|5|||
161504325|NCT01816139|583244458|FG001|Overall Study|Lost to Follow-up|3|||
161504326|NCT01816139|583244457|FG000|Overall Study|Withdrew Consent|6|||
161504327|NCT01816139|583244458|FG001|Overall Study|Withdrew Consent|4|||
161504328|NCT01816139|583244457|FG000|Overall Study|Protocol Violation|6|||
161504329|NCT01816139|583244458|FG001|Overall Study|Protocol Violation|3|||
161504330|NCT01816139|583244457|FG000|Overall Study|Reason not Specified|4|||
161504331|NCT01816139|583244458|FG001|Overall Study|Reason not Specified|2|||
161504332|NCT02554656|583244459|FG000|Overall Study|Protocol Violation|3|||
161504333|NCT01888497|583244460|FG000|Washout Period 1|Withdrawal by Subject|0|||
161504334|NCT01888497|583244461|FG001|Washout Period 1|Withdrawal by Subject|0|||
161504335|NCT01888497|583244462|FG002|Washout Period 1|Withdrawal by Subject|1|||
161504336|NCT01888497|583244463|FG003|Washout Period 1|Withdrawal by Subject|1|||
161504337|NCT01888497|583244460|FG000|Washout Period 2|Adverse Event|0|||
161504338|NCT01888497|583244461|FG001|Washout Period 2|Adverse Event|0|||
161504339|NCT01888497|583244462|FG002|Washout Period 2|Adverse Event|0|||
161504340|NCT01888497|583244463|FG003|Washout Period 2|Adverse Event|1|||
161504341|NCT01888497|583244460|FG000|Washout Period 2|Withdrawal by Subject|0|||
161504342|NCT01888497|583244461|FG001|Washout Period 2|Withdrawal by Subject|0|||
161504343|NCT01888497|583244462|FG002|Washout Period 2|Withdrawal by Subject|0|||
161504344|NCT01888497|583244463|FG003|Washout Period 2|Withdrawal by Subject|1|||
161504345|NCT01140477|583244466|FG000|Overall Study|Lost to Follow-up|4|||
161504346|NCT01140477|583244467|FG001|Overall Study|Lost to Follow-up|0|||
161504347|NCT01140477|583244466|FG000|Overall Study|Withdrawal by Subject|1|||
161504348|NCT01140477|583244467|FG001|Overall Study|Withdrawal by Subject|4|||
161504349|NCT01140477|583244466|FG000|Overall Study|Surgical complication preventing implant|2|||
161504350|NCT01140477|583244467|FG001|Overall Study|Surgical complication preventing implant|0|||
161504351|NCT01140477|583244466|FG000|Overall Study|Death|1|||
161504352|NCT01140477|583244467|FG001|Overall Study|Death|1|||
161504353|NCT01140477|583244466|FG000|Overall Study|Subject explanted|0|||
161504354|NCT01140477|583244467|FG001|Overall Study|Subject explanted|1|||
161504355|NCT04127786|583244472|FG000|Primary Series|Adverse Event|1|||
161504356|NCT04127786|583244473|FG001|Primary Series|Adverse Event|0|||
161504357|NCT04127786|583244474|FG002|Primary Series|Adverse Event|0|||
161504358|NCT04127786|583244475|FG003|Primary Series|Adverse Event|1|||
161504359|NCT04127786|583244476|FG004|Primary Series|Adverse Event|0|||
161504360|NCT04127786|583244477|FG005|Primary Series|Adverse Event|1|||
161504361|NCT04127786|583244472|FG000|Primary Series|Protocol Violation|5|||
161504362|NCT04127786|583244473|FG001|Primary Series|Protocol Violation|3|||
161504363|NCT04127786|583244474|FG002|Primary Series|Protocol Violation|4|||
161504364|NCT04127786|583244475|FG003|Primary Series|Protocol Violation|3|||
161504365|NCT04127786|583244476|FG004|Primary Series|Protocol Violation|2|||
161504366|NCT04127786|583244477|FG005|Primary Series|Protocol Violation|0|||
161504367|NCT04127786|583244472|FG000|Primary Series|Withdrawal by Subject|0|||
161504368|NCT04127786|583244473|FG001|Primary Series|Withdrawal by Subject|0|||
161504369|NCT04127786|583244474|FG002|Primary Series|Withdrawal by Subject|0|||
161504370|NCT04127786|583244475|FG003|Primary Series|Withdrawal by Subject|1|||
161504371|NCT04127786|583244476|FG004|Primary Series|Withdrawal by Subject|0|||
161504372|NCT04127786|583244477|FG005|Primary Series|Withdrawal by Subject|0|||
161504373|NCT04127786|583244472|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
161504374|NCT04127786|583244473|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
161504375|NCT04127786|583244474|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
161504376|NCT04127786|583244475|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
161504377|NCT04127786|583244476|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
161504378|NCT04127786|583244477|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
161504379|NCT04127786|583244472|FG000|Booster Phase|Withdrawal by Subject|2|||
161504380|NCT04127786|583244473|FG001|Booster Phase|Withdrawal by Subject|0|||
161504381|NCT04127786|583244474|FG002|Booster Phase|Withdrawal by Subject|0|||
161504382|NCT04127786|583244475|FG003|Booster Phase|Withdrawal by Subject|0|||
161504383|NCT04127786|583244476|FG004|Booster Phase|Withdrawal by Subject|0|||
161504384|NCT04127786|583244477|FG005|Booster Phase|Withdrawal by Subject|0|||
161504385|NCT01904604|583244478|FG000|Overall Study|Withdrew before receiving dosing|0|||
161504386|NCT01904604|583244479|FG001|Overall Study|Withdrew before receiving dosing|1|||
161504387|NCT01904604|583244480|FG002|Overall Study|Withdrew before receiving dosing|0|||
161504388|NCT01904604|583244478|FG000|Overall Study|Non-compliance|1|||
161504389|NCT01904604|583244479|FG001|Overall Study|Non-compliance|0|||
161504390|NCT01904604|583244480|FG002|Overall Study|Non-compliance|0|||
161504391|NCT01904604|583244478|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
161504392|NCT01904604|583244479|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
161504393|NCT01904604|583244480|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
161504394|NCT01904604|583244478|FG000|Overall Study|Patch site reactions|1|||
161504395|NCT01904604|583244479|FG001|Overall Study|Patch site reactions|1|||
161504396|NCT01904604|583244480|FG002|Overall Study|Patch site reactions|0|||
161504397|NCT01904604|583244478|FG000|Overall Study|Increased syncope|0|||
161504398|NCT01904604|583244479|FG001|Overall Study|Increased syncope|1|||
161504399|NCT01904604|583244480|FG002|Overall Study|Increased syncope|0|||
161504400|NCT01904604|583244478|FG000|Overall Study|Unrelated illness|0|||
161504401|NCT01904604|583244479|FG001|Overall Study|Unrelated illness|1|||
161504402|NCT01904604|583244480|FG002|Overall Study|Unrelated illness|0|||
161504403|NCT01904604|583244478|FG000|Overall Study|Passed Week 52 OFC|1|||
161504404|NCT01904604|583244479|FG001|Overall Study|Passed Week 52 OFC|0|||
161504405|NCT01904604|583244480|FG002|Overall Study|Passed Week 52 OFC|0|||
161504406|NCT01904604|583244478|FG000|Overall Study|Withdrawal by Subject|1|||
161504407|NCT01904604|583244479|FG001|Overall Study|Withdrawal by Subject|2|||
161504408|NCT01904604|583244480|FG002|Overall Study|Withdrawal by Subject|0|||
161504409|NCT01904604|583244478|FG000|Overall Study|Participant Relocated|1|||
161504410|NCT01904604|583244479|FG001|Overall Study|Participant Relocated|1|||
161504411|NCT01904604|583244480|FG002|Overall Study|Participant Relocated|1|||
161504412|NCT01904604|583244478|FG000|Overall Study|Lost to Follow-up|0|||
161504413|NCT01904604|583244479|FG001|Overall Study|Lost to Follow-up|0|||
161504414|NCT01904604|583244480|FG002|Overall Study|Lost to Follow-up|1|||
161504415|NCT02118428|583244484|FG000|Overall Study|Physician Decision|0|||
161504416|NCT02118428|583244485|FG001|Overall Study|Physician Decision|1|||
161504417|NCT02118428|583244486|FG002|Overall Study|Physician Decision|0|||
161504418|NCT02118428|583244484|FG000|Overall Study|Withdrawal by Subject|2|||
161504419|NCT02118428|583244485|FG001|Overall Study|Withdrawal by Subject|2|||
161504420|NCT02118428|583244486|FG002|Overall Study|Withdrawal by Subject|0|||
161504421|NCT02118428|583244484|FG000|Overall Study|Death|7|||
161504422|NCT02118428|583244485|FG001|Overall Study|Death|5|||
161504423|NCT02118428|583244486|FG002|Overall Study|Death|0|||
161504424|NCT02118428|583244484|FG000|Overall Study|Lost to Follow-up|3|||
161504425|NCT02118428|583244485|FG001|Overall Study|Lost to Follow-up|1|||
161504426|NCT02118428|583244486|FG002|Overall Study|Lost to Follow-up|0|||
161504427|NCT02118428|583244484|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
161504428|NCT02118428|583244485|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
161504429|NCT02118428|583244486|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
161504430|NCT03325166|583244487|FG000|Overall Study|Adverse Event|1|||
161504431|NCT01633944|583244488|FG000|Open-label Titration Phase|Adverse Event|109|||
161504432|NCT01633944|583244489|FG001|Open-label Titration Phase|Adverse Event|0|||
161504433|NCT01633944|583244490|FG002|Open-label Titration Phase|Adverse Event|0|||
161504434|NCT01633944|583244488|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
161504435|NCT01633944|583244489|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
161504436|NCT01633944|583244490|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
161504437|NCT01633944|583244488|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
161504438|NCT01633944|583244489|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
161504439|NCT01633944|583244490|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
161504440|NCT01633944|583244488|FG000|Open-label Titration Phase|Protocol Violation|24|||
161504441|NCT01633944|583244489|FG001|Open-label Titration Phase|Protocol Violation|0|||
161504442|NCT01633944|583244490|FG002|Open-label Titration Phase|Protocol Violation|0|||
161504443|NCT01633944|583244488|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
161504444|NCT01633944|583244489|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
161504445|NCT01633944|583244490|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
161504446|NCT01633944|583244488|FG000|Open-label Titration Phase|Other|68|||
161504447|NCT01633944|583244489|FG001|Open-label Titration Phase|Other|0|||
161504448|NCT01633944|583244490|FG002|Open-label Titration Phase|Other|0|||
161504449|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161504450|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Adverse Event|13|||
161504451|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Adverse Event|7|||
161504452|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
161504453|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
161504454|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
161504455|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161504456|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
161504457|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
161504458|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
161504459|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
161504460|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
161504461|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161504462|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
161504463|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
161504464|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
161504465|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
161504466|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
161504467|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
161504468|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
161504469|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
161504470|NCT01633944|583244488|FG000|Double-blind Treatment Phase|Other|0|||
161504471|NCT01633944|583244489|FG001|Double-blind Treatment Phase|Other|7|||
161673893|NCT01968070|583859929|FG012|Period 1|Adverse Event|0|||
161673894|NCT01968070|583859930|FG013|Period 1|Adverse Event|0|||
161673895|NCT01968070|583859931|FG014|Period 1|Adverse Event|0|||
161504472|NCT01633944|583244490|FG002|Double-blind Treatment Phase|Other|0|||
161504473|NCT03354429|583244492|FG000|Overall Study|Withdrawal by Subject|8|||
161504474|NCT03354429|583244493|FG001|Overall Study|Withdrawal by Subject|7|||
161673896|NCT01968070|583859932|FG015|Period 1|Adverse Event|0|||
161673897|NCT01968070|583859933|FG016|Period 1|Adverse Event|0|||
161504475|NCT03354429|583244492|FG000|Overall Study|Lost to Follow-up|1|||
161819780|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161504476|NCT03354429|583244493|FG001|Overall Study|Lost to Follow-up|0|||
161504477|NCT00782210|583244495|FG000|Overall Study|Adverse Event|21|||
161504478|NCT00782210|583244496|FG001|Overall Study|Adverse Event|17|||
161504479|NCT00782210|583244497|FG002|Overall Study|Adverse Event|16|||
161819781|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161819782|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161504480|NCT00782210|583244495|FG000|Overall Study|Lost to Follow-up|2|||
161504481|NCT00782210|583244496|FG001|Overall Study|Lost to Follow-up|1|||
161504482|NCT00782210|583244497|FG002|Overall Study|Lost to Follow-up|2|||
161504483|NCT00782210|583244495|FG000|Overall Study|Withdrawal by Subject|11|||
161504484|NCT00782210|583244496|FG001|Overall Study|Withdrawal by Subject|8|||
161504485|NCT00782210|583244497|FG002|Overall Study|Withdrawal by Subject|11|||
161504486|NCT00782210|583244495|FG000|Overall Study|Non compliance with protocol|0|||
161504487|NCT00782210|583244496|FG001|Overall Study|Non compliance with protocol|3|||
161504488|NCT00782210|583244497|FG002|Overall Study|Non compliance with protocol|2|||
161504489|NCT00782210|583244495|FG000|Overall Study|Lack of Efficacy|13|||
161504490|NCT00782210|583244496|FG001|Overall Study|Lack of Efficacy|4|||
161504491|NCT00782210|583244497|FG002|Overall Study|Lack of Efficacy|1|||
161504492|NCT00782210|583244495|FG000|Overall Study|Other reason not described above|3|||
161504493|NCT00782210|583244496|FG001|Overall Study|Other reason not described above|2|||
161504494|NCT00782210|583244497|FG002|Overall Study|Other reason not described above|3|||
161504495|NCT05923229|583244504|FG000|Overall Study|Withdrawal by Subject|3|||
161504496|NCT05923229|583244505|FG001|Overall Study|Withdrawal by Subject|0|||
161504497|NCT05923229|583244504|FG000|Overall Study|Health related|2|||
161504498|NCT05923229|583244505|FG001|Overall Study|Health related|1|||
161504499|NCT05040152|583244506|FG000|Overall Study|Withdrawal by Subject|5|||
161504500|NCT05040152|583244507|FG001|Overall Study|Withdrawal by Subject|0|||
161504501|NCT05040152|583244506|FG000|Overall Study|Lost to Follow-up|0|||
161504502|NCT05040152|583244507|FG001|Overall Study|Lost to Follow-up|2|||
161504503|NCT02704364|583244510|FG000|Overall Study|Adverse Event|1|||
161504504|NCT02704364|583244511|FG001|Overall Study|Adverse Event|1|||
161504505|NCT02704364|583244512|FG002|Overall Study|Adverse Event|0|||
161504506|NCT02704364|583244510|FG000|Overall Study|Noncompliance with study drug|1|||
161504507|NCT02704364|583244511|FG001|Overall Study|Noncompliance with study drug|1|||
161504508|NCT02704364|583244512|FG002|Overall Study|Noncompliance with study drug|0|||
161504509|NCT02704364|583244510|FG000|Overall Study|Other|0|||
161504510|NCT02704364|583244511|FG001|Overall Study|Other|1|||
161504511|NCT02704364|583244512|FG002|Overall Study|Other|1|||
161504512|NCT04098458|583244513|FG000|Overall Study|Death|1|||
161504513|NCT04098458|583244513|FG000|Overall Study|did not meet study inclusion criteria|3|||
161504514|NCT00453999|583244517|FG000|Overall Study|Adverse Event|1|||
161504515|NCT00453999|583244518|FG001|Overall Study|Adverse Event|2|||
161819783|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161504516|NCT00453999|583244519|FG002|Overall Study|Adverse Event|1|||
161504517|NCT00453999|583244517|FG000|Overall Study|Lost to Follow-up|0|||
161504518|NCT00453999|583244518|FG001|Overall Study|Lost to Follow-up|1|||
161504519|NCT00453999|583244519|FG002|Overall Study|Lost to Follow-up|1|||
161504520|NCT00453999|583244517|FG000|Overall Study|Withdrawal by Subject|2|||
161504521|NCT00453999|583244518|FG001|Overall Study|Withdrawal by Subject|1|||
161504522|NCT00453999|583244519|FG002|Overall Study|Withdrawal by Subject|1|||
161504523|NCT00453999|583244517|FG000|Overall Study|Subject Request|2|||
161504524|NCT00453999|583244518|FG001|Overall Study|Subject Request|1|||
161504525|NCT00453999|583244519|FG002|Overall Study|Subject Request|0|||
161504526|NCT04238728|583244523|FG000|Overall Study|Withdrawal by Subject|1|||
161504527|NCT04238728|583244523|FG000|Overall Study|Lost to Follow-up|2|||
161504528|NCT04225923|583244529|FG000|Overall Study|Protocol Violation|1|||
161504529|NCT04225923|583244530|FG001|Overall Study|Protocol Violation|0|||
161819784|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
161504530|NCT04225923|583244531|FG002|Overall Study|Protocol Violation|1|||
161504531|NCT04225923|583244529|FG000|Overall Study|Withdrawal by Subject|4|||
161819785|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
161819786|NCT00396162|584381139|FG000|Overall Study|Withdrawal by Subject|2|||
161819787|NCT00396162|584381140|FG001|Overall Study|Withdrawal by Subject|3|||
161819788|NCT02694536|584381141|FG000|Overall Study|Progressive Disease|40|||
161819789|NCT02694536|584381141|FG000|Overall Study|Lost to Follow-up|1|||
161504532|NCT04225923|583244530|FG001|Overall Study|Withdrawal by Subject|1|||
161504533|NCT04225923|583244531|FG002|Overall Study|Withdrawal by Subject|3|||
161504534|NCT04225923|583244529|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
161504535|NCT04225923|583244530|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
161504536|NCT04225923|583244531|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
161504537|NCT01907828|583244537|FG000|Overall Study|Exclusion criteria not met|0|||
161504538|NCT01907828|583244538|FG001|Overall Study|Exclusion criteria not met|1|||
161504539|NCT01907828|583244537|FG000|Overall Study|Withdrawal by Subject|3|||
161504540|NCT01907828|583244538|FG001|Overall Study|Withdrawal by Subject|4|||
161504541|NCT01907828|583244537|FG000|Overall Study|Lost to Follow-up|3|||
161504542|NCT01907828|583244538|FG001|Overall Study|Lost to Follow-up|0|||
161504543|NCT01907828|583244537|FG000|Overall Study|Participant refused 24-month follow-up|1|||
161504544|NCT01907828|583244538|FG001|Overall Study|Participant refused 24-month follow-up|0|||
161504545|NCT01907828|583244537|FG000|Overall Study|Participant met exclusion criteria|0|||
161504546|NCT01907828|583244538|FG001|Overall Study|Participant met exclusion criteria|1|||
161504547|NCT00775437|583244551|FG000|Overall Study|Loss of efficacy|2|||
161504548|NCT00775437|583244551|FG000|Overall Study|Withdrawal by Subject|3|||
161504549|NCT00775437|583244551|FG000|Overall Study|Lost to Follow-up|1|||
161504550|NCT04180020|583244556|FG000|Overall Study|missed visit|18|||
161504551|NCT04180020|583244557|FG001|Overall Study|missed visit|16|||
161504552|NCT04180020|583244556|FG000|Overall Study|Death|2|||
161504553|NCT04180020|583244557|FG001|Overall Study|Death|3|||
161504554|NCT04180020|583244556|FG000|Overall Study|Withdrawal by Subject|1|||
161504555|NCT04180020|583244557|FG001|Overall Study|Withdrawal by Subject|5|||
161504556|NCT04180020|583244556|FG000|Overall Study|incarcerated|1|||
161504557|NCT04180020|583244557|FG001|Overall Study|incarcerated|1|||
161504558|NCT04180020|583244556|FG000|Overall Study|Physician Decision|0|||
161504559|NCT04180020|583244557|FG001|Overall Study|Physician Decision|2|||
161504560|NCT03216850|583244562|FG000|Overall Study|Pre-analytical error|6|||
161504561|NCT03554291|583244565|FG000|Overall Study|Death|2|||
161504562|NCT03554291|583244566|FG001|Overall Study|Death|1|||
161504563|NCT03554291|583244565|FG000|Overall Study|Lost to Follow-up|1|||
161504564|NCT03554291|583244566|FG001|Overall Study|Lost to Follow-up|0|||
161504565|NCT03554291|583244565|FG000|Overall Study|Withdrawal by Subject|1|||
161504566|NCT03554291|583244566|FG001|Overall Study|Withdrawal by Subject|0|||
161504567|NCT03554291|583244565|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
161504568|NCT03554291|583244566|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
161504569|NCT01228747|583244567|FG000|Overall Study|Adverse Event|8|||
161504570|NCT01228747|583244568|FG001|Overall Study|Adverse Event|4|||
161504571|NCT01228747|583244567|FG000|Overall Study|Lack of Efficacy|40|||
161504572|NCT01228747|583244568|FG001|Overall Study|Lack of Efficacy|27|||
161504573|NCT01228747|583244567|FG000|Overall Study|Protocol Violation|6|||
161504574|NCT01228747|583244568|FG001|Overall Study|Protocol Violation|5|||
161504575|NCT01228747|583244567|FG000|Overall Study|Lost to Follow-up|4|||
161504576|NCT01228747|583244568|FG001|Overall Study|Lost to Follow-up|3|||
161504577|NCT01228747|583244567|FG000|Overall Study|Withdrawal by Subject|5|||
161504578|NCT01228747|583244568|FG001|Overall Study|Withdrawal by Subject|1|||
161504579|NCT01228747|583244567|FG000|Overall Study|Other Reason|2|||
161504580|NCT01228747|583244568|FG001|Overall Study|Other Reason|5|||
161504581|NCT04258605|583244574|FG000|Overall Study|Death|1|||
161504582|NCT04258605|583244575|FG001|Overall Study|Death|0|||
161504583|NCT04258605|583244574|FG000|Overall Study|Early study termination|21|||
161504584|NCT04258605|583244575|FG001|Overall Study|Early study termination|2|||
161504585|NCT02910167|583244576|FG000|Overall Study|Adverse Event|1|||
161504586|NCT02910167|583244576|FG000|Overall Study|Lost to Follow-up|18|||
161504587|NCT00842348|583244584|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
161504588|NCT00842348|583244585|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
161504589|NCT00842348|583244584|FG000|Study 729|Disease progression/death|19|||
161504590|NCT00842348|583244585|FG001|Study 729|Disease progression/death|30|||
161504591|NCT00842348|583244584|FG000|Study 729|Adverse Event|1|||
161504592|NCT00842348|583244585|FG001|Study 729|Adverse Event|1|||
161504593|NCT00842348|583244584|FG000|Study 729|Protocol Violation|1|||
161504594|NCT00842348|583244585|FG001|Study 729|Protocol Violation|1|||
161504595|NCT00842348|583244584|FG000|Study 729|Withdrawal by Subject|2|||
161504596|NCT00842348|583244585|FG001|Study 729|Withdrawal by Subject|4|||
161504597|NCT00842348|583244584|FG000|Study 729|Due to Sponsor stopping the study|1|||
161504598|NCT00842348|583244585|FG001|Study 729|Due to Sponsor stopping the study|1|||
161504599|NCT00842348|583244584|FG000|Study 729|Due to non-availability of IP|0|||
161504600|NCT00842348|583244585|FG001|Study 729|Due to non-availability of IP|1|||
161504601|NCT00842348|583244584|FG000|Study 729|Sponsor's decision|1|||
161504602|NCT00842348|583244585|FG001|Study 729|Sponsor's decision|0|||
161504603|NCT00842348|583244584|FG000|Study 729|Surgical resection|1|||
161504604|NCT00842348|583244585|FG001|Study 729|Surgical resection|0|||
161504605|NCT00026793|583244590|FG000|Overall Study|Death on study due to underlying disease|4|||
161504606|NCT00026793|583244590|FG000|Overall Study|Physician Decision|2|||
161504607|NCT00026793|583244590|FG000|Overall Study|Off study|2|||
161504608|NCT01449526|583244591|FG000|Overall Study|Lost to Follow-up|1|||
161504609|NCT01449526|583244592|FG001|Overall Study|Lost to Follow-up|2|||
161504610|NCT01449526|583244591|FG000|Overall Study|Withdrawal by Subject|1|||
161504611|NCT01449526|583244592|FG001|Overall Study|Withdrawal by Subject|1|||
161504612|NCT01449526|583244591|FG000|Overall Study|Symptoms/complaints|0|||
161504613|NCT01449526|583244592|FG001|Overall Study|Symptoms/complaints|1|||
161504614|NCT01449526|583244591|FG000|Overall Study|Lack of Motivation|0|||
161504615|NCT01449526|583244592|FG001|Overall Study|Lack of Motivation|1|||
161504616|NCT01449526|583244591|FG000|Overall Study|Cannot maintain visits|0|||
161504617|NCT01449526|583244592|FG001|Overall Study|Cannot maintain visits|1|||
161504618|NCT01132495|583244593|FG000|Overall Study|Various reasons|40|||
161504619|NCT01132495|583244594|FG001|Overall Study|Various reasons|38|||
161504620|NCT01132495|583244595|FG002|Overall Study|Various reasons|20|||
161504621|NCT01132495|583244596|FG003|Overall Study|Various reasons|12|||
161504622|NCT03913091|583244597|FG000|Overall Study|Lost to Follow-up|18|||
161504623|NCT03913091|583244598|FG001|Overall Study|Lost to Follow-up|11|||
161504624|NCT03913091|583244597|FG000|Overall Study|Required additional meds/surgery|1|||
161504625|NCT03913091|583244598|FG001|Overall Study|Required additional meds/surgery|2|||
161504626|NCT03913091|583244597|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
161504627|NCT03913091|583244598|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
161504628|NCT00655564|583244599|FG000|Overall Study|Adverse Event|1|||
161819790|NCT02694536|584381141|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
161819791|NCT02694536|584381141|FG000|Overall Study|Withdrawal by Subject|8|||
161504629|NCT00655564|583244599|FG000|Overall Study|Lost to Follow-up|1|||
161504630|NCT00655564|583244599|FG000|Overall Study|Desired Alternate Therapy|1|||
161504631|NCT04013191|583247092|FG000|Overall Study|Adverse Event|1|||
161504632|NCT04013191|583247093|FG001|Overall Study|Adverse Event|0|||
161504633|NCT00394212|583247104|FG000|Overall Study|Lost to Follow-up|3|||
161504634|NCT00394212|583247105|FG001|Overall Study|Lost to Follow-up|0|||
161504635|NCT00394212|583247104|FG000|Overall Study|Withdrawal by Subject|4|||
161504636|NCT00394212|583247105|FG001|Overall Study|Withdrawal by Subject|1|||
161504637|NCT00588445|583247106|FG000|Overall Study|Protocol Violation|1|||
161504638|NCT00588445|583247106|FG000|Overall Study|Withdrawal by Subject|3|||
161504639|NCT00588445|583247106|FG000|Overall Study|Disease Progression|1|||
161504640|NCT00588445|583247106|FG000|Overall Study|Not Treated|10|||
161504641|NCT00358527|583247107|FG000|Overall Study|Adverse Event|4|||
161504642|NCT00358527|583247108|FG001|Overall Study|Adverse Event|0|||
161504643|NCT00358527|583247107|FG000|Overall Study|Withdrawal by Subject|1|||
161504644|NCT00358527|583247108|FG001|Overall Study|Withdrawal by Subject|1|||
161504645|NCT00358527|583247107|FG000|Overall Study|Non-compliance with protocol|6|||
161504646|NCT00358527|583247108|FG001|Overall Study|Non-compliance with protocol|1|||
161504647|NCT00358527|583247107|FG000|Overall Study|Administrative|2|||
161673898|NCT01968070|583859934|FG017|Period 1|Adverse Event|0|||
161673899|NCT01968070|583859917|FG000|Period 1|Physician Decision|0|||
161673900|NCT01968070|583859918|FG001|Period 1|Physician Decision|0|||
161673901|NCT01968070|583859919|FG002|Period 1|Physician Decision|0|||
161673902|NCT01968070|583859920|FG003|Period 1|Physician Decision|0|||
161673903|NCT01968070|583859921|FG004|Period 1|Physician Decision|0|||
161673904|NCT01968070|583859922|FG005|Period 1|Physician Decision|0|||
161673905|NCT01968070|583859923|FG006|Period 1|Physician Decision|0|||
161673906|NCT01968070|583859924|FG007|Period 1|Physician Decision|0|||
161819792|NCT02694536|584381141|FG000|Overall Study|Death|8|||
161819793|NCT02694536|584381141|FG000|Overall Study|Other|22|||
161819794|NCT01911429|584381142|FG000|Overall Study|Adverse Event|5|||
161504648|NCT00358527|583247108|FG001|Overall Study|Administrative|1|||
161504649|NCT04144166|583247111|FG000|Overall Study|Discharged before study start|1|||
161504650|NCT04144166|583247111|FG000|Overall Study|Pregnancy|1|||
161504651|NCT04144166|583247111|FG000|Overall Study|Nail polish could not be removed from finger|1|||
161504652|NCT00697346|583247112|FG000|Overall Study|Adverse Event|4|||
161504653|NCT00697346|583247113|FG001|Overall Study|Adverse Event|5|||
161504654|NCT00697346|583247114|FG002|Overall Study|Adverse Event|0|||
161504655|NCT00697346|583247112|FG000|Overall Study|Progressive Disease|19|||
161504656|NCT00697346|583247113|FG001|Overall Study|Progressive Disease|18|||
161504657|NCT00697346|583247114|FG002|Overall Study|Progressive Disease|0|||
161504658|NCT00697346|583247112|FG000|Overall Study|Symptomatic Deterioration|0|||
161504659|NCT00697346|583247113|FG001|Overall Study|Symptomatic Deterioration|1|||
161504660|NCT00697346|583247114|FG002|Overall Study|Symptomatic Deterioration|0|||
161504661|NCT00697346|583247112|FG000|Overall Study|Withdrawal by Subject|2|||
161504662|NCT00697346|583247113|FG001|Overall Study|Withdrawal by Subject|2|||
161504663|NCT00697346|583247114|FG002|Overall Study|Withdrawal by Subject|0|||
161504664|NCT00697346|583247112|FG000|Overall Study|Reason not Specified|3|||
161504665|NCT00697346|583247113|FG001|Overall Study|Reason not Specified|0|||
161504666|NCT00697346|583247114|FG002|Overall Study|Reason not Specified|1|||
161504667|NCT03569371|583247115|FG000|Overall Study|Lack of Efficacy|1|||
161504668|NCT03569371|583247115|FG000|Overall Study|Lost to Follow-up|1|||
161504669|NCT03569371|583247115|FG000|Overall Study|Adverse Event|1|||
161504670|NCT03643562|583247116|FG000|Overall Study|Adverse Event|1|||
161504671|NCT03643562|583247117|FG001|Overall Study|Adverse Event|0|||
161504672|NCT03643562|583247116|FG000|Overall Study|Lack of Efficacy|0|||
161504673|NCT03643562|583247117|FG001|Overall Study|Lack of Efficacy|1|||
161504674|NCT03643562|583247116|FG000|Overall Study|Physician Decision|0|||
161504675|NCT03643562|583247117|FG001|Overall Study|Physician Decision|1|||
161504676|NCT03643562|583247116|FG000|Overall Study|Study Terminated by Sponsor|2|||
161504677|NCT03643562|583247117|FG001|Overall Study|Study Terminated by Sponsor|10|||
161504678|NCT03643562|583247116|FG000|Overall Study|Withdrawal by Subject|2|||
161504679|NCT03643562|583247117|FG001|Overall Study|Withdrawal by Subject|2|||
161504680|NCT03643562|583247116|FG000|Overall Study|Other than specified|3|||
161504681|NCT03643562|583247117|FG001|Overall Study|Other than specified|2|||
161504682|NCT01236755|583247119|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
161504683|NCT01236755|583247119|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
161504684|NCT01236755|583247119|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
161504685|NCT01236755|583247119|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
161504686|NCT01481116|583247120|FG000|Overall Study|Adverse Event|26|||
161504687|NCT01481116|583247121|FG001|Overall Study|Adverse Event|26|||
161504688|NCT01481116|583247122|FG002|Overall Study|Adverse Event|42|||
161504689|NCT01481116|583247120|FG000|Overall Study|Major Protocol Deviation|3|||
161504690|NCT01481116|583247121|FG001|Overall Study|Major Protocol Deviation|7|||
161819795|NCT01911429|584381143|FG001|Overall Study|Adverse Event|3|||
161504691|NCT01481116|583247122|FG002|Overall Study|Major Protocol Deviation|1|||
161504692|NCT01481116|583247120|FG000|Overall Study|Lost to Follow-up|8|||
161504693|NCT01481116|583247121|FG001|Overall Study|Lost to Follow-up|12|||
161504694|NCT01481116|583247122|FG002|Overall Study|Lost to Follow-up|11|||
161504695|NCT01481116|583247120|FG000|Overall Study|Withdrawal by Subject|37|||
161673907|NCT01968070|583859925|FG008|Period 1|Physician Decision|0|||
161673908|NCT01968070|583859926|FG009|Period 1|Physician Decision|0|||
161819796|NCT01911429|584381144|FG002|Overall Study|Adverse Event|9|||
161819797|NCT01911429|584381142|FG000|Overall Study|Lack of Efficacy|1|||
161504696|NCT01481116|583247121|FG001|Overall Study|Withdrawal by Subject|33|||
161504697|NCT01481116|583247122|FG002|Overall Study|Withdrawal by Subject|37|||
161819798|NCT01911429|584381143|FG001|Overall Study|Lack of Efficacy|2|||
161504698|NCT01481116|583247120|FG000|Overall Study|Study Termination|730|||
161504699|NCT01481116|583247121|FG001|Overall Study|Study Termination|729|||
161504700|NCT01481116|583247122|FG002|Overall Study|Study Termination|713|||
161504701|NCT01481116|583247120|FG000|Overall Study|Pregnancy|0|||
161504702|NCT01481116|583247121|FG001|Overall Study|Pregnancy|0|||
161504703|NCT01481116|583247122|FG002|Overall Study|Pregnancy|1|||
161504704|NCT01481116|583247120|FG000|Overall Study|Lack of Efficacy|3|||
161504705|NCT01481116|583247121|FG001|Overall Study|Lack of Efficacy|3|||
161504706|NCT01481116|583247122|FG002|Overall Study|Lack of Efficacy|1|||
161504707|NCT01481116|583247120|FG000|Overall Study|Contraindications|1|||
161504708|NCT01481116|583247121|FG001|Overall Study|Contraindications|1|||
161504709|NCT01481116|583247122|FG002|Overall Study|Contraindications|0|||
161504710|NCT01481116|583247120|FG000|Overall Study|Other|1|||
161504711|NCT01481116|583247121|FG001|Overall Study|Other|1|||
161504712|NCT01481116|583247122|FG002|Overall Study|Other|0|||
161504713|NCT01481116|583247120|FG000|Overall Study|Participant Started Taking Glipizide|1|||
161504714|NCT01481116|583247121|FG001|Overall Study|Participant Started Taking Glipizide|0|||
161504715|NCT01481116|583247122|FG002|Overall Study|Participant Started Taking Glipizide|0|||
161504716|NCT01481116|583247120|FG000|Overall Study|Participant Moved Out of Area|2|||
161504717|NCT01481116|583247121|FG001|Overall Study|Participant Moved Out of Area|0|||
161504718|NCT01481116|583247122|FG002|Overall Study|Participant Moved Out of Area|1|||
161504719|NCT01481116|583247120|FG000|Overall Study|Participant Moved Out of Country|1|||
161504720|NCT01481116|583247121|FG001|Overall Study|Participant Moved Out of Country|0|||
161504721|NCT01481116|583247122|FG002|Overall Study|Participant Moved Out of Country|1|||
161504722|NCT01481116|583247120|FG000|Overall Study|Investigator Decision|3|||
161504723|NCT01481116|583247121|FG001|Overall Study|Investigator Decision|2|||
161504724|NCT01481116|583247122|FG002|Overall Study|Investigator Decision|1|||
161504725|NCT01481116|583247120|FG000|Overall Study|Sponsor Decision|0|||
161504726|NCT01481116|583247121|FG001|Overall Study|Sponsor Decision|1|||
161504727|NCT01481116|583247122|FG002|Overall Study|Sponsor Decision|3|||
161504728|NCT01481116|583247120|FG000|Overall Study|Non-Compliant With Study Drug|0|||
161504729|NCT01481116|583247121|FG001|Overall Study|Non-Compliant With Study Drug|1|||
161504730|NCT01481116|583247122|FG002|Overall Study|Non-Compliant With Study Drug|1|||
161504731|NCT01481116|583247120|FG000|Overall Study|Investigator's Discretion|2|||
161504732|NCT01481116|583247121|FG001|Overall Study|Investigator's Discretion|0|||
161504733|NCT01481116|583247122|FG002|Overall Study|Investigator's Discretion|0|||
161504734|NCT01481116|583247120|FG000|Overall Study|Death|2|||
161504735|NCT01481116|583247121|FG001|Overall Study|Death|1|||
161504736|NCT01481116|583247122|FG002|Overall Study|Death|0|||
161504737|NCT01481116|583247120|FG000|Overall Study|Hypoglycemic Event|4|||
161504738|NCT01481116|583247121|FG001|Overall Study|Hypoglycemic Event|0|||
161504739|NCT01481116|583247122|FG002|Overall Study|Hypoglycemic Event|0|||
161504740|NCT03848845|583247123|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
161504741|NCT03848845|583247124|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
161504742|NCT03848845|583247125|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
161504743|NCT03848845|583247126|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
161504744|NCT03848845|583247123|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
161504745|NCT03848845|583247124|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
161504746|NCT03848845|583247125|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
161586135|NCT05338086|583534147|FG004|Transition Period (M12 to M18)|Death|0|||
161586136|NCT05338086|583534143|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
161586137|NCT05338086|583534144|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
161586138|NCT05338086|583534145|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
161586139|NCT05338086|583534146|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
161586140|NCT05338086|583534147|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
161586141|NCT05338086|583534143|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
161586142|NCT05338086|583534144|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
161586143|NCT05338086|583534145|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
161586144|NCT05338086|583534146|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
161673909|NCT01968070|583859927|FG010|Period 1|Physician Decision|0|||
161673910|NCT01968070|583859928|FG011|Period 1|Physician Decision|1|||
161819799|NCT01911429|584381144|FG002|Overall Study|Lack of Efficacy|4|||
161819800|NCT01911429|584381142|FG000|Overall Study|Lost to Follow-up|0|||
161819801|NCT01911429|584381143|FG001|Overall Study|Lost to Follow-up|0|||
161504747|NCT03848845|583247126|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
161504748|NCT03848845|583247123|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
161504749|NCT03848845|583247124|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
161504750|NCT03848845|583247125|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
161504751|NCT03848845|583247126|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
161504752|NCT03848845|583247123|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
161504753|NCT03848845|583247124|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
161504754|NCT03848845|583247125|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
161586145|NCT05338086|583534147|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
161819802|NCT01911429|584381144|FG002|Overall Study|Lost to Follow-up|1|||
161819803|NCT01911429|584381142|FG000|Overall Study|Protocol Violation|0|||
161819804|NCT01911429|584381143|FG001|Overall Study|Protocol Violation|0|||
161819805|NCT01911429|584381144|FG002|Overall Study|Protocol Violation|1|||
161819806|NCT01911429|584381142|FG000|Overall Study|Withdrawal by Subject|5|||
161819807|NCT01911429|584381143|FG001|Overall Study|Withdrawal by Subject|5|||
161819808|NCT01911429|584381144|FG002|Overall Study|Withdrawal by Subject|4|||
161819809|NCT01911429|584381142|FG000|Overall Study|Accidental randomization|0|||
161819810|NCT01911429|584381143|FG001|Overall Study|Accidental randomization|0|||
161819811|NCT01911429|584381144|FG002|Overall Study|Accidental randomization|1|||
161819812|NCT01911429|584381142|FG000|Overall Study|subject left study|1|||
161819813|NCT01911429|584381143|FG001|Overall Study|subject left study|0|||
161819814|NCT01911429|584381144|FG002|Overall Study|subject left study|0|||
161819815|NCT04569032|584381146|FG000|Overall Study|Death|10|||
161819816|NCT04569032|584381147|FG001|Overall Study|Death|13|||
161819817|NCT04569032|584381146|FG000|Overall Study|Withdrawal by Subject|2|||
161819818|NCT04569032|584381147|FG001|Overall Study|Withdrawal by Subject|0|||
161819819|NCT04569032|584381146|FG000|Overall Study|Lost to Follow-up|0|||
161819820|NCT04569032|584381147|FG001|Overall Study|Lost to Follow-up|1|||
161819821|NCT04569032|584381146|FG000|Overall Study|In long term follow up|22|||
161819822|NCT04569032|584381147|FG001|Overall Study|In long term follow up|34|||
161819823|NCT03599362|584381153|FG000|Overall Study|Screen Failure|3|||
161819824|NCT03707587|584381154|FG000|Overall Study|Death|0|||
161819825|NCT03707587|584381155|FG001|Overall Study|Death|1|||
161819826|NCT01634139|584381157|FG000|Overall Study|Non compliant with protocol|1|||
161819827|NCT01634139|584381158|FG001|Overall Study|Non compliant with protocol|0|||
161819828|NCT01634139|584381159|FG002|Overall Study|Non compliant with protocol|0|||
161819829|NCT01634139|584381157|FG000|Overall Study|Consent withdrawn not due to AE|4|||
161819830|NCT01634139|584381158|FG001|Overall Study|Consent withdrawn not due to AE|3|||
161819831|NCT01634139|584381159|FG002|Overall Study|Consent withdrawn not due to AE|2|||
161819832|NCT01634139|584381157|FG000|Overall Study|Other|4|||
161819833|NCT01634139|584381158|FG001|Overall Study|Other|0|||
161819834|NCT01634139|584381159|FG002|Overall Study|Other|3|||
161819835|NCT01634139|584381157|FG000|Overall Study|Lost to Follow-up|0|||
161819836|NCT01634139|584381158|FG001|Overall Study|Lost to Follow-up|2|||
161819837|NCT01634139|584381159|FG002|Overall Study|Lost to Follow-up|0|||
161819838|NCT01634139|584381157|FG000|Overall Study|Not treated|1|||
161819839|NCT01634139|584381158|FG001|Overall Study|Not treated|1|||
161819840|NCT01634139|584381159|FG002|Overall Study|Not treated|0|||
161819841|NCT01168856|584381167|FG000|Overall Study|Lost to Follow-up|4|||
161819842|NCT01168856|584381168|FG001|Overall Study|Lost to Follow-up|34|||
161819843|NCT01168856|584381167|FG000|Overall Study|Withdrawal by Subject|6|||
161819844|NCT01168856|584381168|FG001|Overall Study|Withdrawal by Subject|8|||
161819845|NCT01168856|584381167|FG000|Overall Study|Physician Decision|2|||
161819846|NCT01168856|584381168|FG001|Overall Study|Physician Decision|1|||
161819847|NCT01168856|584381167|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
161819848|NCT01168856|584381168|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
161819849|NCT01168856|584381167|FG000|Overall Study|Participant received anti-HCV treatment|1|||
161819850|NCT01168856|584381168|FG001|Overall Study|Participant received anti-HCV treatment|0|||
161819851|NCT01168856|584381167|FG000|Overall Study|Death|0|||
161819852|NCT01168856|584381168|FG001|Overall Study|Death|2|||
161819853|NCT01168856|584381167|FG000|Overall Study|Other|1|||
161819854|NCT01168856|584381168|FG001|Overall Study|Other|291|||
161819855|NCT01168856|584381167|FG000|Overall Study|Protocol Violation|4|||
161819856|NCT01168856|584381168|FG001|Overall Study|Protocol Violation|6|||
161819857|NCT04442503|584381169|FG000|Overall Study|Adverse Event|1|||
161819858|NCT04442503|584381170|FG001|Overall Study|Adverse Event|1|||
161819859|NCT04442503|584381169|FG000|Overall Study|Lost to Follow-up|8|||
161819860|NCT04442503|584381170|FG001|Overall Study|Lost to Follow-up|6|||
161819861|NCT04442503|584381169|FG000|Overall Study|Physician Decision|0|||
161819862|NCT04442503|584381170|FG001|Overall Study|Physician Decision|2|||
161819863|NCT04442503|584381169|FG000|Overall Study|Withdrawal by Subject|3|||
161504755|NCT03848845|583247126|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
161504756|NCT02433834|583247128|FG000|Overall Study|Protocol-specified criteria|7|||
161504757|NCT02433834|583247128|FG000|Overall Study|Protocol Violation|3|||
161504758|NCT02433834|583247128|FG000|Overall Study|Lost to Follow-up|6|||
161504759|NCT02433834|583247128|FG000|Overall Study|Withdrawal by Subject|14|||
161819864|NCT04442503|584381170|FG001|Overall Study|Withdrawal by Subject|4|||
161819865|NCT04442503|584381169|FG000|Overall Study|Reason not Specified|0|||
161819866|NCT04442503|584381170|FG001|Overall Study|Reason not Specified|1|||
161819867|NCT04442503|584381169|FG000|Overall Study|Randomized but not Treated|3|||
161819868|NCT04442503|584381170|FG001|Overall Study|Randomized but not Treated|1|||
161819869|NCT05562011|584381177|FG000|Overall Study|Withdrawal by Subject|3|||
161819870|NCT05562011|584381177|FG000|Overall Study|Lost to Follow-up|1|||
161819871|NCT05562011|584381177|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
161819872|NCT05562011|584381177|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
161819873|NCT05562011|584381177|FG000|Overall Study|Device malfunction|13|||
161504760|NCT02433834|583247128|FG000|Overall Study|Adverse Event|6|||
161504761|NCT02433834|583247128|FG000|Overall Study|Physician Decision|1|||
161504762|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
161504763|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
161504764|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
161504765|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
161504766|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
161504767|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
161504768|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
161504769|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
161504770|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
161504771|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
161504772|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
161504773|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
161504774|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
161504775|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
161504776|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
161504777|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
161504778|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
161504779|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
161504780|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
161504781|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
161504782|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
161504783|NCT00934544|583247129|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
161504784|NCT00934544|583247130|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
161504785|NCT00934544|583247131|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
161504786|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
161504787|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
161504788|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
161504789|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
161504790|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
161504791|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
161504792|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
161504793|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
161504794|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
161504795|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
161504796|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
161504797|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
161504798|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
161504799|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
161504800|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
161504801|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
161504802|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
161504803|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
161504804|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
161504805|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
161504806|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
161504807|NCT00934544|583247129|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
161504808|NCT00934544|583247130|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
161504809|NCT00934544|583247131|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
161504810|NCT02643251|583247132|FG000|Overall Study|Adverse Event|3|||
161504811|NCT02643251|583247133|FG001|Overall Study|Adverse Event|1|||
161504812|NCT02643251|583247132|FG000|Overall Study|Withdrawal by Subject|2|||
161504813|NCT02643251|583247133|FG001|Overall Study|Withdrawal by Subject|0|||
161504814|NCT02643251|583247132|FG000|Overall Study|Lost to Follow-up|4|||
161504815|NCT02643251|583247133|FG001|Overall Study|Lost to Follow-up|1|||
161504816|NCT02643251|583247132|FG000|Overall Study|Protocol Violation|1|||
161504817|NCT02643251|583247133|FG001|Overall Study|Protocol Violation|0|||
161504818|NCT02643251|583247132|FG000|Overall Study|PI Decision to terminate patient|1|||
161504819|NCT02643251|583247133|FG001|Overall Study|PI Decision to terminate patient|0|||
161504820|NCT00348556|583247134|FG000|Overall Study|Adverse Event|1|||
161504821|NCT00192075|583247135|FG000|Overall Study|Disease Progression|23|||
161504822|NCT00192075|583247136|FG001|Overall Study|Disease Progression|6|||
161586146|NCT05338086|583534143|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
161586147|NCT05338086|583534144|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
161504823|NCT00192075|583247135|FG000|Overall Study|Adverse Event|1|||
161504824|NCT00192075|583247136|FG001|Overall Study|Adverse Event|3|||
161504825|NCT00192075|583247135|FG000|Overall Study|Death|0|||
161504826|NCT00192075|583247136|FG001|Overall Study|Death|1|||
161504827|NCT00192075|583247135|FG000|Overall Study|Lack of Efficacy|0|||
161504828|NCT00192075|583247136|FG001|Overall Study|Lack of Efficacy|0|||
161504829|NCT00192075|583247135|FG000|Overall Study|Physician Decision|3|||
161504830|NCT00192075|583247136|FG001|Overall Study|Physician Decision|0|||
161504831|NCT00192075|583247135|FG000|Overall Study|Withdrawal by Subject|5|||
161504832|NCT00192075|583247136|FG001|Overall Study|Withdrawal by Subject|5|||
161504833|NCT00192075|583247135|FG000|Overall Study|Patient Non-Compliance|0|||
161504834|NCT00192075|583247136|FG001|Overall Study|Patient Non-Compliance|1|||
161504835|NCT00192075|583247135|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
161504836|NCT00192075|583247136|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
161504837|NCT00192075|583247135|FG000|Overall Study|Other|5|||
161504838|NCT00192075|583247136|FG001|Overall Study|Other|2|||
161504839|NCT00779675|583247137|FG000|Treatment Period|Adverse Event|87|||
161504840|NCT00779675|583247137|FG000|Treatment Period|Treatment Failure|80|||
161504841|NCT00779675|583247137|FG000|Treatment Period|Transferred to Another Study|38|||
161504842|NCT00779675|583247137|FG000|Treatment Period|Lost to Follow-up|23|||
161504843|NCT00779675|583247137|FG000|Treatment Period|Withdrawal by Subject|46|||
161504844|NCT00779675|583247137|FG000|Treatment Period|Protocol Violation|54|||
161504845|NCT00779675|583247137|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
161504846|NCT00779675|583247137|FG000|Treatment Period|Administrative|3|||
161504847|NCT00779675|583247137|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
161504848|NCT00779675|583247137|FG000|Extended Treatment Period|Protocol Violation|13|||
161504849|NCT00779675|583247137|FG000|Extended Treatment Period|Adverse Event|6|||
161504850|NCT00779675|583247137|FG000|Extended Treatment Period|Treatment Failure|11|||
161504851|NCT00779675|583247137|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
161504852|NCT00779675|583247137|FG000|Extended Treatment Period|Lost to Follow-up|6|||
161504853|NCT01944059|583247138|FG000|Overall Study|Lost to Follow-up|1|||
161504854|NCT01944059|583247138|FG000|Overall Study|Physician Decision|3|||
161504855|NCT01944059|583247138|FG000|Overall Study|Withdrawal by Subject|1|||
161504856|NCT01944059|583247138|FG000|Overall Study|Adverse Event|2|||
161504857|NCT01956110|583247145|FG000|Overall Study|Protocol Violation|25|||
161504858|NCT01956110|583247146|FG001|Overall Study|Protocol Violation|11|||
161504859|NCT01956110|583247145|FG000|Overall Study|Adverse Event|9|||
161504860|NCT01956110|583247146|FG001|Overall Study|Adverse Event|10|||
161504861|NCT01956110|583247145|FG000|Overall Study|Personal reasons|1|||
161504862|NCT01956110|583247146|FG001|Overall Study|Personal reasons|1|||
161504863|NCT00430092|583247147|FG000|Overall Study|Adverse Event|0|||
161504864|NCT00430092|583247148|FG001|Overall Study|Adverse Event|0|||
161504865|NCT00430092|583247149|FG002|Overall Study|Adverse Event|1|||
161504866|NCT00430092|583247147|FG000|Overall Study|Lack of Efficacy|5|||
161504867|NCT00430092|583247148|FG001|Overall Study|Lack of Efficacy|2|||
161504868|NCT00430092|583247149|FG002|Overall Study|Lack of Efficacy|54|||
161673911|NCT01968070|583859929|FG012|Period 1|Physician Decision|0|||
161504869|NCT00430092|583247147|FG000|Overall Study|Lost to Follow-up|1|||
161504870|NCT00430092|583247148|FG001|Overall Study|Lost to Follow-up|0|||
161504871|NCT00430092|583247149|FG002|Overall Study|Lost to Follow-up|0|||
161504872|NCT00430092|583247147|FG000|Overall Study|Protocol Violation|0|||
161504873|NCT00430092|583247148|FG001|Overall Study|Protocol Violation|1|||
161504874|NCT00430092|583247149|FG002|Overall Study|Protocol Violation|1|||
161504875|NCT00430092|583247147|FG000|Overall Study|Withdrawal by Subject|0|||
161504876|NCT00430092|583247148|FG001|Overall Study|Withdrawal by Subject|1|||
161504877|NCT00430092|583247149|FG002|Overall Study|Withdrawal by Subject|1|||
161504878|NCT00463060|583247156|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
161673912|NCT01968070|583859930|FG013|Period 1|Physician Decision|0|||
161673913|NCT01968070|583859931|FG014|Period 1|Physician Decision|0|||
161673914|NCT01968070|583859932|FG015|Period 1|Physician Decision|0|||
161673915|NCT01968070|583859933|FG016|Period 1|Physician Decision|0|||
161673916|NCT01968070|583859934|FG017|Period 1|Physician Decision|0|||
161673917|NCT01968070|583859917|FG000|Period 2|Withdrawal by Subject|0|||
161504879|NCT00463060|583247156|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
161504880|NCT01400841|583247157|FG000|Initial Study Phase (6 Months)|Death|1|||
161504881|NCT01400841|583247157|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
161504882|NCT00701129|583247158|FG000|Overall Study|Death|2|||
161504883|NCT00910715|583247161|FG000|Overall Study|Lost to Follow-up|22|||
161504884|NCT00910715|583247162|FG001|Overall Study|Lost to Follow-up|26|||
161504885|NCT00910715|583247163|FG002|Overall Study|Lost to Follow-up|0|||
161504886|NCT02412631|583247164|FG000|Overall Study|Adverse Event|1|||
161504887|NCT02412631|583247165|FG001|Overall Study|Adverse Event|2|||
161504888|NCT02412631|583247164|FG000|Overall Study|Lost to Follow-up|5|||
161504889|NCT02412631|583247165|FG001|Overall Study|Lost to Follow-up|9|||
161504890|NCT02412631|583247164|FG000|Overall Study|Withdrawal by Subject|9|||
161673918|NCT01968070|583859918|FG001|Period 2|Withdrawal by Subject|0|||
161673919|NCT01968070|583859919|FG002|Period 2|Withdrawal by Subject|0|||
161504891|NCT02412631|583247165|FG001|Overall Study|Withdrawal by Subject|3|||
161504892|NCT02412631|583247164|FG000|Overall Study|Early stop by FDA|5|||
161504893|NCT02412631|583247165|FG001|Overall Study|Early stop by FDA|2|||
161504894|NCT02412631|583247164|FG000|Overall Study|Unspecified reason|6|||
161504895|NCT02412631|583247165|FG001|Overall Study|Unspecified reason|8|||
161504896|NCT00706966|583247166|FG000|Overall Study|Adverse Event|1|||
161504897|NCT02884089|583247167|FG000|Period 1|Dosing error|2|||
161504898|NCT02884089|583247168|FG001|Period 1|Dosing error|2|||
161504899|NCT02884089|583247169|FG002|Period 1|Dosing error|0|||
161504900|NCT02884089|583247170|FG003|Period 1|Dosing error|0|||
161504901|NCT02884089|583247167|FG000|Washout Period 1|Lost to Follow-up|0|||
161504902|NCT02884089|583247168|FG001|Washout Period 1|Lost to Follow-up|1|||
161504903|NCT02884089|583247169|FG002|Washout Period 1|Lost to Follow-up|0|||
161504904|NCT02884089|583247170|FG003|Washout Period 1|Lost to Follow-up|1|||
161504905|NCT02884089|583247167|FG000|Washout Period 1|Withdrawal by Subject|0|||
161504906|NCT02884089|583247168|FG001|Washout Period 1|Withdrawal by Subject|1|||
161504907|NCT02884089|583247169|FG002|Washout Period 1|Withdrawal by Subject|0|||
161504908|NCT02884089|583247170|FG003|Washout Period 1|Withdrawal by Subject|0|||
161504909|NCT02884089|583247167|FG000|Period 2|Adverse Event|1|||
161504910|NCT02884089|583247168|FG001|Period 2|Adverse Event|0|||
161504911|NCT02884089|583247169|FG002|Period 2|Adverse Event|0|||
161504912|NCT02884089|583247170|FG003|Period 2|Adverse Event|0|||
161504913|NCT02884089|583247167|FG000|Period 3|Withdrawal by Subject|0|||
161504914|NCT02884089|583247168|FG001|Period 3|Withdrawal by Subject|0|||
161504915|NCT02884089|583247169|FG002|Period 3|Withdrawal by Subject|1|||
161504916|NCT02884089|583247170|FG003|Period 3|Withdrawal by Subject|0|||
161504917|NCT02884089|583247167|FG000|Washout Period 3|Withdrawal by Subject|0|||
161504918|NCT02884089|583247168|FG001|Washout Period 3|Withdrawal by Subject|0|||
161504919|NCT02884089|583247169|FG002|Washout Period 3|Withdrawal by Subject|1|||
161504920|NCT02884089|583247170|FG003|Washout Period 3|Withdrawal by Subject|0|||
161504921|NCT02884089|583247167|FG000|Washout Period 3|Lost to Follow-up|0|||
161504922|NCT02884089|583247168|FG001|Washout Period 3|Lost to Follow-up|0|||
161504923|NCT02884089|583247169|FG002|Washout Period 3|Lost to Follow-up|0|||
161504924|NCT02884089|583247170|FG003|Washout Period 3|Lost to Follow-up|1|||
161504925|NCT02884089|583247167|FG000|Period 4|Withdrawal by Subject|0|||
161504926|NCT02884089|583247168|FG001|Period 4|Withdrawal by Subject|1|||
161504927|NCT02884089|583247169|FG002|Period 4|Withdrawal by Subject|0|||
161504928|NCT02884089|583247170|FG003|Period 4|Withdrawal by Subject|0|||
161504929|NCT02884089|583247167|FG000|Period 4|Lost to Follow-up|1|||
161504930|NCT02884089|583247168|FG001|Period 4|Lost to Follow-up|0|||
161504931|NCT02884089|583247169|FG002|Period 4|Lost to Follow-up|0|||
161504932|NCT02884089|583247170|FG003|Period 4|Lost to Follow-up|0|||
161504933|NCT02884089|583247167|FG000|Follow-up Visit|Withdrawal by Subject|1|||
161504934|NCT02884089|583247168|FG001|Follow-up Visit|Withdrawal by Subject|0|||
161504935|NCT02884089|583247169|FG002|Follow-up Visit|Withdrawal by Subject|0|||
161504936|NCT02884089|583247170|FG003|Follow-up Visit|Withdrawal by Subject|1|||
161504937|NCT01631474|583247175|FG000|Overall Study|Lost to Follow-up|8|||
161504938|NCT01631474|583247176|FG001|Overall Study|Lost to Follow-up|5|||
161504939|NCT01631474|583247177|FG002|Overall Study|Lost to Follow-up|7|||
161504940|NCT01631474|583247178|FG003|Overall Study|Lost to Follow-up|5|||
161504941|NCT01631474|583247179|FG004|Overall Study|Lost to Follow-up|5|||
161504942|NCT01631474|583247175|FG000|Overall Study|Withdrawal by Subject|4|||
161504943|NCT01631474|583247176|FG001|Overall Study|Withdrawal by Subject|4|||
161504944|NCT01631474|583247177|FG002|Overall Study|Withdrawal by Subject|2|||
161504945|NCT01631474|583247178|FG003|Overall Study|Withdrawal by Subject|6|||
161504946|NCT01631474|583247179|FG004|Overall Study|Withdrawal by Subject|5|||
161504947|NCT01631474|583247175|FG000|Overall Study|Lack of Efficacy|2|||
161504948|NCT01631474|583247176|FG001|Overall Study|Lack of Efficacy|2|||
161586148|NCT05338086|583534145|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
161819874|NCT00387153|584381178|FG000|Overall Study|Adverse Event|1|||
161504949|NCT01631474|583247177|FG002|Overall Study|Lack of Efficacy|0|||
161504950|NCT01631474|583247178|FG003|Overall Study|Lack of Efficacy|0|||
161504951|NCT01631474|583247179|FG004|Overall Study|Lack of Efficacy|2|||
161504952|NCT01631474|583247175|FG000|Overall Study|Noncompliance with Study Drug|0|||
161504953|NCT01631474|583247176|FG001|Overall Study|Noncompliance with Study Drug|0|||
161586149|NCT05338086|583534146|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
161504954|NCT01631474|583247177|FG002|Overall Study|Noncompliance with Study Drug|0|||
161504955|NCT01631474|583247178|FG003|Overall Study|Noncompliance with Study Drug|0|||
161504956|NCT01631474|583247179|FG004|Overall Study|Noncompliance with Study Drug|1|||
161504957|NCT01631474|583247175|FG000|Overall Study|Adverse Event|0|||
161504958|NCT01631474|583247176|FG001|Overall Study|Adverse Event|1|||
161504959|NCT01631474|583247177|FG002|Overall Study|Adverse Event|0|||
161504960|NCT01631474|583247178|FG003|Overall Study|Adverse Event|0|||
161504961|NCT01631474|583247179|FG004|Overall Study|Adverse Event|0|||
161504962|NCT01467076|583247180|FG000|Overall Study|Lost to Follow-up|1|||
161504963|NCT01467076|583247181|FG001|Overall Study|Lost to Follow-up|0|||
161504964|NCT01467076|583247182|FG002|Overall Study|Lost to Follow-up|0|||
161673920|NCT01968070|583859920|FG003|Period 2|Withdrawal by Subject|0|||
161504965|NCT00654381|583247187|FG000|1st Stage|Adverse Event|3|||
161504966|NCT00654381|583247188|FG001|1st Stage|Adverse Event|3|||
161504967|NCT00654381|583247189|FG002|1st Stage|Adverse Event|3|||
161504968|NCT00654381|583247190|FG003|1st Stage|Adverse Event|3|||
161504969|NCT00654381|583247191|FG004|1st Stage|Adverse Event|2|||
161504970|NCT00654381|583247192|FG005|1st Stage|Adverse Event|1|||
161504971|NCT00654381|583247187|FG000|1st Stage|Withdrawal by Subject|0|||
161504972|NCT00654381|583247188|FG001|1st Stage|Withdrawal by Subject|0|||
161504973|NCT00654381|583247189|FG002|1st Stage|Withdrawal by Subject|0|||
161504974|NCT00654381|583247190|FG003|1st Stage|Withdrawal by Subject|1|||
161504975|NCT00654381|583247191|FG004|1st Stage|Withdrawal by Subject|0|||
161504976|NCT00654381|583247192|FG005|1st Stage|Withdrawal by Subject|1|||
161504977|NCT00654381|583247187|FG000|1st Stage|Investigator's decision|0|||
161504978|NCT00654381|583247188|FG001|1st Stage|Investigator's decision|0|||
161504979|NCT00654381|583247189|FG002|1st Stage|Investigator's decision|0|||
161504980|NCT00654381|583247190|FG003|1st Stage|Investigator's decision|1|||
161504981|NCT00654381|583247191|FG004|1st Stage|Investigator's decision|0|||
161504982|NCT00654381|583247192|FG005|1st Stage|Investigator's decision|0|||
161504983|NCT00654381|583247187|FG000|2nd Stage|Adverse Event|2|||
161504984|NCT00654381|583247188|FG001|2nd Stage|Adverse Event|0|||
161819875|NCT00387153|584381178|FG000|Overall Study|Disease Progression|3|||
161819876|NCT00387153|584381178|FG000|Overall Study|Lack of Response|4|||
161504985|NCT00654381|583247189|FG002|2nd Stage|Adverse Event|2|||
161504986|NCT00654381|583247190|FG003|2nd Stage|Adverse Event|3|||
161504987|NCT00654381|583247191|FG004|2nd Stage|Adverse Event|7|||
161504988|NCT00654381|583247192|FG005|2nd Stage|Adverse Event|2|||
161504989|NCT00654381|583247187|FG000|2nd Stage|Withdrawal by Subject|0|||
161504990|NCT00654381|583247188|FG001|2nd Stage|Withdrawal by Subject|0|||
161504991|NCT00654381|583247189|FG002|2nd Stage|Withdrawal by Subject|0|||
161504992|NCT00654381|583247190|FG003|2nd Stage|Withdrawal by Subject|0|||
161504993|NCT00654381|583247191|FG004|2nd Stage|Withdrawal by Subject|1|||
161504994|NCT00654381|583247192|FG005|2nd Stage|Withdrawal by Subject|1|||
161504995|NCT00654381|583247187|FG000|2nd Stage|Investigator's decision|0|||
161504996|NCT00654381|583247188|FG001|2nd Stage|Investigator's decision|0|||
161504997|NCT00654381|583247189|FG002|2nd Stage|Investigator's decision|1|||
161504998|NCT00654381|583247190|FG003|2nd Stage|Investigator's decision|1|||
161504999|NCT00654381|583247191|FG004|2nd Stage|Investigator's decision|0|||
161505000|NCT00654381|583247192|FG005|2nd Stage|Investigator's decision|0|||
161505001|NCT00654381|583247187|FG000|Extension Stage|Adverse Event|1|||
161505002|NCT00654381|583247188|FG001|Extension Stage|Adverse Event|2|||
161505003|NCT00654381|583247189|FG002|Extension Stage|Adverse Event|9|||
161505004|NCT00654381|583247190|FG003|Extension Stage|Adverse Event|7|||
161505005|NCT00654381|583247191|FG004|Extension Stage|Adverse Event|1|||
161505006|NCT00654381|583247192|FG005|Extension Stage|Adverse Event|1|||
161505007|NCT00654381|583247187|FG000|Extension Stage|Protocol Violation|0|||
161505008|NCT00654381|583247188|FG001|Extension Stage|Protocol Violation|0|||
161505009|NCT00654381|583247189|FG002|Extension Stage|Protocol Violation|0|||
161505010|NCT00654381|583247190|FG003|Extension Stage|Protocol Violation|1|||
161505011|NCT00654381|583247191|FG004|Extension Stage|Protocol Violation|0|||
161505012|NCT00654381|583247192|FG005|Extension Stage|Protocol Violation|0|||
161505013|NCT00654381|583247187|FG000|Extension Stage|Lack of Efficacy|0|||
161505014|NCT00654381|583247188|FG001|Extension Stage|Lack of Efficacy|0|||
161505015|NCT00654381|583247189|FG002|Extension Stage|Lack of Efficacy|1|||
161505016|NCT00654381|583247190|FG003|Extension Stage|Lack of Efficacy|0|||
161505017|NCT00654381|583247191|FG004|Extension Stage|Lack of Efficacy|0|||
161505018|NCT00654381|583247192|FG005|Extension Stage|Lack of Efficacy|0|||
161505019|NCT00654381|583247187|FG000|Extension Stage|Withdrawal by Subject|0|||
161505020|NCT00654381|583247188|FG001|Extension Stage|Withdrawal by Subject|0|||
161505021|NCT00654381|583247189|FG002|Extension Stage|Withdrawal by Subject|1|||
161505022|NCT00654381|583247190|FG003|Extension Stage|Withdrawal by Subject|1|||
161505023|NCT00654381|583247191|FG004|Extension Stage|Withdrawal by Subject|1|||
161505024|NCT00654381|583247192|FG005|Extension Stage|Withdrawal by Subject|1|||
161505025|NCT00654381|583247187|FG000|Extension Stage|Closure of the trial site|0|||
161505026|NCT00654381|583247188|FG001|Extension Stage|Closure of the trial site|0|||
161505027|NCT00654381|583247189|FG002|Extension Stage|Closure of the trial site|0|||
161505028|NCT00654381|583247190|FG003|Extension Stage|Closure of the trial site|0|||
161505029|NCT00654381|583247191|FG004|Extension Stage|Closure of the trial site|1|||
161505030|NCT00654381|583247192|FG005|Extension Stage|Closure of the trial site|1|||
161505031|NCT03100825|583247193|FG000|Overall Study|Participant/Guardian Decision|7|||
161505032|NCT03100825|583247193|FG000|Overall Study|Physician Decision|1|||
161505033|NCT00994448|583247195|FG000|Overall Study|Adverse Event|1|||
161505034|NCT00994448|583247196|FG001|Overall Study|Adverse Event|0|||
161505035|NCT00994448|583247195|FG000|Overall Study|Lost to Follow-up|5|||
161505036|NCT00994448|583247196|FG001|Overall Study|Lost to Follow-up|1|||
161505037|NCT00994448|583247195|FG000|Overall Study|Withdrawal by Subject|1|||
161505038|NCT00994448|583247196|FG001|Overall Study|Withdrawal by Subject|1|||
161505039|NCT00994448|583247195|FG000|Overall Study|Physician Decision|1|||
161505040|NCT00994448|583247196|FG001|Overall Study|Physician Decision|0|||
161505041|NCT05288556|583247198|FG000|Overall Study|Protocol Violation|1|||
161505042|NCT05288556|583247198|FG000|Overall Study|Withdrawal by Subject|1|||
161505043|NCT00006489|583247199|FG000|Overall Study|Adverse Event|3|||
161505044|NCT00006489|583247200|FG001|Overall Study|Adverse Event|2|||
161505045|NCT00006489|583247201|FG002|Overall Study|Adverse Event|4|||
161505046|NCT00006489|583247202|FG003|Overall Study|Adverse Event|3|||
161505047|NCT00006489|583247199|FG000|Overall Study|Withdrawal by Subject|10|||
161505048|NCT00006489|583247200|FG001|Overall Study|Withdrawal by Subject|9|||
161505049|NCT00006489|583247201|FG002|Overall Study|Withdrawal by Subject|9|||
161505050|NCT00006489|583247202|FG003|Overall Study|Withdrawal by Subject|6|||
161505051|NCT00006489|583247199|FG000|Overall Study|Scheduling Conflict|0|||
161505052|NCT00006489|583247200|FG001|Overall Study|Scheduling Conflict|3|||
161505053|NCT00006489|583247201|FG002|Overall Study|Scheduling Conflict|2|||
161505054|NCT00006489|583247202|FG003|Overall Study|Scheduling Conflict|1|||
161505055|NCT00006489|583247199|FG000|Overall Study|Death|0|||
161505056|NCT00006489|583247200|FG001|Overall Study|Death|0|||
161505057|NCT00006489|583247201|FG002|Overall Study|Death|0|||
161505058|NCT00006489|583247202|FG003|Overall Study|Death|1|||
161505059|NCT00578175|583247203|FG000|Overall Study|Adverse Event|0|||
161505060|NCT00578175|583247204|FG001|Overall Study|Adverse Event|1|||
161505061|NCT00578175|583247205|FG002|Overall Study|Adverse Event|1|||
161505062|NCT00578175|583247203|FG000|Overall Study|Other reasons|70|||
161505063|NCT00578175|583247204|FG001|Overall Study|Other reasons|42|||
161505064|NCT00578175|583247205|FG002|Overall Study|Other reasons|23|||
161505065|NCT01479621|583247211|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
161505066|NCT01479621|583247212|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161505067|NCT01479621|583247213|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161505068|NCT01479621|583247214|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161505069|NCT01479621|583247215|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161505070|NCT01479621|583247216|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161505071|NCT01479621|583247217|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161505072|NCT01479621|583247211|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
161505073|NCT01479621|583247212|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161505074|NCT01479621|583247213|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161505075|NCT01479621|583247214|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161505076|NCT01479621|583247215|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161505077|NCT01479621|583247216|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161505078|NCT01479621|583247217|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161505079|NCT01479621|583247211|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
161505080|NCT01479621|583247212|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161505081|NCT01479621|583247213|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161505082|NCT01479621|583247214|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161505083|NCT01479621|583247215|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161505084|NCT01479621|583247216|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161505085|NCT01479621|583247217|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161505086|NCT01479621|583247211|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
161505087|NCT01479621|583247212|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161505088|NCT01479621|583247213|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161505089|NCT01479621|583247214|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161505090|NCT01479621|583247215|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161505091|NCT01479621|583247216|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161505092|NCT01479621|583247217|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161505093|NCT01479621|583247211|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
161505094|NCT01479621|583247212|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161505095|NCT01479621|583247213|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161505096|NCT01479621|583247214|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161505097|NCT01479621|583247215|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161505098|NCT01479621|583247216|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161505099|NCT01479621|583247217|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161586150|NCT05338086|583534147|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
161586151|NCT03424811|583534148|FG000|Overall Study|Lost to Follow-up|9|||
161586152|NCT03424811|583534149|FG001|Overall Study|Lost to Follow-up|0|||
161586153|NCT00567398|583534155|FG000|Overall Study|Adverse Event|6|||
161586154|NCT00567398|583534156|FG001|Overall Study|Adverse Event|14|||
161586155|NCT00567398|583534155|FG000|Overall Study|Physician Decision|0|||
161586156|NCT00567398|583534156|FG001|Overall Study|Physician Decision|4|||
161505100|NCT01479621|583247211|FG000|Treatment Period|Adverse Event|0|||
161505101|NCT01479621|583247212|FG001|Treatment Period|Adverse Event|0|||
161586157|NCT00567398|583534155|FG000|Overall Study|Withdrawal by Subject|0|||
161586158|NCT00567398|583534156|FG001|Overall Study|Withdrawal by Subject|2|||
161586159|NCT00567398|583534155|FG000|Overall Study|Renal Transplantation|0|||
161586160|NCT00567398|583534156|FG001|Overall Study|Renal Transplantation|3|||
161505102|NCT01479621|583247213|FG002|Treatment Period|Adverse Event|0|||
161505103|NCT01479621|583247214|FG003|Treatment Period|Adverse Event|0|||
161505104|NCT01479621|583247215|FG004|Treatment Period|Adverse Event|1|||
161505105|NCT01479621|583247216|FG005|Treatment Period|Adverse Event|2|||
161505106|NCT01479621|583247217|FG006|Treatment Period|Adverse Event|2|||
161505107|NCT01479621|583247211|FG000|Treatment Period|Withdrawal by Subject|0|||
161505108|NCT01479621|583247212|FG001|Treatment Period|Withdrawal by Subject|4|||
161505109|NCT01479621|583247213|FG002|Treatment Period|Withdrawal by Subject|2|||
161505110|NCT01479621|583247214|FG003|Treatment Period|Withdrawal by Subject|2|||
161505111|NCT01479621|583247215|FG004|Treatment Period|Withdrawal by Subject|5|||
161505112|NCT01479621|583247216|FG005|Treatment Period|Withdrawal by Subject|5|||
161505113|NCT01479621|583247217|FG006|Treatment Period|Withdrawal by Subject|1|||
161505114|NCT01479621|583247211|FG000|Treatment Period|Physician Decision|0|||
161505115|NCT01479621|583247212|FG001|Treatment Period|Physician Decision|0|||
161505116|NCT01479621|583247213|FG002|Treatment Period|Physician Decision|0|||
161505117|NCT01479621|583247214|FG003|Treatment Period|Physician Decision|0|||
161505118|NCT01479621|583247215|FG004|Treatment Period|Physician Decision|1|||
161505119|NCT01479621|583247216|FG005|Treatment Period|Physician Decision|1|||
161505120|NCT01479621|583247217|FG006|Treatment Period|Physician Decision|0|||
161505121|NCT01479621|583247211|FG000|Treatment Period|Non-compliance to study drug|0|||
161505122|NCT01479621|583247212|FG001|Treatment Period|Non-compliance to study drug|1|||
161505123|NCT01479621|583247213|FG002|Treatment Period|Non-compliance to study drug|0|||
161505124|NCT01479621|583247214|FG003|Treatment Period|Non-compliance to study drug|0|||
161505125|NCT01479621|583247215|FG004|Treatment Period|Non-compliance to study drug|0|||
161505126|NCT01479621|583247216|FG005|Treatment Period|Non-compliance to study drug|0|||
161505127|NCT01479621|583247217|FG006|Treatment Period|Non-compliance to study drug|1|||
161586161|NCT00567398|583534155|FG000|Overall Study|Other|1|||
161586162|NCT00567398|583534156|FG001|Overall Study|Other|0|||
161586163|NCT03517553|583534157|FG000|Overall Study|Withdrawal by Subject|2|||
161586164|NCT03271151|583534160|FG000|Overall Study|Lost to Follow-up|1|||
161586165|NCT03271151|583534161|FG001|Overall Study|Lost to Follow-up|3|||
161586166|NCT03271151|583534160|FG000|Overall Study|Withdrawal by Subject|1|||
161586167|NCT03271151|583534161|FG001|Overall Study|Withdrawal by Subject|0|||
161586168|NCT04093362|583534162|FG000|Overall Study|Study Termination|1|||
161586169|NCT04093362|583534163|FG001|Overall Study|Study Termination|1|||
161505128|NCT01479621|583247211|FG000|Treatment Period|Protocol Violation|0|||
161505129|NCT01479621|583247212|FG001|Treatment Period|Protocol Violation|9|||
161586170|NCT04093362|583534162|FG000|Overall Study|Withdrawal of Consent|1|||
161586171|NCT04093362|583534163|FG001|Overall Study|Withdrawal of Consent|0|||
161586172|NCT04093362|583534162|FG000|Overall Study|Death|1|||
161586173|NCT04093362|583534163|FG001|Overall Study|Death|3|||
161586174|NCT04093362|583534162|FG000|Overall Study|Reason not Specified|1|||
161586175|NCT04093362|583534163|FG001|Overall Study|Reason not Specified|2|||
161586176|NCT01673984|583534180|FG000|Overall Study|Adverse Event|1|||
161819877|NCT04411680|584381179|FG000|Treatment Period|Adverse Event|3|||
161819878|NCT04411680|584381180|FG001|Treatment Period|Adverse Event|0|||
161819879|NCT04411680|584381179|FG000|Treatment Period|Discharged from hospital|18|||
161819880|NCT04411680|584381180|FG001|Treatment Period|Discharged from hospital|7|||
161819881|NCT04411680|584381179|FG000|Treatment Period|Missed 1 or more doses|8|||
161819882|NCT04411680|584381180|FG001|Treatment Period|Missed 1 or more doses|0|||
161819883|NCT04411680|584381179|FG000|Treatment Period|Transferred to another hospital|0|||
161819884|NCT04411680|584381180|FG001|Treatment Period|Transferred to another hospital|1|||
161819885|NCT04411680|584381179|FG000|Follow up Period|Withdrawal by Subject|2|||
161819886|NCT04411680|584381180|FG001|Follow up Period|Withdrawal by Subject|0|||
161819887|NCT04411680|584381179|FG000|Follow up Period|Lost to Follow-up|5|||
161819888|NCT04411680|584381180|FG001|Follow up Period|Lost to Follow-up|6|||
161819889|NCT04411680|584381179|FG000|Follow up Period|Death|11|||
161819890|NCT04411680|584381180|FG001|Follow up Period|Death|8|||
161819891|NCT05034874|584381181|FG000|Overall Study|Withdrawal by Subject|6|||
161819892|NCT05034874|584381182|FG001|Overall Study|Withdrawal by Subject|6|||
161819893|NCT05034874|584381181|FG000|Overall Study|Lost to Follow-up|18|||
161819894|NCT05034874|584381182|FG001|Overall Study|Lost to Follow-up|8|||
161819895|NCT05034874|584381181|FG000|Overall Study|Physician Decision|0|||
161819896|NCT05034874|584381182|FG001|Overall Study|Physician Decision|1|||
161819897|NCT05034874|584381181|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
161505130|NCT01479621|583247213|FG002|Treatment Period|Protocol Violation|6|||
161505131|NCT01479621|583247214|FG003|Treatment Period|Protocol Violation|5|||
161586177|NCT01673984|583534181|FG001|Overall Study|Adverse Event|0|||
161586178|NCT01673984|583534180|FG000|Overall Study|Study termination|9|||
161586179|NCT01673984|583534181|FG001|Overall Study|Study termination|6|||
161586180|NCT04437433|583534187|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
161586181|NCT04437433|583534188|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
161819898|NCT05034874|584381182|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
161819899|NCT01867658|584381183|FG000|Overall Study|Withdrawal by Subject|6|||
161819900|NCT01867658|584381183|FG000|Overall Study|Death|2|||
161819901|NCT01867658|584381183|FG000|Overall Study|Subject could not be contacted|1|||
161505132|NCT01479621|583247215|FG004|Treatment Period|Protocol Violation|2|||
161505133|NCT01479621|583247216|FG005|Treatment Period|Protocol Violation|10|||
161505134|NCT01479621|583247217|FG006|Treatment Period|Protocol Violation|6|||
161505135|NCT01479621|583247211|FG000|Treatment Period|Pregnancy|0|||
161505136|NCT01479621|583247212|FG001|Treatment Period|Pregnancy|0|||
161505137|NCT01479621|583247213|FG002|Treatment Period|Pregnancy|2|||
161505138|NCT01479621|583247214|FG003|Treatment Period|Pregnancy|0|||
161505139|NCT01479621|583247215|FG004|Treatment Period|Pregnancy|0|||
161505140|NCT01479621|583247216|FG005|Treatment Period|Pregnancy|0|||
161505141|NCT01479621|583247217|FG006|Treatment Period|Pregnancy|0|||
161505142|NCT01479621|583247211|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
161505143|NCT01479621|583247212|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
161505144|NCT01479621|583247213|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
161505145|NCT01479621|583247214|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
161505146|NCT01479621|583247215|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
161505147|NCT01479621|583247216|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
161505148|NCT01479621|583247217|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
161505149|NCT01479621|583247211|FG000|Treatment Period|Lost to Follow-up|0|||
161505150|NCT01479621|583247212|FG001|Treatment Period|Lost to Follow-up|0|||
161505151|NCT01479621|583247213|FG002|Treatment Period|Lost to Follow-up|1|||
161505152|NCT01479621|583247214|FG003|Treatment Period|Lost to Follow-up|0|||
161505153|NCT01479621|583247215|FG004|Treatment Period|Lost to Follow-up|2|||
161505154|NCT01479621|583247216|FG005|Treatment Period|Lost to Follow-up|2|||
161505155|NCT01479621|583247217|FG006|Treatment Period|Lost to Follow-up|1|||
161505156|NCT01479621|583247211|FG000|Treatment Period|Met stopping criteria|0|||
161505157|NCT01479621|583247212|FG001|Treatment Period|Met stopping criteria|8|||
161505158|NCT01479621|583247213|FG002|Treatment Period|Met stopping criteria|7|||
161505159|NCT01479621|583247214|FG003|Treatment Period|Met stopping criteria|4|||
161505160|NCT01479621|583247215|FG004|Treatment Period|Met stopping criteria|9|||
161505161|NCT01479621|583247216|FG005|Treatment Period|Met stopping criteria|20|||
161505162|NCT01479621|583247217|FG006|Treatment Period|Met stopping criteria|6|||
161505163|NCT02308735|583247218|FG000|Overall Study|Physician Decision|2|||
161505164|NCT02308735|583247219|FG001|Overall Study|Physician Decision|0|||
161505165|NCT02308735|583247220|FG002|Overall Study|Physician Decision|0|||
161505166|NCT02308735|583247221|FG003|Overall Study|Physician Decision|2|||
161505167|NCT01417481|583247222|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161505168|NCT01417481|583247223|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161505169|NCT03029624|583247226|FG000|Overall Study|Adverse Event|1|||
161505170|NCT03029624|583247226|FG000|Overall Study|Withdrawal by Subject|1|||
161505171|NCT03029624|583247226|FG000|Overall Study|Lack of Efficacy|1|||
161505172|NCT03029624|583247226|FG000|Overall Study|MRI need|2|||
161505173|NCT01371656|583247228|FG000|Overall Study|Death|7|||
161505174|NCT01371656|583247229|FG001|Overall Study|Death|4|||
161505175|NCT01371656|583247228|FG000|Overall Study|Physician Decision|46|||
161505176|NCT01371656|583247229|FG001|Overall Study|Physician Decision|7|||
161505177|NCT01371656|583247228|FG000|Overall Study|Withdrawal by Subject|7|||
161505178|NCT01371656|583247229|FG001|Overall Study|Withdrawal by Subject|0|||
161505179|NCT01371656|583247228|FG000|Overall Study|Ineligible|4|||
161505180|NCT01371656|583247229|FG001|Overall Study|Ineligible|3|||
161505181|NCT00974571|583247230|FG000|Overall Study|Adverse Event|31|||
161505182|NCT00974571|583247231|FG001|Overall Study|Adverse Event|4|||
161505183|NCT00974571|583247232|FG002|Overall Study|Adverse Event|27|||
161505184|NCT00974571|583247230|FG000|Overall Study|Lack of Efficacy|3|||
161505185|NCT00974571|583247231|FG001|Overall Study|Lack of Efficacy|2|||
161505186|NCT00974571|583247232|FG002|Overall Study|Lack of Efficacy|9|||
161505187|NCT00974571|583247230|FG000|Overall Study|Lost to Follow-up|2|||
161505188|NCT00974571|583247231|FG001|Overall Study|Lost to Follow-up|1|||
161505189|NCT00974571|583247232|FG002|Overall Study|Lost to Follow-up|2|||
161505190|NCT00974571|583247230|FG000|Overall Study|Protocol Violation|13|||
161505191|NCT00974571|583247231|FG001|Overall Study|Protocol Violation|4|||
161505192|NCT00974571|583247232|FG002|Overall Study|Protocol Violation|18|||
161505193|NCT00974571|583247230|FG000|Overall Study|Withdrawal by Subject|14|||
161505194|NCT00974571|583247231|FG001|Overall Study|Withdrawal by Subject|5|||
161505195|NCT00974571|583247232|FG002|Overall Study|Withdrawal by Subject|16|||
161505196|NCT00974571|583247230|FG000|Overall Study|Patient Moved|1|||
161673921|NCT01968070|583859921|FG004|Period 2|Withdrawal by Subject|1|||
161673922|NCT01968070|583859922|FG005|Period 2|Withdrawal by Subject|0|||
161505197|NCT00974571|583247231|FG001|Overall Study|Patient Moved|0|||
161505198|NCT00974571|583247232|FG002|Overall Study|Patient Moved|1|||
161505199|NCT00974571|583247230|FG000|Overall Study|Other|4|||
161505200|NCT00974571|583247231|FG001|Overall Study|Other|0|||
161505201|NCT00974571|583247232|FG002|Overall Study|Other|10|||
161505202|NCT04334460|583247239|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
161505203|NCT04334460|583247240|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
161549243|NCT02291289|583401018|FG009|Induction Treatment|Protocol Violation|2|||
161505204|NCT04334460|583247239|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
161505205|NCT04334460|583247240|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
161505206|NCT03778931|583247241|FG000|Overall Study|Withdrawal by Subject|12|||
161505207|NCT03778931|583247242|FG001|Overall Study|Withdrawal by Subject|25|||
161505208|NCT03778931|583247241|FG000|Overall Study|Physician Decision|1|||
161505209|NCT03778931|583247242|FG001|Overall Study|Physician Decision|3|||
161505210|NCT03778931|583247241|FG000|Overall Study|Participant Noncompliance|1|||
161505211|NCT03778931|583247242|FG001|Overall Study|Participant Noncompliance|1|||
161505212|NCT03778931|583247241|FG000|Overall Study|Lost to Follow-up|4|||
161505213|NCT03778931|583247242|FG001|Overall Study|Lost to Follow-up|1|||
161505214|NCT03778931|583247241|FG000|Overall Study|Death|69|||
161505215|NCT03778931|583247242|FG001|Overall Study|Death|79|||
161505216|NCT02357940|583247245|FG000|Overall Study|Adverse Event|0|||
161505217|NCT02357940|583247246|FG001|Overall Study|Adverse Event|1|||
161505218|NCT02357940|583247245|FG000|Overall Study|Investigator's judgement|0|||
161505219|NCT02357940|583247246|FG001|Overall Study|Investigator's judgement|1|||
161505220|NCT02442778|583247247|FG000|Overall Study|Adverse Event|2|||
161505221|NCT02442778|583247248|FG001|Overall Study|Adverse Event|6|||
161505222|NCT02442778|583247249|FG002|Overall Study|Adverse Event|6|||
161505223|NCT02442778|583247247|FG000|Overall Study|Death|0|||
161505224|NCT02442778|583247248|FG001|Overall Study|Death|2|||
161505225|NCT02442778|583247249|FG002|Overall Study|Death|0|||
161505226|NCT02442778|583247247|FG000|Overall Study|Lack of Efficacy|1|||
161505227|NCT02442778|583247248|FG001|Overall Study|Lack of Efficacy|0|||
161505228|NCT02442778|583247249|FG002|Overall Study|Lack of Efficacy|0|||
161505229|NCT02442778|583247247|FG000|Overall Study|Lost to Follow-up|1|||
161505230|NCT02442778|583247248|FG001|Overall Study|Lost to Follow-up|1|||
161505231|NCT02442778|583247249|FG002|Overall Study|Lost to Follow-up|1|||
161505232|NCT02442778|583247247|FG000|Overall Study|Non-compliance with study drug|2|||
161505233|NCT02442778|583247248|FG001|Overall Study|Non-compliance with study drug|0|||
161505234|NCT02442778|583247249|FG002|Overall Study|Non-compliance with study drug|1|||
161505235|NCT02442778|583247247|FG000|Overall Study|Physician Decision|1|||
161505236|NCT02442778|583247248|FG001|Overall Study|Physician Decision|1|||
161505237|NCT02442778|583247249|FG002|Overall Study|Physician Decision|1|||
161505238|NCT02442778|583247247|FG000|Overall Study|Protocol Deviation|3|||
161505239|NCT02442778|583247248|FG001|Overall Study|Protocol Deviation|0|||
161505240|NCT02442778|583247249|FG002|Overall Study|Protocol Deviation|1|||
161505241|NCT02442778|583247247|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
161505242|NCT02442778|583247248|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
161505243|NCT02442778|583247249|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
161505244|NCT02442778|583247247|FG000|Overall Study|Withdrawal by Subject|4|||
161505245|NCT02442778|583247248|FG001|Overall Study|Withdrawal by Subject|4|||
161505246|NCT02442778|583247249|FG002|Overall Study|Withdrawal by Subject|3|||
161505247|NCT02442778|583247247|FG000|Overall Study|Reason not specified|1|||
161505248|NCT02442778|583247248|FG001|Overall Study|Reason not specified|4|||
161505249|NCT02442778|583247249|FG002|Overall Study|Reason not specified|0|||
161505250|NCT02641379|583247252|FG000|Overall Study|Exclusion criterion during screening|1|||
161505251|NCT02641379|583247253|FG001|Overall Study|Exclusion criterion during screening|0|||
161505252|NCT02641379|583247254|FG002|Overall Study|Exclusion criterion during screening|0|||
161505253|NCT02641379|583247255|FG003|Overall Study|Exclusion criterion during screening|1|||
161505254|NCT02641379|583247256|FG004|Overall Study|Exclusion criterion during screening|2|||
161505255|NCT02641379|583247257|FG005|Overall Study|Exclusion criterion during screening|0|||
161505256|NCT02641379|583247258|FG006|Overall Study|Exclusion criterion during screening|0|||
161505257|NCT02641379|583247259|FG007|Overall Study|Exclusion criterion during screening|0|||
161505258|NCT02641379|583247260|FG008|Overall Study|Exclusion criterion during screening|0|||
161505259|NCT02641379|583247261|FG009|Overall Study|Exclusion criterion during screening|0|||
161505260|NCT02641379|583247262|FG010|Overall Study|Exclusion criterion during screening|0|||
161505261|NCT02641379|583247252|FG000|Overall Study|Withdrawal of informed consent|0|||
161505262|NCT02641379|583247253|FG001|Overall Study|Withdrawal of informed consent|1|||
161505263|NCT02641379|583247254|FG002|Overall Study|Withdrawal of informed consent|0|||
161505264|NCT02641379|583247255|FG003|Overall Study|Withdrawal of informed consent|0|||
161505265|NCT02641379|583247256|FG004|Overall Study|Withdrawal of informed consent|0|||
161505266|NCT02641379|583247257|FG005|Overall Study|Withdrawal of informed consent|0|||
161505267|NCT02641379|583247258|FG006|Overall Study|Withdrawal of informed consent|0|||
161505268|NCT02641379|583247259|FG007|Overall Study|Withdrawal of informed consent|1|||
161505269|NCT02641379|583247260|FG008|Overall Study|Withdrawal of informed consent|0|||
161505270|NCT02641379|583247261|FG009|Overall Study|Withdrawal of informed consent|0|||
161505271|NCT02641379|583247262|FG010|Overall Study|Withdrawal of informed consent|0|||
161505272|NCT02641379|583247252|FG000|Overall Study|Adverse Event|7|||
161505273|NCT02641379|583247253|FG001|Overall Study|Adverse Event|8|||
161505274|NCT02641379|583247254|FG002|Overall Study|Adverse Event|2|||
161505275|NCT02641379|583247255|FG003|Overall Study|Adverse Event|2|||
161505276|NCT02641379|583247256|FG004|Overall Study|Adverse Event|5|||
161586182|NCT04437433|583534187|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
161586183|NCT04437433|583534188|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
161586184|NCT04437433|583534187|FG000|Overall Study|Adverse Event|9|||
161505277|NCT02641379|583247257|FG005|Overall Study|Adverse Event|1|||
161505278|NCT02641379|583247258|FG006|Overall Study|Adverse Event|5|||
161505279|NCT02641379|583247259|FG007|Overall Study|Adverse Event|0|||
161505280|NCT02641379|583247260|FG008|Overall Study|Adverse Event|1|||
161505281|NCT02641379|583247261|FG009|Overall Study|Adverse Event|1|||
161505282|NCT02641379|583247262|FG010|Overall Study|Adverse Event|5|||
161505283|NCT02641379|583247252|FG000|Overall Study|Lack of Efficacy|0|||
161505284|NCT02641379|583247253|FG001|Overall Study|Lack of Efficacy|0|||
161505285|NCT02641379|583247254|FG002|Overall Study|Lack of Efficacy|2|||
161505286|NCT02641379|583247255|FG003|Overall Study|Lack of Efficacy|0|||
161505287|NCT02641379|583247256|FG004|Overall Study|Lack of Efficacy|0|||
161505288|NCT02641379|583247257|FG005|Overall Study|Lack of Efficacy|2|||
161505289|NCT02641379|583247258|FG006|Overall Study|Lack of Efficacy|0|||
161505290|NCT02641379|583247259|FG007|Overall Study|Lack of Efficacy|5|||
161505291|NCT02641379|583247260|FG008|Overall Study|Lack of Efficacy|0|||
161505292|NCT02641379|583247261|FG009|Overall Study|Lack of Efficacy|0|||
161505293|NCT02641379|583247262|FG010|Overall Study|Lack of Efficacy|0|||
161505294|NCT02641379|583247252|FG000|Overall Study|Participant unable to attend study visit|4|||
161505295|NCT02641379|583247253|FG001|Overall Study|Participant unable to attend study visit|10|||
161505296|NCT02641379|583247254|FG002|Overall Study|Participant unable to attend study visit|1|||
161505297|NCT02641379|583247255|FG003|Overall Study|Participant unable to attend study visit|2|||
161505298|NCT02641379|583247256|FG004|Overall Study|Participant unable to attend study visit|5|||
161505299|NCT02641379|583247257|FG005|Overall Study|Participant unable to attend study visit|1|||
161505300|NCT02641379|583247258|FG006|Overall Study|Participant unable to attend study visit|1|||
161505301|NCT02641379|583247259|FG007|Overall Study|Participant unable to attend study visit|1|||
161505302|NCT02641379|583247260|FG008|Overall Study|Participant unable to attend study visit|0|||
161505303|NCT02641379|583247261|FG009|Overall Study|Participant unable to attend study visit|2|||
161505304|NCT02641379|583247262|FG010|Overall Study|Participant unable to attend study visit|0|||
161505305|NCT02641379|583247252|FG000|Overall Study|Participant's compliance|0|||
161505306|NCT02641379|583247253|FG001|Overall Study|Participant's compliance|1|||
161505307|NCT02641379|583247254|FG002|Overall Study|Participant's compliance|0|||
161505308|NCT02641379|583247255|FG003|Overall Study|Participant's compliance|1|||
161505309|NCT02641379|583247256|FG004|Overall Study|Participant's compliance|0|||
161505310|NCT02641379|583247257|FG005|Overall Study|Participant's compliance|2|||
161505311|NCT02641379|583247258|FG006|Overall Study|Participant's compliance|0|||
161505312|NCT02641379|583247259|FG007|Overall Study|Participant's compliance|0|||
161505313|NCT02641379|583247260|FG008|Overall Study|Participant's compliance|1|||
161505314|NCT02641379|583247261|FG009|Overall Study|Participant's compliance|1|||
161586185|NCT04437433|583534188|FG001|Overall Study|Adverse Event|0|||
161586186|NCT04437433|583534187|FG000|Overall Study|Lack of Efficacy|4|||
161819902|NCT00474058|584381184|FG000|Overall Study|Adverse Event|11|||
161586187|NCT04437433|583534188|FG001|Overall Study|Lack of Efficacy|0|||
161586188|NCT04437433|583534187|FG000|Overall Study|Withdrawal by Subject|4|||
161505315|NCT02641379|583247262|FG010|Overall Study|Participant's compliance|1|||
161505316|NCT02641379|583247252|FG000|Overall Study|Participant cannot be reached|4|||
161505317|NCT02641379|583247253|FG001|Overall Study|Participant cannot be reached|4|||
161505318|NCT02641379|583247254|FG002|Overall Study|Participant cannot be reached|0|||
161505319|NCT02641379|583247255|FG003|Overall Study|Participant cannot be reached|8|||
161505320|NCT02641379|583247256|FG004|Overall Study|Participant cannot be reached|2|||
161505321|NCT02641379|583247257|FG005|Overall Study|Participant cannot be reached|1|||
161505322|NCT02641379|583247258|FG006|Overall Study|Participant cannot be reached|0|||
161505323|NCT02641379|583247259|FG007|Overall Study|Participant cannot be reached|1|||
161505324|NCT02641379|583247260|FG008|Overall Study|Participant cannot be reached|0|||
161505325|NCT02641379|583247261|FG009|Overall Study|Participant cannot be reached|2|||
161505326|NCT02641379|583247262|FG010|Overall Study|Participant cannot be reached|1|||
161505327|NCT02641379|583247252|FG000|Overall Study|PCR positive at Week 24|15|||
161505328|NCT02641379|583247253|FG001|Overall Study|PCR positive at Week 24|21|||
161505329|NCT02641379|583247254|FG002|Overall Study|PCR positive at Week 24|62|||
161505330|NCT02641379|583247255|FG003|Overall Study|PCR positive at Week 24|0|||
161505331|NCT02641379|583247256|FG004|Overall Study|PCR positive at Week 24|0|||
161505332|NCT02641379|583247257|FG005|Overall Study|PCR positive at Week 24|6|||
161505333|NCT02641379|583247258|FG006|Overall Study|PCR positive at Week 24|3|||
161505334|NCT02641379|583247259|FG007|Overall Study|PCR positive at Week 24|8|||
161505335|NCT02641379|583247260|FG008|Overall Study|PCR positive at Week 24|0|||
161505336|NCT02641379|583247261|FG009|Overall Study|PCR positive at Week 24|1|||
161505337|NCT02641379|583247262|FG010|Overall Study|PCR positive at Week 24|0|||
161505338|NCT02641379|583247252|FG000|Overall Study|PCR positive at follow up 2|1|||
161505339|NCT02641379|583247253|FG001|Overall Study|PCR positive at follow up 2|0|||
161505340|NCT02641379|583247254|FG002|Overall Study|PCR positive at follow up 2|0|||
161505341|NCT02641379|583247255|FG003|Overall Study|PCR positive at follow up 2|0|||
161505342|NCT02641379|583247256|FG004|Overall Study|PCR positive at follow up 2|0|||
161505343|NCT02641379|583247257|FG005|Overall Study|PCR positive at follow up 2|0|||
161925689|NCT03166631|584774566|FG000|Overall Study|Physician Decision|0|||
161925690|NCT03166631|584774567|FG001|Overall Study|Physician Decision|0|||
161925691|NCT03166631|584774568|FG002|Overall Study|Physician Decision|0|||
161925692|NCT03166631|584774569|FG003|Overall Study|Physician Decision|0|||
161925693|NCT03166631|584774570|FG004|Overall Study|Physician Decision|0|||
161925694|NCT03166631|584774571|FG005|Overall Study|Physician Decision|0|||
161925695|NCT03166631|584774572|FG006|Overall Study|Physician Decision|1|||
161925696|NCT03166631|584774573|FG007|Overall Study|Physician Decision|0|||
161925697|NCT03166631|584774574|FG008|Overall Study|Physician Decision|1|||
161925698|NCT03166631|584774575|FG009|Overall Study|Physician Decision|0|||
161505344|NCT02641379|583247258|FG006|Overall Study|PCR positive at follow up 2|0|||
161505345|NCT02641379|583247259|FG007|Overall Study|PCR positive at follow up 2|0|||
161505346|NCT02641379|583247260|FG008|Overall Study|PCR positive at follow up 2|0|||
161505347|NCT02641379|583247261|FG009|Overall Study|PCR positive at follow up 2|0|||
161505348|NCT02641379|583247262|FG010|Overall Study|PCR positive at follow up 2|0|||
161505349|NCT02641379|583247252|FG000|Overall Study|Participant showed relapse|1|||
161505350|NCT02641379|583247253|FG001|Overall Study|Participant showed relapse|0|||
161505351|NCT02641379|583247254|FG002|Overall Study|Participant showed relapse|0|||
161505352|NCT02641379|583247255|FG003|Overall Study|Participant showed relapse|0|||
161505353|NCT02641379|583247256|FG004|Overall Study|Participant showed relapse|0|||
161586189|NCT04437433|583534188|FG001|Overall Study|Withdrawal by Subject|1|||
161586190|NCT04437433|583534187|FG000|Overall Study|Protocol Deviation|0|||
161586191|NCT04437433|583534188|FG001|Overall Study|Protocol Deviation|1|||
161586192|NCT04437433|583534187|FG000|Overall Study|Other, not specified|0|||
161586193|NCT04437433|583534188|FG001|Overall Study|Other, not specified|1|||
161586194|NCT02365766|583534189|FG000|Overall Study|Withdrawal by Subject|0|||
161586195|NCT02365766|583534190|FG001|Overall Study|Withdrawal by Subject|0|||
161586196|NCT02365766|583534191|FG002|Overall Study|Withdrawal by Subject|1|||
161586197|NCT02365766|583534189|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161586198|NCT02365766|583534190|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161586199|NCT02365766|583534191|FG002|Overall Study|Eligibility Criteria Not Met|1|||
161586200|NCT02724956|583534195|FG000|Overall Study|Physician Decision|1|||
161586201|NCT02724956|583534196|FG001|Overall Study|Physician Decision|0|||
161586202|NCT02724956|583534195|FG000|Overall Study|Lack of Efficacy|0|||
161586203|NCT02724956|583534196|FG001|Overall Study|Lack of Efficacy|1|||
161586204|NCT02724956|583534195|FG000|Overall Study|Withdrawal by Subject|0|||
161586205|NCT02724956|583534196|FG001|Overall Study|Withdrawal by Subject|1|||
161586206|NCT03385629|583534202|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
161586207|NCT03385629|583534203|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
161586208|NCT03385629|583534202|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
161586209|NCT03385629|583534203|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
161586210|NCT03385629|583534202|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
161586211|NCT03385629|583534203|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
161586212|NCT02538900|583534207|FG000|Overall Study|Death|2|||
161586213|NCT02538900|583534208|FG001|Overall Study|Death|2|||
161586214|NCT02538900|583534209|FG002|Overall Study|Death|2|||
161586215|NCT02538900|583534207|FG000|Overall Study|Withdrawal by Subject|18|||
161925699|NCT03166631|584774576|FG010|Overall Study|Physician Decision|1|||
161925700|NCT03166631|584774566|FG000|Overall Study|Death|0|||
161505354|NCT02641379|583247257|FG005|Overall Study|Participant showed relapse|0|||
161925701|NCT03166631|584774567|FG001|Overall Study|Death|0|||
161925702|NCT03166631|584774568|FG002|Overall Study|Death|0|||
161925703|NCT03166631|584774569|FG003|Overall Study|Death|0|||
161925704|NCT03166631|584774570|FG004|Overall Study|Death|1|||
161925705|NCT03166631|584774571|FG005|Overall Study|Death|0|||
161925706|NCT03166631|584774572|FG006|Overall Study|Death|1|||
161925707|NCT03166631|584774573|FG007|Overall Study|Death|0|||
161819903|NCT00474058|584381185|FG001|Overall Study|Adverse Event|6|||
161819904|NCT00474058|584381184|FG000|Overall Study|Lack of Efficacy|0|||
161819905|NCT00474058|584381185|FG001|Overall Study|Lack of Efficacy|4|||
161819906|NCT00474058|584381184|FG000|Overall Study|Withdrawal by Subject|11|||
161925708|NCT03166631|584774574|FG008|Overall Study|Death|0|||
161925709|NCT03166631|584774575|FG009|Overall Study|Death|0|||
161819907|NCT00474058|584381185|FG001|Overall Study|Withdrawal by Subject|7|||
161819908|NCT00474058|584381184|FG000|Overall Study|Other|2|||
161819909|NCT00474058|584381185|FG001|Overall Study|Other|0|||
161819910|NCT03101358|584381186|FG000|Overall Study|Non-compliance with study schedule|1|||
161819911|NCT03101358|584381187|FG001|Overall Study|Non-compliance with study schedule|0|||
161819912|NCT03101358|584381188|FG002|Overall Study|Non-compliance with study schedule|0|||
161819913|NCT03101358|584381189|FG003|Overall Study|Non-compliance with study schedule|1|||
161819914|NCT03101358|584381186|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161819915|NCT03101358|584381187|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161819916|NCT03101358|584381188|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
161819917|NCT03101358|584381189|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161819918|NCT03101358|584381186|FG000|Overall Study|Physician Decision|1|||
161505355|NCT02641379|583247258|FG006|Overall Study|Participant showed relapse|1|||
161819919|NCT03101358|584381187|FG001|Overall Study|Physician Decision|0|||
161819920|NCT03101358|584381188|FG002|Overall Study|Physician Decision|0|||
161819921|NCT03101358|584381189|FG003|Overall Study|Physician Decision|3|||
161819922|NCT03101358|584381186|FG000|Overall Study|Adverse Event|0|||
161819923|NCT03101358|584381187|FG001|Overall Study|Adverse Event|0|||
161819924|NCT03101358|584381188|FG002|Overall Study|Adverse Event|1|||
161819925|NCT03101358|584381189|FG003|Overall Study|Adverse Event|0|||
161819926|NCT03101358|584381186|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161819927|NCT03101358|584381187|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161819928|NCT03101358|584381188|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161819929|NCT03101358|584381189|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
161819930|NCT03101358|584381186|FG000|Overall Study|Lost to Follow-up|1|||
161819931|NCT03101358|584381187|FG001|Overall Study|Lost to Follow-up|0|||
161819932|NCT03101358|584381188|FG002|Overall Study|Lost to Follow-up|0|||
161819933|NCT03101358|584381189|FG003|Overall Study|Lost to Follow-up|1|||
161819934|NCT02640235|584381190|FG000|Overall Study|Withdrawal by Subject|7|||
161819935|NCT02640235|584381191|FG001|Overall Study|Withdrawal by Subject|6|||
161819936|NCT02640235|584381190|FG000|Overall Study|Lost to Follow-up|4|||
161819937|NCT02640235|584381191|FG001|Overall Study|Lost to Follow-up|3|||
161819938|NCT02640235|584381190|FG000|Overall Study|Death|2|||
161819939|NCT02640235|584381191|FG001|Overall Study|Death|3|||
161819940|NCT02640235|584381190|FG000|Overall Study|Other|1|||
161819941|NCT02640235|584381191|FG001|Overall Study|Other|2|||
161819942|NCT02426918|584381192|FG000|Overall Study|Adverse Event|2|||
161819943|NCT02426918|584381193|FG001|Overall Study|Adverse Event|2|||
161819944|NCT02426918|584381194|FG002|Overall Study|Adverse Event|0|||
161925710|NCT03166631|584774576|FG010|Overall Study|Death|0|||
161925711|NCT03166631|584774566|FG000|Overall Study|Adverse Event|1|||
161925712|NCT03166631|584774567|FG001|Overall Study|Adverse Event|0|||
161925713|NCT03166631|584774568|FG002|Overall Study|Adverse Event|0|||
161505356|NCT02641379|583247259|FG007|Overall Study|Participant showed relapse|0|||
161505357|NCT02641379|583247260|FG008|Overall Study|Participant showed relapse|0|||
161505358|NCT02641379|583247261|FG009|Overall Study|Participant showed relapse|0|||
161505359|NCT02641379|583247262|FG010|Overall Study|Participant showed relapse|0|||
161505360|NCT02641379|583247252|FG000|Overall Study|Participant stopped study/treatment|1|||
161505361|NCT02641379|583247253|FG001|Overall Study|Participant stopped study/treatment|3|||
161505362|NCT02641379|583247254|FG002|Overall Study|Participant stopped study/treatment|1|||
161505363|NCT02641379|583247255|FG003|Overall Study|Participant stopped study/treatment|0|||
161505364|NCT02641379|583247256|FG004|Overall Study|Participant stopped study/treatment|0|||
161505365|NCT02641379|583247257|FG005|Overall Study|Participant stopped study/treatment|1|||
161505366|NCT02641379|583247258|FG006|Overall Study|Participant stopped study/treatment|2|||
161505367|NCT02641379|583247259|FG007|Overall Study|Participant stopped study/treatment|0|||
161505368|NCT02641379|583247260|FG008|Overall Study|Participant stopped study/treatment|1|||
161505369|NCT02641379|583247261|FG009|Overall Study|Participant stopped study/treatment|0|||
161505370|NCT02641379|583247262|FG010|Overall Study|Participant stopped study/treatment|0|||
161925714|NCT03166631|584774569|FG003|Overall Study|Adverse Event|0|||
161505371|NCT02641379|583247252|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
161505372|NCT02641379|583247253|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
161505373|NCT02641379|583247254|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
161505374|NCT02641379|583247255|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
161505375|NCT02641379|583247256|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
161505376|NCT02641379|583247257|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
161505377|NCT02641379|583247258|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
161505378|NCT02641379|583247259|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
161505379|NCT02641379|583247260|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
161505380|NCT02641379|583247261|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
161505381|NCT02641379|583247262|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
161505382|NCT02641379|583247252|FG000|Overall Study|Financial problems|0|||
161505383|NCT02641379|583247253|FG001|Overall Study|Financial problems|1|||
161505384|NCT02641379|583247254|FG002|Overall Study|Financial problems|0|||
161505385|NCT02641379|583247255|FG003|Overall Study|Financial problems|0|||
161505386|NCT02641379|583247256|FG004|Overall Study|Financial problems|0|||
161505387|NCT02641379|583247257|FG005|Overall Study|Financial problems|0|||
161505388|NCT02641379|583247258|FG006|Overall Study|Financial problems|0|||
161505389|NCT02641379|583247259|FG007|Overall Study|Financial problems|0|||
161505390|NCT02641379|583247260|FG008|Overall Study|Financial problems|0|||
161505391|NCT02641379|583247261|FG009|Overall Study|Financial problems|0|||
161505392|NCT02641379|583247262|FG010|Overall Study|Financial problems|0|||
161505393|NCT02641379|583247252|FG000|Overall Study|PCR positive at Week 68|0|||
161505394|NCT02641379|583247253|FG001|Overall Study|PCR positive at Week 68|1|||
161505395|NCT02641379|583247254|FG002|Overall Study|PCR positive at Week 68|0|||
161505396|NCT02641379|583247255|FG003|Overall Study|PCR positive at Week 68|0|||
161505397|NCT02641379|583247256|FG004|Overall Study|PCR positive at Week 68|0|||
161505398|NCT02641379|583247257|FG005|Overall Study|PCR positive at Week 68|0|||
161505399|NCT02641379|583247258|FG006|Overall Study|PCR positive at Week 68|0|||
161505400|NCT02641379|583247259|FG007|Overall Study|PCR positive at Week 68|0|||
161505401|NCT02641379|583247260|FG008|Overall Study|PCR positive at Week 68|0|||
161505402|NCT02641379|583247261|FG009|Overall Study|PCR positive at Week 68|0|||
161505403|NCT02641379|583247262|FG010|Overall Study|PCR positive at Week 68|0|||
161505404|NCT02641379|583247252|FG000|Overall Study|PCR positive at Week 48|0|||
161505405|NCT02641379|583247253|FG001|Overall Study|PCR positive at Week 48|1|||
161505406|NCT02641379|583247254|FG002|Overall Study|PCR positive at Week 48|0|||
161505407|NCT02641379|583247255|FG003|Overall Study|PCR positive at Week 48|0|||
161505408|NCT02641379|583247256|FG004|Overall Study|PCR positive at Week 48|0|||
161505409|NCT02641379|583247257|FG005|Overall Study|PCR positive at Week 48|0|||
161505410|NCT02641379|583247258|FG006|Overall Study|PCR positive at Week 48|0|||
161505411|NCT02641379|583247259|FG007|Overall Study|PCR positive at Week 48|0|||
161505412|NCT02641379|583247260|FG008|Overall Study|PCR positive at Week 48|0|||
161505413|NCT02641379|583247261|FG009|Overall Study|PCR positive at Week 48|0|||
161505414|NCT02641379|583247262|FG010|Overall Study|PCR positive at Week 48|0|||
161505415|NCT02641379|583247252|FG000|Overall Study|PCR not performed at Week 12|0|||
161505416|NCT02641379|583247253|FG001|Overall Study|PCR not performed at Week 12|0|||
161505417|NCT02641379|583247254|FG002|Overall Study|PCR not performed at Week 12|1|||
161505418|NCT02641379|583247255|FG003|Overall Study|PCR not performed at Week 12|0|||
161505419|NCT02641379|583247256|FG004|Overall Study|PCR not performed at Week 12|0|||
161505420|NCT02641379|583247257|FG005|Overall Study|PCR not performed at Week 12|0|||
161505421|NCT02641379|583247258|FG006|Overall Study|PCR not performed at Week 12|0|||
161505422|NCT02641379|583247259|FG007|Overall Study|PCR not performed at Week 12|0|||
161505423|NCT02641379|583247260|FG008|Overall Study|PCR not performed at Week 12|0|||
161505424|NCT02641379|583247261|FG009|Overall Study|PCR not performed at Week 12|0|||
161505425|NCT02641379|583247262|FG010|Overall Study|PCR not performed at Week 12|0|||
161586216|NCT02538900|583534208|FG001|Overall Study|Withdrawal by Subject|16|||
161586217|NCT02538900|583534209|FG002|Overall Study|Withdrawal by Subject|15|||
161586218|NCT03732820|583534210|FG000|Overall Study|Death|168|||
161586219|NCT03732820|583534211|FG001|Overall Study|Death|203|||
161586220|NCT03732820|583534210|FG000|Overall Study|Other|2|||
161586221|NCT03732820|583534211|FG001|Overall Study|Other|2|||
161586222|NCT03732820|583534210|FG000|Overall Study|Failure to meet randomisation criteria|1|||
161586223|NCT03732820|583534211|FG001|Overall Study|Failure to meet randomisation criteria|1|||
161586224|NCT03732820|583534210|FG000|Overall Study|Patient decision|14|||
161586225|NCT03732820|583534211|FG001|Overall Study|Patient decision|10|||
161586226|NCT03732820|583534210|FG000|Overall Study|Screen failure|0|||
161586227|NCT03732820|583534211|FG001|Overall Study|Screen failure|1|||
161586228|NCT03732820|583534210|FG000|Overall Study|Patients ongoing study at data cut off|210|||
161586229|NCT03732820|583534211|FG001|Overall Study|Patients ongoing study at data cut off|178|||
161819945|NCT02426918|584381192|FG000|Overall Study|Physician Decision|1|||
161505426|NCT02641379|583247252|FG000|Overall Study|No PCR at baseline|0|||
161505427|NCT02641379|583247253|FG001|Overall Study|No PCR at baseline|0|||
161505428|NCT02641379|583247254|FG002|Overall Study|No PCR at baseline|1|||
161505429|NCT02641379|583247255|FG003|Overall Study|No PCR at baseline|0|||
161586230|NCT03732820|583534210|FG000|Overall Study|Lost to Follow-up|4|||
161673923|NCT01968070|583859923|FG006|Period 2|Withdrawal by Subject|0|||
161673924|NCT01968070|583859924|FG007|Period 2|Withdrawal by Subject|0|||
161673925|NCT01968070|583859925|FG008|Period 2|Withdrawal by Subject|0|||
161673926|NCT01968070|583859926|FG009|Period 2|Withdrawal by Subject|0|||
161673927|NCT01968070|583859927|FG010|Period 2|Withdrawal by Subject|0|||
161505430|NCT02641379|583247256|FG004|Overall Study|No PCR at baseline|0|||
161505431|NCT02641379|583247257|FG005|Overall Study|No PCR at baseline|0|||
161505432|NCT02641379|583247258|FG006|Overall Study|No PCR at baseline|0|||
161505433|NCT02641379|583247259|FG007|Overall Study|No PCR at baseline|0|||
161505434|NCT02641379|583247260|FG008|Overall Study|No PCR at baseline|0|||
161505435|NCT02641379|583247261|FG009|Overall Study|No PCR at baseline|0|||
161505436|NCT02641379|583247262|FG010|Overall Study|No PCR at baseline|0|||
161505437|NCT02641379|583247252|FG000|Overall Study|PCR positive at Week 28|0|||
161505438|NCT02641379|583247253|FG001|Overall Study|PCR positive at Week 28|0|||
161505439|NCT02641379|583247254|FG002|Overall Study|PCR positive at Week 28|1|||
161505440|NCT02641379|583247255|FG003|Overall Study|PCR positive at Week 28|0|||
161505441|NCT02641379|583247256|FG004|Overall Study|PCR positive at Week 28|0|||
161505442|NCT02641379|583247257|FG005|Overall Study|PCR positive at Week 28|0|||
161505443|NCT02641379|583247258|FG006|Overall Study|PCR positive at Week 28|0|||
161505444|NCT02641379|583247259|FG007|Overall Study|PCR positive at Week 28|0|||
161505445|NCT02641379|583247260|FG008|Overall Study|PCR positive at Week 28|0|||
161505446|NCT02641379|583247261|FG009|Overall Study|PCR positive at Week 28|0|||
161505447|NCT02641379|583247262|FG010|Overall Study|PCR positive at Week 28|0|||
161505448|NCT02641379|583247252|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
161505449|NCT02641379|583247253|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
161505450|NCT02641379|583247254|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
161505451|NCT02641379|583247255|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
161505452|NCT02641379|583247256|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
161505453|NCT02641379|583247257|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
161505454|NCT02641379|583247258|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
161505455|NCT02641379|583247259|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
161505456|NCT02641379|583247260|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
161505457|NCT02641379|583247261|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
161505458|NCT02641379|583247262|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
161505459|NCT02641379|583247252|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
161505460|NCT02641379|583247253|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
161505461|NCT02641379|583247254|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
161505462|NCT02641379|583247255|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
161505463|NCT02641379|583247256|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
161505464|NCT02641379|583247257|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
161505465|NCT02641379|583247258|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
161505466|NCT02641379|583247259|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
161505467|NCT02641379|583247260|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
161505468|NCT02641379|583247261|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
161505469|NCT02641379|583247262|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
161505470|NCT02641379|583247252|FG000|Overall Study|Baseline viral load unavailable|0|||
161505471|NCT02641379|583247253|FG001|Overall Study|Baseline viral load unavailable|0|||
161505472|NCT02641379|583247254|FG002|Overall Study|Baseline viral load unavailable|0|||
161505473|NCT02641379|583247255|FG003|Overall Study|Baseline viral load unavailable|1|||
161505474|NCT02641379|583247256|FG004|Overall Study|Baseline viral load unavailable|0|||
161505475|NCT02641379|583247257|FG005|Overall Study|Baseline viral load unavailable|0|||
161505476|NCT02641379|583247258|FG006|Overall Study|Baseline viral load unavailable|0|||
161505477|NCT02641379|583247259|FG007|Overall Study|Baseline viral load unavailable|0|||
161505478|NCT02641379|583247260|FG008|Overall Study|Baseline viral load unavailable|0|||
161505479|NCT02641379|583247261|FG009|Overall Study|Baseline viral load unavailable|0|||
161505480|NCT02641379|583247262|FG010|Overall Study|Baseline viral load unavailable|0|||
161505481|NCT02641379|583247252|FG000|Overall Study|Blood could not be drawn|0|||
161505482|NCT02641379|583247253|FG001|Overall Study|Blood could not be drawn|0|||
161505483|NCT02641379|583247254|FG002|Overall Study|Blood could not be drawn|0|||
161673928|NCT01968070|583859928|FG011|Period 2|Withdrawal by Subject|0|||
161673929|NCT01968070|583859929|FG012|Period 2|Withdrawal by Subject|0|||
161673930|NCT01968070|583859930|FG013|Period 2|Withdrawal by Subject|0|||
161673931|NCT01968070|583859931|FG014|Period 2|Withdrawal by Subject|0|||
161673932|NCT01968070|583859932|FG015|Period 2|Withdrawal by Subject|0|||
161673933|NCT01968070|583859933|FG016|Period 2|Withdrawal by Subject|0|||
161505484|NCT02641379|583247255|FG003|Overall Study|Blood could not be drawn|0|||
161505485|NCT02641379|583247256|FG004|Overall Study|Blood could not be drawn|1|||
161505486|NCT02641379|583247257|FG005|Overall Study|Blood could not be drawn|0|||
161505487|NCT02641379|583247258|FG006|Overall Study|Blood could not be drawn|0|||
161505488|NCT02641379|583247259|FG007|Overall Study|Blood could not be drawn|0|||
161505489|NCT02641379|583247260|FG008|Overall Study|Blood could not be drawn|0|||
161505490|NCT02641379|583247261|FG009|Overall Study|Blood could not be drawn|0|||
161673934|NCT01968070|583859934|FG017|Period 2|Withdrawal by Subject|0|||
161673935|NCT01822522|583859937|FG000|Overall Study|Adverse Event|1|||
161505491|NCT02641379|583247262|FG010|Overall Study|Blood could not be drawn|0|||
161505492|NCT02641379|583247252|FG000|Overall Study|Protocol Violation|0|||
161505493|NCT02641379|583247253|FG001|Overall Study|Protocol Violation|0|||
161505494|NCT02641379|583247254|FG002|Overall Study|Protocol Violation|0|||
161505495|NCT02641379|583247255|FG003|Overall Study|Protocol Violation|0|||
161505496|NCT02641379|583247256|FG004|Overall Study|Protocol Violation|2|||
161505497|NCT02641379|583247257|FG005|Overall Study|Protocol Violation|0|||
161505498|NCT02641379|583247258|FG006|Overall Study|Protocol Violation|0|||
161505499|NCT02641379|583247259|FG007|Overall Study|Protocol Violation|0|||
161505500|NCT02641379|583247260|FG008|Overall Study|Protocol Violation|1|||
161505501|NCT02641379|583247261|FG009|Overall Study|Protocol Violation|0|||
161505502|NCT02641379|583247262|FG010|Overall Study|Protocol Violation|0|||
161505503|NCT02641379|583247252|FG000|Overall Study|Participation in sili rescue study|0|||
161505504|NCT02641379|583247253|FG001|Overall Study|Participation in sili rescue study|0|||
161505505|NCT02641379|583247254|FG002|Overall Study|Participation in sili rescue study|0|||
161505506|NCT02641379|583247255|FG003|Overall Study|Participation in sili rescue study|0|||
161505507|NCT02641379|583247256|FG004|Overall Study|Participation in sili rescue study|0|||
161505508|NCT02641379|583247257|FG005|Overall Study|Participation in sili rescue study|1|||
161505509|NCT02641379|583247258|FG006|Overall Study|Participation in sili rescue study|0|||
161505510|NCT02641379|583247259|FG007|Overall Study|Participation in sili rescue study|0|||
161505511|NCT02641379|583247260|FG008|Overall Study|Participation in sili rescue study|0|||
161505512|NCT02641379|583247261|FG009|Overall Study|Participation in sili rescue study|0|||
161505513|NCT02641379|583247262|FG010|Overall Study|Participation in sili rescue study|0|||
161505514|NCT02641379|583247252|FG000|Overall Study|Lost to Follow-up|0|||
161505515|NCT02641379|583247253|FG001|Overall Study|Lost to Follow-up|0|||
161505516|NCT02641379|583247254|FG002|Overall Study|Lost to Follow-up|0|||
161505517|NCT02641379|583247255|FG003|Overall Study|Lost to Follow-up|0|||
161505518|NCT02641379|583247256|FG004|Overall Study|Lost to Follow-up|0|||
161505519|NCT02641379|583247257|FG005|Overall Study|Lost to Follow-up|0|||
161505520|NCT02641379|583247258|FG006|Overall Study|Lost to Follow-up|0|||
161505521|NCT02641379|583247259|FG007|Overall Study|Lost to Follow-up|0|||
161505522|NCT02641379|583247260|FG008|Overall Study|Lost to Follow-up|1|||
161505523|NCT02641379|583247261|FG009|Overall Study|Lost to Follow-up|0|||
161505524|NCT02641379|583247262|FG010|Overall Study|Lost to Follow-up|0|||
161505525|NCT02641379|583247252|FG000|Overall Study|Source data not found|0|||
161505526|NCT02641379|583247253|FG001|Overall Study|Source data not found|0|||
161505527|NCT02641379|583247254|FG002|Overall Study|Source data not found|0|||
161505528|NCT02641379|583247255|FG003|Overall Study|Source data not found|0|||
161505529|NCT02641379|583247256|FG004|Overall Study|Source data not found|0|||
161505530|NCT02641379|583247257|FG005|Overall Study|Source data not found|1|||
161505531|NCT02641379|583247258|FG006|Overall Study|Source data not found|0|||
161505532|NCT02641379|583247259|FG007|Overall Study|Source data not found|0|||
161505533|NCT02641379|583247260|FG008|Overall Study|Source data not found|0|||
161505534|NCT02641379|583247261|FG009|Overall Study|Source data not found|0|||
161505535|NCT02641379|583247262|FG010|Overall Study|Source data not found|0|||
161505536|NCT02641379|583247252|FG000|Overall Study|Participant showed weight reduction|0|||
161505537|NCT02641379|583247253|FG001|Overall Study|Participant showed weight reduction|0|||
161505538|NCT02641379|583247254|FG002|Overall Study|Participant showed weight reduction|0|||
161505539|NCT02641379|583247255|FG003|Overall Study|Participant showed weight reduction|0|||
161505540|NCT02641379|583247256|FG004|Overall Study|Participant showed weight reduction|0|||
161505541|NCT02641379|583247257|FG005|Overall Study|Participant showed weight reduction|0|||
161505542|NCT02641379|583247258|FG006|Overall Study|Participant showed weight reduction|0|||
161505543|NCT02641379|583247259|FG007|Overall Study|Participant showed weight reduction|1|||
161505544|NCT02641379|583247260|FG008|Overall Study|Participant showed weight reduction|0|||
161505545|NCT02641379|583247261|FG009|Overall Study|Participant showed weight reduction|0|||
161505546|NCT02641379|583247262|FG010|Overall Study|Participant showed weight reduction|0|||
161505547|NCT02641379|583247252|FG000|Overall Study|Non-response Week 12|0|||
161505548|NCT02641379|583247253|FG001|Overall Study|Non-response Week 12|0|||
161505549|NCT02641379|583247254|FG002|Overall Study|Non-response Week 12|0|||
161505550|NCT02641379|583247255|FG003|Overall Study|Non-response Week 12|0|||
161505551|NCT02641379|583247256|FG004|Overall Study|Non-response Week 12|0|||
161505552|NCT02641379|583247257|FG005|Overall Study|Non-response Week 12|0|||
161505553|NCT02641379|583247258|FG006|Overall Study|Non-response Week 12|0|||
161505554|NCT02641379|583247259|FG007|Overall Study|Non-response Week 12|1|||
161505555|NCT02641379|583247260|FG008|Overall Study|Non-response Week 12|0|||
161505556|NCT02641379|583247261|FG009|Overall Study|Non-response Week 12|0|||
161505557|NCT02641379|583247262|FG010|Overall Study|Non-response Week 12|0|||
161505558|NCT02641379|583247252|FG000|Overall Study|No 2 Log drop at Week 12|0|||
161505559|NCT02641379|583247253|FG001|Overall Study|No 2 Log drop at Week 12|0|||
161505560|NCT02641379|583247254|FG002|Overall Study|No 2 Log drop at Week 12|0|||
161673936|NCT01822522|583859938|FG001|Overall Study|Adverse Event|1|||
161505561|NCT02641379|583247255|FG003|Overall Study|No 2 Log drop at Week 12|0|||
161505562|NCT02641379|583247256|FG004|Overall Study|No 2 Log drop at Week 12|0|||
161505563|NCT02641379|583247257|FG005|Overall Study|No 2 Log drop at Week 12|0|||
161505564|NCT02641379|583247258|FG006|Overall Study|No 2 Log drop at Week 12|0|||
161505565|NCT02641379|583247259|FG007|Overall Study|No 2 Log drop at Week 12|0|||
161505566|NCT02641379|583247260|FG008|Overall Study|No 2 Log drop at Week 12|0|||
161505567|NCT02641379|583247261|FG009|Overall Study|No 2 Log drop at Week 12|0|||
161505568|NCT02641379|583247262|FG010|Overall Study|No 2 Log drop at Week 12|1|||
161505569|NCT02641379|583247252|FG000|Overall Study|Negative PCR result|0|||
161505570|NCT02641379|583247253|FG001|Overall Study|Negative PCR result|0|||
161505571|NCT02641379|583247254|FG002|Overall Study|Negative PCR result|0|||
161505572|NCT02641379|583247255|FG003|Overall Study|Negative PCR result|0|||
161505573|NCT02641379|583247256|FG004|Overall Study|Negative PCR result|0|||
161505574|NCT02641379|583247257|FG005|Overall Study|Negative PCR result|0|||
161505575|NCT02641379|583247258|FG006|Overall Study|Negative PCR result|0|||
161505576|NCT02641379|583247259|FG007|Overall Study|Negative PCR result|0|||
161505577|NCT02641379|583247260|FG008|Overall Study|Negative PCR result|0|||
161505578|NCT02641379|583247261|FG009|Overall Study|Negative PCR result|1|||
161505579|NCT02641379|583247262|FG010|Overall Study|Negative PCR result|0|||
161505580|NCT02641379|583247252|FG000|Overall Study|Participant's PCR high|0|||
161505581|NCT02641379|583247253|FG001|Overall Study|Participant's PCR high|0|||
161505582|NCT02641379|583247254|FG002|Overall Study|Participant's PCR high|0|||
161505583|NCT02641379|583247255|FG003|Overall Study|Participant's PCR high|0|||
161505584|NCT02641379|583247256|FG004|Overall Study|Participant's PCR high|0|||
161505585|NCT02641379|583247257|FG005|Overall Study|Participant's PCR high|0|||
161505586|NCT02641379|583247258|FG006|Overall Study|Participant's PCR high|0|||
161505587|NCT02641379|583247259|FG007|Overall Study|Participant's PCR high|1|||
161505588|NCT02641379|583247260|FG008|Overall Study|Participant's PCR high|0|||
161505589|NCT02641379|583247261|FG009|Overall Study|Participant's PCR high|0|||
161505590|NCT02641379|583247262|FG010|Overall Study|Participant's PCR high|0|||
161505591|NCT02641379|583247252|FG000|Overall Study|Participant treated after Week 24|0|||
161505592|NCT02641379|583247253|FG001|Overall Study|Participant treated after Week 24|0|||
161505593|NCT02641379|583247254|FG002|Overall Study|Participant treated after Week 24|0|||
161505594|NCT02641379|583247255|FG003|Overall Study|Participant treated after Week 24|0|||
161505595|NCT02641379|583247256|FG004|Overall Study|Participant treated after Week 24|0|||
161505596|NCT02641379|583247257|FG005|Overall Study|Participant treated after Week 24|0|||
161505597|NCT02641379|583247258|FG006|Overall Study|Participant treated after Week 24|0|||
161505598|NCT02641379|583247259|FG007|Overall Study|Participant treated after Week 24|0|||
161505599|NCT02641379|583247260|FG008|Overall Study|Participant treated after Week 24|1|||
161505600|NCT02641379|583247261|FG009|Overall Study|Participant treated after Week 24|0|||
161505601|NCT02641379|583247262|FG010|Overall Study|Participant treated after Week 24|0|||
161505602|NCT02641379|583247252|FG000|Overall Study|Missing PCR result at Week 8|0|||
161505603|NCT02641379|583247253|FG001|Overall Study|Missing PCR result at Week 8|0|||
161505604|NCT02641379|583247254|FG002|Overall Study|Missing PCR result at Week 8|0|||
161505605|NCT02641379|583247255|FG003|Overall Study|Missing PCR result at Week 8|0|||
161505606|NCT02641379|583247256|FG004|Overall Study|Missing PCR result at Week 8|0|||
161505607|NCT02641379|583247257|FG005|Overall Study|Missing PCR result at Week 8|0|||
161505608|NCT02641379|583247258|FG006|Overall Study|Missing PCR result at Week 8|0|||
161505609|NCT02641379|583247259|FG007|Overall Study|Missing PCR result at Week 8|0|||
161505610|NCT02641379|583247260|FG008|Overall Study|Missing PCR result at Week 8|0|||
161505611|NCT02641379|583247261|FG009|Overall Study|Missing PCR result at Week 8|1|||
161505612|NCT02641379|583247262|FG010|Overall Study|Missing PCR result at Week 8|0|||
161505613|NCT02641379|583247252|FG000|Overall Study|PCR positive|0|||
161505614|NCT02641379|583247253|FG001|Overall Study|PCR positive|0|||
161505615|NCT02641379|583247254|FG002|Overall Study|PCR positive|0|||
161586231|NCT03732820|583534211|FG001|Overall Study|Lost to Follow-up|2|||
161586232|NCT04436107|583534212|FG000|Overall Study|Sponsor Ended Study|2|||
161586233|NCT04436107|583534213|FG001|Overall Study|Sponsor Ended Study|4|||
161586234|NCT04436107|583534214|FG002|Overall Study|Sponsor Ended Study|8|||
161586235|NCT04436107|583534215|FG003|Overall Study|Sponsor Ended Study|20|||
161673937|NCT01822522|583859939|FG002|Overall Study|Adverse Event|1|||
161586236|NCT04436107|583534212|FG000|Overall Study|Death|3|||
161673938|NCT01822522|583859940|FG003|Overall Study|Adverse Event|0|||
161673939|NCT01822522|583859941|FG004|Overall Study|Adverse Event|0|||
161673940|NCT01822522|583859942|FG005|Overall Study|Adverse Event|1|||
161673941|NCT01822522|583859937|FG000|Overall Study|Death|3|||
161673942|NCT01822522|583859938|FG001|Overall Study|Death|0|||
161673943|NCT01822522|583859939|FG002|Overall Study|Death|2|||
161505616|NCT02641379|583247255|FG003|Overall Study|PCR positive|0|||
161505617|NCT02641379|583247256|FG004|Overall Study|PCR positive|0|||
161505618|NCT02641379|583247257|FG005|Overall Study|PCR positive|0|||
161505619|NCT02641379|583247258|FG006|Overall Study|PCR positive|1|||
161505620|NCT02641379|583247259|FG007|Overall Study|PCR positive|0|||
161505621|NCT02641379|583247260|FG008|Overall Study|PCR positive|0|||
161505622|NCT02641379|583247261|FG009|Overall Study|PCR positive|0|||
161586237|NCT04436107|583534213|FG001|Overall Study|Death|5|||
161586238|NCT04436107|583534214|FG002|Overall Study|Death|3|||
161586239|NCT04436107|583534215|FG003|Overall Study|Death|18|||
161673944|NCT01822522|583859940|FG003|Overall Study|Death|0|||
161505623|NCT02641379|583247262|FG010|Overall Study|PCR positive|0|||
161673945|NCT01822522|583859941|FG004|Overall Study|Death|0|||
161505624|NCT01165138|583247263|FG000|Overall Study|Adverse Event|0|||
161505625|NCT01165138|583247264|FG001|Overall Study|Adverse Event|1|||
161505626|NCT01165138|583247265|FG002|Overall Study|Adverse Event|0|||
161505627|NCT01165138|583247266|FG003|Overall Study|Adverse Event|2|||
161505628|NCT01165138|583247263|FG000|Overall Study|Lack of Efficacy|0|||
161505629|NCT01165138|583247264|FG001|Overall Study|Lack of Efficacy|32|||
161505630|NCT01165138|583247265|FG002|Overall Study|Lack of Efficacy|6|||
161505631|NCT01165138|583247266|FG003|Overall Study|Lack of Efficacy|7|||
161505632|NCT01165138|583247263|FG000|Overall Study|Protocol Violation|0|||
161505633|NCT01165138|583247264|FG001|Overall Study|Protocol Violation|7|||
161505634|NCT01165138|583247265|FG002|Overall Study|Protocol Violation|0|||
161673946|NCT01822522|583859942|FG005|Overall Study|Death|0|||
161673947|NCT01822522|583859937|FG000|Overall Study|Lost to Follow-up|0|||
161673948|NCT01822522|583859938|FG001|Overall Study|Lost to Follow-up|0|||
161673949|NCT01822522|583859939|FG002|Overall Study|Lost to Follow-up|1|||
161673950|NCT01822522|583859940|FG003|Overall Study|Lost to Follow-up|1|||
161673951|NCT01822522|583859941|FG004|Overall Study|Lost to Follow-up|0|||
161673952|NCT01822522|583859942|FG005|Overall Study|Lost to Follow-up|1|||
161673953|NCT01822522|583859937|FG000|Overall Study|Withdrawal by Subject|0|||
161673954|NCT01822522|583859938|FG001|Overall Study|Withdrawal by Subject|0|||
161673955|NCT01822522|583859939|FG002|Overall Study|Withdrawal by Subject|0|||
161505635|NCT01165138|583247266|FG003|Overall Study|Protocol Violation|2|||
161505636|NCT01165138|583247263|FG000|Overall Study|Lost to Follow-up|0|||
161505637|NCT01165138|583247264|FG001|Overall Study|Lost to Follow-up|0|||
161505638|NCT01165138|583247265|FG002|Overall Study|Lost to Follow-up|1|||
161505639|NCT01165138|583247266|FG003|Overall Study|Lost to Follow-up|2|||
161505640|NCT01165138|583247263|FG000|Overall Study|Physician Decision|0|||
161505641|NCT01165138|583247264|FG001|Overall Study|Physician Decision|6|||
161505642|NCT01165138|583247265|FG002|Overall Study|Physician Decision|7|||
161505643|NCT01165138|583247266|FG003|Overall Study|Physician Decision|6|||
161505644|NCT01165138|583247263|FG000|Overall Study|Withdrawal by Subject|0|||
161505645|NCT01165138|583247264|FG001|Overall Study|Withdrawal by Subject|6|||
161505646|NCT01165138|583247265|FG002|Overall Study|Withdrawal by Subject|6|||
161505647|NCT01165138|583247266|FG003|Overall Study|Withdrawal by Subject|3|||
161505648|NCT01644175|583247269|FG000|Overall Study|Randomized But Not Treated|0|||
161505649|NCT01644175|583247270|FG001|Overall Study|Randomized But Not Treated|2|||
161505650|NCT01644175|583247269|FG000|Overall Study|Adverse Event|8|||
161505651|NCT01644175|583247270|FG001|Overall Study|Adverse Event|13|||
161505652|NCT01644175|583247269|FG000|Overall Study|Death|1|||
161505653|NCT01644175|583247270|FG001|Overall Study|Death|2|||
161505654|NCT01644175|583247269|FG000|Overall Study|Poor compliance to protocol|9|||
161505655|NCT01644175|583247270|FG001|Overall Study|Poor compliance to protocol|10|||
161505656|NCT01644175|583247269|FG000|Overall Study|Physician Decision|1|||
161505657|NCT01644175|583247270|FG001|Overall Study|Physician Decision|2|||
161673956|NCT01822522|583859940|FG003|Overall Study|Withdrawal by Subject|1|||
161673957|NCT01822522|583859941|FG004|Overall Study|Withdrawal by Subject|0|||
161673958|NCT01822522|583859942|FG005|Overall Study|Withdrawal by Subject|0|||
161673959|NCT01822522|583859937|FG000|Overall Study|Lack of Efficacy|0|||
161673960|NCT01822522|583859938|FG001|Overall Study|Lack of Efficacy|0|||
161673961|NCT01822522|583859939|FG002|Overall Study|Lack of Efficacy|0|||
161673962|NCT01822522|583859940|FG003|Overall Study|Lack of Efficacy|0|||
161673963|NCT01822522|583859941|FG004|Overall Study|Lack of Efficacy|0|||
161505658|NCT01644175|583247269|FG000|Overall Study|Participant Moved|1|||
161505659|NCT01644175|583247270|FG001|Overall Study|Participant Moved|2|||
161505660|NCT01644175|583247269|FG000|Overall Study|Consent withdrawn by participant|3|||
161505661|NCT01644175|583247270|FG001|Overall Study|Consent withdrawn by participant|4|||
161505662|NCT01644175|583247269|FG000|Overall Study|Related to Autoinjector Administration|2|||
161505663|NCT01644175|583247270|FG001|Overall Study|Related to Autoinjector Administration|1|||
161505664|NCT01644175|583247269|FG000|Overall Study|Last visit outside protocol visit window|4|||
161505665|NCT01644175|583247270|FG001|Overall Study|Last visit outside protocol visit window|11|||
161505666|NCT01644175|583247269|FG000|Overall Study|Selection criteria finally not met|0|||
161505667|NCT01644175|583247270|FG001|Overall Study|Selection criteria finally not met|1|||
161505668|NCT01644175|583247269|FG000|Overall Study|Site closure|2|||
161505669|NCT01644175|583247270|FG001|Overall Study|Site closure|2|||
161505670|NCT01644175|583247269|FG000|Overall Study|Lost to Follow-up|1|||
161505671|NCT01644175|583247270|FG001|Overall Study|Lost to Follow-up|0|||
161505672|NCT01644175|583247269|FG000|Overall Study|Other than specified above|0|||
161673964|NCT01822522|583859942|FG005|Overall Study|Lack of Efficacy|2|||
161673965|NCT00890929|583859943|FG000|Overall Study|Death before treatment|2|||
161673966|NCT00890929|583859943|FG000|Overall Study|Withdrawal by Subject|3|||
161673967|NCT00890929|583859943|FG000|Overall Study|Physician Decision|1|||
161673968|NCT00108069|583859944|FG000|Overall Study|Never rec'd study drug|0|||
161505673|NCT01644175|583247270|FG001|Overall Study|Other than specified above|3|||
161505674|NCT01398956|583247274|FG000|Overall Study|Withdrawal by Subject|4|||
161673969|NCT00108069|583859945|FG001|Overall Study|Never rec'd study drug|1|||
161673970|NCT00108069|583859944|FG000|Overall Study|Adverse Event|1|||
161505675|NCT01398956|583247274|FG000|Overall Study|AE, non-serious non-fatal|4|||
161505676|NCT01398956|583247274|FG000|Overall Study|Withdrawal Criteria No.3|1|||
161505677|NCT01398956|583247274|FG000|Overall Study|Subject moved a long distance|1|||
161505678|NCT00856908|583247275|FG000|Overall Study|Lost to Follow-up|1|||
161505679|NCT00856908|583247276|FG001|Overall Study|Lost to Follow-up|0|||
161505680|NCT01063595|583247280|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
161505681|NCT01063595|583247281|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
161505682|NCT01063595|583247280|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
161505683|NCT01063595|583247281|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
161505684|NCT01063595|583247280|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
161505685|NCT01063595|583247281|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
161505686|NCT01063595|583247280|FG000|First Intervention|Adverse Event|1|||
161505687|NCT01063595|583247281|FG001|First Intervention|Adverse Event|4|||
161505688|NCT01063595|583247280|FG000|First Intervention|Withdrawal by Subject|1|||
161505689|NCT01063595|583247281|FG001|First Intervention|Withdrawal by Subject|0|||
161505690|NCT01063595|583247280|FG000|First Intervention|Reason not Specified|0|||
161505691|NCT01063595|583247281|FG001|First Intervention|Reason not Specified|1|||
161505692|NCT04059146|583247282|FG000|Overall Study|Withdrawal by Subject|0|||
161505693|NCT04059146|583247283|FG001|Overall Study|Withdrawal by Subject|1|||
161505694|NCT01623596|583247284|FG000|Overall Study|Abnormal laboratory values|2|||
161505695|NCT01623596|583247285|FG001|Overall Study|Abnormal laboratory values|0|||
161505696|NCT01623596|583247284|FG000|Overall Study|Administrative problems|9|||
161505697|NCT01623596|583247285|FG001|Overall Study|Administrative problems|13|||
161505698|NCT01623596|583247284|FG000|Overall Study|Adverse Event|20|||
161505699|NCT01623596|583247285|FG001|Overall Study|Adverse Event|29|||
161505700|NCT01623596|583247284|FG000|Overall Study|Death|0|||
161505701|NCT01623596|583247285|FG001|Overall Study|Death|2|||
161505702|NCT01623596|583247284|FG000|Overall Study|Lost to Follow-up|12|||
161505703|NCT01623596|583247285|FG001|Overall Study|Lost to Follow-up|16|||
161505704|NCT01623596|583247284|FG000|Overall Study|Withdrawal by Subject|13|||
161505705|NCT01623596|583247285|FG001|Overall Study|Withdrawal by Subject|31|||
161505706|NCT01623596|583247284|FG000|Overall Study|Patient no longer requires study drug|1|||
161505707|NCT01623596|583247285|FG001|Overall Study|Patient no longer requires study drug|0|||
161505708|NCT01623596|583247284|FG000|Overall Study|Protocol Violation|0|||
161505709|NCT01623596|583247285|FG001|Overall Study|Protocol Violation|6|||
161505710|NCT01623596|583247284|FG000|Overall Study|Lack of Efficacy|5|||
161505711|NCT01623596|583247285|FG001|Overall Study|Lack of Efficacy|3|||
161819946|NCT02426918|584381193|FG001|Overall Study|Physician Decision|1|||
161819947|NCT02426918|584381194|FG002|Overall Study|Physician Decision|1|||
161819948|NCT02426918|584381192|FG000|Overall Study|Withdrawal by Subject|5|||
161819949|NCT02426918|584381193|FG001|Overall Study|Withdrawal by Subject|5|||
161819950|NCT02426918|584381194|FG002|Overall Study|Withdrawal by Subject|4|||
161819951|NCT02426918|584381192|FG000|Overall Study|Other|9|||
161819952|NCT02426918|584381193|FG001|Overall Study|Other|11|||
161819953|NCT02426918|584381194|FG002|Overall Study|Other|9|||
161819954|NCT02420353|584381195|FG000|Overall Study|Withdrawal by Subject|0|||
161819955|NCT02420353|584381196|FG001|Overall Study|Withdrawal by Subject|1|||
161819956|NCT00503867|584381197|FG000|Overall Study|Lost to Follow-up|1|||
161819957|NCT00503867|584381197|FG000|Overall Study|Adverse Event|1|||
161819958|NCT05616728|584381198|FG000|Overall Study|Lost to Follow-up|0|||
161819959|NCT05616728|584381199|FG001|Overall Study|Lost to Follow-up|0|||
161819960|NCT05616728|584381200|FG002|Overall Study|Lost to Follow-up|1|||
161819961|NCT05616728|584381198|FG000|Overall Study|Withdrawal by Subject|1|||
161819962|NCT05616728|584381199|FG001|Overall Study|Withdrawal by Subject|1|||
161819963|NCT05616728|584381200|FG002|Overall Study|Withdrawal by Subject|0|||
161819964|NCT05616728|584381198|FG000|Overall Study|Physician Decision|1|||
161819965|NCT05616728|584381199|FG001|Overall Study|Physician Decision|1|||
161819966|NCT05616728|584381200|FG002|Overall Study|Physician Decision|1|||
161819967|NCT05616728|584381198|FG000|Overall Study|Other|0|||
161819968|NCT05616728|584381199|FG001|Overall Study|Other|2|||
161819969|NCT05616728|584381200|FG002|Overall Study|Other|0|||
161819970|NCT05004649|584381207|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
161819971|NCT05004649|584381207|FG000|Overall Study|Lost to Follow-up|1|||
161819972|NCT05004649|584381207|FG000|Overall Study|Withdrawal by Subject|2|||
161819973|NCT05004649|584381207|FG000|Overall Study|COVID-19|1|||
161819974|NCT00301964|584381208|FG000|Overall Study|Second primary|2|||
161819975|NCT00301964|584381208|FG000|Overall Study|Wrong primary|1|||
161819976|NCT00301964|584381208|FG000|Overall Study|Inadequate pathology|1|||
161819977|NCT02385708|584381210|FG000|Overall Study|Withdrawal by Subject|0|||
161819978|NCT02385708|584381211|FG001|Overall Study|Withdrawal by Subject|2|||
161819979|NCT02385708|584381210|FG000|Overall Study|Withdrawn - surgery canceled|2|||
161819980|NCT02385708|584381211|FG001|Overall Study|Withdrawn - surgery canceled|5|||
161819981|NCT02385708|584381210|FG000|Overall Study|Investigator decision|5|||
161819982|NCT02385708|584381211|FG001|Overall Study|Investigator decision|7|||
161819983|NCT02385708|584381210|FG000|Overall Study|Protocol Violation|1|||
161505712|NCT00451035|583247289|FG000|Overall Study|Disease progression|11|||
161505713|NCT00451035|583247289|FG000|Overall Study|Death|3|||
161505714|NCT00451035|583247289|FG000|Overall Study|New anti-neoplastic therapy|3|||
161505715|NCT01712256|583247292|FG000|Overall Study|Lost to Follow-up|1|||
161505716|NCT00962104|583247295|FG000|Overall Study|Adverse Event|10|||
161505717|NCT00962104|583247296|FG001|Overall Study|Adverse Event|3|||
161505718|NCT00962104|583247295|FG000|Overall Study|Entry Criteria Not Met|1|||
161505719|NCT00962104|583247296|FG001|Overall Study|Entry Criteria Not Met|2|||
161505720|NCT00962104|583247295|FG000|Overall Study|Lack of Efficacy|0|||
161505721|NCT00962104|583247296|FG001|Overall Study|Lack of Efficacy|1|||
161505722|NCT00962104|583247295|FG000|Overall Study|Lost to Follow-up|10|||
161505723|NCT00962104|583247296|FG001|Overall Study|Lost to Follow-up|4|||
161505724|NCT00962104|583247295|FG000|Overall Study|Physician Decision|1|||
161505725|NCT00962104|583247296|FG001|Overall Study|Physician Decision|0|||
161505726|NCT00962104|583247295|FG000|Overall Study|Protocol Violation|6|||
161505727|NCT00962104|583247296|FG001|Overall Study|Protocol Violation|8|||
161505728|NCT00962104|583247295|FG000|Overall Study|Sponsor Decision|0|||
161505729|NCT00962104|583247296|FG001|Overall Study|Sponsor Decision|1|||
161505730|NCT00962104|583247295|FG000|Overall Study|Withdrawal by Subject|10|||
161505731|NCT00962104|583247296|FG001|Overall Study|Withdrawal by Subject|6|||
161505732|NCT00962104|583247295|FG000|Overall Study|Other|2|||
161505733|NCT00962104|583247296|FG001|Overall Study|Other|0|||
161505734|NCT03274986|583247297|FG000|Overall Study|Withdrawal by Subject|0|||
161505735|NCT03274986|583247298|FG001|Overall Study|Withdrawal by Subject|1|||
161505736|NCT03274986|583247297|FG000|Overall Study|Lost to Follow-up|0|||
161505737|NCT03274986|583247298|FG001|Overall Study|Lost to Follow-up|1|||
161505738|NCT00603746|583247299|FG000|Overall Study|Adverse Event|2|||
161505739|NCT00603746|583247300|FG001|Overall Study|Adverse Event|3|||
161505740|NCT00603746|583247301|FG002|Overall Study|Adverse Event|0|||
161505741|NCT00603746|583247302|FG003|Overall Study|Adverse Event|1|||
161505742|NCT00603746|583247303|FG004|Overall Study|Adverse Event|0|||
161505743|NCT00603746|583247304|FG005|Overall Study|Adverse Event|4|||
161505744|NCT00603746|583247299|FG000|Overall Study|Lack of Efficacy|34|||
161505745|NCT00603746|583247300|FG001|Overall Study|Lack of Efficacy|11|||
161505746|NCT00603746|583247301|FG002|Overall Study|Lack of Efficacy|6|||
161505747|NCT00603746|583247302|FG003|Overall Study|Lack of Efficacy|11|||
161505748|NCT00603746|583247303|FG004|Overall Study|Lack of Efficacy|12|||
161505749|NCT00603746|583247304|FG005|Overall Study|Lack of Efficacy|8|||
161505750|NCT00603746|583247299|FG000|Overall Study|Protocol Violation|0|||
161505751|NCT00603746|583247300|FG001|Overall Study|Protocol Violation|3|||
161505752|NCT00603746|583247301|FG002|Overall Study|Protocol Violation|1|||
161505753|NCT00603746|583247302|FG003|Overall Study|Protocol Violation|0|||
161505754|NCT00603746|583247303|FG004|Overall Study|Protocol Violation|1|||
161505755|NCT00603746|583247304|FG005|Overall Study|Protocol Violation|0|||
161505756|NCT00603746|583247299|FG000|Overall Study|Lost to Follow-up|0|||
161505757|NCT00603746|583247300|FG001|Overall Study|Lost to Follow-up|1|||
161505758|NCT00603746|583247301|FG002|Overall Study|Lost to Follow-up|1|||
161505759|NCT00603746|583247302|FG003|Overall Study|Lost to Follow-up|0|||
161505760|NCT00603746|583247303|FG004|Overall Study|Lost to Follow-up|0|||
161505761|NCT00603746|583247304|FG005|Overall Study|Lost to Follow-up|0|||
161505762|NCT00603746|583247299|FG000|Overall Study|Physician Decision|1|||
161505763|NCT00603746|583247300|FG001|Overall Study|Physician Decision|0|||
161505764|NCT00603746|583247301|FG002|Overall Study|Physician Decision|0|||
161505765|NCT00603746|583247302|FG003|Overall Study|Physician Decision|0|||
161505766|NCT00603746|583247303|FG004|Overall Study|Physician Decision|1|||
161505767|NCT00603746|583247304|FG005|Overall Study|Physician Decision|0|||
161505768|NCT00603746|583247299|FG000|Overall Study|Withdrawal by Subject|1|||
161505769|NCT00603746|583247300|FG001|Overall Study|Withdrawal by Subject|0|||
161505770|NCT00603746|583247301|FG002|Overall Study|Withdrawal by Subject|0|||
161819984|NCT02385708|584381211|FG001|Overall Study|Protocol Violation|1|||
161819985|NCT02436200|584381212|FG000|Overall Study|Significant outlier|1|||
161819986|NCT02761915|584381213|FG000|Overall Study|Death|3|||
161819987|NCT02761915|584381214|FG001|Overall Study|Death|1|||
161819988|NCT02761915|584381215|FG002|Overall Study|Death|1|||
161819989|NCT02761915|584381216|FG003|Overall Study|Death|1|||
161819990|NCT02761915|584381217|FG004|Overall Study|Death|0|||
161819991|NCT02761915|584381218|FG005|Overall Study|Death|1|||
161819992|NCT02761915|584381213|FG000|Overall Study|Withdrawal by Subject|1|||
161819993|NCT02761915|584381214|FG001|Overall Study|Withdrawal by Subject|0|||
161505771|NCT00603746|583247302|FG003|Overall Study|Withdrawal by Subject|1|||
161505772|NCT00603746|583247303|FG004|Overall Study|Withdrawal by Subject|3|||
161505773|NCT00603746|583247304|FG005|Overall Study|Withdrawal by Subject|1|||
161505774|NCT01524627|583247306|FG000|Overall Study|Physician Decision|0|||
161505775|NCT01524627|583247307|FG001|Overall Study|Physician Decision|1|||
161505776|NCT01524627|583247306|FG000|Overall Study|Lost to Follow-up|1|||
161505777|NCT01524627|583247307|FG001|Overall Study|Lost to Follow-up|1|||
161505778|NCT03323658|583247308|FG000|Overall Study|Adverse Event|0|||
161505779|NCT03323658|583247309|FG001|Overall Study|Adverse Event|1|||
161505780|NCT03323658|583247310|FG002|Overall Study|Adverse Event|0|||
161505781|NCT00615056|583247311|FG000|Overall Study|Death|31|||
161819994|NCT02761915|584381215|FG002|Overall Study|Withdrawal by Subject|0|||
161505782|NCT00615056|583247312|FG001|Overall Study|Death|31|||
161505783|NCT00615056|583247313|FG002|Overall Study|Death|21|||
161505784|NCT00615056|583247314|FG003|Overall Study|Death|23|||
161505785|NCT00615056|583247311|FG000|Overall Study|Lost to Follow-up|1|||
161505786|NCT00615056|583247312|FG001|Overall Study|Lost to Follow-up|2|||
161505787|NCT00615056|583247313|FG002|Overall Study|Lost to Follow-up|4|||
161505788|NCT00615056|583247314|FG003|Overall Study|Lost to Follow-up|5|||
161505789|NCT00615056|583247311|FG000|Overall Study|Other|13|||
161505790|NCT00615056|583247312|FG001|Overall Study|Other|15|||
161505791|NCT00615056|583247313|FG002|Overall Study|Other|10|||
161505792|NCT00615056|583247314|FG003|Overall Study|Other|7|||
161505793|NCT00615056|583247311|FG000|Overall Study|Objective progression or relapse|0|||
161505794|NCT00615056|583247312|FG001|Overall Study|Objective progression or relapse|2|||
161505795|NCT00615056|583247313|FG002|Overall Study|Objective progression or relapse|0|||
161505796|NCT00615056|583247314|FG003|Overall Study|Objective progression or relapse|0|||
161505797|NCT00615056|583247311|FG000|Overall Study|Withdrawal by Subject|0|||
161505798|NCT00615056|583247312|FG001|Overall Study|Withdrawal by Subject|1|||
161505799|NCT00615056|583247313|FG002|Overall Study|Withdrawal by Subject|1|||
161505800|NCT00615056|583247314|FG003|Overall Study|Withdrawal by Subject|0|||
161505801|NCT00615056|583247311|FG000|Overall Study|Discontinued by Sponsor|1|||
161505802|NCT00615056|583247312|FG001|Overall Study|Discontinued by Sponsor|0|||
161505803|NCT00615056|583247313|FG002|Overall Study|Discontinued by Sponsor|0|||
161505804|NCT00615056|583247314|FG003|Overall Study|Discontinued by Sponsor|0|||
161505805|NCT00615056|583247311|FG000|Overall Study|Randomized but not treated|3|||
161505806|NCT00615056|583247312|FG001|Overall Study|Randomized but not treated|0|||
161505807|NCT00615056|583247313|FG002|Overall Study|Randomized but not treated|0|||
161505808|NCT00615056|583247314|FG003|Overall Study|Randomized but not treated|0|||
161505809|NCT05627518|583247315|FG000|Treatment Period 1|Adverse Event|0|||
161505810|NCT05627518|583247316|FG001|Treatment Period 1|Adverse Event|0|||
161505811|NCT05627518|583247317|FG002|Treatment Period 1|Adverse Event|1|||
161505812|NCT05627518|583247318|FG003|Treatment Period 1|Adverse Event|0|||
161505813|NCT05627518|583247319|FG004|Treatment Period 1|Adverse Event|0|||
161505814|NCT05627518|583247320|FG005|Treatment Period 1|Adverse Event|0|||
161505815|NCT05627518|583247321|FG006|Treatment Period 1|Adverse Event|0|||
161505816|NCT05627518|583247322|FG007|Treatment Period 1|Adverse Event|1|||
161505817|NCT05627518|583247315|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161505818|NCT05627518|583247316|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161505819|NCT05627518|583247317|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161505820|NCT05627518|583247318|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161505821|NCT05627518|583247319|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161505822|NCT05627518|583247320|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161505823|NCT05627518|583247321|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161505824|NCT05627518|583247322|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161505825|NCT05627518|583247315|FG000|Treatment Period 1|Protocol Violation|0|||
161505826|NCT05627518|583247316|FG001|Treatment Period 1|Protocol Violation|0|||
161505827|NCT05627518|583247317|FG002|Treatment Period 1|Protocol Violation|0|||
161505828|NCT05627518|583247318|FG003|Treatment Period 1|Protocol Violation|0|||
161505829|NCT05627518|583247319|FG004|Treatment Period 1|Protocol Violation|0|||
161505830|NCT05627518|583247320|FG005|Treatment Period 1|Protocol Violation|0|||
161505831|NCT05627518|583247321|FG006|Treatment Period 1|Protocol Violation|6|||
161505832|NCT05627518|583247322|FG007|Treatment Period 1|Protocol Violation|6|||
161505833|NCT05627518|583247315|FG000|Treatment Period 2|Adverse Event|1|||
161505834|NCT05627518|583247316|FG001|Treatment Period 2|Adverse Event|0|||
161505835|NCT05627518|583247317|FG002|Treatment Period 2|Adverse Event|0|||
161505836|NCT05627518|583247318|FG003|Treatment Period 2|Adverse Event|0|||
161673971|NCT00108069|583859945|FG001|Overall Study|Adverse Event|1|||
161673972|NCT00108069|583859944|FG000|Overall Study|Withdrawal by Subject|1|||
161505837|NCT05627518|583247319|FG004|Treatment Period 2|Adverse Event|0|||
161505838|NCT05627518|583247320|FG005|Treatment Period 2|Adverse Event|0|||
161673973|NCT00108069|583859945|FG001|Overall Study|Withdrawal by Subject|0|||
161505839|NCT05627518|583247321|FG006|Treatment Period 2|Adverse Event|0|||
161505840|NCT05627518|583247322|FG007|Treatment Period 2|Adverse Event|0|||
161505841|NCT05627518|583247315|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161673974|NCT00108069|583859944|FG000|Overall Study|Death|1|||
161505842|NCT05627518|583247316|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161505843|NCT05627518|583247317|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161505844|NCT05627518|583247318|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161505845|NCT05627518|583247319|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161673975|NCT00108069|583859945|FG001|Overall Study|Death|0|||
161505846|NCT05627518|583247320|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161505847|NCT05627518|583247321|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161505848|NCT05627518|583247322|FG007|Treatment Period 2|Withdrawal by Subject|0|||
161505849|NCT01581593|583249316|FG000|Overall Study|Withdrawal by Subject|1|||
161505850|NCT01101841|583249317|FG000|Overall Study|Adverse Event|15|||
161505851|NCT01101841|583249318|FG001|Overall Study|Adverse Event|15|||
161505852|NCT01101841|583249317|FG000|Overall Study|Lost to Follow-up|9|||
161505853|NCT01101841|583249318|FG001|Overall Study|Lost to Follow-up|3|||
161505854|NCT01101841|583249317|FG000|Overall Study|Withdrawal by Subject|21|||
161505855|NCT01101841|583249318|FG001|Overall Study|Withdrawal by Subject|40|||
161505856|NCT01101841|583249317|FG000|Overall Study|Protocol Violation|1|||
161505857|NCT01101841|583249318|FG001|Overall Study|Protocol Violation|1|||
161505858|NCT01101841|583249317|FG000|Overall Study|Physician Decision|0|||
161505859|NCT01101841|583249318|FG001|Overall Study|Physician Decision|2|||
161505860|NCT01101841|583249317|FG000|Overall Study|Lack of Efficacy|0|||
161505861|NCT01101841|583249318|FG001|Overall Study|Lack of Efficacy|2|||
161505862|NCT01101841|583249317|FG000|Overall Study|Other|0|||
161505863|NCT01101841|583249318|FG001|Overall Study|Other|1|||
161505864|NCT01101841|583249317|FG000|Overall Study|Suicidality Tracking Scale|3|||
161505865|NCT01101841|583249318|FG001|Overall Study|Suicidality Tracking Scale|1|||
161505866|NCT01101841|583249317|FG000|Overall Study|Eligibility Criteria|1|||
161505867|NCT01101841|583249318|FG001|Overall Study|Eligibility Criteria|2|||
161505868|NCT00653224|583249321|FG000|Overall Study|Adverse Event|2|||
161505869|NCT00653224|583249322|FG001|Overall Study|Adverse Event|1|||
161505870|NCT00653224|583249321|FG000|Overall Study|Lack of Efficacy|1|||
161505871|NCT00653224|583249322|FG001|Overall Study|Lack of Efficacy|2|||
161505872|NCT00653224|583249321|FG000|Overall Study|Loss of efficacy|1|||
161505873|NCT00653224|583249322|FG001|Overall Study|Loss of efficacy|0|||
161505874|NCT00653224|583249321|FG000|Overall Study|Lost to Follow-up|1|||
161505875|NCT00653224|583249322|FG001|Overall Study|Lost to Follow-up|0|||
161505876|NCT00653224|583249321|FG000|Overall Study|Other|2|||
161505877|NCT00653224|583249322|FG001|Overall Study|Other|4|||
161505878|NCT03756558|583249323|FG000|Overall Study|Death|1|||
161505879|NCT03756558|583249323|FG000|Overall Study|Lost to Follow-up|2|||
161505880|NCT03756558|583249323|FG000|Overall Study|Withdrawal by Subject|2|||
161505881|NCT01700179|583249325|FG000|Overall Study|Physician Decision|2|||
161505882|NCT01302964|583249326|FG000|Overall Study|Adverse Event|1|||
161505883|NCT01302964|583249327|FG001|Overall Study|Adverse Event|0|||
161505884|NCT01945489|583249328|FG000|Cycle 1|Adverse Event|2|||
161505885|NCT01945489|583249329|FG001|Cycle 1|Adverse Event|0|||
161505886|NCT01945489|583249328|FG000|Cycle 1|Lost to Follow-up|4|||
161505887|NCT01945489|583249329|FG001|Cycle 1|Lost to Follow-up|0|||
161505888|NCT01945489|583249328|FG000|Cycle 1|Personal Reasons|4|||
161505889|NCT01945489|583249329|FG001|Cycle 1|Personal Reasons|2|||
161505890|NCT01945489|583249328|FG000|Cycle 1|Protocol Violation|0|||
161505891|NCT01945489|583249329|FG001|Cycle 1|Protocol Violation|1|||
161505892|NCT01945489|583249328|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
161505893|NCT01945489|583249329|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
161505894|NCT01945489|583249328|FG000|Cycle 2|Adverse Event|1|||
161505895|NCT01945489|583249329|FG001|Cycle 2|Adverse Event|0|||
161505896|NCT01945489|583249328|FG000|Cycle 2|Lost to Follow-up|0|||
161505897|NCT01945489|583249329|FG001|Cycle 2|Lost to Follow-up|1|||
161505898|NCT00145509|583249331|FG000|Overall Study|Adverse Event|10|||
161505899|NCT00145509|583249332|FG001|Overall Study|Adverse Event|3|||
161505900|NCT00145509|583249331|FG000|Overall Study|Lack of Efficacy|3|||
161505901|NCT00145509|583249332|FG001|Overall Study|Lack of Efficacy|1|||
161505902|NCT00145509|583249331|FG000|Overall Study|Lost to Follow-up|5|||
161505903|NCT00145509|583249332|FG001|Overall Study|Lost to Follow-up|9|||
161505904|NCT00145509|583249331|FG000|Overall Study|Withdrew Consent|2|||
161505905|NCT00145509|583249332|FG001|Overall Study|Withdrew Consent|7|||
161505906|NCT00145509|583249331|FG000|Overall Study|Reason not provided|2|||
161505907|NCT00145509|583249332|FG001|Overall Study|Reason not provided|1|||
161505908|NCT01982253|583249339|FG000|Overall Study|Withdrawal by Subject|1|||
161505909|NCT01982253|583249340|FG001|Overall Study|Withdrawal by Subject|0|||
161505910|NCT01982253|583249341|FG002|Overall Study|Withdrawal by Subject|0|||
161505911|NCT01982253|583249339|FG000|Overall Study|Study terminated by sponsor|1|||
161505912|NCT01982253|583249340|FG001|Overall Study|Study terminated by sponsor|4|||
161586240|NCT04436107|583534212|FG000|Overall Study|Withdrawal by Subject|1|||
161505913|NCT01982253|583249341|FG002|Overall Study|Study terminated by sponsor|4|||
161505914|NCT02789176|583249345|FG000|Overall Study|Death|0|||
161505915|NCT02789176|583249346|FG001|Overall Study|Death|0|||
161505916|NCT02789176|583249347|FG002|Overall Study|Death|3|||
161505917|NCT02789176|583249348|FG003|Overall Study|Death|0|||
161505918|NCT02789176|583249345|FG000|Overall Study|Withdrawal by Subject|0|||
161505919|NCT02789176|583249346|FG001|Overall Study|Withdrawal by Subject|0|||
161505920|NCT02789176|583249347|FG002|Overall Study|Withdrawal by Subject|1|||
161505921|NCT02789176|583249348|FG003|Overall Study|Withdrawal by Subject|0|||
161505922|NCT02789176|583249345|FG000|Overall Study|Lost to Follow-up|8|||
161505923|NCT02789176|583249346|FG001|Overall Study|Lost to Follow-up|2|||
161505924|NCT02789176|583249347|FG002|Overall Study|Lost to Follow-up|6|||
161505925|NCT02789176|583249348|FG003|Overall Study|Lost to Follow-up|1|||
161505926|NCT02223767|583249349|FG000|Overall Study|Withdrawal by Subject|4|||
161505927|NCT02223767|583249350|FG001|Overall Study|Withdrawal by Subject|4|||
161505928|NCT00770120|583249354|FG000|Overall Study|Progression|31|||
161505929|NCT00770120|583249354|FG000|Overall Study|Adverse Event|11|||
161586241|NCT04436107|583534213|FG001|Overall Study|Withdrawal by Subject|1|||
161586242|NCT04436107|583534214|FG002|Overall Study|Withdrawal by Subject|0|||
161586243|NCT04436107|583534215|FG003|Overall Study|Withdrawal by Subject|1|||
161586244|NCT01095796|583534216|FG000|Overall Study|Randomized but Not Treated|5|||
161586245|NCT01095796|583534217|FG001|Overall Study|Randomized but Not Treated|2|||
161505930|NCT00770120|583249354|FG000|Overall Study|Not Protocol Specified|11|||
161505931|NCT00770120|583249354|FG000|Overall Study|Death|3|||
161505932|NCT00770120|583249354|FG000|Overall Study|Withdrawal by Subject|2|||
161505933|NCT00770120|583249354|FG000|Overall Study|Ineligible|1|||
161505934|NCT00770120|583249354|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
161505935|NCT00770120|583249354|FG000|Overall Study|Reason under Review|1|||
161505936|NCT01232296|583249355|FG000|Overall Study|Adverse Event|24|||
161505937|NCT01232296|583249356|FG001|Overall Study|Adverse Event|12|||
161505938|NCT01232296|583249355|FG000|Overall Study|Physician Decision|1|||
161505939|NCT01232296|583249356|FG001|Overall Study|Physician Decision|1|||
161505940|NCT01232296|583249355|FG000|Overall Study|Progressive disease|43|||
161505941|NCT01232296|583249356|FG001|Overall Study|Progressive disease|61|||
161505942|NCT01232296|583249355|FG000|Overall Study|Study terminated by sponsor|0|||
161505943|NCT01232296|583249356|FG001|Overall Study|Study terminated by sponsor|1|||
161505944|NCT01232296|583249355|FG000|Overall Study|Technical problems|3|||
161505945|NCT01232296|583249356|FG001|Overall Study|Technical problems|0|||
161505946|NCT01232296|583249355|FG000|Overall Study|Subject/guardian decision|10|||
161505947|NCT01232296|583249356|FG001|Overall Study|Subject/guardian decision|2|||
161505948|NCT01232296|583249355|FG000|Overall Study|Death|1|||
161505949|NCT01232296|583249356|FG001|Overall Study|Death|6|||
161505950|NCT01461096|583249358|FG000|Overall Study|Death|3|||
161505951|NCT01461096|583249359|FG001|Overall Study|Death|6|||
161505952|NCT01461096|583249358|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161505953|NCT01461096|583249359|FG001|Overall Study|Severe debilitation, unable to continue|1|||
161505954|NCT01461096|583249358|FG000|Overall Study|Subj not able to get to clinic|15|||
161505955|NCT01461096|583249359|FG001|Overall Study|Subj not able to get to clinic|13|||
161505956|NCT01461096|583249358|FG000|Overall Study|Site is closing|27|||
161505957|NCT01461096|583249359|FG001|Overall Study|Site is closing|30|||
161505958|NCT01461096|583249358|FG000|Overall Study|Withdrawal by Subject|5|||
161505959|NCT01461096|583249359|FG001|Overall Study|Withdrawal by Subject|3|||
161505960|NCT01461096|583249358|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
161505961|NCT01461096|583249359|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
161505962|NCT01461096|583249358|FG000|Overall Study|Lost to Follow-up|8|||
161505963|NCT01461096|583249359|FG001|Overall Study|Lost to Follow-up|4|||
161505964|NCT04889625|583249361|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
161505965|NCT04889625|583249362|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
161505966|NCT04889625|583249361|FG000|Period 1|Subject out of window|0|||
161505967|NCT04889625|583249362|FG001|Period 1|Subject out of window|1|||
161505968|NCT04889625|583249361|FG000|Period 1|Wrong add power dispensed|0|||
161505969|NCT04889625|583249362|FG001|Period 1|Wrong add power dispensed|1|||
161505970|NCT04889625|583249361|FG000|Period 1|Discontinued due to fitting guide error|1|||
161505971|NCT04889625|583249362|FG001|Period 1|Discontinued due to fitting guide error|1|||
161505972|NCT04889625|583249361|FG000|Period 2|Test article no longer available|1|||
161505973|NCT04889625|583249362|FG001|Period 2|Test article no longer available|0|||
161505974|NCT04889625|583249361|FG000|Period 2|Incorrect lens dispensed|1|||
161505975|NCT04889625|583249362|FG001|Period 2|Incorrect lens dispensed|0|||
161505976|NCT04889625|583249361|FG000|Period 2|Wrong add power dispensed|0|||
161505977|NCT04889625|583249362|FG001|Period 2|Wrong add power dispensed|1|||
161505978|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
161505979|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
161505980|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
161505981|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
161505982|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
161505983|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
161505984|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
161505985|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
161505986|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
161505987|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
161505988|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
161505989|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
161505990|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
161505991|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
161505992|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
161505993|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
161586246|NCT01095796|583534216|FG000|Overall Study|Adverse Event|9|||
161819995|NCT02761915|584381216|FG003|Overall Study|Withdrawal by Subject|0|||
161505994|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
161505995|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
161505996|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Death|0|||
161505997|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Death|0|||
161505998|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Death|1|||
161505999|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Death|0|||
161506000|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Death|0|||
161506001|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Death|0|||
161506002|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Death|0|||
161506003|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Death|0|||
161506004|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Death|0|||
161506005|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
161506006|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
161506007|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
161506008|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
161506009|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
161506010|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
161506011|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
161506012|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
161506013|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
161506014|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
161506015|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
161506016|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
161506017|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
161506018|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
161506019|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
161506020|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
161506021|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
161506022|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
161506023|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
161506024|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
161506025|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
161506026|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
161506027|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
161506028|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
161506029|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
161506030|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
161506031|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
161506032|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
161506033|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
161506034|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
161506035|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
161506036|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
161506037|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
161506038|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
161506039|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
161506040|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
161506041|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
161506042|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
161506043|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
161506044|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161506045|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161506046|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161506047|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161506048|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161506049|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161506050|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506051|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
161586247|NCT01095796|583534217|FG001|Overall Study|Adverse Event|19|||
161586248|NCT01095796|583534216|FG000|Overall Study|Death|3|||
161819996|NCT02761915|584381217|FG004|Overall Study|Withdrawal by Subject|1|||
161819997|NCT02761915|584381218|FG005|Overall Study|Withdrawal by Subject|2|||
161819998|NCT02761915|584381213|FG000|Overall Study|Disease Progression|0|||
161819999|NCT02761915|584381214|FG001|Overall Study|Disease Progression|0|||
161820000|NCT02761915|584381215|FG002|Overall Study|Disease Progression|0|||
161586249|NCT01095796|583534217|FG001|Overall Study|Death|2|||
161586250|NCT01095796|583534216|FG000|Overall Study|Pregnancy|2|||
161820001|NCT02761915|584381216|FG003|Overall Study|Disease Progression|2|||
161506052|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506053|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506054|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506055|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506056|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506057|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506058|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
161506059|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
161506060|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
161506061|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
161506062|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
161506063|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
161506064|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
161506065|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
161506066|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
161506067|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
161506068|NCT00404352|583249363|FG000|Double Blind (up to 24 Month)|Other|0|||
161506069|NCT00404352|583249364|FG001|Double Blind (up to 24 Month)|Other|1|||
161506070|NCT00404352|583249365|FG002|Double Blind (up to 24 Month)|Other|0|||
161506071|NCT00404352|583249366|FG003|Double Blind (up to 24 Month)|Other|0|||
161506072|NCT00404352|583249367|FG004|Double Blind (up to 24 Month)|Other|0|||
161506073|NCT00404352|583249368|FG005|Double Blind (up to 24 Month)|Other|0|||
161506074|NCT00404352|583249369|FG006|Double Blind (up to 24 Month)|Other|0|||
161506075|NCT00404352|583249370|FG007|Double Blind (up to 24 Month)|Other|0|||
161506076|NCT00404352|583249371|FG008|Double Blind (up to 24 Month)|Other|0|||
161506077|NCT00404352|583249363|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
161506078|NCT00404352|583249364|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
161506079|NCT00404352|583249365|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
161506080|NCT00404352|583249366|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
161506081|NCT00404352|583249367|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
161506082|NCT00404352|583249368|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
161506083|NCT00404352|583249369|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
161506084|NCT00404352|583249370|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
161506085|NCT00404352|583249371|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
161506086|NCT00404352|583249363|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
161506087|NCT00404352|583249364|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
161506088|NCT00404352|583249365|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
161506089|NCT00404352|583249366|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
161506090|NCT00404352|583249367|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
161506091|NCT00404352|583249368|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
161506092|NCT00404352|583249369|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
161506093|NCT00404352|583249370|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
161506094|NCT00404352|583249371|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
161506095|NCT00404352|583249363|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506096|NCT00404352|583249364|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506097|NCT00404352|583249365|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506098|NCT00404352|583249366|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506099|NCT00404352|583249367|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
161506100|NCT00404352|583249368|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506101|NCT00404352|583249369|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506102|NCT00404352|583249370|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506103|NCT00404352|583249371|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
161506104|NCT00404352|583249363|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506105|NCT00404352|583249364|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506106|NCT00404352|583249365|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506107|NCT00404352|583249366|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506108|NCT00404352|583249367|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506109|NCT00404352|583249368|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
161673976|NCT00108069|583859944|FG000|Overall Study|Progessive disease|27|||
161673977|NCT00108069|583859945|FG001|Overall Study|Progessive disease|11|||
161673978|NCT04029116|583859946|FG000|Overall Study|Adverse Event|0|||
161673979|NCT04029116|583859947|FG001|Overall Study|Adverse Event|2|||
161673980|NCT04029116|583859946|FG000|Overall Study|Lost to Follow-up|3|||
161506110|NCT00404352|583249369|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506111|NCT00404352|583249370|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506112|NCT00404352|583249371|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161506113|NCT00404352|583249363|FG000|Open Label (up to 24 Month)|Disease progression|0|||
161506114|NCT00404352|583249364|FG001|Open Label (up to 24 Month)|Disease progression|0|||
161506115|NCT00404352|583249365|FG002|Open Label (up to 24 Month)|Disease progression|0|||
161673981|NCT04029116|583859947|FG001|Overall Study|Lost to Follow-up|5|||
161673982|NCT04029116|583859946|FG000|Overall Study|Physician Decision|2|||
161673983|NCT04029116|583859947|FG001|Overall Study|Physician Decision|0|||
161673984|NCT04029116|583859946|FG000|Overall Study|Pregnancy|1|||
161506116|NCT00404352|583249366|FG003|Open Label (up to 24 Month)|Disease progression|1|||
161506117|NCT00404352|583249367|FG004|Open Label (up to 24 Month)|Disease progression|0|||
161506118|NCT00404352|583249368|FG005|Open Label (up to 24 Month)|Disease progression|0|||
161506119|NCT00404352|583249369|FG006|Open Label (up to 24 Month)|Disease progression|0|||
161506120|NCT00404352|583249370|FG007|Open Label (up to 24 Month)|Disease progression|0|||
161506121|NCT00404352|583249371|FG008|Open Label (up to 24 Month)|Disease progression|0|||
161506122|NCT00404352|583249363|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506123|NCT00404352|583249364|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506124|NCT00404352|583249365|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506125|NCT00404352|583249366|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506126|NCT00404352|583249367|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506127|NCT00404352|583249368|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506128|NCT00404352|583249369|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
161506129|NCT00404352|583249370|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
161506130|NCT00404352|583249371|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
161506131|NCT00404352|583249363|FG000|Open Label Extension (up to 36 Months)|Other|0|||
161506132|NCT00404352|583249364|FG001|Open Label Extension (up to 36 Months)|Other|0|||
161506133|NCT00404352|583249365|FG002|Open Label Extension (up to 36 Months)|Other|0|||
161506134|NCT00404352|583249366|FG003|Open Label Extension (up to 36 Months)|Other|0|||
161506135|NCT00404352|583249367|FG004|Open Label Extension (up to 36 Months)|Other|0|||
161506136|NCT00404352|583249368|FG005|Open Label Extension (up to 36 Months)|Other|0|||
161506137|NCT00404352|583249369|FG006|Open Label Extension (up to 36 Months)|Other|0|||
161506138|NCT00404352|583249370|FG007|Open Label Extension (up to 36 Months)|Other|0|||
161506139|NCT00404352|583249371|FG008|Open Label Extension (up to 36 Months)|Other|2|||
161506140|NCT02346136|583249374|FG000|Overall Study|Withdrawal by Subject|7|||
161506141|NCT02346136|583249375|FG001|Overall Study|Withdrawal by Subject|5|||
161506142|NCT02346136|583249374|FG000|Overall Study|Death|1|||
161506143|NCT02346136|583249375|FG001|Overall Study|Death|0|||
161506144|NCT02346136|583249374|FG000|Overall Study|Study termination|14|||
161506145|NCT02346136|583249375|FG001|Overall Study|Study termination|18|||
161506146|NCT00582933|583249379|FG000|Overall Study|Physician Decision|3|||
161506147|NCT03316885|583249382|FG000|Overall Study|Adverse Event|1|||
161506148|NCT03316885|583249382|FG000|Overall Study|Death|10|||
161506149|NCT03316885|583249382|FG000|Overall Study|Lost to Follow-up|4|||
161506150|NCT03316885|583249382|FG000|Overall Study|Withdrawal by Subject|9|||
161506151|NCT03316885|583249382|FG000|Overall Study|COVID related|8|||
161506152|NCT01736696|583249390|FG000|Overall Study|Withdrawal by Subject|0|||
161506153|NCT01736696|583249391|FG001|Overall Study|Withdrawal by Subject|0|||
161506154|NCT01736696|583249392|FG002|Overall Study|Withdrawal by Subject|1|||
161506155|NCT01736696|583249393|FG003|Overall Study|Withdrawal by Subject|0|||
161506156|NCT01736696|583249394|FG004|Overall Study|Withdrawal by Subject|0|||
161506157|NCT01736696|583249395|FG005|Overall Study|Withdrawal by Subject|0|||
161506158|NCT01736696|583249396|FG006|Overall Study|Withdrawal by Subject|0|||
161506159|NCT01116232|583249397|FG000|Overall Study|Progressive diease|4|||
161506160|NCT00405548|583249398|FG000|Overall Study|Cognitive Memory problems on study day|1|||
161506161|NCT00405548|583249399|FG001|Overall Study|Cognitive Memory problems on study day|0|||
161506162|NCT00405548|583249398|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
161506163|NCT00405548|583249399|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
161506164|NCT00405548|583249398|FG000|Overall Study|Unable to self-administer shots|1|||
161506165|NCT00405548|583249399|FG001|Overall Study|Unable to self-administer shots|0|||
161506166|NCT00405548|583249398|FG000|Overall Study|Venous access failed during study day|1|||
161506167|NCT00405548|583249399|FG001|Overall Study|Venous access failed during study day|0|||
161506168|NCT00405548|583249398|FG000|Overall Study|Withdrawal by Subject|1|||
161506169|NCT00405548|583249399|FG001|Overall Study|Withdrawal by Subject|0|||
161506170|NCT02036502|583249400|FG000|Part 1:Dose Determination/Escalation|Death|3|||
161506171|NCT02036502|583249401|FG001|Part 1:Dose Determination/Escalation|Death|2|||
161506172|NCT02036502|583249402|FG002|Part 1:Dose Determination/Escalation|Death|0|||
161506173|NCT02036502|583249403|FG003|Part 1:Dose Determination/Escalation|Death|0|||
161673985|NCT04029116|583859947|FG001|Overall Study|Pregnancy|2|||
161673986|NCT04029116|583859946|FG000|Overall Study|Withdrawal by Subject|4|||
161673987|NCT04029116|583859947|FG001|Overall Study|Withdrawal by Subject|6|||
161506174|NCT02036502|583249404|FG004|Part 1:Dose Determination/Escalation|Death|0|||
161506175|NCT02036502|583249405|FG005|Part 1:Dose Determination/Escalation|Death|0|||
161506176|NCT02036502|583249406|FG006|Part 1:Dose Determination/Escalation|Death|0|||
161506177|NCT02036502|583249407|FG007|Part 1:Dose Determination/Escalation|Death|0|||
161506178|NCT02036502|583249400|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
161506179|NCT02036502|583249401|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506180|NCT02036502|583249402|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506181|NCT02036502|583249403|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506182|NCT02036502|583249404|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506183|NCT02036502|583249405|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506184|NCT02036502|583249406|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506185|NCT02036502|583249407|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
161506186|NCT02036502|583249400|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506187|NCT02036502|583249401|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
161673988|NCT04029116|583859946|FG000|Overall Study|Other|2|||
161673989|NCT04029116|583859947|FG001|Overall Study|Other|1|||
161673990|NCT02469896|583859948|FG000|Overall Study|Withdrawal by Subject|2|||
161506188|NCT02036502|583249402|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506189|NCT02036502|583249403|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506190|NCT02036502|583249404|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506191|NCT02036502|583249405|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506192|NCT02036502|583249406|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506193|NCT02036502|583249407|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
161506194|NCT02036502|583249400|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
161506195|NCT02036502|583249401|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
161506196|NCT02036502|583249402|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
161506197|NCT02036502|583249403|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
161506198|NCT02036502|583249404|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
161506199|NCT02036502|583249405|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
161506200|NCT02036502|583249406|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
161506201|NCT02036502|583249407|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
161506202|NCT02036502|583249400|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
161506203|NCT02036502|583249401|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
161506204|NCT02036502|583249402|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
161506205|NCT02036502|583249403|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
161506206|NCT02036502|583249404|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
161506207|NCT02036502|583249405|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
161506208|NCT02036502|583249406|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
161506209|NCT02036502|583249407|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
161506210|NCT02036502|583249400|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506211|NCT02036502|583249401|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506212|NCT02036502|583249402|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
161506213|NCT02036502|583249403|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506214|NCT02036502|583249404|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506215|NCT02036502|583249405|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506216|NCT02036502|583249406|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506217|NCT02036502|583249407|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
161506218|NCT02036502|583249400|FG000|Part 2:Dose Confirmation|Death|0|||
161506219|NCT02036502|583249401|FG001|Part 2:Dose Confirmation|Death|0|||
161506220|NCT02036502|583249402|FG002|Part 2:Dose Confirmation|Death|1|||
161506221|NCT02036502|583249403|FG003|Part 2:Dose Confirmation|Death|0|||
161506222|NCT02036502|583249404|FG004|Part 2:Dose Confirmation|Death|0|||
161506223|NCT02036502|583249405|FG005|Part 2:Dose Confirmation|Death|0|||
161506224|NCT02036502|583249406|FG006|Part 2:Dose Confirmation|Death|0|||
161506225|NCT02036502|583249407|FG007|Part 2:Dose Confirmation|Death|0|||
161506226|NCT02036502|583249400|FG000|Part 2:Dose Confirmation|Not treated|0|||
161506227|NCT02036502|583249401|FG001|Part 2:Dose Confirmation|Not treated|0|||
161506228|NCT02036502|583249402|FG002|Part 2:Dose Confirmation|Not treated|0|||
161506229|NCT02036502|583249403|FG003|Part 2:Dose Confirmation|Not treated|1|||
161506230|NCT02036502|583249404|FG004|Part 2:Dose Confirmation|Not treated|0|||
161673991|NCT02469896|583859949|FG001|Overall Study|Withdrawal by Subject|0|||
161673992|NCT02510560|583859950|FG000|Overall Study|Discontinued from Treatment|27|||
161506231|NCT02036502|583249405|FG005|Part 2:Dose Confirmation|Not treated|0|||
161506232|NCT02036502|583249406|FG006|Part 2:Dose Confirmation|Not treated|0|||
161506233|NCT02036502|583249407|FG007|Part 2:Dose Confirmation|Not treated|0|||
161506234|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Adverse Event|0|||
161506235|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Adverse Event|0|||
161506236|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Adverse Event|0|||
161506237|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Adverse Event|0|||
161506238|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Adverse Event|0|||
161506239|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Adverse Event|4|||
161506240|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Adverse Event|0|||
161506241|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Adverse Event|2|||
161506242|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Death|0|||
161506243|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Death|0|||
161506244|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Death|0|||
161506245|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Death|0|||
161506246|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Death|0|||
161506247|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Death|24|||
161506248|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Death|0|||
161673993|NCT02510560|583859951|FG001|Overall Study|Discontinued from Treatment|18|||
161673994|NCT02510560|583859952|FG002|Overall Study|Discontinued from Treatment|19|||
161673995|NCT02510560|583859950|FG000|Overall Study|Other|4|||
161506249|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Death|3|||
161506250|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506251|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506252|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506253|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506254|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506255|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506256|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
161506257|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
161506258|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Physician Decision|0|||
161506259|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Physician Decision|0|||
161506260|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Physician Decision|0|||
161506261|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Physician Decision|0|||
161506262|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Physician Decision|0|||
161506263|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Physician Decision|1|||
161506264|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Physician Decision|0|||
161506265|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Physician Decision|0|||
161506266|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
161506267|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
161506268|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
161506269|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
161506270|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
161506271|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
161506272|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
161506273|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
161506274|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
161506275|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
161506276|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
161506277|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
161506278|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
161506279|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
161506280|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
161506281|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
161506282|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
161506283|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
161506284|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
161506285|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
161506286|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
161506287|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
161506288|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
161506289|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
161506290|NCT02036502|583249400|FG000|Part 3:Dose Expansion|Not Treated|0|||
161506291|NCT02036502|583249401|FG001|Part 3:Dose Expansion|Not Treated|0|||
161506292|NCT02036502|583249402|FG002|Part 3:Dose Expansion|Not Treated|0|||
161506293|NCT02036502|583249403|FG003|Part 3:Dose Expansion|Not Treated|0|||
161506294|NCT02036502|583249404|FG004|Part 3:Dose Expansion|Not Treated|0|||
161506295|NCT02036502|583249405|FG005|Part 3:Dose Expansion|Not Treated|2|||
161506296|NCT02036502|583249406|FG006|Part 3:Dose Expansion|Not Treated|0|||
161506297|NCT02036502|583249407|FG007|Part 3:Dose Expansion|Not Treated|0|||
161506298|NCT00811577|583249413|FG000|Overall Study|Lost to Follow-up|7|||
161506299|NCT00811577|583249414|FG001|Overall Study|Lost to Follow-up|1|||
161506300|NCT00811577|583249413|FG000|Overall Study|Withdrawal by Subject|3|||
161506301|NCT00811577|583249414|FG001|Overall Study|Withdrawal by Subject|0|||
161506302|NCT04011410|583249415|FG000|Overall Study|Withdrawal by Subject|1|||
161506303|NCT01068509|583249416|FG000|Overall Study|Death|0|||
161506304|NCT01068509|583249417|FG001|Overall Study|Death|0|||
161506305|NCT01068509|583249418|FG002|Overall Study|Death|1|||
161506306|NCT01068509|583249416|FG000|Overall Study|Disease Progression|5|||
161506307|NCT01068509|583249417|FG001|Overall Study|Disease Progression|20|||
161506308|NCT01068509|583249418|FG002|Overall Study|Disease Progression|18|||
161506309|NCT01068509|583249416|FG000|Overall Study|Lost to Follow-up|1|||
161506310|NCT01068509|583249417|FG001|Overall Study|Lost to Follow-up|0|||
161506311|NCT01068509|583249418|FG002|Overall Study|Lost to Follow-up|0|||
161506312|NCT01068509|583249416|FG000|Overall Study|Withdrew Consent|0|||
161506313|NCT01068509|583249417|FG001|Overall Study|Withdrew Consent|1|||
161506314|NCT01068509|583249418|FG002|Overall Study|Withdrew Consent|2|||
161506315|NCT01068509|583249416|FG000|Overall Study|Reason Not Specified|0|||
161506316|NCT01068509|583249417|FG001|Overall Study|Reason Not Specified|1|||
161506317|NCT01068509|583249418|FG002|Overall Study|Reason Not Specified|0|||
161506318|NCT01455012|583249419|FG000|Overall Study|Adverse Event|0|||
161506319|NCT01455012|583249420|FG001|Overall Study|Adverse Event|2|||
161506320|NCT01455012|583249419|FG000|Overall Study|Lack of Efficacy|6|||
161506321|NCT01455012|583249420|FG001|Overall Study|Lack of Efficacy|1|||
161506322|NCT01455012|583249419|FG000|Overall Study|Withdrawal by Subject|3|||
161506323|NCT01455012|583249420|FG001|Overall Study|Withdrawal by Subject|1|||
161673996|NCT02510560|583859951|FG001|Overall Study|Other|4|||
161673997|NCT02510560|583859952|FG002|Overall Study|Other|3|||
161506324|NCT01455012|583249419|FG000|Overall Study|Unknown reason|2|||
161506325|NCT01455012|583249420|FG001|Overall Study|Unknown reason|0|||
161506326|NCT01418937|583249423|FG000|Overall Study|Lost to Follow-up|5|||
161506327|NCT01418937|583249423|FG000|Overall Study|Protocol Violation|1|||
161506328|NCT01418937|583249423|FG000|Overall Study|Pregnancy|1|||
161506329|NCT01418937|583249423|FG000|Overall Study|Withdrawal by Subject|1|||
161506330|NCT00717769|583249444|FG000|Overall Study|Adverse Event|9|||
161506331|NCT00717769|583249445|FG001|Overall Study|Adverse Event|6|||
161506332|NCT00717769|583249446|FG002|Overall Study|Adverse Event|1|||
161506333|NCT00717769|583249444|FG000|Overall Study|Lack of compliance|0|||
161506334|NCT00717769|583249445|FG001|Overall Study|Lack of compliance|2|||
161506335|NCT00717769|583249446|FG002|Overall Study|Lack of compliance|0|||
161506336|NCT00717769|583249444|FG000|Overall Study|Lost to Follow-up|3|||
161506337|NCT00717769|583249445|FG001|Overall Study|Lost to Follow-up|4|||
161506338|NCT00717769|583249446|FG002|Overall Study|Lost to Follow-up|0|||
161506339|NCT00717769|583249444|FG000|Overall Study|Lack of Efficacy|1|||
161506340|NCT00717769|583249445|FG001|Overall Study|Lack of Efficacy|2|||
161506341|NCT00717769|583249446|FG002|Overall Study|Lack of Efficacy|0|||
161506342|NCT00717769|583249444|FG000|Overall Study|Protocol Violation|0|||
161506343|NCT00717769|583249445|FG001|Overall Study|Protocol Violation|2|||
161506344|NCT00717769|583249446|FG002|Overall Study|Protocol Violation|0|||
161506345|NCT00717769|583249444|FG000|Overall Study|Sponsor decision|1|||
161506346|NCT00717769|583249445|FG001|Overall Study|Sponsor decision|0|||
161506347|NCT00717769|583249446|FG002|Overall Study|Sponsor decision|10|||
161506348|NCT00717769|583249444|FG000|Overall Study|Withdrew consent|2|||
161506349|NCT00717769|583249445|FG001|Overall Study|Withdrew consent|2|||
161506350|NCT00717769|583249446|FG002|Overall Study|Withdrew consent|0|||
161506351|NCT02196324|583249450|FG000|Overall Study|Withdrawal by Subject|8|||
161506352|NCT02196324|583249451|FG001|Overall Study|Withdrawal by Subject|4|||
161506353|NCT02196324|583249450|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
161506354|NCT02196324|583249451|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
161506355|NCT02196324|583249450|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
161506356|NCT02196324|583249451|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
161506357|NCT02196324|583249450|FG000|Overall Study|Other|1|||
161506358|NCT02196324|583249451|FG001|Overall Study|Other|0|||
161506359|NCT01380184|583249452|FG000|Part 1 (19 Days)|Adverse Event|1|||
161506360|NCT01380184|583249452|FG000|Part 2|Adverse Event|5|||
161506361|NCT01380184|583249452|FG000|Part 2|Disease Progression|8|||
161506362|NCT01380184|583249452|FG000|Part 2|Lost to Follow-up|1|||
161506363|NCT04248816|583249456|FG000|Overall Study|Ineligible post-randomization|7|||
161506364|NCT04248816|583249457|FG001|Overall Study|Ineligible post-randomization|21|||
161506365|NCT04248816|583249458|FG002|Overall Study|Ineligible post-randomization|25|||
161506366|NCT04327986|583249459|FG000|Overall Study|Physician Decision|2|||
161506367|NCT04327986|583249460|FG001|Overall Study|Physician Decision|0|||
161506368|NCT04327986|583249461|FG002|Overall Study|Physician Decision|0|||
161506369|NCT04327986|583249459|FG000|Overall Study|Death|1|||
161506370|NCT04327986|583249460|FG001|Overall Study|Death|0|||
161506371|NCT04327986|583249461|FG002|Overall Study|Death|0|||
161506372|NCT03350503|583249465|FG000|Overall Study|Adverse Event|5|||
161506373|NCT03350503|583249465|FG000|Overall Study|Withdrawal by Subject|5|||
161506374|NCT03350503|583249465|FG000|Overall Study|Continuation impossible due to move|4|||
161506375|NCT03350503|583249465|FG000|Overall Study|Physician Decision|3|||
161506376|NCT00262067|583249468|FG000|Overall Study|Death|190|||
161506377|NCT00262067|583249469|FG001|Overall Study|Death|89|||
161506378|NCT00262067|583249470|FG002|Overall Study|Death|186|||
161506379|NCT00262067|583249471|FG003|Overall Study|Death|99|||
161506380|NCT00262067|583249468|FG000|Overall Study|Lost to Follow-up|5|||
161506381|NCT00262067|583249469|FG001|Overall Study|Lost to Follow-up|4|||
161506382|NCT00262067|583249470|FG002|Overall Study|Lost to Follow-up|7|||
161506383|NCT00262067|583249471|FG003|Overall Study|Lost to Follow-up|5|||
161506384|NCT00262067|583249468|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
161506385|NCT00262067|583249469|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
161506386|NCT00262067|583249470|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
161506387|NCT00262067|583249471|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
161506388|NCT00262067|583249468|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
161506389|NCT00262067|583249469|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
161506390|NCT00262067|583249470|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
161506391|NCT00262067|583249471|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
161673998|NCT02401412|583859953|FG000|Overall Study|Lost to Follow-up|1|||
161506392|NCT03829046|583249472|FG000|Overall Study|Withdrawal by Subject|1|||
161506393|NCT03829046|583249473|FG001|Overall Study|Withdrawal by Subject|0|||
161506394|NCT04804813|583249476|FG000|Overall Study|Protocol Violation|2|||
161506395|NCT04804813|583249477|FG001|Overall Study|Protocol Violation|0|||
161506396|NCT04804813|583249476|FG000|Overall Study|Withdrawal by Subject|1|||
161506397|NCT04804813|583249477|FG001|Overall Study|Withdrawal by Subject|0|||
161673999|NCT02401412|583859954|FG001|Overall Study|Lost to Follow-up|0|||
161506398|NCT02896400|583251363|FG000|1 Month Follow-up|Lost to Follow-up|7|||
161506399|NCT02896400|583251364|FG001|1 Month Follow-up|Lost to Follow-up|7|||
161506400|NCT02896400|583251365|FG002|1 Month Follow-up|Lost to Follow-up|5|||
161506401|NCT02896400|583251366|FG003|1 Month Follow-up|Lost to Follow-up|8|||
161506402|NCT02896400|583251367|FG004|1 Month Follow-up|Lost to Follow-up|9|||
161506403|NCT02896400|583251368|FG005|1 Month Follow-up|Lost to Follow-up|6|||
161506404|NCT02896400|583251369|FG006|1 Month Follow-up|Lost to Follow-up|5|||
161506405|NCT02896400|583251370|FG007|1 Month Follow-up|Lost to Follow-up|6|||
161506406|NCT02896400|583251371|FG008|1 Month Follow-up|Lost to Follow-up|4|||
161506407|NCT02896400|583251372|FG009|1 Month Follow-up|Lost to Follow-up|7|||
161506408|NCT02896400|583251373|FG010|1 Month Follow-up|Lost to Follow-up|5|||
161506409|NCT02896400|583251374|FG011|1 Month Follow-up|Lost to Follow-up|5|||
161506410|NCT02896400|583251375|FG012|1 Month Follow-up|Lost to Follow-up|3|||
161506411|NCT02896400|583251376|FG013|1 Month Follow-up|Lost to Follow-up|4|||
161506412|NCT02896400|583251377|FG014|1 Month Follow-up|Lost to Follow-up|1|||
161506413|NCT02896400|583251378|FG015|1 Month Follow-up|Lost to Follow-up|2|||
161506414|NCT02896400|583251363|FG000|1 Month Follow-up|Death|0|||
161506415|NCT02896400|583251364|FG001|1 Month Follow-up|Death|0|||
161506416|NCT02896400|583251365|FG002|1 Month Follow-up|Death|0|||
161506417|NCT02896400|583251366|FG003|1 Month Follow-up|Death|0|||
161506418|NCT02896400|583251367|FG004|1 Month Follow-up|Death|0|||
161506419|NCT02896400|583251368|FG005|1 Month Follow-up|Death|0|||
161506420|NCT02896400|583251369|FG006|1 Month Follow-up|Death|0|||
161506421|NCT02896400|583251370|FG007|1 Month Follow-up|Death|0|||
161506422|NCT02896400|583251371|FG008|1 Month Follow-up|Death|0|||
161506423|NCT02896400|583251372|FG009|1 Month Follow-up|Death|0|||
161506424|NCT02896400|583251373|FG010|1 Month Follow-up|Death|0|||
161506425|NCT02896400|583251374|FG011|1 Month Follow-up|Death|0|||
161506426|NCT02896400|583251375|FG012|1 Month Follow-up|Death|0|||
161506427|NCT02896400|583251376|FG013|1 Month Follow-up|Death|0|||
161506428|NCT02896400|583251377|FG014|1 Month Follow-up|Death|0|||
161506429|NCT02896400|583251378|FG015|1 Month Follow-up|Death|1|||
161506430|NCT02896400|583251363|FG000|3 Month Follow-up|Lost to Follow-up|6|||
161506431|NCT02896400|583251364|FG001|3 Month Follow-up|Lost to Follow-up|3|||
161506432|NCT02896400|583251365|FG002|3 Month Follow-up|Lost to Follow-up|6|||
161506433|NCT02896400|583251366|FG003|3 Month Follow-up|Lost to Follow-up|11|||
161506434|NCT02896400|583251367|FG004|3 Month Follow-up|Lost to Follow-up|12|||
161506435|NCT02896400|583251368|FG005|3 Month Follow-up|Lost to Follow-up|6|||
161506436|NCT02896400|583251369|FG006|3 Month Follow-up|Lost to Follow-up|4|||
161506437|NCT02896400|583251370|FG007|3 Month Follow-up|Lost to Follow-up|3|||
161506438|NCT02896400|583251371|FG008|3 Month Follow-up|Lost to Follow-up|6|||
161506439|NCT02896400|583251372|FG009|3 Month Follow-up|Lost to Follow-up|5|||
161506440|NCT02896400|583251373|FG010|3 Month Follow-up|Lost to Follow-up|6|||
161506441|NCT02896400|583251374|FG011|3 Month Follow-up|Lost to Follow-up|6|||
161506442|NCT02896400|583251375|FG012|3 Month Follow-up|Lost to Follow-up|3|||
161506443|NCT02896400|583251376|FG013|3 Month Follow-up|Lost to Follow-up|5|||
161506444|NCT02896400|583251377|FG014|3 Month Follow-up|Lost to Follow-up|3|||
161506445|NCT02896400|583251378|FG015|3 Month Follow-up|Lost to Follow-up|2|||
161506446|NCT02896400|583251363|FG000|3 Month Follow-up|Death|0|||
161506447|NCT02896400|583251364|FG001|3 Month Follow-up|Death|0|||
161506448|NCT02896400|583251365|FG002|3 Month Follow-up|Death|0|||
161506449|NCT02896400|583251366|FG003|3 Month Follow-up|Death|0|||
161506450|NCT02896400|583251367|FG004|3 Month Follow-up|Death|0|||
161506451|NCT02896400|583251368|FG005|3 Month Follow-up|Death|0|||
161506452|NCT02896400|583251369|FG006|3 Month Follow-up|Death|0|||
161506453|NCT02896400|583251370|FG007|3 Month Follow-up|Death|0|||
161506454|NCT02896400|583251371|FG008|3 Month Follow-up|Death|0|||
161506455|NCT02896400|583251372|FG009|3 Month Follow-up|Death|0|||
161506456|NCT02896400|583251373|FG010|3 Month Follow-up|Death|0|||
161506457|NCT02896400|583251374|FG011|3 Month Follow-up|Death|0|||
161506458|NCT02896400|583251375|FG012|3 Month Follow-up|Death|0|||
161820002|NCT02761915|584381217|FG004|Overall Study|Disease Progression|2|||
161506459|NCT02896400|583251376|FG013|3 Month Follow-up|Death|1|||
161506460|NCT02896400|583251377|FG014|3 Month Follow-up|Death|1|||
161506461|NCT02896400|583251378|FG015|3 Month Follow-up|Death|0|||
161506462|NCT02896400|583251363|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161820003|NCT02761915|584381218|FG005|Overall Study|Disease Progression|2|||
161506463|NCT02896400|583251364|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
161506464|NCT02896400|583251365|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506465|NCT02896400|583251366|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506466|NCT02896400|583251367|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
161674000|NCT02401412|583859953|FG000|Overall Study|Discontinued Intervention|15|||
161506467|NCT02896400|583251368|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506468|NCT02896400|583251369|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
161506469|NCT02896400|583251370|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
161506470|NCT02896400|583251371|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506471|NCT02896400|583251372|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506472|NCT02896400|583251373|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
161506473|NCT02896400|583251374|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
161506474|NCT02896400|583251375|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506475|NCT02896400|583251376|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
161506476|NCT02896400|583251377|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
161506477|NCT02896400|583251378|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161506478|NCT02896400|583251363|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
161506479|NCT02896400|583251364|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
161506480|NCT02896400|583251365|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
161506481|NCT02896400|583251366|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
161506482|NCT02896400|583251367|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
161506483|NCT02896400|583251368|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
161506484|NCT02896400|583251369|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
161506485|NCT02896400|583251370|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
161506486|NCT02896400|583251371|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
161506487|NCT02896400|583251372|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
161506488|NCT02896400|583251373|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
161506489|NCT02896400|583251374|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
161506490|NCT02896400|583251375|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
161506491|NCT02896400|583251376|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
161506492|NCT02896400|583251377|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
161506493|NCT02896400|583251378|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
161506494|NCT02984020|583251379|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
161506495|NCT02984020|583251379|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
161506496|NCT02984020|583251379|FG000|Overall Study|Other significant protocol violation|2|||
161506497|NCT01896895|583251380|FG000|Double-blind MP|Physician Decision|0|||
161506498|NCT01896895|583251381|FG001|Double-blind MP|Physician Decision|0|||
161506499|NCT01896895|583251382|FG002|Double-blind MP|Physician Decision|1|||
161506500|NCT01896895|583251383|FG003|Double-blind MP|Physician Decision|0|||
161506501|NCT01896895|583251380|FG000|Double-blind MP|Withdrawal by Subject|0|||
161506502|NCT01896895|583251381|FG001|Double-blind MP|Withdrawal by Subject|2|||
161506503|NCT01896895|583251382|FG002|Double-blind MP|Withdrawal by Subject|1|||
161506504|NCT01896895|583251383|FG003|Double-blind MP|Withdrawal by Subject|0|||
161506505|NCT01896895|583251380|FG000|Double-blind MP|Lost to Follow-up|1|||
161506506|NCT01896895|583251381|FG001|Double-blind MP|Lost to Follow-up|0|||
161506507|NCT01896895|583251382|FG002|Double-blind MP|Lost to Follow-up|1|||
161506508|NCT01896895|583251383|FG003|Double-blind MP|Lost to Follow-up|0|||
161506509|NCT03277846|583251384|FG000|Overall Study|Inpatient stay too brief|12|||
161506510|NCT03277846|583251385|FG001|Overall Study|Inpatient stay too brief|11|||
161506511|NCT01207778|583251386|FG000|Overall Study|Lost to Follow-up|0|||
161506512|NCT01207778|583251387|FG001|Overall Study|Lost to Follow-up|3|||
161506513|NCT01207778|583251388|FG002|Overall Study|Lost to Follow-up|3|||
161506514|NCT05168475|583251391|FG000|Period 1|Protocol Violation|1|||
161506515|NCT05168475|583251391|FG000|Period 1|IMP shortage|2|||
161506516|NCT05168475|583251391|FG000|Period 1|Not randomised|2|||
161506517|NCT05168475|583251391|FG000|Period 2|IMP shortage|1|||
161506518|NCT01589822|583251392|FG000|Overall Study|Withdrawal by Subject|1|||
161506519|NCT01589822|583251393|FG001|Overall Study|Withdrawal by Subject|2|||
161506520|NCT01589822|583251394|FG002|Overall Study|Withdrawal by Subject|0|||
161506521|NCT01589822|583251392|FG000|Overall Study|Death|1|||
161506522|NCT01589822|583251393|FG001|Overall Study|Death|0|||
161506523|NCT01589822|583251394|FG002|Overall Study|Death|0|||
161506524|NCT01589822|583251392|FG000|Overall Study|Missed 90 day visit|2|||
161506525|NCT01589822|583251393|FG001|Overall Study|Missed 90 day visit|1|||
161506526|NCT01589822|583251394|FG002|Overall Study|Missed 90 day visit|1|||
161506527|NCT00646204|583251395|FG000|Overall Study|Adverse Event|3|||
161506528|NCT00646204|583251396|FG001|Overall Study|Adverse Event|0|||
161506529|NCT00646204|583251395|FG000|Overall Study|Withdrawal by Subject|1|||
161506530|NCT00646204|583251396|FG001|Overall Study|Withdrawal by Subject|0|||
161506531|NCT00773175|583251400|FG000|Overall Study|Adverse Event|2|||
161506532|NCT00773175|583251401|FG001|Overall Study|Adverse Event|0|||
161506533|NCT00773175|583251400|FG000|Overall Study|Consent Withdrawn|0|||
161506534|NCT00773175|583251401|FG001|Overall Study|Consent Withdrawn|2|||
161506535|NCT00503841|583251402|FG000|Overall Study|All screen failures|44|||
161506536|NCT00596011|583251403|FG000|Overall Study|Withdrawal by Subject|2|||
161506537|NCT00596011|583251404|FG001|Overall Study|Withdrawal by Subject|3|||
161820004|NCT02654145|584381225|FG000|Overall Study|Lack of Efficacy|1|||
161506538|NCT00596011|583251403|FG000|Overall Study|Adverse Event|11|||
161506539|NCT00596011|583251404|FG001|Overall Study|Adverse Event|7|||
161506540|NCT02347527|583251405|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
161506541|NCT02347527|583251406|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
161506542|NCT02347527|583251407|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
161674001|NCT02401412|583859954|FG001|Overall Study|Discontinued Intervention|21|||
161674002|NCT02401412|583859953|FG000|Overall Study|Withdrawal by Subject|4|||
161674003|NCT02401412|583859954|FG001|Overall Study|Withdrawal by Subject|4|||
161674004|NCT02401412|583859953|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
161674005|NCT02401412|583859954|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
161674006|NCT02401412|583859953|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
161674007|NCT02401412|583859954|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
161674008|NCT03684642|583859961|FG000|Overall Study|Adverse Event|6|||
161674009|NCT03684642|583859962|FG001|Overall Study|Adverse Event|15|||
161674010|NCT03684642|583859963|FG002|Overall Study|Adverse Event|11|||
161674011|NCT03684642|583859961|FG000|Overall Study|Withdrawal by Subject|35|||
161674012|NCT03684642|583859962|FG001|Overall Study|Withdrawal by Subject|53|||
161674013|NCT03684642|583859963|FG002|Overall Study|Withdrawal by Subject|23|||
161674014|NCT03684642|583859961|FG000|Overall Study|Lack of Efficacy|0|||
161674015|NCT03684642|583859962|FG001|Overall Study|Lack of Efficacy|0|||
161674016|NCT03684642|583859963|FG002|Overall Study|Lack of Efficacy|1|||
161674017|NCT03684642|583859961|FG000|Overall Study|Poor compliance to protocol|0|||
161674018|NCT03684642|583859962|FG001|Overall Study|Poor compliance to protocol|4|||
161674019|NCT03684642|583859963|FG002|Overall Study|Poor compliance to protocol|1|||
161674020|NCT03684642|583859961|FG000|Overall Study|Other than specified|62|||
161674021|NCT03684642|583859962|FG001|Overall Study|Other than specified|60|||
161674022|NCT03684642|583859963|FG002|Overall Study|Other than specified|67|||
161674023|NCT03684642|583859961|FG000|Overall Study|Randomized and not treated|0|||
161674024|NCT03684642|583859962|FG001|Overall Study|Randomized and not treated|0|||
161674025|NCT03684642|583859963|FG002|Overall Study|Randomized and not treated|1|||
161674026|NCT03684642|583859961|FG000|Overall Study|Missing completion status but alive at last contact|0|||
161674027|NCT03684642|583859962|FG001|Overall Study|Missing completion status but alive at last contact|1|||
161674028|NCT03684642|583859963|FG002|Overall Study|Missing completion status but alive at last contact|2|||
161674029|NCT01843218|583859966|FG000|Overall Study|Withdrawal by Subject|5|||
161674030|NCT01431534|583859967|FG000|Treatment Phase|Adverse Event|0|||
161674031|NCT01431534|583859968|FG001|Treatment Phase|Adverse Event|0|||
161674032|NCT01431534|583859969|FG002|Treatment Phase|Adverse Event|1|||
161674033|NCT01431534|583859967|FG000|Treatment Phase|Progressive Disease|4|||
161925715|NCT03166631|584774570|FG004|Overall Study|Adverse Event|0|||
161925716|NCT03166631|584774571|FG005|Overall Study|Adverse Event|1|||
161925717|NCT03166631|584774572|FG006|Overall Study|Adverse Event|1|||
161925718|NCT03166631|584774573|FG007|Overall Study|Adverse Event|0|||
161925719|NCT03166631|584774574|FG008|Overall Study|Adverse Event|1|||
161925720|NCT03166631|584774575|FG009|Overall Study|Adverse Event|2|||
161925721|NCT03166631|584774576|FG010|Overall Study|Adverse Event|1|||
161925722|NCT03166631|584774566|FG000|Overall Study|Withdrawal by Subject|0|||
161925723|NCT03166631|584774567|FG001|Overall Study|Withdrawal by Subject|0|||
161925724|NCT03166631|584774568|FG002|Overall Study|Withdrawal by Subject|0|||
161925725|NCT03166631|584774569|FG003|Overall Study|Withdrawal by Subject|0|||
161925726|NCT03166631|584774570|FG004|Overall Study|Withdrawal by Subject|0|||
161925727|NCT03166631|584774571|FG005|Overall Study|Withdrawal by Subject|0|||
161925728|NCT03166631|584774572|FG006|Overall Study|Withdrawal by Subject|0|||
161925729|NCT03166631|584774573|FG007|Overall Study|Withdrawal by Subject|0|||
161674034|NCT01431534|583859968|FG001|Treatment Phase|Progressive Disease|3|||
161674035|NCT01431534|583859969|FG002|Treatment Phase|Progressive Disease|10|||
161674036|NCT02742766|583859973|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674037|NCT02742766|583859974|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674038|NCT02742766|583859975|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674039|NCT02742766|583859976|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674040|NCT02742766|583859977|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674041|NCT02742766|583859978|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674042|NCT02742766|583859979|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674043|NCT02742766|583859980|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674044|NCT02742766|583859981|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674045|NCT02742766|583859982|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674046|NCT02742766|583859983|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674047|NCT02742766|583859984|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674048|NCT02742766|583859985|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674049|NCT02742766|583859986|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
161674050|NCT02742766|583859987|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674051|NCT02742766|583859988|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674052|NCT02742766|583859989|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674053|NCT02742766|583859990|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674054|NCT02742766|583859991|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674055|NCT02742766|583859973|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
161925730|NCT03166631|584774574|FG008|Overall Study|Withdrawal by Subject|1|||
161925731|NCT03166631|584774575|FG009|Overall Study|Withdrawal by Subject|1|||
161925732|NCT03166631|584774576|FG010|Overall Study|Withdrawal by Subject|0|||
161925733|NCT03787212|584774580|FG000|Period 1|Study Termination|2|||
161506543|NCT02347527|583251408|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
161506544|NCT02347527|583251405|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
161506545|NCT02347527|583251406|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
161506546|NCT02347527|583251407|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
161506547|NCT02347527|583251408|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
161506548|NCT02347527|583251405|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
161506549|NCT02347527|583251406|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
161506550|NCT02347527|583251407|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
161506551|NCT02347527|583251408|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
161506552|NCT02347527|583251405|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
161506553|NCT02347527|583251406|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
161506554|NCT02347527|583251407|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
161506555|NCT02347527|583251408|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
161506556|NCT02347527|583251405|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
161506557|NCT02347527|583251406|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
161506558|NCT02347527|583251407|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
161506559|NCT02347527|583251408|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
161506560|NCT01466270|583251413|FG000|Overall Study|Withdrawal by Subject|4|||
161506561|NCT01466270|583251414|FG001|Overall Study|Withdrawal by Subject|1|||
161506562|NCT01466270|583251413|FG000|Overall Study|Physician Decision|1|||
161506563|NCT01466270|583251414|FG001|Overall Study|Physician Decision|0|||
161506564|NCT01466270|583251413|FG000|Overall Study|Lost to Follow-up|1|||
161506565|NCT01466270|583251414|FG001|Overall Study|Lost to Follow-up|3|||
161506566|NCT01466270|583251413|FG000|Overall Study|Progression|1|||
161506567|NCT01466270|583251414|FG001|Overall Study|Progression|0|||
161506568|NCT01466270|583251413|FG000|Overall Study|Toxicity|4|||
161506569|NCT01466270|583251414|FG001|Overall Study|Toxicity|1|||
161506570|NCT01466270|583251413|FG000|Overall Study|Multiple|1|||
161506571|NCT01466270|583251414|FG001|Overall Study|Multiple|1|||
161506572|NCT00749775|583251421|FG000|Overall Study|Protocol Violation|24|||
161506573|NCT00749775|583251421|FG000|Overall Study|Lost to Follow-up|36|||
161506574|NCT00749775|583251421|FG000|Overall Study|No visit after first day of treatment|44|||
161506575|NCT00749775|583251421|FG000|Overall Study|No drug administration|3|||
161506576|NCT03364049|583251431|FG000|Overall Study|Death|6|||
161506577|NCT03364049|583251432|FG001|Overall Study|Death|4|||
161506578|NCT03364049|583251433|FG002|Overall Study|Death|5|||
161506579|NCT03364049|583251434|FG003|Overall Study|Death|14|||
161506580|NCT03364049|583251431|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
161506581|NCT03364049|583251432|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
161506582|NCT03364049|583251433|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
161506583|NCT03364049|583251434|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
161506584|NCT03364049|583251431|FG000|Overall Study|Withdrawal by Subject|0|||
161506585|NCT03364049|583251432|FG001|Overall Study|Withdrawal by Subject|1|||
161506586|NCT03364049|583251433|FG002|Overall Study|Withdrawal by Subject|1|||
161506587|NCT03364049|583251434|FG003|Overall Study|Withdrawal by Subject|1|||
161506588|NCT01340976|583251435|FG000|Overall Study|Physician Decision|2|||
161506589|NCT01340976|583251436|FG001|Overall Study|Physician Decision|0|||
161506590|NCT01340976|583251437|FG002|Overall Study|Physician Decision|1|||
161506591|NCT01340976|583251438|FG003|Overall Study|Physician Decision|1|||
161506592|NCT01340976|583251439|FG004|Overall Study|Physician Decision|1|||
161506593|NCT01340976|583251440|FG005|Overall Study|Physician Decision|0|||
161506594|NCT01340976|583251435|FG000|Overall Study|Death|0|||
161506595|NCT01340976|583251436|FG001|Overall Study|Death|1|||
161506596|NCT01340976|583251437|FG002|Overall Study|Death|0|||
161506597|NCT01340976|583251438|FG003|Overall Study|Death|0|||
161586251|NCT01095796|583534217|FG001|Overall Study|Pregnancy|0|||
161586252|NCT01095796|583534216|FG000|Overall Study|Lack of Efficacy|5|||
161586253|NCT01095796|583534217|FG001|Overall Study|Lack of Efficacy|3|||
161586254|NCT01095796|583534216|FG000|Overall Study|Investigator's Discretion|7|||
161586255|NCT01095796|583534217|FG001|Overall Study|Investigator's Discretion|2|||
161586256|NCT01095796|583534216|FG000|Overall Study|Withdrew Consent|16|||
161586257|NCT01095796|583534217|FG001|Overall Study|Withdrew Consent|22|||
161586258|NCT01095796|583534216|FG000|Overall Study|Lost to Follow-up|27|||
161586259|NCT01095796|583534217|FG001|Overall Study|Lost to Follow-up|29|||
161586260|NCT01095796|583534216|FG000|Overall Study|Participant Noncompliance|5|||
161586261|NCT01095796|583534217|FG001|Overall Study|Participant Noncompliance|10|||
161674056|NCT02742766|583859974|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
161506598|NCT01340976|583251439|FG004|Overall Study|Death|0|||
161506599|NCT01340976|583251440|FG005|Overall Study|Death|0|||
161506600|NCT01340976|583251435|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
161506601|NCT01340976|583251436|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
161506602|NCT01340976|583251437|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
161506603|NCT01340976|583251438|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
161506604|NCT01340976|583251439|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
161506605|NCT01340976|583251440|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
161506606|NCT01340976|583251435|FG000|Overall Study|Withdrawal by Subject|0|||
161506607|NCT01340976|583251436|FG001|Overall Study|Withdrawal by Subject|0|||
161506608|NCT01340976|583251437|FG002|Overall Study|Withdrawal by Subject|0|||
161506609|NCT01340976|583251438|FG003|Overall Study|Withdrawal by Subject|1|||
161506610|NCT01340976|583251439|FG004|Overall Study|Withdrawal by Subject|1|||
161506611|NCT01340976|583251440|FG005|Overall Study|Withdrawal by Subject|0|||
161506612|NCT01340976|583251435|FG000|Overall Study|Other anemia treatment|1|||
161506613|NCT01340976|583251436|FG001|Overall Study|Other anemia treatment|0|||
161506614|NCT01340976|583251437|FG002|Overall Study|Other anemia treatment|2|||
161506615|NCT01340976|583251438|FG003|Overall Study|Other anemia treatment|1|||
161506616|NCT01340976|583251439|FG004|Overall Study|Other anemia treatment|0|||
161506617|NCT01340976|583251440|FG005|Overall Study|Other anemia treatment|1|||
161506618|NCT01340976|583251435|FG000|Overall Study|Adverse Event|0|||
161506619|NCT01340976|583251436|FG001|Overall Study|Adverse Event|1|||
161506620|NCT01340976|583251437|FG002|Overall Study|Adverse Event|0|||
161506621|NCT01340976|583251438|FG003|Overall Study|Adverse Event|0|||
161506622|NCT01340976|583251439|FG004|Overall Study|Adverse Event|0|||
161506623|NCT01340976|583251440|FG005|Overall Study|Adverse Event|0|||
161506624|NCT02953821|583251441|FG000|Overall Study|Adverse Event|0|||
161506625|NCT02953821|583251442|FG001|Overall Study|Adverse Event|4|||
161506626|NCT02953821|583251441|FG000|Overall Study|Death|1|||
161506627|NCT02953821|583251442|FG001|Overall Study|Death|0|||
161506628|NCT02953821|583251441|FG000|Overall Study|Progressive Disease|5|||
161506629|NCT02953821|583251442|FG001|Overall Study|Progressive Disease|1|||
161506630|NCT02953821|583251441|FG000|Overall Study|Lost to Follow-up|2|||
161506631|NCT02953821|583251442|FG001|Overall Study|Lost to Follow-up|0|||
161506632|NCT02953821|583251441|FG000|Overall Study|Physician Decision|1|||
161506633|NCT02953821|583251442|FG001|Overall Study|Physician Decision|1|||
161506634|NCT02953821|583251441|FG000|Overall Study|Withdrawal by Subject|3|||
161506635|NCT02953821|583251442|FG001|Overall Study|Withdrawal by Subject|3|||
161506636|NCT02953821|583251441|FG000|Overall Study|Change of address|0|||
161506637|NCT02953821|583251442|FG001|Overall Study|Change of address|1|||
161506638|NCT02953821|583251441|FG000|Overall Study|Lack of Efficacy|1|||
161506639|NCT02953821|583251442|FG001|Overall Study|Lack of Efficacy|0|||
161506640|NCT02953821|583251441|FG000|Overall Study|Out of state for indeterminate time|0|||
161506641|NCT02953821|583251442|FG001|Overall Study|Out of state for indeterminate time|1|||
161506642|NCT02953821|583251441|FG000|Overall Study|No improvement|0|||
161506643|NCT02953821|583251442|FG001|Overall Study|No improvement|1|||
161506644|NCT02953821|583251441|FG000|Overall Study|Refused follow-up visit|2|||
161506645|NCT02953821|583251442|FG001|Overall Study|Refused follow-up visit|1|||
161506646|NCT01067352|583251443|FG000|Overall Study|Withdrawal by Subject|1|||
161506647|NCT01067352|583251444|FG001|Overall Study|Withdrawal by Subject|2|||
161506648|NCT01067352|583251445|FG002|Overall Study|Withdrawal by Subject|1|||
161506649|NCT01067352|583251443|FG000|Overall Study|Physician Decision|0|||
161506650|NCT01067352|583251444|FG001|Overall Study|Physician Decision|1|||
161506651|NCT01067352|583251445|FG002|Overall Study|Physician Decision|0|||
161506652|NCT00976898|583251446|FG000|Overall Study|Protocol Violation|1|||
161506653|NCT00976898|583251446|FG000|Overall Study|Adverse Event|1|||
161506654|NCT00976898|583251446|FG000|Overall Study|Physician Decision|1|||
161506655|NCT00976898|583251446|FG000|Overall Study|Liver Transplant|1|||
161506656|NCT00976898|583251446|FG000|Overall Study|Progressive Disease|1|||
161506657|NCT03064126|583251447|FG000|Overall Study|Death|40|||
161506658|NCT03064126|583251448|FG001|Overall Study|Death|16|||
161506659|NCT03064126|583251449|FG002|Overall Study|Death|4|||
161506660|NCT03064126|583251450|FG003|Overall Study|Death|2|||
161506661|NCT03064126|583251447|FG000|Overall Study|Withdrawal by Subject|17|||
161506662|NCT03064126|583251448|FG001|Overall Study|Withdrawal by Subject|9|||
161586262|NCT01095796|583534216|FG000|Overall Study|Protocol Violation|1|||
161506663|NCT03064126|583251449|FG002|Overall Study|Withdrawal by Subject|0|||
161506664|NCT03064126|583251450|FG003|Overall Study|Withdrawal by Subject|2|||
161506665|NCT03064126|583251447|FG000|Overall Study|Lost to Follow-up|7|||
161506666|NCT03064126|583251448|FG001|Overall Study|Lost to Follow-up|3|||
161506667|NCT03064126|583251449|FG002|Overall Study|Lost to Follow-up|0|||
161586263|NCT01095796|583534217|FG001|Overall Study|Protocol Violation|0|||
161506668|NCT03064126|583251450|FG003|Overall Study|Lost to Follow-up|0|||
161506669|NCT03064126|583251447|FG000|Overall Study|Adverse Event|2|||
161586264|NCT01095796|583534216|FG000|Overall Study|Participant Transferred to Another Study|215|||
161506670|NCT03064126|583251448|FG001|Overall Study|Adverse Event|0|||
161506671|NCT03064126|583251449|FG002|Overall Study|Adverse Event|0|||
161506672|NCT03064126|583251450|FG003|Overall Study|Adverse Event|0|||
161506673|NCT03064126|583251447|FG000|Overall Study|Physician Decision|3|||
161506674|NCT03064126|583251448|FG001|Overall Study|Physician Decision|0|||
161506675|NCT03064126|583251449|FG002|Overall Study|Physician Decision|0|||
161506676|NCT03064126|583251450|FG003|Overall Study|Physician Decision|0|||
161506677|NCT03064126|583251447|FG000|Overall Study|Other reason for early termination|3|||
161506678|NCT03064126|583251448|FG001|Overall Study|Other reason for early termination|2|||
161506679|NCT03064126|583251449|FG002|Overall Study|Other reason for early termination|0|||
161506680|NCT03064126|583251450|FG003|Overall Study|Other reason for early termination|0|||
161506681|NCT03064126|583251447|FG000|Overall Study|Missed Visit|3|||
161506682|NCT03064126|583251448|FG001|Overall Study|Missed Visit|1|||
161506683|NCT03064126|583251449|FG002|Overall Study|Missed Visit|0|||
161506684|NCT03064126|583251450|FG003|Overall Study|Missed Visit|0|||
161506685|NCT04649151|583251451|FG000|Overall Study|Pregnancy|0|||
161506686|NCT04649151|583251452|FG001|Overall Study|Pregnancy|0|||
161506687|NCT04649151|583251453|FG002|Overall Study|Pregnancy|0|||
161506688|NCT04649151|583251454|FG003|Overall Study|Pregnancy|0|||
161506689|NCT04649151|583251455|FG004|Overall Study|Pregnancy|3|||
161506690|NCT04649151|583251451|FG000|Overall Study|Physician Decision|10|||
161506691|NCT04649151|583251452|FG001|Overall Study|Physician Decision|0|||
161506692|NCT04649151|583251453|FG002|Overall Study|Physician Decision|0|||
161506693|NCT04649151|583251454|FG003|Overall Study|Physician Decision|1|||
161506694|NCT04649151|583251455|FG004|Overall Study|Physician Decision|1|||
161506695|NCT04649151|583251451|FG000|Overall Study|Protocol Deviation|25|||
161506696|NCT04649151|583251452|FG001|Overall Study|Protocol Deviation|3|||
161506697|NCT04649151|583251453|FG002|Overall Study|Protocol Deviation|0|||
161506698|NCT04649151|583251454|FG003|Overall Study|Protocol Deviation|0|||
161506699|NCT04649151|583251455|FG004|Overall Study|Protocol Deviation|0|||
161506700|NCT04649151|583251451|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
161506701|NCT04649151|583251452|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
161506702|NCT04649151|583251453|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
161506703|NCT04649151|583251454|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
161506704|NCT04649151|583251455|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
161506705|NCT04649151|583251451|FG000|Overall Study|Withdrawal by Subject|370|||
161506706|NCT04649151|583251452|FG001|Overall Study|Withdrawal by Subject|113|||
161506707|NCT04649151|583251453|FG002|Overall Study|Withdrawal by Subject|2|||
161506708|NCT04649151|583251454|FG003|Overall Study|Withdrawal by Subject|7|||
161506709|NCT04649151|583251455|FG004|Overall Study|Withdrawal by Subject|15|||
161506710|NCT04649151|583251451|FG000|Overall Study|Adverse Event|1|||
161506711|NCT04649151|583251452|FG001|Overall Study|Adverse Event|0|||
161506712|NCT04649151|583251453|FG002|Overall Study|Adverse Event|0|||
161506713|NCT04649151|583251454|FG003|Overall Study|Adverse Event|0|||
161506714|NCT04649151|583251455|FG004|Overall Study|Adverse Event|0|||
161506715|NCT04649151|583251451|FG000|Overall Study|Lost to Follow-up|256|||
161506716|NCT04649151|583251452|FG001|Overall Study|Lost to Follow-up|29|||
161506717|NCT04649151|583251453|FG002|Overall Study|Lost to Follow-up|10|||
161506718|NCT04649151|583251454|FG003|Overall Study|Lost to Follow-up|3|||
161506719|NCT04649151|583251455|FG004|Overall Study|Lost to Follow-up|6|||
161506720|NCT04649151|583251451|FG000|Overall Study|Other than specified|59|||
161506721|NCT04649151|583251452|FG001|Overall Study|Other than specified|294|||
161506722|NCT04649151|583251453|FG002|Overall Study|Other than specified|0|||
161506723|NCT04649151|583251454|FG003|Overall Study|Other than specified|0|||
161674057|NCT02742766|583859975|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674058|NCT02742766|583859976|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
161586265|NCT01095796|583534217|FG001|Overall Study|Participant Transferred to Another Study|200|||
161586266|NCT00999167|583534220|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
161586267|NCT00999167|583534221|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
161586268|NCT00999167|583534222|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
161586269|NCT00999167|583534220|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
161586270|NCT00999167|583534221|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
161586271|NCT00999167|583534222|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
161586272|NCT00999167|583534220|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
161586273|NCT00999167|583534221|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
161586274|NCT00999167|583534222|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
161586275|NCT00999167|583534220|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
161586276|NCT00999167|583534221|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
161586277|NCT00999167|583534222|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
161506724|NCT04649151|583251455|FG004|Overall Study|Other than specified|4|||
161506725|NCT04649151|583251451|FG000|Overall Study|Death|0|||
161506726|NCT04649151|583251452|FG001|Overall Study|Death|0|||
161506727|NCT04649151|583251453|FG002|Overall Study|Death|0|||
161674059|NCT02742766|583859977|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
161506728|NCT04649151|583251454|FG003|Overall Study|Death|0|||
161506729|NCT04649151|583251455|FG004|Overall Study|Death|1|||
161506730|NCT03752619|583251456|FG000|Overall Study|Lost to Follow-up|2|||
161506731|NCT03752619|583251457|FG001|Overall Study|Lost to Follow-up|1|||
161506732|NCT03752619|583251456|FG000|Overall Study|Withdrawal by Subject|1|||
161506733|NCT03752619|583251457|FG001|Overall Study|Withdrawal by Subject|1|||
161820005|NCT02654145|584381225|FG000|Overall Study|Protocol Violation|1|||
161674060|NCT02742766|583859978|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674061|NCT02742766|583859979|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674062|NCT02742766|583859980|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674063|NCT02742766|583859981|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674064|NCT02742766|583859982|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
161820006|NCT02654145|584381225|FG000|Overall Study|Withdrawal by Subject|5|||
161820007|NCT00354835|584381226|FG000|Overall Study|Death|1|||
161820008|NCT00354835|584381227|FG001|Overall Study|Death|1|||
161820009|NCT00354835|584381226|FG000|Overall Study|Physician Decision|8|||
161820010|NCT00354835|584381227|FG001|Overall Study|Physician Decision|13|||
161820011|NCT00354835|584381226|FG000|Overall Study|Withdrawal by Subject|2|||
161820012|NCT00354835|584381227|FG001|Overall Study|Withdrawal by Subject|1|||
161820013|NCT00354835|584381226|FG000|Overall Study|Ineligible|17|||
161820014|NCT00354835|584381227|FG001|Overall Study|Ineligible|16|||
161820015|NCT00354835|584381226|FG000|Overall Study|Disease progression or relapse|15|||
161820016|NCT00354835|584381227|FG001|Overall Study|Disease progression or relapse|22|||
161820017|NCT00354835|584381226|FG000|Overall Study|Adverse Event|6|||
161820018|NCT00354835|584381227|FG001|Overall Study|Adverse Event|0|||
161820019|NCT00354835|584381226|FG000|Overall Study|Refusal of further therapy|3|||
161820020|NCT00354835|584381227|FG001|Overall Study|Refusal of further therapy|8|||
161820021|NCT06475729|584381228|FG000|Overall Study|Withdrawal by Subject|2|||
161820022|NCT06475729|584381229|FG001|Overall Study|Withdrawal by Subject|1|||
161820023|NCT06475729|584381228|FG000|Overall Study|Randomized but did not receive any dose|3|||
161674065|NCT02742766|583859983|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674066|NCT02742766|583859984|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674067|NCT02742766|583859985|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
161674068|NCT02742766|583859986|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
161674069|NCT02742766|583859987|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674070|NCT02742766|583859988|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
161674071|NCT02742766|583859989|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674072|NCT02742766|583859990|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674073|NCT02742766|583859991|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674074|NCT03739437|583859992|FG000|Overall Study|Lost to Follow-up|2|||
161674075|NCT03739437|583859993|FG001|Overall Study|Lost to Follow-up|5|||
161674076|NCT01395316|583859995|FG000|Overall Study|Lost to Follow-up|2|||
161674077|NCT01395316|583859995|FG000|Overall Study|poor MRI quality|1|||
161674078|NCT03359590|583859996|FG000|First Intervention|Withdrawal by Subject|1|||
161674079|NCT03359590|583859997|FG001|First Intervention|Withdrawal by Subject|1|||
161674080|NCT03359590|583859996|FG000|First Intervention|Protocol Violation|0|||
161674081|NCT03359590|583859997|FG001|First Intervention|Protocol Violation|1|||
161674082|NCT02540538|583859998|FG000|Overall Study|Pregnancy|0|||
161674083|NCT02540538|583859999|FG001|Overall Study|Pregnancy|1|||
161674084|NCT02540538|583860000|FG002|Overall Study|Pregnancy|0|||
161674085|NCT02846532|583860001|FG000|Overall Study|Lost to Follow-up|0|||
161674086|NCT02846532|583860002|FG001|Overall Study|Lost to Follow-up|1|||
161820024|NCT06475729|584381229|FG001|Overall Study|Randomized but did not receive any dose|2|||
161820025|NCT06475729|584381228|FG000|Overall Study|Lost to Follow-up|1|||
161820026|NCT06475729|584381229|FG001|Overall Study|Lost to Follow-up|2|||
161820027|NCT06475729|584381228|FG000|Overall Study|Physician Decision|5|||
161586278|NCT00999167|583534220|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
161586279|NCT00999167|583534221|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
161586280|NCT00999167|583534222|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
161586281|NCT00999167|583534220|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
161586282|NCT00999167|583534221|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
161586283|NCT00999167|583534222|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
161820028|NCT06475729|584381229|FG001|Overall Study|Physician Decision|2|||
161820029|NCT06475729|584381228|FG000|Overall Study|Adverse Event|1|||
161820030|NCT06475729|584381229|FG001|Overall Study|Adverse Event|1|||
161820031|NCT03922750|584381236|FG000|Overall Study|Unclassified|0|||
161674087|NCT02846532|583860003|FG002|Overall Study|Lost to Follow-up|1|||
161674088|NCT02846532|583860001|FG000|Overall Study|Withdrawal by Subject|1|||
161674089|NCT02846532|583860002|FG001|Overall Study|Withdrawal by Subject|2|||
161586284|NCT00999167|583534220|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
161586285|NCT00999167|583534221|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
161820032|NCT03922750|584381237|FG001|Overall Study|Unclassified|0|||
161674090|NCT02846532|583860003|FG002|Overall Study|Withdrawal by Subject|0|||
161674091|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
161674092|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
161674093|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
161674094|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
161674095|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
161674096|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
161674097|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
161674098|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
161674099|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
161674100|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
161820033|NCT03922750|584381238|FG002|Overall Study|Unclassified|1|||
161820034|NCT03922750|584381236|FG000|Overall Study|Adverse Event|0|||
161820035|NCT03922750|584381237|FG001|Overall Study|Adverse Event|1|||
161820036|NCT03922750|584381238|FG002|Overall Study|Adverse Event|0|||
161820037|NCT01046084|584381242|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
161820038|NCT01046084|584381243|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
161820039|NCT02166606|584381244|FG000|Overall Study|Adverse Event|3|||
161820040|NCT02166606|584381244|FG000|Overall Study|Death|31|||
161820041|NCT02166606|584381244|FG000|Overall Study|Protocol Violation|7|||
161586286|NCT00999167|583534222|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
161586287|NCT00999167|583534220|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
161820042|NCT02166606|584381244|FG000|Overall Study|Lost to Follow-up|30|||
161820043|NCT02166606|584381244|FG000|Overall Study|Withdrawal by Subject|1|||
161820044|NCT02166606|584381244|FG000|Overall Study|Physician Decision|1|||
161820045|NCT02166606|584381244|FG000|Overall Study|Device upgrade|1|||
161820046|NCT02166606|584381244|FG000|Overall Study|Enrolled after End of Enrollment|4|||
161820047|NCT01971645|584381245|FG000|Overall Study|Adverse Event|1|||
161820048|NCT01971645|584381246|FG001|Overall Study|Adverse Event|0|||
161820049|NCT01971645|584381247|FG002|Overall Study|Adverse Event|0|||
161820050|NCT01971645|584381245|FG000|Overall Study|Lost to Follow-up|1|||
161820051|NCT01971645|584381246|FG001|Overall Study|Lost to Follow-up|0|||
161820052|NCT01971645|584381247|FG002|Overall Study|Lost to Follow-up|1|||
161820053|NCT01971645|584381245|FG000|Overall Study|Protocol Violation|0|||
161586288|NCT00999167|583534221|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
161586289|NCT00999167|583534222|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
161586290|NCT00604669|583534229|FG000|Overall Study|lack of information in chart|7|||
161586291|NCT01340066|583534230|FG000|Placebo Run in Period|Screen Failures|27|||
161586292|NCT01340066|583534231|FG001|Placebo Run in Period|Screen Failures|0|||
161586293|NCT01340066|583534232|FG002|Placebo Run in Period|Screen Failures|0|||
161586294|NCT01340066|583534230|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
161820054|NCT01971645|584381246|FG001|Overall Study|Protocol Violation|0|||
161820055|NCT01971645|584381247|FG002|Overall Study|Protocol Violation|1|||
161820056|NCT03868631|584381249|FG000|Baseline to Week 6|Adverse Event|0|||
161674101|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
161674102|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
161674103|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
161674104|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
161674105|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
161925734|NCT03787212|584774581|FG001|Period 1|Study Termination|2|||
161506734|NCT03752619|583251456|FG000|Overall Study|Adverse Event|0|||
161506735|NCT03752619|583251457|FG001|Overall Study|Adverse Event|1|||
161506736|NCT03907683|583251463|FG000|Overall Study|Pregnancy|1|||
161506737|NCT03907683|583251463|FG000|Overall Study|Withdrawal by Subject|1|||
161506738|NCT03400332|583251464|FG000|Pre-Treatment|Other reasons|0|||
161506739|NCT03400332|583251465|FG001|Pre-Treatment|Other reasons|0|||
161506740|NCT03400332|583251466|FG002|Pre-Treatment|Other reasons|0|||
161506741|NCT03400332|583251467|FG003|Pre-Treatment|Other reasons|0|||
161506742|NCT03400332|583251468|FG004|Pre-Treatment|Other reasons|0|||
161506743|NCT03400332|583251469|FG005|Pre-Treatment|Other reasons|0|||
161506744|NCT03400332|583251470|FG006|Pre-Treatment|Other reasons|0|||
161506745|NCT03400332|583251471|FG007|Pre-Treatment|Other reasons|0|||
161506746|NCT03400332|583251472|FG008|Pre-Treatment|Other reasons|1|||
161506747|NCT03400332|583251464|FG000|Pre-Treatment|No longer met study criteria|0|||
161506748|NCT03400332|583251465|FG001|Pre-Treatment|No longer met study criteria|0|||
161506749|NCT03400332|583251466|FG002|Pre-Treatment|No longer met study criteria|0|||
161506750|NCT03400332|583251467|FG003|Pre-Treatment|No longer met study criteria|0|||
161506751|NCT03400332|583251468|FG004|Pre-Treatment|No longer met study criteria|0|||
161506752|NCT03400332|583251469|FG005|Pre-Treatment|No longer met study criteria|0|||
161506753|NCT03400332|583251470|FG006|Pre-Treatment|No longer met study criteria|0|||
161506754|NCT03400332|583251471|FG007|Pre-Treatment|No longer met study criteria|0|||
161506755|NCT03400332|583251472|FG008|Pre-Treatment|No longer met study criteria|1|||
161506756|NCT03400332|583251464|FG000|Pre-Treatment|Withdrawal by Subject|0|||
161506757|NCT03400332|583251465|FG001|Pre-Treatment|Withdrawal by Subject|0|||
161506758|NCT03400332|583251466|FG002|Pre-Treatment|Withdrawal by Subject|0|||
161506759|NCT03400332|583251467|FG003|Pre-Treatment|Withdrawal by Subject|0|||
161506760|NCT03400332|583251468|FG004|Pre-Treatment|Withdrawal by Subject|0|||
161506761|NCT03400332|583251469|FG005|Pre-Treatment|Withdrawal by Subject|0|||
161506762|NCT03400332|583251470|FG006|Pre-Treatment|Withdrawal by Subject|0|||
161506763|NCT03400332|583251471|FG007|Pre-Treatment|Withdrawal by Subject|0|||
161506764|NCT03400332|583251472|FG008|Pre-Treatment|Withdrawal by Subject|1|||
161506765|NCT03400332|583251464|FG000|Treatment|Participant withdrew consent|2|||
161506766|NCT03400332|583251465|FG001|Treatment|Participant withdrew consent|2|||
161506767|NCT03400332|583251466|FG002|Treatment|Participant withdrew consent|0|||
161506768|NCT03400332|583251467|FG003|Treatment|Participant withdrew consent|0|||
161506769|NCT03400332|583251468|FG004|Treatment|Participant withdrew consent|3|||
161506770|NCT03400332|583251469|FG005|Treatment|Participant withdrew consent|3|||
161506771|NCT03400332|583251470|FG006|Treatment|Participant withdrew consent|1|||
161506772|NCT03400332|583251471|FG007|Treatment|Participant withdrew consent|1|||
161506773|NCT03400332|583251472|FG008|Treatment|Participant withdrew consent|1|||
161506774|NCT03400332|583251464|FG000|Treatment|Other reasons|0|||
161506775|NCT03400332|583251465|FG001|Treatment|Other reasons|1|||
161506776|NCT03400332|583251466|FG002|Treatment|Other reasons|1|||
161506777|NCT03400332|583251467|FG003|Treatment|Other reasons|0|||
161506778|NCT03400332|583251468|FG004|Treatment|Other reasons|3|||
161506779|NCT03400332|583251469|FG005|Treatment|Other reasons|1|||
161506780|NCT03400332|583251470|FG006|Treatment|Other reasons|2|||
161506781|NCT03400332|583251471|FG007|Treatment|Other reasons|0|||
161506782|NCT03400332|583251472|FG008|Treatment|Other reasons|1|||
161506783|NCT03400332|583251464|FG000|Treatment|Lost to Follow-up|0|||
161506784|NCT03400332|583251465|FG001|Treatment|Lost to Follow-up|1|||
161506785|NCT03400332|583251466|FG002|Treatment|Lost to Follow-up|0|||
161506786|NCT03400332|583251467|FG003|Treatment|Lost to Follow-up|0|||
161506787|NCT03400332|583251468|FG004|Treatment|Lost to Follow-up|0|||
161925735|NCT04289298|584774584|FG000|Overall Study|Lost to Follow-up|5|||
161506788|NCT03400332|583251469|FG005|Treatment|Lost to Follow-up|0|||
161506789|NCT03400332|583251470|FG006|Treatment|Lost to Follow-up|0|||
161506790|NCT03400332|583251471|FG007|Treatment|Lost to Follow-up|0|||
161506791|NCT03400332|583251472|FG008|Treatment|Lost to Follow-up|0|||
161506792|NCT03400332|583251464|FG000|Treatment|Death|3|||
161506793|NCT03400332|583251465|FG001|Treatment|Death|1|||
161506794|NCT03400332|583251466|FG002|Treatment|Death|2|||
161674106|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
161674107|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
161506795|NCT03400332|583251467|FG003|Treatment|Death|3|||
161506796|NCT03400332|583251468|FG004|Treatment|Death|6|||
161506797|NCT03400332|583251469|FG005|Treatment|Death|2|||
161506798|NCT03400332|583251470|FG006|Treatment|Death|1|||
161506799|NCT03400332|583251471|FG007|Treatment|Death|3|||
161506800|NCT03400332|583251472|FG008|Treatment|Death|6|||
161506801|NCT00048542|583251473|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161506802|NCT00048542|583251474|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
161506803|NCT00048542|583251475|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161506804|NCT00048542|583251476|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161506805|NCT00048542|583251477|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161506806|NCT00048542|583251478|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
161506807|NCT00048542|583251479|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
161506808|NCT00048542|583251480|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
161506809|NCT00048542|583251473|FG000|Double-Blind Phase|Protocol Violation|0|||
161506810|NCT00048542|583251474|FG001|Double-Blind Phase|Protocol Violation|0|||
161506811|NCT00048542|583251475|FG002|Double-Blind Phase|Protocol Violation|1|||
161506812|NCT00048542|583251476|FG003|Double-Blind Phase|Protocol Violation|0|||
161506813|NCT00048542|583251477|FG004|Double-Blind Phase|Protocol Violation|0|||
161506814|NCT00048542|583251478|FG005|Double-Blind Phase|Protocol Violation|0|||
161506815|NCT00048542|583251479|FG006|Double-Blind Phase|Protocol Violation|0|||
161506816|NCT00048542|583251480|FG007|Double-Blind Phase|Protocol Violation|0|||
161506817|NCT00048542|583251473|FG000|Double-Blind Phase|Sponsor request or decision|2|||
161506818|NCT00048542|583251474|FG001|Double-Blind Phase|Sponsor request or decision|0|||
161506819|NCT00048542|583251475|FG002|Double-Blind Phase|Sponsor request or decision|0|||
161506820|NCT00048542|583251476|FG003|Double-Blind Phase|Sponsor request or decision|0|||
161506821|NCT00048542|583251477|FG004|Double-Blind Phase|Sponsor request or decision|0|||
161506822|NCT00048542|583251478|FG005|Double-Blind Phase|Sponsor request or decision|0|||
161506823|NCT00048542|583251479|FG006|Double-Blind Phase|Sponsor request or decision|0|||
161506824|NCT00048542|583251480|FG007|Double-Blind Phase|Sponsor request or decision|0|||
161506825|NCT00048542|583251473|FG000|Double-Blind Phase|Randomized in error|1|||
161506826|NCT00048542|583251474|FG001|Double-Blind Phase|Randomized in error|0|||
161506827|NCT00048542|583251475|FG002|Double-Blind Phase|Randomized in error|0|||
161506828|NCT00048542|583251476|FG003|Double-Blind Phase|Randomized in error|0|||
161506829|NCT00048542|583251477|FG004|Double-Blind Phase|Randomized in error|0|||
161506830|NCT00048542|583251478|FG005|Double-Blind Phase|Randomized in error|0|||
161506831|NCT00048542|583251479|FG006|Double-Blind Phase|Randomized in error|0|||
161506832|NCT00048542|583251480|FG007|Double-Blind Phase|Randomized in error|0|||
161506833|NCT00048542|583251473|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
161506834|NCT00048542|583251474|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
161506835|NCT00048542|583251475|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
161506836|NCT00048542|583251476|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
161506837|NCT00048542|583251477|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
161506838|NCT00048542|583251478|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
161506839|NCT00048542|583251479|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
161506840|NCT00048542|583251480|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
161506841|NCT00048542|583251473|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506842|NCT00048542|583251474|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506843|NCT00048542|583251475|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506844|NCT00048542|583251476|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506845|NCT00048542|583251477|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506846|NCT00048542|583251478|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
161506847|NCT00048542|583251479|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506848|NCT00048542|583251480|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
161506849|NCT00048542|583251473|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
161506850|NCT00048542|583251474|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
161506851|NCT00048542|583251475|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
161506852|NCT00048542|583251476|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
161506853|NCT00048542|583251477|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
161506854|NCT00048542|583251478|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
161506855|NCT00048542|583251479|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
161506856|NCT00048542|583251480|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
161506857|NCT00048542|583251473|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
161506858|NCT00048542|583251474|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
161506859|NCT00048542|583251475|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
161506860|NCT00048542|583251476|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
161506861|NCT00048542|583251477|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
161506862|NCT00048542|583251478|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
161506863|NCT00048542|583251479|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
161506864|NCT00048542|583251480|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
161506865|NCT00048542|583251473|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
161506866|NCT00048542|583251474|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
161506867|NCT00048542|583251475|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
161506868|NCT00048542|583251476|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
161506869|NCT00048542|583251477|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
161506870|NCT00048542|583251478|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
161506871|NCT00048542|583251479|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
161506872|NCT00048542|583251480|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
161506873|NCT00048542|583251473|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
161506874|NCT00048542|583251474|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
161506875|NCT00048542|583251475|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
161506876|NCT00048542|583251476|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
161506877|NCT00048542|583251477|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
161506878|NCT00048542|583251478|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
161506879|NCT00048542|583251479|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
161506880|NCT00048542|583251480|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
161506881|NCT00048542|583251473|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
161506882|NCT00048542|583251474|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
161506883|NCT00048542|583251475|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
161506884|NCT00048542|583251476|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
161506885|NCT00048542|583251477|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
161506886|NCT00048542|583251478|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
161506887|NCT00048542|583251479|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
161506888|NCT00048542|583251480|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
161506889|NCT00048542|583251473|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161506890|NCT00048542|583251474|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161506891|NCT00048542|583251475|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161506892|NCT00048542|583251476|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161506893|NCT00048542|583251477|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161506894|NCT00048542|583251478|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161506895|NCT00048542|583251479|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
161506896|NCT00048542|583251480|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
161506897|NCT00048542|583251473|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161506898|NCT00048542|583251474|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161506899|NCT00048542|583251475|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161506900|NCT00048542|583251476|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161506901|NCT00048542|583251477|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161506902|NCT00048542|583251478|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161506903|NCT00048542|583251479|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
161506904|NCT00048542|583251480|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
161506905|NCT00048542|583251473|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
161506906|NCT00048542|583251474|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
161506907|NCT00048542|583251475|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
161506908|NCT00048542|583251476|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
161506909|NCT00048542|583251477|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
161506910|NCT00048542|583251478|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
161506911|NCT00048542|583251479|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
161506912|NCT00048542|583251480|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
161506913|NCT00048542|583251473|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
161506914|NCT00048542|583251474|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
161506915|NCT00048542|583251475|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
161506916|NCT00048542|583251476|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
161506917|NCT00048542|583251477|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
161506918|NCT00048542|583251478|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
161820057|NCT03868631|584381250|FG001|Baseline to Week 6|Adverse Event|3|||
161820058|NCT03868631|584381249|FG000|Baseline to Week 6|Protocol Violation|1|||
161820059|NCT03868631|584381250|FG001|Baseline to Week 6|Protocol Violation|1|||
161820060|NCT03868631|584381249|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
161820061|NCT03868631|584381250|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
161820062|NCT03868631|584381249|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
161820063|NCT03868631|584381250|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
161820064|NCT03868631|584381249|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
161925736|NCT04289298|584774585|FG001|Overall Study|Lost to Follow-up|0|||
161925737|NCT04289298|584774584|FG000|Overall Study|Withdrawal by Subject|2|||
161925738|NCT04289298|584774585|FG001|Overall Study|Withdrawal by Subject|0|||
161925739|NCT01778985|584774589|FG000|Overall Study|Lost to Follow-up|1|||
161925740|NCT01778985|584774590|FG001|Overall Study|Lost to Follow-up|0|||
161925741|NCT01778985|584774589|FG000|Overall Study|Physician Decision|2|||
161925742|NCT01778985|584774590|FG001|Overall Study|Physician Decision|2|||
161925743|NCT01778985|584774589|FG000|Overall Study|Protocol Violation|4|||
161925744|NCT01778985|584774590|FG001|Overall Study|Protocol Violation|1|||
161925745|NCT00504231|584774591|FG000|Overall Study|Discrepant chart documentation re route|0|||
161925746|NCT00504231|584774592|FG001|Overall Study|Discrepant chart documentation re route|0|||
161925747|NCT00504231|584774593|FG002|Overall Study|Discrepant chart documentation re route|1|||
161506919|NCT00048542|583251479|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
161506920|NCT00048542|583251480|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
161506921|NCT04033159|583251484|FG000|Washout Period|Physician Decision|0|||
161506922|NCT04033159|583251485|FG001|Washout Period|Physician Decision|1|||
161506923|NCT04033159|583251486|FG002|Washout Period|Physician Decision|0|||
161506924|NCT04033159|583251484|FG000|Washout Period|Study terminated by Sponsor|0|||
161506925|NCT04033159|583251485|FG001|Washout Period|Study terminated by Sponsor|7|||
161506926|NCT04033159|583251486|FG002|Washout Period|Study terminated by Sponsor|0|||
161506927|NCT04033159|583251484|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
161506928|NCT04033159|583251485|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
161506929|NCT04033159|583251486|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
161586295|NCT01340066|583534231|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
161586296|NCT01340066|583534232|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
161586297|NCT01340066|583534230|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
161506930|NCT01452412|583251497|FG000|Overall Study|Withdrawal by Subject|15|||
161586298|NCT01340066|583534231|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
161586299|NCT01340066|583534232|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
161586300|NCT01340066|583534230|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
161586301|NCT01340066|583534231|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
161586302|NCT01340066|583534232|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
161586303|NCT02789020|583534233|FG000|Overall Study|Withdrawal by Subject|6|||
161586304|NCT02789020|583534234|FG001|Overall Study|Withdrawal by Subject|5|||
161586305|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161586306|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161586307|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
161586308|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161586309|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
161586310|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
161586311|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
161586312|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
161586313|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161586314|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161586315|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
161586316|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161586317|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161586318|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161586319|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
161586320|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161586321|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
161586322|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
161586323|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
161586324|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
161586325|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
161586326|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
161586327|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
161586328|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
161586329|NCT03338816|583534244|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161586330|NCT03338816|583534245|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161586331|NCT03338816|583534246|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161586332|NCT03338816|583534247|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
161586333|NCT04238247|583534253|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
161586334|NCT04238247|583534254|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
161586335|NCT04238247|583534255|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
161586336|NCT04238247|583534256|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
161586337|NCT04238247|583534253|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
161586338|NCT04238247|583534254|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
161586339|NCT04238247|583534255|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
161586340|NCT04238247|583534256|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
161586341|NCT04238247|583534253|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
161586342|NCT04238247|583534254|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
161586343|NCT04238247|583534255|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
161586344|NCT04238247|583534256|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
161586345|NCT04238247|583534253|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
161586346|NCT04238247|583534254|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
161506931|NCT01452412|583251498|FG001|Overall Study|Withdrawal by Subject|11|||
161506932|NCT01452412|583251497|FG000|Overall Study|Adverse Event|4|||
161506933|NCT01452412|583251498|FG001|Overall Study|Adverse Event|3|||
161506934|NCT01452412|583251497|FG000|Overall Study|Lost to Follow-up|5|||
161506935|NCT01452412|583251498|FG001|Overall Study|Lost to Follow-up|3|||
161506936|NCT01452412|583251497|FG000|Overall Study|Death|1|||
161506937|NCT01452412|583251498|FG001|Overall Study|Death|0|||
161506938|NCT01452412|583251497|FG000|Overall Study|Initiated dialysis|1|||
161506939|NCT01452412|583251498|FG001|Overall Study|Initiated dialysis|0|||
161506940|NCT01452412|583251497|FG000|Overall Study|Other|2|||
161506941|NCT01452412|583251498|FG001|Overall Study|Other|0|||
161506942|NCT03047135|583251499|FG000|Overall Study|Still being treated|3|||
161506943|NCT00323414|583251500|FG000|Overall Study|Withdrawal by Subject|0|||
161506944|NCT00323414|583251501|FG001|Overall Study|Withdrawal by Subject|1|||
161506945|NCT01256593|583251504|FG000|Overall Study|Protocol Violation|26|||
161506946|NCT01256593|583251504|FG000|Overall Study|No Drug Administration Information|2|||
161506947|NCT01256593|583251504|FG000|Overall Study|No Visit After Treatment|186|||
161506948|NCT05619692|583251511|FG000|Overall Study|Adverse Event|2|||
161506949|NCT05619692|583251512|FG001|Overall Study|Adverse Event|2|||
161506950|NCT05619692|583251511|FG000|Overall Study|Withdrawal by Participant|3|||
161506951|NCT05619692|583251512|FG001|Overall Study|Withdrawal by Participant|4|||
161506952|NCT05619692|583251511|FG000|Overall Study|Lost to Follow-up|2|||
161820065|NCT03868631|584381250|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
161820066|NCT03868631|584381249|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
161820067|NCT03868631|584381250|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
161820068|NCT01717040|584381252|FG000|Overall Study|Lost to Follow-up|2|||
161820069|NCT01717040|584381253|FG001|Overall Study|Lost to Follow-up|3|||
161820070|NCT01717040|584381252|FG000|Overall Study|Lack of Efficacy|1|||
161820071|NCT01717040|584381253|FG001|Overall Study|Lack of Efficacy|1|||
161506953|NCT05619692|583251512|FG001|Overall Study|Lost to Follow-up|1|||
161506954|NCT05619692|583251511|FG000|Overall Study|Randomized but not treated|1|||
161506955|NCT05619692|583251512|FG001|Overall Study|Randomized but not treated|3|||
161506956|NCT02457598|583251513|FG000|Overall Study|Progressive Disease|2|||
161506957|NCT02457598|583251514|FG001|Overall Study|Progressive Disease|2|||
161506958|NCT02457598|583251515|FG002|Overall Study|Progressive Disease|1|||
161506959|NCT02457598|583251516|FG003|Overall Study|Progressive Disease|11|||
161506960|NCT02457598|583251517|FG004|Overall Study|Progressive Disease|7|||
161506961|NCT02457598|583251518|FG005|Overall Study|Progressive Disease|3|||
161506962|NCT02457598|583251519|FG006|Overall Study|Progressive Disease|2|||
161506963|NCT02457598|583251520|FG007|Overall Study|Progressive Disease|1|||
161506964|NCT02457598|583251521|FG008|Overall Study|Progressive Disease|1|||
161506965|NCT02457598|583251522|FG009|Overall Study|Progressive Disease|2|||
161506966|NCT02457598|583251523|FG010|Overall Study|Progressive Disease|45|||
161506967|NCT02457598|583251524|FG011|Overall Study|Progressive Disease|6|||
161506968|NCT02457598|583251525|FG012|Overall Study|Progressive Disease|2|||
161506969|NCT02457598|583251526|FG013|Overall Study|Progressive Disease|2|||
161506970|NCT02457598|583251527|FG014|Overall Study|Progressive Disease|10|||
161506971|NCT02457598|583251528|FG015|Overall Study|Progressive Disease|1|||
161506972|NCT02457598|583251529|FG016|Overall Study|Progressive Disease|1|||
161506973|NCT02457598|583251513|FG000|Overall Study|Investigator's Discretion|0|||
161506974|NCT02457598|583251514|FG001|Overall Study|Investigator's Discretion|2|||
161506975|NCT02457598|583251515|FG002|Overall Study|Investigator's Discretion|2|||
161506976|NCT02457598|583251516|FG003|Overall Study|Investigator's Discretion|2|||
161506977|NCT02457598|583251517|FG004|Overall Study|Investigator's Discretion|0|||
161506978|NCT02457598|583251518|FG005|Overall Study|Investigator's Discretion|0|||
161506979|NCT02457598|583251519|FG006|Overall Study|Investigator's Discretion|0|||
161506980|NCT02457598|583251520|FG007|Overall Study|Investigator's Discretion|1|||
161506981|NCT02457598|583251521|FG008|Overall Study|Investigator's Discretion|2|||
161506982|NCT02457598|583251522|FG009|Overall Study|Investigator's Discretion|0|||
161506983|NCT02457598|583251523|FG010|Overall Study|Investigator's Discretion|10|||
161506984|NCT02457598|583251524|FG011|Overall Study|Investigator's Discretion|2|||
161506985|NCT02457598|583251525|FG012|Overall Study|Investigator's Discretion|2|||
161506986|NCT02457598|583251526|FG013|Overall Study|Investigator's Discretion|1|||
161506987|NCT02457598|583251527|FG014|Overall Study|Investigator's Discretion|5|||
161506988|NCT02457598|583251528|FG015|Overall Study|Investigator's Discretion|0|||
161586347|NCT04238247|583534255|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
161820072|NCT01717040|584381252|FG000|Overall Study|Adverse Event|1|||
161506989|NCT02457598|583251529|FG016|Overall Study|Investigator's Discretion|0|||
161506990|NCT02457598|583251513|FG000|Overall Study|Study Terminated by Sponsor|0|||
161506991|NCT02457598|583251514|FG001|Overall Study|Study Terminated by Sponsor|1|||
161506992|NCT02457598|583251515|FG002|Overall Study|Study Terminated by Sponsor|0|||
161506993|NCT02457598|583251516|FG003|Overall Study|Study Terminated by Sponsor|4|||
161586348|NCT04238247|583534256|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
161506994|NCT02457598|583251517|FG004|Overall Study|Study Terminated by Sponsor|1|||
161506995|NCT02457598|583251518|FG005|Overall Study|Study Terminated by Sponsor|0|||
161506996|NCT02457598|583251519|FG006|Overall Study|Study Terminated by Sponsor|1|||
161820073|NCT01717040|584381253|FG001|Overall Study|Adverse Event|0|||
161674108|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
161674109|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
161674110|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
161674111|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
161506997|NCT02457598|583251520|FG007|Overall Study|Study Terminated by Sponsor|0|||
161506998|NCT02457598|583251521|FG008|Overall Study|Study Terminated by Sponsor|0|||
161506999|NCT02457598|583251522|FG009|Overall Study|Study Terminated by Sponsor|0|||
161507000|NCT02457598|583251523|FG010|Overall Study|Study Terminated by Sponsor|4|||
161507001|NCT02457598|583251524|FG011|Overall Study|Study Terminated by Sponsor|0|||
161507002|NCT02457598|583251525|FG012|Overall Study|Study Terminated by Sponsor|1|||
161507003|NCT02457598|583251526|FG013|Overall Study|Study Terminated by Sponsor|0|||
161507004|NCT02457598|583251527|FG014|Overall Study|Study Terminated by Sponsor|8|||
161507005|NCT02457598|583251528|FG015|Overall Study|Study Terminated by Sponsor|1|||
161674112|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
161674113|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
161674114|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
161683063|NCT02463409|583891224|FG000|Overall Study|Withdrawal by Subject|1|||
161507006|NCT02457598|583251529|FG016|Overall Study|Study Terminated by Sponsor|0|||
161507007|NCT02457598|583251513|FG000|Overall Study|Adverse Event|0|||
161507008|NCT02457598|583251514|FG001|Overall Study|Adverse Event|1|||
161507009|NCT02457598|583251515|FG002|Overall Study|Adverse Event|1|||
161507010|NCT02457598|583251516|FG003|Overall Study|Adverse Event|4|||
161507011|NCT02457598|583251517|FG004|Overall Study|Adverse Event|1|||
161507012|NCT02457598|583251518|FG005|Overall Study|Adverse Event|0|||
161507013|NCT02457598|583251519|FG006|Overall Study|Adverse Event|0|||
161507014|NCT02457598|583251520|FG007|Overall Study|Adverse Event|1|||
161507015|NCT02457598|583251521|FG008|Overall Study|Adverse Event|0|||
161507016|NCT02457598|583251522|FG009|Overall Study|Adverse Event|1|||
161507017|NCT02457598|583251523|FG010|Overall Study|Adverse Event|6|||
161507018|NCT02457598|583251524|FG011|Overall Study|Adverse Event|0|||
161507019|NCT02457598|583251525|FG012|Overall Study|Adverse Event|0|||
161507020|NCT02457598|583251526|FG013|Overall Study|Adverse Event|1|||
161507021|NCT02457598|583251527|FG014|Overall Study|Adverse Event|2|||
161507022|NCT02457598|583251528|FG015|Overall Study|Adverse Event|0|||
161507023|NCT02457598|583251529|FG016|Overall Study|Adverse Event|0|||
161507024|NCT02457598|583251513|FG000|Overall Study|Death|0|||
161507025|NCT02457598|583251514|FG001|Overall Study|Death|0|||
161507026|NCT02457598|583251515|FG002|Overall Study|Death|0|||
161507027|NCT02457598|583251516|FG003|Overall Study|Death|3|||
161507028|NCT02457598|583251517|FG004|Overall Study|Death|0|||
161507029|NCT02457598|583251518|FG005|Overall Study|Death|1|||
161507030|NCT02457598|583251519|FG006|Overall Study|Death|0|||
161507031|NCT02457598|583251520|FG007|Overall Study|Death|0|||
161507032|NCT02457598|583251521|FG008|Overall Study|Death|0|||
161507033|NCT02457598|583251522|FG009|Overall Study|Death|0|||
161507034|NCT02457598|583251523|FG010|Overall Study|Death|3|||
161507035|NCT02457598|583251524|FG011|Overall Study|Death|0|||
161507036|NCT02457598|583251525|FG012|Overall Study|Death|0|||
161507037|NCT02457598|583251526|FG013|Overall Study|Death|1|||
161507038|NCT02457598|583251527|FG014|Overall Study|Death|2|||
161507039|NCT02457598|583251528|FG015|Overall Study|Death|0|||
161507040|NCT02457598|583251529|FG016|Overall Study|Death|1|||
161507041|NCT02457598|583251513|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507042|NCT02457598|583251514|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
161507043|NCT02457598|583251515|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507044|NCT02457598|583251516|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
161507045|NCT02457598|583251517|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507046|NCT02457598|583251518|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507047|NCT02457598|583251519|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507048|NCT02457598|583251520|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
161507049|NCT02457598|583251521|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507050|NCT02457598|583251522|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507051|NCT02457598|583251523|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
161507052|NCT02457598|583251524|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507053|NCT02457598|583251525|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507054|NCT02457598|583251526|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
161507055|NCT02457598|583251527|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
161507056|NCT02457598|583251528|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
161507057|NCT02457598|583251529|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
161507058|NCT02457598|583251513|FG000|Overall Study|Withdrew Consent|0|||
161507059|NCT02457598|583251514|FG001|Overall Study|Withdrew Consent|0|||
161507060|NCT02457598|583251515|FG002|Overall Study|Withdrew Consent|0|||
161507061|NCT02457598|583251516|FG003|Overall Study|Withdrew Consent|0|||
161507062|NCT02457598|583251517|FG004|Overall Study|Withdrew Consent|0|||
161507063|NCT02457598|583251518|FG005|Overall Study|Withdrew Consent|0|||
161507064|NCT02457598|583251519|FG006|Overall Study|Withdrew Consent|0|||
161586349|NCT05512962|583534257|FG000|Overall Study|Withdrawal by Subject|1|||
161586350|NCT05512962|583534258|FG001|Overall Study|Withdrawal by Subject|0|||
161586351|NCT04950127|583534259|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
161586352|NCT04950127|583534260|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
161586353|NCT04950127|583534261|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
161674115|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
161674116|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
161674117|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
161674118|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
161674119|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
161674120|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
161674121|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
161674122|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
161674123|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
161674124|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161674125|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161674126|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161507065|NCT02457598|583251520|FG007|Overall Study|Withdrew Consent|2|||
161507066|NCT02457598|583251521|FG008|Overall Study|Withdrew Consent|0|||
161507067|NCT02457598|583251522|FG009|Overall Study|Withdrew Consent|0|||
161507068|NCT02457598|583251523|FG010|Overall Study|Withdrew Consent|3|||
161507069|NCT02457598|583251524|FG011|Overall Study|Withdrew Consent|0|||
161507070|NCT02457598|583251525|FG012|Overall Study|Withdrew Consent|0|||
161507071|NCT02457598|583251526|FG013|Overall Study|Withdrew Consent|1|||
161507072|NCT02457598|583251527|FG014|Overall Study|Withdrew Consent|0|||
161507073|NCT02457598|583251528|FG015|Overall Study|Withdrew Consent|0|||
161507074|NCT02457598|583251529|FG016|Overall Study|Withdrew Consent|0|||
161674127|NCT04598477|583860008|FG000|Overall Study|Adverse Event|2|||
161674128|NCT04598477|583860009|FG001|Overall Study|Adverse Event|0|||
161674129|NCT04598477|583860008|FG000|Overall Study|Death|0|||
161674130|NCT04598477|583860009|FG001|Overall Study|Death|1|||
161507075|NCT02457598|583251513|FG000|Overall Study|Unacceptable Toxicity|0|||
161507076|NCT02457598|583251514|FG001|Overall Study|Unacceptable Toxicity|0|||
161507077|NCT02457598|583251515|FG002|Overall Study|Unacceptable Toxicity|0|||
161507078|NCT02457598|583251516|FG003|Overall Study|Unacceptable Toxicity|0|||
161507079|NCT02457598|583251517|FG004|Overall Study|Unacceptable Toxicity|0|||
161507080|NCT02457598|583251518|FG005|Overall Study|Unacceptable Toxicity|0|||
161507081|NCT02457598|583251519|FG006|Overall Study|Unacceptable Toxicity|0|||
161507082|NCT02457598|583251520|FG007|Overall Study|Unacceptable Toxicity|0|||
161507083|NCT02457598|583251521|FG008|Overall Study|Unacceptable Toxicity|0|||
161507084|NCT02457598|583251522|FG009|Overall Study|Unacceptable Toxicity|0|||
161507085|NCT02457598|583251523|FG010|Overall Study|Unacceptable Toxicity|1|||
161507086|NCT02457598|583251524|FG011|Overall Study|Unacceptable Toxicity|0|||
161507087|NCT02457598|583251525|FG012|Overall Study|Unacceptable Toxicity|1|||
161507088|NCT02457598|583251526|FG013|Overall Study|Unacceptable Toxicity|1|||
161507089|NCT02457598|583251527|FG014|Overall Study|Unacceptable Toxicity|1|||
161507090|NCT02457598|583251528|FG015|Overall Study|Unacceptable Toxicity|0|||
161507091|NCT02457598|583251529|FG016|Overall Study|Unacceptable Toxicity|0|||
161507092|NCT02457598|583251513|FG000|Overall Study|Intercurrent Illness|0|||
161507093|NCT02457598|583251514|FG001|Overall Study|Intercurrent Illness|0|||
161674131|NCT04598477|583860008|FG000|Overall Study|Lost to Follow-up|1|||
161674132|NCT04598477|583860009|FG001|Overall Study|Lost to Follow-up|0|||
161674133|NCT04598477|583860008|FG000|Overall Study|Physician Decision|7|||
161674134|NCT04598477|583860009|FG001|Overall Study|Physician Decision|2|||
161674135|NCT04598477|583860008|FG000|Overall Study|Pregnancy|0|||
161674136|NCT04598477|583860009|FG001|Overall Study|Pregnancy|1|||
161674137|NCT04598477|583860008|FG000|Overall Study|Requires Prohibited Medication|0|||
161674138|NCT04598477|583860009|FG001|Overall Study|Requires Prohibited Medication|1|||
161674139|NCT04598477|583860008|FG000|Overall Study|Study Terminated by Sponsor|18|||
161507094|NCT02457598|583251515|FG002|Overall Study|Intercurrent Illness|0|||
161586354|NCT04950127|583534262|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
161586355|NCT04950127|583534263|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
161586356|NCT04950127|583534264|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
161586357|NCT04950127|583534259|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
161586358|NCT04950127|583534260|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
161586359|NCT04950127|583534261|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
161507095|NCT02457598|583251516|FG003|Overall Study|Intercurrent Illness|0|||
161507096|NCT02457598|583251517|FG004|Overall Study|Intercurrent Illness|0|||
161507097|NCT02457598|583251518|FG005|Overall Study|Intercurrent Illness|0|||
161507098|NCT02457598|583251519|FG006|Overall Study|Intercurrent Illness|0|||
161507099|NCT02457598|583251520|FG007|Overall Study|Intercurrent Illness|0|||
161586360|NCT04950127|583534262|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
161674140|NCT04598477|583860009|FG001|Overall Study|Study Terminated by Sponsor|12|||
161507100|NCT02457598|583251521|FG008|Overall Study|Intercurrent Illness|0|||
161507101|NCT02457598|583251522|FG009|Overall Study|Intercurrent Illness|0|||
161507102|NCT02457598|583251523|FG010|Overall Study|Intercurrent Illness|1|||
161507103|NCT02457598|583251524|FG011|Overall Study|Intercurrent Illness|0|||
161507104|NCT02457598|583251525|FG012|Overall Study|Intercurrent Illness|0|||
161507105|NCT02457598|583251526|FG013|Overall Study|Intercurrent Illness|0|||
161507106|NCT02457598|583251527|FG014|Overall Study|Intercurrent Illness|0|||
161507107|NCT02457598|583251528|FG015|Overall Study|Intercurrent Illness|0|||
161507108|NCT02457598|583251529|FG016|Overall Study|Intercurrent Illness|0|||
161507109|NCT02457598|583251513|FG000|Overall Study|Protocol Violation|0|||
161507110|NCT02457598|583251514|FG001|Overall Study|Protocol Violation|0|||
161507111|NCT02457598|583251515|FG002|Overall Study|Protocol Violation|0|||
161507112|NCT02457598|583251516|FG003|Overall Study|Protocol Violation|0|||
161507113|NCT02457598|583251517|FG004|Overall Study|Protocol Violation|0|||
161507114|NCT02457598|583251518|FG005|Overall Study|Protocol Violation|0|||
161507115|NCT02457598|583251519|FG006|Overall Study|Protocol Violation|0|||
161507116|NCT02457598|583251520|FG007|Overall Study|Protocol Violation|0|||
161507117|NCT02457598|583251521|FG008|Overall Study|Protocol Violation|0|||
161507118|NCT02457598|583251522|FG009|Overall Study|Protocol Violation|0|||
161507119|NCT02457598|583251523|FG010|Overall Study|Protocol Violation|1|||
161507120|NCT02457598|583251524|FG011|Overall Study|Protocol Violation|0|||
161507121|NCT02457598|583251525|FG012|Overall Study|Protocol Violation|0|||
161507122|NCT02457598|583251526|FG013|Overall Study|Protocol Violation|0|||
161507123|NCT02457598|583251527|FG014|Overall Study|Protocol Violation|0|||
161507124|NCT02457598|583251528|FG015|Overall Study|Protocol Violation|0|||
161507125|NCT02457598|583251529|FG016|Overall Study|Protocol Violation|0|||
161507126|NCT02703636|583251531|FG000|Overall Study|Adverse Event|14|||
161507127|NCT02703636|583251531|FG000|Overall Study|Study stopped by sponsor|1|||
161507128|NCT02703636|583251531|FG000|Overall Study|Withdrawal by Subject|1|||
161507129|NCT01110915|583251541|FG000|Overall Study|Death|2|||
161507130|NCT01110915|583251542|FG001|Overall Study|Death|1|||
161507131|NCT01110915|583251541|FG000|Overall Study|Lost to Follow-up|1|||
161507132|NCT01110915|583251542|FG001|Overall Study|Lost to Follow-up|0|||
161507133|NCT01110915|583251541|FG000|Overall Study|Withdrawal by Subject|7|||
161507134|NCT01110915|583251542|FG001|Overall Study|Withdrawal by Subject|1|||
161507135|NCT01215227|583251546|FG000|Overall Study|Adverse Event|11|||
161507136|NCT01215227|583251547|FG001|Overall Study|Adverse Event|11|||
161507137|NCT01215227|583251548|FG002|Overall Study|Adverse Event|4|||
161820074|NCT01717040|584381252|FG000|Overall Study|Required Medication Change|0|||
161820075|NCT01717040|584381253|FG001|Overall Study|Required Medication Change|1|||
161820076|NCT01717040|584381252|FG000|Overall Study|New Substance Use Disorder|1|||
161820077|NCT01717040|584381253|FG001|Overall Study|New Substance Use Disorder|0|||
161820078|NCT02957331|584381256|FG000|Overall Study|Protocol Violation|1|||
161820079|NCT02957331|584381257|FG001|Overall Study|Protocol Violation|0|||
161820080|NCT05568615|584382702|FG000|Overall Study|Death|1|||
161820081|NCT05568615|584382702|FG000|Overall Study|Physician Decision|1|||
161820082|NCT00565851|584382703|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
161820083|NCT00565851|584382704|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
161820084|NCT00565851|584382705|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
161820085|NCT00565851|584382706|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
161820086|NCT00565851|584382707|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
161820087|NCT00565851|584382708|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
161820088|NCT00565851|584382709|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
161820089|NCT00565851|584382710|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
161820090|NCT00565851|584382703|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820091|NCT00565851|584382704|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
161820092|NCT00565851|584382705|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820093|NCT00565851|584382706|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
161820094|NCT00565851|584382707|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820095|NCT00565851|584382708|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
161820096|NCT00565851|584382709|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820097|NCT00565851|584382710|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
161820098|NCT03291067|584382711|FG000|Overall Study|Adverse Event|0|||
161820099|NCT03291067|584382712|FG001|Overall Study|Adverse Event|2|||
161820100|NCT03291067|584382713|FG002|Overall Study|Adverse Event|17|||
161820101|NCT03291067|584382714|FG003|Overall Study|Adverse Event|3|||
161820102|NCT03291067|584382711|FG000|Overall Study|Lost to Follow-up|2|||
161820103|NCT03291067|584382712|FG001|Overall Study|Lost to Follow-up|1|||
161820104|NCT03291067|584382713|FG002|Overall Study|Lost to Follow-up|0|||
161507138|NCT01215227|583251549|FG003|Overall Study|Adverse Event|8|||
161507139|NCT01215227|583251550|FG004|Overall Study|Adverse Event|7|||
161507140|NCT01215227|583251551|FG005|Overall Study|Adverse Event|6|||
161507141|NCT01215227|583251546|FG000|Overall Study|Treatment Failure|8|||
161507142|NCT01215227|583251547|FG001|Overall Study|Treatment Failure|4|||
161507143|NCT01215227|583251548|FG002|Overall Study|Treatment Failure|1|||
161507144|NCT01215227|583251549|FG003|Overall Study|Treatment Failure|5|||
161820105|NCT03291067|584382714|FG003|Overall Study|Lost to Follow-up|1|||
161820106|NCT03291067|584382711|FG000|Overall Study|Physician Decision|0|||
161507145|NCT01215227|583251550|FG004|Overall Study|Treatment Failure|1|||
161507146|NCT01215227|583251551|FG005|Overall Study|Treatment Failure|1|||
161507147|NCT01215227|583251546|FG000|Overall Study|Lost to Follow-up|1|||
161507148|NCT01215227|583251547|FG001|Overall Study|Lost to Follow-up|4|||
161507149|NCT01215227|583251548|FG002|Overall Study|Lost to Follow-up|1|||
161507150|NCT01215227|583251549|FG003|Overall Study|Lost to Follow-up|1|||
161507151|NCT01215227|583251550|FG004|Overall Study|Lost to Follow-up|1|||
161507152|NCT01215227|583251551|FG005|Overall Study|Lost to Follow-up|2|||
161507153|NCT01215227|583251546|FG000|Overall Study|Subject Withdrew Consent|16|||
161507154|NCT01215227|583251547|FG001|Overall Study|Subject Withdrew Consent|20|||
161507155|NCT01215227|583251548|FG002|Overall Study|Subject Withdrew Consent|7|||
161507156|NCT01215227|583251549|FG003|Overall Study|Subject Withdrew Consent|10|||
161507157|NCT01215227|583251550|FG004|Overall Study|Subject Withdrew Consent|11|||
161507158|NCT01215227|583251551|FG005|Overall Study|Subject Withdrew Consent|8|||
161507159|NCT01215227|583251546|FG000|Overall Study|Non-Compliance With Protocol|2|||
161507160|NCT01215227|583251547|FG001|Overall Study|Non-Compliance With Protocol|6|||
161507161|NCT01215227|583251548|FG002|Overall Study|Non-Compliance With Protocol|1|||
161507162|NCT01215227|583251549|FG003|Overall Study|Non-Compliance With Protocol|0|||
161507163|NCT01215227|583251550|FG004|Overall Study|Non-Compliance With Protocol|0|||
161507164|NCT01215227|583251551|FG005|Overall Study|Non-Compliance With Protocol|0|||
161507165|NCT01215227|583251546|FG000|Overall Study|Administrative|83|||
161507166|NCT01215227|583251547|FG001|Overall Study|Administrative|73|||
161507167|NCT01215227|583251548|FG002|Overall Study|Administrative|42|||
161507168|NCT01215227|583251549|FG003|Overall Study|Administrative|24|||
161507169|NCT01215227|583251550|FG004|Overall Study|Administrative|28|||
161507170|NCT01215227|583251551|FG005|Overall Study|Administrative|40|||
161507171|NCT01215227|583251546|FG000|Overall Study|Missing Status|0|||
161507172|NCT01215227|583251547|FG001|Overall Study|Missing Status|1|||
161507173|NCT01215227|583251548|FG002|Overall Study|Missing Status|0|||
161507174|NCT01215227|583251549|FG003|Overall Study|Missing Status|0|||
161507175|NCT01215227|583251550|FG004|Overall Study|Missing Status|0|||
161507176|NCT01215227|583251551|FG005|Overall Study|Missing Status|0|||
161586361|NCT04950127|583534263|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
161586362|NCT04950127|583534264|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
161586363|NCT04950127|583534259|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
161586364|NCT04950127|583534260|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
161586365|NCT04950127|583534261|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161586366|NCT04950127|583534262|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161586367|NCT04950127|583534263|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161586368|NCT04950127|583534264|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161586369|NCT04950127|583534259|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161586370|NCT04950127|583534260|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161586371|NCT04950127|583534261|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161586372|NCT04950127|583534262|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161586373|NCT04950127|583534263|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161586374|NCT04950127|583534264|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
161586375|NCT04950127|583534259|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
161586376|NCT04950127|583534260|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
161586377|NCT04950127|583534261|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
161586378|NCT04950127|583534262|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
161586379|NCT04950127|583534263|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
161586380|NCT04950127|583534264|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
161586381|NCT01711632|583534265|FG000|Overall Study|Adverse Event|4|||
161586382|NCT01711632|583534265|FG000|Overall Study|Death|3|||
161586383|NCT01711632|583534265|FG000|Overall Study|Lost to Follow-up|3|||
161586384|NCT01711632|583534265|FG000|Overall Study|Withdrawal by Subject|4|||
161586385|NCT01711632|583534265|FG000|Overall Study|Progressive disease|2|||
161586386|NCT01711632|583534265|FG000|Overall Study|No follow up required in re-treatment|3|||
161586387|NCT01711632|583534265|FG000|Overall Study|No follow up required in re-treatment|3|||
161586388|NCT03517969|583534266|FG000|Overall Study|Never started protocol treatment|3|||
161586389|NCT03517969|583534267|FG001|Overall Study|Never started protocol treatment|5|||
161586390|NCT03517969|583534266|FG000|Overall Study|Disease progression|11|||
161674141|NCT04598477|583860008|FG000|Overall Study|Withdrawal by Subject|16|||
161507177|NCT01215227|583251546|FG000|Overall Study|Randomized but not treated|0|||
161507178|NCT01215227|583251547|FG001|Overall Study|Randomized but not treated|0|||
161507179|NCT01215227|583251548|FG002|Overall Study|Randomized but not treated|1|||
161507180|NCT01215227|583251549|FG003|Overall Study|Randomized but not treated|1|||
161507181|NCT01215227|583251550|FG004|Overall Study|Randomized but not treated|0|||
161507182|NCT01215227|583251551|FG005|Overall Study|Randomized but not treated|1|||
161586391|NCT03517969|583534267|FG001|Overall Study|Disease progression|16|||
161586392|NCT03517969|583534266|FG000|Overall Study|PSA progression|8|||
161586393|NCT03517969|583534267|FG001|Overall Study|PSA progression|1|||
161586394|NCT03517969|583534266|FG000|Overall Study|Clinical progression|4|||
161674142|NCT04598477|583860009|FG001|Overall Study|Withdrawal by Subject|12|||
161674143|NCT04598477|583860008|FG000|Overall Study|Other|15|||
161507183|NCT00692770|583251554|FG000|Overall Study|Protocol Violation|2|||
161507184|NCT00692770|583251555|FG001|Overall Study|Protocol Violation|7|||
161507185|NCT00692770|583251554|FG000|Overall Study|Withdrawal by Subject|97|||
161507186|NCT00692770|583251555|FG001|Overall Study|Withdrawal by Subject|36|||
161507187|NCT00692770|583251554|FG000|Overall Study|Adverse Event|136|||
161507188|NCT00692770|583251555|FG001|Overall Study|Adverse Event|41|||
161507189|NCT00692770|583251554|FG000|Overall Study|Death|10|||
161507190|NCT00692770|583251555|FG001|Overall Study|Death|5|||
161507191|NCT00692770|583251554|FG000|Overall Study|Lost to Follow-up|7|||
161507192|NCT00692770|583251555|FG001|Overall Study|Lost to Follow-up|3|||
161507193|NCT00692770|583251554|FG000|Overall Study|Non-compliant with study medication|11|||
161507194|NCT00692770|583251555|FG001|Overall Study|Non-compliant with study medication|5|||
161507195|NCT00692770|583251554|FG000|Overall Study|Progression by clinical judgment|2|||
161507196|NCT00692770|583251555|FG001|Overall Study|Progression by clinical judgment|3|||
161507197|NCT00692770|583251554|FG000|Overall Study|Physician decision not protocol driven|10|||
161507198|NCT00692770|583251555|FG001|Overall Study|Physician decision not protocol driven|14|||
161507199|NCT00692770|583251554|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
161507200|NCT00692770|583251555|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
161507201|NCT00692770|583251554|FG000|Overall Study|Protocol driven decision point|3|||
161507202|NCT00692770|583251555|FG001|Overall Study|Protocol driven decision point|7|||
161507203|NCT00692770|583251554|FG000|Overall Study|Completed all planned assessments|79|||
161507204|NCT00692770|583251555|FG001|Overall Study|Completed all planned assessments|101|||
161507205|NCT00692770|583251554|FG000|Overall Study|Radiological and clinical progression|8|||
161507206|NCT00692770|583251555|FG001|Overall Study|Radiological and clinical progression|8|||
161507207|NCT00692770|583251554|FG000|Overall Study|Clinical endpoint reached|16|||
161507208|NCT00692770|583251555|FG001|Overall Study|Clinical endpoint reached|43|||
161507209|NCT00692770|583251554|FG000|Overall Study|Study terminated by sponsor|2|||
161507210|NCT00692770|583251555|FG001|Overall Study|Study terminated by sponsor|2|||
161507211|NCT00692770|583251554|FG000|Overall Study|Randomized but not treated|3|||
161507212|NCT00692770|583251555|FG001|Overall Study|Randomized but not treated|4|||
161507213|NCT01399593|583251559|FG000|Overall Study|Physician Decision|1|||
161507214|NCT01399593|583251560|FG001|Overall Study|Physician Decision|0|||
161507215|NCT01399593|583251559|FG000|Overall Study|Adverse Event|1|||
161507216|NCT01399593|583251560|FG001|Overall Study|Adverse Event|0|||
161507217|NCT01399593|583251559|FG000|Overall Study|Death|1|||
161507218|NCT01399593|583251560|FG001|Overall Study|Death|1|||
161507219|NCT01399593|583251559|FG000|Overall Study|Transplantectomy|0|||
161507220|NCT01399593|583251560|FG001|Overall Study|Transplantectomy|1|||
161507221|NCT00344773|583251562|FG000|Overall Study|Adverse Event|2|||
161507222|NCT00344773|583251562|FG000|Overall Study|Objective Disease Progression|16|||
161507223|NCT00344773|583251562|FG000|Overall Study|Withdrawal by Subject|1|||
161507224|NCT00344773|583251562|FG000|Overall Study|Not Eligible for the study|2|||
161507225|NCT02849548|583251570|FG000|Overall Study|Lost to Follow-up|1|||
161507226|NCT02849548|583251571|FG001|Overall Study|Lost to Follow-up|2|||
161507227|NCT02849548|583251570|FG000|Overall Study|Protocol Violation|1|||
161507228|NCT02849548|583251571|FG001|Overall Study|Protocol Violation|0|||
161507229|NCT00714259|583251572|FG000|Overall Study|Death|2|||
161507230|NCT02357147|583251573|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
161507231|NCT02357147|583251574|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
161507232|NCT02357147|583251573|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
161507233|NCT02357147|583251574|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
161507234|NCT02357147|583251573|FG000|Combination Treatment Phase|Investigator Discretion|1|||
161507235|NCT02357147|583251574|FG001|Combination Treatment Phase|Investigator Discretion|1|||
161507236|NCT02357147|583251573|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
161507237|NCT02357147|583251574|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
161507238|NCT02357147|583251573|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
161507239|NCT02357147|583251574|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
161507240|NCT02357147|583251573|FG000|Combination Treatment Phase|Adverse Event|12|||
161507241|NCT02357147|583251574|FG001|Combination Treatment Phase|Adverse Event|4|||
161507242|NCT02357147|583251573|FG000|Combination Treatment Phase|Death|1|||
161507243|NCT02357147|583251574|FG001|Combination Treatment Phase|Death|1|||
161507244|NCT02357147|583251573|FG000|Combination Treatment Phase|Sponsor Decision|0|||
161507245|NCT02357147|583251574|FG001|Combination Treatment Phase|Sponsor Decision|12|||
161507246|NCT02357147|583251573|FG000|Combination Treatment Phase|Other|1|||
161507247|NCT02357147|583251574|FG001|Combination Treatment Phase|Other|0|||
161674144|NCT04598477|583860009|FG001|Overall Study|Other|8|||
161507248|NCT02357147|583251573|FG000|Combination Treatment Phase|Not treated|0|||
161507249|NCT02357147|583251574|FG001|Combination Treatment Phase|Not treated|2|||
161507250|NCT02357147|583251573|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
161507251|NCT02357147|583251574|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
161507252|NCT02357147|583251573|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161674145|NCT05579990|583860017|FG000|Overall Study|Lost to Follow-up|3|||
161674146|NCT00607022|583860018|FG000|Overall Study|Withdrawal by Subject|1|||
161507253|NCT02357147|583251574|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
161507254|NCT02357147|583251573|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
161507255|NCT02357147|583251574|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
161507256|NCT02357147|583251573|FG000|Maintenance Treatment Phase|Adverse Event|0|||
161507257|NCT02357147|583251574|FG001|Maintenance Treatment Phase|Adverse Event|3|||
161507258|NCT02357147|583251573|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
161507259|NCT02357147|583251574|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
161507260|NCT02357147|583251573|FG000|Maintenance Treatment Phase|Not Treated|1|||
161507261|NCT02357147|583251574|FG001|Maintenance Treatment Phase|Not Treated|0|||
161507262|NCT01465802|583253652|FG000|Overall Study|Study terminated by sponsor|1|||
161507263|NCT01465802|583253653|FG001|Overall Study|Study terminated by sponsor|0|||
161507264|NCT01465802|583253654|FG002|Overall Study|Study terminated by sponsor|0|||
161507265|NCT01465802|583253655|FG003|Overall Study|Study terminated by sponsor|1|||
161507266|NCT01465802|583253656|FG004|Overall Study|Study terminated by sponsor|7|||
161507267|NCT01465802|583253652|FG000|Overall Study|Withdrawal by Subject|7|||
161674147|NCT00607022|583860019|FG001|Overall Study|Withdrawal by Subject|0|||
161507268|NCT01465802|583253653|FG001|Overall Study|Withdrawal by Subject|7|||
161507269|NCT01465802|583253654|FG002|Overall Study|Withdrawal by Subject|0|||
161507270|NCT01465802|583253655|FG003|Overall Study|Withdrawal by Subject|8|||
161507271|NCT01465802|583253656|FG004|Overall Study|Withdrawal by Subject|1|||
161507272|NCT01465802|583253652|FG000|Overall Study|Lost to Follow-up|1|||
161674148|NCT00607022|583860020|FG002|Overall Study|Withdrawal by Subject|0|||
161674149|NCT04786119|583860021|FG000|Overall Study|Withdrawal by Subject|4|||
161674150|NCT04786119|583860022|FG001|Overall Study|Withdrawal by Subject|5|||
161674151|NCT04786119|583860021|FG000|Overall Study|Lost to Follow-up|5|||
161507273|NCT01465802|583253653|FG001|Overall Study|Lost to Follow-up|1|||
161507274|NCT01465802|583253654|FG002|Overall Study|Lost to Follow-up|0|||
161507275|NCT01465802|583253655|FG003|Overall Study|Lost to Follow-up|0|||
161507276|NCT01465802|583253656|FG004|Overall Study|Lost to Follow-up|0|||
161507277|NCT01465802|583253652|FG000|Overall Study|Reason not specified|9|||
161507278|NCT01465802|583253653|FG001|Overall Study|Reason not specified|4|||
161507279|NCT01465802|583253654|FG002|Overall Study|Reason not specified|0|||
161507280|NCT01465802|583253655|FG003|Overall Study|Reason not specified|10|||
161586395|NCT03517969|583534267|FG001|Overall Study|Clinical progression|2|||
161586396|NCT03517969|583534266|FG000|Overall Study|Adverse Event|5|||
161586397|NCT03517969|583534267|FG001|Overall Study|Adverse Event|4|||
161586398|NCT03517969|583534266|FG000|Overall Study|Intercurrent illness|1|||
161586399|NCT03517969|583534267|FG001|Overall Study|Intercurrent illness|2|||
161586400|NCT03517969|583534266|FG000|Overall Study|Death|1|||
161507281|NCT01465802|583253656|FG004|Overall Study|Reason not specified|2|||
161507282|NCT01465802|583253652|FG000|Overall Study|Death|15|||
161507283|NCT01465802|583253653|FG001|Overall Study|Death|12|||
161507284|NCT01465802|583253654|FG002|Overall Study|Death|0|||
161507285|NCT01465802|583253655|FG003|Overall Study|Death|10|||
161507286|NCT01465802|583253656|FG004|Overall Study|Death|2|||
161507287|NCT02103478|583253657|FG000|Overall Study|Adverse Event|0|||
161507288|NCT02103478|583253658|FG001|Overall Study|Adverse Event|0|||
161507289|NCT02103478|583253659|FG002|Overall Study|Adverse Event|1|||
161507290|NCT02103478|583253660|FG003|Overall Study|Adverse Event|1|||
161586401|NCT03517969|583534267|FG001|Overall Study|Death|1|||
161586402|NCT03517969|583534266|FG000|Overall Study|Withdrawal by Subject|1|||
161586403|NCT03517969|583534267|FG001|Overall Study|Withdrawal by Subject|2|||
161586404|NCT03517969|583534266|FG000|Overall Study|Physician Decision|1|||
161586405|NCT03517969|583534267|FG001|Overall Study|Physician Decision|1|||
161586406|NCT03517969|583534266|FG000|Overall Study|No clinical benefit|1|||
161586407|NCT03517969|583534267|FG001|Overall Study|No clinical benefit|0|||
161586408|NCT03517969|583534266|FG000|Overall Study|Delayed treatment for dental treatment|1|||
161586409|NCT03517969|583534267|FG001|Overall Study|Delayed treatment for dental treatment|0|||
161586410|NCT03517969|583534266|FG000|Overall Study|Difficult to maintain appointment|0|||
161586411|NCT03517969|583534267|FG001|Overall Study|Difficult to maintain appointment|1|||
161586412|NCT03517969|583534266|FG000|Overall Study|Protocol Violation|0|||
161586413|NCT03517969|583534267|FG001|Overall Study|Protocol Violation|1|||
161586414|NCT01101451|583534270|FG000|Overall Study|Eligible and never treated|0|||
161586415|NCT01101451|583534271|FG001|Overall Study|Eligible and never treated|5|||
161586416|NCT01101451|583534270|FG000|Overall Study|Ineligible and treated|12|||
161674152|NCT04786119|583860022|FG001|Overall Study|Lost to Follow-up|5|||
161674153|NCT04786119|583860021|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
161507291|NCT02103478|583253661|FG004|Overall Study|Adverse Event|2|||
161507292|NCT02103478|583253662|FG005|Overall Study|Adverse Event|1|||
161507293|NCT02103478|583253663|FG006|Overall Study|Adverse Event|0|||
161507294|NCT02103478|583253664|FG007|Overall Study|Adverse Event|0|||
161507295|NCT02103478|583253665|FG008|Overall Study|Adverse Event|0|||
161507296|NCT02103478|583253657|FG000|Overall Study|Death|2|||
161586417|NCT01101451|583534271|FG001|Overall Study|Ineligible and treated|8|||
161683064|NCT02463409|583891224|FG000|Overall Study|Screen failure|1|||
161507297|NCT02103478|583253658|FG001|Overall Study|Death|2|||
161586418|NCT01101451|583534270|FG000|Overall Study|Ineligible and never treated|2|||
161507298|NCT02103478|583253659|FG002|Overall Study|Death|1|||
161507299|NCT02103478|583253660|FG003|Overall Study|Death|1|||
161507300|NCT02103478|583253661|FG004|Overall Study|Death|5|||
161507301|NCT02103478|583253662|FG005|Overall Study|Death|15|||
161507302|NCT02103478|583253663|FG006|Overall Study|Death|14|||
161507303|NCT02103478|583253664|FG007|Overall Study|Death|10|||
161507304|NCT02103478|583253665|FG008|Overall Study|Death|11|||
161507305|NCT02103478|583253657|FG000|Overall Study|Progressive Disease|2|||
161507306|NCT02103478|583253658|FG001|Overall Study|Progressive Disease|1|||
161507307|NCT02103478|583253659|FG002|Overall Study|Progressive Disease|2|||
161507308|NCT02103478|583253660|FG003|Overall Study|Progressive Disease|0|||
161507309|NCT02103478|583253661|FG004|Overall Study|Progressive Disease|9|||
161507310|NCT02103478|583253662|FG005|Overall Study|Progressive Disease|1|||
161507311|NCT02103478|583253663|FG006|Overall Study|Progressive Disease|2|||
161507312|NCT02103478|583253664|FG007|Overall Study|Progressive Disease|0|||
161507313|NCT02103478|583253665|FG008|Overall Study|Progressive Disease|1|||
161507314|NCT02103478|583253657|FG000|Overall Study|Withdrawal by Subject|2|||
161507315|NCT02103478|583253658|FG001|Overall Study|Withdrawal by Subject|0|||
161507316|NCT02103478|583253659|FG002|Overall Study|Withdrawal by Subject|0|||
161507317|NCT02103478|583253660|FG003|Overall Study|Withdrawal by Subject|4|||
161507318|NCT02103478|583253661|FG004|Overall Study|Withdrawal by Subject|0|||
161507319|NCT02103478|583253662|FG005|Overall Study|Withdrawal by Subject|0|||
161507320|NCT02103478|583253663|FG006|Overall Study|Withdrawal by Subject|1|||
161507321|NCT02103478|583253664|FG007|Overall Study|Withdrawal by Subject|1|||
161507322|NCT02103478|583253665|FG008|Overall Study|Withdrawal by Subject|0|||
161507323|NCT02103478|583253657|FG000|Overall Study|Lost to Follow-up|0|||
161507324|NCT02103478|583253658|FG001|Overall Study|Lost to Follow-up|0|||
161507325|NCT02103478|583253659|FG002|Overall Study|Lost to Follow-up|0|||
161507326|NCT02103478|583253660|FG003|Overall Study|Lost to Follow-up|0|||
161507327|NCT02103478|583253661|FG004|Overall Study|Lost to Follow-up|0|||
161507328|NCT02103478|583253662|FG005|Overall Study|Lost to Follow-up|0|||
161507329|NCT02103478|583253663|FG006|Overall Study|Lost to Follow-up|0|||
161507330|NCT02103478|583253664|FG007|Overall Study|Lost to Follow-up|1|||
161507331|NCT02103478|583253665|FG008|Overall Study|Lost to Follow-up|0|||
161507332|NCT02103478|583253657|FG000|Overall Study|Other|1|||
161507333|NCT02103478|583253658|FG001|Overall Study|Other|3|||
161507334|NCT02103478|583253659|FG002|Overall Study|Other|2|||
161507335|NCT02103478|583253660|FG003|Overall Study|Other|0|||
161507336|NCT02103478|583253661|FG004|Overall Study|Other|3|||
161507337|NCT02103478|583253662|FG005|Overall Study|Other|8|||
161507338|NCT02103478|583253663|FG006|Overall Study|Other|8|||
161507339|NCT02103478|583253664|FG007|Overall Study|Other|4|||
161507340|NCT02103478|583253665|FG008|Overall Study|Other|2|||
161507341|NCT03219333|583253666|FG000|Overall Study|Withdrawal by Subject|9|||
161507342|NCT03219333|583253667|FG001|Overall Study|Withdrawal by Subject|4|||
161507343|NCT03219333|583253666|FG000|Overall Study|Lost to Follow-up|1|||
161507344|NCT03219333|583253667|FG001|Overall Study|Lost to Follow-up|1|||
161507345|NCT03219333|583253666|FG000|Overall Study|Death|104|||
161507346|NCT03219333|583253667|FG001|Overall Study|Death|72|||
161507347|NCT03219333|583253666|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
161507348|NCT03219333|583253667|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
161507349|NCT03219333|583253666|FG000|Overall Study|Other|2|||
161507350|NCT03219333|583253667|FG001|Overall Study|Other|2|||
161507351|NCT00723606|583253668|FG000|Overall Study|Adverse Event|2|||
161507352|NCT00723606|583253669|FG001|Overall Study|Adverse Event|5|||
161507353|NCT00723606|583253668|FG000|Overall Study|Other|2|||
161507354|NCT00723606|583253669|FG001|Overall Study|Other|0|||
161507355|NCT00723606|583253668|FG000|Overall Study|Withdrawal by Subject|0|||
161507356|NCT00723606|583253669|FG001|Overall Study|Withdrawal by Subject|2|||
161507357|NCT02566759|583253670|FG000|All Parts|Withdrawal by Subject|0|||
161507358|NCT02566759|583253671|FG001|All Parts|Withdrawal by Subject|1|||
161507359|NCT02566759|583253672|FG002|All Parts|Withdrawal by Subject|0|||
161507360|NCT02566759|583253673|FG003|All Parts|Withdrawal by Subject|0|||
161507361|NCT02566759|583253674|FG004|All Parts|Withdrawal by Subject|0|||
161507362|NCT02566759|583253675|FG005|All Parts|Withdrawal by Subject|0|||
161507363|NCT02566759|583253676|FG006|All Parts|Withdrawal by Subject|0|||
161507364|NCT02566759|583253677|FG007|All Parts|Withdrawal by Subject|0|||
161507365|NCT02566759|583253678|FG008|All Parts|Withdrawal by Subject|0|||
161507366|NCT02566759|583253679|FG009|All Parts|Withdrawal by Subject|0|||
161507367|NCT02566759|583253680|FG010|All Parts|Withdrawal by Subject|0|||
161507368|NCT02566759|583253681|FG011|All Parts|Withdrawal by Subject|0|||
161507369|NCT02566759|583253682|FG012|All Parts|Withdrawal by Subject|0|||
161507370|NCT02566759|583253683|FG013|All Parts|Withdrawal by Subject|0|||
161507371|NCT02566759|583253684|FG014|All Parts|Withdrawal by Subject|0|||
161507372|NCT02566759|583253685|FG015|All Parts|Withdrawal by Subject|0|||
161507373|NCT02566759|583253686|FG016|All Parts|Withdrawal by Subject|0|||
161507374|NCT02566759|583253670|FG000|All Parts|Adverse Event|0|||
161507375|NCT02566759|583253671|FG001|All Parts|Adverse Event|0|||
161507376|NCT02566759|583253672|FG002|All Parts|Adverse Event|0|||
161507377|NCT02566759|583253673|FG003|All Parts|Adverse Event|0|||
161507378|NCT02566759|583253674|FG004|All Parts|Adverse Event|0|||
161674154|NCT04786119|583860022|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
161674155|NCT01130051|583860027|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
161674156|NCT01130051|583860028|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
161674157|NCT01130051|583860027|FG000|Washout Period of 14 Days|Protocol Violation|1|||
161674158|NCT01130051|583860028|FG001|Washout Period of 14 Days|Protocol Violation|1|||
161674159|NCT00835120|583860032|FG000|Overall Study|Lack of Efficacy|1|||
161674160|NCT00835120|583860032|FG000|Overall Study|Lost to Follow-up|3|||
161674161|NCT00835120|583860032|FG000|Overall Study|Adverse Event|2|||
161674162|NCT00835120|583860032|FG000|Overall Study|Withdrawal by Subject|2|||
161674163|NCT03610165|583860033|FG000|Overall Study|Device didn't work|0|||
161674164|NCT03610165|583860034|FG001|Overall Study|Device didn't work|1|||
161674165|NCT04223791|583860037|FG000|Overall Study|Lost to Follow-up|0|||
161674166|NCT04223791|583860038|FG001|Overall Study|Lost to Follow-up|4|||
161674167|NCT04223791|583860037|FG000|Overall Study|Physician Decision|5|||
161674168|NCT04223791|583860038|FG001|Overall Study|Physician Decision|1|||
161674169|NCT04223791|583860037|FG000|Overall Study|Protocol Violation|1|||
161674170|NCT04223791|583860038|FG001|Overall Study|Protocol Violation|1|||
161674171|NCT04223791|583860037|FG000|Overall Study|Withdrawal by Subject|10|||
161674172|NCT04223791|583860038|FG001|Overall Study|Withdrawal by Subject|12|||
161674173|NCT04223791|583860037|FG000|Overall Study|Pregnancy|1|||
161674174|NCT04223791|583860038|FG001|Overall Study|Pregnancy|1|||
161674175|NCT04223791|583860037|FG000|Overall Study|Ongoing in Study|305|||
161674176|NCT04223791|583860038|FG001|Overall Study|Ongoing in Study|302|||
161674177|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
161674178|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
161674179|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
161674180|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
161507379|NCT02566759|583253675|FG005|All Parts|Adverse Event|0|||
161507380|NCT02566759|583253676|FG006|All Parts|Adverse Event|0|||
161507381|NCT02566759|583253677|FG007|All Parts|Adverse Event|0|||
161507382|NCT02566759|583253678|FG008|All Parts|Adverse Event|0|||
161507383|NCT02566759|583253679|FG009|All Parts|Adverse Event|0|||
161507384|NCT02566759|583253680|FG010|All Parts|Adverse Event|0|||
161507385|NCT02566759|583253681|FG011|All Parts|Adverse Event|0|||
161507386|NCT02566759|583253682|FG012|All Parts|Adverse Event|1|||
161507387|NCT02566759|583253683|FG013|All Parts|Adverse Event|3|||
161507388|NCT02566759|583253684|FG014|All Parts|Adverse Event|0|||
161507389|NCT02566759|583253685|FG015|All Parts|Adverse Event|0|||
161507390|NCT02566759|583253686|FG016|All Parts|Adverse Event|0|||
161507391|NCT02566759|583253670|FG000|All Parts|Other|0|||
161507392|NCT02566759|583253671|FG001|All Parts|Other|0|||
161507393|NCT02566759|583253672|FG002|All Parts|Other|0|||
161507394|NCT02566759|583253673|FG003|All Parts|Other|0|||
161507395|NCT02566759|583253674|FG004|All Parts|Other|0|||
161507396|NCT02566759|583253675|FG005|All Parts|Other|0|||
161507397|NCT02566759|583253676|FG006|All Parts|Other|0|||
161507398|NCT02566759|583253677|FG007|All Parts|Other|0|||
161507399|NCT02566759|583253678|FG008|All Parts|Other|0|||
161507400|NCT02566759|583253679|FG009|All Parts|Other|0|||
161507401|NCT02566759|583253680|FG010|All Parts|Other|0|||
161507402|NCT02566759|583253681|FG011|All Parts|Other|0|||
161507403|NCT02566759|583253682|FG012|All Parts|Other|0|||
161507404|NCT02566759|583253683|FG013|All Parts|Other|2|||
161507405|NCT02566759|583253684|FG014|All Parts|Other|0|||
161507406|NCT02566759|583253685|FG015|All Parts|Other|0|||
161507407|NCT02566759|583253686|FG016|All Parts|Other|0|||
161507408|NCT02566759|583253670|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507409|NCT02566759|583253671|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507410|NCT02566759|583253672|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507411|NCT02566759|583253673|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507412|NCT02566759|583253674|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507413|NCT02566759|583253675|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507414|NCT02566759|583253676|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507415|NCT02566759|583253677|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507416|NCT02566759|583253678|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507417|NCT02566759|583253679|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507418|NCT02566759|583253680|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507419|NCT02566759|583253681|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507420|NCT02566759|583253682|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161674181|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
161674182|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
161507421|NCT02566759|583253683|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507422|NCT02566759|583253684|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507423|NCT02566759|583253685|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
161507424|NCT02566759|583253686|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
161507425|NCT01096784|583253687|FG000|Overall Study|Withdrawal by Subject|2|||
161674183|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
161674184|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
161507426|NCT01096784|583253688|FG001|Overall Study|Withdrawal by Subject|1|||
161507427|NCT01096784|583253687|FG000|Overall Study|Adverse Event|11|||
161507428|NCT01096784|583253688|FG001|Overall Study|Adverse Event|9|||
161507429|NCT01096784|583253687|FG000|Overall Study|Protocol Deviation|2|||
161507430|NCT01096784|583253688|FG001|Overall Study|Protocol Deviation|2|||
161507431|NCT01096784|583253687|FG000|Overall Study|Administrative Decision|0|||
161507432|NCT01096784|583253688|FG001|Overall Study|Administrative Decision|1|||
161507433|NCT01096784|583253687|FG000|Overall Study|Other Unspecified|0|||
161507434|NCT01096784|583253688|FG001|Overall Study|Other Unspecified|1|||
161507435|NCT05107128|583253689|FG000|Overall Study|Adverse Event|2|||
161507436|NCT05107128|583253690|FG001|Overall Study|Adverse Event|0|||
161507437|NCT05107128|583253689|FG000|Overall Study|Withdrawal by Subject|3|||
161507438|NCT05107128|583253690|FG001|Overall Study|Withdrawal by Subject|3|||
161507439|NCT05107128|583253689|FG000|Overall Study|Withdrawal of Consent|0|||
161507440|NCT05107128|583253690|FG001|Overall Study|Withdrawal of Consent|1|||
161507441|NCT05107128|583253689|FG000|Overall Study|Reason Not Specified|2|||
161507442|NCT05107128|583253690|FG001|Overall Study|Reason Not Specified|0|||
161507443|NCT03761628|583253691|FG000|Overall Study|Withdrawal by Subject|3|||
161507444|NCT03761628|583253691|FG000|Overall Study|Physician Decision|1|||
161507445|NCT03761628|583253691|FG000|Overall Study|Pregnancy|1|||
161507446|NCT03761628|583253691|FG000|Overall Study|Lost to Follow-up|1|||
161507447|NCT01470469|583253694|FG000|Overall Study|Withdrawal by Subject|4|||
161507448|NCT01470469|583253695|FG001|Overall Study|Withdrawal by Subject|6|||
161507449|NCT01470469|583253694|FG000|Overall Study|Lack of Efficacy|1|||
161507450|NCT01470469|583253695|FG001|Overall Study|Lack of Efficacy|7|||
161507451|NCT01470469|583253694|FG000|Overall Study|Adverse Event|0|||
161507452|NCT01470469|583253695|FG001|Overall Study|Adverse Event|7|||
161507453|NCT01470469|583253694|FG000|Overall Study|Lost to Follow-up|2|||
161507454|NCT01470469|583253695|FG001|Overall Study|Lost to Follow-up|2|||
161507455|NCT01470469|583253694|FG000|Overall Study|Protocol Violation|1|||
161507456|NCT01470469|583253695|FG001|Overall Study|Protocol Violation|1|||
161507457|NCT01470469|583253694|FG000|Overall Study|Other|2|||
161507458|NCT01470469|583253695|FG001|Overall Study|Other|1|||
161507459|NCT05459129|583253696|FG000|Overall Study|Death|1|||
161507460|NCT05459129|583253697|FG001|Overall Study|Death|0|||
161507461|NCT05459129|583253696|FG000|Overall Study|Study Terminated By Sponsor|5|||
161507462|NCT05459129|583253697|FG001|Overall Study|Study Terminated By Sponsor|6|||
161507463|NCT04476017|583253705|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
161507464|NCT04476017|583253706|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
161507465|NCT03362502|583253707|FG000|Overall Study|Death|0|||
161507466|NCT03362502|583253708|FG001|Overall Study|Death|0|||
161820107|NCT03291067|584382712|FG001|Overall Study|Physician Decision|0|||
161820108|NCT03291067|584382713|FG002|Overall Study|Physician Decision|1|||
161820109|NCT03291067|584382714|FG003|Overall Study|Physician Decision|0|||
161507467|NCT03362502|583253709|FG002|Overall Study|Death|1|||
161507468|NCT03795610|583253713|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
161507469|NCT03795610|583253713|FG000|Overall Study|Withdrawal by Subject|1|||
161507470|NCT03795610|583253713|FG000|Overall Study|Screen Failure (Unknown)|1|||
161507471|NCT02775344|583253714|FG000|Overall Study|No ovarian cyst identified|3|||
161507472|NCT02775344|583253715|FG001|Overall Study|No ovarian cyst identified|2|||
161507473|NCT03909165|583253726|FG000|Overall Study|Physician Decision|0|||
161507474|NCT03909165|583253727|FG001|Overall Study|Physician Decision|1|||
161507475|NCT03909165|583253728|FG002|Overall Study|Physician Decision|0|||
161507476|NCT03909165|583253729|FG003|Overall Study|Physician Decision|0|||
161507477|NCT03909165|583253730|FG004|Overall Study|Physician Decision|0|||
161507478|NCT03909165|583253726|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161507479|NCT03909165|583253727|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161507480|NCT03909165|583253728|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161507481|NCT03909165|583253729|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161507482|NCT03909165|583253730|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161507483|NCT03909165|583253726|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161507484|NCT03909165|583253727|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161507485|NCT03909165|583253728|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
161507486|NCT03909165|583253729|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
161820110|NCT03291067|584382711|FG000|Overall Study|Protocol Violation|5|||
161507487|NCT03909165|583253730|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
161507488|NCT03909165|583253726|FG000|Overall Study|Previous Drug Exposure|0|||
161507489|NCT03909165|583253727|FG001|Overall Study|Previous Drug Exposure|0|||
161507490|NCT03909165|583253728|FG002|Overall Study|Previous Drug Exposure|1|||
161507491|NCT03909165|583253729|FG003|Overall Study|Previous Drug Exposure|0|||
161507492|NCT03909165|583253730|FG004|Overall Study|Previous Drug Exposure|0|||
161507493|NCT03909165|583253726|FG000|Overall Study|Early Discharge|1|||
161507494|NCT03909165|583253727|FG001|Overall Study|Early Discharge|0|||
161507495|NCT03909165|583253728|FG002|Overall Study|Early Discharge|0|||
161507496|NCT03909165|583253729|FG003|Overall Study|Early Discharge|0|||
161586419|NCT01101451|583534271|FG001|Overall Study|Ineligible and never treated|2|||
161820111|NCT03291067|584382712|FG001|Overall Study|Protocol Violation|3|||
161507497|NCT03909165|583253730|FG004|Overall Study|Early Discharge|0|||
161507498|NCT06034496|583253731|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
161507499|NCT06034496|583253732|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
161507500|NCT06034496|583253731|FG000|Overall Study|Withdrawal by Subject|5|||
161507501|NCT06034496|583253732|FG001|Overall Study|Withdrawal by Subject|4|||
161507502|NCT02018458|583253733|FG000|Overall Study|Death|4|||
161507503|NCT03277261|583253740|FG000|Overall Study|Adverse Event|17|||
161507504|NCT03277261|583253741|FG001|Overall Study|Adverse Event|1|||
161507505|NCT03277261|583253740|FG000|Overall Study|Participant Withdrawal of Consent|6|||
161507506|NCT03277261|583253741|FG001|Overall Study|Participant Withdrawal of Consent|15|||
161507507|NCT03277261|583253740|FG000|Overall Study|Investigator / Sponsor Decision|4|||
161507508|NCT03277261|583253741|FG001|Overall Study|Investigator / Sponsor Decision|2|||
161507509|NCT03277261|583253740|FG000|Overall Study|Pregnancy|2|||
161507510|NCT03277261|583253741|FG001|Overall Study|Pregnancy|0|||
161507511|NCT03277261|583253740|FG000|Overall Study|Lost to Follow-up|2|||
161507512|NCT03277261|583253741|FG001|Overall Study|Lost to Follow-up|2|||
161507513|NCT03277261|583253740|FG000|Overall Study|Lack of Efficacy|2|||
161507514|NCT03277261|583253741|FG001|Overall Study|Lack of Efficacy|2|||
161507515|NCT03277261|583253740|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
161507516|NCT03277261|583253741|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
161507517|NCT03762083|583253742|FG000|Overall Study|Withdrawal by Subject|2|||
161507518|NCT03762083|583253742|FG000|Overall Study|Physician Decision|1|||
161507519|NCT01203072|583253743|FG000|Overall Study|Adverse Event|5|||
161507520|NCT01203072|583253744|FG001|Overall Study|Adverse Event|3|||
161507521|NCT01203072|583253745|FG002|Overall Study|Adverse Event|2|||
161507522|NCT01203072|583253746|FG003|Overall Study|Adverse Event|4|||
161507523|NCT01203072|583253747|FG004|Overall Study|Adverse Event|2|||
161507524|NCT01203072|583253743|FG000|Overall Study|Lack of Efficacy|1|||
161507525|NCT01203072|583253744|FG001|Overall Study|Lack of Efficacy|0|||
161507526|NCT01203072|583253745|FG002|Overall Study|Lack of Efficacy|0|||
161507527|NCT01203072|583253746|FG003|Overall Study|Lack of Efficacy|0|||
161507528|NCT01203072|583253747|FG004|Overall Study|Lack of Efficacy|0|||
161507529|NCT01203072|583253743|FG000|Overall Study|Lost to Follow-up|0|||
161507530|NCT01203072|583253744|FG001|Overall Study|Lost to Follow-up|1|||
161507531|NCT01203072|583253745|FG002|Overall Study|Lost to Follow-up|0|||
161507532|NCT01203072|583253746|FG003|Overall Study|Lost to Follow-up|0|||
161507533|NCT01203072|583253747|FG004|Overall Study|Lost to Follow-up|0|||
161507534|NCT01203072|583253743|FG000|Overall Study|Protocol Violation|2|||
161507535|NCT01203072|583253744|FG001|Overall Study|Protocol Violation|0|||
161507536|NCT01203072|583253745|FG002|Overall Study|Protocol Violation|0|||
161507537|NCT01203072|583253746|FG003|Overall Study|Protocol Violation|0|||
161507538|NCT01203072|583253747|FG004|Overall Study|Protocol Violation|1|||
161507539|NCT01203072|583253743|FG000|Overall Study|Withdrawal by Subject|2|||
161507540|NCT01203072|583253744|FG001|Overall Study|Withdrawal by Subject|2|||
161507541|NCT01203072|583253745|FG002|Overall Study|Withdrawal by Subject|1|||
161507542|NCT01203072|583253746|FG003|Overall Study|Withdrawal by Subject|2|||
161507543|NCT01203072|583253747|FG004|Overall Study|Withdrawal by Subject|3|||
161507544|NCT00116558|583253748|FG000|Overall Study|Death|11|||
161507545|NCT00116558|583253749|FG001|Overall Study|Death|5|||
161507546|NCT00116558|583253750|FG002|Overall Study|Death|3|||
161507547|NCT00116558|583253748|FG000|Overall Study|Withdrawal by Subject|17|||
161507548|NCT00116558|583253749|FG001|Overall Study|Withdrawal by Subject|3|||
161507549|NCT00116558|583253750|FG002|Overall Study|Withdrawal by Subject|12|||
161507550|NCT00116558|583253748|FG000|Overall Study|disease progression|3|||
161507551|NCT00116558|583253749|FG001|Overall Study|disease progression|7|||
161507552|NCT00116558|583253750|FG002|Overall Study|disease progression|18|||
161507553|NCT00235872|583253751|FG000|Overall Study|Adverse Event|34|||
161507554|NCT00235872|583253751|FG000|Overall Study|Death|1|||
161507555|NCT00235872|583253751|FG000|Overall Study|Lost to Follow-up|1|||
161674185|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
161507556|NCT00235872|583253751|FG000|Overall Study|Withdrawal by Subject|50|||
161507557|NCT00235872|583253751|FG000|Overall Study|Administrative reason|61|||
161507558|NCT02027844|583253752|FG000|Overall Study|Withdrawal by Subject|3|||
161507559|NCT02027844|583253753|FG001|Overall Study|Withdrawal by Subject|2|||
161674186|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
161674187|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
161674188|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
161507560|NCT02027844|583253754|FG002|Overall Study|Withdrawal by Subject|1|||
161507561|NCT02027844|583253752|FG000|Overall Study|Lost to Follow-up|0|||
161507562|NCT02027844|583253753|FG001|Overall Study|Lost to Follow-up|2|||
161507563|NCT02027844|583253754|FG002|Overall Study|Lost to Follow-up|1|||
161507564|NCT02027844|583253752|FG000|Overall Study|Protocol Violation|0|||
161507565|NCT02027844|583253753|FG001|Overall Study|Protocol Violation|2|||
161507566|NCT02027844|583253754|FG002|Overall Study|Protocol Violation|0|||
161507567|NCT02027844|583253752|FG000|Overall Study|Incomlete data|2|||
161507568|NCT02027844|583253753|FG001|Overall Study|Incomlete data|0|||
161507569|NCT02027844|583253754|FG002|Overall Study|Incomlete data|0|||
161507570|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
161674189|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
161674190|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
161674191|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
161674192|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
161674193|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
161674194|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
161674195|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
161674196|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
161674197|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
161674198|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
161674199|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
161674200|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
161925748|NCT00504231|584774594|FG003|Overall Study|Discrepant chart documentation re route|0|||
161925749|NCT02316613|584774598|FG000|Overall Study|Death|63|||
161925750|NCT02316613|584774598|FG000|Overall Study|Lost to Follow-up|9|||
161925751|NCT02316613|584774598|FG000|Overall Study|Lymphoma transformation|2|||
161925752|NCT02316613|584774598|FG000|Overall Study|Participant moved/changed medical team|11|||
161925753|NCT02316613|584774598|FG000|Overall Study|No data and duplicate cases|5|||
161925754|NCT02316613|584774598|FG000|Overall Study|Did not met selection criteria|14|||
161925755|NCT05788328|584774606|FG000|Treatment Period 4 (5 Days)|Other|1|||
161925756|NCT05788328|584774606|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
161925757|NCT02082483|584774607|FG000|Overall Study|Lost to Follow-up|1|||
161925758|NCT02082483|584774608|FG001|Overall Study|Lost to Follow-up|1|||
161925759|NCT02082483|584774607|FG000|Overall Study|Withdrawal by Subject|2|||
161507571|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
161507572|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Graft loss|1|||
161507573|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Graft loss|2|||
161507574|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Death|5|||
161507575|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Death|3|||
161507576|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
161507577|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
161507578|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
161507579|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
161586420|NCT02965846|583534277|FG000|Overall Study|Lost to Follow-up|1|||
161586421|NCT02965846|583534278|FG001|Overall Study|Lost to Follow-up|0|||
161586422|NCT02965846|583534279|FG002|Overall Study|Lost to Follow-up|0|||
161586423|NCT02965846|583534277|FG000|Overall Study|Withdrawal by Subject|0|||
161586424|NCT02965846|583534278|FG001|Overall Study|Withdrawal by Subject|1|||
161586425|NCT02965846|583534279|FG002|Overall Study|Withdrawal by Subject|0|||
161586426|NCT02965846|583534277|FG000|Overall Study|Study Terminated By Sponsor|4|||
161586427|NCT02965846|583534278|FG001|Overall Study|Study Terminated By Sponsor|4|||
161586428|NCT02965846|583534279|FG002|Overall Study|Study Terminated By Sponsor|0|||
161586429|NCT02965846|583534277|FG000|Overall Study|Participants not randomized|0|||
161586430|NCT02965846|583534278|FG001|Overall Study|Participants not randomized|0|||
161586431|NCT02965846|583534279|FG002|Overall Study|Participants not randomized|33|||
161586432|NCT02794480|583534280|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161586433|NCT02794480|583534281|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161586434|NCT02794480|583534282|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
161586435|NCT02794480|583534283|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161586436|NCT02794480|583534280|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161586437|NCT02794480|583534281|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161586438|NCT02794480|583534282|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
161586439|NCT02794480|583534283|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161586440|NCT02794480|583534280|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161586441|NCT02794480|583534281|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161586442|NCT02794480|583534282|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161586443|NCT02794480|583534283|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
161586444|NCT02794480|583534280|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161586445|NCT02794480|583534281|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
161586446|NCT02794480|583534282|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161586447|NCT02794480|583534283|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161586448|NCT02794480|583534280|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161586449|NCT02794480|583534281|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161586450|NCT02794480|583534282|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161586451|NCT02794480|583534283|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161586452|NCT01070069|583534284|FG000|Overall Study|Death|1|||
161586453|NCT01070069|583534285|FG001|Overall Study|Death|0|||
161586454|NCT01070069|583534286|FG002|Overall Study|Death|2|||
161586455|NCT01070069|583534287|FG003|Overall Study|Death|0|||
161674201|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
161674202|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
161925760|NCT02082483|584774608|FG001|Overall Study|Withdrawal by Subject|1|||
161925761|NCT02082483|584774607|FG000|Overall Study|Physician Decision|1|||
161925762|NCT02082483|584774608|FG001|Overall Study|Physician Decision|1|||
161925763|NCT02082483|584774607|FG000|Overall Study|Death|2|||
161925764|NCT02082483|584774608|FG001|Overall Study|Death|3|||
161925765|NCT00422461|584774609|FG000|Overall Study|Adverse Event|1|||
161507580|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
161507581|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
161507582|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
161507583|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
161507584|NCT00378014|583253755|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
161507585|NCT00378014|583253756|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
161507586|NCT00378014|583253755|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
161507587|NCT00378014|583253756|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
161507588|NCT00378014|583253755|FG000|Extension (Month 12 to Month 59)|Death|1|||
161507589|NCT00378014|583253756|FG001|Extension (Month 12 to Month 59)|Death|2|||
161507590|NCT00378014|583253755|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
161586456|NCT01070069|583534288|FG004|Overall Study|Death|1|||
161586457|NCT01070069|583534284|FG000|Overall Study|Withdrawal by Subject|1|||
161586458|NCT01070069|583534285|FG001|Overall Study|Withdrawal by Subject|1|||
161586459|NCT01070069|583534286|FG002|Overall Study|Withdrawal by Subject|4|||
161586460|NCT01070069|583534287|FG003|Overall Study|Withdrawal by Subject|0|||
161586461|NCT01070069|583534288|FG004|Overall Study|Withdrawal by Subject|0|||
161586462|NCT01070069|583534284|FG000|Overall Study|Lost to Follow-up|4|||
161586463|NCT01070069|583534285|FG001|Overall Study|Lost to Follow-up|1|||
161586464|NCT01070069|583534286|FG002|Overall Study|Lost to Follow-up|0|||
161586465|NCT01070069|583534287|FG003|Overall Study|Lost to Follow-up|0|||
161586466|NCT01070069|583534288|FG004|Overall Study|Lost to Follow-up|3|||
161586467|NCT01747486|583534289|FG000|Stage 1|Physician Decision|3|||
161586468|NCT01747486|583534290|FG001|Stage 1|Physician Decision|0|||
161586469|NCT01747486|583534289|FG000|Stage 1|Withdrawal by Subject|4|||
161586470|NCT01747486|583534290|FG001|Stage 1|Withdrawal by Subject|3|||
161586471|NCT01747486|583534289|FG000|Stage 1|Disease progression|4|||
161586472|NCT01747486|583534290|FG001|Stage 1|Disease progression|9|||
161586473|NCT01747486|583534289|FG000|Stage 1|Death|1|||
161586474|NCT01747486|583534290|FG001|Stage 1|Death|1|||
161586475|NCT01747486|583534289|FG000|Stage 2|Physician Decision|2|||
161586476|NCT01747486|583534290|FG001|Stage 2|Physician Decision|0|||
161586477|NCT01747486|583534289|FG000|Stage 2|Withdrawal by Subject|1|||
161586478|NCT01747486|583534290|FG001|Stage 2|Withdrawal by Subject|0|||
161586479|NCT01747486|583534289|FG000|Stage 2|New Cancer Therapy|3|||
161586480|NCT01747486|583534290|FG001|Stage 2|New Cancer Therapy|0|||
161586481|NCT01747486|583534289|FG000|Stage 2|Disease Progression|3|||
161586482|NCT01747486|583534290|FG001|Stage 2|Disease Progression|0|||
161586483|NCT02671435|583534291|FG000|Overall Study|Death|1|||
161586484|NCT02671435|583534292|FG001|Overall Study|Death|3|||
161586485|NCT02671435|583534293|FG002|Overall Study|Death|0|||
161586486|NCT02671435|583534294|FG003|Overall Study|Death|16|||
161586487|NCT02671435|583534295|FG004|Overall Study|Death|14|||
161586488|NCT02671435|583534296|FG005|Overall Study|Death|29|||
161586489|NCT02671435|583534297|FG006|Overall Study|Death|34|||
161586490|NCT02671435|583534298|FG007|Overall Study|Death|28|||
161586491|NCT02671435|583534299|FG008|Overall Study|Death|19|||
161586492|NCT02671435|583534300|FG009|Overall Study|Death|10|||
161586493|NCT02671435|583534301|FG010|Overall Study|Death|8|||
161586494|NCT02671435|583534302|FG011|Overall Study|Death|29|||
161586495|NCT02671435|583534303|FG012|Overall Study|Death|29|||
161586496|NCT02671435|583534304|FG013|Overall Study|Death|29|||
161586497|NCT02671435|583534305|FG014|Overall Study|Death|27|||
161586498|NCT02671435|583534291|FG000|Overall Study|Lost to Follow-up|0|||
161586499|NCT02671435|583534292|FG001|Overall Study|Lost to Follow-up|0|||
161586500|NCT02671435|583534293|FG002|Overall Study|Lost to Follow-up|1|||
161586501|NCT02671435|583534294|FG003|Overall Study|Lost to Follow-up|0|||
161586502|NCT02671435|583534295|FG004|Overall Study|Lost to Follow-up|1|||
161586503|NCT02671435|583534296|FG005|Overall Study|Lost to Follow-up|1|||
161586504|NCT02671435|583534297|FG006|Overall Study|Lost to Follow-up|2|||
161586505|NCT02671435|583534298|FG007|Overall Study|Lost to Follow-up|2|||
161586506|NCT02671435|583534299|FG008|Overall Study|Lost to Follow-up|0|||
161586507|NCT02671435|583534300|FG009|Overall Study|Lost to Follow-up|2|||
161683065|NCT01444742|583891225|FG000|Overall Study|Death|1|||
161925766|NCT00422461|584774610|FG001|Overall Study|Adverse Event|2|||
161925767|NCT00422461|584774611|FG002|Overall Study|Adverse Event|1|||
161925768|NCT00422461|584774612|FG003|Overall Study|Adverse Event|1|||
161507591|NCT00378014|583253756|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
161586508|NCT02671435|583534301|FG010|Overall Study|Lost to Follow-up|0|||
161586509|NCT02671435|583534302|FG011|Overall Study|Lost to Follow-up|3|||
161586510|NCT02671435|583534303|FG012|Overall Study|Lost to Follow-up|3|||
161586511|NCT02671435|583534304|FG013|Overall Study|Lost to Follow-up|2|||
161925769|NCT00422461|584774609|FG000|Overall Study|Other|0|||
161925770|NCT00422461|584774610|FG001|Overall Study|Other|0|||
161507592|NCT00378014|583253755|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
161507593|NCT00378014|583253756|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
161507594|NCT00378014|583253755|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
161507595|NCT00378014|583253756|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
161507596|NCT00378014|583253755|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
161507597|NCT00378014|583253756|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
161507598|NCT00414661|583253760|FG000|Overall Study|Death|2|||
161507599|NCT00414661|583253761|FG001|Overall Study|Death|5|||
161507600|NCT00414661|583253762|FG002|Overall Study|Death|0|||
161507601|NCT00414661|583253763|FG003|Overall Study|Death|0|||
161507602|NCT00414661|583253760|FG000|Overall Study|Lost to Follow-up|1|||
161507603|NCT00414661|583253761|FG001|Overall Study|Lost to Follow-up|4|||
161507604|NCT00414661|583253762|FG002|Overall Study|Lost to Follow-up|0|||
161507605|NCT00414661|583253763|FG003|Overall Study|Lost to Follow-up|1|||
161507606|NCT00414661|583253760|FG000|Overall Study|Withdrawal by Subject|5|||
161507607|NCT00414661|583253761|FG001|Overall Study|Withdrawal by Subject|2|||
161507608|NCT00414661|583253762|FG002|Overall Study|Withdrawal by Subject|2|||
161507609|NCT00414661|583253763|FG003|Overall Study|Withdrawal by Subject|2|||
161507610|NCT00414661|583253760|FG000|Overall Study|Other|6|||
161507611|NCT00414661|583253761|FG001|Overall Study|Other|3|||
161507612|NCT00414661|583253762|FG002|Overall Study|Other|0|||
161507613|NCT00414661|583253763|FG003|Overall Study|Other|0|||
161507614|NCT02852265|583253764|FG000|3-month Follow-up|Lost to Follow-up|1|||
161507615|NCT02852265|583253765|FG001|3-month Follow-up|Lost to Follow-up|1|||
161925771|NCT00422461|584774611|FG002|Overall Study|Other|0|||
161507616|NCT01143090|583253766|FG000|Overall Study|Lack of Efficacy|2|||
161507617|NCT01143090|583253766|FG000|Overall Study|Adverse Event|17|||
161507618|NCT01143090|583253766|FG000|Overall Study|Lost to Follow-up|9|||
161507619|NCT01143090|583253766|FG000|Overall Study|Protocol Violation|2|||
161507620|NCT01143090|583253766|FG000|Overall Study|Withdrawal by Subject|18|||
161507621|NCT01143090|583253766|FG000|Overall Study|Non-compliance with study drug|1|||
161507622|NCT01143090|583253766|FG000|Overall Study|Failure to meet eligibility criteria|1|||
161507623|NCT01143090|583253766|FG000|Overall Study|Administrative|1|||
161507624|NCT01800916|583253769|FG000|Test Period 1 (1 Week)|Convex product user|0|||
161507625|NCT01800916|583253770|FG001|Test Period 1 (1 Week)|Convex product user|0|||
161507626|NCT01800916|583253771|FG002|Test Period 1 (1 Week)|Convex product user|0|||
161507627|NCT01800916|583253772|FG003|Test Period 1 (1 Week)|Convex product user|1|||
161507628|NCT01800916|583253773|FG004|Test Period 1 (1 Week)|Convex product user|0|||
161507629|NCT01800916|583253774|FG005|Test Period 1 (1 Week)|Convex product user|0|||
161507630|NCT01800916|583253775|FG006|Test Period 1 (1 Week)|Convex product user|0|||
161507631|NCT01800916|583253776|FG007|Test Period 1 (1 Week)|Convex product user|0|||
161507632|NCT01800916|583253777|FG008|Test Period 1 (1 Week)|Convex product user|0|||
161507633|NCT01800916|583253769|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
161507634|NCT01800916|583253770|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
161507635|NCT01800916|583253771|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
161507636|NCT01800916|583253772|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
161507637|NCT01800916|583253773|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
161507638|NCT01800916|583253774|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
161507639|NCT01800916|583253775|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
161507640|NCT01800916|583253776|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
161507641|NCT01800916|583253777|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
161507642|NCT00559962|583253785|FG000|Overall Study|Adverse Event|1|||
161507643|NCT00559962|583253786|FG001|Overall Study|Adverse Event|7|||
161507644|NCT00559962|583253787|FG002|Overall Study|Adverse Event|8|||
161507645|NCT00559962|583253788|FG003|Overall Study|Adverse Event|5|||
161507646|NCT00559962|583253789|FG004|Overall Study|Adverse Event|11|||
161507647|NCT00559962|583253790|FG005|Overall Study|Adverse Event|4|||
161507648|NCT00559962|583253791|FG006|Overall Study|Adverse Event|4|||
161507649|NCT00559962|583253792|FG007|Overall Study|Adverse Event|2|||
161507650|NCT00559962|583253785|FG000|Overall Study|Lost to Follow-up|0|||
161507651|NCT00559962|583253786|FG001|Overall Study|Lost to Follow-up|1|||
161925772|NCT00422461|584774612|FG003|Overall Study|Other|2|||
161925773|NCT00422461|584774609|FG000|Overall Study|Participants no longer willing to participate in study|1|||
161507652|NCT00559962|583253787|FG002|Overall Study|Lost to Follow-up|0|||
161507653|NCT00559962|583253788|FG003|Overall Study|Lost to Follow-up|0|||
161507654|NCT00559962|583253789|FG004|Overall Study|Lost to Follow-up|0|||
161507655|NCT00559962|583253790|FG005|Overall Study|Lost to Follow-up|0|||
161507656|NCT00559962|583253791|FG006|Overall Study|Lost to Follow-up|0|||
161507657|NCT00559962|583253792|FG007|Overall Study|Lost to Follow-up|0|||
161507658|NCT00559962|583253785|FG000|Overall Study|Withdrawal by Subject|1|||
161507659|NCT00559962|583253786|FG001|Overall Study|Withdrawal by Subject|1|||
161586512|NCT02671435|583534305|FG014|Overall Study|Lost to Follow-up|0|||
161586513|NCT02671435|583534291|FG000|Overall Study|Withdrawal by Subject|2|||
161586514|NCT02671435|583534292|FG001|Overall Study|Withdrawal by Subject|0|||
161586515|NCT02671435|583534293|FG002|Overall Study|Withdrawal by Subject|2|||
161674203|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
161674204|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
161507660|NCT00559962|583253787|FG002|Overall Study|Withdrawal by Subject|2|||
161507661|NCT00559962|583253788|FG003|Overall Study|Withdrawal by Subject|0|||
161507662|NCT00559962|583253789|FG004|Overall Study|Withdrawal by Subject|3|||
161507663|NCT00559962|583253790|FG005|Overall Study|Withdrawal by Subject|1|||
161507664|NCT00559962|583253791|FG006|Overall Study|Withdrawal by Subject|0|||
161507665|NCT00559962|583253792|FG007|Overall Study|Withdrawal by Subject|2|||
161507666|NCT00559962|583253785|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
161507667|NCT00559962|583253786|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
161507668|NCT00559962|583253787|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
161674205|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
161674206|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
161674207|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
161674208|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
161674209|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
161674210|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
161674211|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
161674212|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
161674213|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
161674214|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
161674215|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
161674216|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
161674217|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
161674218|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
161674219|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
161674220|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
161674221|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
161674222|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Early termination|0|||
161674223|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Early termination|0|||
161674224|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Early termination|34|||
161674225|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
161674226|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
161674227|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
161674228|NCT01493557|583861850|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
161674229|NCT01493557|583861851|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
161674230|NCT01493557|583861852|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
161674231|NCT01493557|583861850|FG000|Randomized to Management Strategies|Other adverse event|8|||
161674232|NCT01493557|583861851|FG001|Randomized to Management Strategies|Other adverse event|5|||
161674233|NCT01493557|583861852|FG002|Randomized to Management Strategies|Other adverse event|0|||
161674234|NCT01493557|583861850|FG000|Randomized to Management Strategies|Protocol Violation|3|||
161674235|NCT01493557|583861851|FG001|Randomized to Management Strategies|Protocol Violation|0|||
161674236|NCT01493557|583861852|FG002|Randomized to Management Strategies|Protocol Violation|0|||
161674237|NCT01493557|583861850|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
161674238|NCT01493557|583861851|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
161674239|NCT01493557|583861852|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
161674240|NCT01493557|583861850|FG000|Randomized to Management Strategies|Other than stated above|1|||
161674241|NCT01493557|583861851|FG001|Randomized to Management Strategies|Other than stated above|3|||
161674242|NCT01493557|583861852|FG002|Randomized to Management Strategies|Other than stated above|0|||
161674243|NCT01493557|583861850|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
161674244|NCT01493557|583861851|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
161674245|NCT01493557|583861852|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
161674246|NCT01493557|583861850|FG000|Adding the Second Strategy|Other adverse event|1|||
161674247|NCT01493557|583861851|FG001|Adding the Second Strategy|Other adverse event|2|||
161674248|NCT01493557|583861852|FG002|Adding the Second Strategy|Other adverse event|0|||
161507669|NCT00559962|583253788|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
161674249|NCT01493557|583861850|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
161674250|NCT01493557|583861851|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
161820112|NCT03291067|584382713|FG002|Overall Study|Protocol Violation|4|||
161820113|NCT03291067|584382714|FG003|Overall Study|Protocol Violation|2|||
161820114|NCT03291067|584382711|FG000|Overall Study|Withdrawal by Subject|3|||
161820115|NCT03291067|584382712|FG001|Overall Study|Withdrawal by Subject|4|||
161820116|NCT03291067|584382713|FG002|Overall Study|Withdrawal by Subject|7|||
161820117|NCT03291067|584382714|FG003|Overall Study|Withdrawal by Subject|5|||
161820118|NCT03291067|584382711|FG000|Overall Study|Other|0|||
161586516|NCT02671435|583534294|FG003|Overall Study|Withdrawal by Subject|2|||
161586517|NCT02671435|583534295|FG004|Overall Study|Withdrawal by Subject|2|||
161586518|NCT02671435|583534296|FG005|Overall Study|Withdrawal by Subject|7|||
161586519|NCT02671435|583534297|FG006|Overall Study|Withdrawal by Subject|2|||
161586520|NCT02671435|583534298|FG007|Overall Study|Withdrawal by Subject|7|||
161586521|NCT02671435|583534299|FG008|Overall Study|Withdrawal by Subject|1|||
161586522|NCT02671435|583534300|FG009|Overall Study|Withdrawal by Subject|1|||
161586523|NCT02671435|583534301|FG010|Overall Study|Withdrawal by Subject|2|||
161586524|NCT02671435|583534302|FG011|Overall Study|Withdrawal by Subject|4|||
161586525|NCT02671435|583534303|FG012|Overall Study|Withdrawal by Subject|4|||
161586526|NCT02671435|583534304|FG013|Overall Study|Withdrawal by Subject|4|||
161586527|NCT02671435|583534305|FG014|Overall Study|Withdrawal by Subject|2|||
161586528|NCT02671435|583534291|FG000|Overall Study|Un-specified|0|||
161586529|NCT02671435|583534292|FG001|Overall Study|Un-specified|0|||
161586530|NCT02671435|583534293|FG002|Overall Study|Un-specified|0|||
161586531|NCT02671435|583534294|FG003|Overall Study|Un-specified|0|||
161586532|NCT02671435|583534295|FG004|Overall Study|Un-specified|1|||
161586533|NCT02671435|583534296|FG005|Overall Study|Un-specified|3|||
161586534|NCT02671435|583534297|FG006|Overall Study|Un-specified|2|||
161586535|NCT02671435|583534298|FG007|Overall Study|Un-specified|3|||
161586536|NCT02671435|583534299|FG008|Overall Study|Un-specified|0|||
161586537|NCT02671435|583534300|FG009|Overall Study|Un-specified|5|||
161586538|NCT02671435|583534301|FG010|Overall Study|Un-specified|8|||
161586539|NCT02671435|583534302|FG011|Overall Study|Un-specified|4|||
161586540|NCT02671435|583534303|FG012|Overall Study|Un-specified|5|||
161586541|NCT02671435|583534304|FG013|Overall Study|Un-specified|9|||
161586542|NCT02671435|583534305|FG014|Overall Study|Un-specified|8|||
161586543|NCT04128319|583534308|FG000|Overall Study|Death|3|||
161586544|NCT00976937|583534309|FG000|Overall Study|Adverse Event|4|||
161586545|NCT00976937|583534310|FG001|Overall Study|Adverse Event|5|||
161586546|NCT00976937|583534309|FG000|Overall Study|Lost to Follow-up|2|||
161586547|NCT00976937|583534310|FG001|Overall Study|Lost to Follow-up|1|||
161586548|NCT00976937|583534309|FG000|Overall Study|Withdrawal by Subject|5|||
161586549|NCT00976937|583534310|FG001|Overall Study|Withdrawal by Subject|3|||
161586550|NCT00976937|583534309|FG000|Overall Study|Poor compliance to protocol|3|||
161586551|NCT00976937|583534310|FG001|Overall Study|Poor compliance to protocol|0|||
161586552|NCT00976937|583534309|FG000|Overall Study|Personal and Familial Reason|2|||
161586553|NCT00976937|583534310|FG001|Overall Study|Personal and Familial Reason|2|||
161586554|NCT01044303|583534313|FG000|Overall Study|Lost to Follow-up|2|||
161586555|NCT01227265|583534314|FG000|Overall Study|Did Not Receive Treatment|1|||
161586556|NCT01227265|583534315|FG001|Overall Study|Did Not Receive Treatment|2|||
161586557|NCT01227265|583534316|FG002|Overall Study|Did Not Receive Treatment|0|||
161586558|NCT01227265|583534314|FG000|Overall Study|Administrative|1|||
161674251|NCT01493557|583861852|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
161674252|NCT02973425|583861853|FG000|Overall Study|Lost to Follow-up|49|||
161674253|NCT02973425|583861854|FG001|Overall Study|Lost to Follow-up|53|||
161674254|NCT03823404|583861855|FG000|Overall Study|Lost to Follow-up|1|||
161674255|NCT03823404|583861856|FG001|Overall Study|Lost to Follow-up|2|||
161586559|NCT01227265|583534315|FG001|Overall Study|Administrative|0|||
161586560|NCT01227265|583534316|FG002|Overall Study|Administrative|2|||
161586561|NCT01227265|583534314|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161586562|NCT01227265|583534315|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161586563|NCT01227265|583534316|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
161586564|NCT01227265|583534314|FG000|Overall Study|Protocol Violation|2|||
161586565|NCT01227265|583534315|FG001|Overall Study|Protocol Violation|1|||
161586566|NCT01227265|583534316|FG002|Overall Study|Protocol Violation|0|||
161586567|NCT01227265|583534314|FG000|Overall Study|Withdrawal by Subject|7|||
161586568|NCT01227265|583534315|FG001|Overall Study|Withdrawal by Subject|7|||
161586569|NCT01227265|583534316|FG002|Overall Study|Withdrawal by Subject|3|||
161586570|NCT01227265|583534314|FG000|Overall Study|Lost to Follow-up|2|||
161586571|NCT01227265|583534315|FG001|Overall Study|Lost to Follow-up|0|||
161586572|NCT01227265|583534316|FG002|Overall Study|Lost to Follow-up|3|||
161586573|NCT01227265|583534314|FG000|Overall Study|Adverse Event|6|||
161586574|NCT01227265|583534315|FG001|Overall Study|Adverse Event|10|||
161586575|NCT01227265|583534316|FG002|Overall Study|Adverse Event|5|||
161586576|NCT06450405|583534320|FG000|Overall Study|Study funding terminated.|0|||
161586577|NCT06450405|583534321|FG001|Overall Study|Study funding terminated.|2|||
161586578|NCT06024174|583534322|FG000|Overall Study|Other Reasons|1|||
161586579|NCT06024174|583534322|FG000|Overall Study|Study terminated by Sponsor|4|||
161586580|NCT03152786|583536151|FG000|Overall Study|Withdrawal by Subject|2|||
161674256|NCT03823404|583861857|FG002|Overall Study|Lost to Follow-up|3|||
161586581|NCT03152786|583536152|FG001|Overall Study|Withdrawal by Subject|1|||
161586582|NCT00979576|583536153|FG000|Combination Treatment Phase|Progressive disease|3|||
161586583|NCT00979576|583536154|FG001|Combination Treatment Phase|Progressive disease|1|||
161586584|NCT00979576|583536155|FG002|Combination Treatment Phase|Progressive disease|5|||
161586585|NCT00979576|583536153|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
161586586|NCT00979576|583536154|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
161586587|NCT00979576|583536155|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
161586588|NCT00979576|583536153|FG000|Combination Treatment Phase|Adverse Event|0|||
161586589|NCT00979576|583536154|FG001|Combination Treatment Phase|Adverse Event|2|||
161586590|NCT00979576|583536155|FG002|Combination Treatment Phase|Adverse Event|2|||
161586591|NCT00979576|583536153|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
161586592|NCT00979576|583536154|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
161586593|NCT00979576|583536155|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
161586594|NCT03438188|583536156|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161586595|NCT03438188|583536157|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161586596|NCT03438188|583536158|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161586597|NCT03438188|583536156|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
161586598|NCT03438188|583536157|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
161586599|NCT03438188|583536158|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
161586600|NCT03438188|583536156|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
161586601|NCT03438188|583536157|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
161586602|NCT03438188|583536158|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
161586603|NCT03438188|583536156|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
161586604|NCT03438188|583536157|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
161586605|NCT03438188|583536158|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
161586606|NCT03438188|583536156|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
161586607|NCT03438188|583536157|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
161586608|NCT03438188|583536158|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
161586609|NCT02163447|583536159|FG000|Overall Study|Withdrawal by Subject|2|||
161586610|NCT02163447|583536160|FG001|Overall Study|Withdrawal by Subject|0|||
161586611|NCT02163447|583536161|FG002|Overall Study|Withdrawal by Subject|1|||
161586612|NCT02163447|583536159|FG000|Overall Study|Lost to Follow-up|1|||
161586613|NCT02163447|583536160|FG001|Overall Study|Lost to Follow-up|3|||
161586614|NCT02163447|583536161|FG002|Overall Study|Lost to Follow-up|0|||
161586615|NCT02163447|583536159|FG000|Overall Study|Moved out of study area|2|||
161586616|NCT02163447|583536160|FG001|Overall Study|Moved out of study area|3|||
161586617|NCT02163447|583536161|FG002|Overall Study|Moved out of study area|2|||
161586618|NCT02163447|583536159|FG000|Overall Study|Became HIV infected at time of delivery|1|||
161586619|NCT02163447|583536160|FG001|Overall Study|Became HIV infected at time of delivery|0|||
161586620|NCT02163447|583536161|FG002|Overall Study|Became HIV infected at time of delivery|0|||
161586621|NCT03157167|583536162|FG000|Overall Study|Withdrawal by Subject|1|||
161586622|NCT03157167|583536163|FG001|Overall Study|Withdrawal by Subject|0|||
161586623|NCT03157167|583536164|FG002|Overall Study|Withdrawal by Subject|0|||
161586624|NCT02597946|583536165|FG000|Overall Study|Withdrawal by Subject|1|||
161586625|NCT02597946|583536165|FG000|Overall Study|Progressive disease|16|||
161586626|NCT02597946|583536165|FG000|Overall Study|Other than above|1|||
161586627|NCT03263026|583536166|FG000|Overall Study|Withdrawal by Subject|1|||
161586628|NCT03263026|583536167|FG001|Overall Study|Withdrawal by Subject|0|||
161586629|NCT03263026|583536166|FG000|Overall Study|Death|1|||
161586630|NCT03263026|583536167|FG001|Overall Study|Death|0|||
161586631|NCT03263026|583536166|FG000|Overall Study|Other/ Various|41|||
161586632|NCT03263026|583536167|FG001|Overall Study|Other/ Various|29|||
161586633|NCT01938547|583536176|FG000|Overall Study|Physician Decision|1|||
161586634|NCT05320432|583536181|FG000|Overall Study|Withdrawal by Subject|0|||
161586635|NCT05320432|583536182|FG001|Overall Study|Withdrawal by Subject|2|||
161586636|NCT04823611|583536183|FG000|Overall Study|Adverse Event|2|||
161586637|NCT04823611|583536184|FG001|Overall Study|Adverse Event|0|||
161586638|NCT04823611|583536185|FG002|Overall Study|Adverse Event|1|||
161586639|NCT04823611|583536186|FG003|Overall Study|Adverse Event|0|||
161586640|NCT04823611|583536187|FG004|Overall Study|Adverse Event|0|||
161586641|NCT04823611|583536188|FG005|Overall Study|Adverse Event|0|||
161674257|NCT03823404|583861855|FG000|Overall Study|Protocol Violation|2|||
161674258|NCT03823404|583861856|FG001|Overall Study|Protocol Violation|0|||
161674259|NCT03823404|583861857|FG002|Overall Study|Protocol Violation|2|||
161674260|NCT03823404|583861855|FG000|Overall Study|Adverse Event|35|||
161674261|NCT03823404|583861856|FG001|Overall Study|Adverse Event|38|||
161674262|NCT03823404|583861857|FG002|Overall Study|Adverse Event|8|||
161674263|NCT03823404|583861855|FG000|Overall Study|Withdrawal by Subject|38|||
161674264|NCT03823404|583861856|FG001|Overall Study|Withdrawal by Subject|40|||
161674265|NCT03823404|583861857|FG002|Overall Study|Withdrawal by Subject|35|||
161674266|NCT03823404|583861855|FG000|Overall Study|Death|4|||
161674267|NCT03823404|583861856|FG001|Overall Study|Death|0|||
161674268|NCT03823404|583861857|FG002|Overall Study|Death|0|||
161586642|NCT04823611|583536189|FG006|Overall Study|Adverse Event|0|||
161586643|NCT05038566|583536190|FG000|Overall Study|Technical Difficulties with the Device|0|||
161674269|NCT03823404|583861855|FG000|Overall Study|Other: Various reasons provided|5|||
161674270|NCT03823404|583861856|FG001|Overall Study|Other: Various reasons provided|5|||
161674271|NCT03823404|583861857|FG002|Overall Study|Other: Various reasons provided|6|||
161820119|NCT03291067|584382712|FG001|Overall Study|Other|4|||
161820120|NCT03291067|584382713|FG002|Overall Study|Other|4|||
161820121|NCT03291067|584382714|FG003|Overall Study|Other|6|||
161820122|NCT01520987|584382722|FG000|Overall Study|Withdrawal by Subject|1|||
161820123|NCT01520987|584382723|FG001|Overall Study|Withdrawal by Subject|0|||
161820124|NCT01520987|584382724|FG002|Overall Study|Withdrawal by Subject|0|||
161820125|NCT01520987|584382725|FG003|Overall Study|Withdrawal by Subject|0|||
161820126|NCT01520987|584382726|FG004|Overall Study|Withdrawal by Subject|0|||
161820127|NCT01520987|584382727|FG005|Overall Study|Withdrawal by Subject|1|||
161820128|NCT01520987|584382728|FG006|Overall Study|Withdrawal by Subject|0|||
161820129|NCT01520987|584382729|FG007|Overall Study|Withdrawal by Subject|0|||
161820130|NCT02005562|584382730|FG000|Overall Study|Death|2|||
161820131|NCT02005562|584382731|FG001|Overall Study|Death|2|||
161820132|NCT02005562|584382730|FG000|Overall Study|Graft loss|7|||
161820133|NCT02005562|584382731|FG001|Overall Study|Graft loss|6|||
161820134|NCT02005562|584382730|FG000|Overall Study|Withdrawal by Subject|2|||
161820135|NCT02005562|584382731|FG001|Overall Study|Withdrawal by Subject|2|||
161820136|NCT02005562|584382730|FG000|Overall Study|No transplant|1|||
161820137|NCT02005562|584382731|FG001|Overall Study|No transplant|4|||
161820138|NCT02005562|584382730|FG000|Overall Study|Physician Decision|0|||
161820139|NCT02005562|584382731|FG001|Overall Study|Physician Decision|1|||
161820140|NCT00660387|584382732|FG000|Overall Study|Adverse Event|1|||
161820141|NCT00660387|584382733|FG001|Overall Study|Adverse Event|2|||
161820142|NCT00660387|584382732|FG000|Overall Study|Lack of Efficacy|0|||
161820143|NCT00660387|584382733|FG001|Overall Study|Lack of Efficacy|1|||
161820144|NCT00660387|584382732|FG000|Overall Study|Protocol Violation|1|||
161820145|NCT00660387|584382733|FG001|Overall Study|Protocol Violation|0|||
161820146|NCT03086135|584382734|FG000|Overall Study|Adverse Event|1|||
161820147|NCT03086135|584382734|FG000|Overall Study|Lost to Follow-up|2|||
161820148|NCT01023061|584382735|FG000|Overall Study|Withdrawal prior to treatment|2|||
161820149|NCT02966340|584382736|FG000|Overall Study|Adverse Event|0|||
161820150|NCT02966340|584382737|FG001|Overall Study|Adverse Event|1|||
161820151|NCT02966340|584382736|FG000|Overall Study|Lost to Follow-up|0|||
161820152|NCT02966340|584382737|FG001|Overall Study|Lost to Follow-up|1|||
161820153|NCT02966340|584382736|FG000|Overall Study|Withdrawal by Subject|1|||
161820154|NCT02966340|584382737|FG001|Overall Study|Withdrawal by Subject|0|||
161820155|NCT02966340|584382736|FG000|Overall Study|data acquisition error|1|||
161820156|NCT02966340|584382737|FG001|Overall Study|data acquisition error|0|||
161820157|NCT02966340|584382736|FG000|Overall Study|startle non-responder|1|||
161820158|NCT02966340|584382737|FG001|Overall Study|startle non-responder|1|||
161820159|NCT04768296|584382739|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
161820160|NCT04768296|584382740|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
161507670|NCT00559962|583253789|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
161507671|NCT00559962|583253790|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
161507672|NCT00559962|583253791|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
161507673|NCT00559962|583253792|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
161507674|NCT01639040|583253802|FG000|Overall Study|Adverse Event|1|||
161507675|NCT01639040|583253803|FG001|Overall Study|Adverse Event|0|||
161507676|NCT04370691|583253804|FG000|Overall Study|Pending visit|48|||
161507677|NCT04370691|583253804|FG000|Overall Study|Have Not Reached Lower Window|15|||
161507678|NCT04370691|583253804|FG000|Overall Study|Termination|14|||
161507679|NCT04370691|583253804|FG000|Overall Study|Missed or Overdue|10|||
161586644|NCT05038566|583536191|FG001|Overall Study|Technical Difficulties with the Device|1|||
161820161|NCT00255346|584382747|FG000|Overall Study|Adverse Event|1|||
161820162|NCT00255346|584382748|FG001|Overall Study|Adverse Event|0|||
161820163|NCT00255346|584382749|FG002|Overall Study|Adverse Event|0|||
161820164|NCT00255346|584382750|FG003|Overall Study|Adverse Event|0|||
161820165|NCT00255346|584382751|FG004|Overall Study|Adverse Event|0|||
161820166|NCT04402489|584382757|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820167|NCT04402489|584382758|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
161820168|NCT04402489|584382759|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820169|NCT04402489|584382760|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820170|NCT04402489|584382761|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820171|NCT04402489|584382757|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
161820172|NCT04402489|584382758|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820173|NCT04402489|584382759|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820174|NCT04402489|584382760|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820175|NCT04402489|584382761|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820176|NCT04402489|584382757|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
161820177|NCT04402489|584382758|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
161820178|NCT04402489|584382759|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
161820179|NCT04402489|584382760|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
161820180|NCT04402489|584382761|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
161674272|NCT01524133|583861860|FG000|Treatment Phase|Withdrawal by Subject|13|||
161674273|NCT01524133|583861861|FG001|Treatment Phase|Withdrawal by Subject|28|||
161674274|NCT01524133|583861862|FG002|Treatment Phase|Withdrawal by Subject|31|||
161674275|NCT01524133|583861860|FG000|Treatment Phase|Physician Decision|6|||
161507680|NCT00486265|583253805|FG000|Overall Study|Adverse Event|1|||
161507681|NCT00486265|583253805|FG000|Overall Study|Lack of Efficacy|8|||
161507682|NCT03013543|583253806|FG000|Overall Study|Withdrawal by Subject|0|||
161507683|NCT03013543|583253807|FG001|Overall Study|Withdrawal by Subject|2|||
161507684|NCT03013543|583253808|FG002|Overall Study|Withdrawal by Subject|0|||
161507685|NCT03013543|583253809|FG003|Overall Study|Withdrawal by Subject|5|||
161507686|NCT03013543|583253810|FG004|Overall Study|Withdrawal by Subject|6|||
161507687|NCT03013543|583253811|FG005|Overall Study|Withdrawal by Subject|2|||
161507688|NCT03013543|583253812|FG006|Overall Study|Withdrawal by Subject|3|||
161507689|NCT03013543|583253813|FG007|Overall Study|Withdrawal by Subject|1|||
161507690|NCT03013543|583253814|FG008|Overall Study|Withdrawal by Subject|0|||
161507691|NCT03013543|583253815|FG009|Overall Study|Withdrawal by Subject|4|||
161507692|NCT03013543|583253806|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161507693|NCT03013543|583253807|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161507694|NCT03013543|583253808|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
161507695|NCT03013543|583253809|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
161507696|NCT03013543|583253810|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
161507697|NCT03013543|583253811|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
161507698|NCT03013543|583253812|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
161507699|NCT03013543|583253813|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
161507700|NCT03013543|583253814|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
161507701|NCT03013543|583253815|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
161507702|NCT03013543|583253806|FG000|Overall Study|Other|0|||
161507703|NCT03013543|583253807|FG001|Overall Study|Other|0|||
161507704|NCT03013543|583253808|FG002|Overall Study|Other|2|||
161507705|NCT03013543|583253809|FG003|Overall Study|Other|0|||
161507706|NCT03013543|583253810|FG004|Overall Study|Other|2|||
161507707|NCT03013543|583253811|FG005|Overall Study|Other|0|||
161507708|NCT03013543|583253812|FG006|Overall Study|Other|0|||
161507709|NCT03013543|583253813|FG007|Overall Study|Other|0|||
161507710|NCT03013543|583253814|FG008|Overall Study|Other|1|||
161507711|NCT03013543|583253815|FG009|Overall Study|Other|0|||
161507712|NCT03013543|583253806|FG000|Overall Study|Adverse Event|0|||
161507713|NCT03013543|583253807|FG001|Overall Study|Adverse Event|0|||
161507714|NCT03013543|583253808|FG002|Overall Study|Adverse Event|0|||
161507715|NCT03013543|583253809|FG003|Overall Study|Adverse Event|3|||
161507716|NCT03013543|583253810|FG004|Overall Study|Adverse Event|2|||
161507717|NCT03013543|583253811|FG005|Overall Study|Adverse Event|1|||
161507718|NCT03013543|583253812|FG006|Overall Study|Adverse Event|3|||
161507719|NCT03013543|583253813|FG007|Overall Study|Adverse Event|8|||
161507720|NCT03013543|583253814|FG008|Overall Study|Adverse Event|0|||
161507721|NCT03013543|583253815|FG009|Overall Study|Adverse Event|2|||
161507722|NCT03013543|583253806|FG000|Overall Study|Death|0|||
161507723|NCT03013543|583253807|FG001|Overall Study|Death|0|||
161507724|NCT03013543|583253808|FG002|Overall Study|Death|0|||
161507725|NCT03013543|583253809|FG003|Overall Study|Death|1|||
161507726|NCT03013543|583253810|FG004|Overall Study|Death|0|||
161507727|NCT03013543|583253811|FG005|Overall Study|Death|0|||
161507728|NCT03013543|583253812|FG006|Overall Study|Death|0|||
161507729|NCT03013543|583253813|FG007|Overall Study|Death|0|||
161507730|NCT03013543|583253814|FG008|Overall Study|Death|0|||
161507731|NCT03013543|583253815|FG009|Overall Study|Death|0|||
161507732|NCT03013543|583253806|FG000|Overall Study|Lack of Efficacy|0|||
161507733|NCT03013543|583253807|FG001|Overall Study|Lack of Efficacy|0|||
161507734|NCT03013543|583253808|FG002|Overall Study|Lack of Efficacy|0|||
161507735|NCT03013543|583253809|FG003|Overall Study|Lack of Efficacy|1|||
161507736|NCT03013543|583253810|FG004|Overall Study|Lack of Efficacy|0|||
161507737|NCT03013543|583253811|FG005|Overall Study|Lack of Efficacy|0|||
161674276|NCT01524133|583861861|FG001|Treatment Phase|Physician Decision|3|||
161507738|NCT03013543|583253812|FG006|Overall Study|Lack of Efficacy|0|||
161507739|NCT03013543|583253813|FG007|Overall Study|Lack of Efficacy|0|||
161674277|NCT01524133|583861862|FG002|Treatment Phase|Physician Decision|3|||
161507740|NCT03013543|583253814|FG008|Overall Study|Lack of Efficacy|0|||
161507741|NCT03013543|583253815|FG009|Overall Study|Lack of Efficacy|0|||
161507742|NCT03013543|583253806|FG000|Overall Study|Lost to Follow-up|0|||
161507743|NCT03013543|583253807|FG001|Overall Study|Lost to Follow-up|0|||
161507744|NCT03013543|583253808|FG002|Overall Study|Lost to Follow-up|0|||
161507745|NCT03013543|583253809|FG003|Overall Study|Lost to Follow-up|1|||
161507746|NCT03013543|583253810|FG004|Overall Study|Lost to Follow-up|0|||
161507747|NCT03013543|583253811|FG005|Overall Study|Lost to Follow-up|0|||
161507748|NCT03013543|583253812|FG006|Overall Study|Lost to Follow-up|1|||
161507749|NCT03013543|583253813|FG007|Overall Study|Lost to Follow-up|0|||
161507750|NCT03013543|583253814|FG008|Overall Study|Lost to Follow-up|0|||
161674278|NCT01524133|583861860|FG000|Treatment Phase|Lost to Follow-up|0|||
161507751|NCT03013543|583253815|FG009|Overall Study|Lost to Follow-up|2|||
161507752|NCT03013543|583253806|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161507753|NCT03013543|583253807|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161507754|NCT03013543|583253808|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161507755|NCT03013543|583253809|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161507756|NCT03013543|583253810|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161507757|NCT03013543|583253811|FG005|Overall Study|Non-Compliance With Study Drug|0|||
161507758|NCT03013543|583253812|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161507759|NCT03013543|583253813|FG007|Overall Study|Non-Compliance With Study Drug|0|||
161507760|NCT03013543|583253814|FG008|Overall Study|Non-Compliance With Study Drug|1|||
161507761|NCT03013543|583253815|FG009|Overall Study|Non-Compliance With Study Drug|0|||
161507762|NCT03013543|583253806|FG000|Overall Study|Physician Decision|0|||
161507763|NCT03013543|583253807|FG001|Overall Study|Physician Decision|0|||
161507764|NCT03013543|583253808|FG002|Overall Study|Physician Decision|0|||
161507765|NCT03013543|583253809|FG003|Overall Study|Physician Decision|0|||
161507766|NCT03013543|583253810|FG004|Overall Study|Physician Decision|1|||
161507767|NCT03013543|583253811|FG005|Overall Study|Physician Decision|0|||
161507768|NCT03013543|583253812|FG006|Overall Study|Physician Decision|0|||
161507769|NCT03013543|583253813|FG007|Overall Study|Physician Decision|0|||
161507770|NCT03013543|583253814|FG008|Overall Study|Physician Decision|0|||
161507771|NCT03013543|583253815|FG009|Overall Study|Physician Decision|0|||
161507772|NCT03013543|583253806|FG000|Overall Study|Protocol Violation|0|||
161507773|NCT03013543|583253807|FG001|Overall Study|Protocol Violation|0|||
161507774|NCT03013543|583253808|FG002|Overall Study|Protocol Violation|0|||
161507775|NCT03013543|583253809|FG003|Overall Study|Protocol Violation|0|||
161507776|NCT03013543|583253810|FG004|Overall Study|Protocol Violation|0|||
161507777|NCT03013543|583253811|FG005|Overall Study|Protocol Violation|0|||
161507778|NCT03013543|583253812|FG006|Overall Study|Protocol Violation|0|||
161507779|NCT03013543|583253813|FG007|Overall Study|Protocol Violation|0|||
161586645|NCT05387447|583536200|FG000|Overall Study|Participants changed their minds about study participation.|3|||
161586646|NCT05387447|583536201|FG001|Overall Study|Participants changed their minds about study participation.|5|||
161586647|NCT04178733|583536202|FG000|Overall Study|Investigator Decision|0|||
161586648|NCT04178733|583536203|FG001|Overall Study|Investigator Decision|0|||
161586649|NCT04178733|583536204|FG002|Overall Study|Investigator Decision|0|||
161586650|NCT04178733|583536205|FG003|Overall Study|Investigator Decision|1|||
161586651|NCT04178733|583536206|FG004|Overall Study|Investigator Decision|2|||
161586652|NCT03655132|583536209|FG000|Overall Study|Lost to Follow-up|2|||
161586653|NCT03655132|583536210|FG001|Overall Study|Lost to Follow-up|1|||
161586654|NCT03655132|583536209|FG000|Overall Study|Withdrawal by Subject|0|||
161586655|NCT03655132|583536210|FG001|Overall Study|Withdrawal by Subject|1|||
161586656|NCT03655132|583536209|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
161586657|NCT03655132|583536210|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
161586658|NCT02651324|583536212|FG000|Overall Study|drug not administered, due dispensing issue|1|||
161586659|NCT02651324|583536213|FG001|Overall Study|drug not administered, due dispensing issue|0|||
161586660|NCT05919082|583536216|FG000|Overall Study|Adverse Event|3|||
161586661|NCT05919082|583536217|FG001|Overall Study|Adverse Event|0|||
161586662|NCT05919082|583536216|FG000|Overall Study|Lost to Follow-up|0|||
161586663|NCT05919082|583536217|FG001|Overall Study|Lost to Follow-up|1|||
161586664|NCT05919082|583536216|FG000|Overall Study|Withdrawal by Subject|8|||
161586665|NCT05919082|583536217|FG001|Overall Study|Withdrawal by Subject|9|||
161586666|NCT05919082|583536216|FG000|Overall Study|Lack of Efficacy|0|||
161586667|NCT05919082|583536217|FG001|Overall Study|Lack of Efficacy|1|||
161586668|NCT05919082|583536216|FG000|Overall Study|Investigator Decision|1|||
161586669|NCT05919082|583536217|FG001|Overall Study|Investigator Decision|0|||
161586670|NCT05439603|583536218|FG000|Overall Study|met withdrawal criteria|2|||
161586671|NCT03896516|583536222|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
161586672|NCT03896516|583536223|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
161586673|NCT03896516|583536222|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
161586674|NCT03896516|583536223|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
161586675|NCT03896516|583536222|FG000|Washout Period|Physician Decision|3|||
161586676|NCT03896516|583536223|FG001|Washout Period|Physician Decision|1|||
161586677|NCT03896516|583536222|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
161586678|NCT03896516|583536223|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
161586679|NCT04791709|583536237|FG000|Overall Study|Withdrawal by Subject|3|||
161586680|NCT04711135|583536238|FG000|Overall Study|Physician Decision|0|||
161586681|NCT04711135|583536239|FG001|Overall Study|Physician Decision|1|||
161586682|NCT04711135|583536238|FG000|Overall Study|Ongoing treatment|0|||
161586683|NCT04711135|583536239|FG001|Overall Study|Ongoing treatment|1|||
161820181|NCT04402489|584382757|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161507780|NCT03013543|583253814|FG008|Overall Study|Protocol Violation|0|||
161507781|NCT03013543|583253815|FG009|Overall Study|Protocol Violation|1|||
161507782|NCT02552316|583253816|FG000|Overall Study|Withdrawal by Subject|1|||
161586684|NCT03578536|583536247|FG000|Overall Study|Lost to Follow-up|1|||
161820182|NCT04402489|584382758|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161507783|NCT02552316|583253816|FG000|Overall Study|Withdrawal due to non-compliance|1|||
161507784|NCT04382911|583253817|FG000|Overall Study|unable to be imaged prior to surgery|2|||
161507785|NCT04116710|583253820|FG000|Overall Study|Death|4|||
161507786|NCT04116710|583253821|FG001|Overall Study|Death|6|||
161507787|NCT04116710|583253822|FG002|Overall Study|Death|3|||
161507788|NCT04116710|583253823|FG003|Overall Study|Death|1|||
161507789|NCT04116710|583253820|FG000|Overall Study|Withdrawal by Subject|0|||
161507790|NCT04116710|583253821|FG001|Overall Study|Withdrawal by Subject|0|||
161507791|NCT04116710|583253822|FG002|Overall Study|Withdrawal by Subject|0|||
161507792|NCT04116710|583253823|FG003|Overall Study|Withdrawal by Subject|1|||
161507793|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
161507794|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
161507795|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
161507796|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
161507797|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
161507798|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
161507799|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
161507800|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
161507801|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
161507802|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
161507803|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
161507804|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
161507805|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
161507806|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
161507807|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
161507808|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
161507809|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
161507810|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
161507811|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
161507812|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
161507813|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
161507814|NCT02161718|583253824|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
161507815|NCT02161718|583253825|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
161507816|NCT02161718|583253826|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
161507817|NCT02161718|583253824|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
161507818|NCT02161718|583253825|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
161507819|NCT02161718|583253826|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
161507820|NCT02161718|583253824|FG000|Post- Randomization Period|Lost to Follow-up|0|||
161507821|NCT02161718|583253825|FG001|Post- Randomization Period|Lost to Follow-up|9|||
161507822|NCT02161718|583253826|FG002|Post- Randomization Period|Lost to Follow-up|15|||
161674279|NCT01524133|583861861|FG001|Treatment Phase|Lost to Follow-up|1|||
161674280|NCT01524133|583861862|FG002|Treatment Phase|Lost to Follow-up|2|||
161674281|NCT01524133|583861860|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
161674282|NCT01524133|583861861|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
161674283|NCT01524133|583861862|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
161674284|NCT01524133|583861860|FG000|Overall Study 52 Weeks|Physician Decision|1|||
161674285|NCT01524133|583861861|FG001|Overall Study 52 Weeks|Physician Decision|0|||
161674286|NCT01524133|583861862|FG002|Overall Study 52 Weeks|Physician Decision|2|||
161674287|NCT01524133|583861860|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
161674288|NCT01524133|583861861|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
161674289|NCT01524133|583861862|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
161674290|NCT01087957|583861863|FG000|Overall Study|Death|2|||
161674291|NCT01087957|583861864|FG001|Overall Study|Death|2|||
161674292|NCT01087957|583861863|FG000|Overall Study|Lost to Follow-up|3|||
161674293|NCT01087957|583861864|FG001|Overall Study|Lost to Follow-up|4|||
161674294|NCT01087957|583861863|FG000|Overall Study|Protocol Violation|13|||
161674295|NCT01087957|583861864|FG001|Overall Study|Protocol Violation|25|||
161674296|NCT01087957|583861863|FG000|Overall Study|Withdrawal by Subject|18|||
161674297|NCT01087957|583861864|FG001|Overall Study|Withdrawal by Subject|15|||
161674298|NCT01087957|583861863|FG000|Overall Study|Physician Decision|5|||
161674299|NCT01087957|583861864|FG001|Overall Study|Physician Decision|9|||
161674300|NCT02366728|583861865|FG000|Overall Study|Death|0|||
161674301|NCT02366728|583861866|FG001|Overall Study|Death|0|||
161674302|NCT02366728|583861867|FG002|Overall Study|Death|1|||
161674303|NCT02366728|583861865|FG000|Overall Study|Adverse Event|1|||
161674304|NCT02366728|583861866|FG001|Overall Study|Adverse Event|0|||
161507823|NCT02161718|583253824|FG000|Post- Randomization Period|Adverse Event|0|||
161507824|NCT02161718|583253825|FG001|Post- Randomization Period|Adverse Event|9|||
161507825|NCT02161718|583253826|FG002|Post- Randomization Period|Adverse Event|10|||
161674305|NCT02366728|583861867|FG002|Overall Study|Adverse Event|0|||
161674306|NCT02366728|583861865|FG000|Overall Study|Screen Failure|2|||
161674307|NCT02366728|583861866|FG001|Overall Study|Screen Failure|1|||
161674308|NCT02366728|583861867|FG002|Overall Study|Screen Failure|0|||
161674309|NCT02366728|583861865|FG000|Overall Study|Only yielded 2 vaccines|1|||
161674310|NCT02366728|583861866|FG001|Overall Study|Only yielded 2 vaccines|0|||
161674311|NCT02366728|583861867|FG002|Overall Study|Only yielded 2 vaccines|0|||
161586685|NCT04600752|583536248|FG000|Overall Study|Physician Decision|0|||
161586686|NCT04600752|583536249|FG001|Overall Study|Physician Decision|0|||
161586687|NCT04600752|583536250|FG002|Overall Study|Physician Decision|1|||
161586688|NCT04600752|583536248|FG000|Overall Study|Adverse Event|0|||
161586689|NCT04600752|583536249|FG001|Overall Study|Adverse Event|1|||
161586690|NCT04600752|583536250|FG002|Overall Study|Adverse Event|0|||
161586691|NCT04600752|583536248|FG000|Overall Study|Withdrawal by Subject|2|||
161586692|NCT04600752|583536249|FG001|Overall Study|Withdrawal by Subject|1|||
161586693|NCT04600752|583536250|FG002|Overall Study|Withdrawal by Subject|0|||
161586694|NCT04600752|583536248|FG000|Overall Study|Lack of Efficacy|1|||
161586695|NCT04600752|583536249|FG001|Overall Study|Lack of Efficacy|0|||
161586696|NCT04600752|583536250|FG002|Overall Study|Lack of Efficacy|0|||
161586697|NCT04431726|583536251|FG000|Overall Study|Ongoing in the Study|55|||
161586698|NCT00274469|583536252|FG000|Overall Study|Death|63|||
161586699|NCT00274469|583536253|FG001|Overall Study|Death|74|||
161586700|NCT00274469|583536252|FG000|Overall Study|Did not consent to OS follow-up|16|||
161586701|NCT00274469|583536253|FG001|Overall Study|Did not consent to OS follow-up|19|||
161586702|NCT02860130|583536254|FG000|Overall Study|Adverse Event|2|||
161586703|NCT02860130|583536255|FG001|Overall Study|Adverse Event|3|||
161586704|NCT02860130|583536254|FG000|Overall Study|Protocol Violation|1|||
161586705|NCT02860130|583536255|FG001|Overall Study|Protocol Violation|1|||
161586706|NCT02860130|583536254|FG000|Overall Study|Withdrawal by Subject|0|||
161586707|NCT02860130|583536255|FG001|Overall Study|Withdrawal by Subject|2|||
161586708|NCT02860130|583536254|FG000|Overall Study|Physician Decision|2|||
161674312|NCT00059839|583861869|FG000|Overall Study|Death|1|||
161674313|NCT00059839|583861870|FG001|Overall Study|Death|1|||
161674314|NCT00059839|583861869|FG000|Overall Study|Lack of Efficacy|6|||
161674315|NCT00059839|583861870|FG001|Overall Study|Lack of Efficacy|5|||
161674316|NCT00059839|583861869|FG000|Overall Study|Lost to Follow-up|2|||
161674317|NCT00059839|583861870|FG001|Overall Study|Lost to Follow-up|0|||
161674318|NCT00059839|583861869|FG000|Overall Study|Physician Decision|1|||
161674319|NCT00059839|583861870|FG001|Overall Study|Physician Decision|2|||
161674320|NCT00059839|583861869|FG000|Overall Study|Withdrawal by Subject|1|||
161674321|NCT00059839|583861870|FG001|Overall Study|Withdrawal by Subject|6|||
161674322|NCT00059839|583861869|FG000|Overall Study|Ineligible|1|||
161674323|NCT00059839|583861870|FG001|Overall Study|Ineligible|3|||
161674324|NCT03842163|583861871|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
161674325|NCT03842163|583861871|FG000|Overall Study|Scintigraphy was not performed|44|||
161674326|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
161674327|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
161674328|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
161674329|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
161674330|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
161674331|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
161674332|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
161674333|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
161674334|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
161674335|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
161674336|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
161674337|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
161674338|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
161674339|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
161674340|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
161674341|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
161674342|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
161674343|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
161674344|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
161674345|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
161674346|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
161674347|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
161674348|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
161674349|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
161586709|NCT02860130|583536255|FG001|Overall Study|Physician Decision|2|||
161674350|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
161586710|NCT02860130|583536254|FG000|Overall Study|Other|2|||
161586711|NCT02860130|583536255|FG001|Overall Study|Other|1|||
161586712|NCT02140645|583536258|FG000|Overall Study|Not linked|5489|||
161674351|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
161674352|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
161586713|NCT02140645|583536259|FG001|Overall Study|Not linked|61654|||
161586714|NCT02140645|583536260|FG002|Overall Study|Not linked|4236|||
161586715|NCT02140645|583536261|FG003|Overall Study|Not linked|13833|||
161586716|NCT02140645|583536262|FG004|Overall Study|Not linked|3286|||
161674353|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
161674354|NCT00698451|583861877|FG000|Overall Study|Adverse Event|22|||
161674355|NCT00698451|583861877|FG000|Overall Study|Physician Decision|2|||
161674356|NCT00698451|583861877|FG000|Overall Study|Protocol Violation|6|||
161674357|NCT00698451|583861877|FG000|Overall Study|Withdrawal by Subject|6|||
161820183|NCT04402489|584382759|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
161820184|NCT04402489|584382760|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161820185|NCT04402489|584382761|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161820186|NCT04402489|584382757|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820187|NCT04402489|584382758|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820188|NCT04402489|584382759|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820189|NCT04402489|584382760|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
161820190|NCT04402489|584382761|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820191|NCT04402489|584382757|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161820192|NCT04402489|584382758|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
161820193|NCT04402489|584382759|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
161820194|NCT04402489|584382760|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161820195|NCT04402489|584382761|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161820196|NCT03192891|584382762|FG000|Overall Study|Lost to Follow-up|55|||
161820197|NCT05223868|584382763|FG000|Overall Study|Lost to Follow-up|1|||
161820198|NCT05223868|584382764|FG001|Overall Study|Lost to Follow-up|3|||
161820199|NCT05223868|584382765|FG002|Overall Study|Lost to Follow-up|0|||
161820200|NCT05223868|584382766|FG003|Overall Study|Lost to Follow-up|0|||
161820201|NCT05223868|584382767|FG004|Overall Study|Lost to Follow-up|0|||
161820202|NCT05223868|584382768|FG005|Overall Study|Lost to Follow-up|1|||
161820203|NCT05223868|584382763|FG000|Overall Study|Withdrawal by Subject|6|||
161820204|NCT05223868|584382764|FG001|Overall Study|Withdrawal by Subject|2|||
161820205|NCT05223868|584382765|FG002|Overall Study|Withdrawal by Subject|3|||
161820206|NCT05223868|584382766|FG003|Overall Study|Withdrawal by Subject|1|||
161820207|NCT05223868|584382767|FG004|Overall Study|Withdrawal by Subject|1|||
161820208|NCT05223868|584382768|FG005|Overall Study|Withdrawal by Subject|2|||
161820209|NCT05223868|584382763|FG000|Overall Study|Other|0|||
161820210|NCT05223868|584382764|FG001|Overall Study|Other|2|||
161820211|NCT05223868|584382765|FG002|Overall Study|Other|0|||
161820212|NCT05223868|584382766|FG003|Overall Study|Other|0|||
161820213|NCT05223868|584382767|FG004|Overall Study|Other|1|||
161820214|NCT05223868|584382768|FG005|Overall Study|Other|1|||
161507826|NCT02161718|583253824|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
161507827|NCT02161718|583253825|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
161507828|NCT02161718|583253826|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
161507829|NCT02161718|583253824|FG000|Post- Randomization Period|Physician Decision|0|||
161507830|NCT02161718|583253825|FG001|Post- Randomization Period|Physician Decision|2|||
161674358|NCT00698451|583861877|FG000|Overall Study|Disease progression|3|||
161674359|NCT02224599|583861880|FG000|Overall Study|Physician Decision|1|||
161674360|NCT02224599|583861880|FG000|Overall Study|Progression of Disease|1|||
161674361|NCT01330914|583861881|FG000|Overall Study|Withdrawal by Subject|4|||
161674362|NCT01330914|583861881|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
161674363|NCT05352048|583861886|FG000|Overall Study|Lost to Follow-up|1|||
161674364|NCT05352048|583861886|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
161674365|NCT03085758|583861887|FG000|Overall Study|Death|26|||
161674366|NCT03085758|583861888|FG001|Overall Study|Death|24|||
161674367|NCT03085758|583861889|FG002|Overall Study|Death|53|||
161674368|NCT03085758|583861887|FG000|Overall Study|Lost to Follow-up|1|||
161674369|NCT03085758|583861888|FG001|Overall Study|Lost to Follow-up|1|||
161674370|NCT03085758|583861889|FG002|Overall Study|Lost to Follow-up|1|||
161674371|NCT03085758|583861887|FG000|Overall Study|Withdrawal by Subject|2|||
161674372|NCT03085758|583861888|FG001|Overall Study|Withdrawal by Subject|2|||
161674373|NCT03085758|583861889|FG002|Overall Study|Withdrawal by Subject|1|||
161674374|NCT03085758|583861887|FG000|Overall Study|Refusal to recall it up to day 90|0|||
161674375|NCT03085758|583861888|FG001|Overall Study|Refusal to recall it up to day 90|0|||
161674376|NCT03085758|583861889|FG002|Overall Study|Refusal to recall it up to day 90|1|||
161674377|NCT03085758|583861887|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
161674378|NCT03085758|583861888|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
161820215|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820216|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820217|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820218|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
161820219|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820220|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820221|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820222|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820223|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
161507831|NCT02161718|583253826|FG002|Post- Randomization Period|Physician Decision|4|||
161507832|NCT02161718|583253824|FG000|Post- Randomization Period|Protocol Violation|0|||
161507833|NCT02161718|583253825|FG001|Post- Randomization Period|Protocol Violation|2|||
161507834|NCT02161718|583253826|FG002|Post- Randomization Period|Protocol Violation|3|||
161674379|NCT03085758|583861889|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
161674380|NCT03974334|583861893|FG000|Overall Study|Lost to Follow-up|1|||
161674381|NCT00024167|583861894|FG000|Overall Study|Death|53|||
161674382|NCT00024167|583861895|FG001|Overall Study|Death|47|||
161674383|NCT01109173|583861896|FG000|Overall Study|Adverse Event|15|||
161674384|NCT01109173|583861897|FG001|Overall Study|Adverse Event|17|||
161674385|NCT01109173|583861898|FG002|Overall Study|Adverse Event|9|||
161674386|NCT01109173|583861899|FG003|Overall Study|Adverse Event|6|||
161674387|NCT01109173|583861896|FG000|Overall Study|Lost to Follow-up|0|||
161674388|NCT01109173|583861897|FG001|Overall Study|Lost to Follow-up|1|||
161674389|NCT01109173|583861898|FG002|Overall Study|Lost to Follow-up|0|||
161674390|NCT01109173|583861899|FG003|Overall Study|Lost to Follow-up|0|||
161674391|NCT01109173|583861896|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
161674392|NCT01109173|583861897|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
161674393|NCT01109173|583861898|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
161674394|NCT01109173|583861899|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
161674395|NCT01109173|583861896|FG000|Overall Study|Noncompliance|0|||
161674396|NCT01109173|583861897|FG001|Overall Study|Noncompliance|1|||
161674397|NCT01109173|583861898|FG002|Overall Study|Noncompliance|0|||
161674398|NCT01109173|583861899|FG003|Overall Study|Noncompliance|0|||
161674399|NCT01109173|583861896|FG000|Overall Study|Treatment Failure|25|||
161674400|NCT01109173|583861897|FG001|Overall Study|Treatment Failure|32|||
161674401|NCT01109173|583861898|FG002|Overall Study|Treatment Failure|69|||
161674402|NCT01109173|583861899|FG003|Overall Study|Treatment Failure|64|||
161674403|NCT01109173|583861896|FG000|Overall Study|Protocol Violation|4|||
161674404|NCT01109173|583861897|FG001|Overall Study|Protocol Violation|5|||
161674405|NCT01109173|583861898|FG002|Overall Study|Protocol Violation|1|||
161674406|NCT01109173|583861899|FG003|Overall Study|Protocol Violation|2|||
161674407|NCT01109173|583861896|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
161674408|NCT01109173|583861897|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
161674409|NCT01109173|583861898|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
161674410|NCT01109173|583861899|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
161674411|NCT01109173|583861896|FG000|Overall Study|Not Specifiied|5|||
161674412|NCT01109173|583861897|FG001|Overall Study|Not Specifiied|4|||
161674413|NCT01109173|583861898|FG002|Overall Study|Not Specifiied|9|||
161674414|NCT01109173|583861899|FG003|Overall Study|Not Specifiied|14|||
161674415|NCT01438151|583861901|FG000|Overall Study|study terminated|8|||
161674416|NCT00006392|583861908|FG000|Overall Study|Ineligible|11|||
161820224|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
161820225|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820226|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820227|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820228|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820229|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
161820230|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820231|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820232|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820233|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820234|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820235|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
161820236|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
161820237|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820238|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820239|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820240|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820241|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
161820242|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
161820243|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820244|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820245|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
161674417|NCT00006392|583861909|FG001|Overall Study|Ineligible|3|||
161674418|NCT00006392|583861910|FG002|Overall Study|Ineligible|5|||
161674419|NCT00006392|583861911|FG003|Overall Study|Ineligible|5|||
161674420|NCT00006392|583861908|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
161674421|NCT00006392|583861909|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161674422|NCT00006392|583861910|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161674423|NCT00006392|583861911|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161674424|NCT02459769|583861913|FG000|Overall Study|Withdrawal by Subject|7|||
161674425|NCT02459769|583861914|FG001|Overall Study|Withdrawal by Subject|4|||
161674426|NCT02459769|583861915|FG002|Overall Study|Withdrawal by Subject|8|||
161674427|NCT02459769|583861916|FG003|Overall Study|Withdrawal by Subject|5|||
161674428|NCT02459769|583861913|FG000|Overall Study|Lost to Follow-up|1|||
161674429|NCT02459769|583861914|FG001|Overall Study|Lost to Follow-up|0|||
161674430|NCT02459769|583861915|FG002|Overall Study|Lost to Follow-up|1|||
161674431|NCT02459769|583861916|FG003|Overall Study|Lost to Follow-up|0|||
161674432|NCT01186796|583861917|FG000|Overall Study|Adverse Event|3|||
161674433|NCT01186796|583861918|FG001|Overall Study|Adverse Event|0|||
161674434|NCT01186796|583861917|FG000|Overall Study|Withdrawal by Subject|1|||
161674435|NCT01186796|583861918|FG001|Overall Study|Withdrawal by Subject|1|||
161674436|NCT01186796|583861917|FG000|Overall Study|Protocol Violation|0|||
161674437|NCT01186796|583861918|FG001|Overall Study|Protocol Violation|1|||
161674438|NCT03838198|583861919|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161674439|NCT03838198|583861920|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161674440|NCT03838198|583861921|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
161507835|NCT02161718|583253824|FG000|Post- Randomization Period|Lack of Efficacy|0|||
161507836|NCT02161718|583253825|FG001|Post- Randomization Period|Lack of Efficacy|0|||
161507837|NCT02161718|583253826|FG002|Post- Randomization Period|Lack of Efficacy|1|||
161507838|NCT02161718|583253824|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
161507839|NCT02161718|583253825|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
161507840|NCT02161718|583253826|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
161507841|NCT02161718|583253824|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
161507842|NCT02161718|583253825|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
161507843|NCT02161718|583253826|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
161507844|NCT02161718|583253824|FG000|Post- Randomization Period|Relocation|0|||
161507845|NCT02161718|583253825|FG001|Post- Randomization Period|Relocation|3|||
161507846|NCT02161718|583253826|FG002|Post- Randomization Period|Relocation|0|||
161507847|NCT02948842|583253828|FG000|Overall Study|Withdrawal by Subject|4|||
161507848|NCT01537783|583253829|FG000|Overall Study|Lost to Follow-up|11|||
161507849|NCT01537783|583253830|FG001|Overall Study|Lost to Follow-up|2|||
161507850|NCT02350309|583253832|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
161507851|NCT02350309|583253833|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
161507852|NCT02350309|583253834|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
161507853|NCT02350309|583253835|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
161507854|NCT02350309|583253836|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
161507855|NCT02350309|583253837|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
161507856|NCT02350309|583253832|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
161507857|NCT02350309|583253833|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
161507858|NCT02350309|583253834|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
161507859|NCT02350309|583253835|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
161507860|NCT02350309|583253836|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
161507861|NCT02350309|583253837|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
161507862|NCT00207142|583253838|FG000|Induction Phase|Adverse Event|9|||
161507863|NCT00207142|583253839|FG001|Induction Phase|Adverse Event|0|||
161507864|NCT00207142|583253840|FG002|Induction Phase|Adverse Event|0|||
161507865|NCT00207142|583253841|FG003|Induction Phase|Adverse Event|0|||
161507866|NCT00207142|583253838|FG000|Induction Phase|Death|1|||
161507867|NCT00207142|583253839|FG001|Induction Phase|Death|0|||
161507868|NCT00207142|583253840|FG002|Induction Phase|Death|0|||
161507869|NCT00207142|583253841|FG003|Induction Phase|Death|0|||
161507870|NCT00207142|583253838|FG000|Induction Phase|Lack of Efficacy|1|||
161507871|NCT00207142|583253839|FG001|Induction Phase|Lack of Efficacy|0|||
161507872|NCT00207142|583253840|FG002|Induction Phase|Lack of Efficacy|0|||
161507873|NCT00207142|583253841|FG003|Induction Phase|Lack of Efficacy|0|||
161507874|NCT00207142|583253838|FG000|Induction Phase|Lost to Follow-up|5|||
161507875|NCT00207142|583253839|FG001|Induction Phase|Lost to Follow-up|0|||
161507876|NCT00207142|583253840|FG002|Induction Phase|Lost to Follow-up|0|||
161507877|NCT00207142|583253841|FG003|Induction Phase|Lost to Follow-up|0|||
161507878|NCT00207142|583253838|FG000|Induction Phase|Physician Decision|2|||
161674441|NCT03838198|583861922|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161507879|NCT00207142|583253839|FG001|Induction Phase|Physician Decision|0|||
161507880|NCT00207142|583253840|FG002|Induction Phase|Physician Decision|0|||
161507881|NCT00207142|583253841|FG003|Induction Phase|Physician Decision|0|||
161507882|NCT00207142|583253838|FG000|Induction Phase|Poor/noncompliance|2|||
161507883|NCT00207142|583253839|FG001|Induction Phase|Poor/noncompliance|0|||
161674442|NCT03838198|583861919|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
161507884|NCT00207142|583253840|FG002|Induction Phase|Poor/noncompliance|0|||
161507885|NCT00207142|583253841|FG003|Induction Phase|Poor/noncompliance|0|||
161507886|NCT00207142|583253838|FG000|Induction Phase|Pregnancy|1|||
161507887|NCT00207142|583253839|FG001|Induction Phase|Pregnancy|0|||
161507888|NCT00207142|583253840|FG002|Induction Phase|Pregnancy|0|||
161507889|NCT00207142|583253841|FG003|Induction Phase|Pregnancy|0|||
161507890|NCT00207142|583253838|FG000|Induction Phase|Subject no longer meets study criteria|3|||
161507891|NCT00207142|583253839|FG001|Induction Phase|Subject no longer meets study criteria|0|||
161507892|NCT00207142|583253840|FG002|Induction Phase|Subject no longer meets study criteria|0|||
161507893|NCT00207142|583253841|FG003|Induction Phase|Subject no longer meets study criteria|0|||
161507894|NCT00207142|583253838|FG000|Induction Phase|Withdrawal by Subject|4|||
161507895|NCT00207142|583253839|FG001|Induction Phase|Withdrawal by Subject|0|||
161507896|NCT00207142|583253840|FG002|Induction Phase|Withdrawal by Subject|0|||
161507897|NCT00207142|583253841|FG003|Induction Phase|Withdrawal by Subject|0|||
161507898|NCT00207142|583253838|FG000|Induction Phase|Incarceration|1|||
161507899|NCT00207142|583253839|FG001|Induction Phase|Incarceration|0|||
161507900|NCT00207142|583253840|FG002|Induction Phase|Incarceration|0|||
161507901|NCT00207142|583253841|FG003|Induction Phase|Incarceration|0|||
161507902|NCT00207142|583253838|FG000|Induction Phase|Missing lab data|1|||
161507903|NCT00207142|583253839|FG001|Induction Phase|Missing lab data|0|||
161507904|NCT00207142|583253840|FG002|Induction Phase|Missing lab data|0|||
161507905|NCT00207142|583253841|FG003|Induction Phase|Missing lab data|0|||
161507906|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
161507907|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
161507908|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
161507909|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
161507910|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
161507911|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
161507912|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
161507913|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
161507914|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
161507915|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
161507916|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
161507917|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
161507918|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
161507919|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
161507920|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
161507921|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
161507922|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
161507923|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
161507924|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
161507925|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
161507926|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
161507927|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
161507928|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
161507929|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
161507930|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
161507931|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
161507932|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
161507933|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
161507934|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Death|0|||
161507935|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Death|0|||
161507936|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Death|0|||
161507937|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Death|1|||
161507938|NCT00207142|583253838|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
161507939|NCT00207142|583253839|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
161507940|NCT00207142|583253840|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
161507941|NCT00207142|583253841|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
161507942|NCT01554618|583253842|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
161507943|NCT01554618|583253843|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
161507944|NCT01554618|583253842|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
161507945|NCT01554618|583253843|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
161507946|NCT01554618|583253842|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
161507947|NCT01554618|583253843|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
161507948|NCT01554618|583253842|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
161507949|NCT01554618|583253843|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
161507950|NCT01554618|583253842|FG000|Open-Label Extension Period|Physician Decision|0|||
161507951|NCT01554618|583253843|FG001|Open-Label Extension Period|Physician Decision|1|||
161507952|NCT01554618|583253842|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161507953|NCT01554618|583253843|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
161507954|NCT01857063|583253844|FG000|Period 1 (7 Days)|Adverse Event|0|||
161507955|NCT01857063|583253845|FG001|Period 1 (7 Days)|Adverse Event|1|||
161507956|NCT01857063|583253844|FG000|Period 1 (7 Days)|Physician Decision|1|||
161507957|NCT01857063|583253845|FG001|Period 1 (7 Days)|Physician Decision|0|||
161586717|NCT02140645|583536263|FG005|Overall Study|Not linked|70896|||
161586718|NCT05450458|583536264|FG000|Overall Study|Lost to Follow-up|4|||
161674443|NCT03838198|583861920|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
161674444|NCT03838198|583861921|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
161674445|NCT03838198|583861922|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
161674446|NCT00578786|583861927|FG000|Overall Study|Adverse Event|27|||
161674447|NCT00578786|583861928|FG001|Overall Study|Adverse Event|37|||
161674448|NCT00578786|583861929|FG002|Overall Study|Adverse Event|17|||
161674449|NCT00578786|583861927|FG000|Overall Study|Lack of Efficacy|2|||
161674450|NCT00578786|583861928|FG001|Overall Study|Lack of Efficacy|5|||
161674451|NCT00578786|583861929|FG002|Overall Study|Lack of Efficacy|2|||
161674452|NCT00578786|583861927|FG000|Overall Study|Early Escape from Prior Study|2|||
161674453|NCT00578786|583861928|FG001|Overall Study|Early Escape from Prior Study|1|||
161674454|NCT00578786|583861929|FG002|Overall Study|Early Escape from Prior Study|2|||
161674455|NCT00578786|583861927|FG000|Overall Study|Withdrawal by Subject|7|||
161674456|NCT00578786|583861928|FG001|Overall Study|Withdrawal by Subject|8|||
161674457|NCT00578786|583861929|FG002|Overall Study|Withdrawal by Subject|5|||
161674458|NCT00578786|583861927|FG000|Overall Study|Protocol Violation|0|||
161674459|NCT00578786|583861928|FG001|Overall Study|Protocol Violation|3|||
161674460|NCT00578786|583861929|FG002|Overall Study|Protocol Violation|1|||
161674461|NCT00578786|583861927|FG000|Overall Study|Physician Decision|1|||
161674462|NCT00578786|583861928|FG001|Overall Study|Physician Decision|0|||
161674463|NCT00578786|583861929|FG002|Overall Study|Physician Decision|1|||
161674464|NCT00578786|583861927|FG000|Overall Study|Sponsor Decision|0|||
161674465|NCT00578786|583861928|FG001|Overall Study|Sponsor Decision|0|||
161674466|NCT00578786|583861929|FG002|Overall Study|Sponsor Decision|1|||
161674467|NCT00578786|583861927|FG000|Overall Study|Lost to Follow-up|0|||
161674468|NCT00578786|583861928|FG001|Overall Study|Lost to Follow-up|4|||
161674469|NCT00578786|583861929|FG002|Overall Study|Lost to Follow-up|0|||
161674470|NCT00578786|583861927|FG000|Overall Study|Pregnancy|0|||
161674471|NCT00578786|583861928|FG001|Overall Study|Pregnancy|1|||
161674472|NCT00578786|583861929|FG002|Overall Study|Pregnancy|0|||
161674473|NCT00578786|583861927|FG000|Overall Study|Not Otherwise Specified|0|||
161674474|NCT00578786|583861928|FG001|Overall Study|Not Otherwise Specified|4|||
161674475|NCT00578786|583861929|FG002|Overall Study|Not Otherwise Specified|1|||
161674476|NCT00578786|583861927|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
161674477|NCT00578786|583861928|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
161674478|NCT00578786|583861929|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
161674479|NCT00312221|583861930|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
161674480|NCT00312221|583861931|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161674481|NCT00312221|583861932|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161674482|NCT00312221|583861933|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
161674483|NCT00312221|583861930|FG000|Open-label Run-in Period|Adverse Event|74|||
161674484|NCT00312221|583861931|FG001|Open-label Run-in Period|Adverse Event|0|||
161674485|NCT00312221|583861932|FG002|Open-label Run-in Period|Adverse Event|0|||
161674486|NCT00312221|583861933|FG003|Open-label Run-in Period|Adverse Event|0|||
161674487|NCT00312221|583861930|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
161674488|NCT00312221|583861931|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161674489|NCT00312221|583861932|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161674490|NCT00312221|583861933|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
161674491|NCT00312221|583861930|FG000|Open-label Run-in Period|Administrative|42|||
161674492|NCT00312221|583861931|FG001|Open-label Run-in Period|Administrative|0|||
161674493|NCT00312221|583861932|FG002|Open-label Run-in Period|Administrative|0|||
161674494|NCT00312221|583861933|FG003|Open-label Run-in Period|Administrative|0|||
161674495|NCT00312221|583861930|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
161674496|NCT00312221|583861931|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161674497|NCT00312221|583861932|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161674498|NCT00312221|583861933|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
161674499|NCT00312221|583861930|FG000|Open-label Run-in Period|Did not qualify|5|||
161674500|NCT00312221|583861931|FG001|Open-label Run-in Period|Did not qualify|0|||
161674501|NCT00312221|583861932|FG002|Open-label Run-in Period|Did not qualify|0|||
161674502|NCT00312221|583861933|FG003|Open-label Run-in Period|Did not qualify|0|||
161674503|NCT00312221|583861930|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161674504|NCT00312221|583861931|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161674505|NCT00312221|583861932|FG002|Double-blind Phase|Withdrawal by Subject|8|||
161674506|NCT00312221|583861933|FG003|Double-blind Phase|Withdrawal by Subject|7|||
161674507|NCT00312221|583861930|FG000|Double-blind Phase|Adverse Event|0|||
161674508|NCT00312221|583861931|FG001|Double-blind Phase|Adverse Event|10|||
161674509|NCT00312221|583861932|FG002|Double-blind Phase|Adverse Event|19|||
161674510|NCT00312221|583861933|FG003|Double-blind Phase|Adverse Event|18|||
161674511|NCT00312221|583861930|FG000|Double-blind Phase|Lost to Follow-up|0|||
161674512|NCT00312221|583861931|FG001|Double-blind Phase|Lost to Follow-up|0|||
161674513|NCT00312221|583861932|FG002|Double-blind Phase|Lost to Follow-up|2|||
161674514|NCT00312221|583861933|FG003|Double-blind Phase|Lost to Follow-up|2|||
161674515|NCT00312221|583861930|FG000|Double-blind Phase|Administrative|0|||
161674516|NCT00312221|583861931|FG001|Double-blind Phase|Administrative|26|||
161674517|NCT00312221|583861932|FG002|Double-blind Phase|Administrative|37|||
161674518|NCT00312221|583861933|FG003|Double-blind Phase|Administrative|33|||
161674519|NCT00312221|583861930|FG000|Double-blind Phase|Lack of Efficacy|0|||
161674520|NCT00312221|583861931|FG001|Double-blind Phase|Lack of Efficacy|17|||
161674521|NCT00312221|583861932|FG002|Double-blind Phase|Lack of Efficacy|6|||
161674522|NCT00312221|583861933|FG003|Double-blind Phase|Lack of Efficacy|10|||
161674523|NCT01019317|583861934|FG000|Overall Study|Not Eligible|4|||
161674524|NCT01807923|583861936|FG000|Overall Study|Adverse Event|2|||
161674525|NCT01807923|583861937|FG001|Overall Study|Adverse Event|1|||
161674526|NCT01807923|583861938|FG002|Overall Study|Adverse Event|2|||
161674527|NCT01807923|583861936|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161674528|NCT01807923|583861937|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161674529|NCT01807923|583861938|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161674530|NCT01807923|583861936|FG000|Overall Study|Physician Decision|0|||
161674531|NCT01807923|583861937|FG001|Overall Study|Physician Decision|0|||
161674532|NCT01807923|583861938|FG002|Overall Study|Physician Decision|1|||
161674533|NCT01807923|583861936|FG000|Overall Study|Not Eligible (Genotype)|0|||
161674534|NCT01807923|583861937|FG001|Overall Study|Not Eligible (Genotype)|0|||
161674535|NCT01807923|583861938|FG002|Overall Study|Not Eligible (Genotype)|1|||
161674536|NCT01807923|583861936|FG000|Overall Study|Randomized But Not Treated|3|||
161674537|NCT01807923|583861937|FG001|Overall Study|Randomized But Not Treated|2|||
161674538|NCT01807923|583861938|FG002|Overall Study|Randomized But Not Treated|5|||
161674539|NCT01237340|583861944|FG000|Overall Study|Adverse Event|3|||
161674540|NCT01237340|583861944|FG000|Overall Study|Withdrawal by Subject|1|||
161674541|NCT01237340|583861944|FG000|Overall Study|Early termination of the trial|36|||
161674542|NCT03836807|583861945|FG000|Overall Study|Physician Decision|1|||
161674543|NCT03836807|583861946|FG001|Overall Study|Physician Decision|0|||
161674544|NCT00685685|583861947|FG000|Washout Period of 7 Days|Adverse Event|2|||
161674545|NCT00685685|583861948|FG001|Washout Period of 7 Days|Adverse Event|0|||
161674546|NCT00685685|583861947|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161674547|NCT00685685|583861948|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161674548|NCT01272947|583861949|FG000|Overall Study|Abnormal Laboratory Value|2|||
161674549|NCT01272947|583861950|FG001|Overall Study|Abnormal Laboratory Value|2|||
161674550|NCT02019420|583861953|FG000|Overall Study|Did not receive study drug|2|||
161674551|NCT02019420|583861954|FG001|Overall Study|Did not receive study drug|2|||
161674552|NCT02019420|583861953|FG000|Overall Study|Withdrawal by Subject|1|||
161674553|NCT02019420|583861954|FG001|Overall Study|Withdrawal by Subject|3|||
161674554|NCT02019420|583861953|FG000|Overall Study|At request of sponsor or investigator|0|||
161674555|NCT02019420|583861954|FG001|Overall Study|At request of sponsor or investigator|1|||
161507958|NCT01857063|583253844|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
161507959|NCT01857063|583253845|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
161507960|NCT01857063|583253844|FG000|Period 2 (7 Days)|Adverse Event|2|||
161507961|NCT01857063|583253845|FG001|Period 2 (7 Days)|Adverse Event|1|||
161507962|NCT01857063|583253844|FG000|Period 2 (7 Days)|Physician Decision|1|||
161507963|NCT01857063|583253845|FG001|Period 2 (7 Days)|Physician Decision|1|||
161507964|NCT01857063|583253844|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
161507965|NCT01857063|583253845|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
161507966|NCT01256710|583253846|FG000|Overall Study|Death|449|||
161507967|NCT01256710|583253846|FG000|Overall Study|System Explant|67|||
161507968|NCT01256710|583253846|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
161507969|NCT01256710|583253846|FG000|Overall Study|Lost to Follow-up|67|||
161507970|NCT01256710|583253846|FG000|Overall Study|Withdrawal by Subject|29|||
161507971|NCT01256710|583253846|FG000|Overall Study|Physician Decision|9|||
161820246|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
161820247|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
161820248|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
161820249|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
161820250|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
161820251|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
161820252|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
161820253|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
161820254|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
161820255|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
161820256|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
161820257|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161820258|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
161507972|NCT01256710|583253846|FG000|Overall Study|Subject Noncompliance|2|||
161507973|NCT01256710|583253846|FG000|Overall Study|Study Terminated by Sponsor|273|||
161674556|NCT02019420|583861953|FG000|Overall Study|Death|104|||
161674557|NCT02019420|583861954|FG001|Overall Study|Death|99|||
161674558|NCT02019420|583861953|FG000|Overall Study|Transferred to other care facility|1|||
161820259|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
161507974|NCT00058825|583253847|FG000|Overall Study|Relapse|9|||
161674559|NCT02019420|583861954|FG001|Overall Study|Transferred to other care facility|1|||
161674560|NCT02014740|583861955|FG000|Overall Study|Lost to Follow-up|4|||
161674561|NCT02014740|583861956|FG001|Overall Study|Lost to Follow-up|4|||
161674562|NCT02014740|583861955|FG000|Overall Study|Withdrawal by Subject|2|||
161674563|NCT02014740|583861956|FG001|Overall Study|Withdrawal by Subject|1|||
161674564|NCT01130974|583861957|FG000|Overall Study|Protocol Violation|10|||
161925774|NCT00422461|584774610|FG001|Overall Study|Participants no longer willing to participate in study|0|||
161925775|NCT00422461|584774611|FG002|Overall Study|Participants no longer willing to participate in study|0|||
161925776|NCT00422461|584774612|FG003|Overall Study|Participants no longer willing to participate in study|0|||
161925777|NCT00422461|584774609|FG000|Overall Study|Randomized but not treated|1|||
161925778|NCT00422461|584774610|FG001|Overall Study|Randomized but not treated|1|||
161925779|NCT00422461|584774611|FG002|Overall Study|Randomized but not treated|0|||
161925780|NCT00422461|584774612|FG003|Overall Study|Randomized but not treated|0|||
161925781|NCT02181621|584774614|FG000|Overall Study|Adverse Event|1|||
161925782|NCT02181621|584774615|FG001|Overall Study|Adverse Event|0|||
161925783|NCT02181621|584774614|FG000|Overall Study|Previously Enrolled|0|||
161925784|NCT02181621|584774615|FG001|Overall Study|Previously Enrolled|1|||
161925785|NCT02181621|584774614|FG000|Overall Study|Enrollment Hold|1|||
161925786|NCT02181621|584774615|FG001|Overall Study|Enrollment Hold|1|||
161925787|NCT01875237|584774620|FG000|Overall Study|GVDH before DLI|1|||
161925788|NCT01875237|584774621|FG001|Overall Study|GVDH before DLI|0|||
161925789|NCT01875237|584774620|FG000|Overall Study|DLI cells could not be produced|1|||
161925790|NCT01875237|584774621|FG001|Overall Study|DLI cells could not be produced|0|||
161925791|NCT02441114|584774622|FG000|Washout2|Withdrawal by Subject|4|||
161925792|NCT05278065|584774623|FG000|Overall Study|Withdrawal by Subject|1|||
161925793|NCT05278065|584774624|FG001|Overall Study|Withdrawal by Subject|0|||
161925794|NCT02070991|584774630|FG000|Overall Study|Death|2|||
161925795|NCT02070991|584774631|FG001|Overall Study|Death|0|||
161925796|NCT02070991|584774630|FG000|Overall Study|Withdrawal by Subject|1|||
161925797|NCT02070991|584774631|FG001|Overall Study|Withdrawal by Subject|0|||
161925798|NCT04999020|584774632|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
161925799|NCT04999020|584774633|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
161925800|NCT04999020|584774634|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
161925801|NCT04999020|584774635|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
161925802|NCT04999020|584774632|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
161925803|NCT04999020|584774633|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
161925804|NCT04999020|584774634|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
161925805|NCT04999020|584774635|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
161925806|NCT04999020|584774632|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
161925807|NCT04999020|584774633|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
161925808|NCT04999020|584774634|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
161925809|NCT04999020|584774635|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
161925810|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161925811|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161925812|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
161925813|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
161925814|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161925815|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161925816|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
161925817|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
161925818|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
161925819|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
161925820|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
161925821|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
161925822|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161925823|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161925824|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
161925825|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161925826|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
161925827|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
161925828|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
161925829|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
161925830|NCT00866320|584774641|FG000|Overall Study|Withdrawal by Subject|4|||
161674565|NCT01130974|583861958|FG001|Overall Study|Protocol Violation|10|||
161674566|NCT01130974|583861957|FG000|Overall Study|Withdrawal by Subject|0|||
161674567|NCT01130974|583861958|FG001|Overall Study|Withdrawal by Subject|1|||
161674568|NCT01130974|583861957|FG000|Overall Study|Ineligibility criteria|5|||
161674569|NCT01130974|583861958|FG001|Overall Study|Ineligibility criteria|2|||
161674570|NCT05118204|583861963|FG000|Overall Study|Lost to Follow-up|3|||
161674571|NCT05118204|583861964|FG001|Overall Study|Lost to Follow-up|2|||
161674572|NCT05118204|583861963|FG000|Overall Study|Withdrawal by Subject|0|||
161674573|NCT05118204|583861964|FG001|Overall Study|Withdrawal by Subject|2|||
161674574|NCT05393037|583861966|FG000|Part A|Death|1|||
161674575|NCT05393037|583861967|FG001|Part A|Death|0|||
161674576|NCT05393037|583861966|FG000|Part A|Lost to Follow-up|1|||
161674577|NCT05393037|583861967|FG001|Part A|Lost to Follow-up|1|||
161674578|NCT05393037|583861966|FG000|Part A|Withdrawal by Subject|2|||
161674579|NCT05393037|583861967|FG001|Part A|Withdrawal by Subject|4|||
161674580|NCT05393037|583861966|FG000|Part B|Lost to Follow-up|1|||
161674581|NCT05393037|583861967|FG001|Part B|Lost to Follow-up|0|||
161674582|NCT04409353|583861968|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
161674583|NCT04409353|583861969|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
161674584|NCT04409353|583861970|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
161674585|NCT04409353|583861968|FG000|Overall Study|Lost to Follow-up|6|||
161674586|NCT04409353|583861969|FG001|Overall Study|Lost to Follow-up|8|||
161674587|NCT04409353|583861970|FG002|Overall Study|Lost to Follow-up|7|||
161674588|NCT04409353|583861968|FG000|Overall Study|Major surgery during participation window|4|||
161674589|NCT04409353|583861969|FG001|Overall Study|Major surgery during participation window|3|||
161674590|NCT04409353|583861970|FG002|Overall Study|Major surgery during participation window|3|||
161674591|NCT04409353|583861968|FG000|Overall Study|Life event occurred during participation window|3|||
161674592|NCT04409353|583861969|FG001|Overall Study|Life event occurred during participation window|2|||
161674593|NCT04409353|583861970|FG002|Overall Study|Life event occurred during participation window|4|||
161674594|NCT04409353|583861968|FG000|Overall Study|Lack of Efficacy|4|||
161674595|NCT04409353|583861969|FG001|Overall Study|Lack of Efficacy|1|||
161674596|NCT04409353|583861970|FG002|Overall Study|Lack of Efficacy|3|||
161674597|NCT04409353|583861968|FG000|Overall Study|Adverse Event|2|||
161674598|NCT04409353|583861969|FG001|Overall Study|Adverse Event|1|||
161674599|NCT04409353|583861970|FG002|Overall Study|Adverse Event|1|||
161674600|NCT04409353|583861968|FG000|Overall Study|Disease burden - unable to participate|0|||
161674601|NCT04409353|583861969|FG001|Overall Study|Disease burden - unable to participate|1|||
161674602|NCT04409353|583861970|FG002|Overall Study|Disease burden - unable to participate|1|||
161674603|NCT04409353|583861968|FG000|Overall Study|Intervention too complicated|1|||
161674604|NCT04409353|583861969|FG001|Overall Study|Intervention too complicated|0|||
161674605|NCT04409353|583861970|FG002|Overall Study|Intervention too complicated|1|||
161674606|NCT01012739|583861971|FG000|Treatment Period 1|Adverse Event|0|||
161674607|NCT01012739|583861972|FG001|Treatment Period 1|Adverse Event|0|||
161674608|NCT01012739|583861973|FG002|Treatment Period 1|Adverse Event|0|||
161674609|NCT01012739|583861974|FG003|Treatment Period 1|Adverse Event|1|||
161674610|NCT01012739|583861971|FG000|Treatment Period 2|Abnormal test procedure results|0|||
161674611|NCT01012739|583861972|FG001|Treatment Period 2|Abnormal test procedure results|0|||
161674612|NCT01012739|583861973|FG002|Treatment Period 2|Abnormal test procedure results|0|||
161674613|NCT01012739|583861974|FG003|Treatment Period 2|Abnormal test procedure results|1|||
161674614|NCT04540133|583861975|FG000|Overall Study|Lost to Follow-up|1|||
161674615|NCT04540133|583861976|FG001|Overall Study|Lost to Follow-up|0|||
161674616|NCT04014361|583861977|FG000|Period 2|Physician Decision|0|||
161674617|NCT04014361|583861978|FG001|Period 2|Physician Decision|0|||
161674618|NCT04014361|583861979|FG002|Period 2|Physician Decision|0|||
161674619|NCT04014361|583861980|FG003|Period 2|Physician Decision|1|||
161674620|NCT04014361|583861981|FG004|Period 2|Physician Decision|0|||
161674621|NCT04014361|583861982|FG005|Period 2|Physician Decision|0|||
161674622|NCT04014361|583861983|FG006|Period 2|Physician Decision|0|||
161674623|NCT04014361|583861984|FG007|Period 2|Physician Decision|0|||
161674624|NCT06308666|583861985|FG000|Overall Study|Withdrawal by Subject|1|||
161674625|NCT06308666|583861985|FG000|Overall Study|Protocol Violation|2|||
161820260|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
161820261|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161507975|NCT00058825|583253847|FG000|Overall Study|Progressive Disease|5|||
161507976|NCT00058825|583253847|FG000|Overall Study|Graft Failure|5|||
161507977|NCT00058825|583253847|FG000|Overall Study|Death|3|||
161507978|NCT01205165|583253848|FG000|Overall Study|Lost to Follow-up|2|||
161507979|NCT00329407|583253856|FG000|Overall Study|Withdrawal by Subject|1|||
161674626|NCT04252287|583861987|FG000|Overall Study|Death|5|||
161674627|NCT04252287|583861988|FG001|Overall Study|Death|3|||
161674628|NCT04252287|583861987|FG000|Overall Study|Lost to Follow-up|4|||
161674629|NCT04252287|583861988|FG001|Overall Study|Lost to Follow-up|6|||
161674630|NCT04252287|583861987|FG000|Overall Study|Withdrawal by Subject|19|||
161674631|NCT04252287|583861988|FG001|Overall Study|Withdrawal by Subject|16|||
161674632|NCT04252287|583861987|FG000|Overall Study|Protocol Violation|3|||
161674633|NCT04252287|583861988|FG001|Overall Study|Protocol Violation|4|||
161674634|NCT00671554|583861996|FG000|Overall Study|Disease progression|3|||
161674635|NCT04600336|583862004|FG000|Initial Treatment|Withdrawal by Subject|1|||
161507980|NCT00978068|583253857|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
161507981|NCT00978068|583253858|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
161507982|NCT00978068|583253857|FG000|Overall Study|Death|1|||
161507983|NCT00978068|583253858|FG001|Overall Study|Death|2|||
161507984|NCT00978068|583253857|FG000|Overall Study|Lost to Follow-up|1|||
161507985|NCT00978068|583253858|FG001|Overall Study|Lost to Follow-up|2|||
161507986|NCT00978068|583253857|FG000|Overall Study|Physician Decision|0|||
161507987|NCT00978068|583253858|FG001|Overall Study|Physician Decision|1|||
161507988|NCT00978068|583253857|FG000|Overall Study|Unable to Comply with Study|0|||
161507989|NCT00978068|583253858|FG001|Overall Study|Unable to Comply with Study|2|||
161507990|NCT02275481|583253859|FG000|Overall Study|Death|2|||
161507991|NCT02275481|583253860|FG001|Overall Study|Death|1|||
161507992|NCT02275481|583253859|FG000|Overall Study|Lost to Follow-up|2|||
161507993|NCT02275481|583253860|FG001|Overall Study|Lost to Follow-up|0|||
161507994|NCT02275481|583253859|FG000|Overall Study|Withdrawal by Subject|3|||
161507995|NCT02275481|583253860|FG001|Overall Study|Withdrawal by Subject|0|||
161507996|NCT02275481|583253859|FG000|Overall Study|all other reasons combined|2|||
161507997|NCT02275481|583253860|FG001|Overall Study|all other reasons combined|1|||
161507998|NCT02275481|583253859|FG000|Overall Study|Physician Decision|0|||
161507999|NCT02275481|583253860|FG001|Overall Study|Physician Decision|1|||
161508000|NCT01393405|583253861|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
161508001|NCT01393405|583253862|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
161508002|NCT01393405|583253863|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
161508003|NCT01393405|583253861|FG000|Induction Period (week1-16)|Adverse Event|16|||
161508004|NCT01393405|583253862|FG001|Induction Period (week1-16)|Adverse Event|0|||
161586719|NCT05480943|583536265|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
161586720|NCT05480943|583536265|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
161586721|NCT05480943|583536265|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
161586722|NCT05480943|583536265|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
161586723|NCT00632749|583536266|FG000|Overall Study|Progressive disease|3|||
161586724|NCT00632749|583536267|FG001|Overall Study|Progressive disease|2|||
161586725|NCT00632749|583536268|FG002|Overall Study|Progressive disease|2|||
161586726|NCT00632749|583536269|FG003|Overall Study|Progressive disease|2|||
161586727|NCT00632749|583536270|FG004|Overall Study|Progressive disease|4|||
161586728|NCT00632749|583536271|FG005|Overall Study|Progressive disease|4|||
161586729|NCT00632749|583536272|FG006|Overall Study|Progressive disease|3|||
161586730|NCT00632749|583536273|FG007|Overall Study|Progressive disease|2|||
161586731|NCT00632749|583536274|FG008|Overall Study|Progressive disease|3|||
161586732|NCT00632749|583536275|FG009|Overall Study|Progressive disease|2|||
161586733|NCT00632749|583536276|FG010|Overall Study|Progressive disease|4|||
161586734|NCT00632749|583536277|FG011|Overall Study|Progressive disease|3|||
161586735|NCT00632749|583536278|FG012|Overall Study|Progressive disease|2|||
161586736|NCT00632749|583536279|FG013|Overall Study|Progressive disease|4|||
161586737|NCT00632749|583536266|FG000|Overall Study|Other Adverse event|1|||
161586738|NCT00632749|583536267|FG001|Overall Study|Other Adverse event|1|||
161586739|NCT00632749|583536268|FG002|Overall Study|Other Adverse event|1|||
161586740|NCT00632749|583536269|FG003|Overall Study|Other Adverse event|1|||
161586741|NCT00632749|583536270|FG004|Overall Study|Other Adverse event|2|||
161586742|NCT00632749|583536271|FG005|Overall Study|Other Adverse event|4|||
161586743|NCT00632749|583536272|FG006|Overall Study|Other Adverse event|1|||
161586744|NCT00632749|583536273|FG007|Overall Study|Other Adverse event|2|||
161586745|NCT00632749|583536274|FG008|Overall Study|Other Adverse event|2|||
161586746|NCT00632749|583536275|FG009|Overall Study|Other Adverse event|0|||
161586747|NCT00632749|583536276|FG010|Overall Study|Other Adverse event|1|||
161586748|NCT00632749|583536277|FG011|Overall Study|Other Adverse event|0|||
161586749|NCT00632749|583536278|FG012|Overall Study|Other Adverse event|1|||
161586750|NCT00632749|583536279|FG013|Overall Study|Other Adverse event|0|||
161674636|NCT04600336|583862005|FG001|Initial Treatment|Withdrawal by Subject|2|||
161674637|NCT04600336|583862006|FG002|Initial Treatment|Withdrawal by Subject|0|||
161674638|NCT04600336|583862007|FG003|Initial Treatment|Withdrawal by Subject|0|||
161674639|NCT04600336|583862004|FG000|Initial Treatment|Adverse Event|0|||
161674640|NCT04600336|583862005|FG001|Initial Treatment|Adverse Event|2|||
161586751|NCT00632749|583536266|FG000|Overall Study|Refuse to continue medication|0|||
161586752|NCT00632749|583536267|FG001|Overall Study|Refuse to continue medication|0|||
161586753|NCT00632749|583536268|FG002|Overall Study|Refuse to continue medication|0|||
161508005|NCT01393405|583253863|FG002|Induction Period (week1-16)|Adverse Event|0|||
161508006|NCT01393405|583253861|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
161508007|NCT01393405|583253862|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
161586754|NCT00632749|583536269|FG003|Overall Study|Refuse to continue medication|1|||
161586755|NCT00632749|583536270|FG004|Overall Study|Refuse to continue medication|0|||
161586756|NCT00632749|583536271|FG005|Overall Study|Refuse to continue medication|0|||
161586757|NCT00632749|583536272|FG006|Overall Study|Refuse to continue medication|0|||
161820262|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161508008|NCT01393405|583253863|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
161508009|NCT01393405|583253861|FG000|Maintenance Period Week|Lack of Efficacy|0|||
161586758|NCT00632749|583536273|FG007|Overall Study|Refuse to continue medication|0|||
161586759|NCT00632749|583536274|FG008|Overall Study|Refuse to continue medication|0|||
161674641|NCT04600336|583862006|FG002|Initial Treatment|Adverse Event|0|||
161674642|NCT04600336|583862007|FG003|Initial Treatment|Adverse Event|0|||
161674643|NCT04600336|583862004|FG000|Initial Treatment|Other complicating disease|0|||
161674644|NCT04600336|583862005|FG001|Initial Treatment|Other complicating disease|0|||
161674645|NCT04600336|583862006|FG002|Initial Treatment|Other complicating disease|1|||
161674646|NCT04600336|583862007|FG003|Initial Treatment|Other complicating disease|0|||
161674647|NCT04600336|583862004|FG000|Crossover Treatment|Withdrawal by Subject|0|||
161674648|NCT04600336|583862005|FG001|Crossover Treatment|Withdrawal by Subject|0|||
161674649|NCT04600336|583862006|FG002|Crossover Treatment|Withdrawal by Subject|2|||
161674650|NCT04600336|583862007|FG003|Crossover Treatment|Withdrawal by Subject|1|||
161674651|NCT04600336|583862004|FG000|Crossover Treatment|Adverse Event|0|||
161674652|NCT04600336|583862005|FG001|Crossover Treatment|Adverse Event|0|||
161674653|NCT04600336|583862006|FG002|Crossover Treatment|Adverse Event|1|||
161674654|NCT04600336|583862007|FG003|Crossover Treatment|Adverse Event|1|||
161674655|NCT03672461|583862008|FG000|Overall Study|COVID Related|4|||
161674656|NCT03672461|583862009|FG001|Overall Study|COVID Related|2|||
161674657|NCT03672461|583862008|FG000|Overall Study|Adverse Event|2|||
161674658|NCT03672461|583862009|FG001|Overall Study|Adverse Event|0|||
161925831|NCT00866320|584774641|FG000|Overall Study|Death|2|||
161925832|NCT06038643|584774643|FG000|Overall Study|Withdrawal by Subject|9|||
161674659|NCT03672461|583862008|FG000|Overall Study|Serious Adverse Event|0|||
161674660|NCT03672461|583862009|FG001|Overall Study|Serious Adverse Event|1|||
161674661|NCT03672461|583862008|FG000|Overall Study|Too Busy|3|||
161674662|NCT03672461|583862009|FG001|Overall Study|Too Busy|1|||
161674663|NCT03672461|583862008|FG000|Overall Study|Lost to Follow-up|1|||
161674664|NCT03672461|583862009|FG001|Overall Study|Lost to Follow-up|2|||
161674665|NCT03672461|583862008|FG000|Overall Study|Family|2|||
161674666|NCT03672461|583862009|FG001|Overall Study|Family|2|||
161674667|NCT03672461|583862008|FG000|Overall Study|No remote technology access|0|||
161674668|NCT03672461|583862009|FG001|Overall Study|No remote technology access|1|||
161674669|NCT03672461|583862008|FG000|Overall Study|Withdrawal by Subject|1|||
161674670|NCT03672461|583862009|FG001|Overall Study|Withdrawal by Subject|0|||
161674671|NCT03672461|583862008|FG000|Overall Study|Cannot tolerate intervention|1|||
161674672|NCT03672461|583862009|FG001|Overall Study|Cannot tolerate intervention|0|||
161674673|NCT03672461|583862008|FG000|Overall Study|Incomplete outcome data|6|||
161674674|NCT03672461|583862009|FG001|Overall Study|Incomplete outcome data|1|||
161674675|NCT00977574|583862010|FG000|Overall Study|Never Treated|4|||
161674676|NCT00977574|583862011|FG001|Overall Study|Never Treated|2|||
161674677|NCT00977574|583862012|FG002|Overall Study|Never Treated|4|||
161674678|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Administrative problems|1|||
161674679|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Administrative problems|1|||
161674680|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
161674681|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
161674682|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
161674683|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
161674684|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Adverse Event|5|||
161674685|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Adverse Event|15|||
161674686|NCT00332839|583862944|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
161674687|NCT00332839|583862945|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
161674688|NCT00332839|583862944|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
161674689|NCT00332839|583862945|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
161674690|NCT00332839|583862944|FG000|Follow-up (Months 12 - 60)|Death|1|||
161674691|NCT00332839|583862945|FG001|Follow-up (Months 12 - 60)|Death|1|||
161586760|NCT00632749|583536275|FG009|Overall Study|Refuse to continue medication|1|||
161586761|NCT00632749|583536276|FG010|Overall Study|Refuse to continue medication|0|||
161586762|NCT00632749|583536277|FG011|Overall Study|Refuse to continue medication|0|||
161586763|NCT00632749|583536278|FG012|Overall Study|Refuse to continue medication|0|||
161586764|NCT00632749|583536279|FG013|Overall Study|Refuse to continue medication|0|||
161586765|NCT00632749|583536266|FG000|Overall Study|Reason other than those specified above|0|||
161586766|NCT00632749|583536267|FG001|Overall Study|Reason other than those specified above|2|||
161586767|NCT00632749|583536268|FG002|Overall Study|Reason other than those specified above|0|||
161586768|NCT00632749|583536269|FG003|Overall Study|Reason other than those specified above|0|||
161674692|NCT01399190|583862946|FG000|Overall Study|Not Eligible for Final Analysis|5|||
161674693|NCT01399190|583862946|FG000|Overall Study|Adverse Event|8|||
161674694|NCT01399190|583862946|FG000|Overall Study|Participant's Request|5|||
161674695|NCT01399190|583862946|FG000|Overall Study|Physician Decision|2|||
161674696|NCT01187550|583862948|FG000|Overall Study|Protocol Violation|3|||
161674697|NCT01187550|583862949|FG001|Overall Study|Protocol Violation|1|||
161674698|NCT01187550|583862948|FG000|Overall Study|Other|3|||
161674699|NCT01187550|583862949|FG001|Overall Study|Other|0|||
161674700|NCT01187550|583862948|FG000|Overall Study|Randomized but not treated|8|||
161674701|NCT01187550|583862949|FG001|Overall Study|Randomized but not treated|0|||
161925833|NCT06038643|584774644|FG001|Overall Study|Withdrawal by Subject|4|||
161925834|NCT06038643|584774643|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
161925835|NCT06038643|584774644|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
161674702|NCT00129623|583862950|FG000|Overall Study|Adverse Event|3|||
161674703|NCT00129623|583862951|FG001|Overall Study|Adverse Event|7|||
161674704|NCT00129623|583862950|FG000|Overall Study|Refused Treatment|5|||
161674705|NCT00129623|583862951|FG001|Overall Study|Refused Treatment|3|||
161674706|NCT00129623|583862950|FG000|Overall Study|Failure to Return|1|||
161674707|NCT00129623|583862951|FG001|Overall Study|Failure to Return|1|||
161674708|NCT00129623|583862950|FG000|Overall Study|Relocated job out of state|1|||
161674709|NCT00129623|583862951|FG001|Overall Study|Relocated job out of state|0|||
161674710|NCT00129623|583862950|FG000|Overall Study|Uncertainty to return|0|||
161674711|NCT00129623|583862951|FG001|Overall Study|Uncertainty to return|1|||
161674712|NCT00596934|583862954|FG000|Overall Study|Protocol Violation|1|||
161508010|NCT01393405|583253862|FG001|Maintenance Period Week|Lack of Efficacy|22|||
161508011|NCT01393405|583253863|FG002|Maintenance Period Week|Lack of Efficacy|22|||
161508012|NCT01393405|583253861|FG000|Maintenance Period Week|Adverse Event|0|||
161508013|NCT01393405|583253862|FG001|Maintenance Period Week|Adverse Event|5|||
161508014|NCT01393405|583253863|FG002|Maintenance Period Week|Adverse Event|2|||
161508015|NCT01393405|583253861|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
161508016|NCT01393405|583253862|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
161508017|NCT01393405|583253863|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
161508018|NCT01393405|583253861|FG000|Maintenance Period Week|Lost to Follow-up|0|||
161508019|NCT01393405|583253862|FG001|Maintenance Period Week|Lost to Follow-up|1|||
161508020|NCT01393405|583253863|FG002|Maintenance Period Week|Lost to Follow-up|0|||
161508021|NCT01434290|583253864|FG000|Overall Study|Protocol Violation|6|||
161508022|NCT01434290|583253865|FG001|Overall Study|Protocol Violation|3|||
161508023|NCT01434290|583253864|FG000|Overall Study|No protocol treatment|2|||
161508024|NCT01434290|583253865|FG001|Overall Study|No protocol treatment|4|||
161508025|NCT02281552|583253866|FG000|Overall Study|Medication error|1|||
161508026|NCT02281552|583253867|FG001|Overall Study|Medication error|0|||
161508027|NCT02281552|583253866|FG000|Overall Study|Insufficient clinical response|0|||
161508028|NCT02281552|583253867|FG001|Overall Study|Insufficient clinical response|1|||
161508029|NCT02281552|583253866|FG000|Overall Study|Adverse Event|3|||
161508030|NCT02281552|583253867|FG001|Overall Study|Adverse Event|9|||
161508031|NCT01224639|583253868|FG000|Overall Study|Withdrawal by Subject|0|||
161508032|NCT01224639|583253869|FG001|Overall Study|Withdrawal by Subject|0|||
161508033|NCT01224639|583253870|FG002|Overall Study|Withdrawal by Subject|0|||
161508034|NCT01224639|583253871|FG003|Overall Study|Withdrawal by Subject|0|||
161508035|NCT01224639|583253872|FG004|Overall Study|Withdrawal by Subject|2|||
161508036|NCT01224639|583253873|FG005|Overall Study|Withdrawal by Subject|0|||
161508037|NCT01224639|583253874|FG006|Overall Study|Withdrawal by Subject|1|||
161508038|NCT01224639|583253875|FG007|Overall Study|Withdrawal by Subject|1|||
161674713|NCT00596934|583862954|FG000|Overall Study|Withdrawal by Subject|1|||
161674714|NCT02315898|583862955|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
161674715|NCT02315898|583862956|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
161674716|NCT02315898|583862957|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
161674717|NCT02315898|583862958|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
161674718|NCT02445755|583862959|FG000|Overall Study|Withdrawal by Subject|2|||
161674719|NCT02445755|583862959|FG000|Overall Study|Protocol Violation|6|||
161674720|NCT02445755|583862959|FG000|Overall Study|Screen Failure|5|||
161674721|NCT03239483|583862960|FG000|Overall Study|Lost to Follow-up|1|||
161674722|NCT03239483|583862961|FG001|Overall Study|Lost to Follow-up|0|||
161674723|NCT03239483|583862960|FG000|Overall Study|Withdrawal by Subject|1|||
161674724|NCT03239483|583862961|FG001|Overall Study|Withdrawal by Subject|0|||
161674725|NCT03678103|583862971|FG000|Overall Study|Withdrawn prior to completion|4|||
161674726|NCT01296035|583862973|FG000|Overall Study|Withdrawal by Subject|1|||
161674727|NCT01674712|583862976|FG000|Overall Study|Adverse Event|5|||
161674728|NCT01674712|583862977|FG001|Overall Study|Adverse Event|6|||
161674729|NCT01674712|583862978|FG002|Overall Study|Adverse Event|3|||
161674730|NCT01674712|583862979|FG003|Overall Study|Adverse Event|4|||
161674731|NCT01674712|583862980|FG004|Overall Study|Adverse Event|6|||
161508039|NCT01224639|583253868|FG000|Overall Study|Adverse Event|0|||
161508040|NCT01224639|583253869|FG001|Overall Study|Adverse Event|0|||
161508041|NCT01224639|583253870|FG002|Overall Study|Adverse Event|0|||
161674732|NCT01674712|583862976|FG000|Overall Study|Lost to Follow-up|1|||
161674733|NCT01674712|583862977|FG001|Overall Study|Lost to Follow-up|0|||
161674734|NCT01674712|583862978|FG002|Overall Study|Lost to Follow-up|0|||
161674735|NCT01674712|583862979|FG003|Overall Study|Lost to Follow-up|0|||
161508042|NCT01224639|583253871|FG003|Overall Study|Adverse Event|0|||
161508043|NCT01224639|583253872|FG004|Overall Study|Adverse Event|0|||
161508044|NCT01224639|583253873|FG005|Overall Study|Adverse Event|0|||
161508045|NCT01224639|583253874|FG006|Overall Study|Adverse Event|0|||
161674736|NCT01674712|583862980|FG004|Overall Study|Lost to Follow-up|0|||
161674737|NCT01674712|583862976|FG000|Overall Study|Protocol Violation|2|||
161674738|NCT01674712|583862977|FG001|Overall Study|Protocol Violation|0|||
161508046|NCT01224639|583253875|FG007|Overall Study|Adverse Event|1|||
161508047|NCT04656132|583253876|FG000|Overall Study|Lost to Follow-up|4|||
161508048|NCT04656132|583253876|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
161508049|NCT04365699|583253877|FG000|Overall Study|Death|2|||
161508050|NCT04365699|583253878|FG001|Overall Study|Death|5|||
161508051|NCT04365699|583253879|FG002|Overall Study|Death|15|||
161508052|NCT00834912|583253881|FG000|Treatment Period 1|Adverse Event|0|||
161508053|NCT00834912|583253882|FG001|Treatment Period 1|Adverse Event|1|||
161508054|NCT00834912|583253883|FG002|Treatment Period 1|Adverse Event|0|||
161508055|NCT00834912|583253884|FG003|Treatment Period 1|Adverse Event|1|||
161508056|NCT00834912|583253885|FG004|Treatment Period 1|Adverse Event|0|||
161508057|NCT00834912|583253886|FG005|Treatment Period 1|Adverse Event|0|||
161508058|NCT00834912|583253881|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161508059|NCT00834912|583253882|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161508060|NCT00834912|583253883|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161508061|NCT00834912|583253884|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161508062|NCT00834912|583253885|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161508063|NCT00834912|583253886|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161508064|NCT01012817|583255207|FG000|Overall Study|Withdrawal by Subject|0|||
161508065|NCT01012817|583255208|FG001|Overall Study|Withdrawal by Subject|0|||
161508066|NCT01012817|583255209|FG002|Overall Study|Withdrawal by Subject|0|||
161508067|NCT01012817|583255210|FG003|Overall Study|Withdrawal by Subject|1|||
161508068|NCT01012817|583255211|FG004|Overall Study|Withdrawal by Subject|0|||
161508069|NCT01012817|583255212|FG005|Overall Study|Withdrawal by Subject|0|||
161508070|NCT01012817|583255213|FG006|Overall Study|Withdrawal by Subject|0|||
161508071|NCT01012817|583255214|FG007|Overall Study|Withdrawal by Subject|1|||
161508072|NCT01012817|583255215|FG008|Overall Study|Withdrawal by Subject|0|||
161508073|NCT01012817|583255216|FG009|Overall Study|Withdrawal by Subject|0|||
161508074|NCT01012817|583255217|FG010|Overall Study|Withdrawal by Subject|1|||
161508075|NCT01012817|583255218|FG011|Overall Study|Withdrawal by Subject|1|||
161508076|NCT01012817|583255219|FG012|Overall Study|Withdrawal by Subject|0|||
161508077|NCT01012817|583255220|FG013|Overall Study|Withdrawal by Subject|1|||
161508078|NCT01012817|583255207|FG000|Overall Study|Adverse Event|0|||
161508079|NCT01012817|583255208|FG001|Overall Study|Adverse Event|0|||
161508080|NCT01012817|583255209|FG002|Overall Study|Adverse Event|0|||
161508081|NCT01012817|583255210|FG003|Overall Study|Adverse Event|0|||
161508082|NCT01012817|583255211|FG004|Overall Study|Adverse Event|0|||
161508083|NCT01012817|583255212|FG005|Overall Study|Adverse Event|1|||
161586769|NCT00632749|583536270|FG004|Overall Study|Reason other than those specified above|1|||
161586770|NCT00632749|583536271|FG005|Overall Study|Reason other than those specified above|0|||
161586771|NCT00632749|583536272|FG006|Overall Study|Reason other than those specified above|1|||
161586772|NCT00632749|583536273|FG007|Overall Study|Reason other than those specified above|0|||
161586773|NCT00632749|583536274|FG008|Overall Study|Reason other than those specified above|0|||
161586774|NCT00632749|583536275|FG009|Overall Study|Reason other than those specified above|0|||
161586775|NCT00632749|583536276|FG010|Overall Study|Reason other than those specified above|2|||
161586776|NCT00632749|583536277|FG011|Overall Study|Reason other than those specified above|1|||
161586777|NCT00632749|583536278|FG012|Overall Study|Reason other than those specified above|0|||
161586778|NCT00632749|583536279|FG013|Overall Study|Reason other than those specified above|2|||
161586779|NCT00611559|583536280|FG000|Overall Study|Lost to Follow-up|0|||
161586780|NCT00611559|583536281|FG001|Overall Study|Lost to Follow-up|1|||
161586781|NCT00611559|583536282|FG002|Overall Study|Lost to Follow-up|0|||
161586782|NCT00611559|583536280|FG000|Overall Study|Protocol Violation|1|||
161586783|NCT00611559|583536281|FG001|Overall Study|Protocol Violation|0|||
161586784|NCT00611559|583536282|FG002|Overall Study|Protocol Violation|1|||
161586785|NCT00879333|583536283|FG000|Overall Study|Adverse Event|94|||
161586786|NCT00879333|583536284|FG001|Overall Study|Adverse Event|34|||
161586787|NCT00879333|583536283|FG000|Overall Study|Abnormal Laboratory Value|1|||
161586788|NCT00879333|583536284|FG001|Overall Study|Abnormal Laboratory Value|0|||
161586789|NCT00879333|583536283|FG000|Overall Study|Withdrawal by Subject|20|||
161586790|NCT00879333|583536284|FG001|Overall Study|Withdrawal by Subject|7|||
161586791|NCT00879333|583536283|FG000|Overall Study|Lost to Follow-up|2|||
161586792|NCT00879333|583536284|FG001|Overall Study|Lost to Follow-up|1|||
161586793|NCT00879333|583536283|FG000|Overall Study|Administrative Problems|2|||
161586794|NCT00879333|583536284|FG001|Overall Study|Administrative Problems|0|||
161586795|NCT00879333|583536283|FG000|Overall Study|Death|16|||
161508084|NCT01012817|583255213|FG006|Overall Study|Adverse Event|0|||
161508085|NCT01012817|583255214|FG007|Overall Study|Adverse Event|0|||
161586796|NCT00879333|583536284|FG001|Overall Study|Death|5|||
161586797|NCT00879333|583536283|FG000|Overall Study|Disease Progression|292|||
161586798|NCT00879333|583536284|FG001|Overall Study|Disease Progression|169|||
161508086|NCT01012817|583255215|FG008|Overall Study|Adverse Event|0|||
161508087|NCT01012817|583255216|FG009|Overall Study|Adverse Event|0|||
161508088|NCT01012817|583255217|FG010|Overall Study|Adverse Event|1|||
161508089|NCT01012817|583255218|FG011|Overall Study|Adverse Event|0|||
161508090|NCT01012817|583255219|FG012|Overall Study|Adverse Event|0|||
161508091|NCT01012817|583255220|FG013|Overall Study|Adverse Event|1|||
161508092|NCT00634647|583255221|FG000|Overall Study|death on study|3|||
161820263|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
161820264|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161820265|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
161820266|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
161820267|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161820268|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161820269|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
161820270|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
161820271|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
161820272|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
161820273|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
161820274|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
161820275|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
161820276|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161820277|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
161820278|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
161820279|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161820280|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161820281|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Death|0|||
161820282|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Death|0|||
161820283|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Death|0|||
161820284|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Death|0|||
161820285|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Death|1|||
161508093|NCT00634647|583255221|FG000|Overall Study|refused further treatment|3|||
161508094|NCT00634647|583255221|FG000|Overall Study|declined to participate before treatment|1|||
161508095|NCT00293384|583255222|FG000|Overall Study|Non-compliance|2|||
161508096|NCT00293384|583255222|FG000|Overall Study|Missed dosage/study drug|1|||
161508097|NCT00293384|583255222|FG000|Overall Study|Ineligible|2|||
161508098|NCT05723770|583255223|FG000|Overall Study|Lost to Follow-up|4|||
161508099|NCT05723770|583255223|FG000|Overall Study|Withdrawal by Subject|2|||
161508100|NCT01359592|583255224|FG000|Initial Registration|Adverse Event|1|||
161508101|NCT01359592|583255225|FG001|Initial Registration|Adverse Event|0|||
161508102|NCT01359592|583255226|FG002|Initial Registration|Adverse Event|0|||
161508103|NCT01359592|583255227|FG003|Initial Registration|Adverse Event|0|||
161508104|NCT01359592|583255224|FG000|Initial Registration|Death|1|||
161508105|NCT01359592|583255225|FG001|Initial Registration|Death|0|||
161508106|NCT01359592|583255226|FG002|Initial Registration|Death|0|||
161508107|NCT01359592|583255227|FG003|Initial Registration|Death|0|||
161508108|NCT01359592|583255224|FG000|Initial Registration|Other reason not protocol specified|1|||
161508109|NCT01359592|583255225|FG001|Initial Registration|Other reason not protocol specified|0|||
161508110|NCT01359592|583255226|FG002|Initial Registration|Other reason not protocol specified|0|||
161508111|NCT01359592|583255227|FG003|Initial Registration|Other reason not protocol specified|0|||
161508112|NCT01359592|583255224|FG000|Initial Registration|Ineligible|26|||
161508113|NCT01359592|583255225|FG001|Initial Registration|Ineligible|0|||
161508114|NCT01359592|583255226|FG002|Initial Registration|Ineligible|0|||
161508115|NCT01359592|583255227|FG003|Initial Registration|Ineligible|0|||
161508116|NCT01359592|583255224|FG000|PET-Directed Therapy|Adverse Event|0|||
161508117|NCT01359592|583255225|FG001|PET-Directed Therapy|Adverse Event|0|||
161508118|NCT01359592|583255226|FG002|PET-Directed Therapy|Adverse Event|1|||
161508119|NCT01359592|583255227|FG003|PET-Directed Therapy|Adverse Event|0|||
161508120|NCT01359592|583255224|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
161508121|NCT01359592|583255225|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
161508122|NCT01359592|583255226|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
161508123|NCT01359592|583255227|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
161508124|NCT01359592|583255224|FG000|PET-Directed Therapy|Ineligible|0|||
161508125|NCT01359592|583255225|FG001|PET-Directed Therapy|Ineligible|0|||
161508126|NCT01359592|583255226|FG002|PET-Directed Therapy|Ineligible|24|||
161508127|NCT01359592|583255227|FG003|PET-Directed Therapy|Ineligible|0|||
161508128|NCT00326612|583255230|FG000|Overall Study|They did not have a seizure requiring tx|129|||
161508129|NCT00326612|583255231|FG001|Overall Study|They did not have a seizure requiring tx|137|||
161820286|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Death|4|||
161820287|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820288|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820289|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820290|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820291|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
161508130|NCT00419562|583255232|FG000|Overall Study|Lost to Follow-up|12|||
161508131|NCT00419562|583255233|FG001|Overall Study|Lost to Follow-up|13|||
161508132|NCT00419562|583255232|FG000|Overall Study|Withdrawal by Subject|20|||
161508133|NCT00419562|583255233|FG001|Overall Study|Withdrawal by Subject|18|||
161586799|NCT00879333|583536283|FG000|Overall Study|Protocol Violation|1|||
161586800|NCT00879333|583536284|FG001|Overall Study|Protocol Violation|1|||
161586801|NCT04999592|583536285|FG000|Overall Study|Withdrawal by Subject|1|||
161586802|NCT04999592|583536286|FG001|Overall Study|Withdrawal by Subject|0|||
161586803|NCT02910713|583536287|FG000|Overall Study|Protocol Violation|2|||
161586804|NCT02910713|583536287|FG000|Overall Study|Subject Choice|4|||
161586805|NCT02910713|583536287|FG000|Overall Study|Received One Application|10|||
161586806|NCT02910713|583536287|FG000|Overall Study|Received Neither Application|18|||
161586807|NCT02910713|583536287|FG000|Overall Study|Enrollment cap|7|||
161586808|NCT02910713|583536287|FG000|Overall Study|Investigator Discretion|1|||
161586809|NCT04442126|583536296|FG000|Overall Study|Withdrawal by Subject|0|||
161586810|NCT04442126|583536297|FG001|Overall Study|Withdrawal by Subject|0|||
161586811|NCT04442126|583536298|FG002|Overall Study|Withdrawal by Subject|0|||
161586812|NCT04442126|583536299|FG003|Overall Study|Withdrawal by Subject|2|||
161586813|NCT04442126|583536300|FG004|Overall Study|Withdrawal by Subject|1|||
161586814|NCT04442126|583536301|FG005|Overall Study|Withdrawal by Subject|0|||
161586815|NCT04442126|583536302|FG006|Overall Study|Withdrawal by Subject|1|||
161586816|NCT04442126|583536303|FG007|Overall Study|Withdrawal by Subject|1|||
161586817|NCT04442126|583536304|FG008|Overall Study|Withdrawal by Subject|3|||
161586818|NCT04442126|583536296|FG000|Overall Study|Death|1|||
161586819|NCT04442126|583536297|FG001|Overall Study|Death|0|||
161586820|NCT04442126|583536298|FG002|Overall Study|Death|0|||
161586821|NCT04442126|583536299|FG003|Overall Study|Death|1|||
161586822|NCT04442126|583536300|FG004|Overall Study|Death|2|||
161586823|NCT04442126|583536301|FG005|Overall Study|Death|2|||
161586824|NCT04442126|583536302|FG006|Overall Study|Death|4|||
161586825|NCT04442126|583536303|FG007|Overall Study|Death|1|||
161586826|NCT04442126|583536304|FG008|Overall Study|Death|5|||
161586827|NCT04442126|583536296|FG000|Overall Study|Study Terminated by Sponsor|0|||
161586828|NCT04442126|583536297|FG001|Overall Study|Study Terminated by Sponsor|0|||
161586829|NCT04442126|583536298|FG002|Overall Study|Study Terminated by Sponsor|0|||
161586830|NCT04442126|583536299|FG003|Overall Study|Study Terminated by Sponsor|0|||
161586831|NCT04442126|583536300|FG004|Overall Study|Study Terminated by Sponsor|0|||
161586832|NCT04442126|583536301|FG005|Overall Study|Study Terminated by Sponsor|1|||
161586833|NCT04442126|583536302|FG006|Overall Study|Study Terminated by Sponsor|4|||
161586834|NCT04442126|583536303|FG007|Overall Study|Study Terminated by Sponsor|2|||
161586835|NCT04442126|583536304|FG008|Overall Study|Study Terminated by Sponsor|10|||
161586836|NCT04442126|583536296|FG000|Overall Study|Lost to Follow-up|0|||
161586837|NCT04442126|583536297|FG001|Overall Study|Lost to Follow-up|0|||
161586838|NCT04442126|583536298|FG002|Overall Study|Lost to Follow-up|0|||
161586839|NCT04442126|583536299|FG003|Overall Study|Lost to Follow-up|0|||
161586840|NCT04442126|583536300|FG004|Overall Study|Lost to Follow-up|0|||
161586841|NCT04442126|583536301|FG005|Overall Study|Lost to Follow-up|0|||
161586842|NCT04442126|583536302|FG006|Overall Study|Lost to Follow-up|0|||
161586843|NCT04442126|583536303|FG007|Overall Study|Lost to Follow-up|1|||
161586844|NCT04442126|583536304|FG008|Overall Study|Lost to Follow-up|2|||
161586845|NCT04442126|583536296|FG000|Overall Study|Progressive Disease|0|||
161586846|NCT04442126|583536297|FG001|Overall Study|Progressive Disease|1|||
161586847|NCT04442126|583536298|FG002|Overall Study|Progressive Disease|3|||
161586848|NCT04442126|583536299|FG003|Overall Study|Progressive Disease|0|||
161586849|NCT04442126|583536300|FG004|Overall Study|Progressive Disease|3|||
161586850|NCT04442126|583536301|FG005|Overall Study|Progressive Disease|0|||
161586851|NCT04442126|583536302|FG006|Overall Study|Progressive Disease|0|||
161586852|NCT04442126|583536303|FG007|Overall Study|Progressive Disease|0|||
161586853|NCT04442126|583536304|FG008|Overall Study|Progressive Disease|0|||
161586854|NCT04442126|583536296|FG000|Overall Study|Other|0|||
161586855|NCT04442126|583536297|FG001|Overall Study|Other|0|||
161586856|NCT04442126|583536298|FG002|Overall Study|Other|0|||
161586857|NCT04442126|583536299|FG003|Overall Study|Other|0|||
161586858|NCT04442126|583536300|FG004|Overall Study|Other|0|||
161586859|NCT04442126|583536301|FG005|Overall Study|Other|0|||
161586860|NCT04442126|583536302|FG006|Overall Study|Other|0|||
161586861|NCT04442126|583536303|FG007|Overall Study|Other|0|||
161586862|NCT04442126|583536304|FG008|Overall Study|Other|1|||
161586863|NCT04623775|583536305|FG000|Randomization|No Longer Meets Study Criteria|2|||
161586864|NCT04623775|583536306|FG001|Randomization|No Longer Meets Study Criteria|1|||
161586865|NCT04623775|583536307|FG002|Randomization|No Longer Meets Study Criteria|0|||
161586866|NCT04623775|583536308|FG003|Randomization|No Longer Meets Study Criteria|0|||
161586867|NCT04623775|583536305|FG000|Randomization|Withdrew Consent|0|||
161586868|NCT04623775|583536306|FG001|Randomization|Withdrew Consent|0|||
161586869|NCT04623775|583536307|FG002|Randomization|Withdrew Consent|0|||
161586870|NCT04623775|583536308|FG003|Randomization|Withdrew Consent|1|||
161586871|NCT04623775|583536305|FG000|Randomization|Other Reasons|0|||
161586872|NCT04623775|583536306|FG001|Randomization|Other Reasons|0|||
161586873|NCT04623775|583536307|FG002|Randomization|Other Reasons|0|||
161586874|NCT04623775|583536308|FG003|Randomization|Other Reasons|1|||
161586875|NCT04623775|583536305|FG000|Treatment Period|participant withdrew consent|4|||
161586876|NCT04623775|583536306|FG001|Treatment Period|participant withdrew consent|0|||
161586877|NCT04623775|583536307|FG002|Treatment Period|participant withdrew consent|1|||
161674739|NCT01674712|583862978|FG002|Overall Study|Protocol Violation|0|||
161925836|NCT03573882|584774645|FG000|Overall Study|Study Terminated by Sponsor|22|||
161925837|NCT03573882|584774646|FG001|Overall Study|Study Terminated by Sponsor|17|||
161925838|NCT03573882|584774647|FG002|Overall Study|Study Terminated by Sponsor|18|||
161508134|NCT00419562|583255232|FG000|Overall Study|Participant Institutionalized|1|||
161508135|NCT00419562|583255233|FG001|Overall Study|Participant Institutionalized|0|||
161508136|NCT02365636|583255234|FG000|Overall Study|Adverse Event|3|||
161508137|NCT02365636|583255235|FG001|Overall Study|Adverse Event|3|||
161508138|NCT02365636|583255236|FG002|Overall Study|Adverse Event|2|||
161508139|NCT02365636|583255234|FG000|Overall Study|Protocol Violation|1|||
161508140|NCT02365636|583255235|FG001|Overall Study|Protocol Violation|4|||
161508141|NCT02365636|583255236|FG002|Overall Study|Protocol Violation|0|||
161508142|NCT02365636|583255234|FG000|Overall Study|Lost to Follow-up|0|||
161508143|NCT02365636|583255235|FG001|Overall Study|Lost to Follow-up|0|||
161508144|NCT02365636|583255236|FG002|Overall Study|Lost to Follow-up|1|||
161508145|NCT02365636|583255234|FG000|Overall Study|Other|2|||
161508146|NCT02365636|583255235|FG001|Overall Study|Other|0|||
161508147|NCT02365636|583255236|FG002|Overall Study|Other|0|||
161508148|NCT00355238|583255237|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161508149|NCT00355238|583255238|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161508150|NCT00355238|583255239|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161508151|NCT00355238|583255240|FG003|Overall Study|Adverse event unrelated to study drug|1|||
161508152|NCT00355238|583255237|FG000|Overall Study|Death|1|||
161508153|NCT00355238|583255238|FG001|Overall Study|Death|0|||
161508154|NCT00355238|583255239|FG002|Overall Study|Death|0|||
161508155|NCT00355238|583255240|FG003|Overall Study|Death|0|||
161508156|NCT00355238|583255237|FG000|Overall Study|Disease progression|37|||
161508157|NCT00355238|583255238|FG001|Overall Study|Disease progression|36|||
161508158|NCT00355238|583255239|FG002|Overall Study|Disease progression|16|||
161508159|NCT00355238|583255240|FG003|Overall Study|Disease progression|11|||
161508160|NCT00355238|583255237|FG000|Overall Study|Study drug toxicity|11|||
161508161|NCT00355238|583255238|FG001|Overall Study|Study drug toxicity|7|||
161508162|NCT00355238|583255239|FG002|Overall Study|Study drug toxicity|5|||
161925839|NCT03573882|584774645|FG000|Overall Study|Withdrawal by Subject|6|||
161925840|NCT03573882|584774646|FG001|Overall Study|Withdrawal by Subject|11|||
161925841|NCT03573882|584774647|FG002|Overall Study|Withdrawal by Subject|7|||
161925842|NCT03573882|584774645|FG000|Overall Study|Adverse Event|7|||
161925843|NCT03573882|584774646|FG001|Overall Study|Adverse Event|5|||
161925844|NCT03573882|584774647|FG002|Overall Study|Adverse Event|6|||
161925845|NCT03573882|584774645|FG000|Overall Study|Lost to Follow-up|2|||
161925846|NCT03573882|584774646|FG001|Overall Study|Lost to Follow-up|5|||
161925847|NCT03573882|584774647|FG002|Overall Study|Lost to Follow-up|3|||
161925848|NCT03573882|584774645|FG000|Overall Study|Physician Decision|4|||
161925849|NCT03573882|584774646|FG001|Overall Study|Physician Decision|3|||
161925850|NCT03573882|584774647|FG002|Overall Study|Physician Decision|2|||
161925851|NCT03573882|584774645|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
161925852|NCT03573882|584774646|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
161925853|NCT03573882|584774647|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
161925854|NCT03573882|584774645|FG000|Overall Study|Pregnancy|1|||
161925855|NCT03573882|584774646|FG001|Overall Study|Pregnancy|2|||
161925856|NCT03573882|584774647|FG002|Overall Study|Pregnancy|0|||
161925857|NCT03573882|584774645|FG000|Overall Study|Other|4|||
161925858|NCT03573882|584774646|FG001|Overall Study|Other|2|||
161925859|NCT03573882|584774647|FG002|Overall Study|Other|2|||
161925860|NCT02691572|584774648|FG000|Overall Study|Withdrawal by Subject|1|||
161925861|NCT02691572|584774649|FG001|Overall Study|Withdrawal by Subject|0|||
161925862|NCT02691572|584774648|FG000|Overall Study|Protocol Violation|0|||
161925863|NCT02691572|584774649|FG001|Overall Study|Protocol Violation|1|||
161925864|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
161925865|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
161925866|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Death|28|||
161508163|NCT00355238|583255240|FG003|Overall Study|Study drug toxicity|2|||
161586878|NCT04623775|583536308|FG003|Treatment Period|participant withdrew consent|2|||
161586879|NCT04623775|583536305|FG000|Treatment Period|Death|3|||
161586880|NCT04623775|583536306|FG001|Treatment Period|Death|1|||
161586881|NCT04623775|583536307|FG002|Treatment Period|Death|4|||
161586882|NCT04623775|583536308|FG003|Treatment Period|Death|2|||
161508164|NCT00355238|583255237|FG000|Overall Study|Participant withdrew consent|3|||
161508165|NCT00355238|583255238|FG001|Overall Study|Participant withdrew consent|1|||
161508166|NCT00355238|583255239|FG002|Overall Study|Participant withdrew consent|0|||
161508167|NCT00355238|583255240|FG003|Overall Study|Participant withdrew consent|0|||
161586883|NCT04623775|583536305|FG000|Treatment Period|Lost to Follow-up|0|||
161586884|NCT04623775|583536306|FG001|Treatment Period|Lost to Follow-up|2|||
161586885|NCT04623775|583536307|FG002|Treatment Period|Lost to Follow-up|0|||
161586886|NCT04623775|583536308|FG003|Treatment Period|Lost to Follow-up|0|||
161586887|NCT04623775|583536305|FG000|Treatment Period|poor/non compliance|0|||
161586888|NCT04623775|583536306|FG001|Treatment Period|poor/non compliance|0|||
161586889|NCT04623775|583536307|FG002|Treatment Period|poor/non compliance|1|||
161586890|NCT04623775|583536308|FG003|Treatment Period|poor/non compliance|0|||
161925867|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Death|29|||
161925868|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
161925869|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
161925870|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Other|30|||
161508168|NCT00355238|583255237|FG000|Overall Study|Participant request to discontinue study treatment|1|||
161508169|NCT00355238|583255238|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161508170|NCT00355238|583255239|FG002|Overall Study|Participant request to discontinue study treatment|1|||
161508171|NCT00355238|583255240|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161508172|NCT01454934|583255241|FG000|Overall Study|Clinical progression|28|||
161508173|NCT01454934|583255242|FG001|Overall Study|Clinical progression|25|||
161508174|NCT01454934|583255241|FG000|Overall Study|Other|6|||
161508175|NCT01454934|583255242|FG001|Overall Study|Other|17|||
161508176|NCT01454934|583255241|FG000|Overall Study|Adverse Event|28|||
161508177|NCT01454934|583255242|FG001|Overall Study|Adverse Event|24|||
161508178|NCT01454934|583255241|FG000|Overall Study|Withdrawn consent|2|||
161508179|NCT01454934|583255242|FG001|Overall Study|Withdrawn consent|5|||
161508180|NCT01454934|583255241|FG000|Overall Study|Withdrawal by Subject|11|||
161508181|NCT01454934|583255242|FG001|Overall Study|Withdrawal by Subject|15|||
161508182|NCT01454934|583255241|FG000|Overall Study|Disease progression|194|||
161508183|NCT01454934|583255242|FG001|Overall Study|Disease progression|181|||
161508184|NCT01454934|583255241|FG000|Overall Study|Lost to Follow-up|0|||
161508185|NCT01454934|583255242|FG001|Overall Study|Lost to Follow-up|1|||
161508186|NCT01454934|583255241|FG000|Overall Study|Not treated|1|||
161508187|NCT01454934|583255242|FG001|Overall Study|Not treated|2|||
161508188|NCT00480636|583255243|FG000|Overall Study|Death|12|||
161508189|NCT00480636|583255243|FG000|Overall Study|Lost to Follow-up|4|||
161508190|NCT00480636|583255243|FG000|Overall Study|Other|2|||
161508191|NCT00480636|583255243|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
161508192|NCT03912233|583255244|FG000|Overall Study|Adverse Event|1|||
161508193|NCT03912233|583255245|FG001|Overall Study|Adverse Event|0|||
161508194|NCT03912233|583255246|FG002|Overall Study|Adverse Event|0|||
161508195|NCT03912233|583255247|FG003|Overall Study|Adverse Event|0|||
161508196|NCT03912233|583255248|FG004|Overall Study|Adverse Event|0|||
161508197|NCT03912233|583255249|FG005|Overall Study|Adverse Event|0|||
161508198|NCT03912233|583255244|FG000|Overall Study|Physician Decision|1|||
161508199|NCT03912233|583255245|FG001|Overall Study|Physician Decision|0|||
161508200|NCT03912233|583255246|FG002|Overall Study|Physician Decision|0|||
161508201|NCT03912233|583255247|FG003|Overall Study|Physician Decision|0|||
161508202|NCT03912233|583255248|FG004|Overall Study|Physician Decision|0|||
161508203|NCT03912233|583255249|FG005|Overall Study|Physician Decision|0|||
161508204|NCT03912233|583255244|FG000|Overall Study|Other|0|||
161674740|NCT01674712|583862979|FG003|Overall Study|Protocol Violation|0|||
161674741|NCT01674712|583862980|FG004|Overall Study|Protocol Violation|0|||
161674742|NCT01674712|583862976|FG000|Overall Study|Withdrawal by Subject|2|||
161674743|NCT01674712|583862977|FG001|Overall Study|Withdrawal by Subject|2|||
161674744|NCT01674712|583862978|FG002|Overall Study|Withdrawal by Subject|5|||
161674745|NCT01674712|583862979|FG003|Overall Study|Withdrawal by Subject|4|||
161674746|NCT01674712|583862980|FG004|Overall Study|Withdrawal by Subject|3|||
161674747|NCT01674712|583862976|FG000|Overall Study|Administrative|0|||
161508205|NCT03912233|583255245|FG001|Overall Study|Other|0|||
161508206|NCT03912233|583255246|FG002|Overall Study|Other|0|||
161925871|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Other|20|||
161925872|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
161508207|NCT03912233|583255247|FG003|Overall Study|Other|0|||
161508208|NCT03912233|583255248|FG004|Overall Study|Other|7|||
161508209|NCT03912233|583255249|FG005|Overall Study|Other|12|||
161508210|NCT02583256|583255252|FG000|Overall Study|Withdrawal by Subject|0|||
161508211|NCT02583256|583255253|FG001|Overall Study|Withdrawal by Subject|1|||
161508212|NCT02583256|583255254|FG002|Overall Study|Withdrawal by Subject|1|||
161674748|NCT01674712|583862977|FG001|Overall Study|Administrative|1|||
161674749|NCT01674712|583862978|FG002|Overall Study|Administrative|0|||
161674750|NCT01674712|583862979|FG003|Overall Study|Administrative|0|||
161674751|NCT01674712|583862980|FG004|Overall Study|Administrative|1|||
161508213|NCT02583256|583255255|FG003|Overall Study|Withdrawal by Subject|0|||
161508214|NCT02583256|583255252|FG000|Overall Study|Lost to Follow-up|1|||
161508215|NCT02583256|583255253|FG001|Overall Study|Lost to Follow-up|1|||
161674752|NCT01674712|583862976|FG000|Overall Study|Lack of Efficacy|0|||
161508216|NCT02583256|583255254|FG002|Overall Study|Lost to Follow-up|0|||
161508217|NCT02583256|583255255|FG003|Overall Study|Lost to Follow-up|1|||
161508218|NCT02583256|583255252|FG000|Overall Study|Administrative/Other|2|||
161508219|NCT02583256|583255253|FG001|Overall Study|Administrative/Other|0|||
161508220|NCT02583256|583255254|FG002|Overall Study|Administrative/Other|1|||
161508221|NCT02583256|583255255|FG003|Overall Study|Administrative/Other|2|||
161925873|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
161508222|NCT02177266|583255261|FG000|Overall Study|Adverse Event|0|||
161674753|NCT01674712|583862977|FG001|Overall Study|Lack of Efficacy|0|||
161674754|NCT01674712|583862978|FG002|Overall Study|Lack of Efficacy|1|||
161674755|NCT01674712|583862979|FG003|Overall Study|Lack of Efficacy|0|||
161508223|NCT02177266|583255262|FG001|Overall Study|Adverse Event|1|||
161508224|NCT02177266|583255261|FG000|Overall Study|Withdrawal by Subject|1|||
161508225|NCT02177266|583255262|FG001|Overall Study|Withdrawal by Subject|0|||
161508226|NCT01023659|583255263|FG000|Overall Study|Lost to Follow-up|73|||
161508227|NCT01023659|583255264|FG001|Overall Study|Lost to Follow-up|228|||
161508228|NCT01023659|583255265|FG002|Overall Study|Lost to Follow-up|99|||
161508229|NCT04537806|583255268|FG000|Overall Study|Randomized but not treated|1|||
161508230|NCT04537806|583255269|FG001|Overall Study|Randomized but not treated|0|||
161508231|NCT04537806|583255268|FG000|Overall Study|Adverse Event|1|||
161508232|NCT04537806|583255269|FG001|Overall Study|Adverse Event|1|||
161508233|NCT03019627|583255270|FG000|Overall Study|Adverse Event|8|||
161508234|NCT03019627|583255271|FG001|Overall Study|Adverse Event|0|||
161508235|NCT03019627|583255270|FG000|Overall Study|Unrelated to adverse event|1|||
161508236|NCT03019627|583255271|FG001|Overall Study|Unrelated to adverse event|3|||
161508237|NCT03019627|583255270|FG000|Overall Study|Lost to Follow-up|2|||
161508238|NCT03019627|583255271|FG001|Overall Study|Lost to Follow-up|1|||
161508239|NCT03019627|583255270|FG000|Overall Study|not compliance|2|||
161508240|NCT03019627|583255271|FG001|Overall Study|not compliance|2|||
161508241|NCT03019627|583255270|FG000|Overall Study|Other|2|||
161508242|NCT03019627|583255271|FG001|Overall Study|Other|2|||
161508243|NCT01802775|583255274|FG000|Overall Study|Death|0|||
161508244|NCT01802775|583255275|FG001|Overall Study|Death|3|||
161508245|NCT01802775|583255274|FG000|Overall Study|Reason not provided|0|||
161508246|NCT01802775|583255275|FG001|Overall Study|Reason not provided|1|||
161508247|NCT01802775|583255274|FG000|Overall Study|Physician Decision|1|||
161508248|NCT01802775|583255275|FG001|Overall Study|Physician Decision|0|||
161508249|NCT01802775|583255274|FG000|Overall Study|Adverse Event|1|||
161508250|NCT01802775|583255275|FG001|Overall Study|Adverse Event|1|||
161508251|NCT01802775|583255274|FG000|Overall Study|Withdrawal by Subject|3|||
161508252|NCT01802775|583255275|FG001|Overall Study|Withdrawal by Subject|5|||
161508253|NCT01802775|583255274|FG000|Overall Study|Lost to Follow-up|1|||
161508254|NCT01802775|583255275|FG001|Overall Study|Lost to Follow-up|2|||
161508255|NCT00519649|583255276|FG000|Overall Study|Withdrawal by Subject|1|||
161508256|NCT00727714|583255277|FG000|Overall Study|Lost to Follow-up|2|||
161508257|NCT00325234|583255280|FG000|Overall Study|Adverse Event|10|||
161508258|NCT00325234|583255281|FG001|Overall Study|Adverse Event|7|||
161508259|NCT00325234|583255280|FG000|Overall Study|Death due to Study Disease|1|||
161508260|NCT00325234|583255281|FG001|Overall Study|Death due to Study Disease|0|||
161508261|NCT00325234|583255280|FG000|Overall Study|Entry Criteria Not Met|1|||
161508262|NCT00325234|583255281|FG001|Overall Study|Entry Criteria Not Met|2|||
161508263|NCT00325234|583255280|FG000|Overall Study|Subject Decision|6|||
161508264|NCT00325234|583255281|FG001|Overall Study|Subject Decision|8|||
161508265|NCT00325234|583255280|FG000|Overall Study|Physician Decision|17|||
161508266|NCT00325234|583255281|FG001|Overall Study|Physician Decision|12|||
161508267|NCT00325234|583255280|FG000|Overall Study|Progressive Disease|34|||
161508268|NCT00325234|583255281|FG001|Overall Study|Progressive Disease|37|||
161508269|NCT01234467|583255282|FG000|Overall Study|Adverse Event|3|||
161508270|NCT01234467|583255282|FG000|Overall Study|Death|2|||
161508271|NCT01234467|583255282|FG000|Overall Study|Withdrawal by Subject|2|||
161508272|NCT01234467|583255282|FG000|Overall Study|Disease Progression|2|||
161508273|NCT01234467|583255282|FG000|Overall Study|Clinical deterioration|1|||
161508274|NCT01234467|583255282|FG000|Overall Study|Physician Decision|1|||
161508275|NCT01234467|583255282|FG000|Overall Study|Other complicating disease (stroke)|1|||
161508276|NCT01120210|583255285|FG000|MAIN INFUSION|Adverse Event|1|||
161508277|NCT01120210|583255286|FG001|MAIN INFUSION|Adverse Event|0|||
161674756|NCT01674712|583862980|FG004|Overall Study|Lack of Efficacy|1|||
161674757|NCT00056862|583862981|FG000|Overall Study|Protocol Violation|1|||
161508278|NCT01120210|583255285|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
161508279|NCT01120210|583255286|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
161508280|NCT04049760|583255294|FG000|Overall Study|Withdrawal by Subject|1|||
161508281|NCT03995953|583255297|FG000|Overall Study|Death|3|||
161508282|NCT03995953|583255298|FG001|Overall Study|Death|0|||
161508283|NCT03995953|583255299|FG002|Overall Study|Death|3|||
161508284|NCT03995953|583255300|FG003|Overall Study|Death|0|||
161508285|NCT03995953|583255301|FG004|Overall Study|Death|3|||
161508286|NCT03995953|583255302|FG005|Overall Study|Death|0|||
161508287|NCT03995953|583255303|FG006|Overall Study|Death|0|||
161508288|NCT03995953|583255304|FG007|Overall Study|Death|0|||
161508289|NCT03995953|583255305|FG008|Overall Study|Death|1|||
161508290|NCT03995953|583255306|FG009|Overall Study|Death|0|||
161508291|NCT03995953|583255307|FG010|Overall Study|Death|0|||
161508292|NCT03995953|583255308|FG011|Overall Study|Death|0|||
161508293|NCT03995953|583255297|FG000|Overall Study|Lost to Follow-up|6|||
161508294|NCT03995953|583255298|FG001|Overall Study|Lost to Follow-up|54|||
161508295|NCT03995953|583255299|FG002|Overall Study|Lost to Follow-up|3|||
161674758|NCT00056862|583862982|FG001|Overall Study|Protocol Violation|0|||
161508296|NCT03995953|583255300|FG003|Overall Study|Lost to Follow-up|32|||
161508297|NCT03995953|583255301|FG004|Overall Study|Lost to Follow-up|5|||
161508298|NCT03995953|583255302|FG005|Overall Study|Lost to Follow-up|44|||
161508299|NCT03995953|583255303|FG006|Overall Study|Lost to Follow-up|0|||
161508300|NCT03995953|583255304|FG007|Overall Study|Lost to Follow-up|31|||
161508301|NCT03995953|583255305|FG008|Overall Study|Lost to Follow-up|8|||
161508302|NCT03995953|583255306|FG009|Overall Study|Lost to Follow-up|36|||
161508303|NCT03995953|583255307|FG010|Overall Study|Lost to Follow-up|5|||
161508304|NCT03995953|583255308|FG011|Overall Study|Lost to Follow-up|41|||
161508305|NCT03995953|583255297|FG000|Overall Study|Withdrawal by Subject|4|||
161508306|NCT03995953|583255298|FG001|Overall Study|Withdrawal by Subject|0|||
161508307|NCT03995953|583255299|FG002|Overall Study|Withdrawal by Subject|1|||
161508308|NCT03995953|583255300|FG003|Overall Study|Withdrawal by Subject|0|||
161508309|NCT03995953|583255301|FG004|Overall Study|Withdrawal by Subject|1|||
161508310|NCT03995953|583255302|FG005|Overall Study|Withdrawal by Subject|0|||
161508311|NCT03995953|583255303|FG006|Overall Study|Withdrawal by Subject|1|||
161508312|NCT03995953|583255304|FG007|Overall Study|Withdrawal by Subject|0|||
161508313|NCT03995953|583255305|FG008|Overall Study|Withdrawal by Subject|3|||
161508314|NCT03995953|583255306|FG009|Overall Study|Withdrawal by Subject|0|||
161508315|NCT03995953|583255307|FG010|Overall Study|Withdrawal by Subject|3|||
161508316|NCT03995953|583255308|FG011|Overall Study|Withdrawal by Subject|0|||
161508317|NCT03995953|583255297|FG000|Overall Study|Health Issues|0|||
161508318|NCT03995953|583255298|FG001|Overall Study|Health Issues|0|||
161508319|NCT03995953|583255299|FG002|Overall Study|Health Issues|0|||
161508320|NCT03995953|583255300|FG003|Overall Study|Health Issues|0|||
161508321|NCT03995953|583255301|FG004|Overall Study|Health Issues|1|||
161508322|NCT03995953|583255302|FG005|Overall Study|Health Issues|0|||
161508323|NCT03995953|583255303|FG006|Overall Study|Health Issues|0|||
161508324|NCT03995953|583255304|FG007|Overall Study|Health Issues|0|||
161508325|NCT03995953|583255305|FG008|Overall Study|Health Issues|4|||
161508326|NCT03995953|583255306|FG009|Overall Study|Health Issues|0|||
161508327|NCT03995953|583255307|FG010|Overall Study|Health Issues|0|||
161508328|NCT03995953|583255308|FG011|Overall Study|Health Issues|0|||
161508329|NCT03995953|583255297|FG000|Overall Study|Relocated|11|||
161508330|NCT03995953|583255298|FG001|Overall Study|Relocated|0|||
161508331|NCT03995953|583255299|FG002|Overall Study|Relocated|16|||
161508332|NCT03995953|583255300|FG003|Overall Study|Relocated|0|||
161508333|NCT03995953|583255301|FG004|Overall Study|Relocated|14|||
161508334|NCT03995953|583255302|FG005|Overall Study|Relocated|0|||
161508335|NCT03995953|583255303|FG006|Overall Study|Relocated|16|||
161508336|NCT03995953|583255304|FG007|Overall Study|Relocated|0|||
161508337|NCT03995953|583255305|FG008|Overall Study|Relocated|14|||
161508338|NCT03995953|583255306|FG009|Overall Study|Relocated|0|||
161508339|NCT03995953|583255307|FG010|Overall Study|Relocated|15|||
161508340|NCT03995953|583255308|FG011|Overall Study|Relocated|0|||
161508341|NCT02130765|583255309|FG000|Overall Study|Did not receive treatment|4|||
161508342|NCT02130765|583255310|FG001|Overall Study|Did not receive treatment|0|||
161508343|NCT02130765|583255311|FG002|Overall Study|Did not receive treatment|0|||
161508344|NCT02130765|583255312|FG003|Overall Study|Did not receive treatment|0|||
161508345|NCT02388997|583255313|FG000|Overall Study|Adverse Event|1|||
161508346|NCT02388997|583255314|FG001|Overall Study|Adverse Event|2|||
161508347|NCT02388997|583255313|FG000|Overall Study|Withdrawal by Subject|2|||
161508348|NCT02388997|583255314|FG001|Overall Study|Withdrawal by Subject|1|||
161508349|NCT02388997|583255313|FG000|Overall Study|Lung function exclusion criteria|0|||
161508350|NCT02388997|583255314|FG001|Overall Study|Lung function exclusion criteria|2|||
161508351|NCT02388997|583255313|FG000|Overall Study|Tested positive for virus during run-in|0|||
161508352|NCT02388997|583255314|FG001|Overall Study|Tested positive for virus during run-in|1|||
161508353|NCT00006184|583255317|FG000|Overall Study|Death|1|||
161508354|NCT00006184|583255318|FG001|Overall Study|Death|0|||
161508355|NCT01838642|583255319|FG000|Overall Study|Died on study|1|||
161508356|NCT04019041|583255322|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
161508357|NCT04019041|583255323|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
161508358|NCT04019041|583255324|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
161508359|NCT04019041|583255325|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
161508360|NCT04019041|583255326|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
161508361|NCT04019041|583255327|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
161508362|NCT04019041|583255322|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
161508363|NCT04019041|583255323|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
161508364|NCT04019041|583255324|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
161586891|NCT04623775|583536305|FG000|Treatment Period|participant no longer meets study criteria|0|||
161586892|NCT04623775|583536306|FG001|Treatment Period|participant no longer meets study criteria|1|||
161508365|NCT04019041|583255325|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
161508366|NCT04019041|583255326|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
161508367|NCT04019041|583255327|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
161508368|NCT04019041|583255322|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
161925874|NCT00699751|584774650|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
161925875|NCT00699751|584774651|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
161925876|NCT00699751|584774650|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
161925877|NCT00699751|584774651|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
161925878|NCT00699751|584774650|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
161925879|NCT00699751|584774651|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
161925880|NCT01947933|584774652|FG000|Overall Study|Withdrawal by Subject|0|||
161925881|NCT01947933|584774653|FG001|Overall Study|Withdrawal by Subject|0|||
161925882|NCT01947933|584774654|FG002|Overall Study|Withdrawal by Subject|1|||
161925883|NCT01947933|584774655|FG003|Overall Study|Withdrawal by Subject|0|||
161508369|NCT04019041|583255323|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
161508370|NCT04019041|583255324|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
161508371|NCT04019041|583255325|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
161508372|NCT04019041|583255326|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
161508373|NCT04019041|583255327|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
161508374|NCT04019041|583255322|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
161508375|NCT04019041|583255323|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
161508376|NCT04019041|583255324|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
161508377|NCT04019041|583255325|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
161508378|NCT04019041|583255326|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
161508379|NCT04019041|583255327|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
161508380|NCT04019041|583255322|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
161508381|NCT04019041|583255323|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
161508382|NCT04019041|583255324|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
161508383|NCT04019041|583255325|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
161508384|NCT04019041|583255326|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
161508385|NCT04019041|583255327|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
161508386|NCT04019041|583255322|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
161508387|NCT04019041|583255323|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
161508388|NCT04019041|583255324|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
161508389|NCT04019041|583255325|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
161508390|NCT04019041|583255326|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
161586893|NCT04623775|583536307|FG002|Treatment Period|participant no longer meets study criteria|0|||
161586894|NCT04623775|583536308|FG003|Treatment Period|participant no longer meets study criteria|0|||
161586895|NCT04623775|583536305|FG000|Treatment Period|administrative reasons by sponsor|3|||
161586896|NCT04623775|583536306|FG001|Treatment Period|administrative reasons by sponsor|2|||
161586897|NCT04623775|583536307|FG002|Treatment Period|administrative reasons by sponsor|0|||
161586898|NCT04623775|583536308|FG003|Treatment Period|administrative reasons by sponsor|0|||
161586899|NCT04623775|583536305|FG000|Treatment Period|other reasons|2|||
161586900|NCT04623775|583536306|FG001|Treatment Period|other reasons|0|||
161586901|NCT04623775|583536307|FG002|Treatment Period|other reasons|1|||
161586902|NCT04623775|583536308|FG003|Treatment Period|other reasons|1|||
161586903|NCT04623775|583536305|FG000|Treatment Period|disease progression|40|||
161586904|NCT04623775|583536306|FG001|Treatment Period|disease progression|35|||
161586905|NCT04623775|583536307|FG002|Treatment Period|disease progression|63|||
161586906|NCT04623775|583536308|FG003|Treatment Period|disease progression|63|||
161586907|NCT04623775|583536305|FG000|Treatment Period|study drug toxicity|12|||
161586908|NCT04623775|583536306|FG001|Treatment Period|study drug toxicity|15|||
161586909|NCT04623775|583536307|FG002|Treatment Period|study drug toxicity|13|||
161586910|NCT04623775|583536308|FG003|Treatment Period|study drug toxicity|12|||
161586911|NCT04623775|583536305|FG000|Treatment Period|AE unrelated to study drug|4|||
161586912|NCT04623775|583536306|FG001|Treatment Period|AE unrelated to study drug|9|||
161586913|NCT04623775|583536307|FG002|Treatment Period|AE unrelated to study drug|12|||
161586914|NCT04623775|583536308|FG003|Treatment Period|AE unrelated to study drug|9|||
161586915|NCT04623775|583536305|FG000|Treatment Period|participant request to discontinue treatment|0|||
161586916|NCT04623775|583536306|FG001|Treatment Period|participant request to discontinue treatment|2|||
161586917|NCT04623775|583536307|FG002|Treatment Period|participant request to discontinue treatment|2|||
161586918|NCT04623775|583536308|FG003|Treatment Period|participant request to discontinue treatment|0|||
161586919|NCT03767517|583536309|FG000|Overall Study|Lost to Follow-up|16|||
161586920|NCT03767517|583536310|FG001|Overall Study|Lost to Follow-up|10|||
161586921|NCT03767517|583536309|FG000|Overall Study|Death|2|||
161586922|NCT03767517|583536310|FG001|Overall Study|Death|3|||
161586923|NCT02525692|583537356|FG000|Overall Study|Withdrawal by Subject|1|||
161586924|NCT02525692|583537357|FG001|Overall Study|Withdrawal by Subject|1|||
161586925|NCT02525692|583537358|FG002|Overall Study|Withdrawal by Subject|0|||
161586926|NCT02525692|583537359|FG003|Overall Study|Withdrawal by Subject|5|||
161586927|NCT02525692|583537360|FG004|Overall Study|Withdrawal by Subject|0|||
161508391|NCT04019041|583255327|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
161508392|NCT04019041|583255322|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
161508393|NCT04019041|583255323|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
161508394|NCT04019041|583255324|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
161508395|NCT04019041|583255325|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
161508396|NCT04019041|583255326|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
161508397|NCT04019041|583255327|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
161674759|NCT00381563|583862986|FG000|Overall Study|Withdrawal by Subject|5|||
161674760|NCT00381563|583862987|FG001|Overall Study|Withdrawal by Subject|5|||
161674761|NCT00381563|583862986|FG000|Overall Study|Lost to Follow-up|2|||
161674762|NCT00381563|583862987|FG001|Overall Study|Lost to Follow-up|0|||
161674763|NCT00381563|583862986|FG000|Overall Study|Protocol Violation|0|||
161674764|NCT00381563|583862987|FG001|Overall Study|Protocol Violation|1|||
161674765|NCT01132612|583862991|FG000|Overall Study|Death|0|||
161674766|NCT01132612|583862992|FG001|Overall Study|Death|0|||
161674767|NCT01132612|583862993|FG002|Overall Study|Death|1|||
161674768|NCT01132612|583862991|FG000|Overall Study|Protocol deviation|0|||
161674769|NCT01132612|583862992|FG001|Overall Study|Protocol deviation|0|||
161674770|NCT01132612|583862993|FG002|Overall Study|Protocol deviation|3|||
161674771|NCT01132612|583862991|FG000|Overall Study|Lost to Follow-up|2|||
161674772|NCT01132612|583862992|FG001|Overall Study|Lost to Follow-up|2|||
161674773|NCT01132612|583862993|FG002|Overall Study|Lost to Follow-up|7|||
161674774|NCT01132612|583862991|FG000|Overall Study|Adverse Event|5|||
161674775|NCT01132612|583862992|FG001|Overall Study|Adverse Event|2|||
161674776|NCT01132612|583862993|FG002|Overall Study|Adverse Event|15|||
161674777|NCT01132612|583862991|FG000|Overall Study|Withdrawal by Subject|5|||
161674778|NCT01132612|583862992|FG001|Overall Study|Withdrawal by Subject|8|||
161674779|NCT01132612|583862993|FG002|Overall Study|Withdrawal by Subject|19|||
161674780|NCT01132612|583862991|FG000|Overall Study|Administrative problems|5|||
161674781|NCT01132612|583862992|FG001|Overall Study|Administrative problems|1|||
161674782|NCT01132612|583862993|FG002|Overall Study|Administrative problems|52|||
161674783|NCT01132612|583862991|FG000|Overall Study|Lack of Efficacy|23|||
161674784|NCT01132612|583862992|FG001|Overall Study|Lack of Efficacy|22|||
161674785|NCT01132612|583862993|FG002|Overall Study|Lack of Efficacy|73|||
161674786|NCT02252536|583862994|FG000|Overall Study|Lost to Follow-up|5|||
161674787|NCT02252536|583862995|FG001|Overall Study|Lost to Follow-up|3|||
161674788|NCT02378220|583862998|FG000|Overall Study|Death|6|||
161674789|NCT02378220|583862999|FG001|Overall Study|Death|1|||
161674790|NCT02060721|583863004|FG000|Overall Study|Lost to Follow-up|1|||
161674791|NCT02060721|583863004|FG000|Overall Study|Physician Decision|2|||
161674792|NCT02060721|583863004|FG000|Overall Study|Death|14|||
161674793|NCT02060721|583863004|FG000|Overall Study|Withdrawal by Subject|2|||
161674794|NCT02060721|583863004|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
161674795|NCT05105789|583863005|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
161674796|NCT00728481|583863009|FG000|Overall Study|Withdrawal by Subject|0|||
161674797|NCT00728481|583863010|FG001|Overall Study|Withdrawal by Subject|1|||
161674798|NCT00728481|583863009|FG000|Overall Study|Adverse Event|0|||
161674799|NCT00728481|583863010|FG001|Overall Study|Adverse Event|1|||
161674800|NCT00728481|583863009|FG000|Overall Study|Study medication non-compliance|0|||
161674801|NCT00728481|583863010|FG001|Overall Study|Study medication non-compliance|2|||
161674802|NCT00728481|583863009|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
161674803|NCT00728481|583863010|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
161674804|NCT03690141|583863011|FG000|Overall Study|Adverse Event|5|||
161674805|NCT03690141|583863011|FG000|Overall Study|Withdrawal by Subject|3|||
161674806|NCT03690141|583863011|FG000|Overall Study|Physician Decision|4|||
161674807|NCT03690141|583863011|FG000|Overall Study|Disease progression|4|||
161674808|NCT01505010|583863012|FG000|Overall Study|Protocol Violation|0|||
161674809|NCT01505010|583863013|FG001|Overall Study|Protocol Violation|1|||
161820292|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
161820293|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820294|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820295|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820296|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820297|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
161820298|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820299|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161820300|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161820301|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161508398|NCT04019041|583255322|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
161674810|NCT01505010|583863012|FG000|Overall Study|Lost to Follow-up|0|||
161674811|NCT01505010|583863013|FG001|Overall Study|Lost to Follow-up|1|||
161674812|NCT04744285|583863014|FG000|Overall Study|Withdrawal by Subject|1|||
161674813|NCT04744285|583863015|FG001|Overall Study|Withdrawal by Subject|1|||
161674814|NCT04744285|583863016|FG002|Overall Study|Withdrawal by Subject|2|||
161674815|NCT04744285|583863017|FG003|Overall Study|Withdrawal by Subject|1|||
161674816|NCT02558231|583863024|FG000|Overall Study|Death|4|||
161674817|NCT02558231|583863025|FG001|Overall Study|Death|12|||
161674818|NCT02558231|583863024|FG000|Overall Study|Lost to Follow-up|7|||
161674819|NCT02558231|583863025|FG001|Overall Study|Lost to Follow-up|4|||
161674820|NCT02558231|583863024|FG000|Overall Study|Withdrawal by Subject|7|||
161674821|NCT02558231|583863025|FG001|Overall Study|Withdrawal by Subject|4|||
161674822|NCT02558231|583863024|FG000|Overall Study|Physician Decision|7|||
161674823|NCT02558231|583863025|FG001|Overall Study|Physician Decision|5|||
161674824|NCT02558231|583863024|FG000|Overall Study|Sponsor Decision|0|||
161674825|NCT02558231|583863025|FG001|Overall Study|Sponsor Decision|1|||
161674826|NCT00995007|583863026|FG000|Overall Study|Withdrew consent|1|||
161674827|NCT00995007|583863027|FG001|Overall Study|Withdrew consent|0|||
161674828|NCT00995007|583863026|FG000|Overall Study|Refused further treatment|8|||
161674829|NCT00995007|583863027|FG001|Overall Study|Refused further treatment|2|||
161674830|NCT00995007|583863026|FG000|Overall Study|Toxicity|8|||
161674831|NCT00995007|583863027|FG001|Overall Study|Toxicity|0|||
161674832|NCT03933397|583863028|FG000|Overall Study|No emergency department visit|65|||
161674833|NCT03933397|583863029|FG001|Overall Study|No emergency department visit|71|||
161674834|NCT03933397|583863028|FG000|Overall Study|Missed emergency department visit|25|||
161674835|NCT03933397|583863029|FG001|Overall Study|Missed emergency department visit|30|||
161674836|NCT03933397|583863028|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
161674837|NCT03933397|583863029|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
161674838|NCT03933397|583863028|FG000|Overall Study|Withdrawal by Subject|1|||
161674839|NCT03933397|583863029|FG001|Overall Study|Withdrawal by Subject|0|||
161674840|NCT03933397|583863028|FG000|Overall Study|Physician Decision|1|||
161674841|NCT03933397|583863029|FG001|Overall Study|Physician Decision|1|||
161674842|NCT03933397|583863028|FG000|Overall Study|missing pain score|1|||
161674843|NCT03933397|583863029|FG001|Overall Study|missing pain score|1|||
161674844|NCT03933397|583863028|FG000|Overall Study|Confirmed COVID-19|1|||
161674845|NCT03933397|583863029|FG001|Overall Study|Confirmed COVID-19|2|||
161674846|NCT02066051|583863031|FG000|Overall Study|Subject developed active GVHD|1|||
161674847|NCT01610687|583863034|FG000|Overall Study|Lack of Efficacy|26|||
161674848|NCT01610687|583863034|FG000|Overall Study|Adverse Event|18|||
161674849|NCT01610687|583863034|FG000|Overall Study|Moved out of area|6|||
161674850|NCT01610687|583863034|FG000|Overall Study|Withdrawal by Subject|7|||
161925884|NCT01947933|584774656|FG004|Overall Study|Withdrawal by Subject|0|||
161925885|NCT01947933|584774657|FG005|Overall Study|Withdrawal by Subject|0|||
161674851|NCT01610687|583863034|FG000|Overall Study|Lost to Follow-up|4|||
161674852|NCT01610687|583863034|FG000|Overall Study|Symptom control without study medication|2|||
161674853|NCT01610687|583863034|FG000|Overall Study|Unable to make journey|1|||
161674854|NCT01610687|583863034|FG000|Overall Study|Death|1|||
161925886|NCT01947933|584774658|FG006|Overall Study|Withdrawal by Subject|0|||
161925887|NCT01947933|584774659|FG007|Overall Study|Withdrawal by Subject|0|||
161674855|NCT01610687|583863034|FG000|Overall Study|Cannabis affecting job|1|||
161674856|NCT01610687|583863034|FG000|Overall Study|Felt more alter without study medication|1|||
161674857|NCT01294150|583863037|FG000|Overall Study|Physician Decision|2|||
161674858|NCT01294150|583863038|FG001|Overall Study|Physician Decision|2|||
161674859|NCT03675776|583863039|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
161674860|NCT03675776|583863040|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
161674861|NCT03675776|583863041|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
161674862|NCT03675776|583863039|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
161674863|NCT03675776|583863040|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161674864|NCT03675776|583863041|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161674865|NCT01093625|583863042|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
161674866|NCT01093625|583863043|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
161674867|NCT01093625|583863042|FG000|2-Week Visit|Withdrawal by Subject|1|||
161674868|NCT01093625|583863043|FG001|2-Week Visit|Withdrawal by Subject|0|||
161925888|NCT01947933|584774660|FG008|Overall Study|Withdrawal by Subject|0|||
161925889|NCT01947933|584774652|FG000|Overall Study|Lost to Follow-up|0|||
161925890|NCT01947933|584774653|FG001|Overall Study|Lost to Follow-up|0|||
161925891|NCT01947933|584774654|FG002|Overall Study|Lost to Follow-up|0|||
161925892|NCT01947933|584774655|FG003|Overall Study|Lost to Follow-up|0|||
161925893|NCT01947933|584774656|FG004|Overall Study|Lost to Follow-up|0|||
161674869|NCT01093625|583863042|FG000|1-Month Visit|Lost to Follow-up|2|||
161674870|NCT01093625|583863043|FG001|1-Month Visit|Lost to Follow-up|0|||
161674871|NCT01093625|583863042|FG000|3-Month Visit|Lost to Follow-up|2|||
161674872|NCT01093625|583863043|FG001|3-Month Visit|Lost to Follow-up|0|||
161674873|NCT01093625|583863042|FG000|6-Month Visit|Withdrawal by Subject|6|||
161925894|NCT01947933|584774657|FG005|Overall Study|Lost to Follow-up|0|||
161925895|NCT01947933|584774658|FG006|Overall Study|Lost to Follow-up|0|||
161925896|NCT01947933|584774659|FG007|Overall Study|Lost to Follow-up|0|||
161925897|NCT01947933|584774660|FG008|Overall Study|Lost to Follow-up|1|||
161925898|NCT00294398|584774661|FG000|Overall Study|Lost to Follow-up|21|||
161925899|NCT00294398|584774662|FG001|Overall Study|Lost to Follow-up|26|||
161925900|NCT00250718|584774665|FG000|Overall Study|Death|1|||
161508399|NCT04019041|583255323|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
161508400|NCT04019041|583255324|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
161508401|NCT04019041|583255325|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
161508402|NCT04019041|583255326|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
161925901|NCT00250718|584774665|FG000|Overall Study|Adverse Event|1|||
161925902|NCT00250718|584774665|FG000|Overall Study|Withdrawal by Subject|1|||
161925903|NCT04439123|584774668|FG000|Overall Study|Adverse Event|11|||
161925904|NCT04439123|584774668|FG000|Overall Study|Death|1|||
161925905|NCT04439123|584774668|FG000|Overall Study|Disease progression|19|||
161925906|NCT04439123|584774668|FG000|Overall Study|Withdrawal by Subject|2|||
161925907|NCT04439123|584774668|FG000|Overall Study|Still on treatment|2|||
161925908|NCT02593864|584774670|FG000|Overall Study|Withdrawal by Subject|3|||
161925909|NCT02593864|584774670|FG000|Overall Study|Lost to Follow-up|3|||
161925910|NCT02114684|584774676|FG000|Overall Study|Death|6|||
161925911|NCT02114684|584774677|FG001|Overall Study|Death|4|||
161925912|NCT02114684|584774676|FG000|Overall Study|Lost to Follow-up|1|||
161925913|NCT02114684|584774677|FG001|Overall Study|Lost to Follow-up|2|||
161925914|NCT02114684|584774676|FG000|Overall Study|Withdrawal by Subject|1|||
161925915|NCT02114684|584774677|FG001|Overall Study|Withdrawal by Subject|2|||
161925916|NCT02114684|584774676|FG000|Overall Study|Relocation|3|||
161925917|NCT02114684|584774677|FG001|Overall Study|Relocation|1|||
161925918|NCT02114684|584774676|FG000|Overall Study|Rifampicin resistant on culture|0|||
161925919|NCT02114684|584774677|FG001|Overall Study|Rifampicin resistant on culture|1|||
161925920|NCT02114684|584774676|FG000|Overall Study|Patient Incarcerated|1|||
161925921|NCT02114684|584774677|FG001|Overall Study|Patient Incarcerated|0|||
161925922|NCT03828383|584774680|FG000|Overall Study|Lost to Follow-up|3|||
161925923|NCT03828383|584774681|FG001|Overall Study|Lost to Follow-up|2|||
161925924|NCT03828383|584774680|FG000|Overall Study|Withdrawal by Subject|4|||
161925925|NCT03828383|584774681|FG001|Overall Study|Withdrawal by Subject|5|||
161925926|NCT03345095|584774682|FG000|Overall Study|Lack of Efficacy|184|||
161925927|NCT03345095|584774683|FG001|Overall Study|Lack of Efficacy|156|||
161925928|NCT03345095|584774682|FG000|Overall Study|Adverse Event|36|||
161925929|NCT03345095|584774683|FG001|Overall Study|Adverse Event|118|||
161925930|NCT03345095|584774682|FG000|Overall Study|Withdrawal by Subject|22|||
161925931|NCT03345095|584774683|FG001|Overall Study|Withdrawal by Subject|59|||
161925932|NCT03345095|584774682|FG000|Overall Study|Physician Decision|3|||
161925933|NCT03345095|584774683|FG001|Overall Study|Physician Decision|18|||
161925934|NCT03345095|584774682|FG000|Overall Study|Death|2|||
161925935|NCT03345095|584774683|FG001|Overall Study|Death|4|||
161925936|NCT03345095|584774682|FG000|Overall Study|Other reasons|2|||
161925937|NCT03345095|584774683|FG001|Overall Study|Other reasons|11|||
161925938|NCT03345095|584774682|FG000|Overall Study|Protocol Violation|0|||
161925939|NCT03345095|584774683|FG001|Overall Study|Protocol Violation|1|||
161925940|NCT03022630|584777014|FG000|Overall Study|Death|9|||
161925941|NCT03022630|584777015|FG001|Overall Study|Death|7|||
161925942|NCT03022630|584777014|FG000|Overall Study|Withdrawal by Subject|0|||
161925943|NCT03022630|584777015|FG001|Overall Study|Withdrawal by Subject|5|||
161925944|NCT00382070|584777016|FG000|Overall Study|No follow up data mapped to Other|17|||
161925945|NCT00382070|584777017|FG001|Overall Study|No follow up data mapped to Other|19|||
161925946|NCT00382070|584777016|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
161925947|NCT00382070|584777017|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
161925948|NCT00382070|584777016|FG000|Overall Study|No clinical assessment|9|||
161925949|NCT00382070|584777017|FG001|Overall Study|No clinical assessment|11|||
161925950|NCT01734928|584777018|FG000|Randomization|Physician Decision|0|||
161925951|NCT01734928|584777019|FG001|Randomization|Physician Decision|1|||
161925952|NCT01734928|584777018|FG000|Randomization|clinical progression|0|||
161925953|NCT01734928|584777019|FG001|Randomization|clinical progression|1|||
161925954|NCT01734928|584777018|FG000|Randomization|progressive disease|0|||
161925955|NCT01734928|584777019|FG001|Randomization|progressive disease|2|||
161925956|NCT01734928|584777018|FG000|Randomization|Withdrew informed consent|0|||
161925957|NCT01734928|584777019|FG001|Randomization|Withdrew informed consent|4|||
161925958|NCT01734928|584777018|FG000|Randomization|Death|1|||
161925959|NCT01734928|584777019|FG001|Randomization|Death|0|||
161925960|NCT01734928|584777018|FG000|Randomization|Randomization error|1|||
161925961|NCT01734928|584777019|FG001|Randomization|Randomization error|0|||
161925962|NCT01734928|584777018|FG000|Randomization|Lost to Follow-up|1|||
161925963|NCT01734928|584777019|FG001|Randomization|Lost to Follow-up|0|||
161925964|NCT01734928|584777018|FG000|Treatment Period|Lost to Follow-up|0|||
161925965|NCT01734928|584777019|FG001|Treatment Period|Lost to Follow-up|2|||
161508403|NCT04019041|583255327|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
161925966|NCT01734928|584777018|FG000|Treatment Period|Progressive Disease|167|||
161925967|NCT01734928|584777019|FG001|Treatment Period|Progressive Disease|165|||
161925968|NCT01734928|584777018|FG000|Treatment Period|Adverse Event|39|||
161925969|NCT01734928|584777019|FG001|Treatment Period|Adverse Event|52|||
161925970|NCT01734928|584777018|FG000|Treatment Period|Withdrawal of Consent|25|||
161925971|NCT01734928|584777019|FG001|Treatment Period|Withdrawal of Consent|22|||
161925972|NCT01734928|584777018|FG000|Treatment Period|Death|20|||
161674874|NCT01093625|583863043|FG001|6-Month Visit|Withdrawal by Subject|7|||
161925973|NCT01734928|584777019|FG001|Treatment Period|Death|9|||
161925974|NCT01734928|584777018|FG000|Treatment Period|Other Reasons|27|||
161925975|NCT01734928|584777019|FG001|Treatment Period|Other Reasons|19|||
161925976|NCT01734928|584777018|FG000|Treatment Period|Pregnancy|0|||
161925977|NCT01734928|584777019|FG001|Treatment Period|Pregnancy|1|||
161925978|NCT01629563|584777020|FG000|Overall Study|Adverse Event|16|||
161925979|NCT01629563|584777021|FG001|Overall Study|Adverse Event|16|||
161925980|NCT01629563|584777020|FG000|Overall Study|Death|2|||
161925981|NCT01629563|584777021|FG001|Overall Study|Death|0|||
161925982|NCT01629563|584777020|FG000|Overall Study|Lack of Efficacy|2|||
161674875|NCT01093625|583863042|FG000|6-Month Visit|Lost to Follow-up|2|||
161674876|NCT01093625|583863043|FG001|6-Month Visit|Lost to Follow-up|2|||
161674877|NCT01093625|583863042|FG000|1-Year Visit|Lost to Follow-up|5|||
161925983|NCT01629563|584777021|FG001|Overall Study|Lack of Efficacy|3|||
161925984|NCT01629563|584777020|FG000|Overall Study|Lost to Follow-up|1|||
161925985|NCT01629563|584777021|FG001|Overall Study|Lost to Follow-up|0|||
161925986|NCT01629563|584777020|FG000|Overall Study|Pregnancy|1|||
161925987|NCT01629563|584777021|FG001|Overall Study|Pregnancy|2|||
161925988|NCT01629563|584777020|FG000|Overall Study|Protocol Violation|0|||
161925989|NCT01629563|584777021|FG001|Overall Study|Protocol Violation|1|||
161925990|NCT01629563|584777020|FG000|Overall Study|Withdrawal by Subject|27|||
161925991|NCT01629563|584777021|FG001|Overall Study|Withdrawal by Subject|20|||
161925992|NCT01629563|584777020|FG000|Overall Study|surgery|0|||
161925993|NCT01629563|584777021|FG001|Overall Study|surgery|3|||
161674878|NCT01093625|583863043|FG001|1-Year Visit|Lost to Follow-up|3|||
161674879|NCT00698932|583863044|FG000|Overall Study|Adverse Event|0|||
161674880|NCT00698932|583863045|FG001|Overall Study|Adverse Event|2|||
161674881|NCT00698932|583863044|FG000|Overall Study|Incorrect enrollment|0|||
161674882|NCT00698932|583863045|FG001|Overall Study|Incorrect enrollment|2|||
161674883|NCT00698932|583863044|FG000|Overall Study|Study specific discontinuation criteria|3|||
161674884|NCT00698932|583863045|FG001|Overall Study|Study specific discontinuation criteria|4|||
161674885|NCT00698932|583863044|FG000|Overall Study|Withdrawal by Subject|11|||
161674886|NCT00698932|583863045|FG001|Overall Study|Withdrawal by Subject|23|||
161674887|NCT00698932|583863044|FG000|Overall Study|Lost to Follow-up|6|||
161674888|NCT00698932|583863045|FG001|Overall Study|Lost to Follow-up|1|||
161674889|NCT00698932|583863044|FG000|Overall Study|Severe non-compliance to protocol|1|||
161674890|NCT00698932|583863045|FG001|Overall Study|Severe non-compliance to protocol|2|||
161674891|NCT00698932|583863044|FG000|Overall Study|Safety reasons|0|||
161674892|NCT00698932|583863045|FG001|Overall Study|Safety reasons|2|||
161508404|NCT04019041|583255322|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161508405|NCT04019041|583255323|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161508406|NCT04019041|583255324|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161508407|NCT04019041|583255325|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161508408|NCT04019041|583255326|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
161508409|NCT04019041|583255327|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
161508410|NCT03925727|583255328|FG000|Overall Study|Adverse Event|4|||
161508411|NCT03925727|583255329|FG001|Overall Study|Adverse Event|0|||
161508412|NCT03925727|583255330|FG002|Overall Study|Adverse Event|3|||
161508413|NCT03925727|583255328|FG000|Overall Study|Protocol Violation|1|||
161674893|NCT00698932|583863044|FG000|Overall Study|Death|1|||
161674894|NCT00698932|583863045|FG001|Overall Study|Death|0|||
161674895|NCT06132425|583863046|FG000|Overall Study|Withdrawal by Subject|3|||
161674896|NCT06132425|583863047|FG001|Overall Study|Withdrawal by Subject|0|||
161674897|NCT06132425|583863046|FG000|Overall Study|Did not follow study instructions|0|||
161674898|NCT06132425|583863047|FG001|Overall Study|Did not follow study instructions|2|||
161674899|NCT06132425|583863046|FG000|Overall Study|Lost to Follow-up|3|||
161674900|NCT06132425|583863047|FG001|Overall Study|Lost to Follow-up|5|||
161674901|NCT00708175|583863048|FG000|Overall Study|Adverse Event|4|||
161674902|NCT00708175|583863049|FG001|Overall Study|Adverse Event|5|||
161674903|NCT00708175|583863048|FG000|Overall Study|Protocol Violation|2|||
161674904|NCT00708175|583863049|FG001|Overall Study|Protocol Violation|3|||
161674905|NCT00708175|583863048|FG000|Overall Study|Lost to Follow-up|5|||
161674906|NCT00708175|583863049|FG001|Overall Study|Lost to Follow-up|3|||
161674907|NCT00708175|583863048|FG000|Overall Study|Withdrawal by Subject|5|||
161674908|NCT00708175|583863049|FG001|Overall Study|Withdrawal by Subject|7|||
161674909|NCT00708175|583863048|FG000|Overall Study|BMD loss >7%|2|||
161674910|NCT00708175|583863049|FG001|Overall Study|BMD loss >7%|3|||
161674911|NCT04435782|583863051|FG000|Overall Study|Study terminated by sponsor|4|||
161674912|NCT04667247|583863052|FG000|Overall Study|Withdrawal by Subject|0|||
161674913|NCT04667247|583863053|FG001|Overall Study|Withdrawal by Subject|1|||
161674914|NCT01876251|583865370|FG000|Overall Study|Clinical progression|1|||
161674915|NCT01876251|583865371|FG001|Overall Study|Clinical progression|0|||
161925994|NCT01629563|584777020|FG000|Overall Study|Lack of return of menses|12|||
161925995|NCT01629563|584777021|FG001|Overall Study|Lack of return of menses|7|||
161674916|NCT01876251|583865372|FG002|Overall Study|Clinical progression|0|||
161925996|NCT01629563|584777020|FG000|Overall Study|Protocol Violation|0|||
161925997|NCT01629563|584777021|FG001|Overall Study|Protocol Violation|1|||
161508414|NCT03925727|583255329|FG001|Overall Study|Protocol Violation|2|||
161508415|NCT03925727|583255330|FG002|Overall Study|Protocol Violation|2|||
161508416|NCT03925727|583255328|FG000|Overall Study|Withdrawal by Subject|3|||
161508417|NCT03925727|583255329|FG001|Overall Study|Withdrawal by Subject|2|||
161508418|NCT03925727|583255330|FG002|Overall Study|Withdrawal by Subject|4|||
161508419|NCT03925727|583255328|FG000|Overall Study|Administrative Reasons|3|||
161508420|NCT03925727|583255329|FG001|Overall Study|Administrative Reasons|1|||
161674917|NCT01876251|583865370|FG000|Overall Study|Death|2|||
161674918|NCT01876251|583865371|FG001|Overall Study|Death|0|||
161674919|NCT01876251|583865372|FG002|Overall Study|Death|1|||
161674920|NCT01876251|583865370|FG000|Overall Study|Participant started new treatment|1|||
161674921|NCT01876251|583865371|FG001|Overall Study|Participant started new treatment|0|||
161674922|NCT01876251|583865372|FG002|Overall Study|Participant started new treatment|1|||
161674923|NCT01876251|583865370|FG000|Overall Study|Participant refused further follow-up|0|||
161674924|NCT01876251|583865371|FG001|Overall Study|Participant refused further follow-up|0|||
161674925|NCT01876251|583865372|FG002|Overall Study|Participant refused further follow-up|1|||
161674926|NCT01876251|583865370|FG000|Overall Study|Study terminated|1|||
161674927|NCT01876251|583865371|FG001|Overall Study|Study terminated|0|||
161674928|NCT01876251|583865372|FG002|Overall Study|Study terminated|0|||
161508421|NCT03925727|583255330|FG002|Overall Study|Administrative Reasons|2|||
161508422|NCT03925727|583255328|FG000|Overall Study|Randomized in error or Disqualified|8|||
161508423|NCT03925727|583255329|FG001|Overall Study|Randomized in error or Disqualified|1|||
161674929|NCT01876251|583865370|FG000|Overall Study|Objective progression or relapse|10|||
161674930|NCT01876251|583865371|FG001|Overall Study|Objective progression or relapse|3|||
161674931|NCT01876251|583865372|FG002|Overall Study|Objective progression or relapse|8|||
161508424|NCT03925727|583255330|FG002|Overall Study|Randomized in error or Disqualified|7|||
161925998|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
161925999|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Adverse Event|1|||
161508425|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
161508426|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
161508427|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
161508428|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
161508429|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
161508430|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
161508431|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
161508432|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
161508433|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
161508434|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
161508435|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
161508436|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
161508437|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
161508438|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
161508439|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
161508440|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
161508441|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
161508442|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
161508443|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
161508444|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
161508445|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Other|3|||
161586928|NCT02525692|583537361|FG005|Overall Study|Withdrawal by Subject|1|||
161586929|NCT02525692|583537356|FG000|Overall Study|Death|16|||
161586930|NCT02525692|583537357|FG001|Overall Study|Death|18|||
161926000|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
161926001|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Physician Decision|1|||
161508446|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Other|0|||
161508447|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Other|2|||
161508448|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Other|2|||
161586931|NCT02525692|583537358|FG002|Overall Study|Death|7|||
161586932|NCT02525692|583537359|FG003|Overall Study|Death|20|||
161586933|NCT02525692|583537360|FG004|Overall Study|Death|3|||
161586934|NCT02525692|583537361|FG005|Overall Study|Death|6|||
161586935|NCT02525692|583537356|FG000|Overall Study|Lost to Follow-up|0|||
161586936|NCT02525692|583537357|FG001|Overall Study|Lost to Follow-up|0|||
161586937|NCT02525692|583537358|FG002|Overall Study|Lost to Follow-up|1|||
161586938|NCT02525692|583537359|FG003|Overall Study|Lost to Follow-up|5|||
161586939|NCT02525692|583537360|FG004|Overall Study|Lost to Follow-up|0|||
161586940|NCT02525692|583537361|FG005|Overall Study|Lost to Follow-up|0|||
161586941|NCT02396199|583537362|FG000|Overall Study|Lost to Follow-up|1|||
161586942|NCT02396199|583537362|FG000|Overall Study|Death|4|||
161586943|NCT04112316|583537365|FG000|First Period (8 Weeks)|Protocol Violation|1|||
161586944|NCT04112316|583537366|FG001|First Period (8 Weeks)|Protocol Violation|0|||
161586945|NCT04112316|583537365|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
161586946|NCT04112316|583537366|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
161586947|NCT04247542|583537376|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
161586948|NCT04247542|583537377|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
161586949|NCT04247542|583537378|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
161586950|NCT04247542|583537376|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
161586951|NCT04247542|583537377|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
161586952|NCT04247542|583537378|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
161586953|NCT06066541|583537379|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
161586954|NCT06066541|583537380|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
161586955|NCT06066541|583537381|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
161586956|NCT06066541|583537382|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
161586957|NCT06066541|583537383|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
161586958|NCT06066541|583537384|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161586959|NCT06066541|583537385|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161586960|NCT06066541|583537379|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
161586961|NCT06066541|583537380|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
161586962|NCT06066541|583537381|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
161586963|NCT06066541|583537382|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
161586964|NCT06066541|583537383|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
161586965|NCT06066541|583537384|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
161586966|NCT06066541|583537385|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
161586967|NCT04533022|583537386|FG000|Overall Study|Withdrawal by Subject|15|||
161586968|NCT04533022|583537386|FG000|Overall Study|Adverse Event|6|||
161586969|NCT04533022|583537386|FG000|Overall Study|Death|1|||
161586970|NCT04533022|583537386|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
161674932|NCT02012296|583865379|FG000|Overall Study|Lack of Efficacy|0|||
161674933|NCT02012296|583865380|FG001|Overall Study|Lack of Efficacy|0|||
161674934|NCT02012296|583865381|FG002|Overall Study|Lack of Efficacy|15|||
161674935|NCT02012296|583865379|FG000|Overall Study|Adverse Event|0|||
161674936|NCT02012296|583865380|FG001|Overall Study|Adverse Event|0|||
161674937|NCT02012296|583865381|FG002|Overall Study|Adverse Event|2|||
161674938|NCT02012296|583865379|FG000|Overall Study|Early study closure|0|||
161674939|NCT02012296|583865380|FG001|Overall Study|Early study closure|0|||
161674940|NCT02012296|583865381|FG002|Overall Study|Early study closure|5|||
161674941|NCT02012296|583865379|FG000|Overall Study|Protocol Violation|0|||
161674942|NCT02012296|583865380|FG001|Overall Study|Protocol Violation|1|||
161674943|NCT02012296|583865381|FG002|Overall Study|Protocol Violation|0|||
161508449|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Other|7|||
161508450|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508451|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508452|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508453|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
161508454|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508455|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
161508456|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
161508457|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
161674944|NCT03876171|583865382|FG000|Overall Study|Withdrawal by Subject|3|||
161508458|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
161508459|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
161508460|NCT00213148|583255331|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
161508461|NCT00213148|583255332|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
161508462|NCT00213148|583255333|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
161508463|NCT00213148|583255334|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
161508464|NCT00213148|583255335|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
161508465|NCT00213148|583255331|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
161508466|NCT00213148|583255332|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
161508467|NCT00213148|583255333|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
161508468|NCT00213148|583255334|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
161508469|NCT00213148|583255335|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
161508470|NCT00213148|583255331|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
161508471|NCT00213148|583255332|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
161820302|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161820303|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
161820304|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
161820305|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820306|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820307|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820308|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820309|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
161820310|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
161820311|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820312|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820313|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820314|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820315|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
161820316|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
161820317|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820318|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820319|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820320|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820321|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
161820322|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
161820323|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Other|0|||
161820324|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Other|0|||
161820325|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Other|0|||
161820326|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Other|0|||
161674945|NCT03876171|583865383|FG001|Overall Study|Withdrawal by Subject|3|||
161674946|NCT03876171|583865382|FG000|Overall Study|Re-arrest|0|||
161674947|NCT03876171|583865383|FG001|Overall Study|Re-arrest|4|||
161508472|NCT00213148|583255333|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
161674948|NCT00727649|583865386|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
161508473|NCT00213148|583255334|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
161508474|NCT00213148|583255335|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
161508475|NCT00213148|583255331|FG000|Cycle 2 (1 Month)|Other|2|||
161508476|NCT00213148|583255332|FG001|Cycle 2 (1 Month)|Other|1|||
161508477|NCT00213148|583255333|FG002|Cycle 2 (1 Month)|Other|2|||
161508478|NCT00213148|583255334|FG003|Cycle 2 (1 Month)|Other|8|||
161508479|NCT00213148|583255335|FG004|Cycle 2 (1 Month)|Other|7|||
161508480|NCT00213148|583255331|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508481|NCT00213148|583255332|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
161508482|NCT00213148|583255333|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508483|NCT00213148|583255334|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508484|NCT00213148|583255335|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
161508485|NCT00213148|583255331|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
161508486|NCT00213148|583255332|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
161508487|NCT00213148|583255333|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
161508488|NCT00213148|583255334|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
161508489|NCT00213148|583255335|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
161674949|NCT00727649|583865387|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
161674950|NCT00727649|583865386|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
161674951|NCT00727649|583865387|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
161674952|NCT00727649|583865386|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
161674953|NCT00727649|583865387|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
161674954|NCT00727649|583865386|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
161926002|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
161926003|NCT00088881|584777023|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
161926004|NCT00088881|584777023|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
161926005|NCT02370394|584777031|FG000|Overall Study|Lost to Follow-up|2|||
161926006|NCT02370394|584777032|FG001|Overall Study|Lost to Follow-up|1|||
161926007|NCT02370394|584777031|FG000|Overall Study|Withdrawal by Subject|0|||
161926008|NCT02370394|584777032|FG001|Overall Study|Withdrawal by Subject|1|||
161926009|NCT00456612|584777033|FG000|Overall Study|Withdrawal by Subject|3|||
161926010|NCT01108796|584777034|FG000|Overall Study|Adverse Event|0|||
161926011|NCT01108796|584777035|FG001|Overall Study|Adverse Event|1|||
161926012|NCT01108796|584777034|FG000|Overall Study|Lost to Follow-up|7|||
161926013|NCT01108796|584777035|FG001|Overall Study|Lost to Follow-up|6|||
161926014|NCT02545127|584777040|FG000|Overall Study|Lost to Follow-up|1|||
161508490|NCT00213148|583255331|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
161674955|NCT00727649|583865387|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
161674956|NCT00727649|583865386|FG000|Second Intervention (4-weeks)|Death|1|||
161674957|NCT00727649|583865387|FG001|Second Intervention (4-weeks)|Death|0|||
161674958|NCT00727649|583865386|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
161674959|NCT00727649|583865387|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
161674960|NCT00727649|583865386|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
161674961|NCT00727649|583865387|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
161674962|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
161674963|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674964|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674965|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674966|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674967|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
161674968|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161674969|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161508491|NCT00213148|583255332|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
161508492|NCT00213148|583255333|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
161820327|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Other|3|||
161820328|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Other|3|||
161820329|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820330|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820331|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820332|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820333|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
161820334|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
161820335|NCT02308241|584382780|FG000|Overall Study|Withdrawal by Subject|3|||
161820336|NCT03609944|584382781|FG000|Overall Study|Lost to Follow-up|1|||
161820337|NCT03609944|584382782|FG001|Overall Study|Lost to Follow-up|5|||
161820338|NCT03609944|584382781|FG000|Overall Study|Withdrawal by Subject|1|||
161820339|NCT03609944|584382782|FG001|Overall Study|Withdrawal by Subject|1|||
161820340|NCT00659815|584382783|FG000|Overall Study|Study related symptoms and complaints|2|||
161820341|NCT00659815|584382784|FG001|Overall Study|Study related symptoms and complaints|1|||
161820342|NCT00659815|584382783|FG000|Overall Study|Inability to maintain wearing schedule|1|||
161820343|NCT00659815|584382784|FG001|Overall Study|Inability to maintain wearing schedule|2|||
161926015|NCT02545127|584777041|FG001|Overall Study|Lost to Follow-up|0|||
161508493|NCT00213148|583255334|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
161508494|NCT00213148|583255335|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
161508495|NCT00213148|583255331|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
161508496|NCT00213148|583255332|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
161508497|NCT00213148|583255333|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
161508498|NCT00213148|583255334|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
161508499|NCT00213148|583255335|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
161508500|NCT00213148|583255331|FG000|Cycle 3 (1 Month)|Other|0|||
161508501|NCT00213148|583255332|FG001|Cycle 3 (1 Month)|Other|0|||
161508502|NCT00213148|583255333|FG002|Cycle 3 (1 Month)|Other|1|||
161508503|NCT00213148|583255334|FG003|Cycle 3 (1 Month)|Other|1|||
161674970|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161674971|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161674972|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
161674973|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674974|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674975|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674976|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674977|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
161674978|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674979|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674980|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674981|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674982|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
161674983|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674984|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674985|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674986|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674987|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
161674988|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161926016|NCT03309605|584777046|FG000|Overall Study|Adverse Event|0|||
161926017|NCT03309605|584777047|FG001|Overall Study|Adverse Event|0|||
161926018|NCT03309605|584777048|FG002|Overall Study|Adverse Event|0|||
161926019|NCT03309605|584777049|FG003|Overall Study|Adverse Event|1|||
161926020|NCT03309605|584777050|FG004|Overall Study|Adverse Event|0|||
161926021|NCT03309605|584777051|FG005|Overall Study|Adverse Event|0|||
161926022|NCT03309605|584777052|FG006|Overall Study|Adverse Event|2|||
161926023|NCT03309605|584777053|FG007|Overall Study|Adverse Event|1|||
161926024|NCT03309605|584777046|FG000|Overall Study|Withdrawal by Subject|0|||
161926025|NCT03309605|584777047|FG001|Overall Study|Withdrawal by Subject|0|||
161926026|NCT03309605|584777048|FG002|Overall Study|Withdrawal by Subject|0|||
161926027|NCT03309605|584777049|FG003|Overall Study|Withdrawal by Subject|0|||
161926028|NCT03309605|584777050|FG004|Overall Study|Withdrawal by Subject|1|||
161926029|NCT03309605|584777051|FG005|Overall Study|Withdrawal by Subject|0|||
161926030|NCT03309605|584777052|FG006|Overall Study|Withdrawal by Subject|1|||
161926031|NCT03309605|584777053|FG007|Overall Study|Withdrawal by Subject|1|||
161926032|NCT01129284|584777054|FG000|Overall Study|Adverse Event|2|||
161926033|NCT01129284|584777055|FG001|Overall Study|Adverse Event|0|||
161926034|NCT01129284|584777056|FG002|Overall Study|Adverse Event|1|||
161926035|NCT00960856|584777057|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161926036|NCT00960856|584777058|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
161926037|NCT00960856|584777059|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
161926038|NCT00960856|584777060|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
161674989|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161674990|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161674991|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161674992|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
161674993|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161674994|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161683066|NCT01148537|583891233|FG000|Overall Study|Withdrawal by Subject|1|||
161926039|NCT00960856|584777057|FG000|Washout Period of 7 Days|Adverse Event|0|||
161926040|NCT00960856|584777058|FG001|Washout Period of 7 Days|Adverse Event|0|||
161926041|NCT00960856|584777059|FG002|Washout Period of 7 Days|Adverse Event|1|||
161926042|NCT00960856|584777060|FG003|Washout Period of 7 Days|Adverse Event|0|||
161926043|NCT04027946|584777062|FG000|Overall Study|Screen failures|3|||
161926044|NCT05938010|584777063|FG000|Overall Study|Lost to Follow-up|2|||
161586971|NCT04533022|583537386|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
161586972|NCT04850807|583537398|FG000|Overall Study|Death|50|||
161586973|NCT04850807|583537399|FG001|Overall Study|Death|55|||
161586974|NCT04850807|583537398|FG000|Overall Study|Discharged|17|||
161586975|NCT04850807|583537399|FG001|Overall Study|Discharged|13|||
161586976|NCT04850807|583537398|FG000|Overall Study|Incomplete baseline data|3|||
161586977|NCT04850807|583537399|FG001|Overall Study|Incomplete baseline data|2|||
161586978|NCT03739996|583537400|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
161586979|NCT03739996|583537400|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
161586980|NCT03739996|583537400|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
161586981|NCT03739996|583537400|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
161586982|NCT03739996|583537400|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
161586983|NCT03739996|583537400|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
161586984|NCT03739996|583537400|FG000|Step 3 (SOC ART)|Death|1|||
161586985|NCT03739996|583537400|FG000|Step 3 (SOC ART)|Participant moved|1|||
161586986|NCT05141903|583537401|FG000|Overall Study|Withdrawal by Subject|0|||
161586987|NCT05141903|583537402|FG001|Overall Study|Withdrawal by Subject|1|||
161586988|NCT05141903|583537403|FG002|Overall Study|Withdrawal by Subject|1|||
161586989|NCT05141903|583537404|FG003|Overall Study|Withdrawal by Subject|0|||
161586990|NCT05141903|583537405|FG004|Overall Study|Withdrawal by Subject|0|||
161586991|NCT05141903|583537401|FG000|Overall Study|Other|1|||
161586992|NCT05141903|583537402|FG001|Overall Study|Other|1|||
161586993|NCT05141903|583537403|FG002|Overall Study|Other|0|||
161586994|NCT05141903|583537404|FG003|Overall Study|Other|0|||
161586995|NCT05141903|583537405|FG004|Overall Study|Other|0|||
161586996|NCT05461131|583537406|FG000|Overall Study|Lost to Follow-up|0|||
161586997|NCT05461131|583537407|FG001|Overall Study|Lost to Follow-up|2|||
161586998|NCT04549168|583537410|FG000|Randomization Phase|Adverse Event|0|||
161586999|NCT04549168|583537411|FG001|Randomization Phase|Adverse Event|0|||
161587000|NCT04549168|583537412|FG002|Randomization Phase|Adverse Event|1|||
161587001|NCT04549168|583537410|FG000|Randomization Phase|Other|0|||
161587002|NCT04549168|583537411|FG001|Randomization Phase|Other|2|||
161587003|NCT04549168|583537412|FG002|Randomization Phase|Other|0|||
161587004|NCT04549168|583537410|FG000|Randomization Phase|Withdrawal by Subject|0|||
161587005|NCT04549168|583537411|FG001|Randomization Phase|Withdrawal by Subject|2|||
161587006|NCT04549168|583537412|FG002|Randomization Phase|Withdrawal by Subject|1|||
161587007|NCT04737772|583537413|FG000|Phase 2 Study|Lost to Follow-up|15|||
161587008|NCT04737772|583537414|FG001|Phase 2 Study|Lost to Follow-up|15|||
161587009|NCT04737772|583537413|FG000|Phase 2 Study|Withdrawal by Subject|0|||
161587010|NCT04737772|583537414|FG001|Phase 2 Study|Withdrawal by Subject|1|||
161587011|NCT04737772|583537413|FG000|Phase 2 Study|Did not take any coaching calls|4|||
161587012|NCT04737772|583537414|FG001|Phase 2 Study|Did not take any coaching calls|0|||
161587013|NCT04737772|583537413|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
161587014|NCT04737772|583537414|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
161587015|NCT04737772|583537413|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
161587016|NCT04737772|583537414|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
161587017|NCT02549339|583537415|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
161587018|NCT02549339|583537416|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
161587019|NCT02549339|583537415|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
161587020|NCT02549339|583537416|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
161820344|NCT00659815|584382783|FG000|Overall Study|Withdrawal by Subject|1|||
161820345|NCT00659815|584382784|FG001|Overall Study|Withdrawal by Subject|1|||
161820346|NCT02578641|584382785|FG000|Overall Study|Adverse Event|5|||
161820347|NCT02578641|584382786|FG001|Overall Study|Adverse Event|15|||
161820348|NCT02578641|584382785|FG000|Overall Study|Death|16|||
161820349|NCT02578641|584382786|FG001|Overall Study|Death|8|||
161820350|NCT02578641|584382785|FG000|Overall Study|Lost to Follow-up|0|||
161820351|NCT02578641|584382786|FG001|Overall Study|Lost to Follow-up|1|||
161587021|NCT02549339|583537415|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
161587022|NCT02549339|583537416|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
161587023|NCT02549339|583537415|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161587024|NCT02549339|583537416|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
161587025|NCT02549339|583537415|FG000|12-month Follow-up|Lack of Efficacy|0|||
161587026|NCT02549339|583537416|FG001|12-month Follow-up|Lack of Efficacy|2|||
161587027|NCT02549339|583537415|FG000|12-month Follow-up|Withdrawal by Subject|8|||
161587028|NCT02549339|583537416|FG001|12-month Follow-up|Withdrawal by Subject|3|||
161820352|NCT02578641|584382785|FG000|Overall Study|Withdrawal by Subject|14|||
161508504|NCT00213148|583255335|FG004|Cycle 3 (1 Month)|Other|0|||
161508505|NCT02321462|583255338|FG000|Overall Study|Withdrawal by Subject|5|||
161508506|NCT02321462|583255339|FG001|Overall Study|Withdrawal by Subject|2|||
161508507|NCT02321462|583255338|FG000|Overall Study|Subject withdrawn before any treatment|1|||
161508508|NCT02321462|583255339|FG001|Overall Study|Subject withdrawn before any treatment|1|||
161508509|NCT03044197|583255350|FG000|Overall Study|Withdrawal by Subject|3|||
161820353|NCT02578641|584382786|FG001|Overall Study|Withdrawal by Subject|7|||
161820354|NCT02578641|584382785|FG000|Overall Study|Progressive Disease|69|||
161820355|NCT02578641|584382786|FG001|Overall Study|Progressive Disease|21|||
161820356|NCT02578641|584382785|FG000|Overall Study|No Study Drug|2|||
161820357|NCT02578641|584382786|FG001|Overall Study|No Study Drug|0|||
161820358|NCT02578641|584382785|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
161820359|NCT02578641|584382786|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
161820360|NCT02578641|584382785|FG000|Overall Study|Non-compliance with Study Schedule|1|||
161820361|NCT02578641|584382786|FG001|Overall Study|Non-compliance with Study Schedule|0|||
161820362|NCT02578641|584382785|FG000|Overall Study|Other|1|||
161508510|NCT03044197|583255351|FG001|Overall Study|Withdrawal by Subject|1|||
161508511|NCT01574352|583255355|FG000|Overall Study|Withdrawal by Subject|6|||
161508512|NCT01574352|583255356|FG001|Overall Study|Withdrawal by Subject|13|||
161508513|NCT01574352|583255355|FG000|Overall Study|Injury in non-camp related sport|1|||
161508514|NCT01574352|583255356|FG001|Overall Study|Injury in non-camp related sport|0|||
161508515|NCT00660348|583255357|FG000|Overall Study|Withdrawal by Subject|1|||
161508516|NCT00660348|583255358|FG001|Overall Study|Withdrawal by Subject|0|||
161508517|NCT02741115|583255359|FG000|Overall Study|Adverse Event|1|||
161508518|NCT02741115|583255360|FG001|Overall Study|Adverse Event|0|||
161508519|NCT02741115|583255359|FG000|Overall Study|Lost to Follow-up|7|||
161508520|NCT02741115|583255360|FG001|Overall Study|Lost to Follow-up|4|||
161508521|NCT02741115|583255359|FG000|Overall Study|Withdrawal by Subject|4|||
161508522|NCT02741115|583255360|FG001|Overall Study|Withdrawal by Subject|2|||
161508523|NCT03945981|583255361|FG000|Overall Study|Lost to Follow-up|12|||
161587029|NCT02549339|583537415|FG000|12-month Follow-up|Lost to Follow-up|1|||
161587030|NCT02549339|583537416|FG001|12-month Follow-up|Lost to Follow-up|3|||
161587031|NCT02549339|583537415|FG000|12-month Follow-up|Other|0|||
161587032|NCT02549339|583537416|FG001|12-month Follow-up|Other|3|||
161587033|NCT02728076|583537417|FG000|Overall Study|Physician Decision|4|||
161587034|NCT05054374|583537418|FG000|Overall Study|Withdrawal by Subject|1|||
161587035|NCT05054374|583537419|FG001|Overall Study|Withdrawal by Subject|0|||
161587036|NCT05054374|583537420|FG002|Overall Study|Withdrawal by Subject|0|||
161587037|NCT05054374|583537421|FG003|Overall Study|Withdrawal by Subject|0|||
161587038|NCT05054374|583537418|FG000|Overall Study|Progressive Disease|5|||
161587039|NCT05054374|583537419|FG001|Overall Study|Progressive Disease|0|||
161587040|NCT05054374|583537420|FG002|Overall Study|Progressive Disease|0|||
161587041|NCT05054374|583537421|FG003|Overall Study|Progressive Disease|0|||
161587042|NCT05691309|583537422|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
161587043|NCT05691309|583537422|FG000|Overall Study|vancomycin levels not evaluable|2|||
161587044|NCT05415410|583537424|FG000|Overall Study|Death|3|||
161587045|NCT05415410|583537425|FG001|Overall Study|Death|6|||
161587046|NCT05415410|583537426|FG002|Overall Study|Death|1|||
161587047|NCT05415410|583537424|FG000|Overall Study|Trial Terminated by Sponsor|1|||
161587048|NCT05415410|583537425|FG001|Overall Study|Trial Terminated by Sponsor|5|||
161587049|NCT05415410|583537426|FG002|Overall Study|Trial Terminated by Sponsor|0|||
161587050|NCT05415410|583537424|FG000|Overall Study|Adverse Event|2|||
161587051|NCT05415410|583537425|FG001|Overall Study|Adverse Event|1|||
161587052|NCT05415410|583537426|FG002|Overall Study|Adverse Event|0|||
161587053|NCT05415410|583537424|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
161587054|NCT05415410|583537425|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
161587055|NCT05415410|583537426|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
161587056|NCT05415410|583537424|FG000|Overall Study|Withdrawal by Subject|1|||
161587057|NCT05415410|583537425|FG001|Overall Study|Withdrawal by Subject|0|||
161587058|NCT05415410|583537426|FG002|Overall Study|Withdrawal by Subject|0|||
161587059|NCT05415410|583537424|FG000|Overall Study|Pregnancy|5|||
161587060|NCT05415410|583537425|FG001|Overall Study|Pregnancy|2|||
161587061|NCT05415410|583537426|FG002|Overall Study|Pregnancy|0|||
161587062|NCT01532388|583537428|FG000|3-month Follow-up|Lost to Follow-up|68|||
161820363|NCT02578641|584382786|FG001|Overall Study|Other|10|||
161820364|NCT02578641|584382785|FG000|Overall Study|Not treated|1|||
161508524|NCT03945981|583255361|FG000|Overall Study|Physician Decision|4|||
161508525|NCT03945981|583255361|FG000|Overall Study|Withdrawal by Subject|6|||
161508526|NCT03945981|583255361|FG000|Overall Study|Protocol Violation|1|||
161587063|NCT01532388|583537429|FG001|3-month Follow-up|Lost to Follow-up|68|||
161587064|NCT01532388|583537428|FG000|6-month Follow-up|Lost to Follow-up|74|||
161587065|NCT01532388|583537429|FG001|6-month Follow-up|Lost to Follow-up|66|||
161587066|NCT01532388|583537428|FG000|12-month Follow-up|Lost to Follow-up|69|||
161587067|NCT01532388|583537429|FG001|12-month Follow-up|Lost to Follow-up|67|||
161587068|NCT00792636|583537430|FG000|Overall Study|Protocol Violation|17|||
161820365|NCT02578641|584382786|FG001|Overall Study|Not treated|4|||
161820366|NCT02655224|584382789|FG000|Overall Study|Adverse Event|1|||
161820367|NCT02655224|584382790|FG001|Overall Study|Adverse Event|1|||
161820368|NCT04227899|584382797|FG000|Overall Study|Withdrawal by Subject|6|||
161820369|NCT04227899|584382798|FG001|Overall Study|Withdrawal by Subject|3|||
161820370|NCT04227899|584382797|FG000|Overall Study|Death|12|||
161820371|NCT04227899|584382798|FG001|Overall Study|Death|6|||
161820372|NCT04227899|584382797|FG000|Overall Study|Lost to Follow-up|2|||
161820373|NCT04227899|584382798|FG001|Overall Study|Lost to Follow-up|1|||
161820374|NCT05151471|584382799|FG000|Overall Study|Adverse Event|21|||
161820375|NCT05151471|584382800|FG001|Overall Study|Adverse Event|16|||
161820376|NCT05151471|584382799|FG000|Overall Study|Death|1|||
161820377|NCT05151471|584382800|FG001|Overall Study|Death|0|||
161820378|NCT05151471|584382799|FG000|Overall Study|Lost to Follow-up|0|||
161820379|NCT05151471|584382800|FG001|Overall Study|Lost to Follow-up|1|||
161820380|NCT05151471|584382799|FG000|Overall Study|Withdrawal by Subject|7|||
161820381|NCT05151471|584382800|FG001|Overall Study|Withdrawal by Subject|9|||
161820382|NCT05151471|584382799|FG000|Overall Study|Study terminated by sponsor|49|||
161820383|NCT05151471|584382800|FG001|Overall Study|Study terminated by sponsor|47|||
161820384|NCT05151471|584382799|FG000|Overall Study|Other|2|||
161820385|NCT05151471|584382800|FG001|Overall Study|Other|1|||
161820386|NCT03292458|584382806|FG000|Period 1|Adverse Event|2|||
161820387|NCT03292458|584382807|FG001|Period 1|Adverse Event|0|||
161820388|NCT01741545|584382808|FG000|Treatment Period|Lack of Efficacy|0|||
161926045|NCT00985192|584777064|FG000|Overall Study|Withdrawal by Subject|1|||
161926046|NCT00985192|584777064|FG000|Overall Study|Disease Progression|1|||
161926047|NCT00985192|584777064|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
161926048|NCT01454063|584777065|FG000|Randomized|Adverse Event|1|||
161926049|NCT01454063|584777066|FG001|Randomized|Adverse Event|1|||
161926050|NCT01454063|584777065|FG000|Randomized|Protocol Violation|0|||
161926051|NCT01454063|584777066|FG001|Randomized|Protocol Violation|1|||
161926052|NCT01562444|584777070|FG000|Overall Study|Did not meet entry criteria|2|||
161926053|NCT01562444|584777071|FG001|Overall Study|Did not meet entry criteria|0|||
161926054|NCT01562444|584777072|FG002|Overall Study|Did not meet entry criteria|3|||
161926055|NCT01562444|584777070|FG000|Overall Study|Did not comply with blood draw schedule|1|||
161926056|NCT01562444|584777071|FG001|Overall Study|Did not comply with blood draw schedule|0|||
161926057|NCT01562444|584777072|FG002|Overall Study|Did not comply with blood draw schedule|1|||
161926058|NCT01562444|584777070|FG000|Overall Study|Unavailable serological results|0|||
161926059|NCT01562444|584777071|FG001|Overall Study|Unavailable serological results|2|||
161926060|NCT01562444|584777072|FG002|Overall Study|Unavailable serological results|2|||
161926061|NCT01562444|584777070|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
161926062|NCT01562444|584777071|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
161926063|NCT01562444|584777072|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
161926064|NCT01562444|584777070|FG000|Overall Study|Protocol forbidden medication|1|||
161926065|NCT01562444|584777071|FG001|Overall Study|Protocol forbidden medication|0|||
161926066|NCT01562444|584777072|FG002|Overall Study|Protocol forbidden medication|0|||
161926067|NCT03055195|584777074|FG000|Overall Study|Lack of Efficacy|1|||
161926068|NCT03055195|584777075|FG001|Overall Study|Lack of Efficacy|0|||
161587069|NCT00792636|583537431|FG001|Overall Study|Protocol Violation|23|||
161587070|NCT00792636|583537432|FG002|Overall Study|Protocol Violation|20|||
161587071|NCT00792636|583537430|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
161587072|NCT00792636|583537431|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
161587073|NCT00792636|583537432|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
161587074|NCT00792636|583537430|FG000|Overall Study|Lost to Follow-up|13|||
161587075|NCT00792636|583537431|FG001|Overall Study|Lost to Follow-up|19|||
161587076|NCT00792636|583537432|FG002|Overall Study|Lost to Follow-up|14|||
161587077|NCT00792636|583537430|FG000|Overall Study|Withdrew Consent|10|||
161587078|NCT00792636|583537431|FG001|Overall Study|Withdrew Consent|13|||
161587079|NCT00792636|583537432|FG002|Overall Study|Withdrew Consent|9|||
161587080|NCT00792636|583537430|FG000|Overall Study|Lack of Efficacy|3|||
161587081|NCT00792636|583537431|FG001|Overall Study|Lack of Efficacy|4|||
161587082|NCT00792636|583537432|FG002|Overall Study|Lack of Efficacy|13|||
161587083|NCT00792636|583537430|FG000|Overall Study|Adverse Event|4|||
161587084|NCT00792636|583537431|FG001|Overall Study|Adverse Event|2|||
161587085|NCT00792636|583537432|FG002|Overall Study|Adverse Event|3|||
161587086|NCT00792636|583537430|FG000|Overall Study|Investigator Discretion|2|||
161587087|NCT00792636|583537431|FG001|Overall Study|Investigator Discretion|0|||
161587088|NCT00792636|583537432|FG002|Overall Study|Investigator Discretion|2|||
161587089|NCT03069313|583537433|FG000|Overall Study|Adverse Event|5|||
161587090|NCT03912831|583537435|FG000|Overall Study|Death|1|||
161587091|NCT03912831|583537436|FG001|Overall Study|Death|1|||
161587092|NCT03912831|583537437|FG002|Overall Study|Death|1|||
161587093|NCT03912831|583537438|FG003|Overall Study|Death|1|||
161587094|NCT03912831|583537439|FG004|Overall Study|Death|1|||
161587095|NCT03912831|583537440|FG005|Overall Study|Death|1|||
161587096|NCT03912831|583537435|FG000|Overall Study|Reason not Specified|0|||
161587097|NCT03912831|583537436|FG001|Overall Study|Reason not Specified|0|||
161587098|NCT03912831|583537437|FG002|Overall Study|Reason not Specified|0|||
161587099|NCT03912831|583537438|FG003|Overall Study|Reason not Specified|0|||
161926069|NCT03055195|584777074|FG000|Overall Study|Withdrawal by Subject|6|||
161926070|NCT03055195|584777075|FG001|Overall Study|Withdrawal by Subject|7|||
161926071|NCT03055195|584777074|FG000|Overall Study|Study Terminated by Sponsor|2|||
161926072|NCT03055195|584777075|FG001|Overall Study|Study Terminated by Sponsor|6|||
161926073|NCT03055195|584777074|FG000|Overall Study|Protocol Violation|2|||
161926074|NCT03055195|584777075|FG001|Overall Study|Protocol Violation|1|||
161926075|NCT03055195|584777074|FG000|Overall Study|Physician Decision|1|||
161926076|NCT03055195|584777075|FG001|Overall Study|Physician Decision|0|||
161926077|NCT00421733|584777079|FG000|Overall Study|Adverse Event|4|||
161926078|NCT00421733|584777080|FG001|Overall Study|Adverse Event|9|||
161587100|NCT03912831|583537439|FG004|Overall Study|Reason not Specified|1|||
161587101|NCT03912831|583537440|FG005|Overall Study|Reason not Specified|0|||
161587102|NCT03912831|583537435|FG000|Overall Study|Withdrawal by Participant|0|||
161587103|NCT03912831|583537436|FG001|Overall Study|Withdrawal by Participant|0|||
161587104|NCT03912831|583537437|FG002|Overall Study|Withdrawal by Participant|0|||
161587105|NCT03912831|583537438|FG003|Overall Study|Withdrawal by Participant|0|||
161587106|NCT03912831|583537439|FG004|Overall Study|Withdrawal by Participant|1|||
161587107|NCT03912831|583537440|FG005|Overall Study|Withdrawal by Participant|0|||
161587108|NCT03580369|583537441|FG000|Overall Study|No treatment due to mis-randomization|1|||
161587109|NCT03580369|583537442|FG001|Overall Study|No treatment due to mis-randomization|0|||
161587110|NCT03580369|583537443|FG002|Overall Study|No treatment due to mis-randomization|0|||
161587111|NCT03580369|583537444|FG003|Overall Study|No treatment due to mis-randomization|0|||
161587112|NCT03580369|583537445|FG004|Overall Study|No treatment due to mis-randomization|3|||
161587113|NCT03580369|583537446|FG005|Overall Study|No treatment due to mis-randomization|0|||
161587114|NCT03580369|583537447|FG006|Overall Study|No treatment due to mis-randomization|0|||
161587115|NCT03580369|583537448|FG007|Overall Study|No treatment due to mis-randomization|0|||
161587116|NCT03580369|583537441|FG000|Overall Study|Reason unknown|0|||
161587117|NCT03580369|583537442|FG001|Overall Study|Reason unknown|0|||
161587118|NCT03580369|583537443|FG002|Overall Study|Reason unknown|1|||
161587119|NCT03580369|583537444|FG003|Overall Study|Reason unknown|0|||
161587120|NCT03580369|583537445|FG004|Overall Study|Reason unknown|0|||
161926079|NCT00421733|584777081|FG002|Overall Study|Adverse Event|2|||
161926080|NCT00421733|584777079|FG000|Overall Study|Lost to Follow-up|1|||
161926081|NCT00421733|584777080|FG001|Overall Study|Lost to Follow-up|2|||
161674995|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161674996|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161674997|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
161674998|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161674999|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161675000|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161675001|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161675002|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
161675003|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675004|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675005|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675006|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675007|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
161675008|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675009|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675010|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675011|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675012|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
161675013|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
161675014|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
161675015|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
161675016|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
161675017|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161675018|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161675019|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
161675020|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
161675021|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161675022|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
161675023|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
161675024|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
161675025|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
161675026|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
161675027|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161675028|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
161675029|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
161675030|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
161675031|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161675032|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675033|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675034|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
161675035|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675036|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675037|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
161675038|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
161675039|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
161675040|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
161675041|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
161675042|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675043|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675044|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675045|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675046|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
161675047|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161675048|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161675049|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161926082|NCT00421733|584777081|FG002|Overall Study|Lost to Follow-up|4|||
161926083|NCT00421733|584777079|FG000|Overall Study|Withdrawal by Subject|1|||
161926084|NCT00421733|584777080|FG001|Overall Study|Withdrawal by Subject|2|||
161926085|NCT00421733|584777081|FG002|Overall Study|Withdrawal by Subject|7|||
161926086|NCT00421733|584777079|FG000|Overall Study|Death|0|||
161926087|NCT00421733|584777080|FG001|Overall Study|Death|3|||
161508527|NCT00256698|583255364|FG000|Overall Study|Withdrawal by Subject|7|||
161508528|NCT00256698|583255365|FG001|Overall Study|Withdrawal by Subject|7|||
161508529|NCT00256698|583255364|FG000|Overall Study|Adverse Event|13|||
161926088|NCT00421733|584777081|FG002|Overall Study|Death|0|||
161926089|NCT00421733|584777079|FG000|Overall Study|Required dialysis|1|||
161926090|NCT00421733|584777080|FG001|Overall Study|Required dialysis|0|||
161926091|NCT00421733|584777081|FG002|Overall Study|Required dialysis|0|||
161926092|NCT00421733|584777079|FG000|Overall Study|Administrative|2|||
161926093|NCT00421733|584777080|FG001|Overall Study|Administrative|0|||
161926094|NCT00421733|584777081|FG002|Overall Study|Administrative|0|||
161926095|NCT00421733|584777079|FG000|Overall Study|Did not satisfy entry criteria|1|||
161926096|NCT00421733|584777080|FG001|Overall Study|Did not satisfy entry criteria|3|||
161926097|NCT00421733|584777081|FG002|Overall Study|Did not satisfy entry criteria|2|||
161926098|NCT00421733|584777079|FG000|Overall Study|Sponsor request|1|||
161926099|NCT00421733|584777080|FG001|Overall Study|Sponsor request|0|||
161926100|NCT00421733|584777081|FG002|Overall Study|Sponsor request|3|||
161926101|NCT00421733|584777079|FG000|Overall Study|Protocol deviation|4|||
161926102|NCT00421733|584777080|FG001|Overall Study|Protocol deviation|7|||
161926103|NCT00421733|584777081|FG002|Overall Study|Protocol deviation|2|||
161926104|NCT00790933|584777082|FG000|Overall Study|Adverse Event|94|||
161926105|NCT00790933|584777083|FG001|Overall Study|Adverse Event|119|||
161926106|NCT00790933|584777084|FG002|Overall Study|Adverse Event|65|||
161926107|NCT00790933|584777085|FG003|Overall Study|Adverse Event|5|||
161926108|NCT00790933|584777086|FG004|Overall Study|Adverse Event|69|||
161926109|NCT00790933|584777082|FG000|Overall Study|Protocol Violation(s)|8|||
161926110|NCT00790933|584777083|FG001|Overall Study|Protocol Violation(s)|18|||
161926111|NCT00790933|584777084|FG002|Overall Study|Protocol Violation(s)|7|||
161926112|NCT00790933|584777085|FG003|Overall Study|Protocol Violation(s)|0|||
161926113|NCT00790933|584777086|FG004|Overall Study|Protocol Violation(s)|12|||
161926114|NCT00790933|584777082|FG000|Overall Study|Lack of Efficacy|192|||
161587121|NCT03580369|583537446|FG005|Overall Study|Reason unknown|0|||
161587122|NCT03580369|583537447|FG006|Overall Study|Reason unknown|0|||
161587123|NCT03580369|583537448|FG007|Overall Study|Reason unknown|0|||
161587124|NCT03580369|583537441|FG000|Overall Study|Technical problems|0|||
161587125|NCT03580369|583537442|FG001|Overall Study|Technical problems|0|||
161587126|NCT03580369|583537443|FG002|Overall Study|Technical problems|0|||
161587127|NCT03580369|583537444|FG003|Overall Study|Technical problems|0|||
161587128|NCT03580369|583537445|FG004|Overall Study|Technical problems|1|||
161587129|NCT03580369|583537446|FG005|Overall Study|Technical problems|0|||
161587130|NCT03580369|583537447|FG006|Overall Study|Technical problems|2|||
161587131|NCT03580369|583537448|FG007|Overall Study|Technical problems|0|||
161587132|NCT03580369|583537441|FG000|Overall Study|Pregnancy|2|||
161587133|NCT03580369|583537442|FG001|Overall Study|Pregnancy|0|||
161587134|NCT03580369|583537443|FG002|Overall Study|Pregnancy|3|||
161587135|NCT03580369|583537444|FG003|Overall Study|Pregnancy|0|||
161587136|NCT03580369|583537445|FG004|Overall Study|Pregnancy|2|||
161587137|NCT03580369|583537446|FG005|Overall Study|Pregnancy|0|||
161587138|NCT03580369|583537447|FG006|Overall Study|Pregnancy|0|||
161587139|NCT03580369|583537448|FG007|Overall Study|Pregnancy|0|||
161587140|NCT03580369|583537441|FG000|Overall Study|Lost to Follow-up|2|||
161587141|NCT03580369|583537442|FG001|Overall Study|Lost to Follow-up|0|||
161587142|NCT03580369|583537443|FG002|Overall Study|Lost to Follow-up|2|||
161587143|NCT03580369|583537444|FG003|Overall Study|Lost to Follow-up|0|||
161587144|NCT03580369|583537445|FG004|Overall Study|Lost to Follow-up|3|||
161587145|NCT03580369|583537446|FG005|Overall Study|Lost to Follow-up|0|||
161926115|NCT00790933|584777083|FG001|Overall Study|Lack of Efficacy|176|||
161926116|NCT00790933|584777084|FG002|Overall Study|Lack of Efficacy|130|||
161587146|NCT03580369|583537447|FG006|Overall Study|Lost to Follow-up|1|||
161587147|NCT03580369|583537448|FG007|Overall Study|Lost to Follow-up|0|||
161587148|NCT03580369|583537441|FG000|Overall Study|Physician Decision|4|||
161587149|NCT03580369|583537442|FG001|Overall Study|Physician Decision|0|||
161587150|NCT03580369|583537443|FG002|Overall Study|Physician Decision|4|||
161587151|NCT03580369|583537444|FG003|Overall Study|Physician Decision|1|||
161587152|NCT03580369|583537445|FG004|Overall Study|Physician Decision|1|||
161587153|NCT03580369|583537446|FG005|Overall Study|Physician Decision|0|||
161926117|NCT00790933|584777085|FG003|Overall Study|Lack of Efficacy|1|||
161926118|NCT00790933|584777086|FG004|Overall Study|Lack of Efficacy|121|||
161926119|NCT00790933|584777082|FG000|Overall Study|Study Terminated by Sponsor|0|||
161926120|NCT00790933|584777083|FG001|Overall Study|Study Terminated by Sponsor|0|||
161926121|NCT00790933|584777084|FG002|Overall Study|Study Terminated by Sponsor|1|||
161926122|NCT00790933|584777085|FG003|Overall Study|Study Terminated by Sponsor|0|||
161926123|NCT00790933|584777086|FG004|Overall Study|Study Terminated by Sponsor|0|||
161926124|NCT00790933|584777082|FG000|Overall Study|Withdrawal by Subject|123|||
161926125|NCT00790933|584777083|FG001|Overall Study|Withdrawal by Subject|120|||
161926126|NCT00790933|584777084|FG002|Overall Study|Withdrawal by Subject|52|||
161926127|NCT00790933|584777085|FG003|Overall Study|Withdrawal by Subject|6|||
161926128|NCT00790933|584777086|FG004|Overall Study|Withdrawal by Subject|50|||
161926129|NCT00790933|584777082|FG000|Overall Study|Lost to Follow-up|13|||
161926130|NCT00790933|584777083|FG001|Overall Study|Lost to Follow-up|31|||
161926131|NCT00790933|584777084|FG002|Overall Study|Lost to Follow-up|10|||
161926132|NCT00790933|584777085|FG003|Overall Study|Lost to Follow-up|1|||
161926133|NCT00790933|584777086|FG004|Overall Study|Lost to Follow-up|15|||
161926134|NCT00790933|584777082|FG000|Overall Study|Reason Not Specified|8|||
161926135|NCT00790933|584777083|FG001|Overall Study|Reason Not Specified|16|||
161926136|NCT00790933|584777084|FG002|Overall Study|Reason Not Specified|4|||
161926137|NCT00790933|584777085|FG003|Overall Study|Reason Not Specified|1|||
161926138|NCT00790933|584777086|FG004|Overall Study|Reason Not Specified|9|||
161926139|NCT00720083|584777089|FG000|Overall Study|Ineligible|1|||
161926140|NCT00720083|584777090|FG001|Overall Study|Ineligible|2|||
161926141|NCT00894647|584777091|FG000|Overall Study|Adverse Event|5|||
161926142|NCT00894647|584777092|FG001|Overall Study|Adverse Event|4|||
161926143|NCT00894647|584777091|FG000|Overall Study|Withdrawal by Subject|4|||
161926144|NCT00894647|584777092|FG001|Overall Study|Withdrawal by Subject|4|||
161926145|NCT00894647|584777091|FG000|Overall Study|Lost to Follow-up|0|||
161926146|NCT00894647|584777092|FG001|Overall Study|Lost to Follow-up|2|||
161926147|NCT00894647|584777091|FG000|Overall Study|Non-compliance with study procedures|0|||
161926148|NCT00894647|584777092|FG001|Overall Study|Non-compliance with study procedures|2|||
161926149|NCT00894647|584777091|FG000|Overall Study|Other, not due to AE|1|||
161926150|NCT00894647|584777092|FG001|Overall Study|Other, not due to AE|2|||
161926151|NCT00245570|584777099|FG000|Washout Between Periods III and IV|Adverse Event|0|||
161926152|NCT00245570|584777100|FG001|Washout Between Periods III and IV|Adverse Event|1|||
161926153|NCT00245570|584777101|FG002|Washout Between Periods III and IV|Adverse Event|0|||
161926154|NCT00245570|584777102|FG003|Washout Between Periods III and IV|Adverse Event|0|||
161926155|NCT00245570|584777103|FG004|Washout Between Periods III and IV|Adverse Event|0|||
161926156|NCT00245570|584777104|FG005|Washout Between Periods III and IV|Adverse Event|0|||
161926157|NCT01913470|584777105|FG000|Overall Study|Lost to Follow-up|0|||
161926158|NCT01913470|584777106|FG001|Overall Study|Lost to Follow-up|1|||
161926159|NCT01913470|584777105|FG000|Overall Study|Physician Decision|0|||
161926160|NCT01913470|584777106|FG001|Overall Study|Physician Decision|1|||
161926161|NCT01913470|584777105|FG000|Overall Study|Withdrawal by Subject|0|||
161926162|NCT01913470|584777106|FG001|Overall Study|Withdrawal by Subject|1|||
161926163|NCT01524705|584777111|FG000|Overall Study|Adverse Event|2|||
161926164|NCT01524705|584777112|FG001|Overall Study|Adverse Event|0|||
161926165|NCT01524705|584777111|FG000|Overall Study|Death|1|||
161926166|NCT01524705|584777112|FG001|Overall Study|Death|0|||
161926167|NCT01524705|584777111|FG000|Overall Study|Lost to Follow-up|0|||
161926168|NCT01524705|584777112|FG001|Overall Study|Lost to Follow-up|1|||
161926169|NCT01524705|584777111|FG000|Overall Study|Withdrawal by Subject|0|||
161926170|NCT01524705|584777112|FG001|Overall Study|Withdrawal by Subject|1|||
161926171|NCT01524705|584777111|FG000|Overall Study|Pancreatic Cancer|0|||
161926172|NCT01524705|584777112|FG001|Overall Study|Pancreatic Cancer|1|||
161926173|NCT01829165|584777118|FG000|Overall Study|Did not complete intervention|2|||
161926174|NCT01829165|584777119|FG001|Overall Study|Did not complete intervention|0|||
161926175|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
161926176|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
161508530|NCT00256698|583255365|FG001|Overall Study|Adverse Event|6|||
161508531|NCT00256698|583255364|FG000|Overall Study|Protocol Violation|6|||
161508532|NCT00256698|583255365|FG001|Overall Study|Protocol Violation|5|||
161508533|NCT00256698|583255364|FG000|Overall Study|Lost to Follow-up|1|||
161508534|NCT00256698|583255365|FG001|Overall Study|Lost to Follow-up|3|||
161508535|NCT00256698|583255364|FG000|Overall Study|disease progression|97|||
161508536|NCT00256698|583255365|FG001|Overall Study|disease progression|105|||
161508537|NCT00256698|583255364|FG000|Overall Study|still ongoing at data cut-off|41|||
161508538|NCT00256698|583255365|FG001|Overall Study|still ongoing at data cut-off|46|||
161508539|NCT00256698|583255364|FG000|Overall Study|withdrawn due to osteoporosis|1|||
161508540|NCT00256698|583255365|FG001|Overall Study|withdrawn due to osteoporosis|0|||
161508541|NCT00256698|583255364|FG000|Overall Study|Prematurely Discontinued|1|||
161926177|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
161926178|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
161926179|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
161926180|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
161926181|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
161926182|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
161926183|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
161926184|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
161926185|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
161926186|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
161508542|NCT00256698|583255365|FG001|Overall Study|Prematurely Discontinued|0|||
161508543|NCT03962543|583255367|FG000|Treatment Phase|Death|0|||
161508544|NCT03962543|583255368|FG001|Treatment Phase|Death|1|||
161508545|NCT03962543|583255367|FG000|Treatment Phase|Withdrawal by Subject|3|||
161508546|NCT03962543|583255368|FG001|Treatment Phase|Withdrawal by Subject|0|||
161508547|NCT03962543|583255367|FG000|Treatment Phase|Adverse Event|3|||
161508548|NCT03962543|583255368|FG001|Treatment Phase|Adverse Event|12|||
161508549|NCT03962543|583255367|FG000|Treatment Phase|Lost to Follow-up|1|||
161508550|NCT03962543|583255368|FG001|Treatment Phase|Lost to Follow-up|2|||
161508551|NCT03962543|583255367|FG000|Treatment Phase|Radiographic PD|9|||
161508552|NCT03962543|583255368|FG001|Treatment Phase|Radiographic PD|3|||
161508553|NCT03962543|583255367|FG000|Treatment Phase|Participant Decision|3|||
161508554|NCT03962543|583255368|FG001|Treatment Phase|Participant Decision|8|||
161508555|NCT03962543|583255367|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
161508556|NCT03962543|583255368|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
161508557|NCT03962543|583255367|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
161508558|NCT03962543|583255368|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
161508559|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
161508560|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
161508561|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
161508562|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
161508563|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
161508564|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
161508565|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
161508566|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
161508567|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
161508568|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
161508569|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
161508570|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
161587154|NCT03580369|583537447|FG006|Overall Study|Physician Decision|0|||
161587155|NCT03580369|583537448|FG007|Overall Study|Physician Decision|0|||
161587156|NCT03580369|583537441|FG000|Overall Study|Lack of Efficacy|3|||
161587157|NCT03580369|583537442|FG001|Overall Study|Lack of Efficacy|0|||
161587158|NCT03580369|583537443|FG002|Overall Study|Lack of Efficacy|7|||
161587159|NCT03580369|583537444|FG003|Overall Study|Lack of Efficacy|0|||
161587160|NCT03580369|583537445|FG004|Overall Study|Lack of Efficacy|2|||
161587161|NCT03580369|583537446|FG005|Overall Study|Lack of Efficacy|0|||
161587162|NCT03580369|583537447|FG006|Overall Study|Lack of Efficacy|3|||
161587163|NCT03580369|583537448|FG007|Overall Study|Lack of Efficacy|0|||
161587164|NCT03580369|583537441|FG000|Overall Study|Protocol Violation|6|||
161587165|NCT03580369|583537442|FG001|Overall Study|Protocol Violation|0|||
161587166|NCT03580369|583537443|FG002|Overall Study|Protocol Violation|6|||
161587167|NCT03580369|583537444|FG003|Overall Study|Protocol Violation|1|||
161587168|NCT03580369|583537445|FG004|Overall Study|Protocol Violation|8|||
161587169|NCT03580369|583537446|FG005|Overall Study|Protocol Violation|2|||
161587170|NCT03580369|583537447|FG006|Overall Study|Protocol Violation|1|||
161587171|NCT03580369|583537448|FG007|Overall Study|Protocol Violation|0|||
161587172|NCT03580369|583537441|FG000|Overall Study|Adverse Event|7|||
161587173|NCT03580369|583537442|FG001|Overall Study|Adverse Event|0|||
161587174|NCT03580369|583537443|FG002|Overall Study|Adverse Event|14|||
161820389|NCT01741545|584382809|FG001|Treatment Period|Lack of Efficacy|1|||
161820390|NCT01741545|584382808|FG000|Treatment Period|Adverse event, non-fatal|1|||
161820391|NCT01741545|584382809|FG001|Treatment Period|Adverse event, non-fatal|3|||
161820392|NCT01741545|584382808|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
161820393|NCT01741545|584382809|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
161820394|NCT01741545|584382808|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161820395|NCT01741545|584382809|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161820396|NCT01664039|584382812|FG000|Overall Study|Adverse Event|3|||
161820397|NCT01664039|584382813|FG001|Overall Study|Adverse Event|4|||
161820398|NCT01664039|584382812|FG000|Overall Study|Lost to Follow-up|1|||
161820399|NCT01664039|584382813|FG001|Overall Study|Lost to Follow-up|1|||
161820400|NCT01664039|584382812|FG000|Overall Study|Withdrawal by Subject|1|||
161820401|NCT01664039|584382813|FG001|Overall Study|Withdrawal by Subject|3|||
161820402|NCT01664039|584382812|FG000|Overall Study|Noncompliance|1|||
161508571|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
161508572|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
161587175|NCT03580369|583537444|FG003|Overall Study|Adverse Event|1|||
161587176|NCT03580369|583537445|FG004|Overall Study|Adverse Event|6|||
161587177|NCT03580369|583537446|FG005|Overall Study|Adverse Event|0|||
161587178|NCT03580369|583537447|FG006|Overall Study|Adverse Event|1|||
161587179|NCT03580369|583537448|FG007|Overall Study|Adverse Event|0|||
161820403|NCT01664039|584382813|FG001|Overall Study|Noncompliance|1|||
161820404|NCT01853176|584382814|FG000|Overall Study|Study terminated|4|||
161820405|NCT01853176|584382815|FG001|Overall Study|Study terminated|0|||
161508573|NCT03962543|583255367|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
161926187|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
161926188|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
161926189|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
161926190|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
161508574|NCT03962543|583255368|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
161508575|NCT03548584|583257254|FG000|Overall Study|Lost to Follow-up|0|||
161508576|NCT03548584|583257255|FG001|Overall Study|Lost to Follow-up|0|||
161508577|NCT03548584|583257256|FG002|Overall Study|Lost to Follow-up|1|||
161508578|NCT03548584|583257254|FG000|Overall Study|Adverse Event|1|||
161508579|NCT03548584|583257255|FG001|Overall Study|Adverse Event|11|||
161508580|NCT03548584|583257256|FG002|Overall Study|Adverse Event|5|||
161508581|NCT03548584|583257254|FG000|Overall Study|Site Terminated by Sponsor|1|||
161926191|NCT02573467|584777120|FG000|Post-treatment Follow up Epoch|Death|1|||
161926192|NCT02573467|584777121|FG001|Post-treatment Follow up Epoch|Death|1|||
161926193|NCT02573467|584777122|FG002|Post-treatment Follow up Epoch|Death|0|||
161926194|NCT02573467|584777123|FG003|Post-treatment Follow up Epoch|Death|1|||
161926195|NCT02573467|584777120|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
161926196|NCT02573467|584777121|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
161926197|NCT02573467|584777122|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
161926198|NCT02573467|584777123|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
161926199|NCT02573467|584777120|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
161926200|NCT02573467|584777121|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
161926201|NCT02573467|584777122|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
161926202|NCT02573467|584777123|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
161926203|NCT00103506|584777124|FG000|Overall Study|Study closed by sponsor|34|||
161926204|NCT00103506|584777125|FG001|Overall Study|Study closed by sponsor|37|||
161926205|NCT00103506|584777124|FG000|Overall Study|Death|257|||
161926206|NCT00103506|584777125|FG001|Overall Study|Death|253|||
161926207|NCT00103506|584777124|FG000|Overall Study|Lost to Follow-up|13|||
161926208|NCT00103506|584777125|FG001|Overall Study|Lost to Follow-up|13|||
161926209|NCT00103506|584777124|FG000|Overall Study|Withdrawal by Subject|18|||
161508582|NCT03548584|583257255|FG001|Overall Study|Site Terminated by Sponsor|3|||
161587180|NCT03580369|583537441|FG000|Overall Study|Withdrawal by Subject|19|||
161587181|NCT03580369|583537442|FG001|Overall Study|Withdrawal by Subject|0|||
161587182|NCT03580369|583537443|FG002|Overall Study|Withdrawal by Subject|17|||
161587183|NCT03580369|583537444|FG003|Overall Study|Withdrawal by Subject|0|||
161587184|NCT03580369|583537445|FG004|Overall Study|Withdrawal by Subject|16|||
161587185|NCT03580369|583537446|FG005|Overall Study|Withdrawal by Subject|1|||
161587186|NCT03580369|583537447|FG006|Overall Study|Withdrawal by Subject|7|||
161587187|NCT03580369|583537448|FG007|Overall Study|Withdrawal by Subject|0|||
161587188|NCT05239039|583537450|FG000|Overall Study|Withdrawal by Subject|0|||
161587189|NCT05239039|583537451|FG001|Overall Study|Withdrawal by Subject|1|||
161587190|NCT03897686|583538793|FG000|Overall Study|Protocol Violation|1|||
161587191|NCT03897686|583538794|FG001|Overall Study|Protocol Violation|1|||
161587192|NCT03897686|583538793|FG000|Overall Study|Withdrawal by Subject|1|||
161587193|NCT03897686|583538794|FG001|Overall Study|Withdrawal by Subject|1|||
161587194|NCT05415436|583538795|FG000|Overall Study|Surgeon cancelled procedure|1|||
161587195|NCT05415436|583538796|FG001|Overall Study|Surgeon cancelled procedure|0|||
161587196|NCT05415436|583538795|FG000|Overall Study|Death|1|||
161587197|NCT05415436|583538796|FG001|Overall Study|Death|0|||
161587198|NCT05386355|583538805|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161587199|NCT05386355|583538806|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161587200|NCT05386355|583538807|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161587201|NCT05386355|583538808|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161587202|NCT03775109|583538813|FG000|Overall Study|Adverse Event|1|||
161587203|NCT03775109|583538814|FG001|Overall Study|Adverse Event|0|||
161587204|NCT03775109|583538813|FG000|Overall Study|COVID-19 outbreak|2|||
161587205|NCT03775109|583538814|FG001|Overall Study|COVID-19 outbreak|0|||
161587206|NCT03775109|583538813|FG000|Overall Study|Lost to Follow-up|0|||
161587207|NCT03775109|583538814|FG001|Overall Study|Lost to Follow-up|2|||
161587208|NCT03775109|583538813|FG000|Overall Study|Withdrawal by Subject|1|||
161587209|NCT03775109|583538814|FG001|Overall Study|Withdrawal by Subject|1|||
161587210|NCT03775109|583538813|FG000|Overall Study|Death|0|||
161926210|NCT00103506|584777125|FG001|Overall Study|Withdrawal by Subject|21|||
161926211|NCT00710970|584777128|FG000|Overall Study|Never took drug|3|||
161926212|NCT02153827|584777129|FG000|Overall Study|Lost to Follow-up|3|||
161926213|NCT02153827|584777130|FG001|Overall Study|Lost to Follow-up|9|||
161587211|NCT03775109|583538814|FG001|Overall Study|Death|1|||
161587212|NCT03775109|583538813|FG000|Overall Study|Lack of Efficacy|1|||
161587213|NCT03775109|583538814|FG001|Overall Study|Lack of Efficacy|0|||
161587214|NCT05691452|583538815|FG000|Overall Study|Withdrawal by Subject|1|||
161675050|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161675051|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
161675052|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675053|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675054|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675055|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675056|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
161675057|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
161675058|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
161675059|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
161675060|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
161675061|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
161675062|NCT00283049|583865396|FG000|Overall Study|Adverse Event|6|||
161675063|NCT00283049|583865397|FG001|Overall Study|Adverse Event|1|||
161675064|NCT00283049|583865398|FG002|Overall Study|Adverse Event|4|||
161675065|NCT00283049|583865396|FG000|Overall Study|Protocol Violation|3|||
161675066|NCT00283049|583865397|FG001|Overall Study|Protocol Violation|0|||
161675067|NCT00283049|583865398|FG002|Overall Study|Protocol Violation|3|||
161675068|NCT00283049|583865396|FG000|Overall Study|Death|1|||
161675069|NCT00283049|583865397|FG001|Overall Study|Death|1|||
161675070|NCT00283049|583865398|FG002|Overall Study|Death|1|||
161675071|NCT00283049|583865396|FG000|Overall Study|Lack of Efficacy|0|||
161675072|NCT00283049|583865397|FG001|Overall Study|Lack of Efficacy|1|||
161675073|NCT00283049|583865398|FG002|Overall Study|Lack of Efficacy|1|||
161675074|NCT00283049|583865396|FG000|Overall Study|Lost to Follow-up|4|||
161675075|NCT00283049|583865397|FG001|Overall Study|Lost to Follow-up|2|||
161675076|NCT00283049|583865398|FG002|Overall Study|Lost to Follow-up|5|||
161675077|NCT00283049|583865396|FG000|Overall Study|Withdrawal by Subject|26|||
161675078|NCT00283049|583865397|FG001|Overall Study|Withdrawal by Subject|24|||
161675079|NCT00283049|583865398|FG002|Overall Study|Withdrawal by Subject|19|||
161675080|NCT00283049|583865396|FG000|Overall Study|Discontinuation of Study|18|||
161675081|NCT00283049|583865397|FG001|Overall Study|Discontinuation of Study|16|||
161675082|NCT00283049|583865398|FG002|Overall Study|Discontinuation of Study|20|||
161675083|NCT00283049|583865396|FG000|Overall Study|No longer requires study treatment|0|||
161675084|NCT00283049|583865397|FG001|Overall Study|No longer requires study treatment|0|||
161675085|NCT00283049|583865398|FG002|Overall Study|No longer requires study treatment|1|||
161675086|NCT02953639|583865399|FG000|Overall Study|Adverse Event|2|||
161675087|NCT02953639|583865400|FG001|Overall Study|Adverse Event|0|||
161675088|NCT02953639|583865401|FG002|Overall Study|Adverse Event|1|||
161675089|NCT02953639|583865399|FG000|Overall Study|Lost to Follow-up|8|||
161675090|NCT02953639|583865400|FG001|Overall Study|Lost to Follow-up|4|||
161675091|NCT02953639|583865401|FG002|Overall Study|Lost to Follow-up|3|||
161675092|NCT02953639|583865399|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161675093|NCT02953639|583865400|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161675094|NCT02953639|583865401|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161675095|NCT02953639|583865399|FG000|Overall Study|Multiple Reasons|1|||
161675096|NCT02953639|583865400|FG001|Overall Study|Multiple Reasons|0|||
161675097|NCT02953639|583865401|FG002|Overall Study|Multiple Reasons|1|||
161675098|NCT02953639|583865399|FG000|Overall Study|Physician Decision|1|||
161675099|NCT02953639|583865400|FG001|Overall Study|Physician Decision|0|||
161675100|NCT02953639|583865401|FG002|Overall Study|Physician Decision|0|||
161675101|NCT02953639|583865399|FG000|Overall Study|Withdrawal by Subject|7|||
161675102|NCT02953639|583865400|FG001|Overall Study|Withdrawal by Subject|8|||
161675103|NCT02953639|583865401|FG002|Overall Study|Withdrawal by Subject|10|||
161675104|NCT02953639|583865399|FG000|Overall Study|Completed or Discontinued information is missing|1|||
161675105|NCT02953639|583865400|FG001|Overall Study|Completed or Discontinued information is missing|0|||
161675106|NCT02953639|583865401|FG002|Overall Study|Completed or Discontinued information is missing|0|||
161675107|NCT01667081|583865402|FG000|Overall Study|Death|43|||
161675108|NCT01667081|583865403|FG001|Overall Study|Death|3|||
161675109|NCT01667081|583865402|FG000|Overall Study|Lost to Follow-up|99|||
161675110|NCT01667081|583865403|FG001|Overall Study|Lost to Follow-up|48|||
161675111|NCT01667081|583865402|FG000|Overall Study|Physician Decision|16|||
161675112|NCT01667081|583865403|FG001|Overall Study|Physician Decision|2|||
161820406|NCT02276885|584382816|FG000|Overall Study|Withdrawal by Subject|2|||
161820407|NCT02276885|584382817|FG001|Overall Study|Withdrawal by Subject|0|||
161820408|NCT02276885|584382816|FG000|Overall Study|Lost to Follow-up|5|||
161675113|NCT01667081|583865402|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
161675114|NCT01667081|583865403|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
161675115|NCT01667081|583865402|FG000|Overall Study|Withdrawal by Subject|90|||
161675116|NCT01667081|583865403|FG001|Overall Study|Withdrawal by Subject|35|||
161675117|NCT03034460|583865404|FG000|Overall Study|Adverse Event|0|||
161675118|NCT03034460|583865405|FG001|Overall Study|Adverse Event|1|||
161675119|NCT03034460|583865404|FG000|Overall Study|Withdrawal by Subject|2|||
161675120|NCT03034460|583865405|FG001|Overall Study|Withdrawal by Subject|2|||
161675121|NCT03034460|583865404|FG000|Overall Study|Personal Reasons|1|||
161675122|NCT03034460|583865405|FG001|Overall Study|Personal Reasons|0|||
161675123|NCT01798992|583865408|FG000|Overall Study|Administrative withdrawal|0|||
161675124|NCT01798992|583865409|FG001|Overall Study|Administrative withdrawal|1|||
161675125|NCT01798992|583865410|FG002|Overall Study|Administrative withdrawal|0|||
161675126|NCT01798992|583865411|FG003|Overall Study|Administrative withdrawal|1|||
161675127|NCT01798992|583865408|FG000|Overall Study|Lost to Follow-up|0|||
161675128|NCT01798992|583865409|FG001|Overall Study|Lost to Follow-up|1|||
161675129|NCT01798992|583865410|FG002|Overall Study|Lost to Follow-up|1|||
161675130|NCT01798992|583865411|FG003|Overall Study|Lost to Follow-up|0|||
161675131|NCT01798992|583865408|FG000|Overall Study|Insufficient biopsy tissue|0|||
161675132|NCT01798992|583865409|FG001|Overall Study|Insufficient biopsy tissue|0|||
161675133|NCT01798992|583865410|FG002|Overall Study|Insufficient biopsy tissue|1|||
161675134|NCT01798992|583865411|FG003|Overall Study|Insufficient biopsy tissue|0|||
161675135|NCT01069120|583865412|FG000|Overall Study|Study prematurely terminated|27|||
161675136|NCT02294682|583865413|FG000|Overall Study|Could not swallow pills|1|||
161675137|NCT02294682|583865414|FG001|Overall Study|Could not swallow pills|0|||
161675138|NCT01516970|583865415|FG000|Overall Study|Lost to Follow-up|7|||
161675139|NCT01516970|583865416|FG001|Overall Study|Lost to Follow-up|8|||
161675140|NCT01516970|583865415|FG000|Overall Study|Adverse Event|1|||
161675141|NCT01516970|583865416|FG001|Overall Study|Adverse Event|5|||
161675142|NCT01516970|583865415|FG000|Overall Study|Withdrawal by Subject|1|||
161675143|NCT01516970|583865416|FG001|Overall Study|Withdrawal by Subject|1|||
161675144|NCT01516970|583865415|FG000|Overall Study|Other|9|||
161675145|NCT01516970|583865416|FG001|Overall Study|Other|7|||
161675146|NCT00434421|583865417|FG000|Overall Study|Withdrawal by Subject|1|||
161675147|NCT00434421|583865417|FG000|Overall Study|Non-compliance with study treatment|1|||
161675148|NCT01301456|583865418|FG000|Stage 1|Withdrawal by Subject|0|||
161675149|NCT01301456|583865419|FG001|Stage 1|Withdrawal by Subject|0|||
161675150|NCT01301456|583865420|FG002|Stage 1|Withdrawal by Subject|1|||
161675151|NCT01301456|583865421|FG003|Stage 1|Withdrawal by Subject|0|||
161675152|NCT01301456|583865422|FG004|Stage 1|Withdrawal by Subject|1|||
161675153|NCT01301456|583865423|FG005|Stage 1|Withdrawal by Subject|0|||
161675154|NCT01301456|583865424|FG006|Stage 1|Withdrawal by Subject|0|||
161675155|NCT01301456|583865425|FG007|Stage 1|Withdrawal by Subject|0|||
161675156|NCT01301456|583865426|FG008|Stage 1|Withdrawal by Subject|0|||
161675157|NCT01301456|583865427|FG009|Stage 1|Withdrawal by Subject|0|||
161675158|NCT01301456|583865428|FG010|Stage 1|Withdrawal by Subject|0|||
161675159|NCT01301456|583865429|FG011|Stage 1|Withdrawal by Subject|0|||
161675160|NCT01301456|583865418|FG000|Stage 1|Randomized but not treated|0|||
161675161|NCT01301456|583865419|FG001|Stage 1|Randomized but not treated|0|||
161675162|NCT01301456|583865420|FG002|Stage 1|Randomized but not treated|0|||
161508583|NCT03548584|583257256|FG002|Overall Study|Site Terminated by Sponsor|2|||
161508584|NCT03548584|583257254|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
161508585|NCT03548584|583257255|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
161508586|NCT03548584|583257256|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
161508587|NCT03548584|583257254|FG000|Overall Study|Lack of Efficacy|0|||
161675163|NCT01301456|583865421|FG003|Stage 1|Randomized but not treated|0|||
161508588|NCT03548584|583257255|FG001|Overall Study|Lack of Efficacy|1|||
161508589|NCT03548584|583257256|FG002|Overall Study|Lack of Efficacy|0|||
161508590|NCT03548584|583257254|FG000|Overall Study|Non-compliance with Study Drug|0|||
161508591|NCT03548584|583257255|FG001|Overall Study|Non-compliance with Study Drug|1|||
161508592|NCT03548584|583257256|FG002|Overall Study|Non-compliance with Study Drug|0|||
161508593|NCT03548584|583257254|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
161508594|NCT03548584|583257255|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
161508595|NCT03548584|583257256|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
161508596|NCT04346615|583257257|FG000|Overall Study|Lost to Follow-up|0|||
161508597|NCT04346615|583257258|FG001|Overall Study|Lost to Follow-up|2|||
161508598|NCT04346615|583257257|FG000|Overall Study|Withdrawal by Subject|1|||
161508599|NCT04346615|583257258|FG001|Overall Study|Withdrawal by Subject|0|||
161508600|NCT04346615|583257257|FG000|Overall Study|Death|5|||
161508601|NCT04346615|583257258|FG001|Overall Study|Death|1|||
161508602|NCT04346615|583257257|FG000|Overall Study|Other|0|||
161508603|NCT04346615|583257258|FG001|Overall Study|Other|2|||
161508604|NCT04346615|583257257|FG000|Overall Study|Randomized not treated|1|||
161508605|NCT04346615|583257258|FG001|Overall Study|Randomized not treated|0|||
161508606|NCT02096835|583257264|FG000|Overall Study|Withdrawal by Subject|1|||
161508607|NCT02096835|583257265|FG001|Overall Study|Withdrawal by Subject|0|||
161508608|NCT02096835|583257266|FG002|Overall Study|Withdrawal by Subject|0|||
161587215|NCT05691452|583538816|FG001|Overall Study|Withdrawal by Subject|1|||
161587216|NCT05691452|583538817|FG002|Overall Study|Withdrawal by Subject|0|||
161587217|NCT05691452|583538815|FG000|Overall Study|Physician Decision|1|||
161587218|NCT05691452|583538816|FG001|Overall Study|Physician Decision|0|||
161587219|NCT05691452|583538817|FG002|Overall Study|Physician Decision|0|||
161587220|NCT05691452|583538815|FG000|Overall Study|Lost to Follow-up|0|||
161587221|NCT05691452|583538816|FG001|Overall Study|Lost to Follow-up|0|||
161587222|NCT05691452|583538817|FG002|Overall Study|Lost to Follow-up|1|||
161587223|NCT05691452|583538815|FG000|Overall Study|Adverse Event|0|||
161587224|NCT05691452|583538816|FG001|Overall Study|Adverse Event|0|||
161587225|NCT05691452|583538817|FG002|Overall Study|Adverse Event|1|||
161675164|NCT01301456|583865422|FG004|Stage 1|Randomized but not treated|0|||
161675165|NCT01301456|583865423|FG005|Stage 1|Randomized but not treated|0|||
161675166|NCT01301456|583865424|FG006|Stage 1|Randomized but not treated|1|||
161675167|NCT01301456|583865425|FG007|Stage 1|Randomized but not treated|0|||
161675168|NCT01301456|583865426|FG008|Stage 1|Randomized but not treated|0|||
161675169|NCT01301456|583865427|FG009|Stage 1|Randomized but not treated|0|||
161926214|NCT00625378|584777137|FG000|Overall Study|Adverse Event|22|||
161926215|NCT00625378|584777138|FG001|Overall Study|Adverse Event|0|||
161926216|NCT00625378|584777137|FG000|Overall Study|Withdrawal by Subject|16|||
161926217|NCT00625378|584777138|FG001|Overall Study|Withdrawal by Subject|0|||
161926218|NCT00625378|584777137|FG000|Overall Study|Death|38|||
161926219|NCT00625378|584777138|FG001|Overall Study|Death|0|||
161926220|NCT00625378|584777137|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
161926221|NCT00625378|584777138|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
161926222|NCT00625378|584777137|FG000|Overall Study|Lost to Follow-up|17|||
161926223|NCT00625378|584777138|FG001|Overall Study|Lost to Follow-up|0|||
161926224|NCT00625378|584777137|FG000|Overall Study|Non-compliant with study medication|3|||
161926225|NCT00625378|584777138|FG001|Overall Study|Non-compliant with study medication|0|||
161926226|NCT00625378|584777137|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
161926227|NCT00625378|584777138|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
161926228|NCT00625378|584777137|FG000|Overall Study|Medical decision|1|||
161926229|NCT00625378|584777138|FG001|Overall Study|Medical decision|0|||
161926230|NCT00625378|584777137|FG000|Overall Study|Multiple toxicities|1|||
161926231|NCT00625378|584777138|FG001|Overall Study|Multiple toxicities|0|||
161926232|NCT00625378|584777137|FG000|Overall Study|New cancer|1|||
161926233|NCT00625378|584777138|FG001|Overall Study|New cancer|0|||
161926234|NCT00625378|584777137|FG000|Overall Study|PTA program|2|||
161926235|NCT00625378|584777138|FG001|Overall Study|PTA program|0|||
161926236|NCT00625378|584777137|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
161926237|NCT00625378|584777138|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
161926238|NCT00625378|584777137|FG000|Overall Study|Sponsor decision|1|||
161926239|NCT00625378|584777138|FG001|Overall Study|Sponsor decision|0|||
161926240|NCT00625378|584777137|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
161926241|NCT00625378|584777138|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
161926242|NCT00625378|584777137|FG000|Overall Study|Switch to commercial drug|6|||
161926243|NCT00625378|584777138|FG001|Overall Study|Switch to commercial drug|1|||
161926244|NCT00625378|584777137|FG000|Overall Study|Missing|2|||
161926245|NCT00625378|584777138|FG001|Overall Study|Missing|0|||
161926246|NCT00625378|584777137|FG000|Overall Study|End of treatment not available|2|||
161587226|NCT03484702|583538820|FG000|Treatment Period|Death|3|||
161587227|NCT03484702|583538821|FG001|Treatment Period|Death|1|||
161926247|NCT00625378|584777138|FG001|Overall Study|End of treatment not available|0|||
161926248|NCT00625378|584777137|FG000|Overall Study|Never treated|2|||
161926249|NCT00625378|584777138|FG001|Overall Study|Never treated|0|||
161587228|NCT03484702|583538822|FG002|Treatment Period|Death|0|||
161675170|NCT01301456|583865428|FG010|Stage 1|Randomized but not treated|0|||
161675171|NCT01301456|583865429|FG011|Stage 1|Randomized but not treated|0|||
161675172|NCT01301456|583865418|FG000|Stage 2|Adverse Event|0|||
161675173|NCT01301456|583865419|FG001|Stage 2|Adverse Event|0|||
161675174|NCT01301456|583865420|FG002|Stage 2|Adverse Event|0|||
161675175|NCT01301456|583865421|FG003|Stage 2|Adverse Event|0|||
161675176|NCT01301456|583865422|FG004|Stage 2|Adverse Event|0|||
161675177|NCT01301456|583865423|FG005|Stage 2|Adverse Event|0|||
161675178|NCT01301456|583865424|FG006|Stage 2|Adverse Event|0|||
161675179|NCT01301456|583865425|FG007|Stage 2|Adverse Event|0|||
161675180|NCT01301456|583865426|FG008|Stage 2|Adverse Event|0|||
161675181|NCT01301456|583865427|FG009|Stage 2|Adverse Event|0|||
161675182|NCT01301456|583865428|FG010|Stage 2|Adverse Event|1|||
161675183|NCT01301456|583865429|FG011|Stage 2|Adverse Event|0|||
161675184|NCT05372653|583865437|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
161675185|NCT05372653|583865438|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
161675186|NCT05372653|583865437|FG000|Overall Study|Adverse Event|0|||
161675187|NCT05372653|583865438|FG001|Overall Study|Adverse Event|1|||
161675188|NCT00117507|583865439|FG000|Overall Study|Adverse Event|4|||
161675189|NCT00117507|583865439|FG000|Overall Study|Abnormal laboratory values|3|||
161675190|NCT00117507|583865439|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161675191|NCT00117507|583865439|FG000|Overall Study|Patient withdrew consent|4|||
161675192|NCT00117507|583865439|FG000|Overall Study|Death|3|||
161675193|NCT00866723|583865440|FG000|Overall Study|Withdrawal by Subject|1|||
161675194|NCT00866723|583865440|FG000|Overall Study|Disease Progression|4|||
161675195|NCT00711529|583865441|FG000|Overall Study|Protocol Violation|2|||
161675196|NCT00711529|583865442|FG001|Overall Study|Protocol Violation|0|||
161675197|NCT00711529|583865441|FG000|Overall Study|Withdrawal by Subject|2|||
161675198|NCT00711529|583865442|FG001|Overall Study|Withdrawal by Subject|6|||
161675199|NCT03740997|583865445|FG000|Overall Study|Withdrawal by Subject|1|||
161675200|NCT03740997|583865446|FG001|Overall Study|Withdrawal by Subject|0|||
161675201|NCT03740997|583865445|FG000|Overall Study|Participant was unable to complete study procedures|1|||
161675202|NCT03740997|583865446|FG001|Overall Study|Participant was unable to complete study procedures|0|||
161675203|NCT01003990|583865447|FG000|Overall Study|Adverse Event|8|||
161675204|NCT01003990|583865448|FG001|Overall Study|Adverse Event|5|||
161675205|NCT01003990|583865449|FG002|Overall Study|Adverse Event|11|||
161675206|NCT01003990|583865447|FG000|Overall Study|Death|0|||
161675207|NCT01003990|583865448|FG001|Overall Study|Death|8|||
161675208|NCT01003990|583865449|FG002|Overall Study|Death|1|||
161675209|NCT01003990|583865447|FG000|Overall Study|Lack of Efficacy|10|||
161675210|NCT01003990|583865448|FG001|Overall Study|Lack of Efficacy|2|||
161675211|NCT01003990|583865449|FG002|Overall Study|Lack of Efficacy|3|||
161675212|NCT01003990|583865447|FG000|Overall Study|Lost to Follow-up|30|||
161675213|NCT01003990|583865448|FG001|Overall Study|Lost to Follow-up|12|||
161675214|NCT01003990|583865449|FG002|Overall Study|Lost to Follow-up|7|||
161675215|NCT01003990|583865447|FG000|Overall Study|Reasons Not Identified|14|||
161675216|NCT01003990|583865448|FG001|Overall Study|Reasons Not Identified|13|||
161675217|NCT01003990|583865449|FG002|Overall Study|Reasons Not Identified|8|||
161675218|NCT01003990|583865447|FG000|Overall Study|Poor/Non-compliance|4|||
161675219|NCT01003990|583865448|FG001|Overall Study|Poor/Non-compliance|3|||
161675220|NCT01003990|583865449|FG002|Overall Study|Poor/Non-compliance|2|||
161675221|NCT01003990|583865447|FG000|Overall Study|Pregnancy|10|||
161675222|NCT01003990|583865448|FG001|Overall Study|Pregnancy|2|||
161675223|NCT01003990|583865449|FG002|Overall Study|Pregnancy|4|||
161675224|NCT01003990|583865447|FG000|Overall Study|No Longer Met Study Criteria|4|||
161675225|NCT01003990|583865448|FG001|Overall Study|No Longer Met Study Criteria|1|||
161675226|NCT01003990|583865449|FG002|Overall Study|No Longer Met Study Criteria|0|||
161508609|NCT02096835|583257264|FG000|Overall Study|converted to open procedures|1|||
161508610|NCT02096835|583257265|FG001|Overall Study|converted to open procedures|0|||
161508611|NCT02096835|583257266|FG002|Overall Study|converted to open procedures|0|||
161508612|NCT02096835|583257264|FG000|Overall Study|Lost to Follow-up|1|||
161508613|NCT02096835|583257265|FG001|Overall Study|Lost to Follow-up|0|||
161508614|NCT02096835|583257266|FG002|Overall Study|Lost to Follow-up|1|||
161675227|NCT01003990|583865447|FG000|Overall Study|Subject Withdrew Consent|12|||
161675228|NCT01003990|583865448|FG001|Overall Study|Subject Withdrew Consent|5|||
161675229|NCT01003990|583865449|FG002|Overall Study|Subject Withdrew Consent|7|||
161508615|NCT01677195|583257267|FG000|Overall Study|Lost to Follow-up|14|||
161508616|NCT01677195|583257268|FG001|Overall Study|Lost to Follow-up|22|||
161675230|NCT01271803|583865450|FG000|Overall Study|Progressive disease|0|||
161675231|NCT01271803|583865451|FG001|Overall Study|Progressive disease|0|||
161675232|NCT01271803|583865452|FG002|Overall Study|Progressive disease|2|||
161675233|NCT01271803|583865450|FG000|Overall Study|Death|53|||
161508617|NCT01677195|583257269|FG002|Overall Study|Lost to Follow-up|22|||
161508618|NCT01677195|583257267|FG000|Overall Study|Withdrawal by Subject|1|||
161675234|NCT01271803|583865451|FG001|Overall Study|Death|34|||
161675235|NCT01271803|583865452|FG002|Overall Study|Death|0|||
161675236|NCT01271803|583865450|FG000|Overall Study|Withdrawal by Subject|1|||
161675237|NCT01271803|583865451|FG001|Overall Study|Withdrawal by Subject|5|||
161675238|NCT01271803|583865452|FG002|Overall Study|Withdrawal by Subject|0|||
161675239|NCT01271803|583865450|FG000|Overall Study|Lost to Follow-up|1|||
161675240|NCT01271803|583865451|FG001|Overall Study|Lost to Follow-up|0|||
161675241|NCT01271803|583865452|FG002|Overall Study|Lost to Follow-up|0|||
161675242|NCT04178967|583865453|FG000|Induction Period|Adverse Event|4|||
161675243|NCT04178967|583865454|FG001|Induction Period|Adverse Event|6|||
161675244|NCT04178967|583865455|FG002|Induction Period|Adverse Event|0|||
161675245|NCT04178967|583865456|FG003|Induction Period|Adverse Event|0|||
161675246|NCT04178967|583865457|FG004|Induction Period|Adverse Event|0|||
161675247|NCT04178967|583865458|FG005|Induction Period|Adverse Event|0|||
161675248|NCT04178967|583865459|FG006|Induction Period|Adverse Event|0|||
161675249|NCT04178967|583865460|FG007|Induction Period|Adverse Event|0|||
161675250|NCT04178967|583865461|FG008|Induction Period|Adverse Event|0|||
161675251|NCT04178967|583865462|FG009|Induction Period|Adverse Event|0|||
161675252|NCT04178967|583865463|FG010|Induction Period|Adverse Event|0|||
161675253|NCT04178967|583865453|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
161675254|NCT04178967|583865454|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
161675255|NCT04178967|583865455|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
161675256|NCT04178967|583865456|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
161675257|NCT04178967|583865457|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
161675258|NCT04178967|583865458|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
161675259|NCT04178967|583865459|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
161675260|NCT04178967|583865460|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
161675261|NCT04178967|583865461|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
161675262|NCT04178967|583865462|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
161675263|NCT04178967|583865463|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
161675264|NCT04178967|583865453|FG000|Induction Period|Lack of Efficacy|4|||
161675265|NCT04178967|583865454|FG001|Induction Period|Lack of Efficacy|1|||
161675266|NCT04178967|583865455|FG002|Induction Period|Lack of Efficacy|0|||
161675267|NCT04178967|583865456|FG003|Induction Period|Lack of Efficacy|0|||
161675268|NCT04178967|583865457|FG004|Induction Period|Lack of Efficacy|0|||
161675269|NCT04178967|583865458|FG005|Induction Period|Lack of Efficacy|0|||
161675270|NCT04178967|583865459|FG006|Induction Period|Lack of Efficacy|0|||
161675271|NCT04178967|583865460|FG007|Induction Period|Lack of Efficacy|0|||
161926250|NCT02609633|584777141|FG000|Overall Study|Consent Withdrawn|0|||
161926251|NCT02609633|584777142|FG001|Overall Study|Consent Withdrawn|1|||
161926252|NCT02609633|584777141|FG000|Overall Study|Protocol Deviation|1|||
161926253|NCT02609633|584777142|FG001|Overall Study|Protocol Deviation|0|||
161926254|NCT02609633|584777141|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
161926255|NCT02609633|584777142|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
161926256|NCT02609633|584777141|FG000|Overall Study|Reason not Specified|2|||
161926257|NCT02609633|584777142|FG001|Overall Study|Reason not Specified|1|||
161926258|NCT01769443|584777145|FG000|Overall Study|Study closure|1|||
161926259|NCT01769443|584777146|FG001|Overall Study|Study closure|0|||
161926260|NCT02583477|584777147|FG000|Overall Study|Adverse Event|0|||
161926261|NCT02583477|584777148|FG001|Overall Study|Adverse Event|2|||
161926262|NCT02583477|584777147|FG000|Overall Study|Death|1|||
161926263|NCT02583477|584777148|FG001|Overall Study|Death|16|||
161926264|NCT02583477|584777147|FG000|Overall Study|Study terminated|2|||
161926265|NCT02583477|584777148|FG001|Overall Study|Study terminated|2|||
161926266|NCT05507450|584777149|FG000|Overall Study|Death|0|||
161926267|NCT05507450|584777150|FG001|Overall Study|Death|0|||
161926268|NCT05507450|584777151|FG002|Overall Study|Death|1|||
161926269|NCT05507450|584777152|FG003|Overall Study|Death|0|||
161926270|NCT05507450|584777149|FG000|Overall Study|Lost to Follow-up|22|||
161926271|NCT05507450|584777150|FG001|Overall Study|Lost to Follow-up|20|||
161926272|NCT05507450|584777151|FG002|Overall Study|Lost to Follow-up|20|||
161508619|NCT01677195|583257268|FG001|Overall Study|Withdrawal by Subject|0|||
161508620|NCT01677195|583257269|FG002|Overall Study|Withdrawal by Subject|1|||
161508621|NCT01677195|583257267|FG000|Overall Study|Adverse Event|6|||
161508622|NCT01677195|583257268|FG001|Overall Study|Adverse Event|4|||
161508623|NCT01677195|583257269|FG002|Overall Study|Adverse Event|1|||
161508624|NCT01677195|583257267|FG000|Overall Study|Physician Decision|1|||
161508625|NCT01677195|583257268|FG001|Overall Study|Physician Decision|2|||
161508626|NCT01677195|583257269|FG002|Overall Study|Physician Decision|2|||
161508627|NCT01677195|583257267|FG000|Overall Study|Pregnancy|0|||
161675272|NCT04178967|583865461|FG008|Induction Period|Lack of Efficacy|0|||
161508628|NCT01677195|583257268|FG001|Overall Study|Pregnancy|1|||
161508629|NCT01677195|583257269|FG002|Overall Study|Pregnancy|0|||
161508630|NCT01677195|583257267|FG000|Overall Study|Protocol Violation|7|||
161675273|NCT04178967|583865462|FG009|Induction Period|Lack of Efficacy|0|||
161675274|NCT04178967|583865463|FG010|Induction Period|Lack of Efficacy|0|||
161675275|NCT04178967|583865453|FG000|Induction Period|Protocol Violation|0|||
161675276|NCT04178967|583865454|FG001|Induction Period|Protocol Violation|6|||
161926273|NCT05507450|584777152|FG003|Overall Study|Lost to Follow-up|7|||
161926274|NCT05507450|584777149|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161926275|NCT05507450|584777150|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161926276|NCT05507450|584777151|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161675277|NCT04178967|583865455|FG002|Induction Period|Protocol Violation|0|||
161508631|NCT01677195|583257268|FG001|Overall Study|Protocol Violation|3|||
161508632|NCT01677195|583257269|FG002|Overall Study|Protocol Violation|4|||
161508633|NCT04368429|583257270|FG000|Overall Study|Adverse Event|1|||
161508634|NCT04368429|583257271|FG001|Overall Study|Adverse Event|0|||
161508635|NCT03633396|583257274|FG000|Overall Study|Withdrawal by Subject|4|||
161508636|NCT03633396|583257275|FG001|Overall Study|Withdrawal by Subject|4|||
161508637|NCT03633396|583257274|FG000|Overall Study|Adverse Event|1|||
161508638|NCT03633396|583257275|FG001|Overall Study|Adverse Event|1|||
161508639|NCT03633396|583257274|FG000|Overall Study|Lack of Efficacy|1|||
161508640|NCT03633396|583257275|FG001|Overall Study|Lack of Efficacy|0|||
161508641|NCT03633396|583257274|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
161508642|NCT03633396|583257275|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
161508643|NCT00023673|583257276|FG000|Overall Study|Ineligible / no protocol treatment|0|||
161508644|NCT00023673|583257277|FG001|Overall Study|Ineligible / no protocol treatment|0|||
161508645|NCT00023673|583257278|FG002|Overall Study|Ineligible / no protocol treatment|0|||
161508646|NCT00023673|583257279|FG003|Overall Study|Ineligible / no protocol treatment|1|||
161508647|NCT00023673|583257276|FG000|Overall Study|Patient withdrew consent|0|||
161508648|NCT00023673|583257277|FG001|Overall Study|Patient withdrew consent|0|||
161508649|NCT00023673|583257278|FG002|Overall Study|Patient withdrew consent|0|||
161820409|NCT02276885|584382817|FG001|Overall Study|Lost to Follow-up|2|||
161820410|NCT03837626|584382818|FG000|Overall Study|Adverse Event|3|||
161508650|NCT00023673|583257279|FG003|Overall Study|Patient withdrew consent|1|||
161508651|NCT00110266|583257280|FG000|Overall Study|Adverse Event|27|||
161820411|NCT03837626|584382819|FG001|Overall Study|Adverse Event|3|||
161508652|NCT00110266|583257280|FG000|Overall Study|Abnormal laboratory value|15|||
161508653|NCT00110266|583257280|FG000|Overall Study|Withdrawal by Subject|16|||
161508654|NCT00110266|583257280|FG000|Overall Study|Death|17|||
161508655|NCT00110266|583257280|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161508656|NCT00110266|583257280|FG000|Overall Study|Participant condition no longer requires study drug|1|||
161508657|NCT00667342|583257285|FG000|Overall Study|Protocol Violation|1|||
161508658|NCT00667342|583257286|FG001|Overall Study|Protocol Violation|0|||
161508659|NCT00667342|583257287|FG002|Overall Study|Protocol Violation|0|||
161508660|NCT00667342|583257285|FG000|Overall Study|Withdrawal by Subject|1|||
161508661|NCT00667342|583257286|FG001|Overall Study|Withdrawal by Subject|0|||
161508662|NCT00667342|583257287|FG002|Overall Study|Withdrawal by Subject|0|||
161508663|NCT00667342|583257285|FG000|Overall Study|Physician Decision|3|||
161508664|NCT00667342|583257286|FG001|Overall Study|Physician Decision|0|||
161508665|NCT00667342|583257287|FG002|Overall Study|Physician Decision|0|||
161508666|NCT00667342|583257285|FG000|Overall Study|Relapse or tumor progression|9|||
161508667|NCT00667342|583257286|FG001|Overall Study|Relapse or tumor progression|0|||
161508668|NCT00667342|583257287|FG002|Overall Study|Relapse or tumor progression|7|||
161508669|NCT00667342|583257285|FG000|Overall Study|Adverse Event|0|||
161508670|NCT00667342|583257286|FG001|Overall Study|Adverse Event|0|||
161508671|NCT00667342|583257287|FG002|Overall Study|Adverse Event|1|||
161820412|NCT03837626|584382818|FG000|Overall Study|Withdrawal by Subject|2|||
161820413|NCT03837626|584382819|FG001|Overall Study|Withdrawal by Subject|4|||
161820414|NCT03837626|584382818|FG000|Overall Study|Physician Decision|2|||
161820415|NCT03837626|584382819|FG001|Overall Study|Physician Decision|3|||
161820416|NCT03837626|584382818|FG000|Overall Study|Lost to Follow-up|3|||
161820417|NCT03837626|584382819|FG001|Overall Study|Lost to Follow-up|1|||
161820418|NCT05740371|584382820|FG000|Overall Study|Death|1|||
161820419|NCT00874822|584382821|FG000|Overall Study|excluded by criteria|8|||
161820420|NCT02627963|584382822|FG000|Overall Study|Randomized but not treated|2|||
161820421|NCT02627963|584382823|FG001|Overall Study|Randomized but not treated|6|||
161820422|NCT03073798|584382824|FG000|Overall Study|Adverse Event|1|||
161820423|NCT03073798|584382824|FG000|Overall Study|Withdrawal by Subject|1|||
161820424|NCT05278858|584382827|FG000|Overall Study|Withdrawal by Subject|1|||
161820425|NCT00840658|584382828|FG000|Overall Study|Death|2|||
161820426|NCT00840658|584382829|FG001|Overall Study|Death|2|||
161820427|NCT00840658|584382830|FG002|Overall Study|Death|3|||
161820428|NCT00840658|584382831|FG003|Overall Study|Death|3|||
161820429|NCT00840658|584382828|FG000|Overall Study|Lost to Follow-up|3|||
161820430|NCT00840658|584382829|FG001|Overall Study|Lost to Follow-up|1|||
161820431|NCT00840658|584382830|FG002|Overall Study|Lost to Follow-up|2|||
161820432|NCT00840658|584382831|FG003|Overall Study|Lost to Follow-up|1|||
161820433|NCT00728754|584382836|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
161820434|NCT00728754|584382837|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
161820435|NCT00728754|584382836|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
161820436|NCT00728754|584382837|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
161820437|NCT00728754|584382836|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
161820438|NCT00728754|584382837|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
161820439|NCT00573313|584382842|FG000|Overall Study|Protocol Violation|5|||
161508672|NCT00667342|583257285|FG000|Overall Study|Ineligible|0|||
161508673|NCT00667342|583257286|FG001|Overall Study|Ineligible|0|||
161508674|NCT00667342|583257287|FG002|Overall Study|Ineligible|1|||
161508675|NCT01433263|583257288|FG000|Overall Study|Adverse Event|3|||
161508676|NCT01433263|583257289|FG001|Overall Study|Adverse Event|1|||
161508677|NCT01433263|583257288|FG000|Overall Study|Death|5|||
161508678|NCT01433263|583257289|FG001|Overall Study|Death|3|||
161508679|NCT01433263|583257288|FG000|Overall Study|Lost to Follow-up|0|||
161508680|NCT01433263|583257289|FG001|Overall Study|Lost to Follow-up|1|||
161508681|NCT01433263|583257288|FG000|Overall Study|Protocol Deviation|1|||
161508682|NCT01433263|583257289|FG001|Overall Study|Protocol Deviation|0|||
161508683|NCT01433263|583257288|FG000|Overall Study|Withdrawal by Subject|10|||
161508684|NCT01433263|583257289|FG001|Overall Study|Withdrawal by Subject|7|||
161508685|NCT04709237|583257291|FG000|Overall Study|Lost to Follow-up|1|||
161508686|NCT04709237|583257292|FG001|Overall Study|Lost to Follow-up|0|||
161508687|NCT04709237|583257293|FG002|Overall Study|Lost to Follow-up|0|||
161508688|NCT02610192|583257294|FG000|Overall Study|Received other treatment|8|||
161508689|NCT02610192|583257294|FG000|Overall Study|Physician Decision|1|||
161508690|NCT00546715|583257300|FG000|Overall Study|Withdrawal by Subject|0|||
161508691|NCT00546715|583257301|FG001|Overall Study|Withdrawal by Subject|1|||
161508692|NCT00546715|583257302|FG002|Overall Study|Withdrawal by Subject|0|||
161508693|NCT00546715|583257303|FG003|Overall Study|Withdrawal by Subject|0|||
161508694|NCT03852316|583257304|FG000|Overall Study|Protocol Violation|1|||
161508695|NCT03852316|583257304|FG000|Overall Study|Withdrawal by Subject|2|||
161508696|NCT03852316|583257304|FG000|Overall Study|Enrolled but Device not Utilized|1|||
161820440|NCT00573313|584382843|FG001|Overall Study|Protocol Violation|0|||
161820441|NCT00573313|584382844|FG002|Overall Study|Protocol Violation|6|||
161820442|NCT00573313|584382845|FG003|Overall Study|Protocol Violation|0|||
161820443|NCT00295490|584382848|FG000|Overall Study|Protocol Violation|0|||
161820444|NCT00295490|584382849|FG001|Overall Study|Protocol Violation|0|||
161820445|NCT00295490|584382850|FG002|Overall Study|Protocol Violation|3|||
161508697|NCT01018264|583257305|FG000|Overall Study|Withdrawal by Subject|1|||
161508698|NCT01018264|583257306|FG001|Overall Study|Withdrawal by Subject|0|||
161820446|NCT00295490|584382851|FG003|Overall Study|Protocol Violation|3|||
161508699|NCT01018264|583257305|FG000|Overall Study|Lost to Follow-up|0|||
161508700|NCT01018264|583257306|FG001|Overall Study|Lost to Follow-up|1|||
161508701|NCT02075840|583257307|FG000|Overall Study|Withdrawal by Subject|13|||
161508702|NCT02075840|583257308|FG001|Overall Study|Withdrawal by Subject|22|||
161508703|NCT02075840|583257307|FG000|Overall Study|Reason not specified|1|||
161508704|NCT02075840|583257308|FG001|Overall Study|Reason not specified|0|||
161508705|NCT02075840|583257307|FG000|Overall Study|Adverse Event|0|||
161508706|NCT02075840|583257308|FG001|Overall Study|Adverse Event|2|||
161926277|NCT05507450|584777152|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161926278|NCT05507450|584777149|FG000|Overall Study|Withdrawal by Subject|4|||
161926279|NCT05507450|584777150|FG001|Overall Study|Withdrawal by Subject|11|||
161926280|NCT05507450|584777151|FG002|Overall Study|Withdrawal by Subject|7|||
161926281|NCT05507450|584777152|FG003|Overall Study|Withdrawal by Subject|3|||
161926282|NCT05507450|584777149|FG000|Overall Study|Participant left the country|0|||
161926283|NCT05507450|584777150|FG001|Overall Study|Participant left the country|0|||
161926284|NCT05507450|584777151|FG002|Overall Study|Participant left the country|1|||
161926285|NCT05507450|584777152|FG003|Overall Study|Participant left the country|0|||
161926286|NCT05436288|584777153|FG000|Overall Study|Lost to Follow-up|1|||
161926287|NCT05436288|584777153|FG000|Overall Study|Adverse Event|1|||
161926288|NCT03767894|584777156|FG000|Overall Study|Withdrawal by Subject|1|||
161926289|NCT00387127|584777157|FG000|Overall Study|Lost to Follow-up|0|||
161926290|NCT00387127|584777158|FG001|Overall Study|Lost to Follow-up|4|||
161926291|NCT00387127|584777157|FG000|Overall Study|Death|16|||
161926292|NCT00387127|584777158|FG001|Overall Study|Death|16|||
161926293|NCT00387127|584777157|FG000|Overall Study|Physician Decision|0|||
161926294|NCT00387127|584777158|FG001|Overall Study|Physician Decision|1|||
161926295|NCT00387127|584777157|FG000|Overall Study|Withdrawal by Subject|3|||
161926296|NCT00387127|584777158|FG001|Overall Study|Withdrawal by Subject|2|||
161926297|NCT00387127|584777157|FG000|Overall Study|Required by Protocol Amendment #4|12|||
161926298|NCT00387127|584777158|FG001|Overall Study|Required by Protocol Amendment #4|10|||
161926299|NCT00387127|584777157|FG000|Overall Study|Serious Adverse Event|1|||
161926300|NCT00387127|584777158|FG001|Overall Study|Serious Adverse Event|1|||
161926301|NCT00387127|584777157|FG000|Overall Study|Sponsor Unblinded|1|||
161926302|NCT00387127|584777158|FG001|Overall Study|Sponsor Unblinded|0|||
161926303|NCT04149353|584777159|FG000|Overall Study|Study terminated|1|||
161926304|NCT01871727|584777160|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
161926305|NCT01871727|584777161|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
161926306|NCT01871727|584777162|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
161926307|NCT01871727|584777163|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
161926308|NCT01871727|584777164|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
161926309|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
161926310|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
161926311|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
161926312|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
161926313|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
161926314|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926315|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926316|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926317|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926318|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
161508707|NCT02075840|583257307|FG000|Overall Study|Death|35|||
161508708|NCT02075840|583257308|FG001|Overall Study|Death|40|||
161587229|NCT03484702|583538823|FG003|Treatment Period|Death|0|||
161587230|NCT03484702|583538824|FG004|Treatment Period|Death|0|||
161587231|NCT03484702|583538825|FG005|Treatment Period|Death|0|||
161587232|NCT03484702|583538820|FG000|Treatment Period|Adverse Event|1|||
161587233|NCT03484702|583538821|FG001|Treatment Period|Adverse Event|0|||
161587234|NCT03484702|583538822|FG002|Treatment Period|Adverse Event|0|||
161587235|NCT03484702|583538823|FG003|Treatment Period|Adverse Event|0|||
161587236|NCT03484702|583538824|FG004|Treatment Period|Adverse Event|0|||
161587237|NCT03484702|583538825|FG005|Treatment Period|Adverse Event|0|||
161587238|NCT03484702|583538820|FG000|Treatment Period|Participant Withdrew from Study|0|||
161587239|NCT03484702|583538821|FG001|Treatment Period|Participant Withdrew from Study|1|||
161587240|NCT03484702|583538822|FG002|Treatment Period|Participant Withdrew from Study|0|||
161587241|NCT03484702|583538823|FG003|Treatment Period|Participant Withdrew from Study|0|||
161587242|NCT03484702|583538824|FG004|Treatment Period|Participant Withdrew from Study|0|||
161587243|NCT03484702|583538825|FG005|Treatment Period|Participant Withdrew from Study|0|||
161926319|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161926320|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161587244|NCT03484702|583538820|FG000|Treatment Period|Physician Decision|0|||
161587245|NCT03484702|583538821|FG001|Treatment Period|Physician Decision|1|||
161508709|NCT02075840|583257307|FG000|Overall Study|Lost to Follow-up|3|||
161508710|NCT02075840|583257308|FG001|Overall Study|Lost to Follow-up|2|||
161508711|NCT02075840|583257307|FG000|Overall Study|Physician Decision|1|||
161675278|NCT04178967|583865456|FG003|Induction Period|Protocol Violation|0|||
161675279|NCT04178967|583865457|FG004|Induction Period|Protocol Violation|0|||
161675280|NCT04178967|583865458|FG005|Induction Period|Protocol Violation|0|||
161675281|NCT04178967|583865459|FG006|Induction Period|Protocol Violation|0|||
161675282|NCT04178967|583865460|FG007|Induction Period|Protocol Violation|0|||
161675283|NCT04178967|583865461|FG008|Induction Period|Protocol Violation|0|||
161675284|NCT04178967|583865462|FG009|Induction Period|Protocol Violation|0|||
161675285|NCT04178967|583865463|FG010|Induction Period|Protocol Violation|0|||
161675286|NCT04178967|583865453|FG000|Induction Period|Withdrawal by Subject|6|||
161675287|NCT04178967|583865454|FG001|Induction Period|Withdrawal by Subject|4|||
161675288|NCT04178967|583865455|FG002|Induction Period|Withdrawal by Subject|0|||
161675289|NCT04178967|583865456|FG003|Induction Period|Withdrawal by Subject|0|||
161675290|NCT04178967|583865457|FG004|Induction Period|Withdrawal by Subject|0|||
161675291|NCT04178967|583865458|FG005|Induction Period|Withdrawal by Subject|0|||
161675292|NCT04178967|583865459|FG006|Induction Period|Withdrawal by Subject|0|||
161675293|NCT04178967|583865460|FG007|Induction Period|Withdrawal by Subject|0|||
161675294|NCT04178967|583865461|FG008|Induction Period|Withdrawal by Subject|0|||
161675295|NCT04178967|583865462|FG009|Induction Period|Withdrawal by Subject|0|||
161675296|NCT04178967|583865463|FG010|Induction Period|Withdrawal by Subject|0|||
161675297|NCT04178967|583865453|FG000|Induction Period|Lost to Follow-up|2|||
161675298|NCT04178967|583865454|FG001|Induction Period|Lost to Follow-up|0|||
161675299|NCT04178967|583865455|FG002|Induction Period|Lost to Follow-up|0|||
161675300|NCT04178967|583865456|FG003|Induction Period|Lost to Follow-up|0|||
161675301|NCT04178967|583865457|FG004|Induction Period|Lost to Follow-up|0|||
161675302|NCT04178967|583865458|FG005|Induction Period|Lost to Follow-up|0|||
161675303|NCT04178967|583865459|FG006|Induction Period|Lost to Follow-up|0|||
161675304|NCT04178967|583865460|FG007|Induction Period|Lost to Follow-up|0|||
161675305|NCT04178967|583865461|FG008|Induction Period|Lost to Follow-up|0|||
161675306|NCT04178967|583865462|FG009|Induction Period|Lost to Follow-up|0|||
161675307|NCT04178967|583865463|FG010|Induction Period|Lost to Follow-up|0|||
161675308|NCT04178967|583865453|FG000|Induction Period|Participant Missed Study Visits|0|||
161675309|NCT04178967|583865454|FG001|Induction Period|Participant Missed Study Visits|1|||
161675310|NCT04178967|583865455|FG002|Induction Period|Participant Missed Study Visits|0|||
161675311|NCT04178967|583865456|FG003|Induction Period|Participant Missed Study Visits|0|||
161675312|NCT04178967|583865457|FG004|Induction Period|Participant Missed Study Visits|0|||
161675313|NCT04178967|583865458|FG005|Induction Period|Participant Missed Study Visits|0|||
161675314|NCT04178967|583865459|FG006|Induction Period|Participant Missed Study Visits|0|||
161675315|NCT04178967|583865460|FG007|Induction Period|Participant Missed Study Visits|0|||
161675316|NCT04178967|583865461|FG008|Induction Period|Participant Missed Study Visits|0|||
161675317|NCT04178967|583865462|FG009|Induction Period|Participant Missed Study Visits|0|||
161675318|NCT04178967|583865463|FG010|Induction Period|Participant Missed Study Visits|0|||
161675319|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675320|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675321|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675322|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675323|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675324|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
161675325|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
161675326|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
161675327|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675328|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675329|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675330|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675331|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675332|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675333|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675334|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675335|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
161675336|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161820447|NCT00295490|584382848|FG000|Overall Study|Withdrawal by Subject|0|||
161675337|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675338|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675339|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675340|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675341|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675342|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675343|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675344|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161675345|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675346|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675347|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675348|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675349|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675350|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675351|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675352|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675353|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675354|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675355|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675356|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675357|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675358|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
161675359|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675360|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675361|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675362|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675363|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675364|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675365|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675366|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675367|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
161675368|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
161675369|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675370|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
161675371|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675372|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675373|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675374|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675375|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675376|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675377|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675378|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675379|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675380|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
161675381|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
161675382|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675383|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675384|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675385|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675386|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675387|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675388|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161675389|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675390|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
161675391|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161675392|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
161675393|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675394|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675395|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675396|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675397|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675398|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161820448|NCT00295490|584382849|FG001|Overall Study|Withdrawal by Subject|2|||
161820449|NCT00295490|584382850|FG002|Overall Study|Withdrawal by Subject|0|||
161820450|NCT00295490|584382851|FG003|Overall Study|Withdrawal by Subject|1|||
161820451|NCT00295490|584382848|FG000|Overall Study|Lost to Follow-up|0|||
161820452|NCT00295490|584382849|FG001|Overall Study|Lost to Follow-up|0|||
161820453|NCT00295490|584382850|FG002|Overall Study|Lost to Follow-up|1|||
161820454|NCT00295490|584382851|FG003|Overall Study|Lost to Follow-up|0|||
161820455|NCT00295490|584382848|FG000|Overall Study|Adverse Event|1|||
161675399|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675400|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161820456|NCT00295490|584382849|FG001|Overall Study|Adverse Event|0|||
161820457|NCT00295490|584382850|FG002|Overall Study|Adverse Event|0|||
161820458|NCT00295490|584382851|FG003|Overall Study|Adverse Event|0|||
161508712|NCT02075840|583257308|FG001|Overall Study|Physician Decision|3|||
161587246|NCT03484702|583538822|FG002|Treatment Period|Physician Decision|0|||
161675401|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675402|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675403|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675404|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
161675405|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
161675406|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675407|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675408|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675409|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675410|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675411|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675412|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675413|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675414|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675415|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
161675416|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
161675417|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
161675418|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675419|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675420|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675421|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675422|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675423|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675424|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161587247|NCT03484702|583538823|FG003|Treatment Period|Physician Decision|0|||
161587248|NCT03484702|583538824|FG004|Treatment Period|Physician Decision|0|||
161587249|NCT03484702|583538825|FG005|Treatment Period|Physician Decision|1|||
161587250|NCT01894061|583538830|FG000|Overall Study|Screen failure|1|||
161587251|NCT01894061|583538830|FG000|Overall Study|Withdrawal by Subject|1|||
161675425|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675426|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675427|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
161675428|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675429|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675430|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675431|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675432|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161587252|NCT00739648|583538831|FG000|Overall Study|Adverse Event|3|||
161587253|NCT00739648|583538832|FG001|Overall Study|Adverse Event|15|||
161587254|NCT00739648|583538831|FG000|Overall Study|Withdrawal by Subject|13|||
161587255|NCT00739648|583538832|FG001|Overall Study|Withdrawal by Subject|25|||
161587256|NCT00739648|583538831|FG000|Overall Study|Lost to Follow-up|4|||
161587257|NCT00739648|583538832|FG001|Overall Study|Lost to Follow-up|7|||
161587258|NCT00739648|583538831|FG000|Overall Study|Death|2|||
161587259|NCT00739648|583538832|FG001|Overall Study|Death|0|||
161587260|NCT00739648|583538831|FG000|Overall Study|Do not know|4|||
161587261|NCT00739648|583538832|FG001|Overall Study|Do not know|6|||
161587262|NCT05110495|583538833|FG000|Overall Study|Lost to Follow-up|1|||
161587263|NCT05110495|583538833|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
161587264|NCT02840474|583538835|FG000|Overall Study|Lost to Follow-up|1|||
161587265|NCT02840474|583538836|FG001|Overall Study|Lost to Follow-up|0|||
161587266|NCT04716634|583538837|FG000|Overall Study|Death|24|||
161587267|NCT04716634|583538838|FG001|Overall Study|Death|24|||
161587268|NCT04716634|583538839|FG002|Overall Study|Death|8|||
161587269|NCT04716634|583538837|FG000|Overall Study|Closed by Sponsor|4|||
161675433|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675434|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675435|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161820459|NCT00295490|584382848|FG000|Overall Study|Other|0|||
161820460|NCT00295490|584382849|FG001|Overall Study|Other|2|||
161820461|NCT00295490|584382850|FG002|Overall Study|Other|0|||
161820462|NCT00295490|584382851|FG003|Overall Study|Other|1|||
161820463|NCT03255980|584382852|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
161820464|NCT03255980|584382853|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
161820465|NCT03255980|584382854|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
161820466|NCT03255980|584382855|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
161587270|NCT04716634|583538838|FG001|Overall Study|Closed by Sponsor|4|||
161587271|NCT04716634|583538839|FG002|Overall Study|Closed by Sponsor|5|||
161587272|NCT04716634|583538837|FG000|Overall Study|Lost to Follow-up|1|||
161587273|NCT04716634|583538838|FG001|Overall Study|Lost to Follow-up|0|||
161587274|NCT04716634|583538839|FG002|Overall Study|Lost to Follow-up|1|||
161587275|NCT04716634|583538837|FG000|Overall Study|Withdrawal by Subject|0|||
161820467|NCT03255980|584382852|FG000|Overall Study|Adverse Event|1|||
161508713|NCT02075840|583257307|FG000|Overall Study|Ongoing at CCOD|99|||
161508714|NCT02075840|583257308|FG001|Overall Study|Ongoing at CCOD|82|||
161508715|NCT03491150|583257309|FG000|Overall Study|Adverse Event|1|||
161508716|NCT03491150|583257310|FG001|Overall Study|Adverse Event|0|||
161508717|NCT03491150|583257309|FG000|Overall Study|Study Terminated by Sponsor|74|||
161508718|NCT03491150|583257310|FG001|Overall Study|Study Terminated by Sponsor|70|||
161508719|NCT03491150|583257309|FG000|Overall Study|Other|0|||
161508720|NCT03491150|583257310|FG001|Overall Study|Other|1|||
161508721|NCT03491150|583257309|FG000|Overall Study|Withdrawal by Subject|1|||
161508722|NCT03491150|583257310|FG001|Overall Study|Withdrawal by Subject|2|||
161508723|NCT02644967|583257313|FG000|Overall Study|Death|26|||
161508724|NCT02644967|583257313|FG000|Overall Study|Physician Decision|1|||
161508725|NCT02644967|583257313|FG000|Overall Study|Withdrawal by Subject|2|||
161587276|NCT04716634|583538838|FG001|Overall Study|Withdrawal by Subject|0|||
161587277|NCT04716634|583538839|FG002|Overall Study|Withdrawal by Subject|1|||
161587278|NCT05418296|583538847|FG000|Overall Study|Withdrawal by Subject|4|||
161587279|NCT05418296|583538848|FG001|Overall Study|Withdrawal by Subject|1|||
161587280|NCT04703322|583538850|FG000|Overall Study|Ongoing|8|||
161587281|NCT04703322|583538850|FG000|Overall Study|Withdrawal by Subject|1|||
161587282|NCT04638998|583538851|FG000|Overall Study|Withdrawal by Subject|1|||
161587283|NCT04638998|583538852|FG001|Overall Study|Withdrawal by Subject|3|||
161587284|NCT04419168|583538855|FG000|Overall Study|Protocol Violation|1|||
161587285|NCT04419168|583538856|FG001|Overall Study|Protocol Violation|1|||
161587286|NCT04419168|583538855|FG000|Overall Study|Lost to Follow-up|7|||
161587287|NCT04419168|583538856|FG001|Overall Study|Lost to Follow-up|7|||
161587288|NCT04419168|583538855|FG000|Overall Study|Missed 6-month Visit|48|||
161587289|NCT04419168|583538856|FG001|Overall Study|Missed 6-month Visit|45|||
161587290|NCT03713086|583538860|FG000|Overall Study|Withdrawal by Subject|0|||
161587291|NCT03713086|583538861|FG001|Overall Study|Withdrawal by Subject|2|||
161587292|NCT03713086|583538862|FG002|Overall Study|Withdrawal by Subject|1|||
161508726|NCT02644967|583257313|FG000|Overall Study|Protocol Violation|1|||
161508727|NCT02644967|583257313|FG000|Overall Study|Progressive Disease|1|||
161587293|NCT03713086|583538863|FG003|Overall Study|Withdrawal by Subject|0|||
161508728|NCT02644967|583257313|FG000|Overall Study|Study Terminated by Sponsor|4|||
161508729|NCT02287896|583257314|FG000|Second Injection Visit|Withdrawal by Subject|0|||
161587294|NCT03713086|583538860|FG000|Overall Study|Lost to Follow-up|0|||
161587295|NCT03713086|583538861|FG001|Overall Study|Lost to Follow-up|1|||
161587296|NCT03713086|583538862|FG002|Overall Study|Lost to Follow-up|0|||
161820468|NCT03255980|584382853|FG001|Overall Study|Adverse Event|1|||
161820469|NCT03255980|584382854|FG002|Overall Study|Adverse Event|0|||
161820470|NCT03255980|584382855|FG003|Overall Study|Adverse Event|1|||
161820471|NCT03255980|584382852|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
161820472|NCT03255980|584382853|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
161820473|NCT03255980|584382854|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
161820474|NCT03255980|584382855|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
161820475|NCT03255980|584382852|FG000|Overall Study|Lost to Follow-up|1|||
161820476|NCT03255980|584382853|FG001|Overall Study|Lost to Follow-up|1|||
161820477|NCT03255980|584382854|FG002|Overall Study|Lost to Follow-up|0|||
161820478|NCT03255980|584382855|FG003|Overall Study|Lost to Follow-up|3|||
161820479|NCT03255980|584382852|FG000|Overall Study|Withdrawal by Subject|0|||
161820480|NCT03255980|584382853|FG001|Overall Study|Withdrawal by Subject|1|||
161820481|NCT03255980|584382854|FG002|Overall Study|Withdrawal by Subject|0|||
161820482|NCT03255980|584382855|FG003|Overall Study|Withdrawal by Subject|3|||
161820483|NCT02611362|584382856|FG000|Overall Study|Withdrawal by Subject|7|||
161820484|NCT02611362|584382857|FG001|Overall Study|Withdrawal by Subject|2|||
161820485|NCT02611362|584382856|FG000|Overall Study|Lost to Follow-up|2|||
161820486|NCT02611362|584382857|FG001|Overall Study|Lost to Follow-up|4|||
161820487|NCT01559116|584382865|FG000|Overall Study|Adverse Event|10|||
161820488|NCT01559116|584382865|FG000|Overall Study|Lack of Efficacy|1|||
161820489|NCT01559116|584382865|FG000|Overall Study|Lost to Follow-up|1|||
161820490|NCT01559116|584382865|FG000|Overall Study|Protocol Violation|1|||
161820491|NCT01559116|584382865|FG000|Overall Study|Withdrawal by Subject|4|||
161820492|NCT01559116|584382865|FG000|Overall Study|other than stated above|9|||
161820493|NCT05468320|584382868|FG000|Overall Study|Other|1|||
161820494|NCT05468320|584382868|FG000|Overall Study|Adverse Event|1|||
161820495|NCT03921554|584382869|FG000|Overall Study|Adverse Event|2|||
161820496|NCT03921554|584382869|FG000|Overall Study|Withdrawal by Subject|1|||
161820497|NCT03921554|584382869|FG000|Overall Study|Death|3|||
161820498|NCT04440592|584382870|FG000|Overall Study|Adverse Event|8|||
161820499|NCT04440592|584382871|FG001|Overall Study|Adverse Event|0|||
161820500|NCT04440592|584382870|FG000|Overall Study|Lost to Follow-up|1|||
161820501|NCT04440592|584382871|FG001|Overall Study|Lost to Follow-up|0|||
161820502|NCT04440592|584382870|FG000|Overall Study|Withdrawal by Subject|1|||
161820503|NCT04440592|584382871|FG001|Overall Study|Withdrawal by Subject|1|||
161820504|NCT04440592|584382870|FG000|Overall Study|Other therapy needed|0|||
161926321|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161926322|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161926323|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
161926324|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926325|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926326|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926327|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926328|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
161926329|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161926330|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161926331|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161926332|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161508730|NCT02287896|583257315|FG001|Second Injection Visit|Withdrawal by Subject|1|||
161508731|NCT05179421|583257316|FG000|First Infusion Day|Adverse Event|1|||
161508732|NCT05179421|583257317|FG001|First Infusion Day|Adverse Event|0|||
161508733|NCT03746522|583257319|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
161508734|NCT03746522|583257320|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
161508735|NCT03746522|583257321|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
161508736|NCT03746522|583257319|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
161508737|NCT03746522|583257320|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
161508738|NCT03746522|583257321|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
161508739|NCT03746522|583257319|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
161508740|NCT03746522|583257320|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
161508741|NCT03746522|583257321|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
161508742|NCT03746522|583257319|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
161508743|NCT03746522|583257320|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
161508744|NCT03746522|583257321|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
161508745|NCT03746522|583257319|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
161508746|NCT03746522|583257320|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
161508747|NCT03746522|583257321|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
161508748|NCT03323099|583257322|FG000|Overall Study|Withdrawal by Subject|6|||
161508749|NCT03323099|583257323|FG001|Overall Study|Withdrawal by Subject|12|||
161508750|NCT03323099|583257322|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
161508751|NCT03323099|583257323|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
161508752|NCT00767676|583257324|FG000|Overall Study|Investigator error|54|||
161508753|NCT05132127|583257330|FG000|Overall Study|Adverse Event|1|||
161508754|NCT05220397|583257331|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
161508755|NCT05220397|583257332|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
161508756|NCT05220397|583257333|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
161508757|NCT05220397|583257334|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
161508758|NCT05220397|583257335|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
161508759|NCT02659020|583257336|FG000|Overall Study|Adverse Event|0|||
161508760|NCT02659020|583257337|FG001|Overall Study|Adverse Event|0|||
161508761|NCT02659020|583257338|FG002|Overall Study|Adverse Event|0|||
161508762|NCT02659020|583257339|FG003|Overall Study|Adverse Event|2|||
161508763|NCT02659020|583257340|FG004|Overall Study|Adverse Event|0|||
161508764|NCT02659020|583257341|FG005|Overall Study|Adverse Event|0|||
161508765|NCT02659020|583257342|FG006|Overall Study|Adverse Event|2|||
161508766|NCT02659020|583257336|FG000|Overall Study|Lost to Follow-up|1|||
161508767|NCT02659020|583257337|FG001|Overall Study|Lost to Follow-up|2|||
161508768|NCT02659020|583257338|FG002|Overall Study|Lost to Follow-up|1|||
161587297|NCT03713086|583538863|FG003|Overall Study|Lost to Follow-up|1|||
161587298|NCT05009251|583538864|FG000|Overall Study|Protocol Violation|100|||
161587299|NCT05009251|583538865|FG001|Overall Study|Protocol Violation|105|||
161587300|NCT05009251|583538866|FG002|Overall Study|Protocol Violation|119|||
161587301|NCT05009251|583538867|FG003|Overall Study|Protocol Violation|120|||
161587302|NCT05009251|583538868|FG004|Overall Study|Protocol Violation|119|||
161587303|NCT05009251|583538864|FG000|Overall Study|Death|25|||
161587304|NCT05009251|583538865|FG001|Overall Study|Death|22|||
161587305|NCT05009251|583538866|FG002|Overall Study|Death|24|||
161587306|NCT05009251|583538867|FG003|Overall Study|Death|19|||
161587307|NCT05009251|583538868|FG004|Overall Study|Death|15|||
161587308|NCT05374837|583538874|FG000|Overall Study|Lost to Follow-up|17|||
161587309|NCT05374837|583538875|FG001|Overall Study|Lost to Follow-up|18|||
161587310|NCT05406921|583538878|FG000|Overall Study|Withdrawal by Subject|25|||
161587311|NCT05406921|583538879|FG001|Overall Study|Withdrawal by Subject|0|||
161587312|NCT05406921|583538880|FG002|Overall Study|Withdrawal by Subject|25|||
161587313|NCT05406921|583538878|FG000|Overall Study|Protocol Violation|0|||
161587314|NCT05406921|583538879|FG001|Overall Study|Protocol Violation|12|||
161587315|NCT05406921|583538880|FG002|Overall Study|Protocol Violation|0|||
161587316|NCT04831281|583538883|FG000|Overall Study|Adverse Event|1|||
161587317|NCT04831281|583538884|FG001|Overall Study|Adverse Event|0|||
161820505|NCT04440592|584382871|FG001|Overall Study|Other therapy needed|1|||
161587318|NCT04831281|583538885|FG002|Overall Study|Adverse Event|3|||
161587319|NCT04831281|583538883|FG000|Overall Study|Withdrawal by Subject|0|||
161587320|NCT04831281|583538884|FG001|Overall Study|Withdrawal by Subject|1|||
161587321|NCT04831281|583538885|FG002|Overall Study|Withdrawal by Subject|2|||
161587322|NCT04831281|583538883|FG000|Overall Study|Undetermined|1|||
161587323|NCT04831281|583538884|FG001|Overall Study|Undetermined|1|||
161508769|NCT02659020|583257339|FG003|Overall Study|Lost to Follow-up|6|||
161508770|NCT02659020|583257340|FG004|Overall Study|Lost to Follow-up|1|||
161508771|NCT02659020|583257341|FG005|Overall Study|Lost to Follow-up|5|||
161508772|NCT02659020|583257342|FG006|Overall Study|Lost to Follow-up|0|||
161508773|NCT02659020|583257336|FG000|Overall Study|Physician Decision|0|||
161508774|NCT02659020|583257337|FG001|Overall Study|Physician Decision|0|||
161508775|NCT02659020|583257338|FG002|Overall Study|Physician Decision|0|||
161508776|NCT02659020|583257339|FG003|Overall Study|Physician Decision|1|||
161508777|NCT02659020|583257340|FG004|Overall Study|Physician Decision|1|||
161508778|NCT02659020|583257341|FG005|Overall Study|Physician Decision|0|||
161508779|NCT02659020|583257342|FG006|Overall Study|Physician Decision|1|||
161508780|NCT02659020|583257336|FG000|Overall Study|Withdrawal by Subject|2|||
161508781|NCT02659020|583257337|FG001|Overall Study|Withdrawal by Subject|1|||
161508782|NCT02659020|583257338|FG002|Overall Study|Withdrawal by Subject|0|||
161508783|NCT02659020|583257339|FG003|Overall Study|Withdrawal by Subject|3|||
161508784|NCT02659020|583257340|FG004|Overall Study|Withdrawal by Subject|3|||
161508785|NCT02659020|583257341|FG005|Overall Study|Withdrawal by Subject|6|||
161508786|NCT02659020|583257342|FG006|Overall Study|Withdrawal by Subject|3|||
161508787|NCT02659020|583257336|FG000|Overall Study|Progressive Disease|0|||
161508788|NCT02659020|583257337|FG001|Overall Study|Progressive Disease|0|||
161508789|NCT02659020|583257338|FG002|Overall Study|Progressive Disease|0|||
161508790|NCT02659020|583257339|FG003|Overall Study|Progressive Disease|4|||
161508791|NCT02659020|583257340|FG004|Overall Study|Progressive Disease|1|||
161508792|NCT02659020|583257341|FG005|Overall Study|Progressive Disease|0|||
161508793|NCT02659020|583257342|FG006|Overall Study|Progressive Disease|2|||
161508794|NCT02052739|583257343|FG000|Overall Study|Withdrew due to Adverse Event|3|||
161508795|NCT02052739|583257344|FG001|Overall Study|Withdrew due to Adverse Event|0|||
161508796|NCT02052739|583257343|FG000|Overall Study|Participant Died|2|||
161508797|NCT02052739|583257344|FG001|Overall Study|Participant Died|1|||
161508798|NCT02043015|583257345|FG000|Overall Study|Lost to Follow-up|4|||
161508799|NCT02043015|583257345|FG000|Overall Study|Withdrawal by Subject|4|||
161508800|NCT02043015|583257345|FG000|Overall Study|Removed once target enrollment reached|15|||
161508801|NCT02043015|583257345|FG000|Overall Study|Participant moved away from study city|4|||
161508802|NCT02043015|583257345|FG000|Overall Study|Incarceration|1|||
161508803|NCT01077960|583257346|FG000|Overall Study|Adverse Event|6|||
161508804|NCT01077960|583257346|FG000|Overall Study|Protocol Violation|3|||
161508805|NCT01077960|583257346|FG000|Overall Study|Lost to Follow-up|5|||
161508806|NCT01077960|583257346|FG000|Overall Study|Subject decision|1|||
161508807|NCT01077960|583257346|FG000|Overall Study|Reason unspecified|1|||
161508808|NCT03837899|583257347|FG000|Overall Study|Death|6|||
161508809|NCT03837899|583257348|FG001|Overall Study|Death|8|||
161508810|NCT03837899|583257349|FG002|Overall Study|Death|3|||
161508811|NCT03837899|583257350|FG003|Overall Study|Death|7|||
161508812|NCT03837899|583257351|FG004|Overall Study|Death|8|||
161508813|NCT03837899|583257352|FG005|Overall Study|Death|7|||
161508814|NCT03837899|583257347|FG000|Overall Study|Moved to post-trial access program|0|||
161508815|NCT03837899|583257348|FG001|Overall Study|Moved to post-trial access program|1|||
161508816|NCT03837899|583257349|FG002|Overall Study|Moved to post-trial access program|0|||
161508817|NCT03837899|583257350|FG003|Overall Study|Moved to post-trial access program|0|||
161508818|NCT03837899|583257351|FG004|Overall Study|Moved to post-trial access program|0|||
161508819|NCT03837899|583257352|FG005|Overall Study|Moved to post-trial access program|0|||
161508820|NCT03837899|583257347|FG000|Overall Study|Other|0|||
161508821|NCT03837899|583257348|FG001|Overall Study|Other|0|||
161508822|NCT03837899|583257349|FG002|Overall Study|Other|0|||
161508823|NCT03837899|583257350|FG003|Overall Study|Other|0|||
161508824|NCT03837899|583257351|FG004|Overall Study|Other|0|||
161508825|NCT03837899|583257352|FG005|Overall Study|Other|2|||
161508826|NCT03837899|583257347|FG000|Overall Study|Lost to Follow-up|0|||
161587324|NCT04831281|583538885|FG002|Overall Study|Undetermined|0|||
161587325|NCT02249949|583538886|FG000|Overall Study|Cancelled prior to treatment|2|||
161508827|NCT03837899|583257348|FG001|Overall Study|Lost to Follow-up|1|||
161508828|NCT03837899|583257349|FG002|Overall Study|Lost to Follow-up|0|||
161508829|NCT03837899|583257350|FG003|Overall Study|Lost to Follow-up|0|||
161508830|NCT03837899|583257351|FG004|Overall Study|Lost to Follow-up|0|||
161587326|NCT02097420|583538889|FG000|Overall Study|Death|6|||
161508831|NCT03837899|583257352|FG005|Overall Study|Lost to Follow-up|0|||
161508832|NCT03837899|583257347|FG000|Overall Study|Withdrawal by Subject|0|||
161508833|NCT03837899|583257348|FG001|Overall Study|Withdrawal by Subject|0|||
161508834|NCT03837899|583257349|FG002|Overall Study|Withdrawal by Subject|0|||
161820506|NCT00762411|584384531|FG000|Initial Treatment|Death|7|||
161587327|NCT02097420|583538889|FG000|Overall Study|Valve explanted|13|||
161508835|NCT03837899|583257350|FG003|Overall Study|Withdrawal by Subject|1|||
161508836|NCT03837899|583257351|FG004|Overall Study|Withdrawal by Subject|0|||
161820507|NCT00762411|584384532|FG001|Initial Treatment|Death|6|||
161820508|NCT00762411|584384531|FG000|Initial Treatment|Adverse Event|132|||
161820509|NCT00762411|584384532|FG001|Initial Treatment|Adverse Event|40|||
161820510|NCT00762411|584384531|FG000|Initial Treatment|Protocol Violation|4|||
161508837|NCT03837899|583257352|FG005|Overall Study|Withdrawal by Subject|0|||
161508838|NCT03837899|583257347|FG000|Overall Study|Study specific discontinuation criteria|0|||
161508839|NCT03837899|583257348|FG001|Overall Study|Study specific discontinuation criteria|1|||
161820511|NCT00762411|584384532|FG001|Initial Treatment|Protocol Violation|1|||
161820512|NCT00762411|584384531|FG000|Initial Treatment|Withdrawal by Subject|65|||
161820513|NCT00762411|584384532|FG001|Initial Treatment|Withdrawal by Subject|52|||
161820514|NCT00762411|584384531|FG000|Initial Treatment|Physician Decision|1|||
161820515|NCT00762411|584384532|FG001|Initial Treatment|Physician Decision|0|||
161820516|NCT00762411|584384531|FG000|Initial Treatment|Sponsor Decision|293|||
161820517|NCT00762411|584384532|FG001|Initial Treatment|Sponsor Decision|401|||
161820518|NCT00762411|584384531|FG000|Initial Treatment|Lost to Follow-up|5|||
161820519|NCT00762411|584384532|FG001|Initial Treatment|Lost to Follow-up|0|||
161508840|NCT03837899|583257349|FG002|Overall Study|Study specific discontinuation criteria|0|||
161508841|NCT03837899|583257350|FG003|Overall Study|Study specific discontinuation criteria|0|||
161508842|NCT03837899|583257351|FG004|Overall Study|Study specific discontinuation criteria|3|||
161508843|NCT03837899|583257352|FG005|Overall Study|Study specific discontinuation criteria|1|||
161508844|NCT01403974|583257353|FG000|Overall Study|Progressive disease according to RECIST|3|||
161508845|NCT01403974|583257354|FG001|Overall Study|Progressive disease according to RECIST|3|||
161508846|NCT01403974|583257355|FG002|Overall Study|Progressive disease according to RECIST|2|||
161508847|NCT01403974|583257356|FG003|Overall Study|Progressive disease according to RECIST|3|||
161508848|NCT01403974|583257357|FG004|Overall Study|Progressive disease according to RECIST|3|||
161508849|NCT01403974|583257358|FG005|Overall Study|Progressive disease according to RECIST|2|||
161508850|NCT01403974|583257359|FG006|Overall Study|Progressive disease according to RECIST|3|||
161508851|NCT01403974|583257360|FG007|Overall Study|Progressive disease according to RECIST|2|||
161508852|NCT01403974|583257361|FG008|Overall Study|Progressive disease according to RECIST|6|||
161508853|NCT01403974|583257362|FG009|Overall Study|Progressive disease according to RECIST|2|||
161508854|NCT01403974|583257363|FG010|Overall Study|Progressive disease according to RECIST|3|||
161508855|NCT01403974|583257364|FG011|Overall Study|Progressive disease according to RECIST|2|||
161508856|NCT01403974|583257365|FG012|Overall Study|Progressive disease according to RECIST|2|||
161508857|NCT01403974|583257366|FG013|Overall Study|Progressive disease according to RECIST|3|||
161508858|NCT01403974|583257367|FG014|Overall Study|Progressive disease according to RECIST|1|||
161508859|NCT01403974|583257368|FG015|Overall Study|Progressive disease according to RECIST|8|||
161508860|NCT01403974|583257353|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
161508861|NCT01403974|583257354|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
161508862|NCT01403974|583257355|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
161820520|NCT00762411|584384531|FG000|Initial Treatment|Caregiver Decision|21|||
161820521|NCT00762411|584384532|FG001|Initial Treatment|Caregiver Decision|16|||
161820522|NCT00762411|584384531|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
161820523|NCT00762411|584384532|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
161820524|NCT00762411|584384531|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
161508863|NCT01403974|583257356|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
161508864|NCT01403974|583257357|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
161508865|NCT01403974|583257358|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
161508866|NCT01403974|583257359|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
161508867|NCT01403974|583257360|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
161508868|NCT01403974|583257361|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
161508869|NCT01403974|583257362|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
161508870|NCT01403974|583257363|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
161508871|NCT01403974|583257364|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
161820525|NCT00762411|584384532|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
161820526|NCT00762411|584384531|FG000|Delayed Start|Adverse Event|0|||
161820527|NCT00762411|584384532|FG001|Delayed Start|Adverse Event|4|||
161820528|NCT00762411|584384531|FG000|Delayed Start|Protocol Violation|0|||
161820529|NCT00762411|584384532|FG001|Delayed Start|Protocol Violation|1|||
161820530|NCT00762411|584384531|FG000|Delayed Start|Sponsor Decision|16|||
161508872|NCT01403974|583257365|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
161508873|NCT01403974|583257366|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
161508874|NCT01403974|583257367|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
161508875|NCT01403974|583257368|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
161508876|NCT01403974|583257353|FG000|Overall Study|Refused to continue study medication|0|||
161508877|NCT01403974|583257354|FG001|Overall Study|Refused to continue study medication|0|||
161508878|NCT01403974|583257355|FG002|Overall Study|Refused to continue study medication|0|||
161675436|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675437|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
161675438|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
161675439|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161675440|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675441|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675442|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675443|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675444|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675445|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675446|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675447|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675448|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675449|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
161675450|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675451|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675452|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675453|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675454|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675455|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675456|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675457|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675458|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675459|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675460|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
161675461|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675462|NCT05211739|583865464|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
161675463|NCT05211739|583865465|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
161675464|NCT05211739|583865464|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
161675465|NCT05211739|583865465|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
161675466|NCT05211739|583865464|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
161675467|NCT05211739|583865465|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
161675468|NCT05211739|583865464|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
161675469|NCT05211739|583865465|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
161675470|NCT01975428|583865469|FG000|Overall Study|Lost to Follow-up|17|||
161675471|NCT01975428|583865470|FG001|Overall Study|Lost to Follow-up|4|||
161675472|NCT01975428|583865469|FG000|Overall Study|Withdrawal by Subject|3|||
161675473|NCT01975428|583865470|FG001|Overall Study|Withdrawal by Subject|10|||
161675474|NCT02187809|583865471|FG000|Overall Study|The study was terminated|3|||
161675475|NCT00628251|583865472|FG000|Randomised Part|Withdrawal by Subject|0|||
161675476|NCT00628251|583865473|FG001|Randomised Part|Withdrawal by Subject|0|||
161675477|NCT00628251|583865474|FG002|Randomised Part|Withdrawal by Subject|1|||
161820531|NCT00762411|584384532|FG001|Delayed Start|Sponsor Decision|20|||
161508879|NCT01403974|583257356|FG003|Overall Study|Refused to continue study medication|0|||
161508880|NCT01403974|583257357|FG004|Overall Study|Refused to continue study medication|0|||
161508881|NCT01403974|583257358|FG005|Overall Study|Refused to continue study medication|1|||
161508882|NCT01403974|583257359|FG006|Overall Study|Refused to continue study medication|0|||
161508883|NCT01403974|583257360|FG007|Overall Study|Refused to continue study medication|0|||
161508884|NCT01403974|583257361|FG008|Overall Study|Refused to continue study medication|1|||
161508885|NCT01403974|583257362|FG009|Overall Study|Refused to continue study medication|0|||
161508886|NCT01403974|583257363|FG010|Overall Study|Refused to continue study medication|1|||
161508887|NCT01403974|583257364|FG011|Overall Study|Refused to continue study medication|0|||
161508888|NCT01403974|583257365|FG012|Overall Study|Refused to continue study medication|0|||
161508889|NCT01403974|583257366|FG013|Overall Study|Refused to continue study medication|0|||
161508890|NCT01403974|583257367|FG014|Overall Study|Refused to continue study medication|0|||
161508891|NCT01403974|583257368|FG015|Overall Study|Refused to continue study medication|4|||
161508892|NCT01403974|583257353|FG000|Overall Study|Adverse Event|0|||
161508893|NCT01403974|583257354|FG001|Overall Study|Adverse Event|0|||
161508894|NCT01403974|583257355|FG002|Overall Study|Adverse Event|1|||
161508895|NCT01403974|583257356|FG003|Overall Study|Adverse Event|0|||
161675478|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
161675479|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
161675480|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
161675481|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
161675482|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
161675483|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
161675484|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
161675485|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
161675486|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
161675487|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
161675488|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
161675489|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
161675490|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
161675491|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
161675492|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
161675493|NCT01245387|583865475|FG000|Overall Study|Lost to Follow-up|106|||
161675494|NCT01245387|583865475|FG000|Overall Study|Lack of Efficacy|195|||
161675495|NCT01245387|583865475|FG000|Overall Study|Adverse Event|9|||
161675496|NCT01245387|583865475|FG000|Overall Study|Death|3|||
161675497|NCT01245387|583865475|FG000|Overall Study|Other|131|||
161675498|NCT01245387|583865475|FG000|Overall Study|Missing discontinuation status|369|||
161675499|NCT00601705|583865476|FG000|Overall Study|Withdrawal by Subject|1|||
161675500|NCT04513665|583865477|FG000|Overall Study|Adverse Event|2|||
161675501|NCT04513665|583865478|FG001|Overall Study|Adverse Event|0|||
161675502|NCT04513665|583865477|FG000|Overall Study|Lack of Efficacy|14|||
161675503|NCT04513665|583865478|FG001|Overall Study|Lack of Efficacy|0|||
161675504|NCT02608879|583865482|FG000|Overall Study|Lost to Follow-up|1|||
161675505|NCT02608879|583865483|FG001|Overall Study|Lost to Follow-up|0|||
161675506|NCT02608879|583865484|FG002|Overall Study|Lost to Follow-up|0|||
161675507|NCT02608879|583865482|FG000|Overall Study|Did not meet continuation criteria|0|||
161675508|NCT02608879|583865483|FG001|Overall Study|Did not meet continuation criteria|0|||
161675509|NCT02608879|583865484|FG002|Overall Study|Did not meet continuation criteria|3|||
161675510|NCT04246801|583865485|FG000|Overall Study|Adverse Event|1|||
161675511|NCT04246801|583865486|FG001|Overall Study|Adverse Event|1|||
161675512|NCT04246801|583865485|FG000|Overall Study|Protocol Violation|1|||
161675513|NCT04246801|583865486|FG001|Overall Study|Protocol Violation|1|||
161675514|NCT04246801|583865485|FG000|Overall Study|Lack of Efficacy|0|||
161675515|NCT04246801|583865486|FG001|Overall Study|Lack of Efficacy|2|||
161675516|NCT04246801|583865485|FG000|Overall Study|Lost to Follow-up|1|||
161675517|NCT04246801|583865486|FG001|Overall Study|Lost to Follow-up|1|||
161675518|NCT04246801|583865485|FG000|Overall Study|Withdrawal by Subject|2|||
161675519|NCT04246801|583865486|FG001|Overall Study|Withdrawal by Subject|1|||
161675520|NCT01368042|583865490|FG000|Overall Study|Death|14|||
161675521|NCT01368042|583865490|FG000|Overall Study|Protocol Violation|11|||
161675522|NCT01368042|583865490|FG000|Overall Study|Lost to Follow-up|4|||
161675523|NCT01368042|583865490|FG000|Overall Study|Transplanted|1|||
161675524|NCT01621542|583865491|FG000|Overall Study|Adverse Event|0|||
161675525|NCT01621542|583865492|FG001|Overall Study|Adverse Event|0|||
161675526|NCT01621542|583865493|FG002|Overall Study|Adverse Event|1|||
161675527|NCT01621542|583865494|FG003|Overall Study|Adverse Event|3|||
161675528|NCT01621542|583865495|FG004|Overall Study|Adverse Event|0|||
161675529|NCT01621542|583865496|FG005|Overall Study|Adverse Event|0|||
161675530|NCT01621542|583865491|FG000|Overall Study|Death|0|||
161675531|NCT01621542|583865492|FG001|Overall Study|Death|1|||
161675532|NCT01621542|583865493|FG002|Overall Study|Death|0|||
161675533|NCT01621542|583865494|FG003|Overall Study|Death|0|||
161675534|NCT01621542|583865495|FG004|Overall Study|Death|0|||
161675535|NCT01621542|583865496|FG005|Overall Study|Death|0|||
161675536|NCT01621542|583865491|FG000|Overall Study|Physician Decision|1|||
161508896|NCT01403974|583257357|FG004|Overall Study|Adverse Event|0|||
161508897|NCT01403974|583257358|FG005|Overall Study|Adverse Event|0|||
161508898|NCT01403974|583257359|FG006|Overall Study|Adverse Event|0|||
161675537|NCT01621542|583865492|FG001|Overall Study|Physician Decision|0|||
161675538|NCT01621542|583865493|FG002|Overall Study|Physician Decision|1|||
161508899|NCT01403974|583257360|FG007|Overall Study|Adverse Event|1|||
161508900|NCT01403974|583257361|FG008|Overall Study|Adverse Event|0|||
161508901|NCT01403974|583257362|FG009|Overall Study|Adverse Event|0|||
161675539|NCT01621542|583865494|FG003|Overall Study|Physician Decision|13|||
161508902|NCT01403974|583257363|FG010|Overall Study|Adverse Event|0|||
161508903|NCT01403974|583257364|FG011|Overall Study|Adverse Event|0|||
161508904|NCT01403974|583257365|FG012|Overall Study|Adverse Event|1|||
161675540|NCT01621542|583865495|FG004|Overall Study|Physician Decision|3|||
161675541|NCT01621542|583865496|FG005|Overall Study|Physician Decision|1|||
161675542|NCT01621542|583865491|FG000|Overall Study|Withdrawal by Subject|2|||
161675543|NCT01621542|583865492|FG001|Overall Study|Withdrawal by Subject|0|||
161675544|NCT01621542|583865493|FG002|Overall Study|Withdrawal by Subject|1|||
161508905|NCT01403974|583257366|FG013|Overall Study|Adverse Event|0|||
161508906|NCT01403974|583257367|FG014|Overall Study|Adverse Event|0|||
161508907|NCT01403974|583257368|FG015|Overall Study|Adverse Event|0|||
161508908|NCT01403974|583257353|FG000|Overall Study|Other than specified|0|||
161508909|NCT01403974|583257354|FG001|Overall Study|Other than specified|0|||
161508910|NCT01403974|583257355|FG002|Overall Study|Other than specified|0|||
161508911|NCT01403974|583257356|FG003|Overall Study|Other than specified|0|||
161508912|NCT01403974|583257357|FG004|Overall Study|Other than specified|0|||
161508913|NCT01403974|583257358|FG005|Overall Study|Other than specified|0|||
161508914|NCT01403974|583257359|FG006|Overall Study|Other than specified|0|||
161508915|NCT01403974|583257360|FG007|Overall Study|Other than specified|0|||
161508916|NCT01403974|583257361|FG008|Overall Study|Other than specified|0|||
161508917|NCT01403974|583257362|FG009|Overall Study|Other than specified|1|||
161508918|NCT01403974|583257363|FG010|Overall Study|Other than specified|0|||
161508919|NCT01403974|583257364|FG011|Overall Study|Other than specified|1|||
161508920|NCT01403974|583257365|FG012|Overall Study|Other than specified|0|||
161508921|NCT01403974|583257366|FG013|Overall Study|Other than specified|0|||
161508922|NCT01403974|583257367|FG014|Overall Study|Other than specified|0|||
161508923|NCT01403974|583257368|FG015|Overall Study|Other than specified|0|||
161508924|NCT01526889|583257369|FG000|Treatment Period|Adverse Event|2|||
161508925|NCT01526889|583257370|FG001|Treatment Period|Adverse Event|0|||
161508926|NCT01526889|583257369|FG000|Treatment Extension Period|Administrative problems|1|||
161508927|NCT01526889|583257370|FG001|Treatment Extension Period|Administrative problems|0|||
161508928|NCT00393939|583257376|FG000|Overall Study|Protocol Violation|1|||
161508929|NCT00393939|583257377|FG001|Overall Study|Protocol Violation|1|||
161508930|NCT00393939|583257376|FG000|Overall Study|Lost to Follow-up|2|||
161508931|NCT00393939|583257377|FG001|Overall Study|Lost to Follow-up|4|||
161508932|NCT00393939|583257376|FG000|Overall Study|Death|10|||
161508933|NCT00393939|583257377|FG001|Overall Study|Death|4|||
161508934|NCT00393939|583257376|FG000|Overall Study|Sponsor|5|||
161508935|NCT00393939|583257377|FG001|Overall Study|Sponsor|13|||
161508936|NCT00393939|583257376|FG000|Overall Study|Objective progression or relapse|239|||
161508937|NCT00393939|583257377|FG001|Overall Study|Objective progression or relapse|223|||
161508938|NCT00393939|583257376|FG000|Overall Study|Withdrawal by Subject|2|||
161508939|NCT00393939|583257377|FG001|Overall Study|Withdrawal by Subject|7|||
161508940|NCT00393939|583257376|FG000|Overall Study|Other|37|||
161508941|NCT00393939|583257377|FG001|Overall Study|Other|45|||
161508942|NCT01494610|583257378|FG000|Period 1|Withdrawal by Subject|1|||
161508943|NCT01494610|583257379|FG001|Period 1|Withdrawal by Subject|1|||
161508944|NCT01494610|583257378|FG000|Period 3|Adverse Event|1|||
161508945|NCT01494610|583257379|FG001|Period 3|Adverse Event|0|||
161508946|NCT01494610|583257378|FG000|Period 3|Withdrawal by Subject|1|||
161508947|NCT01494610|583257379|FG001|Period 3|Withdrawal by Subject|0|||
161508948|NCT01494610|583257378|FG000|Period 4|Protocol Violation|1|||
161508949|NCT01494610|583257379|FG001|Period 4|Protocol Violation|0|||
161508950|NCT02385799|583257380|FG000|Overall Study|Lost to Follow-up|1|||
161508951|NCT02385799|583257381|FG001|Overall Study|Lost to Follow-up|2|||
161508952|NCT02385799|583257380|FG000|Overall Study|Adverse Event|4|||
161508953|NCT02385799|583257381|FG001|Overall Study|Adverse Event|2|||
161508954|NCT02385799|583257380|FG000|Overall Study|Withdrawal by Subject|0|||
161508955|NCT02385799|583257381|FG001|Overall Study|Withdrawal by Subject|4|||
161508956|NCT04958109|583257382|FG000|Overall Study|Withdrawal by Subject|0|||
161508957|NCT04958109|583257383|FG001|Overall Study|Withdrawal by Subject|1|||
161508958|NCT04958109|583257382|FG000|Overall Study|Lost to Follow-up|0|||
161508959|NCT04958109|583257383|FG001|Overall Study|Lost to Follow-up|1|||
161508960|NCT00715793|583257384|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
161508961|NCT00715793|583257385|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
161508962|NCT00715793|583257384|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
161508963|NCT00715793|583257385|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
161508964|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508965|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
161508966|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
161508967|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
161508968|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508969|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508970|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508971|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508972|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508973|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508974|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508975|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508976|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508977|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508978|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161587328|NCT02097420|583538889|FG000|Overall Study|Other Reason|1|||
161508979|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508980|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508981|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508982|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508983|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508984|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508985|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508986|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508987|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
161508988|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508989|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
161508990|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508991|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508992|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508993|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508994|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508995|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508996|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508997|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508998|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161508999|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509000|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509001|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509002|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509003|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509004|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509005|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509006|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509007|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509008|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509009|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509010|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509011|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
161509012|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509013|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
161509014|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161587329|NCT01707030|583538906|FG000|Overall Study|Death|1|||
161587330|NCT01707030|583538907|FG001|Overall Study|Death|1|||
161587331|NCT01707030|583538906|FG000|Overall Study|Withdrawal by Subject|2|||
161587332|NCT01707030|583538907|FG001|Overall Study|Withdrawal by Subject|3|||
161587333|NCT01707030|583538906|FG000|Overall Study|Lost to Follow-up|8|||
161587334|NCT01707030|583538907|FG001|Overall Study|Lost to Follow-up|13|||
161587335|NCT04263311|583538908|FG000|Overall Study|Lost to Follow-up|1|||
161587336|NCT04263311|583538909|FG001|Overall Study|Lost to Follow-up|2|||
161587337|NCT04263311|583538910|FG002|Overall Study|Lost to Follow-up|0|||
161587338|NCT04263311|583538908|FG000|Overall Study|Health Issues|1|||
161587339|NCT04263311|583538909|FG001|Overall Study|Health Issues|0|||
161587340|NCT04263311|583538910|FG002|Overall Study|Health Issues|0|||
161587341|NCT04263311|583538908|FG000|Overall Study|Left the country|1|||
161587342|NCT04263311|583538909|FG001|Overall Study|Left the country|0|||
161587343|NCT04263311|583538910|FG002|Overall Study|Left the country|0|||
161587344|NCT04263311|583538908|FG000|Overall Study|Unable to maintain time commitment|1|||
161587345|NCT04263311|583538909|FG001|Overall Study|Unable to maintain time commitment|0|||
161587346|NCT04263311|583538910|FG002|Overall Study|Unable to maintain time commitment|0|||
161587347|NCT04263311|583538908|FG000|Overall Study|No longer interested|1|||
161587348|NCT04263311|583538909|FG001|Overall Study|No longer interested|0|||
161587349|NCT04263311|583538910|FG002|Overall Study|No longer interested|0|||
161587350|NCT04263311|583538908|FG000|Overall Study|Ineligible post consent|0|||
161587351|NCT04263311|583538909|FG001|Overall Study|Ineligible post consent|0|||
161587352|NCT04263311|583538910|FG002|Overall Study|Ineligible post consent|5|||
161587353|NCT04820855|583538911|FG000|Overall Study|Lost to Follow-up|6|||
161587354|NCT04820855|583538912|FG001|Overall Study|Lost to Follow-up|9|||
161587355|NCT04838262|583538913|FG000|Overall Study|Withdrawal by Subject|9|||
161587356|NCT04838262|583538914|FG001|Overall Study|Withdrawal by Subject|4|||
161587357|NCT02927769|583538915|FG000|Induction Phase|Study drug toxicity|1|||
161587358|NCT02927769|583538916|FG001|Induction Phase|Study drug toxicity|1|||
161587359|NCT02927769|583538915|FG000|Induction Phase|Disease progression|0|||
161587360|NCT02927769|583538916|FG001|Induction Phase|Disease progression|1|||
161587361|NCT02927769|583538915|FG000|Intensification Phase|Study drug toxicity|1|||
161587362|NCT02927769|583538916|FG001|Intensification Phase|Study drug toxicity|0|||
161587363|NCT05524233|583538921|FG000|Overall Study|Lost to Follow-up|2|||
161509015|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509016|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509017|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509018|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509019|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509020|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509021|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509022|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509023|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509024|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509025|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509026|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509027|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509028|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509029|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509030|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509031|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509032|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509033|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509034|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509035|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
161509036|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
161509037|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
161509038|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
161509039|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
161509040|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509041|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509042|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509043|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509044|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509045|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509046|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509047|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509048|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509049|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509050|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509051|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509052|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509053|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509054|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509055|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509056|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509057|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509058|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509059|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
161509060|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
161509061|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
161509062|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
161509063|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
161509064|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509065|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509066|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509067|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509068|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509069|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509070|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509071|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509072|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509073|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509074|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509075|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161587364|NCT05524233|583538921|FG000|Overall Study|Adverse Event|2|||
161587365|NCT05524233|583538921|FG000|Overall Study|Withdrawal by Subject|1|||
161587366|NCT02307565|583538923|FG000|Overall Study|Adverse Event|3|||
161926333|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
161509076|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509077|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509078|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509079|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509080|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509081|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161820532|NCT00762411|584384531|FG000|Delayed Start|Caregiver Decision|1|||
161820533|NCT00762411|584384532|FG001|Delayed Start|Caregiver Decision|1|||
161820534|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
161820535|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
161820536|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161820537|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
161509082|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509083|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161509084|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509085|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
161509086|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509087|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
161509088|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509089|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509090|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509091|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509092|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509093|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509094|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509095|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509096|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509097|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509098|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509099|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509100|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509101|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509102|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509103|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509104|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509105|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509106|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509107|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
161509108|NCT02346240|583257386|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509109|NCT02346240|583257387|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509110|NCT02346240|583257388|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
161509111|NCT02346240|583257389|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509112|NCT02346240|583257390|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509113|NCT02346240|583257391|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509114|NCT02346240|583257392|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509115|NCT02346240|583257393|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509116|NCT02346240|583257394|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509117|NCT02346240|583257395|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509118|NCT02346240|583257396|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509119|NCT02346240|583257397|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509120|NCT02346240|583257398|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509121|NCT02346240|583257399|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509122|NCT02346240|583257400|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509123|NCT02346240|583257401|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509124|NCT02346240|583257402|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509125|NCT02346240|583257403|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509126|NCT02346240|583257404|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509127|NCT02346240|583257405|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509128|NCT02346240|583257406|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509129|NCT02346240|583257407|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509130|NCT02346240|583257408|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161820538|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
161820539|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
161926334|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
161509131|NCT02346240|583257409|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
161509132|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509133|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509134|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509135|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509136|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509137|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509138|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509139|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161509140|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161509141|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509142|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509143|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509144|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509145|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161509146|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
161509147|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161509148|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161509149|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509150|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509151|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509152|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509153|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161587367|NCT02307565|583538924|FG001|Overall Study|Adverse Event|2|||
161587368|NCT02307565|583538923|FG000|Overall Study|Withdrawal by Subject|2|||
161587369|NCT02307565|583538924|FG001|Overall Study|Withdrawal by Subject|2|||
161587370|NCT00650104|583538925|FG000|Overall Study|Adverse Event|17|||
161587371|NCT00650104|583538925|FG000|Overall Study|Death|2|||
161587372|NCT00650104|583538925|FG000|Overall Study|Withdrawal by Subject|11|||
161587373|NCT00650104|583538925|FG000|Overall Study|Physician Decision|7|||
161587374|NCT00650104|583538925|FG000|Overall Study|Lost to Follow-up|1|||
161587375|NCT00650104|583538925|FG000|Overall Study|Non-compliance|2|||
161587376|NCT00650104|583538925|FG000|Overall Study|Sponsor Terminated Dosing|1|||
161587377|NCT05633407|583538930|FG000|Overall Study|Physician Decision|2|||
161587378|NCT05633407|583538931|FG001|Overall Study|Physician Decision|0|||
161587379|NCT05633407|583538930|FG000|Overall Study|Adverse Event|1|||
161587380|NCT05633407|583538931|FG001|Overall Study|Adverse Event|0|||
161587381|NCT05633407|583538930|FG000|Overall Study|Withdrawal by Subject|1|||
161587382|NCT05633407|583538931|FG001|Overall Study|Withdrawal by Subject|0|||
161587383|NCT05633407|583538930|FG000|Overall Study|Other|1|||
161587384|NCT05633407|583538931|FG001|Overall Study|Other|1|||
161587385|NCT00593489|583538932|FG000|Allocation|did not attend workshop; allocation not|2|||
161587386|NCT00593489|583538933|FG001|Allocation|did not attend workshop; allocation not|1|||
161587387|NCT01011946|583538934|FG000|Overall Study|Transferred to another hospital|2|||
161587388|NCT01011946|583538934|FG000|Overall Study|No pathological lab value|1|||
161587389|NCT03527160|583538935|FG000|Overall Study|No urine collected|13|||
161587390|NCT03527160|583538935|FG000|Overall Study|No clinical serum creatinine collected|6|||
161587391|NCT03527160|583538935|FG000|Overall Study|Did not meet inclusion|2|||
161587392|NCT01721291|583538937|FG000|Overall Study|Withdrawal by Subject|1|||
161587393|NCT01721291|583538938|FG001|Overall Study|Withdrawal by Subject|0|||
161587394|NCT01721291|583538937|FG000|Overall Study|did not like the treatment|1|||
161587395|NCT01721291|583538938|FG001|Overall Study|did not like the treatment|0|||
161587396|NCT04173663|583540605|FG000|Overall Study|Withdrawal by Subject|1|||
161587397|NCT04173663|583540606|FG001|Overall Study|Withdrawal by Subject|6|||
161587398|NCT04173663|583540605|FG000|Overall Study|Lost to Follow-up|17|||
161587399|NCT04173663|583540606|FG001|Overall Study|Lost to Follow-up|24|||
161675545|NCT01621542|583865494|FG003|Overall Study|Withdrawal by Subject|3|||
161675546|NCT01621542|583865495|FG004|Overall Study|Withdrawal by Subject|3|||
161587402|NCT04833777|583540613|FG000|Overall Study|Lost to Follow-up|1|||
161675547|NCT01621542|583865496|FG005|Overall Study|Withdrawal by Subject|3|||
161675548|NCT01621542|583865491|FG000|Overall Study|progression/treatment failure|2|||
161509154|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161587403|NCT04833777|583540614|FG001|Overall Study|Lost to Follow-up|0|||
161587404|NCT03089398|583540622|FG000|Overall Study|Death|4|||
161587405|NCT03089398|583540623|FG001|Overall Study|Death|9|||
161587406|NCT03089398|583540622|FG000|Overall Study|Lost to Follow-up|21|||
161587407|NCT03089398|583540623|FG001|Overall Study|Lost to Follow-up|30|||
161587408|NCT03089398|583540622|FG000|Overall Study|Withdrawal by Subject|2|||
161587409|NCT03089398|583540623|FG001|Overall Study|Withdrawal by Subject|2|||
161587410|NCT05249439|583540624|FG000|Overall Study|Withdrawal by Subject|2|||
161587411|NCT05249439|583540625|FG001|Overall Study|Withdrawal by Subject|5|||
161587412|NCT05249439|583540624|FG000|Overall Study|Physician Decision|3|||
161675549|NCT01621542|583865492|FG001|Overall Study|progression/treatment failure|4|||
161509155|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161509156|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509157|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509158|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509159|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509160|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509161|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509162|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509163|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509164|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509165|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509166|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509167|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509168|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509169|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161587413|NCT05249439|583540625|FG001|Overall Study|Physician Decision|1|||
161587414|NCT00616967|583540626|FG000|Overall Study|Withdrawal by Subject|0|||
161587415|NCT00616967|583540627|FG001|Overall Study|Withdrawal by Subject|0|||
161587416|NCT00616967|583540628|FG002|Overall Study|Withdrawal by Subject|1|||
161587417|NCT02910583|583540629|FG000|Overall Study|Death|7|||
161587418|NCT02910583|583540630|FG001|Overall Study|Death|3|||
161587419|NCT02910583|583540629|FG000|Overall Study|Lost to Follow-up|1|||
161587420|NCT02910583|583540630|FG001|Overall Study|Lost to Follow-up|0|||
161587421|NCT02910583|583540629|FG000|Overall Study|Withdrawal by Subject|12|||
161587422|NCT02910583|583540630|FG001|Overall Study|Withdrawal by Subject|8|||
161587423|NCT02910583|583540629|FG000|Overall Study|Other, Not Specified|6|||
161587424|NCT02910583|583540630|FG001|Overall Study|Other, Not Specified|3|||
161587425|NCT05059262|583540631|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
161587426|NCT05059262|583540632|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
161587427|NCT05059262|583540631|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
161587428|NCT05059262|583540632|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
161587429|NCT05059262|583540631|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
161587430|NCT05059262|583540632|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
161587431|NCT05059262|583540631|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
161587432|NCT05059262|583540632|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
161587433|NCT05059262|583540631|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
161587434|NCT05059262|583540632|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
161587435|NCT05059262|583540631|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
161587436|NCT05059262|583540632|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
161587437|NCT05059262|583540631|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
161587438|NCT05059262|583540632|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
161587439|NCT05059262|583540631|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
161587440|NCT05059262|583540632|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
161587441|NCT05059262|583540631|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
161587442|NCT05059262|583540632|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
161587443|NCT05021640|583540635|FG000|Overall Study|Lost to Follow-up|0|||
161587444|NCT05021640|583540636|FG001|Overall Study|Lost to Follow-up|0|||
161587445|NCT05021640|583540637|FG002|Overall Study|Lost to Follow-up|0|||
161587446|NCT05021640|583540638|FG003|Overall Study|Lost to Follow-up|0|||
161587447|NCT05021640|583540639|FG004|Overall Study|Lost to Follow-up|1|||
161587448|NCT02312960|583540640|FG000|Overall Study|Death|24|||
161587449|NCT02312960|583540641|FG001|Overall Study|Death|32|||
161587450|NCT02312960|583540642|FG002|Overall Study|Death|25|||
161587451|NCT02312960|583540643|FG003|Overall Study|Death|11|||
161587452|NCT02312960|583540644|FG004|Overall Study|Death|5|||
161587453|NCT02312960|583540645|FG005|Overall Study|Death|5|||
161587454|NCT02312960|583540646|FG006|Overall Study|Death|8|||
161587455|NCT02312960|583540647|FG007|Overall Study|Death|5|||
161587456|NCT02312960|583540648|FG008|Overall Study|Death|7|||
161587457|NCT02312960|583540649|FG009|Overall Study|Death|3|||
161587458|NCT02312960|583540650|FG010|Overall Study|Death|3|||
161587459|NCT02312960|583540651|FG011|Overall Study|Death|1|||
161587460|NCT02312960|583540652|FG012|Overall Study|Death|25|||
161587461|NCT02312960|583540653|FG013|Overall Study|Death|19|||
161587462|NCT02312960|583540640|FG000|Overall Study|Missing|0|||
161926335|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
161509170|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161587463|NCT02312960|583540641|FG001|Overall Study|Missing|0|||
161509171|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
161587464|NCT02312960|583540642|FG002|Overall Study|Missing|2|||
161587465|NCT02312960|583540643|FG003|Overall Study|Missing|0|||
161587466|NCT02312960|583540644|FG004|Overall Study|Missing|0|||
161587467|NCT02312960|583540645|FG005|Overall Study|Missing|0|||
161587468|NCT02312960|583540646|FG006|Overall Study|Missing|0|||
161509172|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509173|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509174|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509175|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509176|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509177|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509178|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509179|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161509180|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509181|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509182|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509183|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509184|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509185|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509186|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509187|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509188|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509189|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509190|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509191|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509192|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509193|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509194|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
161509195|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509196|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509197|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509198|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509199|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509200|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509201|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509202|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509203|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161509204|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509205|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509206|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509207|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509208|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509209|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161509210|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161509211|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161509212|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161509213|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509214|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161509215|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
161509216|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509217|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
161509218|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
161509219|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
161509220|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161509221|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509222|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509223|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509224|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509225|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509226|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509227|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161509228|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509229|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161820540|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
161820541|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
161820542|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
161820543|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
161820544|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
161587469|NCT02312960|583540647|FG007|Overall Study|Missing|0|||
161509230|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509231|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509232|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509233|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509234|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509235|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509236|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509237|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509238|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509239|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509240|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509241|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
161675550|NCT01621542|583865493|FG002|Overall Study|progression/treatment failure|3|||
161675551|NCT01621542|583865494|FG003|Overall Study|progression/treatment failure|7|||
161675552|NCT01621542|583865495|FG004|Overall Study|progression/treatment failure|3|||
161675553|NCT01621542|583865496|FG005|Overall Study|progression/treatment failure|5|||
161509242|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
161509243|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
161509244|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
161509245|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509246|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509247|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509248|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509249|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509250|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509251|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161509252|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509253|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509254|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509255|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509256|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509257|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509258|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
161509259|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509260|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509261|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509262|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509263|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509264|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509265|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509266|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509267|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509268|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509269|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509270|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509271|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509272|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509273|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509274|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509275|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
161509276|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509277|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509278|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509279|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509280|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509281|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509282|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509283|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509284|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
161509285|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161675554|NCT01621542|583865491|FG000|Overall Study|Protocol Violation|0|||
161509286|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509287|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
161509288|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509289|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
161509290|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
161509291|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161675555|NCT01621542|583865492|FG001|Overall Study|Protocol Violation|0|||
161675556|NCT01621542|583865493|FG002|Overall Study|Protocol Violation|0|||
161675557|NCT01621542|583865494|FG003|Overall Study|Protocol Violation|1|||
161675558|NCT01621542|583865495|FG004|Overall Study|Protocol Violation|0|||
161675559|NCT01621542|583865496|FG005|Overall Study|Protocol Violation|0|||
161675560|NCT01621542|583865491|FG000|Overall Study|study stopped by sponsor|0|||
161675561|NCT01621542|583865492|FG001|Overall Study|study stopped by sponsor|0|||
161675562|NCT01621542|583865493|FG002|Overall Study|study stopped by sponsor|0|||
161675563|NCT01621542|583865494|FG003|Overall Study|study stopped by sponsor|1|||
161675564|NCT01621542|583865495|FG004|Overall Study|study stopped by sponsor|0|||
161675565|NCT01621542|583865496|FG005|Overall Study|study stopped by sponsor|0|||
161675566|NCT02632721|583865498|FG000|Overall Study|Adverse Event|0|||
161509292|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509293|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509294|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509295|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509296|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509297|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509298|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509299|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
161509300|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509301|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509302|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509303|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509304|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509305|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509306|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509307|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509308|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509309|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
161509310|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509311|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509312|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509313|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509314|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509315|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509316|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509317|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509318|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509319|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509320|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509321|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509322|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509323|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161509324|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509325|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509326|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509327|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509328|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509329|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161675567|NCT02632721|583865499|FG001|Overall Study|Adverse Event|0|||
161675568|NCT02632721|583865500|FG002|Overall Study|Adverse Event|2|||
161675569|NCT02632721|583865501|FG003|Overall Study|Adverse Event|5|||
161675570|NCT02632721|583865502|FG004|Overall Study|Adverse Event|3|||
161509330|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509331|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509332|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509333|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509334|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
161509335|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509336|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509337|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509338|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509339|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509340|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509341|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509342|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509343|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509344|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509345|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509346|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509347|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
161509348|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509349|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509350|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509351|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509352|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509353|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509354|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509355|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509356|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509357|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509358|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509359|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509360|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509361|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509362|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
161509363|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509364|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509365|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509366|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509367|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509368|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509369|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509370|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509371|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
161509372|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509373|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509374|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509375|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509376|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509377|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509378|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509379|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509380|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509381|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509382|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509383|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161587470|NCT02312960|583540648|FG008|Overall Study|Missing|0|||
161587471|NCT02312960|583540649|FG009|Overall Study|Missing|0|||
161587472|NCT02312960|583540650|FG010|Overall Study|Missing|0|||
161587473|NCT02312960|583540651|FG011|Overall Study|Missing|0|||
161587474|NCT02312960|583540652|FG012|Overall Study|Missing|0|||
161587475|NCT02312960|583540653|FG013|Overall Study|Missing|0|||
161587476|NCT02312960|583540640|FG000|Overall Study|Lost to Follow-up|0|||
161509384|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161820545|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
161509385|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509386|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
161509387|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509388|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509389|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509390|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509391|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509392|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509393|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509394|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509395|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161509396|NCT02346240|583257386|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509397|NCT02346240|583257387|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509398|NCT02346240|583257388|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509399|NCT02346240|583257389|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509400|NCT02346240|583257390|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509401|NCT02346240|583257391|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509402|NCT02346240|583257392|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509403|NCT02346240|583257393|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509404|NCT02346240|583257394|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509405|NCT02346240|583257395|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509406|NCT02346240|583257396|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509407|NCT02346240|583257397|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509408|NCT02346240|583257398|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509409|NCT02346240|583257399|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509410|NCT02346240|583257400|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
161509411|NCT02346240|583257401|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509412|NCT02346240|583257402|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509413|NCT02346240|583257403|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509414|NCT02346240|583257404|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509415|NCT02346240|583257405|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509416|NCT02346240|583257406|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509417|NCT02346240|583257407|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509418|NCT02346240|583257408|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509419|NCT02346240|583257409|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
161509420|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509421|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509422|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509423|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509424|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509425|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509426|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509427|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509428|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509429|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509430|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509431|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509432|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509433|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509434|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161820546|NCT02710214|584384536|FG000|Overall Study|Lost to Follow-up|1|||
161509435|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509436|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
161509437|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
161509438|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
161509439|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
161509440|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
161820547|NCT02710214|584384537|FG001|Overall Study|Lost to Follow-up|0|||
161820548|NCT02710214|584384536|FG000|Overall Study|Lack of Efficacy|0|||
161675571|NCT02632721|583865498|FG000|Overall Study|Dose limiting toxicity|0|||
161675572|NCT02632721|583865499|FG001|Overall Study|Dose limiting toxicity|0|||
161675573|NCT02632721|583865500|FG002|Overall Study|Dose limiting toxicity|0|||
161675574|NCT02632721|583865501|FG003|Overall Study|Dose limiting toxicity|1|||
161675575|NCT02632721|583865502|FG004|Overall Study|Dose limiting toxicity|0|||
161675576|NCT02632721|583865498|FG000|Overall Study|Progressive disease|3|||
161675577|NCT02632721|583865499|FG001|Overall Study|Progressive disease|0|||
161675578|NCT02632721|583865500|FG002|Overall Study|Progressive disease|4|||
161675579|NCT02632721|583865501|FG003|Overall Study|Progressive disease|6|||
161675580|NCT02632721|583865502|FG004|Overall Study|Progressive disease|5|||
161675581|NCT02632721|583865498|FG000|Overall Study|Refused to continue taking trial medication|0|||
161675582|NCT02632721|583865499|FG001|Overall Study|Refused to continue taking trial medication|1|||
161675583|NCT02632721|583865500|FG002|Overall Study|Refused to continue taking trial medication|1|||
161675584|NCT02632721|583865501|FG003|Overall Study|Refused to continue taking trial medication|1|||
161675585|NCT02632721|583865502|FG004|Overall Study|Refused to continue taking trial medication|2|||
161675586|NCT02632721|583865498|FG000|Overall Study|Inadequate clinical condition|0|||
161675587|NCT02632721|583865499|FG001|Overall Study|Inadequate clinical condition|0|||
161675588|NCT02632721|583865500|FG002|Overall Study|Inadequate clinical condition|0|||
161675589|NCT02632721|583865501|FG003|Overall Study|Inadequate clinical condition|0|||
161675590|NCT02632721|583865502|FG004|Overall Study|Inadequate clinical condition|1|||
161675591|NCT02632721|583865498|FG000|Overall Study|No meet eligibility|0|||
161675592|NCT02632721|583865499|FG001|Overall Study|No meet eligibility|0|||
161675593|NCT02632721|583865500|FG002|Overall Study|No meet eligibility|0|||
161675594|NCT02632721|583865501|FG003|Overall Study|No meet eligibility|0|||
161509441|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
161675595|NCT02632721|583865502|FG004|Overall Study|No meet eligibility|1|||
161675596|NCT02632721|583865498|FG000|Overall Study|Allergic reaction|0|||
161675597|NCT02632721|583865499|FG001|Overall Study|Allergic reaction|0|||
161675598|NCT02632721|583865500|FG002|Overall Study|Allergic reaction|0|||
161675599|NCT02632721|583865501|FG003|Overall Study|Allergic reaction|1|||
161675600|NCT02632721|583865502|FG004|Overall Study|Allergic reaction|0|||
161675601|NCT02632721|583865498|FG000|Overall Study|Receiving Decitabine locally|0|||
161675602|NCT02632721|583865499|FG001|Overall Study|Receiving Decitabine locally|0|||
161675603|NCT02632721|583865500|FG002|Overall Study|Receiving Decitabine locally|1|||
161675604|NCT02632721|583865501|FG003|Overall Study|Receiving Decitabine locally|0|||
161675605|NCT02632721|583865502|FG004|Overall Study|Receiving Decitabine locally|0|||
161675606|NCT02632721|583865498|FG000|Overall Study|No benefit from study treatment|1|||
161675607|NCT02632721|583865499|FG001|Overall Study|No benefit from study treatment|1|||
161675608|NCT02632721|583865500|FG002|Overall Study|No benefit from study treatment|0|||
161675609|NCT02632721|583865501|FG003|Overall Study|No benefit from study treatment|0|||
161675610|NCT02632721|583865502|FG004|Overall Study|No benefit from study treatment|1|||
161675611|NCT02632721|583865498|FG000|Overall Study|Patient wish for other treatment|0|||
161675612|NCT02632721|583865499|FG001|Overall Study|Patient wish for other treatment|1|||
161675613|NCT02632721|583865500|FG002|Overall Study|Patient wish for other treatment|0|||
161675614|NCT02632721|583865501|FG003|Overall Study|Patient wish for other treatment|0|||
161509442|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
161509443|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
161509444|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509445|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509446|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509447|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509448|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509449|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
161675615|NCT02632721|583865502|FG004|Overall Study|Patient wish for other treatment|0|||
161675616|NCT02632721|583865498|FG000|Overall Study|Relapsed Pneumonia|0|||
161675617|NCT02632721|583865499|FG001|Overall Study|Relapsed Pneumonia|0|||
161675618|NCT02632721|583865500|FG002|Overall Study|Relapsed Pneumonia|0|||
161675619|NCT02632721|583865501|FG003|Overall Study|Relapsed Pneumonia|0|||
161675620|NCT02632721|583865502|FG004|Overall Study|Relapsed Pneumonia|1|||
161509450|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
161675621|NCT02632721|583865498|FG000|Overall Study|Therapy refractory AML|0|||
161675622|NCT02632721|583865499|FG001|Overall Study|Therapy refractory AML|0|||
161675623|NCT02632721|583865500|FG002|Overall Study|Therapy refractory AML|0|||
161675624|NCT02632721|583865501|FG003|Overall Study|Therapy refractory AML|0|||
161675625|NCT02632721|583865502|FG004|Overall Study|Therapy refractory AML|1|||
161675626|NCT02632721|583865498|FG000|Overall Study|Increase of white blood cell count|0|||
161675627|NCT02632721|583865499|FG001|Overall Study|Increase of white blood cell count|0|||
161509451|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509452|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
161675628|NCT02632721|583865500|FG002|Overall Study|Increase of white blood cell count|0|||
161509453|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509454|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
161675629|NCT02632721|583865501|FG003|Overall Study|Increase of white blood cell count|0|||
161509455|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509456|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
161587477|NCT02312960|583540641|FG001|Overall Study|Lost to Follow-up|0|||
161587478|NCT02312960|583540642|FG002|Overall Study|Lost to Follow-up|1|||
161587479|NCT02312960|583540643|FG003|Overall Study|Lost to Follow-up|0|||
161587480|NCT02312960|583540644|FG004|Overall Study|Lost to Follow-up|0|||
161587481|NCT02312960|583540645|FG005|Overall Study|Lost to Follow-up|0|||
161587482|NCT02312960|583540646|FG006|Overall Study|Lost to Follow-up|1|||
161587483|NCT02312960|583540647|FG007|Overall Study|Lost to Follow-up|1|||
161587484|NCT02312960|583540648|FG008|Overall Study|Lost to Follow-up|0|||
161587485|NCT02312960|583540649|FG009|Overall Study|Lost to Follow-up|1|||
161587486|NCT02312960|583540650|FG010|Overall Study|Lost to Follow-up|0|||
161587487|NCT02312960|583540651|FG011|Overall Study|Lost to Follow-up|0|||
161587488|NCT02312960|583540652|FG012|Overall Study|Lost to Follow-up|1|||
161587489|NCT02312960|583540653|FG013|Overall Study|Lost to Follow-up|0|||
161587490|NCT02312960|583540640|FG000|Overall Study|Withdrawal by Subject|1|||
161587491|NCT02312960|583540641|FG001|Overall Study|Withdrawal by Subject|2|||
161587492|NCT02312960|583540642|FG002|Overall Study|Withdrawal by Subject|0|||
161675630|NCT02632721|583865502|FG004|Overall Study|Increase of white blood cell count|1|||
161675631|NCT02632721|583865498|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675632|NCT02632721|583865499|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675633|NCT02632721|583865500|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
161675634|NCT02632721|583865501|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675635|NCT02632721|583865502|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675636|NCT00544648|583865506|FG000|Overall Study|Withdrawal by Subject|1|||
161675637|NCT00544648|583865507|FG001|Overall Study|Withdrawal by Subject|0|||
161675638|NCT00544648|583865506|FG000|Overall Study|Adverse Event|1|||
161675639|NCT00544648|583865507|FG001|Overall Study|Adverse Event|1|||
161675640|NCT00544648|583865506|FG000|Overall Study|progression of disease|1|||
161675641|NCT00544648|583865507|FG001|Overall Study|progression of disease|0|||
161675642|NCT02663271|583865508|FG000|Overall Study|Withdrawal by Subject|5|||
161926336|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
161926337|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
161675643|NCT02663271|583865508|FG000|Overall Study|Lack of Efficacy|1|||
161675644|NCT01572675|583865509|FG000|Overall Study|End of prescribed treatment|140|||
161675645|NCT01572675|583865510|FG001|Overall Study|End of prescribed treatment|118|||
161675646|NCT01572675|583865509|FG000|Overall Study|Recovery|16|||
161675647|NCT01572675|583865510|FG001|Overall Study|Recovery|23|||
161675648|NCT01572675|583865509|FG000|Overall Study|Lack of Efficacy|31|||
161675649|NCT01572675|583865510|FG001|Overall Study|Lack of Efficacy|31|||
161675650|NCT01572675|583865509|FG000|Overall Study|Intolerance|6|||
161509457|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509458|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509459|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509460|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509461|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509462|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
161509463|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
161509464|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509465|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
161509466|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509467|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
161509468|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509469|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509470|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509471|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509472|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509473|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509474|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509475|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509476|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509477|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509478|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509479|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161587493|NCT02312960|583540643|FG003|Overall Study|Withdrawal by Subject|0|||
161587494|NCT02312960|583540644|FG004|Overall Study|Withdrawal by Subject|1|||
161675651|NCT01572675|583865510|FG001|Overall Study|Intolerance|5|||
161926338|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
161926339|NCT00002874|584777167|FG000|Overall Study|Withdrawal by Subject|1|||
161509480|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161587495|NCT02312960|583540645|FG005|Overall Study|Withdrawal by Subject|0|||
161587496|NCT02312960|583540646|FG006|Overall Study|Withdrawal by Subject|1|||
161675652|NCT01572675|583865509|FG000|Overall Study|Improved symptoms|8|||
161926340|NCT00002874|584777168|FG001|Overall Study|Withdrawal by Subject|1|||
161926341|NCT00002874|584777167|FG000|Overall Study|Protocol Violation|44|||
161926342|NCT00002874|584777168|FG001|Overall Study|Protocol Violation|34|||
161926343|NCT01397747|584777185|FG000|Overall Study|Multitarget DNA test excluded|689|||
161926344|NCT01397747|584777185|FG000|Overall Study|Colonoscopy excluded|304|||
161926345|NCT01397747|584777185|FG000|Overall Study|FIT excluded|34|||
161509481|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509482|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161675653|NCT01572675|583865510|FG001|Overall Study|Improved symptoms|2|||
161675654|NCT01572675|583865509|FG000|Overall Study|Surgical intervention|3|||
161675655|NCT01572675|583865510|FG001|Overall Study|Surgical intervention|6|||
161675656|NCT01572675|583865509|FG000|Overall Study|Withdrawal by Subject|5|||
161675657|NCT01572675|583865510|FG001|Overall Study|Withdrawal by Subject|1|||
161675658|NCT01572675|583865509|FG000|Overall Study|Physician Decision|2|||
161675659|NCT01572675|583865510|FG001|Overall Study|Physician Decision|2|||
161675660|NCT01572675|583865509|FG000|Overall Study|Death unrelated to coxibs|1|||
161675661|NCT01572675|583865510|FG001|Overall Study|Death unrelated to coxibs|1|||
161675662|NCT01572675|583865509|FG000|Overall Study|Other disease detected|1|||
161675663|NCT01572675|583865510|FG001|Overall Study|Other disease detected|1|||
161675664|NCT01572675|583865509|FG000|Overall Study|Unknown reason|1|||
161675665|NCT01572675|583865510|FG001|Overall Study|Unknown reason|1|||
161675666|NCT01572675|583865509|FG000|Overall Study|Rheumatologist new evaluation|0|||
161675667|NCT01572675|583865510|FG001|Overall Study|Rheumatologist new evaluation|1|||
161675668|NCT01572675|583865509|FG000|Overall Study|Missing data|1|||
161675669|NCT01572675|583865510|FG001|Overall Study|Missing data|4|||
161675670|NCT01572675|583865509|FG000|Overall Study|Lost to Follow-up|22|||
161675671|NCT01572675|583865510|FG001|Overall Study|Lost to Follow-up|27|||
161675672|NCT00999713|583865511|FG000|Overall Study|Physician Decision|2|||
161675673|NCT00999713|583865512|FG001|Overall Study|Physician Decision|0|||
161675674|NCT03346057|583865516|FG000|Overall Study|Death|1|||
161675675|NCT03346057|583865517|FG001|Overall Study|Death|2|||
161675676|NCT03346057|583865518|FG002|Overall Study|Death|0|||
161675677|NCT03346057|583865519|FG003|Overall Study|Death|0|||
161675678|NCT03346057|583865516|FG000|Overall Study|Lost to Follow-up|0|||
161675679|NCT03346057|583865517|FG001|Overall Study|Lost to Follow-up|2|||
161675680|NCT03346057|583865518|FG002|Overall Study|Lost to Follow-up|1|||
161675681|NCT03346057|583865519|FG003|Overall Study|Lost to Follow-up|0|||
161675682|NCT03346057|583865516|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
161675683|NCT03346057|583865517|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
161675684|NCT03346057|583865518|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
161675685|NCT03346057|583865519|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
161675686|NCT03346057|583865516|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
161675687|NCT03346057|583865517|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
161675688|NCT03346057|583865518|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
161675689|NCT03346057|583865519|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
161675690|NCT03346057|583865516|FG000|Overall Study|Physician Decision|3|||
161675691|NCT03346057|583865517|FG001|Overall Study|Physician Decision|2|||
161675692|NCT03346057|583865518|FG002|Overall Study|Physician Decision|0|||
161675693|NCT03346057|583865519|FG003|Overall Study|Physician Decision|2|||
161675694|NCT03346057|583865516|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
161675695|NCT03346057|583865517|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
161675696|NCT03346057|583865518|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
161675697|NCT03346057|583865519|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
161675698|NCT03346057|583865516|FG000|Overall Study|Withdrawal by Subject|1|||
161509483|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509484|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509485|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509486|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161675699|NCT03346057|583865517|FG001|Overall Study|Withdrawal by Subject|0|||
161675700|NCT03346057|583865518|FG002|Overall Study|Withdrawal by Subject|0|||
161675701|NCT03346057|583865519|FG003|Overall Study|Withdrawal by Subject|0|||
161675702|NCT01351623|583865520|FG000|Overall Study|Protocol Violation|2|||
161675703|NCT01351623|583865520|FG000|Overall Study|Adverse Event|4|||
161675704|NCT01351623|583865520|FG000|Overall Study|Withdrawal by Subject|1|||
161926346|NCT00504309|584777186|FG000|Overall Study|Death|0|||
161926347|NCT00504309|584777187|FG001|Overall Study|Death|0|||
161926348|NCT00504309|584777188|FG002|Overall Study|Death|0|||
161926349|NCT00504309|584777189|FG003|Overall Study|Death|0|||
161926350|NCT00504309|584777190|FG004|Overall Study|Death|1|||
161509487|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161675705|NCT01351623|583865520|FG000|Overall Study|Death|2|||
161675706|NCT02966223|583865523|FG000|Overall Study|Physician Decision|3|||
161675707|NCT02966223|583865523|FG000|Overall Study|Withdrawal by Subject|11|||
161675708|NCT02966223|583865523|FG000|Overall Study|Lost to Follow-up|1|||
161675709|NCT01326728|583865524|FG000|Overall Study|Death|13|||
161926351|NCT00504309|584777191|FG005|Overall Study|Death|0|||
161675710|NCT01326728|583865525|FG001|Overall Study|Death|0|||
161675711|NCT01326728|583865524|FG000|Overall Study|Early closure of study|34|||
161675712|NCT01326728|583865525|FG001|Overall Study|Early closure of study|9|||
161675713|NCT04399122|583865528|FG000|Overall Study|Lost to Follow-up|2|||
161675714|NCT04399122|583865529|FG001|Overall Study|Lost to Follow-up|0|||
161675715|NCT04399122|583865528|FG000|Overall Study|Withdrawal by Subject|1|||
161675716|NCT04399122|583865529|FG001|Overall Study|Withdrawal by Subject|0|||
161675717|NCT02536755|583865531|FG000|Overall Study|Adverse Event|4|||
161675718|NCT04448756|583865535|FG000|Overall Study|Adverse Event|0|||
161675719|NCT04448756|583865536|FG001|Overall Study|Adverse Event|1|||
161675720|NCT04448756|583865537|FG002|Overall Study|Adverse Event|0|||
161509488|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509489|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161509490|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509491|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161509492|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509493|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509494|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509495|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161675721|NCT04448756|583865535|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
161675722|NCT04448756|583865536|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
161675723|NCT04448756|583865537|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
161675724|NCT04448756|583865535|FG000|Overall Study|Withdrawal by Subject|0|||
161509496|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509497|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509498|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509499|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509500|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161675725|NCT04448756|583865536|FG001|Overall Study|Withdrawal by Subject|3|||
161675726|NCT04448756|583865537|FG002|Overall Study|Withdrawal by Subject|1|||
161675727|NCT04448756|583865535|FG000|Overall Study|Death|2|||
161675728|NCT04448756|583865536|FG001|Overall Study|Death|1|||
161675729|NCT04448756|583865537|FG002|Overall Study|Death|0|||
161820549|NCT02710214|584384537|FG001|Overall Study|Lack of Efficacy|1|||
161820550|NCT02710214|584384536|FG000|Overall Study|Death|0|||
161820551|NCT02710214|584384537|FG001|Overall Study|Death|1|||
161509501|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509502|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161820552|NCT02832167|584384538|FG000|Treatment Period 1|Disease progression|90|||
161820553|NCT02832167|584384538|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
161509503|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509504|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509505|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509506|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509507|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509508|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509509|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509510|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161675730|NCT02733185|583865538|FG000|Overall Study|Withdrawal by Subject|12|||
161675731|NCT02733185|583865539|FG001|Overall Study|Withdrawal by Subject|10|||
161675732|NCT02733185|583865540|FG002|Overall Study|Withdrawal by Subject|17|||
161675733|NCT02733185|583865541|FG003|Overall Study|Withdrawal by Subject|21|||
161820554|NCT02832167|584384538|FG000|Treatment Period 1|Death|2|||
161820555|NCT02832167|584384538|FG000|Treatment Period 1|Study Drug Toxicity|6|||
161820556|NCT02832167|584384538|FG000|Treatment Period 1|Participant request to discontinue|9|||
161820557|NCT02832167|584384538|FG000|Treatment Period 1|No longer meet study criteria|1|||
161820558|NCT02832167|584384538|FG000|Treatment Period 1|Participant withdrew consent|3|||
161820559|NCT02832167|584384538|FG000|Treatment Period 1|Other reasons|6|||
161820560|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
161820561|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
161820562|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Death|2|||
161820563|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
161820564|NCT02832167|584384538|FG000|Treatment Period 2|Disease progression|69|||
161820565|NCT02832167|584384538|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
161820566|NCT02832167|584384538|FG000|Treatment Period 2|Maximum clinical benefit|1|||
161820567|NCT02832167|584384538|FG000|Treatment Period 2|Study Drug Toxicity|5|||
161820568|NCT02832167|584384538|FG000|Treatment Period 2|Participant request to discontinue|2|||
161820569|NCT02832167|584384538|FG000|Treatment Period 2|Participant withdrew consent|3|||
161820570|NCT02832167|584384538|FG000|Treatment Period 2|Other reasons|3|||
161820571|NCT01754376|584384539|FG000|Overall Study|Adverse Event|1|||
161820572|NCT01754376|584384539|FG000|Overall Study|Lack of Efficacy|2|||
161820573|NCT04590781|584384540|FG000|Overall Study|Death|0|||
161820574|NCT04590781|584384541|FG001|Overall Study|Death|2|||
161509511|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509512|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509513|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
161509514|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509515|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161509516|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509517|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509518|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509519|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509520|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509521|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509522|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509523|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161587497|NCT02312960|583540647|FG007|Overall Study|Withdrawal by Subject|2|||
161587498|NCT02312960|583540648|FG008|Overall Study|Withdrawal by Subject|2|||
161587499|NCT02312960|583540649|FG009|Overall Study|Withdrawal by Subject|3|||
161587500|NCT02312960|583540650|FG010|Overall Study|Withdrawal by Subject|0|||
161587501|NCT02312960|583540651|FG011|Overall Study|Withdrawal by Subject|0|||
161587502|NCT02312960|583540652|FG012|Overall Study|Withdrawal by Subject|2|||
161587503|NCT02312960|583540653|FG013|Overall Study|Withdrawal by Subject|0|||
161587504|NCT03131648|583540654|FG000|Initial Treatment Period|Not dosed|2|||
161587505|NCT03131648|583540655|FG001|Initial Treatment Period|Not dosed|2|||
161587506|NCT03131648|583540656|FG002|Initial Treatment Period|Not dosed|0|||
161587507|NCT03131648|583540657|FG003|Initial Treatment Period|Not dosed|0|||
161587508|NCT03131648|583540658|FG004|Initial Treatment Period|Not dosed|0|||
161587509|NCT03131648|583540659|FG005|Initial Treatment Period|Not dosed|0|||
161587510|NCT03131648|583540660|FG006|Initial Treatment Period|Not dosed|0|||
161587511|NCT03131648|583540661|FG007|Initial Treatment Period|Not dosed|0|||
161587512|NCT03131648|583540654|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
161587513|NCT03131648|583540655|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
161587514|NCT03131648|583540656|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161587515|NCT03131648|583540657|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161587516|NCT03131648|583540658|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161587517|NCT03131648|583540659|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161587518|NCT03131648|583540660|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161587519|NCT03131648|583540661|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161587520|NCT03131648|583540654|FG000|Open-label Treatment|Discontinued IMP|0|||
161587521|NCT03131648|583540655|FG001|Open-label Treatment|Discontinued IMP|0|||
161587522|NCT03131648|583540656|FG002|Open-label Treatment|Discontinued IMP|0|||
161587523|NCT03131648|583540657|FG003|Open-label Treatment|Discontinued IMP|0|||
161587524|NCT03131648|583540658|FG004|Open-label Treatment|Discontinued IMP|0|||
161587525|NCT03131648|583540659|FG005|Open-label Treatment|Discontinued IMP|0|||
161587526|NCT03131648|583540660|FG006|Open-label Treatment|Discontinued IMP|112|||
161587527|NCT03131648|583540661|FG007|Open-label Treatment|Discontinued IMP|0|||
161587528|NCT03131648|583540654|FG000|Open-label Treatment|Completed Week 50|0|||
161587529|NCT03131648|583540655|FG001|Open-label Treatment|Completed Week 50|0|||
161587530|NCT03131648|583540656|FG002|Open-label Treatment|Completed Week 50|0|||
161587531|NCT03131648|583540657|FG003|Open-label Treatment|Completed Week 50|0|||
161587532|NCT03131648|583540658|FG004|Open-label Treatment|Completed Week 50|0|||
161587533|NCT03131648|583540659|FG005|Open-label Treatment|Completed Week 50|0|||
161587534|NCT03131648|583540660|FG006|Open-label Treatment|Completed Week 50|6|||
161587535|NCT03131648|583540661|FG007|Open-label Treatment|Completed Week 50|0|||
161587536|NCT03131648|583540654|FG000|Maintenance Treatment Period|Not dosed|0|||
161587537|NCT03131648|583540655|FG001|Maintenance Treatment Period|Not dosed|0|||
161587538|NCT03131648|583540656|FG002|Maintenance Treatment Period|Not dosed|3|||
161587539|NCT03131648|583540657|FG003|Maintenance Treatment Period|Not dosed|2|||
161587540|NCT03131648|583540658|FG004|Maintenance Treatment Period|Not dosed|1|||
161587541|NCT03131648|583540659|FG005|Maintenance Treatment Period|Not dosed|0|||
161587542|NCT03131648|583540660|FG006|Maintenance Treatment Period|Not dosed|0|||
161587543|NCT03131648|583540661|FG007|Maintenance Treatment Period|Not dosed|0|||
161587544|NCT03131648|583540654|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
161587545|NCT03131648|583540655|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
161587546|NCT03131648|583540656|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
161587547|NCT03131648|583540657|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
161587548|NCT03131648|583540658|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
161587549|NCT03131648|583540659|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
161675734|NCT02733185|583865538|FG000|Overall Study|Death|46|||
161820575|NCT04590781|584384540|FG000|Overall Study|Withdrawal by Subject|2|||
161820576|NCT04590781|584384541|FG001|Overall Study|Withdrawal by Subject|0|||
161926352|NCT00504309|584777186|FG000|Overall Study|Withdrawal by Subject|0|||
161509524|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509525|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509526|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509527|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509528|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509529|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509530|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509531|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509532|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509533|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
161509534|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
161509535|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
161509536|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161509537|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
161509538|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
161509539|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
161509540|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509541|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509542|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509543|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509544|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509545|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509546|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509547|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509548|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509549|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509550|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509551|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509552|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509553|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509554|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509555|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509556|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509557|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509558|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
161509559|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
161509560|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161509561|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
161509562|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
161509563|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
161509564|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509565|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509566|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509567|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509568|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509569|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509570|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509571|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509572|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509573|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509574|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509575|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509576|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509577|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509578|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509579|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509580|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161587550|NCT03131648|583540660|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
161587551|NCT03131648|583540661|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
161587552|NCT03131648|583540654|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161587553|NCT03131648|583540655|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161926353|NCT00504309|584777187|FG001|Overall Study|Withdrawal by Subject|0|||
161675735|NCT02733185|583865539|FG001|Overall Study|Death|34|||
161675736|NCT02733185|583865540|FG002|Overall Study|Death|35|||
161675737|NCT02733185|583865541|FG003|Overall Study|Death|43|||
161675738|NCT02733185|583865538|FG000|Overall Study|Lost to Follow-up|17|||
161675739|NCT02733185|583865539|FG001|Overall Study|Lost to Follow-up|18|||
161675740|NCT02733185|583865540|FG002|Overall Study|Lost to Follow-up|16|||
161675741|NCT02733185|583865541|FG003|Overall Study|Lost to Follow-up|11|||
161675742|NCT02499770|583865545|FG000|Overall Study|Death|17|||
161675743|NCT02499770|583865546|FG001|Overall Study|Death|56|||
161675744|NCT02499770|583865545|FG000|Overall Study|Study completion|1|||
161675745|NCT02499770|583865546|FG001|Overall Study|Study completion|10|||
161675746|NCT02499770|583865545|FG000|Overall Study|Withdrawal by Subject|0|||
161675747|NCT02499770|583865546|FG001|Overall Study|Withdrawal by Subject|7|||
161675748|NCT02499770|583865545|FG000|Overall Study|Lost to Follow-up|0|||
161675749|NCT02499770|583865546|FG001|Overall Study|Lost to Follow-up|2|||
161675750|NCT02499770|583865545|FG000|Overall Study|Subject declined further treatment|1|||
161675751|NCT02499770|583865546|FG001|Overall Study|Subject declined further treatment|0|||
161675752|NCT02499770|583865545|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
161675753|NCT02499770|583865546|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
161675754|NCT02499770|583865545|FG000|Overall Study|Randomized but not enrolled|0|||
161675755|NCT02499770|583865546|FG001|Overall Study|Randomized but not enrolled|1|||
161675756|NCT04275297|583865547|FG000|Overall Study|Lost to Follow-up|1|||
161675757|NCT04275297|583865548|FG001|Overall Study|Lost to Follow-up|1|||
161675758|NCT01093326|583865549|FG000|Overall Study|Death|0|||
161675759|NCT01093326|583865550|FG001|Overall Study|Death|1|||
161675760|NCT01093326|583865551|FG002|Overall Study|Death|0|||
161675761|NCT01093326|583865549|FG000|Overall Study|Lack of Efficacy|7|||
161675762|NCT01093326|583865550|FG001|Overall Study|Lack of Efficacy|6|||
161675763|NCT01093326|583865551|FG002|Overall Study|Lack of Efficacy|3|||
161675764|NCT01093326|583865549|FG000|Overall Study|Lost to Follow-up|2|||
161675765|NCT01093326|583865550|FG001|Overall Study|Lost to Follow-up|5|||
161675766|NCT01093326|583865551|FG002|Overall Study|Lost to Follow-up|4|||
161675767|NCT01093326|583865549|FG000|Overall Study|Physician Decision|3|||
161675768|NCT01093326|583865550|FG001|Overall Study|Physician Decision|1|||
161675769|NCT01093326|583865551|FG002|Overall Study|Physician Decision|3|||
161675770|NCT01093326|583865549|FG000|Overall Study|Withdrawal by Subject|30|||
161675771|NCT01093326|583865550|FG001|Overall Study|Withdrawal by Subject|27|||
161675772|NCT01093326|583865551|FG002|Overall Study|Withdrawal by Subject|26|||
161675773|NCT01093326|583865549|FG000|Overall Study|Adverse Event|2|||
161675774|NCT01093326|583865550|FG001|Overall Study|Adverse Event|1|||
161675775|NCT01093326|583865551|FG002|Overall Study|Adverse Event|4|||
161675776|NCT01093326|583865549|FG000|Overall Study|Other|0|||
161509581|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509582|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
161509583|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161509584|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161820577|NCT03686215|584384543|FG000|Overall Study|Adverse Event|0|||
161820578|NCT03686215|584384544|FG001|Overall Study|Adverse Event|0|||
161820579|NCT03686215|584384545|FG002|Overall Study|Adverse Event|7|||
161820580|NCT03686215|584384543|FG000|Overall Study|Physician Decision|0|||
161820581|NCT03686215|584384544|FG001|Overall Study|Physician Decision|0|||
161509585|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
161509586|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
161509587|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
161509588|NCT02346240|583257386|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161675777|NCT01093326|583865550|FG001|Overall Study|Other|0|||
161675778|NCT01093326|583865551|FG002|Overall Study|Other|1|||
161675779|NCT04225806|583865552|FG000|Overall Study|Trial termination|15|||
161675780|NCT07052682|583865555|FG000|Overall Study|Withdrawal by Subject|4|||
161820582|NCT03686215|584384545|FG002|Overall Study|Physician Decision|1|||
161820583|NCT03686215|584384543|FG000|Overall Study|Protocol Violation|0|||
161675781|NCT05460273|583865556|FG000|Overall Study|Death|43|||
161675782|NCT05460273|583865557|FG001|Overall Study|Death|9|||
161675783|NCT05460273|583865556|FG000|Overall Study|Lost to Follow-up|7|||
161675784|NCT05460273|583865557|FG001|Overall Study|Lost to Follow-up|0|||
161675785|NCT05460273|583865556|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
161675786|NCT05460273|583865557|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
161675787|NCT04124614|583865558|FG000|Placebo Run-in Period|Not Randomized|34|||
161675788|NCT04124614|583865559|FG001|Placebo Run-in Period|Not Randomized|0|||
161675789|NCT04124614|583865560|FG002|Placebo Run-in Period|Not Randomized|0|||
161675790|NCT04124614|583865558|FG000|Double Blind Treatment Period|Adverse Event|0|||
161675791|NCT04124614|583865559|FG001|Double Blind Treatment Period|Adverse Event|7|||
161820584|NCT03686215|584384544|FG001|Overall Study|Protocol Violation|0|||
161820585|NCT03686215|584384545|FG002|Overall Study|Protocol Violation|4|||
161509589|NCT02346240|583257387|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509590|NCT02346240|583257388|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161675792|NCT04124614|583865560|FG002|Double Blind Treatment Period|Adverse Event|22|||
161675793|NCT04124614|583865558|FG000|Double Blind Treatment Period|Death|0|||
161675794|NCT04124614|583865559|FG001|Double Blind Treatment Period|Death|0|||
161509591|NCT02346240|583257389|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509592|NCT02346240|583257390|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509593|NCT02346240|583257391|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509594|NCT02346240|583257392|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509595|NCT02346240|583257393|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509596|NCT02346240|583257394|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509597|NCT02346240|583257395|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509598|NCT02346240|583257396|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509599|NCT02346240|583257397|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509600|NCT02346240|583257398|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509601|NCT02346240|583257399|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509602|NCT02346240|583257400|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509603|NCT02346240|583257401|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509604|NCT02346240|583257402|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509605|NCT02346240|583257403|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509606|NCT02346240|583257404|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
161509607|NCT02346240|583257405|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509608|NCT02346240|583257406|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509609|NCT02346240|583257407|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509610|NCT02346240|583257408|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161675795|NCT04124614|583865560|FG002|Double Blind Treatment Period|Death|1|||
161820586|NCT03686215|584384543|FG000|Overall Study|Device issue|1|||
161820587|NCT03686215|584384544|FG001|Overall Study|Device issue|0|||
161509611|NCT02346240|583257409|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
161509612|NCT02681302|583257410|FG000|Overall Study|Withdrawal by Subject|1|||
161509613|NCT02681302|583257411|FG001|Overall Study|Withdrawal by Subject|1|||
161509614|NCT02681302|583257412|FG002|Overall Study|Withdrawal by Subject|0|||
161509615|NCT02681302|583257413|FG003|Overall Study|Withdrawal by Subject|0|||
161509616|NCT02681302|583257414|FG004|Overall Study|Withdrawal by Subject|1|||
161509617|NCT02681302|583257415|FG005|Overall Study|Withdrawal by Subject|0|||
161509618|NCT02681302|583257410|FG000|Overall Study|Screen Failure|2|||
161509619|NCT02681302|583257411|FG001|Overall Study|Screen Failure|4|||
161509620|NCT02681302|583257412|FG002|Overall Study|Screen Failure|2|||
161509621|NCT02681302|583257413|FG003|Overall Study|Screen Failure|0|||
161509622|NCT02681302|583257414|FG004|Overall Study|Screen Failure|1|||
161509623|NCT02681302|583257415|FG005|Overall Study|Screen Failure|1|||
161509624|NCT02681302|583257410|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
161509625|NCT02681302|583257411|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
161509626|NCT02681302|583257412|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
161509627|NCT02681302|583257413|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
161509628|NCT02681302|583257414|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
161509629|NCT02681302|583257415|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
161509630|NCT02942017|583257416|FG000|Overall Study|Adverse Event|0|||
161509631|NCT02942017|583257417|FG001|Overall Study|Adverse Event|1|||
161509632|NCT02942017|583257416|FG000|Overall Study|Withdrawal by Subject|0|||
161509633|NCT02942017|583257417|FG001|Overall Study|Withdrawal by Subject|1|||
161509634|NCT02942017|583257416|FG000|Overall Study|Lost to Follow-up|1|||
161509635|NCT02942017|583257417|FG001|Overall Study|Lost to Follow-up|1|||
161509636|NCT02942017|583257416|FG000|Overall Study|Randomized but not dosed|1|||
161509637|NCT02942017|583257417|FG001|Overall Study|Randomized but not dosed|3|||
161509638|NCT00477672|583257418|FG000|Overall Study|Adverse Event|3|||
161509639|NCT00477672|583257419|FG001|Overall Study|Adverse Event|5|||
161509640|NCT00477672|583257420|FG002|Overall Study|Adverse Event|6|||
161509641|NCT00477672|583257418|FG000|Overall Study|Death|0|||
161509642|NCT00477672|583257419|FG001|Overall Study|Death|1|||
161509643|NCT00477672|583257420|FG002|Overall Study|Death|0|||
161509644|NCT00477672|583257418|FG000|Overall Study|Disease progression|0|||
161509645|NCT00477672|583257419|FG001|Overall Study|Disease progression|1|||
161509646|NCT00477672|583257420|FG002|Overall Study|Disease progression|0|||
161509647|NCT00477672|583257418|FG000|Overall Study|Physician Decision|1|||
161509648|NCT00477672|583257419|FG001|Overall Study|Physician Decision|0|||
161675796|NCT04124614|583865558|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161509649|NCT00477672|583257420|FG002|Overall Study|Physician Decision|0|||
161509650|NCT00477672|583257418|FG000|Overall Study|Protocol noncompliance|0|||
161509651|NCT00477672|583257419|FG001|Overall Study|Protocol noncompliance|2|||
161509652|NCT00477672|583257420|FG002|Overall Study|Protocol noncompliance|0|||
161509653|NCT00477672|583257418|FG000|Overall Study|Consent withdrawn|2|||
161509654|NCT00477672|583257419|FG001|Overall Study|Consent withdrawn|5|||
161509655|NCT00477672|583257420|FG002|Overall Study|Consent withdrawn|10|||
161509656|NCT00477672|583257418|FG000|Overall Study|Discretion of Sponsor|1|||
161509657|NCT00477672|583257419|FG001|Overall Study|Discretion of Sponsor|2|||
161509658|NCT00477672|583257420|FG002|Overall Study|Discretion of Sponsor|0|||
161509659|NCT00838565|583257421|FG000|Overall Study|Withdrawal by Subject|0|||
161509660|NCT00838565|583257422|FG001|Overall Study|Withdrawal by Subject|0|||
161509661|NCT00838565|583257423|FG002|Overall Study|Withdrawal by Subject|1|||
161509662|NCT00838565|583257424|FG003|Overall Study|Withdrawal by Subject|0|||
161509663|NCT00838565|583257425|FG004|Overall Study|Withdrawal by Subject|0|||
161509664|NCT00838565|583257426|FG005|Overall Study|Withdrawal by Subject|2|||
161509665|NCT00838565|583257421|FG000|Overall Study|Other|0|||
161509666|NCT00838565|583257422|FG001|Overall Study|Other|2|||
161509667|NCT00838565|583257423|FG002|Overall Study|Other|0|||
161509668|NCT00838565|583257424|FG003|Overall Study|Other|0|||
161509669|NCT00838565|583257425|FG004|Overall Study|Other|0|||
161509670|NCT00838565|583257426|FG005|Overall Study|Other|0|||
161509671|NCT00838565|583257421|FG000|Overall Study|Randomized but not Treated|0|||
161509672|NCT00838565|583257422|FG001|Overall Study|Randomized but not Treated|1|||
161509673|NCT00838565|583257423|FG002|Overall Study|Randomized but not Treated|0|||
161509674|NCT00838565|583257424|FG003|Overall Study|Randomized but not Treated|0|||
161509675|NCT00838565|583257425|FG004|Overall Study|Randomized but not Treated|0|||
161509676|NCT00838565|583257426|FG005|Overall Study|Randomized but not Treated|0|||
161509677|NCT00458484|583257427|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
161509678|NCT00458484|583257428|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
161509679|NCT00458484|583257429|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
161509680|NCT00458484|583257430|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
161509681|NCT00458484|583257431|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
161509682|NCT00458484|583257432|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
161509683|NCT00458484|583257433|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
161509684|NCT04907032|583257434|FG000|Overall Study|Withdrawal by Subject|7|||
161509685|NCT04907032|583257435|FG001|Overall Study|Withdrawal by Subject|1|||
161509686|NCT02253810|583257436|FG000|Overall Study|Withdrawal by Subject|2|||
161509687|NCT02253810|583257437|FG001|Overall Study|Withdrawal by Subject|1|||
161509688|NCT02253810|583257436|FG000|Overall Study|Unknown concomitant procedure|3|||
161509689|NCT02253810|583257437|FG001|Overall Study|Unknown concomitant procedure|2|||
161509690|NCT00291668|583257439|FG000|Overall Study|Lack of Efficacy|1|||
161509691|NCT00291668|583257440|FG001|Overall Study|Lack of Efficacy|0|||
161509692|NCT00291668|583257441|FG002|Overall Study|Lack of Efficacy|0|||
161509693|NCT00291668|583257439|FG000|Overall Study|SAE, non-fatal|1|||
161509694|NCT00291668|583257440|FG001|Overall Study|SAE, non-fatal|1|||
161509695|NCT00291668|583257441|FG002|Overall Study|SAE, non-fatal|1|||
161509696|NCT00291668|583257439|FG000|Overall Study|AE, non-serious non-fatal|1|||
161509697|NCT00291668|583257440|FG001|Overall Study|AE, non-serious non-fatal|0|||
161509698|NCT00291668|583257441|FG002|Overall Study|AE, non-serious non-fatal|0|||
161509699|NCT00291668|583257439|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161509700|NCT00291668|583257440|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161509701|NCT00291668|583257441|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161509702|NCT01557400|583257442|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
161509703|NCT01557400|583257442|FG000|Overall Study|Adverse Event|3|||
161509704|NCT01557400|583257442|FG000|Overall Study|Lost to Follow-up|5|||
161509705|NCT01557400|583257442|FG000|Overall Study|Withdrawal by Subject|9|||
161509706|NCT00245765|583257449|FG000|Overall Study|Adverse Event|1|||
161509707|NCT00245765|583257450|FG001|Overall Study|Adverse Event|1|||
161509708|NCT00245765|583257451|FG002|Overall Study|Adverse Event|0|||
161509709|NCT00245765|583257449|FG000|Overall Study|Lack of Efficacy|14|||
161509710|NCT00245765|583257450|FG001|Overall Study|Lack of Efficacy|7|||
161509711|NCT00245765|583257451|FG002|Overall Study|Lack of Efficacy|0|||
161509712|NCT00245765|583257449|FG000|Overall Study|Lost to Follow-up|1|||
161587554|NCT03131648|583540656|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
161509713|NCT00245765|583257450|FG001|Overall Study|Lost to Follow-up|2|||
161587555|NCT03131648|583540657|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
161509714|NCT00245765|583257451|FG002|Overall Study|Lost to Follow-up|0|||
161509715|NCT00245765|583257449|FG000|Overall Study|Withdrawal by Subject|1|||
161509716|NCT00245765|583257450|FG001|Overall Study|Withdrawal by Subject|0|||
161587556|NCT03131648|583540658|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
161820588|NCT03686215|584384545|FG002|Overall Study|Device issue|2|||
161820589|NCT00063258|584384548|FG000|Overall Study|Physician Decision|2|||
161509717|NCT00245765|583257451|FG002|Overall Study|Withdrawal by Subject|3|||
161820590|NCT00063258|584384549|FG001|Overall Study|Physician Decision|0|||
161820591|NCT00063258|584384548|FG000|Overall Study|Lack of Efficacy|2|||
161820592|NCT00063258|584384549|FG001|Overall Study|Lack of Efficacy|0|||
161820593|NCT03988608|584384550|FG000|Overall Study|Adverse Event|1|||
161820594|NCT03988608|584384550|FG000|Overall Study|Lost to Follow-up|1|||
161509718|NCT00245765|583257449|FG000|Overall Study|Other reason|2|||
161509719|NCT00245765|583257450|FG001|Overall Study|Other reason|0|||
161509720|NCT00245765|583257451|FG002|Overall Study|Other reason|1|||
161509721|NCT00245765|583257449|FG000|Overall Study|Other|13|||
161509722|NCT00245765|583257450|FG001|Overall Study|Other|4|||
161509723|NCT00245765|583257451|FG002|Overall Study|Other|4|||
161509724|NCT06425458|583257452|FG000|Overall Study|Removed by study team|2|||
161509725|NCT06425458|583257452|FG000|Overall Study|Lost to Follow-up|5|||
161509726|NCT02777125|583257455|FG000|Overall Study|Consent form violation|14|||
161509727|NCT02777125|583257456|FG001|Overall Study|Consent form violation|12|||
161509728|NCT02777125|583257455|FG000|Overall Study|Assent form violation|21|||
161509729|NCT02777125|583257456|FG001|Overall Study|Assent form violation|23|||
161509730|NCT02777125|583257455|FG000|Overall Study|Protocol Violation|8|||
161509731|NCT02777125|583257456|FG001|Overall Study|Protocol Violation|12|||
161509732|NCT02917031|583257457|FG000|Overall Study|Reason not specified|7|||
161509733|NCT02917031|583257458|FG001|Overall Study|Reason not specified|5|||
161509734|NCT02917031|583257459|FG002|Overall Study|Reason not specified|6|||
161509735|NCT02917031|583257457|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
161509736|NCT02917031|583257458|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
161509737|NCT02917031|583257459|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
161509738|NCT02917031|583257457|FG000|Overall Study|Withdrawal by Subject|3|||
161509739|NCT02917031|583257458|FG001|Overall Study|Withdrawal by Subject|3|||
161509740|NCT02917031|583257459|FG002|Overall Study|Withdrawal by Subject|0|||
161509741|NCT02917031|583257457|FG000|Overall Study|Physician Decision|1|||
161509742|NCT02917031|583257458|FG001|Overall Study|Physician Decision|0|||
161509743|NCT02917031|583257459|FG002|Overall Study|Physician Decision|0|||
161509744|NCT02917031|583257457|FG000|Overall Study|Adverse Event|4|||
161509745|NCT02917031|583257458|FG001|Overall Study|Adverse Event|1|||
161509746|NCT02917031|583257459|FG002|Overall Study|Adverse Event|5|||
161509747|NCT02917031|583257457|FG000|Overall Study|Death|2|||
161509748|NCT02917031|583257458|FG001|Overall Study|Death|3|||
161509749|NCT02917031|583257459|FG002|Overall Study|Death|4|||
161509750|NCT00640510|583258734|FG000|Overall Study|Lack of Efficacy|0|||
161509751|NCT00640510|583258735|FG001|Overall Study|Lack of Efficacy|1|||
161509752|NCT00640510|583258734|FG000|Overall Study|Protocol Violation|1|||
161509753|NCT00640510|583258735|FG001|Overall Study|Protocol Violation|0|||
161509754|NCT00640510|583258734|FG000|Overall Study|Physician Decision|0|||
161509755|NCT00640510|583258735|FG001|Overall Study|Physician Decision|1|||
161509756|NCT01440322|583258736|FG000|Overall Study|Discomfort|2|||
161509757|NCT01440322|583258737|FG001|Overall Study|Discomfort|0|||
161509758|NCT01440322|583258736|FG000|Overall Study|Biomicroscopy|1|||
161509759|NCT01440322|583258737|FG001|Overall Study|Biomicroscopy|0|||
161509760|NCT01440322|583258736|FG000|Overall Study|Symptoms and Problems|1|||
161509761|NCT01440322|583258737|FG001|Overall Study|Symptoms and Problems|0|||
161509762|NCT01440322|583258736|FG000|Overall Study|Unacceptable Subjective Vision|1|||
161509763|NCT01440322|583258737|FG001|Overall Study|Unacceptable Subjective Vision|0|||
161509764|NCT01440322|583258736|FG000|Overall Study|Other Product Related|1|||
161509765|NCT01440322|583258737|FG001|Overall Study|Other Product Related|0|||
161509766|NCT01440322|583258736|FG000|Overall Study|Unrelated Medical Problem|0|||
161509767|NCT01440322|583258737|FG001|Overall Study|Unrelated Medical Problem|1|||
161509768|NCT01440322|583258736|FG000|Overall Study|Other Non-Product Related|1|||
161509769|NCT01440322|583258737|FG001|Overall Study|Other Non-Product Related|0|||
161509770|NCT04300296|583258741|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
161509771|NCT04300296|583258742|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
161509772|NCT04300296|583258743|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
161509773|NCT04300296|583258744|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
161509774|NCT04300296|583258745|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
161509775|NCT04300296|583258746|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
161509776|NCT04300296|583258741|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
161509777|NCT04300296|583258742|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
161509778|NCT04300296|583258743|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
161509779|NCT04300296|583258744|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
161509780|NCT04300296|583258745|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
161509781|NCT04300296|583258746|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
161509782|NCT04300296|583258741|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
161509783|NCT04300296|583258742|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
161509784|NCT04300296|583258743|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
161509785|NCT04300296|583258744|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
161509786|NCT04300296|583258745|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
161587557|NCT03131648|583540659|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
161509787|NCT04300296|583258746|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
161509788|NCT04300296|583258741|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
161675797|NCT04124614|583865559|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
161675798|NCT04124614|583865560|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
161509789|NCT04300296|583258742|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
161509790|NCT04300296|583258743|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
161675799|NCT04124614|583865558|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
161675800|NCT04124614|583865559|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
161675801|NCT04124614|583865560|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
161675802|NCT04124614|583865558|FG000|Double Blind Treatment Period|Physician Decision|0|||
161675803|NCT04124614|583865559|FG001|Double Blind Treatment Period|Physician Decision|0|||
161675804|NCT04124614|583865560|FG002|Double Blind Treatment Period|Physician Decision|3|||
161675805|NCT04124614|583865558|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
161675806|NCT04124614|583865559|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
161675807|NCT04124614|583865560|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
161509791|NCT04300296|583258744|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
161509792|NCT04300296|583258745|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
161509793|NCT04300296|583258746|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
161509794|NCT04300296|583258741|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
161509795|NCT04300296|583258742|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
161509796|NCT04300296|583258743|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
161509797|NCT04300296|583258744|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
161509798|NCT04300296|583258745|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
161509799|NCT04300296|583258746|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
161509800|NCT04300296|583258741|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
161509801|NCT04300296|583258742|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
161509802|NCT04300296|583258743|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
161509803|NCT04300296|583258744|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
161509804|NCT04300296|583258745|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
161509805|NCT04300296|583258746|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
161509806|NCT04300296|583258741|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
161509807|NCT04300296|583258742|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
161509808|NCT04300296|583258743|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
161509809|NCT04300296|583258744|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
161509810|NCT04300296|583258745|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
161509811|NCT04300296|583258746|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
161509812|NCT05044234|583258747|FG000|Overall Study|Lost to Follow-up|2|||
161509813|NCT05044234|583258748|FG001|Overall Study|Lost to Follow-up|1|||
161509814|NCT05044234|583258749|FG002|Overall Study|Lost to Follow-up|1|||
161509815|NCT05044234|583258750|FG003|Overall Study|Lost to Follow-up|2|||
161509816|NCT05044234|583258747|FG000|Overall Study|Withdrawal by Subject|6|||
161509817|NCT05044234|583258748|FG001|Overall Study|Withdrawal by Subject|4|||
161509818|NCT05044234|583258749|FG002|Overall Study|Withdrawal by Subject|5|||
161509819|NCT05044234|583258750|FG003|Overall Study|Withdrawal by Subject|8|||
161509820|NCT05044234|583258747|FG000|Overall Study|Study terminated by Sponsor|21|||
161675808|NCT04124614|583865558|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161675809|NCT04124614|583865559|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
161675810|NCT04124614|583865560|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
161675811|NCT04124614|583865558|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
161675812|NCT04124614|583865559|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
161675813|NCT04124614|583865560|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
161675814|NCT01650285|583867204|FG000|Overall Study|Adverse Event|1|||
161675815|NCT00907257|583867207|FG000|Overall Study|Adverse Event|0|||
161675816|NCT00907257|583867208|FG001|Overall Study|Adverse Event|4|||
161675817|NCT00907257|583867207|FG000|Overall Study|Protocol Violation|1|||
161675818|NCT00907257|583867208|FG001|Overall Study|Protocol Violation|2|||
161675819|NCT00907257|583867207|FG000|Overall Study|Lost to Follow-up|3|||
161675820|NCT00907257|583867208|FG001|Overall Study|Lost to Follow-up|3|||
161675821|NCT00907257|583867207|FG000|Overall Study|Withdrawal by Subject|1|||
161675822|NCT00907257|583867208|FG001|Overall Study|Withdrawal by Subject|2|||
161675823|NCT00907257|583867207|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
161675824|NCT00907257|583867208|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
161675825|NCT00907257|583867207|FG000|Overall Study|Moved|1|||
161675826|NCT00907257|583867208|FG001|Overall Study|Moved|0|||
161675827|NCT00907257|583867207|FG000|Overall Study|Personal Reasons|6|||
161675828|NCT00907257|583867208|FG001|Overall Study|Personal Reasons|1|||
161675829|NCT04163900|583867209|FG000|Overall Study|Radiological disease progression|112|||
161675830|NCT04163900|583867210|FG001|Overall Study|Radiological disease progression|127|||
161675831|NCT04163900|583867209|FG000|Overall Study|Study closure|98|||
161675832|NCT04163900|583867210|FG001|Overall Study|Study closure|133|||
161675833|NCT04163900|583867209|FG000|Overall Study|Adverse Event|78|||
161675834|NCT04163900|583867210|FG001|Overall Study|Adverse Event|32|||
161675835|NCT04163900|583867209|FG000|Overall Study|Withdrawal by Subject|37|||
161820595|NCT03988608|584384550|FG000|Overall Study|Withdrawal by Subject|3|||
161820596|NCT03988608|584384550|FG000|Overall Study|Death|1|||
161820597|NCT01456962|584384558|FG000|Overall Study|Lost to Follow-up|2|||
161820598|NCT01456962|584384559|FG001|Overall Study|Lost to Follow-up|1|||
161820599|NCT03387462|584384561|FG000|Overall Study|Lost to Follow-up|1|||
161820600|NCT01460628|584384562|FG000|Overall Study|Adverse Event|3|||
161820601|NCT01460628|584384562|FG000|Overall Study|Withdrawal by Subject|2|||
161820602|NCT05029687|584384581|FG000|Overall Study|Withdrawal by Subject|4|||
161820603|NCT05029687|584384582|FG001|Overall Study|Withdrawal by Subject|0|||
161820604|NCT05029687|584384583|FG002|Overall Study|Withdrawal by Subject|2|||
161820605|NCT05029687|584384581|FG000|Overall Study|Lost to Follow-up|4|||
161820606|NCT05029687|584384582|FG001|Overall Study|Lost to Follow-up|0|||
161820607|NCT05029687|584384583|FG002|Overall Study|Lost to Follow-up|2|||
161820608|NCT02854800|584384589|FG000|Overall Study|Protocol Violation|16|||
161820609|NCT02854800|584384590|FG001|Overall Study|Protocol Violation|11|||
161820610|NCT02854800|584384591|FG002|Overall Study|Protocol Violation|3|||
161820611|NCT02854800|584384589|FG000|Overall Study|Withdrawal by Subject|4|||
161820612|NCT02854800|584384590|FG001|Overall Study|Withdrawal by Subject|2|||
161820613|NCT02854800|584384591|FG002|Overall Study|Withdrawal by Subject|3|||
161820614|NCT02372006|584384603|FG000|Overall Study|Progressive disease|8|||
161820615|NCT02372006|584384604|FG001|Overall Study|Progressive disease|7|||
161820616|NCT02372006|584384605|FG002|Overall Study|Progressive disease|34|||
161820617|NCT02372006|584384603|FG000|Overall Study|Dose limiting toxicity|0|||
161675836|NCT04163900|583867210|FG001|Overall Study|Withdrawal by Subject|34|||
161675837|NCT04163900|583867209|FG000|Overall Study|Death|29|||
161675838|NCT04163900|583867210|FG001|Overall Study|Death|16|||
161675839|NCT04163900|583867209|FG000|Overall Study|Physician Decision|17|||
161675840|NCT04163900|583867210|FG001|Overall Study|Physician Decision|25|||
161675841|NCT04163900|583867209|FG000|Overall Study|Clinical disease progression|14|||
161675842|NCT04163900|583867210|FG001|Overall Study|Clinical disease progression|13|||
161675843|NCT04163900|583867209|FG000|Overall Study|Protocol Violation|3|||
161675844|NCT04163900|583867210|FG001|Overall Study|Protocol Violation|4|||
161675845|NCT04163900|583867209|FG000|Overall Study|Lost to Follow-up|0|||
161675846|NCT04163900|583867210|FG001|Overall Study|Lost to Follow-up|1|||
161675847|NCT01873417|583867212|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
161675848|NCT01873417|583867212|FG000|Overall Study|Adverse Event|24|||
161675849|NCT01873417|583867212|FG000|Overall Study|Lost to Follow-up|2|||
161675850|NCT01873417|583867212|FG000|Overall Study|Withdrawal by Subject|2|||
161675851|NCT01873417|583867212|FG000|Overall Study|Physician Decision|3|||
161675852|NCT00785044|583867213|FG000|Overall Study|Dosed at non-participating sites|152|||
161675853|NCT00785044|583867213|FG000|Overall Study|Death|77|||
161675854|NCT00785044|583867213|FG000|Overall Study|Lost to Follow-up|266|||
161675855|NCT00785044|583867213|FG000|Overall Study|Withdrawal by Subject|1|||
161675856|NCT01830855|583867214|FG000|Overall Study|Other|7|||
161675857|NCT01830855|583867215|FG001|Overall Study|Other|1|||
161675858|NCT01830855|583867216|FG002|Overall Study|Other|4|||
161675859|NCT01830855|583867217|FG003|Overall Study|Other|4|||
161675860|NCT01830855|583867214|FG000|Overall Study|Medication error without associated AE|1|||
161675861|NCT01830855|583867215|FG001|Overall Study|Medication error without associated AE|0|||
161675862|NCT01830855|583867216|FG002|Overall Study|Medication error without associated AE|0|||
161675863|NCT01830855|583867217|FG003|Overall Study|Medication error without associated AE|1|||
161675864|NCT01830855|583867214|FG000|Overall Study|Pregnancy|3|||
161820618|NCT02372006|584384604|FG001|Overall Study|Dose limiting toxicity|1|||
161820619|NCT02372006|584384605|FG002|Overall Study|Dose limiting toxicity|0|||
161820620|NCT02372006|584384603|FG000|Overall Study|Adverse Event|0|||
161820621|NCT02372006|584384604|FG001|Overall Study|Adverse Event|0|||
161820622|NCT02372006|584384605|FG002|Overall Study|Adverse Event|3|||
161820623|NCT02372006|584384603|FG000|Overall Study|Withdrawal by Subject|0|||
161820624|NCT02372006|584384604|FG001|Overall Study|Withdrawal by Subject|1|||
161675865|NCT01830855|583867215|FG001|Overall Study|Pregnancy|1|||
161675866|NCT01830855|583867216|FG002|Overall Study|Pregnancy|2|||
161675867|NCT01830855|583867217|FG003|Overall Study|Pregnancy|1|||
161675868|NCT01830855|583867214|FG000|Overall Study|No longer meets eligibility criteria|11|||
161675869|NCT01830855|583867215|FG001|Overall Study|No longer meets eligibility criteria|2|||
161675870|NCT01830855|583867216|FG002|Overall Study|No longer meets eligibility criteria|3|||
161675871|NCT01830855|583867217|FG003|Overall Study|No longer meets eligibility criteria|5|||
161675872|NCT01830855|583867214|FG000|Overall Study|Adverse Event|11|||
161675873|NCT01830855|583867215|FG001|Overall Study|Adverse Event|5|||
161675874|NCT01830855|583867216|FG002|Overall Study|Adverse Event|6|||
161820625|NCT02372006|584384605|FG002|Overall Study|Withdrawal by Subject|1|||
161820626|NCT02372006|584384603|FG000|Overall Study|Other reason for not completing|0|||
161820627|NCT02372006|584384604|FG001|Overall Study|Other reason for not completing|0|||
161820628|NCT02372006|584384605|FG002|Overall Study|Other reason for not completing|1|||
161820629|NCT03504085|584384606|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
161820630|NCT03504085|584384607|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
161820631|NCT03504085|584384606|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
161820632|NCT03504085|584384607|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
161820633|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Death|1|||
161820634|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Death|0|||
161509821|NCT05044234|583258748|FG001|Overall Study|Study terminated by Sponsor|21|||
161509822|NCT05044234|583258749|FG002|Overall Study|Study terminated by Sponsor|20|||
161509823|NCT05044234|583258750|FG003|Overall Study|Study terminated by Sponsor|14|||
161509824|NCT05044234|583258747|FG000|Overall Study|Other, not specified|0|||
161820635|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Death|0|||
161509825|NCT05044234|583258748|FG001|Overall Study|Other, not specified|0|||
161509826|NCT05044234|583258749|FG002|Overall Study|Other, not specified|1|||
161509827|NCT05044234|583258750|FG003|Overall Study|Other, not specified|2|||
161509828|NCT05044234|583258747|FG000|Overall Study|Delayed data entry|0|||
161509829|NCT05044234|583258748|FG001|Overall Study|Delayed data entry|0|||
161509830|NCT05044234|583258749|FG002|Overall Study|Delayed data entry|0|||
161509831|NCT05044234|583258750|FG003|Overall Study|Delayed data entry|1|||
161509832|NCT00279708|583258756|FG000|Overall Study|Withdrawal by Subject|2|||
161509833|NCT00279708|583258757|FG001|Overall Study|Withdrawal by Subject|3|||
161509834|NCT00279708|583258756|FG000|Overall Study|Adverse Event|1|||
161509835|NCT00279708|583258757|FG001|Overall Study|Adverse Event|1|||
161509836|NCT02624284|583258758|FG000|Overall Study|Withdrawal by Subject|3|||
161509837|NCT02624284|583258759|FG001|Overall Study|Withdrawal by Subject|6|||
161509838|NCT02624284|583258760|FG002|Overall Study|Withdrawal by Subject|3|||
161509839|NCT02624284|583258758|FG000|Overall Study|Protocol Violation|9|||
161509840|NCT02624284|583258759|FG001|Overall Study|Protocol Violation|10|||
161509841|NCT02624284|583258760|FG002|Overall Study|Protocol Violation|7|||
161509842|NCT02624284|583258758|FG000|Overall Study|Revealed exclusionary condition|2|||
161509843|NCT02624284|583258759|FG001|Overall Study|Revealed exclusionary condition|2|||
161509844|NCT02624284|583258760|FG002|Overall Study|Revealed exclusionary condition|0|||
161509845|NCT02624284|583258758|FG000|Overall Study|Adverse Event|0|||
161509846|NCT02624284|583258759|FG001|Overall Study|Adverse Event|0|||
161509847|NCT02624284|583258760|FG002|Overall Study|Adverse Event|1|||
161509848|NCT01782313|583258761|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
161509849|NCT01782313|583258761|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
161509850|NCT01782313|583258761|FG000|Treated Cycle 3|Progressive Disease|21|||
161509851|NCT01782313|583258761|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
161509852|NCT01782313|583258761|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
161509853|NCT01782313|583258761|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
161509854|NCT01782313|583258761|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
161509855|NCT01782313|583258761|FG000|Survival Follow up|Lost to Follow-up|1|||
161509856|NCT02940691|583258762|FG000|Overall Study|Lost to Follow-up|5|||
161509857|NCT02940691|583258762|FG000|Overall Study|Incarceration|1|||
161509858|NCT02506816|583258763|FG000|Overall Study|Adverse Event|3|||
161509859|NCT00418691|583258766|FG000|Overall Study|Lost to Follow-up|1|||
161509860|NCT00418691|583258767|FG001|Overall Study|Lost to Follow-up|2|||
161509861|NCT00418691|583258768|FG002|Overall Study|Lost to Follow-up|3|||
161509862|NCT00418691|583258766|FG000|Overall Study|Started new medication voiding entry|0|||
161509863|NCT00418691|583258767|FG001|Overall Study|Started new medication voiding entry|0|||
161509864|NCT00418691|583258768|FG002|Overall Study|Started new medication voiding entry|1|||
161509865|NCT00418691|583258766|FG000|Overall Study|Progressive Disease|1|||
161509866|NCT00418691|583258767|FG001|Overall Study|Progressive Disease|0|||
161509867|NCT00418691|583258768|FG002|Overall Study|Progressive Disease|1|||
161509868|NCT02477020|583258773|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
161509869|NCT02477020|583258774|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161587558|NCT03131648|583540660|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161587559|NCT03131648|583540661|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161820636|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Death|0|||
161509870|NCT02477020|583258773|FG000|Overall Study|Voluntary Withdrawal|7|||
161509871|NCT02477020|583258774|FG001|Overall Study|Voluntary Withdrawal|16|||
161509872|NCT02477020|583258773|FG000|Overall Study|Reason not Specified|3|||
161820637|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
161820638|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
161820639|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
161820640|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
161820641|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
161820642|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
161820643|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
161820644|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
161509873|NCT02477020|583258774|FG001|Overall Study|Reason not Specified|1|||
161509874|NCT02477020|583258773|FG000|Overall Study|Lack of Efficacy|14|||
161509875|NCT02477020|583258774|FG001|Overall Study|Lack of Efficacy|5|||
161509876|NCT01049919|583258775|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
161509877|NCT01049919|583258776|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
161509878|NCT01049919|583258775|FG000|Overall Study|Withdrawal by Subject|5|||
161509879|NCT01049919|583258776|FG001|Overall Study|Withdrawal by Subject|0|||
161509880|NCT01049919|583258775|FG000|Overall Study|Lost to Follow-up|6|||
161509881|NCT01049919|583258776|FG001|Overall Study|Lost to Follow-up|1|||
161509882|NCT01049919|583258775|FG000|Overall Study|Physician Decision|2|||
161509883|NCT01049919|583258776|FG001|Overall Study|Physician Decision|0|||
161509884|NCT01049919|583258775|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
161509885|NCT01049919|583258776|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
161509886|NCT01049919|583258775|FG000|Overall Study|Early study termination by sponsor.|2|||
161509887|NCT01049919|583258776|FG001|Overall Study|Early study termination by sponsor.|0|||
161509888|NCT04354831|583258777|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
161509889|NCT04354831|583258778|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
161509890|NCT00812929|583258779|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
161509891|NCT00812929|583258780|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
161509892|NCT00812929|583258781|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
161509893|NCT00812929|583258782|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
161509894|NCT00812929|583258783|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
161509895|NCT00812929|583258784|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
161509896|NCT00812929|583258785|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
161509897|NCT00812929|583258786|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
161509898|NCT00812929|583258787|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
161509899|NCT00812929|583258788|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
161509900|NCT00812929|583258779|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
161509901|NCT00812929|583258780|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
161509902|NCT00812929|583258781|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
161509903|NCT00812929|583258782|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
161509904|NCT00812929|583258783|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
161509905|NCT00812929|583258784|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
161509906|NCT00812929|583258785|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
161509907|NCT00812929|583258786|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
161509908|NCT00812929|583258787|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
161509909|NCT00812929|583258788|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
161509910|NCT00812929|583258779|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
161509911|NCT00812929|583258780|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
161509912|NCT00812929|583258781|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
161509913|NCT00812929|583258782|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
161509914|NCT00812929|583258783|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
161509915|NCT00812929|583258784|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
161509916|NCT00812929|583258785|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
161509917|NCT00812929|583258786|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
161509918|NCT00812929|583258787|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
161509919|NCT00812929|583258788|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
161509920|NCT02504372|583258790|FG000|Overall Study|Death|136|||
161509921|NCT02504372|583258791|FG001|Overall Study|Death|154|||
161509922|NCT02504372|583258790|FG000|Overall Study|Lost to Follow-up|0|||
161509923|NCT02504372|583258791|FG001|Overall Study|Lost to Follow-up|2|||
161509924|NCT02504372|583258790|FG000|Overall Study|Withdrawal of consent|25|||
161509925|NCT02504372|583258791|FG001|Overall Study|Withdrawal of consent|16|||
161509926|NCT02504372|583258790|FG000|Overall Study|Participants ongoing|429|||
161509927|NCT02504372|583258791|FG001|Overall Study|Participants ongoing|415|||
161509928|NCT02975934|583258792|FG000|Treatment Phase|Never initiated study drug|0|||
161509929|NCT02975934|583258793|FG001|Treatment Phase|Never initiated study drug|5|||
161509930|NCT02975934|583258794|FG002|Treatment Phase|Never initiated study drug|0|||
161509931|NCT00499603|583258798|FG000|Overall Study|Adverse Event|0|||
161509932|NCT00499603|583258799|FG001|Overall Study|Adverse Event|1|||
161509933|NCT00937547|583258800|FG000|Overall Study|misdiagnosis|1|||
161509934|NCT00937547|583258801|FG001|Overall Study|misdiagnosis|6|||
161509935|NCT00937547|583258802|FG002|Overall Study|misdiagnosis|7|||
161509936|NCT04439240|583258803|FG000|Overall Study|Ineligible|2|||
161509937|NCT04439240|583258803|FG000|Overall Study|Never started treatment|2|||
161509938|NCT04439240|583258803|FG000|Overall Study|Adverse Event|12|||
161509939|NCT04439240|583258803|FG000|Overall Study|Death|2|||
161509940|NCT04439240|583258803|FG000|Overall Study|Disease progression|25|||
161509941|NCT04439240|583258803|FG000|Overall Study|Other diseases|2|||
161509942|NCT04439240|583258803|FG000|Overall Study|Withdrawal by Subject|3|||
161509943|NCT04439240|583258803|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
161509944|NCT04439240|583258803|FG000|Overall Study|Symptomatic decline|1|||
161509945|NCT04439240|583258803|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
161509946|NCT04439240|583258803|FG000|Overall Study|Clinical progression|1|||
161509947|NCT00079274|583258805|FG000|Overall Study|Withdrawal by Subject|111|||
161509948|NCT00079274|583258806|FG001|Overall Study|Withdrawal by Subject|10|||
161509949|NCT00079274|583258807|FG002|Overall Study|Withdrawal by Subject|12|||
161509950|NCT00079274|583258808|FG003|Overall Study|Withdrawal by Subject|163|||
161509951|NCT00079274|583258809|FG004|Overall Study|Withdrawal by Subject|7|||
161675875|NCT01830855|583867217|FG003|Overall Study|Adverse Event|3|||
161675876|NCT01830855|583867214|FG000|Overall Study|Protocol deviation|10|||
161675877|NCT01830855|583867215|FG001|Overall Study|Protocol deviation|5|||
161675878|NCT01830855|583867216|FG002|Overall Study|Protocol deviation|6|||
161675879|NCT01830855|583867217|FG003|Overall Study|Protocol deviation|6|||
161675880|NCT01830855|583867214|FG000|Overall Study|Withdrawal by Subject|33|||
161675881|NCT01830855|583867215|FG001|Overall Study|Withdrawal by Subject|14|||
161675882|NCT01830855|583867216|FG002|Overall Study|Withdrawal by Subject|10|||
161675883|NCT01830855|583867217|FG003|Overall Study|Withdrawal by Subject|12|||
161675884|NCT01830855|583867214|FG000|Overall Study|No longer willing to participate|32|||
161675885|NCT01830855|583867215|FG001|Overall Study|No longer willing to participate|13|||
161675886|NCT01830855|583867216|FG002|Overall Study|No longer willing to participate|12|||
161675887|NCT01830855|583867217|FG003|Overall Study|No longer willing to participate|17|||
161675888|NCT01830855|583867214|FG000|Overall Study|Lost to Follow-up|47|||
161675889|NCT01830855|583867215|FG001|Overall Study|Lost to Follow-up|20|||
161675890|NCT01830855|583867216|FG002|Overall Study|Lost to Follow-up|23|||
161675891|NCT01830855|583867217|FG003|Overall Study|Lost to Follow-up|33|||
161675892|NCT00295633|583867219|FG000|Overall Study|Lack of Efficacy|19|||
161675893|NCT00295633|583867220|FG001|Overall Study|Lack of Efficacy|7|||
161675894|NCT00295633|583867221|FG002|Overall Study|Lack of Efficacy|16|||
161509952|NCT00079274|583258810|FG005|Overall Study|Withdrawal by Subject|8|||
161509953|NCT00079274|583258811|FG006|Overall Study|Withdrawal by Subject|0|||
161509954|NCT00079274|583258805|FG000|Overall Study|Adverse Event|130|||
161509955|NCT00079274|583258806|FG001|Overall Study|Adverse Event|8|||
161509956|NCT00079274|583258807|FG002|Overall Study|Adverse Event|8|||
161509957|NCT00079274|583258808|FG003|Overall Study|Adverse Event|184|||
161509958|NCT00079274|583258809|FG004|Overall Study|Adverse Event|7|||
161509959|NCT00079274|583258810|FG005|Overall Study|Adverse Event|8|||
161509960|NCT00079274|583258811|FG006|Overall Study|Adverse Event|0|||
161509961|NCT00079274|583258805|FG000|Overall Study|Recurrence|21|||
161509962|NCT00079274|583258806|FG001|Overall Study|Recurrence|0|||
161509963|NCT00079274|583258807|FG002|Overall Study|Recurrence|1|||
161509964|NCT00079274|583258808|FG003|Overall Study|Recurrence|15|||
161509965|NCT00079274|583258809|FG004|Overall Study|Recurrence|0|||
161509966|NCT00079274|583258810|FG005|Overall Study|Recurrence|2|||
161509967|NCT00079274|583258811|FG006|Overall Study|Recurrence|0|||
161509968|NCT00079274|583258805|FG000|Overall Study|Alternate Treatment|6|||
161509969|NCT00079274|583258806|FG001|Overall Study|Alternate Treatment|1|||
161509970|NCT00079274|583258807|FG002|Overall Study|Alternate Treatment|0|||
161509971|NCT00079274|583258808|FG003|Overall Study|Alternate Treatment|3|||
161509972|NCT00079274|583258809|FG004|Overall Study|Alternate Treatment|0|||
161509973|NCT00079274|583258810|FG005|Overall Study|Alternate Treatment|0|||
161509974|NCT00079274|583258811|FG006|Overall Study|Alternate Treatment|0|||
161509975|NCT00079274|583258805|FG000|Overall Study|Other Medical Problems|6|||
161509976|NCT00079274|583258806|FG001|Overall Study|Other Medical Problems|1|||
161509977|NCT00079274|583258807|FG002|Overall Study|Other Medical Problems|0|||
161509978|NCT00079274|583258808|FG003|Overall Study|Other Medical Problems|7|||
161509979|NCT00079274|583258809|FG004|Overall Study|Other Medical Problems|0|||
161509980|NCT00079274|583258810|FG005|Overall Study|Other Medical Problems|0|||
161509981|NCT00079274|583258811|FG006|Overall Study|Other Medical Problems|0|||
161509982|NCT00079274|583258805|FG000|Overall Study|Death|4|||
161509983|NCT00079274|583258806|FG001|Overall Study|Death|0|||
161509984|NCT00079274|583258807|FG002|Overall Study|Death|1|||
161509985|NCT00079274|583258808|FG003|Overall Study|Death|15|||
161509986|NCT00079274|583258809|FG004|Overall Study|Death|0|||
161509987|NCT00079274|583258810|FG005|Overall Study|Death|0|||
161509988|NCT00079274|583258811|FG006|Overall Study|Death|0|||
161509989|NCT00079274|583258805|FG000|Overall Study|Cytogenetic resistance|0|||
161675895|NCT00295633|583867219|FG000|Overall Study|Withdrawal of consent by subject|16|||
161675896|NCT00295633|583867220|FG001|Overall Study|Withdrawal of consent by subject|16|||
161675897|NCT00295633|583867221|FG002|Overall Study|Withdrawal of consent by subject|26|||
161675898|NCT00295633|583867219|FG000|Overall Study|Adverse Event|9|||
161675899|NCT00295633|583867220|FG001|Overall Study|Adverse Event|17|||
161675900|NCT00295633|583867221|FG002|Overall Study|Adverse Event|9|||
161509990|NCT00079274|583258806|FG001|Overall Study|Cytogenetic resistance|0|||
161509991|NCT00079274|583258807|FG002|Overall Study|Cytogenetic resistance|0|||
161675901|NCT00295633|583867219|FG000|Overall Study|Lost to Follow-up|6|||
161509992|NCT00079274|583258808|FG003|Overall Study|Cytogenetic resistance|2|||
161675902|NCT00295633|583867220|FG001|Overall Study|Lost to Follow-up|11|||
161675903|NCT00295633|583867221|FG002|Overall Study|Lost to Follow-up|7|||
161509993|NCT00079274|583258809|FG004|Overall Study|Cytogenetic resistance|0|||
161509994|NCT00079274|583258810|FG005|Overall Study|Cytogenetic resistance|0|||
161509995|NCT00079274|583258811|FG006|Overall Study|Cytogenetic resistance|0|||
161509996|NCT00079274|583258805|FG000|Overall Study|Other|43|||
161675904|NCT00295633|583867219|FG000|Overall Study|Physician Decision|9|||
161675905|NCT00295633|583867220|FG001|Overall Study|Physician Decision|10|||
161509997|NCT00079274|583258806|FG001|Overall Study|Other|7|||
161509998|NCT00079274|583258807|FG002|Overall Study|Other|5|||
161509999|NCT00079274|583258808|FG003|Overall Study|Other|55|||
161510000|NCT00079274|583258809|FG004|Overall Study|Other|1|||
161510001|NCT00079274|583258810|FG005|Overall Study|Other|2|||
161675906|NCT00295633|583867221|FG002|Overall Study|Physician Decision|8|||
161675907|NCT00295633|583867219|FG000|Overall Study|Poor/Noncompliance|2|||
161675908|NCT00295633|583867220|FG001|Overall Study|Poor/Noncompliance|2|||
161675909|NCT00295633|583867221|FG002|Overall Study|Poor/Noncompliance|6|||
161675910|NCT00295633|583867219|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161675911|NCT00295633|583867220|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
161675912|NCT00295633|583867221|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
161675913|NCT00295633|583867219|FG000|Overall Study|Death|1|||
161675914|NCT00295633|583867220|FG001|Overall Study|Death|1|||
161675915|NCT00295633|583867221|FG002|Overall Study|Death|0|||
161675916|NCT00295633|583867219|FG000|Overall Study|Administrative reason by sponsor|0|||
161675917|NCT00295633|583867220|FG001|Overall Study|Administrative reason by sponsor|0|||
161675918|NCT00295633|583867221|FG002|Overall Study|Administrative reason by sponsor|1|||
161675919|NCT01950247|583867222|FG000|Overall Study|Withdrawal by Subject|28|||
161675920|NCT01950247|583867223|FG001|Overall Study|Withdrawal by Subject|13|||
161675921|NCT01950247|583867222|FG000|Overall Study|Lost to Follow-up|18|||
161675922|NCT01950247|583867223|FG001|Overall Study|Lost to Follow-up|16|||
161675923|NCT01950247|583867222|FG000|Overall Study|Physician Decision|3|||
161675924|NCT01950247|583867223|FG001|Overall Study|Physician Decision|4|||
161510002|NCT00079274|583258811|FG006|Overall Study|Other|0|||
161510003|NCT00280566|583258812|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
161510004|NCT00280566|583258813|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
161510005|NCT00280566|583258814|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
161510006|NCT00280566|583258812|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
161510007|NCT00280566|583258813|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
161510008|NCT00280566|583258814|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
161510009|NCT00280566|583258812|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
161510010|NCT00280566|583258813|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
161675925|NCT01950247|583867222|FG000|Overall Study|Adverse Event|3|||
161675926|NCT01950247|583867223|FG001|Overall Study|Adverse Event|2|||
161675927|NCT01950247|583867222|FG000|Overall Study|Death|1|||
161675928|NCT01950247|583867223|FG001|Overall Study|Death|1|||
161675929|NCT01950247|583867222|FG000|Overall Study|Not Defined|4|||
161675930|NCT01950247|583867223|FG001|Overall Study|Not Defined|10|||
161675931|NCT00763971|583867226|FG000|Overall Study|Adverse Event|5|||
161675932|NCT00763971|583867227|FG001|Overall Study|Adverse Event|2|||
161675933|NCT00763971|583867228|FG002|Overall Study|Adverse Event|4|||
161675934|NCT00763971|583867226|FG000|Overall Study|Protocol Violation|3|||
161675935|NCT00763971|583867227|FG001|Overall Study|Protocol Violation|3|||
161675936|NCT00763971|583867228|FG002|Overall Study|Protocol Violation|2|||
161675937|NCT00763971|583867226|FG000|Overall Study|Withdrawal by Subject|4|||
161675938|NCT00763971|583867227|FG001|Overall Study|Withdrawal by Subject|5|||
161675939|NCT00763971|583867228|FG002|Overall Study|Withdrawal by Subject|5|||
161675940|NCT00763971|583867226|FG000|Overall Study|Lost to Follow-up|0|||
161675941|NCT00763971|583867227|FG001|Overall Study|Lost to Follow-up|1|||
161675942|NCT00763971|583867228|FG002|Overall Study|Lost to Follow-up|0|||
161675943|NCT00763971|583867226|FG000|Overall Study|Lack of Efficacy|11|||
161675944|NCT00763971|583867227|FG001|Overall Study|Lack of Efficacy|22|||
161675945|NCT00763971|583867228|FG002|Overall Study|Lack of Efficacy|54|||
161675946|NCT00763971|583867226|FG000|Overall Study|Unable to swallow capsule|2|||
161510011|NCT00280566|583258814|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
161510012|NCT00280566|583258812|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
161510013|NCT00280566|583258813|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
161675947|NCT00763971|583867227|FG001|Overall Study|Unable to swallow capsule|1|||
161510014|NCT00280566|583258814|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
161510015|NCT00280566|583258812|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
161510016|NCT00280566|583258813|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
161510017|NCT00280566|583258814|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
161510018|NCT00280566|583258812|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
161510019|NCT00280566|583258813|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
161510020|NCT00280566|583258814|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
161675948|NCT00763971|583867228|FG002|Overall Study|Unable to swallow capsule|1|||
161675949|NCT00763971|583867226|FG000|Overall Study|Personal reason|3|||
161675950|NCT00763971|583867227|FG001|Overall Study|Personal reason|0|||
161675951|NCT00763971|583867228|FG002|Overall Study|Personal reason|0|||
161675952|NCT00763971|583867226|FG000|Overall Study|Exclusion criteria met|1|||
161675953|NCT00763971|583867227|FG001|Overall Study|Exclusion criteria met|0|||
161675954|NCT00763971|583867228|FG002|Overall Study|Exclusion criteria met|0|||
161675955|NCT00763971|583867226|FG000|Overall Study|Sponsor decision|1|||
161675956|NCT00763971|583867227|FG001|Overall Study|Sponsor decision|0|||
161820645|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161510021|NCT00280566|583258812|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
161510022|NCT00280566|583258813|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
161510023|NCT00280566|583258814|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
161675957|NCT00763971|583867228|FG002|Overall Study|Sponsor decision|0|||
161675958|NCT00763971|583867226|FG000|Overall Study|Due to holiday season|2|||
161675959|NCT00763971|583867227|FG001|Overall Study|Due to holiday season|0|||
161675960|NCT00763971|583867228|FG002|Overall Study|Due to holiday season|1|||
161675961|NCT00763971|583867226|FG000|Overall Study|Randomization error|0|||
161675962|NCT00763971|583867227|FG001|Overall Study|Randomization error|0|||
161675963|NCT00763971|583867228|FG002|Overall Study|Randomization error|1|||
161675964|NCT00763971|583867226|FG000|Overall Study|Medical monitor decision|0|||
161675965|NCT00763971|583867227|FG001|Overall Study|Medical monitor decision|0|||
161820646|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
161820647|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161510024|NCT00280566|583258812|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
161510025|NCT00280566|583258813|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
161510026|NCT00280566|583258814|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
161510027|NCT00280566|583258812|FG000|Period 2 Double Blind|Adverse Event|0|||
161510028|NCT00280566|583258813|FG001|Period 2 Double Blind|Adverse Event|11|||
161510029|NCT00280566|583258814|FG002|Period 2 Double Blind|Adverse Event|15|||
161510030|NCT00280566|583258812|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
161510031|NCT00280566|583258813|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
161510032|NCT00280566|583258814|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
161510033|NCT00280566|583258812|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
161510034|NCT00280566|583258813|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
161510035|NCT00280566|583258814|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
161587560|NCT03131648|583540654|FG000|Maintenance Treatment Period|Completed Week 50|0|||
161587561|NCT03131648|583540655|FG001|Maintenance Treatment Period|Completed Week 50|0|||
161587562|NCT03131648|583540656|FG002|Maintenance Treatment Period|Completed Week 50|0|||
161587563|NCT03131648|583540657|FG003|Maintenance Treatment Period|Completed Week 50|0|||
161587564|NCT03131648|583540658|FG004|Maintenance Treatment Period|Completed Week 50|1|||
161587565|NCT03131648|583540659|FG005|Maintenance Treatment Period|Completed Week 50|0|||
161587566|NCT03131648|583540660|FG006|Maintenance Treatment Period|Completed Week 50|0|||
161587567|NCT03131648|583540661|FG007|Maintenance Treatment Period|Completed Week 50|0|||
161587568|NCT03131648|583540654|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587569|NCT03131648|583540655|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587570|NCT03131648|583540656|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587571|NCT03131648|583540657|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587572|NCT03131648|583540658|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587573|NCT03131648|583540659|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587574|NCT03131648|583540660|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
161587575|NCT03131648|583540661|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
161587576|NCT02724878|583540662|FG000|Overall Study|Still on Active Therapy|15|||
161587577|NCT02724878|583540662|FG000|Overall Study|Disease Progression|31|||
161587578|NCT02724878|583540662|FG000|Overall Study|Toxicity|5|||
161587579|NCT02724878|583540662|FG000|Overall Study|Death|1|||
161587580|NCT02724878|583540662|FG000|Overall Study|Withdrawal by Subject|4|||
161587581|NCT02724878|583540662|FG000|Overall Study|Lost to Follow-up|2|||
161587582|NCT02724878|583540662|FG000|Overall Study|Protocol Violation|1|||
161587583|NCT02724878|583540662|FG000|Overall Study|Ineligible for Study Drug|5|||
161587584|NCT02724878|583540662|FG000|Overall Study|not started|1|||
161587585|NCT02954341|583540663|FG000|Overall Study|Attempted Implant unsuccessful|5|||
161587586|NCT02954341|583540663|FG000|Overall Study|Death|90|||
161587587|NCT02954341|583540663|FG000|Overall Study|Withdrawal by Subject|4|||
161587588|NCT02954341|583540663|FG000|Overall Study|Physician Decision|13|||
161587589|NCT02954341|583540663|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
161587590|NCT02954341|583540663|FG000|Overall Study|Not implanted due to physician's decision|1|||
161587591|NCT02954341|583540663|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
161587592|NCT04245501|583540665|FG000|Overall Study|Adverse Event|2|||
161587593|NCT04245501|583540666|FG001|Overall Study|Adverse Event|0|||
161587594|NCT04245501|583540665|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
161587595|NCT04245501|583540666|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
161587596|NCT01772472|583540672|FG000|Overall Study|Death|126|||
161587597|NCT01772472|583540673|FG001|Overall Study|Death|94|||
161587598|NCT01772472|583540672|FG000|Overall Study|Lost to Follow-up|51|||
161587599|NCT01772472|583540673|FG001|Overall Study|Lost to Follow-up|50|||
161587600|NCT01772472|583540672|FG000|Overall Study|Other|9|||
161587601|NCT01772472|583540673|FG001|Overall Study|Other|7|||
161587602|NCT01772472|583540672|FG000|Overall Study|Physician Decision|1|||
161587603|NCT01772472|583540673|FG001|Overall Study|Physician Decision|7|||
161587604|NCT01772472|583540672|FG000|Overall Study|Withdrawal by Subject|115|||
161587605|NCT01772472|583540673|FG001|Overall Study|Withdrawal by Subject|90|||
161587606|NCT01772472|583540672|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
161587607|NCT01772472|583540673|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
161587608|NCT02697136|583540674|FG000|Overall Study|Adverse Event|3|||
161587609|NCT02697136|583540675|FG001|Overall Study|Adverse Event|0|||
161587610|NCT04391894|583540676|FG000|Overall Study|Adverse Event|1|||
161675966|NCT00763971|583867228|FG002|Overall Study|Medical monitor decision|1|||
161510036|NCT00280566|583258812|FG000|Period 2 Double Blind|miscellaneous|0|||
161510037|NCT00280566|583258813|FG001|Period 2 Double Blind|miscellaneous|10|||
161510038|NCT00280566|583258814|FG002|Period 2 Double Blind|miscellaneous|5|||
161510039|NCT01502644|583258815|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
161510040|NCT01502644|583258816|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
161510041|NCT01502644|583258817|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
161510042|NCT01502644|583258818|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
161510043|NCT01502644|583258815|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
161510044|NCT01502644|583258816|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
161510045|NCT01502644|583258817|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
161510046|NCT01502644|583258818|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
161510047|NCT01502644|583258815|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
161510048|NCT01502644|583258816|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
161510049|NCT01502644|583258817|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
161510050|NCT01502644|583258818|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
161510051|NCT01502644|583258815|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
161510052|NCT01502644|583258816|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
161510053|NCT01502644|583258817|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
161510054|NCT01502644|583258818|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
161510055|NCT01502644|583258815|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
161510056|NCT01502644|583258816|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
161510057|NCT01502644|583258817|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
161510058|NCT01502644|583258818|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
161510059|NCT01302392|583258821|FG000|Overall Study|Lost to Follow-up|1|||
161510060|NCT01302392|583258822|FG001|Overall Study|Lost to Follow-up|0|||
161510061|NCT01302392|583258821|FG000|Overall Study|Withdrawal by Subject|6|||
161510062|NCT01302392|583258822|FG001|Overall Study|Withdrawal by Subject|1|||
161510063|NCT00547703|583258826|FG000|Overall Study|Lost to Follow-up|1|||
161510064|NCT00547703|583258827|FG001|Overall Study|Lost to Follow-up|0|||
161510065|NCT04399161|583258831|FG000|Overall Study|Withdrawal by Subject|1|||
161510066|NCT04399161|583258832|FG001|Overall Study|Withdrawal by Subject|0|||
161510067|NCT04399161|583258833|FG002|Overall Study|Withdrawal by Subject|2|||
161510068|NCT04399161|583258831|FG000|Overall Study|Protocol Violation|1|||
161510069|NCT04399161|583258832|FG001|Overall Study|Protocol Violation|2|||
161510070|NCT04399161|583258833|FG002|Overall Study|Protocol Violation|0|||
161510071|NCT03417141|583258834|FG000|Overall Study|Withdrawal by Subject|1|||
161510072|NCT03417141|583258834|FG000|Overall Study|Protocol Violation|3|||
161510073|NCT03571516|583258835|FG000|Overall Study|Severe diarrhea|1|||
161510074|NCT03571516|583258836|FG001|Overall Study|Severe diarrhea|0|||
161510075|NCT03571516|583258835|FG000|Overall Study|Withdrawal by Subject|0|||
161510076|NCT03571516|583258836|FG001|Overall Study|Withdrawal by Subject|1|||
161510077|NCT00613509|583258840|FG000|Cycle 1|Adverse Event|2|||
161510078|NCT00613509|583258841|FG001|Cycle 1|Adverse Event|1|||
161510079|NCT00613509|583258840|FG000|Cycle 1|Disease Progression|2|||
161510080|NCT00613509|583258841|FG001|Cycle 1|Disease Progression|6|||
161510081|NCT00613509|583258840|FG000|Cycle 1|Unacceptable Toxicity|1|||
161510082|NCT00613509|583258841|FG001|Cycle 1|Unacceptable Toxicity|0|||
161510083|NCT00613509|583258840|FG000|Cycle 1|Other administrative reason|0|||
161510084|NCT00613509|583258841|FG001|Cycle 1|Other administrative reason|1|||
161510085|NCT03465878|583258842|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
161510086|NCT03465878|583258843|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
161510087|NCT03465878|583258844|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
161510088|NCT03465878|583258845|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
161675967|NCT00763971|583867226|FG000|Overall Study|Moved to another country|0|||
161675968|NCT00763971|583867227|FG001|Overall Study|Moved to another country|1|||
161675969|NCT00763971|583867228|FG002|Overall Study|Moved to another country|0|||
161510089|NCT03465878|583258842|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
161510090|NCT03465878|583258843|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
161510091|NCT03465878|583258844|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
161675970|NCT00763971|583867226|FG000|Overall Study|Subject wanted dose reduction|0|||
161510092|NCT03465878|583258845|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
161510093|NCT03465878|583258842|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
161510094|NCT03465878|583258843|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
161510095|NCT03465878|583258844|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
161675971|NCT00763971|583867227|FG001|Overall Study|Subject wanted dose reduction|1|||
161510096|NCT03465878|583258845|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
161510097|NCT02540954|583258846|FG000|Overall Study|Physician Decision|3|||
161510098|NCT02540954|583258847|FG001|Overall Study|Physician Decision|1|||
161510099|NCT02540954|583258846|FG000|Overall Study|Withdrawal by Subject|6|||
161820648|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161820649|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
161820650|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
161820651|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
161510100|NCT02540954|583258847|FG001|Overall Study|Withdrawal by Subject|5|||
161510101|NCT02540954|583258846|FG000|Overall Study|Lost to Follow-up|1|||
161510102|NCT02540954|583258847|FG001|Overall Study|Lost to Follow-up|1|||
161510103|NCT02540954|583258846|FG000|Overall Study|Adverse Event|4|||
161510104|NCT02540954|583258847|FG001|Overall Study|Adverse Event|2|||
161510105|NCT02540954|583258846|FG000|Overall Study|Death|0|||
161510106|NCT02540954|583258847|FG001|Overall Study|Death|3|||
161510107|NCT02540954|583258846|FG000|Overall Study|Treatment failure|1|||
161510108|NCT02540954|583258847|FG001|Overall Study|Treatment failure|0|||
161510109|NCT02540954|583258846|FG000|Overall Study|Other reason|4|||
161510110|NCT02540954|583258847|FG001|Overall Study|Other reason|2|||
161510111|NCT01723228|583258851|FG000|Overall Study|Adverse Event|2|||
161510112|NCT01723228|583258852|FG001|Overall Study|Adverse Event|6|||
161510113|NCT01723228|583258851|FG000|Overall Study|Withdrawal by Subject|2|||
161510114|NCT01723228|583258852|FG001|Overall Study|Withdrawal by Subject|1|||
161510115|NCT01723228|583258851|FG000|Overall Study|Protocol Violation|0|||
161510116|NCT01723228|583258852|FG001|Overall Study|Protocol Violation|2|||
161510117|NCT01723228|583258851|FG000|Overall Study|Lost to Follow-up|2|||
161510118|NCT01723228|583258852|FG001|Overall Study|Lost to Follow-up|1|||
161510119|NCT01723228|583258851|FG000|Overall Study|Other|2|||
161510120|NCT01723228|583258852|FG001|Overall Study|Other|1|||
161510121|NCT01282216|583258853|FG000|Overall Study|Graft failure|0|||
161510122|NCT01282216|583258854|FG001|Overall Study|Graft failure|0|||
161510123|NCT01282216|583258855|FG002|Overall Study|Graft failure|3|||
161510124|NCT01282216|583258856|FG003|Overall Study|Graft failure|2|||
161510125|NCT01282216|583258853|FG000|Overall Study|Physician Decision|0|||
161510126|NCT01282216|583258854|FG001|Overall Study|Physician Decision|0|||
161510127|NCT01282216|583258855|FG002|Overall Study|Physician Decision|11|||
161510128|NCT01282216|583258856|FG003|Overall Study|Physician Decision|0|||
161510129|NCT01282216|583258853|FG000|Overall Study|Relapse|0|||
161510130|NCT01282216|583258854|FG001|Overall Study|Relapse|0|||
161510131|NCT01282216|583258855|FG002|Overall Study|Relapse|17|||
161510132|NCT01282216|583258856|FG003|Overall Study|Relapse|6|||
161510133|NCT01282216|583258853|FG000|Overall Study|Death|0|||
161510134|NCT01282216|583258854|FG001|Overall Study|Death|0|||
161510135|NCT01282216|583258855|FG002|Overall Study|Death|2|||
161510136|NCT01282216|583258856|FG003|Overall Study|Death|0|||
161510137|NCT01864291|583258857|FG000|Overall Study|need for revision surgery|2|||
161510138|NCT01806896|583258858|FG000|Overall Study|Adverse Event|2|||
161510139|NCT01806896|583258859|FG001|Overall Study|Adverse Event|0|||
161510140|NCT01806896|583258858|FG000|Overall Study|Other|1|||
161820652|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
161820653|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161820654|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161510141|NCT01806896|583258859|FG001|Overall Study|Other|0|||
161510142|NCT02448875|583258860|FG000|Overall Study|Adverse Event|2|||
161510143|NCT02448875|583258861|FG001|Overall Study|Adverse Event|1|||
161510144|NCT02448875|583258862|FG002|Overall Study|Adverse Event|0|||
161510145|NCT02448875|583258860|FG000|Overall Study|Lost to Follow-up|1|||
161510146|NCT02448875|583258861|FG001|Overall Study|Lost to Follow-up|0|||
161510147|NCT02448875|583258862|FG002|Overall Study|Lost to Follow-up|0|||
161510148|NCT02448875|583258860|FG000|Overall Study|Investigator Decision|3|||
161510149|NCT02448875|583258861|FG001|Overall Study|Investigator Decision|0|||
161587611|NCT04391894|583540677|FG001|Overall Study|Adverse Event|1|||
161587612|NCT04391894|583540678|FG002|Overall Study|Adverse Event|1|||
161587613|NCT04391894|583540679|FG003|Overall Study|Adverse Event|1|||
161587614|NCT04391894|583540680|FG004|Overall Study|Adverse Event|1|||
161587615|NCT04391894|583540676|FG000|Overall Study|Lost to Follow-up|1|||
161587616|NCT04391894|583540677|FG001|Overall Study|Lost to Follow-up|0|||
161587617|NCT04391894|583540678|FG002|Overall Study|Lost to Follow-up|0|||
161587618|NCT04391894|583540679|FG003|Overall Study|Lost to Follow-up|0|||
161587619|NCT04391894|583540680|FG004|Overall Study|Lost to Follow-up|0|||
161587620|NCT04391894|583540676|FG000|Overall Study|Protocol Violation|0|||
161587621|NCT04391894|583540677|FG001|Overall Study|Protocol Violation|0|||
161510150|NCT02448875|583258862|FG002|Overall Study|Investigator Decision|1|||
161510151|NCT02448875|583258860|FG000|Overall Study|Withdrawal by Subject|1|||
161587622|NCT04391894|583540678|FG002|Overall Study|Protocol Violation|0|||
161587623|NCT04391894|583540679|FG003|Overall Study|Protocol Violation|1|||
161587624|NCT04391894|583540680|FG004|Overall Study|Protocol Violation|0|||
161510152|NCT02448875|583258861|FG001|Overall Study|Withdrawal by Subject|0|||
161510153|NCT02448875|583258862|FG002|Overall Study|Withdrawal by Subject|0|||
161510154|NCT02434770|583258864|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
161510155|NCT02434770|583258865|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
161510156|NCT02434770|583258866|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
161510157|NCT02434770|583258864|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
161675972|NCT00763971|583867228|FG002|Overall Study|Subject wanted dose reduction|0|||
161510158|NCT02434770|583258865|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
161510159|NCT02434770|583258866|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
161510160|NCT02434770|583258864|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
161510161|NCT02434770|583258865|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
161510162|NCT02434770|583258866|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
161510163|NCT02434770|583258864|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
161510164|NCT02434770|583258865|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
161510165|NCT02434770|583258866|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
161510166|NCT02434770|583258864|FG000|Week 1 to Week 18|Death|1|||
161510167|NCT02434770|583258865|FG001|Week 1 to Week 18|Death|0|||
161510168|NCT02434770|583258866|FG002|Week 1 to Week 18|Death|0|||
161510169|NCT02434770|583258864|FG000|Week 18 to Week|Lost to Follow-up|2|||
161510170|NCT02434770|583258865|FG001|Week 18 to Week|Lost to Follow-up|2|||
161510171|NCT02434770|583258866|FG002|Week 18 to Week|Lost to Follow-up|1|||
161510172|NCT02434770|583258864|FG000|Week 18 to Week|Withdrawal by Subject|0|||
161510173|NCT02434770|583258865|FG001|Week 18 to Week|Withdrawal by Subject|0|||
161510174|NCT02434770|583258866|FG002|Week 18 to Week|Withdrawal by Subject|2|||
161510175|NCT02434770|583258864|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
161510176|NCT02434770|583258865|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
161510177|NCT02434770|583258866|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
161510178|NCT01282424|583258872|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
161510179|NCT01282424|583258872|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
161510180|NCT01282424|583258872|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
161510181|NCT01282424|583258872|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
161510182|NCT01282424|583258872|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
161510183|NCT01282424|583258872|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
161510184|NCT01282424|583258872|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
161510185|NCT01282424|583258872|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
161510186|NCT03316872|583258874|FG000|Overall Study|Death|1|||
161510187|NCT02239536|583258875|FG000|Overall Study|Non-neoplastic polyp|23|||
161510188|NCT02239536|583258876|FG001|Overall Study|Non-neoplastic polyp|17|||
161510189|NCT04074317|583258877|FG000|Third Period|Withdrawal by Subject|0|||
161510190|NCT04074317|583258878|FG001|Third Period|Withdrawal by Subject|0|||
161510191|NCT04074317|583258879|FG002|Third Period|Withdrawal by Subject|0|||
161510192|NCT04074317|583258880|FG003|Third Period|Withdrawal by Subject|1|||
161510193|NCT04074317|583258881|FG004|Third Period|Withdrawal by Subject|0|||
161510194|NCT04074317|583258882|FG005|Third Period|Withdrawal by Subject|0|||
161510195|NCT02283788|583258885|FG000|Overall Study|Adverse Event|1|||
161510196|NCT02283788|583258886|FG001|Overall Study|Adverse Event|3|||
161510197|NCT02283788|583258887|FG002|Overall Study|Adverse Event|5|||
161510198|NCT02283788|583258888|FG003|Overall Study|Adverse Event|1|||
161510199|NCT02283788|583258885|FG000|Overall Study|Withdrawal by Subject|0|||
161510200|NCT02283788|583258886|FG001|Overall Study|Withdrawal by Subject|1|||
161510201|NCT02283788|583258887|FG002|Overall Study|Withdrawal by Subject|0|||
161510202|NCT02283788|583258888|FG003|Overall Study|Withdrawal by Subject|1|||
161510203|NCT02742103|583260432|FG000|Overall Study|Protocol Violation|1|||
161510204|NCT02742103|583260433|FG001|Overall Study|Protocol Violation|0|||
161510205|NCT02742103|583260432|FG000|Overall Study|Death|2|||
161510206|NCT02742103|583260433|FG001|Overall Study|Death|2|||
161510207|NCT02742103|583260432|FG000|Overall Study|Adverse Event|1|||
161510208|NCT02742103|583260433|FG001|Overall Study|Adverse Event|0|||
161510209|NCT02742103|583260432|FG000|Overall Study|Moved to another town|0|||
161510210|NCT02742103|583260433|FG001|Overall Study|Moved to another town|1|||
161510211|NCT02742103|583260432|FG000|Overall Study|Withdrawal by Subject|5|||
161510212|NCT02742103|583260433|FG001|Overall Study|Withdrawal by Subject|2|||
161510213|NCT00533949|583260436|FG000|Overall Study|Protocol Violation|12|||
161510214|NCT00533949|583260437|FG001|Overall Study|Protocol Violation|12|||
161510215|NCT00533949|583260438|FG002|Overall Study|Protocol Violation|9|||
161675973|NCT00763971|583867226|FG000|Overall Study|Lack of availability|0|||
161675974|NCT00763971|583867227|FG001|Overall Study|Lack of availability|1|||
161675975|NCT00763971|583867228|FG002|Overall Study|Lack of availability|0|||
161675976|NCT00763971|583867226|FG000|Overall Study|Performed final visit on phone|0|||
161675977|NCT00763971|583867227|FG001|Overall Study|Performed final visit on phone|1|||
161675978|NCT00763971|583867228|FG002|Overall Study|Performed final visit on phone|0|||
161510216|NCT00533949|583260439|FG003|Overall Study|Protocol Violation|9|||
161510217|NCT00533949|583260436|FG000|Overall Study|Withdrawal by Subject|3|||
161510218|NCT00533949|583260437|FG001|Overall Study|Withdrawal by Subject|2|||
161510219|NCT00533949|583260438|FG002|Overall Study|Withdrawal by Subject|1|||
161510220|NCT00533949|583260439|FG003|Overall Study|Withdrawal by Subject|1|||
161510221|NCT00727194|583260440|FG000|Screening Period|Low QMG scores|0|||
161675979|NCT00763971|583867226|FG000|Overall Study|Participation in 489-326 required|1|||
161675980|NCT00763971|583867227|FG001|Overall Study|Participation in 489-326 required|0|||
161510222|NCT00727194|583260441|FG001|Screening Period|Low QMG scores|0|||
161510223|NCT00727194|583260442|FG002|Screening Period|Low QMG scores|6|||
161675981|NCT00763971|583867228|FG002|Overall Study|Participation in 489-326 required|0|||
161675982|NCT02713542|583867233|FG000|Overall Study|Use of prohibited medication|14|||
161675983|NCT02713542|583867234|FG001|Overall Study|Use of prohibited medication|5|||
161675984|NCT02713542|583867233|FG000|Overall Study|Withdrawal by Subject|4|||
161675985|NCT02713542|583867234|FG001|Overall Study|Withdrawal by Subject|1|||
161675986|NCT03631667|583867235|FG000|Overall Study|Withdrawal by Subject|3|||
161675987|NCT01641237|583867236|FG000|Period II|Withdrawal by Subject|1|||
161675988|NCT01641237|583867237|FG001|Period II|Withdrawal by Subject|0|||
161675989|NCT01641237|583867238|FG002|Period II|Withdrawal by Subject|0|||
161675990|NCT01641237|583867239|FG003|Period II|Withdrawal by Subject|0|||
161675991|NCT01641237|583867236|FG000|Period III|Lost to Follow-up|1|||
161675992|NCT01641237|583867237|FG001|Period III|Lost to Follow-up|0|||
161675993|NCT01641237|583867238|FG002|Period III|Lost to Follow-up|0|||
161675994|NCT01641237|583867239|FG003|Period III|Lost to Follow-up|0|||
161675995|NCT00884325|583867251|FG000|Overall Study|Lost to Follow-up|1|||
161675996|NCT00884325|583867252|FG001|Overall Study|Lost to Follow-up|2|||
161675997|NCT00884325|583867251|FG000|Overall Study|Lack of Efficacy|0|||
161675998|NCT00884325|583867252|FG001|Overall Study|Lack of Efficacy|1|||
161675999|NCT00884325|583867251|FG000|Overall Study|Withdrawal by Subject|1|||
161676000|NCT00884325|583867252|FG001|Overall Study|Withdrawal by Subject|1|||
161676001|NCT00884325|583867251|FG000|Overall Study|Not provided|1|||
161676002|NCT00884325|583867252|FG001|Overall Study|Not provided|0|||
161676003|NCT01446016|583867253|FG000|Overall Study|Lost to Follow-up|3|||
161676004|NCT01446016|583867253|FG000|Overall Study|Withdrawal by Subject|1|||
161676005|NCT01446016|583867253|FG000|Overall Study|Toxicity|3|||
161676006|NCT00404066|583867260|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
161676007|NCT00404066|583867260|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
161676008|NCT01949155|583867261|FG000|Overall Study|Lost to Follow-up|1|||
161676009|NCT01949155|583867262|FG001|Overall Study|Lost to Follow-up|0|||
161676010|NCT01949155|583867261|FG000|Overall Study|Protocol Violation|1|||
161676011|NCT01949155|583867262|FG001|Overall Study|Protocol Violation|0|||
161510224|NCT00727194|583260440|FG000|Screening Period|Lacked AChR antibodies|0|||
161510225|NCT00727194|583260441|FG001|Screening Period|Lacked AChR antibodies|0|||
161510226|NCT00727194|583260442|FG002|Screening Period|Lacked AChR antibodies|5|||
161510227|NCT00727194|583260440|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
161510228|NCT00727194|583260441|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
161510229|NCT00727194|583260442|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
161510230|NCT00727194|583260440|FG000|Screening Period|Severe infections|0|||
161510231|NCT00727194|583260441|FG001|Screening Period|Severe infections|0|||
161510232|NCT00727194|583260442|FG002|Screening Period|Severe infections|2|||
161510233|NCT00727194|583260440|FG000|Screening Period|History of thymoma|0|||
161510234|NCT00727194|583260441|FG001|Screening Period|History of thymoma|0|||
161510235|NCT00727194|583260442|FG002|Screening Period|History of thymoma|1|||
161510236|NCT00727194|583260440|FG000|Treatment Period 2|Lack of Efficacy|0|||
161510237|NCT00727194|583260441|FG001|Treatment Period 2|Lack of Efficacy|1|||
161510238|NCT00727194|583260442|FG002|Treatment Period 2|Lack of Efficacy|0|||
161510239|NCT04269161|583260449|FG000|Overall Study|Change of modality and no longer eligible|3|||
161510240|NCT04269161|583260450|FG001|Overall Study|Change of modality and no longer eligible|3|||
161510241|NCT04269161|583260449|FG000|Overall Study|Required procedure outside of NICU|1|||
161510242|NCT04269161|583260450|FG001|Overall Study|Required procedure outside of NICU|0|||
161510243|NCT04269161|583260449|FG000|Overall Study|Equipment issue|1|||
161510244|NCT04269161|583260450|FG001|Overall Study|Equipment issue|1|||
161510245|NCT02472756|583260451|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
161510246|NCT02472756|583260451|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
161510247|NCT02472756|583260451|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
161676012|NCT05395104|583867263|FG000|Overall Study|Met Liver Stopping Criteria|1|||
161676013|NCT05395104|583867263|FG000|Overall Study|Withdrawal by Subject|1|||
161676014|NCT02448225|583867264|FG000|Overall Study|Withdrawal by Subject|1|||
161676015|NCT02448225|583867264|FG000|Overall Study|Did not get FSPG scan|18|||
161676016|NCT02448225|583867264|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
161510248|NCT02472756|583260451|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
161510249|NCT02472756|583260451|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
161510250|NCT02649972|583260456|FG000|Overall Study|Not treated|1|||
161510251|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Adverse Event|9|||
161510252|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Adverse Event|2|||
161510253|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
161676017|NCT01287364|583867269|FG000|Overall Study|Adverse Event|0|||
161676018|NCT01287364|583867270|FG001|Overall Study|Adverse Event|3|||
161676019|NCT01287364|583867269|FG000|Overall Study|Protocol Violation|5|||
161676020|NCT01287364|583867270|FG001|Overall Study|Protocol Violation|5|||
161676021|NCT01287364|583867269|FG000|Overall Study|Other Reason|4|||
161676022|NCT01287364|583867270|FG001|Overall Study|Other Reason|2|||
161676023|NCT04422990|583867272|FG000|Overall Study|Withdrawal by Subject|0|||
161510254|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
161510255|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
161510256|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
161510257|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Physician Decision|1|||
161510258|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Physician Decision|1|||
161510259|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Pregnancy|2|||
161510260|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Pregnancy|0|||
161510261|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
161510262|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
161510263|NCT02896127|583260459|FG000|COMPLETED WEEK 52|Technical problems|1|||
161510264|NCT02896127|583260460|FG001|COMPLETED WEEK 52|Technical problems|0|||
161510265|NCT02896127|583260459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
161510266|NCT02896127|583260460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
161510267|NCT02896127|583260459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
161510268|NCT02896127|583260460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
161510269|NCT02896127|583260459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
161510270|NCT02896127|583260460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
161510271|NCT02896127|583260459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
161510272|NCT02896127|583260460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
161510273|NCT02896127|583260459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
161510274|NCT02896127|583260460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
161510275|NCT00958776|583260461|FG000|Overall Study|Adverse Event|0|||
161510276|NCT00958776|583260462|FG001|Overall Study|Adverse Event|1|||
161510277|NCT00958776|583260461|FG000|Overall Study|Physician Decision|1|||
161510278|NCT00958776|583260462|FG001|Overall Study|Physician Decision|0|||
161510279|NCT00958776|583260461|FG000|Overall Study|Lost to Follow-up|2|||
161510280|NCT00958776|583260462|FG001|Overall Study|Lost to Follow-up|6|||
161510281|NCT00958776|583260461|FG000|Overall Study|Withdrawal by Subject|7|||
161510282|NCT00958776|583260462|FG001|Overall Study|Withdrawal by Subject|16|||
161510283|NCT00958776|583260461|FG000|Overall Study|Protocol Violation|1|||
161510284|NCT00958776|583260462|FG001|Overall Study|Protocol Violation|1|||
161510285|NCT00958776|583260461|FG000|Overall Study|Death|2|||
161510286|NCT00958776|583260462|FG001|Overall Study|Death|1|||
161510287|NCT00958776|583260461|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
161510288|NCT00958776|583260462|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
161510289|NCT00958776|583260461|FG000|Overall Study|Missing|1|||
161510290|NCT00958776|583260462|FG001|Overall Study|Missing|1|||
161510291|NCT00326911|583260463|FG000|Overall Study|Hospitalization prior to treatment|0|||
161510292|NCT00326911|583260464|FG001|Overall Study|Hospitalization prior to treatment|1|||
161510293|NCT00326911|583260463|FG000|Overall Study|Physician decision prior to treatment|1|||
161510294|NCT00326911|583260464|FG001|Overall Study|Physician decision prior to treatment|0|||
161510295|NCT00326911|583260463|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
161510296|NCT00326911|583260464|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
161510297|NCT00501540|583260473|FG000|Overall Study|Death|5|||
161510298|NCT02331446|583260474|FG000|Overall Study|Lost to Follow-up|2|||
161510299|NCT02331446|583260475|FG001|Overall Study|Lost to Follow-up|1|||
161510300|NCT02331446|583260476|FG002|Overall Study|Lost to Follow-up|0|||
161510301|NCT02331446|583260477|FG003|Overall Study|Lost to Follow-up|1|||
161510302|NCT02331446|583260474|FG000|Overall Study|Personal Problem|2|||
161510303|NCT02331446|583260475|FG001|Overall Study|Personal Problem|0|||
161510304|NCT02331446|583260476|FG002|Overall Study|Personal Problem|0|||
161510305|NCT02331446|583260477|FG003|Overall Study|Personal Problem|0|||
161587625|NCT04391894|583540676|FG000|Overall Study|Withdrawal by Subject|2|||
161587626|NCT04391894|583540677|FG001|Overall Study|Withdrawal by Subject|0|||
161587627|NCT04391894|583540678|FG002|Overall Study|Withdrawal by Subject|3|||
161587628|NCT04391894|583540679|FG003|Overall Study|Withdrawal by Subject|0|||
161587629|NCT04391894|583540680|FG004|Overall Study|Withdrawal by Subject|1|||
161587630|NCT04391894|583540676|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
161587631|NCT04391894|583540677|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
161587632|NCT04391894|583540678|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
161587633|NCT04391894|583540679|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
161587634|NCT04391894|583540680|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
161587635|NCT02323321|583540684|FG000|Overall Study|Re-Transplant|1|||
161587636|NCT02323321|583540684|FG000|Overall Study|Death|12|||
161587637|NCT00446225|583540685|FG000|Overall Study|Protocol Violation|1|||
161587638|NCT00446225|583540686|FG001|Overall Study|Protocol Violation|0|||
161587639|NCT02500758|583540689|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
161587640|NCT02500758|583540690|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
161587641|NCT02500758|583540689|FG000|Washout (1 Week)|Lost to Follow-up|2|||
161587642|NCT02500758|583540690|FG001|Washout (1 Week)|Lost to Follow-up|2|||
161587643|NCT02500758|583540689|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
161587644|NCT02500758|583540690|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
161587645|NCT02500758|583540689|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
161587646|NCT02500758|583540690|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
161676024|NCT04422990|583867273|FG001|Overall Study|Withdrawal by Subject|1|||
161676025|NCT04422990|583867272|FG000|Overall Study|Travel|3|||
161510306|NCT02331446|583260474|FG000|Overall Study|Disease|0|||
161510307|NCT02331446|583260475|FG001|Overall Study|Disease|2|||
161510308|NCT02331446|583260476|FG002|Overall Study|Disease|2|||
161510309|NCT02331446|583260477|FG003|Overall Study|Disease|1|||
161510310|NCT02331446|583260474|FG000|Overall Study|Physician Decision|0|||
161510311|NCT02331446|583260475|FG001|Overall Study|Physician Decision|1|||
161510312|NCT02331446|583260476|FG002|Overall Study|Physician Decision|0|||
161510313|NCT02331446|583260477|FG003|Overall Study|Physician Decision|1|||
161510314|NCT02331446|583260474|FG000|Overall Study|Lost before baseline analysis|0|||
161510315|NCT02331446|583260475|FG001|Overall Study|Lost before baseline analysis|1|||
161676026|NCT04422990|583867273|FG001|Overall Study|Travel|0|||
161676027|NCT01849497|583867278|FG000|Overall Study|Withdrawal by Subject|1|||
161676028|NCT01849497|583867279|FG001|Overall Study|Withdrawal by Subject|2|||
161676029|NCT01849497|583867278|FG000|Overall Study|Sponsor Decision|0|||
161676030|NCT01849497|583867279|FG001|Overall Study|Sponsor Decision|1|||
161676031|NCT01849497|583867278|FG000|Overall Study|Lost to Follow-up|0|||
161676032|NCT01849497|583867279|FG001|Overall Study|Lost to Follow-up|1|||
161676033|NCT02146599|583867280|FG000|Overall Study|Failed to meet inclusion criteria|5|||
161676034|NCT02101021|583867281|FG000|Overall Study|Death|4|||
161676035|NCT02101021|583867282|FG001|Overall Study|Death|3|||
161510316|NCT02331446|583260476|FG002|Overall Study|Lost before baseline analysis|1|||
161510317|NCT02331446|583260477|FG003|Overall Study|Lost before baseline analysis|0|||
161510318|NCT02984995|583260478|FG000|Overall Study|Required stem cell transplant|13|||
161510319|NCT02984995|583260479|FG001|Overall Study|Required stem cell transplant|2|||
161510320|NCT02984995|583260478|FG000|Overall Study|Progressive disease|11|||
161510321|NCT02984995|583260479|FG001|Overall Study|Progressive disease|1|||
161510322|NCT02984995|583260478|FG000|Overall Study|Adverse Event|1|||
161510323|NCT02984995|583260479|FG001|Overall Study|Adverse Event|0|||
161510324|NCT04182100|583260480|FG000|Overall Study|Adverse Event|1|||
161510325|NCT04182100|583260480|FG000|Overall Study|Withdrawal by Subject|1|||
161510326|NCT00433654|583260482|FG000|Overall Study|Death|4|||
161510327|NCT00433654|583260483|FG001|Overall Study|Death|0|||
161510328|NCT00433654|583260482|FG000|Overall Study|Missed visit|6|||
161510329|NCT00433654|583260483|FG001|Overall Study|Missed visit|3|||
161510330|NCT00433654|583260482|FG000|Overall Study|Subject not yet due for visit|4|||
161510331|NCT00433654|583260483|FG001|Overall Study|Subject not yet due for visit|0|||
161510332|NCT00433654|583260482|FG000|Overall Study|Withdrawal by Subject|1|||
161510333|NCT00433654|583260483|FG001|Overall Study|Withdrawal by Subject|2|||
161510334|NCT01428193|583260507|FG000|Overall Study|Physician Decision|1|||
161510335|NCT01428193|583260507|FG000|Overall Study|Elevated screening liver enzymes|1|||
161510336|NCT00357370|583260514|FG000|Cohort 2|Lack of Efficacy|0|||
161510337|NCT00357370|583260515|FG001|Cohort 2|Lack of Efficacy|2|||
161510338|NCT00357370|583260516|FG002|Cohort 2|Lack of Efficacy|1|||
161676036|NCT02101021|583867283|FG002|Overall Study|Death|6|||
161676037|NCT02101021|583867284|FG003|Overall Study|Death|0|||
161676038|NCT02101021|583867285|FG004|Overall Study|Death|3|||
161676039|NCT02101021|583867281|FG000|Overall Study|Withdrew Consent from study|1|||
161676040|NCT02101021|583867282|FG001|Overall Study|Withdrew Consent from study|1|||
161676041|NCT02101021|583867283|FG002|Overall Study|Withdrew Consent from study|0|||
161676042|NCT02101021|583867284|FG003|Overall Study|Withdrew Consent from study|2|||
161676043|NCT02101021|583867285|FG004|Overall Study|Withdrew Consent from study|0|||
161676044|NCT02101021|583867281|FG000|Overall Study|Lost to Follow-up|1|||
161676045|NCT02101021|583867282|FG001|Overall Study|Lost to Follow-up|0|||
161676046|NCT02101021|583867283|FG002|Overall Study|Lost to Follow-up|0|||
161676047|NCT02101021|583867284|FG003|Overall Study|Lost to Follow-up|0|||
161676048|NCT02101021|583867285|FG004|Overall Study|Lost to Follow-up|0|||
161676049|NCT02101021|583867281|FG000|Overall Study|Study Terminated by Sponsor|1|||
161676050|NCT02101021|583867282|FG001|Overall Study|Study Terminated by Sponsor|0|||
161676051|NCT02101021|583867283|FG002|Overall Study|Study Terminated by Sponsor|1|||
161510339|NCT00357370|583260514|FG000|Cohort 2|Adverse Event|1|||
161676052|NCT02101021|583867284|FG003|Overall Study|Study Terminated by Sponsor|1|||
161510340|NCT00357370|583260515|FG001|Cohort 2|Adverse Event|1|||
161510341|NCT00357370|583260516|FG002|Cohort 2|Adverse Event|1|||
161510342|NCT00357370|583260514|FG000|Cohort 2|Lost to Follow-up|0|||
161676053|NCT02101021|583867285|FG004|Overall Study|Study Terminated by Sponsor|1|||
161510343|NCT00357370|583260515|FG001|Cohort 2|Lost to Follow-up|1|||
161510344|NCT00357370|583260516|FG002|Cohort 2|Lost to Follow-up|0|||
161510345|NCT00357370|583260514|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
161510346|NCT00357370|583260515|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
161510347|NCT00357370|583260516|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
161510348|NCT00357370|583260514|FG000|Cohort 2|Withdrawal by Subject|0|||
161510349|NCT00357370|583260515|FG001|Cohort 2|Withdrawal by Subject|2|||
161510350|NCT00357370|583260516|FG002|Cohort 2|Withdrawal by Subject|0|||
161510351|NCT01632800|583260518|FG000|Overall Study|Subject did not fit in apparatus|1|||
161676054|NCT02322229|583867290|FG000|Overall Study|Physician Decision|2|||
161676055|NCT03065023|583867291|FG000|Overall Study|Progressive Disease|0|||
161676056|NCT03065023|583867292|FG001|Overall Study|Progressive Disease|1|||
161510352|NCT00813124|583260519|FG000|Overall Study|Death|2|||
161510353|NCT00813124|583260519|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
161510354|NCT00813124|583260519|FG000|Overall Study|Withdrawal by Subject|1|||
161510355|NCT01147653|583260526|FG000|Year 2|Withdrawal by Subject|2|||
161510356|NCT01147653|583260527|FG001|Year 2|Withdrawal by Subject|3|||
161510357|NCT00670228|583260528|FG000|Overall Study|Adverse Event|1|||
161510358|NCT00670228|583260529|FG001|Overall Study|Adverse Event|0|||
161510359|NCT00670228|583260528|FG000|Overall Study|Death or MACE|0|||
161510360|NCT00670228|583260529|FG001|Overall Study|Death or MACE|1|||
161510361|NCT00670228|583260528|FG000|Overall Study|Not treated|2|||
161510362|NCT00670228|583260529|FG001|Overall Study|Not treated|2|||
161510363|NCT00670228|583260528|FG000|Overall Study|Not meeting the selection criteria|2|||
161510364|NCT00670228|583260529|FG001|Overall Study|Not meeting the selection criteria|0|||
161510365|NCT03604692|583260530|FG000|Overall Study|Investigator's Decision|0|||
161510366|NCT03604692|583260531|FG001|Overall Study|Investigator's Decision|0|||
161510367|NCT03604692|583260532|FG002|Overall Study|Investigator's Decision|0|||
161510368|NCT03604692|583260533|FG003|Overall Study|Investigator's Decision|1|||
161510369|NCT03604692|583260534|FG004|Overall Study|Investigator's Decision|0|||
161510370|NCT03604692|583260535|FG005|Overall Study|Investigator's Decision|7|||
161510371|NCT03604692|583260530|FG000|Overall Study|Withdrawal by Subject|0|||
161510372|NCT03604692|583260531|FG001|Overall Study|Withdrawal by Subject|0|||
161510373|NCT03604692|583260532|FG002|Overall Study|Withdrawal by Subject|0|||
161510374|NCT03604692|583260533|FG003|Overall Study|Withdrawal by Subject|0|||
161510375|NCT03604692|583260534|FG004|Overall Study|Withdrawal by Subject|0|||
161510376|NCT03604692|583260535|FG005|Overall Study|Withdrawal by Subject|2|||
161510377|NCT03604692|583260530|FG000|Overall Study|Progressive Disease|1|||
161510378|NCT03604692|583260531|FG001|Overall Study|Progressive Disease|0|||
161510379|NCT03604692|583260532|FG002|Overall Study|Progressive Disease|1|||
161510380|NCT03604692|583260533|FG003|Overall Study|Progressive Disease|0|||
161510381|NCT03604692|583260534|FG004|Overall Study|Progressive Disease|3|||
161510382|NCT03604692|583260535|FG005|Overall Study|Progressive Disease|4|||
161510383|NCT03604692|583260530|FG000|Overall Study|Difficulty Coming into Site|0|||
161510384|NCT03604692|583260531|FG001|Overall Study|Difficulty Coming into Site|0|||
161510385|NCT03604692|583260532|FG002|Overall Study|Difficulty Coming into Site|0|||
161510386|NCT03604692|583260533|FG003|Overall Study|Difficulty Coming into Site|0|||
161510387|NCT03604692|583260534|FG004|Overall Study|Difficulty Coming into Site|0|||
161510388|NCT03604692|583260535|FG005|Overall Study|Difficulty Coming into Site|1|||
161510389|NCT03604692|583260530|FG000|Overall Study|Death|0|||
161510390|NCT03604692|583260531|FG001|Overall Study|Death|0|||
161510391|NCT03604692|583260532|FG002|Overall Study|Death|1|||
161510392|NCT03604692|583260533|FG003|Overall Study|Death|0|||
161510393|NCT03604692|583260534|FG004|Overall Study|Death|0|||
161510394|NCT03604692|583260535|FG005|Overall Study|Death|0|||
161510395|NCT03604692|583260530|FG000|Overall Study|Drug Intolerance|0|||
161510396|NCT03604692|583260531|FG001|Overall Study|Drug Intolerance|0|||
161510397|NCT03604692|583260532|FG002|Overall Study|Drug Intolerance|0|||
161510398|NCT03604692|583260533|FG003|Overall Study|Drug Intolerance|1|||
161510399|NCT03604692|583260534|FG004|Overall Study|Drug Intolerance|0|||
161510400|NCT03604692|583260535|FG005|Overall Study|Drug Intolerance|0|||
161510401|NCT03604692|583260530|FG000|Overall Study|Noncompliance with follow-up visit|0|||
161510402|NCT03604692|583260531|FG001|Overall Study|Noncompliance with follow-up visit|0|||
161510403|NCT03604692|583260532|FG002|Overall Study|Noncompliance with follow-up visit|0|||
161510404|NCT03604692|583260533|FG003|Overall Study|Noncompliance with follow-up visit|1|||
161510405|NCT03604692|583260534|FG004|Overall Study|Noncompliance with follow-up visit|0|||
161510406|NCT03604692|583260535|FG005|Overall Study|Noncompliance with follow-up visit|0|||
161510407|NCT03604692|583260530|FG000|Overall Study|Not Treated|0|||
161510408|NCT03604692|583260531|FG001|Overall Study|Not Treated|0|||
161510409|NCT03604692|583260532|FG002|Overall Study|Not Treated|0|||
161510410|NCT03604692|583260533|FG003|Overall Study|Not Treated|0|||
161510411|NCT03604692|583260534|FG004|Overall Study|Not Treated|1|||
161510412|NCT03604692|583260535|FG005|Overall Study|Not Treated|0|||
161510413|NCT00637195|583260536|FG000|Overall Study|Lost to Follow-up|1|||
161510414|NCT00637195|583260537|FG001|Overall Study|Lost to Follow-up|0|||
161587647|NCT02500758|583540689|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
161587648|NCT02500758|583540690|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
161587649|NCT00220740|583540691|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
161587650|NCT00220740|583540692|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
161587651|NCT00220740|583540691|FG000|Efficacy Period|Adverse Event|1|||
161587652|NCT00220740|583540692|FG001|Efficacy Period|Adverse Event|1|||
161587653|NCT00220740|583540691|FG000|Efficacy Period|Withdrawal by Subject|1|||
161510415|NCT00637195|583260536|FG000|Overall Study|Other|2|||
161510416|NCT00637195|583260537|FG001|Overall Study|Other|0|||
161510417|NCT00637195|583260536|FG000|Overall Study|Withdrawal by Subject|0|||
161510418|NCT00637195|583260537|FG001|Overall Study|Withdrawal by Subject|1|||
161510419|NCT01193556|583260542|FG000|Overall Study|Study termination|26|||
161510420|NCT01193556|583260543|FG001|Overall Study|Study termination|25|||
161510421|NCT01696032|583260544|FG000|Overall Study|Withdrawal by Subject|0|||
161587654|NCT00220740|583540692|FG001|Efficacy Period|Withdrawal by Subject|0|||
161676057|NCT03065023|583867293|FG002|Overall Study|Progressive Disease|0|||
161676058|NCT03065023|583867294|FG003|Overall Study|Progressive Disease|0|||
161510422|NCT01696032|583260545|FG001|Overall Study|Withdrawal by Subject|0|||
161510423|NCT01696032|583260546|FG002|Overall Study|Withdrawal by Subject|1|||
161510424|NCT01696032|583260547|FG003|Overall Study|Withdrawal by Subject|2|||
161510425|NCT01696032|583260544|FG000|Overall Study|Death|14|||
161510426|NCT01696032|583260545|FG001|Overall Study|Death|4|||
161510427|NCT01696032|583260546|FG002|Overall Study|Death|43|||
161510428|NCT01696032|583260547|FG003|Overall Study|Death|18|||
161587655|NCT00220740|583540691|FG000|Efficacy Period|Protocol Violation|1|||
161676059|NCT03065023|583867295|FG004|Overall Study|Progressive Disease|0|||
161676060|NCT03065023|583867291|FG000|Overall Study|Death|2|||
161676061|NCT03065023|583867292|FG001|Overall Study|Death|0|||
161676062|NCT03065023|583867293|FG002|Overall Study|Death|1|||
161676063|NCT03065023|583867294|FG003|Overall Study|Death|1|||
161676064|NCT03065023|583867295|FG004|Overall Study|Death|0|||
161676065|NCT03065023|583867291|FG000|Overall Study|Lost to Follow-up|0|||
161676066|NCT03065023|583867292|FG001|Overall Study|Lost to Follow-up|1|||
161676067|NCT03065023|583867293|FG002|Overall Study|Lost to Follow-up|0|||
161676068|NCT03065023|583867294|FG003|Overall Study|Lost to Follow-up|0|||
161676069|NCT03065023|583867295|FG004|Overall Study|Lost to Follow-up|0|||
161676070|NCT03065023|583867291|FG000|Overall Study|Participant Decision|0|||
161676071|NCT03065023|583867292|FG001|Overall Study|Participant Decision|0|||
161676072|NCT03065023|583867293|FG002|Overall Study|Participant Decision|0|||
161676073|NCT03065023|583867294|FG003|Overall Study|Participant Decision|1|||
161676074|NCT03065023|583867295|FG004|Overall Study|Participant Decision|0|||
161676075|NCT03065023|583867291|FG000|Overall Study|Withdrawal by Subject|0|||
161676076|NCT03065023|583867292|FG001|Overall Study|Withdrawal by Subject|0|||
161676077|NCT03065023|583867293|FG002|Overall Study|Withdrawal by Subject|0|||
161676078|NCT03065023|583867294|FG003|Overall Study|Withdrawal by Subject|1|||
161676079|NCT03065023|583867295|FG004|Overall Study|Withdrawal by Subject|0|||
161676080|NCT00705432|583867296|FG000|Treatment Period|Adverse Event|45|||
161676081|NCT00705432|583867297|FG001|Treatment Period|Adverse Event|37|||
161676082|NCT00705432|583867298|FG002|Treatment Period|Adverse Event|51|||
161676083|NCT00705432|583867299|FG003|Treatment Period|Adverse Event|12|||
161676084|NCT00705432|583867300|FG004|Treatment Period|Adverse Event|8|||
161676085|NCT00705432|583867301|FG005|Treatment Period|Adverse Event|9|||
161676086|NCT00705432|583867296|FG000|Treatment Period|Treatment failure|92|||
161676087|NCT00705432|583867297|FG001|Treatment Period|Treatment failure|42|||
161676088|NCT00705432|583867298|FG002|Treatment Period|Treatment failure|33|||
161676089|NCT00705432|583867299|FG003|Treatment Period|Treatment failure|25|||
161676090|NCT00705432|583867300|FG004|Treatment Period|Treatment failure|13|||
161676091|NCT00705432|583867301|FG005|Treatment Period|Treatment failure|14|||
161676092|NCT00705432|583867296|FG000|Treatment Period|Non medical reason|26|||
161676093|NCT00705432|583867297|FG001|Treatment Period|Non medical reason|32|||
161676094|NCT00705432|583867298|FG002|Treatment Period|Non medical reason|37|||
161676095|NCT00705432|583867299|FG003|Treatment Period|Non medical reason|4|||
161676096|NCT00705432|583867300|FG004|Treatment Period|Non medical reason|7|||
161676097|NCT00705432|583867301|FG005|Treatment Period|Non medical reason|7|||
161676098|NCT00705432|583867296|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
161676099|NCT00705432|583867297|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
161676100|NCT00705432|583867298|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
161587656|NCT00220740|583540692|FG001|Efficacy Period|Protocol Violation|0|||
161587657|NCT00220740|583540691|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
161587658|NCT00220740|583540692|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
161587659|NCT01057433|583540693|FG000|Overall Study|Adverse Event|1|||
161587660|NCT04838613|583540696|FG000|Overall Study|Withdrawal by Subject|3|||
161587661|NCT04838613|583540697|FG001|Overall Study|Withdrawal by Subject|6|||
161587662|NCT04838613|583540696|FG000|Overall Study|Protocol Deviation|3|||
161587663|NCT04838613|583540697|FG001|Overall Study|Protocol Deviation|2|||
161587664|NCT04838613|583540696|FG000|Overall Study|Technical Problems|0|||
161587665|NCT04838613|583540697|FG001|Overall Study|Technical Problems|5|||
161587666|NCT04838613|583540696|FG000|Overall Study|Physician Decision|2|||
161587667|NCT04838613|583540697|FG001|Overall Study|Physician Decision|0|||
161587668|NCT04757610|583540698|FG000|Overall Study|Adverse Event|13|||
161676101|NCT00705432|583867299|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161676102|NCT00705432|583867300|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161676103|NCT00705432|583867301|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161676104|NCT00705432|583867296|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
161676105|NCT00705432|583867297|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
161676106|NCT00705432|583867298|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
161676107|NCT00705432|583867299|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
161676108|NCT00705432|583867300|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
161510429|NCT01696032|583260544|FG000|Overall Study|Lost to Follow-up|0|||
161510430|NCT01696032|583260545|FG001|Overall Study|Lost to Follow-up|1|||
161587669|NCT04757610|583540699|FG001|Overall Study|Adverse Event|10|||
161587670|NCT04757610|583540700|FG002|Overall Study|Adverse Event|5|||
161510431|NCT01696032|583260546|FG002|Overall Study|Lost to Follow-up|0|||
161510432|NCT01696032|583260547|FG003|Overall Study|Lost to Follow-up|0|||
161510433|NCT01696032|583260544|FG000|Overall Study|Database lock|0|||
161510434|NCT01696032|583260545|FG001|Overall Study|Database lock|1|||
161510435|NCT01696032|583260546|FG002|Overall Study|Database lock|7|||
161510436|NCT01696032|583260547|FG003|Overall Study|Database lock|2|||
161510437|NCT00376168|583260550|FG000|Overall Study|Adverse Event|1|||
161510438|NCT00376168|583260551|FG001|Overall Study|Adverse Event|1|||
161510439|NCT00376168|583260550|FG000|Overall Study|Pregnancy|1|||
161510440|NCT00376168|583260551|FG001|Overall Study|Pregnancy|0|||
161510441|NCT01020019|583260552|FG000|Overall Study|Lost to Follow-up|21|||
161510442|NCT01020019|583260553|FG001|Overall Study|Lost to Follow-up|18|||
161510443|NCT01020019|583260552|FG000|Overall Study|Adverse Event|1|||
161510444|NCT01020019|583260553|FG001|Overall Study|Adverse Event|5|||
161510445|NCT01020019|583260552|FG000|Overall Study|not interested in treatment|4|||
161510446|NCT01020019|583260553|FG001|Overall Study|not interested in treatment|4|||
161510447|NCT01020019|583260552|FG000|Overall Study|moving|0|||
161510448|NCT01020019|583260553|FG001|Overall Study|moving|2|||
161510449|NCT05091528|583260554|FG000|Overall Study|Study Termination by Sponsor|0|||
161510450|NCT05091528|583260555|FG001|Overall Study|Study Termination by Sponsor|1|||
161510451|NCT05091528|583260556|FG002|Overall Study|Study Termination by Sponsor|0|||
161510452|NCT05091528|583260557|FG003|Overall Study|Study Termination by Sponsor|1|||
161510453|NCT02214121|583260560|FG000|Part A|Patient decision|2|||
161510454|NCT02214121|583260561|FG001|Part A|Patient decision|0|||
161510455|NCT02214121|583260562|FG002|Part A|Patient decision|0|||
161510456|NCT02214121|583260560|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
161510457|NCT02214121|583260561|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
161510458|NCT02214121|583260562|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
161510459|NCT02214121|583260560|FG000|Part A|Other|1|||
161510460|NCT02214121|583260561|FG001|Part A|Other|0|||
161510461|NCT02214121|583260562|FG002|Part A|Other|0|||
161510462|NCT02214121|583260560|FG000|Part B|Patient decision|0|||
161510463|NCT02214121|583260561|FG001|Part B|Patient decision|1|||
161510464|NCT02214121|583260562|FG002|Part B|Patient decision|0|||
161510465|NCT02214121|583260560|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
161510466|NCT02214121|583260561|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
161510467|NCT02214121|583260562|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
161510468|NCT02214121|583260560|FG000|Part B|Lost to Follow-up|0|||
161510469|NCT02214121|583260561|FG001|Part B|Lost to Follow-up|0|||
161510470|NCT02214121|583260562|FG002|Part B|Lost to Follow-up|1|||
161510471|NCT02375672|583260563|FG000|Overall Study|remain on follow up|20|||
161510472|NCT02203591|583260564|FG000|Overall Study|Did not meet treatment day baseline|147|||
161510473|NCT02203591|583260565|FG001|Overall Study|Did not meet treatment day baseline|141|||
161510474|NCT02203591|583260566|FG002|Overall Study|Did not meet treatment day baseline|150|||
161510475|NCT02203591|583260567|FG003|Overall Study|Did not meet treatment day baseline|45|||
161510476|NCT02203591|583260568|FG004|Overall Study|Did not meet treatment day baseline|33|||
161510477|NCT02203591|583260569|FG005|Overall Study|Did not meet treatment day baseline|35|||
161510478|NCT02203591|583260570|FG006|Overall Study|Did not meet treatment day baseline|29|||
161510479|NCT02203591|583260571|FG007|Overall Study|Did not meet treatment day baseline|12|||
161510480|NCT02203591|583260564|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
161510481|NCT02203591|583260565|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
161510482|NCT02203591|583260566|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
161926354|NCT00504309|584777188|FG002|Overall Study|Withdrawal by Subject|1|||
161926355|NCT00504309|584777189|FG003|Overall Study|Withdrawal by Subject|0|||
161926356|NCT00504309|584777190|FG004|Overall Study|Withdrawal by Subject|0|||
161926357|NCT00504309|584777191|FG005|Overall Study|Withdrawal by Subject|0|||
161926358|NCT00983957|584777194|FG000|Overall Study|Adverse Event|1|||
161926359|NCT00983957|584777194|FG000|Overall Study|Personal Reasons|1|||
161926360|NCT00397930|584778594|FG000|Overall Study|Personal reasons|14|||
161926361|NCT00397930|584778595|FG001|Overall Study|Personal reasons|8|||
161926362|NCT00397930|584778594|FG000|Overall Study|Other medical|9|||
161926363|NCT00397930|584778595|FG001|Overall Study|Other medical|4|||
161926364|NCT00397930|584778594|FG000|Overall Study|Unknown reasons|9|||
161926365|NCT00397930|584778595|FG001|Overall Study|Unknown reasons|14|||
161926366|NCT00397930|584778594|FG000|Overall Study|Noncompliant|3|||
161926367|NCT00397930|584778595|FG001|Overall Study|Noncompliant|2|||
161926368|NCT00397930|584778594|FG000|Overall Study|Too time-consuming|2|||
161926369|NCT00397930|584778595|FG001|Overall Study|Too time-consuming|9|||
161926370|NCT00397930|584778594|FG000|Overall Study|Started own yoga program|1|||
161926371|NCT00397930|584778595|FG001|Overall Study|Started own yoga program|1|||
161926372|NCT00397930|584778594|FG000|Overall Study|Did not want to be in control group|0|||
161510483|NCT02203591|583260567|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
161587671|NCT04757610|583540698|FG000|Overall Study|Death|5|||
161587672|NCT04757610|583540699|FG001|Overall Study|Death|13|||
161926373|NCT00397930|584778595|FG001|Overall Study|Did not want to be in control group|1|||
161926374|NCT00397930|584778594|FG000|Overall Study|Withdrawal by Subject|0|||
161926375|NCT00397930|584778595|FG001|Overall Study|Withdrawal by Subject|8|||
161926376|NCT00397930|584778594|FG000|Overall Study|Missing data|0|||
161510484|NCT02203591|583260568|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
161510485|NCT02203591|583260569|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
161510486|NCT02203591|583260570|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
161510487|NCT02203591|583260571|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
161510488|NCT04115358|583260572|FG000|Overall Study|exfoliation|0|||
161510489|NCT04115358|583260573|FG001|Overall Study|exfoliation|0|||
161510490|NCT04115358|583260574|FG002|Overall Study|exfoliation|1|||
161510491|NCT01573624|583260577|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
161510492|NCT01573624|583260578|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
161510493|NCT01573624|583260579|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
161510494|NCT01573624|583260580|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
161510495|NCT01573624|583260581|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
161510496|NCT01573624|583260582|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
161510497|NCT01573624|583260583|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
161510498|NCT01573624|583260577|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
161510499|NCT01573624|583260578|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
161510500|NCT01573624|583260579|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
161510501|NCT01573624|583260580|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
161510502|NCT01573624|583260581|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
161510503|NCT01573624|583260582|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161510504|NCT01573624|583260583|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
161510505|NCT01573624|583260577|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
161510506|NCT01573624|583260578|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
161510507|NCT01573624|583260579|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
161510508|NCT01573624|583260580|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
161510509|NCT01573624|583260581|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
161510510|NCT01573624|583260582|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
161510511|NCT01573624|583260583|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
161510512|NCT01573624|583260577|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161510513|NCT01573624|583260578|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161510514|NCT01573624|583260579|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161510515|NCT01573624|583260580|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161510516|NCT01573624|583260581|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161676109|NCT00705432|583867301|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
161820655|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
161820656|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
161820657|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
161820658|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
161820659|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
161820660|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
161820661|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
161820662|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
161820663|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
161820664|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
161820665|NCT01859598|584384615|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
161820666|NCT00672984|584384616|FG000|First Intervention|Adverse Event|5|||
161820667|NCT00672984|584384617|FG001|First Intervention|Adverse Event|0|||
161820668|NCT00672984|584384618|FG002|First Intervention|Adverse Event|0|||
161820669|NCT00672984|584384616|FG000|First Intervention|Withdrawal by Subject|1|||
161820670|NCT00672984|584384617|FG001|First Intervention|Withdrawal by Subject|2|||
161820671|NCT00672984|584384618|FG002|First Intervention|Withdrawal by Subject|2|||
161820672|NCT00672984|584384616|FG000|First Intervention|Sponsor decision|3|||
161820673|NCT00672984|584384617|FG001|First Intervention|Sponsor decision|0|||
161820674|NCT00672984|584384618|FG002|First Intervention|Sponsor decision|0|||
161820675|NCT00672984|584384616|FG000|Second Intervention|Non-compliance with facility policies|0|||
161820676|NCT00672984|584384617|FG001|Second Intervention|Non-compliance with facility policies|2|||
161820677|NCT00672984|584384618|FG002|Second Intervention|Non-compliance with facility policies|0|||
161820678|NCT00672984|584384616|FG000|Second Intervention|Withdrawal by Subject|0|||
161820679|NCT00672984|584384617|FG001|Second Intervention|Withdrawal by Subject|3|||
161820680|NCT00672984|584384618|FG002|Second Intervention|Withdrawal by Subject|0|||
161820681|NCT00672984|584384616|FG000|Second Intervention|Protocol Violation|0|||
161820682|NCT00672984|584384617|FG001|Second Intervention|Protocol Violation|1|||
161820683|NCT00672984|584384618|FG002|Second Intervention|Protocol Violation|1|||
161820684|NCT00672984|584384616|FG000|Third Intervention|Adverse Event|1|||
161820685|NCT00672984|584384617|FG001|Third Intervention|Adverse Event|0|||
161820686|NCT00672984|584384618|FG002|Third Intervention|Adverse Event|1|||
161820687|NCT00009945|584384619|FG000|Overall Study|no follow up data|7|||
161820688|NCT00009945|584384620|FG001|Overall Study|no follow up data|5|||
161820689|NCT01597791|584384621|FG000|Overall Study|Physician Decision|2|||
161676110|NCT01102803|583867302|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
161676111|NCT01102803|583867303|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
161676112|NCT01102803|583867302|FG000|Post to Follow-Up|Lost to Follow-up|1|||
161510517|NCT01573624|583260582|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
161510518|NCT01573624|583260583|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161510519|NCT01573624|583260577|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
161510520|NCT01573624|583260578|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
161510521|NCT01573624|583260579|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
161510522|NCT01573624|583260580|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
161510523|NCT01573624|583260581|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
161510524|NCT01573624|583260582|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
161510525|NCT01573624|583260583|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
161510526|NCT01573624|583260577|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
161510527|NCT01573624|583260578|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
161510528|NCT01573624|583260579|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
161510529|NCT01573624|583260580|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
161510530|NCT01573624|583260581|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
161510531|NCT01573624|583260582|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
161510532|NCT01573624|583260583|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
161510533|NCT01573624|583260577|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
161510534|NCT01573624|583260578|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
161510535|NCT01573624|583260579|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
161510536|NCT01573624|583260580|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
161510537|NCT01573624|583260581|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
161510538|NCT01573624|583260582|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
161510539|NCT01573624|583260583|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
161510540|NCT01573624|583260577|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
161510541|NCT01573624|583260578|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161510542|NCT01573624|583260579|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
161510543|NCT01573624|583260580|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
161510544|NCT01573624|583260581|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161510545|NCT01573624|583260582|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161510546|NCT01573624|583260583|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
161510547|NCT01573624|583260577|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
161510548|NCT01573624|583260578|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
161510549|NCT01573624|583260579|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
161510550|NCT01573624|583260580|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
161510551|NCT01573624|583260581|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
161510552|NCT01573624|583260582|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
161510553|NCT01573624|583260583|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
161510554|NCT01573624|583260577|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161510555|NCT01573624|583260578|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161676113|NCT01102803|583867303|FG001|Post to Follow-Up|Lost to Follow-up|3|||
161676114|NCT00521053|583867304|FG000|Observation Phase|Disease Progression|55|||
161676115|NCT00521053|583867304|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
161676116|NCT00521053|583867304|FG000|Observation Phase|Death|2|||
161676117|NCT00521053|583867304|FG000|Observation Phase|Adverse Event|1|||
161676118|NCT00521053|583867304|FG000|Observation Phase|Other non-study melanoma treatment|1|||
161676119|NCT00521053|583867304|FG000|Observation Phase|Physician Decision|1|||
161676120|NCT01557348|583867305|FG000|Overall Study|Adverse Event|6|||
161676121|NCT01557348|583867306|FG001|Overall Study|Adverse Event|16|||
161676122|NCT01557348|583867305|FG000|Overall Study|Infusion reaction event|5|||
161676123|NCT01557348|583867306|FG001|Overall Study|Infusion reaction event|5|||
161676124|NCT01557348|583867305|FG000|Overall Study|Death|7|||
161676125|NCT01557348|583867306|FG001|Overall Study|Death|4|||
161676126|NCT01557348|583867305|FG000|Overall Study|Insufficient Therapeutic Response|13|||
161676127|NCT01557348|583867306|FG001|Overall Study|Insufficient Therapeutic Response|28|||
161676128|NCT01557348|583867305|FG000|Overall Study|Withdrawal by Subject|5|||
161676129|NCT01557348|583867306|FG001|Overall Study|Withdrawal by Subject|4|||
161676130|NCT01557348|583867305|FG000|Overall Study|Lost to Follow-up|26|||
161676131|NCT01557348|583867306|FG001|Overall Study|Lost to Follow-up|22|||
161676132|NCT01557348|583867305|FG000|Overall Study|Administrative|18|||
161676133|NCT01557348|583867306|FG001|Overall Study|Administrative|11|||
161676134|NCT01667107|583867307|FG000|Overall Study|Adverse Event|4|||
161676135|NCT01667107|583867308|FG001|Overall Study|Adverse Event|3|||
161926377|NCT00397930|584778595|FG001|Overall Study|Missing data|4|||
161676136|NCT01667107|583867307|FG000|Overall Study|Tolerability issues|0|||
161926378|NCT01158404|584778596|FG000|Overall Study|Withdrawal by Subject|0|||
161926379|NCT01158404|584778597|FG001|Overall Study|Withdrawal by Subject|1|||
161926380|NCT01158404|584778598|FG002|Overall Study|Withdrawal by Subject|0|||
161926381|NCT01158404|584778599|FG003|Overall Study|Withdrawal by Subject|0|||
161926382|NCT01158404|584778600|FG004|Overall Study|Withdrawal by Subject|3|||
161926383|NCT01158404|584778601|FG005|Overall Study|Withdrawal by Subject|1|||
161926384|NCT01158404|584778602|FG006|Overall Study|Withdrawal by Subject|0|||
161926385|NCT01158404|584778603|FG007|Overall Study|Withdrawal by Subject|1|||
161510556|NCT01573624|583260579|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161510557|NCT01573624|583260580|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
161510558|NCT01573624|583260581|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161510559|NCT01573624|583260582|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
161510560|NCT01573624|583260583|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
161510561|NCT01573624|583260577|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510562|NCT01573624|583260578|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510563|NCT01573624|583260579|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510564|NCT01573624|583260580|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510565|NCT01573624|583260581|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510566|NCT01573624|583260582|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510567|NCT01573624|583260583|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510568|NCT01573624|583260577|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
161510569|NCT01573624|583260578|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
161510570|NCT01573624|583260579|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
161510571|NCT01573624|583260580|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
161510572|NCT01573624|583260581|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
161510573|NCT01573624|583260582|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
161510574|NCT01573624|583260583|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
161510575|NCT01573624|583260577|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
161510576|NCT01573624|583260578|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
161510577|NCT01573624|583260579|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
161510578|NCT01573624|583260580|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
161510579|NCT01573624|583260581|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
161926386|NCT01158404|584778596|FG000|Overall Study|Physician Decision|0|||
161926387|NCT01158404|584778597|FG001|Overall Study|Physician Decision|0|||
161926388|NCT01158404|584778598|FG002|Overall Study|Physician Decision|0|||
161926389|NCT01158404|584778599|FG003|Overall Study|Physician Decision|0|||
161926390|NCT01158404|584778600|FG004|Overall Study|Physician Decision|0|||
161926391|NCT01158404|584778601|FG005|Overall Study|Physician Decision|0|||
161926392|NCT01158404|584778602|FG006|Overall Study|Physician Decision|0|||
161926393|NCT01158404|584778603|FG007|Overall Study|Physician Decision|1|||
161926394|NCT01158404|584778596|FG000|Overall Study|Progressive Disease|0|||
161926395|NCT01158404|584778597|FG001|Overall Study|Progressive Disease|0|||
161926396|NCT01158404|584778598|FG002|Overall Study|Progressive Disease|0|||
161926397|NCT01158404|584778599|FG003|Overall Study|Progressive Disease|0|||
161926398|NCT01158404|584778600|FG004|Overall Study|Progressive Disease|0|||
161926399|NCT01158404|584778601|FG005|Overall Study|Progressive Disease|0|||
161926400|NCT01158404|584778602|FG006|Overall Study|Progressive Disease|1|||
161926401|NCT01158404|584778603|FG007|Overall Study|Progressive Disease|0|||
161926402|NCT02056288|584778604|FG000|In-Hospital Data|Surgery cancelled|1|||
161926403|NCT02056288|584778605|FG001|In-Hospital Data|Surgery cancelled|0|||
161926404|NCT02056288|584778604|FG000|In-Hospital Data|Protocol Violation|3|||
161926405|NCT02056288|584778605|FG001|In-Hospital Data|Protocol Violation|0|||
161926406|NCT02056288|584778604|FG000|In-Hospital Data|Physician Decision|1|||
161926407|NCT02056288|584778605|FG001|In-Hospital Data|Physician Decision|0|||
161926408|NCT02056288|584778604|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
161926409|NCT02056288|584778605|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
161926410|NCT02400580|584778608|FG000|Overall Study|Withdrawal by Subject|1|||
161926411|NCT02400580|584778609|FG001|Overall Study|Withdrawal by Subject|1|||
161926412|NCT02400580|584778608|FG000|Overall Study|Adverse Event|1|||
161926413|NCT02400580|584778609|FG001|Overall Study|Adverse Event|0|||
161926414|NCT00965094|584778610|FG000|Overall Study|Adverse Event|5|||
161926415|NCT00965094|584778611|FG001|Overall Study|Adverse Event|0|||
161926416|NCT00965094|584778610|FG000|Overall Study|Lost to Follow-up|0|||
161926417|NCT00965094|584778611|FG001|Overall Study|Lost to Follow-up|1|||
161926418|NCT01060111|584778612|FG000|Overall Study|Adverse Event|9|||
161926419|NCT01060111|584778613|FG001|Overall Study|Adverse Event|5|||
161926420|NCT01060111|584778614|FG002|Overall Study|Adverse Event|18|||
161926421|NCT01060111|584778612|FG000|Overall Study|Lack of Efficacy|2|||
161926422|NCT01060111|584778613|FG001|Overall Study|Lack of Efficacy|1|||
161926423|NCT01060111|584778614|FG002|Overall Study|Lack of Efficacy|0|||
161926424|NCT01060111|584778612|FG000|Overall Study|Inappropriate participant|5|||
161510580|NCT01573624|583260582|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
161510581|NCT01573624|583260583|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
161510582|NCT01573624|583260577|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
161510583|NCT01573624|583260578|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
161510584|NCT01573624|583260579|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
161510585|NCT01573624|583260580|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
161510586|NCT01573624|583260581|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
161510587|NCT01573624|583260582|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
161510588|NCT01573624|583260583|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
161510589|NCT01573624|583260577|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161510590|NCT01573624|583260578|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
161510591|NCT01573624|583260579|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
161510592|NCT01573624|583260580|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161510593|NCT01573624|583260581|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161510594|NCT01573624|583260582|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
161510595|NCT01573624|583260583|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161510596|NCT01573624|583260577|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
161510597|NCT01573624|583260578|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
161510598|NCT01573624|583260579|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
161510599|NCT01573624|583260580|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
161510600|NCT01573624|583260581|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
161510601|NCT01573624|583260582|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
161510602|NCT01573624|583260583|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
161510603|NCT01573624|583260577|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
161510604|NCT01573624|583260578|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
161510605|NCT01573624|583260579|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
161510606|NCT01573624|583260580|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
161510607|NCT01573624|583260581|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
161510608|NCT01573624|583260582|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
161510609|NCT01573624|583260583|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
161510610|NCT01573624|583260577|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
161510611|NCT01573624|583260578|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
161510612|NCT01573624|583260579|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
161510613|NCT01573624|583260580|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
161587673|NCT04757610|583540700|FG002|Overall Study|Death|8|||
161587674|NCT04757610|583540698|FG000|Overall Study|Lack of Efficacy|1|||
161587675|NCT04757610|583540699|FG001|Overall Study|Lack of Efficacy|2|||
161587676|NCT04757610|583540700|FG002|Overall Study|Lack of Efficacy|3|||
161820690|NCT01597791|584384622|FG001|Overall Study|Physician Decision|1|||
161820691|NCT01597791|584384621|FG000|Overall Study|Cesarean Section|6|||
161820692|NCT01597791|584384622|FG001|Overall Study|Cesarean Section|7|||
161820693|NCT01597791|584384621|FG000|Overall Study|Subject withdrawal|0|||
161820694|NCT01597791|584384622|FG001|Overall Study|Subject withdrawal|1|||
161820695|NCT01597791|584384621|FG000|Overall Study|Protocol Violation|0|||
161820696|NCT01597791|584384622|FG001|Overall Study|Protocol Violation|1|||
161820697|NCT00354159|584384623|FG000|Randomized Study Period|Withdrawal by Subject|5|||
161820698|NCT00354159|584384624|FG001|Randomized Study Period|Withdrawal by Subject|3|||
161820699|NCT00354159|584384623|FG000|Randomized Study Period|Physician Decision|6|||
161820700|NCT00354159|584384624|FG001|Randomized Study Period|Physician Decision|10|||
161820701|NCT00354159|584384623|FG000|Randomized Study Period|Lost to Follow-up|4|||
161820702|NCT00354159|584384624|FG001|Randomized Study Period|Lost to Follow-up|0|||
161820703|NCT00354159|584384623|FG000|Randomized Study Period|Death|7|||
161510614|NCT01573624|583260581|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
161510615|NCT01573624|583260582|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
161510616|NCT01573624|583260583|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
161510617|NCT01573624|583260577|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
161510618|NCT01573624|583260578|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
161510619|NCT01573624|583260579|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
161510620|NCT01573624|583260580|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
161510621|NCT01573624|583260581|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
161510622|NCT01573624|583260582|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
161510623|NCT01573624|583260583|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
161510624|NCT01573624|583260577|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
161510625|NCT01573624|583260578|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
161510626|NCT01573624|583260579|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
161510627|NCT01573624|583260580|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
161510628|NCT01573624|583260581|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
161510629|NCT01573624|583260582|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
161510630|NCT01573624|583260583|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
161510631|NCT01573624|583260577|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161510632|NCT01573624|583260578|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161510633|NCT01573624|583260579|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161510634|NCT01573624|583260580|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161510635|NCT01573624|583260581|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
161510636|NCT01573624|583260582|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
161510637|NCT01573624|583260583|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
161510638|NCT01573624|583260577|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510639|NCT01573624|583260578|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510640|NCT01573624|583260579|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510641|NCT01573624|583260580|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510642|NCT01573624|583260581|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510643|NCT01573624|583260582|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
161510644|NCT01573624|583260583|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
161510645|NCT01573624|583260577|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
161510646|NCT01573624|583260578|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161510647|NCT01573624|583260579|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161587677|NCT04757610|583540698|FG000|Overall Study|Lost to Follow-up|7|||
161587678|NCT04757610|583540699|FG001|Overall Study|Lost to Follow-up|2|||
161587679|NCT04757610|583540700|FG002|Overall Study|Lost to Follow-up|7|||
161587680|NCT04757610|583540698|FG000|Overall Study|Physician Decision|4|||
161587681|NCT04757610|583540699|FG001|Overall Study|Physician Decision|1|||
161587682|NCT04757610|583540700|FG002|Overall Study|Physician Decision|2|||
161587683|NCT04757610|583540698|FG000|Overall Study|Withdrawal by Subject|26|||
161587684|NCT04757610|583540699|FG001|Overall Study|Withdrawal by Subject|25|||
161587685|NCT04757610|583540700|FG002|Overall Study|Withdrawal by Subject|25|||
161587686|NCT04757610|583540698|FG000|Overall Study|Study Terminated by Sponsor|105|||
161587687|NCT04757610|583540699|FG001|Overall Study|Study Terminated by Sponsor|105|||
161587688|NCT04757610|583540700|FG002|Overall Study|Study Terminated by Sponsor|110|||
161587689|NCT04757610|583540698|FG000|Overall Study|Randomized in Error|1|||
161587690|NCT04757610|583540699|FG001|Overall Study|Randomized in Error|0|||
161587691|NCT04757610|583540700|FG002|Overall Study|Randomized in Error|0|||
161587692|NCT00951379|583540705|FG000|Overall Study|Adverse Event|4|||
161587693|NCT00951379|583540706|FG001|Overall Study|Adverse Event|1|||
161587694|NCT00951379|583540705|FG000|Overall Study|Withdrawal by Subject|1|||
161587695|NCT00951379|583540706|FG001|Overall Study|Withdrawal by Subject|0|||
161587696|NCT00951379|583540705|FG000|Overall Study|Noncompliance|1|||
161587697|NCT00951379|583540706|FG001|Overall Study|Noncompliance|0|||
161587698|NCT00951379|583540705|FG000|Overall Study|Disease Progression|0|||
161587699|NCT00951379|583540706|FG001|Overall Study|Disease Progression|1|||
161587700|NCT03432858|583540707|FG000|Overall Study|Protocol Violation|2|||
161587701|NCT03432858|583540708|FG001|Overall Study|Protocol Violation|1|||
161587702|NCT03432858|583540709|FG002|Overall Study|Protocol Violation|9|||
161587703|NCT03432858|583540707|FG000|Overall Study|Withdrawal by Subject|0|||
161587704|NCT03432858|583540708|FG001|Overall Study|Withdrawal by Subject|1|||
161587705|NCT03432858|583540709|FG002|Overall Study|Withdrawal by Subject|1|||
161510648|NCT01573624|583260580|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161510649|NCT01573624|583260581|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
161510650|NCT01573624|583260582|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
161510651|NCT01573624|583260583|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
161510652|NCT01573624|583260577|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
161510653|NCT01573624|583260578|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
161510654|NCT01573624|583260579|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
161820704|NCT00354159|584384624|FG001|Randomized Study Period|Death|9|||
161510655|NCT01573624|583260580|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
161510656|NCT01573624|583260581|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
161510657|NCT01573624|583260582|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
161510658|NCT01573624|583260583|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
161510659|NCT01573624|583260577|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
161510660|NCT01573624|583260578|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
161510661|NCT01573624|583260579|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
161510662|NCT01573624|583260580|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
161510663|NCT01573624|583260581|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
161510664|NCT01573624|583260582|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
161510665|NCT01573624|583260583|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
161510666|NCT01573624|583260577|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
161510667|NCT01573624|583260578|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
161510668|NCT01573624|583260579|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
161510669|NCT01573624|583260580|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
161510670|NCT01573624|583260581|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
161510671|NCT01573624|583260582|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
161510672|NCT01573624|583260583|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
161510673|NCT01573624|583260577|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
161510674|NCT01573624|583260578|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
161510675|NCT01573624|583260579|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
161510676|NCT01573624|583260580|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
161510677|NCT01573624|583260581|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
161510678|NCT01573624|583260582|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
161510679|NCT01573624|583260583|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
161510680|NCT01038778|583260584|FG000|Overall Study|Withdrawal by Subject|0|||
161510681|NCT01038778|583260585|FG001|Overall Study|Withdrawal by Subject|2|||
161510682|NCT01038778|583260586|FG002|Overall Study|Withdrawal by Subject|3|||
161510683|NCT02349711|583262139|FG000|Overall Study|Withdrawal by Subject|2|||
161510684|NCT02349711|583262140|FG001|Overall Study|Withdrawal by Subject|1|||
161510685|NCT02349711|583262139|FG000|Overall Study|Lost to Follow-up|1|||
161510686|NCT02349711|583262140|FG001|Overall Study|Lost to Follow-up|1|||
161510687|NCT01610700|583262144|FG000|Overall Study|Adverse Event|3|||
161510688|NCT01610700|583262145|FG001|Overall Study|Adverse Event|1|||
161510689|NCT01610700|583262144|FG000|Overall Study|Withdrawal by Subject|0|||
161510690|NCT01610700|583262145|FG001|Overall Study|Withdrawal by Subject|1|||
161510691|NCT01610700|583262144|FG000|Overall Study|subject took one dose of street cannabis|0|||
161510692|NCT01610700|583262145|FG001|Overall Study|subject took one dose of street cannabis|1|||
161510693|NCT02143414|583262147|FG000|Induction|Adverse Event|1|||
161510694|NCT02143414|583262148|FG001|Induction|Adverse Event|2|||
161510695|NCT02143414|583262147|FG000|Induction|Death|1|||
161510696|NCT02143414|583262148|FG001|Induction|Death|2|||
161510697|NCT02143414|583262147|FG000|Induction|Patient refusal|1|||
161510698|NCT02143414|583262148|FG001|Induction|Patient refusal|1|||
161510699|NCT02143414|583262147|FG000|Induction|Refractory|1|||
161510700|NCT02143414|583262148|FG001|Induction|Refractory|0|||
161510701|NCT02143414|583262147|FG000|Induction|Began alternative treatment|1|||
161510702|NCT02143414|583262148|FG001|Induction|Began alternative treatment|0|||
161510703|NCT02143414|583262147|FG000|Induction|Ineligible for postremission|5|||
161510704|NCT02143414|583262148|FG001|Induction|Ineligible for postremission|1|||
161510705|NCT02143414|583262147|FG000|Post-remission|Adverse Event|0|||
161510706|NCT02143414|583262148|FG001|Post-remission|Adverse Event|2|||
161510707|NCT02143414|583262147|FG000|Post-remission|Disease progression/relapse|5|||
161510708|NCT02143414|583262148|FG001|Post-remission|Disease progression/relapse|0|||
161510709|NCT02143414|583262147|FG000|Maintenance|Adverse Event|4|||
161510710|NCT02143414|583262148|FG001|Maintenance|Adverse Event|6|||
161510711|NCT02143414|583262147|FG000|Maintenance|Disease progression/relapse|3|||
161510712|NCT02143414|583262148|FG001|Maintenance|Disease progression/relapse|2|||
161510713|NCT02143414|583262147|FG000|Maintenance|Patient refusal|2|||
161510714|NCT02143414|583262148|FG001|Maintenance|Patient refusal|1|||
161510715|NCT02143414|583262147|FG000|Maintenance|Physician Decision|1|||
161510716|NCT02143414|583262148|FG001|Maintenance|Physician Decision|0|||
161510717|NCT02143414|583262147|FG000|Maintenance|Death|0|||
161510718|NCT02143414|583262148|FG001|Maintenance|Death|1|||
161510719|NCT02143414|583262147|FG000|Maintenance|On protocol treatment|0|||
161510720|NCT02143414|583262148|FG001|Maintenance|On protocol treatment|6|||
161510721|NCT00978731|583262152|FG000|Overall Study|Death|4|||
161510722|NCT00978731|583262153|FG001|Overall Study|Death|1|||
161510723|NCT00978731|583262154|FG002|Overall Study|Death|1|||
161510724|NCT00978731|583262155|FG003|Overall Study|Death|0|||
161510725|NCT00978731|583262152|FG000|Overall Study|Lost to Follow-up|0|||
161510726|NCT00978731|583262153|FG001|Overall Study|Lost to Follow-up|0|||
161510727|NCT00978731|583262154|FG002|Overall Study|Lost to Follow-up|0|||
161510728|NCT00978731|583262155|FG003|Overall Study|Lost to Follow-up|1|||
161510729|NCT00978731|583262152|FG000|Overall Study|Adverse Event|5|||
161510730|NCT00978731|583262153|FG001|Overall Study|Adverse Event|2|||
161510731|NCT00978731|583262154|FG002|Overall Study|Adverse Event|0|||
161510732|NCT00978731|583262155|FG003|Overall Study|Adverse Event|0|||
161510733|NCT00978731|583262152|FG000|Overall Study|Participant's request|1|||
161510734|NCT00978731|583262153|FG001|Overall Study|Participant's request|0|||
161510735|NCT00978731|583262154|FG002|Overall Study|Participant's request|0|||
161510736|NCT00978731|583262155|FG003|Overall Study|Participant's request|0|||
161510737|NCT00978731|583262152|FG000|Overall Study|Administrative reason|3|||
161510738|NCT00978731|583262153|FG001|Overall Study|Administrative reason|3|||
161510739|NCT00978731|583262154|FG002|Overall Study|Administrative reason|1|||
161510740|NCT00978731|583262155|FG003|Overall Study|Administrative reason|0|||
161510741|NCT00978731|583262152|FG000|Overall Study|Deterioration without progression|0|||
161510742|NCT00978731|583262153|FG001|Overall Study|Deterioration without progression|1|||
161510743|NCT00978731|583262154|FG002|Overall Study|Deterioration without progression|0|||
161510744|NCT00978731|583262155|FG003|Overall Study|Deterioration without progression|0|||
161510745|NCT00978731|583262152|FG000|Overall Study|Disease progression/relapse|5|||
161510746|NCT00978731|583262153|FG001|Overall Study|Disease progression/relapse|4|||
161510747|NCT00978731|583262154|FG002|Overall Study|Disease progression/relapse|2|||
161510748|NCT00978731|583262155|FG003|Overall Study|Disease progression/relapse|2|||
161510749|NCT00978731|583262152|FG000|Overall Study|Study closure|3|||
161510750|NCT00978731|583262153|FG001|Overall Study|Study closure|4|||
161510751|NCT00978731|583262154|FG002|Overall Study|Study closure|1|||
161510752|NCT00978731|583262155|FG003|Overall Study|Study closure|1|||
161510753|NCT00978731|583262152|FG000|Overall Study|No response|1|||
161510754|NCT00978731|583262153|FG001|Overall Study|No response|0|||
161510755|NCT00978731|583262154|FG002|Overall Study|No response|0|||
161510756|NCT00978731|583262155|FG003|Overall Study|No response|0|||
161510757|NCT03306264|583262160|FG000|Overall Study|Death|33|||
161510758|NCT03306264|583262161|FG001|Overall Study|Death|25|||
161510759|NCT03306264|583262162|FG002|Overall Study|Death|34|||
161510760|NCT03306264|583262163|FG003|Overall Study|Death|34|||
161510761|NCT03306264|583262160|FG000|Overall Study|Complete Consent Withdrawal|4|||
161510762|NCT03306264|583262161|FG001|Overall Study|Complete Consent Withdrawal|4|||
161510763|NCT03306264|583262162|FG002|Overall Study|Complete Consent Withdrawal|1|||
161510764|NCT03306264|583262163|FG003|Overall Study|Complete Consent Withdrawal|8|||
161510765|NCT03306264|583262160|FG000|Overall Study|Lost to Follow-up|1|||
161510766|NCT03306264|583262161|FG001|Overall Study|Lost to Follow-up|0|||
161510767|NCT03306264|583262162|FG002|Overall Study|Lost to Follow-up|1|||
161510768|NCT03306264|583262163|FG003|Overall Study|Lost to Follow-up|0|||
161510769|NCT03306264|583262160|FG000|Overall Study|Rollover to ASTX727-06|10|||
161510770|NCT03306264|583262161|FG001|Overall Study|Rollover to ASTX727-06|18|||
161510771|NCT03306264|583262162|FG002|Overall Study|Rollover to ASTX727-06|4|||
161510772|NCT03306264|583262163|FG003|Overall Study|Rollover to ASTX727-06|2|||
161510773|NCT03306264|583262160|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
161510774|NCT03306264|583262161|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
161510775|NCT03306264|583262162|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
161510776|NCT03306264|583262163|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
161510777|NCT02722928|583262167|FG000|Overall Study|Standard CT was not as required per prot|5|||
161510778|NCT02722928|583262168|FG001|Overall Study|Standard CT was not as required per prot|13|||
161510779|NCT02722928|583262167|FG000|Overall Study|Required Intraoperative MRI|5|||
161510780|NCT02722928|583262168|FG001|Overall Study|Required Intraoperative MRI|7|||
161510781|NCT00094653|583262171|FG000|Overall Study|Death|306|||
161510782|NCT00094653|583262172|FG001|Overall Study|Death|100|||
161510783|NCT00094653|583262173|FG002|Overall Study|Death|119|||
161510784|NCT00094653|583262171|FG000|Overall Study|Subject Withdrew Consent|10|||
161510785|NCT00094653|583262172|FG001|Overall Study|Subject Withdrew Consent|2|||
161510786|NCT00094653|583262173|FG002|Overall Study|Subject Withdrew Consent|3|||
161510787|NCT00094653|583262171|FG000|Overall Study|Other|2|||
161587706|NCT03432858|583540707|FG000|Overall Study|Procedure canceled/rescheduled|0|||
161510788|NCT00094653|583262172|FG001|Overall Study|Other|2|||
161510789|NCT00094653|583262173|FG002|Overall Study|Other|2|||
161587707|NCT03432858|583540708|FG001|Overall Study|Procedure canceled/rescheduled|9|||
161926425|NCT01060111|584778613|FG001|Overall Study|Inappropriate participant|4|||
161926426|NCT01060111|584778614|FG002|Overall Study|Inappropriate participant|5|||
161926427|NCT01060111|584778612|FG000|Overall Study|Participants' evasion for hospital visit|0|||
161926428|NCT01060111|584778613|FG001|Overall Study|Participants' evasion for hospital visit|3|||
161926429|NCT01060111|584778614|FG002|Overall Study|Participants' evasion for hospital visit|2|||
161926430|NCT01060111|584778612|FG000|Overall Study|Participants' non-cooperation|8|||
161926431|NCT01060111|584778613|FG001|Overall Study|Participants' non-cooperation|6|||
161926432|NCT01060111|584778614|FG002|Overall Study|Participants' non-cooperation|6|||
161926433|NCT01060111|584778612|FG000|Overall Study|Adverse event and insufficient effect|0|||
161926434|NCT01060111|584778613|FG001|Overall Study|Adverse event and insufficient effect|1|||
161926435|NCT01060111|584778614|FG002|Overall Study|Adverse event and insufficient effect|0|||
161926436|NCT01060111|584778612|FG000|Overall Study|Participants' non-cooperation|1|||
161926437|NCT01060111|584778613|FG001|Overall Study|Participants' non-cooperation|0|||
161926438|NCT01060111|584778614|FG002|Overall Study|Participants' non-cooperation|0|||
161926439|NCT01060111|584778612|FG000|Overall Study|Other|2|||
161510790|NCT00094653|583262171|FG000|Overall Study|Lost to Follow-up|3|||
161510791|NCT00094653|583262172|FG001|Overall Study|Lost to Follow-up|2|||
161510792|NCT00094653|583262173|FG002|Overall Study|Lost to Follow-up|1|||
161510793|NCT00094653|583262171|FG000|Overall Study|Protocol Violation|0|||
161510794|NCT00094653|583262172|FG001|Overall Study|Protocol Violation|0|||
161510795|NCT00094653|583262173|FG002|Overall Study|Protocol Violation|1|||
161926440|NCT01060111|584778613|FG001|Overall Study|Other|3|||
161926441|NCT01060111|584778614|FG002|Overall Study|Other|4|||
161510796|NCT03921411|583262174|FG000|Overall Study|Withdrawal by Subject|1|||
161510797|NCT03921411|583262174|FG000|Overall Study|Protocol Deviation|2|||
161510798|NCT03921411|583262174|FG000|Overall Study|Enrolled, but never treated|2|||
161510799|NCT02114879|583262175|FG000|Overall Study|Withdrawal by Subject|9|||
161510800|NCT02114879|583262176|FG001|Overall Study|Withdrawal by Subject|5|||
161510801|NCT02114879|583262175|FG000|Overall Study|Death|6|||
161510802|NCT02114879|583262176|FG001|Overall Study|Death|11|||
161510803|NCT02114879|583262175|FG000|Overall Study|Lost to Follow-up|4|||
161510804|NCT02114879|583262176|FG001|Overall Study|Lost to Follow-up|6|||
161510805|NCT02114879|583262175|FG000|Overall Study|Physician Decision|0|||
161510806|NCT02114879|583262176|FG001|Overall Study|Physician Decision|2|||
161510807|NCT03120013|583262180|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161510808|NCT03120013|583262181|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161510809|NCT05059600|583262182|FG000|Overall Study|Enrolled but not Treated|10|||
161510810|NCT02152995|583262183|FG000|Overall Study|Withdrawal by Subject|1|||
161510811|NCT02152995|583262184|FG001|Overall Study|Withdrawal by Subject|0|||
161510812|NCT02098109|583262185|FG000|Overall Study|Protocol Violation|3|||
161510813|NCT02098109|583262186|FG001|Overall Study|Protocol Violation|0|||
161510814|NCT01565291|583262188|FG000|Overall Study|Withdrawal by Subject|1|||
161510815|NCT01565291|583262189|FG001|Overall Study|Withdrawal by Subject|0|||
161510816|NCT04552587|583262195|FG000|Overall Study|Lost to Follow-up|4|||
161510817|NCT01822132|583262196|FG000|Overall Study|Lost to Follow-up|4|||
161510818|NCT01822132|583262197|FG001|Overall Study|Lost to Follow-up|2|||
161510819|NCT00313612|583262198|FG000|Overall Study|Patient never received treatment|0|||
161510820|NCT00313612|583262199|FG001|Overall Study|Patient never received treatment|1|||
161510821|NCT04847674|583262200|FG000|Overall Study|Withdrawal by Subject|0|||
161510822|NCT04847674|583262201|FG001|Overall Study|Withdrawal by Subject|1|||
161510823|NCT04847674|583262202|FG002|Overall Study|Withdrawal by Subject|0|||
161510824|NCT04847674|583262200|FG000|Overall Study|Lost to Follow-up|0|||
161510825|NCT04847674|583262201|FG001|Overall Study|Lost to Follow-up|0|||
161510826|NCT04847674|583262202|FG002|Overall Study|Lost to Follow-up|2|||
161510827|NCT04847674|583262200|FG000|Overall Study|Other than specified|21|||
161510828|NCT04847674|583262201|FG001|Overall Study|Other than specified|20|||
161510829|NCT04847674|583262202|FG002|Overall Study|Other than specified|20|||
161510830|NCT00677807|583262205|FG000|Overall Study|Adverse Event|4|||
161510831|NCT00677807|583262206|FG001|Overall Study|Adverse Event|1|||
161510832|NCT00677807|583262207|FG002|Overall Study|Adverse Event|6|||
161510833|NCT00677807|583262205|FG000|Overall Study|Lack of Efficacy|0|||
161510834|NCT00677807|583262206|FG001|Overall Study|Lack of Efficacy|0|||
161510835|NCT00677807|583262207|FG002|Overall Study|Lack of Efficacy|2|||
161510836|NCT00677807|583262205|FG000|Overall Study|Participant no longer needs study drug|0|||
161926442|NCT01433978|584778615|FG000|Core Study|Adverse Event, Non-Fatal|0|||
161926443|NCT01433978|584778616|FG001|Core Study|Adverse Event, Non-Fatal|1|||
161926444|NCT01433978|584778617|FG002|Core Study|Adverse Event, Non-Fatal|0|||
161510837|NCT00677807|583262206|FG001|Overall Study|Participant no longer needs study drug|0|||
161926445|NCT01433978|584778615|FG000|Core Study|Lack of Efficacy|5|||
161510838|NCT00677807|583262207|FG002|Overall Study|Participant no longer needs study drug|1|||
161510839|NCT00677807|583262205|FG000|Overall Study|Withdrawal by Subject|10|||
161510840|NCT00677807|583262206|FG001|Overall Study|Withdrawal by Subject|3|||
161510841|NCT00677807|583262207|FG002|Overall Study|Withdrawal by Subject|6|||
161510842|NCT00677807|583262205|FG000|Overall Study|Lost to Follow-up|2|||
161510843|NCT00677807|583262206|FG001|Overall Study|Lost to Follow-up|2|||
161510844|NCT00677807|583262207|FG002|Overall Study|Lost to Follow-up|2|||
161510845|NCT00677807|583262205|FG000|Overall Study|Administrative problems|1|||
161510846|NCT00677807|583262206|FG001|Overall Study|Administrative problems|1|||
161510847|NCT00677807|583262207|FG002|Overall Study|Administrative problems|2|||
161510848|NCT00677807|583262205|FG000|Overall Study|Death|0|||
161510849|NCT00677807|583262206|FG001|Overall Study|Death|1|||
161510850|NCT00677807|583262207|FG002|Overall Study|Death|1|||
161510851|NCT00677807|583262205|FG000|Overall Study|Protocol Deviation|1|||
161510852|NCT00677807|583262206|FG001|Overall Study|Protocol Deviation|3|||
161510853|NCT00677807|583262207|FG002|Overall Study|Protocol Deviation|0|||
161510854|NCT01393743|583262208|FG000|Core Study|Adverse Event|5|||
161510855|NCT01393743|583262209|FG001|Core Study|Adverse Event|9|||
161510856|NCT01393743|583262210|FG002|Core Study|Adverse Event|0|||
161510857|NCT01393743|583262208|FG000|Core Study|Lost to Follow-up|1|||
161510858|NCT01393743|583262209|FG001|Core Study|Lost to Follow-up|1|||
161510859|NCT01393743|583262210|FG002|Core Study|Lost to Follow-up|0|||
161510860|NCT01393743|583262208|FG000|Core Study|Participant's Choice|2|||
161510861|NCT01393743|583262209|FG001|Core Study|Participant's Choice|3|||
161510862|NCT01393743|583262210|FG002|Core Study|Participant's Choice|0|||
161510863|NCT01393743|583262208|FG000|Core Study|Inadequate therapeutic effect|2|||
161510864|NCT01393743|583262209|FG001|Core Study|Inadequate therapeutic effect|0|||
161510865|NCT01393743|583262210|FG002|Core Study|Inadequate therapeutic effect|0|||
161510866|NCT01393743|583262208|FG000|Extension Phase|Adverse Event|0|||
161510867|NCT01393743|583262209|FG001|Extension Phase|Adverse Event|0|||
161510868|NCT01393743|583262210|FG002|Extension Phase|Adverse Event|12|||
161510869|NCT01393743|583262208|FG000|Extension Phase|Lost to Follow-up|0|||
161510870|NCT01393743|583262209|FG001|Extension Phase|Lost to Follow-up|0|||
161510871|NCT01393743|583262210|FG002|Extension Phase|Lost to Follow-up|2|||
161510872|NCT01393743|583262208|FG000|Extension Phase|Participant choice|0|||
161510873|NCT01393743|583262209|FG001|Extension Phase|Participant choice|0|||
161510874|NCT01393743|583262210|FG002|Extension Phase|Participant choice|16|||
161510875|NCT01393743|583262208|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161510876|NCT01393743|583262209|FG001|Extension Phase|Inadequate therapeutic effect|0|||
161510877|NCT01393743|583262210|FG002|Extension Phase|Inadequate therapeutic effect|7|||
161510878|NCT01393743|583262208|FG000|Extension Phase|Withdrawal by Subject|0|||
161510879|NCT01393743|583262209|FG001|Extension Phase|Withdrawal by Subject|0|||
161587708|NCT03432858|583540709|FG002|Overall Study|Procedure canceled/rescheduled|6|||
161587709|NCT03432858|583540707|FG000|Overall Study|Required postop mobilization with splinting|0|||
161587710|NCT03432858|583540708|FG001|Overall Study|Required postop mobilization with splinting|0|||
161926446|NCT01433978|584778616|FG001|Core Study|Lack of Efficacy|1|||
161926447|NCT01433978|584778617|FG002|Core Study|Lack of Efficacy|0|||
161926448|NCT01433978|584778615|FG000|Core Study|Study Terminated by Sponsor|6|||
161926449|NCT01433978|584778616|FG001|Core Study|Study Terminated by Sponsor|9|||
161926450|NCT01433978|584778617|FG002|Core Study|Study Terminated by Sponsor|0|||
161926451|NCT01433978|584778615|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
161926452|NCT01433978|584778616|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
161926453|NCT01433978|584778617|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
161926454|NCT01433978|584778615|FG000|Extension Phase|Lack of Efficacy|0|||
161926455|NCT01433978|584778616|FG001|Extension Phase|Lack of Efficacy|0|||
161926456|NCT01433978|584778617|FG002|Extension Phase|Lack of Efficacy|1|||
161926457|NCT01433978|584778615|FG000|Extension Phase|Study Terminated by Sponsor|0|||
161926458|NCT01433978|584778616|FG001|Extension Phase|Study Terminated by Sponsor|0|||
161926459|NCT01433978|584778617|FG002|Extension Phase|Study Terminated by Sponsor|4|||
161926460|NCT01773889|584778619|FG000|Overall Study|lack of funding|2|||
161926461|NCT04233580|584778620|FG000|Overall Study|Adverse Event|3|||
161510880|NCT01393743|583262210|FG002|Extension Phase|Withdrawal by Subject|8|||
161510881|NCT01393743|583262208|FG000|Extension Phase|Pregnancy|0|||
161510882|NCT01393743|583262209|FG001|Extension Phase|Pregnancy|0|||
161510883|NCT01393743|583262210|FG002|Extension Phase|Pregnancy|1|||
161510884|NCT01393743|583262208|FG000|Extension Phase|Other|0|||
161510885|NCT01393743|583262209|FG001|Extension Phase|Other|0|||
161510886|NCT01393743|583262210|FG002|Extension Phase|Other|14|||
161510887|NCT01524770|583262216|FG000|First Intervention|Withdrawal by Subject|1|||
161510888|NCT01524770|583262217|FG001|First Intervention|Withdrawal by Subject|0|||
161510889|NCT01524770|583262216|FG000|First Intervention|Adverse Event|1|||
161510890|NCT01524770|583262217|FG001|First Intervention|Adverse Event|1|||
161510891|NCT01524770|583262216|FG000|First Intervention|Protocol Violation|1|||
161510892|NCT01524770|583262217|FG001|First Intervention|Protocol Violation|0|||
161510893|NCT00989833|583262218|FG000|Overall Study|Lost to Follow-up|0|||
161510894|NCT00989833|583262219|FG001|Overall Study|Lost to Follow-up|1|||
161510895|NCT00989833|583262220|FG002|Overall Study|Lost to Follow-up|0|||
161510896|NCT00989833|583262218|FG000|Overall Study|Protocol Violation|1|||
161510897|NCT00989833|583262219|FG001|Overall Study|Protocol Violation|2|||
161510898|NCT00989833|583262220|FG002|Overall Study|Protocol Violation|1|||
161510899|NCT00989833|583262218|FG000|Overall Study|Withdrawal by Subject|0|||
161510900|NCT00989833|583262219|FG001|Overall Study|Withdrawal by Subject|0|||
161510901|NCT00989833|583262220|FG002|Overall Study|Withdrawal by Subject|1|||
161510902|NCT00989833|583262218|FG000|Overall Study|Incorrectly randomized|1|||
161926462|NCT04233580|584778621|FG001|Overall Study|Adverse Event|3|||
161926463|NCT04233580|584778620|FG000|Overall Study|Withdrawal by Subject|2|||
161926464|NCT04233580|584778621|FG001|Overall Study|Withdrawal by Subject|1|||
161926465|NCT03954938|584778622|FG000|Overall Study|Withdrawal by Subject|2|||
161926466|NCT03954938|584778622|FG000|Overall Study|Adverse Event|1|||
161926467|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
161926468|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
161926469|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
161926470|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
161926471|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
161926472|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
161926473|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
161926474|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
161926475|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
161926476|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
161926477|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
161926478|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
161926479|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
161926480|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
161926481|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
161926482|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
161926483|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
161926484|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
161926485|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161926486|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
161926487|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
161926488|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
161926489|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
161926490|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
161926491|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
161926492|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
161926493|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
161926494|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161926495|NCT00617903|584778625|FG000|Overall Study|Withdrawal by Subject|2|||
161926496|NCT00617903|584778626|FG001|Overall Study|Withdrawal by Subject|3|||
161926497|NCT00617903|584778625|FG000|Overall Study|Lost to Follow-up|1|||
161926498|NCT00617903|584778626|FG001|Overall Study|Lost to Follow-up|1|||
161926499|NCT00617903|584778625|FG000|Overall Study|Lack of Efficacy|0|||
161926500|NCT00617903|584778626|FG001|Overall Study|Lack of Efficacy|1|||
161926501|NCT00617903|584778625|FG000|Overall Study|Adverse Event|0|||
161926502|NCT00617903|584778626|FG001|Overall Study|Adverse Event|1|||
161926503|NCT00617903|584778625|FG000|Overall Study|noncompliance|0|||
161926504|NCT00617903|584778626|FG001|Overall Study|noncompliance|1|||
161926505|NCT01371565|584778627|FG000|Overall Study|Withdrawal by Subject|1|||
161926506|NCT01371565|584778627|FG000|Overall Study|Death|1|||
161926507|NCT01371565|584778627|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
161926508|NCT02565186|584778628|FG000|Overall Study|Adverse Event|113|||
161926509|NCT02565186|584778629|FG001|Overall Study|Adverse Event|148|||
161926510|NCT02565186|584778628|FG000|Overall Study|Lost to Follow-up|102|||
161926511|NCT02565186|584778629|FG001|Overall Study|Lost to Follow-up|93|||
161926512|NCT02565186|584778628|FG000|Overall Study|Non-Compliance|57|||
161510903|NCT00989833|583262219|FG001|Overall Study|Incorrectly randomized|0|||
161510904|NCT00989833|583262220|FG002|Overall Study|Incorrectly randomized|0|||
161510905|NCT01420081|583262222|FG000|Overall Study|Death|1|||
161510906|NCT01420081|583262223|FG001|Overall Study|Death|0|||
161926513|NCT02565186|584778629|FG001|Overall Study|Non-Compliance|55|||
161510907|NCT01420081|583262224|FG002|Overall Study|Death|8|||
161510908|NCT01420081|583262225|FG003|Overall Study|Death|0|||
161510909|NCT01420081|583262226|FG004|Overall Study|Death|7|||
161510910|NCT01420081|583262227|FG005|Overall Study|Death|12|||
161510911|NCT01420081|583262228|FG006|Overall Study|Death|0|||
161587711|NCT03432858|583540709|FG002|Overall Study|Required postop mobilization with splinting|1|||
161926514|NCT02565186|584778628|FG000|Overall Study|Withdrawal by Subject|229|||
161926515|NCT02565186|584778629|FG001|Overall Study|Withdrawal by Subject|214|||
161926516|NCT02565186|584778628|FG000|Overall Study|Physician Decision|18|||
161926517|NCT02565186|584778629|FG001|Overall Study|Physician Decision|16|||
161926518|NCT02565186|584778628|FG000|Overall Study|Sponsor Request|5|||
161926519|NCT02565186|584778629|FG001|Overall Study|Sponsor Request|9|||
161926520|NCT02565186|584778628|FG000|Overall Study|Missing|1|||
161926521|NCT02565186|584778629|FG001|Overall Study|Missing|0|||
161926522|NCT02565186|584778628|FG000|Overall Study|Did Not Receive Study Drug|55|||
161510912|NCT01420081|583262229|FG007|Overall Study|Death|1|||
161510913|NCT01420081|583262230|FG008|Overall Study|Death|1|||
161510914|NCT01420081|583262222|FG000|Overall Study|Lost to Follow-up|0|||
161510915|NCT01420081|583262223|FG001|Overall Study|Lost to Follow-up|0|||
161510916|NCT01420081|583262224|FG002|Overall Study|Lost to Follow-up|0|||
161510917|NCT01420081|583262225|FG003|Overall Study|Lost to Follow-up|0|||
161510918|NCT01420081|583262226|FG004|Overall Study|Lost to Follow-up|1|||
161510919|NCT01420081|583262227|FG005|Overall Study|Lost to Follow-up|1|||
161510920|NCT01420081|583262228|FG006|Overall Study|Lost to Follow-up|0|||
161510921|NCT01420081|583262229|FG007|Overall Study|Lost to Follow-up|0|||
161510922|NCT01420081|583262230|FG008|Overall Study|Lost to Follow-up|0|||
161510923|NCT01420081|583262222|FG000|Overall Study|Study Terminated by Sponsor|2|||
161510924|NCT01420081|583262223|FG001|Overall Study|Study Terminated by Sponsor|1|||
161510925|NCT01420081|583262224|FG002|Overall Study|Study Terminated by Sponsor|1|||
161510926|NCT01420081|583262225|FG003|Overall Study|Study Terminated by Sponsor|3|||
161510927|NCT01420081|583262226|FG004|Overall Study|Study Terminated by Sponsor|11|||
161510928|NCT01420081|583262227|FG005|Overall Study|Study Terminated by Sponsor|7|||
161510929|NCT01420081|583262228|FG006|Overall Study|Study Terminated by Sponsor|3|||
161510930|NCT01420081|583262229|FG007|Overall Study|Study Terminated by Sponsor|2|||
161510931|NCT01420081|583262230|FG008|Overall Study|Study Terminated by Sponsor|2|||
161510932|NCT01420081|583262222|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
161510933|NCT01420081|583262223|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
161510934|NCT01420081|583262224|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
161510935|NCT01420081|583262225|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
161510936|NCT01420081|583262226|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
161510937|NCT01420081|583262227|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
161510938|NCT01420081|583262228|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
161510939|NCT01420081|583262229|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
161510940|NCT01420081|583262230|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
161510941|NCT01420081|583262222|FG000|Overall Study|Other Reasons|0|||
161510942|NCT01420081|583262223|FG001|Overall Study|Other Reasons|0|||
161510943|NCT01420081|583262224|FG002|Overall Study|Other Reasons|1|||
161510944|NCT01420081|583262225|FG003|Overall Study|Other Reasons|0|||
161510945|NCT01420081|583262226|FG004|Overall Study|Other Reasons|0|||
161510946|NCT01420081|583262227|FG005|Overall Study|Other Reasons|0|||
161510947|NCT01420081|583262228|FG006|Overall Study|Other Reasons|0|||
161510948|NCT01420081|583262229|FG007|Overall Study|Other Reasons|0|||
161510949|NCT01420081|583262230|FG008|Overall Study|Other Reasons|0|||
161510950|NCT00678561|583262232|FG000|Overall Study|Adverse Event|0|||
161510951|NCT00678561|583262233|FG001|Overall Study|Adverse Event|1|||
161510952|NCT00678561|583262234|FG002|Overall Study|Adverse Event|1|||
161510953|NCT00678561|583262235|FG003|Overall Study|Adverse Event|0|||
161510954|NCT00678561|583262236|FG004|Overall Study|Adverse Event|1|||
161510955|NCT00678561|583262237|FG005|Overall Study|Adverse Event|0|||
161510956|NCT00678561|583262238|FG006|Overall Study|Adverse Event|0|||
161510957|NCT00678561|583262239|FG007|Overall Study|Adverse Event|0|||
161510958|NCT00678561|583262232|FG000|Overall Study|Protocol Violation|0|||
161510959|NCT00678561|583262233|FG001|Overall Study|Protocol Violation|0|||
161510960|NCT00678561|583262234|FG002|Overall Study|Protocol Violation|0|||
161510961|NCT00678561|583262235|FG003|Overall Study|Protocol Violation|0|||
161510962|NCT00678561|583262236|FG004|Overall Study|Protocol Violation|1|||
161926523|NCT02565186|584778629|FG001|Overall Study|Did Not Receive Study Drug|86|||
161926524|NCT04676646|584778630|FG000|Open-label Run-in Phase|Adverse Event|3|||
161926525|NCT04676646|584778631|FG001|Open-label Run-in Phase|Adverse Event|0|||
161926526|NCT04676646|584778632|FG002|Open-label Run-in Phase|Adverse Event|0|||
161926527|NCT04676646|584778630|FG000|Open-label Run-in Phase|Death|3|||
161676137|NCT01667107|583867308|FG001|Overall Study|Tolerability issues|2|||
161926528|NCT04676646|584778631|FG001|Open-label Run-in Phase|Death|0|||
161926529|NCT04676646|584778632|FG002|Open-label Run-in Phase|Death|0|||
161510963|NCT00678561|583262237|FG005|Overall Study|Protocol Violation|1|||
161510964|NCT00678561|583262238|FG006|Overall Study|Protocol Violation|0|||
161510965|NCT00678561|583262239|FG007|Overall Study|Protocol Violation|0|||
161510966|NCT00678561|583262232|FG000|Overall Study|Withdrawal by Subject|0|||
161510967|NCT00678561|583262233|FG001|Overall Study|Withdrawal by Subject|0|||
161510968|NCT00678561|583262234|FG002|Overall Study|Withdrawal by Subject|0|||
161510969|NCT00678561|583262235|FG003|Overall Study|Withdrawal by Subject|0|||
161510970|NCT00678561|583262236|FG004|Overall Study|Withdrawal by Subject|0|||
161510971|NCT00678561|583262237|FG005|Overall Study|Withdrawal by Subject|0|||
161510972|NCT00678561|583262238|FG006|Overall Study|Withdrawal by Subject|0|||
161510973|NCT00678561|583262239|FG007|Overall Study|Withdrawal by Subject|1|||
161510974|NCT03080961|583262240|FG000|Overall Study|Withdrawal by Subject|3|||
161510975|NCT00689481|583262241|FG000|Overall Study|Adverse Event|7|||
161510976|NCT00689481|583262242|FG001|Overall Study|Adverse Event|1|||
161510977|NCT00689481|583262241|FG000|Overall Study|Lost to Follow-up|4|||
161510978|NCT00689481|583262242|FG001|Overall Study|Lost to Follow-up|3|||
161510979|NCT00689481|583262241|FG000|Overall Study|Lack of Efficacy|4|||
161510980|NCT00689481|583262242|FG001|Overall Study|Lack of Efficacy|3|||
161510981|NCT00689481|583262241|FG000|Overall Study|Non-compliance with study treatment|1|||
161510982|NCT00689481|583262242|FG001|Overall Study|Non-compliance with study treatment|1|||
161510983|NCT00689481|583262241|FG000|Overall Study|Withdrawal by Subject|8|||
161510984|NCT00689481|583262242|FG001|Overall Study|Withdrawal by Subject|4|||
161510985|NCT00689481|583262241|FG000|Overall Study|Excluded medication started during study|0|||
161510986|NCT00689481|583262242|FG001|Overall Study|Excluded medication started during study|1|||
161510987|NCT00689481|583262241|FG000|Overall Study|Subject early term, left on vacation|0|||
161510988|NCT00689481|583262242|FG001|Overall Study|Subject early term, left on vacation|1|||
161510989|NCT03337724|583262245|FG000|Overall Study|Reason not Specified|12|||
161510990|NCT03337724|583262246|FG001|Overall Study|Reason not Specified|21|||
161510991|NCT03337724|583262247|FG002|Overall Study|Reason not Specified|9|||
161510992|NCT03337724|583262248|FG003|Overall Study|Reason not Specified|9|||
161510993|NCT03337724|583262249|FG004|Overall Study|Reason not Specified|29|||
161510994|NCT03337724|583262245|FG000|Overall Study|Withdrawal by Subject|13|||
161510995|NCT03337724|583262246|FG001|Overall Study|Withdrawal by Subject|15|||
161510996|NCT03337724|583262247|FG002|Overall Study|Withdrawal by Subject|4|||
161510997|NCT03337724|583262248|FG003|Overall Study|Withdrawal by Subject|15|||
161510998|NCT03337724|583262249|FG004|Overall Study|Withdrawal by Subject|6|||
161510999|NCT03337724|583262245|FG000|Overall Study|Protocol Deviation|0|||
161511000|NCT03337724|583262246|FG001|Overall Study|Protocol Deviation|1|||
161511001|NCT03337724|583262247|FG002|Overall Study|Protocol Deviation|1|||
161511002|NCT03337724|583262248|FG003|Overall Study|Protocol Deviation|1|||
161511003|NCT03337724|583262249|FG004|Overall Study|Protocol Deviation|0|||
161511004|NCT03337724|583262245|FG000|Overall Study|Adverse Event|1|||
161511005|NCT03337724|583262246|FG001|Overall Study|Adverse Event|1|||
161511006|NCT03337724|583262247|FG002|Overall Study|Adverse Event|0|||
161511007|NCT03337724|583262248|FG003|Overall Study|Adverse Event|1|||
161511008|NCT03337724|583262249|FG004|Overall Study|Adverse Event|0|||
161511009|NCT03337724|583262245|FG000|Overall Study|Death|40|||
161511010|NCT03337724|583262246|FG001|Overall Study|Death|89|||
161511011|NCT03337724|583262247|FG002|Overall Study|Death|43|||
161511012|NCT03337724|583262248|FG003|Overall Study|Death|76|||
161511013|NCT03337724|583262249|FG004|Overall Study|Death|50|||
161511014|NCT03337724|583262245|FG000|Overall Study|Lost to Follow-up|5|||
161511015|NCT03337724|583262246|FG001|Overall Study|Lost to Follow-up|5|||
161511016|NCT03337724|583262247|FG002|Overall Study|Lost to Follow-up|4|||
161511017|NCT03337724|583262248|FG003|Overall Study|Lost to Follow-up|7|||
161511018|NCT03337724|583262249|FG004|Overall Study|Lost to Follow-up|4|||
161511019|NCT03337724|583262245|FG000|Overall Study|Physician Decision|16|||
161511020|NCT03337724|583262246|FG001|Overall Study|Physician Decision|34|||
161511021|NCT03337724|583262247|FG002|Overall Study|Physician Decision|14|||
161511022|NCT03337724|583262248|FG003|Overall Study|Physician Decision|34|||
161511023|NCT03337724|583262249|FG004|Overall Study|Physician Decision|13|||
161511024|NCT03337724|583262245|FG000|Overall Study|Progressive Disease|0|||
161511025|NCT03337724|583262246|FG001|Overall Study|Progressive Disease|2|||
161511026|NCT03337724|583262247|FG002|Overall Study|Progressive Disease|1|||
161820705|NCT00354159|584384623|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
161511027|NCT03337724|583262248|FG003|Overall Study|Progressive Disease|2|||
161511028|NCT03337724|583262249|FG004|Overall Study|Progressive Disease|0|||
161511029|NCT03337724|583262245|FG000|Overall Study|Symptomatic Deterioration|0|||
161511030|NCT03337724|583262246|FG001|Overall Study|Symptomatic Deterioration|0|||
161511031|NCT03337724|583262247|FG002|Overall Study|Symptomatic Deterioration|0|||
161511032|NCT03337724|583262248|FG003|Overall Study|Symptomatic Deterioration|1|||
161511033|NCT03337724|583262249|FG004|Overall Study|Symptomatic Deterioration|0|||
161511034|NCT00528528|583262250|FG000|Overall Study|Lost to Follow-up|0|||
161511035|NCT00528528|583262251|FG001|Overall Study|Lost to Follow-up|0|||
161511036|NCT00528528|583262252|FG002|Overall Study|Lost to Follow-up|1|||
161820706|NCT00354159|584384624|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
161820707|NCT00354159|584384623|FG000|Long-term Follow-up|Physician Decision|127|||
161820708|NCT00354159|584384624|FG001|Long-term Follow-up|Physician Decision|122|||
161511037|NCT00528528|583262253|FG003|Overall Study|Lost to Follow-up|1|||
161511038|NCT00528528|583262250|FG000|Overall Study|Ineligible to continue the trial|0|||
161511039|NCT00528528|583262251|FG001|Overall Study|Ineligible to continue the trial|0|||
161511040|NCT00528528|583262252|FG002|Overall Study|Ineligible to continue the trial|0|||
161820709|NCT00354159|584384623|FG000|Long-term Follow-up|Lost to Follow-up|1|||
161511041|NCT00528528|583262253|FG003|Overall Study|Ineligible to continue the trial|1|||
161511042|NCT00528528|583262250|FG000|Overall Study|Other|0|||
161511043|NCT00528528|583262251|FG001|Overall Study|Other|1|||
161511044|NCT00528528|583262252|FG002|Overall Study|Other|0|||
161511045|NCT00528528|583262253|FG003|Overall Study|Other|0|||
161511046|NCT00528528|583262250|FG000|Overall Study|Withdrawal by Subject|3|||
161511047|NCT00528528|583262251|FG001|Overall Study|Withdrawal by Subject|2|||
161511048|NCT00528528|583262252|FG002|Overall Study|Withdrawal by Subject|1|||
161820710|NCT00354159|584384624|FG001|Long-term Follow-up|Lost to Follow-up|0|||
161511049|NCT00528528|583262253|FG003|Overall Study|Withdrawal by Subject|1|||
161511050|NCT00528528|583262250|FG000|Overall Study|Ongoing participant|0|||
161511051|NCT00528528|583262251|FG001|Overall Study|Ongoing participant|0|||
161511052|NCT00528528|583262252|FG002|Overall Study|Ongoing participant|1|||
161511053|NCT00528528|583262253|FG003|Overall Study|Ongoing participant|0|||
161511054|NCT00773097|583262254|FG000|Overall Study|Withdrawal by Subject|1|||
161511055|NCT00773097|583262254|FG000|Overall Study|Physician Decision|6|||
161511056|NCT04602624|583262261|FG000|Overall Study|Protocol Deviation|1|||
161511057|NCT04602624|583262261|FG000|Overall Study|Withdrawal by Participant|1|||
161511058|NCT04084769|583262262|FG000|Overall Study|Protocol Violation|1|||
161511059|NCT04084769|583262263|FG001|Overall Study|Protocol Violation|3|||
161511060|NCT04084769|583262264|FG002|Overall Study|Protocol Violation|0|||
161511061|NCT04084769|583262265|FG003|Overall Study|Protocol Violation|1|||
161511062|NCT04084769|583262262|FG000|Overall Study|Withdrawal by Subject|0|||
161511063|NCT04084769|583262263|FG001|Overall Study|Withdrawal by Subject|1|||
161511064|NCT04084769|583262264|FG002|Overall Study|Withdrawal by Subject|0|||
161511065|NCT04084769|583262265|FG003|Overall Study|Withdrawal by Subject|0|||
161511066|NCT04084769|583262262|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161511067|NCT04084769|583262263|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161511068|NCT04084769|583262264|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161511069|NCT04084769|583262265|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161511070|NCT04084769|583262262|FG000|Overall Study|Lost to Follow-up|2|||
161511071|NCT04084769|583262263|FG001|Overall Study|Lost to Follow-up|0|||
161511072|NCT04084769|583262264|FG002|Overall Study|Lost to Follow-up|0|||
161511073|NCT04084769|583262265|FG003|Overall Study|Lost to Follow-up|0|||
161511074|NCT03508219|583262266|FG000|Overall Study|Death|2|||
161511075|NCT03508219|583262266|FG000|Overall Study|Withdrawal by Subject|1|||
161511076|NCT03508219|583262266|FG000|Overall Study|Lost to Follow-up|4|||
161511077|NCT03508219|583262266|FG000|Overall Study|Missed visit|2|||
161511078|NCT04466891|583262267|FG000|Overall Study|Death|60|||
161511079|NCT04466891|583262268|FG001|Overall Study|Death|6|||
161511080|NCT04466891|583262267|FG000|Overall Study|Withdrawal by Subject|8|||
161511081|NCT04466891|583262268|FG001|Overall Study|Withdrawal by Subject|1|||
161511082|NCT04466891|583262267|FG000|Overall Study|Study terminated by sponsor|5|||
161511083|NCT04466891|583262268|FG001|Overall Study|Study terminated by sponsor|0|||
161511084|NCT04466891|583262267|FG000|Overall Study|Lost to Follow-up|2|||
161587712|NCT03690206|583540715|FG000|Overall Study|Withdrawal by Subject|2|||
161587713|NCT03690206|583540716|FG001|Overall Study|Withdrawal by Subject|0|||
161587714|NCT03690206|583540717|FG002|Overall Study|Withdrawal by Subject|0|||
161587715|NCT03690206|583540715|FG000|Overall Study|ICF withdrawal|2|||
161587716|NCT03690206|583540716|FG001|Overall Study|ICF withdrawal|0|||
161587717|NCT03690206|583540717|FG002|Overall Study|ICF withdrawal|0|||
161587718|NCT03978637|583540719|FG000|Overall Study|Death|0|||
161587719|NCT03978637|583540720|FG001|Overall Study|Death|2|||
161587720|NCT03978637|583540721|FG002|Overall Study|Death|2|||
161587721|NCT03978637|583540722|FG003|Overall Study|Death|0|||
161587722|NCT03978637|583540719|FG000|Overall Study|Withdrawal by Subject|0|||
161587723|NCT03978637|583540720|FG001|Overall Study|Withdrawal by Subject|0|||
161587724|NCT03978637|583540721|FG002|Overall Study|Withdrawal by Subject|1|||
161587725|NCT03978637|583540722|FG003|Overall Study|Withdrawal by Subject|0|||
161587726|NCT03978637|583540719|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
161926530|NCT04676646|584778630|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
161926531|NCT04676646|584778631|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
161926532|NCT04676646|584778632|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
161926533|NCT04676646|584778630|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
161926534|NCT04676646|584778631|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
161926535|NCT04676646|584778632|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
161926536|NCT04676646|584778630|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
161926537|NCT04676646|584778631|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
161926538|NCT04676646|584778632|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
161926539|NCT04676646|584778630|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
161926540|NCT04676646|584778631|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
161926541|NCT04676646|584778632|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
161926542|NCT04676646|584778630|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
161926543|NCT04676646|584778631|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
161926544|NCT04676646|584778632|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
161926545|NCT04676646|584778630|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
161926546|NCT04676646|584778631|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
161926547|NCT04676646|584778632|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
161926548|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
161926549|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
161511085|NCT04466891|583262268|FG001|Overall Study|Lost to Follow-up|0|||
161511086|NCT04466891|583262267|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
161511087|NCT04466891|583262268|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
161511088|NCT00445328|583262269|FG000|Overall Study|Death|0|||
161511089|NCT00445328|583262270|FG001|Overall Study|Death|1|||
161511090|NCT00445328|583262269|FG000|Overall Study|Adverse Event|0|||
161511091|NCT00445328|583262270|FG001|Overall Study|Adverse Event|3|||
161511092|NCT00445328|583262269|FG000|Overall Study|Other|0|||
161511093|NCT00445328|583262270|FG001|Overall Study|Other|2|||
161926550|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
161926551|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Death|0|||
161926552|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Death|1|||
161926553|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Death|2|||
161926554|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
161926555|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
161926556|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
161926557|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
161926558|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
161926559|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
161926560|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
161926561|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
161926562|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
161926563|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
161926564|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
161926565|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
161926566|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
161926567|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
161926568|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
161926569|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
161926570|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
161926571|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
161926572|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
161926573|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
161926574|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
161926575|NCT04270760|584778633|FG000|Overall Study|Withdrawal by Subject|0|||
161926576|NCT04270760|584778634|FG001|Overall Study|Withdrawal by Subject|1|||
161926577|NCT04270760|584778635|FG002|Overall Study|Withdrawal by Subject|3|||
161926578|NCT04270760|584778636|FG003|Overall Study|Withdrawal by Subject|0|||
161926579|NCT04270760|584778637|FG004|Overall Study|Withdrawal by Subject|0|||
161926580|NCT04270760|584778633|FG000|Overall Study|Lost to Follow-up|1|||
161926581|NCT04270760|584778634|FG001|Overall Study|Lost to Follow-up|2|||
161926582|NCT04270760|584778635|FG002|Overall Study|Lost to Follow-up|1|||
161926583|NCT04270760|584778636|FG003|Overall Study|Lost to Follow-up|0|||
161926584|NCT04270760|584778637|FG004|Overall Study|Lost to Follow-up|0|||
161926585|NCT04270760|584778633|FG000|Overall Study|Death|0|||
161926586|NCT04270760|584778634|FG001|Overall Study|Death|0|||
161926587|NCT04270760|584778635|FG002|Overall Study|Death|0|||
161926588|NCT04270760|584778636|FG003|Overall Study|Death|0|||
161926589|NCT04270760|584778637|FG004|Overall Study|Death|1|||
161926590|NCT05156125|584778638|FG000|Overall Study|Lack of Efficacy|1|||
161926591|NCT05156125|584778639|FG001|Overall Study|Lack of Efficacy|1|||
161511094|NCT00445328|583262269|FG000|Overall Study|Withdrawal by Subject|2|||
161511095|NCT00445328|583262270|FG001|Overall Study|Withdrawal by Subject|0|||
161926592|NCT05156125|584778640|FG002|Overall Study|Lack of Efficacy|1|||
161926593|NCT05156125|584778638|FG000|Overall Study|Physician Decision|0|||
161926594|NCT05156125|584778639|FG001|Overall Study|Physician Decision|0|||
161926595|NCT05156125|584778640|FG002|Overall Study|Physician Decision|1|||
161926596|NCT05156125|584778638|FG000|Overall Study|Non-compliance|0|||
161926597|NCT05156125|584778639|FG001|Overall Study|Non-compliance|1|||
161926598|NCT05156125|584778640|FG002|Overall Study|Non-compliance|1|||
161926599|NCT05156125|584778638|FG000|Overall Study|Withdrawal by Subject|0|||
161926600|NCT05156125|584778639|FG001|Overall Study|Withdrawal by Subject|0|||
161926601|NCT05156125|584778640|FG002|Overall Study|Withdrawal by Subject|1|||
161926602|NCT05156125|584778638|FG000|Overall Study|Adverse Event|2|||
161926603|NCT05156125|584778639|FG001|Overall Study|Adverse Event|1|||
161926604|NCT05156125|584778640|FG002|Overall Study|Adverse Event|0|||
161926605|NCT03670628|584778641|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
161926606|NCT03670628|584778642|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
161926607|NCT03670628|584778641|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
161926608|NCT03670628|584778642|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
161926609|NCT00997126|584778646|FG000|Overall Study|Physician Decision|7|||
161511096|NCT00445328|583262269|FG000|Overall Study|Protocol Violation|1|||
161511097|NCT00445328|583262270|FG001|Overall Study|Protocol Violation|0|||
161926610|NCT00997126|584778647|FG001|Overall Study|Physician Decision|11|||
161926611|NCT01755637|584778648|FG000|Period 1|Adverse Event|0|||
161926612|NCT01755637|584778649|FG001|Period 1|Adverse Event|1|||
161926613|NCT02287025|584778650|FG000|Overall Study|Not treated|2|||
161926614|NCT02287025|584778651|FG001|Overall Study|Not treated|0|||
161926615|NCT02287025|584778650|FG000|Overall Study|Progression of disease|3|||
161926616|NCT02287025|584778651|FG001|Overall Study|Progression of disease|2|||
161926617|NCT02287025|584778650|FG000|Overall Study|Adverse Event|2|||
161926618|NCT02287025|584778651|FG001|Overall Study|Adverse Event|4|||
161926619|NCT02287025|584778650|FG000|Overall Study|Withdrawal by Subject|2|||
161926620|NCT02287025|584778651|FG001|Overall Study|Withdrawal by Subject|2|||
161926621|NCT02287025|584778650|FG000|Overall Study|Screening failed|1|||
161926622|NCT02287025|584778651|FG001|Overall Study|Screening failed|1|||
161926623|NCT00899847|584778652|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
161926624|NCT03338023|584778653|FG000|Overall Study|Withdrawal by Subject|3|||
161926625|NCT03338023|584778654|FG001|Overall Study|Withdrawal by Subject|4|||
161926626|NCT03338023|584778653|FG000|Overall Study|Protocol Violation|3|||
161926627|NCT03338023|584778654|FG001|Overall Study|Protocol Violation|3|||
161926628|NCT03338023|584778653|FG000|Overall Study|Lost to Follow-up|2|||
161926629|NCT03338023|584778654|FG001|Overall Study|Lost to Follow-up|1|||
161926630|NCT03338023|584778653|FG000|Overall Study|Physician Decision|1|||
161926631|NCT03338023|584778654|FG001|Overall Study|Physician Decision|2|||
161926632|NCT04996264|584778655|FG000|Overall Study|Lost to Follow-up|0|||
161926633|NCT04996264|584778656|FG001|Overall Study|Lost to Follow-up|1|||
161926634|NCT04996264|584778655|FG000|Overall Study|Withdrawal by Subject|4|||
161926635|NCT04996264|584778656|FG001|Overall Study|Withdrawal by Subject|3|||
161926636|NCT04996264|584778655|FG000|Overall Study|1 left AMA|0|||
161926637|NCT04996264|584778656|FG001|Overall Study|1 left AMA|1|||
161926638|NCT04996264|584778655|FG000|Overall Study|Subject changed hospitals|0|||
161926639|NCT04996264|584778656|FG001|Overall Study|Subject changed hospitals|1|||
161926640|NCT04996264|584778655|FG000|Overall Study|unable to complete due to work|0|||
161926641|NCT04996264|584778656|FG001|Overall Study|unable to complete due to work|1|||
161926642|NCT00685698|584778657|FG000|Overall Study|Withdrawal by Subject|1|||
161926643|NCT00685698|584778657|FG000|Overall Study|Protocol Violation|6|||
161926644|NCT00685698|584778657|FG000|Overall Study|Adverse Event|3|||
161926645|NCT00685698|584778657|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
161926646|NCT00685698|584778657|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
161926647|NCT00685698|584778657|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
161926648|NCT02030418|584778658|FG000|Overall Study|Death|78|||
161926649|NCT02030418|584778658|FG000|Overall Study|Missed 12-Month Visit|9|||
161926650|NCT02030418|584778658|FG000|Overall Study|Withdrawn|57|||
161926651|NCT03412890|584778659|FG000|Overall Study|Adverse Event|5|||
161926652|NCT03412890|584778660|FG001|Overall Study|Adverse Event|5|||
161926653|NCT03412890|584778661|FG002|Overall Study|Adverse Event|9|||
161926654|NCT03412890|584778659|FG000|Overall Study|Protocol deviation|2|||
161926655|NCT03412890|584778660|FG001|Overall Study|Protocol deviation|1|||
161926656|NCT03412890|584778661|FG002|Overall Study|Protocol deviation|2|||
161511098|NCT00316199|583262273|FG000|Overall Study|Adverse Event|2|||
161511099|NCT00316199|583262273|FG000|Overall Study|Death|8|||
161511100|NCT00316199|583262273|FG000|Overall Study|Lost to Follow-up|2|||
161511101|NCT04477304|583262274|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
161926657|NCT03412890|584778659|FG000|Overall Study|Lost to Follow-up|7|||
161926658|NCT03412890|584778660|FG001|Overall Study|Lost to Follow-up|10|||
161511102|NCT04477304|583262275|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
161926659|NCT03412890|584778661|FG002|Overall Study|Lost to Follow-up|10|||
161926660|NCT03412890|584778659|FG000|Overall Study|Withdrawal by Subject|9|||
161926661|NCT03412890|584778660|FG001|Overall Study|Withdrawal by Subject|12|||
161926662|NCT03412890|584778661|FG002|Overall Study|Withdrawal by Subject|11|||
161926663|NCT03412890|584778659|FG000|Overall Study|Lack of Efficacy|2|||
161926664|NCT03412890|584778660|FG001|Overall Study|Lack of Efficacy|7|||
161926665|NCT03412890|584778661|FG002|Overall Study|Lack of Efficacy|5|||
161926666|NCT03412890|584778659|FG000|Overall Study|Other|5|||
161926667|NCT03412890|584778660|FG001|Overall Study|Other|6|||
161926668|NCT03412890|584778661|FG002|Overall Study|Other|5|||
161926669|NCT03412890|584778659|FG000|Overall Study|Participants who did not receive any study drug|0|||
161926670|NCT03412890|584778660|FG001|Overall Study|Participants who did not receive any study drug|1|||
161926671|NCT03412890|584778661|FG002|Overall Study|Participants who did not receive any study drug|0|||
161926672|NCT00887588|584778665|FG000|Core Period|Death|1|||
161926673|NCT00887588|584778666|FG001|Core Period|Death|1|||
161926674|NCT00887588|584778665|FG000|Core Period|Lost to Follow-up|3|||
161926675|NCT00887588|584778666|FG001|Core Period|Lost to Follow-up|1|||
161926676|NCT00887588|584778665|FG000|Core Period|Withdrawal by Subject|6|||
161926677|NCT00887588|584778666|FG001|Core Period|Withdrawal by Subject|8|||
161926678|NCT00887588|584778665|FG000|Core Period|Adverse Event|9|||
161926679|NCT00887588|584778666|FG001|Core Period|Adverse Event|11|||
161926680|NCT00887588|584778665|FG000|Extension Period|Adverse Event|4|||
161511103|NCT05645432|583262276|FG000|Overall Study|Withdrawal by Subject|1|||
161511104|NCT03107988|583263288|FG000|Overall Study|Adverse Event|0|||
161511105|NCT03107988|583263289|FG001|Overall Study|Adverse Event|0|||
161511106|NCT03107988|583263290|FG002|Overall Study|Adverse Event|0|||
161511107|NCT03107988|583263291|FG003|Overall Study|Adverse Event|1|||
161511108|NCT03107988|583263292|FG004|Overall Study|Adverse Event|0|||
161511109|NCT03107988|583263293|FG005|Overall Study|Adverse Event|1|||
161511110|NCT03107988|583263294|FG006|Overall Study|Adverse Event|0|||
161511111|NCT03107988|583263295|FG007|Overall Study|Adverse Event|1|||
161511112|NCT03107988|583263296|FG008|Overall Study|Adverse Event|0|||
161511113|NCT03107988|583263297|FG009|Overall Study|Adverse Event|0|||
161511114|NCT03107988|583263298|FG010|Overall Study|Adverse Event|0|||
161511115|NCT03107988|583263299|FG011|Overall Study|Adverse Event|0|||
161511116|NCT03107988|583263300|FG012|Overall Study|Adverse Event|0|||
161511117|NCT03107988|583263288|FG000|Overall Study|Disease Progression or Relapse|1|||
161511118|NCT03107988|583263289|FG001|Overall Study|Disease Progression or Relapse|2|||
161511119|NCT03107988|583263290|FG002|Overall Study|Disease Progression or Relapse|2|||
161511120|NCT03107988|583263291|FG003|Overall Study|Disease Progression or Relapse|5|||
161511121|NCT03107988|583263292|FG004|Overall Study|Disease Progression or Relapse|1|||
161511122|NCT03107988|583263293|FG005|Overall Study|Disease Progression or Relapse|1|||
161511123|NCT03107988|583263294|FG006|Overall Study|Disease Progression or Relapse|0|||
161511124|NCT03107988|583263295|FG007|Overall Study|Disease Progression or Relapse|0|||
161511125|NCT03107988|583263296|FG008|Overall Study|Disease Progression or Relapse|0|||
161511126|NCT03107988|583263297|FG009|Overall Study|Disease Progression or Relapse|1|||
161511127|NCT03107988|583263298|FG010|Overall Study|Disease Progression or Relapse|4|||
161511128|NCT03107988|583263299|FG011|Overall Study|Disease Progression or Relapse|0|||
161511129|NCT03107988|583263300|FG012|Overall Study|Disease Progression or Relapse|0|||
161511130|NCT03107988|583263288|FG000|Overall Study|Ineligible|0|||
161511131|NCT03107988|583263289|FG001|Overall Study|Ineligible|0|||
161511132|NCT03107988|583263290|FG002|Overall Study|Ineligible|0|||
161511133|NCT03107988|583263291|FG003|Overall Study|Ineligible|0|||
161511134|NCT03107988|583263292|FG004|Overall Study|Ineligible|0|||
161511135|NCT03107988|583263293|FG005|Overall Study|Ineligible|0|||
161511136|NCT03107988|583263294|FG006|Overall Study|Ineligible|0|||
161511137|NCT03107988|583263295|FG007|Overall Study|Ineligible|0|||
161511138|NCT03107988|583263296|FG008|Overall Study|Ineligible|1|||
161511139|NCT03107988|583263297|FG009|Overall Study|Ineligible|0|||
161511140|NCT03107988|583263298|FG010|Overall Study|Ineligible|0|||
161511141|NCT03107988|583263299|FG011|Overall Study|Ineligible|0|||
161511142|NCT03107988|583263300|FG012|Overall Study|Ineligible|0|||
161511143|NCT01344057|583263301|FG000|Overall Study|Premature Withdrawal|1|||
161511144|NCT00548808|583263302|FG000|Overall Study|Lost to Follow-up|9|||
161511145|NCT00548808|583263303|FG001|Overall Study|Lost to Follow-up|3|||
161511146|NCT00548808|583263302|FG000|Overall Study|Protocol Violation|8|||
161511147|NCT00548808|583263303|FG001|Overall Study|Protocol Violation|8|||
161511148|NCT00548808|583263302|FG000|Overall Study|Withdrawal by Subject|8|||
161511149|NCT00548808|583263303|FG001|Overall Study|Withdrawal by Subject|4|||
161511150|NCT00548808|583263302|FG000|Overall Study|Physician Decision|6|||
161511151|NCT00548808|583263303|FG001|Overall Study|Physician Decision|3|||
161511152|NCT00548808|583263302|FG000|Overall Study|Adverse Event|4|||
161511153|NCT00548808|583263303|FG001|Overall Study|Adverse Event|5|||
161511154|NCT00548808|583263302|FG000|Overall Study|Death|2|||
161511155|NCT00548808|583263303|FG001|Overall Study|Death|0|||
161511156|NCT00548808|583263302|FG000|Overall Study|Entry Criteria Not Met|2|||
161820711|NCT00354159|584384623|FG000|Long-term Follow-up|Death|14|||
161820712|NCT00354159|584384624|FG001|Long-term Follow-up|Death|11|||
161820713|NCT00354159|584384623|FG000|Long-term Follow-up|Study Closed|29|||
161820714|NCT00354159|584384624|FG001|Long-term Follow-up|Study Closed|34|||
161511157|NCT00548808|583263303|FG001|Overall Study|Entry Criteria Not Met|2|||
161511158|NCT00548808|583263302|FG000|Overall Study|Lack of Efficacy|2|||
161511159|NCT00548808|583263303|FG001|Overall Study|Lack of Efficacy|0|||
161511160|NCT00548808|583263302|FG000|Overall Study|Sponsor Decision|1|||
161511161|NCT00548808|583263303|FG001|Overall Study|Sponsor Decision|1|||
161511162|NCT00529386|583263304|FG000|Overall Study|Lost to Follow-up|1|||
161511163|NCT03592641|583263305|FG000|Overall Study|Withdrawal by Subject|1|||
161511164|NCT04027686|583263306|FG000|Overall Study|Lost to Follow-up|2|||
161511165|NCT04027686|583263307|FG001|Overall Study|Lost to Follow-up|0|||
161511166|NCT04027686|583263306|FG000|Overall Study|Withdrawal by Subject|0|||
161511167|NCT04027686|583263307|FG001|Overall Study|Withdrawal by Subject|1|||
161511168|NCT02939404|583263308|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
161511169|NCT02939404|583263309|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
161511170|NCT02939404|583263308|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
161511171|NCT02939404|583263309|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
161511172|NCT04456699|583263315|FG000|Overall Study|Death|48|||
161511173|NCT04456699|583263316|FG001|Overall Study|Death|50|||
161511174|NCT04456699|583263317|FG002|Overall Study|Death|52|||
161511175|NCT04456699|583263315|FG000|Overall Study|Physician Decision|0|||
161511176|NCT04456699|583263316|FG001|Overall Study|Physician Decision|0|||
161511177|NCT04456699|583263317|FG002|Overall Study|Physician Decision|2|||
161511178|NCT04456699|583263315|FG000|Overall Study|Sponsor Decision|55|||
161511179|NCT04456699|583263316|FG001|Overall Study|Sponsor Decision|61|||
161511180|NCT04456699|583263317|FG002|Overall Study|Sponsor Decision|50|||
161511181|NCT04456699|583263315|FG000|Overall Study|Withdrawal by Subject|8|||
161511182|NCT04456699|583263316|FG001|Overall Study|Withdrawal by Subject|4|||
161511183|NCT04456699|583263317|FG002|Overall Study|Withdrawal by Subject|5|||
161511184|NCT02075437|583263322|FG000|Overall Study|Withdrawal by Subject|5|||
161511185|NCT02075437|583263322|FG000|Overall Study|Lost to Follow-up|1|||
161511186|NCT01541826|583263325|FG000|Overall Study|Lost to Follow-up|2|||
161511187|NCT01541826|583263326|FG001|Overall Study|Lost to Follow-up|3|||
161511188|NCT01541826|583263327|FG002|Overall Study|Lost to Follow-up|0|||
161511189|NCT01541826|583263325|FG000|Overall Study|Withdrawal by Subject|2|||
161511190|NCT01541826|583263326|FG001|Overall Study|Withdrawal by Subject|0|||
161511191|NCT01541826|583263327|FG002|Overall Study|Withdrawal by Subject|0|||
161511192|NCT00480779|583263330|FG000|Overall Study|Other|2|||
161511193|NCT00480779|583263331|FG001|Overall Study|Other|0|||
161511194|NCT00480779|583263330|FG000|Overall Study|Job and Health-related|0|||
161511195|NCT00480779|583263331|FG001|Overall Study|Job and Health-related|3|||
161511196|NCT01365273|583263332|FG000|Overall Study|Lost to Follow-up|1|||
161511197|NCT01365273|583263333|FG001|Overall Study|Lost to Follow-up|0|||
161511198|NCT01365273|583263332|FG000|Overall Study|Protocol Violation|0|||
161511199|NCT01365273|583263333|FG001|Overall Study|Protocol Violation|1|||
161511200|NCT01365273|583263332|FG000|Overall Study|Physician Decision|1|||
161511201|NCT01365273|583263333|FG001|Overall Study|Physician Decision|0|||
161511202|NCT00854581|583263338|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
161511203|NCT00854581|583263338|FG000|Induction (Up to Day 21)|Death|1|||
161511204|NCT00854581|583263338|FG000|Induction (Up to Day 21)|Physician Decision|1|||
161511205|NCT00854581|583263338|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
161511206|NCT02705820|583263341|FG000|Overall Study|Death|2|||
161511207|NCT02705820|583263341|FG000|Overall Study|Disease Progression|34|||
161511208|NCT02705820|583263341|FG000|Overall Study|Clinical Deterioration|3|||
161511209|NCT02702401|583263342|FG000|Overall Study|Death|242|||
161511210|NCT02702401|583263343|FG001|Overall Study|Death|125|||
161511211|NCT02702401|583263342|FG000|Overall Study|Withdrawal by Subject|15|||
161511212|NCT02702401|583263343|FG001|Overall Study|Withdrawal by Subject|5|||
161511213|NCT02702401|583263342|FG000|Overall Study|Sponsor Decision|19|||
161511214|NCT02702401|583263343|FG001|Overall Study|Sponsor Decision|3|||
161511215|NCT02702401|583263342|FG000|Overall Study|Physician Decision|1|||
161511216|NCT02702401|583263343|FG001|Overall Study|Physician Decision|2|||
161511217|NCT02702401|583263342|FG000|Overall Study|Lost to Follow-up|1|||
161511218|NCT02702401|583263343|FG001|Overall Study|Lost to Follow-up|0|||
161511219|NCT00590954|583263355|FG000|Overall Study|Inevaluable|2|||
161511220|NCT04579679|583263356|FG000|Overall Study|New Antitumor Therapy|6|||
161511221|NCT04579679|583263357|FG001|Overall Study|New Antitumor Therapy|4|||
161511222|NCT04579679|583263358|FG002|Overall Study|New Antitumor Therapy|7|||
161511223|NCT04579679|583263359|FG003|Overall Study|New Antitumor Therapy|0|||
161511224|NCT04579679|583263356|FG000|Overall Study|Withdrawal of Consent|1|||
161511225|NCT04579679|583263357|FG001|Overall Study|Withdrawal of Consent|1|||
161511226|NCT04579679|583263358|FG002|Overall Study|Withdrawal of Consent|2|||
161511227|NCT04579679|583263359|FG003|Overall Study|Withdrawal of Consent|4|||
161511228|NCT04579679|583263356|FG000|Overall Study|Death|2|||
161511229|NCT04579679|583263357|FG001|Overall Study|Death|2|||
161511230|NCT04579679|583263358|FG002|Overall Study|Death|2|||
161511231|NCT04579679|583263359|FG003|Overall Study|Death|0|||
161511232|NCT04579679|583263356|FG000|Overall Study|Adverse Event|0|||
161511233|NCT04579679|583263357|FG001|Overall Study|Adverse Event|4|||
161511234|NCT04579679|583263358|FG002|Overall Study|Adverse Event|0|||
161511235|NCT04579679|583263359|FG003|Overall Study|Adverse Event|0|||
161511236|NCT04579679|583263356|FG000|Overall Study|Disease Progression|9|||
161511237|NCT04579679|583263357|FG001|Overall Study|Disease Progression|13|||
161587727|NCT03978637|583540720|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
161926681|NCT00887588|584778666|FG001|Extension Period|Adverse Event|4|||
161587728|NCT03978637|583540721|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
161926682|NCT00887588|584778665|FG000|Extension Period|Death|0|||
161926683|NCT00887588|584778666|FG001|Extension Period|Death|1|||
161926684|NCT00887588|584778665|FG000|Extension Period|Protocol deviation|1|||
161926685|NCT00887588|584778666|FG001|Extension Period|Protocol deviation|0|||
161926686|NCT00887588|584778665|FG000|Extension Period|Lost to Follow-up|1|||
161511238|NCT04579679|583263358|FG002|Overall Study|Disease Progression|7|||
161511239|NCT04579679|583263359|FG003|Overall Study|Disease Progression|0|||
161511240|NCT04579679|583263356|FG000|Overall Study|Physician Decision|0|||
161511241|NCT04579679|583263357|FG001|Overall Study|Physician Decision|0|||
161511242|NCT04579679|583263358|FG002|Overall Study|Physician Decision|1|||
161511243|NCT04579679|583263359|FG003|Overall Study|Physician Decision|0|||
161511244|NCT04579679|583263356|FG000|Overall Study|Study Terminated by Sponsor|2|||
161511245|NCT04579679|583263357|FG001|Overall Study|Study Terminated by Sponsor|7|||
161511246|NCT04579679|583263358|FG002|Overall Study|Study Terminated by Sponsor|1|||
161511247|NCT04579679|583263359|FG003|Overall Study|Study Terminated by Sponsor|0|||
161511248|NCT02782949|583263361|FG000|Overall Study|Protocol Violation|1|||
161511249|NCT02782949|583263362|FG001|Overall Study|Protocol Violation|0|||
161511250|NCT02782949|583263361|FG000|Overall Study|Withdrawal by Subject|0|||
161511251|NCT02782949|583263362|FG001|Overall Study|Withdrawal by Subject|1|||
161511252|NCT03238911|583263368|FG000|Overall Study|Withdrawal by Subject|1|||
161511253|NCT03238911|583263369|FG001|Overall Study|Withdrawal by Subject|2|||
161511254|NCT03238911|583263368|FG000|Overall Study|Lost to Follow-up|2|||
161511255|NCT03238911|583263369|FG001|Overall Study|Lost to Follow-up|1|||
161511256|NCT03091192|583263373|FG000|Overall Study|Study terminated by sponsor|21|||
161511257|NCT03091192|583263374|FG001|Overall Study|Study terminated by sponsor|14|||
161511258|NCT03091192|583263373|FG000|Overall Study|Death|9|||
161511259|NCT03091192|583263374|FG001|Overall Study|Death|13|||
161511260|NCT03091192|583263373|FG000|Overall Study|Withdrawal by Subject|2|||
161511261|NCT03091192|583263374|FG001|Overall Study|Withdrawal by Subject|0|||
161511262|NCT03091192|583263373|FG000|Overall Study|Lost to Follow-up|1|||
161511263|NCT03091192|583263374|FG001|Overall Study|Lost to Follow-up|0|||
161511264|NCT06023394|583263375|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
161511265|NCT06023394|583263376|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
161511266|NCT06023394|583263375|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
161511267|NCT06023394|583263376|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
161511268|NCT06023394|583263375|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
161511269|NCT06023394|583263376|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
161511270|NCT06023394|583263375|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
161511271|NCT06023394|583263376|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
161511272|NCT03195478|583263377|FG000|Overall Study|Disease Progression|5|||
161511273|NCT03195478|583263378|FG001|Overall Study|Disease Progression|4|||
161511274|NCT03195478|583263379|FG002|Overall Study|Disease Progression|6|||
161511275|NCT03195478|583263380|FG003|Overall Study|Disease Progression|1|||
161511276|NCT03195478|583263377|FG000|Overall Study|Study Drug Toxicity|2|||
161511277|NCT03195478|583263378|FG001|Overall Study|Study Drug Toxicity|0|||
161511278|NCT03195478|583263379|FG002|Overall Study|Study Drug Toxicity|0|||
161511279|NCT03195478|583263380|FG003|Overall Study|Study Drug Toxicity|1|||
161511280|NCT03195478|583263377|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
161511281|NCT03195478|583263378|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
161511282|NCT03195478|583263379|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
161511283|NCT03195478|583263380|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
161511284|NCT03195478|583263377|FG000|Overall Study|Participant Withdrew Consent|1|||
161511285|NCT03195478|583263378|FG001|Overall Study|Participant Withdrew Consent|0|||
161511286|NCT03195478|583263379|FG002|Overall Study|Participant Withdrew Consent|0|||
161511287|NCT03195478|583263380|FG003|Overall Study|Participant Withdrew Consent|0|||
161511288|NCT03195478|583263377|FG000|Overall Study|Maximum Clinical benefit|0|||
161511289|NCT03195478|583263378|FG001|Overall Study|Maximum Clinical benefit|0|||
161511290|NCT03195478|583263379|FG002|Overall Study|Maximum Clinical benefit|1|||
161511291|NCT03195478|583263380|FG003|Overall Study|Maximum Clinical benefit|0|||
161511292|NCT03195478|583263377|FG000|Overall Study|Other Reasons|0|||
161511293|NCT03195478|583263378|FG001|Overall Study|Other Reasons|0|||
161511294|NCT03195478|583263379|FG002|Overall Study|Other Reasons|1|||
161511295|NCT03195478|583263380|FG003|Overall Study|Other Reasons|0|||
161511296|NCT03370341|583265075|FG000|Overall Study|Lost to Follow-up|0|||
161511297|NCT03370341|583265076|FG001|Overall Study|Lost to Follow-up|1|||
161511298|NCT01707004|583265079|FG000|Overall Study|Physician Decision|3|||
161511299|NCT02573324|583265083|FG000|Overall Study|Withdrawal by Subject|26|||
161511300|NCT02573324|583265084|FG001|Overall Study|Withdrawal by Subject|23|||
161511301|NCT02573324|583265085|FG002|Overall Study|Withdrawal by Subject|3|||
161511302|NCT02573324|583265083|FG000|Overall Study|Lost to Follow-up|4|||
161511303|NCT02573324|583265084|FG001|Overall Study|Lost to Follow-up|5|||
161511304|NCT02573324|583265085|FG002|Overall Study|Lost to Follow-up|0|||
161511305|NCT02573324|583265083|FG000|Overall Study|Study Terminated by Sponsor|107|||
161511306|NCT02573324|583265084|FG001|Overall Study|Study Terminated by Sponsor|89|||
161511307|NCT02573324|583265085|FG002|Overall Study|Study Terminated by Sponsor|2|||
161587729|NCT03978637|583540722|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
161926687|NCT00887588|584778666|FG001|Extension Period|Lost to Follow-up|0|||
161926688|NCT00567112|584778667|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
161926689|NCT00567112|584778668|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
161926690|NCT00567112|584778669|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
161926691|NCT00567112|584778667|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
161926692|NCT00567112|584778668|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
161511308|NCT02573324|583265083|FG000|Overall Study|Death|182|||
161511309|NCT02573324|583265084|FG001|Overall Study|Death|200|||
161511310|NCT02573324|583265085|FG002|Overall Study|Death|1|||
161511311|NCT02573324|583265083|FG000|Overall Study|Other, Not Specified|20|||
161511312|NCT02573324|583265084|FG001|Overall Study|Other, Not Specified|27|||
161511313|NCT02573324|583265085|FG002|Overall Study|Other, Not Specified|0|||
161511314|NCT02573324|583265083|FG000|Overall Study|Unknown Reason|2|||
161511315|NCT02573324|583265084|FG001|Overall Study|Unknown Reason|0|||
161511316|NCT02573324|583265085|FG002|Overall Study|Unknown Reason|0|||
161511317|NCT01607905|583265086|FG000|Overall Study|Withdrawal by participant|7|||
161511318|NCT01607905|583265087|FG001|Overall Study|Withdrawal by participant|2|||
161511319|NCT01607905|583265088|FG002|Overall Study|Withdrawal by participant|4|||
161511320|NCT01607905|583265089|FG003|Overall Study|Withdrawal by participant|6|||
161511321|NCT01607905|583265090|FG004|Overall Study|Withdrawal by participant|0|||
161511322|NCT01607905|583265091|FG005|Overall Study|Withdrawal by participant|4|||
161511323|NCT01607905|583265092|FG006|Overall Study|Withdrawal by participant|12|||
161511324|NCT01607905|583265086|FG000|Overall Study|Incidence or severity of AEs|5|||
161511325|NCT01607905|583265087|FG001|Overall Study|Incidence or severity of AEs|1|||
161511326|NCT01607905|583265088|FG002|Overall Study|Incidence or severity of AEs|1|||
161511327|NCT01607905|583265089|FG003|Overall Study|Incidence or severity of AEs|3|||
161511328|NCT01607905|583265090|FG004|Overall Study|Incidence or severity of AEs|0|||
161511329|NCT01607905|583265091|FG005|Overall Study|Incidence or severity of AEs|2|||
161511330|NCT01607905|583265092|FG006|Overall Study|Incidence or severity of AEs|8|||
161511331|NCT01607905|583265086|FG000|Overall Study|Disease progression|44|||
161511332|NCT01607905|583265087|FG001|Overall Study|Disease progression|16|||
161511333|NCT01607905|583265088|FG002|Overall Study|Disease progression|15|||
161511334|NCT01607905|583265089|FG003|Overall Study|Disease progression|11|||
161511335|NCT01607905|583265090|FG004|Overall Study|Disease progression|6|||
161511336|NCT01607905|583265091|FG005|Overall Study|Disease progression|7|||
161511337|NCT01607905|583265092|FG006|Overall Study|Disease progression|21|||
161511338|NCT01607905|583265086|FG000|Overall Study|Non-compliance with study procedures|0|||
161511339|NCT01607905|583265087|FG001|Overall Study|Non-compliance with study procedures|0|||
161511340|NCT01607905|583265088|FG002|Overall Study|Non-compliance with study procedures|0|||
161511341|NCT01607905|583265089|FG003|Overall Study|Non-compliance with study procedures|0|||
161511342|NCT01607905|583265090|FG004|Overall Study|Non-compliance with study procedures|0|||
161511343|NCT01607905|583265091|FG005|Overall Study|Non-compliance with study procedures|0|||
161511344|NCT01607905|583265092|FG006|Overall Study|Non-compliance with study procedures|1|||
161511345|NCT01607905|583265086|FG000|Overall Study|Death|1|||
161511346|NCT01607905|583265087|FG001|Overall Study|Death|1|||
161511347|NCT01607905|583265088|FG002|Overall Study|Death|1|||
161511348|NCT01607905|583265089|FG003|Overall Study|Death|1|||
161511349|NCT01607905|583265090|FG004|Overall Study|Death|0|||
161511350|NCT01607905|583265091|FG005|Overall Study|Death|0|||
161511351|NCT01607905|583265092|FG006|Overall Study|Death|3|||
161511352|NCT01607905|583265086|FG000|Overall Study|Other treatments become available|1|||
161511353|NCT01607905|583265087|FG001|Overall Study|Other treatments become available|0|||
161511354|NCT01607905|583265088|FG002|Overall Study|Other treatments become available|0|||
161511355|NCT01607905|583265089|FG003|Overall Study|Other treatments become available|0|||
161511356|NCT01607905|583265090|FG004|Overall Study|Other treatments become available|0|||
161511357|NCT01607905|583265091|FG005|Overall Study|Other treatments become available|0|||
161511358|NCT01607905|583265092|FG006|Overall Study|Other treatments become available|1|||
161511359|NCT01607905|583265086|FG000|Overall Study|Investigator discretion|0|||
161511360|NCT01607905|583265087|FG001|Overall Study|Investigator discretion|0|||
161511361|NCT01607905|583265088|FG002|Overall Study|Investigator discretion|0|||
161511362|NCT01607905|583265089|FG003|Overall Study|Investigator discretion|0|||
161511363|NCT01607905|583265090|FG004|Overall Study|Investigator discretion|0|||
161511364|NCT01607905|583265091|FG005|Overall Study|Investigator discretion|1|||
161511365|NCT01607905|583265092|FG006|Overall Study|Investigator discretion|0|||
161511366|NCT01607905|583265086|FG000|Overall Study|Other|1|||
161511367|NCT01607905|583265087|FG001|Overall Study|Other|0|||
161511368|NCT01607905|583265088|FG002|Overall Study|Other|0|||
161511369|NCT01607905|583265089|FG003|Overall Study|Other|0|||
161511370|NCT01607905|583265090|FG004|Overall Study|Other|0|||
161511371|NCT01607905|583265091|FG005|Overall Study|Other|0|||
161511372|NCT01607905|583265092|FG006|Overall Study|Other|1|||
161511373|NCT01607905|583265086|FG000|Overall Study|Randomized but not treated|1|||
161587730|NCT01959698|583540723|FG000|Overall Study|Adverse Event|0|||
161587731|NCT01959698|583540724|FG001|Overall Study|Adverse Event|0|||
161587732|NCT01959698|583540725|FG002|Overall Study|Adverse Event|0|||
161587733|NCT01959698|583540726|FG003|Overall Study|Adverse Event|0|||
161820715|NCT02229084|584384626|FG000|Overall Study|Adverse Event|1|||
161511374|NCT01607905|583265087|FG001|Overall Study|Randomized but not treated|0|||
161511375|NCT01607905|583265088|FG002|Overall Study|Randomized but not treated|0|||
161511376|NCT01607905|583265089|FG003|Overall Study|Randomized but not treated|0|||
161511377|NCT01607905|583265090|FG004|Overall Study|Randomized but not treated|1|||
161511378|NCT01607905|583265091|FG005|Overall Study|Randomized but not treated|1|||
161511379|NCT01607905|583265092|FG006|Overall Study|Randomized but not treated|0|||
161511380|NCT00941733|583265093|FG000|Overall Study|Death|24|||
161511381|NCT00941733|583265094|FG001|Overall Study|Death|10|||
161511382|NCT00941733|583265093|FG000|Overall Study|Withdrawal by Subject|14|||
161511383|NCT00941733|583265094|FG001|Overall Study|Withdrawal by Subject|6|||
161511384|NCT00941733|583265093|FG000|Overall Study|Adverse Event|20|||
161820716|NCT02229084|584384627|FG001|Overall Study|Adverse Event|0|||
161587734|NCT01959698|583540727|FG004|Overall Study|Adverse Event|0|||
161587735|NCT01959698|583540728|FG005|Overall Study|Adverse Event|0|||
161511385|NCT00941733|583265094|FG001|Overall Study|Adverse Event|4|||
161511386|NCT00941733|583265093|FG000|Overall Study|Lost to Follow-up|1|||
161926693|NCT00567112|584778669|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
161926694|NCT00567112|584778667|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
161926695|NCT00567112|584778668|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
161926696|NCT00567112|584778669|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
161926697|NCT03753542|584778673|FG000|Overall Study|Lost to Follow-up|9|||
161926698|NCT03753542|584778674|FG001|Overall Study|Lost to Follow-up|14|||
161926699|NCT04180696|584778677|FG000|Overall Study|Death|5|||
161926700|NCT04180696|584778678|FG001|Overall Study|Death|6|||
161926701|NCT04180696|584778677|FG000|Overall Study|Lost to Follow-up|1|||
161926702|NCT04180696|584778678|FG001|Overall Study|Lost to Follow-up|0|||
161511387|NCT00941733|583265094|FG001|Overall Study|Lost to Follow-up|2|||
161511388|NCT00941733|583265093|FG000|Overall Study|Protocol Violation|15|||
161511389|NCT00941733|583265094|FG001|Overall Study|Protocol Violation|6|||
161820717|NCT02229084|584384628|FG002|Overall Study|Adverse Event|0|||
161820718|NCT02229084|584384629|FG003|Overall Study|Adverse Event|0|||
161820719|NCT02229084|584384630|FG004|Overall Study|Adverse Event|0|||
161820720|NCT02229084|584384631|FG005|Overall Study|Adverse Event|0|||
161820721|NCT02229084|584384632|FG006|Overall Study|Adverse Event|0|||
161820722|NCT02229084|584384626|FG000|Overall Study|Lost to Follow-up|0|||
161820723|NCT02229084|584384627|FG001|Overall Study|Lost to Follow-up|0|||
161820724|NCT02229084|584384628|FG002|Overall Study|Lost to Follow-up|1|||
161820725|NCT02229084|584384629|FG003|Overall Study|Lost to Follow-up|1|||
161820726|NCT02229084|584384630|FG004|Overall Study|Lost to Follow-up|0|||
161820727|NCT02229084|584384631|FG005|Overall Study|Lost to Follow-up|0|||
161820728|NCT02229084|584384632|FG006|Overall Study|Lost to Follow-up|1|||
161820729|NCT02229084|584384626|FG000|Overall Study|Physician Decision|0|||
161820730|NCT02229084|584384627|FG001|Overall Study|Physician Decision|0|||
161820731|NCT02229084|584384628|FG002|Overall Study|Physician Decision|0|||
161820732|NCT02229084|584384629|FG003|Overall Study|Physician Decision|1|||
161820733|NCT02229084|584384630|FG004|Overall Study|Physician Decision|3|||
161820734|NCT02229084|584384631|FG005|Overall Study|Physician Decision|0|||
161820735|NCT02229084|584384632|FG006|Overall Study|Physician Decision|1|||
161820736|NCT02229084|584384626|FG000|Overall Study|Withdrawal by Subject|0|||
161820737|NCT02229084|584384627|FG001|Overall Study|Withdrawal by Subject|0|||
161820738|NCT02229084|584384628|FG002|Overall Study|Withdrawal by Subject|1|||
161820739|NCT02229084|584384629|FG003|Overall Study|Withdrawal by Subject|0|||
161820740|NCT02229084|584384630|FG004|Overall Study|Withdrawal by Subject|1|||
161820741|NCT02229084|584384631|FG005|Overall Study|Withdrawal by Subject|1|||
161820742|NCT02229084|584384632|FG006|Overall Study|Withdrawal by Subject|1|||
161820743|NCT02229084|584384626|FG000|Overall Study|Death|0|||
161820744|NCT02229084|584384627|FG001|Overall Study|Death|0|||
161820745|NCT02229084|584384628|FG002|Overall Study|Death|0|||
161820746|NCT02229084|584384629|FG003|Overall Study|Death|0|||
161820747|NCT02229084|584384630|FG004|Overall Study|Death|0|||
161820748|NCT02229084|584384631|FG005|Overall Study|Death|0|||
161820749|NCT02229084|584384632|FG006|Overall Study|Death|1|||
161820750|NCT01728116|584384635|FG000|Overall Study|Sponsor Terminated Study|106|||
161820751|NCT01728116|584384636|FG001|Overall Study|Sponsor Terminated Study|35|||
161820752|NCT01728116|584384635|FG000|Overall Study|Withdrawal by Subject|16|||
161820753|NCT01728116|584384636|FG001|Overall Study|Withdrawal by Subject|9|||
161820754|NCT01728116|584384635|FG000|Overall Study|Adverse Event|13|||
161820755|NCT01728116|584384636|FG001|Overall Study|Adverse Event|0|||
161820756|NCT01728116|584384635|FG000|Overall Study|Procedure/device failure|7|||
161820757|NCT01728116|584384636|FG001|Overall Study|Procedure/device failure|0|||
161820758|NCT01728116|584384635|FG000|Overall Study|Lost to Follow-up|9|||
161820759|NCT01728116|584384636|FG001|Overall Study|Lost to Follow-up|2|||
161820760|NCT01728116|584384635|FG000|Overall Study|Physician Decision|2|||
161820761|NCT01728116|584384636|FG001|Overall Study|Physician Decision|0|||
161820762|NCT01728116|584384635|FG000|Overall Study|Subject Non-Compliance|2|||
161820763|NCT01728116|584384636|FG001|Overall Study|Subject Non-Compliance|0|||
161820764|NCT01728116|584384635|FG000|Overall Study|Inter-current finding at procedure|1|||
161820765|NCT01728116|584384636|FG001|Overall Study|Inter-current finding at procedure|0|||
161820766|NCT01728116|584384635|FG000|Overall Study|Incorrectly enrolled in Study|0|||
161820767|NCT01728116|584384636|FG001|Overall Study|Incorrectly enrolled in Study|1|||
161820768|NCT01728116|584384635|FG000|Overall Study|various not noted previously|5|||
161820769|NCT01728116|584384636|FG001|Overall Study|various not noted previously|0|||
161820770|NCT01868243|584384640|FG000|Overall Study|Death|0|||
161511390|NCT00194012|583265095|FG000|Randomized Phase|Lack of Efficacy|8|||
161820771|NCT01868243|584384641|FG001|Overall Study|Death|1|||
161820772|NCT01745094|584384643|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
161820773|NCT01745094|584384644|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
161820774|NCT01745094|584384645|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
161820775|NCT01745094|584384646|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
161820776|NCT01745094|584384643|FG000|Overall Study|Adverse Event|0|||
161820777|NCT01745094|584384644|FG001|Overall Study|Adverse Event|0|||
161511391|NCT00194012|583265096|FG001|Randomized Phase|Lack of Efficacy|18|||
161511392|NCT00194012|583265095|FG000|Randomized Phase|Study nonadherence|2|||
161511393|NCT00194012|583265096|FG001|Randomized Phase|Study nonadherence|1|||
161511394|NCT00194012|583265095|FG000|Randomized Phase|Withdrawal by Subject|3|||
161511395|NCT00194012|583265096|FG001|Randomized Phase|Withdrawal by Subject|3|||
161511396|NCT00194012|583265095|FG000|Randomized Phase|Adverse Event|2|||
161511397|NCT00194012|583265096|FG001|Randomized Phase|Adverse Event|1|||
161511398|NCT00194012|583265095|FG000|Randomized Phase|Participant reported having a rash|1|||
161511399|NCT00194012|583265096|FG001|Randomized Phase|Participant reported having a rash|0|||
161511400|NCT00194012|583265095|FG000|Randomized Phase|Emesis and enuresis|0|||
161511401|NCT00194012|583265096|FG001|Randomized Phase|Emesis and enuresis|1|||
161511402|NCT00194012|583265095|FG000|Randomized Phase|Oral/nasal twitching|0|||
161511403|NCT00194012|583265096|FG001|Randomized Phase|Oral/nasal twitching|1|||
161511404|NCT00194012|583265095|FG000|Open Label Extension (OLE)|Weight Gain|1|||
161511405|NCT00194012|583265096|FG001|Open Label Extension (OLE)|Weight Gain|0|||
161511406|NCT00194012|583265095|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
161511407|NCT00194012|583265096|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
161511408|NCT00194012|583265095|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
161511409|NCT00194012|583265096|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
161511410|NCT00194012|583265095|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
161926703|NCT04180696|584778677|FG000|Overall Study|Withdrawal by Subject|0|||
161926704|NCT04180696|584778678|FG001|Overall Study|Withdrawal by Subject|1|||
161926705|NCT04210375|584778679|FG000|Overall Study|Death|0|||
161926706|NCT04210375|584778680|FG001|Overall Study|Death|1|||
161926707|NCT04210375|584778681|FG002|Overall Study|Death|0|||
161926708|NCT04210375|584778682|FG003|Overall Study|Death|0|||
161926709|NCT05752487|584778685|FG000|Overall Study|Enrolled, not treated|9|||
161926710|NCT05752487|584778685|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
161926711|NCT05752487|584778685|FG000|Overall Study|Withdrawal by Subject|2|||
161926712|NCT04124965|584778687|FG000|Overall Study|Adverse event, non-fatal|3|||
161926713|NCT04124965|584778688|FG001|Overall Study|Adverse event, non-fatal|1|||
161926714|NCT04124965|584778687|FG000|Overall Study|Withdrawal by Subject|1|||
161926715|NCT04124965|584778688|FG001|Overall Study|Withdrawal by Subject|1|||
161926716|NCT04124965|584778687|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
161926717|NCT04124965|584778688|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
161511411|NCT00194012|583265096|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
161511412|NCT01105533|583265097|FG000|Overall Study|Death|0|||
161511413|NCT01105533|583265098|FG001|Overall Study|Death|0|||
161511414|NCT01105533|583265099|FG002|Overall Study|Death|0|||
161511415|NCT01105533|583265100|FG003|Overall Study|Death|0|||
161511416|NCT01105533|583265101|FG004|Overall Study|Death|1|||
161511417|NCT01105533|583265102|FG005|Overall Study|Death|0|||
161511418|NCT01105533|583265103|FG006|Overall Study|Death|0|||
161511419|NCT01105533|583265104|FG007|Overall Study|Death|0|||
161511420|NCT01105533|583265105|FG008|Overall Study|Death|0|||
161511421|NCT01105533|583265097|FG000|Overall Study|Lack of Efficacy|1|||
161511422|NCT01105533|583265098|FG001|Overall Study|Lack of Efficacy|1|||
161511423|NCT01105533|583265099|FG002|Overall Study|Lack of Efficacy|3|||
161511424|NCT01105533|583265100|FG003|Overall Study|Lack of Efficacy|3|||
161511425|NCT01105533|583265101|FG004|Overall Study|Lack of Efficacy|4|||
161511426|NCT01105533|583265102|FG005|Overall Study|Lack of Efficacy|5|||
161511427|NCT01105533|583265103|FG006|Overall Study|Lack of Efficacy|3|||
161511428|NCT01105533|583265104|FG007|Overall Study|Lack of Efficacy|2|||
161511429|NCT01105533|583265105|FG008|Overall Study|Lack of Efficacy|9|||
161511430|NCT01105533|583265097|FG000|Overall Study|Adverse Event|0|||
161511431|NCT01105533|583265098|FG001|Overall Study|Adverse Event|0|||
161511432|NCT01105533|583265099|FG002|Overall Study|Adverse Event|0|||
161511433|NCT01105533|583265100|FG003|Overall Study|Adverse Event|0|||
161511434|NCT01105533|583265101|FG004|Overall Study|Adverse Event|1|||
161926718|NCT04124965|584778687|FG000|Overall Study|Pregnancy|1|||
161926719|NCT04124965|584778688|FG001|Overall Study|Pregnancy|0|||
161926720|NCT04124965|584778687|FG000|Overall Study|Sponsor and participant decision|0|||
161511435|NCT01105533|583265102|FG005|Overall Study|Adverse Event|2|||
161511436|NCT01105533|583265103|FG006|Overall Study|Adverse Event|2|||
161511437|NCT01105533|583265104|FG007|Overall Study|Adverse Event|0|||
161511438|NCT01105533|583265105|FG008|Overall Study|Adverse Event|1|||
161511439|NCT01105533|583265097|FG000|Overall Study|Other|0|||
161511440|NCT01105533|583265098|FG001|Overall Study|Other|0|||
161511441|NCT01105533|583265099|FG002|Overall Study|Other|0|||
161511442|NCT01105533|583265100|FG003|Overall Study|Other|0|||
161511443|NCT01105533|583265101|FG004|Overall Study|Other|1|||
161511444|NCT01105533|583265102|FG005|Overall Study|Other|0|||
161511445|NCT01105533|583265103|FG006|Overall Study|Other|3|||
161511446|NCT01105533|583265104|FG007|Overall Study|Other|1|||
161511447|NCT01105533|583265105|FG008|Overall Study|Other|2|||
161511448|NCT01105533|583265097|FG000|Overall Study|Physician Decision|0|||
161511449|NCT01105533|583265098|FG001|Overall Study|Physician Decision|0|||
161511450|NCT01105533|583265099|FG002|Overall Study|Physician Decision|0|||
161511451|NCT01105533|583265100|FG003|Overall Study|Physician Decision|0|||
161511452|NCT01105533|583265101|FG004|Overall Study|Physician Decision|0|||
161511453|NCT01105533|583265102|FG005|Overall Study|Physician Decision|0|||
161511454|NCT01105533|583265103|FG006|Overall Study|Physician Decision|0|||
161511455|NCT01105533|583265104|FG007|Overall Study|Physician Decision|1|||
161511456|NCT01105533|583265105|FG008|Overall Study|Physician Decision|0|||
161511457|NCT03892889|583265106|FG000|Overall Study|Adverse Event|17|||
161511458|NCT03892889|583265106|FG000|Overall Study|Lack of Efficacy|1|||
161511459|NCT03892889|583265106|FG000|Overall Study|Lost to Follow-up|46|||
161511460|NCT03892889|583265106|FG000|Overall Study|Non-compliance with study drug|22|||
161511461|NCT03892889|583265106|FG000|Overall Study|Pregnancy|1|||
161511462|NCT03892889|583265106|FG000|Overall Study|Protocol Deviation|3|||
161511463|NCT03892889|583265106|FG000|Overall Study|Withdrawal by Subject|50|||
161511464|NCT03892889|583265106|FG000|Overall Study|Withdrawal by Caregiver|1|||
161511465|NCT03892889|583265106|FG000|Overall Study|Study Terminated by Sponsor|50|||
161511466|NCT03892889|583265106|FG000|Overall Study|Physician Decision|8|||
161511467|NCT03892889|583265106|FG000|Overall Study|Reason not Specified|5|||
161511468|NCT01639001|583265115|FG000|Overall Study|Refused further follow-up|9|||
161511469|NCT01639001|583265116|FG001|Overall Study|Refused further follow-up|12|||
161511470|NCT01639001|583265115|FG000|Overall Study|Lost to Follow-up|3|||
161587736|NCT01959698|583540729|FG006|Overall Study|Adverse Event|1|||
161587737|NCT01959698|583540723|FG000|Overall Study|Physician Decision|1|||
161587738|NCT01959698|583540724|FG001|Overall Study|Physician Decision|0|||
161587739|NCT01959698|583540725|FG002|Overall Study|Physician Decision|1|||
161587740|NCT01959698|583540726|FG003|Overall Study|Physician Decision|2|||
161587741|NCT01959698|583540727|FG004|Overall Study|Physician Decision|0|||
161926721|NCT04124965|584778688|FG001|Overall Study|Sponsor and participant decision|1|||
161926722|NCT04124965|584778687|FG000|Overall Study|Personal surgery|0|||
161926723|NCT04124965|584778688|FG001|Overall Study|Personal surgery|1|||
161926724|NCT04124965|584778687|FG000|Overall Study|Physician Decision|0|||
161926725|NCT04124965|584778688|FG001|Overall Study|Physician Decision|1|||
161926726|NCT01214720|584778689|FG000|Overall Study|Alive and still on treatment|34|||
161926727|NCT01214720|584778690|FG001|Overall Study|Alive and still on treatment|18|||
161926728|NCT01214720|584778689|FG000|Overall Study|Alive and in follow-up|45|||
161511471|NCT01639001|583265116|FG001|Overall Study|Lost to Follow-up|0|||
161511472|NCT01639001|583265115|FG000|Overall Study|Death|62|||
161511473|NCT01639001|583265116|FG001|Overall Study|Death|61|||
161511474|NCT01639001|583265115|FG000|Overall Study|Randomized but not treated|0|||
161587742|NCT01959698|583540728|FG005|Overall Study|Physician Decision|3|||
161587743|NCT01959698|583540729|FG006|Overall Study|Physician Decision|3|||
161820778|NCT01745094|584384645|FG002|Overall Study|Adverse Event|3|||
161820779|NCT01745094|584384646|FG003|Overall Study|Adverse Event|0|||
161820780|NCT01745094|584384643|FG000|Overall Study|Withdrawal by Subject|2|||
161820781|NCT01745094|584384644|FG001|Overall Study|Withdrawal by Subject|0|||
161820782|NCT01745094|584384645|FG002|Overall Study|Withdrawal by Subject|1|||
161820783|NCT01745094|584384646|FG003|Overall Study|Withdrawal by Subject|2|||
161820784|NCT01745094|584384643|FG000|Overall Study|Protocol Violation|1|||
161820785|NCT01745094|584384644|FG001|Overall Study|Protocol Violation|0|||
161820786|NCT01745094|584384645|FG002|Overall Study|Protocol Violation|3|||
161820787|NCT01745094|584384646|FG003|Overall Study|Protocol Violation|1|||
161820788|NCT01745094|584384643|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
161820789|NCT01745094|584384644|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
161511475|NCT01639001|583265116|FG001|Overall Study|Randomized but not treated|2|||
161511476|NCT01639001|583265115|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
161587744|NCT03819686|583542249|FG000|Overall Study|Lost to Follow-up|2|||
161587745|NCT03819686|583542250|FG001|Overall Study|Lost to Follow-up|3|||
161587746|NCT06143670|583542251|FG000|Overall Study|Lost to Follow-up|0|||
161820790|NCT01745094|584384645|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
161926729|NCT01214720|584778690|FG001|Overall Study|Alive and in follow-up|48|||
161511477|NCT01639001|583265116|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
161587747|NCT06143670|583542252|FG001|Overall Study|Lost to Follow-up|1|||
161511478|NCT02453594|583265117|FG000|Overall Study|Protocol Violation|0|||
161511479|NCT02453594|583265118|FG001|Overall Study|Protocol Violation|0|||
161511480|NCT02453594|583265119|FG002|Overall Study|Protocol Violation|1|||
161511481|NCT02453594|583265117|FG000|Overall Study|Cohort Was Closed|17|||
161511482|NCT02453594|583265118|FG001|Overall Study|Cohort Was Closed|21|||
161511483|NCT02453594|583265119|FG002|Overall Study|Cohort Was Closed|14|||
161511484|NCT02453594|583265117|FG000|Overall Study|Death|20|||
161511485|NCT02453594|583265118|FG001|Overall Study|Death|24|||
161511486|NCT02453594|583265119|FG002|Overall Study|Death|16|||
161511487|NCT02453594|583265117|FG000|Overall Study|Lost to Follow-up|6|||
161511488|NCT02453594|583265118|FG001|Overall Study|Lost to Follow-up|14|||
161511489|NCT02453594|583265119|FG002|Overall Study|Lost to Follow-up|2|||
161511490|NCT02453594|583265117|FG000|Overall Study|Physician Decision|2|||
161511491|NCT02453594|583265118|FG001|Overall Study|Physician Decision|4|||
161511492|NCT02453594|583265119|FG002|Overall Study|Physician Decision|0|||
161511493|NCT02453594|583265117|FG000|Overall Study|Site Terminated by Sponsor|1|||
161511494|NCT02453594|583265118|FG001|Overall Study|Site Terminated by Sponsor|0|||
161511495|NCT02453594|583265119|FG002|Overall Study|Site Terminated by Sponsor|1|||
161511496|NCT02453594|583265117|FG000|Overall Study|Transitioned to Extension Study|16|||
161511497|NCT02453594|583265118|FG001|Overall Study|Transitioned to Extension Study|9|||
161511498|NCT02453594|583265119|FG002|Overall Study|Transitioned to Extension Study|16|||
161511499|NCT02453594|583265117|FG000|Overall Study|Withdrawal by Subject|7|||
161511500|NCT02453594|583265118|FG001|Overall Study|Withdrawal by Subject|9|||
161511501|NCT02453594|583265119|FG002|Overall Study|Withdrawal by Subject|11|||
161511502|NCT02097134|583265120|FG000|Overall Study|Physician Decision|4|||
161511503|NCT02097134|583265120|FG000|Overall Study|Non-Protocol Therapy|1|||
161511504|NCT02097134|583265120|FG000|Overall Study|Progressive Disease|3|||
161511505|NCT02097134|583265120|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
161511506|NCT00679341|583265122|FG000|Overall Study|Disease progression|42|||
161511507|NCT00679341|583265123|FG001|Overall Study|Disease progression|36|||
161511508|NCT00679341|583265122|FG000|Overall Study|Adverse Event|5|||
161511509|NCT00679341|583265123|FG001|Overall Study|Adverse Event|6|||
161511510|NCT00679341|583265122|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
161511511|NCT00679341|583265123|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
161511512|NCT00679341|583265122|FG000|Overall Study|Death|1|||
161511513|NCT00679341|583265123|FG001|Overall Study|Death|1|||
161511514|NCT00679341|583265122|FG000|Overall Study|Other|1|||
161511515|NCT00679341|583265123|FG001|Overall Study|Other|0|||
161511516|NCT00679341|583265122|FG000|Overall Study|Physician Decision|1|||
161511517|NCT00679341|583265123|FG001|Overall Study|Physician Decision|0|||
161511518|NCT00679341|583265122|FG000|Overall Study|Not treated|0|||
161511519|NCT00679341|583265123|FG001|Overall Study|Not treated|2|||
161511520|NCT00679341|583265122|FG000|Overall Study|Physician/patient decision to withdraw|0|||
161511521|NCT00679341|583265123|FG001|Overall Study|Physician/patient decision to withdraw|6|||
161511522|NCT00298896|583265127|FG000|Overall Study|Death|3|||
161511523|NCT00298896|583265127|FG000|Overall Study|Physician Decision|2|||
161511524|NCT00298896|583265127|FG000|Overall Study|Intercurrent Illness|1|||
161511525|NCT00298896|583265127|FG000|Overall Study|Disease Progression|41|||
161511526|NCT00298896|583265127|FG000|Overall Study|Withdrawal by Subject|2|||
161511527|NCT00298896|583265127|FG000|Overall Study|Assigned to treatment in error|1|||
161511528|NCT02880371|583265128|FG000|Phase 1b|Lost to Follow-up|1|||
161511529|NCT02880371|583265129|FG001|Phase 1b|Lost to Follow-up|0|||
161511530|NCT02880371|583265130|FG002|Phase 1b|Lost to Follow-up|0|||
161511531|NCT02880371|583265131|FG003|Phase 1b|Lost to Follow-up|0|||
161511532|NCT02880371|583265132|FG004|Phase 1b|Lost to Follow-up|0|||
161511533|NCT02880371|583265133|FG005|Phase 1b|Lost to Follow-up|0|||
161511534|NCT02880371|583265134|FG006|Phase 1b|Lost to Follow-up|0|||
161511535|NCT02880371|583265135|FG007|Phase 1b|Lost to Follow-up|0|||
161511536|NCT02880371|583265128|FG000|Phase 1b|Participants terminated by Sponsor|1|||
161511537|NCT02880371|583265129|FG001|Phase 1b|Participants terminated by Sponsor|0|||
161511538|NCT02880371|583265130|FG002|Phase 1b|Participants terminated by Sponsor|0|||
161511539|NCT02880371|583265131|FG003|Phase 1b|Participants terminated by Sponsor|0|||
161587748|NCT06143670|583542251|FG000|Overall Study|Withdrawal by Subject|3|||
161587749|NCT06143670|583542252|FG001|Overall Study|Withdrawal by Subject|0|||
161587750|NCT03625882|583542255|FG000|Overall Study|Protocol Violation|3|||
161511540|NCT02880371|583265132|FG004|Phase 1b|Participants terminated by Sponsor|0|||
161511541|NCT02880371|583265133|FG005|Phase 1b|Participants terminated by Sponsor|0|||
161511542|NCT02880371|583265134|FG006|Phase 1b|Participants terminated by Sponsor|0|||
161511543|NCT02880371|583265135|FG007|Phase 1b|Participants terminated by Sponsor|0|||
161511544|NCT02880371|583265128|FG000|Phase 1b|Withdrawal by Subject|0|||
161511545|NCT02880371|583265129|FG001|Phase 1b|Withdrawal by Subject|0|||
161511546|NCT02880371|583265130|FG002|Phase 1b|Withdrawal by Subject|1|||
161511547|NCT02880371|583265131|FG003|Phase 1b|Withdrawal by Subject|0|||
161511548|NCT02880371|583265132|FG004|Phase 1b|Withdrawal by Subject|0|||
161511549|NCT02880371|583265133|FG005|Phase 1b|Withdrawal by Subject|0|||
161511550|NCT02880371|583265134|FG006|Phase 1b|Withdrawal by Subject|0|||
161587751|NCT05058391|583542256|FG000|Overall Study|Adverse Event|1|||
161511551|NCT02880371|583265135|FG007|Phase 1b|Withdrawal by Subject|0|||
161511552|NCT02880371|583265128|FG000|Phase 1b|Death|4|||
161511553|NCT02880371|583265129|FG001|Phase 1b|Death|6|||
161511554|NCT02880371|583265130|FG002|Phase 1b|Death|5|||
161511555|NCT02880371|583265131|FG003|Phase 1b|Death|1|||
161511556|NCT02880371|583265132|FG004|Phase 1b|Death|0|||
161511557|NCT02880371|583265133|FG005|Phase 1b|Death|0|||
161511558|NCT02880371|583265134|FG006|Phase 1b|Death|0|||
161511559|NCT02880371|583265135|FG007|Phase 1b|Death|0|||
161511560|NCT02880371|583265128|FG000|Phase 1b|Enrolled but not Treated|0|||
161511561|NCT02880371|583265129|FG001|Phase 1b|Enrolled but not Treated|1|||
161511562|NCT02880371|583265130|FG002|Phase 1b|Enrolled but not Treated|0|||
161511563|NCT02880371|583265131|FG003|Phase 1b|Enrolled but not Treated|0|||
161511564|NCT02880371|583265132|FG004|Phase 1b|Enrolled but not Treated|0|||
161511565|NCT02880371|583265133|FG005|Phase 1b|Enrolled but not Treated|0|||
161511566|NCT02880371|583265134|FG006|Phase 1b|Enrolled but not Treated|0|||
161511567|NCT02880371|583265135|FG007|Phase 1b|Enrolled but not Treated|0|||
161511568|NCT02880371|583265128|FG000|Phase 2|Enrolled but not Treated|0|||
161511569|NCT02880371|583265129|FG001|Phase 2|Enrolled but not Treated|0|||
161511570|NCT02880371|583265130|FG002|Phase 2|Enrolled but not Treated|0|||
161511571|NCT02880371|583265131|FG003|Phase 2|Enrolled but not Treated|0|||
161511572|NCT02880371|583265132|FG004|Phase 2|Enrolled but not Treated|0|||
161511573|NCT02880371|583265133|FG005|Phase 2|Enrolled but not Treated|1|||
161511574|NCT02880371|583265134|FG006|Phase 2|Enrolled but not Treated|1|||
161511575|NCT02880371|583265135|FG007|Phase 2|Enrolled but not Treated|0|||
161511576|NCT02880371|583265128|FG000|Phase 2|Other|0|||
161511577|NCT02880371|583265129|FG001|Phase 2|Other|0|||
161511578|NCT02880371|583265130|FG002|Phase 2|Other|0|||
161511579|NCT02880371|583265131|FG003|Phase 2|Other|0|||
161511580|NCT02880371|583265132|FG004|Phase 2|Other|0|||
161511581|NCT02880371|583265133|FG005|Phase 2|Other|1|||
161511582|NCT02880371|583265134|FG006|Phase 2|Other|2|||
161511583|NCT02880371|583265135|FG007|Phase 2|Other|1|||
161511584|NCT02880371|583265128|FG000|Phase 2|Participants terminated by Sponsor|0|||
161511585|NCT02880371|583265129|FG001|Phase 2|Participants terminated by Sponsor|0|||
161511586|NCT02880371|583265130|FG002|Phase 2|Participants terminated by Sponsor|0|||
161511587|NCT02880371|583265131|FG003|Phase 2|Participants terminated by Sponsor|0|||
161511588|NCT02880371|583265132|FG004|Phase 2|Participants terminated by Sponsor|1|||
161511589|NCT02880371|583265133|FG005|Phase 2|Participants terminated by Sponsor|6|||
161511590|NCT02880371|583265134|FG006|Phase 2|Participants terminated by Sponsor|1|||
161511591|NCT02880371|583265135|FG007|Phase 2|Participants terminated by Sponsor|5|||
161511592|NCT02880371|583265128|FG000|Phase 2|Death|0|||
161511593|NCT02880371|583265129|FG001|Phase 2|Death|0|||
161511594|NCT02880371|583265130|FG002|Phase 2|Death|0|||
161511595|NCT02880371|583265131|FG003|Phase 2|Death|0|||
161511596|NCT02880371|583265132|FG004|Phase 2|Death|1|||
161511597|NCT02880371|583265133|FG005|Phase 2|Death|10|||
161511598|NCT02880371|583265134|FG006|Phase 2|Death|20|||
161511599|NCT02880371|583265135|FG007|Phase 2|Death|5|||
161511600|NCT02880371|583265128|FG000|Phase 2|Lost to Follow-up|0|||
161511601|NCT02880371|583265129|FG001|Phase 2|Lost to Follow-up|0|||
161511602|NCT02880371|583265130|FG002|Phase 2|Lost to Follow-up|0|||
161511603|NCT02880371|583265131|FG003|Phase 2|Lost to Follow-up|0|||
161587752|NCT03833245|583542259|FG000|Overall Study|Death|0|||
161587753|NCT03833245|583542260|FG001|Overall Study|Death|1|||
161587754|NCT03347383|583542261|FG000|Overall Study|Death|39|||
161587755|NCT03347383|583542261|FG000|Overall Study|Withdrawal by Subject|3|||
161587756|NCT03347383|583542261|FG000|Overall Study|Lost to Follow-up|9|||
161587757|NCT04842643|583542263|FG000|Overall Study|Physician Decision|1|||
161511604|NCT02880371|583265132|FG004|Phase 2|Lost to Follow-up|0|||
161511605|NCT02880371|583265133|FG005|Phase 2|Lost to Follow-up|0|||
161511606|NCT02880371|583265134|FG006|Phase 2|Lost to Follow-up|3|||
161511607|NCT02880371|583265135|FG007|Phase 2|Lost to Follow-up|0|||
161511608|NCT02880371|583265128|FG000|Phase 2|Withdrawal by Subject|0|||
161587758|NCT04842643|583542263|FG000|Overall Study|Other|1|||
161587759|NCT02662062|583542265|FG000|Overall Study|Withdrawal by Subject|1|||
161587760|NCT00676715|583542266|FG000|Treatment Period (TP)|Adverse Event|0|||
161587761|NCT00676715|583542267|FG001|Treatment Period (TP)|Adverse Event|3|||
161587762|NCT00676715|583542268|FG002|Treatment Period (TP)|Adverse Event|2|||
161587763|NCT00676715|583542269|FG003|Treatment Period (TP)|Adverse Event|2|||
161587764|NCT00676715|583542266|FG000|Treatment Period (TP)|Death|0|||
161587765|NCT00676715|583542267|FG001|Treatment Period (TP)|Death|0|||
161587766|NCT00676715|583542268|FG002|Treatment Period (TP)|Death|1|||
161587767|NCT00676715|583542269|FG003|Treatment Period (TP)|Death|0|||
161511609|NCT02880371|583265129|FG001|Phase 2|Withdrawal by Subject|0|||
161511610|NCT02880371|583265130|FG002|Phase 2|Withdrawal by Subject|0|||
161511611|NCT02880371|583265131|FG003|Phase 2|Withdrawal by Subject|0|||
161511612|NCT02880371|583265132|FG004|Phase 2|Withdrawal by Subject|0|||
161511613|NCT02880371|583265133|FG005|Phase 2|Withdrawal by Subject|1|||
161511614|NCT02880371|583265134|FG006|Phase 2|Withdrawal by Subject|1|||
161511615|NCT02880371|583265135|FG007|Phase 2|Withdrawal by Subject|0|||
161511616|NCT02880371|583265128|FG000|Phase 2|End of Study page not completed by error|0|||
161511617|NCT02880371|583265129|FG001|Phase 2|End of Study page not completed by error|0|||
161587768|NCT00676715|583542266|FG000|Treatment Period (TP)|Failure to return|1|||
161587769|NCT00676715|583542267|FG001|Treatment Period (TP)|Failure to return|0|||
161511618|NCT02880371|583265130|FG002|Phase 2|End of Study page not completed by error|0|||
161511619|NCT02880371|583265131|FG003|Phase 2|End of Study page not completed by error|0|||
161511620|NCT02880371|583265132|FG004|Phase 2|End of Study page not completed by error|0|||
161511621|NCT02880371|583265133|FG005|Phase 2|End of Study page not completed by error|1|||
161511622|NCT02880371|583265134|FG006|Phase 2|End of Study page not completed by error|0|||
161511623|NCT02880371|583265135|FG007|Phase 2|End of Study page not completed by error|0|||
161511624|NCT03285646|583265145|FG000|Overall Study|Adverse Event|1|||
161511625|NCT03285646|583265146|FG001|Overall Study|Adverse Event|0|||
161511626|NCT03285646|583265145|FG000|Overall Study|Withdrawal by Subject|10|||
161511627|NCT03285646|583265146|FG001|Overall Study|Withdrawal by Subject|2|||
161511628|NCT03285646|583265145|FG000|Overall Study|Lost to Follow-up|2|||
161511629|NCT03285646|583265146|FG001|Overall Study|Lost to Follow-up|1|||
161511630|NCT03285646|583265145|FG000|Overall Study|Investigator/Sponsor Decision|0|||
161511631|NCT03285646|583265146|FG001|Overall Study|Investigator/Sponsor Decision|1|||
161511632|NCT02660359|583265147|FG000|Overall Study|Protocol Deviation|0|||
161511633|NCT02660359|583265148|FG001|Overall Study|Protocol Deviation|0|||
161511634|NCT02660359|583265149|FG002|Overall Study|Protocol Deviation|1|||
161511635|NCT02660359|583265147|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
161511636|NCT02660359|583265148|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
161511637|NCT02660359|583265149|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
161511638|NCT02660359|583265147|FG000|Overall Study|Lack of Efficacy|1|||
161511639|NCT02660359|583265148|FG001|Overall Study|Lack of Efficacy|1|||
161511640|NCT02660359|583265149|FG002|Overall Study|Lack of Efficacy|1|||
161511641|NCT02660359|583265147|FG000|Overall Study|Adverse Event|0|||
161511642|NCT02660359|583265148|FG001|Overall Study|Adverse Event|1|||
161511643|NCT02660359|583265149|FG002|Overall Study|Adverse Event|0|||
161511644|NCT02660359|583265147|FG000|Overall Study|Other|2|||
161511645|NCT02660359|583265148|FG001|Overall Study|Other|1|||
161511646|NCT02660359|583265149|FG002|Overall Study|Other|3|||
161511647|NCT02660359|583265147|FG000|Overall Study|Withdrawal by Subject|7|||
161511648|NCT02660359|583265148|FG001|Overall Study|Withdrawal by Subject|5|||
161511649|NCT02660359|583265149|FG002|Overall Study|Withdrawal by Subject|8|||
161676138|NCT01667107|583867307|FG000|Overall Study|Protocol Violation|0|||
161511650|NCT02660359|583265147|FG000|Overall Study|Lost to Follow-up|3|||
161511651|NCT02660359|583265148|FG001|Overall Study|Lost to Follow-up|3|||
161511652|NCT02660359|583265149|FG002|Overall Study|Lost to Follow-up|0|||
161511653|NCT01923181|583265152|FG000|Overall Study|Protocol Violation|2|||
161511654|NCT01923181|583265153|FG001|Overall Study|Protocol Violation|2|||
161511655|NCT01923181|583265154|FG002|Overall Study|Protocol Violation|0|||
161511656|NCT01923181|583265155|FG003|Overall Study|Protocol Violation|2|||
161511657|NCT01923181|583265156|FG004|Overall Study|Protocol Violation|2|||
161511658|NCT01923181|583265157|FG005|Overall Study|Protocol Violation|1|||
161511659|NCT01923181|583265158|FG006|Overall Study|Protocol Violation|1|||
161511660|NCT01923181|583265159|FG007|Overall Study|Protocol Violation|2|||
161511661|NCT01923181|583265160|FG008|Overall Study|Protocol Violation|1|||
161511662|NCT01923181|583265152|FG000|Overall Study|Withdrawal by Subject|0|||
161511663|NCT01923181|583265153|FG001|Overall Study|Withdrawal by Subject|1|||
161511664|NCT01923181|583265154|FG002|Overall Study|Withdrawal by Subject|0|||
161511665|NCT01923181|583265155|FG003|Overall Study|Withdrawal by Subject|1|||
161511666|NCT01923181|583265156|FG004|Overall Study|Withdrawal by Subject|4|||
161511667|NCT01923181|583265157|FG005|Overall Study|Withdrawal by Subject|2|||
161511668|NCT01923181|583265158|FG006|Overall Study|Withdrawal by Subject|4|||
161511669|NCT01923181|583265159|FG007|Overall Study|Withdrawal by Subject|3|||
161511670|NCT01923181|583265160|FG008|Overall Study|Withdrawal by Subject|1|||
161511671|NCT01923181|583265152|FG000|Overall Study|Other|1|||
161511672|NCT01923181|583265153|FG001|Overall Study|Other|0|||
161511673|NCT01923181|583265154|FG002|Overall Study|Other|0|||
161511674|NCT01923181|583265155|FG003|Overall Study|Other|1|||
161511675|NCT01923181|583265156|FG004|Overall Study|Other|0|||
161511676|NCT01923181|583265157|FG005|Overall Study|Other|0|||
161511677|NCT01923181|583265158|FG006|Overall Study|Other|0|||
161511678|NCT01923181|583265159|FG007|Overall Study|Other|0|||
161511679|NCT01923181|583265160|FG008|Overall Study|Other|0|||
161511680|NCT01923181|583265152|FG000|Overall Study|Lost to Follow-up|0|||
161511681|NCT01923181|583265153|FG001|Overall Study|Lost to Follow-up|3|||
161511682|NCT01923181|583265154|FG002|Overall Study|Lost to Follow-up|2|||
161511683|NCT01923181|583265155|FG003|Overall Study|Lost to Follow-up|1|||
161511684|NCT01923181|583265156|FG004|Overall Study|Lost to Follow-up|2|||
161511685|NCT01923181|583265157|FG005|Overall Study|Lost to Follow-up|1|||
161511686|NCT01923181|583265158|FG006|Overall Study|Lost to Follow-up|3|||
161511687|NCT01923181|583265159|FG007|Overall Study|Lost to Follow-up|3|||
161511688|NCT01923181|583265160|FG008|Overall Study|Lost to Follow-up|1|||
161511689|NCT04101526|583265162|FG000|Overall Study|Did not complete all sleep diary entries|0|||
161511690|NCT04101526|583265163|FG001|Overall Study|Did not complete all sleep diary entries|1|||
161511691|NCT02944578|583265164|FG000|Overall Study|Physician Decision|1|||
161511692|NCT02944578|583265165|FG001|Overall Study|Physician Decision|0|||
161511693|NCT00424372|583265169|FG000|Overall Study|Death|1|||
161511694|NCT00424372|583265169|FG000|Overall Study|Adverse Event|18|||
161511695|NCT00424372|583265169|FG000|Overall Study|Lack of Efficacy|6|||
161511696|NCT00424372|583265169|FG000|Overall Study|Withdrawal by Subject|4|||
161511697|NCT00424372|583265169|FG000|Overall Study|Protocol Violation|1|||
161511698|NCT00424372|583265169|FG000|Overall Study|Health deterioration|1|||
161511699|NCT00451282|583265171|FG000|Overall Study|Lost to Follow-up|6|||
161511700|NCT00451282|583265172|FG001|Overall Study|Lost to Follow-up|5|||
161511701|NCT01797536|583265173|FG000|Overall Study|Adverse Event|0|||
161926730|NCT01214720|584778689|FG000|Overall Study|Lost to Follow-up|6|||
161511702|NCT01797536|583265174|FG001|Overall Study|Adverse Event|1|||
161511703|NCT01797536|583265175|FG002|Overall Study|Adverse Event|0|||
161926731|NCT01214720|584778690|FG001|Overall Study|Lost to Follow-up|2|||
161926732|NCT04625972|584778691|FG000|Overall Study|Death|3|||
161926733|NCT04625972|584778692|FG001|Overall Study|Death|2|||
161511704|NCT01797536|583265176|FG003|Overall Study|Adverse Event|0|||
161511705|NCT00098839|583265177|FG000|Overall Study|Adverse Event|5|||
161511706|NCT00098839|583265178|FG001|Overall Study|Adverse Event|2|||
161511707|NCT00098839|583265177|FG000|Overall Study|Death|1|||
161511708|NCT00098839|583265178|FG001|Overall Study|Death|2|||
161511709|NCT00098839|583265177|FG000|Overall Study|Physician Decision|4|||
161676139|NCT01667107|583867308|FG001|Overall Study|Protocol Violation|1|||
161676140|NCT01667107|583867307|FG000|Overall Study|Lack of Efficacy|0|||
161676141|NCT01667107|583867308|FG001|Overall Study|Lack of Efficacy|1|||
161511710|NCT00098839|583265178|FG001|Overall Study|Physician Decision|14|||
161511711|NCT00098839|583265177|FG000|Overall Study|Withdrawal by Subject|1|||
161511712|NCT00098839|583265178|FG001|Overall Study|Withdrawal by Subject|0|||
161511713|NCT00098839|583265177|FG000|Overall Study|Refusal of further protocol therapy|3|||
161511714|NCT00098839|583265178|FG001|Overall Study|Refusal of further protocol therapy|1|||
161511715|NCT00098839|583265177|FG000|Overall Study|Relapse|6|||
161511716|NCT00098839|583265178|FG001|Overall Study|Relapse|3|||
161511717|NCT00098839|583265177|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
161511718|NCT00098839|583265178|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
161511719|NCT00098839|583265177|FG000|Overall Study|Ineligible|2|||
161511720|NCT00098839|583265178|FG001|Overall Study|Ineligible|0|||
161511721|NCT04879745|583265179|FG000|Overall Study|Lost to Follow-up|4|||
161587770|NCT00676715|583542268|FG002|Treatment Period (TP)|Failure to return|0|||
161926734|NCT04625972|584778691|FG000|Overall Study|Lost to Follow-up|82|||
161926735|NCT04625972|584778692|FG001|Overall Study|Lost to Follow-up|38|||
161926736|NCT04625972|584778691|FG000|Overall Study|Physician Decision|2|||
161926737|NCT04625972|584778692|FG001|Overall Study|Physician Decision|0|||
161926738|NCT04625972|584778691|FG000|Overall Study|Protocol Violation|0|||
161926739|NCT04625972|584778692|FG001|Overall Study|Protocol Violation|1|||
161926740|NCT04625972|584778691|FG000|Overall Study|Withdrawal by Subject|37|||
161926741|NCT04625972|584778692|FG001|Overall Study|Withdrawal by Subject|24|||
161926742|NCT04625972|584778691|FG000|Overall Study|Not specified elsewhere|8|||
161926743|NCT04625972|584778692|FG001|Overall Study|Not specified elsewhere|6|||
161926744|NCT05591755|584778693|FG000|Overall Study|Screen Failure|1|||
161926745|NCT05591755|584778694|FG001|Overall Study|Screen Failure|0|||
161926746|NCT05591755|584778695|FG002|Overall Study|Screen Failure|0|||
161926747|NCT05591755|584778696|FG003|Overall Study|Screen Failure|0|||
161926748|NCT05591755|584778693|FG000|Overall Study|Protocol Violation|0|||
161926749|NCT05591755|584778694|FG001|Overall Study|Protocol Violation|0|||
161926750|NCT05591755|584778695|FG002|Overall Study|Protocol Violation|2|||
161926751|NCT05591755|584778696|FG003|Overall Study|Protocol Violation|0|||
161926752|NCT05591755|584778693|FG000|Overall Study|Withdrawal by Subject|0|||
161926753|NCT05591755|584778694|FG001|Overall Study|Withdrawal by Subject|1|||
161926754|NCT05591755|584778695|FG002|Overall Study|Withdrawal by Subject|0|||
161926755|NCT05591755|584778696|FG003|Overall Study|Withdrawal by Subject|0|||
161926756|NCT00433290|584778697|FG000|Overall Study|Adverse Event|24|||
161926757|NCT00433290|584778698|FG001|Overall Study|Adverse Event|7|||
161926758|NCT00433290|584778697|FG000|Overall Study|Lack of Efficacy|1|||
161926759|NCT00433290|584778698|FG001|Overall Study|Lack of Efficacy|5|||
161926760|NCT00433290|584778697|FG000|Overall Study|Withdrawal by Subject|4|||
161926761|NCT00433290|584778698|FG001|Overall Study|Withdrawal by Subject|2|||
161926762|NCT00433290|584778697|FG000|Overall Study|Protocol Violation|3|||
161926763|NCT00433290|584778698|FG001|Overall Study|Protocol Violation|2|||
161926764|NCT00433290|584778697|FG000|Overall Study|Physician Decision|2|||
161926765|NCT00433290|584778698|FG001|Overall Study|Physician Decision|0|||
161926766|NCT00433290|584778697|FG000|Overall Study|Entry Criteria Not Met|0|||
161926767|NCT00433290|584778698|FG001|Overall Study|Entry Criteria Not Met|1|||
161926768|NCT00433290|584778697|FG000|Overall Study|Lost to Follow-up|1|||
161926769|NCT00433290|584778698|FG001|Overall Study|Lost to Follow-up|0|||
161926770|NCT00086307|584778699|FG000|Overall Study|Lack of Efficacy|1|||
161926771|NCT00086307|584778700|FG001|Overall Study|Lack of Efficacy|1|||
161926772|NCT00086307|584778701|FG002|Overall Study|Lack of Efficacy|2|||
161926773|NCT00086307|584778699|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
161926774|NCT00086307|584778700|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
161926775|NCT00086307|584778701|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
161926776|NCT00086307|584778699|FG000|Overall Study|Nausea and headaches|0|||
161926777|NCT00086307|584778700|FG001|Overall Study|Nausea and headaches|0|||
161926778|NCT00086307|584778701|FG002|Overall Study|Nausea and headaches|1|||
161926779|NCT00086307|584778699|FG000|Overall Study|Constipation and sleepiness|0|||
161926780|NCT00086307|584778700|FG001|Overall Study|Constipation and sleepiness|0|||
161926781|NCT00086307|584778701|FG002|Overall Study|Constipation and sleepiness|1|||
161926782|NCT00086307|584778699|FG000|Overall Study|Suicidal ideation|0|||
161926783|NCT00086307|584778700|FG001|Overall Study|Suicidal ideation|0|||
161926784|NCT00086307|584778701|FG002|Overall Study|Suicidal ideation|1|||
161926785|NCT00086307|584778699|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
161926786|NCT00086307|584778700|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
161926787|NCT00086307|584778701|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
161926788|NCT00086307|584778699|FG000|Overall Study|Withdrawal by Subject|0|||
161926789|NCT00086307|584778700|FG001|Overall Study|Withdrawal by Subject|0|||
161926790|NCT00086307|584778701|FG002|Overall Study|Withdrawal by Subject|2|||
161587771|NCT00676715|583542269|FG003|Treatment Period (TP)|Failure to return|0|||
161587772|NCT00676715|583542266|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161587773|NCT00676715|583542267|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161587774|NCT00676715|583542268|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
161587775|NCT00676715|583542269|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161587776|NCT00676715|583542266|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
161926791|NCT03158311|584778704|FG000|Overall Study|Subject/Guardian Decision|10|||
161926792|NCT03158311|584778705|FG001|Overall Study|Subject/Guardian Decision|6|||
161926793|NCT03158311|584778706|FG002|Overall Study|Subject/Guardian Decision|11|||
161587777|NCT00676715|583542267|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
161587778|NCT00676715|583542268|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
161926794|NCT03158311|584778704|FG000|Overall Study|Adverse Event|5|||
161926795|NCT03158311|584778705|FG001|Overall Study|Adverse Event|3|||
161926796|NCT03158311|584778706|FG002|Overall Study|Adverse Event|3|||
161926797|NCT03158311|584778704|FG000|Overall Study|Techinical Problems|3|||
161926798|NCT03158311|584778705|FG001|Overall Study|Techinical Problems|1|||
161926799|NCT03158311|584778706|FG002|Overall Study|Techinical Problems|5|||
161926800|NCT03158311|584778704|FG000|Overall Study|Physician Decision|2|||
161587779|NCT00676715|583542269|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
161587780|NCT00676715|583542266|FG000|Treatment Period (TP)|Withdrew consent|3|||
161587781|NCT00676715|583542267|FG001|Treatment Period (TP)|Withdrew consent|3|||
161587782|NCT00676715|583542268|FG002|Treatment Period (TP)|Withdrew consent|3|||
161587783|NCT00676715|583542269|FG003|Treatment Period (TP)|Withdrew consent|3|||
161587784|NCT00676715|583542266|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
161587785|NCT00676715|583542267|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
161926801|NCT03158311|584778705|FG001|Overall Study|Physician Decision|3|||
161926802|NCT03158311|584778706|FG002|Overall Study|Physician Decision|7|||
161926803|NCT03158311|584778704|FG000|Overall Study|Lost to Follow-up|1|||
161511722|NCT04879745|583265180|FG001|Overall Study|Lost to Follow-up|1|||
161511723|NCT00120042|583265181|FG000|Overall Study|all completed protocl|0|||
161511724|NCT00120042|583265182|FG001|Overall Study|all completed protocl|0|||
161511725|NCT00120042|583265183|FG002|Overall Study|all completed protocl|0|||
161511726|NCT04532112|583265186|FG000|Overall Study|Adverse Event|3|||
161511727|NCT04532112|583265187|FG001|Overall Study|Adverse Event|0|||
161511728|NCT01126541|583265189|FG000|Overall Study|Adverse Event|0|||
161511729|NCT01126541|583265190|FG001|Overall Study|Adverse Event|2|||
161511730|NCT01126541|583265191|FG002|Overall Study|Adverse Event|4|||
161511731|NCT01126541|583265189|FG000|Overall Study|Death|0|||
161511732|NCT01126541|583265190|FG001|Overall Study|Death|1|||
161511733|NCT01126541|583265191|FG002|Overall Study|Death|0|||
161511734|NCT01126541|583265189|FG000|Overall Study|Lack of Efficacy|6|||
161511735|NCT01126541|583265190|FG001|Overall Study|Lack of Efficacy|1|||
161511736|NCT01126541|583265191|FG002|Overall Study|Lack of Efficacy|11|||
161511737|NCT01126541|583265189|FG000|Overall Study|Lost to Follow-up|1|||
161511738|NCT01126541|583265190|FG001|Overall Study|Lost to Follow-up|2|||
161511739|NCT01126541|583265191|FG002|Overall Study|Lost to Follow-up|2|||
161511740|NCT01126541|583265189|FG000|Overall Study|Withdrawal by Subject|2|||
161511741|NCT01126541|583265190|FG001|Overall Study|Withdrawal by Subject|5|||
161511742|NCT01126541|583265191|FG002|Overall Study|Withdrawal by Subject|6|||
161511743|NCT01126541|583265189|FG000|Overall Study|Protocol Violation|0|||
161511744|NCT01126541|583265190|FG001|Overall Study|Protocol Violation|0|||
161511745|NCT01126541|583265191|FG002|Overall Study|Protocol Violation|1|||
161511746|NCT01126541|583265189|FG000|Overall Study|Administrative reason or other|1|||
161511747|NCT01126541|583265190|FG001|Overall Study|Administrative reason or other|1|||
161511748|NCT01126541|583265191|FG002|Overall Study|Administrative reason or other|2|||
161511749|NCT02664038|583265193|FG000|13 Week|Lost to Follow-up|7|||
161511750|NCT02664038|583265194|FG001|13 Week|Lost to Follow-up|14|||
161511751|NCT02664038|583265193|FG000|13 Week|Withdrawal by Subject|1|||
161511752|NCT02664038|583265194|FG001|13 Week|Withdrawal by Subject|0|||
161511753|NCT02664038|583265193|FG000|26 Week|Lost to Follow-up|5|||
161511754|NCT02664038|583265194|FG001|26 Week|Lost to Follow-up|4|||
161511755|NCT06640829|583265199|FG000|Overall Study|Withdrawal by Subject|1|||
161511756|NCT06640829|583265199|FG000|Overall Study|Lost to Follow-up|1|||
161511757|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Adverse Event|41|||
161511758|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Adverse Event|24|||
161511759|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
161511760|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
161511761|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
161587786|NCT00676715|583542268|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
161587787|NCT00676715|583542269|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
161587788|NCT00676715|583542266|FG000|Treatment Period (TP)|Administrative|0|||
161926804|NCT03158311|584778705|FG001|Overall Study|Lost to Follow-up|1|||
161926805|NCT03158311|584778706|FG002|Overall Study|Lost to Follow-up|1|||
161926806|NCT03158311|584778704|FG000|Overall Study|Sponsor decision|1|||
161926807|NCT03158311|584778705|FG001|Overall Study|Sponsor decision|0|||
161511762|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
161511763|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Physician Decision|0|||
161511764|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Physician Decision|6|||
161511765|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
161511766|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
161511767|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
161511768|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
161587789|NCT00676715|583542267|FG001|Treatment Period (TP)|Administrative|0|||
161683067|NCT01148537|583891234|FG001|Overall Study|Withdrawal by Subject|0|||
161926808|NCT03158311|584778706|FG002|Overall Study|Sponsor decision|0|||
161511769|NCT00673452|583265201|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
161511770|NCT00673452|583265202|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
161511771|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
161511772|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
161926809|NCT03158311|584778704|FG000|Overall Study|Pregnancy|0|||
161511773|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
161511774|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
161511775|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
161511776|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
161511777|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
161511778|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
161676142|NCT03427125|583867309|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
161676143|NCT03427125|583867310|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
161676144|NCT03427125|583867311|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
161676145|NCT02281357|583867312|FG000|Overall Study|Adverse Event|2|||
161676146|NCT02281357|583867313|FG001|Overall Study|Adverse Event|1|||
161676147|NCT02281357|583867312|FG000|Overall Study|Lost to Follow-up|1|||
161676148|NCT02281357|583867313|FG001|Overall Study|Lost to Follow-up|0|||
161926810|NCT03158311|584778705|FG001|Overall Study|Pregnancy|2|||
161926811|NCT03158311|584778706|FG002|Overall Study|Pregnancy|0|||
161511779|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
161511780|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
161511781|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
161511782|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
161511783|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
161511784|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
161511785|NCT00673452|583265201|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
161511786|NCT00673452|583265202|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
161511787|NCT03025828|583265203|FG000|Overall Study|Lost to Follow-up|1|||
161511788|NCT02519712|583265206|FG000|Overall Study|Disease Relapse|1|||
161511789|NCT02519712|583265206|FG000|Overall Study|Disease Progression|1|||
161511790|NCT02519712|583265206|FG000|Overall Study|Accruals are donors|2|||
161511791|NCT02908529|583265217|FG000|Overall Study|Lost to Follow-up|0|||
161511792|NCT02908529|583265218|FG001|Overall Study|Lost to Follow-up|2|||
161511793|NCT04497987|583265219|FG000|Overall Study|Adverse Event|1|||
161587790|NCT00676715|583542268|FG002|Treatment Period (TP)|Administrative|0|||
161926812|NCT03158311|584778704|FG000|Overall Study|Randomized in error|0|||
161926813|NCT03158311|584778705|FG001|Overall Study|Randomized in error|0|||
161587791|NCT00676715|583542269|FG003|Treatment Period (TP)|Administrative|1|||
161587792|NCT00676715|583542266|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
161587793|NCT00676715|583542267|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
161587794|NCT00676715|583542268|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
161587795|NCT00676715|583542269|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
161587796|NCT00676715|583542266|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
161587797|NCT00676715|583542267|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
161587798|NCT00676715|583542268|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
161587799|NCT00676715|583542269|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
161587800|NCT00676715|583542266|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161587801|NCT00676715|583542267|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161587802|NCT00676715|583542268|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
161587803|NCT00676715|583542269|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161587804|NCT00676715|583542266|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
161587805|NCT00676715|583542267|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
161587806|NCT00676715|583542268|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
161587807|NCT00676715|583542269|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
161587808|NCT00676715|583542266|FG000|Treatment-free Period (TFP)|Death|1|||
161676149|NCT02281357|583867312|FG000|Overall Study|Withdrawal by Subject|4|||
161676150|NCT02281357|583867313|FG001|Overall Study|Withdrawal by Subject|3|||
161926814|NCT03158311|584778706|FG002|Overall Study|Randomized in error|1|||
161926815|NCT00724503|584778707|FG000|Overall Study|Lost to Follow-up|4|||
161926816|NCT00724503|584778708|FG001|Overall Study|Lost to Follow-up|8|||
161926817|NCT00724503|584778707|FG000|Overall Study|Withdrawal by Subject|11|||
161926818|NCT00724503|584778708|FG001|Overall Study|Withdrawal by Subject|23|||
161926819|NCT00724503|584778707|FG000|Overall Study|Death|190|||
161926820|NCT00724503|584778708|FG001|Overall Study|Death|182|||
161926821|NCT00724503|584778707|FG000|Overall Study|Adverse Event|1|||
161587809|NCT00676715|583542267|FG001|Treatment-free Period (TFP)|Death|1|||
161587810|NCT00676715|583542268|FG002|Treatment-free Period (TFP)|Death|1|||
161587811|NCT00676715|583542269|FG003|Treatment-free Period (TFP)|Death|0|||
161587812|NCT00676715|583542266|FG000|Open Label Extension (OLE)|Reason not provided|3|||
161587813|NCT00676715|583542267|FG001|Open Label Extension (OLE)|Reason not provided|4|||
161587814|NCT00676715|583542268|FG002|Open Label Extension (OLE)|Reason not provided|1|||
161587815|NCT00676715|583542269|FG003|Open Label Extension (OLE)|Reason not provided|4|||
161587816|NCT00676715|583542266|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
161511794|NCT04497987|583265220|FG001|Overall Study|Adverse Event|0|||
161511795|NCT04497987|583265219|FG000|Overall Study|Death|21|||
161926822|NCT00724503|584778708|FG001|Overall Study|Adverse Event|0|||
161926823|NCT00724503|584778707|FG000|Overall Study|Not otherwise specified|4|||
161926824|NCT00724503|584778708|FG001|Overall Study|Not otherwise specified|7|||
161926825|NCT01186419|584778709|FG000|Overall Study|Withdrawal by Subject|5|||
161926826|NCT01186419|584778710|FG001|Overall Study|Withdrawal by Subject|3|||
161926827|NCT01186419|584778709|FG000|Overall Study|Adverse Event|1|||
161926828|NCT01186419|584778710|FG001|Overall Study|Adverse Event|2|||
161926829|NCT01186419|584778709|FG000|Overall Study|Physician Decision|0|||
161511796|NCT04497987|583265220|FG001|Overall Study|Death|13|||
161511797|NCT04497987|583265219|FG000|Overall Study|Lost to Follow-up|19|||
161511798|NCT04497987|583265220|FG001|Overall Study|Lost to Follow-up|17|||
161511799|NCT04497987|583265219|FG000|Overall Study|Other - as reported by the investigator|22|||
161511800|NCT04497987|583265220|FG001|Overall Study|Other - as reported by the investigator|16|||
161511801|NCT04497987|583265219|FG000|Overall Study|Physician Decision|1|||
161511802|NCT04497987|583265220|FG001|Overall Study|Physician Decision|0|||
161511803|NCT04497987|583265219|FG000|Overall Study|Withdrawal by Subject|35|||
161511804|NCT04497987|583265220|FG001|Overall Study|Withdrawal by Subject|21|||
161511805|NCT02553421|583265225|FG000|Overall Study|Lost to Follow-up|21|||
161511806|NCT02553421|583265226|FG001|Overall Study|Lost to Follow-up|1|||
161511807|NCT02553421|583265225|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
161511808|NCT02553421|583265226|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
161511809|NCT02553421|583265225|FG000|Overall Study|Improper Device Placement|3|||
161511810|NCT02553421|583265226|FG001|Overall Study|Improper Device Placement|0|||
161511811|NCT01694706|583267940|FG000|Overall Study|Adverse Event|0|||
161511812|NCT01694706|583267941|FG001|Overall Study|Adverse Event|1|||
161511813|NCT01694706|583267942|FG002|Overall Study|Adverse Event|0|||
161511814|NCT01694706|583267940|FG000|Overall Study|other reason not defined above|1|||
161511815|NCT01694706|583267941|FG001|Overall Study|other reason not defined above|0|||
161511816|NCT01694706|583267942|FG002|Overall Study|other reason not defined above|0|||
161511817|NCT00654628|583267943|FG000|6-week Active Treatment Period|Adverse Event|9|||
161511818|NCT00654628|583267943|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
161511819|NCT00654628|583267943|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
161511820|NCT00654628|583267943|FG000|6-week Active Treatment Period|Out of window period|1|||
161511821|NCT00654628|583267943|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
161511822|NCT00654628|583267943|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
161511823|NCT00912405|583267946|FG000|Overall Study|Lost to Follow-up|5|||
161511824|NCT00953329|583267947|FG000|Overall Study|Lack of Efficacy|1|||
161511825|NCT01434823|583267950|FG000|Overall Study|Incomplete data in medical record|4|||
161511826|NCT01434823|583267951|FG001|Overall Study|Incomplete data in medical record|7|||
161511827|NCT00456092|583267956|FG000|Extension Phase|Grade 2 or Greater AE|2|||
161511828|NCT00456092|583267957|FG001|Extension Phase|Grade 2 or Greater AE|2|||
161511829|NCT00456092|583267958|FG002|Extension Phase|Grade 2 or Greater AE|0|||
161926830|NCT01186419|584778710|FG001|Overall Study|Physician Decision|3|||
161926831|NCT01186419|584778709|FG000|Overall Study|Other|1|||
161926832|NCT01186419|584778710|FG001|Overall Study|Other|1|||
161926833|NCT01560416|584778722|FG000|Randomized Phase|Crossover Participants|7|||
161926834|NCT01560416|584778723|FG001|Randomized Phase|Crossover Participants|0|||
161926835|NCT01033071|584778724|FG000|Overall Study|Adverse Event|28|||
161926836|NCT01033071|584778725|FG001|Overall Study|Adverse Event|51|||
161926837|NCT01033071|584778726|FG002|Overall Study|Adverse Event|26|||
161926838|NCT01033071|584778724|FG000|Overall Study|Protocol Violation|0|||
161926839|NCT01033071|584778725|FG001|Overall Study|Protocol Violation|2|||
161926840|NCT01033071|584778726|FG002|Overall Study|Protocol Violation|1|||
161926841|NCT01033071|584778724|FG000|Overall Study|Lost to Follow-up|4|||
161926842|NCT01033071|584778725|FG001|Overall Study|Lost to Follow-up|5|||
161926843|NCT01033071|584778726|FG002|Overall Study|Lost to Follow-up|5|||
161926844|NCT01033071|584778724|FG000|Overall Study|Withdrawal by Subject|17|||
161926845|NCT01033071|584778725|FG001|Overall Study|Withdrawal by Subject|14|||
161926846|NCT01033071|584778726|FG002|Overall Study|Withdrawal by Subject|11|||
161926847|NCT01033071|584778724|FG000|Overall Study|Lack of Efficacy|0|||
161926848|NCT01033071|584778725|FG001|Overall Study|Lack of Efficacy|1|||
161926849|NCT01033071|584778726|FG002|Overall Study|Lack of Efficacy|1|||
161926850|NCT01033071|584778724|FG000|Overall Study|Other|6|||
161511830|NCT00456092|583267959|FG003|Extension Phase|Grade 2 or Greater AE|0|||
161511831|NCT00456092|583267960|FG004|Extension Phase|Grade 2 or Greater AE|2|||
161511832|NCT00456092|583267956|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
161587817|NCT00676715|583542267|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
161926851|NCT01033071|584778725|FG001|Overall Study|Other|4|||
161926852|NCT01033071|584778726|FG002|Overall Study|Other|3|||
161926853|NCT00884949|584780158|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
161511833|NCT00456092|583267957|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
161587818|NCT00676715|583542268|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
161926854|NCT00884949|584780158|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
161926855|NCT03684057|584780163|FG000|Overall Study|Withdrawal by Subject|4|||
161926856|NCT03684057|584780164|FG001|Overall Study|Withdrawal by Subject|5|||
161926857|NCT00758043|584780165|FG000|Overall Study|Adverse Event|1|||
161926858|NCT00758043|584780166|FG001|Overall Study|Adverse Event|20|||
161511834|NCT00456092|583267958|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
161676151|NCT01162239|583867314|FG000|Treatment Phase|Withdrawal by Subject|1|||
161676152|NCT01162239|583867315|FG001|Treatment Phase|Withdrawal by Subject|3|||
161676153|NCT01162239|583867316|FG002|Treatment Phase|Withdrawal by Subject|2|||
161676154|NCT01162239|583867317|FG003|Treatment Phase|Withdrawal by Subject|3|||
161676155|NCT01162239|583867314|FG000|Treatment Phase|Death|0|||
161676156|NCT01162239|583867315|FG001|Treatment Phase|Death|0|||
161676157|NCT01162239|583867316|FG002|Treatment Phase|Death|0|||
161676158|NCT01162239|583867317|FG003|Treatment Phase|Death|1|||
161676159|NCT01162239|583867314|FG000|Treatment Phase|Lost to Follow-up|5|||
161676160|NCT01162239|583867315|FG001|Treatment Phase|Lost to Follow-up|4|||
161676161|NCT01162239|583867316|FG002|Treatment Phase|Lost to Follow-up|2|||
161511835|NCT00456092|583267959|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
161511836|NCT00456092|583267960|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
161511837|NCT00456092|583267956|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
161511838|NCT00456092|583267957|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
161511839|NCT00456092|583267958|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
161511840|NCT00456092|583267959|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
161511841|NCT00456092|583267960|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
161511842|NCT00456092|583267956|FG000|Extension Phase|Withdrew Consent|2|||
161511843|NCT00456092|583267957|FG001|Extension Phase|Withdrew Consent|0|||
161511844|NCT00456092|583267958|FG002|Extension Phase|Withdrew Consent|0|||
161511845|NCT00456092|583267959|FG003|Extension Phase|Withdrew Consent|0|||
161511846|NCT00456092|583267960|FG004|Extension Phase|Withdrew Consent|0|||
161511847|NCT00456092|583267956|FG000|Extension Phase|Lost to Follow-up|1|||
161511848|NCT00456092|583267957|FG001|Extension Phase|Lost to Follow-up|1|||
161511849|NCT00456092|583267958|FG002|Extension Phase|Lost to Follow-up|0|||
161511850|NCT00456092|583267959|FG003|Extension Phase|Lost to Follow-up|0|||
161511851|NCT00456092|583267960|FG004|Extension Phase|Lost to Follow-up|1|||
161511852|NCT00456092|583267956|FG000|Extension Phase|Other|2|||
161511853|NCT00456092|583267957|FG001|Extension Phase|Other|0|||
161511854|NCT00456092|583267958|FG002|Extension Phase|Other|0|||
161511855|NCT00456092|583267959|FG003|Extension Phase|Other|1|||
161511856|NCT00456092|583267960|FG004|Extension Phase|Other|1|||
161511857|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
161511858|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
161511859|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
161511860|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
161511861|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
161511862|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
161511863|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
161511864|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
161511865|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
161511866|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
161511867|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
161511868|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
161511869|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
161511870|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
161511871|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
161511872|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
161511873|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
161511874|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
161511875|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
161511876|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
161676162|NCT01162239|583867317|FG003|Treatment Phase|Lost to Follow-up|1|||
161676163|NCT01162239|583867314|FG000|Extended Follow-up|Lost to Follow-up|8|||
161676164|NCT01162239|583867315|FG001|Extended Follow-up|Lost to Follow-up|13|||
161676165|NCT01162239|583867316|FG002|Extended Follow-up|Lost to Follow-up|8|||
161676166|NCT01162239|583867317|FG003|Extended Follow-up|Lost to Follow-up|6|||
161676167|NCT05975840|583867318|FG000|Overall Study|Other|1|||
161676168|NCT05975840|583867319|FG001|Overall Study|Other|0|||
161676169|NCT05975840|583867320|FG002|Overall Study|Other|0|||
161820791|NCT01745094|584384646|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
161820792|NCT01745094|584384643|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
161511877|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
161676170|NCT05975840|583867321|FG003|Overall Study|Other|0|||
161511878|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
161511879|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
161511880|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
161511881|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
161676171|NCT05975840|583867322|FG004|Overall Study|Other|1|||
161676172|NCT05975840|583867323|FG005|Overall Study|Other|0|||
161676173|NCT05975840|583867324|FG006|Overall Study|Other|0|||
161926859|NCT00758043|584780167|FG002|Overall Study|Adverse Event|12|||
161926860|NCT00758043|584780168|FG003|Overall Study|Adverse Event|62|||
161926861|NCT00758043|584780165|FG000|Overall Study|Lack of Efficacy|0|||
161926862|NCT00758043|584780166|FG001|Overall Study|Lack of Efficacy|6|||
161926863|NCT00758043|584780167|FG002|Overall Study|Lack of Efficacy|18|||
161926864|NCT00758043|584780168|FG003|Overall Study|Lack of Efficacy|12|||
161926865|NCT00758043|584780165|FG000|Overall Study|Refused Further Treatment|0|||
161926866|NCT00758043|584780166|FG001|Overall Study|Refused Further Treatment|11|||
161926867|NCT00758043|584780167|FG002|Overall Study|Refused Further Treatment|5|||
161926868|NCT00758043|584780168|FG003|Overall Study|Refused Further Treatment|8|||
161926869|NCT00758043|584780165|FG000|Overall Study|Lost to Follow-up|0|||
161926870|NCT00758043|584780166|FG001|Overall Study|Lost to Follow-up|2|||
161926871|NCT00758043|584780167|FG002|Overall Study|Lost to Follow-up|2|||
161926872|NCT00758043|584780168|FG003|Overall Study|Lost to Follow-up|5|||
161926873|NCT00758043|584780165|FG000|Overall Study|Withdrawal by Subject|0|||
161926874|NCT00758043|584780166|FG001|Overall Study|Withdrawal by Subject|1|||
161926875|NCT00758043|584780167|FG002|Overall Study|Withdrawal by Subject|1|||
161926876|NCT00758043|584780168|FG003|Overall Study|Withdrawal by Subject|4|||
161926877|NCT00758043|584780165|FG000|Overall Study|Required Prohibited Medication|0|||
161926878|NCT00758043|584780166|FG001|Overall Study|Required Prohibited Medication|0|||
161926879|NCT00758043|584780167|FG002|Overall Study|Required Prohibited Medication|1|||
161926880|NCT00758043|584780168|FG003|Overall Study|Required Prohibited Medication|3|||
161926881|NCT00758043|584780165|FG000|Overall Study|Non-Compliant With study Drug|0|||
161926882|NCT00758043|584780166|FG001|Overall Study|Non-Compliant With study Drug|0|||
161926883|NCT00758043|584780167|FG002|Overall Study|Non-Compliant With study Drug|0|||
161926884|NCT00758043|584780168|FG003|Overall Study|Non-Compliant With study Drug|1|||
161926885|NCT00758043|584780165|FG000|Overall Study|Other Reasons|0|||
161926886|NCT00758043|584780166|FG001|Overall Study|Other Reasons|1|||
161926887|NCT00758043|584780167|FG002|Overall Study|Other Reasons|0|||
161926888|NCT00758043|584780168|FG003|Overall Study|Other Reasons|5|||
161926889|NCT03422718|584780172|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
161926890|NCT03422718|584780173|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
161926891|NCT03422718|584780174|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
161926892|NCT03422718|584780175|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
161926893|NCT03422718|584780176|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
161926894|NCT03422718|584780177|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
161926895|NCT03422718|584780178|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
161926896|NCT03422718|584780179|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
161926897|NCT03422718|584780172|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
161926898|NCT03422718|584780173|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
161926899|NCT03422718|584780174|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
161926900|NCT03422718|584780175|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
161926901|NCT03422718|584780176|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
161926902|NCT03422718|584780177|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
161926903|NCT03422718|584780178|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
161926904|NCT03422718|584780179|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
161926905|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
161926906|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
161926907|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
161926908|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
161926909|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
161926910|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
161926911|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
161926912|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
161926913|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926914|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
161511882|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
161511883|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
161511884|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
161511885|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
161511886|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
161926915|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926916|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926917|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
161926918|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
161926919|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926920|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926921|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
161511887|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
161511888|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
161511889|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
161511890|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
161511891|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
161511892|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161511893|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
161511894|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
161511895|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161511896|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161511897|NCT00456092|583267956|FG000|Treatment Phase (12 Weeks)|Other|1|||
161511898|NCT00456092|583267957|FG001|Treatment Phase (12 Weeks)|Other|0|||
161511899|NCT00456092|583267958|FG002|Treatment Phase (12 Weeks)|Other|1|||
161511900|NCT00456092|583267959|FG003|Treatment Phase (12 Weeks)|Other|0|||
161511901|NCT00456092|583267960|FG004|Treatment Phase (12 Weeks)|Other|0|||
161511902|NCT01252290|583267965|FG000|Overall Study|Withdrawal by Subject|1|||
161511903|NCT02247349|583267966|FG000|Overall Study|Disease Progression|7|||
161511904|NCT02247349|583267967|FG001|Overall Study|Disease Progression|4|||
161511905|NCT02247349|583267968|FG002|Overall Study|Disease Progression|26|||
161511906|NCT02247349|583267969|FG003|Overall Study|Disease Progression|31|||
161511907|NCT02247349|583267970|FG004|Overall Study|Disease Progression|16|||
161511908|NCT02247349|583267971|FG005|Overall Study|Disease Progression|6|||
161511909|NCT02247349|583267966|FG000|Overall Study|Study drug toxicity|0|||
161511910|NCT02247349|583267967|FG001|Overall Study|Study drug toxicity|1|||
161511911|NCT02247349|583267968|FG002|Overall Study|Study drug toxicity|1|||
161511912|NCT02247349|583267969|FG003|Overall Study|Study drug toxicity|1|||
161511913|NCT02247349|583267970|FG004|Overall Study|Study drug toxicity|2|||
161511914|NCT02247349|583267971|FG005|Overall Study|Study drug toxicity|2|||
161511915|NCT02247349|583267966|FG000|Overall Study|Death|0|||
161511916|NCT02247349|583267967|FG001|Overall Study|Death|0|||
161511917|NCT02247349|583267968|FG002|Overall Study|Death|0|||
161511918|NCT02247349|583267969|FG003|Overall Study|Death|1|||
161511919|NCT02247349|583267970|FG004|Overall Study|Death|0|||
161511920|NCT02247349|583267971|FG005|Overall Study|Death|0|||
161511921|NCT02247349|583267966|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
161511922|NCT02247349|583267967|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
161511923|NCT02247349|583267968|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
161511924|NCT02247349|583267969|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
161511925|NCT02247349|583267970|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
161511926|NCT02247349|583267971|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
161511927|NCT02247349|583267966|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161511928|NCT02247349|583267967|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161511929|NCT02247349|583267968|FG002|Overall Study|Participant request to discontinue study treatment|1|||
161511930|NCT02247349|583267969|FG003|Overall Study|Participant request to discontinue study treatment|2|||
161587819|NCT00676715|583542269|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
161587820|NCT00676715|583542266|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
161587821|NCT00676715|583542267|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
161587822|NCT00676715|583542268|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
161587823|NCT00676715|583542269|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
161587824|NCT00676715|583542266|FG000|Open Label Extension (OLE)|Adverse Event|0|||
161587825|NCT00676715|583542267|FG001|Open Label Extension (OLE)|Adverse Event|3|||
161587826|NCT00676715|583542268|FG002|Open Label Extension (OLE)|Adverse Event|1|||
161587827|NCT00676715|583542269|FG003|Open Label Extension (OLE)|Adverse Event|0|||
161587828|NCT00676715|583542266|FG000|Open Label Extension (OLE)|Death|2|||
161587829|NCT00676715|583542267|FG001|Open Label Extension (OLE)|Death|0|||
161587830|NCT00676715|583542268|FG002|Open Label Extension (OLE)|Death|2|||
161587831|NCT00676715|583542269|FG003|Open Label Extension (OLE)|Death|2|||
161587832|NCT05227209|583542283|FG000|Overall Study|Adverse Event|11|||
161587833|NCT05227209|583542283|FG000|Overall Study|Lost to Follow-up|1|||
161587834|NCT05227209|583542283|FG000|Overall Study|Withdrawal by Subject|7|||
161587835|NCT05227209|583542283|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
161587836|NCT05633953|583542284|FG000|Overall Study|Adverse Event|7|||
161820793|NCT01745094|584384644|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
161511931|NCT02247349|583267970|FG004|Overall Study|Participant request to discontinue study treatment|1|||
161511932|NCT02247349|583267971|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161820794|NCT01745094|584384645|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
161511933|NCT02247349|583267966|FG000|Overall Study|Withdrawal by Subject|0|||
161511934|NCT02247349|583267967|FG001|Overall Study|Withdrawal by Subject|1|||
161587837|NCT05633953|583542284|FG000|Overall Study|Death|30|||
161587838|NCT05633953|583542284|FG000|Overall Study|Lost to Follow-up|1|||
161511935|NCT02247349|583267968|FG002|Overall Study|Withdrawal by Subject|0|||
161511936|NCT02247349|583267969|FG003|Overall Study|Withdrawal by Subject|0|||
161587839|NCT05633953|583542284|FG000|Overall Study|Osilodrostat discontinued|4|||
161587840|NCT05633953|583542284|FG000|Overall Study|Physician Decision|1|||
161511937|NCT02247349|583267970|FG004|Overall Study|Withdrawal by Subject|0|||
161511938|NCT02247349|583267971|FG005|Overall Study|Withdrawal by Subject|0|||
161511939|NCT02247349|583267966|FG000|Overall Study|Administrative reason by sponsor|0|||
161511940|NCT02247349|583267967|FG001|Overall Study|Administrative reason by sponsor|0|||
161511941|NCT02247349|583267968|FG002|Overall Study|Administrative reason by sponsor|0|||
161511942|NCT02247349|583267969|FG003|Overall Study|Administrative reason by sponsor|0|||
161511943|NCT02247349|583267970|FG004|Overall Study|Administrative reason by sponsor|1|||
161511944|NCT02247349|583267971|FG005|Overall Study|Administrative reason by sponsor|0|||
161511945|NCT02247349|583267966|FG000|Overall Study|Other reasons|0|||
161511946|NCT02247349|583267967|FG001|Overall Study|Other reasons|0|||
161511947|NCT02247349|583267968|FG002|Overall Study|Other reasons|1|||
161511948|NCT02247349|583267969|FG003|Overall Study|Other reasons|0|||
161511949|NCT02247349|583267970|FG004|Overall Study|Other reasons|0|||
161511950|NCT02247349|583267971|FG005|Overall Study|Other reasons|0|||
161511951|NCT00617240|583267972|FG000|Overall Study|Lack of Efficacy|1|||
161511952|NCT00617240|583267973|FG001|Overall Study|Lack of Efficacy|0|||
161511953|NCT01611259|583267974|FG000|Overall Study|Physician Decision|1|||
161511954|NCT01611259|583267974|FG000|Overall Study|Lack of Efficacy|2|||
161511955|NCT01611259|583267974|FG000|Overall Study|Adverse Event|4|||
161511956|NCT01611259|583267974|FG000|Overall Study|Withdrawal by Subject|7|||
161511957|NCT04936685|583267975|FG000|Overall Study|Protocol Violation|1|||
161511958|NCT04936685|583267976|FG001|Overall Study|Protocol Violation|0|||
161511959|NCT02410811|583267980|FG000|Overall Study|Withdrawal by Subject|0|||
161511960|NCT02410811|583267981|FG001|Overall Study|Withdrawal by Subject|0|||
161511961|NCT02410811|583267982|FG002|Overall Study|Withdrawal by Subject|1|||
161511962|NCT02410811|583267983|FG003|Overall Study|Withdrawal by Subject|0|||
161511963|NCT00353366|583267984|FG000|Overall Study|Adverse Event|8|||
161511964|NCT00353366|583267984|FG000|Overall Study|Protocol Violation|12|||
161511965|NCT00353366|583267984|FG000|Overall Study|Withdrawal by Subject|12|||
161511966|NCT00353366|583267984|FG000|Overall Study|Lost to Follow-up|92|||
161511967|NCT00353366|583267984|FG000|Overall Study|Other|19|||
161511968|NCT00259857|583267985|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
161511969|NCT00259857|583267986|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
161511970|NCT00259857|583267985|FG000|24 Months Treatment|Lost to Follow-up|0|||
161511971|NCT00259857|583267986|FG001|24 Months Treatment|Lost to Follow-up|3|||
161511972|NCT05267054|583267987|FG000|Overall Study|Death|13|||
161511973|NCT05267054|583267988|FG001|Overall Study|Death|14|||
161511974|NCT05267054|583267987|FG000|Overall Study|Study Ended by Sponsor|9|||
161511975|NCT05267054|583267988|FG001|Overall Study|Study Ended by Sponsor|13|||
161511976|NCT05267054|583267987|FG000|Overall Study|Lost to Follow-up|1|||
161511977|NCT05267054|583267988|FG001|Overall Study|Lost to Follow-up|1|||
161511978|NCT05267054|583267987|FG000|Overall Study|Withdrawal by Subject|1|||
161511979|NCT05267054|583267988|FG001|Overall Study|Withdrawal by Subject|1|||
161511980|NCT01552226|583267991|FG000|Overall Study|Withdrawal by Subject|4|||
161511981|NCT01552226|583267992|FG001|Overall Study|Withdrawal by Subject|4|||
161511982|NCT01469065|583267996|FG000|Overall Study|Lack of Efficacy|0|||
161511983|NCT01469065|583267997|FG001|Overall Study|Lack of Efficacy|0|||
161511984|NCT01469065|583267998|FG002|Overall Study|Lack of Efficacy|0|||
161511985|NCT01469065|583267999|FG003|Overall Study|Lack of Efficacy|0|||
161511986|NCT01469065|583268000|FG004|Overall Study|Lack of Efficacy|1|||
161511987|NCT01469065|583267996|FG000|Overall Study|Other|0|||
161511988|NCT01469065|583267997|FG001|Overall Study|Other|1|||
161511989|NCT01469065|583267998|FG002|Overall Study|Other|0|||
161511990|NCT01469065|583267999|FG003|Overall Study|Other|0|||
161511991|NCT01469065|583268000|FG004|Overall Study|Other|0|||
161511992|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
161511993|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
161587841|NCT05633953|583542284|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
161587842|NCT05633953|583542284|FG000|Overall Study|Progressive disease|2|||
161587843|NCT03526861|583542287|FG000|Initial Treatment Period|Not dosed|1|||
161511994|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
161511995|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
161511996|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
161511997|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
161511998|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
161511999|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
161512000|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
161512001|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
161512002|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
161512003|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
161512004|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
161512005|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
161512006|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
161512007|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
161587844|NCT03526861|583542288|FG001|Initial Treatment Period|Not dosed|1|||
161512008|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
161512009|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
161512010|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
161512011|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
161512012|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
161512013|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
161512014|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
161512015|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
161512016|NCT04542070|583268001|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
161512017|NCT04542070|583268002|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
161512018|NCT04542070|583268003|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
161512019|NCT04542070|583268004|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
161512020|NCT04542070|583268001|FG000|Maintenance + Extension Period|Adverse Event|10|||
161512021|NCT04542070|583268002|FG001|Maintenance + Extension Period|Adverse Event|2|||
161512022|NCT04542070|583268003|FG002|Maintenance + Extension Period|Adverse Event|0|||
161512023|NCT04542070|583268004|FG003|Maintenance + Extension Period|Adverse Event|0|||
161512024|NCT04542070|583268001|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
161512025|NCT04542070|583268002|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
161512026|NCT04542070|583268003|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
161512027|NCT04542070|583268004|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
161512028|NCT04542070|583268001|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
161512029|NCT04542070|583268002|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
161512030|NCT04542070|583268003|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
161512031|NCT04542070|583268004|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
161512032|NCT04542070|583268001|FG000|Maintenance + Extension Period|Physician Decision|1|||
161512033|NCT04542070|583268002|FG001|Maintenance + Extension Period|Physician Decision|1|||
161512034|NCT04542070|583268003|FG002|Maintenance + Extension Period|Physician Decision|0|||
161512035|NCT04542070|583268004|FG003|Maintenance + Extension Period|Physician Decision|0|||
161512036|NCT04542070|583268001|FG000|Maintenance + Extension Period|Protocol Violation|2|||
161512037|NCT04542070|583268002|FG001|Maintenance + Extension Period|Protocol Violation|5|||
161512038|NCT04542070|583268003|FG002|Maintenance + Extension Period|Protocol Violation|0|||
161512039|NCT04542070|583268004|FG003|Maintenance + Extension Period|Protocol Violation|0|||
161512040|NCT04542070|583268001|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
161512041|NCT04542070|583268002|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
161512042|NCT04542070|583268003|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
161512043|NCT04542070|583268004|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
161512044|NCT04542070|583268001|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
161512045|NCT04542070|583268002|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
161512046|NCT04542070|583268003|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
161512047|NCT04542070|583268004|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
161512048|NCT04542070|583268001|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
161512049|NCT04542070|583268002|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
161512050|NCT04542070|583268003|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
161512051|NCT04542070|583268004|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
161512052|NCT04542070|583268001|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
161512053|NCT04542070|583268002|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
161512054|NCT04542070|583268003|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
161512055|NCT04542070|583268004|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
161512056|NCT04542070|583268001|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
161512057|NCT04542070|583268002|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
161512058|NCT04542070|583268003|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
161512059|NCT04542070|583268004|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
161512060|NCT04542070|583268001|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
161512061|NCT04542070|583268002|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
161512062|NCT04542070|583268003|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
161512063|NCT04542070|583268004|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
161587845|NCT03526861|583542289|FG002|Initial Treatment Period|Not dosed|1|||
161587846|NCT03526861|583542290|FG003|Initial Treatment Period|Not dosed|0|||
161587847|NCT03526861|583542291|FG004|Initial Treatment Period|Not dosed|0|||
161587848|NCT03526861|583542292|FG005|Initial Treatment Period|Not dosed|0|||
161587849|NCT03526861|583542293|FG006|Initial Treatment Period|Not dosed|0|||
161587850|NCT03526861|583542294|FG007|Initial Treatment Period|Not dosed|0|||
161587851|NCT03526861|583542295|FG008|Initial Treatment Period|Not dosed|0|||
161587852|NCT03526861|583542287|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
161512064|NCT04542070|583268001|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
161512065|NCT04542070|583268002|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
161512066|NCT04542070|583268003|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
161512067|NCT04542070|583268004|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
161512068|NCT03511560|583268007|FG000|Overall Study|Death|0|||
161512069|NCT03511560|583268008|FG001|Overall Study|Death|1|||
161512070|NCT03511560|583268007|FG000|Overall Study|Adverse Event|0|||
161512071|NCT03511560|583268008|FG001|Overall Study|Adverse Event|2|||
161512072|NCT03511560|583268007|FG000|Overall Study|Transplant cancelled|0|||
161512073|NCT03511560|583268008|FG001|Overall Study|Transplant cancelled|1|||
161512074|NCT03511560|583268007|FG000|Overall Study|Patient switched to another drug|1|||
161512075|NCT03511560|583268008|FG001|Overall Study|Patient switched to another drug|0|||
161512076|NCT03049813|583268014|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
161512077|NCT03049813|583268015|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
161512078|NCT03049813|583268016|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
161512079|NCT03049813|583268017|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
161512080|NCT03049813|583268014|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
161512081|NCT03049813|583268015|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
161512082|NCT03049813|583268016|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
161512083|NCT03049813|583268017|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
161512084|NCT03049813|583268014|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
161512085|NCT03049813|583268015|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
161512086|NCT03049813|583268016|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
161512087|NCT03049813|583268017|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
161512088|NCT03049813|583268014|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
161512089|NCT03049813|583268015|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
161512090|NCT03049813|583268016|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
161512091|NCT03049813|583268017|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
161512092|NCT00382733|583268018|FG000|Overall Study|Withdrawal by Subject|0|||
161512093|NCT00382733|583268019|FG001|Overall Study|Withdrawal by Subject|1|||
161512094|NCT00382733|583268020|FG002|Overall Study|Withdrawal by Subject|0|||
161512095|NCT00382733|583268021|FG003|Overall Study|Withdrawal by Subject|0|||
161512096|NCT00382733|583268022|FG004|Overall Study|Withdrawal by Subject|0|||
161512097|NCT00179413|583268023|FG000|Overall Study|Adverse Event|38|||
161512098|NCT00179413|583268024|FG001|Overall Study|Adverse Event|20|||
161512099|NCT00179413|583268023|FG000|Overall Study|Withdrawal by Subject|87|||
161512100|NCT00179413|583268024|FG001|Overall Study|Withdrawal by Subject|95|||
161512101|NCT01813019|583268027|FG000|Overall Study|Adverse Event|0|||
161512102|NCT01813019|583268028|FG001|Overall Study|Adverse Event|3|||
161512103|NCT01813019|583268027|FG000|Overall Study|Withdrawal by Subject|3|||
161512104|NCT01813019|583268028|FG001|Overall Study|Withdrawal by Subject|2|||
161512105|NCT01813019|583268027|FG000|Overall Study|administrative problems|2|||
161512106|NCT01813019|583268028|FG001|Overall Study|administrative problems|0|||
161512107|NCT01813019|583268027|FG000|Overall Study|Protocol Deviation|2|||
161512108|NCT01813019|583268028|FG001|Overall Study|Protocol Deviation|1|||
161512109|NCT03075644|583268029|FG000|Overall Study|Withdrawal by Subject|1|||
161512110|NCT03075644|583268030|FG001|Overall Study|Withdrawal by Subject|1|||
161512111|NCT00439140|583268031|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
161512112|NCT00439140|583268032|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
161512113|NCT00439140|583268033|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
161512114|NCT00439140|583268031|FG000|Treatment Cycle 1|Personal reasons|0|||
161512115|NCT00439140|583268032|FG001|Treatment Cycle 1|Personal reasons|2|||
161512116|NCT00439140|583268033|FG002|Treatment Cycle 1|Personal reasons|0|||
161512117|NCT00439140|583268031|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
161512118|NCT00439140|583268032|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
161512119|NCT00439140|583268033|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
161512120|NCT00439140|583268031|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
161512121|NCT00439140|583268032|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
161512122|NCT00439140|583268033|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
161512123|NCT00439140|583268031|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
161512124|NCT00439140|583268032|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
161512125|NCT00439140|583268033|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
161512126|NCT01458171|583268039|FG000|Overall Study|Adverse Event|1|||
161676174|NCT05975840|583867325|FG007|Overall Study|Other|0|||
161512127|NCT00578565|583268044|FG000|Overall Study|Adverse Event|3|||
161512128|NCT01192152|583268045|FG000|Period 1|left prematurely (while on treatment B)|0|||
161512129|NCT01192152|583268046|FG001|Period 1|left prematurely (while on treatment B)|1|||
161512130|NCT01192152|583268045|FG000|Period 3|family emergency|1|||
161512131|NCT01192152|583268046|FG001|Period 3|family emergency|0|||
161512132|NCT02143843|583268048|FG000|Overall Study|Adverse Event|8|||
161512133|NCT02143843|583268048|FG000|Overall Study|Lack of Efficacy|2|||
161512134|NCT02143843|583268048|FG000|Overall Study|Withdrawal by Subject|2|||
161512135|NCT01339390|583268049|FG000|Overall Study|Death|32|||
161820795|NCT01745094|584384646|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
161820796|NCT01745094|584384643|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
161676175|NCT05975840|583867318|FG000|Overall Study|Lost to Follow-up|3|||
161676176|NCT05975840|583867319|FG001|Overall Study|Lost to Follow-up|6|||
161676177|NCT05975840|583867320|FG002|Overall Study|Lost to Follow-up|3|||
161676178|NCT05975840|583867321|FG003|Overall Study|Lost to Follow-up|1|||
161676179|NCT05975840|583867322|FG004|Overall Study|Lost to Follow-up|4|||
161676180|NCT05975840|583867323|FG005|Overall Study|Lost to Follow-up|1|||
161676181|NCT05975840|583867324|FG006|Overall Study|Lost to Follow-up|2|||
161676182|NCT05975840|583867325|FG007|Overall Study|Lost to Follow-up|4|||
161676183|NCT05975840|583867318|FG000|Overall Study|Migrated/moved from the study area|1|||
161676184|NCT05975840|583867319|FG001|Overall Study|Migrated/moved from the study area|0|||
161820797|NCT01745094|584384644|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161820798|NCT01745094|584384645|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161820799|NCT01745094|584384646|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161512136|NCT01339390|583268050|FG001|Overall Study|Death|29|||
161512137|NCT01339390|583268049|FG000|Overall Study|Lost to Follow-up|125|||
161512138|NCT01339390|583268050|FG001|Overall Study|Lost to Follow-up|127|||
161512139|NCT00378703|583268051|FG000|Overall Study|Disease progression|59|||
161512140|NCT00378703|583268052|FG001|Overall Study|Disease progression|43|||
161512141|NCT00378703|583268053|FG002|Overall Study|Disease progression|48|||
161512142|NCT00378703|583268054|FG003|Overall Study|Disease progression|49|||
161512143|NCT00378703|583268051|FG000|Overall Study|Adverse Event|11|||
161512144|NCT00378703|583268052|FG001|Overall Study|Adverse Event|17|||
161512145|NCT00378703|583268053|FG002|Overall Study|Adverse Event|20|||
161512146|NCT00378703|583268054|FG003|Overall Study|Adverse Event|18|||
161512147|NCT00378703|583268051|FG000|Overall Study|Death|2|||
161512148|NCT00378703|583268052|FG001|Overall Study|Death|2|||
161512149|NCT00378703|583268053|FG002|Overall Study|Death|4|||
161512150|NCT00378703|583268054|FG003|Overall Study|Death|3|||
161512151|NCT00378703|583268051|FG000|Overall Study|Withdrawal by Subject|4|||
161512152|NCT00378703|583268052|FG001|Overall Study|Withdrawal by Subject|8|||
161512153|NCT00378703|583268053|FG002|Overall Study|Withdrawal by Subject|5|||
161676185|NCT05975840|583867320|FG002|Overall Study|Migrated/moved from the study area|0|||
161676186|NCT05975840|583867321|FG003|Overall Study|Migrated/moved from the study area|0|||
161512154|NCT00378703|583268054|FG003|Overall Study|Withdrawal by Subject|7|||
161512155|NCT00378703|583268051|FG000|Overall Study|Physician Decision|1|||
161512156|NCT00378703|583268052|FG001|Overall Study|Physician Decision|4|||
161512157|NCT00378703|583268053|FG002|Overall Study|Physician Decision|1|||
161512158|NCT00378703|583268054|FG003|Overall Study|Physician Decision|0|||
161926922|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
161926923|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
161926924|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
161926925|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
161926926|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
161926927|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
161926928|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
161926929|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
161926930|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
161926931|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
161926932|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
161926933|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
161926934|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
161926935|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
161926936|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
161926937|NCT03197935|584780185|FG000|Overall Study|Death due to any cause|26|||
161926938|NCT03197935|584780186|FG001|Overall Study|Death due to any cause|15|||
161926939|NCT03197935|584780185|FG000|Overall Study|Lost to Follow-up|3|||
161926940|NCT03197935|584780186|FG001|Overall Study|Lost to Follow-up|5|||
161926941|NCT03197935|584780185|FG000|Overall Study|Physician Decision|2|||
161926942|NCT03197935|584780186|FG001|Overall Study|Physician Decision|1|||
161926943|NCT03197935|584780185|FG000|Overall Study|Withdrawal by Subject|16|||
161926944|NCT03197935|584780186|FG001|Overall Study|Withdrawal by Subject|8|||
161926945|NCT03315689|584780191|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
161926946|NCT03315689|584780192|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
161926947|NCT03315689|584780191|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
161926948|NCT03315689|584780192|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
161926949|NCT03315689|584780191|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
161926950|NCT03315689|584780192|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
161926951|NCT00864513|584780193|FG000|Overall Study|Withdrawal by Subject|3|||
161926952|NCT00762788|584780194|FG000|Overall Study|Lost to Follow-up|26|||
161926953|NCT00762788|584780195|FG001|Overall Study|Lost to Follow-up|37|||
161926954|NCT00762788|584780196|FG002|Overall Study|Lost to Follow-up|21|||
161926955|NCT00762788|584780197|FG003|Overall Study|Lost to Follow-up|26|||
161926956|NCT00762788|584780198|FG004|Overall Study|Lost to Follow-up|13|||
161926957|NCT00762788|584780199|FG005|Overall Study|Lost to Follow-up|21|||
161926958|NCT03073109|584780200|FG000|Overall Study|Adverse Event|0|||
161926959|NCT03073109|584780201|FG001|Overall Study|Adverse Event|1|||
161926960|NCT03073109|584780200|FG000|Overall Study|Other|2|||
161926961|NCT03073109|584780201|FG001|Overall Study|Other|0|||
161926962|NCT03073109|584780200|FG000|Overall Study|Lost to Follow-up|8|||
161926963|NCT03073109|584780201|FG001|Overall Study|Lost to Follow-up|1|||
161926964|NCT01297244|584780204|FG000|Overall Study|Progressive disease|22|||
161926965|NCT01297244|584780205|FG001|Overall Study|Progressive disease|3|||
161926966|NCT01297244|584780204|FG000|Overall Study|Adverse Event|9|||
161926967|NCT01297244|584780205|FG001|Overall Study|Adverse Event|1|||
161926968|NCT01297244|584780204|FG000|Overall Study|Death|1|||
161926969|NCT01297244|584780205|FG001|Overall Study|Death|1|||
161926970|NCT01297244|584780204|FG000|Overall Study|Clinical progression|1|||
161926971|NCT01297244|584780205|FG001|Overall Study|Clinical progression|1|||
161926972|NCT01297244|584780204|FG000|Overall Study|Withdrawal by Subject|2|||
161926973|NCT01297244|584780205|FG001|Overall Study|Withdrawal by Subject|0|||
161926974|NCT02595749|584780206|FG000|Overall Study|Withdrawal by Subject|12|||
161926975|NCT02595749|584780207|FG001|Overall Study|Withdrawal by Subject|7|||
161926976|NCT00669331|584780208|FG000|Randomisation to First Dose|Adverse Event|1|||
161926977|NCT00669331|584780209|FG001|Randomisation to First Dose|Adverse Event|0|||
161926978|NCT00669331|584780208|FG000|Randomisation to First Dose|Protocol Violation|1|||
161926979|NCT00669331|584780209|FG001|Randomisation to First Dose|Protocol Violation|0|||
161926980|NCT00669331|584780208|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
161926981|NCT00669331|584780209|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
161926982|NCT00669331|584780208|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
161926983|NCT00669331|584780209|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
161926984|NCT00669331|584780208|FG000|Randomisation to First Dose|Death|1|||
161926985|NCT00669331|584780209|FG001|Randomisation to First Dose|Death|0|||
161926986|NCT00669331|584780208|FG000|Randomisation to First Dose|Sponsor decision|0|||
161926987|NCT00669331|584780209|FG001|Randomisation to First Dose|Sponsor decision|1|||
161926988|NCT00669331|584780208|FG000|Randomisation to First Dose|Randomised in error|3|||
161926989|NCT00669331|584780209|FG001|Randomisation to First Dose|Randomised in error|10|||
161926990|NCT00669331|584780208|FG000|Blinded Treatment Period|Adverse Event|16|||
161926991|NCT00669331|584780209|FG001|Blinded Treatment Period|Adverse Event|10|||
161926992|NCT00669331|584780208|FG000|Blinded Treatment Period|Protocol Violation|1|||
161926993|NCT00669331|584780209|FG001|Blinded Treatment Period|Protocol Violation|1|||
161926994|NCT00669331|584780208|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
161820800|NCT04610580|584384647|FG000|Two-way Crossover Period|Adverse Event|1|||
161820801|NCT04610580|584384648|FG001|Two-way Crossover Period|Adverse Event|0|||
161820802|NCT04610580|584384649|FG002|Two-way Crossover Period|Adverse Event|0|||
161820803|NCT04610580|584384650|FG003|Two-way Crossover Period|Adverse Event|0|||
161820804|NCT04610580|584384651|FG004|Two-way Crossover Period|Adverse Event|0|||
161820805|NCT04610580|584384652|FG005|Two-way Crossover Period|Adverse Event|0|||
161820806|NCT04610580|584384647|FG000|Two-way Crossover Period|Physician Decision|1|||
161820807|NCT04610580|584384648|FG001|Two-way Crossover Period|Physician Decision|0|||
161820808|NCT04610580|584384649|FG002|Two-way Crossover Period|Physician Decision|0|||
161820809|NCT04610580|584384650|FG003|Two-way Crossover Period|Physician Decision|0|||
161820810|NCT04610580|584384651|FG004|Two-way Crossover Period|Physician Decision|0|||
161820811|NCT04610580|584384652|FG005|Two-way Crossover Period|Physician Decision|0|||
161820812|NCT04610580|584384647|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
161820813|NCT04610580|584384648|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
161820814|NCT04610580|584384649|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
161820815|NCT04610580|584384650|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
161820816|NCT04610580|584384651|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
161820817|NCT04610580|584384652|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
161820818|NCT04610580|584384647|FG000|Two-way Crossover Period|Other than specified|0|||
161820819|NCT04610580|584384648|FG001|Two-way Crossover Period|Other than specified|1|||
161820820|NCT04610580|584384649|FG002|Two-way Crossover Period|Other than specified|0|||
161820821|NCT04610580|584384650|FG003|Two-way Crossover Period|Other than specified|0|||
161820822|NCT04610580|584384651|FG004|Two-way Crossover Period|Other than specified|0|||
161820823|NCT04610580|584384652|FG005|Two-way Crossover Period|Other than specified|0|||
161820824|NCT04610580|584384647|FG000|Washout Before Extension Period|Other than specified|0|||
161820825|NCT04610580|584384648|FG001|Washout Before Extension Period|Other than specified|1|||
161820826|NCT04610580|584384649|FG002|Washout Before Extension Period|Other than specified|0|||
161820827|NCT04610580|584384650|FG003|Washout Before Extension Period|Other than specified|0|||
161820828|NCT04610580|584384651|FG004|Washout Before Extension Period|Other than specified|0|||
161820829|NCT04610580|584384652|FG005|Washout Before Extension Period|Other than specified|0|||
161820830|NCT04610580|584384647|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
161820831|NCT04610580|584384648|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
161820832|NCT04610580|584384649|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
161820833|NCT04610580|584384650|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
161820834|NCT04610580|584384651|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
161820835|NCT04610580|584384652|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
161820836|NCT04610580|584384647|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820837|NCT04610580|584384648|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820838|NCT04610580|584384649|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820839|NCT04610580|584384650|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820840|NCT04610580|584384651|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
161820841|NCT04610580|584384652|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820842|NCT01451541|584384654|FG000|Overall Study|Adverse Event|4|||
161820843|NCT01451541|584384655|FG001|Overall Study|Adverse Event|3|||
161820844|NCT01451541|584384656|FG002|Overall Study|Adverse Event|6|||
161820845|NCT01451541|584384654|FG000|Overall Study|Lack of Efficacy|2|||
161512159|NCT00378703|583268051|FG000|Overall Study|Alternative therapy|4|||
161512160|NCT00378703|583268052|FG001|Overall Study|Alternative therapy|2|||
161512161|NCT00378703|583268053|FG002|Overall Study|Alternative therapy|0|||
161512162|NCT00378703|583268054|FG003|Overall Study|Alternative therapy|0|||
161512163|NCT00378703|583268051|FG000|Overall Study|Other complicated disease|0|||
161512164|NCT00378703|583268052|FG001|Overall Study|Other complicated disease|2|||
161512165|NCT00378703|583268053|FG002|Overall Study|Other complicated disease|2|||
161512166|NCT00378703|583268054|FG003|Overall Study|Other complicated disease|0|||
161512167|NCT00378703|583268051|FG000|Overall Study|Symptomatic deterioration|0|||
161512168|NCT00378703|583268052|FG001|Overall Study|Symptomatic deterioration|1|||
161512169|NCT00378703|583268053|FG002|Overall Study|Symptomatic deterioration|0|||
161512170|NCT00378703|583268054|FG003|Overall Study|Symptomatic deterioration|2|||
161512171|NCT00378703|583268051|FG000|Overall Study|Surgery|1|||
161512172|NCT00378703|583268052|FG001|Overall Study|Surgery|0|||
161512173|NCT00378703|583268053|FG002|Overall Study|Surgery|0|||
161512174|NCT00378703|583268054|FG003|Overall Study|Surgery|1|||
161512175|NCT00378703|583268051|FG000|Overall Study|Joint decision of physician and patient|1|||
161512176|NCT00378703|583268052|FG001|Overall Study|Joint decision of physician and patient|0|||
161512177|NCT00378703|583268053|FG002|Overall Study|Joint decision of physician and patient|0|||
161512178|NCT00378703|583268054|FG003|Overall Study|Joint decision of physician and patient|0|||
161512179|NCT00378703|583268051|FG000|Overall Study|Adverse events and progressive disease|0|||
161512180|NCT00378703|583268052|FG001|Overall Study|Adverse events and progressive disease|0|||
161512181|NCT00378703|583268053|FG002|Overall Study|Adverse events and progressive disease|0|||
161512182|NCT00378703|583268054|FG003|Overall Study|Adverse events and progressive disease|1|||
161512183|NCT00378703|583268051|FG000|Overall Study|Relocation|0|||
161512184|NCT00378703|583268052|FG001|Overall Study|Relocation|0|||
161512185|NCT00378703|583268053|FG002|Overall Study|Relocation|1|||
161512186|NCT00378703|583268054|FG003|Overall Study|Relocation|0|||
161512187|NCT00378703|583268051|FG000|Overall Study|Ineligible|4|||
161512188|NCT00378703|583268052|FG001|Overall Study|Ineligible|7|||
161512189|NCT00378703|583268053|FG002|Overall Study|Ineligible|7|||
161512190|NCT00378703|583268054|FG003|Overall Study|Ineligible|7|||
161512191|NCT00378703|583268051|FG000|Overall Study|Never started treatment|1|||
161512192|NCT00378703|583268052|FG001|Overall Study|Never started treatment|4|||
161512193|NCT00378703|583268053|FG002|Overall Study|Never started treatment|0|||
161512194|NCT00378703|583268054|FG003|Overall Study|Never started treatment|0|||
161512195|NCT00378703|583268051|FG000|Overall Study|Other|1|||
161512196|NCT00378703|583268052|FG001|Overall Study|Other|1|||
161512197|NCT00378703|583268053|FG002|Overall Study|Other|2|||
161512198|NCT00378703|583268054|FG003|Overall Study|Other|3|||
161512199|NCT03181542|583268057|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
161512200|NCT03181542|583268058|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
161512201|NCT01462357|583268065|FG000|Overall Study|Death|0|||
161512202|NCT01462357|583268066|FG001|Overall Study|Death|0|||
161512203|NCT01462357|583268067|FG002|Overall Study|Death|1|||
161512204|NCT01462357|583268065|FG000|Overall Study|Withdrawal by Subject|3|||
161512205|NCT01462357|583268066|FG001|Overall Study|Withdrawal by Subject|11|||
161512206|NCT01462357|583268067|FG002|Overall Study|Withdrawal by Subject|3|||
161512207|NCT01462357|583268065|FG000|Overall Study|Migrated/moved from study area|2|||
161512208|NCT01462357|583268066|FG001|Overall Study|Migrated/moved from study area|3|||
161512209|NCT01462357|583268067|FG002|Overall Study|Migrated/moved from study area|1|||
161512210|NCT01462357|583268065|FG000|Overall Study|Lost to Follow-up|3|||
161512211|NCT01462357|583268066|FG001|Overall Study|Lost to Follow-up|5|||
161512212|NCT01462357|583268067|FG002|Overall Study|Lost to Follow-up|7|||
161512213|NCT04292730|583268076|FG000|Overall Study|Lost to Follow-up|8|||
161512214|NCT04292730|583268077|FG001|Overall Study|Lost to Follow-up|12|||
161512215|NCT04292730|583268078|FG002|Overall Study|Lost to Follow-up|12|||
161512216|NCT04292730|583268079|FG003|Overall Study|Lost to Follow-up|48|||
161512217|NCT04292730|583268076|FG000|Overall Study|Death|2|||
161512218|NCT04292730|583268077|FG001|Overall Study|Death|2|||
161512219|NCT04292730|583268078|FG002|Overall Study|Death|4|||
161512220|NCT04292730|583268079|FG003|Overall Study|Death|12|||
161512221|NCT04292730|583268076|FG000|Overall Study|Withdrew Consent|2|||
161512222|NCT04292730|583268077|FG001|Overall Study|Withdrew Consent|2|||
161512223|NCT04292730|583268078|FG002|Overall Study|Withdrew Consent|5|||
161512224|NCT04292730|583268079|FG003|Overall Study|Withdrew Consent|6|||
161512225|NCT04292730|583268076|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161512226|NCT04292730|583268077|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161820846|NCT01451541|584384655|FG001|Overall Study|Lack of Efficacy|0|||
161926995|NCT00669331|584780209|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
161926996|NCT00669331|584780208|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
161926997|NCT00669331|584780209|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
161926998|NCT00669331|584780208|FG000|Blinded Treatment Period|Death|0|||
161926999|NCT00669331|584780209|FG001|Blinded Treatment Period|Death|2|||
161927000|NCT00669331|584780208|FG000|Blinded Treatment Period|Physician Decision|3|||
161927001|NCT00669331|584780209|FG001|Blinded Treatment Period|Physician Decision|3|||
161927002|NCT00669331|584780208|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
161927003|NCT00669331|584780209|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
161927004|NCT03387046|584780215|FG000|Overall Study|Adverse Event|1|||
161927005|NCT03387046|584780216|FG001|Overall Study|Adverse Event|1|||
161927006|NCT00509600|584780217|FG000|Overall Study|Adverse Event|1|||
161927007|NCT00986232|584780220|FG000|Overall Study|Adverse Event|1|||
161927008|NCT00986232|584780221|FG001|Overall Study|Adverse Event|2|||
161927009|NCT00986232|584780222|FG002|Overall Study|Adverse Event|3|||
161927010|NCT00986232|584780223|FG003|Overall Study|Adverse Event|0|||
161927011|NCT00986232|584780220|FG000|Overall Study|Lost to Follow-up|19|||
161927012|NCT00986232|584780221|FG001|Overall Study|Lost to Follow-up|12|||
161927013|NCT00986232|584780222|FG002|Overall Study|Lost to Follow-up|12|||
161927014|NCT00986232|584780223|FG003|Overall Study|Lost to Follow-up|7|||
161927015|NCT00986232|584780220|FG000|Overall Study|Protocol Violation|2|||
161927016|NCT00986232|584780221|FG001|Overall Study|Protocol Violation|3|||
161927017|NCT00986232|584780222|FG002|Overall Study|Protocol Violation|0|||
161927018|NCT00986232|584780223|FG003|Overall Study|Protocol Violation|1|||
161927019|NCT00986232|584780220|FG000|Overall Study|Withdrawal by Subject|13|||
161927020|NCT00986232|584780221|FG001|Overall Study|Withdrawal by Subject|16|||
161927021|NCT00986232|584780222|FG002|Overall Study|Withdrawal by Subject|12|||
161587853|NCT03526861|583542288|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
161587854|NCT03526861|583542289|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
161587855|NCT03526861|583542290|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587856|NCT03526861|583542291|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587857|NCT03526861|583542292|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587858|NCT03526861|583542293|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587859|NCT03526861|583542294|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587860|NCT03526861|583542295|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587861|NCT03526861|583542287|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
161587862|NCT03526861|583542288|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
161587863|NCT03526861|583542289|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
161587864|NCT03526861|583542290|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161587865|NCT03526861|583542291|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161587866|NCT03526861|583542292|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161587867|NCT03526861|583542293|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161587868|NCT03526861|583542294|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161587869|NCT03526861|583542295|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161587870|NCT03526861|583542287|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587871|NCT03526861|583542288|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587872|NCT03526861|583542289|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587873|NCT03526861|583542290|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161587874|NCT03526861|583542291|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161676187|NCT05975840|583867322|FG004|Overall Study|Migrated/moved from the study area|0|||
161820847|NCT01451541|584384656|FG002|Overall Study|Lack of Efficacy|0|||
161820848|NCT01451541|584384654|FG000|Overall Study|Lost to Follow-up|4|||
161820849|NCT01451541|584384655|FG001|Overall Study|Lost to Follow-up|4|||
161820850|NCT01451541|584384656|FG002|Overall Study|Lost to Follow-up|7|||
161820851|NCT01451541|584384654|FG000|Overall Study|Withdrawal by Subject|15|||
161820852|NCT01451541|584384655|FG001|Overall Study|Withdrawal by Subject|8|||
161820853|NCT01451541|584384656|FG002|Overall Study|Withdrawal by Subject|6|||
161820854|NCT01451541|584384654|FG000|Overall Study|randomization error, noncompliance|11|||
161820855|NCT01451541|584384655|FG001|Overall Study|randomization error, noncompliance|10|||
161820856|NCT01451541|584384656|FG002|Overall Study|randomization error, noncompliance|8|||
161820857|NCT05665387|584384657|FG000|Overall Study|Withdrawal by Subject|1|||
161820858|NCT05665387|584384658|FG001|Overall Study|Withdrawal by Subject|0|||
161820859|NCT05665387|584384659|FG002|Overall Study|Withdrawal by Subject|1|||
161820860|NCT01824498|584384660|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
161820861|NCT01824498|584384661|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
161927022|NCT00986232|584780223|FG003|Overall Study|Withdrawal by Subject|3|||
161820862|NCT01824498|584384662|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
161820863|NCT01824498|584384663|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
161820864|NCT01824498|584384664|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
161820865|NCT01824498|584384665|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
161820866|NCT00006436|584384666|FG000|Overall Study|Refused further treatment|2|||
161820867|NCT00006436|584384666|FG000|Overall Study|Declined to participate (before treatment started)|1|||
161820868|NCT00939523|584384667|FG000|Overall Study|Lack of Efficacy|1|||
161820869|NCT00939523|584384667|FG000|Overall Study|Physician Decision|2|||
161820870|NCT01528735|584384674|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
161820871|NCT01528735|584384675|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
161820872|NCT01528735|584384674|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
161820873|NCT01528735|584384675|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
161820874|NCT03555695|584384676|FG000|Overall Study|Withdrawal by Subject|1|||
161820875|NCT03555695|584384676|FG000|Overall Study|Lost to Follow-up|1|||
161820876|NCT03555695|584384676|FG000|Overall Study|appendicitis (unrelated)|1|||
161820877|NCT03555695|584384676|FG000|Overall Study|pre-existing sciatica|1|||
161820878|NCT00757172|584384677|FG000|Overall Study|Withdrawal by Subject|4|||
161820879|NCT00757172|584384677|FG000|Overall Study|Physician Decision|3|||
161820880|NCT00757172|584384677|FG000|Overall Study|Progression|4|||
161820881|NCT01942135|584384680|FG000|Overall Study|Adverse Event|21|||
161820882|NCT01942135|584384681|FG001|Overall Study|Adverse Event|7|||
161820883|NCT01942135|584384680|FG000|Overall Study|Global Deterioration of Health Status|9|||
161820884|NCT01942135|584384681|FG001|Overall Study|Global Deterioration of Health Status|6|||
161820885|NCT01942135|584384680|FG000|Overall Study|Randomized Not Treated|2|||
161820886|NCT01942135|584384681|FG001|Overall Study|Randomized Not Treated|2|||
161820887|NCT01942135|584384680|FG000|Overall Study|Death|2|||
161820888|NCT01942135|584384681|FG001|Overall Study|Death|1|||
161820889|NCT01942135|584384680|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
161820890|NCT01942135|584384681|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
161820891|NCT01942135|584384680|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
161820892|NCT01942135|584384681|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
161820893|NCT01942135|584384680|FG000|Overall Study|Withdrawal by Subject|4|||
161820894|NCT01942135|584384681|FG001|Overall Study|Withdrawal by Subject|3|||
161820895|NCT01942135|584384680|FG000|Overall Study|Protocol Violation|1|||
161820896|NCT01942135|584384681|FG001|Overall Study|Protocol Violation|0|||
161927023|NCT00986232|584780220|FG000|Overall Study|Missed one or more bleeds|13|||
161927024|NCT00986232|584780221|FG001|Overall Study|Missed one or more bleeds|10|||
161820897|NCT01942135|584384680|FG000|Overall Study|Other|19|||
161820898|NCT01942135|584384681|FG001|Overall Study|Other|4|||
161820899|NCT01499043|584384682|FG000|Overall Study|Progressive disease (radiographic)|2|||
161512227|NCT04292730|583268078|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161512228|NCT04292730|583268079|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161512229|NCT04292730|583268076|FG000|Overall Study|Protocol Violation|0|||
161512230|NCT04292730|583268077|FG001|Overall Study|Protocol Violation|0|||
161512231|NCT04292730|583268078|FG002|Overall Study|Protocol Violation|1|||
161512232|NCT04292730|583268079|FG003|Overall Study|Protocol Violation|0|||
161512233|NCT04292730|583268076|FG000|Overall Study|Randomized but not Treated|8|||
161512234|NCT04292730|583268077|FG001|Overall Study|Randomized but not Treated|4|||
161512235|NCT04292730|583268078|FG002|Overall Study|Randomized but not Treated|0|||
161512236|NCT04292730|583268079|FG003|Overall Study|Randomized but not Treated|14|||
161512237|NCT01527292|583268080|FG000|Overall Study|Physician Decision|0|||
161512238|NCT01527292|583268081|FG001|Overall Study|Physician Decision|3|||
161512239|NCT01482767|583268082|FG000|Overall Study|Death|1|||
161512240|NCT01482767|583268083|FG001|Overall Study|Death|1|||
161820900|NCT01499043|584384682|FG000|Overall Study|Progressive disease (clinical)|1|||
161820901|NCT01499043|584384682|FG000|Overall Study|Withdrawal by Subject|2|||
161927025|NCT00986232|584780222|FG002|Overall Study|Missed one or more bleeds|6|||
161927026|NCT00986232|584780223|FG003|Overall Study|Missed one or more bleeds|7|||
161927027|NCT00986232|584780220|FG000|Overall Study|Incomplete safety follow-up|3|||
161927028|NCT00986232|584780221|FG001|Overall Study|Incomplete safety follow-up|7|||
161927029|NCT00986232|584780222|FG002|Overall Study|Incomplete safety follow-up|2|||
161927030|NCT00986232|584780223|FG003|Overall Study|Incomplete safety follow-up|2|||
161820902|NCT01499043|584384682|FG000|Overall Study|Adverse Event|1|||
161820903|NCT01596127|584384685|FG000|Overall Study|Patient Ineligible|1|||
161820904|NCT00685334|584384691|FG000|Overall Study|Withdrawal by Subject|5|||
161512241|NCT01482767|583268082|FG000|Overall Study|Withdrawal by Subject|7|||
161512242|NCT01482767|583268083|FG001|Overall Study|Withdrawal by Subject|5|||
161587875|NCT03526861|583542292|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161820905|NCT00685334|584384692|FG001|Overall Study|Withdrawal by Subject|6|||
161512243|NCT01482767|583268082|FG000|Overall Study|Lost to Follow-up|12|||
161927031|NCT02568423|584780224|FG000|Overall Study|Lost to Follow-up|0|||
161512244|NCT01482767|583268083|FG001|Overall Study|Lost to Follow-up|6|||
161820906|NCT00685334|584384691|FG000|Overall Study|Lost to Follow-up|4|||
161820907|NCT00685334|584384692|FG001|Overall Study|Lost to Follow-up|0|||
161927032|NCT02568423|584780225|FG001|Overall Study|Lost to Follow-up|2|||
161512245|NCT01482767|583268082|FG000|Overall Study|Adverse Event|0|||
161512246|NCT01482767|583268083|FG001|Overall Study|Adverse Event|3|||
161512247|NCT01482767|583268082|FG000|Overall Study|Site closure|22|||
161512248|NCT01482767|583268083|FG001|Overall Study|Site closure|14|||
161512249|NCT01482767|583268082|FG000|Overall Study|Non-adherence to study requirements|4|||
161512250|NCT01482767|583268083|FG001|Overall Study|Non-adherence to study requirements|7|||
161512251|NCT01482767|583268082|FG000|Overall Study|Alternate HCV treatment|7|||
161512252|NCT01482767|583268083|FG001|Overall Study|Alternate HCV treatment|8|||
161512253|NCT01482767|583268082|FG000|Overall Study|Ineligible|0|||
161512254|NCT01482767|583268083|FG001|Overall Study|Ineligible|5|||
161512255|NCT01482767|583268082|FG000|Overall Study|Nurse error|1|||
161512256|NCT01482767|583268083|FG001|Overall Study|Nurse error|0|||
161512257|NCT00314366|583268084|FG000|Overall Study|not treated due to patient medical condi|1|||
161512258|NCT00314366|583268085|FG001|Overall Study|not treated due to patient medical condi|0|||
161512259|NCT03400033|583268097|FG000|Overall Study|Withdrawal by Subject|1|||
161512260|NCT03400033|583268098|FG001|Overall Study|Withdrawal by Subject|2|||
161512261|NCT00806546|583268101|FG000|Overall Study|Enrolled, not treated|35|||
161512262|NCT00806546|583268101|FG000|Overall Study|Lost to Follow-up|32|||
161512263|NCT00806546|583268101|FG000|Overall Study|Adverse Event|74|||
161512264|NCT00806546|583268101|FG000|Overall Study|Withdrawal by Subject|75|||
161512265|NCT00806546|583268101|FG000|Overall Study|Protocol Violation|49|||
161512266|NCT00806546|583268101|FG000|Overall Study|Various|42|||
161512267|NCT01247090|583268102|FG000|Overall Study|Physician Decision|1|||
161512268|NCT01247090|583268103|FG001|Overall Study|Physician Decision|0|||
161512269|NCT01247090|583268104|FG002|Overall Study|Physician Decision|0|||
161512270|NCT01247090|583268102|FG000|Overall Study|Withdrawal by Subject|0|||
161512271|NCT01247090|583268103|FG001|Overall Study|Withdrawal by Subject|1|||
161512272|NCT01247090|583268104|FG002|Overall Study|Withdrawal by Subject|0|||
161512273|NCT00006916|583268106|FG000|Overall Study|Device not inserted|4|||
161512274|NCT00006916|583268106|FG000|Overall Study|Complication of device insertion|1|||
161512275|NCT00558103|583268109|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
161512276|NCT00558103|583268110|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
161927033|NCT02568423|584780226|FG002|Overall Study|Lost to Follow-up|0|||
161927034|NCT02568423|584780227|FG003|Overall Study|Lost to Follow-up|0|||
161512277|NCT00558103|583268111|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
161512278|NCT00558103|583268112|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
161512279|NCT00558103|583268113|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
161512280|NCT00558103|583268114|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
161512281|NCT00558103|583268109|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
161512282|NCT00558103|583268110|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
161512283|NCT00558103|583268111|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
161512284|NCT00558103|583268112|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
161512285|NCT00558103|583268113|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
161512286|NCT00558103|583268114|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
161512287|NCT00558103|583268109|FG000|Randomized Treatment Phase|Disease Progression|1|||
161512288|NCT00558103|583268110|FG001|Randomized Treatment Phase|Disease Progression|0|||
161512289|NCT00558103|583268111|FG002|Randomized Treatment Phase|Disease Progression|1|||
161512290|NCT00558103|583268112|FG003|Randomized Treatment Phase|Disease Progression|0|||
161512291|NCT00558103|583268113|FG004|Randomized Treatment Phase|Disease Progression|0|||
161512292|NCT00558103|583268114|FG005|Randomized Treatment Phase|Disease Progression|0|||
161512293|NCT00558103|583268109|FG000|Randomized Treatment Phase|Adverse Event|0|||
161512294|NCT00558103|583268110|FG001|Randomized Treatment Phase|Adverse Event|0|||
161512295|NCT00558103|583268111|FG002|Randomized Treatment Phase|Adverse Event|0|||
161512296|NCT00558103|583268112|FG003|Randomized Treatment Phase|Adverse Event|1|||
161512297|NCT00558103|583268113|FG004|Randomized Treatment Phase|Adverse Event|1|||
161512298|NCT00558103|583268114|FG005|Randomized Treatment Phase|Adverse Event|0|||
161512299|NCT00558103|583268109|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
161512300|NCT00558103|583268110|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
161512301|NCT00558103|583268111|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
161512302|NCT00558103|583268112|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
161512303|NCT00558103|583268113|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
161512304|NCT00558103|583268114|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
161512305|NCT00558103|583268109|FG000|Monotherapy Extension Phase|Disease Progression|0|||
161512306|NCT00558103|583268110|FG001|Monotherapy Extension Phase|Disease Progression|0|||
161512307|NCT00558103|583268111|FG002|Monotherapy Extension Phase|Disease Progression|0|||
161512308|NCT00558103|583268112|FG003|Monotherapy Extension Phase|Disease Progression|0|||
161512309|NCT00558103|583268113|FG004|Monotherapy Extension Phase|Disease Progression|0|||
161512310|NCT00558103|583268114|FG005|Monotherapy Extension Phase|Disease Progression|8|||
161512311|NCT02457325|583268121|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
161512312|NCT02457325|583268122|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
161512313|NCT01541930|583268125|FG000|Overall Study|Withdrawal by Subject|1|||
161512314|NCT03385239|583268126|FG000|Overall Study|Voluntary Withdrawal|2|||
161927035|NCT02568423|584780228|FG004|Overall Study|Lost to Follow-up|0|||
161512315|NCT03385239|583268127|FG001|Overall Study|Voluntary Withdrawal|3|||
161512316|NCT03385239|583268128|FG002|Overall Study|Voluntary Withdrawal|2|||
161512317|NCT03385239|583268129|FG003|Overall Study|Voluntary Withdrawal|3|||
161512318|NCT03385239|583268130|FG004|Overall Study|Voluntary Withdrawal|0|||
161512319|NCT03385239|583268126|FG000|Overall Study|Adverse Event|0|||
161512320|NCT03385239|583268127|FG001|Overall Study|Adverse Event|0|||
161512321|NCT03385239|583268128|FG002|Overall Study|Adverse Event|1|||
161927036|NCT02568423|584780229|FG005|Overall Study|Lost to Follow-up|0|||
161927037|NCT02568423|584780230|FG006|Overall Study|Lost to Follow-up|0|||
161927038|NCT02568423|584780231|FG007|Overall Study|Lost to Follow-up|0|||
161927039|NCT02568423|584780224|FG000|Overall Study|Physician Decision|0|||
161927040|NCT02568423|584780225|FG001|Overall Study|Physician Decision|0|||
161927041|NCT02568423|584780226|FG002|Overall Study|Physician Decision|0|||
161927042|NCT02568423|584780227|FG003|Overall Study|Physician Decision|0|||
161927043|NCT02568423|584780228|FG004|Overall Study|Physician Decision|0|||
161927044|NCT02568423|584780229|FG005|Overall Study|Physician Decision|1|||
161927045|NCT02568423|584780230|FG006|Overall Study|Physician Decision|0|||
161927046|NCT02568423|584780231|FG007|Overall Study|Physician Decision|0|||
161927047|NCT03794544|584780232|FG000|Overall Study|Withdrawal by Subject|1|||
161927048|NCT03794544|584780233|FG001|Overall Study|Withdrawal by Subject|1|||
161927049|NCT03794544|584780234|FG002|Overall Study|Withdrawal by Subject|0|||
161927050|NCT03794544|584780235|FG003|Overall Study|Withdrawal by Subject|0|||
161927051|NCT03794544|584780232|FG000|Overall Study|Death|0|||
161927052|NCT03794544|584780233|FG001|Overall Study|Death|0|||
161927053|NCT03794544|584780234|FG002|Overall Study|Death|0|||
161927054|NCT03794544|584780235|FG003|Overall Study|Death|1|||
161927055|NCT03794544|584780232|FG000|Overall Study|Lost to Follow-up|0|||
161927056|NCT03794544|584780233|FG001|Overall Study|Lost to Follow-up|1|||
161927057|NCT03794544|584780234|FG002|Overall Study|Lost to Follow-up|1|||
161927058|NCT03794544|584780235|FG003|Overall Study|Lost to Follow-up|0|||
161927059|NCT03794544|584780232|FG000|Overall Study|Other|0|||
161927060|NCT03794544|584780233|FG001|Overall Study|Other|1|||
161927061|NCT03794544|584780234|FG002|Overall Study|Other|0|||
161927062|NCT03794544|584780235|FG003|Overall Study|Other|0|||
161927063|NCT02502383|584780237|FG000|Overall Study|Lost to Follow-up|130|||
161927064|NCT02502383|584780238|FG001|Overall Study|Lost to Follow-up|131|||
161927065|NCT02502383|584780237|FG000|Overall Study|Withdrawal by Subject|31|||
161927066|NCT02502383|584780238|FG001|Overall Study|Withdrawal by Subject|24|||
161927067|NCT01428713|584780239|FG000|Overall Study|Non-compliance|2|||
161927068|NCT01428713|584780240|FG001|Overall Study|Non-compliance|2|||
161927069|NCT01428713|584780239|FG000|Overall Study|Withdrawal by Subject|1|||
161927070|NCT01428713|584780240|FG001|Overall Study|Withdrawal by Subject|1|||
161927071|NCT01428713|584780239|FG000|Overall Study|Adverse Event|0|||
161927072|NCT01428713|584780240|FG001|Overall Study|Adverse Event|2|||
161927073|NCT00875667|584780243|FG000|Overall Study|Adverse Event|29|||
161927074|NCT00875667|584780244|FG001|Overall Study|Adverse Event|10|||
161927075|NCT00875667|584780243|FG000|Overall Study|Withdrawal by Subject|17|||
161927076|NCT00875667|584780244|FG001|Overall Study|Withdrawal by Subject|5|||
161512322|NCT03385239|583268129|FG003|Overall Study|Adverse Event|0|||
161512323|NCT03385239|583268130|FG004|Overall Study|Adverse Event|0|||
161512324|NCT03385239|583268126|FG000|Overall Study|Other|0|||
161587876|NCT03526861|583542293|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161587877|NCT03526861|583542294|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587878|NCT03526861|583542295|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587879|NCT03526861|583542287|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161587880|NCT03526861|583542288|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161927077|NCT00875667|584780243|FG000|Overall Study|Death|7|||
161927078|NCT00875667|584780244|FG001|Overall Study|Death|2|||
161927079|NCT00875667|584780243|FG000|Overall Study|Protocol Violation|2|||
161927080|NCT00875667|584780244|FG001|Overall Study|Protocol Violation|0|||
161927081|NCT00875667|584780243|FG000|Overall Study|Disease Progression|100|||
161927082|NCT00875667|584780244|FG001|Overall Study|Disease Progression|49|||
161927083|NCT00875667|584780243|FG000|Overall Study|Miscellaneous|12|||
161927084|NCT00875667|584780244|FG001|Overall Study|Miscellaneous|6|||
161927085|NCT00875667|584780243|FG000|Overall Study|Randomized but no Study Drug Given|3|||
161927086|NCT00875667|584780244|FG001|Overall Study|Randomized but no Study Drug Given|1|||
161927087|NCT00120250|584780245|FG000|Overall Study|Lost to Follow-up|1|||
161927088|NCT00120250|584780246|FG001|Overall Study|Lost to Follow-up|1|||
161927089|NCT00120250|584780245|FG000|Overall Study|Protocol Violation|0|||
161512325|NCT03385239|583268127|FG001|Overall Study|Other|0|||
161512326|NCT03385239|583268128|FG002|Overall Study|Other|0|||
161927090|NCT00120250|584780246|FG001|Overall Study|Protocol Violation|1|||
161927091|NCT01967277|584780247|FG000|Overall Study|Lost to Follow-up|1|||
161512327|NCT03385239|583268129|FG003|Overall Study|Other|1|||
161587881|NCT03526861|583542289|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161587882|NCT03526861|583542290|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
161927092|NCT01967277|584780248|FG001|Overall Study|Lost to Follow-up|2|||
161927093|NCT01967277|584780247|FG000|Overall Study|Unrelated illness|0|||
161512328|NCT03385239|583268130|FG004|Overall Study|Other|0|||
161512329|NCT01574703|583268131|FG000|Overall Study|Adverse Event|0|||
161512330|NCT01574703|583268132|FG001|Overall Study|Adverse Event|2|||
161512331|NCT01574703|583268133|FG002|Overall Study|Adverse Event|1|||
161512332|NCT01574703|583268134|FG003|Overall Study|Adverse Event|1|||
161512333|NCT01574703|583268131|FG000|Overall Study|Protocol Violation|0|||
161512334|NCT01574703|583268132|FG001|Overall Study|Protocol Violation|0|||
161512335|NCT01574703|583268133|FG002|Overall Study|Protocol Violation|0|||
161512336|NCT01574703|583268134|FG003|Overall Study|Protocol Violation|1|||
161512337|NCT01574703|583268131|FG000|Overall Study|Unspecified Reason|27|||
161512338|NCT01574703|583268132|FG001|Overall Study|Unspecified Reason|15|||
161512339|NCT01574703|583268133|FG002|Overall Study|Unspecified Reason|20|||
161512340|NCT01574703|583268134|FG003|Overall Study|Unspecified Reason|16|||
161512341|NCT01574703|583268131|FG000|Overall Study|Withdrawal by Subject|53|||
161512342|NCT01574703|583268132|FG001|Overall Study|Withdrawal by Subject|52|||
161512343|NCT01574703|583268133|FG002|Overall Study|Withdrawal by Subject|36|||
161512344|NCT01574703|583268134|FG003|Overall Study|Withdrawal by Subject|61|||
161512345|NCT01574703|583268131|FG000|Overall Study|Met Withdrawal Criteria|0|||
161512346|NCT01574703|583268132|FG001|Overall Study|Met Withdrawal Criteria|1|||
161512347|NCT01574703|583268133|FG002|Overall Study|Met Withdrawal Criteria|1|||
161512348|NCT01574703|583268134|FG003|Overall Study|Met Withdrawal Criteria|0|||
161512349|NCT01574703|583268131|FG000|Overall Study|Lost to Follow-up|43|||
161512350|NCT01574703|583268132|FG001|Overall Study|Lost to Follow-up|41|||
161512351|NCT01574703|583268133|FG002|Overall Study|Lost to Follow-up|46|||
161512352|NCT01574703|583268134|FG003|Overall Study|Lost to Follow-up|35|||
161512353|NCT01574703|583268131|FG000|Overall Study|Death|2|||
161512354|NCT01574703|583268132|FG001|Overall Study|Death|1|||
161512355|NCT01574703|583268133|FG002|Overall Study|Death|1|||
161512356|NCT01574703|583268134|FG003|Overall Study|Death|0|||
161512357|NCT02469610|583268138|FG000|Overall Study|Death|1|||
161512358|NCT02469610|583268139|FG001|Overall Study|Death|0|||
161512359|NCT02469610|583268138|FG000|Overall Study|Lost to Follow-up|1|||
161512360|NCT02469610|583268139|FG001|Overall Study|Lost to Follow-up|0|||
161512361|NCT02469610|583268138|FG000|Overall Study|exclusion criteria|2|||
161512362|NCT02469610|583268139|FG001|Overall Study|exclusion criteria|1|||
161512363|NCT02920983|583268142|FG000|Dispense 1|Unacceptable Lens Fit|0|||
161512364|NCT02920983|583268143|FG001|Dispense 1|Unacceptable Lens Fit|0|||
161512365|NCT02920983|583268144|FG002|Dispense 1|Unacceptable Lens Fit|0|||
161512366|NCT02920983|583268145|FG003|Dispense 1|Unacceptable Lens Fit|0|||
161512367|NCT02920983|583268146|FG004|Dispense 1|Unacceptable Lens Fit|1|||
161512368|NCT02920983|583268147|FG005|Dispense 1|Unacceptable Lens Fit|0|||
161512369|NCT02920983|583268142|FG000|Dispense 2|Unscceptable lens fit|1|||
161512370|NCT02920983|583268143|FG001|Dispense 2|Unscceptable lens fit|0|||
161512371|NCT02920983|583268144|FG002|Dispense 2|Unscceptable lens fit|0|||
161512372|NCT02920983|583268145|FG003|Dispense 2|Unscceptable lens fit|0|||
161512373|NCT02920983|583268146|FG004|Dispense 2|Unscceptable lens fit|1|||
161512374|NCT02920983|583268147|FG005|Dispense 2|Unscceptable lens fit|0|||
161512375|NCT02920983|583268142|FG000|Dispense 3|Unacceptable Lens Fit|1|||
161512376|NCT02920983|583268143|FG001|Dispense 3|Unacceptable Lens Fit|1|||
161512377|NCT02920983|583268144|FG002|Dispense 3|Unacceptable Lens Fit|0|||
161512378|NCT02920983|583268145|FG003|Dispense 3|Unacceptable Lens Fit|0|||
161512379|NCT02920983|583268146|FG004|Dispense 3|Unacceptable Lens Fit|1|||
161820908|NCT00685334|584384691|FG000|Overall Study|Chose to enter hospital|1|||
161820909|NCT00685334|584384692|FG001|Overall Study|Chose to enter hospital|1|||
161820910|NCT04577404|584384693|FG000|Overall Study|Adverse Event|31|||
161820911|NCT04577404|584384693|FG000|Overall Study|Death|1|||
161820912|NCT04577404|584384693|FG000|Overall Study|Lack of Efficacy|3|||
161512380|NCT02920983|583268147|FG005|Dispense 3|Unacceptable Lens Fit|0|||
161512381|NCT01451424|583268148|FG000|Overall Study|Withdrawal by Subject|1|||
161820913|NCT04577404|584384693|FG000|Overall Study|Physician Decision|7|||
161820914|NCT04577404|584384693|FG000|Overall Study|Withdrawal by Subject|21|||
161820915|NCT04577404|584384693|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
161820916|NCT00820599|584385744|FG000|Overall Study|Death|129|||
161820917|NCT00820599|584385744|FG000|Overall Study|Withdrawal by Subject|2|||
161820918|NCT00202839|584385745|FG000|Overall Study|Adverse Event|1|||
161512382|NCT01451424|583268149|FG001|Overall Study|Withdrawal by Subject|1|||
161512383|NCT01451424|583268150|FG002|Overall Study|Withdrawal by Subject|0|||
161512384|NCT01451424|583268151|FG003|Overall Study|Withdrawal by Subject|2|||
161512385|NCT01451424|583268148|FG000|Overall Study|Lost to Follow-up|0|||
161512386|NCT01451424|583268149|FG001|Overall Study|Lost to Follow-up|1|||
161512387|NCT01451424|583268150|FG002|Overall Study|Lost to Follow-up|0|||
161512388|NCT01451424|583268151|FG003|Overall Study|Lost to Follow-up|1|||
161820919|NCT00202839|584385746|FG001|Overall Study|Adverse Event|5|||
161820920|NCT00202839|584385745|FG000|Overall Study|Physician Decision|12|||
161820921|NCT00202839|584385746|FG001|Overall Study|Physician Decision|0|||
161820922|NCT00202839|584385745|FG000|Overall Study|Withdrawal by Subject|6|||
161512389|NCT01451424|583268148|FG000|Overall Study|Physician Decision|0|||
161512390|NCT01451424|583268149|FG001|Overall Study|Physician Decision|0|||
161512391|NCT01451424|583268150|FG002|Overall Study|Physician Decision|1|||
161512392|NCT01451424|583268151|FG003|Overall Study|Physician Decision|1|||
161512393|NCT01451424|583268148|FG000|Overall Study|Adverse Event|0|||
161512394|NCT01451424|583268149|FG001|Overall Study|Adverse Event|0|||
161512395|NCT01451424|583268150|FG002|Overall Study|Adverse Event|0|||
161512396|NCT01451424|583268151|FG003|Overall Study|Adverse Event|1|||
161512397|NCT01387607|583268157|FG000|Overall Study|Adverse Event|23|||
161512398|NCT01387607|583268158|FG001|Overall Study|Adverse Event|11|||
161512399|NCT01387607|583268157|FG000|Overall Study|Lack of Efficacy|8|||
161512400|NCT01387607|583268158|FG001|Overall Study|Lack of Efficacy|6|||
161512401|NCT01387607|583268157|FG000|Overall Study|Lost to Follow-up|2|||
161512402|NCT01387607|583268158|FG001|Overall Study|Lost to Follow-up|1|||
161512403|NCT01387607|583268157|FG000|Overall Study|No longer meets eligibility criteria|0|||
161512404|NCT01387607|583268158|FG001|Overall Study|No longer meets eligibility criteria|1|||
161512405|NCT01387607|583268157|FG000|Overall Study|Protocol Violation|1|||
161512406|NCT01387607|583268158|FG001|Overall Study|Protocol Violation|5|||
161512407|NCT01387607|583268157|FG000|Overall Study|Withdrawal by Subject|13|||
161512408|NCT01387607|583268158|FG001|Overall Study|Withdrawal by Subject|14|||
161512409|NCT01387607|583268157|FG000|Overall Study|Other|1|||
161512410|NCT01387607|583268158|FG001|Overall Study|Other|1|||
161512411|NCT01387607|583268157|FG000|Overall Study|Randomized, not treated|3|||
161512412|NCT01387607|583268158|FG001|Overall Study|Randomized, not treated|6|||
161512413|NCT03890367|583268166|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161512414|NCT03890367|583268167|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161512415|NCT03890367|583268168|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161512416|NCT03890367|583268166|FG000|Overall Study|Protocol deviation|2|||
161512417|NCT03890367|583268167|FG001|Overall Study|Protocol deviation|2|||
161512418|NCT03890367|583268168|FG002|Overall Study|Protocol deviation|1|||
161512419|NCT03890367|583268166|FG000|Overall Study|Lost to Follow-up|1|||
161512420|NCT03890367|583268167|FG001|Overall Study|Lost to Follow-up|1|||
161512421|NCT03890367|583268168|FG002|Overall Study|Lost to Follow-up|0|||
161512422|NCT02556710|583269631|FG000|Overall Study|Surgical treatment|3|||
161512423|NCT02556710|583269632|FG001|Overall Study|Surgical treatment|0|||
161512424|NCT02556710|583269631|FG000|Overall Study|Required proscribed pain medication|2|||
161512425|NCT02556710|583269632|FG001|Overall Study|Required proscribed pain medication|1|||
161512426|NCT02556710|583269631|FG000|Overall Study|Lack of Efficacy|1|||
161512427|NCT02556710|583269632|FG001|Overall Study|Lack of Efficacy|0|||
161512428|NCT02556710|583269631|FG000|Overall Study|Worsening osteoarthritis|1|||
161512429|NCT02556710|583269632|FG001|Overall Study|Worsening osteoarthritis|0|||
161512430|NCT02556710|583269631|FG000|Overall Study|Moved out of state|1|||
161512431|NCT02556710|583269632|FG001|Overall Study|Moved out of state|0|||
161512432|NCT02556710|583269631|FG000|Overall Study|Missing reason|3|||
161512433|NCT02556710|583269632|FG001|Overall Study|Missing reason|1|||
161512434|NCT02556710|583269631|FG000|Overall Study|Pain as lack of efficacy|0|||
161512435|NCT02556710|583269632|FG001|Overall Study|Pain as lack of efficacy|4|||
161676188|NCT05975840|583867323|FG005|Overall Study|Migrated/moved from the study area|0|||
161820923|NCT00202839|584385746|FG001|Overall Study|Withdrawal by Subject|2|||
161820924|NCT00202839|584385745|FG000|Overall Study|Protocol Violation|2|||
161820925|NCT00202839|584385746|FG001|Overall Study|Protocol Violation|1|||
161820926|NCT00202839|584385745|FG000|Overall Study|Lost to Follow-up|3|||
161820927|NCT00202839|584385746|FG001|Overall Study|Lost to Follow-up|2|||
161820928|NCT01662024|584385749|FG000|Overall Study|Pregnancy|2|||
161820929|NCT01662024|584385749|FG000|Overall Study|Withdrawal by Subject|3|||
161820930|NCT01490190|584385753|FG000|Overall Study|Withdrawal by Subject|9|||
161820931|NCT01490190|584385753|FG000|Overall Study|Adverse Event|17|||
161820932|NCT01490190|584385753|FG000|Overall Study|Protocol Violation|5|||
161820933|NCT01490190|584385753|FG000|Overall Study|Lost to Follow-up|13|||
161820934|NCT01490190|584385753|FG000|Overall Study|Relocation|1|||
161820935|NCT01490190|584385753|FG000|Overall Study|Inconvenience|1|||
161820936|NCT01490190|584385753|FG000|Overall Study|Ring expulsion|2|||
161820937|NCT02483416|584385756|FG000|Overall Study|Other reason|0|||
161820938|NCT02483416|584385757|FG001|Overall Study|Other reason|1|||
161512436|NCT04524403|583269635|FG000|Overall Study|Withdrawal by Subject|10|||
161512437|NCT04524403|583269636|FG001|Overall Study|Withdrawal by Subject|3|||
161512438|NCT04524403|583269637|FG002|Overall Study|Withdrawal by Subject|8|||
161512439|NCT04524403|583269635|FG000|Overall Study|Lost to Follow-up|3|||
161512440|NCT04524403|583269636|FG001|Overall Study|Lost to Follow-up|4|||
161512441|NCT04524403|583269637|FG002|Overall Study|Lost to Follow-up|3|||
161512442|NCT04524403|583269635|FG000|Overall Study|Adverse Event|3|||
161512443|NCT04524403|583269636|FG001|Overall Study|Adverse Event|1|||
161820939|NCT02483416|584385756|FG000|Overall Study|Treatment stop|3|||
161820940|NCT02483416|584385757|FG001|Overall Study|Treatment stop|0|||
161512444|NCT04524403|583269637|FG002|Overall Study|Adverse Event|4|||
161512445|NCT04524403|583269635|FG000|Overall Study|Non-compliant with study drug|1|||
161820941|NCT00969124|584385760|FG000|Overall Study|Protocol Violation|2|||
161820942|NCT00969124|584385760|FG000|Overall Study|Inadequate bowel preparation|15|||
161512446|NCT04524403|583269636|FG001|Overall Study|Non-compliant with study drug|2|||
161512447|NCT04524403|583269637|FG002|Overall Study|Non-compliant with study drug|3|||
161512448|NCT04524403|583269635|FG000|Overall Study|Moved|0|||
161512449|NCT04524403|583269636|FG001|Overall Study|Moved|1|||
161676189|NCT05975840|583867324|FG006|Overall Study|Migrated/moved from the study area|0|||
161676190|NCT05975840|583867325|FG007|Overall Study|Migrated/moved from the study area|0|||
161512450|NCT04524403|583269637|FG002|Overall Study|Moved|0|||
161512451|NCT00991302|583269638|FG000|Overall Study|Death|0|||
161512452|NCT00991302|583269639|FG001|Overall Study|Death|1|||
161512453|NCT00991302|583269638|FG000|Overall Study|Lost to Follow-up|14|||
161512454|NCT00991302|583269639|FG001|Overall Study|Lost to Follow-up|12|||
161512455|NCT01709318|583269640|FG000|Overall Study|Adverse Event|3|||
161512456|NCT01709318|583269641|FG001|Overall Study|Adverse Event|4|||
161512457|NCT01709318|583269642|FG002|Overall Study|Adverse Event|2|||
161512458|NCT01709318|583269643|FG003|Overall Study|Adverse Event|2|||
161512459|NCT01709318|583269644|FG004|Overall Study|Adverse Event|0|||
161512460|NCT01709318|583269645|FG005|Overall Study|Adverse Event|1|||
161512461|NCT01709318|583269646|FG006|Overall Study|Adverse Event|2|||
161512462|NCT01709318|583269640|FG000|Overall Study|Lost to Follow-up|2|||
161512463|NCT01709318|583269641|FG001|Overall Study|Lost to Follow-up|0|||
161512464|NCT01709318|583269642|FG002|Overall Study|Lost to Follow-up|0|||
161512465|NCT01709318|583269643|FG003|Overall Study|Lost to Follow-up|0|||
161512466|NCT01709318|583269644|FG004|Overall Study|Lost to Follow-up|1|||
161512467|NCT01709318|583269645|FG005|Overall Study|Lost to Follow-up|1|||
161512468|NCT01709318|583269646|FG006|Overall Study|Lost to Follow-up|1|||
161512469|NCT01709318|583269640|FG000|Overall Study|Non-compliance with Study Drug|0|||
161512470|NCT01709318|583269641|FG001|Overall Study|Non-compliance with Study Drug|2|||
161512471|NCT01709318|583269642|FG002|Overall Study|Non-compliance with Study Drug|1|||
161512472|NCT01709318|583269643|FG003|Overall Study|Non-compliance with Study Drug|1|||
161512473|NCT01709318|583269644|FG004|Overall Study|Non-compliance with Study Drug|0|||
161512474|NCT01709318|583269645|FG005|Overall Study|Non-compliance with Study Drug|0|||
161512475|NCT01709318|583269646|FG006|Overall Study|Non-compliance with Study Drug|2|||
161512476|NCT01709318|583269640|FG000|Overall Study|Physician Decision|0|||
161512477|NCT01709318|583269641|FG001|Overall Study|Physician Decision|0|||
161512478|NCT01709318|583269642|FG002|Overall Study|Physician Decision|0|||
161512479|NCT01709318|583269643|FG003|Overall Study|Physician Decision|0|||
161512480|NCT01709318|583269644|FG004|Overall Study|Physician Decision|0|||
161512481|NCT01709318|583269645|FG005|Overall Study|Physician Decision|0|||
161512482|NCT01709318|583269646|FG006|Overall Study|Physician Decision|1|||
161512483|NCT01709318|583269640|FG000|Overall Study|Pregnancy|0|||
161512484|NCT01709318|583269641|FG001|Overall Study|Pregnancy|0|||
161512485|NCT01709318|583269642|FG002|Overall Study|Pregnancy|0|||
161512486|NCT01709318|583269643|FG003|Overall Study|Pregnancy|0|||
161512487|NCT01709318|583269644|FG004|Overall Study|Pregnancy|1|||
161512488|NCT01709318|583269645|FG005|Overall Study|Pregnancy|0|||
161512489|NCT01709318|583269646|FG006|Overall Study|Pregnancy|0|||
161512490|NCT01709318|583269640|FG000|Overall Study|Protocol Violation|0|||
161512491|NCT01709318|583269641|FG001|Overall Study|Protocol Violation|0|||
161512492|NCT01709318|583269642|FG002|Overall Study|Protocol Violation|0|||
161512493|NCT01709318|583269643|FG003|Overall Study|Protocol Violation|0|||
161512494|NCT01709318|583269644|FG004|Overall Study|Protocol Violation|2|||
161512495|NCT01709318|583269645|FG005|Overall Study|Protocol Violation|0|||
161512496|NCT01709318|583269646|FG006|Overall Study|Protocol Violation|1|||
161512497|NCT01709318|583269640|FG000|Overall Study|Technical Problems|1|||
161512498|NCT01709318|583269641|FG001|Overall Study|Technical Problems|0|||
161512499|NCT01709318|583269642|FG002|Overall Study|Technical Problems|0|||
161512500|NCT01709318|583269643|FG003|Overall Study|Technical Problems|0|||
161512501|NCT01709318|583269644|FG004|Overall Study|Technical Problems|0|||
161512502|NCT01709318|583269645|FG005|Overall Study|Technical Problems|0|||
161512503|NCT01709318|583269646|FG006|Overall Study|Technical Problems|0|||
161512504|NCT01709318|583269640|FG000|Overall Study|Withdrawal by Subject|3|||
161676191|NCT05975840|583867318|FG000|Overall Study|Withdrawal by Subject|0|||
161927094|NCT01967277|584780248|FG001|Overall Study|Unrelated illness|1|||
161512505|NCT01709318|583269641|FG001|Overall Study|Withdrawal by Subject|0|||
161512506|NCT01709318|583269642|FG002|Overall Study|Withdrawal by Subject|3|||
161512507|NCT01709318|583269643|FG003|Overall Study|Withdrawal by Subject|3|||
161512508|NCT01709318|583269644|FG004|Overall Study|Withdrawal by Subject|0|||
161512509|NCT01709318|583269645|FG005|Overall Study|Withdrawal by Subject|2|||
161512510|NCT01709318|583269646|FG006|Overall Study|Withdrawal by Subject|4|||
161512511|NCT01709318|583269640|FG000|Overall Study|Other Protocol Specified Criteria|0|||
161512512|NCT01709318|583269641|FG001|Overall Study|Other Protocol Specified Criteria|1|||
161512513|NCT01709318|583269642|FG002|Overall Study|Other Protocol Specified Criteria|0|||
161512514|NCT01709318|583269643|FG003|Overall Study|Other Protocol Specified Criteria|0|||
161512515|NCT01709318|583269644|FG004|Overall Study|Other Protocol Specified Criteria|0|||
161512516|NCT01709318|583269645|FG005|Overall Study|Other Protocol Specified Criteria|0|||
161512517|NCT01709318|583269646|FG006|Overall Study|Other Protocol Specified Criteria|0|||
161512518|NCT00646958|583269651|FG000|Overall Study|Lack of Efficacy|1|||
161512519|NCT00646958|583269652|FG001|Overall Study|Lack of Efficacy|0|||
161512520|NCT00646958|583269653|FG002|Overall Study|Lack of Efficacy|0|||
161512521|NCT00646958|583269651|FG000|Overall Study|Adverse Event|4|||
161512522|NCT00646958|583269652|FG001|Overall Study|Adverse Event|0|||
161512523|NCT00646958|583269653|FG002|Overall Study|Adverse Event|0|||
161587883|NCT03526861|583542291|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
161587884|NCT03526861|583542292|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
161587885|NCT03526861|583542293|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
161820943|NCT00969124|584385760|FG000|Overall Study|Inability to reach cecum|9|||
161587886|NCT03526861|583542294|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
161587887|NCT03526861|583542295|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161587888|NCT03526861|583542287|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587889|NCT03526861|583542288|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587890|NCT03526861|583542289|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587891|NCT03526861|583542290|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
161587892|NCT03526861|583542291|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161820944|NCT00969124|584385760|FG000|Overall Study|Previously unrecognized disease|3|||
161820945|NCT00969124|584385760|FG000|Overall Study|Technical error|1|||
161820946|NCT00210639|584385761|FG000|Overall Study|Lost to Follow-up|37|||
161820947|NCT00210639|584385762|FG001|Overall Study|Lost to Follow-up|29|||
161820948|NCT00210639|584385761|FG000|Overall Study|Withdrawal by Subject|8|||
161820949|NCT00210639|584385762|FG001|Overall Study|Withdrawal by Subject|1|||
161820950|NCT00210639|584385761|FG000|Overall Study|Other|18|||
161820951|NCT00210639|584385762|FG001|Overall Study|Other|12|||
161820952|NCT04697173|584385769|FG000|Overall Study|Withdrawal by Subject|34|||
161820953|NCT04697173|584385770|FG001|Overall Study|Withdrawal by Subject|38|||
161820954|NCT03277248|584385775|FG000|Overall Study|Adverse Event|3|||
161820955|NCT03277248|584385776|FG001|Overall Study|Adverse Event|1|||
161820956|NCT03277248|584385775|FG000|Overall Study|Subject Withdrawal of Consent|6|||
161820957|NCT03277248|584385776|FG001|Overall Study|Subject Withdrawal of Consent|23|||
161820958|NCT03277248|584385775|FG000|Overall Study|Investigator/Sponsor Decision|2|||
161820959|NCT03277248|584385776|FG001|Overall Study|Investigator/Sponsor Decision|2|||
161820960|NCT03277248|584385775|FG000|Overall Study|Pregnancy|4|||
161820961|NCT03277248|584385776|FG001|Overall Study|Pregnancy|1|||
161820962|NCT03277248|584385775|FG000|Overall Study|Lost to Follow-up|0|||
161820963|NCT03277248|584385776|FG001|Overall Study|Lost to Follow-up|2|||
161820964|NCT03277248|584385775|FG000|Overall Study|Lack of Efficacy|0|||
161820965|NCT03277248|584385776|FG001|Overall Study|Lack of Efficacy|2|||
161820966|NCT03277248|584385775|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
161820967|NCT03277248|584385776|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
161512524|NCT00646958|583269651|FG000|Overall Study|Lost to Follow-up|1|||
161512525|NCT00646958|583269652|FG001|Overall Study|Lost to Follow-up|5|||
161512526|NCT00646958|583269653|FG002|Overall Study|Lost to Follow-up|7|||
161512527|NCT00646958|583269651|FG000|Overall Study|Protocol Violation|1|||
161512528|NCT00646958|583269652|FG001|Overall Study|Protocol Violation|1|||
161512529|NCT00646958|583269653|FG002|Overall Study|Protocol Violation|0|||
161512530|NCT00646958|583269651|FG000|Overall Study|Abnormal screening lab tests|1|||
161512531|NCT00646958|583269652|FG001|Overall Study|Abnormal screening lab tests|1|||
161512532|NCT00646958|583269653|FG002|Overall Study|Abnormal screening lab tests|0|||
161512533|NCT00646958|583269651|FG000|Overall Study|Withdrawal by Subject|1|||
161512534|NCT00646958|583269652|FG001|Overall Study|Withdrawal by Subject|2|||
161512535|NCT00646958|583269653|FG002|Overall Study|Withdrawal by Subject|0|||
161512536|NCT00646958|583269651|FG000|Overall Study|Did not receive study drug|2|||
161512537|NCT00646958|583269652|FG001|Overall Study|Did not receive study drug|0|||
161512538|NCT00646958|583269653|FG002|Overall Study|Did not receive study drug|2|||
161512539|NCT00827372|583269654|FG000|Overall Study|Adverse Event|5|||
161512540|NCT00827372|583269654|FG000|Overall Study|Lack of Efficacy|3|||
161512541|NCT03085927|583269655|FG000|Overall Study|Withdrawal by Subject|1|||
161512542|NCT03085927|583269656|FG001|Overall Study|Withdrawal by Subject|4|||
161512543|NCT03085927|583269655|FG000|Overall Study|Lost to Follow-up|3|||
161512544|NCT03085927|583269656|FG001|Overall Study|Lost to Follow-up|1|||
161512545|NCT03085927|583269655|FG000|Overall Study|Death|1|||
161512546|NCT03085927|583269656|FG001|Overall Study|Death|0|||
161512547|NCT03085927|583269655|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
161512548|NCT03085927|583269656|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
161512549|NCT03085927|583269655|FG000|Overall Study|Dyad Became Ineligible|0|||
161512550|NCT03085927|583269656|FG001|Overall Study|Dyad Became Ineligible|1|||
161512551|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
161512552|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161512553|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161512554|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161512555|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161512556|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161512557|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
161512558|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161512559|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161512560|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161512561|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161512562|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161512563|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
161512564|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161512565|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161512566|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161512567|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161512568|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161512569|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
161512570|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161512571|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161512572|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161512573|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161512574|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161512575|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
161512576|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161512577|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161512578|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161512579|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161512580|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161512581|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
161512582|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161512583|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161512584|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161512585|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161512586|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161512587|NCT02139644|583269657|FG000|Run-In Period (Pre-assignment)|Other|6|||
161512588|NCT02139644|583269658|FG001|Run-In Period (Pre-assignment)|Other|0|||
161820968|NCT01993940|584385777|FG000|Overall Study|Adverse Event|16|||
161512589|NCT02139644|583269659|FG002|Run-In Period (Pre-assignment)|Other|0|||
161512590|NCT02139644|583269660|FG003|Run-In Period (Pre-assignment)|Other|0|||
161512591|NCT02139644|583269661|FG004|Run-In Period (Pre-assignment)|Other|0|||
161820969|NCT01993940|584385778|FG001|Overall Study|Adverse Event|11|||
161820970|NCT01993940|584385777|FG000|Overall Study|Withdrawal by Subject|15|||
161512592|NCT02139644|583269662|FG005|Run-In Period (Pre-assignment)|Other|0|||
161512593|NCT02139644|583269657|FG000|Treatment Period|Adverse Event|0|||
161512594|NCT02139644|583269658|FG001|Treatment Period|Adverse Event|0|||
161512595|NCT02139644|583269659|FG002|Treatment Period|Adverse Event|3|||
161512596|NCT02139644|583269660|FG003|Treatment Period|Adverse Event|2|||
161512597|NCT02139644|583269661|FG004|Treatment Period|Adverse Event|1|||
161512598|NCT02139644|583269662|FG005|Treatment Period|Adverse Event|6|||
161512599|NCT02139644|583269657|FG000|Treatment Period|Withdrawal by Subject|0|||
161512600|NCT02139644|583269658|FG001|Treatment Period|Withdrawal by Subject|0|||
161512601|NCT02139644|583269659|FG002|Treatment Period|Withdrawal by Subject|2|||
161512602|NCT02139644|583269660|FG003|Treatment Period|Withdrawal by Subject|2|||
161927095|NCT00585585|584780253|FG000|Overall Study|Adverse Event|1|||
161927096|NCT01964560|584780258|FG000|Overall Study|Adverse Event|23|||
161927097|NCT01964560|584780258|FG000|Overall Study|Lack of Efficacy|46|||
161927098|NCT01964560|584780258|FG000|Overall Study|Protocol deviation|2|||
161927099|NCT01964560|584780258|FG000|Overall Study|Lost to Follow-up|4|||
161927100|NCT01964560|584780258|FG000|Overall Study|Withdrawal by Subject|64|||
161927101|NCT01964560|584780258|FG000|Overall Study|Surgery-hemispherotomy|1|||
161927102|NCT01964560|584780258|FG000|Overall Study|Surgery|1|||
161927103|NCT01964560|584780258|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
161927104|NCT01964560|584780258|FG000|Overall Study|Patient and Investigator choice|1|||
161927105|NCT01964560|584780258|FG000|Overall Study|Patient was prescribed CBD|1|||
161927106|NCT01964560|584780258|FG000|Overall Study|Participant moved to another country|1|||
161927107|NCT02384460|584780274|FG000|Overall Study|Protocol Violation|0|||
161927108|NCT02384460|584780275|FG001|Overall Study|Protocol Violation|1|||
161927109|NCT02384460|584780274|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
161927110|NCT02384460|584780275|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
161927111|NCT02384460|584780274|FG000|Overall Study|Adverse Event|5|||
161927112|NCT02384460|584780275|FG001|Overall Study|Adverse Event|2|||
161927113|NCT02384460|584780274|FG000|Overall Study|Withdrawal by Subject|0|||
161512603|NCT02139644|583269661|FG004|Treatment Period|Withdrawal by Subject|3|||
161512604|NCT02139644|583269662|FG005|Treatment Period|Withdrawal by Subject|2|||
161512605|NCT02139644|583269657|FG000|Treatment Period|Non-compliance|0|||
161512606|NCT02139644|583269658|FG001|Treatment Period|Non-compliance|0|||
161512607|NCT02139644|583269659|FG002|Treatment Period|Non-compliance|0|||
161512608|NCT02139644|583269660|FG003|Treatment Period|Non-compliance|1|||
161512609|NCT02139644|583269661|FG004|Treatment Period|Non-compliance|0|||
161512610|NCT02139644|583269662|FG005|Treatment Period|Non-compliance|0|||
161512611|NCT02139644|583269657|FG000|Treatment Period|Protocol Violation|0|||
161512612|NCT02139644|583269658|FG001|Treatment Period|Protocol Violation|0|||
161512613|NCT02139644|583269659|FG002|Treatment Period|Protocol Violation|0|||
161512614|NCT02139644|583269660|FG003|Treatment Period|Protocol Violation|1|||
161512615|NCT02139644|583269661|FG004|Treatment Period|Protocol Violation|1|||
161512616|NCT02139644|583269662|FG005|Treatment Period|Protocol Violation|1|||
161512617|NCT02139644|583269657|FG000|Treatment Period|Disease progression|0|||
161512618|NCT02139644|583269658|FG001|Treatment Period|Disease progression|0|||
161512619|NCT02139644|583269659|FG002|Treatment Period|Disease progression|0|||
161512620|NCT02139644|583269660|FG003|Treatment Period|Disease progression|1|||
161512621|NCT02139644|583269661|FG004|Treatment Period|Disease progression|1|||
161512622|NCT02139644|583269662|FG005|Treatment Period|Disease progression|2|||
161512623|NCT02139644|583269657|FG000|Treatment Period|Lost to Follow-up|0|||
161512624|NCT02139644|583269658|FG001|Treatment Period|Lost to Follow-up|0|||
161512625|NCT02139644|583269659|FG002|Treatment Period|Lost to Follow-up|1|||
161512626|NCT02139644|583269660|FG003|Treatment Period|Lost to Follow-up|1|||
161927114|NCT02384460|584780275|FG001|Overall Study|Withdrawal by Subject|3|||
161927115|NCT02384460|584780274|FG000|Overall Study|Elective medical treatment|1|||
161927116|NCT02384460|584780275|FG001|Overall Study|Elective medical treatment|0|||
161927117|NCT02384460|584780274|FG000|Overall Study|Non-compliance|1|||
161927118|NCT02384460|584780275|FG001|Overall Study|Non-compliance|0|||
161927119|NCT02301429|584780279|FG000|Overall Study|not acceptable vascular anatomy|3|||
161927120|NCT02217982|584780281|FG000|Overall Study|Trial discontinued|1|||
161927121|NCT02217982|584780282|FG001|Overall Study|Trial discontinued|0|||
161512627|NCT02139644|583269661|FG004|Treatment Period|Lost to Follow-up|1|||
161512628|NCT02139644|583269662|FG005|Treatment Period|Lost to Follow-up|1|||
161512629|NCT02139644|583269657|FG000|Treatment Period|Lack of Efficacy|0|||
161512630|NCT02139644|583269658|FG001|Treatment Period|Lack of Efficacy|0|||
161512631|NCT02139644|583269659|FG002|Treatment Period|Lack of Efficacy|1|||
161512632|NCT02139644|583269660|FG003|Treatment Period|Lack of Efficacy|0|||
161512633|NCT02139644|583269661|FG004|Treatment Period|Lack of Efficacy|1|||
161512634|NCT02139644|583269662|FG005|Treatment Period|Lack of Efficacy|4|||
161587893|NCT03526861|583542292|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161927122|NCT02217982|584780281|FG000|Overall Study|Adverse Event|0|||
161927123|NCT02217982|584780282|FG001|Overall Study|Adverse Event|1|||
161927124|NCT01279200|584780289|FG000|Overall Study|Withdrawal by Subject|1|||
161927125|NCT01279200|584780290|FG001|Overall Study|Withdrawal by Subject|3|||
161512635|NCT02139644|583269657|FG000|Treatment Period|Other|0|||
161512636|NCT02139644|583269658|FG001|Treatment Period|Other|3|||
161512637|NCT02139644|583269659|FG002|Treatment Period|Other|1|||
161512638|NCT02139644|583269660|FG003|Treatment Period|Other|1|||
161512639|NCT02139644|583269661|FG004|Treatment Period|Other|0|||
161512640|NCT02139644|583269662|FG005|Treatment Period|Other|1|||
161512641|NCT00630877|583269665|FG000|Overall Study|Adverse Event|11|||
161512642|NCT00630877|583269666|FG001|Overall Study|Adverse Event|8|||
161512643|NCT00630877|583269667|FG002|Overall Study|Adverse Event|7|||
161512644|NCT00630877|583269665|FG000|Overall Study|Withdrawal by Subject|3|||
161512645|NCT00630877|583269666|FG001|Overall Study|Withdrawal by Subject|4|||
161512646|NCT00630877|583269667|FG002|Overall Study|Withdrawal by Subject|0|||
161512647|NCT00630877|583269665|FG000|Overall Study|Lost to Follow-up|2|||
161512648|NCT00630877|583269666|FG001|Overall Study|Lost to Follow-up|0|||
161512649|NCT00630877|583269667|FG002|Overall Study|Lost to Follow-up|0|||
161512650|NCT00630877|583269665|FG000|Overall Study|Noncompliance|2|||
161512651|NCT00630877|583269666|FG001|Overall Study|Noncompliance|3|||
161512652|NCT00630877|583269667|FG002|Overall Study|Noncompliance|1|||
161512653|NCT00630877|583269665|FG000|Overall Study|Protocol violation|1|||
161587894|NCT03526861|583542293|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161927126|NCT01279200|584780289|FG000|Overall Study|Patient withdrawal due to high cost|0|||
161927127|NCT01279200|584780290|FG001|Overall Study|Patient withdrawal due to high cost|1|||
161927128|NCT01279200|584780289|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
161927129|NCT01279200|584780290|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
161927130|NCT01279200|584780289|FG000|Overall Study|ultrasound screening failure|0|||
161927131|NCT01279200|584780290|FG001|Overall Study|ultrasound screening failure|1|||
161927132|NCT01279200|584780289|FG000|Overall Study|Lost to Follow-up|0|||
161927133|NCT01279200|584780290|FG001|Overall Study|Lost to Follow-up|1|||
161927134|NCT01279200|584780289|FG000|Overall Study|Adverse Event|1|||
161927135|NCT01279200|584780290|FG001|Overall Study|Adverse Event|0|||
161927136|NCT01399099|584780291|FG000|Overall Study|Lost to Follow-up|14|||
161927137|NCT01399099|584780291|FG000|Overall Study|Physician Decision|1|||
161927138|NCT01399099|584780291|FG000|Overall Study|Protocol Violation|1|||
161927139|NCT01399099|584780291|FG000|Overall Study|Skin Irritation|13|||
161927140|NCT01399099|584780291|FG000|Overall Study|Infection|1|||
161587895|NCT03526861|583542294|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587896|NCT03526861|583542295|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587897|NCT03526861|583542287|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587898|NCT03526861|583542288|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587899|NCT03526861|583542289|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587900|NCT03526861|583542290|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587901|NCT03526861|583542291|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587902|NCT03526861|583542292|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587903|NCT03526861|583542293|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587904|NCT03526861|583542294|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161587905|NCT03526861|583542295|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
161587906|NCT03526861|583542287|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587907|NCT03526861|583542288|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587908|NCT03526861|583542289|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587909|NCT03526861|583542290|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587910|NCT03526861|583542291|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587911|NCT03526861|583542292|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587912|NCT03526861|583542293|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161676192|NCT05975840|583867319|FG001|Overall Study|Withdrawal by Subject|5|||
161927141|NCT01399099|584780291|FG000|Overall Study|Miscellaneous|4|||
161927142|NCT01179516|584780292|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
161927143|NCT01179516|584780293|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
161512654|NCT00630877|583269666|FG001|Overall Study|Protocol violation|0|||
161512655|NCT00630877|583269667|FG002|Overall Study|Protocol violation|1|||
161512656|NCT00630877|583269665|FG000|Overall Study|Personal reasons|0|||
161512657|NCT00630877|583269666|FG001|Overall Study|Personal reasons|0|||
161512658|NCT00630877|583269667|FG002|Overall Study|Personal reasons|1|||
161512659|NCT01312909|583269668|FG000|Overall Study|Randomized but not treated|1|||
161512660|NCT01312909|583269669|FG001|Overall Study|Randomized but not treated|3|||
161512661|NCT01312909|583269670|FG002|Overall Study|Randomized but not treated|1|||
161512662|NCT01312909|583269668|FG000|Overall Study|Adverse Event|1|||
161512663|NCT01312909|583269669|FG001|Overall Study|Adverse Event|0|||
161512664|NCT01312909|583269670|FG002|Overall Study|Adverse Event|3|||
161512665|NCT01312909|583269668|FG000|Overall Study|Protocol Violation|2|||
161512666|NCT01312909|583269669|FG001|Overall Study|Protocol Violation|0|||
161512667|NCT01312909|583269670|FG002|Overall Study|Protocol Violation|2|||
161512668|NCT01312909|583269668|FG000|Overall Study|Other|9|||
161512669|NCT01312909|583269669|FG001|Overall Study|Other|6|||
161512670|NCT01312909|583269670|FG002|Overall Study|Other|11|||
161512671|NCT01312909|583269668|FG000|Overall Study|Withdrawal by Subject|8|||
161512672|NCT01312909|583269669|FG001|Overall Study|Withdrawal by Subject|10|||
161512673|NCT01312909|583269670|FG002|Overall Study|Withdrawal by Subject|7|||
161512674|NCT01312909|583269668|FG000|Overall Study|Lost to Follow-up|21|||
161512675|NCT01312909|583269669|FG001|Overall Study|Lost to Follow-up|17|||
161512676|NCT01312909|583269670|FG002|Overall Study|Lost to Follow-up|20|||
161512677|NCT01312909|583269668|FG000|Overall Study|Insufficient clinical response|0|||
161512678|NCT01312909|583269669|FG001|Overall Study|Insufficient clinical response|0|||
161512679|NCT01312909|583269670|FG002|Overall Study|Insufficient clinical response|1|||
161512680|NCT01312909|583269668|FG000|Overall Study|Entrance criteria not met|0|||
161512681|NCT01312909|583269669|FG001|Overall Study|Entrance criteria not met|0|||
161512682|NCT01312909|583269670|FG002|Overall Study|Entrance criteria not met|2|||
161512683|NCT02200042|583269671|FG000|Overall Study|Withdrawal by Subject|0|||
161512684|NCT02200042|583269672|FG001|Overall Study|Withdrawal by Subject|1|||
161512685|NCT00306592|583269675|FG000|Overall Study|Adverse Event|8|||
161512686|NCT00306592|583269676|FG001|Overall Study|Adverse Event|15|||
161512687|NCT00306592|583269675|FG000|Overall Study|Lost to Follow-up|1|||
161512688|NCT00306592|583269676|FG001|Overall Study|Lost to Follow-up|0|||
161512689|NCT00306592|583269675|FG000|Overall Study|Noncompliance|0|||
161512690|NCT00306592|583269676|FG001|Overall Study|Noncompliance|2|||
161512691|NCT00306592|583269675|FG000|Overall Study|Persistent Antibodies|6|||
161512692|NCT00306592|583269676|FG001|Overall Study|Persistent Antibodies|3|||
161512693|NCT00306592|583269675|FG000|Overall Study|Voluntary|10|||
161512694|NCT00306592|583269676|FG001|Overall Study|Voluntary|6|||
161512695|NCT00306592|583269675|FG000|Overall Study|Other|5|||
161512696|NCT00306592|583269676|FG001|Overall Study|Other|10|||
161512697|NCT00306592|583269675|FG000|Overall Study|Other|1|||
161512698|NCT00306592|583269676|FG001|Overall Study|Other|2|||
161512699|NCT00306592|583269675|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
161512700|NCT00306592|583269676|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
161512701|NCT00796861|583269684|FG000|Overall Study|Withdrawal by Subject|2|||
161512702|NCT00796861|583269684|FG000|Overall Study|Death|2|||
161512703|NCT00844545|583269689|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
161512704|NCT00844545|583269689|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
161512705|NCT00844545|583269689|FG000|Extension Treatment Period|Adverse Event|2|||
161512706|NCT00844545|583269689|FG000|Post Treatment Period|Withdrawal by Subject|1|||
161512707|NCT00403455|583269690|FG000|Overall Study|Withdrawal by Subject|1|||
161512708|NCT01358981|583269691|FG000|Period 1|Withdrawal by Subject|0|||
161587913|NCT03526861|583542294|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161587914|NCT03526861|583542295|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
161587915|NCT03526861|583542287|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587916|NCT03526861|583542288|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587917|NCT03526861|583542289|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587918|NCT03526861|583542290|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587919|NCT03526861|583542291|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587920|NCT03526861|583542292|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161820971|NCT01993940|584385778|FG001|Overall Study|Withdrawal by Subject|19|||
161820972|NCT01993940|584385777|FG000|Overall Study|Lost to Follow-up|2|||
161820973|NCT01993940|584385778|FG001|Overall Study|Lost to Follow-up|5|||
161820974|NCT01993940|584385777|FG000|Overall Study|Protocol Violation|5|||
161512709|NCT01358981|583269692|FG001|Period 1|Withdrawal by Subject|0|||
161512710|NCT01358981|583269693|FG002|Period 1|Withdrawal by Subject|0|||
161512711|NCT01358981|583269694|FG003|Period 1|Withdrawal by Subject|1|||
161512712|NCT01358981|583269695|FG004|Period 1|Withdrawal by Subject|0|||
161512713|NCT01358981|583269696|FG005|Period 1|Withdrawal by Subject|0|||
161512714|NCT01358981|583269697|FG006|Period 1|Withdrawal by Subject|0|||
161512715|NCT04574362|583269698|FG000|Overall Study|Other|0|||
161512716|NCT04574362|583269699|FG001|Overall Study|Other|5|||
161512717|NCT04574362|583269698|FG000|Overall Study|COVID-19|0|||
161512718|NCT04574362|583269699|FG001|Overall Study|COVID-19|1|||
161512719|NCT04574362|583269698|FG000|Overall Study|Adverse Event|1|||
161512720|NCT04574362|583269699|FG001|Overall Study|Adverse Event|1|||
161512721|NCT04574362|583269698|FG000|Overall Study|Withdrawal by Subject|2|||
161512722|NCT04574362|583269699|FG001|Overall Study|Withdrawal by Subject|4|||
161512723|NCT04574362|583269698|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
161512724|NCT04574362|583269699|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
161512725|NCT04574362|583269698|FG000|Overall Study|Participant refused to come to the hospital|1|||
161512726|NCT04574362|583269699|FG001|Overall Study|Participant refused to come to the hospital|0|||
161512727|NCT04574362|583269698|FG000|Overall Study|Participant refused the visit|1|||
161512728|NCT04574362|583269699|FG001|Overall Study|Participant refused the visit|0|||
161512729|NCT04574362|583269698|FG000|Overall Study|Participant quit early because of business trip|1|||
161512730|NCT04574362|583269699|FG001|Overall Study|Participant quit early because of business trip|0|||
161512731|NCT01785524|583269700|FG000|Overall Study|Withdrawal by Subject|2|||
161512732|NCT01785524|583269701|FG001|Overall Study|Withdrawal by Subject|2|||
161512733|NCT01060384|583269702|FG000|Overall Study|Withdrawal by Subject|0|||
161512734|NCT01060384|583269703|FG001|Overall Study|Withdrawal by Subject|1|||
161512735|NCT01060384|583269704|FG002|Overall Study|Withdrawal by Subject|0|||
161512736|NCT01060384|583269705|FG003|Overall Study|Withdrawal by Subject|0|||
161512737|NCT01060384|583269706|FG004|Overall Study|Withdrawal by Subject|0|||
161512738|NCT01060384|583269702|FG000|Overall Study|Death|0|||
161512739|NCT01060384|583269703|FG001|Overall Study|Death|0|||
161512740|NCT01060384|583269704|FG002|Overall Study|Death|0|||
161512741|NCT01060384|583269705|FG003|Overall Study|Death|0|||
161512742|NCT01060384|583269706|FG004|Overall Study|Death|1|||
161512743|NCT01060384|583269702|FG000|Overall Study|Intercurrent illness|0|||
161512744|NCT01060384|583269703|FG001|Overall Study|Intercurrent illness|0|||
161512745|NCT01060384|583269704|FG002|Overall Study|Intercurrent illness|0|||
161512746|NCT01060384|583269705|FG003|Overall Study|Intercurrent illness|0|||
161512747|NCT01060384|583269706|FG004|Overall Study|Intercurrent illness|1|||
161512748|NCT01332305|583269707|FG000|Overall Study|Adverse Event|1|||
161512749|NCT01332305|583269708|FG001|Overall Study|Adverse Event|4|||
161512750|NCT01332305|583269709|FG002|Overall Study|Adverse Event|6|||
161512751|NCT01332305|583269710|FG003|Overall Study|Adverse Event|3|||
161512752|NCT01332305|583269711|FG004|Overall Study|Adverse Event|5|||
161512753|NCT01332305|583269707|FG000|Overall Study|Withdrawal by Subject|6|||
161512754|NCT01332305|583269708|FG001|Overall Study|Withdrawal by Subject|5|||
161512755|NCT01332305|583269709|FG002|Overall Study|Withdrawal by Subject|4|||
161512756|NCT01332305|583269710|FG003|Overall Study|Withdrawal by Subject|1|||
161512757|NCT01332305|583269711|FG004|Overall Study|Withdrawal by Subject|0|||
161512758|NCT01332305|583269707|FG000|Overall Study|Lost to Follow-up|0|||
161512759|NCT01332305|583269708|FG001|Overall Study|Lost to Follow-up|2|||
161512760|NCT01332305|583269709|FG002|Overall Study|Lost to Follow-up|3|||
161512761|NCT01332305|583269710|FG003|Overall Study|Lost to Follow-up|2|||
161512762|NCT01332305|583269711|FG004|Overall Study|Lost to Follow-up|3|||
161512763|NCT01332305|583269707|FG000|Overall Study|Protocol Violation|1|||
161512764|NCT01332305|583269708|FG001|Overall Study|Protocol Violation|2|||
161587921|NCT03526861|583542293|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587922|NCT03526861|583542294|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161587923|NCT03526861|583542295|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
161587924|NCT02506959|583542297|FG000|Overall Study|Physician Decision|2|||
161587925|NCT02506959|583542298|FG001|Overall Study|Physician Decision|1|||
161587926|NCT04294225|583542302|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
161587927|NCT04294225|583542302|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
161587928|NCT04294225|583542302|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
161587929|NCT04294225|583542302|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
161587930|NCT04294225|583542302|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
161587931|NCT04812535|583542310|FG000|Overall Study|Withdrawal by Subject|0|||
161587932|NCT04812535|583542311|FG001|Overall Study|Withdrawal by Subject|0|||
161587933|NCT04812535|583542312|FG002|Overall Study|Withdrawal by Subject|0|||
161587934|NCT04812535|583542313|FG003|Overall Study|Withdrawal by Subject|1|||
161820975|NCT01993940|584385778|FG001|Overall Study|Protocol Violation|8|||
161820976|NCT01993940|584385777|FG000|Overall Study|Death|1|||
161820977|NCT01993940|584385778|FG001|Overall Study|Death|0|||
161820978|NCT01993940|584385777|FG000|Overall Study|Other - Miscellaneous|1|||
161820979|NCT01993940|584385778|FG001|Overall Study|Other - Miscellaneous|1|||
161820980|NCT01949532|584385779|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
161820981|NCT01949532|584385780|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
161820982|NCT00379353|584385781|FG000|Overall Study|Hospitalization|3|||
161820983|NCT00379353|584385782|FG001|Overall Study|Hospitalization|3|||
161820984|NCT00379353|584385781|FG000|Overall Study|Withdrawal by Subject|5|||
161820985|NCT00379353|584385782|FG001|Overall Study|Withdrawal by Subject|2|||
161820986|NCT00379353|584385781|FG000|Overall Study|Death|1|||
161820987|NCT00379353|584385782|FG001|Overall Study|Death|0|||
161512765|NCT01332305|583269709|FG002|Overall Study|Protocol Violation|1|||
161512766|NCT01332305|583269710|FG003|Overall Study|Protocol Violation|0|||
161512767|NCT01332305|583269711|FG004|Overall Study|Protocol Violation|3|||
161512768|NCT01332305|583269707|FG000|Overall Study|Withdrawal by Sponsor|1|||
161512769|NCT01332305|583269708|FG001|Overall Study|Withdrawal by Sponsor|0|||
161512770|NCT01332305|583269709|FG002|Overall Study|Withdrawal by Sponsor|0|||
161512771|NCT01332305|583269710|FG003|Overall Study|Withdrawal by Sponsor|1|||
161512772|NCT01332305|583269711|FG004|Overall Study|Withdrawal by Sponsor|1|||
161512773|NCT01332305|583269707|FG000|Overall Study|Treatment Failure|1|||
161512774|NCT01332305|583269708|FG001|Overall Study|Treatment Failure|1|||
161512775|NCT01332305|583269709|FG002|Overall Study|Treatment Failure|0|||
161512776|NCT01332305|583269710|FG003|Overall Study|Treatment Failure|0|||
161512777|NCT01332305|583269711|FG004|Overall Study|Treatment Failure|0|||
161512778|NCT01332305|583269707|FG000|Overall Study|Physician Decision|0|||
161512779|NCT01332305|583269708|FG001|Overall Study|Physician Decision|0|||
161512780|NCT01332305|583269709|FG002|Overall Study|Physician Decision|0|||
161512781|NCT01332305|583269710|FG003|Overall Study|Physician Decision|1|||
161512782|NCT01332305|583269711|FG004|Overall Study|Physician Decision|0|||
161512783|NCT01600040|583269714|FG000|Overall Study|Withdrawal by Subject|1|||
161512784|NCT01401530|583269718|FG000|Overall Study|Disease Progression|1|||
161512785|NCT01401530|583269719|FG001|Overall Study|Disease Progression|2|||
161512786|NCT01401530|583269720|FG002|Overall Study|Disease Progression|1|||
161512787|NCT01401530|583269718|FG000|Overall Study|Adverse Event|1|||
161512788|NCT01401530|583269719|FG001|Overall Study|Adverse Event|1|||
161512789|NCT01401530|583269720|FG002|Overall Study|Adverse Event|1|||
161512790|NCT01401530|583269718|FG000|Overall Study|Participant Choice|1|||
161512791|NCT01401530|583269719|FG001|Overall Study|Participant Choice|2|||
161512792|NCT01401530|583269720|FG002|Overall Study|Participant Choice|1|||
161512793|NCT01401530|583269718|FG000|Overall Study|Physician Decision|0|||
161512794|NCT01401530|583269719|FG001|Overall Study|Physician Decision|1|||
161512795|NCT01401530|583269720|FG002|Overall Study|Physician Decision|0|||
161512796|NCT03670810|583269721|FG000|Main Study|Adverse Event|37|||
161512797|NCT03670810|583269722|FG001|Main Study|Adverse Event|38|||
161512798|NCT03670810|583269723|FG002|Main Study|Adverse Event|3|||
161512799|NCT03670810|583269724|FG003|Main Study|Adverse Event|4|||
161512800|NCT03670810|583269725|FG004|Main Study|Adverse Event|4|||
161512801|NCT03670810|583269726|FG005|Main Study|Adverse Event|5|||
161512802|NCT03670810|583269727|FG006|Main Study|Adverse Event|0|||
161512803|NCT03670810|583269728|FG007|Main Study|Adverse Event|0|||
161512804|NCT03670810|583269729|FG008|Main Study|Adverse Event|0|||
161512805|NCT03670810|583269721|FG000|Main Study|Lack of Efficacy|8|||
161512806|NCT03670810|583269722|FG001|Main Study|Lack of Efficacy|9|||
161512807|NCT03670810|583269723|FG002|Main Study|Lack of Efficacy|3|||
161512808|NCT03670810|583269724|FG003|Main Study|Lack of Efficacy|4|||
161512809|NCT03670810|583269725|FG004|Main Study|Lack of Efficacy|0|||
161512810|NCT03670810|583269726|FG005|Main Study|Lack of Efficacy|0|||
161512811|NCT03670810|583269727|FG006|Main Study|Lack of Efficacy|0|||
161512812|NCT03670810|583269728|FG007|Main Study|Lack of Efficacy|0|||
161512813|NCT03670810|583269729|FG008|Main Study|Lack of Efficacy|0|||
161512814|NCT03670810|583269721|FG000|Main Study|Lost to Follow-up|9|||
161512815|NCT03670810|583269722|FG001|Main Study|Lost to Follow-up|7|||
161512816|NCT03670810|583269723|FG002|Main Study|Lost to Follow-up|4|||
161512817|NCT03670810|583269724|FG003|Main Study|Lost to Follow-up|6|||
161512818|NCT03670810|583269725|FG004|Main Study|Lost to Follow-up|1|||
161512819|NCT03670810|583269726|FG005|Main Study|Lost to Follow-up|0|||
161512820|NCT03670810|583269727|FG006|Main Study|Lost to Follow-up|0|||
161512821|NCT03670810|583269728|FG007|Main Study|Lost to Follow-up|0|||
161512822|NCT03670810|583269729|FG008|Main Study|Lost to Follow-up|0|||
161512823|NCT03670810|583269721|FG000|Main Study|Non-compliance with Study Drug|0|||
161512824|NCT03670810|583269722|FG001|Main Study|Non-compliance with Study Drug|2|||
161512825|NCT03670810|583269723|FG002|Main Study|Non-compliance with Study Drug|3|||
161512826|NCT03670810|583269724|FG003|Main Study|Non-compliance with Study Drug|0|||
161512827|NCT03670810|583269725|FG004|Main Study|Non-compliance with Study Drug|0|||
161512828|NCT03670810|583269726|FG005|Main Study|Non-compliance with Study Drug|0|||
161512829|NCT03670810|583269727|FG006|Main Study|Non-compliance with Study Drug|0|||
161512830|NCT03670810|583269728|FG007|Main Study|Non-compliance with Study Drug|1|||
161512831|NCT03670810|583269729|FG008|Main Study|Non-compliance with Study Drug|0|||
161512832|NCT03670810|583269721|FG000|Main Study|Physician Decision|3|||
161512833|NCT03670810|583269722|FG001|Main Study|Physician Decision|0|||
161512834|NCT03670810|583269723|FG002|Main Study|Physician Decision|1|||
161512835|NCT03670810|583269724|FG003|Main Study|Physician Decision|0|||
161512836|NCT03670810|583269725|FG004|Main Study|Physician Decision|0|||
161512837|NCT03670810|583269726|FG005|Main Study|Physician Decision|0|||
161512838|NCT03670810|583269727|FG006|Main Study|Physician Decision|1|||
161512839|NCT03670810|583269728|FG007|Main Study|Physician Decision|1|||
161512840|NCT03670810|583269729|FG008|Main Study|Physician Decision|0|||
161512841|NCT03670810|583269721|FG000|Main Study|Pregnancy|1|||
161512842|NCT03670810|583269722|FG001|Main Study|Pregnancy|2|||
161512843|NCT03670810|583269723|FG002|Main Study|Pregnancy|0|||
161512844|NCT03670810|583269724|FG003|Main Study|Pregnancy|0|||
161512845|NCT03670810|583269725|FG004|Main Study|Pregnancy|0|||
161512846|NCT03670810|583269726|FG005|Main Study|Pregnancy|0|||
161512847|NCT03670810|583269727|FG006|Main Study|Pregnancy|0|||
161512848|NCT03670810|583269728|FG007|Main Study|Pregnancy|0|||
161512849|NCT03670810|583269729|FG008|Main Study|Pregnancy|0|||
161512850|NCT03670810|583269721|FG000|Main Study|Protocol Deviation|2|||
161512851|NCT03670810|583269722|FG001|Main Study|Protocol Deviation|12|||
161512852|NCT03670810|583269723|FG002|Main Study|Protocol Deviation|8|||
161512853|NCT03670810|583269724|FG003|Main Study|Protocol Deviation|4|||
161512854|NCT03670810|583269725|FG004|Main Study|Protocol Deviation|0|||
161512855|NCT03670810|583269726|FG005|Main Study|Protocol Deviation|0|||
161512856|NCT03670810|583269727|FG006|Main Study|Protocol Deviation|0|||
161512857|NCT03670810|583269728|FG007|Main Study|Protocol Deviation|0|||
161512858|NCT03670810|583269729|FG008|Main Study|Protocol Deviation|0|||
161512859|NCT03670810|583269721|FG000|Main Study|Withdrawal by Subject|21|||
161512860|NCT03670810|583269722|FG001|Main Study|Withdrawal by Subject|21|||
161512861|NCT03670810|583269723|FG002|Main Study|Withdrawal by Subject|8|||
161512862|NCT03670810|583269724|FG003|Main Study|Withdrawal by Subject|9|||
161512863|NCT03670810|583269725|FG004|Main Study|Withdrawal by Subject|5|||
161512864|NCT03670810|583269726|FG005|Main Study|Withdrawal by Subject|2|||
161512865|NCT03670810|583269727|FG006|Main Study|Withdrawal by Subject|1|||
161512866|NCT03670810|583269728|FG007|Main Study|Withdrawal by Subject|1|||
161512867|NCT03670810|583269729|FG008|Main Study|Withdrawal by Subject|0|||
161512868|NCT03670810|583269721|FG000|Main Study|Participant did not want to take the three other treatments|1|||
161512869|NCT03670810|583269722|FG001|Main Study|Participant did not want to take the three other treatments|0|||
161512870|NCT03670810|583269723|FG002|Main Study|Participant did not want to take the three other treatments|0|||
161512871|NCT03670810|583269724|FG003|Main Study|Participant did not want to take the three other treatments|0|||
161512872|NCT03670810|583269725|FG004|Main Study|Participant did not want to take the three other treatments|0|||
161512873|NCT03670810|583269726|FG005|Main Study|Participant did not want to take the three other treatments|0|||
161512874|NCT03670810|583269727|FG006|Main Study|Participant did not want to take the three other treatments|0|||
161512875|NCT03670810|583269728|FG007|Main Study|Participant did not want to take the three other treatments|0|||
161512876|NCT03670810|583269729|FG008|Main Study|Participant did not want to take the three other treatments|0|||
161512877|NCT03670810|583269721|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512878|NCT03670810|583269722|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
161512879|NCT03670810|583269723|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512880|NCT03670810|583269724|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512881|NCT03670810|583269725|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512882|NCT03670810|583269726|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512883|NCT03670810|583269727|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512884|NCT03670810|583269728|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512885|NCT03670810|583269729|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
161512886|NCT03670810|583269721|FG000|Main Study|Travel and Coronavirus issues|0|||
161512887|NCT03670810|583269722|FG001|Main Study|Travel and Coronavirus issues|0|||
161512888|NCT03670810|583269723|FG002|Main Study|Travel and Coronavirus issues|0|||
161512889|NCT03670810|583269724|FG003|Main Study|Travel and Coronavirus issues|1|||
161512890|NCT03670810|583269725|FG004|Main Study|Travel and Coronavirus issues|0|||
161512891|NCT03670810|583269726|FG005|Main Study|Travel and Coronavirus issues|0|||
161512892|NCT03670810|583269727|FG006|Main Study|Travel and Coronavirus issues|0|||
161512893|NCT03670810|583269728|FG007|Main Study|Travel and Coronavirus issues|0|||
161512894|NCT03670810|583269729|FG008|Main Study|Travel and Coronavirus issues|0|||
161512895|NCT03670810|583269721|FG000|Open Label Extension|Protocol Deviation|0|||
161512896|NCT03670810|583269722|FG001|Open Label Extension|Protocol Deviation|0|||
161512897|NCT03670810|583269723|FG002|Open Label Extension|Protocol Deviation|0|||
161512898|NCT03670810|583269724|FG003|Open Label Extension|Protocol Deviation|0|||
161512899|NCT03670810|583269725|FG004|Open Label Extension|Protocol Deviation|0|||
161512900|NCT03670810|583269726|FG005|Open Label Extension|Protocol Deviation|0|||
161512901|NCT03670810|583269727|FG006|Open Label Extension|Protocol Deviation|0|||
161512902|NCT03670810|583269728|FG007|Open Label Extension|Protocol Deviation|0|||
161512903|NCT03670810|583269729|FG008|Open Label Extension|Protocol Deviation|5|||
161512904|NCT03670810|583269721|FG000|Open Label Extension|Death|0|||
161512905|NCT03670810|583269722|FG001|Open Label Extension|Death|0|||
161512906|NCT03670810|583269723|FG002|Open Label Extension|Death|0|||
161512907|NCT03670810|583269724|FG003|Open Label Extension|Death|0|||
161676193|NCT05975840|583867320|FG002|Overall Study|Withdrawal by Subject|2|||
161676194|NCT05975840|583867321|FG003|Overall Study|Withdrawal by Subject|2|||
161676195|NCT05975840|583867322|FG004|Overall Study|Withdrawal by Subject|0|||
161676196|NCT05975840|583867323|FG005|Overall Study|Withdrawal by Subject|2|||
161676197|NCT05975840|583867324|FG006|Overall Study|Withdrawal by Subject|2|||
161676198|NCT05975840|583867325|FG007|Overall Study|Withdrawal by Subject|1|||
161512908|NCT03670810|583269725|FG004|Open Label Extension|Death|0|||
161676199|NCT05975840|583867318|FG000|Overall Study|Protocol Violation|0|||
161512909|NCT03670810|583269726|FG005|Open Label Extension|Death|0|||
161512910|NCT03670810|583269727|FG006|Open Label Extension|Death|0|||
161512911|NCT03670810|583269728|FG007|Open Label Extension|Death|0|||
161512912|NCT03670810|583269729|FG008|Open Label Extension|Death|1|||
161512913|NCT03670810|583269721|FG000|Open Label Extension|COVID-19|0|||
161512914|NCT03670810|583269722|FG001|Open Label Extension|COVID-19|0|||
161512915|NCT03670810|583269723|FG002|Open Label Extension|COVID-19|0|||
161512916|NCT03670810|583269724|FG003|Open Label Extension|COVID-19|0|||
161512917|NCT03670810|583269725|FG004|Open Label Extension|COVID-19|0|||
161512918|NCT03670810|583269726|FG005|Open Label Extension|COVID-19|0|||
161512919|NCT03670810|583269727|FG006|Open Label Extension|COVID-19|0|||
161512920|NCT03670810|583269728|FG007|Open Label Extension|COVID-19|0|||
161512921|NCT03670810|583269729|FG008|Open Label Extension|COVID-19|1|||
161512922|NCT03670810|583269721|FG000|Open Label Extension|Lack of Efficacy|0|||
161512923|NCT03670810|583269722|FG001|Open Label Extension|Lack of Efficacy|0|||
161512924|NCT03670810|583269723|FG002|Open Label Extension|Lack of Efficacy|0|||
161512925|NCT03670810|583269724|FG003|Open Label Extension|Lack of Efficacy|0|||
161512926|NCT03670810|583269725|FG004|Open Label Extension|Lack of Efficacy|0|||
161512927|NCT03670810|583269726|FG005|Open Label Extension|Lack of Efficacy|0|||
161512928|NCT03670810|583269727|FG006|Open Label Extension|Lack of Efficacy|0|||
161512929|NCT03670810|583269728|FG007|Open Label Extension|Lack of Efficacy|0|||
161512930|NCT03670810|583269729|FG008|Open Label Extension|Lack of Efficacy|39|||
161512931|NCT03670810|583269721|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
161512932|NCT03670810|583269722|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
161512933|NCT03670810|583269723|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
161512934|NCT03670810|583269724|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
161512935|NCT03670810|583269725|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
161512936|NCT03670810|583269726|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
161512937|NCT03670810|583269727|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
161512938|NCT03670810|583269728|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
161512939|NCT03670810|583269729|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
161512940|NCT03670810|583269721|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512941|NCT03670810|583269722|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512942|NCT03670810|583269723|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512943|NCT03670810|583269724|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512944|NCT03670810|583269725|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512945|NCT03670810|583269726|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512946|NCT03670810|583269727|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512947|NCT03670810|583269728|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
161512948|NCT03670810|583269729|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
161512949|NCT03670810|583269721|FG000|Open Label Extension|Withdrawal by Subject|0|||
161512950|NCT03670810|583269722|FG001|Open Label Extension|Withdrawal by Subject|0|||
161512951|NCT03670810|583269723|FG002|Open Label Extension|Withdrawal by Subject|0|||
161512952|NCT03670810|583269724|FG003|Open Label Extension|Withdrawal by Subject|0|||
161512953|NCT03670810|583269725|FG004|Open Label Extension|Withdrawal by Subject|0|||
161512954|NCT03670810|583269726|FG005|Open Label Extension|Withdrawal by Subject|0|||
161512955|NCT03670810|583269727|FG006|Open Label Extension|Withdrawal by Subject|0|||
161512956|NCT03670810|583269728|FG007|Open Label Extension|Withdrawal by Subject|0|||
161512957|NCT03670810|583269729|FG008|Open Label Extension|Withdrawal by Subject|46|||
161512958|NCT03670810|583269721|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512959|NCT03670810|583269722|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512960|NCT03670810|583269723|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512961|NCT03670810|583269724|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512962|NCT03670810|583269725|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161676200|NCT05975840|583867319|FG001|Overall Study|Protocol Violation|1|||
161676201|NCT05975840|583867320|FG002|Overall Study|Protocol Violation|0|||
161676202|NCT05975840|583867321|FG003|Overall Study|Protocol Violation|0|||
161676203|NCT05975840|583867322|FG004|Overall Study|Protocol Violation|0|||
161512963|NCT03670810|583269726|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512964|NCT03670810|583269727|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512965|NCT03670810|583269728|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161512966|NCT03670810|583269729|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
161512967|NCT03670810|583269721|FG000|Open Label Extension|Physician Decision|0|||
161512968|NCT03670810|583269722|FG001|Open Label Extension|Physician Decision|0|||
161676204|NCT05975840|583867323|FG005|Overall Study|Protocol Violation|0|||
161676205|NCT05975840|583867324|FG006|Overall Study|Protocol Violation|0|||
161676206|NCT05975840|583867325|FG007|Overall Study|Protocol Violation|0|||
161676207|NCT05975840|583867318|FG000|Overall Study|Adverse Event|0|||
161512969|NCT03670810|583269723|FG002|Open Label Extension|Physician Decision|0|||
161512970|NCT03670810|583269724|FG003|Open Label Extension|Physician Decision|0|||
161512971|NCT03670810|583269725|FG004|Open Label Extension|Physician Decision|0|||
161512972|NCT03670810|583269726|FG005|Open Label Extension|Physician Decision|0|||
161512973|NCT03670810|583269727|FG006|Open Label Extension|Physician Decision|0|||
161512974|NCT03670810|583269728|FG007|Open Label Extension|Physician Decision|0|||
161512975|NCT03670810|583269729|FG008|Open Label Extension|Physician Decision|2|||
161512976|NCT03670810|583269721|FG000|Open Label Extension|Non-compliance with study drug|0|||
161512977|NCT03670810|583269722|FG001|Open Label Extension|Non-compliance with study drug|0|||
161512978|NCT03670810|583269723|FG002|Open Label Extension|Non-compliance with study drug|0|||
161512979|NCT03670810|583269724|FG003|Open Label Extension|Non-compliance with study drug|0|||
161512980|NCT03670810|583269725|FG004|Open Label Extension|Non-compliance with study drug|0|||
161512981|NCT03670810|583269726|FG005|Open Label Extension|Non-compliance with study drug|0|||
161512982|NCT03670810|583269727|FG006|Open Label Extension|Non-compliance with study drug|0|||
161512983|NCT03670810|583269728|FG007|Open Label Extension|Non-compliance with study drug|0|||
161512984|NCT03670810|583269729|FG008|Open Label Extension|Non-compliance with study drug|5|||
161512985|NCT03670810|583269721|FG000|Open Label Extension|Pregnancy|0|||
161512986|NCT03670810|583269722|FG001|Open Label Extension|Pregnancy|0|||
161512987|NCT03670810|583269723|FG002|Open Label Extension|Pregnancy|0|||
161512988|NCT03670810|583269724|FG003|Open Label Extension|Pregnancy|0|||
161512989|NCT03670810|583269725|FG004|Open Label Extension|Pregnancy|0|||
161512990|NCT03670810|583269726|FG005|Open Label Extension|Pregnancy|0|||
161512991|NCT03670810|583269727|FG006|Open Label Extension|Pregnancy|0|||
161512992|NCT03670810|583269728|FG007|Open Label Extension|Pregnancy|0|||
161512993|NCT03670810|583269729|FG008|Open Label Extension|Pregnancy|3|||
161512994|NCT03670810|583269721|FG000|Open Label Extension|Adverse Event|0|||
161512995|NCT03670810|583269722|FG001|Open Label Extension|Adverse Event|0|||
161512996|NCT03670810|583269723|FG002|Open Label Extension|Adverse Event|0|||
161512997|NCT03670810|583269724|FG003|Open Label Extension|Adverse Event|0|||
161512998|NCT03670810|583269725|FG004|Open Label Extension|Adverse Event|0|||
161512999|NCT03670810|583269726|FG005|Open Label Extension|Adverse Event|0|||
161513000|NCT03670810|583269727|FG006|Open Label Extension|Adverse Event|0|||
161513001|NCT03670810|583269728|FG007|Open Label Extension|Adverse Event|0|||
161513002|NCT03670810|583269729|FG008|Open Label Extension|Adverse Event|24|||
161513003|NCT03670810|583269721|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
161513004|NCT03670810|583269722|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
161513005|NCT03670810|583269723|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
161513006|NCT03670810|583269724|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
161513007|NCT03670810|583269725|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
161513008|NCT03670810|583269726|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
161513009|NCT03670810|583269727|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
161513010|NCT03670810|583269728|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
161513011|NCT03670810|583269729|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
161513012|NCT03670810|583269721|FG000|Open Label Extension|Lost to Follow-up|0|||
161513013|NCT03670810|583269722|FG001|Open Label Extension|Lost to Follow-up|0|||
161513014|NCT03670810|583269723|FG002|Open Label Extension|Lost to Follow-up|0|||
161513015|NCT03670810|583269724|FG003|Open Label Extension|Lost to Follow-up|0|||
161513016|NCT03670810|583269725|FG004|Open Label Extension|Lost to Follow-up|0|||
161513017|NCT03670810|583269726|FG005|Open Label Extension|Lost to Follow-up|0|||
161513018|NCT03670810|583269727|FG006|Open Label Extension|Lost to Follow-up|0|||
161513019|NCT03670810|583269728|FG007|Open Label Extension|Lost to Follow-up|0|||
161513020|NCT03670810|583269729|FG008|Open Label Extension|Lost to Follow-up|23|||
161513021|NCT00678691|583269730|FG000|Overall Study|Adverse Event|6|||
161587935|NCT04812535|583542310|FG000|Overall Study|Death|7|||
161587936|NCT04812535|583542311|FG001|Overall Study|Death|2|||
161587937|NCT04812535|583542312|FG002|Overall Study|Death|4|||
161820988|NCT00379353|584385781|FG000|Overall Study|Cardiac Tamponade|1|||
161820989|NCT00379353|584385782|FG001|Overall Study|Cardiac Tamponade|0|||
161820990|NCT00379353|584385781|FG000|Overall Study|Non-compliance|1|||
161820991|NCT00379353|584385782|FG001|Overall Study|Non-compliance|0|||
161820992|NCT00379353|584385781|FG000|Overall Study|Conflicting drug treatment|0|||
161820993|NCT00379353|584385782|FG001|Overall Study|Conflicting drug treatment|1|||
161820994|NCT01211262|584385787|FG000|Overall Study|Progressive Disease|18|||
161820995|NCT01211262|584385788|FG001|Overall Study|Progressive Disease|9|||
161820996|NCT01211262|584385787|FG000|Overall Study|Adverse Event|4|||
161513022|NCT00678691|583269731|FG001|Overall Study|Adverse Event|4|||
161513023|NCT03192150|583269738|FG000|Overall Study|Adverse Event|14|||
161513024|NCT03192150|583269739|FG001|Overall Study|Adverse Event|12|||
161513025|NCT03192150|583269738|FG000|Overall Study|Lack of Efficacy|23|||
161587938|NCT04812535|583542313|FG003|Overall Study|Death|1|||
161587939|NCT04812535|583542310|FG000|Overall Study|Due to premature study termination by sponsor|2|||
161587940|NCT04812535|583542311|FG001|Overall Study|Due to premature study termination by sponsor|0|||
161820997|NCT01211262|584385788|FG001|Overall Study|Adverse Event|0|||
161820998|NCT01211262|584385787|FG000|Overall Study|Withdrawal of Consent|1|||
161513026|NCT03192150|583269739|FG001|Overall Study|Lack of Efficacy|30|||
161513027|NCT03192150|583269738|FG000|Overall Study|Lost to Follow-up|1|||
161513028|NCT03192150|583269739|FG001|Overall Study|Lost to Follow-up|1|||
161513029|NCT03192150|583269738|FG000|Overall Study|Withdrawal by Subject|4|||
161513030|NCT03192150|583269739|FG001|Overall Study|Withdrawal by Subject|2|||
161513031|NCT03192150|583269738|FG000|Overall Study|Protocol Violation|5|||
161513032|NCT03192150|583269739|FG001|Overall Study|Protocol Violation|2|||
161513033|NCT03192150|583269738|FG000|Overall Study|Surgery Canceled|6|||
161513034|NCT03192150|583269739|FG001|Overall Study|Surgery Canceled|2|||
161513035|NCT03192150|583269738|FG000|Overall Study|Other-Various Administrative Reasons|2|||
161513036|NCT03192150|583269739|FG001|Overall Study|Other-Various Administrative Reasons|5|||
161513037|NCT00779766|583269740|FG000|Month 24|Serious Adverse Event|2|||
161513038|NCT00779766|583269741|FG001|Month 24|Serious Adverse Event|3|||
161513039|NCT00779766|583269740|FG000|Month 24|Adverse Event|3|||
161513040|NCT00779766|583269741|FG001|Month 24|Adverse Event|3|||
161513041|NCT00779766|583269740|FG000|Month 24|Protocol Violation|3|||
161513042|NCT00779766|583269741|FG001|Month 24|Protocol Violation|1|||
161513043|NCT00779766|583269740|FG000|Month 24|Withdrawal by Subject|159|||
161513044|NCT00779766|583269741|FG001|Month 24|Withdrawal by Subject|127|||
161513045|NCT00779766|583269740|FG000|Month 24|Migrated/moved from study area|138|||
161513046|NCT00779766|583269741|FG001|Month 24|Migrated/moved from study area|162|||
161513047|NCT00779766|583269740|FG000|Month 24|Lost to Follow-up|9|||
161513048|NCT00779766|583269741|FG001|Month 24|Lost to Follow-up|9|||
161513049|NCT00779766|583269740|FG000|Month 24|Other|18|||
161513050|NCT00779766|583269741|FG001|Month 24|Other|27|||
161513051|NCT00779766|583269740|FG000|Month 48|Withdrawal by Subject|68|||
161513052|NCT00779766|583269741|FG001|Month 48|Withdrawal by Subject|63|||
161513053|NCT00779766|583269740|FG000|Month 48|Migrated/moved from study area|76|||
161513054|NCT00779766|583269741|FG001|Month 48|Migrated/moved from study area|75|||
161513055|NCT00779766|583269740|FG000|Month 48|Lost to Follow-up|29|||
161513056|NCT00779766|583269741|FG001|Month 48|Lost to Follow-up|30|||
161513057|NCT00779766|583269740|FG000|Month 48|Other|1|||
161513058|NCT00779766|583269741|FG001|Month 48|Other|0|||
161513059|NCT00779766|583269740|FG000|Month 72|Withdrawal by Subject|55|||
161513060|NCT00779766|583269741|FG001|Month 72|Withdrawal by Subject|71|||
161513061|NCT00779766|583269740|FG000|Month 72|Migrated/moved from study area|124|||
161513062|NCT00779766|583269741|FG001|Month 72|Migrated/moved from study area|109|||
161513063|NCT00779766|583269740|FG000|Month 72|Lost to Follow-up|6|||
161513064|NCT00779766|583269741|FG001|Month 72|Lost to Follow-up|8|||
161513065|NCT00779766|583269740|FG000|Month 72|Other|0|||
161513066|NCT00779766|583269741|FG001|Month 72|Other|1|||
161513067|NCT01412424|583269742|FG000|Core Treatment Period|Treatment Failure|24|||
161513068|NCT01412424|583269742|FG000|Core Treatment Period|Adverse Event|21|||
161513069|NCT01412424|583269742|FG000|Core Treatment Period|Patient Request|5|||
161513070|NCT01412424|583269742|FG000|Core Treatment Period|Lost to Follow-up|2|||
161513071|NCT01412424|583269742|FG000|Core Treatment Period|Sponsor Request|1|||
161513072|NCT01412424|583269742|FG000|Extension Treatment Period|Adverse Event|2|||
161513073|NCT01412424|583269742|FG000|Extension Treatment Period|Treatment Failure|2|||
161513074|NCT01412424|583269742|FG000|Extension Treatment Period|Patient Request|2|||
161513075|NCT01274637|583269743|FG000|Overall Study|Withdrawal by Subject|0|||
161513076|NCT01274637|583269744|FG001|Overall Study|Withdrawal by Subject|1|||
161513077|NCT01274637|583269743|FG000|Overall Study|Lost to Follow-up|0|||
161513078|NCT01274637|583269744|FG001|Overall Study|Lost to Follow-up|1|||
161513079|NCT02751983|583269747|FG000|Treatment|Stopped ACT, but Remained in study|2|||
161513080|NCT02751983|583269748|FG001|Treatment|Stopped ACT, but Remained in study|0|||
161513081|NCT02751983|583269747|FG000|Treatment|Discharged prior to beginning ACT|2|||
161513082|NCT02751983|583269748|FG001|Treatment|Discharged prior to beginning ACT|0|||
161513083|NCT02751983|583269747|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
161513084|NCT02751983|583269748|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
161513085|NCT02751983|583269747|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
161513086|NCT02751983|583269748|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
161587941|NCT04812535|583542312|FG002|Overall Study|Due to premature study termination by sponsor|1|||
161587942|NCT04812535|583542313|FG003|Overall Study|Due to premature study termination by sponsor|3|||
161513087|NCT02751983|583269747|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
161513088|NCT02751983|583269748|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
161513089|NCT00308711|583269749|FG000|Overall Study|Withdrawal by Subject|1|||
161513090|NCT00308711|583269750|FG001|Overall Study|Withdrawal by Subject|0|||
161513091|NCT00308711|583269751|FG002|Overall Study|Withdrawal by Subject|1|||
161587943|NCT03436745|583542314|FG000|Overall Study|Ineligible|0|||
161513092|NCT00308711|583269749|FG000|Overall Study|Protocol Violation|0|||
161513093|NCT00308711|583269750|FG001|Overall Study|Protocol Violation|1|||
161513094|NCT00308711|583269751|FG002|Overall Study|Protocol Violation|1|||
161513095|NCT00308711|583269749|FG000|Overall Study|Lost to Follow-up|0|||
161513096|NCT00308711|583269750|FG001|Overall Study|Lost to Follow-up|1|||
161513097|NCT00308711|583269751|FG002|Overall Study|Lost to Follow-up|0|||
161513098|NCT00308711|583269749|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
161513099|NCT00308711|583269750|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
161513100|NCT00308711|583269751|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
161513101|NCT00308711|583269749|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
161513102|NCT00308711|583269750|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
161513103|NCT00308711|583269751|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
161513104|NCT02167256|583269754|FG000|Overall Study|Adverse Event|13|||
161513105|NCT02167256|583269755|FG001|Overall Study|Adverse Event|6|||
161513106|NCT02167256|583269754|FG000|Overall Study|Withdrawal by Subject|4|||
161513107|NCT02167256|583269755|FG001|Overall Study|Withdrawal by Subject|4|||
161513108|NCT02167256|583269754|FG000|Overall Study|non-compliance|3|||
161513109|NCT02167256|583269755|FG001|Overall Study|non-compliance|0|||
161513110|NCT02167256|583269754|FG000|Overall Study|Study partner unable to participate|1|||
161513111|NCT02167256|583269755|FG001|Overall Study|Study partner unable to participate|0|||
161513112|NCT03139916|583269756|FG000|Overall Study|Withdrawal by Subject|2|||
161513113|NCT03139916|583269756|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
161513114|NCT01957475|583269757|FG000|Test Period 1|Withdrawal by Subject|1|||
161513115|NCT01957475|583269758|FG001|Test Period 1|Withdrawal by Subject|0|||
161513116|NCT01957475|583269757|FG000|Test Period 1|Other|1|||
161513117|NCT01957475|583269758|FG001|Test Period 1|Other|0|||
161513118|NCT01957475|583269757|FG000|Test Period 1|Lack of Efficacy|0|||
161513119|NCT01957475|583269758|FG001|Test Period 1|Lack of Efficacy|1|||
161513120|NCT01957475|583269757|FG000|Test Period 2|Adverse Event|1|||
161513121|NCT01957475|583269758|FG001|Test Period 2|Adverse Event|0|||
161513122|NCT00414388|583269759|FG000|Overall Study|Adverse Event|1|||
161513123|NCT03467425|583269760|FG000|Overall Study|Adverse Event|9|||
161513124|NCT03467425|583269761|FG001|Overall Study|Adverse Event|9|||
161513125|NCT03467425|583269760|FG000|Overall Study|Lack of Efficacy|3|||
161513126|NCT03467425|583269761|FG001|Overall Study|Lack of Efficacy|1|||
161513127|NCT03467425|583269760|FG000|Overall Study|Protocol Violation|0|||
161513128|NCT03467425|583269761|FG001|Overall Study|Protocol Violation|1|||
161513129|NCT03467425|583269760|FG000|Overall Study|Lost to Follow-up|18|||
161513130|NCT03467425|583269761|FG001|Overall Study|Lost to Follow-up|25|||
161513131|NCT03467425|583269760|FG000|Overall Study|Physician Decision|2|||
161513132|NCT03467425|583269761|FG001|Overall Study|Physician Decision|1|||
161513133|NCT03467425|583269760|FG000|Overall Study|Withdrawal by Subject|15|||
161513134|NCT03467425|583269761|FG001|Overall Study|Withdrawal by Subject|17|||
161513135|NCT02318693|583269762|FG000|Overall Study|Protocol Violation|0|||
161513136|NCT02318693|583269763|FG001|Overall Study|Protocol Violation|1|||
161513137|NCT00025883|583269764|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
161513138|NCT00025883|583269764|FG000|Overall Study|no baseline data|1|||
161513139|NCT00025883|583269764|FG000|Overall Study|Death|1|||
161513140|NCT00025883|583269764|FG000|Overall Study|Adverse Event|1|||
161513141|NCT00025883|583269764|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
161513142|NCT03591575|583269765|FG000|Overall Study|Adverse Event|2|||
161513143|NCT03591575|583269766|FG001|Overall Study|Adverse Event|0|||
161513144|NCT03591575|583269765|FG000|Overall Study|Withdrawal by Subject|4|||
161513145|NCT03591575|583269766|FG001|Overall Study|Withdrawal by Subject|1|||
161513146|NCT00813358|583269769|FG000|Overall Study|Death|32|||
161513147|NCT00813358|583269769|FG000|Overall Study|Lost to Follow-up|12|||
161513148|NCT00813358|583269769|FG000|Overall Study|other endpoints|5|||
161513149|NCT00813358|583269769|FG000|Overall Study|Withdrawal by Subject|20|||
161513150|NCT00218543|583269770|FG000|Overall Study|Lost to Follow-up|8|||
161513151|NCT00218543|583269770|FG000|Overall Study|relocated|1|||
161513152|NCT00218543|583269770|FG000|Overall Study|Withdrawal by Subject|1|||
161513153|NCT00218543|583269770|FG000|Overall Study|Physician Decision|3|||
161513154|NCT00218543|583269770|FG000|Overall Study|Adverse Event|2|||
161513155|NCT03665038|583269771|FG000|Overall Study|Lost to Follow-up|0|||
161513156|NCT03665038|583269772|FG001|Overall Study|Lost to Follow-up|0|||
161513157|NCT03665038|583269773|FG002|Overall Study|Lost to Follow-up|1|||
161513158|NCT03013491|583269774|FG000|Main Study|Death|2|||
161513159|NCT03013491|583269775|FG001|Main Study|Death|2|||
161513160|NCT03013491|583269776|FG002|Main Study|Death|5|||
161513161|NCT03013491|583269777|FG003|Main Study|Death|3|||
161513162|NCT03013491|583269778|FG004|Main Study|Death|9|||
161513163|NCT03013491|583269779|FG005|Main Study|Death|12|||
161513164|NCT03013491|583269780|FG006|Main Study|Death|3|||
161513165|NCT03013491|583269781|FG007|Main Study|Death|5|||
161513166|NCT03013491|583269782|FG008|Main Study|Death|1|||
161513167|NCT03013491|583269783|FG009|Main Study|Death|2|||
161513168|NCT03013491|583269784|FG010|Main Study|Death|4|||
161513169|NCT03013491|583269785|FG011|Main Study|Death|1|||
161513170|NCT03013491|583269786|FG012|Main Study|Death|1|||
161513171|NCT03013491|583269787|FG013|Main Study|Death|4|||
161513172|NCT03013491|583269788|FG014|Main Study|Death|0|||
161513173|NCT03013491|583269789|FG015|Main Study|Death|3|||
161513174|NCT03013491|583269790|FG016|Main Study|Death|5|||
161513175|NCT03013491|583269791|FG017|Main Study|Death|1|||
161513176|NCT03013491|583269792|FG018|Main Study|Death|47|||
161513177|NCT03013491|583269774|FG000|Main Study|Lost to Follow-up|0|||
161513178|NCT03013491|583269775|FG001|Main Study|Lost to Follow-up|0|||
161513179|NCT03013491|583269776|FG002|Main Study|Lost to Follow-up|1|||
161513180|NCT03013491|583269777|FG003|Main Study|Lost to Follow-up|0|||
161513181|NCT03013491|583269778|FG004|Main Study|Lost to Follow-up|1|||
161513182|NCT03013491|583269779|FG005|Main Study|Lost to Follow-up|0|||
161513183|NCT03013491|583269780|FG006|Main Study|Lost to Follow-up|0|||
161513184|NCT03013491|583269781|FG007|Main Study|Lost to Follow-up|0|||
161513185|NCT03013491|583269782|FG008|Main Study|Lost to Follow-up|0|||
161513186|NCT03013491|583269783|FG009|Main Study|Lost to Follow-up|0|||
161513187|NCT03013491|583269784|FG010|Main Study|Lost to Follow-up|0|||
161513188|NCT03013491|583269785|FG011|Main Study|Lost to Follow-up|0|||
161513189|NCT03013491|583269786|FG012|Main Study|Lost to Follow-up|0|||
161513190|NCT03013491|583269787|FG013|Main Study|Lost to Follow-up|0|||
161513191|NCT03013491|583269788|FG014|Main Study|Lost to Follow-up|0|||
161513192|NCT03013491|583269789|FG015|Main Study|Lost to Follow-up|0|||
161513193|NCT03013491|583269790|FG016|Main Study|Lost to Follow-up|0|||
161513194|NCT03013491|583269791|FG017|Main Study|Lost to Follow-up|0|||
161513195|NCT03013491|583269792|FG018|Main Study|Lost to Follow-up|3|||
161513196|NCT03013491|583269774|FG000|Main Study|Termination of the study by Sponsor|0|||
161513197|NCT03013491|583269775|FG001|Main Study|Termination of the study by Sponsor|0|||
161513198|NCT03013491|583269776|FG002|Main Study|Termination of the study by Sponsor|2|||
161513199|NCT03013491|583269777|FG003|Main Study|Termination of the study by Sponsor|0|||
161513200|NCT03013491|583269778|FG004|Main Study|Termination of the study by Sponsor|1|||
161513201|NCT03013491|583269779|FG005|Main Study|Termination of the study by Sponsor|2|||
161513202|NCT03013491|583269780|FG006|Main Study|Termination of the study by Sponsor|0|||
161513203|NCT03013491|583269781|FG007|Main Study|Termination of the study by Sponsor|0|||
161513204|NCT03013491|583269782|FG008|Main Study|Termination of the study by Sponsor|1|||
161513205|NCT03013491|583269783|FG009|Main Study|Termination of the study by Sponsor|1|||
161513206|NCT03013491|583269784|FG010|Main Study|Termination of the study by Sponsor|1|||
161513207|NCT03013491|583269785|FG011|Main Study|Termination of the study by Sponsor|2|||
161513208|NCT03013491|583269786|FG012|Main Study|Termination of the study by Sponsor|0|||
161513209|NCT03013491|583269787|FG013|Main Study|Termination of the study by Sponsor|0|||
161513210|NCT03013491|583269788|FG014|Main Study|Termination of the study by Sponsor|0|||
161513211|NCT03013491|583269789|FG015|Main Study|Termination of the study by Sponsor|0|||
161513212|NCT03013491|583269790|FG016|Main Study|Termination of the study by Sponsor|0|||
161513213|NCT03013491|583269791|FG017|Main Study|Termination of the study by Sponsor|1|||
161513214|NCT03013491|583269792|FG018|Main Study|Termination of the study by Sponsor|13|||
161513215|NCT03013491|583269774|FG000|Main Study|Withdrawal by Subject|0|||
161513216|NCT03013491|583269775|FG001|Main Study|Withdrawal by Subject|0|||
161513217|NCT03013491|583269776|FG002|Main Study|Withdrawal by Subject|0|||
161513218|NCT03013491|583269777|FG003|Main Study|Withdrawal by Subject|4|||
161513219|NCT03013491|583269778|FG004|Main Study|Withdrawal by Subject|2|||
161513220|NCT03013491|583269779|FG005|Main Study|Withdrawal by Subject|1|||
161513221|NCT03013491|583269780|FG006|Main Study|Withdrawal by Subject|0|||
161513222|NCT03013491|583269781|FG007|Main Study|Withdrawal by Subject|0|||
161513223|NCT03013491|583269782|FG008|Main Study|Withdrawal by Subject|0|||
161513224|NCT03013491|583269783|FG009|Main Study|Withdrawal by Subject|0|||
161513225|NCT03013491|583269784|FG010|Main Study|Withdrawal by Subject|1|||
161513226|NCT03013491|583269785|FG011|Main Study|Withdrawal by Subject|2|||
161513227|NCT03013491|583269786|FG012|Main Study|Withdrawal by Subject|0|||
161513228|NCT03013491|583269787|FG013|Main Study|Withdrawal by Subject|2|||
161513229|NCT03013491|583269788|FG014|Main Study|Withdrawal by Subject|0|||
161513230|NCT03013491|583269789|FG015|Main Study|Withdrawal by Subject|0|||
161513231|NCT03013491|583269790|FG016|Main Study|Withdrawal by Subject|0|||
161513232|NCT03013491|583269791|FG017|Main Study|Withdrawal by Subject|0|||
161513233|NCT03013491|583269792|FG018|Main Study|Withdrawal by Subject|18|||
161513234|NCT03013491|583269774|FG000|Main Study|Disease progression|0|||
161513235|NCT03013491|583269775|FG001|Main Study|Disease progression|0|||
161513236|NCT03013491|583269776|FG002|Main Study|Disease progression|0|||
161513237|NCT03013491|583269777|FG003|Main Study|Disease progression|1|||
161513238|NCT03013491|583269778|FG004|Main Study|Disease progression|0|||
161513239|NCT03013491|583269779|FG005|Main Study|Disease progression|0|||
161513240|NCT03013491|583269780|FG006|Main Study|Disease progression|0|||
161513241|NCT03013491|583269781|FG007|Main Study|Disease progression|0|||
161513242|NCT03013491|583269782|FG008|Main Study|Disease progression|1|||
161513243|NCT03013491|583269783|FG009|Main Study|Disease progression|0|||
161513244|NCT03013491|583269784|FG010|Main Study|Disease progression|1|||
161513245|NCT03013491|583269785|FG011|Main Study|Disease progression|0|||
161513246|NCT03013491|583269786|FG012|Main Study|Disease progression|0|||
161513247|NCT03013491|583269787|FG013|Main Study|Disease progression|0|||
161513248|NCT03013491|583269788|FG014|Main Study|Disease progression|0|||
161513249|NCT03013491|583269789|FG015|Main Study|Disease progression|0|||
161513250|NCT03013491|583269790|FG016|Main Study|Disease progression|0|||
161513251|NCT03013491|583269791|FG017|Main Study|Disease progression|0|||
161513252|NCT03013491|583269792|FG018|Main Study|Disease progression|4|||
161513253|NCT03013491|583269774|FG000|Main Study|Symptomatic deterioration|0|||
161513254|NCT03013491|583269775|FG001|Main Study|Symptomatic deterioration|0|||
161513255|NCT03013491|583269776|FG002|Main Study|Symptomatic deterioration|0|||
161513256|NCT03013491|583269777|FG003|Main Study|Symptomatic deterioration|0|||
161513257|NCT03013491|583269778|FG004|Main Study|Symptomatic deterioration|0|||
161513258|NCT03013491|583269779|FG005|Main Study|Symptomatic deterioration|1|||
161513259|NCT03013491|583269780|FG006|Main Study|Symptomatic deterioration|0|||
161513260|NCT03013491|583269781|FG007|Main Study|Symptomatic deterioration|0|||
161513261|NCT03013491|583269782|FG008|Main Study|Symptomatic deterioration|0|||
161513262|NCT03013491|583269783|FG009|Main Study|Symptomatic deterioration|0|||
161513263|NCT03013491|583269784|FG010|Main Study|Symptomatic deterioration|0|||
161513264|NCT03013491|583269785|FG011|Main Study|Symptomatic deterioration|0|||
161513265|NCT03013491|583269786|FG012|Main Study|Symptomatic deterioration|0|||
161513266|NCT03013491|583269787|FG013|Main Study|Symptomatic deterioration|0|||
161513267|NCT03013491|583269788|FG014|Main Study|Symptomatic deterioration|0|||
161513268|NCT03013491|583269789|FG015|Main Study|Symptomatic deterioration|0|||
161513269|NCT03013491|583269790|FG016|Main Study|Symptomatic deterioration|0|||
161513270|NCT03013491|583269791|FG017|Main Study|Symptomatic deterioration|0|||
161513271|NCT03013491|583269792|FG018|Main Study|Symptomatic deterioration|0|||
161513272|NCT03013491|583269774|FG000|Main Study|Protocol version 8.0 approval|0|||
161513273|NCT03013491|583269775|FG001|Main Study|Protocol version 8.0 approval|0|||
161513274|NCT03013491|583269776|FG002|Main Study|Protocol version 8.0 approval|0|||
161513275|NCT03013491|583269777|FG003|Main Study|Protocol version 8.0 approval|0|||
161513276|NCT03013491|583269778|FG004|Main Study|Protocol version 8.0 approval|0|||
161513277|NCT03013491|583269779|FG005|Main Study|Protocol version 8.0 approval|0|||
161513278|NCT03013491|583269780|FG006|Main Study|Protocol version 8.0 approval|0|||
161513279|NCT03013491|583269781|FG007|Main Study|Protocol version 8.0 approval|0|||
161513280|NCT03013491|583269782|FG008|Main Study|Protocol version 8.0 approval|0|||
161513281|NCT03013491|583269783|FG009|Main Study|Protocol version 8.0 approval|0|||
161513282|NCT03013491|583269784|FG010|Main Study|Protocol version 8.0 approval|1|||
161513283|NCT03013491|583269785|FG011|Main Study|Protocol version 8.0 approval|0|||
161513284|NCT03013491|583269786|FG012|Main Study|Protocol version 8.0 approval|0|||
161513285|NCT03013491|583269787|FG013|Main Study|Protocol version 8.0 approval|0|||
161513286|NCT03013491|583269788|FG014|Main Study|Protocol version 8.0 approval|0|||
161513287|NCT03013491|583269789|FG015|Main Study|Protocol version 8.0 approval|0|||
161513288|NCT03013491|583269790|FG016|Main Study|Protocol version 8.0 approval|0|||
161513289|NCT03013491|583269791|FG017|Main Study|Protocol version 8.0 approval|0|||
161513290|NCT03013491|583269792|FG018|Main Study|Protocol version 8.0 approval|0|||
161513291|NCT03013491|583269774|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
161513292|NCT03013491|583269775|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
161927144|NCT01179516|584780294|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
161927145|NCT01179516|584780292|FG000|Overall Study|Lack of Efficacy|4|||
161927146|NCT01179516|584780293|FG001|Overall Study|Lack of Efficacy|2|||
161927147|NCT01179516|584780294|FG002|Overall Study|Lack of Efficacy|0|||
161927148|NCT01179516|584780292|FG000|Overall Study|Noncompliance with Study Drug|2|||
161927149|NCT01179516|584780293|FG001|Overall Study|Noncompliance with Study Drug|0|||
161927150|NCT01179516|584780294|FG002|Overall Study|Noncompliance with Study Drug|1|||
161927151|NCT01179516|584780292|FG000|Overall Study|Protocol Deviations|4|||
161927152|NCT01179516|584780293|FG001|Overall Study|Protocol Deviations|3|||
161927153|NCT01179516|584780294|FG002|Overall Study|Protocol Deviations|3|||
161927154|NCT01179516|584780292|FG000|Overall Study|Withdrawal of Consent|2|||
161927155|NCT01179516|584780293|FG001|Overall Study|Withdrawal of Consent|6|||
161927156|NCT01179516|584780294|FG002|Overall Study|Withdrawal of Consent|10|||
161927157|NCT01179516|584780292|FG000|Overall Study|Lost to Follow-up|7|||
161927158|NCT01179516|584780293|FG001|Overall Study|Lost to Follow-up|7|||
161927159|NCT01179516|584780294|FG002|Overall Study|Lost to Follow-up|3|||
161927160|NCT01179516|584780292|FG000|Overall Study|Other|2|||
161927161|NCT01179516|584780293|FG001|Overall Study|Other|0|||
161927162|NCT01179516|584780294|FG002|Overall Study|Other|2|||
161927163|NCT01668537|584780295|FG000|Overall Study|Request to Discontinue Prematurely|1|||
161927164|NCT01668537|584780296|FG001|Overall Study|Request to Discontinue Prematurely|1|||
161927165|NCT01668537|584780295|FG000|Overall Study|Subject unwilling/unable to comply|5|||
161927166|NCT01668537|584780296|FG001|Overall Study|Subject unwilling/unable to comply|0|||
161927167|NCT01668537|584780295|FG000|Overall Study|Reason Precludes Participation|1|||
161927168|NCT01668537|584780296|FG001|Overall Study|Reason Precludes Participation|0|||
161927169|NCT01668537|584780295|FG000|Overall Study|Lost to Follow-up|13|||
161927170|NCT01668537|584780296|FG001|Overall Study|Lost to Follow-up|6|||
161513293|NCT03013491|583269776|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
161513294|NCT03013491|583269777|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
161513295|NCT03013491|583269778|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
161513296|NCT03013491|583269779|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
161513297|NCT03013491|583269780|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
161513298|NCT03013491|583269781|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
161513299|NCT03013491|583269782|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
161513300|NCT03013491|583269783|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
161927171|NCT01668537|584780295|FG000|Overall Study|Other|2|||
161927172|NCT01668537|584780296|FG001|Overall Study|Other|3|||
161927173|NCT01149538|584780299|FG000|Overall Study|Lost to Follow-up|0|||
161927174|NCT01149538|584780300|FG001|Overall Study|Lost to Follow-up|1|||
161676208|NCT05975840|583867319|FG001|Overall Study|Adverse Event|0|||
161676209|NCT05975840|583867320|FG002|Overall Study|Adverse Event|0|||
161676210|NCT05975840|583867321|FG003|Overall Study|Adverse Event|1|||
161676211|NCT05975840|583867322|FG004|Overall Study|Adverse Event|0|||
161676212|NCT05975840|583867323|FG005|Overall Study|Adverse Event|0|||
161676213|NCT05975840|583867324|FG006|Overall Study|Adverse Event|0|||
161676214|NCT05975840|583867325|FG007|Overall Study|Adverse Event|0|||
161676215|NCT05975840|583867318|FG000|Overall Study|Death|0|||
161676216|NCT05975840|583867319|FG001|Overall Study|Death|1|||
161676217|NCT05975840|583867320|FG002|Overall Study|Death|0|||
161676218|NCT05975840|583867321|FG003|Overall Study|Death|0|||
161676219|NCT05975840|583867322|FG004|Overall Study|Death|0|||
161676220|NCT05975840|583867323|FG005|Overall Study|Death|0|||
161676221|NCT05975840|583867324|FG006|Overall Study|Death|0|||
161676222|NCT05975840|583867325|FG007|Overall Study|Death|1|||
161676223|NCT05390580|583867328|FG000|Overall Study|Physician Decision|3|||
161676224|NCT05390580|583867329|FG001|Overall Study|Physician Decision|2|||
161676225|NCT02129205|583867332|FG000|Overall Study|Withdrawal by Subject|0|||
161676226|NCT02129205|583867333|FG001|Overall Study|Withdrawal by Subject|0|||
161676227|NCT02129205|583867334|FG002|Overall Study|Withdrawal by Subject|0|||
161676228|NCT02129205|583867335|FG003|Overall Study|Withdrawal by Subject|0|||
161927175|NCT01149538|584780299|FG000|Overall Study|Withdrawal by Subject|5|||
161927176|NCT01149538|584780300|FG001|Overall Study|Withdrawal by Subject|3|||
161927177|NCT02336503|584780303|FG000|Overall Study|Lost to Follow-up|0|||
161676229|NCT02129205|583867336|FG004|Overall Study|Withdrawal by Subject|1|||
161676230|NCT02129205|583867337|FG005|Overall Study|Withdrawal by Subject|1|||
161676231|NCT02129205|583867338|FG006|Overall Study|Withdrawal by Subject|1|||
161676232|NCT02129205|583867339|FG007|Overall Study|Withdrawal by Subject|0|||
161676233|NCT02129205|583867340|FG008|Overall Study|Withdrawal by Subject|1|||
161676234|NCT02129205|583867341|FG009|Overall Study|Withdrawal by Subject|0|||
161676235|NCT02129205|583867332|FG000|Overall Study|Other|1|||
161676236|NCT02129205|583867333|FG001|Overall Study|Other|0|||
161676237|NCT02129205|583867334|FG002|Overall Study|Other|0|||
161676238|NCT02129205|583867335|FG003|Overall Study|Other|0|||
161676239|NCT02129205|583867336|FG004|Overall Study|Other|2|||
161676240|NCT02129205|583867337|FG005|Overall Study|Other|3|||
161676241|NCT02129205|583867338|FG006|Overall Study|Other|3|||
161676242|NCT02129205|583867339|FG007|Overall Study|Other|2|||
161676243|NCT02129205|583867340|FG008|Overall Study|Other|1|||
161676244|NCT02129205|583867341|FG009|Overall Study|Other|0|||
161676245|NCT02877927|583867342|FG000|Overall Study|Adverse Event|1|||
161676246|NCT02877927|583867343|FG001|Overall Study|Adverse Event|0|||
161676247|NCT02877927|583867342|FG000|Overall Study|Lost to Follow-up|37|||
161676248|NCT02877927|583867343|FG001|Overall Study|Lost to Follow-up|38|||
161676249|NCT02877927|583867342|FG000|Overall Study|Withdrawal by Subject|11|||
161676250|NCT02877927|583867343|FG001|Overall Study|Withdrawal by Subject|12|||
161676251|NCT02877927|583867342|FG000|Overall Study|Physician Decision|0|||
161676252|NCT02877927|583867343|FG001|Overall Study|Physician Decision|1|||
161676253|NCT02877927|583867342|FG000|Overall Study|Missed EOT/PTE Visit|5|||
161676254|NCT02877927|583867343|FG001|Overall Study|Missed EOT/PTE Visit|6|||
161927178|NCT02336503|584780304|FG001|Overall Study|Lost to Follow-up|3|||
161927179|NCT02336503|584780305|FG002|Overall Study|Lost to Follow-up|0|||
161927180|NCT02336503|584780306|FG003|Overall Study|Lost to Follow-up|2|||
161927181|NCT02336503|584780303|FG000|Overall Study|Withdrawal by Subject|2|||
161927182|NCT02336503|584780304|FG001|Overall Study|Withdrawal by Subject|0|||
161927183|NCT02336503|584780305|FG002|Overall Study|Withdrawal by Subject|0|||
161927184|NCT02336503|584780306|FG003|Overall Study|Withdrawal by Subject|4|||
161927185|NCT02336503|584780303|FG000|Overall Study|Adverse Event|0|||
161927186|NCT02336503|584780304|FG001|Overall Study|Adverse Event|0|||
161927187|NCT02336503|584780305|FG002|Overall Study|Adverse Event|1|||
161927188|NCT02336503|584780306|FG003|Overall Study|Adverse Event|0|||
161927189|NCT01436500|584780308|FG000|Overall Study|Death|1|||
161927190|NCT01436500|584780309|FG001|Overall Study|Death|0|||
161676255|NCT04376060|583867345|FG000|Overall Study|Physician Decision|1|||
161676256|NCT01791803|583867348|FG000|Overall Study|Withdrawal by Subject|0|||
161676257|NCT01791803|583867349|FG001|Overall Study|Withdrawal by Subject|0|||
161676258|NCT01791803|583867350|FG002|Overall Study|Withdrawal by Subject|0|||
161676259|NCT01791803|583867351|FG003|Overall Study|Withdrawal by Subject|2|||
161676260|NCT01791803|583867348|FG000|Overall Study|Physician Decision|0|||
161676261|NCT01791803|583867349|FG001|Overall Study|Physician Decision|2|||
161676262|NCT01791803|583867350|FG002|Overall Study|Physician Decision|0|||
161927191|NCT01436500|584780310|FG002|Overall Study|Death|0|||
161927192|NCT01436500|584780311|FG003|Overall Study|Death|0|||
161927193|NCT01436500|584780312|FG004|Overall Study|Death|0|||
161676263|NCT01791803|583867351|FG003|Overall Study|Physician Decision|1|||
161676264|NCT01791803|583867348|FG000|Overall Study|Death|0|||
161676265|NCT01791803|583867349|FG001|Overall Study|Death|0|||
161676266|NCT01791803|583867350|FG002|Overall Study|Death|2|||
161676267|NCT01791803|583867351|FG003|Overall Study|Death|2|||
161676268|NCT04572854|583867352|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
161676269|NCT04572854|583867353|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
161676270|NCT04572854|583867354|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
161676271|NCT04572854|583867355|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
161676272|NCT04572854|583867352|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161676273|NCT04572854|583867353|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161676274|NCT04572854|583867354|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
161676275|NCT04572854|583867355|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161676276|NCT00972777|583867358|FG000|Overall Study|Adverse Event|3|||
161676277|NCT00972777|583867359|FG001|Overall Study|Adverse Event|2|||
161676278|NCT00972777|583867358|FG000|Overall Study|Lost to Follow-up|0|||
161676279|NCT00972777|583867359|FG001|Overall Study|Lost to Follow-up|4|||
161676280|NCT00972777|583867358|FG000|Overall Study|Withdrawal by Subject|4|||
161676281|NCT00972777|583867359|FG001|Overall Study|Withdrawal by Subject|5|||
161676282|NCT00972777|583867358|FG000|Overall Study|Physician Decision|4|||
161676283|NCT00972777|583867359|FG001|Overall Study|Physician Decision|0|||
161676284|NCT00972777|583867358|FG000|Overall Study|Protocol Violation|0|||
161676285|NCT00972777|583867359|FG001|Overall Study|Protocol Violation|2|||
161676286|NCT00972777|583867358|FG000|Overall Study|Screening Failure|2|||
161676287|NCT00972777|583867359|FG001|Overall Study|Screening Failure|1|||
161676288|NCT00972777|583867358|FG000|Overall Study|Missed visit|1|||
161676289|NCT00972777|583867359|FG001|Overall Study|Missed visit|0|||
161927194|NCT01436500|584780308|FG000|Overall Study|Adverse Event|0|||
161927195|NCT01436500|584780309|FG001|Overall Study|Adverse Event|2|||
161927196|NCT01436500|584780310|FG002|Overall Study|Adverse Event|2|||
161927197|NCT01436500|584780311|FG003|Overall Study|Adverse Event|0|||
161927198|NCT01436500|584780312|FG004|Overall Study|Adverse Event|1|||
161927199|NCT01436500|584780308|FG000|Overall Study|Withdrawal by Subject|0|||
161927200|NCT01436500|584780309|FG001|Overall Study|Withdrawal by Subject|0|||
161927201|NCT01436500|584780310|FG002|Overall Study|Withdrawal by Subject|2|||
161927202|NCT01436500|584780311|FG003|Overall Study|Withdrawal by Subject|0|||
161927203|NCT01436500|584780312|FG004|Overall Study|Withdrawal by Subject|2|||
161927204|NCT01436500|584780308|FG000|Overall Study|Physician Decision|0|||
161927205|NCT01436500|584780309|FG001|Overall Study|Physician Decision|0|||
161927206|NCT01436500|584780310|FG002|Overall Study|Physician Decision|1|||
161927207|NCT01436500|584780311|FG003|Overall Study|Physician Decision|0|||
161927208|NCT01436500|584780312|FG004|Overall Study|Physician Decision|0|||
161927209|NCT01436500|584780308|FG000|Overall Study|liver transplant|1|||
161927210|NCT01436500|584780309|FG001|Overall Study|liver transplant|0|||
161927211|NCT01436500|584780310|FG002|Overall Study|liver transplant|0|||
161927212|NCT01436500|584780311|FG003|Overall Study|liver transplant|0|||
161927213|NCT01436500|584780312|FG004|Overall Study|liver transplant|0|||
161927214|NCT01436500|584780308|FG000|Overall Study|initiation of dialysis|0|||
161927215|NCT01436500|584780309|FG001|Overall Study|initiation of dialysis|0|||
161927216|NCT01436500|584780310|FG002|Overall Study|initiation of dialysis|0|||
161927217|NCT01436500|584780311|FG003|Overall Study|initiation of dialysis|0|||
161927218|NCT01436500|584780312|FG004|Overall Study|initiation of dialysis|1|||
161927219|NCT01436500|584780308|FG000|Overall Study|discontinued study drug|1|||
161927220|NCT01436500|584780309|FG001|Overall Study|discontinued study drug|0|||
161927221|NCT01436500|584780310|FG002|Overall Study|discontinued study drug|0|||
161927222|NCT01436500|584780311|FG003|Overall Study|discontinued study drug|0|||
161927223|NCT01436500|584780312|FG004|Overall Study|discontinued study drug|0|||
161676290|NCT05749952|583867362|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
161927224|NCT01436500|584780308|FG000|Overall Study|Other|0|||
161927225|NCT01436500|584780309|FG001|Overall Study|Other|1|||
161513301|NCT03013491|583269784|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
161513302|NCT03013491|583269785|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
161513303|NCT03013491|583269786|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
161513304|NCT03013491|583269787|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
161513305|NCT03013491|583269788|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
161513306|NCT03013491|583269789|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
161513307|NCT03013491|583269790|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
161513308|NCT03013491|583269791|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
161513309|NCT03013491|583269792|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
161513310|NCT03013491|583269774|FG000|Main Study|Start of new anticancer therapy|0|||
161513311|NCT03013491|583269775|FG001|Main Study|Start of new anticancer therapy|0|||
161513312|NCT03013491|583269776|FG002|Main Study|Start of new anticancer therapy|0|||
161513313|NCT03013491|583269777|FG003|Main Study|Start of new anticancer therapy|0|||
161513314|NCT03013491|583269778|FG004|Main Study|Start of new anticancer therapy|0|||
161513315|NCT03013491|583269779|FG005|Main Study|Start of new anticancer therapy|0|||
161513316|NCT03013491|583269780|FG006|Main Study|Start of new anticancer therapy|0|||
161513317|NCT03013491|583269781|FG007|Main Study|Start of new anticancer therapy|0|||
161513318|NCT03013491|583269782|FG008|Main Study|Start of new anticancer therapy|0|||
161513319|NCT03013491|583269783|FG009|Main Study|Start of new anticancer therapy|0|||
161513320|NCT03013491|583269784|FG010|Main Study|Start of new anticancer therapy|0|||
161513321|NCT03013491|583269785|FG011|Main Study|Start of new anticancer therapy|0|||
161513322|NCT03013491|583269786|FG012|Main Study|Start of new anticancer therapy|0|||
161513323|NCT03013491|583269787|FG013|Main Study|Start of new anticancer therapy|0|||
161513324|NCT03013491|583269788|FG014|Main Study|Start of new anticancer therapy|0|||
161513325|NCT03013491|583269789|FG015|Main Study|Start of new anticancer therapy|0|||
161513326|NCT03013491|583269790|FG016|Main Study|Start of new anticancer therapy|0|||
161513327|NCT03013491|583269791|FG017|Main Study|Start of new anticancer therapy|0|||
161513328|NCT03013491|583269792|FG018|Main Study|Start of new anticancer therapy|2|||
161513329|NCT03013491|583269774|FG000|Long-term Extension|Disease progression|0|||
161513330|NCT03013491|583269775|FG001|Long-term Extension|Disease progression|0|||
161513331|NCT03013491|583269776|FG002|Long-term Extension|Disease progression|0|||
161513332|NCT03013491|583269777|FG003|Long-term Extension|Disease progression|1|||
161513333|NCT03013491|583269778|FG004|Long-term Extension|Disease progression|0|||
161513334|NCT03013491|583269779|FG005|Long-term Extension|Disease progression|0|||
161513335|NCT03013491|583269780|FG006|Long-term Extension|Disease progression|0|||
161513336|NCT03013491|583269781|FG007|Long-term Extension|Disease progression|0|||
161513337|NCT03013491|583269782|FG008|Long-term Extension|Disease progression|0|||
161513338|NCT03013491|583269783|FG009|Long-term Extension|Disease progression|0|||
161513339|NCT03013491|583269784|FG010|Long-term Extension|Disease progression|0|||
161513340|NCT03013491|583269785|FG011|Long-term Extension|Disease progression|0|||
161513341|NCT03013491|583269786|FG012|Long-term Extension|Disease progression|0|||
161513342|NCT03013491|583269787|FG013|Long-term Extension|Disease progression|0|||
161513343|NCT03013491|583269788|FG014|Long-term Extension|Disease progression|0|||
161513344|NCT03013491|583269789|FG015|Long-term Extension|Disease progression|0|||
161513345|NCT03013491|583269790|FG016|Long-term Extension|Disease progression|0|||
161513346|NCT03013491|583269791|FG017|Long-term Extension|Disease progression|0|||
161513347|NCT03013491|583269792|FG018|Long-term Extension|Disease progression|1|||
161513348|NCT03013491|583269774|FG000|Long-term Extension|Withdrawal by Subject|0|||
161513349|NCT03013491|583269775|FG001|Long-term Extension|Withdrawal by Subject|0|||
161513350|NCT03013491|583269776|FG002|Long-term Extension|Withdrawal by Subject|0|||
161513351|NCT03013491|583269777|FG003|Long-term Extension|Withdrawal by Subject|0|||
161513352|NCT03013491|583269778|FG004|Long-term Extension|Withdrawal by Subject|0|||
161513353|NCT03013491|583269779|FG005|Long-term Extension|Withdrawal by Subject|0|||
161513354|NCT03013491|583269780|FG006|Long-term Extension|Withdrawal by Subject|0|||
161513355|NCT03013491|583269781|FG007|Long-term Extension|Withdrawal by Subject|1|||
161513356|NCT03013491|583269782|FG008|Long-term Extension|Withdrawal by Subject|0|||
161513357|NCT03013491|583269783|FG009|Long-term Extension|Withdrawal by Subject|0|||
161513358|NCT03013491|583269784|FG010|Long-term Extension|Withdrawal by Subject|0|||
161513359|NCT03013491|583269785|FG011|Long-term Extension|Withdrawal by Subject|0|||
161513360|NCT03013491|583269786|FG012|Long-term Extension|Withdrawal by Subject|0|||
161513361|NCT03013491|583269787|FG013|Long-term Extension|Withdrawal by Subject|0|||
161513362|NCT03013491|583269788|FG014|Long-term Extension|Withdrawal by Subject|0|||
161513363|NCT03013491|583269789|FG015|Long-term Extension|Withdrawal by Subject|0|||
161513364|NCT03013491|583269790|FG016|Long-term Extension|Withdrawal by Subject|0|||
161513365|NCT03013491|583269791|FG017|Long-term Extension|Withdrawal by Subject|0|||
161513366|NCT03013491|583269792|FG018|Long-term Extension|Withdrawal by Subject|0|||
161513367|NCT03013491|583269774|FG000|Long-term Extension|Adverse Event|0|||
161513368|NCT03013491|583269775|FG001|Long-term Extension|Adverse Event|0|||
161513369|NCT03013491|583269776|FG002|Long-term Extension|Adverse Event|0|||
161513370|NCT03013491|583269777|FG003|Long-term Extension|Adverse Event|0|||
161513371|NCT03013491|583269778|FG004|Long-term Extension|Adverse Event|0|||
161513372|NCT03013491|583269779|FG005|Long-term Extension|Adverse Event|0|||
161513373|NCT03013491|583269780|FG006|Long-term Extension|Adverse Event|0|||
161513374|NCT03013491|583269781|FG007|Long-term Extension|Adverse Event|0|||
161513375|NCT03013491|583269782|FG008|Long-term Extension|Adverse Event|0|||
161513376|NCT03013491|583269783|FG009|Long-term Extension|Adverse Event|0|||
161513377|NCT03013491|583269784|FG010|Long-term Extension|Adverse Event|0|||
161513378|NCT03013491|583269785|FG011|Long-term Extension|Adverse Event|0|||
161513379|NCT03013491|583269786|FG012|Long-term Extension|Adverse Event|0|||
161513380|NCT03013491|583269787|FG013|Long-term Extension|Adverse Event|0|||
161513381|NCT03013491|583269788|FG014|Long-term Extension|Adverse Event|0|||
161513382|NCT03013491|583269789|FG015|Long-term Extension|Adverse Event|0|||
161513383|NCT03013491|583269790|FG016|Long-term Extension|Adverse Event|0|||
161513384|NCT03013491|583269791|FG017|Long-term Extension|Adverse Event|0|||
161513385|NCT03013491|583269792|FG018|Long-term Extension|Adverse Event|1|||
161513386|NCT03013491|583269774|FG000|Long-term Extension|Death|0|||
161513387|NCT03013491|583269775|FG001|Long-term Extension|Death|0|||
161513388|NCT03013491|583269776|FG002|Long-term Extension|Death|0|||
161513389|NCT03013491|583269777|FG003|Long-term Extension|Death|0|||
161513390|NCT03013491|583269778|FG004|Long-term Extension|Death|0|||
161513391|NCT03013491|583269779|FG005|Long-term Extension|Death|0|||
161513392|NCT03013491|583269780|FG006|Long-term Extension|Death|0|||
161513393|NCT03013491|583269781|FG007|Long-term Extension|Death|0|||
161587944|NCT03436745|583542315|FG001|Overall Study|Ineligible|0|||
161587945|NCT03436745|583542316|FG002|Overall Study|Ineligible|1|||
161587946|NCT04401800|583542319|FG000|Overall Study|Death|17|||
161587947|NCT04401800|583542319|FG000|Overall Study|Lost to Follow-up|5|||
161587948|NCT04401800|583542319|FG000|Overall Study|Withdrawal by Subject|4|||
161587949|NCT04927065|583542320|FG000|First Booster|Adverse Event|1|||
161587950|NCT04927065|583542321|FG001|First Booster|Adverse Event|0|||
161513394|NCT03013491|583269782|FG008|Long-term Extension|Death|0|||
161513395|NCT03013491|583269783|FG009|Long-term Extension|Death|0|||
161513396|NCT03013491|583269784|FG010|Long-term Extension|Death|0|||
161587951|NCT04927065|583542322|FG002|First Booster|Adverse Event|0|||
161587952|NCT04927065|583542323|FG003|First Booster|Adverse Event|0|||
161513397|NCT03013491|583269785|FG011|Long-term Extension|Death|0|||
161513398|NCT03013491|583269786|FG012|Long-term Extension|Death|0|||
161513399|NCT03013491|583269787|FG013|Long-term Extension|Death|0|||
161513400|NCT03013491|583269788|FG014|Long-term Extension|Death|0|||
161513401|NCT03013491|583269789|FG015|Long-term Extension|Death|0|||
161513402|NCT03013491|583269790|FG016|Long-term Extension|Death|0|||
161513403|NCT03013491|583269791|FG017|Long-term Extension|Death|0|||
161587953|NCT04927065|583542324|FG004|First Booster|Adverse Event|0|||
161587954|NCT04927065|583542325|FG005|First Booster|Adverse Event|0|||
161513404|NCT03013491|583269792|FG018|Long-term Extension|Death|1|||
161513405|NCT04740034|583269795|FG000|Overall Study|Death|0|||
161513406|NCT04740034|583269796|FG001|Overall Study|Death|1|||
161513407|NCT04740034|583269797|FG002|Overall Study|Death|2|||
161513408|NCT04740034|583269798|FG003|Overall Study|Death|3|||
161513409|NCT04740034|583269799|FG004|Overall Study|Death|4|||
161513410|NCT04740034|583269800|FG005|Overall Study|Death|4|||
161513411|NCT04740034|583269801|FG006|Overall Study|Death|2|||
161513412|NCT04740034|583269802|FG007|Overall Study|Death|2|||
161513413|NCT04740034|583269803|FG008|Overall Study|Death|2|||
161513414|NCT04740034|583269804|FG009|Overall Study|Death|4|||
161513415|NCT04740034|583269805|FG010|Overall Study|Death|0|||
161513416|NCT04740034|583269795|FG000|Overall Study|Lost to Follow-up|0|||
161513417|NCT04740034|583269796|FG001|Overall Study|Lost to Follow-up|0|||
161513418|NCT04740034|583269797|FG002|Overall Study|Lost to Follow-up|0|||
161513419|NCT04740034|583269798|FG003|Overall Study|Lost to Follow-up|1|||
161513420|NCT04740034|583269799|FG004|Overall Study|Lost to Follow-up|2|||
161513421|NCT04740034|583269800|FG005|Overall Study|Lost to Follow-up|2|||
161513422|NCT04740034|583269801|FG006|Overall Study|Lost to Follow-up|0|||
161513423|NCT04740034|583269802|FG007|Overall Study|Lost to Follow-up|0|||
161513424|NCT04740034|583269803|FG008|Overall Study|Lost to Follow-up|0|||
161513425|NCT04740034|583269804|FG009|Overall Study|Lost to Follow-up|1|||
161513426|NCT04740034|583269805|FG010|Overall Study|Lost to Follow-up|0|||
161513427|NCT04740034|583269795|FG000|Overall Study|Withdrawal by Subject|1|||
161513428|NCT04740034|583269796|FG001|Overall Study|Withdrawal by Subject|0|||
161513429|NCT04740034|583269797|FG002|Overall Study|Withdrawal by Subject|0|||
161513430|NCT04740034|583269798|FG003|Overall Study|Withdrawal by Subject|0|||
161513431|NCT04740034|583269799|FG004|Overall Study|Withdrawal by Subject|0|||
161513432|NCT04740034|583269800|FG005|Overall Study|Withdrawal by Subject|0|||
161513433|NCT04740034|583269801|FG006|Overall Study|Withdrawal by Subject|0|||
161513434|NCT04740034|583269802|FG007|Overall Study|Withdrawal by Subject|1|||
161513435|NCT04740034|583269803|FG008|Overall Study|Withdrawal by Subject|0|||
161513436|NCT04740034|583269804|FG009|Overall Study|Withdrawal by Subject|1|||
161513437|NCT04740034|583269805|FG010|Overall Study|Withdrawal by Subject|0|||
161513438|NCT04740034|583269795|FG000|Overall Study|Decision by sponsor|0|||
161513439|NCT04740034|583269796|FG001|Overall Study|Decision by sponsor|0|||
161513440|NCT04740034|583269797|FG002|Overall Study|Decision by sponsor|1|||
161513441|NCT04740034|583269798|FG003|Overall Study|Decision by sponsor|0|||
161513442|NCT04740034|583269799|FG004|Overall Study|Decision by sponsor|0|||
161513443|NCT04740034|583269800|FG005|Overall Study|Decision by sponsor|0|||
161513444|NCT04740034|583269801|FG006|Overall Study|Decision by sponsor|1|||
161513445|NCT04740034|583269802|FG007|Overall Study|Decision by sponsor|2|||
161587955|NCT04927065|583542326|FG006|First Booster|Adverse Event|0|||
161587956|NCT04927065|583542327|FG007|First Booster|Adverse Event|1|||
161587957|NCT04927065|583542328|FG008|First Booster|Adverse Event|0|||
161587958|NCT04927065|583542329|FG009|First Booster|Adverse Event|0|||
161587959|NCT04927065|583542330|FG010|First Booster|Adverse Event|0|||
161587960|NCT04927065|583542331|FG011|First Booster|Adverse Event|0|||
161587961|NCT04927065|583542332|FG012|First Booster|Adverse Event|0|||
161587962|NCT04927065|583542333|FG013|First Booster|Adverse Event|0|||
161587963|NCT04927065|583542334|FG014|First Booster|Adverse Event|0|||
161587964|NCT04927065|583542335|FG015|First Booster|Adverse Event|0|||
161513446|NCT04740034|583269803|FG008|Overall Study|Decision by sponsor|1|||
161820999|NCT01211262|584385788|FG001|Overall Study|Withdrawal of Consent|0|||
161821000|NCT01211262|584385787|FG000|Overall Study|Other|0|||
161821001|NCT01211262|584385788|FG001|Overall Study|Other|1|||
161513447|NCT04740034|583269804|FG009|Overall Study|Decision by sponsor|1|||
161513448|NCT04740034|583269805|FG010|Overall Study|Decision by sponsor|2|||
161513449|NCT02383758|583271741|FG000|Overall Study|Withdrawal by Subject|0|||
161513450|NCT02383758|583271742|FG001|Overall Study|Withdrawal by Subject|2|||
161513451|NCT02564471|583271743|FG000|Overall Study|Adverse Event|1|||
161513452|NCT02564471|583271744|FG001|Overall Study|Adverse Event|0|||
161513453|NCT02564471|583271745|FG002|Overall Study|Adverse Event|0|||
161513454|NCT02564471|583271746|FG003|Overall Study|Adverse Event|0|||
161587965|NCT04927065|583542320|FG000|First Booster|Death|1|||
161587966|NCT04927065|583542321|FG001|First Booster|Death|0|||
161587967|NCT04927065|583542322|FG002|First Booster|Death|0|||
161587968|NCT04927065|583542323|FG003|First Booster|Death|1|||
161821002|NCT01277510|584385791|FG000|Double-blind Phase|Non-compliance|0|||
161821003|NCT01277510|584385792|FG001|Double-blind Phase|Non-compliance|1|||
161513455|NCT02564471|583271743|FG000|Overall Study|Withdrawal by Subject|2|||
161587969|NCT04927065|583542324|FG004|First Booster|Death|0|||
161513456|NCT02564471|583271744|FG001|Overall Study|Withdrawal by Subject|1|||
161513457|NCT02564471|583271745|FG002|Overall Study|Withdrawal by Subject|3|||
161513458|NCT02564471|583271746|FG003|Overall Study|Withdrawal by Subject|0|||
161513459|NCT02564471|583271743|FG000|Overall Study|Lost to Follow-up|0|||
161513460|NCT02564471|583271744|FG001|Overall Study|Lost to Follow-up|2|||
161513461|NCT02564471|583271745|FG002|Overall Study|Lost to Follow-up|0|||
161513462|NCT02564471|583271746|FG003|Overall Study|Lost to Follow-up|0|||
161587970|NCT04927065|583542325|FG005|First Booster|Death|1|||
161587971|NCT04927065|583542326|FG006|First Booster|Death|0|||
161513463|NCT01643473|583271749|FG000|Overall Study|Lost to Follow-up|1|||
161513464|NCT01643473|583271750|FG001|Overall Study|Lost to Follow-up|0|||
161513465|NCT01519518|583271752|FG000|Overall Study|Consent not available|7|||
161513466|NCT01519518|583271753|FG001|Overall Study|Consent not available|10|||
161513467|NCT02033889|583271754|FG000|Overall Study|Adverse Event|3|||
161513468|NCT02033889|583271755|FG001|Overall Study|Adverse Event|1|||
161513469|NCT02033889|583271756|FG002|Overall Study|Adverse Event|3|||
161513470|NCT02033889|583271754|FG000|Overall Study|Death|3|||
161513471|NCT02033889|583271755|FG001|Overall Study|Death|1|||
161513472|NCT02033889|583271756|FG002|Overall Study|Death|2|||
161513473|NCT02033889|583271754|FG000|Overall Study|Excluded Medication|1|||
161513474|NCT02033889|583271755|FG001|Overall Study|Excluded Medication|1|||
161513475|NCT02033889|583271756|FG002|Overall Study|Excluded Medication|0|||
161513476|NCT02033889|583271754|FG000|Overall Study|Lost to Follow-up|8|||
161513477|NCT02033889|583271755|FG001|Overall Study|Lost to Follow-up|5|||
161513478|NCT02033889|583271756|FG002|Overall Study|Lost to Follow-up|6|||
161513479|NCT02033889|583271754|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161513480|NCT02033889|583271755|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161513481|NCT02033889|583271756|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161513482|NCT02033889|583271754|FG000|Overall Study|Physician Decision|0|||
161513483|NCT02033889|583271755|FG001|Overall Study|Physician Decision|1|||
161513484|NCT02033889|583271756|FG002|Overall Study|Physician Decision|1|||
161513485|NCT02033889|583271754|FG000|Overall Study|Participant moved|0|||
161513486|NCT02033889|583271755|FG001|Overall Study|Participant moved|1|||
161513487|NCT02033889|583271756|FG002|Overall Study|Participant moved|0|||
161513488|NCT02033889|583271754|FG000|Overall Study|Withdrawal by Subject|18|||
161513489|NCT02033889|583271755|FG001|Overall Study|Withdrawal by Subject|10|||
161513490|NCT02033889|583271756|FG002|Overall Study|Withdrawal by Subject|13|||
161513491|NCT00182689|583271762|FG000|Overall Study|Adverse Event|8|||
161513492|NCT00182689|583271763|FG001|Overall Study|Adverse Event|11|||
161513493|NCT00182689|583271762|FG000|Overall Study|Withdrawal by Subject|2|||
161513494|NCT00182689|583271763|FG001|Overall Study|Withdrawal by Subject|2|||
161513495|NCT00182689|583271762|FG000|Overall Study|Progression|27|||
161513496|NCT00182689|583271763|FG001|Overall Study|Progression|29|||
161513497|NCT00182689|583271762|FG000|Overall Study|Death|1|||
161513498|NCT00182689|583271763|FG001|Overall Study|Death|0|||
161513499|NCT00182689|583271762|FG000|Overall Study|not protocol specified|0|||
161513500|NCT00182689|583271763|FG001|Overall Study|not protocol specified|3|||
161513501|NCT00182689|583271762|FG000|Overall Study|Ineligible|1|||
161513502|NCT00182689|583271763|FG001|Overall Study|Ineligible|4|||
161513503|NCT00182689|583271762|FG000|Overall Study|Never received treatment|1|||
161513504|NCT00182689|583271763|FG001|Overall Study|Never received treatment|0|||
161513505|NCT01640301|583271764|FG000|Overall Study|Death|0|||
161513506|NCT01640301|583271765|FG001|Overall Study|Death|8|||
161513507|NCT00659646|583271766|FG000|Overall Study|Protocol Violation|12|||
161513508|NCT00659646|583271767|FG001|Overall Study|Protocol Violation|8|||
161513509|NCT00659646|583271766|FG000|Overall Study|Adverse Event|1|||
161513510|NCT00659646|583271767|FG001|Overall Study|Adverse Event|0|||
161513511|NCT00659646|583271766|FG000|Overall Study|Lost to Follow-up|1|||
161513512|NCT00659646|583271767|FG001|Overall Study|Lost to Follow-up|0|||
161513513|NCT00659646|583271766|FG000|Overall Study|protocol noncompliance after randomized|1|||
161513514|NCT00659646|583271767|FG001|Overall Study|protocol noncompliance after randomized|0|||
161513515|NCT02391948|583271773|FG000|6-month Assessment|Death|0|||
161513516|NCT02391948|583271774|FG001|6-month Assessment|Death|0|||
161927226|NCT01436500|584780310|FG002|Overall Study|Other|0|||
161513517|NCT02391948|583271775|FG002|6-month Assessment|Death|0|||
161513518|NCT02391948|583271776|FG003|6-month Assessment|Death|0|||
161513519|NCT02391948|583271777|FG004|6-month Assessment|Death|1|||
161513520|NCT02391948|583271773|FG000|6-month Assessment|Withdrawal by Subject|0|||
161513521|NCT02391948|583271774|FG001|6-month Assessment|Withdrawal by Subject|0|||
161513522|NCT02391948|583271775|FG002|6-month Assessment|Withdrawal by Subject|1|||
161513523|NCT02391948|583271776|FG003|6-month Assessment|Withdrawal by Subject|2|||
161513524|NCT02391948|583271777|FG004|6-month Assessment|Withdrawal by Subject|0|||
161513525|NCT02391948|583271773|FG000|6-month Assessment|Lost to Follow-up|4|||
161513526|NCT02391948|583271774|FG001|6-month Assessment|Lost to Follow-up|5|||
161927227|NCT01436500|584780311|FG003|Overall Study|Other|1|||
161513527|NCT02391948|583271775|FG002|6-month Assessment|Lost to Follow-up|2|||
161513528|NCT02391948|583271776|FG003|6-month Assessment|Lost to Follow-up|3|||
161513529|NCT02391948|583271777|FG004|6-month Assessment|Lost to Follow-up|1|||
161513530|NCT02391948|583271773|FG000|6-month Assessment|Medical issue/illness|1|||
161513531|NCT02391948|583271774|FG001|6-month Assessment|Medical issue/illness|1|||
161513532|NCT02391948|583271775|FG002|6-month Assessment|Medical issue/illness|0|||
161513533|NCT02391948|583271776|FG003|6-month Assessment|Medical issue/illness|0|||
161513534|NCT02391948|583271777|FG004|6-month Assessment|Medical issue/illness|0|||
161513535|NCT02391948|583271773|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
161513536|NCT02391948|583271774|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
161513537|NCT02391948|583271775|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
161587972|NCT04927065|583542327|FG007|First Booster|Death|0|||
161927228|NCT01436500|584780312|FG004|Overall Study|Other|0|||
161513538|NCT02391948|583271776|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
161513539|NCT02391948|583271777|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
161513540|NCT02391948|583271773|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
161513541|NCT02391948|583271774|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
161513542|NCT02391948|583271775|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
161513543|NCT02391948|583271776|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
161513544|NCT02391948|583271777|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
161513545|NCT02391948|583271773|FG000|12-month Assessment|Death|0|||
161513546|NCT02391948|583271774|FG001|12-month Assessment|Death|0|||
161513547|NCT02391948|583271775|FG002|12-month Assessment|Death|0|||
161513548|NCT02391948|583271776|FG003|12-month Assessment|Death|1|||
161513549|NCT02391948|583271777|FG004|12-month Assessment|Death|0|||
161513550|NCT02391948|583271773|FG000|12-month Assessment|Withdrawal by Subject|1|||
161513551|NCT02391948|583271774|FG001|12-month Assessment|Withdrawal by Subject|0|||
161513552|NCT02391948|583271775|FG002|12-month Assessment|Withdrawal by Subject|0|||
161513553|NCT02391948|583271776|FG003|12-month Assessment|Withdrawal by Subject|1|||
161513554|NCT02391948|583271777|FG004|12-month Assessment|Withdrawal by Subject|0|||
161513555|NCT02391948|583271773|FG000|12-month Assessment|Lost to Follow-up|5|||
161513556|NCT02391948|583271774|FG001|12-month Assessment|Lost to Follow-up|4|||
161513557|NCT02391948|583271775|FG002|12-month Assessment|Lost to Follow-up|4|||
161513558|NCT02391948|583271776|FG003|12-month Assessment|Lost to Follow-up|4|||
161513559|NCT02391948|583271777|FG004|12-month Assessment|Lost to Follow-up|5|||
161513560|NCT02391948|583271773|FG000|12-month Assessment|Medical issue/illness|0|||
161513561|NCT02391948|583271774|FG001|12-month Assessment|Medical issue/illness|1|||
161513562|NCT02391948|583271775|FG002|12-month Assessment|Medical issue/illness|0|||
161513563|NCT02391948|583271776|FG003|12-month Assessment|Medical issue/illness|1|||
161513564|NCT02391948|583271777|FG004|12-month Assessment|Medical issue/illness|0|||
161513565|NCT02391948|583271773|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
161513566|NCT02391948|583271774|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
161513567|NCT02391948|583271775|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
161513568|NCT02391948|583271776|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
161513569|NCT02391948|583271777|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
161513570|NCT02391948|583271773|FG000|18-month Assessment|Death|0|||
161513571|NCT02391948|583271774|FG001|18-month Assessment|Death|0|||
161513572|NCT02391948|583271775|FG002|18-month Assessment|Death|0|||
161513573|NCT02391948|583271776|FG003|18-month Assessment|Death|1|||
161513574|NCT02391948|583271777|FG004|18-month Assessment|Death|1|||
161513575|NCT02391948|583271773|FG000|18-month Assessment|Withdrawal by Subject|1|||
161513576|NCT02391948|583271774|FG001|18-month Assessment|Withdrawal by Subject|0|||
161513577|NCT02391948|583271775|FG002|18-month Assessment|Withdrawal by Subject|0|||
161513578|NCT02391948|583271776|FG003|18-month Assessment|Withdrawal by Subject|1|||
161513579|NCT02391948|583271777|FG004|18-month Assessment|Withdrawal by Subject|0|||
161513580|NCT02391948|583271773|FG000|18-month Assessment|Lost to Follow-up|2|||
161513581|NCT02391948|583271774|FG001|18-month Assessment|Lost to Follow-up|6|||
161513582|NCT02391948|583271775|FG002|18-month Assessment|Lost to Follow-up|2|||
161513583|NCT02391948|583271776|FG003|18-month Assessment|Lost to Follow-up|2|||
161513584|NCT02391948|583271777|FG004|18-month Assessment|Lost to Follow-up|3|||
161513585|NCT02391948|583271773|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
161513586|NCT02391948|583271774|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
161513587|NCT02391948|583271775|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
161513588|NCT02391948|583271776|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
161587973|NCT04927065|583542328|FG008|First Booster|Death|0|||
161587974|NCT04927065|583542329|FG009|First Booster|Death|0|||
161587975|NCT04927065|583542330|FG010|First Booster|Death|0|||
161587976|NCT04927065|583542331|FG011|First Booster|Death|0|||
161587977|NCT04927065|583542332|FG012|First Booster|Death|0|||
161587978|NCT04927065|583542333|FG013|First Booster|Death|0|||
161587979|NCT04927065|583542334|FG014|First Booster|Death|0|||
161587980|NCT04927065|583542335|FG015|First Booster|Death|0|||
161587981|NCT04927065|583542320|FG000|First Booster|Lost to Follow-up|8|||
161587982|NCT04927065|583542321|FG001|First Booster|Lost to Follow-up|20|||
161587983|NCT04927065|583542322|FG002|First Booster|Lost to Follow-up|0|||
161587984|NCT04927065|583542323|FG003|First Booster|Lost to Follow-up|11|||
161587985|NCT04927065|583542324|FG004|First Booster|Lost to Follow-up|43|||
161587986|NCT04927065|583542325|FG005|First Booster|Lost to Follow-up|30|||
161513589|NCT02391948|583271777|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
161513590|NCT02391948|583271773|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
161513591|NCT02391948|583271774|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
161513592|NCT02391948|583271775|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
161513593|NCT02391948|583271776|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
161513594|NCT02391948|583271777|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
161513595|NCT02391948|583271773|FG000|24-month Assessment|Death|0|||
161513596|NCT02391948|583271774|FG001|24-month Assessment|Death|0|||
161587987|NCT04927065|583542326|FG006|First Booster|Lost to Follow-up|28|||
161587988|NCT04927065|583542327|FG007|First Booster|Lost to Follow-up|23|||
161513597|NCT02391948|583271775|FG002|24-month Assessment|Death|0|||
161513598|NCT02391948|583271776|FG003|24-month Assessment|Death|0|||
161513599|NCT02391948|583271777|FG004|24-month Assessment|Death|1|||
161513600|NCT02391948|583271773|FG000|24-month Assessment|Withdrawal by Subject|1|||
161513601|NCT02391948|583271774|FG001|24-month Assessment|Withdrawal by Subject|1|||
161513602|NCT02391948|583271775|FG002|24-month Assessment|Withdrawal by Subject|0|||
161513603|NCT02391948|583271776|FG003|24-month Assessment|Withdrawal by Subject|0|||
161513604|NCT02391948|583271777|FG004|24-month Assessment|Withdrawal by Subject|1|||
161513605|NCT02391948|583271773|FG000|24-month Assessment|Lost to Follow-up|5|||
161513606|NCT02391948|583271774|FG001|24-month Assessment|Lost to Follow-up|4|||
161513607|NCT02391948|583271775|FG002|24-month Assessment|Lost to Follow-up|0|||
161513608|NCT02391948|583271776|FG003|24-month Assessment|Lost to Follow-up|0|||
161513609|NCT02391948|583271777|FG004|24-month Assessment|Lost to Follow-up|0|||
161513610|NCT02391948|583271773|FG000|24-month Assessment|Medical issue/illness|0|||
161513611|NCT02391948|583271774|FG001|24-month Assessment|Medical issue/illness|0|||
161513612|NCT02391948|583271775|FG002|24-month Assessment|Medical issue/illness|1|||
161513613|NCT02391948|583271776|FG003|24-month Assessment|Medical issue/illness|0|||
161513614|NCT02391948|583271777|FG004|24-month Assessment|Medical issue/illness|0|||
161513615|NCT02391948|583271773|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
161513616|NCT02391948|583271774|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
161513617|NCT02391948|583271775|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
161513618|NCT02391948|583271776|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
161513619|NCT02391948|583271777|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
161513620|NCT02348489|583271778|FG000|Overall Study|Death|336|||
161513621|NCT02348489|583271779|FG001|Overall Study|Death|335|||
161513622|NCT02348489|583271778|FG000|Overall Study|Withdrawal by Subject|14|||
161513623|NCT02348489|583271779|FG001|Overall Study|Withdrawal by Subject|27|||
161513624|NCT02348489|583271778|FG000|Overall Study|Lost to Follow-up|3|||
161513625|NCT02348489|583271779|FG001|Overall Study|Lost to Follow-up|5|||
161513626|NCT00201006|583271780|FG000|Overall Study|Withdrawal by Subject|7|||
161513627|NCT00201006|583271781|FG001|Overall Study|Withdrawal by Subject|2|||
161513628|NCT00201006|583271782|FG002|Overall Study|Withdrawal by Subject|3|||
161513629|NCT00201006|583271780|FG000|Overall Study|Adverse Event|1|||
161513630|NCT00201006|583271781|FG001|Overall Study|Adverse Event|0|||
161513631|NCT00201006|583271782|FG002|Overall Study|Adverse Event|1|||
161513632|NCT01969838|583271785|FG000|Double-blind Phase|Adverse Event|10|||
161513633|NCT01969838|583271786|FG001|Double-blind Phase|Adverse Event|4|||
161513634|NCT01969838|583271787|FG002|Double-blind Phase|Adverse Event|0|||
161513635|NCT01969838|583271788|FG003|Double-blind Phase|Adverse Event|0|||
161513636|NCT01969838|583271785|FG000|Double-blind Phase|Death|5|||
161513637|NCT01969838|583271786|FG001|Double-blind Phase|Death|2|||
161513638|NCT01969838|583271787|FG002|Double-blind Phase|Death|0|||
161513639|NCT01969838|583271788|FG003|Double-blind Phase|Death|0|||
161513640|NCT01969838|583271785|FG000|Double-blind Phase|Physician Decision|5|||
161513641|NCT01969838|583271786|FG001|Double-blind Phase|Physician Decision|1|||
161513642|NCT01969838|583271787|FG002|Double-blind Phase|Physician Decision|0|||
161513643|NCT01969838|583271788|FG003|Double-blind Phase|Physician Decision|0|||
161513644|NCT01969838|583271785|FG000|Double-blind Phase|Subject Decision|4|||
161513645|NCT01969838|583271786|FG001|Double-blind Phase|Subject Decision|2|||
161513646|NCT01969838|583271787|FG002|Double-blind Phase|Subject Decision|0|||
161513647|NCT01969838|583271788|FG003|Double-blind Phase|Subject Decision|0|||
161513648|NCT01969838|583271785|FG000|Double-blind Phase|Disease Progression|2|||
161513649|NCT01969838|583271786|FG001|Double-blind Phase|Disease Progression|0|||
161513650|NCT01969838|583271787|FG002|Double-blind Phase|Disease Progression|0|||
161513651|NCT01969838|583271788|FG003|Double-blind Phase|Disease Progression|0|||
161513652|NCT01969838|583271785|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
161513653|NCT01969838|583271786|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
161513654|NCT01969838|583271787|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
161513655|NCT01969838|583271788|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
161821004|NCT01277510|584385791|FG000|Double-blind Phase|Adverse Event|1|||
161821005|NCT01277510|584385792|FG001|Double-blind Phase|Adverse Event|0|||
161821006|NCT01277510|584385791|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161513656|NCT01969838|583271785|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
161513657|NCT01969838|583271786|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
161513658|NCT01969838|583271787|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
161513659|NCT01969838|583271788|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
161513660|NCT01969838|583271785|FG000|Open-label Phase|Adverse Event|0|||
161513661|NCT01969838|583271786|FG001|Open-label Phase|Adverse Event|0|||
161513662|NCT01969838|583271787|FG002|Open-label Phase|Adverse Event|37|||
161513663|NCT01969838|583271788|FG003|Open-label Phase|Adverse Event|49|||
161513664|NCT01969838|583271785|FG000|Open-label Phase|Disease Progression|0|||
161513665|NCT01969838|583271786|FG001|Open-label Phase|Disease Progression|0|||
161821007|NCT01277510|584385792|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161513666|NCT01969838|583271787|FG002|Open-label Phase|Disease Progression|26|||
161513667|NCT01969838|583271788|FG003|Open-label Phase|Disease Progression|27|||
161821008|NCT01277510|584385791|FG000|Double-blind Phase|Administrative decision|7|||
161513668|NCT01969838|583271785|FG000|Open-label Phase|Lack of Efficacy|0|||
161513669|NCT01969838|583271786|FG001|Open-label Phase|Lack of Efficacy|0|||
161513670|NCT01969838|583271787|FG002|Open-label Phase|Lack of Efficacy|17|||
161513671|NCT01969838|583271788|FG003|Open-label Phase|Lack of Efficacy|19|||
161513672|NCT01969838|583271785|FG000|Open-label Phase|Subject Decision|0|||
161513673|NCT01969838|583271786|FG001|Open-label Phase|Subject Decision|0|||
161513674|NCT01969838|583271787|FG002|Open-label Phase|Subject Decision|14|||
161513675|NCT01969838|583271788|FG003|Open-label Phase|Subject Decision|15|||
161513676|NCT01969838|583271785|FG000|Open-label Phase|Death|0|||
161513677|NCT01969838|583271786|FG001|Open-label Phase|Death|0|||
161513678|NCT01969838|583271787|FG002|Open-label Phase|Death|13|||
161513679|NCT01969838|583271788|FG003|Open-label Phase|Death|11|||
161513680|NCT01969838|583271785|FG000|Open-label Phase|Physician Decision|0|||
161513681|NCT01969838|583271786|FG001|Open-label Phase|Physician Decision|0|||
161513682|NCT01969838|583271787|FG002|Open-label Phase|Physician Decision|9|||
161513683|NCT01969838|583271788|FG003|Open-label Phase|Physician Decision|14|||
161513684|NCT01969838|583271785|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
161513685|NCT01969838|583271786|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
161513686|NCT01969838|583271787|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
161513687|NCT01969838|583271788|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
161513688|NCT00408993|583271789|FG000|Overall Study|Adverse Event|15|||
161513689|NCT00408993|583271790|FG001|Overall Study|Adverse Event|4|||
161513690|NCT00408993|583271789|FG000|Overall Study|Protocol Violation|1|||
161513691|NCT00408993|583271790|FG001|Overall Study|Protocol Violation|6|||
161513692|NCT00408993|583271789|FG000|Overall Study|Lack of Efficacy|1|||
161513693|NCT00408993|583271790|FG001|Overall Study|Lack of Efficacy|4|||
161513694|NCT00408993|583271789|FG000|Overall Study|Withdrawal by Subject|2|||
161513695|NCT00408993|583271790|FG001|Overall Study|Withdrawal by Subject|3|||
161513696|NCT04193202|583271795|FG000|Overall Study|Adverse Event|2|||
161513697|NCT04193202|583271796|FG001|Overall Study|Adverse Event|1|||
161513698|NCT04193202|583271795|FG000|Overall Study|Death|0|||
161513699|NCT04193202|583271796|FG001|Overall Study|Death|1|||
161513700|NCT04193202|583271795|FG000|Overall Study|Physician Decision|1|||
161513701|NCT04193202|583271796|FG001|Overall Study|Physician Decision|1|||
161513702|NCT04193202|583271795|FG000|Overall Study|Protocol Violation|2|||
161513703|NCT04193202|583271796|FG001|Overall Study|Protocol Violation|2|||
161513704|NCT04193202|583271795|FG000|Overall Study|Withdrawal by Subject|11|||
161513705|NCT04193202|583271796|FG001|Overall Study|Withdrawal by Subject|5|||
161513706|NCT01777997|583271797|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
161513707|NCT01777997|583271797|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
161513708|NCT01777997|583271797|FG000|Weeks 48 to 72/96 on ART|Death|1|||
161513709|NCT01777997|583271797|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
161513710|NCT02488629|583271799|FG000|Overall Study|Lack of Efficacy|3|||
161513711|NCT02488629|583271800|FG001|Overall Study|Lack of Efficacy|1|||
161513712|NCT02488629|583271801|FG002|Overall Study|Lack of Efficacy|0|||
161513713|NCT02488629|583271802|FG003|Overall Study|Lack of Efficacy|0|||
161513714|NCT02488629|583271799|FG000|Overall Study|Withdrawal by Subject|0|||
161513715|NCT02488629|583271800|FG001|Overall Study|Withdrawal by Subject|1|||
161513716|NCT02488629|583271801|FG002|Overall Study|Withdrawal by Subject|0|||
161513717|NCT02488629|583271802|FG003|Overall Study|Withdrawal by Subject|0|||
161513718|NCT02932891|583271803|FG000|Overall Study|Lost to Follow-up|2|||
161513719|NCT02932891|583271803|FG000|Overall Study|HPA Suppress|2|||
161513720|NCT04622254|583271804|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
161513721|NCT04622254|583271805|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
161587989|NCT04927065|583542328|FG008|First Booster|Lost to Follow-up|4|||
161927229|NCT03983109|584780314|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
161927230|NCT03983109|584780315|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
161927231|NCT01068249|584780319|FG000|Overall Study|Death|1|||
161927232|NCT01068249|584780319|FG000|Overall Study|Withdrawal by Subject|3|||
161927233|NCT01740427|584780320|FG000|Overall Study|Objective Progression or Relapse|286|||
161927234|NCT01740427|584780321|FG001|Overall Study|Objective Progression or Relapse|172|||
161513722|NCT04622254|583271806|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
161513723|NCT04622254|583271807|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
161513724|NCT04622254|583271808|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
161513725|NCT04622254|583271809|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
161513726|NCT04622254|583271804|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
161513727|NCT04622254|583271805|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
161513728|NCT04622254|583271806|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
161513729|NCT04622254|583271807|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161513730|NCT04622254|583271808|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161513731|NCT04622254|583271809|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161513732|NCT04622254|583271804|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
161513733|NCT04622254|583271805|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
161513734|NCT04622254|583271806|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
161513735|NCT04622254|583271807|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
161513736|NCT04622254|583271808|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
161513737|NCT04622254|583271809|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
161513738|NCT04622254|583271804|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161513739|NCT04622254|583271805|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
161513740|NCT04622254|583271806|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161513741|NCT04622254|583271807|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161513742|NCT04622254|583271808|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161513743|NCT04622254|583271809|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161513744|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161513745|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161513746|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161513747|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
161513748|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161513749|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161513750|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161513751|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161513752|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161513753|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
161513754|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161513755|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
161513756|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161513757|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161513758|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161513759|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
161513760|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161513761|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161513762|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161513763|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161513764|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161513765|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
161513766|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161513767|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161513768|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161513769|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161513770|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161513771|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
161513772|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
161513773|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
161513774|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161513775|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161513776|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161513777|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
161513778|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
161513779|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
161513780|NCT04622254|583271804|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
161513781|NCT04622254|583271805|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
161513782|NCT04622254|583271806|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
161513783|NCT04622254|583271807|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
161513784|NCT04622254|583271808|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
161513785|NCT04622254|583271809|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
161513786|NCT02652624|583271810|FG000|Randomized Phase|Pregnancy|3|||
161513787|NCT02652624|583271811|FG001|Randomized Phase|Pregnancy|1|||
161513788|NCT02652624|583271810|FG000|Randomized Phase|Investigator's Discretion|0|||
161513789|NCT02652624|583271811|FG001|Randomized Phase|Investigator's Discretion|2|||
161513790|NCT02652624|583271810|FG000|Randomized Phase|Death|0|||
161513791|NCT02652624|583271811|FG001|Randomized Phase|Death|1|||
161513792|NCT02652624|583271810|FG000|Randomized Phase|Lost to Follow-up|0|||
161513793|NCT02652624|583271811|FG001|Randomized Phase|Lost to Follow-up|1|||
161513794|NCT02652624|583271810|FG000|Extension Phase|Lost to Follow-up|3|||
161513795|NCT02652624|583271811|FG001|Extension Phase|Lost to Follow-up|1|||
161513796|NCT02652624|583271810|FG000|Extension Phase|Pregnancy|1|||
161513797|NCT02652624|583271811|FG001|Extension Phase|Pregnancy|1|||
161513798|NCT02652624|583271810|FG000|Extension Phase|Adverse Event|0|||
161513799|NCT02652624|583271811|FG001|Extension Phase|Adverse Event|1|||
161513800|NCT02652624|583271810|FG000|Extension Phase|Withdrew Consent|0|||
161513801|NCT02652624|583271811|FG001|Extension Phase|Withdrew Consent|1|||
161513802|NCT00577122|583271812|FG000|Overall Study|Adverse Event|0|||
161513803|NCT00577122|583271813|FG001|Overall Study|Adverse Event|2|||
161513804|NCT00577122|583271812|FG000|Overall Study|Progression, relapse during active trt|6|||
161513805|NCT00577122|583271813|FG001|Overall Study|Progression, relapse during active trt|8|||
161587990|NCT04927065|583542329|FG009|First Booster|Lost to Follow-up|15|||
161513806|NCT00577122|583271812|FG000|Overall Study|Prog, refract disease during active trt|8|||
161513807|NCT00577122|583271813|FG001|Overall Study|Prog, refract disease during active trt|5|||
161513808|NCT00577122|583271812|FG000|Overall Study|Alternative Therapy|0|||
161513809|NCT00577122|583271813|FG001|Overall Study|Alternative Therapy|1|||
161513810|NCT03228680|583271814|FG000|Overall Study|Adverse Event|13|||
161513811|NCT03228680|583271815|FG001|Overall Study|Adverse Event|18|||
161513812|NCT03228680|583271814|FG000|Overall Study|Randomization failure|0|||
161513813|NCT03228680|583271815|FG001|Overall Study|Randomization failure|1|||
161513814|NCT03228680|583271814|FG000|Overall Study|Withdrawal by Subject|1|||
161513815|NCT03228680|583271815|FG001|Overall Study|Withdrawal by Subject|0|||
161513816|NCT03228680|583271814|FG000|Overall Study|Other|9|||
161513817|NCT03228680|583271815|FG001|Overall Study|Other|16|||
161513818|NCT02167035|583271816|FG000|Overall Study|Adverse Event|2|||
161513819|NCT02167035|583271817|FG001|Overall Study|Adverse Event|2|||
161513820|NCT02167035|583271816|FG000|Overall Study|Lost to Follow-up|3|||
161513821|NCT02167035|583271817|FG001|Overall Study|Lost to Follow-up|3|||
161513822|NCT02167035|583271816|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
161513823|NCT02167035|583271817|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
161513824|NCT02252081|583271818|FG000|Overall Study|Withdrawal by Subject|2|||
161513825|NCT02252081|583271819|FG001|Overall Study|Withdrawal by Subject|1|||
161513826|NCT02252081|583271818|FG000|Overall Study|Adverse Event|4|||
161513827|NCT02252081|583271819|FG001|Overall Study|Adverse Event|1|||
161513828|NCT02252081|583271818|FG000|Overall Study|non compliance & others|0|||
161513829|NCT02252081|583271819|FG001|Overall Study|non compliance & others|2|||
161513830|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
161513831|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
161513832|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
161513833|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
161513834|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
161513835|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
161513836|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
161513837|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
161513838|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
161513839|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
161513840|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
161513841|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
161513842|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
161513843|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
161513844|NCT03732638|583271826|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
161513845|NCT03732638|583271827|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
161513846|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
161513847|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
161513848|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
161513849|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
161513850|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
161513851|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
161513852|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
161513853|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
161513854|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
161513855|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
161513856|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
161513857|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
161513858|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
161513859|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
161513860|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
161513861|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
161513862|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
161513863|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
161513864|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
161513865|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
161587991|NCT04927065|583542330|FG010|First Booster|Lost to Follow-up|0|||
161587992|NCT04927065|583542331|FG011|First Booster|Lost to Follow-up|0|||
161587993|NCT04927065|583542332|FG012|First Booster|Lost to Follow-up|0|||
161587994|NCT04927065|583542333|FG013|First Booster|Lost to Follow-up|0|||
161587995|NCT04927065|583542334|FG014|First Booster|Lost to Follow-up|0|||
161587996|NCT04927065|583542335|FG015|First Booster|Lost to Follow-up|0|||
161587997|NCT04927065|583542320|FG000|First Booster|Physician Decision|1|||
161513866|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
161513867|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
161513868|NCT03732638|583271826|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
161513869|NCT03732638|583271827|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
161587998|NCT04927065|583542321|FG001|First Booster|Physician Decision|0|||
161587999|NCT04927065|583542322|FG002|First Booster|Physician Decision|0|||
161513870|NCT03732638|583271826|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
161513871|NCT03732638|583271827|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
161513872|NCT03732638|583271826|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
161513873|NCT03732638|583271827|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
161513874|NCT03732638|583271826|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
161513875|NCT03732638|583271827|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
161513876|NCT03732638|583271826|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
161513877|NCT03732638|583271827|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
161513878|NCT00642304|583271828|FG000|Overall Study|Adverse Event|1|||
161513879|NCT00642304|583271828|FG000|Overall Study|Death|1|||
161513880|NCT00642304|583271828|FG000|Overall Study|Blood transfusion|2|||
161513881|NCT00642304|583271828|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
161513882|NCT00642304|583271828|FG000|Overall Study|Transplantation|1|||
161513883|NCT00482391|583271829|FG000|Overall Study|Withdrawal by Subject|1|||
161513884|NCT00482391|583271829|FG000|Overall Study|Adverse Event|1|||
161513885|NCT00482391|583271829|FG000|Overall Study|Death|1|||
161513886|NCT01824303|583271847|FG000|Randomized Study|Withdrawal by Subject|1|||
161513887|NCT01824303|583271848|FG001|Randomized Study|Withdrawal by Subject|1|||
161513888|NCT01824303|583271847|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
161513889|NCT01824303|583271848|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
161513890|NCT02606136|583271856|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
161513891|NCT02606136|583271856|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
161513892|NCT02606136|583271856|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
161513893|NCT02606136|583271856|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
161513894|NCT03296696|583271857|FG000|Overall Study|Started Other Antitumor Therapy|1|||
161513895|NCT03296696|583271858|FG001|Overall Study|Started Other Antitumor Therapy|2|||
161513896|NCT03296696|583271859|FG002|Overall Study|Started Other Antitumor Therapy|1|||
161513897|NCT03296696|583271860|FG003|Overall Study|Started Other Antitumor Therapy|2|||
161513898|NCT03296696|583271861|FG004|Overall Study|Started Other Antitumor Therapy|1|||
161513899|NCT03296696|583271862|FG005|Overall Study|Started Other Antitumor Therapy|1|||
161513900|NCT03296696|583271863|FG006|Overall Study|Started Other Antitumor Therapy|2|||
161513901|NCT03296696|583271864|FG007|Overall Study|Started Other Antitumor Therapy|3|||
161513902|NCT03296696|583271865|FG008|Overall Study|Started Other Antitumor Therapy|1|||
161513903|NCT03296696|583271866|FG009|Overall Study|Started Other Antitumor Therapy|0|||
161513904|NCT03296696|583271857|FG000|Overall Study|Death|0|||
161513905|NCT03296696|583271858|FG001|Overall Study|Death|1|||
161513906|NCT03296696|583271859|FG002|Overall Study|Death|1|||
161513907|NCT03296696|583271860|FG003|Overall Study|Death|2|||
161513908|NCT03296696|583271861|FG004|Overall Study|Death|2|||
161513909|NCT03296696|583271862|FG005|Overall Study|Death|3|||
161513910|NCT03296696|583271863|FG006|Overall Study|Death|1|||
161513911|NCT03296696|583271864|FG007|Overall Study|Death|2|||
161513912|NCT03296696|583271865|FG008|Overall Study|Death|0|||
161513913|NCT03296696|583271866|FG009|Overall Study|Death|0|||
161513914|NCT03296696|583271857|FG000|Overall Study|Withdrawal by Subject|0|||
161513915|NCT03296696|583271858|FG001|Overall Study|Withdrawal by Subject|0|||
161513916|NCT03296696|583271859|FG002|Overall Study|Withdrawal by Subject|1|||
161513917|NCT03296696|583271860|FG003|Overall Study|Withdrawal by Subject|0|||
161513918|NCT03296696|583271861|FG004|Overall Study|Withdrawal by Subject|1|||
161513919|NCT03296696|583271862|FG005|Overall Study|Withdrawal by Subject|0|||
161513920|NCT03296696|583271863|FG006|Overall Study|Withdrawal by Subject|0|||
161513921|NCT03296696|583271864|FG007|Overall Study|Withdrawal by Subject|0|||
161513922|NCT03296696|583271865|FG008|Overall Study|Withdrawal by Subject|0|||
161513923|NCT03296696|583271866|FG009|Overall Study|Withdrawal by Subject|1|||
161513924|NCT04694131|583271869|FG000|Overall Study|Withdrawal by Subject|7|||
161513925|NCT04694131|583271869|FG000|Overall Study|Screen Failure|1|||
161513926|NCT04694131|583271869|FG000|Overall Study|High stimulation threshold|3|||
161513927|NCT01350128|583271870|FG000|Overall Study|Withdrawal by Subject|3|||
161513928|NCT01350128|583271870|FG000|Overall Study|Protocol discontinuation criteria|8|||
161513929|NCT01350128|583271870|FG000|Overall Study|Physician Decision|1|||
161513930|NCT01350128|583271870|FG000|Overall Study|Lost to Follow-up|2|||
161513931|NCT02399085|583271874|FG000|Overall Study|Adverse Event|16|||
161513932|NCT02399085|583271874|FG000|Overall Study|Death|2|||
161513933|NCT02399085|583271874|FG000|Overall Study|Withdrawal by Subject|8|||
161513934|NCT02399085|583271874|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
161513935|NCT02399085|583271874|FG000|Overall Study|Physician Decision|5|||
161513936|NCT01859715|583271875|FG000|Overall Study|No 2nd VAS|16|||
161821009|NCT01277510|584385792|FG001|Double-blind Phase|Administrative decision|9|||
161821010|NCT01277510|584385791|FG000|Double-blind Phase|Death|0|||
161513937|NCT01859715|583271876|FG001|Overall Study|No 2nd VAS|8|||
161513938|NCT01859715|583271877|FG002|Overall Study|No 2nd VAS|23|||
161513939|NCT00086580|583271881|FG000|Treatment Period|Disease progression|9|||
161513940|NCT00086580|583271882|FG001|Treatment Period|Disease progression|8|||
161513941|NCT00086580|583271881|FG000|Treatment Period|Unable to comply with protocol|3|||
161513942|NCT00086580|583271882|FG001|Treatment Period|Unable to comply with protocol|1|||
161513943|NCT00086580|583271881|FG000|Treatment Period|Withdrawal by Subject|7|||
161513944|NCT00086580|583271882|FG001|Treatment Period|Withdrawal by Subject|8|||
161513945|NCT00086580|583271881|FG000|Treatment Period|Physician Decision|13|||
161513946|NCT00086580|583271882|FG001|Treatment Period|Physician Decision|7|||
161513947|NCT00086580|583271881|FG000|Treatment Period|AE - not treatment related|7|||
161513948|NCT00086580|583271882|FG001|Treatment Period|AE - not treatment related|7|||
161513949|NCT00086580|583271881|FG000|Treatment Period|Toxicity - treatment related|15|||
161513950|NCT00086580|583271882|FG001|Treatment Period|Toxicity - treatment related|15|||
161513951|NCT00086580|583271881|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
161513952|NCT00086580|583271882|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
161513953|NCT00086580|583271881|FG000|Treatment Period|Death|5|||
161513954|NCT00086580|583271882|FG001|Treatment Period|Death|7|||
161513955|NCT00086580|583271881|FG000|Treatment Period|Other|5|||
161513956|NCT00086580|583271882|FG001|Treatment Period|Other|3|||
161513957|NCT00086580|583271881|FG000|Follow-up Period|Disease progression|72|||
161513958|NCT00086580|583271882|FG001|Follow-up Period|Disease progression|99|||
161513959|NCT00086580|583271881|FG000|Follow-up Period|Unable to comply with protocol|5|||
161513960|NCT00086580|583271882|FG001|Follow-up Period|Unable to comply with protocol|0|||
161513961|NCT00086580|583271881|FG000|Follow-up Period|Withdrawal by Subject|6|||
161588000|NCT04927065|583542323|FG003|First Booster|Physician Decision|3|||
161588001|NCT04927065|583542324|FG004|First Booster|Physician Decision|1|||
161588002|NCT04927065|583542325|FG005|First Booster|Physician Decision|1|||
161588003|NCT04927065|583542326|FG006|First Booster|Physician Decision|0|||
161588004|NCT04927065|583542327|FG007|First Booster|Physician Decision|3|||
161588005|NCT04927065|583542328|FG008|First Booster|Physician Decision|0|||
161588006|NCT04927065|583542329|FG009|First Booster|Physician Decision|0|||
161513962|NCT00086580|583271882|FG001|Follow-up Period|Withdrawal by Subject|6|||
161588007|NCT04927065|583542330|FG010|First Booster|Physician Decision|0|||
161588008|NCT04927065|583542331|FG011|First Booster|Physician Decision|0|||
161588009|NCT04927065|583542332|FG012|First Booster|Physician Decision|0|||
161588010|NCT04927065|583542333|FG013|First Booster|Physician Decision|0|||
161588011|NCT04927065|583542334|FG014|First Booster|Physician Decision|0|||
161821011|NCT01277510|584385792|FG001|Double-blind Phase|Death|1|||
161821012|NCT01277510|584385791|FG000|Double-blind Phase|Protocol-specified criteria|2|||
161821013|NCT01277510|584385792|FG001|Double-blind Phase|Protocol-specified criteria|6|||
161821014|NCT01277510|584385791|FG000|Double-blind Phase|Other|1|||
161821015|NCT01277510|584385792|FG001|Double-blind Phase|Other|1|||
161821016|NCT01277510|584385791|FG000|Open-label Phase|Administrative decision|4|||
161821017|NCT01277510|584385792|FG001|Open-label Phase|Administrative decision|3|||
161821018|NCT01277510|584385791|FG000|Open-label Phase|Protocol-specified criteria|1|||
161821019|NCT01277510|584385792|FG001|Open-label Phase|Protocol-specified criteria|0|||
161821020|NCT01277510|584385791|FG000|Open-label Phase|Never received investigational product|2|||
161821021|NCT01277510|584385792|FG001|Open-label Phase|Never received investigational product|0|||
161821022|NCT00533507|584385793|FG000|Overall Study|Withdrawal by Subject|1|||
161821023|NCT02119936|584385802|FG000|Overall Study|Lost to Follow-up|10|||
161821024|NCT00570128|584385803|FG000|Overall Study|Adverse Event|1|||
161821025|NCT00570128|584385804|FG001|Overall Study|Adverse Event|0|||
161821026|NCT00570128|584385803|FG000|Overall Study|Lost to Follow-up|1|||
161821027|NCT00570128|584385804|FG001|Overall Study|Lost to Follow-up|0|||
161821028|NCT00570128|584385803|FG000|Overall Study|Withdrawal by Subject|2|||
161821029|NCT00570128|584385804|FG001|Overall Study|Withdrawal by Subject|0|||
161821030|NCT01426854|584385807|FG000|Overall Study|Adverse Event|1|||
161821031|NCT01426854|584385808|FG001|Overall Study|Adverse Event|5|||
161821032|NCT01426854|584385807|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
161821033|NCT01426854|584385808|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
161821034|NCT01426854|584385807|FG000|Overall Study|Lost to Follow-up|3|||
161821035|NCT01426854|584385808|FG001|Overall Study|Lost to Follow-up|0|||
161821036|NCT01426854|584385807|FG000|Overall Study|Noncompliance|0|||
161821037|NCT01426854|584385808|FG001|Overall Study|Noncompliance|1|||
161821038|NCT01426854|584385807|FG000|Overall Study|Treatment Failure|0|||
161821039|NCT01426854|584385808|FG001|Overall Study|Treatment Failure|16|||
161821040|NCT01426854|584385807|FG000|Overall Study|Protocol Deviation|0|||
161821041|NCT01426854|584385808|FG001|Overall Study|Protocol Deviation|1|||
161821042|NCT01426854|584385807|FG000|Overall Study|Other|3|||
161927235|NCT01740427|584780320|FG000|Overall Study|Adverse Event|32|||
161927236|NCT01740427|584780321|FG001|Overall Study|Adverse Event|9|||
161927237|NCT01740427|584780320|FG000|Overall Study|Global Deterioration of Health Status|28|||
161927238|NCT01740427|584780321|FG001|Overall Study|Global Deterioration of Health Status|12|||
161513963|NCT00086580|583271881|FG000|Follow-up Period|Physician Decision|0|||
161821043|NCT01426854|584385808|FG001|Overall Study|Other|2|||
161821044|NCT01566435|584385810|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
161821045|NCT00438633|584385811|FG000|Overall Study|Withdrawal by Subject|1|||
161821046|NCT00438633|584385812|FG001|Overall Study|Withdrawal by Subject|0|||
161821047|NCT00438633|584385811|FG000|Overall Study|Lost to Follow-up|15|||
161821048|NCT00438633|584385812|FG001|Overall Study|Lost to Follow-up|17|||
161927239|NCT01740427|584780320|FG000|Overall Study|Participant Refused Continued Treatment|27|||
161588012|NCT04927065|583542335|FG015|First Booster|Physician Decision|0|||
161676291|NCT02246582|583868735|FG000|Overall Study|Withdrawal by Subject|3|||
161676292|NCT02246582|583868736|FG001|Overall Study|Withdrawal by Subject|4|||
161676293|NCT02060383|583868738|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
161821049|NCT04569084|584385813|FG000|Overall Study|Adverse Event|10|||
161821050|NCT04569084|584385814|FG001|Overall Study|Adverse Event|14|||
161821051|NCT04569084|584385813|FG000|Overall Study|Death|2|||
161821052|NCT04569084|584385814|FG001|Overall Study|Death|3|||
161821053|NCT04569084|584385813|FG000|Overall Study|Lost to Follow-up|1|||
161821054|NCT04569084|584385814|FG001|Overall Study|Lost to Follow-up|1|||
161821055|NCT04569084|584385813|FG000|Overall Study|Physician Decision|3|||
161821056|NCT04569084|584385814|FG001|Overall Study|Physician Decision|3|||
161821057|NCT04569084|584385813|FG000|Overall Study|Protocol Violation|2|||
161821058|NCT04569084|584385814|FG001|Overall Study|Protocol Violation|1|||
161821059|NCT04569084|584385813|FG000|Overall Study|Withdrawal by Subject|20|||
161821060|NCT04569084|584385814|FG001|Overall Study|Withdrawal by Subject|21|||
161821061|NCT04569084|584385813|FG000|Overall Study|Study terminated by sponsor|26|||
161821062|NCT04569084|584385814|FG001|Overall Study|Study terminated by sponsor|23|||
161821063|NCT04569084|584385813|FG000|Overall Study|Other|3|||
161821064|NCT04569084|584385814|FG001|Overall Study|Other|5|||
161821065|NCT03196284|584385815|FG000|Main Part|Withdrawal by Subject|0|||
161821066|NCT03196284|584385816|FG001|Main Part|Withdrawal by Subject|1|||
161821067|NCT03196284|584385817|FG002|Main Part|Withdrawal by Subject|0|||
161821068|NCT03196284|584385815|FG000|Extension Part|Lack of Efficacy|0|||
161821069|NCT03196284|584385816|FG001|Extension Part|Lack of Efficacy|0|||
161821070|NCT03196284|584385817|FG002|Extension Part|Lack of Efficacy|1|||
161821071|NCT03196284|584385815|FG000|Extension Part|Withdrawal by Subject|0|||
161821072|NCT03196284|584385816|FG001|Extension Part|Withdrawal by Subject|0|||
161821073|NCT03196284|584385817|FG002|Extension Part|Withdrawal by Subject|1|||
161821074|NCT03196284|584385815|FG000|Extension Part|Physician Decision|0|||
161821075|NCT03196284|584385816|FG001|Extension Part|Physician Decision|0|||
161821076|NCT03196284|584385817|FG002|Extension Part|Physician Decision|1|||
161821077|NCT03820947|584385818|FG000|Overall Study|Physician Decision|0|||
161821078|NCT03820947|584385819|FG001|Overall Study|Physician Decision|1|||
161821079|NCT03820947|584385820|FG002|Overall Study|Physician Decision|1|||
161821080|NCT03820947|584385821|FG003|Overall Study|Physician Decision|0|||
161821081|NCT03820947|584385822|FG004|Overall Study|Physician Decision|3|||
161821082|NCT03820947|584385818|FG000|Overall Study|Withdrawal by Subject|6|||
161821083|NCT03820947|584385819|FG001|Overall Study|Withdrawal by Subject|10|||
161821084|NCT03820947|584385820|FG002|Overall Study|Withdrawal by Subject|3|||
161821085|NCT03820947|584385821|FG003|Overall Study|Withdrawal by Subject|8|||
161821086|NCT03820947|584385822|FG004|Overall Study|Withdrawal by Subject|5|||
161821087|NCT03820947|584385818|FG000|Overall Study|Procedure Not Attempted|0|||
161821088|NCT03820947|584385819|FG001|Overall Study|Procedure Not Attempted|2|||
161821089|NCT03820947|584385820|FG002|Overall Study|Procedure Not Attempted|1|||
161821090|NCT03820947|584385821|FG003|Overall Study|Procedure Not Attempted|0|||
161821091|NCT03820947|584385822|FG004|Overall Study|Procedure Not Attempted|0|||
161821092|NCT03820947|584385818|FG000|Overall Study|Other Exit|1|||
161821093|NCT03820947|584385819|FG001|Overall Study|Other Exit|3|||
161821094|NCT03820947|584385820|FG002|Overall Study|Other Exit|3|||
161821095|NCT03820947|584385821|FG003|Overall Study|Other Exit|3|||
161821096|NCT03820947|584385822|FG004|Overall Study|Other Exit|0|||
161821097|NCT03820947|584385818|FG000|Overall Study|Follow-up Not Done|10|||
161821098|NCT03820947|584385819|FG001|Overall Study|Follow-up Not Done|13|||
161821099|NCT03820947|584385820|FG002|Overall Study|Follow-up Not Done|2|||
161821100|NCT03820947|584385821|FG003|Overall Study|Follow-up Not Done|3|||
161821101|NCT03820947|584385822|FG004|Overall Study|Follow-up Not Done|12|||
161821102|NCT03820947|584385818|FG000|Overall Study|Death|0|||
161821103|NCT03820947|584385819|FG001|Overall Study|Death|0|||
161821104|NCT03820947|584385820|FG002|Overall Study|Death|0|||
161821105|NCT03820947|584385821|FG003|Overall Study|Death|0|||
161821106|NCT03820947|584385822|FG004|Overall Study|Death|9|||
161821107|NCT03820947|584385818|FG000|Overall Study|Lost to Follow-up|4|||
161821108|NCT03820947|584385819|FG001|Overall Study|Lost to Follow-up|6|||
161821109|NCT03820947|584385820|FG002|Overall Study|Lost to Follow-up|0|||
161821110|NCT03820947|584385821|FG003|Overall Study|Lost to Follow-up|0|||
161821111|NCT03820947|584385822|FG004|Overall Study|Lost to Follow-up|9|||
161821112|NCT04729101|584387570|FG000|Overall Study|Adverse Event|1|||
161821113|NCT04729101|584387571|FG001|Overall Study|Adverse Event|0|||
161821114|NCT04729101|584387570|FG000|Overall Study|Physician Decision|1|||
161821115|NCT04729101|584387571|FG001|Overall Study|Physician Decision|0|||
161821116|NCT04729101|584387570|FG000|Overall Study|Withdrawal by Subject|1|||
161821117|NCT04729101|584387571|FG001|Overall Study|Withdrawal by Subject|0|||
161821118|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
161821119|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161821120|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161821121|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161927240|NCT01740427|584780321|FG001|Overall Study|Participant Refused Continued Treatment|15|||
161927241|NCT01740427|584780320|FG000|Overall Study|Unspecified reasons|52|||
161927242|NCT01740427|584780321|FG001|Overall Study|Unspecified reasons|8|||
161927243|NCT01740427|584780320|FG000|Overall Study|Death|10|||
161927244|NCT01740427|584780321|FG001|Overall Study|Death|3|||
161927245|NCT01740427|584780320|FG000|Overall Study|Protocol Violation|5|||
161927246|NCT01740427|584780321|FG001|Overall Study|Protocol Violation|3|||
161927247|NCT01740427|584780320|FG000|Overall Study|Lost to Follow-up|3|||
161927248|NCT01740427|584780321|FG001|Overall Study|Lost to Follow-up|0|||
161927249|NCT01740427|584780320|FG000|Overall Study|Site Terminated by Sponsor|1|||
161927250|NCT01740427|584780321|FG001|Overall Study|Site Terminated by Sponsor|0|||
161927251|NCT02184156|584780323|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
161927252|NCT02184156|584780324|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
161927253|NCT02184156|584780323|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
161927254|NCT02184156|584780324|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
161927255|NCT02405962|584780326|FG000|Overall Study|Lost to Follow-up|1|||
161927256|NCT02405962|584780327|FG001|Overall Study|Lost to Follow-up|4|||
161927257|NCT02405962|584780326|FG000|Overall Study|A participant has moved to another place|0|||
161927258|NCT02405962|584780327|FG001|Overall Study|A participant has moved to another place|1|||
161927259|NCT01980888|584780328|FG000|Overall Study|Study Terminated by Sponsor|116|||
161927260|NCT01980888|584780329|FG001|Overall Study|Study Terminated by Sponsor|122|||
161927261|NCT01980888|584780328|FG000|Overall Study|Withdrew Consent|17|||
161927262|NCT01980888|584780329|FG001|Overall Study|Withdrew Consent|6|||
161927263|NCT01980888|584780328|FG000|Overall Study|Investigator's Discretion|8|||
161927264|NCT01980888|584780329|FG001|Overall Study|Investigator's Discretion|3|||
161927265|NCT01980888|584780328|FG000|Overall Study|Non-Compliance with Study Drug|3|||
161927266|NCT01980888|584780329|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161927267|NCT01018953|584780330|FG000|Overall Study|Adverse Event|2|||
161927268|NCT01018953|584780330|FG000|Overall Study|Withdrawal by Subject|1|||
161927269|NCT01018953|584780330|FG000|Overall Study|Study termination by sponsor|5|||
161927270|NCT01184118|584780331|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
161927271|NCT01184118|584780331|FG000|Overall Study|No physiologic confirmation of asthma|8|||
161927272|NCT01184118|584780331|FG000|Overall Study|FEV1 <60% predicted|2|||
161927273|NCT01184118|584780331|FG000|Overall Study|Exclusionary medical condition|2|||
161927274|NCT01184118|584780331|FG000|Overall Study|Withdrawal by Subject|5|||
161927275|NCT04073407|584780332|FG000|Part 1|Withdrawal by Subject|1|||
161927276|NCT04073407|584780333|FG001|Part 1|Withdrawal by Subject|0|||
161927277|NCT04073407|584780332|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
161927278|NCT04073407|584780333|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
161927279|NCT04073407|584780332|FG000|Part 2|Withdrawal by Subject|0|||
161927280|NCT04073407|584780333|FG001|Part 2|Withdrawal by Subject|1|||
161927281|NCT03791060|584781912|FG000|Overall Study|Withdrawal by Subject|1|||
161927282|NCT01011283|584781913|FG000|Overall Study|Adverse Event|4|||
161927283|NCT01011283|584781914|FG001|Overall Study|Adverse Event|2|||
161927284|NCT01011283|584781913|FG000|Overall Study|Progressive Disease|0|||
161927285|NCT01011283|584781914|FG001|Overall Study|Progressive Disease|2|||
161927286|NCT01011283|584781913|FG000|Overall Study|Terminated by Sponsor|5|||
161927287|NCT01011283|584781914|FG001|Overall Study|Terminated by Sponsor|5|||
161927288|NCT01011283|584781913|FG000|Overall Study|Other|2|||
161927289|NCT01011283|584781914|FG001|Overall Study|Other|2|||
161927290|NCT01717859|584781915|FG000|Overall Study|Adverse Event|5|||
161927291|NCT01717859|584781915|FG000|Overall Study|Moved out of state|1|||
161927292|NCT01717859|584781915|FG000|Overall Study|Patient concerned about mental health|1|||
161927293|NCT01717859|584781915|FG000|Overall Study|Lost to Follow-up|1|||
161513964|NCT00086580|583271882|FG001|Follow-up Period|Physician Decision|1|||
161513965|NCT00086580|583271881|FG000|Follow-up Period|AE - not related|1|||
161513966|NCT00086580|583271882|FG001|Follow-up Period|AE - not related|0|||
161513967|NCT00086580|583271881|FG000|Follow-up Period|Death|13|||
161513968|NCT00086580|583271882|FG001|Follow-up Period|Death|7|||
161513969|NCT00086580|583271881|FG000|Follow-up Period|Other|7|||
161513970|NCT00086580|583271882|FG001|Follow-up Period|Other|6|||
161927294|NCT01717859|584781915|FG000|Overall Study|Withdrawal by Subject|2|||
161927295|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|No Data|249|||
161927296|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|No Data|66|||
161927297|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|No Data|2|||
161927298|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|Other|33|||
161927299|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|Other|20|||
161927300|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|Other|0|||
161927301|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
161513971|NCT00086580|583271881|FG000|Observation Period|Unable to comply with protocol|1|||
161513972|NCT00086580|583271882|FG001|Observation Period|Unable to comply with protocol|1|||
161927302|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
161927303|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
161927304|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
161927305|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
161927306|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
161927307|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
161927308|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
161927309|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
161927310|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|Other|5|||
161927311|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|Other|1|||
161927312|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|Other|0|||
161927313|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|No Data|43|||
161927314|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|No Data|11|||
161927315|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|No Data|0|||
161927316|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
161927317|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
161927318|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
161927319|NCT01814332|584781919|FG000|Overall Study|Adverse Event|8|||
161927320|NCT01814332|584781920|FG001|Overall Study|Adverse Event|3|||
161927321|NCT01814332|584781919|FG000|Overall Study|Withdrawal by Subject|3|||
161927322|NCT01814332|584781920|FG001|Overall Study|Withdrawal by Subject|8|||
161927323|NCT01814332|584781919|FG000|Overall Study|Protocol Violation|0|||
161927324|NCT01814332|584781920|FG001|Overall Study|Protocol Violation|4|||
161927325|NCT01814332|584781919|FG000|Overall Study|Lost to Follow-up|5|||
161927326|NCT01814332|584781920|FG001|Overall Study|Lost to Follow-up|1|||
161927327|NCT04389671|584781921|FG000|Overall Study|Death|7|||
161927328|NCT05987540|584781922|FG000|Overall Study|Withdrawal by Subject|2|||
161927329|NCT05987540|584781922|FG000|Overall Study|Death|1|||
161927330|NCT05987540|584781922|FG000|Overall Study|Study Termination|1|||
161927331|NCT05987540|584781922|FG000|Overall Study|Adverse Event|2|||
161927332|NCT04053452|584781923|FG000|Overall Study|Withdrawal by Subject|1|||
161927333|NCT04053452|584781924|FG001|Overall Study|Withdrawal by Subject|0|||
161927334|NCT04053452|584781923|FG000|Overall Study|Time restraint due to inpatient needs|1|||
161927335|NCT04053452|584781924|FG001|Overall Study|Time restraint due to inpatient needs|2|||
161927336|NCT01421134|584781925|FG000|Overall Study|Adverse Event|3|||
161927337|NCT01421134|584781926|FG001|Overall Study|Adverse Event|5|||
161927338|NCT01421134|584781925|FG000|Overall Study|Lack of Efficacy|2|||
161927339|NCT01421134|584781926|FG001|Overall Study|Lack of Efficacy|4|||
161927340|NCT01421134|584781925|FG000|Overall Study|Protocol Violation|0|||
161927341|NCT01421134|584781926|FG001|Overall Study|Protocol Violation|3|||
161927342|NCT01421134|584781925|FG000|Overall Study|Withdrawal by Subject|1|||
161927343|NCT01421134|584781926|FG001|Overall Study|Withdrawal by Subject|1|||
161927344|NCT01421134|584781925|FG000|Overall Study|Administrative|0|||
161821122|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821123|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821124|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821125|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821126|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161821127|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821128|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821129|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821130|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821131|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821132|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821133|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161927345|NCT01421134|584781926|FG001|Overall Study|Administrative|1|||
161927346|NCT01421134|584781925|FG000|Overall Study|Lost to Follow-up|1|||
161927347|NCT01421134|584781926|FG001|Overall Study|Lost to Follow-up|1|||
161927348|NCT02959892|584781927|FG000|Overall Study|PET tracer synthesis failure|1|||
161513973|NCT00086580|583271881|FG000|Observation Period|Withdrawal by Subject|4|||
161513974|NCT00086580|583271882|FG001|Observation Period|Withdrawal by Subject|2|||
161513975|NCT00086580|583271881|FG000|Observation Period|Death|33|||
161513976|NCT00086580|583271882|FG001|Observation Period|Death|55|||
161513977|NCT00086580|583271881|FG000|Observation Period|Other|8|||
161513978|NCT00086580|583271882|FG001|Observation Period|Other|7|||
161927349|NCT02959892|584781928|FG001|Overall Study|PET tracer synthesis failure|0|||
161927350|NCT02959892|584781927|FG000|Overall Study|Study termination|0|||
161927351|NCT02959892|584781928|FG001|Overall Study|Study termination|1|||
161513979|NCT03235024|583271884|FG000|Overall Study|Adverse Event|2|||
161513980|NCT03235024|583271885|FG001|Overall Study|Adverse Event|2|||
161513981|NCT03235024|583271884|FG000|Overall Study|Death|1|||
161513982|NCT03235024|583271885|FG001|Overall Study|Death|0|||
161513983|NCT03235024|583271884|FG000|Overall Study|Lost to Follow-up|2|||
161821134|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161821135|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161927352|NCT00122187|584781929|FG000|Overall Study|Withdrew because of resource limitations|2|||
161927353|NCT00122187|584781930|FG001|Overall Study|Withdrew because of resource limitations|2|||
161927354|NCT02061592|584781934|FG000|Period 1|Withdrawal by Subject|1|||
161927355|NCT02061592|584781935|FG001|Period 1|Withdrawal by Subject|0|||
161927356|NCT02061592|584781934|FG000|Period 1|Protocol Violation|1|||
161927357|NCT02061592|584781935|FG001|Period 1|Protocol Violation|0|||
161927358|NCT02061592|584781934|FG000|Period 2|Lost to Follow-up|0|||
161927359|NCT02061592|584781935|FG001|Period 2|Lost to Follow-up|1|||
161927360|NCT04433975|584781936|FG000|1-month Follow Up|Withdrawal by Subject|1|||
161927361|NCT04433975|584781937|FG001|1-month Follow Up|Withdrawal by Subject|1|||
161927362|NCT04433975|584781936|FG000|1-month Follow Up|Lost to Follow-up|21|||
161676294|NCT02060383|583868739|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
161927363|NCT04433975|584781937|FG001|1-month Follow Up|Lost to Follow-up|25|||
161927364|NCT04433975|584781936|FG000|3-month Follow Up|Lost to Follow-up|20|||
161927365|NCT04433975|584781937|FG001|3-month Follow Up|Lost to Follow-up|24|||
161927366|NCT04433975|584781936|FG000|3-month Follow Up|Death|1|||
161927367|NCT04433975|584781937|FG001|3-month Follow Up|Death|0|||
161927368|NCT04433975|584781936|FG000|3-month Follow Up|Withdrawal by Subject|2|||
161927369|NCT04433975|584781937|FG001|3-month Follow Up|Withdrawal by Subject|0|||
161927370|NCT04433975|584781936|FG000|6-month Follow Up|Lost to Follow-up|23|||
161927371|NCT04433975|584781937|FG001|6-month Follow Up|Lost to Follow-up|28|||
161927372|NCT04433975|584781936|FG000|6-month Follow Up|Withdrawal by Subject|1|||
161513984|NCT03235024|583271885|FG001|Overall Study|Lost to Follow-up|5|||
161513985|NCT03235024|583271884|FG000|Overall Study|Protocol Violation|1|||
161513986|NCT03235024|583271885|FG001|Overall Study|Protocol Violation|0|||
161513987|NCT03235024|583271884|FG000|Overall Study|Withdrawal by Subject|0|||
161513988|NCT03235024|583271885|FG001|Overall Study|Withdrawal by Subject|3|||
161513989|NCT02357576|583271886|FG000|Treatment Period|Withdrawal by Subject|0|||
161513990|NCT02357576|583271887|FG001|Treatment Period|Withdrawal by Subject|1|||
161513991|NCT02357576|583271886|FG000|Treatment Period|Physician Decision|0|||
161513992|NCT02357576|583271887|FG001|Treatment Period|Physician Decision|1|||
161513993|NCT02357576|583271886|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
161513994|NCT02357576|583271887|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
161513995|NCT02357576|583271886|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
161513996|NCT02357576|583271887|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
161513997|NCT02357576|583271886|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
161513998|NCT02357576|583271887|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
161513999|NCT02357576|583271886|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
161514000|NCT02357576|583271887|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
161514001|NCT00261716|583271888|FG000|Overall Study|Withdrawal by Subject|6|||
161514002|NCT00261716|583271889|FG001|Overall Study|Withdrawal by Subject|8|||
161588013|NCT04927065|583542320|FG000|First Booster|Protocol Violation|4|||
161588014|NCT04927065|583542321|FG001|First Booster|Protocol Violation|4|||
161588015|NCT04927065|583542322|FG002|First Booster|Protocol Violation|0|||
161588016|NCT04927065|583542323|FG003|First Booster|Protocol Violation|3|||
161588017|NCT04927065|583542324|FG004|First Booster|Protocol Violation|0|||
161588018|NCT04927065|583542325|FG005|First Booster|Protocol Violation|0|||
161588019|NCT04927065|583542326|FG006|First Booster|Protocol Violation|0|||
161588020|NCT04927065|583542327|FG007|First Booster|Protocol Violation|2|||
161588021|NCT04927065|583542328|FG008|First Booster|Protocol Violation|0|||
161588022|NCT04927065|583542329|FG009|First Booster|Protocol Violation|0|||
161588023|NCT04927065|583542330|FG010|First Booster|Protocol Violation|0|||
161588024|NCT04927065|583542331|FG011|First Booster|Protocol Violation|0|||
161588025|NCT04927065|583542332|FG012|First Booster|Protocol Violation|0|||
161588026|NCT04927065|583542333|FG013|First Booster|Protocol Violation|0|||
161588027|NCT04927065|583542334|FG014|First Booster|Protocol Violation|0|||
161588028|NCT04927065|583542335|FG015|First Booster|Protocol Violation|0|||
161588029|NCT04927065|583542320|FG000|First Booster|Withdrawal by Subject|8|||
161588030|NCT04927065|583542321|FG001|First Booster|Withdrawal by Subject|23|||
161588031|NCT04927065|583542322|FG002|First Booster|Withdrawal by Subject|0|||
161588032|NCT04927065|583542323|FG003|First Booster|Withdrawal by Subject|19|||
161588033|NCT04927065|583542324|FG004|First Booster|Withdrawal by Subject|20|||
161588034|NCT04927065|583542325|FG005|First Booster|Withdrawal by Subject|15|||
161588035|NCT04927065|583542326|FG006|First Booster|Withdrawal by Subject|6|||
161588036|NCT04927065|583542327|FG007|First Booster|Withdrawal by Subject|24|||
161588037|NCT04927065|583542328|FG008|First Booster|Withdrawal by Subject|0|||
161588038|NCT04927065|583542329|FG009|First Booster|Withdrawal by Subject|4|||
161588039|NCT04927065|583542330|FG010|First Booster|Withdrawal by Subject|0|||
161588040|NCT04927065|583542331|FG011|First Booster|Withdrawal by Subject|0|||
161588041|NCT04927065|583542332|FG012|First Booster|Withdrawal by Subject|0|||
161588042|NCT04927065|583542333|FG013|First Booster|Withdrawal by Subject|0|||
161588043|NCT04927065|583542334|FG014|First Booster|Withdrawal by Subject|0|||
161588044|NCT04927065|583542335|FG015|First Booster|Withdrawal by Subject|0|||
161588045|NCT04927065|583542320|FG000|First Booster|Other Than Specified|1|||
161588046|NCT04927065|583542321|FG001|First Booster|Other Than Specified|1|||
161588047|NCT04927065|583542322|FG002|First Booster|Other Than Specified|0|||
161588048|NCT04927065|583542323|FG003|First Booster|Other Than Specified|1|||
161588049|NCT04927065|583542324|FG004|First Booster|Other Than Specified|2|||
161927373|NCT04433975|584781937|FG001|6-month Follow Up|Withdrawal by Subject|1|||
161514003|NCT00261716|583271888|FG000|Overall Study|Lost to Follow-up|0|||
161927374|NCT04433975|584781936|FG000|9-month Follow Up|Lost to Follow-up|27|||
161927375|NCT04433975|584781937|FG001|9-month Follow Up|Lost to Follow-up|36|||
161927376|NCT04433975|584781936|FG000|9-month Follow Up|Death|0|||
161927377|NCT04433975|584781937|FG001|9-month Follow Up|Death|1|||
161927378|NCT04433975|584781936|FG000|12-month Follow Up|Lost to Follow-up|27|||
161927379|NCT04433975|584781937|FG001|12-month Follow Up|Lost to Follow-up|31|||
161927380|NCT04392635|584781938|FG000|Overall Study|Lost to Follow-up|0|||
161927381|NCT04392635|584781939|FG001|Overall Study|Lost to Follow-up|1|||
161927382|NCT00724893|584781948|FG000|Overall Study|Adverse Event|76|||
161927383|NCT00724893|584781949|FG001|Overall Study|Adverse Event|142|||
161927384|NCT00724893|584781948|FG000|Overall Study|Withdrawal by Subject|0|||
161927385|NCT00724893|584781949|FG001|Overall Study|Withdrawal by Subject|1|||
161927386|NCT00724893|584781948|FG000|Overall Study|Lack of virologic response|94|||
161927387|NCT00724893|584781949|FG001|Overall Study|Lack of virologic response|202|||
161927388|NCT00724893|584781948|FG000|Overall Study|Reason not specified|193|||
161927389|NCT00724893|584781949|FG001|Overall Study|Reason not specified|7|||
161927390|NCT00724893|584781948|FG000|Overall Study|Patient choice|0|||
161927391|NCT00724893|584781949|FG001|Overall Study|Patient choice|26|||
161927392|NCT00724893|584781948|FG000|Overall Study|Geographic reasons|0|||
161927393|NCT00724893|584781949|FG001|Overall Study|Geographic reasons|11|||
161927394|NCT00724893|584781948|FG000|Overall Study|Incarceration|0|||
161927395|NCT00724893|584781949|FG001|Overall Study|Incarceration|9|||
161927396|NCT00724893|584781948|FG000|Overall Study|Substance abuse|0|||
161927397|NCT00724893|584781949|FG001|Overall Study|Substance abuse|3|||
161927398|NCT00724893|584781948|FG000|Overall Study|Financial reasons|0|||
161927399|NCT00724893|584781949|FG001|Overall Study|Financial reasons|2|||
161927400|NCT00724893|584781948|FG000|Overall Study|Assigned shorter treatment|0|||
161927401|NCT00724893|584781949|FG001|Overall Study|Assigned shorter treatment|2|||
161927402|NCT00724893|584781948|FG000|Overall Study|Lost to Follow-up|0|||
161927403|NCT00724893|584781949|FG001|Overall Study|Lost to Follow-up|52|||
161927404|NCT00724893|584781948|FG000|Overall Study|Unknown, missing data|1|||
161927405|NCT00724893|584781949|FG001|Overall Study|Unknown, missing data|1|||
161927406|NCT01290731|584781950|FG000|Overall Study|Withdrawal by Subject|1|||
161927407|NCT02181738|584781958|FG000|Overall Study|Participant Withdrew Consent|2|||
161676295|NCT02060383|583868740|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
161676296|NCT02060383|583868741|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
161676297|NCT02060383|583868742|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
161676298|NCT02060383|583868738|FG000|Core Phase|Adverse Event|2|||
161927408|NCT02181738|584781959|FG001|Overall Study|Participant Withdrew Consent|1|||
161927409|NCT02181738|584781960|FG002|Overall Study|Participant Withdrew Consent|1|||
161927410|NCT02181738|584781961|FG003|Overall Study|Participant Withdrew Consent|1|||
161927411|NCT02181738|584781958|FG000|Overall Study|Lost to Follow-up|1|||
161927412|NCT02181738|584781959|FG001|Overall Study|Lost to Follow-up|2|||
161927413|NCT02181738|584781960|FG002|Overall Study|Lost to Follow-up|1|||
161927414|NCT02181738|584781961|FG003|Overall Study|Lost to Follow-up|1|||
161927415|NCT02181738|584781958|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
161927416|NCT02181738|584781959|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
161927417|NCT02181738|584781960|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
161927418|NCT02181738|584781961|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
161927419|NCT02181738|584781958|FG000|Overall Study|Poor/Non-Compliance|1|||
161927420|NCT02181738|584781959|FG001|Overall Study|Poor/Non-Compliance|0|||
161927421|NCT02181738|584781960|FG002|Overall Study|Poor/Non-Compliance|2|||
161927422|NCT02181738|584781961|FG003|Overall Study|Poor/Non-Compliance|1|||
161927423|NCT02181738|584781958|FG000|Overall Study|Disease Progression|28|||
161927424|NCT02181738|584781959|FG001|Overall Study|Disease Progression|35|||
161927425|NCT02181738|584781960|FG002|Overall Study|Disease Progression|40|||
161927426|NCT02181738|584781961|FG003|Overall Study|Disease Progression|0|||
161927427|NCT02181738|584781958|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
161927428|NCT02181738|584781959|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
161927429|NCT02181738|584781960|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
161927430|NCT02181738|584781961|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
161927431|NCT02181738|584781958|FG000|Overall Study|Study Drug Toxicity|6|||
161927432|NCT02181738|584781959|FG001|Overall Study|Study Drug Toxicity|11|||
161927433|NCT02181738|584781960|FG002|Overall Study|Study Drug Toxicity|8|||
161927434|NCT02181738|584781961|FG003|Overall Study|Study Drug Toxicity|1|||
161927435|NCT02181738|584781958|FG000|Overall Study|Other Reasons|14|||
161927436|NCT02181738|584781959|FG001|Overall Study|Other Reasons|16|||
161927437|NCT02181738|584781960|FG002|Overall Study|Other Reasons|28|||
161927438|NCT02181738|584781961|FG003|Overall Study|Other Reasons|0|||
161927439|NCT02181738|584781958|FG000|Overall Study|Maximum Clinical Benefit|3|||
161927440|NCT02181738|584781959|FG001|Overall Study|Maximum Clinical Benefit|0|||
161927441|NCT02181738|584781960|FG002|Overall Study|Maximum Clinical Benefit|1|||
161927442|NCT02181738|584781961|FG003|Overall Study|Maximum Clinical Benefit|0|||
161927443|NCT02181738|584781958|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161927444|NCT02181738|584781959|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161927445|NCT02181738|584781960|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161927446|NCT02181738|584781961|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161927447|NCT00888849|584781964|FG000|Overall Study|Death|4|||
161927448|NCT00888849|584781965|FG001|Overall Study|Death|7|||
161927449|NCT00888849|584781964|FG000|Overall Study|Lost to Follow-up|1|||
161927450|NCT00888849|584781965|FG001|Overall Study|Lost to Follow-up|2|||
161927451|NCT05064800|584781966|FG000|Period 3|Withdrawal by Subject|0|||
161927452|NCT05064800|584781967|FG001|Period 3|Withdrawal by Subject|0|||
161927453|NCT05064800|584781968|FG002|Period 3|Withdrawal by Subject|0|||
161927454|NCT05064800|584781969|FG003|Period 3|Withdrawal by Subject|0|||
161927455|NCT05064800|584781970|FG004|Period 3|Withdrawal by Subject|1|||
161927456|NCT05064800|584781971|FG005|Period 3|Withdrawal by Subject|0|||
161927457|NCT00629239|584781972|FG000|Overall Study|Adverse Event|7|||
161927458|NCT00629239|584781973|FG001|Overall Study|Adverse Event|4|||
161927459|NCT00629239|584781972|FG000|Overall Study|Physician Decision|1|||
161927460|NCT00629239|584781973|FG001|Overall Study|Physician Decision|0|||
161927461|NCT01851369|584781976|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927462|NCT01851369|584781977|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161514004|NCT00261716|583271889|FG001|Overall Study|Lost to Follow-up|2|||
161514005|NCT00699699|583271892|FG000|Overall Study|Adverse Event|36|||
161514006|NCT00699699|583271892|FG000|Overall Study|Individual different reasons|21|||
161514007|NCT02047110|583271893|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
161514008|NCT02047110|583271894|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
161514009|NCT02047110|583271895|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
161514010|NCT02047110|583271896|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
161514011|NCT02047110|583271893|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
161514012|NCT02047110|583271894|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
161514013|NCT02047110|583271895|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
161514014|NCT02047110|583271896|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
161514015|NCT02047110|583271893|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
161514016|NCT02047110|583271894|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
161514017|NCT02047110|583271895|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
161514018|NCT02047110|583271896|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
161514019|NCT02047110|583271893|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
161514020|NCT02047110|583271894|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
161514021|NCT02047110|583271895|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
161514022|NCT02047110|583271896|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
161514023|NCT02047110|583271893|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
161514024|NCT02047110|583271894|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
161514025|NCT02047110|583271895|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
161514026|NCT02047110|583271896|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
161514027|NCT02047110|583271893|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
161514028|NCT02047110|583271894|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
161514029|NCT02047110|583271895|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
161514030|NCT02047110|583271896|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
161514031|NCT02047110|583271893|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
161514032|NCT02047110|583271894|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
161514033|NCT02047110|583271895|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
161514034|NCT02047110|583271896|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
161514035|NCT02047110|583271893|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
161514036|NCT02047110|583271894|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
161514037|NCT02047110|583271895|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
161514038|NCT02047110|583271896|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
161927463|NCT01851369|584781978|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927464|NCT01851369|584781979|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927465|NCT01851369|584781980|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927466|NCT01851369|584781981|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
161927467|NCT01851369|584781982|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927468|NCT01851369|584781983|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927469|NCT01851369|584781984|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927470|NCT01851369|584781985|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927471|NCT01851369|584781986|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927472|NCT01851369|584781987|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927473|NCT01851369|584781988|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927474|NCT00183391|584781989|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
161927475|NCT00183391|584781990|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
161927476|NCT00183391|584781989|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
161927477|NCT00183391|584781990|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
161927478|NCT00395512|584781991|FG000|Overall Study|Adverse Event|3|||
161676299|NCT02060383|583868739|FG001|Core Phase|Adverse Event|0|||
161676300|NCT02060383|583868740|FG002|Core Phase|Adverse Event|0|||
161676301|NCT02060383|583868741|FG003|Core Phase|Adverse Event|2|||
161676302|NCT02060383|583868742|FG004|Core Phase|Adverse Event|6|||
161676303|NCT02060383|583868738|FG000|Core Phase|Administrative problems|0|||
161676304|NCT02060383|583868739|FG001|Core Phase|Administrative problems|1|||
161676305|NCT02060383|583868740|FG002|Core Phase|Administrative problems|0|||
161676306|NCT02060383|583868741|FG003|Core Phase|Administrative problems|0|||
161676307|NCT02060383|583868742|FG004|Core Phase|Administrative problems|0|||
161676308|NCT02060383|583868738|FG000|Core Phase|Protocol Violation|0|||
161676309|NCT02060383|583868739|FG001|Core Phase|Protocol Violation|0|||
161676310|NCT02060383|583868740|FG002|Core Phase|Protocol Violation|0|||
161676311|NCT02060383|583868741|FG003|Core Phase|Protocol Violation|1|||
161676312|NCT02060383|583868742|FG004|Core Phase|Protocol Violation|0|||
161676313|NCT02060383|583868738|FG000|Core Phase|Withdrawal by Subject|0|||
161676314|NCT02060383|583868739|FG001|Core Phase|Withdrawal by Subject|0|||
161821136|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161821137|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821138|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821139|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821140|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821141|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821142|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
161821143|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821144|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821145|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821146|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821147|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821148|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821149|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821150|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821151|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821152|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
161821153|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821154|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821155|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821156|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821157|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821158|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Not reported|0|||
161821159|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Not reported|0|||
161821160|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Not reported|0|||
161821161|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Not reported|0|||
161821162|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Not reported|0|||
161821163|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Not reported|1|||
161821164|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Not reported|0|||
161821165|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Not reported|0|||
161821166|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821167|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821168|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821169|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821170|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821171|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821172|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821173|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
161821174|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
161821175|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
161821176|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
161821177|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
161821178|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
161821179|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
161821180|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
161821181|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
161821182|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161821183|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161821184|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161821185|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161676315|NCT02060383|583868740|FG002|Core Phase|Withdrawal by Subject|0|||
161676316|NCT02060383|583868741|FG003|Core Phase|Withdrawal by Subject|4|||
161927479|NCT00395512|584781992|FG001|Overall Study|Adverse Event|8|||
161927480|NCT00395512|584781993|FG002|Overall Study|Adverse Event|6|||
161927481|NCT00395512|584781994|FG003|Overall Study|Adverse Event|6|||
161927482|NCT00395512|584781991|FG000|Overall Study|Protocol Violation|2|||
161927483|NCT00395512|584781992|FG001|Overall Study|Protocol Violation|3|||
161927484|NCT00395512|584781993|FG002|Overall Study|Protocol Violation|6|||
161927485|NCT00395512|584781994|FG003|Overall Study|Protocol Violation|7|||
161927486|NCT00395512|584781991|FG000|Overall Study|Lost to Follow-up|2|||
161927487|NCT00395512|584781992|FG001|Overall Study|Lost to Follow-up|6|||
161927488|NCT00395512|584781993|FG002|Overall Study|Lost to Follow-up|5|||
161927489|NCT00395512|584781994|FG003|Overall Study|Lost to Follow-up|5|||
161927490|NCT00395512|584781991|FG000|Overall Study|Withdrawal by Subject|6|||
161927491|NCT00395512|584781992|FG001|Overall Study|Withdrawal by Subject|5|||
161927492|NCT00395512|584781993|FG002|Overall Study|Withdrawal by Subject|5|||
161927493|NCT00395512|584781994|FG003|Overall Study|Withdrawal by Subject|12|||
161927494|NCT00395512|584781991|FG000|Overall Study|Physician Decision|6|||
161927495|NCT00395512|584781992|FG001|Overall Study|Physician Decision|4|||
161927496|NCT00395512|584781993|FG002|Overall Study|Physician Decision|2|||
161927497|NCT00395512|584781994|FG003|Overall Study|Physician Decision|2|||
161927498|NCT00395512|584781991|FG000|Overall Study|Other|1|||
161927499|NCT00395512|584781992|FG001|Overall Study|Other|1|||
161927500|NCT00395512|584781993|FG002|Overall Study|Other|0|||
161927501|NCT00395512|584781994|FG003|Overall Study|Other|0|||
161927502|NCT00395512|584781991|FG000|Overall Study|Hyperglycemic Rescue|18|||
161927503|NCT00395512|584781992|FG001|Overall Study|Hyperglycemic Rescue|10|||
161927504|NCT00395512|584781993|FG002|Overall Study|Hyperglycemic Rescue|4|||
161927505|NCT00395512|584781994|FG003|Overall Study|Hyperglycemic Rescue|6|||
161927506|NCT04584554|584781995|FG000|Overall Study|Withdrawal by Subject|2|||
161927507|NCT04584554|584781996|FG001|Overall Study|Withdrawal by Subject|2|||
161927508|NCT02021318|584782002|FG000|Overall Study|Adverse Event|2|||
161927509|NCT02021318|584782003|FG001|Overall Study|Adverse Event|1|||
161927510|NCT02021318|584782002|FG000|Overall Study|Death|33|||
161927511|NCT02021318|584782003|FG001|Overall Study|Death|34|||
161927512|NCT02021318|584782002|FG000|Overall Study|Lost to Follow-up|3|||
161927513|NCT02021318|584782003|FG001|Overall Study|Lost to Follow-up|3|||
161927514|NCT02021318|584782002|FG000|Overall Study|Progressive Disease|0|||
161927515|NCT02021318|584782003|FG001|Overall Study|Progressive Disease|1|||
161927516|NCT02021318|584782002|FG000|Overall Study|Withdrawal by Subject|30|||
161927517|NCT02021318|584782003|FG001|Overall Study|Withdrawal by Subject|18|||
161927518|NCT02021318|584782002|FG000|Overall Study|Physician Decision|3|||
161927519|NCT02021318|584782003|FG001|Overall Study|Physician Decision|3|||
161927520|NCT02021318|584782002|FG000|Overall Study|Miscellaneous|2|||
161927521|NCT02021318|584782003|FG001|Overall Study|Miscellaneous|3|||
161927522|NCT00165698|584782006|FG000|Overall Study|Adverse Event|2|||
161927523|NCT00165698|584782007|FG001|Overall Study|Adverse Event|10|||
161927524|NCT00165698|584782006|FG000|Overall Study|Lost to Follow-up|2|||
161927525|NCT00165698|584782007|FG001|Overall Study|Lost to Follow-up|2|||
161927526|NCT00165698|584782006|FG000|Overall Study|Withdrawal by Subject|2|||
161927527|NCT00165698|584782007|FG001|Overall Study|Withdrawal by Subject|1|||
161927528|NCT00165698|584782006|FG000|Overall Study|Protocol Violation|1|||
161927529|NCT00165698|584782007|FG001|Overall Study|Protocol Violation|0|||
161927530|NCT00165698|584782006|FG000|Overall Study|Not Taken/Lost the medicine|1|||
161927531|NCT00165698|584782007|FG001|Overall Study|Not Taken/Lost the medicine|2|||
161927532|NCT01483651|584782008|FG000|Overall Study|Withdrawal by Subject|0|||
161927533|NCT01483651|584782009|FG001|Overall Study|Withdrawal by Subject|1|||
161927534|NCT01483651|584782010|FG002|Overall Study|Withdrawal by Subject|1|||
161514039|NCT02047110|583271893|FG000|Escape Treatment Period|Adverse Event|1|||
161514040|NCT02047110|583271894|FG001|Escape Treatment Period|Adverse Event|2|||
161514041|NCT02047110|583271895|FG002|Escape Treatment Period|Adverse Event|2|||
161514042|NCT02047110|583271896|FG003|Escape Treatment Period|Adverse Event|0|||
161514043|NCT02047110|583271893|FG000|Escape Treatment Period|Other than specified|1|||
161514044|NCT02047110|583271894|FG001|Escape Treatment Period|Other than specified|2|||
161927535|NCT01483651|584782011|FG003|Overall Study|Withdrawal by Subject|0|||
161927536|NCT01483651|584782012|FG004|Overall Study|Withdrawal by Subject|0|||
161927537|NCT01483651|584782013|FG005|Overall Study|Withdrawal by Subject|1|||
161927538|NCT02547935|584782020|FG000|Overall Study|Other|0|||
161927539|NCT02547935|584782021|FG001|Overall Study|Other|1|||
161927540|NCT02547935|584782022|FG002|Overall Study|Other|0|||
161676317|NCT02060383|583868742|FG004|Core Phase|Withdrawal by Subject|2|||
161927541|NCT02547935|584782020|FG000|Overall Study|Withdrawal by Subject|2|||
161927542|NCT02547935|584782021|FG001|Overall Study|Withdrawal by Subject|3|||
161927543|NCT02547935|584782022|FG002|Overall Study|Withdrawal by Subject|4|||
161927544|NCT02547935|584782020|FG000|Overall Study|Screen Failure|2|||
161927545|NCT02547935|584782021|FG001|Overall Study|Screen Failure|0|||
161927546|NCT02547935|584782022|FG002|Overall Study|Screen Failure|0|||
161927547|NCT02547935|584782020|FG000|Overall Study|Physician Decision|0|||
161927548|NCT02547935|584782021|FG001|Overall Study|Physician Decision|1|||
161927549|NCT02547935|584782022|FG002|Overall Study|Physician Decision|0|||
161927550|NCT02547935|584782020|FG000|Overall Study|Lost to Follow-up|0|||
161927551|NCT02547935|584782021|FG001|Overall Study|Lost to Follow-up|2|||
161927552|NCT02547935|584782022|FG002|Overall Study|Lost to Follow-up|1|||
161927553|NCT02547935|584782020|FG000|Overall Study|Death|1|||
161927554|NCT02547935|584782021|FG001|Overall Study|Death|1|||
161927555|NCT02547935|584782022|FG002|Overall Study|Death|0|||
161927556|NCT03020888|584782027|FG000|Overall Study|Physician Decision|4|||
161927557|NCT03020888|584782027|FG000|Overall Study|Withdrawal by Subject|6|||
161927558|NCT03020888|584782027|FG000|Overall Study|Insurance coverage|2|||
161927559|NCT03020888|584782027|FG000|Overall Study|Lost to Follow-up|1|||
161927560|NCT01928771|584782031|FG000|Overall Study|Adverse Event|6|||
161927561|NCT01928771|584782032|FG001|Overall Study|Adverse Event|5|||
161927562|NCT01928771|584782033|FG002|Overall Study|Adverse Event|1|||
161927563|NCT01928771|584782031|FG000|Overall Study|Death|2|||
161927564|NCT01928771|584782032|FG001|Overall Study|Death|2|||
161927565|NCT01928771|584782033|FG002|Overall Study|Death|2|||
161927566|NCT01928771|584782031|FG000|Overall Study|Lost to Follow-up|5|||
161927567|NCT01928771|584782032|FG001|Overall Study|Lost to Follow-up|6|||
161927568|NCT01928771|584782033|FG002|Overall Study|Lost to Follow-up|3|||
161927569|NCT01928771|584782031|FG000|Overall Study|Withdrawal by Subject|20|||
161927570|NCT01928771|584782032|FG001|Overall Study|Withdrawal by Subject|15|||
161927571|NCT01928771|584782033|FG002|Overall Study|Withdrawal by Subject|17|||
161927572|NCT01928771|584782031|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
161927573|NCT01928771|584782032|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161927574|NCT01928771|584782033|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
161927575|NCT01928771|584782031|FG000|Overall Study|Other Reasons|9|||
161927576|NCT01928771|584782032|FG001|Overall Study|Other Reasons|9|||
161927577|NCT01928771|584782033|FG002|Overall Study|Other Reasons|14|||
161927578|NCT01928771|584782031|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161927579|NCT01928771|584782032|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161927580|NCT01928771|584782033|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
161927581|NCT01937117|584782034|FG000|Overall Study|Disease Progression|7|||
161927582|NCT01937117|584782034|FG000|Overall Study|Physician Decision|4|||
161927583|NCT01937117|584782034|FG000|Overall Study|Adverse Event|2|||
161927584|NCT01407367|584782039|FG000|Overall Study|Death|24|||
161927585|NCT01407367|584782040|FG001|Overall Study|Death|32|||
161927586|NCT01407367|584782039|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
161927587|NCT01407367|584782040|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
161927588|NCT01407367|584782039|FG000|Overall Study|Withdrawal by Subject|4|||
161927589|NCT01407367|584782040|FG001|Overall Study|Withdrawal by Subject|15|||
161927590|NCT01407367|584782039|FG000|Overall Study|Lost to Follow-up|0|||
161927591|NCT01407367|584782040|FG001|Overall Study|Lost to Follow-up|2|||
161927592|NCT01695772|584782044|FG000|Overall Study|Withdrawal by Subject|18|||
161927593|NCT01695772|584782044|FG000|Overall Study|Progressive Disease|8|||
161927594|NCT01695772|584782044|FG000|Overall Study|Investigator Decision|5|||
161927595|NCT01695772|584782044|FG000|Overall Study|Lost to Follow-up|4|||
161927596|NCT01695772|584782044|FG000|Overall Study|Protocol Violation|2|||
161927597|NCT01695772|584782044|FG000|Overall Study|Unspecified Reason|1|||
161927598|NCT00004859|584782045|FG000|Overall Study|Lack of Efficacy|43|||
161927599|NCT00004859|584782046|FG001|Overall Study|Lack of Efficacy|113|||
161927600|NCT00004859|584782045|FG000|Overall Study|Adverse Event|31|||
161927601|NCT00004859|584782046|FG001|Overall Study|Adverse Event|93|||
161927602|NCT00004859|584782045|FG000|Overall Study|Death|5|||
161927603|NCT00004859|584782046|FG001|Overall Study|Death|5|||
161927604|NCT00004859|584782045|FG000|Overall Study|Withdrawal by Subject|7|||
161927605|NCT00004859|584782046|FG001|Overall Study|Withdrawal by Subject|33|||
161588050|NCT04927065|583542325|FG005|First Booster|Other Than Specified|3|||
161588051|NCT04927065|583542326|FG006|First Booster|Other Than Specified|2|||
161588052|NCT04927065|583542327|FG007|First Booster|Other Than Specified|6|||
161588053|NCT04927065|583542328|FG008|First Booster|Other Than Specified|0|||
161588054|NCT04927065|583542329|FG009|First Booster|Other Than Specified|4|||
161588055|NCT04927065|583542330|FG010|First Booster|Other Than Specified|0|||
161588056|NCT04927065|583542331|FG011|First Booster|Other Than Specified|0|||
161927606|NCT00004859|584782045|FG000|Overall Study|Protocol Violation|2|||
161927607|NCT00004859|584782046|FG001|Overall Study|Protocol Violation|2|||
161927608|NCT00004859|584782045|FG000|Overall Study|other disease|0|||
161927609|NCT00004859|584782046|FG001|Overall Study|other disease|3|||
161927610|NCT00004859|584782045|FG000|Overall Study|error|3|||
161588057|NCT04927065|583542332|FG012|First Booster|Other Than Specified|0|||
161676318|NCT02060383|583868738|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
161676319|NCT02060383|583868739|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
161927611|NCT00004859|584782046|FG001|Overall Study|error|1|||
161927612|NCT00004859|584782045|FG000|Overall Study|missing data|14|||
161927613|NCT00004859|584782046|FG001|Overall Study|missing data|11|||
161927614|NCT00004859|584782045|FG000|Overall Study|Other|13|||
161927615|NCT00004859|584782046|FG001|Overall Study|Other|21|||
161927616|NCT03882801|584783658|FG000|Period 1|Adverse Event|0|||
161927617|NCT03882801|584783659|FG001|Period 1|Adverse Event|1|||
161927618|NCT03882801|584783658|FG000|Period 1|Non-compliance with study drug|1|||
161927619|NCT03882801|584783659|FG001|Period 1|Non-compliance with study drug|1|||
161927620|NCT03882801|584783658|FG000|Period 1|Never treated with study drug|1|||
161927621|NCT03882801|584783659|FG001|Period 1|Never treated with study drug|0|||
161927622|NCT03882801|584783658|FG000|Washout Period|Physician Decision|0|||
161927623|NCT03882801|584783659|FG001|Washout Period|Physician Decision|1|||
161927624|NCT03882801|584783658|FG000|Period 2|Non-compliance with study drug|0|||
161927625|NCT03882801|584783659|FG001|Period 2|Non-compliance with study drug|1|||
161927626|NCT01793129|584783660|FG000|Overall Study|Lost to Follow-up|3|||
161927627|NCT01793129|584783661|FG001|Overall Study|Lost to Follow-up|7|||
161927628|NCT01793129|584783660|FG000|Overall Study|Withdrawal by Subject|0|||
161927629|NCT01793129|584783661|FG001|Overall Study|Withdrawal by Subject|2|||
161927630|NCT01567085|584783664|FG000|Overall Study|Death|6|||
161927631|NCT01567085|584783664|FG000|Overall Study|Adverse Event|6|||
161927632|NCT01567085|584783664|FG000|Overall Study|Lost to Follow-up|3|||
161927633|NCT01567085|584783664|FG000|Overall Study|Graft loss|2|||
161927634|NCT01567085|584783664|FG000|Overall Study|Renal transplantectomy|1|||
161927635|NCT01567085|584783664|FG000|Overall Study|Returned to chronic dialysis|1|||
161927636|NCT01567085|584783664|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
161927637|NCT04193176|584783665|FG000|Overall Study|Withdrawal by Subject|6|||
161927638|NCT04193176|584783666|FG001|Overall Study|Withdrawal by Subject|10|||
161927639|NCT00944645|584783671|FG000|Period 2|Adverse Event|1|||
161927640|NCT00944645|584783672|FG001|Period 2|Adverse Event|0|||
161927641|NCT00944645|584783671|FG000|Period 2|Lost to Follow-up|0|||
161927642|NCT00944645|584783672|FG001|Period 2|Lost to Follow-up|3|||
161927643|NCT00944645|584783671|FG000|Period 2|Withdrawal by Subject|7|||
161927644|NCT00944645|584783672|FG001|Period 2|Withdrawal by Subject|6|||
161927645|NCT03537729|584783676|FG000|Overall Study|Death|2|||
161927646|NCT03537729|584783677|FG001|Overall Study|Death|2|||
161927647|NCT03537729|584783678|FG002|Overall Study|Death|7|||
161927648|NCT03537729|584783676|FG000|Overall Study|Withdrawal by Subject|3|||
161927649|NCT03537729|584783677|FG001|Overall Study|Withdrawal by Subject|3|||
161927650|NCT03537729|584783678|FG002|Overall Study|Withdrawal by Subject|0|||
161927651|NCT03537729|584783676|FG000|Overall Study|Subject Moved|8|||
161927652|NCT03537729|584783677|FG001|Overall Study|Subject Moved|5|||
161927653|NCT03537729|584783678|FG002|Overall Study|Subject Moved|4|||
161927654|NCT03537729|584783676|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
161927655|NCT03537729|584783677|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
161927656|NCT03537729|584783678|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
161927657|NCT03537729|584783676|FG000|Overall Study|COVID-19 Site Restrictions|11|||
161927658|NCT03537729|584783677|FG001|Overall Study|COVID-19 Site Restrictions|15|||
161927659|NCT03537729|584783678|FG002|Overall Study|COVID-19 Site Restrictions|18|||
161927660|NCT03537729|584783676|FG000|Overall Study|Decline in Health|5|||
161927661|NCT03537729|584783677|FG001|Overall Study|Decline in Health|9|||
161927662|NCT03537729|584783678|FG002|Overall Study|Decline in Health|4|||
161927663|NCT03537729|584783676|FG000|Overall Study|Determined Ineligible|0|||
161927664|NCT03537729|584783677|FG001|Overall Study|Determined Ineligible|0|||
161927665|NCT03537729|584783678|FG002|Overall Study|Determined Ineligible|1|||
161927666|NCT00284934|584783681|FG000|Overall Study|Adverse Event|1|||
161927667|NCT00284934|584783682|FG001|Overall Study|Adverse Event|2|||
161927668|NCT00284934|584783681|FG000|Overall Study|Other reasons|3|||
161927669|NCT00284934|584783682|FG001|Overall Study|Other reasons|1|||
161927670|NCT00454142|584783683|FG000|Overall Study|Withdrawal by Subject|1|||
161927671|NCT01783015|584783689|FG000|Blinded Treatment|Adverse Event|0|||
161927672|NCT01783015|584783690|FG001|Blinded Treatment|Adverse Event|1|||
161927673|NCT01783015|584783691|FG002|Blinded Treatment|Adverse Event|0|||
161927674|NCT01783015|584783689|FG000|Blinded Treatment|Protocol Violation|0|||
161588058|NCT04927065|583542333|FG013|First Booster|Other Than Specified|0|||
161588059|NCT04927065|583542334|FG014|First Booster|Other Than Specified|0|||
161588060|NCT04927065|583542335|FG015|First Booster|Other Than Specified|0|||
161588061|NCT04927065|583542320|FG000|Second Booster|Death|0|||
161588062|NCT04927065|583542321|FG001|Second Booster|Death|0|||
161588063|NCT04927065|583542322|FG002|Second Booster|Death|0|||
161588064|NCT04927065|583542323|FG003|Second Booster|Death|0|||
161588065|NCT04927065|583542324|FG004|Second Booster|Death|0|||
161588066|NCT04927065|583542325|FG005|Second Booster|Death|0|||
161676320|NCT02060383|583868740|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161927675|NCT01783015|584783690|FG001|Blinded Treatment|Protocol Violation|1|||
161927676|NCT01783015|584783691|FG002|Blinded Treatment|Protocol Violation|0|||
161927677|NCT01783015|584783689|FG000|Blinded Treatment|Withdrawal by Subject|0|||
161927678|NCT01783015|584783690|FG001|Blinded Treatment|Withdrawal by Subject|1|||
161927679|NCT01783015|584783691|FG002|Blinded Treatment|Withdrawal by Subject|0|||
161927680|NCT01783015|584783689|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
161927681|NCT01783015|584783690|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
161927682|NCT01783015|584783691|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
161927683|NCT01783015|584783689|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
161927684|NCT01783015|584783690|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
161927685|NCT01783015|584783691|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
161927686|NCT01348698|584783692|FG000|Overall Study|Does not meet lesion size criteria|1|||
161927687|NCT01348698|584783692|FG000|Overall Study|Death|3|||
161927688|NCT01348698|584783692|FG000|Overall Study|PI decision to close study|68|||
161927689|NCT00504556|584783693|FG000|Overall Study|Adverse Event|11|||
161927690|NCT00504556|584783694|FG001|Overall Study|Adverse Event|11|||
161927691|NCT00504556|584783695|FG002|Overall Study|Adverse Event|14|||
161927692|NCT00504556|584783696|FG003|Overall Study|Adverse Event|13|||
161927693|NCT00504556|584783697|FG004|Overall Study|Adverse Event|5|||
161927694|NCT00504556|584783693|FG000|Overall Study|Death|3|||
161927695|NCT00504556|584783694|FG001|Overall Study|Death|3|||
161588067|NCT04927065|583542326|FG006|Second Booster|Death|0|||
161588068|NCT04927065|583542327|FG007|Second Booster|Death|0|||
161588069|NCT04927065|583542328|FG008|Second Booster|Death|0|||
161588070|NCT04927065|583542329|FG009|Second Booster|Death|0|||
161588071|NCT04927065|583542330|FG010|Second Booster|Death|2|||
161588072|NCT04927065|583542331|FG011|Second Booster|Death|0|||
161588073|NCT04927065|583542332|FG012|Second Booster|Death|2|||
161927696|NCT00504556|584783695|FG002|Overall Study|Death|1|||
161927697|NCT00504556|584783696|FG003|Overall Study|Death|0|||
161927698|NCT00504556|584783697|FG004|Overall Study|Death|2|||
161927699|NCT00504556|584783693|FG000|Overall Study|Protocol Violation|1|||
161927700|NCT00504556|584783694|FG001|Overall Study|Protocol Violation|3|||
161927701|NCT00504556|584783695|FG002|Overall Study|Protocol Violation|2|||
161927702|NCT00504556|584783696|FG003|Overall Study|Protocol Violation|1|||
161927703|NCT00504556|584783697|FG004|Overall Study|Protocol Violation|2|||
161927704|NCT00504556|584783693|FG000|Overall Study|Lost to Follow-up|0|||
161927705|NCT00504556|584783694|FG001|Overall Study|Lost to Follow-up|0|||
161927706|NCT00504556|584783695|FG002|Overall Study|Lost to Follow-up|1|||
161927707|NCT00504556|584783696|FG003|Overall Study|Lost to Follow-up|1|||
161927708|NCT00504556|584783697|FG004|Overall Study|Lost to Follow-up|1|||
161821186|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
161821187|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
161821188|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161821189|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161927709|NCT00504556|584783693|FG000|Overall Study|Withdrawal by Subject|16|||
161927710|NCT00504556|584783694|FG001|Overall Study|Withdrawal by Subject|16|||
161927711|NCT00504556|584783695|FG002|Overall Study|Withdrawal by Subject|7|||
161927712|NCT00504556|584783696|FG003|Overall Study|Withdrawal by Subject|8|||
161927713|NCT00504556|584783697|FG004|Overall Study|Withdrawal by Subject|12|||
161927714|NCT00504556|584783693|FG000|Overall Study|administrative reasons|0|||
161588074|NCT04927065|583542333|FG013|Second Booster|Death|2|||
161588075|NCT04927065|583542334|FG014|Second Booster|Death|0|||
161588076|NCT04927065|583542335|FG015|Second Booster|Death|0|||
161821190|NCT01680016|584387583|FG000|Overall Study|Adverse Event|0|||
161821191|NCT01680016|584387584|FG001|Overall Study|Adverse Event|0|||
161821192|NCT01680016|584387585|FG002|Overall Study|Adverse Event|1|||
161821193|NCT01680016|584387586|FG003|Overall Study|Adverse Event|4|||
161821194|NCT01680016|584387583|FG000|Overall Study|The Subject went out of The Trial|1|||
161821195|NCT01680016|584387584|FG001|Overall Study|The Subject went out of The Trial|0|||
161821196|NCT01680016|584387585|FG002|Overall Study|The Subject went out of The Trial|3|||
161821197|NCT01680016|584387586|FG003|Overall Study|The Subject went out of The Trial|0|||
161821198|NCT01680016|584387583|FG000|Overall Study|Protocol Violation|0|||
161821199|NCT01680016|584387584|FG001|Overall Study|Protocol Violation|1|||
161821200|NCT01680016|584387585|FG002|Overall Study|Protocol Violation|0|||
161821201|NCT01680016|584387586|FG003|Overall Study|Protocol Violation|0|||
161821202|NCT01680016|584387583|FG000|Overall Study|Withdrawal by Subject|5|||
161821203|NCT01680016|584387584|FG001|Overall Study|Withdrawal by Subject|7|||
161821204|NCT01680016|584387585|FG002|Overall Study|Withdrawal by Subject|1|||
161821205|NCT01680016|584387586|FG003|Overall Study|Withdrawal by Subject|1|||
161821206|NCT01958060|584387588|FG000|Overall Study|Not treated|2|||
161821207|NCT01958060|584387589|FG001|Overall Study|Not treated|0|||
161927715|NCT00504556|584783694|FG001|Overall Study|administrative reasons|2|||
161588077|NCT04927065|583542320|FG000|Second Booster|Lost to Follow-up|0|||
161588078|NCT04927065|583542321|FG001|Second Booster|Lost to Follow-up|0|||
161588079|NCT04927065|583542322|FG002|Second Booster|Lost to Follow-up|3|||
161588080|NCT04927065|583542323|FG003|Second Booster|Lost to Follow-up|0|||
161588081|NCT04927065|583542324|FG004|Second Booster|Lost to Follow-up|0|||
161588082|NCT04927065|583542325|FG005|Second Booster|Lost to Follow-up|0|||
161588083|NCT04927065|583542326|FG006|Second Booster|Lost to Follow-up|0|||
161588084|NCT04927065|583542327|FG007|Second Booster|Lost to Follow-up|0|||
161821208|NCT01958060|584387590|FG002|Overall Study|Not treated|0|||
161821209|NCT01958060|584387591|FG003|Overall Study|Not treated|0|||
161927716|NCT00504556|584783695|FG002|Overall Study|administrative reasons|2|||
161927717|NCT00504556|584783696|FG003|Overall Study|administrative reasons|1|||
161927718|NCT00504556|584783697|FG004|Overall Study|administrative reasons|2|||
161927719|NCT00504556|584783693|FG000|Overall Study|did not meet entry criteria|2|||
161927720|NCT00504556|584783694|FG001|Overall Study|did not meet entry criteria|0|||
161927721|NCT00504556|584783695|FG002|Overall Study|did not meet entry criteria|1|||
161927722|NCT00504556|584783696|FG003|Overall Study|did not meet entry criteria|1|||
161927723|NCT00504556|584783697|FG004|Overall Study|did not meet entry criteria|0|||
161927724|NCT00504556|584783693|FG000|Overall Study|data monitor committee decision|0|||
161927725|NCT00504556|584783694|FG001|Overall Study|data monitor committee decision|0|||
161927726|NCT00504556|584783695|FG002|Overall Study|data monitor committee decision|0|||
161927727|NCT00504556|584783696|FG003|Overall Study|data monitor committee decision|100|||
161927728|NCT00504556|584783697|FG004|Overall Study|data monitor committee decision|0|||
161927729|NCT00504556|584783693|FG000|Overall Study|Other|2|||
161927730|NCT00504556|584783694|FG001|Overall Study|Other|2|||
161927731|NCT00504556|584783695|FG002|Overall Study|Other|2|||
161927732|NCT00504556|584783696|FG003|Overall Study|Other|3|||
161927733|NCT00504556|584783697|FG004|Overall Study|Other|0|||
161927734|NCT00504556|584783693|FG000|Overall Study|not in safety analysis set|0|||
161588085|NCT04927065|583542328|FG008|Second Booster|Lost to Follow-up|0|||
161588086|NCT04927065|583542329|FG009|Second Booster|Lost to Follow-up|0|||
161588087|NCT04927065|583542330|FG010|Second Booster|Lost to Follow-up|14|||
161588088|NCT04927065|583542331|FG011|Second Booster|Lost to Follow-up|10|||
161588089|NCT04927065|583542332|FG012|Second Booster|Lost to Follow-up|13|||
161588090|NCT04927065|583542333|FG013|Second Booster|Lost to Follow-up|16|||
161588091|NCT04927065|583542334|FG014|Second Booster|Lost to Follow-up|0|||
161588092|NCT04927065|583542335|FG015|Second Booster|Lost to Follow-up|0|||
161588093|NCT04927065|583542320|FG000|Second Booster|Physician Decision|0|||
161588094|NCT04927065|583542321|FG001|Second Booster|Physician Decision|0|||
161588095|NCT04927065|583542322|FG002|Second Booster|Physician Decision|0|||
161588096|NCT04927065|583542323|FG003|Second Booster|Physician Decision|0|||
161588097|NCT04927065|583542324|FG004|Second Booster|Physician Decision|0|||
161588098|NCT04927065|583542325|FG005|Second Booster|Physician Decision|0|||
161588099|NCT04927065|583542326|FG006|Second Booster|Physician Decision|0|||
161588100|NCT04927065|583542327|FG007|Second Booster|Physician Decision|0|||
161588101|NCT04927065|583542328|FG008|Second Booster|Physician Decision|0|||
161588102|NCT04927065|583542329|FG009|Second Booster|Physician Decision|0|||
161588103|NCT04927065|583542330|FG010|Second Booster|Physician Decision|0|||
161588104|NCT04927065|583542331|FG011|Second Booster|Physician Decision|3|||
161588105|NCT04927065|583542332|FG012|Second Booster|Physician Decision|0|||
161588106|NCT04927065|583542333|FG013|Second Booster|Physician Decision|1|||
161588107|NCT04927065|583542334|FG014|Second Booster|Physician Decision|0|||
161588108|NCT04927065|583542335|FG015|Second Booster|Physician Decision|0|||
161588109|NCT04927065|583542320|FG000|Second Booster|Withdrawal by Subject|0|||
161588110|NCT04927065|583542321|FG001|Second Booster|Withdrawal by Subject|0|||
161588111|NCT04927065|583542322|FG002|Second Booster|Withdrawal by Subject|4|||
161588112|NCT04927065|583542323|FG003|Second Booster|Withdrawal by Subject|0|||
161588113|NCT04927065|583542324|FG004|Second Booster|Withdrawal by Subject|0|||
161588114|NCT04927065|583542325|FG005|Second Booster|Withdrawal by Subject|0|||
161588115|NCT04927065|583542326|FG006|Second Booster|Withdrawal by Subject|0|||
161588116|NCT04927065|583542327|FG007|Second Booster|Withdrawal by Subject|0|||
161588117|NCT04927065|583542328|FG008|Second Booster|Withdrawal by Subject|0|||
161588118|NCT04927065|583542329|FG009|Second Booster|Withdrawal by Subject|0|||
161588119|NCT04927065|583542330|FG010|Second Booster|Withdrawal by Subject|3|||
161588120|NCT04927065|583542331|FG011|Second Booster|Withdrawal by Subject|16|||
161588121|NCT04927065|583542332|FG012|Second Booster|Withdrawal by Subject|13|||
161588122|NCT04927065|583542333|FG013|Second Booster|Withdrawal by Subject|9|||
161588123|NCT04927065|583542334|FG014|Second Booster|Withdrawal by Subject|0|||
161588124|NCT04927065|583542335|FG015|Second Booster|Withdrawal by Subject|0|||
161588125|NCT04927065|583542320|FG000|Second Booster|Other Than Specified|0|||
161588126|NCT04927065|583542321|FG001|Second Booster|Other Than Specified|0|||
161588127|NCT04927065|583542322|FG002|Second Booster|Other Than Specified|0|||
161588128|NCT04927065|583542323|FG003|Second Booster|Other Than Specified|0|||
161588129|NCT04927065|583542324|FG004|Second Booster|Other Than Specified|0|||
161588130|NCT04927065|583542325|FG005|Second Booster|Other Than Specified|0|||
161588131|NCT04927065|583542326|FG006|Second Booster|Other Than Specified|0|||
161588132|NCT04927065|583542327|FG007|Second Booster|Other Than Specified|0|||
161588133|NCT04927065|583542328|FG008|Second Booster|Other Than Specified|0|||
161588134|NCT04927065|583542329|FG009|Second Booster|Other Than Specified|0|||
161588135|NCT04927065|583542330|FG010|Second Booster|Other Than Specified|1|||
161588136|NCT04927065|583542331|FG011|Second Booster|Other Than Specified|1|||
161588137|NCT04927065|583542332|FG012|Second Booster|Other Than Specified|4|||
161588138|NCT04927065|583542333|FG013|Second Booster|Other Than Specified|0|||
161588139|NCT04927065|583542334|FG014|Second Booster|Other Than Specified|0|||
161588140|NCT04927065|583542335|FG015|Second Booster|Other Than Specified|0|||
161588141|NCT04927065|583542320|FG000|Third Booster|Lost to Follow-up|0|||
161588142|NCT04927065|583542321|FG001|Third Booster|Lost to Follow-up|0|||
161588143|NCT04927065|583542322|FG002|Third Booster|Lost to Follow-up|0|||
161588144|NCT04927065|583542323|FG003|Third Booster|Lost to Follow-up|0|||
161588145|NCT04927065|583542324|FG004|Third Booster|Lost to Follow-up|0|||
161588146|NCT04927065|583542325|FG005|Third Booster|Lost to Follow-up|0|||
161588147|NCT04927065|583542326|FG006|Third Booster|Lost to Follow-up|0|||
161588148|NCT04927065|583542327|FG007|Third Booster|Lost to Follow-up|0|||
161927735|NCT00504556|584783694|FG001|Overall Study|not in safety analysis set|1|||
161927736|NCT00504556|584783695|FG002|Overall Study|not in safety analysis set|1|||
161927737|NCT00504556|584783696|FG003|Overall Study|not in safety analysis set|0|||
161927738|NCT00504556|584783697|FG004|Overall Study|not in safety analysis set|1|||
161927739|NCT03558672|584783698|FG000|Overall Study|Study Early Termination|10|||
161927740|NCT03607695|584783699|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
161927741|NCT03607695|584783699|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
161927742|NCT02741193|584783700|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
161927743|NCT02741193|584783700|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
161927744|NCT01027416|584783701|FG000|Overall Study|Withdrawal by Subject|0|||
161927745|NCT01027416|584783702|FG001|Overall Study|Withdrawal by Subject|1|||
161927746|NCT01027416|584783701|FG000|Overall Study|Physician Decision|1|||
161927747|NCT01027416|584783702|FG001|Overall Study|Physician Decision|4|||
161927748|NCT01560988|584783728|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
161927749|NCT01560988|584783729|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
161927750|NCT01560988|584783728|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
161927751|NCT01560988|584783729|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
161927752|NCT01560988|584783728|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
161927753|NCT01560988|584783729|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
161927754|NCT01441414|584783732|FG000|Overall Study|Participant died|9|||
161927755|NCT01441414|584783732|FG000|Overall Study|Other reasons|3|||
161927756|NCT01441414|584783732|FG000|Overall Study|Study terminated by sponsor|2|||
161927757|NCT01441414|584783732|FG000|Overall Study|Subject refused further follow-up|1|||
161927758|NCT00500110|584783733|FG000|Overall Study|Withdrawal by Subject|3|||
161927759|NCT00605657|584783734|FG000|Overall Study|Adverse Event|1|||
161927760|NCT00605657|584783734|FG000|Overall Study|Protocol Violation|1|||
161927761|NCT04535362|584783738|FG000|Overall Study|Lost to Follow-up|3|||
161927762|NCT04535362|584783739|FG001|Overall Study|Lost to Follow-up|1|||
161927763|NCT02018887|584783747|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
161927764|NCT02018887|584783748|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927765|NCT02018887|584783749|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927766|NCT02018887|584783750|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927767|NCT02018887|584783751|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927768|NCT02018887|584783752|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927769|NCT02018887|584783753|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927770|NCT02018887|584783754|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927771|NCT02018887|584783755|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927772|NCT02018887|584783756|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927773|NCT02018887|584783757|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927774|NCT02018887|584783747|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927775|NCT02018887|584783748|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927776|NCT02018887|584783749|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927777|NCT02018887|584783750|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927778|NCT02018887|584783751|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
161927779|NCT02018887|584783752|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927780|NCT02018887|584783753|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
161927781|NCT02018887|584783754|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
161927782|NCT02018887|584783755|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927783|NCT02018887|584783756|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927784|NCT02018887|584783757|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927785|NCT02018887|584783747|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
161927786|NCT02018887|584783748|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
161927787|NCT02018887|584783749|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
161927788|NCT02018887|584783750|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
161927789|NCT02018887|584783751|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
161927790|NCT02018887|584783752|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
161927791|NCT02018887|584783753|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
161927792|NCT02018887|584783754|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
161927793|NCT02018887|584783755|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
161927794|NCT02018887|584783756|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
161927795|NCT02018887|584783757|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
161927796|NCT02018887|584783747|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
161927797|NCT02018887|584783748|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
161927798|NCT02018887|584783749|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
161927799|NCT02018887|584783750|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
161927800|NCT02018887|584783751|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
161927801|NCT02018887|584783752|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
161927802|NCT02018887|584783753|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
161927803|NCT02018887|584783754|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
161927804|NCT02018887|584783755|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
161927805|NCT02018887|584783756|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
161927806|NCT02018887|584783757|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
161927807|NCT01058005|584783758|FG000|Overall Study|Adverse Event|0|||
161927808|NCT01058005|584783759|FG001|Overall Study|Adverse Event|2|||
161927809|NCT01058005|584783760|FG002|Overall Study|Adverse Event|1|||
161927810|NCT01058005|584783758|FG000|Overall Study|Physician Decision|2|||
161927811|NCT01058005|584783759|FG001|Overall Study|Physician Decision|2|||
161927812|NCT01058005|584783760|FG002|Overall Study|Physician Decision|0|||
161927813|NCT01058005|584783758|FG000|Overall Study|Withdrawal by Subject|4|||
161927814|NCT01058005|584783759|FG001|Overall Study|Withdrawal by Subject|5|||
161927815|NCT01058005|584783760|FG002|Overall Study|Withdrawal by Subject|11|||
161927816|NCT01058005|584783758|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
161927817|NCT01058005|584783759|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
161927818|NCT01058005|584783760|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
161821210|NCT01958060|584387592|FG004|Overall Study|Not treated|1|||
161927819|NCT01058005|584783758|FG000|Overall Study|Reason Missing|5|||
161927820|NCT01058005|584783759|FG001|Overall Study|Reason Missing|3|||
161927821|NCT01058005|584783760|FG002|Overall Study|Reason Missing|1|||
161927822|NCT04882215|584783761|FG000|Overall Study|Withdrawal by Subject|5|||
161927823|NCT04882215|584783762|FG001|Overall Study|Withdrawal by Subject|0|||
161821211|NCT01958060|584387593|FG005|Overall Study|Not treated|0|||
161821212|NCT02846883|584387596|FG000|Overall Study|Death|0|||
161821213|NCT02846883|584387597|FG001|Overall Study|Death|1|||
161821214|NCT02846883|584387598|FG002|Overall Study|Death|1|||
161821215|NCT02846883|584387596|FG000|Overall Study|Lost to Follow-up|0|||
161821216|NCT02846883|584387597|FG001|Overall Study|Lost to Follow-up|0|||
161821217|NCT02846883|584387598|FG002|Overall Study|Lost to Follow-up|1|||
161821218|NCT02846883|584387596|FG000|Overall Study|Withdrawal by Subject|1|||
161821219|NCT02846883|584387597|FG001|Overall Study|Withdrawal by Subject|0|||
161821220|NCT02846883|584387598|FG002|Overall Study|Withdrawal by Subject|0|||
161821221|NCT02846883|584387596|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
161821222|NCT02846883|584387597|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
161821223|NCT02846883|584387598|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
161821224|NCT02846883|584387596|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
161821225|NCT02846883|584387597|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
161821226|NCT02846883|584387598|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
161821227|NCT00927251|584387599|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
161821228|NCT01011335|584387601|FG000|Overall Study|Lost to Follow-up|0|||
161821229|NCT01011335|584387602|FG001|Overall Study|Lost to Follow-up|0|||
161821230|NCT01011335|584387603|FG002|Overall Study|Lost to Follow-up|1|||
161821231|NCT01011335|584387604|FG003|Overall Study|Lost to Follow-up|1|||
161821232|NCT01011335|584387605|FG004|Overall Study|Lost to Follow-up|1|||
161821233|NCT01011335|584387606|FG005|Overall Study|Lost to Follow-up|1|||
161821234|NCT01011335|584387607|FG006|Overall Study|Lost to Follow-up|2|||
161821235|NCT01011335|584387608|FG007|Overall Study|Lost to Follow-up|2|||
161821236|NCT01011335|584387609|FG008|Overall Study|Lost to Follow-up|1|||
161821237|NCT01011335|584387610|FG009|Overall Study|Lost to Follow-up|0|||
161821238|NCT01011335|584387611|FG010|Overall Study|Lost to Follow-up|0|||
161821239|NCT01011335|584387612|FG011|Overall Study|Lost to Follow-up|1|||
161927824|NCT06083493|584783763|FG000|Overall Study|Technical issues with the interventional device|2|||
161927825|NCT06083493|584783764|FG001|Overall Study|Technical issues with the interventional device|2|||
161927826|NCT06083493|584783763|FG000|Overall Study|Performed incorrect visual task|1|||
161927827|NCT06083493|584783764|FG001|Overall Study|Performed incorrect visual task|0|||
161927828|NCT06083493|584783763|FG000|Overall Study|Insufficient baseline performance|0|||
161927829|NCT06083493|584783764|FG001|Overall Study|Insufficient baseline performance|1|||
161927830|NCT02460380|584783770|FG000|Overall Study|Withdrawal by Subject|10|||
161927831|NCT02460380|584783771|FG001|Overall Study|Withdrawal by Subject|5|||
161927832|NCT01936974|584783776|FG000|Overall Study|Physician Decision|2|||
161927833|NCT01936974|584783777|FG001|Overall Study|Physician Decision|5|||
161927834|NCT00063999|584783778|FG000|Overall Study|Withdrawal by Subject|1|||
161927835|NCT00063999|584783779|FG001|Overall Study|Withdrawal by Subject|0|||
161927836|NCT00063999|584783778|FG000|Overall Study|Ineligible|44|||
161927837|NCT00063999|584783779|FG001|Overall Study|Ineligible|24|||
161927838|NCT02497755|584783780|FG000|Overall Study|Protocol Violation|1|||
161927839|NCT02497755|584783781|FG001|Overall Study|Protocol Violation|0|||
161927840|NCT04560309|584783794|FG000|Overall Study|Meet drop out criteria|1|||
161927841|NCT04560309|584783795|FG001|Overall Study|Meet drop out criteria|1|||
161927842|NCT05085405|584783796|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161927843|NCT05085405|584783797|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161821240|NCT01011335|584387613|FG012|Overall Study|Lost to Follow-up|2|||
161821241|NCT01011335|584387601|FG000|Overall Study|Protocol Violation|0|||
161821242|NCT01011335|584387602|FG001|Overall Study|Protocol Violation|1|||
161821243|NCT01011335|584387603|FG002|Overall Study|Protocol Violation|0|||
161821244|NCT01011335|584387604|FG003|Overall Study|Protocol Violation|0|||
161927844|NCT05085405|584783798|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
161821245|NCT01011335|584387605|FG004|Overall Study|Protocol Violation|0|||
161927845|NCT05085405|584783799|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
161927846|NCT05085405|584783800|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161927847|NCT05085405|584783801|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161927848|NCT05085405|584783796|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927849|NCT05085405|584783797|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927850|NCT05085405|584783798|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927851|NCT05085405|584783799|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
161927852|NCT05085405|584783800|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927853|NCT05085405|584783801|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927854|NCT01860404|584783802|FG000|Overall Study|Lost to Follow-up|3|||
161927855|NCT01860404|584783803|FG001|Overall Study|Lost to Follow-up|4|||
161927856|NCT01860404|584783804|FG002|Overall Study|Lost to Follow-up|1|||
161927857|NCT01860404|584783805|FG003|Overall Study|Lost to Follow-up|6|||
161927858|NCT01860404|584783806|FG004|Overall Study|Lost to Follow-up|4|||
161927859|NCT01860404|584783802|FG000|Overall Study|Withdrawal by Subject|0|||
161821246|NCT01011335|584387606|FG005|Overall Study|Protocol Violation|0|||
161821247|NCT01011335|584387607|FG006|Overall Study|Protocol Violation|0|||
161821248|NCT01011335|584387608|FG007|Overall Study|Protocol Violation|0|||
161821249|NCT01011335|584387609|FG008|Overall Study|Protocol Violation|0|||
161821250|NCT01011335|584387610|FG009|Overall Study|Protocol Violation|0|||
161821251|NCT01011335|584387611|FG010|Overall Study|Protocol Violation|0|||
161821252|NCT01011335|584387612|FG011|Overall Study|Protocol Violation|0|||
161821253|NCT01011335|584387613|FG012|Overall Study|Protocol Violation|0|||
161821254|NCT01011335|584387601|FG000|Overall Study|Moved/deployed or no booster|1|||
161821255|NCT01011335|584387602|FG001|Overall Study|Moved/deployed or no booster|0|||
161821256|NCT01011335|584387603|FG002|Overall Study|Moved/deployed or no booster|0|||
161821257|NCT01011335|584387604|FG003|Overall Study|Moved/deployed or no booster|1|||
161821258|NCT01011335|584387605|FG004|Overall Study|Moved/deployed or no booster|0|||
161821259|NCT01011335|584387606|FG005|Overall Study|Moved/deployed or no booster|0|||
161821260|NCT01011335|584387607|FG006|Overall Study|Moved/deployed or no booster|1|||
161821261|NCT01011335|584387608|FG007|Overall Study|Moved/deployed or no booster|0|||
161821262|NCT01011335|584387609|FG008|Overall Study|Moved/deployed or no booster|1|||
161821263|NCT01011335|584387610|FG009|Overall Study|Moved/deployed or no booster|0|||
161821264|NCT01011335|584387611|FG010|Overall Study|Moved/deployed or no booster|2|||
161821265|NCT01011335|584387612|FG011|Overall Study|Moved/deployed or no booster|0|||
161821266|NCT01011335|584387613|FG012|Overall Study|Moved/deployed or no booster|0|||
161821267|NCT01011335|584387601|FG000|Overall Study|Adverse Event|0|||
161821268|NCT01011335|584387602|FG001|Overall Study|Adverse Event|0|||
161821269|NCT01011335|584387603|FG002|Overall Study|Adverse Event|0|||
161821270|NCT01011335|584387604|FG003|Overall Study|Adverse Event|0|||
161821271|NCT01011335|584387605|FG004|Overall Study|Adverse Event|0|||
161821272|NCT01011335|584387606|FG005|Overall Study|Adverse Event|0|||
161821273|NCT01011335|584387607|FG006|Overall Study|Adverse Event|0|||
161821274|NCT01011335|584387608|FG007|Overall Study|Adverse Event|0|||
161821275|NCT01011335|584387609|FG008|Overall Study|Adverse Event|0|||
161821276|NCT01011335|584387610|FG009|Overall Study|Adverse Event|0|||
161821277|NCT01011335|584387611|FG010|Overall Study|Adverse Event|4|||
161821278|NCT01011335|584387612|FG011|Overall Study|Adverse Event|0|||
161821279|NCT01011335|584387613|FG012|Overall Study|Adverse Event|1|||
161821280|NCT01813435|584387614|FG000|Overall Study|did not finish experimental regimen|1902|||
161821281|NCT01813435|584387615|FG001|Overall Study|did not finish experimental regimen|770|||
161821282|NCT01813435|584387614|FG000|Overall Study|Lost to Follow-up|268|||
161821283|NCT01813435|584387615|FG001|Overall Study|Lost to Follow-up|237|||
161821284|NCT01765751|584387622|FG000|Overall Study|Lost to Follow-up|0|||
161821285|NCT01765751|584387623|FG001|Overall Study|Lost to Follow-up|2|||
161821286|NCT01765751|584387624|FG002|Overall Study|Lost to Follow-up|1|||
161821287|NCT01120899|584387625|FG000|Overall Study|Withdrawal by Subject|3|||
161821288|NCT00452348|584387626|FG000|Overall Study|Adverse Event|6|||
161821289|NCT00452348|584387627|FG001|Overall Study|Adverse Event|9|||
161821290|NCT00452348|584387626|FG000|Overall Study|Lack of Efficacy|10|||
161821291|NCT00452348|584387627|FG001|Overall Study|Lack of Efficacy|9|||
161821292|NCT00452348|584387626|FG000|Overall Study|Lost to Follow-up|14|||
161821293|NCT00452348|584387627|FG001|Overall Study|Lost to Follow-up|8|||
161821294|NCT00452348|584387626|FG000|Overall Study|Protocol Violation|22|||
161821295|NCT00452348|584387627|FG001|Overall Study|Protocol Violation|28|||
161821296|NCT00452348|584387626|FG000|Overall Study|Withdrawal by Subject|18|||
161821297|NCT00452348|584387627|FG001|Overall Study|Withdrawal by Subject|21|||
161821298|NCT00452348|584387626|FG000|Overall Study|Other|9|||
161821299|NCT00452348|584387627|FG001|Overall Study|Other|9|||
161821300|NCT02435433|584387630|FG000|Overall Study|Withdrawal by Subject|2|||
161821301|NCT02435433|584387631|FG001|Overall Study|Withdrawal by Subject|3|||
161821302|NCT02435433|584387632|FG002|Overall Study|Withdrawal by Subject|1|||
161927860|NCT01860404|584783803|FG001|Overall Study|Withdrawal by Subject|0|||
161927861|NCT01860404|584783804|FG002|Overall Study|Withdrawal by Subject|4|||
161927862|NCT01860404|584783805|FG003|Overall Study|Withdrawal by Subject|0|||
161927863|NCT01860404|584783806|FG004|Overall Study|Withdrawal by Subject|0|||
161927864|NCT00356421|584783808|FG000|Overall Study|Lack of Efficacy|3|||
161927865|NCT00356421|584783809|FG001|Overall Study|Lack of Efficacy|0|||
161927866|NCT00356421|584783808|FG000|Overall Study|Withdrawal by Subject|9|||
161927867|NCT00356421|584783809|FG001|Overall Study|Withdrawal by Subject|2|||
161927868|NCT00356421|584783808|FG000|Overall Study|Related to study drug|15|||
161927869|NCT00356421|584783809|FG001|Overall Study|Related to study drug|12|||
161927870|NCT00356421|584783808|FG000|Overall Study|Not related to study drug|5|||
161927871|NCT00356421|584783809|FG001|Overall Study|Not related to study drug|3|||
161927872|NCT04689009|584783810|FG000|Overall Study|Adverse Event|1|||
161927873|NCT04689009|584783811|FG001|Overall Study|Adverse Event|0|||
161927874|NCT04689009|584783810|FG000|Overall Study|Lost to Follow-up|1|||
161927875|NCT04689009|584783811|FG001|Overall Study|Lost to Follow-up|2|||
161927876|NCT04689009|584783810|FG000|Overall Study|Withdrawal by Subject|4|||
161927877|NCT04689009|584783811|FG001|Overall Study|Withdrawal by Subject|3|||
161927878|NCT04689009|584783810|FG000|Overall Study|Protocol Violation|1|||
161927879|NCT04689009|584783811|FG001|Overall Study|Protocol Violation|0|||
161927880|NCT02187055|584783812|FG000|Overall Study|Lack of Efficacy|10|||
161927881|NCT02187055|584783813|FG001|Overall Study|Lack of Efficacy|3|||
161927882|NCT02187055|584783814|FG002|Overall Study|Lack of Efficacy|7|||
161927883|NCT02187055|584783812|FG000|Overall Study|Lost to Follow-up|2|||
161927884|NCT02187055|584783813|FG001|Overall Study|Lost to Follow-up|7|||
161927885|NCT02187055|584783814|FG002|Overall Study|Lost to Follow-up|3|||
161927886|NCT02187055|584783812|FG000|Overall Study|No longer meets eligibility criteria|0|||
161927887|NCT02187055|584783813|FG001|Overall Study|No longer meets eligibility criteria|2|||
161927888|NCT02187055|584783814|FG002|Overall Study|No longer meets eligibility criteria|0|||
161927889|NCT02187055|584783812|FG000|Overall Study|No longer willing to participate|6|||
161927890|NCT02187055|584783813|FG001|Overall Study|No longer willing to participate|8|||
161927891|NCT02187055|584783814|FG002|Overall Study|No longer willing to participate|10|||
161927892|NCT02187055|584783812|FG000|Overall Study|Other|5|||
161927893|NCT02187055|584783813|FG001|Overall Study|Other|6|||
161927894|NCT02187055|584783814|FG002|Overall Study|Other|3|||
161927895|NCT02187055|584783812|FG000|Overall Study|Protocol Violation|9|||
161927896|NCT02187055|584783813|FG001|Overall Study|Protocol Violation|9|||
161927897|NCT02187055|584783814|FG002|Overall Study|Protocol Violation|4|||
161927898|NCT02187055|584783812|FG000|Overall Study|Pregnancy|3|||
161927899|NCT02187055|584783813|FG001|Overall Study|Pregnancy|1|||
161927900|NCT02187055|584783814|FG002|Overall Study|Pregnancy|0|||
161927901|NCT02187055|584783812|FG000|Overall Study|Withdrawal by Subject|11|||
161927902|NCT02187055|584783813|FG001|Overall Study|Withdrawal by Subject|11|||
161927903|NCT02187055|584783814|FG002|Overall Study|Withdrawal by Subject|11|||
161927904|NCT02187055|584783812|FG000|Overall Study|Adverse Event|21|||
161927905|NCT02187055|584783813|FG001|Overall Study|Adverse Event|26|||
161927906|NCT02187055|584783814|FG002|Overall Study|Adverse Event|36|||
161927907|NCT02187055|584783812|FG000|Overall Study|Death|2|||
161927908|NCT02187055|584783813|FG001|Overall Study|Death|0|||
161927909|NCT02187055|584783814|FG002|Overall Study|Death|0|||
161927910|NCT00985790|584783817|FG000|Overall Study|Withdrawal by Subject|1|||
161927911|NCT00985790|584783818|FG001|Overall Study|Withdrawal by Subject|1|||
161927912|NCT00985790|584783817|FG000|Overall Study|Lost to Follow-up|6|||
161927913|NCT00985790|584783818|FG001|Overall Study|Lost to Follow-up|7|||
161927914|NCT04796207|584783819|FG000|Overall Study|Lost to Follow-up|7|||
161927915|NCT04796207|584783820|FG001|Overall Study|Lost to Follow-up|2|||
161927916|NCT01030900|584783821|FG000|Overall Study|Not treated due to congestive heart failure|1|||
161927917|NCT01030900|584783821|FG000|Overall Study|Not treated due to rapid disease|1|||
161927918|NCT00441896|584783822|FG000|Overall Study|Withdrawal by Subject|0|||
161927919|NCT00441896|584783823|FG001|Overall Study|Withdrawal by Subject|0|||
161927920|NCT00441896|584783824|FG002|Overall Study|Withdrawal by Subject|0|||
161927921|NCT00441896|584783825|FG003|Overall Study|Withdrawal by Subject|1|||
161927922|NCT00441896|584783826|FG004|Overall Study|Withdrawal by Subject|0|||
161927923|NCT00441896|584783827|FG005|Overall Study|Withdrawal by Subject|0|||
161927924|NCT00441896|584783828|FG006|Overall Study|Withdrawal by Subject|0|||
161927925|NCT00441896|584783829|FG007|Overall Study|Withdrawal by Subject|0|||
161927926|NCT00441896|584783830|FG008|Overall Study|Withdrawal by Subject|0|||
161927927|NCT00441896|584783831|FG009|Overall Study|Withdrawal by Subject|0|||
161927928|NCT00441896|584783822|FG000|Overall Study|Other|0|||
161927929|NCT00441896|584783823|FG001|Overall Study|Other|0|||
161927930|NCT00441896|584783824|FG002|Overall Study|Other|0|||
161927931|NCT00441896|584783825|FG003|Overall Study|Other|0|||
161927932|NCT00441896|584783826|FG004|Overall Study|Other|1|||
161927933|NCT00441896|584783827|FG005|Overall Study|Other|0|||
161927934|NCT00441896|584783828|FG006|Overall Study|Other|0|||
161927935|NCT00441896|584783829|FG007|Overall Study|Other|0|||
161927936|NCT00441896|584783830|FG008|Overall Study|Other|0|||
161927937|NCT00441896|584783831|FG009|Overall Study|Other|0|||
161927938|NCT01301092|584783832|FG000|Overall Study|Lost to Follow-up|0|||
161927939|NCT01301092|584783833|FG001|Overall Study|Lost to Follow-up|0|||
161927940|NCT01301092|584783834|FG002|Overall Study|Lost to Follow-up|1|||
161927941|NCT03334175|584783835|FG000|Overall Study|Lost to Follow-up|0|||
161927942|NCT03334175|584783836|FG001|Overall Study|Lost to Follow-up|1|||
161927943|NCT00520572|584785415|FG000|Overall Study|Adverse Event|9|||
161927944|NCT00520572|584785416|FG001|Overall Study|Adverse Event|3|||
161927945|NCT00520572|584785417|FG002|Overall Study|Adverse Event|6|||
161927946|NCT00520572|584785418|FG003|Overall Study|Adverse Event|9|||
161927947|NCT00520572|584785419|FG004|Overall Study|Adverse Event|7|||
161927948|NCT00520572|584785420|FG005|Overall Study|Adverse Event|2|||
161927949|NCT00520572|584785415|FG000|Overall Study|Withdrawal by Subject|0|||
161927950|NCT00520572|584785416|FG001|Overall Study|Withdrawal by Subject|9|||
161927951|NCT00520572|584785417|FG002|Overall Study|Withdrawal by Subject|5|||
161927952|NCT00520572|584785418|FG003|Overall Study|Withdrawal by Subject|2|||
161927953|NCT00520572|584785419|FG004|Overall Study|Withdrawal by Subject|2|||
161927954|NCT00520572|584785420|FG005|Overall Study|Withdrawal by Subject|0|||
161927955|NCT00520572|584785415|FG000|Overall Study|Protocol Violation|0|||
161927956|NCT00520572|584785416|FG001|Overall Study|Protocol Violation|0|||
161927957|NCT00520572|584785417|FG002|Overall Study|Protocol Violation|1|||
161927958|NCT00520572|584785418|FG003|Overall Study|Protocol Violation|0|||
161927959|NCT00520572|584785419|FG004|Overall Study|Protocol Violation|0|||
161927960|NCT00520572|584785420|FG005|Overall Study|Protocol Violation|0|||
161927961|NCT00520572|584785415|FG000|Overall Study|Lack of Efficacy|1|||
161927962|NCT00520572|584785416|FG001|Overall Study|Lack of Efficacy|1|||
161927963|NCT00520572|584785417|FG002|Overall Study|Lack of Efficacy|1|||
161927964|NCT00520572|584785418|FG003|Overall Study|Lack of Efficacy|2|||
161927965|NCT00520572|584785419|FG004|Overall Study|Lack of Efficacy|1|||
161927966|NCT00520572|584785420|FG005|Overall Study|Lack of Efficacy|0|||
161927967|NCT00520572|584785415|FG000|Overall Study|Lost to Follow-up|0|||
161927968|NCT00520572|584785416|FG001|Overall Study|Lost to Follow-up|0|||
161927969|NCT00520572|584785417|FG002|Overall Study|Lost to Follow-up|0|||
161927970|NCT00520572|584785418|FG003|Overall Study|Lost to Follow-up|0|||
161927971|NCT00520572|584785419|FG004|Overall Study|Lost to Follow-up|1|||
161927972|NCT00520572|584785420|FG005|Overall Study|Lost to Follow-up|0|||
161927973|NCT00520572|584785415|FG000|Overall Study|Incorrect enrollment|1|||
161821303|NCT02435433|584387633|FG003|Overall Study|Withdrawal by Subject|0|||
161821304|NCT02435433|584387634|FG004|Overall Study|Withdrawal by Subject|0|||
161821305|NCT02435433|584387630|FG000|Overall Study|Lost to Follow-up|2|||
161821306|NCT02435433|584387631|FG001|Overall Study|Lost to Follow-up|2|||
161821307|NCT02435433|584387632|FG002|Overall Study|Lost to Follow-up|4|||
161821308|NCT02435433|584387633|FG003|Overall Study|Lost to Follow-up|1|||
161821309|NCT02435433|584387634|FG004|Overall Study|Lost to Follow-up|0|||
161821310|NCT01243151|584387635|FG000|Overall Study|Adverse Event|0|||
161821311|NCT01243151|584387636|FG001|Overall Study|Adverse Event|1|||
161927974|NCT00520572|584785416|FG001|Overall Study|Incorrect enrollment|0|||
161927975|NCT00520572|584785417|FG002|Overall Study|Incorrect enrollment|1|||
161927976|NCT00520572|584785418|FG003|Overall Study|Incorrect enrollment|0|||
161927977|NCT00520572|584785419|FG004|Overall Study|Incorrect enrollment|1|||
161927978|NCT00520572|584785420|FG005|Overall Study|Incorrect enrollment|0|||
161927979|NCT00520572|584785415|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927980|NCT00520572|584785416|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
161927981|NCT00520572|584785417|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927982|NCT00520572|584785418|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927983|NCT00520572|584785419|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927984|NCT00520572|584785420|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927985|NCT00520572|584785415|FG000|Overall Study|Long break in taking Medication|0|||
161821312|NCT01243151|584387637|FG002|Overall Study|Adverse Event|0|||
161927986|NCT00520572|584785416|FG001|Overall Study|Long break in taking Medication|0|||
161927987|NCT00520572|584785417|FG002|Overall Study|Long break in taking Medication|0|||
161927988|NCT00520572|584785418|FG003|Overall Study|Long break in taking Medication|1|||
161927989|NCT00520572|584785419|FG004|Overall Study|Long break in taking Medication|0|||
161927990|NCT00520572|584785420|FG005|Overall Study|Long break in taking Medication|0|||
161927991|NCT00520572|584785415|FG000|Overall Study|Did not receive Treatment|1|||
161927992|NCT00520572|584785416|FG001|Overall Study|Did not receive Treatment|0|||
161927993|NCT00520572|584785417|FG002|Overall Study|Did not receive Treatment|1|||
161927994|NCT00520572|584785418|FG003|Overall Study|Did not receive Treatment|0|||
161927995|NCT00520572|584785419|FG004|Overall Study|Did not receive Treatment|0|||
161927996|NCT00520572|584785420|FG005|Overall Study|Did not receive Treatment|0|||
161927997|NCT03548415|584785423|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161927998|NCT03548415|584785424|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161927999|NCT03548415|584785425|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
161928000|NCT03548415|584785426|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
161928001|NCT03548415|584785427|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
161928002|NCT04605588|584785428|FG000|Overall Study|Withdrawal by Subject|1|||
161928003|NCT04605588|584785429|FG001|Overall Study|Withdrawal by Subject|0|||
161928004|NCT01230814|584785430|FG000|Overall Study|Lost to Follow-up|11|||
161928005|NCT01230814|584785431|FG001|Overall Study|Lost to Follow-up|3|||
161928006|NCT01230814|584785430|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
161928007|NCT01230814|584785431|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
161928008|NCT01803737|584785432|FG000|Overall Study|Lack of Time|1|||
161928009|NCT01803737|584785433|FG001|Overall Study|Lack of Time|0|||
161928010|NCT01803737|584785432|FG000|Overall Study|Medical Reason|0|||
161928011|NCT01803737|584785433|FG001|Overall Study|Medical Reason|1|||
161928012|NCT01803737|584785432|FG000|Overall Study|Lost to Follow-up|0|||
161928013|NCT01803737|584785433|FG001|Overall Study|Lost to Follow-up|2|||
161928014|NCT00676052|584785435|FG000|Overall Study|Adverse Event|0|||
161928015|NCT00676052|584785436|FG001|Overall Study|Adverse Event|1|||
161928016|NCT00676052|584785437|FG002|Overall Study|Adverse Event|1|||
161928017|NCT00676052|584785438|FG003|Overall Study|Adverse Event|2|||
161928018|NCT00676052|584785439|FG004|Overall Study|Adverse Event|2|||
161928019|NCT00676052|584785440|FG005|Overall Study|Adverse Event|2|||
161928020|NCT00676052|584785435|FG000|Overall Study|Lack of Efficacy|2|||
161928021|NCT00676052|584785436|FG001|Overall Study|Lack of Efficacy|2|||
161928022|NCT00676052|584785437|FG002|Overall Study|Lack of Efficacy|1|||
161928023|NCT00676052|584785438|FG003|Overall Study|Lack of Efficacy|1|||
161588149|NCT04927065|583542328|FG008|Third Booster|Lost to Follow-up|0|||
161928024|NCT00676052|584785439|FG004|Overall Study|Lack of Efficacy|2|||
161928025|NCT00676052|584785440|FG005|Overall Study|Lack of Efficacy|1|||
161928026|NCT00676052|584785435|FG000|Overall Study|Protocol Violation|5|||
161928027|NCT00676052|584785436|FG001|Overall Study|Protocol Violation|3|||
161928028|NCT00676052|584785437|FG002|Overall Study|Protocol Violation|2|||
161928029|NCT00676052|584785438|FG003|Overall Study|Protocol Violation|2|||
161928030|NCT00676052|584785439|FG004|Overall Study|Protocol Violation|1|||
161928031|NCT00676052|584785440|FG005|Overall Study|Protocol Violation|2|||
161928032|NCT00676052|584785435|FG000|Overall Study|Lost to Follow-up|0|||
161928033|NCT00676052|584785436|FG001|Overall Study|Lost to Follow-up|0|||
161928034|NCT00676052|584785437|FG002|Overall Study|Lost to Follow-up|0|||
161928035|NCT00676052|584785438|FG003|Overall Study|Lost to Follow-up|0|||
161928036|NCT00676052|584785439|FG004|Overall Study|Lost to Follow-up|1|||
161928037|NCT00676052|584785440|FG005|Overall Study|Lost to Follow-up|0|||
161928038|NCT00676052|584785435|FG000|Overall Study|Physician Decision|1|||
161928039|NCT00676052|584785436|FG001|Overall Study|Physician Decision|1|||
161928040|NCT00676052|584785437|FG002|Overall Study|Physician Decision|1|||
161928041|NCT00676052|584785438|FG003|Overall Study|Physician Decision|0|||
161928042|NCT00676052|584785439|FG004|Overall Study|Physician Decision|0|||
161928043|NCT00676052|584785440|FG005|Overall Study|Physician Decision|1|||
161928044|NCT00676052|584785435|FG000|Overall Study|Withdrawal by Subject|1|||
161928045|NCT00676052|584785436|FG001|Overall Study|Withdrawal by Subject|0|||
161928046|NCT00676052|584785437|FG002|Overall Study|Withdrawal by Subject|1|||
161928047|NCT00676052|584785438|FG003|Overall Study|Withdrawal by Subject|0|||
161928048|NCT00676052|584785439|FG004|Overall Study|Withdrawal by Subject|0|||
161928049|NCT00676052|584785440|FG005|Overall Study|Withdrawal by Subject|0|||
161928050|NCT02930941|584785441|FG000|Overall Study|Lost to Follow-up|1|||
161928051|NCT02930941|584785442|FG001|Overall Study|Lost to Follow-up|2|||
161928052|NCT00289978|584785443|FG000|Overall Study|Withdrawal by Subject|31|||
161928053|NCT00289978|584785444|FG001|Overall Study|Withdrawal by Subject|17|||
161928054|NCT00289978|584785445|FG002|Overall Study|Withdrawal by Subject|28|||
161928055|NCT00289978|584785443|FG000|Overall Study|Adverse Event|22|||
161928056|NCT00289978|584785444|FG001|Overall Study|Adverse Event|13|||
161928057|NCT00289978|584785445|FG002|Overall Study|Adverse Event|18|||
161928058|NCT00289978|584785443|FG000|Overall Study|Lack of Efficacy|13|||
161928059|NCT00289978|584785444|FG001|Overall Study|Lack of Efficacy|6|||
161928060|NCT00289978|584785445|FG002|Overall Study|Lack of Efficacy|25|||
161928061|NCT00289978|584785443|FG000|Overall Study|Abnormal laboratory value(s)|20|||
161928062|NCT00289978|584785444|FG001|Overall Study|Abnormal laboratory value(s)|9|||
161928063|NCT00289978|584785445|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161928064|NCT00289978|584785443|FG000|Overall Study|Lost to Follow-up|3|||
161928065|NCT00289978|584785444|FG001|Overall Study|Lost to Follow-up|5|||
161928066|NCT00289978|584785445|FG002|Overall Study|Lost to Follow-up|7|||
161928067|NCT00289978|584785443|FG000|Overall Study|Protocol Violation|5|||
161928068|NCT00289978|584785444|FG001|Overall Study|Protocol Violation|5|||
161928069|NCT00289978|584785445|FG002|Overall Study|Protocol Violation|4|||
161928070|NCT00289978|584785443|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161928071|NCT00289978|584785444|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161928072|NCT00289978|584785445|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161928073|NCT00289978|584785443|FG000|Overall Study|Death|1|||
161928074|NCT00289978|584785444|FG001|Overall Study|Death|0|||
161928075|NCT00289978|584785445|FG002|Overall Study|Death|2|||
161928076|NCT00903344|584785446|FG000|Overall Study|Pregnancy|2|||
161928077|NCT00903344|584785447|FG001|Overall Study|Pregnancy|3|||
161928078|NCT00903344|584785446|FG000|Overall Study|Lost to Follow-up|3|||
161928079|NCT00903344|584785447|FG001|Overall Study|Lost to Follow-up|0|||
161928080|NCT00585169|584785448|FG000|Overall Study|Withdrawal by Subject|1|||
161928081|NCT03055221|584785449|FG000|Overall Study|Adverse Event|2|||
161928082|NCT03055221|584785449|FG000|Overall Study|Withdrawal by Subject|4|||
161928083|NCT03055221|584785449|FG000|Overall Study|Death|6|||
161928084|NCT03055221|584785449|FG000|Overall Study|Physician Decision|1|||
161928085|NCT03055221|584785449|FG000|Overall Study|Study terminated by Sponsor|3|||
161928086|NCT03055221|584785449|FG000|Overall Study|Lost to Follow-up|4|||
161928087|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
161928088|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
161928089|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
161928090|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
161928091|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
161928092|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
161928093|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
161514045|NCT02047110|583271895|FG002|Escape Treatment Period|Other than specified|0|||
161928094|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
161514046|NCT02047110|583271896|FG003|Escape Treatment Period|Other than specified|1|||
161928095|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
161928096|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
161514047|NCT02047110|583271893|FG000|OLE Treatment Period|Other than specified|0|||
161514048|NCT02047110|583271894|FG001|OLE Treatment Period|Other than specified|0|||
161514049|NCT02047110|583271895|FG002|OLE Treatment Period|Other than specified|1|||
161514050|NCT02047110|583271896|FG003|OLE Treatment Period|Other than specified|0|||
161514051|NCT00705575|583271897|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161928097|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
161928098|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
161928099|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
161928100|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
161928101|NCT01243424|584785450|FG000|Discontinuation From Treatment|Not treated|5|||
161928102|NCT01243424|584785451|FG001|Discontinuation From Treatment|Not treated|4|||
161928103|NCT01243424|584785450|FG000|Discontinuation From Treatment|Adverse Event|457|||
161928104|NCT01243424|584785451|FG001|Discontinuation From Treatment|Adverse Event|523|||
161928105|NCT01243424|584785450|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
161928106|NCT01243424|584785451|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
161928107|NCT01243424|584785450|FG000|Discontinuation From Treatment|Protocol Violation|46|||
161928108|NCT01243424|584785451|FG001|Discontinuation From Treatment|Protocol Violation|47|||
161928109|NCT01243424|584785450|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
161928110|NCT01243424|584785451|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
161928111|NCT01243424|584785450|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
161928112|NCT01243424|584785451|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
161928113|NCT01243424|584785450|FG000|Discontinuation From Treatment|Other than listed above|230|||
161928114|NCT01243424|584785451|FG001|Discontinuation From Treatment|Other than listed above|211|||
161928115|NCT02391584|584785457|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
161928116|NCT02391584|584785458|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
161676321|NCT02060383|583868741|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
161676322|NCT02060383|583868742|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
161676323|NCT02060383|583868738|FG000|Extension Phase|Adverse Event|1|||
161676324|NCT02060383|583868739|FG001|Extension Phase|Adverse Event|1|||
161676325|NCT02060383|583868740|FG002|Extension Phase|Adverse Event|2|||
161676326|NCT02060383|583868741|FG003|Extension Phase|Adverse Event|0|||
161676327|NCT02060383|583868742|FG004|Extension Phase|Adverse Event|1|||
161676328|NCT02060383|583868738|FG000|Extension Phase|Withdrawal by Subject|0|||
161676329|NCT02060383|583868739|FG001|Extension Phase|Withdrawal by Subject|1|||
161676330|NCT02060383|583868740|FG002|Extension Phase|Withdrawal by Subject|0|||
161676331|NCT02060383|583868741|FG003|Extension Phase|Withdrawal by Subject|0|||
161676332|NCT02060383|583868742|FG004|Extension Phase|Withdrawal by Subject|2|||
161676333|NCT02060383|583868738|FG000|Extension Phase|Administrative problems|1|||
161676334|NCT02060383|583868739|FG001|Extension Phase|Administrative problems|0|||
161676335|NCT02060383|583868740|FG002|Extension Phase|Administrative problems|0|||
161676336|NCT02060383|583868741|FG003|Extension Phase|Administrative problems|0|||
161676337|NCT02060383|583868742|FG004|Extension Phase|Administrative problems|0|||
161676338|NCT02060383|583868738|FG000|Extension Phase|Death|0|||
161676339|NCT02060383|583868739|FG001|Extension Phase|Death|0|||
161676340|NCT02060383|583868740|FG002|Extension Phase|Death|1|||
161676341|NCT02060383|583868741|FG003|Extension Phase|Death|0|||
161676342|NCT02060383|583868742|FG004|Extension Phase|Death|1|||
161676343|NCT02060383|583868738|FG000|Extension Phase|Protocol Violation|0|||
161676344|NCT02060383|583868739|FG001|Extension Phase|Protocol Violation|0|||
161928117|NCT02391584|584785457|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
161928118|NCT02391584|584785458|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
161928119|NCT02391584|584785457|FG000|3 Month|Lost to Follow-up|1|||
161928120|NCT02391584|584785458|FG001|3 Month|Lost to Follow-up|0|||
161928121|NCT02391584|584785457|FG000|6 Month|Withdrawal by Subject|1|||
161928122|NCT02391584|584785458|FG001|6 Month|Withdrawal by Subject|0|||
161928123|NCT02391584|584785457|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
161928124|NCT02391584|584785458|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
161928125|NCT04621786|584785459|FG000|Overall Study|Lost to Follow-up|9|||
161928126|NCT04621786|584785459|FG000|Overall Study|Protocol Violation|3|||
161928127|NCT00710554|584785460|FG000|Overall Study|Adverse Event|24|||
161928128|NCT00710554|584785461|FG001|Overall Study|Adverse Event|7|||
161676345|NCT02060383|583868740|FG002|Extension Phase|Protocol Violation|0|||
161928129|NCT00710554|584785460|FG000|Overall Study|Withdrawal by Subject|7|||
161928130|NCT00710554|584785461|FG001|Overall Study|Withdrawal by Subject|3|||
161676346|NCT02060383|583868741|FG003|Extension Phase|Protocol Violation|0|||
161676347|NCT02060383|583868742|FG004|Extension Phase|Protocol Violation|1|||
161676348|NCT03426787|583868743|FG000|Overall Study|Withdrawal by Subject|6|||
161676349|NCT03426787|583868743|FG000|Overall Study|Lost to Follow-up|7|||
161821313|NCT01243151|584387638|FG003|Overall Study|Adverse Event|0|||
161821314|NCT01243151|584387639|FG004|Overall Study|Adverse Event|0|||
161821315|NCT01243151|584387635|FG000|Overall Study|Protocol Violation|0|||
161821316|NCT01243151|584387636|FG001|Overall Study|Protocol Violation|0|||
161821317|NCT01243151|584387637|FG002|Overall Study|Protocol Violation|1|||
161821318|NCT01243151|584387638|FG003|Overall Study|Protocol Violation|0|||
161821319|NCT01243151|584387639|FG004|Overall Study|Protocol Violation|0|||
161821320|NCT01243151|584387635|FG000|Overall Study|Other|0|||
161821321|NCT01243151|584387636|FG001|Overall Study|Other|0|||
161821322|NCT01243151|584387637|FG002|Overall Study|Other|0|||
161676350|NCT03426787|583868743|FG000|Overall Study|Unrelated to intervention death|1|||
161676351|NCT00257166|583868749|FG000|Overall Study|Adverse Event|18|||
161928131|NCT00710554|584785460|FG000|Overall Study|Lost to Follow-up|7|||
161928132|NCT00710554|584785461|FG001|Overall Study|Lost to Follow-up|1|||
161928133|NCT00710554|584785460|FG000|Overall Study|Lack of Efficacy|11|||
161928134|NCT00710554|584785461|FG001|Overall Study|Lack of Efficacy|12|||
161928135|NCT00710554|584785460|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
161928136|NCT00710554|584785461|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
161928137|NCT01093885|584785462|FG000|Overall Study|Adverse Event|4|||
161928138|NCT01093885|584785462|FG000|Overall Study|Lost to Follow-up|1|||
161928139|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
161928140|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
161928141|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
161928142|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
161928143|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
161928144|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
161928145|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
161928146|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
161928147|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
161928148|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
161928149|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
161928150|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
161928151|NCT00292370|584785463|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
161928152|NCT00292370|584785464|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
161928153|NCT00292370|584785465|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
161928154|NCT00292370|584785463|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
161928155|NCT00292370|584785464|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
161928156|NCT00292370|584785465|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
161928157|NCT01301001|584785466|FG000|First Intervention|Lost to Follow-up|4|||
161928158|NCT01301001|584785467|FG001|First Intervention|Lost to Follow-up|4|||
161928159|NCT01301001|584785466|FG000|First Intervention|Withdrawal by Subject|1|||
161928160|NCT01301001|584785467|FG001|First Intervention|Withdrawal by Subject|4|||
161928161|NCT01301001|584785466|FG000|First Intervention|Adverse Event|5|||
161928162|NCT01301001|584785467|FG001|First Intervention|Adverse Event|0|||
161928163|NCT01301001|584785466|FG000|First Intervention|Protocol Violation|0|||
161928164|NCT01301001|584785467|FG001|First Intervention|Protocol Violation|1|||
161928165|NCT01301001|584785466|FG000|Second Intervention|Adverse Event|2|||
161928166|NCT01301001|584785467|FG001|Second Intervention|Adverse Event|0|||
161928167|NCT01301001|584785466|FG000|Second Intervention|Withdrawal by Subject|2|||
161928168|NCT01301001|584785467|FG001|Second Intervention|Withdrawal by Subject|0|||
161928169|NCT01346709|584785468|FG000|Overall Study|Protocol Violation|35|||
161928170|NCT01346709|584785468|FG000|Overall Study|Lost to Follow-up|31|||
161514052|NCT00705575|583271898|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161928171|NCT01346709|584785468|FG000|Overall Study|Missing data in candidate risk factor|285|||
161928172|NCT02365064|584785473|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
161928173|NCT02365064|584785474|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
161514053|NCT00705575|583271897|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161514054|NCT00705575|583271898|FG001|Overall Study|Abnormal test procedure result(s)|12|||
161514055|NCT00705575|583271897|FG000|Overall Study|Adverse Event|11|||
161514056|NCT00705575|583271898|FG001|Overall Study|Adverse Event|15|||
161514057|NCT00705575|583271897|FG000|Overall Study|Lost to Follow-up|3|||
161514058|NCT00705575|583271898|FG001|Overall Study|Lost to Follow-up|4|||
161514059|NCT00705575|583271897|FG000|Overall Study|Protocol Violation|2|||
161514060|NCT00705575|583271898|FG001|Overall Study|Protocol Violation|2|||
161514061|NCT00705575|583271897|FG000|Overall Study|Withdrawal by Subject|5|||
161514062|NCT00705575|583271898|FG001|Overall Study|Withdrawal by Subject|10|||
161514063|NCT02170727|583271901|FG000|Overall Study|Lost to Follow-up|1|||
161514064|NCT02170727|583271902|FG001|Overall Study|Lost to Follow-up|0|||
161514065|NCT02170727|583271901|FG000|Overall Study|Withdrawal by Subject|2|||
161514066|NCT02170727|583271902|FG001|Overall Study|Withdrawal by Subject|0|||
161514067|NCT01959581|583271907|FG000|Overall Study|Lost to Follow-up|5|||
161514068|NCT00700011|583271910|FG000|Overall Study|Death|0|||
161514069|NCT00700011|583271911|FG001|Overall Study|Death|1|||
161514070|NCT00004031|583271912|FG000|Overall Study|Adverse Event|5|||
161514071|NCT00004031|583271913|FG001|Overall Study|Adverse Event|0|||
161514072|NCT00004031|583271912|FG000|Overall Study|Refusal unrelated to adverse events|2|||
161514073|NCT00004031|583271913|FG001|Overall Study|Refusal unrelated to adverse events|11|||
161514074|NCT00004031|583271912|FG000|Overall Study|Progression/relapse|9|||
161514075|NCT00004031|583271913|FG001|Overall Study|Progression/relapse|4|||
161514076|NCT00004031|583271912|FG000|Overall Study|Death|3|||
161514077|NCT00004031|583271913|FG001|Overall Study|Death|1|||
161514078|NCT00004031|583271912|FG000|Overall Study|Other- not protocol specified|3|||
161514079|NCT00004031|583271913|FG001|Overall Study|Other- not protocol specified|3|||
161514080|NCT00004031|583271912|FG000|Overall Study|Reason under review|3|||
161514081|NCT00004031|583271913|FG001|Overall Study|Reason under review|2|||
161514082|NCT00829621|583271914|FG000|Overall Study|Death|1|||
161514083|NCT00829621|583271915|FG001|Overall Study|Death|0|||
161821323|NCT01243151|584387638|FG003|Overall Study|Other|1|||
161821324|NCT01243151|584387639|FG004|Overall Study|Other|0|||
161821325|NCT01243151|584387635|FG000|Overall Study|Randomized but not treated|0|||
161821326|NCT01243151|584387636|FG001|Overall Study|Randomized but not treated|0|||
161821327|NCT01243151|584387637|FG002|Overall Study|Randomized but not treated|0|||
161821328|NCT01243151|584387638|FG003|Overall Study|Randomized but not treated|1|||
161821329|NCT01243151|584387639|FG004|Overall Study|Randomized but not treated|0|||
161821330|NCT03119662|584387640|FG000|Overall Study|Withdrawal by Subject|0|||
161821331|NCT03119662|584387641|FG001|Overall Study|Withdrawal by Subject|1|||
161821332|NCT02817828|584387642|FG000|Overall Study|Lost to Follow-up|41|||
161821333|NCT02817828|584387642|FG000|Overall Study|Adverse event not related to bleeding|104|||
161821334|NCT02817828|584387642|FG000|Overall Study|Adverse event related to bleeding|53|||
161821335|NCT02817828|584387642|FG000|Overall Study|Protocol Violation|11|||
161821336|NCT02817828|584387642|FG000|Overall Study|Pregnancy|7|||
161821337|NCT02817828|584387642|FG000|Overall Study|Pregnancy wish|15|||
161821338|NCT02817828|584387642|FG000|Overall Study|Withdrawal by Subject|78|||
161821339|NCT02817828|584387642|FG000|Overall Study|Other|26|||
161821340|NCT00522041|584387644|FG000|Overall Study|Adverse Event|9|||
161821341|NCT00522041|584387645|FG001|Overall Study|Adverse Event|3|||
161821342|NCT00522041|584387644|FG000|Overall Study|Protocol Violation|2|||
161821343|NCT00522041|584387645|FG001|Overall Study|Protocol Violation|0|||
161821344|NCT00522041|584387644|FG000|Overall Study|Lost to Follow-up|1|||
161821345|NCT00522041|584387645|FG001|Overall Study|Lost to Follow-up|4|||
161821346|NCT00522041|584387644|FG000|Overall Study|Voluntary withdrawal|5|||
161821347|NCT00522041|584387645|FG001|Overall Study|Voluntary withdrawal|4|||
161821348|NCT00522041|584387644|FG000|Overall Study|Did not receive treatment|0|||
161821349|NCT00522041|584387645|FG001|Overall Study|Did not receive treatment|1|||
161821350|NCT00544167|584387646|FG000|Overall Study|Adverse Event|21|||
161821351|NCT00544167|584387646|FG000|Overall Study|Physician Decision|8|||
161821352|NCT00874549|584387647|FG000|Overall Study|Adverse Event|0|||
161821353|NCT00874549|584387648|FG001|Overall Study|Adverse Event|0|||
161821354|NCT00874549|584387649|FG002|Overall Study|Adverse Event|1|||
161821355|NCT00874549|584387650|FG003|Overall Study|Adverse Event|0|||
161821356|NCT00874549|584387647|FG000|Overall Study|Protocol Violation|1|||
161821357|NCT00874549|584387648|FG001|Overall Study|Protocol Violation|0|||
161821358|NCT00874549|584387649|FG002|Overall Study|Protocol Violation|2|||
161821359|NCT00874549|584387650|FG003|Overall Study|Protocol Violation|1|||
161821360|NCT00874549|584387647|FG000|Overall Study|Lost to Follow-up|0|||
161821361|NCT00874549|584387648|FG001|Overall Study|Lost to Follow-up|0|||
161821362|NCT00874549|584387649|FG002|Overall Study|Lost to Follow-up|1|||
161821363|NCT00874549|584387650|FG003|Overall Study|Lost to Follow-up|0|||
161821364|NCT00874549|584387647|FG000|Overall Study|Withdrawal by Subject|0|||
161821365|NCT00874549|584387648|FG001|Overall Study|Withdrawal by Subject|1|||
161821366|NCT00874549|584387649|FG002|Overall Study|Withdrawal by Subject|0|||
161821367|NCT00874549|584387650|FG003|Overall Study|Withdrawal by Subject|1|||
161821368|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
161821369|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
161821370|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
161821371|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
161821372|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
161821373|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
161821374|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
161821375|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
161821376|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
161821377|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
161821378|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
161821379|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
161821380|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
161821381|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
161821382|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
161821383|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
161821384|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
161821385|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
161821386|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
161821387|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
161821388|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
161821389|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
161821390|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
161821391|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
161514084|NCT00829621|583271914|FG000|Overall Study|Lost to Follow-up|3|||
161821392|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
161676352|NCT00257166|583868750|FG001|Overall Study|Adverse Event|13|||
161676353|NCT00257166|583868749|FG000|Overall Study|Laboratory abnormality|1|||
161676354|NCT00257166|583868750|FG001|Overall Study|Laboratory abnormality|0|||
161676355|NCT00257166|583868749|FG000|Overall Study|Lost to Follow-up|8|||
161676356|NCT00257166|583868750|FG001|Overall Study|Lost to Follow-up|1|||
161676357|NCT00257166|583868749|FG000|Overall Study|Withdrawal by Subject|9|||
161676358|NCT00257166|583868750|FG001|Overall Study|Withdrawal by Subject|2|||
161676359|NCT00257166|583868749|FG000|Overall Study|Other|16|||
161676360|NCT00257166|583868750|FG001|Overall Study|Other|21|||
161676361|NCT00257166|583868749|FG000|Overall Study|Randomized, but not treated|1|||
161676362|NCT00257166|583868750|FG001|Overall Study|Randomized, but not treated|0|||
161676363|NCT02592551|583868751|FG000|Overall Study|Not evaluable|1|||
161676364|NCT02592551|583868752|FG001|Overall Study|Not evaluable|3|||
161676365|NCT02592551|583868753|FG002|Overall Study|Not evaluable|0|||
161676366|NCT00761306|583868754|FG000|Overall Study|Adverse Event|5|||
161676367|NCT00761306|583868754|FG000|Overall Study|Lack of Efficacy|4|||
161676368|NCT00761306|583868754|FG000|Overall Study|Protocol Violation|2|||
161676369|NCT00761306|583868754|FG000|Overall Study|Withdrawal of Consent|3|||
161676370|NCT00761306|583868754|FG000|Overall Study|Lost to Follow-up|1|||
161676371|NCT00761306|583868754|FG000|Overall Study|Administrative or Other Reasons|5|||
161676372|NCT05162027|583868755|FG000|Overall Study|Adverse Event|1|||
161676373|NCT05162027|583868756|FG001|Overall Study|Adverse Event|0|||
161676374|NCT00525044|583868757|FG000|Overall Study|Lost to Follow-up|0|||
161676375|NCT00525044|583868758|FG001|Overall Study|Lost to Follow-up|1|||
161676376|NCT02460497|583868764|FG000|Overall Study|Participant Requested Withdrawal|4|||
161676377|NCT02460497|583868764|FG000|Overall Study|Non-Compliance|1|||
161676378|NCT02460497|583868764|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
161676379|NCT02460497|583868764|FG000|Overall Study|Lost to Follow-up|2|||
161676380|NCT02460497|583868764|FG000|Overall Study|Investigator Decision|1|||
161676381|NCT00908583|583868765|FG000|Phase 1|Withdrawal by Subject|1|||
161676382|NCT00908583|583868765|FG000|Phase 1|Adverse Event|4|||
161676383|NCT00908583|583868765|FG000|Phase 2|Physician Decision|1|||
161676384|NCT00908583|583868765|FG000|Phase 2|Adverse Event|1|||
161676385|NCT00908583|583868765|FG000|Phase 3|Adverse Event|2|||
161676386|NCT00908583|583868765|FG000|Phase 4|Adverse Event|1|||
161676387|NCT00908583|583868765|FG000|Phase 4|Physician Decision|1|||
161676388|NCT00908583|583868765|FG000|Phase 5|Adverse Event|3|||
161676389|NCT00993954|583868766|FG000|Overall Study|Protocol Violation|21|||
161676390|NCT00993954|583868767|FG001|Overall Study|Protocol Violation|2|||
161676391|NCT00860951|583868770|FG000|Overall Study|Withdrawal by Subject|2|||
161676392|NCT00860951|583868770|FG000|Overall Study|Lost to Follow-up|5|||
161676393|NCT02982239|583868773|FG000|Overall Study|Lost to Follow-up|3|||
161676394|NCT02982239|583868774|FG001|Overall Study|Lost to Follow-up|2|||
161676395|NCT01628107|583868775|FG000|Overall Study|Withdrawal by Subject|17|||
161676396|NCT01628107|583868775|FG000|Overall Study|Lost to Follow-up|4|||
161676397|NCT01628107|583868775|FG000|Overall Study|Adverse Event|33|||
161676398|NCT01628107|583868775|FG000|Overall Study|Physician Decision|2|||
161676399|NCT01628107|583868775|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
161676400|NCT01628107|583868775|FG000|Overall Study|Non-compliant with Study Procedures|10|||
161514085|NCT00829621|583271915|FG001|Overall Study|Lost to Follow-up|4|||
161514086|NCT03551210|583271916|FG000|Overall Study|Adverse Event|5|||
161514087|NCT03551210|583271917|FG001|Overall Study|Adverse Event|6|||
161514088|NCT03551210|583271916|FG000|Overall Study|Withdrawal by Subject|1|||
161514089|NCT03551210|583271917|FG001|Overall Study|Withdrawal by Subject|7|||
161514090|NCT03551210|583271916|FG000|Overall Study|Needed in other antibiotic treatment|2|||
161514091|NCT03551210|583271917|FG001|Overall Study|Needed in other antibiotic treatment|5|||
161514092|NCT03551210|583271916|FG000|Overall Study|Lost to Follow-up|1|||
161514093|NCT03551210|583271917|FG001|Overall Study|Lost to Follow-up|1|||
161514094|NCT03551210|583271916|FG000|Overall Study|Absence of visit 4 and 5|1|||
161514095|NCT03551210|583271917|FG001|Overall Study|Absence of visit 4 and 5|0|||
161676401|NCT01628107|583868775|FG000|Overall Study|Not Treated|8|||
161676402|NCT01628107|583868775|FG000|Overall Study|Sponsor Decision|11|||
161676403|NCT01628107|583868775|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
161676404|NCT01628107|583868775|FG000|Overall Study|Relocated|8|||
161676405|NCT01628107|583868775|FG000|Overall Study|Kidney Transplant|9|||
161676406|NCT01628107|583868775|FG000|Overall Study|Use of Standard of Care|9|||
161676407|NCT01086410|583868776|FG000|Overall Study|Adverse Event|1|||
161676408|NCT01086410|583868777|FG001|Overall Study|Adverse Event|0|||
161676409|NCT01086410|583868778|FG002|Overall Study|Adverse Event|0|||
161676410|NCT01086410|583868779|FG003|Overall Study|Adverse Event|2|||
161821393|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
161676411|NCT01086410|583868776|FG000|Overall Study|Lack of Efficacy|1|||
161676412|NCT01086410|583868777|FG001|Overall Study|Lack of Efficacy|1|||
161514096|NCT03551210|583271916|FG000|Overall Study|No drug for dispensing|0|||
161514097|NCT03551210|583271917|FG001|Overall Study|No drug for dispensing|1|||
161676413|NCT01086410|583868778|FG002|Overall Study|Lack of Efficacy|0|||
161676414|NCT01086410|583868779|FG003|Overall Study|Lack of Efficacy|0|||
161676415|NCT01086410|583868776|FG000|Overall Study|Protocol Violation|1|||
161676416|NCT01086410|583868777|FG001|Overall Study|Protocol Violation|1|||
161676417|NCT01086410|583868778|FG002|Overall Study|Protocol Violation|0|||
161676418|NCT01086410|583868779|FG003|Overall Study|Protocol Violation|0|||
161676419|NCT01086410|583868776|FG000|Overall Study|Lost to Follow-up|0|||
161676420|NCT01086410|583868777|FG001|Overall Study|Lost to Follow-up|0|||
161676421|NCT01086410|583868778|FG002|Overall Study|Lost to Follow-up|1|||
161676422|NCT01086410|583868779|FG003|Overall Study|Lost to Follow-up|0|||
161676423|NCT02230254|583868780|FG000|Overall Study|Lost to Follow-up|3|||
161676424|NCT00621751|583868781|FG000|Overall Study|Adverse Event|0|||
161676425|NCT00621751|583868782|FG001|Overall Study|Adverse Event|1|||
161676426|NCT03583450|583868783|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
161676427|NCT03583450|583868784|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
161676428|NCT01186939|583868785|FG000|Overall Study|Death|7|||
161676429|NCT01186939|583868785|FG000|Overall Study|Withdrawal by Subject|2|||
161676430|NCT01186939|583868785|FG000|Overall Study|No longer receiving clinical benefit|17|||
161676431|NCT01186939|583868785|FG000|Overall Study|Program closed|5|||
161676432|NCT01186939|583868785|FG000|Overall Study|Sponsor decision|4|||
161676433|NCT01186939|583868785|FG000|Overall Study|Started additional treatment|1|||
161676434|NCT01186939|583868785|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
161676435|NCT01186939|583868785|FG000|Overall Study|Myocardial infarction|1|||
161676436|NCT01186939|583868785|FG000|Overall Study|Bone marrow transplant|1|||
161676437|NCT01186939|583868785|FG000|Overall Study|Transformation to AML|1|||
161676438|NCT05097716|583868786|FG000|Period 1|Adverse Event|1|||
161821394|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
161821395|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
161821396|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
161821397|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
161821398|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
161821399|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
161821400|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
161821401|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
161821402|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
161821403|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
161821404|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
161821405|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
161821406|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
161821407|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
161821408|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
161821409|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
161821410|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
161821411|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
161821412|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
161821413|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
161821414|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
161821415|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
161821416|NCT01710358|584387653|FG000|Rescue Period|Adverse Event|0|||
161821417|NCT01710358|584387654|FG001|Rescue Period|Adverse Event|15|||
161821418|NCT01710358|584387655|FG002|Rescue Period|Adverse Event|0|||
161821419|NCT01710358|584387653|FG000|Rescue Period|Death|0|||
161821420|NCT01710358|584387654|FG001|Rescue Period|Death|1|||
161821421|NCT01710358|584387655|FG002|Rescue Period|Death|0|||
161821422|NCT01710358|584387653|FG000|Rescue Period|Lack of Efficacy|0|||
161821423|NCT01710358|584387654|FG001|Rescue Period|Lack of Efficacy|7|||
161821424|NCT01710358|584387655|FG002|Rescue Period|Lack of Efficacy|0|||
161821425|NCT01710358|584387653|FG000|Rescue Period|Withdrawal by Subject|0|||
161821426|NCT01710358|584387654|FG001|Rescue Period|Withdrawal by Subject|8|||
161821427|NCT01710358|584387655|FG002|Rescue Period|Withdrawal by Subject|0|||
161821428|NCT00799708|584387658|FG000|Overall Study|non-compliance|1|||
161821429|NCT00799708|584387659|FG001|Overall Study|non-compliance|0|||
161821430|NCT00799708|584387660|FG002|Overall Study|non-compliance|0|||
161821431|NCT00880334|584387661|FG000|Randomized Phase|Physician Decision|1|||
161821432|NCT00880334|584387662|FG001|Randomized Phase|Physician Decision|0|||
161821433|NCT00880334|584387661|FG000|Randomized Phase|Withdrawal by Subject|2|||
161821434|NCT00880334|584387662|FG001|Randomized Phase|Withdrawal by Subject|1|||
161821435|NCT00880334|584387661|FG000|Randomized Phase|Inadequate Labs|1|||
161821436|NCT00880334|584387662|FG001|Randomized Phase|Inadequate Labs|1|||
161514098|NCT03265119|583271918|FG000|Overall Study|Adverse Event|2|||
161676439|NCT05097716|583868786|FG000|Period 1|Close contact with highly-transmissible infection|1|||
161676440|NCT00791258|583868789|FG000|Overall Study|Adverse Event|87|||
161676441|NCT00791258|583868789|FG000|Overall Study|Lost to Follow-up|18|||
161676442|NCT00791258|583868789|FG000|Overall Study|Protocol Violation|109|||
161821437|NCT00880334|584387661|FG000|Randomized Phase|Brain Metastasis|0|||
161821438|NCT00880334|584387662|FG001|Randomized Phase|Brain Metastasis|1|||
161821439|NCT00880334|584387661|FG000|Randomized Phase|Crossover Participants|0|||
161821440|NCT00880334|584387662|FG001|Randomized Phase|Crossover Participants|37|||
161821441|NCT03343639|584387663|FG000|Overall Study|Withdrawal by Subject|10|||
161821442|NCT03343639|584387664|FG001|Overall Study|Withdrawal by Subject|6|||
161821443|NCT03343639|584387663|FG000|Overall Study|Lost to Follow-up|4|||
161821444|NCT03343639|584387664|FG001|Overall Study|Lost to Follow-up|5|||
161821445|NCT03343639|584387663|FG000|Overall Study|Protocol Violation|0|||
161821446|NCT03343639|584387664|FG001|Overall Study|Protocol Violation|1|||
161821447|NCT00735696|584387669|FG000|Overall Study|Withdrawal by Subject|1|||
161821448|NCT00735696|584387669|FG000|Overall Study|Enrolled but never Treated|1|||
161821449|NCT00084864|584387670|FG000|Overall Study|Adverse Event|1|||
161821450|NCT00084864|584387671|FG001|Overall Study|Adverse Event|0|||
161821451|NCT00084864|584387672|FG002|Overall Study|Adverse Event|0|||
161821452|NCT00084864|584387673|FG003|Overall Study|Adverse Event|0|||
161821453|NCT02460835|584387678|FG000|Overall Study|Disease progression prior to treatment|3|||
161821454|NCT02460835|584387678|FG000|Overall Study|Unable to complete planning scans|2|||
161821455|NCT02460835|584387678|FG000|Overall Study|Decrease in performance status|1|||
161821456|NCT02460835|584387678|FG000|Overall Study|Withdrawal by Subject|3|||
161821457|NCT02460835|584387678|FG000|Overall Study|Underwent fractionated RT|10|||
161821458|NCT02460835|584387678|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
161821459|NCT02786953|584387693|FG000|Overall Study|Withdrawal by Subject|3|||
161821460|NCT02786953|584387694|FG001|Overall Study|Withdrawal by Subject|0|||
161821461|NCT02786953|584387693|FG000|Overall Study|Physician Decision|0|||
161821462|NCT02786953|584387694|FG001|Overall Study|Physician Decision|1|||
161821463|NCT01186458|584387700|FG000|Overall Study|Adverse Event|1|||
161821464|NCT04281472|584387701|FG000|Stage A|Lack of Efficacy|8|||
161821465|NCT04281472|584387702|FG001|Stage A|Lack of Efficacy|0|||
161821466|NCT04281472|584387703|FG002|Stage A|Lack of Efficacy|0|||
161821467|NCT04281472|584387701|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
161821468|NCT04281472|584387702|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161821469|NCT04281472|584387703|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161821470|NCT04281472|584387701|FG000|Stage A|Adverse Event|20|||
161821471|NCT04281472|584387702|FG001|Stage A|Adverse Event|0|||
161821472|NCT04281472|584387703|FG002|Stage A|Adverse Event|0|||
161821473|NCT04281472|584387701|FG000|Stage A|Death|1|||
161821474|NCT04281472|584387702|FG001|Stage A|Death|0|||
161821475|NCT04281472|584387703|FG002|Stage A|Death|0|||
161821476|NCT04281472|584387701|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
161821477|NCT04281472|584387702|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
161821478|NCT04281472|584387703|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
161821479|NCT04281472|584387701|FG000|Stage A|Lost to Follow-up|2|||
161821480|NCT04281472|584387702|FG001|Stage A|Lost to Follow-up|0|||
161821481|NCT04281472|584387703|FG002|Stage A|Lost to Follow-up|0|||
161821482|NCT04281472|584387701|FG000|Stage A|Non-compliance with study drug|1|||
161821483|NCT04281472|584387702|FG001|Stage A|Non-compliance with study drug|0|||
161821484|NCT04281472|584387703|FG002|Stage A|Non-compliance with study drug|0|||
161821485|NCT04281472|584387701|FG000|Stage A|Physician Decision|1|||
161821486|NCT04281472|584387702|FG001|Stage A|Physician Decision|0|||
161821487|NCT04281472|584387703|FG002|Stage A|Physician Decision|0|||
161821488|NCT04281472|584387701|FG000|Stage A|Prohibited medications|2|||
161821489|NCT04281472|584387702|FG001|Stage A|Prohibited medications|0|||
161821490|NCT04281472|584387703|FG002|Stage A|Prohibited medications|0|||
161821491|NCT04281472|584387701|FG000|Stage A|Withdrawal by Subject|11|||
161821492|NCT04281472|584387702|FG001|Stage A|Withdrawal by Subject|0|||
161821493|NCT04281472|584387703|FG002|Stage A|Withdrawal by Subject|0|||
161821494|NCT04281472|584387701|FG000|Stage A|Other|5|||
161821495|NCT04281472|584387702|FG001|Stage A|Other|0|||
161821496|NCT04281472|584387703|FG002|Stage A|Other|0|||
161821497|NCT04281472|584387701|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161821498|NCT04281472|584387702|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
161821499|NCT04281472|584387703|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
161821500|NCT04281472|584387701|FG000|Stage B|Adverse Event|0|||
161821501|NCT04281472|584387702|FG001|Stage B|Adverse Event|3|||
161821502|NCT04281472|584387703|FG002|Stage B|Adverse Event|0|||
161514099|NCT03265119|583271919|FG001|Overall Study|Adverse Event|1|||
161821503|NCT04281472|584387701|FG000|Stage B|Death|0|||
161821504|NCT04281472|584387702|FG001|Stage B|Death|0|||
161821505|NCT04281472|584387703|FG002|Stage B|Death|1|||
161821506|NCT04281472|584387701|FG000|Stage B|Lack of Efficacy|0|||
161821507|NCT04281472|584387702|FG001|Stage B|Lack of Efficacy|0|||
161928174|NCT02365064|584785473|FG000|Overall Study|Withdrawal by Subject|6|||
161821508|NCT04281472|584387703|FG002|Stage B|Lack of Efficacy|1|||
161821509|NCT04281472|584387701|FG000|Stage B|Lost to Follow-up|0|||
161821510|NCT04281472|584387702|FG001|Stage B|Lost to Follow-up|0|||
161821511|NCT04281472|584387703|FG002|Stage B|Lost to Follow-up|2|||
161821512|NCT04281472|584387701|FG000|Stage B|Prohibited medications|0|||
161821513|NCT04281472|584387702|FG001|Stage B|Prohibited medications|2|||
161821514|NCT04281472|584387703|FG002|Stage B|Prohibited medications|1|||
161928175|NCT02365064|584785474|FG001|Overall Study|Withdrawal by Subject|9|||
161928176|NCT02365064|584785473|FG000|Overall Study|Treatment intolerance|2|||
161928177|NCT02365064|584785474|FG001|Overall Study|Treatment intolerance|4|||
161928178|NCT00662038|584785483|FG000|Overall Study|Reason not specified|3|||
161928179|NCT00662038|584785483|FG000|Overall Study|Withdrawn consent|22|||
161928180|NCT00662038|584785483|FG000|Overall Study|Withdrawal by Subject|83|||
161928181|NCT00662038|584785483|FG000|Overall Study|Sponsor decision|1|||
161928182|NCT00662038|584785483|FG000|Overall Study|Physician Decision|19|||
161676443|NCT00791258|583868789|FG000|Overall Study|Withdrawal by Subject|40|||
161676444|NCT00791258|583868789|FG000|Overall Study|Did not take medication for >3 days|1|||
161676445|NCT00791258|583868789|FG000|Overall Study|subject left area|2|||
161676446|NCT00791258|583868789|FG000|Overall Study|non-compliance|3|||
161676447|NCT00791258|583868789|FG000|Overall Study|Subject incarcerated|1|||
161676448|NCT00791258|583868789|FG000|Overall Study|Subject required restricted medication|1|||
161676449|NCT00791258|583868789|FG000|Overall Study|Lack of Efficacy|1|||
161676450|NCT00436618|583868790|FG000|Overall Study|Withdrawal by Subject|5|||
161676451|NCT00436618|583868791|FG001|Overall Study|Withdrawal by Subject|8|||
161676452|NCT00436618|583868792|FG002|Overall Study|Withdrawal by Subject|11|||
161676453|NCT00436618|583868790|FG000|Overall Study|Adverse Event|8|||
161676454|NCT00436618|583868791|FG001|Overall Study|Adverse Event|8|||
161676455|NCT00436618|583868792|FG002|Overall Study|Adverse Event|9|||
161676456|NCT00436618|583868790|FG000|Overall Study|Alternate Treatment|3|||
161821515|NCT04281472|584387701|FG000|Stage B|Protocol Violation|0|||
161821516|NCT04281472|584387702|FG001|Stage B|Protocol Violation|1|||
161821517|NCT04281472|584387703|FG002|Stage B|Protocol Violation|1|||
161821518|NCT04281472|584387701|FG000|Stage B|Sponsor decision|0|||
161821519|NCT04281472|584387702|FG001|Stage B|Sponsor decision|0|||
161821520|NCT04281472|584387703|FG002|Stage B|Sponsor decision|1|||
161821521|NCT04281472|584387701|FG000|Stage B|Withdrawal by Subject|0|||
161821522|NCT04281472|584387702|FG001|Stage B|Withdrawal by Subject|3|||
161821523|NCT04281472|584387703|FG002|Stage B|Withdrawal by Subject|3|||
161821524|NCT04281472|584387701|FG000|Stage B|Other|0|||
161821525|NCT04281472|584387702|FG001|Stage B|Other|3|||
161821526|NCT04281472|584387703|FG002|Stage B|Other|0|||
161821527|NCT01055834|584387706|FG000|Treatment Period I|Adverse Event|1|||
161821528|NCT01055834|584387707|FG001|Treatment Period I|Adverse Event|0|||
161821529|NCT00467597|584387708|FG000|Overall Study|Withdrawal by Subject|2|||
161821530|NCT00467597|584387709|FG001|Overall Study|Withdrawal by Subject|0|||
161821531|NCT03141151|584387710|FG000|Overall Study|Lost to Follow-up|3|||
161821532|NCT03141151|584387711|FG001|Overall Study|Lost to Follow-up|2|||
161821533|NCT03141151|584387710|FG000|Overall Study|Withdrawal by Subject|3|||
161821534|NCT03141151|584387711|FG001|Overall Study|Withdrawal by Subject|2|||
161821535|NCT04561115|584387718|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
161821536|NCT04561115|584387719|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
161821537|NCT04561115|584387718|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
161821538|NCT04561115|584387719|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
161821539|NCT04561115|584387718|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
161821540|NCT04561115|584387719|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
161821541|NCT00743145|584387720|FG000|Overall Study|Withdrawal by Subject|1|||
161821542|NCT00743145|584387720|FG000|Overall Study|Adverse Event|2|||
161821543|NCT00743145|584387720|FG000|Overall Study|Pregnancy|1|||
161821544|NCT01670097|584387721|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
161821545|NCT01670097|584387722|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
161821546|NCT01670097|584387721|FG000|Overall Study|Study burden|1|||
161821547|NCT01670097|584387722|FG001|Overall Study|Study burden|0|||
161821548|NCT01670097|584387721|FG000|Overall Study|COPD exacerbation|0|||
161821549|NCT01670097|584387722|FG001|Overall Study|COPD exacerbation|1|||
161821550|NCT01670097|584387721|FG000|Overall Study|Neutropenia|0|||
161821551|NCT01670097|584387722|FG001|Overall Study|Neutropenia|1|||
161821552|NCT01670097|584387721|FG000|Overall Study|Clinical deterioration|0|||
161821553|NCT01670097|584387722|FG001|Overall Study|Clinical deterioration|1|||
161821554|NCT01670097|584387721|FG000|Overall Study|Disease progression|0|||
161821555|NCT01670097|584387722|FG001|Overall Study|Disease progression|1|||
161821556|NCT02311894|584387723|FG000|Overall Study|Discontinued in error|1|||
161821557|NCT02311894|584387723|FG000|Overall Study|Lost to Follow-up|1|||
161821558|NCT02311894|584387723|FG000|Overall Study|Adverse Event|1|||
161821559|NCT02311894|584387723|FG000|Overall Study|Withdrawal by Subject|1|||
161821560|NCT00884390|584387724|FG000|Overall Study|Adverse Event|0|||
161676457|NCT00436618|583868791|FG001|Overall Study|Alternate Treatment|4|||
161676458|NCT00436618|583868792|FG002|Overall Study|Alternate Treatment|12|||
161821561|NCT00884390|584387725|FG001|Overall Study|Adverse Event|1|||
161821562|NCT00884390|584387724|FG000|Overall Study|Lost to Follow-up|0|||
161821563|NCT00884390|584387725|FG001|Overall Study|Lost to Follow-up|1|||
161821564|NCT00884390|584387724|FG000|Overall Study|Physician Decision|2|||
161928183|NCT00662038|584785483|FG000|Overall Study|Lung transplantation|44|||
161821565|NCT00884390|584387725|FG001|Overall Study|Physician Decision|1|||
161821566|NCT00884390|584387724|FG000|Overall Study|Protocol Violation|4|||
161821567|NCT00884390|584387725|FG001|Overall Study|Protocol Violation|1|||
161821568|NCT00884390|584387724|FG000|Overall Study|Withdrawal by Subject|4|||
161821569|NCT00884390|584387725|FG001|Overall Study|Withdrawal by Subject|1|||
161821570|NCT00884390|584387724|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
161821571|NCT00884390|584387725|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
161821572|NCT00884390|584387724|FG000|Overall Study|Other|11|||
161821573|NCT00884390|584387725|FG001|Overall Study|Other|1|||
161821574|NCT01691612|584387726|FG000|Overall Study|deemed ineligible after 1st visit|6|||
161821575|NCT01691612|584387726|FG000|Overall Study|Adverse Event|1|||
161821576|NCT04049097|584387730|FG000|Overall Study|Adverse Event|18|||
161821577|NCT04049097|584387730|FG000|Overall Study|Death|2|||
161821578|NCT04049097|584387730|FG000|Overall Study|Lost to Follow-up|1|||
161821579|NCT04049097|584387730|FG000|Overall Study|Physician Decision|2|||
161821580|NCT04049097|584387730|FG000|Overall Study|Withdrawal by Subject|9|||
161821581|NCT04049097|584387730|FG000|Overall Study|Protocol Violation|2|||
161821582|NCT04049097|584387730|FG000|Overall Study|Other|1|||
161821583|NCT04049097|584387730|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
161821584|NCT01874535|584387734|FG000|Overall Study|Lost to Follow-up|10|||
161821585|NCT01874535|584387735|FG001|Overall Study|Lost to Follow-up|9|||
161821586|NCT01874535|584387734|FG000|Overall Study|incomplete symptom resolution|45|||
161821587|NCT01874535|584387735|FG001|Overall Study|incomplete symptom resolution|35|||
161821588|NCT05263505|584387737|FG000|Overall Study|Adverse Event|0|||
161821589|NCT05263505|584387738|FG001|Overall Study|Adverse Event|1|||
161821590|NCT02616380|584387739|FG000|Overall Study|Lost to Follow-up|1|||
161821591|NCT02616380|584387739|FG000|Overall Study|Other|2|||
161821592|NCT05065619|584387740|FG000|Up to Day 42|Lost to Follow-up|1|||
161821593|NCT05065619|584387741|FG001|Up to Day 42|Lost to Follow-up|0|||
161821594|NCT05065619|584387740|FG000|Up to Day 42|Withdrawal by Subject|1|||
161821595|NCT05065619|584387741|FG001|Up to Day 42|Withdrawal by Subject|0|||
161821596|NCT05065619|584387740|FG000|After Day 43|Lost to Follow-up|1|||
161821597|NCT05065619|584387741|FG001|After Day 43|Lost to Follow-up|0|||
161821598|NCT05065619|584387740|FG000|After Day 43|Physician Decision|3|||
161821599|NCT05065619|584387741|FG001|After Day 43|Physician Decision|0|||
161821600|NCT05065619|584387740|FG000|After Day 43|Withdrawal by Subject|1|||
161821601|NCT05065619|584387741|FG001|After Day 43|Withdrawal by Subject|2|||
161821602|NCT05065619|584387740|FG000|After Day 43|Public vaccination|6|||
161821603|NCT05065619|584387741|FG001|After Day 43|Public vaccination|8|||
161821604|NCT05065619|584387740|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
161821605|NCT05065619|584387741|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
161821606|NCT05065619|584387740|FG000|After Day 43|Study Terminated by Sponsor|88|||
161821607|NCT05065619|584387741|FG001|After Day 43|Study Terminated by Sponsor|16|||
161821608|NCT01050764|584387742|FG000|Overall Study|Death, before HSCT|1|||
161821609|NCT01050764|584387742|FG000|Overall Study|Donor mobilization failure, death|1|||
161821610|NCT01050764|584387742|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
161821611|NCT01929681|584387747|FG000|Overall Study|Withdrawal by Subject|1|||
161821612|NCT01929681|584387748|FG001|Overall Study|Withdrawal by Subject|0|||
161821613|NCT01929681|584387747|FG000|Overall Study|Physician Decision|1|||
161821614|NCT01929681|584387748|FG001|Overall Study|Physician Decision|1|||
161821615|NCT05315713|584387749|FG000|Overall Study|Death|5|||
161821616|NCT05315713|584387749|FG000|Overall Study|Progressive disease|1|||
161821617|NCT05315713|584387749|FG000|Overall Study|Withdrawal by Subject|1|||
161821618|NCT05315713|584387749|FG000|Overall Study|Study terminated by sponsor|1|||
161821619|NCT04194151|584387751|FG000|Overall Study|Physician Decision|1|||
161821620|NCT04194151|584387752|FG001|Overall Study|Physician Decision|1|||
161821621|NCT04194151|584387753|FG002|Overall Study|Physician Decision|1|||
161821622|NCT04194151|584387754|FG003|Overall Study|Physician Decision|1|||
161821623|NCT04194151|584387755|FG004|Overall Study|Physician Decision|0|||
161821624|NCT04194151|584387756|FG005|Overall Study|Physician Decision|1|||
161821625|NCT04194151|584387751|FG000|Overall Study|Monitorization problem|0|||
161821626|NCT04194151|584387752|FG001|Overall Study|Monitorization problem|1|||
161821627|NCT04194151|584387753|FG002|Overall Study|Monitorization problem|0|||
161821628|NCT04194151|584387754|FG003|Overall Study|Monitorization problem|0|||
161821629|NCT04194151|584387755|FG004|Overall Study|Monitorization problem|0|||
161821630|NCT04194151|584387756|FG005|Overall Study|Monitorization problem|0|||
161821631|NCT00421304|584387757|FG000|Overall Study|Lost to Follow-up|5|||
161821632|NCT00421304|584387758|FG001|Overall Study|Lost to Follow-up|2|||
161821633|NCT00421304|584387759|FG002|Overall Study|Lost to Follow-up|5|||
161821634|NCT00421304|584387757|FG000|Overall Study|Withdrawal by Subject|2|||
161821635|NCT00421304|584387758|FG001|Overall Study|Withdrawal by Subject|2|||
161821636|NCT00421304|584387759|FG002|Overall Study|Withdrawal by Subject|2|||
161821637|NCT00421304|584387757|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
161821638|NCT00421304|584387758|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
161821639|NCT00421304|584387759|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
161821640|NCT00421304|584387757|FG000|Overall Study|Did not attend Day 360 visit|0|||
161928184|NCT00662038|584785483|FG000|Overall Study|Lost to Follow-up|1|||
161928185|NCT00662038|584785483|FG000|Overall Study|Death|95|||
161928186|NCT00662038|584785483|FG000|Overall Study|Adverse Event|358|||
161928187|NCT00662038|584785483|FG000|Overall Study|Continued treatment|5|||
161928188|NCT00397046|584785484|FG000|Overall Study|Disease Progression|3|||
161928189|NCT00397046|584785485|FG001|Overall Study|Disease Progression|3|||
161928190|NCT00397046|584785486|FG002|Overall Study|Disease Progression|10|||
161928191|NCT00397046|584785487|FG003|Overall Study|Disease Progression|5|||
161676459|NCT00436618|583868790|FG000|Overall Study|Other Medical Problems|3|||
161676460|NCT00436618|583868791|FG001|Overall Study|Other Medical Problems|1|||
161676461|NCT00436618|583868792|FG002|Overall Study|Other Medical Problems|7|||
161676462|NCT00436618|583868790|FG000|Overall Study|Death|4|||
161676463|NCT00436618|583868791|FG001|Overall Study|Death|2|||
161676464|NCT00436618|583868792|FG002|Overall Study|Death|3|||
161676465|NCT00436618|583868790|FG000|Overall Study|New Primary or Other Reasons|6|||
161676466|NCT00436618|583868791|FG001|Overall Study|New Primary or Other Reasons|2|||
161928192|NCT01975285|584785488|FG000|Overall Study|Failed Block and follow up|2|||
161928193|NCT01975285|584785489|FG001|Overall Study|Failed Block and follow up|2|||
161928194|NCT02421510|584785490|FG000|Overall Study|Other|4|||
161928195|NCT02421510|584785491|FG001|Overall Study|Other|2|||
161928196|NCT02421510|584785492|FG002|Overall Study|Other|3|||
161928197|NCT02421510|584785490|FG000|Overall Study|Protocol Violation|1|||
161928198|NCT02421510|584785491|FG001|Overall Study|Protocol Violation|2|||
161928199|NCT02421510|584785492|FG002|Overall Study|Protocol Violation|0|||
161928200|NCT02421510|584785490|FG000|Overall Study|Death|1|||
161928201|NCT02421510|584785491|FG001|Overall Study|Death|0|||
161928202|NCT02421510|584785492|FG002|Overall Study|Death|0|||
161928203|NCT02421510|584785490|FG000|Overall Study|Noncompliance with study drug|1|||
161928204|NCT02421510|584785491|FG001|Overall Study|Noncompliance with study drug|0|||
161928205|NCT02421510|584785492|FG002|Overall Study|Noncompliance with study drug|0|||
161928206|NCT02421510|584785490|FG000|Overall Study|Physician Decision|1|||
161928207|NCT02421510|584785491|FG001|Overall Study|Physician Decision|1|||
161928208|NCT02421510|584785492|FG002|Overall Study|Physician Decision|3|||
161928209|NCT02421510|584785490|FG000|Overall Study|Adverse Event|9|||
161928210|NCT02421510|584785491|FG001|Overall Study|Adverse Event|10|||
161928211|NCT02421510|584785492|FG002|Overall Study|Adverse Event|18|||
161928212|NCT02421510|584785490|FG000|Overall Study|Pregnancy|1|||
161928213|NCT02421510|584785491|FG001|Overall Study|Pregnancy|1|||
161928214|NCT02421510|584785492|FG002|Overall Study|Pregnancy|0|||
161928215|NCT02421510|584785490|FG000|Overall Study|Withdrawal by Subject|14|||
161928216|NCT02421510|584785491|FG001|Overall Study|Withdrawal by Subject|18|||
161928217|NCT02421510|584785492|FG002|Overall Study|Withdrawal by Subject|12|||
161928218|NCT02421510|584785490|FG000|Overall Study|Lost to Follow-up|1|||
161514100|NCT03265119|583271918|FG000|Overall Study|Lack of Efficacy|3|||
161514101|NCT03265119|583271919|FG001|Overall Study|Lack of Efficacy|0|||
161514102|NCT03265119|583271918|FG000|Overall Study|Protocol Violation|1|||
161676467|NCT00436618|583868792|FG002|Overall Study|New Primary or Other Reasons|12|||
161676468|NCT00436618|583868790|FG000|Overall Study|Still on treatment|1|||
161676469|NCT00436618|583868791|FG001|Overall Study|Still on treatment|2|||
161676470|NCT00436618|583868792|FG002|Overall Study|Still on treatment|7|||
161676471|NCT00698204|583868793|FG000|Overall Study|Withdrawal by Subject|1|||
161676472|NCT00698204|583868794|FG001|Overall Study|Withdrawal by Subject|0|||
161676473|NCT00314249|583868795|FG000|Overall Study|Adverse Event|73|||
161676474|NCT00314249|583868796|FG001|Overall Study|Adverse Event|94|||
161676475|NCT00314249|583868795|FG000|Overall Study|Lack of Efficacy|33|||
161676476|NCT00314249|583868796|FG001|Overall Study|Lack of Efficacy|24|||
161676477|NCT00314249|583868795|FG000|Overall Study|Withdrawal by Subject|21|||
161676478|NCT00314249|583868796|FG001|Overall Study|Withdrawal by Subject|28|||
161676479|NCT00314249|583868795|FG000|Overall Study|Lost to Follow-up|15|||
161676480|NCT00314249|583868796|FG001|Overall Study|Lost to Follow-up|9|||
161676481|NCT00314249|583868795|FG000|Overall Study|Physician Decision|1|||
161676482|NCT00314249|583868796|FG001|Overall Study|Physician Decision|1|||
161676483|NCT00314249|583868795|FG000|Overall Study|Withdrawn for other reasons|4|||
161676484|NCT00314249|583868796|FG001|Overall Study|Withdrawn for other reasons|1|||
161676485|NCT00314249|583868795|FG000|Overall Study|Non-Compliant|5|||
161676486|NCT00314249|583868796|FG001|Overall Study|Non-Compliant|6|||
161676487|NCT00058552|583868797|FG000|Overall Study|Died prior to receiving treatment|4|||
161676488|NCT00058552|583868798|FG001|Overall Study|Died prior to receiving treatment|2|||
161928219|NCT02421510|584785491|FG001|Overall Study|Lost to Follow-up|1|||
161928220|NCT02421510|584785492|FG002|Overall Study|Lost to Follow-up|0|||
161514103|NCT03265119|583271919|FG001|Overall Study|Protocol Violation|2|||
161676489|NCT00058552|583868797|FG000|Overall Study|Disease progression|52|||
161676490|NCT00058552|583868798|FG001|Overall Study|Disease progression|44|||
161676491|NCT00058552|583868797|FG000|Overall Study|Adverse Event|4|||
161928221|NCT04098302|584785500|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
161928222|NCT04098302|584785501|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
161928223|NCT04098302|584785502|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
161928224|NCT04098302|584785503|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
161676492|NCT00058552|583868798|FG001|Overall Study|Adverse Event|2|||
161676493|NCT00058552|583868797|FG000|Overall Study|Withdrawal by Subject|3|||
161676494|NCT00058552|583868798|FG001|Overall Study|Withdrawal by Subject|5|||
161676495|NCT00058552|583868797|FG000|Overall Study|Physician Decision|2|||
161676496|NCT00058552|583868798|FG001|Overall Study|Physician Decision|5|||
161676497|NCT00058552|583868797|FG000|Overall Study|Clinical disease progression|0|||
161676498|NCT00058552|583868798|FG001|Overall Study|Clinical disease progression|4|||
161676499|NCT02066311|583868799|FG000|Overall Study|Adverse Event|4|||
161676500|NCT02066311|583868799|FG000|Overall Study|Withdrawal by Subject|1|||
161676501|NCT01372150|583868802|FG000|Overall Study|Lack of Efficacy|3|||
161676502|NCT01372150|583868803|FG001|Overall Study|Lack of Efficacy|0|||
161676503|NCT01372150|583868804|FG002|Overall Study|Lack of Efficacy|1|||
161676504|NCT01372150|583868802|FG000|Overall Study|Lost to Follow-up|4|||
161676505|NCT01372150|583868803|FG001|Overall Study|Lost to Follow-up|5|||
161676506|NCT01372150|583868804|FG002|Overall Study|Lost to Follow-up|6|||
161676507|NCT01372150|583868802|FG000|Overall Study|Protocol Violation|1|||
161676508|NCT01372150|583868803|FG001|Overall Study|Protocol Violation|0|||
161676509|NCT01372150|583868804|FG002|Overall Study|Protocol Violation|3|||
161676510|NCT01372150|583868802|FG000|Overall Study|Withdrawal by Subject|2|||
161676511|NCT01372150|583868803|FG001|Overall Study|Withdrawal by Subject|7|||
161676512|NCT01372150|583868804|FG002|Overall Study|Withdrawal by Subject|2|||
161676513|NCT01372150|583868802|FG000|Overall Study|Other|1|||
161676514|NCT01372150|583868803|FG001|Overall Study|Other|0|||
161676515|NCT01372150|583868804|FG002|Overall Study|Other|2|||
161676516|NCT01372150|583868802|FG000|Overall Study|Adverse Event|2|||
161676517|NCT01372150|583868803|FG001|Overall Study|Adverse Event|1|||
161676518|NCT01372150|583868804|FG002|Overall Study|Adverse Event|2|||
161676519|NCT01372150|583868802|FG000|Overall Study|Randomized but not treated|0|||
161676520|NCT01372150|583868803|FG001|Overall Study|Randomized but not treated|1|||
161676521|NCT01372150|583868804|FG002|Overall Study|Randomized but not treated|0|||
161676522|NCT02316340|583868805|FG000|First Progression|Clinical progression|2|||
161676523|NCT02316340|583868806|FG001|First Progression|Clinical progression|1|||
161676524|NCT02316340|583868805|FG000|First Progression|Withdrawal by Subject|1|||
161676525|NCT02316340|583868806|FG001|First Progression|Withdrawal by Subject|0|||
161676526|NCT03781323|583868807|FG000|Overall Study|Withdrawal by Subject|1|||
161676527|NCT00770770|583868810|FG000|Overall Study|Lost to Follow-up|1|||
161676528|NCT00770770|583868811|FG001|Overall Study|Lost to Follow-up|0|||
161676529|NCT00770770|583868810|FG000|Overall Study|Withdrawal by Subject|1|||
161676530|NCT00770770|583868811|FG001|Overall Study|Withdrawal by Subject|0|||
161676531|NCT00770770|583868810|FG000|Overall Study|Death|0|||
161676532|NCT00770770|583868811|FG001|Overall Study|Death|1|||
161676533|NCT00770770|583868810|FG000|Overall Study|Study Terminated|8|||
161676534|NCT00770770|583868811|FG001|Overall Study|Study Terminated|0|||
161676535|NCT02486653|583868812|FG000|Overall Study|Withdrawal by Subject|1|||
161676536|NCT02486653|583868813|FG001|Overall Study|Withdrawal by Subject|3|||
161676537|NCT02486653|583868812|FG000|Overall Study|Protocol Violation|1|||
161676538|NCT02486653|583868813|FG001|Overall Study|Protocol Violation|0|||
161676539|NCT02486653|583868812|FG000|Overall Study|surgery cancelled|4|||
161676540|NCT02486653|583868813|FG001|Overall Study|surgery cancelled|1|||
161676541|NCT00800436|583868814|FG000|Overall Study|Withdrawal by Subject|0|||
161676542|NCT00800436|583868815|FG001|Overall Study|Withdrawal by Subject|0|||
161676543|NCT00800436|583868816|FG002|Overall Study|Withdrawal by Subject|1|||
161676544|NCT00800436|583868817|FG003|Overall Study|Withdrawal by Subject|1|||
161928225|NCT04098302|584785500|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
161928226|NCT04098302|584785501|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
161928227|NCT04098302|584785502|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
161928228|NCT04098302|584785503|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
161676545|NCT00800436|583868818|FG004|Overall Study|Withdrawal by Subject|0|||
161928229|NCT04098302|584785500|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
161928230|NCT04098302|584785501|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
161928231|NCT04098302|584785502|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
161928232|NCT04098302|584785503|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
161928233|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
161928234|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
161928235|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
161928236|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
161928237|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
161928238|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
161676546|NCT00800436|583868819|FG005|Overall Study|Withdrawal by Subject|0|||
161676547|NCT00800436|583868820|FG006|Overall Study|Withdrawal by Subject|0|||
161676548|NCT01230554|583868823|FG000|Overall Study|Lost to Follow-up|2|||
161676549|NCT01230554|583868823|FG000|Overall Study|Inability to maintain visit schedule|1|||
161676550|NCT01006265|583868824|FG000|Overall Study|Lost to Follow-up|1|||
161676551|NCT01006265|583868825|FG001|Overall Study|Lost to Follow-up|0|||
161676552|NCT01006265|583868826|FG002|Overall Study|Lost to Follow-up|1|||
161676553|NCT01006265|583868827|FG003|Overall Study|Lost to Follow-up|0|||
161928239|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
161928240|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
161928241|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
161928242|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
161928243|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
161928244|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
161928245|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
161928246|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
161928247|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
161928248|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
161928249|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
161928250|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
161928251|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
161928252|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
161928253|NCT05061706|584785504|FG000|Overall Study|Adverse Event|29|||
161928254|NCT05061706|584785505|FG001|Overall Study|Adverse Event|1|||
161928255|NCT05061706|584785504|FG000|Overall Study|Lack of Efficacy|0|||
161928256|NCT05061706|584785505|FG001|Overall Study|Lack of Efficacy|1|||
161928257|NCT05061706|584785504|FG000|Overall Study|Lost to Follow-up|2|||
161928258|NCT05061706|584785505|FG001|Overall Study|Lost to Follow-up|2|||
161928259|NCT05061706|584785504|FG000|Overall Study|Protocol Violation|3|||
161928260|NCT05061706|584785505|FG001|Overall Study|Protocol Violation|1|||
161928261|NCT05061706|584785504|FG000|Overall Study|Withdrawal by Subject|3|||
161928262|NCT05061706|584785505|FG001|Overall Study|Withdrawal by Subject|9|||
161928263|NCT00191152|584785506|FG000|Initial Treatment|Adverse Event|43|||
161928264|NCT00191152|584785507|FG001|Initial Treatment|Adverse Event|67|||
161928265|NCT00191152|584785506|FG000|Initial Treatment|Physician Decision|40|||
161928266|NCT00191152|584785507|FG001|Initial Treatment|Physician Decision|31|||
161928267|NCT00191152|584785506|FG000|Initial Treatment|Withdrawal by Subject|40|||
161928268|NCT00191152|584785507|FG001|Initial Treatment|Withdrawal by Subject|28|||
161928269|NCT00191152|584785506|FG000|Initial Treatment|Lost to Follow-up|0|||
161928270|NCT00191152|584785507|FG001|Initial Treatment|Lost to Follow-up|6|||
161928271|NCT00191152|584785506|FG000|Initial Treatment|Other|18|||
161928272|NCT00191152|584785507|FG001|Initial Treatment|Other|21|||
161928273|NCT00191152|584785506|FG000|Crossover Treatment|Adverse Event|8|||
161928274|NCT00191152|584785507|FG001|Crossover Treatment|Adverse Event|8|||
161928275|NCT00191152|584785506|FG000|Crossover Treatment|Physician Decision|7|||
161928276|NCT00191152|584785507|FG001|Crossover Treatment|Physician Decision|7|||
161928277|NCT00191152|584785506|FG000|Crossover Treatment|Withdrawal by Subject|6|||
161928278|NCT00191152|584785507|FG001|Crossover Treatment|Withdrawal by Subject|9|||
161928279|NCT00191152|584785506|FG000|Crossover Treatment|Lost to Follow-up|2|||
161928280|NCT00191152|584785507|FG001|Crossover Treatment|Lost to Follow-up|1|||
161928281|NCT00191152|584785506|FG000|Crossover Treatment|Other|4|||
161928282|NCT00191152|584785507|FG001|Crossover Treatment|Other|3|||
161928283|NCT00114777|584785511|FG000|Randomization to Month 36|Death|10|||
161676554|NCT01006265|583868824|FG000|Overall Study|Withdrawal by Subject|4|||
161676555|NCT01006265|583868825|FG001|Overall Study|Withdrawal by Subject|7|||
161676556|NCT01006265|583868826|FG002|Overall Study|Withdrawal by Subject|5|||
161676557|NCT01006265|583868827|FG003|Overall Study|Withdrawal by Subject|5|||
161676558|NCT01006265|583868824|FG000|Overall Study|Administrative reason|1|||
161676559|NCT01006265|583868825|FG001|Overall Study|Administrative reason|2|||
161676560|NCT01006265|583868826|FG002|Overall Study|Administrative reason|3|||
161676561|NCT01006265|583868827|FG003|Overall Study|Administrative reason|0|||
161676562|NCT01177384|583868828|FG000|Overall Study|Adverse Event|6|||
161676563|NCT01177384|583868829|FG001|Overall Study|Adverse Event|4|||
161676564|NCT01177384|583868828|FG000|Overall Study|Lack of Efficacy|0|||
161676565|NCT01177384|583868829|FG001|Overall Study|Lack of Efficacy|1|||
161676566|NCT01177384|583868828|FG000|Overall Study|Lost to Follow-up|3|||
161676567|NCT01177384|583868829|FG001|Overall Study|Lost to Follow-up|4|||
161676568|NCT01177384|583868828|FG000|Overall Study|Physician Decision|0|||
161676569|NCT01177384|583868829|FG001|Overall Study|Physician Decision|3|||
161676570|NCT01177384|583868828|FG000|Overall Study|Protocol Violation|0|||
161928284|NCT00114777|584785512|FG001|Randomization to Month 36|Death|4|||
161928285|NCT00114777|584785513|FG002|Randomization to Month 36|Death|3|||
161928286|NCT00114777|584785511|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
161928287|NCT00114777|584785512|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
161928288|NCT00114777|584785513|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
161928289|NCT00114777|584785511|FG000|Randomization to Month 36|Lack of Efficacy|19|||
161676571|NCT01177384|583868829|FG001|Overall Study|Protocol Violation|2|||
161676572|NCT01177384|583868828|FG000|Overall Study|Withdrawal by Subject|5|||
161928290|NCT00114777|584785512|FG001|Randomization to Month 36|Lack of Efficacy|15|||
161676573|NCT01177384|583868829|FG001|Overall Study|Withdrawal by Subject|12|||
161928291|NCT00114777|584785513|FG002|Randomization to Month 36|Lack of Efficacy|17|||
161928292|NCT00114777|584785511|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
161928293|NCT00114777|584785512|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
161821641|NCT00421304|584387758|FG001|Overall Study|Did not attend Day 360 visit|0|||
161821642|NCT00421304|584387759|FG002|Overall Study|Did not attend Day 360 visit|1|||
161821643|NCT00903877|584387760|FG000|Overall Study|Did not meet study criteria|33|||
161821644|NCT00903877|584387760|FG000|Overall Study|Withdrawal by Subject|3|||
161821645|NCT00903877|584387760|FG000|Overall Study|Adverse Event|2|||
161821646|NCT00903877|584387760|FG000|Overall Study|Lost to Follow-up|1|||
161928294|NCT00114777|584785513|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
161928295|NCT00114777|584785511|FG000|Randomization to Month 36|Adverse Event|34|||
161928296|NCT00114777|584785512|FG001|Randomization to Month 36|Adverse Event|35|||
161928297|NCT00114777|584785513|FG002|Randomization to Month 36|Adverse Event|44|||
161928298|NCT00114777|584785511|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
161928299|NCT00114777|584785512|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
161928300|NCT00114777|584785513|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
161928301|NCT00114777|584785511|FG000|Randomization to Month 36|Other|9|||
161928302|NCT00114777|584785512|FG001|Randomization to Month 36|Other|3|||
161928303|NCT00114777|584785513|FG002|Randomization to Month 36|Other|12|||
161928304|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Death|8|||
161928305|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Death|13|||
161928306|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Death|7|||
161928307|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
161928308|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
161928309|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
161928310|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
161928311|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
161928312|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
161928313|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
161928314|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
161928315|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
161928316|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
161928317|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
161928318|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
161928319|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
161928320|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
161928321|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
161928322|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
161928323|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
161928324|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
161928325|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
161928326|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
161928327|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
161928328|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Other|2|||
161588150|NCT04927065|583542329|FG009|Third Booster|Lost to Follow-up|0|||
161821647|NCT00903877|584387760|FG000|Overall Study|Participation put on hold|4|||
161821648|NCT00919711|584387761|FG000|Overall Study|Withdrawal by Subject|15|||
161928329|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Other|0|||
161928330|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Other|2|||
161928331|NCT01181128|584785514|FG000|Overall Study|Withdrawal by Subject|2|||
161928332|NCT01181128|584785515|FG001|Overall Study|Withdrawal by Subject|2|||
161928333|NCT01181128|584785516|FG002|Overall Study|Withdrawal by Subject|0|||
161928334|NCT01181128|584785514|FG000|Overall Study|Death|1|||
161588151|NCT04927065|583542330|FG010|Third Booster|Lost to Follow-up|0|||
161588152|NCT04927065|583542331|FG011|Third Booster|Lost to Follow-up|0|||
161588153|NCT04927065|583542332|FG012|Third Booster|Lost to Follow-up|0|||
161588154|NCT04927065|583542333|FG013|Third Booster|Lost to Follow-up|0|||
161588155|NCT04927065|583542334|FG014|Third Booster|Lost to Follow-up|0|||
161588156|NCT04927065|583542335|FG015|Third Booster|Lost to Follow-up|1|||
161588157|NCT04927065|583542320|FG000|Third Booster|Withdrawal by Subject|0|||
161588158|NCT04927065|583542321|FG001|Third Booster|Withdrawal by Subject|0|||
161588159|NCT04927065|583542322|FG002|Third Booster|Withdrawal by Subject|0|||
161588160|NCT04927065|583542323|FG003|Third Booster|Withdrawal by Subject|0|||
161821649|NCT00919711|584387762|FG001|Overall Study|Withdrawal by Subject|7|||
161821650|NCT00919711|584387761|FG000|Overall Study|Adverse Event|13|||
161821651|NCT00919711|584387762|FG001|Overall Study|Adverse Event|3|||
161928335|NCT01181128|584785515|FG001|Overall Study|Death|0|||
161928336|NCT01181128|584785516|FG002|Overall Study|Death|0|||
161928337|NCT01181128|584785514|FG000|Overall Study|Physician Decision|2|||
161928338|NCT01181128|584785515|FG001|Overall Study|Physician Decision|0|||
161928339|NCT01181128|584785516|FG002|Overall Study|Physician Decision|0|||
161928340|NCT01181128|584785514|FG000|Overall Study|Adverse Event|0|||
161928341|NCT01181128|584785515|FG001|Overall Study|Adverse Event|2|||
161928342|NCT01181128|584785516|FG002|Overall Study|Adverse Event|0|||
161588161|NCT04927065|583542324|FG004|Third Booster|Withdrawal by Subject|0|||
161588162|NCT04927065|583542325|FG005|Third Booster|Withdrawal by Subject|0|||
161588163|NCT04927065|583542326|FG006|Third Booster|Withdrawal by Subject|0|||
161588164|NCT04927065|583542327|FG007|Third Booster|Withdrawal by Subject|0|||
161588165|NCT04927065|583542328|FG008|Third Booster|Withdrawal by Subject|0|||
161821652|NCT00919711|584387761|FG000|Overall Study|Other|1|||
161821653|NCT00919711|584387762|FG001|Overall Study|Other|2|||
161821654|NCT00919711|584387761|FG000|Overall Study|Administrative Decision|0|||
161821655|NCT00919711|584387762|FG001|Overall Study|Administrative Decision|1|||
161821656|NCT00919711|584387761|FG000|Overall Study|Lost to Follow-up|2|||
161821657|NCT00919711|584387762|FG001|Overall Study|Lost to Follow-up|0|||
161821658|NCT00919711|584387761|FG000|Overall Study|Death|1|||
161821659|NCT00919711|584387762|FG001|Overall Study|Death|0|||
161821660|NCT00919711|584387761|FG000|Overall Study|Noncompliance|1|||
161821661|NCT00919711|584387762|FG001|Overall Study|Noncompliance|0|||
161821662|NCT03694197|584387763|FG000|Overall Study|Adverse Event|9|||
161821663|NCT03694197|584387763|FG000|Overall Study|Protocol became inconvenient to participate|1|||
161821664|NCT03694197|584387763|FG000|Overall Study|Physician Decision|4|||
161821665|NCT03694197|584387763|FG000|Overall Study|Study terminated by sponsor|1350|||
161821666|NCT03694197|584387763|FG000|Overall Study|Participant moved|5|||
161821667|NCT03694197|584387763|FG000|Overall Study|Participant withdrew consent|10|||
161821668|NCT03694197|584387763|FG000|Overall Study|Related to IMP administration|1|||
161821669|NCT03694197|584387763|FG000|Overall Study|Not disclosed|5|||
161821670|NCT02940522|584389122|FG000|Overall Study|Lost to Follow-up|1|||
161821671|NCT02940522|584389123|FG001|Overall Study|Lost to Follow-up|2|||
161821672|NCT02940522|584389122|FG000|Overall Study|Withdrawal by Subject|1|||
161821673|NCT02940522|584389123|FG001|Overall Study|Withdrawal by Subject|0|||
161821674|NCT00274625|584389124|FG000|Overall Study|Lost to Follow-up|46|||
161821675|NCT00274625|584389125|FG001|Overall Study|Lost to Follow-up|54|||
161821676|NCT00274625|584389124|FG000|Overall Study|Excluded from analysis|14|||
161821677|NCT00274625|584389125|FG001|Overall Study|Excluded from analysis|8|||
161821678|NCT05135273|584389126|FG000|Overall Study|Recruited into the army|0|||
161821679|NCT05135273|584389127|FG001|Overall Study|Recruited into the army|0|||
161821680|NCT05135273|584389128|FG002|Overall Study|Recruited into the army|0|||
161821681|NCT05135273|584389129|FG003|Overall Study|Recruited into the army|0|||
161821682|NCT05135273|584389130|FG004|Overall Study|Recruited into the army|1|||
161821683|NCT05135273|584389131|FG005|Overall Study|Recruited into the army|0|||
161821684|NCT05135273|584389132|FG006|Overall Study|Recruited into the army|0|||
161821685|NCT05135273|584389133|FG007|Overall Study|Recruited into the army|0|||
161821686|NCT05135273|584389126|FG000|Overall Study|Moved away from study site|0|||
161821687|NCT05135273|584389127|FG001|Overall Study|Moved away from study site|0|||
161821688|NCT05135273|584389128|FG002|Overall Study|Moved away from study site|0|||
161821689|NCT05135273|584389129|FG003|Overall Study|Moved away from study site|0|||
161821690|NCT05135273|584389130|FG004|Overall Study|Moved away from study site|0|||
161821691|NCT05135273|584389131|FG005|Overall Study|Moved away from study site|1|||
161821692|NCT05135273|584389132|FG006|Overall Study|Moved away from study site|1|||
161821693|NCT05135273|584389133|FG007|Overall Study|Moved away from study site|0|||
161821694|NCT05135273|584389126|FG000|Overall Study|Travel|0|||
161821695|NCT05135273|584389127|FG001|Overall Study|Travel|0|||
161821696|NCT05135273|584389128|FG002|Overall Study|Travel|0|||
161821697|NCT05135273|584389129|FG003|Overall Study|Travel|0|||
161821698|NCT05135273|584389130|FG004|Overall Study|Travel|0|||
161821699|NCT05135273|584389131|FG005|Overall Study|Travel|0|||
161821700|NCT05135273|584389132|FG006|Overall Study|Travel|0|||
161821701|NCT05135273|584389133|FG007|Overall Study|Travel|1|||
161821702|NCT04264819|584389139|FG000|Overall Study|Physician Decision|19|||
161821703|NCT04264819|584389139|FG000|Overall Study|Adverse Event|12|||
161821704|NCT04264819|584389139|FG000|Overall Study|Withdrawal by Subject|11|||
161821705|NCT04264819|584389139|FG000|Overall Study|Lost to Follow-up|2|||
161821706|NCT04264819|584389139|FG000|Overall Study|Death|2|||
161821707|NCT01188226|584389147|FG000|Overall Study|Withdrawal by Subject|4|||
161821708|NCT04980456|584389148|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
161821709|NCT04980456|584389149|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
161821710|NCT04980456|584389148|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
161821711|NCT04980456|584389149|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
161821712|NCT04980456|584389148|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
161821713|NCT04980456|584389149|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
161821714|NCT04980456|584389148|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
161821715|NCT04980456|584389149|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
161821716|NCT00442351|584389152|FG000|Overall Study|Administrative|6|||
161821717|NCT00442351|584389153|FG001|Overall Study|Administrative|5|||
161821718|NCT00442351|584389152|FG000|Overall Study|Did not meet protocol eligibility|1|||
161821719|NCT00442351|584389153|FG001|Overall Study|Did not meet protocol eligibility|0|||
161821720|NCT00442351|584389152|FG000|Overall Study|Other|0|||
161821721|NCT00442351|584389153|FG001|Overall Study|Other|1|||
161821722|NCT00500318|584389154|FG000|Overall Study|Adverse Event|3|||
161821723|NCT00500318|584389155|FG001|Overall Study|Adverse Event|8|||
161821724|NCT00500318|584389154|FG000|Overall Study|Protocol Violation|1|||
161821725|NCT00500318|584389155|FG001|Overall Study|Protocol Violation|3|||
161821726|NCT00500318|584389154|FG000|Overall Study|Withdrawal by Subject|1|||
161821727|NCT00500318|584389155|FG001|Overall Study|Withdrawal by Subject|2|||
161821728|NCT00500318|584389154|FG000|Overall Study|Lack of Efficacy|0|||
161821729|NCT00500318|584389155|FG001|Overall Study|Lack of Efficacy|3|||
161821730|NCT00500318|584389154|FG000|Overall Study|Other Reason|0|||
161821731|NCT00500318|584389155|FG001|Overall Study|Other Reason|1|||
161821732|NCT01579006|584389159|FG000|Overall Study|Lack of Efficacy|10|||
161821733|NCT01579006|584389159|FG000|Overall Study|Adverse Event|13|||
161821734|NCT01579006|584389159|FG000|Overall Study|Withdrawal by Subject|5|||
161821735|NCT01579006|584389159|FG000|Overall Study|Non-compliance|3|||
161821736|NCT01579006|584389159|FG000|Overall Study|Due to participant's health fund|1|||
161821737|NCT01579006|584389159|FG000|Overall Study|Scheduled surgery|1|||
161821738|NCT01708954|584389163|FG000|Step 1|Disease progression|26|||
161821739|NCT01708954|584389164|FG001|Step 1|Disease progression|17|||
161821740|NCT01708954|584389165|FG002|Step 1|Disease progression|14|||
161821741|NCT01708954|584389163|FG000|Step 1|Adverse Event|3|||
161821742|NCT01708954|584389164|FG001|Step 1|Adverse Event|11|||
161821743|NCT01708954|584389165|FG002|Step 1|Adverse Event|13|||
161821744|NCT01708954|584389163|FG000|Step 1|Death|3|||
161821745|NCT01708954|584389164|FG001|Step 1|Death|2|||
161821746|NCT01708954|584389165|FG002|Step 1|Death|3|||
161821747|NCT01708954|584389163|FG000|Step 1|Withdrawal by Subject|2|||
161821748|NCT01708954|584389164|FG001|Step 1|Withdrawal by Subject|5|||
161821749|NCT01708954|584389165|FG002|Step 1|Withdrawal by Subject|3|||
161821750|NCT01708954|584389163|FG000|Step 1|Other complicating disease|0|||
161821751|NCT01708954|584389164|FG001|Step 1|Other complicating disease|2|||
161821752|NCT01708954|584389165|FG002|Step 1|Other complicating disease|0|||
161821753|NCT01708954|584389163|FG000|Step 1|Crossed over to Step 2|2|||
161821754|NCT01708954|584389164|FG001|Step 1|Crossed over to Step 2|0|||
161821755|NCT01708954|584389165|FG002|Step 1|Crossed over to Step 2|0|||
161821756|NCT01708954|584389163|FG000|Step 1|Symptomatic deterioration|1|||
161821757|NCT01708954|584389164|FG001|Step 1|Symptomatic deterioration|0|||
161821758|NCT01708954|584389165|FG002|Step 1|Symptomatic deterioration|1|||
161821759|NCT01708954|584389163|FG000|Step 1|Off-treatment reason not submitted|1|||
161928343|NCT01181128|584785514|FG000|Overall Study|Other|1|||
161676574|NCT00955279|583868830|FG000|Overall Study|Other|0|||
161676575|NCT00955279|583868831|FG001|Overall Study|Other|0|||
161676576|NCT00955279|583868832|FG002|Overall Study|Other|3|||
161676577|NCT00955279|583868830|FG000|Overall Study|Death|1|||
161676578|NCT00955279|583868831|FG001|Overall Study|Death|1|||
161676579|NCT00955279|583868832|FG002|Overall Study|Death|1|||
161676580|NCT00955279|583868830|FG000|Overall Study|Lost to Follow-up|0|||
161676581|NCT00955279|583868831|FG001|Overall Study|Lost to Follow-up|3|||
161676582|NCT00955279|583868832|FG002|Overall Study|Lost to Follow-up|1|||
161676583|NCT00955279|583868830|FG000|Overall Study|Withdrawal by Subject|2|||
161676584|NCT00955279|583868831|FG001|Overall Study|Withdrawal by Subject|0|||
161676585|NCT00955279|583868832|FG002|Overall Study|Withdrawal by Subject|3|||
161676586|NCT02921269|583868833|FG000|Overall Study|Did not complete DLT period|1|||
161676587|NCT00387764|583868844|FG000|Overall Study|Adverse Event|12|||
161676588|NCT00387764|583868844|FG000|Overall Study|Withdrawal by Subject|8|||
161676589|NCT00387764|583868844|FG000|Overall Study|Sponsor Terminated Study|1|||
161676590|NCT00387764|583868844|FG000|Overall Study|Physician Decision|1|||
161676591|NCT00387764|583868844|FG000|Overall Study|Other|2|||
161676592|NCT00387764|583868844|FG000|Overall Study|Death|7|||
161928344|NCT01181128|584785515|FG001|Overall Study|Other|1|||
161928345|NCT01181128|584785516|FG002|Overall Study|Other|1|||
161928346|NCT04477486|584785519|FG000|Overall Study|Death|2|||
161928347|NCT04477486|584785519|FG000|Overall Study|Ongoing at Time of Analysis|11|||
161928348|NCT01543503|584785521|FG000|Overall Study|Lost to Follow-up|32|||
161928349|NCT01543503|584785522|FG001|Overall Study|Lost to Follow-up|36|||
161676593|NCT01184053|583868845|FG000|Overall Study|progression while on treatment|3|||
161676594|NCT01174238|583868848|FG000|Overall Study|Lost to Follow-up|2|||
161821760|NCT01708954|584389164|FG001|Step 1|Off-treatment reason not submitted|1|||
161821761|NCT01708954|584389165|FG002|Step 1|Off-treatment reason not submitted|1|||
161676595|NCT02301936|583868849|FG000|Overall Study|Lost to Follow-up|1|||
161676596|NCT02301936|583868850|FG001|Overall Study|Lost to Follow-up|0|||
161676597|NCT00232141|583868854|FG000|Overall Study|Adverse Event|9|||
161821762|NCT01708954|584389163|FG000|Step 1|Ineligible or never received treatment|4|||
161821763|NCT01708954|584389164|FG001|Step 1|Ineligible or never received treatment|2|||
161821764|NCT01708954|584389165|FG002|Step 1|Ineligible or never received treatment|8|||
161821765|NCT01708954|584389163|FG000|Step 2|Disease progression|9|||
161821766|NCT01708954|584389164|FG001|Step 2|Disease progression|4|||
161821767|NCT01708954|584389165|FG002|Step 2|Disease progression|0|||
161821768|NCT01708954|584389163|FG000|Step 2|Adverse Event|3|||
161821769|NCT01708954|584389164|FG001|Step 2|Adverse Event|2|||
161821770|NCT01708954|584389165|FG002|Step 2|Adverse Event|0|||
161928350|NCT01543503|584785521|FG000|Overall Study|Adverse Event|9|||
161928351|NCT01543503|584785522|FG001|Overall Study|Adverse Event|13|||
161928352|NCT01543503|584785521|FG000|Overall Study|Lack of Efficacy|4|||
161928353|NCT01543503|584785522|FG001|Overall Study|Lack of Efficacy|16|||
161928354|NCT01543503|584785521|FG000|Overall Study|Participant withdrew informed consent|8|||
161928355|NCT01543503|584785522|FG001|Overall Study|Participant withdrew informed consent|10|||
161928356|NCT01543503|584785521|FG000|Overall Study|Change of jobs|0|||
161928357|NCT01543503|584785522|FG001|Overall Study|Change of jobs|1|||
161928358|NCT01543503|584785521|FG000|Overall Study|Intolerance to the biologic treatment|0|||
161928359|NCT01543503|584785522|FG001|Overall Study|Intolerance to the biologic treatment|1|||
161928360|NCT01543503|584785521|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
161928361|NCT01543503|584785522|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
161928362|NCT01543503|584785521|FG000|Overall Study|Participant did not complete last visit|0|||
161928363|NCT01543503|584785522|FG001|Overall Study|Participant did not complete last visit|2|||
161928364|NCT01543503|584785521|FG000|Overall Study|Refused to continue treatment|7|||
161928365|NCT01543503|584785522|FG001|Overall Study|Refused to continue treatment|0|||
161928366|NCT01543503|584785521|FG000|Overall Study|Incorrect medication received|1|||
161928367|NCT01543503|584785522|FG001|Overall Study|Incorrect medication received|0|||
161928368|NCT01543503|584785521|FG000|Overall Study|Participant moved to another city|2|||
161928369|NCT01543503|584785522|FG001|Overall Study|Participant moved to another city|0|||
161928370|NCT01543503|584785521|FG000|Overall Study|Participant will not return for visits|0|||
161928371|NCT01543503|584785522|FG001|Overall Study|Participant will not return for visits|2|||
161928372|NCT01543503|584785521|FG000|Overall Study|Participant transferred to another city|1|||
161928373|NCT01543503|584785522|FG001|Overall Study|Participant transferred to another city|0|||
161928374|NCT01543503|584785521|FG000|Overall Study|Participant moved to Scotland|1|||
161928375|NCT01543503|584785522|FG001|Overall Study|Participant moved to Scotland|0|||
161928376|NCT01543503|584785521|FG000|Overall Study|Participant decision to stop treatment|1|||
161928377|NCT01543503|584785522|FG001|Overall Study|Participant decision to stop treatment|0|||
161928378|NCT01543503|584785521|FG000|Overall Study|Investigator did not wish to participate|1|||
161928379|NCT01543503|584785522|FG001|Overall Study|Investigator did not wish to participate|1|||
161928380|NCT01543503|584785521|FG000|Overall Study|Participant recruited after closing date|0|||
161928381|NCT01543503|584785522|FG001|Overall Study|Participant recruited after closing date|1|||
161928382|NCT01543503|584785521|FG000|Overall Study|Site stopped participation|5|||
161928383|NCT01543503|584785522|FG001|Overall Study|Site stopped participation|1|||
161928384|NCT01543503|584785521|FG000|Overall Study|Participant did not attend a visit|1|||
161928385|NCT01543503|584785522|FG001|Overall Study|Participant did not attend a visit|0|||
161928386|NCT01543503|584785521|FG000|Overall Study|Moved to other rheumatologic site|0|||
161928387|NCT01543503|584785522|FG001|Overall Study|Moved to other rheumatologic site|1|||
161928388|NCT01543503|584785521|FG000|Overall Study|Participant consented to another study|0|||
161928389|NCT01543503|584785522|FG001|Overall Study|Participant consented to another study|2|||
161928390|NCT01543503|584785521|FG000|Overall Study|Participant went to United States|1|||
161928391|NCT01543503|584785522|FG001|Overall Study|Participant went to United States|0|||
161928392|NCT01543503|584785521|FG000|Overall Study|Screen failure|1|||
161928393|NCT01543503|584785522|FG001|Overall Study|Screen failure|0|||
161928394|NCT01986751|584785523|FG000|Overall Study|improperly consented|10|||
161514104|NCT03265119|583271918|FG000|Overall Study|Withdrawal by Subject|2|||
161514105|NCT03265119|583271919|FG001|Overall Study|Withdrawal by Subject|4|||
161514106|NCT03265119|583271918|FG000|Overall Study|Lost to Follow-up|1|||
161514107|NCT03265119|583271919|FG001|Overall Study|Lost to Follow-up|0|||
161514108|NCT03265119|583271918|FG000|Overall Study|Lack of Compliance|1|||
161514109|NCT03265119|583271919|FG001|Overall Study|Lack of Compliance|0|||
161514110|NCT00600821|583273490|FG000|Overall Study|Death|45|||
161514111|NCT00600821|583273491|FG001|Overall Study|Death|46|||
161514112|NCT00600821|583273490|FG000|Overall Study|Lost to Follow-up|2|||
161514113|NCT00600821|583273491|FG001|Overall Study|Lost to Follow-up|2|||
161514114|NCT00600821|583273490|FG000|Overall Study|Withdrawal by Subject|1|||
161514115|NCT00600821|583273491|FG001|Overall Study|Withdrawal by Subject|1|||
161514116|NCT00600821|583273490|FG000|Overall Study|Terminated by sponsor|8|||
161514117|NCT00600821|583273491|FG001|Overall Study|Terminated by sponsor|6|||
161514118|NCT00600821|583273490|FG000|Overall Study|Objective progression or relapse|0|||
161514119|NCT00600821|583273491|FG001|Overall Study|Objective progression or relapse|1|||
161514120|NCT00600821|583273490|FG000|Overall Study|Randomized but not treated|0|||
161514121|NCT00600821|583273491|FG001|Overall Study|Randomized but not treated|1|||
161514122|NCT00600821|583273490|FG000|Overall Study|Other|2|||
161514123|NCT00600821|583273491|FG001|Overall Study|Other|3|||
161514124|NCT02602288|583273494|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
161514125|NCT02602288|583273495|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
161514126|NCT02602288|583273494|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
161928395|NCT01986751|584785524|FG001|Overall Study|improperly consented|2|||
161928396|NCT00052715|584785530|FG000|Overall Study|wrong histology|1|||
161514127|NCT02602288|583273495|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
161514128|NCT02602288|583273494|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
161676598|NCT00232141|583868855|FG001|Overall Study|Adverse Event|4|||
161676599|NCT00232141|583868854|FG000|Overall Study|Lack of Efficacy|0|||
161676600|NCT00232141|583868855|FG001|Overall Study|Lack of Efficacy|3|||
161676601|NCT00232141|583868854|FG000|Overall Study|Lost to Follow-up|9|||
161676602|NCT00232141|583868855|FG001|Overall Study|Lost to Follow-up|6|||
161676603|NCT00232141|583868854|FG000|Overall Study|Other|8|||
161676604|NCT00232141|583868855|FG001|Overall Study|Other|10|||
161676605|NCT00232141|583868854|FG000|Overall Study|Withdrawal by Subject|5|||
161676606|NCT00232141|583868855|FG001|Overall Study|Withdrawal by Subject|3|||
161676607|NCT00601250|583868859|FG000|Overall Study|Adverse Event|3|||
161676608|NCT00601250|583868860|FG001|Overall Study|Adverse Event|9|||
161676609|NCT00601250|583868859|FG000|Overall Study|Protocol Violation|3|||
161676610|NCT00601250|583868860|FG001|Overall Study|Protocol Violation|2|||
161676611|NCT00601250|583868859|FG000|Overall Study|Lost to Follow-up|2|||
161676612|NCT00601250|583868860|FG001|Overall Study|Lost to Follow-up|6|||
161676613|NCT00601250|583868859|FG000|Overall Study|Withdrawal by Subject|4|||
161676614|NCT00601250|583868860|FG001|Overall Study|Withdrawal by Subject|13|||
161676615|NCT00601250|583868859|FG000|Overall Study|Other incl. lack of efficacy|2|||
161676616|NCT00601250|583868860|FG001|Overall Study|Other incl. lack of efficacy|9|||
161676617|NCT01810016|583868861|FG000|Overall Study|Progressive disease|1|||
161676618|NCT01810016|583868862|FG001|Overall Study|Progressive disease|1|||
161676619|NCT01810016|583868863|FG002|Overall Study|Progressive disease|0|||
161676620|NCT01810016|583868861|FG000|Overall Study|Death|0|||
161676621|NCT01810016|583868862|FG001|Overall Study|Death|0|||
161676622|NCT01810016|583868863|FG002|Overall Study|Death|1|||
161676623|NCT06950879|583868865|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
161676624|NCT02229539|583870463|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
161676625|NCT02229539|583870464|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
161676626|NCT02229539|583870465|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
161676627|NCT02229539|583870463|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
161676628|NCT02229539|583870464|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
161676629|NCT02229539|583870465|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
161676630|NCT02229539|583870463|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
161676631|NCT02229539|583870464|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
161676632|NCT02229539|583870465|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
161676633|NCT02229539|583870463|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
161676634|NCT02229539|583870464|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
161676635|NCT02229539|583870465|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
161676636|NCT02229539|583870463|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
161676637|NCT02229539|583870464|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
161676638|NCT02229539|583870465|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
161676639|NCT02229539|583870463|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
161676640|NCT02229539|583870464|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
161676641|NCT02229539|583870465|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
161676642|NCT03441334|583870466|FG000|Overall Study|Withdrawal by Subject|1|||
161676643|NCT03441334|583870467|FG001|Overall Study|Withdrawal by Subject|0|||
161676644|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
161676645|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
161676646|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Adverse Event|14|||
161676647|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Adverse Event|19|||
161676648|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Death|11|||
161676649|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Death|12|||
161676650|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
161676651|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
161676652|NCT00088907|583870468|FG000|Randomized Study (Step 1)|complicating disease|3|||
161676653|NCT00088907|583870469|FG001|Randomized Study (Step 1)|complicating disease|1|||
161676654|NCT00088907|583870468|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
161676655|NCT00088907|583870469|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
161676656|NCT00088907|583870468|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
161676657|NCT00088907|583870469|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
161676658|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
161676659|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
161676660|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
161676661|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
161821771|NCT01708954|584389163|FG000|Step 2|Withdrawal by Subject|1|||
161821772|NCT01708954|584389164|FG001|Step 2|Withdrawal by Subject|1|||
161821773|NCT01708954|584389165|FG002|Step 2|Withdrawal by Subject|0|||
161821774|NCT01192776|584389166|FG000|Overall Study|Death|8|||
161821775|NCT01192776|584389167|FG001|Overall Study|Death|15|||
161676662|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
161676663|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
161821776|NCT01192776|584389168|FG002|Overall Study|Death|18|||
161514129|NCT02602288|583273495|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
161676664|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
161676665|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
161676666|NCT00682448|583870476|FG000|Overall Study|Adverse Event|1|||
161676667|NCT00682448|583870477|FG001|Overall Study|Adverse Event|2|||
161676668|NCT00682448|583870476|FG000|Overall Study|Lack of Efficacy|1|||
161676669|NCT00682448|583870477|FG001|Overall Study|Lack of Efficacy|0|||
161676670|NCT00682448|583870476|FG000|Overall Study|Lost to Follow-up|1|||
161676671|NCT00682448|583870477|FG001|Overall Study|Lost to Follow-up|3|||
161676672|NCT00682448|583870476|FG000|Overall Study|Pregnancy|0|||
161676673|NCT00682448|583870477|FG001|Overall Study|Pregnancy|1|||
161676674|NCT00682448|583870476|FG000|Overall Study|Withdrawal by Subject|2|||
161676675|NCT00682448|583870477|FG001|Overall Study|Withdrawal by Subject|0|||
161676676|NCT04050670|583870480|FG000|Period 3|Physician Decision|0|||
161676677|NCT04050670|583870481|FG001|Period 3|Physician Decision|1|||
161676678|NCT04050670|583870482|FG002|Period 3|Physician Decision|0|||
161676679|NCT00268437|583870483|FG000|Overall Study|Ineligible|1|||
161676680|NCT02553265|583870484|FG000|Enrollment|Death|0|||
161676681|NCT02553265|583870485|FG001|Enrollment|Death|0|||
161676682|NCT02553265|583870486|FG002|Enrollment|Death|1|||
161676683|NCT02553265|583870484|FG000|First Intervention (28 Days)|Adverse Event|1|||
161676684|NCT02553265|583870485|FG001|First Intervention (28 Days)|Adverse Event|0|||
161676685|NCT02553265|583870486|FG002|First Intervention (28 Days)|Adverse Event|0|||
161676686|NCT02553265|583870484|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
161676687|NCT02553265|583870485|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
161676688|NCT02553265|583870486|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
161676689|NCT02553265|583870484|FG000|Second Intervention (28 Days)|Adverse Event|1|||
161676690|NCT02553265|583870485|FG001|Second Intervention (28 Days)|Adverse Event|0|||
161676691|NCT02553265|583870486|FG002|Second Intervention (28 Days)|Adverse Event|0|||
161676692|NCT02553265|583870484|FG000|Third Intervention (28 Days)|Adverse Event|1|||
161676693|NCT02553265|583870485|FG001|Third Intervention (28 Days)|Adverse Event|0|||
161676694|NCT02553265|583870486|FG002|Third Intervention (28 Days)|Adverse Event|0|||
161676695|NCT02553265|583870484|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
161676696|NCT02553265|583870485|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
161676697|NCT02553265|583870486|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
161676698|NCT00659529|583870487|FG000|Overall Study|Withdrawal by Subject|4|||
161676699|NCT00659529|583870487|FG000|Overall Study|Protocol Violation|3|||
161676700|NCT00659529|583870487|FG000|Overall Study|Screen failure|9|||
161676701|NCT01022996|583870491|FG000|Overall Study|Adverse Event|14|||
161676702|NCT01022996|583870491|FG000|Overall Study|Withdrawal by Subject|3|||
161676703|NCT01022996|583870491|FG000|Overall Study|Lost to Follow-up|1|||
161676704|NCT01022996|583870491|FG000|Overall Study|Administrative problems|6|||
161676705|NCT01022996|583870491|FG000|Overall Study|Disease Progression|32|||
161676706|NCT01022996|583870491|FG000|Overall Study|Protocol Violation|1|||
161676707|NCT02767323|583870492|FG000|Overall Study|Withdrawal by Subject|17|||
161676708|NCT02767323|583870493|FG001|Overall Study|Withdrawal by Subject|5|||
161676709|NCT02767323|583870494|FG002|Overall Study|Withdrawal by Subject|13|||
161676710|NCT02767323|583870495|FG003|Overall Study|Withdrawal by Subject|0|||
161676711|NCT02767323|583870492|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
161676712|NCT02767323|583870493|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
161676713|NCT02767323|583870494|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
161676714|NCT02767323|583870495|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
161676715|NCT00930722|583870496|FG000|Overall Study|Lost to Follow-up|16|||
161676716|NCT00930722|583870496|FG000|Overall Study|No longer willing to participate|9|||
161676717|NCT00930722|583870496|FG000|Overall Study|Study terminated by sponsor|2|||
161676718|NCT02023242|583870497|FG000|Overall Study|Lost to Follow-up|3|||
161676719|NCT02023242|583870498|FG001|Overall Study|Lost to Follow-up|1|||
161676720|NCT02023242|583870497|FG000|Overall Study|Death|0|||
161821777|NCT01192776|584389169|FG003|Overall Study|Death|15|||
161676721|NCT02023242|583870498|FG001|Overall Study|Death|1|||
161676722|NCT00710879|583870504|FG000|Overall Study|Lost to Follow-up|2|||
161676723|NCT00710879|583870505|FG001|Overall Study|Lost to Follow-up|1|||
161821778|NCT01192776|584389166|FG000|Overall Study|Lost to Follow-up|3|||
161821779|NCT01192776|584389167|FG001|Overall Study|Lost to Follow-up|6|||
161821780|NCT01192776|584389168|FG002|Overall Study|Lost to Follow-up|3|||
161821781|NCT01192776|584389169|FG003|Overall Study|Lost to Follow-up|5|||
161821782|NCT02587143|584389173|FG000|Overall Study|Adverse Event|1|||
161676724|NCT00710879|583870504|FG000|Overall Study|Protocol Violation|0|||
161676725|NCT00710879|583870505|FG001|Overall Study|Protocol Violation|3|||
161821783|NCT02587143|584389174|FG001|Overall Study|Adverse Event|0|||
161676726|NCT01809132|583870506|FG000|Overall Study|Withdrawal by Subject|0|||
161676727|NCT01809132|583870507|FG001|Overall Study|Withdrawal by Subject|0|||
161821784|NCT00611884|584389175|FG000|Overall Study|Adverse Event|1|||
161821785|NCT00611884|584389176|FG001|Overall Study|Adverse Event|0|||
161821786|NCT00611884|584389177|FG002|Overall Study|Adverse Event|0|||
161821787|NCT00611884|584389178|FG003|Overall Study|Adverse Event|1|||
161928397|NCT01774370|584785537|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
161928398|NCT01774370|584785537|FG000|Overall Study|Administered prior to the contract date|4|||
161928399|NCT01774370|584785537|FG000|Overall Study|Subjects of contraindications|34|||
161928400|NCT01774370|584785537|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
161928401|NCT01774370|584785537|FG000|Overall Study|Follow-up failure|34|||
161928402|NCT00514917|584785538|FG000|Overall Study|Death|4|||
161928403|NCT00514917|584785539|FG001|Overall Study|Death|10|||
161928404|NCT00514917|584785538|FG000|Overall Study|Protocol Violation|1|||
161928405|NCT00514917|584785539|FG001|Overall Study|Protocol Violation|0|||
161928406|NCT00514917|584785538|FG000|Overall Study|Lost to Follow-up|4|||
161928407|NCT00514917|584785539|FG001|Overall Study|Lost to Follow-up|3|||
161928408|NCT00514917|584785538|FG000|Overall Study|Withdrawal by Subject|18|||
161928409|NCT00514917|584785539|FG001|Overall Study|Withdrawal by Subject|16|||
161928410|NCT00514917|584785538|FG000|Overall Study|Discontinued due to study closure|88|||
161928411|NCT00514917|584785539|FG001|Overall Study|Discontinued due to study closure|81|||
161928412|NCT00514917|584785538|FG000|Overall Study|Undefined|11|||
161928413|NCT00514917|584785539|FG001|Overall Study|Undefined|5|||
161928414|NCT04243837|584785540|FG000|Overall Study|Adverse Event|2|||
161928415|NCT04243837|584785541|FG001|Overall Study|Adverse Event|1|||
161928416|NCT04243837|584785540|FG000|Overall Study|Withdrawal by Subject|4|||
161928417|NCT04243837|584785541|FG001|Overall Study|Withdrawal by Subject|2|||
161928418|NCT04243837|584785540|FG000|Overall Study|Covid-19 lock down|1|||
161928419|NCT04243837|584785541|FG001|Overall Study|Covid-19 lock down|0|||
161928420|NCT04243837|584785540|FG000|Overall Study|Study Terminated by Sponsor|11|||
161928421|NCT04243837|584785541|FG001|Overall Study|Study Terminated by Sponsor|12|||
161928422|NCT02280499|584785542|FG000|Overall Study|Death|14|||
161928423|NCT02280499|584785542|FG000|Overall Study|Lost to Follow-up|42|||
161928424|NCT02280499|584785542|FG000|Overall Study|Adverse Event|5|||
161928425|NCT01666314|584785548|FG000|Overall Study|Adverse Event|3|||
161928426|NCT01666314|584785549|FG001|Overall Study|Adverse Event|13|||
161928427|NCT01666314|584785550|FG002|Overall Study|Adverse Event|7|||
161928428|NCT01666314|584785551|FG003|Overall Study|Adverse Event|7|||
161928429|NCT01666314|584785548|FG000|Overall Study|Progressive Disease|11|||
161928430|NCT01666314|584785549|FG001|Overall Study|Progressive Disease|9|||
161928431|NCT01666314|584785550|FG002|Overall Study|Progressive Disease|19|||
161928432|NCT01666314|584785551|FG003|Overall Study|Progressive Disease|20|||
161928433|NCT01666314|584785548|FG000|Overall Study|Symptomatic Deterioration|1|||
161928434|NCT01666314|584785549|FG001|Overall Study|Symptomatic Deterioration|0|||
161928435|NCT01666314|584785550|FG002|Overall Study|Symptomatic Deterioration|2|||
161928436|NCT01666314|584785551|FG003|Overall Study|Symptomatic Deterioration|0|||
161928437|NCT01666314|584785548|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
161928438|NCT01666314|584785549|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
161928439|NCT01666314|584785550|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
161928440|NCT01666314|584785551|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
161928441|NCT01666314|584785548|FG000|Overall Study|Withdrawal by Subject|1|||
161928442|NCT01666314|584785549|FG001|Overall Study|Withdrawal by Subject|1|||
161928443|NCT01666314|584785550|FG002|Overall Study|Withdrawal by Subject|2|||
161928444|NCT01666314|584785551|FG003|Overall Study|Withdrawal by Subject|3|||
161928445|NCT01666314|584785548|FG000|Overall Study|Reason not Specified|10|||
161928446|NCT01666314|584785549|FG001|Overall Study|Reason not Specified|7|||
161821788|NCT00611884|584389175|FG000|Overall Study|Non-Compliance|1|||
161821789|NCT00611884|584389176|FG001|Overall Study|Non-Compliance|4|||
161821790|NCT00611884|584389177|FG002|Overall Study|Non-Compliance|2|||
161821791|NCT00611884|584389178|FG003|Overall Study|Non-Compliance|2|||
161821792|NCT00611884|584389175|FG000|Overall Study|Lack of Efficacy|0|||
161821793|NCT00611884|584389176|FG001|Overall Study|Lack of Efficacy|1|||
161821794|NCT00611884|584389177|FG002|Overall Study|Lack of Efficacy|0|||
161821795|NCT00611884|584389178|FG003|Overall Study|Lack of Efficacy|0|||
161821796|NCT00611884|584389175|FG000|Overall Study|Unclassified|7|||
161821797|NCT00611884|584389176|FG001|Overall Study|Unclassified|4|||
161821798|NCT00611884|584389177|FG002|Overall Study|Unclassified|2|||
161821799|NCT00611884|584389178|FG003|Overall Study|Unclassified|3|||
161821800|NCT00981799|584389179|FG000|Overall Study|Adverse Event|1|||
161821801|NCT00981799|584389180|FG001|Overall Study|Adverse Event|1|||
161928447|NCT01666314|584785550|FG002|Overall Study|Reason not Specified|5|||
161928448|NCT01666314|584785551|FG003|Overall Study|Reason not Specified|5|||
161928449|NCT03462563|584785555|FG000|Overall Study|Death|1|||
161928450|NCT03462563|584785556|FG001|Overall Study|Death|1|||
161928451|NCT03462563|584785555|FG000|Overall Study|Termination of study|2|||
161821802|NCT00981799|584389181|FG002|Overall Study|Adverse Event|0|||
161821803|NCT00981799|584389182|FG003|Overall Study|Adverse Event|0|||
161928452|NCT03462563|584785556|FG001|Overall Study|Termination of study|1|||
161928453|NCT03462563|584785555|FG000|Overall Study|Adverse Event|1|||
161928454|NCT03462563|584785556|FG001|Overall Study|Adverse Event|3|||
161928455|NCT03462563|584785555|FG000|Overall Study|Unspecified reason|10|||
161928456|NCT03462563|584785556|FG001|Overall Study|Unspecified reason|12|||
161928457|NCT03462563|584785555|FG000|Overall Study|Physician Decision|1|||
161514130|NCT02602288|583273494|FG000|12 Month Follow-up|Lost to Follow-up|0|||
161514131|NCT02602288|583273495|FG001|12 Month Follow-up|Lost to Follow-up|4|||
161514132|NCT02602288|583273494|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
161514133|NCT02602288|583273495|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
161514134|NCT01310413|583273496|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
161514135|NCT01310413|583273497|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
161514136|NCT01310413|583273498|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
161514137|NCT01310413|583273499|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
161514138|NCT01310413|583273500|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
161514139|NCT01310413|583273501|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
161514140|NCT01310413|583273502|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
161514141|NCT01310413|583273496|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
161821804|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Death|0|||
161821805|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Death|1|||
161821806|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
161821807|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
161821808|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
161821809|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
161821810|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
161821811|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
161821812|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
161821813|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
161821814|NCT01717313|584389189|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
161821815|NCT01717313|584389190|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
161821816|NCT01717313|584389189|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
161821817|NCT01717313|584389190|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
161821818|NCT01717313|584389189|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
161821819|NCT01717313|584389190|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
161821820|NCT01717313|584389189|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
161821821|NCT01717313|584389190|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
161821822|NCT01943435|584389191|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
161821823|NCT01943435|584389192|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
161821824|NCT01943435|584389193|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
161821825|NCT01943435|584389191|FG000|Intervention Period|Withdrawal by Subject|3|||
161821826|NCT01943435|584389192|FG001|Intervention Period|Withdrawal by Subject|3|||
161821827|NCT01943435|584389193|FG002|Intervention Period|Withdrawal by Subject|4|||
161821828|NCT01943435|584389191|FG000|2 Month Follow up|Lost to Follow-up|2|||
161821829|NCT01943435|584389192|FG001|2 Month Follow up|Lost to Follow-up|3|||
161821830|NCT01943435|584389193|FG002|2 Month Follow up|Lost to Follow-up|0|||
161821831|NCT01943435|584389191|FG000|6 Month Follow up|Lost to Follow-up|12|||
161821832|NCT01943435|584389192|FG001|6 Month Follow up|Lost to Follow-up|7|||
161821833|NCT01943435|584389193|FG002|6 Month Follow up|Lost to Follow-up|15|||
161821834|NCT01617096|584389198|FG000|Overall Study|Withdrawal by Subject|96|||
161821835|NCT01617096|584389199|FG001|Overall Study|Withdrawal by Subject|81|||
161821836|NCT01617096|584389198|FG000|Overall Study|Lost to Follow-up|37|||
161821837|NCT01617096|584389199|FG001|Overall Study|Lost to Follow-up|32|||
161821838|NCT01617096|584389198|FG000|Overall Study|Physician Decision|10|||
161821839|NCT01617096|584389199|FG001|Overall Study|Physician Decision|18|||
161821840|NCT01617096|584389198|FG000|Overall Study|Death|4|||
161821841|NCT01617096|584389199|FG001|Overall Study|Death|3|||
161821842|NCT01617096|584389198|FG000|Overall Study|Other|1|||
161821843|NCT01617096|584389199|FG001|Overall Study|Other|3|||
161821844|NCT04535986|584389202|FG000|Overall Study|Death|4|||
161821845|NCT04535986|584389203|FG001|Overall Study|Death|5|||
161821846|NCT04535986|584389202|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
161821847|NCT04535986|584389203|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
161821848|NCT04535986|584389202|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
161821849|NCT04535986|584389203|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
161821850|NCT04535986|584389202|FG000|Overall Study|Adverse Event|10|||
161821851|NCT04535986|584389203|FG001|Overall Study|Adverse Event|1|||
161821852|NCT04535986|584389202|FG000|Overall Study|Lack of Efficacy|3|||
161821853|NCT04535986|584389203|FG001|Overall Study|Lack of Efficacy|2|||
161821854|NCT04535986|584389202|FG000|Overall Study|Investigator discretion|3|||
161821855|NCT04535986|584389203|FG001|Overall Study|Investigator discretion|0|||
161821856|NCT04535986|584389202|FG000|Overall Study|Withdrawal by Subject|32|||
161514142|NCT01310413|583273497|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
161821857|NCT04535986|584389203|FG001|Overall Study|Withdrawal by Subject|14|||
161821858|NCT04535986|584389202|FG000|Overall Study|Lost to Follow-up|5|||
161821859|NCT04535986|584389203|FG001|Overall Study|Lost to Follow-up|3|||
161514143|NCT01310413|583273498|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
161821860|NCT04535986|584389202|FG000|Overall Study|Other|7|||
161821861|NCT04535986|584389203|FG001|Overall Study|Other|3|||
161821862|NCT01532908|584389206|FG000|Overall Study|Not Transplanted|1|||
161821863|NCT01532908|584389207|FG001|Overall Study|Not Transplanted|0|||
161821864|NCT01196390|584389208|FG000|Overall Study|Protocol Violation|4|||
161821865|NCT01196390|584389209|FG001|Overall Study|Protocol Violation|5|||
161821866|NCT00252564|584389210|FG000|Overall Study|Adverse Event|17|||
161821867|NCT00252564|584389211|FG001|Overall Study|Adverse Event|13|||
161821868|NCT00252564|584389210|FG000|Overall Study|Unrelated Complication|2|||
161821869|NCT00252564|584389211|FG001|Overall Study|Unrelated Complication|1|||
161928458|NCT03462563|584785556|FG001|Overall Study|Physician Decision|0|||
161928459|NCT05089357|584785557|FG000|Overall Study|Withdrawal by Subject|23|||
161928460|NCT05089357|584785557|FG000|Overall Study|Lost to Follow-up|6|||
161928461|NCT05089357|584785557|FG000|Overall Study|Medical reason|1|||
161928462|NCT05089357|584785557|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
161928463|NCT05089357|584785557|FG000|Overall Study|Pregnancy|2|||
161928464|NCT00689052|584785558|FG000|Overall Study|Adverse Event|4|||
161928465|NCT00689052|584785559|FG001|Overall Study|Adverse Event|6|||
161928466|NCT00689052|584785558|FG000|Overall Study|Protocol Violation|1|||
161928467|NCT00689052|584785559|FG001|Overall Study|Protocol Violation|0|||
161928468|NCT00689052|584785558|FG000|Overall Study|Lost to Follow-up|2|||
161928469|NCT00689052|584785559|FG001|Overall Study|Lost to Follow-up|0|||
161928470|NCT00689052|584785558|FG000|Overall Study|Withdrawal by Subject|2|||
161928471|NCT00689052|584785559|FG001|Overall Study|Withdrawal by Subject|0|||
161928472|NCT00689052|584785558|FG000|Overall Study|Early termination of the trial|22|||
161928473|NCT00689052|584785559|FG001|Overall Study|Early termination of the trial|24|||
161928474|NCT01860989|584785560|FG000|Overall Study|Unsatisfactory therapeutic|5|||
161928475|NCT04739709|584785563|FG000|Overall Study|Physician Decision|1|||
161928476|NCT04739709|584785564|FG001|Overall Study|Physician Decision|0|||
161928477|NCT03003468|584785565|FG000|Overall Study|Withdrawal by Subject|0|||
161928478|NCT03003468|584785566|FG001|Overall Study|Withdrawal by Subject|0|||
161928479|NCT03003468|584785567|FG002|Overall Study|Withdrawal by Subject|1|||
161928480|NCT03003468|584785565|FG000|Overall Study|No measurable lesions|0|||
161928481|NCT03003468|584785566|FG001|Overall Study|No measurable lesions|0|||
161928482|NCT03003468|584785567|FG002|Overall Study|No measurable lesions|1|||
161928483|NCT00421993|584785570|FG000|Overall Study|Withdrawal by Subject|22|||
161928484|NCT00421993|584785571|FG001|Overall Study|Withdrawal by Subject|23|||
161928485|NCT00421993|584785572|FG002|Overall Study|Withdrawal by Subject|23|||
161928486|NCT00421993|584785573|FG003|Overall Study|Withdrawal by Subject|24|||
161928487|NCT00421993|584785570|FG000|Overall Study|Lost to Follow-up|18|||
161928488|NCT00421993|584785571|FG001|Overall Study|Lost to Follow-up|19|||
161928489|NCT00421993|584785572|FG002|Overall Study|Lost to Follow-up|22|||
161928490|NCT00421993|584785573|FG003|Overall Study|Lost to Follow-up|20|||
161928491|NCT00421993|584785570|FG000|Overall Study|Adverse Event|11|||
161928492|NCT00421993|584785571|FG001|Overall Study|Adverse Event|1|||
161928493|NCT00421993|584785572|FG002|Overall Study|Adverse Event|6|||
161928494|NCT00421993|584785573|FG003|Overall Study|Adverse Event|4|||
161928495|NCT00421993|584785570|FG000|Overall Study|Protocol Violation|2|||
161928496|NCT00421993|584785571|FG001|Overall Study|Protocol Violation|2|||
161928497|NCT00421993|584785572|FG002|Overall Study|Protocol Violation|0|||
161928498|NCT00421993|584785573|FG003|Overall Study|Protocol Violation|1|||
161928499|NCT00421993|584785570|FG000|Overall Study|Lack of Efficacy|0|||
161928500|NCT00421993|584785571|FG001|Overall Study|Lack of Efficacy|3|||
161928501|NCT00421993|584785572|FG002|Overall Study|Lack of Efficacy|0|||
161928502|NCT00421993|584785573|FG003|Overall Study|Lack of Efficacy|5|||
161514144|NCT01310413|583273499|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
161514145|NCT01310413|583273500|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
161821870|NCT00252564|584389210|FG000|Overall Study|Disease Progression|14|||
161928503|NCT00421993|584785570|FG000|Overall Study|Pregnancy|0|||
161928504|NCT00421993|584785571|FG001|Overall Study|Pregnancy|1|||
161928505|NCT00421993|584785572|FG002|Overall Study|Pregnancy|1|||
161928506|NCT00421993|584785573|FG003|Overall Study|Pregnancy|2|||
161928507|NCT00421993|584785570|FG000|Overall Study|Subject transportation issues|0|||
161928508|NCT00421993|584785571|FG001|Overall Study|Subject transportation issues|0|||
161928509|NCT00421993|584785572|FG002|Overall Study|Subject transportation issues|0|||
161928510|NCT00421993|584785573|FG003|Overall Study|Subject transportation issues|1|||
161928511|NCT01751685|584785574|FG000|6-mo Followup|Missed study visit|1|||
161514146|NCT01310413|583273501|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
161821871|NCT00252564|584389211|FG001|Overall Study|Disease Progression|20|||
161821872|NCT00252564|584389210|FG000|Overall Study|Death|0|||
161821873|NCT00252564|584389211|FG001|Overall Study|Death|3|||
161821874|NCT00252564|584389210|FG000|Overall Study|Physician Decision|1|||
161821875|NCT00252564|584389211|FG001|Overall Study|Physician Decision|0|||
161821876|NCT00252564|584389210|FG000|Overall Study|Lost to Follow-up|1|||
161928512|NCT01751685|584785575|FG001|6-mo Followup|Missed study visit|0|||
161928513|NCT01751685|584785574|FG000|6-mo Followup|Withdrawal by Subject|2|||
161928514|NCT01751685|584785575|FG001|6-mo Followup|Withdrawal by Subject|2|||
161928515|NCT01751685|584785574|FG000|6-mo Followup|Lost to Follow-up|0|||
161928516|NCT01751685|584785575|FG001|6-mo Followup|Lost to Follow-up|1|||
161928517|NCT01751685|584785574|FG000|12-mo Followup|Lost to Follow-up|5|||
161928518|NCT01751685|584785575|FG001|12-mo Followup|Lost to Follow-up|0|||
161928519|NCT01727154|584785580|FG000|Overall Study|Death|17|||
161821877|NCT00252564|584389211|FG001|Overall Study|Lost to Follow-up|0|||
161821878|NCT00252564|584389210|FG000|Overall Study|Patient Request|4|||
161821879|NCT00252564|584389211|FG001|Overall Study|Patient Request|5|||
161821880|NCT00252564|584389210|FG000|Overall Study|Withdrawal by Subject|0|||
161821881|NCT00252564|584389211|FG001|Overall Study|Withdrawal by Subject|2|||
161821882|NCT01632306|584389212|FG000|Overall Study|Protocol Violation|1|||
161821883|NCT01632306|584389213|FG001|Overall Study|Protocol Violation|0|||
161821884|NCT01632306|584389214|FG002|Overall Study|Protocol Violation|0|||
161821885|NCT02179190|584389219|FG000|Enrollment|Exit Prior to Device Attempt|11|||
161821886|NCT02179190|584389219|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
161821887|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
161821888|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
161821889|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
161821890|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
161821891|NCT03480022|584389220|FG000|Overall Study|Pregnancy|2|||
161821892|NCT03480022|584389221|FG001|Overall Study|Pregnancy|0|||
161514147|NCT01310413|583273502|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
161514148|NCT01310413|583273496|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
161514149|NCT01310413|583273497|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
161514150|NCT01310413|583273498|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
161821893|NCT03480022|584389220|FG000|Overall Study|Adverse Event|6|||
161821894|NCT03480022|584389221|FG001|Overall Study|Adverse Event|0|||
161821895|NCT03480022|584389220|FG000|Overall Study|Lack of Efficacy|0|||
161821896|NCT03480022|584389221|FG001|Overall Study|Lack of Efficacy|2|||
161821897|NCT03480022|584389220|FG000|Overall Study|Physician Decision|0|||
161821898|NCT03480022|584389221|FG001|Overall Study|Physician Decision|1|||
161821899|NCT03480022|584389220|FG000|Overall Study|Withdrawal by Subject|2|||
161821900|NCT03480022|584389221|FG001|Overall Study|Withdrawal by Subject|0|||
161821901|NCT03480022|584389220|FG000|Overall Study|Medication concerns|1|||
161821902|NCT03480022|584389221|FG001|Overall Study|Medication concerns|0|||
161821903|NCT03480022|584389220|FG000|Overall Study|Family member COVID exposure|0|||
161821904|NCT03480022|584389221|FG001|Overall Study|Family member COVID exposure|1|||
161821905|NCT00881569|584389222|FG000|Overall Study|Disease progression|1|||
161821906|NCT00881569|584389223|FG001|Overall Study|Disease progression|1|||
161821907|NCT02623218|584389228|FG000|Overall Study|Lost to Follow-up|0|||
161821908|NCT02623218|584389229|FG001|Overall Study|Lost to Follow-up|1|||
161821909|NCT02623218|584389230|FG002|Overall Study|Lost to Follow-up|0|||
161821910|NCT02623218|584389231|FG003|Overall Study|Lost to Follow-up|0|||
161821911|NCT02623218|584389232|FG004|Overall Study|Lost to Follow-up|0|||
161821912|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
161821913|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
161821914|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
161821915|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
161821916|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Death|3|||
161821917|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Death|1|||
161821918|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
161821919|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
161821920|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
161821921|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
161821922|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
161821923|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
161821924|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Adverse Event|2|||
161821925|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Adverse Event|11|||
161821926|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
161821927|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
161821928|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Death|2|||
161821929|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Death|2|||
161821930|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
161821931|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
161821932|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
161821933|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
161821934|NCT01970592|584389238|FG000|Overall Study|Withdrawal by Subject|4|||
161821935|NCT01970592|584389238|FG000|Overall Study|Physician Decision|1|||
161821936|NCT01970592|584389238|FG000|Overall Study|Adverse Event|1|||
161821937|NCT03980522|584389241|FG000|Treatment Period|Adverse Event|1|||
161821938|NCT03980522|584389242|FG001|Treatment Period|Adverse Event|0|||
161821939|NCT03980522|584389243|FG002|Treatment Period|Adverse Event|0|||
161821940|NCT03980522|584389244|FG003|Treatment Period|Adverse Event|0|||
161821941|NCT03980522|584389245|FG004|Treatment Period|Adverse Event|0|||
161821942|NCT01320722|584389246|FG000|Overall Study|Did not Receive Intervention|3|||
161821943|NCT01320722|584389247|FG001|Overall Study|Did not Receive Intervention|2|||
161928520|NCT01727154|584785580|FG000|Overall Study|Withdrawal by Subject|14|||
161928521|NCT01727154|584785580|FG000|Overall Study|Subject Withdrew Consent|18|||
161928522|NCT01727154|584785580|FG000|Overall Study|Study Terminated|6|||
161928523|NCT01727154|584785580|FG000|Overall Study|No Discontinuation Documentation|4|||
161928524|NCT00003474|584785581|FG000|Overall Study|Not Evaluable|14|||
161928525|NCT01198548|584785585|FG000|Overall Study|Disease Progression|9|||
161928526|NCT01198548|584785585|FG000|Overall Study|Administrative Decision|1|||
161928527|NCT02186171|584785587|FG000|Overall Study|Withdrawal by Subject|1|||
161928528|NCT02186171|584785588|FG001|Overall Study|Withdrawal by Subject|9|||
161928529|NCT02186171|584785587|FG000|Overall Study|Lost to Follow-up|2|||
161928530|NCT02186171|584785588|FG001|Overall Study|Lost to Follow-up|2|||
161928531|NCT02186171|584785587|FG000|Overall Study|Death|1|||
161928532|NCT02186171|584785588|FG001|Overall Study|Death|2|||
161928533|NCT02186171|584785587|FG000|Overall Study|Protocol-specified Criteria|0|||
161928534|NCT02186171|584785588|FG001|Overall Study|Protocol-specified Criteria|2|||
161928535|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
161928536|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
161928537|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
161928538|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Physician Decision|2|||
161928539|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Physician Decision|4|||
161928540|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Physician Decision|0|||
161928541|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
161928542|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
161928543|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
161928544|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
161928545|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
161928546|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
161928547|NCT01245062|584785589|FG000|Cross-over Phase|Lost to Follow-up|0|||
161514151|NCT01310413|583273499|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
161514152|NCT01310413|583273500|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
161514153|NCT01310413|583273501|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
161514154|NCT01310413|583273502|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
161514155|NCT01310413|583273496|FG000|Day 0 to Day 385|Other|1|||
161514156|NCT01310413|583273497|FG001|Day 0 to Day 385|Other|0|||
161514157|NCT01310413|583273498|FG002|Day 0 to Day 385|Other|3|||
161514158|NCT01310413|583273499|FG003|Day 0 to Day 385|Other|0|||
161514159|NCT01310413|583273500|FG004|Day 0 to Day 385|Other|0|||
161514160|NCT01310413|583273501|FG005|Day 0 to Day 385|Other|0|||
161514161|NCT01310413|583273502|FG006|Day 0 to Day 385|Other|0|||
161514162|NCT01310413|583273496|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
161514163|NCT01310413|583273497|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
161514164|NCT01310413|583273498|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
161514165|NCT01310413|583273499|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
161514166|NCT01310413|583273500|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
161514167|NCT01310413|583273501|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
161514168|NCT01310413|583273502|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
161514169|NCT01310413|583273496|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
161588166|NCT04927065|583542329|FG009|Third Booster|Withdrawal by Subject|0|||
161514170|NCT01310413|583273497|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
161514171|NCT01310413|583273498|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
161514172|NCT01310413|583273499|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
161588167|NCT04927065|583542330|FG010|Third Booster|Withdrawal by Subject|0|||
161588168|NCT04927065|583542331|FG011|Third Booster|Withdrawal by Subject|0|||
161588169|NCT04927065|583542332|FG012|Third Booster|Withdrawal by Subject|0|||
161588170|NCT04927065|583542333|FG013|Third Booster|Withdrawal by Subject|0|||
161928548|NCT01245062|584785590|FG001|Cross-over Phase|Lost to Follow-up|0|||
161928549|NCT01245062|584785591|FG002|Cross-over Phase|Lost to Follow-up|1|||
161928550|NCT01245062|584785589|FG000|Cross-over Phase|Physician Decision|0|||
161928551|NCT01245062|584785590|FG001|Cross-over Phase|Physician Decision|0|||
161928552|NCT01245062|584785591|FG002|Cross-over Phase|Physician Decision|1|||
161928553|NCT01245062|584785589|FG000|Cross-over Phase|Withdrew Consent|0|||
161928554|NCT01245062|584785590|FG001|Cross-over Phase|Withdrew Consent|0|||
161928555|NCT01245062|584785591|FG002|Cross-over Phase|Withdrew Consent|4|||
161588171|NCT04927065|583542334|FG014|Third Booster|Withdrawal by Subject|0|||
161514173|NCT01310413|583273500|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
161514174|NCT01310413|583273501|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
161514175|NCT01310413|583273502|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
161514176|NCT02066298|583273504|FG000|Overall Study|Lost to Follow-up|3|||
161588172|NCT04927065|583542335|FG015|Third Booster|Withdrawal by Subject|1|||
161588173|NCT03846505|583542336|FG000|Treatment Phase|Withdrawal by Subject|9|||
161928556|NCT01245062|584785589|FG000|Cross-over Phase|Study closed/ terminated|0|||
161928557|NCT01245062|584785590|FG001|Cross-over Phase|Study closed/ terminated|0|||
161928558|NCT01245062|584785591|FG002|Cross-over Phase|Study closed/ terminated|11|||
161928559|NCT06025695|584785592|FG000|Overall Study|Adverse Event|5|||
161514177|NCT02066298|583273505|FG001|Overall Study|Lost to Follow-up|2|||
161676728|NCT01809132|583870508|FG002|Overall Study|Withdrawal by Subject|1|||
161676729|NCT04854434|583870509|FG000|Overall Study|Death|1|||
161676730|NCT04854434|583870510|FG001|Overall Study|Death|3|||
161676731|NCT04854434|583870511|FG002|Overall Study|Death|4|||
161928560|NCT06025695|584785593|FG001|Overall Study|Adverse Event|6|||
161928561|NCT06025695|584785592|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
161928562|NCT06025695|584785593|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
161928563|NCT06025695|584785592|FG000|Overall Study|Other|23|||
161928564|NCT06025695|584785593|FG001|Overall Study|Other|19|||
161928565|NCT06025695|584785592|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
161928566|NCT06025695|584785593|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
161928567|NCT01452347|584785594|FG000|Overall Study|Adverse Event|2|||
161928568|NCT01452347|584785595|FG001|Overall Study|Adverse Event|1|||
161928569|NCT01452347|584785594|FG000|Overall Study|Non compliance protocol|2|||
161928570|NCT01452347|584785595|FG001|Overall Study|Non compliance protocol|0|||
161928571|NCT01452347|584785594|FG000|Overall Study|Lost to Follow-up|2|||
161928572|NCT01452347|584785595|FG001|Overall Study|Lost to Follow-up|0|||
161928573|NCT01452347|584785594|FG000|Overall Study|Withdrawal by Subject|3|||
161928574|NCT01452347|584785595|FG001|Overall Study|Withdrawal by Subject|3|||
161928575|NCT01452347|584785594|FG000|Overall Study|Not treated|6|||
161928576|NCT01452347|584785595|FG001|Overall Study|Not treated|3|||
161928577|NCT01452347|584785594|FG000|Overall Study|Other reason not defined above|2|||
161928578|NCT01452347|584785595|FG001|Overall Study|Other reason not defined above|0|||
161928579|NCT05762744|584785596|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
161928580|NCT05762744|584785597|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
161928581|NCT05762744|584785596|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
161928582|NCT05762744|584785597|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
161928583|NCT02724644|584787724|FG000|Overall Study|Adverse Event|7|||
161928584|NCT02724644|584787725|FG001|Overall Study|Adverse Event|1|||
161928585|NCT02724644|584787724|FG000|Overall Study|Lost to Follow-up|6|||
161928586|NCT02724644|584787725|FG001|Overall Study|Lost to Follow-up|2|||
161928587|NCT02724644|584787724|FG000|Overall Study|Withdrawal by Subject|7|||
161928588|NCT02724644|584787725|FG001|Overall Study|Withdrawal by Subject|1|||
161928589|NCT02724644|584787724|FG000|Overall Study|Administrative|1|||
161928590|NCT02724644|584787725|FG001|Overall Study|Administrative|0|||
161928591|NCT01882829|584787726|FG000|Overall Study|Adverse Event|4|||
161928592|NCT01882829|584787726|FG000|Overall Study|Protocol Violation|1|||
161928593|NCT01882829|584787726|FG000|Overall Study|Withdrawal by Subject|1|||
161928594|NCT03312114|584787727|FG000|Overall Study|All the five enrolled dropped out of the|5|||
161928595|NCT02469961|584787734|FG000|Overall Study|Physician Decision|4|||
161928596|NCT02469961|584787735|FG001|Overall Study|Physician Decision|1|||
161928597|NCT01245751|584787743|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
161928598|NCT01245751|584787744|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
161928599|NCT01245751|584787745|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
161928600|NCT01245751|584787746|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
161928601|NCT01245751|584787743|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161928602|NCT01245751|584787744|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161928603|NCT01245751|584787745|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161928604|NCT01245751|584787746|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
161928605|NCT01245751|584787743|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161928606|NCT01245751|584787744|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
161928607|NCT01245751|584787745|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161928608|NCT01245751|584787746|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161928609|NCT01748552|584787751|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
161514178|NCT02066298|583273506|FG002|Overall Study|Lost to Follow-up|3|||
161514179|NCT02066298|583273507|FG003|Overall Study|Lost to Follow-up|2|||
161514180|NCT02066298|583273508|FG004|Overall Study|Lost to Follow-up|3|||
161514181|NCT02066298|583273509|FG005|Overall Study|Lost to Follow-up|4|||
161676732|NCT04854434|583870509|FG000|Overall Study|Study Terminated by Sponsor|2|||
161676733|NCT04854434|583870510|FG001|Overall Study|Study Terminated by Sponsor|0|||
161676734|NCT04854434|583870511|FG002|Overall Study|Study Terminated by Sponsor|0|||
161676735|NCT04854434|583870509|FG000|Overall Study|Other|1|||
161928610|NCT01748552|584787752|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
161928611|NCT01748552|584787753|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
161928612|NCT01748552|584787754|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
161928613|NCT01748552|584787755|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
161928614|NCT01748552|584787756|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
161928615|NCT01748552|584787757|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
161928616|NCT01748552|584787758|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
161928617|NCT01748552|584787759|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
161514182|NCT02066298|583273504|FG000|Overall Study|Withdrawal by Subject|6|||
161514183|NCT02066298|583273505|FG001|Overall Study|Withdrawal by Subject|6|||
161514184|NCT02066298|583273506|FG002|Overall Study|Withdrawal by Subject|6|||
161514185|NCT02066298|583273507|FG003|Overall Study|Withdrawal by Subject|4|||
161514186|NCT02066298|583273508|FG004|Overall Study|Withdrawal by Subject|5|||
161514187|NCT02066298|583273509|FG005|Overall Study|Withdrawal by Subject|8|||
161514188|NCT02066298|583273504|FG000|Overall Study|Physician Decision|0|||
161514189|NCT02066298|583273505|FG001|Overall Study|Physician Decision|0|||
161514190|NCT02066298|583273506|FG002|Overall Study|Physician Decision|1|||
161514191|NCT02066298|583273507|FG003|Overall Study|Physician Decision|0|||
161514192|NCT02066298|583273508|FG004|Overall Study|Physician Decision|1|||
161514193|NCT02066298|583273509|FG005|Overall Study|Physician Decision|0|||
161514194|NCT04260191|583273510|FG000|Overall Study|Decision by Sponsor|0|||
161514195|NCT04260191|583273511|FG001|Overall Study|Decision by Sponsor|1|||
161514196|NCT04260191|583273512|FG002|Overall Study|Decision by Sponsor|0|||
161514197|NCT04260191|583273510|FG000|Overall Study|Withdrawal by Subject|1|||
161514198|NCT04260191|583273511|FG001|Overall Study|Withdrawal by Subject|0|||
161514199|NCT04260191|583273512|FG002|Overall Study|Withdrawal by Subject|3|||
161514200|NCT04260191|583273510|FG000|Overall Study|Death|4|||
161514201|NCT04260191|583273511|FG001|Overall Study|Death|3|||
161514202|NCT04260191|583273512|FG002|Overall Study|Death|2|||
161514203|NCT01513317|583273513|FG000|Overall Study|Withdrawal by Subject|15|||
161514204|NCT01513317|583273514|FG001|Overall Study|Withdrawal by Subject|4|||
161514205|NCT01513317|583273513|FG000|Overall Study|Death|1|||
161514206|NCT01513317|583273514|FG001|Overall Study|Death|1|||
161514207|NCT01513317|583273513|FG000|Overall Study|Study terminated by sponsor|18|||
161514208|NCT01513317|583273514|FG001|Overall Study|Study terminated by sponsor|18|||
161514209|NCT01513317|583273513|FG000|Overall Study|Other|0|||
161514210|NCT01513317|583273514|FG001|Overall Study|Other|1|||
161514211|NCT01265953|583273515|FG000|Overall Study|Non compliance|5|||
161514212|NCT01265953|583273516|FG001|Overall Study|Non compliance|3|||
161514213|NCT02564198|583273517|FG000|Overall Study|Withdrawal by Subject|2|||
161514214|NCT02564198|583273518|FG001|Overall Study|Withdrawal by Subject|4|||
161514215|NCT02564198|583273519|FG002|Overall Study|Withdrawal by Subject|0|||
161514216|NCT02564198|583273517|FG000|Overall Study|Adverse Event|0|||
161514217|NCT02564198|583273518|FG001|Overall Study|Adverse Event|1|||
161514218|NCT02564198|583273519|FG002|Overall Study|Adverse Event|0|||
161514219|NCT00274716|583273522|FG000|Phase A|Other non-reported reason|4|||
161514220|NCT00274716|583273523|FG001|Phase A|Other non-reported reason|2|||
161514221|NCT00274716|583273524|FG002|Phase A|Other non-reported reason|1|||
161514222|NCT00274716|583273525|FG003|Phase A|Other non-reported reason|2|||
161514223|NCT00274716|583273526|FG004|Phase A|Other non-reported reason|0|||
161514224|NCT00274716|583273527|FG005|Phase A|Other non-reported reason|1|||
161514225|NCT00274716|583273522|FG000|Phase A|Participant moved|0|||
161514226|NCT00274716|583273523|FG001|Phase A|Participant moved|0|||
161514227|NCT00274716|583273524|FG002|Phase A|Participant moved|1|||
161676736|NCT04854434|583870510|FG001|Overall Study|Other|1|||
161676737|NCT04854434|583870511|FG002|Overall Study|Other|0|||
161821944|NCT01320722|584389248|FG002|Overall Study|Did not Receive Intervention|1|||
161514228|NCT00274716|583273525|FG003|Phase A|Participant moved|0|||
161514229|NCT00274716|583273526|FG004|Phase A|Participant moved|0|||
161514230|NCT00274716|583273527|FG005|Phase A|Participant moved|1|||
161514231|NCT00274716|583273522|FG000|Phase A|Site Terminated|0|||
161514232|NCT00274716|583273523|FG001|Phase A|Site Terminated|0|||
161514233|NCT00274716|583273524|FG002|Phase A|Site Terminated|0|||
161514234|NCT00274716|583273525|FG003|Phase A|Site Terminated|1|||
161514235|NCT00274716|583273526|FG004|Phase A|Site Terminated|0|||
161514236|NCT00274716|583273527|FG005|Phase A|Site Terminated|0|||
161514237|NCT00274716|583273522|FG000|Phase A|Protocol Violation|1|||
161514238|NCT00274716|583273523|FG001|Phase A|Protocol Violation|0|||
161514239|NCT00274716|583273524|FG002|Phase A|Protocol Violation|0|||
161514240|NCT00274716|583273525|FG003|Phase A|Protocol Violation|1|||
161514241|NCT00274716|583273526|FG004|Phase A|Protocol Violation|0|||
161514242|NCT00274716|583273527|FG005|Phase A|Protocol Violation|0|||
161514243|NCT00274716|583273522|FG000|Phase A|Met criteria for discontinuation|1|||
161514244|NCT00274716|583273523|FG001|Phase A|Met criteria for discontinuation|1|||
161514245|NCT00274716|583273524|FG002|Phase A|Met criteria for discontinuation|0|||
161514246|NCT00274716|583273525|FG003|Phase A|Met criteria for discontinuation|0|||
161514247|NCT00274716|583273526|FG004|Phase A|Met criteria for discontinuation|0|||
161514248|NCT00274716|583273527|FG005|Phase A|Met criteria for discontinuation|0|||
161514249|NCT00274716|583273522|FG000|Phase A|Withdrawal by Subject|2|||
161514250|NCT00274716|583273523|FG001|Phase A|Withdrawal by Subject|2|||
161514251|NCT00274716|583273524|FG002|Phase A|Withdrawal by Subject|1|||
161514252|NCT00274716|583273525|FG003|Phase A|Withdrawal by Subject|3|||
161514253|NCT00274716|583273526|FG004|Phase A|Withdrawal by Subject|0|||
161514254|NCT00274716|583273527|FG005|Phase A|Withdrawal by Subject|1|||
161514255|NCT00274716|583273522|FG000|Phase A|Adverse Event|2|||
161514256|NCT00274716|583273523|FG001|Phase A|Adverse Event|3|||
161514257|NCT00274716|583273524|FG002|Phase A|Adverse Event|3|||
161514258|NCT00274716|583273525|FG003|Phase A|Adverse Event|0|||
161514259|NCT00274716|583273526|FG004|Phase A|Adverse Event|2|||
161514260|NCT00274716|583273527|FG005|Phase A|Adverse Event|0|||
161514261|NCT00274716|583273522|FG000|Phase A|Completed but did not enter Phase B|1|||
161514262|NCT00274716|583273523|FG001|Phase A|Completed but did not enter Phase B|2|||
161514263|NCT00274716|583273524|FG002|Phase A|Completed but did not enter Phase B|2|||
161514264|NCT00274716|583273525|FG003|Phase A|Completed but did not enter Phase B|2|||
161514265|NCT00274716|583273526|FG004|Phase A|Completed but did not enter Phase B|1|||
161514266|NCT00274716|583273527|FG005|Phase A|Completed but did not enter Phase B|1|||
161514267|NCT00274716|583273522|FG000|Phase B|Adverse Event|0|||
161514268|NCT00274716|583273523|FG001|Phase B|Adverse Event|0|||
161514269|NCT00274716|583273524|FG002|Phase B|Adverse Event|2|||
161514270|NCT00274716|583273525|FG003|Phase B|Adverse Event|0|||
161514271|NCT00274716|583273526|FG004|Phase B|Adverse Event|0|||
161514272|NCT00274716|583273527|FG005|Phase B|Adverse Event|1|||
161514273|NCT00274716|583273522|FG000|Phase B|Protocol Violation|0|||
161514274|NCT00274716|583273523|FG001|Phase B|Protocol Violation|2|||
161514275|NCT00274716|583273524|FG002|Phase B|Protocol Violation|0|||
161514276|NCT00274716|583273525|FG003|Phase B|Protocol Violation|0|||
161514277|NCT00274716|583273526|FG004|Phase B|Protocol Violation|0|||
161514278|NCT00274716|583273527|FG005|Phase B|Protocol Violation|0|||
161514279|NCT00274716|583273522|FG000|Phase B|Withdrawal by Subject|0|||
161514280|NCT00274716|583273523|FG001|Phase B|Withdrawal by Subject|1|||
161514281|NCT00274716|583273524|FG002|Phase B|Withdrawal by Subject|0|||
161514282|NCT00274716|583273525|FG003|Phase B|Withdrawal by Subject|0|||
161514283|NCT00274716|583273526|FG004|Phase B|Withdrawal by Subject|0|||
161514284|NCT00274716|583273527|FG005|Phase B|Withdrawal by Subject|0|||
161514285|NCT00274716|583273522|FG000|Phase B|Participant moved|1|||
161514286|NCT00274716|583273523|FG001|Phase B|Participant moved|0|||
161514287|NCT00274716|583273524|FG002|Phase B|Participant moved|0|||
161514288|NCT00274716|583273525|FG003|Phase B|Participant moved|0|||
161514289|NCT00274716|583273526|FG004|Phase B|Participant moved|0|||
161514290|NCT00274716|583273527|FG005|Phase B|Participant moved|0|||
161514291|NCT00274716|583273522|FG000|Phase B|Other non-reported reason|0|||
161514292|NCT00274716|583273523|FG001|Phase B|Other non-reported reason|0|||
161514293|NCT00274716|583273524|FG002|Phase B|Other non-reported reason|1|||
161514294|NCT00274716|583273525|FG003|Phase B|Other non-reported reason|1|||
161514295|NCT00274716|583273526|FG004|Phase B|Other non-reported reason|0|||
161514296|NCT00274716|583273527|FG005|Phase B|Other non-reported reason|0|||
161514297|NCT00274716|583273522|FG000|Phase B|Lost to Follow-up|0|||
161514298|NCT00274716|583273523|FG001|Phase B|Lost to Follow-up|1|||
161588174|NCT03846505|583542337|FG001|Treatment Phase|Withdrawal by Subject|11|||
161588175|NCT03846505|583542336|FG000|Treatment Phase|Lost to Follow-up|6|||
161588176|NCT03846505|583542337|FG001|Treatment Phase|Lost to Follow-up|2|||
161588177|NCT03846505|583542336|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
161588178|NCT03846505|583542337|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
161588179|NCT03846505|583542336|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
161588180|NCT03846505|583542337|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
161514299|NCT00274716|583273524|FG002|Phase B|Lost to Follow-up|0|||
161514300|NCT00274716|583273525|FG003|Phase B|Lost to Follow-up|0|||
161514301|NCT00274716|583273526|FG004|Phase B|Lost to Follow-up|0|||
161514302|NCT00274716|583273527|FG005|Phase B|Lost to Follow-up|0|||
161514303|NCT01257204|583273528|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161514304|NCT01257204|583273529|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
161588181|NCT04021602|583542344|FG000|Overall Study|Lost to Follow-up|3|||
161588182|NCT04021602|583542345|FG001|Overall Study|Lost to Follow-up|3|||
161588183|NCT04021602|583542346|FG002|Overall Study|Lost to Follow-up|1|||
161514305|NCT01257204|583273530|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
161514306|NCT01257204|583273528|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
161514307|NCT01257204|583273529|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
161514308|NCT01257204|583273530|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
161514309|NCT01257204|583273528|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
161514310|NCT01257204|583273529|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
161514311|NCT01257204|583273530|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
161514312|NCT01257204|583273528|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161514313|NCT01257204|583273529|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
161514314|NCT01257204|583273530|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161514315|NCT01257204|583273528|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
161514316|NCT01257204|583273529|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
161514317|NCT01257204|583273530|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
161514318|NCT01257204|583273528|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
161514319|NCT01257204|583273529|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
161514320|NCT01257204|583273530|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
161514321|NCT01257204|583273528|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
161514322|NCT01257204|583273529|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
161514323|NCT01257204|583273530|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
161514324|NCT01257204|583273528|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
161514325|NCT01257204|583273529|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
161514326|NCT01257204|583273530|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
161514327|NCT01257204|583273528|FG000|Follow-up Period (up to Week 48)|Other|0|||
161514328|NCT01257204|583273529|FG001|Follow-up Period (up to Week 48)|Other|0|||
161514329|NCT01257204|583273530|FG002|Follow-up Period (up to Week 48)|Other|5|||
161514330|NCT03394391|583273531|FG000|Overall Study|Lost to Follow-up|1|||
161514331|NCT03394391|583273532|FG001|Overall Study|Lost to Follow-up|2|||
161514332|NCT00723801|583273534|FG000|Overall Study|Lost to Follow-up|1|||
161514333|NCT00723801|583273535|FG001|Overall Study|Lost to Follow-up|2|||
161514334|NCT00723801|583273534|FG000|Overall Study|Protocol Violation|2|||
161514335|NCT00723801|583273535|FG001|Overall Study|Protocol Violation|1|||
161514336|NCT02148003|583273536|FG000|Overall Study|Failed inclusion criteria|1|||
161514337|NCT02148003|583273537|FG001|Overall Study|Failed inclusion criteria|0|||
161514338|NCT02148003|583273536|FG000|Overall Study|Met exclusion criteria|0|||
161514339|NCT02148003|583273537|FG001|Overall Study|Met exclusion criteria|1|||
161514340|NCT02148003|583273536|FG000|Overall Study|Withdrawal by Subject|0|||
161514341|NCT02148003|583273537|FG001|Overall Study|Withdrawal by Subject|1|||
161514342|NCT02039427|583273539|FG000|Overall Study|Duration of surgery > 3h|1|||
161514343|NCT02039427|583273540|FG001|Overall Study|Duration of surgery > 3h|1|||
161514344|NCT02039427|583273541|FG002|Overall Study|Duration of surgery > 3h|0|||
161514345|NCT02039427|583273542|FG003|Overall Study|Duration of surgery > 3h|0|||
161514346|NCT02039427|583273539|FG000|Overall Study|Withdrawal on concent|0|||
161514347|NCT02039427|583273540|FG001|Overall Study|Withdrawal on concent|0|||
161514348|NCT02039427|583273541|FG002|Overall Study|Withdrawal on concent|0|||
161514349|NCT02039427|583273542|FG003|Overall Study|Withdrawal on concent|1|||
161514350|NCT02039427|583273539|FG000|Overall Study|Cancellation of surgery|0|||
161514351|NCT02039427|583273540|FG001|Overall Study|Cancellation of surgery|0|||
161514352|NCT02039427|583273541|FG002|Overall Study|Cancellation of surgery|1|||
161514353|NCT02039427|583273542|FG003|Overall Study|Cancellation of surgery|0|||
161514354|NCT02039427|583273539|FG000|Overall Study|Loss of follow - up|1|||
161514355|NCT02039427|583273540|FG001|Overall Study|Loss of follow - up|0|||
161514356|NCT02039427|583273541|FG002|Overall Study|Loss of follow - up|2|||
161514357|NCT02039427|583273542|FG003|Overall Study|Loss of follow - up|4|||
161514358|NCT02039427|583273539|FG000|Overall Study|Steroid Use|1|||
161514359|NCT02039427|583273540|FG001|Overall Study|Steroid Use|0|||
161514360|NCT02039427|583273541|FG002|Overall Study|Steroid Use|0|||
161514361|NCT02039427|583273542|FG003|Overall Study|Steroid Use|0|||
161514362|NCT03160703|583273544|FG000|Overall Study|Withdrawal by Subject|0|||
161514363|NCT03160703|583273545|FG001|Overall Study|Withdrawal by Subject|0|||
161514364|NCT03160703|583273546|FG002|Overall Study|Withdrawal by Subject|0|||
161514365|NCT03160703|583273547|FG003|Overall Study|Withdrawal by Subject|1|||
161514366|NCT00087568|583273548|FG000|Overall Study|Adverse Event|4|||
161514367|NCT00087568|583273549|FG001|Overall Study|Adverse Event|0|||
161514368|NCT00087568|583273548|FG000|Overall Study|Withdrawal by Subject|1|||
161514369|NCT00087568|583273549|FG001|Overall Study|Withdrawal by Subject|1|||
161514370|NCT00087568|583273548|FG000|Overall Study|Lost to Follow-up|1|||
161514371|NCT00087568|583273549|FG001|Overall Study|Lost to Follow-up|0|||
161514372|NCT00087568|583273548|FG000|Overall Study|Lack of Efficacy|24|||
161514373|NCT00087568|583273549|FG001|Overall Study|Lack of Efficacy|1|||
161514374|NCT01513291|583273550|FG000|Treatment Period|Adverse Event|8|||
161514375|NCT01513291|583273551|FG001|Treatment Period|Adverse Event|4|||
161514376|NCT01513291|583273552|FG002|Treatment Period|Adverse Event|0|||
161514377|NCT01513291|583273553|FG003|Treatment Period|Adverse Event|0|||
161514378|NCT01513291|583273554|FG004|Treatment Period|Adverse Event|0|||
161514379|NCT01513291|583273550|FG000|Treatment Period|Lack of Efficacy|3|||
161514380|NCT01513291|583273551|FG001|Treatment Period|Lack of Efficacy|0|||
161514381|NCT01513291|583273552|FG002|Treatment Period|Lack of Efficacy|0|||
161514382|NCT01513291|583273553|FG003|Treatment Period|Lack of Efficacy|0|||
161514383|NCT01513291|583273554|FG004|Treatment Period|Lack of Efficacy|0|||
161514384|NCT01513291|583273550|FG000|Treatment Period|Lost to Follow-up|2|||
161514385|NCT01513291|583273551|FG001|Treatment Period|Lost to Follow-up|3|||
161514386|NCT01513291|583273552|FG002|Treatment Period|Lost to Follow-up|0|||
161514387|NCT01513291|583273553|FG003|Treatment Period|Lost to Follow-up|0|||
161514388|NCT01513291|583273554|FG004|Treatment Period|Lost to Follow-up|0|||
161514389|NCT01513291|583273550|FG000|Treatment Period|Physician Decision|1|||
161514390|NCT01513291|583273551|FG001|Treatment Period|Physician Decision|0|||
161514391|NCT01513291|583273552|FG002|Treatment Period|Physician Decision|0|||
161514392|NCT01513291|583273553|FG003|Treatment Period|Physician Decision|0|||
161514393|NCT01513291|583273554|FG004|Treatment Period|Physician Decision|0|||
161514394|NCT01513291|583273550|FG000|Treatment Period|Protocol Violation|1|||
161514395|NCT01513291|583273551|FG001|Treatment Period|Protocol Violation|2|||
161514396|NCT01513291|583273552|FG002|Treatment Period|Protocol Violation|0|||
161514397|NCT01513291|583273553|FG003|Treatment Period|Protocol Violation|0|||
161514398|NCT01513291|583273554|FG004|Treatment Period|Protocol Violation|0|||
161514399|NCT01513291|583273550|FG000|Treatment Period|Withdrawal by Subject|8|||
161514400|NCT01513291|583273551|FG001|Treatment Period|Withdrawal by Subject|5|||
161514401|NCT01513291|583273552|FG002|Treatment Period|Withdrawal by Subject|0|||
161514402|NCT01513291|583273553|FG003|Treatment Period|Withdrawal by Subject|0|||
161514403|NCT01513291|583273554|FG004|Treatment Period|Withdrawal by Subject|0|||
161514404|NCT01513291|583273550|FG000|Treatment Period|Randomized not treated|0|||
161514405|NCT01513291|583273551|FG001|Treatment Period|Randomized not treated|2|||
161514406|NCT01513291|583273552|FG002|Treatment Period|Randomized not treated|0|||
161514407|NCT01513291|583273553|FG003|Treatment Period|Randomized not treated|0|||
161514408|NCT01513291|583273554|FG004|Treatment Period|Randomized not treated|0|||
161514409|NCT01513291|583273550|FG000|Run-out Period|Lost to Follow-up|0|||
161514410|NCT01513291|583273551|FG001|Run-out Period|Lost to Follow-up|0|||
161514411|NCT01513291|583273552|FG002|Run-out Period|Lost to Follow-up|0|||
161514412|NCT01513291|583273553|FG003|Run-out Period|Lost to Follow-up|1|||
161514413|NCT01513291|583273554|FG004|Run-out Period|Lost to Follow-up|0|||
161514414|NCT01513291|583273550|FG000|Run-out Period|Withdrawal by Subject|0|||
161514415|NCT01513291|583273551|FG001|Run-out Period|Withdrawal by Subject|0|||
161514416|NCT01513291|583273552|FG002|Run-out Period|Withdrawal by Subject|0|||
161514417|NCT01513291|583273553|FG003|Run-out Period|Withdrawal by Subject|1|||
161821945|NCT01320722|584389249|FG003|Overall Study|Did not Receive Intervention|1|||
161821946|NCT01320722|584389250|FG004|Overall Study|Did not Receive Intervention|2|||
161514418|NCT01513291|583273554|FG004|Run-out Period|Withdrawal by Subject|0|||
161588184|NCT04021602|583542344|FG000|Overall Study|Adverse Event|1|||
161588185|NCT04021602|583542345|FG001|Overall Study|Adverse Event|0|||
161588186|NCT04021602|583542346|FG002|Overall Study|Adverse Event|1|||
161588187|NCT05592418|583542347|FG000|Overall Study|Adverse Event|1|||
161588188|NCT05592418|583542348|FG001|Overall Study|Adverse Event|0|||
161514419|NCT03728582|583273559|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
161514420|NCT03728582|583273560|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
161514421|NCT03728582|583273559|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
161514422|NCT03728582|583273560|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
161514423|NCT02992899|583273561|FG000|Overall Study|Withdrawal by Subject|1|||
161514424|NCT02992899|583273562|FG001|Overall Study|Withdrawal by Subject|0|||
161514425|NCT02992899|583273561|FG000|Overall Study|Lost to Follow-up|1|||
161514426|NCT02992899|583273562|FG001|Overall Study|Lost to Follow-up|3|||
161514427|NCT02738775|583273563|FG000|Overall Study|Withdrawal by Subject|0|||
161514428|NCT02738775|583273564|FG001|Overall Study|Withdrawal by Subject|1|||
161514429|NCT02738775|583273565|FG002|Overall Study|Withdrawal by Subject|0|||
161514430|NCT02738775|583273566|FG003|Overall Study|Withdrawal by Subject|0|||
161514431|NCT02738775|583273567|FG004|Overall Study|Withdrawal by Subject|0|||
161514432|NCT02738775|583273568|FG005|Overall Study|Withdrawal by Subject|0|||
161514433|NCT02738775|583273563|FG000|Overall Study|Adverse Event|0|||
161514434|NCT02738775|583273564|FG001|Overall Study|Adverse Event|0|||
161514435|NCT02738775|583273565|FG002|Overall Study|Adverse Event|0|||
161514436|NCT02738775|583273566|FG003|Overall Study|Adverse Event|1|||
161514437|NCT02738775|583273567|FG004|Overall Study|Adverse Event|0|||
161514438|NCT02738775|583273568|FG005|Overall Study|Adverse Event|0|||
161514439|NCT02738775|583273563|FG000|Overall Study|Pregnancy|0|||
161514440|NCT02738775|583273564|FG001|Overall Study|Pregnancy|1|||
161514441|NCT02738775|583273565|FG002|Overall Study|Pregnancy|0|||
161514442|NCT02738775|583273566|FG003|Overall Study|Pregnancy|0|||
161514443|NCT02738775|583273567|FG004|Overall Study|Pregnancy|0|||
161514444|NCT02738775|583273568|FG005|Overall Study|Pregnancy|0|||
161514445|NCT02738775|583273563|FG000|Overall Study|Missing|0|||
161514446|NCT02738775|583273564|FG001|Overall Study|Missing|0|||
161514447|NCT02738775|583273565|FG002|Overall Study|Missing|0|||
161514448|NCT02738775|583273566|FG003|Overall Study|Missing|0|||
161514449|NCT02738775|583273567|FG004|Overall Study|Missing|0|||
161514450|NCT02738775|583273568|FG005|Overall Study|Missing|1|||
161514451|NCT02370888|583273569|FG000|Overall Study|disease progression|2|||
161514452|NCT02370888|583273569|FG000|Overall Study|did not meet chimerism criteria|6|||
161514453|NCT00047463|583273570|FG000|Overall Study|Withdrawal by Subject|0|||
161514454|NCT00047463|583273571|FG001|Overall Study|Withdrawal by Subject|3|||
161514455|NCT01000051|583273577|FG000|Overall Study|Withdrawal by Subject|1|||
161514456|NCT01000051|583273578|FG001|Overall Study|Withdrawal by Subject|1|||
161514457|NCT01000051|583273577|FG000|Overall Study|Disease Progression|1|||
161514458|NCT01000051|583273578|FG001|Overall Study|Disease Progression|0|||
161588189|NCT05592418|583542347|FG000|Overall Study|Lost to Follow-up|1|||
161588190|NCT05592418|583542348|FG001|Overall Study|Lost to Follow-up|3|||
161588191|NCT05592418|583542347|FG000|Overall Study|Withdrawal by Subject|2|||
161588192|NCT05592418|583542348|FG001|Overall Study|Withdrawal by Subject|7|||
161588193|NCT04450342|583542351|FG000|Overall Study|Adverse Event|1|||
161588194|NCT04450342|583542352|FG001|Overall Study|Adverse Event|1|||
161588195|NCT04450342|583542353|FG002|Overall Study|Adverse Event|0|||
161588196|NCT04450342|583542351|FG000|Overall Study|Device not used|1|||
161588197|NCT04450342|583542352|FG001|Overall Study|Device not used|0|||
161588198|NCT04450342|583542353|FG002|Overall Study|Device not used|0|||
161588199|NCT04450342|583542351|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
161588200|NCT04450342|583542352|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
161588201|NCT04450342|583542353|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
161588202|NCT04450342|583542351|FG000|Overall Study|Physician Decision|1|||
161588203|NCT04450342|583542352|FG001|Overall Study|Physician Decision|0|||
161588204|NCT04450342|583542353|FG002|Overall Study|Physician Decision|1|||
161588205|NCT04450342|583542351|FG000|Overall Study|Protocol Deviation|0|||
161588206|NCT04450342|583542352|FG001|Overall Study|Protocol Deviation|1|||
161588207|NCT04450342|583542353|FG002|Overall Study|Protocol Deviation|0|||
161588208|NCT04450342|583542351|FG000|Overall Study|Reoperation|1|||
161588209|NCT04450342|583542352|FG001|Overall Study|Reoperation|1|||
161676738|NCT03349775|583870512|FG000|Overall Study|Side Effects|1|||
161676739|NCT03349775|583870513|FG001|Overall Study|Side Effects|2|||
161821947|NCT01320722|584389246|FG000|Overall Study|Lost to Follow-up|0|||
161821948|NCT01320722|584389247|FG001|Overall Study|Lost to Follow-up|1|||
161821949|NCT01320722|584389248|FG002|Overall Study|Lost to Follow-up|0|||
161514459|NCT01000051|583273577|FG000|Overall Study|Serious noncompliance|1|||
161514460|NCT01000051|583273578|FG001|Overall Study|Serious noncompliance|0|||
161514461|NCT03304379|583273589|FG000|Overall Study|Protocol Violation|8|||
161514462|NCT03304379|583273590|FG001|Overall Study|Protocol Violation|10|||
161514463|NCT03304379|583273591|FG002|Overall Study|Protocol Violation|5|||
161514464|NCT03304379|583273592|FG003|Overall Study|Protocol Violation|0|||
161514465|NCT03304379|583273593|FG004|Overall Study|Protocol Violation|2|||
161514466|NCT03304379|583273589|FG000|Overall Study|Adverse Event|4|||
161514467|NCT03304379|583273590|FG001|Overall Study|Adverse Event|20|||
161514468|NCT03304379|583273591|FG002|Overall Study|Adverse Event|17|||
161588210|NCT04450342|583542353|FG002|Overall Study|Reoperation|0|||
161588211|NCT04450342|583542351|FG000|Overall Study|Screen Failures|0|||
161588212|NCT04450342|583542352|FG001|Overall Study|Screen Failures|0|||
161588213|NCT04450342|583542353|FG002|Overall Study|Screen Failures|2|||
161588214|NCT04450342|583542351|FG000|Overall Study|Site Terminated by Sponsor|1|||
161588215|NCT04450342|583542352|FG001|Overall Study|Site Terminated by Sponsor|1|||
161588216|NCT04450342|583542353|FG002|Overall Study|Site Terminated by Sponsor|1|||
161588217|NCT04450342|583542351|FG000|Overall Study|Study Terminated by Sponsor|31|||
161588218|NCT04450342|583542352|FG001|Overall Study|Study Terminated by Sponsor|29|||
161588219|NCT04450342|583542353|FG002|Overall Study|Study Terminated by Sponsor|6|||
161588220|NCT04450342|583542351|FG000|Overall Study|Withdrawal by Subject|0|||
161588221|NCT04450342|583542352|FG001|Overall Study|Withdrawal by Subject|1|||
161588222|NCT04450342|583542353|FG002|Overall Study|Withdrawal by Subject|2|||
161588223|NCT05481320|583542354|FG000|Overall Study|Withdrawal by Subject|1|||
161588224|NCT05481320|583542355|FG001|Overall Study|Withdrawal by Subject|1|||
161588225|NCT05481320|583542354|FG000|Overall Study|Care recipent passed away|0|||
161588226|NCT05481320|583542355|FG001|Overall Study|Care recipent passed away|1|||
161588227|NCT05481320|583542354|FG000|Overall Study|Out-of-window assessment|0|||
161588228|NCT05481320|583542355|FG001|Overall Study|Out-of-window assessment|1|||
161588229|NCT05481320|583542354|FG000|Overall Study|No longer a primary caregiver|3|||
161588230|NCT05481320|583542355|FG001|Overall Study|No longer a primary caregiver|0|||
161588231|NCT05481320|583542354|FG000|Overall Study|Unable to contact|1|||
161588232|NCT05481320|583542355|FG001|Overall Study|Unable to contact|0|||
161588233|NCT02874534|583542356|FG000|Overall Study|Withdrawal by Subject|5|||
161588234|NCT02874534|583542357|FG001|Overall Study|Withdrawal by Subject|8|||
161588235|NCT02874534|583542356|FG000|Overall Study|Lost to Follow-up|2|||
161588236|NCT02874534|583542357|FG001|Overall Study|Lost to Follow-up|2|||
161588237|NCT02874534|583542356|FG000|Overall Study|Ongoing in study|1|||
161588238|NCT02874534|583542357|FG001|Overall Study|Ongoing in study|1|||
161588239|NCT02923180|583542358|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
161588240|NCT02923180|583542358|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
161588241|NCT05198310|583542359|FG000|Overall Study|Lost to Follow-up|0|||
161588242|NCT05198310|583542360|FG001|Overall Study|Lost to Follow-up|1|||
161588243|NCT05198310|583542361|FG002|Overall Study|Lost to Follow-up|0|||
161588244|NCT05198310|583542362|FG003|Overall Study|Lost to Follow-up|0|||
161588245|NCT05198310|583542363|FG004|Overall Study|Lost to Follow-up|0|||
161588246|NCT05198310|583542364|FG005|Overall Study|Lost to Follow-up|0|||
161676740|NCT03349775|583870512|FG000|Overall Study|Withdrawal by Subject|1|||
161821950|NCT01320722|584389249|FG003|Overall Study|Lost to Follow-up|1|||
161588247|NCT05198310|583542365|FG006|Overall Study|Lost to Follow-up|0|||
161588248|NCT05198310|583542366|FG007|Overall Study|Lost to Follow-up|0|||
161588249|NCT05198310|583542359|FG000|Overall Study|Withdrawal by Subject|0|||
161588250|NCT05198310|583542360|FG001|Overall Study|Withdrawal by Subject|0|||
161588251|NCT05198310|583542361|FG002|Overall Study|Withdrawal by Subject|0|||
161588252|NCT05198310|583542362|FG003|Overall Study|Withdrawal by Subject|2|||
161821951|NCT01320722|584389250|FG004|Overall Study|Lost to Follow-up|3|||
161821952|NCT01320722|584389246|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
161821953|NCT01320722|584389247|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
161821954|NCT01320722|584389248|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
161821955|NCT01320722|584389249|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
161821956|NCT01320722|584389250|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
161821957|NCT01320722|584389246|FG000|Overall Study|Participant Developed a Rash|0|||
161821958|NCT01320722|584389247|FG001|Overall Study|Participant Developed a Rash|0|||
161821959|NCT01320722|584389248|FG002|Overall Study|Participant Developed a Rash|2|||
161821960|NCT01320722|584389249|FG003|Overall Study|Participant Developed a Rash|1|||
161821961|NCT01320722|584389250|FG004|Overall Study|Participant Developed a Rash|1|||
161821962|NCT01320722|584389246|FG000|Overall Study|Non-compliant with Medication|0|||
161821963|NCT01320722|584389247|FG001|Overall Study|Non-compliant with Medication|0|||
161821964|NCT01320722|584389248|FG002|Overall Study|Non-compliant with Medication|1|||
161821965|NCT01320722|584389249|FG003|Overall Study|Non-compliant with Medication|0|||
161821966|NCT01320722|584389250|FG004|Overall Study|Non-compliant with Medication|0|||
161821967|NCT01320722|584389246|FG000|Overall Study|Adverse Event|0|||
161821968|NCT01320722|584389247|FG001|Overall Study|Adverse Event|0|||
161821969|NCT01320722|584389248|FG002|Overall Study|Adverse Event|3|||
161821970|NCT01320722|584389249|FG003|Overall Study|Adverse Event|6|||
161821971|NCT01320722|584389250|FG004|Overall Study|Adverse Event|0|||
161821972|NCT01320722|584389246|FG000|Overall Study|Not Compliant with Study Procedures|0|||
161821973|NCT01320722|584389247|FG001|Overall Study|Not Compliant with Study Procedures|0|||
161821974|NCT01320722|584389248|FG002|Overall Study|Not Compliant with Study Procedures|0|||
161821975|NCT01320722|584389249|FG003|Overall Study|Not Compliant with Study Procedures|4|||
161821976|NCT01320722|584389250|FG004|Overall Study|Not Compliant with Study Procedures|0|||
161821977|NCT01320722|584389246|FG000|Overall Study|Pregnancy|0|||
161821978|NCT01320722|584389247|FG001|Overall Study|Pregnancy|0|||
161821979|NCT01320722|584389248|FG002|Overall Study|Pregnancy|0|||
161821980|NCT01320722|584389249|FG003|Overall Study|Pregnancy|1|||
161821981|NCT01320722|584389250|FG004|Overall Study|Pregnancy|0|||
161821982|NCT01320722|584389246|FG000|Overall Study|Started an Exclusionary Medication|0|||
161514469|NCT03304379|583273592|FG003|Overall Study|Adverse Event|1|||
161514470|NCT03304379|583273593|FG004|Overall Study|Adverse Event|0|||
161514471|NCT03304379|583273589|FG000|Overall Study|Lack of Efficacy|17|||
161514472|NCT03304379|583273590|FG001|Overall Study|Lack of Efficacy|16|||
161514473|NCT03304379|583273591|FG002|Overall Study|Lack of Efficacy|20|||
161514474|NCT03304379|583273592|FG003|Overall Study|Lack of Efficacy|0|||
161514475|NCT03304379|583273593|FG004|Overall Study|Lack of Efficacy|0|||
161514476|NCT03304379|583273589|FG000|Overall Study|Physician Decision|6|||
161514477|NCT03304379|583273590|FG001|Overall Study|Physician Decision|10|||
161514478|NCT03304379|583273591|FG002|Overall Study|Physician Decision|6|||
161514479|NCT03304379|583273592|FG003|Overall Study|Physician Decision|9|||
161514480|NCT03304379|583273593|FG004|Overall Study|Physician Decision|10|||
161514481|NCT03304379|583273589|FG000|Overall Study|Withdrawal by Subject|26|||
161514482|NCT03304379|583273590|FG001|Overall Study|Withdrawal by Subject|58|||
161514483|NCT03304379|583273591|FG002|Overall Study|Withdrawal by Subject|66|||
161514484|NCT03304379|583273592|FG003|Overall Study|Withdrawal by Subject|3|||
161514485|NCT03304379|583273593|FG004|Overall Study|Withdrawal by Subject|5|||
161514486|NCT03304379|583273589|FG000|Overall Study|Lost to Follow-up|8|||
161514487|NCT03304379|583273590|FG001|Overall Study|Lost to Follow-up|24|||
161514488|NCT03304379|583273591|FG002|Overall Study|Lost to Follow-up|35|||
161514489|NCT03304379|583273592|FG003|Overall Study|Lost to Follow-up|4|||
161514490|NCT03304379|583273593|FG004|Overall Study|Lost to Follow-up|0|||
161514491|NCT03304379|583273589|FG000|Overall Study|Death|1|||
161514492|NCT03304379|583273590|FG001|Overall Study|Death|2|||
161514493|NCT03304379|583273591|FG002|Overall Study|Death|0|||
161514494|NCT03304379|583273592|FG003|Overall Study|Death|0|||
161514495|NCT03304379|583273593|FG004|Overall Study|Death|0|||
161514496|NCT03304379|583273589|FG000|Overall Study|Other|0|||
161514497|NCT03304379|583273590|FG001|Overall Study|Other|1|||
161514498|NCT03304379|583273591|FG002|Overall Study|Other|0|||
161514499|NCT03304379|583273592|FG003|Overall Study|Other|0|||
161514500|NCT03304379|583273593|FG004|Overall Study|Other|0|||
161514501|NCT02802345|583273601|FG000|Overall Study|Not Treated|0|||
161514502|NCT02802345|583273602|FG001|Overall Study|Not Treated|1|||
161514503|NCT02802345|583273601|FG000|Overall Study|Adverse Event|28|||
161514504|NCT02802345|583273602|FG001|Overall Study|Adverse Event|20|||
161514505|NCT02802345|583273601|FG000|Overall Study|Withdrawal by Subject|3|||
161514506|NCT02802345|583273602|FG001|Overall Study|Withdrawal by Subject|3|||
161514507|NCT02802345|583273601|FG000|Overall Study|Protocol Violation|0|||
161514508|NCT02802345|583273602|FG001|Overall Study|Protocol Violation|1|||
161514509|NCT02802345|583273601|FG000|Overall Study|Other than listed|1|||
161514510|NCT02802345|583273602|FG001|Overall Study|Other than listed|5|||
161514511|NCT03969212|583273603|FG000|Overall Study|Adverse Event|1|||
161514512|NCT03969212|583273604|FG001|Overall Study|Adverse Event|0|||
161514513|NCT03969212|583273605|FG002|Overall Study|Adverse Event|0|||
161514514|NCT03969212|583273606|FG003|Overall Study|Adverse Event|0|||
161514515|NCT03969212|583273603|FG000|Overall Study|Lost to Follow-up|2|||
161514516|NCT03969212|583273604|FG001|Overall Study|Lost to Follow-up|2|||
161514517|NCT03969212|583273605|FG002|Overall Study|Lost to Follow-up|2|||
161514518|NCT03969212|583273606|FG003|Overall Study|Lost to Follow-up|2|||
161514519|NCT03969212|583273603|FG000|Overall Study|Protocol Violation|0|||
161514520|NCT03969212|583273604|FG001|Overall Study|Protocol Violation|0|||
161514521|NCT03969212|583273605|FG002|Overall Study|Protocol Violation|0|||
161514522|NCT03969212|583273606|FG003|Overall Study|Protocol Violation|1|||
161514523|NCT03969212|583273603|FG000|Overall Study|Withdrawal by Subject|7|||
161514524|NCT03969212|583273604|FG001|Overall Study|Withdrawal by Subject|13|||
161514525|NCT03969212|583273605|FG002|Overall Study|Withdrawal by Subject|5|||
161514526|NCT03969212|583273606|FG003|Overall Study|Withdrawal by Subject|11|||
161514527|NCT03969212|583273603|FG000|Overall Study|Physician Decision|0|||
161514528|NCT03969212|583273604|FG001|Overall Study|Physician Decision|0|||
161514529|NCT03969212|583273605|FG002|Overall Study|Physician Decision|1|||
161514530|NCT03969212|583273606|FG003|Overall Study|Physician Decision|0|||
161514531|NCT03969212|583273603|FG000|Overall Study|Reason not Specified|22|||
161514532|NCT03969212|583273604|FG001|Overall Study|Reason not Specified|23|||
161821983|NCT01320722|584389247|FG001|Overall Study|Started an Exclusionary Medication|0|||
161821984|NCT01320722|584389248|FG002|Overall Study|Started an Exclusionary Medication|0|||
161821985|NCT01320722|584389249|FG003|Overall Study|Started an Exclusionary Medication|0|||
161821986|NCT01320722|584389250|FG004|Overall Study|Started an Exclusionary Medication|1|||
161821987|NCT01320722|584389246|FG000|Overall Study|Withdrew due to Health Condition|0|||
161514533|NCT03969212|583273605|FG002|Overall Study|Reason not Specified|28|||
161514534|NCT03969212|583273606|FG003|Overall Study|Reason not Specified|26|||
161514535|NCT02075320|583273607|FG000|Overall Study|Withdrawal by Subject|2|||
161514536|NCT03773757|583273609|FG000|Overall Study|Withdrawal by Subject|2|||
161514537|NCT03773757|583273610|FG001|Overall Study|Withdrawal by Subject|4|||
161514538|NCT00057746|583273611|FG000|Overall Study|Withdrawal by Subject|0|||
161514539|NCT00057746|583273612|FG001|Overall Study|Withdrawal by Subject|0|||
161514540|NCT00057746|583273613|FG002|Overall Study|Withdrawal by Subject|1|||
161514541|NCT02985736|583273618|FG000|Overall Study|Lost to Follow-up|3|||
161514542|NCT00550836|583273619|FG000|Overall Study|Withdrawal by Subject|3|||
161514543|NCT00550836|583273620|FG001|Overall Study|Withdrawal by Subject|9|||
161514544|NCT01856543|583273621|FG000|Overall Study|Treatment discontinued|6|||
161514545|NCT01856543|583273622|FG001|Overall Study|Treatment discontinued|3|||
161514546|NCT01856543|583273621|FG000|Overall Study|Withdrawn before start|7|||
161514547|NCT01856543|583273622|FG001|Overall Study|Withdrawn before start|3|||
161514548|NCT04545515|583273623|FG000|Overall Study|Adverse Event|1|||
161514549|NCT04545515|583273623|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
161514550|NCT04545515|583273623|FG000|Overall Study|Commercial drug is available for participant|7|||
161514551|NCT01552772|583273624|FG000|Overall Study|Lost to Follow-up|2|||
161514552|NCT01552772|583273624|FG000|Overall Study|Adverse Event|1|||
161514553|NCT01552772|583273624|FG000|Overall Study|Protocol Deviation|1|||
161514554|NCT01848990|583273625|FG000|Overall Study|Adverse Event|6|||
161514555|NCT01848990|583273626|FG001|Overall Study|Adverse Event|2|||
161514556|NCT01848990|583273627|FG002|Overall Study|Adverse Event|0|||
161514557|NCT01848990|583273625|FG000|Overall Study|Lost to Follow-up|6|||
161514558|NCT01848990|583273626|FG001|Overall Study|Lost to Follow-up|2|||
161514559|NCT01848990|583273627|FG002|Overall Study|Lost to Follow-up|2|||
161514560|NCT01848990|583273625|FG000|Overall Study|Protocol Violation|1|||
161514561|NCT01848990|583273626|FG001|Overall Study|Protocol Violation|1|||
161514562|NCT01848990|583273627|FG002|Overall Study|Protocol Violation|0|||
161514563|NCT01848990|583273625|FG000|Overall Study|Withdrawal by Subject|29|||
161514564|NCT01848990|583273626|FG001|Overall Study|Withdrawal by Subject|10|||
161514565|NCT01848990|583273627|FG002|Overall Study|Withdrawal by Subject|11|||
161514566|NCT01848990|583273625|FG000|Overall Study|Physician Decision|1|||
161514567|NCT01848990|583273626|FG001|Overall Study|Physician Decision|1|||
161514568|NCT01848990|583273627|FG002|Overall Study|Physician Decision|0|||
161514569|NCT01848990|583273625|FG000|Overall Study|Non Compliance|1|||
161514570|NCT01848990|583273626|FG001|Overall Study|Non Compliance|0|||
161514571|NCT01848990|583273627|FG002|Overall Study|Non Compliance|0|||
161514572|NCT01848990|583273625|FG000|Overall Study|Death|1|||
161514573|NCT01848990|583273626|FG001|Overall Study|Death|0|||
161514574|NCT01848990|583273627|FG002|Overall Study|Death|1|||
161514575|NCT01848990|583273625|FG000|Overall Study|Other|1|||
161514576|NCT01848990|583273626|FG001|Overall Study|Other|4|||
161514577|NCT01848990|583273627|FG002|Overall Study|Other|2|||
161514578|NCT00512096|583273633|FG000|Overall Study|Adverse Event|2|||
161514579|NCT00512096|583273633|FG000|Overall Study|Withdrawal by Subject|2|||
161514580|NCT00512096|583273633|FG000|Overall Study|Lack of Efficacy|3|||
161514581|NCT00298038|583273640|FG000|Overall Study|Lost to Follow-up|0|||
161514582|NCT00298038|583273641|FG001|Overall Study|Lost to Follow-up|1|||
161514583|NCT00298038|583273640|FG000|Overall Study|Liver Transplant|0|||
161514584|NCT00298038|583273641|FG001|Overall Study|Liver Transplant|1|||
161676741|NCT03349775|583870513|FG001|Overall Study|Withdrawal by Subject|1|||
161676742|NCT03349775|583870512|FG000|Overall Study|No primary outcome measurements|0|||
161676743|NCT03349775|583870513|FG001|Overall Study|No primary outcome measurements|1|||
161676744|NCT04479436|583870518|FG000|Overall Study|Progressive disease|26|||
161676745|NCT04479436|583870519|FG001|Overall Study|Progressive disease|1|||
161676746|NCT04479436|583870518|FG000|Overall Study|Adverse Event|6|||
161676747|NCT04479436|583870519|FG001|Overall Study|Adverse Event|0|||
161676748|NCT04479436|583870518|FG000|Overall Study|Withdrawal by Subject|5|||
161676749|NCT04479436|583870519|FG001|Overall Study|Withdrawal by Subject|0|||
161676750|NCT04479436|583870518|FG000|Overall Study|Clinical progression|1|||
161676751|NCT04479436|583870519|FG001|Overall Study|Clinical progression|0|||
161676752|NCT04479436|583870518|FG000|Overall Study|Physician Decision|1|||
161676753|NCT04479436|583870519|FG001|Overall Study|Physician Decision|0|||
161676754|NCT03383289|583870527|FG000|Overall Study|Death|83|||
161676755|NCT03383289|583870528|FG001|Overall Study|Death|78|||
161514585|NCT00298038|583273640|FG000|Overall Study|Protocol Violation|1|||
161514586|NCT00298038|583273641|FG001|Overall Study|Protocol Violation|3|||
161514587|NCT00298038|583273640|FG000|Overall Study|Death|6|||
161514588|NCT00298038|583273641|FG001|Overall Study|Death|3|||
161676756|NCT03383289|583870527|FG000|Overall Study|discharge from facility|84|||
161676757|NCT03383289|583870528|FG001|Overall Study|discharge from facility|84|||
161676758|NCT03383289|583870527|FG000|Overall Study|Withdrawal by Subject|4|||
161676759|NCT03383289|583870528|FG001|Overall Study|Withdrawal by Subject|1|||
161514589|NCT00298038|583273640|FG000|Overall Study|Withdrawal by Subject|6|||
161514590|NCT00298038|583273641|FG001|Overall Study|Withdrawal by Subject|9|||
161514591|NCT00298038|583273640|FG000|Overall Study|Adverse Event|8|||
161514592|NCT00298038|583273641|FG001|Overall Study|Adverse Event|7|||
161514593|NCT00298038|583273640|FG000|Overall Study|Breakthrough overt HE episode|28|||
161821988|NCT01320722|584389247|FG001|Overall Study|Withdrew due to Health Condition|0|||
161821989|NCT01320722|584389248|FG002|Overall Study|Withdrew due to Health Condition|0|||
161821990|NCT01320722|584389249|FG003|Overall Study|Withdrew due to Health Condition|0|||
161821991|NCT01320722|584389250|FG004|Overall Study|Withdrew due to Health Condition|1|||
161821992|NCT01091363|584389251|FG000|Overall Study|Withdrawal by Subject|11|||
161821993|NCT01091363|584389252|FG001|Overall Study|Withdrawal by Subject|15|||
161514594|NCT00298038|583273641|FG001|Overall Study|Breakthrough overt HE episode|69|||
161514595|NCT00298038|583273640|FG000|Overall Study|Noncompliance|1|||
161514596|NCT00298038|583273641|FG001|Overall Study|Noncompliance|0|||
161514597|NCT00298038|583273640|FG000|Overall Study|Cocaine Abuse|1|||
161514598|NCT00298038|583273641|FG001|Overall Study|Cocaine Abuse|0|||
161514599|NCT00298038|583273640|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
161514600|NCT00298038|583273641|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
161514601|NCT02696096|583273642|FG000|Overall Study|ruled out at screening|1|||
161514602|NCT02696096|583273642|FG000|Overall Study|did not attend second fMRI|1|||
161514603|NCT01940705|583273646|FG000|Overall Study|Lost to Follow-up|1|||
161514604|NCT01940705|583273647|FG001|Overall Study|Lost to Follow-up|3|||
161514605|NCT01940705|583273648|FG002|Overall Study|Lost to Follow-up|2|||
161514606|NCT01940705|583273649|FG003|Overall Study|Lost to Follow-up|2|||
161514607|NCT01940705|583273646|FG000|Overall Study|Withdrawal by Subject|2|||
161514608|NCT01940705|583273647|FG001|Overall Study|Withdrawal by Subject|2|||
161514609|NCT01940705|583273648|FG002|Overall Study|Withdrawal by Subject|3|||
161514610|NCT01940705|583273649|FG003|Overall Study|Withdrawal by Subject|2|||
161514611|NCT01940705|583273646|FG000|Overall Study|Intervention not given|0|||
161514612|NCT01940705|583273647|FG001|Overall Study|Intervention not given|3|||
161514613|NCT01940705|583273648|FG002|Overall Study|Intervention not given|3|||
161514614|NCT01940705|583273649|FG003|Overall Study|Intervention not given|0|||
161514615|NCT01940705|583273646|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
161514616|NCT01940705|583273647|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
161514617|NCT01940705|583273648|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
161514618|NCT01940705|583273649|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
161514619|NCT02447991|583273650|FG000|Overall Study|Withdrawn by subject - no data|0|||
161514620|NCT02447991|583273651|FG001|Overall Study|Withdrawn by subject - no data|2|||
161514621|NCT02447991|583273650|FG000|Overall Study|Withdrawn by Subject - with data|4|||
161514622|NCT02447991|583273651|FG001|Overall Study|Withdrawn by Subject - with data|4|||
161514623|NCT02447991|583273650|FG000|Overall Study|Lost to Follow-up - no data|3|||
161514624|NCT02447991|583273651|FG001|Overall Study|Lost to Follow-up - no data|6|||
161514625|NCT02447991|583273650|FG000|Overall Study|Lost to follow-up - with data|0|||
161514626|NCT02447991|583273651|FG001|Overall Study|Lost to follow-up - with data|3|||
161514627|NCT02447991|583273650|FG000|Overall Study|End of study - no treatment results|3|||
161514628|NCT02447991|583273651|FG001|Overall Study|End of study - no treatment results|6|||
161514629|NCT02447991|583273650|FG000|Overall Study|End of study - partial treatment results|0|||
161514630|NCT02447991|583273651|FG001|Overall Study|End of study - partial treatment results|9|||
161514631|NCT01076400|583275464|FG000|Overall Study|Adverse Event|2|||
161514632|NCT01076400|583275465|FG001|Overall Study|Adverse Event|0|||
161514633|NCT01076400|583275466|FG002|Overall Study|Adverse Event|0|||
161514634|NCT01076400|583275464|FG000|Overall Study|Progressive Disease|5|||
161514635|NCT01076400|583275465|FG001|Overall Study|Progressive Disease|0|||
161514636|NCT01076400|583275466|FG002|Overall Study|Progressive Disease|0|||
161514637|NCT02766608|583275469|FG000|Overall Study|Adverse Event|27|||
161514638|NCT02766608|583275470|FG001|Overall Study|Adverse Event|22|||
161514639|NCT02766608|583275471|FG002|Overall Study|Adverse Event|17|||
161514640|NCT02766608|583275472|FG003|Overall Study|Adverse Event|13|||
161514641|NCT02766608|583275473|FG004|Overall Study|Adverse Event|12|||
161514642|NCT02766608|583275469|FG000|Overall Study|Withdrawal by Subject|21|||
161514643|NCT02766608|583275470|FG001|Overall Study|Withdrawal by Subject|20|||
161514644|NCT02766608|583275471|FG002|Overall Study|Withdrawal by Subject|24|||
161514645|NCT02766608|583275472|FG003|Overall Study|Withdrawal by Subject|13|||
161514646|NCT02766608|583275473|FG004|Overall Study|Withdrawal by Subject|10|||
161514647|NCT02766608|583275469|FG000|Overall Study|Lack of Efficacy|16|||
161514648|NCT02766608|583275470|FG001|Overall Study|Lack of Efficacy|15|||
161514649|NCT02766608|583275471|FG002|Overall Study|Lack of Efficacy|32|||
161514650|NCT02766608|583275472|FG003|Overall Study|Lack of Efficacy|8|||
161514651|NCT02766608|583275473|FG004|Overall Study|Lack of Efficacy|2|||
161588253|NCT05198310|583542363|FG004|Overall Study|Withdrawal by Subject|0|||
161588254|NCT05198310|583542364|FG005|Overall Study|Withdrawal by Subject|2|||
161588255|NCT05198310|583542365|FG006|Overall Study|Withdrawal by Subject|1|||
161588256|NCT05198310|583542366|FG007|Overall Study|Withdrawal by Subject|3|||
161588257|NCT04116736|583542369|FG000|Overall Study|Withdrew consent during study|3|||
161588258|NCT04116736|583542370|FG001|Overall Study|Withdrew consent during study|1|||
161588259|NCT04116736|583542369|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
161588260|NCT04116736|583542370|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
161588261|NCT04116736|583542369|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
161588262|NCT04116736|583542370|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
161514652|NCT02766608|583275469|FG000|Overall Study|Lost to Follow-up|6|||
161514653|NCT02766608|583275470|FG001|Overall Study|Lost to Follow-up|3|||
161514654|NCT02766608|583275471|FG002|Overall Study|Lost to Follow-up|5|||
161514655|NCT02766608|583275472|FG003|Overall Study|Lost to Follow-up|2|||
161514656|NCT02766608|583275473|FG004|Overall Study|Lost to Follow-up|2|||
161514657|NCT02766608|583275469|FG000|Overall Study|Physician Decision|3|||
161588263|NCT04116736|583542369|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
161514658|NCT02766608|583275470|FG001|Overall Study|Physician Decision|2|||
161514659|NCT02766608|583275471|FG002|Overall Study|Physician Decision|3|||
161514660|NCT02766608|583275472|FG003|Overall Study|Physician Decision|1|||
161514661|NCT02766608|583275473|FG004|Overall Study|Physician Decision|2|||
161514662|NCT02766608|583275469|FG000|Overall Study|Protocol disc criteria|3|||
161514663|NCT02766608|583275470|FG001|Overall Study|Protocol disc criteria|3|||
161514664|NCT02766608|583275471|FG002|Overall Study|Protocol disc criteria|4|||
161514665|NCT02766608|583275472|FG003|Overall Study|Protocol disc criteria|0|||
161514666|NCT02766608|583275473|FG004|Overall Study|Protocol disc criteria|0|||
161514667|NCT02766608|583275469|FG000|Overall Study|Protocol Violation|0|||
161514668|NCT02766608|583275470|FG001|Overall Study|Protocol Violation|4|||
161514669|NCT02766608|583275471|FG002|Overall Study|Protocol Violation|4|||
161514670|NCT02766608|583275472|FG003|Overall Study|Protocol Violation|0|||
161514671|NCT02766608|583275473|FG004|Overall Study|Protocol Violation|1|||
161514672|NCT02766608|583275469|FG000|Overall Study|Administrative Reasons|3|||
161514673|NCT02766608|583275470|FG001|Overall Study|Administrative Reasons|1|||
161514674|NCT02766608|583275471|FG002|Overall Study|Administrative Reasons|1|||
161514675|NCT02766608|583275472|FG003|Overall Study|Administrative Reasons|0|||
161514676|NCT02766608|583275473|FG004|Overall Study|Administrative Reasons|0|||
161514677|NCT02343458|583275474|FG000|Overall Study|Adverse Event|15|||
161514678|NCT02343458|583275475|FG001|Overall Study|Adverse Event|14|||
161514679|NCT02343458|583275476|FG002|Overall Study|Adverse Event|15|||
161514680|NCT02343458|583275477|FG003|Overall Study|Adverse Event|3|||
161514681|NCT02343458|583275474|FG000|Overall Study|Lack of Efficacy|3|||
161514682|NCT02343458|583275475|FG001|Overall Study|Lack of Efficacy|8|||
161514683|NCT02343458|583275476|FG002|Overall Study|Lack of Efficacy|4|||
161514684|NCT02343458|583275477|FG003|Overall Study|Lack of Efficacy|8|||
161514685|NCT02343458|583275474|FG000|Overall Study|Withdrawal by Subject|18|||
161514686|NCT02343458|583275475|FG001|Overall Study|Withdrawal by Subject|17|||
161514687|NCT02343458|583275476|FG002|Overall Study|Withdrawal by Subject|23|||
161514688|NCT02343458|583275477|FG003|Overall Study|Withdrawal by Subject|14|||
161514689|NCT02343458|583275474|FG000|Overall Study|Physician Decision|1|||
161514690|NCT02343458|583275475|FG001|Overall Study|Physician Decision|4|||
161514691|NCT02343458|583275476|FG002|Overall Study|Physician Decision|2|||
161514692|NCT02343458|583275477|FG003|Overall Study|Physician Decision|2|||
161514693|NCT02343458|583275474|FG000|Overall Study|Lost to Follow-up|5|||
161514694|NCT02343458|583275475|FG001|Overall Study|Lost to Follow-up|5|||
161514695|NCT02343458|583275476|FG002|Overall Study|Lost to Follow-up|3|||
161514696|NCT02343458|583275477|FG003|Overall Study|Lost to Follow-up|1|||
161514697|NCT02343458|583275474|FG000|Overall Study|Protocol Violation|2|||
161514698|NCT02343458|583275475|FG001|Overall Study|Protocol Violation|5|||
161514699|NCT02343458|583275476|FG002|Overall Study|Protocol Violation|2|||
161514700|NCT02343458|583275477|FG003|Overall Study|Protocol Violation|2|||
161514701|NCT02343458|583275474|FG000|Overall Study|Protocol Specified Criteria|17|||
161514702|NCT02343458|583275475|FG001|Overall Study|Protocol Specified Criteria|13|||
161514703|NCT02343458|583275476|FG002|Overall Study|Protocol Specified Criteria|14|||
161514704|NCT02343458|583275477|FG003|Overall Study|Protocol Specified Criteria|8|||
161514705|NCT01913041|583275478|FG000|Overall Study|Protocol Violation|35|||
161514706|NCT01913041|583275478|FG000|Overall Study|Withdrawal by Subject|3|||
161514707|NCT01913041|583275478|FG000|Overall Study|Physician Decision|1|||
161514708|NCT02866682|583275481|FG000|Overall Study|Death|0|||
161514709|NCT02866682|583275482|FG001|Overall Study|Death|1|||
161514710|NCT02866682|583275481|FG000|Overall Study|Lost to Follow-up|0|||
161514711|NCT02866682|583275482|FG001|Overall Study|Lost to Follow-up|4|||
161514712|NCT02866682|583275481|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
161821994|NCT01091363|584389251|FG000|Overall Study|Lost to Follow-up|2|||
161821995|NCT01091363|584389252|FG001|Overall Study|Lost to Follow-up|2|||
161821996|NCT00160524|584389253|FG000|Overall Study|Adverse Event|119|||
161821997|NCT00160524|584389253|FG000|Overall Study|Adverse Event and Other|94|||
161821998|NCT00160524|584389253|FG000|Overall Study|Protocol Violation|16|||
161821999|NCT00160524|584389253|FG000|Overall Study|Protocol Violation and Other|2|||
161822000|NCT00160524|584389253|FG000|Overall Study|Withdrawal by Subject|141|||
161822001|NCT00160524|584389253|FG000|Overall Study|Withdrawal by Subject and Other|17|||
161822002|NCT00160524|584389253|FG000|Overall Study|Physician Decision|27|||
161514713|NCT02866682|583275482|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
161822003|NCT00160524|584389253|FG000|Overall Study|Physician Decision and Other|6|||
161822004|NCT00160524|584389253|FG000|Overall Study|Lost to Follow-up|13|||
161514714|NCT02866682|583275481|FG000|Overall Study|Other|0|||
161514715|NCT02866682|583275482|FG001|Overall Study|Other|1|||
161514716|NCT01750268|583275483|FG000|Overall Study|Lost to Follow-up|0|||
161514717|NCT01750268|583275484|FG001|Overall Study|Lost to Follow-up|2|||
161514718|NCT01750268|583275483|FG000|Overall Study|Physician Decision|0|||
161514719|NCT01750268|583275484|FG001|Overall Study|Physician Decision|3|||
161514720|NCT01750268|583275483|FG000|Overall Study|Withdrawal by Subject|2|||
161514721|NCT01750268|583275484|FG001|Overall Study|Withdrawal by Subject|0|||
161514722|NCT02086591|583275485|FG000|Overall Study|Adverse Event|1|||
161514723|NCT02086591|583275485|FG000|Overall Study|Withdrawal by Subject|1|||
161822005|NCT00160524|584389253|FG000|Overall Study|Lost to Follow-up and Other|1|||
161822006|NCT00160524|584389253|FG000|Overall Study|Lack of Efficacy|21|||
161514724|NCT02086591|583275485|FG000|Overall Study|protocol terminated|3|||
161514725|NCT01529645|583275486|FG000|Overall Study|Lost to Follow-up|0|||
161514726|NCT01529645|583275487|FG001|Overall Study|Lost to Follow-up|1|||
161514727|NCT01529645|583275488|FG002|Overall Study|Lost to Follow-up|1|||
161514728|NCT01529645|583275489|FG003|Overall Study|Lost to Follow-up|1|||
161514729|NCT01529645|583275490|FG004|Overall Study|Lost to Follow-up|1|||
161514730|NCT01529645|583275491|FG005|Overall Study|Lost to Follow-up|0|||
161514731|NCT01529645|583275492|FG006|Overall Study|Lost to Follow-up|2|||
161514732|NCT01529645|583275493|FG007|Overall Study|Lost to Follow-up|0|||
161514733|NCT01529645|583275494|FG008|Overall Study|Lost to Follow-up|1|||
161514734|NCT01529645|583275495|FG009|Overall Study|Lost to Follow-up|0|||
161514735|NCT01529645|583275486|FG000|Overall Study|SAE - Premature contractions|0|||
161514736|NCT01529645|583275487|FG001|Overall Study|SAE - Premature contractions|0|||
161514737|NCT01529645|583275488|FG002|Overall Study|SAE - Premature contractions|1|||
161514738|NCT01529645|583275489|FG003|Overall Study|SAE - Premature contractions|0|||
161514739|NCT01529645|583275490|FG004|Overall Study|SAE - Premature contractions|0|||
161514740|NCT01529645|583275491|FG005|Overall Study|SAE - Premature contractions|0|||
161514741|NCT01529645|583275492|FG006|Overall Study|SAE - Premature contractions|0|||
161514742|NCT01529645|583275493|FG007|Overall Study|SAE - Premature contractions|0|||
161514743|NCT01529645|583275494|FG008|Overall Study|SAE - Premature contractions|0|||
161514744|NCT01529645|583275495|FG009|Overall Study|SAE - Premature contractions|0|||
161514745|NCT01529645|583275486|FG000|Overall Study|Withdrawal by Subject|2|||
161514746|NCT01529645|583275487|FG001|Overall Study|Withdrawal by Subject|0|||
161514747|NCT01529645|583275488|FG002|Overall Study|Withdrawal by Subject|0|||
161514748|NCT01529645|583275489|FG003|Overall Study|Withdrawal by Subject|1|||
161514749|NCT01529645|583275490|FG004|Overall Study|Withdrawal by Subject|1|||
161514750|NCT01529645|583275491|FG005|Overall Study|Withdrawal by Subject|1|||
161514751|NCT01529645|583275492|FG006|Overall Study|Withdrawal by Subject|0|||
161514752|NCT01529645|583275493|FG007|Overall Study|Withdrawal by Subject|0|||
161514753|NCT01529645|583275494|FG008|Overall Study|Withdrawal by Subject|0|||
161514754|NCT01529645|583275495|FG009|Overall Study|Withdrawal by Subject|0|||
161514755|NCT02489981|583275503|FG000|Overall Study|Adverse Event|21|||
161514756|NCT02489981|583275503|FG000|Overall Study|Insufficient effectiveness|16|||
161514757|NCT02489981|583275503|FG000|Overall Study|Improved|31|||
161514758|NCT02489981|583275503|FG000|Overall Study|Lost to Follow-up|31|||
161514759|NCT02489981|583275503|FG000|Overall Study|Other than listed|28|||
161514760|NCT01565993|583275511|FG000|Overall Study|Physician Decision|0|||
161514761|NCT01565993|583275512|FG001|Overall Study|Physician Decision|3|||
161514762|NCT03348904|583275515|FG000|Overall Study|Administrative reason by the sponsor|0|||
161514763|NCT03348904|583275516|FG001|Overall Study|Administrative reason by the sponsor|1|||
161514764|NCT03348904|583275517|FG002|Overall Study|Administrative reason by the sponsor|0|||
161514765|NCT04086472|583275518|FG000|Overall Study|Lost to Follow-up|1|||
161514766|NCT04086472|583275519|FG001|Overall Study|Lost to Follow-up|0|||
161514767|NCT04086472|583275520|FG002|Overall Study|Lost to Follow-up|0|||
161514768|NCT04086472|583275521|FG003|Overall Study|Lost to Follow-up|0|||
161514769|NCT04086472|583275522|FG004|Overall Study|Lost to Follow-up|1|||
161514770|NCT04086472|583275518|FG000|Overall Study|Physician Decision|0|||
161514771|NCT04086472|583275519|FG001|Overall Study|Physician Decision|1|||
161514772|NCT04086472|583275520|FG002|Overall Study|Physician Decision|1|||
161514773|NCT04086472|583275521|FG003|Overall Study|Physician Decision|0|||
161514774|NCT04086472|583275522|FG004|Overall Study|Physician Decision|0|||
161928618|NCT01748552|584787760|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
161928619|NCT01748552|584787761|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
161928620|NCT01748552|584787762|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
161928621|NCT01748552|584787751|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928622|NCT01748552|584787752|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928623|NCT01748552|584787753|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928624|NCT01748552|584787754|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928625|NCT01748552|584787755|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928626|NCT01748552|584787756|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928627|NCT01748552|584787757|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161928628|NCT01748552|584787758|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161928629|NCT01748552|584787759|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161928630|NCT01748552|584787760|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161514775|NCT04086472|583275518|FG000|Overall Study|Withdrawal by Subject|1|||
161514776|NCT04086472|583275519|FG001|Overall Study|Withdrawal by Subject|1|||
161514777|NCT04086472|583275520|FG002|Overall Study|Withdrawal by Subject|1|||
161514778|NCT04086472|583275521|FG003|Overall Study|Withdrawal by Subject|0|||
161514779|NCT04086472|583275522|FG004|Overall Study|Withdrawal by Subject|0|||
161514780|NCT04086472|583275518|FG000|Overall Study|Various reasons|2|||
161514781|NCT04086472|583275519|FG001|Overall Study|Various reasons|0|||
161514782|NCT04086472|583275520|FG002|Overall Study|Various reasons|0|||
161514783|NCT04086472|583275521|FG003|Overall Study|Various reasons|3|||
161514784|NCT04086472|583275522|FG004|Overall Study|Various reasons|1|||
161514785|NCT00436280|583275528|FG000|Period 1: Induction|Adverse Event|8|||
161514786|NCT00436280|583275528|FG000|Period 1: Induction|Progressive Disease|12|||
161514787|NCT00436280|583275528|FG000|Period 1: Induction|Stable Disease|6|||
161514788|NCT00436280|583275528|FG000|Period 1: Induction|Withdrawal by Subject|1|||
161514789|NCT00436280|583275528|FG000|Period 1: Induction|Death|1|||
161514790|NCT00436280|583275528|FG000|Period 2: Consolidation|Adverse Event|1|||
161514791|NCT00436280|583275528|FG000|Period 2: Consolidation|Progressive Disease|10|||
161514792|NCT00436280|583275528|FG000|Period 2: Consolidation|Stable Disease|1|||
161514793|NCT00436280|583275528|FG000|Period 2: Consolidation|Physician Decision|2|||
161514794|NCT00436280|583275528|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
161514795|NCT00436280|583275528|FG000|Period 2: Consolidation|Death|1|||
161514796|NCT00436280|583275528|FG000|Period 3: Maintenance|Adverse Event|6|||
161514797|NCT00436280|583275528|FG000|Period 3: Maintenance|Progressive Disease|12|||
161514798|NCT00048724|583275529|FG000|Overall Study|Adverse Event|53|||
161514799|NCT00048724|583275530|FG001|Overall Study|Adverse Event|12|||
161514800|NCT00048724|583275529|FG000|Overall Study|Withdrawal by Subject|34|||
161514801|NCT00048724|583275530|FG001|Overall Study|Withdrawal by Subject|54|||
161514802|NCT00048724|583275529|FG000|Overall Study|Lost to Follow-up|5|||
161514803|NCT00048724|583275530|FG001|Overall Study|Lost to Follow-up|5|||
161514804|NCT00048724|583275529|FG000|Overall Study|Protocol-defined Clinical Event|17|||
161514805|NCT00048724|583275530|FG001|Overall Study|Protocol-defined Clinical Event|32|||
161514806|NCT00048724|583275529|FG000|Overall Study|Noncompliance With Protocol|4|||
161514807|NCT00048724|583275530|FG001|Overall Study|Noncompliance With Protocol|12|||
161514808|NCT00048724|583275529|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
161514809|NCT00048724|583275530|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
161514810|NCT00048724|583275529|FG000|Overall Study|Administrative|1|||
161514811|NCT00048724|583275530|FG001|Overall Study|Administrative|1|||
161514812|NCT01532687|583275534|FG000|Overall Study|Death|2|||
161514813|NCT01532687|583275535|FG001|Overall Study|Death|0|||
161514814|NCT01532687|583275534|FG000|Overall Study|Adverse Event|6|||
161514815|NCT01532687|583275535|FG001|Overall Study|Adverse Event|1|||
161514816|NCT01532687|583275534|FG000|Overall Study|Withdrawal by Subject|1|||
161514817|NCT01532687|583275535|FG001|Overall Study|Withdrawal by Subject|0|||
161514818|NCT01532687|583275534|FG000|Overall Study|Physician Decision|2|||
161514819|NCT01532687|583275535|FG001|Overall Study|Physician Decision|1|||
161514820|NCT01532687|583275534|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
161514821|NCT01532687|583275535|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
161514822|NCT03586869|583275536|FG000|Overall Study|Progressive Disease|3|||
161514823|NCT04116229|583275537|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
161514824|NCT04116229|583275538|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
161514825|NCT04116229|583275537|FG000|Overall Study|Scheduling not possible.|0|||
161514826|NCT04116229|583275538|FG001|Overall Study|Scheduling not possible.|1|||
161514827|NCT02809976|583275541|FG000|Overall Study|Lost to Follow-up|1|||
161514828|NCT02809976|583275541|FG000|Overall Study|Withdrawal by Subject|1|||
161514829|NCT02732847|583275542|FG000|Overall Study|some filled early|42|||
161514830|NCT02732847|583275543|FG001|Overall Study|some filled early|42|||
161514831|NCT01163682|583275544|FG000|Overall Study|Lost to Follow-up|6|||
161514832|NCT01163682|583275545|FG001|Overall Study|Lost to Follow-up|9|||
161514833|NCT01034397|583275546|FG000|Overall Study|Lack of compliance|0|||
161514834|NCT01034397|583275547|FG001|Overall Study|Lack of compliance|1|||
161514835|NCT01034397|583275546|FG000|Overall Study|Lack of Efficacy|3|||
161514836|NCT01034397|583275547|FG001|Overall Study|Lack of Efficacy|0|||
161514837|NCT01034397|583275546|FG000|Overall Study|Adverse Event|4|||
161514838|NCT01034397|583275547|FG001|Overall Study|Adverse Event|0|||
161514839|NCT01034397|583275546|FG000|Overall Study|Other|0|||
161588264|NCT04116736|583542370|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
161588265|NCT04116736|583542369|FG000|Overall Study|Subject was enrolled in error|2|||
161588266|NCT04116736|583542370|FG001|Overall Study|Subject was enrolled in error|0|||
161588267|NCT04116736|583542369|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
161588268|NCT04116736|583542370|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
161588269|NCT04116736|583542369|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
161514840|NCT01034397|583275547|FG001|Overall Study|Other|1|||
161676760|NCT04439071|583870529|FG000|Overall Study|Lost to Follow-up|0|||
161514841|NCT00211081|583275551|FG000|Overall Study|Withdrawal by Subject|2|||
161514842|NCT01931839|583275552|FG000|Overall Study|Death|0|||
161514843|NCT01931839|583275553|FG001|Overall Study|Death|1|||
161514844|NCT01931839|583275554|FG002|Overall Study|Death|2|||
161514845|NCT01931839|583275555|FG003|Overall Study|Death|0|||
161514846|NCT01931839|583275556|FG004|Overall Study|Death|0|||
161514847|NCT01931839|583275557|FG005|Overall Study|Death|0|||
161514848|NCT01931839|583275558|FG006|Overall Study|Death|0|||
161514849|NCT01931839|583275552|FG000|Overall Study|Physician Decision|1|||
161514850|NCT01931839|583275553|FG001|Overall Study|Physician Decision|0|||
161514851|NCT01931839|583275554|FG002|Overall Study|Physician Decision|1|||
161514852|NCT01931839|583275555|FG003|Overall Study|Physician Decision|0|||
161514853|NCT01931839|583275556|FG004|Overall Study|Physician Decision|0|||
161514854|NCT01931839|583275557|FG005|Overall Study|Physician Decision|0|||
161514855|NCT01931839|583275558|FG006|Overall Study|Physician Decision|1|||
161514856|NCT01931839|583275552|FG000|Overall Study|Withdrawal of consent|0|||
161514857|NCT01931839|583275553|FG001|Overall Study|Withdrawal of consent|0|||
161514858|NCT01931839|583275554|FG002|Overall Study|Withdrawal of consent|0|||
161514859|NCT01931839|583275555|FG003|Overall Study|Withdrawal of consent|0|||
161514860|NCT01931839|583275556|FG004|Overall Study|Withdrawal of consent|1|||
161514861|NCT01931839|583275557|FG005|Overall Study|Withdrawal of consent|0|||
161514862|NCT01931839|583275558|FG006|Overall Study|Withdrawal of consent|0|||
161514863|NCT01931839|583275552|FG000|Overall Study|Adverse Event|9|||
161514864|NCT01931839|583275553|FG001|Overall Study|Adverse Event|4|||
161514865|NCT01931839|583275554|FG002|Overall Study|Adverse Event|1|||
161514866|NCT01931839|583275555|FG003|Overall Study|Adverse Event|3|||
161588270|NCT04116736|583542370|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
161588271|NCT04116736|583542369|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
161588272|NCT04116736|583542370|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
161588273|NCT03941860|583542377|FG000|Overall Study|Withdrawal by Subject|0|||
161588274|NCT03941860|583542378|FG001|Overall Study|Withdrawal by Subject|1|||
161588275|NCT03361748|583542379|FG000|Overall Study|Death|77|||
161514867|NCT01931839|583275556|FG004|Overall Study|Adverse Event|0|||
161514868|NCT01931839|583275557|FG005|Overall Study|Adverse Event|0|||
161514869|NCT01931839|583275558|FG006|Overall Study|Adverse Event|1|||
161588276|NCT03361748|583542379|FG000|Overall Study|Lost to Follow-up|4|||
161588277|NCT03361748|583542379|FG000|Overall Study|Withdrawal by Subject|20|||
161514870|NCT01931839|583275552|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
161514871|NCT01931839|583275553|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
161514872|NCT01931839|583275554|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
161514873|NCT01931839|583275555|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
161514874|NCT01931839|583275556|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
161514875|NCT01931839|583275557|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
161514876|NCT01931839|583275558|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
161514877|NCT01931839|583275552|FG000|Overall Study|Other non-compliance|15|||
161514878|NCT01931839|583275553|FG001|Overall Study|Other non-compliance|9|||
161514879|NCT01931839|583275554|FG002|Overall Study|Other non-compliance|12|||
161514880|NCT01931839|583275555|FG003|Overall Study|Other non-compliance|3|||
161514881|NCT01931839|583275556|FG004|Overall Study|Other non-compliance|0|||
161514882|NCT01931839|583275557|FG005|Overall Study|Other non-compliance|3|||
161514883|NCT01931839|583275558|FG006|Overall Study|Other non-compliance|0|||
161514884|NCT01931839|583275552|FG000|Overall Study|Lost to Follow-up|1|||
161514885|NCT01931839|583275553|FG001|Overall Study|Lost to Follow-up|2|||
161514886|NCT01931839|583275554|FG002|Overall Study|Lost to Follow-up|4|||
161514887|NCT01931839|583275555|FG003|Overall Study|Lost to Follow-up|5|||
161514888|NCT01931839|583275556|FG004|Overall Study|Lost to Follow-up|0|||
161514889|NCT01931839|583275557|FG005|Overall Study|Lost to Follow-up|0|||
161514890|NCT01931839|583275558|FG006|Overall Study|Lost to Follow-up|0|||
161514891|NCT01931839|583275552|FG000|Overall Study|Other|4|||
161514892|NCT01931839|583275553|FG001|Overall Study|Other|2|||
161514893|NCT01931839|583275554|FG002|Overall Study|Other|6|||
161514894|NCT01931839|583275555|FG003|Overall Study|Other|0|||
161514895|NCT01931839|583275556|FG004|Overall Study|Other|0|||
161514896|NCT01931839|583275557|FG005|Overall Study|Other|0|||
161514897|NCT01931839|583275558|FG006|Overall Study|Other|0|||
161514898|NCT01263873|583275559|FG000|Overall Study|One provider unable to complete numbers|1|||
161514899|NCT01263873|583275560|FG001|Overall Study|One provider unable to complete numbers|1|||
161514900|NCT00113516|583275561|FG000|Part 1|Adverse Event|6|||
161514901|NCT00113516|583275562|FG001|Part 1|Adverse Event|0|||
161514902|NCT00113516|583275561|FG000|Part 1|Death|3|||
161514903|NCT00113516|583275562|FG001|Part 1|Death|0|||
161514904|NCT00113516|583275561|FG000|Part 1|Other|3|||
161514905|NCT00113516|583275562|FG001|Part 1|Other|0|||
161928631|NCT01748552|584787761|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928632|NCT01748552|584787762|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928633|NCT01386645|584787765|FG000|Overall Study|Physician Decision|0|||
161928634|NCT01386645|584787766|FG001|Overall Study|Physician Decision|0|||
161928635|NCT01386645|584787767|FG002|Overall Study|Physician Decision|1|||
161928636|NCT01386645|584787765|FG000|Overall Study|Withdrawal by Subject|0|||
161928637|NCT01386645|584787766|FG001|Overall Study|Withdrawal by Subject|1|||
161928638|NCT01386645|584787767|FG002|Overall Study|Withdrawal by Subject|1|||
161928639|NCT00527748|584787780|FG000|Overall Study|Other|3|||
161928640|NCT01160744|584787781|FG000|Overall Study|Withdrawal by Subject|11|||
161928641|NCT01160744|584787782|FG001|Overall Study|Withdrawal by Subject|5|||
161928642|NCT01160744|584787783|FG002|Overall Study|Withdrawal by Subject|6|||
161928643|NCT01160744|584787784|FG003|Overall Study|Withdrawal by Subject|4|||
161928644|NCT01160744|584787781|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
161928645|NCT01160744|584787782|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
161928646|NCT01160744|584787783|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
161928647|NCT01160744|584787784|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
161928648|NCT01502072|584787785|FG000|Overall Study|Withdrawal by Subject|1|||
161928649|NCT01502072|584787786|FG001|Overall Study|Withdrawal by Subject|0|||
161928650|NCT01502072|584787787|FG002|Overall Study|Withdrawal by Subject|0|||
161928651|NCT01502072|584787785|FG000|Overall Study|Death|0|||
161928652|NCT01502072|584787786|FG001|Overall Study|Death|1|||
161928653|NCT01502072|584787787|FG002|Overall Study|Death|0|||
161514906|NCT00113516|583275561|FG000|Part 1|Withdrawal by Subject|2|||
161514907|NCT00113516|583275562|FG001|Part 1|Withdrawal by Subject|0|||
161514908|NCT00113516|583275561|FG000|Part 1|Lack of Efficacy|2|||
161514909|NCT00113516|583275562|FG001|Part 1|Lack of Efficacy|0|||
161514910|NCT00113516|583275561|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
161514911|NCT00113516|583275562|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
161514912|NCT00113516|583275561|FG000|Part 1|Laboratory Abnormality|1|||
161588278|NCT04093752|583542380|FG000|Overall Study|Adverse Event|7|||
161928654|NCT04821245|584787788|FG000|Overall Study|Withdrawal by Subject|3|||
161928655|NCT04821245|584787788|FG000|Overall Study|Physician Decision|1|||
161928656|NCT04821245|584787788|FG000|Overall Study|Protocol Violation|5|||
161514913|NCT00113516|583275562|FG001|Part 1|Laboratory Abnormality|0|||
161514914|NCT00113516|583275561|FG000|Part 1|Ongoing|1|||
161514915|NCT00113516|583275562|FG001|Part 1|Ongoing|0|||
161514916|NCT00113516|583275561|FG000|Part 1|Missing|65|||
161928657|NCT02773537|584787796|FG000|Overall Study|Lost to Follow-up|0|||
161928658|NCT02773537|584787797|FG001|Overall Study|Lost to Follow-up|1|||
161676761|NCT04439071|583870530|FG001|Overall Study|Lost to Follow-up|3|||
161676762|NCT04439071|583870529|FG000|Overall Study|Withdrawal by Subject|3|||
161514917|NCT00113516|583275562|FG001|Part 1|Missing|0|||
161514918|NCT00113516|583275561|FG000|Part 2|Adverse Event|0|||
161514919|NCT00113516|583275562|FG001|Part 2|Adverse Event|16|||
161514920|NCT00113516|583275561|FG000|Part 2|Death|0|||
161514921|NCT00113516|583275562|FG001|Part 2|Death|5|||
161514922|NCT00113516|583275561|FG000|Part 2|Lack of Efficacy|0|||
161514923|NCT00113516|583275562|FG001|Part 2|Lack of Efficacy|37|||
161514924|NCT00113516|583275561|FG000|Part 2|Withdrawal by Subject|0|||
161514925|NCT00113516|583275562|FG001|Part 2|Withdrawal by Subject|3|||
161514926|NCT00113516|583275561|FG000|Part 2|Other|0|||
161514927|NCT00113516|583275562|FG001|Part 2|Other|3|||
161514928|NCT00113516|583275561|FG000|Part 2|Laboratory Abnormality|0|||
161514929|NCT00113516|583275562|FG001|Part 2|Laboratory Abnormality|1|||
161514930|NCT00113516|583275561|FG000|Part 2|Ongoing|0|||
161514931|NCT00113516|583275562|FG001|Part 2|Ongoing|1|||
161514932|NCT03217136|583275571|FG000|Overall Study|Lost to Follow-up|2|||
161514933|NCT03217136|583275572|FG001|Overall Study|Lost to Follow-up|1|||
161514934|NCT03217136|583275571|FG000|Overall Study|Site Randomized Participant in Error|0|||
161514935|NCT03217136|583275572|FG001|Overall Study|Site Randomized Participant in Error|1|||
161514936|NCT03217136|583275571|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
161514937|NCT03217136|583275572|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
161514938|NCT03217136|583275571|FG000|Overall Study|Dispensing Error|1|||
161514939|NCT03217136|583275572|FG001|Overall Study|Dispensing Error|0|||
161514940|NCT03217136|583275571|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161514941|NCT03217136|583275572|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161514942|NCT03755765|583275573|FG000|Overall Study|Withdrawal by Subject|2|||
161514943|NCT03755765|583275574|FG001|Overall Study|Withdrawal by Subject|4|||
161514944|NCT03755765|583275575|FG002|Overall Study|Withdrawal by Subject|4|||
161676763|NCT04439071|583870530|FG001|Overall Study|Withdrawal by Subject|8|||
161676764|NCT04439071|583870529|FG000|Overall Study|Death|6|||
161514945|NCT02104557|583275576|FG000|Overall Study|Adverse Event|24|||
161514946|NCT02104557|583275576|FG000|Overall Study|Lost to Follow-up|34|||
161514947|NCT02104557|583275576|FG000|Overall Study|Violated the usage and dosage|14|||
161514948|NCT02104557|583275576|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
161514949|NCT02104557|583275576|FG000|Overall Study|Administered Sayana prior to the contract|1|||
161514950|NCT02104557|583275576|FG000|Overall Study|Other|17|||
161514951|NCT02104557|583275576|FG000|Overall Study|Change to other contraception methods|5|||
161514952|NCT02104557|583275576|FG000|Overall Study|Discontinuation due to no pain|1|||
161514953|NCT02104557|583275576|FG000|Overall Study|Withdrawal consent|2|||
161514954|NCT02104557|583275576|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
161514955|NCT02104557|583275576|FG000|Overall Study|Discontinuation of contraception|9|||
161514956|NCT01158222|583275580|FG000|Overall Study|Not eligible for intermediate phase|17|||
161514957|NCT00111228|583275583|FG000|Overall Study|Withdrawal by Subject|5|||
161514958|NCT00111228|583275584|FG001|Overall Study|Withdrawal by Subject|1|||
161514959|NCT00111228|583275585|FG002|Overall Study|Withdrawal by Subject|0|||
161514960|NCT02579616|583275586|FG000|Overall Study|Participants did not receive treatment|3|||
161514961|NCT01430585|583275587|FG000|Overall Study|Death|1|||
161514962|NCT01430585|583275587|FG000|Overall Study|Objective Progression or Relapse|3|||
161514963|NCT01430585|583275587|FG000|Overall Study|Study Terminated by Sponsor|3|||
161514964|NCT01430585|583275587|FG000|Overall Study|Other|7|||
161676765|NCT04439071|583870530|FG001|Overall Study|Death|4|||
161514965|NCT01448850|583275588|FG000|Overall Study|Death|3|||
161676766|NCT04439071|583870529|FG000|Overall Study|Other than specified|3|||
161676767|NCT04439071|583870530|FG001|Overall Study|Other than specified|3|||
161676768|NCT04439071|583870529|FG000|Overall Study|Randomized but not treated|2|||
161676769|NCT04439071|583870530|FG001|Overall Study|Randomized but not treated|0|||
161514966|NCT01448850|583275589|FG001|Overall Study|Death|6|||
161514967|NCT01448850|583275588|FG000|Overall Study|Withdrawal by Subject|13|||
161514968|NCT01448850|583275589|FG001|Overall Study|Withdrawal by Subject|21|||
161514969|NCT01448850|583275588|FG000|Overall Study|Lost to Follow-up|3|||
161514970|NCT01448850|583275589|FG001|Overall Study|Lost to Follow-up|1|||
161514971|NCT01448850|583275588|FG000|Overall Study|Other|15|||
161514972|NCT01448850|583275589|FG001|Overall Study|Other|12|||
161514973|NCT01490060|583275592|FG000|Cycle 1|Change of Treatment|0|||
161676770|NCT00832117|583870531|FG000|Overall Study|Death|1|||
161514974|NCT01490060|583275593|FG001|Cycle 1|Change of Treatment|1|||
161514975|NCT01490060|583275594|FG002|Cycle 1|Change of Treatment|1|||
161514976|NCT01490060|583275595|FG003|Cycle 1|Change of Treatment|1|||
161514977|NCT01490060|583275592|FG000|Cycle 1|Insurance Denied|0|||
161514978|NCT01490060|583275593|FG001|Cycle 1|Insurance Denied|0|||
161514979|NCT01490060|583275594|FG002|Cycle 1|Insurance Denied|2|||
161514980|NCT01490060|583275595|FG003|Cycle 1|Insurance Denied|0|||
161514981|NCT01490060|583275592|FG000|Cycle 1|Withdrawal by Subject|0|||
161514982|NCT01490060|583275593|FG001|Cycle 1|Withdrawal by Subject|0|||
161514983|NCT01490060|583275594|FG002|Cycle 1|Withdrawal by Subject|0|||
161676771|NCT00832117|583870531|FG000|Overall Study|Disease Progression|11|||
161676772|NCT00892177|583870532|FG000|Phase II|Ineligible|0|||
161676773|NCT00892177|583870533|FG001|Phase II|Ineligible|0|||
161676774|NCT00892177|583870534|FG002|Phase II|Ineligible|0|||
161676775|NCT00892177|583870535|FG003|Phase II|Ineligible|0|||
161676776|NCT00892177|583870536|FG004|Phase II|Ineligible|1|||
161676777|NCT00892177|583870537|FG005|Phase II|Ineligible|1|||
161676778|NCT00892177|583870532|FG000|Phase II|Withdrawal by Subject|0|||
161676779|NCT00892177|583870533|FG001|Phase II|Withdrawal by Subject|0|||
161676780|NCT00892177|583870534|FG002|Phase II|Withdrawal by Subject|0|||
161676781|NCT00892177|583870535|FG003|Phase II|Withdrawal by Subject|0|||
161676782|NCT00892177|583870536|FG004|Phase II|Withdrawal by Subject|4|||
161676783|NCT00892177|583870537|FG005|Phase II|Withdrawal by Subject|1|||
161676784|NCT01835015|583870542|FG000|Overall Study|Adverse Event|0|||
161676785|NCT01835015|583870543|FG001|Overall Study|Adverse Event|0|||
161676786|NCT01835015|583870544|FG002|Overall Study|Adverse Event|1|||
161676787|NCT01835015|583870545|FG003|Overall Study|Adverse Event|0|||
161676788|NCT01835015|583870546|FG004|Overall Study|Adverse Event|0|||
161676789|NCT00975715|583870550|FG000|Titration Period|Adverse Event|6|||
161676790|NCT00975715|583870551|FG001|Titration Period|Adverse Event|0|||
161676791|NCT00975715|583870550|FG000|Titration Period|Protocol Violation|1|||
161676792|NCT00975715|583870551|FG001|Titration Period|Protocol Violation|0|||
161676793|NCT00975715|583870550|FG000|Maintenance Period|Adverse Event|2|||
161676794|NCT00975715|583870551|FG001|Maintenance Period|Adverse Event|1|||
161676795|NCT01241552|583870555|FG000|Overall Study|Lack of Efficacy|1|||
161676796|NCT01241552|583870556|FG001|Overall Study|Lack of Efficacy|0|||
161676797|NCT01241552|583870557|FG002|Overall Study|Lack of Efficacy|0|||
161676798|NCT01241552|583870558|FG003|Overall Study|Lack of Efficacy|0|||
161676799|NCT01241552|583870555|FG000|Overall Study|Death|26|||
161514984|NCT01490060|583275595|FG003|Cycle 1|Withdrawal by Subject|1|||
161514985|NCT01490060|583275592|FG000|Cycle 1|Treatment at Another Facility|0|||
161514986|NCT01490060|583275593|FG001|Cycle 1|Treatment at Another Facility|0|||
161514987|NCT01490060|583275594|FG002|Cycle 1|Treatment at Another Facility|0|||
161514988|NCT01490060|583275595|FG003|Cycle 1|Treatment at Another Facility|1|||
161514989|NCT01490060|583275592|FG000|Cycle 2|Change of Treatment|1|||
161514990|NCT01490060|583275593|FG001|Cycle 2|Change of Treatment|1|||
161514991|NCT01490060|583275594|FG002|Cycle 2|Change of Treatment|0|||
161514992|NCT01490060|583275595|FG003|Cycle 2|Change of Treatment|0|||
161514993|NCT01490060|583275592|FG000|Cycle 2|Non-Compliance|0|||
161514994|NCT01490060|583275593|FG001|Cycle 2|Non-Compliance|0|||
161514995|NCT01490060|583275594|FG002|Cycle 2|Non-Compliance|1|||
161514996|NCT01490060|583275595|FG003|Cycle 2|Non-Compliance|0|||
161514997|NCT01490060|583275592|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
161514998|NCT01490060|583275593|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
161514999|NCT01490060|583275594|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
161515000|NCT01490060|583275595|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
161515001|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
161515002|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
161515003|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
161515004|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
161515005|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
161515006|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
161515007|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
161515008|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
161515009|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
161676800|NCT01241552|583870556|FG001|Overall Study|Death|30|||
161515010|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
161676801|NCT01241552|583870557|FG002|Overall Study|Death|20|||
161676802|NCT01241552|583870558|FG003|Overall Study|Death|25|||
161676803|NCT01241552|583870555|FG000|Overall Study|Adverse Event|1|||
161822007|NCT00160524|584389253|FG000|Overall Study|Lack of Efficacy and Other|1|||
161515011|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
161515012|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
161515013|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
161515014|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
161676804|NCT01241552|583870556|FG001|Overall Study|Adverse Event|1|||
161676805|NCT01241552|583870557|FG002|Overall Study|Adverse Event|0|||
161676806|NCT01241552|583870558|FG003|Overall Study|Adverse Event|0|||
161676807|NCT01241552|583870555|FG000|Overall Study|Technical Problems|2|||
161676808|NCT01241552|583870556|FG001|Overall Study|Technical Problems|0|||
161676809|NCT01241552|583870557|FG002|Overall Study|Technical Problems|2|||
161676810|NCT01241552|583870558|FG003|Overall Study|Technical Problems|2|||
161515015|NCT02464969|583275596|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
161515016|NCT02464969|583275597|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
161515017|NCT02464969|583275596|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
161515018|NCT02464969|583275597|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
161515019|NCT02464969|583275596|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
161515020|NCT02464969|583275597|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
161515021|NCT02464969|583275596|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
161515022|NCT02464969|583275597|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
161515023|NCT02863354|583275598|FG000|Year 1|Lost to Follow-up|1|||
161515024|NCT02863354|583275599|FG001|Year 1|Lost to Follow-up|1|||
161515025|NCT02863354|583275598|FG000|Year 1|Withdrawal by Subject|3|||
161515026|NCT02863354|583275599|FG001|Year 1|Withdrawal by Subject|0|||
161515027|NCT02863354|583275598|FG000|Year 1|Death|0|||
161515028|NCT02863354|583275599|FG001|Year 1|Death|1|||
161515029|NCT02863354|583275598|FG000|Year 2|Lost to Follow-up|2|||
161515030|NCT02863354|583275599|FG001|Year 2|Lost to Follow-up|2|||
161515031|NCT00720876|583275605|FG000|Overall Study|found to be ineligible after starting tx|2|||
161515032|NCT03495908|583275607|FG000|Overall Study|Withdrawal by Subject|3|||
161515033|NCT03495908|583275608|FG001|Overall Study|Withdrawal by Subject|1|||
161515034|NCT03495908|583275607|FG000|Overall Study|Lost to Follow-up|1|||
161515035|NCT03495908|583275608|FG001|Overall Study|Lost to Follow-up|4|||
161515036|NCT03495908|583275607|FG000|Overall Study|Adverse Event|0|||
161515037|NCT03495908|583275608|FG001|Overall Study|Adverse Event|2|||
161515038|NCT03495908|583275607|FG000|Overall Study|Death|1|||
161515039|NCT03495908|583275608|FG001|Overall Study|Death|0|||
161515040|NCT03495908|583275607|FG000|Overall Study|Physician Decision|5|||
161515041|NCT03495908|583275608|FG001|Overall Study|Physician Decision|4|||
161515042|NCT03495908|583275607|FG000|Overall Study|No documented reason|0|||
161515043|NCT03495908|583275608|FG001|Overall Study|No documented reason|2|||
161676811|NCT01241552|583870555|FG000|Overall Study|Progressive Disease|0|||
161676812|NCT01241552|583870556|FG001|Overall Study|Progressive Disease|0|||
161676813|NCT01241552|583870557|FG002|Overall Study|Progressive Disease|1|||
161676814|NCT01241552|583870558|FG003|Overall Study|Progressive Disease|2|||
161676815|NCT01241552|583870555|FG000|Overall Study|Protocol Violation|0|||
161676816|NCT01241552|583870556|FG001|Overall Study|Protocol Violation|2|||
161676817|NCT01241552|583870557|FG002|Overall Study|Protocol Violation|6|||
161928659|NCT02773537|584787798|FG002|Overall Study|Lost to Follow-up|4|||
161928660|NCT01840163|584787799|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
161928661|NCT01840163|584787800|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
161928662|NCT01840163|584787799|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
161515044|NCT01109316|583275609|FG000|Study Period 1|Adverse Event|0|||
161515045|NCT01109316|583275610|FG001|Study Period 1|Adverse Event|0|||
161515046|NCT01109316|583275611|FG002|Study Period 1|Adverse Event|1|||
161515047|NCT01109316|583275612|FG003|Study Period 1|Adverse Event|0|||
161515048|NCT01109316|583275613|FG004|Study Period 1|Adverse Event|0|||
161515049|NCT01109316|583275614|FG005|Study Period 1|Adverse Event|0|||
161515050|NCT01109316|583275609|FG000|Study Period 1|Lost to Follow-up|0|||
161515051|NCT01109316|583275610|FG001|Study Period 1|Lost to Follow-up|0|||
161515052|NCT01109316|583275611|FG002|Study Period 1|Lost to Follow-up|1|||
161515053|NCT01109316|583275612|FG003|Study Period 1|Lost to Follow-up|1|||
161515054|NCT01109316|583275613|FG004|Study Period 1|Lost to Follow-up|0|||
161515055|NCT01109316|583275614|FG005|Study Period 1|Lost to Follow-up|0|||
161515056|NCT01109316|583275609|FG000|Study Period 1|Withdrawal by Subject|0|||
161515057|NCT01109316|583275610|FG001|Study Period 1|Withdrawal by Subject|0|||
161515058|NCT01109316|583275611|FG002|Study Period 1|Withdrawal by Subject|1|||
161515059|NCT01109316|583275612|FG003|Study Period 1|Withdrawal by Subject|0|||
161515060|NCT01109316|583275613|FG004|Study Period 1|Withdrawal by Subject|2|||
161676818|NCT01241552|583870558|FG003|Overall Study|Protocol Violation|1|||
161676819|NCT01241552|583870555|FG000|Overall Study|Withdrawal by Subject|7|||
161676820|NCT01241552|583870556|FG001|Overall Study|Withdrawal by Subject|15|||
161928663|NCT01840163|584787800|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
161928664|NCT01840163|584787799|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
161676821|NCT01241552|583870557|FG002|Overall Study|Withdrawal by Subject|14|||
161676822|NCT01241552|583870558|FG003|Overall Study|Withdrawal by Subject|15|||
161928665|NCT01840163|584787800|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
161515061|NCT01109316|583275614|FG005|Study Period 1|Withdrawal by Subject|0|||
161515062|NCT01109316|583275609|FG000|Study Period 1|Sponsor Decision|0|||
161515063|NCT01109316|583275610|FG001|Study Period 1|Sponsor Decision|0|||
161515064|NCT01109316|583275611|FG002|Study Period 1|Sponsor Decision|0|||
161515065|NCT01109316|583275612|FG003|Study Period 1|Sponsor Decision|0|||
161515066|NCT01109316|583275613|FG004|Study Period 1|Sponsor Decision|0|||
161515067|NCT01109316|583275614|FG005|Study Period 1|Sponsor Decision|2|||
161515068|NCT01109316|583275609|FG000|Study Period 2|Entry Criteria Not Met|0|||
161515069|NCT01109316|583275610|FG001|Study Period 2|Entry Criteria Not Met|1|||
161515070|NCT01109316|583275611|FG002|Study Period 2|Entry Criteria Not Met|0|||
161515071|NCT01109316|583275612|FG003|Study Period 2|Entry Criteria Not Met|0|||
161515072|NCT01109316|583275613|FG004|Study Period 2|Entry Criteria Not Met|0|||
161515073|NCT01109316|583275614|FG005|Study Period 2|Entry Criteria Not Met|0|||
161515074|NCT01109316|583275609|FG000|Study Period 2|Physician Decision|0|||
161588279|NCT04093752|583542381|FG001|Overall Study|Adverse Event|19|||
161588280|NCT04093752|583542382|FG002|Overall Study|Adverse Event|18|||
161588281|NCT04093752|583542383|FG003|Overall Study|Adverse Event|4|||
161588282|NCT04093752|583542380|FG000|Overall Study|Withdrawal by Subject|6|||
161588283|NCT04093752|583542381|FG001|Overall Study|Withdrawal by Subject|6|||
161588284|NCT04093752|583542382|FG002|Overall Study|Withdrawal by Subject|8|||
161588285|NCT04093752|583542383|FG003|Overall Study|Withdrawal by Subject|20|||
161588286|NCT04093752|583542380|FG000|Overall Study|Lost to Follow-up|2|||
161588287|NCT04093752|583542381|FG001|Overall Study|Lost to Follow-up|1|||
161588288|NCT04093752|583542382|FG002|Overall Study|Lost to Follow-up|1|||
161588289|NCT04093752|583542383|FG003|Overall Study|Lost to Follow-up|1|||
161588290|NCT04093752|583542380|FG000|Overall Study|Death|0|||
161515075|NCT01109316|583275610|FG001|Study Period 2|Physician Decision|0|||
161515076|NCT01109316|583275611|FG002|Study Period 2|Physician Decision|0|||
161515077|NCT01109316|583275612|FG003|Study Period 2|Physician Decision|1|||
161515078|NCT01109316|583275613|FG004|Study Period 2|Physician Decision|0|||
161515079|NCT01109316|583275614|FG005|Study Period 2|Physician Decision|0|||
161515080|NCT01109316|583275609|FG000|Study Period 2|Protocol Violation|1|||
161588291|NCT04093752|583542381|FG001|Overall Study|Death|0|||
161588292|NCT04093752|583542382|FG002|Overall Study|Death|1|||
161588293|NCT04093752|583542383|FG003|Overall Study|Death|2|||
161822008|NCT00160524|584389253|FG000|Overall Study|Other|20|||
161822009|NCT00021541|584389254|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
161822010|NCT00021541|584389255|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
161822011|NCT00021541|584389254|FG000|Period 1-First Treatment|Adverse Event|2|||
161822012|NCT00021541|584389255|FG001|Period 1-First Treatment|Adverse Event|1|||
161822013|NCT00021541|584389254|FG000|Period 1-First Treatment|non-adherence|3|||
161822014|NCT00021541|584389255|FG001|Period 1-First Treatment|non-adherence|0|||
161822015|NCT00021541|584389254|FG000|Period 1-First Treatment|Death|1|||
161822016|NCT00021541|584389255|FG001|Period 1-First Treatment|Death|0|||
161822017|NCT00021541|584389254|FG000|Period 1-First Treatment|Pts that did not progress|2|||
161822018|NCT00021541|584389255|FG001|Period 1-First Treatment|Pts that did not progress|2|||
161822019|NCT00021541|584389254|FG000|Period 1-First Treatment|Ineligible|0|||
161822020|NCT00021541|584389255|FG001|Period 1-First Treatment|Ineligible|2|||
161822021|NCT00021541|584389254|FG000|Period 2-crossover|refused phase B|2|||
161822022|NCT00021541|584389255|FG001|Period 2-crossover|refused phase B|2|||
161822023|NCT00021541|584389254|FG000|Period 2-crossover|Withdrawal by Subject|3|||
161822024|NCT00021541|584389255|FG001|Period 2-crossover|Withdrawal by Subject|4|||
161822025|NCT00021541|584389254|FG000|Period 2-crossover|Adverse Event|2|||
161822026|NCT00021541|584389255|FG001|Period 2-crossover|Adverse Event|2|||
161822027|NCT00021541|584389254|FG000|Period 2-crossover|non-adherence|1|||
161822028|NCT00021541|584389255|FG001|Period 2-crossover|non-adherence|0|||
161822029|NCT00021541|584389254|FG000|Period 2-crossover|Pts that did not progress|2|||
161822030|NCT00021541|584389255|FG001|Period 2-crossover|Pts that did not progress|3|||
161822031|NCT04892147|584389256|FG000|Overall Study|Withdrawal by Subject|2|||
161822032|NCT04892147|584389257|FG001|Overall Study|Withdrawal by Subject|0|||
161822033|NCT01215721|584389259|FG000|Overall Study|Adverse Event|2|||
161822034|NCT00045162|584389260|FG000|Overall Study|Ineligible|12|||
161822035|NCT00045162|584389261|FG001|Overall Study|Ineligible|8|||
161822036|NCT00045162|584389260|FG000|Overall Study|Not treated|7|||
161822037|NCT00045162|584389261|FG001|Overall Study|Not treated|2|||
161822038|NCT00045162|584389260|FG000|Overall Study|Adverse Event|55|||
161822039|NCT00045162|584389261|FG001|Overall Study|Adverse Event|50|||
161822040|NCT00045162|584389260|FG000|Overall Study|Lack of Efficacy|32|||
161822041|NCT00045162|584389261|FG001|Overall Study|Lack of Efficacy|29|||
161822042|NCT00045162|584389260|FG000|Overall Study|Death|10|||
161822043|NCT00045162|584389261|FG001|Overall Study|Death|10|||
161822044|NCT00045162|584389260|FG000|Overall Study|Withdrawal by Subject|5|||
161588294|NCT04093752|583542380|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
161588295|NCT04093752|583542381|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
161515081|NCT01109316|583275610|FG001|Study Period 2|Protocol Violation|0|||
161515082|NCT01109316|583275611|FG002|Study Period 2|Protocol Violation|0|||
161515083|NCT01109316|583275612|FG003|Study Period 2|Protocol Violation|0|||
161822045|NCT00045162|584389261|FG001|Overall Study|Withdrawal by Subject|3|||
161822046|NCT00045162|584389260|FG000|Overall Study|Other|21|||
161822047|NCT00045162|584389261|FG001|Overall Study|Other|16|||
161822048|NCT01044433|584389262|FG000|Overall Study|Lost to Follow-up|3|||
161822049|NCT01044433|584389262|FG000|Overall Study|Withdrawal by Subject|3|||
161822050|NCT00826241|584389263|FG000|Overall Study|Withdrawal from Follow-up|1|||
161822051|NCT00826241|584389263|FG000|Overall Study|Withdrew consent|2|||
161822052|NCT00826241|584389263|FG000|Overall Study|Death|4|||
161515084|NCT01109316|583275613|FG004|Study Period 2|Protocol Violation|0|||
161515085|NCT01109316|583275614|FG005|Study Period 2|Protocol Violation|0|||
161515086|NCT01109316|583275609|FG000|Study Period 2|Withdrawal by Subject|0|||
161588296|NCT04093752|583542382|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
161515087|NCT01109316|583275610|FG001|Study Period 2|Withdrawal by Subject|0|||
161515088|NCT01109316|583275611|FG002|Study Period 2|Withdrawal by Subject|1|||
161515089|NCT01109316|583275612|FG003|Study Period 2|Withdrawal by Subject|0|||
161515090|NCT01109316|583275613|FG004|Study Period 2|Withdrawal by Subject|0|||
161515091|NCT01109316|583275614|FG005|Study Period 2|Withdrawal by Subject|1|||
161515092|NCT01109316|583275609|FG000|Study Period 3|Lost to Follow-up|0|||
161515093|NCT01109316|583275610|FG001|Study Period 3|Lost to Follow-up|0|||
161515094|NCT01109316|583275611|FG002|Study Period 3|Lost to Follow-up|0|||
161515095|NCT01109316|583275612|FG003|Study Period 3|Lost to Follow-up|0|||
161515096|NCT01109316|583275613|FG004|Study Period 3|Lost to Follow-up|1|||
161515097|NCT01109316|583275614|FG005|Study Period 3|Lost to Follow-up|0|||
161515098|NCT01109316|583275609|FG000|Study Period 3|Withdrawal by Subject|1|||
161515099|NCT01109316|583275610|FG001|Study Period 3|Withdrawal by Subject|0|||
161515100|NCT01109316|583275611|FG002|Study Period 3|Withdrawal by Subject|0|||
161515101|NCT01109316|583275612|FG003|Study Period 3|Withdrawal by Subject|0|||
161515102|NCT01109316|583275613|FG004|Study Period 3|Withdrawal by Subject|1|||
161588297|NCT04093752|583542383|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
161588298|NCT04093752|583542380|FG000|Overall Study|Covid 19|0|||
161588299|NCT04093752|583542381|FG001|Overall Study|Covid 19|0|||
161588300|NCT04093752|583542382|FG002|Overall Study|Covid 19|0|||
161588301|NCT04093752|583542383|FG003|Overall Study|Covid 19|1|||
161588302|NCT04093752|583542380|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161588303|NCT04093752|583542381|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161588304|NCT04093752|583542382|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
161588305|NCT04093752|583542383|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161588306|NCT04093752|583542380|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
161588307|NCT04093752|583542381|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
161588308|NCT04093752|583542382|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
161588309|NCT04093752|583542383|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
161588310|NCT04093752|583542380|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
161588311|NCT04093752|583542381|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
161588312|NCT04093752|583542382|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
161588313|NCT04093752|583542383|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
161588314|NCT04854096|583542386|FG000|Overall Study|Adverse Event|1|||
161588315|NCT04854096|583542387|FG001|Overall Study|Adverse Event|0|||
161588316|NCT04854096|583542386|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
161588317|NCT04854096|583542387|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
161588318|NCT04854096|583542386|FG000|Overall Study|Withdrawal by Subject|1|||
161588319|NCT04854096|583542387|FG001|Overall Study|Withdrawal by Subject|0|||
161588320|NCT04854096|583542386|FG000|Overall Study|Other reasons|1|||
161928666|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
161928667|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
161928668|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161928669|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161928670|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161928671|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161928672|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
161928673|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
161928674|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
161515103|NCT01109316|583275614|FG005|Study Period 3|Withdrawal by Subject|0|||
161588321|NCT04854096|583542387|FG001|Overall Study|Other reasons|0|||
161588322|NCT01084707|583542391|FG000|Overall Study|Withdrawal by Subject|6|||
161588323|NCT00901901|583542392|FG000|Treatment Period|Adverse Event|120|||
161588324|NCT00901901|583542393|FG001|Treatment Period|Adverse Event|128|||
161515104|NCT01559311|583275617|FG000|Overall Study|Protocol Violation|0|||
161515105|NCT01559311|583275618|FG001|Overall Study|Protocol Violation|0|||
161515106|NCT01559311|583275619|FG002|Overall Study|Protocol Violation|2|||
161515107|NCT01559311|583275617|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
161515108|NCT01559311|583275618|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
161515109|NCT01559311|583275619|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
161515110|NCT01559311|583275617|FG000|Overall Study|Withdrawal by Subject|2|||
161515111|NCT01559311|583275618|FG001|Overall Study|Withdrawal by Subject|1|||
161515112|NCT01559311|583275619|FG002|Overall Study|Withdrawal by Subject|0|||
161515113|NCT01559311|583275617|FG000|Overall Study|Death|0|||
161515114|NCT01559311|583275618|FG001|Overall Study|Death|2|||
161515115|NCT01559311|583275619|FG002|Overall Study|Death|3|||
161515116|NCT01559311|583275617|FG000|Overall Study|Lost to Follow-up|0|||
161515117|NCT01559311|583275618|FG001|Overall Study|Lost to Follow-up|3|||
161515118|NCT01559311|583275619|FG002|Overall Study|Lost to Follow-up|2|||
161515119|NCT01559311|583275617|FG000|Overall Study|Adverse Event|0|||
161515120|NCT01559311|583275618|FG001|Overall Study|Adverse Event|0|||
161515121|NCT01559311|583275619|FG002|Overall Study|Adverse Event|1|||
161515122|NCT03027466|583275622|FG000|Overall Study|Opting out of the app|1869|||
161515123|NCT03027466|583275623|FG001|Overall Study|Opting out of the app|1819|||
161515124|NCT03027466|583275624|FG002|Overall Study|Opting out of the app|1743|||
161515125|NCT03027466|583275625|FG003|Overall Study|Opting out of the app|1821|||
161515126|NCT03286140|583275626|FG000|Overall Study|Withdrawal by Subject|10|||
161515127|NCT03286140|583275627|FG001|Overall Study|Withdrawal by Subject|5|||
161515128|NCT03286140|583275626|FG000|Overall Study|Lost to Follow-up|5|||
161515129|NCT03286140|583275627|FG001|Overall Study|Lost to Follow-up|10|||
161515130|NCT03286140|583275626|FG000|Overall Study|Failure to comply|0|||
161515131|NCT03286140|583275627|FG001|Overall Study|Failure to comply|1|||
161515132|NCT01826825|583275632|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
161515133|NCT01826825|583275633|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
161515134|NCT01858194|583275634|FG000|Overall Study|Total Artificial Heart Implant|0|||
161515135|NCT01858194|583275635|FG001|Overall Study|Total Artificial Heart Implant|1|||
161515136|NCT01858194|583275634|FG000|Overall Study|Lost to Follow-up|0|||
161588325|NCT00901901|583542392|FG000|Treatment Period|Withdrawal by Subject|26|||
161588326|NCT00901901|583542393|FG001|Treatment Period|Withdrawal by Subject|24|||
161588327|NCT00901901|583542392|FG000|Treatment Period|Physician Decision|2|||
161822053|NCT00826241|584389263|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
161822054|NCT00826241|584389263|FG000|Overall Study|Non-compliance|1|||
161822055|NCT00826241|584389263|FG000|Overall Study|Progression of disease|1|||
161822056|NCT00826241|584389263|FG000|Overall Study|Patient refused follow-up|3|||
161822057|NCT00826241|584389263|FG000|Overall Study|Lost to Follow-up|9|||
161822058|NCT00826241|584389263|FG000|Overall Study|Could not obtain records|1|||
161822059|NCT00826241|584389263|FG000|Overall Study|Screen failure|2|||
161822060|NCT00826241|584389263|FG000|Overall Study|Pt unable to proceed to registration|1|||
161822061|NCT00826241|584389263|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
161822062|NCT00556673|584389265|FG000|Overall Study|Protocol deviation|3|||
161822063|NCT00556673|584389266|FG001|Overall Study|Protocol deviation|2|||
161822064|NCT01971554|584389267|FG000|Overall Study|Lost to Follow-up|1|||
161822065|NCT01971554|584389268|FG001|Overall Study|Lost to Follow-up|0|||
161822066|NCT01971554|584389269|FG002|Overall Study|Lost to Follow-up|0|||
161822067|NCT01971554|584389270|FG003|Overall Study|Lost to Follow-up|0|||
161822068|NCT00087529|584389272|FG000|Overall Study|Death|1|||
161822069|NCT00087529|584389273|FG001|Overall Study|Death|0|||
161822070|NCT00087529|584389272|FG000|Overall Study|Adverse Event|0|||
161822071|NCT00087529|584389273|FG001|Overall Study|Adverse Event|8|||
161822072|NCT00087529|584389272|FG000|Overall Study|Pregnancy|0|||
161822073|NCT00087529|584389273|FG001|Overall Study|Pregnancy|1|||
161822074|NCT00087529|584389272|FG000|Overall Study|Lost to Follow-up|2|||
161822075|NCT00087529|584389273|FG001|Overall Study|Lost to Follow-up|3|||
161822076|NCT00087529|584389272|FG000|Overall Study|Participant Decision|14|||
161822077|NCT00087529|584389273|FG001|Overall Study|Participant Decision|37|||
161822078|NCT00087529|584389272|FG000|Overall Study|Physician Decision|4|||
161822079|NCT00087529|584389273|FG001|Overall Study|Physician Decision|8|||
161822080|NCT00087529|584389272|FG000|Overall Study|Initiation of Excluded Therapy|0|||
161822081|NCT00087529|584389273|FG001|Overall Study|Initiation of Excluded Therapy|1|||
161822082|NCT00087529|584389272|FG000|Overall Study|Participant Noncompliance|0|||
161822083|NCT00087529|584389273|FG001|Overall Study|Participant Noncompliance|1|||
161822084|NCT00087529|584389272|FG000|Overall Study|Disease Progression|5|||
161822085|NCT00087529|584389273|FG001|Overall Study|Disease Progression|4|||
161822086|NCT00087529|584389272|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
161822087|NCT00087529|584389273|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
161822088|NCT02535923|584389274|FG000|Overall Study|Lost to Follow-up|5|||
161822089|NCT02535923|584389275|FG001|Overall Study|Lost to Follow-up|5|||
161822090|NCT02535923|584389274|FG000|Overall Study|Withdrawal by Subject|4|||
161822091|NCT02535923|584389275|FG001|Overall Study|Withdrawal by Subject|3|||
161822092|NCT04388787|584389276|FG000|Blinded Period|Patient could not follow instructions|1|||
161515137|NCT01858194|583275635|FG001|Overall Study|Lost to Follow-up|1|||
161515138|NCT02158039|583275636|FG000|Overall Study|Withdrawal by Subject|1|||
161515139|NCT02158039|583275636|FG000|Overall Study|Screen Failure|9|||
161928675|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
161928676|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
161928677|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
161928678|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Other|6|||
161928679|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Other|3|||
161928680|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Other|0|||
161928681|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
161928682|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161928683|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161928684|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
161928685|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
161928686|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
161928687|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Adverse Event|0|||
161928688|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Adverse Event|0|||
161928689|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Adverse Event|21|||
161928690|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
161928691|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
161928692|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
161928693|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
161928694|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
161928695|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
161928696|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
161928697|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
161928698|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
161928699|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Administrative|0|||
161928700|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Administrative|0|||
161928701|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Administrative|36|||
161515140|NCT02563028|583275644|FG000|Overall Study|Lack of equipment|1|||
161515141|NCT02563028|583275644|FG000|Overall Study|Unable to elicit VEP post induction|1|||
161515142|NCT02188485|583275649|FG000|Overall Study|Withdrawal by Subject|2|||
161822093|NCT04388787|584389276|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
161822094|NCT01350934|584391007|FG000|Base Study|Adverse Event|6|||
161822095|NCT01350934|584391008|FG001|Base Study|Adverse Event|0|||
161822096|NCT01350934|584391007|FG000|Base Study|Lost to Follow-up|1|||
161822097|NCT01350934|584391008|FG001|Base Study|Lost to Follow-up|0|||
161822098|NCT01350934|584391007|FG000|Base Study|Protocol Violation|1|||
161822099|NCT01350934|584391008|FG001|Base Study|Protocol Violation|1|||
161822100|NCT01350934|584391007|FG000|Base Study|Withdrawal by Subject|1|||
161822101|NCT01350934|584391008|FG001|Base Study|Withdrawal by Subject|2|||
161822102|NCT01350934|584391007|FG000|Base Study|Non-Compliance With Study Drug|2|||
161822103|NCT01350934|584391008|FG001|Base Study|Non-Compliance With Study Drug|0|||
161822104|NCT01350934|584391007|FG000|Extension Study|Adverse Event|2|||
161822105|NCT01350934|584391008|FG001|Extension Study|Adverse Event|1|||
161822106|NCT01350934|584391007|FG000|Extension Study|Lost to Follow-up|2|||
161822107|NCT01350934|584391008|FG001|Extension Study|Lost to Follow-up|0|||
161822108|NCT01350934|584391007|FG000|Extension Study|Protocol Violation|1|||
161822109|NCT01350934|584391008|FG001|Extension Study|Protocol Violation|1|||
161822110|NCT01350934|584391007|FG000|Extension Study|Lack of Efficacy|0|||
161822111|NCT01350934|584391008|FG001|Extension Study|Lack of Efficacy|1|||
161822112|NCT01350934|584391007|FG000|Extension Study|Withdrawal by Subject|0|||
161822113|NCT01350934|584391008|FG001|Extension Study|Withdrawal by Subject|1|||
161822114|NCT02415387|584391009|FG000|Overall Study|Withdrawal by Subject|6|||
161822115|NCT02415387|584391010|FG001|Overall Study|Withdrawal by Subject|1|||
161822116|NCT02415387|584391009|FG000|Overall Study|blood draw problem|0|||
161822117|NCT02415387|584391010|FG001|Overall Study|blood draw problem|1|||
161822118|NCT02415387|584391009|FG000|Overall Study|Protocol Violation|1|||
161822119|NCT02415387|584391010|FG001|Overall Study|Protocol Violation|0|||
161822120|NCT01151280|584391011|FG000|Overall Study|Adverse Event|1|||
161822121|NCT01151280|584391011|FG000|Overall Study|Lack of Efficacy|3|||
161822122|NCT02473393|584391013|FG000|Overall Study|Adverse Event|0|||
161822123|NCT02473393|584391014|FG001|Overall Study|Adverse Event|0|||
161822124|NCT02473393|584391015|FG002|Overall Study|Adverse Event|1|||
161822125|NCT02473393|584391016|FG003|Overall Study|Adverse Event|0|||
161822126|NCT02473393|584391013|FG000|Overall Study|Withdrawal by Subject|0|||
161822127|NCT02473393|584391014|FG001|Overall Study|Withdrawal by Subject|0|||
161822128|NCT02473393|584391015|FG002|Overall Study|Withdrawal by Subject|1|||
161822129|NCT02473393|584391016|FG003|Overall Study|Withdrawal by Subject|1|||
161822130|NCT02274558|584391019|FG000|Overall Study|Adverse Event|2|||
161822131|NCT02274558|584391020|FG001|Overall Study|Adverse Event|4|||
161822132|NCT02274558|584391021|FG002|Overall Study|Adverse Event|2|||
161822133|NCT02274558|584391019|FG000|Overall Study|Non-compliance|2|||
161928702|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Other|0|||
161928703|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Other|0|||
161928704|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Other|9|||
161822134|NCT02274558|584391020|FG001|Overall Study|Non-compliance|1|||
161822135|NCT02274558|584391021|FG002|Overall Study|Non-compliance|0|||
161822136|NCT02274558|584391019|FG000|Overall Study|Withdrawal by Subject|1|||
161822137|NCT02274558|584391020|FG001|Overall Study|Withdrawal by Subject|5|||
161822138|NCT02274558|584391021|FG002|Overall Study|Withdrawal by Subject|4|||
161822139|NCT02274558|584391019|FG000|Overall Study|Death|0|||
161822140|NCT02274558|584391020|FG001|Overall Study|Death|0|||
161822141|NCT02274558|584391021|FG002|Overall Study|Death|1|||
161822142|NCT02274558|584391019|FG000|Overall Study|Lost to Follow-up|2|||
161822143|NCT02274558|584391020|FG001|Overall Study|Lost to Follow-up|1|||
161822144|NCT02274558|584391021|FG002|Overall Study|Lost to Follow-up|1|||
161515143|NCT02188485|583275650|FG001|Overall Study|Withdrawal by Subject|1|||
161515144|NCT02188485|583275649|FG000|Overall Study|PI withdrew, lack of capacity|0|||
161515145|NCT02188485|583275650|FG001|Overall Study|PI withdrew, lack of capacity|2|||
161515146|NCT00799617|583275651|FG000|Main Testosterone Trial|Randomized in error|1|||
161515147|NCT00799617|583275652|FG001|Main Testosterone Trial|Randomized in error|1|||
161515148|NCT00799617|583275651|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
161515149|NCT00799617|583275652|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
161515150|NCT00799617|583275651|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
161515151|NCT00799617|583275652|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
161515152|NCT00799617|583275651|FG000|Sexual Funtion Trial|No Baseline Data|4|||
161588328|NCT00901901|583542393|FG001|Treatment Period|Physician Decision|2|||
161588329|NCT00901901|583542392|FG000|Treatment Period|Lost to Follow-up|3|||
161588330|NCT00901901|583542393|FG001|Treatment Period|Lost to Follow-up|5|||
161588331|NCT00901901|583542392|FG000|Treatment Period|Noncompliance with study medication|4|||
161822145|NCT02274558|584391019|FG000|Overall Study|Physician Decision|0|||
161822146|NCT02274558|584391020|FG001|Overall Study|Physician Decision|2|||
161822147|NCT02274558|584391021|FG002|Overall Study|Physician Decision|1|||
161588332|NCT00901901|583542393|FG001|Treatment Period|Noncompliance with study medication|1|||
161822148|NCT02733627|584391022|FG000|Overall Study|Adverse Event|0|||
161822149|NCT02733627|584391023|FG001|Overall Study|Adverse Event|1|||
161822150|NCT02733627|584391024|FG002|Overall Study|Adverse Event|1|||
161822151|NCT02733627|584391025|FG003|Overall Study|Adverse Event|0|||
161822152|NCT02733627|584391022|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161822153|NCT02733627|584391023|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161822154|NCT02733627|584391024|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
161928705|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
161928706|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
161928707|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
161928708|NCT02852434|584787822|FG000|Overall Study|Withdrawal by Subject|0|||
161928709|NCT02852434|584787823|FG001|Overall Study|Withdrawal by Subject|1|||
161928710|NCT02852434|584787822|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
161928711|NCT02852434|584787823|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
161928712|NCT03774810|584787826|FG000|Phase 1|Lack of Efficacy|21|||
161928713|NCT03774810|584787827|FG001|Phase 1|Lack of Efficacy|0|||
161928714|NCT03774810|584787828|FG002|Phase 1|Lack of Efficacy|0|||
161928715|NCT03774810|584787829|FG003|Phase 1|Lack of Efficacy|0|||
161928716|NCT03774810|584787830|FG004|Phase 1|Lack of Efficacy|0|||
161928717|NCT03774810|584787826|FG000|Phase 1|Withdrawal by Subject|9|||
161928718|NCT03774810|584787827|FG001|Phase 1|Withdrawal by Subject|0|||
161928719|NCT03774810|584787828|FG002|Phase 1|Withdrawal by Subject|0|||
161928720|NCT03774810|584787829|FG003|Phase 1|Withdrawal by Subject|0|||
161928721|NCT03774810|584787830|FG004|Phase 1|Withdrawal by Subject|0|||
161928722|NCT03774810|584787826|FG000|Phase 1|Lost to Follow-up|2|||
161928723|NCT03774810|584787827|FG001|Phase 1|Lost to Follow-up|0|||
161928724|NCT03774810|584787828|FG002|Phase 1|Lost to Follow-up|0|||
161928725|NCT03774810|584787829|FG003|Phase 1|Lost to Follow-up|0|||
161928726|NCT03774810|584787830|FG004|Phase 1|Lost to Follow-up|0|||
161928727|NCT03774810|584787826|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
161928728|NCT03774810|584787827|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
161822155|NCT02733627|584391025|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161928729|NCT03774810|584787828|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
161928730|NCT03774810|584787829|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
161928731|NCT03774810|584787830|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
161928732|NCT03774810|584787826|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
161928733|NCT03774810|584787827|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
161822156|NCT02246764|584391026|FG000|Overall Study|Adverse Event|15|||
161928734|NCT03774810|584787828|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
161928735|NCT03774810|584787829|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
161515153|NCT00799617|583275652|FG001|Sexual Funtion Trial|No Baseline Data|7|||
161515154|NCT00799617|583275651|FG000|Physical Function Trial|Lost to Follow-up|6|||
161588333|NCT00901901|583542392|FG000|Treatment Period|Missing|1|||
161928736|NCT03774810|584787830|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
161928737|NCT03774810|584787826|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
161515155|NCT00799617|583275652|FG001|Physical Function Trial|Lost to Follow-up|11|||
161515156|NCT00799617|583275651|FG000|Vitality Trial|Lost to Follow-up|7|||
161515157|NCT00799617|583275652|FG001|Vitality Trial|Lost to Follow-up|22|||
161515158|NCT00799617|583275651|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
161515159|NCT00799617|583275652|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
161515160|NCT00799617|583275651|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
161515161|NCT00799617|583275652|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
161515162|NCT00799617|583275651|FG000|Bone Trial|Month 12 scan not available|6|||
161515163|NCT00799617|583275652|FG001|Bone Trial|Month 12 scan not available|16|||
161515164|NCT00799617|583275651|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
161515165|NCT00799617|583275652|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
161515166|NCT00799617|583275651|FG000|Anemia Trial|Withdrawal by Subject|3|||
161515167|NCT00799617|583275652|FG001|Anemia Trial|Withdrawal by Subject|3|||
161515168|NCT02052466|583275653|FG000|Overall Study|Withdrawal by Subject|1|||
161515169|NCT02052466|583275653|FG000|Overall Study|Acromial fracture|1|||
161515170|NCT03851016|583275655|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161515171|NCT03851016|583275656|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
161515172|NCT01660412|583275657|FG000|Overall Study|Protocol Violation|0|||
161515173|NCT01660412|583275658|FG001|Overall Study|Protocol Violation|3|||
161515174|NCT02293005|583277037|FG000|Overall Study|Adverse Event|2|||
161515175|NCT02293005|583277037|FG000|Overall Study|Death|4|||
161515176|NCT02293005|583277037|FG000|Overall Study|Lost to Follow-up|1|||
161515177|NCT02293005|583277037|FG000|Overall Study|Withdrawal by Subject|2|||
161515178|NCT02293005|583277037|FG000|Overall Study|Progression|17|||
161515179|NCT00608829|583277038|FG000|Overall Study|Death|6|||
161515180|NCT00608829|583277038|FG000|Overall Study|Withdrawal by Subject|4|||
161515181|NCT00608829|583277038|FG000|Overall Study|Subject refuses to follow up or return.|5|||
161515182|NCT02080091|583277041|FG000|Overall Study|Study Terminated|22|||
161515183|NCT02080091|583277041|FG000|Overall Study|Death|1|||
161515184|NCT02080091|583277041|FG000|Overall Study|Withdrawal by Subject|1|||
161515185|NCT02080091|583277041|FG000|Overall Study|Other|1|||
161515186|NCT03019536|583277042|FG000|Overall Study|Withdrawal by Subject|1|||
161676823|NCT01241552|583870555|FG000|Overall Study|Physician Decision|2|||
161676824|NCT01241552|583870556|FG001|Overall Study|Physician Decision|4|||
161676825|NCT01241552|583870557|FG002|Overall Study|Physician Decision|2|||
161676826|NCT01241552|583870558|FG003|Overall Study|Physician Decision|3|||
161822157|NCT02246764|584391027|FG001|Overall Study|Adverse Event|29|||
161822158|NCT02246764|584391028|FG002|Overall Study|Adverse Event|1|||
161515187|NCT03019536|583277043|FG001|Overall Study|Withdrawal by Subject|1|||
161515188|NCT03019536|583277044|FG002|Overall Study|Withdrawal by Subject|0|||
161676827|NCT01241552|583870555|FG000|Overall Study|Lost to Follow-up|2|||
161822159|NCT02246764|584391026|FG000|Overall Study|Withdrawal by Subject|0|||
161822160|NCT02246764|584391027|FG001|Overall Study|Withdrawal by Subject|0|||
161822161|NCT02246764|584391028|FG002|Overall Study|Withdrawal by Subject|1|||
161822162|NCT02246764|584391026|FG000|Overall Study|Disallowed Concomitant Medication|1|||
161822163|NCT02246764|584391027|FG001|Overall Study|Disallowed Concomitant Medication|0|||
161822164|NCT02246764|584391028|FG002|Overall Study|Disallowed Concomitant Medication|0|||
161822165|NCT02246764|584391026|FG000|Overall Study|Physician Decision|0|||
161822166|NCT02246764|584391027|FG001|Overall Study|Physician Decision|2|||
161822167|NCT02246764|584391028|FG002|Overall Study|Physician Decision|1|||
161822168|NCT02246764|584391026|FG000|Overall Study|Protocol Violation|2|||
161822169|NCT02246764|584391027|FG001|Overall Study|Protocol Violation|1|||
161822170|NCT02246764|584391028|FG002|Overall Study|Protocol Violation|1|||
161822171|NCT05393271|584391029|FG000|Overall Study|Physician Decision|0|||
161822172|NCT05393271|584391030|FG001|Overall Study|Physician Decision|0|||
161822173|NCT05393271|584391031|FG002|Overall Study|Physician Decision|0|||
161822174|NCT05393271|584391032|FG003|Overall Study|Physician Decision|0|||
161822175|NCT05393271|584391033|FG004|Overall Study|Physician Decision|0|||
161822176|NCT05393271|584391034|FG005|Overall Study|Physician Decision|0|||
161822177|NCT05393271|584391035|FG006|Overall Study|Physician Decision|1|||
161822178|NCT05393271|584391036|FG007|Overall Study|Physician Decision|0|||
161822179|NCT05393271|584391037|FG008|Overall Study|Physician Decision|0|||
161822180|NCT05393271|584391038|FG009|Overall Study|Physician Decision|0|||
161822181|NCT05393271|584391039|FG010|Overall Study|Physician Decision|0|||
161822182|NCT02048813|584391040|FG000|Overall Study|Still on treatment|279|||
161822183|NCT02048813|584391041|FG001|Overall Study|Still on treatment|0|||
161822184|NCT02048813|584391040|FG000|Overall Study|Adverse Event|40|||
161822185|NCT02048813|584391041|FG001|Overall Study|Adverse Event|38|||
161822186|NCT02048813|584391040|FG000|Overall Study|Disease progression|13|||
161822187|NCT02048813|584391041|FG001|Overall Study|Disease progression|3|||
161515189|NCT03019536|583277042|FG000|Overall Study|Adverse Event|0|||
161822188|NCT02048813|584391040|FG000|Overall Study|Withdrawal by Subject|7|||
161822189|NCT02048813|584391041|FG001|Overall Study|Withdrawal by Subject|8|||
161822190|NCT02048813|584391040|FG000|Overall Study|Death|2|||
161822191|NCT02048813|584391041|FG001|Overall Study|Death|1|||
161515190|NCT03019536|583277043|FG001|Overall Study|Adverse Event|0|||
161822192|NCT02048813|584391040|FG000|Overall Study|Complication|2|||
161822193|NCT02048813|584391041|FG001|Overall Study|Complication|2|||
161588334|NCT00901901|583542393|FG001|Treatment Period|Missing|0|||
161588335|NCT00901901|583542392|FG000|Treatment Period|Never treated|0|||
161588336|NCT00901901|583542393|FG001|Treatment Period|Never treated|3|||
161588337|NCT00901901|583542392|FG000|Treatment Period|Protocol driven decision point|0|||
161588338|NCT00901901|583542393|FG001|Treatment Period|Protocol driven decision point|2|||
161588339|NCT00901901|583542392|FG000|Treatment Period|Study terminated by sponsor|2|||
161588340|NCT00901901|583542393|FG001|Treatment Period|Study terminated by sponsor|0|||
161928738|NCT03774810|584787827|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
161588341|NCT00901901|583542392|FG000|Treatment Period|Protocol Violation|5|||
161588342|NCT00901901|583542393|FG001|Treatment Period|Protocol Violation|9|||
161588343|NCT00901901|583542392|FG000|Treatment Period|Switch to commercial drug|1|||
161588344|NCT00901901|583542393|FG001|Treatment Period|Switch to commercial drug|1|||
161588345|NCT00901901|583542392|FG000|Treatment Period|Transfer to treatment continuation study|5|||
161588346|NCT00901901|583542393|FG001|Treatment Period|Transfer to treatment continuation study|2|||
161588347|NCT00901901|583542392|FG000|Follow-up Period|Death|181|||
161588348|NCT00901901|583542393|FG001|Follow-up Period|Death|208|||
161588349|NCT00901901|583542392|FG000|Follow-up Period|Protocol driven decision point|47|||
161588350|NCT00901901|583542393|FG001|Follow-up Period|Protocol driven decision point|36|||
161588351|NCT00901901|583542392|FG000|Follow-up Period|Withdrawal by Subject|6|||
161588352|NCT00901901|583542393|FG001|Follow-up Period|Withdrawal by Subject|9|||
161588353|NCT00901901|583542392|FG000|Follow-up Period|Lost to Follow-up|12|||
161588354|NCT00901901|583542393|FG001|Follow-up Period|Lost to Follow-up|8|||
161588355|NCT00901901|583542392|FG000|Follow-up Period|Missing|94|||
161928739|NCT03774810|584787828|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
161928740|NCT03774810|584787829|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
161928741|NCT03774810|584787830|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
161928742|NCT03774810|584787826|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
161928743|NCT03774810|584787827|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
161928744|NCT03774810|584787828|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
161928745|NCT03774810|584787829|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
161928746|NCT03774810|584787830|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
161928747|NCT03774810|584787826|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
161928748|NCT03774810|584787827|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
161928749|NCT03774810|584787828|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
161928750|NCT03774810|584787829|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
161928751|NCT03774810|584787830|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
161928752|NCT03774810|584787826|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
161928753|NCT03774810|584787827|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
161928754|NCT03774810|584787828|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
161928755|NCT03774810|584787829|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
161928756|NCT03774810|584787830|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
161928757|NCT00927186|584787831|FG000|12 Months Primary Study|Adverse Event|5|||
161928758|NCT00927186|584787832|FG001|12 Months Primary Study|Adverse Event|2|||
161928759|NCT00927186|584787831|FG000|12 Months Primary Study|Lost to Follow-up|1|||
161928760|NCT00927186|584787832|FG001|12 Months Primary Study|Lost to Follow-up|0|||
161928761|NCT00927186|584787831|FG000|12 Months Primary Study|Protocol Violation|0|||
161928762|NCT00927186|584787832|FG001|12 Months Primary Study|Protocol Violation|1|||
161928763|NCT00927186|584787831|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
161928764|NCT00927186|584787832|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
161928765|NCT01145222|584787833|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
161928766|NCT01145222|584787834|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
161928767|NCT01145222|584787835|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
161928768|NCT01145222|584787836|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
161928769|NCT01145222|584787833|FG000|Overall Study|Poor bowel preparation|0|||
161928770|NCT01145222|584787834|FG001|Overall Study|Poor bowel preparation|0|||
161928771|NCT01145222|584787835|FG002|Overall Study|Poor bowel preparation|0|||
161928772|NCT01145222|584787836|FG003|Overall Study|Poor bowel preparation|1|||
161928773|NCT00604383|584787837|FG000|Overall Study|Withdrawal by Subject|33|||
161928774|NCT00604383|584787838|FG001|Overall Study|Withdrawal by Subject|31|||
161928775|NCT00604383|584787837|FG000|Overall Study|Lost to Follow-up|24|||
161928776|NCT00604383|584787838|FG001|Overall Study|Lost to Follow-up|19|||
161928777|NCT00604383|584787837|FG000|Overall Study|Death|14|||
161928778|NCT00604383|584787838|FG001|Overall Study|Death|22|||
161928779|NCT00604383|584787837|FG000|Overall Study|Adverse Event|16|||
161928780|NCT00604383|584787838|FG001|Overall Study|Adverse Event|9|||
161928781|NCT00604383|584787837|FG000|Overall Study|Physician Decision|0|||
161928782|NCT00604383|584787838|FG001|Overall Study|Physician Decision|3|||
161928783|NCT01698008|584787839|FG000|Overall Study|Withdrawal by Subject|1|||
161928784|NCT01698008|584787840|FG001|Overall Study|Withdrawal by Subject|2|||
161928785|NCT03994120|584787845|FG000|Overall Study|Lost to Follow-up|3|||
161928786|NCT03994120|584787846|FG001|Overall Study|Lost to Follow-up|1|||
161928787|NCT01429623|584787847|FG000|Overall Study|Death|1|||
161515191|NCT03019536|583277044|FG002|Overall Study|Adverse Event|2|||
161515192|NCT02648698|583277052|FG000|Overall Study|Protocol Violation|1|||
161515193|NCT02648698|583277053|FG001|Overall Study|Protocol Violation|5|||
161515194|NCT03143829|583277056|FG000|Overall Study|Withdrawal by Subject|2|||
161515195|NCT03143829|583277057|FG001|Overall Study|Withdrawal by Subject|5|||
161515196|NCT03143829|583277056|FG000|Overall Study|Lost to Follow-up|0|||
161515197|NCT03143829|583277057|FG001|Overall Study|Lost to Follow-up|2|||
161515198|NCT03143829|583277056|FG000|Overall Study|Death|1|||
161515199|NCT03143829|583277057|FG001|Overall Study|Death|1|||
161515200|NCT03143829|583277056|FG000|Overall Study|changed treatment, no longer eligible|2|||
161515201|NCT03143829|583277057|FG001|Overall Study|changed treatment, no longer eligible|2|||
161515202|NCT00672477|583277058|FG000|Overall Study|Adverse Event|10|||
161515203|NCT00672477|583277059|FG001|Overall Study|Adverse Event|7|||
161515204|NCT00672477|583277058|FG000|Overall Study|Death|7|||
161515205|NCT00672477|583277059|FG001|Overall Study|Death|11|||
161515206|NCT00672477|583277058|FG000|Overall Study|Physician Decision|2|||
161515207|NCT00672477|583277059|FG001|Overall Study|Physician Decision|0|||
161515208|NCT00672477|583277058|FG000|Overall Study|Protocol Violation|1|||
161515209|NCT00672477|583277059|FG001|Overall Study|Protocol Violation|1|||
161515210|NCT00672477|583277058|FG000|Overall Study|Withdrawal by Subject|5|||
161515211|NCT00672477|583277059|FG001|Overall Study|Withdrawal by Subject|3|||
161515212|NCT00672477|583277058|FG000|Overall Study|Lack of Efficacy|1|||
161515213|NCT00672477|583277059|FG001|Overall Study|Lack of Efficacy|1|||
161515214|NCT00672477|583277058|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
161515215|NCT00672477|583277059|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
161515216|NCT00938431|583277063|FG000|Overall Study|Adverse Event|5|||
161515217|NCT00938431|583277064|FG001|Overall Study|Adverse Event|8|||
161515218|NCT00938431|583277065|FG002|Overall Study|Adverse Event|6|||
161515219|NCT00938431|583277063|FG000|Overall Study|Lack of Efficacy|0|||
161515220|NCT00938431|583277064|FG001|Overall Study|Lack of Efficacy|1|||
161515221|NCT00938431|583277065|FG002|Overall Study|Lack of Efficacy|0|||
161515222|NCT00938431|583277063|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
161515223|NCT00938431|583277064|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
161515224|NCT00938431|583277065|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
161515225|NCT00938431|583277063|FG000|Overall Study|Dosing compliance issue|0|||
161515226|NCT00938431|583277064|FG001|Overall Study|Dosing compliance issue|0|||
161515227|NCT00938431|583277065|FG002|Overall Study|Dosing compliance issue|1|||
161515228|NCT00938431|583277063|FG000|Overall Study|Reached maximum dose early|0|||
161515229|NCT00938431|583277064|FG001|Overall Study|Reached maximum dose early|0|||
161515230|NCT00938431|583277065|FG002|Overall Study|Reached maximum dose early|1|||
161588356|NCT00901901|583542393|FG001|Follow-up Period|Missing|80|||
161588357|NCT03930342|583542397|FG000|Overall Study|Lost to Follow-up|70|||
161588358|NCT03930342|583542398|FG001|Overall Study|Lost to Follow-up|77|||
161588359|NCT02742519|583542401|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
161588360|NCT02742519|583542402|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
161588361|NCT02742519|583542403|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
161588362|NCT02742519|583542401|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
161588363|NCT02742519|583542402|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
161588364|NCT02742519|583542403|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
161588365|NCT02742519|583542401|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
161588366|NCT02742519|583542402|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
161588367|NCT02742519|583542403|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
161588368|NCT01872078|583542405|FG000|Overall Study|Adverse Event|0|||
161588369|NCT01872078|583542406|FG001|Overall Study|Adverse Event|0|||
161588370|NCT01872078|583542407|FG002|Overall Study|Adverse Event|1|||
161588371|NCT01872078|583542408|FG003|Overall Study|Adverse Event|0|||
161588372|NCT01872078|583542405|FG000|Overall Study|Dose administration non-compliance|0|||
161588373|NCT01872078|583542406|FG001|Overall Study|Dose administration non-compliance|0|||
161588374|NCT01872078|583542407|FG002|Overall Study|Dose administration non-compliance|0|||
161588375|NCT01872078|583542408|FG003|Overall Study|Dose administration non-compliance|1|||
161588376|NCT01872078|583542405|FG000|Overall Study|Protocol Violation|0|||
161676828|NCT01241552|583870556|FG001|Overall Study|Lost to Follow-up|11|||
161676829|NCT01241552|583870557|FG002|Overall Study|Lost to Follow-up|15|||
161928788|NCT01429623|584787848|FG001|Overall Study|Death|0|||
161515231|NCT03738865|583277070|FG000|Overall Study|Withdrawal by Subject|3|||
161515232|NCT03738865|583277071|FG001|Overall Study|Withdrawal by Subject|3|||
161515233|NCT03738865|583277070|FG000|Overall Study|Adverse Event|2|||
161515234|NCT03738865|583277071|FG001|Overall Study|Adverse Event|0|||
161515235|NCT03738865|583277070|FG000|Overall Study|Physician Decision|0|||
161588377|NCT01872078|583542406|FG001|Overall Study|Protocol Violation|0|||
161588378|NCT01872078|583542407|FG002|Overall Study|Protocol Violation|1|||
161588379|NCT01872078|583542408|FG003|Overall Study|Protocol Violation|0|||
161588380|NCT01872078|583542405|FG000|Overall Study|Withdrawal by Subject|0|||
161515236|NCT03738865|583277071|FG001|Overall Study|Physician Decision|1|||
161515237|NCT01175824|583277072|FG000|Overall Study|Adverse Event|2|||
161515238|NCT01175824|583277073|FG001|Overall Study|Adverse Event|1|||
161515239|NCT01175824|583277072|FG000|Overall Study|Lack of Efficacy|2|||
161515240|NCT01175824|583277073|FG001|Overall Study|Lack of Efficacy|0|||
161515241|NCT01175824|583277072|FG000|Overall Study|Lost to Follow-up|0|||
161515242|NCT01175824|583277073|FG001|Overall Study|Lost to Follow-up|1|||
161515243|NCT01175824|583277072|FG000|Overall Study|Physician Decision|0|||
161515244|NCT01175824|583277073|FG001|Overall Study|Physician Decision|4|||
161515245|NCT01175824|583277072|FG000|Overall Study|Protocol Violation|2|||
161515246|NCT01175824|583277073|FG001|Overall Study|Protocol Violation|5|||
161515247|NCT01175824|583277072|FG000|Overall Study|Withdrawal by Subject|3|||
161515248|NCT01175824|583277073|FG001|Overall Study|Withdrawal by Subject|7|||
161515249|NCT01175824|583277072|FG000|Overall Study|Sponsor Decision|1|||
161515250|NCT01175824|583277073|FG001|Overall Study|Sponsor Decision|0|||
161515251|NCT01175824|583277072|FG000|Overall Study|Entry Criteria Not Met|6|||
161515252|NCT01175824|583277073|FG001|Overall Study|Entry Criteria Not Met|4|||
161515253|NCT03455855|583277074|FG000|Overall Study|Lost to Follow-up|4|||
161515254|NCT03455855|583277075|FG001|Overall Study|Lost to Follow-up|2|||
161515255|NCT01774903|583277076|FG000|Overall Study|Adverse Event|7|||
161515256|NCT01774903|583277076|FG000|Overall Study|Withdrawal by Subject|2|||
161515257|NCT01774903|583277076|FG000|Overall Study|Lack of Efficacy|1|||
161515258|NCT01774903|583277076|FG000|Overall Study|Ineligible to continue the trial|1|||
161515259|NCT00924950|583277077|FG000|Overall Study|Lost to Follow-up|2|||
161928789|NCT01429623|584787847|FG000|Overall Study|Adverse Event|7|||
161928790|NCT01429623|584787848|FG001|Overall Study|Adverse Event|14|||
161928791|NCT01429623|584787847|FG000|Overall Study|Withdrawal by Subject|19|||
161928792|NCT01429623|584787848|FG001|Overall Study|Withdrawal by Subject|13|||
161928793|NCT01429623|584787847|FG000|Overall Study|Physician Decision|2|||
161928794|NCT01429623|584787848|FG001|Overall Study|Physician Decision|3|||
161928795|NCT01429623|584787847|FG000|Overall Study|Protocol Violation|3|||
161928796|NCT01429623|584787848|FG001|Overall Study|Protocol Violation|2|||
161928797|NCT01429623|584787847|FG000|Overall Study|Assorted|1|||
161928798|NCT01429623|584787848|FG001|Overall Study|Assorted|2|||
161928799|NCT01429623|584787847|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
161928800|NCT01429623|584787848|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
161928801|NCT01429623|584787847|FG000|Overall Study|No post baseline data|4|||
161928802|NCT01429623|584787848|FG001|Overall Study|No post baseline data|4|||
161928803|NCT02619812|584787849|FG000|Overall Study|Withdrawal by Subject|0|||
161928804|NCT02619812|584787850|FG001|Overall Study|Withdrawal by Subject|0|||
161928805|NCT02619812|584787851|FG002|Overall Study|Withdrawal by Subject|1|||
161928806|NCT02619812|584787852|FG003|Overall Study|Withdrawal by Subject|2|||
161928807|NCT00981175|584787853|FG000|Primary Dose Vaccination|Adverse Event|1|||
161928808|NCT00981175|584787854|FG001|Primary Dose Vaccination|Adverse Event|0|||
161928809|NCT00981175|584787853|FG000|Primary Dose Vaccination|Protocol Violation|0|||
161928810|NCT00981175|584787854|FG001|Primary Dose Vaccination|Protocol Violation|1|||
161928811|NCT00981175|584787853|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
161928812|NCT00981175|584787854|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
161928813|NCT00981175|584787853|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
161928814|NCT00981175|584787854|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
161928815|NCT04985682|584787866|FG000|Overall Study|Withdrawal by Subject|1|||
161928816|NCT00621322|584787867|FG000|Overall Study|Lost to Follow-up|0|||
161928817|NCT00621322|584787868|FG001|Overall Study|Lost to Follow-up|0|||
161928818|NCT00621322|584787869|FG002|Overall Study|Lost to Follow-up|0|||
161928819|NCT00621322|584787870|FG003|Overall Study|Lost to Follow-up|0|||
161928820|NCT00621322|584787871|FG004|Overall Study|Lost to Follow-up|1|||
161928821|NCT00621322|584787872|FG005|Overall Study|Lost to Follow-up|0|||
161928822|NCT00621322|584787867|FG000|Overall Study|Physician Decision|0|||
161928823|NCT00621322|584787868|FG001|Overall Study|Physician Decision|0|||
161928824|NCT00621322|584787869|FG002|Overall Study|Physician Decision|1|||
161928825|NCT00621322|584787870|FG003|Overall Study|Physician Decision|1|||
161515260|NCT01602315|583277078|FG000|Overall Study|Protocol Violation|0|||
161515261|NCT01602315|583277079|FG001|Overall Study|Protocol Violation|0|||
161515262|NCT01602315|583277080|FG002|Overall Study|Protocol Violation|0|||
161515263|NCT01602315|583277081|FG003|Overall Study|Protocol Violation|0|||
161515264|NCT01602315|583277082|FG004|Overall Study|Protocol Violation|0|||
161515265|NCT01602315|583277083|FG005|Overall Study|Protocol Violation|1|||
161515266|NCT01602315|583277084|FG006|Overall Study|Protocol Violation|0|||
161515267|NCT01602315|583277078|FG000|Overall Study|Physician Decision|2|||
161515268|NCT01602315|583277079|FG001|Overall Study|Physician Decision|0|||
161928826|NCT00621322|584787871|FG004|Overall Study|Physician Decision|0|||
161515269|NCT01602315|583277080|FG002|Overall Study|Physician Decision|0|||
161515270|NCT01602315|583277081|FG003|Overall Study|Physician Decision|0|||
161515271|NCT01602315|583277082|FG004|Overall Study|Physician Decision|2|||
161515272|NCT01602315|583277083|FG005|Overall Study|Physician Decision|1|||
161515273|NCT01602315|583277084|FG006|Overall Study|Physician Decision|1|||
161515274|NCT01602315|583277078|FG000|Overall Study|Disease progression|6|||
161928827|NCT00621322|584787872|FG005|Overall Study|Physician Decision|0|||
161928828|NCT00621322|584787867|FG000|Overall Study|Withdrawal by Subject|0|||
161928829|NCT00621322|584787868|FG001|Overall Study|Withdrawal by Subject|0|||
161928830|NCT00621322|584787869|FG002|Overall Study|Withdrawal by Subject|0|||
161928831|NCT00621322|584787870|FG003|Overall Study|Withdrawal by Subject|1|||
161928832|NCT00621322|584787871|FG004|Overall Study|Withdrawal by Subject|0|||
161928833|NCT00621322|584787872|FG005|Overall Study|Withdrawal by Subject|2|||
161928834|NCT00621322|584787867|FG000|Overall Study|Migrated/moved from study area|1|||
161928835|NCT00621322|584787868|FG001|Overall Study|Migrated/moved from study area|0|||
161928836|NCT00621322|584787869|FG002|Overall Study|Migrated/moved from study area|1|||
161928837|NCT00621322|584787870|FG003|Overall Study|Migrated/moved from study area|1|||
161928838|NCT00621322|584787871|FG004|Overall Study|Migrated/moved from study area|0|||
161928839|NCT00621322|584787872|FG005|Overall Study|Migrated/moved from study area|2|||
161928840|NCT00756444|584787879|FG000|Overall Study|Adverse Event|1|||
161928841|NCT00756444|584787880|FG001|Overall Study|Adverse Event|1|||
161928842|NCT00756444|584787879|FG000|Overall Study|Withdrawal by Subject|6|||
161928843|NCT00756444|584787880|FG001|Overall Study|Withdrawal by Subject|8|||
161928844|NCT00756444|584787879|FG000|Overall Study|Lost to Follow-up|0|||
161928845|NCT00756444|584787880|FG001|Overall Study|Lost to Follow-up|1|||
161928846|NCT00756444|584787879|FG000|Overall Study|Death|5|||
161928847|NCT00756444|584787880|FG001|Overall Study|Death|4|||
161928848|NCT00756444|584787879|FG000|Overall Study|Disease Progression|2|||
161928849|NCT00756444|584787880|FG001|Overall Study|Disease Progression|7|||
161928850|NCT00756444|584787879|FG000|Overall Study|Ineligibility Determined|1|||
161928851|NCT00756444|584787880|FG001|Overall Study|Ineligibility Determined|0|||
161928852|NCT04865978|584787881|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
161928853|NCT04865978|584787882|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
161928854|NCT05587998|584787883|FG000|Overall Study|Withdrawal by Subject|1|||
161928855|NCT05587998|584787884|FG001|Overall Study|Withdrawal by Subject|1|||
161928856|NCT05587998|584787883|FG000|Overall Study|Not treated|3|||
161928857|NCT05587998|584787884|FG001|Overall Study|Not treated|1|||
161928858|NCT05587998|584787883|FG000|Overall Study|Non-compliance with study procedures|0|||
161928859|NCT05587998|584787884|FG001|Overall Study|Non-compliance with study procedures|1|||
161928860|NCT04263532|584787885|FG000|Overall Study|Withdrawal by Subject|2|||
161928861|NCT04263532|584787886|FG001|Overall Study|Withdrawal by Subject|0|||
161928862|NCT00601107|584787887|FG000|Overall Study|Adverse Event|0|||
161928863|NCT00601107|584787888|FG001|Overall Study|Adverse Event|1|||
161928864|NCT00601107|584787889|FG002|Overall Study|Adverse Event|3|||
161928865|NCT00601107|584787890|FG003|Overall Study|Adverse Event|0|||
161928866|NCT00601107|584787887|FG000|Overall Study|Withdrawal by Subject|5|||
161928867|NCT00601107|584787888|FG001|Overall Study|Withdrawal by Subject|4|||
161928868|NCT00601107|584787889|FG002|Overall Study|Withdrawal by Subject|7|||
161928869|NCT00601107|584787890|FG003|Overall Study|Withdrawal by Subject|4|||
161928870|NCT00601107|584787887|FG000|Overall Study|Lost to Follow-up|3|||
161928871|NCT00601107|584787888|FG001|Overall Study|Lost to Follow-up|3|||
161928872|NCT00601107|584787889|FG002|Overall Study|Lost to Follow-up|0|||
161928873|NCT00601107|584787890|FG003|Overall Study|Lost to Follow-up|3|||
161928874|NCT00601107|584787887|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
161928875|NCT00601107|584787888|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
161928876|NCT00601107|584787889|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
161928877|NCT00601107|584787890|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
161928878|NCT00601107|584787887|FG000|Overall Study|Worsening of Psoriasis|4|||
161928879|NCT00601107|584787888|FG001|Overall Study|Worsening of Psoriasis|1|||
161928880|NCT00601107|584787889|FG002|Overall Study|Worsening of Psoriasis|1|||
161928881|NCT00601107|584787890|FG003|Overall Study|Worsening of Psoriasis|4|||
161928882|NCT00601107|584787887|FG000|Overall Study|Undefined|1|||
161928883|NCT00601107|584787888|FG001|Overall Study|Undefined|0|||
161928884|NCT00601107|584787889|FG002|Overall Study|Undefined|1|||
161515275|NCT01602315|583277079|FG001|Overall Study|Disease progression|3|||
161515276|NCT01602315|583277080|FG002|Overall Study|Disease progression|10|||
161515277|NCT01602315|583277081|FG003|Overall Study|Disease progression|1|||
161515278|NCT01602315|583277082|FG004|Overall Study|Disease progression|41|||
161515279|NCT01602315|583277083|FG005|Overall Study|Disease progression|12|||
161515280|NCT01602315|583277084|FG006|Overall Study|Disease progression|15|||
161515281|NCT01602315|583277078|FG000|Overall Study|Death|1|||
161515282|NCT01602315|583277079|FG001|Overall Study|Death|1|||
161515283|NCT01602315|583277080|FG002|Overall Study|Death|1|||
161515284|NCT01602315|583277081|FG003|Overall Study|Death|1|||
161515285|NCT01602315|583277082|FG004|Overall Study|Death|7|||
161515286|NCT01602315|583277083|FG005|Overall Study|Death|2|||
161588381|NCT01872078|583542406|FG001|Overall Study|Withdrawal by Subject|0|||
161515287|NCT01602315|583277084|FG006|Overall Study|Death|2|||
161515288|NCT01602315|583277078|FG000|Overall Study|Withdrawal by Subject|2|||
161515289|NCT01602315|583277079|FG001|Overall Study|Withdrawal by Subject|0|||
161928885|NCT00601107|584787890|FG003|Overall Study|Undefined|0|||
161928886|NCT03892915|584787891|FG000|Overall Study|Lost to Follow-up|6|||
161928887|NCT03892915|584787892|FG001|Overall Study|Lost to Follow-up|12|||
161928888|NCT03892915|584787891|FG000|Overall Study|Death|0|||
161928889|NCT03892915|584787892|FG001|Overall Study|Death|2|||
161928890|NCT03892915|584787891|FG000|Overall Study|Withdrawal by Subject|1|||
161928891|NCT03892915|584787892|FG001|Overall Study|Withdrawal by Subject|1|||
161928892|NCT03892915|584787891|FG000|Overall Study|unsuccessful delivery|13|||
161928893|NCT03892915|584787892|FG001|Overall Study|unsuccessful delivery|18|||
161928894|NCT01078545|584787902|FG000|Overall Study|Lost to Follow-up|13|||
161928895|NCT01078545|584787902|FG000|Overall Study|Physician Decision|6|||
161928896|NCT01078545|584787902|FG000|Overall Study|Withdrawal by Subject|3|||
161928897|NCT01078545|584787902|FG000|Overall Study|Death|3|||
161928898|NCT01078545|584787902|FG000|Overall Study|Participant moved to another physician|1|||
161928899|NCT03501277|584787911|FG000|Intervention Period 1 (4 Days)|Other|0|||
161928900|NCT03501277|584787912|FG001|Intervention Period 1 (4 Days)|Other|0|||
161928901|NCT03501277|584787913|FG002|Intervention Period 1 (4 Days)|Other|1|||
161928902|NCT03501277|584787914|FG003|Intervention Period 1 (4 Days)|Other|0|||
161928903|NCT03501277|584787911|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
161928904|NCT03501277|584787912|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
161928905|NCT03501277|584787913|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
161928906|NCT03501277|584787914|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
161928907|NCT03501277|584787911|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
161928908|NCT03501277|584787912|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
161928909|NCT03501277|584787913|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
161928910|NCT03501277|584787914|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
161928911|NCT03501277|584787911|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
161928912|NCT03501277|584787912|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
161928913|NCT03501277|584787913|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
161928914|NCT03501277|584787914|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
161928915|NCT01489358|584787915|FG000|Overall Study|Lost to Follow-up|0|||
161928916|NCT01489358|584787916|FG001|Overall Study|Lost to Follow-up|0|||
161928917|NCT01489358|584787917|FG002|Overall Study|Lost to Follow-up|2|||
161928918|NCT01873833|584787918|FG000|Overall Study|Withdrawal by Subject|1|||
161928919|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Adverse Event|14|||
161928920|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Adverse Event|27|||
161928921|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Adverse Event|60|||
161928922|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Adverse Event|0|||
161928923|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Adverse Event|0|||
161928924|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Pregnancy|0|||
161928925|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Pregnancy|7|||
161928926|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Pregnancy|9|||
161928927|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Pregnancy|0|||
161928928|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Pregnancy|0|||
161928929|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
161928930|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
161928931|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
161928932|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
161928933|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
161928934|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
161928935|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
161928936|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
161928937|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
161928938|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
161928939|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Death|1|||
161928940|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Death|2|||
161928941|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Death|2|||
161928942|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Death|0|||
161928943|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Death|0|||
161928944|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
161928945|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
161928946|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
161928947|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
161928948|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
161928949|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
161928950|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
161928951|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
161928952|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
161928953|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
161928954|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
161928955|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
161928956|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
161928957|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
161928958|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
161515290|NCT01602315|583277080|FG002|Overall Study|Withdrawal by Subject|2|||
161515291|NCT01602315|583277081|FG003|Overall Study|Withdrawal by Subject|0|||
161515292|NCT01602315|583277082|FG004|Overall Study|Withdrawal by Subject|6|||
161928959|NCT00098293|584787919|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161515293|NCT01602315|583277083|FG005|Overall Study|Withdrawal by Subject|0|||
161515294|NCT01602315|583277084|FG006|Overall Study|Withdrawal by Subject|1|||
161515295|NCT01602315|583277078|FG000|Overall Study|Adverse Event|5|||
161515296|NCT01602315|583277079|FG001|Overall Study|Adverse Event|1|||
161515297|NCT01602315|583277080|FG002|Overall Study|Adverse Event|5|||
161515298|NCT01602315|583277081|FG003|Overall Study|Adverse Event|4|||
161515299|NCT01602315|583277082|FG004|Overall Study|Adverse Event|15|||
161515300|NCT01602315|583277083|FG005|Overall Study|Adverse Event|3|||
161515301|NCT01602315|583277084|FG006|Overall Study|Adverse Event|9|||
161515302|NCT01602315|583277078|FG000|Overall Study|Subject/guardian decision|0|||
161515303|NCT01602315|583277079|FG001|Overall Study|Subject/guardian decision|0|||
161515304|NCT01602315|583277080|FG002|Overall Study|Subject/guardian decision|0|||
161515305|NCT01602315|583277081|FG003|Overall Study|Subject/guardian decision|0|||
161515306|NCT01602315|583277082|FG004|Overall Study|Subject/guardian decision|0|||
161515307|NCT01602315|583277083|FG005|Overall Study|Subject/guardian decision|0|||
161515308|NCT01602315|583277084|FG006|Overall Study|Subject/guardian decision|1|||
161515309|NCT01602315|583277078|FG000|Overall Study|Cross-over patients to combo treatment|0|||
161515310|NCT01602315|583277079|FG001|Overall Study|Cross-over patients to combo treatment|0|||
161515311|NCT01602315|583277080|FG002|Overall Study|Cross-over patients to combo treatment|0|||
161515312|NCT01602315|583277081|FG003|Overall Study|Cross-over patients to combo treatment|0|||
161515313|NCT01602315|583277082|FG004|Overall Study|Cross-over patients to combo treatment|0|||
161515314|NCT01602315|583277083|FG005|Overall Study|Cross-over patients to combo treatment|16|||
161515315|NCT01602315|583277084|FG006|Overall Study|Cross-over patients to combo treatment|0|||
161515316|NCT02212730|583277087|FG000|Overall Study|Tumor not of the required cell histology|1|||
161515317|NCT02212730|583277088|FG001|Overall Study|Tumor not of the required cell histology|0|||
161515318|NCT02212730|583277087|FG000|Overall Study|Withdrawal by Subject|1|||
161515319|NCT02212730|583277088|FG001|Overall Study|Withdrawal by Subject|0|||
161515320|NCT02212730|583277087|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
161515321|NCT02212730|583277088|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
161515322|NCT00961259|583277089|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
161515323|NCT00961259|583277090|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
161515324|NCT00961259|583277091|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
161515325|NCT02691455|583277094|FG000|Overall Study|Withdrawal by Subject|1|||
161515326|NCT02691455|583277095|FG001|Overall Study|Withdrawal by Subject|2|||
161515327|NCT02691455|583277094|FG000|Overall Study|Lost to Follow-up|15|||
161515328|NCT02691455|583277095|FG001|Overall Study|Lost to Follow-up|15|||
161515329|NCT02057757|583277096|FG000|Overall Study|Withdrawal by Subject|3|||
161515330|NCT02057757|583277097|FG001|Overall Study|Withdrawal by Subject|5|||
161515331|NCT02057757|583277096|FG000|Overall Study|Death|2|||
161515332|NCT02057757|583277097|FG001|Overall Study|Death|0|||
161515333|NCT02057757|583277096|FG000|Overall Study|Lost to Follow-up|8|||
161515334|NCT02057757|583277097|FG001|Overall Study|Lost to Follow-up|3|||
161515335|NCT02057757|583277096|FG000|Overall Study|Non-compliance|1|||
161515336|NCT02057757|583277097|FG001|Overall Study|Non-compliance|0|||
161515337|NCT00440271|583277098|FG000|Overall Study|Protocol Violation|1|||
161515338|NCT00440271|583277099|FG001|Overall Study|Protocol Violation|1|||
161515339|NCT00440271|583277098|FG000|Overall Study|Adverse Event|0|||
161515340|NCT00440271|583277099|FG001|Overall Study|Adverse Event|1|||
161515341|NCT00440271|583277098|FG000|Overall Study|Lost to Follow-up|1|||
161515342|NCT00440271|583277099|FG001|Overall Study|Lost to Follow-up|0|||
161515343|NCT00440271|583277098|FG000|Overall Study|Withdrawal by Subject|0|||
161515344|NCT00440271|583277099|FG001|Overall Study|Withdrawal by Subject|2|||
161515345|NCT00440271|583277098|FG000|Overall Study|Lack of Efficacy|0|||
161515346|NCT00440271|583277099|FG001|Overall Study|Lack of Efficacy|1|||
161515347|NCT00440271|583277098|FG000|Overall Study|Due to closure of trial|8|||
161928960|NCT00098293|584787920|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161928961|NCT00098293|584787921|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
161928962|NCT00098293|584787922|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161928963|NCT00098293|584787923|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161928964|NCT00098293|584787919|FG000|Open-label (OL) Phase|Adverse Event|0|||
161515348|NCT00440271|583277099|FG001|Overall Study|Due to closure of trial|10|||
161515349|NCT00440271|583277098|FG000|Overall Study|Other|2|||
161515350|NCT00440271|583277099|FG001|Overall Study|Other|0|||
161515351|NCT00226941|583277103|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
161515352|NCT00226941|583277104|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
161515353|NCT00226941|583277105|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
161515354|NCT00226941|583277106|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
161588382|NCT01872078|583542407|FG002|Overall Study|Withdrawal by Subject|1|||
161588383|NCT01872078|583542408|FG003|Overall Study|Withdrawal by Subject|0|||
161588384|NCT01872078|583542405|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
161588385|NCT01872078|583542406|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
161588386|NCT01872078|583542407|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
161676830|NCT01241552|583870558|FG003|Overall Study|Lost to Follow-up|16|||
161928965|NCT00098293|584787920|FG001|Open-label (OL) Phase|Adverse Event|3|||
161928966|NCT00098293|584787921|FG002|Open-label (OL) Phase|Adverse Event|7|||
161928967|NCT00098293|584787922|FG003|Open-label (OL) Phase|Adverse Event|6|||
161928968|NCT00098293|584787923|FG004|Open-label (OL) Phase|Adverse Event|0|||
161928969|NCT00098293|584787919|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
161928970|NCT00098293|584787920|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
161928971|NCT00098293|584787921|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
161928972|NCT00098293|584787922|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
161928973|NCT00098293|584787923|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
161588387|NCT01872078|583542408|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
161928974|NCT00098293|584787919|FG000|Open-label (OL) Phase|Pregnancy|0|||
161928975|NCT00098293|584787920|FG001|Open-label (OL) Phase|Pregnancy|1|||
161928976|NCT00098293|584787921|FG002|Open-label (OL) Phase|Pregnancy|0|||
161928977|NCT00098293|584787922|FG003|Open-label (OL) Phase|Pregnancy|3|||
161928978|NCT00098293|584787923|FG004|Open-label (OL) Phase|Pregnancy|0|||
161928979|NCT00098293|584787919|FG000|Open-label (OL) Phase|Protocol Violation|0|||
161928980|NCT00098293|584787920|FG001|Open-label (OL) Phase|Protocol Violation|6|||
161928981|NCT00098293|584787921|FG002|Open-label (OL) Phase|Protocol Violation|13|||
161928982|NCT00098293|584787922|FG003|Open-label (OL) Phase|Protocol Violation|16|||
161928983|NCT00098293|584787923|FG004|Open-label (OL) Phase|Protocol Violation|0|||
161928984|NCT00098293|584787919|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
161928985|NCT00098293|584787920|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
161928986|NCT00098293|584787921|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
161928987|NCT00098293|584787922|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
161928988|NCT00098293|584787923|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
161928989|NCT00098293|584787919|FG000|Open-label (OL) Phase|Death|0|||
161928990|NCT00098293|584787920|FG001|Open-label (OL) Phase|Death|2|||
161928991|NCT00098293|584787921|FG002|Open-label (OL) Phase|Death|3|||
161928992|NCT00098293|584787922|FG003|Open-label (OL) Phase|Death|0|||
161928993|NCT00098293|584787923|FG004|Open-label (OL) Phase|Death|0|||
161588388|NCT01091168|583542409|FG000|Overall Study|Progressive disease|250|||
161588389|NCT01091168|583542410|FG001|Overall Study|Progressive disease|234|||
161588390|NCT01091168|583542409|FG000|Overall Study|Adverse Event|21|||
161588391|NCT01091168|583542410|FG001|Overall Study|Adverse Event|24|||
161588392|NCT01091168|583542409|FG000|Overall Study|Lost to Follow-up|0|||
161588393|NCT01091168|583542410|FG001|Overall Study|Lost to Follow-up|1|||
161588394|NCT01091168|583542409|FG000|Overall Study|Physician, patient's decision, other|27|||
161588395|NCT01091168|583542410|FG001|Overall Study|Physician, patient's decision, other|37|||
161588396|NCT04774237|583542413|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
161588397|NCT04774237|583542414|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
161588398|NCT04774237|583542415|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
161588399|NCT04774237|583542416|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
161588400|NCT04774237|583542417|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
161588401|NCT04774237|583542418|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
161588402|NCT05792423|583542419|FG000|Overall Study|Withdrawal by Subject|2|||
161588403|NCT04052516|583544457|FG000|Overall Study|Withdrawal by Subject|4|||
161588404|NCT04052516|583544458|FG001|Overall Study|Withdrawal by Subject|5|||
161588405|NCT04052516|583544459|FG002|Overall Study|Withdrawal by Subject|6|||
161588406|NCT04052516|583544457|FG000|Overall Study|Adverse Event|3|||
161588407|NCT04052516|583544458|FG001|Overall Study|Adverse Event|2|||
161588408|NCT04052516|583544459|FG002|Overall Study|Adverse Event|8|||
161588409|NCT04052516|583544457|FG000|Overall Study|Lost to Follow-up|2|||
161588410|NCT04052516|583544458|FG001|Overall Study|Lost to Follow-up|5|||
161588411|NCT04052516|583544459|FG002|Overall Study|Lost to Follow-up|3|||
161588412|NCT04052516|583544457|FG000|Overall Study|Protocol Violation|1|||
161588413|NCT04052516|583544458|FG001|Overall Study|Protocol Violation|1|||
161588414|NCT04052516|583544459|FG002|Overall Study|Protocol Violation|0|||
161588415|NCT04052516|583544457|FG000|Overall Study|Death|1|||
161588416|NCT04052516|583544458|FG001|Overall Study|Death|0|||
161588417|NCT04052516|583544459|FG002|Overall Study|Death|0|||
161588418|NCT04052516|583544457|FG000|Overall Study|Physician Decision|0|||
161588419|NCT04052516|583544458|FG001|Overall Study|Physician Decision|1|||
161588420|NCT04052516|583544459|FG002|Overall Study|Physician Decision|0|||
161588421|NCT04052516|583544457|FG000|Overall Study|Pregnancy|1|||
161588422|NCT04052516|583544458|FG001|Overall Study|Pregnancy|0|||
161588423|NCT04052516|583544459|FG002|Overall Study|Pregnancy|0|||
161588424|NCT04052516|583544457|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
161676831|NCT04004429|583870559|FG000|Overall Study|Protocol Violation|1|||
161928994|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Death|0|||
161928995|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Death|0|||
161928996|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Death|0|||
161928997|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Death|0|||
161928998|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Death|1|||
161515355|NCT00226941|583277103|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
161515356|NCT00226941|583277104|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
161515357|NCT00226941|583277105|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
161515358|NCT00226941|583277106|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
161515359|NCT00724451|583277108|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
161515360|NCT00724451|583277108|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
161515361|NCT00724451|583277108|FG000|Overall Study|Not Eligible for Treatment|431|||
161515362|NCT00724451|583277108|FG000|Overall Study|Participant Refused Treatment|89|||
161515363|NCT00724451|583277108|FG000|Overall Study|Never Started Treatment|89|||
161588425|NCT04052516|583544458|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
161588426|NCT04052516|583544459|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
161588427|NCT04052516|583544457|FG000|Overall Study|Reason not recorded|0|||
161588428|NCT04052516|583544458|FG001|Overall Study|Reason not recorded|1|||
161588429|NCT04052516|583544459|FG002|Overall Study|Reason not recorded|0|||
161588430|NCT03747484|583544461|FG000|Overall Study|Lack of Efficacy|0|||
161588431|NCT03747484|583544462|FG001|Overall Study|Lack of Efficacy|1|||
161928999|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929000|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929001|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929002|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929003|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
161929004|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929005|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929006|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929007|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929008|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
161929009|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Other|0|||
161929010|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Other|0|||
161929011|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Other|0|||
161929012|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Other|0|||
161929013|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Other|22|||
161929014|NCT01968785|584787924|FG000|Overall Study|Withdrawal by Subject|1|||
161929015|NCT01968785|584787925|FG001|Overall Study|Withdrawal by Subject|0|||
161929016|NCT01350973|584787930|FG000|Overall Study|Adverse Event|4|||
161929017|NCT01350973|584787931|FG001|Overall Study|Adverse Event|7|||
161929018|NCT01350973|584787932|FG002|Overall Study|Adverse Event|7|||
161929019|NCT01350973|584787930|FG000|Overall Study|Voluntary Withdrawal|2|||
161929020|NCT01350973|584787931|FG001|Overall Study|Voluntary Withdrawal|1|||
161929021|NCT01350973|584787932|FG002|Overall Study|Voluntary Withdrawal|1|||
161929022|NCT03188705|584789740|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
161929023|NCT03188705|584789740|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
161676832|NCT04004429|583870560|FG001|Overall Study|Protocol Violation|0|||
161676833|NCT04004429|583870561|FG002|Overall Study|Protocol Violation|0|||
161676834|NCT04004429|583870559|FG000|Overall Study|Physician Decision|0|||
161676835|NCT04004429|583870560|FG001|Overall Study|Physician Decision|1|||
161822194|NCT02048813|584391040|FG000|Overall Study|Non-protocol therapy|0|||
161822195|NCT02048813|584391041|FG001|Overall Study|Non-protocol therapy|1|||
161822196|NCT02048813|584391040|FG000|Overall Study|Second primary cancer|2|||
161822197|NCT02048813|584391041|FG001|Overall Study|Second primary cancer|0|||
161822198|NCT02048813|584391040|FG000|Overall Study|Insurance|2|||
161822199|NCT02048813|584391041|FG001|Overall Study|Insurance|0|||
161822200|NCT02048813|584391040|FG000|Overall Study|Wound infection/healing|2|||
161822201|NCT02048813|584391041|FG001|Overall Study|Wound infection/healing|0|||
161822202|NCT02048813|584391040|FG000|Overall Study|Missed appointment|3|||
161822203|NCT02048813|584391041|FG001|Overall Study|Missed appointment|0|||
161822204|NCT02048813|584391040|FG000|Overall Study|Never started treatment|2|||
161822205|NCT02048813|584391041|FG001|Overall Study|Never started treatment|17|||
161822206|NCT03314857|584391042|FG000|Overall Study|Death|4|||
161822207|NCT03314857|584391042|FG000|Overall Study|Physician Decision|1|||
161822208|NCT01119625|584391043|FG000|Overall Study|Lost to Follow-up|1|||
161822209|NCT01119625|584391044|FG001|Overall Study|Lost to Follow-up|2|||
161822210|NCT01119625|584391043|FG000|Overall Study|Withdrawal by Subject|2|||
161822211|NCT01119625|584391044|FG001|Overall Study|Withdrawal by Subject|1|||
161822212|NCT01119625|584391043|FG000|Overall Study|Other|0|||
161822213|NCT01119625|584391044|FG001|Overall Study|Other|1|||
161822214|NCT01721772|584391049|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
161822215|NCT01721772|584391050|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
161822216|NCT01721772|584391049|FG000|Pre-Treatment|Poor/non-compliance|0|||
161822217|NCT01721772|584391050|FG001|Pre-Treatment|Poor/non-compliance|1|||
161822218|NCT01721772|584391049|FG000|Pre-Treatment|Participant withdrew consent|0|||
161822219|NCT01721772|584391050|FG001|Pre-Treatment|Participant withdrew consent|1|||
161822220|NCT01721772|584391049|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161822221|NCT01721772|584391050|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
161822222|NCT01721772|584391049|FG000|Treatment|Disease progression|119|||
161822223|NCT01721772|584391050|FG001|Treatment|Disease progression|168|||
161822224|NCT01721772|584391049|FG000|Treatment|Study drug toxicity|19|||
161822225|NCT01721772|584391050|FG001|Treatment|Study drug toxicity|10|||
161822226|NCT01721772|584391049|FG000|Treatment|Adverse event unrelated to study drug|7|||
161822227|NCT01721772|584391050|FG001|Treatment|Adverse event unrelated to study drug|7|||
161822228|NCT01721772|584391049|FG000|Treatment|Maximum clinical benefit|16|||
161822229|NCT01721772|584391050|FG001|Treatment|Maximum clinical benefit|4|||
161822230|NCT01721772|584391049|FG000|Treatment|Other|19|||
161822231|NCT01721772|584391050|FG001|Treatment|Other|2|||
161822232|NCT01721772|584391049|FG000|Treatment|Participant withdrew consent|2|||
161822233|NCT01721772|584391050|FG001|Treatment|Participant withdrew consent|5|||
161822234|NCT01721772|584391049|FG000|Treatment|Participant request to discontinue study treatment|21|||
161822235|NCT01721772|584391050|FG001|Treatment|Participant request to discontinue study treatment|8|||
161822236|NCT01721772|584391049|FG000|Treatment|Death|1|||
161822237|NCT01721772|584391050|FG001|Treatment|Death|0|||
161822238|NCT01721772|584391049|FG000|Treatment|Not reported|1|||
161822239|NCT01721772|584391050|FG001|Treatment|Not reported|0|||
161929024|NCT03156621|584789742|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
161929025|NCT03156621|584789743|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
161676836|NCT04004429|583870561|FG002|Overall Study|Physician Decision|1|||
161676837|NCT04004429|583870559|FG000|Overall Study|Withdrawal by Subject|1|||
161822240|NCT01721772|584391049|FG000|Treatment|Poor/non-compliance|1|||
161822241|NCT01721772|584391050|FG001|Treatment|Poor/non-compliance|0|||
161822242|NCT01721772|584391049|FG000|Treatment|Lost to Follow-up|0|||
161822243|NCT01721772|584391050|FG001|Treatment|Lost to Follow-up|1|||
161822244|NCT02754492|584391051|FG000|Overall Study|Protocol Violation|2|||
161822245|NCT02754492|584391052|FG001|Overall Study|Protocol Violation|2|||
161822246|NCT02754492|584391053|FG002|Overall Study|Protocol Violation|0|||
161822247|NCT02754492|584391054|FG003|Overall Study|Protocol Violation|1|||
161822248|NCT02754492|584391051|FG000|Overall Study|Withdrawal by Subject|2|||
161822249|NCT02754492|584391052|FG001|Overall Study|Withdrawal by Subject|0|||
161822250|NCT02754492|584391053|FG002|Overall Study|Withdrawal by Subject|0|||
161822251|NCT02754492|584391054|FG003|Overall Study|Withdrawal by Subject|0|||
161822252|NCT02754492|584391051|FG000|Overall Study|Equipment malfuntion|0|||
161822253|NCT02754492|584391052|FG001|Overall Study|Equipment malfuntion|0|||
161822254|NCT02754492|584391053|FG002|Overall Study|Equipment malfuntion|2|||
161822255|NCT02754492|584391054|FG003|Overall Study|Equipment malfuntion|5|||
161822256|NCT02754492|584391051|FG000|Overall Study|Adverse Event|0|||
161822257|NCT02754492|584391052|FG001|Overall Study|Adverse Event|0|||
161822258|NCT02754492|584391053|FG002|Overall Study|Adverse Event|0|||
161822259|NCT02754492|584391054|FG003|Overall Study|Adverse Event|13|||
161822260|NCT02754492|584391051|FG000|Overall Study|Venous access issues not resulting in AE|0|||
161822261|NCT02754492|584391052|FG001|Overall Study|Venous access issues not resulting in AE|0|||
161822262|NCT02754492|584391053|FG002|Overall Study|Venous access issues not resulting in AE|0|||
161822263|NCT02754492|584391054|FG003|Overall Study|Venous access issues not resulting in AE|4|||
161822264|NCT01408888|584391055|FG000|First Intervention|Adverse Event|0|||
161822265|NCT01408888|584391056|FG001|First Intervention|Adverse Event|1|||
161822266|NCT01408888|584391055|FG000|First Intervention|Withdrawal by Subject|0|||
161822267|NCT01408888|584391056|FG001|First Intervention|Withdrawal by Subject|2|||
161822268|NCT01408888|584391055|FG000|Second Intervention|Withdrawal by Subject|1|||
161822269|NCT01408888|584391056|FG001|Second Intervention|Withdrawal by Subject|0|||
161822270|NCT01408888|584391055|FG000|Second Intervention|Adverse Event|1|||
161822271|NCT01408888|584391056|FG001|Second Intervention|Adverse Event|0|||
161822272|NCT04542694|584391057|FG000|Overall Study|The need for prohibited therapy|2|||
161822273|NCT04542694|584391058|FG001|Overall Study|The need for prohibited therapy|0|||
161822274|NCT04542694|584391057|FG000|Overall Study|Adverse Event|1|||
161822275|NCT04542694|584391058|FG001|Overall Study|Adverse Event|0|||
161822276|NCT04542694|584391057|FG000|Overall Study|Protocol Violation|1|||
161822277|NCT04542694|584391058|FG001|Overall Study|Protocol Violation|0|||
161822278|NCT04633642|584391061|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
161822279|NCT04633642|584391062|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
161822280|NCT05387408|584391063|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
161822281|NCT00397254|584391064|FG000|Overall Study|Lost to Follow-up|2|||
161822282|NCT00397254|584391065|FG001|Overall Study|Lost to Follow-up|2|||
161822283|NCT00152451|584391071|FG000|Overall Study|Adverse Event|4|||
161822284|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
161822285|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
161822286|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
161822287|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
161515364|NCT00724451|583277108|FG000|Overall Study|Unknown; No Data Sources Available|9|||
161515365|NCT00724451|583277108|FG000|Overall Study|Physician Decision|116|||
161515366|NCT00724451|583277108|FG000|Overall Study|Withdrawal by Subject|45|||
161515367|NCT00724451|583277108|FG000|Overall Study|Investigator + Participant Decision|13|||
161515368|NCT00414050|583277110|FG000|Overall Study|Adverse Event|1|||
161515369|NCT00414050|583277111|FG001|Overall Study|Adverse Event|1|||
161515370|NCT00414050|583277112|FG002|Overall Study|Adverse Event|1|||
161515371|NCT00414050|583277113|FG003|Overall Study|Adverse Event|1|||
161515372|NCT00414050|583277110|FG000|Overall Study|Lost to Follow-up|2|||
161515373|NCT00414050|583277111|FG001|Overall Study|Lost to Follow-up|2|||
161515374|NCT00414050|583277112|FG002|Overall Study|Lost to Follow-up|1|||
161515375|NCT00414050|583277113|FG003|Overall Study|Lost to Follow-up|1|||
161515376|NCT00414050|583277110|FG000|Overall Study|Withdrawal by Subject|5|||
161515377|NCT00414050|583277111|FG001|Overall Study|Withdrawal by Subject|3|||
161515378|NCT00414050|583277112|FG002|Overall Study|Withdrawal by Subject|2|||
161515379|NCT00414050|583277113|FG003|Overall Study|Withdrawal by Subject|4|||
161515380|NCT00414050|583277110|FG000|Overall Study|Subject discontinued for other reason|1|||
161822288|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
161822289|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
161822290|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
161822291|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
161822292|NCT00323258|584391074|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
161822293|NCT00323258|584391075|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
161676838|NCT04004429|583870560|FG001|Overall Study|Withdrawal by Subject|1|||
161929026|NCT03156621|584789742|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161929027|NCT03156621|584789743|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
161929028|NCT03016403|584789746|FG000|Baseline|Death|5|||
161929029|NCT03016403|584789747|FG001|Baseline|Death|8|||
161929030|NCT03016403|584789748|FG002|Baseline|Death|1|||
161929031|NCT03016403|584789749|FG003|Baseline|Death|0|||
161929032|NCT03016403|584789746|FG000|Baseline|Withdrawal by Subject|2|||
161676839|NCT04004429|583870561|FG002|Overall Study|Withdrawal by Subject|1|||
161676840|NCT00718549|583870562|FG000|Induction Phase|Disease Progression|1|||
161676841|NCT00718549|583870563|FG001|Induction Phase|Disease Progression|0|||
161676842|NCT00718549|583870564|FG002|Induction Phase|Disease Progression|0|||
161676843|NCT00718549|583870562|FG000|Induction Phase|Eligibility Criteria Violation|2|||
161676844|NCT00718549|583870563|FG001|Induction Phase|Eligibility Criteria Violation|0|||
161676845|NCT00718549|583870564|FG002|Induction Phase|Eligibility Criteria Violation|0|||
161676846|NCT00718549|583870562|FG000|Induction Phase|Early Termination - No Additional Info|59|||
161676847|NCT00718549|583870563|FG001|Induction Phase|Early Termination - No Additional Info|0|||
161676848|NCT00718549|583870564|FG002|Induction Phase|Early Termination - No Additional Info|0|||
161676849|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
161676850|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
161676851|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
161676852|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Death|0|||
161676853|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Death|1|||
161676854|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Death|2|||
161929033|NCT03016403|584789747|FG001|Baseline|Withdrawal by Subject|8|||
161929034|NCT03016403|584789748|FG002|Baseline|Withdrawal by Subject|4|||
161929035|NCT03016403|584789749|FG003|Baseline|Withdrawal by Subject|10|||
161929036|NCT03016403|584789746|FG000|Baseline|Lost to Follow-up|9|||
161929037|NCT03016403|584789747|FG001|Baseline|Lost to Follow-up|11|||
161929038|NCT03016403|584789748|FG002|Baseline|Lost to Follow-up|6|||
161929039|NCT03016403|584789749|FG003|Baseline|Lost to Follow-up|24|||
161929040|NCT03016403|584789746|FG000|6-week Follow-up|Death|1|||
161929041|NCT03016403|584789747|FG001|6-week Follow-up|Death|4|||
161929042|NCT03016403|584789748|FG002|6-week Follow-up|Death|0|||
161929043|NCT03016403|584789749|FG003|6-week Follow-up|Death|0|||
161929044|NCT03016403|584789746|FG000|6-week Follow-up|Lost to Follow-up|2|||
161929045|NCT03016403|584789747|FG001|6-week Follow-up|Lost to Follow-up|7|||
161929046|NCT03016403|584789748|FG002|6-week Follow-up|Lost to Follow-up|4|||
161929047|NCT03016403|584789749|FG003|6-week Follow-up|Lost to Follow-up|8|||
161929048|NCT03016403|584789746|FG000|6-week Follow-up|Withdrawal by Subject|0|||
161929049|NCT03016403|584789747|FG001|6-week Follow-up|Withdrawal by Subject|2|||
161929050|NCT03016403|584789748|FG002|6-week Follow-up|Withdrawal by Subject|0|||
161929051|NCT03016403|584789749|FG003|6-week Follow-up|Withdrawal by Subject|1|||
161929052|NCT03016403|584789746|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
161929053|NCT03016403|584789747|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
161929054|NCT03016403|584789748|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
161929055|NCT03016403|584789749|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
161929056|NCT03016403|584789746|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
161929057|NCT03016403|584789747|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
161929058|NCT03016403|584789748|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
161929059|NCT03016403|584789749|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
161929060|NCT03016403|584789746|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161929061|NCT03016403|584789747|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161929062|NCT03016403|584789748|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161929063|NCT03016403|584789749|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
161929064|NCT00799864|584789750|FG000|Overall Study|Participant reached a virologic endpoint|9|||
161929065|NCT00799864|584789751|FG001|Overall Study|Participant reached a virologic endpoint|2|||
161929066|NCT00799864|584789752|FG002|Overall Study|Participant reached a virologic endpoint|2|||
161929067|NCT00799864|584789753|FG003|Overall Study|Participant reached a virologic endpoint|0|||
161676855|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
161929068|NCT00799864|584789754|FG004|Overall Study|Participant reached a virologic endpoint|0|||
161929069|NCT00799864|584789750|FG000|Overall Study|Other|2|||
161929070|NCT00799864|584789751|FG001|Overall Study|Other|1|||
161929071|NCT00799864|584789752|FG002|Overall Study|Other|0|||
161929072|NCT00799864|584789753|FG003|Overall Study|Other|0|||
161929073|NCT00799864|584789754|FG004|Overall Study|Other|0|||
161929074|NCT00225758|584789755|FG000|Overall Study|Adverse Event|4|||
161929075|NCT00576407|584789756|FG000|Overall Study|Death|7|||
161929076|NCT00576407|584789756|FG000|Overall Study|Physician Decision|1|||
161929077|NCT04641975|584789757|FG000|Overall Study|Protocol Violation|1|||
161929078|NCT04641975|584789758|FG001|Overall Study|Protocol Violation|2|||
161929079|NCT04641975|584789759|FG002|Overall Study|Protocol Violation|0|||
161929080|NCT04641975|584789760|FG003|Overall Study|Protocol Violation|0|||
161929081|NCT04641975|584789757|FG000|Overall Study|Adverse Event|0|||
161929082|NCT04641975|584789758|FG001|Overall Study|Adverse Event|0|||
161929083|NCT04641975|584789759|FG002|Overall Study|Adverse Event|1|||
161929084|NCT04641975|584789760|FG003|Overall Study|Adverse Event|1|||
161929085|NCT04641975|584789757|FG000|Overall Study|Withdrawal by Subject|1|||
161929086|NCT04641975|584789758|FG001|Overall Study|Withdrawal by Subject|0|||
161929087|NCT04641975|584789759|FG002|Overall Study|Withdrawal by Subject|0|||
161929088|NCT04641975|584789760|FG003|Overall Study|Withdrawal by Subject|0|||
161929089|NCT01259024|584789761|FG000|Overall Study|Physician Decision|1|||
161929090|NCT01657500|584789762|FG000|Overall Study|set impropperly matched|3|||
161929091|NCT01657500|584789763|FG001|Overall Study|set impropperly matched|3|||
161929092|NCT01657500|584789762|FG000|Overall Study|Lost to Follow-up|2|||
161929093|NCT01657500|584789763|FG001|Overall Study|Lost to Follow-up|2|||
161929094|NCT03142334|584789764|FG000|Overall Study|Death|18|||
161929095|NCT03142334|584789765|FG001|Overall Study|Death|33|||
161929096|NCT03142334|584789764|FG000|Overall Study|Withdrawal by Subject|15|||
161929097|NCT03142334|584789765|FG001|Overall Study|Withdrawal by Subject|11|||
161929098|NCT03142334|584789764|FG000|Overall Study|Ongoing on trial follow up|463|||
161929099|NCT03142334|584789765|FG001|Overall Study|Ongoing on trial follow up|454|||
161929100|NCT01217047|584789766|FG000|Overall Study|Lost to Follow-up|0|||
161929101|NCT01217047|584789767|FG001|Overall Study|Lost to Follow-up|1|||
161929102|NCT01217047|584789768|FG002|Overall Study|Lost to Follow-up|0|||
161929103|NCT03528577|584789771|FG000|Sequence 1|Failed Spirometry|1|||
161929104|NCT03528577|584789771|FG000|Sequence 1|Restricted medication|1|||
161929105|NCT03528577|584789771|FG000|Sequence 2|Adverse Event|1|||
161929106|NCT03528577|584789771|FG000|Sequence 2|Withdrawal by Subject|1|||
161929107|NCT03528577|584789771|FG000|Sequence 2|Failed Spirometry|1|||
161929108|NCT03528577|584789771|FG000|Sequence 3|Failed Spirometry|1|||
161929109|NCT03528577|584789771|FG000|Sequence 4|Failed Spirometry|2|||
161929110|NCT03528577|584789771|FG000|Sequence 4|Adverse Event|1|||
161929111|NCT03835117|584789772|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
161929112|NCT03835117|584789773|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
161929113|NCT03225989|584789777|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
161929114|NCT03225989|584789778|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
161929115|NCT03225989|584789779|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
161588432|NCT03747484|583544463|FG002|Overall Study|Lack of Efficacy|1|||
161588433|NCT03747484|583544464|FG003|Overall Study|Lack of Efficacy|2|||
161588434|NCT03747484|583544465|FG004|Overall Study|Lack of Efficacy|2|||
161588435|NCT05062265|583544470|FG000|Overall Study|Withdrawal by Subject|1|||
161588436|NCT05062265|583544471|FG001|Overall Study|Withdrawal by Subject|0|||
161588437|NCT03101904|583544475|FG000|Wash Out (10 Days)|Adverse Event|1|||
161588438|NCT03101904|583544476|FG001|Wash Out (10 Days)|Adverse Event|0|||
161588439|NCT03101904|583544475|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
161588440|NCT03101904|583544476|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
161588441|NCT04538417|583544477|FG000|Overall Study|Withdrawal by Subject|2|||
161588442|NCT01331005|583544479|FG000|Overall Study|Lost to Follow-up|2|||
161588443|NCT01331005|583544480|FG001|Overall Study|Lost to Follow-up|1|||
161588444|NCT01331005|583544479|FG000|Overall Study|Withdrawal by Subject|2|||
161588445|NCT01331005|583544480|FG001|Overall Study|Withdrawal by Subject|3|||
161588446|NCT03161379|583544481|FG000|Overall Study|Withdrawal by Subject|4|||
161588447|NCT03161379|583544481|FG000|Overall Study|disease progression during chemotherapy|5|||
161588448|NCT03161379|583544481|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
161588449|NCT03161379|583544481|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
161588450|NCT03393975|583544483|FG000|Urgent Treatment Period|Physician Decision|0|||
161588451|NCT03393975|583544484|FG001|Urgent Treatment Period|Physician Decision|0|||
161588452|NCT03393975|583544485|FG002|Urgent Treatment Period|Physician Decision|0|||
161588453|NCT03393975|583544486|FG003|Urgent Treatment Period|Physician Decision|1|||
161588454|NCT03393975|583544483|FG000|Prophylaxis Period 1|Reason not Specified|0|||
161588455|NCT03393975|583544484|FG001|Prophylaxis Period 1|Reason not Specified|1|||
161588456|NCT03393975|583544485|FG002|Prophylaxis Period 1|Reason not Specified|0|||
161929116|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
161929117|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
161929118|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
161588457|NCT03393975|583544486|FG003|Prophylaxis Period 1|Reason not Specified|0|||
161929119|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
161929120|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
161929121|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
161588458|NCT03393975|583544483|FG000|Prophylaxis Period 2|Reason not Specified|0|||
161588459|NCT03393975|583544484|FG001|Prophylaxis Period 2|Reason not Specified|1|||
161588460|NCT03393975|583544485|FG002|Prophylaxis Period 2|Reason not Specified|0|||
161588461|NCT03393975|583544486|FG003|Prophylaxis Period 2|Reason not Specified|0|||
161588462|NCT01140880|583544490|FG000|Overall Study|Death|0|||
161588463|NCT01140880|583544491|FG001|Overall Study|Death|1|||
161929122|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
161929123|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
161929124|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
161929125|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
161929126|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
161929127|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
161929128|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
161929129|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
161929130|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
161929131|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
161929132|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
161929133|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
161929134|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
161929135|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
161929136|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
161929137|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
161929138|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
161929139|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
161929140|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
161929141|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
161929142|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
161929143|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
161929144|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
161929145|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
161929146|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
161929147|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
161929148|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
161929149|NCT03093870|584789783|FG000|Overall Study|Withdrawal by Subject|2|||
161929150|NCT03093870|584789784|FG001|Overall Study|Withdrawal by Subject|6|||
161929151|NCT03093870|584789785|FG002|Overall Study|Withdrawal by Subject|5|||
161929152|NCT03093870|584789783|FG000|Overall Study|Death|1|||
161929153|NCT03093870|584789784|FG001|Overall Study|Death|35|||
161929154|NCT03093870|584789785|FG002|Overall Study|Death|35|||
161929155|NCT03093870|584789783|FG000|Overall Study|Radiographic disease progression|10|||
161929156|NCT03093870|584789784|FG001|Overall Study|Radiographic disease progression|0|||
161929157|NCT03093870|584789785|FG002|Overall Study|Radiographic disease progression|0|||
161929158|NCT03093870|584789783|FG000|Overall Study|Clinical disease progression|1|||
161929159|NCT03093870|584789784|FG001|Overall Study|Clinical disease progression|0|||
161929160|NCT03093870|584789785|FG002|Overall Study|Clinical disease progression|0|||
161515381|NCT00414050|583277111|FG001|Overall Study|Subject discontinued for other reason|2|||
161515382|NCT00414050|583277112|FG002|Overall Study|Subject discontinued for other reason|2|||
161515383|NCT00414050|583277113|FG003|Overall Study|Subject discontinued for other reason|1|||
161515384|NCT00414050|583277110|FG000|Overall Study|Subject Moved|0|||
161515385|NCT00414050|583277111|FG001|Overall Study|Subject Moved|0|||
161515386|NCT00414050|583277112|FG002|Overall Study|Subject Moved|0|||
161515387|NCT00414050|583277113|FG003|Overall Study|Subject Moved|1|||
161515388|NCT02550652|583277120|FG000|Overall Study|Death|1|||
161515389|NCT02550652|583277121|FG001|Overall Study|Death|4|||
161515390|NCT02550652|583277120|FG000|Overall Study|Lack of Efficacy|1|||
161515391|NCT02550652|583277121|FG001|Overall Study|Lack of Efficacy|0|||
161515392|NCT02550652|583277120|FG000|Overall Study|Withdrawal by Subject|4|||
161515393|NCT02550652|583277121|FG001|Overall Study|Withdrawal by Subject|7|||
161515394|NCT02550652|583277120|FG000|Overall Study|Post Trial Access|1|||
161515395|NCT02550652|583277121|FG001|Overall Study|Post Trial Access|0|||
161515396|NCT02550652|583277120|FG000|Overall Study|Lost to Follow-up|1|||
161515397|NCT02550652|583277121|FG001|Overall Study|Lost to Follow-up|3|||
161515398|NCT02550652|583277120|FG000|Overall Study|Physician Decision|0|||
161515399|NCT02550652|583277121|FG001|Overall Study|Physician Decision|2|||
161515400|NCT02550652|583277120|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
161515401|NCT02550652|583277121|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
161515402|NCT01706250|583277122|FG000|Overall Study|Lost to Follow-up|2|||
161515403|NCT00515827|583277128|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
161929161|NCT03093870|584789783|FG000|Overall Study|Physician Decision|2|||
161929162|NCT03093870|584789784|FG001|Overall Study|Physician Decision|0|||
161515404|NCT00515827|583277129|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
161515405|NCT00515827|583277128|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
161515406|NCT00515827|583277129|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
161515407|NCT03254134|583277131|FG000|Overall Study|Not eligible patients|599|||
161515408|NCT03254134|583277132|FG001|Overall Study|Not eligible patients|3630|||
161515409|NCT00205712|583277133|FG000|Overall Study|Lost to Follow-up|0|||
161515410|NCT00205712|583277134|FG001|Overall Study|Lost to Follow-up|1|||
161515411|NCT01009099|583277135|FG000|Overall Study|Lost to Follow-up|1|||
161515412|NCT01009099|583277136|FG001|Overall Study|Lost to Follow-up|0|||
161822294|NCT00323258|584391074|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
161822295|NCT00323258|584391075|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
161822296|NCT00323258|584391074|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
161822297|NCT00323258|584391075|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
161515413|NCT01009099|583277135|FG000|Overall Study|Physician Decision|3|||
161515414|NCT01009099|583277136|FG001|Overall Study|Physician Decision|2|||
161515415|NCT01009099|583277135|FG000|Overall Study|Withdrawal by Subject|1|||
161515416|NCT01009099|583277136|FG001|Overall Study|Withdrawal by Subject|1|||
161515417|NCT01009099|583277135|FG000|Overall Study|Death|0|||
161515418|NCT01009099|583277136|FG001|Overall Study|Death|1|||
161515419|NCT01712984|583277137|FG000|Overall Study|Adverse Event|0|||
161515420|NCT01712984|583277138|FG001|Overall Study|Adverse Event|0|||
161515421|NCT01712984|583277139|FG002|Overall Study|Adverse Event|1|||
161822298|NCT04473326|584391080|FG000|Overall Study|Death|0|||
161822299|NCT04473326|584391081|FG001|Overall Study|Death|1|||
161822300|NCT04473326|584391080|FG000|Overall Study|Withdrawal by Subject|1|||
161822301|NCT04473326|584391081|FG001|Overall Study|Withdrawal by Subject|2|||
161822302|NCT02046122|584391082|FG000|Overall Study|Physician Decision|8|||
161822303|NCT02046122|584391082|FG000|Overall Study|Withdrawal by Subject|1|||
161822304|NCT01097694|584391087|FG000|Overall Study|Adverse Event|5|||
161822305|NCT01097694|584391088|FG001|Overall Study|Adverse Event|0|||
161822306|NCT01097694|584391087|FG000|Overall Study|Lost to Follow-up|0|||
161822307|NCT01097694|584391088|FG001|Overall Study|Lost to Follow-up|3|||
161822308|NCT01097694|584391087|FG000|Overall Study|Withdrawal by Subject|3|||
161822309|NCT01097694|584391088|FG001|Overall Study|Withdrawal by Subject|1|||
161822310|NCT00668395|584391090|FG000|Overall Study|Withdrawal by Subject|4|||
161822311|NCT00668395|584391091|FG001|Overall Study|Withdrawal by Subject|4|||
161822312|NCT00668395|584391092|FG002|Overall Study|Withdrawal by Subject|1|||
161822313|NCT00668395|584391090|FG000|Overall Study|Adverse Event|1|||
161822314|NCT00668395|584391091|FG001|Overall Study|Adverse Event|1|||
161822315|NCT00668395|584391092|FG002|Overall Study|Adverse Event|0|||
161822316|NCT00668395|584391090|FG000|Overall Study|Physician Decision|1|||
161822317|NCT00668395|584391091|FG001|Overall Study|Physician Decision|1|||
161822318|NCT00668395|584391092|FG002|Overall Study|Physician Decision|0|||
161822319|NCT04164758|584391093|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
161822320|NCT04164758|584391094|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
161822321|NCT04164758|584391095|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
161822322|NCT04164758|584391093|FG000|Overall Study|Adverse Event|0|||
161822323|NCT04164758|584391094|FG001|Overall Study|Adverse Event|1|||
161822324|NCT04164758|584391095|FG002|Overall Study|Adverse Event|0|||
161822325|NCT03259165|584391096|FG000|Overall Study|COVID 19 pandemic|1|||
161822326|NCT03259165|584391097|FG001|Overall Study|COVID 19 pandemic|1|||
161822327|NCT01567527|584391100|FG000|Conversion Phase.|Protocol deviation|3|||
161822328|NCT01567527|584391101|FG001|Conversion Phase.|Protocol deviation|0|||
161822329|NCT01567527|584391102|FG002|Conversion Phase.|Protocol deviation|0|||
161822330|NCT01567527|584391103|FG003|Conversion Phase.|Protocol deviation|0|||
161822331|NCT01567527|584391104|FG004|Conversion Phase.|Protocol deviation|0|||
161822332|NCT01567527|584391100|FG000|Conversion Phase.|Met withdrawal criteria|10|||
161822333|NCT01567527|584391101|FG001|Conversion Phase.|Met withdrawal criteria|0|||
161822334|NCT01567527|584391102|FG002|Conversion Phase.|Met withdrawal criteria|0|||
161822335|NCT01567527|584391103|FG003|Conversion Phase.|Met withdrawal criteria|0|||
161822336|NCT01567527|584391104|FG004|Conversion Phase.|Met withdrawal criteria|0|||
161822337|NCT01567527|584391100|FG000|Conversion Phase.|Withdrawal by Subject|32|||
161822338|NCT01567527|584391101|FG001|Conversion Phase.|Withdrawal by Subject|0|||
161822339|NCT01567527|584391102|FG002|Conversion Phase.|Withdrawal by Subject|0|||
161822340|NCT01567527|584391103|FG003|Conversion Phase.|Withdrawal by Subject|0|||
161822341|NCT01567527|584391104|FG004|Conversion Phase.|Withdrawal by Subject|0|||
161822342|NCT01567527|584391100|FG000|Conversion Phase.|Lost to Follow-up|16|||
161929163|NCT03093870|584789785|FG002|Overall Study|Physician Decision|0|||
161515422|NCT01712984|583277137|FG000|Overall Study|Protocol Violation|2|||
161515423|NCT01712984|583277138|FG001|Overall Study|Protocol Violation|0|||
161515424|NCT01712984|583277139|FG002|Overall Study|Protocol Violation|1|||
161588464|NCT01140880|583544490|FG000|Overall Study|Withdrawal by Subject|6|||
161588465|NCT01140880|583544491|FG001|Overall Study|Withdrawal by Subject|3|||
161588466|NCT01140880|583544490|FG000|Overall Study|Lost to Follow-up|8|||
161588467|NCT01140880|583544491|FG001|Overall Study|Lost to Follow-up|10|||
161588468|NCT01140880|583544490|FG000|Overall Study|Protocol Violation|0|||
161822343|NCT01567527|584391101|FG001|Conversion Phase.|Lost to Follow-up|0|||
161822344|NCT01567527|584391102|FG002|Conversion Phase.|Lost to Follow-up|0|||
161822345|NCT01567527|584391103|FG003|Conversion Phase.|Lost to Follow-up|0|||
161822346|NCT01567527|584391104|FG004|Conversion Phase.|Lost to Follow-up|0|||
161822347|NCT01567527|584391100|FG000|Conversion Phase.|Lack of Efficacy|2|||
161822348|NCT01567527|584391101|FG001|Conversion Phase.|Lack of Efficacy|0|||
161822349|NCT01567527|584391102|FG002|Conversion Phase.|Lack of Efficacy|0|||
161822350|NCT01567527|584391103|FG003|Conversion Phase.|Lack of Efficacy|0|||
161822351|NCT01567527|584391104|FG004|Conversion Phase.|Lack of Efficacy|0|||
161929164|NCT03093870|584789783|FG000|Overall Study|Adverse Event|7|||
161929165|NCT03093870|584789784|FG001|Overall Study|Adverse Event|0|||
161929166|NCT03093870|584789785|FG002|Overall Study|Adverse Event|0|||
161929167|NCT03093870|584789783|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
161929168|NCT03093870|584789784|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
161929169|NCT03093870|584789785|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
161929170|NCT03093870|584789783|FG000|Overall Study|Lost to Follow-up|0|||
161929171|NCT03093870|584789784|FG001|Overall Study|Lost to Follow-up|0|||
161929172|NCT03093870|584789785|FG002|Overall Study|Lost to Follow-up|1|||
161929173|NCT01530997|584789786|FG000|Overall Study|Physician Decision|1|||
161929174|NCT01530997|584789786|FG000|Overall Study|Withdrawal by Subject|1|||
161929175|NCT02318277|584789788|FG000|Overall Study|Physician Decision|0|||
161929176|NCT02318277|584789789|FG001|Overall Study|Physician Decision|0|||
161929177|NCT02318277|584789790|FG002|Overall Study|Physician Decision|0|||
161929178|NCT02318277|584789791|FG003|Overall Study|Physician Decision|0|||
161929179|NCT02318277|584789792|FG004|Overall Study|Physician Decision|0|||
161929180|NCT02318277|584789793|FG005|Overall Study|Physician Decision|0|||
161929181|NCT02318277|584789794|FG006|Overall Study|Physician Decision|0|||
161929182|NCT02318277|584789795|FG007|Overall Study|Physician Decision|1|||
161929183|NCT02318277|584789788|FG000|Overall Study|Other|0|||
161929184|NCT02318277|584789789|FG001|Overall Study|Other|0|||
161929185|NCT02318277|584789790|FG002|Overall Study|Other|0|||
161929186|NCT02318277|584789791|FG003|Overall Study|Other|0|||
161515425|NCT01712984|583277137|FG000|Overall Study|Lost to Follow-up|8|||
161515426|NCT01712984|583277138|FG001|Overall Study|Lost to Follow-up|10|||
161929187|NCT02318277|584789792|FG004|Overall Study|Other|0|||
161929188|NCT02318277|584789793|FG005|Overall Study|Other|0|||
161929189|NCT02318277|584789794|FG006|Overall Study|Other|1|||
161929190|NCT02318277|584789795|FG007|Overall Study|Other|0|||
161929191|NCT02318277|584789788|FG000|Overall Study|Withdrawal by Subject|0|||
161929192|NCT02318277|584789789|FG001|Overall Study|Withdrawal by Subject|0|||
161929193|NCT02318277|584789790|FG002|Overall Study|Withdrawal by Subject|1|||
161929194|NCT02318277|584789791|FG003|Overall Study|Withdrawal by Subject|0|||
161929195|NCT02318277|584789792|FG004|Overall Study|Withdrawal by Subject|1|||
161929196|NCT02318277|584789793|FG005|Overall Study|Withdrawal by Subject|1|||
161929197|NCT02318277|584789794|FG006|Overall Study|Withdrawal by Subject|6|||
161929198|NCT02318277|584789795|FG007|Overall Study|Withdrawal by Subject|14|||
161929199|NCT02318277|584789788|FG000|Overall Study|Participant trial terminated by sponsor|0|||
161929200|NCT02318277|584789789|FG001|Overall Study|Participant trial terminated by sponsor|0|||
161929201|NCT02318277|584789790|FG002|Overall Study|Participant trial terminated by sponsor|1|||
161929202|NCT02318277|584789791|FG003|Overall Study|Participant trial terminated by sponsor|0|||
161929203|NCT02318277|584789792|FG004|Overall Study|Participant trial terminated by sponsor|1|||
161929204|NCT02318277|584789793|FG005|Overall Study|Participant trial terminated by sponsor|2|||
161929205|NCT02318277|584789794|FG006|Overall Study|Participant trial terminated by sponsor|5|||
161929206|NCT02318277|584789795|FG007|Overall Study|Participant trial terminated by sponsor|16|||
161929207|NCT02318277|584789788|FG000|Overall Study|Lost to Follow-up|1|||
161929208|NCT02318277|584789789|FG001|Overall Study|Lost to Follow-up|0|||
161929209|NCT02318277|584789790|FG002|Overall Study|Lost to Follow-up|1|||
161929210|NCT02318277|584789791|FG003|Overall Study|Lost to Follow-up|0|||
161929211|NCT02318277|584789792|FG004|Overall Study|Lost to Follow-up|0|||
161929212|NCT02318277|584789793|FG005|Overall Study|Lost to Follow-up|0|||
161929213|NCT02318277|584789794|FG006|Overall Study|Lost to Follow-up|3|||
161929214|NCT02318277|584789795|FG007|Overall Study|Lost to Follow-up|4|||
161929215|NCT02318277|584789788|FG000|Overall Study|Death|5|||
161929216|NCT02318277|584789789|FG001|Overall Study|Death|3|||
161929217|NCT02318277|584789790|FG002|Overall Study|Death|1|||
161929218|NCT02318277|584789791|FG003|Overall Study|Death|4|||
161515427|NCT01712984|583277139|FG002|Overall Study|Lost to Follow-up|1|||
161515428|NCT01712984|583277137|FG000|Overall Study|Withdrawal by Subject|6|||
161515429|NCT01712984|583277138|FG001|Overall Study|Withdrawal by Subject|6|||
161515430|NCT01712984|583277139|FG002|Overall Study|Withdrawal by Subject|7|||
161515431|NCT00096044|583277142|FG000|Overall Study|Withdrawal by Subject|9|||
161515432|NCT00096044|583277142|FG000|Overall Study|Adverse Event|21|||
161515433|NCT00096044|583277142|FG000|Overall Study|Disease Progression|4|||
161515434|NCT03149237|583277143|FG000|Overall Study|Withdrawal by Subject|4|||
161515435|NCT03149237|583277144|FG001|Overall Study|Withdrawal by Subject|5|||
161515436|NCT02442830|583277145|FG000|Overall Study|Technical Failure|0|||
161929219|NCT02318277|584789792|FG004|Overall Study|Death|6|||
161929220|NCT02318277|584789793|FG005|Overall Study|Death|5|||
161515437|NCT02442830|583277146|FG001|Overall Study|Technical Failure|1|||
161515438|NCT04587193|583277147|FG000|Overall Study|Screen failure after consent|3|||
161515439|NCT04587193|583277148|FG001|Overall Study|Screen failure after consent|0|||
161929221|NCT02318277|584789794|FG006|Overall Study|Death|34|||
161929222|NCT02318277|584789795|FG007|Overall Study|Death|58|||
161929223|NCT02318277|584789788|FG000|Overall Study|Transitioned to Hospice|0|||
161588469|NCT01140880|583544491|FG001|Overall Study|Protocol Violation|30|||
161515440|NCT04587193|583277147|FG000|Overall Study|Device broke during study|3|||
161515441|NCT04587193|583277148|FG001|Overall Study|Device broke during study|2|||
161515442|NCT00508742|583277149|FG000|Period 1: Infant Series|Adverse Event|5|||
161515443|NCT00508742|583277150|FG001|Period 1: Infant Series|Adverse Event|4|||
161515444|NCT00508742|583277149|FG000|Period 1: Infant Series|Protocol Violation|1|||
161515445|NCT00508742|583277150|FG001|Period 1: Infant Series|Protocol Violation|0|||
161515446|NCT00508742|583277149|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
161515447|NCT00508742|583277150|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
161515448|NCT00508742|583277149|FG000|Period 1: Infant Series|Physician Decision|1|||
161515449|NCT00508742|583277150|FG001|Period 1: Infant Series|Physician Decision|0|||
161588470|NCT03779204|583544492|FG000|Overall Study|Lost to Follow-up|2|||
161588471|NCT03779204|583544493|FG001|Overall Study|Lost to Follow-up|0|||
161588472|NCT04258709|583544494|FG000|Overall Study|Lost to Follow-up|10|||
161588473|NCT04258709|583544495|FG001|Overall Study|Lost to Follow-up|4|||
161822352|NCT01567527|584391100|FG000|Conversion Phase.|Adverse Event|33|||
161822353|NCT01567527|584391101|FG001|Conversion Phase.|Adverse Event|0|||
161822354|NCT01567527|584391102|FG002|Conversion Phase.|Adverse Event|0|||
161822355|NCT01567527|584391103|FG003|Conversion Phase.|Adverse Event|0|||
161822356|NCT01567527|584391104|FG004|Conversion Phase.|Adverse Event|0|||
161822357|NCT01567527|584391100|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
161822358|NCT01567527|584391101|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
161822359|NCT01567527|584391102|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
161822360|NCT01567527|584391103|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
161822361|NCT01567527|584391104|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
161822362|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822363|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
161822364|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822365|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822366|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822367|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822368|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
161822369|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822370|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822371|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822372|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822373|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
161822374|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822375|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822376|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822377|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822378|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
161822379|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822380|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822381|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822382|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822383|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
161822384|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822385|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822386|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822387|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822388|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
161822389|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822390|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822391|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822392|NCT01567527|584391100|FG000|IM Depot Stabilization.|Protocol deviation|0|||
161822393|NCT01567527|584391101|FG001|IM Depot Stabilization.|Protocol deviation|0|||
161822394|NCT01567527|584391102|FG002|IM Depot Stabilization.|Protocol deviation|5|||
161822395|NCT01567527|584391103|FG003|IM Depot Stabilization.|Protocol deviation|0|||
161822396|NCT01567527|584391104|FG004|IM Depot Stabilization.|Protocol deviation|0|||
161822397|NCT01567527|584391100|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
161822398|NCT01567527|584391101|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
161822399|NCT01567527|584391102|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
161822400|NCT01567527|584391103|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
161929224|NCT02318277|584789789|FG001|Overall Study|Transitioned to Hospice|0|||
161929225|NCT02318277|584789790|FG002|Overall Study|Transitioned to Hospice|0|||
161929226|NCT02318277|584789791|FG003|Overall Study|Transitioned to Hospice|0|||
161929227|NCT02318277|584789792|FG004|Overall Study|Transitioned to Hospice|0|||
161929228|NCT02318277|584789793|FG005|Overall Study|Transitioned to Hospice|1|||
161929229|NCT02318277|584789794|FG006|Overall Study|Transitioned to Hospice|0|||
161929230|NCT02318277|584789795|FG007|Overall Study|Transitioned to Hospice|0|||
161929231|NCT03364686|584789796|FG000|Overall Study|Physician Decision|2|||
161929232|NCT01520714|584789797|FG000|Overall Study|Protocol Violation|0|||
161929233|NCT01520714|584789798|FG001|Overall Study|Protocol Violation|3|||
161929234|NCT01520714|584789797|FG000|Overall Study|Adverse Event|0|||
161515450|NCT00508742|583277149|FG000|Period 1: Infant Series|Other|4|||
161515451|NCT00508742|583277150|FG001|Period 1: Infant Series|Other|1|||
161515452|NCT00508742|583277149|FG000|Period 2: After Infant Series|Adverse Event|2|||
161515453|NCT00508742|583277150|FG001|Period 2: After Infant Series|Adverse Event|6|||
161515454|NCT00508742|583277149|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
161515455|NCT00508742|583277150|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
161515456|NCT00508742|583277149|FG000|Period 2: After Infant Series|Protocol Violation|1|||
161515457|NCT00508742|583277150|FG001|Period 2: After Infant Series|Protocol Violation|0|||
161515458|NCT00508742|583277149|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
161515459|NCT00508742|583277150|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
161515460|NCT00508742|583277149|FG000|Period 2: After Infant Series|Failed to Return|1|||
161515461|NCT00508742|583277150|FG001|Period 2: After Infant Series|Failed to Return|0|||
161515462|NCT00508742|583277149|FG000|Period 2: After Infant Series|Other|2|||
161515463|NCT00508742|583277150|FG001|Period 2: After Infant Series|Other|1|||
161515464|NCT00508742|583277149|FG000|Period 3: Toddler Dose|Adverse Event|1|||
161515465|NCT00508742|583277150|FG001|Period 3: Toddler Dose|Adverse Event|0|||
161515466|NCT00508742|583277149|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
161515467|NCT00508742|583277150|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
161515468|NCT00508742|583277149|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
161515469|NCT00508742|583277150|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
161515470|NCT00508742|583277149|FG000|Period 3: Toddler Dose|Other|5|||
161515471|NCT00508742|583277150|FG001|Period 3: Toddler Dose|Other|4|||
161515472|NCT02501096|583277151|FG000|Overall Study|Lost to Follow-up|0|||
161515473|NCT02501096|583277152|FG001|Overall Study|Lost to Follow-up|0|||
161515474|NCT02501096|583277153|FG002|Overall Study|Lost to Follow-up|0|||
161676856|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
161929235|NCT01520714|584789798|FG001|Overall Study|Adverse Event|2|||
161929236|NCT01520714|584789797|FG000|Overall Study|Lack of Efficacy|0|||
161929237|NCT01520714|584789798|FG001|Overall Study|Lack of Efficacy|1|||
161929238|NCT01478087|584789802|FG000|Overall Study|due to sponsor closing study|1|||
161929239|NCT03566550|584789803|FG000|Overall Study|Withdrawal by Subject|0|||
161929240|NCT03566550|584789804|FG001|Overall Study|Withdrawal by Subject|1|||
161929241|NCT03518203|584789806|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
161929242|NCT03518203|584789806|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
161929243|NCT02829957|584789807|FG000|Overall Study|Lost to Follow-up|2|||
161929244|NCT02829957|584789808|FG001|Overall Study|Lost to Follow-up|1|||
161515475|NCT02501096|583277154|FG003|Overall Study|Lost to Follow-up|0|||
161515476|NCT02501096|583277155|FG004|Overall Study|Lost to Follow-up|1|||
161515477|NCT02501096|583277156|FG005|Overall Study|Lost to Follow-up|1|||
161515478|NCT02501096|583277157|FG006|Overall Study|Lost to Follow-up|3|||
161515479|NCT02501096|583277158|FG007|Overall Study|Lost to Follow-up|0|||
161515480|NCT02501096|583277159|FG008|Overall Study|Lost to Follow-up|0|||
161515481|NCT02501096|583277151|FG000|Overall Study|Withdrawal by Subject|1|||
161515482|NCT02501096|583277152|FG001|Overall Study|Withdrawal by Subject|0|||
161515483|NCT02501096|583277153|FG002|Overall Study|Withdrawal by Subject|7|||
161515484|NCT02501096|583277154|FG003|Overall Study|Withdrawal by Subject|13|||
161515485|NCT02501096|583277155|FG004|Overall Study|Withdrawal by Subject|2|||
161515486|NCT02501096|583277156|FG005|Overall Study|Withdrawal by Subject|2|||
161515487|NCT02501096|583277157|FG006|Overall Study|Withdrawal by Subject|2|||
161515488|NCT02501096|583277158|FG007|Overall Study|Withdrawal by Subject|3|||
161515489|NCT02501096|583277159|FG008|Overall Study|Withdrawal by Subject|0|||
161515490|NCT02501096|583277151|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
161515491|NCT02501096|583277152|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
161515492|NCT02501096|583277153|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
161515493|NCT02501096|583277154|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
161515494|NCT02501096|583277155|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
161515495|NCT02501096|583277156|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
161515496|NCT02501096|583277157|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
161515497|NCT02501096|583277158|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
161515498|NCT02501096|583277159|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
161515499|NCT02501096|583277151|FG000|Overall Study|Death|1|||
161515500|NCT02501096|583277152|FG001|Overall Study|Death|1|||
161676857|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
161676858|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Progression|0|||
161676859|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Progression|5|||
161676860|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Progression|14|||
161676861|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Relapse|0|||
161676862|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Relapse|3|||
161676863|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Relapse|2|||
161676864|NCT02606461|583870565|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676865|NCT02606461|583870566|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676866|NCT02606461|583870567|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
161676867|NCT02606461|583870568|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676868|NCT02606461|583870569|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676869|NCT02606461|583870570|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676870|NCT00239226|583870571|FG000|Overall Study|permAF during stabilization period|0|||
161676871|NCT00239226|583870572|FG001|Overall Study|permAF during stabilization period|0|||
161676872|NCT00239226|583870573|FG002|Overall Study|permAF during stabilization period|0|||
161676873|NCT00239226|583870574|FG003|Overall Study|permAF during stabilization period|3|||
161676874|NCT00239226|583870571|FG000|Overall Study|Lost to Follow-up|1|||
161676875|NCT00239226|583870572|FG001|Overall Study|Lost to Follow-up|0|||
161676876|NCT00239226|583870573|FG002|Overall Study|Lost to Follow-up|1|||
161929245|NCT03511066|584789810|FG000|Overall Study|Withdrawal by Subject|1|||
161929246|NCT03511066|584789811|FG001|Overall Study|Withdrawal by Subject|2|||
161929247|NCT03511066|584789812|FG002|Overall Study|Withdrawal by Subject|3|||
161929248|NCT03511066|584789810|FG000|Overall Study|Lost to Follow-up|2|||
161929249|NCT03511066|584789811|FG001|Overall Study|Lost to Follow-up|3|||
161929250|NCT03511066|584789812|FG002|Overall Study|Lost to Follow-up|0|||
161929251|NCT04146909|584789813|FG000|Overall Study|Withdrawal by Subject|3|||
161929252|NCT04146909|584789813|FG000|Overall Study|Did not qualify after consented|1|||
161929253|NCT00345592|584789814|FG000|Overall Study|Death|14|||
161929254|NCT00345592|584789815|FG001|Overall Study|Death|16|||
161929255|NCT00345592|584789814|FG000|Overall Study|Withdrawal by Subject|11|||
161929256|NCT00345592|584789815|FG001|Overall Study|Withdrawal by Subject|8|||
161929257|NCT03467945|584789820|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161929258|NCT03467945|584789821|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161929259|NCT03467945|584789822|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161929260|NCT03467945|584789823|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161929261|NCT03467945|584789820|FG000|Treatment Period 3|Withdrawal by Subject|1|||
161929262|NCT03467945|584789821|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161929263|NCT03467945|584789822|FG002|Treatment Period 3|Withdrawal by Subject|2|||
161929264|NCT03467945|584789823|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161929265|NCT03336866|584789838|FG000|Overall Study|Lost to Follow-up|2|||
161929266|NCT03336866|584789839|FG001|Overall Study|Lost to Follow-up|0|||
161929267|NCT03336866|584789840|FG002|Overall Study|Lost to Follow-up|3|||
161929268|NCT03336866|584789838|FG000|Overall Study|Withdrawal by Subject|1|||
161929269|NCT03336866|584789839|FG001|Overall Study|Withdrawal by Subject|1|||
161929270|NCT03336866|584789840|FG002|Overall Study|Withdrawal by Subject|0|||
161929271|NCT03336866|584789838|FG000|Overall Study|Noncompliance with clinic house rules|0|||
161929272|NCT03336866|584789839|FG001|Overall Study|Noncompliance with clinic house rules|0|||
161929273|NCT03336866|584789840|FG002|Overall Study|Noncompliance with clinic house rules|1|||
161929274|NCT00032487|584789841|FG000|Overall Study|Withdrawal by Subject|67|||
161929275|NCT00032487|584789842|FG001|Overall Study|Withdrawal by Subject|43|||
161929276|NCT00032487|584789841|FG000|Overall Study|Adverse Event|3|||
161929277|NCT00032487|584789842|FG001|Overall Study|Adverse Event|7|||
161929278|NCT00032487|584789841|FG000|Overall Study|Lost to Follow-up|57|||
161929279|NCT00032487|584789842|FG001|Overall Study|Lost to Follow-up|58|||
161929280|NCT00032487|584789841|FG000|Overall Study|Had other reason|12|||
161929281|NCT00032487|584789842|FG001|Overall Study|Had other reason|12|||
161929282|NCT02218268|584789843|FG000|24 Hour Washout|Physician Decision|11|||
161929283|NCT02218268|584789844|FG001|24 Hour Washout|Physician Decision|9|||
161929284|NCT03651336|584789845|FG000|Overall Study|Withdrawal by Subject|4|||
161929285|NCT01341990|584789846|FG000|Overall Study|Adverse Event|0|||
161929286|NCT01341990|584789847|FG001|Overall Study|Adverse Event|1|||
161929287|NCT01341990|584789846|FG000|Overall Study|Torn Study Lens|1|||
161929288|NCT01341990|584789847|FG001|Overall Study|Torn Study Lens|0|||
161929289|NCT01341990|584789846|FG000|Overall Study|Withdrawal by Subject|2|||
161929290|NCT01341990|584789847|FG001|Overall Study|Withdrawal by Subject|0|||
161929291|NCT01125748|584789849|FG000|Overall Study|Adverse Event|0|||
161929292|NCT01125748|584789850|FG001|Overall Study|Adverse Event|2|||
161929293|NCT01125748|584789849|FG000|Overall Study|Lost to Follow-up|0|||
161929294|NCT01125748|584789850|FG001|Overall Study|Lost to Follow-up|1|||
161929295|NCT01125748|584789849|FG000|Overall Study|Physician Decision|8|||
161929296|NCT01125748|584789850|FG001|Overall Study|Physician Decision|7|||
161929297|NCT01125748|584789849|FG000|Overall Study|Patient Decision to Withdraw|2|||
161929298|NCT01125748|584789850|FG001|Overall Study|Patient Decision to Withdraw|4|||
161929299|NCT01028391|584789851|FG000|Overall Study|Adverse Event|4|||
161929300|NCT01028391|584789852|FG001|Overall Study|Adverse Event|0|||
161929301|NCT01028391|584789851|FG000|Overall Study|Lack of Efficacy|0|||
161929302|NCT01028391|584789852|FG001|Overall Study|Lack of Efficacy|2|||
161929303|NCT01028391|584789851|FG000|Overall Study|Lost to Follow-up|3|||
161929304|NCT01028391|584789852|FG001|Overall Study|Lost to Follow-up|4|||
161929305|NCT01028391|584789851|FG000|Overall Study|Physician Decision|0|||
161929306|NCT01028391|584789852|FG001|Overall Study|Physician Decision|1|||
161929307|NCT01028391|584789851|FG000|Overall Study|Withdrawal by Subject|6|||
161929308|NCT01028391|584789852|FG001|Overall Study|Withdrawal by Subject|3|||
161929309|NCT01028391|584789851|FG000|Overall Study|Needed excluded medication|1|||
161929310|NCT01028391|584789852|FG001|Overall Study|Needed excluded medication|1|||
161929311|NCT01107457|584789853|FG000|Part A|Adverse Event|1|||
161929312|NCT01107457|584789854|FG001|Part A|Adverse Event|2|||
161929313|NCT01107457|584789855|FG002|Part A|Adverse Event|1|||
161929314|NCT01107457|584789856|FG003|Part A|Adverse Event|0|||
161929315|NCT01107457|584789857|FG004|Part A|Adverse Event|0|||
161929316|NCT01107457|584789858|FG005|Part A|Adverse Event|0|||
161929317|NCT01107457|584789853|FG000|Part A|Withdrawal by Subject|3|||
161929318|NCT01107457|584789854|FG001|Part A|Withdrawal by Subject|3|||
161929319|NCT01107457|584789855|FG002|Part A|Withdrawal by Subject|0|||
161929320|NCT01107457|584789856|FG003|Part A|Withdrawal by Subject|3|||
161929321|NCT01107457|584789857|FG004|Part A|Withdrawal by Subject|1|||
161929322|NCT01107457|584789858|FG005|Part A|Withdrawal by Subject|0|||
161929323|NCT01107457|584789853|FG000|Part A|Lost to Follow-up|0|||
161929324|NCT01107457|584789854|FG001|Part A|Lost to Follow-up|1|||
161929325|NCT01107457|584789855|FG002|Part A|Lost to Follow-up|0|||
161929326|NCT01107457|584789856|FG003|Part A|Lost to Follow-up|0|||
161929327|NCT01107457|584789857|FG004|Part A|Lost to Follow-up|0|||
161929328|NCT01107457|584789858|FG005|Part A|Lost to Follow-up|0|||
161929329|NCT01107457|584789853|FG000|Part A|Lack of Efficacy|1|||
161929330|NCT01107457|584789854|FG001|Part A|Lack of Efficacy|0|||
161929331|NCT01107457|584789855|FG002|Part A|Lack of Efficacy|0|||
161929332|NCT01107457|584789856|FG003|Part A|Lack of Efficacy|0|||
161929333|NCT01107457|584789857|FG004|Part A|Lack of Efficacy|0|||
161929334|NCT01107457|584789858|FG005|Part A|Lack of Efficacy|0|||
161929335|NCT01107457|584789853|FG000|Part A|Protocol Violation|0|||
161929336|NCT01107457|584789854|FG001|Part A|Protocol Violation|1|||
161929337|NCT01107457|584789855|FG002|Part A|Protocol Violation|0|||
161929338|NCT01107457|584789856|FG003|Part A|Protocol Violation|0|||
161929339|NCT01107457|584789857|FG004|Part A|Protocol Violation|0|||
161929340|NCT01107457|584789858|FG005|Part A|Protocol Violation|0|||
161929341|NCT01107457|584789853|FG000|Part B and C|Adverse Event|0|||
161929342|NCT01107457|584789854|FG001|Part B and C|Adverse Event|0|||
161929343|NCT01107457|584789855|FG002|Part B and C|Adverse Event|0|||
161515501|NCT02501096|583277153|FG002|Overall Study|Death|88|||
161676877|NCT00239226|583870574|FG003|Overall Study|Lost to Follow-up|0|||
161929344|NCT01107457|584789856|FG003|Part B and C|Adverse Event|0|||
161929345|NCT01107457|584789857|FG004|Part B and C|Adverse Event|0|||
161929346|NCT01107457|584789858|FG005|Part B and C|Adverse Event|12|||
161929347|NCT01107457|584789853|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929348|NCT01107457|584789854|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929349|NCT01107457|584789855|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929350|NCT01107457|584789856|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929351|NCT01107457|584789857|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929352|NCT01107457|584789858|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
161929353|NCT01107457|584789853|FG000|Part B and C|Physician Decision|0|||
161929354|NCT01107457|584789854|FG001|Part B and C|Physician Decision|0|||
161929355|NCT01107457|584789855|FG002|Part B and C|Physician Decision|0|||
161929356|NCT01107457|584789856|FG003|Part B and C|Physician Decision|0|||
161929357|NCT01107457|584789857|FG004|Part B and C|Physician Decision|0|||
161515502|NCT02501096|583277154|FG003|Overall Study|Death|74|||
161676878|NCT01303965|583870576|FG000|Overall Study|Adverse Event|1|||
161929358|NCT01107457|584789858|FG005|Part B and C|Physician Decision|3|||
161929359|NCT01107457|584789853|FG000|Part B and C|Lack of Efficacy|0|||
161929360|NCT01107457|584789854|FG001|Part B and C|Lack of Efficacy|0|||
161929361|NCT01107457|584789855|FG002|Part B and C|Lack of Efficacy|0|||
161929362|NCT01107457|584789856|FG003|Part B and C|Lack of Efficacy|0|||
161929363|NCT01107457|584789857|FG004|Part B and C|Lack of Efficacy|0|||
161929364|NCT01107457|584789858|FG005|Part B and C|Lack of Efficacy|7|||
161929365|NCT01107457|584789853|FG000|Part B and C|Lost to Follow-up|0|||
161676879|NCT01303965|583870577|FG001|Overall Study|Adverse Event|1|||
161929366|NCT01107457|584789854|FG001|Part B and C|Lost to Follow-up|0|||
161929367|NCT01107457|584789855|FG002|Part B and C|Lost to Follow-up|0|||
161929368|NCT01107457|584789856|FG003|Part B and C|Lost to Follow-up|0|||
161929369|NCT01107457|584789857|FG004|Part B and C|Lost to Follow-up|0|||
161929370|NCT01107457|584789858|FG005|Part B and C|Lost to Follow-up|10|||
161929371|NCT01107457|584789853|FG000|Part B and C|Protocol Violation|0|||
161676880|NCT01303965|583870576|FG000|Overall Study|Death|0|||
161929372|NCT01107457|584789854|FG001|Part B and C|Protocol Violation|0|||
161929373|NCT01107457|584789855|FG002|Part B and C|Protocol Violation|0|||
161929374|NCT01107457|584789856|FG003|Part B and C|Protocol Violation|0|||
161929375|NCT01107457|584789857|FG004|Part B and C|Protocol Violation|0|||
161515503|NCT02501096|583277155|FG004|Overall Study|Death|15|||
161515504|NCT02501096|583277156|FG005|Overall Study|Death|16|||
161822401|NCT01567527|584391104|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
161822402|NCT01567527|584391100|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822403|NCT01567527|584391101|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822404|NCT01567527|584391102|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
161515505|NCT02501096|583277157|FG006|Overall Study|Death|15|||
161515506|NCT02501096|583277158|FG007|Overall Study|Death|16|||
161515507|NCT02501096|583277159|FG008|Overall Study|Death|1|||
161515508|NCT00437034|583277160|FG000|Overall Study|Adverse Event|1|||
161515509|NCT00437034|583277160|FG000|Overall Study|Disease progression during treatment|5|||
161515510|NCT00595582|583277161|FG000|Overall Study|Pilot study that PI terminated|2|||
161515511|NCT00595582|583277161|FG000|Overall Study|Lost to Follow-up|1|||
161515512|NCT00595582|583277161|FG000|Overall Study|Adverse Event|2|||
161515513|NCT00595582|583277161|FG000|Overall Study|Physician Decision|5|||
161515514|NCT03878134|583277162|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
161515515|NCT00586469|583277163|FG000|Overall Study|Adverse Event|0|||
161515516|NCT00586469|583277164|FG001|Overall Study|Adverse Event|1|||
161515517|NCT04055116|583277165|FG000|First Intervention|Physician Decision|2|||
161515518|NCT04055116|583277166|FG001|First Intervention|Physician Decision|7|||
161515519|NCT01978184|583277167|FG000|Overall Study|Progressive disease|5|||
161515520|NCT01978184|583277168|FG001|Overall Study|Progressive disease|5|||
161515521|NCT01978184|583277167|FG000|Overall Study|Other than PDA|2|||
161515522|NCT01978184|583277168|FG001|Overall Study|Other than PDA|2|||
161515523|NCT01978184|583277167|FG000|Overall Study|Physician Decision|0|||
161929376|NCT01107457|584789858|FG005|Part B and C|Protocol Violation|1|||
161929377|NCT01107457|584789853|FG000|Part B and C|Sponsor Decision|0|||
161515524|NCT01978184|583277168|FG001|Overall Study|Physician Decision|3|||
161515525|NCT01978184|583277167|FG000|Overall Study|Noncompliance|1|||
161515526|NCT01978184|583277168|FG001|Overall Study|Noncompliance|2|||
161515527|NCT01978184|583277167|FG000|Overall Study|Death|1|||
161515528|NCT01978184|583277168|FG001|Overall Study|Death|0|||
161515529|NCT01978184|583277167|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
161515530|NCT01978184|583277168|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
161515531|NCT02770391|583277169|FG000|Overall Study|Lost to Follow-up|2|||
161515532|NCT02770391|583277169|FG000|Overall Study|Withdrawal by Subject|1|||
161515533|NCT02770391|583277169|FG000|Overall Study|Surgery delayed unevaluable|2|||
161515534|NCT02770391|583277169|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
161515535|NCT01976845|583277172|FG000|Overall Study|Physician Decision|8|||
161515536|NCT01976845|583277173|FG001|Overall Study|Physician Decision|8|||
161515537|NCT01976845|583277174|FG002|Overall Study|Physician Decision|3|||
161515538|NCT04258839|583278433|FG000|Overall Study|Adverse Event|2|||
161515539|NCT04258839|583278434|FG001|Overall Study|Adverse Event|4|||
161515540|NCT04258839|583278433|FG000|Overall Study|Lack of Efficacy|0|||
161515541|NCT04258839|583278434|FG001|Overall Study|Lack of Efficacy|2|||
161515542|NCT04258839|583278433|FG000|Overall Study|Lost to Follow-up|2|||
161515543|NCT04258839|583278434|FG001|Overall Study|Lost to Follow-up|0|||
161822405|NCT01567527|584391103|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822406|NCT01567527|584391104|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822407|NCT01567527|584391100|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822408|NCT01567527|584391101|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822409|NCT01567527|584391102|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
161822410|NCT01567527|584391103|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822411|NCT01567527|584391104|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822412|NCT01567527|584391100|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
161822413|NCT01567527|584391101|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
161822414|NCT01567527|584391102|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
161822415|NCT01567527|584391103|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
161822416|NCT01567527|584391104|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
161822417|NCT01567527|584391100|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
161822418|NCT01567527|584391101|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
161822419|NCT01567527|584391102|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
161822420|NCT01567527|584391103|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
161822421|NCT01567527|584391104|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
161929378|NCT01107457|584789854|FG001|Part B and C|Sponsor Decision|0|||
161515544|NCT04258839|583278433|FG000|Overall Study|Withdrawal by Subject|1|||
161515545|NCT04258839|583278434|FG001|Overall Study|Withdrawal by Subject|2|||
161515546|NCT04258839|583278433|FG000|Overall Study|Withdrawal by Caregiver|5|||
161822422|NCT01567527|584391100|FG000|IM Depot Stabilization.|Adverse Event|0|||
161822423|NCT01567527|584391101|FG001|IM Depot Stabilization.|Adverse Event|0|||
161515547|NCT04258839|583278434|FG001|Overall Study|Withdrawal by Caregiver|6|||
161515548|NCT04258839|583278433|FG000|Overall Study|Reason not Specified|0|||
161515549|NCT04258839|583278434|FG001|Overall Study|Reason not Specified|1|||
161515550|NCT03328897|583278435|FG000|Randomized-treatment Epoch|Adverse Event|4|||
161822424|NCT01567527|584391102|FG002|IM Depot Stabilization.|Adverse Event|37|||
161822425|NCT01567527|584391103|FG003|IM Depot Stabilization.|Adverse Event|0|||
161929379|NCT01107457|584789855|FG002|Part B and C|Sponsor Decision|0|||
161929380|NCT01107457|584789856|FG003|Part B and C|Sponsor Decision|0|||
161929381|NCT01107457|584789857|FG004|Part B and C|Sponsor Decision|0|||
161929382|NCT01107457|584789858|FG005|Part B and C|Sponsor Decision|66|||
161929383|NCT01107457|584789853|FG000|Part B and C|Withdrawal by Subject|0|||
161929384|NCT01107457|584789854|FG001|Part B and C|Withdrawal by Subject|0|||
161929385|NCT01107457|584789855|FG002|Part B and C|Withdrawal by Subject|0|||
161929386|NCT01107457|584789856|FG003|Part B and C|Withdrawal by Subject|0|||
161929387|NCT01107457|584789857|FG004|Part B and C|Withdrawal by Subject|0|||
161929388|NCT01107457|584789858|FG005|Part B and C|Withdrawal by Subject|16|||
161929389|NCT01107457|584789853|FG000|Part B and C|Clinical Relapse|0|||
161929390|NCT01107457|584789854|FG001|Part B and C|Clinical Relapse|0|||
161929391|NCT01107457|584789855|FG002|Part B and C|Clinical Relapse|0|||
161929392|NCT01107457|584789856|FG003|Part B and C|Clinical Relapse|0|||
161929393|NCT01107457|584789857|FG004|Part B and C|Clinical Relapse|0|||
161929394|NCT01107457|584789858|FG005|Part B and C|Clinical Relapse|4|||
161929395|NCT00694161|584789859|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
161929396|NCT00694161|584789859|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
161929397|NCT00694161|584789859|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
161929398|NCT03601052|584789860|FG000|Overall Study|Lost to Follow-up|2|||
161929399|NCT01227395|584789861|FG000|Overall Study|Protocol Violation|0|||
161515551|NCT03328897|583278436|FG001|Randomized-treatment Epoch|Adverse Event|1|||
161515552|NCT03328897|583278437|FG002|Randomized-treatment Epoch|Adverse Event|1|||
161515553|NCT03328897|583278435|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
161515554|NCT03328897|583278436|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
161515555|NCT03328897|583278437|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
161515556|NCT03328897|583278435|FG000|Randomized-treatment Epoch|Pregnancy|3|||
161515557|NCT03328897|583278436|FG001|Randomized-treatment Epoch|Pregnancy|0|||
161515558|NCT03328897|583278437|FG002|Randomized-treatment Epoch|Pregnancy|0|||
161515559|NCT03328897|583278435|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
161515560|NCT03328897|583278436|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
161515561|NCT03328897|583278437|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
161515562|NCT03328897|583278435|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
161515563|NCT03328897|583278436|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
161515564|NCT03328897|583278437|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
161515565|NCT03328897|583278435|FG000|Follow-up Epoch|Adverse Event|4|||
161515566|NCT03328897|583278436|FG001|Follow-up Epoch|Adverse Event|0|||
161515567|NCT03328897|583278437|FG002|Follow-up Epoch|Adverse Event|1|||
161515568|NCT03328897|583278435|FG000|Follow-up Epoch|Lack of Efficacy|1|||
161929400|NCT01227395|584789862|FG001|Overall Study|Protocol Violation|1|||
161929401|NCT00105508|584789863|FG000|Overall Study|Prephase Dropout|1|||
161929402|NCT00105508|584789864|FG001|Overall Study|Prephase Dropout|0|||
161929403|NCT00105508|584789863|FG000|Overall Study|Adverse Event|16|||
161929404|NCT00105508|584789864|FG001|Overall Study|Adverse Event|19|||
161929405|NCT00105508|584789863|FG000|Overall Study|Insufficient Efficacy|1|||
161929406|NCT00105508|584789864|FG001|Overall Study|Insufficient Efficacy|0|||
161929407|NCT00105508|584789863|FG000|Overall Study|Withdrawal by Subject|10|||
161929408|NCT00105508|584789864|FG001|Overall Study|Withdrawal by Subject|6|||
161929409|NCT00105508|584789863|FG000|Overall Study|Lost to Follow-up|3|||
161929410|NCT00105508|584789864|FG001|Overall Study|Lost to Follow-up|0|||
161929411|NCT00105508|584789863|FG000|Overall Study|Protocol Violation|1|||
161929412|NCT00105508|584789864|FG001|Overall Study|Protocol Violation|2|||
161929413|NCT00105508|584789863|FG000|Overall Study|Other|8|||
161929414|NCT00105508|584789864|FG001|Overall Study|Other|9|||
161929415|NCT00683384|584789865|FG000|Overall Study|Death|1|||
161929416|NCT00683384|584789865|FG000|Overall Study|Adverse Event|1|||
161929417|NCT00120874|584789866|FG000|Overall Study|Death|0|||
161929418|NCT00120874|584789867|FG001|Overall Study|Death|1|||
161929419|NCT01108055|584789868|FG000|Overall Study|Ineligible|11|||
161929420|NCT01108055|584789868|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
161515569|NCT03328897|583278436|FG001|Follow-up Epoch|Lack of Efficacy|1|||
161929421|NCT01348490|584789871|FG000|Overall Study|Death|1|||
161929422|NCT01348490|584789871|FG000|Overall Study|Adverse Event|3|||
161929423|NCT01348490|584789871|FG000|Overall Study|Consent withdrawn|7|||
161929424|NCT01348490|584789871|FG000|Overall Study|Disease progression|3|||
161929425|NCT01348490|584789871|FG000|Overall Study|Lost to Follow-up|1|||
161929426|NCT01348490|584789871|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
161515570|NCT03328897|583278437|FG002|Follow-up Epoch|Lack of Efficacy|1|||
161515571|NCT03328897|583278435|FG000|Follow-up Epoch|Lost to Follow-up|0|||
161515572|NCT03328897|583278436|FG001|Follow-up Epoch|Lost to Follow-up|1|||
161929427|NCT01348490|584789871|FG000|Overall Study|Other Unspecified|8|||
161929428|NCT03632720|584789872|FG000|Overall Study|Adverse Event|2|||
161929429|NCT03632720|584789873|FG001|Overall Study|Adverse Event|0|||
161929430|NCT03632720|584789874|FG002|Overall Study|Adverse Event|0|||
161929431|NCT03632720|584789872|FG000|Overall Study|Lost to Follow-up|0|||
161515573|NCT03328897|583278437|FG002|Follow-up Epoch|Lost to Follow-up|0|||
161515574|NCT03328897|583278435|FG000|Follow-up Epoch|Pregnancy|1|||
161515575|NCT03328897|583278436|FG001|Follow-up Epoch|Pregnancy|0|||
161515576|NCT03328897|583278437|FG002|Follow-up Epoch|Pregnancy|0|||
161515577|NCT03328897|583278435|FG000|Follow-up Epoch|Patient/guardian decision|2|||
161515578|NCT03328897|583278436|FG001|Follow-up Epoch|Patient/guardian decision|1|||
161515579|NCT03328897|583278437|FG002|Follow-up Epoch|Patient/guardian decision|0|||
161515580|NCT00317772|583278439|FG000|Overall Study|Adverse Event|0|||
161515581|NCT00317772|583278440|FG001|Overall Study|Adverse Event|0|||
161515582|NCT00317772|583278441|FG002|Overall Study|Adverse Event|0|||
161515583|NCT00317772|583278442|FG003|Overall Study|Adverse Event|2|||
161515584|NCT00317772|583278439|FG000|Overall Study|Disease Progression|2|||
161515585|NCT00317772|583278440|FG001|Overall Study|Disease Progression|2|||
161515586|NCT00317772|583278441|FG002|Overall Study|Disease Progression|1|||
161515587|NCT00317772|583278442|FG003|Overall Study|Disease Progression|7|||
161515588|NCT00966940|583278443|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
161515589|NCT00966940|583278444|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
161515590|NCT00966940|583278443|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
161822426|NCT01567527|584391104|FG004|IM Depot Stabilization.|Adverse Event|0|||
161822427|NCT01567527|584391100|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822428|NCT01567527|584391101|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822429|NCT01567527|584391102|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
161822430|NCT01567527|584391103|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822431|NCT01567527|584391104|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822432|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161822433|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161822434|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161822435|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
161822436|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
161822437|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161822438|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161822439|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161822440|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
161822441|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
161822442|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161822443|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161822444|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161822445|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
161822446|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
161822447|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161822448|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161822449|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161822450|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
161822451|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
161822452|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161822453|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161822454|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161822455|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
161822456|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
161822457|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161822458|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161822459|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161822460|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
161822461|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
161822462|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161822463|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161822464|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161822465|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
161822466|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
161929432|NCT03632720|584789873|FG001|Overall Study|Lost to Follow-up|1|||
161929433|NCT03632720|584789874|FG002|Overall Study|Lost to Follow-up|0|||
161515591|NCT00966940|583278444|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
161515592|NCT01040871|583278447|FG000|Overall Study|Adverse Event|6|||
161515593|NCT01040871|583278448|FG001|Overall Study|Adverse Event|2|||
161515594|NCT01040871|583278447|FG000|Overall Study|Withdrawal by Subject|2|||
161515595|NCT01040871|583278448|FG001|Overall Study|Withdrawal by Subject|0|||
161929434|NCT03632720|584789872|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
161929435|NCT03632720|584789873|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
161929436|NCT03632720|584789874|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
161929437|NCT03632720|584789872|FG000|Overall Study|Screen failure|0|||
161929438|NCT03632720|584789873|FG001|Overall Study|Screen failure|1|||
161929439|NCT03632720|584789874|FG002|Overall Study|Screen failure|0|||
161929440|NCT01049828|584789875|FG000|Overall Study|Claustrophibia and Frustration|2|||
161929441|NCT02015104|584789876|FG000|Overall Study|Withdrew consent after first dose drug|1|||
161929442|NCT02015104|584789877|FG001|Overall Study|Withdrew consent after first dose drug|0|||
161929443|NCT02015104|584789876|FG000|Overall Study|Withdrew consent prior to treatment|0|||
161929444|NCT02015104|584789877|FG001|Overall Study|Withdrew consent prior to treatment|1|||
161929445|NCT03011372|584789878|FG000|Overall Study|Death|16|||
161929446|NCT03011372|584789878|FG000|Overall Study|Lost to Follow-up|2|||
161929447|NCT03011372|584789878|FG000|Overall Study|Sponsor Decision|17|||
161929448|NCT03011372|584789878|FG000|Overall Study|Withdrawal by Subject|7|||
161929449|NCT03011372|584789878|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
161929450|NCT03011372|584789878|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
161929451|NCT03011372|584789878|FG000|Overall Study|Sponsor's Decision|2|||
161929452|NCT03572218|584789879|FG000|Overall Study|Lost to Follow-up|3|||
161929453|NCT03572218|584789880|FG001|Overall Study|Lost to Follow-up|2|||
161929454|NCT03572218|584789879|FG000|Overall Study|No longer available for study visits|2|||
161929455|NCT03572218|584789880|FG001|Overall Study|No longer available for study visits|1|||
161929456|NCT03572218|584789879|FG000|Overall Study|No longer interested|1|||
161929457|NCT03572218|584789880|FG001|Overall Study|No longer interested|2|||
161929458|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161929459|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
161929460|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161929461|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
161929462|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
161929463|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161929464|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
161929465|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
161929466|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
161929467|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
161929468|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
161929469|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
161929470|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
161929471|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161929472|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161929473|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161929474|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161929475|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
161929476|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
161588474|NCT04258709|583544494|FG000|Overall Study|Withdrawal by Subject|1|||
161588475|NCT04258709|583544495|FG001|Overall Study|Withdrawal by Subject|0|||
161588476|NCT04258709|583544494|FG000|Overall Study|Fetal demise|0|||
161929477|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
161929478|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
161929479|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
161929480|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
161929481|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
161929482|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
161929483|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
161929484|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
161929485|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
161929486|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
161929487|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
161929488|NCT00853047|584789884|FG000|Core Phase|Participant Request|0|||
161929489|NCT00853047|584789885|FG001|Core Phase|Participant Request|0|||
161929490|NCT00853047|584789886|FG002|Core Phase|Participant Request|0|||
161929491|NCT00853047|584789887|FG003|Core Phase|Participant Request|1|||
161929492|NCT00853047|584789888|FG004|Core Phase|Participant Request|0|||
161929493|NCT00853047|584789889|FG005|Core Phase|Participant Request|0|||
161929494|NCT00853047|584789884|FG000|Open-Label Extension Phase|Participant Request|0|||
161929495|NCT00853047|584789885|FG001|Open-Label Extension Phase|Participant Request|0|||
161929496|NCT00853047|584789886|FG002|Open-Label Extension Phase|Participant Request|0|||
161588477|NCT04258709|583544495|FG001|Overall Study|Fetal demise|1|||
161588478|NCT04258709|583544494|FG000|Overall Study|Protocol Violation|1|||
161929497|NCT00853047|584789887|FG003|Open-Label Extension Phase|Participant Request|0|||
161929498|NCT00853047|584789888|FG004|Open-Label Extension Phase|Participant Request|0|||
161929499|NCT00853047|584789889|FG005|Open-Label Extension Phase|Participant Request|7|||
161929500|NCT00853047|584789884|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161929501|NCT00853047|584789885|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161929502|NCT00853047|584789886|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161929503|NCT00853047|584789887|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
161929504|NCT00853047|584789888|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
161929505|NCT00853047|584789889|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
161929506|NCT00853047|584789884|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929507|NCT00853047|584789885|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929508|NCT00853047|584789886|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929509|NCT00853047|584789887|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929510|NCT00853047|584789888|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929511|NCT00853047|584789889|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
161929512|NCT00853047|584789884|FG000|Open-Label Extension Phase|Investigator Decision|0|||
161929513|NCT00853047|584789885|FG001|Open-Label Extension Phase|Investigator Decision|0|||
161929514|NCT00853047|584789886|FG002|Open-Label Extension Phase|Investigator Decision|0|||
161929515|NCT00853047|584789887|FG003|Open-Label Extension Phase|Investigator Decision|0|||
161929516|NCT00853047|584789888|FG004|Open-Label Extension Phase|Investigator Decision|0|||
161929517|NCT00853047|584789889|FG005|Open-Label Extension Phase|Investigator Decision|1|||
161929518|NCT00853047|584789884|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
161929519|NCT00853047|584789885|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
161929520|NCT00853047|584789886|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
161929521|NCT00853047|584789887|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
161929522|NCT00853047|584789888|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
161929523|NCT00853047|584789889|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
161929524|NCT02638493|584789890|FG000|Overall Study|Inability to provide semen samples|2|||
161929525|NCT02638493|584789891|FG001|Overall Study|Inability to provide semen samples|0|||
161929526|NCT02638493|584789892|FG002|Overall Study|Inability to provide semen samples|0|||
161929527|NCT01569763|584792308|FG000|Overall Study|Lack of Efficacy|2|||
161929528|NCT01569763|584792309|FG001|Overall Study|Lack of Efficacy|7|||
161929529|NCT01569763|584792308|FG000|Overall Study|Adverse Event|1|||
161929530|NCT01569763|584792309|FG001|Overall Study|Adverse Event|0|||
161929531|NCT01926509|584792310|FG000|Overall Study|vital sign met discontinuation criteria|1|||
161929532|NCT01926509|584792311|FG001|Overall Study|vital sign met discontinuation criteria|0|||
161929533|NCT01926509|584792312|FG002|Overall Study|vital sign met discontinuation criteria|0|||
161929534|NCT01926509|584792313|FG003|Overall Study|vital sign met discontinuation criteria|0|||
161929535|NCT02730169|584792314|FG000|Overall Study|Protocol Violation|1|||
161929536|NCT02730169|584792315|FG001|Overall Study|Protocol Violation|0|||
161929537|NCT02730169|584792316|FG002|Overall Study|Protocol Violation|0|||
161929538|NCT02730169|584792317|FG003|Overall Study|Protocol Violation|1|||
161929539|NCT02730169|584792314|FG000|Overall Study|Adverse Event|2|||
161929540|NCT02730169|584792315|FG001|Overall Study|Adverse Event|3|||
161929541|NCT02730169|584792316|FG002|Overall Study|Adverse Event|3|||
161929542|NCT02730169|584792317|FG003|Overall Study|Adverse Event|0|||
161929543|NCT02730169|584792314|FG000|Overall Study|Adverse Event of Special Interest|0|||
161929544|NCT02730169|584792315|FG001|Overall Study|Adverse Event of Special Interest|1|||
161929545|NCT02730169|584792316|FG002|Overall Study|Adverse Event of Special Interest|2|||
161929546|NCT02730169|584792317|FG003|Overall Study|Adverse Event of Special Interest|0|||
161929547|NCT02730169|584792314|FG000|Overall Study|Withdrawal by Subject|6|||
161929548|NCT02730169|584792315|FG001|Overall Study|Withdrawal by Subject|11|||
161929549|NCT02730169|584792316|FG002|Overall Study|Withdrawal by Subject|6|||
161929550|NCT02730169|584792317|FG003|Overall Study|Withdrawal by Subject|8|||
161929551|NCT02730169|584792314|FG000|Overall Study|Lost to Follow-up|5|||
161929552|NCT02730169|584792315|FG001|Overall Study|Lost to Follow-up|6|||
161929553|NCT02730169|584792316|FG002|Overall Study|Lost to Follow-up|5|||
161929554|NCT02730169|584792317|FG003|Overall Study|Lost to Follow-up|6|||
161929555|NCT02730169|584792314|FG000|Overall Study|Other|0|||
161929556|NCT02730169|584792315|FG001|Overall Study|Other|0|||
161929557|NCT02730169|584792316|FG002|Overall Study|Other|1|||
161929558|NCT02730169|584792317|FG003|Overall Study|Other|1|||
161929559|NCT03004183|584792318|FG000|Overall Study|Adverse Event|7|||
161588479|NCT04258709|583544495|FG001|Overall Study|Protocol Violation|1|||
161588480|NCT02592330|583544496|FG000|Overall Study|Withdrawal by Subject|1|||
161588481|NCT02592330|583544497|FG001|Overall Study|Withdrawal by Subject|0|||
161588482|NCT02592330|583544496|FG000|Overall Study|Failed Biopsy|1|||
161588483|NCT02592330|583544497|FG001|Overall Study|Failed Biopsy|0|||
161588484|NCT03958955|583544498|FG000|Overall Study|Adverse Event|1|||
161588485|NCT02807636|583544499|FG000|Overall Study|Lost to Follow-up|10|||
161588486|NCT02807636|583544500|FG001|Overall Study|Lost to Follow-up|13|||
161588487|NCT02807636|583544501|FG002|Overall Study|Lost to Follow-up|6|||
161588488|NCT02807636|583544499|FG000|Overall Study|Protocol Deviation|1|||
161588489|NCT02807636|583544500|FG001|Overall Study|Protocol Deviation|0|||
161588490|NCT02807636|583544501|FG002|Overall Study|Protocol Deviation|0|||
161588491|NCT02807636|583544499|FG000|Overall Study|Symptomatic Deterioration|0|||
161588492|NCT02807636|583544500|FG001|Overall Study|Symptomatic Deterioration|1|||
161588493|NCT02807636|583544501|FG002|Overall Study|Symptomatic Deterioration|0|||
161588494|NCT02807636|583544499|FG000|Overall Study|Withdrawal by Subject|39|||
161929560|NCT03004183|584792318|FG000|Overall Study|Lost to Follow-up|1|||
161929561|NCT03004183|584792318|FG000|Overall Study|Physician Decision|40|||
161929562|NCT03004183|584792318|FG000|Overall Study|Withdrawal by Subject|1|||
161929563|NCT03004183|584792318|FG000|Overall Study|COVID-19|1|||
161929564|NCT02698787|584792322|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
161929565|NCT02698787|584792323|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
161588495|NCT02807636|583544500|FG001|Overall Study|Withdrawal by Subject|28|||
161929566|NCT02168439|584792327|FG000|Overall Study|Protocol Violation|0|||
161929567|NCT02168439|584792328|FG001|Overall Study|Protocol Violation|2|||
161588496|NCT02807636|583544501|FG002|Overall Study|Withdrawal by Subject|24|||
161588497|NCT02807636|583544499|FG000|Overall Study|Death|303|||
161588498|NCT02807636|583544500|FG001|Overall Study|Death|332|||
161929568|NCT02004275|584792329|FG000|Phase 1|Ineligible|0|||
161929569|NCT02004275|584792330|FG001|Phase 1|Ineligible|0|||
161929570|NCT02004275|584792331|FG002|Phase 1|Ineligible|0|||
161929571|NCT02004275|584792332|FG003|Phase 1|Ineligible|1|||
161929572|NCT02004275|584792333|FG004|Phase 1|Ineligible|1|||
161929573|NCT02004275|584792334|FG005|Phase 1|Ineligible|0|||
161929574|NCT02004275|584792329|FG000|Phase 1|Protocol Violation|0|||
161929575|NCT02004275|584792330|FG001|Phase 1|Protocol Violation|0|||
161929576|NCT02004275|584792331|FG002|Phase 1|Protocol Violation|0|||
161929577|NCT02004275|584792332|FG003|Phase 1|Protocol Violation|1|||
161929578|NCT02004275|584792333|FG004|Phase 1|Protocol Violation|0|||
161929579|NCT02004275|584792334|FG005|Phase 1|Protocol Violation|5|||
161929580|NCT02004275|584792329|FG000|Phase 2 Part 1|Ineligible|6|||
161929581|NCT02004275|584792330|FG001|Phase 2 Part 1|Ineligible|9|||
161929582|NCT02004275|584792331|FG002|Phase 2 Part 1|Ineligible|0|||
161929583|NCT02004275|584792332|FG003|Phase 2 Part 1|Ineligible|0|||
161929584|NCT02004275|584792333|FG004|Phase 2 Part 1|Ineligible|0|||
161929585|NCT02004275|584792334|FG005|Phase 2 Part 1|Ineligible|0|||
161929586|NCT02004275|584792329|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
161929587|NCT02004275|584792330|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
161929588|NCT02004275|584792331|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
161929589|NCT02004275|584792332|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
161929590|NCT02004275|584792333|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
161929591|NCT02004275|584792334|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
161929592|NCT02533674|584792335|FG000|Dose Level I|Progressive disease|1|||
161929593|NCT02533674|584792336|FG001|Dose Level I|Progressive disease|0|||
161929594|NCT02533674|584792337|FG002|Dose Level I|Progressive disease|0|||
161929595|NCT02533674|584792338|FG003|Dose Level I|Progressive disease|0|||
161929596|NCT02533674|584792339|FG004|Dose Level I|Progressive disease|0|||
161929597|NCT02533674|584792340|FG005|Dose Level I|Progressive disease|0|||
161929598|NCT02533674|584792341|FG006|Dose Level I|Progressive disease|0|||
161929599|NCT02533674|584792342|FG007|Dose Level I|Progressive disease|0|||
161929600|NCT02533674|584792335|FG000|Dose Level I|Withdrawal by Subject|1|||
161929601|NCT02533674|584792336|FG001|Dose Level I|Withdrawal by Subject|0|||
161929602|NCT02533674|584792337|FG002|Dose Level I|Withdrawal by Subject|0|||
161929603|NCT02533674|584792338|FG003|Dose Level I|Withdrawal by Subject|0|||
161929604|NCT02533674|584792339|FG004|Dose Level I|Withdrawal by Subject|0|||
161929605|NCT02533674|584792340|FG005|Dose Level I|Withdrawal by Subject|0|||
161929606|NCT02533674|584792341|FG006|Dose Level I|Withdrawal by Subject|0|||
161929607|NCT02533674|584792342|FG007|Dose Level I|Withdrawal by Subject|0|||
161929608|NCT02533674|584792335|FG000|Dose Level I|Physician Decision|1|||
161929609|NCT02533674|584792336|FG001|Dose Level I|Physician Decision|0|||
161588499|NCT02807636|583544501|FG002|Overall Study|Death|272|||
161588500|NCT02807636|583544499|FG000|Overall Study|Study Terminated By Sponsor|47|||
161588501|NCT02807636|583544500|FG001|Overall Study|Study Terminated By Sponsor|76|||
161588502|NCT02807636|583544501|FG002|Overall Study|Study Terminated By Sponsor|60|||
161588503|NCT02807636|583544499|FG000|Overall Study|Physician Decision|0|||
161588504|NCT02807636|583544500|FG001|Overall Study|Physician Decision|1|||
161588505|NCT02807636|583544501|FG002|Overall Study|Physician Decision|0|||
161588506|NCT03315754|583544502|FG000|Overall Study|COVID-19 complications leading to death|1|||
161588507|NCT03315754|583544502|FG000|Overall Study|insurance coverage issue|1|||
161588508|NCT05337748|583544516|FG000|Overall Study|Withdrawal by Subject|1|||
161588509|NCT05337748|583544517|FG001|Overall Study|Withdrawal by Subject|0|||
161588510|NCT05337748|583544516|FG000|Overall Study|Death|1|||
161588511|NCT05337748|583544517|FG001|Overall Study|Death|0|||
161588512|NCT03453619|583544521|FG000|Core Study (Part A)|Physician Decision|0|||
161588513|NCT03453619|583544522|FG001|Core Study (Part A)|Physician Decision|0|||
161588514|NCT03453619|583544523|FG002|Core Study (Part A)|Physician Decision|2|||
161588515|NCT03453619|583544524|FG003|Core Study (Part A)|Physician Decision|0|||
161588516|NCT03453619|583544521|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
161588517|NCT03453619|583544522|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
161588518|NCT03453619|583544523|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
161588519|NCT03453619|583544524|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
161588520|NCT03453619|583544521|FG000|Core Study (Part A)|Other|0|||
161588521|NCT03453619|583544522|FG001|Core Study (Part A)|Other|1|||
161588522|NCT03453619|583544523|FG002|Core Study (Part A)|Other|0|||
161588523|NCT03453619|583544524|FG003|Core Study (Part A)|Other|0|||
161588524|NCT03453619|583544521|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
161588525|NCT03453619|583544522|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
161588526|NCT03453619|583544523|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
161588527|NCT03453619|583544524|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
161588528|NCT03453619|583544521|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
161588529|NCT03453619|583544522|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
161588530|NCT03453619|583544523|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
161588531|NCT03453619|583544524|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
161929610|NCT02533674|584792337|FG002|Dose Level I|Physician Decision|0|||
161929611|NCT02533674|584792338|FG003|Dose Level I|Physician Decision|0|||
161929612|NCT02533674|584792339|FG004|Dose Level I|Physician Decision|0|||
161676881|NCT01303965|583870577|FG001|Overall Study|Death|3|||
161676882|NCT01303965|583870576|FG000|Overall Study|Withdrawal by Subject|1|||
161676883|NCT01303965|583870577|FG001|Overall Study|Withdrawal by Subject|0|||
161676884|NCT01303965|583870576|FG000|Overall Study|Disease Progression|1|||
161676885|NCT01303965|583870577|FG001|Overall Study|Disease Progression|6|||
161676886|NCT04060563|583870582|FG000|Overall Study|Lost to Follow-up|1|||
161676887|NCT04060563|583870583|FG001|Overall Study|Lost to Follow-up|1|||
161676888|NCT04060563|583870582|FG000|Overall Study|Physician Decision|0|||
161676889|NCT04060563|583870583|FG001|Overall Study|Physician Decision|1|||
161676890|NCT00851682|583870584|FG000|Overall Study|screen failure|5|||
161676891|NCT00851682|583870585|FG001|Overall Study|screen failure|0|||
161929613|NCT02533674|584792340|FG005|Dose Level I|Physician Decision|0|||
161929614|NCT02533674|584792341|FG006|Dose Level I|Physician Decision|0|||
161929615|NCT02533674|584792342|FG007|Dose Level I|Physician Decision|0|||
161929616|NCT02533674|584792335|FG000|Dose Level I|Death|1|||
161929617|NCT02533674|584792336|FG001|Dose Level I|Death|0|||
161929618|NCT02533674|584792337|FG002|Dose Level I|Death|0|||
161929619|NCT02533674|584792338|FG003|Dose Level I|Death|0|||
161929620|NCT02533674|584792339|FG004|Dose Level I|Death|0|||
161929621|NCT02533674|584792340|FG005|Dose Level I|Death|0|||
161929622|NCT02533674|584792341|FG006|Dose Level I|Death|0|||
161929623|NCT02533674|584792342|FG007|Dose Level I|Death|0|||
161929624|NCT02533674|584792335|FG000|Dose Level I|Never Treated|1|||
161929625|NCT02533674|584792336|FG001|Dose Level I|Never Treated|0|||
161929626|NCT02533674|584792337|FG002|Dose Level I|Never Treated|0|||
161929627|NCT02533674|584792338|FG003|Dose Level I|Never Treated|0|||
161929628|NCT02533674|584792339|FG004|Dose Level I|Never Treated|0|||
161929629|NCT02533674|584792340|FG005|Dose Level I|Never Treated|0|||
161929630|NCT02533674|584792341|FG006|Dose Level I|Never Treated|0|||
161929631|NCT02533674|584792342|FG007|Dose Level I|Never Treated|0|||
161929632|NCT02533674|584792335|FG000|Dose Level II|Progressive disease|0|||
161929633|NCT02533674|584792336|FG001|Dose Level II|Progressive disease|3|||
161929634|NCT02533674|584792337|FG002|Dose Level II|Progressive disease|0|||
161929635|NCT02533674|584792338|FG003|Dose Level II|Progressive disease|0|||
161929636|NCT02533674|584792339|FG004|Dose Level II|Progressive disease|0|||
161929637|NCT02533674|584792340|FG005|Dose Level II|Progressive disease|0|||
161929638|NCT02533674|584792341|FG006|Dose Level II|Progressive disease|0|||
161929639|NCT02533674|584792342|FG007|Dose Level II|Progressive disease|0|||
161929640|NCT02533674|584792335|FG000|Dose Level II|Withdrawal by Subject|0|||
161929641|NCT02533674|584792336|FG001|Dose Level II|Withdrawal by Subject|1|||
161929642|NCT02533674|584792337|FG002|Dose Level II|Withdrawal by Subject|0|||
161929643|NCT02533674|584792338|FG003|Dose Level II|Withdrawal by Subject|0|||
161929644|NCT02533674|584792339|FG004|Dose Level II|Withdrawal by Subject|0|||
161929645|NCT02533674|584792340|FG005|Dose Level II|Withdrawal by Subject|0|||
161929646|NCT02533674|584792341|FG006|Dose Level II|Withdrawal by Subject|0|||
161929647|NCT02533674|584792342|FG007|Dose Level II|Withdrawal by Subject|0|||
161929648|NCT02533674|584792335|FG000|Dose Level II|Treatment-related AE|0|||
161929649|NCT02533674|584792336|FG001|Dose Level II|Treatment-related AE|1|||
161929650|NCT02533674|584792337|FG002|Dose Level II|Treatment-related AE|0|||
161929651|NCT02533674|584792338|FG003|Dose Level II|Treatment-related AE|0|||
161929652|NCT02533674|584792339|FG004|Dose Level II|Treatment-related AE|0|||
161929653|NCT02533674|584792340|FG005|Dose Level II|Treatment-related AE|0|||
161929654|NCT02533674|584792341|FG006|Dose Level II|Treatment-related AE|0|||
161929655|NCT02533674|584792342|FG007|Dose Level II|Treatment-related AE|0|||
161929656|NCT02533674|584792335|FG000|Dose Level II|Physician Decision|0|||
161929657|NCT02533674|584792336|FG001|Dose Level II|Physician Decision|1|||
161929658|NCT02533674|584792337|FG002|Dose Level II|Physician Decision|0|||
161929659|NCT02533674|584792338|FG003|Dose Level II|Physician Decision|0|||
161929660|NCT02533674|584792339|FG004|Dose Level II|Physician Decision|0|||
161929661|NCT02533674|584792340|FG005|Dose Level II|Physician Decision|0|||
161929662|NCT02533674|584792341|FG006|Dose Level II|Physician Decision|0|||
161929663|NCT02533674|584792342|FG007|Dose Level II|Physician Decision|0|||
161929664|NCT02533674|584792335|FG000|Dose Level II|Non-treatment-related AE|0|||
161929665|NCT02533674|584792336|FG001|Dose Level II|Non-treatment-related AE|1|||
161929666|NCT02533674|584792337|FG002|Dose Level II|Non-treatment-related AE|0|||
161929667|NCT02533674|584792338|FG003|Dose Level II|Non-treatment-related AE|0|||
161929668|NCT02533674|584792339|FG004|Dose Level II|Non-treatment-related AE|0|||
161929669|NCT02533674|584792340|FG005|Dose Level II|Non-treatment-related AE|0|||
161929670|NCT02533674|584792341|FG006|Dose Level II|Non-treatment-related AE|0|||
161929671|NCT02533674|584792342|FG007|Dose Level II|Non-treatment-related AE|0|||
161929672|NCT02533674|584792335|FG000|Dose Level III|Progressive disease|0|||
161676892|NCT01379573|583870589|FG000|Overall Study|Lost to Follow-up|1|||
161676893|NCT01379573|583870589|FG000|Overall Study|Screen Failure|10|||
161929673|NCT02533674|584792336|FG001|Dose Level III|Progressive disease|0|||
161929674|NCT02533674|584792337|FG002|Dose Level III|Progressive disease|2|||
161929675|NCT02533674|584792338|FG003|Dose Level III|Progressive disease|0|||
161676894|NCT01829425|583870600|FG000|Overall Study|Withdrawal by Subject|4|||
161929676|NCT02533674|584792339|FG004|Dose Level III|Progressive disease|0|||
161929677|NCT02533674|584792340|FG005|Dose Level III|Progressive disease|0|||
161929678|NCT02533674|584792341|FG006|Dose Level III|Progressive disease|0|||
161929679|NCT02533674|584792342|FG007|Dose Level III|Progressive disease|0|||
161929680|NCT02533674|584792335|FG000|Dose Level III|Withdrawal by Subject|0|||
161929681|NCT02533674|584792336|FG001|Dose Level III|Withdrawal by Subject|0|||
161929682|NCT02533674|584792337|FG002|Dose Level III|Withdrawal by Subject|1|||
161929683|NCT02533674|584792338|FG003|Dose Level III|Withdrawal by Subject|0|||
161929684|NCT02533674|584792339|FG004|Dose Level III|Withdrawal by Subject|0|||
161929685|NCT02533674|584792340|FG005|Dose Level III|Withdrawal by Subject|0|||
161929686|NCT02533674|584792341|FG006|Dose Level III|Withdrawal by Subject|0|||
161929687|NCT02533674|584792342|FG007|Dose Level III|Withdrawal by Subject|0|||
161929688|NCT02533674|584792335|FG000|Dose Level III|Treatment-related AE|0|||
161929689|NCT02533674|584792336|FG001|Dose Level III|Treatment-related AE|0|||
161929690|NCT02533674|584792337|FG002|Dose Level III|Treatment-related AE|1|||
161929691|NCT02533674|584792338|FG003|Dose Level III|Treatment-related AE|0|||
161929692|NCT02533674|584792339|FG004|Dose Level III|Treatment-related AE|0|||
161929693|NCT02533674|584792340|FG005|Dose Level III|Treatment-related AE|0|||
161929694|NCT02533674|584792341|FG006|Dose Level III|Treatment-related AE|0|||
161929695|NCT02533674|584792342|FG007|Dose Level III|Treatment-related AE|0|||
161929696|NCT02533674|584792335|FG000|Dose Level IV|Progressive disease|0|||
161929697|NCT02533674|584792336|FG001|Dose Level IV|Progressive disease|0|||
161929698|NCT02533674|584792337|FG002|Dose Level IV|Progressive disease|0|||
161929699|NCT02533674|584792338|FG003|Dose Level IV|Progressive disease|3|||
161929700|NCT02533674|584792339|FG004|Dose Level IV|Progressive disease|0|||
161929701|NCT02533674|584792340|FG005|Dose Level IV|Progressive disease|0|||
161929702|NCT02533674|584792341|FG006|Dose Level IV|Progressive disease|0|||
161929703|NCT02533674|584792342|FG007|Dose Level IV|Progressive disease|0|||
161929704|NCT02533674|584792335|FG000|Dose Level IV|Withdrawal by Subject|0|||
161929705|NCT02533674|584792336|FG001|Dose Level IV|Withdrawal by Subject|0|||
161929706|NCT02533674|584792337|FG002|Dose Level IV|Withdrawal by Subject|0|||
161929707|NCT02533674|584792338|FG003|Dose Level IV|Withdrawal by Subject|1|||
161929708|NCT02533674|584792339|FG004|Dose Level IV|Withdrawal by Subject|0|||
161929709|NCT02533674|584792340|FG005|Dose Level IV|Withdrawal by Subject|0|||
161929710|NCT02533674|584792341|FG006|Dose Level IV|Withdrawal by Subject|0|||
161929711|NCT02533674|584792342|FG007|Dose Level IV|Withdrawal by Subject|0|||
161929712|NCT02533674|584792335|FG000|Dose Level IV|Physician Decision|0|||
161929713|NCT02533674|584792336|FG001|Dose Level IV|Physician Decision|0|||
161929714|NCT02533674|584792337|FG002|Dose Level IV|Physician Decision|0|||
161929715|NCT02533674|584792338|FG003|Dose Level IV|Physician Decision|1|||
161929716|NCT02533674|584792339|FG004|Dose Level IV|Physician Decision|0|||
161929717|NCT02533674|584792340|FG005|Dose Level IV|Physician Decision|0|||
161929718|NCT02533674|584792341|FG006|Dose Level IV|Physician Decision|0|||
161929719|NCT02533674|584792342|FG007|Dose Level IV|Physician Decision|0|||
161929720|NCT02533674|584792335|FG000|Dose Level V|Progressive disease|0|||
161929721|NCT02533674|584792336|FG001|Dose Level V|Progressive disease|0|||
161929722|NCT02533674|584792337|FG002|Dose Level V|Progressive disease|0|||
161929723|NCT02533674|584792338|FG003|Dose Level V|Progressive disease|0|||
161929724|NCT02533674|584792339|FG004|Dose Level V|Progressive disease|3|||
161929725|NCT02533674|584792340|FG005|Dose Level V|Progressive disease|0|||
161929726|NCT02533674|584792341|FG006|Dose Level V|Progressive disease|0|||
161929727|NCT02533674|584792342|FG007|Dose Level V|Progressive disease|0|||
161929728|NCT02533674|584792335|FG000|Dose Level V|Withdrawal by Subject|0|||
161929729|NCT02533674|584792336|FG001|Dose Level V|Withdrawal by Subject|0|||
161929730|NCT02533674|584792337|FG002|Dose Level V|Withdrawal by Subject|0|||
161929731|NCT02533674|584792338|FG003|Dose Level V|Withdrawal by Subject|0|||
161929732|NCT02533674|584792339|FG004|Dose Level V|Withdrawal by Subject|1|||
161929733|NCT02533674|584792340|FG005|Dose Level V|Withdrawal by Subject|0|||
161929734|NCT02533674|584792341|FG006|Dose Level V|Withdrawal by Subject|0|||
161929735|NCT02533674|584792342|FG007|Dose Level V|Withdrawal by Subject|0|||
161929736|NCT02533674|584792335|FG000|Dose Level V|Physician Decision|0|||
161929737|NCT02533674|584792336|FG001|Dose Level V|Physician Decision|0|||
161929738|NCT02533674|584792337|FG002|Dose Level V|Physician Decision|0|||
161929739|NCT02533674|584792338|FG003|Dose Level V|Physician Decision|0|||
161515596|NCT01040871|583278447|FG000|Overall Study|Death|1|||
161929740|NCT02533674|584792339|FG004|Dose Level V|Physician Decision|1|||
161929741|NCT02533674|584792340|FG005|Dose Level V|Physician Decision|0|||
161929742|NCT02533674|584792341|FG006|Dose Level V|Physician Decision|0|||
161929743|NCT02533674|584792342|FG007|Dose Level V|Physician Decision|0|||
161929744|NCT02533674|584792335|FG000|Dose Level VI|Progressive disease|0|||
161929745|NCT02533674|584792336|FG001|Dose Level VI|Progressive disease|0|||
161929746|NCT02533674|584792337|FG002|Dose Level VI|Progressive disease|0|||
161929747|NCT02533674|584792338|FG003|Dose Level VI|Progressive disease|0|||
161929748|NCT02533674|584792339|FG004|Dose Level VI|Progressive disease|0|||
161929749|NCT02533674|584792340|FG005|Dose Level VI|Progressive disease|7|||
161929750|NCT02533674|584792341|FG006|Dose Level VI|Progressive disease|0|||
161929751|NCT02533674|584792342|FG007|Dose Level VI|Progressive disease|0|||
161929752|NCT02533674|584792335|FG000|Dose Level VI|Withdrawal by Subject|0|||
161929753|NCT02533674|584792336|FG001|Dose Level VI|Withdrawal by Subject|0|||
161515597|NCT01040871|583278448|FG001|Overall Study|Death|3|||
161929754|NCT02533674|584792337|FG002|Dose Level VI|Withdrawal by Subject|0|||
161929755|NCT02533674|584792338|FG003|Dose Level VI|Withdrawal by Subject|0|||
161929756|NCT02533674|584792339|FG004|Dose Level VI|Withdrawal by Subject|0|||
161929757|NCT02533674|584792340|FG005|Dose Level VI|Withdrawal by Subject|1|||
161929758|NCT02533674|584792341|FG006|Dose Level VI|Withdrawal by Subject|0|||
161929759|NCT02533674|584792342|FG007|Dose Level VI|Withdrawal by Subject|0|||
161929760|NCT02533674|584792335|FG000|Dose Level VI|Treatment-related AE|0|||
161929761|NCT02533674|584792336|FG001|Dose Level VI|Treatment-related AE|0|||
161929762|NCT02533674|584792337|FG002|Dose Level VI|Treatment-related AE|0|||
161929763|NCT02533674|584792338|FG003|Dose Level VI|Treatment-related AE|0|||
161929764|NCT02533674|584792339|FG004|Dose Level VI|Treatment-related AE|0|||
161929765|NCT02533674|584792340|FG005|Dose Level VI|Treatment-related AE|1|||
161929766|NCT02533674|584792341|FG006|Dose Level VI|Treatment-related AE|0|||
161929767|NCT02533674|584792342|FG007|Dose Level VI|Treatment-related AE|0|||
161929768|NCT02533674|584792335|FG000|Dose Level VII|Progressive disease|0|||
161929769|NCT02533674|584792336|FG001|Dose Level VII|Progressive disease|0|||
161929770|NCT02533674|584792337|FG002|Dose Level VII|Progressive disease|0|||
161929771|NCT02533674|584792338|FG003|Dose Level VII|Progressive disease|0|||
161929772|NCT02533674|584792339|FG004|Dose Level VII|Progressive disease|0|||
161929773|NCT02533674|584792340|FG005|Dose Level VII|Progressive disease|0|||
161929774|NCT02533674|584792341|FG006|Dose Level VII|Progressive disease|10|||
161929775|NCT02533674|584792342|FG007|Dose Level VII|Progressive disease|0|||
161929776|NCT02533674|584792335|FG000|Dose Level VII|Withdrawal by Subject|0|||
161929777|NCT02533674|584792336|FG001|Dose Level VII|Withdrawal by Subject|0|||
161929778|NCT02533674|584792337|FG002|Dose Level VII|Withdrawal by Subject|0|||
161929779|NCT02533674|584792338|FG003|Dose Level VII|Withdrawal by Subject|0|||
161929780|NCT02533674|584792339|FG004|Dose Level VII|Withdrawal by Subject|0|||
161929781|NCT02533674|584792340|FG005|Dose Level VII|Withdrawal by Subject|0|||
161929782|NCT02533674|584792341|FG006|Dose Level VII|Withdrawal by Subject|3|||
161929783|NCT02533674|584792342|FG007|Dose Level VII|Withdrawal by Subject|0|||
161929784|NCT02533674|584792335|FG000|Dose Level VII|Treatment-related AE|0|||
161929785|NCT02533674|584792336|FG001|Dose Level VII|Treatment-related AE|0|||
161929786|NCT02533674|584792337|FG002|Dose Level VII|Treatment-related AE|0|||
161929787|NCT02533674|584792338|FG003|Dose Level VII|Treatment-related AE|0|||
161929788|NCT02533674|584792339|FG004|Dose Level VII|Treatment-related AE|0|||
161929789|NCT02533674|584792340|FG005|Dose Level VII|Treatment-related AE|0|||
161929790|NCT02533674|584792341|FG006|Dose Level VII|Treatment-related AE|1|||
161929791|NCT02533674|584792342|FG007|Dose Level VII|Treatment-related AE|0|||
161929792|NCT02533674|584792335|FG000|Dose Level VII|Death|0|||
161929793|NCT02533674|584792336|FG001|Dose Level VII|Death|0|||
161929794|NCT02533674|584792337|FG002|Dose Level VII|Death|0|||
161929795|NCT02533674|584792338|FG003|Dose Level VII|Death|0|||
161929796|NCT02533674|584792339|FG004|Dose Level VII|Death|0|||
161929797|NCT02533674|584792340|FG005|Dose Level VII|Death|0|||
161929798|NCT02533674|584792341|FG006|Dose Level VII|Death|2|||
161929799|NCT02533674|584792342|FG007|Dose Level VII|Death|0|||
161929800|NCT02533674|584792335|FG000|Dose Level VIII|Progressive disease|0|||
161929801|NCT02533674|584792336|FG001|Dose Level VIII|Progressive disease|0|||
161929802|NCT02533674|584792337|FG002|Dose Level VIII|Progressive disease|0|||
161929803|NCT02533674|584792338|FG003|Dose Level VIII|Progressive disease|0|||
161929804|NCT02533674|584792339|FG004|Dose Level VIII|Progressive disease|0|||
161929805|NCT02533674|584792340|FG005|Dose Level VIII|Progressive disease|0|||
161929806|NCT02533674|584792341|FG006|Dose Level VIII|Progressive disease|0|||
161929807|NCT02533674|584792342|FG007|Dose Level VIII|Progressive disease|3|||
161929808|NCT02533674|584792335|FG000|Dose Level VIII|Withdrawal by Subject|0|||
161929809|NCT02533674|584792336|FG001|Dose Level VIII|Withdrawal by Subject|0|||
161929810|NCT02533674|584792337|FG002|Dose Level VIII|Withdrawal by Subject|0|||
161929811|NCT02533674|584792338|FG003|Dose Level VIII|Withdrawal by Subject|0|||
161929812|NCT02533674|584792339|FG004|Dose Level VIII|Withdrawal by Subject|0|||
161929813|NCT02533674|584792340|FG005|Dose Level VIII|Withdrawal by Subject|0|||
161929814|NCT02533674|584792341|FG006|Dose Level VIII|Withdrawal by Subject|0|||
161929815|NCT02533674|584792342|FG007|Dose Level VIII|Withdrawal by Subject|1|||
161929816|NCT02533674|584792335|FG000|Dose Level VIII|Treatment-related AE|0|||
161929817|NCT02533674|584792336|FG001|Dose Level VIII|Treatment-related AE|0|||
161929818|NCT02533674|584792337|FG002|Dose Level VIII|Treatment-related AE|0|||
161588532|NCT03453619|583544521|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161588533|NCT03453619|583544522|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161929819|NCT02533674|584792338|FG003|Dose Level VIII|Treatment-related AE|0|||
161929820|NCT02533674|584792339|FG004|Dose Level VIII|Treatment-related AE|0|||
161929821|NCT02533674|584792340|FG005|Dose Level VIII|Treatment-related AE|0|||
161929822|NCT02533674|584792341|FG006|Dose Level VIII|Treatment-related AE|0|||
161929823|NCT02533674|584792342|FG007|Dose Level VIII|Treatment-related AE|1|||
161929824|NCT02533674|584792335|FG000|Dose Level VIII|Never treated|0|||
161929825|NCT02533674|584792336|FG001|Dose Level VIII|Never treated|0|||
161929826|NCT02533674|584792337|FG002|Dose Level VIII|Never treated|0|||
161929827|NCT02533674|584792338|FG003|Dose Level VIII|Never treated|0|||
161929828|NCT02533674|584792339|FG004|Dose Level VIII|Never treated|0|||
161929829|NCT02533674|584792340|FG005|Dose Level VIII|Never treated|0|||
161929830|NCT02533674|584792341|FG006|Dose Level VIII|Never treated|0|||
161929831|NCT02533674|584792342|FG007|Dose Level VIII|Never treated|1|||
161929832|NCT01908699|584792350|FG000|Overall Study|Adverse Event|8|||
161929833|NCT01908699|584792351|FG001|Overall Study|Adverse Event|12|||
161929834|NCT01908699|584792350|FG000|Overall Study|Lack of Efficacy|2|||
161929835|NCT01908699|584792351|FG001|Overall Study|Lack of Efficacy|2|||
161929836|NCT01908699|584792350|FG000|Overall Study|Lost to Follow-up|2|||
161929837|NCT01908699|584792351|FG001|Overall Study|Lost to Follow-up|4|||
161929838|NCT01908699|584792350|FG000|Overall Study|Physician Decision|8|||
161588534|NCT03453619|583544523|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161929839|NCT01908699|584792351|FG001|Overall Study|Physician Decision|8|||
161929840|NCT01908699|584792350|FG000|Overall Study|Withdrawal by Subject|15|||
161929841|NCT01908699|584792351|FG001|Overall Study|Withdrawal by Subject|10|||
161929842|NCT01908699|584792350|FG000|Overall Study|Pregnancy|0|||
161929843|NCT01908699|584792351|FG001|Overall Study|Pregnancy|1|||
161929844|NCT01908699|584792350|FG000|Overall Study|Randomized in Error|1|||
161929845|NCT01908699|584792351|FG001|Overall Study|Randomized in Error|0|||
161929846|NCT01908699|584792350|FG000|Overall Study|Death|9|||
161929847|NCT01908699|584792351|FG001|Overall Study|Death|12|||
161929848|NCT01908699|584792350|FG000|Overall Study|Progressive Disease|30|||
161929849|NCT01908699|584792351|FG001|Overall Study|Progressive Disease|29|||
161929850|NCT01697501|584792352|FG000|Overall Study|Protocol Violation|2|||
161929851|NCT02242903|584792353|FG000|Overall Study|Withdrawal by Subject|1|||
161929852|NCT02242903|584792354|FG001|Overall Study|Withdrawal by Subject|0|||
161929853|NCT02242903|584792355|FG002|Overall Study|Withdrawal by Subject|0|||
161929854|NCT02242903|584792356|FG003|Overall Study|Withdrawal by Subject|0|||
161588535|NCT03453619|583544524|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
161588536|NCT03453619|583544521|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
161588537|NCT03453619|583544522|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
161588538|NCT03453619|583544523|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
161588539|NCT03453619|583544524|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
161588540|NCT04089371|583544525|FG000|Overall Study|Withdrawal by Subject|0|||
161588541|NCT04089371|583544526|FG001|Overall Study|Withdrawal by Subject|1|||
161588542|NCT04089371|583544525|FG000|Overall Study|Study terminated early|0|||
161588543|NCT04089371|583544526|FG001|Overall Study|Study terminated early|9|||
161588544|NCT04382898|583544527|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
161588545|NCT04382898|583544528|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
161588546|NCT04382898|583544529|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
161588547|NCT04382898|583544530|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
161588548|NCT04382898|583544531|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
161588549|NCT04382898|583544527|FG000|Part 1: Dose Titration|Death|6|||
161588550|NCT04382898|583544528|FG001|Part 1: Dose Titration|Death|0|||
161588551|NCT04382898|583544529|FG002|Part 1: Dose Titration|Death|0|||
161588552|NCT04382898|583544530|FG003|Part 1: Dose Titration|Death|0|||
161588553|NCT04382898|583544531|FG004|Part 1: Dose Titration|Death|0|||
161588554|NCT04382898|583544527|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161588555|NCT04382898|583544528|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161588556|NCT04382898|583544529|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161588557|NCT04382898|583544530|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161588558|NCT04382898|583544531|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161588559|NCT04382898|583544527|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
161588560|NCT04382898|583544528|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
161588561|NCT04382898|583544529|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
161588562|NCT04382898|583544530|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
161588563|NCT04382898|583544531|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
161588564|NCT04382898|583544527|FG000|Part 2: Dose Expansion|Death|0|||
161588565|NCT04382898|583544528|FG001|Part 2: Dose Expansion|Death|17|||
161588566|NCT04382898|583544529|FG002|Part 2: Dose Expansion|Death|13|||
161588567|NCT04382898|583544530|FG003|Part 2: Dose Expansion|Death|1|||
161588568|NCT04382898|583544531|FG004|Part 2: Dose Expansion|Death|0|||
161588569|NCT04382898|583544527|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
161929855|NCT02242903|584792357|FG004|Overall Study|Withdrawal by Subject|0|||
161929856|NCT02242903|584792358|FG005|Overall Study|Withdrawal by Subject|0|||
161588570|NCT04382898|583544528|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
161588571|NCT04382898|583544529|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
161588572|NCT04382898|583544530|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
161588573|NCT04382898|583544531|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
161588574|NCT04382898|583544527|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161929857|NCT02242903|584792359|FG006|Overall Study|Withdrawal by Subject|0|||
161929858|NCT02105012|584792360|FG000|Overall Study|Withdrawal by Subject|11|||
161588575|NCT04382898|583544528|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161929859|NCT02105012|584792360|FG000|Overall Study|Protocol Specified Criteria|9|||
161929860|NCT02105012|584792360|FG000|Overall Study|Lost to Follow-up|4|||
161929861|NCT02105012|584792360|FG000|Overall Study|Protocol Violation|4|||
161929862|NCT02105012|584792360|FG000|Overall Study|Physician Decision|3|||
161929863|NCT02105012|584792360|FG000|Overall Study|Adverse Event|1|||
161929864|NCT02105012|584792360|FG000|Overall Study|Lack of Efficacy|1|||
161929865|NCT00493285|584792361|FG000|Overall Study|Lost to Follow-up|0|||
161929866|NCT00493285|584792362|FG001|Overall Study|Lost to Follow-up|0|||
161929867|NCT00493285|584792363|FG002|Overall Study|Lost to Follow-up|0|||
161929868|NCT00493285|584792364|FG003|Overall Study|Lost to Follow-up|0|||
161929869|NCT00493285|584792365|FG004|Overall Study|Lost to Follow-up|1|||
161929870|NCT00493285|584792366|FG005|Overall Study|Lost to Follow-up|0|||
161929871|NCT03021005|584792367|FG000|Overall Study|Lost to Follow-up|39|||
161929872|NCT03021005|584792368|FG001|Overall Study|Lost to Follow-up|26|||
161929873|NCT00779909|584792371|FG000|Overall Study|Lost to Follow-up|1|||
161929874|NCT00779909|584792372|FG001|Overall Study|Lost to Follow-up|0|||
161929875|NCT00779909|584792373|FG002|Overall Study|Lost to Follow-up|0|||
161929876|NCT00779909|584792374|FG003|Overall Study|Lost to Follow-up|1|||
161929877|NCT00779909|584792371|FG000|Overall Study|Withdrawal by Subject|0|||
161929878|NCT00779909|584792372|FG001|Overall Study|Withdrawal by Subject|1|||
161929879|NCT00779909|584792373|FG002|Overall Study|Withdrawal by Subject|0|||
161929880|NCT00779909|584792374|FG003|Overall Study|Withdrawal by Subject|0|||
161929881|NCT01174459|584792378|FG000|Overall Study|case report form (CRF) not collected|5|||
161929882|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
161929883|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
161929884|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
161929885|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
161929886|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
161929887|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
161929888|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
161929889|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
161929890|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
161929891|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
161929892|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
161929893|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
161929894|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
161929895|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
161929896|NCT00290758|584792379|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
161929897|NCT00290758|584792380|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
161929898|NCT00215553|584792382|FG000|Overall Study|Adverse Event|0|||
161929899|NCT00215553|584792383|FG001|Overall Study|Adverse Event|1|||
161929900|NCT00215553|584792384|FG002|Overall Study|Adverse Event|2|||
161929901|NCT00215553|584792385|FG003|Overall Study|Adverse Event|1|||
161929902|NCT00215553|584792386|FG004|Overall Study|Adverse Event|2|||
161929903|NCT00215553|584792387|FG005|Overall Study|Adverse Event|6|||
161929904|NCT00215553|584792388|FG006|Overall Study|Adverse Event|0|||
161929905|NCT01111292|584792389|FG000|Treatment|Physician Decision|1|||
161929906|NCT01111292|584792390|FG001|Treatment|Physician Decision|1|||
161929907|NCT02006654|584792391|FG000|Overall Study|Withdrawal before treatment|4|||
161929908|NCT02006654|584792392|FG001|Overall Study|Withdrawal before treatment|2|||
161929909|NCT02006654|584792391|FG000|Overall Study|Adverse Event|16|||
161929910|NCT02006654|584792392|FG001|Overall Study|Adverse Event|17|||
161929911|NCT02006654|584792391|FG000|Overall Study|Death|1|||
161929912|NCT02006654|584792392|FG001|Overall Study|Death|0|||
161929913|NCT02006654|584792391|FG000|Overall Study|Withdrawal by Subject|14|||
161929914|NCT02006654|584792392|FG001|Overall Study|Withdrawal by Subject|12|||
161929915|NCT02006654|584792391|FG000|Overall Study|Protocol Violation|5|||
161929916|NCT02006654|584792392|FG001|Overall Study|Protocol Violation|8|||
161929917|NCT02006654|584792391|FG000|Overall Study|Lost to Follow-up|1|||
161929918|NCT02006654|584792392|FG001|Overall Study|Lost to Follow-up|0|||
161929919|NCT02006654|584792391|FG000|Overall Study|patient's will|2|||
161929920|NCT02006654|584792392|FG001|Overall Study|patient's will|1|||
161929921|NCT02006654|584792391|FG000|Overall Study|insufficient compliance|1|||
161929922|NCT02006654|584792392|FG001|Overall Study|insufficient compliance|0|||
161929923|NCT02006654|584792391|FG000|Overall Study|worsening cognitive condition|0|||
161929924|NCT02006654|584792392|FG001|Overall Study|worsening cognitive condition|1|||
161929925|NCT02006654|584792391|FG000|Overall Study|faecal incontinence|0|||
161929926|NCT02006654|584792392|FG001|Overall Study|faecal incontinence|1|||
161929927|NCT02006654|584792391|FG000|Overall Study|mood disorder|0|||
161929928|NCT02006654|584792392|FG001|Overall Study|mood disorder|1|||
161929929|NCT02006654|584792391|FG000|Overall Study|disallowed medication|1|||
161929930|NCT02006654|584792392|FG001|Overall Study|disallowed medication|0|||
161929931|NCT02006654|584792391|FG000|Overall Study|moving out of state|0|||
161929932|NCT02006654|584792392|FG001|Overall Study|moving out of state|1|||
161929933|NCT04193527|584792393|FG000|Overall Study|Other|1|||
161929934|NCT04193527|584792394|FG001|Overall Study|Other|1|||
161929935|NCT04193527|584792395|FG002|Overall Study|Other|0|||
161929936|NCT03808909|584792396|FG000|Overall Study|Lost to Follow-up|3|||
161929937|NCT03808909|584792397|FG001|Overall Study|Lost to Follow-up|0|||
161929938|NCT00676689|584792400|FG000|Overall Study|Screen Failure|2|||
161929939|NCT00676689|584792400|FG000|Overall Study|Death|2|||
161929940|NCT00676689|584792400|FG000|Overall Study|Lost to Follow-up|4|||
161929941|NCT00676689|584792400|FG000|Overall Study|Physician Decision|1|||
161822467|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161822468|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161929942|NCT00676689|584792400|FG000|Overall Study|Withdrawal by Subject|3|||
161929943|NCT00676689|584792400|FG000|Overall Study|Continuing FU|49|||
161929944|NCT01827943|584792401|FG000|Overall Study|Protocol Violation|8|||
161929945|NCT01827943|584792401|FG000|Overall Study|Never treated because of an rapid progression|1|||
161929946|NCT00501085|584792402|FG000|Overall Study|Lost to Follow-up|195|||
161929947|NCT00501085|584792402|FG000|Overall Study|Withdrawal by Subject|34|||
161929948|NCT00501085|584792402|FG000|Overall Study|Subject Decision|1|||
161929949|NCT00501085|584792402|FG000|Overall Study|Revision Surgery|7|||
161929950|NCT00501085|584792402|FG000|Overall Study|Explantation Surgery|26|||
161929951|NCT00501085|584792402|FG000|Overall Study|Adverse Event|4|||
161929952|NCT00501085|584792402|FG000|Overall Study|Non-Compliance|24|||
161929953|NCT00501085|584792402|FG000|Overall Study|Study closed by sponsor|109|||
161929954|NCT00501085|584792402|FG000|Overall Study|Other loss to follow-up|32|||
161929955|NCT01487161|584792403|FG000|Overall Study|Adverse Event|1|||
161929956|NCT01487161|584792404|FG001|Overall Study|Adverse Event|0|||
161822469|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161822470|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
161822471|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
161822472|NCT02004691|584391105|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
161822473|NCT02004691|584391106|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
161822474|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
161822475|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
161822476|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
161822477|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
161822478|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
161822479|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
161822480|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
161822481|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
161822482|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
161822483|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
161822484|NCT01726803|584391107|FG000|Overall Study|Lost to Follow-up|6|||
161822485|NCT01726803|584391108|FG001|Overall Study|Lost to Follow-up|1|||
161822486|NCT01726803|584391107|FG000|Overall Study|Withdrawal by Subject|1|||
161822487|NCT01726803|584391108|FG001|Overall Study|Withdrawal by Subject|0|||
161822488|NCT03407729|584391110|FG000|Overall Study|Lost to Follow-up|2|||
161822489|NCT03407729|584391111|FG001|Overall Study|Lost to Follow-up|0|||
161822490|NCT03407729|584391110|FG000|Overall Study|Unable to schedule|0|||
161822491|NCT03407729|584391111|FG001|Overall Study|Unable to schedule|3|||
161822492|NCT00024258|584391114|FG000|Overall Study|Withdrawal by Subject|1|||
161822493|NCT00024258|584391114|FG000|Overall Study|Disease Progression|8|||
161822494|NCT00830167|584391117|FG000|Overall Study|Lack of Efficacy|26|||
161822495|NCT00830167|584391118|FG001|Overall Study|Lack of Efficacy|10|||
161822496|NCT00830167|584391117|FG000|Overall Study|Adverse Event|8|||
161822497|NCT00830167|584391118|FG001|Overall Study|Adverse Event|24|||
161822498|NCT00830167|584391117|FG000|Overall Study|Not meeting entrance criteria|2|||
161822499|NCT00830167|584391118|FG001|Overall Study|Not meeting entrance criteria|5|||
161822500|NCT00830167|584391117|FG000|Overall Study|Withdrawal by Subject|2|||
161822501|NCT00830167|584391118|FG001|Overall Study|Withdrawal by Subject|0|||
161822502|NCT00830167|584391117|FG000|Overall Study|Lost to Follow-up|0|||
161822503|NCT00830167|584391118|FG001|Overall Study|Lost to Follow-up|1|||
161929957|NCT01487161|584792405|FG002|Overall Study|Adverse Event|0|||
161929958|NCT01487161|584792406|FG003|Overall Study|Adverse Event|0|||
161929959|NCT01487161|584792403|FG000|Overall Study|Withdrawal by Subject|1|||
161929960|NCT01487161|584792404|FG001|Overall Study|Withdrawal by Subject|1|||
161929961|NCT01487161|584792405|FG002|Overall Study|Withdrawal by Subject|1|||
161929962|NCT01487161|584792406|FG003|Overall Study|Withdrawal by Subject|2|||
161929963|NCT01487161|584792403|FG000|Overall Study|missing data|0|||
161929964|NCT01487161|584792404|FG001|Overall Study|missing data|1|||
161929965|NCT01487161|584792405|FG002|Overall Study|missing data|0|||
161929966|NCT01487161|584792406|FG003|Overall Study|missing data|0|||
161929967|NCT01084135|584792407|FG000|20 Week|Physician Decision|0|||
161929968|NCT01084135|584792408|FG001|20 Week|Physician Decision|1|||
161929969|NCT00663351|584792409|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
161929970|NCT00663351|584792410|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
161822504|NCT00830167|584391117|FG000|Overall Study|Protocol Violation|0|||
161822505|NCT00830167|584391118|FG001|Overall Study|Protocol Violation|1|||
161822506|NCT00830167|584391117|FG000|Overall Study|Other|2|||
161822507|NCT00830167|584391118|FG001|Overall Study|Other|2|||
161676895|NCT01829425|583870601|FG001|Overall Study|Withdrawal by Subject|3|||
161676896|NCT01829425|583870600|FG000|Overall Study|Lost to Follow-up|2|||
161676897|NCT01829425|583870601|FG001|Overall Study|Lost to Follow-up|1|||
161676898|NCT03681951|583870602|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
161676899|NCT03681951|583870603|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676900|NCT03681951|583870604|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676901|NCT03681951|583870605|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676902|NCT03681951|583870606|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676903|NCT03681951|583870607|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676904|NCT03681951|583870608|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676905|NCT03681951|583870609|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676906|NCT03681951|583870602|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
161929971|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
161929972|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
161929973|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
161929974|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
161929975|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
161929976|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
161929977|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
161929978|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
161929979|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
161929980|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
161929981|NCT02366130|584792411|FG000|Overall Study|Withdrawal by Subject|3|||
161929982|NCT02366130|584792411|FG000|Overall Study|Ineligible|6|||
161929983|NCT01065766|584792412|FG000|Overall Study|Assessed before the contracted date|1|||
161929984|NCT01065766|584792412|FG000|Overall Study|Contraindication to administration|6|||
161929985|NCT01065766|584792412|FG000|Overall Study|Violated dosage/administration|25|||
161929986|NCT01608308|584792416|FG000|Overall Study|pretreatment medical and billing reasons|0|||
161929987|NCT01608308|584792417|FG001|Overall Study|pretreatment medical and billing reasons|2|||
161929988|NCT03113136|584792418|FG000|Overall Study|Lost to Follow-up|22|||
161929989|NCT03113136|584792419|FG001|Overall Study|Lost to Follow-up|47|||
161929990|NCT03113136|584792420|FG002|Overall Study|Lost to Follow-up|54|||
161929991|NCT03113136|584792418|FG000|Overall Study|Withdrawal by Subject|4|||
161929992|NCT03113136|584792419|FG001|Overall Study|Withdrawal by Subject|13|||
161929993|NCT03113136|584792420|FG002|Overall Study|Withdrawal by Subject|14|||
161929994|NCT03113136|584792418|FG000|Overall Study|Ineligible|0|||
161929995|NCT03113136|584792419|FG001|Overall Study|Ineligible|2|||
161929996|NCT03113136|584792420|FG002|Overall Study|Ineligible|1|||
161929997|NCT03113136|584792418|FG000|Overall Study|Study Team Decision|1|||
161929998|NCT03113136|584792419|FG001|Overall Study|Study Team Decision|4|||
161929999|NCT03113136|584792420|FG002|Overall Study|Study Team Decision|0|||
161930000|NCT02362412|584792426|FG000|Treatment Period III|Lost to Follow-up|0|||
161930001|NCT02362412|584792427|FG001|Treatment Period III|Lost to Follow-up|1|||
161930002|NCT02675452|584792429|FG000|Overall Study|Sponsor decision|0|||
161930003|NCT02675452|584792430|FG001|Overall Study|Sponsor decision|0|||
161930004|NCT02675452|584792431|FG002|Overall Study|Sponsor decision|0|||
161930005|NCT02675452|584792432|FG003|Overall Study|Sponsor decision|0|||
161676907|NCT03681951|583870603|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676908|NCT03681951|583870604|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676909|NCT03681951|583870605|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676910|NCT03681951|583870606|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676911|NCT03681951|583870607|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676912|NCT03681951|583870608|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676913|NCT03681951|583870609|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676914|NCT03681951|583870602|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
161676915|NCT03681951|583870603|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676916|NCT03681951|583870604|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676917|NCT03681951|583870605|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676918|NCT03681951|583870606|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676919|NCT03681951|583870607|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676920|NCT03681951|583870608|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676921|NCT03681951|583870609|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676922|NCT01020448|583870610|FG000|Pre-assignment|Adverse Event|6|||
161676923|NCT01020448|583870610|FG000|Pre-assignment|Withdrawal by Subject|5|||
161930006|NCT02675452|584792433|FG004|Overall Study|Sponsor decision|0|||
161930007|NCT02675452|584792434|FG005|Overall Study|Sponsor decision|0|||
161930008|NCT02675452|584792435|FG006|Overall Study|Sponsor decision|0|||
161930009|NCT02675452|584792436|FG007|Overall Study|Sponsor decision|0|||
161930010|NCT02675452|584792437|FG008|Overall Study|Sponsor decision|0|||
161930011|NCT02675452|584792438|FG009|Overall Study|Sponsor decision|1|||
161930012|NCT02675452|584792439|FG010|Overall Study|Sponsor decision|0|||
161822508|NCT03428945|584391119|FG000|Overall Study|Lost to Follow-up|5|||
161822509|NCT03428945|584391120|FG001|Overall Study|Lost to Follow-up|3|||
161822510|NCT03428945|584391119|FG000|Overall Study|Withdrawal by Subject|10|||
161822511|NCT03428945|584391120|FG001|Overall Study|Withdrawal by Subject|10|||
161822512|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
161822513|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
161822514|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
161822515|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
161822516|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
161822517|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
161822518|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
161822519|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
161822520|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
161822521|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
161822522|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
161822523|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
161822524|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
161822525|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
161822526|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
161822527|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
161822528|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
161822529|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
161822530|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
161822531|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
161822532|NCT00360490|584391126|FG000|Overall Study|Adverse Event|4|||
161822533|NCT00360490|584391127|FG001|Overall Study|Adverse Event|2|||
161822534|NCT00360490|584391126|FG000|Overall Study|Lost to Follow-up|2|||
161822535|NCT00360490|584391127|FG001|Overall Study|Lost to Follow-up|1|||
161822536|NCT00360490|584391126|FG000|Overall Study|Physician Decision|2|||
161822537|NCT00360490|584391127|FG001|Overall Study|Physician Decision|1|||
161822538|NCT00360490|584391126|FG000|Overall Study|Protocol Violation|0|||
161822539|NCT00360490|584391127|FG001|Overall Study|Protocol Violation|4|||
161822540|NCT00360490|584391126|FG000|Overall Study|Withdrawal by Subject|1|||
161822541|NCT00360490|584391127|FG001|Overall Study|Withdrawal by Subject|3|||
161822542|NCT02289820|584391128|FG000|Overall Study|Withdrawal by Subject|2|||
161822543|NCT02289820|584391129|FG001|Overall Study|Withdrawal by Subject|1|||
161822544|NCT02289820|584391130|FG002|Overall Study|Withdrawal by Subject|2|||
161822545|NCT02289820|584391131|FG003|Overall Study|Withdrawal by Subject|1|||
161822546|NCT02289820|584391132|FG004|Overall Study|Withdrawal by Subject|0|||
161822547|NCT02289820|584391133|FG005|Overall Study|Withdrawal by Subject|0|||
161822548|NCT02289820|584391134|FG006|Overall Study|Withdrawal by Subject|1|||
161822549|NCT02289820|584391128|FG000|Overall Study|Death|0|||
161822550|NCT02289820|584391129|FG001|Overall Study|Death|0|||
161822551|NCT02289820|584391130|FG002|Overall Study|Death|1|||
161822552|NCT02289820|584391131|FG003|Overall Study|Death|0|||
161822553|NCT02289820|584391132|FG004|Overall Study|Death|0|||
161822554|NCT02289820|584391133|FG005|Overall Study|Death|0|||
161822555|NCT02289820|584391134|FG006|Overall Study|Death|0|||
161822556|NCT02289820|584391128|FG000|Overall Study|Lost to Follow-up|0|||
161822557|NCT02289820|584391129|FG001|Overall Study|Lost to Follow-up|0|||
161822558|NCT02289820|584391130|FG002|Overall Study|Lost to Follow-up|3|||
161822559|NCT02289820|584391131|FG003|Overall Study|Lost to Follow-up|1|||
161822560|NCT02289820|584391132|FG004|Overall Study|Lost to Follow-up|0|||
161822561|NCT02289820|584391133|FG005|Overall Study|Lost to Follow-up|1|||
161822562|NCT02289820|584391134|FG006|Overall Study|Lost to Follow-up|1|||
161822563|NCT02289820|584391128|FG000|Overall Study|withdrawal of consent|0|||
161822564|NCT02289820|584391129|FG001|Overall Study|withdrawal of consent|1|||
161822565|NCT02289820|584391130|FG002|Overall Study|withdrawal of consent|0|||
161822566|NCT02289820|584391131|FG003|Overall Study|withdrawal of consent|0|||
161822567|NCT02289820|584391132|FG004|Overall Study|withdrawal of consent|0|||
161822568|NCT02289820|584391133|FG005|Overall Study|withdrawal of consent|0|||
161822569|NCT02289820|584391134|FG006|Overall Study|withdrawal of consent|0|||
161822570|NCT02005276|584391135|FG000|Overall Study|No longer interested|5|||
161822571|NCT02005276|584391136|FG001|Overall Study|No longer interested|2|||
161822572|NCT02005276|584391137|FG002|Overall Study|No longer interested|3|||
161822573|NCT02005276|584391138|FG003|Overall Study|No longer interested|3|||
161822574|NCT00124618|584391139|FG000|Overall Study|Ineligible|1|||
161822575|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
161822576|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
161930013|NCT02675452|584792440|FG011|Overall Study|Sponsor decision|0|||
161822577|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
161822578|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
161822579|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
161930014|NCT02675452|584792441|FG012|Overall Study|Sponsor decision|0|||
161822580|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
161930015|NCT02675452|584792442|FG013|Overall Study|Sponsor decision|2|||
161822581|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
161930016|NCT02675452|584792443|FG014|Overall Study|Sponsor decision|1|||
161930017|NCT02675452|584792444|FG015|Overall Study|Sponsor decision|0|||
161930018|NCT02675452|584792445|FG016|Overall Study|Sponsor decision|1|||
161930019|NCT02675452|584792446|FG017|Overall Study|Sponsor decision|0|||
161930020|NCT02675452|584792447|FG018|Overall Study|Sponsor decision|0|||
161930021|NCT02675452|584792448|FG019|Overall Study|Sponsor decision|0|||
161930022|NCT02675452|584792449|FG020|Overall Study|Sponsor decision|0|||
161930023|NCT02675452|584792450|FG021|Overall Study|Sponsor decision|0|||
161930024|NCT02675452|584792451|FG022|Overall Study|Sponsor decision|0|||
161930025|NCT02675452|584792452|FG023|Overall Study|Sponsor decision|0|||
161930026|NCT02675452|584792453|FG024|Overall Study|Sponsor decision|0|||
161930027|NCT02675452|584792454|FG025|Overall Study|Sponsor decision|0|||
161930028|NCT02675452|584792455|FG026|Overall Study|Sponsor decision|2|||
161930029|NCT02675452|584792456|FG027|Overall Study|Sponsor decision|0|||
161930030|NCT02675452|584792457|FG028|Overall Study|Sponsor decision|0|||
161930031|NCT02675452|584792429|FG000|Overall Study|Withdrawal by Subject|0|||
161930032|NCT02675452|584792430|FG001|Overall Study|Withdrawal by Subject|0|||
161930033|NCT02675452|584792431|FG002|Overall Study|Withdrawal by Subject|0|||
161930034|NCT02675452|584792432|FG003|Overall Study|Withdrawal by Subject|0|||
161930035|NCT02675452|584792433|FG004|Overall Study|Withdrawal by Subject|0|||
161930036|NCT02675452|584792434|FG005|Overall Study|Withdrawal by Subject|0|||
161930037|NCT02675452|584792435|FG006|Overall Study|Withdrawal by Subject|0|||
161930038|NCT02675452|584792436|FG007|Overall Study|Withdrawal by Subject|0|||
161930039|NCT02675452|584792437|FG008|Overall Study|Withdrawal by Subject|0|||
161930040|NCT02675452|584792438|FG009|Overall Study|Withdrawal by Subject|1|||
161930041|NCT02675452|584792439|FG010|Overall Study|Withdrawal by Subject|0|||
161930042|NCT02675452|584792440|FG011|Overall Study|Withdrawal by Subject|1|||
161930043|NCT02675452|584792441|FG012|Overall Study|Withdrawal by Subject|0|||
161930044|NCT02675452|584792442|FG013|Overall Study|Withdrawal by Subject|1|||
161930045|NCT02675452|584792443|FG014|Overall Study|Withdrawal by Subject|1|||
161930046|NCT02675452|584792444|FG015|Overall Study|Withdrawal by Subject|0|||
161930047|NCT02675452|584792445|FG016|Overall Study|Withdrawal by Subject|2|||
161930048|NCT02675452|584792446|FG017|Overall Study|Withdrawal by Subject|0|||
161930049|NCT02675452|584792447|FG018|Overall Study|Withdrawal by Subject|0|||
161930050|NCT02675452|584792448|FG019|Overall Study|Withdrawal by Subject|0|||
161930051|NCT02675452|584792449|FG020|Overall Study|Withdrawal by Subject|0|||
161930052|NCT02675452|584792450|FG021|Overall Study|Withdrawal by Subject|0|||
161930053|NCT02675452|584792451|FG022|Overall Study|Withdrawal by Subject|3|||
161930054|NCT02675452|584792452|FG023|Overall Study|Withdrawal by Subject|0|||
161930055|NCT02675452|584792453|FG024|Overall Study|Withdrawal by Subject|1|||
161930056|NCT02675452|584792454|FG025|Overall Study|Withdrawal by Subject|0|||
161930057|NCT02675452|584792455|FG026|Overall Study|Withdrawal by Subject|1|||
161930058|NCT02675452|584792456|FG027|Overall Study|Withdrawal by Subject|3|||
161930059|NCT02675452|584792457|FG028|Overall Study|Withdrawal by Subject|4|||
161930060|NCT02675452|584792429|FG000|Overall Study|Death|0|||
161930061|NCT02675452|584792430|FG001|Overall Study|Death|0|||
161930062|NCT02675452|584792431|FG002|Overall Study|Death|1|||
161930063|NCT02675452|584792432|FG003|Overall Study|Death|0|||
161930064|NCT02675452|584792433|FG004|Overall Study|Death|0|||
161930065|NCT02675452|584792434|FG005|Overall Study|Death|1|||
161822582|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
161822583|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
161822584|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
161822585|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
161822586|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
161822587|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
161822588|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
161930066|NCT02675452|584792435|FG006|Overall Study|Death|0|||
161930067|NCT02675452|584792436|FG007|Overall Study|Death|0|||
161930068|NCT02675452|584792437|FG008|Overall Study|Death|1|||
161930069|NCT02675452|584792438|FG009|Overall Study|Death|0|||
161930070|NCT02675452|584792439|FG010|Overall Study|Death|0|||
161930071|NCT02675452|584792440|FG011|Overall Study|Death|0|||
161930072|NCT02675452|584792441|FG012|Overall Study|Death|1|||
161930073|NCT02675452|584792442|FG013|Overall Study|Death|0|||
161930074|NCT02675452|584792443|FG014|Overall Study|Death|0|||
161930075|NCT02675452|584792444|FG015|Overall Study|Death|2|||
161930076|NCT02675452|584792445|FG016|Overall Study|Death|0|||
161930077|NCT02675452|584792446|FG017|Overall Study|Death|0|||
161930078|NCT02675452|584792447|FG018|Overall Study|Death|4|||
161930079|NCT02675452|584792448|FG019|Overall Study|Death|3|||
161930080|NCT02675452|584792449|FG020|Overall Study|Death|3|||
161930081|NCT02675452|584792450|FG021|Overall Study|Death|3|||
161930082|NCT02675452|584792451|FG022|Overall Study|Death|7|||
161822589|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
161822590|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
161822591|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
161822592|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
161822593|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
161822594|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
161822595|NCT00950300|584391140|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
161822596|NCT00950300|584391141|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
161822597|NCT00950300|584391140|FG000|TFFU Period|Death|4|||
161822598|NCT00950300|584391141|FG001|TFFU Period|Death|1|||
161822599|NCT00950300|584391140|FG000|TFFU Period|Refused Treatment|10|||
161822600|NCT00950300|584391141|FG001|TFFU Period|Refused Treatment|11|||
161822601|NCT00950300|584391140|FG000|TFFU Period|Failure to Return|16|||
161822602|NCT00950300|584391141|FG001|TFFU Period|Failure to Return|16|||
161822603|NCT00950300|584391140|FG000|TFFU Period|Recurrence of Disease|63|||
161822604|NCT00950300|584391141|FG001|TFFU Period|Recurrence of Disease|72|||
161822605|NCT00950300|584391140|FG000|TFFU Period|Other|4|||
161822606|NCT00950300|584391141|FG001|TFFU Period|Other|3|||
161822607|NCT00950300|584391140|FG000|SFU Period|Death|44|||
161822608|NCT00950300|584391141|FG001|SFU Period|Death|42|||
161822609|NCT00950300|584391140|FG000|SFU Period|Lost to Follow-up|30|||
161822610|NCT00950300|584391141|FG001|SFU Period|Lost to Follow-up|28|||
161822611|NCT00950300|584391140|FG000|SFU Period|Withdrawal by Subject|4|||
161822612|NCT00950300|584391141|FG001|SFU Period|Withdrawal by Subject|8|||
161822613|NCT04750239|584391142|FG000|Overall Study|Withdrawal by Subject|2|||
161822614|NCT04750239|584391142|FG000|Overall Study|Trial terminated by sponsor|1|||
161822615|NCT01912807|584391143|FG000|Overall Study|Did not meet elegibility criteria|6|||
161822616|NCT01912807|584391144|FG001|Overall Study|Did not meet elegibility criteria|4|||
161822617|NCT01912807|584391143|FG000|Overall Study|Lost to Follow-up|36|||
161822618|NCT01912807|584391144|FG001|Overall Study|Lost to Follow-up|37|||
161822619|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Adverse Event|8|||
161822620|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Adverse Event|5|||
161822621|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Adverse Event|9|||
161822622|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Adverse Event|0|||
161822623|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Adverse Event|0|||
161822624|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Adverse Event|0|||
161822625|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
161822626|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
161822627|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
161822628|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
161822629|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
161822630|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
161822631|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
161822632|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
161822633|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
161822634|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
161822635|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
161822636|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
161822637|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Physician Decision|4|||
161822638|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Physician Decision|0|||
161822639|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Physician Decision|2|||
161822640|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Physician Decision|0|||
161822641|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Physician Decision|0|||
161822642|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Physician Decision|0|||
161822643|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Pregnancy|1|||
161822644|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Pregnancy|2|||
161822645|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Pregnancy|0|||
161822646|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Pregnancy|0|||
161822647|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Pregnancy|0|||
161822648|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Pregnancy|0|||
161822649|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
161822650|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
161822651|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
161822652|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
161822653|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
161822654|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
161822655|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
161822656|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822657|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822658|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822659|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822660|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822661|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
161930083|NCT02675452|584792452|FG023|Overall Study|Death|5|||
161822662|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
161930084|NCT02675452|584792453|FG024|Overall Study|Death|3|||
161930085|NCT02675452|584792454|FG025|Overall Study|Death|4|||
161930086|NCT02675452|584792455|FG026|Overall Study|Death|7|||
161930087|NCT02675452|584792456|FG027|Overall Study|Death|6|||
161930088|NCT02675452|584792457|FG028|Overall Study|Death|9|||
161930089|NCT02675452|584792429|FG000|Overall Study|Lost to Follow-up|0|||
161930090|NCT02675452|584792430|FG001|Overall Study|Lost to Follow-up|1|||
161930091|NCT02675452|584792431|FG002|Overall Study|Lost to Follow-up|0|||
161930092|NCT02675452|584792432|FG003|Overall Study|Lost to Follow-up|0|||
161930093|NCT02675452|584792433|FG004|Overall Study|Lost to Follow-up|0|||
161930094|NCT02675452|584792434|FG005|Overall Study|Lost to Follow-up|0|||
161930095|NCT02675452|584792435|FG006|Overall Study|Lost to Follow-up|0|||
161930096|NCT02675452|584792436|FG007|Overall Study|Lost to Follow-up|0|||
161930097|NCT02675452|584792437|FG008|Overall Study|Lost to Follow-up|0|||
161930098|NCT02675452|584792438|FG009|Overall Study|Lost to Follow-up|0|||
161822663|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
161822664|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
161822665|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161822666|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161822667|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
161822668|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
161822669|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
161822670|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
161822671|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
161822672|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
161822673|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
161822674|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161822675|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161822676|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161822677|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
161822678|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161822679|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
161822680|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
161822681|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
161822682|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
161822683|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
161822684|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
161822685|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822686|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
161822687|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822688|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822689|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
161822690|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822691|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
161822692|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161822693|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
161822694|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161822695|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161822696|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161822697|NCT01539239|584391151|FG000|Overall Study|Death|5|||
161822698|NCT01539239|584391152|FG001|Overall Study|Death|5|||
161822699|NCT01539239|584391151|FG000|Overall Study|Lost to Follow-up|7|||
161822700|NCT01539239|584391152|FG001|Overall Study|Lost to Follow-up|12|||
161822701|NCT01562613|584391153|FG000|Overall Study|Lost to Follow-up|2|||
161822702|NCT01562613|584391153|FG000|Overall Study|Withdrawal by Subject|2|||
161822703|NCT00633022|584391158|FG000|Overall Study|Adverse Event|1|||
161930099|NCT02675452|584792439|FG010|Overall Study|Lost to Follow-up|0|||
161930100|NCT02675452|584792440|FG011|Overall Study|Lost to Follow-up|0|||
161930101|NCT02675452|584792441|FG012|Overall Study|Lost to Follow-up|1|||
161930102|NCT02675452|584792442|FG013|Overall Study|Lost to Follow-up|0|||
161930103|NCT02675452|584792443|FG014|Overall Study|Lost to Follow-up|0|||
161822704|NCT00633022|584391159|FG001|Overall Study|Adverse Event|0|||
161822705|NCT00633022|584391160|FG002|Overall Study|Adverse Event|5|||
161822706|NCT00633022|584391158|FG000|Overall Study|Physician Decision|0|||
161822707|NCT00633022|584391159|FG001|Overall Study|Physician Decision|1|||
161930104|NCT02675452|584792444|FG015|Overall Study|Lost to Follow-up|0|||
161930105|NCT02675452|584792445|FG016|Overall Study|Lost to Follow-up|0|||
161930106|NCT02675452|584792446|FG017|Overall Study|Lost to Follow-up|0|||
161930107|NCT02675452|584792447|FG018|Overall Study|Lost to Follow-up|0|||
161930108|NCT02675452|584792448|FG019|Overall Study|Lost to Follow-up|0|||
161930109|NCT02675452|584792449|FG020|Overall Study|Lost to Follow-up|0|||
161930110|NCT02675452|584792450|FG021|Overall Study|Lost to Follow-up|0|||
161930111|NCT02675452|584792451|FG022|Overall Study|Lost to Follow-up|0|||
161930112|NCT02675452|584792452|FG023|Overall Study|Lost to Follow-up|0|||
161930113|NCT02675452|584792453|FG024|Overall Study|Lost to Follow-up|0|||
161930114|NCT02675452|584792454|FG025|Overall Study|Lost to Follow-up|0|||
161930115|NCT02675452|584792455|FG026|Overall Study|Lost to Follow-up|1|||
161930116|NCT02675452|584792456|FG027|Overall Study|Lost to Follow-up|0|||
161930117|NCT02675452|584792457|FG028|Overall Study|Lost to Follow-up|0|||
161930118|NCT02675452|584792429|FG000|Overall Study|Other|0|||
161930119|NCT02675452|584792430|FG001|Overall Study|Other|0|||
161930120|NCT02675452|584792431|FG002|Overall Study|Other|0|||
161930121|NCT02675452|584792432|FG003|Overall Study|Other|0|||
161930122|NCT02675452|584792433|FG004|Overall Study|Other|0|||
161930123|NCT02675452|584792434|FG005|Overall Study|Other|0|||
161930124|NCT02675452|584792435|FG006|Overall Study|Other|0|||
161930125|NCT02675452|584792436|FG007|Overall Study|Other|0|||
161930126|NCT02675452|584792437|FG008|Overall Study|Other|0|||
161930127|NCT02675452|584792438|FG009|Overall Study|Other|0|||
161930128|NCT02675452|584792439|FG010|Overall Study|Other|0|||
161930129|NCT02675452|584792440|FG011|Overall Study|Other|0|||
161930130|NCT02675452|584792441|FG012|Overall Study|Other|0|||
161930131|NCT02675452|584792442|FG013|Overall Study|Other|0|||
161930132|NCT02675452|584792443|FG014|Overall Study|Other|0|||
161930133|NCT02675452|584792444|FG015|Overall Study|Other|0|||
161930134|NCT02675452|584792445|FG016|Overall Study|Other|0|||
161930135|NCT02675452|584792446|FG017|Overall Study|Other|0|||
161930136|NCT02675452|584792447|FG018|Overall Study|Other|0|||
161930137|NCT02675452|584792448|FG019|Overall Study|Other|0|||
161930138|NCT02675452|584792449|FG020|Overall Study|Other|0|||
161930139|NCT02675452|584792450|FG021|Overall Study|Other|0|||
161930140|NCT02675452|584792451|FG022|Overall Study|Other|0|||
161930141|NCT02675452|584792452|FG023|Overall Study|Other|0|||
161930142|NCT02675452|584792453|FG024|Overall Study|Other|0|||
161930143|NCT02675452|584792454|FG025|Overall Study|Other|0|||
161930144|NCT02675452|584792455|FG026|Overall Study|Other|1|||
161930145|NCT02675452|584792456|FG027|Overall Study|Other|0|||
161930146|NCT02675452|584792457|FG028|Overall Study|Other|0|||
161930147|NCT00977561|584792458|FG000|Overall Study|Death|3|||
161930148|NCT00977561|584792459|FG001|Overall Study|Death|2|||
161930149|NCT00977561|584792458|FG000|Overall Study|Study terminated|0|||
161930150|NCT00977561|584792459|FG001|Overall Study|Study terminated|2|||
161930151|NCT00977561|584792458|FG000|Overall Study|Other|2|||
161930152|NCT00977561|584792459|FG001|Overall Study|Other|0|||
161930153|NCT04595370|584792460|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
161930154|NCT04595370|584792461|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930155|NCT04595370|584792462|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930156|NCT04595370|584792463|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930157|NCT04595370|584792464|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930158|NCT04595370|584792465|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930159|NCT04595370|584792460|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930160|NCT04595370|584792461|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930161|NCT04595370|584792462|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
161930162|NCT04595370|584792463|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930163|NCT04595370|584792464|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930164|NCT04595370|584792465|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930165|NCT04595370|584792460|FG000|Overall Study|Adverse Event|0|||
161930166|NCT04595370|584792461|FG001|Overall Study|Adverse Event|4|||
161930167|NCT04595370|584792462|FG002|Overall Study|Adverse Event|3|||
161930168|NCT04595370|584792463|FG003|Overall Study|Adverse Event|1|||
161930169|NCT04595370|584792464|FG004|Overall Study|Adverse Event|1|||
161930170|NCT04595370|584792465|FG005|Overall Study|Adverse Event|1|||
161930171|NCT04595370|584792460|FG000|Overall Study|Withdrawal of Consent|1|||
161930172|NCT04595370|584792461|FG001|Overall Study|Withdrawal of Consent|1|||
161930173|NCT04595370|584792462|FG002|Overall Study|Withdrawal of Consent|1|||
161930174|NCT04595370|584792463|FG003|Overall Study|Withdrawal of Consent|0|||
161930175|NCT04595370|584792464|FG004|Overall Study|Withdrawal of Consent|0|||
161930176|NCT04595370|584792465|FG005|Overall Study|Withdrawal of Consent|0|||
161930177|NCT04595370|584792460|FG000|Overall Study|Death|0|||
161930178|NCT04595370|584792461|FG001|Overall Study|Death|1|||
161930179|NCT04595370|584792462|FG002|Overall Study|Death|0|||
161930180|NCT04595370|584792463|FG003|Overall Study|Death|0|||
161930181|NCT04595370|584792464|FG004|Overall Study|Death|1|||
161930182|NCT04595370|584792465|FG005|Overall Study|Death|0|||
161930183|NCT04595370|584792460|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930184|NCT04595370|584792461|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930185|NCT04595370|584792462|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161930186|NCT04595370|584792463|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930187|NCT04595370|584792464|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930188|NCT04595370|584792465|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930189|NCT04595370|584792460|FG000|Overall Study|Withdrawal by Subject|0|||
161930190|NCT04595370|584792461|FG001|Overall Study|Withdrawal by Subject|0|||
161930191|NCT04595370|584792462|FG002|Overall Study|Withdrawal by Subject|1|||
161930192|NCT04595370|584792463|FG003|Overall Study|Withdrawal by Subject|0|||
161930193|NCT04595370|584792464|FG004|Overall Study|Withdrawal by Subject|2|||
161930194|NCT04595370|584792465|FG005|Overall Study|Withdrawal by Subject|0|||
161930195|NCT04595370|584792460|FG000|Overall Study|Lost to Follow-up|0|||
161930196|NCT04595370|584792461|FG001|Overall Study|Lost to Follow-up|0|||
161930197|NCT04595370|584792462|FG002|Overall Study|Lost to Follow-up|0|||
161930198|NCT04595370|584792463|FG003|Overall Study|Lost to Follow-up|0|||
161930199|NCT04595370|584792464|FG004|Overall Study|Lost to Follow-up|1|||
161930200|NCT04595370|584792465|FG005|Overall Study|Lost to Follow-up|0|||
161930201|NCT04595370|584792460|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
161930202|NCT04595370|584792461|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
161930203|NCT04595370|584792462|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
161930204|NCT04595370|584792463|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
161930205|NCT04595370|584792464|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
161930206|NCT04595370|584792465|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
161930207|NCT03520387|584792466|FG000|Pre-Randomization|Withdrawal by Subject|1|||
161930208|NCT03520387|584792467|FG001|Pre-Randomization|Withdrawal by Subject|0|||
161930209|NCT03520387|584792468|FG002|Pre-Randomization|Withdrawal by Subject|0|||
161930210|NCT03520387|584792469|FG003|Pre-Randomization|Withdrawal by Subject|0|||
161930211|NCT03520387|584792470|FG004|Pre-Randomization|Withdrawal by Subject|0|||
161930212|NCT03520387|584792466|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
161930213|NCT03520387|584792467|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930214|NCT03520387|584792468|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930215|NCT03520387|584792469|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930216|NCT03520387|584792470|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930217|NCT00541775|584792471|FG000|Overall Study|Adverse Event|3|||
161930218|NCT00541775|584792472|FG001|Overall Study|Adverse Event|2|||
161930219|NCT00541775|584792473|FG002|Overall Study|Adverse Event|1|||
161930220|NCT00541775|584792471|FG000|Overall Study|Lack of Efficacy|0|||
161930221|NCT00541775|584792472|FG001|Overall Study|Lack of Efficacy|0|||
161930222|NCT00541775|584792473|FG002|Overall Study|Lack of Efficacy|3|||
161930223|NCT00541775|584792471|FG000|Overall Study|Lost to Follow-up|0|||
161930224|NCT00541775|584792472|FG001|Overall Study|Lost to Follow-up|0|||
161930225|NCT00541775|584792473|FG002|Overall Study|Lost to Follow-up|2|||
161930226|NCT00541775|584792471|FG000|Overall Study|Protocol Violation|1|||
161930227|NCT00541775|584792472|FG001|Overall Study|Protocol Violation|0|||
161930228|NCT00541775|584792473|FG002|Overall Study|Protocol Violation|0|||
161930229|NCT00541775|584792471|FG000|Overall Study|Withdrawal by Subject and Other|5|||
161930230|NCT00541775|584792472|FG001|Overall Study|Withdrawal by Subject and Other|0|||
161930231|NCT00541775|584792473|FG002|Overall Study|Withdrawal by Subject and Other|2|||
161930232|NCT01945242|584792474|FG000|Overall Study|Physician Decision|3|||
161930233|NCT01945242|584792475|FG001|Overall Study|Physician Decision|3|||
161930234|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Death|0|||
161930235|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Death|2|||
161676924|NCT01020448|583870610|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
161930236|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Death|2|||
161930237|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Death|0|||
161930238|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
161930239|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
161930240|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
161930241|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
161930242|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
161930243|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
161930244|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
161930245|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
161930246|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
161515598|NCT01040871|583278447|FG000|Overall Study|Lack of Efficacy|1|||
161515599|NCT01040871|583278448|FG001|Overall Study|Lack of Efficacy|1|||
161515600|NCT01040871|583278447|FG000|Overall Study|drug supply issue|1|||
161515601|NCT01040871|583278448|FG001|Overall Study|drug supply issue|0|||
161515602|NCT01040871|583278447|FG000|Overall Study|Randomized and Not Treated|2|||
161676925|NCT01020448|583870610|FG000|Treatment|Adverse Event|11|||
161930247|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
161930248|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
161930249|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
161930250|NCT04913675|584792477|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
161930251|NCT04913675|584792478|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
161930252|NCT04913675|584792479|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
161676926|NCT01020448|583870610|FG000|Treatment|Consent Withdrawn|3|||
161822708|NCT00633022|584391160|FG002|Overall Study|Physician Decision|0|||
161822709|NCT00663234|584391162|FG000|Overall Study|Not willing to adhere to requirements|1|||
161822710|NCT01253564|584391165|FG000|Overall Study|Disease Progression|22|||
161822711|NCT01253564|584391165|FG000|Overall Study|Withdrawal by Subject|1|||
161822712|NCT01253564|584391165|FG000|Overall Study|Serious Adverse Event|1|||
161822713|NCT02129062|584392418|FG000|Overall Study|Death|1|||
161822714|NCT02129062|584392418|FG000|Overall Study|Disease Progression|2|||
161822715|NCT04662710|584392419|FG000|Overall Study|Death|14|||
161822716|NCT04662710|584392420|FG001|Overall Study|Death|331|||
161822717|NCT04662710|584392421|FG002|Overall Study|Death|367|||
161822718|NCT04662710|584392419|FG000|Overall Study|Ongoing|1|||
161822719|NCT04662710|584392420|FG001|Overall Study|Ongoing|109|||
161822720|NCT04662710|584392421|FG002|Overall Study|Ongoing|56|||
161822721|NCT04662710|584392419|FG000|Overall Study|Withdrawal by Subject|0|||
161822722|NCT04662710|584392420|FG001|Overall Study|Withdrawal by Subject|3|||
161822723|NCT04662710|584392421|FG002|Overall Study|Withdrawal by Subject|14|||
161822724|NCT02722616|584392423|FG000|Overall Study|Sponsor closed study after one month|2|||
161822725|NCT02722616|584392424|FG001|Overall Study|Sponsor closed study after one month|0|||
161822726|NCT02722616|584392425|FG002|Overall Study|Sponsor closed study after one month|0|||
161822727|NCT00224484|584392426|FG000|Overall Study|Serious Adverse Event|1|||
161822728|NCT00224484|584392427|FG001|Overall Study|Serious Adverse Event|1|||
161822729|NCT00224484|584392428|FG002|Overall Study|Serious Adverse Event|0|||
161822730|NCT00224484|584392426|FG000|Overall Study|Non-Serious Adverse Event|5|||
161822731|NCT00224484|584392427|FG001|Overall Study|Non-Serious Adverse Event|7|||
161822732|NCT00224484|584392428|FG002|Overall Study|Non-Serious Adverse Event|3|||
161822733|NCT00224484|584392426|FG000|Overall Study|Protocol Violation|2|||
161822734|NCT00224484|584392427|FG001|Overall Study|Protocol Violation|2|||
161822735|NCT00224484|584392428|FG002|Overall Study|Protocol Violation|0|||
161822736|NCT00224484|584392426|FG000|Overall Study|Withdrawal by Subject|49|||
161822737|NCT00224484|584392427|FG001|Overall Study|Withdrawal by Subject|18|||
161822738|NCT00224484|584392428|FG002|Overall Study|Withdrawal by Subject|16|||
161822739|NCT00224484|584392426|FG000|Overall Study|Migrated/moved from study area|18|||
161822740|NCT00224484|584392427|FG001|Overall Study|Migrated/moved from study area|5|||
161822741|NCT00224484|584392428|FG002|Overall Study|Migrated/moved from study area|5|||
161822742|NCT00224484|584392426|FG000|Overall Study|Lost to Follow-up|66|||
161822743|NCT00224484|584392427|FG001|Overall Study|Lost to Follow-up|28|||
161822744|NCT00224484|584392428|FG002|Overall Study|Lost to Follow-up|36|||
161822745|NCT00224484|584392426|FG000|Overall Study|Reason not specified|5|||
161822746|NCT00224484|584392427|FG001|Overall Study|Reason not specified|4|||
161515603|NCT01040871|583278448|FG001|Overall Study|Randomized and Not Treated|1|||
161515604|NCT02886572|583278449|FG000|Overall Study|Death|8|||
161822747|NCT00224484|584392428|FG002|Overall Study|Reason not specified|2|||
161822748|NCT00108628|584392431|FG000|Overall Study|Withdrawal by Subject|17|||
161822749|NCT00108628|584392432|FG001|Overall Study|Withdrawal by Subject|9|||
161822750|NCT00108628|584392431|FG000|Overall Study|Lack of Efficacy|2|||
161822751|NCT00108628|584392432|FG001|Overall Study|Lack of Efficacy|1|||
161822752|NCT00108628|584392431|FG000|Overall Study|Death|1|||
161822753|NCT00108628|584392432|FG001|Overall Study|Death|0|||
161822754|NCT01453153|584392433|FG000|Overall Study|Physician Decision|0|||
161822755|NCT01453153|584392434|FG001|Overall Study|Physician Decision|0|||
161822756|NCT01453153|584392435|FG002|Overall Study|Physician Decision|1|||
161822757|NCT01453153|584392433|FG000|Overall Study|Progressive Disease|3|||
161822758|NCT01453153|584392434|FG001|Overall Study|Progressive Disease|2|||
161822759|NCT01453153|584392435|FG002|Overall Study|Progressive Disease|16|||
161822760|NCT01453153|584392433|FG000|Overall Study|Withdrawal by Subject|0|||
161822761|NCT01453153|584392434|FG001|Overall Study|Withdrawal by Subject|1|||
161822762|NCT01453153|584392435|FG002|Overall Study|Withdrawal by Subject|2|||
161822763|NCT01453153|584392433|FG000|Overall Study|Adverse Event|1|||
161822764|NCT01453153|584392434|FG001|Overall Study|Adverse Event|1|||
161822765|NCT01453153|584392435|FG002|Overall Study|Adverse Event|1|||
161822766|NCT03547635|584392438|FG000|Overall Study|Adverse Event|5|||
161822767|NCT03547635|584392439|FG001|Overall Study|Adverse Event|2|||
161822768|NCT03547635|584392440|FG002|Overall Study|Adverse Event|3|||
161822769|NCT03547635|584392438|FG000|Overall Study|Lost to Follow-up|1|||
161822770|NCT03547635|584392439|FG001|Overall Study|Lost to Follow-up|3|||
161822771|NCT03547635|584392440|FG002|Overall Study|Lost to Follow-up|4|||
161822772|NCT03547635|584392438|FG000|Overall Study|Withdrawal by Subject|1|||
161822773|NCT03547635|584392439|FG001|Overall Study|Withdrawal by Subject|0|||
161822774|NCT03547635|584392440|FG002|Overall Study|Withdrawal by Subject|0|||
161822775|NCT03547635|584392438|FG000|Overall Study|Withdrawal By PI|0|||
161822776|NCT03547635|584392439|FG001|Overall Study|Withdrawal By PI|1|||
161822777|NCT03547635|584392440|FG002|Overall Study|Withdrawal By PI|0|||
161822778|NCT03547635|584392438|FG000|Overall Study|Withdrawal by Sponsor|0|||
161822779|NCT03547635|584392439|FG001|Overall Study|Withdrawal by Sponsor|0|||
161822780|NCT03547635|584392440|FG002|Overall Study|Withdrawal by Sponsor|1|||
161822781|NCT03547635|584392438|FG000|Overall Study|Errant Randomization before Treatment|0|||
161822782|NCT03547635|584392439|FG001|Overall Study|Errant Randomization before Treatment|1|||
161822783|NCT03547635|584392440|FG002|Overall Study|Errant Randomization before Treatment|0|||
161822784|NCT03547635|584392438|FG000|Overall Study|Withdrawal by Subject|1|||
161822785|NCT03547635|584392439|FG001|Overall Study|Withdrawal by Subject|0|||
161822786|NCT03547635|584392440|FG002|Overall Study|Withdrawal by Subject|0|||
161822787|NCT03243396|584392441|FG000|Overall Study|Lost to Follow-up|2|||
161822788|NCT03243396|584392442|FG001|Overall Study|Lost to Follow-up|3|||
161822789|NCT03243396|584392443|FG002|Overall Study|Lost to Follow-up|15|||
161822790|NCT03243396|584392444|FG003|Overall Study|Lost to Follow-up|8|||
161822791|NCT03243396|584392445|FG004|Overall Study|Lost to Follow-up|1|||
161822792|NCT03243396|584392446|FG005|Overall Study|Lost to Follow-up|4|||
161822793|NCT03243396|584392447|FG006|Overall Study|Lost to Follow-up|9|||
161822794|NCT03687242|584392448|FG000|Overall Study|Adverse Event|1|||
161822795|NCT00288704|584392449|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
161822796|NCT00288704|584392450|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
161822797|NCT00288704|584392451|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
161822798|NCT00288704|584392449|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
161822799|NCT00288704|584392450|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
161822800|NCT00288704|584392451|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
161822801|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
161822802|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
161822803|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
161822804|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
161822805|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
161822806|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
161930253|NCT04913675|584792480|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
161930254|NCT01541254|584792484|FG000|Overall Study|Withdrawal by Subject|1|||
161822807|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
161822808|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
161822809|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
161822810|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
161822811|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
161822812|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
161822813|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
161822814|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
161822815|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
161676927|NCT01020448|583870610|FG000|Treatment|Disease Progression|2|||
161930255|NCT01541254|584792484|FG000|Overall Study|excluded - metal allergy|1|||
161930256|NCT01541254|584792484|FG000|Overall Study|enrolled after study closed|1|||
161930257|NCT01541254|584792484|FG000|Overall Study|GI bleed prior to procedure|1|||
161930258|NCT01541254|584792484|FG000|Overall Study|stent not required|1|||
161930259|NCT01541254|584792484|FG000|Overall Study|alternate stent used|1|||
161930260|NCT05660538|584792485|FG000|Overall Study|Adverse Event|0|||
161930261|NCT05660538|584792486|FG001|Overall Study|Adverse Event|0|||
161930262|NCT05660538|584792487|FG002|Overall Study|Adverse Event|1|||
161930263|NCT05660538|584792488|FG003|Overall Study|Adverse Event|0|||
161930264|NCT05660538|584792485|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161930265|NCT05660538|584792486|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161930266|NCT05660538|584792487|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
161930267|NCT05660538|584792488|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
161930268|NCT05660538|584792485|FG000|Overall Study|Lost to Follow-up|0|||
161930269|NCT05660538|584792486|FG001|Overall Study|Lost to Follow-up|0|||
161930270|NCT05660538|584792487|FG002|Overall Study|Lost to Follow-up|1|||
161930271|NCT05660538|584792488|FG003|Overall Study|Lost to Follow-up|1|||
161930272|NCT05660538|584792485|FG000|Overall Study|Death|0|||
161930273|NCT05660538|584792486|FG001|Overall Study|Death|0|||
161930274|NCT05660538|584792487|FG002|Overall Study|Death|1|||
161930275|NCT05660538|584792488|FG003|Overall Study|Death|0|||
161930276|NCT05660538|584792485|FG000|Overall Study|Physician Decision|0|||
161930277|NCT05660538|584792486|FG001|Overall Study|Physician Decision|0|||
161930278|NCT05660538|584792487|FG002|Overall Study|Physician Decision|0|||
161930279|NCT05660538|584792488|FG003|Overall Study|Physician Decision|1|||
161930280|NCT05660538|584792485|FG000|Overall Study|Sponsor Decision|1|||
161930281|NCT05660538|584792486|FG001|Overall Study|Sponsor Decision|0|||
161930282|NCT05660538|584792487|FG002|Overall Study|Sponsor Decision|0|||
161930283|NCT05660538|584792488|FG003|Overall Study|Sponsor Decision|0|||
161930284|NCT05660538|584792485|FG000|Overall Study|Other|1|||
161588576|NCT04382898|583544529|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161588577|NCT04382898|583544530|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161588578|NCT04382898|583544531|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161588579|NCT04382898|583544527|FG000|Part 2: Dose Expansion|Other|0|||
161588580|NCT04382898|583544528|FG001|Part 2: Dose Expansion|Other|0|||
161588581|NCT04382898|583544529|FG002|Part 2: Dose Expansion|Other|1|||
161588582|NCT04382898|583544530|FG003|Part 2: Dose Expansion|Other|0|||
161588583|NCT04382898|583544531|FG004|Part 2: Dose Expansion|Other|0|||
161588584|NCT05229120|583544532|FG000|Overall Study|Withdrawal by Subject|8|||
161676928|NCT01020448|583870610|FG000|Treatment|Lack of Efficacy|8|||
161676929|NCT01020448|583870610|FG000|Treatment|Lost to Follow-up|2|||
161676930|NCT01390272|583870621|FG000|Overall Study|Death|3|||
161822816|NCT00676650|584392452|FG000|Overall Study|Death|45|||
161822817|NCT00676650|584392453|FG001|Overall Study|Death|14|||
161822818|NCT00676650|584392452|FG000|Overall Study|Adverse Event|159|||
161676931|NCT01390272|583870622|FG001|Overall Study|Death|2|||
161822819|NCT00676650|584392453|FG001|Overall Study|Adverse Event|21|||
161822820|NCT00676650|584392452|FG000|Overall Study|Global deterioration of health status|66|||
161822821|NCT00676650|584392453|FG001|Overall Study|Global deterioration of health status|31|||
161822822|NCT00676650|584392452|FG000|Overall Study|Lost to Follow-up|0|||
161822823|NCT00676650|584392453|FG001|Overall Study|Lost to Follow-up|1|||
161822824|NCT00676650|584392452|FG000|Overall Study|Objective progression or relapse|189|||
161822825|NCT00676650|584392453|FG001|Overall Study|Objective progression or relapse|140|||
161930285|NCT05660538|584792486|FG001|Overall Study|Other|0|||
161930286|NCT05660538|584792487|FG002|Overall Study|Other|0|||
161930287|NCT05660538|584792488|FG003|Overall Study|Other|1|||
161930288|NCT05660538|584792485|FG000|Overall Study|Randomized but did not receive study drug|1|||
161930289|NCT05660538|584792486|FG001|Overall Study|Randomized but did not receive study drug|0|||
161930290|NCT05660538|584792487|FG002|Overall Study|Randomized but did not receive study drug|0|||
161930291|NCT05660538|584792488|FG003|Overall Study|Randomized but did not receive study drug|1|||
161930292|NCT05660538|584792485|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
161930293|NCT05660538|584792486|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
161930294|NCT05660538|584792487|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
161930295|NCT05660538|584792488|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
161930296|NCT04518410|584792489|FG000|Overall Study|Lost to Follow-up|1|||
161930297|NCT04518410|584792490|FG001|Overall Study|Lost to Follow-up|1|||
161930298|NCT04518410|584792491|FG002|Overall Study|Lost to Follow-up|8|||
161930299|NCT04518410|584792492|FG003|Overall Study|Lost to Follow-up|5|||
161930300|NCT04518410|584792493|FG004|Overall Study|Lost to Follow-up|92|||
161930301|NCT04518410|584792494|FG005|Overall Study|Lost to Follow-up|25|||
161930302|NCT04518410|584792495|FG006|Overall Study|Lost to Follow-up|25|||
161930303|NCT04518410|584792496|FG007|Overall Study|Lost to Follow-up|3|||
161930304|NCT04518410|584792497|FG008|Overall Study|Lost to Follow-up|2|||
161930305|NCT04518410|584792498|FG009|Overall Study|Lost to Follow-up|13|||
161930306|NCT04518410|584792499|FG010|Overall Study|Lost to Follow-up|9|||
161822826|NCT00676650|584392452|FG000|Overall Study|Other|14|||
161822827|NCT00676650|584392453|FG001|Overall Study|Other|10|||
161822828|NCT00676650|584392452|FG000|Overall Study|Protocol Violation|3|||
161822829|NCT00676650|584392453|FG001|Overall Study|Protocol Violation|1|||
161822830|NCT00676650|584392452|FG000|Overall Study|Study terminated by sponsor|57|||
161822831|NCT00676650|584392453|FG001|Overall Study|Study terminated by sponsor|43|||
161822832|NCT00676650|584392452|FG000|Overall Study|Withdrawal by Subject|48|||
161515605|NCT03087591|583278451|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
161515606|NCT03087591|583278451|FG000|Overall Study|Withdrawal by Subject|1|||
161515607|NCT02621606|583278452|FG000|Overall Study|Withdrawal by Subject|0|||
161515608|NCT02621606|583278453|FG001|Overall Study|Withdrawal by Subject|1|||
161515609|NCT02621606|583278454|FG002|Overall Study|Withdrawal by Subject|0|||
161515610|NCT00982319|583278455|FG000|Overall Study|Surgery date change|1|||
161515611|NCT00982319|583278456|FG001|Overall Study|Surgery date change|0|||
161515612|NCT00982319|583278455|FG000|Overall Study|Preop values out of acceptable range|1|||
161588585|NCT03932682|583544535|FG000|Overall Study|Death|1|||
161822833|NCT00676650|584392453|FG001|Overall Study|Withdrawal by Subject|24|||
161822834|NCT00676650|584392452|FG000|Overall Study|Randomized but not treated|3|||
161822835|NCT00676650|584392453|FG001|Overall Study|Randomized but not treated|4|||
161822836|NCT02297841|584392457|FG000|Overall Study|Withdrawal by Subject|1|||
161515613|NCT00982319|583278456|FG001|Overall Study|Preop values out of acceptable range|1|||
161822837|NCT02297841|584392457|FG000|Overall Study|Protocol Violation|7|||
161822838|NCT05061992|584392458|FG000|Overall Study|Excess bowel movements|1|||
161822839|NCT05061992|584392459|FG001|Overall Study|Excess bowel movements|0|||
161822840|NCT05061992|584392458|FG000|Overall Study|Complications of Medical Care|1|||
161822841|NCT05061992|584392459|FG001|Overall Study|Complications of Medical Care|0|||
161822842|NCT05061992|584392458|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
161822843|NCT05061992|584392459|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
161930307|NCT04518410|584792500|FG011|Overall Study|Lost to Follow-up|13|||
161930308|NCT04518410|584792501|FG012|Overall Study|Lost to Follow-up|9|||
161930309|NCT04518410|584792502|FG013|Overall Study|Lost to Follow-up|13|||
161930310|NCT04518410|584792503|FG014|Overall Study|Lost to Follow-up|8|||
161930311|NCT04518410|584792504|FG015|Overall Study|Lost to Follow-up|10|||
161930312|NCT04518410|584792505|FG016|Overall Study|Lost to Follow-up|6|||
161930313|NCT04518410|584792506|FG017|Overall Study|Lost to Follow-up|13|||
161930314|NCT04518410|584792507|FG018|Overall Study|Lost to Follow-up|21|||
161930315|NCT04518410|584792508|FG019|Overall Study|Lost to Follow-up|6|||
161930316|NCT04518410|584792509|FG020|Overall Study|Lost to Follow-up|7|||
161930317|NCT04518410|584792510|FG021|Overall Study|Lost to Follow-up|21|||
161930318|NCT04518410|584792511|FG022|Overall Study|Lost to Follow-up|1|||
161930319|NCT04518410|584792512|FG023|Overall Study|Lost to Follow-up|7|||
161930320|NCT04518410|584792513|FG024|Overall Study|Lost to Follow-up|6|||
161930321|NCT04518410|584792489|FG000|Overall Study|Withdrawal by Subject|1|||
161930322|NCT04518410|584792490|FG001|Overall Study|Withdrawal by Subject|2|||
161930323|NCT04518410|584792491|FG002|Overall Study|Withdrawal by Subject|2|||
161930324|NCT04518410|584792492|FG003|Overall Study|Withdrawal by Subject|3|||
161930325|NCT04518410|584792493|FG004|Overall Study|Withdrawal by Subject|20|||
161822844|NCT05061992|584392458|FG000|Overall Study|Withdrawal by Subject|0|||
161822845|NCT05061992|584392459|FG001|Overall Study|Withdrawal by Subject|1|||
161822846|NCT01257581|584392464|FG000|Overall Study|Early Termination|3|||
161822847|NCT01257581|584392465|FG001|Overall Study|Early Termination|1|||
161822848|NCT01257581|584392466|FG002|Overall Study|Early Termination|2|||
161822849|NCT01257581|584392464|FG000|Overall Study|Death|2|||
161822850|NCT01257581|584392465|FG001|Overall Study|Death|2|||
161822851|NCT01257581|584392466|FG002|Overall Study|Death|4|||
161822852|NCT01157234|584392467|FG000|Overall Study|Withdrawal by Subject|1|||
161822853|NCT01157234|584392468|FG001|Overall Study|Withdrawal by Subject|0|||
161822854|NCT05996198|584392481|FG000|Overall Study|Withdrawal by Subject|1|||
161822855|NCT05996198|584392482|FG001|Overall Study|Withdrawal by Subject|0|||
161822856|NCT00059332|584392486|FG000|Overall Study|Withdrawal by Subject|2|||
161822857|NCT00059332|584392487|FG001|Overall Study|Withdrawal by Subject|1|||
161930326|NCT04518410|584792494|FG005|Overall Study|Withdrawal by Subject|20|||
161930327|NCT04518410|584792495|FG006|Overall Study|Withdrawal by Subject|25|||
161930328|NCT04518410|584792496|FG007|Overall Study|Withdrawal by Subject|6|||
161930329|NCT04518410|584792497|FG008|Overall Study|Withdrawal by Subject|1|||
161930330|NCT04518410|584792498|FG009|Overall Study|Withdrawal by Subject|12|||
161930331|NCT04518410|584792499|FG010|Overall Study|Withdrawal by Subject|5|||
161930332|NCT04518410|584792500|FG011|Overall Study|Withdrawal by Subject|7|||
161930333|NCT04518410|584792501|FG012|Overall Study|Withdrawal by Subject|2|||
161930334|NCT04518410|584792502|FG013|Overall Study|Withdrawal by Subject|13|||
161930335|NCT04518410|584792503|FG014|Overall Study|Withdrawal by Subject|4|||
161930336|NCT04518410|584792504|FG015|Overall Study|Withdrawal by Subject|9|||
161930337|NCT04518410|584792505|FG016|Overall Study|Withdrawal by Subject|0|||
161930338|NCT04518410|584792506|FG017|Overall Study|Withdrawal by Subject|15|||
161930339|NCT04518410|584792507|FG018|Overall Study|Withdrawal by Subject|12|||
161930340|NCT04518410|584792508|FG019|Overall Study|Withdrawal by Subject|9|||
161930341|NCT04518410|584792509|FG020|Overall Study|Withdrawal by Subject|14|||
161930342|NCT04518410|584792510|FG021|Overall Study|Withdrawal by Subject|3|||
161930343|NCT04518410|584792511|FG022|Overall Study|Withdrawal by Subject|2|||
161930344|NCT04518410|584792512|FG023|Overall Study|Withdrawal by Subject|9|||
161822858|NCT00059332|584392486|FG000|Overall Study|Lost to Follow-up|1|||
161822859|NCT00059332|584392487|FG001|Overall Study|Lost to Follow-up|1|||
161822860|NCT00487695|584392490|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
161822861|NCT00487695|584392491|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
161822862|NCT00487695|584392490|FG000|First Procedure|active wheezing (did not have procedure)|1|||
161822863|NCT00487695|584392491|FG001|First Procedure|active wheezing (did not have procedure)|0|||
161822864|NCT00487695|584392490|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
161822865|NCT00487695|584392491|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
161822866|NCT00487695|584392490|FG000|Second Procedure|active wheezing|0|||
161930345|NCT04518410|584792513|FG024|Overall Study|Withdrawal by Subject|8|||
161930346|NCT04518410|584792489|FG000|Overall Study|Other|1|||
161930347|NCT04518410|584792490|FG001|Overall Study|Other|0|||
161930348|NCT04518410|584792491|FG002|Overall Study|Other|0|||
161930349|NCT04518410|584792492|FG003|Overall Study|Other|1|||
161930350|NCT04518410|584792493|FG004|Overall Study|Other|6|||
161930351|NCT04518410|584792494|FG005|Overall Study|Other|6|||
161930352|NCT04518410|584792495|FG006|Overall Study|Other|5|||
161930353|NCT04518410|584792496|FG007|Overall Study|Other|2|||
161822867|NCT00487695|584392491|FG001|Second Procedure|active wheezing|1|||
161822868|NCT00487695|584392490|FG000|Second Procedure|Withdrawal by Subject|1|||
161822869|NCT00487695|584392491|FG001|Second Procedure|Withdrawal by Subject|2|||
161822870|NCT01698554|584392497|FG000|Overall Study|Adverse Event|2|||
161822871|NCT01698554|584392498|FG001|Overall Study|Adverse Event|5|||
161930354|NCT04518410|584792497|FG008|Overall Study|Other|0|||
161930355|NCT04518410|584792498|FG009|Overall Study|Other|1|||
161930356|NCT04518410|584792499|FG010|Overall Study|Other|0|||
161930357|NCT04518410|584792500|FG011|Overall Study|Other|2|||
161930358|NCT04518410|584792501|FG012|Overall Study|Other|0|||
161930359|NCT04518410|584792502|FG013|Overall Study|Other|0|||
161930360|NCT04518410|584792503|FG014|Overall Study|Other|0|||
161930361|NCT04518410|584792504|FG015|Overall Study|Other|3|||
161930362|NCT04518410|584792505|FG016|Overall Study|Other|1|||
161930363|NCT04518410|584792506|FG017|Overall Study|Other|1|||
161930364|NCT04518410|584792507|FG018|Overall Study|Other|1|||
161930365|NCT04518410|584792508|FG019|Overall Study|Other|0|||
161930366|NCT04518410|584792509|FG020|Overall Study|Other|1|||
161930367|NCT04518410|584792510|FG021|Overall Study|Other|0|||
161930368|NCT04518410|584792511|FG022|Overall Study|Other|1|||
161930369|NCT04518410|584792512|FG023|Overall Study|Other|2|||
161930370|NCT04518410|584792513|FG024|Overall Study|Other|2|||
161930371|NCT04518410|584792489|FG000|Overall Study|Protocol Violation|0|||
161930372|NCT04518410|584792490|FG001|Overall Study|Protocol Violation|0|||
161930373|NCT04518410|584792491|FG002|Overall Study|Protocol Violation|0|||
161930374|NCT04518410|584792492|FG003|Overall Study|Protocol Violation|2|||
161930375|NCT04518410|584792493|FG004|Overall Study|Protocol Violation|17|||
161930376|NCT04518410|584792494|FG005|Overall Study|Protocol Violation|1|||
161930377|NCT04518410|584792495|FG006|Overall Study|Protocol Violation|2|||
161930378|NCT04518410|584792496|FG007|Overall Study|Protocol Violation|1|||
161930379|NCT04518410|584792497|FG008|Overall Study|Protocol Violation|0|||
161930380|NCT04518410|584792498|FG009|Overall Study|Protocol Violation|0|||
161930381|NCT04518410|584792499|FG010|Overall Study|Protocol Violation|0|||
161930382|NCT04518410|584792500|FG011|Overall Study|Protocol Violation|0|||
161930383|NCT04518410|584792501|FG012|Overall Study|Protocol Violation|0|||
161930384|NCT04518410|584792502|FG013|Overall Study|Protocol Violation|0|||
161930385|NCT04518410|584792503|FG014|Overall Study|Protocol Violation|0|||
161930386|NCT04518410|584792504|FG015|Overall Study|Protocol Violation|0|||
161930387|NCT04518410|584792505|FG016|Overall Study|Protocol Violation|1|||
161930388|NCT04518410|584792506|FG017|Overall Study|Protocol Violation|1|||
161930389|NCT04518410|584792507|FG018|Overall Study|Protocol Violation|0|||
161930390|NCT04518410|584792508|FG019|Overall Study|Protocol Violation|0|||
161930391|NCT04518410|584792509|FG020|Overall Study|Protocol Violation|1|||
161930392|NCT04518410|584792510|FG021|Overall Study|Protocol Violation|2|||
161930393|NCT04518410|584792511|FG022|Overall Study|Protocol Violation|0|||
161930394|NCT04518410|584792512|FG023|Overall Study|Protocol Violation|3|||
161930395|NCT04518410|584792513|FG024|Overall Study|Protocol Violation|0|||
161930396|NCT04518410|584792489|FG000|Overall Study|Death|0|||
161930397|NCT04518410|584792490|FG001|Overall Study|Death|0|||
161930398|NCT04518410|584792491|FG002|Overall Study|Death|0|||
161930399|NCT04518410|584792492|FG003|Overall Study|Death|0|||
161930400|NCT04518410|584792493|FG004|Overall Study|Death|12|||
161930401|NCT04518410|584792494|FG005|Overall Study|Death|2|||
161930402|NCT04518410|584792495|FG006|Overall Study|Death|11|||
161930403|NCT04518410|584792496|FG007|Overall Study|Death|0|||
161930404|NCT04518410|584792497|FG008|Overall Study|Death|1|||
161930405|NCT04518410|584792498|FG009|Overall Study|Death|0|||
161930406|NCT04518410|584792499|FG010|Overall Study|Death|0|||
161930407|NCT04518410|584792500|FG011|Overall Study|Death|0|||
161930408|NCT04518410|584792501|FG012|Overall Study|Death|0|||
161822872|NCT01698554|584392499|FG002|Overall Study|Adverse Event|0|||
161822873|NCT01698554|584392500|FG003|Overall Study|Adverse Event|1|||
161822874|NCT01698554|584392497|FG000|Overall Study|Lost to Follow-up|1|||
161930409|NCT04518410|584792502|FG013|Overall Study|Death|1|||
161930410|NCT04518410|584792503|FG014|Overall Study|Death|1|||
161930411|NCT04518410|584792504|FG015|Overall Study|Death|0|||
161930412|NCT04518410|584792505|FG016|Overall Study|Death|0|||
161930413|NCT04518410|584792506|FG017|Overall Study|Death|1|||
161930414|NCT04518410|584792507|FG018|Overall Study|Death|4|||
161930415|NCT04518410|584792508|FG019|Overall Study|Death|4|||
161930416|NCT04518410|584792509|FG020|Overall Study|Death|1|||
161930417|NCT04518410|584792510|FG021|Overall Study|Death|0|||
161930418|NCT04518410|584792511|FG022|Overall Study|Death|0|||
161930419|NCT04518410|584792512|FG023|Overall Study|Death|0|||
161930420|NCT04518410|584792513|FG024|Overall Study|Death|0|||
161930421|NCT04518410|584792489|FG000|Overall Study|Requirement to start alternative therapy|0|||
161930422|NCT04518410|584792490|FG001|Overall Study|Requirement to start alternative therapy|0|||
161930423|NCT04518410|584792491|FG002|Overall Study|Requirement to start alternative therapy|1|||
161930424|NCT04518410|584792492|FG003|Overall Study|Requirement to start alternative therapy|0|||
161515614|NCT00982319|583278455|FG000|Overall Study|Pregnancy|0|||
161515615|NCT00982319|583278456|FG001|Overall Study|Pregnancy|1|||
161515616|NCT01933334|583278457|FG000|Overall Study|Adverse Event|5|||
161930425|NCT04518410|584792493|FG004|Overall Study|Requirement to start alternative therapy|0|||
161930426|NCT04518410|584792494|FG005|Overall Study|Requirement to start alternative therapy|0|||
161930427|NCT04518410|584792495|FG006|Overall Study|Requirement to start alternative therapy|0|||
161930428|NCT04518410|584792496|FG007|Overall Study|Requirement to start alternative therapy|0|||
161930429|NCT04518410|584792497|FG008|Overall Study|Requirement to start alternative therapy|0|||
161930430|NCT04518410|584792498|FG009|Overall Study|Requirement to start alternative therapy|0|||
161930431|NCT04518410|584792499|FG010|Overall Study|Requirement to start alternative therapy|0|||
161822875|NCT01698554|584392498|FG001|Overall Study|Lost to Follow-up|0|||
161822876|NCT01698554|584392499|FG002|Overall Study|Lost to Follow-up|0|||
161822877|NCT01698554|584392500|FG003|Overall Study|Lost to Follow-up|0|||
161822878|NCT01698554|584392497|FG000|Overall Study|Personal Reasons|0|||
161822879|NCT01698554|584392498|FG001|Overall Study|Personal Reasons|5|||
161822880|NCT01698554|584392499|FG002|Overall Study|Personal Reasons|1|||
161822881|NCT01698554|584392500|FG003|Overall Study|Personal Reasons|1|||
161822882|NCT01698554|584392497|FG000|Overall Study|Protocol Violation|2|||
161822883|NCT01698554|584392498|FG001|Overall Study|Protocol Violation|0|||
161822884|NCT01698554|584392499|FG002|Overall Study|Protocol Violation|1|||
161822885|NCT01698554|584392500|FG003|Overall Study|Protocol Violation|0|||
161822886|NCT01698554|584392497|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161822887|NCT01698554|584392498|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161822888|NCT01698554|584392499|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161822889|NCT01698554|584392500|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161822890|NCT00697827|584392503|FG000|Overall Study|enrolled but not treated|2|||
161822891|NCT00697827|584392504|FG001|Overall Study|enrolled but not treated|1|||
161822892|NCT03732833|584392505|FG000|Overall Study|Adverse Event|0|||
161822893|NCT03732833|584392506|FG001|Overall Study|Adverse Event|3|||
161822894|NCT03732833|584392507|FG002|Overall Study|Adverse Event|1|||
161822895|NCT03732833|584392505|FG000|Overall Study|Withdrawal by Subject|11|||
161822896|NCT03732833|584392506|FG001|Overall Study|Withdrawal by Subject|13|||
161822897|NCT03732833|584392507|FG002|Overall Study|Withdrawal by Subject|8|||
161822898|NCT03732833|584392505|FG000|Overall Study|Lost to Follow-up|3|||
161822899|NCT03732833|584392506|FG001|Overall Study|Lost to Follow-up|5|||
161822900|NCT03732833|584392507|FG002|Overall Study|Lost to Follow-up|4|||
161822901|NCT03732833|584392505|FG000|Overall Study|Pregnancy|0|||
161822902|NCT03732833|584392506|FG001|Overall Study|Pregnancy|2|||
161822903|NCT03732833|584392507|FG002|Overall Study|Pregnancy|0|||
161822904|NCT03732833|584392505|FG000|Overall Study|Physician Decision|2|||
161822905|NCT03732833|584392506|FG001|Overall Study|Physician Decision|3|||
161822906|NCT03732833|584392507|FG002|Overall Study|Physician Decision|1|||
161822907|NCT03732833|584392505|FG000|Overall Study|Covid-19 related and other reasons|2|||
161822908|NCT03732833|584392506|FG001|Overall Study|Covid-19 related and other reasons|7|||
161822909|NCT03732833|584392507|FG002|Overall Study|Covid-19 related and other reasons|3|||
161822910|NCT00766493|584392508|FG000|30 Days Post-Procedure|Discontinued|7|||
161822911|NCT00766493|584392508|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
161822912|NCT00766493|584392508|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
161822913|NCT01849458|584392509|FG000|Overall Study|Lost to Follow-up|4|||
161822914|NCT01863433|584392510|FG000|Overall Study|Protocol Violation|1|||
161822915|NCT03950674|584392511|FG000|Overall Study|Death|16|||
161515617|NCT01933334|583278458|FG001|Overall Study|Adverse Event|1|||
161515618|NCT01933334|583278457|FG000|Overall Study|Withdrawal by Subject|0|||
161515619|NCT01933334|583278458|FG001|Overall Study|Withdrawal by Subject|1|||
161515620|NCT00767000|583278459|FG000|54-week Study|Adverse Event|4|||
161822916|NCT03950674|584392512|FG001|Overall Study|Death|15|||
161822917|NCT03950674|584392511|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
161822918|NCT03950674|584392512|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
161822919|NCT01688882|584392519|FG000|Overall Study|Adverse Event|1|||
161822920|NCT01688882|584392520|FG001|Overall Study|Adverse Event|0|||
161822921|NCT01688882|584392519|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161822922|NCT01688882|584392520|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161822923|NCT01688882|584392519|FG000|Overall Study|Administrative problems|1|||
161822924|NCT01688882|584392520|FG001|Overall Study|Administrative problems|0|||
161822925|NCT00494013|584392525|FG000|Overall Study|Adverse Event|0|||
161822926|NCT00494013|584392526|FG001|Overall Study|Adverse Event|1|||
161822927|NCT00494013|584392525|FG000|Overall Study|Entry Criteria Not Met|1|||
161822928|NCT00494013|584392526|FG001|Overall Study|Entry Criteria Not Met|4|||
161822929|NCT00494013|584392525|FG000|Overall Study|Lost to Follow-up|5|||
161822930|NCT00494013|584392526|FG001|Overall Study|Lost to Follow-up|6|||
161822931|NCT00494013|584392525|FG000|Overall Study|Physician Decision|3|||
161822932|NCT00494013|584392526|FG001|Overall Study|Physician Decision|5|||
161822933|NCT00494013|584392525|FG000|Overall Study|Protocol Violation|8|||
161822934|NCT00494013|584392526|FG001|Overall Study|Protocol Violation|5|||
161822935|NCT00494013|584392525|FG000|Overall Study|Withdrawal by Subject|13|||
161822936|NCT00494013|584392526|FG001|Overall Study|Withdrawal by Subject|14|||
161822937|NCT00494013|584392525|FG000|Overall Study|Sponsor Decision|0|||
161822938|NCT00494013|584392526|FG001|Overall Study|Sponsor Decision|1|||
161822939|NCT00834613|584392528|FG000|First Intervention|Protocol Violation|1|||
161822940|NCT00834613|584392529|FG001|First Intervention|Protocol Violation|0|||
161588586|NCT03932682|583544536|FG001|Overall Study|Death|2|||
161822941|NCT04584983|584392530|FG000|Overall Study|Parental request for withdraw|2|||
161822942|NCT04584983|584392531|FG001|Overall Study|Parental request for withdraw|0|||
161822943|NCT02293460|584394007|FG000|Overall Study|Protocol Violation|1|||
161822944|NCT02293460|584394007|FG000|Overall Study|Lack of Efficacy|2|||
161822945|NCT02293460|584394007|FG000|Overall Study|Adverse Event|2|||
161822946|NCT02293460|584394007|FG000|Overall Study|Withdrawal by Subject|1|||
161822947|NCT01636934|584394009|FG000|Overall Study|Withdrawal by Subject|3|||
161822948|NCT01636934|584394010|FG001|Overall Study|Withdrawal by Subject|2|||
161822949|NCT01636934|584394009|FG000|Overall Study|Chemo cancel|1|||
161822950|NCT01636934|584394010|FG001|Overall Study|Chemo cancel|0|||
161822951|NCT01636934|584394009|FG000|Overall Study|Too ill to continue|1|||
161822952|NCT01636934|584394010|FG001|Overall Study|Too ill to continue|0|||
161822953|NCT01636934|584394009|FG000|Overall Study|Never started study medication|1|||
161822954|NCT01636934|584394010|FG001|Overall Study|Never started study medication|1|||
161822955|NCT03035890|584394018|FG000|Overall Study|Death|1|||
161822956|NCT02459418|584394024|FG000|Overall Study|Exclusion Criteria|4|||
161822957|NCT02459418|584394025|FG001|Overall Study|Exclusion Criteria|0|||
161822958|NCT02459418|584394024|FG000|Overall Study|Protocol Violation|0|||
161822959|NCT02459418|584394025|FG001|Overall Study|Protocol Violation|2|||
161822960|NCT02459418|584394024|FG000|Overall Study|Physician Decision|0|||
161822961|NCT02459418|584394025|FG001|Overall Study|Physician Decision|2|||
161822962|NCT02459418|584394024|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
161822963|NCT02459418|584394025|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
161822964|NCT02459418|584394024|FG000|Overall Study|Adverse Event|0|||
161822965|NCT02459418|584394025|FG001|Overall Study|Adverse Event|1|||
161822966|NCT02459418|584394024|FG000|Overall Study|Withdrawal by Subject|1|||
161822967|NCT02459418|584394025|FG001|Overall Study|Withdrawal by Subject|1|||
161822968|NCT02459418|584394024|FG000|Overall Study|Elevated Creatine Kinase|1|||
161822969|NCT02459418|584394025|FG001|Overall Study|Elevated Creatine Kinase|0|||
161822970|NCT02459418|584394024|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
161822971|NCT02459418|584394025|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
161822972|NCT03167606|584394026|FG000|Overall Study|Lost to Follow-up|73|||
161822973|NCT03167606|584394027|FG001|Overall Study|Lost to Follow-up|64|||
161822974|NCT03167606|584394026|FG000|Overall Study|Withdrawal by Subject|6|||
161588587|NCT03932682|583544535|FG000|Overall Study|Withdrawal by Subject|37|||
161588588|NCT03932682|583544536|FG001|Overall Study|Withdrawal by Subject|45|||
161588589|NCT03932682|583544535|FG000|Overall Study|Lost to Follow-up|19|||
161588590|NCT03932682|583544536|FG001|Overall Study|Lost to Follow-up|25|||
161588591|NCT03932682|583544535|FG000|Overall Study|Protocol Violation|0|||
161588592|NCT03932682|583544536|FG001|Overall Study|Protocol Violation|2|||
161588593|NCT03932682|583544535|FG000|Overall Study|Other|9|||
161588594|NCT03932682|583544536|FG001|Overall Study|Other|23|||
161822975|NCT03167606|584394027|FG001|Overall Study|Withdrawal by Subject|5|||
161822976|NCT03167606|584394026|FG000|Overall Study|Withdrawal by Investigator|0|||
161822977|NCT03167606|584394027|FG001|Overall Study|Withdrawal by Investigator|2|||
161822978|NCT00413049|584394028|FG000|Overall Study|Adverse Event|10|||
161822979|NCT00413049|584394029|FG001|Overall Study|Adverse Event|8|||
161822980|NCT00413049|584394028|FG000|Overall Study|Withdrawal by Subject|7|||
161822981|NCT00413049|584394029|FG001|Overall Study|Withdrawal by Subject|5|||
161822982|NCT00413049|584394028|FG000|Overall Study|Lost to Follow-up|2|||
161822983|NCT00413049|584394029|FG001|Overall Study|Lost to Follow-up|3|||
161822984|NCT00413049|584394028|FG000|Overall Study|Protocol Violation|3|||
161822985|NCT00413049|584394029|FG001|Overall Study|Protocol Violation|1|||
161822986|NCT00413049|584394028|FG000|Overall Study|Subject no longer requires study drug|0|||
161822987|NCT00413049|584394029|FG001|Overall Study|Subject no longer requires study drug|1|||
161822988|NCT00413049|584394028|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161822989|NCT00413049|584394029|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161822990|NCT00413049|584394028|FG000|Overall Study|Lack of Efficacy|1|||
161822991|NCT00413049|584394029|FG001|Overall Study|Lack of Efficacy|0|||
161822992|NCT03653026|584394036|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
161822993|NCT03653026|584394037|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
161588595|NCT04321031|583544537|FG000|Overall Study|Adverse Event|0|||
161822994|NCT03653026|584394038|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
161822995|NCT03653026|584394039|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
161822996|NCT03653026|584394036|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
161822997|NCT03653026|584394037|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
161588596|NCT04321031|583544538|FG001|Overall Study|Adverse Event|2|||
161588597|NCT04321031|583544539|FG002|Overall Study|Adverse Event|2|||
161822998|NCT03653026|584394038|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161822999|NCT03653026|584394039|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161823000|NCT03653026|584394036|FG000|Part 1: Placebo-controlled Period|Other|0|||
161823001|NCT03653026|584394037|FG001|Part 1: Placebo-controlled Period|Other|3|||
161823002|NCT03653026|584394038|FG002|Part 1: Placebo-controlled Period|Other|0|||
161823003|NCT03653026|584394039|FG003|Part 1: Placebo-controlled Period|Other|0|||
161588598|NCT04321031|583544540|FG003|Overall Study|Adverse Event|2|||
161930432|NCT04518410|584792500|FG011|Overall Study|Requirement to start alternative therapy|0|||
161930433|NCT04518410|584792501|FG012|Overall Study|Requirement to start alternative therapy|0|||
161930434|NCT04518410|584792502|FG013|Overall Study|Requirement to start alternative therapy|0|||
161823004|NCT03653026|584394036|FG000|Part 2: Open-label Extension|Adverse Event|0|||
161823005|NCT03653026|584394037|FG001|Part 2: Open-label Extension|Adverse Event|0|||
161823006|NCT03653026|584394038|FG002|Part 2: Open-label Extension|Adverse Event|1|||
161823007|NCT03653026|584394039|FG003|Part 2: Open-label Extension|Adverse Event|1|||
161930435|NCT04518410|584792503|FG014|Overall Study|Requirement to start alternative therapy|0|||
161930436|NCT04518410|584792504|FG015|Overall Study|Requirement to start alternative therapy|0|||
161930437|NCT04518410|584792505|FG016|Overall Study|Requirement to start alternative therapy|0|||
161930438|NCT04518410|584792506|FG017|Overall Study|Requirement to start alternative therapy|0|||
161930439|NCT04518410|584792507|FG018|Overall Study|Requirement to start alternative therapy|0|||
161930440|NCT04518410|584792508|FG019|Overall Study|Requirement to start alternative therapy|0|||
161930441|NCT04518410|584792509|FG020|Overall Study|Requirement to start alternative therapy|0|||
161930442|NCT04518410|584792510|FG021|Overall Study|Requirement to start alternative therapy|0|||
161930443|NCT04518410|584792511|FG022|Overall Study|Requirement to start alternative therapy|0|||
161930444|NCT04518410|584792512|FG023|Overall Study|Requirement to start alternative therapy|0|||
161930445|NCT04518410|584792513|FG024|Overall Study|Requirement to start alternative therapy|0|||
161930446|NCT04518410|584792489|FG000|Overall Study|Randomized but not treated|0|||
161930447|NCT04518410|584792490|FG001|Overall Study|Randomized but not treated|0|||
161930448|NCT04518410|584792491|FG002|Overall Study|Randomized but not treated|0|||
161930449|NCT04518410|584792492|FG003|Overall Study|Randomized but not treated|2|||
161930450|NCT04518410|584792493|FG004|Overall Study|Randomized but not treated|6|||
161930451|NCT04518410|584792494|FG005|Overall Study|Randomized but not treated|4|||
161930452|NCT04518410|584792495|FG006|Overall Study|Randomized but not treated|3|||
161930453|NCT04518410|584792496|FG007|Overall Study|Randomized but not treated|3|||
161930454|NCT04518410|584792497|FG008|Overall Study|Randomized but not treated|0|||
161930455|NCT04518410|584792498|FG009|Overall Study|Randomized but not treated|4|||
161930456|NCT04518410|584792499|FG010|Overall Study|Randomized but not treated|0|||
161930457|NCT04518410|584792500|FG011|Overall Study|Randomized but not treated|0|||
161930458|NCT04518410|584792501|FG012|Overall Study|Randomized but not treated|1|||
161930459|NCT04518410|584792502|FG013|Overall Study|Randomized but not treated|3|||
161930460|NCT04518410|584792503|FG014|Overall Study|Randomized but not treated|3|||
161930461|NCT04518410|584792504|FG015|Overall Study|Randomized but not treated|3|||
161930462|NCT04518410|584792505|FG016|Overall Study|Randomized but not treated|4|||
161930463|NCT04518410|584792506|FG017|Overall Study|Randomized but not treated|5|||
161930464|NCT04518410|584792507|FG018|Overall Study|Randomized but not treated|4|||
161930465|NCT04518410|584792508|FG019|Overall Study|Randomized but not treated|0|||
161930466|NCT04518410|584792509|FG020|Overall Study|Randomized but not treated|0|||
161930467|NCT04518410|584792510|FG021|Overall Study|Randomized but not treated|5|||
161930468|NCT04518410|584792511|FG022|Overall Study|Randomized but not treated|0|||
161930469|NCT04518410|584792512|FG023|Overall Study|Randomized but not treated|3|||
161930470|NCT04518410|584792513|FG024|Overall Study|Randomized but not treated|1|||
161930471|NCT04518410|584792489|FG000|Overall Study|Screen Fail but Randomized|0|||
161930472|NCT04518410|584792490|FG001|Overall Study|Screen Fail but Randomized|0|||
161930473|NCT04518410|584792491|FG002|Overall Study|Screen Fail but Randomized|0|||
161930474|NCT04518410|584792492|FG003|Overall Study|Screen Fail but Randomized|0|||
161930475|NCT04518410|584792493|FG004|Overall Study|Screen Fail but Randomized|2|||
161930476|NCT04518410|584792494|FG005|Overall Study|Screen Fail but Randomized|0|||
161823008|NCT03653026|584394036|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161823009|NCT03653026|584394037|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161823010|NCT03653026|584394038|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
161823011|NCT03653026|584394039|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
161823012|NCT03653026|584394036|FG000|Part 2: Open-label Extension|Other|0|||
161823013|NCT03653026|584394037|FG001|Part 2: Open-label Extension|Other|0|||
161823014|NCT03653026|584394038|FG002|Part 2: Open-label Extension|Other|1|||
161823015|NCT03653026|584394039|FG003|Part 2: Open-label Extension|Other|2|||
161823016|NCT02104817|584394042|FG000|Overall Study|Death|363|||
161823017|NCT02104817|584394043|FG001|Overall Study|Death|330|||
161823018|NCT02104817|584394042|FG000|Overall Study|Lost to Follow-up|3|||
161823019|NCT02104817|584394043|FG001|Overall Study|Lost to Follow-up|2|||
161823020|NCT02104817|584394042|FG000|Overall Study|Protocol Violation|0|||
161930477|NCT04518410|584792495|FG006|Overall Study|Screen Fail but Randomized|0|||
161930478|NCT04518410|584792496|FG007|Overall Study|Screen Fail but Randomized|0|||
161823021|NCT02104817|584394043|FG001|Overall Study|Protocol Violation|1|||
161823022|NCT02104817|584394042|FG000|Overall Study|Study terminated by sponsor|5854|||
161823023|NCT02104817|584394043|FG001|Overall Study|Study terminated by sponsor|5901|||
161823024|NCT02104817|584394042|FG000|Overall Study|Withdrawal by Subject|111|||
161823025|NCT02104817|584394043|FG001|Overall Study|Withdrawal by Subject|78|||
161823026|NCT02104817|584394042|FG000|Overall Study|Other reasons|128|||
161930479|NCT04518410|584792497|FG008|Overall Study|Screen Fail but Randomized|0|||
161823027|NCT02104817|584394043|FG001|Overall Study|Other reasons|135|||
161930480|NCT04518410|584792498|FG009|Overall Study|Screen Fail but Randomized|0|||
161588599|NCT04321031|583544541|FG004|Overall Study|Adverse Event|2|||
161588600|NCT04321031|583544542|FG005|Overall Study|Adverse Event|2|||
161588601|NCT04321031|583544543|FG006|Overall Study|Adverse Event|0|||
161588602|NCT04321031|583544537|FG000|Overall Study|Lost to Follow-up|0|||
161823028|NCT00852917|584394044|FG000|Overall Study|Adverse Event|13|||
161823029|NCT00852917|584394045|FG001|Overall Study|Adverse Event|20|||
161823030|NCT00852917|584394046|FG002|Overall Study|Adverse Event|35|||
161823031|NCT00852917|584394047|FG003|Overall Study|Adverse Event|17|||
161823032|NCT00852917|584394044|FG000|Overall Study|Lack of Efficacy|21|||
161823033|NCT00852917|584394045|FG001|Overall Study|Lack of Efficacy|11|||
161823034|NCT00852917|584394046|FG002|Overall Study|Lack of Efficacy|11|||
161823035|NCT00852917|584394047|FG003|Overall Study|Lack of Efficacy|47|||
161823036|NCT00852917|584394044|FG000|Overall Study|Withdrawal by Subject|4|||
161823037|NCT00852917|584394045|FG001|Overall Study|Withdrawal by Subject|8|||
161823038|NCT00852917|584394046|FG002|Overall Study|Withdrawal by Subject|10|||
161823039|NCT00852917|584394047|FG003|Overall Study|Withdrawal by Subject|9|||
161823040|NCT00852917|584394044|FG000|Overall Study|Physician Decision|6|||
161823041|NCT00852917|584394045|FG001|Overall Study|Physician Decision|7|||
161823042|NCT00852917|584394046|FG002|Overall Study|Physician Decision|2|||
161823043|NCT00852917|584394047|FG003|Overall Study|Physician Decision|19|||
161823044|NCT00852917|584394044|FG000|Overall Study|Death|0|||
161823045|NCT00852917|584394045|FG001|Overall Study|Death|0|||
161823046|NCT00852917|584394046|FG002|Overall Study|Death|0|||
161823047|NCT00852917|584394047|FG003|Overall Study|Death|1|||
161823048|NCT01358877|584394048|FG000|Overall Study|Withdrawal by Subject|475|||
161823049|NCT01358877|584394049|FG001|Overall Study|Withdrawal by Subject|466|||
161823050|NCT01358877|584394048|FG000|Overall Study|Recurrence of disease|181|||
161823051|NCT01358877|584394049|FG001|Overall Study|Recurrence of disease|269|||
161823052|NCT01358877|584394048|FG000|Overall Study|Lost to Follow-up|181|||
161823053|NCT01358877|584394049|FG001|Overall Study|Lost to Follow-up|176|||
161823054|NCT01358877|584394048|FG000|Overall Study|Death|41|||
161823055|NCT01358877|584394049|FG001|Overall Study|Death|46|||
161823056|NCT01358877|584394048|FG000|Overall Study|Adverse Event|39|||
161823057|NCT01358877|584394049|FG001|Overall Study|Adverse Event|42|||
161823058|NCT01358877|584394048|FG000|Overall Study|Physician Decision|43|||
161823059|NCT01358877|584394049|FG001|Overall Study|Physician Decision|32|||
161823060|NCT01358877|584394048|FG000|Overall Study|Contralateral breast cancer|42|||
161823061|NCT01358877|584394049|FG001|Overall Study|Contralateral breast cancer|28|||
161823062|NCT01358877|584394048|FG000|Overall Study|Reason not specified|37|||
161823063|NCT01358877|584394049|FG001|Overall Study|Reason not specified|29|||
161823064|NCT02161549|584394053|FG000|Overall Study|Physician Decision|6|||
161823065|NCT02161549|584394054|FG001|Overall Study|Physician Decision|2|||
161823066|NCT03433703|584394055|FG000|Overall Study|Study terminated by Sponsor|2|||
161823067|NCT01583530|584394056|FG000|Overall Study|Adverse Event|0|||
161823068|NCT01583530|584394057|FG001|Overall Study|Adverse Event|0|||
161823069|NCT01583530|584394058|FG002|Overall Study|Adverse Event|0|||
161823070|NCT01583530|584394059|FG003|Overall Study|Adverse Event|0|||
161823071|NCT01583530|584394060|FG004|Overall Study|Adverse Event|0|||
161823072|NCT01583530|584394061|FG005|Overall Study|Adverse Event|1|||
161823073|NCT01583530|584394056|FG000|Overall Study|Withdrawal by Subject|0|||
161823074|NCT01583530|584394057|FG001|Overall Study|Withdrawal by Subject|3|||
161823075|NCT01583530|584394058|FG002|Overall Study|Withdrawal by Subject|0|||
161823076|NCT01583530|584394059|FG003|Overall Study|Withdrawal by Subject|1|||
161823077|NCT01583530|584394060|FG004|Overall Study|Withdrawal by Subject|1|||
161823078|NCT01583530|584394061|FG005|Overall Study|Withdrawal by Subject|2|||
161823079|NCT01583530|584394056|FG000|Overall Study|Lost to Follow-up|0|||
161823080|NCT01583530|584394057|FG001|Overall Study|Lost to Follow-up|0|||
161823081|NCT01583530|584394058|FG002|Overall Study|Lost to Follow-up|0|||
161823082|NCT01583530|584394059|FG003|Overall Study|Lost to Follow-up|0|||
161823083|NCT01583530|584394060|FG004|Overall Study|Lost to Follow-up|3|||
161823084|NCT01583530|584394061|FG005|Overall Study|Lost to Follow-up|0|||
161823085|NCT01583530|584394056|FG000|Overall Study|Lack of compliance|0|||
161823086|NCT01583530|584394057|FG001|Overall Study|Lack of compliance|0|||
161823087|NCT01583530|584394058|FG002|Overall Study|Lack of compliance|0|||
161823088|NCT01583530|584394059|FG003|Overall Study|Lack of compliance|0|||
161823089|NCT01583530|584394060|FG004|Overall Study|Lack of compliance|1|||
161823090|NCT01583530|584394061|FG005|Overall Study|Lack of compliance|0|||
161823091|NCT02416180|584394062|FG000|Overall Study|Withdrawal by Subject|1|||
161823092|NCT00640926|584394063|FG000|Overall Study|Adverse Event|2|||
161823093|NCT00640926|584394064|FG001|Overall Study|Adverse Event|3|||
161823094|NCT00640926|584394065|FG002|Overall Study|Adverse Event|2|||
161823095|NCT00640926|584394063|FG000|Overall Study|Lack of Efficacy|0|||
161823096|NCT00640926|584394064|FG001|Overall Study|Lack of Efficacy|2|||
161823097|NCT00640926|584394065|FG002|Overall Study|Lack of Efficacy|1|||
161823098|NCT00640926|584394063|FG000|Overall Study|Protocol Violation|2|||
161823099|NCT00640926|584394064|FG001|Overall Study|Protocol Violation|0|||
161823100|NCT00640926|584394065|FG002|Overall Study|Protocol Violation|2|||
161823101|NCT00640926|584394063|FG000|Overall Study|Lost to Follow-up|3|||
161823102|NCT00640926|584394064|FG001|Overall Study|Lost to Follow-up|1|||
161823103|NCT00640926|584394065|FG002|Overall Study|Lost to Follow-up|2|||
161930481|NCT04518410|584792499|FG010|Overall Study|Screen Fail but Randomized|0|||
161930482|NCT04518410|584792500|FG011|Overall Study|Screen Fail but Randomized|0|||
161930483|NCT04518410|584792501|FG012|Overall Study|Screen Fail but Randomized|0|||
161930484|NCT04518410|584792502|FG013|Overall Study|Screen Fail but Randomized|0|||
161930485|NCT04518410|584792503|FG014|Overall Study|Screen Fail but Randomized|0|||
161930486|NCT04518410|584792504|FG015|Overall Study|Screen Fail but Randomized|0|||
161823104|NCT00640926|584394063|FG000|Overall Study|Withdrawal by Subject|1|||
161823105|NCT00640926|584394064|FG001|Overall Study|Withdrawal by Subject|0|||
161823106|NCT00640926|584394065|FG002|Overall Study|Withdrawal by Subject|1|||
161823107|NCT02985398|584394066|FG000|Overall Study|Adverse Event|1|||
161823108|NCT02985398|584394066|FG000|Overall Study|Lost to Follow-up|4|||
161823109|NCT02985398|584394066|FG000|Overall Study|Withdrawal by Subject|8|||
161823110|NCT02985398|584394066|FG000|Overall Study|Study Burden|9|||
161823111|NCT01841073|584394067|FG000|Overall Study|Adverse Event|1|||
161823112|NCT01841073|584394068|FG001|Overall Study|Adverse Event|1|||
161823113|NCT01841073|584394067|FG000|Overall Study|Physician Decision|1|||
161823114|NCT01841073|584394068|FG001|Overall Study|Physician Decision|0|||
161823115|NCT01841073|584394067|FG000|Overall Study|Lost to Follow-up|0|||
161823116|NCT01841073|584394068|FG001|Overall Study|Lost to Follow-up|2|||
161823117|NCT00283842|584394073|FG000|Overall Study|Adverse Event|8|||
161823118|NCT00283842|584394074|FG001|Overall Study|Adverse Event|7|||
161930487|NCT04518410|584792505|FG016|Overall Study|Screen Fail but Randomized|0|||
161930488|NCT04518410|584792506|FG017|Overall Study|Screen Fail but Randomized|0|||
161930489|NCT04518410|584792507|FG018|Overall Study|Screen Fail but Randomized|0|||
161823119|NCT00283842|584394075|FG002|Overall Study|Adverse Event|21|||
161823120|NCT00283842|584394076|FG003|Overall Study|Adverse Event|21|||
161823121|NCT00283842|584394077|FG004|Overall Study|Adverse Event|5|||
161823122|NCT00283842|584394073|FG000|Overall Study|Protocol Violation|1|||
161823123|NCT00283842|584394074|FG001|Overall Study|Protocol Violation|5|||
161823124|NCT00283842|584394075|FG002|Overall Study|Protocol Violation|4|||
161823125|NCT00283842|584394076|FG003|Overall Study|Protocol Violation|0|||
161823126|NCT00283842|584394077|FG004|Overall Study|Protocol Violation|0|||
161823127|NCT00283842|584394073|FG000|Overall Study|Protocol deviation|0|||
161823128|NCT00283842|584394074|FG001|Overall Study|Protocol deviation|0|||
161823129|NCT00283842|584394075|FG002|Overall Study|Protocol deviation|0|||
161823130|NCT00283842|584394076|FG003|Overall Study|Protocol deviation|0|||
161823131|NCT00283842|584394077|FG004|Overall Study|Protocol deviation|2|||
161823132|NCT00283842|584394073|FG000|Overall Study|Withdrawal by Subject|2|||
161823133|NCT00283842|584394074|FG001|Overall Study|Withdrawal by Subject|1|||
161823134|NCT00283842|584394075|FG002|Overall Study|Withdrawal by Subject|1|||
161823135|NCT00283842|584394076|FG003|Overall Study|Withdrawal by Subject|5|||
161823136|NCT00283842|584394077|FG004|Overall Study|Withdrawal by Subject|4|||
161823137|NCT00283842|584394073|FG000|Overall Study|Lack of Efficacy|1|||
161823138|NCT00283842|584394074|FG001|Overall Study|Lack of Efficacy|3|||
161823139|NCT00283842|584394075|FG002|Overall Study|Lack of Efficacy|1|||
161823140|NCT00283842|584394076|FG003|Overall Study|Lack of Efficacy|0|||
161823141|NCT00283842|584394077|FG004|Overall Study|Lack of Efficacy|3|||
161823142|NCT00283842|584394073|FG000|Overall Study|Lost to Follow-up|0|||
161823143|NCT00283842|584394074|FG001|Overall Study|Lost to Follow-up|2|||
161823144|NCT00283842|584394075|FG002|Overall Study|Lost to Follow-up|4|||
161823145|NCT00283842|584394076|FG003|Overall Study|Lost to Follow-up|1|||
161823146|NCT00283842|584394077|FG004|Overall Study|Lost to Follow-up|1|||
161823147|NCT00550147|584394078|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
161823148|NCT00550147|584394078|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
161823149|NCT00550147|584394078|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
161823150|NCT00550147|584394078|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
161823151|NCT00550147|584394078|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
161823152|NCT02472639|584394079|FG000|Overall Study|Physician Decision|4|||
161823153|NCT02472639|584394080|FG001|Overall Study|Physician Decision|3|||
161823154|NCT00046839|584394081|FG000|Overall Study|Ineligible / No protocol treatment|0|||
161930490|NCT04518410|584792508|FG019|Overall Study|Screen Fail but Randomized|0|||
161930491|NCT04518410|584792509|FG020|Overall Study|Screen Fail but Randomized|0|||
161930492|NCT04518410|584792510|FG021|Overall Study|Screen Fail but Randomized|0|||
161930493|NCT04518410|584792511|FG022|Overall Study|Screen Fail but Randomized|0|||
161823155|NCT00046839|584394082|FG001|Overall Study|Ineligible / No protocol treatment|2|||
161823156|NCT00046839|584394081|FG000|Overall Study|Withdrawal of consent|1|||
161823157|NCT00046839|584394082|FG001|Overall Study|Withdrawal of consent|0|||
161823158|NCT00751023|584394084|FG000|Overall Study|Lost to Follow-up|11|||
161823159|NCT00751023|584394085|FG001|Overall Study|Lost to Follow-up|7|||
161823160|NCT02050321|584394086|FG000|Overall Study|Withdrawal by Subject|1|||
161823161|NCT02050321|584394086|FG000|Overall Study|Adverse Event|1|||
161823162|NCT04768114|584394087|FG000|Overall Study|Lost to Follow-up|5|||
161823163|NCT04768114|584394088|FG001|Overall Study|Lost to Follow-up|10|||
161823164|NCT04768114|584394087|FG000|Overall Study|Withdrawal by Subject|0|||
161930494|NCT04518410|584792512|FG023|Overall Study|Screen Fail but Randomized|0|||
161823165|NCT04768114|584394088|FG001|Overall Study|Withdrawal by Subject|1|||
161823166|NCT00715676|584394097|FG000|Overall Study|Adverse Event|3|||
161515621|NCT00767000|583278460|FG001|54-week Study|Adverse Event|6|||
161515622|NCT00767000|583278461|FG002|54-week Study|Adverse Event|6|||
161515623|NCT00767000|583278462|FG003|54-week Study|Adverse Event|8|||
161930495|NCT04518410|584792513|FG024|Overall Study|Screen Fail but Randomized|0|||
161930496|NCT04518410|584792489|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930497|NCT04518410|584792490|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930498|NCT04518410|584792491|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930499|NCT04518410|584792492|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930500|NCT04518410|584792493|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
161930501|NCT04518410|584792494|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
161930502|NCT04518410|584792495|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
161930503|NCT04518410|584792496|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930504|NCT04518410|584792497|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
161930505|NCT04518410|584792498|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
161930506|NCT04518410|584792499|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930507|NCT04518410|584792500|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930508|NCT04518410|584792501|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930509|NCT04518410|584792502|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930510|NCT04518410|584792503|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930511|NCT04518410|584792504|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
161930512|NCT04518410|584792505|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
161930513|NCT04518410|584792506|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
161930514|NCT04518410|584792507|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
161930515|NCT04518410|584792508|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
161930516|NCT04518410|584792509|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
161930517|NCT04518410|584792510|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
161930518|NCT04518410|584792511|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
161930519|NCT04518410|584792512|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930520|NCT04518410|584792513|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
161930521|NCT04518410|584792489|FG000|Overall Study|Dual Enrolled Subject|0|||
161930522|NCT04518410|584792490|FG001|Overall Study|Dual Enrolled Subject|0|||
161930523|NCT04518410|584792491|FG002|Overall Study|Dual Enrolled Subject|0|||
161930524|NCT04518410|584792492|FG003|Overall Study|Dual Enrolled Subject|0|||
161930525|NCT04518410|584792493|FG004|Overall Study|Dual Enrolled Subject|0|||
161930526|NCT04518410|584792494|FG005|Overall Study|Dual Enrolled Subject|0|||
161930527|NCT04518410|584792495|FG006|Overall Study|Dual Enrolled Subject|0|||
161930528|NCT04518410|584792496|FG007|Overall Study|Dual Enrolled Subject|0|||
161930529|NCT04518410|584792497|FG008|Overall Study|Dual Enrolled Subject|0|||
161930530|NCT04518410|584792498|FG009|Overall Study|Dual Enrolled Subject|0|||
161930531|NCT04518410|584792499|FG010|Overall Study|Dual Enrolled Subject|0|||
161930532|NCT04518410|584792500|FG011|Overall Study|Dual Enrolled Subject|0|||
161930533|NCT04518410|584792501|FG012|Overall Study|Dual Enrolled Subject|0|||
161930534|NCT04518410|584792502|FG013|Overall Study|Dual Enrolled Subject|0|||
161930535|NCT04518410|584792503|FG014|Overall Study|Dual Enrolled Subject|0|||
161930536|NCT04518410|584792504|FG015|Overall Study|Dual Enrolled Subject|0|||
161930537|NCT04518410|584792505|FG016|Overall Study|Dual Enrolled Subject|0|||
161930538|NCT04518410|584792506|FG017|Overall Study|Dual Enrolled Subject|1|||
161930539|NCT04518410|584792507|FG018|Overall Study|Dual Enrolled Subject|0|||
161930540|NCT04518410|584792508|FG019|Overall Study|Dual Enrolled Subject|0|||
161930541|NCT04518410|584792509|FG020|Overall Study|Dual Enrolled Subject|0|||
161930542|NCT04518410|584792510|FG021|Overall Study|Dual Enrolled Subject|0|||
161930543|NCT04518410|584792511|FG022|Overall Study|Dual Enrolled Subject|0|||
161930544|NCT04518410|584792512|FG023|Overall Study|Dual Enrolled Subject|0|||
161930545|NCT04518410|584792513|FG024|Overall Study|Dual Enrolled Subject|0|||
161930546|NCT05737745|584792514|FG000|Overall Study|Withdrawal by Subject|0|||
161930547|NCT05737745|584792515|FG001|Overall Study|Withdrawal by Subject|6|||
161930548|NCT05737745|584792516|FG002|Overall Study|Withdrawal by Subject|1|||
161930549|NCT04648241|584792517|FG000|Overall Study|Lost to Follow-up|1|||
161930550|NCT04648241|584792518|FG001|Overall Study|Lost to Follow-up|0|||
161930551|NCT02057666|584792519|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
161930552|NCT02057666|584792520|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
161930553|NCT02057666|584792519|FG000|Double Blind Treatment Period|Poor tolerability|7|||
161930554|NCT02057666|584792520|FG001|Double Blind Treatment Period|Poor tolerability|2|||
161930555|NCT02057666|584792519|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
161930556|NCT02057666|584792520|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
161930557|NCT02057666|584792519|FG000|Double Blind Treatment Period|Physician Decision|1|||
161930558|NCT02057666|584792520|FG001|Double Blind Treatment Period|Physician Decision|0|||
161930559|NCT02057666|584792519|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
161930560|NCT02057666|584792520|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
161930561|NCT02057666|584792519|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
161515624|NCT00767000|583278463|FG004|54-week Study|Adverse Event|4|||
161515625|NCT00767000|583278459|FG000|54-week Study|Creaninine/creatinine clearance|2|||
161515626|NCT00767000|583278460|FG001|54-week Study|Creaninine/creatinine clearance|1|||
161588603|NCT04321031|583544538|FG001|Overall Study|Lost to Follow-up|0|||
161588604|NCT04321031|583544539|FG002|Overall Study|Lost to Follow-up|0|||
161588605|NCT04321031|583544540|FG003|Overall Study|Lost to Follow-up|1|||
161588606|NCT04321031|583544541|FG004|Overall Study|Lost to Follow-up|0|||
161588607|NCT04321031|583544542|FG005|Overall Study|Lost to Follow-up|2|||
161588608|NCT04321031|583544543|FG006|Overall Study|Lost to Follow-up|1|||
161588609|NCT04321031|583544537|FG000|Overall Study|Withdrawal by Subject|2|||
161588610|NCT04321031|583544538|FG001|Overall Study|Withdrawal by Subject|2|||
161588611|NCT04321031|583544539|FG002|Overall Study|Withdrawal by Subject|1|||
161588612|NCT04321031|583544540|FG003|Overall Study|Withdrawal by Subject|3|||
161588613|NCT04321031|583544541|FG004|Overall Study|Withdrawal by Subject|1|||
161588614|NCT04321031|583544542|FG005|Overall Study|Withdrawal by Subject|0|||
161588615|NCT04321031|583544543|FG006|Overall Study|Withdrawal by Subject|1|||
161588616|NCT04321031|583544537|FG000|Overall Study|Non-compliance with study drug|0|||
161588617|NCT04321031|583544538|FG001|Overall Study|Non-compliance with study drug|0|||
161588618|NCT04321031|583544539|FG002|Overall Study|Non-compliance with study drug|0|||
161588619|NCT04321031|583544540|FG003|Overall Study|Non-compliance with study drug|0|||
161588620|NCT04321031|583544541|FG004|Overall Study|Non-compliance with study drug|0|||
161588621|NCT04321031|583544542|FG005|Overall Study|Non-compliance with study drug|1|||
161588622|NCT04321031|583544543|FG006|Overall Study|Non-compliance with study drug|0|||
161588623|NCT04321031|583544537|FG000|Overall Study|Other|0|||
161588624|NCT04321031|583544538|FG001|Overall Study|Other|0|||
161588625|NCT04321031|583544539|FG002|Overall Study|Other|0|||
161588626|NCT04321031|583544540|FG003|Overall Study|Other|1|||
161588627|NCT04321031|583544541|FG004|Overall Study|Other|0|||
161588628|NCT04321031|583544542|FG005|Overall Study|Other|0|||
161588629|NCT04321031|583544543|FG006|Overall Study|Other|0|||
161588630|NCT04237298|583544544|FG000|Overall Study|Lost to Follow-up|4|||
161588631|NCT04237298|583544545|FG001|Overall Study|Lost to Follow-up|5|||
161588632|NCT04556656|583544549|FG000|Overall Study|Withdrawal by Subject|14|||
161588633|NCT04556656|583544550|FG001|Overall Study|Withdrawal by Subject|12|||
161588634|NCT04556656|583544549|FG000|Overall Study|Physician Decision|1|||
161588635|NCT04556656|583544550|FG001|Overall Study|Physician Decision|0|||
161588636|NCT04556656|583544549|FG000|Overall Study|Adverse Event|4|||
161588637|NCT04556656|583544550|FG001|Overall Study|Adverse Event|7|||
161588638|NCT04556656|583544549|FG000|Overall Study|Death|4|||
161588639|NCT04556656|583544550|FG001|Overall Study|Death|0|||
161930562|NCT02057666|584792520|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
161930563|NCT02057666|584792519|FG000|Double Blind Treatment Period|Sponsor's request|70|||
161515627|NCT00767000|583278461|FG002|54-week Study|Creaninine/creatinine clearance|2|||
161515628|NCT00767000|583278462|FG003|54-week Study|Creaninine/creatinine clearance|2|||
161515629|NCT00767000|583278463|FG004|54-week Study|Creaninine/creatinine clearance|4|||
161515630|NCT00767000|583278459|FG000|54-week Study|Hyperglycemia|0|||
161515631|NCT00767000|583278460|FG001|54-week Study|Hyperglycemia|0|||
161515632|NCT00767000|583278461|FG002|54-week Study|Hyperglycemia|1|||
161515633|NCT00767000|583278462|FG003|54-week Study|Hyperglycemia|0|||
161515634|NCT00767000|583278463|FG004|54-week Study|Hyperglycemia|1|||
161515635|NCT00767000|583278459|FG000|54-week Study|Hypoglycemia|0|||
161515636|NCT00767000|583278460|FG001|54-week Study|Hypoglycemia|1|||
161588640|NCT04556656|583544549|FG000|Overall Study|Lost to Follow-up|3|||
161588641|NCT04556656|583544550|FG001|Overall Study|Lost to Follow-up|2|||
161588642|NCT04556656|583544549|FG000|Overall Study|Not further specified|2|||
161588643|NCT04556656|583544550|FG001|Overall Study|Not further specified|1|||
161588644|NCT04541706|583544551|FG000|Overall Study|Withdrawal by Subject|3|||
161588645|NCT04541706|583544551|FG000|Overall Study|Progressive disease|33|||
161588646|NCT04541706|583544551|FG000|Overall Study|Physician Decision|1|||
161588647|NCT04541706|583544551|FG000|Overall Study|Lost to Follow-up|2|||
161588648|NCT04541706|583544551|FG000|Overall Study|Death|5|||
161930564|NCT02057666|584792520|FG001|Double Blind Treatment Period|Sponsor's request|34|||
161515637|NCT00767000|583278461|FG002|54-week Study|Hypoglycemia|0|||
161515638|NCT00767000|583278462|FG003|54-week Study|Hypoglycemia|0|||
161930565|NCT02057666|584792519|FG000|Open-Label Treatment Period|Poor tolerability|0|||
161930566|NCT02057666|584792520|FG001|Open-Label Treatment Period|Poor tolerability|1|||
161930567|NCT02057666|584792519|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
161930568|NCT02057666|584792520|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
161930569|NCT02057666|584792519|FG000|Open-Label Treatment Period|Sponsor's request|0|||
161930570|NCT02057666|584792520|FG001|Open-Label Treatment Period|Sponsor's request|4|||
161930571|NCT02569242|584792521|FG000|Overall Study|Death|1|||
161930572|NCT02569242|584792522|FG001|Overall Study|Death|0|||
161930573|NCT02569242|584792521|FG000|Overall Study|Withdrawal by Subject|0|||
161930574|NCT02569242|584792522|FG001|Overall Study|Withdrawal by Subject|1|||
161930575|NCT05661734|584792523|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
161930576|NCT05661734|584792523|FG000|Overall Study|Lost to Follow-up|13|||
161930577|NCT05661734|584792523|FG000|Overall Study|Enrolled but not dosed|2|||
161930578|NCT02489045|584792526|FG000|Overall Study|unable to collect usable data|53|||
161930579|NCT02489045|584792526|FG000|Follow-up|Lost to Follow-up|10|||
161930580|NCT00837330|584792527|FG000|Overall Study|Lost to Follow-up|1|||
161930581|NCT00837330|584792528|FG001|Overall Study|Lost to Follow-up|3|||
161930582|NCT02774278|584792529|FG000|Overall Study|Lack of Efficacy|199|||
161930583|NCT02774278|584792529|FG000|Overall Study|Death|29|||
161930584|NCT02774278|584792529|FG000|Overall Study|Adverse event/intercurrent illness|16|||
161930585|NCT02774278|584792529|FG000|Overall Study|Refused treatment/did not cooperate|9|||
161930586|NCT02774278|584792529|FG000|Overall Study|Administrative reasons|6|||
161930587|NCT02774278|584792529|FG000|Overall Study|Withdrawal by Subject|3|||
161930588|NCT02774278|584792529|FG000|Overall Study|Protocol Violation|2|||
161930589|NCT00694122|584792536|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
161930590|NCT00694122|584792537|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
161930591|NCT00694122|584792536|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
161930592|NCT00694122|584792537|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
161930593|NCT00694122|584792536|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
161930594|NCT00694122|584792537|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
161930595|NCT03339453|584792545|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
161930596|NCT03339453|584792546|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
161823167|NCT00715676|584394098|FG001|Overall Study|Adverse Event|5|||
161823168|NCT00715676|584394099|FG002|Overall Study|Adverse Event|21|||
161823169|NCT00715676|584394097|FG000|Overall Study|Withdrawal by Subject|1|||
161823170|NCT00715676|584394098|FG001|Overall Study|Withdrawal by Subject|3|||
161823171|NCT00715676|584394099|FG002|Overall Study|Withdrawal by Subject|8|||
161823172|NCT00715676|584394097|FG000|Overall Study|Lost to Follow-up|1|||
161823173|NCT00715676|584394098|FG001|Overall Study|Lost to Follow-up|2|||
161823174|NCT00715676|584394099|FG002|Overall Study|Lost to Follow-up|1|||
161823175|NCT00715676|584394097|FG000|Overall Study|Terminated by Sponsor|1|||
161823176|NCT00715676|584394098|FG001|Overall Study|Terminated by Sponsor|0|||
161823177|NCT00715676|584394099|FG002|Overall Study|Terminated by Sponsor|0|||
161930597|NCT00300495|584792548|FG000|Overall Study|Protocol Violation|4|||
161930598|NCT00300495|584792549|FG001|Overall Study|Protocol Violation|1|||
161930599|NCT00290238|584792559|FG000|Overall Study|Study terminated|27|||
161930600|NCT00290238|584792560|FG001|Overall Study|Study terminated|27|||
161930601|NCT00290238|584792559|FG000|Overall Study|Lost to Follow-up|0|||
161930602|NCT00290238|584792560|FG001|Overall Study|Lost to Follow-up|1|||
161930603|NCT00290238|584792559|FG000|Overall Study|Withdrawal by Subject|15|||
161823178|NCT00715676|584394097|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
161823179|NCT00715676|584394098|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
161823180|NCT00715676|584394099|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
161823181|NCT00715676|584394097|FG000|Overall Study|Use of Exclusionary Medication|0|||
161823182|NCT00715676|584394098|FG001|Overall Study|Use of Exclusionary Medication|0|||
161823183|NCT00715676|584394099|FG002|Overall Study|Use of Exclusionary Medication|1|||
161823184|NCT00715676|584394097|FG000|Overall Study|Elevated Blood Glucose|0|||
161930604|NCT00290238|584792560|FG001|Overall Study|Withdrawal by Subject|13|||
161588649|NCT04541706|583544551|FG000|Overall Study|Adverse Event|1|||
161588650|NCT05536440|583544552|FG000|Overall Study|Adverse Event|0|||
161823185|NCT00715676|584394098|FG001|Overall Study|Elevated Blood Glucose|1|||
161823186|NCT00715676|584394099|FG002|Overall Study|Elevated Blood Glucose|0|||
161823187|NCT01547728|584394100|FG000|Overall Study|Change in procedure and equipment|1|||
161823188|NCT01547728|584394100|FG000|Overall Study|Drug not ready for subject|1|||
161823189|NCT01547728|584394100|FG000|Overall Study|Screen failure|39|||
161823190|NCT03828539|584394101|FG000|Overall Study|Adverse Event|3|||
161823191|NCT03828539|584394102|FG001|Overall Study|Adverse Event|12|||
161930605|NCT03834883|584792561|FG000|Second Treatment|Withdrawal by Subject|1|||
161930606|NCT03834883|584792562|FG001|Second Treatment|Withdrawal by Subject|0|||
161930607|NCT03834883|584792563|FG002|Second Treatment|Withdrawal by Subject|0|||
161588651|NCT05536440|583544553|FG001|Overall Study|Adverse Event|0|||
161930608|NCT03834883|584792564|FG003|Second Treatment|Withdrawal by Subject|0|||
161930609|NCT03834883|584792561|FG000|Second Treatment|COVID-19 pandemic|1|||
161930610|NCT03834883|584792562|FG001|Second Treatment|COVID-19 pandemic|0|||
161930611|NCT03834883|584792563|FG002|Second Treatment|COVID-19 pandemic|1|||
161930612|NCT03834883|584792564|FG003|Second Treatment|COVID-19 pandemic|1|||
161930613|NCT01179399|584792565|FG000|Overall Study|Adverse Event|1|||
161930614|NCT01179399|584792565|FG000|Overall Study|Lack of Efficacy|30|||
161930615|NCT01179399|584792565|FG000|Overall Study|Withdrawal by Subject|1|||
161930616|NCT01213251|584794163|FG000|Overall Study|Death|2|||
161930617|NCT01213251|584794164|FG001|Overall Study|Death|1|||
161930618|NCT01213251|584794165|FG002|Overall Study|Death|2|||
161930619|NCT01213251|584794163|FG000|Overall Study|Exit|3|||
161930620|NCT01213251|584794164|FG001|Overall Study|Exit|2|||
161930621|NCT01213251|584794165|FG002|Overall Study|Exit|8|||
161930622|NCT01213251|584794163|FG000|Overall Study|Protocol Violation|1|||
161930623|NCT01213251|584794164|FG001|Overall Study|Protocol Violation|1|||
161930624|NCT01213251|584794165|FG002|Overall Study|Protocol Violation|0|||
161930625|NCT01213251|584794163|FG000|Overall Study|Missed 18-Month Follow-up|0|||
161930626|NCT01213251|584794164|FG001|Overall Study|Missed 18-Month Follow-up|0|||
161930627|NCT01213251|584794165|FG002|Overall Study|Missed 18-Month Follow-up|1|||
161930628|NCT02933151|584794166|FG000|Overall Study|Lost to Follow-up|19|||
161930629|NCT02933151|584794167|FG001|Overall Study|Lost to Follow-up|18|||
161930630|NCT02933151|584794166|FG000|Overall Study|Death|1732|||
161930631|NCT02933151|584794167|FG001|Overall Study|Death|1827|||
161930632|NCT02933151|584794166|FG000|Overall Study|Transplant|210|||
161930633|NCT02933151|584794167|FG001|Overall Study|Transplant|278|||
161930634|NCT02933151|584794166|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
161930635|NCT02933151|584794167|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
161930636|NCT02933151|584794166|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
161930637|NCT02933151|584794167|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
161930638|NCT02933151|584794166|FG000|Overall Study|Recovered Kidney Function|47|||
161930639|NCT02933151|584794167|FG001|Overall Study|Recovered Kidney Function|29|||
161930640|NCT00394472|584794168|FG000|Overall Study|Protocol Violation|1|||
161930641|NCT00394472|584794169|FG001|Overall Study|Protocol Violation|3|||
161930642|NCT00394472|584794168|FG000|Overall Study|incorrect enrolment|4|||
161930643|NCT00394472|584794169|FG001|Overall Study|incorrect enrolment|2|||
161930644|NCT00394472|584794168|FG000|Overall Study|Adverse Event|4|||
161930645|NCT00394472|584794169|FG001|Overall Study|Adverse Event|2|||
161930646|NCT00394472|584794168|FG000|Overall Study|Withdrawal by Subject|0|||
161930647|NCT00394472|584794169|FG001|Overall Study|Withdrawal by Subject|2|||
161930648|NCT00394472|584794168|FG000|Overall Study|Physician Decision|0|||
161930649|NCT00394472|584794169|FG001|Overall Study|Physician Decision|1|||
161930650|NCT00394472|584794168|FG000|Overall Study|Lost to Follow-up|0|||
161930651|NCT00394472|584794169|FG001|Overall Study|Lost to Follow-up|1|||
161930652|NCT03211858|584794170|FG000|Overall Study|Adverse Event|8|||
161930653|NCT03211858|584794171|FG001|Overall Study|Adverse Event|6|||
161930654|NCT03211858|584794170|FG000|Overall Study|Lack of Efficacy|0|||
161930655|NCT03211858|584794171|FG001|Overall Study|Lack of Efficacy|4|||
161930656|NCT03211858|584794170|FG000|Overall Study|Poor compliance to protocol|6|||
161930657|NCT03211858|584794171|FG001|Overall Study|Poor compliance to protocol|2|||
161930658|NCT03211858|584794170|FG000|Overall Study|Non-serious Hypoglycemia|1|||
161930659|NCT03211858|584794171|FG001|Overall Study|Non-serious Hypoglycemia|0|||
161930660|NCT03211858|584794170|FG000|Overall Study|Other than specified above|22|||
161930661|NCT03211858|584794171|FG001|Overall Study|Other than specified above|21|||
161930662|NCT01529112|584794174|FG000|Overall Study|Adverse Event|2|||
161930663|NCT01529112|584794175|FG001|Overall Study|Adverse Event|0|||
161930664|NCT01529112|584794174|FG000|Overall Study|Death|59|||
161930665|NCT01529112|584794175|FG001|Overall Study|Death|38|||
161930666|NCT01529112|584794174|FG000|Overall Study|Protocol Violation|1|||
161930667|NCT01529112|584794175|FG001|Overall Study|Protocol Violation|0|||
161930668|NCT01529112|584794174|FG000|Overall Study|Withdrawal by Subject|7|||
161930669|NCT01529112|584794175|FG001|Overall Study|Withdrawal by Subject|3|||
161930670|NCT00004228|584794176|FG000|Overall Study|Adverse Event|0|||
161930671|NCT00004228|584794177|FG001|Overall Study|Adverse Event|1|||
161588652|NCT05536440|583544554|FG002|Overall Study|Adverse Event|0|||
161588653|NCT05536440|583544555|FG003|Overall Study|Adverse Event|0|||
161930672|NCT00004228|584794178|FG002|Overall Study|Adverse Event|0|||
161930673|NCT00004228|584794179|FG003|Overall Study|Adverse Event|0|||
161930674|NCT00004228|584794180|FG004|Overall Study|Adverse Event|1|||
161930675|NCT00004228|584794181|FG005|Overall Study|Adverse Event|0|||
161930676|NCT00004228|584794182|FG006|Overall Study|Adverse Event|0|||
161930677|NCT00004228|584794176|FG000|Overall Study|Death|0|||
161930678|NCT00004228|584794177|FG001|Overall Study|Death|1|||
161930679|NCT00004228|584794178|FG002|Overall Study|Death|2|||
161930680|NCT00004228|584794179|FG003|Overall Study|Death|0|||
161930681|NCT00004228|584794180|FG004|Overall Study|Death|1|||
161930682|NCT00004228|584794181|FG005|Overall Study|Death|0|||
161930683|NCT00004228|584794182|FG006|Overall Study|Death|0|||
161930684|NCT00004228|584794176|FG000|Overall Study|Lack of Efficacy|1|||
161930685|NCT00004228|584794177|FG001|Overall Study|Lack of Efficacy|6|||
161930686|NCT00004228|584794178|FG002|Overall Study|Lack of Efficacy|5|||
161930687|NCT00004228|584794179|FG003|Overall Study|Lack of Efficacy|3|||
161930688|NCT00004228|584794180|FG004|Overall Study|Lack of Efficacy|9|||
161930689|NCT00004228|584794181|FG005|Overall Study|Lack of Efficacy|8|||
161930690|NCT00004228|584794182|FG006|Overall Study|Lack of Efficacy|4|||
161930691|NCT00004228|584794176|FG000|Overall Study|Lost to Follow-up|0|||
161930692|NCT00004228|584794177|FG001|Overall Study|Lost to Follow-up|0|||
161930693|NCT00004228|584794178|FG002|Overall Study|Lost to Follow-up|1|||
161930694|NCT00004228|584794179|FG003|Overall Study|Lost to Follow-up|0|||
161930695|NCT00004228|584794180|FG004|Overall Study|Lost to Follow-up|0|||
161930696|NCT00004228|584794181|FG005|Overall Study|Lost to Follow-up|0|||
161930697|NCT00004228|584794182|FG006|Overall Study|Lost to Follow-up|0|||
161930698|NCT00004228|584794176|FG000|Overall Study|Physician Decision|1|||
161930699|NCT00004228|584794177|FG001|Overall Study|Physician Decision|0|||
161930700|NCT00004228|584794178|FG002|Overall Study|Physician Decision|3|||
161930701|NCT00004228|584794179|FG003|Overall Study|Physician Decision|2|||
161930702|NCT00004228|584794180|FG004|Overall Study|Physician Decision|1|||
161930703|NCT00004228|584794181|FG005|Overall Study|Physician Decision|1|||
161930704|NCT00004228|584794182|FG006|Overall Study|Physician Decision|1|||
161930705|NCT00004228|584794176|FG000|Overall Study|Protocol Violation|0|||
161930706|NCT00004228|584794177|FG001|Overall Study|Protocol Violation|5|||
161930707|NCT00004228|584794178|FG002|Overall Study|Protocol Violation|2|||
161930708|NCT00004228|584794179|FG003|Overall Study|Protocol Violation|1|||
161930709|NCT00004228|584794180|FG004|Overall Study|Protocol Violation|1|||
161930710|NCT00004228|584794181|FG005|Overall Study|Protocol Violation|2|||
161930711|NCT00004228|584794182|FG006|Overall Study|Protocol Violation|0|||
161930712|NCT00004228|584794176|FG000|Overall Study|Withdrawal by Subject|3|||
161930713|NCT00004228|584794177|FG001|Overall Study|Withdrawal by Subject|0|||
161930714|NCT00004228|584794178|FG002|Overall Study|Withdrawal by Subject|1|||
161930715|NCT00004228|584794179|FG003|Overall Study|Withdrawal by Subject|0|||
161930716|NCT00004228|584794180|FG004|Overall Study|Withdrawal by Subject|2|||
161930717|NCT00004228|584794181|FG005|Overall Study|Withdrawal by Subject|1|||
161930718|NCT00004228|584794182|FG006|Overall Study|Withdrawal by Subject|2|||
161930719|NCT00004228|584794176|FG000|Overall Study|Other|0|||
161930720|NCT00004228|584794177|FG001|Overall Study|Other|0|||
161930721|NCT00004228|584794178|FG002|Overall Study|Other|1|||
161930722|NCT00004228|584794179|FG003|Overall Study|Other|0|||
161930723|NCT00004228|584794180|FG004|Overall Study|Other|0|||
161930724|NCT00004228|584794181|FG005|Overall Study|Other|0|||
161930725|NCT00004228|584794182|FG006|Overall Study|Other|0|||
161930726|NCT00004228|584794176|FG000|Overall Study|ineligible|4|||
161930727|NCT00004228|584794177|FG001|Overall Study|ineligible|2|||
161930728|NCT00004228|584794178|FG002|Overall Study|ineligible|4|||
161930729|NCT00004228|584794179|FG003|Overall Study|ineligible|1|||
161515639|NCT00767000|583278463|FG004|54-week Study|Hypoglycemia|0|||
161515640|NCT00767000|583278459|FG000|54-week Study|Interruption of study medication|0|||
161515641|NCT00767000|583278460|FG001|54-week Study|Interruption of study medication|0|||
161515642|NCT00767000|583278461|FG002|54-week Study|Interruption of study medication|1|||
161515643|NCT00767000|583278462|FG003|54-week Study|Interruption of study medication|0|||
161515644|NCT00767000|583278463|FG004|54-week Study|Interruption of study medication|0|||
161515645|NCT00767000|583278459|FG000|54-week Study|Lack of Efficacy|2|||
161515646|NCT00767000|583278460|FG001|54-week Study|Lack of Efficacy|0|||
161588654|NCT05536440|583544556|FG004|Overall Study|Adverse Event|0|||
161588655|NCT05536440|583544557|FG005|Overall Study|Adverse Event|0|||
161930730|NCT00004228|584794180|FG004|Overall Study|ineligible|1|||
161930731|NCT00004228|584794181|FG005|Overall Study|ineligible|2|||
161930732|NCT00004228|584794182|FG006|Overall Study|ineligible|5|||
161930733|NCT00107614|584794183|FG000|Overall Study|Physician Decision|10|||
161930734|NCT00107614|584794183|FG000|Overall Study|Death|2|||
161930735|NCT01013870|584794184|FG000|Overall Study|Lost to Follow-up|1|||
161930736|NCT01013870|584794185|FG001|Overall Study|Lost to Follow-up|3|||
161930737|NCT02457546|584794187|FG000|Overall Study|Other reasons|4|||
161930738|NCT02457546|584794188|FG001|Overall Study|Other reasons|1|||
161930739|NCT02457546|584794187|FG000|Overall Study|Refused to complete study/procedures|1|||
161930740|NCT02457546|584794188|FG001|Overall Study|Refused to complete study/procedures|1|||
161930741|NCT02457546|584794187|FG000|Overall Study|Lost to Follow-up|4|||
161930742|NCT02457546|584794188|FG001|Overall Study|Lost to Follow-up|1|||
161930743|NCT02457546|584794187|FG000|Overall Study|Adverse Event|0|||
161930744|NCT02457546|584794188|FG001|Overall Study|Adverse Event|1|||
161930745|NCT00090402|584794189|FG000|Overall Study|Death|1|||
161930746|NCT00090402|584794190|FG001|Overall Study|Death|1|||
161930747|NCT00090402|584794191|FG002|Overall Study|Death|0|||
161930748|NCT00090402|584794189|FG000|Overall Study|subject moved|0|||
161930749|NCT00090402|584794190|FG001|Overall Study|subject moved|1|||
161930750|NCT00090402|584794191|FG002|Overall Study|subject moved|0|||
161930751|NCT00090402|584794189|FG000|Overall Study|stopped taking study medication|1|||
161930752|NCT00090402|584794190|FG001|Overall Study|stopped taking study medication|0|||
161930753|NCT00090402|584794191|FG002|Overall Study|stopped taking study medication|1|||
161930754|NCT01530256|584794194|FG000|Overall Study|Death|2|||
161930755|NCT00862277|584794195|FG000|Overall Study|Protocol Violation|1|||
161930756|NCT00862277|584794196|FG001|Overall Study|Protocol Violation|2|||
161930757|NCT00862277|584794197|FG002|Overall Study|Protocol Violation|5|||
161930758|NCT02462057|584794198|FG000|Overall Study|Left Vitality|32|||
161930759|NCT02462057|584794199|FG001|Overall Study|Left Vitality|27|||
161515647|NCT00767000|583278461|FG002|54-week Study|Lack of Efficacy|1|||
161515648|NCT00767000|583278462|FG003|54-week Study|Lack of Efficacy|0|||
161515649|NCT00767000|583278463|FG004|54-week Study|Lack of Efficacy|5|||
161515650|NCT00767000|583278459|FG000|54-week Study|Lost to Follow-up|4|||
161515651|NCT00767000|583278460|FG001|54-week Study|Lost to Follow-up|0|||
161515652|NCT00767000|583278461|FG002|54-week Study|Lost to Follow-up|1|||
161515653|NCT00767000|583278462|FG003|54-week Study|Lost to Follow-up|4|||
161823192|NCT03828539|584394101|FG000|Overall Study|Patient's/guardian's decision|3|||
161823193|NCT03828539|584394102|FG001|Overall Study|Patient's/guardian's decision|5|||
161823194|NCT03828539|584394101|FG000|Overall Study|Lost to Follow-up|4|||
161823195|NCT03828539|584394102|FG001|Overall Study|Lost to Follow-up|2|||
161823196|NCT03828539|584394101|FG000|Overall Study|Protocol Violation|3|||
161823197|NCT03828539|584394102|FG001|Overall Study|Protocol Violation|2|||
161823198|NCT03828539|584394101|FG000|Overall Study|Withdrawal of informed consent|2|||
161823199|NCT03828539|584394102|FG001|Overall Study|Withdrawal of informed consent|1|||
161823200|NCT03828539|584394101|FG000|Overall Study|New therapy for study indication|1|||
161823201|NCT03828539|584394102|FG001|Overall Study|New therapy for study indication|0|||
161823202|NCT01341405|584394103|FG000|Overall Study|Adverse Event|0|||
161823203|NCT01341405|584394104|FG001|Overall Study|Adverse Event|1|||
161823204|NCT01341405|584394105|FG002|Overall Study|Adverse Event|1|||
161823205|NCT01341405|584394103|FG000|Overall Study|Withdrawal by Subject|3|||
161823206|NCT01341405|584394104|FG001|Overall Study|Withdrawal by Subject|2|||
161823207|NCT01341405|584394105|FG002|Overall Study|Withdrawal by Subject|1|||
161823208|NCT02760433|584394106|FG000|Overall Study|Lost to Follow-up|1|||
161823209|NCT02760433|584394107|FG001|Overall Study|Lost to Follow-up|0|||
161823210|NCT02760433|584394108|FG002|Overall Study|Lost to Follow-up|1|||
161823211|NCT02760433|584394109|FG003|Overall Study|Lost to Follow-up|0|||
161515654|NCT00767000|583278463|FG004|54-week Study|Lost to Follow-up|2|||
161515655|NCT00767000|583278459|FG000|54-week Study|Physician Decision|4|||
161515656|NCT00767000|583278460|FG001|54-week Study|Physician Decision|0|||
161515657|NCT00767000|583278461|FG002|54-week Study|Physician Decision|1|||
161515658|NCT00767000|583278462|FG003|54-week Study|Physician Decision|1|||
161515659|NCT00767000|583278463|FG004|54-week Study|Physician Decision|1|||
161515660|NCT00767000|583278459|FG000|54-week Study|Progressive disease|0|||
161515661|NCT00767000|583278460|FG001|54-week Study|Progressive disease|0|||
161515662|NCT00767000|583278461|FG002|54-week Study|Progressive disease|1|||
161515663|NCT00767000|583278462|FG003|54-week Study|Progressive disease|0|||
161515664|NCT00767000|583278463|FG004|54-week Study|Progressive disease|0|||
161515665|NCT00767000|583278459|FG000|54-week Study|Protocol Violation|0|||
161515666|NCT00767000|583278460|FG001|54-week Study|Protocol Violation|0|||
161515667|NCT00767000|583278461|FG002|54-week Study|Protocol Violation|1|||
161515668|NCT00767000|583278462|FG003|54-week Study|Protocol Violation|2|||
161515669|NCT00767000|583278463|FG004|54-week Study|Protocol Violation|0|||
161515670|NCT00767000|583278459|FG000|54-week Study|Withdrawal by Subject|2|||
161515671|NCT00767000|583278460|FG001|54-week Study|Withdrawal by Subject|3|||
161515672|NCT00767000|583278461|FG002|54-week Study|Withdrawal by Subject|5|||
161515673|NCT00767000|583278462|FG003|54-week Study|Withdrawal by Subject|11|||
161515674|NCT00767000|583278463|FG004|54-week Study|Withdrawal by Subject|13|||
161515675|NCT00767000|583278459|FG000|54-week Study|Study terminated by sponsor|90|||
161515676|NCT00767000|583278460|FG001|54-week Study|Study terminated by sponsor|102|||
161515677|NCT00767000|583278461|FG002|54-week Study|Study terminated by sponsor|89|||
161515678|NCT00767000|583278462|FG003|54-week Study|Study terminated by sponsor|196|||
161515679|NCT00767000|583278463|FG004|54-week Study|Study terminated by sponsor|194|||
161515680|NCT00767000|583278459|FG000|54-week Study|Reason not reported|0|||
161515681|NCT00767000|583278460|FG001|54-week Study|Reason not reported|0|||
161515682|NCT00767000|583278461|FG002|54-week Study|Reason not reported|0|||
161515683|NCT00767000|583278462|FG003|54-week Study|Reason not reported|1|||
161515684|NCT00767000|583278463|FG004|54-week Study|Reason not reported|0|||
161515685|NCT00767000|583278459|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
161515686|NCT00767000|583278460|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
161515687|NCT00767000|583278461|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
161515688|NCT00767000|583278462|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
161515689|NCT00767000|583278463|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
161515690|NCT01252251|583278471|FG000|Overall Study|Withdrawal by Subject|1|||
161515691|NCT01324024|583278472|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
161515692|NCT01324024|583278473|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161515693|NCT00097591|583278475|FG000|Overall Study|Withdrawal of consent|342|||
161515694|NCT00097591|583278476|FG001|Overall Study|Withdrawal of consent|323|||
161515695|NCT00097591|583278475|FG000|Overall Study|Less than 6 months on study drug|9|||
161515696|NCT00097591|583278476|FG001|Overall Study|Less than 6 months on study drug|7|||
161515697|NCT00097591|583278475|FG000|Overall Study|Unable to attend termination visit|53|||
161823212|NCT02760433|584394110|FG004|Overall Study|Lost to Follow-up|0|||
161823213|NCT02760433|584394106|FG000|Overall Study|Withdrawal by Subject|23|||
161515698|NCT00097591|583278476|FG001|Overall Study|Unable to attend termination visit|51|||
161515699|NCT00097591|583278475|FG000|Overall Study|Lost to follow up|6|||
161515700|NCT00097591|583278476|FG001|Overall Study|Lost to follow up|10|||
161515701|NCT00097591|583278475|FG000|Overall Study|Other|0|||
161823214|NCT02760433|584394107|FG001|Overall Study|Withdrawal by Subject|9|||
161823215|NCT02760433|584394108|FG002|Overall Study|Withdrawal by Subject|0|||
161823216|NCT02760433|584394109|FG003|Overall Study|Withdrawal by Subject|2|||
161823217|NCT02760433|584394110|FG004|Overall Study|Withdrawal by Subject|9|||
161823218|NCT02760433|584394106|FG000|Overall Study|Lack of Response At Week 14|0|||
161823219|NCT02760433|584394107|FG001|Overall Study|Lack of Response At Week 14|0|||
161823220|NCT02760433|584394108|FG002|Overall Study|Lack of Response At Week 14|0|||
161823221|NCT02760433|584394109|FG003|Overall Study|Lack of Response At Week 14|0|||
161823222|NCT02760433|584394110|FG004|Overall Study|Lack of Response At Week 14|1|||
161823223|NCT02760433|584394106|FG000|Overall Study|Subject refused to continue the study|1|||
161823224|NCT02760433|584394107|FG001|Overall Study|Subject refused to continue the study|0|||
161823225|NCT02760433|584394108|FG002|Overall Study|Subject refused to continue the study|0|||
161823226|NCT02760433|584394109|FG003|Overall Study|Subject refused to continue the study|0|||
161823227|NCT02760433|584394110|FG004|Overall Study|Subject refused to continue the study|0|||
161823228|NCT02760433|584394106|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
161823229|NCT02760433|584394107|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823230|NCT02760433|584394108|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823231|NCT02760433|584394109|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823232|NCT02760433|584394110|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823233|NCT02760433|584394106|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823234|NCT02760433|584394107|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
161823235|NCT02760433|584394108|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823236|NCT02760433|584394109|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823237|NCT02760433|584394110|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823238|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
161823239|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
161823240|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
161823241|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
161823242|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
161823243|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
161823244|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
161823245|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
161823246|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
161823247|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
161823248|NCT02786927|584394119|FG000|Overall Study|Adverse Event|1|||
161823249|NCT02786927|584394119|FG000|Overall Study|Protocol Violation|4|||
161823250|NCT01801917|584394120|FG000|Period 1 - Randomized|Adverse Event|1|||
161823251|NCT01801917|584394121|FG001|Period 1 - Randomized|Adverse Event|0|||
161823252|NCT01801917|584394122|FG002|Period 1 - Randomized|Adverse Event|1|||
161823253|NCT01801917|584394123|FG003|Period 1 - Randomized|Adverse Event|0|||
161823254|NCT01924364|584394124|FG000|Overall Study|Physician Decision|3|||
161823255|NCT00265785|584394125|FG000|Overall Study|Adverse Event|4|||
161823256|NCT00265785|584394125|FG000|Overall Study|Withdrawal by Subject|3|||
161823257|NCT00265785|584394125|FG000|Overall Study|Progression/Relapse|15|||
161823258|NCT00265785|584394125|FG000|Overall Study|Not protocol specified|2|||
161823259|NCT00265785|584394125|FG000|Overall Study|Ineligible|1|||
161823260|NCT00265785|584394125|FG000|Overall Study|Did not receive protocol treatment|2|||
161823261|NCT03919695|584394126|FG000|3-month Follow-up|Death|1|||
161823262|NCT03919695|584394127|FG001|3-month Follow-up|Death|1|||
161823263|NCT03919695|584394126|FG000|3-month Follow-up|unable to contact|0|||
161823264|NCT03919695|584394127|FG001|3-month Follow-up|unable to contact|3|||
161823265|NCT03919695|584394126|FG000|3-month Follow-up|in prison|0|||
161823266|NCT03919695|584394127|FG001|3-month Follow-up|in prison|1|||
161823267|NCT03919695|584394126|FG000|6-month Follow-up|Death|0|||
161823268|NCT03919695|584394127|FG001|6-month Follow-up|Death|1|||
161823269|NCT03919695|584394126|FG000|6-month Follow-up|Lost to Follow-up|1|||
161823270|NCT03919695|584394127|FG001|6-month Follow-up|Lost to Follow-up|2|||
161823271|NCT03919695|584394126|FG000|6-month Follow-up|in prison|0|||
161823272|NCT03919695|584394127|FG001|6-month Follow-up|in prison|2|||
161823273|NCT03919695|584394126|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
161823274|NCT03919695|584394127|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
161823275|NCT03919695|584394126|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
161823276|NCT03919695|584394127|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
161823277|NCT02416934|584394128|FG000|Overall Study|given steroids|1|||
161823278|NCT02416934|584394129|FG001|Overall Study|given steroids|2|||
161823279|NCT02416934|584394128|FG000|Overall Study|Lost to Follow-up|0|||
161823280|NCT02416934|584394129|FG001|Overall Study|Lost to Follow-up|2|||
161823281|NCT02416934|584394128|FG000|Overall Study|Withdrawal by Subject|1|||
161930760|NCT02462057|584794200|FG002|Overall Study|Left Vitality|23|||
161930761|NCT02462057|584794201|FG003|Overall Study|Left Vitality|35|||
161930762|NCT02462057|584794202|FG004|Overall Study|Left Vitality|33|||
161930763|NCT02462057|584794198|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
161823282|NCT02416934|584394129|FG001|Overall Study|Withdrawal by Subject|0|||
161823283|NCT02416934|584394128|FG000|Overall Study|recruited during continuing renewal proc|0|||
161823284|NCT02416934|584394129|FG001|Overall Study|recruited during continuing renewal proc|1|||
161823285|NCT02416934|584394128|FG000|Overall Study|Protocol Violation|0|||
161823286|NCT02416934|584394129|FG001|Overall Study|Protocol Violation|1|||
161823287|NCT02416934|584394128|FG000|Overall Study|surgery started late|0|||
161823288|NCT02416934|584394129|FG001|Overall Study|surgery started late|1|||
161823289|NCT02416934|584394128|FG000|Overall Study|re-operation|1|||
161823290|NCT02416934|584394129|FG001|Overall Study|re-operation|0|||
161823291|NCT05467540|584394132|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
161823292|NCT05467540|584394132|FG000|3-Month Follow-up|Lost to Follow-up|4|||
161823293|NCT05467540|584394132|FG000|3-Month Follow-up|Death|5|||
161930764|NCT02462057|584794199|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
161930765|NCT02462057|584794200|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
161930766|NCT02462057|584794201|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
161930767|NCT02462057|584794202|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
161930768|NCT00474968|584794205|FG000|Overall Study|Withdrawal by Subject|8|||
161823294|NCT05467540|584394132|FG000|12-Month Follow-up|Lost to Follow-up|6|||
161823295|NCT05467540|584394132|FG000|12-Month Follow-up|Death|8|||
161823296|NCT05467540|584394132|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
161823297|NCT03382041|584394156|FG000|Overall Study|Consent Form Lost|2|||
161823298|NCT03382041|584394157|FG001|Overall Study|Consent Form Lost|1|||
161823299|NCT03382041|584394156|FG000|Overall Study|Withdrawal by Subject|1|||
161823300|NCT03382041|584394157|FG001|Overall Study|Withdrawal by Subject|4|||
161823301|NCT03382041|584394156|FG000|Overall Study|Lost to Follow-up|1|||
161823302|NCT03382041|584394157|FG001|Overall Study|Lost to Follow-up|4|||
161823303|NCT01374451|584394160|FG000|Overall Study|Administrative problems|1|||
161823304|NCT01374451|584394161|FG001|Overall Study|Administrative problems|0|||
161823305|NCT01337596|584394162|FG000|Overall Study|Withdrawal by Subject|0|||
161823306|NCT01337596|584394163|FG001|Overall Study|Withdrawal by Subject|0|||
161823307|NCT01337596|584394164|FG002|Overall Study|Withdrawal by Subject|0|||
161823308|NCT01337596|584394165|FG003|Overall Study|Withdrawal by Subject|0|||
161823309|NCT01337596|584394166|FG004|Overall Study|Withdrawal by Subject|2|||
161823310|NCT01337596|584394167|FG005|Overall Study|Withdrawal by Subject|0|||
161823311|NCT01337596|584394168|FG006|Overall Study|Withdrawal by Subject|0|||
161823312|NCT01337596|584394169|FG007|Overall Study|Withdrawal by Subject|0|||
161823313|NCT01337596|584394170|FG008|Overall Study|Withdrawal by Subject|0|||
161823314|NCT04640194|584394171|FG000|Overall Study|Adverse Event|3|||
161823315|NCT04640194|584394172|FG001|Overall Study|Adverse Event|7|||
161823316|NCT04640194|584394173|FG002|Overall Study|Adverse Event|0|||
161823317|NCT04640194|584394174|FG003|Overall Study|Adverse Event|5|||
161823318|NCT04640194|584394175|FG004|Overall Study|Adverse Event|0|||
161823319|NCT04640194|584394176|FG005|Overall Study|Adverse Event|4|||
161823320|NCT04640194|584394177|FG006|Overall Study|Adverse Event|0|||
161823321|NCT04640194|584394171|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
161930769|NCT00474968|584794206|FG001|Overall Study|Withdrawal by Subject|7|||
161930770|NCT00474968|584794205|FG000|Overall Study|Protocol Violation|9|||
161930771|NCT00474968|584794206|FG001|Overall Study|Protocol Violation|8|||
161930772|NCT00474968|584794205|FG000|Overall Study|Sample not collected|1|||
161930773|NCT00474968|584794206|FG001|Overall Study|Sample not collected|1|||
161930774|NCT04914000|584794207|FG000|Overall Study|Lost to Follow-up|8|||
161930775|NCT04914000|584794207|FG000|Overall Study|Withdrawal by Subject|1|||
161930776|NCT01096186|584794209|FG000|Overall Study|Adverse Event|16|||
161930777|NCT01096186|584794209|FG000|Overall Study|Death|4|||
161930778|NCT01096186|584794209|FG000|Overall Study|Lack of Efficacy|4|||
161930779|NCT01096186|584794209|FG000|Overall Study|Lost to Follow-up|2|||
161930780|NCT01096186|584794209|FG000|Overall Study|Withdrawal by Subject|22|||
161930781|NCT01096186|584794209|FG000|Overall Study|Physician Decision|1|||
161823322|NCT04640194|584394172|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
161676932|NCT01390272|583870621|FG000|Overall Study|Withdrawal by Subject|9|||
161930782|NCT01096186|584794209|FG000|Overall Study|Noncompliance with study drug|1|||
161930783|NCT01896986|584794210|FG000|Overall Study|samples lost|14|||
161930784|NCT01896986|584794211|FG001|Overall Study|samples lost|23|||
161823323|NCT04640194|584394173|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
161823324|NCT04640194|584394174|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
161823325|NCT04640194|584394175|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
161823326|NCT04640194|584394176|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
161823327|NCT04640194|584394177|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
161823328|NCT04640194|584394171|FG000|Overall Study|fibrinogen level too low|0|||
161930785|NCT01750281|584794212|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
161823329|NCT04640194|584394172|FG001|Overall Study|fibrinogen level too low|0|||
161823330|NCT04640194|584394173|FG002|Overall Study|fibrinogen level too low|0|||
161823331|NCT04640194|584394174|FG003|Overall Study|fibrinogen level too low|1|||
161930786|NCT01750281|584794213|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
161930787|NCT01750281|584794214|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
161930788|NCT01750281|584794212|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
161930789|NCT01750281|584794213|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
161930790|NCT01750281|584794214|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
161930791|NCT01750281|584794212|FG000|Overall Study|Did not receive treatment|0|||
161930792|NCT01750281|584794213|FG001|Overall Study|Did not receive treatment|1|||
161930793|NCT01750281|584794214|FG002|Overall Study|Did not receive treatment|0|||
161930794|NCT01658735|584794216|FG000|Overall Study|Lack of Efficacy|1|||
161930795|NCT01658735|584794217|FG001|Overall Study|Lack of Efficacy|0|||
161930796|NCT01658735|584794218|FG002|Overall Study|Lack of Efficacy|1|||
161930797|NCT01658735|584794216|FG000|Overall Study|Lost to Follow-up|1|||
161930798|NCT01658735|584794217|FG001|Overall Study|Lost to Follow-up|1|||
161930799|NCT01658735|584794218|FG002|Overall Study|Lost to Follow-up|0|||
161930800|NCT01658735|584794216|FG000|Overall Study|Protocol Violation|0|||
161930801|NCT01658735|584794217|FG001|Overall Study|Protocol Violation|1|||
161930802|NCT01658735|584794218|FG002|Overall Study|Protocol Violation|0|||
161930803|NCT01658735|584794216|FG000|Overall Study|Withdrawal by Subject|3|||
161930804|NCT01658735|584794217|FG001|Overall Study|Withdrawal by Subject|5|||
161930805|NCT01658735|584794218|FG002|Overall Study|Withdrawal by Subject|3|||
161930806|NCT03302936|584794222|FG000|Overall Study|Protocol Violation|3|||
161930807|NCT03302936|584794223|FG001|Overall Study|Protocol Violation|4|||
161930808|NCT01379937|584794224|FG000|Overall Study|Protocol Violation|0|||
161930809|NCT01379937|584794225|FG001|Overall Study|Protocol Violation|0|||
161930810|NCT01379937|584794226|FG002|Overall Study|Protocol Violation|0|||
161930811|NCT01379937|584794227|FG003|Overall Study|Protocol Violation|1|||
161930812|NCT01379937|584794224|FG000|Overall Study|Consent withdrawal|0|||
161930813|NCT01379937|584794225|FG001|Overall Study|Consent withdrawal|1|||
161930814|NCT01379937|584794226|FG002|Overall Study|Consent withdrawal|0|||
161930815|NCT01379937|584794227|FG003|Overall Study|Consent withdrawal|0|||
161930816|NCT01379937|584794224|FG000|Overall Study|Lost to Follow-up|1|||
161930817|NCT01379937|584794225|FG001|Overall Study|Lost to Follow-up|2|||
161930818|NCT01379937|584794226|FG002|Overall Study|Lost to Follow-up|2|||
161930819|NCT01379937|584794227|FG003|Overall Study|Lost to Follow-up|0|||
161930820|NCT01122680|584794228|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
161930821|NCT01122680|584794229|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
161930822|NCT01122680|584794230|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
161930823|NCT01122680|584794231|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
161930824|NCT01122680|584794228|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
161930825|NCT01122680|584794229|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
161930826|NCT01122680|584794230|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
161930827|NCT01122680|584794231|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
161930828|NCT01122680|584794228|FG000|Period 1 (4 Weeks)|Other|1|||
161930829|NCT01122680|584794229|FG001|Period 1 (4 Weeks)|Other|1|||
161930830|NCT01122680|584794230|FG002|Period 1 (4 Weeks)|Other|0|||
161930831|NCT01122680|584794231|FG003|Period 1 (4 Weeks)|Other|0|||
161930832|NCT01122680|584794228|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
161930833|NCT01122680|584794229|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
161930834|NCT01122680|584794230|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
161930835|NCT01122680|584794231|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
161930836|NCT01122680|584794228|FG000|Period 2 (4 Weeks)|Other|1|||
161930837|NCT01122680|584794229|FG001|Period 2 (4 Weeks)|Other|0|||
161930838|NCT01122680|584794230|FG002|Period 2 (4 Weeks)|Other|0|||
161930839|NCT01122680|584794231|FG003|Period 2 (4 Weeks)|Other|0|||
161930840|NCT01122680|584794228|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
161930841|NCT01122680|584794229|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
161930842|NCT01122680|584794230|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
161930843|NCT01122680|584794231|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
161930844|NCT01122680|584794228|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161930845|NCT01122680|584794229|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
161930846|NCT01122680|584794230|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161930847|NCT01122680|584794231|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161930848|NCT00079781|584794236|FG000|Pre-implant Period|Withdrawal by Subject|2|||
161930849|NCT00079781|584794237|FG001|Pre-implant Period|Withdrawal by Subject|0|||
161930850|NCT00079781|584794238|FG002|Pre-implant Period|Withdrawal by Subject|0|||
161930851|NCT00079781|584794236|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
161930852|NCT00079781|584794237|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
161930853|NCT00079781|584794238|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
161930854|NCT00079781|584794236|FG000|Follow-up Period|Withdrawal by Subject|3|||
161930855|NCT00079781|584794237|FG001|Follow-up Period|Withdrawal by Subject|0|||
161930856|NCT00079781|584794238|FG002|Follow-up Period|Withdrawal by Subject|1|||
161930857|NCT00079781|584794236|FG000|Follow-up Period|Lost to Follow-up|1|||
161930858|NCT00079781|584794237|FG001|Follow-up Period|Lost to Follow-up|0|||
161930859|NCT00079781|584794238|FG002|Follow-up Period|Lost to Follow-up|0|||
161930860|NCT00079781|584794236|FG000|Follow-up Period|Death|0|||
161930861|NCT00079781|584794237|FG001|Follow-up Period|Death|0|||
161930862|NCT00079781|584794238|FG002|Follow-up Period|Death|1|||
161930863|NCT00564070|584794239|FG000|Overall Study|Lost to Follow-up|9|||
161588656|NCT05536440|583544558|FG006|Overall Study|Adverse Event|0|||
161588657|NCT05536440|583544559|FG007|Overall Study|Adverse Event|0|||
161588658|NCT05536440|583544560|FG008|Overall Study|Adverse Event|1|||
161588659|NCT01566695|583544563|FG000|Overall Study|Lack of Efficacy|1|||
161588660|NCT01566695|583544564|FG001|Overall Study|Lack of Efficacy|0|||
161588661|NCT01566695|583544563|FG000|Overall Study|Adverse Event|3|||
161588662|NCT01566695|583544564|FG001|Overall Study|Adverse Event|0|||
161588663|NCT01566695|583544563|FG000|Overall Study|Death|79|||
161588664|NCT01566695|583544564|FG001|Overall Study|Death|86|||
161588665|NCT01566695|583544563|FG000|Overall Study|Withdrawal by Subject|13|||
161588666|NCT01566695|583544564|FG001|Overall Study|Withdrawal by Subject|12|||
161588667|NCT01566695|583544563|FG000|Overall Study|Lost to Follow-up|0|||
161588668|NCT01566695|583544564|FG001|Overall Study|Lost to Follow-up|3|||
161588669|NCT01566695|583544563|FG000|Overall Study|Other reasons|11|||
161588670|NCT01566695|583544564|FG001|Overall Study|Other reasons|8|||
161588671|NCT01416831|583544565|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
161588672|NCT01416831|583544566|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
161588673|NCT05470400|583544567|FG000|Overall Study|Lost to Follow-up|0|||
161588674|NCT05470400|583544568|FG001|Overall Study|Lost to Follow-up|0|||
161588675|NCT05470400|583544569|FG002|Overall Study|Lost to Follow-up|0|||
161588676|NCT05470400|583544570|FG003|Overall Study|Lost to Follow-up|0|||
161588677|NCT05470400|583544571|FG004|Overall Study|Lost to Follow-up|0|||
161588678|NCT05470400|583544572|FG005|Overall Study|Lost to Follow-up|0|||
161588679|NCT05470400|583544573|FG006|Overall Study|Lost to Follow-up|0|||
161588680|NCT05470400|583544574|FG007|Overall Study|Lost to Follow-up|1|||
161588681|NCT05470400|583544567|FG000|Overall Study|Withdrawal by Subject|1|||
161588682|NCT05470400|583544568|FG001|Overall Study|Withdrawal by Subject|0|||
161588683|NCT05470400|583544569|FG002|Overall Study|Withdrawal by Subject|0|||
161588684|NCT05470400|583544570|FG003|Overall Study|Withdrawal by Subject|0|||
161588685|NCT05470400|583544571|FG004|Overall Study|Withdrawal by Subject|0|||
161588686|NCT05470400|583544572|FG005|Overall Study|Withdrawal by Subject|1|||
161588687|NCT05470400|583544573|FG006|Overall Study|Withdrawal by Subject|0|||
161588688|NCT05470400|583544574|FG007|Overall Study|Withdrawal by Subject|2|||
161588689|NCT05956002|583544575|FG000|Treatment Period 3|Adverse Event|0|||
161588690|NCT05956002|583544576|FG001|Treatment Period 3|Adverse Event|0|||
161588691|NCT05956002|583544577|FG002|Treatment Period 3|Adverse Event|1|||
161588692|NCT05956002|583544578|FG003|Treatment Period 3|Adverse Event|0|||
161588693|NCT04784559|583544579|FG000|Overall Study|Withdrawal by Subject|3|||
161588694|NCT04784559|583544580|FG001|Overall Study|Withdrawal by Subject|2|||
161588695|NCT04784559|583544581|FG002|Overall Study|Withdrawal by Subject|1|||
161588696|NCT04784559|583544579|FG000|Overall Study|Death|2|||
161588697|NCT04784559|583544580|FG001|Overall Study|Death|1|||
161588698|NCT04784559|583544581|FG002|Overall Study|Death|2|||
161588699|NCT04784559|583544579|FG000|Overall Study|Lost to Follow-up|0|||
161588700|NCT04784559|583544580|FG001|Overall Study|Lost to Follow-up|0|||
161588701|NCT04784559|583544581|FG002|Overall Study|Lost to Follow-up|2|||
161588702|NCT04784559|583544579|FG000|Overall Study|Participant worsened, PI decision|1|||
161588703|NCT04784559|583544580|FG001|Overall Study|Participant worsened, PI decision|0|||
161588704|NCT04784559|583544581|FG002|Overall Study|Participant worsened, PI decision|0|||
161588705|NCT04784559|583544579|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
161588706|NCT04784559|583544580|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
161588707|NCT04784559|583544581|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
161823332|NCT04640194|584394175|FG004|Overall Study|fibrinogen level too low|0|||
161823333|NCT04640194|584394176|FG005|Overall Study|fibrinogen level too low|0|||
161823334|NCT04640194|584394177|FG006|Overall Study|fibrinogen level too low|0|||
161823335|NCT04640194|584394171|FG000|Overall Study|mild bleeding|0|||
161823336|NCT04640194|584394172|FG001|Overall Study|mild bleeding|0|||
161823337|NCT04640194|584394173|FG002|Overall Study|mild bleeding|0|||
161823338|NCT04640194|584394174|FG003|Overall Study|mild bleeding|1|||
161823339|NCT04640194|584394175|FG004|Overall Study|mild bleeding|0|||
161823340|NCT04640194|584394176|FG005|Overall Study|mild bleeding|0|||
161823341|NCT04640194|584394177|FG006|Overall Study|mild bleeding|0|||
161823342|NCT04640194|584394171|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823343|NCT04640194|584394172|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
161823344|NCT04640194|584394173|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823345|NCT04640194|584394174|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823346|NCT04640194|584394175|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823347|NCT04640194|584394176|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161930864|NCT00564070|584794240|FG001|Overall Study|Lost to Follow-up|7|||
161588708|NCT04784559|583544579|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
161588709|NCT04784559|583544580|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
161588710|NCT04784559|583544581|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
161588711|NCT04784559|583544579|FG000|Overall Study|Did not meet all inclusion criteria|0|||
161588712|NCT04784559|583544580|FG001|Overall Study|Did not meet all inclusion criteria|1|||
161588713|NCT04784559|583544581|FG002|Overall Study|Did not meet all inclusion criteria|0|||
161588714|NCT04784559|583544579|FG000|Overall Study|The participant was transferred to IRCU|0|||
161930865|NCT00564070|584794239|FG000|Overall Study|Worsening depression, referred to care|3|||
161930866|NCT00564070|584794240|FG001|Overall Study|Worsening depression, referred to care|0|||
161930867|NCT02264821|584794243|FG000|Overall Study|Protocol Violation|1|||
161930868|NCT02264821|584794244|FG001|Overall Study|Protocol Violation|3|||
161930869|NCT02264821|584794245|FG002|Overall Study|Protocol Violation|6|||
161930870|NCT00552279|584794246|FG000|Overall Study|Adverse Event|0|||
161930871|NCT00552279|584794247|FG001|Overall Study|Adverse Event|1|||
161930872|NCT00552279|584794246|FG000|Overall Study|Withdrawal by Subject|12|||
161930873|NCT00552279|584794247|FG001|Overall Study|Withdrawal by Subject|1|||
161930874|NCT00552279|584794246|FG000|Overall Study|Lost to Follow-up|1|||
161930875|NCT00552279|584794247|FG001|Overall Study|Lost to Follow-up|0|||
161930876|NCT00552279|584794246|FG000|Overall Study|Other|1|||
161930877|NCT00552279|584794247|FG001|Overall Study|Other|1|||
161930878|NCT02067156|584794250|FG000|Overall Study|Lost to Follow-up|4|||
161930879|NCT01853280|584794251|FG000|Overall Study|Lack of Efficacy|2|||
161930880|NCT01853280|584794252|FG001|Overall Study|Lack of Efficacy|2|||
161930881|NCT01853280|584794251|FG000|Overall Study|Lost to Follow-up|0|||
161930882|NCT01853280|584794252|FG001|Overall Study|Lost to Follow-up|1|||
161930883|NCT01853280|584794251|FG000|Overall Study|Physician Decision|0|||
161823348|NCT04640194|584394177|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823349|NCT03201003|584394181|FG000|Overall Study|Adverse Event|14|||
161823350|NCT03201003|584394182|FG001|Overall Study|Adverse Event|1|||
161823351|NCT03201003|584394181|FG000|Overall Study|Other reasons|5|||
161930884|NCT01853280|584794252|FG001|Overall Study|Physician Decision|1|||
161930885|NCT01853280|584794251|FG000|Overall Study|Withdrawal by Subject|0|||
161930886|NCT01853280|584794252|FG001|Overall Study|Withdrawal by Subject|1|||
161930887|NCT01853280|584794251|FG000|Overall Study|Ineligible|0|||
161930888|NCT01853280|584794252|FG001|Overall Study|Ineligible|1|||
161930889|NCT01655069|584794253|FG000|Overall Study|Physician Decision|0|||
161930890|NCT01655069|584794254|FG001|Overall Study|Physician Decision|0|||
161930891|NCT01655069|584794255|FG002|Overall Study|Physician Decision|0|||
161930892|NCT01655069|584794256|FG003|Overall Study|Physician Decision|1|||
161930893|NCT01655069|584794253|FG000|Overall Study|Adverse Event|6|||
161930894|NCT01655069|584794254|FG001|Overall Study|Adverse Event|7|||
161930895|NCT01655069|584794255|FG002|Overall Study|Adverse Event|2|||
161930896|NCT01655069|584794256|FG003|Overall Study|Adverse Event|3|||
161930897|NCT01655069|584794253|FG000|Overall Study|Lack of Efficacy|0|||
161930898|NCT01655069|584794254|FG001|Overall Study|Lack of Efficacy|1|||
161930899|NCT01655069|584794255|FG002|Overall Study|Lack of Efficacy|0|||
161930900|NCT01655069|584794256|FG003|Overall Study|Lack of Efficacy|0|||
161930901|NCT01655069|584794253|FG000|Overall Study|No Treatment Needed|0|||
161930902|NCT01655069|584794254|FG001|Overall Study|No Treatment Needed|1|||
161930903|NCT01655069|584794255|FG002|Overall Study|No Treatment Needed|0|||
161930904|NCT01655069|584794256|FG003|Overall Study|No Treatment Needed|0|||
161930905|NCT01655069|584794253|FG000|Overall Study|Withdrawal by Subject|2|||
161930906|NCT01655069|584794254|FG001|Overall Study|Withdrawal by Subject|3|||
161930907|NCT01655069|584794255|FG002|Overall Study|Withdrawal by Subject|0|||
161930908|NCT01655069|584794256|FG003|Overall Study|Withdrawal by Subject|0|||
161930909|NCT00104884|584794257|FG000|Overall Study|Disease progression|4|||
161930910|NCT02346370|584794258|FG000|Overall Study|Not treated|1|||
161930911|NCT02346370|584794259|FG001|Overall Study|Not treated|0|||
161930912|NCT02346370|584794260|FG002|Overall Study|Not treated|0|||
161930913|NCT02346370|584794258|FG000|Overall Study|Withdrawal of consent|1|||
161930914|NCT02346370|584794259|FG001|Overall Study|Withdrawal of consent|0|||
161930915|NCT02346370|584794260|FG002|Overall Study|Withdrawal of consent|0|||
161930916|NCT02346370|584794258|FG000|Overall Study|Death|1|||
161930917|NCT02346370|584794259|FG001|Overall Study|Death|3|||
161930918|NCT02346370|584794260|FG002|Overall Study|Death|1|||
161930919|NCT02346370|584794258|FG000|Overall Study|Sponsor discontinued study|5|||
161930920|NCT02346370|584794259|FG001|Overall Study|Sponsor discontinued study|0|||
161930921|NCT02346370|584794260|FG002|Overall Study|Sponsor discontinued study|2|||
161930922|NCT02346370|584794258|FG000|Overall Study|Radiologic progression|0|||
161930923|NCT02346370|584794259|FG001|Overall Study|Radiologic progression|0|||
161930924|NCT02346370|584794260|FG002|Overall Study|Radiologic progression|1|||
161930925|NCT02346370|584794258|FG000|Overall Study|Physician Decision|0|||
161588715|NCT04784559|583544580|FG001|Overall Study|The participant was transferred to IRCU|1|||
161823352|NCT03201003|584394182|FG001|Overall Study|Other reasons|1|||
161823353|NCT03201003|584394181|FG000|Overall Study|Withdrawal by Subject|4|||
161823354|NCT03201003|584394182|FG001|Overall Study|Withdrawal by Subject|1|||
161823355|NCT03201003|584394181|FG000|Overall Study|Lost to Follow-up|2|||
161823356|NCT03201003|584394182|FG001|Overall Study|Lost to Follow-up|0|||
161823357|NCT03201003|584394181|FG000|Overall Study|Protocol Violation|1|||
161930926|NCT02346370|584794259|FG001|Overall Study|Physician Decision|1|||
161930927|NCT02346370|584794260|FG002|Overall Study|Physician Decision|0|||
161930928|NCT03473301|584794261|FG000|Overall Study|Protocol Violation|4|||
161930929|NCT03473301|584794262|FG001|Overall Study|Protocol Violation|0|||
161930930|NCT03473301|584794263|FG002|Overall Study|Protocol Violation|0|||
161676933|NCT01390272|583870622|FG001|Overall Study|Withdrawal by Subject|5|||
161676934|NCT01390272|583870621|FG000|Overall Study|Patient moved, no longer eligible|5|||
161676935|NCT01390272|583870622|FG001|Overall Study|Patient moved, no longer eligible|8|||
161676936|NCT00590044|583870623|FG000|Overall Study|Withdrawal by Subject|2|||
161676937|NCT00590044|583870624|FG001|Overall Study|Withdrawal by Subject|2|||
161676938|NCT00590044|583870623|FG000|Overall Study|wrong insulin arm assigned|1|||
161676939|NCT00590044|583870624|FG001|Overall Study|wrong insulin arm assigned|0|||
161676940|NCT00590044|583870623|FG000|Overall Study|Protocol Violation|1|||
161676941|NCT00590044|583870624|FG001|Overall Study|Protocol Violation|0|||
161676942|NCT01514136|583870625|FG000|Test Period 1; Test A|Protocol Violation|1|||
161676943|NCT01514136|583870626|FG001|Test Period 1; Test A|Protocol Violation|0|||
161676944|NCT01514136|583870627|FG002|Test Period 1; Test A|Protocol Violation|0|||
161676945|NCT01514136|583870628|FG003|Test Period 1; Test A|Protocol Violation|0|||
161676946|NCT01514136|583870629|FG004|Test Period 1; Test A|Protocol Violation|0|||
161676947|NCT01514136|583870630|FG005|Test Period 1; Test A|Protocol Violation|0|||
161676948|NCT01514136|583870631|FG006|Test Period 1; Test A|Protocol Violation|0|||
161676949|NCT01514136|583870632|FG007|Test Period 1; Test A|Protocol Violation|0|||
161930931|NCT03473301|584794261|FG000|Overall Study|Withdrawal by Subject|0|||
161930932|NCT03473301|584794262|FG001|Overall Study|Withdrawal by Subject|1|||
161930933|NCT03473301|584794263|FG002|Overall Study|Withdrawal by Subject|0|||
161930934|NCT03473301|584794261|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
161930935|NCT03473301|584794262|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
161930936|NCT03473301|584794263|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
161676950|NCT01514136|583870625|FG000|Test Period 1; Test A|Break from study holiday|2|||
161676951|NCT01514136|583870626|FG001|Test Period 1; Test A|Break from study holiday|0|||
161676952|NCT01514136|583870627|FG002|Test Period 1; Test A|Break from study holiday|0|||
161676953|NCT01514136|583870628|FG003|Test Period 1; Test A|Break from study holiday|0|||
161676954|NCT01514136|583870629|FG004|Test Period 1; Test A|Break from study holiday|0|||
161676955|NCT01514136|583870630|FG005|Test Period 1; Test A|Break from study holiday|0|||
161676956|NCT01514136|583870631|FG006|Test Period 1; Test A|Break from study holiday|0|||
161676957|NCT01514136|583870632|FG007|Test Period 1; Test A|Break from study holiday|0|||
161676958|NCT01514136|583870625|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
161676959|NCT01514136|583870626|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
161930937|NCT00835042|584794264|FG000|First Intervention|Withdrawal by Subject|3|||
161930938|NCT00835042|584794265|FG001|First Intervention|Withdrawal by Subject|0|||
161930939|NCT00835042|584794264|FG000|First Intervention|Adverse Event|1|||
161930940|NCT00835042|584794265|FG001|First Intervention|Adverse Event|2|||
161930941|NCT00835042|584794264|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
161930942|NCT00835042|584794265|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
161930943|NCT02453191|584794267|FG000|Overall Study|Withdrawal by Subject|1|||
161930944|NCT02571244|584794268|FG000|Overall Study|Lost to Follow-up|0|||
161676960|NCT01514136|583870627|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
161676961|NCT01514136|583870628|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
161930945|NCT02571244|584794269|FG001|Overall Study|Lost to Follow-up|1|||
161930946|NCT02571244|584794268|FG000|Overall Study|Unable to reach out post discharge|3|||
161930947|NCT02571244|584794269|FG001|Overall Study|Unable to reach out post discharge|0|||
161930948|NCT01696214|584794272|FG000|Overall Study|Lost to Follow-up|1|||
161930949|NCT01696214|584794273|FG001|Overall Study|Lost to Follow-up|0|||
161930950|NCT01696214|584794274|FG002|Overall Study|Lost to Follow-up|0|||
161930951|NCT01696214|584794275|FG003|Overall Study|Lost to Follow-up|0|||
161930952|NCT02134028|584794276|FG000|Overall Study|Lack of Efficacy|1|||
161930953|NCT02134028|584794277|FG001|Overall Study|Lack of Efficacy|0|||
161930954|NCT02134028|584794278|FG002|Overall Study|Lack of Efficacy|3|||
161930955|NCT02134028|584794279|FG003|Overall Study|Lack of Efficacy|2|||
161930956|NCT02134028|584794280|FG004|Overall Study|Lack of Efficacy|1|||
161930957|NCT02134028|584794281|FG005|Overall Study|Lack of Efficacy|2|||
161930958|NCT02134028|584794282|FG006|Overall Study|Lack of Efficacy|1|||
161930959|NCT02134028|584794283|FG007|Overall Study|Lack of Efficacy|0|||
161930960|NCT02134028|584794276|FG000|Overall Study|Poor compliance to protocol|1|||
161930961|NCT02134028|584794277|FG001|Overall Study|Poor compliance to protocol|1|||
161930962|NCT02134028|584794278|FG002|Overall Study|Poor compliance to protocol|3|||
161930963|NCT02134028|584794279|FG003|Overall Study|Poor compliance to protocol|7|||
161930964|NCT02134028|584794280|FG004|Overall Study|Poor compliance to protocol|1|||
161930965|NCT02134028|584794281|FG005|Overall Study|Poor compliance to protocol|1|||
161515702|NCT00097591|583278476|FG001|Overall Study|Other|3|||
161515703|NCT01743092|583278477|FG000|Overall Study|Lost to Follow-up|14|||
161515704|NCT01743092|583278478|FG001|Overall Study|Lost to Follow-up|15|||
161515705|NCT03603964|583278479|FG000|Overall Study|Death|9|||
161515706|NCT03603964|583278479|FG000|Overall Study|Withdrawal by participant|7|||
161515707|NCT03603964|583278479|FG000|Overall Study|Study terminated by Sponsor|19|||
161515708|NCT00563797|583278480|FG000|Overall Study|Lost to Follow-up|7|||
161515709|NCT00563797|583278481|FG001|Overall Study|Lost to Follow-up|2|||
161515710|NCT00009737|583278484|FG000|Overall Study|Adverse Event|112|||
161515711|NCT00009737|583278485|FG001|Overall Study|Adverse Event|75|||
161515712|NCT00009737|583278484|FG000|Overall Study|Death|4|||
161515713|NCT00009737|583278485|FG001|Overall Study|Death|6|||
161930966|NCT02134028|584794282|FG006|Overall Study|Poor compliance to protocol|0|||
161930967|NCT02134028|584794283|FG007|Overall Study|Poor compliance to protocol|0|||
161930968|NCT02134028|584794276|FG000|Overall Study|Other unspecified|4|||
161930969|NCT02134028|584794277|FG001|Overall Study|Other unspecified|22|||
161930970|NCT02134028|584794278|FG002|Overall Study|Other unspecified|33|||
161930971|NCT02134028|584794279|FG003|Overall Study|Other unspecified|64|||
161930972|NCT02134028|584794280|FG004|Overall Study|Other unspecified|8|||
161930973|NCT02134028|584794281|FG005|Overall Study|Other unspecified|6|||
161930974|NCT02134028|584794282|FG006|Overall Study|Other unspecified|2|||
161930975|NCT02134028|584794283|FG007|Overall Study|Other unspecified|1|||
161930976|NCT02134028|584794276|FG000|Overall Study|Adverse Event|3|||
161930977|NCT02134028|584794277|FG001|Overall Study|Adverse Event|19|||
161930978|NCT02134028|584794278|FG002|Overall Study|Adverse Event|13|||
161930979|NCT02134028|584794279|FG003|Overall Study|Adverse Event|32|||
161930980|NCT02134028|584794280|FG004|Overall Study|Adverse Event|4|||
161930981|NCT02134028|584794281|FG005|Overall Study|Adverse Event|5|||
161930982|NCT02134028|584794282|FG006|Overall Study|Adverse Event|1|||
161930983|NCT02134028|584794283|FG007|Overall Study|Adverse Event|2|||
161930984|NCT01309100|584794286|FG000|Overall Study|Protocol Violation|1|||
161930985|NCT01309100|584794286|FG000|Overall Study|Positive Slit lamp finding|1|||
161930986|NCT03722030|584794287|FG000|Overall Study|Withdrawal by Subject|1|||
161930987|NCT03722030|584794288|FG001|Overall Study|Withdrawal by Subject|0|||
161930988|NCT01663987|584794290|FG000|Overall Study|Adverse Event|7|||
161930989|NCT01663987|584794291|FG001|Overall Study|Adverse Event|2|||
161930990|NCT01663987|584794290|FG000|Overall Study|Lost to Follow-up|1|||
161930991|NCT01663987|584794291|FG001|Overall Study|Lost to Follow-up|1|||
161930992|NCT01663987|584794290|FG000|Overall Study|Withdrawal by Subject|2|||
161930993|NCT01663987|584794291|FG001|Overall Study|Withdrawal by Subject|3|||
161930994|NCT01663987|584794290|FG000|Overall Study|Other reason not defined above|3|||
161930995|NCT01663987|584794291|FG001|Overall Study|Other reason not defined above|0|||
161930996|NCT00545948|584794292|FG000|Overall Study|Not Treated|1|||
161930997|NCT00545948|584794293|FG001|Overall Study|Not Treated|1|||
161930998|NCT00545948|584794294|FG002|Overall Study|Not Treated|7|||
161930999|NCT02487199|584794297|FG000|Overall Study|Withdrew Consent|0|||
161931000|NCT02487199|584794298|FG001|Overall Study|Withdrew Consent|1|||
161931001|NCT00286455|584794299|FG000|Overall Study|Hyperglycemia rescue|19|||
161931002|NCT00286455|584794300|FG001|Overall Study|Hyperglycemia rescue|13|||
161931003|NCT00286455|584794301|FG002|Overall Study|Hyperglycemia rescue|10|||
161931004|NCT00286455|584794299|FG000|Overall Study|Adverse Event|1|||
161931005|NCT00286455|584794300|FG001|Overall Study|Adverse Event|3|||
161931006|NCT00286455|584794301|FG002|Overall Study|Adverse Event|2|||
161931007|NCT00286455|584794299|FG000|Overall Study|Lost to Follow-up|0|||
161931008|NCT00286455|584794300|FG001|Overall Study|Lost to Follow-up|3|||
161931009|NCT00286455|584794301|FG002|Overall Study|Lost to Follow-up|3|||
161931010|NCT00286455|584794299|FG000|Overall Study|Physician Decision|3|||
161931011|NCT00286455|584794300|FG001|Overall Study|Physician Decision|0|||
161931012|NCT00286455|584794301|FG002|Overall Study|Physician Decision|2|||
161931013|NCT00286455|584794299|FG000|Overall Study|Protocol Violation|1|||
161931014|NCT00286455|584794300|FG001|Overall Study|Protocol Violation|1|||
161931015|NCT00286455|584794301|FG002|Overall Study|Protocol Violation|0|||
161931016|NCT00286455|584794299|FG000|Overall Study|Participant Non-compliance|1|||
161931017|NCT00286455|584794300|FG001|Overall Study|Participant Non-compliance|0|||
161931018|NCT00286455|584794301|FG002|Overall Study|Participant Non-compliance|0|||
161931019|NCT00286455|584794299|FG000|Overall Study|Withdrawal by Subject|0|||
161931020|NCT00286455|584794300|FG001|Overall Study|Withdrawal by Subject|8|||
161931021|NCT00286455|584794301|FG002|Overall Study|Withdrawal by Subject|7|||
161931022|NCT01654250|584796362|FG000|Overall Study|Lost to Follow-up|1|||
161931023|NCT01654250|584796363|FG001|Overall Study|Lost to Follow-up|0|||
161931024|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
161931025|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
161931026|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
161931027|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
161931028|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
161931029|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
161931030|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
161931031|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
161931032|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
161931033|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
161931034|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
161931035|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
161931036|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
161931037|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
161931038|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
161931039|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
161931040|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
161588716|NCT04784559|583544581|FG002|Overall Study|The participant was transferred to IRCU|0|||
161588717|NCT04784559|583544579|FG000|Overall Study|SAE|0|||
161588718|NCT04784559|583544580|FG001|Overall Study|SAE|1|||
161588719|NCT04784559|583544581|FG002|Overall Study|SAE|0|||
161588720|NCT04784559|583544579|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
161588721|NCT04784559|583544580|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
161588722|NCT04784559|583544581|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
161588723|NCT05323084|583544583|FG000|Period 2 - Washout|Lost to Follow-up|0|||
161588724|NCT05323084|583544584|FG001|Period 2 - Washout|Lost to Follow-up|1|||
161588725|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
161588726|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
161588727|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
161588728|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588729|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588730|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588731|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588732|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588733|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588734|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588735|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588736|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588737|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161588738|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
161588739|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
161588740|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588741|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588742|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588743|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588744|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588745|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588746|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588747|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588748|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588749|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588750|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161588751|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
161588752|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
161588753|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588754|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588755|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588756|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588757|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588758|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588759|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588760|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588761|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588762|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588763|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161588764|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
161588765|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
161588766|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161588767|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161823358|NCT03201003|584394182|FG001|Overall Study|Protocol Violation|0|||
161823359|NCT01709903|584394188|FG000|Overall Study|administrative problems|2|||
161823360|NCT01709903|584394189|FG001|Overall Study|administrative problems|6|||
161823361|NCT01709903|584394188|FG000|Overall Study|Abnormal test procedure results|1|||
161823362|NCT01709903|584394189|FG001|Overall Study|Abnormal test procedure results|0|||
161823363|NCT01709903|584394188|FG000|Overall Study|In ability to use device|1|||
161823364|NCT01709903|584394189|FG001|Overall Study|In ability to use device|1|||
161823365|NCT01709903|584394188|FG000|Overall Study|no longer needed study drug|0|||
161823366|NCT01709903|584394189|FG001|Overall Study|no longer needed study drug|1|||
161823367|NCT01709903|584394188|FG000|Overall Study|Lost to Follow-up|0|||
161823368|NCT01709903|584394189|FG001|Overall Study|Lost to Follow-up|2|||
161823369|NCT01709903|584394188|FG000|Overall Study|Death|2|||
161823370|NCT01709903|584394189|FG001|Overall Study|Death|0|||
161823371|NCT01709903|584394188|FG000|Overall Study|Protocol Violation|3|||
161823372|NCT01709903|584394189|FG001|Overall Study|Protocol Violation|2|||
161823373|NCT01709903|584394188|FG000|Overall Study|Lack of Efficacy|3|||
161823374|NCT01709903|584394189|FG001|Overall Study|Lack of Efficacy|3|||
161823375|NCT01709903|584394188|FG000|Overall Study|Withdrawal by Subject|6|||
161823376|NCT01709903|584394189|FG001|Overall Study|Withdrawal by Subject|6|||
161823377|NCT01709903|584394188|FG000|Overall Study|Adverse Event|11|||
161823378|NCT01709903|584394189|FG001|Overall Study|Adverse Event|18|||
161823379|NCT01751087|584394194|FG000|Overall Study|Withdrawal by Subject|1|||
161823380|NCT01751087|584394195|FG001|Overall Study|Withdrawal by Subject|0|||
161823381|NCT01751087|584394196|FG002|Overall Study|Withdrawal by Subject|0|||
161823382|NCT01751087|584394194|FG000|Overall Study|Physician Decision|0|||
161823383|NCT01751087|584394195|FG001|Overall Study|Physician Decision|0|||
161823384|NCT01751087|584394196|FG002|Overall Study|Physician Decision|1|||
161823385|NCT05377489|584394197|FG000|Overall Study|Withdrawal by Subject|122|||
161823386|NCT05377489|584394197|FG000|Overall Study|Lost to Follow-up|21|||
161823387|NCT05377489|584394197|FG000|Overall Study|Lack of Efficacy|10|||
161823388|NCT05377489|584394197|FG000|Overall Study|Adverse Event|5|||
161823389|NCT05377489|584394197|FG000|Overall Study|Death|4|||
161823390|NCT05377489|584394197|FG000|Overall Study|Physician Decision|3|||
161823391|NCT05377489|584394197|FG000|Overall Study|Protocol Violation|1|||
161823392|NCT05377489|584394197|FG000|Overall Study|Other|9|||
161823393|NCT00724958|584394198|FG000|Overall Study|Adverse Event|28|||
161823394|NCT00724958|584394198|FG000|Overall Study|Loss of Response|40|||
161823395|NCT00724958|584394198|FG000|Overall Study|No Response|18|||
161823396|NCT00724958|584394198|FG000|Overall Study|Remission|7|||
161823397|NCT00724958|584394198|FG000|Overall Study|Other Reason|76|||
161823398|NCT00724958|584394198|FG000|Overall Study|No documentation for end of therapy|13|||
161823399|NCT00697619|584394199|FG000|Overall Study|Lack of Efficacy|2|||
161823400|NCT00697619|584394200|FG001|Overall Study|Lack of Efficacy|2|||
161823401|NCT00697619|584394199|FG000|Overall Study|Adverse Event|4|||
161823402|NCT00697619|584394200|FG001|Overall Study|Adverse Event|6|||
161823403|NCT00559637|584396155|FG000|Overall Study|Adverse Event|22|||
161823404|NCT00559637|584396155|FG000|Overall Study|Withdrawal by Subject|4|||
161823405|NCT00559637|584396155|FG000|Overall Study|Protocol Violation|6|||
161823406|NCT00559637|584396155|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
161823407|NCT00559637|584396155|FG000|Overall Study|Failure to return|6|||
161823408|NCT00559637|584396155|FG000|Overall Study|Insufficient response|3|||
161823409|NCT00559637|584396155|FG000|Overall Study|Started requiring dialysis after month 7|2|||
161823410|NCT00559637|584396155|FG000|Overall Study|Suspected lung cancer|1|||
161823411|NCT00559637|584396155|FG000|Overall Study|Participation in another study|1|||
161823412|NCT00559637|584396155|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
161823413|NCT00559637|584396155|FG000|Overall Study|Change of center|1|||
161823414|NCT00559637|584396155|FG000|Overall Study|Change of home|1|||
161823415|NCT00559637|584396155|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
161823416|NCT01705717|584396156|FG000|Overall Study|Adverse Event|2|||
161823417|NCT01705717|584396157|FG001|Overall Study|Adverse Event|2|||
161823418|NCT01705717|584396156|FG000|Overall Study|Lack of Efficacy|0|||
161823419|NCT01705717|584396157|FG001|Overall Study|Lack of Efficacy|1|||
161823420|NCT01705717|584396156|FG000|Overall Study|Other|0|||
161823421|NCT01705717|584396157|FG001|Overall Study|Other|2|||
161823422|NCT02031237|584396158|FG000|Overall Study|Death|1|||
161823423|NCT02031237|584396159|FG001|Overall Study|Death|5|||
161823424|NCT02031237|584396160|FG002|Overall Study|Death|0|||
161823425|NCT02031237|584396158|FG000|Overall Study|Physician Decision|0|||
161823426|NCT02031237|584396159|FG001|Overall Study|Physician Decision|1|||
161823427|NCT02031237|584396160|FG002|Overall Study|Physician Decision|0|||
161823428|NCT02031237|584396158|FG000|Overall Study|Withdrawal by Subject|2|||
161823429|NCT02031237|584396159|FG001|Overall Study|Withdrawal by Subject|2|||
161823430|NCT02031237|584396160|FG002|Overall Study|Withdrawal by Subject|0|||
161823431|NCT02031237|584396158|FG000|Overall Study|Protocol Violation|2|||
161823432|NCT02031237|584396159|FG001|Overall Study|Protocol Violation|6|||
161823433|NCT02031237|584396160|FG002|Overall Study|Protocol Violation|0|||
161823434|NCT02031237|584396158|FG000|Overall Study|Alternate Treatment Given|0|||
161823435|NCT02031237|584396159|FG001|Overall Study|Alternate Treatment Given|0|||
161823436|NCT02031237|584396160|FG002|Overall Study|Alternate Treatment Given|3|||
161823437|NCT01074008|584396164|FG000|Overall Study|Adverse Event|0|||
161823438|NCT01074008|584396165|FG001|Overall Study|Adverse Event|1|||
161823439|NCT01074008|584396166|FG002|Overall Study|Adverse Event|0|||
161823440|NCT01074008|584396167|FG003|Overall Study|Adverse Event|0|||
161823441|NCT01074008|584396168|FG004|Overall Study|Adverse Event|0|||
161823442|NCT01074008|584396169|FG005|Overall Study|Adverse Event|0|||
161823443|NCT01074008|584396170|FG006|Overall Study|Adverse Event|0|||
161823444|NCT01074008|584396171|FG007|Overall Study|Adverse Event|0|||
161823445|NCT01074008|584396172|FG008|Overall Study|Adverse Event|0|||
161823446|NCT01074008|584396164|FG000|Overall Study|Withdrawal by Subject|1|||
161823447|NCT01074008|584396165|FG001|Overall Study|Withdrawal by Subject|1|||
161823448|NCT01074008|584396166|FG002|Overall Study|Withdrawal by Subject|1|||
161823449|NCT01074008|584396167|FG003|Overall Study|Withdrawal by Subject|0|||
161823450|NCT01074008|584396168|FG004|Overall Study|Withdrawal by Subject|1|||
161823451|NCT01074008|584396169|FG005|Overall Study|Withdrawal by Subject|0|||
161823452|NCT01074008|584396170|FG006|Overall Study|Withdrawal by Subject|0|||
161931041|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
161931042|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
161931043|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
161931044|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
161931045|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
161931046|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
161823453|NCT01074008|584396171|FG007|Overall Study|Withdrawal by Subject|0|||
161823454|NCT01074008|584396172|FG008|Overall Study|Withdrawal by Subject|0|||
161823455|NCT01074008|584396164|FG000|Overall Study|Lost to Follow-up|0|||
161823456|NCT01074008|584396165|FG001|Overall Study|Lost to Follow-up|1|||
161823457|NCT01074008|584396166|FG002|Overall Study|Lost to Follow-up|1|||
161823458|NCT01074008|584396167|FG003|Overall Study|Lost to Follow-up|1|||
161823459|NCT01074008|584396168|FG004|Overall Study|Lost to Follow-up|1|||
161823460|NCT01074008|584396169|FG005|Overall Study|Lost to Follow-up|0|||
161823461|NCT01074008|584396170|FG006|Overall Study|Lost to Follow-up|1|||
161823462|NCT01074008|584396171|FG007|Overall Study|Lost to Follow-up|0|||
161823463|NCT01074008|584396172|FG008|Overall Study|Lost to Follow-up|4|||
161823464|NCT02805309|584396175|FG000|Overall Study|Lost to Follow-up|2|||
161823465|NCT02805309|584396176|FG001|Overall Study|Lost to Follow-up|2|||
161823466|NCT02805309|584396177|FG002|Overall Study|Lost to Follow-up|2|||
161823467|NCT02805309|584396175|FG000|Overall Study|Post-Randomization Exclusion|0|||
161823468|NCT02805309|584396176|FG001|Overall Study|Post-Randomization Exclusion|2|||
161823469|NCT02805309|584396177|FG002|Overall Study|Post-Randomization Exclusion|1|||
161823470|NCT05480800|584396186|FG000|Overall Study|Withdrawal by Subject|0|||
161823471|NCT05480800|584396187|FG001|Overall Study|Withdrawal by Subject|0|||
161823472|NCT05480800|584396188|FG002|Overall Study|Withdrawal by Subject|2|||
161823473|NCT05480800|584396189|FG003|Overall Study|Withdrawal by Subject|1|||
161823474|NCT05480800|584396190|FG004|Overall Study|Withdrawal by Subject|0|||
161823475|NCT05480800|584396191|FG005|Overall Study|Withdrawal by Subject|0|||
161823476|NCT05480800|584396192|FG006|Overall Study|Withdrawal by Subject|1|||
161823477|NCT05480800|584396193|FG007|Overall Study|Withdrawal by Subject|0|||
161823478|NCT05480800|584396186|FG000|Overall Study|Other|0|||
161823479|NCT05480800|584396187|FG001|Overall Study|Other|0|||
161931047|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
161931048|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
161931049|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
161931050|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
161823480|NCT05480800|584396188|FG002|Overall Study|Other|0|||
161823481|NCT05480800|584396189|FG003|Overall Study|Other|0|||
161823482|NCT05480800|584396190|FG004|Overall Study|Other|0|||
161823483|NCT05480800|584396191|FG005|Overall Study|Other|0|||
161823484|NCT05480800|584396192|FG006|Overall Study|Other|1|||
161823485|NCT05480800|584396193|FG007|Overall Study|Other|0|||
161823486|NCT00377156|584396196|FG000|Overall Study|Death|23|||
161823487|NCT00377156|584396197|FG001|Overall Study|Death|19|||
161823488|NCT00377156|584396196|FG000|Overall Study|Withdrawal by Subject|16|||
161823489|NCT00377156|584396197|FG001|Overall Study|Withdrawal by Subject|24|||
161823490|NCT00377156|584396196|FG000|Overall Study|Had follow-up <90 d|3|||
161931051|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
161823491|NCT00377156|584396197|FG001|Overall Study|Had follow-up <90 d|6|||
161823492|NCT00377156|584396196|FG000|Overall Study|Cancellation|1|||
161823493|NCT00377156|584396197|FG001|Overall Study|Cancellation|0|||
161823494|NCT00377156|584396196|FG000|Overall Study|Refused testing|0|||
161823495|NCT00377156|584396197|FG001|Overall Study|Refused testing|1|||
161823496|NCT00377156|584396196|FG000|Overall Study|Ineligible|0|||
161823497|NCT00377156|584396197|FG001|Overall Study|Ineligible|1|||
161931052|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
161931053|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
161931054|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
161931055|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
161931056|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
161823498|NCT00377156|584396196|FG000|Overall Study|Disability or language problem|0|||
161823499|NCT00377156|584396197|FG001|Overall Study|Disability or language problem|1|||
161823500|NCT00377156|584396196|FG000|Overall Study|Other|5|||
161823501|NCT00377156|584396197|FG001|Overall Study|Other|2|||
161823502|NCT01802216|584396198|FG000|4 Month Visit|Participant did not show to visit|3|||
161823503|NCT01802216|584396199|FG001|4 Month Visit|Participant did not show to visit|4|||
161823504|NCT01802216|584396198|FG000|8 Month Visit|Participant did not show to visit|3|||
161823505|NCT01802216|584396199|FG001|8 Month Visit|Participant did not show to visit|5|||
161823506|NCT01802216|584396198|FG000|12 Month Visit|Participant did not show to visit|3|||
161823507|NCT01802216|584396199|FG001|12 Month Visit|Participant did not show to visit|4|||
161823508|NCT00683592|584396202|FG000|Overall Study|Adverse Event|12|||
161823509|NCT00683592|584396203|FG001|Overall Study|Adverse Event|4|||
161823510|NCT00683592|584396202|FG000|Overall Study|Withdrawal by Subject|11|||
161823511|NCT00683592|584396203|FG001|Overall Study|Withdrawal by Subject|11|||
161931057|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
161931058|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
161931059|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
161931060|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
161931061|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
161931062|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
161931063|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
161931064|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
161931065|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
161931066|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
161931067|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
161931068|NCT03280615|584796368|FG000|Overall Study|Lost to Follow-up|1|||
161931069|NCT03280615|584796369|FG001|Overall Study|Lost to Follow-up|2|||
161931070|NCT03280615|584796368|FG000|Overall Study|Adverse Event|1|||
161931071|NCT03280615|584796369|FG001|Overall Study|Adverse Event|1|||
161931072|NCT03280615|584796368|FG000|Overall Study|Withdrawal by Subject|2|||
161931073|NCT03280615|584796369|FG001|Overall Study|Withdrawal by Subject|2|||
161931074|NCT04432298|584796374|FG000|Overall Study|Other than specified|1|||
161931075|NCT04432298|584796375|FG001|Overall Study|Other than specified|0|||
161931076|NCT04432298|584796374|FG000|Overall Study|Lost to Follow-up|0|||
161931077|NCT04432298|584796375|FG001|Overall Study|Lost to Follow-up|1|||
161931078|NCT04432298|584796374|FG000|Overall Study|Death|3|||
161931079|NCT04432298|584796375|FG001|Overall Study|Death|2|||
161931080|NCT04432298|584796374|FG000|Overall Study|Withdrawal by Subject|2|||
161931081|NCT04432298|584796375|FG001|Overall Study|Withdrawal by Subject|0|||
161931082|NCT02451007|584796378|FG000|Overall Study|Withdrawal by Subject|4|||
161931083|NCT02451007|584796378|FG000|Overall Study|Adverse Event|1|||
161931084|NCT02451007|584796378|FG000|Overall Study|Disease Progression|2|||
161931085|NCT01716559|584796379|FG000|Overall Study|Adverse Event|11|||
161931086|NCT01716559|584796379|FG000|Overall Study|Death|21|||
161931087|NCT01716559|584796379|FG000|Overall Study|Withdrawal by Subject|4|||
161931088|NCT01716559|584796379|FG000|Overall Study|Other withdrawal reason|75|||
161931089|NCT00348374|584796380|FG000|Overall Study|Adverse Event|1|||
161931090|NCT00348374|584796381|FG001|Overall Study|Adverse Event|4|||
161931091|NCT00348374|584796380|FG000|Overall Study|Lost to Follow-up|1|||
161931092|NCT00348374|584796381|FG001|Overall Study|Lost to Follow-up|3|||
161931093|NCT00348374|584796380|FG000|Overall Study|Withdrawal by Subject|5|||
161931094|NCT00348374|584796381|FG001|Overall Study|Withdrawal by Subject|5|||
161931095|NCT00348374|584796380|FG000|Overall Study|Other|11|||
161931096|NCT00348374|584796381|FG001|Overall Study|Other|12|||
161931097|NCT00348374|584796380|FG000|Overall Study|ongoing at date of cutoff|1|||
161931098|NCT00348374|584796381|FG001|Overall Study|ongoing at date of cutoff|1|||
161931099|NCT00348374|584796380|FG000|Overall Study|randomized but did not receive treatment|0|||
161931100|NCT00348374|584796381|FG001|Overall Study|randomized but did not receive treatment|7|||
161931101|NCT02123511|584796390|FG000|Overall Study|Cancelled treatment|1|||
161931102|NCT02123511|584796391|FG001|Overall Study|Cancelled treatment|0|||
161931103|NCT02123511|584796390|FG000|Overall Study|Incomplete data|1|||
161931104|NCT02123511|584796391|FG001|Overall Study|Incomplete data|3|||
161931105|NCT02123511|584796390|FG000|Overall Study|Ineligible|0|||
161931106|NCT02123511|584796391|FG001|Overall Study|Ineligible|1|||
161931107|NCT01423084|584796392|FG000|Overall Study|Adverse Event|0|||
161931108|NCT01423084|584796393|FG001|Overall Study|Adverse Event|1|||
161931109|NCT01423084|584796392|FG000|Overall Study|Withdrawal by Subject|2|||
161931110|NCT01423084|584796393|FG001|Overall Study|Withdrawal by Subject|3|||
161931111|NCT01133977|584796397|FG000|Overall Study|Adverse Event|0|||
161931112|NCT01133977|584796398|FG001|Overall Study|Adverse Event|0|||
161931113|NCT01133977|584796399|FG002|Overall Study|Adverse Event|1|||
161931114|NCT01133977|584796400|FG003|Overall Study|Adverse Event|0|||
161931115|NCT01133977|584796401|FG004|Overall Study|Adverse Event|0|||
161931116|NCT01133977|584796397|FG000|Overall Study|Death|1|||
161515714|NCT00009737|583278484|FG000|Overall Study|Lack of Efficacy|17|||
161515715|NCT00009737|583278485|FG001|Overall Study|Lack of Efficacy|15|||
161515716|NCT00009737|583278484|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
161515717|NCT00009737|583278485|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
161931117|NCT01133977|584796398|FG001|Overall Study|Death|1|||
161931118|NCT01133977|584796399|FG002|Overall Study|Death|1|||
161931119|NCT01133977|584796400|FG003|Overall Study|Death|7|||
161931120|NCT01133977|584796401|FG004|Overall Study|Death|3|||
161931121|NCT01133977|584796397|FG000|Overall Study|Started a New Line of Therapy|2|||
161931122|NCT01133977|584796398|FG001|Overall Study|Started a New Line of Therapy|6|||
161931123|NCT01133977|584796399|FG002|Overall Study|Started a New Line of Therapy|4|||
161931124|NCT01133977|584796400|FG003|Overall Study|Started a New Line of Therapy|25|||
161931125|NCT01133977|584796401|FG004|Overall Study|Started a New Line of Therapy|33|||
161931126|NCT01133977|584796397|FG000|Overall Study|Lost to Follow-up|0|||
161931127|NCT01133977|584796398|FG001|Overall Study|Lost to Follow-up|0|||
161931128|NCT01133977|584796399|FG002|Overall Study|Lost to Follow-up|0|||
161931129|NCT01133977|584796400|FG003|Overall Study|Lost to Follow-up|2|||
161931130|NCT01133977|584796401|FG004|Overall Study|Lost to Follow-up|1|||
161931131|NCT01133977|584796397|FG000|Overall Study|Withdrawal by Subject|0|||
161931132|NCT01133977|584796398|FG001|Overall Study|Withdrawal by Subject|0|||
161931133|NCT01133977|584796399|FG002|Overall Study|Withdrawal by Subject|0|||
161931134|NCT01133977|584796400|FG003|Overall Study|Withdrawal by Subject|5|||
161931135|NCT01133977|584796401|FG004|Overall Study|Withdrawal by Subject|1|||
161931136|NCT01682603|584796402|FG000|Overall Study|Lost to Follow-up|3|||
161931137|NCT01791205|584796403|FG000|Phase II|Lack of Efficacy|6|||
161931138|NCT01791205|584796404|FG001|Phase II|Lack of Efficacy|0|||
161931139|NCT01791205|584796403|FG000|Phase II|Adverse Event|2|||
161931140|NCT01791205|584796404|FG001|Phase II|Adverse Event|0|||
161931141|NCT01791205|584796403|FG000|Phase II|Safety|1|||
161931142|NCT01791205|584796404|FG001|Phase II|Safety|0|||
161931143|NCT01791205|584796403|FG000|Phase II|Lost to Follow-up|1|||
161931144|NCT01791205|584796404|FG001|Phase II|Lost to Follow-up|0|||
161931145|NCT01791205|584796403|FG000|Phase II|Remission of disease|1|||
161931146|NCT01791205|584796404|FG001|Phase II|Remission of disease|0|||
161931147|NCT01791205|584796403|FG000|Phase II|Physician's decision|1|||
161931148|NCT01791205|584796404|FG001|Phase II|Physician's decision|0|||
161931149|NCT05345405|584796417|FG000|Overall Study|Withdrawal by Subject|2|||
161931150|NCT05345405|584796418|FG001|Overall Study|Withdrawal by Subject|0|||
161931151|NCT05345405|584796419|FG002|Overall Study|Withdrawal by Subject|0|||
161931152|NCT05345405|584796417|FG000|Overall Study|Did not meet eligibility criteria|0|||
161931153|NCT05345405|584796418|FG001|Overall Study|Did not meet eligibility criteria|2|||
161931154|NCT05345405|584796419|FG002|Overall Study|Did not meet eligibility criteria|0|||
161931155|NCT05345405|584796417|FG000|Overall Study|Lost to Follow-up|0|||
161931156|NCT05345405|584796418|FG001|Overall Study|Lost to Follow-up|0|||
161931157|NCT05345405|584796419|FG002|Overall Study|Lost to Follow-up|1|||
161931158|NCT04189588|584796420|FG000|Overall Study|Death|0|||
161931159|NCT04189588|584796421|FG001|Overall Study|Death|1|||
161931160|NCT04189588|584796420|FG000|Overall Study|Lost to Follow-up|0|||
161931161|NCT04189588|584796421|FG001|Overall Study|Lost to Follow-up|1|||
161931162|NCT03757715|584796424|FG000|Overall Study|Lost to Follow-up|4|||
161931163|NCT03757715|584796425|FG001|Overall Study|Lost to Follow-up|9|||
161931164|NCT03757715|584796424|FG000|Overall Study|Withdrawal by Subject|1|||
161931165|NCT03757715|584796425|FG001|Overall Study|Withdrawal by Subject|1|||
161931166|NCT00281580|584796426|FG000|Overall Study|Adverse Event|2|||
161931167|NCT00281580|584796427|FG001|Overall Study|Adverse Event|0|||
161931168|NCT00281580|584796428|FG002|Overall Study|Adverse Event|2|||
161931169|NCT00281580|584796429|FG003|Overall Study|Adverse Event|4|||
161931170|NCT00281580|584796430|FG004|Overall Study|Adverse Event|1|||
161931171|NCT00281580|584796431|FG005|Overall Study|Adverse Event|0|||
161931172|NCT00281580|584796432|FG006|Overall Study|Adverse Event|1|||
161931173|NCT00281580|584796433|FG007|Overall Study|Adverse Event|0|||
161931174|NCT00281580|584796434|FG008|Overall Study|Adverse Event|1|||
161931175|NCT00281580|584796435|FG009|Overall Study|Adverse Event|6|||
161931176|NCT00281580|584796436|FG010|Overall Study|Adverse Event|0|||
161931177|NCT00281580|584796437|FG011|Overall Study|Adverse Event|5|||
161931178|NCT00281580|584796438|FG012|Overall Study|Adverse Event|8|||
161931179|NCT00281580|584796439|FG013|Overall Study|Adverse Event|2|||
161676962|NCT01514136|583870629|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
161676963|NCT01514136|583870630|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
161676964|NCT01514136|583870631|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
161676965|NCT01514136|583870632|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
161676966|NCT01514136|583870625|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
161823512|NCT00683592|584396202|FG000|Overall Study|Lost to Follow-up|17|||
161823513|NCT00683592|584396203|FG001|Overall Study|Lost to Follow-up|17|||
161823514|NCT00683592|584396202|FG000|Overall Study|Lack of Efficacy|3|||
161823515|NCT00683592|584396203|FG001|Overall Study|Lack of Efficacy|7|||
161823516|NCT00683592|584396202|FG000|Overall Study|Physician Decision|0|||
161823517|NCT00683592|584396203|FG001|Overall Study|Physician Decision|1|||
161823518|NCT00683592|584396202|FG000|Overall Study|Non-compliance|3|||
161823519|NCT00683592|584396203|FG001|Overall Study|Non-compliance|5|||
161823520|NCT00683592|584396202|FG000|Overall Study|Other|1|||
161823521|NCT00683592|584396203|FG001|Overall Study|Other|1|||
161931180|NCT00281580|584796440|FG014|Overall Study|Adverse Event|3|||
161931181|NCT00281580|584796441|FG015|Overall Study|Adverse Event|3|||
161931182|NCT00281580|584796426|FG000|Overall Study|Protocol Violation|0|||
161931183|NCT00281580|584796427|FG001|Overall Study|Protocol Violation|0|||
161931184|NCT00281580|584796428|FG002|Overall Study|Protocol Violation|1|||
161931185|NCT00281580|584796429|FG003|Overall Study|Protocol Violation|1|||
161931186|NCT00281580|584796430|FG004|Overall Study|Protocol Violation|0|||
161931187|NCT00281580|584796431|FG005|Overall Study|Protocol Violation|0|||
161931188|NCT00281580|584796432|FG006|Overall Study|Protocol Violation|1|||
161931189|NCT00281580|584796433|FG007|Overall Study|Protocol Violation|0|||
161931190|NCT00281580|584796434|FG008|Overall Study|Protocol Violation|2|||
161931191|NCT00281580|584796435|FG009|Overall Study|Protocol Violation|0|||
161931192|NCT00281580|584796436|FG010|Overall Study|Protocol Violation|1|||
161931193|NCT00281580|584796437|FG011|Overall Study|Protocol Violation|2|||
161931194|NCT00281580|584796438|FG012|Overall Study|Protocol Violation|0|||
161823522|NCT03303417|584396212|FG000|Overall Study|Withdrawal by Subject|1|||
161823523|NCT03303417|584396213|FG001|Overall Study|Withdrawal by Subject|1|||
161823524|NCT02697617|584396214|FG000|Overall Study|Withdrawal by Subject|0|||
161823525|NCT02697617|584396215|FG001|Overall Study|Withdrawal by Subject|2|||
161823526|NCT02697617|584396214|FG000|Overall Study|Pregnancy|1|||
161823527|NCT02697617|584396215|FG001|Overall Study|Pregnancy|0|||
161823528|NCT00329160|584396218|FG000|Overall Study|Adverse Event|27|||
161823529|NCT00329160|584396218|FG000|Overall Study|Withdrawal by Subject|13|||
161823530|NCT00329160|584396218|FG000|Overall Study|Protocol Violation|2|||
161823531|NCT00329160|584396218|FG000|Overall Study|Did not Receive Study Drug|1|||
161823532|NCT00329160|584396218|FG000|Overall Study|Incomplete IVUS|45|||
161823533|NCT05212948|584396223|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
161823534|NCT05212948|584396224|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
161823535|NCT05212948|584396223|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
161823536|NCT05212948|584396224|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
161823537|NCT05212948|584396223|FG000|Initial Vaccination Period|Pregnancy|20|||
161823538|NCT05212948|584396224|FG001|Initial Vaccination Period|Pregnancy|14|||
161823539|NCT05212948|584396223|FG000|Initial Vaccination Period|Physician Decision|686|||
161823540|NCT05212948|584396224|FG001|Initial Vaccination Period|Physician Decision|401|||
161823541|NCT05212948|584396223|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
161823542|NCT05212948|584396224|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
161823543|NCT05212948|584396223|FG000|Initial Vaccination Period|Death|23|||
161823544|NCT05212948|584396224|FG001|Initial Vaccination Period|Death|18|||
161823545|NCT05212948|584396223|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
161823546|NCT05212948|584396224|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
161823547|NCT05212948|584396223|FG000|Initial Vaccination Period|Adverse Event|36|||
161823548|NCT05212948|584396224|FG001|Initial Vaccination Period|Adverse Event|23|||
161823549|NCT05212948|584396223|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
161823550|NCT05212948|584396224|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
161823551|NCT05212948|584396223|FG000|Crossover Vaccination Period|Pregnancy|6|||
161823552|NCT05212948|584396224|FG001|Crossover Vaccination Period|Pregnancy|1|||
161823553|NCT05212948|584396223|FG000|Crossover Vaccination Period|Physician Decision|49|||
161823554|NCT05212948|584396224|FG001|Crossover Vaccination Period|Physician Decision|24|||
161823555|NCT05212948|584396223|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
161823556|NCT05212948|584396224|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
161823557|NCT05212948|584396223|FG000|Crossover Vaccination Period|Death|10|||
161823558|NCT05212948|584396224|FG001|Crossover Vaccination Period|Death|5|||
161823559|NCT05212948|584396223|FG000|Crossover Vaccination Period|Adverse Event|9|||
161823560|NCT05212948|584396224|FG001|Crossover Vaccination Period|Adverse Event|4|||
161823561|NCT05347693|584396225|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
161823562|NCT05347693|584396226|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
161823563|NCT05347693|584396227|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
161823564|NCT05347693|584396225|FG000|Inpatient Period|Withdrawal of consent|10|||
161823565|NCT05347693|584396226|FG001|Inpatient Period|Withdrawal of consent|0|||
161823566|NCT05347693|584396227|FG002|Inpatient Period|Withdrawal of consent|0|||
161823567|NCT05347693|584396225|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
161823568|NCT05347693|584396226|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
161823569|NCT05347693|584396227|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
161823570|NCT05347693|584396225|FG000|Inpatient Period|Screening Failure|8|||
161823571|NCT05347693|584396226|FG001|Inpatient Period|Screening Failure|0|||
161823572|NCT05347693|584396227|FG002|Inpatient Period|Screening Failure|0|||
161823573|NCT05347693|584396225|FG000|Inpatient Period|Death|2|||
161823574|NCT05347693|584396226|FG001|Inpatient Period|Death|0|||
161823575|NCT05347693|584396227|FG002|Inpatient Period|Death|0|||
161823576|NCT05347693|584396225|FG000|Inpatient Period|Physician Decision|5|||
161823577|NCT05347693|584396226|FG001|Inpatient Period|Physician Decision|0|||
161823578|NCT05347693|584396227|FG002|Inpatient Period|Physician Decision|0|||
161823579|NCT05347693|584396225|FG000|Inpatient Period|Adverse Event|3|||
161823580|NCT05347693|584396226|FG001|Inpatient Period|Adverse Event|0|||
161823581|NCT05347693|584396227|FG002|Inpatient Period|Adverse Event|0|||
161823582|NCT05347693|584396225|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
161823583|NCT05347693|584396226|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
161823584|NCT05347693|584396227|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
161823585|NCT05347693|584396225|FG000|Outpatient Period|Adverse Event|0|||
161823586|NCT05347693|584396226|FG001|Outpatient Period|Adverse Event|9|||
161823587|NCT05347693|584396227|FG002|Outpatient Period|Adverse Event|0|||
161823588|NCT05347693|584396225|FG000|Outpatient Period|Death|0|||
161823589|NCT05347693|584396226|FG001|Outpatient Period|Death|6|||
161823590|NCT05347693|584396227|FG002|Outpatient Period|Death|2|||
161823591|NCT05347693|584396225|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
161823592|NCT05347693|584396226|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
161931195|NCT00281580|584796439|FG013|Overall Study|Protocol Violation|1|||
161931196|NCT00281580|584796440|FG014|Overall Study|Protocol Violation|1|||
161931197|NCT00281580|584796441|FG015|Overall Study|Protocol Violation|3|||
161931198|NCT00281580|584796426|FG000|Overall Study|Withdrawal by Subject|3|||
161931199|NCT00281580|584796427|FG001|Overall Study|Withdrawal by Subject|0|||
161931200|NCT00281580|584796428|FG002|Overall Study|Withdrawal by Subject|1|||
161931201|NCT00281580|584796429|FG003|Overall Study|Withdrawal by Subject|1|||
161931202|NCT00281580|584796430|FG004|Overall Study|Withdrawal by Subject|1|||
161931203|NCT00281580|584796431|FG005|Overall Study|Withdrawal by Subject|2|||
161931204|NCT00281580|584796432|FG006|Overall Study|Withdrawal by Subject|2|||
161931205|NCT00281580|584796433|FG007|Overall Study|Withdrawal by Subject|0|||
161931206|NCT00281580|584796434|FG008|Overall Study|Withdrawal by Subject|1|||
161931207|NCT00281580|584796435|FG009|Overall Study|Withdrawal by Subject|4|||
161931208|NCT00281580|584796436|FG010|Overall Study|Withdrawal by Subject|1|||
161931209|NCT00281580|584796437|FG011|Overall Study|Withdrawal by Subject|1|||
161931210|NCT00281580|584796438|FG012|Overall Study|Withdrawal by Subject|2|||
161931211|NCT00281580|584796439|FG013|Overall Study|Withdrawal by Subject|2|||
161931212|NCT00281580|584796440|FG014|Overall Study|Withdrawal by Subject|1|||
161931213|NCT00281580|584796441|FG015|Overall Study|Withdrawal by Subject|5|||
161931214|NCT00281580|584796426|FG000|Overall Study|Lack of Efficacy|2|||
161931215|NCT00281580|584796427|FG001|Overall Study|Lack of Efficacy|1|||
161931216|NCT00281580|584796428|FG002|Overall Study|Lack of Efficacy|1|||
161931217|NCT00281580|584796429|FG003|Overall Study|Lack of Efficacy|6|||
161931218|NCT00281580|584796430|FG004|Overall Study|Lack of Efficacy|2|||
161931219|NCT00281580|584796431|FG005|Overall Study|Lack of Efficacy|0|||
161931220|NCT00281580|584796432|FG006|Overall Study|Lack of Efficacy|0|||
161931221|NCT00281580|584796433|FG007|Overall Study|Lack of Efficacy|0|||
161931222|NCT00281580|584796434|FG008|Overall Study|Lack of Efficacy|0|||
161931223|NCT00281580|584796435|FG009|Overall Study|Lack of Efficacy|0|||
161931224|NCT00281580|584796436|FG010|Overall Study|Lack of Efficacy|0|||
161931225|NCT00281580|584796437|FG011|Overall Study|Lack of Efficacy|1|||
161931226|NCT00281580|584796438|FG012|Overall Study|Lack of Efficacy|0|||
161931227|NCT00281580|584796439|FG013|Overall Study|Lack of Efficacy|2|||
161931228|NCT00281580|584796440|FG014|Overall Study|Lack of Efficacy|1|||
161931229|NCT00281580|584796441|FG015|Overall Study|Lack of Efficacy|0|||
161931230|NCT00281580|584796426|FG000|Overall Study|Lost to Follow-up|0|||
161931231|NCT00281580|584796427|FG001|Overall Study|Lost to Follow-up|0|||
161931232|NCT00281580|584796428|FG002|Overall Study|Lost to Follow-up|0|||
161931233|NCT00281580|584796429|FG003|Overall Study|Lost to Follow-up|3|||
161931234|NCT00281580|584796430|FG004|Overall Study|Lost to Follow-up|0|||
161931235|NCT00281580|584796431|FG005|Overall Study|Lost to Follow-up|1|||
161931236|NCT00281580|584796432|FG006|Overall Study|Lost to Follow-up|0|||
161931237|NCT00281580|584796433|FG007|Overall Study|Lost to Follow-up|1|||
161931238|NCT00281580|584796434|FG008|Overall Study|Lost to Follow-up|2|||
161931239|NCT00281580|584796435|FG009|Overall Study|Lost to Follow-up|1|||
161931240|NCT00281580|584796436|FG010|Overall Study|Lost to Follow-up|1|||
161931241|NCT00281580|584796437|FG011|Overall Study|Lost to Follow-up|0|||
161931242|NCT00281580|584796438|FG012|Overall Study|Lost to Follow-up|1|||
161931243|NCT00281580|584796439|FG013|Overall Study|Lost to Follow-up|0|||
161931244|NCT00281580|584796440|FG014|Overall Study|Lost to Follow-up|0|||
161931245|NCT00281580|584796441|FG015|Overall Study|Lost to Follow-up|0|||
161931246|NCT00281580|584796426|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
161931247|NCT00281580|584796427|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
161931248|NCT00281580|584796428|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
161931249|NCT00281580|584796429|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
161931250|NCT00281580|584796430|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
161931251|NCT00281580|584796431|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
161931252|NCT00281580|584796432|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
161931253|NCT00281580|584796433|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
161931254|NCT00281580|584796434|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
161931255|NCT00281580|584796435|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
161931256|NCT00281580|584796436|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
161931257|NCT00281580|584796437|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
161931258|NCT00281580|584796438|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
161931259|NCT00281580|584796439|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
161931260|NCT00281580|584796440|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
161931261|NCT00281580|584796441|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
161931262|NCT05463705|584796442|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
161931263|NCT05463705|584796443|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
161931264|NCT05463705|584796444|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
161931265|NCT05463705|584796445|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
161931266|NCT05463705|584796446|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
161931267|NCT05463705|584796447|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
161931268|NCT03071965|584796448|FG000|Overall Study|Adverse Event|0|||
161931269|NCT03071965|584796449|FG001|Overall Study|Adverse Event|0|||
161931270|NCT03071965|584796450|FG002|Overall Study|Adverse Event|1|||
161931271|NCT03071965|584796451|FG003|Overall Study|Adverse Event|0|||
161931272|NCT03071965|584796448|FG000|Overall Study|Death|0|||
161931273|NCT03071965|584796449|FG001|Overall Study|Death|0|||
161931274|NCT03071965|584796450|FG002|Overall Study|Death|1|||
161823593|NCT05347693|584396227|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
161823594|NCT05347693|584396225|FG000|Outpatient Period|Lost to Follow-up|0|||
161823595|NCT05347693|584396226|FG001|Outpatient Period|Lost to Follow-up|0|||
161931275|NCT03071965|584796451|FG003|Overall Study|Death|1|||
161931276|NCT03071965|584796448|FG000|Overall Study|COVID-19|0|||
161931277|NCT03071965|584796449|FG001|Overall Study|COVID-19|1|||
161931278|NCT03071965|584796450|FG002|Overall Study|COVID-19|0|||
161931279|NCT03071965|584796451|FG003|Overall Study|COVID-19|1|||
161931280|NCT03071965|584796448|FG000|Overall Study|Other Health Reason|0|||
161931281|NCT03071965|584796449|FG001|Overall Study|Other Health Reason|0|||
161931282|NCT03071965|584796450|FG002|Overall Study|Other Health Reason|0|||
161931283|NCT03071965|584796451|FG003|Overall Study|Other Health Reason|1|||
161931284|NCT05529173|584796452|FG000|Overall Study|Physician Decision|3|||
161931285|NCT05529173|584796453|FG001|Overall Study|Physician Decision|6|||
161931286|NCT05529173|584796452|FG000|Overall Study|Sample shipment delay more than one day|4|||
161931287|NCT05529173|584796453|FG001|Overall Study|Sample shipment delay more than one day|0|||
161931288|NCT03760081|584796456|FG000|Overall Study|Miscellaneous|0|||
161931289|NCT03760081|584796457|FG001|Overall Study|Miscellaneous|1|||
161931290|NCT03760081|584796456|FG000|Overall Study|Progressive Disease|5|||
161931291|NCT03760081|584796457|FG001|Overall Study|Progressive Disease|10|||
161931292|NCT03760081|584796456|FG000|Overall Study|Death|1|||
161931293|NCT03760081|584796457|FG001|Overall Study|Death|1|||
161931294|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
161931295|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
161931296|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
161931297|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
161931298|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
161931299|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
161931300|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161931301|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161931302|NCT04034056|584796460|FG000|Overall Study|Withdrawal by Subject|2|||
161931303|NCT04034056|584796460|FG000|Overall Study|Reason Not Specified|13|||
161931304|NCT04034056|584796460|FG000|Overall Study|Adverse Event|56|||
161931305|NCT04135352|584796461|FG000|Overall Study|Not treated-randomization error|0|||
161931306|NCT04135352|584796462|FG001|Overall Study|Not treated-randomization error|0|||
161931307|NCT04135352|584796463|FG002|Overall Study|Not treated-randomization error|1|||
161931308|NCT04135352|584796464|FG003|Overall Study|Not treated-randomization error|0|||
161931309|NCT04135352|584796465|FG004|Overall Study|Not treated-randomization error|0|||
161515718|NCT00009737|583278484|FG000|Overall Study|Other Protocol Violation|1|||
161515719|NCT00009737|583278485|FG001|Overall Study|Other Protocol Violation|0|||
161515720|NCT00009737|583278484|FG000|Overall Study|Refused Treatment|15|||
161515721|NCT00009737|583278485|FG001|Overall Study|Refused Treatment|16|||
161515722|NCT00009737|583278484|FG000|Overall Study|Lost to Follow-up|1|||
161515723|NCT00009737|583278485|FG001|Overall Study|Lost to Follow-up|1|||
161515724|NCT00009737|583278484|FG000|Overall Study|Administrative/Other Reasons|7|||
161515725|NCT00009737|583278485|FG001|Overall Study|Administrative/Other Reasons|1|||
161515726|NCT00530023|583278486|FG000|Overall Study|Withdrawal by Subject|0|||
161515727|NCT00530023|583278487|FG001|Overall Study|Withdrawal by Subject|1|||
161515728|NCT00003498|583278488|FG000|Overall Study|Not evaluable.|4|||
161588768|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161823596|NCT05347693|584396227|FG002|Outpatient Period|Lost to Follow-up|1|||
161823597|NCT05347693|584396225|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
161823598|NCT05347693|584396226|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
161823599|NCT05347693|584396227|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
161823600|NCT05347693|584396225|FG000|Outpatient Period|Scheduled hemodialysis|0|||
161823601|NCT05347693|584396226|FG001|Outpatient Period|Scheduled hemodialysis|1|||
161823602|NCT05347693|584396227|FG002|Outpatient Period|Scheduled hemodialysis|0|||
161931310|NCT04135352|584796466|FG005|Overall Study|Not treated-randomization error|0|||
161931311|NCT04135352|584796467|FG006|Overall Study|Not treated-randomization error|0|||
161931312|NCT04135352|584796468|FG007|Overall Study|Not treated-randomization error|0|||
161931313|NCT04135352|584796461|FG000|Overall Study|Withdrawal by Subject|0|||
161931314|NCT04135352|584796462|FG001|Overall Study|Withdrawal by Subject|0|||
161931315|NCT04135352|584796463|FG002|Overall Study|Withdrawal by Subject|2|||
161931316|NCT04135352|584796464|FG003|Overall Study|Withdrawal by Subject|0|||
161515729|NCT01416805|583278498|FG000|Overall Study|Lost to Follow-up|4|||
161515730|NCT01416805|583278499|FG001|Overall Study|Lost to Follow-up|4|||
161515731|NCT02604589|583278506|FG000|Overall Study|catheter dislodgement|0|||
161515732|NCT02604589|583278507|FG001|Overall Study|catheter dislodgement|0|||
161823603|NCT05347693|584396225|FG000|Outpatient Period|Severe HK|0|||
161823604|NCT05347693|584396226|FG001|Outpatient Period|Severe HK|0|||
161823605|NCT05347693|584396227|FG002|Outpatient Period|Severe HK|1|||
161823606|NCT05347693|584396225|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
161823607|NCT05347693|584396226|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
161823608|NCT05347693|584396227|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
161823609|NCT05347693|584396225|FG000|Outpatient Period|Start of dialysis|0|||
161823610|NCT05347693|584396226|FG001|Outpatient Period|Start of dialysis|0|||
161823611|NCT05347693|584396227|FG002|Outpatient Period|Start of dialysis|1|||
161823612|NCT05347693|584396225|FG000|Outpatient Period|The participant entered hemodialysis|0|||
161823613|NCT05347693|584396226|FG001|Outpatient Period|The participant entered hemodialysis|0|||
161823614|NCT05347693|584396227|FG002|Outpatient Period|The participant entered hemodialysis|1|||
161823615|NCT05347693|584396225|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
161823616|NCT05347693|584396226|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
161823617|NCT05347693|584396227|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
161823618|NCT05347693|584396225|FG000|Outpatient Period|Withdrawal by Subject|0|||
161823619|NCT05347693|584396226|FG001|Outpatient Period|Withdrawal by Subject|8|||
161823620|NCT05347693|584396227|FG002|Outpatient Period|Withdrawal by Subject|5|||
161823621|NCT01755975|584396228|FG000|Overall Study|Adverse Event|0|||
161823622|NCT01755975|584396229|FG001|Overall Study|Adverse Event|0|||
161823623|NCT01755975|584396230|FG002|Overall Study|Adverse Event|1|||
161823624|NCT01755975|584396231|FG003|Overall Study|Adverse Event|0|||
161823625|NCT01755975|584396232|FG004|Overall Study|Adverse Event|2|||
161823626|NCT01597479|584396233|FG000|Overall Study|Protocol Violation|1|||
161823627|NCT01597479|584396234|FG001|Overall Study|Protocol Violation|0|||
161823628|NCT01597479|584396233|FG000|Overall Study|Lost to Follow-up|1|||
161823629|NCT01597479|584396234|FG001|Overall Study|Lost to Follow-up|0|||
161823630|NCT02167594|584396235|FG000|Overall Study|Withdrawal by Subject|2|||
161823631|NCT02167594|584396236|FG001|Overall Study|Withdrawal by Subject|0|||
161823632|NCT02167594|584396237|FG002|Overall Study|Withdrawal by Subject|0|||
161823633|NCT02167594|584396235|FG000|Overall Study|Death|0|||
161823634|NCT02167594|584396236|FG001|Overall Study|Death|1|||
161823635|NCT02167594|584396237|FG002|Overall Study|Death|0|||
161823636|NCT02340780|584396238|FG000|Overall Study|Ineligible|1|||
161823637|NCT02858037|584396241|FG000|Overall Study|Death|1|||
161823638|NCT02858037|584396241|FG000|Overall Study|Withdrawal by Subject|18|||
161823639|NCT02858037|584396241|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
161823640|NCT02858037|584396241|FG000|Overall Study|Lost to Follow-up|3|||
161823641|NCT02858037|584396241|FG000|Overall Study|Other|4|||
161823642|NCT04320745|584396246|FG000|Overall Study|Adverse Event|26|||
161823643|NCT04320745|584396246|FG000|Overall Study|Withdrawal by Subject|4|||
161823644|NCT04320745|584396246|FG000|Overall Study|Lost to Follow-up|12|||
161823645|NCT04320745|584396246|FG000|Overall Study|Protocol Deviation|2|||
161823646|NCT04320745|584396246|FG000|Overall Study|Non-compliance With Study Drug|2|||
161823647|NCT04320745|584396246|FG000|Overall Study|Reason Not Specified|1|||
161823648|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
161823649|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
161823650|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
161823651|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
161823652|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161823653|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
161823654|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161823655|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161823656|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161823657|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
161823658|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161823659|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161515733|NCT02604589|583278508|FG002|Overall Study|catheter dislodgement|1|||
161515734|NCT01700946|583278514|FG000|Overall Study|Lost to Follow-up|1|||
161823660|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
161823661|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
161823662|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
161823663|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
161823664|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
161823665|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
161823666|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
161823667|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
161823668|NCT01963260|584396256|FG000|Overall Study|Withdrawal by Subject|2|||
161823669|NCT01963260|584396257|FG001|Overall Study|Withdrawal by Subject|0|||
161823670|NCT01963260|584396258|FG002|Overall Study|Withdrawal by Subject|0|||
161823671|NCT01963260|584396259|FG003|Overall Study|Withdrawal by Subject|1|||
161823672|NCT01963260|584396260|FG004|Overall Study|Withdrawal by Subject|2|||
161823673|NCT01963260|584396261|FG005|Overall Study|Withdrawal by Subject|0|||
161931317|NCT04135352|584796465|FG004|Overall Study|Withdrawal by Subject|0|||
161931318|NCT04135352|584796466|FG005|Overall Study|Withdrawal by Subject|0|||
161931319|NCT04135352|584796467|FG006|Overall Study|Withdrawal by Subject|0|||
161931320|NCT04135352|584796468|FG007|Overall Study|Withdrawal by Subject|0|||
161931321|NCT04135352|584796461|FG000|Overall Study|Sponsor Decision|0|||
161931322|NCT04135352|584796462|FG001|Overall Study|Sponsor Decision|0|||
161931323|NCT04135352|584796463|FG002|Overall Study|Sponsor Decision|2|||
161931324|NCT04135352|584796464|FG003|Overall Study|Sponsor Decision|5|||
161931325|NCT04135352|584796465|FG004|Overall Study|Sponsor Decision|1|||
161931326|NCT04135352|584796466|FG005|Overall Study|Sponsor Decision|4|||
161931327|NCT04135352|584796467|FG006|Overall Study|Sponsor Decision|0|||
161931328|NCT04135352|584796468|FG007|Overall Study|Sponsor Decision|0|||
161931329|NCT04135352|584796461|FG000|Overall Study|Physician Decision|0|||
161931330|NCT04135352|584796462|FG001|Overall Study|Physician Decision|0|||
161931331|NCT04135352|584796463|FG002|Overall Study|Physician Decision|1|||
161931332|NCT04135352|584796464|FG003|Overall Study|Physician Decision|0|||
161931333|NCT04135352|584796465|FG004|Overall Study|Physician Decision|1|||
161515735|NCT01700946|583278515|FG001|Overall Study|Lost to Follow-up|0|||
161515736|NCT01700946|583278514|FG000|Overall Study|Physician Decision|7|||
161515737|NCT01700946|583278515|FG001|Overall Study|Physician Decision|12|||
161515738|NCT01700946|583278514|FG000|Overall Study|Withdrawal by Subject|0|||
161515739|NCT01700946|583278515|FG001|Overall Study|Withdrawal by Subject|2|||
161515740|NCT01700946|583278514|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
161515741|NCT01700946|583278515|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
161515742|NCT01700946|583278514|FG000|Overall Study|Relapse|2|||
161515743|NCT01700946|583278515|FG001|Overall Study|Relapse|1|||
161515744|NCT01700946|583278514|FG000|Overall Study|Unacceptable toxicity|1|||
161515745|NCT01700946|583278515|FG001|Overall Study|Unacceptable toxicity|0|||
161515746|NCT04632940|583278519|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
161588769|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161823674|NCT01963260|584396262|FG006|Overall Study|Withdrawal by Subject|0|||
161823675|NCT01963260|584396263|FG007|Overall Study|Withdrawal by Subject|0|||
161823676|NCT01963260|584396264|FG008|Overall Study|Withdrawal by Subject|0|||
161823677|NCT01963260|584396265|FG009|Overall Study|Withdrawal by Subject|0|||
161823678|NCT02340962|584396266|FG000|Overall Study|Lost to Follow-up|1|||
161823679|NCT02340962|584396267|FG001|Overall Study|Lost to Follow-up|0|||
161823680|NCT04994431|584396268|FG000|Overall Study|Adverse Event|1|||
161823681|NCT04994431|584396269|FG001|Overall Study|Adverse Event|0|||
161823682|NCT02151149|584396273|FG000|Treatment Period|Death|2|||
161823683|NCT02151149|584396274|FG001|Treatment Period|Death|3|||
161823684|NCT02151149|584396273|FG000|Treatment Period|Adverse Event|17|||
161823685|NCT02151149|584396274|FG001|Treatment Period|Adverse Event|14|||
161823686|NCT02151149|584396273|FG000|Treatment Period|Progressive Disease|25|||
161823687|NCT02151149|584396274|FG001|Treatment Period|Progressive Disease|24|||
161823688|NCT02151149|584396273|FG000|Treatment Period|Symptomatic Deterioration|2|||
161823689|NCT02151149|584396274|FG001|Treatment Period|Symptomatic Deterioration|10|||
161823690|NCT02151149|584396273|FG000|Treatment Period|Withdrawal by Subject|13|||
161823691|NCT02151149|584396274|FG001|Treatment Period|Withdrawal by Subject|11|||
161823692|NCT02151149|584396273|FG000|Treatment Period|Miscellaneous|8|||
161823693|NCT02151149|584396274|FG001|Treatment Period|Miscellaneous|7|||
161823694|NCT02151149|584396273|FG000|Treatment Period|Participants randomized but not treated|3|||
161823695|NCT02151149|584396274|FG001|Treatment Period|Participants randomized but not treated|2|||
161823696|NCT02151149|584396273|FG000|Follow-Up Period|Lost to Follow-up|2|||
161823697|NCT02151149|584396274|FG001|Follow-Up Period|Lost to Follow-up|3|||
161823698|NCT02151149|584396273|FG000|Follow-Up Period|Death|37|||
161823699|NCT02151149|584396274|FG001|Follow-Up Period|Death|34|||
161823700|NCT03419962|584396278|FG000|Overall Study|Change to other medication|1|||
161823701|NCT03419962|584396278|FG000|Overall Study|Refusal of continuing with trial drug|1|||
161823702|NCT03419962|584396278|FG000|Overall Study|Lost to Follow-up|3|||
161823703|NCT03419962|584396278|FG000|Overall Study|Difficulty in inhaling the doses|1|||
161823704|NCT03419962|584396278|FG000|Overall Study|Missing completion data|31|||
161823705|NCT03439085|584396279|FG000|Overall Study|Death|2|||
161823706|NCT03439085|584396279|FG000|Overall Study|Screen Failure|20|||
161823707|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
161823708|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
161823709|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
161823710|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
161823711|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
161823712|NCT01898598|584396284|FG000|Overall Study|Adverse Event|1|||
161823713|NCT01898598|584396285|FG001|Overall Study|Adverse Event|0|||
161823714|NCT01898598|584396284|FG000|Overall Study|Withdrawal by Subject|3|||
161823715|NCT01898598|584396285|FG001|Overall Study|Withdrawal by Subject|0|||
161823716|NCT01898598|584396284|FG000|Overall Study|Lost to Follow-up|0|||
161931334|NCT04135352|584796466|FG005|Overall Study|Physician Decision|0|||
161931335|NCT04135352|584796467|FG006|Overall Study|Physician Decision|0|||
161931336|NCT04135352|584796468|FG007|Overall Study|Physician Decision|0|||
161931337|NCT04135352|584796461|FG000|Overall Study|Death|3|||
161931338|NCT04135352|584796462|FG001|Overall Study|Death|4|||
161931339|NCT04135352|584796463|FG002|Overall Study|Death|7|||
161931340|NCT04135352|584796464|FG003|Overall Study|Death|0|||
161931341|NCT04135352|584796465|FG004|Overall Study|Death|3|||
161931342|NCT04135352|584796466|FG005|Overall Study|Death|1|||
161931343|NCT04135352|584796467|FG006|Overall Study|Death|0|||
161931344|NCT04135352|584796468|FG007|Overall Study|Death|0|||
161931345|NCT01210443|584796469|FG000|Overall Study|Study terminated by sponsor|2|||
161931346|NCT02807181|584796470|FG000|Overall Study|Death|28|||
161931347|NCT02807181|584796471|FG001|Overall Study|Death|24|||
161931348|NCT02807181|584796470|FG000|Overall Study|Withdrawal by Subject|1|||
161931349|NCT02807181|584796471|FG001|Overall Study|Withdrawal by Subject|1|||
161931350|NCT02807181|584796470|FG000|Overall Study|Lost to Follow-up|0|||
161931351|NCT02807181|584796471|FG001|Overall Study|Lost to Follow-up|2|||
161931352|NCT02807181|584796470|FG000|Overall Study|Subject decision|1|||
161931353|NCT02807181|584796471|FG001|Overall Study|Subject decision|0|||
161931354|NCT02807181|584796470|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
161931355|NCT02807181|584796471|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
161931356|NCT02807181|584796470|FG000|Overall Study|In Study|3|||
161931357|NCT02807181|584796471|FG001|Overall Study|In Study|3|||
161931358|NCT02807181|584796470|FG000|Overall Study|Post Progression|3|||
161931359|NCT02807181|584796471|FG001|Overall Study|Post Progression|2|||
161931360|NCT01452789|584796476|FG000|Overall Study|Withdrawal by Subject|3|||
161931361|NCT01452789|584796477|FG001|Overall Study|Withdrawal by Subject|2|||
161931362|NCT00066170|584796478|FG000|Overall Study|Adverse Event|2|||
161931363|NCT00066170|584796479|FG001|Overall Study|Adverse Event|4|||
161931364|NCT00066170|584796480|FG002|Overall Study|Adverse Event|1|||
161931365|NCT00066170|584796481|FG003|Overall Study|Adverse Event|7|||
161931366|NCT00066170|584796478|FG000|Overall Study|Serious Adverse Event|0|||
161931367|NCT00066170|584796479|FG001|Overall Study|Serious Adverse Event|0|||
161931368|NCT00066170|584796480|FG002|Overall Study|Serious Adverse Event|1|||
161931369|NCT00066170|584796481|FG003|Overall Study|Serious Adverse Event|1|||
161931370|NCT00066170|584796478|FG000|Overall Study|Lost to Follow-up|0|||
161931371|NCT00066170|584796479|FG001|Overall Study|Lost to Follow-up|1|||
161931372|NCT00066170|584796480|FG002|Overall Study|Lost to Follow-up|0|||
161931373|NCT00066170|584796481|FG003|Overall Study|Lost to Follow-up|0|||
161931374|NCT00066170|584796478|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
161931375|NCT00066170|584796479|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
161931376|NCT00066170|584796480|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
161931377|NCT00066170|584796481|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
161515747|NCT04632940|583278520|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
161515748|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
161515749|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
161515750|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
161515751|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
161515752|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
161515753|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
161515754|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
161515755|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
161676967|NCT01514136|583870626|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676968|NCT01514136|583870627|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
161823717|NCT01898598|584396285|FG001|Overall Study|Lost to Follow-up|1|||
161823718|NCT01898598|584396284|FG000|Overall Study|Other|0|||
161823719|NCT01898598|584396285|FG001|Overall Study|Other|1|||
161823720|NCT03833427|584396286|FG000|Overall Study|Death|4|||
161823721|NCT03833427|584396287|FG001|Overall Study|Death|2|||
161823722|NCT03833427|584396288|FG002|Overall Study|Death|9|||
161823723|NCT03833427|584396289|FG003|Overall Study|Death|11|||
161823724|NCT03833427|584396290|FG004|Overall Study|Death|0|||
161823725|NCT03833427|584396291|FG005|Overall Study|Death|0|||
161823726|NCT03833427|584396292|FG006|Overall Study|Death|0|||
161823727|NCT03833427|584396286|FG000|Overall Study|Withdrawal by Subject|0|||
161823728|NCT03833427|584396287|FG001|Overall Study|Withdrawal by Subject|1|||
161823729|NCT03833427|584396288|FG002|Overall Study|Withdrawal by Subject|1|||
161823730|NCT03833427|584396289|FG003|Overall Study|Withdrawal by Subject|0|||
161823731|NCT03833427|584396290|FG004|Overall Study|Withdrawal by Subject|0|||
161823732|NCT03833427|584396291|FG005|Overall Study|Withdrawal by Subject|0|||
161823733|NCT03833427|584396292|FG006|Overall Study|Withdrawal by Subject|0|||
161823734|NCT03833427|584396286|FG000|Overall Study|Sponsor Decision|0|||
161931378|NCT00066170|584796478|FG000|Overall Study|Protocol Violation|3|||
161931379|NCT00066170|584796479|FG001|Overall Study|Protocol Violation|0|||
161931380|NCT00066170|584796480|FG002|Overall Study|Protocol Violation|0|||
161931381|NCT00066170|584796481|FG003|Overall Study|Protocol Violation|0|||
161931382|NCT00066170|584796478|FG000|Overall Study|Other|1|||
161931383|NCT00066170|584796479|FG001|Overall Study|Other|5|||
161931384|NCT00066170|584796480|FG002|Overall Study|Other|2|||
161931385|NCT00066170|584796481|FG003|Overall Study|Other|0|||
161931386|NCT01089543|584796484|FG000|Overall Study|Withdrawal by Subject|2|||
161931387|NCT01089543|584796485|FG001|Overall Study|Withdrawal by Subject|3|||
161931388|NCT01089543|584796486|FG002|Overall Study|Withdrawal by Subject|3|||
161931389|NCT01089543|584796487|FG003|Overall Study|Withdrawal by Subject|1|||
161931390|NCT01089543|584796484|FG000|Overall Study|Physician Decision|1|||
161931391|NCT01089543|584796485|FG001|Overall Study|Physician Decision|0|||
161931392|NCT01089543|584796486|FG002|Overall Study|Physician Decision|0|||
161931393|NCT01089543|584796487|FG003|Overall Study|Physician Decision|1|||
161931394|NCT01089543|584796484|FG000|Overall Study|Adverse Event|0|||
161931395|NCT01089543|584796485|FG001|Overall Study|Adverse Event|1|||
161931396|NCT01089543|584796486|FG002|Overall Study|Adverse Event|0|||
161931397|NCT01089543|584796487|FG003|Overall Study|Adverse Event|0|||
161931398|NCT00452530|584796488|FG000|Overall Study|Death|1|||
161931399|NCT00452530|584796489|FG001|Overall Study|Death|0|||
161931400|NCT00452530|584796488|FG000|Overall Study|Adverse Event|40|||
161931401|NCT00452530|584796489|FG001|Overall Study|Adverse Event|44|||
161931402|NCT00452530|584796488|FG000|Overall Study|Withdrawal by Subject|68|||
161931403|NCT00452530|584796489|FG001|Overall Study|Withdrawal by Subject|57|||
161931404|NCT00452530|584796488|FG000|Overall Study|Lost to Follow-up|1|||
161931405|NCT00452530|584796489|FG001|Overall Study|Lost to Follow-up|0|||
161931406|NCT00452530|584796488|FG000|Overall Study|Poor compliance/noncompliance|1|||
161931407|NCT00452530|584796489|FG001|Overall Study|Poor compliance/noncompliance|2|||
161931408|NCT00452530|584796488|FG000|Overall Study|No longer met study criteria|18|||
161931409|NCT00452530|584796489|FG001|Overall Study|No longer met study criteria|22|||
161931410|NCT00452530|584796488|FG000|Overall Study|Other|7|||
161931411|NCT00452530|584796489|FG001|Overall Study|Other|11|||
161931412|NCT00754559|584796491|FG000|Overall Study|Adverse Event|15|||
161931413|NCT00754559|584796491|FG000|Overall Study|Protocol Violation|11|||
161931414|NCT00754559|584796491|FG000|Overall Study|Lack of Efficacy|10|||
161931415|NCT00754559|584796491|FG000|Overall Study|Lost to Follow-up|2|||
161931416|NCT00754559|584796491|FG000|Overall Study|Administrative reason|1|||
161931417|NCT00754559|584796491|FG000|Overall Study|Other|5|||
161931418|NCT00754559|584796491|FG000|Overall Study|Withdrawal by Subject|3|||
161931419|NCT01248468|584796492|FG000|Overall Study|Administrative problem|1|||
161931420|NCT01248468|584796493|FG001|Overall Study|Administrative problem|0|||
161931421|NCT01248468|584796494|FG002|Overall Study|Administrative problem|0|||
161931422|NCT01248468|584796492|FG000|Overall Study|Lost to Follow-up|9|||
161931423|NCT01248468|584796493|FG001|Overall Study|Lost to Follow-up|12|||
161931424|NCT01248468|584796494|FG002|Overall Study|Lost to Follow-up|4|||
161515756|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
161515757|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
161515758|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Other than specified|0|||
161515759|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Other than specified|1|||
161515760|NCT04632940|583278519|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
161515761|NCT04632940|583278520|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
161515762|NCT00179647|583278524|FG000|Overall Study|Adverse Event|294|||
161515763|NCT00179647|583278524|FG000|Overall Study|Lack of Efficacy|478|||
161515764|NCT00179647|583278524|FG000|Overall Study|Withdrawal by Subject|83|||
161515765|NCT00179647|583278524|FG000|Overall Study|Lost to Follow-up|4|||
161515766|NCT00179647|583278524|FG000|Overall Study|Death|94|||
161515767|NCT00179647|583278524|FG000|Overall Study|Other|960|||
161515768|NCT00622635|583278525|FG000|Treatment Period 1|Adverse Event|0|||
161931425|NCT01248468|584796492|FG000|Overall Study|Pregnancy|1|||
161931426|NCT01248468|584796493|FG001|Overall Study|Pregnancy|0|||
161931427|NCT01248468|584796494|FG002|Overall Study|Pregnancy|0|||
161931428|NCT01248468|584796492|FG000|Overall Study|Withdrawal by Subject|4|||
161931429|NCT01248468|584796493|FG001|Overall Study|Withdrawal by Subject|2|||
161931430|NCT01248468|584796494|FG002|Overall Study|Withdrawal by Subject|0|||
161931431|NCT02191397|584796495|FG000|Overall Study|Adverse Event|28|||
161931432|NCT02191397|584796496|FG001|Overall Study|Adverse Event|17|||
161931433|NCT02191397|584796495|FG000|Overall Study|Lack of Efficacy|10|||
161931434|NCT02191397|584796496|FG001|Overall Study|Lack of Efficacy|5|||
161931435|NCT02191397|584796495|FG000|Overall Study|Protocol Violation|0|||
161931436|NCT02191397|584796496|FG001|Overall Study|Protocol Violation|3|||
161931437|NCT02191397|584796495|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
161931438|NCT02191397|584796496|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
161931439|NCT02191397|584796495|FG000|Overall Study|Lost to Follow-up|10|||
161931440|NCT02191397|584796496|FG001|Overall Study|Lost to Follow-up|11|||
161931441|NCT02191397|584796495|FG000|Overall Study|Physician Decision|8|||
161931442|NCT02191397|584796496|FG001|Overall Study|Physician Decision|3|||
161931443|NCT02191397|584796495|FG000|Overall Study|Withdrawal by Subject|22|||
161931444|NCT02191397|584796496|FG001|Overall Study|Withdrawal by Subject|27|||
161931445|NCT00468546|584796499|FG000|Week 24 Analysis|Lack of Efficacy|83|||
161515769|NCT00622635|583278526|FG001|Treatment Period 1|Adverse Event|0|||
161515770|NCT00622635|583278527|FG002|Treatment Period 1|Adverse Event|1|||
161515771|NCT00622635|583278528|FG003|Treatment Period 1|Adverse Event|0|||
161515772|NCT00622635|583278529|FG004|Treatment Period 1|Adverse Event|0|||
161515773|NCT00622635|583278530|FG005|Treatment Period 1|Adverse Event|0|||
161931446|NCT00468546|584796500|FG001|Week 24 Analysis|Lack of Efficacy|37|||
161931447|NCT00468546|584796499|FG000|Week 24 Analysis|Refused treatment|5|||
161931448|NCT00468546|584796500|FG001|Week 24 Analysis|Refused treatment|5|||
161931449|NCT00468546|584796499|FG000|Week 24 Analysis|Adverse Event|1|||
161931450|NCT00468546|584796500|FG001|Week 24 Analysis|Adverse Event|8|||
161931451|NCT00468546|584796499|FG000|Week 24 Analysis|Failure to return|3|||
161931452|NCT00468546|584796500|FG001|Week 24 Analysis|Failure to return|4|||
161931453|NCT00468546|584796499|FG000|Week 24 Analysis|Rescue therapy|2|||
161931454|NCT00468546|584796500|FG001|Week 24 Analysis|Rescue therapy|0|||
161931455|NCT00468546|584796499|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
161931456|NCT00468546|584796500|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
161931457|NCT00468546|584796499|FG000|Week 24 Analysis|Due to clinical hold|1|||
161931458|NCT00468546|584796500|FG001|Week 24 Analysis|Due to clinical hold|0|||
161931459|NCT00468546|584796499|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
161931460|NCT00468546|584796500|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
161931461|NCT00468546|584796499|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
161931462|NCT00468546|584796500|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
161931463|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
161931464|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
161931465|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Death|1|||
161931466|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Death|0|||
161931467|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
161931468|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
161931469|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
161931470|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
161931471|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
161931472|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
161931473|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
161931474|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
161931475|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
161931476|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
161931477|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Other|17|||
161931478|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Other|14|||
161931479|NCT04000724|584796503|FG000|Overall Study|Withdrawal by Subject|5|||
161931480|NCT04000724|584796504|FG001|Overall Study|Withdrawal by Subject|3|||
161931481|NCT04000724|584796505|FG002|Overall Study|Withdrawal by Subject|4|||
161931482|NCT04000724|584796503|FG000|Overall Study|Lost to Follow-up|11|||
161931483|NCT04000724|584796504|FG001|Overall Study|Lost to Follow-up|7|||
161931484|NCT04000724|584796505|FG002|Overall Study|Lost to Follow-up|13|||
161931485|NCT00455455|584796506|FG000|Washout|Withdrawal by Subject|0|||
161931486|NCT00455455|584796507|FG001|Washout|Withdrawal by Subject|1|||
161931487|NCT00455455|584796506|FG000|Washout|Withdrawal by Subject|1|||
161931488|NCT00455455|584796507|FG001|Washout|Withdrawal by Subject|0|||
161931489|NCT00472641|584796508|FG000|Overall Study|Lack of Efficacy|3|||
161931490|NCT00472641|584796508|FG000|Overall Study|Adverse Event|3|||
161931491|NCT00472641|584796508|FG000|Overall Study|Lost to Follow-up|1|||
161931492|NCT01370538|584796509|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
161931493|NCT01370538|584796510|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
161931494|NCT01370538|584796509|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161931495|NCT01370538|584796510|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161931496|NCT01370538|584796509|FG000|Overall Study|Adverse Event|1|||
161931497|NCT01370538|584796510|FG001|Overall Study|Adverse Event|0|||
161931498|NCT01370538|584796509|FG000|Overall Study|Protocol Violation|8|||
161931499|NCT01370538|584796510|FG001|Overall Study|Protocol Violation|5|||
161931500|NCT01370538|584796509|FG000|Overall Study|Development of study specific withdrawal|1|||
161931501|NCT01370538|584796510|FG001|Overall Study|Development of study specific withdrawal|1|||
161931502|NCT01370538|584796509|FG000|Overall Study|Lost to follow up|6|||
161931503|NCT01370538|584796510|FG001|Overall Study|Lost to follow up|10|||
161931504|NCT00309244|584796511|FG000|Overall Study|Adverse Event|29|||
161931505|NCT00309244|584796512|FG001|Overall Study|Adverse Event|12|||
161931506|NCT00309244|584796511|FG000|Overall Study|Lost to Follow-up|6|||
161931507|NCT00309244|584796512|FG001|Overall Study|Lost to Follow-up|22|||
161931508|NCT00309244|584796511|FG000|Overall Study|Physician Decision|5|||
161931509|NCT00309244|584796512|FG001|Overall Study|Physician Decision|8|||
161931510|NCT00309244|584796511|FG000|Overall Study|Protocol Violation|6|||
161931511|NCT00309244|584796512|FG001|Overall Study|Protocol Violation|3|||
161931512|NCT00309244|584796511|FG000|Overall Study|Withdrawal by Subject|50|||
161931513|NCT00309244|584796512|FG001|Overall Study|Withdrawal by Subject|32|||
161931514|NCT00309244|584796511|FG000|Overall Study|Various|7|||
161931515|NCT00309244|584796512|FG001|Overall Study|Various|7|||
161931516|NCT00309244|584796511|FG000|Overall Study|Randomized but not dosed|11|||
161931517|NCT00309244|584796512|FG001|Overall Study|Randomized but not dosed|12|||
161931518|NCT00309244|584796511|FG000|Overall Study|Death|4|||
161931519|NCT00309244|584796512|FG001|Overall Study|Death|1|||
161931520|NCT01905267|584796513|FG000|Overall Study|Physician Decision|2|||
161931521|NCT01905267|584796514|FG001|Overall Study|Physician Decision|2|||
161931522|NCT03438656|584796515|FG000|Overall Study|Lost to Follow-up|2|||
161931523|NCT03335566|584796516|FG000|Overall Study|Adverse Event|0|||
161931524|NCT03335566|584796517|FG001|Overall Study|Adverse Event|1|||
161931525|NCT03335566|584796516|FG000|Overall Study|Lost to Follow-up|1|||
161931526|NCT03335566|584796517|FG001|Overall Study|Lost to Follow-up|0|||
161931527|NCT03335566|584796516|FG000|Overall Study|Technical Problems|1|||
161931528|NCT03335566|584796517|FG001|Overall Study|Technical Problems|0|||
161931529|NCT03335566|584796516|FG000|Overall Study|Protocol Violation|1|||
161931530|NCT03335566|584796517|FG001|Overall Study|Protocol Violation|0|||
161931531|NCT03335566|584796516|FG000|Overall Study|Other than specified above|1|||
161931532|NCT03335566|584796517|FG001|Overall Study|Other than specified above|2|||
161931533|NCT04223687|584796518|FG000|Overall Study|Missing primary outcome|1|||
161931534|NCT04223687|584796519|FG001|Overall Study|Missing primary outcome|0|||
161931535|NCT02945046|584796521|FG000|Overall Study|Adverse Event|1|||
161931536|NCT02945046|584796522|FG001|Overall Study|Adverse Event|0|||
161931537|NCT02945046|584796523|FG002|Overall Study|Adverse Event|2|||
161931538|NCT02945046|584796521|FG000|Overall Study|Withdrawal by Subject|3|||
161931539|NCT02945046|584796522|FG001|Overall Study|Withdrawal by Subject|3|||
161931540|NCT02945046|584796523|FG002|Overall Study|Withdrawal by Subject|3|||
161931541|NCT02945046|584796521|FG000|Overall Study|Protocol Violation|2|||
161931542|NCT02945046|584796522|FG001|Overall Study|Protocol Violation|3|||
161931543|NCT02945046|584796523|FG002|Overall Study|Protocol Violation|2|||
161931544|NCT02945046|584796521|FG000|Overall Study|Lost to Follow-up|1|||
161931545|NCT02945046|584796522|FG001|Overall Study|Lost to Follow-up|1|||
161931546|NCT02945046|584796523|FG002|Overall Study|Lost to Follow-up|0|||
161931547|NCT02945046|584796521|FG000|Overall Study|Lack of Efficacy|1|||
161931548|NCT02945046|584796522|FG001|Overall Study|Lack of Efficacy|2|||
161931549|NCT02945046|584796523|FG002|Overall Study|Lack of Efficacy|1|||
161931550|NCT02945046|584796521|FG000|Overall Study|Other than specified|5|||
161931551|NCT02945046|584796522|FG001|Overall Study|Other than specified|4|||
161931552|NCT02945046|584796523|FG002|Overall Study|Other than specified|7|||
161931553|NCT03259308|584796529|FG000|Overall Study|Adverse Event|5|||
161931554|NCT03259308|584796530|FG001|Overall Study|Adverse Event|4|||
161931555|NCT03259308|584796531|FG002|Overall Study|Adverse Event|1|||
161931556|NCT03259308|584796529|FG000|Overall Study|Withdrawal by Subject|2|||
161931557|NCT03259308|584796530|FG001|Overall Study|Withdrawal by Subject|1|||
161931558|NCT03259308|584796531|FG002|Overall Study|Withdrawal by Subject|3|||
161931559|NCT03259308|584796529|FG000|Overall Study|Lost to Follow-up|0|||
161931560|NCT03259308|584796530|FG001|Overall Study|Lost to Follow-up|0|||
161931561|NCT03259308|584796531|FG002|Overall Study|Lost to Follow-up|1|||
161931562|NCT03259308|584796529|FG000|Overall Study|Pregnancy|0|||
161931563|NCT03259308|584796530|FG001|Overall Study|Pregnancy|0|||
161931564|NCT03259308|584796531|FG002|Overall Study|Pregnancy|1|||
161931565|NCT03259308|584796529|FG000|Overall Study|Protocol Deviation|0|||
161931566|NCT03259308|584796530|FG001|Overall Study|Protocol Deviation|3|||
161931567|NCT03259308|584796531|FG002|Overall Study|Protocol Deviation|0|||
161931568|NCT03259308|584796529|FG000|Overall Study|Lack of Efficacy|0|||
161931569|NCT03259308|584796530|FG001|Overall Study|Lack of Efficacy|0|||
161931570|NCT03259308|584796531|FG002|Overall Study|Lack of Efficacy|1|||
161931571|NCT01117350|584796539|FG000|Comparative Period|Not Treated|5|||
161931572|NCT01117350|584796540|FG001|Comparative Period|Not Treated|8|||
161931573|NCT01117350|584796539|FG000|Comparative Period|Adverse Event|6|||
161931574|NCT01117350|584796540|FG001|Comparative Period|Adverse Event|33|||
161931575|NCT01117350|584796539|FG000|Comparative Period|Lost to Follow-up|11|||
161931576|NCT01117350|584796540|FG001|Comparative Period|Lost to Follow-up|7|||
161931577|NCT01117350|584796539|FG000|Comparative Period|Withdrawal by Subject|9|||
161931578|NCT01117350|584796540|FG001|Comparative Period|Withdrawal by Subject|13|||
161931579|NCT01117350|584796539|FG000|Comparative Period|Protocol Violation|8|||
161931580|NCT01117350|584796540|FG001|Comparative Period|Protocol Violation|12|||
161588770|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161588771|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161588772|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161588773|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161931581|NCT01117350|584796539|FG000|Comparative Period|Lack of Efficacy|1|||
161931582|NCT01117350|584796540|FG001|Comparative Period|Lack of Efficacy|0|||
161931583|NCT01117350|584796539|FG000|Comparative Period|Physician Decision|0|||
161931584|NCT01117350|584796540|FG001|Comparative Period|Physician Decision|1|||
161931585|NCT01117350|584796539|FG000|Comparative Period|Move to another city/country|2|||
161931586|NCT01117350|584796540|FG001|Comparative Period|Move to another city/country|1|||
161931587|NCT01117350|584796539|FG000|Extension Period|Not included in extension, not treated|0|||
161931588|NCT01117350|584796540|FG001|Extension Period|Not included in extension, not treated|50|||
161931589|NCT01117350|584796539|FG000|Extension Period|Adverse Event|0|||
161931590|NCT01117350|584796540|FG001|Extension Period|Adverse Event|2|||
161931591|NCT01117350|584796539|FG000|Extension Period|Protocol Violation|0|||
161931592|NCT01117350|584796540|FG001|Extension Period|Protocol Violation|2|||
161588774|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161588775|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161931593|NCT01117350|584796539|FG000|Extension Period|Lost to Follow-up|0|||
161931594|NCT01117350|584796540|FG001|Extension Period|Lost to Follow-up|2|||
161931595|NCT01117350|584796539|FG000|Extension Period|Withdrawal by Subject|0|||
161931596|NCT01117350|584796540|FG001|Extension Period|Withdrawal by Subject|3|||
161931597|NCT01117350|584796539|FG000|Extension Period|Lack of Efficacy|0|||
161931598|NCT01117350|584796540|FG001|Extension Period|Lack of Efficacy|2|||
161931599|NCT01117350|584796539|FG000|Extension Period|Inclusion criteria not respected|0|||
161931600|NCT01117350|584796540|FG001|Extension Period|Inclusion criteria not respected|1|||
161931601|NCT01117350|584796539|FG000|Extension Period|Prohibited medication|0|||
161931602|NCT01117350|584796540|FG001|Extension Period|Prohibited medication|1|||
161931603|NCT06868667|584796545|FG000|Overall Study|Death|0|||
161676969|NCT01514136|583870628|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
161676970|NCT01514136|583870629|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676971|NCT01514136|583870630|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676972|NCT01514136|583870631|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676973|NCT01514136|583870632|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676974|NCT01514136|583870625|FG000|Test Period 2; Test A*|Adverse Event|0|||
161676975|NCT01514136|583870626|FG001|Test Period 2; Test A*|Adverse Event|0|||
161676976|NCT01514136|583870627|FG002|Test Period 2; Test A*|Adverse Event|0|||
161676977|NCT01514136|583870628|FG003|Test Period 2; Test A*|Adverse Event|0|||
161676978|NCT01514136|583870629|FG004|Test Period 2; Test A*|Adverse Event|1|||
161676979|NCT01514136|583870630|FG005|Test Period 2; Test A*|Adverse Event|0|||
161676980|NCT01514136|583870631|FG006|Test Period 2; Test A*|Adverse Event|0|||
161676981|NCT01514136|583870632|FG007|Test Period 2; Test A*|Adverse Event|0|||
161676982|NCT01514136|583870625|FG000|Test Period 2; Test A*|Holiday|0|||
161676983|NCT01514136|583870626|FG001|Test Period 2; Test A*|Holiday|0|||
161676984|NCT01514136|583870627|FG002|Test Period 2; Test A*|Holiday|0|||
161676985|NCT01514136|583870628|FG003|Test Period 2; Test A*|Holiday|0|||
161676986|NCT01514136|583870629|FG004|Test Period 2; Test A*|Holiday|1|||
161676987|NCT01514136|583870630|FG005|Test Period 2; Test A*|Holiday|0|||
161676988|NCT01514136|583870631|FG006|Test Period 2; Test A*|Holiday|0|||
161676989|NCT01514136|583870632|FG007|Test Period 2; Test A*|Holiday|0|||
161676990|NCT01514136|583870625|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676991|NCT01514136|583870626|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676992|NCT01514136|583870627|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676993|NCT01514136|583870628|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676994|NCT01514136|583870629|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676995|NCT01514136|583870630|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
161676996|NCT01514136|583870631|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676997|NCT01514136|583870632|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676998|NCT01514136|583870625|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
161676999|NCT01514136|583870626|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677000|NCT01514136|583870627|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677001|NCT01514136|583870628|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677002|NCT01514136|583870629|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677003|NCT01514136|583870630|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677004|NCT01514136|583870631|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
161677005|NCT01514136|583870632|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677006|NCT01514136|583870625|FG000|Test Period 2; Test C*|holiday|0|||
161677007|NCT01514136|583870626|FG001|Test Period 2; Test C*|holiday|0|||
161677008|NCT01514136|583870627|FG002|Test Period 2; Test C*|holiday|0|||
161931604|NCT06868667|584796546|FG001|Overall Study|Death|4|||
161931605|NCT06868667|584796545|FG000|Overall Study|Lost to Follow-up|0|||
161931606|NCT06868667|584796546|FG001|Overall Study|Lost to Follow-up|1|||
161931607|NCT06868667|584796545|FG000|Overall Study|Withdrawal by Subject|1|||
161515774|NCT00622635|583278525|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161515775|NCT00622635|583278526|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161515776|NCT00622635|583278527|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161515777|NCT00622635|583278528|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161515778|NCT00622635|583278529|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161515779|NCT00622635|583278530|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161515780|NCT00622635|583278525|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
161515781|NCT00622635|583278526|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
161515782|NCT00622635|583278527|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
161515783|NCT00622635|583278528|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
161515784|NCT00622635|583278529|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
161515785|NCT00622635|583278530|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
161515786|NCT00622635|583278525|FG000|Treatment Period 2|Adverse Event|1|||
161515787|NCT00622635|583278526|FG001|Treatment Period 2|Adverse Event|0|||
161515788|NCT00622635|583278527|FG002|Treatment Period 2|Adverse Event|0|||
161515789|NCT00622635|583278528|FG003|Treatment Period 2|Adverse Event|0|||
161515790|NCT00622635|583278529|FG004|Treatment Period 2|Adverse Event|0|||
161515791|NCT00622635|583278530|FG005|Treatment Period 2|Adverse Event|0|||
161677009|NCT01514136|583870628|FG003|Test Period 2; Test C*|holiday|0|||
161515792|NCT00622635|583278525|FG000|Treatment Period 3|Adverse Event|0|||
161515793|NCT00622635|583278526|FG001|Treatment Period 3|Adverse Event|0|||
161931608|NCT06868667|584796546|FG001|Overall Study|Withdrawal by Subject|0|||
161931609|NCT06868667|584796545|FG000|Overall Study|Ongoing|9|||
161931610|NCT06868667|584796546|FG001|Overall Study|Ongoing|9|||
161931611|NCT01251965|584798652|FG000|Overall Study|Participant/physician decision|1|||
161931612|NCT01251965|584798653|FG001|Overall Study|Participant/physician decision|2|||
161931613|NCT01251965|584798654|FG002|Overall Study|Participant/physician decision|0|||
161931614|NCT01251965|584798652|FG000|Overall Study|Death|0|||
161931615|NCT01251965|584798653|FG001|Overall Study|Death|0|||
161931616|NCT01251965|584798654|FG002|Overall Study|Death|11|||
161931617|NCT03681093|584798655|FG000|Overall Study|Subject decision|0|||
161931618|NCT03681093|584798656|FG001|Overall Study|Subject decision|2|||
161931619|NCT03681093|584798657|FG002|Overall Study|Subject decision|1|||
161931620|NCT01027754|584798658|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
161931621|NCT01027754|584798659|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
161931622|NCT01027754|584798658|FG000|Overall Study|Withdrawal by Subject|0|||
161931623|NCT01027754|584798659|FG001|Overall Study|Withdrawal by Subject|5|||
161931624|NCT02529488|584798660|FG000|Overall Study|Adverse Event|1|||
161677010|NCT01514136|583870629|FG004|Test Period 2; Test C*|holiday|0|||
161677011|NCT01514136|583870630|FG005|Test Period 2; Test C*|holiday|0|||
161677012|NCT01514136|583870631|FG006|Test Period 2; Test C*|holiday|1|||
161677013|NCT01514136|583870632|FG007|Test Period 2; Test C*|holiday|0|||
161677014|NCT01514136|583870625|FG000|Test Period 2; Test C*|Protocol Violation|0|||
161677015|NCT01514136|583870626|FG001|Test Period 2; Test C*|Protocol Violation|0|||
161677016|NCT01514136|583870627|FG002|Test Period 2; Test C*|Protocol Violation|0|||
161677017|NCT01514136|583870628|FG003|Test Period 2; Test C*|Protocol Violation|0|||
161677018|NCT01514136|583870629|FG004|Test Period 2; Test C*|Protocol Violation|0|||
161677019|NCT01514136|583870630|FG005|Test Period 2; Test C*|Protocol Violation|0|||
161677020|NCT01514136|583870631|FG006|Test Period 2; Test C*|Protocol Violation|1|||
161677021|NCT01514136|583870632|FG007|Test Period 2; Test C*|Protocol Violation|0|||
161677022|NCT00757003|583870636|FG000|Overall Study|Death|33|||
161677023|NCT00757003|583870636|FG000|Overall Study|Lost to Follow-up|9|||
161677024|NCT00757003|583870636|FG000|Overall Study|Withdrawal by Subject|4|||
161677025|NCT00757003|583870636|FG000|Overall Study|Surgically explanted|2|||
161677026|NCT00757003|583870636|FG000|Overall Study|Not implanted|1|||
161931625|NCT02529488|584798660|FG000|Overall Study|Death|3|||
161931626|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
161931627|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931628|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931629|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931630|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161677027|NCT03044249|583870639|FG000|Overall Study|Adverse Event|4|||
161677028|NCT03044249|583870640|FG001|Overall Study|Adverse Event|9|||
161931631|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
161931632|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931633|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
161931634|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931635|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
161931636|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931637|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931638|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931639|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931640|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
161931641|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931642|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931643|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161515794|NCT00622635|583278527|FG002|Treatment Period 3|Adverse Event|0|||
161515795|NCT00622635|583278528|FG003|Treatment Period 3|Adverse Event|2|||
161515796|NCT00622635|583278529|FG004|Treatment Period 3|Adverse Event|0|||
161515797|NCT00622635|583278530|FG005|Treatment Period 3|Adverse Event|0|||
161515798|NCT00622635|583278525|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161515799|NCT00622635|583278526|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161515800|NCT00622635|583278527|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161515801|NCT00622635|583278528|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161515802|NCT00622635|583278529|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161515803|NCT00622635|583278530|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161677029|NCT03044249|583870639|FG000|Overall Study|Lost to Follow-up|1|||
161677030|NCT03044249|583870640|FG001|Overall Study|Lost to Follow-up|0|||
161931644|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931645|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931646|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161515804|NCT05013905|583278533|FG000|Overall Study|Adverse Event|1|||
161515805|NCT05013905|583278533|FG000|Overall Study|Lack of Efficacy|1|||
161931647|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
161515806|NCT01849588|583278536|FG000|Overall Study|Lack of Efficacy|3|||
161515807|NCT02486406|583278544|FG000|Overall Study|Withdrew consent|1|||
161515808|NCT02486406|583278545|FG001|Overall Study|Withdrew consent|0|||
161515809|NCT02486406|583278546|FG002|Overall Study|Withdrew consent|0|||
161515810|NCT02486406|583278547|FG003|Overall Study|Withdrew consent|1|||
161515811|NCT02486406|583278544|FG000|Overall Study|Lost to Follow-up|1|||
161515812|NCT02486406|583278545|FG001|Overall Study|Lost to Follow-up|3|||
161515813|NCT02486406|583278546|FG002|Overall Study|Lost to Follow-up|1|||
161515814|NCT02486406|583278547|FG003|Overall Study|Lost to Follow-up|3|||
161515815|NCT02486406|583278544|FG000|Overall Study|Other, not specified|0|||
161515816|NCT02486406|583278545|FG001|Overall Study|Other, not specified|0|||
161515817|NCT02486406|583278546|FG002|Overall Study|Other, not specified|1|||
161515818|NCT02486406|583278547|FG003|Overall Study|Other, not specified|0|||
161515819|NCT03509948|583278559|FG000|Overall Study|Protocol Violation|0|||
161515820|NCT03509948|583278560|FG001|Overall Study|Protocol Violation|1|||
161515821|NCT01071512|583278571|FG000|Overall Study|Adverse Event|1|||
161515822|NCT01071512|583278571|FG000|Overall Study|Development of antibodies to drug|2|||
161515823|NCT01071512|583278571|FG000|Overall Study|positive anti-JC virus antibody test|2|||
161515824|NCT00183872|583278572|FG000|Overall Study|Death|3|||
161515825|NCT00183872|583278572|FG000|Overall Study|Adverse Event|9|||
161515826|NCT00183872|583278572|FG000|Overall Study|Withdrawal by Subject|2|||
161515827|NCT00183872|583278572|FG000|Overall Study|Drug delayed more than 28 days|2|||
161515828|NCT00853658|583278573|FG000|Overall Study|Death|713|||
161515829|NCT00853658|583278574|FG001|Overall Study|Death|768|||
161823735|NCT03833427|584396287|FG001|Overall Study|Sponsor Decision|0|||
161515830|NCT00853658|583278575|FG002|Overall Study|Death|753|||
161515831|NCT00853658|583278573|FG000|Overall Study|Lost to Follow-up|11|||
161515832|NCT00853658|583278574|FG001|Overall Study|Lost to Follow-up|6|||
161515833|NCT00853658|583278575|FG002|Overall Study|Lost to Follow-up|11|||
161823736|NCT03833427|584396288|FG002|Overall Study|Sponsor Decision|1|||
161823737|NCT03833427|584396289|FG003|Overall Study|Sponsor Decision|3|||
161823738|NCT03833427|584396290|FG004|Overall Study|Sponsor Decision|0|||
161823739|NCT03833427|584396291|FG005|Overall Study|Sponsor Decision|0|||
161823740|NCT03833427|584396292|FG006|Overall Study|Sponsor Decision|0|||
161823741|NCT01499160|584396294|FG000|Overall Study|Adverse Event|1|||
161823742|NCT01499160|584396294|FG000|Overall Study|Withdrawal by Subject|1|||
161823743|NCT01438476|584396295|FG000|Overall Study|Protocol Violation|1|||
161823744|NCT01438476|584396296|FG001|Overall Study|Protocol Violation|0|||
161823745|NCT01438476|584396295|FG000|Overall Study|Withdrawal by Subject|1|||
161823746|NCT01438476|584396296|FG001|Overall Study|Withdrawal by Subject|0|||
161823747|NCT01438476|584396295|FG000|Overall Study|No Surgery- Disease|8|||
161823748|NCT01438476|584396296|FG001|Overall Study|No Surgery- Disease|10|||
161823749|NCT01438476|584396295|FG000|Overall Study|Communication barrier|0|||
161823750|NCT01438476|584396296|FG001|Overall Study|Communication barrier|1|||
161823751|NCT03294317|584396301|FG000|Overall Study|Physician Decision|1|||
161823752|NCT03294317|584396301|FG000|Overall Study|Withdrawal by Subject|6|||
161823753|NCT03294317|584396301|FG000|Overall Study|Lost to Follow-up|1|||
161823754|NCT03294317|584396301|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
161823755|NCT03294317|584396301|FG000|Overall Study|Failed HB lead implant|8|||
161823756|NCT03294317|584396301|FG000|Overall Study|Received CRT instead|1|||
161823757|NCT03294317|584396301|FG000|Overall Study|Exited after lead revision|2|||
161823758|NCT03847974|584396302|FG000|Overall Study|relocated out of region|3|||
161823759|NCT03847974|584396302|FG000|Overall Study|Withdrawal by Subject|2|||
161823760|NCT03847974|584396302|FG000|Overall Study|Adverse Event|1|||
161823761|NCT02911935|584396303|FG000|Overall Study|Lost to Follow-up|5|||
161823762|NCT02911935|584396304|FG001|Overall Study|Lost to Follow-up|7|||
161823763|NCT00603512|584396305|FG000|Overall Study|Adverse Event|0|||
161823764|NCT00603512|584396306|FG001|Overall Study|Adverse Event|2|||
161823765|NCT00603512|584396307|FG002|Overall Study|Adverse Event|4|||
161823766|NCT00603512|584396308|FG003|Overall Study|Adverse Event|4|||
161823767|NCT00603512|584396309|FG004|Overall Study|Adverse Event|2|||
161823768|NCT00603512|584396305|FG000|Overall Study|Lack of Efficacy|0|||
161823769|NCT00603512|584396306|FG001|Overall Study|Lack of Efficacy|1|||
161823770|NCT00603512|584396307|FG002|Overall Study|Lack of Efficacy|0|||
161823771|NCT00603512|584396308|FG003|Overall Study|Lack of Efficacy|0|||
161823772|NCT00603512|584396309|FG004|Overall Study|Lack of Efficacy|1|||
161823773|NCT00603512|584396305|FG000|Overall Study|Other|2|||
161823774|NCT00603512|584396306|FG001|Overall Study|Other|1|||
161823775|NCT00603512|584396307|FG002|Overall Study|Other|0|||
161823776|NCT00603512|584396308|FG003|Overall Study|Other|1|||
161823777|NCT00603512|584396309|FG004|Overall Study|Other|1|||
161823778|NCT00603512|584396305|FG000|Overall Study|Withdrawal by Subject|0|||
161823779|NCT00603512|584396306|FG001|Overall Study|Withdrawal by Subject|0|||
161823780|NCT00603512|584396307|FG002|Overall Study|Withdrawal by Subject|0|||
161823781|NCT00603512|584396308|FG003|Overall Study|Withdrawal by Subject|0|||
161823782|NCT00603512|584396309|FG004|Overall Study|Withdrawal by Subject|1|||
161823783|NCT00603512|584396305|FG000|Overall Study|Randomized but not treated|0|||
161931648|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931649|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931650|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931651|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931652|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
161931653|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931654|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931655|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
161931656|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931657|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931658|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931659|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931660|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931661|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931662|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931663|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931664|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931665|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931666|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
161931667|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
161931668|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931669|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161931670|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161931671|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931672|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931673|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161931674|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931675|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
161931676|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931677|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
161931678|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931679|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931680|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931681|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931682|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
161931683|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
161931684|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931685|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931686|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931687|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
161931688|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931689|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
161931690|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
161931691|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931692|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931693|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931694|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931695|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931696|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931697|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931698|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931699|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
161931700|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931701|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931702|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931703|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
161931704|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
161931705|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161588776|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161588777|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
161823784|NCT00603512|584396306|FG001|Overall Study|Randomized but not treated|1|||
161588778|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
161588779|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
161588780|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588781|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588782|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588783|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161823785|NCT00603512|584396307|FG002|Overall Study|Randomized but not treated|1|||
161823786|NCT00603512|584396308|FG003|Overall Study|Randomized but not treated|2|||
161823787|NCT00603512|584396309|FG004|Overall Study|Randomized but not treated|0|||
161823788|NCT04979858|584396310|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
161823789|NCT04979858|584396311|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
161823790|NCT04253236|584396312|FG000|Overall Study|Adverse Event|1|||
161823791|NCT04253236|584396313|FG001|Overall Study|Adverse Event|0|||
161823792|NCT04253236|584396312|FG000|Overall Study|Safety Concerns|1|||
161823793|NCT04253236|584396313|FG001|Overall Study|Safety Concerns|0|||
161823794|NCT04253236|584396312|FG000|Overall Study|Study Terminated by Sponsor|1|||
161823795|NCT04253236|584396313|FG001|Overall Study|Study Terminated by Sponsor|0|||
161823796|NCT01896505|584396314|FG000|Overall Study|Adverse Event|1|||
161823797|NCT01896505|584396315|FG001|Overall Study|Adverse Event|0|||
161823798|NCT01896505|584396316|FG002|Overall Study|Adverse Event|2|||
161823799|NCT01896505|584396317|FG003|Overall Study|Adverse Event|1|||
161823800|NCT01896505|584396318|FG004|Overall Study|Adverse Event|1|||
161823801|NCT01896505|584396319|FG005|Overall Study|Adverse Event|0|||
161823802|NCT01896505|584396314|FG000|Overall Study|Physician Decision|1|||
161823803|NCT01896505|584396315|FG001|Overall Study|Physician Decision|3|||
161823804|NCT01896505|584396316|FG002|Overall Study|Physician Decision|2|||
161823805|NCT01896505|584396317|FG003|Overall Study|Physician Decision|0|||
161823806|NCT01896505|584396318|FG004|Overall Study|Physician Decision|0|||
161823807|NCT01896505|584396319|FG005|Overall Study|Physician Decision|1|||
161823808|NCT01896505|584396314|FG000|Overall Study|Withdrawal by Subject|1|||
161823809|NCT01896505|584396315|FG001|Overall Study|Withdrawal by Subject|0|||
161823810|NCT01896505|584396316|FG002|Overall Study|Withdrawal by Subject|3|||
161823811|NCT01896505|584396317|FG003|Overall Study|Withdrawal by Subject|1|||
161823812|NCT01896505|584396318|FG004|Overall Study|Withdrawal by Subject|0|||
161823813|NCT01896505|584396319|FG005|Overall Study|Withdrawal by Subject|0|||
161823814|NCT01896505|584396314|FG000|Overall Study|Disease Progression|7|||
161823815|NCT01896505|584396315|FG001|Overall Study|Disease Progression|5|||
161823816|NCT01896505|584396316|FG002|Overall Study|Disease Progression|8|||
161823817|NCT01896505|584396317|FG003|Overall Study|Disease Progression|4|||
161823818|NCT01896505|584396318|FG004|Overall Study|Disease Progression|4|||
161823819|NCT01896505|584396319|FG005|Overall Study|Disease Progression|4|||
161823820|NCT01896505|584396314|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
161823821|NCT01896505|584396315|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
161823822|NCT01896505|584396316|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
161823823|NCT01896505|584396317|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
161823824|NCT01896505|584396318|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
161823825|NCT01896505|584396319|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
161823826|NCT01896505|584396314|FG000|Overall Study|Intercurrent illness|0|||
161823827|NCT01896505|584396315|FG001|Overall Study|Intercurrent illness|1|||
161823828|NCT01896505|584396316|FG002|Overall Study|Intercurrent illness|0|||
161823829|NCT01896505|584396317|FG003|Overall Study|Intercurrent illness|0|||
161823830|NCT01896505|584396318|FG004|Overall Study|Intercurrent illness|0|||
161823831|NCT01896505|584396319|FG005|Overall Study|Intercurrent illness|0|||
161823832|NCT01896505|584396314|FG000|Overall Study|Death|0|||
161823833|NCT01896505|584396315|FG001|Overall Study|Death|0|||
161823834|NCT01896505|584396316|FG002|Overall Study|Death|1|||
161823835|NCT01896505|584396317|FG003|Overall Study|Death|1|||
161823836|NCT01896505|584396318|FG004|Overall Study|Death|0|||
161823837|NCT01896505|584396319|FG005|Overall Study|Death|1|||
161823838|NCT02063217|584396320|FG000|Overall Study|Withdrawal by Subject|1|||
161823839|NCT02063217|584396321|FG001|Overall Study|Withdrawal by Subject|0|||
161823840|NCT02063217|584396322|FG002|Overall Study|Withdrawal by Subject|0|||
161823841|NCT04291508|584396323|FG000|Overall Study|Withdrawal by Subject|1|||
161823842|NCT04291508|584396324|FG001|Overall Study|Withdrawal by Subject|0|||
161823843|NCT04291508|584396325|FG002|Overall Study|Withdrawal by Subject|1|||
161823844|NCT04291508|584396326|FG003|Overall Study|Withdrawal by Subject|0|||
161823845|NCT04291508|584396323|FG000|Overall Study|lost to follow up|4|||
161823846|NCT04291508|584396324|FG001|Overall Study|lost to follow up|0|||
161823847|NCT04291508|584396325|FG002|Overall Study|lost to follow up|1|||
161823848|NCT04291508|584396326|FG003|Overall Study|lost to follow up|0|||
161823849|NCT03566238|584396327|FG000|Overall Study|Adverse Event|0|||
161823850|NCT03566238|584396328|FG001|Overall Study|Adverse Event|0|||
161823851|NCT03566238|584396329|FG002|Overall Study|Adverse Event|1|||
161823852|NCT03566238|584396327|FG000|Overall Study|Lack of Efficacy|5|||
161931706|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931707|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931708|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931709|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931710|NCT01313676|584798674|FG000|Overall Study|Adverse Event|395|||
161931711|NCT01313676|584798675|FG001|Overall Study|Adverse Event|365|||
161931712|NCT01313676|584798676|FG002|Overall Study|Adverse Event|372|||
161931713|NCT01313676|584798677|FG003|Overall Study|Adverse Event|333|||
161931714|NCT01313676|584798674|FG000|Overall Study|Lack of Efficacy|98|||
161931715|NCT01313676|584798675|FG001|Overall Study|Lack of Efficacy|90|||
161931716|NCT01313676|584798676|FG002|Overall Study|Lack of Efficacy|65|||
161931717|NCT01313676|584798677|FG003|Overall Study|Lack of Efficacy|46|||
161931718|NCT01313676|584798674|FG000|Overall Study|Protocol Violation|37|||
161931719|NCT01313676|584798675|FG001|Overall Study|Protocol Violation|44|||
161931720|NCT01313676|584798676|FG002|Overall Study|Protocol Violation|46|||
161931721|NCT01313676|584798677|FG003|Overall Study|Protocol Violation|44|||
161931722|NCT01313676|584798674|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
161931723|NCT01313676|584798675|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
161931724|NCT01313676|584798676|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
161931725|NCT01313676|584798677|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
161931726|NCT01313676|584798674|FG000|Overall Study|Study Closed/terminated|7|||
161931727|NCT01313676|584798675|FG001|Overall Study|Study Closed/terminated|6|||
161931728|NCT01313676|584798676|FG002|Overall Study|Study Closed/terminated|9|||
161931729|NCT01313676|584798677|FG003|Overall Study|Study Closed/terminated|9|||
161931730|NCT01313676|584798674|FG000|Overall Study|Lost to Follow-up|0|||
161931731|NCT01313676|584798675|FG001|Overall Study|Lost to Follow-up|0|||
161931732|NCT01313676|584798676|FG002|Overall Study|Lost to Follow-up|1|||
161931733|NCT01313676|584798677|FG003|Overall Study|Lost to Follow-up|0|||
161931734|NCT01313676|584798674|FG000|Overall Study|Physician Decision|53|||
161931735|NCT01313676|584798675|FG001|Overall Study|Physician Decision|64|||
161931736|NCT01313676|584798676|FG002|Overall Study|Physician Decision|62|||
161931737|NCT01313676|584798677|FG003|Overall Study|Physician Decision|48|||
161931738|NCT01313676|584798674|FG000|Overall Study|Decision by Participant or Proxy|643|||
161931739|NCT01313676|584798675|FG001|Overall Study|Decision by Participant or Proxy|527|||
161931740|NCT01313676|584798676|FG002|Overall Study|Decision by Participant or Proxy|515|||
161931741|NCT01313676|584798677|FG003|Overall Study|Decision by Participant or Proxy|492|||
161931742|NCT01313676|584798674|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
161931743|NCT01313676|584798675|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
161931744|NCT01313676|584798676|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
161931745|NCT01313676|584798677|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
161931746|NCT01313676|584798674|FG000|Overall Study|Investigator Site Closed|12|||
161931747|NCT01313676|584798675|FG001|Overall Study|Investigator Site Closed|11|||
161931748|NCT01313676|584798676|FG002|Overall Study|Investigator Site Closed|15|||
161931749|NCT01313676|584798677|FG003|Overall Study|Investigator Site Closed|10|||
161931750|NCT01313676|584798674|FG000|Overall Study|Missing|1|||
161931751|NCT01313676|584798675|FG001|Overall Study|Missing|1|||
161931752|NCT01313676|584798676|FG002|Overall Study|Missing|1|||
161931753|NCT01313676|584798677|FG003|Overall Study|Missing|0|||
161931754|NCT01902303|584798678|FG000|Overall Study|Adverse Event|0|||
161931755|NCT01902303|584798679|FG001|Overall Study|Adverse Event|1|||
161931756|NCT01902303|584798678|FG000|Overall Study|Lost to Follow-up|0|||
161931757|NCT01902303|584798679|FG001|Overall Study|Lost to Follow-up|1|||
161931758|NCT01902303|584798678|FG000|Overall Study|Protocol Violation|2|||
161931759|NCT01902303|584798679|FG001|Overall Study|Protocol Violation|2|||
161931760|NCT01902303|584798678|FG000|Overall Study|subject lost investigational product|0|||
161931761|NCT01902303|584798679|FG001|Overall Study|subject lost investigational product|1|||
161677031|NCT03044249|583870639|FG000|Overall Study|Non-compliance with Study Drug|1|||
161677032|NCT03044249|583870640|FG001|Overall Study|Non-compliance with Study Drug|0|||
161931762|NCT01902303|584798678|FG000|Overall Study|Did not develop a cold sore|21|||
161931763|NCT01902303|584798679|FG001|Overall Study|Did not develop a cold sore|19|||
161931764|NCT00326495|584798680|FG000|Overall Study|Switched to alternative treatment|1|||
161515834|NCT00853658|583278573|FG000|Overall Study|H.A. Request|26|||
161677033|NCT03044249|583870639|FG000|Overall Study|Study Terminated by Sponsor|2|||
161931765|NCT00326495|584798680|FG000|Overall Study|Disease progression before treatment|1|||
161931766|NCT00326495|584798680|FG000|Overall Study|Refused further treatment|2|||
161931767|NCT00326495|584798680|FG000|Overall Study|Subject off study before assessment|1|||
161931768|NCT01897896|584798683|FG000|Overall Study|Death|1|||
161931769|NCT01897896|584798684|FG001|Overall Study|Death|0|||
161931770|NCT01897896|584798683|FG000|Overall Study|Adverse Event|11|||
161931771|NCT01897896|584798684|FG001|Overall Study|Adverse Event|1|||
161931772|NCT01897896|584798683|FG000|Overall Study|Lost to Follow-up|1|||
161931773|NCT01897896|584798684|FG001|Overall Study|Lost to Follow-up|0|||
161931774|NCT01897896|584798683|FG000|Overall Study|Non-compliance with study drug dosing|1|||
161931775|NCT01897896|584798684|FG001|Overall Study|Non-compliance with study drug dosing|1|||
161931776|NCT01897896|584798683|FG000|Overall Study|Withdrawal by Subject|7|||
161931777|NCT01897896|584798684|FG001|Overall Study|Withdrawal by Subject|1|||
161931778|NCT01897896|584798683|FG000|Overall Study|Require drug that interfere with study|1|||
161931779|NCT01897896|584798684|FG001|Overall Study|Require drug that interfere with study|4|||
161931780|NCT01897896|584798683|FG000|Overall Study|Protocol Violation|1|||
161931781|NCT01897896|584798684|FG001|Overall Study|Protocol Violation|1|||
161931782|NCT01897896|584798683|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
161931783|NCT01897896|584798684|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
161931784|NCT01897896|584798683|FG000|Overall Study|Caregiver can no longer participate|0|||
161931785|NCT01897896|584798684|FG001|Overall Study|Caregiver can no longer participate|2|||
161931786|NCT01897896|584798683|FG000|Overall Study|Other than specified|2|||
161931787|NCT01897896|584798684|FG001|Overall Study|Other than specified|1|||
161823853|NCT03566238|584396328|FG001|Overall Study|Lack of Efficacy|4|||
161823854|NCT03566238|584396329|FG002|Overall Study|Lack of Efficacy|2|||
161823855|NCT03566238|584396327|FG000|Overall Study|Other|0|||
161931788|NCT01292473|584798694|FG000|Overall Study|Adverse Event|1|||
161931789|NCT01292473|584798695|FG001|Overall Study|Adverse Event|0|||
161931790|NCT01292473|584798696|FG002|Overall Study|Adverse Event|1|||
161931791|NCT01292473|584798697|FG003|Overall Study|Adverse Event|1|||
161931792|NCT01292473|584798694|FG000|Overall Study|Lost to Follow-up|1|||
161931793|NCT01292473|584798695|FG001|Overall Study|Lost to Follow-up|1|||
161931794|NCT01292473|584798696|FG002|Overall Study|Lost to Follow-up|2|||
161931795|NCT01292473|584798697|FG003|Overall Study|Lost to Follow-up|2|||
161931796|NCT01292473|584798694|FG000|Overall Study|Withdrawal by Subject|3|||
161931797|NCT01292473|584798695|FG001|Overall Study|Withdrawal by Subject|4|||
161931798|NCT01292473|584798696|FG002|Overall Study|Withdrawal by Subject|3|||
161931799|NCT01292473|584798697|FG003|Overall Study|Withdrawal by Subject|3|||
161931800|NCT01292473|584798694|FG000|Overall Study|Physician Decision|0|||
161931801|NCT01292473|584798695|FG001|Overall Study|Physician Decision|1|||
161931802|NCT01292473|584798696|FG002|Overall Study|Physician Decision|0|||
161931803|NCT01292473|584798697|FG003|Overall Study|Physician Decision|0|||
161677034|NCT03044249|583870640|FG001|Overall Study|Study Terminated by Sponsor|0|||
161677035|NCT03044249|583870639|FG000|Overall Study|Withdrawal by Subject|2|||
161677036|NCT03044249|583870640|FG001|Overall Study|Withdrawal by Subject|5|||
161677037|NCT04263896|583870642|FG000|Overall Study|Withdrawal by Subject|2|||
161677038|NCT04263896|583870643|FG001|Overall Study|Withdrawal by Subject|4|||
161677039|NCT04263896|583870642|FG000|Overall Study|converted to open procedure|0|||
161677040|NCT04263896|583870643|FG001|Overall Study|converted to open procedure|1|||
161677041|NCT04263896|583870642|FG000|Overall Study|Lost to Follow-up|9|||
161677042|NCT04263896|583870643|FG001|Overall Study|Lost to Follow-up|11|||
161677043|NCT04263896|583870642|FG000|Overall Study|surveys lost in mail|5|||
161677044|NCT04263896|583870643|FG001|Overall Study|surveys lost in mail|3|||
161677045|NCT04263896|583870642|FG000|Overall Study|excluded from analysis|1|||
161677046|NCT04263896|583870643|FG001|Overall Study|excluded from analysis|0|||
161677047|NCT00880555|583871980|FG000|Overall Study|Physician Decision|0|||
161677048|NCT00880555|583871981|FG001|Overall Study|Physician Decision|8|||
161677049|NCT00880555|583871982|FG002|Overall Study|Physician Decision|0|||
161677050|NCT00880555|583871983|FG003|Overall Study|Physician Decision|2|||
161677051|NCT00880555|583871984|FG004|Overall Study|Physician Decision|1|||
161677052|NCT00880555|583871985|FG005|Overall Study|Physician Decision|0|||
161931804|NCT01292473|584798694|FG000|Overall Study|Disease Progression|0|||
161931805|NCT01292473|584798695|FG001|Overall Study|Disease Progression|1|||
161931806|NCT01292473|584798696|FG002|Overall Study|Disease Progression|3|||
161823856|NCT03566238|584396328|FG001|Overall Study|Other|1|||
161823857|NCT03566238|584396329|FG002|Overall Study|Other|0|||
161931807|NCT01292473|584798697|FG003|Overall Study|Disease Progression|6|||
161931808|NCT00458705|584798700|FG000|Overall Study|Adverse Event|4|||
161931809|NCT00458705|584798700|FG000|Overall Study|Not Treated|1|||
161931810|NCT02180672|584798701|FG000|Overall Study|Lost to Follow-up|5|||
161931811|NCT02180672|584798702|FG001|Overall Study|Lost to Follow-up|7|||
161931812|NCT00378560|584798706|FG000|Overall Study|Adverse Event|1|||
161931813|NCT00378560|584798707|FG001|Overall Study|Adverse Event|0|||
161823858|NCT00593827|584396336|FG000|Overall Study|On Active Treatment/Pending|0|||
161931814|NCT00378560|584798706|FG000|Overall Study|Lost to Follow-up|24|||
161931815|NCT00378560|584798707|FG001|Overall Study|Lost to Follow-up|29|||
161823859|NCT00593827|584396337|FG001|Overall Study|On Active Treatment/Pending|2|||
161823860|NCT00089973|584396338|FG000|Overall Study|Adverse Event|3|||
161931816|NCT00378560|584798706|FG000|Overall Study|Protocol Violation|2|||
161823861|NCT00089973|584396338|FG000|Overall Study|Withdrawal by Subject|1|||
161677053|NCT00880555|583871980|FG000|Overall Study|Withdrawal by Subject|1|||
161931817|NCT00378560|584798707|FG001|Overall Study|Protocol Violation|0|||
161931818|NCT00378560|584798706|FG000|Overall Study|Withdrawal by Subject|17|||
161677054|NCT00880555|583871981|FG001|Overall Study|Withdrawal by Subject|1|||
161931819|NCT00378560|584798707|FG001|Overall Study|Withdrawal by Subject|21|||
161931820|NCT00378560|584798706|FG000|Overall Study|Moved|4|||
161931821|NCT00378560|584798707|FG001|Overall Study|Moved|3|||
161823862|NCT00089973|584396338|FG000|Overall Study|Disease progression|45|||
161823863|NCT00089973|584396338|FG000|Overall Study|Death|1|||
161931822|NCT00378560|584798706|FG000|Overall Study|Pregnancy|7|||
161931823|NCT00378560|584798707|FG001|Overall Study|Pregnancy|5|||
161515835|NCT00853658|583278574|FG001|Overall Study|H.A. Request|23|||
161515836|NCT00853658|583278575|FG002|Overall Study|H.A. Request|19|||
161515837|NCT00853658|583278573|FG000|Overall Study|IRB request|0|||
161515838|NCT00853658|583278574|FG001|Overall Study|IRB request|0|||
161515839|NCT00853658|583278575|FG002|Overall Study|IRB request|2|||
161515840|NCT00853658|583278573|FG000|Overall Study|Vital Status known (alive) at study end|2|||
161515841|NCT00853658|583278574|FG001|Overall Study|Vital Status known (alive) at study end|3|||
161515842|NCT00853658|583278575|FG002|Overall Study|Vital Status known (alive) at study end|3|||
161823864|NCT01049581|584396341|FG000|Overall Study|Lost to Follow-up|2|||
161823865|NCT01049581|584396342|FG001|Overall Study|Lost to Follow-up|1|||
161823866|NCT00653159|584397857|FG000|Overall Study|Adverse Event|4|||
161823867|NCT00653159|584397858|FG001|Overall Study|Adverse Event|1|||
161823868|NCT00653159|584397857|FG000|Overall Study|Lost to Follow-up|1|||
161823869|NCT00653159|584397858|FG001|Overall Study|Lost to Follow-up|2|||
161823870|NCT01872715|584397859|FG000|Overall Study|Adverse Event|1|||
161823871|NCT01872715|584397859|FG000|Overall Study|Protocol Violation|1|||
161823872|NCT01872715|584397859|FG000|Overall Study|Withdrawal by Subject|2|||
161823873|NCT01848210|584397860|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
161823874|NCT01848210|584397861|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
161823875|NCT01848210|584397860|FG000|Overall Study|Lost to Follow-up|24|||
161823876|NCT01848210|584397861|FG001|Overall Study|Lost to Follow-up|12|||
161823877|NCT01848210|584397860|FG000|Overall Study|Protocol Violation|3|||
161823878|NCT01848210|584397861|FG001|Overall Study|Protocol Violation|5|||
161823879|NCT01848210|584397860|FG000|Overall Study|Use of Forbidden Drugs|9|||
161823880|NCT01848210|584397861|FG001|Overall Study|Use of Forbidden Drugs|10|||
161823881|NCT01848210|584397860|FG000|Overall Study|Impedition Condition|5|||
161823882|NCT01848210|584397861|FG001|Overall Study|Impedition Condition|9|||
161823883|NCT01848210|584397860|FG000|Overall Study|Adverse Event|7|||
161823884|NCT01848210|584397861|FG001|Overall Study|Adverse Event|9|||
161823885|NCT01848210|584397860|FG000|Overall Study|Discontinuation Criterion|5|||
161823886|NCT01848210|584397861|FG001|Overall Study|Discontinuation Criterion|7|||
161823887|NCT01848210|584397860|FG000|Overall Study|Hypesensitivity|1|||
161823888|NCT01848210|584397861|FG001|Overall Study|Hypesensitivity|0|||
161823889|NCT01848210|584397860|FG000|Overall Study|Hepatic Function Alteration|4|||
161823890|NCT01848210|584397861|FG001|Overall Study|Hepatic Function Alteration|0|||
161823891|NCT01848210|584397860|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
161823892|NCT01848210|584397861|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
161823893|NCT01848210|584397860|FG000|Overall Study|Administrative|1|||
161823894|NCT01848210|584397861|FG001|Overall Study|Administrative|0|||
161823895|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
161823896|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
161823897|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
161823898|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
161823899|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
161823900|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
161823901|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
161823902|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
161823903|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
161823904|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
161823905|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
161823906|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
161823907|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
161823908|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
161823909|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
161823910|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
161823911|NCT04592419|584397862|FG000|Open-Label Extension Period|Adverse Event|1|||
161823912|NCT04592419|584397863|FG001|Open-Label Extension Period|Adverse Event|2|||
161823913|NCT04592419|584397862|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
161823914|NCT04592419|584397863|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
161823915|NCT04592419|584397862|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
161823916|NCT04592419|584397863|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
161823917|NCT04592419|584397862|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161823918|NCT04592419|584397863|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
161823919|NCT04592419|584397862|FG000|Open-Label Extension Period|Sponsor Request|73|||
161823920|NCT04592419|584397863|FG001|Open-Label Extension Period|Sponsor Request|84|||
161823921|NCT00381849|584397864|FG000|Wash Out|Withdrawal by Subject|0|||
161823922|NCT00381849|584397865|FG001|Wash Out|Withdrawal by Subject|1|||
161823923|NCT01765270|584397869|FG000|Overall Study|Physician Decision|1|||
161823924|NCT01765270|584397870|FG001|Overall Study|Physician Decision|0|||
161823925|NCT01765270|584397869|FG000|Overall Study|Withdrawal by Subject|0|||
161823926|NCT01765270|584397870|FG001|Overall Study|Withdrawal by Subject|1|||
161823927|NCT00517192|584397871|FG000|Overall Study|Adverse Event|1|||
161823928|NCT00517192|584397872|FG001|Overall Study|Adverse Event|1|||
161588784|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588785|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588786|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588787|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588788|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588789|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161588790|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161588791|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161588792|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161588793|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588794|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588795|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588796|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588797|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588798|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588799|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161588800|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161931824|NCT00378560|584798706|FG000|Overall Study|Laboratory test values abnormal|1|||
161931825|NCT00378560|584798707|FG001|Overall Study|Laboratory test values abnormal|0|||
161931826|NCT02070380|584798708|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
161931827|NCT02070380|584798709|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
161931828|NCT02070380|584798710|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
161931829|NCT02070380|584798711|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
161931830|NCT02070380|584798708|FG000|Second Injection|Image sets missing or technically inadeq|0|||
161931831|NCT02070380|584798709|FG001|Second Injection|Image sets missing or technically inadeq|1|||
161931832|NCT02070380|584798710|FG002|Second Injection|Image sets missing or technically inadeq|0|||
161931833|NCT02070380|584798711|FG003|Second Injection|Image sets missing or technically inadeq|0|||
161931834|NCT02070380|584798708|FG000|Second Injection|Protocol Violation|0|||
161931835|NCT02070380|584798709|FG001|Second Injection|Protocol Violation|1|||
161931836|NCT02070380|584798710|FG002|Second Injection|Protocol Violation|1|||
161931837|NCT02070380|584798711|FG003|Second Injection|Protocol Violation|5|||
161931838|NCT03596983|584798726|FG000|Overall Study|Withdrawal by Subject|3|||
161931839|NCT03654326|584798727|FG000|Overall Study|Withdrawal by Subject|5|||
161931840|NCT03654326|584798728|FG001|Overall Study|Withdrawal by Subject|3|||
161931841|NCT03654326|584798727|FG000|Overall Study|Physician Decision|0|||
161931842|NCT03654326|584798728|FG001|Overall Study|Physician Decision|1|||
161931843|NCT03654326|584798727|FG000|Overall Study|Unable to adhere to study schedule|0|||
161931844|NCT03654326|584798728|FG001|Overall Study|Unable to adhere to study schedule|1|||
161931845|NCT03654326|584798727|FG000|Overall Study|Lost to Follow-up|1|||
161931846|NCT03654326|584798728|FG001|Overall Study|Lost to Follow-up|1|||
161931847|NCT05287685|584798729|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
161931848|NCT05287685|584798730|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
161931849|NCT05287685|584798729|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
161931850|NCT05287685|584798730|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
161931851|NCT04829214|584798731|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
161931852|NCT04829214|584798732|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
161931853|NCT04829214|584798731|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
161931854|NCT04829214|584798732|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
161931855|NCT06399471|584798733|FG000|Overall Study|Withdrawal by Subject|1|||
161931856|NCT00609973|584798735|FG000|Overall Study|Adverse Event|2|||
161931857|NCT00609973|584798736|FG001|Overall Study|Adverse Event|1|||
161931858|NCT00609973|584798735|FG000|Overall Study|Protocol Violation|4|||
161931859|NCT00609973|584798736|FG001|Overall Study|Protocol Violation|3|||
161931860|NCT00609973|584798735|FG000|Overall Study|Lost to Follow-up|2|||
161931861|NCT00609973|584798736|FG001|Overall Study|Lost to Follow-up|1|||
161931862|NCT00609973|584798735|FG000|Overall Study|Withdrawal by Subject|0|||
161931863|NCT00609973|584798736|FG001|Overall Study|Withdrawal by Subject|1|||
161931864|NCT01362270|584798739|FG000|Overall Study|Withdrawal by Subject|1|||
161931865|NCT01362270|584798740|FG001|Overall Study|Withdrawal by Subject|0|||
161588801|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161931866|NCT01362270|584798739|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
161588802|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161931867|NCT01362270|584798740|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
161931868|NCT01362270|584798739|FG000|Overall Study|Met excl. criteria before 1st session|1|||
161931869|NCT01362270|584798740|FG001|Overall Study|Met excl. criteria before 1st session|1|||
161931870|NCT01691482|584798743|FG000|Treatment Period 2|Adverse Event|0|||
161931871|NCT01691482|584798744|FG001|Treatment Period 2|Adverse Event|1|||
161515843|NCT00853658|583278573|FG000|Overall Study|Vital Status unknown at study end|1|||
161515844|NCT00853658|583278574|FG001|Overall Study|Vital Status unknown at study end|1|||
161823929|NCT00517192|584397871|FG000|Overall Study|Lost to Follow-up|1|||
161823930|NCT00517192|584397872|FG001|Overall Study|Lost to Follow-up|1|||
161823931|NCT00517192|584397871|FG000|Overall Study|Withdrawal by Subject|1|||
161823932|NCT00517192|584397872|FG001|Overall Study|Withdrawal by Subject|0|||
161823933|NCT00517192|584397871|FG000|Overall Study|Early termination of the trial|16|||
161823934|NCT00517192|584397872|FG001|Overall Study|Early termination of the trial|18|||
161823935|NCT04501094|584397876|FG000|Overall Study|Death (unrelated to research)|1|||
161823936|NCT04501094|584397877|FG001|Overall Study|Death (unrelated to research)|0|||
161823937|NCT05693805|584397880|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
161823938|NCT05693805|584397881|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
161823939|NCT02943993|584397884|FG000|Overall Study|Withdrawal by Subject|52|||
161823940|NCT02943993|584397884|FG000|Overall Study|Transfer to another institution|6|||
161823941|NCT02943993|584397884|FG000|Overall Study|Lost to Follow-up|135|||
161823942|NCT02943993|584397884|FG000|Overall Study|Death|98|||
161823943|NCT02943993|584397884|FG000|Overall Study|Other reason for premature termination|32|||
161823944|NCT02943993|584397884|FG000|Overall Study|Missing reason for termination|7|||
161823945|NCT02152982|584397886|FG000|Overall Study|Withdrawal by Subject|17|||
161823946|NCT02152982|584397887|FG001|Overall Study|Withdrawal by Subject|16|||
161823947|NCT02152982|584397886|FG000|Overall Study|Did not start treatment|11|||
161823948|NCT02152982|584397887|FG001|Overall Study|Did not start treatment|5|||
161823949|NCT02152982|584397886|FG000|Overall Study|Disease progression|41|||
161823950|NCT02152982|584397887|FG001|Overall Study|Disease progression|52|||
161823951|NCT02152982|584397886|FG000|Overall Study|Adverse Event|7|||
161823952|NCT02152982|584397887|FG001|Overall Study|Adverse Event|12|||
161823953|NCT02152982|584397886|FG000|Overall Study|Complicating disease|1|||
161823954|NCT02152982|584397887|FG001|Overall Study|Complicating disease|1|||
161823955|NCT02152982|584397886|FG000|Overall Study|Death|0|||
161823956|NCT02152982|584397887|FG001|Overall Study|Death|3|||
161823957|NCT02152982|584397886|FG000|Overall Study|Physician Decision|3|||
161823958|NCT02152982|584397887|FG001|Overall Study|Physician Decision|0|||
161823959|NCT02510261|584397888|FG000|Overall Study|Adverse Event|5|||
161823960|NCT02510261|584397889|FG001|Overall Study|Adverse Event|8|||
161823961|NCT02510261|584397890|FG002|Overall Study|Adverse Event|0|||
161823962|NCT02510261|584397888|FG000|Overall Study|Physician Decision|1|||
161823963|NCT02510261|584397889|FG001|Overall Study|Physician Decision|5|||
161823964|NCT02510261|584397890|FG002|Overall Study|Physician Decision|0|||
161823965|NCT02510261|584397888|FG000|Overall Study|Death|19|||
161823966|NCT02510261|584397889|FG001|Overall Study|Death|19|||
161823967|NCT02510261|584397890|FG002|Overall Study|Death|0|||
161823968|NCT02510261|584397888|FG000|Overall Study|Withdrawal by Subject|3|||
161823969|NCT02510261|584397889|FG001|Overall Study|Withdrawal by Subject|10|||
161823970|NCT02510261|584397890|FG002|Overall Study|Withdrawal by Subject|3|||
161823971|NCT02003222|584397892|FG000|Induction|Never started treatment|0|||
161823972|NCT02003222|584397893|FG001|Induction|Never started treatment|0|||
161823973|NCT02003222|584397894|FG002|Induction|Never started treatment|0|||
161823974|NCT02003222|584397895|FG003|Induction|Never started treatment|0|||
161823975|NCT02003222|584397896|FG004|Induction|Never started treatment|8|||
161823976|NCT02003222|584397892|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823977|NCT02003222|584397893|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823978|NCT02003222|584397894|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823979|NCT02003222|584397895|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823980|NCT02003222|584397896|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
161823981|NCT02003222|584397892|FG000|Induction|Adverse Event|0|||
161823982|NCT02003222|584397893|FG001|Induction|Adverse Event|0|||
161823983|NCT02003222|584397894|FG002|Induction|Adverse Event|0|||
161823984|NCT02003222|584397895|FG003|Induction|Adverse Event|0|||
161823985|NCT02003222|584397896|FG004|Induction|Adverse Event|13|||
161823986|NCT02003222|584397892|FG000|Induction|Alternative therapy|0|||
161823987|NCT02003222|584397893|FG001|Induction|Alternative therapy|0|||
161823988|NCT02003222|584397894|FG002|Induction|Alternative therapy|0|||
161823989|NCT02003222|584397895|FG003|Induction|Alternative therapy|0|||
161823990|NCT02003222|584397896|FG004|Induction|Alternative therapy|12|||
161823991|NCT02003222|584397892|FG000|Induction|Disease progression|0|||
161823992|NCT02003222|584397893|FG001|Induction|Disease progression|0|||
161823993|NCT02003222|584397894|FG002|Induction|Disease progression|0|||
161823994|NCT02003222|584397895|FG003|Induction|Disease progression|0|||
161823995|NCT02003222|584397896|FG004|Induction|Disease progression|22|||
161823996|NCT02003222|584397892|FG000|Induction|Death|0|||
161823997|NCT02003222|584397893|FG001|Induction|Death|0|||
161823998|NCT02003222|584397894|FG002|Induction|Death|0|||
161823999|NCT02003222|584397895|FG003|Induction|Death|0|||
161824000|NCT02003222|584397896|FG004|Induction|Death|3|||
161931872|NCT01691482|584798743|FG000|Treatment Period 2|Protocol Violation|1|||
161931873|NCT01691482|584798744|FG001|Treatment Period 2|Protocol Violation|1|||
161931874|NCT01953354|584798745|FG000|Overall Study|Withdrawal by Subject|0|||
161931875|NCT01953354|584798746|FG001|Overall Study|Withdrawal by Subject|1|||
161931876|NCT01953354|584798745|FG000|Overall Study|Decision of Sponsor|0|||
161931877|NCT01953354|584798746|FG001|Overall Study|Decision of Sponsor|1|||
161931878|NCT01953354|584798745|FG000|Overall Study|Disease Exacerbation|1|||
161931879|NCT01953354|584798746|FG001|Overall Study|Disease Exacerbation|0|||
161931880|NCT01392495|584798747|FG000|Overall Study|Death|3|||
161931881|NCT01392495|584798747|FG000|Overall Study|Administrative problems|8|||
161931882|NCT01392495|584798747|FG000|Overall Study|Withdrawal by Subject|2|||
161931883|NCT01392495|584798747|FG000|Overall Study|Adverse Event|3|||
161931884|NCT02965976|584798748|FG000|Overall Study|Withdrawal by Subject|2|||
161931885|NCT02965976|584798749|FG001|Overall Study|Withdrawal by Subject|0|||
161931886|NCT00806026|584798750|FG000|Overall Study|Death|0|||
161931887|NCT00806026|584798751|FG001|Overall Study|Death|0|||
161931888|NCT00806026|584798752|FG002|Overall Study|Death|0|||
161931889|NCT00806026|584798753|FG003|Overall Study|Death|1|||
161931890|NCT00806026|584798754|FG004|Overall Study|Death|0|||
161931891|NCT00806026|584798755|FG005|Overall Study|Death|0|||
161931892|NCT00806026|584798750|FG000|Overall Study|Did not meet entrance criteria|4|||
161931893|NCT00806026|584798751|FG001|Overall Study|Did not meet entrance criteria|1|||
161931894|NCT00806026|584798752|FG002|Overall Study|Did not meet entrance criteria|2|||
161931895|NCT00806026|584798753|FG003|Overall Study|Did not meet entrance criteria|1|||
161931896|NCT00806026|584798754|FG004|Overall Study|Did not meet entrance criteria|0|||
161931897|NCT00806026|584798755|FG005|Overall Study|Did not meet entrance criteria|0|||
161931898|NCT00806026|584798750|FG000|Overall Study|Lack of Efficacy|5|||
161931899|NCT00806026|584798751|FG001|Overall Study|Lack of Efficacy|18|||
161931900|NCT00806026|584798752|FG002|Overall Study|Lack of Efficacy|13|||
161931901|NCT00806026|584798753|FG003|Overall Study|Lack of Efficacy|4|||
161931902|NCT00806026|584798754|FG004|Overall Study|Lack of Efficacy|8|||
161931903|NCT00806026|584798755|FG005|Overall Study|Lack of Efficacy|7|||
161931904|NCT00806026|584798750|FG000|Overall Study|Lost to Follow-up|8|||
161931905|NCT00806026|584798751|FG001|Overall Study|Lost to Follow-up|15|||
161931906|NCT00806026|584798752|FG002|Overall Study|Lost to Follow-up|8|||
161931907|NCT00806026|584798753|FG003|Overall Study|Lost to Follow-up|2|||
161931908|NCT00806026|584798754|FG004|Overall Study|Lost to Follow-up|6|||
161931909|NCT00806026|584798755|FG005|Overall Study|Lost to Follow-up|6|||
161931910|NCT00806026|584798750|FG000|Overall Study|Withdrawal by Subject|14|||
161931911|NCT00806026|584798751|FG001|Overall Study|Withdrawal by Subject|17|||
161931912|NCT00806026|584798752|FG002|Overall Study|Withdrawal by Subject|9|||
161931913|NCT00806026|584798753|FG003|Overall Study|Withdrawal by Subject|2|||
161931914|NCT00806026|584798754|FG004|Overall Study|Withdrawal by Subject|5|||
161931915|NCT00806026|584798755|FG005|Overall Study|Withdrawal by Subject|3|||
161931916|NCT00806026|584798750|FG000|Overall Study|Other|3|||
161931917|NCT00806026|584798751|FG001|Overall Study|Other|6|||
161931918|NCT00806026|584798752|FG002|Overall Study|Other|8|||
161931919|NCT00806026|584798753|FG003|Overall Study|Other|2|||
161931920|NCT00806026|584798754|FG004|Overall Study|Other|0|||
161931921|NCT00806026|584798755|FG005|Overall Study|Other|4|||
161931922|NCT00806026|584798750|FG000|Overall Study|Protocol Violation|6|||
161931923|NCT00806026|584798751|FG001|Overall Study|Protocol Violation|9|||
161931924|NCT00806026|584798752|FG002|Overall Study|Protocol Violation|9|||
161931925|NCT00806026|584798753|FG003|Overall Study|Protocol Violation|0|||
161931926|NCT00806026|584798754|FG004|Overall Study|Protocol Violation|2|||
161931927|NCT00806026|584798755|FG005|Overall Study|Protocol Violation|3|||
161931928|NCT00806026|584798750|FG000|Overall Study|Adverse Event|52|||
161931929|NCT00806026|584798751|FG001|Overall Study|Adverse Event|35|||
161931930|NCT00806026|584798752|FG002|Overall Study|Adverse Event|44|||
161931931|NCT00806026|584798753|FG003|Overall Study|Adverse Event|17|||
161931932|NCT00806026|584798754|FG004|Overall Study|Adverse Event|9|||
161931933|NCT00806026|584798755|FG005|Overall Study|Adverse Event|9|||
161931934|NCT00819832|584798756|FG000|Overall Study|Sponsor Termination of Study|3|||
161931935|NCT00819832|584798757|FG001|Overall Study|Sponsor Termination of Study|0|||
161931936|NCT00819832|584798758|FG002|Overall Study|Sponsor Termination of Study|0|||
161931937|NCT00819832|584798759|FG003|Overall Study|Sponsor Termination of Study|0|||
161931938|NCT00819832|584798760|FG004|Overall Study|Sponsor Termination of Study|0|||
161931939|NCT00819832|584798761|FG005|Overall Study|Sponsor Termination of Study|0|||
161931940|NCT01370642|584798765|FG000|Overall Study|Adverse Event|2|||
161931941|NCT01370642|584798766|FG001|Overall Study|Adverse Event|1|||
161931942|NCT01370642|584798767|FG002|Overall Study|Adverse Event|1|||
161931943|NCT01370642|584798765|FG000|Overall Study|Detectable HCV RNA|0|||
161931944|NCT01370642|584798766|FG001|Overall Study|Detectable HCV RNA|0|||
161931945|NCT01370642|584798767|FG002|Overall Study|Detectable HCV RNA|22|||
161931946|NCT01370642|584798765|FG000|Overall Study|Lost to Follow-up|0|||
161931947|NCT01370642|584798766|FG001|Overall Study|Lost to Follow-up|0|||
161931948|NCT01370642|584798767|FG002|Overall Study|Lost to Follow-up|1|||
161931949|NCT01370642|584798765|FG000|Overall Study|Physician Decision|4|||
161931950|NCT01370642|584798766|FG001|Overall Study|Physician Decision|1|||
161824001|NCT02003222|584397892|FG000|Induction|Withdrawal by Subject|0|||
161824002|NCT02003222|584397893|FG001|Induction|Withdrawal by Subject|0|||
161824003|NCT02003222|584397894|FG002|Induction|Withdrawal by Subject|0|||
161824004|NCT02003222|584397895|FG003|Induction|Withdrawal by Subject|0|||
161824005|NCT02003222|584397896|FG004|Induction|Withdrawal by Subject|8|||
161824006|NCT02003222|584397892|FG000|Induction|Other reasons|0|||
161515845|NCT00853658|583278575|FG002|Overall Study|Vital Status unknown at study end|0|||
161515846|NCT00853658|583278573|FG000|Overall Study|Vital Status at study end N/A|8|||
161515847|NCT00853658|583278574|FG001|Overall Study|Vital Status at study end N/A|10|||
161515848|NCT00853658|583278575|FG002|Overall Study|Vital Status at study end N/A|10|||
161515849|NCT00853658|583278573|FG000|Overall Study|Patient's request|21|||
161515850|NCT00853658|583278574|FG001|Overall Study|Patient's request|17|||
161515851|NCT00853658|583278575|FG002|Overall Study|Patient's request|11|||
161515852|NCT00853658|583278573|FG000|Overall Study|Missing study completion information|5|||
161515853|NCT00853658|583278574|FG001|Overall Study|Missing study completion information|4|||
161515854|NCT00853658|583278575|FG002|Overall Study|Missing study completion information|6|||
161515855|NCT02797262|583278576|FG000|Overall Study|Withdrawal by Subject|5|||
161515856|NCT02797262|583278577|FG001|Overall Study|Withdrawal by Subject|1|||
161515857|NCT02797262|583278576|FG000|Overall Study|Lost to Follow-up|10|||
161515858|NCT02797262|583278577|FG001|Overall Study|Lost to Follow-up|7|||
161515859|NCT02797262|583278576|FG000|Overall Study|Death|1|||
161515860|NCT02797262|583278577|FG001|Overall Study|Death|2|||
161515861|NCT02797262|583278576|FG000|Overall Study|Adverse Event|1|||
161515862|NCT02797262|583278577|FG001|Overall Study|Adverse Event|0|||
161515863|NCT02797262|583278576|FG000|Overall Study|COVID-19|2|||
161515864|NCT02797262|583278577|FG001|Overall Study|COVID-19|1|||
161515865|NCT02797262|583278576|FG000|Overall Study|Out-of-country|1|||
161515866|NCT02797262|583278577|FG001|Overall Study|Out-of-country|0|||
161515867|NCT01600586|583278578|FG000|Overall Study|Physician Decision|3|||
161515868|NCT01600586|583278579|FG001|Overall Study|Physician Decision|3|||
161515869|NCT01227512|583278581|FG000|Overall Study|Physician Decision|6|||
161515870|NCT01227512|583278582|FG001|Overall Study|Physician Decision|6|||
161515871|NCT01227512|583278581|FG000|Overall Study|Adverse Event|4|||
161515872|NCT01227512|583278582|FG001|Overall Study|Adverse Event|3|||
161515873|NCT01227512|583278581|FG000|Overall Study|Withdrawal by Subject|3|||
161515874|NCT01227512|583278582|FG001|Overall Study|Withdrawal by Subject|0|||
161515875|NCT01227512|583278581|FG000|Overall Study|Participant met withdrawal criteria|0|||
161515876|NCT01227512|583278582|FG001|Overall Study|Participant met withdrawal criteria|1|||
161515877|NCT01069289|583278584|FG000|Overall Study|Withdrawal by Subject|15|||
161515878|NCT01069289|583278585|FG001|Overall Study|Withdrawal by Subject|26|||
161515879|NCT01069289|583278584|FG000|Overall Study|Adverse Event|21|||
161515880|NCT01069289|583278585|FG001|Overall Study|Adverse Event|28|||
161515881|NCT01069289|583278584|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161515882|NCT01069289|583278585|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161515883|NCT01069289|583278584|FG000|Overall Study|Severe non-compliance to protocol|3|||
161515884|NCT01069289|583278585|FG001|Overall Study|Severe non-compliance to protocol|2|||
161515885|NCT01069289|583278584|FG000|Overall Study|Due to deteriorating health condition|1|||
161515886|NCT01069289|583278585|FG001|Overall Study|Due to deteriorating health condition|0|||
161515887|NCT01818336|583279883|FG000|Overall Study|Declined retest visit|0|||
161515888|NCT01818336|583279884|FG001|Overall Study|Declined retest visit|11|||
161515889|NCT01818336|583279883|FG000|Overall Study|Lost to Follow-up|0|||
161515890|NCT01818336|583279884|FG001|Overall Study|Lost to Follow-up|1|||
161515891|NCT03042312|583279887|FG000|Overall Study|Administrative Reason|1|||
161515892|NCT03042312|583279888|FG001|Overall Study|Administrative Reason|1|||
161515893|NCT03042312|583279887|FG000|Overall Study|Adverse Event|0|||
161515894|NCT03042312|583279888|FG001|Overall Study|Adverse Event|1|||
161515895|NCT03042312|583279887|FG000|Overall Study|Lost to Follow-up|1|||
161515896|NCT03042312|583279888|FG001|Overall Study|Lost to Follow-up|3|||
161515897|NCT03042312|583279887|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
161515898|NCT03042312|583279888|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
161515899|NCT03042312|583279887|FG000|Overall Study|Withdrawal by Subject|4|||
161515900|NCT03042312|583279888|FG001|Overall Study|Withdrawal by Subject|5|||
161515901|NCT03422003|583279899|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
161515902|NCT03422003|583279900|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
161515903|NCT03422003|583279899|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
161515904|NCT03422003|583279900|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
161515905|NCT00812812|583279907|FG000|Overall Study|Adverse Event|2|||
161515906|NCT00812812|583279908|FG001|Overall Study|Adverse Event|1|||
161515907|NCT00812812|583279907|FG000|Overall Study|Lack of Efficacy|1|||
161515908|NCT00812812|583279908|FG001|Overall Study|Lack of Efficacy|0|||
161515909|NCT00812812|583279907|FG000|Overall Study|Lost to Follow-up|0|||
161515910|NCT00812812|583279908|FG001|Overall Study|Lost to Follow-up|1|||
161515911|NCT00812812|583279907|FG000|Overall Study|Withdrawal by Subject|0|||
161515912|NCT00812812|583279908|FG001|Overall Study|Withdrawal by Subject|2|||
161515913|NCT02114892|583279909|FG000|Overall Study|Lost to Follow-up|1|||
161515914|NCT02114892|583279910|FG001|Overall Study|Lost to Follow-up|2|||
161515915|NCT02013765|583279911|FG000|Overall Study|Trial was terminated by sponsor|1|||
161515916|NCT02178475|583279917|FG000|Overall Study|Withdrawal by Subject|7|||
161515917|NCT02178475|583279917|FG000|Overall Study|Lost to Follow-up|10|||
161515918|NCT02178475|583279917|FG000|Overall Study|Death|13|||
161515919|NCT02178475|583279917|FG000|Overall Study|Protocol-specified Criteria|99|||
161515920|NCT00718042|583279918|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
161515921|NCT00718042|583279919|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
161515922|NCT00718042|583279920|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
161515923|NCT00718042|583279921|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
161515924|NCT00718042|583279922|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
161515925|NCT00718042|583279923|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
161515926|NCT00718042|583279918|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
161515927|NCT00718042|583279919|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
161515928|NCT00718042|583279920|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
161515929|NCT00718042|583279921|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
161515930|NCT00718042|583279922|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
161515931|NCT00718042|583279923|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
161515932|NCT00718042|583279918|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
161515933|NCT00718042|583279919|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
161515934|NCT00718042|583279920|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
161515935|NCT00718042|583279921|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
161515936|NCT00718042|583279922|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
161515937|NCT00718042|583279923|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
161515938|NCT00718042|583279918|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
161515939|NCT00718042|583279919|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
161515940|NCT00718042|583279920|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
161515941|NCT00718042|583279921|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
161515942|NCT00718042|583279922|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
161515943|NCT00718042|583279923|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
161515944|NCT00718042|583279918|FG000|Donor Follow-up|Lost to Follow-up|13|||
161515945|NCT00718042|583279919|FG001|Donor Follow-up|Lost to Follow-up|0|||
161515946|NCT00718042|583279920|FG002|Donor Follow-up|Lost to Follow-up|0|||
161515947|NCT00718042|583279921|FG003|Donor Follow-up|Lost to Follow-up|0|||
161515948|NCT00718042|583279922|FG004|Donor Follow-up|Lost to Follow-up|19|||
161515949|NCT00718042|583279923|FG005|Donor Follow-up|Lost to Follow-up|0|||
161515950|NCT04327934|583279924|FG000|Overall Study|Did not qualify|7|||
161515951|NCT04327934|583279925|FG001|Overall Study|Did not qualify|4|||
161515952|NCT04327934|583279924|FG000|Overall Study|Physician Decision|0|||
161515953|NCT04327934|583279925|FG001|Overall Study|Physician Decision|1|||
161515954|NCT02443298|583279926|FG000|Overall Study|Adverse Event|3|||
161515955|NCT02443298|583279927|FG001|Overall Study|Adverse Event|3|||
161515956|NCT02443298|583279926|FG000|Overall Study|Withdrawal by Subject|1|||
161515957|NCT02443298|583279927|FG001|Overall Study|Withdrawal by Subject|2|||
161515958|NCT03095417|583279928|FG000|Overall Study|missed|1|||
161515959|NCT03095417|583279929|FG001|Overall Study|missed|2|||
161515960|NCT03095417|583279930|FG002|Overall Study|missed|0|||
161588803|NCT01261312|583544585|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
161588804|NCT01261312|583544586|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588805|NCT01261312|583544587|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
161588806|NCT01261312|583544588|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588807|NCT01261312|583544589|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588808|NCT01261312|583544590|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588809|NCT01261312|583544591|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161931951|NCT01370642|584798767|FG002|Overall Study|Physician Decision|2|||
161931952|NCT01370642|584798765|FG000|Overall Study|Withdrawal by Subject|2|||
161931953|NCT01370642|584798766|FG001|Overall Study|Withdrawal by Subject|4|||
161931954|NCT01370642|584798767|FG002|Overall Study|Withdrawal by Subject|3|||
161931955|NCT00147537|584798774|FG000|Phase 1b|Death|0|||
161931956|NCT00147537|584798775|FG001|Phase 1b|Death|1|||
161931957|NCT00147537|584798776|FG002|Phase 1b|Death|2|||
161931958|NCT00147537|584798777|FG003|Phase 1b|Death|1|||
161515961|NCT03095417|583279931|FG003|Overall Study|missed|1|||
161515962|NCT03095417|583279928|FG000|Overall Study|Lost to Follow-up|2|||
161515963|NCT03095417|583279929|FG001|Overall Study|Lost to Follow-up|2|||
161515964|NCT03095417|583279930|FG002|Overall Study|Lost to Follow-up|1|||
161515965|NCT03095417|583279931|FG003|Overall Study|Lost to Follow-up|0|||
161515966|NCT03095417|583279928|FG000|Overall Study|refusal|0|||
161515967|NCT03095417|583279929|FG001|Overall Study|refusal|1|||
161515968|NCT03095417|583279930|FG002|Overall Study|refusal|0|||
161515969|NCT03095417|583279931|FG003|Overall Study|refusal|1|||
161515970|NCT03095417|583279928|FG000|Overall Study|Withdrawal by Subject|8|||
161931959|NCT00147537|584798778|FG004|Phase 1b|Death|2|||
161515971|NCT03095417|583279929|FG001|Overall Study|Withdrawal by Subject|2|||
161515972|NCT03095417|583279930|FG002|Overall Study|Withdrawal by Subject|5|||
161515973|NCT03095417|583279931|FG003|Overall Study|Withdrawal by Subject|4|||
161515974|NCT03095417|583279928|FG000|Overall Study|Physician Decision|1|||
161515975|NCT03095417|583279929|FG001|Overall Study|Physician Decision|2|||
161515976|NCT03095417|583279930|FG002|Overall Study|Physician Decision|2|||
161515977|NCT03095417|583279931|FG003|Overall Study|Physician Decision|2|||
161515978|NCT03095417|583279928|FG000|Overall Study|Death|1|||
161515979|NCT03095417|583279929|FG001|Overall Study|Death|2|||
161515980|NCT03095417|583279930|FG002|Overall Study|Death|1|||
161515981|NCT03095417|583279931|FG003|Overall Study|Death|3|||
161515982|NCT02571452|583279932|FG000|Overall Study Treatment|Protocol Violation|0|||
161515983|NCT02571452|583279933|FG001|Overall Study Treatment|Protocol Violation|1|||
161515984|NCT02571452|583279932|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
161515985|NCT02571452|583279933|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
161515986|NCT02571452|583279932|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
161515987|NCT02571452|583279933|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
161515988|NCT01877421|583279934|FG000|Phase 2|Lost to Follow-up|0|||
161515989|NCT01877421|583279935|FG001|Phase 2|Lost to Follow-up|0|||
161515990|NCT01877421|583279936|FG002|Phase 2|Lost to Follow-up|0|||
161515991|NCT01877421|583279937|FG003|Phase 2|Lost to Follow-up|0|||
161515992|NCT01877421|583279938|FG004|Phase 2|Lost to Follow-up|0|||
161515993|NCT01877421|583279939|FG005|Phase 2|Lost to Follow-up|0|||
161515994|NCT01877421|583279940|FG006|Phase 2|Lost to Follow-up|1|||
161515995|NCT01877421|583279941|FG007|Phase 2|Lost to Follow-up|0|||
161515996|NCT01877421|583279942|FG008|Phase 2|Lost to Follow-up|0|||
161515997|NCT01877421|583279943|FG009|Phase 2|Lost to Follow-up|0|||
161515998|NCT01877421|583279944|FG010|Phase 2|Lost to Follow-up|0|||
161515999|NCT01877421|583279945|FG011|Phase 2|Lost to Follow-up|0|||
161516000|NCT01877421|583279946|FG012|Phase 2|Lost to Follow-up|0|||
161516001|NCT01877421|583279947|FG013|Phase 2|Lost to Follow-up|0|||
161516002|NCT01877421|583279948|FG014|Phase 2|Lost to Follow-up|0|||
161516003|NCT01877421|583279949|FG015|Phase 2|Lost to Follow-up|0|||
161516004|NCT01877421|583279950|FG016|Phase 2|Lost to Follow-up|0|||
161516005|NCT01877421|583279951|FG017|Phase 2|Lost to Follow-up|0|||
161516006|NCT01877421|583279934|FG000|Phase 2|Withdrawal by Subject|0|||
161516007|NCT01877421|583279935|FG001|Phase 2|Withdrawal by Subject|0|||
161516008|NCT01877421|583279936|FG002|Phase 2|Withdrawal by Subject|0|||
161516009|NCT01877421|583279937|FG003|Phase 2|Withdrawal by Subject|0|||
161516010|NCT01877421|583279938|FG004|Phase 2|Withdrawal by Subject|0|||
161516011|NCT01877421|583279939|FG005|Phase 2|Withdrawal by Subject|0|||
161516012|NCT01877421|583279940|FG006|Phase 2|Withdrawal by Subject|0|||
161516013|NCT01877421|583279941|FG007|Phase 2|Withdrawal by Subject|0|||
161516014|NCT01877421|583279942|FG008|Phase 2|Withdrawal by Subject|1|||
161516015|NCT01877421|583279943|FG009|Phase 2|Withdrawal by Subject|0|||
161516016|NCT01877421|583279944|FG010|Phase 2|Withdrawal by Subject|1|||
161516017|NCT01877421|583279945|FG011|Phase 2|Withdrawal by Subject|0|||
161516018|NCT01877421|583279946|FG012|Phase 2|Withdrawal by Subject|1|||
161516019|NCT01877421|583279947|FG013|Phase 2|Withdrawal by Subject|0|||
161516020|NCT01877421|583279948|FG014|Phase 2|Withdrawal by Subject|0|||
161516021|NCT01877421|583279949|FG015|Phase 2|Withdrawal by Subject|1|||
161516022|NCT01877421|583279950|FG016|Phase 2|Withdrawal by Subject|0|||
161516023|NCT01877421|583279951|FG017|Phase 2|Withdrawal by Subject|0|||
161516024|NCT01877421|583279934|FG000|Phase 2|Protocol Violation|0|||
161516025|NCT01877421|583279935|FG001|Phase 2|Protocol Violation|0|||
161516026|NCT01877421|583279936|FG002|Phase 2|Protocol Violation|0|||
161516027|NCT01877421|583279937|FG003|Phase 2|Protocol Violation|0|||
161516028|NCT01877421|583279938|FG004|Phase 2|Protocol Violation|0|||
161516029|NCT01877421|583279939|FG005|Phase 2|Protocol Violation|0|||
161516030|NCT01877421|583279940|FG006|Phase 2|Protocol Violation|0|||
161516031|NCT01877421|583279941|FG007|Phase 2|Protocol Violation|0|||
161516032|NCT01877421|583279942|FG008|Phase 2|Protocol Violation|0|||
161516033|NCT01877421|583279943|FG009|Phase 2|Protocol Violation|0|||
161516034|NCT01877421|583279944|FG010|Phase 2|Protocol Violation|1|||
161516035|NCT01877421|583279945|FG011|Phase 2|Protocol Violation|0|||
161516036|NCT01877421|583279946|FG012|Phase 2|Protocol Violation|0|||
161516037|NCT01877421|583279947|FG013|Phase 2|Protocol Violation|0|||
161516038|NCT01877421|583279948|FG014|Phase 2|Protocol Violation|0|||
161516039|NCT01877421|583279949|FG015|Phase 2|Protocol Violation|0|||
161516040|NCT01877421|583279950|FG016|Phase 2|Protocol Violation|0|||
161516041|NCT01877421|583279951|FG017|Phase 2|Protocol Violation|0|||
161516042|NCT03698773|583279965|FG000|Overall Study|Lost to Follow-up|2|||
161516043|NCT03698773|583279966|FG001|Overall Study|Lost to Follow-up|1|||
161516044|NCT01158924|583279968|FG000|Overall Study|Withdrawal by Subject|1|||
161516045|NCT01158924|583279969|FG001|Overall Study|Withdrawal by Subject|2|||
161516046|NCT01158924|583279968|FG000|Overall Study|Lost to Follow-up|0|||
161516047|NCT01158924|583279969|FG001|Overall Study|Lost to Follow-up|1|||
161516048|NCT01260922|583279973|FG000|First Intervention|Withdrawal by Subject|0|||
161516049|NCT01260922|583279974|FG001|First Intervention|Withdrawal by Subject|1|||
161516050|NCT01260922|583279973|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
161516051|NCT01260922|583279974|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
161516052|NCT01260922|583279973|FG000|Second Intervention|Emesis|0|||
161516053|NCT01260922|583279974|FG001|Second Intervention|Emesis|2|||
161516054|NCT03732248|583279977|FG000|Overall Study|Withdrawal by Subject|1|||
161516055|NCT03732248|583279978|FG001|Overall Study|Withdrawal by Subject|0|||
161516056|NCT01599650|583279979|FG000|Overall Study|Administrative issue|1|||
161516057|NCT01599650|583279980|FG001|Overall Study|Administrative issue|0|||
161516058|NCT01599650|583279981|FG002|Overall Study|Administrative issue|1|||
161516059|NCT01599650|583279979|FG000|Overall Study|Physician Decision|2|||
161516060|NCT01599650|583279980|FG001|Overall Study|Physician Decision|0|||
161516061|NCT01599650|583279981|FG002|Overall Study|Physician Decision|7|||
161516062|NCT01599650|583279979|FG000|Overall Study|Protocol Violation|0|||
161516063|NCT01599650|583279980|FG001|Overall Study|Protocol Violation|3|||
161516064|NCT01599650|583279981|FG002|Overall Study|Protocol Violation|0|||
161516065|NCT01599650|583279979|FG000|Overall Study|Death|2|||
161516066|NCT01599650|583279980|FG001|Overall Study|Death|1|||
161516067|NCT01599650|583279981|FG002|Overall Study|Death|2|||
161516068|NCT01599650|583279979|FG000|Overall Study|Lost to Follow-up|3|||
161516069|NCT01599650|583279980|FG001|Overall Study|Lost to Follow-up|3|||
161516070|NCT01599650|583279981|FG002|Overall Study|Lost to Follow-up|3|||
161516071|NCT01599650|583279979|FG000|Overall Study|Withdrawal by Subject|11|||
161516072|NCT01599650|583279980|FG001|Overall Study|Withdrawal by Subject|11|||
161516073|NCT01599650|583279981|FG002|Overall Study|Withdrawal by Subject|10|||
161516074|NCT01599650|583279979|FG000|Overall Study|Adverse Event|3|||
161516075|NCT01599650|583279980|FG001|Overall Study|Adverse Event|8|||
161516076|NCT01599650|583279981|FG002|Overall Study|Adverse Event|4|||
161516077|NCT01731171|583279982|FG000|Overall Study|Withdrawal by Subject|4|||
161516078|NCT01731171|583279983|FG001|Overall Study|Withdrawal by Subject|1|||
161516079|NCT01731171|583279982|FG000|Overall Study|Lost to Follow-up|3|||
161516080|NCT01731171|583279983|FG001|Overall Study|Lost to Follow-up|2|||
161516081|NCT01731171|583279982|FG000|Overall Study|Moved out of Area|0|||
161516082|NCT01731171|583279983|FG001|Overall Study|Moved out of Area|2|||
161516083|NCT01731171|583279982|FG000|Overall Study|Terminated for Lack of Adherence|0|||
161516084|NCT01731171|583279983|FG001|Overall Study|Terminated for Lack of Adherence|1|||
161516085|NCT01731171|583279982|FG000|Overall Study|Terminated for Safety Reasons|0|||
161516086|NCT01731171|583279983|FG001|Overall Study|Terminated for Safety Reasons|1|||
161516087|NCT01410110|583279984|FG000|Overall Study|Withdrawal by Subject|4|||
161516088|NCT01410110|583279985|FG001|Overall Study|Withdrawal by Subject|2|||
161516089|NCT00684424|583279986|FG000|Overall Study|Adverse Event|1|||
161516090|NCT00684424|583279986|FG000|Overall Study|Lost to Follow-up|2|||
161516091|NCT00684424|583279986|FG000|Overall Study|Other|2|||
161516092|NCT02520531|583279989|FG000|Overall Study|Revision of study device components|2|||
161677055|NCT00880555|583871982|FG002|Overall Study|Withdrawal by Subject|0|||
161824007|NCT02003222|584397893|FG001|Induction|Other reasons|0|||
161516093|NCT02520531|583279990|FG001|Overall Study|Revision of study device components|2|||
161516094|NCT02520531|583279989|FG000|Overall Study|Death|1|||
161516095|NCT02520531|583279990|FG001|Overall Study|Death|2|||
161516096|NCT02520531|583279989|FG000|Overall Study|Lost to Follow-up|1|||
161516097|NCT02520531|583279990|FG001|Overall Study|Lost to Follow-up|1|||
161516098|NCT02520531|583279989|FG000|Overall Study|Meet exclusion criterion|0|||
161516099|NCT02520531|583279990|FG001|Overall Study|Meet exclusion criterion|1|||
161516100|NCT02520531|583279989|FG000|Overall Study|Withdrawal by Subject|1|||
161516101|NCT02520531|583279990|FG001|Overall Study|Withdrawal by Subject|0|||
161824008|NCT02003222|584397894|FG002|Induction|Other reasons|0|||
161824009|NCT02003222|584397895|FG003|Induction|Other reasons|0|||
161824010|NCT02003222|584397896|FG004|Induction|Other reasons|22|||
161824011|NCT02003222|584397892|FG000|Intensification|Never started treatment|0|||
161824012|NCT02003222|584397893|FG001|Intensification|Never started treatment|0|||
161824013|NCT02003222|584397894|FG002|Intensification|Never started treatment|0|||
161824014|NCT02003222|584397895|FG003|Intensification|Never started treatment|0|||
161824015|NCT02003222|584397896|FG004|Intensification|Never started treatment|2|||
161824016|NCT02003222|584397892|FG000|Intensification|Adverse Event|0|||
161824017|NCT02003222|584397893|FG001|Intensification|Adverse Event|0|||
161824018|NCT02003222|584397894|FG002|Intensification|Adverse Event|0|||
161824019|NCT02003222|584397895|FG003|Intensification|Adverse Event|0|||
161824020|NCT02003222|584397896|FG004|Intensification|Adverse Event|6|||
161824021|NCT02003222|584397892|FG000|Intensification|Alternative therapy|0|||
161824022|NCT02003222|584397893|FG001|Intensification|Alternative therapy|0|||
161824023|NCT02003222|584397894|FG002|Intensification|Alternative therapy|0|||
161824024|NCT02003222|584397895|FG003|Intensification|Alternative therapy|0|||
161824025|NCT02003222|584397896|FG004|Intensification|Alternative therapy|8|||
161824026|NCT02003222|584397892|FG000|Intensification|Disease progression|0|||
161824027|NCT02003222|584397893|FG001|Intensification|Disease progression|0|||
161824028|NCT02003222|584397894|FG002|Intensification|Disease progression|0|||
161824029|NCT02003222|584397895|FG003|Intensification|Disease progression|0|||
161824030|NCT02003222|584397896|FG004|Intensification|Disease progression|18|||
161824031|NCT02003222|584397892|FG000|Intensification|Withdrawal by Subject|0|||
161824032|NCT02003222|584397893|FG001|Intensification|Withdrawal by Subject|0|||
161516102|NCT02520531|583279989|FG000|Overall Study|Not study device|1|||
161516103|NCT02520531|583279990|FG001|Overall Study|Not study device|0|||
161516104|NCT01649856|583279996|FG000|Overall Study|Withdrawal by Subject|14|||
161516105|NCT01649856|583279997|FG001|Overall Study|Withdrawal by Subject|14|||
161516106|NCT01649856|583279996|FG000|Overall Study|Protocol Violation|4|||
161516107|NCT01649856|583279997|FG001|Overall Study|Protocol Violation|4|||
161516108|NCT01649856|583279996|FG000|Overall Study|Treatment Failure|1|||
161516109|NCT01649856|583279997|FG001|Overall Study|Treatment Failure|1|||
161516110|NCT01649856|583279996|FG000|Overall Study|Death|69|||
161516111|NCT01649856|583279997|FG001|Overall Study|Death|34|||
161516112|NCT01649856|583279996|FG000|Overall Study|Stable or Progressed Disease|5|||
161516113|NCT01649856|583279997|FG001|Overall Study|Stable or Progressed Disease|3|||
161516114|NCT01649856|583279996|FG000|Overall Study|Lost to Follow-up|20|||
161516115|NCT01649856|583279997|FG001|Overall Study|Lost to Follow-up|16|||
161516116|NCT01649856|583279996|FG000|Overall Study|Lack of Compliance|6|||
161516117|NCT01649856|583279997|FG001|Overall Study|Lack of Compliance|1|||
161516118|NCT01649856|583279996|FG000|Overall Study|Other|20|||
161516119|NCT01649856|583279997|FG001|Overall Study|Other|5|||
161516120|NCT00281840|583279998|FG000|Overall Study|Adverse Event|12|||
161516121|NCT00281840|583279998|FG000|Overall Study|Physician Decision|6|||
161516122|NCT00281840|583279998|FG000|Overall Study|Withdrawal by Subject|3|||
161516123|NCT00281840|583279998|FG000|Overall Study|Disease Progression|2|||
161516124|NCT00281840|583279998|FG000|Overall Study|exceed maximum delay in treatment|1|||
161516125|NCT00281840|583279998|FG000|Overall Study|Complicating Disease|1|||
161516126|NCT00835406|583279999|FG000|Period: First Intervention|Adverse Event|0|||
161516127|NCT00835406|583280000|FG001|Period: First Intervention|Adverse Event|1|||
161516128|NCT00835406|583279999|FG000|Period: First Intervention|Withdrawal by Subject|2|||
161516129|NCT00835406|583280000|FG001|Period: First Intervention|Withdrawal by Subject|0|||
161516130|NCT00835406|583279999|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
161516131|NCT00835406|583280000|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
161516132|NCT02138214|583280001|FG000|Overall Study|Withdrawal by Subject|0|||
161516133|NCT02138214|583280002|FG001|Overall Study|Withdrawal by Subject|1|||
161516134|NCT02138214|583280003|FG002|Overall Study|Withdrawal by Subject|0|||
161516135|NCT02138214|583280001|FG000|Overall Study|Lost to Follow-up|0|||
161516136|NCT02138214|583280002|FG001|Overall Study|Lost to Follow-up|2|||
161516137|NCT02138214|583280003|FG002|Overall Study|Lost to Follow-up|4|||
161516138|NCT02138214|583280001|FG000|Overall Study|Screen Failure|0|||
161516139|NCT02138214|583280002|FG001|Overall Study|Screen Failure|1|||
161516140|NCT02138214|583280003|FG002|Overall Study|Screen Failure|0|||
161516141|NCT02185768|583280004|FG000|Overall Study|Patients were not treated|2|||
161516142|NCT01079234|583280005|FG000|Main: Week 0 to 26|Adverse Event|5|||
161516143|NCT01079234|583280006|FG001|Main: Week 0 to 26|Adverse Event|4|||
161516144|NCT01079234|583280007|FG002|Main: Week 0 to 26|Adverse Event|1|||
161516145|NCT01079234|583280008|FG003|Main: Week 0 to 26|Adverse Event|0|||
161516146|NCT01079234|583280005|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
161516147|NCT01079234|583280006|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
161516148|NCT01079234|583280007|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
161516149|NCT01079234|583280008|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
161516150|NCT01079234|583280005|FG000|Main: Week 0 to 26|Protocol Violation|6|||
161516151|NCT01079234|583280006|FG001|Main: Week 0 to 26|Protocol Violation|2|||
161516152|NCT01079234|583280007|FG002|Main: Week 0 to 26|Protocol Violation|4|||
161516153|NCT01079234|583280008|FG003|Main: Week 0 to 26|Protocol Violation|0|||
161516154|NCT01079234|583280005|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
161516155|NCT01079234|583280006|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
161516156|NCT01079234|583280007|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
161516157|NCT01079234|583280008|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
161516158|NCT01079234|583280005|FG000|Main: Week 0 to 26|Unclassified|7|||
161516159|NCT01079234|583280006|FG001|Main: Week 0 to 26|Unclassified|13|||
161516160|NCT01079234|583280007|FG002|Main: Week 0 to 26|Unclassified|4|||
161516161|NCT01079234|583280008|FG003|Main: Week 0 to 26|Unclassified|0|||
161516162|NCT01079234|583280005|FG000|Extension: Week 27 to 52|Adverse Event|0|||
161516163|NCT01079234|583280006|FG001|Extension: Week 27 to 52|Adverse Event|0|||
161516164|NCT01079234|583280007|FG002|Extension: Week 27 to 52|Adverse Event|1|||
161516165|NCT01079234|583280008|FG003|Extension: Week 27 to 52|Adverse Event|0|||
161516166|NCT01079234|583280005|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
161516167|NCT01079234|583280006|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
161516168|NCT01079234|583280007|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
161516169|NCT01079234|583280008|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
161516170|NCT01079234|583280005|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
161516171|NCT01079234|583280006|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
161516172|NCT01079234|583280007|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
161516173|NCT01079234|583280008|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
161516174|NCT01079234|583280005|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
161516175|NCT01079234|583280006|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
161516176|NCT01079234|583280007|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
161516177|NCT01079234|583280008|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
161516178|NCT01079234|583280005|FG000|Extension: Week 27 to 52|Unclassified|0|||
161516179|NCT01079234|583280006|FG001|Extension: Week 27 to 52|Unclassified|0|||
161516180|NCT01079234|583280007|FG002|Extension: Week 27 to 52|Unclassified|4|||
161516181|NCT01079234|583280008|FG003|Extension: Week 27 to 52|Unclassified|7|||
161516182|NCT02707640|583280010|FG000|Overall Study|Adverse Event|4|||
161516183|NCT02707640|583280011|FG001|Overall Study|Adverse Event|2|||
161516184|NCT02707640|583280010|FG000|Overall Study|Death|1|||
161516185|NCT02707640|583280011|FG001|Overall Study|Death|2|||
161516186|NCT02707640|583280010|FG000|Overall Study|Physician Decision|2|||
161516187|NCT02707640|583280011|FG001|Overall Study|Physician Decision|0|||
161516188|NCT02707640|583280010|FG000|Overall Study|Withdrawal by Subject|0|||
161516189|NCT02707640|583280011|FG001|Overall Study|Withdrawal by Subject|1|||
161516190|NCT02707640|583280010|FG000|Overall Study|Participant's Personal Decision|1|||
161516191|NCT02707640|583280011|FG001|Overall Study|Participant's Personal Decision|2|||
161516192|NCT02707640|583280010|FG000|Overall Study|Sponsor Discretion|1|||
161516193|NCT02707640|583280011|FG001|Overall Study|Sponsor Discretion|0|||
161516194|NCT02517905|583280012|FG000|Overall Study|Lost to Follow-up|4|||
161516195|NCT02517905|583280013|FG001|Overall Study|Lost to Follow-up|0|||
161516196|NCT02517905|583280012|FG000|Overall Study|Withdrawal by Subject|4|||
161931960|NCT00147537|584798779|FG005|Phase 1b|Death|2|||
161931961|NCT00147537|584798780|FG006|Phase 1b|Death|1|||
161516197|NCT02517905|583280013|FG001|Overall Study|Withdrawal by Subject|0|||
161516198|NCT02517905|583280012|FG000|Overall Study|Screen failure|2|||
161516199|NCT02517905|583280013|FG001|Overall Study|Screen failure|2|||
161516200|NCT00023452|583280014|FG000|Overall Study|Ineligible for Study|163|||
161516201|NCT00023452|583280015|FG001|Overall Study|Ineligible for Study|159|||
161516202|NCT00023452|583280014|FG000|Overall Study|Out of Window|129|||
161516203|NCT00023452|583280015|FG001|Overall Study|Out of Window|69|||
161516204|NCT00023452|583280014|FG000|Overall Study|Death|2|||
161516205|NCT00023452|583280015|FG001|Overall Study|Death|0|||
161516206|NCT00023452|583280014|FG000|Overall Study|Withdrawal by Subject|66|||
161516207|NCT00023452|583280015|FG001|Overall Study|Withdrawal by Subject|54|||
161516208|NCT00023452|583280014|FG000|Overall Study|Adverse Event|139|||
161516209|NCT00023452|583280015|FG001|Overall Study|Adverse Event|196|||
161516210|NCT00023452|583280014|FG000|Overall Study|Lost to Follow-up|293|||
161516211|NCT00023452|583280015|FG001|Overall Study|Lost to Follow-up|60|||
161516212|NCT00023452|583280014|FG000|Overall Study|Physician Decision|49|||
161516213|NCT00023452|583280015|FG001|Overall Study|Physician Decision|21|||
161516214|NCT00023452|583280014|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
161516215|NCT00023452|583280015|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
161516216|NCT00023452|583280014|FG000|Overall Study|Pregnant|53|||
161516217|NCT00023452|583280015|FG001|Overall Study|Pregnant|20|||
161516218|NCT00023452|583280014|FG000|Overall Study|Other|204|||
161516219|NCT00023452|583280015|FG001|Overall Study|Other|69|||
161516220|NCT05789875|583280016|FG000|Overall Study|Lost to Follow-up|6|||
161516221|NCT01994395|583280017|FG000|Overall Study|Withdrawal by Subject|1|||
161516222|NCT01994395|583280018|FG001|Overall Study|Withdrawal by Subject|2|||
161516223|NCT00459134|583280026|FG000|Overall Study|Physician Decision|1|||
161516224|NCT00459134|583280027|FG001|Overall Study|Physician Decision|1|||
161516225|NCT00459134|583280026|FG000|Overall Study|Withdrawal by Subject|8|||
161516226|NCT00459134|583280027|FG001|Overall Study|Withdrawal by Subject|7|||
161516227|NCT00459134|583280026|FG000|Overall Study|Lost to Follow-up|6|||
161516228|NCT00459134|583280027|FG001|Overall Study|Lost to Follow-up|7|||
161516229|NCT00459134|583280026|FG000|Overall Study|Surgery|1|||
161516230|NCT00459134|583280027|FG001|Overall Study|Surgery|2|||
161516231|NCT00459134|583280026|FG000|Overall Study|Toxicity|4|||
161516232|NCT00459134|583280027|FG001|Overall Study|Toxicity|5|||
161516233|NCT00459134|583280026|FG000|Overall Study|Progression|1|||
161516234|NCT00459134|583280027|FG001|Overall Study|Progression|0|||
161516235|NCT00459134|583280026|FG000|Overall Study|Multiple Reasons|2|||
161516236|NCT00459134|583280027|FG001|Overall Study|Multiple Reasons|3|||
161516237|NCT03333486|583280028|FG000|Overall Study|Withdrawal by Subject|1|||
161516238|NCT03333486|583280028|FG000|Overall Study|Lost to Follow-up|1|||
161516239|NCT01755416|583280032|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
161516240|NCT01755416|583280033|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
161677056|NCT00880555|583871983|FG003|Overall Study|Withdrawal by Subject|0|||
161588810|NCT01261312|583544592|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588811|NCT01261312|583544593|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588812|NCT01261312|583544594|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161588813|NCT01261312|583544595|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161677057|NCT00880555|583871984|FG004|Overall Study|Withdrawal by Subject|0|||
161677058|NCT00880555|583871985|FG005|Overall Study|Withdrawal by Subject|0|||
161677059|NCT00880555|583871980|FG000|Overall Study|Lack of resources (hired rater)|9|||
161677060|NCT00880555|583871981|FG001|Overall Study|Lack of resources (hired rater)|7|||
161677061|NCT00880555|583871982|FG002|Overall Study|Lack of resources (hired rater)|5|||
161677062|NCT00880555|583871983|FG003|Overall Study|Lack of resources (hired rater)|0|||
161677063|NCT00880555|583871984|FG004|Overall Study|Lack of resources (hired rater)|0|||
161931962|NCT00147537|584798781|FG007|Phase 1b|Death|3|||
161931963|NCT00147537|584798782|FG008|Phase 1b|Death|9|||
161677064|NCT00880555|583871985|FG005|Overall Study|Lack of resources (hired rater)|0|||
161677065|NCT00880555|583871980|FG000|Overall Study|Death|0|||
161677066|NCT00880555|583871981|FG001|Overall Study|Death|0|||
161677067|NCT00880555|583871982|FG002|Overall Study|Death|0|||
161677068|NCT00880555|583871983|FG003|Overall Study|Death|0|||
161677069|NCT00880555|583871984|FG004|Overall Study|Death|0|||
161677070|NCT00880555|583871985|FG005|Overall Study|Death|1|||
161677071|NCT00880555|583871980|FG000|Overall Study|Lost to Follow-up|0|||
161677072|NCT00880555|583871981|FG001|Overall Study|Lost to Follow-up|1|||
161677073|NCT00880555|583871982|FG002|Overall Study|Lost to Follow-up|0|||
161677074|NCT00880555|583871983|FG003|Overall Study|Lost to Follow-up|0|||
161677075|NCT00880555|583871984|FG004|Overall Study|Lost to Follow-up|0|||
161677076|NCT00880555|583871985|FG005|Overall Study|Lost to Follow-up|0|||
161677077|NCT04196803|583871986|FG000|Overall Study|Withdrawal by Subject|1|||
161677078|NCT04196803|583871987|FG001|Overall Study|Withdrawal by Subject|3|||
161677079|NCT04196803|583871986|FG000|Overall Study|Adverse Event|4|||
161677080|NCT04196803|583871987|FG001|Overall Study|Adverse Event|2|||
161677081|NCT04196803|583871986|FG000|Overall Study|Lost to Follow-up|0|||
161677082|NCT04196803|583871987|FG001|Overall Study|Lost to Follow-up|1|||
161677083|NCT01168973|583871988|FG000|Overall Study|Progressive Disease|341|||
161516268|NCT02805257|583282561|FG000|Overall Study|Lost to Follow-up|7|||
161516269|NCT02805257|583282562|FG001|Overall Study|Lost to Follow-up|6|||
161516270|NCT02805257|583282561|FG000|Overall Study|Death|0|||
161516271|NCT02805257|583282562|FG001|Overall Study|Death|1|||
161516272|NCT00612066|583282563|FG000|Overall Study|Adverse Event|1|||
161516273|NCT01043874|583282566|FG000|Overall Study|Adverse Event|3|||
161516274|NCT01043874|583282566|FG000|Overall Study|Withdrawal by Subject|1|||
161516275|NCT01043874|583282566|FG000|Overall Study|Lack of Efficacy|1|||
161516276|NCT01043874|583282566|FG000|Overall Study|Administrative Problems|1|||
161516277|NCT01337089|583282567|FG000|Overall Study|Adverse Event|237|||
161516278|NCT01337089|583282567|FG000|Overall Study|Withdrawal by Subject|129|||
161516279|NCT01337089|583282567|FG000|Overall Study|Withdrawal by Investigator|33|||
161516280|NCT01337089|583282567|FG000|Overall Study|Met Withdrawal Criteria|3|||
161516281|NCT01337089|583282567|FG000|Overall Study|Lost to Follow-up|2|||
161516282|NCT01404312|583282568|FG000|Overall Study|Death|21|||
161516283|NCT01404312|583282569|FG001|Overall Study|Death|27|||
161516284|NCT01404312|583282568|FG000|Overall Study|Withdrawal by Subject|15|||
161516285|NCT01404312|583282569|FG001|Overall Study|Withdrawal by Subject|18|||
161516286|NCT01404312|583282568|FG000|Overall Study|Participant Unable to get to clinic|93|||
161516287|NCT01404312|583282569|FG001|Overall Study|Participant Unable to get to clinic|103|||
161516288|NCT01404312|583282568|FG000|Overall Study|Lost to Follow-up|115|||
161516289|NCT01404312|583282569|FG001|Overall Study|Lost to Follow-up|111|||
161516290|NCT01404312|583282568|FG000|Overall Study|Site closed|22|||
161516291|NCT01404312|583282569|FG001|Overall Study|Site closed|21|||
161516292|NCT01404312|583282568|FG000|Overall Study|Participant not willing to adhere to req|31|||
161516293|NCT01404312|583282569|FG001|Overall Study|Participant not willing to adhere to req|29|||
161516294|NCT01404312|583282568|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161516295|NCT01404312|583282569|FG001|Overall Study|Severe debilitation, unable to continue|2|||
161516296|NCT02627677|583282571|FG000|Overall Study|Adverse event (not progressive disease)|1|||
161516297|NCT02627677|583282572|FG001|Overall Study|Adverse event (not progressive disease)|4|||
161516298|NCT02627677|583282573|FG002|Overall Study|Adverse event (not progressive disease)|1|||
161516299|NCT02627677|583282571|FG000|Overall Study|Progressive disease|1|||
161516300|NCT02627677|583282572|FG001|Overall Study|Progressive disease|3|||
161516301|NCT02627677|583282573|FG002|Overall Study|Progressive disease|0|||
161516302|NCT02627677|583282571|FG000|Overall Study|Lack of Efficacy|1|||
161516303|NCT02627677|583282572|FG001|Overall Study|Lack of Efficacy|2|||
161516304|NCT02627677|583282573|FG002|Overall Study|Lack of Efficacy|0|||
161516305|NCT02627677|583282571|FG000|Overall Study|Lost to Follow-up|0|||
161588814|NCT01261312|583544596|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161824033|NCT02003222|584397894|FG002|Intensification|Withdrawal by Subject|0|||
161824034|NCT02003222|584397895|FG003|Intensification|Withdrawal by Subject|0|||
161824035|NCT02003222|584397896|FG004|Intensification|Withdrawal by Subject|5|||
161516306|NCT02627677|583282572|FG001|Overall Study|Lost to Follow-up|0|||
161516307|NCT02627677|583282573|FG002|Overall Study|Lost to Follow-up|1|||
161516308|NCT02627677|583282571|FG000|Overall Study|Pregnancy|0|||
161516309|NCT02627677|583282572|FG001|Overall Study|Pregnancy|1|||
161516310|NCT02627677|583282573|FG002|Overall Study|Pregnancy|0|||
161516311|NCT02627677|583282571|FG000|Overall Study|Study Terminated by Sponsor|5|||
161516312|NCT02627677|583282572|FG001|Overall Study|Study Terminated by Sponsor|10|||
161516313|NCT02627677|583282573|FG002|Overall Study|Study Terminated by Sponsor|6|||
161516314|NCT02627677|583282571|FG000|Overall Study|Physician Decision|0|||
161677084|NCT01168973|583871989|FG001|Overall Study|Progressive Disease|429|||
161824036|NCT02003222|584397892|FG000|Intensification|Other reasons|0|||
161677085|NCT01168973|583871988|FG000|Overall Study|Adverse Event|94|||
161677086|NCT01168973|583871989|FG001|Overall Study|Adverse Event|55|||
161677087|NCT01168973|583871988|FG000|Overall Study|Withdrawal by Subject|90|||
161677088|NCT01168973|583871989|FG001|Overall Study|Withdrawal by Subject|53|||
161677089|NCT01168973|583871988|FG000|Overall Study|Death|42|||
161824037|NCT02003222|584397893|FG001|Intensification|Other reasons|0|||
161516315|NCT02627677|583282572|FG001|Overall Study|Physician Decision|0|||
161516316|NCT02627677|583282573|FG002|Overall Study|Physician Decision|2|||
161516317|NCT02627677|583282571|FG000|Overall Study|Withdrawal by Subject|2|||
161516318|NCT02627677|583282572|FG001|Overall Study|Withdrawal by Subject|1|||
161516319|NCT02627677|583282573|FG002|Overall Study|Withdrawal by Subject|1|||
161516320|NCT02627677|583282571|FG000|Overall Study|Reason not Specified|0|||
161516321|NCT02627677|583282572|FG001|Overall Study|Reason not Specified|0|||
161516322|NCT02627677|583282573|FG002|Overall Study|Reason not Specified|1|||
161516323|NCT02627677|583282571|FG000|Overall Study|Randomized but not Treated|1|||
161516324|NCT02627677|583282572|FG001|Overall Study|Randomized but not Treated|0|||
161516325|NCT02627677|583282573|FG002|Overall Study|Randomized but not Treated|0|||
161516326|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Adverse Event|5|||
161516327|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Adverse Event|8|||
161516328|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Adverse Event|4|||
161516329|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Adverse Event|8|||
161516330|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
161516331|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
161516332|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
161824038|NCT02003222|584397894|FG002|Intensification|Other reasons|0|||
161824039|NCT02003222|584397895|FG003|Intensification|Other reasons|0|||
161516333|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
161516334|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
161516335|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
161516336|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
161516337|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
161516338|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Physician Decision|1|||
161516339|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Physician Decision|0|||
161516340|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Physician Decision|0|||
161516341|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Physician Decision|0|||
161516342|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
161516343|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
161516344|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
161516345|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
161516346|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Pregnancy|0|||
161516347|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Pregnancy|1|||
161516348|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Pregnancy|0|||
161516349|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Pregnancy|0|||
161516350|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
161516351|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
161516352|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
161516353|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
161516354|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Death|0|||
161516355|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Death|1|||
161516356|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Death|0|||
161516357|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Death|0|||
161516358|NCT00071487|583282579|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
161516359|NCT00071487|583282580|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
161516360|NCT00071487|583282581|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
161516361|NCT00071487|583282582|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
161516362|NCT00071487|583282579|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
161516363|NCT00071487|583282580|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
161516364|NCT00071487|583282581|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
161516365|NCT00071487|583282582|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
161516366|NCT00071487|583282579|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
161516367|NCT00071487|583282580|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
161588815|NCT01261312|583544597|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161824040|NCT02003222|584397896|FG004|Intensification|Other reasons|8|||
161824041|NCT04941768|584397901|FG000|Overall Study|Lost to Follow-up|10|||
161824042|NCT04941768|584397901|FG000|Overall Study|Death|24|||
161824043|NCT04941768|584397901|FG000|Overall Study|Progressive Disease|4|||
161824044|NCT04941768|584397901|FG000|Overall Study|Withdrawal by Subject|4|||
161824045|NCT04941768|584397901|FG000|Overall Study|Other|3|||
161824046|NCT04941768|584397901|FG000|Overall Study|Treatment ongoing|21|||
161824047|NCT04941768|584397901|FG000|Overall Study|Off treatment and in follow-up|21|||
161824048|NCT03302078|584397903|FG000|Washout Period|Adverse Event|0|||
161824049|NCT03302078|584397904|FG001|Washout Period|Adverse Event|1|||
161824050|NCT01886872|584397905|FG000|Overall Study|Ineligible|7|||
161824051|NCT01886872|584397906|FG001|Overall Study|Ineligible|4|||
161824052|NCT01886872|584397907|FG002|Overall Study|Ineligible|12|||
161824053|NCT05148299|584397908|FG000|Treatment Period|Adverse Event|1|||
161824054|NCT05148299|584397908|FG000|Treatment Period|Physician Decision|1|||
161824055|NCT05148299|584397908|FG000|Treatment Period|Death|1|||
161824056|NCT05148299|584397908|FG000|Follow-up Period|Death|3|||
161824057|NCT01957150|584397909|FG000|Overall Study|Adverse Event|23|||
161824058|NCT01957150|584397910|FG001|Overall Study|Adverse Event|20|||
161677090|NCT01168973|583871989|FG001|Overall Study|Death|45|||
161677091|NCT01168973|583871988|FG000|Overall Study|Physician Decision|37|||
161677092|NCT01168973|583871989|FG001|Overall Study|Physician Decision|19|||
161677093|NCT01168973|583871988|FG000|Overall Study|Sponsor Decision|2|||
161677094|NCT01168973|583871989|FG001|Overall Study|Sponsor Decision|1|||
161677095|NCT01168973|583871988|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
161677096|NCT01168973|583871989|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
161677097|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Adverse Event|2|||
161677098|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Adverse Event|2|||
161516368|NCT00071487|583282581|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
161516369|NCT00071487|583282582|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
161516370|NCT00071487|583282579|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161516371|NCT00071487|583282580|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161516372|NCT00071487|583282581|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161516373|NCT00071487|583282582|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
161516374|NCT00071487|583282579|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
161516375|NCT00071487|583282580|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
161516376|NCT00071487|583282581|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
161516377|NCT00071487|583282582|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
161516378|NCT00071487|583282579|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
161516379|NCT00071487|583282580|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
161516380|NCT00071487|583282581|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
161516381|NCT00071487|583282582|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
161516382|NCT00071487|583282579|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
161516383|NCT00071487|583282580|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
161516384|NCT00071487|583282581|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
161516385|NCT00071487|583282582|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
161516386|NCT01073618|583282587|FG000|Overall Study|Death|208|||
161516387|NCT01073618|583282587|FG000|Overall Study|Adverse Event|19|||
161516388|NCT01073618|583282587|FG000|Overall Study|Other|80|||
161516389|NCT02696850|583282588|FG000|Overall Study|Withdrawal by Subject|3|||
161588816|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588817|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588818|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588819|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
161588820|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
161588821|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
161588822|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588823|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588824|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588825|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161677099|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Adverse Event|4|||
161677100|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Adverse Event|0|||
161677101|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Adverse Event|0|||
161677102|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Progressive disease|0|||
161677103|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Progressive disease|0|||
161677104|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Progressive disease|1|||
161677105|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Progressive disease|0|||
161677106|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Progressive disease|0|||
161677107|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
161677108|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
161677109|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
161931964|NCT00147537|584798783|FG009|Phase 1b|Death|0|||
161931965|NCT00147537|584798784|FG010|Phase 1b|Death|0|||
161931966|NCT00147537|584798774|FG000|Phase 1b|Lost to Follow-up|2|||
161931967|NCT00147537|584798775|FG001|Phase 1b|Lost to Follow-up|1|||
161931968|NCT00147537|584798776|FG002|Phase 1b|Lost to Follow-up|0|||
161931969|NCT00147537|584798777|FG003|Phase 1b|Lost to Follow-up|0|||
161931970|NCT00147537|584798778|FG004|Phase 1b|Lost to Follow-up|0|||
161931971|NCT00147537|584798779|FG005|Phase 1b|Lost to Follow-up|0|||
161516390|NCT02696850|583282589|FG001|Overall Study|Withdrawal by Subject|3|||
161516391|NCT02696850|583282588|FG000|Overall Study|Lost to Follow-up|8|||
161516392|NCT02696850|583282589|FG001|Overall Study|Lost to Follow-up|5|||
161516393|NCT00673049|583282592|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
161516394|NCT00673049|583282593|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
161588826|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588827|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161677110|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
161677111|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
161677112|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
161931972|NCT00147537|584798780|FG006|Phase 1b|Lost to Follow-up|2|||
161516395|NCT00673049|583282594|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
161677113|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677114|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677115|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677116|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677117|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
161677118|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
161677119|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
161516396|NCT00673049|583282595|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
161516397|NCT00673049|583282592|FG000|Before Progression on Erlotinib|Death|235|||
161516398|NCT00673049|583282593|FG001|Before Progression on Erlotinib|Death|167|||
161516399|NCT00673049|583282594|FG002|Before Progression on Erlotinib|Death|1|||
161516400|NCT00673049|583282595|FG003|Before Progression on Erlotinib|Death|0|||
161516401|NCT00673049|583282592|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
161516402|NCT00673049|583282593|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
161516403|NCT00673049|583282594|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
161516404|NCT00673049|583282595|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
161516405|NCT00673049|583282592|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
161516406|NCT00673049|583282593|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
161516407|NCT00673049|583282594|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
161516408|NCT00673049|583282595|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
161516409|NCT00673049|583282592|FG000|Before Progression on Erlotinib|Other|1|||
161516410|NCT00673049|583282593|FG001|Before Progression on Erlotinib|Other|2|||
161516411|NCT00673049|583282594|FG002|Before Progression on Erlotinib|Other|0|||
161516412|NCT00673049|583282595|FG003|Before Progression on Erlotinib|Other|0|||
161516413|NCT00673049|583282592|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
161516414|NCT00673049|583282593|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
161516415|NCT00673049|583282594|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
161516416|NCT00673049|583282595|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
161516417|NCT00673049|583282592|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
161516418|NCT00673049|583282593|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
161516419|NCT00673049|583282594|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
161516420|NCT00673049|583282595|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
161516421|NCT00673049|583282592|FG000|After Progression on Erlotinib|Death|0|||
161516422|NCT00673049|583282593|FG001|After Progression on Erlotinib|Death|0|||
161516423|NCT00673049|583282594|FG002|After Progression on Erlotinib|Death|0|||
161516424|NCT00673049|583282595|FG003|After Progression on Erlotinib|Death|71|||
161516425|NCT00673049|583282592|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
161516426|NCT00673049|583282593|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
161516427|NCT00673049|583282594|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
161516428|NCT00673049|583282595|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
161516429|NCT00673049|583282592|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
161516430|NCT00673049|583282593|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
161516431|NCT00673049|583282594|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
161516432|NCT00673049|583282595|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
161516433|NCT00673049|583282592|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
161516434|NCT00673049|583282593|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
161516435|NCT00673049|583282594|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
161516436|NCT00673049|583282595|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
161516437|NCT02044510|583282596|FG000|Overall Study|Adverse Event|1|||
161516438|NCT02044510|583282597|FG001|Overall Study|Adverse Event|2|||
161516439|NCT00975975|583282604|FG000|Overall Study|Death|6|||
161516440|NCT04265755|583282607|FG000|Overall Study|Withdrawal by Subject|39|||
161516441|NCT04265755|583282607|FG000|Overall Study|Decision by sponsor|2|||
161516442|NCT04265755|583282607|FG000|Overall Study|Lost to Follow-up|11|||
161516443|NCT04265755|583282607|FG000|Overall Study|Death|1|||
161516444|NCT01863446|583282610|FG000|Overall Study|Withdrawal by Subject|1|||
161516445|NCT01863446|583282611|FG001|Overall Study|Withdrawal by Subject|0|||
161516446|NCT01863446|583282612|FG002|Overall Study|Withdrawal by Subject|1|||
161516447|NCT01863446|583282613|FG003|Overall Study|Withdrawal by Subject|2|||
161516448|NCT01863446|583282610|FG000|Overall Study|Physician Decision|0|||
161516449|NCT01863446|583282611|FG001|Overall Study|Physician Decision|0|||
161516450|NCT01863446|583282612|FG002|Overall Study|Physician Decision|1|||
161677120|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
161677121|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
161824059|NCT01957150|584397909|FG000|Overall Study|Withdrawal by Subject|13|||
161824060|NCT01957150|584397910|FG001|Overall Study|Withdrawal by Subject|17|||
161516451|NCT01863446|583282613|FG003|Overall Study|Physician Decision|0|||
161516452|NCT02554773|583282614|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
161516453|NCT02554773|583282615|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
161516454|NCT02554773|583282614|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
161677122|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
161931973|NCT00147537|584798781|FG007|Phase 1b|Lost to Follow-up|0|||
161516455|NCT02554773|583282615|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
161516456|NCT02554773|583282614|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
161516457|NCT02554773|583282615|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
161516458|NCT02554773|583282614|FG000|Original Dose Regimen (SAS 1)|Death|1|||
161516459|NCT02554773|583282615|FG001|Original Dose Regimen (SAS 1)|Death|0|||
161516460|NCT02554773|583282614|FG000|Original Dose Regimen (SAS 1)|Other|4|||
161516461|NCT02554773|583282615|FG001|Original Dose Regimen (SAS 1)|Other|0|||
161516462|NCT02554773|583282614|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
161516463|NCT02554773|583282615|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
161516464|NCT02554773|583282614|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
161516465|NCT02554773|583282615|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
161516466|NCT02554773|583282614|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
161516467|NCT02554773|583282615|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
161516468|NCT02554773|583282614|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
161516469|NCT02554773|583282615|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
161516470|NCT02956629|583282619|FG000|Overall Study|Adverse Event|0|||
161516471|NCT02956629|583282620|FG001|Overall Study|Adverse Event|0|||
161516472|NCT02956629|583282621|FG002|Overall Study|Adverse Event|1|||
161516473|NCT02956629|583282622|FG003|Overall Study|Adverse Event|0|||
161516474|NCT02956629|583282623|FG004|Overall Study|Adverse Event|0|||
161516475|NCT02956629|583282624|FG005|Overall Study|Adverse Event|0|||
161516476|NCT02956629|583282619|FG000|Overall Study|Lost to Follow-up|2|||
161516477|NCT02956629|583282620|FG001|Overall Study|Lost to Follow-up|5|||
161516478|NCT02956629|583282621|FG002|Overall Study|Lost to Follow-up|3|||
161516479|NCT02956629|583282622|FG003|Overall Study|Lost to Follow-up|1|||
161516480|NCT02956629|583282623|FG004|Overall Study|Lost to Follow-up|0|||
161516481|NCT02956629|583282624|FG005|Overall Study|Lost to Follow-up|1|||
161516482|NCT02956629|583282619|FG000|Overall Study|Withdrawal by Subject|3|||
161516483|NCT02956629|583282620|FG001|Overall Study|Withdrawal by Subject|1|||
161516484|NCT02956629|583282621|FG002|Overall Study|Withdrawal by Subject|0|||
161516485|NCT02956629|583282622|FG003|Overall Study|Withdrawal by Subject|0|||
161516486|NCT02956629|583282623|FG004|Overall Study|Withdrawal by Subject|0|||
161516487|NCT02956629|583282624|FG005|Overall Study|Withdrawal by Subject|0|||
161516488|NCT03224468|583282628|FG000|Overall Study|Did not obtain MM card|53|||
161516489|NCT03224468|583282629|FG001|Overall Study|Did not obtain MM card|0|||
161516490|NCT03224468|583282628|FG000|Overall Study|Lost to Follow-up|4|||
161516491|NCT03224468|583282629|FG001|Overall Study|Lost to Follow-up|11|||
161516492|NCT03224468|583282628|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
161516493|NCT03224468|583282629|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
161516494|NCT04713748|583282630|FG000|Overall Study|Not enough kits allocated|35|||
161516495|NCT00406029|583282631|FG000|Overall Study|Adverse Event|12|||
161516496|NCT00406029|583282632|FG001|Overall Study|Adverse Event|2|||
161516497|NCT00406029|583282633|FG002|Overall Study|Adverse Event|5|||
161516498|NCT00406029|583282634|FG003|Overall Study|Adverse Event|10|||
161516499|NCT00406029|583282635|FG004|Overall Study|Adverse Event|7|||
161516500|NCT00406029|583282631|FG000|Overall Study|Withdrawal by Subject|3|||
161516501|NCT00406029|583282632|FG001|Overall Study|Withdrawal by Subject|4|||
161516502|NCT00406029|583282633|FG002|Overall Study|Withdrawal by Subject|2|||
161516503|NCT00406029|583282634|FG003|Overall Study|Withdrawal by Subject|2|||
161516504|NCT00406029|583282635|FG004|Overall Study|Withdrawal by Subject|0|||
161516505|NCT00406029|583282631|FG000|Overall Study|Protocol Violation|1|||
161516506|NCT00406029|583282632|FG001|Overall Study|Protocol Violation|2|||
161516507|NCT00406029|583282633|FG002|Overall Study|Protocol Violation|0|||
161516508|NCT00406029|583282634|FG003|Overall Study|Protocol Violation|2|||
161516509|NCT00406029|583282635|FG004|Overall Study|Protocol Violation|0|||
161516510|NCT00406029|583282631|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161516511|NCT00406029|583282632|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161516512|NCT00406029|583282633|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
161516513|NCT00406029|583282634|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
161516514|NCT00406029|583282635|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
161824061|NCT01957150|584397909|FG000|Overall Study|Physician Decision|3|||
161824062|NCT01957150|584397910|FG001|Overall Study|Physician Decision|6|||
161824063|NCT01957150|584397909|FG000|Overall Study|Lost to Follow-up|4|||
161824064|NCT01957150|584397910|FG001|Overall Study|Lost to Follow-up|4|||
161824065|NCT01957150|584397909|FG000|Overall Study|Protocol Violation|1|||
161516515|NCT00406029|583282631|FG000|Overall Study|Randomized in Error|0|||
161516516|NCT00406029|583282632|FG001|Overall Study|Randomized in Error|0|||
161824066|NCT01957150|584397910|FG001|Overall Study|Protocol Violation|0|||
161824067|NCT01957150|584397909|FG000|Overall Study|Lack of Efficacy|11|||
161516517|NCT00406029|583282633|FG002|Overall Study|Randomized in Error|2|||
161516518|NCT00406029|583282634|FG003|Overall Study|Randomized in Error|3|||
161516519|NCT00406029|583282635|FG004|Overall Study|Randomized in Error|1|||
161516520|NCT04067141|583282636|FG000|First Intervention|Withdrawal by Subject|0|||
161516521|NCT04067141|583282637|FG001|First Intervention|Withdrawal by Subject|1|||
161824068|NCT01957150|584397910|FG001|Overall Study|Lack of Efficacy|11|||
161931974|NCT00147537|584798782|FG008|Phase 1b|Lost to Follow-up|1|||
161931975|NCT00147537|584798783|FG009|Phase 1b|Lost to Follow-up|0|||
161516522|NCT04067141|583282636|FG000|Second Intervention|Adverse Event|0|||
161516523|NCT04067141|583282637|FG001|Second Intervention|Adverse Event|2|||
161516524|NCT01557946|583282638|FG000|Overall Study|Adverse Event|3|||
161516525|NCT01557946|583282639|FG001|Overall Study|Adverse Event|0|||
161516526|NCT02822794|583282640|FG000|Overall Study|Withdrew Consent|1|||
161516527|NCT02822794|583282641|FG001|Overall Study|Withdrew Consent|0|||
161516528|NCT04788147|583282642|FG000|Overall Study|Screen Failure|3|||
161516529|NCT04788147|583282643|FG001|Overall Study|Screen Failure|10|||
161516530|NCT04788147|583282642|FG000|Overall Study|Incomplete RMRS image session|2|||
161516531|NCT04788147|583282643|FG001|Overall Study|Incomplete RMRS image session|0|||
161516532|NCT02266381|583282644|FG000|Overall Study|Physician Decision|3|||
161516533|NCT02266381|583282645|FG001|Overall Study|Physician Decision|5|||
161516534|NCT02266381|583282646|FG002|Overall Study|Physician Decision|4|||
161516535|NCT05101252|583282647|FG000|Overall Study|Unsatisfactory Test Article|1|||
161516536|NCT05101252|583282648|FG001|Overall Study|Unsatisfactory Test Article|0|||
161516537|NCT05101252|583282647|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161516538|NCT05101252|583282648|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
161516539|NCT05101252|583282647|FG000|Overall Study|Withdrew Consent during study|0|||
161516540|NCT05101252|583282648|FG001|Overall Study|Withdrew Consent during study|1|||
161516541|NCT05101252|583282647|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
161516542|NCT05101252|583282648|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
161516543|NCT03221257|583282653|FG000|Overall Study|Lost to Follow-up|0|||
161516544|NCT03221257|583282654|FG001|Overall Study|Lost to Follow-up|1|||
161516545|NCT03221257|583282653|FG000|Overall Study|Withdrawal by Subject|1|||
161516546|NCT03221257|583282654|FG001|Overall Study|Withdrawal by Subject|1|||
161516547|NCT01334866|583282657|FG000|Overall Study|Withdrawal by Subject|10|||
161516548|NCT01334866|583282657|FG000|Overall Study|Lost to Follow-up|3|||
161516549|NCT01334866|583282657|FG000|Overall Study|Physician Decision|3|||
161931976|NCT00147537|584798784|FG010|Phase 1b|Lost to Follow-up|0|||
161931977|NCT00147537|584798774|FG000|Phase 1b|Other|0|||
161516550|NCT01334866|583282657|FG000|Overall Study|medically necessary prior to procedure|2|||
161516551|NCT01334866|583282657|FG000|Overall Study|medically necessary post-procedure|1|||
161516552|NCT01971346|583282661|FG000|Overall Study|Protocol Violation|3|||
161516553|NCT01971346|583282661|FG000|Overall Study|Lost to Follow-up|2|||
161516554|NCT01971346|583282661|FG000|Overall Study|Withdrawal by Subject|2|||
161516555|NCT01971346|583282661|FG000|Overall Study|Physician Decision|1|||
161516556|NCT04187196|583282664|FG000|Overall Study|Screen Failure|2|||
161516557|NCT04187196|583282665|FG001|Overall Study|Screen Failure|0|||
161516558|NCT01687166|583282666|FG000|Overall Study|Attempt subject|2|||
161516559|NCT01687166|583282667|FG001|Overall Study|Attempt subject|3|||
161516560|NCT01687166|583282668|FG002|Overall Study|Attempt subject|2|||
161516561|NCT01687166|583282669|FG003|Overall Study|Attempt subject|0|||
161516562|NCT01687166|583282666|FG000|Overall Study|Did not meet eligibility criteria|4|||
161516563|NCT01687166|583282667|FG001|Overall Study|Did not meet eligibility criteria|6|||
161516564|NCT01687166|583282668|FG002|Overall Study|Did not meet eligibility criteria|1|||
161516565|NCT01687166|583282669|FG003|Overall Study|Did not meet eligibility criteria|1|||
161516566|NCT01687166|583282666|FG000|Overall Study|Adverse Event|2|||
161516567|NCT01687166|583282667|FG001|Overall Study|Adverse Event|1|||
161931978|NCT00147537|584798775|FG001|Phase 1b|Other|0|||
161516568|NCT01687166|583282668|FG002|Overall Study|Adverse Event|0|||
161516569|NCT01687166|583282669|FG003|Overall Study|Adverse Event|0|||
161516570|NCT01687166|583282666|FG000|Overall Study|Physician Decision|3|||
161516571|NCT01687166|583282667|FG001|Overall Study|Physician Decision|2|||
161516572|NCT01687166|583282668|FG002|Overall Study|Physician Decision|1|||
161516573|NCT01687166|583282669|FG003|Overall Study|Physician Decision|0|||
161516574|NCT01687166|583282666|FG000|Overall Study|Withdrawal by Subject|11|||
161516575|NCT01687166|583282667|FG001|Overall Study|Withdrawal by Subject|4|||
161516576|NCT01687166|583282668|FG002|Overall Study|Withdrawal by Subject|3|||
161931979|NCT00147537|584798776|FG002|Phase 1b|Other|2|||
161516577|NCT01687166|583282669|FG003|Overall Study|Withdrawal by Subject|0|||
161516578|NCT01687166|583282666|FG000|Overall Study|Lost to Follow-up|2|||
161516579|NCT01687166|583282667|FG001|Overall Study|Lost to Follow-up|5|||
161588828|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161588829|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588830|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588831|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161931980|NCT00147537|584798777|FG003|Phase 1b|Other|1|||
161588832|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588833|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
161516580|NCT01687166|583282668|FG002|Overall Study|Lost to Follow-up|1|||
161516581|NCT01687166|583282669|FG003|Overall Study|Lost to Follow-up|0|||
161516582|NCT01687166|583282666|FG000|Overall Study|Equipment/Device Availability|0|||
161516583|NCT01687166|583282667|FG001|Overall Study|Equipment/Device Availability|1|||
161516584|NCT01687166|583282668|FG002|Overall Study|Equipment/Device Availability|0|||
161931981|NCT00147537|584798778|FG004|Phase 1b|Other|1|||
161516585|NCT01687166|583282669|FG003|Overall Study|Equipment/Device Availability|0|||
161516586|NCT01687166|583282666|FG000|Overall Study|Death|1|||
161516587|NCT01687166|583282667|FG001|Overall Study|Death|1|||
161516588|NCT01687166|583282668|FG002|Overall Study|Death|0|||
161516589|NCT01687166|583282669|FG003|Overall Study|Death|0|||
161516590|NCT01687166|583282666|FG000|Overall Study|Protocol Violation|1|||
161516591|NCT01687166|583282667|FG001|Overall Study|Protocol Violation|1|||
161516592|NCT01687166|583282668|FG002|Overall Study|Protocol Violation|1|||
161516593|NCT01687166|583282669|FG003|Overall Study|Protocol Violation|0|||
161516594|NCT01687166|583282666|FG000|Overall Study|Subject moved out of state|0|||
161516595|NCT01687166|583282667|FG001|Overall Study|Subject moved out of state|1|||
161516596|NCT01687166|583282668|FG002|Overall Study|Subject moved out of state|0|||
161516597|NCT01687166|583282669|FG003|Overall Study|Subject moved out of state|0|||
161516598|NCT01687166|583282666|FG000|Overall Study|Patient unable to be compliant|1|||
161516599|NCT01687166|583282667|FG001|Overall Study|Patient unable to be compliant|0|||
161516600|NCT01687166|583282668|FG002|Overall Study|Patient unable to be compliant|0|||
161516601|NCT01687166|583282669|FG003|Overall Study|Patient unable to be compliant|0|||
161516602|NCT01687166|583282666|FG000|Overall Study|Physician choice to use different device|1|||
161516603|NCT01687166|583282667|FG001|Overall Study|Physician choice to use different device|2|||
161516604|NCT01687166|583282668|FG002|Overall Study|Physician choice to use different device|4|||
161516605|NCT01687166|583282669|FG003|Overall Study|Physician choice to use different device|0|||
161516606|NCT01687166|583282666|FG000|Overall Study|Insurance|0|||
161516607|NCT01687166|583282667|FG001|Overall Study|Insurance|0|||
161516608|NCT01687166|583282668|FG002|Overall Study|Insurance|1|||
161516609|NCT01687166|583282669|FG003|Overall Study|Insurance|1|||
161516610|NCT02755831|583282670|FG000|Overall Study|Lost to Follow-up|3|||
161516611|NCT02755831|583282671|FG001|Overall Study|Lost to Follow-up|3|||
161516612|NCT02316717|583282672|FG000|Overall Study|Adverse Event|2|||
161516613|NCT02316717|583282673|FG001|Overall Study|Adverse Event|2|||
161516614|NCT02316717|583282674|FG002|Overall Study|Adverse Event|0|||
161516615|NCT02316717|583282672|FG000|Overall Study|Lost to Follow-up|1|||
161516616|NCT02316717|583282673|FG001|Overall Study|Lost to Follow-up|2|||
161516617|NCT02316717|583282674|FG002|Overall Study|Lost to Follow-up|1|||
161516618|NCT02316717|583282672|FG000|Overall Study|Non compliance|3|||
161516619|NCT02316717|583282673|FG001|Overall Study|Non compliance|1|||
161516620|NCT02316717|583282674|FG002|Overall Study|Non compliance|0|||
161516621|NCT02316717|583282672|FG000|Overall Study|Protocol Violation|2|||
161516622|NCT02316717|583282673|FG001|Overall Study|Protocol Violation|0|||
161516623|NCT02316717|583282674|FG002|Overall Study|Protocol Violation|0|||
161516624|NCT02316717|583282672|FG000|Overall Study|Withdrawal by Subject|2|||
161516625|NCT02316717|583282673|FG001|Overall Study|Withdrawal by Subject|1|||
161516626|NCT02316717|583282674|FG002|Overall Study|Withdrawal by Subject|1|||
161516627|NCT02316717|583282672|FG000|Overall Study|Death|0|||
161516628|NCT02316717|583282673|FG001|Overall Study|Death|0|||
161516629|NCT02316717|583282674|FG002|Overall Study|Death|1|||
161516630|NCT02316717|583282672|FG000|Overall Study|Physician Decision|0|||
161516631|NCT02316717|583282673|FG001|Overall Study|Physician Decision|1|||
161516632|NCT02316717|583282674|FG002|Overall Study|Physician Decision|0|||
161516633|NCT02316717|583282672|FG000|Overall Study|TBC|1|||
161516634|NCT02316717|583282673|FG001|Overall Study|TBC|0|||
161516635|NCT02316717|583282674|FG002|Overall Study|TBC|0|||
161516636|NCT02460224|583282675|FG000|Overall Study|Adverse Event|0|||
161516637|NCT02460224|583282676|FG001|Overall Study|Adverse Event|0|||
161516638|NCT02460224|583282677|FG002|Overall Study|Adverse Event|0|||
161516639|NCT02460224|583282678|FG003|Overall Study|Adverse Event|0|||
161516640|NCT02460224|583282679|FG004|Overall Study|Adverse Event|0|||
161516641|NCT02460224|583282680|FG005|Overall Study|Adverse Event|0|||
161516642|NCT02460224|583282681|FG006|Overall Study|Adverse Event|1|||
161516643|NCT02460224|583282682|FG007|Overall Study|Adverse Event|0|||
161516644|NCT02460224|583282683|FG008|Overall Study|Adverse Event|0|||
161516645|NCT02460224|583282684|FG009|Overall Study|Adverse Event|0|||
161931982|NCT00147537|584798779|FG005|Phase 1b|Other|1|||
161931983|NCT00147537|584798780|FG006|Phase 1b|Other|14|||
161931984|NCT00147537|584798781|FG007|Phase 1b|Other|4|||
161931985|NCT00147537|584798782|FG008|Phase 1b|Other|4|||
161931986|NCT00147537|584798783|FG009|Phase 1b|Other|0|||
161931987|NCT00147537|584798784|FG010|Phase 1b|Other|0|||
161516646|NCT02460224|583282685|FG010|Overall Study|Adverse Event|0|||
161516647|NCT02460224|583282686|FG011|Overall Study|Adverse Event|0|||
161516648|NCT02460224|583282687|FG012|Overall Study|Adverse Event|1|||
161931988|NCT00147537|584798774|FG000|Phase 1b|Withdrawal by Subject|0|||
161516649|NCT02460224|583282688|FG013|Overall Study|Adverse Event|0|||
161516650|NCT02460224|583282689|FG014|Overall Study|Adverse Event|0|||
161516651|NCT02460224|583282690|FG015|Overall Study|Adverse Event|0|||
161516652|NCT02460224|583282691|FG016|Overall Study|Adverse Event|1|||
161516653|NCT02460224|583282692|FG017|Overall Study|Adverse Event|0|||
161516654|NCT02460224|583282693|FG018|Overall Study|Adverse Event|1|||
161516655|NCT02460224|583282694|FG019|Overall Study|Adverse Event|0|||
161516656|NCT02460224|583282695|FG020|Overall Study|Adverse Event|1|||
161931989|NCT00147537|584798775|FG001|Phase 1b|Withdrawal by Subject|0|||
161931990|NCT00147537|584798776|FG002|Phase 1b|Withdrawal by Subject|0|||
161516657|NCT02460224|583282696|FG021|Overall Study|Adverse Event|1|||
161516658|NCT02460224|583282697|FG022|Overall Study|Adverse Event|1|||
161516659|NCT02460224|583282698|FG023|Overall Study|Adverse Event|0|||
161516660|NCT02460224|583282699|FG024|Overall Study|Adverse Event|0|||
161516661|NCT02460224|583282700|FG025|Overall Study|Adverse Event|0|||
161516662|NCT02460224|583282701|FG026|Overall Study|Adverse Event|11|||
161516663|NCT02460224|583282702|FG027|Overall Study|Adverse Event|1|||
161516664|NCT02460224|583282703|FG028|Overall Study|Adverse Event|6|||
161516665|NCT02460224|583282675|FG000|Overall Study|Death|0|||
161516666|NCT02460224|583282676|FG001|Overall Study|Death|0|||
161516667|NCT02460224|583282677|FG002|Overall Study|Death|0|||
161516668|NCT02460224|583282678|FG003|Overall Study|Death|0|||
161516669|NCT02460224|583282679|FG004|Overall Study|Death|0|||
161516670|NCT02460224|583282680|FG005|Overall Study|Death|2|||
161516671|NCT02460224|583282681|FG006|Overall Study|Death|1|||
161516672|NCT02460224|583282682|FG007|Overall Study|Death|0|||
161516673|NCT02460224|583282683|FG008|Overall Study|Death|0|||
161516674|NCT02460224|583282684|FG009|Overall Study|Death|1|||
161516675|NCT02460224|583282685|FG010|Overall Study|Death|0|||
161516676|NCT02460224|583282686|FG011|Overall Study|Death|0|||
161516677|NCT02460224|583282687|FG012|Overall Study|Death|0|||
161516678|NCT02460224|583282688|FG013|Overall Study|Death|1|||
161516679|NCT02460224|583282689|FG014|Overall Study|Death|0|||
161516680|NCT02460224|583282690|FG015|Overall Study|Death|0|||
161516681|NCT02460224|583282691|FG016|Overall Study|Death|2|||
161516682|NCT02460224|583282692|FG017|Overall Study|Death|1|||
161516683|NCT02460224|583282693|FG018|Overall Study|Death|0|||
161516684|NCT02460224|583282694|FG019|Overall Study|Death|2|||
161516685|NCT02460224|583282695|FG020|Overall Study|Death|0|||
161516686|NCT02460224|583282696|FG021|Overall Study|Death|0|||
161516687|NCT02460224|583282697|FG022|Overall Study|Death|0|||
161516688|NCT02460224|583282698|FG023|Overall Study|Death|0|||
161516689|NCT02460224|583282699|FG024|Overall Study|Death|1|||
161516690|NCT02460224|583282700|FG025|Overall Study|Death|1|||
161516691|NCT02460224|583282701|FG026|Overall Study|Death|5|||
161516692|NCT02460224|583282702|FG027|Overall Study|Death|0|||
161516693|NCT02460224|583282703|FG028|Overall Study|Death|1|||
161516694|NCT02460224|583282675|FG000|Overall Study|Lost to Follow-up|0|||
161516695|NCT02460224|583282676|FG001|Overall Study|Lost to Follow-up|0|||
161516696|NCT02460224|583282677|FG002|Overall Study|Lost to Follow-up|0|||
161516697|NCT02460224|583282678|FG003|Overall Study|Lost to Follow-up|0|||
161516698|NCT02460224|583282679|FG004|Overall Study|Lost to Follow-up|0|||
161516699|NCT02460224|583282680|FG005|Overall Study|Lost to Follow-up|0|||
161516700|NCT02460224|583282681|FG006|Overall Study|Lost to Follow-up|0|||
161516701|NCT02460224|583282682|FG007|Overall Study|Lost to Follow-up|0|||
161516702|NCT02460224|583282683|FG008|Overall Study|Lost to Follow-up|0|||
161516703|NCT02460224|583282684|FG009|Overall Study|Lost to Follow-up|0|||
161516704|NCT02460224|583282685|FG010|Overall Study|Lost to Follow-up|0|||
161516705|NCT02460224|583282686|FG011|Overall Study|Lost to Follow-up|0|||
161516706|NCT02460224|583282687|FG012|Overall Study|Lost to Follow-up|0|||
161516707|NCT02460224|583282688|FG013|Overall Study|Lost to Follow-up|0|||
161516708|NCT02460224|583282689|FG014|Overall Study|Lost to Follow-up|0|||
161516709|NCT02460224|583282690|FG015|Overall Study|Lost to Follow-up|0|||
161516710|NCT02460224|583282691|FG016|Overall Study|Lost to Follow-up|0|||
161588834|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
161588835|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588836|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588837|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588838|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588839|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588840|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588841|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161588842|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161516711|NCT02460224|583282692|FG017|Overall Study|Lost to Follow-up|0|||
161516712|NCT02460224|583282693|FG018|Overall Study|Lost to Follow-up|0|||
161931991|NCT00147537|584798777|FG003|Phase 1b|Withdrawal by Subject|0|||
161516713|NCT02460224|583282694|FG019|Overall Study|Lost to Follow-up|0|||
161516714|NCT02460224|583282695|FG020|Overall Study|Lost to Follow-up|0|||
161588843|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161516715|NCT02460224|583282696|FG021|Overall Study|Lost to Follow-up|0|||
161516716|NCT02460224|583282697|FG022|Overall Study|Lost to Follow-up|1|||
161516717|NCT02460224|583282698|FG023|Overall Study|Lost to Follow-up|0|||
161516718|NCT02460224|583282699|FG024|Overall Study|Lost to Follow-up|0|||
161516719|NCT02460224|583282700|FG025|Overall Study|Lost to Follow-up|0|||
161516720|NCT02460224|583282701|FG026|Overall Study|Lost to Follow-up|0|||
161516721|NCT02460224|583282702|FG027|Overall Study|Lost to Follow-up|0|||
161516722|NCT02460224|583282703|FG028|Overall Study|Lost to Follow-up|0|||
161516723|NCT02460224|583282675|FG000|Overall Study|Physician Decision|0|||
161516724|NCT02460224|583282676|FG001|Overall Study|Physician Decision|1|||
161516725|NCT02460224|583282677|FG002|Overall Study|Physician Decision|0|||
161516726|NCT02460224|583282678|FG003|Overall Study|Physician Decision|0|||
161516727|NCT02460224|583282679|FG004|Overall Study|Physician Decision|1|||
161516728|NCT02460224|583282680|FG005|Overall Study|Physician Decision|0|||
161516729|NCT02460224|583282681|FG006|Overall Study|Physician Decision|0|||
161516730|NCT02460224|583282682|FG007|Overall Study|Physician Decision|1|||
161516731|NCT02460224|583282683|FG008|Overall Study|Physician Decision|0|||
161516732|NCT02460224|583282684|FG009|Overall Study|Physician Decision|0|||
161516733|NCT02460224|583282685|FG010|Overall Study|Physician Decision|0|||
161516734|NCT02460224|583282686|FG011|Overall Study|Physician Decision|1|||
161516735|NCT02460224|583282687|FG012|Overall Study|Physician Decision|0|||
161516736|NCT02460224|583282688|FG013|Overall Study|Physician Decision|1|||
161516737|NCT02460224|583282689|FG014|Overall Study|Physician Decision|0|||
161516738|NCT02460224|583282690|FG015|Overall Study|Physician Decision|0|||
161516739|NCT02460224|583282691|FG016|Overall Study|Physician Decision|2|||
161516740|NCT02460224|583282692|FG017|Overall Study|Physician Decision|1|||
161516741|NCT02460224|583282693|FG018|Overall Study|Physician Decision|1|||
161516742|NCT02460224|583282694|FG019|Overall Study|Physician Decision|2|||
161516743|NCT02460224|583282695|FG020|Overall Study|Physician Decision|1|||
161516744|NCT02460224|583282696|FG021|Overall Study|Physician Decision|1|||
161516745|NCT02460224|583282697|FG022|Overall Study|Physician Decision|0|||
161516746|NCT02460224|583282698|FG023|Overall Study|Physician Decision|0|||
161516747|NCT02460224|583282699|FG024|Overall Study|Physician Decision|1|||
161516748|NCT02460224|583282700|FG025|Overall Study|Physician Decision|0|||
161516749|NCT02460224|583282701|FG026|Overall Study|Physician Decision|14|||
161516750|NCT02460224|583282702|FG027|Overall Study|Physician Decision|1|||
161516751|NCT02460224|583282703|FG028|Overall Study|Physician Decision|6|||
161516752|NCT02460224|583282675|FG000|Overall Study|Progressive disease|15|||
161516753|NCT02460224|583282676|FG001|Overall Study|Progressive disease|11|||
161516754|NCT02460224|583282677|FG002|Overall Study|Progressive disease|5|||
161516755|NCT02460224|583282678|FG003|Overall Study|Progressive disease|6|||
161516756|NCT02460224|583282679|FG004|Overall Study|Progressive disease|3|||
161516757|NCT02460224|583282680|FG005|Overall Study|Progressive disease|26|||
161516758|NCT02460224|583282681|FG006|Overall Study|Progressive disease|28|||
161516759|NCT02460224|583282682|FG007|Overall Study|Progressive disease|4|||
161516760|NCT02460224|583282683|FG008|Overall Study|Progressive disease|5|||
161516761|NCT02460224|583282684|FG009|Overall Study|Progressive disease|9|||
161516762|NCT02460224|583282685|FG010|Overall Study|Progressive disease|5|||
161516763|NCT02460224|583282686|FG011|Overall Study|Progressive disease|4|||
161516764|NCT02460224|583282687|FG012|Overall Study|Progressive disease|5|||
161516765|NCT02460224|583282688|FG013|Overall Study|Progressive disease|4|||
161516766|NCT02460224|583282689|FG014|Overall Study|Progressive disease|5|||
161516767|NCT02460224|583282690|FG015|Overall Study|Progressive disease|5|||
161516768|NCT02460224|583282691|FG016|Overall Study|Progressive disease|15|||
161516769|NCT02460224|583282692|FG017|Overall Study|Progressive disease|3|||
161516770|NCT02460224|583282693|FG018|Overall Study|Progressive disease|8|||
161516771|NCT02460224|583282694|FG019|Overall Study|Progressive disease|3|||
161516772|NCT02460224|583282695|FG020|Overall Study|Progressive disease|4|||
161516773|NCT02460224|583282696|FG021|Overall Study|Progressive disease|9|||
161516774|NCT02460224|583282697|FG022|Overall Study|Progressive disease|4|||
161516775|NCT02460224|583282698|FG023|Overall Study|Progressive disease|11|||
161516776|NCT02460224|583282699|FG024|Overall Study|Progressive disease|4|||
161516777|NCT02460224|583282700|FG025|Overall Study|Progressive disease|5|||
161516778|NCT02460224|583282701|FG026|Overall Study|Progressive disease|85|||
161516779|NCT02460224|583282702|FG027|Overall Study|Progressive disease|17|||
161516780|NCT02460224|583282703|FG028|Overall Study|Progressive disease|77|||
161516781|NCT02460224|583282675|FG000|Overall Study|Subject/guardian decision|2|||
161516782|NCT02460224|583282676|FG001|Overall Study|Subject/guardian decision|0|||
161516783|NCT02460224|583282677|FG002|Overall Study|Subject/guardian decision|1|||
161516784|NCT02460224|583282678|FG003|Overall Study|Subject/guardian decision|0|||
161516785|NCT02460224|583282679|FG004|Overall Study|Subject/guardian decision|2|||
161516786|NCT02460224|583282680|FG005|Overall Study|Subject/guardian decision|2|||
161516787|NCT02460224|583282681|FG006|Overall Study|Subject/guardian decision|0|||
161516788|NCT02460224|583282682|FG007|Overall Study|Subject/guardian decision|0|||
161516789|NCT02460224|583282683|FG008|Overall Study|Subject/guardian decision|1|||
161516790|NCT02460224|583282684|FG009|Overall Study|Subject/guardian decision|1|||
161516791|NCT02460224|583282685|FG010|Overall Study|Subject/guardian decision|0|||
161516792|NCT02460224|583282686|FG011|Overall Study|Subject/guardian decision|1|||
161516793|NCT02460224|583282687|FG012|Overall Study|Subject/guardian decision|0|||
161516794|NCT02460224|583282688|FG013|Overall Study|Subject/guardian decision|0|||
161516795|NCT02460224|583282689|FG014|Overall Study|Subject/guardian decision|0|||
161516796|NCT02460224|583282690|FG015|Overall Study|Subject/guardian decision|1|||
161516797|NCT02460224|583282691|FG016|Overall Study|Subject/guardian decision|0|||
161516798|NCT02460224|583282692|FG017|Overall Study|Subject/guardian decision|1|||
161516799|NCT02460224|583282693|FG018|Overall Study|Subject/guardian decision|2|||
161516800|NCT02460224|583282694|FG019|Overall Study|Subject/guardian decision|0|||
161516801|NCT02460224|583282695|FG020|Overall Study|Subject/guardian decision|0|||
161516802|NCT02460224|583282696|FG021|Overall Study|Subject/guardian decision|1|||
161516803|NCT02460224|583282697|FG022|Overall Study|Subject/guardian decision|0|||
161931992|NCT00147537|584798778|FG004|Phase 1b|Withdrawal by Subject|0|||
161516804|NCT02460224|583282698|FG023|Overall Study|Subject/guardian decision|0|||
161516805|NCT02460224|583282699|FG024|Overall Study|Subject/guardian decision|0|||
161516806|NCT02460224|583282700|FG025|Overall Study|Subject/guardian decision|0|||
161516807|NCT02460224|583282701|FG026|Overall Study|Subject/guardian decision|6|||
161516808|NCT02460224|583282702|FG027|Overall Study|Subject/guardian decision|2|||
161516809|NCT02460224|583282703|FG028|Overall Study|Subject/guardian decision|3|||
161516810|NCT02774681|583282710|FG000|Treatment on Study|Progressive Disease|7|||
161516811|NCT02774681|583282710|FG000|Follow-Up for 3 Years|Death|11|||
161824069|NCT01856192|584397911|FG000|Overall Study|Adverse Event|12|||
161824070|NCT01856192|584397912|FG001|Overall Study|Adverse Event|4|||
161824071|NCT01856192|584397911|FG000|Overall Study|Alternative therapy|0|||
161824072|NCT01856192|584397912|FG001|Overall Study|Alternative therapy|3|||
161824073|NCT01856192|584397911|FG000|Overall Study|Death|3|||
161824074|NCT01856192|584397912|FG001|Overall Study|Death|5|||
161824075|NCT01856192|584397911|FG000|Overall Study|Lack of Efficacy|0|||
161824076|NCT01856192|584397912|FG001|Overall Study|Lack of Efficacy|5|||
161824077|NCT01856192|584397911|FG000|Overall Study|Withdrawal by Subject|1|||
161824078|NCT01856192|584397912|FG001|Overall Study|Withdrawal by Subject|1|||
161824079|NCT01856192|584397911|FG000|Overall Study|Other diseases|1|||
161824080|NCT01856192|584397912|FG001|Overall Study|Other diseases|0|||
161824081|NCT01856192|584397911|FG000|Overall Study|Never started treatment|7|||
161824082|NCT01856192|584397912|FG001|Overall Study|Never started treatment|5|||
161824083|NCT01856192|584397911|FG000|Overall Study|Path ineligible|20|||
161824084|NCT01856192|584397912|FG001|Overall Study|Path ineligible|34|||
161824085|NCT01856192|584397911|FG000|Overall Study|Non-path ineligible|2|||
161824086|NCT01856192|584397912|FG001|Overall Study|Non-path ineligible|2|||
161824087|NCT01856192|584397911|FG000|Overall Study|Physician Decision|1|||
161824088|NCT01856192|584397912|FG001|Overall Study|Physician Decision|1|||
161516812|NCT02774681|583282710|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
161516813|NCT03146650|583282715|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
161516814|NCT03146650|583282715|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
161516815|NCT03146650|583282715|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
161516816|NCT03146650|583282715|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
161516817|NCT03146650|583282715|FG000|2 Year Follow-up|Death|11|||
161516818|NCT03146650|583282715|FG000|2 Year Follow-up|Still in follow-up|7|||
161516819|NCT03146650|583282715|FG000|2 Year Follow-up|Lost to Follow-up|1|||
161516820|NCT02460198|583282718|FG000|Overall Study|Adverse Event|1|||
161516821|NCT02460198|583282719|FG001|Overall Study|Adverse Event|3|||
161516822|NCT02460198|583282718|FG000|Overall Study|Death|36|||
161516823|NCT02460198|583282719|FG001|Overall Study|Death|28|||
161516824|NCT02460198|583282718|FG000|Overall Study|Lost to Follow-up|1|||
161516825|NCT02460198|583282719|FG001|Overall Study|Lost to Follow-up|1|||
161516826|NCT02460198|583282718|FG000|Overall Study|Transferred to Extension Study|15|||
161516827|NCT02460198|583282719|FG001|Overall Study|Transferred to Extension Study|15|||
161516828|NCT02460198|583282718|FG000|Overall Study|Withdrawal by Subject|2|||
161516829|NCT02460198|583282719|FG001|Overall Study|Withdrawal by Subject|4|||
161516830|NCT02460198|583282718|FG000|Overall Study|Site Terminated By Sponsor|0|||
161516831|NCT02460198|583282719|FG001|Overall Study|Site Terminated By Sponsor|1|||
161516832|NCT02460198|583282718|FG000|Overall Study|Did Not Continue on Extension Study|6|||
161516833|NCT02460198|583282719|FG001|Overall Study|Did Not Continue on Extension Study|11|||
161516834|NCT00931307|583282720|FG000|Overall Study|Lack of Efficacy|12|||
161516835|NCT00931307|583282720|FG000|Overall Study|Biomicroscopy|1|||
161516836|NCT00965848|583282723|FG000|Overall Study|Protocol Violation|3|||
161516837|NCT00965848|583282724|FG001|Overall Study|Protocol Violation|0|||
161516838|NCT00965848|583282725|FG002|Overall Study|Protocol Violation|1|||
161516839|NCT00965848|583282723|FG000|Overall Study|Death|11|||
161516840|NCT00965848|583282724|FG001|Overall Study|Death|1|||
161516841|NCT00965848|583282725|FG002|Overall Study|Death|5|||
161516842|NCT00965848|583282723|FG000|Overall Study|Lost to Follow-up|0|||
161516843|NCT00965848|583282724|FG001|Overall Study|Lost to Follow-up|0|||
161516844|NCT00965848|583282725|FG002|Overall Study|Lost to Follow-up|1|||
161516845|NCT00965848|583282723|FG000|Overall Study|Withdrawal by Subject|1|||
161516846|NCT00965848|583282724|FG001|Overall Study|Withdrawal by Subject|0|||
161516847|NCT00965848|583282725|FG002|Overall Study|Withdrawal by Subject|0|||
161516848|NCT00965848|583282723|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
161516849|NCT00965848|583282724|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
161516850|NCT00965848|583282725|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
161516851|NCT00965848|583282723|FG000|Overall Study|Not Clinically Evaluable|7|||
161516852|NCT00965848|583282724|FG001|Overall Study|Not Clinically Evaluable|1|||
161516853|NCT00965848|583282725|FG002|Overall Study|Not Clinically Evaluable|1|||
161516854|NCT00965848|583282723|FG000|Overall Study|Other|5|||
161516855|NCT00965848|583282724|FG001|Overall Study|Other|0|||
161516856|NCT00965848|583282725|FG002|Overall Study|Other|1|||
161516857|NCT00813761|583282726|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
161824089|NCT01856192|584397911|FG000|Overall Study|Suspicion of progressive disease|1|||
161824090|NCT01856192|584397912|FG001|Overall Study|Suspicion of progressive disease|0|||
161824091|NCT01856192|584397911|FG000|Overall Study|Non-compliance|1|||
161824092|NCT01856192|584397912|FG001|Overall Study|Non-compliance|0|||
161824093|NCT00098475|584397913|FG000|Step 1|Progressive disease|33|||
161931993|NCT00147537|584798779|FG005|Phase 1b|Withdrawal by Subject|0|||
161931994|NCT00147537|584798780|FG006|Phase 1b|Withdrawal by Subject|0|||
161931995|NCT00147537|584798781|FG007|Phase 1b|Withdrawal by Subject|0|||
161931996|NCT00147537|584798782|FG008|Phase 1b|Withdrawal by Subject|2|||
161931997|NCT00147537|584798783|FG009|Phase 1b|Withdrawal by Subject|0|||
161931998|NCT00147537|584798784|FG010|Phase 1b|Withdrawal by Subject|0|||
161931999|NCT00147537|584798774|FG000|Phase 1b|Randomized but not treated|0|||
161932000|NCT00147537|584798775|FG001|Phase 1b|Randomized but not treated|0|||
161932001|NCT00147537|584798776|FG002|Phase 1b|Randomized but not treated|0|||
161516858|NCT00813761|583282727|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
161516859|NCT00813761|583282728|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
161516860|NCT00813761|583282729|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
161516861|NCT00813761|583282726|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
161516862|NCT00813761|583282727|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
161516863|NCT00813761|583282728|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
161932002|NCT00147537|584798777|FG003|Phase 1b|Randomized but not treated|0|||
161516864|NCT00813761|583282729|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
161516865|NCT00813761|583282726|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
161516866|NCT00813761|583282727|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
161516867|NCT00813761|583282728|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
161516868|NCT00813761|583282729|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
161516869|NCT00813761|583282726|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
161516870|NCT00813761|583282727|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
161516871|NCT00813761|583282728|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
161516872|NCT00813761|583282729|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
161516873|NCT00813761|583282726|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
161516874|NCT00813761|583282727|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
161516875|NCT00813761|583282728|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
161516876|NCT00813761|583282729|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
161516877|NCT00813761|583282726|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
161588844|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161932003|NCT00147537|584798778|FG004|Phase 1b|Randomized but not treated|0|||
161932004|NCT00147537|584798779|FG005|Phase 1b|Randomized but not treated|0|||
161932005|NCT00147537|584798780|FG006|Phase 1b|Randomized but not treated|1|||
161932006|NCT00147537|584798781|FG007|Phase 1b|Randomized but not treated|0|||
161932007|NCT00147537|584798782|FG008|Phase 1b|Randomized but not treated|1|||
161932008|NCT00147537|584798783|FG009|Phase 1b|Randomized but not treated|0|||
161932009|NCT00147537|584798784|FG010|Phase 1b|Randomized but not treated|0|||
161932010|NCT00147537|584798774|FG000|Phase 2|Death|0|||
161932011|NCT00147537|584798775|FG001|Phase 2|Death|0|||
161932012|NCT00147537|584798776|FG002|Phase 2|Death|0|||
161932013|NCT00147537|584798777|FG003|Phase 2|Death|0|||
161932014|NCT00147537|584798778|FG004|Phase 2|Death|0|||
161932015|NCT00147537|584798779|FG005|Phase 2|Death|0|||
161932016|NCT00147537|584798780|FG006|Phase 2|Death|0|||
161932017|NCT00147537|584798781|FG007|Phase 2|Death|0|||
161932018|NCT00147537|584798782|FG008|Phase 2|Death|0|||
161932019|NCT00147537|584798783|FG009|Phase 2|Death|85|||
161932020|NCT00147537|584798784|FG010|Phase 2|Death|31|||
161932021|NCT00147537|584798774|FG000|Phase 2|Lost to Follow-up|0|||
161932022|NCT00147537|584798775|FG001|Phase 2|Lost to Follow-up|0|||
161932023|NCT00147537|584798776|FG002|Phase 2|Lost to Follow-up|0|||
161932024|NCT00147537|584798777|FG003|Phase 2|Lost to Follow-up|0|||
161932025|NCT00147537|584798778|FG004|Phase 2|Lost to Follow-up|0|||
161932026|NCT00147537|584798779|FG005|Phase 2|Lost to Follow-up|0|||
161932027|NCT00147537|584798780|FG006|Phase 2|Lost to Follow-up|0|||
161932028|NCT00147537|584798781|FG007|Phase 2|Lost to Follow-up|0|||
161932029|NCT00147537|584798782|FG008|Phase 2|Lost to Follow-up|0|||
161932030|NCT00147537|584798783|FG009|Phase 2|Lost to Follow-up|12|||
161516878|NCT00813761|583282727|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
161516879|NCT00813761|583282728|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
161516880|NCT00813761|583282729|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
161588845|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588846|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
161588847|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
161932031|NCT00147537|584798784|FG010|Phase 2|Lost to Follow-up|4|||
161932032|NCT00147537|584798774|FG000|Phase 2|Other|0|||
161932033|NCT00147537|584798775|FG001|Phase 2|Other|0|||
161516881|NCT00813761|583282726|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
161932034|NCT00147537|584798776|FG002|Phase 2|Other|0|||
161932035|NCT00147537|584798777|FG003|Phase 2|Other|0|||
161932036|NCT00147537|584798778|FG004|Phase 2|Other|0|||
161932037|NCT00147537|584798779|FG005|Phase 2|Other|0|||
161932038|NCT00147537|584798780|FG006|Phase 2|Other|0|||
161932039|NCT00147537|584798781|FG007|Phase 2|Other|0|||
161932040|NCT00147537|584798782|FG008|Phase 2|Other|0|||
161932041|NCT00147537|584798783|FG009|Phase 2|Other|47|||
161932042|NCT00147537|584798784|FG010|Phase 2|Other|12|||
161932043|NCT00147537|584798774|FG000|Phase 2|Withdrawal by Subject|0|||
161932044|NCT00147537|584798775|FG001|Phase 2|Withdrawal by Subject|0|||
161516882|NCT00813761|583282727|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
161516883|NCT00813761|583282728|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
161516884|NCT00813761|583282729|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
161516885|NCT00813761|583282726|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
161516886|NCT00813761|583282727|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
161516887|NCT00813761|583282728|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
161516888|NCT00813761|583282729|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
161516889|NCT00813761|583282726|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
161516890|NCT00813761|583282727|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
161516891|NCT00813761|583282728|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
161516892|NCT00813761|583282729|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
161516893|NCT00813761|583282726|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
161516894|NCT00813761|583282727|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
161516895|NCT00813761|583282728|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
161516896|NCT00813761|583282729|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
161516897|NCT00813761|583282726|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
161516898|NCT00813761|583282727|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
161516899|NCT00813761|583282728|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
161516900|NCT00813761|583282729|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
161516901|NCT00813761|583282726|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
161516902|NCT00813761|583282727|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
161516903|NCT00813761|583282728|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
161516904|NCT00813761|583282729|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
161516905|NCT00691210|583282730|FG000|Overall Study|Progression of Disease|0|||
161516906|NCT00691210|583282731|FG001|Overall Study|Progression of Disease|0|||
161932045|NCT00147537|584798776|FG002|Phase 2|Withdrawal by Subject|0|||
161932046|NCT00147537|584798777|FG003|Phase 2|Withdrawal by Subject|0|||
161932047|NCT00147537|584798778|FG004|Phase 2|Withdrawal by Subject|0|||
161932048|NCT00147537|584798779|FG005|Phase 2|Withdrawal by Subject|0|||
161932049|NCT00147537|584798780|FG006|Phase 2|Withdrawal by Subject|0|||
161932050|NCT00147537|584798781|FG007|Phase 2|Withdrawal by Subject|0|||
161932051|NCT00147537|584798782|FG008|Phase 2|Withdrawal by Subject|0|||
161932052|NCT00147537|584798783|FG009|Phase 2|Withdrawal by Subject|16|||
161932053|NCT00147537|584798784|FG010|Phase 2|Withdrawal by Subject|4|||
161932054|NCT00147537|584798774|FG000|Phase 2|Randomized but not treated|0|||
161932055|NCT00147537|584798775|FG001|Phase 2|Randomized but not treated|0|||
161932056|NCT00147537|584798776|FG002|Phase 2|Randomized but not treated|0|||
161932057|NCT00147537|584798777|FG003|Phase 2|Randomized but not treated|0|||
161932058|NCT00147537|584798778|FG004|Phase 2|Randomized but not treated|0|||
161932059|NCT00147537|584798779|FG005|Phase 2|Randomized but not treated|0|||
161932060|NCT00147537|584798780|FG006|Phase 2|Randomized but not treated|0|||
161932061|NCT00147537|584798781|FG007|Phase 2|Randomized but not treated|0|||
161932062|NCT00147537|584798782|FG008|Phase 2|Randomized but not treated|0|||
161932063|NCT00147537|584798783|FG009|Phase 2|Randomized but not treated|1|||
161932064|NCT00147537|584798784|FG010|Phase 2|Randomized but not treated|1|||
161932065|NCT01927861|584798785|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
161932066|NCT01927861|584798786|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
161932067|NCT01927861|584798785|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
161932068|NCT01927861|584798786|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
161932069|NCT00987935|584798787|FG000|Overall Study|Progressive disease|3|||
161932070|NCT00987935|584798788|FG001|Overall Study|Progressive disease|2|||
161932071|NCT00987935|584798789|FG002|Overall Study|Progressive disease|3|||
161932072|NCT00987935|584798790|FG003|Overall Study|Progressive disease|2|||
161932073|NCT00987935|584798791|FG004|Overall Study|Progressive disease|5|||
161932074|NCT00987935|584798792|FG005|Overall Study|Progressive disease|3|||
161932075|NCT00987935|584798793|FG006|Overall Study|Progressive disease|9|||
161932076|NCT00987935|584798794|FG007|Overall Study|Progressive disease|48|||
161932077|NCT00987935|584798795|FG008|Overall Study|Progressive disease|23|||
161932078|NCT00987935|584798787|FG000|Overall Study|Adverse Event|0|||
161516907|NCT00691210|583282732|FG002|Overall Study|Progression of Disease|0|||
161516908|NCT00691210|583282733|FG003|Overall Study|Progression of Disease|2|||
161516909|NCT00691210|583282734|FG004|Overall Study|Progression of Disease|0|||
161516910|NCT00691210|583282735|FG005|Overall Study|Progression of Disease|0|||
161516911|NCT00691210|583282736|FG006|Overall Study|Progression of Disease|0|||
161932079|NCT00987935|584798788|FG001|Overall Study|Adverse Event|1|||
161516912|NCT00691210|583282737|FG007|Overall Study|Progression of Disease|0|||
161516913|NCT00691210|583282730|FG000|Overall Study|Lack of Efficacy|0|||
161932080|NCT00987935|584798789|FG002|Overall Study|Adverse Event|0|||
161932081|NCT00987935|584798790|FG003|Overall Study|Adverse Event|1|||
161932082|NCT00987935|584798791|FG004|Overall Study|Adverse Event|1|||
161932083|NCT00987935|584798792|FG005|Overall Study|Adverse Event|0|||
161932084|NCT00987935|584798793|FG006|Overall Study|Adverse Event|2|||
161932085|NCT00987935|584798794|FG007|Overall Study|Adverse Event|10|||
161932086|NCT00987935|584798795|FG008|Overall Study|Adverse Event|6|||
161932087|NCT00987935|584798787|FG000|Overall Study|Refused to continue taking trial med.|1|||
161516914|NCT00691210|583282731|FG001|Overall Study|Lack of Efficacy|0|||
161516915|NCT00691210|583282732|FG002|Overall Study|Lack of Efficacy|0|||
161516916|NCT00691210|583282733|FG003|Overall Study|Lack of Efficacy|1|||
161516917|NCT00691210|583282734|FG004|Overall Study|Lack of Efficacy|0|||
161516918|NCT00691210|583282735|FG005|Overall Study|Lack of Efficacy|1|||
161932088|NCT00987935|584798788|FG001|Overall Study|Refused to continue taking trial med.|0|||
161932089|NCT00987935|584798789|FG002|Overall Study|Refused to continue taking trial med.|0|||
161932090|NCT00987935|584798790|FG003|Overall Study|Refused to continue taking trial med.|0|||
161932091|NCT00987935|584798791|FG004|Overall Study|Refused to continue taking trial med.|1|||
161932092|NCT00987935|584798792|FG005|Overall Study|Refused to continue taking trial med.|0|||
161932093|NCT00987935|584798793|FG006|Overall Study|Refused to continue taking trial med.|4|||
161932094|NCT00987935|584798794|FG007|Overall Study|Refused to continue taking trial med.|4|||
161932095|NCT00987935|584798795|FG008|Overall Study|Refused to continue taking trial med.|2|||
161932096|NCT00987935|584798787|FG000|Overall Study|Reason other than those specified above|0|||
161932097|NCT00987935|584798788|FG001|Overall Study|Reason other than those specified above|0|||
161932098|NCT00987935|584798789|FG002|Overall Study|Reason other than those specified above|0|||
161932099|NCT00987935|584798790|FG003|Overall Study|Reason other than those specified above|0|||
161932100|NCT00987935|584798791|FG004|Overall Study|Reason other than those specified above|0|||
161932101|NCT00987935|584798792|FG005|Overall Study|Reason other than those specified above|0|||
161932102|NCT00987935|584798793|FG006|Overall Study|Reason other than those specified above|0|||
161932103|NCT00987935|584798794|FG007|Overall Study|Reason other than those specified above|0|||
161932104|NCT00987935|584798795|FG008|Overall Study|Reason other than those specified above|1|||
161932105|NCT00728182|584798796|FG000|Overall Study|Adverse Event|1|||
161932106|NCT00728182|584798797|FG001|Overall Study|Adverse Event|0|||
161932107|NCT00728182|584798796|FG000|Overall Study|Lost to Follow-up|2|||
161932108|NCT00728182|584798797|FG001|Overall Study|Lost to Follow-up|0|||
161932109|NCT00728182|584798796|FG000|Overall Study|Death|0|||
161932110|NCT00728182|584798797|FG001|Overall Study|Death|2|||
161932111|NCT00728182|584798796|FG000|Overall Study|Protocol Noncompliance|0|||
161932112|NCT00728182|584798797|FG001|Overall Study|Protocol Noncompliance|1|||
161932113|NCT01898091|584798800|FG000|Overall Study|Lost to Follow-up|1|||
161932114|NCT01898091|584798801|FG001|Overall Study|Lost to Follow-up|1|||
161932115|NCT01898091|584798800|FG000|Overall Study|Withdrawal by Subject|1|||
161932116|NCT01898091|584798801|FG001|Overall Study|Withdrawal by Subject|5|||
161932117|NCT03888482|584798804|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
161932118|NCT03888482|584798805|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
161932119|NCT03888482|584798804|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
161932120|NCT03888482|584798805|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
161932121|NCT02294019|584798806|FG000|Overall Study|Adverse Event|2|||
161932122|NCT02294019|584798806|FG000|Overall Study|Protocol Violation|68|||
161932123|NCT02294019|584798806|FG000|Overall Study|Lost to Follow-up|31|||
161932124|NCT02294019|584798806|FG000|Overall Study|Other|1|||
161932125|NCT02294019|584798806|FG000|Overall Study|Withdrawal by Subject|1|||
161932126|NCT01189227|584798808|FG000|Overall Study|Study terminated due to low accrual|6|||
161932127|NCT01189227|584798809|FG001|Overall Study|Study terminated due to low accrual|3|||
161932128|NCT01016015|584798810|FG000|Overall Study|Not Treated|3|||
161932129|NCT01016015|584798810|FG000|Overall Study|Withdrawal by Subject|1|||
161932130|NCT01016015|584798810|FG000|Overall Study|Adverse Event|15|||
161932131|NCT00362609|584798816|FG000|Overall Study|Withdrawal by Subject|0|||
161932132|NCT00362609|584798817|FG001|Overall Study|Withdrawal by Subject|1|||
161932133|NCT00362609|584798816|FG000|Overall Study|Protocol Violation|0|||
161932134|NCT00362609|584798817|FG001|Overall Study|Protocol Violation|1|||
161932135|NCT02205359|584798818|FG000|Overall Study|Death|293|||
161932136|NCT02205359|584798819|FG001|Overall Study|Death|327|||
161932137|NCT02205359|584798818|FG000|Overall Study|Lost to Follow-up|182|||
161932138|NCT02205359|584798819|FG001|Overall Study|Lost to Follow-up|162|||
161932139|NCT02205359|584798818|FG000|Overall Study|Physician Decision|51|||
161932140|NCT02205359|584798819|FG001|Overall Study|Physician Decision|53|||
161932141|NCT02205359|584798818|FG000|Overall Study|Withdrawal by Subject|167|||
161932142|NCT02205359|584798819|FG001|Overall Study|Withdrawal by Subject|169|||
161932143|NCT00236197|584798820|FG000|Overall Study|Withdrawal by Subject|3|||
161932144|NCT00236197|584798821|FG001|Overall Study|Withdrawal by Subject|2|||
161516919|NCT00691210|583282736|FG006|Overall Study|Lack of Efficacy|0|||
161516920|NCT00691210|583282737|FG007|Overall Study|Lack of Efficacy|0|||
161516921|NCT02047604|583282740|FG000|Overall Study|Withdrawal by Subject|0|||
161932145|NCT00236197|584798820|FG000|Overall Study|Lost to Follow-up|1|||
161932146|NCT00236197|584798821|FG001|Overall Study|Lost to Follow-up|5|||
161932147|NCT00236197|584798820|FG000|Overall Study|Protocol Violation|0|||
161932148|NCT00236197|584798821|FG001|Overall Study|Protocol Violation|3|||
161516922|NCT02047604|583282741|FG001|Overall Study|Withdrawal by Subject|0|||
161932149|NCT00236197|584798820|FG000|Overall Study|Medication non-compliance|1|||
161932150|NCT00236197|584798821|FG001|Overall Study|Medication non-compliance|2|||
161932151|NCT00236197|584798820|FG000|Overall Study|Other|0|||
161932152|NCT00236197|584798821|FG001|Overall Study|Other|2|||
161932153|NCT00480025|584798822|FG000|Overall Study|Protocol Violation|12|||
161932154|NCT00480025|584798823|FG001|Overall Study|Protocol Violation|7|||
161516923|NCT02047604|583282742|FG002|Overall Study|Withdrawal by Subject|0|||
161516924|NCT02047604|583282743|FG003|Overall Study|Withdrawal by Subject|0|||
161516925|NCT02047604|583282744|FG004|Overall Study|Withdrawal by Subject|1|||
161516926|NCT02047604|583282745|FG005|Overall Study|Withdrawal by Subject|1|||
161516927|NCT00983814|583282746|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
161516928|NCT00983814|583282747|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
161516929|NCT00983814|583282748|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
161516930|NCT00983814|583282746|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
161516931|NCT00983814|583282747|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
161516932|NCT00983814|583282748|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
161516933|NCT00983814|583282746|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
161516934|NCT00983814|583282747|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
161516935|NCT00983814|583282748|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
161516936|NCT00983814|583282746|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
161516937|NCT00983814|583282747|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
161516938|NCT00983814|583282748|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
161516939|NCT00983814|583282746|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
161516940|NCT00983814|583282747|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
161516941|NCT00983814|583282748|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
161516942|NCT01181895|583282749|FG000|Overall Study|Adverse Event|3|||
161516943|NCT01181895|583282750|FG001|Overall Study|Adverse Event|1|||
161516944|NCT01181895|583282751|FG002|Overall Study|Adverse Event|1|||
161516945|NCT01181895|583282749|FG000|Overall Study|Lack of Efficacy|8|||
161516946|NCT01181895|583282750|FG001|Overall Study|Lack of Efficacy|9|||
161516947|NCT01181895|583282751|FG002|Overall Study|Lack of Efficacy|9|||
161516948|NCT01181895|583282749|FG000|Overall Study|Protocol Violation|2|||
161516949|NCT01181895|583282750|FG001|Overall Study|Protocol Violation|1|||
161516950|NCT01181895|583282751|FG002|Overall Study|Protocol Violation|0|||
161516951|NCT01181895|583282749|FG000|Overall Study|Lost to Follow-up|0|||
161516952|NCT01181895|583282750|FG001|Overall Study|Lost to Follow-up|1|||
161516953|NCT01181895|583282751|FG002|Overall Study|Lost to Follow-up|2|||
161516954|NCT01181895|583282749|FG000|Overall Study|Investigator Discretion|1|||
161588848|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588849|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588850|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588851|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588852|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161516955|NCT01181895|583282750|FG001|Overall Study|Investigator Discretion|2|||
161516956|NCT01181895|583282751|FG002|Overall Study|Investigator Discretion|1|||
161516957|NCT01181895|583282749|FG000|Overall Study|Withdrawal by Subject|3|||
161516958|NCT01181895|583282750|FG001|Overall Study|Withdrawal by Subject|0|||
161516959|NCT01181895|583282751|FG002|Overall Study|Withdrawal by Subject|5|||
161588853|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588854|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161588855|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
161824094|NCT00098475|584397914|FG001|Step 1|Progressive disease|35|||
161824095|NCT00098475|584397915|FG002|Step 1|Progressive disease|2|||
161824096|NCT00098475|584397916|FG003|Step 1|Progressive disease|1|||
161824097|NCT00098475|584397913|FG000|Step 1|Adverse Event|56|||
161824098|NCT00098475|584397914|FG001|Step 1|Adverse Event|37|||
161824099|NCT00098475|584397915|FG002|Step 1|Adverse Event|0|||
161824100|NCT00098475|584397916|FG003|Step 1|Adverse Event|1|||
161824101|NCT00098475|584397913|FG000|Step 1|Death|8|||
161824102|NCT00098475|584397914|FG001|Step 1|Death|5|||
161824103|NCT00098475|584397915|FG002|Step 1|Death|0|||
161824104|NCT00098475|584397916|FG003|Step 1|Death|1|||
161824105|NCT00098475|584397913|FG000|Step 1|Withdrawal by Subject|14|||
161824106|NCT00098475|584397914|FG001|Step 1|Withdrawal by Subject|11|||
161824107|NCT00098475|584397915|FG002|Step 1|Withdrawal by Subject|0|||
161824108|NCT00098475|584397916|FG003|Step 1|Withdrawal by Subject|0|||
161824109|NCT00098475|584397913|FG000|Step 1|Physician Decision|5|||
161824110|NCT00098475|584397914|FG001|Step 1|Physician Decision|2|||
161824111|NCT00098475|584397915|FG002|Step 1|Physician Decision|0|||
161824112|NCT00098475|584397916|FG003|Step 1|Physician Decision|0|||
161824113|NCT00098475|584397913|FG000|Step 1|Alternative therapy|31|||
161824114|NCT00098475|584397914|FG001|Step 1|Alternative therapy|43|||
161824115|NCT00098475|584397915|FG002|Step 1|Alternative therapy|1|||
161824116|NCT00098475|584397916|FG003|Step 1|Alternative therapy|0|||
161824117|NCT00098475|584397913|FG000|Step 1|Other disease|2|||
161824118|NCT00098475|584397914|FG001|Step 1|Other disease|1|||
161824119|NCT00098475|584397915|FG002|Step 1|Other disease|1|||
161824120|NCT00098475|584397916|FG003|Step 1|Other disease|0|||
161824121|NCT00098475|584397913|FG000|Step 1|Never started treatment|0|||
161824122|NCT00098475|584397914|FG001|Step 1|Never started treatment|2|||
161824123|NCT00098475|584397915|FG002|Step 1|Never started treatment|0|||
161824124|NCT00098475|584397916|FG003|Step 1|Never started treatment|0|||
161824125|NCT00098475|584397913|FG000|Step 1|Still on treatment as of this analysis|14|||
161824126|NCT00098475|584397914|FG001|Step 1|Still on treatment as of this analysis|27|||
161824127|NCT00098475|584397915|FG002|Step 1|Still on treatment as of this analysis|0|||
161824128|NCT00098475|584397916|FG003|Step 1|Still on treatment as of this analysis|0|||
161824129|NCT00098475|584397913|FG000|Step 1|Knee surgery|1|||
161824130|NCT00098475|584397914|FG001|Step 1|Knee surgery|0|||
161824131|NCT00098475|584397915|FG002|Step 1|Knee surgery|0|||
161824132|NCT00098475|584397916|FG003|Step 1|Knee surgery|0|||
161824133|NCT00098475|584397913|FG000|Step 1|Complications|1|||
161824134|NCT00098475|584397914|FG001|Step 1|Complications|0|||
161824135|NCT00098475|584397915|FG002|Step 1|Complications|0|||
161824136|NCT00098475|584397916|FG003|Step 1|Complications|0|||
161824137|NCT00098475|584397913|FG000|Step 1|Cannot comply due to other tx|0|||
161824138|NCT00098475|584397914|FG001|Step 1|Cannot comply due to other tx|1|||
161824139|NCT00098475|584397915|FG002|Step 1|Cannot comply due to other tx|0|||
161824140|NCT00098475|584397916|FG003|Step 1|Cannot comply due to other tx|0|||
161824141|NCT00098475|584397913|FG000|Step 1|Both patient and physician's decision|2|||
161516960|NCT00555438|583282752|FG000|10 Days Post-operative|Death|4|||
161516961|NCT00555438|583282752|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
161516962|NCT00441337|583282754|FG000|Overall Study|Disease Progression|6|||
161516963|NCT00441337|583282755|FG001|Overall Study|Disease Progression|6|||
161516964|NCT00441337|583282756|FG002|Overall Study|Disease Progression|4|||
161516965|NCT00441337|583282757|FG003|Overall Study|Disease Progression|18|||
161516966|NCT00441337|583282754|FG000|Overall Study|Lost to Follow-up|0|||
161516967|NCT00441337|583282755|FG001|Overall Study|Lost to Follow-up|0|||
161516968|NCT00441337|583282756|FG002|Overall Study|Lost to Follow-up|0|||
161516969|NCT00441337|583282757|FG003|Overall Study|Lost to Follow-up|1|||
161516970|NCT00441337|583282754|FG000|Overall Study|Sponsor Decision|0|||
161588856|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588857|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588858|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
161588859|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
161588860|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
161588861|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588862|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588863|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588864|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588865|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588866|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588867|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
161588868|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588869|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161516971|NCT00441337|583282755|FG001|Overall Study|Sponsor Decision|0|||
161516972|NCT00441337|583282756|FG002|Overall Study|Sponsor Decision|1|||
161516973|NCT00441337|583282757|FG003|Overall Study|Sponsor Decision|2|||
161516974|NCT00441337|583282754|FG000|Overall Study|Did not meet inclusion criteria|0|||
161516975|NCT00441337|583282755|FG001|Overall Study|Did not meet inclusion criteria|0|||
161516976|NCT00441337|583282756|FG002|Overall Study|Did not meet inclusion criteria|1|||
161516977|NCT00441337|583282757|FG003|Overall Study|Did not meet inclusion criteria|0|||
161516978|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
161516979|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
161516980|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
161516981|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Death|1|||
161516982|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Death|0|||
161516983|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Death|0|||
161516984|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
161516985|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
161516986|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
161516987|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
161516988|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
161516989|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
161516990|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
161516991|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
161516992|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
161516993|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
161516994|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
161588870|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588871|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588872|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588873|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
161588874|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161824142|NCT00098475|584397914|FG001|Step 1|Both patient and physician's decision|1|||
161516995|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
161516996|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
161824143|NCT00098475|584397915|FG002|Step 1|Both patient and physician's decision|0|||
161932155|NCT00480025|584798822|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
161932156|NCT00480025|584798823|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
161932157|NCT00480025|584798822|FG000|Overall Study|Disease Progression / Recurrence|449|||
161932158|NCT00480025|584798823|FG001|Overall Study|Disease Progression / Recurrence|224|||
161516997|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
161516998|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
161516999|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
161517000|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
161517001|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
161517002|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
161517003|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
161517004|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
161517005|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
161517006|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
161517007|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
161517008|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
161517009|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
161517010|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
161517011|NCT03655236|583282758|FG000|Subject Disposition in Part 1 Period|Other|0|||
161517012|NCT03655236|583282759|FG001|Subject Disposition in Part 1 Period|Other|2|||
161517013|NCT03655236|583282760|FG002|Subject Disposition in Part 1 Period|Other|2|||
161517014|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
161517015|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
161588875|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588876|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588877|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588878|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588879|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588880|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161588881|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588882|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588883|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588884|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
161588885|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
161588886|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
161588887|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588888|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588889|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588890|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588891|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588892|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588893|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161588894|NCT01261312|583544585|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588895|NCT01261312|583544586|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588896|NCT01261312|583544587|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588897|NCT01261312|583544588|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
161588898|NCT01261312|583544589|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161588899|NCT01261312|583544590|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161588900|NCT01261312|583544591|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588901|NCT01261312|583544592|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588902|NCT01261312|583544593|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588903|NCT01261312|583544594|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588904|NCT01261312|583544595|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588905|NCT01261312|583544596|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588906|NCT01261312|583544597|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161588907|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588908|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588909|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588910|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588911|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588912|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161932159|NCT00480025|584798822|FG000|Overall Study|Adverse Event|44|||
161588913|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
161588914|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
161932160|NCT00480025|584798823|FG001|Overall Study|Adverse Event|12|||
161932161|NCT00480025|584798822|FG000|Overall Study|Other|70|||
161932162|NCT00480025|584798823|FG001|Overall Study|Other|29|||
161932163|NCT00480025|584798822|FG000|Overall Study|SAE including intercurrent illness|76|||
161932164|NCT00480025|584798823|FG001|Overall Study|SAE including intercurrent illness|42|||
161932165|NCT01064622|584798824|FG000|Randomized Phase II|Withdrawal by Subject|2|||
161932166|NCT01064622|584798825|FG001|Randomized Phase II|Withdrawal by Subject|2|||
161517016|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
161517017|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
161517018|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
161517019|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
161517020|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
161517021|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
161517022|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
161517023|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
161517024|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
161517025|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
161517026|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
161517027|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
161517028|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
161517029|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
161517030|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
161517031|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
161517032|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
161517033|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
161517034|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
161517035|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
161517036|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
161517037|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
161517038|NCT03655236|583282758|FG000|Subject Disposition in Part 2 Period|Other|1|||
161517039|NCT03655236|583282759|FG001|Subject Disposition in Part 2 Period|Other|0|||
161517040|NCT03655236|583282760|FG002|Subject Disposition in Part 2 Period|Other|0|||
161517041|NCT06748040|583282761|FG000|Overall Study|Death|3|||
161517042|NCT06748040|583282762|FG001|Overall Study|Death|4|||
161517043|NCT06748040|583282761|FG000|Overall Study|Lost to Follow-up|134|||
161517044|NCT06748040|583282762|FG001|Overall Study|Lost to Follow-up|132|||
161517045|NCT06748040|583282761|FG000|Overall Study|Withdrawal by Subject|3|||
161517046|NCT06748040|583282762|FG001|Overall Study|Withdrawal by Subject|5|||
161517047|NCT03136068|583284397|FG000|Overall Study|Lost to Follow-up|1|||
161517048|NCT03136068|583284398|FG001|Overall Study|Lost to Follow-up|1|||
161517049|NCT03136068|583284397|FG000|Overall Study|Protocol Violation|1|||
161517050|NCT03136068|583284398|FG001|Overall Study|Protocol Violation|0|||
161517051|NCT00432380|583284399|FG000|Overall Study|Migrated/moved from study area|3|||
161517052|NCT00432380|583284400|FG001|Overall Study|Migrated/moved from study area|4|||
161517053|NCT00432380|583284401|FG002|Overall Study|Migrated/moved from study area|1|||
161517054|NCT00432380|583284399|FG000|Overall Study|Adverse Event|1|||
161517055|NCT00432380|583284400|FG001|Overall Study|Adverse Event|0|||
161517056|NCT00432380|583284401|FG002|Overall Study|Adverse Event|0|||
161824144|NCT00098475|584397916|FG003|Step 1|Both patient and physician's decision|0|||
161824145|NCT00098475|584397913|FG000|Step 1|Incorrect disease assessment|2|||
161824146|NCT00098475|584397914|FG001|Step 1|Incorrect disease assessment|0|||
161824147|NCT00098475|584397915|FG002|Step 1|Incorrect disease assessment|0|||
161824148|NCT00098475|584397916|FG003|Step 1|Incorrect disease assessment|0|||
161824149|NCT00098475|584397913|FG000|Step 1|Off treatment for > specified timeframe|1|||
161824150|NCT00098475|584397914|FG001|Step 1|Off treatment for > specified timeframe|1|||
161824151|NCT00098475|584397915|FG002|Step 1|Off treatment for > specified timeframe|0|||
161932167|NCT01064622|584798824|FG000|Randomized Phase II|Protocol Violation|0|||
161517057|NCT01071395|583284402|FG000|Overall Study|Withdrawal by Subject|2|||
161517058|NCT01071395|583284403|FG001|Overall Study|Withdrawal by Subject|1|||
161517059|NCT01071395|583284402|FG000|Overall Study|Adverse Event|3|||
161517060|NCT01071395|583284403|FG001|Overall Study|Adverse Event|1|||
161517061|NCT04419493|583284404|FG000|Wash-out After Period 1|Adverse Event|1|||
161517062|NCT04419493|583284405|FG001|Wash-out After Period 1|Adverse Event|2|||
161517063|NCT04419493|583284406|FG002|Wash-out After Period 1|Adverse Event|1|||
161588915|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
161932168|NCT01064622|584798825|FG001|Randomized Phase II|Protocol Violation|1|||
161517064|NCT04419493|583284407|FG003|Wash-out After Period 1|Adverse Event|0|||
161517065|NCT00524134|583284408|FG000|Overall Study|Withdrawal by Subject|1|||
161517066|NCT00524134|583284408|FG000|Overall Study|Physician Decision|1|||
161517067|NCT03794089|583284409|FG000|Overall Study|Lost to Follow-up|4|||
161517068|NCT03794089|583284410|FG001|Overall Study|Lost to Follow-up|1|||
161517069|NCT03794089|583284409|FG000|Overall Study|Withdrawal by Subject|2|||
161588916|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161517070|NCT03794089|583284410|FG001|Overall Study|Withdrawal by Subject|0|||
161517071|NCT03985423|583284411|FG000|Overall Study|Adverse Event|1|||
161517072|NCT03985423|583284411|FG000|Overall Study|Death|2|||
161517073|NCT03985423|583284411|FG000|Overall Study|Physician Decision|1|||
161517074|NCT03985423|583284411|FG000|Overall Study|Withdrawal by Subject|2|||
161517075|NCT03985423|583284411|FG000|Overall Study|Lack of insurance and citizenship|1|||
161517076|NCT01045447|583284422|FG000|Overall Study|Adverse Event|0|||
161517077|NCT01045447|583284423|FG001|Overall Study|Adverse Event|1|||
161517078|NCT01045447|583284422|FG000|Overall Study|Lack of Efficacy|3|||
161517079|NCT01045447|583284423|FG001|Overall Study|Lack of Efficacy|1|||
161517080|NCT01045447|583284422|FG000|Overall Study|Protocol Violation|6|||
161517081|NCT01045447|583284423|FG001|Overall Study|Protocol Violation|3|||
161517082|NCT01045447|583284422|FG000|Overall Study|Withdrawal Criteria|10|||
161517083|NCT01045447|583284423|FG001|Overall Study|Withdrawal Criteria|10|||
161517084|NCT01045447|583284422|FG000|Overall Study|Unclassified|17|||
161517085|NCT01045447|583284423|FG001|Overall Study|Unclassified|13|||
161517086|NCT01782131|583284427|FG000|Overall Study|Death|93|||
161517087|NCT01782131|583284428|FG001|Overall Study|Death|96|||
161517088|NCT01782131|583284427|FG000|Overall Study|Lost to Follow-up|1|||
161517089|NCT01782131|583284428|FG001|Overall Study|Lost to Follow-up|3|||
161517090|NCT01782131|583284427|FG000|Overall Study|Withdrawal by Subject|10|||
161517091|NCT01782131|583284428|FG001|Overall Study|Withdrawal by Subject|10|||
161517092|NCT01782131|583284427|FG000|Overall Study|Randomized but not treated|5|||
161517093|NCT01782131|583284428|FG001|Overall Study|Randomized but not treated|5|||
161517094|NCT01782131|583284427|FG000|Overall Study|Reason not provided|0|||
161517095|NCT01782131|583284428|FG001|Overall Study|Reason not provided|1|||
161517096|NCT01627249|583284429|FG000|Overall Study|Death|3|||
161824152|NCT00098475|584397916|FG003|Step 1|Off treatment for > specified timeframe|0|||
161824153|NCT00098475|584397913|FG000|Step 1|Declining performance status|0|||
161824154|NCT00098475|584397914|FG001|Step 1|Declining performance status|1|||
161824155|NCT00098475|584397915|FG002|Step 1|Declining performance status|0|||
161824156|NCT00098475|584397916|FG003|Step 1|Declining performance status|0|||
161824157|NCT00098475|584397913|FG000|Step 1|Insurance issue|0|||
161824158|NCT00098475|584397914|FG001|Step 1|Insurance issue|1|||
161824159|NCT00098475|584397915|FG002|Step 1|Insurance issue|0|||
161824160|NCT00098475|584397916|FG003|Step 1|Insurance issue|0|||
161824161|NCT00098475|584397913|FG000|Step 1|Rising paraprotein|0|||
161824162|NCT00098475|584397914|FG001|Step 1|Rising paraprotein|1|||
161824163|NCT00098475|584397915|FG002|Step 1|Rising paraprotein|0|||
161517097|NCT01627249|583284430|FG001|Overall Study|Death|5|||
161517098|NCT01627249|583284431|FG002|Overall Study|Death|3|||
161517099|NCT01627249|583284429|FG000|Overall Study|Withdrawal by Subject|12|||
161517100|NCT01627249|583284430|FG001|Overall Study|Withdrawal by Subject|6|||
161517101|NCT01627249|583284431|FG002|Overall Study|Withdrawal by Subject|9|||
161517102|NCT01627249|583284429|FG000|Overall Study|Missed Visit|1|||
161517103|NCT01627249|583284430|FG001|Overall Study|Missed Visit|1|||
161517104|NCT01627249|583284431|FG002|Overall Study|Missed Visit|0|||
161517105|NCT00796718|583284432|FG000|Overall Study|Adverse Event|2|||
161517106|NCT00796718|583284432|FG000|Overall Study|Exclusion Criteria|1|||
161517107|NCT00796718|583284432|FG000|Overall Study|Lost to Follow-up|5|||
161517108|NCT00796718|583284432|FG000|Overall Study|Withdrawal by Informed Consent|1|||
161517109|NCT03266588|583284433|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
161517110|NCT03266588|583284434|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
161517111|NCT03266588|583284435|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
161517112|NCT03266588|583284433|FG000|Observational Period|Withdrawal by Subject|44|||
161517113|NCT03266588|583284434|FG001|Observational Period|Withdrawal by Subject|22|||
161824164|NCT00098475|584397916|FG003|Step 1|Rising paraprotein|0|||
161824165|NCT00098475|584397913|FG000|Step 1|Referred to other physicians|0|||
161517114|NCT03266588|583284435|FG002|Observational Period|Withdrawal by Subject|13|||
161517115|NCT03266588|583284433|FG000|Observational Period|Non-compliance|18|||
161517116|NCT03266588|583284434|FG001|Observational Period|Non-compliance|12|||
161517117|NCT03266588|583284435|FG002|Observational Period|Non-compliance|10|||
161517118|NCT03266588|583284433|FG000|Observational Period|Lost to Follow-up|8|||
161517119|NCT03266588|583284434|FG001|Observational Period|Lost to Follow-up|12|||
161517120|NCT03266588|583284435|FG002|Observational Period|Lost to Follow-up|4|||
161517121|NCT03266588|583284433|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
161517122|NCT03266588|583284434|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
161517123|NCT03266588|583284435|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
161517124|NCT03266588|583284433|FG000|Observational Period|Protocol Deviation|1|||
161517125|NCT03266588|583284434|FG001|Observational Period|Protocol Deviation|0|||
161517126|NCT03266588|583284435|FG002|Observational Period|Protocol Deviation|0|||
161517127|NCT03266588|583284433|FG000|Observational Period|Other Reasons|3|||
161517128|NCT03266588|583284434|FG001|Observational Period|Other Reasons|0|||
161517129|NCT03266588|583284435|FG002|Observational Period|Other Reasons|1|||
161517130|NCT03266588|583284433|FG000|Long-term Treatment Period|Adverse Event|33|||
161517131|NCT03266588|583284434|FG001|Long-term Treatment Period|Adverse Event|17|||
161824166|NCT00098475|584397914|FG001|Step 1|Referred to other physicians|1|||
161517132|NCT03266588|583284435|FG002|Long-term Treatment Period|Adverse Event|8|||
161517133|NCT03266588|583284433|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
161517134|NCT03266588|583284434|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
161517135|NCT03266588|583284435|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
161517136|NCT03266588|583284433|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
161517137|NCT03266588|583284434|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
161517138|NCT03266588|583284435|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
161517139|NCT03266588|583284433|FG000|Long-term Treatment Period|Non-Compliance|126|||
161517140|NCT03266588|583284434|FG001|Long-term Treatment Period|Non-Compliance|57|||
161517141|NCT03266588|583284435|FG002|Long-term Treatment Period|Non-Compliance|7|||
161517142|NCT03266588|583284433|FG000|Long-term Treatment Period|Pregnancy|11|||
161517143|NCT03266588|583284434|FG001|Long-term Treatment Period|Pregnancy|5|||
161517144|NCT03266588|583284435|FG002|Long-term Treatment Period|Pregnancy|0|||
161517145|NCT03266588|583284433|FG000|Long-term Treatment Period|Protocol Deviation|17|||
161517146|NCT03266588|583284434|FG001|Long-term Treatment Period|Protocol Deviation|10|||
161517147|NCT03266588|583284435|FG002|Long-term Treatment Period|Protocol Deviation|4|||
161517148|NCT03266588|583284433|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
161517149|NCT03266588|583284434|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
161517150|NCT03266588|583284435|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
161517151|NCT03266588|583284433|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
161517152|NCT03266588|583284434|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
161517153|NCT03266588|583284435|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
161517154|NCT03266588|583284433|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
161932169|NCT05330429|584798826|FG000|Overall Study|Study Terminated by Sponsor|4|||
161932170|NCT05330429|584798827|FG001|Overall Study|Study Terminated by Sponsor|33|||
161932171|NCT05330429|584798828|FG002|Overall Study|Study Terminated by Sponsor|12|||
161932172|NCT05330429|584798826|FG000|Overall Study|Death|5|||
161932173|NCT05330429|584798827|FG001|Overall Study|Death|2|||
161932174|NCT05330429|584798828|FG002|Overall Study|Death|4|||
161932175|NCT05330429|584798826|FG000|Overall Study|Withdrew Consent|0|||
161932176|NCT05330429|584798827|FG001|Overall Study|Withdrew Consent|5|||
161517155|NCT03266588|583284434|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
161517156|NCT03266588|583284435|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
161517157|NCT03266588|583284433|FG000|Long-term Treatment Period|Other Reasons|5|||
161517158|NCT03266588|583284434|FG001|Long-term Treatment Period|Other Reasons|0|||
161517159|NCT03266588|583284435|FG002|Long-term Treatment Period|Other Reasons|0|||
161517160|NCT03266588|583284433|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
161517161|NCT03266588|583284434|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
161517162|NCT03266588|583284435|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
161517163|NCT02039505|583284438|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
161517164|NCT02039505|583284439|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
161517165|NCT02039505|583284440|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
161517166|NCT02039505|583284441|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
161517167|NCT02039505|583284442|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
161517168|NCT02039505|583284443|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
161517169|NCT02039505|583284444|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
161517170|NCT02039505|583284438|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
161517171|NCT02039505|583284439|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
161517172|NCT02039505|583284440|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
161517173|NCT02039505|583284441|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
161517174|NCT02039505|583284442|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
161517175|NCT02039505|583284443|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
161517176|NCT02039505|583284444|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
161517177|NCT02039505|583284438|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
161517178|NCT02039505|583284439|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
161517179|NCT02039505|583284440|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
161517180|NCT02039505|583284441|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
161517181|NCT02039505|583284442|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
161517182|NCT02039505|583284443|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
161517183|NCT02039505|583284444|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
161517184|NCT02039505|583284438|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
161932177|NCT05330429|584798828|FG002|Overall Study|Withdrew Consent|4|||
161932178|NCT05330429|584798826|FG000|Overall Study|Investigator's Discretion|0|||
161932179|NCT05330429|584798827|FG001|Overall Study|Investigator's Discretion|1|||
161932180|NCT05330429|584798828|FG002|Overall Study|Investigator's Discretion|3|||
161932181|NCT05330429|584798826|FG000|Overall Study|Subject Decision|1|||
161932182|NCT05330429|584798827|FG001|Overall Study|Subject Decision|2|||
161932183|NCT05330429|584798828|FG002|Overall Study|Subject Decision|0|||
161932184|NCT05330429|584798826|FG000|Overall Study|Lost to Follow-up|0|||
161517185|NCT02039505|583284439|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
161517186|NCT02039505|583284440|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
161517187|NCT02039505|583284441|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
161517188|NCT02039505|583284442|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
161517189|NCT02039505|583284443|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
161517190|NCT02039505|583284444|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
161517191|NCT02039505|583284438|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
161517192|NCT02039505|583284439|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
161517193|NCT02039505|583284440|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
161517194|NCT02039505|583284441|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
161517195|NCT02039505|583284442|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
161517196|NCT02039505|583284443|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
161517197|NCT02039505|583284444|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
161517198|NCT02039505|583284438|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
161517199|NCT02039505|583284439|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
161517200|NCT02039505|583284440|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
161517201|NCT02039505|583284441|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
161517202|NCT02039505|583284442|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
161517203|NCT02039505|583284443|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
161517204|NCT02039505|583284444|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
161517205|NCT02039505|583284438|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
161517206|NCT02039505|583284439|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
161517207|NCT02039505|583284440|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
161517208|NCT02039505|583284441|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
161517209|NCT02039505|583284442|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
161517210|NCT02039505|583284443|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
161517211|NCT02039505|583284444|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
161517212|NCT02039505|583284438|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
161517213|NCT02039505|583284439|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
161517214|NCT02039505|583284440|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
161517215|NCT02039505|583284441|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
161517216|NCT02039505|583284442|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
161517217|NCT02039505|583284443|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
161517218|NCT02039505|583284444|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
161517219|NCT02039505|583284438|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
161517220|NCT02039505|583284439|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
161517221|NCT02039505|583284440|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
161517222|NCT02039505|583284441|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
161517223|NCT02039505|583284442|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
161517224|NCT02039505|583284443|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
161517225|NCT02039505|583284444|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
161517226|NCT02039505|583284438|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
161517227|NCT02039505|583284439|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
161517228|NCT02039505|583284440|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
161517229|NCT02039505|583284441|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
161517230|NCT02039505|583284442|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
161517231|NCT02039505|583284443|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
161517232|NCT02039505|583284444|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
161517233|NCT02039505|583284438|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
161517234|NCT02039505|583284439|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
161517235|NCT02039505|583284440|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
161517236|NCT02039505|583284441|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
161517237|NCT02039505|583284442|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
161517238|NCT02039505|583284443|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
161517239|NCT02039505|583284444|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
161517240|NCT00353704|583284451|FG000|Overall Study|Protocol Violation|3|||
161517241|NCT00353704|583284452|FG001|Overall Study|Protocol Violation|1|||
161517242|NCT01154166|583284453|FG000|Overall Study|Adverse Event|14|||
161517243|NCT01154166|583284454|FG001|Overall Study|Adverse Event|9|||
161517244|NCT01154166|583284453|FG000|Overall Study|Lost to Follow-up|1|||
161517245|NCT01154166|583284454|FG001|Overall Study|Lost to Follow-up|1|||
161517246|NCT01154166|583284453|FG000|Overall Study|Protocol Violation|4|||
161517247|NCT01154166|583284454|FG001|Overall Study|Protocol Violation|1|||
161517248|NCT01154166|583284453|FG000|Overall Study|Withdrawal by Subject|10|||
161517249|NCT01154166|583284454|FG001|Overall Study|Withdrawal by Subject|1|||
161517250|NCT01154166|583284453|FG000|Overall Study|Lack of Efficacy|3|||
161517251|NCT01154166|583284454|FG001|Overall Study|Lack of Efficacy|0|||
161517252|NCT01154166|583284453|FG000|Overall Study|Disease Progression|1|||
161517253|NCT01154166|583284454|FG001|Overall Study|Disease Progression|0|||
161517254|NCT01154166|583284453|FG000|Overall Study|Poor Compliance|1|||
161517255|NCT01154166|583284454|FG001|Overall Study|Poor Compliance|0|||
161517256|NCT01375049|583284455|FG000|Overall Study|Adverse Event|2|||
161517257|NCT01375049|583284455|FG000|Overall Study|Lost to Follow-up|1|||
161517258|NCT01375049|583284455|FG000|Overall Study|Withdrawal by Subject|2|||
161517259|NCT01375049|583284455|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
161517260|NCT03614793|583284456|FG000|Overall Study|Lost to Follow-up|1|||
161517261|NCT03614793|583284457|FG001|Overall Study|Lost to Follow-up|2|||
161517262|NCT03614793|583284456|FG000|Overall Study|Lack of Efficacy|0|||
161517263|NCT03614793|583284457|FG001|Overall Study|Lack of Efficacy|5|||
161517264|NCT03614793|583284456|FG000|Overall Study|Withdrawal by Subject|0|||
161517265|NCT03614793|583284457|FG001|Overall Study|Withdrawal by Subject|1|||
161517266|NCT03614793|583284456|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
161517267|NCT03614793|583284457|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
161517268|NCT02082522|583284458|FG000|Overall Study|Sponsor termination|5|||
161517269|NCT02082522|583284459|FG001|Overall Study|Sponsor termination|3|||
161517270|NCT02082522|583284458|FG000|Overall Study|Withdrawal by Subject|2|||
161517271|NCT02082522|583284459|FG001|Overall Study|Withdrawal by Subject|4|||
161517272|NCT02082522|583284458|FG000|Overall Study|Death|1|||
161517273|NCT02082522|583284459|FG001|Overall Study|Death|0|||
161517274|NCT02082522|583284458|FG000|Overall Study|Lost to Follow-up|1|||
161517275|NCT02082522|583284459|FG001|Overall Study|Lost to Follow-up|0|||
161517276|NCT02082522|583284458|FG000|Overall Study|Physician Decision|3|||
161517277|NCT02082522|583284459|FG001|Overall Study|Physician Decision|1|||
161517278|NCT02082522|583284458|FG000|Overall Study|Disease progression|2|||
161932185|NCT05330429|584798827|FG001|Overall Study|Lost to Follow-up|1|||
161932186|NCT05330429|584798828|FG002|Overall Study|Lost to Follow-up|0|||
161932187|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
161932188|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
161932189|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
161932190|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Adverse Event|5|||
161932191|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Adverse Event|1|||
161932192|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Adverse Event|0|||
161932193|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
161932194|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
161932195|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
161932196|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Death|8|||
161932197|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Death|24|||
161932198|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Death|0|||
161932199|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
161932200|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
161932201|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
161932202|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
161932203|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
161932204|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
161932205|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
161932206|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
161932207|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
161932208|NCT02931539|584798832|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
161932209|NCT02931539|584798833|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
161932210|NCT02931539|584798834|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
161932211|NCT06097273|584798837|FG000|Overall Study|Death|2|||
161932212|NCT06097273|584798838|FG001|Overall Study|Death|1|||
161517279|NCT02082522|583284459|FG001|Overall Study|Disease progression|2|||
161517280|NCT02082522|583284458|FG000|Overall Study|Chemotherapy change|1|||
161517281|NCT02082522|583284459|FG001|Overall Study|Chemotherapy change|3|||
161932213|NCT06097273|584798839|FG002|Overall Study|Death|2|||
161932214|NCT06097273|584798840|FG003|Overall Study|Death|2|||
161932215|NCT06097273|584798837|FG000|Overall Study|Lost to Follow-up|27|||
161932216|NCT06097273|584798838|FG001|Overall Study|Lost to Follow-up|18|||
161932217|NCT06097273|584798839|FG002|Overall Study|Lost to Follow-up|36|||
161932218|NCT06097273|584798840|FG003|Overall Study|Lost to Follow-up|31|||
161932219|NCT06097273|584798837|FG000|Overall Study|Physician Decision|0|||
161932220|NCT06097273|584798838|FG001|Overall Study|Physician Decision|1|||
161932221|NCT06097273|584798839|FG002|Overall Study|Physician Decision|0|||
161932222|NCT06097273|584798840|FG003|Overall Study|Physician Decision|3|||
161932223|NCT06097273|584798837|FG000|Overall Study|Protocol Violation|1|||
161517282|NCT00633984|583284460|FG000|Overall Study|Lost to Follow-up|0|||
161517283|NCT00633984|583284461|FG001|Overall Study|Lost to Follow-up|6|||
161517284|NCT00633984|583284460|FG000|Overall Study|Withdrawal by Subject|8|||
161517285|NCT00633984|583284461|FG001|Overall Study|Withdrawal by Subject|7|||
161517286|NCT00633984|583284460|FG000|Overall Study|Hospitalized|1|||
161932224|NCT06097273|584798838|FG001|Overall Study|Protocol Violation|1|||
161932225|NCT06097273|584798839|FG002|Overall Study|Protocol Violation|2|||
161932226|NCT06097273|584798840|FG003|Overall Study|Protocol Violation|1|||
161932227|NCT06097273|584798837|FG000|Overall Study|Withdrawal by Subject|14|||
161932228|NCT06097273|584798838|FG001|Overall Study|Withdrawal by Subject|11|||
161932229|NCT06097273|584798839|FG002|Overall Study|Withdrawal by Subject|14|||
161932230|NCT06097273|584798840|FG003|Overall Study|Withdrawal by Subject|15|||
161932231|NCT06097273|584798837|FG000|Overall Study|Other Than Specified|7|||
161932232|NCT06097273|584798838|FG001|Overall Study|Other Than Specified|3|||
161932233|NCT06097273|584798839|FG002|Overall Study|Other Than Specified|11|||
161932234|NCT06097273|584798840|FG003|Overall Study|Other Than Specified|6|||
161932235|NCT00368849|584800420|FG000|Overall Study|Withdrawal by Subject|0|||
161932236|NCT00368849|584800421|FG001|Overall Study|Withdrawal by Subject|1|||
161932237|NCT00368849|584800420|FG000|Overall Study|Physician Decision|0|||
161517287|NCT00633984|583284461|FG001|Overall Study|Hospitalized|0|||
161517288|NCT02840877|583284462|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
161517289|NCT02840877|583284462|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
161517290|NCT02840877|583284462|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
161517291|NCT02840877|583284462|FG000|Baseline to 12 Weeks|Death|1|||
161517292|NCT02840877|583284462|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
161517293|NCT02840877|583284462|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
161517294|NCT02840877|583284462|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
161517295|NCT02840877|583284462|FG000|12 Weeks to 6 Months|Treatment failure|1|||
161517296|NCT02840877|583284462|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
161517297|NCT02840877|583284462|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
161517298|NCT02840877|583284462|FG000|12 Weeks to 6 Months|Death|1|||
161517299|NCT02840877|583284462|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
161517300|NCT02840877|583284462|FG000|6 Months to 18 Months|Treatment failure|7|||
161517301|NCT02840877|583284462|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
161517302|NCT02840877|583284462|FG000|6 Months to 18 Months|Moved/transferred out|6|||
161517303|NCT02840877|583284462|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
161517304|NCT02840877|583284462|FG000|6 Months to 18 Months|Death|4|||
161517305|NCT02840877|583284462|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
161517306|NCT02840877|583284462|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
161517307|NCT02840877|583284462|FG000|6 Months to 18 Months|Still in study.|14|||
161517308|NCT02496884|583284463|FG000|Overall Study|Counted twice as enrolled|2|||
161517309|NCT02496884|583284464|FG001|Overall Study|Counted twice as enrolled|0|||
161517310|NCT02496884|583284465|FG002|Overall Study|Counted twice as enrolled|0|||
161517311|NCT02496884|583284466|FG003|Overall Study|Counted twice as enrolled|0|||
161517312|NCT02496884|583284463|FG000|Overall Study|Withdrawal by Subject|0|||
161517313|NCT02496884|583284464|FG001|Overall Study|Withdrawal by Subject|3|||
161517314|NCT02496884|583284465|FG002|Overall Study|Withdrawal by Subject|0|||
161517315|NCT02496884|583284466|FG003|Overall Study|Withdrawal by Subject|0|||
161517316|NCT01168999|583284467|FG000|Overall Study|Lost to Follow-up|2|||
161517317|NCT01168999|583284468|FG001|Overall Study|Lost to Follow-up|1|||
161517318|NCT01168999|583284469|FG002|Overall Study|Lost to Follow-up|0|||
161517319|NCT01168999|583284470|FG003|Overall Study|Lost to Follow-up|0|||
161517320|NCT04317586|583284471|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
161517321|NCT04317586|583284471|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
161517322|NCT01276327|583284474|FG000|Overall Study|Adverse Event|1|||
161517323|NCT01276327|583284475|FG001|Overall Study|Adverse Event|3|||
161517324|NCT01276327|583284474|FG000|Overall Study|Withdrawal by Subject|1|||
161517325|NCT01276327|583284475|FG001|Overall Study|Withdrawal by Subject|0|||
161517326|NCT00807092|583284476|FG000|Overall Study|Adverse Event|0|||
161517327|NCT00807092|583284477|FG001|Overall Study|Adverse Event|1|||
161517328|NCT00807092|583284476|FG000|Overall Study|Protocol Violation|0|||
161517329|NCT00807092|583284477|FG001|Overall Study|Protocol Violation|2|||
161517330|NCT00807092|583284476|FG000|Overall Study|Withdrawal by Subject|1|||
161517331|NCT00807092|583284477|FG001|Overall Study|Withdrawal by Subject|0|||
161517332|NCT00807092|583284476|FG000|Overall Study|CGMS data collection failed|0|||
161517333|NCT00807092|583284477|FG001|Overall Study|CGMS data collection failed|1|||
161517334|NCT01794949|583284478|FG000|Overall Study|Lost to Follow-up|1|||
161517335|NCT01794949|583284479|FG001|Overall Study|Lost to Follow-up|0|||
161517336|NCT03003676|583284480|FG000|Overall Study|Lack of Efficacy|5|||
161517337|NCT03003676|583284481|FG001|Overall Study|Lack of Efficacy|7|||
161517338|NCT03003676|583284480|FG000|Overall Study|Withdrawal by Subject|0|||
161517339|NCT03003676|583284481|FG001|Overall Study|Withdrawal by Subject|1|||
161517340|NCT03003676|583284480|FG000|Overall Study|Hepatitis B infection|1|||
161932238|NCT00368849|584800421|FG001|Overall Study|Physician Decision|1|||
161517341|NCT03003676|583284481|FG001|Overall Study|Hepatitis B infection|0|||
161517342|NCT00887341|583284500|FG000|Overall Study|Refused treatment|1|||
161932239|NCT01699685|584800422|FG000|Period 1|Adverse Event|1|||
161517343|NCT00887341|583284501|FG001|Overall Study|Refused treatment|0|||
161517344|NCT00887341|583284500|FG000|Overall Study|Withdrawal by Subject|1|||
161932240|NCT01699685|584800423|FG001|Period 1|Adverse Event|1|||
161824167|NCT00098475|584397915|FG002|Step 1|Referred to other physicians|0|||
161824168|NCT00098475|584397916|FG003|Step 1|Referred to other physicians|0|||
161824169|NCT00098475|584397913|FG000|Step 1|Criteria to continue treatment not met|0|||
161824170|NCT00098475|584397914|FG001|Step 1|Criteria to continue treatment not met|1|||
161824171|NCT00098475|584397915|FG002|Step 1|Criteria to continue treatment not met|0|||
161824172|NCT00098475|584397916|FG003|Step 1|Criteria to continue treatment not met|0|||
161824173|NCT00098475|584397913|FG000|Step 1|Misinterpretation of lab data|0|||
161824174|NCT00098475|584397914|FG001|Step 1|Misinterpretation of lab data|1|||
161824175|NCT00098475|584397915|FG002|Step 1|Misinterpretation of lab data|0|||
161824176|NCT00098475|584397916|FG003|Step 1|Misinterpretation of lab data|0|||
161824177|NCT00098475|584397913|FG000|Step 1|Patient fell with fracture|1|||
161824178|NCT00098475|584397914|FG001|Step 1|Patient fell with fracture|0|||
161824179|NCT00098475|584397915|FG002|Step 1|Patient fell with fracture|0|||
161824180|NCT00098475|584397916|FG003|Step 1|Patient fell with fracture|0|||
161824181|NCT00098475|584397913|FG000|Step 1|Not documented|0|||
161824182|NCT00098475|584397914|FG001|Step 1|Not documented|1|||
161824183|NCT00098475|584397915|FG002|Step 1|Not documented|0|||
161824184|NCT00098475|584397916|FG003|Step 1|Not documented|0|||
161824185|NCT00098475|584397913|FG000|Step 2|Disease progression|1|||
161824186|NCT00098475|584397914|FG001|Step 2|Disease progression|4|||
161824187|NCT00098475|584397915|FG002|Step 2|Disease progression|0|||
161824188|NCT00098475|584397916|FG003|Step 2|Disease progression|0|||
161824189|NCT00098475|584397913|FG000|Step 2|Adverse Event|2|||
161824190|NCT00098475|584397914|FG001|Step 2|Adverse Event|0|||
161824191|NCT00098475|584397915|FG002|Step 2|Adverse Event|0|||
161824192|NCT00098475|584397916|FG003|Step 2|Adverse Event|0|||
161824193|NCT00098475|584397913|FG000|Step 2|Withdrawal by Subject|0|||
161824194|NCT00098475|584397914|FG001|Step 2|Withdrawal by Subject|2|||
161824195|NCT00098475|584397915|FG002|Step 2|Withdrawal by Subject|0|||
161824196|NCT00098475|584397916|FG003|Step 2|Withdrawal by Subject|0|||
161824197|NCT00098475|584397913|FG000|Step 2|Physician Decision|0|||
161824198|NCT00098475|584397914|FG001|Step 2|Physician Decision|1|||
161824199|NCT00098475|584397915|FG002|Step 2|Physician Decision|0|||
161824200|NCT00098475|584397916|FG003|Step 2|Physician Decision|0|||
161824201|NCT00098475|584397913|FG000|Step 2|Alternative therapy|1|||
161824202|NCT00098475|584397914|FG001|Step 2|Alternative therapy|2|||
161824203|NCT00098475|584397915|FG002|Step 2|Alternative therapy|0|||
161824204|NCT00098475|584397916|FG003|Step 2|Alternative therapy|0|||
161824205|NCT00098475|584397913|FG000|Step 2|Never started treatment|1|||
161824206|NCT00098475|584397914|FG001|Step 2|Never started treatment|1|||
161824207|NCT00098475|584397915|FG002|Step 2|Never started treatment|0|||
161824208|NCT00098475|584397916|FG003|Step 2|Never started treatment|0|||
161824209|NCT03422068|584397917|FG000|Overall Study|Adverse Event|0|||
161824210|NCT03422068|584397918|FG001|Overall Study|Adverse Event|1|||
161824211|NCT03422068|584397917|FG000|Overall Study|Inconvenience to frequent study visits|0|||
161824212|NCT03422068|584397918|FG001|Overall Study|Inconvenience to frequent study visits|1|||
161824213|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
161824214|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
161824215|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
161824216|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
161824217|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
161824218|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
161824219|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
161824220|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
161824221|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
161824222|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
161824223|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
161824224|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
161824225|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
161824226|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
161824227|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
161824228|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
161824229|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
161824230|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
161824231|NCT01067521|584397921|FG000|Open-Label Period|Death|3|||
161824232|NCT01067521|584397922|FG001|Open-Label Period|Death|1|||
161824233|NCT01067521|584397921|FG000|Open-Label Period|Adverse Event|30|||
161824234|NCT01067521|584397922|FG001|Open-Label Period|Adverse Event|28|||
161824235|NCT01067521|584397921|FG000|Open-Label Period|Withdrawal by Subject|160|||
161824236|NCT01067521|584397922|FG001|Open-Label Period|Withdrawal by Subject|88|||
161824237|NCT01067521|584397921|FG000|Open-Label Period|Physician Decision|13|||
161824238|NCT01067521|584397922|FG001|Open-Label Period|Physician Decision|11|||
161824239|NCT01067521|584397921|FG000|Open-Label Period|Non-compliance with study drug|5|||
161824240|NCT01067521|584397922|FG001|Open-Label Period|Non-compliance with study drug|0|||
161824241|NCT01067521|584397921|FG000|Open-Label Period|Protocol Violation|3|||
161824242|NCT01067521|584397922|FG001|Open-Label Period|Protocol Violation|0|||
161824243|NCT01067521|584397921|FG000|Open-Label Period|Pregnancy|14|||
161824244|NCT01067521|584397922|FG001|Open-Label Period|Pregnancy|8|||
161824245|NCT01067521|584397921|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
161824246|NCT01067521|584397922|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
161824247|NCT01067521|584397921|FG000|Open-Label Period|Lost to Follow-up|21|||
161517345|NCT00887341|583284501|FG001|Overall Study|Withdrawal by Subject|1|||
161517346|NCT00887341|583284500|FG000|Overall Study|Adverse Event|0|||
161517347|NCT00887341|583284501|FG001|Overall Study|Adverse Event|1|||
161517348|NCT00887341|583284500|FG000|Overall Study|Lost to Follow-up|0|||
161517349|NCT00887341|583284501|FG001|Overall Study|Lost to Follow-up|1|||
161517350|NCT02617589|583284502|FG000|Randomization|Request to Discontinue Study Treatment|1|||
161517351|NCT02617589|583284503|FG001|Randomization|Request to Discontinue Study Treatment|3|||
161517352|NCT02617589|583284502|FG000|Randomization|Participant Withdrew Consent|1|||
161517353|NCT02617589|583284503|FG001|Randomization|Participant Withdrew Consent|2|||
161517354|NCT02617589|583284502|FG000|Treatment|Other Reasons|3|||
161517355|NCT02617589|583284503|FG001|Treatment|Other Reasons|3|||
161517356|NCT02617589|583284502|FG000|Treatment|Poor/Non Compliance|1|||
161517357|NCT02617589|583284503|FG001|Treatment|Poor/Non Compliance|1|||
161517358|NCT02617589|583284502|FG000|Treatment|Maximum Clinical Benefit|0|||
161517359|NCT02617589|583284503|FG001|Treatment|Maximum Clinical Benefit|2|||
161517360|NCT02617589|583284502|FG000|Treatment|Participant Withdrew Consent|2|||
161517361|NCT02617589|583284503|FG001|Treatment|Participant Withdrew Consent|6|||
161517362|NCT02617589|583284502|FG000|Treatment|Participant Request to Discontinue|12|||
161517363|NCT02617589|583284503|FG001|Treatment|Participant Request to Discontinue|21|||
161517364|NCT02617589|583284502|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
161517365|NCT02617589|583284503|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
161824248|NCT01067521|584397922|FG001|Open-Label Period|Lost to Follow-up|20|||
161824249|NCT00057941|584397926|FG000|Overall Study|Death|1|||
161824250|NCT00057941|584397927|FG001|Overall Study|Death|2|||
161824251|NCT00057941|584397926|FG000|Overall Study|Adverse Event|7|||
161824252|NCT00057941|584397927|FG001|Overall Study|Adverse Event|9|||
161824253|NCT00057941|584397926|FG000|Overall Study|Lack of Efficacy|54|||
161824254|NCT00057941|584397927|FG001|Overall Study|Lack of Efficacy|53|||
161824255|NCT00057941|584397926|FG000|Overall Study|Withdrawal by Subject|6|||
161824256|NCT00057941|584397927|FG001|Overall Study|Withdrawal by Subject|1|||
161824257|NCT00057941|584397926|FG000|Overall Study|still on treatment|3|||
161824258|NCT00057941|584397927|FG001|Overall Study|still on treatment|1|||
161824259|NCT00057941|584397926|FG000|Overall Study|insurance, symptomatic deterioration|1|||
161824260|NCT00057941|584397927|FG001|Overall Study|insurance, symptomatic deterioration|3|||
161824261|NCT00057941|584397926|FG000|Overall Study|Ineligible|2|||
161824262|NCT00057941|584397927|FG001|Overall Study|Ineligible|5|||
161824263|NCT04142658|584397928|FG000|Overall Study|Death|2|||
161824264|NCT04142658|584397929|FG001|Overall Study|Death|1|||
161824265|NCT04142658|584397928|FG000|Overall Study|Lost to Follow-up|4|||
161824266|NCT04142658|584397929|FG001|Overall Study|Lost to Follow-up|13|||
161824267|NCT04142658|584397928|FG000|Overall Study|Withdrawal by Subject|9|||
161824268|NCT04142658|584397929|FG001|Overall Study|Withdrawal by Subject|16|||
161824269|NCT01781234|584397930|FG000|Overall Study|Adverse Event|2|||
161824270|NCT01781234|584397931|FG001|Overall Study|Adverse Event|0|||
161824271|NCT01781234|584397930|FG000|Overall Study|Protocol Violation|3|||
161824272|NCT01781234|584397931|FG001|Overall Study|Protocol Violation|0|||
161824273|NCT01781234|584397930|FG000|Overall Study|Withdrawal by Subject|4|||
161824274|NCT01781234|584397931|FG001|Overall Study|Withdrawal by Subject|3|||
161517366|NCT02617589|583284502|FG000|Treatment|Death|1|||
161517367|NCT02617589|583284503|FG001|Treatment|Death|1|||
161517368|NCT02617589|583284502|FG000|Treatment|Study Drug Toxicity|27|||
161517369|NCT02617589|583284503|FG001|Treatment|Study Drug Toxicity|20|||
161517370|NCT02617589|583284502|FG000|Treatment|Disease Progression|216|||
161517371|NCT02617589|583284503|FG001|Treatment|Disease Progression|136|||
161517372|NCT01752933|583284506|FG000|Treatment|Disease Progression|3|||
161517373|NCT01752933|583284507|FG001|Treatment|Disease Progression|29|||
161824275|NCT01685216|584397938|FG000|Overall Study|Did not receive study drug|1|||
161824276|NCT01294449|584397939|FG000|Overall Study|Death|11|||
161824277|NCT01294449|584397940|FG001|Overall Study|Death|12|||
161824278|NCT01294449|584397939|FG000|Overall Study|Withdrawal by Subject|1|||
161824279|NCT01294449|584397940|FG001|Overall Study|Withdrawal by Subject|3|||
161824280|NCT02466386|584397941|FG000|Overall Study|Adverse Event|5|||
161517374|NCT01752933|583284506|FG000|Treatment|Withdrawal by Subject|0|||
161517375|NCT01752933|583284507|FG001|Treatment|Withdrawal by Subject|5|||
161517376|NCT01752933|583284506|FG000|Treatment|Adverse Event|1|||
161517377|NCT01752933|583284507|FG001|Treatment|Adverse Event|4|||
161517378|NCT01752933|583284506|FG000|Treatment|Physician Decision|0|||
161517379|NCT01752933|583284507|FG001|Treatment|Physician Decision|3|||
161824281|NCT02466386|584397941|FG000|Overall Study|Protocol Violation|2|||
161824282|NCT02466386|584397941|FG000|Overall Study|Withdrawal by Subject|14|||
161824283|NCT02466386|584397941|FG000|Overall Study|Lost to Follow-up|5|||
161517380|NCT01752933|583284506|FG000|Treatment|Death|0|||
161824284|NCT02466386|584397941|FG000|Overall Study|Lack of Efficacy|8|||
161677123|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
161932241|NCT01699685|584800422|FG000|Period 1|Medical or ethical, noncompliance|2|||
161517381|NCT01752933|583284507|FG001|Treatment|Death|2|||
161517382|NCT01752933|583284506|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
161517383|NCT01752933|583284507|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
161517384|NCT01752933|583284506|FG000|Treatment|Patient noncompliant|0|||
161517385|NCT01752933|583284507|FG001|Treatment|Patient noncompliant|1|||
161517386|NCT01752933|583284506|FG000|Treatment|Patient unable to travel to appointments|0|||
161517387|NCT01752933|583284507|FG001|Treatment|Patient unable to travel to appointments|1|||
161517388|NCT01752933|583284506|FG000|Overall Study and Follow-up|Death|4|||
161517389|NCT01752933|583284507|FG001|Overall Study and Follow-up|Death|34|||
161517390|NCT01752933|583284506|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
161517391|NCT01752933|583284507|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
161517392|NCT01752933|583284506|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
161517393|NCT01752933|583284507|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
161517394|NCT01752933|583284506|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
161517395|NCT01752933|583284507|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
161517396|NCT01591681|583284508|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
161517397|NCT01591681|583284508|FG000|Overall Study|Failed to use system during run-in|1|||
161517398|NCT03062891|583284509|FG000|Overall Study|Withdrawal by Subject|2|||
161517399|NCT03062891|583284510|FG001|Overall Study|Withdrawal by Subject|0|||
161517400|NCT03062891|583284509|FG000|Overall Study|Lost to Follow-up|50|||
161517401|NCT03062891|583284510|FG001|Overall Study|Lost to Follow-up|38|||
161517402|NCT05402995|583284514|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
161517403|NCT05402995|583284515|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
161517404|NCT05402995|583284516|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
161517405|NCT05402995|583284517|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
161517406|NCT00958880|583284526|FG000|Overall Study|Lost to Follow-up|2|||
161517407|NCT00958880|583284527|FG001|Overall Study|Lost to Follow-up|2|||
161517408|NCT02296112|583284528|FG000|Overall Study|Disease progression|7|||
161517409|NCT02296112|583284528|FG000|Overall Study|Toxicity|1|||
161517410|NCT02296112|583284528|FG000|Overall Study|Began an alternate therapy|1|||
161517411|NCT00298831|583284529|FG000|Overall Study|Adverse Event|1|||
161517412|NCT00298831|583284529|FG000|Overall Study|Lost to Follow-up|3|||
161517413|NCT00298831|583284529|FG000|Overall Study|Withdrawal by Subject|1|||
161517414|NCT00298831|583284529|FG000|Overall Study|Participants did not receive treatment|27|||
161517415|NCT01516879|583284530|FG000|Overall Study|Withdrawal by Subject|9|||
161517416|NCT01516879|583284531|FG001|Overall Study|Withdrawal by Subject|11|||
161517417|NCT01516879|583284530|FG000|Overall Study|Death|0|||
161517418|NCT01516879|583284531|FG001|Overall Study|Death|2|||
161517419|NCT01516879|583284530|FG000|Overall Study|Lost to Follow-up|2|||
161517420|NCT01516879|583284531|FG001|Overall Study|Lost to Follow-up|11|||
161517421|NCT01516879|583284530|FG000|Overall Study|Other|5|||
161517422|NCT01516879|583284531|FG001|Overall Study|Other|10|||
161517423|NCT04568122|583284532|FG000|Overall Study|Lost to Follow-up|48|||
161517424|NCT04568122|583284533|FG001|Overall Study|Lost to Follow-up|44|||
161517425|NCT04568122|583284534|FG002|Overall Study|Lost to Follow-up|4|||
161517426|NCT04568122|583284535|FG003|Overall Study|Lost to Follow-up|0|||
161517427|NCT04568122|583284536|FG004|Overall Study|Lost to Follow-up|0|||
161517428|NCT01916304|583284542|FG000|Overall Study|Screening failure|17|||
161517429|NCT04666441|583284543|FG000|Overall Study|Lost to Follow-up|1|||
161517430|NCT04666441|583284544|FG001|Overall Study|Lost to Follow-up|4|||
161517431|NCT04666441|583284545|FG002|Overall Study|Lost to Follow-up|1|||
161517432|NCT04666441|583284546|FG003|Overall Study|Lost to Follow-up|3|||
161517433|NCT04666441|583284547|FG004|Overall Study|Lost to Follow-up|0|||
161517434|NCT04666441|583284548|FG005|Overall Study|Lost to Follow-up|2|||
161517435|NCT04666441|583284549|FG006|Overall Study|Lost to Follow-up|2|||
161517436|NCT04666441|583284550|FG007|Overall Study|Lost to Follow-up|2|||
161517437|NCT04666441|583284543|FG000|Overall Study|Subject Decision|1|||
161517438|NCT04666441|583284544|FG001|Overall Study|Subject Decision|1|||
161517439|NCT04666441|583284545|FG002|Overall Study|Subject Decision|3|||
161517440|NCT04666441|583284546|FG003|Overall Study|Subject Decision|1|||
161517441|NCT04666441|583284547|FG004|Overall Study|Subject Decision|0|||
161517442|NCT04666441|583284548|FG005|Overall Study|Subject Decision|1|||
161517443|NCT04666441|583284549|FG006|Overall Study|Subject Decision|3|||
161517444|NCT04666441|583284550|FG007|Overall Study|Subject Decision|2|||
161517445|NCT00766415|583284565|FG000|Overall Study|Withdrawal by Subject|0|||
161517446|NCT00766415|583284566|FG001|Overall Study|Withdrawal by Subject|1|||
161517447|NCT01114516|583284567|FG000|Overall Study|Lost to Follow-up|2|||
161517448|NCT01114516|583284568|FG001|Overall Study|Lost to Follow-up|1|||
161517449|NCT01431508|583284573|FG000|Overall Study|Lack of Efficacy|1|||
161517450|NCT01431508|583284573|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
161517451|NCT00132769|583284574|FG000|Overall Study|Withdrawal by Subject|1|||
161517452|NCT00132769|583284575|FG001|Overall Study|Withdrawal by Subject|3|||
161517453|NCT00132769|583284574|FG000|Overall Study|Lack of Efficacy|7|||
161517454|NCT00132769|583284575|FG001|Overall Study|Lack of Efficacy|6|||
161932242|NCT01699685|584800423|FG001|Period 1|Medical or ethical, noncompliance|0|||
161517455|NCT00132769|583284574|FG000|Overall Study|Adverse Event|2|||
161517456|NCT00132769|583284575|FG001|Overall Study|Adverse Event|1|||
161517457|NCT00132769|583284574|FG000|Overall Study|Protocol Violation|1|||
161517458|NCT00132769|583284575|FG001|Overall Study|Protocol Violation|1|||
161932243|NCT01699685|584800422|FG000|Period 1|Other|0|||
161932244|NCT01699685|584800423|FG001|Period 1|Other|1|||
161932245|NCT01699685|584800422|FG000|Period 1|Patient request|0|||
161932246|NCT01699685|584800423|FG001|Period 1|Patient request|1|||
161932247|NCT01699685|584800422|FG000|Period 2|Lost to Follow-up|1|||
161932248|NCT01699685|584800423|FG001|Period 2|Lost to Follow-up|0|||
161932249|NCT03635996|584800424|FG000|Overall Study|Study terminated by Sponsor|94|||
161932250|NCT03635996|584800424|FG000|Overall Study|Withdrawal by Subject|20|||
161932251|NCT03635996|584800424|FG000|Overall Study|Ablation|26|||
161932252|NCT03635996|584800424|FG000|Overall Study|Adverse Event|7|||
161932253|NCT03635996|584800424|FG000|Overall Study|Physician Decision|3|||
161932254|NCT03635996|584800424|FG000|Overall Study|Prohibited medication|5|||
161932255|NCT03635996|584800424|FG000|Overall Study|Did not meet eligibility criteria|5|||
161932256|NCT03635996|584800424|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
161932257|NCT03635996|584800424|FG000|Overall Study|Protocol Violation|1|||
161932258|NCT03635996|584800424|FG000|Overall Study|Lost to Follow-up|1|||
161932259|NCT02821000|584800425|FG000|Overall Study|Death|89|||
161932260|NCT02821000|584800425|FG000|Overall Study|Sponsor Decision|12|||
161932261|NCT02821000|584800425|FG000|Overall Study|Withdrawal by Subject|2|||
161932262|NCT05058456|584800426|FG000|Overall Study|Death|1|||
161932263|NCT05058456|584800426|FG000|Overall Study|End of Study data not yet due for release|34|||
161932264|NCT02802865|584800427|FG000|Overall Study|Pregnancy|1|||
161517459|NCT00129259|583284576|FG000|Overall Study|Lost to Follow-up|1|||
161517460|NCT00129259|583284577|FG001|Overall Study|Lost to Follow-up|1|||
161932265|NCT02802865|584800428|FG001|Overall Study|Pregnancy|1|||
161932266|NCT02802865|584800427|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
161932267|NCT02802865|584800428|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
161932268|NCT01862029|584800429|FG000|Overall Study|Physician Decision|1|||
161932269|NCT03931785|584800430|FG000|Overall Study|Lost to Follow-up|4|||
161932270|NCT03931785|584800431|FG001|Overall Study|Lost to Follow-up|1|||
161932271|NCT03931785|584800432|FG002|Overall Study|Lost to Follow-up|4|||
161932272|NCT03931785|584800433|FG003|Overall Study|Lost to Follow-up|3|||
161932273|NCT03931785|584800430|FG000|Overall Study|Adverse Event|1|||
161932274|NCT03931785|584800431|FG001|Overall Study|Adverse Event|0|||
161932275|NCT03931785|584800432|FG002|Overall Study|Adverse Event|3|||
161932276|NCT03931785|584800433|FG003|Overall Study|Adverse Event|4|||
161932277|NCT03931785|584800430|FG000|Overall Study|Protocol Violation|0|||
161932278|NCT03931785|584800431|FG001|Overall Study|Protocol Violation|1|||
161932279|NCT03931785|584800432|FG002|Overall Study|Protocol Violation|0|||
161932280|NCT03931785|584800433|FG003|Overall Study|Protocol Violation|0|||
161932281|NCT03931785|584800430|FG000|Overall Study|Noncompliance With Study drug|0|||
161932282|NCT03931785|584800431|FG001|Overall Study|Noncompliance With Study drug|1|||
161932283|NCT03931785|584800432|FG002|Overall Study|Noncompliance With Study drug|0|||
161932284|NCT03931785|584800433|FG003|Overall Study|Noncompliance With Study drug|0|||
161932285|NCT03931785|584800430|FG000|Overall Study|Other Not specified|0|||
161932286|NCT03931785|584800431|FG001|Overall Study|Other Not specified|2|||
161932287|NCT03931785|584800432|FG002|Overall Study|Other Not specified|2|||
161932288|NCT03931785|584800433|FG003|Overall Study|Other Not specified|2|||
161932289|NCT03931785|584800430|FG000|Overall Study|Withdrawal by Subject|0|||
161932290|NCT03931785|584800431|FG001|Overall Study|Withdrawal by Subject|2|||
161932291|NCT03931785|584800432|FG002|Overall Study|Withdrawal by Subject|4|||
161932292|NCT03931785|584800433|FG003|Overall Study|Withdrawal by Subject|1|||
161932293|NCT03931785|584800430|FG000|Overall Study|Pregnancy|0|||
161932294|NCT03931785|584800431|FG001|Overall Study|Pregnancy|0|||
161932295|NCT03931785|584800432|FG002|Overall Study|Pregnancy|0|||
161932296|NCT03931785|584800433|FG003|Overall Study|Pregnancy|1|||
161932297|NCT01832038|584800434|FG000|Overall Study|Death|5|||
161932298|NCT01832038|584800434|FG000|Overall Study|Adverse Event|50|||
161932299|NCT01832038|584800434|FG000|Overall Study|Lack of Efficacy|81|||
161517461|NCT00129259|583284576|FG000|Overall Study|Withdrawal by Subject|2|||
161517462|NCT00129259|583284577|FG001|Overall Study|Withdrawal by Subject|1|||
161932300|NCT01832038|584800434|FG000|Overall Study|Protocol Violation|7|||
161932301|NCT01832038|584800434|FG000|Overall Study|Lost to Follow-up|10|||
161932302|NCT01832038|584800434|FG000|Overall Study|Withdrawal by Subject|49|||
161932303|NCT01832038|584800434|FG000|Overall Study|Visit non-compliance|2|||
161932304|NCT01832038|584800434|FG000|Overall Study|Subject refused to return visit|2|||
161932305|NCT01832038|584800434|FG000|Overall Study|Not convenient to come back to site|2|||
161932306|NCT01832038|584800434|FG000|Overall Study|Participant was asked to quit|5|||
161932307|NCT01832038|584800434|FG000|Overall Study|Back home|1|||
161932308|NCT01832038|584800434|FG000|Overall Study|Pregnancy|1|||
161932309|NCT01832038|584800434|FG000|Overall Study|Low compliance|3|||
161932310|NCT01832038|584800434|FG000|Overall Study|Prohibit procedure|2|||
161932311|NCT01832038|584800434|FG000|Overall Study|Not possible to visit the hospital|1|||
161932312|NCT01832038|584800434|FG000|Overall Study|Changes of implementation system|3|||
161588917|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588918|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588919|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161588920|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588921|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588922|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588923|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588924|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588925|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588926|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588927|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
161588928|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
161588929|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588930|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588931|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588932|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161588933|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588934|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588935|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588936|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588937|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588938|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588939|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161588940|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161588941|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161588942|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588943|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588944|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588945|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161588946|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
161588947|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
161588948|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
161932313|NCT01832038|584800434|FG000|Overall Study|Plan to pregnancy|7|||
161932314|NCT01832038|584800434|FG000|Overall Study|Bad mood and has suicidal thought|1|||
161932315|NCT01832038|584800434|FG000|Overall Study|Prohibited concomitant medication|1|||
161932316|NCT01832038|584800434|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
161932317|NCT01832038|584800434|FG000|Overall Study|Subject considered the efficacy was poor|1|||
161932318|NCT03810365|584800435|FG000|Overall Study|Lost to Follow-up|2|||
161588949|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
161588950|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
161588951|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
161588952|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
161588953|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
161588954|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
161588955|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
161588956|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
161588957|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
161588958|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
161588959|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588960|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588961|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588962|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588963|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588964|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588965|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161588966|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161588967|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
161588968|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161932319|NCT03810365|584800436|FG001|Overall Study|Lost to Follow-up|2|||
161932320|NCT03810365|584800435|FG000|Overall Study|Withdrawal by Subject|4|||
161932321|NCT03810365|584800436|FG001|Overall Study|Withdrawal by Subject|5|||
161932322|NCT00449787|584800437|FG000|Overall Study|Lost to Follow-up|10|||
161588969|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588970|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588971|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161588972|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588973|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161932323|NCT00449787|584800438|FG001|Overall Study|Lost to Follow-up|8|||
161932324|NCT00449787|584800437|FG000|Overall Study|Did not require medication|95|||
161932325|NCT00449787|584800438|FG001|Overall Study|Did not require medication|92|||
161824285|NCT02466386|584397941|FG000|Overall Study|Other|10|||
161824286|NCT05317195|584397942|FG000|Randomization|Withdrawal by Subject|1|||
161824287|NCT05317195|584397942|FG000|Randomization|Discontinued|6|||
161824288|NCT05317195|584397942|FG000|Admission|Withdrawal by Subject|2|||
161824289|NCT00889252|584397943|FG000|Overall Study|Adverse Event|2|||
161824290|NCT00889252|584397944|FG001|Overall Study|Adverse Event|4|||
161824291|NCT00889252|584397943|FG000|Overall Study|Withdrawal by Subject|3|||
161824292|NCT00889252|584397944|FG001|Overall Study|Withdrawal by Subject|0|||
161824293|NCT00889252|584397943|FG000|Overall Study|Protocol Violation|2|||
161824294|NCT00889252|584397944|FG001|Overall Study|Protocol Violation|0|||
161824295|NCT01833169|584397948|FG000|Overall Study|Disease Progression|99|||
161824296|NCT01833169|584397948|FG000|Overall Study|Adverse Event|33|||
161824297|NCT01833169|584397948|FG000|Overall Study|Withdrawal by Subject|9|||
161824298|NCT01833169|584397948|FG000|Overall Study|Death|3|||
161824299|NCT01833169|584397948|FG000|Overall Study|Physician Decision|2|||
161824300|NCT04718129|584397953|FG000|Overall Study|Lost to Follow-up|6|||
161824301|NCT04718129|584397954|FG001|Overall Study|Lost to Follow-up|7|||
161824302|NCT02212457|584397955|FG000|Overall Study|Adverse Event|1|||
161824303|NCT02212457|584397956|FG001|Overall Study|Adverse Event|2|||
161824304|NCT02212457|584397957|FG002|Overall Study|Adverse Event|2|||
161824305|NCT02212457|584397958|FG003|Overall Study|Adverse Event|2|||
161824306|NCT02212457|584397959|FG004|Overall Study|Adverse Event|0|||
161824307|NCT02212457|584397960|FG005|Overall Study|Adverse Event|1|||
161824308|NCT02212457|584397955|FG000|Overall Study|Withdrawal by Subject|8|||
161824309|NCT02212457|584397956|FG001|Overall Study|Withdrawal by Subject|10|||
161824310|NCT02212457|584397957|FG002|Overall Study|Withdrawal by Subject|8|||
161824311|NCT02212457|584397958|FG003|Overall Study|Withdrawal by Subject|6|||
161824312|NCT02212457|584397959|FG004|Overall Study|Withdrawal by Subject|5|||
161824313|NCT02212457|584397960|FG005|Overall Study|Withdrawal by Subject|4|||
161517463|NCT00129259|583284576|FG000|Overall Study|Only available minimal phone assessments|0|||
161517464|NCT00129259|583284577|FG001|Overall Study|Only available minimal phone assessments|1|||
161517465|NCT02758236|583284579|FG000|Overall Study|Investigator discretion|43|||
161517466|NCT01632579|583284582|FG000|Washout Period|Adverse Event|1|||
161517467|NCT01632579|583284583|FG001|Washout Period|Adverse Event|0|||
161517468|NCT01632579|583284584|FG002|Washout Period|Adverse Event|0|||
161517469|NCT01632579|583284585|FG003|Washout Period|Adverse Event|0|||
161517470|NCT01632579|583284586|FG004|Washout Period|Adverse Event|0|||
161824314|NCT02212457|584397955|FG000|Overall Study|Lost to Follow-up|6|||
161824315|NCT02212457|584397956|FG001|Overall Study|Lost to Follow-up|7|||
161517471|NCT01632579|583284587|FG005|Washout Period|Adverse Event|0|||
161517472|NCT01632579|583284588|FG006|Washout Period|Adverse Event|0|||
161824316|NCT02212457|584397957|FG002|Overall Study|Lost to Follow-up|4|||
161824317|NCT02212457|584397958|FG003|Overall Study|Lost to Follow-up|1|||
161517473|NCT01632579|583284589|FG007|Washout Period|Adverse Event|0|||
161517474|NCT01632579|583284590|FG008|Washout Period|Adverse Event|0|||
161517475|NCT01632579|583284582|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
161517476|NCT01632579|583284583|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
161517477|NCT01632579|583284584|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
161517478|NCT01632579|583284585|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
161517479|NCT01632579|583284586|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
161517480|NCT01632579|583284587|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
161517481|NCT01632579|583284588|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
161517482|NCT01632579|583284589|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
161517483|NCT01632579|583284590|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
161517484|NCT01722331|583286697|FG000|Part 1|Adverse Event|5|||
161517485|NCT01722331|583286698|FG001|Part 1|Adverse Event|0|||
161517486|NCT01722331|583286699|FG002|Part 1|Adverse Event|0|||
161517487|NCT01722331|583286700|FG003|Part 1|Adverse Event|0|||
161517488|NCT01722331|583286701|FG004|Part 1|Adverse Event|0|||
161517489|NCT01722331|583286702|FG005|Part 1|Adverse Event|0|||
161517490|NCT01722331|583286703|FG006|Part 1|Adverse Event|0|||
161517491|NCT01722331|583286697|FG000|Part 1|Lack of Efficacy|0|||
161824318|NCT02212457|584397959|FG004|Overall Study|Lost to Follow-up|8|||
161824319|NCT02212457|584397960|FG005|Overall Study|Lost to Follow-up|4|||
161824320|NCT02212457|584397955|FG000|Overall Study|Protocol Violation|2|||
161824321|NCT02212457|584397956|FG001|Overall Study|Protocol Violation|1|||
161824322|NCT02212457|584397957|FG002|Overall Study|Protocol Violation|0|||
161588974|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161824323|NCT02212457|584397958|FG003|Overall Study|Protocol Violation|1|||
161824324|NCT02212457|584397959|FG004|Overall Study|Protocol Violation|2|||
161824325|NCT02212457|584397960|FG005|Overall Study|Protocol Violation|3|||
161824326|NCT02212457|584397955|FG000|Overall Study|Other|2|||
161824327|NCT02212457|584397956|FG001|Overall Study|Other|1|||
161824328|NCT02212457|584397957|FG002|Overall Study|Other|2|||
161824329|NCT02212457|584397958|FG003|Overall Study|Other|1|||
161824330|NCT02212457|584397959|FG004|Overall Study|Other|0|||
161824331|NCT02212457|584397960|FG005|Overall Study|Other|1|||
161824332|NCT01120691|584397963|FG000|Overall Study|Adverse Event|59|||
161824333|NCT01120691|584397964|FG001|Overall Study|Adverse Event|67|||
161824334|NCT01120691|584397965|FG002|Overall Study|Adverse Event|47|||
161824335|NCT01120691|584397963|FG000|Overall Study|Subject withdrew consent|33|||
161824336|NCT01120691|584397964|FG001|Overall Study|Subject withdrew consent|50|||
161824337|NCT01120691|584397965|FG002|Overall Study|Subject withdrew consent|44|||
161824338|NCT01120691|584397963|FG000|Overall Study|Death|21|||
161824339|NCT01120691|584397964|FG001|Overall Study|Death|22|||
161824340|NCT01120691|584397965|FG002|Overall Study|Death|24|||
161824341|NCT01120691|584397963|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
161824342|NCT01120691|584397964|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
161824343|NCT01120691|584397965|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
161824344|NCT01120691|584397963|FG000|Overall Study|Administrative problems|15|||
161824345|NCT01120691|584397964|FG001|Overall Study|Administrative problems|8|||
161824346|NCT01120691|584397965|FG002|Overall Study|Administrative problems|9|||
161824347|NCT01120691|584397963|FG000|Overall Study|Protocol deviation|13|||
161824348|NCT01120691|584397964|FG001|Overall Study|Protocol deviation|12|||
161824349|NCT01120691|584397965|FG002|Overall Study|Protocol deviation|12|||
161824350|NCT01120691|584397963|FG000|Overall Study|Lost to Follow-up|5|||
161824351|NCT01120691|584397964|FG001|Overall Study|Lost to Follow-up|6|||
161824352|NCT01120691|584397965|FG002|Overall Study|Lost to Follow-up|4|||
161824353|NCT01120691|584397963|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161824354|NCT01120691|584397964|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161824355|NCT01120691|584397965|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161824356|NCT01120691|584397963|FG000|Overall Study|Patient's inability to use the device|3|||
161824357|NCT01120691|584397964|FG001|Overall Study|Patient's inability to use the device|1|||
161824358|NCT01120691|584397965|FG002|Overall Study|Patient's inability to use the device|0|||
161824359|NCT01120691|584397963|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161824360|NCT01120691|584397964|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161824361|NCT01120691|584397965|FG002|Overall Study|Abnormal laboratory value(s)|4|||
161824362|NCT00772148|584397967|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
161824363|NCT00772148|584397968|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
161824364|NCT00772148|584397967|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
161824365|NCT00772148|584397968|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
161824366|NCT00772148|584397967|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
161517492|NCT01722331|583286698|FG001|Part 1|Lack of Efficacy|0|||
161517493|NCT01722331|583286699|FG002|Part 1|Lack of Efficacy|1|||
161517494|NCT01722331|583286700|FG003|Part 1|Lack of Efficacy|0|||
161824367|NCT00772148|584397968|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
161824368|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Death|2|||
161824369|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Death|2|||
161824370|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
161824371|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
161517495|NCT01722331|583286701|FG004|Part 1|Lack of Efficacy|2|||
161517496|NCT01722331|583286702|FG005|Part 1|Lack of Efficacy|0|||
161517497|NCT01722331|583286703|FG006|Part 1|Lack of Efficacy|0|||
161517498|NCT01722331|583286697|FG000|Part 1|Lost to Follow-up|1|||
161517499|NCT01722331|583286698|FG001|Part 1|Lost to Follow-up|0|||
161517500|NCT01722331|583286699|FG002|Part 1|Lost to Follow-up|2|||
161517501|NCT01722331|583286700|FG003|Part 1|Lost to Follow-up|0|||
161517502|NCT01722331|583286701|FG004|Part 1|Lost to Follow-up|1|||
161517503|NCT01722331|583286702|FG005|Part 1|Lost to Follow-up|0|||
161517504|NCT01722331|583286703|FG006|Part 1|Lost to Follow-up|0|||
161517505|NCT01722331|583286697|FG000|Part 1|Physician Decision|0|||
161517506|NCT01722331|583286698|FG001|Part 1|Physician Decision|0|||
161517507|NCT01722331|583286699|FG002|Part 1|Physician Decision|3|||
161517508|NCT01722331|583286700|FG003|Part 1|Physician Decision|0|||
161677124|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
161677125|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
161677126|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
161932326|NCT03574389|584800443|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
161932327|NCT03574389|584800444|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
161932328|NCT03574389|584800445|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
161932329|NCT03574389|584800446|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
161932330|NCT03574389|584800447|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
161932331|NCT03574389|584800448|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
161932332|NCT03574389|584800449|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
161932333|NCT03574389|584800443|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
161932334|NCT03574389|584800444|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
161932335|NCT03574389|584800445|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
161932336|NCT03574389|584800446|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
161932337|NCT03574389|584800447|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
161932338|NCT03574389|584800448|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
161932339|NCT03574389|584800449|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
161932340|NCT03574389|584800443|FG000|Vaccination Period|Other|6|||
161932341|NCT03574389|584800444|FG001|Vaccination Period|Other|0|||
161932342|NCT03574389|584800445|FG002|Vaccination Period|Other|0|||
161932343|NCT03574389|584800446|FG003|Vaccination Period|Other|0|||
161932344|NCT03574389|584800447|FG004|Vaccination Period|Other|0|||
161932345|NCT03574389|584800448|FG005|Vaccination Period|Other|0|||
161932346|NCT03574389|584800449|FG006|Vaccination Period|Other|0|||
161932347|NCT03574389|584800443|FG000|Vaccination Period|Adverse Event|0|||
161932348|NCT03574389|584800444|FG001|Vaccination Period|Adverse Event|1|||
161932349|NCT03574389|584800445|FG002|Vaccination Period|Adverse Event|0|||
161932350|NCT03574389|584800446|FG003|Vaccination Period|Adverse Event|0|||
161932351|NCT03574389|584800447|FG004|Vaccination Period|Adverse Event|0|||
161932352|NCT03574389|584800448|FG005|Vaccination Period|Adverse Event|0|||
161932353|NCT03574389|584800449|FG006|Vaccination Period|Adverse Event|0|||
161932354|NCT03574389|584800443|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
161932355|NCT03574389|584800444|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
161932356|NCT03574389|584800445|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
161932357|NCT03574389|584800446|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
161932358|NCT03574389|584800447|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
161932359|NCT03574389|584800448|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
161932360|NCT03574389|584800449|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
161932361|NCT02094885|584800454|FG000|Overall Study|Death|1|||
161932362|NCT02094885|584800455|FG001|Overall Study|Death|5|||
161677127|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
161677128|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
161677129|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
161677130|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
161677131|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
161677132|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Adverse Event|0|||
161677133|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Adverse Event|0|||
161677134|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Adverse Event|0|||
161677135|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Adverse Event|1|||
161932363|NCT02094885|584800454|FG000|Overall Study|Withdrawn due to age|1|||
161932364|NCT02094885|584800455|FG001|Overall Study|Withdrawn due to age|0|||
161517509|NCT01722331|583286701|FG004|Part 1|Physician Decision|1|||
161517510|NCT01722331|583286702|FG005|Part 1|Physician Decision|0|||
161677136|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Adverse Event|2|||
161677137|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161677138|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161932365|NCT00337194|584800456|FG000|Overall Study|Adverse Event|5|||
161932366|NCT00337194|584800457|FG001|Overall Study|Adverse Event|1|||
161932367|NCT00337194|584800456|FG000|Overall Study|Death|2|||
161932368|NCT00337194|584800457|FG001|Overall Study|Death|0|||
161932369|NCT00337194|584800456|FG000|Overall Study|Withdrawal by Subject|1|||
161932370|NCT00337194|584800457|FG001|Overall Study|Withdrawal by Subject|0|||
161932371|NCT00337194|584800456|FG000|Overall Study|Disease progression|1|||
161932372|NCT00337194|584800457|FG001|Overall Study|Disease progression|2|||
161677139|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161677140|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161677141|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
161677142|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161677143|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161677144|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161677145|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
161677146|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
161677147|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
161677148|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
161677149|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
161677150|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
161677151|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
161677152|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
161677153|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
161677154|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
161677155|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
161677156|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
161677157|NCT01274715|583871995|FG000|Overall Study|Lost to Follow-up|1|||
161677158|NCT01274715|583871995|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161677159|NCT01274715|583871995|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161677160|NCT01274715|583871995|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161677161|NCT00467779|583872000|FG000|Stage 1|Adverse Event|1|||
161677162|NCT00467779|583872001|FG001|Stage 1|Adverse Event|0|||
161677163|NCT00467779|583872002|FG002|Stage 1|Adverse Event|0|||
161677164|NCT00467779|583872003|FG003|Stage 1|Adverse Event|0|||
161677165|NCT00467779|583872004|FG004|Stage 1|Adverse Event|0|||
161677166|NCT00467779|583872005|FG005|Stage 1|Adverse Event|1|||
161677167|NCT00467779|583872006|FG006|Stage 1|Adverse Event|2|||
161677168|NCT00467779|583872007|FG007|Stage 1|Adverse Event|1|||
161677169|NCT00467779|583872008|FG008|Stage 1|Adverse Event|0|||
161677170|NCT00467779|583872009|FG009|Stage 1|Adverse Event|0|||
161677171|NCT00467779|583872010|FG010|Stage 1|Adverse Event|0|||
161677172|NCT00467779|583872011|FG011|Stage 1|Adverse Event|0|||
161677173|NCT00467779|583872012|FG012|Stage 1|Adverse Event|0|||
161677174|NCT00467779|583872013|FG013|Stage 1|Adverse Event|0|||
161677175|NCT00467779|583872014|FG014|Stage 1|Adverse Event|0|||
161677176|NCT00467779|583872000|FG000|Stage 1|Disease Progression|2|||
161677177|NCT00467779|583872001|FG001|Stage 1|Disease Progression|2|||
161677178|NCT00467779|583872002|FG002|Stage 1|Disease Progression|2|||
161677179|NCT00467779|583872003|FG003|Stage 1|Disease Progression|3|||
161677180|NCT00467779|583872004|FG004|Stage 1|Disease Progression|2|||
161677181|NCT00467779|583872005|FG005|Stage 1|Disease Progression|2|||
161677182|NCT00467779|583872006|FG006|Stage 1|Disease Progression|4|||
161677183|NCT00467779|583872007|FG007|Stage 1|Disease Progression|5|||
161677184|NCT00467779|583872008|FG008|Stage 1|Disease Progression|0|||
161677185|NCT00467779|583872009|FG009|Stage 1|Disease Progression|0|||
161677186|NCT00467779|583872010|FG010|Stage 1|Disease Progression|0|||
161677187|NCT00467779|583872011|FG011|Stage 1|Disease Progression|0|||
161677188|NCT00467779|583872012|FG012|Stage 1|Disease Progression|0|||
161677189|NCT00467779|583872013|FG013|Stage 1|Disease Progression|0|||
161677190|NCT00467779|583872014|FG014|Stage 1|Disease Progression|0|||
161677191|NCT00467779|583872000|FG000|Stage 1|Unspecified Reason|1|||
161677192|NCT00467779|583872001|FG001|Stage 1|Unspecified Reason|0|||
161932373|NCT00337194|584800456|FG000|Overall Study|Subsequent non-protocol therapy|3|||
161932374|NCT00337194|584800457|FG001|Overall Study|Subsequent non-protocol therapy|1|||
161932375|NCT01061710|584800460|FG000|Overall Study|Protocol Violation|14|||
161932376|NCT01903720|584800461|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
161932377|NCT01903720|584800461|FG000|Overall Study|Adverse Event|1|||
161677193|NCT00467779|583872002|FG002|Stage 1|Unspecified Reason|1|||
161677194|NCT00467779|583872003|FG003|Stage 1|Unspecified Reason|0|||
161932378|NCT01903720|584800461|FG000|Overall Study|Rescinding of informed consent|2|||
161932379|NCT01903720|584800461|FG000|Overall Study|Lost to Follow-up|2|||
161517511|NCT01722331|583286703|FG006|Part 1|Physician Decision|0|||
161517512|NCT01722331|583286697|FG000|Part 1|Pregnancy|1|||
161677195|NCT00467779|583872004|FG004|Stage 1|Unspecified Reason|1|||
161677196|NCT00467779|583872005|FG005|Stage 1|Unspecified Reason|2|||
161677197|NCT00467779|583872006|FG006|Stage 1|Unspecified Reason|0|||
161677198|NCT00467779|583872007|FG007|Stage 1|Unspecified Reason|0|||
161677199|NCT00467779|583872008|FG008|Stage 1|Unspecified Reason|0|||
161677200|NCT00467779|583872009|FG009|Stage 1|Unspecified Reason|0|||
161677201|NCT00467779|583872010|FG010|Stage 1|Unspecified Reason|0|||
161677202|NCT00467779|583872011|FG011|Stage 1|Unspecified Reason|0|||
161677203|NCT00467779|583872012|FG012|Stage 1|Unspecified Reason|0|||
161677204|NCT00467779|583872013|FG013|Stage 1|Unspecified Reason|0|||
161677205|NCT00467779|583872014|FG014|Stage 1|Unspecified Reason|0|||
161677206|NCT00467779|583872000|FG000|Stage 1|Physician Decision|0|||
161677207|NCT00467779|583872001|FG001|Stage 1|Physician Decision|1|||
161932380|NCT01903720|584800461|FG000|Overall Study|Treatment with alternative drug|1|||
161677208|NCT00467779|583872002|FG002|Stage 1|Physician Decision|0|||
161677209|NCT00467779|583872003|FG003|Stage 1|Physician Decision|0|||
161677210|NCT00467779|583872004|FG004|Stage 1|Physician Decision|0|||
161677211|NCT00467779|583872005|FG005|Stage 1|Physician Decision|0|||
161677212|NCT00467779|583872006|FG006|Stage 1|Physician Decision|0|||
161677213|NCT00467779|583872007|FG007|Stage 1|Physician Decision|0|||
161677214|NCT00467779|583872008|FG008|Stage 1|Physician Decision|0|||
161677215|NCT00467779|583872009|FG009|Stage 1|Physician Decision|0|||
161677216|NCT00467779|583872010|FG010|Stage 1|Physician Decision|0|||
161677217|NCT00467779|583872011|FG011|Stage 1|Physician Decision|0|||
161677218|NCT00467779|583872012|FG012|Stage 1|Physician Decision|0|||
161677219|NCT00467779|583872013|FG013|Stage 1|Physician Decision|0|||
161677220|NCT00467779|583872014|FG014|Stage 1|Physician Decision|0|||
161677221|NCT00467779|583872000|FG000|Stage 1|Withdrawal by Subject|0|||
161677222|NCT00467779|583872001|FG001|Stage 1|Withdrawal by Subject|0|||
161677223|NCT00467779|583872002|FG002|Stage 1|Withdrawal by Subject|0|||
161677224|NCT00467779|583872003|FG003|Stage 1|Withdrawal by Subject|0|||
161677225|NCT00467779|583872004|FG004|Stage 1|Withdrawal by Subject|0|||
161677226|NCT00467779|583872005|FG005|Stage 1|Withdrawal by Subject|0|||
161677227|NCT00467779|583872006|FG006|Stage 1|Withdrawal by Subject|1|||
161677228|NCT00467779|583872007|FG007|Stage 1|Withdrawal by Subject|1|||
161677229|NCT00467779|583872008|FG008|Stage 1|Withdrawal by Subject|0|||
161677230|NCT00467779|583872009|FG009|Stage 1|Withdrawal by Subject|0|||
161677231|NCT00467779|583872010|FG010|Stage 1|Withdrawal by Subject|0|||
161677232|NCT00467779|583872011|FG011|Stage 1|Withdrawal by Subject|0|||
161677233|NCT00467779|583872012|FG012|Stage 1|Withdrawal by Subject|0|||
161677234|NCT00467779|583872013|FG013|Stage 1|Withdrawal by Subject|0|||
161677235|NCT00467779|583872014|FG014|Stage 1|Withdrawal by Subject|0|||
161677236|NCT00467779|583872000|FG000|Stage 1A|Adverse Event|0|||
161677237|NCT00467779|583872001|FG001|Stage 1A|Adverse Event|0|||
161677238|NCT00467779|583872002|FG002|Stage 1A|Adverse Event|0|||
161677239|NCT00467779|583872003|FG003|Stage 1A|Adverse Event|0|||
161677240|NCT00467779|583872004|FG004|Stage 1A|Adverse Event|0|||
161677241|NCT00467779|583872005|FG005|Stage 1A|Adverse Event|0|||
161677242|NCT00467779|583872006|FG006|Stage 1A|Adverse Event|0|||
161677243|NCT00467779|583872007|FG007|Stage 1A|Adverse Event|0|||
161677244|NCT00467779|583872008|FG008|Stage 1A|Adverse Event|0|||
161677245|NCT00467779|583872009|FG009|Stage 1A|Adverse Event|0|||
161677246|NCT00467779|583872010|FG010|Stage 1A|Adverse Event|0|||
161677247|NCT00467779|583872011|FG011|Stage 1A|Adverse Event|0|||
161677248|NCT00467779|583872012|FG012|Stage 1A|Adverse Event|1|||
161677249|NCT00467779|583872013|FG013|Stage 1A|Adverse Event|0|||
161677250|NCT00467779|583872014|FG014|Stage 1A|Adverse Event|0|||
161677251|NCT00467779|583872000|FG000|Stage 1A|Death|0|||
161677252|NCT00467779|583872001|FG001|Stage 1A|Death|0|||
161677253|NCT00467779|583872002|FG002|Stage 1A|Death|0|||
161677254|NCT00467779|583872003|FG003|Stage 1A|Death|0|||
161677255|NCT00467779|583872004|FG004|Stage 1A|Death|0|||
161677256|NCT00467779|583872005|FG005|Stage 1A|Death|0|||
161677257|NCT00467779|583872006|FG006|Stage 1A|Death|0|||
161677258|NCT00467779|583872007|FG007|Stage 1A|Death|0|||
161677259|NCT00467779|583872008|FG008|Stage 1A|Death|0|||
161677260|NCT00467779|583872009|FG009|Stage 1A|Death|0|||
161677261|NCT00467779|583872010|FG010|Stage 1A|Death|0|||
161677262|NCT00467779|583872011|FG011|Stage 1A|Death|1|||
161677263|NCT00467779|583872012|FG012|Stage 1A|Death|1|||
161677264|NCT00467779|583872013|FG013|Stage 1A|Death|0|||
161677265|NCT00467779|583872014|FG014|Stage 1A|Death|0|||
161677266|NCT00467779|583872000|FG000|Stage 1A|Disease Progression|0|||
161677267|NCT00467779|583872001|FG001|Stage 1A|Disease Progression|0|||
161677268|NCT00467779|583872002|FG002|Stage 1A|Disease Progression|0|||
161677269|NCT00467779|583872003|FG003|Stage 1A|Disease Progression|0|||
161677270|NCT00467779|583872004|FG004|Stage 1A|Disease Progression|0|||
161677271|NCT00467779|583872005|FG005|Stage 1A|Disease Progression|0|||
161677272|NCT00467779|583872006|FG006|Stage 1A|Disease Progression|0|||
161677273|NCT00467779|583872007|FG007|Stage 1A|Disease Progression|0|||
161677274|NCT00467779|583872008|FG008|Stage 1A|Disease Progression|0|||
161824372|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
161677275|NCT00467779|583872009|FG009|Stage 1A|Disease Progression|2|||
161677276|NCT00467779|583872010|FG010|Stage 1A|Disease Progression|2|||
161677277|NCT00467779|583872011|FG011|Stage 1A|Disease Progression|5|||
161677278|NCT00467779|583872012|FG012|Stage 1A|Disease Progression|2|||
161824373|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
161677279|NCT00467779|583872013|FG013|Stage 1A|Disease Progression|0|||
161677280|NCT00467779|583872014|FG014|Stage 1A|Disease Progression|0|||
161677281|NCT00467779|583872000|FG000|Stage 1A|Physician Decision|0|||
161677282|NCT00467779|583872001|FG001|Stage 1A|Physician Decision|0|||
161677283|NCT00467779|583872002|FG002|Stage 1A|Physician Decision|0|||
161677284|NCT00467779|583872003|FG003|Stage 1A|Physician Decision|0|||
161677285|NCT00467779|583872004|FG004|Stage 1A|Physician Decision|0|||
161677286|NCT00467779|583872005|FG005|Stage 1A|Physician Decision|0|||
161677287|NCT00467779|583872006|FG006|Stage 1A|Physician Decision|0|||
161677288|NCT00467779|583872007|FG007|Stage 1A|Physician Decision|0|||
161677289|NCT00467779|583872008|FG008|Stage 1A|Physician Decision|0|||
161932381|NCT00159874|584800462|FG000|Overall Study|Adverse Event|2|||
161932382|NCT00159874|584800463|FG001|Overall Study|Adverse Event|2|||
161932383|NCT00159874|584800464|FG002|Overall Study|Adverse Event|5|||
161932384|NCT00159874|584800465|FG003|Overall Study|Adverse Event|1|||
161932385|NCT00159874|584800466|FG004|Overall Study|Adverse Event|1|||
161932386|NCT00159874|584800467|FG005|Overall Study|Adverse Event|2|||
161932387|NCT00159874|584800468|FG006|Overall Study|Adverse Event|0|||
161677290|NCT00467779|583872009|FG009|Stage 1A|Physician Decision|1|||
161677291|NCT00467779|583872010|FG010|Stage 1A|Physician Decision|0|||
161677292|NCT00467779|583872011|FG011|Stage 1A|Physician Decision|0|||
161677293|NCT00467779|583872012|FG012|Stage 1A|Physician Decision|0|||
161677294|NCT00467779|583872013|FG013|Stage 1A|Physician Decision|0|||
161677295|NCT00467779|583872014|FG014|Stage 1A|Physician Decision|0|||
161677296|NCT00467779|583872000|FG000|Stage 1A|Withdrawal by Subject|0|||
161677297|NCT00467779|583872001|FG001|Stage 1A|Withdrawal by Subject|0|||
161677298|NCT00467779|583872002|FG002|Stage 1A|Withdrawal by Subject|0|||
161677299|NCT00467779|583872003|FG003|Stage 1A|Withdrawal by Subject|0|||
161677300|NCT00467779|583872004|FG004|Stage 1A|Withdrawal by Subject|0|||
161677301|NCT00467779|583872005|FG005|Stage 1A|Withdrawal by Subject|0|||
161677302|NCT00467779|583872006|FG006|Stage 1A|Withdrawal by Subject|0|||
161677303|NCT00467779|583872007|FG007|Stage 1A|Withdrawal by Subject|0|||
161677304|NCT00467779|583872008|FG008|Stage 1A|Withdrawal by Subject|0|||
161677305|NCT00467779|583872009|FG009|Stage 1A|Withdrawal by Subject|0|||
161677306|NCT00467779|583872010|FG010|Stage 1A|Withdrawal by Subject|1|||
161677307|NCT00467779|583872011|FG011|Stage 1A|Withdrawal by Subject|1|||
161677308|NCT00467779|583872012|FG012|Stage 1A|Withdrawal by Subject|1|||
161677309|NCT00467779|583872013|FG013|Stage 1A|Withdrawal by Subject|0|||
161677310|NCT00467779|583872014|FG014|Stage 1A|Withdrawal by Subject|0|||
161677311|NCT00467779|583872000|FG000|Stage 1A|Unspecified Reason|0|||
161677312|NCT00467779|583872001|FG001|Stage 1A|Unspecified Reason|0|||
161677313|NCT00467779|583872002|FG002|Stage 1A|Unspecified Reason|0|||
161677314|NCT00467779|583872003|FG003|Stage 1A|Unspecified Reason|0|||
161677315|NCT00467779|583872004|FG004|Stage 1A|Unspecified Reason|0|||
161677316|NCT00467779|583872005|FG005|Stage 1A|Unspecified Reason|0|||
161677317|NCT00467779|583872006|FG006|Stage 1A|Unspecified Reason|0|||
161677318|NCT00467779|583872007|FG007|Stage 1A|Unspecified Reason|0|||
161677319|NCT00467779|583872008|FG008|Stage 1A|Unspecified Reason|0|||
161677320|NCT00467779|583872009|FG009|Stage 1A|Unspecified Reason|0|||
161677321|NCT00467779|583872010|FG010|Stage 1A|Unspecified Reason|0|||
161677322|NCT00467779|583872011|FG011|Stage 1A|Unspecified Reason|1|||
161677323|NCT00467779|583872012|FG012|Stage 1A|Unspecified Reason|1|||
161677324|NCT00467779|583872013|FG013|Stage 1A|Unspecified Reason|0|||
161677325|NCT00467779|583872014|FG014|Stage 1A|Unspecified Reason|0|||
161677326|NCT00467779|583872000|FG000|Stage 2|Adverse Event|0|||
161677327|NCT00467779|583872001|FG001|Stage 2|Adverse Event|0|||
161517513|NCT01722331|583286698|FG001|Part 1|Pregnancy|0|||
161517514|NCT01722331|583286699|FG002|Part 1|Pregnancy|0|||
161517515|NCT01722331|583286700|FG003|Part 1|Pregnancy|0|||
161677328|NCT00467779|583872002|FG002|Stage 2|Adverse Event|0|||
161677329|NCT00467779|583872003|FG003|Stage 2|Adverse Event|0|||
161677330|NCT00467779|583872004|FG004|Stage 2|Adverse Event|0|||
161677331|NCT00467779|583872005|FG005|Stage 2|Adverse Event|0|||
161677332|NCT00467779|583872006|FG006|Stage 2|Adverse Event|0|||
161677333|NCT00467779|583872007|FG007|Stage 2|Adverse Event|0|||
161677334|NCT00467779|583872008|FG008|Stage 2|Adverse Event|1|||
161677335|NCT00467779|583872009|FG009|Stage 2|Adverse Event|0|||
161677336|NCT00467779|583872010|FG010|Stage 2|Adverse Event|0|||
161517516|NCT01722331|583286701|FG004|Part 1|Pregnancy|0|||
161517517|NCT01722331|583286702|FG005|Part 1|Pregnancy|0|||
161517518|NCT01722331|583286703|FG006|Part 1|Pregnancy|0|||
161517519|NCT01722331|583286697|FG000|Part 1|Progressive Disease|0|||
161517520|NCT01722331|583286698|FG001|Part 1|Progressive Disease|0|||
161517521|NCT01722331|583286699|FG002|Part 1|Progressive Disease|0|||
161517522|NCT01722331|583286700|FG003|Part 1|Progressive Disease|0|||
161517523|NCT01722331|583286701|FG004|Part 1|Progressive Disease|1|||
161517524|NCT01722331|583286702|FG005|Part 1|Progressive Disease|0|||
161517525|NCT01722331|583286703|FG006|Part 1|Progressive Disease|0|||
161517526|NCT01722331|583286697|FG000|Part 1|Protocol Violation|1|||
161517527|NCT01722331|583286698|FG001|Part 1|Protocol Violation|0|||
161517528|NCT01722331|583286699|FG002|Part 1|Protocol Violation|0|||
161677337|NCT00467779|583872011|FG011|Stage 2|Adverse Event|0|||
161677338|NCT00467779|583872012|FG012|Stage 2|Adverse Event|0|||
161677339|NCT00467779|583872013|FG013|Stage 2|Adverse Event|0|||
161677340|NCT00467779|583872014|FG014|Stage 2|Adverse Event|0|||
161677341|NCT00467779|583872000|FG000|Stage 2|Death|0|||
161677342|NCT00467779|583872001|FG001|Stage 2|Death|0|||
161677343|NCT00467779|583872002|FG002|Stage 2|Death|0|||
161677344|NCT00467779|583872003|FG003|Stage 2|Death|0|||
161677345|NCT00467779|583872004|FG004|Stage 2|Death|0|||
161677346|NCT00467779|583872005|FG005|Stage 2|Death|0|||
161677347|NCT00467779|583872006|FG006|Stage 2|Death|0|||
161677348|NCT00467779|583872007|FG007|Stage 2|Death|0|||
161932388|NCT00159874|584800462|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
161932389|NCT00159874|584800463|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
161677349|NCT00467779|583872008|FG008|Stage 2|Death|1|||
161677350|NCT00467779|583872009|FG009|Stage 2|Death|0|||
161677351|NCT00467779|583872010|FG010|Stage 2|Death|0|||
161677352|NCT00467779|583872011|FG011|Stage 2|Death|0|||
161677353|NCT00467779|583872012|FG012|Stage 2|Death|0|||
161677354|NCT00467779|583872013|FG013|Stage 2|Death|0|||
161677355|NCT00467779|583872014|FG014|Stage 2|Death|0|||
161677356|NCT00467779|583872000|FG000|Stage 2|Disease Progression|0|||
161677357|NCT00467779|583872001|FG001|Stage 2|Disease Progression|0|||
161677358|NCT00467779|583872002|FG002|Stage 2|Disease Progression|0|||
161677359|NCT00467779|583872003|FG003|Stage 2|Disease Progression|0|||
161677360|NCT00467779|583872004|FG004|Stage 2|Disease Progression|0|||
161677361|NCT00467779|583872005|FG005|Stage 2|Disease Progression|0|||
161677362|NCT00467779|583872006|FG006|Stage 2|Disease Progression|0|||
161677363|NCT00467779|583872007|FG007|Stage 2|Disease Progression|0|||
161677364|NCT00467779|583872008|FG008|Stage 2|Disease Progression|16|||
161677365|NCT00467779|583872009|FG009|Stage 2|Disease Progression|0|||
161677366|NCT00467779|583872010|FG010|Stage 2|Disease Progression|0|||
161677367|NCT00467779|583872011|FG011|Stage 2|Disease Progression|0|||
161677368|NCT00467779|583872012|FG012|Stage 2|Disease Progression|0|||
161677369|NCT00467779|583872013|FG013|Stage 2|Disease Progression|0|||
161677370|NCT00467779|583872014|FG014|Stage 2|Disease Progression|0|||
161677371|NCT00467779|583872000|FG000|Stage 2|Unspecified Reason|0|||
161677372|NCT00467779|583872001|FG001|Stage 2|Unspecified Reason|0|||
161677373|NCT00467779|583872002|FG002|Stage 2|Unspecified Reason|0|||
161677374|NCT00467779|583872003|FG003|Stage 2|Unspecified Reason|0|||
161677375|NCT00467779|583872004|FG004|Stage 2|Unspecified Reason|0|||
161677376|NCT00467779|583872005|FG005|Stage 2|Unspecified Reason|0|||
161677377|NCT00467779|583872006|FG006|Stage 2|Unspecified Reason|0|||
161677378|NCT00467779|583872007|FG007|Stage 2|Unspecified Reason|0|||
161677379|NCT00467779|583872008|FG008|Stage 2|Unspecified Reason|3|||
161677380|NCT00467779|583872009|FG009|Stage 2|Unspecified Reason|0|||
161677381|NCT00467779|583872010|FG010|Stage 2|Unspecified Reason|0|||
161677382|NCT00467779|583872011|FG011|Stage 2|Unspecified Reason|0|||
161677383|NCT00467779|583872012|FG012|Stage 2|Unspecified Reason|0|||
161677384|NCT00467779|583872013|FG013|Stage 2|Unspecified Reason|0|||
161677385|NCT00467779|583872014|FG014|Stage 2|Unspecified Reason|0|||
161677386|NCT00467779|583872000|FG000|Stage 2A|Adverse Event|0|||
161677387|NCT00467779|583872001|FG001|Stage 2A|Adverse Event|0|||
161677388|NCT00467779|583872002|FG002|Stage 2A|Adverse Event|0|||
161677389|NCT00467779|583872003|FG003|Stage 2A|Adverse Event|0|||
161677390|NCT00467779|583872004|FG004|Stage 2A|Adverse Event|0|||
161677391|NCT00467779|583872005|FG005|Stage 2A|Adverse Event|0|||
161677392|NCT00467779|583872006|FG006|Stage 2A|Adverse Event|0|||
161677393|NCT00467779|583872007|FG007|Stage 2A|Adverse Event|0|||
161677394|NCT00467779|583872008|FG008|Stage 2A|Adverse Event|0|||
161677395|NCT00467779|583872009|FG009|Stage 2A|Adverse Event|0|||
161677396|NCT00467779|583872010|FG010|Stage 2A|Adverse Event|0|||
161677397|NCT00467779|583872011|FG011|Stage 2A|Adverse Event|0|||
161677398|NCT00467779|583872012|FG012|Stage 2A|Adverse Event|0|||
161677399|NCT00467779|583872013|FG013|Stage 2A|Adverse Event|2|||
161677400|NCT00467779|583872014|FG014|Stage 2A|Adverse Event|0|||
161677401|NCT00467779|583872000|FG000|Stage 2A|Death|0|||
161677402|NCT00467779|583872001|FG001|Stage 2A|Death|0|||
161677403|NCT00467779|583872002|FG002|Stage 2A|Death|0|||
161677404|NCT00467779|583872003|FG003|Stage 2A|Death|0|||
161677405|NCT00467779|583872004|FG004|Stage 2A|Death|0|||
161677406|NCT00467779|583872005|FG005|Stage 2A|Death|0|||
161677407|NCT00467779|583872006|FG006|Stage 2A|Death|0|||
161677408|NCT00467779|583872007|FG007|Stage 2A|Death|0|||
161677409|NCT00467779|583872008|FG008|Stage 2A|Death|0|||
161677410|NCT00467779|583872009|FG009|Stage 2A|Death|0|||
161677411|NCT00467779|583872010|FG010|Stage 2A|Death|0|||
161677412|NCT00467779|583872011|FG011|Stage 2A|Death|0|||
161677413|NCT00467779|583872012|FG012|Stage 2A|Death|0|||
161677414|NCT00467779|583872013|FG013|Stage 2A|Death|1|||
161677415|NCT00467779|583872014|FG014|Stage 2A|Death|0|||
161677416|NCT00467779|583872000|FG000|Stage 2A|Disease Progression|0|||
161677417|NCT00467779|583872001|FG001|Stage 2A|Disease Progression|0|||
161677418|NCT00467779|583872002|FG002|Stage 2A|Disease Progression|0|||
161932390|NCT00159874|584800464|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
161677419|NCT00467779|583872003|FG003|Stage 2A|Disease Progression|0|||
161677420|NCT00467779|583872004|FG004|Stage 2A|Disease Progression|0|||
161677421|NCT00467779|583872005|FG005|Stage 2A|Disease Progression|0|||
161677422|NCT00467779|583872006|FG006|Stage 2A|Disease Progression|0|||
161932391|NCT00159874|584800465|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
161677423|NCT00467779|583872007|FG007|Stage 2A|Disease Progression|0|||
161677424|NCT00467779|583872008|FG008|Stage 2A|Disease Progression|0|||
161677425|NCT00467779|583872009|FG009|Stage 2A|Disease Progression|0|||
161677426|NCT00467779|583872010|FG010|Stage 2A|Disease Progression|0|||
161677427|NCT00467779|583872011|FG011|Stage 2A|Disease Progression|0|||
161677428|NCT00467779|583872012|FG012|Stage 2A|Disease Progression|0|||
161677429|NCT00467779|583872013|FG013|Stage 2A|Disease Progression|10|||
161677430|NCT00467779|583872014|FG014|Stage 2A|Disease Progression|0|||
161677431|NCT00467779|583872000|FG000|Stage 2A|Unspecified Reason|0|||
161517529|NCT01722331|583286700|FG003|Part 1|Protocol Violation|0|||
161517530|NCT01722331|583286701|FG004|Part 1|Protocol Violation|1|||
161517531|NCT01722331|583286702|FG005|Part 1|Protocol Violation|0|||
161517532|NCT01722331|583286703|FG006|Part 1|Protocol Violation|0|||
161677432|NCT00467779|583872001|FG001|Stage 2A|Unspecified Reason|0|||
161677433|NCT00467779|583872002|FG002|Stage 2A|Unspecified Reason|0|||
161677434|NCT00467779|583872003|FG003|Stage 2A|Unspecified Reason|0|||
161677435|NCT00467779|583872004|FG004|Stage 2A|Unspecified Reason|0|||
161677436|NCT00467779|583872005|FG005|Stage 2A|Unspecified Reason|0|||
161677437|NCT00467779|583872006|FG006|Stage 2A|Unspecified Reason|0|||
161677438|NCT00467779|583872007|FG007|Stage 2A|Unspecified Reason|0|||
161677439|NCT00467779|583872008|FG008|Stage 2A|Unspecified Reason|0|||
161517533|NCT01722331|583286697|FG000|Part 1|Withdrawal by Subject|2|||
161517534|NCT01722331|583286698|FG001|Part 1|Withdrawal by Subject|0|||
161517535|NCT01722331|583286699|FG002|Part 1|Withdrawal by Subject|3|||
161517536|NCT01722331|583286700|FG003|Part 1|Withdrawal by Subject|0|||
161517537|NCT01722331|583286701|FG004|Part 1|Withdrawal by Subject|3|||
161517538|NCT01722331|583286702|FG005|Part 1|Withdrawal by Subject|0|||
161517539|NCT01722331|583286703|FG006|Part 1|Withdrawal by Subject|0|||
161517540|NCT01722331|583286697|FG000|Part 2|Adverse Event|3|||
161517541|NCT01722331|583286698|FG001|Part 2|Adverse Event|0|||
161517542|NCT01722331|583286699|FG002|Part 2|Adverse Event|0|||
161517543|NCT01722331|583286700|FG003|Part 2|Adverse Event|0|||
161517544|NCT01722331|583286701|FG004|Part 2|Adverse Event|0|||
161517545|NCT01722331|583286702|FG005|Part 2|Adverse Event|1|||
161517546|NCT01722331|583286703|FG006|Part 2|Adverse Event|0|||
161517547|NCT01722331|583286697|FG000|Part 2|Lack of Efficacy|3|||
161517548|NCT01722331|583286698|FG001|Part 2|Lack of Efficacy|0|||
161517549|NCT01722331|583286699|FG002|Part 2|Lack of Efficacy|11|||
161517550|NCT01722331|583286700|FG003|Part 2|Lack of Efficacy|0|||
161517551|NCT01722331|583286701|FG004|Part 2|Lack of Efficacy|0|||
161517552|NCT01722331|583286702|FG005|Part 2|Lack of Efficacy|3|||
161517553|NCT01722331|583286703|FG006|Part 2|Lack of Efficacy|3|||
161517554|NCT01722331|583286697|FG000|Part 2|Lost to Follow-up|0|||
161517555|NCT01722331|583286698|FG001|Part 2|Lost to Follow-up|0|||
161517556|NCT01722331|583286699|FG002|Part 2|Lost to Follow-up|3|||
161517557|NCT01722331|583286700|FG003|Part 2|Lost to Follow-up|0|||
161517558|NCT01722331|583286701|FG004|Part 2|Lost to Follow-up|0|||
161517559|NCT01722331|583286702|FG005|Part 2|Lost to Follow-up|1|||
161517560|NCT01722331|583286703|FG006|Part 2|Lost to Follow-up|1|||
161517561|NCT01722331|583286697|FG000|Part 2|Non-Compliance with Study Drug|1|||
161517562|NCT01722331|583286698|FG001|Part 2|Non-Compliance with Study Drug|0|||
161517563|NCT01722331|583286699|FG002|Part 2|Non-Compliance with Study Drug|1|||
161517564|NCT01722331|583286700|FG003|Part 2|Non-Compliance with Study Drug|0|||
161517565|NCT01722331|583286701|FG004|Part 2|Non-Compliance with Study Drug|0|||
161517566|NCT01722331|583286702|FG005|Part 2|Non-Compliance with Study Drug|0|||
161517567|NCT01722331|583286703|FG006|Part 2|Non-Compliance with Study Drug|0|||
161517568|NCT01722331|583286697|FG000|Part 2|Physician Decision|0|||
161517569|NCT01722331|583286698|FG001|Part 2|Physician Decision|0|||
161517570|NCT01722331|583286699|FG002|Part 2|Physician Decision|2|||
161517571|NCT01722331|583286700|FG003|Part 2|Physician Decision|0|||
161517572|NCT01722331|583286701|FG004|Part 2|Physician Decision|0|||
161517573|NCT01722331|583286702|FG005|Part 2|Physician Decision|0|||
161517574|NCT01722331|583286703|FG006|Part 2|Physician Decision|0|||
161517575|NCT01722331|583286697|FG000|Part 2|Pregnancy|0|||
161517576|NCT01722331|583286698|FG001|Part 2|Pregnancy|0|||
161517577|NCT01722331|583286699|FG002|Part 2|Pregnancy|0|||
161517578|NCT01722331|583286700|FG003|Part 2|Pregnancy|0|||
161677440|NCT00467779|583872009|FG009|Stage 2A|Unspecified Reason|0|||
161677441|NCT00467779|583872010|FG010|Stage 2A|Unspecified Reason|0|||
161677442|NCT00467779|583872011|FG011|Stage 2A|Unspecified Reason|0|||
161824374|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
161824375|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
161824376|NCT00688844|584397969|FG000|Overall Study|Lost to Follow-up|10|||
161824377|NCT01321697|584397975|FG000|Overall Study|Study Terminated|7|||
161824378|NCT00857818|584397976|FG000|Overall Study|Lack of Efficacy|1|||
161824379|NCT00857818|584397977|FG001|Overall Study|Lack of Efficacy|0|||
161517579|NCT01722331|583286701|FG004|Part 2|Pregnancy|0|||
161517580|NCT01722331|583286702|FG005|Part 2|Pregnancy|1|||
161517581|NCT01722331|583286703|FG006|Part 2|Pregnancy|0|||
161517582|NCT01722331|583286697|FG000|Part 2|Progressive Disease|0|||
161824380|NCT00857818|584397976|FG000|Overall Study|Adverse Event|3|||
161517583|NCT01722331|583286698|FG001|Part 2|Progressive Disease|0|||
161517584|NCT01722331|583286699|FG002|Part 2|Progressive Disease|1|||
161517585|NCT01722331|583286700|FG003|Part 2|Progressive Disease|0|||
161517586|NCT01722331|583286701|FG004|Part 2|Progressive Disease|0|||
161517587|NCT01722331|583286702|FG005|Part 2|Progressive Disease|0|||
161517588|NCT01722331|583286703|FG006|Part 2|Progressive Disease|0|||
161824381|NCT00857818|584397977|FG001|Overall Study|Adverse Event|0|||
161517589|NCT01722331|583286697|FG000|Part 2|Protocol Violation|1|||
161517590|NCT01722331|583286698|FG001|Part 2|Protocol Violation|0|||
161517591|NCT01722331|583286699|FG002|Part 2|Protocol Violation|0|||
161517592|NCT01722331|583286700|FG003|Part 2|Protocol Violation|0|||
161517593|NCT01722331|583286701|FG004|Part 2|Protocol Violation|0|||
161517594|NCT01722331|583286702|FG005|Part 2|Protocol Violation|0|||
161517595|NCT01722331|583286703|FG006|Part 2|Protocol Violation|0|||
161517596|NCT01722331|583286697|FG000|Part 2|Withdrawal by Subject|5|||
161517597|NCT01722331|583286698|FG001|Part 2|Withdrawal by Subject|0|||
161517598|NCT01722331|583286699|FG002|Part 2|Withdrawal by Subject|3|||
161517599|NCT01722331|583286700|FG003|Part 2|Withdrawal by Subject|0|||
161517600|NCT01722331|583286701|FG004|Part 2|Withdrawal by Subject|0|||
161517601|NCT01722331|583286702|FG005|Part 2|Withdrawal by Subject|2|||
161517602|NCT01722331|583286703|FG006|Part 2|Withdrawal by Subject|2|||
161517603|NCT01722331|583286697|FG000|Part 2|Other Protocol Specified Criteria|6|||
161517604|NCT01722331|583286698|FG001|Part 2|Other Protocol Specified Criteria|0|||
161517605|NCT01722331|583286699|FG002|Part 2|Other Protocol Specified Criteria|10|||
161517606|NCT01722331|583286700|FG003|Part 2|Other Protocol Specified Criteria|0|||
161517607|NCT01722331|583286701|FG004|Part 2|Other Protocol Specified Criteria|0|||
161517608|NCT01722331|583286702|FG005|Part 2|Other Protocol Specified Criteria|2|||
161517609|NCT01722331|583286703|FG006|Part 2|Other Protocol Specified Criteria|1|||
161517610|NCT01722331|583286697|FG000|Part 3|Adverse Event|2|||
161517611|NCT01722331|583286698|FG001|Part 3|Adverse Event|2|||
161517612|NCT01722331|583286699|FG002|Part 3|Adverse Event|0|||
161517613|NCT01722331|583286700|FG003|Part 3|Adverse Event|1|||
161517614|NCT01722331|583286701|FG004|Part 3|Adverse Event|0|||
161517615|NCT01722331|583286702|FG005|Part 3|Adverse Event|0|||
161517616|NCT01722331|583286703|FG006|Part 3|Adverse Event|0|||
161517617|NCT01722331|583286697|FG000|Part 3|Death|1|||
161517618|NCT01722331|583286698|FG001|Part 3|Death|0|||
161517619|NCT01722331|583286699|FG002|Part 3|Death|0|||
161517620|NCT01722331|583286700|FG003|Part 3|Death|0|||
161517621|NCT01722331|583286701|FG004|Part 3|Death|0|||
161517622|NCT01722331|583286702|FG005|Part 3|Death|0|||
161517623|NCT01722331|583286703|FG006|Part 3|Death|0|||
161517624|NCT01722331|583286697|FG000|Part 3|Lack of Efficacy|1|||
161517625|NCT01722331|583286698|FG001|Part 3|Lack of Efficacy|0|||
161517626|NCT01722331|583286699|FG002|Part 3|Lack of Efficacy|0|||
161517627|NCT01722331|583286700|FG003|Part 3|Lack of Efficacy|0|||
161517628|NCT01722331|583286701|FG004|Part 3|Lack of Efficacy|0|||
161517629|NCT01722331|583286702|FG005|Part 3|Lack of Efficacy|0|||
161517630|NCT01722331|583286703|FG006|Part 3|Lack of Efficacy|0|||
161517631|NCT01722331|583286697|FG000|Part 3|Lost to Follow-up|3|||
161517632|NCT01722331|583286698|FG001|Part 3|Lost to Follow-up|4|||
161517633|NCT01722331|583286699|FG002|Part 3|Lost to Follow-up|0|||
161517634|NCT01722331|583286700|FG003|Part 3|Lost to Follow-up|0|||
161517635|NCT01722331|583286701|FG004|Part 3|Lost to Follow-up|0|||
161517636|NCT01722331|583286702|FG005|Part 3|Lost to Follow-up|1|||
161517637|NCT01722331|583286703|FG006|Part 3|Lost to Follow-up|0|||
161517638|NCT01722331|583286697|FG000|Part 3|Non-Compliance with Study Drug|0|||
161517639|NCT01722331|583286698|FG001|Part 3|Non-Compliance with Study Drug|1|||
161517640|NCT01722331|583286699|FG002|Part 3|Non-Compliance with Study Drug|0|||
161517641|NCT01722331|583286700|FG003|Part 3|Non-Compliance with Study Drug|0|||
161517642|NCT01722331|583286701|FG004|Part 3|Non-Compliance with Study Drug|0|||
161517643|NCT01722331|583286702|FG005|Part 3|Non-Compliance with Study Drug|0|||
161517644|NCT01722331|583286703|FG006|Part 3|Non-Compliance with Study Drug|0|||
161517645|NCT01722331|583286697|FG000|Part 3|Physician Decision|1|||
161517646|NCT01722331|583286698|FG001|Part 3|Physician Decision|1|||
161517647|NCT01722331|583286699|FG002|Part 3|Physician Decision|0|||
161517648|NCT01722331|583286700|FG003|Part 3|Physician Decision|0|||
161517649|NCT01722331|583286701|FG004|Part 3|Physician Decision|0|||
161932392|NCT00159874|584800466|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
161932393|NCT00159874|584800467|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
161932394|NCT00159874|584800468|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
161932395|NCT00159874|584800462|FG000|Overall Study|Lack of Efficacy|2|||
161932396|NCT00159874|584800463|FG001|Overall Study|Lack of Efficacy|0|||
161932397|NCT00159874|584800464|FG002|Overall Study|Lack of Efficacy|1|||
161932398|NCT00159874|584800465|FG003|Overall Study|Lack of Efficacy|1|||
161932399|NCT00159874|584800466|FG004|Overall Study|Lack of Efficacy|0|||
161932400|NCT00159874|584800467|FG005|Overall Study|Lack of Efficacy|3|||
161932401|NCT00159874|584800468|FG006|Overall Study|Lack of Efficacy|0|||
161932402|NCT00159874|584800462|FG000|Overall Study|Lost to Follow-up|1|||
161517650|NCT01722331|583286702|FG005|Part 3|Physician Decision|0|||
161517651|NCT01722331|583286703|FG006|Part 3|Physician Decision|1|||
161517652|NCT01722331|583286697|FG000|Part 3|Protocol Violation|2|||
161517653|NCT01722331|583286698|FG001|Part 3|Protocol Violation|1|||
161517654|NCT01722331|583286699|FG002|Part 3|Protocol Violation|0|||
161517655|NCT01722331|583286700|FG003|Part 3|Protocol Violation|0|||
161517656|NCT01722331|583286701|FG004|Part 3|Protocol Violation|0|||
161517657|NCT01722331|583286702|FG005|Part 3|Protocol Violation|0|||
161517658|NCT01722331|583286703|FG006|Part 3|Protocol Violation|0|||
161517659|NCT01722331|583286697|FG000|Part 3|Withdrawal by Subject|4|||
161517660|NCT01722331|583286698|FG001|Part 3|Withdrawal by Subject|7|||
161517661|NCT01722331|583286699|FG002|Part 3|Withdrawal by Subject|0|||
161517662|NCT01722331|583286700|FG003|Part 3|Withdrawal by Subject|0|||
161517663|NCT01722331|583286701|FG004|Part 3|Withdrawal by Subject|0|||
161932403|NCT00159874|584800463|FG001|Overall Study|Lost to Follow-up|0|||
161932404|NCT00159874|584800464|FG002|Overall Study|Lost to Follow-up|3|||
161932405|NCT00159874|584800465|FG003|Overall Study|Lost to Follow-up|0|||
161932406|NCT00159874|584800466|FG004|Overall Study|Lost to Follow-up|1|||
161517664|NCT01722331|583286702|FG005|Part 3|Withdrawal by Subject|2|||
161517665|NCT01722331|583286703|FG006|Part 3|Withdrawal by Subject|1|||
161517666|NCT01722331|583286697|FG000|Part 3|Other Protocol Specified Criteria|1|||
161517667|NCT01722331|583286698|FG001|Part 3|Other Protocol Specified Criteria|1|||
161517668|NCT01722331|583286699|FG002|Part 3|Other Protocol Specified Criteria|0|||
161517669|NCT01722331|583286700|FG003|Part 3|Other Protocol Specified Criteria|0|||
161517670|NCT01722331|583286701|FG004|Part 3|Other Protocol Specified Criteria|0|||
161517671|NCT01722331|583286702|FG005|Part 3|Other Protocol Specified Criteria|0|||
161517672|NCT01722331|583286703|FG006|Part 3|Other Protocol Specified Criteria|0|||
161517673|NCT02807948|583286706|FG000|Overall Study|Physician Decision|1|||
161517674|NCT02807948|583286707|FG001|Overall Study|Physician Decision|0|||
161517675|NCT03727750|583286708|FG000|Overall Study|Death|45|||
161517676|NCT03727750|583286708|FG000|Overall Study|Withdrawal by Subject|2|||
161517677|NCT03727750|583286708|FG000|Overall Study|Lost to Follow-up|1|||
161517678|NCT03727750|583286708|FG000|Overall Study|Other|1|||
161517679|NCT03766646|583286710|FG000|Overall Study|Withdrawal by Subject|1|||
161517680|NCT03766646|583286711|FG001|Overall Study|Withdrawal by Subject|0|||
161517681|NCT03766646|583286710|FG000|Overall Study|Protocol Violation|0|||
161517682|NCT03766646|583286711|FG001|Overall Study|Protocol Violation|3|||
161517683|NCT02530619|583286721|FG000|Registered for Study|Withdrawal by Subject|2|||
161517684|NCT02530619|583286721|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
161517685|NCT02530619|583286721|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
161517686|NCT02530619|583286721|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
161517687|NCT02530619|583286721|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
161517688|NCT02530619|583286721|FG000|Follow-up Period (6 Months)|Death|4|||
161517689|NCT02530619|583286721|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
161517690|NCT02530619|583286721|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
161517691|NCT01854554|583286725|FG000|Overall Study|Denial of Insurance Coverage|12|||
161517692|NCT01854554|583286726|FG001|Overall Study|Denial of Insurance Coverage|0|||
161517693|NCT01854554|583286725|FG000|Overall Study|Decided to get treatment locally|1|||
161517694|NCT01854554|583286726|FG001|Overall Study|Decided to get treatment locally|5|||
161517695|NCT01854554|583286725|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
161517696|NCT01854554|583286726|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
161517697|NCT01854554|583286725|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161517698|NCT01854554|583286726|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
161517699|NCT01854554|583286725|FG000|Overall Study|Progression|0|||
161517700|NCT01854554|583286726|FG001|Overall Study|Progression|1|||
161517701|NCT01854554|583286725|FG000|Overall Study|Lost to Follow-up|0|||
161517702|NCT01854554|583286726|FG001|Overall Study|Lost to Follow-up|1|||
161517703|NCT02819726|583286727|FG000|Part A (All Participants)|Lost to Follow-up|0|||
161517704|NCT02819726|583286728|FG001|Part A (All Participants)|Lost to Follow-up|1|||
161517705|NCT02819726|583286729|FG002|Part A (All Participants)|Lost to Follow-up|0|||
161517706|NCT02819726|583286730|FG003|Part A (All Participants)|Lost to Follow-up|0|||
161517707|NCT02819726|583286727|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
161517708|NCT02819726|583286728|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
161517709|NCT02819726|583286729|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
161517710|NCT02819726|583286730|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
161517711|NCT02819726|583286727|FG000|Part A (All Participants)|Protocol non-compliance|3|||
161517712|NCT02819726|583286728|FG001|Part A (All Participants)|Protocol non-compliance|4|||
161517713|NCT02819726|583286729|FG002|Part A (All Participants)|Protocol non-compliance|5|||
161517714|NCT02819726|583286730|FG003|Part A (All Participants)|Protocol non-compliance|0|||
161517715|NCT02819726|583286727|FG000|Part B (All Participants)|Lost to Follow-up|1|||
161517716|NCT02819726|583286728|FG001|Part B (All Participants)|Lost to Follow-up|1|||
161517717|NCT02819726|583286729|FG002|Part B (All Participants)|Lost to Follow-up|2|||
161517718|NCT02819726|583286730|FG003|Part B (All Participants)|Lost to Follow-up|2|||
161517719|NCT02819726|583286727|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
161517720|NCT02819726|583286728|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
161517721|NCT02819726|583286729|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
161517722|NCT02819726|583286730|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
161517723|NCT02819726|583286727|FG000|Part B (All Participants)|Protocol non-compliance|0|||
161517724|NCT02819726|583286728|FG001|Part B (All Participants)|Protocol non-compliance|0|||
161517725|NCT02819726|583286729|FG002|Part B (All Participants)|Protocol non-compliance|1|||
161517726|NCT02819726|583286730|FG003|Part B (All Participants)|Protocol non-compliance|0|||
161517727|NCT00359762|583286731|FG000|Period II|Adverse Event|17|||
161517728|NCT00359762|583286732|FG001|Period II|Adverse Event|0|||
161517729|NCT00359762|583286733|FG002|Period II|Adverse Event|0|||
161932407|NCT00159874|584800467|FG005|Overall Study|Lost to Follow-up|2|||
161932408|NCT00159874|584800468|FG006|Overall Study|Lost to Follow-up|1|||
161932409|NCT00159874|584800462|FG000|Overall Study|Other|8|||
161932410|NCT00159874|584800463|FG001|Overall Study|Other|8|||
161517730|NCT00359762|583286734|FG003|Period II|Adverse Event|0|||
161517731|NCT00359762|583286735|FG004|Period II|Adverse Event|49|||
161932411|NCT00159874|584800464|FG002|Overall Study|Other|8|||
161932412|NCT00159874|584800465|FG003|Overall Study|Other|0|||
161517732|NCT00359762|583286731|FG000|Period II|Protocol Violation|18|||
161517733|NCT00359762|583286732|FG001|Period II|Protocol Violation|0|||
161517734|NCT00359762|583286733|FG002|Period II|Protocol Violation|0|||
161517735|NCT00359762|583286734|FG003|Period II|Protocol Violation|0|||
161517736|NCT00359762|583286735|FG004|Period II|Protocol Violation|11|||
161517737|NCT00359762|583286731|FG000|Period II|Physician Decision|17|||
161517738|NCT00359762|583286732|FG001|Period II|Physician Decision|0|||
161517739|NCT00359762|583286733|FG002|Period II|Physician Decision|0|||
161517740|NCT00359762|583286734|FG003|Period II|Physician Decision|0|||
161517741|NCT00359762|583286735|FG004|Period II|Physician Decision|23|||
161517742|NCT00359762|583286731|FG000|Period II|Death|2|||
161517743|NCT00359762|583286732|FG001|Period II|Death|0|||
161517744|NCT00359762|583286733|FG002|Period II|Death|0|||
161517745|NCT00359762|583286734|FG003|Period II|Death|0|||
161517746|NCT00359762|583286735|FG004|Period II|Death|4|||
161517747|NCT00359762|583286731|FG000|Period II|Lack of Efficacy|11|||
161517748|NCT00359762|583286732|FG001|Period II|Lack of Efficacy|0|||
161517749|NCT00359762|583286733|FG002|Period II|Lack of Efficacy|0|||
161517750|NCT00359762|583286734|FG003|Period II|Lack of Efficacy|0|||
161517751|NCT00359762|583286735|FG004|Period II|Lack of Efficacy|8|||
161517752|NCT00359762|583286731|FG000|Period II|Lost to follow up|5|||
161517753|NCT00359762|583286732|FG001|Period II|Lost to follow up|0|||
161517754|NCT00359762|583286733|FG002|Period II|Lost to follow up|0|||
161517755|NCT00359762|583286734|FG003|Period II|Lost to follow up|0|||
161517756|NCT00359762|583286735|FG004|Period II|Lost to follow up|5|||
161517757|NCT00359762|583286731|FG000|Period II|Entry Criteria Not Met|8|||
161517758|NCT00359762|583286732|FG001|Period II|Entry Criteria Not Met|0|||
161517759|NCT00359762|583286733|FG002|Period II|Entry Criteria Not Met|0|||
161517760|NCT00359762|583286734|FG003|Period II|Entry Criteria Not Met|0|||
161517761|NCT00359762|583286735|FG004|Period II|Entry Criteria Not Met|4|||
161517762|NCT00359762|583286731|FG000|Period II|Subject Decision|50|||
161517763|NCT00359762|583286732|FG001|Period II|Subject Decision|0|||
161517764|NCT00359762|583286733|FG002|Period II|Subject Decision|0|||
161517765|NCT00359762|583286734|FG003|Period II|Subject Decision|0|||
161517766|NCT00359762|583286735|FG004|Period II|Subject Decision|70|||
161517767|NCT00359762|583286731|FG000|Period III|Protocol Violation|0|||
161517768|NCT00359762|583286732|FG001|Period III|Protocol Violation|5|||
161517769|NCT00359762|583286733|FG002|Period III|Protocol Violation|3|||
161517770|NCT00359762|583286734|FG003|Period III|Protocol Violation|8|||
161517771|NCT00359762|583286735|FG004|Period III|Protocol Violation|0|||
161517772|NCT00359762|583286731|FG000|Period III|Adverse Event|0|||
161517773|NCT00359762|583286732|FG001|Period III|Adverse Event|3|||
161517774|NCT00359762|583286733|FG002|Period III|Adverse Event|4|||
161517775|NCT00359762|583286734|FG003|Period III|Adverse Event|10|||
161517776|NCT00359762|583286735|FG004|Period III|Adverse Event|0|||
161517777|NCT00359762|583286731|FG000|Period III|Physician Decision|0|||
161517778|NCT00359762|583286732|FG001|Period III|Physician Decision|5|||
161517779|NCT00359762|583286733|FG002|Period III|Physician Decision|9|||
161517780|NCT00359762|583286734|FG003|Period III|Physician Decision|15|||
161517781|NCT00359762|583286735|FG004|Period III|Physician Decision|0|||
161517782|NCT00359762|583286731|FG000|Period III|Lack of Efficacy|0|||
161517783|NCT00359762|583286732|FG001|Period III|Lack of Efficacy|7|||
161517784|NCT00359762|583286733|FG002|Period III|Lack of Efficacy|5|||
161517785|NCT00359762|583286734|FG003|Period III|Lack of Efficacy|9|||
161517786|NCT00359762|583286735|FG004|Period III|Lack of Efficacy|0|||
161517787|NCT00359762|583286731|FG000|Period III|Lost to follow up|0|||
161517788|NCT00359762|583286732|FG001|Period III|Lost to follow up|1|||
161517789|NCT00359762|583286733|FG002|Period III|Lost to follow up|1|||
161517790|NCT00359762|583286734|FG003|Period III|Lost to follow up|2|||
161517791|NCT00359762|583286735|FG004|Period III|Lost to follow up|0|||
161517792|NCT00359762|583286731|FG000|Period III|Entry Criteria Not Met|0|||
161517793|NCT00359762|583286732|FG001|Period III|Entry Criteria Not Met|1|||
161517794|NCT00359762|583286733|FG002|Period III|Entry Criteria Not Met|0|||
161517795|NCT00359762|583286734|FG003|Period III|Entry Criteria Not Met|1|||
161517796|NCT00359762|583286735|FG004|Period III|Entry Criteria Not Met|0|||
161517797|NCT00359762|583286731|FG000|Period III|Subject Decision|0|||
161517798|NCT00359762|583286732|FG001|Period III|Subject Decision|7|||
161517799|NCT00359762|583286733|FG002|Period III|Subject Decision|8|||
161517800|NCT00359762|583286734|FG003|Period III|Subject Decision|20|||
161517801|NCT00359762|583286735|FG004|Period III|Subject Decision|0|||
161517802|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
161517803|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
161517804|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
161517805|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161517806|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161517807|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161517808|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161517809|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161517810|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161517811|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
161932413|NCT00159874|584800466|FG004|Overall Study|Other|2|||
161932414|NCT00159874|584800467|FG005|Overall Study|Other|1|||
161932415|NCT00159874|584800468|FG006|Overall Study|Other|3|||
161932416|NCT00159874|584800462|FG000|Overall Study|Protocol Violation|0|||
161517812|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
161517813|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
161517814|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161517815|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161517816|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161517817|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161517818|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161517819|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161517820|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517821|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161517822|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
161517823|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517824|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517825|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517826|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517827|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517828|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161517829|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
161517830|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
161517831|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
161517832|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161517833|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161517834|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161517835|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161517836|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161517837|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161517838|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517839|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
161517840|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517841|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517842|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517843|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517844|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517845|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517846|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
161517847|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
161517848|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517849|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517850|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517851|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517852|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517853|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517854|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517855|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161517856|NCT01172938|583286738|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517857|NCT01172938|583286739|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
161517858|NCT01172938|583286740|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
161517859|NCT01172938|583286741|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517860|NCT01172938|583286742|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517861|NCT01172938|583286743|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517862|NCT01172938|583286744|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517863|NCT01172938|583286745|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517864|NCT01172938|583286746|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
161517865|NCT01172938|583286738|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
161517866|NCT01172938|583286739|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
161517867|NCT01172938|583286740|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
161517868|NCT01172938|583286741|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
161517869|NCT01172938|583286742|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
161517870|NCT01172938|583286743|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
161517871|NCT01172938|583286744|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
161517872|NCT01172938|583286745|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
161932417|NCT00159874|584800463|FG001|Overall Study|Protocol Violation|5|||
161517873|NCT01172938|583286746|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
161517874|NCT01172938|583286738|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
161517875|NCT01172938|583286739|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
161517876|NCT01172938|583286740|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
161517877|NCT01172938|583286741|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
161517878|NCT01172938|583286742|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
161517879|NCT01172938|583286743|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
161517880|NCT01172938|583286744|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
161517881|NCT01172938|583286745|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
161517882|NCT01172938|583286746|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
161517883|NCT01172938|583286738|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517884|NCT01172938|583286739|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517885|NCT01172938|583286740|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
161517886|NCT01172938|583286741|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517887|NCT01172938|583286742|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517888|NCT01172938|583286743|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517889|NCT01172938|583286744|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517890|NCT01172938|583286745|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517891|NCT01172938|583286746|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
161517892|NCT01172938|583286738|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
161517893|NCT01172938|583286739|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
161517894|NCT01172938|583286740|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
161517895|NCT01172938|583286741|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
161517896|NCT01172938|583286742|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
161517897|NCT01172938|583286743|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
161517898|NCT01172938|583286744|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
161517899|NCT01172938|583286745|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
161517900|NCT01172938|583286746|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
161517901|NCT01172938|583286738|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
161517902|NCT01172938|583286739|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
161517903|NCT01172938|583286740|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
161517904|NCT01172938|583286741|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
161517905|NCT01172938|583286742|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
161517906|NCT01172938|583286743|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
161517907|NCT01172938|583286744|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
161517908|NCT01172938|583286745|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
161517909|NCT01172938|583286746|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
161517910|NCT01172938|583286738|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
161517911|NCT01172938|583286739|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
161517912|NCT01172938|583286740|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
161517913|NCT01172938|583286741|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
161517914|NCT01172938|583286742|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
161932418|NCT00159874|584800464|FG002|Overall Study|Protocol Violation|2|||
161517915|NCT01172938|583286743|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
161517916|NCT01172938|583286744|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
161517917|NCT01172938|583286745|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
161517918|NCT01172938|583286746|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
161517919|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
161517920|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
161517921|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
161517922|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
161517923|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
161517924|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
161517925|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
161517926|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
161517927|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
161517928|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
161517929|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
161517930|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
161517931|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
161517932|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
161517933|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
161517934|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
161517935|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
161677443|NCT00467779|583872012|FG012|Stage 2A|Unspecified Reason|0|||
161517936|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
161517937|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517938|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517939|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
161517940|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517941|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517942|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517943|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517944|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517945|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161517946|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
161517947|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
161517948|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
161517949|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
161517950|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
161517951|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
161517952|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
161517953|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
161517954|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
161517955|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517956|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517957|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
161517958|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517959|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517960|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517961|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517962|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517963|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
161517964|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161517965|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
161517966|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
161517967|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161517968|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161517969|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161517970|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161517971|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
161517972|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161517973|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517974|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
161517975|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517976|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517977|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517978|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517979|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517980|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
161517981|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
161517982|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517983|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
161517984|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517985|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517986|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517987|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517988|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517989|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517990|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
161517991|NCT01172938|583286738|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517992|NCT01172938|583286739|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517993|NCT01172938|583286740|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517994|NCT01172938|583286741|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517995|NCT01172938|583286742|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517996|NCT01172938|583286743|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161824382|NCT00857818|584397976|FG000|Overall Study|Withdrawal by Subject|0|||
161824383|NCT00857818|584397977|FG001|Overall Study|Withdrawal by Subject|4|||
161824384|NCT00857818|584397976|FG000|Overall Study|Sponsor terminated study|6|||
161824385|NCT00857818|584397977|FG001|Overall Study|Sponsor terminated study|4|||
161932419|NCT00159874|584800465|FG003|Overall Study|Protocol Violation|0|||
161517997|NCT01172938|583286744|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517998|NCT01172938|583286745|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
161517999|NCT01172938|583286746|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
161518000|NCT01172938|583286738|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
161518001|NCT01172938|583286739|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
161518002|NCT01172938|583286740|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
161518003|NCT01172938|583286741|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
161518004|NCT01172938|583286742|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
161518005|NCT01172938|583286743|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
161518006|NCT01172938|583286744|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
161518007|NCT01172938|583286745|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
161518008|NCT01172938|583286746|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
161518009|NCT01172938|583286738|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
161518010|NCT01172938|583286739|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
161518011|NCT01172938|583286740|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
161518012|NCT01172938|583286741|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
161518013|NCT01172938|583286742|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
161518014|NCT01172938|583286743|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
161518015|NCT01172938|583286744|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
161518016|NCT01172938|583286745|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
161518017|NCT01172938|583286746|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
161518018|NCT01172938|583286738|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518019|NCT01172938|583286739|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518020|NCT01172938|583286740|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518021|NCT01172938|583286741|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518022|NCT01172938|583286742|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
161677444|NCT00467779|583872013|FG013|Stage 2A|Unspecified Reason|7|||
161677445|NCT00467779|583872014|FG014|Stage 2A|Unspecified Reason|0|||
161677446|NCT00467779|583872000|FG000|Stage 2A|Withdrawal by Subject|0|||
161677447|NCT00467779|583872001|FG001|Stage 2A|Withdrawal by Subject|0|||
161677448|NCT00467779|583872002|FG002|Stage 2A|Withdrawal by Subject|0|||
161677449|NCT00467779|583872003|FG003|Stage 2A|Withdrawal by Subject|0|||
161677450|NCT00467779|583872004|FG004|Stage 2A|Withdrawal by Subject|0|||
161677451|NCT00467779|583872005|FG005|Stage 2A|Withdrawal by Subject|0|||
161677452|NCT00467779|583872006|FG006|Stage 2A|Withdrawal by Subject|0|||
161677453|NCT00467779|583872007|FG007|Stage 2A|Withdrawal by Subject|0|||
161677454|NCT00467779|583872008|FG008|Stage 2A|Withdrawal by Subject|0|||
161677455|NCT00467779|583872009|FG009|Stage 2A|Withdrawal by Subject|0|||
161677456|NCT00467779|583872010|FG010|Stage 2A|Withdrawal by Subject|0|||
161677457|NCT00467779|583872011|FG011|Stage 2A|Withdrawal by Subject|0|||
161677458|NCT00467779|583872012|FG012|Stage 2A|Withdrawal by Subject|0|||
161677459|NCT00467779|583872013|FG013|Stage 2A|Withdrawal by Subject|1|||
161677460|NCT00467779|583872014|FG014|Stage 2A|Withdrawal by Subject|0|||
161677461|NCT00467779|583872000|FG000|Stage 3|Adverse Event|0|||
161677462|NCT00467779|583872001|FG001|Stage 3|Adverse Event|0|||
161677463|NCT00467779|583872002|FG002|Stage 3|Adverse Event|0|||
161677464|NCT00467779|583872003|FG003|Stage 3|Adverse Event|0|||
161677465|NCT00467779|583872004|FG004|Stage 3|Adverse Event|0|||
161677466|NCT00467779|583872005|FG005|Stage 3|Adverse Event|0|||
161677467|NCT00467779|583872006|FG006|Stage 3|Adverse Event|0|||
161677468|NCT00467779|583872007|FG007|Stage 3|Adverse Event|0|||
161677469|NCT00467779|583872008|FG008|Stage 3|Adverse Event|0|||
161677470|NCT00467779|583872009|FG009|Stage 3|Adverse Event|0|||
161518023|NCT01172938|583286743|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518024|NCT01172938|583286744|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518025|NCT01172938|583286745|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
161518026|NCT01172938|583286746|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
161518027|NCT01172938|583286738|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518028|NCT01172938|583286739|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
161518029|NCT01172938|583286740|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518030|NCT01172938|583286741|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518031|NCT01172938|583286742|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518032|NCT01172938|583286743|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518033|NCT01172938|583286744|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518034|NCT01172938|583286745|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518035|NCT01172938|583286746|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
161518036|NCT01172938|583286738|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518037|NCT01172938|583286739|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161677471|NCT00467779|583872010|FG010|Stage 3|Adverse Event|0|||
161677472|NCT00467779|583872011|FG011|Stage 3|Adverse Event|0|||
161677473|NCT00467779|583872012|FG012|Stage 3|Adverse Event|0|||
161677474|NCT00467779|583872013|FG013|Stage 3|Adverse Event|0|||
161677475|NCT00467779|583872014|FG014|Stage 3|Adverse Event|2|||
161518038|NCT01172938|583286740|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
161518039|NCT01172938|583286741|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518040|NCT01172938|583286742|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518041|NCT01172938|583286743|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518042|NCT01172938|583286744|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518043|NCT01172938|583286745|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518044|NCT01172938|583286746|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
161518045|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
161518046|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
161518047|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
161518048|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
161518049|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
161518050|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
161518051|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
161518052|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
161518053|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
161518054|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
161518055|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
161518056|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
161518057|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
161518058|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
161518059|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
161518060|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
161518061|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
161518062|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
161518063|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
161518064|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
161518065|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
161518066|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
161518067|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
161518068|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
161518069|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
161518070|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
161518071|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
161518072|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518073|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518074|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
161518075|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518076|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518077|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518078|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518079|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
161518080|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
161518081|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518082|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518083|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518084|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518085|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518086|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518087|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518088|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
161518089|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
161518090|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
161518091|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
161518092|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
161518093|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
161518094|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
161518095|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
161518096|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
161518097|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
161518098|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
161518099|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518100|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518101|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
161518102|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518103|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518104|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518105|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518106|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518107|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
161518108|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518109|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
161518110|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518111|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518112|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518113|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518114|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518115|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
161518116|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
161518117|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
161518118|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
161518119|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
161518120|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
161518121|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
161518122|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
161518123|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
161518124|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
161518125|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
161518126|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518127|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518128|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
161518129|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518130|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518131|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518132|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518133|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518134|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
161518135|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518136|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518137|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
161518138|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518139|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518140|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518141|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518142|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518143|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161518144|NCT01172938|583286738|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518145|NCT01172938|583286739|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518146|NCT01172938|583286740|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518147|NCT01172938|583286741|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518148|NCT01172938|583286742|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518149|NCT01172938|583286743|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518150|NCT01172938|583286744|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518151|NCT01172938|583286745|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
161518152|NCT01172938|583286746|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
161518153|NCT02613481|583286747|FG000|Overall Study|Lost to Follow-up|7|||
161518154|NCT02613481|583286747|FG000|Overall Study|Withdrawal by Subject|2|||
161518155|NCT01033747|583286748|FG000|Overall Study|Adverse Event|9|||
161518156|NCT01033747|583286749|FG001|Overall Study|Adverse Event|4|||
161518157|NCT01033747|583286748|FG000|Overall Study|Abnormal Laboratory Value|1|||
161518158|NCT01033747|583286749|FG001|Overall Study|Abnormal Laboratory Value|0|||
161518159|NCT01033747|583286748|FG000|Overall Study|Abnormal test procedure|0|||
161518160|NCT01033747|583286749|FG001|Overall Study|Abnormal test procedure|1|||
161518161|NCT01033747|583286748|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
161518162|NCT01033747|583286749|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161518163|NCT01033747|583286748|FG000|Overall Study|Protocol Violation|1|||
161518164|NCT01033747|583286749|FG001|Overall Study|Protocol Violation|0|||
161518165|NCT01033747|583286748|FG000|Overall Study|Withdrawal by Subject|9|||
161518166|NCT01033747|583286749|FG001|Overall Study|Withdrawal by Subject|6|||
161518167|NCT01033747|583286748|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
161518168|NCT01033747|583286749|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
161518169|NCT01033747|583286748|FG000|Overall Study|Stopped at end of Extension 1|2|||
161518170|NCT01033747|583286749|FG001|Overall Study|Stopped at end of Extension 1|0|||
161518171|NCT02647658|583286750|FG000|Overall Study|Consent refusal|15|||
161518172|NCT02647658|583286751|FG001|Overall Study|Consent refusal|24|||
161518173|NCT00803023|583286752|FG000|Overall Study|Adverse Event|5|||
161518174|NCT00803023|583286753|FG001|Overall Study|Adverse Event|4|||
161518175|NCT00803023|583286754|FG002|Overall Study|Adverse Event|8|||
161518176|NCT00803023|583286755|FG003|Overall Study|Adverse Event|6|||
161518177|NCT00803023|583286752|FG000|Overall Study|Withdrawal by Subject|0|||
161518178|NCT00803023|583286753|FG001|Overall Study|Withdrawal by Subject|2|||
161518179|NCT00803023|583286754|FG002|Overall Study|Withdrawal by Subject|0|||
161518180|NCT00803023|583286755|FG003|Overall Study|Withdrawal by Subject|0|||
161518181|NCT00803023|583286752|FG000|Overall Study|Lost to Follow-up|0|||
161518182|NCT00803023|583286753|FG001|Overall Study|Lost to Follow-up|1|||
161518183|NCT00803023|583286754|FG002|Overall Study|Lost to Follow-up|2|||
161518184|NCT00803023|583286755|FG003|Overall Study|Lost to Follow-up|1|||
161518185|NCT00803023|583286752|FG000|Overall Study|Lack of Efficacy|0|||
161518186|NCT00803023|583286753|FG001|Overall Study|Lack of Efficacy|1|||
161518187|NCT00803023|583286754|FG002|Overall Study|Lack of Efficacy|1|||
161518188|NCT00803023|583286755|FG003|Overall Study|Lack of Efficacy|1|||
161518189|NCT01542528|583286760|FG000|Overall Study|Lost to Follow-up|2|||
161518190|NCT01542528|583286761|FG001|Overall Study|Lost to Follow-up|1|||
161518191|NCT01542528|583286760|FG000|Overall Study|Physician Decision|1|||
161518192|NCT01542528|583286761|FG001|Overall Study|Physician Decision|0|||
161518193|NCT01542528|583286760|FG000|Overall Study|Withdrawal by Subject|9|||
161518194|NCT01542528|583286761|FG001|Overall Study|Withdrawal by Subject|6|||
161518195|NCT05282004|583286762|FG000|Overall Study|Adverse Event|2|||
161518196|NCT04808609|583286763|FG000|Overall Study|Lost to Follow-up|0|||
161518197|NCT04808609|583286764|FG001|Overall Study|Lost to Follow-up|2|||
161518198|NCT04808609|583286763|FG000|Overall Study|Administrative Withdrawal|0|||
161518199|NCT04808609|583286764|FG001|Overall Study|Administrative Withdrawal|1|||
161518200|NCT00562159|583286765|FG000|Overall Study|Adverse Event|11|||
161518201|NCT00562159|583286766|FG001|Overall Study|Adverse Event|8|||
161518202|NCT00562159|583286765|FG000|Overall Study|Lost to Follow-up|5|||
161518203|NCT00562159|583286766|FG001|Overall Study|Lost to Follow-up|4|||
161518204|NCT00562159|583286765|FG000|Overall Study|Withdrawal by Subject|9|||
161518205|NCT00562159|583286766|FG001|Overall Study|Withdrawal by Subject|8|||
161518206|NCT00562159|583286765|FG000|Overall Study|Protocol Violation|12|||
161518207|NCT00562159|583286766|FG001|Overall Study|Protocol Violation|12|||
161518208|NCT00562159|583286765|FG000|Overall Study|Did not meet protocol eligibility|1|||
161518209|NCT00562159|583286766|FG001|Overall Study|Did not meet protocol eligibility|1|||
161518210|NCT04382326|583286770|FG000|Overall Study|Adverse Event, not serious|1|||
161518211|NCT04382326|583286771|FG001|Overall Study|Adverse Event, not serious|2|||
161518212|NCT04382326|583286770|FG000|Overall Study|Other|1|||
161518213|NCT04382326|583286771|FG001|Overall Study|Other|0|||
161518214|NCT04382326|583286770|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
161518215|NCT04382326|583286771|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
161518216|NCT04382326|583286770|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
161518217|NCT04382326|583286771|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
161518218|NCT04382326|583286770|FG000|Overall Study|Protocol Violation|29|||
161518219|NCT04382326|583286771|FG001|Overall Study|Protocol Violation|23|||
161518220|NCT04382326|583286770|FG000|Overall Study|Physician Decision|0|||
161518221|NCT04382326|583286771|FG001|Overall Study|Physician Decision|1|||
161518222|NCT04382326|583286770|FG000|Overall Study|Lost to Follow-up|48|||
161588975|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588976|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588977|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588978|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
161518223|NCT04382326|583286771|FG001|Overall Study|Lost to Follow-up|63|||
161518224|NCT04382326|583286770|FG000|Overall Study|Adverse Event, non-fatal|1|||
161518225|NCT04382326|583286771|FG001|Overall Study|Adverse Event, non-fatal|1|||
161518226|NCT01181921|583286774|FG000|Overall Study|Lost to Follow-up|1|||
161518227|NCT02461589|583286780|FG000|Overall Study|Withdrawal by Subject|5|||
161518228|NCT02461589|583286781|FG001|Overall Study|Withdrawal by Subject|1|||
161518229|NCT02461589|583286782|FG002|Overall Study|Withdrawal by Subject|3|||
161518230|NCT02461589|583286783|FG003|Overall Study|Withdrawal by Subject|2|||
161518231|NCT02461589|583286784|FG004|Overall Study|Withdrawal by Subject|1|||
161588979|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
161518232|NCT02461589|583286785|FG005|Overall Study|Withdrawal by Subject|2|||
161518233|NCT02461589|583286786|FG006|Overall Study|Withdrawal by Subject|1|||
161518234|NCT02461589|583286787|FG007|Overall Study|Withdrawal by Subject|3|||
161518235|NCT02461589|583286788|FG008|Overall Study|Withdrawal by Subject|3|||
161518236|NCT02461589|583286789|FG009|Overall Study|Withdrawal by Subject|1|||
161518237|NCT02461589|583286780|FG000|Overall Study|Lost to Follow-up|0|||
161932420|NCT00159874|584800466|FG004|Overall Study|Protocol Violation|0|||
161932421|NCT00159874|584800467|FG005|Overall Study|Protocol Violation|0|||
161932422|NCT00159874|584800468|FG006|Overall Study|Protocol Violation|0|||
161932423|NCT00159874|584800462|FG000|Overall Study|Death|3|||
161932424|NCT00159874|584800463|FG001|Overall Study|Death|8|||
161518238|NCT02461589|583286781|FG001|Overall Study|Lost to Follow-up|0|||
161518239|NCT02461589|583286782|FG002|Overall Study|Lost to Follow-up|2|||
161518240|NCT02461589|583286783|FG003|Overall Study|Lost to Follow-up|3|||
161518241|NCT02461589|583286784|FG004|Overall Study|Lost to Follow-up|1|||
161518242|NCT02461589|583286785|FG005|Overall Study|Lost to Follow-up|1|||
161518243|NCT02461589|583286786|FG006|Overall Study|Lost to Follow-up|3|||
161518244|NCT02461589|583286787|FG007|Overall Study|Lost to Follow-up|1|||
161518245|NCT02461589|583286788|FG008|Overall Study|Lost to Follow-up|3|||
161518246|NCT02461589|583286789|FG009|Overall Study|Lost to Follow-up|1|||
161518247|NCT02461589|583286780|FG000|Overall Study|Death|0|||
161518248|NCT02461589|583286781|FG001|Overall Study|Death|0|||
161518249|NCT02461589|583286782|FG002|Overall Study|Death|0|||
161518250|NCT02461589|583286783|FG003|Overall Study|Death|0|||
161518251|NCT02461589|583286784|FG004|Overall Study|Death|0|||
161518252|NCT02461589|583286785|FG005|Overall Study|Death|0|||
161518253|NCT02461589|583286786|FG006|Overall Study|Death|0|||
161518254|NCT02461589|583286787|FG007|Overall Study|Death|1|||
161518255|NCT02461589|583286788|FG008|Overall Study|Death|0|||
161518256|NCT02461589|583286789|FG009|Overall Study|Death|0|||
161518257|NCT02461589|583286780|FG000|Overall Study|Unclassified|0|||
161518258|NCT02461589|583286781|FG001|Overall Study|Unclassified|0|||
161518259|NCT02461589|583286782|FG002|Overall Study|Unclassified|0|||
161518260|NCT02461589|583286783|FG003|Overall Study|Unclassified|0|||
161518261|NCT02461589|583286784|FG004|Overall Study|Unclassified|0|||
161518262|NCT02461589|583286785|FG005|Overall Study|Unclassified|0|||
161518263|NCT02461589|583286786|FG006|Overall Study|Unclassified|1|||
161518264|NCT02461589|583286787|FG007|Overall Study|Unclassified|0|||
161518265|NCT02461589|583286788|FG008|Overall Study|Unclassified|0|||
161518266|NCT02461589|583286789|FG009|Overall Study|Unclassified|2|||
161518267|NCT02461589|583286780|FG000|Overall Study|Missing follow-up information|1|||
161518268|NCT02461589|583286781|FG001|Overall Study|Missing follow-up information|1|||
161518269|NCT02461589|583286782|FG002|Overall Study|Missing follow-up information|0|||
161518270|NCT02461589|583286783|FG003|Overall Study|Missing follow-up information|0|||
161518271|NCT02461589|583286784|FG004|Overall Study|Missing follow-up information|0|||
161518272|NCT02461589|583286785|FG005|Overall Study|Missing follow-up information|0|||
161518273|NCT02461589|583286786|FG006|Overall Study|Missing follow-up information|1|||
161518274|NCT02461589|583286787|FG007|Overall Study|Missing follow-up information|0|||
161518275|NCT02461589|583286788|FG008|Overall Study|Missing follow-up information|0|||
161518276|NCT02461589|583286789|FG009|Overall Study|Missing follow-up information|0|||
161518277|NCT02461589|583286780|FG000|Overall Study|Withdrawal from trial before exposure|0|||
161518278|NCT02461589|583286781|FG001|Overall Study|Withdrawal from trial before exposure|0|||
161518279|NCT02461589|583286782|FG002|Overall Study|Withdrawal from trial before exposure|0|||
161518280|NCT02461589|583286783|FG003|Overall Study|Withdrawal from trial before exposure|0|||
161518281|NCT02461589|583286784|FG004|Overall Study|Withdrawal from trial before exposure|0|||
161518282|NCT02461589|583286785|FG005|Overall Study|Withdrawal from trial before exposure|0|||
161518283|NCT02461589|583286786|FG006|Overall Study|Withdrawal from trial before exposure|0|||
161518284|NCT02461589|583286787|FG007|Overall Study|Withdrawal from trial before exposure|0|||
161518285|NCT02461589|583286788|FG008|Overall Study|Withdrawal from trial before exposure|0|||
161518286|NCT02461589|583286789|FG009|Overall Study|Withdrawal from trial before exposure|1|||
161518287|NCT01978119|583286794|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
161518288|NCT01978119|583286795|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
161518289|NCT01978119|583286794|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
161518290|NCT01978119|583286795|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161518291|NCT01978119|583286794|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161518292|NCT01978119|583286795|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
161518293|NCT03295201|583286798|FG000|Overall Study|Lost to Follow-up|1|||
161518294|NCT03295201|583286799|FG001|Overall Study|Lost to Follow-up|1|||
161518295|NCT03295201|583286798|FG000|Overall Study|Hospital admission|0|||
161518296|NCT03295201|583286799|FG001|Overall Study|Hospital admission|1|||
161518297|NCT02519504|583286800|FG000|Overall Study|Protocol Violation|6|||
161518298|NCT02519504|583286801|FG001|Overall Study|Protocol Violation|5|||
161518299|NCT02519504|583286800|FG000|Overall Study|Ineligible for direct testing|12|||
161518300|NCT02519504|583286801|FG001|Overall Study|Ineligible for direct testing|12|||
161518301|NCT02519504|583286800|FG000|Overall Study|Did not participate in direct testing|95|||
161518302|NCT02519504|583286801|FG001|Overall Study|Did not participate in direct testing|86|||
161518303|NCT02548962|583286802|FG000|Overall Study|Withdrawal by Subject|1|||
161518304|NCT02548962|583286803|FG001|Overall Study|Withdrawal by Subject|0|||
161932425|NCT00159874|584800464|FG002|Overall Study|Death|15|||
161932426|NCT00159874|584800465|FG003|Overall Study|Death|0|||
161932427|NCT00159874|584800466|FG004|Overall Study|Death|1|||
161932428|NCT00159874|584800467|FG005|Overall Study|Death|2|||
161824386|NCT00857818|584397976|FG000|Overall Study|Investigator decision|1|||
161518305|NCT01958918|583286804|FG000|Overall Study|Death|1|||
161518306|NCT01958918|583286805|FG001|Overall Study|Death|3|||
161518307|NCT01958918|583286804|FG000|Overall Study|Lost to Follow-up|4|||
161518308|NCT01958918|583286805|FG001|Overall Study|Lost to Follow-up|7|||
161518309|NCT01958918|583286804|FG000|Overall Study|Withdrawal by Subject|13|||
161518310|NCT01958918|583286805|FG001|Overall Study|Withdrawal by Subject|8|||
161518311|NCT01958918|583286804|FG000|Overall Study|Lack of Efficacy|13|||
161518312|NCT01958918|583286805|FG001|Overall Study|Lack of Efficacy|10|||
161518313|NCT01958918|583286804|FG000|Overall Study|Adverse Event|12|||
161518314|NCT01958918|583286805|FG001|Overall Study|Adverse Event|12|||
161518315|NCT01958918|583286804|FG000|Overall Study|administrative problems|0|||
161518316|NCT01958918|583286805|FG001|Overall Study|administrative problems|2|||
161518317|NCT00659269|583286809|FG000|Overall Study|Physician Decision|1|||
161518318|NCT00659269|583286810|FG001|Overall Study|Physician Decision|1|||
161518319|NCT00908960|583286812|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
161518320|NCT00908960|583286813|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
161518321|NCT00908960|583286814|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
161518322|NCT02401672|583286817|FG000|Overall Study|Withdrawal by Subject|1|||
161518323|NCT02401672|583286818|FG001|Overall Study|Withdrawal by Subject|3|||
161518324|NCT03653429|583286821|FG000|Overall Study|Physician Decision|4|||
161518325|NCT03653429|583286822|FG001|Overall Study|Physician Decision|10|||
161518326|NCT00403546|583286823|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
161518327|NCT00403546|583286824|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
161518328|NCT00403546|583286825|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
161518329|NCT00403546|583286823|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
161518330|NCT00403546|583286824|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
161518331|NCT00403546|583286825|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
161518332|NCT00403546|583286823|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
161518333|NCT00403546|583286824|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
161518334|NCT00403546|583286825|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
161518335|NCT00403546|583286823|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
161518336|NCT00403546|583286824|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
161518337|NCT00403546|583286825|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
161518338|NCT00403546|583286823|FG000|Screening Phase|Screening Failure|22|||
161518339|NCT00403546|583286824|FG001|Screening Phase|Screening Failure|0|||
161518340|NCT00403546|583286825|FG002|Screening Phase|Screening Failure|0|||
161518341|NCT00403546|583286823|FG000|Screening Phase|Adverse Event|1|||
161518342|NCT00403546|583286824|FG001|Screening Phase|Adverse Event|0|||
161518343|NCT00403546|583286825|FG002|Screening Phase|Adverse Event|0|||
161518344|NCT00403546|583286823|FG000|Screening Phase|Terminated Prior to Randomization|5|||
161518345|NCT00403546|583286824|FG001|Screening Phase|Terminated Prior to Randomization|0|||
161518346|NCT00403546|583286825|FG002|Screening Phase|Terminated Prior to Randomization|0|||
161518347|NCT00403546|583286823|FG000|Randomized Trial|Early Terminations|0|||
161518348|NCT00403546|583286824|FG001|Randomized Trial|Early Terminations|17|||
161518349|NCT00403546|583286825|FG002|Randomized Trial|Early Terminations|16|||
161518350|NCT00793910|583286829|FG000|Overall Study|discarded study pills|0|||
161518351|NCT00793910|583286830|FG001|Overall Study|discarded study pills|1|||
161518352|NCT00793910|583286829|FG000|Overall Study|did not pick up medications|1|||
161518353|NCT00793910|583286830|FG001|Overall Study|did not pick up medications|1|||
161518354|NCT00793910|583286829|FG000|Overall Study|ineligible based on entry criteria|2|||
161518355|NCT00793910|583286830|FG001|Overall Study|ineligible based on entry criteria|3|||
161518356|NCT00793910|583286829|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
161518357|NCT00793910|583286830|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
161518358|NCT00793910|583286829|FG000|Overall Study|Withdrawal by Subject|0|||
161518359|NCT00793910|583286830|FG001|Overall Study|Withdrawal by Subject|1|||
161518360|NCT03634579|583286833|FG000|Overall Study|study termination|9|||
161518361|NCT02480621|583286834|FG000|Randomization|Withdrawal by Subject|1|||
161518362|NCT02480621|583286835|FG001|Randomization|Withdrawal by Subject|0|||
161518363|NCT02480621|583286834|FG000|Randomization|Surgeon did not give intervention|0|||
161518364|NCT02480621|583286835|FG001|Randomization|Surgeon did not give intervention|1|||
161518365|NCT02480621|583286834|FG000|Follow Up|Lost to Follow-up|4|||
161518366|NCT02480621|583286835|FG001|Follow Up|Lost to Follow-up|2|||
161518367|NCT05061446|583286836|FG000|Overall Study|Adverse Event|2|||
161518368|NCT05061446|583286837|FG001|Overall Study|Adverse Event|0|||
161588980|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
161518369|NCT05061446|583286838|FG002|Overall Study|Adverse Event|0|||
161518370|NCT05061446|583286836|FG000|Overall Study|Participant no longer available due to personal reason|0|||
161518371|NCT05061446|583286837|FG001|Overall Study|Participant no longer available due to personal reason|1|||
161518372|NCT05061446|583286838|FG002|Overall Study|Participant no longer available due to personal reason|0|||
161518373|NCT04111497|583286839|FG000|Overall Study|relapse of primary disease|1|||
161518374|NCT04111497|583286839|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
161518375|NCT01993719|583286842|FG000|First Drug Administration|Not treated|1|||
161518376|NCT01993719|583286843|FG001|First Drug Administration|Not treated|0|||
161518377|NCT01993719|583286844|FG002|First Drug Administration|Not treated|0|||
161518378|NCT01993719|583286845|FG003|First Drug Administration|Not treated|0|||
161518379|NCT01993719|583286846|FG004|First Drug Administration|Not treated|0|||
161518380|NCT05857527|583286847|FG000|Overall Study|Withdrawal by Subject|0|||
161518381|NCT05857527|583286848|FG001|Overall Study|Withdrawal by Subject|1|||
161518382|NCT02799082|583286849|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
161518383|NCT02799082|583286850|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
161518384|NCT02799082|583286849|FG000|Overall Study|Protocol Violation|0|||
161518385|NCT02799082|583286850|FG001|Overall Study|Protocol Violation|1|||
161518386|NCT01592708|583286852|FG000|Overall Study|Protocol Violation|3|||
161518387|NCT01592708|583286853|FG001|Overall Study|Protocol Violation|0|||
161518388|NCT01748994|583286855|FG000|Overall Study|Lost to Follow-up|8|||
161518389|NCT01748994|583286856|FG001|Overall Study|Lost to Follow-up|6|||
161518390|NCT03105362|583286857|FG000|Overall Study|Withdrawal by Subject|1|||
161518391|NCT03105362|583286857|FG000|Overall Study|Lost to Follow-up|1|||
161518392|NCT01723904|583286861|FG000|Overall Study|Noncompliant|3|||
161518393|NCT01723904|583286861|FG000|Overall Study|Adverse Event|5|||
161518394|NCT01723904|583286861|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
161518395|NCT02610140|583286872|FG000|Randomization and Treatment Period|Radiological progression|23|||
161518396|NCT02610140|583286873|FG001|Randomization and Treatment Period|Radiological progression|15|||
161518397|NCT02610140|583286872|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
161518398|NCT02610140|583286873|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
161518399|NCT02610140|583286872|FG000|Randomization and Treatment Period|Protocol Violation|1|||
161518400|NCT02610140|583286873|FG001|Randomization and Treatment Period|Protocol Violation|0|||
161518401|NCT02610140|583286872|FG000|Randomization and Treatment Period|Physician Decision|0|||
161518402|NCT02610140|583286873|FG001|Randomization and Treatment Period|Physician Decision|1|||
161518403|NCT02610140|583286872|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
161518404|NCT02610140|583286873|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
161518405|NCT02610140|583286872|FG000|Randomization and Treatment Period|Death|7|||
161518406|NCT02610140|583286873|FG001|Randomization and Treatment Period|Death|1|||
161518407|NCT02610140|583286872|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
161518408|NCT02610140|583286873|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
161518409|NCT02610140|583286872|FG000|Randomization and Treatment Period|Adverse Event|44|||
161518410|NCT02610140|583286873|FG001|Randomization and Treatment Period|Adverse Event|13|||
161518411|NCT02610140|583286872|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
161518412|NCT02610140|583286873|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
161518413|NCT02610140|583286872|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
161518414|NCT02610140|583286873|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
161518415|NCT02610140|583286872|FG000|Randomization and Treatment Period|Not treated|3|||
161518416|NCT02610140|583286873|FG001|Randomization and Treatment Period|Not treated|10|||
161518417|NCT02610140|583286872|FG000|Safety Follow-up|Other|0|||
161518418|NCT02610140|583286873|FG001|Safety Follow-up|Other|2|||
161518419|NCT02610140|583286872|FG000|Safety Follow-up|Lost to Follow-up|1|||
161518420|NCT02610140|583286873|FG001|Safety Follow-up|Lost to Follow-up|0|||
161518421|NCT02610140|583286872|FG000|Safety Follow-up|No follow-up|5|||
161518422|NCT02610140|583286873|FG001|Safety Follow-up|No follow-up|3|||
161518423|NCT02610140|583286872|FG000|Safety Follow-up|Death|12|||
161518424|NCT02610140|583286873|FG001|Safety Follow-up|Death|2|||
161518425|NCT02610140|583286872|FG000|Safety Follow-up|Deterioration of general conditions|15|||
161518426|NCT02610140|583286873|FG001|Safety Follow-up|Deterioration of general conditions|5|||
161518427|NCT02610140|583286872|FG000|Safety Follow-up|Withdrawal by Subject|12|||
161518428|NCT02610140|583286873|FG001|Safety Follow-up|Withdrawal by Subject|12|||
161518429|NCT02610140|583286872|FG000|Active Follow-up|Progressive disease - radiological|30|||
161518430|NCT02610140|583286873|FG001|Active Follow-up|Progressive disease - radiological|22|||
161518431|NCT02610140|583286872|FG000|Active Follow-up|Death|8|||
161518432|NCT02610140|583286873|FG001|Active Follow-up|Death|1|||
161588981|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161518433|NCT02610140|583286872|FG000|Active Follow-up|Withdrawal by Subject|4|||
161518434|NCT02610140|583286873|FG001|Active Follow-up|Withdrawal by Subject|0|||
161518435|NCT02610140|583286872|FG000|Active Follow-up|Progressive disease - clinical|1|||
161518436|NCT02610140|583286873|FG001|Active Follow-up|Progressive disease - clinical|2|||
161518437|NCT02610140|583286872|FG000|Active Follow-up|Deterioration of general conditions|1|||
161518438|NCT02610140|583286873|FG001|Active Follow-up|Deterioration of general conditions|0|||
161518439|NCT02610140|583286872|FG000|Active Follow-up|Ongoing but not completed|4|||
161518440|NCT02610140|583286873|FG001|Active Follow-up|Ongoing but not completed|1|||
161518441|NCT02610140|583286872|FG000|Long-term Follow-up|Death|86|||
161518442|NCT02610140|583286873|FG001|Long-term Follow-up|Death|44|||
161518443|NCT02610140|583286872|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
161518444|NCT02610140|583286873|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
161518445|NCT02610140|583286872|FG000|Long-term Follow-up|Lost to Follow-up|1|||
161518446|NCT02610140|583286873|FG001|Long-term Follow-up|Lost to Follow-up|2|||
161518447|NCT02610140|583286872|FG000|Long-term Follow-up|Ongoing but not completed|30|||
161518448|NCT02610140|583286873|FG001|Long-term Follow-up|Ongoing but not completed|17|||
161518449|NCT01312961|583286874|FG000|Overall Study|Adverse Event|3|||
161518450|NCT01312961|583286875|FG001|Overall Study|Adverse Event|3|||
161518451|NCT01312961|583286874|FG000|Overall Study|Lack of Efficacy|11|||
161518452|NCT01312961|583286875|FG001|Overall Study|Lack of Efficacy|1|||
161518453|NCT01312961|583286874|FG000|Overall Study|Poor compliance to protocol|1|||
161518454|NCT01312961|583286875|FG001|Overall Study|Poor compliance to protocol|0|||
161518455|NCT01312961|583286874|FG000|Overall Study|Other than specified above|2|||
161518456|NCT01312961|583286875|FG001|Overall Study|Other than specified above|3|||
161518457|NCT01337297|583286877|FG000|Overall Study|They entered to single anodal tDCS|4|||
161518458|NCT01337297|583286878|FG001|Overall Study|They entered to single anodal tDCS|3|||
161518459|NCT01337297|583286877|FG000|Overall Study|Lost to Follow-up|1|||
161518460|NCT01337297|583286878|FG001|Overall Study|Lost to Follow-up|3|||
161518461|NCT01800903|583286879|FG000|Second Test Period|unable to catheterise|1|||
161518462|NCT01800903|583286880|FG001|Second Test Period|unable to catheterise|0|||
161518463|NCT01800903|583286881|FG002|Second Test Period|unable to catheterise|0|||
161518464|NCT01800903|583286882|FG003|Second Test Period|unable to catheterise|0|||
161518465|NCT01800903|583286883|FG004|Second Test Period|unable to catheterise|0|||
161518466|NCT01800903|583286884|FG005|Second Test Period|unable to catheterise|0|||
161518467|NCT01306617|583286887|FG000|Overall Study|Adverse Event|1|||
161518468|NCT01306617|583286888|FG001|Overall Study|Adverse Event|0|||
161518469|NCT01306617|583286889|FG002|Overall Study|Adverse Event|0|||
161518470|NCT01306617|583286887|FG000|Overall Study|Virologic Failure|0|||
161518471|NCT01306617|583286888|FG001|Overall Study|Virologic Failure|0|||
161518472|NCT01306617|583286889|FG002|Overall Study|Virologic Failure|5|||
161518473|NCT01306617|583286887|FG000|Overall Study|Non-compliance|0|||
161518474|NCT01306617|583286888|FG001|Overall Study|Non-compliance|1|||
161518475|NCT01306617|583286889|FG002|Overall Study|Non-compliance|0|||
161518476|NCT01208233|583286891|FG000|Overall Study|Adverse Event|0|||
161518477|NCT01208233|583286892|FG001|Overall Study|Adverse Event|1|||
161518478|NCT01208233|583286893|FG002|Overall Study|Adverse Event|2|||
161518479|NCT01208233|583286894|FG003|Overall Study|Adverse Event|0|||
161518480|NCT01208233|583286895|FG004|Overall Study|Adverse Event|3|||
161518481|NCT01208233|583286896|FG005|Overall Study|Adverse Event|5|||
161518482|NCT01208233|583286891|FG000|Overall Study|Death|0|||
161518483|NCT01208233|583286892|FG001|Overall Study|Death|0|||
161518484|NCT01208233|583286893|FG002|Overall Study|Death|0|||
161518485|NCT01208233|583286894|FG003|Overall Study|Death|0|||
161518486|NCT01208233|583286895|FG004|Overall Study|Death|3|||
161518487|NCT01208233|583286896|FG005|Overall Study|Death|5|||
161518488|NCT01208233|583286891|FG000|Overall Study|Did not meet entrance criteria|2|||
161518489|NCT01208233|583286892|FG001|Overall Study|Did not meet entrance criteria|1|||
161518490|NCT01208233|583286893|FG002|Overall Study|Did not meet entrance criteria|1|||
161518491|NCT01208233|583286894|FG003|Overall Study|Did not meet entrance criteria|0|||
161518492|NCT01208233|583286895|FG004|Overall Study|Did not meet entrance criteria|1|||
161518493|NCT01208233|583286896|FG005|Overall Study|Did not meet entrance criteria|0|||
161518494|NCT01208233|583286891|FG000|Overall Study|Medication error without adverse event|0|||
161518495|NCT01208233|583286892|FG001|Overall Study|Medication error without adverse event|0|||
161518496|NCT01208233|583286893|FG002|Overall Study|Medication error without adverse event|0|||
161518497|NCT01208233|583286894|FG003|Overall Study|Medication error without adverse event|0|||
161518498|NCT01208233|583286895|FG004|Overall Study|Medication error without adverse event|0|||
161518499|NCT01208233|583286896|FG005|Overall Study|Medication error without adverse event|1|||
161518500|NCT01208233|583286891|FG000|Overall Study|Study terminated by sponsor|0|||
161518501|NCT01208233|583286892|FG001|Overall Study|Study terminated by sponsor|0|||
161518502|NCT01208233|583286893|FG002|Overall Study|Study terminated by sponsor|0|||
161518503|NCT01208233|583286894|FG003|Overall Study|Study terminated by sponsor|0|||
161518504|NCT01208233|583286895|FG004|Overall Study|Study terminated by sponsor|10|||
161518505|NCT01208233|583286896|FG005|Overall Study|Study terminated by sponsor|7|||
161518506|NCT01208233|583286891|FG000|Overall Study|Protocol Violation|0|||
161518507|NCT01208233|583286892|FG001|Overall Study|Protocol Violation|0|||
161518508|NCT01208233|583286893|FG002|Overall Study|Protocol Violation|0|||
161518509|NCT01208233|583286894|FG003|Overall Study|Protocol Violation|0|||
161518510|NCT01208233|583286895|FG004|Overall Study|Protocol Violation|3|||
161518511|NCT01208233|583286896|FG005|Overall Study|Protocol Violation|0|||
161518512|NCT01208233|583286891|FG000|Overall Study|Other|2|||
161518513|NCT01208233|583286892|FG001|Overall Study|Other|1|||
161518514|NCT01208233|583286893|FG002|Overall Study|Other|0|||
161518515|NCT01208233|583286894|FG003|Overall Study|Other|0|||
161518516|NCT01208233|583286895|FG004|Overall Study|Other|0|||
161518517|NCT01208233|583286896|FG005|Overall Study|Other|1|||
161518518|NCT01208233|583286891|FG000|Overall Study|Withdrawal by Subject|1|||
161518519|NCT01208233|583286892|FG001|Overall Study|Withdrawal by Subject|0|||
161518520|NCT01208233|583286893|FG002|Overall Study|Withdrawal by Subject|1|||
161518521|NCT01208233|583286894|FG003|Overall Study|Withdrawal by Subject|1|||
161518522|NCT01208233|583286895|FG004|Overall Study|Withdrawal by Subject|4|||
161518523|NCT01208233|583286896|FG005|Overall Study|Withdrawal by Subject|2|||
161518524|NCT04028388|583286900|FG000|Overall Study|Evaluations missing|3|||
161518525|NCT04028388|583286901|FG001|Overall Study|Evaluations missing|6|||
161518526|NCT04028388|583286900|FG000|Overall Study|Not started|2|||
161518527|NCT04028388|583286901|FG001|Overall Study|Not started|0|||
161518528|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518529|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518530|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518531|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518532|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
161518533|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518534|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518535|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
161518536|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
161518537|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518538|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
161518539|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
161518540|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518541|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518542|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518543|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
161518544|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
161518545|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
161518546|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
161518547|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
161518548|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
161518549|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
161518550|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
161518551|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
161518552|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
161518553|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
161518554|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
161518555|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
161518556|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
161518557|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
161518558|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
161518559|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
161518560|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518561|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518562|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518563|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518564|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518565|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
161518566|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
161518567|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518568|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518569|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
161518570|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
161518571|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
161518572|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518573|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518574|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518575|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
161518576|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518577|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518578|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518579|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518580|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518581|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
161518582|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518583|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518584|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518585|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518586|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518587|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
161518588|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518589|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518590|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518591|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161518592|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518593|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518594|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518595|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518596|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518597|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
161518598|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518599|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518600|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518601|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518602|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518603|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518604|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518605|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518606|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518607|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161518608|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518609|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518610|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518611|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518612|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518613|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518614|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518615|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518616|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
161518617|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518618|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518619|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518620|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518621|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518622|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518623|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
161518624|NCT01609556|583286902|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
161518625|NCT01609556|583286903|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518626|NCT01609556|583286904|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518627|NCT01609556|583286905|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518628|NCT01609556|583286906|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518629|NCT01609556|583286907|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
161518630|NCT01609556|583286908|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518631|NCT01609556|583286909|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518632|NCT01609556|583286910|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518633|NCT01609556|583286911|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518634|NCT01609556|583286912|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
161518635|NCT01609556|583286913|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518636|NCT01609556|583286914|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518637|NCT01609556|583286915|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161677476|NCT00467779|583872000|FG000|Stage 3|Death|0|||
161677477|NCT00467779|583872001|FG001|Stage 3|Death|0|||
161932429|NCT00159874|584800468|FG006|Overall Study|Death|0|||
161932430|NCT00159874|584800462|FG000|Overall Study|Withdrawal by Subject|2|||
161932431|NCT00159874|584800463|FG001|Overall Study|Withdrawal by Subject|6|||
161932432|NCT00159874|584800464|FG002|Overall Study|Withdrawal by Subject|8|||
161932433|NCT00159874|584800465|FG003|Overall Study|Withdrawal by Subject|4|||
161932434|NCT00159874|584800466|FG004|Overall Study|Withdrawal by Subject|3|||
161932435|NCT00159874|584800467|FG005|Overall Study|Withdrawal by Subject|2|||
161932436|NCT00159874|584800468|FG006|Overall Study|Withdrawal by Subject|1|||
161518638|NCT01609556|583286916|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518639|NCT01609556|583286917|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
161518640|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518641|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518642|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518643|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518644|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518645|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518646|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518647|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518648|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518649|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518650|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518651|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
161518652|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
161518653|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
161518654|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
161518655|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
161518656|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518657|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518658|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518659|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518660|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518661|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518662|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518663|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518664|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518665|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518666|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518667|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
161518668|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
161518669|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
161518670|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
161518671|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
161518672|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518673|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518674|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518675|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518676|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518677|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518678|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518679|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518680|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518681|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518682|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518683|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
161518684|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
161518685|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
161518686|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
161518687|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
161518688|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518689|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518690|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518691|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518692|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518693|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518694|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518695|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518696|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518697|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518698|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518699|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518700|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
161518701|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161677478|NCT00467779|583872002|FG002|Stage 3|Death|0|||
161677479|NCT00467779|583872003|FG003|Stage 3|Death|0|||
161677480|NCT00467779|583872004|FG004|Stage 3|Death|0|||
161932437|NCT00159874|584800462|FG000|Overall Study|Pregnancy|1|||
161932438|NCT00159874|584800463|FG001|Overall Study|Pregnancy|1|||
161932439|NCT00159874|584800464|FG002|Overall Study|Pregnancy|0|||
161932440|NCT00159874|584800465|FG003|Overall Study|Pregnancy|0|||
161932441|NCT00159874|584800466|FG004|Overall Study|Pregnancy|0|||
161518702|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518703|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
161518704|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518705|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518706|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518707|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518708|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518709|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518710|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518711|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518712|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518713|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518714|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518715|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
161518716|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
161518717|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
161518718|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
161518719|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
161518720|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518721|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518722|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518723|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518724|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518725|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518726|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518727|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518728|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518729|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518730|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518731|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518732|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518733|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518734|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
161518735|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
161518736|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518737|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518738|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518739|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518740|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518741|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518742|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518743|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518744|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518745|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518746|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518747|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518748|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
161518749|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
161518750|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
161518751|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
161518752|NCT01609556|583286902|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518753|NCT01609556|583286903|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518754|NCT01609556|583286904|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518755|NCT01609556|583286905|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518756|NCT01609556|583286906|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161588982|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588983|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588984|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161588985|NCT01261312|583544585|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161588986|NCT01261312|583544586|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161588987|NCT01261312|583544587|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161932442|NCT00159874|584800467|FG005|Overall Study|Pregnancy|0|||
161932443|NCT00159874|584800468|FG006|Overall Study|Pregnancy|0|||
161932444|NCT01104870|584800469|FG000|Overall Study|Adverse Event|1|||
161518757|NCT01609556|583286907|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518758|NCT01609556|583286908|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518759|NCT01609556|583286909|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518760|NCT01609556|583286910|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518761|NCT01609556|583286911|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518762|NCT01609556|583286912|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518763|NCT01609556|583286913|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518764|NCT01609556|583286914|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
161518765|NCT01609556|583286915|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518766|NCT01609556|583286916|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518767|NCT01609556|583286917|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161518768|NCT01539291|583288751|FG000|Study GS-US-312-0116|Adverse Event|9|||
161518769|NCT01539291|583288752|FG001|Study GS-US-312-0116|Adverse Event|0|||
161518770|NCT01539291|583288753|FG002|Study GS-US-312-0116|Adverse Event|0|||
161518771|NCT01539291|583288754|FG003|Study GS-US-312-0116|Adverse Event|0|||
161518772|NCT01539291|583288751|FG000|Study GS-US-312-0116|Physician Decision|1|||
161518773|NCT01539291|583288752|FG001|Study GS-US-312-0116|Physician Decision|0|||
161518774|NCT01539291|583288753|FG002|Study GS-US-312-0116|Physician Decision|0|||
161518775|NCT01539291|583288754|FG003|Study GS-US-312-0116|Physician Decision|0|||
161518776|NCT01539291|583288751|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
161518777|NCT01539291|583288752|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
161518778|NCT01539291|583288753|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
161518779|NCT01539291|583288754|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
161518780|NCT01539291|583288751|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
161518781|NCT01539291|583288752|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
161518782|NCT01539291|583288753|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
161518783|NCT01539291|583288754|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
161518784|NCT01539291|583288751|FG000|Study GS-US-312-0116|Other|1|||
161518785|NCT01539291|583288752|FG001|Study GS-US-312-0116|Other|0|||
161518786|NCT01539291|583288753|FG002|Study GS-US-312-0116|Other|0|||
161518787|NCT01539291|583288754|FG003|Study GS-US-312-0116|Other|0|||
161518788|NCT01539291|583288751|FG000|Study GS-US-312-0117|Adverse Event|22|||
161518789|NCT01539291|583288752|FG001|Study GS-US-312-0117|Adverse Event|1|||
161518790|NCT01539291|583288753|FG002|Study GS-US-312-0117|Adverse Event|9|||
161518791|NCT01539291|583288754|FG003|Study GS-US-312-0117|Adverse Event|12|||
161518792|NCT01539291|583288751|FG000|Study GS-US-312-0117|Physician Decision|9|||
161518793|NCT01539291|583288752|FG001|Study GS-US-312-0117|Physician Decision|0|||
161518794|NCT01539291|583288753|FG002|Study GS-US-312-0117|Physician Decision|6|||
161518795|NCT01539291|583288754|FG003|Study GS-US-312-0117|Physician Decision|4|||
161518796|NCT01539291|583288751|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
161518797|NCT01539291|583288752|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
161518798|NCT01539291|583288753|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
161518799|NCT01539291|583288754|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
161518800|NCT01539291|583288751|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
161518801|NCT01539291|583288752|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
161518802|NCT01539291|583288753|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
161518803|NCT01539291|583288754|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
161518804|NCT01539291|583288751|FG000|Study GS-US-312-0117|Other|2|||
161518805|NCT01539291|583288752|FG001|Study GS-US-312-0117|Other|1|||
161518806|NCT01539291|583288753|FG002|Study GS-US-312-0117|Other|1|||
161518807|NCT01539291|583288754|FG003|Study GS-US-312-0117|Other|1|||
161518808|NCT00129987|583288759|FG000|1st Educational Session|Withdrawal by Subject|141|||
161518809|NCT00129987|583288760|FG001|1st Educational Session|Withdrawal by Subject|109|||
161518810|NCT00129987|583288759|FG000|1 Year|Withdrawal by Subject|32|||
161518811|NCT00129987|583288760|FG001|1 Year|Withdrawal by Subject|21|||
161518812|NCT00116805|583288761|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
161518813|NCT00116805|583288762|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
161518814|NCT00116805|583288761|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
161518815|NCT00116805|583288762|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
161518816|NCT00116805|583288761|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
161518817|NCT00116805|583288762|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
161518818|NCT00116805|583288761|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
161518819|NCT00116805|583288762|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
161677481|NCT00467779|583872005|FG005|Stage 3|Death|0|||
161677482|NCT00467779|583872006|FG006|Stage 3|Death|0|||
161518820|NCT00116805|583288761|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
161518821|NCT00116805|583288762|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
161518822|NCT00116805|583288761|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
161518823|NCT00116805|583288762|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
161518824|NCT00116805|583288761|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
161518825|NCT00116805|583288762|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
161518826|NCT00116805|583288761|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
161518827|NCT00116805|583288762|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
161518828|NCT00116805|583288761|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
161518829|NCT00116805|583288762|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
161518830|NCT00116805|583288761|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
161518831|NCT00116805|583288762|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
161518832|NCT00116805|583288761|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
161518833|NCT00116805|583288762|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
161518834|NCT00116805|583288761|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
161518835|NCT00116805|583288762|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
161518836|NCT00116805|583288761|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
161518837|NCT00116805|583288762|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
161518838|NCT00116805|583288761|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
161518839|NCT00116805|583288762|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
161518840|NCT00116805|583288761|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
161518841|NCT00116805|583288762|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
161518842|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
161518843|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
161518844|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
161518845|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
161518846|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
161518847|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
161518848|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
161518849|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
161518850|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
161518851|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
161518852|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
161518853|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
161518854|NCT00116805|583288761|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
161518855|NCT00116805|583288762|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
161518856|NCT00116805|583288761|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
161518857|NCT00116805|583288762|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
161518858|NCT00116805|583288761|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
161518859|NCT00116805|583288762|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
161518860|NCT00116805|583288761|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
161518861|NCT00116805|583288762|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
161518862|NCT00116805|583288761|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
161518863|NCT00116805|583288762|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
161518864|NCT00116805|583288761|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
161518865|NCT00116805|583288762|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
161518866|NCT00116805|583288761|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
161518867|NCT00116805|583288762|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
161518868|NCT00116805|583288761|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
161518869|NCT00116805|583288762|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
161518870|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
161518871|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
161518872|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
161518873|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
161518874|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
161518875|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
161518876|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
161518877|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
161518878|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
161518879|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
161518880|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
161518881|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
161518882|NCT00116805|583288761|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
161518883|NCT00116805|583288762|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
161518884|NCT00116805|583288761|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
161518885|NCT00116805|583288762|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
161518886|NCT00116805|583288761|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
161588988|NCT01261312|583544588|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161588989|NCT01261312|583544589|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161518887|NCT00116805|583288762|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
161518888|NCT00116805|583288761|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
161518889|NCT00116805|583288762|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
161518890|NCT00116805|583288761|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
161518891|NCT00116805|583288762|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
161518892|NCT00116805|583288761|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
161518893|NCT00116805|583288762|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
161518894|NCT00116805|583288761|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
161518895|NCT00116805|583288762|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
161518896|NCT00116805|583288761|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
161518897|NCT00116805|583288762|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
161518898|NCT00116805|583288761|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
161518899|NCT00116805|583288762|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
161518900|NCT00116805|583288761|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
161518901|NCT00116805|583288762|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
161518902|NCT01159938|583288763|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
161518903|NCT01159938|583288764|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
161518904|NCT01159938|583288765|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
161518905|NCT01159938|583288766|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
161518906|NCT01159938|583288767|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
161518907|NCT02105116|583288769|FG000|Overall Study|not eligible for step 2 of trial|5|||
161518908|NCT02105116|583288769|FG000|Overall Study|Death|1|||
161518909|NCT02318329|583288771|FG000|Overall Study|Progressive Disease|2|||
161518910|NCT02318329|583288772|FG001|Overall Study|Progressive Disease|3|||
161518911|NCT02318329|583288773|FG002|Overall Study|Progressive Disease|2|||
161518912|NCT02318329|583288774|FG003|Overall Study|Progressive Disease|3|||
161518913|NCT02318329|583288775|FG004|Overall Study|Progressive Disease|3|||
161518914|NCT02318329|583288776|FG005|Overall Study|Progressive Disease|3|||
161518915|NCT02318329|583288777|FG006|Overall Study|Progressive Disease|1|||
161518916|NCT02318329|583288778|FG007|Overall Study|Progressive Disease|1|||
161518917|NCT02318329|583288779|FG008|Overall Study|Progressive Disease|5|||
161518918|NCT02318329|583288780|FG009|Overall Study|Progressive Disease|39|||
161518919|NCT02318329|583288771|FG000|Overall Study|Death|0|||
161518920|NCT02318329|583288772|FG001|Overall Study|Death|0|||
161518921|NCT02318329|583288773|FG002|Overall Study|Death|0|||
161518922|NCT02318329|583288774|FG003|Overall Study|Death|0|||
161518923|NCT02318329|583288775|FG004|Overall Study|Death|0|||
161518924|NCT02318329|583288776|FG005|Overall Study|Death|0|||
161518925|NCT02318329|583288777|FG006|Overall Study|Death|0|||
161518926|NCT02318329|583288778|FG007|Overall Study|Death|0|||
161518927|NCT02318329|583288779|FG008|Overall Study|Death|0|||
161518928|NCT02318329|583288780|FG009|Overall Study|Death|5|||
161518929|NCT02318329|583288771|FG000|Overall Study|Lost to Follow-up|0|||
161518930|NCT02318329|583288772|FG001|Overall Study|Lost to Follow-up|0|||
161518931|NCT02318329|583288773|FG002|Overall Study|Lost to Follow-up|0|||
161518932|NCT02318329|583288774|FG003|Overall Study|Lost to Follow-up|0|||
161518933|NCT02318329|583288775|FG004|Overall Study|Lost to Follow-up|0|||
161518934|NCT02318329|583288776|FG005|Overall Study|Lost to Follow-up|0|||
161518935|NCT02318329|583288777|FG006|Overall Study|Lost to Follow-up|0|||
161518936|NCT02318329|583288778|FG007|Overall Study|Lost to Follow-up|0|||
161518937|NCT02318329|583288779|FG008|Overall Study|Lost to Follow-up|0|||
161824387|NCT00857818|584397977|FG001|Overall Study|Investigator decision|0|||
161824388|NCT02061280|584397981|FG000|Overall Study|Protocol Violation|12|||
161824389|NCT02061280|584397982|FG001|Overall Study|Protocol Violation|8|||
161824390|NCT02061280|584397981|FG000|Overall Study|moved out of state|0|||
161824391|NCT02061280|584397982|FG001|Overall Study|moved out of state|1|||
161824392|NCT02061280|584397981|FG000|Overall Study|Withdrawal by Subject|1|||
161518938|NCT02318329|583288780|FG009|Overall Study|Lost to Follow-up|1|||
161518939|NCT02318329|583288771|FG000|Overall Study|Withdrawal by Subject|0|||
161518940|NCT02318329|583288772|FG001|Overall Study|Withdrawal by Subject|0|||
161518941|NCT02318329|583288773|FG002|Overall Study|Withdrawal by Subject|0|||
161518942|NCT02318329|583288774|FG003|Overall Study|Withdrawal by Subject|0|||
161518943|NCT02318329|583288775|FG004|Overall Study|Withdrawal by Subject|0|||
161518944|NCT02318329|583288776|FG005|Overall Study|Withdrawal by Subject|0|||
161518945|NCT02318329|583288777|FG006|Overall Study|Withdrawal by Subject|0|||
161518946|NCT02318329|583288778|FG007|Overall Study|Withdrawal by Subject|0|||
161518947|NCT02318329|583288779|FG008|Overall Study|Withdrawal by Subject|0|||
161518948|NCT02318329|583288780|FG009|Overall Study|Withdrawal by Subject|6|||
161518949|NCT02318329|583288771|FG000|Overall Study|Other|1|||
161518950|NCT02318329|583288772|FG001|Overall Study|Other|1|||
161518951|NCT02318329|583288773|FG002|Overall Study|Other|1|||
161518952|NCT02318329|583288774|FG003|Overall Study|Other|0|||
161518953|NCT02318329|583288775|FG004|Overall Study|Other|0|||
161518954|NCT02318329|583288776|FG005|Overall Study|Other|0|||
161518955|NCT02318329|583288777|FG006|Overall Study|Other|0|||
161518956|NCT02318329|583288778|FG007|Overall Study|Other|0|||
161518957|NCT02318329|583288779|FG008|Overall Study|Other|1|||
161518958|NCT02318329|583288780|FG009|Overall Study|Other|1|||
161518959|NCT04837482|583288781|FG000|Period 2|Withdrawal by Subject|0|||
161518960|NCT04837482|583288782|FG001|Period 2|Withdrawal by Subject|1|||
161518961|NCT00581945|583288783|FG000|Overall Study|Adverse Event|4|||
161518962|NCT00581945|583288784|FG001|Overall Study|Adverse Event|4|||
161518963|NCT00581945|583288783|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161518964|NCT00581945|583288784|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161518965|NCT00581945|583288783|FG000|Overall Study|Withdrawal by Subject|2|||
161518966|NCT00581945|583288784|FG001|Overall Study|Withdrawal by Subject|6|||
161518967|NCT00581945|583288783|FG000|Overall Study|Death|1|||
161518968|NCT00581945|583288784|FG001|Overall Study|Death|0|||
161518969|NCT02979535|583288785|FG000|Overall Study|Non compliance with the protocol|78|||
161518970|NCT02979535|583288786|FG001|Overall Study|Non compliance with the protocol|82|||
161518971|NCT02979535|583288785|FG000|Overall Study|Consent withdrawn by participant|11|||
161518972|NCT02979535|583288786|FG001|Overall Study|Consent withdrawn by participant|18|||
161518973|NCT02979535|583288785|FG000|Overall Study|Lost to Follow-up|6|||
161518974|NCT02979535|583288786|FG001|Overall Study|Lost to Follow-up|1|||
161518975|NCT04820673|583288787|FG000|Overall Study|Adverse Event|6|||
161518976|NCT04820673|583288787|FG000|Overall Study|Due to Lack of Effectiveness|1|||
161518977|NCT04820673|583288787|FG000|Overall Study|Pregnancy|1|||
161518978|NCT04820673|583288787|FG000|Overall Study|Voluntary Withdrawal|20|||
161518979|NCT04820673|583288787|FG000|Overall Study|Lost to Follow-up|10|||
161518980|NCT00587587|583288790|FG000|Overall Study|Lost to Follow-up|6|||
161518981|NCT00587587|583288791|FG001|Overall Study|Lost to Follow-up|1|||
161518982|NCT02032901|583288794|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
161518983|NCT02032901|583288795|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
161518984|NCT02032901|583288794|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
161518985|NCT02032901|583288795|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
161518986|NCT00466193|583288796|FG000|Overall Study|Adverse Event|0|||
161518987|NCT00466193|583288797|FG001|Overall Study|Adverse Event|1|||
161518988|NCT00466193|583288796|FG000|Overall Study|Lost to Follow-up|2|||
161518989|NCT00466193|583288797|FG001|Overall Study|Lost to Follow-up|4|||
161518990|NCT00466193|583288796|FG000|Overall Study|Physician Decision|1|||
161518991|NCT00466193|583288797|FG001|Overall Study|Physician Decision|0|||
161518992|NCT00466193|583288796|FG000|Overall Study|Protocol Violation|1|||
161518993|NCT00466193|583288797|FG001|Overall Study|Protocol Violation|1|||
161518994|NCT00466193|583288796|FG000|Overall Study|Withdrawal by Subject|7|||
161518995|NCT00466193|583288797|FG001|Overall Study|Withdrawal by Subject|2|||
161518996|NCT00466193|583288796|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
161518997|NCT00466193|583288797|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
161518998|NCT00086346|583288804|FG000|Randomization|Did not receive test article|4|||
161518999|NCT00086346|583288805|FG001|Randomization|Did not receive test article|4|||
161519000|NCT00086346|583288804|FG000|Patients Dosed With Test Article|Adverse Event|94|||
161519001|NCT00086346|583288805|FG001|Patients Dosed With Test Article|Adverse Event|11|||
161519002|NCT00086346|583288804|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
161519003|NCT00086346|583288805|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
161519004|NCT00086346|583288804|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
161519005|NCT00086346|583288805|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
161519006|NCT00086346|583288804|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
161519007|NCT00086346|583288805|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
161519008|NCT00086346|583288804|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
161519009|NCT00086346|583288805|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
161519010|NCT00086346|583288804|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
161519011|NCT00086346|583288805|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
161519012|NCT04495374|583288806|FG000|Overall Study|Protocol Violation|2|||
161519013|NCT04495374|583288807|FG001|Overall Study|Protocol Violation|1|||
161519014|NCT02473614|583288808|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
161519015|NCT02473614|583288809|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
161519016|NCT02525133|583288810|FG000|Overall Study|Adverse Event|0|||
161519017|NCT02525133|583288811|FG001|Overall Study|Adverse Event|1|||
161519018|NCT02525133|583288810|FG000|Overall Study|Death|0|||
161519019|NCT02525133|583288811|FG001|Overall Study|Death|1|||
161519020|NCT02525133|583288810|FG000|Overall Study|did not meet randomization criteria|1|||
161519021|NCT02525133|583288811|FG001|Overall Study|did not meet randomization criteria|0|||
161519022|NCT02525133|583288810|FG000|Overall Study|Lost to Follow-up|5|||
161519023|NCT02525133|583288811|FG001|Overall Study|Lost to Follow-up|1|||
161519024|NCT02525133|583288810|FG000|Overall Study|randomized not enrolled|3|||
161519025|NCT02525133|583288811|FG001|Overall Study|randomized not enrolled|0|||
161519026|NCT02525133|583288810|FG000|Overall Study|Withdrawal by Subject|1|||
161519027|NCT02525133|583288811|FG001|Overall Study|Withdrawal by Subject|0|||
161519028|NCT01343082|583288812|FG000|The run-in Period|Not meeting criteria|3|||
161519029|NCT01343082|583288813|FG001|The run-in Period|Not meeting criteria|4|||
161519030|NCT01343082|583288814|FG002|The run-in Period|Not meeting criteria|5|||
161519031|NCT01343082|583288812|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
161519032|NCT01343082|583288813|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
161519033|NCT01343082|583288814|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
161519034|NCT01343082|583288812|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
161519035|NCT01343082|583288813|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
161519036|NCT01343082|583288814|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
161519037|NCT01343082|583288812|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
161519038|NCT01343082|583288813|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
161519039|NCT01343082|583288814|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
161519040|NCT01343082|583288812|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
161519041|NCT01343082|583288813|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
161519042|NCT01343082|583288814|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
161519043|NCT01075074|583288815|FG000|Overall Study|Surgeon changed to open incisional case|1|||
161519044|NCT01075074|583288816|FG001|Overall Study|Surgeon changed to open incisional case|2|||
161519045|NCT01075074|583288817|FG002|Overall Study|Surgeon changed to open incisional case|2|||
161519046|NCT01575561|583288819|FG000|Overall Study|Adverse Event|9|||
161519047|NCT01575561|583288819|FG000|Overall Study|Lack of Efficacy|8|||
161519048|NCT01575561|583288819|FG000|Overall Study|Lost to Follow-up|6|||
161519049|NCT01575561|583288819|FG000|Overall Study|Protocol Violation|4|||
161519050|NCT01575561|583288819|FG000|Overall Study|Withdrawal by Subject|11|||
161519051|NCT01575561|583288819|FG000|Overall Study|administration|1|||
161519052|NCT00844194|583288820|FG000|Overall Study|Adverse Event|17|||
161519053|NCT00844194|583288821|FG001|Overall Study|Adverse Event|5|||
161519054|NCT00844194|583288820|FG000|Overall Study|Protocol Violation|1|||
161519055|NCT00844194|583288821|FG001|Overall Study|Protocol Violation|1|||
161519056|NCT00844194|583288820|FG000|Overall Study|Lost to Follow-up|1|||
161519057|NCT00844194|583288821|FG001|Overall Study|Lost to Follow-up|1|||
161519058|NCT00844194|583288820|FG000|Overall Study|Withdrawal by Subject|2|||
161519059|NCT00844194|583288821|FG001|Overall Study|Withdrawal by Subject|1|||
161519060|NCT00844194|583288820|FG000|Overall Study|Lack of Efficacy|3|||
161519061|NCT00844194|583288821|FG001|Overall Study|Lack of Efficacy|0|||
161519062|NCT00844194|583288820|FG000|Overall Study|Other reason (not specified)|1|||
161519063|NCT00844194|583288821|FG001|Overall Study|Other reason (not specified)|0|||
161519064|NCT01038921|583288822|FG000|Overall Study|Withdrawal by Subject|1|||
161519065|NCT01038921|583288823|FG001|Overall Study|Withdrawal by Subject|0|||
161519066|NCT01038921|583288822|FG000|Overall Study|Physician Decision|1|||
161519067|NCT01038921|583288823|FG001|Overall Study|Physician Decision|0|||
161519068|NCT00572572|583288824|FG000|Overall Study|Withdrawal by Subject|3|||
161519069|NCT00572572|583288825|FG001|Overall Study|Withdrawal by Subject|6|||
161519070|NCT01831089|583288826|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
161519071|NCT01831089|583288827|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
161519072|NCT01831089|583288828|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
161519073|NCT01831089|583288829|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
161519074|NCT01831089|583288830|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
161519075|NCT01831089|583288831|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
161519076|NCT01831089|583288826|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
161519077|NCT01831089|583288827|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
161519078|NCT01831089|583288828|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
161519079|NCT01831089|583288829|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
161519080|NCT01831089|583288830|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
161519081|NCT01831089|583288831|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
161519082|NCT01831089|583288826|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
161519083|NCT01831089|583288827|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
161519084|NCT01831089|583288828|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
161519085|NCT01831089|583288829|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
161519086|NCT01831089|583288830|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
161519087|NCT01831089|583288831|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
161588990|NCT01261312|583544590|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161588991|NCT01261312|583544591|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
161588992|NCT01261312|583544592|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
161588993|NCT01261312|583544593|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
161519088|NCT01831089|583288826|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
161519089|NCT01831089|583288827|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
161519090|NCT01831089|583288828|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
161519091|NCT01831089|583288829|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
161519092|NCT01831089|583288830|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
161519093|NCT01831089|583288831|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
161519094|NCT01831089|583288826|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
161519095|NCT01831089|583288827|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
161519096|NCT01831089|583288828|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
161519097|NCT01831089|583288829|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
161519098|NCT01831089|583288830|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
161519099|NCT01831089|583288831|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
161519100|NCT01831089|583288826|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
161519101|NCT01831089|583288827|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
161519102|NCT01831089|583288828|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
161519103|NCT01831089|583288829|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
161519104|NCT01831089|583288830|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
161519105|NCT01831089|583288831|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
161519106|NCT01831089|583288826|FG000|Cohort III: Dose Level 3|Global end of study|0|||
161519107|NCT01831089|583288827|FG001|Cohort III: Dose Level 3|Global end of study|0|||
161519108|NCT01831089|583288828|FG002|Cohort III: Dose Level 3|Global end of study|1|||
161519109|NCT01831089|583288829|FG003|Cohort III: Dose Level 3|Global end of study|0|||
161519110|NCT01831089|583288830|FG004|Cohort III: Dose Level 3|Global end of study|0|||
161519111|NCT01831089|583288831|FG005|Cohort III: Dose Level 3|Global end of study|0|||
161519112|NCT01831089|583288826|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
161519113|NCT01831089|583288827|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
161519114|NCT01831089|583288828|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
161519115|NCT01831089|583288829|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
161519116|NCT01831089|583288830|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
161519117|NCT01831089|583288831|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
161519118|NCT01831089|583288826|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
161519119|NCT01831089|583288827|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
161519120|NCT01831089|583288828|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
161519121|NCT01831089|583288829|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
161519122|NCT01831089|583288830|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
161519123|NCT01831089|583288831|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
161519124|NCT01831089|583288826|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
161519125|NCT01831089|583288827|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
161519126|NCT01831089|583288828|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
161519127|NCT01831089|583288829|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
161519128|NCT01831089|583288830|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
161519129|NCT01831089|583288831|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
161519130|NCT01831089|583288826|FG000|Cohort V: Dose Level 5|Death|0|||
161519131|NCT01831089|583288827|FG001|Cohort V: Dose Level 5|Death|0|||
161519132|NCT01831089|583288828|FG002|Cohort V: Dose Level 5|Death|0|||
161519133|NCT01831089|583288829|FG003|Cohort V: Dose Level 5|Death|0|||
161519134|NCT01831089|583288830|FG004|Cohort V: Dose Level 5|Death|1|||
161519135|NCT01831089|583288831|FG005|Cohort V: Dose Level 5|Death|0|||
161519136|NCT01831089|583288826|FG000|Cohort V: Dose Level 5|Global end of study|0|||
161519137|NCT01831089|583288827|FG001|Cohort V: Dose Level 5|Global end of study|0|||
161519138|NCT01831089|583288828|FG002|Cohort V: Dose Level 5|Global end of study|0|||
161519139|NCT01831089|583288829|FG003|Cohort V: Dose Level 5|Global end of study|0|||
161519140|NCT01831089|583288830|FG004|Cohort V: Dose Level 5|Global end of study|2|||
161519141|NCT01831089|583288831|FG005|Cohort V: Dose Level 5|Global end of study|0|||
161519142|NCT01831089|583288826|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
161519143|NCT01831089|583288827|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
161519144|NCT01831089|583288828|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
161519145|NCT01831089|583288829|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
161519146|NCT01831089|583288830|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
161519147|NCT01831089|583288831|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
161519148|NCT01831089|583288826|FG000|Cohort B: Arm B|Progressive disease|0|||
161519149|NCT01831089|583288827|FG001|Cohort B: Arm B|Progressive disease|0|||
161519150|NCT01831089|583288828|FG002|Cohort B: Arm B|Progressive disease|0|||
161519151|NCT01831089|583288829|FG003|Cohort B: Arm B|Progressive disease|0|||
161519152|NCT01831089|583288830|FG004|Cohort B: Arm B|Progressive disease|0|||
161519153|NCT01831089|583288831|FG005|Cohort B: Arm B|Progressive disease|8|||
161519154|NCT01831089|583288826|FG000|Cohort B: Arm B|Physician Decision|0|||
161519155|NCT01831089|583288827|FG001|Cohort B: Arm B|Physician Decision|0|||
161519156|NCT01831089|583288828|FG002|Cohort B: Arm B|Physician Decision|0|||
161519157|NCT01831089|583288829|FG003|Cohort B: Arm B|Physician Decision|0|||
161519158|NCT01831089|583288830|FG004|Cohort B: Arm B|Physician Decision|0|||
161588994|NCT01261312|583544594|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161519159|NCT01831089|583288831|FG005|Cohort B: Arm B|Physician Decision|2|||
161588995|NCT01261312|583544595|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161519160|NCT01831089|583288826|FG000|Cohort B: Arm B|Never treated|0|||
161519161|NCT01831089|583288827|FG001|Cohort B: Arm B|Never treated|0|||
161588996|NCT01261312|583544596|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161519162|NCT01831089|583288828|FG002|Cohort B: Arm B|Never treated|0|||
161519163|NCT01831089|583288829|FG003|Cohort B: Arm B|Never treated|0|||
161519164|NCT01831089|583288830|FG004|Cohort B: Arm B|Never treated|0|||
161588997|NCT01261312|583544597|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161519165|NCT01831089|583288831|FG005|Cohort B: Arm B|Never treated|2|||
161519166|NCT01831089|583288826|FG000|Cohort B: Arm B|Adverse Event|0|||
161519167|NCT01831089|583288827|FG001|Cohort B: Arm B|Adverse Event|0|||
161519168|NCT01831089|583288828|FG002|Cohort B: Arm B|Adverse Event|0|||
161519169|NCT01831089|583288829|FG003|Cohort B: Arm B|Adverse Event|0|||
161519170|NCT01831089|583288830|FG004|Cohort B: Arm B|Adverse Event|0|||
161519171|NCT01831089|583288831|FG005|Cohort B: Arm B|Adverse Event|1|||
161519172|NCT01831089|583288826|FG000|Cohort B: Arm B|Global end of study|0|||
161519173|NCT01831089|583288827|FG001|Cohort B: Arm B|Global end of study|0|||
161519174|NCT01831089|583288828|FG002|Cohort B: Arm B|Global end of study|0|||
161519175|NCT01831089|583288829|FG003|Cohort B: Arm B|Global end of study|0|||
161519176|NCT01831089|583288830|FG004|Cohort B: Arm B|Global end of study|0|||
161519177|NCT01831089|583288831|FG005|Cohort B: Arm B|Global end of study|1|||
161519178|NCT00889421|583288835|FG000|Overall Study|Lack of Efficacy|3|||
161519179|NCT03551938|583288836|FG000|3-Month Follow Up|Lost to Follow-up|39|||
161519180|NCT03551938|583288837|FG001|3-Month Follow Up|Lost to Follow-up|38|||
161519181|NCT03551938|583288836|FG000|6-Month Follow Up|Lost to Follow-up|46|||
161519182|NCT03551938|583288837|FG001|6-Month Follow Up|Lost to Follow-up|42|||
161519183|NCT03551938|583288836|FG000|9-Month Follow Up|Lost to Follow-up|44|||
161519184|NCT03551938|583288837|FG001|9-Month Follow Up|Lost to Follow-up|43|||
161519185|NCT01114646|583288838|FG000|Overall Study|Withdrawal by Subject|3|||
161519186|NCT01114646|583288839|FG001|Overall Study|Withdrawal by Subject|2|||
161519187|NCT02667912|583288849|FG000|Overall Study|Death|3|||
161519188|NCT02667912|583288850|FG001|Overall Study|Death|1|||
161519189|NCT02667912|583288849|FG000|Overall Study|Withdrawal by Subject|1|||
161519190|NCT02667912|583288850|FG001|Overall Study|Withdrawal by Subject|2|||
161519191|NCT02667912|583288849|FG000|Overall Study|Withdrawal by Subject|1|||
161519192|NCT02667912|583288850|FG001|Overall Study|Withdrawal by Subject|0|||
161519193|NCT04443218|583288851|FG000|Overall Study|Exited study for other reasons|9|||
161519194|NCT04443218|583288851|FG000|Overall Study|Withdrawal by Subject|1|||
161519195|NCT04443218|583288851|FG000|Overall Study|Lost to Follow-up|4|||
161519196|NCT04443218|583288851|FG000|Overall Study|Death|19|||
161519197|NCT00781326|583288852|FG000|Phase I|Adverse Event|1|||
161519198|NCT00781326|583288852|FG000|Phase I|Withdrawal by Subject|1|||
161519199|NCT00781326|583288852|FG000|Phase I|Physician Decision|2|||
161519200|NCT00096941|583288853|FG000|Overall Study|disease progression|3|||
161519201|NCT00861341|583288861|FG000|Overall Study|Withdrawal by Subject|2|||
161519202|NCT01440946|583288862|FG000|Overall Study|Lost to Follow-up|1|||
161519203|NCT01440946|583288863|FG001|Overall Study|Lost to Follow-up|1|||
161519204|NCT01440946|583288862|FG000|Overall Study|Physician Decision|1|||
161519205|NCT01440946|583288863|FG001|Overall Study|Physician Decision|0|||
161519206|NCT01975389|583288864|FG000|Overall Study|Adverse Event|10|||
161519207|NCT01975389|583288865|FG001|Overall Study|Adverse Event|6|||
161519208|NCT01975389|583288864|FG000|Overall Study|Death|61|||
161519209|NCT01975389|583288865|FG001|Overall Study|Death|54|||
161519210|NCT01975389|583288864|FG000|Overall Study|Lost to Follow-up|81|||
161519211|NCT01975389|583288865|FG001|Overall Study|Lost to Follow-up|86|||
161519212|NCT01975389|583288864|FG000|Overall Study|Withdrawal by Subject|90|||
161519213|NCT01975389|583288865|FG001|Overall Study|Withdrawal by Subject|76|||
161519214|NCT01975389|583288864|FG000|Overall Study|Other|6|||
161519215|NCT01975389|583288865|FG001|Overall Study|Other|9|||
161519216|NCT01975389|583288864|FG000|Overall Study|Randomized, not treated|4|||
161519217|NCT01975389|583288865|FG001|Overall Study|Randomized, not treated|5|||
161519218|NCT02778204|583288870|FG000|Overall Study|Adverse Event|1|||
161519219|NCT02778204|583288871|FG001|Overall Study|Adverse Event|0|||
161519220|NCT02778204|583288872|FG002|Overall Study|Adverse Event|0|||
161519221|NCT02778204|583288873|FG003|Overall Study|Adverse Event|0|||
161519222|NCT02778204|583288870|FG000|Overall Study|Withdrawal by Subject|0|||
161519223|NCT02778204|583288871|FG001|Overall Study|Withdrawal by Subject|0|||
161519224|NCT02778204|583288872|FG002|Overall Study|Withdrawal by Subject|1|||
161519225|NCT02778204|583288873|FG003|Overall Study|Withdrawal by Subject|2|||
161519226|NCT02778204|583288870|FG000|Overall Study|Lost to Follow-up|1|||
161519227|NCT02778204|583288871|FG001|Overall Study|Lost to Follow-up|0|||
161519228|NCT02778204|583288872|FG002|Overall Study|Lost to Follow-up|2|||
161519229|NCT02778204|583288873|FG003|Overall Study|Lost to Follow-up|1|||
161519230|NCT02778204|583288870|FG000|Overall Study|Protocol Violation|0|||
161519231|NCT02778204|583288871|FG001|Overall Study|Protocol Violation|0|||
161519232|NCT02778204|583288872|FG002|Overall Study|Protocol Violation|1|||
161519233|NCT02778204|583288873|FG003|Overall Study|Protocol Violation|0|||
161519234|NCT02778204|583288870|FG000|Overall Study|Eligibility Violation|0|||
161519235|NCT02778204|583288871|FG001|Overall Study|Eligibility Violation|0|||
161519236|NCT02778204|583288872|FG002|Overall Study|Eligibility Violation|0|||
161519237|NCT02778204|583288873|FG003|Overall Study|Eligibility Violation|1|||
161519238|NCT01720069|583288874|FG000|Overall Study|Could not use e-diary correctly|0|||
161519239|NCT01720069|583288875|FG001|Overall Study|Could not use e-diary correctly|1|||
161519240|NCT01720069|583288876|FG002|Overall Study|Could not use e-diary correctly|1|||
161519241|NCT01720069|583288874|FG000|Overall Study|Randomised without baseline values|0|||
161519242|NCT01720069|583288875|FG001|Overall Study|Randomised without baseline values|0|||
161519243|NCT01720069|583288876|FG002|Overall Study|Randomised without baseline values|1|||
161519244|NCT01720069|583288874|FG000|Overall Study|Adverse Event|0|||
161519245|NCT01720069|583288875|FG001|Overall Study|Adverse Event|0|||
161519246|NCT01720069|583288876|FG002|Overall Study|Adverse Event|1|||
161519247|NCT01720069|583288874|FG000|Overall Study|Lack of Efficacy|0|||
161519248|NCT01720069|583288875|FG001|Overall Study|Lack of Efficacy|4|||
161519249|NCT01720069|583288876|FG002|Overall Study|Lack of Efficacy|0|||
161519250|NCT01720069|583288874|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
161519251|NCT01720069|583288875|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
161519252|NCT01720069|583288876|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
161519253|NCT01720069|583288874|FG000|Overall Study|Withdrawal by Subject|0|||
161519254|NCT01720069|583288875|FG001|Overall Study|Withdrawal by Subject|2|||
161519255|NCT01720069|583288876|FG002|Overall Study|Withdrawal by Subject|1|||
161519256|NCT01720069|583288874|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
161519257|NCT01720069|583288875|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
161519258|NCT01720069|583288876|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
161519259|NCT01720069|583288874|FG000|Overall Study|Non-compliance on using e-diary|0|||
161519260|NCT01720069|583288875|FG001|Overall Study|Non-compliance on using e-diary|0|||
161519261|NCT01720069|583288876|FG002|Overall Study|Non-compliance on using e-diary|1|||
161519262|NCT01720069|583288874|FG000|Overall Study|Lost to Follow-up|0|||
161519263|NCT01720069|583288875|FG001|Overall Study|Lost to Follow-up|0|||
161519264|NCT01720069|583288876|FG002|Overall Study|Lost to Follow-up|1|||
161519265|NCT00360334|583288877|FG000|Overall Study|Adverse Event|7|||
161519266|NCT00360334|583288878|FG001|Overall Study|Adverse Event|4|||
161519267|NCT00360334|583288877|FG000|Overall Study|Protocol Violation|1|||
161519268|NCT00360334|583288878|FG001|Overall Study|Protocol Violation|1|||
161519269|NCT00360334|583288877|FG000|Overall Study|Physician Decision|2|||
161519270|NCT00360334|583288878|FG001|Overall Study|Physician Decision|3|||
161519271|NCT00360334|583288877|FG000|Overall Study|Lack of Efficacy|0|||
161519272|NCT00360334|583288878|FG001|Overall Study|Lack of Efficacy|1|||
161519273|NCT00360334|583288877|FG000|Overall Study|Entry criterion not met|1|||
161519274|NCT00360334|583288878|FG001|Overall Study|Entry criterion not met|2|||
161519275|NCT00360334|583288877|FG000|Overall Study|Subject decision|8|||
161519276|NCT00360334|583288878|FG001|Overall Study|Subject decision|2|||
161519277|NCT01898793|583288880|FG000|Overall Study|Death|2|||
161519278|NCT01898793|583288881|FG001|Overall Study|Death|1|||
161519279|NCT01898793|583288882|FG002|Overall Study|Death|4|||
161519280|NCT01898793|583288883|FG003|Overall Study|Death|0|||
161519281|NCT01898793|583288884|FG004|Overall Study|Death|0|||
161519282|NCT01898793|583288885|FG005|Overall Study|Death|0|||
161519283|NCT01898793|583288886|FG006|Overall Study|Death|0|||
161519284|NCT00162136|583288888|FG000|Overall Study|Adverse Event|1|||
161519285|NCT00162136|583288888|FG000|Overall Study|Death|1|||
161519286|NCT00162136|583288888|FG000|Overall Study|Disease Progression/Relapse|23|||
161519287|NCT00162136|583288888|FG000|Overall Study|Investigator Request|5|||
161519288|NCT00162136|583288888|FG000|Overall Study|Study Drug Toxicity|4|||
161519289|NCT00162136|583288888|FG000|Overall Study|Withdrawal by Subject|1|||
161519290|NCT00836875|583288890|FG000|Overall Study|Death|3|||
161519291|NCT00836875|583288891|FG001|Overall Study|Death|2|||
161519292|NCT00836875|583288890|FG000|Overall Study|Withdrawal by Subject|0|||
161519293|NCT00836875|583288891|FG001|Overall Study|Withdrawal by Subject|1|||
161519294|NCT03964454|583288900|FG000|Overall Study|Lost to Follow-up|13|||
161519295|NCT03964454|583288901|FG001|Overall Study|Lost to Follow-up|7|||
161519296|NCT03964454|583288900|FG000|Overall Study|Withdrawal by Subject|4|||
161519297|NCT03964454|583288901|FG001|Overall Study|Withdrawal by Subject|11|||
161519298|NCT04450264|583290853|FG000|Overall Study|Incomplete survey|13|||
161519299|NCT04450264|583290854|FG001|Overall Study|Incomplete survey|19|||
161519300|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
161588998|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161588999|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161589000|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161589001|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161589002|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161589003|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161589004|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161519301|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
161519302|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
161519303|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
161519304|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Adverse Event|5|||
161519305|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Adverse Event|3|||
161519306|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Adverse Event|4|||
161519307|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Adverse Event|10|||
161589005|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161589006|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161519308|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
161519309|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
161519310|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
161519311|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
161519312|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
161519313|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
161519314|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
161519315|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
161519316|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Pregnancy|5|||
161519317|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Pregnancy|0|||
161519318|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Pregnancy|3|||
161519319|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Pregnancy|2|||
161519320|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Non-compliance|1|||
161519321|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Non-compliance|4|||
161519322|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Non-compliance|0|||
161519323|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Non-compliance|3|||
161519324|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Other|0|||
161519325|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Other|3|||
161519326|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Other|3|||
161519327|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Other|1|||
161519328|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
161519329|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
161519330|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
161519331|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
161519332|NCT01760954|583290858|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
161519333|NCT01760954|583290859|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
161519334|NCT01760954|583290860|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
161519335|NCT01760954|583290861|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
161519336|NCT01760954|583290858|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
161519337|NCT01760954|583290859|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
161519338|NCT01760954|583290860|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
161519339|NCT01760954|583290861|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
161519340|NCT01760954|583290858|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
161519341|NCT01760954|583290859|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
161519342|NCT01760954|583290860|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
161519343|NCT01760954|583290861|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
161519344|NCT01760954|583290858|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
161519345|NCT01760954|583290859|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
161519346|NCT01760954|583290860|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
161519347|NCT01760954|583290861|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
161519348|NCT01760954|583290858|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
161519349|NCT01760954|583290859|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
161519350|NCT01760954|583290860|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
161519351|NCT01760954|583290861|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
161519352|NCT01760954|583290858|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
161519353|NCT01760954|583290859|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
161519354|NCT01760954|583290860|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
161519355|NCT01760954|583290861|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
161519356|NCT01760954|583290858|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
161519357|NCT01760954|583290859|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
161519358|NCT01760954|583290860|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
161519359|NCT01760954|583290861|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
161519360|NCT00982020|583290862|FG000|Overall Study|Adverse Event|19|||
161519361|NCT00982020|583290863|FG001|Overall Study|Adverse Event|15|||
161519362|NCT00982020|583290862|FG000|Overall Study|Withdrawal by Subject|11|||
161519363|NCT00982020|583290863|FG001|Overall Study|Withdrawal by Subject|14|||
161519364|NCT00982020|583290862|FG000|Overall Study|Lost to Follow-up|5|||
161519365|NCT00982020|583290863|FG001|Overall Study|Lost to Follow-up|11|||
161519366|NCT00982020|583290862|FG000|Overall Study|Lack of Efficacy|10|||
161519367|NCT00982020|583290863|FG001|Overall Study|Lack of Efficacy|4|||
161519368|NCT00982020|583290862|FG000|Overall Study|Parent/Caregiver Decision|5|||
161519369|NCT00982020|583290863|FG001|Overall Study|Parent/Caregiver Decision|5|||
161589007|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
161589008|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
161589009|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
161589010|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
161519370|NCT00982020|583290862|FG000|Overall Study|Treatment Non-compliance|3|||
161589011|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589012|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161932445|NCT01104870|584800470|FG001|Overall Study|Adverse Event|1|||
161519371|NCT00982020|583290863|FG001|Overall Study|Treatment Non-compliance|6|||
161519372|NCT00982020|583290862|FG000|Overall Study|Physician Decision|2|||
161519373|NCT00982020|583290863|FG001|Overall Study|Physician Decision|5|||
161519374|NCT00982020|583290862|FG000|Overall Study|Entry Criteria Not Met|2|||
161519375|NCT00982020|583290863|FG001|Overall Study|Entry Criteria Not Met|1|||
161519376|NCT00982020|583290862|FG000|Overall Study|Protocol Violation|0|||
161519377|NCT00982020|583290863|FG001|Overall Study|Protocol Violation|2|||
161519378|NCT00982020|583290862|FG000|Overall Study|Clinical Relapse|0|||
161519379|NCT00982020|583290863|FG001|Overall Study|Clinical Relapse|1|||
161519380|NCT01762761|583290866|FG000|Overall Study|Adverse Event|15|||
161519381|NCT01762761|583290867|FG001|Overall Study|Adverse Event|17|||
161519382|NCT01762761|583290866|FG000|Overall Study|Lack of Efficacy|9|||
161519383|NCT01762761|583290867|FG001|Overall Study|Lack of Efficacy|25|||
161519384|NCT01762761|583290866|FG000|Overall Study|Protocol Violation|1|||
161519385|NCT01762761|583290867|FG001|Overall Study|Protocol Violation|1|||
161519386|NCT01762761|583290866|FG000|Overall Study|Study closed/terminated|0|||
161519387|NCT01762761|583290867|FG001|Overall Study|Study closed/terminated|2|||
161519388|NCT01762761|583290866|FG000|Overall Study|Lost to Follow-up|3|||
161519389|NCT01762761|583290867|FG001|Overall Study|Lost to Follow-up|6|||
161519390|NCT01762761|583290866|FG000|Overall Study|Physician Decision|4|||
161519391|NCT01762761|583290867|FG001|Overall Study|Physician Decision|6|||
161519392|NCT01762761|583290866|FG000|Overall Study|Withdrawal by Subject|7|||
161519393|NCT01762761|583290867|FG001|Overall Study|Withdrawal by Subject|8|||
161519394|NCT01992536|583290868|FG000|Overall Study|Administrative Reason|0|||
161519395|NCT01992536|583290869|FG001|Overall Study|Administrative Reason|0|||
161519396|NCT01992536|583290870|FG002|Overall Study|Administrative Reason|0|||
161519397|NCT01992536|583290871|FG003|Overall Study|Administrative Reason|0|||
161519398|NCT01992536|583290872|FG004|Overall Study|Administrative Reason|0|||
161519399|NCT01992536|583290873|FG005|Overall Study|Administrative Reason|0|||
161519400|NCT01992536|583290874|FG006|Overall Study|Administrative Reason|7|||
161519401|NCT01992536|583290875|FG007|Overall Study|Administrative Reason|0|||
161519402|NCT01992536|583290876|FG008|Overall Study|Administrative Reason|0|||
161519403|NCT01992536|583290877|FG009|Overall Study|Administrative Reason|0|||
161519404|NCT01992536|583290868|FG000|Overall Study|Lost to Follow-up|4|||
161519405|NCT01992536|583290869|FG001|Overall Study|Lost to Follow-up|2|||
161519406|NCT01992536|583290870|FG002|Overall Study|Lost to Follow-up|1|||
161519407|NCT01992536|583290871|FG003|Overall Study|Lost to Follow-up|0|||
161519408|NCT01992536|583290872|FG004|Overall Study|Lost to Follow-up|0|||
161589013|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589014|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589015|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589016|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589017|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589018|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589019|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589020|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
161589021|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161589022|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
161589023|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
161589024|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589025|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589026|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589027|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589028|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589029|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589030|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589031|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161677483|NCT00467779|583872007|FG007|Stage 3|Death|0|||
161932446|NCT01104870|584800471|FG002|Overall Study|Adverse Event|0|||
161932447|NCT01104870|584800469|FG000|Overall Study|Death|0|||
161932448|NCT01104870|584800470|FG001|Overall Study|Death|0|||
161932449|NCT01104870|584800471|FG002|Overall Study|Death|1|||
161932450|NCT01104870|584800469|FG000|Overall Study|Withdrawal by Subject|0|||
161932451|NCT01104870|584800470|FG001|Overall Study|Withdrawal by Subject|0|||
161932452|NCT01104870|584800471|FG002|Overall Study|Withdrawal by Subject|1|||
161932453|NCT02771145|584800477|FG000|Overall Study|Adverse Event|3|||
161932454|NCT02771145|584800477|FG000|Overall Study|Lost to Follow-up|1|||
161932455|NCT00276380|584800478|FG000|Overall Study|Adverse Event|5|||
161932456|NCT00276380|584800479|FG001|Overall Study|Adverse Event|3|||
161932457|NCT00276380|584800478|FG000|Overall Study|Lost to Follow-up|1|||
161932458|NCT00276380|584800479|FG001|Overall Study|Lost to Follow-up|1|||
161519409|NCT01992536|583290873|FG005|Overall Study|Lost to Follow-up|1|||
161677484|NCT00467779|583872008|FG008|Stage 3|Death|0|||
161932459|NCT00276380|584800478|FG000|Overall Study|Withdrawal by Subject|3|||
161519410|NCT01992536|583290874|FG006|Overall Study|Lost to Follow-up|0|||
161519411|NCT01992536|583290875|FG007|Overall Study|Lost to Follow-up|0|||
161519412|NCT01992536|583290876|FG008|Overall Study|Lost to Follow-up|1|||
161519413|NCT01992536|583290877|FG009|Overall Study|Lost to Follow-up|1|||
161519414|NCT01992536|583290868|FG000|Overall Study|Withdrawal by Subject|0|||
161519415|NCT01992536|583290869|FG001|Overall Study|Withdrawal by Subject|1|||
161519416|NCT01992536|583290870|FG002|Overall Study|Withdrawal by Subject|0|||
161519417|NCT01992536|583290871|FG003|Overall Study|Withdrawal by Subject|2|||
161519418|NCT01992536|583290872|FG004|Overall Study|Withdrawal by Subject|0|||
161519419|NCT01992536|583290873|FG005|Overall Study|Withdrawal by Subject|0|||
161519420|NCT01992536|583290874|FG006|Overall Study|Withdrawal by Subject|0|||
161519421|NCT01992536|583290875|FG007|Overall Study|Withdrawal by Subject|0|||
161519422|NCT01992536|583290876|FG008|Overall Study|Withdrawal by Subject|0|||
161519423|NCT01992536|583290877|FG009|Overall Study|Withdrawal by Subject|0|||
161519424|NCT02352493|583290880|FG000|Overall Study|Pregnancy|0|||
161519425|NCT02352493|583290881|FG001|Overall Study|Pregnancy|0|||
161519426|NCT02352493|583290882|FG002|Overall Study|Pregnancy|0|||
161519427|NCT02352493|583290883|FG003|Overall Study|Pregnancy|0|||
161519428|NCT02352493|583290884|FG004|Overall Study|Pregnancy|0|||
161519429|NCT02352493|583290885|FG005|Overall Study|Pregnancy|0|||
161519430|NCT02352493|583290886|FG006|Overall Study|Pregnancy|1|||
161519431|NCT02352493|583290887|FG007|Overall Study|Pregnancy|0|||
161519432|NCT02352493|583290888|FG008|Overall Study|Pregnancy|1|||
161519433|NCT02352493|583290889|FG009|Overall Study|Pregnancy|0|||
161519434|NCT02352493|583290890|FG010|Overall Study|Pregnancy|0|||
161519435|NCT02352493|583290891|FG011|Overall Study|Pregnancy|0|||
161519436|NCT02352493|583290892|FG012|Overall Study|Pregnancy|0|||
161519437|NCT02352493|583290893|FG013|Overall Study|Pregnancy|0|||
161519438|NCT02352493|583290894|FG014|Overall Study|Pregnancy|0|||
161519439|NCT02352493|583290895|FG015|Overall Study|Pregnancy|0|||
161519440|NCT02352493|583290896|FG016|Overall Study|Pregnancy|0|||
161519441|NCT02352493|583290897|FG017|Overall Study|Pregnancy|0|||
161519442|NCT02352493|583290880|FG000|Overall Study|Withdrawal by Subject|0|||
161519443|NCT02352493|583290881|FG001|Overall Study|Withdrawal by Subject|0|||
161519444|NCT02352493|583290882|FG002|Overall Study|Withdrawal by Subject|0|||
161519445|NCT02352493|583290883|FG003|Overall Study|Withdrawal by Subject|0|||
161519446|NCT02352493|583290884|FG004|Overall Study|Withdrawal by Subject|0|||
161519447|NCT02352493|583290885|FG005|Overall Study|Withdrawal by Subject|0|||
161519448|NCT02352493|583290886|FG006|Overall Study|Withdrawal by Subject|0|||
161519449|NCT02352493|583290887|FG007|Overall Study|Withdrawal by Subject|0|||
161519450|NCT02352493|583290888|FG008|Overall Study|Withdrawal by Subject|1|||
161519451|NCT02352493|583290889|FG009|Overall Study|Withdrawal by Subject|0|||
161519452|NCT02352493|583290890|FG010|Overall Study|Withdrawal by Subject|0|||
161519453|NCT02352493|583290891|FG011|Overall Study|Withdrawal by Subject|0|||
161519454|NCT02352493|583290892|FG012|Overall Study|Withdrawal by Subject|0|||
161519455|NCT02352493|583290893|FG013|Overall Study|Withdrawal by Subject|0|||
161519456|NCT02352493|583290894|FG014|Overall Study|Withdrawal by Subject|1|||
161932460|NCT00276380|584800479|FG001|Overall Study|Withdrawal by Subject|6|||
161932461|NCT00276380|584800478|FG000|Overall Study|Death|5|||
161932462|NCT00276380|584800479|FG001|Overall Study|Death|3|||
161932463|NCT00276380|584800478|FG000|Overall Study|Abnormal aPPT Levels|0|||
161932464|NCT00276380|584800479|FG001|Overall Study|Abnormal aPPT Levels|1|||
161932465|NCT02150863|584800480|FG000|Overall Study|Lost to Follow-up|0|||
161932466|NCT02150863|584800481|FG001|Overall Study|Lost to Follow-up|1|||
161932467|NCT02150863|584800482|FG002|Overall Study|Lost to Follow-up|0|||
161932468|NCT01651208|584800483|FG000|Overall Study|Lost to Follow-up|14|||
161932469|NCT01651208|584800484|FG001|Overall Study|Lost to Follow-up|16|||
161932470|NCT04008069|584800488|FG000|Open-Label Period|Adverse Event|1|||
161932471|NCT04008069|584800489|FG001|Open-Label Period|Adverse Event|0|||
161932472|NCT04008069|584800490|FG002|Open-Label Period|Adverse Event|0|||
161932473|NCT04008069|584800488|FG000|Open-Label Period|Lack of Efficacy|4|||
161932474|NCT04008069|584800489|FG001|Open-Label Period|Lack of Efficacy|0|||
161932475|NCT04008069|584800490|FG002|Open-Label Period|Lack of Efficacy|0|||
161519457|NCT02352493|583290895|FG015|Overall Study|Withdrawal by Subject|0|||
161519458|NCT02352493|583290896|FG016|Overall Study|Withdrawal by Subject|0|||
161519459|NCT02352493|583290897|FG017|Overall Study|Withdrawal by Subject|0|||
161519460|NCT02352493|583290880|FG000|Overall Study|Lost to Follow-up|0|||
161519461|NCT02352493|583290881|FG001|Overall Study|Lost to Follow-up|0|||
161519462|NCT02352493|583290882|FG002|Overall Study|Lost to Follow-up|0|||
161519463|NCT02352493|583290883|FG003|Overall Study|Lost to Follow-up|0|||
161519464|NCT02352493|583290884|FG004|Overall Study|Lost to Follow-up|0|||
161519465|NCT02352493|583290885|FG005|Overall Study|Lost to Follow-up|0|||
161519466|NCT02352493|583290886|FG006|Overall Study|Lost to Follow-up|0|||
161519467|NCT02352493|583290887|FG007|Overall Study|Lost to Follow-up|0|||
161519468|NCT02352493|583290888|FG008|Overall Study|Lost to Follow-up|0|||
161932476|NCT04008069|584800488|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
161932477|NCT04008069|584800489|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
161932478|NCT04008069|584800490|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
161519469|NCT02352493|583290889|FG009|Overall Study|Lost to Follow-up|1|||
161519470|NCT02352493|583290890|FG010|Overall Study|Lost to Follow-up|0|||
161932479|NCT04008069|584800488|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
161932480|NCT04008069|584800489|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
161932481|NCT04008069|584800490|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
161519471|NCT02352493|583290891|FG011|Overall Study|Lost to Follow-up|0|||
161519472|NCT02352493|583290892|FG012|Overall Study|Lost to Follow-up|1|||
161519473|NCT02352493|583290893|FG013|Overall Study|Lost to Follow-up|2|||
161519474|NCT02352493|583290894|FG014|Overall Study|Lost to Follow-up|0|||
161519475|NCT02352493|583290895|FG015|Overall Study|Lost to Follow-up|0|||
161519476|NCT02352493|583290896|FG016|Overall Study|Lost to Follow-up|0|||
161519477|NCT02352493|583290897|FG017|Overall Study|Lost to Follow-up|0|||
161519478|NCT02162810|583290898|FG000|Overall Study|Protocol Violation|1|||
161519479|NCT02162810|583290899|FG001|Overall Study|Protocol Violation|0|||
161519480|NCT02162810|583290898|FG000|Overall Study|patients did not report compliance|4|||
161519481|NCT02162810|583290899|FG001|Overall Study|patients did not report compliance|1|||
161519482|NCT00389324|583290900|FG000|Run-In Phase|Adverse Event|1|||
161519483|NCT00389324|583290900|FG000|Run-In Phase|Lost to Follow-up|1|||
161519484|NCT00389324|583290900|FG000|Run-In Phase|Withdrawal by Subject|1|||
161519485|NCT00389324|583290900|FG000|Subcutaneous Phase|Adverse Event|2|||
161519486|NCT00389324|583290900|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
161519487|NCT00389324|583290900|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
161519488|NCT00389324|583290900|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
161519489|NCT02317575|583290901|FG000|Period 1|Difficulty with venous cannulation|0|||
161519490|NCT02317575|583290902|FG001|Period 1|Difficulty with venous cannulation|1|||
161519491|NCT02317575|583290903|FG002|Period 1|Difficulty with venous cannulation|0|||
161519492|NCT02317575|583290904|FG003|Period 1|Difficulty with venous cannulation|0|||
161519493|NCT02317575|583290905|FG004|Period 1|Difficulty with venous cannulation|0|||
161519494|NCT02317575|583290901|FG000|Period 1|Withdrawal by Subject|1|||
161519495|NCT02317575|583290902|FG001|Period 1|Withdrawal by Subject|0|||
161519496|NCT02317575|583290903|FG002|Period 1|Withdrawal by Subject|0|||
161519497|NCT02317575|583290904|FG003|Period 1|Withdrawal by Subject|0|||
161519498|NCT02317575|583290905|FG004|Period 1|Withdrawal by Subject|0|||
161519499|NCT01465334|583290906|FG000|Overall Study|Disease Progression|1|||
161519500|NCT01465334|583290907|FG001|Overall Study|Disease Progression|0|||
161519501|NCT01465334|583290906|FG000|Overall Study|Adverse Event|1|||
161519502|NCT01465334|583290907|FG001|Overall Study|Adverse Event|0|||
161519503|NCT01465334|583290906|FG000|Overall Study|Richter's transformation|0|||
161519504|NCT01465334|583290907|FG001|Overall Study|Richter's transformation|3|||
161519505|NCT01465334|583290906|FG000|Overall Study|Refractory Disease|0|||
161519506|NCT01465334|583290907|FG001|Overall Study|Refractory Disease|3|||
161519507|NCT03936244|583290913|FG000|Overall Study|Lost to Follow-up|5|||
161519508|NCT03936244|583290914|FG001|Overall Study|Lost to Follow-up|1|||
161519509|NCT03936244|583290913|FG000|Overall Study|Physician Decision|7|||
161519510|NCT03936244|583290914|FG001|Overall Study|Physician Decision|3|||
161519511|NCT01925183|583290915|FG000|Overall Study|Adverse Event|1|||
161519512|NCT01925183|583290916|FG001|Overall Study|Adverse Event|0|||
161519513|NCT01046110|583290917|FG000|Overall Study|Adverse Event|9|||
161519514|NCT01046110|583290918|FG001|Overall Study|Adverse Event|2|||
161519515|NCT01046110|583290917|FG000|Overall Study|Lack of Efficacy|0|||
161519516|NCT01046110|583290918|FG001|Overall Study|Lack of Efficacy|1|||
161519517|NCT01046110|583290917|FG000|Overall Study|Protocol Violation|7|||
161519518|NCT01046110|583290918|FG001|Overall Study|Protocol Violation|12|||
161519519|NCT01046110|583290917|FG000|Overall Study|Withdrawal Criteria|3|||
161519520|NCT01046110|583290918|FG001|Overall Study|Withdrawal Criteria|5|||
161519521|NCT01046110|583290917|FG000|Overall Study|Unclassified|36|||
161932482|NCT00511199|584800492|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
161932483|NCT00511199|584800493|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
161932484|NCT00511199|584800492|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
161932485|NCT00511199|584800493|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
161519522|NCT01046110|583290918|FG001|Overall Study|Unclassified|35|||
161519523|NCT01047683|583290923|FG000|Overall Study|Adverse Event|3|||
161519524|NCT01047683|583290924|FG001|Overall Study|Adverse Event|1|||
161519525|NCT01047683|583290925|FG002|Overall Study|Adverse Event|0|||
161519526|NCT01047683|583290923|FG000|Overall Study|Withdrew Consent|1|||
161519527|NCT01047683|583290924|FG001|Overall Study|Withdrew Consent|4|||
161519528|NCT01047683|583290925|FG002|Overall Study|Withdrew Consent|2|||
161519529|NCT01047683|583290923|FG000|Overall Study|Lost to Follow-up|0|||
161519530|NCT01047683|583290924|FG001|Overall Study|Lost to Follow-up|1|||
161519531|NCT01047683|583290925|FG002|Overall Study|Lost to Follow-up|0|||
161519532|NCT01047683|583290923|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
161519533|NCT01047683|583290924|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
161519534|NCT01047683|583290925|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
161519535|NCT03447769|583290926|FG000|Overall Study|Progressive disease|138|||
161519536|NCT03447769|583290927|FG001|Overall Study|Progressive disease|148|||
161519537|NCT03447769|583290926|FG000|Overall Study|Study terminated by Sponsor|60|||
161519538|NCT03447769|583290927|FG001|Overall Study|Study terminated by Sponsor|44|||
161519539|NCT03447769|583290926|FG000|Overall Study|Adverse Event|34|||
161519540|NCT03447769|583290927|FG001|Overall Study|Adverse Event|31|||
161519541|NCT03447769|583290926|FG000|Overall Study|Patient decision|27|||
161519542|NCT03447769|583290927|FG001|Overall Study|Patient decision|27|||
161519543|NCT03447769|583290926|FG000|Overall Study|Protocol deviation|4|||
161519544|NCT03447769|583290927|FG001|Overall Study|Protocol deviation|6|||
161519545|NCT03447769|583290926|FG000|Overall Study|Death|2|||
161519546|NCT03447769|583290927|FG001|Overall Study|Death|7|||
161519547|NCT03447769|583290926|FG000|Overall Study|Technical problems|1|||
161519548|NCT03447769|583290927|FG001|Overall Study|Technical problems|0|||
161519549|NCT03447769|583290926|FG000|Overall Study|Lost to Follow-up|0|||
161519550|NCT03447769|583290927|FG001|Overall Study|Lost to Follow-up|1|||
161519551|NCT03447769|583290926|FG000|Overall Study|Physician Decision|13|||
161519552|NCT03447769|583290927|FG001|Overall Study|Physician Decision|5|||
161519553|NCT01485861|583290930|FG000|Phase Ib|Death|1|||
161519554|NCT01485861|583290931|FG001|Phase Ib|Death|0|||
161519555|NCT01485861|583290932|FG002|Phase Ib|Death|0|||
161519556|NCT01485861|583290933|FG003|Phase Ib|Death|0|||
161519557|NCT01485861|583290934|FG004|Phase Ib|Death|0|||
161519558|NCT01485861|583290935|FG005|Phase Ib|Death|0|||
161519559|NCT01485861|583290930|FG000|Phase Ib|Physician Decision|1|||
161519560|NCT01485861|583290931|FG001|Phase Ib|Physician Decision|1|||
161519561|NCT01485861|583290932|FG002|Phase Ib|Physician Decision|0|||
161519562|NCT01485861|583290933|FG003|Phase Ib|Physician Decision|0|||
161519563|NCT01485861|583290934|FG004|Phase Ib|Physician Decision|0|||
161519564|NCT01485861|583290935|FG005|Phase Ib|Physician Decision|0|||
161519565|NCT01485861|583290930|FG000|Phase Ib|Adverse Event|0|||
161519566|NCT01485861|583290931|FG001|Phase Ib|Adverse Event|4|||
161519567|NCT01485861|583290932|FG002|Phase Ib|Adverse Event|0|||
161519568|NCT01485861|583290933|FG003|Phase Ib|Adverse Event|0|||
161519569|NCT01485861|583290934|FG004|Phase Ib|Adverse Event|0|||
161519570|NCT01485861|583290935|FG005|Phase Ib|Adverse Event|0|||
161519571|NCT01485861|583290930|FG000|Phase Ib|Progression of disease|5|||
161519572|NCT01485861|583290931|FG001|Phase Ib|Progression of disease|0|||
161519573|NCT01485861|583290932|FG002|Phase Ib|Progression of disease|0|||
161519574|NCT01485861|583290933|FG003|Phase Ib|Progression of disease|0|||
161519575|NCT01485861|583290934|FG004|Phase Ib|Progression of disease|0|||
161519576|NCT01485861|583290935|FG005|Phase Ib|Progression of disease|0|||
161519577|NCT01485861|583290930|FG000|Phase Ib|Other|3|||
161519578|NCT01485861|583290931|FG001|Phase Ib|Other|0|||
161519579|NCT01485861|583290932|FG002|Phase Ib|Other|0|||
161519580|NCT01485861|583290933|FG003|Phase Ib|Other|0|||
161519581|NCT01485861|583290934|FG004|Phase Ib|Other|0|||
161519582|NCT01485861|583290935|FG005|Phase Ib|Other|0|||
161519583|NCT01485861|583290930|FG000|Phase Ib|Withdrawal by Subject|4|||
161519584|NCT01485861|583290931|FG001|Phase Ib|Withdrawal by Subject|1|||
161519585|NCT01485861|583290932|FG002|Phase Ib|Withdrawal by Subject|0|||
161519586|NCT01485861|583290933|FG003|Phase Ib|Withdrawal by Subject|0|||
161519587|NCT01485861|583290934|FG004|Phase Ib|Withdrawal by Subject|0|||
161519588|NCT01485861|583290935|FG005|Phase Ib|Withdrawal by Subject|0|||
161519589|NCT01485861|583290930|FG000|Phase II|Death|0|||
161519590|NCT01485861|583290931|FG001|Phase II|Death|0|||
161519591|NCT01485861|583290932|FG002|Phase II|Death|67|||
161519592|NCT01485861|583290933|FG003|Phase II|Death|71|||
161519593|NCT01485861|583290934|FG004|Phase II|Death|68|||
161519594|NCT01485861|583290935|FG005|Phase II|Death|0|||
161519595|NCT01485861|583290930|FG000|Phase II|Progression of Disease|0|||
161519596|NCT01485861|583290931|FG001|Phase II|Progression of Disease|0|||
161519597|NCT01485861|583290932|FG002|Phase II|Progression of Disease|1|||
161519598|NCT01485861|583290933|FG003|Phase II|Progression of Disease|0|||
161519599|NCT01485861|583290934|FG004|Phase II|Progression of Disease|0|||
161519600|NCT01485861|583290935|FG005|Phase II|Progression of Disease|0|||
161519601|NCT01485861|583290930|FG000|Phase II|Other|0|||
161519602|NCT01485861|583290931|FG001|Phase II|Other|0|||
161519603|NCT01485861|583290932|FG002|Phase II|Other|0|||
161519604|NCT01485861|583290933|FG003|Phase II|Other|1|||
161519605|NCT01485861|583290934|FG004|Phase II|Other|0|||
161519606|NCT01485861|583290935|FG005|Phase II|Other|0|||
161519607|NCT01485861|583290930|FG000|Phase II|Withdrawal by Subject|0|||
161519608|NCT01485861|583290931|FG001|Phase II|Withdrawal by Subject|0|||
161519609|NCT01485861|583290932|FG002|Phase II|Withdrawal by Subject|6|||
161519610|NCT01485861|583290933|FG003|Phase II|Withdrawal by Subject|3|||
161519611|NCT01485861|583290934|FG004|Phase II|Withdrawal by Subject|4|||
161519612|NCT01485861|583290935|FG005|Phase II|Withdrawal by Subject|0|||
161519613|NCT01485861|583290930|FG000|Phase II|Lost to Follow-up|0|||
161519614|NCT01485861|583290931|FG001|Phase II|Lost to Follow-up|0|||
161519615|NCT01485861|583290932|FG002|Phase II|Lost to Follow-up|2|||
161519616|NCT01485861|583290933|FG003|Phase II|Lost to Follow-up|3|||
161519617|NCT01485861|583290934|FG004|Phase II|Lost to Follow-up|5|||
161519618|NCT01485861|583290935|FG005|Phase II|Lost to Follow-up|0|||
161519619|NCT01485861|583290930|FG000|Phase II|Study Ended|0|||
161519620|NCT01485861|583290931|FG001|Phase II|Study Ended|0|||
161519621|NCT01485861|583290932|FG002|Phase II|Study Ended|7|||
161519622|NCT01485861|583290933|FG003|Phase II|Study Ended|8|||
161519623|NCT01485861|583290934|FG004|Phase II|Study Ended|6|||
161519624|NCT01485861|583290935|FG005|Phase II|Study Ended|0|||
161519625|NCT01485861|583290930|FG000|Safety Phase|Death|0|||
161519626|NCT01485861|583290931|FG001|Safety Phase|Death|0|||
161519627|NCT01485861|583290932|FG002|Safety Phase|Death|0|||
161519628|NCT01485861|583290933|FG003|Safety Phase|Death|0|||
161519629|NCT01485861|583290934|FG004|Safety Phase|Death|0|||
161519630|NCT01485861|583290935|FG005|Safety Phase|Death|2|||
161519631|NCT01485861|583290930|FG000|Safety Phase|Adverse Event|0|||
161519632|NCT01485861|583290931|FG001|Safety Phase|Adverse Event|0|||
161519633|NCT01485861|583290932|FG002|Safety Phase|Adverse Event|0|||
161519634|NCT01485861|583290933|FG003|Safety Phase|Adverse Event|0|||
161519635|NCT01485861|583290934|FG004|Safety Phase|Adverse Event|0|||
161519636|NCT01485861|583290935|FG005|Safety Phase|Adverse Event|1|||
161519637|NCT01485861|583290930|FG000|Safety Phase|Other|0|||
161519638|NCT01485861|583290931|FG001|Safety Phase|Other|0|||
161519639|NCT01485861|583290932|FG002|Safety Phase|Other|0|||
161519640|NCT01485861|583290933|FG003|Safety Phase|Other|0|||
161519641|NCT01485861|583290934|FG004|Safety Phase|Other|0|||
161519642|NCT01485861|583290935|FG005|Safety Phase|Other|5|||
161519643|NCT01485861|583290930|FG000|Safety Phase|Progression of Disease|0|||
161519644|NCT01485861|583290931|FG001|Safety Phase|Progression of Disease|0|||
161519645|NCT01485861|583290932|FG002|Safety Phase|Progression of Disease|0|||
161519646|NCT01485861|583290933|FG003|Safety Phase|Progression of Disease|0|||
161519647|NCT01485861|583290934|FG004|Safety Phase|Progression of Disease|0|||
161519648|NCT01485861|583290935|FG005|Safety Phase|Progression of Disease|9|||
161519649|NCT01485861|583290930|FG000|Safety Phase|Withdrawal by Subject|0|||
161519650|NCT01485861|583290931|FG001|Safety Phase|Withdrawal by Subject|0|||
161519651|NCT01485861|583290932|FG002|Safety Phase|Withdrawal by Subject|0|||
161519652|NCT01485861|583290933|FG003|Safety Phase|Withdrawal by Subject|0|||
161519653|NCT01485861|583290934|FG004|Safety Phase|Withdrawal by Subject|0|||
161519654|NCT01485861|583290935|FG005|Safety Phase|Withdrawal by Subject|6|||
161519655|NCT01485861|583290930|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
161519656|NCT01485861|583290931|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
161519657|NCT01485861|583290932|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
161519658|NCT01485861|583290933|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
161519659|NCT01485861|583290934|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
161519660|NCT01485861|583290935|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
161519661|NCT03795922|583290936|FG000|Overall Study|Adverse Event|2|||
161519662|NCT03795922|583290937|FG001|Overall Study|Adverse Event|1|||
161519663|NCT03795922|583290936|FG000|Overall Study|Withdrawal by Subject|5|||
161519664|NCT03795922|583290937|FG001|Overall Study|Withdrawal by Subject|13|||
161519665|NCT03795922|583290936|FG000|Overall Study|Lost to Follow-up|2|||
161519666|NCT03795922|583290937|FG001|Overall Study|Lost to Follow-up|3|||
161519667|NCT03795922|583290936|FG000|Overall Study|Pregnancy|0|||
161519668|NCT03795922|583290937|FG001|Overall Study|Pregnancy|1|||
161519669|NCT03795922|583290936|FG000|Overall Study|Physician Decision|1|||
161519670|NCT03795922|583290937|FG001|Overall Study|Physician Decision|2|||
161519671|NCT03795922|583290936|FG000|Overall Study|Protocol Violation|0|||
161519672|NCT03795922|583290937|FG001|Overall Study|Protocol Violation|1|||
161519673|NCT03795922|583290936|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
161519674|NCT03795922|583290937|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
161519675|NCT00437489|583290943|FG000|Overall Study|Study terminated by sponsor|23|||
161519676|NCT00437489|583290944|FG001|Overall Study|Study terminated by sponsor|21|||
161519677|NCT00437489|583290943|FG000|Overall Study|Lost to Follow-up|0|||
161519678|NCT00437489|583290944|FG001|Overall Study|Lost to Follow-up|1|||
161519679|NCT01525082|583290949|FG000|Overall Study|Death|1|||
161519680|NCT00022516|583290957|FG000|Overall Study|Adverse Event|0|||
161519681|NCT00022516|583290958|FG001|Overall Study|Adverse Event|59|||
161519682|NCT00022516|583290957|FG000|Overall Study|Lack of Efficacy|0|||
161677485|NCT00467779|583872009|FG009|Stage 3|Death|0|||
161824393|NCT02061280|584397982|FG001|Overall Study|Withdrawal by Subject|2|||
161824394|NCT02061280|584397981|FG000|Overall Study|Lost to Follow-up|5|||
161519683|NCT00022516|583290958|FG001|Overall Study|Lack of Efficacy|27|||
161519684|NCT00022516|583290957|FG000|Overall Study|Physician Decision|0|||
161519685|NCT00022516|583290958|FG001|Overall Study|Physician Decision|1|||
161519686|NCT00022516|583290957|FG000|Overall Study|Protocol Violation|1|||
161519687|NCT00022516|583290958|FG001|Overall Study|Protocol Violation|3|||
161519688|NCT00022516|583290957|FG000|Overall Study|Withdrawal by Subject|2|||
161519689|NCT00022516|583290958|FG001|Overall Study|Withdrawal by Subject|113|||
161519690|NCT00022516|583290957|FG000|Overall Study|Incomplete documentation|0|||
161519691|NCT00022516|583290958|FG001|Overall Study|Incomplete documentation|27|||
161519692|NCT03321019|583290960|FG000|Overall Study|Withdrawal by Subject|0|||
161519693|NCT03321019|583290961|FG001|Overall Study|Withdrawal by Subject|6|||
161519694|NCT03321019|583290960|FG000|Overall Study|Lost to Follow-up|0|||
161519695|NCT03321019|583290961|FG001|Overall Study|Lost to Follow-up|22|||
161519696|NCT03056690|583290963|FG000|Overall Study|Adverse Event|3|||
161519697|NCT03056690|583290964|FG001|Overall Study|Adverse Event|2|||
161519698|NCT03056690|583290963|FG000|Overall Study|Lack of Efficacy|1|||
161519699|NCT03056690|583290964|FG001|Overall Study|Lack of Efficacy|2|||
161519700|NCT03056690|583290963|FG000|Overall Study|Lost to Follow-up|3|||
161519701|NCT03056690|583290964|FG001|Overall Study|Lost to Follow-up|2|||
161519702|NCT03056690|583290963|FG000|Overall Study|Protocol Violation|2|||
161677486|NCT00467779|583872010|FG010|Stage 3|Death|0|||
161519703|NCT03056690|583290964|FG001|Overall Study|Protocol Violation|2|||
161519704|NCT03056690|583290963|FG000|Overall Study|Withdrawal by Subject|3|||
161519705|NCT03056690|583290964|FG001|Overall Study|Withdrawal by Subject|6|||
161519706|NCT03056690|583290963|FG000|Overall Study|Non-compliance with Study Drug|1|||
161519707|NCT03056690|583290964|FG001|Overall Study|Non-compliance with Study Drug|0|||
161519708|NCT03056690|583290963|FG000|Overall Study|Miscellaneous|1|||
161519709|NCT03056690|583290964|FG001|Overall Study|Miscellaneous|2|||
161519710|NCT01568047|583290969|FG000|Overall Study|Ineligibility|1|||
161519711|NCT01568047|583290970|FG001|Overall Study|Ineligibility|0|||
161519712|NCT01568047|583290971|FG002|Overall Study|Ineligibility|0|||
161519713|NCT01568047|583290972|FG003|Overall Study|Ineligibility|0|||
161519714|NCT01568047|583290969|FG000|Overall Study|Withdrawal by Subject|0|||
161519715|NCT01568047|583290970|FG001|Overall Study|Withdrawal by Subject|1|||
161519716|NCT01568047|583290971|FG002|Overall Study|Withdrawal by Subject|0|||
161519717|NCT01568047|583290972|FG003|Overall Study|Withdrawal by Subject|0|||
161519718|NCT01568047|583290969|FG000|Overall Study|Adverse Event|0|||
161519719|NCT01568047|583290970|FG001|Overall Study|Adverse Event|0|||
161519720|NCT01568047|583290971|FG002|Overall Study|Adverse Event|1|||
161519721|NCT01568047|583290972|FG003|Overall Study|Adverse Event|1|||
161519722|NCT03783923|583290973|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
161519723|NCT03783923|583290974|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
161519724|NCT03783923|583290973|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
161519725|NCT03783923|583290974|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
161519726|NCT03783923|583290973|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161519727|NCT03783923|583290974|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
161519728|NCT03783923|583290973|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
161519729|NCT03783923|583290974|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
161519730|NCT03783923|583290973|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
161519731|NCT03783923|583290974|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
161519732|NCT02328326|583290979|FG000|Overall Study|Withdrawal by Subject|10|||
161519733|NCT02328326|583290980|FG001|Overall Study|Withdrawal by Subject|3|||
161519734|NCT02328326|583290979|FG000|Overall Study|Death|2|||
161519735|NCT02328326|583290980|FG001|Overall Study|Death|1|||
161519736|NCT02328326|583290979|FG000|Overall Study|Lost to Follow-up|10|||
161519737|NCT02328326|583290980|FG001|Overall Study|Lost to Follow-up|4|||
161519738|NCT02543346|583290981|FG000|Second Priming Visit|Withdrawal by Subject|0|||
161519739|NCT02543346|583290982|FG001|Second Priming Visit|Withdrawal by Subject|2|||
161519740|NCT02543346|583290983|FG002|Second Priming Visit|Withdrawal by Subject|2|||
161519741|NCT02543346|583290984|FG003|Second Priming Visit|Withdrawal by Subject|2|||
161519742|NCT02543346|583290981|FG000|Second Priming Visit|Adverse Event|1|||
161519743|NCT02543346|583290982|FG001|Second Priming Visit|Adverse Event|0|||
161519744|NCT02543346|583290983|FG002|Second Priming Visit|Adverse Event|0|||
161519745|NCT02543346|583290984|FG003|Second Priming Visit|Adverse Event|0|||
161519746|NCT02209324|583290987|FG000|Overall Study|Adverse Event|2|||
161519747|NCT02209324|583290987|FG000|Overall Study|Lack of Efficacy|1|||
161519748|NCT02209324|583290987|FG000|Overall Study|Lost to Follow-up|1|||
161519749|NCT02209324|583290987|FG000|Overall Study|Physician Decision|3|||
161519750|NCT02209324|583290987|FG000|Overall Study|Protocol Violation|14|||
161519751|NCT02209324|583290987|FG000|Overall Study|Withdrawal by Subject|8|||
161519752|NCT02209324|583290987|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
161519753|NCT02209324|583290987|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
161519754|NCT02209324|583290987|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
161519755|NCT01985126|583290988|FG000|Overall Study|Death|15|||
161519756|NCT01985126|583290989|FG001|Overall Study|Death|69|||
161519757|NCT01985126|583290988|FG000|Overall Study|Lost to Follow-up|0|||
161519758|NCT01985126|583290989|FG001|Overall Study|Lost to Follow-up|8|||
161589032|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161589033|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
161932486|NCT00511199|584800492|FG000|Overall Study|Withdrawal of Informed Consent|19|||
161932487|NCT00511199|584800493|FG001|Overall Study|Withdrawal of Informed Consent|4|||
161589034|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
161589035|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
161519759|NCT01985126|583290988|FG000|Overall Study|Study Terminated By Sponsor|1|||
161519760|NCT01985126|583290989|FG001|Overall Study|Study Terminated By Sponsor|22|||
161519761|NCT01985126|583290988|FG000|Overall Study|Withdrawal by Subject|2|||
161519762|NCT01985126|583290989|FG001|Overall Study|Withdrawal by Subject|7|||
161519763|NCT03433456|583290992|FG000|Overall Study|Death|1|||
161519764|NCT03433456|583290993|FG001|Overall Study|Death|1|||
161519765|NCT03433456|583290992|FG000|Overall Study|Lost to Follow-up|14|||
161519766|NCT03433456|583290993|FG001|Overall Study|Lost to Follow-up|11|||
161519767|NCT03433456|583290992|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
161519768|NCT03433456|583290993|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
161519769|NCT01198600|583290998|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
161519770|NCT01198600|583290999|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
161519771|NCT01198600|583291000|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
161519772|NCT01198600|583291001|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
161519773|NCT01198600|583290998|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
161519774|NCT01198600|583290999|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
161519775|NCT01198600|583291000|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
161519776|NCT01198600|583291001|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
161519777|NCT01198600|583290998|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
161519778|NCT01198600|583290999|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
161519779|NCT01198600|583291000|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
161519780|NCT01198600|583291001|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
161519781|NCT01198600|583290998|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
161519782|NCT01198600|583290999|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
161519783|NCT01198600|583291000|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
161519784|NCT01198600|583291001|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
161519785|NCT01198600|583290998|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
161519786|NCT01198600|583290999|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
161519787|NCT01198600|583291000|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
161519788|NCT01198600|583291001|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
161519789|NCT01198600|583290998|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
161519790|NCT01198600|583290999|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
161519791|NCT01198600|583291000|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
161519792|NCT01198600|583291001|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
161519793|NCT01198600|583290998|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
161519794|NCT01198600|583290999|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
161519795|NCT01198600|583291000|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
161519796|NCT01198600|583291001|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
161519797|NCT01785602|583291002|FG000|Overall Study|Withdrawal by Subject|2|||
161519798|NCT01785602|583291003|FG001|Overall Study|Withdrawal by Subject|0|||
161519799|NCT01785602|583291002|FG000|Overall Study|Lost to Follow-up|1|||
161519800|NCT01785602|583291003|FG001|Overall Study|Lost to Follow-up|1|||
161519801|NCT01785602|583291002|FG000|Overall Study|Adverse Event|3|||
161519802|NCT01785602|583291003|FG001|Overall Study|Adverse Event|5|||
161519803|NCT01785602|583291002|FG000|Overall Study|Administrative problems|7|||
161519804|NCT01785602|583291003|FG001|Overall Study|Administrative problems|3|||
161519805|NCT02141516|583291006|FG000|Overall Study|Adverse Event|0|||
161519806|NCT02141516|583291007|FG001|Overall Study|Adverse Event|1|||
161519807|NCT02141516|583291008|FG002|Overall Study|Adverse Event|0|||
161519808|NCT02141516|583291006|FG000|Overall Study|Lost to Follow-up|0|||
161519809|NCT02141516|583291007|FG001|Overall Study|Lost to Follow-up|1|||
161519810|NCT02141516|583291008|FG002|Overall Study|Lost to Follow-up|0|||
161519811|NCT02141516|583291006|FG000|Overall Study|Other|0|||
161519812|NCT02141516|583291007|FG001|Overall Study|Other|3|||
161519813|NCT02141516|583291008|FG002|Overall Study|Other|0|||
161519814|NCT03251924|583291010|FG000|Overall Study|Disease Progression|6|||
161519815|NCT03251924|583291011|FG001|Overall Study|Disease Progression|6|||
161519816|NCT03251924|583291012|FG002|Overall Study|Disease Progression|7|||
161519817|NCT03251924|583291013|FG003|Overall Study|Disease Progression|8|||
161519818|NCT03251924|583291014|FG004|Overall Study|Disease Progression|8|||
161519819|NCT03251924|583291015|FG005|Overall Study|Disease Progression|7|||
161519820|NCT03251924|583291016|FG006|Overall Study|Disease Progression|6|||
161519821|NCT03251924|583291017|FG007|Overall Study|Disease Progression|10|||
161519822|NCT03251924|583291018|FG008|Overall Study|Disease Progression|6|||
161519823|NCT03251924|583291010|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
161824395|NCT02061280|584397982|FG001|Overall Study|Lost to Follow-up|1|||
161824396|NCT01977456|584397983|FG000|Overall Study|Death|5|||
161519824|NCT03251924|583291011|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
161519825|NCT03251924|583291012|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
161519826|NCT03251924|583291013|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
161519827|NCT03251924|583291014|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
161519828|NCT03251924|583291015|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
161519829|NCT03251924|583291016|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
161519830|NCT03251924|583291017|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
161519831|NCT03251924|583291018|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
161824397|NCT01841060|584399749|FG000|Overall Study|Protocol Violation|10|||
161519832|NCT03251924|583291010|FG000|Overall Study|Death|0|||
161519833|NCT03251924|583291011|FG001|Overall Study|Death|1|||
161519834|NCT03251924|583291012|FG002|Overall Study|Death|0|||
161519835|NCT03251924|583291013|FG003|Overall Study|Death|1|||
161519836|NCT03251924|583291014|FG004|Overall Study|Death|1|||
161519837|NCT03251924|583291015|FG005|Overall Study|Death|1|||
161519838|NCT03251924|583291016|FG006|Overall Study|Death|0|||
161519839|NCT03251924|583291017|FG007|Overall Study|Death|0|||
161519840|NCT03251924|583291018|FG008|Overall Study|Death|0|||
161824398|NCT02419573|584399750|FG000|Overall Study|Lost to Follow-up|3|||
161932488|NCT00511199|584800492|FG000|Overall Study|Pregnancy|6|||
161932489|NCT00511199|584800493|FG001|Overall Study|Pregnancy|3|||
161932490|NCT00511199|584800492|FG000|Overall Study|Pregnancy Wish|16|||
161932491|NCT00511199|584800493|FG001|Overall Study|Pregnancy Wish|8|||
161932492|NCT00511199|584800492|FG000|Overall Study|Lost to Follow-up|40|||
161932493|NCT00511199|584800493|FG001|Overall Study|Lost to Follow-up|17|||
161932494|NCT00511199|584800492|FG000|Overall Study|Other Reason|78|||
161932495|NCT00511199|584800493|FG001|Overall Study|Other Reason|37|||
161932496|NCT01570192|584800498|FG000|Overall Study|no qualifying organism|6|||
161932497|NCT01570192|584800499|FG001|Overall Study|no qualifying organism|12|||
161932498|NCT01570192|584800498|FG000|Overall Study|changed to palliative care|1|||
161932499|NCT01570192|584800499|FG001|Overall Study|changed to palliative care|0|||
161932500|NCT01570192|584800498|FG000|Overall Study|Physician Decision|0|||
161932501|NCT01570192|584800499|FG001|Overall Study|Physician Decision|1|||
161932502|NCT01063881|584800500|FG000|Overall Study|Adverse Event|12|||
161932503|NCT01063881|584800501|FG001|Overall Study|Adverse Event|2|||
161932504|NCT01063881|584800502|FG002|Overall Study|Adverse Event|0|||
161932505|NCT01063881|584800500|FG000|Overall Study|Lost to Follow-up|13|||
161932506|NCT01063881|584800501|FG001|Overall Study|Lost to Follow-up|7|||
161932507|NCT01063881|584800502|FG002|Overall Study|Lost to Follow-up|1|||
161932508|NCT01063881|584800500|FG000|Overall Study|Withdrawal by Subject|25|||
161932509|NCT01063881|584800501|FG001|Overall Study|Withdrawal by Subject|1|||
161932510|NCT01063881|584800502|FG002|Overall Study|Withdrawal by Subject|0|||
161932511|NCT01063881|584800500|FG000|Overall Study|Reason for not completed not specified|5|||
161519841|NCT03251924|583291010|FG000|Overall Study|Study Drug Toxicity|0|||
161519842|NCT03251924|583291011|FG001|Overall Study|Study Drug Toxicity|0|||
161519843|NCT03251924|583291012|FG002|Overall Study|Study Drug Toxicity|0|||
161519844|NCT03251924|583291013|FG003|Overall Study|Study Drug Toxicity|1|||
161519845|NCT03251924|583291014|FG004|Overall Study|Study Drug Toxicity|0|||
161519846|NCT03251924|583291015|FG005|Overall Study|Study Drug Toxicity|0|||
161519847|NCT03251924|583291016|FG006|Overall Study|Study Drug Toxicity|0|||
161519848|NCT03251924|583291017|FG007|Overall Study|Study Drug Toxicity|0|||
161519849|NCT03251924|583291018|FG008|Overall Study|Study Drug Toxicity|1|||
161519850|NCT03251924|583291010|FG000|Overall Study|Other Reasons|0|||
161519851|NCT03251924|583291011|FG001|Overall Study|Other Reasons|0|||
161519852|NCT03251924|583291012|FG002|Overall Study|Other Reasons|0|||
161519853|NCT03251924|583291013|FG003|Overall Study|Other Reasons|0|||
161519854|NCT03251924|583291014|FG004|Overall Study|Other Reasons|0|||
161519855|NCT03251924|583291015|FG005|Overall Study|Other Reasons|0|||
161519856|NCT03251924|583291016|FG006|Overall Study|Other Reasons|0|||
161519857|NCT03251924|583291017|FG007|Overall Study|Other Reasons|0|||
161519858|NCT03251924|583291018|FG008|Overall Study|Other Reasons|1|||
161519859|NCT03251924|583291010|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161519860|NCT03251924|583291011|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161519861|NCT03251924|583291012|FG002|Overall Study|Participant request to discontinue study treatment|0|||
161519862|NCT03251924|583291013|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161519863|NCT03251924|583291014|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161519864|NCT03251924|583291015|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161519865|NCT03251924|583291016|FG006|Overall Study|Participant request to discontinue study treatment|0|||
161519866|NCT03251924|583291017|FG007|Overall Study|Participant request to discontinue study treatment|1|||
161519867|NCT03251924|583291018|FG008|Overall Study|Participant request to discontinue study treatment|0|||
161519868|NCT00784043|583291019|FG000|Overall Study|Withdrawal by Subject|8|||
161519869|NCT00784043|583291020|FG001|Overall Study|Withdrawal by Subject|5|||
161519870|NCT00784043|583291019|FG000|Overall Study|Protocol Terminated|23|||
161932512|NCT01063881|584800501|FG001|Overall Study|Reason for not completed not specified|1|||
161932513|NCT01063881|584800502|FG002|Overall Study|Reason for not completed not specified|0|||
161932514|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
161932515|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
161932516|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
161932517|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
161932518|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
161519871|NCT00784043|583291020|FG001|Overall Study|Protocol Terminated|1|||
161519872|NCT02127307|583291027|FG000|Overall Study|Protocol Violation|36|||
161519873|NCT02127307|583291027|FG000|Overall Study|Lost to Follow-up|2|||
161519874|NCT02127307|583291027|FG000|Overall Study|Death|101|||
161519875|NCT02127307|583291027|FG000|Overall Study|Other than specified above|169|||
161519876|NCT00235989|583291028|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
161519877|NCT00235989|583291029|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
161519878|NCT00235989|583291030|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
161932519|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
161932520|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
161932521|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
161932522|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
161519879|NCT00235989|583291031|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
161519880|NCT00235989|583291032|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
161519881|NCT00235989|583291033|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
161519882|NCT00235989|583291028|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
161519883|NCT00235989|583291029|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
161519884|NCT00235989|583291030|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
161519885|NCT00235989|583291031|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
161519886|NCT00235989|583291032|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
161519887|NCT00235989|583291033|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
161519888|NCT00235989|583291028|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
161519889|NCT00235989|583291029|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
161519890|NCT00235989|583291030|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
161519891|NCT00235989|583291031|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
161519892|NCT00235989|583291032|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
161519893|NCT00235989|583291033|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
161519894|NCT00235989|583291028|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
161519895|NCT00235989|583291029|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
161519896|NCT00235989|583291030|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
161519897|NCT00235989|583291031|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
161519898|NCT00235989|583291032|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
161519899|NCT00235989|583291033|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
161519900|NCT00235989|583291028|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
161519901|NCT00235989|583291029|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
161519902|NCT00235989|583291030|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
161519903|NCT00235989|583291031|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
161519904|NCT00235989|583291032|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
161519905|NCT00235989|583291033|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
161519906|NCT00983580|583291039|FG000|Overall Study|Cancel Prior to treatment|1|||
161519907|NCT00983580|583291040|FG001|Overall Study|Cancel Prior to treatment|3|||
161519908|NCT00983580|583291039|FG000|Overall Study|Protocol Violation|1|||
161519909|NCT00983580|583291040|FG001|Overall Study|Protocol Violation|1|||
161519910|NCT00983580|583291039|FG000|Overall Study|Ineligible|3|||
161519911|NCT00983580|583291040|FG001|Overall Study|Ineligible|0|||
161519912|NCT00074282|583292530|FG000|Step 1|Adverse Event|32|||
161519913|NCT00074282|583292531|FG001|Step 1|Adverse Event|0|||
161519914|NCT00074282|583292532|FG002|Step 1|Adverse Event|0|||
161519915|NCT00074282|583292530|FG000|Step 1|Death|6|||
161519916|NCT00074282|583292531|FG001|Step 1|Death|0|||
161519917|NCT00074282|583292532|FG002|Step 1|Death|0|||
161519918|NCT00074282|583292530|FG000|Step 1|Withdrawal by Subject|7|||
161519919|NCT00074282|583292531|FG001|Step 1|Withdrawal by Subject|0|||
161519920|NCT00074282|583292532|FG002|Step 1|Withdrawal by Subject|0|||
161824399|NCT02419573|584399751|FG001|Overall Study|Lost to Follow-up|0|||
161824400|NCT02419573|584399750|FG000|Overall Study|Withdrawal by Subject|1|||
161824401|NCT02419573|584399751|FG001|Overall Study|Withdrawal by Subject|0|||
161824402|NCT00493792|584399752|FG000|Overall Study|Death|55|||
161824403|NCT00493792|584399753|FG001|Overall Study|Death|50|||
161824404|NCT00493792|584399752|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
161824405|NCT00493792|584399753|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
161824406|NCT00685035|584399758|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
161824407|NCT00685035|584399759|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
161824408|NCT02426541|584399760|FG000|Overall Study|Protocol Violation|1|||
161824409|NCT02426541|584399761|FG001|Overall Study|Protocol Violation|0|||
161824410|NCT00784979|584399764|FG000|Overall Study|incomplete data|6|||
161824411|NCT04241133|584399765|FG000|Overall Study|COVID19 Precautions|14|||
161824412|NCT04241133|584399766|FG001|Overall Study|COVID19 Precautions|34|||
161824413|NCT04968925|584399773|FG000|Phase I- Period 1|COVID-19 related|0|||
161824414|NCT04968925|584399774|FG001|Phase I- Period 1|COVID-19 related|1|||
161824415|NCT04968925|584399775|FG002|Phase I- Period 1|COVID-19 related|0|||
161824416|NCT04968925|584399776|FG003|Phase I- Period 1|COVID-19 related|0|||
161824417|NCT04968925|584399773|FG000|Phase I- Period 1|Subject enrolled in error|1|||
161824418|NCT04968925|584399774|FG001|Phase I- Period 1|Subject enrolled in error|1|||
161824419|NCT04968925|584399775|FG002|Phase I- Period 1|Subject enrolled in error|0|||
161824420|NCT04968925|584399776|FG003|Phase I- Period 1|Subject enrolled in error|0|||
161824421|NCT04968925|584399773|FG000|Phase II- Period 1|COVID-19 Related|0|||
161824422|NCT04968925|584399774|FG001|Phase II- Period 1|COVID-19 Related|0|||
161824423|NCT04968925|584399775|FG002|Phase II- Period 1|COVID-19 Related|6|||
161824424|NCT04968925|584399776|FG003|Phase II- Period 1|COVID-19 Related|6|||
161519921|NCT00074282|583292530|FG000|Step 1|Disease progression|2|||
161519922|NCT00074282|583292531|FG001|Step 1|Disease progression|0|||
161519923|NCT00074282|583292532|FG002|Step 1|Disease progression|0|||
161519924|NCT00074282|583292530|FG000|Step 1|Alternative therapy|2|||
161519925|NCT00074282|583292531|FG001|Step 1|Alternative therapy|0|||
161519926|NCT00074282|583292532|FG002|Step 1|Alternative therapy|0|||
161519927|NCT00074282|583292530|FG000|Step 1|Other complicating disease|2|||
161932523|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
161932524|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
161932525|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
161932526|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161932527|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161932528|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
161932529|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
161932530|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
161932531|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
161932532|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
161932533|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
161932534|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
161932535|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
161932536|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
161932537|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
161519928|NCT00074282|583292531|FG001|Step 1|Other complicating disease|0|||
161519929|NCT00074282|583292532|FG002|Step 1|Other complicating disease|0|||
161519930|NCT00074282|583292530|FG000|Step 1|Physician Decision|1|||
161519931|NCT00074282|583292531|FG001|Step 1|Physician Decision|0|||
161519932|NCT00074282|583292532|FG002|Step 1|Physician Decision|0|||
161519933|NCT00074282|583292530|FG000|Step 1|Ineligible|4|||
161519934|NCT00074282|583292531|FG001|Step 1|Ineligible|0|||
161519935|NCT00074282|583292532|FG002|Step 1|Ineligible|0|||
161519936|NCT00074282|583292530|FG000|Step 1|Never started treatment|2|||
161519937|NCT00074282|583292531|FG001|Step 1|Never started treatment|0|||
161519938|NCT00074282|583292532|FG002|Step 1|Never started treatment|0|||
161519939|NCT00074282|583292530|FG000|Step 2|Adverse Event|0|||
161519940|NCT00074282|583292531|FG001|Step 2|Adverse Event|2|||
161519941|NCT00074282|583292532|FG002|Step 2|Adverse Event|12|||
161519942|NCT00074282|583292530|FG000|Step 2|Disease progression|0|||
161519943|NCT00074282|583292531|FG001|Step 2|Disease progression|0|||
161519944|NCT00074282|583292532|FG002|Step 2|Disease progression|5|||
161519945|NCT00074282|583292530|FG000|Step 2|Death|0|||
161519946|NCT00074282|583292531|FG001|Step 2|Death|0|||
161519947|NCT00074282|583292532|FG002|Step 2|Death|3|||
161519948|NCT00074282|583292530|FG000|Step 2|Withdrawal by Subject|0|||
161519949|NCT00074282|583292531|FG001|Step 2|Withdrawal by Subject|0|||
161519950|NCT00074282|583292532|FG002|Step 2|Withdrawal by Subject|2|||
161519951|NCT00074282|583292530|FG000|Step 2|Physician Decision|0|||
161519952|NCT00074282|583292531|FG001|Step 2|Physician Decision|0|||
161519953|NCT00074282|583292532|FG002|Step 2|Physician Decision|1|||
161519954|NCT00074282|583292530|FG000|Step 2|Ineligible|0|||
161519955|NCT00074282|583292531|FG001|Step 2|Ineligible|0|||
161519956|NCT00074282|583292532|FG002|Step 2|Ineligible|1|||
161519957|NCT00464542|583292533|FG000|Pre-treatment|Withdrawal by Subject|2|||
161519958|NCT02159482|583292536|FG000|Overall Study|Withdrawal by Subject|2|||
161519959|NCT02159482|583292536|FG000|Overall Study|Physician Decision|3|||
161519960|NCT01233817|583292537|FG000|Overall Study|Lost to Follow-up|1|||
161519961|NCT01233817|583292537|FG000|Overall Study|Withdrawal by Subject|2|||
161519962|NCT01248884|583292538|FG000|Overall Study|Withdrawal by Subject|1|||
161519963|NCT01248884|583292539|FG001|Overall Study|Withdrawal by Subject|3|||
161519964|NCT01248884|583292540|FG002|Overall Study|Withdrawal by Subject|1|||
161519965|NCT01248884|583292538|FG000|Overall Study|Adverse Event|1|||
161519966|NCT01248884|583292539|FG001|Overall Study|Adverse Event|0|||
161519967|NCT01248884|583292540|FG002|Overall Study|Adverse Event|0|||
161519968|NCT04479618|583292541|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
161519969|NCT04479618|583292542|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
161519970|NCT04479618|583292543|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
161519971|NCT04479618|583292541|FG000|Overall Study|Lack of Efficacy|1|||
161519972|NCT04479618|583292542|FG001|Overall Study|Lack of Efficacy|0|||
161519973|NCT04479618|583292543|FG002|Overall Study|Lack of Efficacy|0|||
161519974|NCT04479618|583292541|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
161519975|NCT04479618|583292542|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
161519976|NCT04479618|583292543|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
161519977|NCT04479618|583292541|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
161519978|NCT04479618|583292542|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
161519979|NCT04479618|583292543|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
161519980|NCT04479618|583292541|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
161549244|NCT02291289|583401019|FG010|Induction Treatment|Protocol Violation|0|||
161932538|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
161932539|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
161932540|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
161932541|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
161932542|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
161932543|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
161932544|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
161932545|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
161932546|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
161932547|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
161932548|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
161932549|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
161932550|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
161932551|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
161932552|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
161932553|NCT00736476|584800506|FG000|Overall Study|Adverse Event|1|||
161932554|NCT00736476|584800507|FG001|Overall Study|Adverse Event|0|||
161932555|NCT01796470|584800508|FG000|Overall Study|Adverse Event|4|||
161932556|NCT01796470|584800509|FG001|Overall Study|Adverse Event|2|||
161932557|NCT01796470|584800510|FG002|Overall Study|Adverse Event|2|||
161932558|NCT01796470|584800511|FG003|Overall Study|Adverse Event|1|||
161932559|NCT01796470|584800512|FG004|Overall Study|Adverse Event|3|||
161932560|NCT01796470|584800508|FG000|Overall Study|Death|2|||
161519981|NCT04479618|583292542|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
161519982|NCT04479618|583292543|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
161519983|NCT04479618|583292541|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
161519984|NCT04479618|583292542|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
161519985|NCT04479618|583292543|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
161519986|NCT01430130|583292544|FG000|Overall Study|Lost to Follow-up|1|||
161519987|NCT01430130|583292544|FG000|Overall Study|Infection on Control Side of Incision|1|||
161519988|NCT00833924|583292545|FG000|Overall Study|Death|21|||
161519989|NCT00833924|583292545|FG000|Overall Study|Conversion|2|||
161519990|NCT00833924|583292545|FG000|Overall Study|Lost to Follow-up|2|||
161519991|NCT00833924|583292545|FG000|Overall Study|Withdrawal by Subject|13|||
161519992|NCT00833924|583292545|FG000|Overall Study|In study follow-up|71|||
161519993|NCT00797667|583292546|FG000|Overall Study|Lack of Efficacy|0|||
161519994|NCT00797667|583292547|FG001|Overall Study|Lack of Efficacy|1|||
161824425|NCT04968925|584399773|FG000|Phase II- Period 1|Subject enrolled in error|0|||
161824426|NCT04968925|584399774|FG001|Phase II- Period 1|Subject enrolled in error|0|||
161824427|NCT04968925|584399775|FG002|Phase II- Period 1|Subject enrolled in error|1|||
161824428|NCT04968925|584399776|FG003|Phase II- Period 1|Subject enrolled in error|0|||
161824429|NCT04968925|584399773|FG000|Phase II -Period 2|COVID-19 related|0|||
161824430|NCT04968925|584399774|FG001|Phase II -Period 2|COVID-19 related|0|||
161824431|NCT04968925|584399775|FG002|Phase II -Period 2|COVID-19 related|4|||
161824432|NCT04968925|584399776|FG003|Phase II -Period 2|COVID-19 related|3|||
161824433|NCT04968925|584399773|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
161824434|NCT04968925|584399774|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
161824435|NCT04968925|584399775|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
161824436|NCT04968925|584399776|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
161824437|NCT00835796|584399782|FG000|First Intervention|Withdrawal by Subject|0|||
161824438|NCT00835796|584399783|FG001|First Intervention|Withdrawal by Subject|1|||
161824439|NCT00396630|584399784|FG000|Overall Study|Lost to Follow-up|1|||
161824440|NCT00396630|584399785|FG001|Overall Study|Lost to Follow-up|1|||
161824441|NCT00396630|584399784|FG000|Overall Study|Withdrawal by Subject|1|||
161824442|NCT00396630|584399785|FG001|Overall Study|Withdrawal by Subject|1|||
161824443|NCT00396630|584399784|FG000|Overall Study|Not vaccinated at Visit 3|3|||
161824444|NCT00396630|584399785|FG001|Overall Study|Not vaccinated at Visit 3|3|||
161824445|NCT00876265|584399786|FG000|Overall Study|Miscellaneous reasons|4|||
161824446|NCT00876265|584399786|FG000|Overall Study|Lost to Follow-up|6|||
161824447|NCT00876265|584399786|FG000|Overall Study|Withdrawal by Subject|2|||
161824448|NCT02327325|584399787|FG000|Overall Study|Withdrawal by Subject|1|||
161824449|NCT02327325|584399788|FG001|Overall Study|Withdrawal by Subject|4|||
161824450|NCT02327325|584399789|FG002|Overall Study|Withdrawal by Subject|4|||
161824451|NCT02327325|584399787|FG000|Overall Study|Excluded by Study Team|0|||
161824452|NCT02327325|584399788|FG001|Overall Study|Excluded by Study Team|0|||
161824453|NCT02327325|584399789|FG002|Overall Study|Excluded by Study Team|1|||
161824454|NCT00651183|584399792|FG000|Overall Study|Lack of Efficacy|1|||
161824455|NCT00651183|584399793|FG001|Overall Study|Lack of Efficacy|0|||
161824456|NCT00651183|584399792|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
161932561|NCT01796470|584800509|FG001|Overall Study|Death|0|||
161519995|NCT00797667|583292548|FG002|Overall Study|Lack of Efficacy|0|||
161519996|NCT00797667|583292546|FG000|Overall Study|Lost to Follow-up|8|||
161519997|NCT00797667|583292547|FG001|Overall Study|Lost to Follow-up|12|||
161519998|NCT00797667|583292548|FG002|Overall Study|Lost to Follow-up|2|||
161519999|NCT00797667|583292546|FG000|Overall Study|Physician Decision|3|||
161520000|NCT00797667|583292547|FG001|Overall Study|Physician Decision|1|||
161520001|NCT00797667|583292548|FG002|Overall Study|Physician Decision|0|||
161520002|NCT00797667|583292546|FG000|Overall Study|Pregnancy|2|||
161520003|NCT00797667|583292547|FG001|Overall Study|Pregnancy|0|||
161520004|NCT00797667|583292548|FG002|Overall Study|Pregnancy|0|||
161520005|NCT00797667|583292546|FG000|Overall Study|Protocol Violation|2|||
161520006|NCT00797667|583292547|FG001|Overall Study|Protocol Violation|7|||
161520007|NCT00797667|583292548|FG002|Overall Study|Protocol Violation|0|||
161520008|NCT00797667|583292546|FG000|Overall Study|Study Terminated by Sponsor|217|||
161520009|NCT00797667|583292547|FG001|Overall Study|Study Terminated by Sponsor|216|||
161520010|NCT00797667|583292548|FG002|Overall Study|Study Terminated by Sponsor|115|||
161824457|NCT00651183|584399793|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
161824458|NCT00651183|584399792|FG000|Overall Study|Tolerability insufficient|5|||
161824459|NCT00651183|584399793|FG001|Overall Study|Tolerability insufficient|2|||
161824460|NCT00651183|584399792|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
161824461|NCT00651183|584399793|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
161824462|NCT00651183|584399792|FG000|Overall Study|Withdrawal by Subject|6|||
161824463|NCT00651183|584399793|FG001|Overall Study|Withdrawal by Subject|3|||
161824464|NCT00651183|584399792|FG000|Overall Study|Lost to Follow-up|3|||
161824465|NCT00651183|584399793|FG001|Overall Study|Lost to Follow-up|1|||
161824466|NCT00651183|584399792|FG000|Overall Study|Other reasons|4|||
161824467|NCT00651183|584399793|FG001|Overall Study|Other reasons|2|||
161824468|NCT00651183|584399792|FG000|Overall Study|missing|1|||
161824469|NCT00651183|584399793|FG001|Overall Study|missing|0|||
161824470|NCT00695110|584399798|FG000|Treatment Period 1|Adverse Event|1|||
161824471|NCT00695110|584399798|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161824472|NCT00695110|584399798|FG000|Treatment Period 3|Withdrawal by Subject|1|||
161824473|NCT00695110|584399798|FG000|Treatment Period 4|Adverse Event|1|||
161824474|NCT01933919|584399808|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
161824475|NCT01933919|584399809|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
161824476|NCT01933919|584399808|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
161824477|NCT01933919|584399809|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
161824478|NCT01933919|584399808|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
161824479|NCT01933919|584399809|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
161824480|NCT01933919|584399808|FG000|Open-label Long-term Phase|Adverse Event|2|||
161824481|NCT01933919|584399809|FG001|Open-label Long-term Phase|Adverse Event|0|||
161824482|NCT01933919|584399808|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
161824483|NCT01933919|584399809|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
161824484|NCT01933919|584399808|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
161824485|NCT01933919|584399809|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
161824486|NCT01933919|584399808|FG000|Open-label Long-term Phase|Other|1|||
161824487|NCT01933919|584399809|FG001|Open-label Long-term Phase|Other|2|||
161824488|NCT02575339|584399810|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161824489|NCT02575339|584399811|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161824490|NCT02575339|584399812|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161824491|NCT02575339|584399810|FG000|Study Treatment|Disease Progression|5|||
161824492|NCT02575339|584399811|FG001|Study Treatment|Disease Progression|2|||
161824493|NCT02575339|584399812|FG002|Study Treatment|Disease Progression|0|||
161824494|NCT02575339|584399810|FG000|Study Treatment|Adverse Event|1|||
161824495|NCT02575339|584399811|FG001|Study Treatment|Adverse Event|2|||
161824496|NCT02575339|584399812|FG002|Study Treatment|Adverse Event|0|||
161824497|NCT02575339|584399810|FG000|Follow up|Death|6|||
161824498|NCT02575339|584399811|FG001|Follow up|Death|2|||
161824499|NCT02575339|584399812|FG002|Follow up|Death|0|||
161824500|NCT02575339|584399810|FG000|Follow up|Study Terminated|0|||
161824501|NCT02575339|584399811|FG001|Follow up|Study Terminated|2|||
161824502|NCT02575339|584399812|FG002|Follow up|Study Terminated|0|||
161824503|NCT02575339|584399810|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
161824504|NCT02575339|584399811|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
161824505|NCT02575339|584399812|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
161824506|NCT04675775|584399813|FG000|Overall Study|Withdrawal by Subject|7|||
161824507|NCT00108082|584399816|FG000|Overall Study|Adverse Event|14|||
161824508|NCT00108082|584399817|FG001|Overall Study|Adverse Event|12|||
161824509|NCT00108082|584399818|FG002|Overall Study|Adverse Event|17|||
161824510|NCT00108082|584399816|FG000|Overall Study|Lost to Follow-up|6|||
161824511|NCT00108082|584399817|FG001|Overall Study|Lost to Follow-up|3|||
161824512|NCT00108082|584399818|FG002|Overall Study|Lost to Follow-up|7|||
161824513|NCT00108082|584399816|FG000|Overall Study|Consent Withdrawn|3|||
161520011|NCT00797667|583292546|FG000|Overall Study|Withdrawal by Subject|9|||
161520012|NCT00797667|583292547|FG001|Overall Study|Withdrawal by Subject|14|||
161520013|NCT00797667|583292548|FG002|Overall Study|Withdrawal by Subject|2|||
161589036|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
161589037|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589038|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589039|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589040|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589041|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589042|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589043|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589044|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589045|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161589046|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
161589047|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
161932562|NCT01796470|584800510|FG002|Overall Study|Death|0|||
161932563|NCT01796470|584800511|FG003|Overall Study|Death|0|||
161932564|NCT01796470|584800512|FG004|Overall Study|Death|1|||
161932565|NCT01796470|584800508|FG000|Overall Study|Initiated New Therapy|9|||
161932566|NCT01796470|584800509|FG001|Overall Study|Initiated New Therapy|0|||
161932567|NCT01796470|584800510|FG002|Overall Study|Initiated New Therapy|0|||
161932568|NCT01796470|584800511|FG003|Overall Study|Initiated New Therapy|0|||
161520014|NCT00797667|583292546|FG000|Overall Study|Adverse Event|19|||
161520015|NCT00797667|583292547|FG001|Overall Study|Adverse Event|8|||
161520016|NCT00797667|583292548|FG002|Overall Study|Adverse Event|8|||
161520017|NCT01986829|583292553|FG000|Overall Study|Death|1|||
161520018|NCT01229436|583292554|FG000|Overall Study|Withdrawal by Subject|2|||
161520019|NCT01229436|583292554|FG000|Overall Study|Lost to Follow-up|3|||
161520020|NCT00701051|583292559|FG000|Screening|Failed Screening|40|||
161520021|NCT00701051|583292560|FG001|Screening|Failed Screening|0|||
161520022|NCT00701051|583292561|FG002|Screening|Failed Screening|0|||
161520023|NCT00701051|583292559|FG000|Screening|Time conflicts|19|||
161520024|NCT00701051|583292560|FG001|Screening|Time conflicts|0|||
161520025|NCT00701051|583292561|FG002|Screening|Time conflicts|0|||
161520026|NCT00701051|583292559|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
161520027|NCT00701051|583292560|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
161520028|NCT00701051|583292561|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
161520029|NCT02059148|583292562|FG000|Treatment 1|Protocol Violation|0|||
161520030|NCT02059148|583292563|FG001|Treatment 1|Protocol Violation|0|||
161520031|NCT02059148|583292564|FG002|Treatment 1|Protocol Violation|0|||
161520032|NCT02059148|583292565|FG003|Treatment 1|Protocol Violation|0|||
161520033|NCT02059148|583292566|FG004|Treatment 1|Protocol Violation|0|||
161520034|NCT02059148|583292567|FG005|Treatment 1|Protocol Violation|1|||
161520035|NCT01243944|583292570|FG000|Overall Study|Adverse Event|15|||
161520036|NCT01243944|583292571|FG001|Overall Study|Adverse Event|13|||
161520037|NCT01243944|583292570|FG000|Overall Study|Lost to Follow-up|2|||
161520038|NCT01243944|583292571|FG001|Overall Study|Lost to Follow-up|1|||
161520039|NCT01243944|583292570|FG000|Overall Study|Physician Decision|2|||
161520040|NCT01243944|583292571|FG001|Overall Study|Physician Decision|7|||
161520041|NCT01243944|583292570|FG000|Overall Study|Disease progression|12|||
161520042|NCT01243944|583292571|FG001|Overall Study|Disease progression|11|||
161520043|NCT01243944|583292570|FG000|Overall Study|Protocol deviation|1|||
161520044|NCT01243944|583292571|FG001|Overall Study|Protocol deviation|1|||
161520045|NCT01243944|583292570|FG000|Overall Study|Participant decision|10|||
161520046|NCT01243944|583292571|FG001|Overall Study|Participant decision|15|||
161520047|NCT01243944|583292570|FG000|Overall Study|Death|2|||
161520048|NCT01243944|583292571|FG001|Overall Study|Death|3|||
161520049|NCT01243944|583292570|FG000|Overall Study|Non-compliance with study treatment|1|||
161520050|NCT01243944|583292571|FG001|Overall Study|Non-compliance with study treatment|0|||
161520051|NCT03029208|583292574|FG000|Overall Study|Withdrawal by Subject|2|||
161520052|NCT03029208|583292575|FG001|Overall Study|Withdrawal by Subject|3|||
161520053|NCT03029208|583292574|FG000|Overall Study|Lost to Follow-up|0|||
161589048|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
161932569|NCT01796470|584800512|FG004|Overall Study|Initiated New Therapy|2|||
161932570|NCT01796470|584800508|FG000|Overall Study|Lost to Follow-up|0|||
161520054|NCT03029208|583292575|FG001|Overall Study|Lost to Follow-up|1|||
161520055|NCT02673697|583292580|FG000|Overall Study|Adverse Event|2|||
161589049|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
161932571|NCT01796470|584800509|FG001|Overall Study|Lost to Follow-up|1|||
161520056|NCT02673697|583292581|FG001|Overall Study|Adverse Event|0|||
161520057|NCT02673697|583292580|FG000|Overall Study|Death|32|||
161520058|NCT02673697|583292581|FG001|Overall Study|Death|24|||
161520059|NCT02673697|583292580|FG000|Overall Study|Lost to Follow-up|5|||
161520060|NCT02673697|583292581|FG001|Overall Study|Lost to Follow-up|2|||
161520061|NCT02673697|583292580|FG000|Overall Study|Physician Decision|2|||
161520062|NCT02673697|583292581|FG001|Overall Study|Physician Decision|1|||
161520063|NCT02673697|583292580|FG000|Overall Study|Withdrawal by Subject|10|||
161520064|NCT02673697|583292581|FG001|Overall Study|Withdrawal by Subject|7|||
161520065|NCT02673697|583292580|FG000|Overall Study|Change subj medical status|1|||
161520066|NCT02673697|583292581|FG001|Overall Study|Change subj medical status|2|||
161932572|NCT01796470|584800510|FG002|Overall Study|Lost to Follow-up|0|||
161932573|NCT01796470|584800511|FG003|Overall Study|Lost to Follow-up|0|||
161932574|NCT01796470|584800512|FG004|Overall Study|Lost to Follow-up|0|||
161932575|NCT01796470|584800508|FG000|Overall Study|Physician Decision|5|||
161932576|NCT01796470|584800509|FG001|Overall Study|Physician Decision|4|||
161932577|NCT01796470|584800510|FG002|Overall Study|Physician Decision|1|||
161932578|NCT01796470|584800511|FG003|Overall Study|Physician Decision|0|||
161520067|NCT02673697|583292580|FG000|Overall Study|Explant|10|||
161520068|NCT02673697|583292581|FG001|Overall Study|Explant|5|||
161520069|NCT02673697|583292580|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
161520070|NCT02673697|583292581|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
161932579|NCT01796470|584800512|FG004|Overall Study|Physician Decision|1|||
161932580|NCT01796470|584800508|FG000|Overall Study|Progressive Disease|7|||
161932581|NCT01796470|584800509|FG001|Overall Study|Progressive Disease|7|||
161932582|NCT01796470|584800510|FG002|Overall Study|Progressive Disease|3|||
161932583|NCT01796470|584800511|FG003|Overall Study|Progressive Disease|2|||
161932584|NCT01796470|584800512|FG004|Overall Study|Progressive Disease|0|||
161932585|NCT01796470|584800508|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
161932586|NCT01796470|584800509|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
161932587|NCT01796470|584800510|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
161932588|NCT01796470|584800511|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
161932589|NCT01796470|584800512|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
161932590|NCT01796470|584800508|FG000|Overall Study|Withdrawal by Subject|7|||
161932591|NCT01796470|584800509|FG001|Overall Study|Withdrawal by Subject|0|||
161932592|NCT01796470|584800510|FG002|Overall Study|Withdrawal by Subject|0|||
161932593|NCT01796470|584800511|FG003|Overall Study|Withdrawal by Subject|0|||
161932594|NCT01796470|584800512|FG004|Overall Study|Withdrawal by Subject|1|||
161932595|NCT04818086|584800519|FG000|Overall Study|Physician Decision|1|||
161932596|NCT04818086|584800520|FG001|Overall Study|Physician Decision|0|||
161932597|NCT04818086|584800519|FG000|Overall Study|Withdrawal by Subject|0|||
161932598|NCT04818086|584800520|FG001|Overall Study|Withdrawal by Subject|1|||
161932599|NCT04128228|584800522|FG000|Overall Study|Withdrawal by Subject|3|||
161932600|NCT04128228|584800523|FG001|Overall Study|Withdrawal by Subject|3|||
161932601|NCT04128228|584800524|FG002|Overall Study|Withdrawal by Subject|0|||
161932602|NCT04128228|584800525|FG003|Overall Study|Withdrawal by Subject|0|||
161932603|NCT04128228|584800522|FG000|Overall Study|noncompliance|2|||
161932604|NCT04128228|584800523|FG001|Overall Study|noncompliance|2|||
161932605|NCT04128228|584800524|FG002|Overall Study|noncompliance|0|||
161932606|NCT04128228|584800525|FG003|Overall Study|noncompliance|0|||
161932607|NCT03760666|584800526|FG000|Overall Study|Adverse Event|2|||
161932608|NCT03760666|584800527|FG001|Overall Study|Adverse Event|4|||
161932609|NCT03760666|584800528|FG002|Overall Study|Adverse Event|1|||
161932610|NCT03760666|584800526|FG000|Overall Study|AML Disease Progression|3|||
161932611|NCT03760666|584800527|FG001|Overall Study|AML Disease Progression|3|||
161932612|NCT03760666|584800528|FG002|Overall Study|AML Disease Progression|0|||
161932613|NCT03760666|584800526|FG000|Overall Study|Physician Decision|0|||
161932614|NCT03760666|584800527|FG001|Overall Study|Physician Decision|3|||
161932615|NCT03760666|584800528|FG002|Overall Study|Physician Decision|0|||
161932616|NCT03760666|584800526|FG000|Overall Study|Withdrawal by Subject|0|||
161932617|NCT03760666|584800527|FG001|Overall Study|Withdrawal by Subject|1|||
161932618|NCT03760666|584800528|FG002|Overall Study|Withdrawal by Subject|0|||
161932619|NCT01800058|584800534|FG000|Overall Study|Lost to Follow-up|1|||
161932620|NCT00992394|584800539|FG000|Overall Study|Lack of Efficacy|6|||
161932621|NCT00992394|584800540|FG001|Overall Study|Lack of Efficacy|3|||
161932622|NCT00992394|584800539|FG000|Overall Study|Adverse Event|4|||
161932623|NCT00992394|584800540|FG001|Overall Study|Adverse Event|5|||
161932624|NCT00992394|584800539|FG000|Overall Study|Withdrawal by Subject|8|||
161932625|NCT00992394|584800540|FG001|Overall Study|Withdrawal by Subject|2|||
161932626|NCT00992394|584800539|FG000|Overall Study|Physician Decision|1|||
161932627|NCT00992394|584800540|FG001|Overall Study|Physician Decision|0|||
161520071|NCT03893448|583292584|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
161520072|NCT03893448|583292585|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
161520073|NCT03893448|583292584|FG000|Overall Study|Physician Decision|8|||
161520074|NCT03893448|583292585|FG001|Overall Study|Physician Decision|14|||
161520075|NCT03893448|583292584|FG000|Overall Study|Lost to Follow-up|34|||
161932628|NCT00992394|584800539|FG000|Overall Study|Protocol Violation|2|||
161520076|NCT03893448|583292585|FG001|Overall Study|Lost to Follow-up|27|||
161520077|NCT03893448|583292584|FG000|Overall Study|Death|1|||
161932629|NCT00992394|584800540|FG001|Overall Study|Protocol Violation|4|||
161932630|NCT00992394|584800539|FG000|Overall Study|Lost to Follow-up|2|||
161932631|NCT00992394|584800540|FG001|Overall Study|Lost to Follow-up|0|||
161932632|NCT00992394|584800539|FG000|Overall Study|Other event|1|||
161932633|NCT00992394|584800540|FG001|Overall Study|Other event|0|||
161932634|NCT01245049|584800541|FG000|Overall Study|Migrated/moved from study area|0|||
161932635|NCT01245049|584800542|FG001|Overall Study|Migrated/moved from study area|1|||
161520078|NCT03893448|583292585|FG001|Overall Study|Death|0|||
161520079|NCT03321981|583292587|FG000|Overall Study|Progressive Disease (PD)|15|||
161932636|NCT01245049|584800541|FG000|Overall Study|Withdrawal by Subject|0|||
161932637|NCT01245049|584800542|FG001|Overall Study|Withdrawal by Subject|1|||
161520080|NCT03321981|583292588|FG001|Overall Study|Progressive Disease (PD)|30|||
161520081|NCT03321981|583292589|FG002|Overall Study|Progressive Disease (PD)|47|||
161520082|NCT03321981|583292587|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
161520083|NCT03321981|583292588|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
161520084|NCT03321981|583292589|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
161932638|NCT01245049|584800541|FG000|Overall Study|Lost to Follow-up|1|||
161932639|NCT01245049|584800542|FG001|Overall Study|Lost to Follow-up|2|||
161932640|NCT00450749|584800543|FG000|Overall Study|Withdrawal by Subject|0|||
161932641|NCT00450749|584800544|FG001|Overall Study|Withdrawal by Subject|0|||
161932642|NCT00450749|584800545|FG002|Overall Study|Withdrawal by Subject|2|||
161932643|NCT00450749|584800543|FG000|Overall Study|Noncompliant|0|||
161932644|NCT00450749|584800544|FG001|Overall Study|Noncompliant|1|||
161932645|NCT00450749|584800545|FG002|Overall Study|Noncompliant|0|||
161932646|NCT02151604|584800546|FG000|Overall Study|Lost to Follow-up|3|||
161932647|NCT02151604|584800546|FG000|Overall Study|Withdrawal by Subject|2|||
161932648|NCT02151604|584800546|FG000|Overall Study|Physician Decision|3|||
161932649|NCT02151604|584800546|FG000|Overall Study|Death|1|||
161932650|NCT02568254|584800548|FG000|Period 2|Adverse Event|0|||
161932651|NCT02568254|584800549|FG001|Period 2|Adverse Event|0|||
161932652|NCT02568254|584800550|FG002|Period 2|Adverse Event|1|||
161932653|NCT02568254|584800551|FG003|Period 2|Adverse Event|0|||
161932654|NCT02568254|584800552|FG004|Period 2|Adverse Event|0|||
161932655|NCT02568254|584800553|FG005|Period 2|Adverse Event|0|||
161932656|NCT02568254|584800548|FG000|Period 3|Unstatisfactory Lens fitting|0|||
161932657|NCT02568254|584800549|FG001|Period 3|Unstatisfactory Lens fitting|0|||
161932658|NCT02568254|584800550|FG002|Period 3|Unstatisfactory Lens fitting|0|||
161932659|NCT02568254|584800551|FG003|Period 3|Unstatisfactory Lens fitting|0|||
161932660|NCT02568254|584800552|FG004|Period 3|Unstatisfactory Lens fitting|1|||
161932661|NCT02568254|584800553|FG005|Period 3|Unstatisfactory Lens fitting|0|||
161932662|NCT00655746|584800554|FG000|Overall Study|Withdrawal by Subject|1|||
161932663|NCT00561821|584800555|FG000|Overall Study|Not treated|0|||
161932664|NCT00561821|584800556|FG001|Overall Study|Not treated|0|||
161932665|NCT00561821|584800557|FG002|Overall Study|Not treated|1|||
161932666|NCT00561821|584800558|FG003|Overall Study|Not treated|0|||
161932667|NCT00561821|584800555|FG000|Overall Study|Withdrawal by Subject|0|||
161932668|NCT00561821|584800556|FG001|Overall Study|Withdrawal by Subject|1|||
161932669|NCT00561821|584800557|FG002|Overall Study|Withdrawal by Subject|0|||
161932670|NCT00561821|584800558|FG003|Overall Study|Withdrawal by Subject|2|||
161932671|NCT00561821|584800555|FG000|Overall Study|Reasons not related to trial|2|||
161932672|NCT00561821|584800556|FG001|Overall Study|Reasons not related to trial|1|||
161932673|NCT00561821|584800557|FG002|Overall Study|Reasons not related to trial|0|||
161932674|NCT00561821|584800558|FG003|Overall Study|Reasons not related to trial|0|||
161932675|NCT00561821|584800555|FG000|Overall Study|Other (reason not specified)|1|||
161932676|NCT00561821|584800556|FG001|Overall Study|Other (reason not specified)|1|||
161932677|NCT00561821|584800557|FG002|Overall Study|Other (reason not specified)|0|||
161932678|NCT00561821|584800558|FG003|Overall Study|Other (reason not specified)|0|||
161932679|NCT00561821|584800555|FG000|Overall Study|Adverse Event|2|||
161932680|NCT00561821|584800556|FG001|Overall Study|Adverse Event|3|||
161932681|NCT00561821|584800557|FG002|Overall Study|Adverse Event|1|||
161932682|NCT00561821|584800558|FG003|Overall Study|Adverse Event|1|||
161932683|NCT03178942|584800559|FG000|Overall Study|Withdrawal by Subject|2|||
161932684|NCT03178942|584800560|FG001|Overall Study|Withdrawal by Subject|0|||
161932685|NCT03178942|584800559|FG000|Overall Study|Lost to Follow-up|1|||
161932686|NCT03178942|584800560|FG001|Overall Study|Lost to Follow-up|2|||
161932687|NCT02562040|584802312|FG000|Overall Study|Lost to Follow-up|20|||
161932688|NCT02562040|584802313|FG001|Overall Study|Lost to Follow-up|28|||
161932689|NCT02562040|584802312|FG000|Overall Study|Withdrawal by Subject|8|||
161932690|NCT02562040|584802313|FG001|Overall Study|Withdrawal by Subject|7|||
161932691|NCT02562040|584802312|FG000|Overall Study|Adverse Event|1|||
161932692|NCT02562040|584802313|FG001|Overall Study|Adverse Event|0|||
161932693|NCT04359680|584802316|FG000|Overall Study|Withdrawal by Subject|29|||
161932694|NCT04359680|584802317|FG001|Overall Study|Withdrawal by Subject|24|||
161932695|NCT04359680|584802316|FG000|Overall Study|Adverse Event|6|||
161932696|NCT04359680|584802317|FG001|Overall Study|Adverse Event|2|||
161932697|NCT04359680|584802316|FG000|Overall Study|Lost to Follow-up|56|||
161932698|NCT04359680|584802317|FG001|Overall Study|Lost to Follow-up|59|||
161932699|NCT04359680|584802316|FG000|Overall Study|Protocol Violation|3|||
161932700|NCT04359680|584802317|FG001|Overall Study|Protocol Violation|5|||
161932701|NCT04359680|584802316|FG000|Overall Study|Physician Decision|1|||
161932702|NCT04359680|584802317|FG001|Overall Study|Physician Decision|1|||
161932703|NCT04359680|584802316|FG000|Overall Study|Sponsor Decision|0|||
161932704|NCT04359680|584802317|FG001|Overall Study|Sponsor Decision|1|||
161932705|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
161932706|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
161932707|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
161932708|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
161932709|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
161932710|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
161932711|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
161932712|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
161932713|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
161932714|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
161932715|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
161932716|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
161932717|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
161932718|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
161932719|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
161932720|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
161932721|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
161932722|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
161932723|NCT01755156|584802319|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
161932724|NCT01755156|584802320|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
161932725|NCT01755156|584802319|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
161932726|NCT01755156|584802320|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
161932727|NCT03142451|584802321|FG000|Overall Study|Adverse Event|5|||
161932728|NCT03142451|584802322|FG001|Overall Study|Adverse Event|2|||
161932729|NCT03142451|584802321|FG000|Overall Study|Lost to Follow-up|25|||
161932730|NCT03142451|584802322|FG001|Overall Study|Lost to Follow-up|8|||
161932731|NCT03142451|584802321|FG000|Overall Study|Participant request|24|||
161932732|NCT03142451|584802322|FG001|Overall Study|Participant request|12|||
161932733|NCT03142451|584802321|FG000|Overall Study|Protocol Violation|3|||
161932734|NCT03142451|584802322|FG001|Overall Study|Protocol Violation|1|||
161932735|NCT03142451|584802321|FG000|Overall Study|Other|1|||
161932736|NCT03142451|584802322|FG001|Overall Study|Other|1|||
161932737|NCT05333965|584802323|FG000|First Intervention|Adverse Event|0|||
161932738|NCT05333965|584802324|FG001|First Intervention|Adverse Event|1|||
161932739|NCT05333965|584802323|FG000|First Intervention|Withdrawal by Subject|0|||
161932740|NCT05333965|584802324|FG001|First Intervention|Withdrawal by Subject|1|||
161932741|NCT03048019|584802325|FG000|Overall Study|Adverse Event|1|||
161932742|NCT03048019|584802326|FG001|Overall Study|Adverse Event|0|||
161932743|NCT01730729|584802329|FG000|Overall Study|Adverse Event|1|||
161932744|NCT01730729|584802329|FG000|Overall Study|Death|1|||
161932745|NCT01730729|584802329|FG000|Overall Study|Progressive Disease|12|||
161932746|NCT00871000|584802330|FG000|Overall Study|Withdrawal by Subject|1|||
161932747|NCT00871000|584802331|FG001|Overall Study|Withdrawal by Subject|0|||
161932748|NCT01052428|584802332|FG000|Overall Study|Death|1|||
161932749|NCT01052428|584802333|FG001|Overall Study|Death|0|||
161932750|NCT01052428|584802332|FG000|Overall Study|Withdrawal by Subject|0|||
161932751|NCT01052428|584802333|FG001|Overall Study|Withdrawal by Subject|1|||
161932752|NCT00382863|584802334|FG000|Overall Study|Death|9|||
161932753|NCT00382863|584802335|FG001|Overall Study|Death|9|||
161932754|NCT00382863|584802334|FG000|Overall Study|Lost to Follow-up|1|||
161932755|NCT00382863|584802335|FG001|Overall Study|Lost to Follow-up|2|||
161932756|NCT00382863|584802334|FG000|Overall Study|Withdrawal by Subject|5|||
161932757|NCT00382863|584802335|FG001|Overall Study|Withdrawal by Subject|25|||
161932758|NCT00203242|584802338|FG000|Overall Study|Lost to Follow-up|1|||
161932759|NCT02595437|584802339|FG000|Triferic Via IV|Withdrawal by Subject|1|||
161932760|NCT02837952|584802341|FG000|Overall Study|Adverse Event|0|||
161932761|NCT02837952|584802342|FG001|Overall Study|Adverse Event|1|||
161932762|NCT02837952|584802341|FG000|Overall Study|Withdrawal by Subject|4|||
161932763|NCT02837952|584802342|FG001|Overall Study|Withdrawal by Subject|5|||
161932764|NCT02837952|584802341|FG000|Overall Study|Medication Error|1|||
161932765|NCT02837952|584802342|FG001|Overall Study|Medication Error|0|||
161932766|NCT00835549|584802345|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
161932767|NCT00835549|584802346|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161932768|NCT00986102|584802360|FG000|Overall Study|Lost to Follow-up|0|||
161932769|NCT00986102|584802361|FG001|Overall Study|Lost to Follow-up|1|||
161932770|NCT00986102|584802362|FG002|Overall Study|Lost to Follow-up|0|||
161932771|NCT00986102|584802363|FG003|Overall Study|Lost to Follow-up|1|||
161932772|NCT00986102|584802360|FG000|Overall Study|Withdrawal by Subject|1|||
161932773|NCT00986102|584802361|FG001|Overall Study|Withdrawal by Subject|1|||
161932774|NCT00986102|584802362|FG002|Overall Study|Withdrawal by Subject|0|||
161932775|NCT00986102|584802363|FG003|Overall Study|Withdrawal by Subject|0|||
161932776|NCT02314247|584802364|FG000|Overall Study|Adverse Event|2|||
161932777|NCT02314247|584802365|FG001|Overall Study|Adverse Event|1|||
161932778|NCT02314247|584802366|FG002|Overall Study|Adverse Event|0|||
161932779|NCT02314247|584802364|FG000|Overall Study|Withdrawal by Subject|1|||
161932780|NCT02314247|584802365|FG001|Overall Study|Withdrawal by Subject|3|||
161932781|NCT02314247|584802366|FG002|Overall Study|Withdrawal by Subject|1|||
161932782|NCT02314247|584802364|FG000|Overall Study|Progression of Disease|6|||
161932783|NCT02314247|584802365|FG001|Overall Study|Progression of Disease|2|||
161932784|NCT02314247|584802366|FG002|Overall Study|Progression of Disease|0|||
161932785|NCT00489359|584802374|FG000|Overall Study|Death|0|||
161932786|NCT00489359|584802375|FG001|Overall Study|Death|2|||
161932787|NCT00489359|584802374|FG000|Overall Study|Progressive Disease|5|||
161932788|NCT00489359|584802375|FG001|Overall Study|Progressive Disease|6|||
161932789|NCT00489359|584802374|FG000|Overall Study|Lost to Follow-up|1|||
161932790|NCT00489359|584802375|FG001|Overall Study|Lost to Follow-up|0|||
161932791|NCT00489359|584802374|FG000|Overall Study|Withdrawal by Subject|1|||
161932792|NCT00489359|584802375|FG001|Overall Study|Withdrawal by Subject|5|||
161932793|NCT00489359|584802374|FG000|Overall Study|Adverse Event|0|||
161932794|NCT00489359|584802375|FG001|Overall Study|Adverse Event|16|||
161932795|NCT03180138|584802376|FG000|Overall Study|Mobile-phone could not be verified|2|||
161932796|NCT03180138|584802377|FG001|Overall Study|Mobile-phone could not be verified|13|||
161932797|NCT03180138|584802378|FG002|Overall Study|Mobile-phone could not be verified|15|||
161932798|NCT03180138|584802376|FG000|Overall Study|No prior immunization records|17|||
161932799|NCT03180138|584802377|FG001|Overall Study|No prior immunization records|0|||
161932800|NCT03180138|584802378|FG002|Overall Study|No prior immunization records|6|||
161932801|NCT03180138|584802376|FG000|Overall Study|Found to be >24 mon after randomization|3|||
161932802|NCT03180138|584802377|FG001|Overall Study|Found to be >24 mon after randomization|0|||
161932803|NCT03180138|584802378|FG002|Overall Study|Found to be >24 mon after randomization|3|||
161932804|NCT01260311|584802381|FG000|Overall Study|Adverse Event|11|||
161932805|NCT01260311|584802381|FG000|Overall Study|Lack of Efficacy|4|||
161932806|NCT01260311|584802381|FG000|Overall Study|Lost to Follow-up|25|||
161932807|NCT01260311|584802381|FG000|Overall Study|Withdrawal by Subject|6|||
161932808|NCT01260311|584802381|FG000|Overall Study|Financial Constraints|77|||
161932809|NCT01260311|584802381|FG000|Overall Study|Gone to Province|2|||
161932810|NCT01260311|584802381|FG000|Overall Study|Medication Stopped|1|||
161932811|NCT01260311|584802381|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
161932812|NCT01340170|584802382|FG000|Overall Study|Lost to Follow-up|2|||
161932813|NCT01340170|584802383|FG001|Overall Study|Lost to Follow-up|4|||
161932814|NCT01340170|584802384|FG002|Overall Study|Lost to Follow-up|0|||
161932815|NCT01340170|584802382|FG000|Overall Study|Implant failure|1|||
161932816|NCT01340170|584802383|FG001|Overall Study|Implant failure|3|||
161932817|NCT01340170|584802384|FG002|Overall Study|Implant failure|0|||
161932818|NCT03878602|584802385|FG000|Overall Study|cord blood donation|7|||
161932819|NCT03878602|584802386|FG001|Overall Study|cord blood donation|1|||
161932820|NCT03878602|584802385|FG000|Overall Study|incomplete data collection|2|||
161932821|NCT03878602|584802386|FG001|Overall Study|incomplete data collection|0|||
161932822|NCT02633527|584802387|FG000|Overall Study|Failed to meet eligibility|0|||
161932823|NCT02633527|584802388|FG001|Overall Study|Failed to meet eligibility|1|||
161932824|NCT02633527|584802389|FG002|Overall Study|Failed to meet eligibility|1|||
161932825|NCT02633527|584802390|FG003|Overall Study|Failed to meet eligibility|0|||
161932826|NCT02633527|584802391|FG004|Overall Study|Failed to meet eligibility|1|||
161932827|NCT02633527|584802387|FG000|Overall Study|Adverse Event|0|||
161932828|NCT02633527|584802388|FG001|Overall Study|Adverse Event|4|||
161932829|NCT02633527|584802389|FG002|Overall Study|Adverse Event|3|||
161932830|NCT02633527|584802390|FG003|Overall Study|Adverse Event|1|||
161932831|NCT02633527|584802391|FG004|Overall Study|Adverse Event|5|||
161932832|NCT02633527|584802387|FG000|Overall Study|Lost to Follow-up|1|||
161932833|NCT02633527|584802388|FG001|Overall Study|Lost to Follow-up|2|||
161932834|NCT02633527|584802389|FG002|Overall Study|Lost to Follow-up|5|||
161932835|NCT02633527|584802390|FG003|Overall Study|Lost to Follow-up|5|||
161932836|NCT02633527|584802391|FG004|Overall Study|Lost to Follow-up|4|||
161932837|NCT02633527|584802387|FG000|Overall Study|Withdrawal by Subject|0|||
161932838|NCT02633527|584802388|FG001|Overall Study|Withdrawal by Subject|3|||
161932839|NCT02633527|584802389|FG002|Overall Study|Withdrawal by Subject|5|||
161932840|NCT02633527|584802390|FG003|Overall Study|Withdrawal by Subject|4|||
161932841|NCT02633527|584802391|FG004|Overall Study|Withdrawal by Subject|4|||
161932842|NCT02633527|584802387|FG000|Overall Study|Protocol Violation|0|||
161932843|NCT02633527|584802388|FG001|Overall Study|Protocol Violation|1|||
161932844|NCT02633527|584802389|FG002|Overall Study|Protocol Violation|1|||
161932845|NCT02633527|584802390|FG003|Overall Study|Protocol Violation|1|||
161932846|NCT02633527|584802391|FG004|Overall Study|Protocol Violation|1|||
161932847|NCT02633527|584802387|FG000|Overall Study|Physician Decision|0|||
161932848|NCT02633527|584802388|FG001|Overall Study|Physician Decision|0|||
161932849|NCT02633527|584802389|FG002|Overall Study|Physician Decision|0|||
161932850|NCT02633527|584802390|FG003|Overall Study|Physician Decision|0|||
161932851|NCT02633527|584802391|FG004|Overall Study|Physician Decision|1|||
161932852|NCT02633527|584802387|FG000|Overall Study|Administrative reason|1|||
161932853|NCT02633527|584802388|FG001|Overall Study|Administrative reason|0|||
161932854|NCT02633527|584802389|FG002|Overall Study|Administrative reason|0|||
161932855|NCT02633527|584802390|FG003|Overall Study|Administrative reason|1|||
161932856|NCT02633527|584802391|FG004|Overall Study|Administrative reason|0|||
161932857|NCT02633527|584802387|FG000|Overall Study|Multiple reasons|1|||
161932858|NCT02633527|584802388|FG001|Overall Study|Multiple reasons|0|||
161932859|NCT02633527|584802389|FG002|Overall Study|Multiple reasons|2|||
161932860|NCT02633527|584802390|FG003|Overall Study|Multiple reasons|2|||
161932861|NCT02633527|584802391|FG004|Overall Study|Multiple reasons|1|||
161932862|NCT06091956|584802392|FG000|Overall Study|Withdrawal by Subject|1|||
161932863|NCT06091956|584802392|FG000|Overall Study|Complicating Disease|1|||
161932864|NCT02176525|584802395|FG000|Overall Study|Adverse Event|0|||
161932865|NCT02176525|584802396|FG001|Overall Study|Adverse Event|0|||
161932866|NCT02176525|584802397|FG002|Overall Study|Adverse Event|0|||
161932867|NCT02176525|584802398|FG003|Overall Study|Adverse Event|1|||
161932868|NCT02176525|584802399|FG004|Overall Study|Adverse Event|1|||
161932869|NCT02176525|584802400|FG005|Overall Study|Adverse Event|0|||
161932870|NCT02176525|584802401|FG006|Overall Study|Adverse Event|1|||
161932871|NCT02176525|584802402|FG007|Overall Study|Adverse Event|0|||
161932872|NCT02176525|584802395|FG000|Overall Study|not treated|1|||
161932873|NCT02176525|584802396|FG001|Overall Study|not treated|0|||
161932874|NCT02176525|584802397|FG002|Overall Study|not treated|0|||
161932875|NCT02176525|584802398|FG003|Overall Study|not treated|0|||
161932876|NCT02176525|584802399|FG004|Overall Study|not treated|0|||
161932877|NCT02176525|584802400|FG005|Overall Study|not treated|1|||
161932878|NCT02176525|584802401|FG006|Overall Study|not treated|0|||
161932879|NCT02176525|584802402|FG007|Overall Study|not treated|0|||
161932880|NCT02100644|584802405|FG000|LTG Escalation Phase|Adverse Event|9|||
161932881|NCT02100644|584802406|FG001|LTG Escalation Phase|Adverse Event|0|||
161932882|NCT02100644|584802407|FG002|LTG Escalation Phase|Adverse Event|0|||
161932883|NCT02100644|584802405|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
161932884|NCT02100644|584802406|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
161932885|NCT02100644|584802407|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
161932886|NCT02100644|584802405|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
161932887|NCT02100644|584802406|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
161932888|NCT02100644|584802407|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
161932889|NCT00478140|584802408|FG000|Overall Study|Clinical Disease Progression|1|||
161932890|NCT03163264|584802412|FG000|Overall Study|Withdrawal by Subject|13|||
161932891|NCT03163264|584802413|FG001|Overall Study|Withdrawal by Subject|3|||
161932892|NCT03163264|584802414|FG002|Overall Study|Withdrawal by Subject|4|||
161932893|NCT03163264|584802415|FG003|Overall Study|Withdrawal by Subject|2|||
161932894|NCT03163264|584802412|FG000|Overall Study|Lost to Follow-up|17|||
161932895|NCT03163264|584802413|FG001|Overall Study|Lost to Follow-up|20|||
161932896|NCT03163264|584802414|FG002|Overall Study|Lost to Follow-up|0|||
161932897|NCT03163264|584802415|FG003|Overall Study|Lost to Follow-up|0|||
161932898|NCT03163264|584802412|FG000|Overall Study|Death|0|||
161932899|NCT03163264|584802413|FG001|Overall Study|Death|2|||
161932900|NCT03163264|584802414|FG002|Overall Study|Death|0|||
161932901|NCT03163264|584802415|FG003|Overall Study|Death|0|||
161932902|NCT02614066|584802416|FG000|Overall Study|Death|6|||
161932903|NCT02614066|584802417|FG001|Overall Study|Death|14|||
161932904|NCT02614066|584802418|FG002|Overall Study|Death|11|||
161932905|NCT02614066|584802419|FG003|Overall Study|Death|29|||
161932906|NCT02614066|584802416|FG000|Overall Study|Full consent withdrawn|0|||
161932907|NCT02614066|584802417|FG001|Overall Study|Full consent withdrawn|1|||
161932908|NCT02614066|584802418|FG002|Overall Study|Full consent withdrawn|0|||
161932909|NCT02614066|584802419|FG003|Overall Study|Full consent withdrawn|8|||
161932910|NCT02614066|584802416|FG000|Overall Study|Lost to Follow-up|0|||
161932911|NCT02614066|584802417|FG001|Overall Study|Lost to Follow-up|2|||
161932912|NCT02614066|584802418|FG002|Overall Study|Lost to Follow-up|2|||
161932913|NCT02614066|584802419|FG003|Overall Study|Lost to Follow-up|2|||
161932914|NCT02614066|584802416|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
161932915|NCT02614066|584802417|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
161932916|NCT02614066|584802418|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
161932917|NCT02614066|584802419|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
161932918|NCT02614066|584802416|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
161932919|NCT02614066|584802417|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
161932920|NCT02614066|584802418|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
161932921|NCT02614066|584802419|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
161932922|NCT02614066|584802416|FG000|Overall Study|Reason not specified|0|||
161932923|NCT02614066|584802417|FG001|Overall Study|Reason not specified|2|||
161932924|NCT02614066|584802418|FG002|Overall Study|Reason not specified|1|||
161932925|NCT02614066|584802419|FG003|Overall Study|Reason not specified|1|||
161932926|NCT04565756|584802420|FG000|Overall Study|Withdrawal by Subject|0|||
161932927|NCT04565756|584802421|FG001|Overall Study|Withdrawal by Subject|0|||
161677487|NCT00467779|583872011|FG011|Stage 3|Death|0|||
161932928|NCT04565756|584802422|FG002|Overall Study|Withdrawal by Subject|0|||
161932929|NCT04565756|584802423|FG003|Overall Study|Withdrawal by Subject|0|||
161932930|NCT04565756|584802424|FG004|Overall Study|Withdrawal by Subject|1|||
161932931|NCT04565756|584802425|FG005|Overall Study|Withdrawal by Subject|0|||
161932932|NCT04565756|584802420|FG000|Overall Study|Protocol Violation|0|||
161932933|NCT04565756|584802421|FG001|Overall Study|Protocol Violation|0|||
161932934|NCT04565756|584802422|FG002|Overall Study|Protocol Violation|0|||
161932935|NCT04565756|584802423|FG003|Overall Study|Protocol Violation|0|||
161932936|NCT04565756|584802424|FG004|Overall Study|Protocol Violation|0|||
161932937|NCT04565756|584802425|FG005|Overall Study|Protocol Violation|1|||
161932938|NCT00968968|584802430|FG000|Overall Study|Study closed/terminated|10|||
161932939|NCT00968968|584802431|FG001|Overall Study|Study closed/terminated|10|||
161932940|NCT00968968|584802430|FG000|Overall Study|Protocol defined stopping criteria|3|||
161932941|NCT00968968|584802431|FG001|Overall Study|Protocol defined stopping criteria|1|||
161932942|NCT00968968|584802430|FG000|Overall Study|Withdrawal by Subject|2|||
161932943|NCT00968968|584802431|FG001|Overall Study|Withdrawal by Subject|0|||
161932944|NCT00968968|584802430|FG000|Overall Study|Physician Decision|1|||
161932945|NCT00968968|584802431|FG001|Overall Study|Physician Decision|2|||
161932946|NCT00968968|584802430|FG000|Overall Study|Lost to Follow-up|0|||
161932947|NCT00968968|584802431|FG001|Overall Study|Lost to Follow-up|1|||
161932948|NCT04401293|584802432|FG000|Overall Study|Withdrawal by Subject|1|||
161932949|NCT04401293|584802433|FG001|Overall Study|Withdrawal by Subject|3|||
161932950|NCT01026038|584802434|FG000|Overall Study|Lost to Follow-up|1|||
161932951|NCT01026038|584802435|FG001|Overall Study|Lost to Follow-up|1|||
161932952|NCT01026038|584802436|FG002|Overall Study|Lost to Follow-up|0|||
161932953|NCT03679884|584802437|FG000|Overall Study|Other|12|||
161932954|NCT03679884|584802438|FG001|Overall Study|Other|12|||
161932955|NCT03679884|584802439|FG002|Overall Study|Other|12|||
161932956|NCT03679884|584802440|FG003|Overall Study|Other|7|||
161932957|NCT03679884|584802441|FG004|Overall Study|Other|8|||
161932958|NCT03679884|584802437|FG000|Overall Study|Lack of Efficacy|15|||
161932959|NCT03679884|584802438|FG001|Overall Study|Lack of Efficacy|29|||
161932960|NCT03679884|584802439|FG002|Overall Study|Lack of Efficacy|13|||
161932961|NCT03679884|584802440|FG003|Overall Study|Lack of Efficacy|29|||
161520085|NCT03321981|583292587|FG000|Overall Study|Adverse Event|0|||
161589050|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589051|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589052|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589053|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589054|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589055|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589056|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589057|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589058|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161589059|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
161589060|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
161824514|NCT00108082|584399817|FG001|Overall Study|Consent Withdrawn|3|||
161824515|NCT00108082|584399818|FG002|Overall Study|Consent Withdrawn|5|||
161824516|NCT00108082|584399816|FG000|Overall Study|Protocol Violation|1|||
161824517|NCT00108082|584399817|FG001|Overall Study|Protocol Violation|2|||
161824518|NCT00108082|584399818|FG002|Overall Study|Protocol Violation|0|||
161824519|NCT00108082|584399816|FG000|Overall Study|Lack of Efficacy|3|||
161824520|NCT00108082|584399817|FG001|Overall Study|Lack of Efficacy|1|||
161824521|NCT00108082|584399818|FG002|Overall Study|Lack of Efficacy|2|||
161824522|NCT00108082|584399816|FG000|Overall Study|Amendment 4: > Month 12|5|||
161824523|NCT00108082|584399817|FG001|Overall Study|Amendment 4: > Month 12|7|||
161824524|NCT00108082|584399818|FG002|Overall Study|Amendment 4: > Month 12|5|||
161824525|NCT00108082|584399816|FG000|Overall Study|Woman of Child-bearing Potential|2|||
161824526|NCT00108082|584399817|FG001|Overall Study|Woman of Child-bearing Potential|0|||
161824527|NCT00108082|584399818|FG002|Overall Study|Woman of Child-bearing Potential|2|||
161824528|NCT00108082|584399816|FG000|Overall Study|Incorrectly Randomized|0|||
161824529|NCT00108082|584399817|FG001|Overall Study|Incorrectly Randomized|0|||
161824530|NCT00108082|584399818|FG002|Overall Study|Incorrectly Randomized|2|||
161824531|NCT00108082|584399816|FG000|Overall Study|Non-compliance|1|||
161824532|NCT00108082|584399817|FG001|Overall Study|Non-compliance|0|||
161824533|NCT00108082|584399818|FG002|Overall Study|Non-compliance|2|||
161824534|NCT00108082|584399816|FG000|Overall Study|Stopped Study Medication|0|||
161932962|NCT03679884|584802441|FG004|Overall Study|Lack of Efficacy|10|||
161520086|NCT03321981|583292588|FG001|Overall Study|Adverse Event|0|||
161520087|NCT03321981|583292589|FG002|Overall Study|Adverse Event|2|||
161520088|NCT03321981|583292587|FG000|Overall Study|symptomatic deterioration|0|||
161520089|NCT03321981|583292588|FG001|Overall Study|symptomatic deterioration|1|||
161520090|NCT03321981|583292589|FG002|Overall Study|symptomatic deterioration|1|||
161520091|NCT03321981|583292587|FG000|Overall Study|Lack of compliance|0|||
161520092|NCT03321981|583292588|FG001|Overall Study|Lack of compliance|1|||
161520093|NCT03321981|583292589|FG002|Overall Study|Lack of compliance|0|||
161520094|NCT03321981|583292587|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
161520095|NCT03321981|583292588|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
161520096|NCT03321981|583292589|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
161932963|NCT03679884|584802437|FG000|Overall Study|Death|1|||
161932964|NCT03679884|584802438|FG001|Overall Study|Death|0|||
161932965|NCT03679884|584802439|FG002|Overall Study|Death|0|||
161932966|NCT03679884|584802440|FG003|Overall Study|Death|0|||
161932967|NCT03679884|584802441|FG004|Overall Study|Death|0|||
161932968|NCT03679884|584802437|FG000|Overall Study|Adverse Event|2|||
161589061|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
161589062|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
161589063|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589064|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589065|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589066|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161677488|NCT00467779|583872012|FG012|Stage 3|Death|0|||
161677489|NCT00467779|583872013|FG013|Stage 3|Death|0|||
161677490|NCT00467779|583872014|FG014|Stage 3|Death|1|||
161677491|NCT00467779|583872000|FG000|Stage 3|Disease Progression|0|||
161677492|NCT00467779|583872001|FG001|Stage 3|Disease Progression|0|||
161677493|NCT00467779|583872002|FG002|Stage 3|Disease Progression|0|||
161677494|NCT00467779|583872003|FG003|Stage 3|Disease Progression|0|||
161677495|NCT00467779|583872004|FG004|Stage 3|Disease Progression|0|||
161677496|NCT00467779|583872005|FG005|Stage 3|Disease Progression|0|||
161677497|NCT00467779|583872006|FG006|Stage 3|Disease Progression|0|||
161677498|NCT00467779|583872007|FG007|Stage 3|Disease Progression|0|||
161677499|NCT00467779|583872008|FG008|Stage 3|Disease Progression|0|||
161677500|NCT00467779|583872009|FG009|Stage 3|Disease Progression|0|||
161677501|NCT00467779|583872010|FG010|Stage 3|Disease Progression|0|||
161677502|NCT00467779|583872011|FG011|Stage 3|Disease Progression|0|||
161677503|NCT00467779|583872012|FG012|Stage 3|Disease Progression|0|||
161932969|NCT03679884|584802438|FG001|Overall Study|Adverse Event|10|||
161932970|NCT03679884|584802439|FG002|Overall Study|Adverse Event|9|||
161932971|NCT03679884|584802440|FG003|Overall Study|Adverse Event|6|||
161932972|NCT03679884|584802441|FG004|Overall Study|Adverse Event|6|||
161932973|NCT03679884|584802437|FG000|Overall Study|Withdrawal by Subject|12|||
161932974|NCT03679884|584802438|FG001|Overall Study|Withdrawal by Subject|23|||
161932975|NCT03679884|584802439|FG002|Overall Study|Withdrawal by Subject|8|||
161932976|NCT03679884|584802440|FG003|Overall Study|Withdrawal by Subject|8|||
161589067|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589068|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589069|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589070|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589071|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161589072|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
161589073|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
161589074|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
161589075|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
161589076|NCT01261312|583544585|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589077|NCT01261312|583544586|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589078|NCT01261312|583544587|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589079|NCT01261312|583544588|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589080|NCT01261312|583544589|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589081|NCT01261312|583544590|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589082|NCT01261312|583544591|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589083|NCT01261312|583544592|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589084|NCT01261312|583544593|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161589085|NCT01261312|583544594|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161589086|NCT01261312|583544595|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161589087|NCT01261312|583544596|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161589088|NCT01261312|583544597|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
161589089|NCT03336333|583544598|FG000|Overall Study|Remained on study at time of data cut-off|202|||
161589090|NCT03336333|583544599|FG001|Overall Study|Remained on study at time of data cut-off|219|||
161589091|NCT03336333|583544600|FG002|Overall Study|Remained on study at time of data cut-off|102|||
161589092|NCT03336333|583544598|FG000|Overall Study|Death|14|||
161589093|NCT03336333|583544599|FG001|Overall Study|Death|16|||
161589094|NCT03336333|583544600|FG002|Overall Study|Death|8|||
161589095|NCT03336333|583544598|FG000|Overall Study|Withdrawal by Subject|16|||
161589096|NCT03336333|583544599|FG001|Overall Study|Withdrawal by Subject|5|||
161589097|NCT03336333|583544600|FG002|Overall Study|Withdrawal by Subject|1|||
161589098|NCT03336333|583544598|FG000|Overall Study|Physician Decision|5|||
161589099|NCT03336333|583544599|FG001|Overall Study|Physician Decision|1|||
161677504|NCT00467779|583872013|FG013|Stage 3|Disease Progression|0|||
161677505|NCT00467779|583872014|FG014|Stage 3|Disease Progression|9|||
161677506|NCT00467779|583872000|FG000|Stage 3|Unspecified Reason|0|||
161932977|NCT03679884|584802441|FG004|Overall Study|Withdrawal by Subject|9|||
161677507|NCT00467779|583872001|FG001|Stage 3|Unspecified Reason|0|||
161932978|NCT03679884|584802437|FG000|Overall Study|Lost to Follow-up|1|||
161932979|NCT03679884|584802438|FG001|Overall Study|Lost to Follow-up|4|||
161677508|NCT00467779|583872002|FG002|Stage 3|Unspecified Reason|0|||
161932980|NCT03679884|584802439|FG002|Overall Study|Lost to Follow-up|2|||
161932981|NCT03679884|584802440|FG003|Overall Study|Lost to Follow-up|0|||
161932982|NCT03679884|584802441|FG004|Overall Study|Lost to Follow-up|3|||
161932983|NCT01783938|584802450|FG000|Overall Study|Disease Progression|18|||
161932984|NCT01783938|584802451|FG001|Overall Study|Disease Progression|41|||
161932985|NCT01783938|584802450|FG000|Overall Study|Study Drug Toxicity|27|||
161932986|NCT01783938|584802451|FG001|Overall Study|Study Drug Toxicity|14|||
161932987|NCT01783938|584802450|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
161932988|NCT01783938|584802451|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
161932989|NCT01783938|584802450|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
161932990|NCT01783938|584802451|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
161932991|NCT01783938|584802450|FG000|Overall Study|Participant Withdrew Consent|2|||
161932992|NCT01783938|584802451|FG001|Overall Study|Participant Withdrew Consent|0|||
161932993|NCT01783938|584802450|FG000|Overall Study|Maximum Clinical Benefit|1|||
161932994|NCT01783938|584802451|FG001|Overall Study|Maximum Clinical Benefit|0|||
161932995|NCT01783938|584802450|FG000|Overall Study|Other Reasons|3|||
161932996|NCT01783938|584802451|FG001|Overall Study|Other Reasons|1|||
161932997|NCT00930176|584802453|FG000|Overall Study|Death|1|||
161932998|NCT01712074|584802458|FG000|Placebo Run-in Period|Adverse Event|2|||
161932999|NCT01712074|584802459|FG001|Placebo Run-in Period|Adverse Event|0|||
161933000|NCT01712074|584802460|FG002|Placebo Run-in Period|Adverse Event|0|||
161933001|NCT01712074|584802458|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
161933002|NCT01712074|584802459|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
161933003|NCT01712074|584802460|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
161933004|NCT01712074|584802458|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
161824535|NCT00108082|584399817|FG001|Overall Study|Stopped Study Medication|0|||
161824536|NCT00108082|584399818|FG002|Overall Study|Stopped Study Medication|1|||
161824537|NCT00108082|584399816|FG000|Overall Study|Site Closed Study|0|||
161824538|NCT00108082|584399817|FG001|Overall Study|Site Closed Study|2|||
161824539|NCT00108082|584399818|FG002|Overall Study|Site Closed Study|0|||
161824540|NCT00108082|584399816|FG000|Overall Study|Protocol Amendment|0|||
161824541|NCT00108082|584399817|FG001|Overall Study|Protocol Amendment|1|||
161824542|NCT00108082|584399818|FG002|Overall Study|Protocol Amendment|0|||
161824543|NCT00108082|584399816|FG000|Overall Study|Study Medication Not Tapered|0|||
161824544|NCT00108082|584399817|FG001|Overall Study|Study Medication Not Tapered|1|||
161824545|NCT00108082|584399818|FG002|Overall Study|Study Medication Not Tapered|0|||
161824546|NCT00108082|584399816|FG000|Overall Study|Subject Left Site Location|1|||
161824547|NCT00108082|584399817|FG001|Overall Study|Subject Left Site Location|0|||
161824548|NCT00108082|584399818|FG002|Overall Study|Subject Left Site Location|0|||
161824549|NCT00108082|584399816|FG000|Overall Study|Investigator Not at Site|1|||
161824550|NCT00108082|584399817|FG001|Overall Study|Investigator Not at Site|0|||
161824551|NCT00108082|584399818|FG002|Overall Study|Investigator Not at Site|0|||
161824552|NCT00108082|584399816|FG000|Overall Study|Blood Pressure Not Controlled|1|||
161824553|NCT00108082|584399817|FG001|Overall Study|Blood Pressure Not Controlled|0|||
161824554|NCT00108082|584399818|FG002|Overall Study|Blood Pressure Not Controlled|0|||
161824555|NCT01091103|584399822|FG000|Overall Study|Adverse Event|1|||
161824556|NCT01091103|584399822|FG000|Overall Study|Progressive Disease|3|||
161824557|NCT01270620|584399823|FG000|Overall Study|Withdrawal by Subject|1|||
161824558|NCT01270620|584399824|FG001|Overall Study|Withdrawal by Subject|3|||
161824559|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
161824560|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
161824561|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
161824562|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
161824563|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
161824564|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
161824565|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
161824566|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
161824567|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
161824568|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
161824569|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
161824570|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
161824571|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
161824572|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
161824573|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
161824574|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
161824575|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
161933005|NCT01712074|584802459|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
161933006|NCT01712074|584802460|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
161824576|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
161824577|NCT00348816|584399827|FG000|Overall Study|Noncompliance with radiation treatment|1|||
161824578|NCT00809965|584399828|FG000|Overall Study|Death|194|||
161824579|NCT00809965|584399829|FG001|Overall Study|Death|147|||
161520097|NCT03321981|583292587|FG000|Overall Study|Death|0|||
161520098|NCT03321981|583292588|FG001|Overall Study|Death|1|||
161520099|NCT03321981|583292589|FG002|Overall Study|Death|0|||
161520100|NCT03321981|583292587|FG000|Overall Study|Subject withdrawal of investigational product|0|||
161520101|NCT03321981|583292588|FG001|Overall Study|Subject withdrawal of investigational product|1|||
161520102|NCT03321981|583292589|FG002|Overall Study|Subject withdrawal of investigational product|0|||
161520103|NCT03321981|583292587|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
161520104|NCT03321981|583292588|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
161520105|NCT03321981|583292589|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
161520106|NCT03321981|583292587|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
161520107|NCT03321981|583292588|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
161520108|NCT03321981|583292589|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
161824580|NCT00809965|584399830|FG002|Overall Study|Death|196|||
161824581|NCT00809965|584399828|FG000|Overall Study|Lost to Follow-up|17|||
161824582|NCT00809965|584399829|FG001|Overall Study|Lost to Follow-up|10|||
161824583|NCT00809965|584399830|FG002|Overall Study|Lost to Follow-up|18|||
161824584|NCT00809965|584399828|FG000|Overall Study|Withdrawal by Subject|405|||
161824585|NCT00809965|584399829|FG001|Overall Study|Withdrawal by Subject|448|||
161824586|NCT00809965|584399830|FG002|Overall Study|Withdrawal by Subject|441|||
161824587|NCT00809965|584399828|FG000|Overall Study|Other Reason|167|||
161824588|NCT00809965|584399829|FG001|Overall Study|Other Reason|170|||
161824589|NCT00809965|584399830|FG002|Overall Study|Other Reason|189|||
161824590|NCT02780167|584399831|FG000|Overall Study|Adverse Event|9|||
161824591|NCT02780167|584399832|FG001|Overall Study|Adverse Event|8|||
161824592|NCT02780167|584399833|FG002|Overall Study|Adverse Event|8|||
161824593|NCT02780167|584399834|FG003|Overall Study|Adverse Event|12|||
161824594|NCT02780167|584399835|FG004|Overall Study|Adverse Event|8|||
161824595|NCT02780167|584399831|FG000|Overall Study|Lack of Efficacy|6|||
161824596|NCT02780167|584399832|FG001|Overall Study|Lack of Efficacy|5|||
161824597|NCT02780167|584399833|FG002|Overall Study|Lack of Efficacy|6|||
161824598|NCT02780167|584399834|FG003|Overall Study|Lack of Efficacy|1|||
161824599|NCT02780167|584399835|FG004|Overall Study|Lack of Efficacy|0|||
161824600|NCT02780167|584399831|FG000|Overall Study|Lost to Follow-up|2|||
161824601|NCT02780167|584399832|FG001|Overall Study|Lost to Follow-up|0|||
161824602|NCT02780167|584399833|FG002|Overall Study|Lost to Follow-up|1|||
161824603|NCT02780167|584399834|FG003|Overall Study|Lost to Follow-up|0|||
161824604|NCT02780167|584399835|FG004|Overall Study|Lost to Follow-up|0|||
161824605|NCT02780167|584399831|FG000|Overall Study|Does not meet entrance criteria|0|||
161824606|NCT02780167|584399832|FG001|Overall Study|Does not meet entrance criteria|0|||
161824607|NCT02780167|584399833|FG002|Overall Study|Does not meet entrance criteria|1|||
161824608|NCT02780167|584399834|FG003|Overall Study|Does not meet entrance criteria|0|||
161824609|NCT02780167|584399835|FG004|Overall Study|Does not meet entrance criteria|0|||
161824610|NCT02780167|584399831|FG000|Overall Study|No longer meets eligibility criteria|0|||
161824611|NCT02780167|584399832|FG001|Overall Study|No longer meets eligibility criteria|0|||
161824612|NCT02780167|584399833|FG002|Overall Study|No longer meets eligibility criteria|0|||
161824613|NCT02780167|584399834|FG003|Overall Study|No longer meets eligibility criteria|1|||
161824614|NCT02780167|584399835|FG004|Overall Study|No longer meets eligibility criteria|1|||
161824615|NCT02780167|584399831|FG000|Overall Study|Protocol Violation|5|||
161824616|NCT02780167|584399832|FG001|Overall Study|Protocol Violation|5|||
161824617|NCT02780167|584399833|FG002|Overall Study|Protocol Violation|1|||
161824618|NCT02780167|584399834|FG003|Overall Study|Protocol Violation|1|||
161824619|NCT02780167|584399835|FG004|Overall Study|Protocol Violation|2|||
161824620|NCT02780167|584399831|FG000|Overall Study|Withdrawal by Subject|6|||
161824621|NCT02780167|584399832|FG001|Overall Study|Withdrawal by Subject|4|||
161824622|NCT02780167|584399833|FG002|Overall Study|Withdrawal by Subject|4|||
161824623|NCT02780167|584399834|FG003|Overall Study|Withdrawal by Subject|3|||
161824624|NCT02780167|584399835|FG004|Overall Study|Withdrawal by Subject|4|||
161824625|NCT02780167|584399831|FG000|Overall Study|Other|0|||
161824626|NCT02780167|584399832|FG001|Overall Study|Other|0|||
161824627|NCT02780167|584399833|FG002|Overall Study|Other|3|||
161824628|NCT02780167|584399834|FG003|Overall Study|Other|1|||
161824629|NCT02780167|584399835|FG004|Overall Study|Other|2|||
161824630|NCT05552261|584399837|FG000|Overall Study|Withdrawal by Subject|1|||
161824631|NCT05552261|584399837|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
161824632|NCT02315066|584399838|FG000|Overall Study|Lost to Follow-up|0|||
161824633|NCT02315066|584399839|FG001|Overall Study|Lost to Follow-up|1|||
161824634|NCT02315066|584399840|FG002|Overall Study|Lost to Follow-up|1|||
161824635|NCT02315066|584399841|FG003|Overall Study|Lost to Follow-up|0|||
161824636|NCT02315066|584399842|FG004|Overall Study|Lost to Follow-up|1|||
161824637|NCT02315066|584399843|FG005|Overall Study|Lost to Follow-up|0|||
161824638|NCT02315066|584399844|FG006|Overall Study|Lost to Follow-up|2|||
161824639|NCT02315066|584399845|FG007|Overall Study|Lost to Follow-up|1|||
161824640|NCT02315066|584399846|FG008|Overall Study|Lost to Follow-up|0|||
161520109|NCT03880578|583292590|FG000|Overall Study|Withdrawal by Subject|0|||
161520110|NCT03880578|583292591|FG001|Overall Study|Withdrawal by Subject|3|||
161520111|NCT03880578|583292592|FG002|Overall Study|Withdrawal by Subject|1|||
161520112|NCT03880578|583292590|FG000|Overall Study|Death|0|||
161520113|NCT03880578|583292591|FG001|Overall Study|Death|1|||
161520114|NCT03880578|583292592|FG002|Overall Study|Death|0|||
161520115|NCT04934670|583292593|FG000|Overall Study|Death|4|||
161520116|NCT04934670|583292594|FG001|Overall Study|Death|0|||
161520117|NCT04934670|583292593|FG000|Overall Study|Lost to Follow-up|1|||
161520118|NCT04934670|583292594|FG001|Overall Study|Lost to Follow-up|4|||
161520119|NCT00856583|583292595|FG000|Overall Study|Lack of Efficacy|389|||
161520120|NCT00856583|583292596|FG001|Overall Study|Lack of Efficacy|377|||
161520121|NCT00856583|583292595|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
161520122|NCT00856583|583292596|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
161520123|NCT00856583|583292595|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
161520124|NCT00856583|583292596|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
161520125|NCT00856583|583292595|FG000|Overall Study|Non-compliance|305|||
161520126|NCT00856583|583292596|FG001|Overall Study|Non-compliance|262|||
161520127|NCT00856583|583292595|FG000|Overall Study|Withdrawal by Subject|1092|||
161520128|NCT00856583|583292596|FG001|Overall Study|Withdrawal by Subject|919|||
161520129|NCT00856583|583292595|FG000|Overall Study|Physician Decision|59|||
161520130|NCT00856583|583292596|FG001|Overall Study|Physician Decision|82|||
161520131|NCT00856583|583292595|FG000|Overall Study|Pregnancy|14|||
161520132|NCT00856583|583292596|FG001|Overall Study|Pregnancy|5|||
161520133|NCT00856583|583292595|FG000|Overall Study|Other|92|||
161520134|NCT00856583|583292596|FG001|Overall Study|Other|104|||
161677509|NCT00467779|583872003|FG003|Stage 3|Unspecified Reason|0|||
161824641|NCT02315066|584399847|FG009|Overall Study|Lost to Follow-up|0|||
161824642|NCT02315066|584399848|FG010|Overall Study|Lost to Follow-up|1|||
161824643|NCT02315066|584399849|FG011|Overall Study|Lost to Follow-up|2|||
161824644|NCT02315066|584399850|FG012|Overall Study|Lost to Follow-up|0|||
161824645|NCT02315066|584399851|FG013|Overall Study|Lost to Follow-up|4|||
161824646|NCT02315066|584399838|FG000|Overall Study|Death|2|||
161824647|NCT02315066|584399839|FG001|Overall Study|Death|7|||
161824648|NCT02315066|584399840|FG002|Overall Study|Death|6|||
161824649|NCT02315066|584399841|FG003|Overall Study|Death|11|||
161824650|NCT02315066|584399842|FG004|Overall Study|Death|10|||
161824651|NCT02315066|584399843|FG005|Overall Study|Death|3|||
161824652|NCT02315066|584399844|FG006|Overall Study|Death|9|||
161824653|NCT02315066|584399845|FG007|Overall Study|Death|9|||
161824654|NCT02315066|584399846|FG008|Overall Study|Death|10|||
161824655|NCT02315066|584399847|FG009|Overall Study|Death|8|||
161824656|NCT02315066|584399848|FG010|Overall Study|Death|10|||
161824657|NCT02315066|584399849|FG011|Overall Study|Death|7|||
161824658|NCT02315066|584399850|FG012|Overall Study|Death|8|||
161824659|NCT02315066|584399851|FG013|Overall Study|Death|21|||
161824660|NCT02315066|584399838|FG000|Overall Study|Other|0|||
161824661|NCT02315066|584399839|FG001|Overall Study|Other|0|||
161824662|NCT02315066|584399840|FG002|Overall Study|Other|0|||
161824663|NCT02315066|584399841|FG003|Overall Study|Other|0|||
161824664|NCT02315066|584399842|FG004|Overall Study|Other|0|||
161824665|NCT02315066|584399843|FG005|Overall Study|Other|0|||
161824666|NCT02315066|584399844|FG006|Overall Study|Other|0|||
161824667|NCT02315066|584399845|FG007|Overall Study|Other|1|||
161824668|NCT02315066|584399846|FG008|Overall Study|Other|1|||
161824669|NCT02315066|584399847|FG009|Overall Study|Other|2|||
161824670|NCT02315066|584399848|FG010|Overall Study|Other|0|||
161824671|NCT02315066|584399849|FG011|Overall Study|Other|0|||
161824672|NCT02315066|584399850|FG012|Overall Study|Other|0|||
161824673|NCT02315066|584399851|FG013|Overall Study|Other|0|||
161824674|NCT02315066|584399838|FG000|Overall Study|Subject refused further follow-up|0|||
161824675|NCT02315066|584399839|FG001|Overall Study|Subject refused further follow-up|2|||
161824676|NCT02315066|584399840|FG002|Overall Study|Subject refused further follow-up|2|||
161824677|NCT02315066|584399841|FG003|Overall Study|Subject refused further follow-up|0|||
161824678|NCT02315066|584399842|FG004|Overall Study|Subject refused further follow-up|0|||
161824679|NCT02315066|584399843|FG005|Overall Study|Subject refused further follow-up|0|||
161824680|NCT02315066|584399844|FG006|Overall Study|Subject refused further follow-up|2|||
161824681|NCT02315066|584399845|FG007|Overall Study|Subject refused further follow-up|3|||
161824682|NCT02315066|584399846|FG008|Overall Study|Subject refused further follow-up|0|||
161824683|NCT02315066|584399847|FG009|Overall Study|Subject refused further follow-up|1|||
161824684|NCT02315066|584399848|FG010|Overall Study|Subject refused further follow-up|1|||
161824685|NCT02315066|584399849|FG011|Overall Study|Subject refused further follow-up|2|||
161824686|NCT02315066|584399850|FG012|Overall Study|Subject refused further follow-up|2|||
161824687|NCT02315066|584399851|FG013|Overall Study|Subject refused further follow-up|4|||
161824688|NCT02315066|584399838|FG000|Overall Study|Study ongoing at date of cut-off|0|||
161520135|NCT00856583|583292595|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
161520136|NCT00856583|583292596|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
161520137|NCT01944046|583292601|FG000|Randomized to DB|Adverse Event|5|||
161520138|NCT01944046|583292602|FG001|Randomized to DB|Adverse Event|2|||
161520139|NCT01944046|583292601|FG000|Randomized to DB|Clinical Worsening|3|||
161520140|NCT01944046|583292602|FG001|Randomized to DB|Clinical Worsening|2|||
161520141|NCT01944046|583292601|FG000|Randomized to DB|Lost to Follow-up|3|||
161520142|NCT01944046|583292602|FG001|Randomized to DB|Lost to Follow-up|3|||
161520143|NCT01944046|583292601|FG000|Randomized to DB|Withdrawal by Subject|2|||
161520144|NCT01944046|583292602|FG001|Randomized to DB|Withdrawal by Subject|4|||
161520145|NCT01944046|583292601|FG000|Randomized to DB|Physician Decision|1|||
161520146|NCT01944046|583292602|FG001|Randomized to DB|Physician Decision|2|||
161824689|NCT02315066|584399839|FG001|Overall Study|Study ongoing at date of cut-off|0|||
161824690|NCT02315066|584399840|FG002|Overall Study|Study ongoing at date of cut-off|0|||
161824691|NCT02315066|584399841|FG003|Overall Study|Study ongoing at date of cut-off|0|||
161824692|NCT02315066|584399842|FG004|Overall Study|Study ongoing at date of cut-off|0|||
161824693|NCT02315066|584399843|FG005|Overall Study|Study ongoing at date of cut-off|0|||
161824694|NCT02315066|584399844|FG006|Overall Study|Study ongoing at date of cut-off|0|||
161824695|NCT02315066|584399845|FG007|Overall Study|Study ongoing at date of cut-off|0|||
161824696|NCT02315066|584399846|FG008|Overall Study|Study ongoing at date of cut-off|0|||
161824697|NCT02315066|584399847|FG009|Overall Study|Study ongoing at date of cut-off|0|||
161824698|NCT02315066|584399848|FG010|Overall Study|Study ongoing at date of cut-off|0|||
161824699|NCT02315066|584399849|FG011|Overall Study|Study ongoing at date of cut-off|0|||
161824700|NCT02315066|584399850|FG012|Overall Study|Study ongoing at date of cut-off|0|||
161824701|NCT02315066|584399851|FG013|Overall Study|Study ongoing at date of cut-off|1|||
161824702|NCT03259789|584399852|FG000|Overall Study|Adverse Event|3|||
161824703|NCT03259789|584399853|FG001|Overall Study|Adverse Event|2|||
161824704|NCT03259789|584399854|FG002|Overall Study|Adverse Event|1|||
161824705|NCT03259789|584399852|FG000|Overall Study|Withdrawal by Subject|9|||
161824706|NCT03259789|584399853|FG001|Overall Study|Withdrawal by Subject|5|||
161824707|NCT03259789|584399854|FG002|Overall Study|Withdrawal by Subject|1|||
161824708|NCT03259789|584399852|FG000|Overall Study|Lost to Follow-up|5|||
161824709|NCT03259789|584399853|FG001|Overall Study|Lost to Follow-up|9|||
161824710|NCT03259789|584399854|FG002|Overall Study|Lost to Follow-up|4|||
161824711|NCT03259789|584399852|FG000|Overall Study|Physician Decision|0|||
161824712|NCT03259789|584399853|FG001|Overall Study|Physician Decision|1|||
161824713|NCT03259789|584399854|FG002|Overall Study|Physician Decision|0|||
161824714|NCT00860262|584399858|FG000|Overall Study|Adverse Event|9|||
161824715|NCT00860262|584399859|FG001|Overall Study|Adverse Event|6|||
161824716|NCT00860262|584399860|FG002|Overall Study|Adverse Event|7|||
161824717|NCT00860262|584399858|FG000|Overall Study|Protocol Violation|0|||
161824718|NCT00860262|584399859|FG001|Overall Study|Protocol Violation|1|||
161824719|NCT00860262|584399860|FG002|Overall Study|Protocol Violation|0|||
161824720|NCT00860262|584399858|FG000|Overall Study|Lost to Follow-up|2|||
161824721|NCT00860262|584399859|FG001|Overall Study|Lost to Follow-up|0|||
161824722|NCT00860262|584399860|FG002|Overall Study|Lost to Follow-up|1|||
161824723|NCT00860262|584399858|FG000|Overall Study|Withdrawal by Subject|4|||
161824724|NCT00860262|584399859|FG001|Overall Study|Withdrawal by Subject|8|||
161824725|NCT00860262|584399860|FG002|Overall Study|Withdrawal by Subject|6|||
161824726|NCT00860262|584399858|FG000|Overall Study|Lack of Efficacy|0|||
161824727|NCT00860262|584399859|FG001|Overall Study|Lack of Efficacy|4|||
161824728|NCT00860262|584399860|FG002|Overall Study|Lack of Efficacy|3|||
161824729|NCT00860262|584399858|FG000|Overall Study|Other|5|||
161824730|NCT00860262|584399859|FG001|Overall Study|Other|3|||
161824731|NCT00860262|584399860|FG002|Overall Study|Other|1|||
161824732|NCT01183884|584399861|FG000|Overall Study|Progressive Disease|26|||
161824733|NCT01183884|584399861|FG000|Overall Study|Adverse Event|3|||
161824734|NCT01183884|584399861|FG000|Overall Study|Withdrawal by Subject|1|||
161824735|NCT01183884|584399861|FG000|Overall Study|Other Complicating Disease|3|||
161824736|NCT01183884|584399861|FG000|Overall Study|Not Treated|1|||
161824737|NCT01183884|584399861|FG000|Overall Study|Other|4|||
161824738|NCT02169336|584399862|FG000|Overall Study|Lack of Efficacy|1|||
161824739|NCT02169336|584399863|FG001|Overall Study|Lack of Efficacy|1|||
161824740|NCT02169336|584399864|FG002|Overall Study|Lack of Efficacy|0|||
161824741|NCT02169336|584399862|FG000|Overall Study|Adverse Event|2|||
161824742|NCT02169336|584399863|FG001|Overall Study|Adverse Event|3|||
161824743|NCT02169336|584399864|FG002|Overall Study|Adverse Event|1|||
161824744|NCT02169336|584399862|FG000|Overall Study|Withdrawal by Subject|1|||
161824745|NCT02169336|584399863|FG001|Overall Study|Withdrawal by Subject|0|||
161824746|NCT02169336|584399864|FG002|Overall Study|Withdrawal by Subject|0|||
161824747|NCT02169336|584399862|FG000|Overall Study|Physician Decision|0|||
161824748|NCT02169336|584399863|FG001|Overall Study|Physician Decision|0|||
161824749|NCT02169336|584399864|FG002|Overall Study|Physician Decision|1|||
161824750|NCT02169336|584399862|FG000|Overall Study|Subject declined to continue dosing|0|||
161824751|NCT02169336|584399863|FG001|Overall Study|Subject declined to continue dosing|0|||
161824752|NCT02169336|584399864|FG002|Overall Study|Subject declined to continue dosing|1|||
161824753|NCT01598896|584399865|FG000|Overall Study|Withdrawal by Subject|0|||
161824754|NCT01598896|584399866|FG001|Overall Study|Withdrawal by Subject|1|||
161520147|NCT01944046|583292601|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
161520148|NCT01944046|583292602|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
161520149|NCT01944046|583292601|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
161520150|NCT01944046|583292602|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
161520151|NCT01944046|583292601|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
161520152|NCT01944046|583292602|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
161520153|NCT01944046|583292601|FG000|Open Label Eligible and Consented|Adverse Event|6|||
161520154|NCT01944046|583292602|FG001|Open Label Eligible and Consented|Adverse Event|1|||
161677510|NCT00467779|583872004|FG004|Stage 3|Unspecified Reason|0|||
161520155|NCT01944046|583292601|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
161520156|NCT01944046|583292602|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
161520157|NCT01944046|583292601|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
161520158|NCT01944046|583292602|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
161520159|NCT02056301|583292605|FG000|Overall Study|Protocol Violation|1|||
161520160|NCT02056301|583292606|FG001|Overall Study|Protocol Violation|2|||
161520161|NCT02056301|583292605|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
161520162|NCT02056301|583292606|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
161520163|NCT02056301|583292605|FG000|Overall Study|Withdrawal by Subject|0|||
161520164|NCT02056301|583292606|FG001|Overall Study|Withdrawal by Subject|1|||
161520165|NCT02056301|583292605|FG000|Overall Study|Issues with epidural|0|||
161520166|NCT02056301|583292606|FG001|Overall Study|Issues with epidural|3|||
161589100|NCT03336333|583544600|FG002|Overall Study|Physician Decision|0|||
161589101|NCT03336333|583544598|FG000|Overall Study|Lost to Follow-up|1|||
161589102|NCT03336333|583544599|FG001|Overall Study|Lost to Follow-up|0|||
161589103|NCT03336333|583544600|FG002|Overall Study|Lost to Follow-up|0|||
161520167|NCT04496258|583292615|FG000|Overall Study|Withdrawal by Subject|2|||
161520168|NCT04496258|583292616|FG001|Overall Study|Withdrawal by Subject|1|||
161520169|NCT02041429|583292617|FG000|Overall Study|Progressive Disease|2|||
161520170|NCT02041429|583292618|FG001|Overall Study|Progressive Disease|2|||
161824755|NCT01598896|584399865|FG000|Overall Study|Lack of Efficacy|0|||
161824756|NCT01598896|584399866|FG001|Overall Study|Lack of Efficacy|1|||
161824757|NCT00420095|584399867|FG000|Overall Study|Adverse Event|1|||
161824758|NCT00420095|584399868|FG001|Overall Study|Adverse Event|0|||
161824759|NCT00420095|584399867|FG000|Overall Study|Protocol Violation|1|||
161824760|NCT00420095|584399868|FG001|Overall Study|Protocol Violation|1|||
161824761|NCT00420095|584399867|FG000|Overall Study|Lost to Follow-up|1|||
161824762|NCT00420095|584399868|FG001|Overall Study|Lost to Follow-up|0|||
161824763|NCT00393705|584399869|FG000|Overall Study|Adverse Event|0|||
161824764|NCT00393705|584399870|FG001|Overall Study|Adverse Event|2|||
161824765|NCT00393705|584399869|FG000|Overall Study|Death|0|||
161824766|NCT00393705|584399870|FG001|Overall Study|Death|1|||
161824767|NCT00393705|584399869|FG000|Overall Study|Lost to Follow-up|2|||
161824768|NCT00393705|584399870|FG001|Overall Study|Lost to Follow-up|2|||
161824769|NCT00393705|584399869|FG000|Overall Study|Entry Criteria Not Met|10|||
161824770|NCT00393705|584399870|FG001|Overall Study|Entry Criteria Not Met|10|||
161824771|NCT00393705|584399869|FG000|Overall Study|Protocol Violation|4|||
161824772|NCT00393705|584399870|FG001|Overall Study|Protocol Violation|3|||
161824773|NCT00393705|584399869|FG000|Overall Study|Withdrawal by Subject|5|||
161824774|NCT00393705|584399870|FG001|Overall Study|Withdrawal by Subject|3|||
161824775|NCT00393705|584399869|FG000|Overall Study|Physician Decision|2|||
161520171|NCT02041429|583292619|FG002|Overall Study|Progressive Disease|3|||
161520172|NCT02041429|583292620|FG003|Overall Study|Progressive Disease|2|||
161589104|NCT00931710|583544603|FG000|Overall Study|Adverse Event|16|||
161589105|NCT00931710|583544604|FG001|Overall Study|Adverse Event|10|||
161589106|NCT00931710|583544603|FG000|Overall Study|Abnormal test procedure results|2|||
161589107|NCT00931710|583544604|FG001|Overall Study|Abnormal test procedure results|0|||
161589108|NCT00931710|583544603|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
161589109|NCT00931710|583544604|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
161589110|NCT00931710|583544603|FG000|Overall Study|Patient withdrew consent|4|||
161589111|NCT00931710|583544604|FG001|Overall Study|Patient withdrew consent|9|||
161589112|NCT00931710|583544603|FG000|Overall Study|Lost to Follow-up|6|||
161589113|NCT00931710|583544604|FG001|Overall Study|Lost to Follow-up|5|||
161589114|NCT00931710|583544603|FG000|Overall Study|Protocol deviation|1|||
161589115|NCT00931710|583544604|FG001|Overall Study|Protocol deviation|2|||
161589116|NCT02281955|583544610|FG000|Overall Study|Death|1|||
161589117|NCT03892616|583544611|FG000|Washout Period 2|Met discontinuation criterion|0|||
161589118|NCT03892616|583544612|FG001|Washout Period 2|Met discontinuation criterion|0|||
161589119|NCT03892616|583544613|FG002|Washout Period 2|Met discontinuation criterion|0|||
161589120|NCT03892616|583544614|FG003|Washout Period 2|Met discontinuation criterion|0|||
161589121|NCT03892616|583544615|FG004|Washout Period 2|Met discontinuation criterion|0|||
161589122|NCT03892616|583544616|FG005|Washout Period 2|Met discontinuation criterion|0|||
161824776|NCT00393705|584399870|FG001|Overall Study|Physician Decision|2|||
161824777|NCT04553406|584399873|FG000|Overall Study|Study Discontinuation|0|||
161824778|NCT04553406|584399874|FG001|Overall Study|Study Discontinuation|1|||
161824779|NCT03370510|584399875|FG000|Overall Study|COVID-19|2|||
161824780|NCT03370510|584399876|FG001|Overall Study|COVID-19|0|||
161933007|NCT01712074|584802458|FG000|Placebo Run-in Period|Other|1|||
161933008|NCT01712074|584802459|FG001|Placebo Run-in Period|Other|0|||
161520173|NCT02041429|583292617|FG000|Overall Study|Toxicity|0|||
161520174|NCT02041429|583292618|FG001|Overall Study|Toxicity|1|||
161520175|NCT02041429|583292619|FG002|Overall Study|Toxicity|4|||
161520176|NCT02041429|583292620|FG003|Overall Study|Toxicity|2|||
161520177|NCT02041429|583292617|FG000|Overall Study|Withdrawal by Subject|0|||
161520178|NCT02041429|583292618|FG001|Overall Study|Withdrawal by Subject|1|||
161520179|NCT02041429|583292619|FG002|Overall Study|Withdrawal by Subject|0|||
161520180|NCT02041429|583292620|FG003|Overall Study|Withdrawal by Subject|0|||
161520181|NCT02041429|583292617|FG000|Overall Study|On Maintenance Therapy|1|||
161520182|NCT02041429|583292618|FG001|Overall Study|On Maintenance Therapy|0|||
161520183|NCT02041429|583292619|FG002|Overall Study|On Maintenance Therapy|0|||
161520184|NCT02041429|583292620|FG003|Overall Study|On Maintenance Therapy|2|||
161520185|NCT01427712|583292621|FG000|Overall Study|Transfer to a different hospital|2|||
161520186|NCT01427712|583292621|FG000|Overall Study|Lost to Follow-up|1|||
161520187|NCT01427712|583292621|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
161520188|NCT01427712|583292621|FG000|Overall Study|Failure to visit|1|||
161520189|NCT00153101|583292622|FG000|Overall Study|Lost to Follow-up|14|||
161520190|NCT00153101|583292623|FG001|Overall Study|Lost to Follow-up|14|||
161520191|NCT00153101|583292624|FG002|Overall Study|Lost to Follow-up|12|||
161520192|NCT00153101|583292625|FG003|Overall Study|Lost to Follow-up|5|||
161520193|NCT00153101|583292626|FG004|Overall Study|Lost to Follow-up|5|||
161520194|NCT00153101|583292622|FG000|Overall Study|Withdrawal by Subject|3|||
161520195|NCT00153101|583292623|FG001|Overall Study|Withdrawal by Subject|4|||
161520196|NCT00153101|583292624|FG002|Overall Study|Withdrawal by Subject|3|||
161520197|NCT00153101|583292625|FG003|Overall Study|Withdrawal by Subject|3|||
161520198|NCT00153101|583292626|FG004|Overall Study|Withdrawal by Subject|5|||
161520199|NCT03169153|583292627|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
161520200|NCT03169153|583292628|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
161520201|NCT03169153|583292627|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
161520202|NCT03169153|583292628|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
161520203|NCT03169153|583292627|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
161520204|NCT03169153|583292628|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
161520205|NCT03169153|583292627|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
161520206|NCT03169153|583292628|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
161520207|NCT00439777|583292629|FG000|Treatment Period|Death|29|||
161520208|NCT00439777|583292630|FG001|Treatment Period|Death|21|||
161520209|NCT00439777|583292629|FG000|Treatment Period|Study terminated by sponsor|125|||
161520210|NCT00439777|583292630|FG001|Treatment Period|Study terminated by sponsor|132|||
161520211|NCT00439777|583292629|FG000|Treatment Period|Site closed by investigator|0|||
161520212|NCT00439777|583292630|FG001|Treatment Period|Site closed by investigator|1|||
161520213|NCT00439777|583292629|FG000|Treatment Period|Did not take study treatment|7|||
161520214|NCT00439777|583292630|FG001|Treatment Period|Did not take study treatment|8|||
161520215|NCT00439777|583292629|FG000|Treatment Period|Adverse Event|111|||
161520216|NCT00439777|583292630|FG001|Treatment Period|Adverse Event|92|||
161520217|NCT00439777|583292629|FG000|Treatment Period|Protocol Violation|23|||
161520218|NCT00439777|583292630|FG001|Treatment Period|Protocol Violation|30|||
161520219|NCT00439777|583292629|FG000|Treatment Period|Withdrawal by Subject|66|||
161933009|NCT01712074|584802460|FG002|Placebo Run-in Period|Other|0|||
161933010|NCT01712074|584802458|FG000|Placebo Run-in Period|No longer willing to participate|1|||
161933011|NCT01712074|584802459|FG001|Placebo Run-in Period|No longer willing to participate|0|||
161933012|NCT01712074|584802460|FG002|Placebo Run-in Period|No longer willing to participate|0|||
161933013|NCT01712074|584802458|FG000|Double Blind Period|Adverse Event|0|||
161933014|NCT01712074|584802459|FG001|Double Blind Period|Adverse Event|2|||
161933015|NCT01712074|584802460|FG002|Double Blind Period|Adverse Event|1|||
161933016|NCT01712074|584802458|FG000|Double Blind Period|No longer willing to participate|0|||
161933017|NCT01712074|584802459|FG001|Double Blind Period|No longer willing to participate|2|||
161933018|NCT01712074|584802460|FG002|Double Blind Period|No longer willing to participate|4|||
161933019|NCT01712074|584802458|FG000|Double Blind Period|Death|0|||
161520220|NCT00439777|583292630|FG001|Treatment Period|Withdrawal by Subject|118|||
161520221|NCT00439777|583292629|FG000|Treatment Period|Lack of Efficacy|1|||
161520222|NCT00439777|583292630|FG001|Treatment Period|Lack of Efficacy|4|||
161520223|NCT00439777|583292629|FG000|Treatment Period|Lost to Follow-up|8|||
161520224|NCT00439777|583292630|FG001|Treatment Period|Lost to Follow-up|10|||
161520225|NCT00439777|583292629|FG000|Treatment Period|Protocol driven decision point|1|||
161520226|NCT00439777|583292630|FG001|Treatment Period|Protocol driven decision point|3|||
161933020|NCT01712074|584802459|FG001|Double Blind Period|Death|1|||
161933021|NCT01712074|584802460|FG002|Double Blind Period|Death|0|||
161933022|NCT01712074|584802458|FG000|Double Blind Period|Lost to Follow-up|0|||
161520227|NCT00439777|583292629|FG000|Treatment Period|Physician Decision|7|||
161520228|NCT00439777|583292630|FG001|Treatment Period|Physician Decision|18|||
161933023|NCT01712074|584802459|FG001|Double Blind Period|Lost to Follow-up|2|||
161589123|NCT03892616|583544617|FG006|Washout Period 2|Met discontinuation criterion|0|||
161589124|NCT03892616|583544618|FG007|Washout Period 2|Met discontinuation criterion|0|||
161589125|NCT03892616|583544619|FG008|Washout Period 2|Met discontinuation criterion|1|||
161589126|NCT03892616|583544620|FG009|Washout Period 2|Met discontinuation criterion|0|||
161589127|NCT03892616|583544621|FG010|Washout Period 2|Met discontinuation criterion|0|||
161589128|NCT03892616|583544622|FG011|Washout Period 2|Met discontinuation criterion|0|||
161589129|NCT02689284|583544628|FG000|Overall Study|Adverse Event|1|||
161589130|NCT02689284|583544629|FG001|Overall Study|Adverse Event|8|||
161589131|NCT02689284|583544628|FG000|Overall Study|Death|0|||
161589132|NCT02689284|583544629|FG001|Overall Study|Death|1|||
161589133|NCT02689284|583544628|FG000|Overall Study|Physician Decision|1|||
161589134|NCT02689284|583544629|FG001|Overall Study|Physician Decision|2|||
161589135|NCT02689284|583544628|FG000|Overall Study|Withdrawal by Subject|0|||
161589136|NCT02689284|583544629|FG001|Overall Study|Withdrawal by Subject|1|||
161589137|NCT02689284|583544628|FG000|Overall Study|progression of cancer|1|||
161589138|NCT02689284|583544629|FG001|Overall Study|progression of cancer|72|||
161589139|NCT02689284|583544628|FG000|Overall Study|decreased heart function|0|||
161589140|NCT02689284|583544629|FG001|Overall Study|decreased heart function|1|||
161589141|NCT02689284|583544628|FG000|Overall Study|concern for anemia|0|||
161589142|NCT02689284|583544629|FG001|Overall Study|concern for anemia|1|||
161589143|NCT02689284|583544628|FG000|Overall Study|no measurable cancer for evaluation|0|||
161589144|NCT02689284|583544629|FG001|Overall Study|no measurable cancer for evaluation|1|||
161589145|NCT03665597|583544630|FG000|Period 1|Adverse Event|1|||
161589146|NCT03665597|583544631|FG001|Period 1|Adverse Event|0|||
161589147|NCT03665597|583544632|FG002|Period 1|Adverse Event|0|||
161589148|NCT03665597|583544633|FG003|Period 1|Adverse Event|1|||
161589149|NCT03665597|583544634|FG004|Period 1|Adverse Event|0|||
161589150|NCT03665597|583544635|FG005|Period 1|Adverse Event|0|||
161589151|NCT03665597|583544636|FG006|Period 1|Adverse Event|0|||
161589152|NCT03665597|583544630|FG000|Period 1|Screen Failure|0|||
161589153|NCT03665597|583544631|FG001|Period 1|Screen Failure|0|||
161589154|NCT03665597|583544632|FG002|Period 1|Screen Failure|0|||
161589155|NCT03665597|583544633|FG003|Period 1|Screen Failure|1|||
161589156|NCT03665597|583544634|FG004|Period 1|Screen Failure|0|||
161589157|NCT03665597|583544635|FG005|Period 1|Screen Failure|0|||
161589158|NCT03665597|583544636|FG006|Period 1|Screen Failure|0|||
161589159|NCT03665597|583544630|FG000|Period 1|Death|0|||
161589160|NCT03665597|583544631|FG001|Period 1|Death|0|||
161589161|NCT03665597|583544632|FG002|Period 1|Death|0|||
161589162|NCT03665597|583544633|FG003|Period 1|Death|0|||
161589163|NCT03665597|583544634|FG004|Period 1|Death|0|||
161589164|NCT03665597|583544635|FG005|Period 1|Death|0|||
161589165|NCT03665597|583544636|FG006|Period 1|Death|45|||
161589166|NCT03665597|583544630|FG000|Period 1|Withdrawal by Subject|0|||
161589167|NCT03665597|583544631|FG001|Period 1|Withdrawal by Subject|0|||
161589168|NCT03665597|583544632|FG002|Period 1|Withdrawal by Subject|0|||
161589169|NCT03665597|583544633|FG003|Period 1|Withdrawal by Subject|0|||
161589170|NCT03665597|583544634|FG004|Period 1|Withdrawal by Subject|0|||
161589171|NCT03665597|583544635|FG005|Period 1|Withdrawal by Subject|0|||
161589172|NCT03665597|583544636|FG006|Period 1|Withdrawal by Subject|5|||
161589173|NCT03665597|583544630|FG000|Period 2|Adverse Event|0|||
161589174|NCT03665597|583544631|FG001|Period 2|Adverse Event|0|||
161589175|NCT03665597|583544632|FG002|Period 2|Adverse Event|0|||
161824781|NCT05258630|584401718|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
161824782|NCT05258630|584401719|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
161824783|NCT05258630|584401718|FG000|Overall Study|Lost to Follow-up|0|||
161824784|NCT05258630|584401719|FG001|Overall Study|Lost to Follow-up|2|||
161824785|NCT03431337|584401720|FG000|Overall Study|Lost to Follow-up|21|||
161589176|NCT03665597|583544633|FG003|Period 2|Adverse Event|0|||
161589177|NCT03665597|583544634|FG004|Period 2|Adverse Event|0|||
161589178|NCT03665597|583544635|FG005|Period 2|Adverse Event|1|||
161589179|NCT03665597|583544636|FG006|Period 2|Adverse Event|0|||
161589180|NCT03665597|583544630|FG000|Period 3|Adverse Event|0|||
161589181|NCT03665597|583544631|FG001|Period 3|Adverse Event|1|||
161589182|NCT03665597|583544632|FG002|Period 3|Adverse Event|0|||
161589183|NCT03665597|583544633|FG003|Period 3|Adverse Event|0|||
161589184|NCT03665597|583544634|FG004|Period 3|Adverse Event|0|||
161589185|NCT03665597|583544635|FG005|Period 3|Adverse Event|0|||
161589186|NCT03665597|583544636|FG006|Period 3|Adverse Event|0|||
161589187|NCT03665597|583544630|FG000|Period 3|Death|0|||
161589188|NCT03665597|583544631|FG001|Period 3|Death|0|||
161589189|NCT03665597|583544632|FG002|Period 3|Death|0|||
161589190|NCT03665597|583544633|FG003|Period 3|Death|0|||
161589191|NCT03665597|583544634|FG004|Period 3|Death|1|||
161589192|NCT03665597|583544635|FG005|Period 3|Death|0|||
161589193|NCT03665597|583544636|FG006|Period 3|Death|0|||
161589194|NCT03665597|583544630|FG000|Period 4|Adverse Event|2|||
161589195|NCT03665597|583544631|FG001|Period 4|Adverse Event|2|||
161589196|NCT03665597|583544632|FG002|Period 4|Adverse Event|2|||
161589197|NCT03665597|583544633|FG003|Period 4|Adverse Event|2|||
161589198|NCT03665597|583544634|FG004|Period 4|Adverse Event|1|||
161589199|NCT03665597|583544635|FG005|Period 4|Adverse Event|0|||
161589200|NCT03665597|583544636|FG006|Period 4|Adverse Event|0|||
161589201|NCT03665597|583544630|FG000|Period 4|Death|0|||
161933024|NCT01712074|584802460|FG002|Double Blind Period|Lost to Follow-up|1|||
161933025|NCT01712074|584802458|FG000|Double Blind Period|Other|0|||
161933026|NCT01712074|584802459|FG001|Double Blind Period|Other|4|||
161933027|NCT01712074|584802460|FG002|Double Blind Period|Other|1|||
161933028|NCT01712074|584802458|FG000|Double Blind Period|Protocol Violation|0|||
161933029|NCT01712074|584802459|FG001|Double Blind Period|Protocol Violation|0|||
161933030|NCT01712074|584802460|FG002|Double Blind Period|Protocol Violation|1|||
161933031|NCT01712074|584802458|FG000|Double Blind Period|No longer met eligibility criteria|0|||
161933032|NCT01712074|584802459|FG001|Double Blind Period|No longer met eligibility criteria|3|||
161933033|NCT01712074|584802460|FG002|Double Blind Period|No longer met eligibility criteria|0|||
161933034|NCT03478787|584802461|FG000|Overall Study|Adverse Event|5|||
161933035|NCT03478787|584802462|FG001|Overall Study|Adverse Event|1|||
161933036|NCT03478787|584802461|FG000|Overall Study|Protocol Violation|3|||
161933037|NCT03478787|584802462|FG001|Overall Study|Protocol Violation|0|||
161933038|NCT03478787|584802461|FG000|Overall Study|Lack of Efficacy|7|||
161933039|NCT03478787|584802462|FG001|Overall Study|Lack of Efficacy|1|||
161933040|NCT03478787|584802461|FG000|Overall Study|Lost to Follow-up|9|||
161933041|NCT03478787|584802462|FG001|Overall Study|Lost to Follow-up|5|||
161933042|NCT03478787|584802461|FG000|Overall Study|Withdrawal by Subject|2|||
161933043|NCT03478787|584802462|FG001|Overall Study|Withdrawal by Subject|6|||
161933044|NCT03478787|584802461|FG000|Overall Study|Other, Not Specified|3|||
161933045|NCT03478787|584802462|FG001|Overall Study|Other, Not Specified|0|||
161933046|NCT02792257|584802467|FG000|Overall Study|Lost to Follow-up|3|||
161933047|NCT02792257|584802468|FG001|Overall Study|Lost to Follow-up|4|||
161933048|NCT02792257|584802467|FG000|Overall Study|Allergy|0|||
161933049|NCT02792257|584802468|FG001|Overall Study|Allergy|1|||
161933050|NCT02792257|584802467|FG000|Overall Study|Protocol Violation|2|||
161933051|NCT02792257|584802468|FG001|Overall Study|Protocol Violation|0|||
161933052|NCT02792257|584802467|FG000|Overall Study|Excessive Agitation|0|||
161933053|NCT02792257|584802468|FG001|Overall Study|Excessive Agitation|1|||
161933054|NCT02792257|584802467|FG000|Overall Study|Not Feeling Well|0|||
161933055|NCT02792257|584802468|FG001|Overall Study|Not Feeling Well|1|||
161933056|NCT02766478|584802470|FG000|Overall Study|Withdrawal by Subject|1|||
161933057|NCT02766478|584802471|FG001|Overall Study|Withdrawal by Subject|1|||
161933058|NCT01093573|584802472|FG000|Overall Study|Physician Decision|0|||
161933059|NCT01093573|584802473|FG001|Overall Study|Physician Decision|0|||
161933060|NCT01093573|584802474|FG002|Overall Study|Physician Decision|1|||
161520229|NCT00439777|583292629|FG000|Treatment Period|Clinical endpoint reached|26|||
161520230|NCT00439777|583292630|FG001|Treatment Period|Clinical endpoint reached|13|||
161520231|NCT00439777|583292629|FG000|Treatment Period|Technical problems|3|||
161520232|NCT00439777|583292630|FG001|Treatment Period|Technical problems|1|||
161520233|NCT00439777|583292629|FG000|Treatment Period|Participant convenience|12|||
161520234|NCT00439777|583292630|FG001|Treatment Period|Participant convenience|8|||
161520235|NCT00439777|583292629|FG000|Observational Period|Protocol Violation|0|||
161520236|NCT00439777|583292630|FG001|Observational Period|Protocol Violation|2|||
161520237|NCT00439777|583292629|FG000|Observational Period|Withdrawal by Subject|9|||
161520238|NCT00439777|583292630|FG001|Observational Period|Withdrawal by Subject|5|||
161520239|NCT00439777|583292629|FG000|Observational Period|Lost to Follow-up|1|||
161520240|NCT00439777|583292630|FG001|Observational Period|Lost to Follow-up|11|||
161520241|NCT00439777|583292629|FG000|Observational Period|Death|27|||
161520242|NCT00439777|583292630|FG001|Observational Period|Death|20|||
161520243|NCT00439777|583292629|FG000|Observational Period|Study terminated by sponsor|3|||
161520244|NCT00439777|583292630|FG001|Observational Period|Study terminated by sponsor|1|||
161520245|NCT00439777|583292629|FG000|Observational Period|Protocol driven decision point|0|||
161520246|NCT00439777|583292630|FG001|Observational Period|Protocol driven decision point|1|||
161520247|NCT00439777|583292629|FG000|Observational Period|Lack of Efficacy|1|||
161520248|NCT00439777|583292630|FG001|Observational Period|Lack of Efficacy|0|||
161520249|NCT00439777|583292629|FG000|Observational Period|Technical problems|0|||
161520250|NCT00439777|583292630|FG001|Observational Period|Technical problems|1|||
161520251|NCT00661492|583292631|FG000|Overall Study|Adverse Event|16|||
161933061|NCT01093573|584802472|FG000|Overall Study|Insurance Denied|0|||
161933062|NCT01093573|584802473|FG001|Overall Study|Insurance Denied|0|||
161933063|NCT01093573|584802474|FG002|Overall Study|Insurance Denied|1|||
161520252|NCT00661492|583292632|FG001|Overall Study|Adverse Event|13|||
161520253|NCT00661492|583292631|FG000|Overall Study|Disease Progression|44|||
161520254|NCT00661492|583292632|FG001|Overall Study|Disease Progression|14|||
161520255|NCT00661492|583292631|FG000|Overall Study|Patient Request|6|||
161933064|NCT05626686|584802475|FG000|Overall Study|Protocol Violation|3|||
161933065|NCT05626686|584802475|FG000|Overall Study|Withdrawal by Subject|3|||
161933066|NCT00682435|584802476|FG000|Overall Study|Insufficient data|5|||
161933067|NCT00682435|584802476|FG000|Overall Study|Erroneously enrolled twice|2|||
161933068|NCT00089583|584802477|FG000|Overall Study|Adverse Event|0|||
161933069|NCT00089583|584802478|FG001|Overall Study|Adverse Event|3|||
161933070|NCT00089583|584802477|FG000|Overall Study|Insufficient Viral Load Response|5|||
161933071|NCT00089583|584802478|FG001|Overall Study|Insufficient Viral Load Response|5|||
161933072|NCT00089583|584802477|FG000|Overall Study|Withdrawal by Subject|0|||
161520256|NCT00661492|583292632|FG001|Overall Study|Patient Request|1|||
161520257|NCT00661492|583292631|FG000|Overall Study|Investigator Request|1|||
161520258|NCT00661492|583292632|FG001|Overall Study|Investigator Request|0|||
161520259|NCT00661492|583292631|FG000|Overall Study|Lost to Follow-up|0|||
161520260|NCT00661492|583292632|FG001|Overall Study|Lost to Follow-up|1|||
161520261|NCT00661492|583292631|FG000|Overall Study|Other|1|||
161520262|NCT00661492|583292632|FG001|Overall Study|Other|0|||
161520263|NCT00803634|583292633|FG000|Overall Study|Withdrew Consent|1|||
161520264|NCT00803634|583292634|FG001|Overall Study|Withdrew Consent|0|||
161520265|NCT00803634|583292633|FG000|Overall Study|Lost to Follow-up|2|||
161520266|NCT00803634|583292634|FG001|Overall Study|Lost to Follow-up|3|||
161520267|NCT00803634|583292633|FG000|Overall Study|Death|3|||
161520268|NCT00803634|583292634|FG001|Overall Study|Death|2|||
161520269|NCT03791398|583292637|FG000|Overall Study|Progression of Disease Under Study|2|||
161520270|NCT03791398|583292638|FG001|Overall Study|Progression of Disease Under Study|0|||
161520271|NCT03791398|583292639|FG002|Overall Study|Progression of Disease Under Study|0|||
161520272|NCT00766376|583292640|FG000|Overall Study|Withdrawal by Subject|27|||
161520273|NCT01072201|583292641|FG000|Overall Study|Lost to Follow-up|0|||
161520274|NCT01072201|583292642|FG001|Overall Study|Lost to Follow-up|1|||
161520275|NCT04382612|583292643|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
161520276|NCT01328002|583292645|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
161520277|NCT01328002|583292646|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
161520278|NCT01328002|583292645|FG000|Open-Label Period|Adverse Event|8|||
161520279|NCT01328002|583292646|FG001|Open-Label Period|Adverse Event|0|||
161520280|NCT01328002|583292645|FG000|Open-Label Period|Lack of Efficacy|3|||
161520281|NCT01328002|583292646|FG001|Open-Label Period|Lack of Efficacy|0|||
161520282|NCT01328002|583292645|FG000|Open-Label Period|Protocol Violation|2|||
161589202|NCT03665597|583544631|FG001|Period 4|Death|0|||
161589203|NCT03665597|583544632|FG002|Period 4|Death|2|||
161589204|NCT03665597|583544633|FG003|Period 4|Death|0|||
161589205|NCT03665597|583544634|FG004|Period 4|Death|0|||
161520283|NCT01328002|583292646|FG001|Open-Label Period|Protocol Violation|0|||
161520284|NCT01328002|583292645|FG000|Open-Label Period|Withdrawal by Subject|9|||
161520285|NCT01328002|583292646|FG001|Open-Label Period|Withdrawal by Subject|0|||
161520286|NCT01328002|583292645|FG000|Open-Label Period|Lost to Follow-up|6|||
161520287|NCT01328002|583292646|FG001|Open-Label Period|Lost to Follow-up|0|||
161589206|NCT03665597|583544635|FG005|Period 4|Death|0|||
161589207|NCT03665597|583544636|FG006|Period 4|Death|0|||
161824786|NCT03431337|584401721|FG001|Overall Study|Lost to Follow-up|19|||
161824787|NCT03431337|584401720|FG000|Overall Study|Withdrawal by Subject|8|||
161824788|NCT03431337|584401721|FG001|Overall Study|Withdrawal by Subject|3|||
161824789|NCT00894933|584401728|FG000|Overall Study|Lost to Follow-up|2|||
161824790|NCT00894933|584401728|FG000|Overall Study|Cancelled Procedure|1|||
161824791|NCT00894933|584401728|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
161824792|NCT00631007|584401730|FG000|Overall Study|Adverse Event|0|||
161824793|NCT00631007|584401731|FG001|Overall Study|Adverse Event|2|||
161824794|NCT00631007|584401732|FG002|Overall Study|Adverse Event|0|||
161824795|NCT00631007|584401733|FG003|Overall Study|Adverse Event|2|||
161824796|NCT00631007|584401734|FG004|Overall Study|Adverse Event|3|||
161824797|NCT00631007|584401735|FG005|Overall Study|Adverse Event|2|||
161824798|NCT00631007|584401730|FG000|Overall Study|Lost to Follow-up|2|||
161824799|NCT00631007|584401731|FG001|Overall Study|Lost to Follow-up|1|||
161824800|NCT00631007|584401732|FG002|Overall Study|Lost to Follow-up|2|||
161824801|NCT00631007|584401733|FG003|Overall Study|Lost to Follow-up|4|||
161824802|NCT00631007|584401734|FG004|Overall Study|Lost to Follow-up|5|||
161824803|NCT00631007|584401735|FG005|Overall Study|Lost to Follow-up|3|||
161824804|NCT00631007|584401730|FG000|Overall Study|Physician Decision|1|||
161824805|NCT00631007|584401731|FG001|Overall Study|Physician Decision|0|||
161824806|NCT00631007|584401732|FG002|Overall Study|Physician Decision|1|||
161824807|NCT00631007|584401733|FG003|Overall Study|Physician Decision|0|||
161824808|NCT00631007|584401734|FG004|Overall Study|Physician Decision|0|||
161824809|NCT00631007|584401735|FG005|Overall Study|Physician Decision|2|||
161824810|NCT00631007|584401730|FG000|Overall Study|Persistent Hyperglycemia|2|||
161824811|NCT00631007|584401731|FG001|Overall Study|Persistent Hyperglycemia|2|||
161824812|NCT00631007|584401732|FG002|Overall Study|Persistent Hyperglycemia|5|||
161824813|NCT00631007|584401733|FG003|Overall Study|Persistent Hyperglycemia|1|||
161824814|NCT00631007|584401734|FG004|Overall Study|Persistent Hyperglycemia|2|||
161824815|NCT00631007|584401735|FG005|Overall Study|Persistent Hyperglycemia|5|||
161824816|NCT00631007|584401730|FG000|Overall Study|Withdrawal by Subject|4|||
161824817|NCT00631007|584401731|FG001|Overall Study|Withdrawal by Subject|5|||
161824818|NCT00631007|584401732|FG002|Overall Study|Withdrawal by Subject|2|||
161824819|NCT00631007|584401733|FG003|Overall Study|Withdrawal by Subject|2|||
161824820|NCT00631007|584401734|FG004|Overall Study|Withdrawal by Subject|1|||
161824821|NCT00631007|584401735|FG005|Overall Study|Withdrawal by Subject|3|||
161824822|NCT00631007|584401730|FG000|Overall Study|Other|2|||
161824823|NCT00631007|584401731|FG001|Overall Study|Other|1|||
161824824|NCT00631007|584401732|FG002|Overall Study|Other|0|||
161824825|NCT00631007|584401733|FG003|Overall Study|Other|0|||
161824826|NCT00631007|584401734|FG004|Overall Study|Other|1|||
161824827|NCT00631007|584401735|FG005|Overall Study|Other|0|||
161933073|NCT00089583|584802478|FG001|Overall Study|Withdrawal by Subject|4|||
161933074|NCT00089583|584802477|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
161520288|NCT01328002|583292645|FG000|Open-Label Period|Other Reason|2|||
161520289|NCT01328002|583292646|FG001|Open-Label Period|Other Reason|0|||
161520290|NCT01328002|583292645|FG000|Double-Blind Period|Adverse Event|1|||
161520291|NCT01328002|583292646|FG001|Double-Blind Period|Adverse Event|0|||
161520292|NCT01328002|583292645|FG000|Double-Blind Period|Lack of Efficacy|1|||
161520293|NCT01328002|583292646|FG001|Double-Blind Period|Lack of Efficacy|0|||
161520294|NCT01578551|583292647|FG000|Overall Study|Adverse Event|1|||
161520295|NCT01578551|583292648|FG001|Overall Study|Adverse Event|0|||
161520296|NCT00061048|583292650|FG000|Overall Study|Adverse Event|2|||
161520297|NCT00061048|583292650|FG000|Overall Study|disease progression|20|||
161520298|NCT02752048|583292651|FG000|Overall Study|Withdrawal by Subject|0|||
161520299|NCT02752048|583292652|FG001|Overall Study|Withdrawal by Subject|0|||
161520300|NCT02752048|583292653|FG002|Overall Study|Withdrawal by Subject|3|||
161520301|NCT03779841|583292657|FG000|Randomized Population|Did Not Receive Treatment|3|||
161520302|NCT03779841|583292658|FG001|Randomized Population|Did Not Receive Treatment|1|||
161520303|NCT03779841|583292659|FG002|Randomized Population|Did Not Receive Treatment|0|||
161520304|NCT03779841|583292657|FG000|Treated (Safety) Population|Adverse Event|1|||
161520305|NCT03779841|583292658|FG001|Treated (Safety) Population|Adverse Event|1|||
161520306|NCT03779841|583292659|FG002|Treated (Safety) Population|Adverse Event|0|||
161520307|NCT03779841|583292657|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
161520308|NCT03779841|583292658|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
161520309|NCT03779841|583292659|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
161520310|NCT03779841|583292657|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
161520311|NCT03779841|583292658|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
161520312|NCT03779841|583292659|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
161520313|NCT03779841|583292657|FG000|Treated (Safety) Population|Death|1|||
161520314|NCT03779841|583292658|FG001|Treated (Safety) Population|Death|0|||
161520315|NCT03779841|583292659|FG002|Treated (Safety) Population|Death|2|||
161520316|NCT02788175|583292660|FG000|Overall Study|Protocol Violation|3|||
161520317|NCT02788175|583292660|FG000|Overall Study|Withdrawal by Subject|4|||
161520318|NCT02788175|583292660|FG000|Overall Study|Ineligible prior to study agent|6|||
161520319|NCT00818441|583292661|FG000|Overall Study|Death|69|||
161520320|NCT00818441|583292662|FG001|Overall Study|Death|26|||
161520321|NCT00818441|583292661|FG000|Overall Study|Other|5|||
161520322|NCT00818441|583292662|FG001|Overall Study|Other|0|||
161520323|NCT00818441|583292661|FG000|Overall Study|Lost to Follow-up|2|||
161520324|NCT00818441|583292662|FG001|Overall Study|Lost to Follow-up|1|||
161520325|NCT00818441|583292661|FG000|Overall Study|Withdrawal by Subject|2|||
161520326|NCT00818441|583292662|FG001|Overall Study|Withdrawal by Subject|0|||
161520327|NCT00818441|583292661|FG000|Overall Study|Adverse Event|0|||
161520328|NCT00818441|583292662|FG001|Overall Study|Adverse Event|1|||
161520329|NCT00818441|583292661|FG000|Overall Study|Study terminated by sponsor|11|||
161520330|NCT00818441|583292662|FG001|Overall Study|Study terminated by sponsor|2|||
161520331|NCT00898677|583292663|FG000|Overall Study|Adverse Event|0|||
161520332|NCT00898677|583292664|FG001|Overall Study|Adverse Event|0|||
161520333|NCT00898677|583292665|FG002|Overall Study|Adverse Event|1|||
161520334|NCT00898677|583292666|FG003|Overall Study|Adverse Event|0|||
161520335|NCT00898677|583292663|FG000|Overall Study|Lost to Follow-up|0|||
161520336|NCT00898677|583292664|FG001|Overall Study|Lost to Follow-up|0|||
161520337|NCT00898677|583292665|FG002|Overall Study|Lost to Follow-up|2|||
161520338|NCT00898677|583292666|FG003|Overall Study|Lost to Follow-up|0|||
161520339|NCT00898677|583292663|FG000|Overall Study|Protocol Violation|1|||
161520340|NCT00898677|583292664|FG001|Overall Study|Protocol Violation|1|||
161520341|NCT00898677|583292665|FG002|Overall Study|Protocol Violation|2|||
161520342|NCT00898677|583292666|FG003|Overall Study|Protocol Violation|0|||
161520343|NCT00898677|583292663|FG000|Overall Study|Withdrawal by Subject|0|||
161520344|NCT00898677|583292664|FG001|Overall Study|Withdrawal by Subject|0|||
161520345|NCT00898677|583292665|FG002|Overall Study|Withdrawal by Subject|0|||
161520346|NCT00898677|583292666|FG003|Overall Study|Withdrawal by Subject|1|||
161520347|NCT00898677|583292663|FG000|Overall Study|Not Treated: Adverse Event|0|||
161520348|NCT00898677|583292664|FG001|Overall Study|Not Treated: Adverse Event|2|||
161520349|NCT00898677|583292665|FG002|Overall Study|Not Treated: Adverse Event|1|||
161520350|NCT00898677|583292666|FG003|Overall Study|Not Treated: Adverse Event|0|||
161520351|NCT00898677|583292663|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
161520352|NCT00898677|583292664|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
161520353|NCT00898677|583292665|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
161520354|NCT00898677|583292666|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
161520355|NCT00898677|583292663|FG000|Overall Study|Not Treated: Pregnancy|0|||
161520356|NCT00898677|583292664|FG001|Overall Study|Not Treated: Pregnancy|0|||
161520357|NCT00898677|583292665|FG002|Overall Study|Not Treated: Pregnancy|1|||
161520358|NCT00898677|583292666|FG003|Overall Study|Not Treated: Pregnancy|0|||
161520359|NCT00898677|583292663|FG000|Overall Study|Not Treated: Protocol Violation|2|||
161520360|NCT00898677|583292664|FG001|Overall Study|Not Treated: Protocol Violation|0|||
161520361|NCT00898677|583292665|FG002|Overall Study|Not Treated: Protocol Violation|2|||
161520362|NCT00898677|583292666|FG003|Overall Study|Not Treated: Protocol Violation|0|||
161520363|NCT00898677|583292663|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
161520364|NCT00898677|583292664|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
161520365|NCT00898677|583292665|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
161520366|NCT00898677|583292666|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
161520367|NCT00898677|583292663|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
161520368|NCT00898677|583292664|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
161520369|NCT00898677|583292665|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
161520370|NCT00898677|583292666|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
161520371|NCT00898677|583292663|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
161520372|NCT00898677|583292664|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
161520373|NCT00898677|583292665|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
161933075|NCT00089583|584802478|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
161933076|NCT00089583|584802477|FG000|Overall Study|Participant Refused Study Medication|0|||
161933077|NCT00089583|584802478|FG001|Overall Study|Participant Refused Study Medication|2|||
161933078|NCT00089583|584802477|FG000|Overall Study|Non-Compliance|0|||
161933079|NCT00089583|584802478|FG001|Overall Study|Non-Compliance|4|||
161933080|NCT00089583|584802477|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
161933081|NCT00089583|584802478|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
161933082|NCT00089583|584802477|FG000|Overall Study|Participant Management Criteria Met|0|||
161933083|NCT00089583|584802478|FG001|Overall Study|Participant Management Criteria Met|1|||
161933084|NCT00089583|584802477|FG000|Overall Study|Reason Not Provided|0|||
161933085|NCT00089583|584802478|FG001|Overall Study|Reason Not Provided|1|||
161933086|NCT00089583|584802477|FG000|Overall Study|Protocol Violation|0|||
161933087|NCT00089583|584802478|FG001|Overall Study|Protocol Violation|3|||
161933088|NCT00089583|584802477|FG000|Overall Study|Principal Investigator Decision|0|||
161933089|NCT00089583|584802478|FG001|Overall Study|Principal Investigator Decision|10|||
161933090|NCT00089583|584802477|FG000|Overall Study|Start of Disallowed Medication|0|||
161933091|NCT00089583|584802478|FG001|Overall Study|Start of Disallowed Medication|1|||
161933092|NCT00089583|584802477|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
161933093|NCT00089583|584802478|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
161933094|NCT00089583|584802477|FG000|Overall Study|Participant Incarcerated|0|||
161933095|NCT00089583|584802478|FG001|Overall Study|Participant Incarcerated|1|||
161933096|NCT01412983|584802479|FG000|1st Period|Ineligible|0|||
161933097|NCT01412983|584802480|FG001|1st Period|Ineligible|1|||
161933098|NCT01412983|584802479|FG000|1st Period|Positive slit lamp finding|0|||
161933099|NCT01412983|584802480|FG001|1st Period|Positive slit lamp finding|1|||
161933100|NCT01412983|584802479|FG000|1st Period|Unacceptable lens movement|0|||
161933101|NCT01412983|584802480|FG001|1st Period|Unacceptable lens movement|1|||
161933102|NCT01412983|584802479|FG000|1st Period|Inability to maintain wear|0|||
161933103|NCT01412983|584802480|FG001|1st Period|Inability to maintain wear|1|||
161933104|NCT02946996|584802481|FG000|Overall Study|non-evaluable|3|||
161933105|NCT02946996|584802482|FG001|Overall Study|non-evaluable|6|||
161933106|NCT02946996|584802483|FG002|Overall Study|non-evaluable|5|||
161933107|NCT00176254|584802484|FG000|Overall Study|Lost to Follow-up|1|||
161933108|NCT03289741|584802485|FG000|Overall Study|Adverse Event|1|||
161933109|NCT03289741|584802486|FG001|Overall Study|Adverse Event|1|||
161933110|NCT03289741|584802485|FG000|Overall Study|Physician Decision|2|||
161933111|NCT03289741|584802486|FG001|Overall Study|Physician Decision|2|||
161933112|NCT03289741|584802485|FG000|Overall Study|Withdrawal by Subject|1|||
161933113|NCT03289741|584802486|FG001|Overall Study|Withdrawal by Subject|0|||
161933114|NCT00537082|584802490|FG000|Overall Study|Adverse Event|6|||
161933115|NCT00537082|584802491|FG001|Overall Study|Adverse Event|6|||
161933116|NCT00537082|584802492|FG002|Overall Study|Adverse Event|3|||
161933117|NCT00537082|584802490|FG000|Overall Study|Protocol Violation|0|||
161933118|NCT00537082|584802491|FG001|Overall Study|Protocol Violation|2|||
161933119|NCT00537082|584802492|FG002|Overall Study|Protocol Violation|1|||
161933120|NCT00537082|584802490|FG000|Overall Study|Lack of Efficacy|0|||
161933121|NCT00537082|584802491|FG001|Overall Study|Lack of Efficacy|0|||
161933122|NCT00537082|584802492|FG002|Overall Study|Lack of Efficacy|2|||
161933123|NCT00537082|584802490|FG000|Overall Study|Withdrawal by Subject|0|||
161933124|NCT00537082|584802491|FG001|Overall Study|Withdrawal by Subject|1|||
161933125|NCT00537082|584802492|FG002|Overall Study|Withdrawal by Subject|0|||
161520374|NCT00898677|583292666|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
161589208|NCT03665597|583544630|FG000|Period 4|Physician Decision|1|||
161589209|NCT03665597|583544631|FG001|Period 4|Physician Decision|2|||
161933126|NCT00537082|584802490|FG000|Overall Study|Discontinued before initiating treatment|3|||
161933127|NCT00537082|584802491|FG001|Overall Study|Discontinued before initiating treatment|0|||
161933128|NCT00537082|584802492|FG002|Overall Study|Discontinued before initiating treatment|0|||
161933129|NCT04495478|584802493|FG000|Overall Study|Withdrawal by Subject|0|||
161933130|NCT04495478|584802494|FG001|Overall Study|Withdrawal by Subject|0|||
161933131|NCT04495478|584802495|FG002|Overall Study|Withdrawal by Subject|0|||
161933132|NCT04495478|584802496|FG003|Overall Study|Withdrawal by Subject|1|||
161589210|NCT03665597|583544632|FG002|Period 4|Physician Decision|0|||
161933133|NCT04495478|584802497|FG004|Overall Study|Withdrawal by Subject|0|||
161933134|NCT04495478|584802498|FG005|Overall Study|Withdrawal by Subject|0|||
161933135|NCT04495478|584802499|FG006|Overall Study|Withdrawal by Subject|0|||
161933136|NCT04495478|584802493|FG000|Overall Study|Physician Decision|0|||
161933137|NCT04495478|584802494|FG001|Overall Study|Physician Decision|1|||
161933138|NCT04495478|584802495|FG002|Overall Study|Physician Decision|0|||
161933139|NCT04495478|584802496|FG003|Overall Study|Physician Decision|0|||
161933140|NCT04495478|584802497|FG004|Overall Study|Physician Decision|1|||
161933141|NCT04495478|584802498|FG005|Overall Study|Physician Decision|0|||
161933142|NCT04495478|584802499|FG006|Overall Study|Physician Decision|0|||
161933143|NCT01197300|584804121|FG000|Overall Study|Lost to Follow-up|0|||
161933144|NCT01197300|584804122|FG001|Overall Study|Lost to Follow-up|1|||
161933145|NCT01197300|584804121|FG000|Overall Study|Protocol Violation|0|||
161520375|NCT00898677|583292663|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
161520376|NCT00898677|583292664|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
161933146|NCT01197300|584804122|FG001|Overall Study|Protocol Violation|1|||
161933147|NCT02113878|584804125|FG000|Overall Study|Adverse Event|1|||
161933148|NCT02113878|584804126|FG001|Overall Study|Adverse Event|0|||
161933149|NCT02113878|584804125|FG000|Overall Study|Withdrawal by Subject|1|||
161933150|NCT02113878|584804126|FG001|Overall Study|Withdrawal by Subject|0|||
161933151|NCT02113878|584804125|FG000|Overall Study|patient non-compliance|1|||
161933152|NCT02113878|584804126|FG001|Overall Study|patient non-compliance|0|||
161933153|NCT02255279|584804127|FG000|Overall Study|Lost to Follow-up|2|||
161933154|NCT02255279|584804128|FG001|Overall Study|Lost to Follow-up|2|||
161933155|NCT02255279|584804127|FG000|Overall Study|Protocol Violation|0|||
161933156|NCT02255279|584804128|FG001|Overall Study|Protocol Violation|1|||
161933157|NCT02255279|584804127|FG000|Overall Study|Withdrawal by Subject|3|||
161933158|NCT02255279|584804128|FG001|Overall Study|Withdrawal by Subject|6|||
161933159|NCT02144337|584804150|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
161933160|NCT02144337|584804151|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
161933161|NCT02144337|584804150|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
161520377|NCT00898677|583292665|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
161520378|NCT00898677|583292666|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
161520379|NCT00898677|583292663|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
161520380|NCT00898677|583292664|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
161520381|NCT00898677|583292665|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
161520382|NCT00898677|583292666|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
161520383|NCT00898677|583292663|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
161520384|NCT00898677|583292664|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
161520385|NCT00898677|583292665|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
161520386|NCT00898677|583292666|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
161520387|NCT00898677|583292663|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
161520388|NCT00898677|583292664|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
161520389|NCT00898677|583292665|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
161520390|NCT00898677|583292666|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
161520391|NCT00852397|583292667|FG000|Overall Study|Adverse Event|4|||
161520392|NCT00852397|583292668|FG001|Overall Study|Adverse Event|6|||
161520393|NCT00852397|583292669|FG002|Overall Study|Adverse Event|4|||
161520394|NCT00852397|583292667|FG000|Overall Study|Death|0|||
161933162|NCT02144337|584804151|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
161933163|NCT02144337|584804150|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
161520395|NCT00852397|583292668|FG001|Overall Study|Death|0|||
161520396|NCT00852397|583292669|FG002|Overall Study|Death|1|||
161520397|NCT00852397|583292667|FG000|Overall Study|Withdrawal by Subject|4|||
161520398|NCT00852397|583292668|FG001|Overall Study|Withdrawal by Subject|1|||
161520399|NCT00852397|583292669|FG002|Overall Study|Withdrawal by Subject|2|||
161520400|NCT00852397|583292667|FG000|Overall Study|Study terminated by sponsor|2|||
161520401|NCT00852397|583292668|FG001|Overall Study|Study terminated by sponsor|1|||
161589211|NCT03665597|583544633|FG003|Period 4|Physician Decision|0|||
161589212|NCT03665597|583544634|FG004|Period 4|Physician Decision|0|||
161589213|NCT03665597|583544635|FG005|Period 4|Physician Decision|0|||
161589214|NCT03665597|583544636|FG006|Period 4|Physician Decision|0|||
161589215|NCT00753090|583546369|FG000|Overall Study|Withdrawal by Subject|10|||
161933164|NCT02144337|584804151|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
161933165|NCT02144337|584804150|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
161933166|NCT02144337|584804151|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
161933167|NCT02144337|584804150|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
161933168|NCT02144337|584804151|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
161933169|NCT03400787|584804152|FG000|Overall Study|Lost to Follow-up|1|||
161520402|NCT00852397|583292669|FG002|Overall Study|Study terminated by sponsor|6|||
161520403|NCT00852397|583292667|FG000|Overall Study|Difficulty in study site visit|1|||
161520404|NCT00852397|583292668|FG001|Overall Study|Difficulty in study site visit|0|||
161520405|NCT00852397|583292669|FG002|Overall Study|Difficulty in study site visit|0|||
161589216|NCT00753090|583546370|FG001|Overall Study|Withdrawal by Subject|10|||
161520406|NCT00852397|583292667|FG000|Overall Study|Protocol Violation|0|||
161520407|NCT00852397|583292668|FG001|Overall Study|Protocol Violation|0|||
161520408|NCT00852397|583292669|FG002|Overall Study|Protocol Violation|1|||
161520409|NCT00774995|583292676|FG000|Overall Study|Protocol Violation|0|||
161520410|NCT00774995|583292677|FG001|Overall Study|Protocol Violation|0|||
161520411|NCT00774995|583292678|FG002|Overall Study|Protocol Violation|1|||
161520412|NCT00774995|583292679|FG003|Overall Study|Protocol Violation|0|||
161520413|NCT02055352|583294573|FG000|Overall Study|Adverse Event|0|||
161520414|NCT02055352|583294574|FG001|Overall Study|Adverse Event|1|||
161520415|NCT02055352|583294573|FG000|Overall Study|Non-eligible|0|||
161520416|NCT02055352|583294574|FG001|Overall Study|Non-eligible|1|||
161520417|NCT02055352|583294573|FG000|Overall Study|Poor compliance|1|||
161520418|NCT02055352|583294574|FG001|Overall Study|Poor compliance|1|||
161520419|NCT02055352|583294573|FG000|Overall Study|Death|1|||
161520420|NCT02055352|583294574|FG001|Overall Study|Death|2|||
161520421|NCT02055352|583294573|FG000|Overall Study|Patient decision|1|||
161520422|NCT02055352|583294574|FG001|Overall Study|Patient decision|1|||
161520423|NCT02055352|583294573|FG000|Overall Study|Use of prohibited treatment|0|||
161520424|NCT02055352|583294574|FG001|Overall Study|Use of prohibited treatment|3|||
161520425|NCT02055352|583294573|FG000|Overall Study|AE, study drug would be detrimental|1|||
161520426|NCT02055352|583294574|FG001|Overall Study|AE, study drug would be detrimental|3|||
161520427|NCT02055352|583294573|FG000|Overall Study|Withdrawal of informed consent|1|||
161520428|NCT02055352|583294574|FG001|Overall Study|Withdrawal of informed consent|0|||
161520429|NCT02055352|583294573|FG000|Overall Study|Reason unknown|1|||
161520430|NCT02055352|583294574|FG001|Overall Study|Reason unknown|5|||
161520431|NCT04745169|583294575|FG000|Overall Study|Kidney transplantation|1|||
161520432|NCT04745169|583294575|FG000|Overall Study|Participant health problems|3|||
161520433|NCT04745169|583294575|FG000|Overall Study|Physician Decision|2|||
161520434|NCT00993447|583294576|FG000|Overall Study|Withdrawal by Subject|23|||
161520435|NCT00993447|583294577|FG001|Overall Study|Withdrawal by Subject|8|||
161589217|NCT00753090|583546369|FG000|Overall Study|Death|17|||
161589218|NCT00753090|583546370|FG001|Overall Study|Death|6|||
161589219|NCT00753090|583546369|FG000|Overall Study|Study Prosthesis Removed|12|||
161589220|NCT00753090|583546370|FG001|Overall Study|Study Prosthesis Removed|3|||
161824828|NCT00683787|584401736|FG000|Overall Study|Progression|3|||
161824829|NCT00683787|584401737|FG001|Overall Study|Progression|3|||
161824830|NCT00683787|584401738|FG002|Overall Study|Progression|0|||
161824831|NCT00683787|584401736|FG000|Overall Study|Adverse Event|0|||
161824832|NCT00683787|584401737|FG001|Overall Study|Adverse Event|0|||
161824833|NCT00683787|584401738|FG002|Overall Study|Adverse Event|2|||
161824834|NCT02674633|584401739|FG000|Overall Study|Lost to Follow-up|3|||
161824835|NCT02674633|584401740|FG001|Overall Study|Lost to Follow-up|2|||
161824836|NCT02674633|584401739|FG000|Overall Study|Physician Decision|1|||
161824837|NCT02674633|584401740|FG001|Overall Study|Physician Decision|0|||
161824838|NCT02674633|584401739|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161824839|NCT02674633|584401740|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161824840|NCT00460109|584401741|FG000|Overall Study|Death|1|||
161824841|NCT04167618|584401742|FG000|Overall Study|Trial terminated by sponsor|1|||
161824842|NCT04167618|584401743|FG001|Overall Study|Trial terminated by sponsor|1|||
161824843|NCT01235715|584401744|FG000|Overall Study|Physician Decision|0|||
161824844|NCT01235715|584401745|FG001|Overall Study|Physician Decision|2|||
161824845|NCT03619876|584401746|FG000|Overall Study|Withdrawal by Subject|1|||
161824846|NCT03619876|584401747|FG001|Overall Study|Withdrawal by Subject|2|||
161824847|NCT03619876|584401746|FG000|Overall Study|Withdrawal due to incidental finding|0|||
161824848|NCT03619876|584401747|FG001|Overall Study|Withdrawal due to incidental finding|2|||
161824849|NCT02994394|584401748|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824850|NCT02994394|584401749|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824851|NCT02994394|584401750|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
161824852|NCT02994394|584401751|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824853|NCT02994394|584401752|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
161520436|NCT00993447|583294576|FG000|Overall Study|Protocol Violation|12|||
161520437|NCT00993447|583294577|FG001|Overall Study|Protocol Violation|8|||
161520438|NCT00993447|583294576|FG000|Overall Study|Lost to Follow-up|1|||
161520439|NCT00993447|583294577|FG001|Overall Study|Lost to Follow-up|3|||
161520440|NCT00993447|583294576|FG000|Overall Study|Adverse Event|1|||
161520441|NCT00993447|583294577|FG001|Overall Study|Adverse Event|0|||
161520442|NCT02707055|583294578|FG000|Phase 1|Withdrawal by Subject|1|||
161520443|NCT02707055|583294579|FG001|Phase 1|Withdrawal by Subject|2|||
161589221|NCT00753090|583546369|FG000|Overall Study|Lost to Follow-up|2|||
161824854|NCT02994394|584401753|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824855|NCT02994394|584401748|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824856|NCT02994394|584401749|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
161520444|NCT02707055|583294578|FG000|Phase 1|Physician Decision|0|||
161520445|NCT02707055|583294579|FG001|Phase 1|Physician Decision|1|||
161520446|NCT02707055|583294578|FG000|Phase 2|Adverse Event|1|||
161520447|NCT02707055|583294579|FG001|Phase 2|Adverse Event|2|||
161520448|NCT01880424|583294580|FG000|Overall Study|Adverse Event|7|||
161520449|NCT01880424|583294581|FG001|Overall Study|Adverse Event|6|||
161589222|NCT00753090|583546370|FG001|Overall Study|Lost to Follow-up|2|||
161824857|NCT02994394|584401750|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824858|NCT02994394|584401751|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824859|NCT02994394|584401752|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
161824860|NCT02994394|584401753|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824861|NCT02344745|584401754|FG000|Overall Study|Data collection sheets were lost|2|||
161824862|NCT02344745|584401755|FG001|Overall Study|Data collection sheets were lost|0|||
161824863|NCT02788513|584401756|FG000|Overall Study|Withdrawal by Subject|3|||
161824864|NCT02788513|584401757|FG001|Overall Study|Withdrawal by Subject|0|||
161824865|NCT02788513|584401758|FG002|Overall Study|Withdrawal by Subject|2|||
161824866|NCT02788513|584401759|FG003|Overall Study|Withdrawal by Subject|3|||
161824867|NCT02788513|584401760|FG004|Overall Study|Withdrawal by Subject|1|||
161824868|NCT02788513|584401756|FG000|Overall Study|Lost to Follow-up|1|||
161824869|NCT02788513|584401757|FG001|Overall Study|Lost to Follow-up|0|||
161824870|NCT02788513|584401758|FG002|Overall Study|Lost to Follow-up|0|||
161824871|NCT02788513|584401759|FG003|Overall Study|Lost to Follow-up|0|||
161824872|NCT02788513|584401760|FG004|Overall Study|Lost to Follow-up|1|||
161824873|NCT02788513|584401756|FG000|Overall Study|Adverse Event|5|||
161824874|NCT02788513|584401757|FG001|Overall Study|Adverse Event|8|||
161824875|NCT02788513|584401758|FG002|Overall Study|Adverse Event|4|||
161824876|NCT02788513|584401759|FG003|Overall Study|Adverse Event|2|||
161824877|NCT02788513|584401760|FG004|Overall Study|Adverse Event|2|||
161824878|NCT02788513|584401756|FG000|Overall Study|Protocol Violation|0|||
161824879|NCT02788513|584401757|FG001|Overall Study|Protocol Violation|0|||
161824880|NCT02788513|584401758|FG002|Overall Study|Protocol Violation|1|||
161824881|NCT02788513|584401759|FG003|Overall Study|Protocol Violation|1|||
161824882|NCT02788513|584401760|FG004|Overall Study|Protocol Violation|0|||
161824883|NCT02788513|584401756|FG000|Overall Study|Subject decided to stop taking treatment|0|||
161824884|NCT02788513|584401757|FG001|Overall Study|Subject decided to stop taking treatment|0|||
161824885|NCT02788513|584401758|FG002|Overall Study|Subject decided to stop taking treatment|1|||
161824886|NCT02788513|584401759|FG003|Overall Study|Subject decided to stop taking treatment|0|||
161824887|NCT02788513|584401760|FG004|Overall Study|Subject decided to stop taking treatment|0|||
161824888|NCT02788513|584401756|FG000|Overall Study|Decision by the study team|0|||
161824889|NCT02788513|584401757|FG001|Overall Study|Decision by the study team|0|||
161824890|NCT02788513|584401758|FG002|Overall Study|Decision by the study team|0|||
161824891|NCT02788513|584401759|FG003|Overall Study|Decision by the study team|0|||
161824892|NCT02788513|584401760|FG004|Overall Study|Decision by the study team|1|||
161824893|NCT04982445|584401762|FG000|Overall Study|Protocol Violation|1|||
161824894|NCT04982445|584401762|FG000|Overall Study|Withdrawal by Subject|4|||
161824895|NCT04982445|584401762|FG000|Overall Study|Lost to Follow-up|1|||
161824896|NCT03230487|584401766|FG000|Overall Study|Adverse Event|0|||
161824897|NCT03230487|584401767|FG001|Overall Study|Adverse Event|0|||
161824898|NCT03230487|584401768|FG002|Overall Study|Adverse Event|0|||
161824899|NCT03230487|584401769|FG003|Overall Study|Adverse Event|1|||
161824900|NCT03230487|584401770|FG004|Overall Study|Adverse Event|0|||
161824901|NCT03230487|584401771|FG005|Overall Study|Adverse Event|0|||
161824902|NCT01961882|584401774|FG000|Overall Study|Adverse Event|3|||
161824903|NCT01961882|584401775|FG001|Overall Study|Adverse Event|2|||
161824904|NCT01961882|584401774|FG000|Overall Study|Physician Decision|1|||
161824905|NCT01961882|584401775|FG001|Overall Study|Physician Decision|0|||
161824906|NCT01961882|584401774|FG000|Overall Study|Withdrawal by Subject|4|||
161824907|NCT01961882|584401775|FG001|Overall Study|Withdrawal by Subject|1|||
161824908|NCT01961882|584401774|FG000|Overall Study|Relapse of AML|39|||
161824909|NCT01961882|584401775|FG001|Overall Study|Relapse of AML|37|||
161824910|NCT01961882|584401774|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
161824911|NCT01961882|584401775|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
161824912|NCT01961882|584401774|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
161589223|NCT00753090|583546369|FG000|Overall Study|Other|127|||
161589224|NCT00753090|583546370|FG001|Overall Study|Other|75|||
161589225|NCT05113966|583546373|FG000|Overall Study|Death|21|||
161589226|NCT05113966|583546373|FG000|Overall Study|Study Terminated by Sponsor|9|||
161589227|NCT04521478|583546374|FG000|Overall Study|Protocol Violation|2|||
161589228|NCT04521478|583546375|FG001|Overall Study|Protocol Violation|0|||
161589229|NCT04521478|583546376|FG002|Overall Study|Protocol Violation|1|||
161824913|NCT01961882|584401775|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
161589230|NCT04521478|583546377|FG003|Overall Study|Protocol Violation|0|||
161824914|NCT01901848|584401776|FG000|Randomized and Treated|Lost to Follow-up|3|||
161824915|NCT01901848|584401777|FG001|Randomized and Treated|Lost to Follow-up|6|||
161824916|NCT01901848|584401776|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
161824917|NCT01901848|584401777|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
161824918|NCT02916693|584401778|FG000|Overall Study|Lost to Follow-up|7|||
161824919|NCT01190930|584401779|FG000|Induction|Adverse Event|17|||
161589231|NCT04521478|583546378|FG004|Overall Study|Protocol Violation|0|||
161589232|NCT04521478|583546379|FG005|Overall Study|Protocol Violation|0|||
161589233|NCT04521478|583546374|FG000|Overall Study|Technical Problems|0|||
161824920|NCT01190930|584401780|FG001|Induction|Adverse Event|0|||
161589234|NCT04521478|583546375|FG001|Overall Study|Technical Problems|0|||
161824921|NCT01190930|584401781|FG002|Induction|Adverse Event|0|||
161824922|NCT01190930|584401782|FG003|Induction|Adverse Event|0|||
161824923|NCT01190930|584401783|FG004|Induction|Adverse Event|0|||
161824924|NCT01190930|584401784|FG005|Induction|Adverse Event|0|||
161824925|NCT01190930|584401785|FG006|Induction|Adverse Event|0|||
161824926|NCT01190930|584401786|FG007|Induction|Adverse Event|0|||
161824927|NCT01190930|584401787|FG008|Induction|Adverse Event|0|||
161824928|NCT01190930|584401788|FG009|Induction|Adverse Event|0|||
161824929|NCT01190930|584401779|FG000|Induction|Death|34|||
161824930|NCT01190930|584401780|FG001|Induction|Death|0|||
161824931|NCT01190930|584401781|FG002|Induction|Death|0|||
161824932|NCT01190930|584401782|FG003|Induction|Death|0|||
161824933|NCT01190930|584401783|FG004|Induction|Death|0|||
161824934|NCT01190930|584401784|FG005|Induction|Death|0|||
161824935|NCT01190930|584401785|FG006|Induction|Death|0|||
161824936|NCT01190930|584401786|FG007|Induction|Death|0|||
161824937|NCT01190930|584401787|FG008|Induction|Death|0|||
161824938|NCT01190930|584401788|FG009|Induction|Death|0|||
161824939|NCT01190930|584401779|FG000|Induction|Lost to Follow-up|1|||
161824940|NCT01190930|584401780|FG001|Induction|Lost to Follow-up|0|||
161824941|NCT01190930|584401781|FG002|Induction|Lost to Follow-up|0|||
161824942|NCT01190930|584401782|FG003|Induction|Lost to Follow-up|0|||
161824943|NCT01190930|584401783|FG004|Induction|Lost to Follow-up|0|||
161824944|NCT01190930|584401784|FG005|Induction|Lost to Follow-up|0|||
161824945|NCT01190930|584401785|FG006|Induction|Lost to Follow-up|0|||
161824946|NCT01190930|584401786|FG007|Induction|Lost to Follow-up|0|||
161824947|NCT01190930|584401787|FG008|Induction|Lost to Follow-up|0|||
161824948|NCT01190930|584401788|FG009|Induction|Lost to Follow-up|0|||
161824949|NCT01190930|584401779|FG000|Induction|Physician Decision|125|||
161824950|NCT01190930|584401780|FG001|Induction|Physician Decision|3|||
161824951|NCT01190930|584401781|FG002|Induction|Physician Decision|0|||
161824952|NCT01190930|584401782|FG003|Induction|Physician Decision|0|||
161824953|NCT01190930|584401783|FG004|Induction|Physician Decision|0|||
161824954|NCT01190930|584401784|FG005|Induction|Physician Decision|0|||
161824955|NCT01190930|584401785|FG006|Induction|Physician Decision|0|||
161824956|NCT01190930|584401786|FG007|Induction|Physician Decision|0|||
161824957|NCT01190930|584401787|FG008|Induction|Physician Decision|0|||
161824958|NCT01190930|584401788|FG009|Induction|Physician Decision|0|||
161824959|NCT01190930|584401779|FG000|Induction|Withdrawal by Subject|9|||
161824960|NCT01190930|584401780|FG001|Induction|Withdrawal by Subject|0|||
161824961|NCT01190930|584401781|FG002|Induction|Withdrawal by Subject|0|||
161824962|NCT01190930|584401782|FG003|Induction|Withdrawal by Subject|0|||
161824963|NCT01190930|584401783|FG004|Induction|Withdrawal by Subject|0|||
161824964|NCT01190930|584401784|FG005|Induction|Withdrawal by Subject|0|||
161824965|NCT01190930|584401785|FG006|Induction|Withdrawal by Subject|0|||
161824966|NCT01190930|584401786|FG007|Induction|Withdrawal by Subject|0|||
161824967|NCT01190930|584401787|FG008|Induction|Withdrawal by Subject|0|||
161824968|NCT01190930|584401788|FG009|Induction|Withdrawal by Subject|0|||
161824969|NCT01190930|584401779|FG000|Induction|Refusal|235|||
161824970|NCT01190930|584401780|FG001|Induction|Refusal|0|||
161824971|NCT01190930|584401781|FG002|Induction|Refusal|0|||
161824972|NCT01190930|584401782|FG003|Induction|Refusal|0|||
161824973|NCT01190930|584401783|FG004|Induction|Refusal|0|||
161824974|NCT01190930|584401784|FG005|Induction|Refusal|0|||
161824975|NCT01190930|584401785|FG006|Induction|Refusal|0|||
161589235|NCT04521478|583546376|FG002|Overall Study|Technical Problems|0|||
161589236|NCT04521478|583546377|FG003|Overall Study|Technical Problems|1|||
161589237|NCT04521478|583546378|FG004|Overall Study|Technical Problems|0|||
161589238|NCT04521478|583546379|FG005|Overall Study|Technical Problems|0|||
161589239|NCT04521478|583546374|FG000|Overall Study|Burden of Study Procedures|1|||
161589240|NCT04521478|583546375|FG001|Overall Study|Burden of Study Procedures|0|||
161589241|NCT04521478|583546376|FG002|Overall Study|Burden of Study Procedures|0|||
161824976|NCT01190930|584401786|FG007|Induction|Refusal|0|||
161824977|NCT01190930|584401787|FG008|Induction|Refusal|0|||
161824978|NCT01190930|584401788|FG009|Induction|Refusal|0|||
161824979|NCT01190930|584401779|FG000|Induction|Inevaluable|23|||
161824980|NCT01190930|584401780|FG001|Induction|Inevaluable|1|||
161824981|NCT01190930|584401781|FG002|Induction|Inevaluable|0|||
161824982|NCT01190930|584401782|FG003|Induction|Inevaluable|0|||
161824983|NCT01190930|584401783|FG004|Induction|Inevaluable|0|||
161589242|NCT04521478|583546377|FG003|Overall Study|Burden of Study Procedures|1|||
161824984|NCT01190930|584401784|FG005|Induction|Inevaluable|0|||
161824985|NCT01190930|584401785|FG006|Induction|Inevaluable|0|||
161824986|NCT01190930|584401786|FG007|Induction|Inevaluable|0|||
161824987|NCT01190930|584401787|FG008|Induction|Inevaluable|0|||
161824988|NCT01190930|584401788|FG009|Induction|Inevaluable|0|||
161824989|NCT01190930|584401779|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
161824990|NCT01190930|584401780|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824991|NCT01190930|584401781|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824992|NCT01190930|584401782|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824993|NCT01190930|584401783|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161520450|NCT01880424|583294580|FG000|Overall Study|Lack of Efficacy|1|||
161520451|NCT01880424|583294581|FG001|Overall Study|Lack of Efficacy|4|||
161520452|NCT01880424|583294580|FG000|Overall Study|Lost to Follow-up|3|||
161520453|NCT01880424|583294581|FG001|Overall Study|Lost to Follow-up|2|||
161520454|NCT01880424|583294580|FG000|Overall Study|Protocol Violation|11|||
161520455|NCT01880424|583294581|FG001|Overall Study|Protocol Violation|13|||
161520456|NCT01880424|583294580|FG000|Overall Study|Withdrawal by Subject|10|||
161520457|NCT01880424|583294581|FG001|Overall Study|Withdrawal by Subject|30|||
161520458|NCT01880424|583294580|FG000|Overall Study|Other|1|||
161520459|NCT01880424|583294581|FG001|Overall Study|Other|0|||
161520460|NCT02280044|583294584|FG000|Overall Study|Planned alternate|0|||
161520461|NCT02280044|583294585|FG001|Overall Study|Planned alternate|2|||
161520462|NCT05706506|583294586|FG000|Overall Study|Adverse Event|1|||
161520463|NCT05706506|583294586|FG000|Overall Study|Withdrawal by Subject|4|||
161520464|NCT05706506|583294586|FG000|Overall Study|Lost to Follow-up|2|||
161520465|NCT05706506|583294586|FG000|Overall Study|Inadvertent Enrolment|12|||
161520466|NCT05706506|583294586|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
161520467|NCT05706506|583294586|FG000|Overall Study|Participant Moved Out of State|1|||
161520468|NCT02246998|583294587|FG000|Overall Study|Adverse Event|0|||
161520469|NCT02246998|583294588|FG001|Overall Study|Adverse Event|1|||
161520470|NCT02246998|583294589|FG002|Overall Study|Adverse Event|1|||
161520471|NCT02246998|583294590|FG003|Overall Study|Adverse Event|0|||
161520472|NCT02246998|583294587|FG000|Overall Study|Lost to Follow-up|1|||
161520473|NCT02246998|583294588|FG001|Overall Study|Lost to Follow-up|0|||
161520474|NCT02246998|583294589|FG002|Overall Study|Lost to Follow-up|0|||
161520475|NCT02246998|583294590|FG003|Overall Study|Lost to Follow-up|1|||
161520476|NCT02246998|583294587|FG000|Overall Study|Randomized but Never Dosed|1|||
161520477|NCT02246998|583294588|FG001|Overall Study|Randomized but Never Dosed|2|||
161520478|NCT02246998|583294589|FG002|Overall Study|Randomized but Never Dosed|2|||
161520479|NCT02246998|583294590|FG003|Overall Study|Randomized but Never Dosed|1|||
161520480|NCT01303627|583294592|FG000|Overall Study|the failure while performing URS|0|||
161520481|NCT01303627|583294593|FG001|Overall Study|the failure while performing URS|1|||
161520482|NCT01709227|583294597|FG000|Overall Study|Physician Decision|1|||
161520483|NCT01709227|583294598|FG001|Overall Study|Physician Decision|0|||
161520484|NCT01709227|583294597|FG000|Overall Study|Pleural Peritoneal communication|0|||
161520485|NCT01709227|583294598|FG001|Overall Study|Pleural Peritoneal communication|9|||
161520486|NCT04831736|583294601|FG000|Overall Study|Withdrawal by Subject|0|||
161520487|NCT04831736|583294602|FG001|Overall Study|Withdrawal by Subject|1|||
161520488|NCT00795600|583294603|FG000|Overall Study|Adverse Event|1|||
161520489|NCT00795600|583294604|FG001|Overall Study|Adverse Event|1|||
161520490|NCT00795600|583294603|FG000|Overall Study|Protocol Violation|1|||
161520491|NCT00795600|583294604|FG001|Overall Study|Protocol Violation|2|||
161520492|NCT00795600|583294603|FG000|Overall Study|Withdrawal by Subject|1|||
161677511|NCT00467779|583872005|FG005|Stage 3|Unspecified Reason|0|||
161677512|NCT00467779|583872006|FG006|Stage 3|Unspecified Reason|0|||
161677513|NCT00467779|583872007|FG007|Stage 3|Unspecified Reason|0|||
161677514|NCT00467779|583872008|FG008|Stage 3|Unspecified Reason|0|||
161677515|NCT00467779|583872009|FG009|Stage 3|Unspecified Reason|0|||
161677516|NCT00467779|583872010|FG010|Stage 3|Unspecified Reason|0|||
161677517|NCT00467779|583872011|FG011|Stage 3|Unspecified Reason|0|||
161677518|NCT00467779|583872012|FG012|Stage 3|Unspecified Reason|0|||
161677519|NCT00467779|583872013|FG013|Stage 3|Unspecified Reason|0|||
161677520|NCT00467779|583872014|FG014|Stage 3|Unspecified Reason|5|||
161677521|NCT01509079|583872015|FG000|Overall Study|Lack of Efficacy|0|||
161677522|NCT01509079|583872016|FG001|Overall Study|Lack of Efficacy|2|||
161677523|NCT01509079|583872015|FG000|Overall Study|started an excluded medication|0|||
161677524|NCT01509079|583872016|FG001|Overall Study|started an excluded medication|1|||
161677525|NCT01195090|583872017|FG000|Overall Study|Adverse Event|1|||
161677526|NCT01195090|583872018|FG001|Overall Study|Adverse Event|2|||
161677527|NCT01195090|583872017|FG000|Overall Study|Lost to Follow-up|2|||
161677528|NCT01195090|583872018|FG001|Overall Study|Lost to Follow-up|2|||
161677529|NCT01195090|583872017|FG000|Overall Study|Protocol Violation|3|||
161520493|NCT00795600|583294604|FG001|Overall Study|Withdrawal by Subject|0|||
161520494|NCT00795600|583294603|FG000|Overall Study|Unclassified|1|||
161520495|NCT00795600|583294604|FG001|Overall Study|Unclassified|1|||
161520496|NCT01659021|583294605|FG000|Main Study|Adverse Event|2|||
161677530|NCT01195090|583872018|FG001|Overall Study|Protocol Violation|4|||
161677531|NCT05111041|583872019|FG000|Overall Study|Lost to Follow-up|6|||
161677532|NCT05111041|583872020|FG001|Overall Study|Lost to Follow-up|7|||
161520497|NCT01659021|583294606|FG001|Main Study|Adverse Event|3|||
161677533|NCT05111041|583872019|FG000|Overall Study|Withdrawal by Subject|1|||
161520498|NCT01659021|583294605|FG000|Main Study|Lost to Follow-up|1|||
161520499|NCT01659021|583294606|FG001|Main Study|Lost to Follow-up|0|||
161520500|NCT01659021|583294605|FG000|Main Study|Unknown Reasons|2|||
161520501|NCT01659021|583294606|FG001|Main Study|Unknown Reasons|1|||
161520502|NCT01659021|583294605|FG000|Main Study|Physician Decision|34|||
161520503|NCT01659021|583294606|FG001|Main Study|Physician Decision|16|||
161520504|NCT01659021|583294605|FG000|Main Study|Withdrawal by Subject|19|||
161677534|NCT05111041|583872020|FG001|Overall Study|Withdrawal by Subject|0|||
161520505|NCT01659021|583294606|FG001|Main Study|Withdrawal by Subject|16|||
161520506|NCT01659021|583294605|FG000|Main Study|Study Terminated by Sponsor|16|||
161520507|NCT01659021|583294606|FG001|Main Study|Study Terminated by Sponsor|1|||
161520508|NCT01659021|583294605|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
161520509|NCT01659021|583294606|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
161520510|NCT01659021|583294605|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
161520511|NCT01659021|583294606|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
161520512|NCT01202773|583294607|FG000|Overall Study|Adverse Event|4|||
161520513|NCT01202773|583294608|FG001|Overall Study|Adverse Event|5|||
161520514|NCT01202773|583294609|FG002|Overall Study|Adverse Event|5|||
161520515|NCT01202773|583294607|FG000|Overall Study|Lack of Efficacy|5|||
161520516|NCT01202773|583294608|FG001|Overall Study|Lack of Efficacy|4|||
161520517|NCT01202773|583294609|FG002|Overall Study|Lack of Efficacy|9|||
161520518|NCT01202773|583294607|FG000|Overall Study|Entry Criteria Not Met|2|||
161520519|NCT01202773|583294608|FG001|Overall Study|Entry Criteria Not Met|0|||
161520520|NCT01202773|583294609|FG002|Overall Study|Entry Criteria Not Met|1|||
161520521|NCT01202773|583294607|FG000|Overall Study|Lost to Follow-up|1|||
161520522|NCT01202773|583294608|FG001|Overall Study|Lost to Follow-up|2|||
161520523|NCT01202773|583294609|FG002|Overall Study|Lost to Follow-up|2|||
161520524|NCT01202773|583294607|FG000|Overall Study|Withdrawal by Subject|13|||
161520525|NCT01202773|583294608|FG001|Overall Study|Withdrawal by Subject|6|||
161520526|NCT01202773|583294609|FG002|Overall Study|Withdrawal by Subject|5|||
161520527|NCT01202773|583294607|FG000|Overall Study|Physician Decision|2|||
161520528|NCT01202773|583294608|FG001|Overall Study|Physician Decision|0|||
161520529|NCT01202773|583294609|FG002|Overall Study|Physician Decision|0|||
161520530|NCT01202773|583294607|FG000|Overall Study|Protocol Violation|11|||
161520531|NCT01202773|583294608|FG001|Overall Study|Protocol Violation|6|||
161520532|NCT01202773|583294609|FG002|Overall Study|Protocol Violation|10|||
161520533|NCT01202773|583294607|FG000|Overall Study|Sponsor Decision|19|||
161520534|NCT01202773|583294608|FG001|Overall Study|Sponsor Decision|20|||
161520535|NCT01202773|583294609|FG002|Overall Study|Sponsor Decision|23|||
161520536|NCT00575588|583294612|FG000|Overall Study|Adverse Event|11|||
161520537|NCT00575588|583294613|FG001|Overall Study|Adverse Event|13|||
161520538|NCT00575588|583294612|FG000|Overall Study|Withdrawal by Subject|27|||
161520539|NCT00575588|583294613|FG001|Overall Study|Withdrawal by Subject|31|||
161520540|NCT00575588|583294612|FG000|Overall Study|Lost to Follow-up|1|||
161589243|NCT04521478|583546378|FG004|Overall Study|Burden of Study Procedures|0|||
161589244|NCT04521478|583546379|FG005|Overall Study|Burden of Study Procedures|1|||
161589245|NCT04521478|583546374|FG000|Overall Study|Lack of Efficacy|0|||
161589246|NCT04521478|583546375|FG001|Overall Study|Lack of Efficacy|0|||
161824994|NCT01190930|584401784|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824995|NCT01190930|584401785|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824996|NCT01190930|584401786|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824997|NCT01190930|584401787|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824998|NCT01190930|584401788|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824999|NCT01190930|584401779|FG000|Induction|High Risk Downs|80|||
161825000|NCT01190930|584401780|FG001|Induction|High Risk Downs|0|||
161825001|NCT01190930|584401781|FG002|Induction|High Risk Downs|0|||
161825002|NCT01190930|584401782|FG003|Induction|High Risk Downs|0|||
161825003|NCT01190930|584401783|FG004|Induction|High Risk Downs|0|||
161825004|NCT01190930|584401784|FG005|Induction|High Risk Downs|0|||
161825005|NCT01190930|584401785|FG006|Induction|High Risk Downs|0|||
161825006|NCT01190930|584401786|FG007|Induction|High Risk Downs|0|||
161825007|NCT01190930|584401787|FG008|Induction|High Risk Downs|0|||
161825008|NCT01190930|584401788|FG009|Induction|High Risk Downs|0|||
161825009|NCT01190930|584401779|FG000|Induction|Enrollment onto another COG Protocol|1|||
161825010|NCT01190930|584401780|FG001|Induction|Enrollment onto another COG Protocol|0|||
161825011|NCT01190930|584401781|FG002|Induction|Enrollment onto another COG Protocol|0|||
161825012|NCT01190930|584401782|FG003|Induction|Enrollment onto another COG Protocol|0|||
161825013|NCT01190930|584401783|FG004|Induction|Enrollment onto another COG Protocol|0|||
161825014|NCT01190930|584401784|FG005|Induction|Enrollment onto another COG Protocol|0|||
161825015|NCT01190930|584401785|FG006|Induction|Enrollment onto another COG Protocol|0|||
161825016|NCT01190930|584401786|FG007|Induction|Enrollment onto another COG Protocol|0|||
161825017|NCT01190930|584401787|FG008|Induction|Enrollment onto another COG Protocol|0|||
161825018|NCT01190930|584401788|FG009|Induction|Enrollment onto another COG Protocol|0|||
161825019|NCT01190930|584401779|FG000|Induction|Average Risk|1847|||
161825020|NCT01190930|584401780|FG001|Induction|Average Risk|0|||
161825021|NCT01190930|584401781|FG002|Induction|Average Risk|0|||
161825022|NCT01190930|584401782|FG003|Induction|Average Risk|0|||
161825023|NCT01190930|584401783|FG004|Induction|Average Risk|0|||
161825024|NCT01190930|584401784|FG005|Induction|Average Risk|0|||
161825025|NCT01190930|584401785|FG006|Induction|Average Risk|0|||
161825026|NCT01190930|584401786|FG007|Induction|Average Risk|0|||
161825027|NCT01190930|584401787|FG008|Induction|Average Risk|0|||
161520541|NCT00575588|583294613|FG001|Overall Study|Lost to Follow-up|3|||
161520542|NCT00575588|583294612|FG000|Overall Study|Death|4|||
161520543|NCT00575588|583294613|FG001|Overall Study|Death|2|||
161520544|NCT00575588|583294612|FG000|Overall Study|Incorrect enrollment|8|||
161825028|NCT01190930|584401788|FG009|Induction|Average Risk|0|||
161933170|NCT03400787|584804153|FG001|Overall Study|Lost to Follow-up|0|||
161933171|NCT03400787|584804152|FG000|Overall Study|Death|1|||
161933172|NCT03400787|584804153|FG001|Overall Study|Death|0|||
161933173|NCT03400787|584804152|FG000|Overall Study|Protocol Violation|0|||
161933174|NCT03400787|584804153|FG001|Overall Study|Protocol Violation|2|||
161933175|NCT03400787|584804152|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
161933176|NCT03400787|584804153|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
161933177|NCT02402907|584804156|FG000|Overall Study|Delivered vaginally|9|||
161933178|NCT02402907|584804157|FG001|Overall Study|Delivered vaginally|3|||
161933179|NCT02402907|584804156|FG000|Overall Study|Delivered outside of Sinai|1|||
161933180|NCT02402907|584804157|FG001|Overall Study|Delivered outside of Sinai|1|||
161933181|NCT02402907|584804156|FG000|Overall Study|Lost to follow up after C-Section|10|||
161933182|NCT02402907|584804157|FG001|Overall Study|Lost to follow up after C-Section|23|||
161933183|NCT01959919|584804159|FG000|Overall Study|Did not meet the eligibility criteria|2|||
161933184|NCT03439072|584804160|FG000|Overall Study|Withdrawal by Subject|2|||
161933185|NCT03439072|584804161|FG001|Overall Study|Withdrawal by Subject|3|||
161933186|NCT03439072|584804160|FG000|Overall Study|Physician Decision|0|||
161933187|NCT03439072|584804161|FG001|Overall Study|Physician Decision|1|||
161933188|NCT02003898|584804163|FG000|Overall Study|Death|3|||
161933189|NCT02003898|584804163|FG000|Overall Study|Lost to Follow-up|12|||
161933190|NCT02003898|584804163|FG000|Overall Study|Withdrawal by Subject|52|||
161933191|NCT01537432|584804164|FG000|Overall Study|Lost to Follow-up|3|||
161933192|NCT01537432|584804165|FG001|Overall Study|Lost to Follow-up|1|||
161933193|NCT01537432|584804164|FG000|Overall Study|Withdrawal by Subject|0|||
161933194|NCT01537432|584804165|FG001|Overall Study|Withdrawal by Subject|1|||
161933195|NCT01537432|584804164|FG000|Overall Study|Administrative problems|1|||
161520545|NCT00575588|583294613|FG001|Overall Study|Incorrect enrollment|4|||
161520546|NCT00575588|583294612|FG000|Overall Study|Study specific discontinuation criteria|203|||
161520547|NCT00575588|583294613|FG001|Overall Study|Study specific discontinuation criteria|218|||
161520548|NCT00575588|583294612|FG000|Overall Study|Severe non-compliance to protocol|5|||
161520549|NCT00575588|583294613|FG001|Overall Study|Severe non-compliance to protocol|7|||
161520550|NCT00575588|583294612|FG000|Overall Study|Safety reasons|2|||
161520551|NCT00575588|583294613|FG001|Overall Study|Safety reasons|1|||
161520552|NCT00575588|583294612|FG000|Overall Study|Elevated triglyceride|1|||
161520553|NCT00575588|583294613|FG001|Overall Study|Elevated triglyceride|0|||
161520554|NCT00575588|583294612|FG000|Overall Study|Patient moved|1|||
161520555|NCT00575588|583294613|FG001|Overall Study|Patient moved|3|||
161520556|NCT00575588|583294612|FG000|Overall Study|Impossible to determine HbA1c|0|||
161520557|NCT00575588|583294613|FG001|Overall Study|Impossible to determine HbA1c|1|||
161520558|NCT00614939|583294615|FG000|Overall Study|Withdrawal by Subject|10|||
161520559|NCT00614939|583294616|FG001|Overall Study|Withdrawal by Subject|17|||
161520560|NCT00614939|583294615|FG000|Overall Study|Study specific discontinuation criteris|13|||
161520561|NCT00614939|583294616|FG001|Overall Study|Study specific discontinuation criteris|16|||
161520562|NCT00614939|583294615|FG000|Overall Study|Adverse Event|2|||
161520563|NCT00614939|583294616|FG001|Overall Study|Adverse Event|5|||
161520564|NCT00614939|583294615|FG000|Overall Study|Incorrect enrollment|1|||
161520565|NCT00614939|583294616|FG001|Overall Study|Incorrect enrollment|2|||
161520566|NCT00614939|583294615|FG000|Overall Study|Death|4|||
161520567|NCT00614939|583294616|FG001|Overall Study|Death|3|||
161520568|NCT00614939|583294615|FG000|Overall Study|Poor/non-compliance|4|||
161520569|NCT00614939|583294616|FG001|Overall Study|Poor/non-compliance|0|||
161520570|NCT00614939|583294615|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
161520571|NCT00614939|583294616|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
161520572|NCT00840970|583294617|FG000|Overall Study|Adverse Event|0|||
161520573|NCT00840970|583294618|FG001|Overall Study|Adverse Event|0|||
161589247|NCT04521478|583546376|FG002|Overall Study|Lack of Efficacy|0|||
161589248|NCT04521478|583546377|FG003|Overall Study|Lack of Efficacy|0|||
161589249|NCT04521478|583546378|FG004|Overall Study|Lack of Efficacy|1|||
161589250|NCT04521478|583546379|FG005|Overall Study|Lack of Efficacy|1|||
161589251|NCT04521478|583546374|FG000|Overall Study|Adverse Event|7|||
161589252|NCT04521478|583546375|FG001|Overall Study|Adverse Event|0|||
161589253|NCT04521478|583546376|FG002|Overall Study|Adverse Event|2|||
161589254|NCT04521478|583546377|FG003|Overall Study|Adverse Event|1|||
161589255|NCT04521478|583546378|FG004|Overall Study|Adverse Event|2|||
161520574|NCT00840970|583294619|FG002|Overall Study|Adverse Event|1|||
161520575|NCT03465540|583294620|FG000|Overall Study|Withdrawal by Subject|0|||
161589256|NCT04521478|583546379|FG005|Overall Study|Adverse Event|7|||
161933196|NCT01537432|584804165|FG001|Overall Study|Administrative problems|0|||
161933197|NCT01537432|584804164|FG000|Overall Study|Adverse Event|1|||
161933198|NCT01537432|584804165|FG001|Overall Study|Adverse Event|0|||
161933199|NCT01537432|584804164|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161933200|NCT01537432|584804165|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161520576|NCT03465540|583294621|FG001|Overall Study|Withdrawal by Subject|0|||
161933201|NCT03682367|584804168|FG000|Overall Study|Protocol Violation|2|||
161933202|NCT03682367|584804169|FG001|Overall Study|Protocol Violation|1|||
161933203|NCT03682367|584804168|FG000|Overall Study|Closed Study Early|0|||
161933204|NCT03682367|584804169|FG001|Overall Study|Closed Study Early|3|||
161825029|NCT01190930|584401779|FG000|Induction|High Risk|1227|||
161825030|NCT01190930|584401780|FG001|Induction|High Risk|0|||
161825031|NCT01190930|584401781|FG002|Induction|High Risk|0|||
161825032|NCT01190930|584401782|FG003|Induction|High Risk|0|||
161825033|NCT01190930|584401783|FG004|Induction|High Risk|0|||
161825034|NCT01190930|584401784|FG005|Induction|High Risk|0|||
161825035|NCT01190930|584401785|FG006|Induction|High Risk|0|||
161825036|NCT01190930|584401786|FG007|Induction|High Risk|0|||
161825037|NCT01190930|584401787|FG008|Induction|High Risk|0|||
161825038|NCT01190930|584401788|FG009|Induction|High Risk|0|||
161825039|NCT01190930|584401779|FG000|Induction|Low Risk|443|||
161825040|NCT01190930|584401780|FG001|Induction|Low Risk|0|||
161825041|NCT01190930|584401781|FG002|Induction|Low Risk|0|||
161825042|NCT01190930|584401782|FG003|Induction|Low Risk|0|||
161825043|NCT01190930|584401783|FG004|Induction|Low Risk|0|||
161825044|NCT01190930|584401784|FG005|Induction|Low Risk|0|||
161825045|NCT01190930|584401785|FG006|Induction|Low Risk|0|||
161825046|NCT01190930|584401786|FG007|Induction|Low Risk|0|||
161825047|NCT01190930|584401787|FG008|Induction|Low Risk|0|||
161825048|NCT01190930|584401788|FG009|Induction|Low Risk|0|||
161825049|NCT01190930|584401779|FG000|Induction|Very High Risk|1012|||
161825050|NCT01190930|584401780|FG001|Induction|Very High Risk|0|||
161825051|NCT01190930|584401781|FG002|Induction|Very High Risk|0|||
161825052|NCT01190930|584401782|FG003|Induction|Very High Risk|0|||
161825053|NCT01190930|584401783|FG004|Induction|Very High Risk|0|||
161825054|NCT01190930|584401784|FG005|Induction|Very High Risk|0|||
161825055|NCT01190930|584401785|FG006|Induction|Very High Risk|0|||
161825056|NCT01190930|584401786|FG007|Induction|Very High Risk|0|||
161825057|NCT01190930|584401787|FG008|Induction|Very High Risk|0|||
161825058|NCT01190930|584401788|FG009|Induction|Very High Risk|0|||
161825059|NCT01190930|584401779|FG000|Induction|Philadelphia chromosome-positive|99|||
161825060|NCT01190930|584401780|FG001|Induction|Philadelphia chromosome-positive|0|||
161825061|NCT01190930|584401781|FG002|Induction|Philadelphia chromosome-positive|0|||
161825062|NCT01190930|584401782|FG003|Induction|Philadelphia chromosome-positive|0|||
161825063|NCT01190930|584401783|FG004|Induction|Philadelphia chromosome-positive|0|||
161825064|NCT01190930|584401784|FG005|Induction|Philadelphia chromosome-positive|0|||
161825065|NCT01190930|584401785|FG006|Induction|Philadelphia chromosome-positive|0|||
161825066|NCT01190930|584401786|FG007|Induction|Philadelphia chromosome-positive|0|||
161825067|NCT01190930|584401787|FG008|Induction|Philadelphia chromosome-positive|0|||
161825068|NCT01190930|584401788|FG009|Induction|Philadelphia chromosome-positive|0|||
161825069|NCT01190930|584401779|FG000|Induction|Incomplete Induction data|63|||
161825070|NCT01190930|584401780|FG001|Induction|Incomplete Induction data|0|||
161825071|NCT01190930|584401781|FG002|Induction|Incomplete Induction data|0|||
161825072|NCT01190930|584401782|FG003|Induction|Incomplete Induction data|0|||
161825073|NCT01190930|584401783|FG004|Induction|Incomplete Induction data|0|||
161825074|NCT01190930|584401784|FG005|Induction|Incomplete Induction data|0|||
161825075|NCT01190930|584401785|FG006|Induction|Incomplete Induction data|0|||
161825076|NCT01190930|584401786|FG007|Induction|Incomplete Induction data|0|||
161825077|NCT01190930|584401787|FG008|Induction|Incomplete Induction data|0|||
161825078|NCT01190930|584401788|FG009|Induction|Incomplete Induction data|0|||
161825079|NCT01190930|584401779|FG000|Induction|Progressive disease|0|||
161825080|NCT01190930|584401780|FG001|Induction|Progressive disease|1|||
161825081|NCT01190930|584401781|FG002|Induction|Progressive disease|0|||
161825082|NCT01190930|584401782|FG003|Induction|Progressive disease|0|||
161825083|NCT01190930|584401783|FG004|Induction|Progressive disease|0|||
161825084|NCT01190930|584401784|FG005|Induction|Progressive disease|0|||
161825085|NCT01190930|584401785|FG006|Induction|Progressive disease|0|||
161825086|NCT01190930|584401786|FG007|Induction|Progressive disease|0|||
161825087|NCT01190930|584401787|FG008|Induction|Progressive disease|0|||
161825088|NCT01190930|584401788|FG009|Induction|Progressive disease|0|||
161825089|NCT01190930|584401779|FG000|Induction|No treatment|3|||
161825090|NCT01190930|584401780|FG001|Induction|No treatment|0|||
161825091|NCT01190930|584401781|FG002|Induction|No treatment|0|||
161825092|NCT01190930|584401782|FG003|Induction|No treatment|0|||
161825093|NCT01190930|584401783|FG004|Induction|No treatment|0|||
161825094|NCT01190930|584401784|FG005|Induction|No treatment|0|||
161825095|NCT01190930|584401785|FG006|Induction|No treatment|0|||
161825096|NCT01190930|584401786|FG007|Induction|No treatment|0|||
161825097|NCT01190930|584401787|FG008|Induction|No treatment|0|||
161825098|NCT01190930|584401788|FG009|Induction|No treatment|0|||
161825099|NCT01190930|584401779|FG000|Induction|Ineligible|69|||
161825100|NCT01190930|584401780|FG001|Induction|Ineligible|4|||
161825101|NCT01190930|584401781|FG002|Induction|Ineligible|0|||
161933205|NCT05166902|584804170|FG000|First Intervention|Lost to Follow-up|0|||
161825102|NCT01190930|584401782|FG003|Induction|Ineligible|0|||
161825103|NCT01190930|584401783|FG004|Induction|Ineligible|0|||
161825104|NCT01190930|584401784|FG005|Induction|Ineligible|0|||
161825105|NCT01190930|584401785|FG006|Induction|Ineligible|0|||
161825106|NCT01190930|584401786|FG007|Induction|Ineligible|0|||
161825107|NCT01190930|584401787|FG008|Induction|Ineligible|0|||
161825108|NCT01190930|584401788|FG009|Induction|Ineligible|0|||
161825109|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
161933206|NCT05166902|584804171|FG001|First Intervention|Lost to Follow-up|1|||
161933207|NCT00128492|584804172|FG000|Overall Study|AE unrelated to study|2|||
161933208|NCT00128492|584804173|FG001|Overall Study|AE unrelated to study|9|||
161933209|NCT00128492|584804172|FG000|Overall Study|Study drug intolerance (AE)|2|||
161933210|NCT00128492|584804173|FG001|Overall Study|Study drug intolerance (AE)|8|||
161933211|NCT00128492|584804172|FG000|Overall Study|AE related to study|1|||
161933212|NCT00128492|584804173|FG001|Overall Study|AE related to study|4|||
161933213|NCT00128492|584804172|FG000|Overall Study|Death|1|||
161933214|NCT00128492|584804173|FG001|Overall Study|Death|0|||
161825110|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
161825111|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
161825112|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
161825113|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
161825114|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
161825115|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
161825116|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
161825117|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
161825118|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
161825119|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Death|0|||
161825120|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Death|0|||
161825121|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Death|8|||
161825122|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Death|4|||
161825123|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Death|0|||
161825124|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Death|0|||
161825125|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Death|0|||
161825126|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Death|0|||
161825127|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Death|0|||
161825128|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Death|0|||
161825129|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
161825130|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
161825131|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
161825132|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
161825133|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
161825134|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
161825135|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
161825136|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
161825137|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
161825138|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
161825139|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825140|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
161825141|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
161825142|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
161825143|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825144|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825145|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825146|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825147|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825148|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825149|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Refusal|0|||
161825150|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Refusal|2|||
161825151|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Refusal|694|||
161825152|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Refusal|4|||
161825153|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Refusal|0|||
161825154|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Refusal|3|||
161825155|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Refusal|0|||
161825156|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Refusal|0|||
161825157|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Refusal|0|||
161825158|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Refusal|0|||
161825159|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
161825160|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
161825161|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
161825162|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
161825163|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
161825164|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
161825165|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
161825166|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
161933215|NCT00128492|584804172|FG000|Overall Study|Lost to Follow-up|1|||
161933216|NCT00128492|584804173|FG001|Overall Study|Lost to Follow-up|5|||
161589257|NCT04521478|583546374|FG000|Overall Study|No Reason Available|0|||
161520577|NCT03465540|583294622|FG002|Overall Study|Withdrawal by Subject|1|||
161520578|NCT03465540|583294623|FG003|Overall Study|Withdrawal by Subject|1|||
161520579|NCT03465540|583294624|FG004|Overall Study|Withdrawal by Subject|1|||
161520580|NCT03465540|583294625|FG005|Overall Study|Withdrawal by Subject|0|||
161520581|NCT03465540|583294620|FG000|Overall Study|Lost to Follow-up|0|||
161520582|NCT03465540|583294621|FG001|Overall Study|Lost to Follow-up|1|||
161520583|NCT03465540|583294622|FG002|Overall Study|Lost to Follow-up|0|||
161520584|NCT03465540|583294623|FG003|Overall Study|Lost to Follow-up|0|||
161520585|NCT03465540|583294624|FG004|Overall Study|Lost to Follow-up|1|||
161520586|NCT03465540|583294625|FG005|Overall Study|Lost to Follow-up|0|||
161520587|NCT03465540|583294620|FG000|Overall Study|Death|1|||
161520588|NCT03465540|583294621|FG001|Overall Study|Death|1|||
161520589|NCT03465540|583294622|FG002|Overall Study|Death|0|||
161520590|NCT03465540|583294623|FG003|Overall Study|Death|2|||
161520591|NCT03465540|583294624|FG004|Overall Study|Death|0|||
161825167|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
161825168|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
161825169|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825170|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
161825171|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825172|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825173|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825174|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825175|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825176|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825177|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825178|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825179|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
161825180|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
161825181|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
161825182|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
161825183|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
161825184|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
161825185|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
161825186|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
161825187|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
161825188|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
161825189|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Relapse|0|||
161825190|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Relapse|0|||
161825191|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Relapse|1|||
161825192|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Relapse|0|||
161825193|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Relapse|0|||
161825194|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Relapse|0|||
161825195|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Relapse|0|||
161825196|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Relapse|0|||
161825197|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Relapse|0|||
161825198|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Relapse|0|||
161825199|NCT01190930|584401779|FG000|Maintenance|Adverse Event|0|||
161825200|NCT01190930|584401780|FG001|Maintenance|Adverse Event|0|||
161825201|NCT01190930|584401781|FG002|Maintenance|Adverse Event|0|||
161825202|NCT01190930|584401782|FG003|Maintenance|Adverse Event|0|||
161825203|NCT01190930|584401783|FG004|Maintenance|Adverse Event|0|||
161825204|NCT01190930|584401784|FG005|Maintenance|Adverse Event|1|||
161825205|NCT01190930|584401785|FG006|Maintenance|Adverse Event|1|||
161825206|NCT01190930|584401786|FG007|Maintenance|Adverse Event|3|||
161825207|NCT01190930|584401787|FG008|Maintenance|Adverse Event|3|||
161825208|NCT01190930|584401788|FG009|Maintenance|Adverse Event|0|||
161825209|NCT01190930|584401779|FG000|Maintenance|Death|0|||
161825210|NCT01190930|584401780|FG001|Maintenance|Death|0|||
161825211|NCT01190930|584401781|FG002|Maintenance|Death|0|||
161825212|NCT01190930|584401782|FG003|Maintenance|Death|1|||
161825213|NCT01190930|584401783|FG004|Maintenance|Death|0|||
161825214|NCT01190930|584401784|FG005|Maintenance|Death|0|||
161825215|NCT01190930|584401785|FG006|Maintenance|Death|2|||
161825216|NCT01190930|584401786|FG007|Maintenance|Death|2|||
161825217|NCT01190930|584401787|FG008|Maintenance|Death|2|||
161825218|NCT01190930|584401788|FG009|Maintenance|Death|2|||
161825219|NCT01190930|584401779|FG000|Maintenance|Lost to Follow-up|0|||
161825220|NCT01190930|584401780|FG001|Maintenance|Lost to Follow-up|0|||
161825221|NCT01190930|584401781|FG002|Maintenance|Lost to Follow-up|0|||
161825222|NCT01190930|584401782|FG003|Maintenance|Lost to Follow-up|0|||
161825223|NCT01190930|584401783|FG004|Maintenance|Lost to Follow-up|0|||
161825224|NCT01190930|584401784|FG005|Maintenance|Lost to Follow-up|0|||
161825225|NCT01190930|584401785|FG006|Maintenance|Lost to Follow-up|1|||
161825226|NCT01190930|584401786|FG007|Maintenance|Lost to Follow-up|1|||
161825227|NCT01190930|584401787|FG008|Maintenance|Lost to Follow-up|1|||
161933217|NCT00128492|584804172|FG000|Overall Study|Noncompliance|0|||
161933218|NCT00128492|584804173|FG001|Overall Study|Noncompliance|5|||
161933219|NCT00128492|584804172|FG000|Overall Study|Personal or administrative|10|||
161933220|NCT00128492|584804173|FG001|Overall Study|Personal or administrative|22|||
161933221|NCT00128492|584804172|FG000|Overall Study|Withdrawal by Subject|3|||
161933222|NCT00128492|584804173|FG001|Overall Study|Withdrawal by Subject|5|||
161933223|NCT00128492|584804172|FG000|Overall Study|Pregnancy|0|||
161933224|NCT00128492|584804173|FG001|Overall Study|Pregnancy|1|||
161933225|NCT03436420|584804175|FG000|Overall Study|Lack of Efficacy|3|||
161933226|NCT00756314|584804176|FG000|Overall Study|Lost to Follow-up|2|||
161933227|NCT00756314|584804177|FG001|Overall Study|Lost to Follow-up|59|||
161933228|NCT02605967|584804178|FG000|Overall Study|subject / guardian decision|1|||
161933229|NCT02605967|584804179|FG001|Overall Study|subject / guardian decision|2|||
161933230|NCT02605967|584804178|FG000|Overall Study|Physician Decision|10|||
161933231|NCT02605967|584804179|FG001|Overall Study|Physician Decision|1|||
161933232|NCT02605967|584804178|FG000|Overall Study|Death|4|||
161933233|NCT02605967|584804179|FG001|Overall Study|Death|2|||
161933234|NCT02605967|584804178|FG000|Overall Study|Adverse Event|1|||
161933235|NCT02605967|584804179|FG001|Overall Study|Adverse Event|0|||
161933236|NCT02605967|584804178|FG000|Overall Study|progressive disease|66|||
161933237|NCT02605967|584804179|FG001|Overall Study|progressive disease|35|||
161933238|NCT03627468|584804180|FG000|Overall Study|Adverse Event|5|||
161933239|NCT03627468|584804181|FG001|Overall Study|Adverse Event|33|||
161933240|NCT03627468|584804180|FG000|Overall Study|Withdrawal by Subject|13|||
161933241|NCT03627468|584804181|FG001|Overall Study|Withdrawal by Subject|23|||
161933242|NCT03627468|584804180|FG000|Overall Study|Physician Decision|1|||
161933243|NCT03627468|584804181|FG001|Overall Study|Physician Decision|0|||
161933244|NCT03627468|584804180|FG000|Overall Study|Protocol Violation|0|||
161933245|NCT03627468|584804181|FG001|Overall Study|Protocol Violation|2|||
161933246|NCT03627468|584804180|FG000|Overall Study|Lost to Follow-up|10|||
161933247|NCT03627468|584804181|FG001|Overall Study|Lost to Follow-up|16|||
161933248|NCT03627468|584804180|FG000|Overall Study|Death|1|||
161933249|NCT03627468|584804181|FG001|Overall Study|Death|0|||
161933250|NCT03627468|584804180|FG000|Overall Study|Pregnancy|1|||
161933251|NCT03627468|584804181|FG001|Overall Study|Pregnancy|1|||
161933252|NCT03627468|584804180|FG000|Overall Study|Lack of Efficacy|0|||
161933253|NCT03627468|584804181|FG001|Overall Study|Lack of Efficacy|2|||
161933254|NCT03627468|584804180|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
161933255|NCT03627468|584804181|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
161933256|NCT01475825|584804185|FG000|Overall Study|Adverse Event|41|||
161933257|NCT01475825|584804186|FG001|Overall Study|Adverse Event|15|||
161933258|NCT01475825|584804187|FG002|Overall Study|Adverse Event|27|||
161933259|NCT01475825|584804188|FG003|Overall Study|Adverse Event|11|||
161933260|NCT01475825|584804185|FG000|Overall Study|Death|1|||
161933261|NCT01475825|584804186|FG001|Overall Study|Death|0|||
161933262|NCT01475825|584804187|FG002|Overall Study|Death|1|||
161933263|NCT01475825|584804188|FG003|Overall Study|Death|0|||
161933264|NCT01475825|584804185|FG000|Overall Study|Lack of Efficacy|0|||
161933265|NCT01475825|584804186|FG001|Overall Study|Lack of Efficacy|0|||
161933266|NCT01475825|584804187|FG002|Overall Study|Lack of Efficacy|1|||
161933267|NCT01475825|584804188|FG003|Overall Study|Lack of Efficacy|0|||
161933268|NCT01475825|584804185|FG000|Overall Study|Lost to Follow-up|0|||
161933269|NCT01475825|584804186|FG001|Overall Study|Lost to Follow-up|0|||
161933270|NCT01475825|584804187|FG002|Overall Study|Lost to Follow-up|3|||
161933271|NCT01475825|584804188|FG003|Overall Study|Lost to Follow-up|1|||
161933272|NCT01475825|584804185|FG000|Overall Study|Non-compliance with Study Drug|1|||
161933273|NCT01475825|584804186|FG001|Overall Study|Non-compliance with Study Drug|2|||
161933274|NCT01475825|584804187|FG002|Overall Study|Non-compliance with Study Drug|4|||
161677535|NCT04912245|583872021|FG000|Overall Study|Withdrawal by Subject|21|||
161677536|NCT04912245|583872022|FG001|Overall Study|Withdrawal by Subject|4|||
161677537|NCT04912245|583872021|FG000|Overall Study|Lost to Follow-up|5|||
161677538|NCT04912245|583872022|FG001|Overall Study|Lost to Follow-up|11|||
161677539|NCT01205230|583872023|FG000|Overall Study|Adverse Event|4|||
161933275|NCT01475825|584804188|FG003|Overall Study|Non-compliance with Study Drug|0|||
161933276|NCT01475825|584804185|FG000|Overall Study|Other: Not available|0|||
161933277|NCT01475825|584804186|FG001|Overall Study|Other: Not available|0|||
161933278|NCT01475825|584804187|FG002|Overall Study|Other: Not available|2|||
161933279|NCT01475825|584804188|FG003|Overall Study|Other: Not available|0|||
161677540|NCT01205230|583872024|FG001|Overall Study|Adverse Event|0|||
161677541|NCT01205230|583872023|FG000|Overall Study|Physician Decision|1|||
161933280|NCT01475825|584804185|FG000|Overall Study|Protocol Violation|1|||
161933281|NCT01475825|584804186|FG001|Overall Study|Protocol Violation|0|||
161933282|NCT01475825|584804187|FG002|Overall Study|Protocol Violation|0|||
161933283|NCT01475825|584804188|FG003|Overall Study|Protocol Violation|0|||
161933284|NCT01475825|584804185|FG000|Overall Study|Physician Decision|0|||
161933285|NCT01475825|584804186|FG001|Overall Study|Physician Decision|1|||
161933286|NCT01475825|584804187|FG002|Overall Study|Physician Decision|0|||
161933287|NCT01475825|584804188|FG003|Overall Study|Physician Decision|0|||
161933288|NCT01475825|584804185|FG000|Overall Study|Withdrawal by Subject|8|||
161933289|NCT01475825|584804186|FG001|Overall Study|Withdrawal by Subject|3|||
161825228|NCT01190930|584401788|FG009|Maintenance|Lost to Follow-up|0|||
161825229|NCT01190930|584401779|FG000|Maintenance|Physician Decision|0|||
161825230|NCT01190930|584401780|FG001|Maintenance|Physician Decision|1|||
161933290|NCT01475825|584804187|FG002|Overall Study|Withdrawal by Subject|11|||
161933291|NCT01475825|584804188|FG003|Overall Study|Withdrawal by Subject|7|||
161933292|NCT01475825|584804185|FG000|Overall Study|Did not enter OLC|15|||
161520592|NCT03465540|583294625|FG005|Overall Study|Death|2|||
161520593|NCT03465540|583294620|FG000|Overall Study|Protocol specified criteria|0|||
161520594|NCT03465540|583294621|FG001|Overall Study|Protocol specified criteria|2|||
161520595|NCT03465540|583294622|FG002|Overall Study|Protocol specified criteria|2|||
161520596|NCT03465540|583294623|FG003|Overall Study|Protocol specified criteria|0|||
161520597|NCT03465540|583294624|FG004|Overall Study|Protocol specified criteria|2|||
161520598|NCT03465540|583294625|FG005|Overall Study|Protocol specified criteria|0|||
161520599|NCT00504829|583294626|FG000|Overall Study|Protocol Violation|6|||
161520600|NCT00504829|583294627|FG001|Overall Study|Protocol Violation|4|||
161520601|NCT00504829|583294628|FG002|Overall Study|Protocol Violation|10|||
161520602|NCT01854827|583294629|FG000|Overall Study|Death|1|||
161520603|NCT00736996|583294630|FG000|Overall Study|Lost to Follow-up|1|||
161520604|NCT00736996|583294631|FG001|Overall Study|Lost to Follow-up|9|||
161520605|NCT00736996|583294632|FG002|Overall Study|Lost to Follow-up|2|||
161520606|NCT00462384|583294633|FG000|Overall Study|Adverse Event|2|||
161520607|NCT00462384|583294633|FG000|Overall Study|Death|2|||
161520608|NCT00462384|583294633|FG000|Overall Study|Withdrawal by Subject|1|||
161520609|NCT00462384|583294633|FG000|Overall Study|Other|4|||
161520610|NCT04000165|583294634|FG000|Overall Study|Physician Decision|1|||
161520611|NCT04000165|583294634|FG000|Overall Study|Withdrawal by Subject|1|||
161520612|NCT01751568|583294639|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
161520613|NCT01751568|583294640|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
161520614|NCT01751568|583294641|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
161520615|NCT02660944|583294650|FG000|Overall Study|Adverse Event|3|||
161520616|NCT02660944|583294651|FG001|Overall Study|Adverse Event|4|||
161520617|NCT02660944|583294650|FG000|Overall Study|Physician Decision|3|||
161520618|NCT02660944|583294651|FG001|Overall Study|Physician Decision|1|||
161520619|NCT02660944|583294650|FG000|Overall Study|Withdrawal by Subject|5|||
161520620|NCT02660944|583294651|FG001|Overall Study|Withdrawal by Subject|3|||
161520621|NCT02660944|583294650|FG000|Overall Study|Lost to Follow-up|4|||
161520622|NCT02660944|583294651|FG001|Overall Study|Lost to Follow-up|1|||
161825231|NCT01190930|584401781|FG002|Maintenance|Physician Decision|0|||
161825232|NCT01190930|584401782|FG003|Maintenance|Physician Decision|5|||
161825233|NCT01190930|584401783|FG004|Maintenance|Physician Decision|9|||
161825234|NCT01190930|584401784|FG005|Maintenance|Physician Decision|4|||
161825235|NCT01190930|584401785|FG006|Maintenance|Physician Decision|8|||
161825236|NCT01190930|584401786|FG007|Maintenance|Physician Decision|8|||
161825237|NCT01190930|584401787|FG008|Maintenance|Physician Decision|10|||
161825238|NCT01190930|584401788|FG009|Maintenance|Physician Decision|17|||
161825239|NCT01190930|584401779|FG000|Maintenance|Withdrawal by Subject|0|||
161825240|NCT01190930|584401780|FG001|Maintenance|Withdrawal by Subject|0|||
161825241|NCT01190930|584401781|FG002|Maintenance|Withdrawal by Subject|0|||
161825242|NCT01190930|584401782|FG003|Maintenance|Withdrawal by Subject|0|||
161825243|NCT01190930|584401783|FG004|Maintenance|Withdrawal by Subject|0|||
161825244|NCT01190930|584401784|FG005|Maintenance|Withdrawal by Subject|0|||
161825245|NCT01190930|584401785|FG006|Maintenance|Withdrawal by Subject|2|||
161825246|NCT01190930|584401786|FG007|Maintenance|Withdrawal by Subject|1|||
161825247|NCT01190930|584401787|FG008|Maintenance|Withdrawal by Subject|4|||
161825248|NCT01190930|584401788|FG009|Maintenance|Withdrawal by Subject|1|||
161825249|NCT01190930|584401779|FG000|Maintenance|Refusal|0|||
161825250|NCT01190930|584401780|FG001|Maintenance|Refusal|1|||
161825251|NCT01190930|584401781|FG002|Maintenance|Refusal|0|||
161825252|NCT01190930|584401782|FG003|Maintenance|Refusal|2|||
161825253|NCT01190930|584401783|FG004|Maintenance|Refusal|0|||
161825254|NCT01190930|584401784|FG005|Maintenance|Refusal|4|||
161825255|NCT01190930|584401785|FG006|Maintenance|Refusal|5|||
161825256|NCT01190930|584401786|FG007|Maintenance|Refusal|17|||
161825257|NCT01190930|584401787|FG008|Maintenance|Refusal|13|||
161825258|NCT01190930|584401788|FG009|Maintenance|Refusal|6|||
161520623|NCT02660944|583294650|FG000|Overall Study|Subject schedule|0|||
161520624|NCT02660944|583294651|FG001|Overall Study|Subject schedule|1|||
161520625|NCT02660944|583294650|FG000|Overall Study|Exclusion criteria met|2|||
161589258|NCT04521478|583546375|FG001|Overall Study|No Reason Available|2|||
161825259|NCT01190930|584401779|FG000|Maintenance|second malignant neoplasm|0|||
161825260|NCT01190930|584401780|FG001|Maintenance|second malignant neoplasm|0|||
161825261|NCT01190930|584401781|FG002|Maintenance|second malignant neoplasm|0|||
161825262|NCT01190930|584401782|FG003|Maintenance|second malignant neoplasm|1|||
161825263|NCT01190930|584401783|FG004|Maintenance|second malignant neoplasm|0|||
161520626|NCT02660944|583294651|FG001|Overall Study|Exclusion criteria met|0|||
161825264|NCT01190930|584401784|FG005|Maintenance|second malignant neoplasm|1|||
161520627|NCT02843568|583294652|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
161589259|NCT04521478|583546376|FG002|Overall Study|No Reason Available|0|||
161933293|NCT01475825|584804186|FG001|Overall Study|Did not enter OLC|11|||
161933294|NCT01475825|584804187|FG002|Overall Study|Did not enter OLC|15|||
161933295|NCT01475825|584804188|FG003|Overall Study|Did not enter OLC|11|||
161933296|NCT01903733|584804189|FG000|Overall Study|Death|23|||
161933297|NCT01903733|584804190|FG001|Overall Study|Death|54|||
161933298|NCT01903733|584804191|FG002|Overall Study|Death|30|||
161933299|NCT01903733|584804192|FG003|Overall Study|Death|98|||
161933300|NCT01903733|584804189|FG000|Overall Study|Participant refused further follow-up|35|||
161933301|NCT01903733|584804190|FG001|Overall Study|Participant refused further follow-up|38|||
161933302|NCT01903733|584804191|FG002|Overall Study|Participant refused further follow-up|13|||
161933303|NCT01903733|584804192|FG003|Overall Study|Participant refused further follow-up|9|||
161933304|NCT01903733|584804189|FG000|Overall Study|Lost to Follow-up|18|||
161933305|NCT01903733|584804190|FG001|Overall Study|Lost to Follow-up|19|||
161933306|NCT01903733|584804191|FG002|Overall Study|Lost to Follow-up|6|||
161933307|NCT01903733|584804192|FG003|Overall Study|Lost to Follow-up|9|||
161933308|NCT01903733|584804189|FG000|Overall Study|Other|10|||
161933309|NCT01903733|584804190|FG001|Overall Study|Other|15|||
161933310|NCT01903733|584804191|FG002|Overall Study|Other|12|||
161933311|NCT01903733|584804192|FG003|Overall Study|Other|3|||
161933312|NCT01903733|584804189|FG000|Overall Study|Missing|2|||
161933313|NCT01903733|584804190|FG001|Overall Study|Missing|0|||
161933314|NCT01903733|584804191|FG002|Overall Study|Missing|0|||
161933315|NCT01903733|584804192|FG003|Overall Study|Missing|0|||
161933316|NCT01903733|584804189|FG000|Overall Study|Investigator request|18|||
161933317|NCT01903733|584804190|FG001|Overall Study|Investigator request|0|||
161825265|NCT01190930|584401785|FG006|Maintenance|second malignant neoplasm|0|||
161825266|NCT01190930|584401786|FG007|Maintenance|second malignant neoplasm|0|||
161825267|NCT01190930|584401787|FG008|Maintenance|second malignant neoplasm|1|||
161520628|NCT02843568|583294653|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
161933318|NCT01903733|584804191|FG002|Overall Study|Investigator request|0|||
161933319|NCT01903733|584804192|FG003|Overall Study|Investigator request|0|||
161933320|NCT01714063|584804193|FG000|Overall Study|Equipment malfunction|2|||
161825268|NCT01190930|584401788|FG009|Maintenance|second malignant neoplasm|0|||
161825269|NCT01190930|584401779|FG000|Maintenance|Inevaluable|0|||
161825270|NCT01190930|584401780|FG001|Maintenance|Inevaluable|0|||
161825271|NCT01190930|584401781|FG002|Maintenance|Inevaluable|0|||
161520629|NCT02843568|583294652|FG000|Overall Study|Death|3|||
161520630|NCT02843568|583294653|FG001|Overall Study|Death|3|||
161933321|NCT03721107|584804194|FG000|Overall Study|Adverse Event|1|||
161933322|NCT03721107|584804195|FG001|Overall Study|Adverse Event|1|||
161933323|NCT03721107|584804196|FG002|Overall Study|Adverse Event|6|||
161933324|NCT03721107|584804197|FG003|Overall Study|Adverse Event|5|||
161933325|NCT03721107|584804194|FG000|Overall Study|Lost to Follow-up|2|||
161933326|NCT03721107|584804195|FG001|Overall Study|Lost to Follow-up|0|||
161933327|NCT03721107|584804196|FG002|Overall Study|Lost to Follow-up|3|||
161933328|NCT03721107|584804197|FG003|Overall Study|Lost to Follow-up|0|||
161933329|NCT03721107|584804194|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
161933330|NCT03721107|584804195|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
161933331|NCT03721107|584804196|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
161933332|NCT03721107|584804197|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
161933333|NCT03721107|584804194|FG000|Overall Study|Physician Decision|0|||
161933334|NCT03721107|584804195|FG001|Overall Study|Physician Decision|1|||
161933335|NCT03721107|584804196|FG002|Overall Study|Physician Decision|0|||
161933336|NCT03721107|584804197|FG003|Overall Study|Physician Decision|0|||
161933337|NCT03721107|584804194|FG000|Overall Study|Pregnancy|0|||
161520631|NCT02843568|583294652|FG000|Overall Study|Withdrawal by Subject|1|||
161520632|NCT02843568|583294653|FG001|Overall Study|Withdrawal by Subject|1|||
161520633|NCT02843568|583294652|FG000|Overall Study|Lost to Follow-up|2|||
161520634|NCT02843568|583294653|FG001|Overall Study|Lost to Follow-up|0|||
161520635|NCT03586999|583294654|FG000|Overall Study|Lack of Efficacy|2|||
161677542|NCT01205230|583872024|FG001|Overall Study|Physician Decision|0|||
161933338|NCT03721107|584804195|FG001|Overall Study|Pregnancy|0|||
161933339|NCT03721107|584804196|FG002|Overall Study|Pregnancy|1|||
161933340|NCT03721107|584804197|FG003|Overall Study|Pregnancy|0|||
161933341|NCT03721107|584804194|FG000|Overall Study|Withdrawal by Subject|1|||
161933342|NCT03721107|584804195|FG001|Overall Study|Withdrawal by Subject|1|||
161825272|NCT01190930|584401782|FG003|Maintenance|Inevaluable|0|||
161933343|NCT03721107|584804196|FG002|Overall Study|Withdrawal by Subject|5|||
161677543|NCT03945591|583872025|FG000|Overall Study|Participant not transplanted|1|||
161677544|NCT03945591|583872025|FG000|Overall Study|Change in treatment plan|3|||
161933344|NCT03721107|584804197|FG003|Overall Study|Withdrawal by Subject|5|||
161933345|NCT03721107|584804194|FG000|Overall Study|Other|1|||
161933346|NCT03721107|584804195|FG001|Overall Study|Other|0|||
161933347|NCT03721107|584804196|FG002|Overall Study|Other|0|||
161933348|NCT03721107|584804197|FG003|Overall Study|Other|1|||
161520636|NCT04096560|583294655|FG000|Overall Study|Reason not Specified|1|||
161825273|NCT01190930|584401783|FG004|Maintenance|Inevaluable|0|||
161933349|NCT02369159|584804200|FG000|Overall Study|Adverse Event|0|||
161933350|NCT02369159|584804201|FG001|Overall Study|Adverse Event|1|||
161825274|NCT01190930|584401784|FG005|Maintenance|Inevaluable|1|||
161520637|NCT04096560|583294656|FG001|Overall Study|Reason not Specified|0|||
161520638|NCT04096560|583294657|FG002|Overall Study|Reason not Specified|0|||
161520639|NCT04096560|583294658|FG003|Overall Study|Reason not Specified|0|||
161520640|NCT04096560|583294659|FG004|Overall Study|Reason not Specified|1|||
161520641|NCT04096560|583294660|FG005|Overall Study|Reason not Specified|1|||
161520642|NCT04096560|583294661|FG006|Overall Study|Reason not Specified|1|||
161520643|NCT04096560|583294662|FG007|Overall Study|Reason not Specified|0|||
161520644|NCT04096560|583294655|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
161520645|NCT04096560|583294656|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
161520646|NCT04096560|583294657|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
161520647|NCT04096560|583294658|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
161520648|NCT04096560|583294659|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
161520649|NCT04096560|583294660|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
161520650|NCT04096560|583294661|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
161520651|NCT04096560|583294662|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
161520652|NCT04096560|583294655|FG000|Overall Study|Study Terminated by Sponsor|0|||
161520653|NCT04096560|583294656|FG001|Overall Study|Study Terminated by Sponsor|0|||
161520654|NCT04096560|583294657|FG002|Overall Study|Study Terminated by Sponsor|0|||
161520655|NCT04096560|583294658|FG003|Overall Study|Study Terminated by Sponsor|5|||
161520656|NCT04096560|583294659|FG004|Overall Study|Study Terminated by Sponsor|6|||
161520657|NCT04096560|583294660|FG005|Overall Study|Study Terminated by Sponsor|4|||
161520658|NCT04096560|583294661|FG006|Overall Study|Study Terminated by Sponsor|6|||
161520659|NCT04096560|583294662|FG007|Overall Study|Study Terminated by Sponsor|1|||
161520660|NCT04096560|583294655|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520661|NCT04096560|583294656|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520662|NCT04096560|583294657|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520663|NCT04096560|583294658|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520664|NCT04096560|583294659|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520665|NCT04096560|583294660|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520666|NCT04096560|583294661|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
161520667|NCT04096560|583294662|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
161520668|NCT00534352|583294665|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
161520669|NCT00534352|583294665|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
161520670|NCT00534352|583294665|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
161520671|NCT00534352|583294665|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
161520672|NCT00534352|583294665|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
161520673|NCT00534352|583294665|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
161520674|NCT03264989|583294668|FG000|Overall Study|Lost to Follow-up|1|||
161520675|NCT03264989|583294669|FG001|Overall Study|Lost to Follow-up|0|||
161520676|NCT03264989|583294668|FG000|Overall Study|New Therapy for study Indication|1|||
161520677|NCT03264989|583294669|FG001|Overall Study|New Therapy for study Indication|0|||
161520678|NCT03264989|583294668|FG000|Overall Study|Protocol Violation|0|||
161520679|NCT03264989|583294669|FG001|Overall Study|Protocol Violation|1|||
161520680|NCT03264989|583294668|FG000|Overall Study|Patient decision|13|||
161520681|NCT03264989|583294669|FG001|Overall Study|Patient decision|0|||
161520682|NCT03264989|583294668|FG000|Overall Study|Physician Decision|6|||
161520683|NCT03264989|583294669|FG001|Overall Study|Physician Decision|4|||
161520684|NCT03264989|583294668|FG000|Overall Study|Adverse Event|2|||
161520685|NCT03264989|583294669|FG001|Overall Study|Adverse Event|1|||
161520686|NCT03264989|583294668|FG000|Overall Study|Death|1|||
161520687|NCT03264989|583294669|FG001|Overall Study|Death|1|||
161520688|NCT03264989|583294668|FG000|Overall Study|Pregnancy|2|||
161520689|NCT03264989|583294669|FG001|Overall Study|Pregnancy|0|||
161520690|NCT03264989|583294668|FG000|Overall Study|End of Study|19|||
161520691|NCT03264989|583294669|FG001|Overall Study|End of Study|5|||
161520692|NCT02504866|583294675|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
161520693|NCT02504866|583294676|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
161520694|NCT02504866|583294677|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
161520695|NCT01775137|583294678|FG000|Overall Study|Death|1|||
161520696|NCT01775137|583294678|FG000|Overall Study|Protocol deviation|2|||
161520697|NCT01775137|583294678|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161520698|NCT01775137|583294678|FG000|Overall Study|Adverse Event|1|||
161520699|NCT01775137|583294678|FG000|Overall Study|Withdrawal by participants|5|||
161825275|NCT01190930|584401785|FG006|Maintenance|Inevaluable|1|||
161825276|NCT01190930|584401786|FG007|Maintenance|Inevaluable|1|||
161825277|NCT01190930|584401787|FG008|Maintenance|Inevaluable|0|||
161825278|NCT01190930|584401788|FG009|Maintenance|Inevaluable|0|||
161825279|NCT01190930|584401779|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
161825280|NCT01190930|584401780|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
161825281|NCT01190930|584401781|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
161825282|NCT01190930|584401782|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
161933351|NCT02369159|584804200|FG000|Overall Study|Lost to Follow-up|1|||
161520700|NCT04796610|583294679|FG000|Overall Study|Withdrawal by Subject|1|||
161520701|NCT04796610|583294680|FG001|Overall Study|Withdrawal by Subject|0|||
161520702|NCT04796610|583294681|FG002|Overall Study|Withdrawal by Subject|0|||
161520703|NCT04796610|583294682|FG003|Overall Study|Withdrawal by Subject|0|||
161520704|NCT04796610|583294679|FG000|Overall Study|Lost to Follow-up|2|||
161520705|NCT04796610|583294680|FG001|Overall Study|Lost to Follow-up|0|||
161520706|NCT04796610|583294681|FG002|Overall Study|Lost to Follow-up|1|||
161520707|NCT04796610|583294682|FG003|Overall Study|Lost to Follow-up|1|||
161520708|NCT01459796|583294683|FG000|Overall Study|Non compliance with protocol|2|||
161520709|NCT01459796|583294684|FG001|Overall Study|Non compliance with protocol|4|||
161520710|NCT01459796|583294683|FG000|Overall Study|Adverse Event|5|||
161520711|NCT01459796|583294684|FG001|Overall Study|Adverse Event|5|||
161520712|NCT01459796|583294683|FG000|Overall Study|Withdrawal by Subject|6|||
161520713|NCT01459796|583294684|FG001|Overall Study|Withdrawal by Subject|3|||
161520714|NCT01459796|583294683|FG000|Overall Study|Lost to Follow-up|5|||
161520715|NCT01459796|583294684|FG001|Overall Study|Lost to Follow-up|4|||
161520716|NCT01459796|583294683|FG000|Overall Study|Reason unspecified|1|||
161520717|NCT01459796|583294684|FG001|Overall Study|Reason unspecified|2|||
161520718|NCT01459796|583294683|FG000|Overall Study|Decision by the sponsor|75|||
161520719|NCT01459796|583294684|FG001|Overall Study|Decision by the sponsor|108|||
161520720|NCT00733824|583294685|FG000|Phase I|Withdrawal by Subject|1|||
161520721|NCT00733824|583294686|FG001|Phase I|Withdrawal by Subject|0|||
161520722|NCT00733824|583294687|FG002|Phase I|Withdrawal by Subject|0|||
161520723|NCT00733824|583294688|FG003|Phase I|Withdrawal by Subject|0|||
161520724|NCT00733824|583294689|FG004|Phase I|Withdrawal by Subject|0|||
161520725|NCT01343056|583294690|FG000|Overall Study|Lost to Follow-up|7|||
161520726|NCT01343056|583294691|FG001|Overall Study|Lost to Follow-up|5|||
161520727|NCT01343056|583294692|FG002|Overall Study|Lost to Follow-up|3|||
161520728|NCT01343056|583294693|FG003|Overall Study|Lost to Follow-up|9|||
161520729|NCT03231371|583294694|FG000|Overall Study|Withdrawal by Subject|1|||
161520730|NCT03231371|583294694|FG000|Overall Study|chose or were ineligible to have MRI|12|||
161520731|NCT03067441|583294697|FG000|Overall Study|Withdrawal by Subject|16|||
161520732|NCT03067441|583294698|FG001|Overall Study|Withdrawal by Subject|34|||
161520733|NCT03067441|583294697|FG000|Overall Study|Lost to Follow-up|7|||
161520734|NCT03067441|583294698|FG001|Overall Study|Lost to Follow-up|5|||
161520735|NCT03067441|583294697|FG000|Overall Study|Adverse Event|7|||
161520736|NCT03067441|583294698|FG001|Overall Study|Adverse Event|14|||
161520737|NCT03067441|583294697|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
161520738|NCT03067441|583294698|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
161520739|NCT03067441|583294697|FG000|Overall Study|Physician Decision|1|||
161520740|NCT03067441|583294698|FG001|Overall Study|Physician Decision|3|||
161520741|NCT03067441|583294697|FG000|Overall Study|Other|1|||
161520742|NCT03067441|583294698|FG001|Overall Study|Other|1|||
161520743|NCT00499889|583294699|FG000|Overall Study|Infection prior to treatment|1|||
161520744|NCT03299192|583294700|FG000|Overall Study|Fell before classes started|1|||
161520745|NCT03299192|583294701|FG001|Overall Study|Fell before classes started|0|||
161520746|NCT03299192|583294702|FG002|Overall Study|Fell before classes started|0|||
161520747|NCT03299192|583294700|FG000|Overall Study|Other|0|||
161520748|NCT03299192|583294701|FG001|Overall Study|Other|2|||
161520749|NCT03299192|583294702|FG002|Overall Study|Other|1|||
161520750|NCT00101101|583294708|FG000|Overall Study|never received vaccine|20|||
161825283|NCT01190930|584401783|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
161825284|NCT01190930|584401784|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
161825285|NCT01190930|584401785|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
161825286|NCT01190930|584401786|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
161825287|NCT01190930|584401787|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
161825288|NCT01190930|584401788|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
161825289|NCT01190930|584401779|FG000|Maintenance|Relapse|0|||
161825290|NCT01190930|584401780|FG001|Maintenance|Relapse|0|||
161825291|NCT01190930|584401781|FG002|Maintenance|Relapse|0|||
161825292|NCT01190930|584401782|FG003|Maintenance|Relapse|2|||
161825293|NCT01190930|584401783|FG004|Maintenance|Relapse|0|||
161825294|NCT01190930|584401784|FG005|Maintenance|Relapse|1|||
161825295|NCT01190930|584401785|FG006|Maintenance|Relapse|6|||
161825296|NCT01190930|584401786|FG007|Maintenance|Relapse|13|||
161825297|NCT01190930|584401787|FG008|Maintenance|Relapse|11|||
161825298|NCT01190930|584401788|FG009|Maintenance|Relapse|11|||
161825299|NCT01190930|584401779|FG000|Maintenance|Still on therapy|0|||
161825300|NCT01190930|584401780|FG001|Maintenance|Still on therapy|8|||
161825301|NCT01190930|584401781|FG002|Maintenance|Still on therapy|0|||
161825302|NCT01190930|584401782|FG003|Maintenance|Still on therapy|29|||
161520751|NCT01418209|583294709|FG000|Overall Study|Withdrawal by Subject|1|||
161520752|NCT01418209|583294710|FG001|Overall Study|Withdrawal by Subject|0|||
161520753|NCT01418209|583294711|FG002|Overall Study|Withdrawal by Subject|1|||
161520754|NCT01418209|583294709|FG000|Overall Study|Did not provide hot flash diary data|1|||
161520755|NCT01418209|583294710|FG001|Overall Study|Did not provide hot flash diary data|3|||
161825303|NCT01190930|584401783|FG004|Maintenance|Still on therapy|0|||
161933352|NCT02369159|584804201|FG001|Overall Study|Lost to Follow-up|1|||
161933353|NCT02369159|584804200|FG000|Overall Study|Withdrawal by Subject|7|||
161933354|NCT02369159|584804201|FG001|Overall Study|Withdrawal by Subject|0|||
161933355|NCT00563316|584804204|FG000|Overall Study|Adverse Event|2|||
161933356|NCT00563316|584804204|FG000|Overall Study|Physician Decision|1|||
161933357|NCT00563316|584804204|FG000|Overall Study|Lost to Follow-up|2|||
161933358|NCT00563316|584804204|FG000|Overall Study|Death|1|||
161933359|NCT00563316|584804204|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
161933360|NCT00563316|584804204|FG000|Overall Study|Other|1|||
161933361|NCT02991859|584804208|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933362|NCT02991859|584804209|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
161933363|NCT02991859|584804210|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933364|NCT02991859|584804211|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933365|NCT02991859|584804212|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
161933366|NCT02991859|584804213|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933367|NCT02991859|584804214|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933368|NCT02991859|584804215|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933369|NCT02991859|584804216|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933370|NCT02991859|584804217|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933371|NCT02991859|584804218|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933372|NCT02991859|584804219|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933373|NCT02991859|584804220|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933374|NCT02991859|584804221|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933375|NCT02991859|584804222|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933376|NCT02991859|584804223|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933377|NCT02991859|584804224|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933378|NCT02991859|584804208|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933379|NCT02991859|584804209|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933380|NCT02991859|584804210|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933381|NCT02991859|584804211|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933382|NCT02991859|584804212|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933383|NCT02991859|584804213|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933384|NCT02991859|584804214|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933385|NCT02991859|584804215|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933386|NCT02991859|584804216|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933387|NCT02991859|584804217|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933388|NCT02991859|584804218|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933389|NCT02991859|584804219|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933390|NCT02991859|584804220|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
161933391|NCT02991859|584804221|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
161933392|NCT02991859|584804222|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933393|NCT02991859|584804223|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933394|NCT02991859|584804224|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933395|NCT02991859|584804208|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933396|NCT02991859|584804209|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933397|NCT02991859|584804210|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933398|NCT02991859|584804211|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933399|NCT02991859|584804212|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933400|NCT02991859|584804213|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
161933401|NCT02991859|584804214|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933402|NCT02991859|584804215|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933403|NCT02991859|584804216|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933404|NCT02991859|584804217|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933405|NCT02991859|584804218|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933406|NCT02991859|584804219|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933407|NCT02991859|584804220|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933408|NCT02991859|584804221|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161520756|NCT01418209|583294711|FG002|Overall Study|Did not provide hot flash diary data|3|||
161520757|NCT01603875|583294712|FG000|Overall Study|Preexisting rabies antibody|3|||
161520758|NCT01603875|583294713|FG001|Overall Study|Preexisting rabies antibody|4|||
161520759|NCT01603875|583294714|FG002|Overall Study|Preexisting rabies antibody|3|||
161520760|NCT01603875|583294712|FG000|Overall Study|Lost to Follow-up|4|||
161520761|NCT01603875|583294713|FG001|Overall Study|Lost to Follow-up|3|||
161520762|NCT01603875|583294714|FG002|Overall Study|Lost to Follow-up|6|||
161520763|NCT01603875|583294712|FG000|Overall Study|Protocol Violation|0|||
161520764|NCT01603875|583294713|FG001|Overall Study|Protocol Violation|1|||
161520765|NCT01603875|583294714|FG002|Overall Study|Protocol Violation|0|||
161520766|NCT01652716|583294718|FG000|Overall Study|Loss of glucose control|1|||
161520767|NCT01652716|583294719|FG001|Overall Study|Loss of glucose control|0|||
161520768|NCT01652716|583294718|FG000|Overall Study|Administrative|0|||
161520769|NCT01652716|583294719|FG001|Overall Study|Administrative|2|||
161520770|NCT01652716|583294718|FG000|Overall Study|Investigator decision|1|||
161520771|NCT01652716|583294719|FG001|Overall Study|Investigator decision|4|||
161520772|NCT01652716|583294718|FG000|Overall Study|Lost to Follow-up|12|||
161520773|NCT01652716|583294719|FG001|Overall Study|Lost to Follow-up|11|||
161589260|NCT04521478|583546377|FG003|Overall Study|No Reason Available|0|||
161589261|NCT04521478|583546378|FG004|Overall Study|No Reason Available|1|||
161589262|NCT04521478|583546379|FG005|Overall Study|No Reason Available|0|||
161589263|NCT04521478|583546374|FG000|Overall Study|Other than listed|3|||
161825304|NCT01190930|584401784|FG005|Maintenance|Still on therapy|0|||
161825305|NCT01190930|584401785|FG006|Maintenance|Still on therapy|0|||
161825306|NCT01190930|584401786|FG007|Maintenance|Still on therapy|0|||
161825307|NCT01190930|584401787|FG008|Maintenance|Still on therapy|0|||
161825308|NCT01190930|584401788|FG009|Maintenance|Still on therapy|0|||
161825309|NCT00979212|584401792|FG000|Overall Study|Protocol Violation|1|||
161825310|NCT00979212|584401793|FG001|Overall Study|Protocol Violation|8|||
161825311|NCT00979212|584401792|FG000|Overall Study|No protocol therapy received|1|||
161825312|NCT00979212|584401793|FG001|Overall Study|No protocol therapy received|0|||
161825313|NCT00035555|584401794|FG000|Overall Study|Adverse Event|5|||
161825314|NCT00035555|584401795|FG001|Overall Study|Adverse Event|8|||
161825315|NCT00035555|584401796|FG002|Overall Study|Adverse Event|9|||
161825316|NCT00035555|584401794|FG000|Overall Study|Allograft loss|1|||
161825317|NCT00035555|584401795|FG001|Overall Study|Allograft loss|1|||
161825318|NCT00035555|584401796|FG002|Overall Study|Allograft loss|2|||
161825319|NCT00035555|584401794|FG000|Overall Study|Death|0|||
161825320|NCT00035555|584401795|FG001|Overall Study|Death|0|||
161825321|NCT00035555|584401796|FG002|Overall Study|Death|2|||
161825322|NCT00035555|584401794|FG000|Overall Study|Lost to Follow-up|0|||
161825323|NCT00035555|584401795|FG001|Overall Study|Lost to Follow-up|0|||
161825324|NCT00035555|584401796|FG002|Overall Study|Lost to Follow-up|1|||
161825325|NCT00035555|584401794|FG000|Overall Study|Noncompliance|0|||
161825326|NCT00035555|584401795|FG001|Overall Study|Noncompliance|1|||
161825327|NCT00035555|584401796|FG002|Overall Study|Noncompliance|1|||
161825328|NCT00035555|584401794|FG000|Overall Study|Prohibited medication|1|||
161825329|NCT00035555|584401795|FG001|Overall Study|Prohibited medication|1|||
161825330|NCT00035555|584401796|FG002|Overall Study|Prohibited medication|0|||
161825331|NCT00035555|584401794|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
161825332|NCT00035555|584401795|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
161825333|NCT00035555|584401796|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
161825334|NCT00035555|584401794|FG000|Overall Study|Withdrawal by Subject|2|||
161825335|NCT00035555|584401795|FG001|Overall Study|Withdrawal by Subject|0|||
161825336|NCT00035555|584401796|FG002|Overall Study|Withdrawal by Subject|2|||
161825337|NCT00035555|584401794|FG000|Overall Study|Investigator deemed not a good candidate|0|||
161825338|NCT00035555|584401795|FG001|Overall Study|Investigator deemed not a good candidate|0|||
161825339|NCT00035555|584401796|FG002|Overall Study|Investigator deemed not a good candidate|1|||
161825340|NCT00035555|584401794|FG000|Overall Study|Received cyclosporin in error|0|||
161825341|NCT00035555|584401795|FG001|Overall Study|Received cyclosporin in error|0|||
161825342|NCT00035555|584401796|FG002|Overall Study|Received cyclosporin in error|1|||
161825343|NCT00337428|584401797|FG000|Overall Study|Withdrawal by Subject|1|||
161825344|NCT00337428|584401798|FG001|Overall Study|Withdrawal by Subject|2|||
161825345|NCT00337428|584401797|FG000|Overall Study|Lack of Time|1|||
161825346|NCT00337428|584401798|FG001|Overall Study|Lack of Time|1|||
161825347|NCT00337428|584401797|FG000|Overall Study|Unwilling to Continue|1|||
161825348|NCT00337428|584401798|FG001|Overall Study|Unwilling to Continue|0|||
161825349|NCT00337428|584401797|FG000|Overall Study|Anorexia|1|||
161825350|NCT00337428|584401798|FG001|Overall Study|Anorexia|0|||
161825351|NCT02618382|584401799|FG000|Overall Study|Physician Decision|1|||
161825352|NCT02618382|584401799|FG000|Overall Study|Withdrawal by Subject|1|||
161825353|NCT02618382|584401799|FG000|Overall Study|Protocol Violation|1|||
161825354|NCT03223909|584401800|FG000|Overall Study|Protocol Violation|48|||
161825355|NCT03223909|584401801|FG001|Overall Study|Protocol Violation|45|||
161825356|NCT03223909|584401802|FG002|Overall Study|Protocol Violation|16|||
161825357|NCT04886063|584401809|FG000|Overall Study|Adverse Event|50|||
161825358|NCT04886063|584401809|FG000|Overall Study|Lack of Efficacy|31|||
161825359|NCT04886063|584401809|FG000|Overall Study|Withdrawal by Subject|45|||
161825360|NCT04886063|584401809|FG000|Overall Study|Physician Decision|3|||
161825361|NCT04886063|584401809|FG000|Overall Study|Protocol Violation|3|||
161825362|NCT04886063|584401809|FG000|Overall Study|Site closure|4|||
161825363|NCT04886063|584401809|FG000|Overall Study|Nursing home replacement|3|||
161825364|NCT04886063|584401809|FG000|Overall Study|Lost to Follow-up|5|||
161825365|NCT04886063|584401809|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
161825366|NCT04886063|584401809|FG000|Overall Study|>1 reason|20|||
161825367|NCT01628549|584401810|FG000|Overall Study|Adverse Event|1|||
161825368|NCT01628549|584401811|FG001|Overall Study|Adverse Event|1|||
161825369|NCT01628549|584401812|FG002|Overall Study|Adverse Event|0|||
161520774|NCT01652716|583294718|FG000|Overall Study|Protocol Violation|2|||
161520775|NCT01652716|583294719|FG001|Overall Study|Protocol Violation|1|||
161520776|NCT01652716|583294718|FG000|Overall Study|Adverse Event|7|||
161520777|NCT01652716|583294719|FG001|Overall Study|Adverse Event|10|||
161520778|NCT01652716|583294718|FG000|Overall Study|Withdrawal by Subject|33|||
161520779|NCT01652716|583294719|FG001|Overall Study|Withdrawal by Subject|18|||
161520780|NCT04122443|583294722|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
161520781|NCT04122443|583294723|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
161520782|NCT04122443|583294724|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
161520783|NCT04122443|583294722|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
161520784|NCT04122443|583294723|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
161520785|NCT04122443|583294724|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
161520786|NCT05204134|583294725|FG000|Overall Study|Withdrawal by Subject|3|||
161520787|NCT05204134|583294725|FG000|Overall Study|Physician Decision|1|||
161520788|NCT01312467|583294729|FG000|Overall Study|Adverse Event|4|||
161520789|NCT01312467|583294729|FG000|Overall Study|Lost to Follow-up|1|||
161520790|NCT01312467|583294729|FG000|Overall Study|Withdrawal by Subject|2|||
161520791|NCT01312467|583294729|FG000|Overall Study|Deported to country of origin|1|||
161520792|NCT01312467|583294729|FG000|Overall Study|Another medical condition|1|||
161520793|NCT01312467|583294729|FG000|Overall Study|Ineligible|4|||
161520794|NCT01059617|583294732|FG000|Overall Study|Other|7|||
161520795|NCT01059617|583294733|FG001|Overall Study|Other|1|||
161520796|NCT01059617|583294734|FG002|Overall Study|Other|8|||
161520797|NCT01059617|583294735|FG003|Overall Study|Other|6|||
161520798|NCT01968434|583294736|FG000|Overall Study|Lost to Follow-up|3|||
161520799|NCT01968434|583294737|FG001|Overall Study|Lost to Follow-up|6|||
161520800|NCT02199691|583294739|FG000|Overall Study|Protocol Violation|3|||
161520801|NCT02199691|583294740|FG001|Overall Study|Protocol Violation|3|||
161520802|NCT02199691|583294741|FG002|Overall Study|Protocol Violation|6|||
161520803|NCT02199691|583294742|FG003|Overall Study|Protocol Violation|7|||
161520804|NCT02199691|583294739|FG000|Overall Study|Withdrawal by Subject|5|||
161520805|NCT02199691|583294740|FG001|Overall Study|Withdrawal by Subject|3|||
161520806|NCT02199691|583294741|FG002|Overall Study|Withdrawal by Subject|12|||
161520807|NCT02199691|583294742|FG003|Overall Study|Withdrawal by Subject|13|||
161520808|NCT02199691|583294739|FG000|Overall Study|Lost to Follow-up|2|||
161520809|NCT02199691|583294740|FG001|Overall Study|Lost to Follow-up|1|||
161520810|NCT02199691|583294741|FG002|Overall Study|Lost to Follow-up|9|||
161520811|NCT02199691|583294742|FG003|Overall Study|Lost to Follow-up|10|||
161520812|NCT00612313|583294745|FG000|Overall Study|Withdrawal by Subject|6|||
161520813|NCT00612313|583294746|FG001|Overall Study|Withdrawal by Subject|9|||
161520814|NCT00612313|583294745|FG000|Overall Study|Lost to Follow-up|11|||
161520815|NCT00612313|583294746|FG001|Overall Study|Lost to Follow-up|4|||
161520816|NCT02239510|583297351|FG000|Overall Study|Lost to Follow-up|2|||
161589264|NCT04521478|583546375|FG001|Overall Study|Other than listed|3|||
161589265|NCT04521478|583546376|FG002|Overall Study|Other than listed|3|||
161589266|NCT04521478|583546377|FG003|Overall Study|Other than listed|2|||
161933409|NCT02991859|584804222|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933410|NCT02991859|584804223|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933411|NCT02991859|584804224|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933412|NCT02991859|584804208|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933413|NCT02991859|584804209|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933414|NCT02991859|584804210|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161520817|NCT02239510|583297352|FG001|Overall Study|Lost to Follow-up|1|||
161520818|NCT05349617|583297356|FG000|Overall Study|Death|1|||
161520819|NCT05349617|583297357|FG001|Overall Study|Death|1|||
161520820|NCT05349617|583297356|FG000|Overall Study|Lost to Follow-up|3|||
161520821|NCT05349617|583297357|FG001|Overall Study|Lost to Follow-up|8|||
161520822|NCT05349617|583297356|FG000|Overall Study|Withdrawal by Subject|2|||
161520823|NCT05349617|583297357|FG001|Overall Study|Withdrawal by Subject|10|||
161520824|NCT00970502|583297362|FG000|Overall Study|Withdrawal by Subject|1|||
161520825|NCT04401579|583297363|FG000|Overall Study|Death|23|||
161520826|NCT04401579|583297364|FG001|Overall Study|Death|36|||
161520827|NCT04401579|583297363|FG000|Overall Study|Lost to Follow-up|40|||
161520828|NCT04401579|583297364|FG001|Overall Study|Lost to Follow-up|41|||
161933415|NCT02991859|584804211|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161520829|NCT04401579|583297363|FG000|Overall Study|Withdrawal by Subject|8|||
161520830|NCT04401579|583297364|FG001|Overall Study|Withdrawal by Subject|16|||
161520831|NCT04401579|583297363|FG000|Overall Study|Physician Decision|1|||
161520832|NCT04401579|583297364|FG001|Overall Study|Physician Decision|2|||
161520833|NCT04401579|583297363|FG000|Overall Study|Became ineligible after enrollment|1|||
161520834|NCT04401579|583297364|FG001|Overall Study|Became ineligible after enrollment|1|||
161520835|NCT04401579|583297363|FG000|Overall Study|Enrolled but treatment not administered|7|||
161933416|NCT02991859|584804212|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933417|NCT02991859|584804213|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161520836|NCT04401579|583297364|FG001|Overall Study|Enrolled but treatment not administered|9|||
161520837|NCT04401579|583297363|FG000|Overall Study|Adverse Event|2|||
161520838|NCT04401579|583297364|FG001|Overall Study|Adverse Event|1|||
161520839|NCT04401579|583297363|FG000|Overall Study|Scheduling error|1|||
161520840|NCT04401579|583297364|FG001|Overall Study|Scheduling error|2|||
161520841|NCT04401579|583297363|FG000|Overall Study|Transferred to another hospital|1|||
161520842|NCT04401579|583297364|FG001|Overall Study|Transferred to another hospital|2|||
161520843|NCT00489970|583297365|FG000|Persistence Year 9|Lost to Follow-up|2|||
161520844|NCT00489970|583297366|FG001|Persistence Year 9|Lost to Follow-up|2|||
161520845|NCT00489970|583297367|FG002|Persistence Year 9|Lost to Follow-up|3|||
161520846|NCT00489970|583297365|FG000|Persistence Year 9|Other|1|||
161520847|NCT00489970|583297366|FG001|Persistence Year 9|Other|0|||
161520848|NCT00489970|583297367|FG002|Persistence Year 9|Other|2|||
161520849|NCT01075321|583297373|FG000|Overall Study|Withdrawal by Subject|0|||
161520850|NCT01075321|583297374|FG001|Overall Study|Withdrawal by Subject|0|||
161520851|NCT01075321|583297375|FG002|Overall Study|Withdrawal by Subject|1|||
161520852|NCT01075321|583297376|FG003|Overall Study|Withdrawal by Subject|1|||
161520853|NCT01075321|583297373|FG000|Overall Study|Protocol Violation|0|||
161520854|NCT01075321|583297374|FG001|Overall Study|Protocol Violation|0|||
161520855|NCT01075321|583297375|FG002|Overall Study|Protocol Violation|1|||
161520856|NCT01075321|583297376|FG003|Overall Study|Protocol Violation|0|||
161520857|NCT01075321|583297373|FG000|Overall Study|Treatment Incomplete due to progression|1|||
161520858|NCT01075321|583297374|FG001|Overall Study|Treatment Incomplete due to progression|0|||
161520859|NCT01075321|583297375|FG002|Overall Study|Treatment Incomplete due to progression|0|||
161520860|NCT01075321|583297376|FG003|Overall Study|Treatment Incomplete due to progression|0|||
161520861|NCT01075321|583297373|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
161520862|NCT01075321|583297374|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
161520863|NCT01075321|583297375|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
161520864|NCT01075321|583297376|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
161520865|NCT02646423|583297377|FG000|Overall Study|Adverse Event|5|||
161520866|NCT02646423|583297378|FG001|Overall Study|Adverse Event|7|||
161520867|NCT02646423|583297377|FG000|Overall Study|Ineligible|2|||
161520868|NCT02646423|583297378|FG001|Overall Study|Ineligible|1|||
161520869|NCT00003457|583297379|FG000|Overall Study|Not evaluable|9|||
161520870|NCT01054729|583297383|FG000|Overall Study|Randomized but Not Treated|0|||
161520871|NCT01054729|583297384|FG001|Overall Study|Randomized but Not Treated|1|||
161520872|NCT01054729|583297385|FG002|Overall Study|Randomized but Not Treated|0|||
161520873|NCT01054729|583297386|FG003|Overall Study|Randomized but Not Treated|0|||
161520874|NCT01054729|583297383|FG000|Overall Study|Adverse Event|1|||
161520875|NCT01054729|583297384|FG001|Overall Study|Adverse Event|1|||
161520876|NCT01054729|583297385|FG002|Overall Study|Adverse Event|2|||
161520877|NCT01054729|583297386|FG003|Overall Study|Adverse Event|1|||
161520878|NCT01054729|583297383|FG000|Overall Study|Withdrawal by Subject|1|||
161520879|NCT01054729|583297384|FG001|Overall Study|Withdrawal by Subject|0|||
161520880|NCT01054729|583297385|FG002|Overall Study|Withdrawal by Subject|1|||
161520881|NCT01054729|583297386|FG003|Overall Study|Withdrawal by Subject|0|||
161520882|NCT01054729|583297383|FG000|Overall Study|Lost to Follow-up|0|||
161520883|NCT01054729|583297384|FG001|Overall Study|Lost to Follow-up|1|||
161520884|NCT01054729|583297385|FG002|Overall Study|Lost to Follow-up|0|||
161520885|NCT01054729|583297386|FG003|Overall Study|Lost to Follow-up|0|||
161520886|NCT01054729|583297383|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
161520887|NCT01054729|583297384|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
161520888|NCT01054729|583297385|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
161520889|NCT01054729|583297386|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
161520890|NCT01054729|583297383|FG000|Overall Study|Non-responder|1|||
161825370|NCT01628549|584401813|FG003|Overall Study|Adverse Event|4|||
161520891|NCT01054729|583297384|FG001|Overall Study|Non-responder|0|||
161520892|NCT01054729|583297385|FG002|Overall Study|Non-responder|1|||
161520893|NCT01054729|583297386|FG003|Overall Study|Non-responder|1|||
161520894|NCT01054729|583297383|FG000|Overall Study|PEG/RBV Non-responder|1|||
161825371|NCT01628549|584401810|FG000|Overall Study|Lost to Follow-up|3|||
161825372|NCT01628549|584401811|FG001|Overall Study|Lost to Follow-up|4|||
161825373|NCT01628549|584401812|FG002|Overall Study|Lost to Follow-up|3|||
161825374|NCT01628549|584401813|FG003|Overall Study|Lost to Follow-up|3|||
161825375|NCT01628549|584401810|FG000|Overall Study|Withdrawal by Subject|3|||
161825376|NCT01628549|584401811|FG001|Overall Study|Withdrawal by Subject|4|||
161825377|NCT01628549|584401812|FG002|Overall Study|Withdrawal by Subject|4|||
161825378|NCT01628549|584401813|FG003|Overall Study|Withdrawal by Subject|1|||
161825379|NCT01628549|584401810|FG000|Overall Study|Protocol Violation|2|||
161520895|NCT01054729|583297384|FG001|Overall Study|PEG/RBV Non-responder|0|||
161520896|NCT01054729|583297385|FG002|Overall Study|PEG/RBV Non-responder|1|||
161520897|NCT01054729|583297386|FG003|Overall Study|PEG/RBV Non-responder|0|||
161520898|NCT01054729|583297383|FG000|Overall Study|Personal/Obligations|0|||
161520899|NCT01054729|583297384|FG001|Overall Study|Personal/Obligations|1|||
161520900|NCT01054729|583297385|FG002|Overall Study|Personal/Obligations|0|||
161520901|NCT01054729|583297386|FG003|Overall Study|Personal/Obligations|0|||
161520902|NCT01054729|583297383|FG000|Overall Study|Subject moved|0|||
161825380|NCT01628549|584401811|FG001|Overall Study|Protocol Violation|1|||
161933418|NCT02991859|584804214|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933419|NCT02991859|584804215|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933420|NCT02991859|584804216|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933421|NCT02991859|584804217|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
161933422|NCT02991859|584804218|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933423|NCT02991859|584804219|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933424|NCT02991859|584804220|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933425|NCT02991859|584804221|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933426|NCT02991859|584804222|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933427|NCT02991859|584804223|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933428|NCT02991859|584804224|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933429|NCT02991859|584804208|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933430|NCT02991859|584804209|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933431|NCT02991859|584804210|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933432|NCT02991859|584804211|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933433|NCT02991859|584804212|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933434|NCT02991859|584804213|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161520903|NCT01054729|583297384|FG001|Overall Study|Subject moved|0|||
161520904|NCT01054729|583297385|FG002|Overall Study|Subject moved|1|||
161520905|NCT01054729|583297386|FG003|Overall Study|Subject moved|0|||
161520906|NCT01054729|583297383|FG000|Overall Study|Lack of Efficacy|0|||
161520907|NCT01054729|583297384|FG001|Overall Study|Lack of Efficacy|0|||
161520908|NCT01054729|583297385|FG002|Overall Study|Lack of Efficacy|0|||
161520909|NCT01054729|583297386|FG003|Overall Study|Lack of Efficacy|1|||
161520910|NCT00321919|583297387|FG000|Overall Study|Adverse Event|17|||
161520911|NCT00321919|583297388|FG001|Overall Study|Adverse Event|10|||
161520912|NCT00321919|583297387|FG000|Overall Study|Death|21|||
161520913|NCT00321919|583297388|FG001|Overall Study|Death|17|||
161933435|NCT02991859|584804214|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933436|NCT02991859|584804215|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933437|NCT02991859|584804216|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
161933438|NCT02991859|584804217|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933439|NCT02991859|584804218|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933440|NCT02991859|584804219|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933441|NCT02991859|584804220|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933442|NCT02991859|584804221|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933443|NCT02991859|584804222|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933444|NCT02991859|584804223|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933445|NCT02991859|584804224|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933446|NCT00425854|584804232|FG000|Overall Study|Progressive Disease|19|||
161933447|NCT00425854|584804233|FG001|Overall Study|Progressive Disease|12|||
161933448|NCT00425854|584804232|FG000|Overall Study|Dose reduction toxicity AE|8|||
161933449|NCT00425854|584804233|FG001|Overall Study|Dose reduction toxicity AE|7|||
161933450|NCT00425854|584804232|FG000|Overall Study|Other Adverse Event|2|||
161933451|NCT00425854|584804233|FG001|Overall Study|Other Adverse Event|2|||
161933452|NCT01630811|584804234|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161933453|NCT01630811|584804235|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161933454|NCT01725308|584804238|FG000|Treatment Period I|Did Not Receive Drug|1|||
161933455|NCT01725308|584804239|FG001|Treatment Period I|Did Not Receive Drug|0|||
161933456|NCT01725308|584804240|FG002|Treatment Period I|Did Not Receive Drug|0|||
161933457|NCT01725308|584804238|FG000|Treatment Period I|Adverse Event|5|||
161933458|NCT01725308|584804239|FG001|Treatment Period I|Adverse Event|4|||
161933459|NCT01725308|584804240|FG002|Treatment Period I|Adverse Event|21|||
161933460|NCT01725308|584804238|FG000|Treatment Period I|Insufficient Response|7|||
161933461|NCT01725308|584804239|FG001|Treatment Period I|Insufficient Response|0|||
161933462|NCT01725308|584804240|FG002|Treatment Period I|Insufficient Response|5|||
161933463|NCT01725308|584804238|FG000|Treatment Period I|Worsening of the Target Disease|8|||
161933464|NCT01725308|584804239|FG001|Treatment Period I|Worsening of the Target Disease|0|||
161933465|NCT01725308|584804240|FG002|Treatment Period I|Worsening of the Target Disease|2|||
161520914|NCT00321919|583297387|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161520915|NCT00321919|583297388|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161520916|NCT00321919|583297387|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161520917|NCT00321919|583297388|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161933466|NCT01725308|584804238|FG000|Treatment Period I|Changes in the Episodes|3|||
161933467|NCT01725308|584804239|FG001|Treatment Period I|Changes in the Episodes|0|||
161933468|NCT01725308|584804240|FG002|Treatment Period I|Changes in the Episodes|2|||
161933469|NCT01725308|584804238|FG000|Treatment Period I|Withdrawal of Consent|12|||
161933470|NCT01725308|584804239|FG001|Treatment Period I|Withdrawal of Consent|7|||
161933471|NCT01725308|584804240|FG002|Treatment Period I|Withdrawal of Consent|5|||
161520918|NCT00321919|583297387|FG000|Overall Study|Refused Treatment|23|||
161520919|NCT00321919|583297388|FG001|Overall Study|Refused Treatment|14|||
161825381|NCT01628549|584401812|FG002|Overall Study|Protocol Violation|1|||
161825382|NCT01628549|584401813|FG003|Overall Study|Protocol Violation|0|||
161825383|NCT01628549|584401810|FG000|Overall Study|withdrawn for noncompliance|0|||
161825384|NCT01628549|584401811|FG001|Overall Study|withdrawn for noncompliance|2|||
161825385|NCT01628549|584401812|FG002|Overall Study|withdrawn for noncompliance|1|||
161825386|NCT01628549|584401813|FG003|Overall Study|withdrawn for noncompliance|0|||
161825387|NCT01628549|584401810|FG000|Overall Study|abnormal laboratory test results|0|||
161825388|NCT01628549|584401811|FG001|Overall Study|abnormal laboratory test results|0|||
161825389|NCT01628549|584401812|FG002|Overall Study|abnormal laboratory test results|1|||
161825390|NCT01628549|584401813|FG003|Overall Study|abnormal laboratory test results|0|||
161825391|NCT01628549|584401810|FG000|Overall Study|positive pregnancy test|0|||
161825392|NCT01628549|584401811|FG001|Overall Study|positive pregnancy test|0|||
161825393|NCT01628549|584401812|FG002|Overall Study|positive pregnancy test|0|||
161825394|NCT01628549|584401813|FG003|Overall Study|positive pregnancy test|1|||
161825395|NCT00177164|584401821|FG000|Overall Study|Protocol Violation|0|||
161825396|NCT00177164|584401822|FG001|Overall Study|Protocol Violation|7|||
161825397|NCT00177164|584401821|FG000|Overall Study|Lost to Follow-up|4|||
161825398|NCT00177164|584401822|FG001|Overall Study|Lost to Follow-up|5|||
161825399|NCT00177164|584401821|FG000|Overall Study|increase in alcohol and drug use|1|||
161825400|NCT00177164|584401822|FG001|Overall Study|increase in alcohol and drug use|2|||
161825401|NCT00177164|584401821|FG000|Overall Study|Adverse Event|1|||
161825402|NCT00177164|584401822|FG001|Overall Study|Adverse Event|0|||
161825403|NCT00177164|584401821|FG000|Overall Study|discharge from hospital|1|||
161825404|NCT00177164|584401822|FG001|Overall Study|discharge from hospital|0|||
161825405|NCT00177164|584401821|FG000|Overall Study|Lack of Efficacy|2|||
161825406|NCT00177164|584401822|FG001|Overall Study|Lack of Efficacy|1|||
161825407|NCT00177164|584401821|FG000|Overall Study|Pregnancy|0|||
161825408|NCT00177164|584401822|FG001|Overall Study|Pregnancy|1|||
161825409|NCT03807440|584401825|FG000|Overall Study|No documentation of index date 2|320|||
161825410|NCT03807440|584401825|FG000|Overall Study|No informed consent for index date 2|117|||
161825411|NCT02451358|584401826|FG000|Overall Study|Withdrawal by Subject|1|||
161825412|NCT02451358|584401827|FG001|Overall Study|Withdrawal by Subject|1|||
161825413|NCT02451358|584401828|FG002|Overall Study|Withdrawal by Subject|0|||
161825414|NCT02451358|584401829|FG003|Overall Study|Withdrawal by Subject|0|||
161825415|NCT02451358|584401826|FG000|Overall Study|Protocol Violation|0|||
161825416|NCT02451358|584401827|FG001|Overall Study|Protocol Violation|1|||
161825417|NCT02451358|584401828|FG002|Overall Study|Protocol Violation|1|||
161825418|NCT02451358|584401829|FG003|Overall Study|Protocol Violation|0|||
161825419|NCT06128525|584401830|FG000|Overall Study|Patient withdrew consent|1|||
161825420|NCT03414034|584401835|FG000|Overall Study|Adverse Event|6|||
161825421|NCT03414034|584401836|FG001|Overall Study|Adverse Event|1|||
161825422|NCT03414034|584401837|FG002|Overall Study|Adverse Event|1|||
161825423|NCT03414034|584401835|FG000|Overall Study|Death|0|||
161825424|NCT03414034|584401836|FG001|Overall Study|Death|0|||
161825425|NCT03414034|584401837|FG002|Overall Study|Death|1|||
161825426|NCT03414034|584401835|FG000|Overall Study|Non-compliance With Study Drug|0|||
161825427|NCT03414034|584401836|FG001|Overall Study|Non-compliance With Study Drug|0|||
161825428|NCT03414034|584401837|FG002|Overall Study|Non-compliance With Study Drug|1|||
161825429|NCT03414034|584401835|FG000|Overall Study|Physician Decision|1|||
161825430|NCT03414034|584401836|FG001|Overall Study|Physician Decision|3|||
161825431|NCT03414034|584401837|FG002|Overall Study|Physician Decision|2|||
161825432|NCT03414034|584401835|FG000|Overall Study|Withdrawal of Informed Consent|2|||
161825433|NCT03414034|584401836|FG001|Overall Study|Withdrawal of Informed Consent|1|||
161825434|NCT03414034|584401837|FG002|Overall Study|Withdrawal of Informed Consent|4|||
161825435|NCT03414034|584401835|FG000|Overall Study|Progressive Disease|15|||
161825436|NCT03414034|584401836|FG001|Overall Study|Progressive Disease|15|||
161825437|NCT03414034|584401837|FG002|Overall Study|Progressive Disease|17|||
161825438|NCT03414034|584401835|FG000|Overall Study|Miscellaneous|0|||
161825439|NCT03414034|584401836|FG001|Overall Study|Miscellaneous|0|||
161825440|NCT03414034|584401837|FG002|Overall Study|Miscellaneous|2|||
161825441|NCT01332968|584401839|FG000|Induction Period|Adverse Event|23|||
161825442|NCT01332968|584401840|FG001|Induction Period|Adverse Event|26|||
161825443|NCT01332968|584401841|FG002|Induction Period|Adverse Event|0|||
161825444|NCT01332968|584401842|FG003|Induction Period|Adverse Event|0|||
161825445|NCT01332968|584401843|FG004|Induction Period|Adverse Event|0|||
161825446|NCT01332968|584401844|FG005|Induction Period|Adverse Event|0|||
161825447|NCT01332968|584401845|FG006|Induction Period|Adverse Event|0|||
161825448|NCT01332968|584401846|FG007|Induction Period|Adverse Event|0|||
161825449|NCT01332968|584401839|FG000|Induction Period|Death|1|||
161825450|NCT01332968|584401840|FG001|Induction Period|Death|4|||
161825451|NCT01332968|584401841|FG002|Induction Period|Death|0|||
161825452|NCT01332968|584401842|FG003|Induction Period|Death|0|||
161825453|NCT01332968|584401843|FG004|Induction Period|Death|0|||
161825454|NCT01332968|584401844|FG005|Induction Period|Death|0|||
161825455|NCT01332968|584401845|FG006|Induction Period|Death|0|||
161825456|NCT01332968|584401846|FG007|Induction Period|Death|0|||
161825457|NCT01332968|584401839|FG000|Induction Period|Non-compliance|1|||
161825458|NCT01332968|584401840|FG001|Induction Period|Non-compliance|0|||
161825459|NCT01332968|584401841|FG002|Induction Period|Non-compliance|0|||
161933472|NCT01725308|584804238|FG000|Treatment Period I|Lost to Follow-up|3|||
161933473|NCT01725308|584804239|FG001|Treatment Period I|Lost to Follow-up|2|||
161933474|NCT01725308|584804240|FG002|Treatment Period I|Lost to Follow-up|2|||
161933475|NCT01725308|584804238|FG000|Treatment Period I|Protocol Deviations|3|||
161933476|NCT01725308|584804239|FG001|Treatment Period I|Protocol Deviations|1|||
161933477|NCT01725308|584804240|FG002|Treatment Period I|Protocol Deviations|1|||
161933478|NCT01725308|584804238|FG000|Treatment Period I|Miscellaneous|2|||
161933479|NCT01725308|584804239|FG001|Treatment Period I|Miscellaneous|0|||
161933480|NCT01725308|584804240|FG002|Treatment Period I|Miscellaneous|3|||
161933481|NCT01725308|584804238|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
161933482|NCT01725308|584804239|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
161933483|NCT01725308|584804240|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
161933484|NCT01725308|584804238|FG000|Treatment Period II|Did Not Receive Drug|4|||
161520920|NCT00321919|583297387|FG000|Overall Study|Other Protocol Violation|2|||
161520921|NCT00321919|583297388|FG001|Overall Study|Other Protocol Violation|3|||
161520922|NCT00321919|583297387|FG000|Overall Study|Failure to Return|3|||
161520923|NCT00321919|583297388|FG001|Overall Study|Failure to Return|1|||
161520924|NCT00321919|583297387|FG000|Overall Study|Other withdrawal reason|7|||
161520925|NCT00321919|583297388|FG001|Overall Study|Other withdrawal reason|6|||
161520926|NCT02624804|583297389|FG000|Overall Study|Screen Failure|5|||
161520927|NCT02590354|583297390|FG000|Phase 1|Active hepatitis B or C infection|1|||
161933485|NCT01725308|584804239|FG001|Treatment Period II|Did Not Receive Drug|0|||
161933486|NCT01725308|584804240|FG002|Treatment Period II|Did Not Receive Drug|0|||
161933487|NCT01725308|584804238|FG000|Treatment Period II|Adverse Event|13|||
161933488|NCT01725308|584804239|FG001|Treatment Period II|Adverse Event|8|||
161933489|NCT01725308|584804240|FG002|Treatment Period II|Adverse Event|20|||
161933490|NCT01725308|584804238|FG000|Treatment Period II|Insufficient Response|2|||
161933491|NCT01725308|584804239|FG001|Treatment Period II|Insufficient Response|4|||
161933492|NCT01725308|584804240|FG002|Treatment Period II|Insufficient Response|6|||
161933493|NCT01725308|584804238|FG000|Treatment Period II|Worsening of the Target Disease|1|||
161933494|NCT01725308|584804239|FG001|Treatment Period II|Worsening of the Target Disease|4|||
161933495|NCT01725308|584804240|FG002|Treatment Period II|Worsening of the Target Disease|2|||
161933496|NCT01725308|584804238|FG000|Treatment Period II|Changes in the Episodes|1|||
161933497|NCT01725308|584804239|FG001|Treatment Period II|Changes in the Episodes|0|||
161933498|NCT01725308|584804240|FG002|Treatment Period II|Changes in the Episodes|5|||
161933499|NCT01725308|584804238|FG000|Treatment Period II|Withdrawal of Consent|28|||
161520928|NCT02590354|583297390|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
161520929|NCT02590354|583297390|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
161933500|NCT01725308|584804239|FG001|Treatment Period II|Withdrawal of Consent|2|||
161933501|NCT01725308|584804240|FG002|Treatment Period II|Withdrawal of Consent|16|||
161933502|NCT01725308|584804238|FG000|Treatment Period II|Lost to Follow-up|1|||
161933503|NCT01725308|584804239|FG001|Treatment Period II|Lost to Follow-up|5|||
161933504|NCT01725308|584804240|FG002|Treatment Period II|Lost to Follow-up|3|||
161933505|NCT01725308|584804238|FG000|Treatment Period II|Protocol Deviations|0|||
161933506|NCT01725308|584804239|FG001|Treatment Period II|Protocol Deviations|0|||
161933507|NCT01725308|584804240|FG002|Treatment Period II|Protocol Deviations|1|||
161933508|NCT01725308|584804238|FG000|Treatment Period II|Miscellaneous|5|||
161933509|NCT01725308|584804239|FG001|Treatment Period II|Miscellaneous|3|||
161933510|NCT01725308|584804240|FG002|Treatment Period II|Miscellaneous|7|||
161933511|NCT05652140|584804242|FG000|Overall Study|Lost to Follow-up|7|||
161933512|NCT05652140|584804243|FG001|Overall Study|Lost to Follow-up|16|||
161933513|NCT05652140|584804244|FG002|Overall Study|Lost to Follow-up|22|||
161520930|NCT02590354|583297390|FG000|Phase 1|Subject does not want to participate|20|||
161520931|NCT02590354|583297390|FG000|Phase 1|Lost to Follow-up|1|||
161520932|NCT02590354|583297390|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
161933514|NCT05652140|584804245|FG003|Overall Study|Lost to Follow-up|31|||
161933515|NCT06048705|584804249|FG000|Overall Study|Physician Decision|1|||
161933516|NCT06048705|584804250|FG001|Overall Study|Physician Decision|0|||
161933517|NCT06048705|584804251|FG002|Overall Study|Physician Decision|0|||
161520933|NCT00996996|583297391|FG000|Overall Study|Progressive Disease|10|||
161520934|NCT00996996|583297391|FG000|Overall Study|Non-compliance|8|||
161933518|NCT06048705|584804249|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
161933519|NCT06048705|584804250|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
161520935|NCT00996996|583297391|FG000|Overall Study|Lost to Follow-up|9|||
161933520|NCT06048705|584804251|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
161933521|NCT06048705|584804249|FG000|Overall Study|Death prior to lymphodepletion|0|||
161933522|NCT06048705|584804250|FG001|Overall Study|Death prior to lymphodepletion|0|||
161933523|NCT06048705|584804251|FG002|Overall Study|Death prior to lymphodepletion|1|||
161520936|NCT00996996|583297391|FG000|Overall Study|Death|5|||
161520937|NCT00996996|583297391|FG000|Overall Study|Did Not Receive Study Medications|1|||
161933524|NCT03378635|584804254|FG000|Overall Study|Adverse Event|1|||
161933525|NCT03378635|584804255|FG001|Overall Study|Adverse Event|0|||
161933526|NCT03378635|584804256|FG002|Overall Study|Adverse Event|0|||
161933527|NCT03378635|584804254|FG000|Overall Study|Withdrawal by Subject|1|||
161933528|NCT03378635|584804255|FG001|Overall Study|Withdrawal by Subject|0|||
161520938|NCT01227889|583297392|FG000|Randomized Phase (RP)|Adverse Event|13|||
161520939|NCT01227889|583297393|FG001|Randomized Phase (RP)|Adverse Event|0|||
161520940|NCT01227889|583297392|FG000|Randomized Phase (RP)|Physician Decision|13|||
161520941|NCT01227889|583297393|FG001|Randomized Phase (RP)|Physician Decision|5|||
161520942|NCT01227889|583297392|FG000|Randomized Phase (RP)|Progressive Disease|135|||
161520943|NCT01227889|583297393|FG001|Randomized Phase (RP)|Progressive Disease|52|||
161520944|NCT01227889|583297392|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
161520945|NCT01227889|583297393|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
161520946|NCT01227889|583297392|FG000|Randomized Phase (RP)|Missing|1|||
161520947|NCT01227889|583297393|FG001|Randomized Phase (RP)|Missing|3|||
161825460|NCT01332968|584401842|FG003|Induction Period|Non-compliance|0|||
161825461|NCT01332968|584401843|FG004|Induction Period|Non-compliance|0|||
161825462|NCT01332968|584401844|FG005|Induction Period|Non-compliance|0|||
161825463|NCT01332968|584401845|FG006|Induction Period|Non-compliance|0|||
161825464|NCT01332968|584401846|FG007|Induction Period|Non-compliance|0|||
161825465|NCT01332968|584401839|FG000|Induction Period|Other|2|||
161825466|NCT01332968|584401840|FG001|Induction Period|Other|2|||
161825467|NCT01332968|584401841|FG002|Induction Period|Other|0|||
161825468|NCT01332968|584401842|FG003|Induction Period|Other|0|||
161825469|NCT01332968|584401843|FG004|Induction Period|Other|0|||
161825470|NCT01332968|584401844|FG005|Induction Period|Other|0|||
161825471|NCT01332968|584401845|FG006|Induction Period|Other|0|||
161825472|NCT01332968|584401846|FG007|Induction Period|Other|0|||
161825473|NCT01332968|584401839|FG000|Induction Period|Physician Decision|6|||
161825474|NCT01332968|584401840|FG001|Induction Period|Physician Decision|1|||
161825475|NCT01332968|584401841|FG002|Induction Period|Physician Decision|0|||
161825476|NCT01332968|584401842|FG003|Induction Period|Physician Decision|0|||
161825477|NCT01332968|584401843|FG004|Induction Period|Physician Decision|0|||
161825478|NCT01332968|584401844|FG005|Induction Period|Physician Decision|0|||
161825479|NCT01332968|584401845|FG006|Induction Period|Physician Decision|0|||
161825480|NCT01332968|584401846|FG007|Induction Period|Physician Decision|0|||
161825481|NCT01332968|584401839|FG000|Induction Period|Progressive Disease|15|||
161825482|NCT01332968|584401840|FG001|Induction Period|Progressive Disease|7|||
161825483|NCT01332968|584401841|FG002|Induction Period|Progressive Disease|0|||
161825484|NCT01332968|584401842|FG003|Induction Period|Progressive Disease|0|||
161825485|NCT01332968|584401843|FG004|Induction Period|Progressive Disease|0|||
161825486|NCT01332968|584401844|FG005|Induction Period|Progressive Disease|0|||
161825487|NCT01332968|584401845|FG006|Induction Period|Progressive Disease|0|||
161825488|NCT01332968|584401846|FG007|Induction Period|Progressive Disease|0|||
161825489|NCT01332968|584401839|FG000|Induction Period|Protocol Violation|3|||
161825490|NCT01332968|584401840|FG001|Induction Period|Protocol Violation|4|||
161825491|NCT01332968|584401841|FG002|Induction Period|Protocol Violation|0|||
161825492|NCT01332968|584401842|FG003|Induction Period|Protocol Violation|0|||
161825493|NCT01332968|584401843|FG004|Induction Period|Protocol Violation|0|||
161825494|NCT01332968|584401844|FG005|Induction Period|Protocol Violation|0|||
161825495|NCT01332968|584401845|FG006|Induction Period|Protocol Violation|0|||
161825496|NCT01332968|584401846|FG007|Induction Period|Protocol Violation|0|||
161825497|NCT01332968|584401839|FG000|Induction Period|Withdrawal by Subject|3|||
161825498|NCT01332968|584401840|FG001|Induction Period|Withdrawal by Subject|5|||
161825499|NCT01332968|584401841|FG002|Induction Period|Withdrawal by Subject|0|||
161825500|NCT01332968|584401842|FG003|Induction Period|Withdrawal by Subject|0|||
161825501|NCT01332968|584401843|FG004|Induction Period|Withdrawal by Subject|0|||
161825502|NCT01332968|584401844|FG005|Induction Period|Withdrawal by Subject|0|||
161825503|NCT01332968|584401845|FG006|Induction Period|Withdrawal by Subject|0|||
161825504|NCT01332968|584401846|FG007|Induction Period|Withdrawal by Subject|0|||
161825505|NCT01332968|584401839|FG000|Induction Period|Randomised but not treated|4|||
161825506|NCT01332968|584401840|FG001|Induction Period|Randomised but not treated|7|||
161825507|NCT01332968|584401841|FG002|Induction Period|Randomised but not treated|0|||
161825508|NCT01332968|584401842|FG003|Induction Period|Randomised but not treated|0|||
161825509|NCT01332968|584401843|FG004|Induction Period|Randomised but not treated|0|||
161825510|NCT01332968|584401844|FG005|Induction Period|Randomised but not treated|0|||
161825511|NCT01332968|584401845|FG006|Induction Period|Randomised but not treated|0|||
161825512|NCT01332968|584401846|FG007|Induction Period|Randomised but not treated|0|||
161825513|NCT01332968|584401839|FG000|Maintenance/Observation Period|Adverse Event|0|||
161825514|NCT01332968|584401840|FG001|Maintenance/Observation Period|Adverse Event|0|||
161825515|NCT01332968|584401841|FG002|Maintenance/Observation Period|Adverse Event|53|||
161825516|NCT01332968|584401842|FG003|Maintenance/Observation Period|Adverse Event|66|||
161825517|NCT01332968|584401843|FG004|Maintenance/Observation Period|Adverse Event|0|||
161825518|NCT01332968|584401844|FG005|Maintenance/Observation Period|Adverse Event|0|||
161825519|NCT01332968|584401845|FG006|Maintenance/Observation Period|Adverse Event|0|||
161825520|NCT01332968|584401846|FG007|Maintenance/Observation Period|Adverse Event|0|||
161825521|NCT01332968|584401839|FG000|Maintenance/Observation Period|Death|0|||
161825522|NCT01332968|584401840|FG001|Maintenance/Observation Period|Death|0|||
161825523|NCT01332968|584401841|FG002|Maintenance/Observation Period|Death|5|||
161825524|NCT01332968|584401842|FG003|Maintenance/Observation Period|Death|6|||
161825525|NCT01332968|584401843|FG004|Maintenance/Observation Period|Death|0|||
161520948|NCT01227889|583297392|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
161520949|NCT01227889|583297393|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
161520950|NCT01227889|583297392|FG000|Crossover Phase|Adverse Event|0|||
161520951|NCT01227889|583297393|FG001|Crossover Phase|Adverse Event|1|||
161520952|NCT01227889|583297392|FG000|Crossover Phase|Physician Decision|0|||
161520953|NCT01227889|583297393|FG001|Crossover Phase|Physician Decision|3|||
161520954|NCT01227889|583297392|FG000|Crossover Phase|Progressive Disease|0|||
161520955|NCT01227889|583297393|FG001|Crossover Phase|Progressive Disease|31|||
161520956|NCT01227889|583297392|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
161520957|NCT01227889|583297393|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
161520958|NCT01227889|583297392|FG000|Crossover Phase|Withdrawal by Subject|0|||
161520959|NCT01227889|583297393|FG001|Crossover Phase|Withdrawal by Subject|1|||
161520960|NCT01148810|583297396|FG000|Overall Study|Adverse Event|0|||
161520961|NCT01148810|583297397|FG001|Overall Study|Adverse Event|2|||
161520962|NCT01148810|583297396|FG000|Overall Study|Lack of Efficacy|0|||
161520963|NCT01148810|583297397|FG001|Overall Study|Lack of Efficacy|1|||
161520964|NCT01148810|583297396|FG000|Overall Study|Withdrawal by Subject|0|||
161520965|NCT01148810|583297397|FG001|Overall Study|Withdrawal by Subject|2|||
161520966|NCT01148810|583297396|FG000|Overall Study|Protocol Violation|1|||
161520967|NCT01148810|583297397|FG001|Overall Study|Protocol Violation|0|||
161520968|NCT02731131|583297404|FG000|Overall Study|Psychiatric Disorder|0|||
161520969|NCT02731131|583297405|FG001|Overall Study|Psychiatric Disorder|1|||
161520970|NCT02731131|583297404|FG000|Overall Study|Refused Therapy|0|||
161520971|NCT02731131|583297405|FG001|Overall Study|Refused Therapy|1|||
161520972|NCT02348216|583297411|FG000|Overall Study|Death|5|||
161520973|NCT02348216|583297412|FG001|Overall Study|Death|53|||
161589267|NCT04521478|583546378|FG004|Overall Study|Other than listed|3|||
161589268|NCT04521478|583546379|FG005|Overall Study|Other than listed|3|||
161589269|NCT04521478|583546374|FG000|Overall Study|Not treated|0|||
161589270|NCT04521478|583546375|FG001|Overall Study|Not treated|0|||
161589271|NCT04521478|583546376|FG002|Overall Study|Not treated|0|||
161589272|NCT04521478|583546377|FG003|Overall Study|Not treated|0|||
161589273|NCT04521478|583546378|FG004|Overall Study|Not treated|0|||
161589274|NCT04521478|583546379|FG005|Overall Study|Not treated|1|||
161589275|NCT02630823|583546394|FG000|Overall Study|Withdrawal by Subject|1|||
161589276|NCT02630823|583546394|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
161589277|NCT02682316|583546408|FG000|Overall Study|Benign Final Pathology|27|||
161589278|NCT02682316|583546409|FG001|Overall Study|Benign Final Pathology|26|||
161589279|NCT02682316|583546408|FG000|Overall Study|Reoperation before 30 days|7|||
161589280|NCT02682316|583546409|FG001|Overall Study|Reoperation before 30 days|6|||
161589281|NCT02682316|583546408|FG000|Overall Study|Ineligible|1|||
161677545|NCT03945591|583872025|FG000|Overall Study|Adverse Event|1|||
161825526|NCT01332968|584401844|FG005|Maintenance/Observation Period|Death|0|||
161825527|NCT01332968|584401845|FG006|Maintenance/Observation Period|Death|0|||
161825528|NCT01332968|584401846|FG007|Maintenance/Observation Period|Death|0|||
161825529|NCT01332968|584401839|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
161825530|NCT01332968|584401840|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
161825531|NCT01332968|584401841|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
161825532|NCT01332968|584401842|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
161825533|NCT01332968|584401843|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
161825534|NCT01332968|584401844|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
161825535|NCT01332968|584401845|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
161825536|NCT01332968|584401846|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
161825537|NCT01332968|584401839|FG000|Maintenance/Observation Period|Non-compliance|0|||
161825538|NCT01332968|584401840|FG001|Maintenance/Observation Period|Non-compliance|0|||
161825539|NCT01332968|584401841|FG002|Maintenance/Observation Period|Non-compliance|4|||
161825540|NCT01332968|584401842|FG003|Maintenance/Observation Period|Non-compliance|3|||
161825541|NCT01332968|584401843|FG004|Maintenance/Observation Period|Non-compliance|0|||
161825542|NCT01332968|584401844|FG005|Maintenance/Observation Period|Non-compliance|0|||
161825543|NCT01332968|584401845|FG006|Maintenance/Observation Period|Non-compliance|0|||
161825544|NCT01332968|584401846|FG007|Maintenance/Observation Period|Non-compliance|0|||
161825545|NCT01332968|584401839|FG000|Maintenance/Observation Period|Other|0|||
161825546|NCT01332968|584401840|FG001|Maintenance/Observation Period|Other|0|||
161825547|NCT01332968|584401841|FG002|Maintenance/Observation Period|Other|4|||
161825548|NCT01332968|584401842|FG003|Maintenance/Observation Period|Other|7|||
161825549|NCT01332968|584401843|FG004|Maintenance/Observation Period|Other|0|||
161825550|NCT01332968|584401844|FG005|Maintenance/Observation Period|Other|0|||
161825551|NCT01332968|584401845|FG006|Maintenance/Observation Period|Other|0|||
161825552|NCT01332968|584401846|FG007|Maintenance/Observation Period|Other|0|||
161825553|NCT01332968|584401839|FG000|Maintenance/Observation Period|Physician Decision|0|||
161825554|NCT01332968|584401840|FG001|Maintenance/Observation Period|Physician Decision|0|||
161825555|NCT01332968|584401841|FG002|Maintenance/Observation Period|Physician Decision|14|||
161825556|NCT01332968|584401842|FG003|Maintenance/Observation Period|Physician Decision|19|||
161825557|NCT01332968|584401843|FG004|Maintenance/Observation Period|Physician Decision|0|||
161825558|NCT01332968|584401844|FG005|Maintenance/Observation Period|Physician Decision|1|||
161589282|NCT02682316|583546409|FG001|Overall Study|Ineligible|0|||
161589283|NCT02682316|583546408|FG000|Overall Study|Death|1|||
161589284|NCT02682316|583546409|FG001|Overall Study|Death|0|||
161589285|NCT02682316|583546408|FG000|Overall Study|Lost to Follow-up|7|||
161589286|NCT02682316|583546409|FG001|Overall Study|Lost to Follow-up|3|||
161589287|NCT04630262|583546411|FG000|Overall Study|Intraoperative Screen Failure|5|||
161589288|NCT04630262|583546411|FG000|Overall Study|Study terminated prematurely|71|||
161589289|NCT04630262|583546411|FG000|Overall Study|Withdrawal by Subject|2|||
161589290|NCT04630262|583546411|FG000|Overall Study|Physician Decision|2|||
161589291|NCT03692676|583546413|FG000|Overall Study|exclude patients with prior use|4424|||
161589292|NCT03692676|583546414|FG001|Overall Study|exclude patients with prior use|24726|||
161589293|NCT03692676|583546415|FG002|Overall Study|exclude patients with prior use|0|||
161589294|NCT03692676|583546416|FG003|Overall Study|exclude patients with prior use|0|||
161589295|NCT03692676|583546413|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
161589296|NCT03692676|583546414|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
161589297|NCT03692676|583546415|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
161589298|NCT03692676|583546416|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
161589299|NCT03692676|583546413|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
161589300|NCT03692676|583546414|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
161589301|NCT03692676|583546415|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
161589302|NCT03692676|583546416|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
161589303|NCT03692676|583546413|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
161589304|NCT03692676|583546414|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
161589305|NCT03692676|583546415|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
161589306|NCT03692676|583546416|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
161589307|NCT03692676|583546413|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
161589308|NCT03692676|583546414|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
161589309|NCT03692676|583546415|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
161589310|NCT03692676|583546416|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
161589311|NCT03692676|583546413|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
161589312|NCT03692676|583546414|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
161589313|NCT03692676|583546415|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
161589314|NCT03692676|583546416|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
161589315|NCT03692676|583546413|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
161589316|NCT03692676|583546414|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
161589317|NCT03692676|583546415|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
161589318|NCT03692676|583546416|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
161589319|NCT03692676|583546413|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
161589320|NCT03692676|583546414|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
161589321|NCT03692676|583546415|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
161589322|NCT03692676|583546416|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
161589323|NCT03692676|583546413|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
161589324|NCT03692676|583546414|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
161589325|NCT03692676|583546415|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
161589326|NCT03692676|583546416|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
161589327|NCT03692676|583546413|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
161589328|NCT03692676|583546414|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
161589329|NCT03692676|583546415|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
161589330|NCT03692676|583546416|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
161589331|NCT03692676|583546413|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161933529|NCT03378635|584804256|FG002|Overall Study|Withdrawal by Subject|0|||
161933530|NCT02413346|584804257|FG000|Overall Study|Adverse Event|6|||
161933531|NCT02413346|584804258|FG001|Overall Study|Adverse Event|6|||
161933532|NCT02413346|584804257|FG000|Overall Study|Withdrawal by Subject|30|||
161933533|NCT02413346|584804258|FG001|Overall Study|Withdrawal by Subject|40|||
161933534|NCT02413346|584804257|FG000|Overall Study|Lost to Follow-up|17|||
161933535|NCT02413346|584804258|FG001|Overall Study|Lost to Follow-up|21|||
161933536|NCT02413346|584804257|FG000|Overall Study|Protocol Violation|2|||
161933537|NCT02413346|584804258|FG001|Overall Study|Protocol Violation|0|||
161933538|NCT02413346|584804257|FG000|Overall Study|Other Miscellaneous Reasons|4|||
161933539|NCT02413346|584804258|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161589332|NCT03692676|583546414|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161589333|NCT03692676|583546415|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161589334|NCT03692676|583546416|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
161589335|NCT03692676|583546413|FG000|Overall Study|Other|0|||
161589336|NCT03692676|583546414|FG001|Overall Study|Other|805|||
161589337|NCT03692676|583546415|FG002|Overall Study|Other|758|||
161589338|NCT03692676|583546416|FG003|Overall Study|Other|277|||
161589339|NCT03692676|583546413|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161589340|NCT03692676|583546414|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161589341|NCT03692676|583546415|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161589342|NCT03692676|583546416|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
161589343|NCT01180634|583546417|FG000|Overall Study|Adverse Event|4|||
161589344|NCT01180634|583546418|FG001|Overall Study|Adverse Event|1|||
161589345|NCT01180634|583546417|FG000|Overall Study|Miscellaneous|2|||
161589346|NCT01180634|583546418|FG001|Overall Study|Miscellaneous|0|||
161589347|NCT01180634|583546417|FG000|Overall Study|Withdrawal by Subject|4|||
161589348|NCT01180634|583546418|FG001|Overall Study|Withdrawal by Subject|0|||
161589349|NCT03692611|583546419|FG000|Overall Study|Found to be ineligible postrandomization|3|||
161589350|NCT03692611|583546420|FG001|Overall Study|Found to be ineligible postrandomization|0|||
161589351|NCT06311084|583546421|FG000|Overall Study|Lost to Follow-up|14|||
161589352|NCT03988634|583546422|FG000|Double-Blind|Adverse Event|4|||
161589353|NCT03988634|583546423|FG001|Double-Blind|Adverse Event|0|||
161589354|NCT03988634|583546424|FG002|Double-Blind|Adverse Event|0|||
161589355|NCT03988634|583546422|FG000|Double-Blind|Death|18|||
161589356|NCT03988634|583546423|FG001|Double-Blind|Death|26|||
161589357|NCT03988634|583546424|FG002|Double-Blind|Death|0|||
161589358|NCT03988634|583546422|FG000|Double-Blind|Lost to Follow-up|6|||
161589359|NCT03988634|583546423|FG001|Double-Blind|Lost to Follow-up|7|||
161589360|NCT03988634|583546424|FG002|Double-Blind|Lost to Follow-up|0|||
161589361|NCT03988634|583546422|FG000|Double-Blind|Physician Decision|9|||
161589362|NCT03988634|583546423|FG001|Double-Blind|Physician Decision|5|||
161589363|NCT03988634|583546424|FG002|Double-Blind|Physician Decision|0|||
161589364|NCT03988634|583546422|FG000|Double-Blind|Subject decision|24|||
161589365|NCT03988634|583546423|FG001|Double-Blind|Subject decision|13|||
161520974|NCT02348216|583297413|FG002|Overall Study|Death|11|||
161520975|NCT02348216|583297414|FG003|Overall Study|Death|20|||
161520976|NCT02348216|583297415|FG004|Overall Study|Death|16|||
161520977|NCT02348216|583297416|FG005|Overall Study|Death|32|||
161520978|NCT02348216|583297417|FG006|Overall Study|Death|17|||
161520979|NCT02348216|583297411|FG000|Overall Study|Full consent withdrawal|0|||
161520980|NCT02348216|583297412|FG001|Overall Study|Full consent withdrawal|0|||
161520981|NCT02348216|583297413|FG002|Overall Study|Full consent withdrawal|0|||
161520982|NCT02348216|583297414|FG003|Overall Study|Full consent withdrawal|1|||
161520983|NCT02348216|583297415|FG004|Overall Study|Full consent withdrawal|3|||
161520984|NCT02348216|583297416|FG005|Overall Study|Full consent withdrawal|0|||
161520985|NCT02348216|583297417|FG006|Overall Study|Full consent withdrawal|3|||
161520986|NCT02348216|583297411|FG000|Overall Study|Lost to Follow-up|0|||
161520987|NCT02348216|583297412|FG001|Overall Study|Lost to Follow-up|5|||
161520988|NCT02348216|583297413|FG002|Overall Study|Lost to Follow-up|2|||
161520989|NCT02348216|583297414|FG003|Overall Study|Lost to Follow-up|0|||
161520990|NCT02348216|583297415|FG004|Overall Study|Lost to Follow-up|1|||
161520991|NCT02348216|583297416|FG005|Overall Study|Lost to Follow-up|1|||
161520992|NCT02348216|583297417|FG006|Overall Study|Lost to Follow-up|1|||
161520993|NCT02348216|583297411|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
161520994|NCT02348216|583297412|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
161520995|NCT02348216|583297413|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
161520996|NCT02348216|583297414|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
161520997|NCT02348216|583297415|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
161520998|NCT02348216|583297416|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
161589366|NCT03988634|583546424|FG002|Double-Blind|Subject decision|0|||
161589367|NCT03988634|583546422|FG000|Open-Label|Adverse Event|0|||
161589368|NCT03988634|583546423|FG001|Open-Label|Adverse Event|0|||
161589369|NCT03988634|583546424|FG002|Open-Label|Adverse Event|7|||
161589370|NCT03988634|583546422|FG000|Open-Label|Physician Decision|0|||
161589371|NCT03988634|583546423|FG001|Open-Label|Physician Decision|0|||
161589372|NCT03988634|583546424|FG002|Open-Label|Physician Decision|1|||
161589373|NCT03988634|583546422|FG000|Open-Label|Technical problems|0|||
161520999|NCT02348216|583297417|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
161521000|NCT02348216|583297411|FG000|Overall Study|Reason not specified|2|||
161521001|NCT02348216|583297412|FG001|Overall Study|Reason not specified|19|||
161521002|NCT02348216|583297413|FG002|Overall Study|Reason not specified|11|||
161521003|NCT02348216|583297414|FG003|Overall Study|Reason not specified|17|||
161589374|NCT03988634|583546423|FG001|Open-Label|Technical problems|0|||
161589375|NCT03988634|583546424|FG002|Open-Label|Technical problems|1|||
161521004|NCT02348216|583297415|FG004|Overall Study|Reason not specified|21|||
161521005|NCT02348216|583297416|FG005|Overall Study|Reason not specified|17|||
161521006|NCT02348216|583297417|FG006|Overall Study|Reason not specified|19|||
161521007|NCT01055639|583297418|FG000|Overall Study|Adverse Event|0|||
161521008|NCT01055639|583297419|FG001|Overall Study|Adverse Event|1|||
161521009|NCT01055639|583297418|FG000|Overall Study|Lack of Efficacy|0|||
161521010|NCT01055639|583297419|FG001|Overall Study|Lack of Efficacy|1|||
161521011|NCT01055639|583297418|FG000|Overall Study|Lost to Follow-up|8|||
161521012|NCT01055639|583297419|FG001|Overall Study|Lost to Follow-up|11|||
161521013|NCT01055639|583297418|FG000|Overall Study|Protocol Violation|5|||
161521014|NCT01055639|583297419|FG001|Overall Study|Protocol Violation|5|||
161521015|NCT01055639|583297418|FG000|Overall Study|Withdrawal by Subject|8|||
161521016|NCT01055639|583297419|FG001|Overall Study|Withdrawal by Subject|11|||
161521017|NCT00765245|583297420|FG000|Overall Study|disease progression|3|||
161521018|NCT00765245|583297421|FG001|Overall Study|disease progression|2|||
161521019|NCT00765245|583297420|FG000|Overall Study|Withdrawal by Subject|3|||
161521020|NCT00765245|583297421|FG001|Overall Study|Withdrawal by Subject|0|||
161521021|NCT00765245|583297420|FG000|Overall Study|Adverse Event|5|||
161521022|NCT00765245|583297421|FG001|Overall Study|Adverse Event|0|||
161521023|NCT00765245|583297420|FG000|Overall Study|Physician Decision|1|||
161521024|NCT00765245|583297421|FG001|Overall Study|Physician Decision|0|||
161521025|NCT00765245|583297420|FG000|Overall Study|Death|1|||
161521026|NCT00765245|583297421|FG001|Overall Study|Death|0|||
161521027|NCT03058679|583297423|FG000|Baseline to Week 6|Lost to Follow-up|3|||
161521028|NCT03058679|583297424|FG001|Baseline to Week 6|Lost to Follow-up|2|||
161521029|NCT03058679|583297423|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
161521030|NCT03058679|583297424|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
161521031|NCT03058679|583297423|FG000|Baseline to Week 6|Adverse Event|6|||
161521032|NCT03058679|583297424|FG001|Baseline to Week 6|Adverse Event|6|||
161521033|NCT03058679|583297423|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
161521034|NCT03058679|583297424|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
161521035|NCT03058679|583297423|FG000|Baseline to Week 6|Difficulty following the diet|0|||
161521036|NCT03058679|583297424|FG001|Baseline to Week 6|Difficulty following the diet|2|||
161521037|NCT03058679|583297423|FG000|Baseline to Week 6|Physician Decision|1|||
161521038|NCT03058679|583297424|FG001|Baseline to Week 6|Physician Decision|0|||
161933540|NCT01835431|584804261|FG000|Overall Study|Adverse Event|1|||
161933541|NCT01835431|584804262|FG001|Overall Study|Adverse Event|0|||
161933542|NCT01835431|584804261|FG000|Overall Study|other|0|||
161933543|NCT01835431|584804262|FG001|Overall Study|other|2|||
161933544|NCT01835431|584804261|FG000|Overall Study|Withdrawal by Subject|6|||
161933545|NCT01835431|584804262|FG001|Overall Study|Withdrawal by Subject|10|||
161933546|NCT01835431|584804261|FG000|Overall Study|Protocol Violation|1|||
161933547|NCT01835431|584804262|FG001|Overall Study|Protocol Violation|0|||
161933548|NCT00562861|584804265|FG000|Overall Study|Adverse Event|1|||
161933549|NCT00562861|584804266|FG001|Overall Study|Adverse Event|1|||
161933550|NCT00562861|584804265|FG000|Overall Study|Lack of Efficacy|5|||
161933551|NCT00562861|584804266|FG001|Overall Study|Lack of Efficacy|5|||
161933552|NCT00562861|584804265|FG000|Overall Study|noncompliance, moved|7|||
161933553|NCT00562861|584804266|FG001|Overall Study|noncompliance, moved|2|||
161933554|NCT00562861|584804265|FG000|Overall Study|Lost to Follow-up|7|||
161933555|NCT00562861|584804266|FG001|Overall Study|Lost to Follow-up|3|||
161933556|NCT00655356|584804269|FG000|Overall Study|Withdrawal by Subject|3|||
161933557|NCT00655356|584804270|FG001|Overall Study|Withdrawal by Subject|4|||
161933558|NCT00655356|584804269|FG000|Overall Study|Sponsor Request|10|||
161521039|NCT03058679|583297423|FG000|Week 6 to Week 12|Change in medication|5|||
161521040|NCT03058679|583297424|FG001|Week 6 to Week 12|Change in medication|7|||
161521041|NCT03058679|583297423|FG000|Week 6 to Week 12|Adverse Event|4|||
161521042|NCT03058679|583297424|FG001|Week 6 to Week 12|Adverse Event|3|||
161521043|NCT03058679|583297423|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
161521044|NCT03058679|583297424|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
161521045|NCT03058679|583297423|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
161521046|NCT03058679|583297424|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
161521047|NCT04137380|583297429|FG000|Overall Study|Physician Decision|0|||
161521048|NCT04137380|583297430|FG001|Overall Study|Physician Decision|0|||
161521049|NCT04137380|583297431|FG002|Overall Study|Physician Decision|0|||
161521050|NCT04137380|583297432|FG003|Overall Study|Physician Decision|1|||
161521051|NCT04137380|583297433|FG004|Overall Study|Physician Decision|0|||
161521052|NCT04137380|583297434|FG005|Overall Study|Physician Decision|0|||
161521053|NCT04137380|583297435|FG006|Overall Study|Physician Decision|0|||
161521054|NCT02265705|583297441|FG000|Treatment Period Week 0-24|Adverse Event|3|||
161521055|NCT02265705|583297442|FG001|Treatment Period Week 0-24|Adverse Event|2|||
161521056|NCT02265705|583297443|FG002|Treatment Period Week 0-24|Adverse Event|0|||
161933559|NCT00655356|584804270|FG001|Overall Study|Sponsor Request|4|||
161933560|NCT00655356|584804269|FG000|Overall Study|Adverse Event|1|||
161933561|NCT00655356|584804270|FG001|Overall Study|Adverse Event|1|||
161933562|NCT00655356|584804269|FG000|Overall Study|Protocol Violation|2|||
161521057|NCT02265705|583297444|FG003|Treatment Period Week 0-24|Adverse Event|0|||
161521058|NCT02265705|583297445|FG004|Treatment Period Week 0-24|Adverse Event|0|||
161521059|NCT02265705|583297446|FG005|Treatment Period Week 0-24|Adverse Event|0|||
161521060|NCT02265705|583297447|FG006|Treatment Period Week 0-24|Adverse Event|0|||
161521061|NCT02265705|583297441|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
161521062|NCT02265705|583297442|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
161521063|NCT02265705|583297443|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
161521064|NCT02265705|583297444|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
161521065|NCT02265705|583297445|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
161521066|NCT02265705|583297446|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
161521067|NCT02265705|583297447|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
161521068|NCT02265705|583297441|FG000|Treatment Period Week 0-24|Physician Decision|1|||
161825559|NCT01332968|584401845|FG006|Maintenance/Observation Period|Physician Decision|0|||
161521069|NCT02265705|583297442|FG001|Treatment Period Week 0-24|Physician Decision|0|||
161521070|NCT02265705|583297443|FG002|Treatment Period Week 0-24|Physician Decision|0|||
161521071|NCT02265705|583297444|FG003|Treatment Period Week 0-24|Physician Decision|0|||
161521072|NCT02265705|583297445|FG004|Treatment Period Week 0-24|Physician Decision|0|||
161521073|NCT02265705|583297446|FG005|Treatment Period Week 0-24|Physician Decision|0|||
161521074|NCT02265705|583297447|FG006|Treatment Period Week 0-24|Physician Decision|0|||
161521075|NCT02265705|583297441|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
161521076|NCT02265705|583297442|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
161521077|NCT02265705|583297443|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
161521078|NCT02265705|583297444|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
161521079|NCT02265705|583297445|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
161521080|NCT02265705|583297446|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
161521081|NCT02265705|583297447|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
161825560|NCT01332968|584401846|FG007|Maintenance/Observation Period|Physician Decision|0|||
161521082|NCT02265705|583297441|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
161521083|NCT02265705|583297442|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
161521084|NCT02265705|583297443|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
161521085|NCT02265705|583297444|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
161521086|NCT02265705|583297445|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
161521087|NCT02265705|583297446|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
161589376|NCT04725240|583546425|FG000|Overall Study|Adverse Event|2|||
161589377|NCT04083235|583546444|FG000|Overall Study|Death|252|||
161825561|NCT01332968|584401839|FG000|Maintenance/Observation Period|Progressive Disease|0|||
161825562|NCT01332968|584401840|FG001|Maintenance/Observation Period|Progressive Disease|0|||
161825563|NCT01332968|584401841|FG002|Maintenance/Observation Period|Progressive Disease|72|||
161825564|NCT01332968|584401842|FG003|Maintenance/Observation Period|Progressive Disease|40|||
161825565|NCT01332968|584401843|FG004|Maintenance/Observation Period|Progressive Disease|0|||
161825566|NCT01332968|584401844|FG005|Maintenance/Observation Period|Progressive Disease|0|||
161825567|NCT01332968|584401845|FG006|Maintenance/Observation Period|Progressive Disease|0|||
161825568|NCT01332968|584401846|FG007|Maintenance/Observation Period|Progressive Disease|0|||
161825569|NCT01332968|584401839|FG000|Maintenance/Observation Period|Protocol Violation|0|||
161825570|NCT01332968|584401840|FG001|Maintenance/Observation Period|Protocol Violation|0|||
161825571|NCT01332968|584401841|FG002|Maintenance/Observation Period|Protocol Violation|1|||
161825572|NCT01332968|584401842|FG003|Maintenance/Observation Period|Protocol Violation|1|||
161825573|NCT01332968|584401843|FG004|Maintenance/Observation Period|Protocol Violation|0|||
161825574|NCT01332968|584401844|FG005|Maintenance/Observation Period|Protocol Violation|0|||
161825575|NCT01332968|584401845|FG006|Maintenance/Observation Period|Protocol Violation|0|||
161825576|NCT01332968|584401846|FG007|Maintenance/Observation Period|Protocol Violation|0|||
161825577|NCT01332968|584401839|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825578|NCT01332968|584401840|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825579|NCT01332968|584401841|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
161825580|NCT01332968|584401842|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
161825581|NCT01332968|584401843|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825582|NCT01332968|584401844|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825583|NCT01332968|584401845|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825584|NCT01332968|584401846|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825585|NCT01332968|584401839|FG000|Follow-Up Period|Adverse Event|0|||
161825586|NCT01332968|584401840|FG001|Follow-Up Period|Adverse Event|0|||
161825587|NCT01332968|584401841|FG002|Follow-Up Period|Adverse Event|0|||
161825588|NCT01332968|584401842|FG003|Follow-Up Period|Adverse Event|0|||
161825589|NCT01332968|584401843|FG004|Follow-Up Period|Adverse Event|0|||
161825590|NCT01332968|584401844|FG005|Follow-Up Period|Adverse Event|0|||
161825591|NCT01332968|584401845|FG006|Follow-Up Period|Adverse Event|0|||
161825592|NCT01332968|584401846|FG007|Follow-Up Period|Adverse Event|4|||
161825593|NCT01332968|584401839|FG000|Follow-Up Period|Death|0|||
161825594|NCT01332968|584401840|FG001|Follow-Up Period|Death|0|||
161825595|NCT01332968|584401841|FG002|Follow-Up Period|Death|0|||
161825596|NCT01332968|584401842|FG003|Follow-Up Period|Death|0|||
161825597|NCT01332968|584401843|FG004|Follow-Up Period|Death|0|||
161521088|NCT02265705|583297447|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
161521089|NCT02265705|583297441|FG000|Rescue Period|Withdrawal by Subject|0|||
161521090|NCT02265705|583297442|FG001|Rescue Period|Withdrawal by Subject|0|||
161521091|NCT02265705|583297443|FG002|Rescue Period|Withdrawal by Subject|1|||
161521092|NCT02265705|583297444|FG003|Rescue Period|Withdrawal by Subject|0|||
161521093|NCT02265705|583297445|FG004|Rescue Period|Withdrawal by Subject|0|||
161521094|NCT02265705|583297446|FG005|Rescue Period|Withdrawal by Subject|0|||
161521095|NCT02265705|583297447|FG006|Rescue Period|Withdrawal by Subject|0|||
161521096|NCT02265705|583297441|FG000|Rescue Period|Death|0|||
161521097|NCT02265705|583297442|FG001|Rescue Period|Death|0|||
161521098|NCT02265705|583297443|FG002|Rescue Period|Death|1|||
161521099|NCT02265705|583297444|FG003|Rescue Period|Death|0|||
161521100|NCT02265705|583297445|FG004|Rescue Period|Death|0|||
161521101|NCT02265705|583297446|FG005|Rescue Period|Death|0|||
161521102|NCT02265705|583297447|FG006|Rescue Period|Death|0|||
161521103|NCT02265705|583297441|FG000|Rescue Period|Lack of Efficacy|0|||
161521104|NCT02265705|583297442|FG001|Rescue Period|Lack of Efficacy|0|||
161521105|NCT02265705|583297443|FG002|Rescue Period|Lack of Efficacy|1|||
161521106|NCT02265705|583297444|FG003|Rescue Period|Lack of Efficacy|0|||
161521107|NCT02265705|583297445|FG004|Rescue Period|Lack of Efficacy|0|||
161521108|NCT02265705|583297446|FG005|Rescue Period|Lack of Efficacy|0|||
161521109|NCT02265705|583297447|FG006|Rescue Period|Lack of Efficacy|0|||
161521110|NCT02265705|583297441|FG000|Open Label Period|Adverse Event|0|||
161521111|NCT02265705|583297442|FG001|Open Label Period|Adverse Event|0|||
161521112|NCT02265705|583297443|FG002|Open Label Period|Adverse Event|0|||
161521113|NCT02265705|583297444|FG003|Open Label Period|Adverse Event|2|||
161521114|NCT02265705|583297445|FG004|Open Label Period|Adverse Event|2|||
161521115|NCT02265705|583297446|FG005|Open Label Period|Adverse Event|0|||
161521116|NCT02265705|583297447|FG006|Open Label Period|Adverse Event|0|||
161521117|NCT02265705|583297441|FG000|Open Label Period|Physician Decision|0|||
161521118|NCT02265705|583297442|FG001|Open Label Period|Physician Decision|0|||
161521119|NCT02265705|583297443|FG002|Open Label Period|Physician Decision|0|||
161521120|NCT02265705|583297444|FG003|Open Label Period|Physician Decision|0|||
161521121|NCT02265705|583297445|FG004|Open Label Period|Physician Decision|1|||
161521122|NCT02265705|583297446|FG005|Open Label Period|Physician Decision|0|||
161521123|NCT02265705|583297447|FG006|Open Label Period|Physician Decision|0|||
161521124|NCT02265705|583297441|FG000|Open Label Period|Withdrawal by Subject|0|||
161521125|NCT02265705|583297442|FG001|Open Label Period|Withdrawal by Subject|0|||
161521126|NCT02265705|583297443|FG002|Open Label Period|Withdrawal by Subject|0|||
161521127|NCT02265705|583297444|FG003|Open Label Period|Withdrawal by Subject|0|||
161521128|NCT02265705|583297445|FG004|Open Label Period|Withdrawal by Subject|2|||
161521129|NCT02265705|583297446|FG005|Open Label Period|Withdrawal by Subject|0|||
161933563|NCT00655356|584804270|FG001|Overall Study|Protocol Violation|1|||
161933564|NCT00655356|584804269|FG000|Overall Study|Other Reason|1|||
161933565|NCT00655356|584804270|FG001|Overall Study|Other Reason|0|||
161933566|NCT01623154|584804273|FG000|Overall Study|Did not drink Pranactin Citric|4|||
161933567|NCT04349098|584804274|FG000|Overall Study|Death|16|||
161933568|NCT04349098|584804275|FG001|Overall Study|Death|8|||
161933569|NCT04349098|584804274|FG000|Overall Study|Lost to Follow-up|11|||
161933570|NCT04349098|584804275|FG001|Overall Study|Lost to Follow-up|8|||
161933571|NCT04349098|584804274|FG000|Overall Study|Withdrawal by Subject|8|||
161933572|NCT04349098|584804275|FG001|Overall Study|Withdrawal by Subject|5|||
161933573|NCT04349098|584804274|FG000|Overall Study|Other|3|||
161933574|NCT04349098|584804275|FG001|Overall Study|Other|5|||
161933575|NCT00800384|584804276|FG000|Overall Study|Withdrawal by Subject|24|||
161933576|NCT00800384|584804277|FG001|Overall Study|Withdrawal by Subject|17|||
161933577|NCT00800384|584804276|FG000|Overall Study|Lost to Follow-up|17|||
161933578|NCT00800384|584804277|FG001|Overall Study|Lost to Follow-up|26|||
161933579|NCT04280783|584806459|FG000|Overall Study|Family issues unrelated to the study.|1|||
161933580|NCT04280783|584806460|FG001|Overall Study|Family issues unrelated to the study.|0|||
161933581|NCT04280783|584806459|FG000|Overall Study|Withdrawal by Subject|0|||
161933582|NCT04280783|584806460|FG001|Overall Study|Withdrawal by Subject|1|||
161521130|NCT02265705|583297447|FG006|Open Label Period|Withdrawal by Subject|0|||
161521131|NCT02265705|583297441|FG000|Follow-up Period|Sponsor Decision|0|||
161521132|NCT02265705|583297442|FG001|Follow-up Period|Sponsor Decision|0|||
161521133|NCT02265705|583297443|FG002|Follow-up Period|Sponsor Decision|0|||
161521134|NCT02265705|583297444|FG003|Follow-up Period|Sponsor Decision|0|||
161521135|NCT02265705|583297445|FG004|Follow-up Period|Sponsor Decision|0|||
161521136|NCT02265705|583297446|FG005|Follow-up Period|Sponsor Decision|1|||
161521137|NCT02265705|583297447|FG006|Follow-up Period|Sponsor Decision|6|||
161521138|NCT02265705|583297441|FG000|Follow-up Period|Adverse Event|0|||
161521139|NCT02265705|583297442|FG001|Follow-up Period|Adverse Event|0|||
161521140|NCT02265705|583297443|FG002|Follow-up Period|Adverse Event|0|||
161521141|NCT02265705|583297444|FG003|Follow-up Period|Adverse Event|0|||
161521142|NCT02265705|583297445|FG004|Follow-up Period|Adverse Event|0|||
161521143|NCT02265705|583297446|FG005|Follow-up Period|Adverse Event|0|||
161933583|NCT03443401|584806467|FG000|Overall Study|Lost to Follow-up|13|||
161933584|NCT03443401|584806467|FG000|Overall Study|Influential outlier|1|||
161521144|NCT02265705|583297447|FG006|Follow-up Period|Adverse Event|3|||
161933585|NCT02363283|584806468|FG000|Overall Study|Withdrawal by Subject|1|||
161933586|NCT02363283|584806468|FG000|Overall Study|Not eligible due to transaminitis|1|||
161933587|NCT00530257|584806474|FG000|Overall Study|Lost to Follow-up|1|||
161933588|NCT01394185|584806478|FG000|Overall Study|Withdrawal by Subject|2|||
161933589|NCT01394185|584806479|FG001|Overall Study|Withdrawal by Subject|0|||
161933590|NCT01394185|584806480|FG002|Overall Study|Withdrawal by Subject|0|||
161933591|NCT01394185|584806481|FG003|Overall Study|Withdrawal by Subject|0|||
161933592|NCT01394185|584806482|FG004|Overall Study|Withdrawal by Subject|1|||
161933593|NCT01394185|584806483|FG005|Overall Study|Withdrawal by Subject|0|||
161933594|NCT01394185|584806478|FG000|Overall Study|Change in protocol|3|||
161933595|NCT01394185|584806479|FG001|Overall Study|Change in protocol|0|||
161933596|NCT01394185|584806480|FG002|Overall Study|Change in protocol|0|||
161933597|NCT01394185|584806481|FG003|Overall Study|Change in protocol|0|||
161933598|NCT01394185|584806482|FG004|Overall Study|Change in protocol|3|||
161933599|NCT01394185|584806483|FG005|Overall Study|Change in protocol|0|||
161933600|NCT01394185|584806478|FG000|Overall Study|Protocol Violation|1|||
161933601|NCT01394185|584806479|FG001|Overall Study|Protocol Violation|0|||
161933602|NCT01394185|584806480|FG002|Overall Study|Protocol Violation|0|||
161933603|NCT01394185|584806481|FG003|Overall Study|Protocol Violation|1|||
161933604|NCT01394185|584806482|FG004|Overall Study|Protocol Violation|0|||
161933605|NCT01394185|584806483|FG005|Overall Study|Protocol Violation|1|||
161933606|NCT04110145|584806484|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933607|NCT04110145|584806485|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933608|NCT04110145|584806486|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933609|NCT04110145|584806487|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
161933610|NCT04110145|584806488|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933611|NCT05401409|584806489|FG000|Overall Study|Lost to Follow-up|1|||
161933612|NCT05401409|584806490|FG001|Overall Study|Lost to Follow-up|0|||
161933613|NCT02371889|584806491|FG000|Overall Study|Adverse medication effect|11|||
161933614|NCT02371889|584806492|FG001|Overall Study|Adverse medication effect|2|||
161933615|NCT02371889|584806491|FG000|Overall Study|Lost to Follow-up|6|||
161933616|NCT02371889|584806492|FG001|Overall Study|Lost to Follow-up|5|||
161933617|NCT02371889|584806491|FG000|Overall Study|Personal time constraints|2|||
161933618|NCT02371889|584806492|FG001|Overall Study|Personal time constraints|4|||
161933619|NCT02371889|584806491|FG000|Overall Study|Lack of Efficacy|0|||
161933620|NCT02371889|584806492|FG001|Overall Study|Lack of Efficacy|2|||
161933621|NCT02371889|584806491|FG000|Overall Study|Relapse|0|||
161933622|NCT02371889|584806492|FG001|Overall Study|Relapse|1|||
161933623|NCT02410200|584806496|FG000|Overall Study|Adverse Event|2|||
161825598|NCT01332968|584401844|FG005|Follow-Up Period|Death|0|||
161825599|NCT01332968|584401845|FG006|Follow-Up Period|Death|27|||
161825600|NCT01332968|584401846|FG007|Follow-Up Period|Death|30|||
161825601|NCT01332968|584401839|FG000|Follow-Up Period|Lost to Follow-up|0|||
161825602|NCT01332968|584401840|FG001|Follow-Up Period|Lost to Follow-up|0|||
161825603|NCT01332968|584401841|FG002|Follow-Up Period|Lost to Follow-up|0|||
161825604|NCT01332968|584401842|FG003|Follow-Up Period|Lost to Follow-up|0|||
161825605|NCT01332968|584401843|FG004|Follow-Up Period|Lost to Follow-up|0|||
161825606|NCT01332968|584401844|FG005|Follow-Up Period|Lost to Follow-up|0|||
161825607|NCT01332968|584401845|FG006|Follow-Up Period|Lost to Follow-up|11|||
161825608|NCT01332968|584401846|FG007|Follow-Up Period|Lost to Follow-up|15|||
161825609|NCT01332968|584401839|FG000|Follow-Up Period|Non-compliance|0|||
161825610|NCT01332968|584401840|FG001|Follow-Up Period|Non-compliance|0|||
161825611|NCT01332968|584401841|FG002|Follow-Up Period|Non-compliance|0|||
161825612|NCT01332968|584401842|FG003|Follow-Up Period|Non-compliance|0|||
161825613|NCT01332968|584401843|FG004|Follow-Up Period|Non-compliance|0|||
161825614|NCT01332968|584401844|FG005|Follow-Up Period|Non-compliance|0|||
161825615|NCT01332968|584401845|FG006|Follow-Up Period|Non-compliance|4|||
161825616|NCT01332968|584401846|FG007|Follow-Up Period|Non-compliance|9|||
161825617|NCT01332968|584401839|FG000|Follow-Up Period|Other|0|||
161825618|NCT01332968|584401840|FG001|Follow-Up Period|Other|0|||
161825619|NCT01332968|584401841|FG002|Follow-Up Period|Other|0|||
161825620|NCT01332968|584401842|FG003|Follow-Up Period|Other|0|||
161825621|NCT01332968|584401843|FG004|Follow-Up Period|Other|0|||
161825622|NCT01332968|584401844|FG005|Follow-Up Period|Other|0|||
161825623|NCT01332968|584401845|FG006|Follow-Up Period|Other|18|||
161825624|NCT01332968|584401846|FG007|Follow-Up Period|Other|21|||
161825625|NCT01332968|584401839|FG000|Follow-Up Period|Physician Decision|0|||
161825626|NCT01332968|584401840|FG001|Follow-Up Period|Physician Decision|0|||
161825627|NCT01332968|584401841|FG002|Follow-Up Period|Physician Decision|0|||
161825628|NCT01332968|584401842|FG003|Follow-Up Period|Physician Decision|0|||
161825629|NCT01332968|584401843|FG004|Follow-Up Period|Physician Decision|0|||
161825630|NCT01332968|584401844|FG005|Follow-Up Period|Physician Decision|0|||
161825631|NCT01332968|584401845|FG006|Follow-Up Period|Physician Decision|12|||
161825632|NCT01332968|584401846|FG007|Follow-Up Period|Physician Decision|15|||
161825633|NCT01332968|584401839|FG000|Follow-Up Period|Progressive Disease|0|||
161825634|NCT01332968|584401840|FG001|Follow-Up Period|Progressive Disease|0|||
161825635|NCT01332968|584401841|FG002|Follow-Up Period|Progressive Disease|0|||
161933624|NCT00432991|584806497|FG000|Overall Study|Protocol Violation|7|||
161933625|NCT00432991|584806498|FG001|Overall Study|Protocol Violation|12|||
161933626|NCT00363467|584806499|FG000|Overall Study|Physician Decision|1|||
161933627|NCT03160573|584806502|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
161933628|NCT03160573|584806503|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
161933629|NCT03160573|584806504|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
161933630|NCT03160573|584806505|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
161933631|NCT00101400|584806506|FG000|Survival Follow-Up|Alive|7|||
161933632|NCT02715856|584806511|FG000|Overall Study|Software Issues|12|||
161933633|NCT02715856|584806512|FG001|Overall Study|Software Issues|7|||
161933634|NCT02715856|584806511|FG000|Overall Study|Death|6|||
161933635|NCT02715856|584806512|FG001|Overall Study|Death|5|||
161933636|NCT02715856|584806511|FG000|Overall Study|Non- Compliant|0|||
161933637|NCT02715856|584806512|FG001|Overall Study|Non- Compliant|40|||
161933638|NCT02336555|584806513|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161933639|NCT02336555|584806514|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161933640|NCT02336555|584806513|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
161933641|NCT02336555|584806514|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
161933642|NCT02336555|584806513|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
161933643|NCT02336555|584806514|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
161933644|NCT04157738|584806522|FG000|Overall Study|Moved out of state|0|||
161933645|NCT04157738|584806523|FG001|Overall Study|Moved out of state|2|||
161933646|NCT04157738|584806522|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
161933647|NCT04157738|584806523|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
161933648|NCT00309946|584806524|FG000|Overall Study|Withdrawal by Subject|1|||
161933649|NCT02244957|584806525|FG000|Overall Study|Lack of Efficacy|1|||
161933650|NCT02244957|584806526|FG001|Overall Study|Lack of Efficacy|0|||
161933651|NCT01347086|584806527|FG000|Overall Study|failed screening visit|0|||
161933652|NCT01347086|584806528|FG001|Overall Study|failed screening visit|0|||
161933653|NCT01347086|584806529|FG002|Overall Study|failed screening visit|1|||
161933654|NCT01347086|584806530|FG003|Overall Study|failed screening visit|0|||
161933655|NCT01347086|584806531|FG004|Overall Study|failed screening visit|0|||
161933656|NCT01347086|584806532|FG005|Overall Study|failed screening visit|0|||
161933657|NCT01347086|584806533|FG006|Overall Study|failed screening visit|1|||
161933658|NCT01347086|584806534|FG007|Overall Study|failed screening visit|1|||
161933659|NCT01347086|584806535|FG008|Overall Study|failed screening visit|0|||
161933660|NCT01347086|584806536|FG009|Overall Study|failed screening visit|1|||
161933661|NCT02624687|584806539|FG000|Overall Study|Withdrawal by Subject|1|||
161933662|NCT02624687|584806540|FG001|Overall Study|Withdrawal by Subject|1|||
161521145|NCT02265705|583297441|FG000|Follow-up Period|Physician Decision|0|||
161521146|NCT02265705|583297442|FG001|Follow-up Period|Physician Decision|0|||
161521147|NCT02265705|583297443|FG002|Follow-up Period|Physician Decision|0|||
161521148|NCT02265705|583297444|FG003|Follow-up Period|Physician Decision|0|||
161521149|NCT02265705|583297445|FG004|Follow-up Period|Physician Decision|0|||
161521150|NCT02265705|583297446|FG005|Follow-up Period|Physician Decision|0|||
161521151|NCT02265705|583297447|FG006|Follow-up Period|Physician Decision|1|||
161521152|NCT02265705|583297441|FG000|Follow-up Period|Withdrawal by Subject|0|||
161521153|NCT02265705|583297442|FG001|Follow-up Period|Withdrawal by Subject|0|||
161521154|NCT02265705|583297443|FG002|Follow-up Period|Withdrawal by Subject|0|||
161521155|NCT02265705|583297444|FG003|Follow-up Period|Withdrawal by Subject|0|||
161521156|NCT02265705|583297445|FG004|Follow-up Period|Withdrawal by Subject|0|||
161521157|NCT02265705|583297446|FG005|Follow-up Period|Withdrawal by Subject|0|||
161521158|NCT02265705|583297447|FG006|Follow-up Period|Withdrawal by Subject|1|||
161521159|NCT02828111|583297451|FG000|Overall Study|Withdrawal by Subject|0|||
161521160|NCT02828111|583297452|FG001|Overall Study|Withdrawal by Subject|0|||
161521161|NCT02828111|583297453|FG002|Overall Study|Withdrawal by Subject|2|||
161521162|NCT02828111|583297454|FG003|Overall Study|Withdrawal by Subject|0|||
161521163|NCT02828111|583297455|FG004|Overall Study|Withdrawal by Subject|0|||
161521164|NCT02828111|583297451|FG000|Overall Study|Lost to Follow-up|0|||
161521165|NCT02828111|583297452|FG001|Overall Study|Lost to Follow-up|0|||
161521166|NCT02828111|583297453|FG002|Overall Study|Lost to Follow-up|0|||
161521167|NCT02828111|583297454|FG003|Overall Study|Lost to Follow-up|1|||
161521168|NCT02828111|583297455|FG004|Overall Study|Lost to Follow-up|1|||
161521169|NCT02079805|583297459|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161521170|NCT02079805|583297460|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161521171|NCT02079805|583297459|FG000|Overall Study|Voluntary Withdrawal|0|||
161521172|NCT02079805|583297460|FG001|Overall Study|Voluntary Withdrawal|1|||
161521173|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
161521174|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
161933663|NCT02624687|584806539|FG000|Overall Study|medical leave from work|0|||
161933664|NCT02624687|584806540|FG001|Overall Study|medical leave from work|1|||
161933665|NCT03111108|584806541|FG000|Overall Study|Death|0|||
161933666|NCT03111108|584806542|FG001|Overall Study|Death|1|||
161933667|NCT03111108|584806541|FG000|Overall Study|Withdrawal by Subject|1|||
161933668|NCT03111108|584806542|FG001|Overall Study|Withdrawal by Subject|0|||
161933669|NCT01514357|584806543|FG000|Overall Study|Screen failure|2|||
161933670|NCT01514357|584806544|FG001|Overall Study|Screen failure|0|||
161933671|NCT01514357|584806543|FG000|Overall Study|Withdrawal by Subject|2|||
161933672|NCT01514357|584806544|FG001|Overall Study|Withdrawal by Subject|0|||
161933673|NCT04691115|584806547|FG000|Overall Study|Withdrawal by Subject|0|||
161933674|NCT04691115|584806548|FG001|Overall Study|Withdrawal by Subject|0|||
161933675|NCT04691115|584806549|FG002|Overall Study|Withdrawal by Subject|0|||
161933676|NCT04691115|584806550|FG003|Overall Study|Withdrawal by Subject|0|||
161933677|NCT04691115|584806551|FG004|Overall Study|Withdrawal by Subject|0|||
161933678|NCT04691115|584806552|FG005|Overall Study|Withdrawal by Subject|1|||
161933679|NCT04691115|584806553|FG006|Overall Study|Withdrawal by Subject|0|||
161933680|NCT04691115|584806554|FG007|Overall Study|Withdrawal by Subject|0|||
161933681|NCT04691115|584806555|FG008|Overall Study|Withdrawal by Subject|0|||
161933682|NCT04691115|584806556|FG009|Overall Study|Withdrawal by Subject|0|||
161933683|NCT04691115|584806557|FG010|Overall Study|Withdrawal by Subject|0|||
161933684|NCT04691115|584806558|FG011|Overall Study|Withdrawal by Subject|0|||
161933685|NCT04691115|584806559|FG012|Overall Study|Withdrawal by Subject|0|||
161933686|NCT04691115|584806560|FG013|Overall Study|Withdrawal by Subject|0|||
161933687|NCT00830336|584806564|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161933688|NCT00830336|584806565|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
161933689|NCT00867334|584806566|FG000|Overall Study|Withdrawal by Subject|0|||
161933690|NCT00867334|584806567|FG001|Overall Study|Withdrawal by Subject|1|||
161933691|NCT00867334|584806566|FG000|Overall Study|Withdrawal by Subject|1|||
161933692|NCT00867334|584806567|FG001|Overall Study|Withdrawal by Subject|0|||
161933693|NCT00867334|584806566|FG000|Overall Study|Withdrawal by Subject|1|||
161933694|NCT00867334|584806567|FG001|Overall Study|Withdrawal by Subject|0|||
161933695|NCT00347269|584806572|FG000|Overall Study|Lost to Follow-up|74|||
161933696|NCT00347269|584806573|FG001|Overall Study|Lost to Follow-up|65|||
161933697|NCT00347269|584806572|FG000|Overall Study|Withdrawal by Subject|18|||
161933698|NCT00347269|584806573|FG001|Overall Study|Withdrawal by Subject|38|||
161933699|NCT00347269|584806572|FG000|Overall Study|Death|2|||
161933700|NCT00347269|584806573|FG001|Overall Study|Death|3|||
161933701|NCT01689649|584806574|FG000|Overall Study|Lack of Efficacy|3|||
161933702|NCT01689649|584806574|FG000|Overall Study|Non-compliance|11|||
161933703|NCT01689649|584806574|FG000|Overall Study|Protocol Violation|3|||
161933704|NCT01689649|584806574|FG000|Overall Study|Lost to Follow-up|5|||
161933705|NCT04893811|584806575|FG000|Vaccination Phase|Death|1|||
161933706|NCT04893811|584806576|FG001|Vaccination Phase|Death|0|||
161933707|NCT04893811|584806575|FG000|Vaccination Phase|Lost to Follow-up|1|||
161933708|NCT04893811|584806576|FG001|Vaccination Phase|Lost to Follow-up|1|||
161933709|NCT04893811|584806575|FG000|Vaccination Phase|Protocol Violation|2|||
161933710|NCT04893811|584806576|FG001|Vaccination Phase|Protocol Violation|0|||
161521175|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
161521176|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
161521177|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
161521178|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161521179|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
161521180|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161521181|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
161521182|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
161521183|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
161521184|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
161521185|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161521186|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161521187|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161521188|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
161933711|NCT04893811|584806575|FG000|Vaccination Phase|Withdrawal by Subject|2|||
161933712|NCT04893811|584806576|FG001|Vaccination Phase|Withdrawal by Subject|1|||
161933713|NCT04893811|584806575|FG000|Vaccination Phase|Other|0|||
161933714|NCT04893811|584806576|FG001|Vaccination Phase|Other|1|||
161933715|NCT04893811|584806575|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
161933716|NCT04893811|584806576|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
161933717|NCT04893811|584806575|FG000|Follow-up Phase|Lost to Follow-up|0|||
161933718|NCT04893811|584806576|FG001|Follow-up Phase|Lost to Follow-up|1|||
161933719|NCT03268499|584806577|FG000|Overall Study|Withdrawal by Subject|2|||
161933720|NCT03268499|584806578|FG001|Overall Study|Withdrawal by Subject|1|||
161933721|NCT01725282|584806583|FG000|Overall Study|Adverse Event|1|||
161933722|NCT01725282|584806584|FG001|Overall Study|Adverse Event|3|||
161933723|NCT01725282|584806585|FG002|Overall Study|Adverse Event|6|||
161933724|NCT01725282|584806586|FG003|Overall Study|Adverse Event|4|||
161933725|NCT01725282|584806583|FG000|Overall Study|Exacerbation of Target Disease|1|||
161933726|NCT01725282|584806584|FG001|Overall Study|Exacerbation of Target Disease|0|||
161933727|NCT01725282|584806585|FG002|Overall Study|Exacerbation of Target Disease|0|||
161933728|NCT01725282|584806586|FG003|Overall Study|Exacerbation of Target Disease|1|||
161933729|NCT01725282|584806583|FG000|Overall Study|Met Exclusion Criteria|0|||
161933730|NCT01725282|584806584|FG001|Overall Study|Met Exclusion Criteria|0|||
161933731|NCT01725282|584806585|FG002|Overall Study|Met Exclusion Criteria|1|||
161933732|NCT01725282|584806586|FG003|Overall Study|Met Exclusion Criteria|0|||
161933733|NCT01725282|584806583|FG000|Overall Study|Study Site Withdrawal|0|||
161933734|NCT01725282|584806584|FG001|Overall Study|Study Site Withdrawal|1|||
161933735|NCT01725282|584806585|FG002|Overall Study|Study Site Withdrawal|0|||
161933736|NCT01725282|584806586|FG003|Overall Study|Study Site Withdrawal|0|||
161933737|NCT01725282|584806583|FG000|Overall Study|Withdrawal by Subject|0|||
161933738|NCT01725282|584806584|FG001|Overall Study|Withdrawal by Subject|0|||
161933739|NCT01725282|584806585|FG002|Overall Study|Withdrawal by Subject|1|||
161933740|NCT01725282|584806586|FG003|Overall Study|Withdrawal by Subject|1|||
161933741|NCT01725282|584806583|FG000|Overall Study|Lack of Efficacy|0|||
161933742|NCT01725282|584806584|FG001|Overall Study|Lack of Efficacy|1|||
161933743|NCT01725282|584806585|FG002|Overall Study|Lack of Efficacy|0|||
161933744|NCT01725282|584806586|FG003|Overall Study|Lack of Efficacy|1|||
161933745|NCT04064567|584806587|FG000|Overall Study|Lost to Follow-up|23|||
161933746|NCT04064567|584806588|FG001|Overall Study|Lost to Follow-up|22|||
161933747|NCT04064567|584806587|FG000|Overall Study|Withdrawal by Subject|0|||
161933748|NCT04064567|584806588|FG001|Overall Study|Withdrawal by Subject|1|||
161933749|NCT04064567|584806587|FG000|Overall Study|Reincarcerated|7|||
161933750|NCT04064567|584806588|FG001|Overall Study|Reincarcerated|10|||
161933751|NCT04064567|584806587|FG000|Overall Study|Moved out of U.S.|0|||
161933752|NCT04064567|584806588|FG001|Overall Study|Moved out of U.S.|1|||
161933753|NCT05071027|584806589|FG000|Overall Study|Lost to Follow-up|1|||
161933754|NCT05071027|584806590|FG001|Overall Study|Lost to Follow-up|4|||
161933755|NCT04576481|584806591|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
161933756|NCT04576481|584806592|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
161933757|NCT04576481|584806593|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
161933758|NCT04576481|584806594|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
161933759|NCT03464461|584806600|FG000|Overall Study|exclusionary medication given ,|1|||
161933760|NCT03464461|584806601|FG001|Overall Study|exclusionary medication given ,|2|||
161933761|NCT03464461|584806602|FG002|Overall Study|exclusionary medication given ,|0|||
161933762|NCT03464461|584806600|FG000|Overall Study|Physician Decision|0|||
161933763|NCT03464461|584806601|FG001|Overall Study|Physician Decision|1|||
161933764|NCT03464461|584806602|FG002|Overall Study|Physician Decision|0|||
161933765|NCT05524948|584806603|FG000|Overall Study|Withdrawal by Subject|1|||
161933766|NCT05524948|584806604|FG001|Overall Study|Withdrawal by Subject|0|||
161933767|NCT05524948|584806603|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
161933768|NCT05524948|584806604|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
161933769|NCT05463952|584806605|FG000|Treatment|Progressive disease|4|||
161933770|NCT05463952|584806605|FG000|Treatment|Ongoing|2|||
161933771|NCT02739828|584806607|FG000|Overall Study|Adverse Event|1|||
161933772|NCT02739828|584806607|FG000|Overall Study|Lost to Follow-up|4|||
161933773|NCT04191733|584806609|FG000|Overall Study|Withdrawn due to study closure|13|||
161933774|NCT04191733|584806610|FG001|Overall Study|Withdrawn due to study closure|14|||
161933775|NCT04191733|584806609|FG000|Overall Study|Withdrawal by Subject|2|||
161933776|NCT04191733|584806610|FG001|Overall Study|Withdrawal by Subject|4|||
161933777|NCT04191733|584806609|FG000|Overall Study|Physician Decision|1|||
161933778|NCT04191733|584806610|FG001|Overall Study|Physician Decision|1|||
161933779|NCT04191733|584806609|FG000|Overall Study|Lost to Follow-up|5|||
161933780|NCT04191733|584806610|FG001|Overall Study|Lost to Follow-up|6|||
161933781|NCT04191733|584806609|FG000|Overall Study|Death|0|||
161933782|NCT04191733|584806610|FG001|Overall Study|Death|1|||
161677546|NCT00041080|583872026|FG000|Overall Study|Adverse Event|21|||
161677547|NCT00041080|583872027|FG001|Overall Study|Adverse Event|1|||
161677548|NCT00041080|583872026|FG000|Overall Study|Withdrawal by Subject|6|||
161677549|NCT00041080|583872027|FG001|Overall Study|Withdrawal by Subject|6|||
161677550|NCT00041080|583872026|FG000|Overall Study|Concommitant Illness/Other|1|||
161677551|NCT00041080|583872027|FG001|Overall Study|Concommitant Illness/Other|2|||
161933783|NCT02202577|584806613|FG000|Overall Study|Lost to Follow-up|6|||
161933784|NCT02202577|584806614|FG001|Overall Study|Lost to Follow-up|16|||
161933785|NCT02202577|584806613|FG000|Overall Study|Protocol Violation|7|||
161933786|NCT02202577|584806614|FG001|Overall Study|Protocol Violation|3|||
161933787|NCT01646216|584806615|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
161933788|NCT01646216|584806616|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
161933789|NCT01646216|584806615|FG000|Overall Study|Did not complete training|0|||
161933790|NCT01646216|584806616|FG001|Overall Study|Did not complete training|2|||
161933791|NCT01646216|584806615|FG000|Overall Study|Investigator decision|1|||
161933792|NCT01646216|584806616|FG001|Overall Study|Investigator decision|1|||
161933793|NCT01514422|584806617|FG000|Overall Study|Lost to Follow-up|1|||
161933794|NCT03511209|584806618|FG000|Overall Study|Withdrawal by Subject|2|||
161933795|NCT03511209|584806619|FG001|Overall Study|Withdrawal by Subject|4|||
161677552|NCT00041080|583872026|FG000|Overall Study|Did not start therapy|1|||
161677553|NCT00041080|583872027|FG001|Overall Study|Did not start therapy|1|||
161933796|NCT03511209|584806618|FG000|Overall Study|Death|1|||
161933797|NCT03511209|584806619|FG001|Overall Study|Death|0|||
161933798|NCT03511209|584806618|FG000|Overall Study|Lost to Follow-up|0|||
161933799|NCT03511209|584806619|FG001|Overall Study|Lost to Follow-up|2|||
161933800|NCT02757963|584806622|FG000|Overall Study|Adverse Event|3|||
161933801|NCT02757963|584806622|FG000|Overall Study|Reached Stopping Criteria|1054|||
161933802|NCT02757963|584806622|FG000|Overall Study|Lost to Follow-up|5|||
161933803|NCT02757963|584806622|FG000|Overall Study|Physician Decision|1|||
161933804|NCT02757963|584806622|FG000|Overall Study|Withdrawal by Subject|34|||
161933805|NCT03769467|584806623|FG000|Overall Study|Adverse Event|1|||
161933806|NCT03769467|584806624|FG001|Overall Study|Adverse Event|1|||
161933807|NCT03769467|584806625|FG002|Overall Study|Adverse Event|0|||
161933808|NCT03769467|584806623|FG000|Overall Study|Death|3|||
161933809|NCT03769467|584806624|FG001|Overall Study|Death|3|||
161933810|NCT03769467|584806625|FG002|Overall Study|Death|0|||
161933811|NCT03769467|584806623|FG000|Overall Study|Study Terminated By Sponsor|2|||
161933812|NCT03769467|584806624|FG001|Overall Study|Study Terminated By Sponsor|1|||
161933813|NCT03769467|584806625|FG002|Overall Study|Study Terminated By Sponsor|0|||
161933814|NCT03769467|584806623|FG000|Overall Study|Withdrawal by Subject|0|||
161933815|NCT03769467|584806624|FG001|Overall Study|Withdrawal by Subject|1|||
161933816|NCT03769467|584806625|FG002|Overall Study|Withdrawal by Subject|0|||
161933817|NCT01887600|584806626|FG000|Overall Study|Death|39|||
161933818|NCT01887600|584806627|FG001|Overall Study|Death|16|||
161933819|NCT01887600|584806626|FG000|Overall Study|Lack of Efficacy|3|||
161521189|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
161521190|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
161933820|NCT01887600|584806627|FG001|Overall Study|Lack of Efficacy|26|||
161933821|NCT01887600|584806626|FG000|Overall Study|Lost to Follow-up|5|||
161933822|NCT01887600|584806627|FG001|Overall Study|Lost to Follow-up|1|||
161933823|NCT01887600|584806626|FG000|Overall Study|Physician Decision|7|||
161933824|NCT01887600|584806627|FG001|Overall Study|Physician Decision|8|||
161933825|NCT01887600|584806626|FG000|Overall Study|Protocol Deviation|3|||
161933826|NCT01887600|584806627|FG001|Overall Study|Protocol Deviation|0|||
161933827|NCT01887600|584806626|FG000|Overall Study|Withdrawal by Subject|58|||
161933828|NCT01887600|584806627|FG001|Overall Study|Withdrawal by Subject|52|||
161933829|NCT01887600|584806626|FG000|Overall Study|Adverse Event|21|||
161521191|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
161521192|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
161521193|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
161933830|NCT01887600|584806627|FG001|Overall Study|Adverse Event|9|||
161933831|NCT01887600|584806626|FG000|Overall Study|Non-compliance with study drug|3|||
161933832|NCT01887600|584806627|FG001|Overall Study|Non-compliance with study drug|0|||
161933833|NCT01887600|584806626|FG000|Overall Study|Miscellaneous|6|||
161933834|NCT01887600|584806627|FG001|Overall Study|Miscellaneous|2|||
161933835|NCT01887600|584806626|FG000|Overall Study|Progressive Disease|1|||
161933836|NCT01887600|584806627|FG001|Overall Study|Progressive Disease|0|||
161933837|NCT03688139|584806628|FG000|Overall Study|Lost to Follow-up|2|||
161933838|NCT03688139|584806629|FG001|Overall Study|Lost to Follow-up|0|||
161933839|NCT03688139|584806628|FG000|Overall Study|Physician Decision|0|||
161933840|NCT03688139|584806629|FG001|Overall Study|Physician Decision|1|||
161933841|NCT03688139|584806628|FG000|Overall Study|Withdrawal by Subject|2|||
161933842|NCT03688139|584806629|FG001|Overall Study|Withdrawal by Subject|3|||
161933843|NCT00127933|584806630|FG000|Overall Study|Randomized but not dosed|1|||
161933844|NCT00127933|584806631|FG001|Overall Study|Randomized but not dosed|0|||
161933845|NCT00498485|584806632|FG000|Overall Study|Adverse Event|1|||
161933846|NCT00498485|584806633|FG001|Overall Study|Adverse Event|5|||
161933847|NCT00452400|584806634|FG000|Overall Study|Adverse Event|1|||
161933848|NCT00452400|584806635|FG001|Overall Study|Adverse Event|1|||
161933849|NCT00452400|584806636|FG002|Overall Study|Adverse Event|5|||
161933850|NCT00452400|584806637|FG003|Overall Study|Adverse Event|0|||
161933851|NCT00452400|584806638|FG004|Overall Study|Adverse Event|2|||
161933852|NCT00452400|584806634|FG000|Overall Study|Protocol Violation|0|||
161521194|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
161589378|NCT04083235|583546445|FG001|Overall Study|Death|277|||
161933853|NCT00452400|584806635|FG001|Overall Study|Protocol Violation|0|||
161933854|NCT00452400|584806636|FG002|Overall Study|Protocol Violation|1|||
161933855|NCT00452400|584806637|FG003|Overall Study|Protocol Violation|0|||
161933856|NCT00452400|584806638|FG004|Overall Study|Protocol Violation|0|||
161933857|NCT00452400|584806634|FG000|Overall Study|Lost to Follow-up|1|||
161933858|NCT00452400|584806635|FG001|Overall Study|Lost to Follow-up|0|||
161933859|NCT00452400|584806636|FG002|Overall Study|Lost to Follow-up|0|||
161933860|NCT00452400|584806637|FG003|Overall Study|Lost to Follow-up|0|||
161933861|NCT00452400|584806638|FG004|Overall Study|Lost to Follow-up|0|||
161933862|NCT00452400|584806634|FG000|Overall Study|Withdrawal by Subject|1|||
161933863|NCT00452400|584806635|FG001|Overall Study|Withdrawal by Subject|0|||
161933864|NCT00452400|584806636|FG002|Overall Study|Withdrawal by Subject|1|||
161933865|NCT00452400|584806637|FG003|Overall Study|Withdrawal by Subject|0|||
161933866|NCT00452400|584806638|FG004|Overall Study|Withdrawal by Subject|0|||
161933867|NCT00452400|584806634|FG000|Overall Study|Lack of Efficacy|2|||
161933868|NCT00452400|584806635|FG001|Overall Study|Lack of Efficacy|0|||
161933869|NCT00452400|584806636|FG002|Overall Study|Lack of Efficacy|0|||
161933870|NCT00452400|584806637|FG003|Overall Study|Lack of Efficacy|0|||
161933871|NCT00452400|584806638|FG004|Overall Study|Lack of Efficacy|0|||
161933872|NCT00452400|584806634|FG000|Overall Study|Other reasons not listed above|0|||
161933873|NCT00452400|584806635|FG001|Overall Study|Other reasons not listed above|0|||
161933874|NCT00452400|584806636|FG002|Overall Study|Other reasons not listed above|0|||
161933875|NCT00452400|584806637|FG003|Overall Study|Other reasons not listed above|1|||
161933876|NCT00452400|584806638|FG004|Overall Study|Other reasons not listed above|1|||
161933877|NCT01943825|584806639|FG000|Overall Study|Lost to Follow-up|9|||
161933878|NCT01943825|584806640|FG001|Overall Study|Lost to Follow-up|3|||
161933879|NCT01943825|584806641|FG002|Overall Study|Lost to Follow-up|12|||
161933880|NCT01943825|584806642|FG003|Overall Study|Lost to Follow-up|8|||
161933881|NCT01943825|584806639|FG000|Overall Study|Withdrawal by Subject|1|||
161933882|NCT01943825|584806640|FG001|Overall Study|Withdrawal by Subject|0|||
161933883|NCT01943825|584806641|FG002|Overall Study|Withdrawal by Subject|3|||
161933884|NCT01943825|584806642|FG003|Overall Study|Withdrawal by Subject|2|||
161933885|NCT01943825|584806639|FG000|Overall Study|Other than specified above|0|||
161933886|NCT01943825|584806640|FG001|Overall Study|Other than specified above|1|||
161933887|NCT01943825|584806641|FG002|Overall Study|Other than specified above|0|||
161933888|NCT01943825|584806642|FG003|Overall Study|Other than specified above|1|||
161933889|NCT01472835|584806645|FG000|Overall Study|Lost to Follow-up|2|||
161933890|NCT01472835|584806646|FG001|Overall Study|Lost to Follow-up|0|||
161933891|NCT01316900|584806663|FG000|Overall Study|Adverse Event|10|||
161933892|NCT01316900|584806664|FG001|Overall Study|Adverse Event|10|||
161933893|NCT01316900|584806665|FG002|Overall Study|Adverse Event|15|||
161933894|NCT01316900|584806666|FG003|Overall Study|Adverse Event|9|||
161933895|NCT01316900|584806663|FG000|Overall Study|Lack of Efficacy|17|||
161933896|NCT01316900|584806664|FG001|Overall Study|Lack of Efficacy|9|||
161933897|NCT01316900|584806665|FG002|Overall Study|Lack of Efficacy|5|||
161933898|NCT01316900|584806666|FG003|Overall Study|Lack of Efficacy|7|||
161933899|NCT01316900|584806663|FG000|Overall Study|Protocol Violation|7|||
161933900|NCT01316900|584806664|FG001|Overall Study|Protocol Violation|1|||
161933901|NCT01316900|584806665|FG002|Overall Study|Protocol Violation|4|||
161933902|NCT01316900|584806666|FG003|Overall Study|Protocol Violation|0|||
161933903|NCT01316900|584806663|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
161933904|NCT01316900|584806664|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
161933905|NCT01316900|584806665|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
161933906|NCT01316900|584806666|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
161933907|NCT01316900|584806663|FG000|Overall Study|Lost to Follow-up|1|||
161933908|NCT01316900|584806664|FG001|Overall Study|Lost to Follow-up|0|||
161933909|NCT01316900|584806665|FG002|Overall Study|Lost to Follow-up|1|||
161933910|NCT01316900|584806666|FG003|Overall Study|Lost to Follow-up|1|||
161933911|NCT01316900|584806663|FG000|Overall Study|Withdrawal by Subject|7|||
161933912|NCT01316900|584806664|FG001|Overall Study|Withdrawal by Subject|8|||
161933913|NCT01316900|584806665|FG002|Overall Study|Withdrawal by Subject|6|||
161933914|NCT01316900|584806666|FG003|Overall Study|Withdrawal by Subject|9|||
161933915|NCT05346640|584806667|FG000|Overall Study|Lack of Efficacy|2|||
161933916|NCT05346640|584806667|FG000|Overall Study|Lost to Follow-up|14|||
161933917|NCT05346640|584806667|FG000|Overall Study|Protocol Violation|4|||
161933918|NCT05346640|584806667|FG000|Overall Study|Withdrawal by Subject|2|||
161933919|NCT05346640|584806667|FG000|Overall Study|Physiological Complications|3|||
161933920|NCT05346640|584806667|FG000|Overall Study|Other Reason|3|||
161933921|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161933922|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
161933923|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161933924|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
161933925|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
161933926|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
161933927|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
161933928|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161933929|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161933930|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
161933931|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161933932|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161933933|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161933934|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161933935|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
161933936|NCT01703221|584806668|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
161933937|NCT01703221|584806669|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
161933938|NCT01703221|584806670|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
161933939|NCT01703221|584806668|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
161933940|NCT01703221|584806669|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
161933941|NCT01703221|584806670|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
161521195|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
161521196|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
161521197|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
161521198|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
161521199|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
161521200|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
161521201|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
161589379|NCT04083235|583546444|FG000|Overall Study|Withdrawal by Subject|13|||
161933942|NCT01703221|584806668|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
161933943|NCT01703221|584806669|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
161933944|NCT01703221|584806670|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
161933945|NCT01152385|584806671|FG000|Overall Study|Withdrawal by Subject|3|||
161933946|NCT01152385|584806672|FG001|Overall Study|Withdrawal by Subject|1|||
161933947|NCT01152385|584806673|FG002|Overall Study|Withdrawal by Subject|1|||
161933948|NCT01152385|584806674|FG003|Overall Study|Withdrawal by Subject|1|||
161933949|NCT01152385|584806671|FG000|Overall Study|Protocol Violation|0|||
161933950|NCT01152385|584806672|FG001|Overall Study|Protocol Violation|0|||
161933951|NCT01152385|584806673|FG002|Overall Study|Protocol Violation|0|||
161933952|NCT01152385|584806674|FG003|Overall Study|Protocol Violation|1|||
161933953|NCT01152385|584806671|FG000|Overall Study|Adverse Event|1|||
161933954|NCT01152385|584806672|FG001|Overall Study|Adverse Event|1|||
161933955|NCT01152385|584806673|FG002|Overall Study|Adverse Event|0|||
161933956|NCT01152385|584806674|FG003|Overall Study|Adverse Event|0|||
161933957|NCT01152385|584806671|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161933958|NCT01152385|584806672|FG001|Overall Study|Study-specific withdrawal criteria|1|||
161933959|NCT01152385|584806673|FG002|Overall Study|Study-specific withdrawal criteria|2|||
161933960|NCT01152385|584806674|FG003|Overall Study|Study-specific withdrawal criteria|0|||
161933961|NCT01152385|584806671|FG000|Overall Study|Other|4|||
161933962|NCT01152385|584806672|FG001|Overall Study|Other|3|||
161933963|NCT01152385|584806673|FG002|Overall Study|Other|2|||
161933964|NCT01152385|584806674|FG003|Overall Study|Other|3|||
161933965|NCT03927846|584806677|FG000|Overall Study|Lost to Follow-up|10|||
161933966|NCT03927846|584806678|FG001|Overall Study|Lost to Follow-up|11|||
161933967|NCT03061214|584806681|FG000|Overall Study|Withdrawal by Subject|21|||
161933968|NCT03061214|584806682|FG001|Overall Study|Withdrawal by Subject|26|||
161933969|NCT03061214|584806683|FG002|Overall Study|Withdrawal by Subject|9|||
161933970|NCT03061214|584806681|FG000|Overall Study|Lost to Follow-up|3|||
161933971|NCT03061214|584806682|FG001|Overall Study|Lost to Follow-up|1|||
161933972|NCT03061214|584806683|FG002|Overall Study|Lost to Follow-up|1|||
161933973|NCT03061214|584806681|FG000|Overall Study|Death|1|||
161933974|NCT03061214|584806682|FG001|Overall Study|Death|1|||
161933975|NCT03061214|584806683|FG002|Overall Study|Death|0|||
161933976|NCT05130281|584808353|FG000|Overall Study|Withdrawal by Subject|0|||
161933977|NCT05130281|584808354|FG001|Overall Study|Withdrawal by Subject|0|||
161933978|NCT05130281|584808355|FG002|Overall Study|Withdrawal by Subject|1|||
161933979|NCT06844812|584808356|FG000|Overall Study|Lost to Follow-up|5|||
161933980|NCT06844812|584808356|FG000|Overall Study|stigmatization concerns|2|||
161933981|NCT06844812|584808356|FG000|Overall Study|medication refusal|2|||
161933982|NCT06844812|584808356|FG000|Overall Study|concerns about possible side effects|2|||
161933983|NCT06844812|584808356|FG000|Overall Study|wanting to seek another specialist opinion|2|||
161933984|NCT06844812|584808356|FG000|Overall Study|side effects (dizziness)|1|||
161933985|NCT05520333|584808360|FG000|Overall Study|Lost to Follow-up|3|||
161933986|NCT05520333|584808361|FG001|Overall Study|Lost to Follow-up|6|||
161933987|NCT05069415|584808367|FG000|Overall Study|Withdrawal by Subject|2|||
161933988|NCT05069415|584808368|FG001|Overall Study|Withdrawal by Subject|0|||
161933989|NCT05069415|584808367|FG000|Overall Study|Adverse Event|2|||
161933990|NCT05069415|584808368|FG001|Overall Study|Adverse Event|0|||
161933991|NCT03701074|584808369|FG000|Overall Study|Physician Decision|1|||
161589380|NCT04083235|583546445|FG001|Overall Study|Withdrawal by Subject|17|||
161933992|NCT03701074|584808370|FG001|Overall Study|Physician Decision|0|||
161933993|NCT01661595|584808371|FG000|Phase 1: Week 0-4|Adverse Event|1|||
161933994|NCT01661595|584808372|FG001|Phase 1: Week 0-4|Adverse Event|0|||
161933995|NCT01661595|584808373|FG002|Phase 1: Week 0-4|Adverse Event|0|||
161933996|NCT01661595|584808374|FG003|Phase 1: Week 0-4|Adverse Event|0|||
161933997|NCT01661595|584808371|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
161933998|NCT01661595|584808372|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
161933999|NCT01661595|584808373|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
161934000|NCT01661595|584808374|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
161934001|NCT01500135|584808375|FG000|Overall Study|Withdrawal of Consent|4|||
161934002|NCT01500135|584808376|FG001|Overall Study|Withdrawal of Consent|0|||
161934003|NCT01500135|584808375|FG000|Overall Study|Lost to Follow-up|6|||
161934004|NCT01500135|584808376|FG001|Overall Study|Lost to Follow-up|4|||
161934005|NCT01500135|584808375|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
161934006|NCT01500135|584808376|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
161934007|NCT01500135|584808375|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
161934008|NCT01500135|584808376|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
161934009|NCT01500135|584808375|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
161934010|NCT01500135|584808376|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
161934011|NCT01500135|584808375|FG000|Overall Study|Participant was a Safety Concern|1|||
161934012|NCT01500135|584808376|FG001|Overall Study|Participant was a Safety Concern|0|||
161934013|NCT01500135|584808375|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
161934014|NCT01500135|584808376|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
161934015|NCT00661687|584808377|FG000|Overall Study|Study related symptoms and complaints|5|||
161934016|NCT00661687|584808377|FG000|Overall Study|Positive slit lamp findings|4|||
161934017|NCT00661687|584808377|FG000|Overall Study|Inability to maintain wearing schedule|3|||
161934018|NCT00661687|584808377|FG000|Overall Study|Physician Decision|1|||
161934019|NCT00661687|584808377|FG000|Overall Study|Adverse Event|2|||
161934020|NCT00912509|584808378|FG000|Overall Study|Lost to Follow-up|1|||
161934021|NCT00912509|584808379|FG001|Overall Study|Lost to Follow-up|0|||
161934022|NCT00912509|584808378|FG000|Overall Study|Lack of Efficacy|4|||
161934023|NCT00912509|584808379|FG001|Overall Study|Lack of Efficacy|3|||
161934024|NCT05538728|584808380|FG000|Overall Study|Withdrawal by Subject|1|||
161934025|NCT05538728|584808381|FG001|Overall Study|Withdrawal by Subject|1|||
161934026|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Adverse Event|2|||
161934027|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Adverse Event|0|||
161934028|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Physician Decision|0|||
161934029|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Physician Decision|1|||
161934030|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
161934031|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
161934032|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
161934033|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
161934034|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
161934035|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
161521202|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
161521203|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
161521204|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
161521205|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
161521206|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161521207|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
161521208|NCT00383435|583297461|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
161521209|NCT00383435|583297462|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
161521210|NCT00383435|583297463|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
161521211|NCT00383435|583297464|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
161521212|NCT00383435|583297465|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
161521213|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
161521214|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
161521215|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
161521216|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
161521217|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
161521218|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161521219|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161521220|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161589381|NCT04083235|583546444|FG000|Overall Study|Lost to Follow-up|1|||
161521221|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161521222|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161589382|NCT04083235|583546445|FG001|Overall Study|Lost to Follow-up|1|||
161934036|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
161934037|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
161934038|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
161934039|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
161934040|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
161934041|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
161934042|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
161934043|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
161934044|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
161934045|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
161934046|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
161934047|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
161934048|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
161934049|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
161934050|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
161934051|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
161934052|NCT01517178|584808385|FG000|Period 1|Adverse Event|1|||
161934053|NCT01517178|584808386|FG001|Period 1|Adverse Event|2|||
161934054|NCT01517178|584808385|FG000|Period 1|Lack of Efficacy|0|||
161934055|NCT01517178|584808386|FG001|Period 1|Lack of Efficacy|1|||
161934056|NCT01517178|584808385|FG000|Period 1|E.g. study termination|3|||
161934057|NCT01517178|584808386|FG001|Period 1|E.g. study termination|1|||
161934058|NCT01517178|584808385|FG000|Period 1|Withdrawal by Subject|0|||
161934059|NCT01517178|584808386|FG001|Period 1|Withdrawal by Subject|1|||
161934060|NCT01517178|584808385|FG000|Period 2|Adverse Event|1|||
161934061|NCT01517178|584808386|FG001|Period 2|Adverse Event|0|||
161934062|NCT01517178|584808385|FG000|Period 2|Withdrawal by Subject|3|||
161934063|NCT01517178|584808386|FG001|Period 2|Withdrawal by Subject|0|||
161934064|NCT01517178|584808385|FG000|Period 2|E.g. study termination|2|||
161934065|NCT01517178|584808386|FG001|Period 2|E.g. study termination|2|||
161934066|NCT01557569|584808387|FG000|Overall Study|Adverse Event|2|||
161934067|NCT01557569|584808388|FG001|Overall Study|Adverse Event|0|||
161934068|NCT01557569|584808387|FG000|Overall Study|high blood pressure|0|||
161934069|NCT01557569|584808388|FG001|Overall Study|high blood pressure|1|||
161934070|NCT01557569|584808387|FG000|Overall Study|Withdrawal by Subject|3|||
161934071|NCT01557569|584808388|FG001|Overall Study|Withdrawal by Subject|5|||
161934072|NCT01557569|584808387|FG000|Overall Study|noncompliance with rules of residential|0|||
161934073|NCT01557569|584808388|FG001|Overall Study|noncompliance with rules of residential|1|||
161934074|NCT02254460|584808389|FG000|Overall Study|Adverse Event|1|||
161934075|NCT02254460|584808390|FG001|Overall Study|Adverse Event|0|||
161934076|NCT01050218|584808391|FG000|Overall Study|Adverse Event|37|||
161934077|NCT01050218|584808391|FG000|Overall Study|Lack of Efficacy|8|||
161934078|NCT01050218|584808391|FG000|Overall Study|Protocol Violation|3|||
161934079|NCT01050218|584808391|FG000|Overall Study|Withdrawal by Subject|18|||
161934080|NCT01050218|584808391|FG000|Overall Study|Discontinued by sponsor|18|||
161934081|NCT01050218|584808391|FG000|Overall Study|Compliance|2|||
161934082|NCT01050218|584808391|FG000|Overall Study|Failed to return|7|||
161934083|NCT01050218|584808391|FG000|Overall Study|Serious Adverse Event|1|||
161934084|NCT01050218|584808391|FG000|Overall Study|Family emergency|1|||
161934085|NCT01772693|584808392|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
161934086|NCT01772693|584808393|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
161934087|NCT01772693|584808392|FG000|Overall Study|Withdrawal by Subject|2|||
161934088|NCT01772693|584808393|FG001|Overall Study|Withdrawal by Subject|0|||
161934089|NCT01772693|584808392|FG000|Overall Study|Alternative Treatment|2|||
161934090|NCT01772693|584808393|FG001|Overall Study|Alternative Treatment|0|||
161934091|NCT01633112|584808394|FG000|Overall Study|Lack of Efficacy|1|||
161934092|NCT01633112|584808395|FG001|Overall Study|Lack of Efficacy|6|||
161934093|NCT01633112|584808396|FG002|Overall Study|Lack of Efficacy|13|||
161934094|NCT01633112|584808394|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161934095|NCT01633112|584808395|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161934096|NCT01633112|584808396|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161934097|NCT01633112|584808394|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161934098|NCT01633112|584808395|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161934099|NCT01633112|584808396|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161934100|NCT01633112|584808394|FG000|Overall Study|Administrative problems|1|||
161934101|NCT01633112|584808395|FG001|Overall Study|Administrative problems|2|||
161934102|NCT01633112|584808396|FG002|Overall Study|Administrative problems|5|||
161934103|NCT01633112|584808394|FG000|Overall Study|Adverse Event|16|||
161934104|NCT01633112|584808395|FG001|Overall Study|Adverse Event|18|||
161934105|NCT01633112|584808396|FG002|Overall Study|Adverse Event|20|||
161934106|NCT01633112|584808394|FG000|Overall Study|Lost to Follow-up|7|||
161934107|NCT01633112|584808395|FG001|Overall Study|Lost to Follow-up|19|||
161934108|NCT01633112|584808396|FG002|Overall Study|Lost to Follow-up|6|||
161934109|NCT01633112|584808394|FG000|Overall Study|Protocol Violation|4|||
161934110|NCT01633112|584808395|FG001|Overall Study|Protocol Violation|0|||
161934111|NCT01633112|584808396|FG002|Overall Study|Protocol Violation|2|||
161934112|NCT01633112|584808394|FG000|Overall Study|Subject no longer requires study drug|0|||
161934113|NCT01633112|584808395|FG001|Overall Study|Subject no longer requires study drug|0|||
161934114|NCT01633112|584808396|FG002|Overall Study|Subject no longer requires study drug|1|||
161934115|NCT01633112|584808394|FG000|Overall Study|Withdrawal by Subject|20|||
161934116|NCT01633112|584808395|FG001|Overall Study|Withdrawal by Subject|12|||
161934117|NCT01633112|584808396|FG002|Overall Study|Withdrawal by Subject|41|||
161934118|NCT01633112|584808394|FG000|Overall Study|missing Study Completion CRF|1|||
161934119|NCT01633112|584808395|FG001|Overall Study|missing Study Completion CRF|1|||
161934120|NCT01633112|584808396|FG002|Overall Study|missing Study Completion CRF|4|||
161934121|NCT02872142|584808398|FG000|Overall Study|Adverse Event|2|||
161934122|NCT02872142|584808398|FG000|Overall Study|Death|1|||
161934123|NCT02872142|584808398|FG000|Overall Study|Participant Decision|3|||
161934124|NCT01550965|584808401|FG000|Overall Study|Adverse Event|26|||
161934125|NCT01550965|584808401|FG000|Overall Study|Withdrawal by Subject|10|||
161934126|NCT01550965|584808401|FG000|Overall Study|Lost to Follow-up|2|||
161934127|NCT01550965|584808401|FG000|Overall Study|Lack of Efficacy|59|||
161934128|NCT01550965|584808401|FG000|Overall Study|Other|13|||
161934129|NCT00160563|584808404|FG000|Overall Study|Adverse Event|1|||
161934130|NCT00160563|584808405|FG001|Overall Study|Adverse Event|1|||
161934131|NCT00160563|584808406|FG002|Overall Study|Adverse Event|1|||
161934132|NCT00160563|584808404|FG000|Overall Study|Lost to Follow-up|1|||
161934133|NCT00160563|584808405|FG001|Overall Study|Lost to Follow-up|1|||
161934134|NCT00160563|584808406|FG002|Overall Study|Lost to Follow-up|2|||
161934135|NCT00160563|584808404|FG000|Overall Study|Protocol Violation|0|||
161934136|NCT00160563|584808405|FG001|Overall Study|Protocol Violation|0|||
161934137|NCT00160563|584808406|FG002|Overall Study|Protocol Violation|3|||
161934138|NCT00160563|584808404|FG000|Overall Study|Withdrawal by Subject|1|||
161934139|NCT00160563|584808405|FG001|Overall Study|Withdrawal by Subject|2|||
161934140|NCT00160563|584808406|FG002|Overall Study|Withdrawal by Subject|3|||
161934141|NCT00160563|584808404|FG000|Overall Study|Other (listed in the study report)|48|||
161934142|NCT00160563|584808405|FG001|Overall Study|Other (listed in the study report)|40|||
161934143|NCT00160563|584808406|FG002|Overall Study|Other (listed in the study report)|81|||
161934144|NCT00160563|584808404|FG000|Overall Study|Missing reason|0|||
161934145|NCT00160563|584808405|FG001|Overall Study|Missing reason|1|||
161934146|NCT00160563|584808406|FG002|Overall Study|Missing reason|0|||
161934147|NCT01148771|584808412|FG000|Washout Period|Withdrawal by Subject|0|||
161934148|NCT01148771|584808413|FG001|Washout Period|Withdrawal by Subject|1|||
161934149|NCT01437189|584808414|FG000|Overall Study|Adverse Event|3|||
161934150|NCT01437189|584808414|FG000|Overall Study|Lack of Efficacy|4|||
161934151|NCT01437189|584808414|FG000|Overall Study|Withdrawal by Subject|8|||
161934152|NCT00595075|584808419|FG000|Overall Study|Withdrawal by Subject|1|||
161934153|NCT00595075|584808420|FG001|Overall Study|Withdrawal by Subject|0|||
161934154|NCT05261490|584808422|FG000|Overall Study|Other|1|||
161934155|NCT05261490|584808423|FG001|Overall Study|Other|0|||
161934156|NCT05261490|584808424|FG002|Overall Study|Other|0|||
161934157|NCT05261490|584808422|FG000|Overall Study|Study Terminated by Sponsor|1|||
161934158|NCT05261490|584808423|FG001|Overall Study|Study Terminated by Sponsor|1|||
161934159|NCT05261490|584808424|FG002|Overall Study|Study Terminated by Sponsor|4|||
161934160|NCT05261490|584808422|FG000|Overall Study|Death|1|||
161934161|NCT05261490|584808423|FG001|Overall Study|Death|2|||
161934162|NCT05261490|584808424|FG002|Overall Study|Death|0|||
161934163|NCT03777020|584808426|FG000|Overall Study|Withdrawal by Subject|4|||
161934164|NCT03777020|584808427|FG001|Overall Study|Withdrawal by Subject|4|||
161934165|NCT03777020|584808426|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
161934166|NCT03777020|584808427|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
161934167|NCT03460704|584808428|FG000|Overall Study|Withdrawal by Subject|11|||
161934168|NCT03460704|584808429|FG001|Overall Study|Withdrawal by Subject|14|||
161934169|NCT03460704|584808428|FG000|Overall Study|Study terminated by the Sponsor|29|||
161934170|NCT03460704|584808429|FG001|Overall Study|Study terminated by the Sponsor|19|||
161934171|NCT03460704|584808428|FG000|Overall Study|Adverse Event|10|||
161934172|NCT03460704|584808429|FG001|Overall Study|Adverse Event|5|||
161934173|NCT03460704|584808428|FG000|Overall Study|Death|3|||
161934174|NCT03460704|584808429|FG001|Overall Study|Death|2|||
161934175|NCT03460704|584808428|FG000|Overall Study|Non-Compliance with Study Drug|3|||
161934176|NCT03460704|584808429|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161934177|NCT03460704|584808428|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161934178|NCT03460704|584808429|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
161934179|NCT03460704|584808428|FG000|Overall Study|Other|2|||
161934180|NCT03460704|584808429|FG001|Overall Study|Other|1|||
161934181|NCT02913326|584808430|FG000|Overall Study|Reason not listed|0|||
161934182|NCT02913326|584808431|FG001|Overall Study|Reason not listed|1|||
161934183|NCT02913326|584808430|FG000|Overall Study|Lost to Follow-up|0|||
161934184|NCT02913326|584808431|FG001|Overall Study|Lost to Follow-up|1|||
161934185|NCT02913326|584808430|FG000|Overall Study|Adverse Event|1|||
161934186|NCT02913326|584808431|FG001|Overall Study|Adverse Event|0|||
161934187|NCT01767857|584808432|FG000|Overall Study|Adverse Event|27|||
161934188|NCT01767857|584808433|FG001|Overall Study|Adverse Event|7|||
161934189|NCT01767857|584808432|FG000|Overall Study|Death|28|||
161934190|NCT01767857|584808433|FG001|Overall Study|Death|13|||
161934191|NCT01767857|584808432|FG000|Overall Study|Lack of Efficacy|299|||
161934192|NCT01767857|584808433|FG001|Overall Study|Lack of Efficacy|151|||
161521223|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161521224|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
161521225|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161521226|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161521227|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161521228|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
161521229|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
161521230|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
161521231|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
161521232|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
161521233|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161521234|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
161521235|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
161521236|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
161521237|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161521238|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
161521239|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161521240|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161521241|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161521242|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
161521243|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161521244|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161521245|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161521246|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161521247|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161521248|NCT00383435|583297461|FG000|26-Week Treatment Safety Extension|Administrative|1|||
161521249|NCT00383435|583297462|FG001|26-Week Treatment Safety Extension|Administrative|1|||
161677554|NCT00041080|583872026|FG000|Overall Study|Ineligible|1|||
161677555|NCT00041080|583872027|FG001|Overall Study|Ineligible|0|||
161677556|NCT01011439|583872028|FG000|Overall Study|Death|37|||
161677557|NCT01011439|583872028|FG000|Overall Study|Lost to Follow-up|4|||
161677558|NCT01011439|583872028|FG000|Overall Study|Withdrawal by Subject|1|||
161677559|NCT01011439|583872028|FG000|Overall Study|Sponsor's decision|15|||
161825636|NCT01332968|584401842|FG003|Follow-Up Period|Progressive Disease|0|||
161825637|NCT01332968|584401843|FG004|Follow-Up Period|Progressive Disease|0|||
161825638|NCT01332968|584401844|FG005|Follow-Up Period|Progressive Disease|0|||
161825639|NCT01332968|584401845|FG006|Follow-Up Period|Progressive Disease|126|||
161825640|NCT01332968|584401846|FG007|Follow-Up Period|Progressive Disease|106|||
161825641|NCT01332968|584401839|FG000|Follow-Up Period|Protocol Violation|0|||
161825642|NCT01332968|584401840|FG001|Follow-Up Period|Protocol Violation|0|||
161825643|NCT01332968|584401841|FG002|Follow-Up Period|Protocol Violation|0|||
161825644|NCT01332968|584401842|FG003|Follow-Up Period|Protocol Violation|0|||
161825645|NCT01332968|584401843|FG004|Follow-Up Period|Protocol Violation|0|||
161825646|NCT01332968|584401844|FG005|Follow-Up Period|Protocol Violation|0|||
161825647|NCT01332968|584401845|FG006|Follow-Up Period|Protocol Violation|1|||
161825648|NCT01332968|584401846|FG007|Follow-Up Period|Protocol Violation|0|||
161825649|NCT01332968|584401839|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161825650|NCT01332968|584401840|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161825651|NCT01332968|584401841|FG002|Follow-Up Period|Withdrawal by Subject|0|||
161825652|NCT01332968|584401842|FG003|Follow-Up Period|Withdrawal by Subject|0|||
161825653|NCT01332968|584401843|FG004|Follow-Up Period|Withdrawal by Subject|0|||
161825654|NCT01332968|584401844|FG005|Follow-Up Period|Withdrawal by Subject|0|||
161825655|NCT01332968|584401845|FG006|Follow-Up Period|Withdrawal by Subject|29|||
161825656|NCT01332968|584401846|FG007|Follow-Up Period|Withdrawal by Subject|32|||
161825657|NCT01332968|584401839|FG000|Follow-Up Period|No reason provided|0|||
161825658|NCT01332968|584401840|FG001|Follow-Up Period|No reason provided|0|||
161825659|NCT01332968|584401841|FG002|Follow-Up Period|No reason provided|0|||
161825660|NCT01332968|584401842|FG003|Follow-Up Period|No reason provided|0|||
161825661|NCT01332968|584401843|FG004|Follow-Up Period|No reason provided|0|||
161825662|NCT01332968|584401844|FG005|Follow-Up Period|No reason provided|0|||
161825663|NCT01332968|584401845|FG006|Follow-Up Period|No reason provided|2|||
161825664|NCT01332968|584401846|FG007|Follow-Up Period|No reason provided|3|||
161825665|NCT02351167|584401847|FG000|Overall Study|Withdrawal by Subject|19|||
161825666|NCT02351167|584401848|FG001|Overall Study|Withdrawal by Subject|18|||
161825667|NCT02351167|584401849|FG002|Overall Study|Withdrawal by Subject|21|||
161825668|NCT00194792|584401850|FG000|Overall Study|Withdrawal by Subject|1|||
161825669|NCT02448563|584401851|FG000|Overall Study|Lost to Follow-up|16|||
161825670|NCT02448563|584401852|FG001|Overall Study|Lost to Follow-up|10|||
161934193|NCT01767857|584808432|FG000|Overall Study|Lost to Follow-up|1|||
161934194|NCT01767857|584808433|FG001|Overall Study|Lost to Follow-up|1|||
161521250|NCT00383435|583297463|FG002|26-Week Treatment Safety Extension|Administrative|0|||
161521251|NCT00383435|583297464|FG003|26-Week Treatment Safety Extension|Administrative|1|||
161521252|NCT00383435|583297465|FG004|26-Week Treatment Safety Extension|Administrative|0|||
161521253|NCT01753193|583297466|FG000|Overall Study|Withdrawal by Subject|23|||
161521254|NCT01753193|583297466|FG000|Overall Study|Lost to Follow-up|6|||
161521255|NCT01753193|583297466|FG000|Overall Study|Death|1|||
161521256|NCT01753193|583297466|FG000|Overall Study|Other|16|||
161521257|NCT00583557|583297467|FG000|Overall Study|Withdrawal by Subject|18|||
161521258|NCT00583557|583297467|FG000|Overall Study|Adverse Event|9|||
161521259|NCT00583557|583297467|FG000|Overall Study|Lack of Efficacy|31|||
161521260|NCT00583557|583297467|FG000|Overall Study|Lack of Compliance|5|||
161521261|NCT00583557|583297467|FG000|Overall Study|Other|5|||
161521262|NCT00583557|583297467|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
161521263|NCT01131312|583297468|FG000|Overall Study|Lost to Follow-up|425|||
161521264|NCT01131312|583297469|FG001|Overall Study|Lost to Follow-up|229|||
161521265|NCT01131312|583297470|FG002|Overall Study|Lost to Follow-up|351|||
161521266|NCT02347761|583297471|FG000|All Collected|Death|1|||
161521267|NCT02347761|583297472|FG001|All Collected|Death|0|||
161521268|NCT02347761|583297473|FG002|All Collected|Death|0|||
161521269|NCT02347761|583297471|FG000|All Collected|Lost to Follow-up|3|||
161521270|NCT02347761|583297472|FG001|All Collected|Lost to Follow-up|2|||
161934195|NCT01767857|584808432|FG000|Overall Study|Withdrawal by Subject|38|||
161934196|NCT01767857|584808433|FG001|Overall Study|Withdrawal by Subject|18|||
161934197|NCT01767857|584808432|FG000|Overall Study|Physician Decision|17|||
161934198|NCT01767857|584808433|FG001|Overall Study|Physician Decision|10|||
161521271|NCT02347761|583297473|FG002|All Collected|Lost to Follow-up|3|||
161521272|NCT02347761|583297471|FG000|All Collected|Withdrawal by Subject|11|||
161521273|NCT02347761|583297472|FG001|All Collected|Withdrawal by Subject|11|||
161521274|NCT02347761|583297473|FG002|All Collected|Withdrawal by Subject|22|||
161521275|NCT02347761|583297471|FG000|All Collected|invetigator disretion|2|||
161521276|NCT02347761|583297472|FG001|All Collected|invetigator disretion|0|||
161521277|NCT02347761|583297473|FG002|All Collected|invetigator disretion|0|||
161521278|NCT02347761|583297471|FG000|All Collected|instillation site pain|0|||
161521279|NCT02347761|583297472|FG001|All Collected|instillation site pain|0|||
161521280|NCT02347761|583297473|FG002|All Collected|instillation site pain|1|||
161521281|NCT02347761|583297471|FG000|All Collected|exacerbation of COPD|0|||
161521282|NCT02347761|583297472|FG001|All Collected|exacerbation of COPD|0|||
161521283|NCT02347761|583297473|FG002|All Collected|exacerbation of COPD|1|||
161521284|NCT02347761|583297471|FG000|All Collected|moved/travel|0|||
161521285|NCT02347761|583297472|FG001|All Collected|moved/travel|1|||
161521286|NCT02347761|583297473|FG002|All Collected|moved/travel|0|||
161521287|NCT02347761|583297471|FG000|On Study Treatment|Lack of Efficacy|2|||
161521288|NCT02347761|583297472|FG001|On Study Treatment|Lack of Efficacy|3|||
161521289|NCT02347761|583297473|FG002|On Study Treatment|Lack of Efficacy|4|||
161521290|NCT02347761|583297471|FG000|On Study Treatment|non-compliance with study medication|0|||
161521291|NCT02347761|583297472|FG001|On Study Treatment|non-compliance with study medication|0|||
161521292|NCT02347761|583297473|FG002|On Study Treatment|non-compliance with study medication|2|||
161934199|NCT01767857|584808432|FG000|Overall Study|Protocol Terminated|1|||
161521293|NCT02347761|583297471|FG000|On Study Treatment|Withdrawal by Subject|7|||
161521294|NCT02347761|583297472|FG001|On Study Treatment|Withdrawal by Subject|3|||
161589383|NCT04083235|583546444|FG000|Overall Study|Does not meet entry criteria|1|||
161934200|NCT01767857|584808433|FG001|Overall Study|Protocol Terminated|0|||
161934201|NCT01767857|584808432|FG000|Overall Study|Randomized But Never Treated|19|||
161934202|NCT01767857|584808433|FG001|Overall Study|Randomized But Never Treated|13|||
161934203|NCT01421459|584808434|FG000|Overall Study|Adverse Event|6|||
161934204|NCT01421459|584808435|FG001|Overall Study|Adverse Event|10|||
161934205|NCT01421459|584808434|FG000|Overall Study|Death|1|||
161934206|NCT01421459|584808435|FG001|Overall Study|Death|1|||
161934207|NCT01421459|584808434|FG000|Overall Study|Lack of Efficacy|1|||
161589384|NCT04083235|583546445|FG001|Overall Study|Does not meet entry criteria|0|||
161589385|NCT04083235|583546444|FG000|Overall Study|Did not receive treatment|13|||
161589386|NCT04083235|583546445|FG001|Overall Study|Did not receive treatment|8|||
161934208|NCT01421459|584808435|FG001|Overall Study|Lack of Efficacy|2|||
161934209|NCT01421459|584808434|FG000|Overall Study|Lost to Follow-up|8|||
161521295|NCT02347761|583297473|FG002|On Study Treatment|Withdrawal by Subject|5|||
161521296|NCT02347761|583297471|FG000|On Study Treatment|move/travel|2|||
161521297|NCT02347761|583297472|FG001|On Study Treatment|move/travel|6|||
161521298|NCT02347761|583297473|FG002|On Study Treatment|move/travel|5|||
161589387|NCT04083235|583546444|FG000|Overall Study|Ongoing at the time of DCO|44|||
161934210|NCT01421459|584808435|FG001|Overall Study|Lost to Follow-up|9|||
161521299|NCT02347761|583297471|FG000|On Study Treatment|dissastisfaction with device|2|||
161521300|NCT02347761|583297472|FG001|On Study Treatment|dissastisfaction with device|1|||
161521301|NCT02347761|583297473|FG002|On Study Treatment|dissastisfaction with device|4|||
161521302|NCT02347761|583297471|FG000|On Study Treatment|Lost to Follow-up|2|||
161521303|NCT02347761|583297472|FG001|On Study Treatment|Lost to Follow-up|1|||
161934211|NCT01421459|584808434|FG000|Overall Study|Physician Decision|9|||
161934212|NCT01421459|584808435|FG001|Overall Study|Physician Decision|9|||
161521304|NCT02347761|583297473|FG002|On Study Treatment|Lost to Follow-up|1|||
161521305|NCT02347761|583297471|FG000|On Study Treatment|investigator discretion|2|||
161521306|NCT02347761|583297472|FG001|On Study Treatment|investigator discretion|0|||
161521307|NCT02347761|583297473|FG002|On Study Treatment|investigator discretion|0|||
161521308|NCT02347761|583297471|FG000|On Study Treatment|durg not working|0|||
161521309|NCT02347761|583297472|FG001|On Study Treatment|durg not working|1|||
161521310|NCT02347761|583297473|FG002|On Study Treatment|durg not working|1|||
161677560|NCT02428855|583872029|FG000|Overall Study|Withdrawal by Subject|2|||
161677561|NCT00210184|583872030|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
161677562|NCT01338415|583872031|FG000|Core + Extension|Adverse Event|8|||
161677563|NCT01338415|583872032|FG001|Core + Extension|Adverse Event|6|||
161677564|NCT01338415|583872033|FG002|Core + Extension|Adverse Event|0|||
161677565|NCT01338415|583872031|FG000|Core + Extension|Withdrawal by Subject|1|||
161677566|NCT01338415|583872032|FG001|Core + Extension|Withdrawal by Subject|1|||
161677567|NCT01338415|583872033|FG002|Core + Extension|Withdrawal by Subject|0|||
161677568|NCT01338415|583872031|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
161677569|NCT01338415|583872032|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
161677570|NCT01338415|583872033|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
161677571|NCT01338415|583872031|FG000|Core + Extension|Other (administrative reason)|1|||
161677572|NCT01338415|583872032|FG001|Core + Extension|Other (administrative reason)|0|||
161825671|NCT02448563|584401851|FG000|Overall Study|Withdrawal by Subject|0|||
161825672|NCT02448563|584401852|FG001|Overall Study|Withdrawal by Subject|1|||
161825673|NCT00702507|584401854|FG000|Initial Treatment Phase|Adverse Event|2|||
161521311|NCT02347761|583297471|FG000|On Study Treatment|Adverse Event|10|||
161521312|NCT02347761|583297472|FG001|On Study Treatment|Adverse Event|8|||
161521313|NCT02347761|583297473|FG002|On Study Treatment|Adverse Event|20|||
161521314|NCT02682264|583297474|FG000|Overall Study|Withdrawal by Subject|56|||
161825674|NCT00702507|584401854|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
161825675|NCT00702507|584401854|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
161825676|NCT00702507|584401854|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
161825677|NCT00702507|584401854|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
161825678|NCT00702507|584401854|FG000|Follow-up Phase|Protocol Violation|2|||
161825679|NCT00702507|584401854|FG000|Follow-up Phase|Lost to Follow-up|23|||
161825680|NCT00702507|584401854|FG000|Follow-up Phase|Late Enrollment|1|||
161825681|NCT00113919|584401855|FG000|Overall Study|Physician Decision|8|||
161825682|NCT00113919|584401855|FG000|Overall Study|Death|6|||
161825683|NCT00721955|584401863|FG000|Overall Study|Adverse Event|0|||
161825684|NCT00721955|584401864|FG001|Overall Study|Adverse Event|0|||
161825685|NCT00721955|584401865|FG002|Overall Study|Adverse Event|2|||
161825686|NCT04194008|584401870|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
161825687|NCT04194008|584401870|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
161825688|NCT04194008|584401870|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
161825689|NCT04194008|584401870|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
161825690|NCT04194008|584401870|FG000|Treatment Phase With Nerivio|Missing data|4|||
161825691|NCT04194008|584401870|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
161825692|NCT01785615|584401871|FG000|Dietary Phase|Lost to Follow-up|0|||
161825693|NCT01785615|584401872|FG001|Dietary Phase|Lost to Follow-up|0|||
161825694|NCT01785615|584401873|FG002|Dietary Phase|Lost to Follow-up|0|||
161825695|NCT01785615|584401874|FG003|Dietary Phase|Lost to Follow-up|24|||
161825696|NCT02522780|584401875|FG000|Overall Study|Consent withdrawn by subject|5|||
161825697|NCT02522780|584401876|FG001|Overall Study|Consent withdrawn by subject|7|||
161825698|NCT02522780|584401875|FG000|Overall Study|Protocol deviation|1|||
161825699|NCT02522780|584401876|FG001|Overall Study|Protocol deviation|3|||
161825700|NCT02522780|584401875|FG000|Overall Study|Subject refused endoscopic procedure|0|||
161825701|NCT02522780|584401876|FG001|Overall Study|Subject refused endoscopic procedure|1|||
161825702|NCT02522780|584401875|FG000|Overall Study|Adverse event, non-fatal|11|||
161825703|NCT02522780|584401876|FG001|Overall Study|Adverse event, non-fatal|16|||
161825704|NCT00926367|584401877|FG000|Overall Study|Withdrawal by Subject|0|||
161825705|NCT00926367|584401878|FG001|Overall Study|Withdrawal by Subject|1|||
161825706|NCT00926367|584401877|FG000|Overall Study|Lost to Follow-up|1|||
161825707|NCT00926367|584401878|FG001|Overall Study|Lost to Follow-up|0|||
161825708|NCT00926367|584401877|FG000|Overall Study|Skin Irritation|1|||
161825709|NCT00926367|584401878|FG001|Overall Study|Skin Irritation|2|||
161825710|NCT01517867|584401879|FG000|Overall Study|never started treatment|29|||
161825711|NCT01517867|584401880|FG001|Overall Study|never started treatment|32|||
161825712|NCT01517867|584401879|FG000|Overall Study|Withdrawal by Subject|34|||
161825713|NCT01517867|584401880|FG001|Overall Study|Withdrawal by Subject|30|||
161825714|NCT01517867|584401879|FG000|Overall Study|Still in treatment at study end|0|||
161825715|NCT01517867|584401880|FG001|Overall Study|Still in treatment at study end|3|||
161825716|NCT04203667|584401885|FG000|Overall Study|Withdrawal by Subject|1|||
161825717|NCT04203667|584401885|FG000|Overall Study|Lost to Follow-up|1|||
161825718|NCT04203667|584401885|FG000|Overall Study|Death|1|||
161521315|NCT02682264|583297475|FG001|Overall Study|Withdrawal by Subject|45|||
161521316|NCT02682264|583297474|FG000|Overall Study|Lost to Follow-up|49|||
161521317|NCT02682264|583297475|FG001|Overall Study|Lost to Follow-up|41|||
161521318|NCT02682264|583297474|FG000|Overall Study|Lack of Efficacy|14|||
161521319|NCT02682264|583297475|FG001|Overall Study|Lack of Efficacy|16|||
161521320|NCT02682264|583297474|FG000|Overall Study|Withdrawal by Parent|6|||
161521321|NCT02682264|583297475|FG001|Overall Study|Withdrawal by Parent|7|||
161521322|NCT02682264|583297474|FG000|Overall Study|Adverse Event|9|||
161521323|NCT02682264|583297475|FG001|Overall Study|Adverse Event|0|||
161521324|NCT02682264|583297474|FG000|Overall Study|Noncompliance with study drug|1|||
161521325|NCT02682264|583297475|FG001|Overall Study|Noncompliance with study drug|4|||
161521326|NCT02682264|583297474|FG000|Overall Study|Pregnancy|1|||
161521327|NCT02682264|583297475|FG001|Overall Study|Pregnancy|2|||
161521328|NCT02682264|583297474|FG000|Overall Study|Recovery|1|||
161521329|NCT02682264|583297475|FG001|Overall Study|Recovery|2|||
161521330|NCT02682264|583297474|FG000|Overall Study|Progressive Disease|1|||
161521331|NCT02682264|583297475|FG001|Overall Study|Progressive Disease|0|||
161934213|NCT01421459|584808434|FG000|Overall Study|Protocol Violation|8|||
161934214|NCT01421459|584808435|FG001|Overall Study|Protocol Violation|5|||
161934215|NCT01421459|584808434|FG000|Overall Study|Withdrawal by Subject|12|||
161934216|NCT01421459|584808435|FG001|Overall Study|Withdrawal by Subject|16|||
161934217|NCT01422382|584808436|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
161934218|NCT00967499|584808437|FG000|Overall Study|Adverse Event|0|||
161934219|NCT00967499|584808438|FG001|Overall Study|Adverse Event|1|||
161934220|NCT00967499|584808437|FG000|Overall Study|Protocol Violation|1|||
161934221|NCT00967499|584808438|FG001|Overall Study|Protocol Violation|0|||
161521332|NCT02682264|583297474|FG000|Overall Study|Technical Problems|0|||
161521333|NCT02682264|583297475|FG001|Overall Study|Technical Problems|1|||
161521334|NCT02682264|583297474|FG000|Overall Study|Moved abroad and unable to continue|0|||
161521335|NCT02682264|583297475|FG001|Overall Study|Moved abroad and unable to continue|3|||
161521336|NCT02682264|583297474|FG000|Overall Study|Stopped test article application|0|||
161521337|NCT02682264|583297475|FG001|Overall Study|Stopped test article application|1|||
161521338|NCT01255358|583297476|FG000|Overall Study|Adverse Event|2|||
161521339|NCT01255358|583297476|FG000|Overall Study|Protocol Violation|2|||
161521340|NCT04079933|583297479|FG000|Overall Study|Withdrawal by Subject|3|||
161521341|NCT04079933|583297480|FG001|Overall Study|Withdrawal by Subject|4|||
161521342|NCT04079933|583297479|FG000|Overall Study|Lost to Follow-up|0|||
161521343|NCT04079933|583297480|FG001|Overall Study|Lost to Follow-up|1|||
161521344|NCT03207750|583297481|FG000|Overall Study|Adverse Event|3|||
161521345|NCT03207750|583297482|FG001|Overall Study|Adverse Event|2|||
161521346|NCT03207750|583297481|FG000|Overall Study|Lost to Follow-up|21|||
161521347|NCT03207750|583297482|FG001|Overall Study|Lost to Follow-up|29|||
161521348|NCT03207750|583297481|FG000|Overall Study|Protocol Violation|0|||
161521349|NCT03207750|583297482|FG001|Overall Study|Protocol Violation|1|||
161521350|NCT03207750|583297481|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
161521351|NCT03207750|583297482|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
161521352|NCT03207750|583297481|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
161934222|NCT00967499|584808437|FG000|Overall Study|Sponsor Decision|1|||
161934223|NCT00967499|584808438|FG001|Overall Study|Sponsor Decision|0|||
161934224|NCT00967499|584808437|FG000|Overall Study|Randomized but not treated|63|||
161934225|NCT00967499|584808438|FG001|Overall Study|Randomized but not treated|59|||
161934226|NCT02899754|584808439|FG000|Overall Study|Lost to Follow-up|7|||
161934227|NCT02899754|584808440|FG001|Overall Study|Lost to Follow-up|9|||
161934228|NCT04818229|584808441|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
161934229|NCT04818229|584808442|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
161934230|NCT04818229|584808443|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
161934231|NCT04818229|584808441|FG000|Overall Study|Adverse Event|3|||
161934232|NCT04818229|584808442|FG001|Overall Study|Adverse Event|1|||
161934233|NCT04818229|584808443|FG002|Overall Study|Adverse Event|1|||
161934234|NCT04818229|584808441|FG000|Overall Study|Withdrawal by Subject|0|||
161934235|NCT04818229|584808442|FG001|Overall Study|Withdrawal by Subject|0|||
161934236|NCT04818229|584808443|FG002|Overall Study|Withdrawal by Subject|2|||
161934237|NCT04818229|584808441|FG000|Overall Study|Lost to Follow-up|0|||
161934238|NCT04818229|584808442|FG001|Overall Study|Lost to Follow-up|0|||
161934239|NCT04818229|584808443|FG002|Overall Study|Lost to Follow-up|1|||
161521353|NCT03207750|583297482|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
161521354|NCT03207750|583297481|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
161521355|NCT03207750|583297482|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
161521356|NCT03207750|583297481|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
161521357|NCT03207750|583297482|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
161521358|NCT03207750|583297481|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
161521359|NCT03207750|583297482|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
161934240|NCT04082364|584808444|FG000|Overall Study|Death|23|||
161934241|NCT04082364|584808445|FG001|Overall Study|Death|1|||
161934242|NCT04082364|584808446|FG002|Overall Study|Death|1|||
161934243|NCT04082364|584808447|FG003|Overall Study|Death|2|||
161934244|NCT04082364|584808448|FG004|Overall Study|Death|1|||
161521360|NCT02493361|583297483|FG000|Overall Study|Withdrawal by Subject|3|||
161521361|NCT02937545|583297487|FG000|Overall Study|Withdrawal by Subject|1|||
161521362|NCT02937545|583297488|FG001|Overall Study|Withdrawal by Subject|2|||
161521363|NCT02937545|583297489|FG002|Overall Study|Withdrawal by Subject|6|||
161521364|NCT02937545|583297490|FG003|Overall Study|Withdrawal by Subject|7|||
161521365|NCT02937545|583297487|FG000|Overall Study|Lost to Follow-up|1|||
161521366|NCT02937545|583297488|FG001|Overall Study|Lost to Follow-up|0|||
161521367|NCT02937545|583297489|FG002|Overall Study|Lost to Follow-up|0|||
161521368|NCT02937545|583297490|FG003|Overall Study|Lost to Follow-up|0|||
161521369|NCT02504294|583297493|FG000|Overall Study|Adverse Event|15|||
161521370|NCT02504294|583297494|FG001|Overall Study|Adverse Event|12|||
161521371|NCT02504294|583297493|FG000|Overall Study|Withdrawal by Subject|7|||
161521372|NCT02504294|583297494|FG001|Overall Study|Withdrawal by Subject|1|||
161521373|NCT02504294|583297493|FG000|Overall Study|Protocol Violation|27|||
161521374|NCT02504294|583297494|FG001|Overall Study|Protocol Violation|26|||
161521375|NCT02504294|583297493|FG000|Overall Study|Physician Decision|1|||
161934245|NCT04082364|584808444|FG000|Overall Study|Lost to Follow-up|1|||
161934246|NCT04082364|584808445|FG001|Overall Study|Lost to Follow-up|0|||
161934247|NCT04082364|584808446|FG002|Overall Study|Lost to Follow-up|0|||
161934248|NCT04082364|584808447|FG003|Overall Study|Lost to Follow-up|0|||
161934249|NCT04082364|584808448|FG004|Overall Study|Lost to Follow-up|1|||
161934250|NCT04082364|584808444|FG000|Overall Study|Physician Decision|1|||
161521376|NCT02504294|583297494|FG001|Overall Study|Physician Decision|2|||
161521377|NCT02504294|583297493|FG000|Overall Study|Lost to Follow-up|6|||
161521378|NCT02504294|583297494|FG001|Overall Study|Lost to Follow-up|7|||
161521379|NCT02252211|583297497|FG000|Overall Study|Adverse Event|0|||
161521380|NCT02252211|583297498|FG001|Overall Study|Adverse Event|1|||
161934251|NCT04082364|584808445|FG001|Overall Study|Physician Decision|1|||
161934252|NCT04082364|584808446|FG002|Overall Study|Physician Decision|0|||
161934253|NCT04082364|584808447|FG003|Overall Study|Physician Decision|2|||
161934254|NCT04082364|584808448|FG004|Overall Study|Physician Decision|1|||
161934255|NCT04082364|584808444|FG000|Overall Study|Withdrawal by Subject|1|||
161934256|NCT04082364|584808445|FG001|Overall Study|Withdrawal by Subject|1|||
161934257|NCT04082364|584808446|FG002|Overall Study|Withdrawal by Subject|0|||
161934258|NCT04082364|584808447|FG003|Overall Study|Withdrawal by Subject|0|||
161934259|NCT04082364|584808448|FG004|Overall Study|Withdrawal by Subject|1|||
161934260|NCT04082364|584808444|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
161934261|NCT04082364|584808445|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
161934262|NCT04082364|584808446|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
161934263|NCT04082364|584808447|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
161934264|NCT04082364|584808448|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
161934265|NCT04082364|584808444|FG000|Overall Study|Disease progression|0|||
161934266|NCT04082364|584808445|FG001|Overall Study|Disease progression|0|||
161934267|NCT04082364|584808446|FG002|Overall Study|Disease progression|0|||
161934268|NCT04082364|584808447|FG003|Overall Study|Disease progression|1|||
161934269|NCT04082364|584808448|FG004|Overall Study|Disease progression|0|||
161934270|NCT03186378|584808449|FG000|Overall Study|Lost to Follow-up|1|||
161934271|NCT03186378|584808450|FG001|Overall Study|Lost to Follow-up|0|||
161934272|NCT03247673|584808452|FG000|Overall Study|Withdrawal by Subject|1|||
161934273|NCT03247673|584808453|FG001|Overall Study|Withdrawal by Subject|0|||
161934274|NCT03247673|584808454|FG002|Overall Study|Withdrawal by Subject|3|||
161934275|NCT03247673|584808452|FG000|Overall Study|Lost to Follow-up|0|||
161934276|NCT03247673|584808453|FG001|Overall Study|Lost to Follow-up|0|||
161934277|NCT03247673|584808454|FG002|Overall Study|Lost to Follow-up|1|||
161934278|NCT02971137|584808459|FG000|Overall Study|Lost to Follow-up|44|||
161934279|NCT02971137|584808460|FG001|Overall Study|Lost to Follow-up|56|||
161934280|NCT04755231|584808461|FG000|Overall Study|Lost to Follow-up|5|||
161934281|NCT04755231|584808461|FG000|Overall Study|Withdrawal by Subject|5|||
161934282|NCT00215657|584808465|FG000|Overall Study|Adverse Event|5|||
161934283|NCT00215657|584808466|FG001|Overall Study|Adverse Event|1|||
161934284|NCT00215657|584808467|FG002|Overall Study|Adverse Event|3|||
161934285|NCT00215657|584808468|FG003|Overall Study|Adverse Event|0|||
161934286|NCT00215657|584808469|FG004|Overall Study|Adverse Event|3|||
161934287|NCT00215657|584808470|FG005|Overall Study|Adverse Event|1|||
161934288|NCT00215657|584808471|FG006|Overall Study|Adverse Event|0|||
161934289|NCT00215657|584808472|FG007|Overall Study|Adverse Event|3|||
161521381|NCT02252211|583297499|FG002|Overall Study|Adverse Event|0|||
161521382|NCT02252211|583297497|FG000|Overall Study|Progressive disease|3|||
161521383|NCT02252211|583297498|FG001|Overall Study|Progressive disease|2|||
161521384|NCT02252211|583297499|FG002|Overall Study|Progressive disease|0|||
161934290|NCT00215657|584808465|FG000|Overall Study|Withdrawal by Subject|6|||
161934291|NCT00215657|584808466|FG001|Overall Study|Withdrawal by Subject|3|||
161934292|NCT00215657|584808467|FG002|Overall Study|Withdrawal by Subject|3|||
161934293|NCT00215657|584808468|FG003|Overall Study|Withdrawal by Subject|1|||
161521385|NCT02252211|583297497|FG000|Overall Study|Withdrawal by Subject|1|||
161521386|NCT02252211|583297498|FG001|Overall Study|Withdrawal by Subject|0|||
161934294|NCT00215657|584808469|FG004|Overall Study|Withdrawal by Subject|6|||
161934295|NCT00215657|584808470|FG005|Overall Study|Withdrawal by Subject|1|||
161521387|NCT02252211|583297499|FG002|Overall Study|Withdrawal by Subject|0|||
161934296|NCT00215657|584808471|FG006|Overall Study|Withdrawal by Subject|10|||
161521388|NCT02252211|583297497|FG000|Overall Study|Serious Adverse Event During Screening|1|||
161521389|NCT02252211|583297498|FG001|Overall Study|Serious Adverse Event During Screening|0|||
161521390|NCT02252211|583297499|FG002|Overall Study|Serious Adverse Event During Screening|1|||
161521391|NCT05799495|583297504|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
161521392|NCT05799495|583297505|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
161521393|NCT05799495|583297506|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
161521394|NCT05799495|583297507|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
161521395|NCT05799495|583297504|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
161521396|NCT05799495|583297505|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
161521397|NCT05799495|583297506|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
161521398|NCT05799495|583297507|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
161521399|NCT05799495|583297504|FG000|Treatment (Up to 5 Days)|Other|0|||
161521400|NCT05799495|583297505|FG001|Treatment (Up to 5 Days)|Other|1|||
161521401|NCT05799495|583297506|FG002|Treatment (Up to 5 Days)|Other|0|||
161521402|NCT05799495|583297507|FG003|Treatment (Up to 5 Days)|Other|0|||
161521403|NCT05799495|583297504|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
161521404|NCT05799495|583297505|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
161521405|NCT05799495|583297506|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
161521406|NCT05799495|583297507|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
161521407|NCT05799495|583297504|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
161521408|NCT05799495|583297505|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
161521409|NCT05799495|583297506|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
161521410|NCT05799495|583297507|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
161521411|NCT05799495|583297504|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161521412|NCT05799495|583297505|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161521413|NCT05799495|583297506|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
161521414|NCT05799495|583297507|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161521415|NCT03694548|583297511|FG000|Part A Survey|Protocol Violation|3|||
161521416|NCT03694548|583297512|FG001|Part A Survey|Protocol Violation|3|||
161521417|NCT03694548|583297513|FG002|Part A Survey|Protocol Violation|0|||
161521418|NCT03694548|583297511|FG000|Part B Yoga Program|Protocol Violation|0|||
161521419|NCT03694548|583297512|FG001|Part B Yoga Program|Protocol Violation|0|||
161521420|NCT03694548|583297513|FG002|Part B Yoga Program|Protocol Violation|3|||
161521421|NCT03694548|583297511|FG000|Part B Yoga Program|Did not attend intervention|0|||
161521422|NCT03694548|583297512|FG001|Part B Yoga Program|Did not attend intervention|0|||
161521423|NCT03694548|583297513|FG002|Part B Yoga Program|Did not attend intervention|8|||
161521424|NCT04177108|583297514|FG000|Overall Study|Withdrawal by Subject|4|||
161521425|NCT04177108|583297515|FG001|Overall Study|Withdrawal by Subject|8|||
161521426|NCT04177108|583297516|FG002|Overall Study|Withdrawal by Subject|9|||
161521427|NCT04177108|583297517|FG003|Overall Study|Withdrawal by Subject|11|||
161521428|NCT04177108|583297518|FG004|Overall Study|Withdrawal by Subject|13|||
161521429|NCT04177108|583297514|FG000|Overall Study|Physician Decision|23|||
161521430|NCT04177108|583297515|FG001|Overall Study|Physician Decision|15|||
161521431|NCT04177108|583297516|FG002|Overall Study|Physician Decision|18|||
161521432|NCT04177108|583297517|FG003|Overall Study|Physician Decision|29|||
161521433|NCT04177108|583297518|FG004|Overall Study|Physician Decision|23|||
161521434|NCT04177108|583297514|FG000|Overall Study|Reason Not Specified|0|||
161521435|NCT04177108|583297515|FG001|Overall Study|Reason Not Specified|1|||
161521436|NCT04177108|583297516|FG002|Overall Study|Reason Not Specified|0|||
161521437|NCT04177108|583297517|FG003|Overall Study|Reason Not Specified|0|||
161521438|NCT04177108|583297518|FG004|Overall Study|Reason Not Specified|2|||
161521439|NCT04177108|583297514|FG000|Overall Study|Lost to Follow-up|0|||
161521440|NCT04177108|583297515|FG001|Overall Study|Lost to Follow-up|0|||
161677573|NCT01338415|583872033|FG002|Core + Extension|Other (administrative reason)|0|||
161934297|NCT00215657|584808472|FG007|Overall Study|Withdrawal by Subject|3|||
161934298|NCT00215657|584808465|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
161934299|NCT00215657|584808466|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
161934300|NCT00215657|584808467|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
161934301|NCT00215657|584808468|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
161934302|NCT00215657|584808469|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
161934303|NCT00215657|584808470|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
161934304|NCT00215657|584808471|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
161934305|NCT00215657|584808472|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
161934306|NCT00215657|584808465|FG000|Overall Study|Insufficient testosterone response|5|||
161934307|NCT00215657|584808466|FG001|Overall Study|Insufficient testosterone response|4|||
161521441|NCT04177108|583297516|FG002|Overall Study|Lost to Follow-up|1|||
161521442|NCT04177108|583297517|FG003|Overall Study|Lost to Follow-up|1|||
161521443|NCT04177108|583297518|FG004|Overall Study|Lost to Follow-up|1|||
161521444|NCT04177108|583297514|FG000|Overall Study|Death|16|||
161521445|NCT04177108|583297515|FG001|Overall Study|Death|19|||
161521446|NCT04177108|583297516|FG002|Overall Study|Death|13|||
161521447|NCT04177108|583297517|FG003|Overall Study|Death|17|||
161521448|NCT04177108|583297518|FG004|Overall Study|Death|18|||
161521449|NCT01143259|583297520|FG000|Overall Study|Withdrawal by Subject|3|||
161521450|NCT01143259|583297521|FG001|Overall Study|Withdrawal by Subject|2|||
161521451|NCT01143259|583297520|FG000|Overall Study|Protocol Violation|13|||
161521452|NCT01143259|583297521|FG001|Overall Study|Protocol Violation|9|||
161521453|NCT01143259|583297520|FG000|Overall Study|Screen Failure|7|||
161521454|NCT01143259|583297521|FG001|Overall Study|Screen Failure|9|||
161521455|NCT00099983|583297522|FG000|Overall Study|Lost to Follow-up|2|||
161521456|NCT00099983|583297523|FG001|Overall Study|Lost to Follow-up|3|||
161521457|NCT00099983|583297522|FG000|Overall Study|Missing Source Documents|14|||
161521458|NCT00099983|583297523|FG001|Overall Study|Missing Source Documents|15|||
161521459|NCT00099983|583297522|FG000|Overall Study|Withdrawal by Subject|3|||
161521460|NCT00099983|583297523|FG001|Overall Study|Withdrawal by Subject|2|||
161521461|NCT00099983|583297522|FG000|Overall Study|Adverse Event|1|||
161521462|NCT00099983|583297523|FG001|Overall Study|Adverse Event|1|||
161521463|NCT00099983|583297522|FG000|Overall Study|Lack of Efficacy|0|||
161521464|NCT00099983|583297523|FG001|Overall Study|Lack of Efficacy|1|||
161521465|NCT00099983|583297522|FG000|Overall Study|Unable to return for appointments|1|||
161521466|NCT00099983|583297523|FG001|Overall Study|Unable to return for appointments|1|||
161521467|NCT00099983|583297522|FG000|Overall Study|Moved|1|||
161521468|NCT00099983|583297523|FG001|Overall Study|Moved|0|||
161521469|NCT00099983|583297522|FG000|Overall Study|Other psychiatric problem|1|||
161521470|NCT00099983|583297523|FG001|Overall Study|Other psychiatric problem|0|||
161521471|NCT00099983|583297522|FG000|Overall Study|Incarcerated|0|||
161521472|NCT00099983|583297523|FG001|Overall Study|Incarcerated|1|||
161521473|NCT00099983|583297522|FG000|Overall Study|Intolerant of burden of visits|0|||
161521474|NCT00099983|583297523|FG001|Overall Study|Intolerant of burden of visits|1|||
161521475|NCT00099983|583297522|FG000|Overall Study|Other issue|1|||
161521476|NCT00099983|583297523|FG001|Overall Study|Other issue|0|||
161521477|NCT02641080|583297524|FG000|Overall Study|Physician Decision|2|||
161521478|NCT02641080|583297525|FG001|Overall Study|Physician Decision|0|||
161521479|NCT02641080|583297524|FG000|Overall Study|Withdrawal by Subject|0|||
161521480|NCT02641080|583297525|FG001|Overall Study|Withdrawal by Subject|1|||
161521481|NCT02641080|583297524|FG000|Overall Study|Rehab Center denied use of pumps|0|||
161521482|NCT02641080|583297525|FG001|Overall Study|Rehab Center denied use of pumps|3|||
161521483|NCT02641080|583297524|FG000|Overall Study|Lost to Follow-up|0|||
161521484|NCT02641080|583297525|FG001|Overall Study|Lost to Follow-up|3|||
161521485|NCT06281548|583297526|FG000|Overall Study|Lost to Follow-up|3|||
161521486|NCT03835533|583297527|FG000|Overall Study|Death|5|||
161521487|NCT03835533|583297528|FG001|Overall Study|Death|10|||
161521488|NCT03835533|583297529|FG002|Overall Study|Death|9|||
161521489|NCT03835533|583297527|FG000|Overall Study|Withdrawal by Subject|2|||
161521490|NCT03835533|583297528|FG001|Overall Study|Withdrawal by Subject|2|||
161521491|NCT03835533|583297529|FG002|Overall Study|Withdrawal by Subject|2|||
161521492|NCT03835533|583297527|FG000|Overall Study|Lost to Follow-up|1|||
161521493|NCT03835533|583297528|FG001|Overall Study|Lost to Follow-up|0|||
161521494|NCT03835533|583297529|FG002|Overall Study|Lost to Follow-up|0|||
161521495|NCT01866709|583297533|FG000|Overall Study|Adverse Event|1|||
161521496|NCT01866709|583297534|FG001|Overall Study|Adverse Event|0|||
161521497|NCT02207829|583297536|FG000|Overall Study|Adverse Event|10|||
161521498|NCT02207829|583297537|FG001|Overall Study|Adverse Event|9|||
161521499|NCT02207829|583297536|FG000|Overall Study|Lack of Efficacy|7|||
161521500|NCT02207829|583297537|FG001|Overall Study|Lack of Efficacy|5|||
161521501|NCT02207829|583297536|FG000|Overall Study|Lost to Follow-up|2|||
161521502|NCT02207829|583297537|FG001|Overall Study|Lost to Follow-up|2|||
161521503|NCT02207829|583297536|FG000|Overall Study|Protocol deviation|5|||
161521504|NCT02207829|583297537|FG001|Overall Study|Protocol deviation|4|||
161521505|NCT02207829|583297536|FG000|Overall Study|Withdrew consent|18|||
161521506|NCT02207829|583297537|FG001|Overall Study|Withdrew consent|14|||
161521507|NCT03285477|583297539|FG000|Treatment and Response Assessment Period|Death|1|||
161521508|NCT03285477|583297540|FG001|Treatment and Response Assessment Period|Death|0|||
161521509|NCT03285477|583297539|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
161521510|NCT03285477|583297540|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
161521511|NCT03285477|583297539|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
161521512|NCT03285477|583297540|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
161521513|NCT03285477|583297539|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
161589388|NCT04083235|583546445|FG001|Overall Study|Ongoing at the time of DCO|7|||
161589389|NCT03016169|583546448|FG000|Overall Study|Lost to Follow-up|4|||
161521514|NCT03285477|583297540|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
161589390|NCT03016169|583546448|FG000|Overall Study|Death|54|||
161521515|NCT03285477|583297539|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
161521516|NCT03285477|583297540|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
161521517|NCT00560833|583297553|FG000|Overall Study|Adverse Event|16|||
161521518|NCT00560833|583297554|FG001|Overall Study|Adverse Event|10|||
161521519|NCT00560833|583297555|FG002|Overall Study|Adverse Event|25|||
161521520|NCT00560833|583297556|FG003|Overall Study|Adverse Event|23|||
161521521|NCT00560833|583297557|FG004|Overall Study|Adverse Event|35|||
161521522|NCT00560833|583297553|FG000|Overall Study|Lost to Follow-up|0|||
161521523|NCT00560833|583297554|FG001|Overall Study|Lost to Follow-up|0|||
161934308|NCT00215657|584808467|FG002|Overall Study|Insufficient testosterone response|1|||
161934309|NCT00215657|584808468|FG003|Overall Study|Insufficient testosterone response|12|||
161521524|NCT00560833|583297555|FG002|Overall Study|Lost to Follow-up|1|||
161521525|NCT00560833|583297556|FG003|Overall Study|Lost to Follow-up|0|||
161521526|NCT00560833|583297557|FG004|Overall Study|Lost to Follow-up|0|||
161521527|NCT00560833|583297553|FG000|Overall Study|Lack of Efficacy|22|||
161521528|NCT00560833|583297554|FG001|Overall Study|Lack of Efficacy|9|||
161521529|NCT00560833|583297555|FG002|Overall Study|Lack of Efficacy|6|||
161521530|NCT00560833|583297556|FG003|Overall Study|Lack of Efficacy|4|||
161521531|NCT00560833|583297557|FG004|Overall Study|Lack of Efficacy|4|||
161521532|NCT00560833|583297553|FG000|Overall Study|Participant uncooperative|5|||
161521533|NCT00560833|583297554|FG001|Overall Study|Participant uncooperative|5|||
161521534|NCT00560833|583297555|FG002|Overall Study|Participant uncooperative|4|||
161521535|NCT00560833|583297556|FG003|Overall Study|Participant uncooperative|4|||
161521536|NCT00560833|583297557|FG004|Overall Study|Participant uncooperative|2|||
161521537|NCT00560833|583297553|FG000|Overall Study|Other|1|||
161521538|NCT00560833|583297554|FG001|Overall Study|Other|1|||
161521539|NCT00560833|583297555|FG002|Overall Study|Other|3|||
161521540|NCT00560833|583297556|FG003|Overall Study|Other|0|||
161934310|NCT00215657|584808469|FG004|Overall Study|Insufficient testosterone response|8|||
161521541|NCT00560833|583297557|FG004|Overall Study|Other|0|||
161825719|NCT04203667|584401885|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
161825720|NCT01160640|584401886|FG000|Overall Study|Physician Decision|3|||
161521542|NCT00560833|583297553|FG000|Overall Study|Never received drug|0|||
161521543|NCT00560833|583297554|FG001|Overall Study|Never received drug|1|||
161521544|NCT00560833|583297555|FG002|Overall Study|Never received drug|0|||
161521545|NCT00560833|583297556|FG003|Overall Study|Never received drug|0|||
161521546|NCT00560833|583297557|FG004|Overall Study|Never received drug|1|||
161521547|NCT03283670|583297558|FG000|Placebo Gas|Withdrawal by Subject|2|||
161521548|NCT03283670|583297558|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
161521549|NCT03283670|583297558|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
161521550|NCT01307501|583297559|FG000|Overall Study|Treatment Failure|1|||
161521551|NCT01307501|583297559|FG000|Overall Study|Death|20|||
161521552|NCT01307501|583297559|FG000|Overall Study|Lost to Follow-up|1|||
161521553|NCT01307501|583297559|FG000|Overall Study|Starting Hospice|1|||
161521554|NCT01209624|583297562|FG000|Overall Study|Death|2|||
161521555|NCT01209624|583297562|FG000|Overall Study|Adverse Event|13|||
161521556|NCT01209624|583297562|FG000|Overall Study|Lack of Efficacy|17|||
161521557|NCT01209624|583297562|FG000|Overall Study|Lost to Follow-up|290|||
161521558|NCT01209624|583297562|FG000|Overall Study|Other|4|||
161521559|NCT03564496|583297563|FG000|Overall Study|Withdrawal by Subject|1|||
161521560|NCT03564496|583297564|FG001|Overall Study|Withdrawal by Subject|1|||
161521561|NCT03564496|583297565|FG002|Overall Study|Withdrawal by Subject|0|||
161521562|NCT03564496|583297563|FG000|Overall Study|Screen failure|0|||
161521563|NCT03564496|583297564|FG001|Overall Study|Screen failure|3|||
161521564|NCT03564496|583297565|FG002|Overall Study|Screen failure|0|||
161521565|NCT00428610|583297566|FG000|Overall Study|Death Due to Adverse Event|3|||
161521566|NCT00428610|583297567|FG001|Overall Study|Death Due to Adverse Event|0|||
161521567|NCT00428610|583297568|FG002|Overall Study|Death Due to Adverse Event|5|||
161521568|NCT00428610|583297566|FG000|Overall Study|Death Due to Progressive Disease|0|||
161521569|NCT00428610|583297567|FG001|Overall Study|Death Due to Progressive Disease|0|||
161825721|NCT01160640|584401887|FG001|Overall Study|Physician Decision|3|||
161825722|NCT01160640|584401886|FG000|Overall Study|Incarceration|1|||
161825723|NCT01160640|584401887|FG001|Overall Study|Incarceration|0|||
161825724|NCT01160640|584401886|FG000|Overall Study|Withdrawal by Subject|0|||
161825725|NCT01160640|584401887|FG001|Overall Study|Withdrawal by Subject|3|||
161825726|NCT01525628|584401888|FG000|Overall Study|Adverse Event|1|||
161825727|NCT01525628|584401889|FG001|Overall Study|Adverse Event|1|||
161825728|NCT01525628|584401890|FG002|Overall Study|Adverse Event|2|||
161825729|NCT01525628|584401891|FG003|Overall Study|Adverse Event|0|||
161825730|NCT01525628|584401892|FG004|Overall Study|Adverse Event|1|||
161825731|NCT01525628|584401888|FG000|Overall Study|Lack of Efficacy|0|||
161825732|NCT01525628|584401889|FG001|Overall Study|Lack of Efficacy|2|||
161825733|NCT01525628|584401890|FG002|Overall Study|Lack of Efficacy|2|||
161825734|NCT01525628|584401891|FG003|Overall Study|Lack of Efficacy|1|||
161521570|NCT00428610|583297568|FG002|Overall Study|Death Due to Progressive Disease|2|||
161521571|NCT00428610|583297566|FG000|Overall Study|Adverse Event|2|||
161521572|NCT00428610|583297567|FG001|Overall Study|Adverse Event|3|||
161521573|NCT00428610|583297568|FG002|Overall Study|Adverse Event|2|||
161521574|NCT00428610|583297566|FG000|Overall Study|Investigator Decision|2|||
161521575|NCT00428610|583297567|FG001|Overall Study|Investigator Decision|1|||
161521576|NCT00428610|583297568|FG002|Overall Study|Investigator Decision|1|||
161521577|NCT00428610|583297566|FG000|Overall Study|Progressive Disease|42|||
161521578|NCT00428610|583297567|FG001|Overall Study|Progressive Disease|14|||
161521579|NCT00428610|583297568|FG002|Overall Study|Progressive Disease|22|||
161521580|NCT00428610|583297566|FG000|Overall Study|Withdrawal by Subject|4|||
161521581|NCT00428610|583297567|FG001|Overall Study|Withdrawal by Subject|0|||
161825735|NCT01525628|584401892|FG004|Overall Study|Lack of Efficacy|2|||
161825736|NCT01525628|584401888|FG000|Overall Study|Protocol Violation|0|||
161521582|NCT00428610|583297568|FG002|Overall Study|Withdrawal by Subject|0|||
161521583|NCT00136955|583299598|FG000|Overall Study|Adverse Event|8|||
161521584|NCT00136955|583299598|FG000|Overall Study|Lost to Follow-up|1|||
161521585|NCT00136955|583299598|FG000|Overall Study|Withdrawal by Subject|2|||
161521586|NCT00136955|583299598|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
161934311|NCT00215657|584808470|FG005|Overall Study|Insufficient testosterone response|12|||
161934312|NCT00215657|584808471|FG006|Overall Study|Insufficient testosterone response|4|||
161934313|NCT00215657|584808472|FG007|Overall Study|Insufficient testosterone response|7|||
161934314|NCT00215657|584808465|FG000|Overall Study|Other|3|||
161521587|NCT01773226|583299599|FG000|Overall Study|Withdrawal by Subject|1|||
161521588|NCT00724282|583299602|FG000|Overall Study|Withdrawal by Subject|3|||
161521589|NCT00724282|583299602|FG000|Overall Study|Physician Decision|1|||
161521590|NCT03811912|583299603|FG000|Overall Study|Withdrew Consent|4|||
161521591|NCT03811912|583299604|FG001|Overall Study|Withdrew Consent|2|||
161521592|NCT01438411|583299605|FG000|Overall Study|Adverse Event|8|||
161521593|NCT01438411|583299605|FG000|Overall Study|Lost to Follow-up|1|||
161521594|NCT01438411|583299605|FG000|Overall Study|Lack of Efficacy|1|||
161521595|NCT01438411|583299605|FG000|Overall Study|Withdrawal by Subject|3|||
161521596|NCT01863680|583299606|FG000|Overall Study|Adverse Event|17|||
161521597|NCT01863680|583299606|FG000|Overall Study|Risk of OHSS|17|||
161521598|NCT01863680|583299606|FG000|Overall Study|Spontaneous pregnancy|2|||
161521599|NCT01863680|583299606|FG000|Overall Study|Withdrawal by Subject|1|||
161521600|NCT01863680|583299606|FG000|Overall Study|Did not undergo IVF/ET|14|||
161521601|NCT01863680|583299606|FG000|Overall Study|Other|6|||
161521602|NCT00618514|583299607|FG000|Overall Study|Lost to Follow-up|11|||
161521603|NCT00618514|583299608|FG001|Overall Study|Lost to Follow-up|12|||
161521604|NCT00618514|583299609|FG002|Overall Study|Lost to Follow-up|4|||
161521605|NCT00566228|583299616|FG000|Overall Study|Withdrawal by Subject|1|||
161589391|NCT03016169|583546448|FG000|Overall Study|Device Explant|11|||
161589392|NCT03016169|583546448|FG000|Overall Study|Withdrawal by Subject|19|||
161589393|NCT03016169|583546448|FG000|Overall Study|Other Reasons|1|||
161589394|NCT04060355|583546449|FG000|Overall Study|Lost to Follow-up|41|||
161589395|NCT04421378|583546454|FG000|Overall Study|Adverse Event|2|||
161589396|NCT04421378|583546455|FG001|Overall Study|Adverse Event|7|||
161589397|NCT04421378|583546456|FG002|Overall Study|Adverse Event|0|||
161589398|NCT04421378|583546457|FG003|Overall Study|Adverse Event|1|||
161589399|NCT04421378|583546458|FG004|Overall Study|Adverse Event|0|||
161589400|NCT04421378|583546454|FG000|Overall Study|Physician Decision|1|||
161589401|NCT04421378|583546455|FG001|Overall Study|Physician Decision|2|||
161589402|NCT04421378|583546456|FG002|Overall Study|Physician Decision|0|||
161589403|NCT04421378|583546457|FG003|Overall Study|Physician Decision|0|||
161589404|NCT04421378|583546458|FG004|Overall Study|Physician Decision|0|||
161589405|NCT04421378|583546454|FG000|Overall Study|Progressive Disease|16|||
161589406|NCT04421378|583546455|FG001|Overall Study|Progressive Disease|4|||
161589407|NCT04421378|583546456|FG002|Overall Study|Progressive Disease|18|||
161589408|NCT04421378|583546457|FG003|Overall Study|Progressive Disease|11|||
161589409|NCT04421378|583546458|FG004|Overall Study|Progressive Disease|3|||
161589410|NCT04421378|583546454|FG000|Overall Study|Study Terminated by Sponsor|0|||
161589411|NCT04421378|583546455|FG001|Overall Study|Study Terminated by Sponsor|1|||
161589412|NCT04421378|583546456|FG002|Overall Study|Study Terminated by Sponsor|1|||
161589413|NCT04421378|583546457|FG003|Overall Study|Study Terminated by Sponsor|0|||
161589414|NCT04421378|583546458|FG004|Overall Study|Study Terminated by Sponsor|0|||
161589415|NCT04421378|583546454|FG000|Overall Study|Withdrawal by Subject|3|||
161589416|NCT04421378|583546455|FG001|Overall Study|Withdrawal by Subject|1|||
161589417|NCT04421378|583546456|FG002|Overall Study|Withdrawal by Subject|0|||
161934315|NCT00215657|584808466|FG001|Overall Study|Other|1|||
161934316|NCT00215657|584808467|FG002|Overall Study|Other|2|||
161934317|NCT00215657|584808468|FG003|Overall Study|Other|3|||
161934318|NCT00215657|584808469|FG004|Overall Study|Other|5|||
161934319|NCT00215657|584808470|FG005|Overall Study|Other|4|||
161934320|NCT00215657|584808471|FG006|Overall Study|Other|6|||
161934321|NCT00215657|584808472|FG007|Overall Study|Other|1|||
161934322|NCT04754399|584808473|FG000|Overall Study|Adverse Event|5|||
161589418|NCT04421378|583546457|FG003|Overall Study|Withdrawal by Subject|2|||
161589419|NCT04421378|583546458|FG004|Overall Study|Withdrawal by Subject|0|||
161589420|NCT04421378|583546454|FG000|Overall Study|Other|1|||
161589421|NCT04421378|583546455|FG001|Overall Study|Other|0|||
161934323|NCT04754399|584808473|FG000|Overall Study|Withdrawal by Subject|6|||
161934324|NCT05259722|584808476|FG000|Overall Study|Adverse Event|2|||
161589422|NCT04421378|583546456|FG002|Overall Study|Other|0|||
161589423|NCT04421378|583546457|FG003|Overall Study|Other|0|||
161589424|NCT04421378|583546458|FG004|Overall Study|Other|0|||
161934325|NCT05259722|584808477|FG001|Overall Study|Adverse Event|24|||
161934326|NCT05259722|584808476|FG000|Overall Study|Lost to Follow-up|5|||
161521606|NCT00566228|583299617|FG001|Overall Study|Withdrawal by Subject|0|||
161521607|NCT00566228|583299616|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
161521608|NCT00566228|583299617|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
161521609|NCT00566228|583299616|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
161521610|NCT00566228|583299617|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
161521611|NCT00566228|583299616|FG000|Overall Study|progressed before infusion could occur|0|||
161521612|NCT00566228|583299617|FG001|Overall Study|progressed before infusion could occur|1|||
161521613|NCT03320070|583299620|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
161521614|NCT03320070|583299621|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
161521615|NCT03320070|583299620|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
161521616|NCT03320070|583299621|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
161521617|NCT03320070|583299620|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
161521618|NCT03320070|583299621|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
161521619|NCT03320070|583299620|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
161521620|NCT03320070|583299621|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
161521621|NCT03320070|583299620|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
161521622|NCT03320070|583299621|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
161521623|NCT03320070|583299620|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
161521624|NCT03320070|583299621|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
161521625|NCT03586648|583299622|FG000|Period 1|Withdrawal by Subject|0|||
161521626|NCT03586648|583299623|FG001|Period 1|Withdrawal by Subject|1|||
161521627|NCT03586648|583299622|FG000|Period 1|Lost to Follow-up|1|||
161521628|NCT03586648|583299623|FG001|Period 1|Lost to Follow-up|1|||
161521629|NCT03586648|583299622|FG000|Period 1|Adverse Event|1|||
161521630|NCT03586648|583299623|FG001|Period 1|Adverse Event|0|||
161521631|NCT03586648|583299622|FG000|Period 1|Study related symptoms or complaints|2|||
161521632|NCT03586648|583299623|FG001|Period 1|Study related symptoms or complaints|1|||
161521633|NCT03586648|583299622|FG000|Period 1|Physician Decision|0|||
161521634|NCT03586648|583299623|FG001|Period 1|Physician Decision|1|||
161521635|NCT03586648|583299622|FG000|Period 2|Adverse Event|1|||
161521636|NCT03586648|583299623|FG001|Period 2|Adverse Event|0|||
161521637|NCT02041195|583299624|FG000|Overall Study|Adverse Event|1|||
161521638|NCT02041195|583299625|FG001|Overall Study|Adverse Event|2|||
161521639|NCT02041195|583299626|FG002|Overall Study|Adverse Event|0|||
161521640|NCT02041195|583299627|FG003|Overall Study|Adverse Event|0|||
161521641|NCT02041195|583299628|FG004|Overall Study|Adverse Event|0|||
161521642|NCT02041195|583299629|FG005|Overall Study|Adverse Event|0|||
161521643|NCT02041195|583299630|FG006|Overall Study|Adverse Event|3|||
161521644|NCT02041195|583299631|FG007|Overall Study|Adverse Event|0|||
161521645|NCT02041195|583299624|FG000|Overall Study|Withdrawal by Subject|1|||
161521646|NCT02041195|583299625|FG001|Overall Study|Withdrawal by Subject|0|||
161521647|NCT02041195|583299626|FG002|Overall Study|Withdrawal by Subject|0|||
161521648|NCT02041195|583299627|FG003|Overall Study|Withdrawal by Subject|0|||
161521649|NCT02041195|583299628|FG004|Overall Study|Withdrawal by Subject|0|||
161521650|NCT02041195|583299629|FG005|Overall Study|Withdrawal by Subject|0|||
161521651|NCT02041195|583299630|FG006|Overall Study|Withdrawal by Subject|4|||
161521652|NCT02041195|583299631|FG007|Overall Study|Withdrawal by Subject|3|||
161521653|NCT02041195|583299624|FG000|Overall Study|Unable to comply with study visits|0|||
161521654|NCT02041195|583299625|FG001|Overall Study|Unable to comply with study visits|1|||
161521655|NCT02041195|583299626|FG002|Overall Study|Unable to comply with study visits|0|||
161521656|NCT02041195|583299627|FG003|Overall Study|Unable to comply with study visits|0|||
161521657|NCT02041195|583299628|FG004|Overall Study|Unable to comply with study visits|1|||
161521658|NCT02041195|583299629|FG005|Overall Study|Unable to comply with study visits|0|||
161521659|NCT02041195|583299630|FG006|Overall Study|Unable to comply with study visits|0|||
161521660|NCT02041195|583299631|FG007|Overall Study|Unable to comply with study visits|0|||
161521661|NCT02367911|583299634|FG000|Overall Study|Withdrawal by Subject|3|||
161521662|NCT02367911|583299635|FG001|Overall Study|Withdrawal by Subject|2|||
161521663|NCT02367911|583299634|FG000|Overall Study|Lost to Follow-up|2|||
161521664|NCT02367911|583299635|FG001|Overall Study|Lost to Follow-up|2|||
161521665|NCT00263666|583299636|FG000|Overall Study|Adverse Event|6|||
161521666|NCT00263666|583299637|FG001|Overall Study|Adverse Event|8|||
161521667|NCT00263666|583299636|FG000|Overall Study|Lost to Follow-up|1|||
161521668|NCT00263666|583299637|FG001|Overall Study|Lost to Follow-up|2|||
161934327|NCT05259722|584808477|FG001|Overall Study|Lost to Follow-up|1|||
161934328|NCT05259722|584808476|FG000|Overall Study|Lack of Efficacy|8|||
161934329|NCT05259722|584808477|FG001|Overall Study|Lack of Efficacy|26|||
161934330|NCT05259722|584808476|FG000|Overall Study|Withdrawal by Subject|15|||
161934331|NCT05259722|584808477|FG001|Overall Study|Withdrawal by Subject|33|||
161934332|NCT05259722|584808476|FG000|Overall Study|Various reasons|3|||
161521669|NCT00263666|583299636|FG000|Overall Study|Withdrawal by Subject|0|||
161521670|NCT00263666|583299637|FG001|Overall Study|Withdrawal by Subject|1|||
161521671|NCT00896168|583299638|FG000|Overall Study|Adverse Event|4|||
161521672|NCT00896168|583299639|FG001|Overall Study|Adverse Event|7|||
161521673|NCT00896168|583299638|FG000|Overall Study|Treatment failure|8|||
161521674|NCT00896168|583299639|FG001|Overall Study|Treatment failure|10|||
161521675|NCT00896168|583299638|FG000|Overall Study|Lost to Follow-up|1|||
161521676|NCT00896168|583299639|FG001|Overall Study|Lost to Follow-up|1|||
161521677|NCT00896168|583299638|FG000|Overall Study|Other|1|||
161521678|NCT00896168|583299639|FG001|Overall Study|Other|1|||
161521679|NCT00902304|583299640|FG000|Overall Study|Adverse Event|4|||
161934333|NCT05259722|584808477|FG001|Overall Study|Various reasons|9|||
161825737|NCT01525628|584401889|FG001|Overall Study|Protocol Violation|0|||
161825738|NCT01525628|584401890|FG002|Overall Study|Protocol Violation|1|||
161521680|NCT00902304|583299641|FG001|Overall Study|Adverse Event|10|||
161521681|NCT00902304|583299642|FG002|Overall Study|Adverse Event|25|||
161521682|NCT00902304|583299640|FG000|Overall Study|Investigator discretion|3|||
161521683|NCT00902304|583299641|FG001|Overall Study|Investigator discretion|5|||
161521684|NCT00902304|583299642|FG002|Overall Study|Investigator discretion|13|||
161521685|NCT00902304|583299640|FG000|Overall Study|Lost to Follow-up|7|||
161521686|NCT00902304|583299641|FG001|Overall Study|Lost to Follow-up|7|||
161521687|NCT00902304|583299642|FG002|Overall Study|Lost to Follow-up|7|||
161521688|NCT00902304|583299640|FG000|Overall Study|Protocol Violation|9|||
161521689|NCT00902304|583299641|FG001|Overall Study|Protocol Violation|18|||
161521690|NCT00902304|583299642|FG002|Overall Study|Protocol Violation|20|||
161521691|NCT00902304|583299640|FG000|Overall Study|Withdrawal by Subject|32|||
161521692|NCT00902304|583299641|FG001|Overall Study|Withdrawal by Subject|22|||
161521693|NCT00902304|583299642|FG002|Overall Study|Withdrawal by Subject|43|||
161521694|NCT00902304|583299640|FG000|Overall Study|includes pregnancy|3|||
161521695|NCT00902304|583299641|FG001|Overall Study|includes pregnancy|9|||
161521696|NCT00902304|583299642|FG002|Overall Study|includes pregnancy|2|||
161521697|NCT02492100|583299643|FG000|Overall Study|Death|1|||
161521698|NCT03832010|583299644|FG000|Overall Study|Withdrawal by Subject|2|||
161521699|NCT03832010|583299645|FG001|Overall Study|Withdrawal by Subject|1|||
161521700|NCT03832010|583299646|FG002|Overall Study|Withdrawal by Subject|0|||
161521701|NCT03832010|583299644|FG000|Overall Study|Lost to Follow-up|2|||
161521702|NCT03832010|583299645|FG001|Overall Study|Lost to Follow-up|1|||
161521703|NCT03832010|583299646|FG002|Overall Study|Lost to Follow-up|1|||
161521704|NCT04969783|583299647|FG000|Overall Study|Lost to Follow-up|2|||
161521705|NCT04969783|583299648|FG001|Overall Study|Lost to Follow-up|0|||
161521706|NCT04969783|583299647|FG000|Overall Study|Withdrawal by Subject|4|||
161521707|NCT04969783|583299648|FG001|Overall Study|Withdrawal by Subject|0|||
161521708|NCT04969783|583299647|FG000|Overall Study|Physician Decision|6|||
161521709|NCT04969783|583299648|FG001|Overall Study|Physician Decision|0|||
161521710|NCT02489500|583299649|FG000|Overall Study|Death|1|||
161521711|NCT02489500|583299650|FG001|Overall Study|Death|1|||
161521712|NCT00987467|583299655|FG000|Overall Study|Lost to Follow-up|2|||
161521713|NCT00512135|583299656|FG000|Overall Study|Not Treated|5|||
161521714|NCT00512135|583299656|FG000|Overall Study|Lack of Efficacy|2|||
161521715|NCT00512135|583299656|FG000|Overall Study|Adverse Event|6|||
161521716|NCT00512135|583299656|FG000|Overall Study|Withdrawal by Subject|22|||
161521717|NCT00512135|583299656|FG000|Overall Study|Lost to Follow-up|27|||
161521718|NCT00512135|583299656|FG000|Overall Study|Other|22|||
161521719|NCT00262834|583299657|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
161521720|NCT00262834|583299658|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
161521721|NCT03422250|583299659|FG000|Intervention|Adverse Event|0|||
161521722|NCT03422250|583299660|FG001|Intervention|Adverse Event|1|||
161521723|NCT03422250|583299661|FG002|Intervention|Adverse Event|0|||
161521724|NCT03422250|583299662|FG003|Intervention|Adverse Event|1|||
161521725|NCT03422250|583299659|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
161521726|NCT03422250|583299660|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
161521727|NCT03422250|583299661|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
161521728|NCT03422250|583299662|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
161521729|NCT03422250|583299659|FG000|Follow-up|Withdrawal by Subject|0|||
161521730|NCT03422250|583299660|FG001|Follow-up|Withdrawal by Subject|0|||
161825739|NCT01525628|584401891|FG003|Overall Study|Protocol Violation|0|||
161521731|NCT03422250|583299661|FG002|Follow-up|Withdrawal by Subject|0|||
161521732|NCT03422250|583299662|FG003|Follow-up|Withdrawal by Subject|1|||
161521733|NCT03422250|583299659|FG000|Follow-up|Adverse Event|0|||
161521734|NCT03422250|583299660|FG001|Follow-up|Adverse Event|0|||
161521735|NCT03422250|583299661|FG002|Follow-up|Adverse Event|0|||
161825740|NCT01525628|584401892|FG004|Overall Study|Protocol Violation|0|||
161825741|NCT01525628|584401888|FG000|Overall Study|Lost to Follow-up|1|||
161825742|NCT01525628|584401889|FG001|Overall Study|Lost to Follow-up|1|||
161825743|NCT01525628|584401890|FG002|Overall Study|Lost to Follow-up|0|||
161825744|NCT01525628|584401891|FG003|Overall Study|Lost to Follow-up|0|||
161825745|NCT01525628|584401892|FG004|Overall Study|Lost to Follow-up|0|||
161825746|NCT01525628|584401888|FG000|Overall Study|Withdrawal by Subject|0|||
161825747|NCT01525628|584401889|FG001|Overall Study|Withdrawal by Subject|1|||
161825748|NCT01525628|584401890|FG002|Overall Study|Withdrawal by Subject|0|||
161825749|NCT01525628|584401891|FG003|Overall Study|Withdrawal by Subject|0|||
161825750|NCT01525628|584401892|FG004|Overall Study|Withdrawal by Subject|0|||
161521736|NCT03422250|583299662|FG003|Follow-up|Adverse Event|1|||
161521737|NCT00377819|583299665|FG000|Overall Study|Adverse Event|2|||
161521738|NCT00377819|583299666|FG001|Overall Study|Adverse Event|3|||
161521739|NCT00377819|583299665|FG000|Overall Study|Withdrawal by Subject|10|||
161521740|NCT00377819|583299666|FG001|Overall Study|Withdrawal by Subject|4|||
161521741|NCT00377819|583299665|FG000|Overall Study|Death|0|||
161521742|NCT00377819|583299666|FG001|Overall Study|Death|1|||
161521743|NCT00377819|583299665|FG000|Overall Study|Lost to Follow-up|0|||
161521744|NCT00377819|583299666|FG001|Overall Study|Lost to Follow-up|1|||
161521745|NCT00377819|583299665|FG000|Overall Study|Protocol Violation|1|||
161521746|NCT00377819|583299666|FG001|Overall Study|Protocol Violation|1|||
161521747|NCT02416791|583299667|FG000|6 Months|Lost to Follow-up|0|||
161521748|NCT02416791|583299668|FG001|6 Months|Lost to Follow-up|0|||
161521749|NCT02416791|583299669|FG002|6 Months|Lost to Follow-up|1|||
161521750|NCT01054820|583299670|FG000|Overall Study|Withdrawal by Subject|2|||
161521751|NCT00467870|583299677|FG000|Overall Study|Adverse Event|13|||
161521752|NCT00467870|583299678|FG001|Overall Study|Adverse Event|9|||
161521753|NCT00467870|583299679|FG002|Overall Study|Adverse Event|1|||
161521754|NCT00467870|583299680|FG003|Overall Study|Adverse Event|15|||
161521755|NCT00467870|583299681|FG004|Overall Study|Adverse Event|15|||
161521756|NCT00467870|583299682|FG005|Overall Study|Adverse Event|1|||
161521757|NCT00467870|583299677|FG000|Overall Study|Protocol Violation|2|||
161521758|NCT00467870|583299678|FG001|Overall Study|Protocol Violation|1|||
161521759|NCT00467870|583299679|FG002|Overall Study|Protocol Violation|1|||
161521760|NCT00467870|583299680|FG003|Overall Study|Protocol Violation|2|||
161521761|NCT00467870|583299681|FG004|Overall Study|Protocol Violation|0|||
161521762|NCT00467870|583299682|FG005|Overall Study|Protocol Violation|0|||
161521763|NCT00467870|583299677|FG000|Overall Study|Withdrawal by Subject|14|||
161521764|NCT00467870|583299678|FG001|Overall Study|Withdrawal by Subject|21|||
161521765|NCT00467870|583299679|FG002|Overall Study|Withdrawal by Subject|0|||
161521766|NCT00467870|583299680|FG003|Overall Study|Withdrawal by Subject|9|||
161521767|NCT00467870|583299681|FG004|Overall Study|Withdrawal by Subject|10|||
161521768|NCT00467870|583299682|FG005|Overall Study|Withdrawal by Subject|1|||
161521769|NCT00467870|583299677|FG000|Overall Study|Lost to Follow-up|5|||
161521770|NCT00467870|583299678|FG001|Overall Study|Lost to Follow-up|3|||
161521771|NCT00467870|583299679|FG002|Overall Study|Lost to Follow-up|1|||
161521772|NCT00467870|583299680|FG003|Overall Study|Lost to Follow-up|1|||
161521773|NCT00467870|583299681|FG004|Overall Study|Lost to Follow-up|3|||
161521774|NCT00467870|583299682|FG005|Overall Study|Lost to Follow-up|0|||
161521775|NCT00467870|583299677|FG000|Overall Study|Subject Non-compliance|3|||
161521776|NCT00467870|583299678|FG001|Overall Study|Subject Non-compliance|4|||
161521777|NCT00467870|583299679|FG002|Overall Study|Subject Non-compliance|0|||
161521778|NCT00467870|583299680|FG003|Overall Study|Subject Non-compliance|1|||
161521779|NCT00467870|583299681|FG004|Overall Study|Subject Non-compliance|5|||
161521780|NCT00467870|583299682|FG005|Overall Study|Subject Non-compliance|0|||
161521781|NCT00467870|583299677|FG000|Overall Study|Other/Unknown|8|||
161521782|NCT00467870|583299678|FG001|Overall Study|Other/Unknown|5|||
161521783|NCT00467870|583299679|FG002|Overall Study|Other/Unknown|1|||
161521784|NCT00467870|583299680|FG003|Overall Study|Other/Unknown|5|||
161521785|NCT00467870|583299681|FG004|Overall Study|Other/Unknown|4|||
161521786|NCT00467870|583299682|FG005|Overall Study|Other/Unknown|0|||
161677574|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
161677575|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
161677576|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
161677577|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
161677578|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
161677579|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
161677580|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
161825751|NCT01525628|584401888|FG000|Overall Study|Other reason not defined above|0|||
161825752|NCT01525628|584401889|FG001|Overall Study|Other reason not defined above|0|||
161521787|NCT03489304|583299683|FG000|Overall Study|Lost to Follow-up|4|||
161521788|NCT02239679|583299684|FG000|Overall Study|Lost to Follow-up|1|||
161521789|NCT02239679|583299685|FG001|Overall Study|Lost to Follow-up|0|||
161521790|NCT02239679|583299686|FG002|Overall Study|Lost to Follow-up|0|||
161521791|NCT02239679|583299684|FG000|Overall Study|Withdrawal by Subject|2|||
161521792|NCT02239679|583299685|FG001|Overall Study|Withdrawal by Subject|3|||
161521793|NCT02239679|583299686|FG002|Overall Study|Withdrawal by Subject|1|||
161825753|NCT01525628|584401890|FG002|Overall Study|Other reason not defined above|0|||
161825754|NCT01525628|584401891|FG003|Overall Study|Other reason not defined above|3|||
161825755|NCT01525628|584401892|FG004|Overall Study|Other reason not defined above|0|||
161825756|NCT00787605|584401893|FG000|Overall Study|Administrative Problems|3|||
161521794|NCT01917526|583299687|FG000|Overall Study|Protocol Violation|1|||
161521795|NCT01917526|583299688|FG001|Overall Study|Protocol Violation|1|||
161521796|NCT00760929|583299692|FG000|Overall Study|Adverse Event|2|||
161521797|NCT00760929|583299693|FG001|Overall Study|Adverse Event|0|||
161521798|NCT00760929|583299694|FG002|Overall Study|Adverse Event|6|||
161521799|NCT00760929|583299695|FG003|Overall Study|Adverse Event|10|||
161521800|NCT00760929|583299692|FG000|Overall Study|Lack of Efficacy|0|||
161521801|NCT00760929|583299693|FG001|Overall Study|Lack of Efficacy|2|||
161521802|NCT00760929|583299694|FG002|Overall Study|Lack of Efficacy|1|||
161521803|NCT00760929|583299695|FG003|Overall Study|Lack of Efficacy|0|||
161521804|NCT00760929|583299692|FG000|Overall Study|Withdrawal by Subject|1|||
161521805|NCT00760929|583299693|FG001|Overall Study|Withdrawal by Subject|0|||
161521806|NCT00760929|583299694|FG002|Overall Study|Withdrawal by Subject|9|||
161521807|NCT00760929|583299695|FG003|Overall Study|Withdrawal by Subject|1|||
161521808|NCT00760929|583299692|FG000|Overall Study|Lost to Follow-up|0|||
161521809|NCT00760929|583299693|FG001|Overall Study|Lost to Follow-up|0|||
161521810|NCT00760929|583299694|FG002|Overall Study|Lost to Follow-up|1|||
161521811|NCT00760929|583299695|FG003|Overall Study|Lost to Follow-up|0|||
161521812|NCT00760929|583299692|FG000|Overall Study|Progression of Disease|21|||
161521813|NCT00760929|583299693|FG001|Overall Study|Progression of Disease|26|||
161521814|NCT00760929|583299694|FG002|Overall Study|Progression of Disease|38|||
161521815|NCT00760929|583299695|FG003|Overall Study|Progression of Disease|42|||
161521816|NCT00760929|583299692|FG000|Overall Study|Other|2|||
161521817|NCT00760929|583299693|FG001|Overall Study|Other|0|||
161521818|NCT00760929|583299694|FG002|Overall Study|Other|2|||
161521819|NCT00760929|583299695|FG003|Overall Study|Other|1|||
161521820|NCT00760929|583299692|FG000|Overall Study|Death|0|||
161521821|NCT00760929|583299693|FG001|Overall Study|Death|0|||
161521822|NCT00760929|583299694|FG002|Overall Study|Death|1|||
161521823|NCT00760929|583299695|FG003|Overall Study|Death|0|||
161521824|NCT00760929|583299692|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161521825|NCT00760929|583299693|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161521826|NCT00760929|583299694|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161521827|NCT00760929|583299695|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
161521828|NCT02099838|583299696|FG000|Overall Study|Death|1|||
161521829|NCT02099838|583299697|FG001|Overall Study|Death|0|||
161521830|NCT02099838|583299696|FG000|Overall Study|Lost to Follow-up|3|||
161521831|NCT02099838|583299697|FG001|Overall Study|Lost to Follow-up|1|||
161521832|NCT02099838|583299696|FG000|Overall Study|Withdrawal by Subject|0|||
161521833|NCT02099838|583299697|FG001|Overall Study|Withdrawal by Subject|1|||
161521834|NCT04121962|583299700|FG000|Overall Study|Lost to Follow-up|42|||
161521835|NCT04121962|583299701|FG001|Overall Study|Lost to Follow-up|39|||
161521836|NCT01175382|583299702|FG000|Overall Study|Lost to Follow-up|4|||
161521837|NCT01175382|583299703|FG001|Overall Study|Lost to Follow-up|3|||
161521838|NCT01175382|583299704|FG002|Overall Study|Lost to Follow-up|1|||
161521839|NCT01175382|583299702|FG000|Overall Study|Physician Decision|0|||
161521840|NCT01175382|583299703|FG001|Overall Study|Physician Decision|1|||
161521841|NCT01175382|583299704|FG002|Overall Study|Physician Decision|0|||
161521842|NCT01175382|583299702|FG000|Overall Study|Withdrawal by Subject|0|||
161521843|NCT01175382|583299703|FG001|Overall Study|Withdrawal by Subject|0|||
161521844|NCT01175382|583299704|FG002|Overall Study|Withdrawal by Subject|1|||
161521845|NCT01175382|583299702|FG000|Overall Study|No longer having problem|1|||
161521846|NCT01175382|583299703|FG001|Overall Study|No longer having problem|0|||
161521847|NCT01175382|583299704|FG002|Overall Study|No longer having problem|1|||
161521848|NCT01175382|583299702|FG000|Overall Study|Unable/unwilling to attend visits|3|||
161521849|NCT01175382|583299703|FG001|Overall Study|Unable/unwilling to attend visits|1|||
161521850|NCT01175382|583299704|FG002|Overall Study|Unable/unwilling to attend visits|2|||
161521851|NCT01175382|583299702|FG000|Overall Study|Unwilling to follow protocol|0|||
161521852|NCT01175382|583299703|FG001|Overall Study|Unwilling to follow protocol|1|||
161521853|NCT01175382|583299704|FG002|Overall Study|Unwilling to follow protocol|0|||
161521854|NCT01175382|583299702|FG000|Overall Study|Unable to tolerate study meds|0|||
161521855|NCT01175382|583299703|FG001|Overall Study|Unable to tolerate study meds|1|||
161521856|NCT01175382|583299704|FG002|Overall Study|Unable to tolerate study meds|1|||
161521857|NCT00774787|583299705|FG000|Overall Study|Lost to Follow-up|1|||
161521858|NCT02019719|583299706|FG000|Overall Study|Adverse Event|1|||
161521859|NCT02019719|583299707|FG001|Overall Study|Adverse Event|0|||
161521860|NCT02019719|583299708|FG002|Overall Study|Adverse Event|0|||
161521861|NCT02019719|583299709|FG003|Overall Study|Adverse Event|1|||
161521862|NCT02019719|583299710|FG004|Overall Study|Adverse Event|1|||
161521863|NCT02019719|583299706|FG000|Overall Study|Protocol Violation|1|||
161521864|NCT02019719|583299707|FG001|Overall Study|Protocol Violation|1|||
161521865|NCT02019719|583299708|FG002|Overall Study|Protocol Violation|0|||
161521866|NCT02019719|583299709|FG003|Overall Study|Protocol Violation|0|||
161825757|NCT00787605|584401894|FG001|Overall Study|Administrative Problems|0|||
161825758|NCT00787605|584401893|FG000|Overall Study|Adverse Event|14|||
161825759|NCT00787605|584401894|FG001|Overall Study|Adverse Event|25|||
161825760|NCT00787605|584401893|FG000|Overall Study|Lost to Follow-up|3|||
161521867|NCT02019719|583299710|FG004|Overall Study|Protocol Violation|0|||
161521868|NCT02019719|583299706|FG000|Overall Study|Protocol defined stopping criteria|2|||
161521869|NCT02019719|583299707|FG001|Overall Study|Protocol defined stopping criteria|0|||
161521870|NCT02019719|583299708|FG002|Overall Study|Protocol defined stopping criteria|0|||
161521871|NCT02019719|583299709|FG003|Overall Study|Protocol defined stopping criteria|1|||
161521872|NCT02019719|583299710|FG004|Overall Study|Protocol defined stopping criteria|1|||
161521873|NCT02019719|583299706|FG000|Overall Study|Physician Decision|2|||
161521874|NCT02019719|583299707|FG001|Overall Study|Physician Decision|0|||
161521875|NCT02019719|583299708|FG002|Overall Study|Physician Decision|0|||
161825761|NCT00787605|584401894|FG001|Overall Study|Lost to Follow-up|6|||
161521876|NCT02019719|583299709|FG003|Overall Study|Physician Decision|0|||
161521877|NCT02019719|583299710|FG004|Overall Study|Physician Decision|0|||
161521878|NCT04535037|583299711|FG000|Overall Study|Protocol Violation|1|||
161521879|NCT04535037|583299712|FG001|Overall Study|Protocol Violation|0|||
161825762|NCT00787605|584401893|FG000|Overall Study|Protocol Violation|7|||
161521880|NCT04535037|583299711|FG000|Overall Study|Withdrawal by Subject|8|||
161521881|NCT04535037|583299712|FG001|Overall Study|Withdrawal by Subject|9|||
161521882|NCT04535037|583299711|FG000|Overall Study|Migrated / moved from the study area|1|||
161521883|NCT04535037|583299712|FG001|Overall Study|Migrated / moved from the study area|4|||
161521884|NCT04535037|583299711|FG000|Overall Study|Other|2|||
161521885|NCT04535037|583299712|FG001|Overall Study|Other|5|||
161521886|NCT02031276|583299713|FG000|Period 1 Double-blind IV|Adverse Event|6|||
161521887|NCT02031276|583299714|FG001|Period 1 Double-blind IV|Adverse Event|5|||
161521888|NCT02031276|583299715|FG002|Period 1 Double-blind IV|Adverse Event|1|||
161521889|NCT02031276|583299713|FG000|Period 1 Double-blind IV|Other|0|||
161521890|NCT02031276|583299714|FG001|Period 1 Double-blind IV|Other|1|||
161521891|NCT02031276|583299715|FG002|Period 1 Double-blind IV|Other|0|||
161521892|NCT02031276|583299713|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
161521893|NCT02031276|583299714|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
161521894|NCT02031276|583299715|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
161521895|NCT02031276|583299713|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
161521896|NCT02031276|583299714|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
161521897|NCT02031276|583299715|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
161521898|NCT02031276|583299713|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
161521899|NCT02031276|583299714|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
161521900|NCT02031276|583299715|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
161521901|NCT02031276|583299713|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
161521902|NCT02031276|583299714|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
161521903|NCT02031276|583299715|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
161521904|NCT02031276|583299713|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
161521905|NCT02031276|583299714|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
161521906|NCT02031276|583299715|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
161521907|NCT02031276|583299713|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
161521908|NCT02031276|583299714|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
161589425|NCT03090152|583546459|FG000|Overall Study|Withdrawal by Subject|0|||
161589426|NCT03090152|583546460|FG001|Overall Study|Withdrawal by Subject|2|||
161589427|NCT03090152|583546461|FG002|Overall Study|Withdrawal by Subject|1|||
161589428|NCT03090152|583546459|FG000|Overall Study|Surgery Canceled|1|||
161589429|NCT03090152|583546460|FG001|Overall Study|Surgery Canceled|0|||
161589430|NCT03090152|583546461|FG002|Overall Study|Surgery Canceled|0|||
161589431|NCT03090152|583546459|FG000|Overall Study|Epidural catheter could not be placed|0|||
161589432|NCT03090152|583546460|FG001|Overall Study|Epidural catheter could not be placed|2|||
161589433|NCT03090152|583546461|FG002|Overall Study|Epidural catheter could not be placed|0|||
161589434|NCT04673929|583546462|FG000|Overall Study|Death|73|||
161589435|NCT04673929|583546462|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
161589436|NCT05082909|583546466|FG000|Overall Study|Protocol Violation|0|||
161589437|NCT05082909|583546467|FG001|Overall Study|Protocol Violation|0|||
161589438|NCT05082909|583546468|FG002|Overall Study|Protocol Violation|1|||
161589439|NCT05082909|583546469|FG003|Overall Study|Protocol Violation|0|||
161589440|NCT05082909|583546470|FG004|Overall Study|Protocol Violation|0|||
161589441|NCT05082909|583546471|FG005|Overall Study|Protocol Violation|0|||
161589442|NCT04088630|583546472|FG000|Overall Study|Lost to Follow-up|3|||
161589443|NCT04088630|583546473|FG001|Overall Study|Lost to Follow-up|2|||
161589444|NCT04088630|583546474|FG002|Overall Study|Lost to Follow-up|6|||
161589445|NCT04088630|583546472|FG000|Overall Study|Death|3|||
161589446|NCT04088630|583546473|FG001|Overall Study|Death|1|||
161589447|NCT04088630|583546474|FG002|Overall Study|Death|1|||
161589448|NCT04088630|583546472|FG000|Overall Study|Physician Decision|0|||
161589449|NCT04088630|583546473|FG001|Overall Study|Physician Decision|1|||
161589450|NCT04088630|583546474|FG002|Overall Study|Physician Decision|1|||
161589451|NCT03175029|583546477|FG000|Overall Study|Withdrawal by Subject|2|||
161589452|NCT03175029|583546478|FG001|Overall Study|Withdrawal by Subject|1|||
161589453|NCT03175029|583546477|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
161521909|NCT02031276|583299715|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
161521910|NCT02031276|583299713|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
161521911|NCT02031276|583299714|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
161589454|NCT03175029|583546478|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
161589455|NCT03338790|583546485|FG000|Overall Study|Disease Progression|65|||
161825763|NCT00787605|584401894|FG001|Overall Study|Protocol Violation|3|||
161589456|NCT03338790|583546486|FG001|Overall Study|Disease Progression|43|||
161589457|NCT03338790|583546487|FG002|Overall Study|Disease Progression|50|||
161589458|NCT03338790|583546488|FG003|Overall Study|Disease Progression|37|||
161589459|NCT03338790|583546485|FG000|Overall Study|Study Drug Toxicity|9|||
161589460|NCT03338790|583546486|FG001|Overall Study|Study Drug Toxicity|8|||
161825764|NCT00787605|584401893|FG000|Overall Study|Withdrawal by Subject|6|||
161825765|NCT00787605|584401894|FG001|Overall Study|Withdrawal by Subject|13|||
161825766|NCT00787605|584401893|FG000|Overall Study|Lack of Efficacy|13|||
161825767|NCT00787605|584401894|FG001|Overall Study|Lack of Efficacy|9|||
161825768|NCT01223027|584401895|FG000|Overall Study|Adverse Event|20|||
161521912|NCT02031276|583299715|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
161521913|NCT02417246|583299717|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
161521914|NCT02417246|583299718|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
161521915|NCT02417246|583299717|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
161521916|NCT02417246|583299718|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
161521917|NCT02417246|583299717|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
161521918|NCT02417246|583299718|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
161521919|NCT02417246|583299717|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
161521920|NCT02417246|583299718|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
161521921|NCT04408469|583299728|FG000|Overall Study|Lost to Follow-up|6|||
161677581|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
161677582|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
161677583|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Death|0|||
161677584|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Death|0|||
161677585|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Death|1|||
161677586|NCT01118325|583872034|FG000|Overall Study|Adverse Event|1|||
161677587|NCT01118325|583872035|FG001|Overall Study|Adverse Event|0|||
161677588|NCT01118325|583872036|FG002|Overall Study|Adverse Event|1|||
161677589|NCT00536809|583872037|FG000|Phase II|Adverse Event|1|||
161677590|NCT00536809|583872037|FG000|Phase II|Referred for surgical resection|1|||
161677591|NCT03334409|583872038|FG000|Overall Study|Did not meet inclusion criteria|1|||
161677592|NCT03334409|583872039|FG001|Overall Study|Did not meet inclusion criteria|0|||
161677593|NCT00233363|583872044|FG000|Overall Study|Adverse Event|1|||
161677594|NCT00233363|583872045|FG001|Overall Study|Adverse Event|2|||
161677595|NCT00233363|583872044|FG000|Overall Study|Lack of Efficacy|0|||
161677596|NCT00233363|583872045|FG001|Overall Study|Lack of Efficacy|2|||
161677597|NCT00233363|583872044|FG000|Overall Study|Withdrawal by Subject|1|||
161677598|NCT00233363|583872045|FG001|Overall Study|Withdrawal by Subject|1|||
161677599|NCT00233363|583872044|FG000|Overall Study|Aggravation of complication|1|||
161677600|NCT00233363|583872045|FG001|Overall Study|Aggravation of complication|0|||
161677601|NCT05215262|583872051|FG000|Overall Study|Lost to Follow-up|12|||
161677602|NCT05215262|583872052|FG001|Overall Study|Lost to Follow-up|0|||
161677603|NCT04880447|583872054|FG000|Overall Study|No vaccination information|1|||
161677604|NCT04880447|583872054|FG000|Overall Study|No adverse event information (missing information)|1|||
161677605|NCT04880447|583872054|FG000|Overall Study|Disease not covered in this study|35|||
161677606|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Adverse Event|1|||
161677607|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Adverse Event|1|||
161677608|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Adverse Event|1|||
161521922|NCT04408469|583299729|FG001|Overall Study|Lost to Follow-up|9|||
161521923|NCT04408469|583299728|FG000|Overall Study|Withdrawal by Subject|6|||
161521924|NCT04408469|583299729|FG001|Overall Study|Withdrawal by Subject|1|||
161521925|NCT04408469|583299728|FG000|Overall Study|Dismissal due to ineligibility|0|||
161521926|NCT04408469|583299729|FG001|Overall Study|Dismissal due to ineligibility|1|||
161677609|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Adverse Event|0|||
161677610|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Adverse Event|0|||
161677611|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Adverse Event|0|||
161521927|NCT04321460|583299730|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
161521928|NCT04321460|583299731|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
161677612|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Adverse Event|0|||
161677613|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Adverse Event|0|||
161677614|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161677615|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161825769|NCT01223027|584401896|FG001|Overall Study|Adverse Event|10|||
161825770|NCT01223027|584401895|FG000|Overall Study|Death|42|||
161825771|NCT01223027|584401896|FG001|Overall Study|Death|42|||
161825772|NCT01223027|584401895|FG000|Overall Study|Lost to Follow-up|2|||
161825773|NCT01223027|584401896|FG001|Overall Study|Lost to Follow-up|1|||
161825774|NCT01223027|584401895|FG000|Overall Study|Physician Decision|4|||
161825775|NCT01223027|584401896|FG001|Overall Study|Physician Decision|8|||
161825776|NCT01223027|584401895|FG000|Overall Study|Progressive Disease|167|||
161825777|NCT01223027|584401896|FG001|Overall Study|Progressive Disease|183|||
161825778|NCT01223027|584401895|FG000|Overall Study|Protocol Violation|2|||
161825779|NCT01223027|584401896|FG001|Overall Study|Protocol Violation|1|||
161825780|NCT01223027|584401895|FG000|Overall Study|Subject/guardian decicion|18|||
161825781|NCT01223027|584401896|FG001|Overall Study|Subject/guardian decicion|16|||
161825782|NCT01223027|584401895|FG000|Overall Study|New therapy for study indication|17|||
161825783|NCT01223027|584401896|FG001|Overall Study|New therapy for study indication|8|||
161825784|NCT01223027|584401895|FG000|Overall Study|Study terminated by sponsor|2|||
161825785|NCT01223027|584401896|FG001|Overall Study|Study terminated by sponsor|8|||
161825786|NCT03493919|584401897|FG000|Overall Study|Other|2|||
161825787|NCT03493919|584401898|FG001|Overall Study|Other|0|||
161825788|NCT03493919|584401899|FG002|Overall Study|Other|1|||
161521929|NCT03669081|583299734|FG000|Overall Study|Data could not be validated|1|||
161521930|NCT03669081|583299735|FG001|Overall Study|Data could not be validated|1|||
161521931|NCT01308749|583299740|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
161521932|NCT01308749|583299741|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
161521933|NCT01308749|583299740|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
161521934|NCT01308749|583299741|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
161521935|NCT01308749|583299740|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
161521936|NCT01308749|583299741|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
161521937|NCT02546544|583299742|FG000|Overall Study|Disease Progression|14|||
161521938|NCT02546544|583299742|FG000|Overall Study|Adverse Event|1|||
161521939|NCT02546544|583299742|FG000|Overall Study|Withdrawal by Subject|1|||
161521940|NCT01921348|583299743|FG000|Overall Study|Withdrawal by Subject|1|||
161521941|NCT01921348|583299744|FG001|Overall Study|Withdrawal by Subject|0|||
161521942|NCT01921348|583299743|FG000|Overall Study|Lost to Follow-up|0|||
161521943|NCT01921348|583299744|FG001|Overall Study|Lost to Follow-up|2|||
161521944|NCT02223390|583299745|FG000|Overall Study|Lost to Follow-up|9|||
161521945|NCT02223390|583299746|FG001|Overall Study|Lost to Follow-up|4|||
161521946|NCT01197950|583299752|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
161521947|NCT01197950|583299753|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
161521948|NCT01197950|583299754|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
161521949|NCT02553330|583299755|FG000|Overall Study|Study Terminated by Sponsor|2|||
161521950|NCT02553330|583299756|FG001|Overall Study|Study Terminated by Sponsor|13|||
161521951|NCT02553330|583299757|FG002|Overall Study|Study Terminated by Sponsor|12|||
161521952|NCT02553330|583299755|FG000|Overall Study|Withdrawal by Subject|3|||
161521953|NCT02553330|583299756|FG001|Overall Study|Withdrawal by Subject|19|||
161521954|NCT02553330|583299757|FG002|Overall Study|Withdrawal by Subject|21|||
161521955|NCT02553330|583299755|FG000|Overall Study|Other|0|||
161521956|NCT02553330|583299756|FG001|Overall Study|Other|1|||
161521957|NCT02553330|583299757|FG002|Overall Study|Other|0|||
161521958|NCT02553330|583299755|FG000|Overall Study|Non compliance to study treatment|0|||
161521959|NCT02553330|583299756|FG001|Overall Study|Non compliance to study treatment|1|||
161521960|NCT02553330|583299757|FG002|Overall Study|Non compliance to study treatment|0|||
161521961|NCT02553330|583299755|FG000|Overall Study|Adverse Event|0|||
161521962|NCT02553330|583299756|FG001|Overall Study|Adverse Event|1|||
161521963|NCT02553330|583299757|FG002|Overall Study|Adverse Event|0|||
161521964|NCT02553330|583299755|FG000|Overall Study|Lost to Follow-up|0|||
161521965|NCT02553330|583299756|FG001|Overall Study|Lost to Follow-up|4|||
161521966|NCT02553330|583299757|FG002|Overall Study|Lost to Follow-up|4|||
161521967|NCT02896855|583299758|FG000|Overall Study|Death|50|||
161589461|NCT03338790|583546487|FG002|Overall Study|Study Drug Toxicity|15|||
161589462|NCT03338790|583546488|FG003|Overall Study|Study Drug Toxicity|0|||
161589463|NCT03338790|583546485|FG000|Overall Study|Death|1|||
161589464|NCT03338790|583546486|FG001|Overall Study|Death|1|||
161589465|NCT03338790|583546487|FG002|Overall Study|Death|1|||
161521968|NCT02896855|583299759|FG001|Overall Study|Death|40|||
161521969|NCT02896855|583299758|FG000|Overall Study|Lost to Follow-up|15|||
161589466|NCT03338790|583546488|FG003|Overall Study|Death|0|||
161589467|NCT03338790|583546485|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
161589468|NCT03338790|583546486|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
161589469|NCT03338790|583546487|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
161589470|NCT03338790|583546488|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
161589471|NCT03338790|583546485|FG000|Overall Study|Participant request to discontinue study treatment|3|||
161589472|NCT03338790|583546486|FG001|Overall Study|Participant request to discontinue study treatment|3|||
161589473|NCT03338790|583546487|FG002|Overall Study|Participant request to discontinue study treatment|2|||
161589474|NCT03338790|583546488|FG003|Overall Study|Participant request to discontinue study treatment|1|||
161589475|NCT03338790|583546485|FG000|Overall Study|Poor/non-compliance|0|||
161589476|NCT03338790|583546486|FG001|Overall Study|Poor/non-compliance|1|||
161589477|NCT03338790|583546487|FG002|Overall Study|Poor/non-compliance|0|||
161589478|NCT03338790|583546488|FG003|Overall Study|Poor/non-compliance|0|||
161589479|NCT03338790|583546485|FG000|Overall Study|Participant withdrew consent|1|||
161677616|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161521970|NCT02896855|583299759|FG001|Overall Study|Lost to Follow-up|9|||
161521971|NCT02896855|583299758|FG000|Overall Study|Withdrawal by Subject|7|||
161521972|NCT02896855|583299759|FG001|Overall Study|Withdrawal by Subject|4|||
161521973|NCT01205685|583299760|FG000|Overall Study|Disease Progression|10|||
161521974|NCT01205685|583299760|FG000|Overall Study|Withdrawal by Subject|1|||
161521975|NCT02169674|583299761|FG000|Overall Study|Withdrawal by Subject|2|||
161521976|NCT02169674|583299762|FG001|Overall Study|Withdrawal by Subject|1|||
161521977|NCT02169674|583299761|FG000|Overall Study|Seroprotected|30|||
161589480|NCT03338790|583546486|FG001|Overall Study|Participant withdrew consent|0|||
161521978|NCT02169674|583299762|FG001|Overall Study|Seroprotected|76|||
161589481|NCT03338790|583546487|FG002|Overall Study|Participant withdrew consent|1|||
161589482|NCT03338790|583546488|FG003|Overall Study|Participant withdrew consent|1|||
161677617|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161677618|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677619|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677620|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677621|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677622|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677623|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161521979|NCT02169674|583299761|FG000|Overall Study|Lost to Follow-up|0|||
161521980|NCT02169674|583299762|FG001|Overall Study|Lost to Follow-up|1|||
161521981|NCT01666002|583299763|FG000|Overall Study|Lost to Follow-up|5|||
161521982|NCT01666002|583299764|FG001|Overall Study|Lost to Follow-up|0|||
161521983|NCT02511431|583299765|FG000|Treatment|Lost to Follow-up|0|||
161521984|NCT02511431|583299766|FG001|Treatment|Lost to Follow-up|0|||
161521985|NCT02511431|583299767|FG002|Treatment|Lost to Follow-up|1|||
161521986|NCT02511431|583299768|FG003|Treatment|Lost to Follow-up|0|||
161521987|NCT02511431|583299769|FG004|Treatment|Lost to Follow-up|0|||
161677624|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
161677625|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677626|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677627|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677628|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677629|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677630|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677631|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677632|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
161677633|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677634|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161825789|NCT03493919|584401900|FG003|Overall Study|Other|0|||
161825790|NCT03493919|584401897|FG000|Overall Study|Withdrawal by Subject|9|||
161825791|NCT03493919|584401898|FG001|Overall Study|Withdrawal by Subject|3|||
161825792|NCT03493919|584401899|FG002|Overall Study|Withdrawal by Subject|1|||
161825793|NCT03493919|584401900|FG003|Overall Study|Withdrawal by Subject|1|||
161825794|NCT03493919|584401897|FG000|Overall Study|Lost to Follow-up|5|||
161825795|NCT03493919|584401898|FG001|Overall Study|Lost to Follow-up|0|||
161825796|NCT03493919|584401899|FG002|Overall Study|Lost to Follow-up|0|||
161825797|NCT03493919|584401900|FG003|Overall Study|Lost to Follow-up|3|||
161825798|NCT03493919|584401897|FG000|Overall Study|Adverse Event|0|||
161825799|NCT03493919|584401898|FG001|Overall Study|Adverse Event|1|||
161825800|NCT03493919|584401899|FG002|Overall Study|Adverse Event|0|||
161825801|NCT03493919|584401900|FG003|Overall Study|Adverse Event|0|||
161825802|NCT01475487|584401901|FG000|Overall Study|had to leave early for personal reasons|2|||
161825803|NCT01475487|584401902|FG001|Overall Study|had to leave early for personal reasons|1|||
161825804|NCT04428645|584401903|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
161825805|NCT00401245|584403733|FG000|Double Blind Titration Phase|Adverse Event|3|||
161825806|NCT00401245|584403734|FG001|Double Blind Titration Phase|Adverse Event|2|||
161825807|NCT00401245|584403735|FG002|Double Blind Titration Phase|Adverse Event|5|||
161825808|NCT00401245|584403736|FG003|Double Blind Titration Phase|Adverse Event|12|||
161825809|NCT00401245|584403737|FG004|Double Blind Titration Phase|Adverse Event|0|||
161825810|NCT00401245|584403738|FG005|Double Blind Titration Phase|Adverse Event|0|||
161825811|NCT00401245|584403739|FG006|Double Blind Titration Phase|Adverse Event|0|||
161825812|NCT00401245|584403740|FG007|Double Blind Titration Phase|Adverse Event|0|||
161825813|NCT00401245|584403733|FG000|Double Blind Titration Phase|Other|0|||
161825814|NCT00401245|584403734|FG001|Double Blind Titration Phase|Other|0|||
161825815|NCT00401245|584403735|FG002|Double Blind Titration Phase|Other|1|||
161825816|NCT00401245|584403736|FG003|Double Blind Titration Phase|Other|0|||
161825817|NCT00401245|584403737|FG004|Double Blind Titration Phase|Other|0|||
161825818|NCT00401245|584403738|FG005|Double Blind Titration Phase|Other|0|||
161825819|NCT00401245|584403739|FG006|Double Blind Titration Phase|Other|0|||
161825820|NCT00401245|584403740|FG007|Double Blind Titration Phase|Other|0|||
161825821|NCT00401245|584403733|FG000|Double Blind Titration Phase|Protocol Violation|0|||
161825822|NCT00401245|584403734|FG001|Double Blind Titration Phase|Protocol Violation|0|||
161825823|NCT00401245|584403735|FG002|Double Blind Titration Phase|Protocol Violation|0|||
161825824|NCT00401245|584403736|FG003|Double Blind Titration Phase|Protocol Violation|1|||
161825825|NCT00401245|584403737|FG004|Double Blind Titration Phase|Protocol Violation|0|||
161825826|NCT00401245|584403738|FG005|Double Blind Titration Phase|Protocol Violation|0|||
161825827|NCT00401245|584403739|FG006|Double Blind Titration Phase|Protocol Violation|0|||
161825828|NCT00401245|584403740|FG007|Double Blind Titration Phase|Protocol Violation|0|||
161825829|NCT00401245|584403733|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
161825830|NCT00401245|584403734|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
161825831|NCT00401245|584403735|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
161521988|NCT02511431|583299770|FG005|Treatment|Lost to Follow-up|1|||
161521989|NCT03525834|583299789|FG000|Overall Study|Progressive disease|1|||
161521990|NCT00346034|583299792|FG000|Overall Study|Adverse Event|34|||
161521991|NCT00346034|583299792|FG000|Overall Study|Lack of Efficacy|8|||
161521992|NCT00346034|583299792|FG000|Overall Study|Withdrawal by Subject|13|||
161521993|NCT00346034|583299792|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
161521994|NCT00346034|583299792|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
161521995|NCT00941603|583299793|FG000|Overall Study|Adverse Event|10|||
161521996|NCT00941603|583299794|FG001|Overall Study|Adverse Event|15|||
161521997|NCT00941603|583299795|FG002|Overall Study|Adverse Event|5|||
161521998|NCT00941603|583299796|FG003|Overall Study|Adverse Event|1|||
161521999|NCT00941603|583299797|FG004|Overall Study|Adverse Event|4|||
161522000|NCT00941603|583299798|FG005|Overall Study|Adverse Event|0|||
161522001|NCT00941603|583299793|FG000|Overall Study|Lost to Follow-up|0|||
161522002|NCT00941603|583299794|FG001|Overall Study|Lost to Follow-up|0|||
161522003|NCT00941603|583299795|FG002|Overall Study|Lost to Follow-up|0|||
161522004|NCT00941603|583299796|FG003|Overall Study|Lost to Follow-up|1|||
161522005|NCT00941603|583299797|FG004|Overall Study|Lost to Follow-up|0|||
161522006|NCT00941603|583299798|FG005|Overall Study|Lost to Follow-up|2|||
161522007|NCT00941603|583299793|FG000|Overall Study|Withdrawal by Subject|0|||
161522008|NCT00941603|583299794|FG001|Overall Study|Withdrawal by Subject|0|||
161522009|NCT00941603|583299795|FG002|Overall Study|Withdrawal by Subject|0|||
161522010|NCT00941603|583299796|FG003|Overall Study|Withdrawal by Subject|2|||
161522011|NCT00941603|583299797|FG004|Overall Study|Withdrawal by Subject|0|||
161522012|NCT00941603|583299798|FG005|Overall Study|Withdrawal by Subject|1|||
161522013|NCT00941603|583299793|FG000|Overall Study|Protocol Violation|0|||
161522014|NCT00941603|583299794|FG001|Overall Study|Protocol Violation|1|||
161522015|NCT00941603|583299795|FG002|Overall Study|Protocol Violation|0|||
161522016|NCT00941603|583299796|FG003|Overall Study|Protocol Violation|0|||
161522017|NCT00941603|583299797|FG004|Overall Study|Protocol Violation|0|||
161522018|NCT00941603|583299798|FG005|Overall Study|Protocol Violation|0|||
161522019|NCT00941603|583299793|FG000|Overall Study|Did not meet protocol eligibility|1|||
161522020|NCT00941603|583299794|FG001|Overall Study|Did not meet protocol eligibility|0|||
161522021|NCT00941603|583299795|FG002|Overall Study|Did not meet protocol eligibility|0|||
161522022|NCT00941603|583299796|FG003|Overall Study|Did not meet protocol eligibility|0|||
161522023|NCT00941603|583299797|FG004|Overall Study|Did not meet protocol eligibility|0|||
161522024|NCT00941603|583299798|FG005|Overall Study|Did not meet protocol eligibility|0|||
161522025|NCT01732835|583299802|FG000|6-month Primary Endpoint|Did not receive device|19|||
161522026|NCT01732835|583299802|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
161522027|NCT01732835|583299802|FG000|6-month Primary Endpoint|Adverse Event|3|||
161522028|NCT01732835|583299802|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
161522029|NCT01732835|583299802|FG000|2-year Extended Follow-up|Adverse Event|3|||
161522030|NCT01732835|583299802|FG000|2-year Extended Follow-up|Death|1|||
161522031|NCT04827576|583301740|FG000|Overall Study|Death|5|||
161522032|NCT04827576|583301741|FG001|Overall Study|Death|17|||
161522033|NCT04827576|583301742|FG002|Overall Study|Death|17|||
161522034|NCT04827576|583301743|FG003|Overall Study|Death|32|||
161522035|NCT04827576|583301740|FG000|Overall Study|Study Terminated by Sponsor|2|||
161522036|NCT04827576|583301741|FG001|Overall Study|Study Terminated by Sponsor|9|||
161522037|NCT04827576|583301742|FG002|Overall Study|Study Terminated by Sponsor|7|||
161522038|NCT04827576|583301743|FG003|Overall Study|Study Terminated by Sponsor|5|||
161522039|NCT04827576|583301740|FG000|Overall Study|Investigator's Discretion|1|||
161522040|NCT04827576|583301741|FG001|Overall Study|Investigator's Discretion|0|||
161522041|NCT04827576|583301742|FG002|Overall Study|Investigator's Discretion|2|||
161522042|NCT04827576|583301743|FG003|Overall Study|Investigator's Discretion|5|||
161522043|NCT04827576|583301740|FG000|Overall Study|Withdrew Consent|0|||
161522044|NCT04827576|583301741|FG001|Overall Study|Withdrew Consent|3|||
161522045|NCT04827576|583301742|FG002|Overall Study|Withdrew Consent|0|||
161522046|NCT04827576|583301743|FG003|Overall Study|Withdrew Consent|0|||
161522047|NCT04827576|583301740|FG000|Overall Study|Lost to Follow-up|1|||
161522048|NCT04827576|583301741|FG001|Overall Study|Lost to Follow-up|0|||
161522049|NCT04827576|583301742|FG002|Overall Study|Lost to Follow-up|0|||
161522050|NCT04827576|583301743|FG003|Overall Study|Lost to Follow-up|0|||
161522051|NCT00791765|583301744|FG000|Weeks 1 to 12|Adverse Event|0|||
161522052|NCT00791765|583301745|FG001|Weeks 1 to 12|Adverse Event|1|||
161522053|NCT00791765|583301744|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
161522054|NCT00791765|583301745|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
161522055|NCT00791765|583301744|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
161522056|NCT00791765|583301745|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
161522057|NCT00791765|583301744|FG000|Weeks 1 to 12|Physician Decision|1|||
161522058|NCT00791765|583301745|FG001|Weeks 1 to 12|Physician Decision|0|||
161522059|NCT00791765|583301744|FG000|Weeks 1 to 12|Disease progression|3|||
161522060|NCT00791765|583301745|FG001|Weeks 1 to 12|Disease progression|0|||
161522061|NCT00791765|583301744|FG000|Weeks 1 to 12|Ineligibility determined|0|||
161522062|NCT00791765|583301745|FG001|Weeks 1 to 12|Ineligibility determined|3|||
161522063|NCT00791765|583301744|FG000|Weeks 13 to 24|Protocol deviation|2|||
161522064|NCT00791765|583301745|FG001|Weeks 13 to 24|Protocol deviation|0|||
161522065|NCT00791765|583301744|FG000|Weeks 13 to 24|Adverse Event|0|||
161522066|NCT00791765|583301745|FG001|Weeks 13 to 24|Adverse Event|3|||
161522067|NCT00791765|583301744|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
161522068|NCT00791765|583301745|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
161522069|NCT00791765|583301744|FG000|Weeks 13 to 24|Disease progression|0|||
161522070|NCT00791765|583301745|FG001|Weeks 13 to 24|Disease progression|1|||
161522071|NCT00791765|583301744|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
161522072|NCT00791765|583301745|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
161522073|NCT00791765|583301744|FG000|Weeks 13 to 24|Other|0|||
161522074|NCT00791765|583301745|FG001|Weeks 13 to 24|Other|1|||
161522075|NCT04295564|583301746|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
161522076|NCT04295564|583301747|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
161522077|NCT04537923|583301748|FG000|Overall Study|Adverse Event|2|||
161522078|NCT04537923|583301749|FG001|Overall Study|Adverse Event|1|||
161522079|NCT04537923|583301750|FG002|Overall Study|Adverse Event|2|||
161522080|NCT04537923|583301751|FG003|Overall Study|Adverse Event|4|||
161522081|NCT04537923|583301748|FG000|Overall Study|Death|3|||
161522082|NCT04537923|583301749|FG001|Overall Study|Death|3|||
161522083|NCT04537923|583301750|FG002|Overall Study|Death|1|||
161522084|NCT04537923|583301751|FG003|Overall Study|Death|11|||
161522085|NCT04537923|583301748|FG000|Overall Study|Lost to Follow-up|1|||
161522086|NCT04537923|583301749|FG001|Overall Study|Lost to Follow-up|2|||
161522087|NCT04537923|583301750|FG002|Overall Study|Lost to Follow-up|1|||
161825832|NCT00401245|584403736|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
161825833|NCT00401245|584403737|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825834|NCT00401245|584403738|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825835|NCT00401245|584403739|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825836|NCT00401245|584403740|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825837|NCT00401245|584403733|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825838|NCT00401245|584403734|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
161825839|NCT00401245|584403735|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825840|NCT00401245|584403736|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
161825841|NCT00401245|584403737|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825842|NCT00401245|584403738|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825843|NCT00401245|584403739|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825844|NCT00401245|584403740|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825845|NCT00401245|584403733|FG000|Open Label Phase|Adverse Event|5|||
161825846|NCT00401245|584403734|FG001|Open Label Phase|Adverse Event|14|||
161825847|NCT00401245|584403735|FG002|Open Label Phase|Adverse Event|6|||
161825848|NCT00401245|584403736|FG003|Open Label Phase|Adverse Event|7|||
161825849|NCT00401245|584403737|FG004|Open Label Phase|Adverse Event|0|||
161825850|NCT00401245|584403738|FG005|Open Label Phase|Adverse Event|0|||
161825851|NCT00401245|584403739|FG006|Open Label Phase|Adverse Event|0|||
161825852|NCT00401245|584403740|FG007|Open Label Phase|Adverse Event|0|||
161825853|NCT00401245|584403733|FG000|Open Label Phase|Lost to Follow-up|5|||
161825854|NCT00401245|584403734|FG001|Open Label Phase|Lost to Follow-up|7|||
161825855|NCT00401245|584403735|FG002|Open Label Phase|Lost to Follow-up|5|||
161825856|NCT00401245|584403736|FG003|Open Label Phase|Lost to Follow-up|4|||
161825857|NCT00401245|584403737|FG004|Open Label Phase|Lost to Follow-up|0|||
161825858|NCT00401245|584403738|FG005|Open Label Phase|Lost to Follow-up|0|||
161825859|NCT00401245|584403739|FG006|Open Label Phase|Lost to Follow-up|0|||
161825860|NCT00401245|584403740|FG007|Open Label Phase|Lost to Follow-up|0|||
161825861|NCT00401245|584403733|FG000|Open Label Phase|Other|4|||
161825862|NCT00401245|584403734|FG001|Open Label Phase|Other|8|||
161825863|NCT00401245|584403735|FG002|Open Label Phase|Other|7|||
161825864|NCT00401245|584403736|FG003|Open Label Phase|Other|8|||
161825865|NCT00401245|584403737|FG004|Open Label Phase|Other|0|||
161825866|NCT00401245|584403738|FG005|Open Label Phase|Other|0|||
161825867|NCT00401245|584403739|FG006|Open Label Phase|Other|0|||
161825868|NCT00401245|584403740|FG007|Open Label Phase|Other|0|||
161825869|NCT00401245|584403733|FG000|Open Label Phase|Protocol Violation|0|||
161825870|NCT00401245|584403734|FG001|Open Label Phase|Protocol Violation|1|||
161825871|NCT00401245|584403735|FG002|Open Label Phase|Protocol Violation|0|||
161825872|NCT00401245|584403736|FG003|Open Label Phase|Protocol Violation|1|||
161825873|NCT00401245|584403737|FG004|Open Label Phase|Protocol Violation|0|||
161825874|NCT00401245|584403738|FG005|Open Label Phase|Protocol Violation|0|||
161825875|NCT00401245|584403739|FG006|Open Label Phase|Protocol Violation|0|||
161825876|NCT00401245|584403740|FG007|Open Label Phase|Protocol Violation|0|||
161825877|NCT00401245|584403733|FG000|Open Label Phase|Withdrawal by Subject|3|||
161825878|NCT00401245|584403734|FG001|Open Label Phase|Withdrawal by Subject|3|||
161825879|NCT00401245|584403735|FG002|Open Label Phase|Withdrawal by Subject|2|||
161825880|NCT00401245|584403736|FG003|Open Label Phase|Withdrawal by Subject|1|||
161825881|NCT00401245|584403737|FG004|Open Label Phase|Withdrawal by Subject|0|||
161825882|NCT00401245|584403738|FG005|Open Label Phase|Withdrawal by Subject|0|||
161825883|NCT00401245|584403739|FG006|Open Label Phase|Withdrawal by Subject|0|||
161825884|NCT00401245|584403740|FG007|Open Label Phase|Withdrawal by Subject|0|||
161825885|NCT00401245|584403733|FG000|Open Label Phase|Lack of Efficacy|4|||
161825886|NCT00401245|584403734|FG001|Open Label Phase|Lack of Efficacy|2|||
161825887|NCT00401245|584403735|FG002|Open Label Phase|Lack of Efficacy|3|||
161522088|NCT04537923|583301751|FG003|Overall Study|Lost to Follow-up|6|||
161522089|NCT04537923|583301748|FG000|Overall Study|Physician Decision|1|||
161522090|NCT04537923|583301749|FG001|Overall Study|Physician Decision|0|||
161522091|NCT04537923|583301750|FG002|Overall Study|Physician Decision|2|||
161522092|NCT04537923|583301751|FG003|Overall Study|Physician Decision|5|||
161522093|NCT04537923|583301748|FG000|Overall Study|Pregnancy|1|||
161522094|NCT04537923|583301749|FG001|Overall Study|Pregnancy|0|||
161522095|NCT04537923|583301750|FG002|Overall Study|Pregnancy|0|||
161522096|NCT04537923|583301751|FG003|Overall Study|Pregnancy|0|||
161522097|NCT04537923|583301748|FG000|Overall Study|Withdrawal by Subject|4|||
161522098|NCT04537923|583301749|FG001|Overall Study|Withdrawal by Subject|4|||
161522099|NCT04537923|583301750|FG002|Overall Study|Withdrawal by Subject|4|||
161522100|NCT04537923|583301751|FG003|Overall Study|Withdrawal by Subject|58|||
161522101|NCT04537923|583301748|FG000|Overall Study|Missed study visits|2|||
161522102|NCT04537923|583301749|FG001|Overall Study|Missed study visits|0|||
161522103|NCT04537923|583301750|FG002|Overall Study|Missed study visits|0|||
161522104|NCT04537923|583301751|FG003|Overall Study|Missed study visits|3|||
161522105|NCT04537923|583301748|FG000|Overall Study|Sponsor's decision|0|||
161522106|NCT04537923|583301749|FG001|Overall Study|Sponsor's decision|0|||
161522107|NCT04537923|583301750|FG002|Overall Study|Sponsor's decision|1|||
161522108|NCT04537923|583301751|FG003|Overall Study|Sponsor's decision|1|||
161522109|NCT04537923|583301748|FG000|Overall Study|Safety reasons|1|||
161522110|NCT04537923|583301749|FG001|Overall Study|Safety reasons|0|||
161522111|NCT04537923|583301750|FG002|Overall Study|Safety reasons|0|||
161522112|NCT04537923|583301751|FG003|Overall Study|Safety reasons|0|||
161522113|NCT01261611|583301752|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
161522114|NCT01261611|583301753|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
161522115|NCT01261611|583301754|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
161522116|NCT01261611|583301752|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
161522117|NCT01261611|583301753|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
161522118|NCT01261611|583301754|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
161522119|NCT01261611|583301752|FG000|Treatment Cycle 1|Adverse Event|0|||
161522120|NCT01261611|583301753|FG001|Treatment Cycle 1|Adverse Event|1|||
161522121|NCT01261611|583301754|FG002|Treatment Cycle 1|Adverse Event|0|||
161522122|NCT01261611|583301752|FG000|Treatment Cycle 1|Protocol Violation|0|||
161522123|NCT01261611|583301753|FG001|Treatment Cycle 1|Protocol Violation|0|||
161522124|NCT01261611|583301754|FG002|Treatment Cycle 1|Protocol Violation|2|||
161522125|NCT01261611|583301752|FG000|Treatment Cycle 2|Completed study|4|||
161522126|NCT01261611|583301753|FG001|Treatment Cycle 2|Completed study|0|||
161522127|NCT01261611|583301754|FG002|Treatment Cycle 2|Completed study|0|||
161522128|NCT01261611|583301752|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
161522129|NCT01261611|583301753|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
161522130|NCT01261611|583301754|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
161522131|NCT01261611|583301752|FG000|Treatment Cycle 2|Adverse Event|1|||
161522132|NCT01261611|583301753|FG001|Treatment Cycle 2|Adverse Event|0|||
161522133|NCT01261611|583301754|FG002|Treatment Cycle 2|Adverse Event|0|||
161522134|NCT01261611|583301752|FG000|Treatment Cycle 2|Protocol Violation|2|||
161522135|NCT01261611|583301753|FG001|Treatment Cycle 2|Protocol Violation|0|||
161522136|NCT01261611|583301754|FG002|Treatment Cycle 2|Protocol Violation|0|||
161522137|NCT01261611|583301752|FG000|Treatment Cycle 2|Not otherwise specified|2|||
161522138|NCT01261611|583301753|FG001|Treatment Cycle 2|Not otherwise specified|0|||
161522139|NCT01261611|583301754|FG002|Treatment Cycle 2|Not otherwise specified|0|||
161522140|NCT01261611|583301752|FG000|Treatment Cycle 3|Completed study|24|||
161522141|NCT01261611|583301753|FG001|Treatment Cycle 3|Completed study|0|||
161522142|NCT01261611|583301754|FG002|Treatment Cycle 3|Completed study|0|||
161522143|NCT01261611|583301752|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
161522144|NCT01261611|583301753|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
161522145|NCT01261611|583301754|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
161522146|NCT01261611|583301752|FG000|Treatment Cycle 3|Adverse Event|1|||
161522147|NCT01261611|583301753|FG001|Treatment Cycle 3|Adverse Event|0|||
161522148|NCT01261611|583301754|FG002|Treatment Cycle 3|Adverse Event|0|||
161522149|NCT01261611|583301752|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
161522150|NCT01261611|583301753|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
161522151|NCT01261611|583301754|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
161522152|NCT01261611|583301752|FG000|Treatment Cycle 4|Completed study|87|||
161825888|NCT00401245|584403736|FG003|Open Label Phase|Lack of Efficacy|0|||
161825889|NCT00401245|584403737|FG004|Open Label Phase|Lack of Efficacy|0|||
161522153|NCT01261611|583301753|FG001|Treatment Cycle 4|Completed study|0|||
161522154|NCT01261611|583301754|FG002|Treatment Cycle 4|Completed study|0|||
161522155|NCT01261611|583301752|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
161825890|NCT00401245|584403738|FG005|Open Label Phase|Lack of Efficacy|0|||
161825891|NCT00401245|584403739|FG006|Open Label Phase|Lack of Efficacy|0|||
161825892|NCT00401245|584403740|FG007|Open Label Phase|Lack of Efficacy|0|||
161825893|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Adverse Event|0|||
161825894|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Adverse Event|0|||
161522156|NCT01261611|583301753|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
161825895|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Adverse Event|0|||
161825896|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Adverse Event|0|||
161825897|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Adverse Event|1|||
161825898|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Adverse Event|1|||
161825899|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Adverse Event|2|||
161825900|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Adverse Event|4|||
161825901|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Investigator request|0|||
161825902|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Investigator request|0|||
161825903|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Investigator request|0|||
161825904|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Investigator request|0|||
161825905|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Investigator request|0|||
161825906|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Investigator request|0|||
161825907|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Investigator request|0|||
161825908|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Investigator request|1|||
161825909|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Other|0|||
161825910|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Other|0|||
161825911|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Other|0|||
161825912|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Other|0|||
161825913|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Other|1|||
161825914|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Other|0|||
161825915|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Other|2|||
161825916|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Other|2|||
161825917|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825918|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825919|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161522157|NCT01261611|583301754|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
161522158|NCT01261611|583301752|FG000|Treatment Cycle 4|Adverse Event|1|||
161522159|NCT01261611|583301753|FG001|Treatment Cycle 4|Adverse Event|0|||
161522160|NCT01261611|583301754|FG002|Treatment Cycle 4|Adverse Event|0|||
161522161|NCT01261611|583301752|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
161522162|NCT01261611|583301753|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
161522163|NCT01261611|583301754|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
161522164|NCT01261611|583301752|FG000|Treatment Cycle 4|Not otherwise specified|3|||
161522165|NCT01261611|583301753|FG001|Treatment Cycle 4|Not otherwise specified|0|||
161522166|NCT01261611|583301754|FG002|Treatment Cycle 4|Not otherwise specified|0|||
161522167|NCT01261611|583301752|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
161522168|NCT01261611|583301753|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
161522169|NCT01261611|583301754|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
161522170|NCT01261611|583301752|FG000|Treatment Cycle 5|Adverse Event|1|||
161522171|NCT01261611|583301753|FG001|Treatment Cycle 5|Adverse Event|0|||
161522172|NCT01261611|583301754|FG002|Treatment Cycle 5|Adverse Event|0|||
161522173|NCT01261611|583301752|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
161522174|NCT01261611|583301753|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
161522175|NCT01261611|583301754|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
161522176|NCT02527798|583301755|FG000|Overall Study|Physician Decision|1|||
161522177|NCT02527798|583301756|FG001|Overall Study|Physician Decision|0|||
161522178|NCT02527798|583301757|FG002|Overall Study|Physician Decision|1|||
161522179|NCT02527798|583301758|FG003|Overall Study|Physician Decision|1|||
161522180|NCT02527798|583301759|FG004|Overall Study|Physician Decision|0|||
161522181|NCT02527798|583301760|FG005|Overall Study|Physician Decision|0|||
161522182|NCT02527798|583301755|FG000|Overall Study|Death|0|||
161522183|NCT02527798|583301756|FG001|Overall Study|Death|0|||
161522184|NCT02527798|583301757|FG002|Overall Study|Death|1|||
161522185|NCT02527798|583301758|FG003|Overall Study|Death|0|||
161522186|NCT02527798|583301759|FG004|Overall Study|Death|0|||
161522187|NCT02527798|583301760|FG005|Overall Study|Death|0|||
161522188|NCT02527798|583301755|FG000|Overall Study|Withdrawal by Subject|0|||
161522189|NCT02527798|583301756|FG001|Overall Study|Withdrawal by Subject|1|||
161522190|NCT02527798|583301757|FG002|Overall Study|Withdrawal by Subject|2|||
161522191|NCT02527798|583301758|FG003|Overall Study|Withdrawal by Subject|0|||
161522192|NCT02527798|583301759|FG004|Overall Study|Withdrawal by Subject|0|||
161522193|NCT02527798|583301760|FG005|Overall Study|Withdrawal by Subject|0|||
161522194|NCT02527798|583301755|FG000|Overall Study|Reason undisclosed|1|||
161522195|NCT02527798|583301756|FG001|Overall Study|Reason undisclosed|0|||
161825920|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825921|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
161522196|NCT02527798|583301757|FG002|Overall Study|Reason undisclosed|1|||
161522197|NCT02527798|583301758|FG003|Overall Study|Reason undisclosed|0|||
161522198|NCT02527798|583301759|FG004|Overall Study|Reason undisclosed|0|||
161522199|NCT02527798|583301760|FG005|Overall Study|Reason undisclosed|0|||
161825922|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
161825923|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
161825924|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825925|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825926|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825927|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
161934334|NCT05259722|584808476|FG000|Overall Study|Not exposed to IMP|1|||
161934335|NCT05259722|584808477|FG001|Overall Study|Not exposed to IMP|12|||
161934336|NCT05259722|584808476|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
161934337|NCT05259722|584808477|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
161934338|NCT00962650|584808478|FG000|Overall Study|Transgastric DP was not completed|2|||
161934339|NCT00231465|584808479|FG000|Overall Study|Completed only one cycle|1|||
161934340|NCT00231465|584808479|FG000|Overall Study|Did not have follow up CT scans|1|||
161522200|NCT02527798|583301755|FG000|Overall Study|Did not receive intervention|1|||
161522201|NCT02527798|583301756|FG001|Overall Study|Did not receive intervention|1|||
161522202|NCT02527798|583301757|FG002|Overall Study|Did not receive intervention|0|||
161522203|NCT02527798|583301758|FG003|Overall Study|Did not receive intervention|0|||
161522204|NCT02527798|583301759|FG004|Overall Study|Did not receive intervention|0|||
161522205|NCT02527798|583301760|FG005|Overall Study|Did not receive intervention|0|||
161522206|NCT03859323|583301762|FG000|Overall Study|Lost to Follow-up|0|||
161522207|NCT03859323|583301763|FG001|Overall Study|Lost to Follow-up|0|||
161522208|NCT03859323|583301764|FG002|Overall Study|Lost to Follow-up|0|||
161522209|NCT03859323|583301765|FG003|Overall Study|Lost to Follow-up|0|||
161522210|NCT03859323|583301766|FG004|Overall Study|Lost to Follow-up|0|||
161522211|NCT03859323|583301767|FG005|Overall Study|Lost to Follow-up|0|||
161522212|NCT03859323|583301768|FG006|Overall Study|Lost to Follow-up|1|||
161522213|NCT03859323|583301769|FG007|Overall Study|Lost to Follow-up|0|||
161522214|NCT03859323|583301770|FG008|Overall Study|Lost to Follow-up|0|||
161522215|NCT03859323|583301771|FG009|Overall Study|Lost to Follow-up|0|||
161522216|NCT03859323|583301772|FG010|Overall Study|Lost to Follow-up|0|||
161522217|NCT03859323|583301773|FG011|Overall Study|Lost to Follow-up|0|||
161522218|NCT03859323|583301774|FG012|Overall Study|Lost to Follow-up|0|||
161522219|NCT03859323|583301762|FG000|Overall Study|Withdrawal by Subject|0|||
161522220|NCT03859323|583301763|FG001|Overall Study|Withdrawal by Subject|0|||
161522221|NCT03859323|583301764|FG002|Overall Study|Withdrawal by Subject|1|||
161522222|NCT03859323|583301765|FG003|Overall Study|Withdrawal by Subject|0|||
161522223|NCT03859323|583301766|FG004|Overall Study|Withdrawal by Subject|0|||
161522224|NCT03859323|583301767|FG005|Overall Study|Withdrawal by Subject|1|||
161522225|NCT03859323|583301768|FG006|Overall Study|Withdrawal by Subject|0|||
161522226|NCT03859323|583301769|FG007|Overall Study|Withdrawal by Subject|0|||
161522227|NCT03859323|583301770|FG008|Overall Study|Withdrawal by Subject|0|||
161522228|NCT03859323|583301771|FG009|Overall Study|Withdrawal by Subject|1|||
161934341|NCT00420056|584808480|FG000|Overall Study|Objective progression or relapse|17|||
161522229|NCT03859323|583301772|FG010|Overall Study|Withdrawal by Subject|1|||
161522230|NCT03859323|583301773|FG011|Overall Study|Withdrawal by Subject|2|||
161522231|NCT03859323|583301774|FG012|Overall Study|Withdrawal by Subject|1|||
161522232|NCT03859323|583301762|FG000|Overall Study|Pregnancy|0|||
161522233|NCT03859323|583301763|FG001|Overall Study|Pregnancy|0|||
161522234|NCT03859323|583301764|FG002|Overall Study|Pregnancy|0|||
161522235|NCT03859323|583301765|FG003|Overall Study|Pregnancy|0|||
161522236|NCT03859323|583301766|FG004|Overall Study|Pregnancy|0|||
161522237|NCT03859323|583301767|FG005|Overall Study|Pregnancy|0|||
161522238|NCT03859323|583301768|FG006|Overall Study|Pregnancy|0|||
161522239|NCT03859323|583301769|FG007|Overall Study|Pregnancy|0|||
161522240|NCT03859323|583301770|FG008|Overall Study|Pregnancy|0|||
161522241|NCT03859323|583301771|FG009|Overall Study|Pregnancy|1|||
161522242|NCT03859323|583301772|FG010|Overall Study|Pregnancy|0|||
161522243|NCT03859323|583301773|FG011|Overall Study|Pregnancy|0|||
161522244|NCT03859323|583301774|FG012|Overall Study|Pregnancy|0|||
161522245|NCT01682460|583301776|FG000|Overall Study|Withdrawal by Subject|2|||
161522246|NCT01682460|583301776|FG000|Overall Study|Did not meet inclusion criteria|2|||
161522247|NCT01808690|583301780|FG000|Overall Study|Withdrawal by Subject|1|||
161522248|NCT01808690|583301781|FG001|Overall Study|Withdrawal by Subject|2|||
161522249|NCT02891187|583301782|FG000|Overall Study|Lost to Follow-up|1|||
161522250|NCT02891187|583301783|FG001|Overall Study|Lost to Follow-up|2|||
161522251|NCT00674986|583301784|FG000|Overall Study|Adverse Event|2|||
161522252|NCT00674986|583301785|FG001|Overall Study|Adverse Event|1|||
161522253|NCT00674986|583301784|FG000|Overall Study|Subject withdrew consent|12|||
161522254|NCT00674986|583301785|FG001|Overall Study|Subject withdrew consent|19|||
161522255|NCT00674986|583301784|FG000|Overall Study|Lost to Follow-up|25|||
161522256|NCT00674986|583301785|FG001|Overall Study|Lost to Follow-up|53|||
161522257|NCT00674986|583301784|FG000|Overall Study|Other reasons|4|||
161522258|NCT00674986|583301785|FG001|Overall Study|Other reasons|8|||
161522259|NCT00377234|583301786|FG000|Overall Study|Adverse Event|14|||
161522260|NCT00377234|583301787|FG001|Overall Study|Adverse Event|17|||
161522261|NCT00377234|583301786|FG000|Overall Study|Withdrawal by Subject|11|||
161522262|NCT00377234|583301787|FG001|Overall Study|Withdrawal by Subject|9|||
161522263|NCT00377234|583301786|FG000|Overall Study|Lost to Follow-up|4|||
161522264|NCT00377234|583301787|FG001|Overall Study|Lost to Follow-up|2|||
161522265|NCT00377234|583301786|FG000|Overall Study|Administrative|2|||
161522266|NCT00377234|583301787|FG001|Overall Study|Administrative|1|||
161522267|NCT00377234|583301786|FG000|Overall Study|Not assigned|3|||
161522268|NCT00377234|583301787|FG001|Overall Study|Not assigned|2|||
161934342|NCT03072875|584808483|FG000|Overall Study|Lost to Follow-up|1|||
161522269|NCT02053350|583301794|FG000|Overall Study|Withdrawal by Subject|1|||
161522270|NCT02053350|583301794|FG000|Overall Study|Adverse Event|4|||
161522271|NCT01275625|583301795|FG000|Overall Study|Death|1|||
161522272|NCT01275625|583301795|FG000|Overall Study|Lack of Efficacy|2|||
161522273|NCT01275625|583301795|FG000|Overall Study|Lost to Follow-up|1|||
161522274|NCT01275625|583301795|FG000|Overall Study|Withdrawal by Subject|3|||
161522275|NCT01275625|583301795|FG000|Overall Study|Protocol Violation|1|||
161934343|NCT03111732|584808484|FG000|Overall Study|Enrolled in different study|1|||
161934344|NCT03111732|584808484|FG000|Overall Study|Progressive disease|3|||
161934345|NCT03111732|584808484|FG000|Overall Study|Withdrawal by Subject|1|||
161934346|NCT02268851|584808490|FG000|Overall Study|Death|0|||
161934347|NCT02268851|584808491|FG001|Overall Study|Death|0|||
161934348|NCT02268851|584808492|FG002|Overall Study|Death|0|||
161934349|NCT02268851|584808493|FG003|Overall Study|Death|1|||
161934350|NCT02268851|584808494|FG004|Overall Study|Death|2|||
161934351|NCT02268851|584808495|FG005|Overall Study|Death|1|||
161934352|NCT02268851|584808490|FG000|Overall Study|Adverse Event|0|||
161934353|NCT02268851|584808491|FG001|Overall Study|Adverse Event|0|||
161934354|NCT02268851|584808492|FG002|Overall Study|Adverse Event|0|||
161934355|NCT02268851|584808493|FG003|Overall Study|Adverse Event|0|||
161934356|NCT02268851|584808494|FG004|Overall Study|Adverse Event|2|||
161934357|NCT02268851|584808495|FG005|Overall Study|Adverse Event|2|||
161934358|NCT02268851|584808490|FG000|Overall Study|Withdrawal by Subject|0|||
161934359|NCT02268851|584808491|FG001|Overall Study|Withdrawal by Subject|0|||
161934360|NCT02268851|584808492|FG002|Overall Study|Withdrawal by Subject|0|||
161934361|NCT02268851|584808493|FG003|Overall Study|Withdrawal by Subject|2|||
161934362|NCT02268851|584808494|FG004|Overall Study|Withdrawal by Subject|0|||
161522276|NCT01275625|583301795|FG000|Overall Study|Adverse Event|4|||
161522277|NCT01275625|583301795|FG000|Overall Study|Other|1|||
161522278|NCT01585103|583301797|FG000|Overall Study|Unable to swallow Cytosponge|6|||
161522279|NCT03521635|583301798|FG000|Overall Study|Adverse Event|1|||
161522280|NCT03521635|583301799|FG001|Overall Study|Adverse Event|1|||
161522281|NCT03521635|583301798|FG000|Overall Study|Refused to complete study visit|1|||
161522282|NCT03521635|583301799|FG001|Overall Study|Refused to complete study visit|0|||
161522283|NCT03521635|583301798|FG000|Overall Study|Refused to continue trial medication|2|||
161522284|NCT03521635|583301799|FG001|Overall Study|Refused to continue trial medication|2|||
161522285|NCT03521635|583301798|FG000|Overall Study|Lost to Follow-up|0|||
161522286|NCT03521635|583301799|FG001|Overall Study|Lost to Follow-up|1|||
161522287|NCT03521635|583301798|FG000|Overall Study|Meet exclusion criteria|0|||
161522288|NCT03521635|583301799|FG001|Overall Study|Meet exclusion criteria|1|||
161522289|NCT03521635|583301798|FG000|Overall Study|Patient not taken study medicine|0|||
161522290|NCT03521635|583301799|FG001|Overall Study|Patient not taken study medicine|1|||
161522291|NCT02244944|583301800|FG000|Overall Study|Withdrawal by Subject|1|||
161522292|NCT02244944|583301800|FG000|Overall Study|Study Terminated|1|||
161522293|NCT01747772|583301801|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
161522294|NCT00626522|583301804|FG000|Overall Study|Protocol Violation|0|||
161522295|NCT00626522|583301805|FG001|Overall Study|Protocol Violation|0|||
161522296|NCT00626522|583301806|FG002|Overall Study|Protocol Violation|0|||
161522297|NCT00626522|583301807|FG003|Overall Study|Protocol Violation|0|||
161522298|NCT00626522|583301808|FG004|Overall Study|Protocol Violation|1|||
161522299|NCT00626522|583301809|FG005|Overall Study|Protocol Violation|0|||
161522300|NCT00626522|583301804|FG000|Overall Study|Adverse Event|2|||
161522301|NCT00626522|583301805|FG001|Overall Study|Adverse Event|1|||
161522302|NCT00626522|583301806|FG002|Overall Study|Adverse Event|2|||
161522303|NCT00626522|583301807|FG003|Overall Study|Adverse Event|0|||
161522304|NCT00626522|583301808|FG004|Overall Study|Adverse Event|1|||
161522305|NCT00626522|583301809|FG005|Overall Study|Adverse Event|1|||
161522306|NCT00626522|583301804|FG000|Overall Study|Withdrawal by Subject|2|||
161522307|NCT00626522|583301805|FG001|Overall Study|Withdrawal by Subject|5|||
161522308|NCT00626522|583301806|FG002|Overall Study|Withdrawal by Subject|5|||
161522309|NCT00626522|583301807|FG003|Overall Study|Withdrawal by Subject|0|||
161522310|NCT00626522|583301808|FG004|Overall Study|Withdrawal by Subject|4|||
161522311|NCT00626522|583301809|FG005|Overall Study|Withdrawal by Subject|1|||
161522312|NCT00626522|583301804|FG000|Overall Study|COPD exacerbation|0|||
161522313|NCT00626522|583301805|FG001|Overall Study|COPD exacerbation|0|||
161522314|NCT00626522|583301806|FG002|Overall Study|COPD exacerbation|0|||
161522315|NCT00626522|583301807|FG003|Overall Study|COPD exacerbation|1|||
161522316|NCT00626522|583301808|FG004|Overall Study|COPD exacerbation|1|||
161589483|NCT03338790|583546485|FG000|Overall Study|Other reasons|0|||
161934363|NCT02268851|584808495|FG005|Overall Study|Withdrawal by Subject|1|||
161934364|NCT02268851|584808490|FG000|Overall Study|Progressive Disease|1|||
161934365|NCT02268851|584808491|FG001|Overall Study|Progressive Disease|3|||
161934366|NCT02268851|584808492|FG002|Overall Study|Progressive Disease|0|||
161934367|NCT02268851|584808493|FG003|Overall Study|Progressive Disease|0|||
161934368|NCT02268851|584808494|FG004|Overall Study|Progressive Disease|1|||
161934369|NCT02268851|584808495|FG005|Overall Study|Progressive Disease|4|||
161934370|NCT02268851|584808490|FG000|Overall Study|Physician Decision|0|||
161934371|NCT02268851|584808491|FG001|Overall Study|Physician Decision|0|||
161825928|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825929|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825930|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
161825931|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825932|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825933|NCT02014441|584403742|FG000|Overall Study|Withdrawal by Subject|12|||
161825934|NCT01363011|584403744|FG000|Main Study|Adverse Event|2|||
161825935|NCT01363011|584403745|FG001|Main Study|Adverse Event|3|||
161825936|NCT01363011|584403744|FG000|Main Study|Investigator's Discretion|1|||
161825937|NCT01363011|584403745|FG001|Main Study|Investigator's Discretion|1|||
161825938|NCT01363011|584403744|FG000|Main Study|Withdrew Consent|1|||
161825939|NCT01363011|584403745|FG001|Main Study|Withdrew Consent|4|||
161825940|NCT01363011|584403744|FG000|Main Study|Protocol Violation|0|||
161825941|NCT01363011|584403745|FG001|Main Study|Protocol Violation|1|||
161825942|NCT01363011|584403744|FG000|Extension Phase|Adverse Event|1|||
161825943|NCT01363011|584403745|FG001|Extension Phase|Adverse Event|1|||
161825944|NCT01363011|584403744|FG000|Extension Phase|Lack of Efficacy|0|||
161825945|NCT01363011|584403745|FG001|Extension Phase|Lack of Efficacy|1|||
161825946|NCT01363011|584403744|FG000|Extension Phase|Investigator's Discretion|2|||
161825947|NCT01363011|584403745|FG001|Extension Phase|Investigator's Discretion|2|||
161825948|NCT01363011|584403744|FG000|Extension Phase|Withdrew Consent|0|||
161825949|NCT01363011|584403745|FG001|Extension Phase|Withdrew Consent|1|||
161825950|NCT01363011|584403744|FG000|Extension Phase|Lost to Follow-up|0|||
161825951|NCT01363011|584403745|FG001|Extension Phase|Lost to Follow-up|2|||
161825952|NCT01363011|584403744|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
161825953|NCT01363011|584403745|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
161825954|NCT04412057|584403746|FG000|Overall Study|Death|3|||
161522317|NCT00626522|583301809|FG005|Overall Study|COPD exacerbation|0|||
161522318|NCT00626522|583301804|FG000|Overall Study|Lost to Follow-up|0|||
161522319|NCT00626522|583301805|FG001|Overall Study|Lost to Follow-up|1|||
161522320|NCT00626522|583301806|FG002|Overall Study|Lost to Follow-up|0|||
161522321|NCT00626522|583301807|FG003|Overall Study|Lost to Follow-up|0|||
161522322|NCT00626522|583301808|FG004|Overall Study|Lost to Follow-up|0|||
161522323|NCT00626522|583301809|FG005|Overall Study|Lost to Follow-up|0|||
161522324|NCT00626522|583301804|FG000|Overall Study|Inconsistent reason reported|1|||
161522325|NCT00626522|583301805|FG001|Overall Study|Inconsistent reason reported|0|||
161522326|NCT00626522|583301806|FG002|Overall Study|Inconsistent reason reported|0|||
161522327|NCT00626522|583301807|FG003|Overall Study|Inconsistent reason reported|0|||
161522328|NCT00626522|583301808|FG004|Overall Study|Inconsistent reason reported|0|||
161522329|NCT00626522|583301809|FG005|Overall Study|Inconsistent reason reported|0|||
161522330|NCT00626522|583301804|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
161522331|NCT00626522|583301805|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
161522332|NCT00626522|583301806|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
161522333|NCT00626522|583301807|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
161522334|NCT00626522|583301808|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
161522335|NCT00626522|583301809|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
161522336|NCT01928719|583301810|FG000|Overall Study|Lost to Follow-up|26|||
161522337|NCT01928719|583301811|FG001|Overall Study|Lost to Follow-up|11|||
161522338|NCT01928719|583301810|FG000|Overall Study|Withdrawal by Subject|22|||
161522339|NCT01928719|583301811|FG001|Overall Study|Withdrawal by Subject|7|||
161522340|NCT01928719|583301810|FG000|Overall Study|Protocol Violation|3|||
161522341|NCT01928719|583301811|FG001|Overall Study|Protocol Violation|1|||
161522342|NCT01928719|583301810|FG000|Overall Study|Adverse Event|1|||
161825955|NCT04412057|584403747|FG001|Overall Study|Death|7|||
161825956|NCT04412057|584403746|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
161825957|NCT04412057|584403747|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
161825958|NCT00114231|584403748|FG000|Overall Study|No consent|2|||
161825959|NCT00114231|584403749|FG001|Overall Study|No consent|0|||
161825960|NCT00114231|584403748|FG000|Overall Study|QARC requirement not met|1|||
161825961|NCT00114231|584403749|FG001|Overall Study|QARC requirement not met|0|||
161825962|NCT00114231|584403748|FG000|Overall Study|Suspected metastatic disease|1|||
161825963|NCT00114231|584403749|FG001|Overall Study|Suspected metastatic disease|0|||
161825964|NCT00114231|584403748|FG000|Overall Study|No adenocarcinoma|1|||
161934372|NCT02268851|584808492|FG002|Overall Study|Physician Decision|1|||
161522343|NCT01928719|583301811|FG001|Overall Study|Adverse Event|0|||
161522344|NCT03725982|583301812|FG000|First Intervention|Withdrawal by Subject|0|||
161522345|NCT03725982|583301813|FG001|First Intervention|Withdrawal by Subject|1|||
161522346|NCT03725982|583301812|FG000|First Intervention|Physician Decision|1|||
161825965|NCT00114231|584403749|FG001|Overall Study|No adenocarcinoma|0|||
161825966|NCT00114231|584403748|FG000|Overall Study|Low creatinine clearance|0|||
161522347|NCT03725982|583301813|FG001|First Intervention|Physician Decision|1|||
161677635|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161825967|NCT00114231|584403749|FG001|Overall Study|Low creatinine clearance|1|||
161825968|NCT00114231|584403748|FG000|Overall Study|Tumor size > 4cm|1|||
161825969|NCT00114231|584403749|FG001|Overall Study|Tumor size > 4cm|0|||
161934373|NCT02268851|584808493|FG003|Overall Study|Physician Decision|0|||
161934374|NCT02268851|584808494|FG004|Overall Study|Physician Decision|0|||
161934375|NCT02268851|584808495|FG005|Overall Study|Physician Decision|1|||
161934376|NCT02268851|584808490|FG000|Overall Study|Patient Compliance|0|||
161934377|NCT02268851|584808491|FG001|Overall Study|Patient Compliance|0|||
161934378|NCT02268851|584808492|FG002|Overall Study|Patient Compliance|0|||
161934379|NCT02268851|584808493|FG003|Overall Study|Patient Compliance|0|||
161934380|NCT02268851|584808494|FG004|Overall Study|Patient Compliance|1|||
161934381|NCT02268851|584808495|FG005|Overall Study|Patient Compliance|1|||
161522348|NCT01003899|583301814|FG000|Overall Study|Other Adverse Event|8|||
161522349|NCT01003899|583301814|FG000|Overall Study|Not entered|4|||
161522350|NCT01003899|583301814|FG000|Overall Study|Not treated|1|||
161522351|NCT01003899|583301814|FG000|Overall Study|Progressive disease|34|||
161522352|NCT03879798|583301819|FG000|Overall Study|Adverse Event|0|||
161522353|NCT03879798|583301820|FG001|Overall Study|Adverse Event|0|||
161522354|NCT03879798|583301821|FG002|Overall Study|Adverse Event|0|||
161522355|NCT03879798|583301822|FG003|Overall Study|Adverse Event|0|||
161522356|NCT03879798|583301823|FG004|Overall Study|Adverse Event|0|||
161522357|NCT03879798|583301824|FG005|Overall Study|Adverse Event|1|||
161934382|NCT02268851|584808490|FG000|Overall Study|Co-Morbid Condition|0|||
161934383|NCT02268851|584808491|FG001|Overall Study|Co-Morbid Condition|0|||
161522358|NCT03879798|583301819|FG000|Overall Study|Lack of Efficacy|0|||
161522359|NCT03879798|583301820|FG001|Overall Study|Lack of Efficacy|0|||
161522360|NCT03879798|583301821|FG002|Overall Study|Lack of Efficacy|0|||
161522361|NCT03879798|583301822|FG003|Overall Study|Lack of Efficacy|0|||
161522362|NCT03879798|583301823|FG004|Overall Study|Lack of Efficacy|0|||
161522363|NCT03879798|583301824|FG005|Overall Study|Lack of Efficacy|1|||
161522364|NCT03879798|583301819|FG000|Overall Study|Withdrawal by Subject|0|||
161522365|NCT03879798|583301820|FG001|Overall Study|Withdrawal by Subject|0|||
161522366|NCT03879798|583301821|FG002|Overall Study|Withdrawal by Subject|0|||
161522367|NCT03879798|583301822|FG003|Overall Study|Withdrawal by Subject|0|||
161522368|NCT03879798|583301823|FG004|Overall Study|Withdrawal by Subject|0|||
161522369|NCT03879798|583301824|FG005|Overall Study|Withdrawal by Subject|1|||
161522370|NCT01343407|583301825|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
161522371|NCT01343407|583301826|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
161522372|NCT01343407|583301827|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
161522373|NCT01343407|583301828|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
161522374|NCT01343407|583301829|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
161522375|NCT01343407|583301830|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
161522376|NCT01343407|583301825|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
161522377|NCT01343407|583301826|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
161522378|NCT01343407|583301827|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
161522379|NCT01343407|583301828|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
161522380|NCT01343407|583301829|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
161522381|NCT01343407|583301830|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
161522382|NCT06027216|583301831|FG000|Overall Study|Did not qualify|8|||
161522383|NCT00345579|583301832|FG000|Overall Study|Adverse Event|9|||
161934384|NCT02268851|584808492|FG002|Overall Study|Co-Morbid Condition|0|||
161934385|NCT02268851|584808493|FG003|Overall Study|Co-Morbid Condition|0|||
161934386|NCT02268851|584808494|FG004|Overall Study|Co-Morbid Condition|1|||
161522384|NCT00345579|583301833|FG001|Overall Study|Adverse Event|6|||
161522385|NCT00345579|583301832|FG000|Overall Study|Protocol Violation|14|||
161522386|NCT00345579|583301833|FG001|Overall Study|Protocol Violation|5|||
161522387|NCT00345579|583301832|FG000|Overall Study|Withdrawal by Subject|50|||
161522388|NCT00345579|583301833|FG001|Overall Study|Withdrawal by Subject|17|||
161522389|NCT00345579|583301832|FG000|Overall Study|Lost to Follow-up|82|||
161522390|NCT00345579|583301833|FG001|Overall Study|Lost to Follow-up|36|||
161522391|NCT00345579|583301832|FG000|Overall Study|Other|9|||
161589484|NCT03338790|583546486|FG001|Overall Study|Other reasons|5|||
161522392|NCT00345579|583301833|FG001|Overall Study|Other|1|||
161522393|NCT03646513|583301834|FG000|Overall Study|Premature study termination|4|||
161522394|NCT02043782|583301835|FG000|Period 1|Adverse Event|0|||
161522395|NCT02043782|583301836|FG001|Period 1|Adverse Event|0|||
161522396|NCT02043782|583301837|FG002|Period 1|Adverse Event|1|||
161522397|NCT02043782|583301838|FG003|Period 1|Adverse Event|0|||
161522398|NCT02043782|583301839|FG004|Period 1|Adverse Event|0|||
161522399|NCT02043782|583301840|FG005|Period 1|Adverse Event|0|||
161522400|NCT00874029|583301841|FG000|Overall Study|Withdrawal by Subject|10|||
161522401|NCT00874029|583301841|FG000|Overall Study|Pregnancy|4|||
161522402|NCT00874029|583301841|FG000|Overall Study|Physician Decision|1|||
161522403|NCT00874029|583301841|FG000|Overall Study|Adverse Event|1|||
161522404|NCT00874029|583301841|FG000|Overall Study|Lost to Follow-up|5|||
161589485|NCT03338790|583546487|FG002|Overall Study|Other reasons|0|||
161934387|NCT02268851|584808495|FG005|Overall Study|Co-Morbid Condition|1|||
161934388|NCT01684033|584808498|FG000|Period 1, First 30 Days|Adverse Event|1|||
161522405|NCT02007577|583301842|FG000|Overall Study|Adverse Event|1|||
161934389|NCT01684033|584808499|FG001|Period 1, First 30 Days|Adverse Event|1|||
161934390|NCT01684033|584808498|FG000|Period 1, First 30 Days|Noncompliance|1|||
161934391|NCT01684033|584808499|FG001|Period 1, First 30 Days|Noncompliance|0|||
161522406|NCT02007577|583301843|FG001|Overall Study|Adverse Event|0|||
161522407|NCT02007577|583301842|FG000|Overall Study|Withdrawal by Subject|0|||
161522408|NCT02007577|583301843|FG001|Overall Study|Withdrawal by Subject|1|||
161522409|NCT01767116|583301844|FG000|Overall Study|Lost to Follow-up|2|||
161522410|NCT01767116|583301845|FG001|Overall Study|Lost to Follow-up|2|||
161522411|NCT00968669|583301846|FG000|Overall Study|Lost to Follow-up|5|||
161522412|NCT00968669|583301847|FG001|Overall Study|Lost to Follow-up|2|||
161522413|NCT00968669|583301848|FG002|Overall Study|Lost to Follow-up|1|||
161522414|NCT00968669|583301849|FG003|Overall Study|Lost to Follow-up|4|||
161522415|NCT00968669|583301846|FG000|Overall Study|Withdrawal by Subject|9|||
161522416|NCT00968669|583301847|FG001|Overall Study|Withdrawal by Subject|7|||
161522417|NCT00968669|583301848|FG002|Overall Study|Withdrawal by Subject|5|||
161522418|NCT00968669|583301849|FG003|Overall Study|Withdrawal by Subject|3|||
161522419|NCT00968669|583301846|FG000|Overall Study|Pregnancy|0|||
161522420|NCT00968669|583301847|FG001|Overall Study|Pregnancy|0|||
161522421|NCT00968669|583301848|FG002|Overall Study|Pregnancy|2|||
161522422|NCT00968669|583301849|FG003|Overall Study|Pregnancy|0|||
161522423|NCT00968669|583301846|FG000|Overall Study|AE|1|||
161522424|NCT00968669|583301847|FG001|Overall Study|AE|0|||
161522425|NCT00968669|583301848|FG002|Overall Study|AE|0|||
161522426|NCT00968669|583301849|FG003|Overall Study|AE|0|||
161522427|NCT00968669|583301846|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
161522428|NCT00968669|583301847|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
161522429|NCT00968669|583301848|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
161522430|NCT00968669|583301849|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
161522431|NCT00968669|583301846|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
161522432|NCT00968669|583301847|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
161522433|NCT00968669|583301848|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
161522434|NCT00968669|583301849|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
161522435|NCT00968669|583301846|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
161522436|NCT00968669|583301847|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
161522437|NCT00968669|583301848|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
161522438|NCT00968669|583301849|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
161522439|NCT00968669|583301846|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
161522440|NCT00968669|583301847|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
161522441|NCT00968669|583301848|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
161522442|NCT00968669|583301849|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
161522443|NCT00968669|583301846|FG000|Overall Study|EARLY WITHDRAWAL|0|||
161522444|NCT00968669|583301847|FG001|Overall Study|EARLY WITHDRAWAL|1|||
161522445|NCT00968669|583301848|FG002|Overall Study|EARLY WITHDRAWAL|0|||
161522446|NCT00968669|583301849|FG003|Overall Study|EARLY WITHDRAWAL|0|||
161522447|NCT00968669|583301846|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
161522448|NCT00968669|583301847|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
161522449|NCT00968669|583301848|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
161522450|NCT00968669|583301849|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
161522451|NCT00968669|583301846|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
161522452|NCT00968669|583301847|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
161522453|NCT00968669|583301848|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
161522454|NCT00968669|583301849|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
161522455|NCT00968669|583301846|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
161522456|NCT00968669|583301847|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
161522457|NCT00968669|583301848|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
161522458|NCT00968669|583301849|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
161522459|NCT00968669|583301846|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
161522460|NCT00968669|583301847|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
161522461|NCT00968669|583301848|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
161522462|NCT00968669|583301849|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
161522463|NCT00968669|583301846|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
161522464|NCT00968669|583301847|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
161522465|NCT00968669|583301848|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
161522466|NCT00968669|583301849|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
161522467|NCT00968669|583301846|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
161522468|NCT00968669|583301847|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
161522469|NCT00968669|583301848|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
161522470|NCT00968669|583301849|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
161522471|NCT00968669|583301846|FG000|Overall Study|SPONSOR DECISION|0|||
161522472|NCT00968669|583301847|FG001|Overall Study|SPONSOR DECISION|1|||
161522473|NCT00968669|583301848|FG002|Overall Study|SPONSOR DECISION|0|||
161522474|NCT00968669|583301849|FG003|Overall Study|SPONSOR DECISION|0|||
161522475|NCT00968669|583301846|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
161522476|NCT00968669|583301847|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
161522477|NCT00968669|583301848|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
161522478|NCT00968669|583301849|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
161522479|NCT00968669|583301846|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
161522480|NCT00968669|583301847|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
161522481|NCT00968669|583301848|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
161522482|NCT00968669|583301849|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
161522483|NCT00968669|583301846|FG000|Overall Study|SUBJECT INCARCERATED|0|||
161522484|NCT00968669|583301847|FG001|Overall Study|SUBJECT INCARCERATED|1|||
161522485|NCT00968669|583301848|FG002|Overall Study|SUBJECT INCARCERATED|0|||
161522486|NCT00968669|583301849|FG003|Overall Study|SUBJECT INCARCERATED|0|||
161522487|NCT00968669|583301846|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
161522488|NCT00968669|583301847|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
161522489|NCT00968669|583301848|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
161522490|NCT00968669|583301849|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
161522491|NCT00968669|583301846|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
161522492|NCT00968669|583301847|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
161522493|NCT00968669|583301848|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
161522494|NCT00968669|583301849|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
161522495|NCT02338362|583301852|FG000|Overall Study|Withdrawal by Subject|1|||
161522496|NCT02338362|583301853|FG001|Overall Study|Withdrawal by Subject|1|||
161522497|NCT01669343|583301854|FG000|Part A: All Patients|Withdrawal by Subject|7|||
161522498|NCT01669343|583301854|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
161522499|NCT01669343|583301854|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
161522500|NCT01669343|583301854|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
161522501|NCT01669343|583301854|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
161522502|NCT02371369|583301859|FG000|Part 1|Physician Decision|0|||
161522503|NCT02371369|583301860|FG001|Part 1|Physician Decision|3|||
161677636|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677637|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677638|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677639|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
161677640|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677641|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677642|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677643|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677644|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677645|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677646|NCT02871778|583872064|FG000|Part A: Treatment Period 2|Adverse Event|2|||
161677647|NCT02871778|583872065|FG001|Part A: Treatment Period 2|Adverse Event|2|||
161677648|NCT02871778|583872066|FG002|Part A: Treatment Period 2|Adverse Event|0|||
161677649|NCT02871778|583872067|FG003|Part A: Treatment Period 2|Adverse Event|0|||
161677650|NCT02871778|583872068|FG004|Part A: Treatment Period 2|Adverse Event|0|||
161677651|NCT02871778|583872069|FG005|Part A: Treatment Period 2|Adverse Event|0|||
161677652|NCT02871778|583872070|FG006|Part A: Treatment Period 2|Adverse Event|0|||
161677653|NCT02871778|583872071|FG007|Part A: Treatment Period 2|Adverse Event|0|||
161677654|NCT02871778|583872064|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677655|NCT02871778|583872065|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677656|NCT02871778|583872066|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677657|NCT02871778|583872067|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
161677658|NCT02871778|583872068|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677659|NCT02871778|583872069|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677660|NCT02871778|583872070|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677661|NCT02871778|583872071|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677662|NCT02871778|583872064|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
161677663|NCT02871778|583872065|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677664|NCT02871778|583872066|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
161677665|NCT02871778|583872067|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677666|NCT02871778|583872068|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677667|NCT02871778|583872069|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677668|NCT02871778|583872070|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677669|NCT02871778|583872071|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677670|NCT02871778|583872064|FG000|Part B: Treatment Period 3|Adverse Event|0|||
161677671|NCT02871778|583872065|FG001|Part B: Treatment Period 3|Adverse Event|0|||
161677672|NCT02871778|583872066|FG002|Part B: Treatment Period 3|Adverse Event|0|||
161522504|NCT02371369|583301859|FG000|Part 1|Adverse Event|8|||
161522505|NCT02371369|583301860|FG001|Part 1|Adverse Event|0|||
161522506|NCT02371369|583301859|FG000|Part 1|Withdrawal by Subject|1|||
161522507|NCT02371369|583301860|FG001|Part 1|Withdrawal by Subject|6|||
161522508|NCT02371369|583301859|FG000|Part 1|Disease progression|0|||
161522509|NCT02371369|583301860|FG001|Part 1|Disease progression|1|||
161522510|NCT02371369|583301859|FG000|Part 1|Protocol Violation|0|||
161522511|NCT02371369|583301860|FG001|Part 1|Protocol Violation|1|||
161522512|NCT02371369|583301859|FG000|Part 2|Adverse Event|6|||
161825970|NCT00114231|584403748|FG000|Overall Study|Tumor fixed on digital exam|0|||
161825971|NCT00114231|584403749|FG001|Overall Study|Tumor fixed on digital exam|1|||
161825972|NCT00114231|584403748|FG000|Overall Study|No Absolute Neutrophil Count|2|||
161825973|NCT00114231|584403749|FG001|Overall Study|No Absolute Neutrophil Count|0|||
161825974|NCT00114231|584403748|FG000|Overall Study|Biopsy done after registration|1|||
161522513|NCT02371369|583301860|FG001|Part 2|Adverse Event|5|||
161522514|NCT02371369|583301859|FG000|Part 2|Withdrawal by Subject|16|||
161522515|NCT02371369|583301860|FG001|Part 2|Withdrawal by Subject|6|||
161522516|NCT02371369|583301859|FG000|Part 2|Investigator decision|1|||
161522517|NCT02371369|583301860|FG001|Part 2|Investigator decision|2|||
161522518|NCT02371369|583301859|FG000|Part 2|Death|0|||
161522519|NCT02371369|583301860|FG001|Part 2|Death|1|||
161522520|NCT02371369|583301859|FG000|Part 2|Disease progression|1|||
161522521|NCT02371369|583301860|FG001|Part 2|Disease progression|0|||
161522522|NCT02371369|583301859|FG000|Part 2|Subject Noncompliance|1|||
161522523|NCT02371369|583301860|FG001|Part 2|Subject Noncompliance|0|||
161522524|NCT02371369|583301859|FG000|Part 2|Lost to Follow-up|1|||
161522525|NCT02371369|583301860|FG001|Part 2|Lost to Follow-up|1|||
161522526|NCT02371369|583301859|FG000|Part 2|Subject transitioned to commercial supply|6|||
161522527|NCT02371369|583301860|FG001|Part 2|Subject transitioned to commercial supply|4|||
161522528|NCT02371369|583301859|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
161522529|NCT02371369|583301860|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
161522530|NCT02371369|583301859|FG000|Part 2|Surgical resection of tumor|1|||
161522531|NCT02371369|583301860|FG001|Part 2|Surgical resection of tumor|1|||
161522532|NCT02371369|583301859|FG000|Part 2|Other|0|||
161522533|NCT02371369|583301860|FG001|Part 2|Other|1|||
161522534|NCT01024387|583301861|FG000|Overall Study|Radiographic Progression|29|||
161522535|NCT01024387|583301861|FG000|Overall Study|Symptomatic Progression|10|||
161522536|NCT01024387|583301861|FG000|Overall Study|Physician Decision|5|||
161522537|NCT01024387|583301861|FG000|Overall Study|Withdrawal by Subject|5|||
161522538|NCT01024387|583301861|FG000|Overall Study|Death|2|||
161522539|NCT01024387|583301861|FG000|Overall Study|Prolonged Treatment Delay|1|||
161522540|NCT01024387|583301861|FG000|Overall Study|Adverse Event|3|||
161522541|NCT01024387|583301861|FG000|Overall Study|Other|5|||
161522542|NCT03855189|583301862|FG000|Overall Study|Adverse Event|5|||
161522543|NCT03855189|583301863|FG001|Overall Study|Adverse Event|2|||
161522544|NCT03855189|583301864|FG002|Overall Study|Adverse Event|4|||
161522545|NCT03855189|583301862|FG000|Overall Study|Treatment Failure|1|||
161522546|NCT03855189|583301863|FG001|Overall Study|Treatment Failure|1|||
161522547|NCT03855189|583301864|FG002|Overall Study|Treatment Failure|2|||
161522548|NCT03855189|583301862|FG000|Overall Study|Noncompliance with Protocol|0|||
161522549|NCT03855189|583301863|FG001|Overall Study|Noncompliance with Protocol|1|||
161522550|NCT03855189|583301864|FG002|Overall Study|Noncompliance with Protocol|0|||
161522551|NCT03855189|583301862|FG000|Overall Study|Did Not Return|4|||
161522552|NCT03855189|583301863|FG001|Overall Study|Did Not Return|3|||
161522553|NCT03855189|583301864|FG002|Overall Study|Did Not Return|0|||
161522554|NCT04307186|583301867|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
161522555|NCT04307186|583301867|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
161522556|NCT04307186|583301867|FG000|Washout 3-14 Days|Progressive disease|1|||
161522557|NCT04307186|583301867|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
161522558|NCT04307186|583301867|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
161522559|NCT01618838|583301870|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
161522560|NCT01434602|583301871|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
161522561|NCT01434602|583301872|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
161522562|NCT01434602|583301873|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
161522563|NCT01434602|583301874|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
161522564|NCT01434602|583301875|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
161522565|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
161589486|NCT03338790|583546488|FG003|Overall Study|Other reasons|2|||
161522566|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
161589487|NCT03338790|583546485|FG000|Overall Study|Not reported|0|||
161825975|NCT00114231|584403749|FG001|Overall Study|Biopsy done after registration|0|||
161825976|NCT02457819|584403750|FG000|Overall Study|reason not given|8|||
161522567|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
161522568|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
161589488|NCT03338790|583546486|FG001|Overall Study|Not reported|0|||
161825977|NCT02457819|584403750|FG000|Overall Study|Withdrawal by Subject|24|||
161825978|NCT02457819|584403750|FG000|Overall Study|Protocol Violation|1|||
161825979|NCT02457819|584403750|FG000|Overall Study|non compliance with study drug|4|||
161825980|NCT02457819|584403750|FG000|Overall Study|Lost to Follow-up|10|||
161825981|NCT02457819|584403750|FG000|Overall Study|Lack of Efficacy|19|||
161825982|NCT02457819|584403750|FG000|Overall Study|Adverse Event|33|||
161825983|NCT03330236|584403753|FG000|Overall Study|Death|2|||
161677673|NCT02871778|583872067|FG003|Part B: Treatment Period 3|Adverse Event|0|||
161677674|NCT02871778|583872068|FG004|Part B: Treatment Period 3|Adverse Event|1|||
161522569|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
161677675|NCT02871778|583872069|FG005|Part B: Treatment Period 3|Adverse Event|1|||
161677676|NCT02871778|583872070|FG006|Part B: Treatment Period 3|Adverse Event|1|||
161522570|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
161522571|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
161522572|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
161522573|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
161522574|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
161522575|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
161522576|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
161522577|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
161522578|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
161522579|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
161522580|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
161522581|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
161522582|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
161522583|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
161522584|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
161522585|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
161522586|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
161522587|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
161522588|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
161522589|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
161522590|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
161522591|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
161522592|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
161522593|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
161522594|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
161522595|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
161522596|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
161522597|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
161522598|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
161522599|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
161522600|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
161522601|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
161522602|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
161522603|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
161522604|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
161522605|NCT01434602|583301871|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
161522606|NCT01434602|583301872|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
161522607|NCT01434602|583301873|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
161522608|NCT01434602|583301874|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
161522609|NCT01434602|583301875|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
161522610|NCT01587651|583301880|FG000|Overall Study|Adverse Event|0|||
161522611|NCT01587651|583301881|FG001|Overall Study|Adverse Event|1|||
161522612|NCT01587651|583301882|FG002|Overall Study|Adverse Event|0|||
161522613|NCT01587651|583301880|FG000|Overall Study|Protocol Violation|0|||
161522614|NCT01587651|583301881|FG001|Overall Study|Protocol Violation|1|||
161522615|NCT01587651|583301882|FG002|Overall Study|Protocol Violation|1|||
161522616|NCT01587651|583301880|FG000|Overall Study|Withdrawal by Subject|0|||
161522617|NCT01587651|583301881|FG001|Overall Study|Withdrawal by Subject|1|||
161825984|NCT03330236|584403754|FG001|Overall Study|Death|1|||
161825985|NCT03330236|584403753|FG000|Overall Study|Withdrawal by Subject|2|||
161825986|NCT03330236|584403754|FG001|Overall Study|Withdrawal by Subject|4|||
161825987|NCT03330236|584403753|FG000|Overall Study|Lost to Follow-up|0|||
161825988|NCT03330236|584403754|FG001|Overall Study|Lost to Follow-up|2|||
161825989|NCT03330236|584403753|FG000|Overall Study|Physician Decision|2|||
161825990|NCT03330236|584403754|FG001|Overall Study|Physician Decision|0|||
161825991|NCT03330236|584403753|FG000|Overall Study|Protocol Violation|4|||
161825992|NCT03330236|584403754|FG001|Overall Study|Protocol Violation|3|||
161825993|NCT03330236|584403753|FG000|Overall Study|SedLine malfunction/blinding|19|||
161522618|NCT01587651|583301882|FG002|Overall Study|Withdrawal by Subject|0|||
161522619|NCT03864900|583301885|FG000|Overall Study|Withdrawal by Subject|1|||
161522620|NCT03864900|583301886|FG001|Overall Study|Withdrawal by Subject|1|||
161522621|NCT03864900|583301885|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
161522622|NCT03864900|583301886|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
161522623|NCT00759109|583301889|FG000|Overall Study|Adverse Event|17|||
161522624|NCT00759109|583301890|FG001|Overall Study|Adverse Event|12|||
161522625|NCT00759109|583301889|FG000|Overall Study|Inability to comply|1|||
161522626|NCT00759109|583301890|FG001|Overall Study|Inability to comply|1|||
161522627|NCT00759109|583301889|FG000|Overall Study|Withdrawal by Subject|9|||
161522628|NCT00759109|583301890|FG001|Overall Study|Withdrawal by Subject|5|||
161522629|NCT00759109|583301889|FG000|Overall Study|Death|4|||
161522630|NCT00759109|583301890|FG001|Overall Study|Death|3|||
161522631|NCT00759109|583301889|FG000|Overall Study|Lost to Follow-up|4|||
161589489|NCT03338790|583546487|FG002|Overall Study|Not reported|1|||
161589490|NCT03338790|583546488|FG003|Overall Study|Not reported|0|||
161589491|NCT03338790|583546485|FG000|Overall Study|Completed treatment period|1|||
161589492|NCT03338790|583546486|FG001|Overall Study|Completed treatment period|2|||
161589493|NCT03338790|583546487|FG002|Overall Study|Completed treatment period|0|||
161589494|NCT03338790|583546488|FG003|Overall Study|Completed treatment period|0|||
161589495|NCT04588298|583546489|FG000|Overall Study|Adverse Event|0|||
161589496|NCT04588298|583546490|FG001|Overall Study|Adverse Event|0|||
161589497|NCT04588298|583546491|FG002|Overall Study|Adverse Event|1|||
161589498|NCT04588298|583546492|FG003|Overall Study|Adverse Event|0|||
161589499|NCT04588298|583546493|FG004|Overall Study|Adverse Event|2|||
161589500|NCT04588298|583546489|FG000|Overall Study|Withdrawal by Subject|1|||
161589501|NCT04588298|583546490|FG001|Overall Study|Withdrawal by Subject|0|||
161589502|NCT04588298|583546491|FG002|Overall Study|Withdrawal by Subject|0|||
161589503|NCT04588298|583546492|FG003|Overall Study|Withdrawal by Subject|1|||
161589504|NCT04588298|583546493|FG004|Overall Study|Withdrawal by Subject|0|||
161589505|NCT03683719|583546494|FG000|Overall Study|Lack of Efficacy|1|||
161589506|NCT03683719|583546495|FG001|Overall Study|Lack of Efficacy|3|||
161589507|NCT03683719|583546496|FG002|Overall Study|Lack of Efficacy|4|||
161589508|NCT03683719|583546497|FG003|Overall Study|Lack of Efficacy|0|||
161589509|NCT03683719|583546498|FG004|Overall Study|Lack of Efficacy|4|||
161589510|NCT03683719|583546494|FG000|Overall Study|Adverse Event|6|||
161589511|NCT03683719|583546495|FG001|Overall Study|Adverse Event|6|||
161589512|NCT03683719|583546496|FG002|Overall Study|Adverse Event|0|||
161589513|NCT03683719|583546497|FG003|Overall Study|Adverse Event|1|||
161589514|NCT03683719|583546498|FG004|Overall Study|Adverse Event|3|||
161589515|NCT03683719|583546494|FG000|Overall Study|Withdrawal by Subject|4|||
161589516|NCT03683719|583546495|FG001|Overall Study|Withdrawal by Subject|4|||
161589517|NCT03683719|583546496|FG002|Overall Study|Withdrawal by Subject|3|||
161589518|NCT03683719|583546497|FG003|Overall Study|Withdrawal by Subject|5|||
161589519|NCT03683719|583546498|FG004|Overall Study|Withdrawal by Subject|5|||
161589520|NCT03683719|583546494|FG000|Overall Study|Lost to Follow-up|1|||
161589521|NCT03683719|583546495|FG001|Overall Study|Lost to Follow-up|0|||
161589522|NCT03683719|583546496|FG002|Overall Study|Lost to Follow-up|0|||
161589523|NCT03683719|583546497|FG003|Overall Study|Lost to Follow-up|1|||
161589524|NCT03683719|583546498|FG004|Overall Study|Lost to Follow-up|1|||
161589525|NCT03683719|583546494|FG000|Overall Study|Other personal reasons|0|||
161589526|NCT03683719|583546495|FG001|Overall Study|Other personal reasons|0|||
161589527|NCT03683719|583546496|FG002|Overall Study|Other personal reasons|1|||
161589528|NCT03683719|583546497|FG003|Overall Study|Other personal reasons|0|||
161589529|NCT03683719|583546498|FG004|Overall Study|Other personal reasons|1|||
161589530|NCT00601900|583546499|FG000|Overall Study|Withdrawal by Subject|0|||
161589531|NCT00601900|583546500|FG001|Overall Study|Withdrawal by Subject|3|||
161589532|NCT03924986|583546501|FG000|Overall Study|Death|57|||
161589533|NCT03924986|583546502|FG001|Overall Study|Death|66|||
161589534|NCT03924986|583546501|FG000|Overall Study|Study Concluded by Sponsor|51|||
161589535|NCT03924986|583546502|FG001|Overall Study|Study Concluded by Sponsor|41|||
161589536|NCT03924986|583546501|FG000|Overall Study|Withdrawal by Subject|15|||
161522632|NCT00759109|583301890|FG001|Overall Study|Lost to Follow-up|6|||
161589537|NCT03924986|583546502|FG001|Overall Study|Withdrawal by Subject|20|||
161522633|NCT00759109|583301889|FG000|Overall Study|Started new therapy|2|||
161522634|NCT00759109|583301890|FG001|Overall Study|Started new therapy|6|||
161522635|NCT00759109|583301889|FG000|Overall Study|HCV RNA negative|1|||
161522636|NCT00759109|583301890|FG001|Overall Study|HCV RNA negative|0|||
161522637|NCT00759109|583301889|FG000|Overall Study|Participant moved to a different city|0|||
161522638|NCT00759109|583301890|FG001|Overall Study|Participant moved to a different city|1|||
161589538|NCT03924986|583546501|FG000|Overall Study|Lost to Follow-up|7|||
161589539|NCT03924986|583546502|FG001|Overall Study|Lost to Follow-up|5|||
161589540|NCT03924986|583546501|FG000|Overall Study|Miscellaneous|1|||
161589541|NCT03924986|583546502|FG001|Overall Study|Miscellaneous|0|||
161522639|NCT00759109|583301889|FG000|Overall Study|Participant had a liver transplant|0|||
161589542|NCT05569252|583546503|FG000|Overall Study|Adverse event (central vision loss)|1|||
161589543|NCT05569252|583546504|FG001|Overall Study|Adverse event (central vision loss)|0|||
161522640|NCT00759109|583301890|FG001|Overall Study|Participant had a liver transplant|1|||
161522641|NCT00759109|583301889|FG000|Overall Study|Lost during study|1|||
161522642|NCT00759109|583301890|FG001|Overall Study|Lost during study|0|||
161522643|NCT03238001|583301891|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
161522644|NCT03238001|583301891|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
161522645|NCT03238001|583301891|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
161522646|NCT03238001|583301891|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
161522647|NCT03238001|583301891|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
161522648|NCT03238001|583301891|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
161522649|NCT03238001|583301891|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
161522650|NCT03238001|583301891|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
161522651|NCT03325712|583301902|FG000|Overall Study|Protocol Violation|0|||
161522652|NCT03325712|583301903|FG001|Overall Study|Protocol Violation|0|||
161522653|NCT03325712|583301904|FG002|Overall Study|Protocol Violation|0|||
161522654|NCT03325712|583301905|FG003|Overall Study|Protocol Violation|0|||
161522655|NCT03325712|583301906|FG004|Overall Study|Protocol Violation|1|||
161522656|NCT03325712|583301907|FG005|Overall Study|Protocol Violation|0|||
161522657|NCT03325712|583301908|FG006|Overall Study|Protocol Violation|0|||
161522658|NCT03325712|583301909|FG007|Overall Study|Protocol Violation|0|||
161522659|NCT03325712|583301902|FG000|Overall Study|Adverse Event|0|||
161522660|NCT03325712|583301903|FG001|Overall Study|Adverse Event|0|||
161522661|NCT03325712|583301904|FG002|Overall Study|Adverse Event|0|||
161522662|NCT03325712|583301905|FG003|Overall Study|Adverse Event|0|||
161522663|NCT03325712|583301906|FG004|Overall Study|Adverse Event|1|||
161522664|NCT03325712|583301907|FG005|Overall Study|Adverse Event|0|||
161522665|NCT03325712|583301908|FG006|Overall Study|Adverse Event|0|||
161522666|NCT03325712|583301909|FG007|Overall Study|Adverse Event|0|||
161522667|NCT02265237|583301910|FG000|As Treated (Overall Study)|Adverse Event|1|||
161522668|NCT02265237|583301911|FG001|As Treated (Overall Study)|Adverse Event|1|||
161522669|NCT02265237|583301912|FG002|As Treated (Overall Study)|Adverse Event|0|||
161522670|NCT02265237|583301913|FG003|As Treated (Overall Study)|Adverse Event|0|||
161522671|NCT02265237|583301910|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
161522672|NCT02265237|583301911|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
161522673|NCT02265237|583301912|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
161522674|NCT02265237|583301913|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
161522675|NCT02265237|583301910|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
161522676|NCT02265237|583301911|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
161522677|NCT02265237|583301912|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
161522678|NCT02265237|583301913|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
161522679|NCT02265237|583301910|FG000|As Treated (Overall Study)|Other|2|||
161522680|NCT02265237|583301911|FG001|As Treated (Overall Study)|Other|0|||
161522681|NCT02265237|583301912|FG002|As Treated (Overall Study)|Other|3|||
161522682|NCT02265237|583301913|FG003|As Treated (Overall Study)|Other|1|||
161825994|NCT03330236|584403754|FG001|Overall Study|SedLine malfunction/blinding|14|||
161934392|NCT01684033|584808498|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
161522683|NCT01178853|583301915|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
161522684|NCT01178853|583301916|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
161522685|NCT01178853|583301915|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
161522686|NCT01178853|583301916|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
161522687|NCT01178853|583301915|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
161522688|NCT01178853|583301916|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
161522689|NCT01178853|583301915|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
161522690|NCT01178853|583301916|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
161522691|NCT01178853|583301915|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
161522692|NCT01178853|583301916|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
161522693|NCT03550313|583301917|FG000|Overall Study|Adverse Event|0|||
161522694|NCT03550313|583301918|FG001|Overall Study|Adverse Event|1|||
161522695|NCT03550313|583301919|FG002|Overall Study|Adverse Event|0|||
161522696|NCT03550313|583301917|FG000|Overall Study|Lost to Follow-up|5|||
161522697|NCT03550313|583301918|FG001|Overall Study|Lost to Follow-up|7|||
161522698|NCT03550313|583301919|FG002|Overall Study|Lost to Follow-up|12|||
161522699|NCT03550313|583301917|FG000|Overall Study|Study terminated by sponsor|44|||
161522700|NCT03550313|583301918|FG001|Overall Study|Study terminated by sponsor|37|||
161825995|NCT03330236|584403753|FG000|Overall Study|Volatile anesthetics used|11|||
161825996|NCT03330236|584403754|FG001|Overall Study|Volatile anesthetics used|8|||
161825997|NCT03330236|584403753|FG000|Overall Study|Surgery aborted/converted to open|60|||
161825998|NCT03330236|584403754|FG001|Overall Study|Surgery aborted/converted to open|52|||
161825999|NCT00763555|584403758|FG000|Overall Study|Adverse Event|2|||
161826000|NCT00763555|584403759|FG001|Overall Study|Adverse Event|1|||
161826001|NCT00763555|584403758|FG000|Overall Study|Withdrawal by Subject|2|||
161522701|NCT03550313|583301919|FG002|Overall Study|Study terminated by sponsor|48|||
161522702|NCT03550313|583301917|FG000|Overall Study|No longer met eligibility criteria|3|||
161522703|NCT03550313|583301918|FG001|Overall Study|No longer met eligibility criteria|5|||
161826002|NCT00763555|584403759|FG001|Overall Study|Withdrawal by Subject|6|||
161934393|NCT01684033|584808499|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
161934394|NCT01684033|584808498|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
161934395|NCT01684033|584808499|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
161934396|NCT01684033|584808498|FG000|Period 2, Second 30 Days|Adverse Event|1|||
161934397|NCT01684033|584808499|FG001|Period 2, Second 30 Days|Adverse Event|0|||
161934398|NCT03726879|584808500|FG000|Overall Study|Death|11|||
161934399|NCT03726879|584808501|FG001|Overall Study|Death|13|||
161934400|NCT03726879|584808500|FG000|Overall Study|Physician Decision|0|||
161934401|NCT03726879|584808501|FG001|Overall Study|Physician Decision|2|||
161934402|NCT03726879|584808500|FG000|Overall Study|Protocol Violation|0|||
161934403|NCT03726879|584808501|FG001|Overall Study|Protocol Violation|1|||
161934404|NCT03726879|584808500|FG000|Overall Study|Withdrawal by Subject|5|||
161934405|NCT03726879|584808501|FG001|Overall Study|Withdrawal by Subject|6|||
161934406|NCT03726879|584808500|FG000|Overall Study|TSH result is unstable|0|||
161934407|NCT03726879|584808501|FG001|Overall Study|TSH result is unstable|1|||
161934408|NCT03726879|584808500|FG000|Overall Study|Disease relapse|1|||
161934409|NCT03726879|584808501|FG001|Overall Study|Disease relapse|0|||
161522704|NCT03550313|583301919|FG002|Overall Study|No longer met eligibility criteria|6|||
161522705|NCT03550313|583301917|FG000|Overall Study|Withdrawal by parent/guardian|20|||
161522706|NCT03550313|583301918|FG001|Overall Study|Withdrawal by parent/guardian|18|||
161522707|NCT03550313|583301919|FG002|Overall Study|Withdrawal by parent/guardian|26|||
161522708|NCT03550313|583301917|FG000|Overall Study|Other|4|||
161522709|NCT03550313|583301918|FG001|Overall Study|Other|2|||
161522710|NCT03550313|583301919|FG002|Overall Study|Other|2|||
161522711|NCT03550313|583301917|FG000|Overall Study|Randomized but not vaccinated|3|||
161522712|NCT03550313|583301918|FG001|Overall Study|Randomized but not vaccinated|23|||
161522713|NCT03550313|583301919|FG002|Overall Study|Randomized but not vaccinated|2|||
161522714|NCT03550313|583301917|FG000|Overall Study|Sites terminated due to quality issues|18|||
161522715|NCT03550313|583301918|FG001|Overall Study|Sites terminated due to quality issues|17|||
161522716|NCT03550313|583301919|FG002|Overall Study|Sites terminated due to quality issues|18|||
161522717|NCT00839072|583301920|FG000|First Intervention Period|Withdrawal by Subject|1|||
161522718|NCT00839072|583301921|FG001|First Intervention Period|Withdrawal by Subject|0|||
161522719|NCT00839072|583301920|FG000|First Intervention Period|Adverse Event|1|||
161522720|NCT00839072|583301921|FG001|First Intervention Period|Adverse Event|1|||
161522721|NCT00839072|583301920|FG000|Second Intervention Period|Withdrawal by Subject|1|||
161522722|NCT00839072|583301921|FG001|Second Intervention Period|Withdrawal by Subject|0|||
161522723|NCT00380068|583301922|FG000|Overall Study|Adverse Event|40|||
161522724|NCT00380068|583301922|FG000|Overall Study|Withdrawal by Subject|10|||
161522725|NCT00380068|583301922|FG000|Overall Study|Not compliant|6|||
161522726|NCT00380068|583301922|FG000|Overall Study|Lost to Follow-up|1|||
161522727|NCT00380068|583301922|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
161522728|NCT00380068|583301922|FG000|Overall Study|Lung transplant|3|||
161522729|NCT00380068|583301922|FG000|Overall Study|Physician Decision|2|||
161522730|NCT00380068|583301922|FG000|Overall Study|Partipant moved away|1|||
161522731|NCT00380068|583301922|FG000|Overall Study|Lack of Efficacy|5|||
161522732|NCT01297062|583301923|FG000|Overall Study|Adverse Event|2|||
161522733|NCT01297062|583301924|FG001|Overall Study|Adverse Event|0|||
161522734|NCT01297062|583301925|FG002|Overall Study|Adverse Event|1|||
161522735|NCT01297062|583301926|FG003|Overall Study|Adverse Event|0|||
161522736|NCT01297062|583301927|FG004|Overall Study|Adverse Event|0|||
161522737|NCT01297062|583301928|FG005|Overall Study|Adverse Event|0|||
161522738|NCT01297062|583301929|FG006|Overall Study|Adverse Event|0|||
161522739|NCT01297062|583301923|FG000|Overall Study|Physician Decision|1|||
161522740|NCT01297062|583301924|FG001|Overall Study|Physician Decision|0|||
161522741|NCT01297062|583301925|FG002|Overall Study|Physician Decision|1|||
161522742|NCT01297062|583301926|FG003|Overall Study|Physician Decision|0|||
161522743|NCT01297062|583301927|FG004|Overall Study|Physician Decision|0|||
161522744|NCT01297062|583301928|FG005|Overall Study|Physician Decision|0|||
161522745|NCT01297062|583301929|FG006|Overall Study|Physician Decision|6|||
161522746|NCT01297062|583301923|FG000|Overall Study|Protocol Violation|0|||
161522747|NCT01297062|583301924|FG001|Overall Study|Protocol Violation|0|||
161522748|NCT01297062|583301925|FG002|Overall Study|Protocol Violation|0|||
161522749|NCT01297062|583301926|FG003|Overall Study|Protocol Violation|0|||
161522750|NCT01297062|583301927|FG004|Overall Study|Protocol Violation|1|||
161522751|NCT01297062|583301928|FG005|Overall Study|Protocol Violation|0|||
161522752|NCT01297062|583301929|FG006|Overall Study|Protocol Violation|0|||
161522753|NCT01297062|583301923|FG000|Overall Study|Subject Decision|1|||
161522754|NCT01297062|583301924|FG001|Overall Study|Subject Decision|1|||
161522755|NCT01297062|583301925|FG002|Overall Study|Subject Decision|0|||
161522756|NCT01297062|583301926|FG003|Overall Study|Subject Decision|1|||
161522757|NCT01297062|583301927|FG004|Overall Study|Subject Decision|1|||
161522758|NCT01297062|583301928|FG005|Overall Study|Subject Decision|1|||
161934410|NCT03726879|584808500|FG000|Overall Study|Lost to Follow-up|3|||
161934411|NCT03726879|584808501|FG001|Overall Study|Lost to Follow-up|0|||
161934412|NCT02496156|584808503|FG000|Overall Study|Lost to Follow-up|5|||
161934413|NCT02496156|584808504|FG001|Overall Study|Lost to Follow-up|0|||
161522759|NCT01297062|583301929|FG006|Overall Study|Subject Decision|2|||
161934414|NCT02496156|584808503|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
161934415|NCT02496156|584808504|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
161934416|NCT00507507|584808505|FG000|Treatment Period|Lost to Follow-up|0|||
161934417|NCT00507507|584808506|FG001|Treatment Period|Lost to Follow-up|2|||
161934418|NCT00507507|584808505|FG000|Treatment Period|Physician Decision|4|||
161934419|NCT00507507|584808506|FG001|Treatment Period|Physician Decision|1|||
161934420|NCT00507507|584808505|FG000|Treatment Period|Protocol Violation|1|||
161934421|NCT00507507|584808506|FG001|Treatment Period|Protocol Violation|2|||
161934422|NCT00507507|584808505|FG000|Treatment Period|Adverse Event|1|||
161934423|NCT00507507|584808506|FG001|Treatment Period|Adverse Event|1|||
161934424|NCT00507507|584808505|FG000|Treatment Period|Withdrawal by Subject|46|||
161934425|NCT00507507|584808506|FG001|Treatment Period|Withdrawal by Subject|47|||
161934426|NCT00507507|584808505|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
161934427|NCT00507507|584808506|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
161934428|NCT00507507|584808505|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
161934429|NCT00507507|584808506|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
161934430|NCT00507507|584808505|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
161934431|NCT00507507|584808506|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
161934432|NCT00289900|584808509|FG000|Overall Study|Adverse Event|28|||
161934433|NCT00289900|584808510|FG001|Overall Study|Adverse Event|40|||
161934434|NCT00289900|584808511|FG002|Overall Study|Adverse Event|13|||
161934435|NCT00289900|584808512|FG003|Overall Study|Adverse Event|19|||
161934436|NCT00289900|584808513|FG004|Overall Study|Adverse Event|20|||
161934437|NCT00289900|584808514|FG005|Overall Study|Adverse Event|33|||
161934438|NCT00289900|584808509|FG000|Overall Study|Lost to Follow-up|7|||
161934439|NCT00289900|584808510|FG001|Overall Study|Lost to Follow-up|7|||
161934440|NCT00289900|584808511|FG002|Overall Study|Lost to Follow-up|8|||
161934441|NCT00289900|584808512|FG003|Overall Study|Lost to Follow-up|8|||
161934442|NCT00289900|584808513|FG004|Overall Study|Lost to Follow-up|4|||
161934443|NCT00289900|584808514|FG005|Overall Study|Lost to Follow-up|8|||
161934444|NCT00289900|584808509|FG000|Overall Study|Participant had flushing|18|||
161934445|NCT00289900|584808510|FG001|Overall Study|Participant had flushing|42|||
161934446|NCT00289900|584808511|FG002|Overall Study|Participant had flushing|1|||
161934447|NCT00289900|584808512|FG003|Overall Study|Participant had flushing|2|||
161934448|NCT00289900|584808513|FG004|Overall Study|Participant had flushing|0|||
161934449|NCT00289900|584808514|FG005|Overall Study|Participant had flushing|4|||
161934450|NCT00289900|584808509|FG000|Overall Study|Other|0|||
161934451|NCT00289900|584808510|FG001|Overall Study|Other|0|||
161934452|NCT00289900|584808511|FG002|Overall Study|Other|0|||
161934453|NCT00289900|584808512|FG003|Overall Study|Other|5|||
161934454|NCT00289900|584808513|FG004|Overall Study|Other|1|||
161934455|NCT00289900|584808514|FG005|Overall Study|Other|0|||
161934456|NCT00289900|584808509|FG000|Overall Study|Participant moved|1|||
161934457|NCT00289900|584808510|FG001|Overall Study|Participant moved|0|||
161934458|NCT00289900|584808511|FG002|Overall Study|Participant moved|0|||
161934459|NCT00289900|584808512|FG003|Overall Study|Participant moved|1|||
161934460|NCT00289900|584808513|FG004|Overall Study|Participant moved|1|||
161934461|NCT00289900|584808514|FG005|Overall Study|Participant moved|1|||
161934462|NCT00289900|584808509|FG000|Overall Study|Withdrawal by Subject|10|||
161934463|NCT00289900|584808510|FG001|Overall Study|Withdrawal by Subject|21|||
161934464|NCT00289900|584808511|FG002|Overall Study|Withdrawal by Subject|8|||
161934465|NCT00289900|584808512|FG003|Overall Study|Withdrawal by Subject|18|||
161934466|NCT00289900|584808513|FG004|Overall Study|Withdrawal by Subject|12|||
161934467|NCT00289900|584808514|FG005|Overall Study|Withdrawal by Subject|11|||
161934468|NCT00289900|584808509|FG000|Overall Study|Protocol Violation|3|||
161934469|NCT00289900|584808510|FG001|Overall Study|Protocol Violation|9|||
161934470|NCT00289900|584808511|FG002|Overall Study|Protocol Violation|2|||
161934471|NCT00289900|584808512|FG003|Overall Study|Protocol Violation|6|||
161934472|NCT00289900|584808513|FG004|Overall Study|Protocol Violation|7|||
161934473|NCT00289900|584808514|FG005|Overall Study|Protocol Violation|4|||
161589544|NCT05569252|583546505|FG002|Overall Study|Adverse event (central vision loss)|0|||
161589545|NCT05569252|583546506|FG003|Overall Study|Adverse event (central vision loss)|0|||
161589546|NCT05516147|583546507|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
161589547|NCT05371652|583546511|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
161934474|NCT00289900|584808509|FG000|Overall Study|site terminated|1|||
161934475|NCT00289900|584808510|FG001|Overall Study|site terminated|0|||
161934476|NCT00289900|584808511|FG002|Overall Study|site terminated|1|||
161934477|NCT00289900|584808512|FG003|Overall Study|site terminated|0|||
161934478|NCT00289900|584808513|FG004|Overall Study|site terminated|0|||
161934479|NCT00289900|584808514|FG005|Overall Study|site terminated|0|||
161589548|NCT05371652|583546511|FG000|Overall Study|Withdrawal by Subject|12|||
161934480|NCT00289900|584808509|FG000|Overall Study|Not treated|0|||
161934481|NCT00289900|584808510|FG001|Overall Study|Not treated|1|||
161934482|NCT00289900|584808511|FG002|Overall Study|Not treated|0|||
161934483|NCT00289900|584808512|FG003|Overall Study|Not treated|0|||
161934484|NCT00289900|584808513|FG004|Overall Study|Not treated|0|||
161934485|NCT00289900|584808514|FG005|Overall Study|Not treated|0|||
161934486|NCT03249558|584808515|FG000|Overall Study|Lost to Follow-up|2|||
161934487|NCT03249558|584808516|FG001|Overall Study|Lost to Follow-up|1|||
161934488|NCT03249558|584808517|FG002|Overall Study|Lost to Follow-up|4|||
161934489|NCT03249558|584808515|FG000|Overall Study|Physician Decision|1|||
161934490|NCT03249558|584808516|FG001|Overall Study|Physician Decision|0|||
161934491|NCT03249558|584808517|FG002|Overall Study|Physician Decision|0|||
161934492|NCT03249558|584808515|FG000|Overall Study|Withdrawal by Subject|6|||
161934493|NCT03249558|584808516|FG001|Overall Study|Withdrawal by Subject|5|||
161934494|NCT03249558|584808517|FG002|Overall Study|Withdrawal by Subject|7|||
161934495|NCT03249558|584808515|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
161934496|NCT03249558|584808516|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
161934497|NCT03249558|584808517|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
161934498|NCT03249558|584808515|FG000|Overall Study|Protocol Violation|1|||
161934499|NCT03249558|584808516|FG001|Overall Study|Protocol Violation|1|||
161934500|NCT03249558|584808517|FG002|Overall Study|Protocol Violation|2|||
161934501|NCT02656173|584808518|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
161934502|NCT02656173|584808519|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
161934503|NCT02656173|584808518|FG000|Overall Study|Adverse Event|7|||
161934504|NCT02656173|584808519|FG001|Overall Study|Adverse Event|5|||
161934505|NCT02656173|584808518|FG000|Overall Study|Withdrawal by Subject|1|||
161934506|NCT02656173|584808519|FG001|Overall Study|Withdrawal by Subject|3|||
161934507|NCT02656173|584808518|FG000|Overall Study|Protocol Violation|0|||
161934508|NCT02656173|584808519|FG001|Overall Study|Protocol Violation|1|||
161934509|NCT02656173|584808518|FG000|Overall Study|Miscellaneous|2|||
161934510|NCT02656173|584808519|FG001|Overall Study|Miscellaneous|0|||
161934511|NCT03449147|584808521|FG000|52-week Treatment Period|Death|0|||
161934512|NCT03449147|584808522|FG001|52-week Treatment Period|Death|1|||
161934513|NCT03449147|584808523|FG002|52-week Treatment Period|Death|0|||
161934514|NCT03449147|584808521|FG000|52-week Treatment Period|Lost to Follow-up|6|||
161934515|NCT03449147|584808522|FG001|52-week Treatment Period|Lost to Follow-up|2|||
161934516|NCT03449147|584808523|FG002|52-week Treatment Period|Lost to Follow-up|5|||
161934517|NCT03449147|584808521|FG000|52-week Treatment Period|Other|0|||
161934518|NCT03449147|584808522|FG001|52-week Treatment Period|Other|1|||
161934519|NCT03449147|584808523|FG002|52-week Treatment Period|Other|2|||
161934520|NCT03449147|584808521|FG000|52-week Treatment Period|Physician Decision|1|||
161934521|NCT03449147|584808522|FG001|52-week Treatment Period|Physician Decision|0|||
161934522|NCT03449147|584808523|FG002|52-week Treatment Period|Physician Decision|3|||
161934523|NCT03449147|584808521|FG000|52-week Treatment Period|Screen Failure|1|||
161522760|NCT03191903|583301930|FG000|Overall Study|Withdrawal by Subject|6|||
161522761|NCT03191903|583301931|FG001|Overall Study|Withdrawal by Subject|5|||
161522762|NCT03191903|583301932|FG002|Overall Study|Withdrawal by Subject|4|||
161522763|NCT03191903|583301930|FG000|Overall Study|Adverse Event|1|||
161522764|NCT03191903|583301931|FG001|Overall Study|Adverse Event|0|||
161522765|NCT03191903|583301932|FG002|Overall Study|Adverse Event|0|||
161522766|NCT03149328|583301933|FG000|Overall Study|Withdrawal by Subject|30|||
161522767|NCT03149328|583301934|FG001|Overall Study|Withdrawal by Subject|26|||
161522768|NCT03149328|583301933|FG000|Overall Study|Changed Dialysis Modality|18|||
161522769|NCT03149328|583301934|FG001|Overall Study|Changed Dialysis Modality|1|||
161522770|NCT03149328|583301933|FG000|Overall Study|Transplant|9|||
161522771|NCT03149328|583301934|FG001|Overall Study|Transplant|1|||
161522772|NCT03149328|583301933|FG000|Overall Study|Lost to Follow-up|25|||
161522773|NCT03149328|583301934|FG001|Overall Study|Lost to Follow-up|16|||
161522774|NCT03149328|583301933|FG000|Overall Study|Left Study Site|1|||
161522775|NCT03149328|583301934|FG001|Overall Study|Left Study Site|2|||
161522776|NCT03149328|583301933|FG000|Overall Study|Language Barrier|1|||
161522777|NCT03149328|583301934|FG001|Overall Study|Language Barrier|0|||
161522778|NCT00503685|583301938|FG000|Overall Study|Adverse Event|0|||
161522779|NCT00503685|583301939|FG001|Overall Study|Adverse Event|0|||
161522780|NCT00503685|583301940|FG002|Overall Study|Adverse Event|2|||
161522781|NCT00503685|583301938|FG000|Overall Study|Withdrawal by Subject|0|||
161522782|NCT00503685|583301939|FG001|Overall Study|Withdrawal by Subject|1|||
161522783|NCT00503685|583301940|FG002|Overall Study|Withdrawal by Subject|0|||
161522784|NCT00503685|583301938|FG000|Overall Study|Protocol Violation|0|||
161522785|NCT00503685|583301939|FG001|Overall Study|Protocol Violation|1|||
161522786|NCT00503685|583301940|FG002|Overall Study|Protocol Violation|0|||
161522787|NCT00503685|583301938|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161522788|NCT00503685|583301939|FG001|Overall Study|Eligibility Criteria Not Met|1|||
161522789|NCT00503685|583301940|FG002|Overall Study|Eligibility Criteria Not Met|0|||
161522790|NCT01110239|583301941|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
161522791|NCT01110239|583301942|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
161522792|NCT01110239|583301943|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
161522793|NCT01110239|583301944|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
161934524|NCT03449147|584808522|FG001|52-week Treatment Period|Screen Failure|2|||
161934525|NCT03449147|584808523|FG002|52-week Treatment Period|Screen Failure|0|||
161934526|NCT03449147|584808521|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
161934527|NCT03449147|584808522|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
161934528|NCT03449147|584808523|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
161934529|NCT03449147|584808521|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
161934530|NCT03449147|584808522|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
161934531|NCT03449147|584808523|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
161934532|NCT03449147|584808521|FG000|12-Week Off-Treatment Durability Period|Other|0|||
161934533|NCT03449147|584808522|FG001|12-Week Off-Treatment Durability Period|Other|1|||
161934534|NCT03449147|584808523|FG002|12-Week Off-Treatment Durability Period|Other|0|||
161934535|NCT00954538|584808525|FG000|Part III|Withdrawal by Subject|0|||
161934536|NCT00954538|584808526|FG001|Part III|Withdrawal by Subject|0|||
161934537|NCT00954538|584808527|FG002|Part III|Withdrawal by Subject|0|||
161934538|NCT00954538|584808528|FG003|Part III|Withdrawal by Subject|0|||
161934539|NCT00954538|584808529|FG004|Part III|Withdrawal by Subject|1|||
161934540|NCT00954538|584808530|FG005|Part III|Withdrawal by Subject|0|||
161934541|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Death|2|||
161934542|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
161934543|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
161934544|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
161934545|NCT00974233|584808534|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
161934546|NCT00974233|584808534|FG000|Maintenance Lenalidomide|Adverse Event|8|||
161934547|NCT01691092|584808535|FG000|Overall Study|Lost to Follow-up|10|||
161934548|NCT01691092|584808535|FG000|Overall Study|Physician Decision|4|||
161934549|NCT01691092|584808535|FG000|Overall Study|Withdrawal by Subject|3|||
161934550|NCT01691092|584808535|FG000|Overall Study|non-compliance|3|||
161934551|NCT01691092|584808535|FG000|Overall Study|used for different study|2|||
161934552|NCT01691092|584808535|FG000|Overall Study|screen fail|19|||
161522794|NCT01110239|583301941|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
161522795|NCT01110239|583301942|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
161522796|NCT01110239|583301943|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
161522797|NCT01110239|583301944|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
161522798|NCT00080223|583301949|FG000|Overall Study|Adverse Event|23|||
161522799|NCT00080223|583301949|FG000|Overall Study|Death|21|||
161522800|NCT00080223|583301949|FG000|Overall Study|Withdrawal by Subject|13|||
161522801|NCT00080223|583301949|FG000|Overall Study|Lung Transplantation|9|||
161522802|NCT00080223|583301949|FG000|Overall Study|Non-compliance With Study Treatment|7|||
161522803|NCT00080223|583301949|FG000|Overall Study|Participant unwilling to continue|2|||
161522804|NCT00080223|583301949|FG000|Overall Study|Physician Decision|1|||
161549245|NCT02291289|583401020|FG011|Induction Treatment|Protocol Violation|0|||
161549246|NCT02291289|583401021|FG012|Induction Treatment|Protocol Violation|0|||
161677677|NCT02871778|583872071|FG007|Part B: Treatment Period 3|Adverse Event|0|||
161677678|NCT02653300|583872072|FG000|Overall Study|Withdrawal by Subject|2|||
161677679|NCT00911625|583872076|FG000|Overall Study|Lost to Follow-up|7|||
161677680|NCT00911625|583872077|FG001|Overall Study|Lost to Follow-up|0|||
161677681|NCT00888381|583872082|FG000|Overall Study|Lost to Follow-up|0|||
161677682|NCT00888381|583872083|FG001|Overall Study|Lost to Follow-up|1|||
161677683|NCT02729740|583872084|FG000|Overall Study|Early Termination|130|||
161677684|NCT02729740|583872084|FG000|Overall Study|Other|1|||
161677685|NCT00307333|583872085|FG000|Overall Study|Lost to Follow-up|11|||
161677686|NCT00307333|583872086|FG001|Overall Study|Lost to Follow-up|3|||
161677687|NCT04166383|583872087|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
161677688|NCT04166383|583872087|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
161677689|NCT04166383|583872087|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
161677690|NCT03044886|583872088|FG000|Overall Study|Lost to Follow-up|15|||
161677691|NCT03044886|583872089|FG001|Overall Study|Lost to Follow-up|10|||
161677692|NCT03044886|583872090|FG002|Overall Study|Lost to Follow-up|12|||
161677693|NCT03785678|583872093|FG000|Overall Study|Death|44|||
161677694|NCT03785678|583872094|FG001|Overall Study|Death|42|||
161677695|NCT03785678|583872093|FG000|Overall Study|Lost to Follow-up|4|||
161677696|NCT03785678|583872094|FG001|Overall Study|Lost to Follow-up|2|||
161677697|NCT03785678|583872093|FG000|Overall Study|Physician Decision|0|||
161677698|NCT03785678|583872094|FG001|Overall Study|Physician Decision|2|||
161549247|NCT02291289|583401009|FG000|Induction Treatment|Missing|4|||
161549248|NCT02291289|583401010|FG001|Induction Treatment|Missing|0|||
161549249|NCT02291289|583401011|FG002|Induction Treatment|Missing|0|||
161677699|NCT03785678|583872093|FG000|Overall Study|Withdrawal by Subject|5|||
161677700|NCT03785678|583872094|FG001|Overall Study|Withdrawal by Subject|3|||
161677701|NCT01159912|583872095|FG000|Overall Study|Adverse Event|2|||
161677702|NCT01159912|583872096|FG001|Overall Study|Adverse Event|2|||
161677703|NCT01159912|583872097|FG002|Overall Study|Adverse Event|3|||
161677704|NCT01159912|583872095|FG000|Overall Study|Lack of Efficacy|23|||
161549250|NCT02291289|583401012|FG003|Induction Treatment|Missing|14|||
161677705|NCT01159912|583872096|FG001|Overall Study|Lack of Efficacy|15|||
161934553|NCT01657942|584808536|FG000|Overall Study|Alternative Treatment|7|||
161934554|NCT01657942|584808536|FG000|Overall Study|Lost to Follow-up|1|||
161934555|NCT02904265|584809974|FG000|Overall Study|Physician Decision|1|||
161934556|NCT02904265|584809975|FG001|Overall Study|Physician Decision|2|||
161934557|NCT00185614|584809978|FG000|Inter-treatment Period|Physician Decision|1|||
161934558|NCT00185614|584809978|FG000|Inter-treatment Period|Relapse|2|||
161934559|NCT00185614|584809978|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
161934560|NCT01034657|584809987|FG000|Core Phase|Withdrawal by Subject|1|||
161934561|NCT01034657|584809988|FG001|Core Phase|Withdrawal by Subject|0|||
161934562|NCT01034657|584809989|FG002|Core Phase|Withdrawal by Subject|0|||
161934563|NCT01034657|584809987|FG000|Core Phase|Lack of Efficacy|2|||
161934564|NCT01034657|584809988|FG001|Core Phase|Lack of Efficacy|0|||
161934565|NCT01034657|584809989|FG002|Core Phase|Lack of Efficacy|0|||
161934566|NCT01034657|584809987|FG000|Core Phase|Abnormal laboratory value|1|||
161934567|NCT01034657|584809988|FG001|Core Phase|Abnormal laboratory value|0|||
161934568|NCT01034657|584809989|FG002|Core Phase|Abnormal laboratory value|0|||
161934569|NCT01034657|584809987|FG000|Core Phase|Adverse Event|8|||
161934570|NCT01034657|584809988|FG001|Core Phase|Adverse Event|0|||
161934571|NCT01034657|584809989|FG002|Core Phase|Adverse Event|0|||
161934572|NCT01034657|584809987|FG000|Core Phase|Protocol Violation|2|||
161934573|NCT01034657|584809988|FG001|Core Phase|Protocol Violation|0|||
161934574|NCT01034657|584809989|FG002|Core Phase|Protocol Violation|0|||
161934575|NCT01034657|584809987|FG000|Randomized Phase|Withdrawal by Subject|0|||
161934576|NCT01034657|584809988|FG001|Randomized Phase|Withdrawal by Subject|2|||
161934577|NCT01034657|584809989|FG002|Randomized Phase|Withdrawal by Subject|0|||
161934578|NCT01034657|584809987|FG000|Randomized Phase|Lack of Efficacy|5|||
161934579|NCT01034657|584809988|FG001|Randomized Phase|Lack of Efficacy|1|||
161934580|NCT01034657|584809989|FG002|Randomized Phase|Lack of Efficacy|0|||
161934581|NCT01034657|584809987|FG000|Randomized Phase|Abnormal laboratory value|0|||
161934582|NCT01034657|584809988|FG001|Randomized Phase|Abnormal laboratory value|1|||
161934583|NCT01034657|584809989|FG002|Randomized Phase|Abnormal laboratory value|0|||
161934584|NCT01034657|584809987|FG000|Randomized Phase|Adverse Event|0|||
161934585|NCT01034657|584809988|FG001|Randomized Phase|Adverse Event|2|||
161934586|NCT01034657|584809989|FG002|Randomized Phase|Adverse Event|1|||
161934587|NCT01225952|584810003|FG000|Overall Study|Lost to Follow-up|1|||
161934588|NCT01225952|584810004|FG001|Overall Study|Lost to Follow-up|0|||
161522805|NCT01349569|583303898|FG000|Overall Study|Lack of Efficacy|4|||
161522806|NCT03581305|583303899|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
161522807|NCT03581305|583303900|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
161522808|NCT03581305|583303899|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
161522809|NCT03581305|583303900|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
161522810|NCT03581305|583303899|FG000|Serotonergic Study|Withdrawal by Subject|5|||
161522811|NCT03581305|583303900|FG001|Serotonergic Study|Withdrawal by Subject|1|||
161522812|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
161522813|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
161522814|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
161522815|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
161522816|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
161522817|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
161522818|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
161522819|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
161522820|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
161522821|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
161522822|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
161522823|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
161522824|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
161522825|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
161522826|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
161522827|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
161589549|NCT05371652|583546511|FG000|Overall Study|Adverse Event|1|||
161934589|NCT01225952|584810005|FG002|Overall Study|Lost to Follow-up|0|||
161934590|NCT01225952|584810003|FG000|Overall Study|Study Eye Explanted|0|||
161934591|NCT01225952|584810004|FG001|Overall Study|Study Eye Explanted|0|||
161934592|NCT01225952|584810005|FG002|Overall Study|Study Eye Explanted|1|||
161934593|NCT01225952|584810003|FG000|Overall Study|Withdrawal by Subject|4|||
161934594|NCT01225952|584810004|FG001|Overall Study|Withdrawal by Subject|4|||
161934595|NCT01225952|584810005|FG002|Overall Study|Withdrawal by Subject|5|||
161522828|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
161522829|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
161522830|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
161522831|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
161934596|NCT01225952|584810003|FG000|Overall Study|Surgical complications|1|||
161934597|NCT01225952|584810004|FG001|Overall Study|Surgical complications|0|||
161934598|NCT01225952|584810005|FG002|Overall Study|Surgical complications|0|||
161934599|NCT00889005|584810006|FG000|Overall Study|Lost to Follow-up|4|||
161934600|NCT00889005|584810007|FG001|Overall Study|Lost to Follow-up|2|||
161934601|NCT00889005|584810006|FG000|Overall Study|Withdrawal by Subject|4|||
161934602|NCT00889005|584810007|FG001|Overall Study|Withdrawal by Subject|0|||
161934603|NCT01998477|584810010|FG000|Overall Study|Lost to Follow-up|4|||
161934604|NCT01998477|584810011|FG001|Overall Study|Lost to Follow-up|5|||
161934605|NCT01998477|584810010|FG000|Overall Study|Withdrawal by Subject|6|||
161934606|NCT01998477|584810011|FG001|Overall Study|Withdrawal by Subject|0|||
161589550|NCT05371652|583546511|FG000|Overall Study|Other|11|||
161589551|NCT05256706|583546512|FG000|Overall Study|Lost to Follow-up|9|||
161589552|NCT05256706|583546513|FG001|Overall Study|Lost to Follow-up|3|||
161589553|NCT05256706|583546512|FG000|Overall Study|Withdrawal by Subject|7|||
161589554|NCT05256706|583546513|FG001|Overall Study|Withdrawal by Subject|11|||
161589555|NCT05256706|583546512|FG000|Overall Study|Screen Failures|3|||
161589556|NCT05256706|583546513|FG001|Overall Study|Screen Failures|0|||
161589557|NCT04410042|583546515|FG000|Overall Study|Not Eligible|1|||
161589558|NCT04410042|583546516|FG001|Overall Study|Not Eligible|1|||
161589559|NCT01494662|583546517|FG000|Overall Study|Withdrawal by Subject|0|||
161589560|NCT01494662|583546518|FG001|Overall Study|Withdrawal by Subject|0|||
161589561|NCT01494662|583546519|FG002|Overall Study|Withdrawal by Subject|1|||
161589562|NCT01494662|583546520|FG003|Overall Study|Withdrawal by Subject|0|||
161589563|NCT01494662|583546521|FG004|Overall Study|Withdrawal by Subject|0|||
161522832|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
161522833|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
161522834|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
161522835|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
161522836|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522837|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522838|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522839|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522840|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522841|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522842|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522843|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522844|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522845|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522846|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522847|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522848|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522849|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522850|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522851|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161522852|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522853|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522854|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
161522855|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
161522856|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
161522857|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522858|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161589564|NCT01494662|583546522|FG005|Overall Study|Withdrawal by Subject|0|||
161589565|NCT01494662|583546523|FG006|Overall Study|Withdrawal by Subject|0|||
161589566|NCT01494662|583546517|FG000|Overall Study|Physician Decision|0|||
161589567|NCT01494662|583546518|FG001|Overall Study|Physician Decision|0|||
161589568|NCT01494662|583546519|FG002|Overall Study|Physician Decision|1|||
161589569|NCT01494662|583546520|FG003|Overall Study|Physician Decision|0|||
161589570|NCT01494662|583546521|FG004|Overall Study|Physician Decision|0|||
161589571|NCT01494662|583546522|FG005|Overall Study|Physician Decision|0|||
161589572|NCT01494662|583546523|FG006|Overall Study|Physician Decision|0|||
161589573|NCT03302494|583546524|FG000|Overall Study|Other|7|||
161589574|NCT03302494|583546525|FG001|Overall Study|Other|4|||
161589575|NCT03302494|583546526|FG002|Overall Study|Other|6|||
161589576|NCT03302494|583546524|FG000|Overall Study|Withdrawal by Subject|10|||
161589577|NCT03302494|583546525|FG001|Overall Study|Withdrawal by Subject|2|||
161589578|NCT03302494|583546526|FG002|Overall Study|Withdrawal by Subject|9|||
161589579|NCT03302494|583546524|FG000|Overall Study|Study Terminated by Sponsor|32|||
161589580|NCT03302494|583546525|FG001|Overall Study|Study Terminated by Sponsor|29|||
161677706|NCT01159912|583872097|FG002|Overall Study|Lack of Efficacy|14|||
161522859|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522860|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161677707|NCT01159912|583872095|FG000|Overall Study|Protocol Violation|1|||
161522861|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522862|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522863|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522864|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161589581|NCT03302494|583546526|FG002|Overall Study|Study Terminated by Sponsor|30|||
161589582|NCT03302494|583546524|FG000|Overall Study|Physician Decision|1|||
161677708|NCT01159912|583872096|FG001|Overall Study|Protocol Violation|2|||
161677709|NCT01159912|583872097|FG002|Overall Study|Protocol Violation|3|||
161677710|NCT01159912|583872095|FG000|Overall Study|Lost to Follow-up|4|||
161677711|NCT01159912|583872096|FG001|Overall Study|Lost to Follow-up|0|||
161589583|NCT03302494|583546525|FG001|Overall Study|Physician Decision|0|||
161677712|NCT01159912|583872097|FG002|Overall Study|Lost to Follow-up|0|||
161677713|NCT01159912|583872095|FG000|Overall Study|Physician Decision|0|||
161677714|NCT01159912|583872096|FG001|Overall Study|Physician Decision|0|||
161677715|NCT01159912|583872097|FG002|Overall Study|Physician Decision|3|||
161677716|NCT01159912|583872095|FG000|Overall Study|Withdrawal by Subject|10|||
161677717|NCT01159912|583872096|FG001|Overall Study|Withdrawal by Subject|3|||
161677718|NCT01159912|583872097|FG002|Overall Study|Withdrawal by Subject|3|||
161677719|NCT00375219|583872098|FG000|Overall Study|Failure to achieve a response|16|||
161677720|NCT00375219|583872099|FG001|Overall Study|Failure to achieve a response|2|||
161677721|NCT00375219|583872100|FG002|Overall Study|Failure to achieve a response|0|||
161677722|NCT00375219|583872098|FG000|Overall Study|Adverse Event|8|||
161522865|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522866|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522867|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522868|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522869|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522870|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522871|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
161522872|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
161522873|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
161522874|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
161522875|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
161522876|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
161522877|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
161522878|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
161522879|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
161522880|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
161522881|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
161522882|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
161522883|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
161522884|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
161522885|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
161522886|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
161522887|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
161522888|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
161522889|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
161522890|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
161522891|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
161522892|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
161522893|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522894|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522895|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522896|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522897|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522898|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522899|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522900|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522901|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522902|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522903|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522904|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522905|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522906|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522907|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522908|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522909|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522910|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
161549251|NCT02291289|583401013|FG004|Induction Treatment|Missing|0|||
161677723|NCT00375219|583872099|FG001|Overall Study|Adverse Event|2|||
161677724|NCT00375219|583872100|FG002|Overall Study|Adverse Event|1|||
161677725|NCT00375219|583872098|FG000|Overall Study|Protocol Violation|1|||
161677726|NCT00375219|583872099|FG001|Overall Study|Protocol Violation|0|||
161677727|NCT00375219|583872100|FG002|Overall Study|Protocol Violation|1|||
161677728|NCT00375219|583872098|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
161677729|NCT00375219|583872099|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
161677730|NCT00375219|583872100|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
161677731|NCT00375219|583872098|FG000|Overall Study|Lost to Follow-up|1|||
161677732|NCT00375219|583872099|FG001|Overall Study|Lost to Follow-up|1|||
161677733|NCT00375219|583872100|FG002|Overall Study|Lost to Follow-up|0|||
161677734|NCT00375219|583872098|FG000|Overall Study|Disease progression|18|||
161677735|NCT00375219|583872099|FG001|Overall Study|Disease progression|9|||
161522911|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
161522912|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
161522913|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
161522914|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522915|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
161522916|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
161522917|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522918|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522919|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522920|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522921|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522922|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522923|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522924|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522925|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522926|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522927|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522928|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522929|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522930|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522931|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161522932|NCT01490632|583303901|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522933|NCT01490632|583303902|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522934|NCT01490632|583303903|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522935|NCT01490632|583303904|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522936|NCT01490632|583303905|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
161522937|NCT01490632|583303906|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522938|NCT01490632|583303907|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522939|NCT01490632|583303908|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522940|NCT01490632|583303909|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522941|NCT01490632|583303910|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522942|NCT01490632|583303911|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522943|NCT01490632|583303912|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522944|NCT01490632|583303913|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522945|NCT01490632|583303914|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522946|NCT01490632|583303915|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522947|NCT01490632|583303916|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522948|NCT01490632|583303917|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161934607|NCT00129974|584810012|FG000|Overall Study|Other|1|||
161934608|NCT05122143|584810013|FG000|Overall Study|Adverse Event|1|||
161522949|NCT01490632|583303918|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522950|NCT01490632|583303919|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522951|NCT01490632|583303920|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
161522952|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522953|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522954|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522955|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522956|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522957|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
161522958|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
161522959|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522960|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522961|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
161522962|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
161522963|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
161522964|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522965|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
161549252|NCT02291289|583401014|FG005|Induction Treatment|Missing|0|||
161934609|NCT05122143|584810014|FG001|Overall Study|Adverse Event|0|||
161934610|NCT05122143|584810015|FG002|Overall Study|Adverse Event|0|||
161934611|NCT05122143|584810016|FG003|Overall Study|Adverse Event|0|||
161934612|NCT05122143|584810017|FG004|Overall Study|Adverse Event|1|||
161934613|NCT05122143|584810018|FG005|Overall Study|Adverse Event|0|||
161934614|NCT05122143|584810013|FG000|Overall Study|Protocol non-compliance|0|||
161934615|NCT05122143|584810014|FG001|Overall Study|Protocol non-compliance|0|||
161934616|NCT05122143|584810015|FG002|Overall Study|Protocol non-compliance|1|||
161522966|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522967|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522968|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522969|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522970|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522971|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
161522972|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522973|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522974|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522975|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522976|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522977|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522978|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
161522979|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522980|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
161522981|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
161522982|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
161522983|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522984|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522985|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522986|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522987|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522988|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522989|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522990|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522991|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161522992|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161522993|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161522994|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161522995|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161522996|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161522997|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161522998|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
161522999|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523000|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523001|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
161523002|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523003|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523004|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523005|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523006|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523007|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523008|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523009|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523010|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523011|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
161523012|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523013|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523014|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523015|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523016|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523017|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523018|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
161523019|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
161934617|NCT05122143|584810016|FG003|Overall Study|Protocol non-compliance|0|||
161934618|NCT05122143|584810017|FG004|Overall Study|Protocol non-compliance|0|||
161934619|NCT05122143|584810018|FG005|Overall Study|Protocol non-compliance|0|||
161934620|NCT05122143|584810013|FG000|Overall Study|Covid contact|0|||
161934621|NCT05122143|584810014|FG001|Overall Study|Covid contact|0|||
161934622|NCT05122143|584810015|FG002|Overall Study|Covid contact|0|||
161934623|NCT05122143|584810016|FG003|Overall Study|Covid contact|0|||
161934624|NCT05122143|584810017|FG004|Overall Study|Covid contact|1|||
161934625|NCT05122143|584810018|FG005|Overall Study|Covid contact|0|||
161934626|NCT00692237|584810019|FG000|Overall Study|Withdrawal by Subject|1|||
161523020|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
161934627|NCT00692237|584810020|FG001|Overall Study|Withdrawal by Subject|3|||
161934628|NCT00692237|584810019|FG000|Overall Study|Adverse Event|0|||
161934629|NCT00692237|584810020|FG001|Overall Study|Adverse Event|1|||
161523021|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523022|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523023|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523024|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523025|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523026|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523027|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523028|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523029|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
161934630|NCT00395447|584810021|FG000|Overall Study|Death|37|||
161523030|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523031|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
161523032|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523033|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523034|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523035|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523036|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523037|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
161523038|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523039|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523040|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161589584|NCT03302494|583546526|FG002|Overall Study|Physician Decision|1|||
161589585|NCT03302494|583546524|FG000|Overall Study|Lost to Follow-up|1|||
161589586|NCT03302494|583546525|FG001|Overall Study|Lost to Follow-up|3|||
161589587|NCT03302494|583546526|FG002|Overall Study|Lost to Follow-up|3|||
161589588|NCT03302494|583546524|FG000|Overall Study|Death|13|||
161589589|NCT03302494|583546525|FG001|Overall Study|Death|11|||
161589590|NCT03302494|583546526|FG002|Overall Study|Death|4|||
161589591|NCT03302494|583546524|FG000|Overall Study|Adverse Event|1|||
161589592|NCT03302494|583546525|FG001|Overall Study|Adverse Event|2|||
161589593|NCT03302494|583546526|FG002|Overall Study|Adverse Event|0|||
161589594|NCT03302494|583546524|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
161589595|NCT03302494|583546525|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
161589596|NCT03302494|583546526|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
161589597|NCT02596126|583546535|FG000|Overall Study|Lost to Follow-up|12|||
161589598|NCT02596126|583546536|FG001|Overall Study|Lost to Follow-up|21|||
161589599|NCT02596126|583546535|FG000|Overall Study|Protocol Violation|7|||
161589600|NCT02596126|583546536|FG001|Overall Study|Protocol Violation|9|||
161589601|NCT01195831|583548110|FG000|Overall Study|Lost to Follow-up|2|||
161589602|NCT01195831|583548111|FG001|Overall Study|Lost to Follow-up|4|||
161589603|NCT01195831|583548110|FG000|Overall Study|Withdrawal by Subject|2|||
161589604|NCT01195831|583548111|FG001|Overall Study|Withdrawal by Subject|2|||
161589605|NCT01195831|583548110|FG000|Overall Study|Adverse Event|4|||
161589606|NCT01195831|583548111|FG001|Overall Study|Adverse Event|2|||
161589607|NCT01195831|583548110|FG000|Overall Study|Protocol Violation|0|||
161589608|NCT01195831|583548111|FG001|Overall Study|Protocol Violation|2|||
161589609|NCT04490915|583548113|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161589610|NCT04490915|583548114|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161589611|NCT04490915|583548113|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161589612|NCT04490915|583548114|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161589613|NCT04490915|583548113|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161589614|NCT04490915|583548114|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
161589615|NCT04490915|583548113|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
161589616|NCT04490915|583548114|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
161589617|NCT04490915|583548113|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
161589618|NCT04490915|583548114|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
161589619|NCT04490915|583548113|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
161589620|NCT04490915|583548114|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
161589621|NCT04490915|583548113|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
161589622|NCT04490915|583548114|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
161589623|NCT04024813|583548116|FG000|Overall Study|Study terminated by Sponsor|1|||
161934631|NCT00395447|584810022|FG001|Overall Study|Death|32|||
161934632|NCT00395447|584810021|FG000|Overall Study|Lost to Follow-up|52|||
161934633|NCT00395447|584810022|FG001|Overall Study|Lost to Follow-up|43|||
161934634|NCT00395447|584810021|FG000|Overall Study|Withdrawal by Subject|24|||
161589624|NCT03047928|583548117|FG000|Overall Study|Adverse Event|0|||
161589625|NCT03047928|583548118|FG001|Overall Study|Adverse Event|2|||
161523041|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523042|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161589626|NCT03047928|583548119|FG002|Overall Study|Adverse Event|0|||
161589627|NCT03047928|583548117|FG000|Overall Study|Protocol Violation|0|||
161589628|NCT03047928|583548118|FG001|Overall Study|Protocol Violation|1|||
161523043|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523044|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523045|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523046|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523047|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523048|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523049|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523050|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523051|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161523052|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523053|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523054|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523055|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523056|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523057|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523058|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
161523059|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523060|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
161523061|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523062|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
161523063|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
161523064|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523065|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523066|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523067|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523068|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523069|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523070|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523071|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161523072|NCT01490632|583303901|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523073|NCT01490632|583303902|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523074|NCT01490632|583303903|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523075|NCT01490632|583303904|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523076|NCT01490632|583303905|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523077|NCT01490632|583303906|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
161523078|NCT01490632|583303907|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
161523079|NCT01490632|583303908|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
161523080|NCT01490632|583303909|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
161523081|NCT01490632|583303910|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
161523082|NCT01490632|583303911|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
161523083|NCT01490632|583303912|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
161523084|NCT01490632|583303913|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523085|NCT01490632|583303914|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523086|NCT01490632|583303915|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523087|NCT01490632|583303916|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523088|NCT01490632|583303917|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161589629|NCT03047928|583548119|FG002|Overall Study|Protocol Violation|0|||
161589630|NCT03047928|583548117|FG000|Overall Study|included in another protocol|0|||
161589631|NCT03047928|583548118|FG001|Overall Study|included in another protocol|1|||
161589632|NCT03047928|583548119|FG002|Overall Study|included in another protocol|0|||
161589633|NCT02729311|583548120|FG000|Overall Study|Withdrawal by Subject|8|||
161589634|NCT02729311|583548121|FG001|Overall Study|Withdrawal by Subject|2|||
161589635|NCT05324124|583548122|FG000|Period 1|Withdrawal by Subject|1|||
161589636|NCT05324124|583548123|FG001|Period 1|Withdrawal by Subject|0|||
161826003|NCT00763555|584403758|FG000|Overall Study|Lost to Follow-up|0|||
161826004|NCT00763555|584403759|FG001|Overall Study|Lost to Follow-up|3|||
161826005|NCT01729026|584403760|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
161826006|NCT01729026|584403761|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
161826007|NCT01729026|584403760|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
161826008|NCT01729026|584403761|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
161826009|NCT00298740|584403763|FG000|Overall Study|Lack of Efficacy|6|||
161826010|NCT00298740|584403763|FG000|Overall Study|Withdrawal by Subject|3|||
161826011|NCT00684567|584403765|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
161826012|NCT00684567|584403765|FG000|Monotherapy Period|Adverse Event|2|||
161934635|NCT00395447|584810022|FG001|Overall Study|Withdrawal by Subject|19|||
161934636|NCT00395447|584810021|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
161934637|NCT00395447|584810022|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
161523089|NCT01490632|583303918|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523090|NCT01490632|583303919|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523091|NCT01490632|583303920|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
161523092|NCT01490632|583303901|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523093|NCT01490632|583303902|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523094|NCT01490632|583303903|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523095|NCT01490632|583303904|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523096|NCT01490632|583303905|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523097|NCT01490632|583303906|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523098|NCT01490632|583303907|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523099|NCT01490632|583303908|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523100|NCT01490632|583303909|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523101|NCT01490632|583303910|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
161589637|NCT05324124|583548122|FG000|Period 1|Physician Decision|0|||
161589638|NCT05324124|583548123|FG001|Period 1|Physician Decision|1|||
161589639|NCT02287610|583548124|FG000|Overall Study|Lost to Follow-up|3|||
161589640|NCT02287610|583548124|FG000|Overall Study|Withdrawal by Subject|8|||
161589641|NCT02287610|583548124|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
161589642|NCT04950660|583548125|FG000|Overall Study|Protocol Violation|4|||
161589643|NCT04950660|583548126|FG001|Overall Study|Protocol Violation|2|||
161589644|NCT04950660|583548125|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
161589645|NCT04950660|583548126|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
161589646|NCT04950660|583548125|FG000|Overall Study|Withdrawal by Subject|0|||
161589647|NCT04950660|583548126|FG001|Overall Study|Withdrawal by Subject|1|||
161589648|NCT04950660|583548125|FG000|Overall Study|Hypotension|1|||
161589649|NCT04950660|583548126|FG001|Overall Study|Hypotension|0|||
161589650|NCT04783935|583548129|FG000|Overall Study|Withdrawal by Subject|6|||
161589651|NCT04783935|583548129|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
161589652|NCT04783935|583548129|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
161589653|NCT04783935|583548129|FG000|Overall Study|Lost to Follow-up|3|||
161589654|NCT04783935|583548129|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
161589655|NCT02437318|583548130|FG000|Overall Study|Progressive disease|207|||
161589656|NCT02437318|583548131|FG001|Overall Study|Progressive disease|240|||
161589657|NCT02437318|583548130|FG000|Overall Study|Subject/guardian decision|24|||
161589658|NCT02437318|583548131|FG001|Overall Study|Subject/guardian decision|11|||
161589659|NCT02437318|583548130|FG000|Overall Study|Physician Decision|29|||
161589660|NCT02437318|583548131|FG001|Overall Study|Physician Decision|22|||
161589661|NCT02437318|583548130|FG000|Overall Study|Adverse Event|14|||
161589662|NCT02437318|583548131|FG001|Overall Study|Adverse Event|4|||
161589663|NCT02437318|583548130|FG000|Overall Study|Death|4|||
161589664|NCT02437318|583548131|FG001|Overall Study|Death|4|||
161589665|NCT02437318|583548130|FG000|Overall Study|Protocol deviation|5|||
161589666|NCT02437318|583548131|FG001|Overall Study|Protocol deviation|7|||
161589667|NCT02437318|583548130|FG000|Overall Study|Sponsor decision|1|||
161589668|NCT02437318|583548131|FG001|Overall Study|Sponsor decision|0|||
161589669|NCT00920621|583548135|FG000|Overall Study|Lost to Follow-up|16|||
161589670|NCT00920621|583548136|FG001|Overall Study|Lost to Follow-up|17|||
161589671|NCT00920621|583548137|FG002|Overall Study|Lost to Follow-up|19|||
161589672|NCT00920621|583548138|FG003|Overall Study|Lost to Follow-up|21|||
161589673|NCT00920621|583548135|FG000|Overall Study|Fetal/neonatal deaths|16|||
161589674|NCT00920621|583548136|FG001|Overall Study|Fetal/neonatal deaths|14|||
161589675|NCT00920621|583548137|FG002|Overall Study|Fetal/neonatal deaths|16|||
161589676|NCT00920621|583548138|FG003|Overall Study|Fetal/neonatal deaths|14|||
161934638|NCT03766906|584810023|FG000|Overall Study|Withdrawal by Subject|6|||
161523102|NCT01490632|583303911|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523103|NCT01490632|583303912|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523104|NCT01490632|583303913|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
161589677|NCT00920621|583548135|FG000|Overall Study|Blood sample not collected|22|||
161589678|NCT00920621|583548136|FG001|Overall Study|Blood sample not collected|14|||
161589679|NCT00920621|583548137|FG002|Overall Study|Blood sample not collected|0|||
161589680|NCT00920621|583548138|FG003|Overall Study|Blood sample not collected|0|||
161589681|NCT06074523|583548139|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
161589682|NCT06074523|583548139|FG000|Overall Study|Withdrawal by Subject|1|||
161589683|NCT01426425|583548140|FG000|Overall Study|Exited prior to EP study|22|||
161589684|NCT01426425|583548140|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
161589685|NCT01426425|583548140|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
161589686|NCT03281291|583548146|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
161589687|NCT03281291|583548147|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
161589688|NCT03281291|583548148|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
161589689|NCT03281291|583548149|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
161934639|NCT00836901|584810024|FG000|First Intervention|Withdrawal by Subject|1|||
161934640|NCT00836901|584810025|FG001|First Intervention|Withdrawal by Subject|0|||
161934641|NCT01047540|584810028|FG000|Overall Study|Protocol Violation|1|||
161934642|NCT01047540|584810029|FG001|Overall Study|Protocol Violation|0|||
161934643|NCT01047540|584810030|FG002|Overall Study|Protocol Violation|0|||
161934644|NCT01047540|584810031|FG003|Overall Study|Protocol Violation|0|||
161934645|NCT01047540|584810032|FG004|Overall Study|Protocol Violation|0|||
161934646|NCT01047540|584810028|FG000|Overall Study|Lost to Follow-up|1|||
161934647|NCT01047540|584810029|FG001|Overall Study|Lost to Follow-up|0|||
161934648|NCT01047540|584810030|FG002|Overall Study|Lost to Follow-up|0|||
161934649|NCT01047540|584810031|FG003|Overall Study|Lost to Follow-up|0|||
161934650|NCT01047540|584810032|FG004|Overall Study|Lost to Follow-up|0|||
161934651|NCT01047540|584810028|FG000|Overall Study|Withdrawal by Subject|1|||
161934652|NCT01047540|584810029|FG001|Overall Study|Withdrawal by Subject|0|||
161934653|NCT01047540|584810030|FG002|Overall Study|Withdrawal by Subject|3|||
161934654|NCT01047540|584810031|FG003|Overall Study|Withdrawal by Subject|0|||
161934655|NCT01047540|584810032|FG004|Overall Study|Withdrawal by Subject|1|||
161934656|NCT01047540|584810028|FG000|Overall Study|Pregnancy|1|||
161934657|NCT01047540|584810029|FG001|Overall Study|Pregnancy|0|||
161934658|NCT01047540|584810030|FG002|Overall Study|Pregnancy|0|||
161934659|NCT01047540|584810031|FG003|Overall Study|Pregnancy|0|||
161934660|NCT01047540|584810032|FG004|Overall Study|Pregnancy|0|||
161934661|NCT01047540|584810028|FG000|Overall Study|Adverse Event|1|||
161523105|NCT01490632|583303914|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523106|NCT01490632|583303915|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
161523107|NCT01490632|583303916|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
161523108|NCT01490632|583303917|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523109|NCT01490632|583303918|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523110|NCT01490632|583303919|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523111|NCT01490632|583303920|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
161523112|NCT01490632|583303901|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523113|NCT01490632|583303902|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523114|NCT01490632|583303903|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523115|NCT01490632|583303904|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161589690|NCT03281291|583548150|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
161589691|NCT03281291|583548146|FG000|Overall Study|Protocol Deviation|2|||
161589692|NCT03281291|583548147|FG001|Overall Study|Protocol Deviation|0|||
161677736|NCT00375219|583872100|FG002|Overall Study|Disease progression|12|||
161677737|NCT00375219|583872098|FG000|Overall Study|Death|4|||
161677738|NCT00375219|583872099|FG001|Overall Study|Death|3|||
161677739|NCT00375219|583872100|FG002|Overall Study|Death|7|||
161677740|NCT00375219|583872098|FG000|Overall Study|Hematologic resistance|1|||
161677741|NCT00375219|583872099|FG001|Overall Study|Hematologic resistance|0|||
161677742|NCT00375219|583872100|FG002|Overall Study|Hematologic resistance|0|||
161677743|NCT00375219|583872098|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
161677744|NCT00375219|583872099|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
161677745|NCT00375219|583872100|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
161677746|NCT00375219|583872098|FG000|Overall Study|Allograft|2|||
161677747|NCT00375219|583872099|FG001|Overall Study|Allograft|0|||
161677748|NCT00375219|583872100|FG002|Overall Study|Allograft|0|||
161677749|NCT00375219|583872098|FG000|Overall Study|Cord blood transplantation|1|||
161677750|NCT00375219|583872099|FG001|Overall Study|Cord blood transplantation|0|||
161677751|NCT00375219|583872100|FG002|Overall Study|Cord blood transplantation|0|||
161934662|NCT01047540|584810029|FG001|Overall Study|Adverse Event|0|||
161934663|NCT01047540|584810030|FG002|Overall Study|Adverse Event|0|||
161934664|NCT01047540|584810031|FG003|Overall Study|Adverse Event|0|||
161934665|NCT01047540|584810032|FG004|Overall Study|Adverse Event|0|||
161934666|NCT03032484|584810038|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
161934667|NCT03032484|584810039|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
161589693|NCT03281291|583548148|FG002|Overall Study|Protocol Deviation|1|||
161589694|NCT03281291|583548149|FG003|Overall Study|Protocol Deviation|2|||
161589695|NCT03281291|583548150|FG004|Overall Study|Protocol Deviation|1|||
161589696|NCT03281291|583548146|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
161589697|NCT03281291|583548147|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161589698|NCT03281291|583548148|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
161589699|NCT03281291|583548149|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161934668|NCT03032484|584810038|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
161934669|NCT03032484|584810039|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
161677752|NCT00375219|583872098|FG000|Overall Study|Withdrawal by Subject|1|||
161677753|NCT00375219|583872099|FG001|Overall Study|Withdrawal by Subject|0|||
161934670|NCT01335685|584810046|FG000|Overall Study|Study Terminated by Sponsor|2|||
161934671|NCT01335685|584810047|FG001|Overall Study|Study Terminated by Sponsor|1|||
161934672|NCT01335685|584810048|FG002|Overall Study|Study Terminated by Sponsor|1|||
161934673|NCT01335685|584810049|FG003|Overall Study|Study Terminated by Sponsor|10|||
161934674|NCT01335685|584810050|FG004|Overall Study|Study Terminated by Sponsor|0|||
161826013|NCT00684567|584403765|FG000|Monotherapy Period|Death|1|||
161826014|NCT00684567|584403765|FG000|Monotherapy Period|Progression of primary disease|11|||
161826015|NCT02744755|584403766|FG000|Study Period 1|Protocol Violation|2|||
161826016|NCT02744755|584403767|FG001|Study Period 1|Protocol Violation|1|||
161826017|NCT02744755|584403766|FG000|Study Period 1|not defined|0|||
161826018|NCT02744755|584403767|FG001|Study Period 1|not defined|1|||
161826019|NCT02744755|584403766|FG000|Study Period 1|Pregnancy|1|||
161826020|NCT02744755|584403767|FG001|Study Period 1|Pregnancy|0|||
161826021|NCT02744755|584403766|FG000|Study Period 1|Adverse Event|1|||
161826022|NCT02744755|584403767|FG001|Study Period 1|Adverse Event|1|||
161826023|NCT02744755|584403766|FG000|Study Period 1|Lost to Follow-up|1|||
161826024|NCT02744755|584403767|FG001|Study Period 1|Lost to Follow-up|1|||
161826025|NCT02744755|584403766|FG000|Study Period 1|Lack of Efficacy|1|||
161826026|NCT02744755|584403767|FG001|Study Period 1|Lack of Efficacy|0|||
161826027|NCT02744755|584403766|FG000|Study Period 1|Withdrawal by Subject|8|||
161826028|NCT02744755|584403767|FG001|Study Period 1|Withdrawal by Subject|4|||
161826029|NCT02744755|584403766|FG000|Study Period 2|Adverse Event|5|||
161826030|NCT02744755|584403767|FG001|Study Period 2|Adverse Event|0|||
161826031|NCT02744755|584403766|FG000|Study Period 2|Protocol Violation|1|||
161826032|NCT02744755|584403767|FG001|Study Period 2|Protocol Violation|0|||
161826033|NCT02744755|584403766|FG000|Study Period 2|not defined|3|||
161826034|NCT02744755|584403767|FG001|Study Period 2|not defined|2|||
161826035|NCT02744755|584403766|FG000|Study Period 2|Lost to Follow-up|0|||
161826036|NCT02744755|584403767|FG001|Study Period 2|Lost to Follow-up|2|||
161826037|NCT02744755|584403766|FG000|Study Period 2|Withdrawal by Subject|2|||
161826038|NCT02744755|584403767|FG001|Study Period 2|Withdrawal by Subject|2|||
161826039|NCT02744755|584403766|FG000|Study Period 2|Lack of Efficacy|3|||
161826040|NCT02744755|584403767|FG001|Study Period 2|Lack of Efficacy|2|||
161826041|NCT00965757|584403768|FG000|Double-blind Phase|Progression of concomitant disease|1|||
161826042|NCT00965757|584403769|FG001|Double-blind Phase|Progression of concomitant disease|2|||
161826043|NCT00965757|584403770|FG002|Double-blind Phase|Progression of concomitant disease|0|||
161826044|NCT00965757|584403771|FG003|Double-blind Phase|Progression of concomitant disease|0|||
161826045|NCT00965757|584403768|FG000|Double-blind Phase|Adverse drug reaction|2|||
161826046|NCT00965757|584403769|FG001|Double-blind Phase|Adverse drug reaction|1|||
161826047|NCT00965757|584403770|FG002|Double-blind Phase|Adverse drug reaction|0|||
161826048|NCT00965757|584403771|FG003|Double-blind Phase|Adverse drug reaction|0|||
161826049|NCT00965757|584403768|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
161826050|NCT00965757|584403769|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
161826051|NCT00965757|584403770|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
161826052|NCT00965757|584403771|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
161826053|NCT00965757|584403768|FG000|Double-blind Phase|Lack of Efficacy|7|||
161826054|NCT00965757|584403769|FG001|Double-blind Phase|Lack of Efficacy|11|||
161826055|NCT00965757|584403770|FG002|Double-blind Phase|Lack of Efficacy|0|||
161826056|NCT00965757|584403771|FG003|Double-blind Phase|Lack of Efficacy|0|||
161826057|NCT00965757|584403768|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
161826058|NCT00965757|584403769|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161826059|NCT00965757|584403770|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161826060|NCT00965757|584403771|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161934675|NCT01335685|584810051|FG005|Overall Study|Study Terminated by Sponsor|4|||
161934676|NCT01335685|584810052|FG006|Overall Study|Study Terminated by Sponsor|2|||
161589700|NCT03281291|583548150|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
161589701|NCT03281291|583548146|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
161589702|NCT03281291|583548147|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
161589703|NCT03281291|583548148|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
161589704|NCT03281291|583548149|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
161589705|NCT03281291|583548150|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
161589706|NCT03281291|583548146|FG000|Overall Study|Lost to Follow-up|10|||
161589707|NCT03281291|583548147|FG001|Overall Study|Lost to Follow-up|10|||
161589708|NCT03281291|583548148|FG002|Overall Study|Lost to Follow-up|4|||
161589709|NCT03281291|583548149|FG003|Overall Study|Lost to Follow-up|6|||
161589710|NCT03281291|583548150|FG004|Overall Study|Lost to Follow-up|10|||
161826061|NCT00965757|584403768|FG000|Double-blind Phase|Lost to Follow-up|0|||
161826062|NCT00965757|584403769|FG001|Double-blind Phase|Lost to Follow-up|1|||
161826063|NCT00965757|584403770|FG002|Double-blind Phase|Lost to Follow-up|0|||
161826064|NCT00965757|584403771|FG003|Double-blind Phase|Lost to Follow-up|0|||
161826065|NCT00965757|584403768|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
161826066|NCT00965757|584403769|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
161826067|NCT00965757|584403770|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
161826068|NCT00965757|584403771|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
161826069|NCT00965757|584403768|FG000|Double-blind Phase|Other|1|||
161826070|NCT00965757|584403769|FG001|Double-blind Phase|Other|0|||
161826071|NCT00965757|584403770|FG002|Double-blind Phase|Other|0|||
161589711|NCT03281291|583548146|FG000|Overall Study|Other|0|||
161677754|NCT00375219|583872100|FG002|Overall Study|Withdrawal by Subject|0|||
161677755|NCT02684279|583872103|FG000|Overall Study|Adverse Event|87|||
161523116|NCT01490632|583303905|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523117|NCT01490632|583303906|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523118|NCT01490632|583303907|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523119|NCT01490632|583303908|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523120|NCT01490632|583303909|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523121|NCT01490632|583303910|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523122|NCT01490632|583303911|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523123|NCT01490632|583303912|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523124|NCT01490632|583303913|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523125|NCT01490632|583303914|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
161523126|NCT01490632|583303915|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523127|NCT01490632|583303916|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523128|NCT01490632|583303917|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523129|NCT01490632|583303918|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523130|NCT01490632|583303919|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523131|NCT01490632|583303920|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161523132|NCT01490632|583303901|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523133|NCT01490632|583303902|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523134|NCT01490632|583303903|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523135|NCT01490632|583303904|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523136|NCT01490632|583303905|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523137|NCT01490632|583303906|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523138|NCT01490632|583303907|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523139|NCT01490632|583303908|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161677756|NCT02684279|583872103|FG000|Overall Study|Lack of Efficacy|4|||
161677757|NCT02684279|583872103|FG000|Overall Study|Lost to Follow-up|61|||
161677758|NCT02684279|583872103|FG000|Overall Study|Protocol Violation|6|||
161677759|NCT02684279|583872103|FG000|Overall Study|Pregnancy|8|||
161677760|NCT02684279|583872103|FG000|Overall Study|Withdrawal by Subject|92|||
161677761|NCT02684279|583872103|FG000|Overall Study|non-compliance with study drug|9|||
161677762|NCT02684279|583872103|FG000|Overall Study|non compliance with study visits|2|||
161677763|NCT02684279|583872103|FG000|Overall Study|subject to have surgery|1|||
161677764|NCT02684279|583872103|FG000|Overall Study|family emergency|1|||
161677765|NCT02684279|583872103|FG000|Overall Study|Site closures|7|||
161677766|NCT02684279|583872103|FG000|Overall Study|Physician Decision|1|||
161677767|NCT00228566|583872104|FG000|Overall Study|Adverse Event|31|||
161677768|NCT00228566|583872104|FG000|Overall Study|Lack of Efficacy|14|||
161677769|NCT00228566|583872104|FG000|Overall Study|Lost to Follow-up|16|||
161677770|NCT00228566|583872104|FG000|Overall Study|Physician Decision|5|||
161677771|NCT00228566|583872104|FG000|Overall Study|Withdrawal by Subject|4|||
161677772|NCT00228566|583872104|FG000|Overall Study|Miscellaneous|1|||
161677773|NCT01479829|583872105|FG000|Overall Study|Withdrawal by Subject|8|||
161677774|NCT01479829|583872106|FG001|Overall Study|Withdrawal by Subject|10|||
161677775|NCT01444456|583872111|FG000|Overall Study|Withdrawal by Subject|21|||
161677776|NCT01444456|583872111|FG000|Overall Study|Physician Decision|9|||
161677777|NCT01444456|583872111|FG000|Overall Study|Lost to Follow-up|37|||
161677778|NCT01444456|583872111|FG000|Overall Study|Death|73|||
161677779|NCT01444456|583872111|FG000|Overall Study|Ineligibility determined|23|||
161677780|NCT01444456|583872111|FG000|Overall Study|Other|18|||
161677781|NCT01444456|583872111|FG000|Overall Study|Not treated|104|||
161677782|NCT02142738|583873552|FG000|Overall Study|Adverse Event|13|||
161677783|NCT02142738|583873553|FG001|Overall Study|Adverse Event|9|||
161677784|NCT02142738|583873552|FG000|Overall Study|Death|92|||
161677785|NCT02142738|583873553|FG001|Overall Study|Death|112|||
161677786|NCT02142738|583873552|FG000|Overall Study|Lost to Follow-up|0|||
161934677|NCT01335685|584810053|FG007|Overall Study|Study Terminated by Sponsor|3|||
161523140|NCT01490632|583303909|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523141|NCT01490632|583303910|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523142|NCT01490632|583303911|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523143|NCT01490632|583303912|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523144|NCT01490632|583303913|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523145|NCT01490632|583303914|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523146|NCT01490632|583303915|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
161523147|NCT01490632|583303916|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
161523148|NCT01490632|583303917|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523149|NCT01490632|583303918|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523150|NCT01490632|583303919|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161523151|NCT01490632|583303920|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161549253|NCT02291289|583401015|FG006|Induction Treatment|Missing|0|||
161677787|NCT02142738|583873553|FG001|Overall Study|Lost to Follow-up|3|||
161677788|NCT02142738|583873552|FG000|Overall Study|Withdrawal by Subject|6|||
161934678|NCT01335685|584810046|FG000|Overall Study|Withdrawal by Subject|1|||
161934679|NCT01335685|584810047|FG001|Overall Study|Withdrawal by Subject|0|||
161934680|NCT01335685|584810048|FG002|Overall Study|Withdrawal by Subject|0|||
161934681|NCT01335685|584810049|FG003|Overall Study|Withdrawal by Subject|1|||
161934682|NCT01335685|584810050|FG004|Overall Study|Withdrawal by Subject|0|||
161523152|NCT01490632|583303901|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523153|NCT01490632|583303902|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523154|NCT01490632|583303903|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523155|NCT01490632|583303904|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523156|NCT01490632|583303905|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161934683|NCT01335685|584810051|FG005|Overall Study|Withdrawal by Subject|0|||
161934684|NCT01335685|584810052|FG006|Overall Study|Withdrawal by Subject|0|||
161934685|NCT01335685|584810053|FG007|Overall Study|Withdrawal by Subject|0|||
161934686|NCT01335685|584810046|FG000|Overall Study|Reason not Specified|0|||
161934687|NCT01335685|584810047|FG001|Overall Study|Reason not Specified|0|||
161934688|NCT01335685|584810048|FG002|Overall Study|Reason not Specified|1|||
161934689|NCT01335685|584810049|FG003|Overall Study|Reason not Specified|0|||
161934690|NCT01335685|584810050|FG004|Overall Study|Reason not Specified|0|||
161934691|NCT01335685|584810051|FG005|Overall Study|Reason not Specified|1|||
161934692|NCT01335685|584810052|FG006|Overall Study|Reason not Specified|0|||
161934693|NCT01335685|584810053|FG007|Overall Study|Reason not Specified|0|||
161934694|NCT02554474|584810056|FG000|Overall Study|Protocol Violation|1|||
161523157|NCT01490632|583303906|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523158|NCT01490632|583303907|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523159|NCT01490632|583303908|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523160|NCT01490632|583303909|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523161|NCT01490632|583303910|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523162|NCT01490632|583303911|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523163|NCT01490632|583303912|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523164|NCT01490632|583303913|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
161523165|NCT01490632|583303914|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
161523166|NCT01490632|583303915|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
161523167|NCT01490632|583303916|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
161523168|NCT01490632|583303917|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523169|NCT01490632|583303918|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523170|NCT01490632|583303919|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523171|NCT01490632|583303920|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161523172|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
161523173|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
161523174|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
161523175|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
161523176|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
161523177|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
161523178|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
161523179|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
161523180|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
161523181|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
161523182|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
161523183|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
161523184|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
161523185|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
161523186|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
161523187|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
161523188|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
161523189|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
161523190|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
161523191|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
161523192|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Death|0|||
161589712|NCT03281291|583548147|FG001|Overall Study|Other|2|||
161589713|NCT03281291|583548148|FG002|Overall Study|Other|0|||
161589714|NCT03281291|583548149|FG003|Overall Study|Other|2|||
161589715|NCT03281291|583548150|FG004|Overall Study|Other|1|||
161589716|NCT00512070|583548151|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
161934695|NCT02554474|584810057|FG001|Overall Study|Protocol Violation|1|||
161934696|NCT02554474|584810056|FG000|Overall Study|Health issue not related to the study|1|||
161934697|NCT02554474|584810057|FG001|Overall Study|Health issue not related to the study|0|||
161934698|NCT02554474|584810056|FG000|Overall Study|Withdrawal by Subject|1|||
161934699|NCT02554474|584810057|FG001|Overall Study|Withdrawal by Subject|1|||
161934700|NCT03211832|584810058|FG000|Overall Study|No longer with agency|32|||
161934701|NCT03211832|584810059|FG001|Overall Study|No longer with agency|49|||
161934702|NCT03211832|584810060|FG002|Overall Study|No longer with agency|30|||
161934703|NCT03211832|584810058|FG000|Overall Study|Declined survey|3|||
161934704|NCT03211832|584810059|FG001|Overall Study|Declined survey|3|||
161934705|NCT03211832|584810060|FG002|Overall Study|Declined survey|2|||
161934706|NCT03211832|584810058|FG000|Overall Study|Not available during data collection|1|||
161934707|NCT03211832|584810059|FG001|Overall Study|Not available during data collection|0|||
161934708|NCT03211832|584810060|FG002|Overall Study|Not available during data collection|2|||
161934709|NCT00489476|584810064|FG000|Overall Study|Lost to Follow-up|0|||
161934710|NCT00489476|584810065|FG001|Overall Study|Lost to Follow-up|1|||
161934711|NCT00489476|584810066|FG002|Overall Study|Lost to Follow-up|0|||
161934712|NCT00489476|584810067|FG003|Overall Study|Lost to Follow-up|0|||
161934713|NCT04003389|584810070|FG000|Overall Study|Adverse Event|27|||
161934714|NCT04003389|584810071|FG001|Overall Study|Adverse Event|34|||
161934715|NCT04003389|584810072|FG002|Overall Study|Adverse Event|28|||
161934716|NCT04003389|584810070|FG000|Overall Study|Lost to Follow-up|39|||
161934717|NCT04003389|584810071|FG001|Overall Study|Lost to Follow-up|30|||
161934718|NCT04003389|584810072|FG002|Overall Study|Lost to Follow-up|33|||
161934719|NCT04003389|584810070|FG000|Overall Study|Protocol Violation|1|||
161934720|NCT04003389|584810071|FG001|Overall Study|Protocol Violation|6|||
161934721|NCT04003389|584810072|FG002|Overall Study|Protocol Violation|5|||
161523193|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Death|0|||
161523194|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Death|0|||
161523195|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Death|0|||
161934722|NCT04003389|584810070|FG000|Overall Study|Withdrawal by Subject|119|||
161934723|NCT04003389|584810071|FG001|Overall Study|Withdrawal by Subject|79|||
161934724|NCT04003389|584810072|FG002|Overall Study|Withdrawal by Subject|85|||
161934725|NCT04003389|584810070|FG000|Overall Study|Miscellaneous|14|||
161934726|NCT04003389|584810071|FG001|Overall Study|Miscellaneous|11|||
161934727|NCT04003389|584810072|FG002|Overall Study|Miscellaneous|14|||
161934728|NCT04003389|584810070|FG000|Overall Study|Participant did not receive study drug|1|||
161934729|NCT04003389|584810071|FG001|Overall Study|Participant did not receive study drug|0|||
161934730|NCT04003389|584810072|FG002|Overall Study|Participant did not receive study drug|0|||
161934731|NCT03769116|584810077|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
161934732|NCT03769116|584810078|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
161934733|NCT03769116|584810077|FG000|Part 3 - Open Label|Physician Decision|1|||
161934734|NCT03769116|584810078|FG001|Part 3 - Open Label|Physician Decision|0|||
161934735|NCT03769116|584810077|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
161934736|NCT03769116|584810078|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
161523196|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Death|0|||
161523197|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Death|0|||
161523198|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Death|0|||
161523199|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Death|0|||
161523200|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Death|0|||
161523201|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Death|0|||
161523202|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Death|0|||
161523203|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Death|0|||
161523204|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Death|0|||
161523205|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Death|0|||
161523206|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Death|0|||
161934737|NCT02514746|584810082|FG000|Overall Study|Chronically Ill|1|||
161934738|NCT02514746|584810083|FG001|Overall Study|Chronically Ill|2|||
161934739|NCT02514746|584810082|FG000|Overall Study|Physician Decision|4|||
161934740|NCT02514746|584810083|FG001|Overall Study|Physician Decision|2|||
161523207|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Death|0|||
161523208|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Death|0|||
161523209|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Death|0|||
161523210|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Death|1|||
161523211|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Death|0|||
161523212|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523213|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161589717|NCT00512070|583548152|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
161589718|NCT00512070|583548153|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
161589719|NCT00512070|583548151|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
161934741|NCT02514746|584810082|FG000|Overall Study|Withdrawal by Subject|12|||
161934742|NCT02514746|584810083|FG001|Overall Study|Withdrawal by Subject|10|||
161934743|NCT02514746|584810082|FG000|Overall Study|Other|5|||
161934744|NCT02514746|584810083|FG001|Overall Study|Other|1|||
161523214|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523215|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523216|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161934745|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
161934746|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
161934747|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
161523217|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523218|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523219|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523220|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523221|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523222|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523223|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523224|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523225|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523226|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523227|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523228|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
161523229|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
161523230|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
161523231|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
161523232|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523233|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523234|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523235|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523236|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523237|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523238|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523239|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523240|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523241|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523242|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161589720|NCT00512070|583548152|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
161589721|NCT00512070|583548153|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
161589722|NCT04956861|583548154|FG000|Overall Study|Withdrawal by Subject|4|||
161589723|NCT04956861|583548155|FG001|Overall Study|Withdrawal by Subject|4|||
161589724|NCT04956861|583548156|FG002|Overall Study|Withdrawal by Subject|2|||
161589725|NCT04956861|583548154|FG000|Overall Study|Physician Decision|4|||
161589726|NCT04956861|583548155|FG001|Overall Study|Physician Decision|5|||
161589727|NCT04956861|583548156|FG002|Overall Study|Physician Decision|1|||
161589728|NCT00961571|583548157|FG000|Overall Study|Physician Decision|39|||
161589729|NCT05862870|583548161|FG000|Overall Study|Lost to Follow-up|3|||
161589730|NCT02900924|583548162|FG000|Overall Study|Death|52|||
161589731|NCT02900924|583548162|FG000|Overall Study|Lost to Follow-up|4|||
161589732|NCT02900924|583548162|FG000|Overall Study|Withdrawal by Subject|20|||
161589733|NCT02900924|583548162|FG000|Overall Study|Missed Visit|33|||
161589734|NCT03143153|583548163|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
161589735|NCT03143153|583548164|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
161589736|NCT03143153|583548165|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
161589737|NCT03143153|583548163|FG000|Pre-Treatment|Participant withdrew consent|0|||
161589738|NCT03143153|583548164|FG001|Pre-Treatment|Participant withdrew consent|1|||
161589739|NCT03143153|583548165|FG002|Pre-Treatment|Participant withdrew consent|12|||
161589740|NCT03143153|583548163|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
161589741|NCT03143153|583548164|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
161589742|NCT03143153|583548165|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
161523243|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523244|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523245|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161589743|NCT03143153|583548163|FG000|Pre-Treatment|Other Reasons|1|||
161589744|NCT03143153|583548164|FG001|Pre-Treatment|Other Reasons|2|||
161589745|NCT03143153|583548165|FG002|Pre-Treatment|Other Reasons|1|||
161589746|NCT03143153|583548163|FG000|Pre-Treatment|Disease Progression|1|||
161826072|NCT00965757|584403771|FG003|Double-blind Phase|Other|0|||
161589747|NCT03143153|583548164|FG001|Pre-Treatment|Disease Progression|1|||
161826073|NCT00965757|584403768|FG000|Extension Phase|Progression of concomitant disease|0|||
161826074|NCT00965757|584403769|FG001|Extension Phase|Progression of concomitant disease|0|||
161826075|NCT00965757|584403770|FG002|Extension Phase|Progression of concomitant disease|4|||
161826076|NCT00965757|584403771|FG003|Extension Phase|Progression of concomitant disease|2|||
161826077|NCT00965757|584403768|FG000|Extension Phase|Adverse drug reaction|0|||
161826078|NCT00965757|584403769|FG001|Extension Phase|Adverse drug reaction|0|||
161826079|NCT00965757|584403770|FG002|Extension Phase|Adverse drug reaction|6|||
161826080|NCT00965757|584403771|FG003|Extension Phase|Adverse drug reaction|3|||
161826081|NCT00965757|584403768|FG000|Extension Phase|Abnormal Laboratory Value|0|||
161826082|NCT00965757|584403769|FG001|Extension Phase|Abnormal Laboratory Value|0|||
161826083|NCT00965757|584403770|FG002|Extension Phase|Abnormal Laboratory Value|6|||
161826084|NCT00965757|584403771|FG003|Extension Phase|Abnormal Laboratory Value|1|||
161523246|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523247|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523248|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523249|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523250|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
161523251|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
161523252|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
161523253|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
161523254|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
161523255|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
161523256|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
161523257|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
161523258|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
161523259|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
161523260|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
161523261|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
161523262|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
161523263|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
161523264|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
161523265|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
161523266|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
161523267|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
161523268|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
161523269|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
161523270|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
161523271|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
161523272|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
161523273|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
161523274|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
161523275|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
161523276|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
161523277|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
161523278|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
161523279|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
161523280|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
161826085|NCT00965757|584403768|FG000|Extension Phase|Lack of Efficacy|0|||
161826086|NCT00965757|584403769|FG001|Extension Phase|Lack of Efficacy|0|||
161523281|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
161523282|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
161523283|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
161523284|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
161523285|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
161523286|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
161523287|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
161523288|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
161523289|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
161523290|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
161523291|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
161589748|NCT03143153|583548165|FG002|Pre-Treatment|Disease Progression|2|||
161589749|NCT03143153|583548163|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161523292|NCT01490632|583303901|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523293|NCT01490632|583303902|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523294|NCT01490632|583303903|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523295|NCT01490632|583303904|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523296|NCT01490632|583303905|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523297|NCT01490632|583303906|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523298|NCT01490632|583303907|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523299|NCT01490632|583303908|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523300|NCT01490632|583303909|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523301|NCT01490632|583303910|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523302|NCT01490632|583303911|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523303|NCT01490632|583303912|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523304|NCT01490632|583303913|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523305|NCT01490632|583303914|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161589750|NCT03143153|583548164|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
161826087|NCT00965757|584403770|FG002|Extension Phase|Lack of Efficacy|8|||
161826088|NCT00965757|584403771|FG003|Extension Phase|Lack of Efficacy|12|||
161826089|NCT00965757|584403768|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161826090|NCT00965757|584403769|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161826091|NCT00965757|584403770|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
161523306|NCT01490632|583303915|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523307|NCT01490632|583303916|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523308|NCT01490632|583303917|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
161523309|NCT01490632|583303918|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
161523310|NCT01490632|583303919|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
161523311|NCT01490632|583303920|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
161523312|NCT02332720|583303921|FG000|Part A and Part B|Lost to Follow-up|1|||
161934748|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
161934749|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
161934750|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161934751|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
161934752|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161934753|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
161934754|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
161934755|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
161934756|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
161934757|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
161934758|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
161934759|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
161934760|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
161934761|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
161934762|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
161934763|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
161934764|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
161934765|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
161934766|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
161934767|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
161934768|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
161934769|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
161934770|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
161589751|NCT03143153|583548165|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
161589752|NCT03143153|583548163|FG000|Treatment|Disease progression|174|||
161589753|NCT03143153|583548164|FG001|Treatment|Disease progression|184|||
161589754|NCT03143153|583548165|FG002|Treatment|Disease progression|193|||
161589755|NCT03143153|583548163|FG000|Treatment|Study drug toxicity|59|||
161589756|NCT03143153|583548164|FG001|Treatment|Study drug toxicity|33|||
161589757|NCT03143153|583548165|FG002|Treatment|Study drug toxicity|40|||
161589758|NCT03143153|583548163|FG000|Treatment|Death|5|||
161589759|NCT03143153|583548164|FG001|Treatment|Death|3|||
161589760|NCT03143153|583548165|FG002|Treatment|Death|4|||
161589761|NCT03143153|583548163|FG000|Treatment|Adverse event unrelated to study drug|19|||
161589762|NCT03143153|583548164|FG001|Treatment|Adverse event unrelated to study drug|28|||
161589763|NCT03143153|583548165|FG002|Treatment|Adverse event unrelated to study drug|12|||
161589764|NCT03143153|583548163|FG000|Treatment|Participant request to discontinue study treatment|13|||
161589765|NCT03143153|583548164|FG001|Treatment|Participant request to discontinue study treatment|15|||
161589766|NCT03143153|583548165|FG002|Treatment|Participant request to discontinue study treatment|20|||
161589767|NCT03143153|583548163|FG000|Treatment|Participant withdrew consent|3|||
161934771|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
161934772|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
161934773|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
161523313|NCT02332720|583303922|FG001|Part A and Part B|Lost to Follow-up|0|||
161523314|NCT02332720|583303923|FG002|Part A and Part B|Lost to Follow-up|0|||
161523315|NCT02332720|583303924|FG003|Part A and Part B|Lost to Follow-up|0|||
161523316|NCT02332720|583303925|FG004|Part A and Part B|Lost to Follow-up|0|||
161523317|NCT02332720|583303926|FG005|Part A and Part B|Lost to Follow-up|2|||
161523318|NCT02332720|583303927|FG006|Part A and Part B|Lost to Follow-up|1|||
161523319|NCT02332720|583303928|FG007|Part A and Part B|Lost to Follow-up|1|||
161523320|NCT02332720|583303929|FG008|Part A and Part B|Lost to Follow-up|0|||
161523321|NCT02332720|583303930|FG009|Part A and Part B|Lost to Follow-up|0|||
161523322|NCT02332720|583303931|FG010|Part A and Part B|Lost to Follow-up|0|||
161523323|NCT02332720|583303932|FG011|Part A and Part B|Lost to Follow-up|0|||
161523324|NCT02332720|583303933|FG012|Part A and Part B|Lost to Follow-up|0|||
161523325|NCT02332720|583303934|FG013|Part A and Part B|Lost to Follow-up|0|||
161523326|NCT02332720|583303935|FG014|Part A and Part B|Lost to Follow-up|0|||
161523327|NCT02332720|583303936|FG015|Part A and Part B|Lost to Follow-up|1|||
161523328|NCT02332720|583303937|FG016|Part A and Part B|Lost to Follow-up|0|||
161523329|NCT02332720|583303938|FG017|Part A and Part B|Lost to Follow-up|0|||
161523330|NCT02332720|583303939|FG018|Part A and Part B|Lost to Follow-up|0|||
161523331|NCT02332720|583303940|FG019|Part A and Part B|Lost to Follow-up|0|||
161523332|NCT02332720|583303941|FG020|Part A and Part B|Lost to Follow-up|0|||
161523333|NCT02332720|583303942|FG021|Part A and Part B|Lost to Follow-up|0|||
161589768|NCT03143153|583548164|FG001|Treatment|Participant withdrew consent|4|||
161934774|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
161677789|NCT02142738|583873553|FG001|Overall Study|Withdrawal by Subject|7|||
161677790|NCT02142738|583873552|FG000|Overall Study|Follow up ended by sponsor|43|||
161826092|NCT00965757|584403771|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161826093|NCT00965757|584403768|FG000|Extension Phase|Lost to Follow-up|0|||
161826094|NCT00965757|584403769|FG001|Extension Phase|Lost to Follow-up|0|||
161523334|NCT02332720|583303943|FG022|Part A and Part B|Lost to Follow-up|0|||
161523335|NCT02332720|583303921|FG000|Part A and Part B|Adverse Event|0|||
161523336|NCT02332720|583303922|FG001|Part A and Part B|Adverse Event|0|||
161677791|NCT02142738|583873553|FG001|Overall Study|Follow up ended by sponsor|20|||
161677792|NCT03713034|583873554|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
161677793|NCT03713034|583873555|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
161677794|NCT02615470|583873556|FG000|Overall Study|Lost to Follow-up|21|||
161677795|NCT02615470|583873557|FG001|Overall Study|Lost to Follow-up|32|||
161677796|NCT02982590|583873561|FG000|Overall Study|Lost to Follow-up|0|||
161677797|NCT02982590|583873562|FG001|Overall Study|Lost to Follow-up|1|||
161677798|NCT02982590|583873561|FG000|Overall Study|Death|4|||
161677799|NCT02982590|583873562|FG001|Overall Study|Death|0|||
161677800|NCT00419120|583873566|FG000|Long Term Follow up Period|study ongoing|10|||
161677801|NCT00388505|583873567|FG000|Overall Study|Adverse Event or Death|43|||
161677802|NCT00388505|583873568|FG001|Overall Study|Adverse Event or Death|17|||
161677803|NCT00388505|583873567|FG000|Overall Study|Withdrawal by Subject|24|||
161677804|NCT00388505|583873568|FG001|Overall Study|Withdrawal by Subject|9|||
161677805|NCT00388505|583873567|FG000|Overall Study|Lost to Follow-up|5|||
161677806|NCT00388505|583873568|FG001|Overall Study|Lost to Follow-up|3|||
161677807|NCT00388505|583873567|FG000|Overall Study|Inappropriate Enrollment|0|||
161677808|NCT00388505|583873568|FG001|Overall Study|Inappropriate Enrollment|1|||
161677809|NCT00388505|583873567|FG000|Overall Study|Administrative Reason|1|||
161677810|NCT00388505|583873568|FG001|Overall Study|Administrative Reason|0|||
161677811|NCT00388505|583873567|FG000|Overall Study|Protocol Violation|6|||
161677812|NCT00388505|583873568|FG001|Overall Study|Protocol Violation|5|||
161677813|NCT00388505|583873567|FG000|Overall Study|Unable to classify|4|||
161677814|NCT00388505|583873568|FG001|Overall Study|Unable to classify|3|||
161677815|NCT02667275|583873570|FG000|Overall Study|Protocol Violation|11|||
161677816|NCT02667275|583873571|FG001|Overall Study|Protocol Violation|7|||
161677817|NCT02667275|583873570|FG000|Overall Study|Lost to Follow-up|0|||
161677818|NCT02667275|583873571|FG001|Overall Study|Lost to Follow-up|2|||
161677819|NCT02667275|583873570|FG000|Overall Study|Withdrawal by Subject|0|||
161677820|NCT02667275|583873571|FG001|Overall Study|Withdrawal by Subject|5|||
161677821|NCT02667275|583873570|FG000|Overall Study|Discontinued early without completing|0|||
161677822|NCT02667275|583873571|FG001|Overall Study|Discontinued early without completing|1|||
161677823|NCT01756040|583873572|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
161677824|NCT01756040|583873572|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
161677825|NCT01756040|583873572|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
161826095|NCT00965757|584403770|FG002|Extension Phase|Lost to Follow-up|0|||
161826096|NCT00965757|584403771|FG003|Extension Phase|Lost to Follow-up|1|||
161826097|NCT00965757|584403768|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
161826098|NCT00965757|584403769|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
161826099|NCT00965757|584403770|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
161826100|NCT00965757|584403771|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
161826101|NCT00965757|584403768|FG000|Extension Phase|Protocol Violation|0|||
161826102|NCT00965757|584403769|FG001|Extension Phase|Protocol Violation|0|||
161826103|NCT00965757|584403770|FG002|Extension Phase|Protocol Violation|0|||
161826104|NCT00965757|584403771|FG003|Extension Phase|Protocol Violation|1|||
161826105|NCT00965757|584403768|FG000|Extension Phase|Other|0|||
161826106|NCT00965757|584403769|FG001|Extension Phase|Other|0|||
161826107|NCT00965757|584403770|FG002|Extension Phase|Other|2|||
161826108|NCT00965757|584403771|FG003|Extension Phase|Other|1|||
161826109|NCT01344018|584403775|FG000|Overall Study|Death|22|||
161826110|NCT01344018|584403776|FG001|Overall Study|Death|25|||
161826111|NCT01344018|584403775|FG000|Overall Study|Lost to Follow-up|4|||
161826112|NCT01344018|584403776|FG001|Overall Study|Lost to Follow-up|7|||
161826113|NCT04010227|584403777|FG000|Overall Study|Death|1|||
161826114|NCT04010227|584403778|FG001|Overall Study|Death|2|||
161826115|NCT04010227|584403777|FG000|Overall Study|Medical Reasons|4|||
161826116|NCT04010227|584403778|FG001|Overall Study|Medical Reasons|3|||
161826117|NCT04010227|584403777|FG000|Overall Study|Withdrawal by Subject|2|||
161826118|NCT04010227|584403778|FG001|Overall Study|Withdrawal by Subject|0|||
161826119|NCT04010227|584403777|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
161826120|NCT04010227|584403778|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
161826121|NCT02308696|584403779|FG000|Overall Study|Lost to Follow-up|28|||
161826122|NCT02308696|584403780|FG001|Overall Study|Lost to Follow-up|21|||
161826123|NCT02308696|584403779|FG000|Overall Study|Death|8|||
161826124|NCT02308696|584403780|FG001|Overall Study|Death|4|||
161826125|NCT02308696|584403779|FG000|Overall Study|Moved to a Higher Level of Care|17|||
161826126|NCT02308696|584403780|FG001|Overall Study|Moved to a Higher Level of Care|6|||
161826127|NCT02914457|584403781|FG000|Overall Study|Withdrawal by Subject|1|||
161934775|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Death|0|||
161934776|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Death|0|||
161523337|NCT02332720|583303923|FG002|Part A and Part B|Adverse Event|0|||
161523338|NCT02332720|583303924|FG003|Part A and Part B|Adverse Event|0|||
161523339|NCT02332720|583303925|FG004|Part A and Part B|Adverse Event|0|||
161523340|NCT02332720|583303926|FG005|Part A and Part B|Adverse Event|0|||
161523341|NCT02332720|583303927|FG006|Part A and Part B|Adverse Event|0|||
161523342|NCT02332720|583303928|FG007|Part A and Part B|Adverse Event|0|||
161523343|NCT02332720|583303929|FG008|Part A and Part B|Adverse Event|0|||
161523344|NCT02332720|583303930|FG009|Part A and Part B|Adverse Event|0|||
161523345|NCT02332720|583303931|FG010|Part A and Part B|Adverse Event|0|||
161523346|NCT02332720|583303932|FG011|Part A and Part B|Adverse Event|0|||
161523347|NCT02332720|583303933|FG012|Part A and Part B|Adverse Event|0|||
161523348|NCT02332720|583303934|FG013|Part A and Part B|Adverse Event|0|||
161523349|NCT02332720|583303935|FG014|Part A and Part B|Adverse Event|0|||
161523350|NCT02332720|583303936|FG015|Part A and Part B|Adverse Event|0|||
161523351|NCT02332720|583303937|FG016|Part A and Part B|Adverse Event|0|||
161523352|NCT02332720|583303938|FG017|Part A and Part B|Adverse Event|1|||
161523353|NCT02332720|583303939|FG018|Part A and Part B|Adverse Event|0|||
161523354|NCT02332720|583303940|FG019|Part A and Part B|Adverse Event|0|||
161523355|NCT02332720|583303941|FG020|Part A and Part B|Adverse Event|0|||
161523356|NCT02332720|583303942|FG021|Part A and Part B|Adverse Event|0|||
161523357|NCT02332720|583303943|FG022|Part A and Part B|Adverse Event|0|||
161523358|NCT02332720|583303921|FG000|Part A and Part B|Physician Decision|0|||
161523359|NCT02332720|583303922|FG001|Part A and Part B|Physician Decision|0|||
161523360|NCT02332720|583303923|FG002|Part A and Part B|Physician Decision|0|||
161523361|NCT02332720|583303924|FG003|Part A and Part B|Physician Decision|0|||
161523362|NCT02332720|583303925|FG004|Part A and Part B|Physician Decision|0|||
161523363|NCT02332720|583303926|FG005|Part A and Part B|Physician Decision|0|||
161523364|NCT02332720|583303927|FG006|Part A and Part B|Physician Decision|0|||
161523365|NCT02332720|583303928|FG007|Part A and Part B|Physician Decision|0|||
161523366|NCT02332720|583303929|FG008|Part A and Part B|Physician Decision|0|||
161523367|NCT02332720|583303930|FG009|Part A and Part B|Physician Decision|0|||
161523368|NCT02332720|583303931|FG010|Part A and Part B|Physician Decision|0|||
161523369|NCT02332720|583303932|FG011|Part A and Part B|Physician Decision|0|||
161523370|NCT02332720|583303933|FG012|Part A and Part B|Physician Decision|0|||
161523371|NCT02332720|583303934|FG013|Part A and Part B|Physician Decision|0|||
161523372|NCT02332720|583303935|FG014|Part A and Part B|Physician Decision|0|||
161523373|NCT02332720|583303936|FG015|Part A and Part B|Physician Decision|0|||
161523374|NCT02332720|583303937|FG016|Part A and Part B|Physician Decision|0|||
161523375|NCT02332720|583303938|FG017|Part A and Part B|Physician Decision|0|||
161934777|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Death|0|||
161934778|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Death|0|||
161934779|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Death|1|||
161934780|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
161523376|NCT02332720|583303939|FG018|Part A and Part B|Physician Decision|1|||
161523377|NCT02332720|583303940|FG019|Part A and Part B|Physician Decision|0|||
161523378|NCT02332720|583303941|FG020|Part A and Part B|Physician Decision|0|||
161523379|NCT02332720|583303942|FG021|Part A and Part B|Physician Decision|0|||
161523380|NCT02332720|583303943|FG022|Part A and Part B|Physician Decision|0|||
161523381|NCT02332720|583303921|FG000|Part A and Part B|Withdrawal by Subject|0|||
161523382|NCT02332720|583303922|FG001|Part A and Part B|Withdrawal by Subject|0|||
161523383|NCT02332720|583303923|FG002|Part A and Part B|Withdrawal by Subject|0|||
161523384|NCT02332720|583303924|FG003|Part A and Part B|Withdrawal by Subject|0|||
161523385|NCT02332720|583303925|FG004|Part A and Part B|Withdrawal by Subject|0|||
161523386|NCT02332720|583303926|FG005|Part A and Part B|Withdrawal by Subject|1|||
161523387|NCT02332720|583303927|FG006|Part A and Part B|Withdrawal by Subject|0|||
161523388|NCT02332720|583303928|FG007|Part A and Part B|Withdrawal by Subject|0|||
161523389|NCT02332720|583303929|FG008|Part A and Part B|Withdrawal by Subject|0|||
161523390|NCT02332720|583303930|FG009|Part A and Part B|Withdrawal by Subject|0|||
161523391|NCT02332720|583303931|FG010|Part A and Part B|Withdrawal by Subject|0|||
161523392|NCT02332720|583303932|FG011|Part A and Part B|Withdrawal by Subject|0|||
161523393|NCT02332720|583303933|FG012|Part A and Part B|Withdrawal by Subject|0|||
161589769|NCT03143153|583548165|FG002|Treatment|Participant withdrew consent|12|||
161589770|NCT03143153|583548163|FG000|Treatment|Pregnancy|1|||
161589771|NCT03143153|583548164|FG001|Treatment|Pregnancy|0|||
161589772|NCT03143153|583548165|FG002|Treatment|Pregnancy|0|||
161589773|NCT03143153|583548163|FG000|Treatment|Maximum clinical benefit|1|||
161589774|NCT03143153|583548164|FG001|Treatment|Maximum clinical benefit|3|||
161589775|NCT03143153|583548165|FG002|Treatment|Maximum clinical benefit|4|||
161589776|NCT03143153|583548163|FG000|Treatment|Completed treatment as per Protocol|13|||
161589777|NCT03143153|583548164|FG001|Treatment|Completed treatment as per Protocol|8|||
161934781|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
161523394|NCT02332720|583303934|FG013|Part A and Part B|Withdrawal by Subject|0|||
161523395|NCT02332720|583303935|FG014|Part A and Part B|Withdrawal by Subject|0|||
161523396|NCT02332720|583303936|FG015|Part A and Part B|Withdrawal by Subject|0|||
161934782|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
161523397|NCT02332720|583303937|FG016|Part A and Part B|Withdrawal by Subject|0|||
161523398|NCT02332720|583303938|FG017|Part A and Part B|Withdrawal by Subject|0|||
161523399|NCT02332720|583303939|FG018|Part A and Part B|Withdrawal by Subject|0|||
161523400|NCT02332720|583303940|FG019|Part A and Part B|Withdrawal by Subject|1|||
161523401|NCT02332720|583303941|FG020|Part A and Part B|Withdrawal by Subject|0|||
161523402|NCT02332720|583303942|FG021|Part A and Part B|Withdrawal by Subject|0|||
161523403|NCT02332720|583303943|FG022|Part A and Part B|Withdrawal by Subject|0|||
161523404|NCT05732454|583303944|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
161523405|NCT05732454|583303945|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
161523406|NCT05732454|583303944|FG000|Part 1: DB Period|Adverse Event|1|||
161523407|NCT05732454|583303945|FG001|Part 1: DB Period|Adverse Event|0|||
161523408|NCT05732454|583303944|FG000|Part 1: DB Period|Lost to Follow-up|1|||
161523409|NCT05732454|583303945|FG001|Part 1: DB Period|Lost to Follow-up|0|||
161523410|NCT05732454|583303944|FG000|Part 1: DB Period|Protocol Violation|0|||
161523411|NCT05732454|583303945|FG001|Part 1: DB Period|Protocol Violation|1|||
161523412|NCT05732454|583303944|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
161523413|NCT05732454|583303945|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
161523414|NCT05732454|583303944|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
161523415|NCT05732454|583303945|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
161523416|NCT05732454|583303944|FG000|Part 1: OLE Period|Adverse Event|0|||
161523417|NCT05732454|583303945|FG001|Part 1: OLE Period|Adverse Event|1|||
161523418|NCT05732454|583303944|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
161523419|NCT05732454|583303945|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
161523420|NCT00838110|583303948|FG000|Overall Study|Death|0|||
161523421|NCT00838110|583303949|FG001|Overall Study|Death|0|||
161523422|NCT00838110|583303950|FG002|Overall Study|Death|1|||
161523423|NCT00838110|583303951|FG003|Overall Study|Death|2|||
161523424|NCT00838110|583303948|FG000|Overall Study|Adverse Event|11|||
161523425|NCT00838110|583303949|FG001|Overall Study|Adverse Event|10|||
161523426|NCT00838110|583303950|FG002|Overall Study|Adverse Event|8|||
161826128|NCT02914457|584403781|FG000|Overall Study|Physician Decision|1|||
161826129|NCT02914457|584403781|FG000|Overall Study|No veins available for lead placement|1|||
161523427|NCT00838110|583303951|FG003|Overall Study|Adverse Event|7|||
161523428|NCT00838110|583303948|FG000|Overall Study|Withdrawal by Subject|5|||
161589778|NCT03143153|583548165|FG002|Treatment|Completed treatment as per Protocol|0|||
161589779|NCT03143153|583548163|FG000|Treatment|Other reasons|12|||
161589780|NCT03143153|583548164|FG001|Treatment|Other reasons|7|||
161589781|NCT03143153|583548165|FG002|Treatment|Other reasons|15|||
161589782|NCT03143153|583548163|FG000|Treatment|Not reported|1|||
161589783|NCT03143153|583548164|FG001|Treatment|Not reported|0|||
161589784|NCT03143153|583548165|FG002|Treatment|Not reported|0|||
161589785|NCT02736409|583548166|FG000|Overall Study|Withdrawal by Subject|4|||
161589786|NCT02736409|583548167|FG001|Overall Study|Withdrawal by Subject|2|||
161589787|NCT02736409|583548168|FG002|Overall Study|Withdrawal by Subject|17|||
161589788|NCT02736409|583548169|FG003|Overall Study|Withdrawal by Subject|3|||
161589789|NCT02736409|583548166|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161589790|NCT02736409|583548167|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161589791|NCT02736409|583548168|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161589792|NCT02736409|583548169|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161589793|NCT02736409|583548166|FG000|Overall Study|Adverse Event|0|||
161589794|NCT02736409|583548167|FG001|Overall Study|Adverse Event|1|||
161589795|NCT02736409|583548168|FG002|Overall Study|Adverse Event|5|||
161589796|NCT02736409|583548169|FG003|Overall Study|Adverse Event|4|||
161589797|NCT02736409|583548166|FG000|Overall Study|Other|0|||
161589798|NCT02736409|583548167|FG001|Overall Study|Other|0|||
161589799|NCT02736409|583548168|FG002|Overall Study|Other|1|||
161589800|NCT02736409|583548169|FG003|Overall Study|Other|1|||
161589801|NCT02736409|583548166|FG000|Overall Study|Pregnancy|0|||
161589802|NCT02736409|583548167|FG001|Overall Study|Pregnancy|0|||
161589803|NCT02736409|583548168|FG002|Overall Study|Pregnancy|1|||
161589804|NCT02736409|583548169|FG003|Overall Study|Pregnancy|0|||
161589805|NCT02736409|583548166|FG000|Overall Study|Lost to Follow-up|0|||
161589806|NCT02736409|583548167|FG001|Overall Study|Lost to Follow-up|0|||
161589807|NCT02736409|583548168|FG002|Overall Study|Lost to Follow-up|2|||
161826130|NCT02914457|584403781|FG000|Overall Study|Electrical instability of patient|1|||
161826131|NCT02914457|584403781|FG000|Overall Study|ECG acquisition error due to sweating|1|||
161826132|NCT02914457|584403781|FG000|Overall Study|Protocol Violation|1|||
161826133|NCT01055886|584403782|FG000|Overall Study|Withdrawal by Subject|4|||
161826134|NCT01055886|584403783|FG001|Overall Study|Withdrawal by Subject|9|||
161826135|NCT01055886|584403782|FG000|Overall Study|Lost to Follow-up|1|||
161826136|NCT01055886|584403783|FG001|Overall Study|Lost to Follow-up|1|||
161826137|NCT01055886|584403782|FG000|Overall Study|Withdrawal by PI|0|||
161826138|NCT01055886|584403783|FG001|Overall Study|Withdrawal by PI|1|||
161589808|NCT02736409|583548169|FG003|Overall Study|Lost to Follow-up|1|||
161589809|NCT02736409|583548166|FG000|Overall Study|Physician Decision|0|||
161589810|NCT02736409|583548167|FG001|Overall Study|Physician Decision|0|||
161589811|NCT02736409|583548168|FG002|Overall Study|Physician Decision|0|||
161589812|NCT02736409|583548169|FG003|Overall Study|Physician Decision|2|||
161826139|NCT04254809|584403786|FG000|Overall Study|Lost to Follow-up|5|||
161677826|NCT01179672|583873582|FG000|Overall Study|Adverse Event|17|||
161677827|NCT01179672|583873583|FG001|Overall Study|Adverse Event|8|||
161677828|NCT01179672|583873582|FG000|Overall Study|Withdrawal by Subject|10|||
161677829|NCT01179672|583873583|FG001|Overall Study|Withdrawal by Subject|12|||
161677830|NCT01179672|583873582|FG000|Overall Study|Entry Criteria Not Met|0|||
161677831|NCT01179672|583873583|FG001|Overall Study|Entry Criteria Not Met|2|||
161677832|NCT01179672|583873582|FG000|Overall Study|Lost to Follow-up|0|||
161677833|NCT01179672|583873583|FG001|Overall Study|Lost to Follow-up|1|||
161677834|NCT01179672|583873582|FG000|Overall Study|Protocol Violation|2|||
161677835|NCT01179672|583873583|FG001|Overall Study|Protocol Violation|2|||
161677836|NCT01179672|583873582|FG000|Overall Study|Physician Decision|1|||
161677837|NCT01179672|583873583|FG001|Overall Study|Physician Decision|1|||
161677838|NCT01994382|583873584|FG000|Overall Study|Informed consent withdrawn|0|||
161677839|NCT01994382|583873585|FG001|Overall Study|Informed consent withdrawn|0|||
161677840|NCT01994382|583873586|FG002|Overall Study|Informed consent withdrawn|0|||
161677841|NCT01994382|583873587|FG003|Overall Study|Informed consent withdrawn|0|||
161677842|NCT01994382|583873588|FG004|Overall Study|Informed consent withdrawn|0|||
161677843|NCT01994382|583873589|FG005|Overall Study|Informed consent withdrawn|0|||
161677844|NCT01994382|583873590|FG006|Overall Study|Informed consent withdrawn|1|||
161677845|NCT01994382|583873591|FG007|Overall Study|Informed consent withdrawn|0|||
161677846|NCT01994382|583873592|FG008|Overall Study|Informed consent withdrawn|0|||
161523429|NCT00838110|583303949|FG001|Overall Study|Withdrawal by Subject|6|||
161523430|NCT00838110|583303950|FG002|Overall Study|Withdrawal by Subject|3|||
161523431|NCT00838110|583303951|FG003|Overall Study|Withdrawal by Subject|4|||
161523432|NCT00838110|583303948|FG000|Overall Study|Other|3|||
161523433|NCT00838110|583303949|FG001|Overall Study|Other|3|||
161523434|NCT00838110|583303950|FG002|Overall Study|Other|3|||
161523435|NCT00838110|583303951|FG003|Overall Study|Other|2|||
161523436|NCT00838110|583303948|FG000|Overall Study|Protocol Violation|0|||
161523437|NCT00838110|583303949|FG001|Overall Study|Protocol Violation|2|||
161523438|NCT00838110|583303950|FG002|Overall Study|Protocol Violation|1|||
161523439|NCT00838110|583303951|FG003|Overall Study|Protocol Violation|1|||
161523440|NCT00838110|583303948|FG000|Overall Study|Lost to Follow-up|3|||
161523441|NCT00838110|583303949|FG001|Overall Study|Lost to Follow-up|0|||
161523442|NCT00838110|583303950|FG002|Overall Study|Lost to Follow-up|0|||
161523443|NCT00838110|583303951|FG003|Overall Study|Lost to Follow-up|0|||
161523444|NCT00838110|583303948|FG000|Overall Study|Did not meet eligibility criteria|0|||
161523445|NCT00838110|583303949|FG001|Overall Study|Did not meet eligibility criteria|0|||
161523446|NCT00838110|583303950|FG002|Overall Study|Did not meet eligibility criteria|1|||
161523447|NCT00838110|583303951|FG003|Overall Study|Did not meet eligibility criteria|2|||
161523448|NCT00838110|583303948|FG000|Overall Study|Randomized but not treated|0|||
161523449|NCT00838110|583303949|FG001|Overall Study|Randomized but not treated|1|||
161523450|NCT00838110|583303950|FG002|Overall Study|Randomized but not treated|0|||
161523451|NCT00838110|583303951|FG003|Overall Study|Randomized but not treated|0|||
161523452|NCT00352365|583303952|FG000|Induction Therapy|Adverse Event|7|||
161523453|NCT00352365|583303952|FG000|Induction Therapy|Progression/Relapse|8|||
161523454|NCT00352365|583303952|FG000|Induction Therapy|Death|7|||
161523455|NCT00352365|583303952|FG000|Induction Therapy|Not protocol specified|1|||
161523456|NCT00352365|583303952|FG000|Induction Therapy|Not eligible|3|||
161523457|NCT00352365|583303952|FG000|Induction Therapy|Death before starting protocol therapy|1|||
161523458|NCT00352365|583303952|FG000|Maintenance Therapy|Progression/Relapse|3|||
161677847|NCT01994382|583873593|FG009|Overall Study|Informed consent withdrawn|0|||
161677848|NCT01994382|583873594|FG010|Overall Study|Informed consent withdrawn|0|||
161677849|NCT01994382|583873595|FG011|Overall Study|Informed consent withdrawn|0|||
161523459|NCT00352365|583303952|FG000|Maintenance Therapy|Death|2|||
161523460|NCT00352365|583303952|FG000|Maintenance Therapy|Not protocol specified|3|||
161523461|NCT00352365|583303952|FG000|Maintenance Therapy|Not eligible|4|||
161523462|NCT01262651|583303953|FG000|Overall Study|Adverse Event|40|||
161523463|NCT01262651|583303954|FG001|Overall Study|Adverse Event|35|||
161523464|NCT01262651|583303953|FG000|Overall Study|Withdrawal by Subject|15|||
161523465|NCT01262651|583303954|FG001|Overall Study|Withdrawal by Subject|11|||
161523466|NCT01262651|583303953|FG000|Overall Study|Withdrawal by Investigator|2|||
161677850|NCT01994382|583873596|FG012|Overall Study|Informed consent withdrawn|0|||
161523467|NCT01262651|583303954|FG001|Overall Study|Withdrawal by Investigator|2|||
161523468|NCT01262651|583303953|FG000|Overall Study|Met Withdrawal Criteria|1|||
161523469|NCT01262651|583303954|FG001|Overall Study|Met Withdrawal Criteria|0|||
161523470|NCT04743908|583303955|FG000|Overall Study|Death|1|||
161677851|NCT01994382|583873597|FG013|Overall Study|Informed consent withdrawn|0|||
161677852|NCT01994382|583873598|FG014|Overall Study|Informed consent withdrawn|0|||
161677853|NCT01994382|583873599|FG015|Overall Study|Informed consent withdrawn|0|||
161677854|NCT01994382|583873600|FG016|Overall Study|Informed consent withdrawn|0|||
161677855|NCT01994382|583873584|FG000|Overall Study|Progressive disease|3|||
161677856|NCT01994382|583873585|FG001|Overall Study|Progressive disease|4|||
161523471|NCT04743908|583303956|FG001|Overall Study|Death|0|||
161523472|NCT04743908|583303955|FG000|Overall Study|Lost to Follow-up|181|||
161523473|NCT04743908|583303956|FG001|Overall Study|Lost to Follow-up|180|||
161549254|NCT02291289|583401016|FG007|Induction Treatment|Missing|0|||
161523474|NCT04743908|583303955|FG000|Overall Study|Withdrawal by Subject|1|||
161523475|NCT04743908|583303956|FG001|Overall Study|Withdrawal by Subject|2|||
161934783|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
161934784|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
161934785|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934786|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934787|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
161934788|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934789|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934790|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
161523476|NCT03822533|583303957|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
161523477|NCT03822533|583303958|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
161523478|NCT03822533|583303957|FG000|3 Month Follow-up|Lost to Follow-up|2|||
161523479|NCT03822533|583303958|FG001|3 Month Follow-up|Lost to Follow-up|2|||
161523480|NCT03822533|583303957|FG000|6 Month Follow-up|Lost to Follow-up|3|||
161523481|NCT03822533|583303958|FG001|6 Month Follow-up|Lost to Follow-up|0|||
161523482|NCT03822533|583303957|FG000|12 Month Follow-up|Lost to Follow-up|2|||
161523483|NCT03822533|583303958|FG001|12 Month Follow-up|Lost to Follow-up|3|||
161523484|NCT03822533|583303957|FG000|12 Month Follow-up|Pregnancy|0|||
161523485|NCT03822533|583303958|FG001|12 Month Follow-up|Pregnancy|1|||
161523486|NCT03822533|583303957|FG000|12 Month Follow-up|Surgery|2|||
161523487|NCT03822533|583303958|FG001|12 Month Follow-up|Surgery|0|||
161523488|NCT03822533|583303957|FG000|12 Month Follow-up|Wrong address|1|||
161523489|NCT03822533|583303958|FG001|12 Month Follow-up|Wrong address|0|||
161523490|NCT03822533|583303957|FG000|12 Month Follow-up|No symptoms|1|||
161523491|NCT03822533|583303958|FG001|12 Month Follow-up|No symptoms|0|||
161523492|NCT03822533|583303957|FG000|12 Month Follow-up|Changed primary care center|0|||
161523493|NCT03822533|583303958|FG001|12 Month Follow-up|Changed primary care center|1|||
161523494|NCT01412944|583303959|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
161523495|NCT01412944|583303960|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
161523496|NCT01412944|583303961|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
161523497|NCT01412944|583303962|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
161523498|NCT01412944|583303963|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
161523499|NCT01412944|583303964|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
161523500|NCT01412944|583303959|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
161523501|NCT01412944|583303960|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
161523502|NCT01412944|583303961|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
161934791|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
161934792|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
161523503|NCT01412944|583303962|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
161523504|NCT01412944|583303963|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
161523505|NCT01412944|583303964|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
161523506|NCT01412944|583303959|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
161523507|NCT01412944|583303960|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
161523508|NCT01412944|583303961|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
161523509|NCT01412944|583303962|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
161523510|NCT01412944|583303963|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
161523511|NCT01412944|583303964|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
161523512|NCT01412944|583303959|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
161523513|NCT01412944|583303960|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
161523514|NCT01412944|583303961|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
161523515|NCT01412944|583303962|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
161523516|NCT01412944|583303963|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
161523517|NCT01412944|583303964|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
161523518|NCT01412944|583303959|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
161523519|NCT01412944|583303960|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
161934793|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
161523520|NCT01412944|583303961|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
161523521|NCT01412944|583303962|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
161523522|NCT01412944|583303963|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
161523523|NCT01412944|583303964|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
161523524|NCT01412944|583303959|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
161523525|NCT01412944|583303960|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
161523526|NCT01412944|583303961|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
161523527|NCT01412944|583303962|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
161523528|NCT01412944|583303963|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
161523529|NCT01412944|583303964|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
161523530|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161523531|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161934794|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
161523532|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
161523533|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
161523534|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
161523535|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161523536|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Adverse Event|0|||
161523537|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Adverse Event|0|||
161523538|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Adverse Event|0|||
161523539|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Adverse Event|0|||
161523540|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Adverse Event|1|||
161523541|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Adverse Event|0|||
161523542|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
161523543|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
161523544|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
161523545|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
161523546|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
161523547|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
161523548|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523549|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523550|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523551|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523552|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523553|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
161523554|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523555|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523556|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523557|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523558|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
161523559|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523560|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
161523561|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
161523562|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161523563|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161523564|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161523565|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
161523566|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
161523567|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
161523568|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
161523569|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
161826140|NCT04254809|584403787|FG001|Overall Study|Lost to Follow-up|10|||
161826141|NCT02972515|584403788|FG000|Overall Study|Lost to Follow-up|78|||
161826142|NCT01928615|584403789|FG000|Overall Study|Study Terminated by Sponsor|2|||
161826143|NCT04531527|584403790|FG000|Overall Study|Found to be Ineligible|3|||
161826144|NCT01077258|584403798|FG000|Overall Study|Lost to Follow-up|1390|||
161523570|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
161523571|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
161523572|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523573|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
161523574|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523575|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523576|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523577|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
161523578|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523579|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
161523580|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523581|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523582|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523583|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
161523584|NCT01412944|583303959|FG000|Entire: IV + Maintenance|Adverse Event|0|||
161523585|NCT01412944|583303960|FG001|Entire: IV + Maintenance|Adverse Event|1|||
161523586|NCT01412944|583303961|FG002|Entire: IV + Maintenance|Adverse Event|0|||
161523587|NCT01412944|583303962|FG003|Entire: IV + Maintenance|Adverse Event|0|||
161523588|NCT01412944|583303963|FG004|Entire: IV + Maintenance|Adverse Event|0|||
161589813|NCT01415154|583548170|FG000|Overall Study|Lack of Efficacy|4|||
161826145|NCT01077258|584403798|FG000|Overall Study|Adverse drug reaction|218|||
161826146|NCT01077258|584403798|FG000|Overall Study|Lack of Efficacy|663|||
161826147|NCT01077258|584403798|FG000|Overall Study|Clinical remission|37|||
161826148|NCT01077258|584403798|FG000|Overall Study|Other reasons|260|||
161826149|NCT00726895|584403799|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161826150|NCT00726895|584403800|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161826151|NCT01881737|584403802|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
161826152|NCT01881737|584403802|FG000|Overall Study|Withdrawal by Subject|1|||
161826153|NCT01881737|584403802|FG000|Overall Study|Worsening of baseline behavior|1|||
161826154|NCT03496298|584403805|FG000|Overall Study|Adverse Event|49|||
161523589|NCT01412944|583303964|FG005|Entire: IV + Maintenance|Adverse Event|0|||
161523590|NCT01990950|583303965|FG000|Overall Study|Death|3|||
161523591|NCT01990950|583303965|FG000|Overall Study|Lost to Follow-up|2|||
161523592|NCT01990950|583303965|FG000|Overall Study|Withdrawal by Subject|6|||
161523593|NCT02863926|583303966|FG000|Overall Study|Physician Decision|1|||
161523594|NCT02863926|583303967|FG001|Overall Study|Physician Decision|0|||
161523595|NCT02863926|583303966|FG000|Overall Study|Lost to Follow-up|1|||
161523596|NCT02863926|583303967|FG001|Overall Study|Lost to Follow-up|1|||
161523597|NCT02261363|583303972|FG000|Overall Study|Lost to Follow-up|21|||
161523598|NCT01517802|583303973|FG000|Overall Study|Death|1|||
161523599|NCT02605954|583303974|FG000|Overall Study|Adverse Event|5|||
161523600|NCT02605954|583303975|FG001|Overall Study|Adverse Event|1|||
161523601|NCT02605954|583303974|FG000|Overall Study|Investigator's Discretion|1|||
161523602|NCT02605954|583303975|FG001|Overall Study|Investigator's Discretion|0|||
161523603|NCT02605954|583303974|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161523604|NCT02605954|583303975|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161523605|NCT02605954|583303974|FG000|Overall Study|Withdrew Consent|2|||
161523606|NCT02605954|583303975|FG001|Overall Study|Withdrew Consent|2|||
161523607|NCT02605954|583303974|FG000|Overall Study|Lost to Follow-up|3|||
161523608|NCT02605954|583303975|FG001|Overall Study|Lost to Follow-up|0|||
161523609|NCT02605954|583303974|FG000|Overall Study|Randomized but not treated|0|||
161523610|NCT02605954|583303975|FG001|Overall Study|Randomized but not treated|1|||
161523611|NCT02301143|583303976|FG000|Induction Period|Enrolled But Not Treated|1|||
161523612|NCT02301143|583303977|FG001|Induction Period|Enrolled But Not Treated|0|||
161523613|NCT02301143|583303976|FG000|Induction Period|Death|1|||
161523614|NCT02301143|583303977|FG001|Induction Period|Death|0|||
161523615|NCT02301143|583303976|FG000|Induction Period|Adverse Event|22|||
161523616|NCT02301143|583303977|FG001|Induction Period|Adverse Event|0|||
161523617|NCT02301143|583303976|FG000|Induction Period|Progressive Disease|8|||
161523618|NCT02301143|583303977|FG001|Induction Period|Progressive Disease|0|||
161523619|NCT02301143|583303976|FG000|Induction Period|Withdrawal by Subject|3|||
161523620|NCT02301143|583303977|FG001|Induction Period|Withdrawal by Subject|0|||
161523621|NCT02301143|583303976|FG000|Induction Period|Noncompliance with Study Drug|1|||
161523622|NCT02301143|583303977|FG001|Induction Period|Noncompliance with Study Drug|0|||
161523623|NCT02301143|583303976|FG000|Induction Period|Physician Decision|4|||
161523624|NCT02301143|583303977|FG001|Induction Period|Physician Decision|0|||
161523625|NCT02301143|583303976|FG000|Induction Period|Symptomatic Deterioration|2|||
161523626|NCT02301143|583303977|FG001|Induction Period|Symptomatic Deterioration|0|||
161523627|NCT02301143|583303976|FG000|Induction Period|Protocol Violation|2|||
161523628|NCT02301143|583303977|FG001|Induction Period|Protocol Violation|0|||
161523629|NCT02301143|583303976|FG000|Induction Period|Other|1|||
161523630|NCT02301143|583303977|FG001|Induction Period|Other|0|||
161523631|NCT02301143|583303976|FG000|Investigator's Choice|Adverse Event|0|||
161523632|NCT02301143|583303977|FG001|Investigator's Choice|Adverse Event|3|||
161523633|NCT02301143|583303976|FG000|Investigator's Choice|Progressive Disease|0|||
161523634|NCT02301143|583303977|FG001|Investigator's Choice|Progressive Disease|3|||
161523635|NCT02301143|583303976|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
161523636|NCT02301143|583303977|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
161523637|NCT02301143|583303976|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
161523638|NCT02301143|583303977|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
161523639|NCT02301143|583303976|FG000|Investigator's Choice|Other|0|||
161523640|NCT02301143|583303977|FG001|Investigator's Choice|Other|1|||
161523641|NCT02301143|583303976|FG000|Investigator's Choice|Unresectable Surgery|0|||
161523642|NCT02301143|583303977|FG001|Investigator's Choice|Unresectable Surgery|1|||
161523643|NCT03214367|583303980|FG000|Lead-in Period|Withdrawal by Subject|50|||
161523644|NCT03214367|583303981|FG001|Lead-in Period|Withdrawal by Subject|0|||
161523645|NCT03214367|583303982|FG002|Lead-in Period|Withdrawal by Subject|0|||
161523646|NCT03214367|583303983|FG003|Lead-in Period|Withdrawal by Subject|0|||
161523647|NCT03214367|583303984|FG004|Lead-in Period|Withdrawal by Subject|2|||
161523648|NCT03214367|583303985|FG005|Lead-in Period|Withdrawal by Subject|0|||
161523649|NCT03214367|583303986|FG006|Lead-in Period|Withdrawal by Subject|0|||
161523650|NCT03214367|583303987|FG007|Lead-in Period|Withdrawal by Subject|0|||
161523651|NCT03214367|583303980|FG000|Lead-in Period|Adverse Event|3|||
161523652|NCT03214367|583303981|FG001|Lead-in Period|Adverse Event|0|||
161523653|NCT03214367|583303982|FG002|Lead-in Period|Adverse Event|0|||
161523654|NCT03214367|583303983|FG003|Lead-in Period|Adverse Event|0|||
161523655|NCT03214367|583303984|FG004|Lead-in Period|Adverse Event|0|||
161523656|NCT03214367|583303985|FG005|Lead-in Period|Adverse Event|0|||
161523657|NCT03214367|583303986|FG006|Lead-in Period|Adverse Event|0|||
161523658|NCT03214367|583303987|FG007|Lead-in Period|Adverse Event|0|||
161523659|NCT03214367|583303980|FG000|Lead-in Period|Lost to Follow-up|12|||
161589814|NCT01415154|583548171|FG001|Overall Study|Lack of Efficacy|5|||
161589815|NCT01415154|583548170|FG000|Overall Study|Withdrawal by Subject|7|||
161589816|NCT01415154|583548171|FG001|Overall Study|Withdrawal by Subject|8|||
161523660|NCT03214367|583303981|FG001|Lead-in Period|Lost to Follow-up|0|||
161523661|NCT03214367|583303982|FG002|Lead-in Period|Lost to Follow-up|0|||
161589817|NCT01415154|583548170|FG000|Overall Study|Lost to Follow-up|1|||
161934795|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
161934796|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
161934797|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
161934798|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
161934799|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
161934800|NCT04806373|584810092|FG000|Overall Study|Withdrawal by Subject|1|||
161934801|NCT04806373|584810093|FG001|Overall Study|Withdrawal by Subject|1|||
161934802|NCT03382873|584810094|FG000|Overall Study|Lost to Follow-up|9|||
161934803|NCT03382873|584810095|FG001|Overall Study|Lost to Follow-up|10|||
161934804|NCT03382873|584810094|FG000|Overall Study|Withdrawal by Subject|6|||
161523662|NCT03214367|583303983|FG003|Lead-in Period|Lost to Follow-up|0|||
161523663|NCT03214367|583303984|FG004|Lead-in Period|Lost to Follow-up|0|||
161523664|NCT03214367|583303985|FG005|Lead-in Period|Lost to Follow-up|0|||
161523665|NCT03214367|583303986|FG006|Lead-in Period|Lost to Follow-up|0|||
161523666|NCT03214367|583303987|FG007|Lead-in Period|Lost to Follow-up|0|||
161523667|NCT03214367|583303980|FG000|Lead-in Period|Sponsor Decision|11|||
161523668|NCT03214367|583303981|FG001|Lead-in Period|Sponsor Decision|0|||
161523669|NCT03214367|583303982|FG002|Lead-in Period|Sponsor Decision|0|||
161523670|NCT03214367|583303983|FG003|Lead-in Period|Sponsor Decision|0|||
161523671|NCT03214367|583303984|FG004|Lead-in Period|Sponsor Decision|0|||
161523672|NCT03214367|583303985|FG005|Lead-in Period|Sponsor Decision|0|||
161523673|NCT03214367|583303986|FG006|Lead-in Period|Sponsor Decision|0|||
161523674|NCT03214367|583303987|FG007|Lead-in Period|Sponsor Decision|0|||
161523675|NCT03214367|583303980|FG000|Lead-in Period|Physician Decision|12|||
161523676|NCT03214367|583303981|FG001|Lead-in Period|Physician Decision|0|||
161523677|NCT03214367|583303982|FG002|Lead-in Period|Physician Decision|0|||
161523678|NCT03214367|583303983|FG003|Lead-in Period|Physician Decision|0|||
161523679|NCT03214367|583303984|FG004|Lead-in Period|Physician Decision|0|||
161523680|NCT03214367|583303985|FG005|Lead-in Period|Physician Decision|0|||
161523681|NCT03214367|583303986|FG006|Lead-in Period|Physician Decision|0|||
161523682|NCT03214367|583303987|FG007|Lead-in Period|Physician Decision|0|||
161523683|NCT03214367|583303980|FG000|Lead-in Period|Protocol Violation|5|||
161523684|NCT03214367|583303981|FG001|Lead-in Period|Protocol Violation|0|||
161523685|NCT03214367|583303982|FG002|Lead-in Period|Protocol Violation|0|||
161523686|NCT03214367|583303983|FG003|Lead-in Period|Protocol Violation|0|||
161523687|NCT03214367|583303984|FG004|Lead-in Period|Protocol Violation|0|||
161523688|NCT03214367|583303985|FG005|Lead-in Period|Protocol Violation|0|||
161934805|NCT03382873|584810095|FG001|Overall Study|Withdrawal by Subject|11|||
161934806|NCT03382873|584810094|FG000|Overall Study|Visit not completed due to pandemic|16|||
161934807|NCT03382873|584810095|FG001|Overall Study|Visit not completed due to pandemic|41|||
161934808|NCT03624036|584810096|FG000|Overall Study|Death|2|||
161934809|NCT03624036|584810097|FG001|Overall Study|Death|3|||
161934810|NCT03624036|584810098|FG002|Overall Study|Death|0|||
161934811|NCT03624036|584810099|FG003|Overall Study|Death|1|||
161934812|NCT03624036|584810096|FG000|Overall Study|Withdrawal by Subject|1|||
161934813|NCT03624036|584810097|FG001|Overall Study|Withdrawal by Subject|0|||
161934814|NCT03624036|584810098|FG002|Overall Study|Withdrawal by Subject|1|||
161934815|NCT03624036|584810099|FG003|Overall Study|Withdrawal by Subject|0|||
161934816|NCT03624036|584810096|FG000|Overall Study|Enrolled but Never Treated|1|||
161934817|NCT03624036|584810097|FG001|Overall Study|Enrolled but Never Treated|0|||
161934818|NCT03624036|584810098|FG002|Overall Study|Enrolled but Never Treated|0|||
161523689|NCT03214367|583303986|FG006|Lead-in Period|Protocol Violation|0|||
161523690|NCT03214367|583303987|FG007|Lead-in Period|Protocol Violation|0|||
161523691|NCT03214367|583303980|FG000|Lead-in Period|Treatment Interruption|1|||
161523692|NCT03214367|583303981|FG001|Lead-in Period|Treatment Interruption|0|||
161523693|NCT03214367|583303982|FG002|Lead-in Period|Treatment Interruption|0|||
161523694|NCT03214367|583303983|FG003|Lead-in Period|Treatment Interruption|0|||
161934819|NCT03624036|584810099|FG003|Overall Study|Enrolled but Never Treated|0|||
161934820|NCT03624036|584810096|FG000|Overall Study|Reason not Specified|3|||
161523695|NCT03214367|583303984|FG004|Lead-in Period|Treatment Interruption|0|||
161523696|NCT03214367|583303985|FG005|Lead-in Period|Treatment Interruption|0|||
161523697|NCT03214367|583303986|FG006|Lead-in Period|Treatment Interruption|0|||
161523698|NCT03214367|583303987|FG007|Lead-in Period|Treatment Interruption|0|||
161523699|NCT03214367|583303980|FG000|Treatment Period|Adverse Event|0|||
161523700|NCT03214367|583303981|FG001|Treatment Period|Adverse Event|1|||
161677857|NCT01994382|583873586|FG002|Overall Study|Progressive disease|4|||
161523701|NCT03214367|583303982|FG002|Treatment Period|Adverse Event|4|||
161523702|NCT03214367|583303983|FG003|Treatment Period|Adverse Event|2|||
161677858|NCT01994382|583873587|FG003|Overall Study|Progressive disease|3|||
161677859|NCT01994382|583873588|FG004|Overall Study|Progressive disease|2|||
161523703|NCT03214367|583303984|FG004|Treatment Period|Adverse Event|0|||
161523704|NCT03214367|583303985|FG005|Treatment Period|Adverse Event|0|||
161934821|NCT03624036|584810097|FG001|Overall Study|Reason not Specified|0|||
161934822|NCT03624036|584810098|FG002|Overall Study|Reason not Specified|2|||
161523705|NCT03214367|583303986|FG006|Treatment Period|Adverse Event|0|||
161523706|NCT03214367|583303987|FG007|Treatment Period|Adverse Event|0|||
161934823|NCT03624036|584810099|FG003|Overall Study|Reason not Specified|2|||
161934824|NCT01185366|584810108|FG000|First Line Therapy|Insurance Coverage Denied|1|||
161934825|NCT01185366|584810109|FG001|First Line Therapy|Insurance Coverage Denied|1|||
161523707|NCT03214367|583303980|FG000|Treatment Period|Death|0|||
161523708|NCT03214367|583303981|FG001|Treatment Period|Death|1|||
161523709|NCT03214367|583303982|FG002|Treatment Period|Death|1|||
161523710|NCT03214367|583303983|FG003|Treatment Period|Death|1|||
161523711|NCT03214367|583303984|FG004|Treatment Period|Death|0|||
161523712|NCT03214367|583303985|FG005|Treatment Period|Death|0|||
161523713|NCT03214367|583303986|FG006|Treatment Period|Death|0|||
161523714|NCT03214367|583303987|FG007|Treatment Period|Death|0|||
161523715|NCT03214367|583303980|FG000|Treatment Period|Lost to Follow-up|0|||
161523716|NCT03214367|583303981|FG001|Treatment Period|Lost to Follow-up|5|||
161523717|NCT03214367|583303982|FG002|Treatment Period|Lost to Follow-up|3|||
161523718|NCT03214367|583303983|FG003|Treatment Period|Lost to Follow-up|2|||
161523719|NCT03214367|583303984|FG004|Treatment Period|Lost to Follow-up|0|||
161523720|NCT03214367|583303985|FG005|Treatment Period|Lost to Follow-up|2|||
161523721|NCT03214367|583303986|FG006|Treatment Period|Lost to Follow-up|1|||
161523722|NCT03214367|583303987|FG007|Treatment Period|Lost to Follow-up|0|||
161523723|NCT03214367|583303980|FG000|Treatment Period|Sponsor Decision|0|||
161523724|NCT03214367|583303981|FG001|Treatment Period|Sponsor Decision|3|||
161523725|NCT03214367|583303982|FG002|Treatment Period|Sponsor Decision|0|||
161523726|NCT03214367|583303983|FG003|Treatment Period|Sponsor Decision|0|||
161523727|NCT03214367|583303984|FG004|Treatment Period|Sponsor Decision|0|||
161523728|NCT03214367|583303985|FG005|Treatment Period|Sponsor Decision|0|||
161523729|NCT03214367|583303986|FG006|Treatment Period|Sponsor Decision|0|||
161523730|NCT03214367|583303987|FG007|Treatment Period|Sponsor Decision|0|||
161523731|NCT03214367|583303980|FG000|Treatment Period|Physician Decision|0|||
161523732|NCT03214367|583303981|FG001|Treatment Period|Physician Decision|1|||
161523733|NCT03214367|583303982|FG002|Treatment Period|Physician Decision|2|||
161523734|NCT03214367|583303983|FG003|Treatment Period|Physician Decision|0|||
161523735|NCT03214367|583303984|FG004|Treatment Period|Physician Decision|0|||
161523736|NCT03214367|583303985|FG005|Treatment Period|Physician Decision|0|||
161523737|NCT03214367|583303986|FG006|Treatment Period|Physician Decision|0|||
161523738|NCT03214367|583303987|FG007|Treatment Period|Physician Decision|0|||
161523739|NCT03214367|583303980|FG000|Treatment Period|Protocol Violation|0|||
161523740|NCT03214367|583303981|FG001|Treatment Period|Protocol Violation|3|||
161523741|NCT03214367|583303982|FG002|Treatment Period|Protocol Violation|0|||
161523742|NCT03214367|583303983|FG003|Treatment Period|Protocol Violation|0|||
161523743|NCT03214367|583303984|FG004|Treatment Period|Protocol Violation|0|||
161523744|NCT03214367|583303985|FG005|Treatment Period|Protocol Violation|0|||
161523745|NCT03214367|583303986|FG006|Treatment Period|Protocol Violation|0|||
161523746|NCT03214367|583303987|FG007|Treatment Period|Protocol Violation|0|||
161523747|NCT03214367|583303980|FG000|Treatment Period|Withdrawal by Subject|0|||
161523748|NCT03214367|583303981|FG001|Treatment Period|Withdrawal by Subject|20|||
161523749|NCT03214367|583303982|FG002|Treatment Period|Withdrawal by Subject|23|||
161523750|NCT03214367|583303983|FG003|Treatment Period|Withdrawal by Subject|14|||
161523751|NCT03214367|583303984|FG004|Treatment Period|Withdrawal by Subject|0|||
161523752|NCT03214367|583303985|FG005|Treatment Period|Withdrawal by Subject|1|||
161523753|NCT03214367|583303986|FG006|Treatment Period|Withdrawal by Subject|1|||
161523754|NCT03214367|583303987|FG007|Treatment Period|Withdrawal by Subject|1|||
161523755|NCT03268811|583303990|FG000|Overall Study|Adverse Event|0|||
161523756|NCT03268811|583303991|FG001|Overall Study|Adverse Event|1|||
161523757|NCT00455195|583303992|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
161523758|NCT00455195|583303993|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
161523759|NCT00455195|583303992|FG000|Double-blind Study AGLU02704|Death|1|||
161523760|NCT00455195|583303993|FG001|Double-blind Study AGLU02704|Death|0|||
161523761|NCT00455195|583303992|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
161523762|NCT00455195|583303993|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
161523763|NCT00455195|583303992|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
161523764|NCT00455195|583303993|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
161523765|NCT02117570|583303994|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
161523766|NCT02117570|583303995|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
161523767|NCT02117570|583303996|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
161523768|NCT02117570|583303994|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
161523769|NCT02117570|583303995|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
161523770|NCT02117570|583303996|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
161523771|NCT02117570|583303994|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
161523772|NCT02117570|583303995|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
161523773|NCT02117570|583303996|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
161523774|NCT02117570|583303994|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
161523775|NCT02117570|583303995|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
161523776|NCT02117570|583303996|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
161523777|NCT02117570|583303994|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
161523778|NCT02117570|583303995|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
161523779|NCT02117570|583303996|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
161523780|NCT02117570|583303994|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
161523781|NCT02117570|583303995|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
161523782|NCT02117570|583303996|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
161523783|NCT02117570|583303994|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
161523784|NCT02117570|583303995|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
161589818|NCT01415154|583548171|FG001|Overall Study|Lost to Follow-up|4|||
161589819|NCT01415154|583548170|FG000|Overall Study|Protocol Violation|0|||
161589820|NCT01415154|583548171|FG001|Overall Study|Protocol Violation|1|||
161589821|NCT01415154|583548170|FG000|Overall Study|Satisfactory Response|0|||
161589822|NCT01415154|583548171|FG001|Overall Study|Satisfactory Response|1|||
161589823|NCT01415154|583548170|FG000|Overall Study|Adverse Event|1|||
161589824|NCT01415154|583548171|FG001|Overall Study|Adverse Event|1|||
161589825|NCT03763708|583548175|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
161589826|NCT03763708|583548176|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589827|NCT03763708|583548177|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589828|NCT03763708|583548178|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589829|NCT03763708|583548179|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589830|NCT03763708|583548180|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589831|NCT03763708|583548181|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589832|NCT03763708|583548182|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589833|NCT03763708|583548183|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161589834|NCT03763708|583548175|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589835|NCT03763708|583548176|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589836|NCT03763708|583548177|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
161589837|NCT03763708|583548178|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589838|NCT03763708|583548179|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589839|NCT03763708|583548180|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589840|NCT03763708|583548181|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589841|NCT03763708|583548182|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589842|NCT03763708|583548183|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161589843|NCT03763708|583548175|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589844|NCT03763708|583548176|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589845|NCT03763708|583548177|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589846|NCT03763708|583548178|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
161589847|NCT03763708|583548179|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589848|NCT03763708|583548180|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589849|NCT03763708|583548181|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589850|NCT03763708|583548182|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161589851|NCT03763708|583548183|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161826155|NCT03496298|584403806|FG001|Overall Study|Adverse Event|68|||
161826156|NCT03496298|584403807|FG002|Overall Study|Adverse Event|79|||
161826157|NCT03496298|584403805|FG000|Overall Study|Study terminated by Sponsor|1050|||
161826158|NCT03496298|584403806|FG001|Overall Study|Study terminated by Sponsor|1063|||
161826159|NCT03496298|584403807|FG002|Overall Study|Study terminated by Sponsor|1071|||
161826160|NCT03496298|584403805|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
161523785|NCT02117570|583303996|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
161523786|NCT02148250|583303997|FG000|Screening|Withdrawal by Subject|5|||
161523787|NCT02148250|583303998|FG001|Screening|Withdrawal by Subject|0|||
161523788|NCT01286779|583303999|FG000|Overall Study|Withdrawal by Subject|9|||
161523789|NCT01286779|583303999|FG000|Overall Study|Protocol Violation|5|||
161523790|NCT01286779|583303999|FG000|Overall Study|Physician Decision|2|||
161523791|NCT01286779|583303999|FG000|Overall Study|Participant had scheduled surgery|1|||
161523792|NCT01286779|583303999|FG000|Overall Study|Participant moved to another country|1|||
161523793|NCT01286779|583303999|FG000|Overall Study|Discontinued by sponsor|1|||
161523794|NCT00563784|583304000|FG000|Overall Study|Withdrawal by Subject|2|||
161523795|NCT00563784|583304000|FG000|Overall Study|Screen Failures|20|||
161523796|NCT04004611|583304001|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161523797|NCT04004611|583304002|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161589852|NCT03763708|583548175|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589853|NCT03763708|583548176|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589854|NCT03763708|583548177|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589855|NCT03763708|583548178|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161677860|NCT01994382|583873589|FG005|Overall Study|Progressive disease|3|||
161826161|NCT03496298|584403806|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
161826162|NCT03496298|584403807|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
161826163|NCT03496298|584403805|FG000|Overall Study|Withdrawal by Subject|176|||
161826164|NCT03496298|584403806|FG001|Overall Study|Withdrawal by Subject|154|||
161826165|NCT03496298|584403807|FG002|Overall Study|Withdrawal by Subject|151|||
161523798|NCT04004611|583304003|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161934826|NCT01185366|584810108|FG000|First Line Therapy|Withdrawal by Subject|1|||
161934827|NCT01185366|584810109|FG001|First Line Therapy|Withdrawal by Subject|0|||
161934828|NCT01185366|584810108|FG000|First Line Therapy|Lack of Metastatic Site|1|||
161934829|NCT01185366|584810109|FG001|First Line Therapy|Lack of Metastatic Site|0|||
161934830|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
161934831|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
161934832|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
161934833|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
161523799|NCT04004611|583304004|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161523800|NCT04004611|583304005|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161523801|NCT04004611|583304006|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161523802|NCT04004611|583304007|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161523803|NCT04004611|583304008|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
161523804|NCT04004611|583304009|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
161523805|NCT04004611|583304001|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
161523806|NCT04004611|583304002|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
161523807|NCT04004611|583304003|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
161523808|NCT04004611|583304004|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
161523809|NCT04004611|583304005|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
161523810|NCT04004611|583304006|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
161523811|NCT04004611|583304007|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
161523812|NCT04004611|583304008|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
161523813|NCT04004611|583304009|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
161523814|NCT04004611|583304001|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523815|NCT04004611|583304002|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523816|NCT04004611|583304003|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523817|NCT04004611|583304004|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523818|NCT04004611|583304005|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
161523819|NCT04004611|583304006|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523820|NCT04004611|583304007|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523821|NCT04004611|583304008|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523822|NCT04004611|583304009|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161523823|NCT04004611|583304001|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
161523824|NCT04004611|583304002|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
161523825|NCT04004611|583304003|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
161523826|NCT04004611|583304004|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
161523827|NCT04004611|583304005|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
161523828|NCT04004611|583304006|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
161934834|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
161934835|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
161934836|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
161934837|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
161934838|NCT02539394|584810114|FG000|Overall Study|Protocol Violation|1|||
161523829|NCT04004611|583304007|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
161523830|NCT04004611|583304008|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
161523831|NCT04004611|583304009|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
161523832|NCT04004611|583304001|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
161549255|NCT02291289|583401017|FG008|Induction Treatment|Missing|0|||
161549256|NCT02291289|583401018|FG009|Induction Treatment|Missing|54|||
161549257|NCT02291289|583401019|FG010|Induction Treatment|Missing|0|||
161549258|NCT02291289|583401020|FG011|Induction Treatment|Missing|0|||
161549259|NCT02291289|583401021|FG012|Induction Treatment|Missing|0|||
161549260|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549261|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549262|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549263|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549264|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
161549265|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
161549266|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549267|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549268|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549269|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549270|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
161549271|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
161549272|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161549273|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Death|0|||
161549274|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Death|29|||
161549275|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Death|16|||
161549276|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Death|0|||
161934839|NCT02539394|584810115|FG001|Overall Study|Protocol Violation|3|||
161934840|NCT02539394|584810114|FG000|Overall Study|Lost to Follow-up|1|||
161934841|NCT02539394|584810115|FG001|Overall Study|Lost to Follow-up|2|||
161934842|NCT02539394|584810114|FG000|Overall Study|Incomplete dataset|6|||
161934843|NCT02539394|584810115|FG001|Overall Study|Incomplete dataset|6|||
161934844|NCT03425188|584810117|FG000|Overall Study|Withdrawal by Subject|1|||
161934845|NCT00834587|584810118|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161934846|NCT00834587|584810119|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161934847|NCT02536339|584810121|FG000|Overall Study|Death|20|||
161934848|NCT02536339|584810121|FG000|Overall Study|Withdrawal by Subject|3|||
161934849|NCT02536339|584810121|FG000|Overall Study|Lost to Follow-up|2|||
161934850|NCT02536339|584810121|FG000|Overall Study|Treatment discontinued|2|||
161934851|NCT02536339|584810121|FG000|Overall Study|Physician Decision|1|||
161934852|NCT01905683|584810124|FG000|Overall Study|Protocol Violation|1|||
161934853|NCT01905683|584810124|FG000|Overall Study|Re-injection criteria not met; others|13|||
161934854|NCT01905683|584810124|FG000|Overall Study|Physician Decision|1|||
161934855|NCT01905683|584810124|FG000|Overall Study|Lack of Efficacy|8|||
161934856|NCT01905683|584810124|FG000|Overall Study|Withdrawal by Subject|20|||
161934857|NCT01905683|584810124|FG000|Overall Study|Adverse Event|4|||
161934858|NCT01905683|584810124|FG000|Overall Study|Lost to Follow-up|4|||
161934859|NCT02037984|584810127|FG000|Overall Study|Lack of Efficacy|0|||
161934860|NCT02037984|584810128|FG001|Overall Study|Lack of Efficacy|0|||
161934861|NCT02037984|584810129|FG002|Overall Study|Lack of Efficacy|3|||
161934862|NCT02037984|584810130|FG003|Overall Study|Lack of Efficacy|10|||
161934863|NCT02037984|584810131|FG004|Overall Study|Lack of Efficacy|2|||
161934864|NCT02037984|584810132|FG005|Overall Study|Lack of Efficacy|2|||
161934865|NCT02037984|584810133|FG006|Overall Study|Lack of Efficacy|4|||
161934866|NCT02037984|584810134|FG007|Overall Study|Lack of Efficacy|3|||
161934867|NCT02037984|584810127|FG000|Overall Study|Lost to Follow-up|1|||
161934868|NCT02037984|584810128|FG001|Overall Study|Lost to Follow-up|0|||
161934869|NCT02037984|584810129|FG002|Overall Study|Lost to Follow-up|3|||
161934870|NCT02037984|584810130|FG003|Overall Study|Lost to Follow-up|5|||
161934871|NCT02037984|584810131|FG004|Overall Study|Lost to Follow-up|2|||
161934872|NCT02037984|584810132|FG005|Overall Study|Lost to Follow-up|2|||
161934873|NCT02037984|584810133|FG006|Overall Study|Lost to Follow-up|2|||
161934874|NCT02037984|584810134|FG007|Overall Study|Lost to Follow-up|4|||
161934875|NCT02037984|584810127|FG000|Overall Study|Physician Decision|0|||
161934876|NCT02037984|584810128|FG001|Overall Study|Physician Decision|0|||
161934877|NCT02037984|584810129|FG002|Overall Study|Physician Decision|0|||
161934878|NCT02037984|584810130|FG003|Overall Study|Physician Decision|0|||
161934879|NCT02037984|584810131|FG004|Overall Study|Physician Decision|0|||
161934880|NCT02037984|584810132|FG005|Overall Study|Physician Decision|0|||
161934881|NCT02037984|584810133|FG006|Overall Study|Physician Decision|1|||
161934882|NCT02037984|584810134|FG007|Overall Study|Physician Decision|0|||
161934883|NCT02037984|584810127|FG000|Overall Study|Protocol Violation|0|||
161934884|NCT02037984|584810128|FG001|Overall Study|Protocol Violation|0|||
161523833|NCT04004611|583304002|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523834|NCT04004611|583304003|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
161523835|NCT04004611|583304004|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523836|NCT04004611|583304005|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523837|NCT04004611|583304006|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523838|NCT04004611|583304007|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523839|NCT04004611|583304008|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523840|NCT04004611|583304009|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
161523841|NCT04004611|583304001|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161523842|NCT04004611|583304002|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
161523843|NCT04004611|583304003|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161523844|NCT04004611|583304004|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161934885|NCT02037984|584810129|FG002|Overall Study|Protocol Violation|0|||
161934886|NCT02037984|584810130|FG003|Overall Study|Protocol Violation|0|||
161934887|NCT02037984|584810131|FG004|Overall Study|Protocol Violation|0|||
161934888|NCT02037984|584810132|FG005|Overall Study|Protocol Violation|1|||
161934889|NCT02037984|584810133|FG006|Overall Study|Protocol Violation|2|||
161934890|NCT02037984|584810134|FG007|Overall Study|Protocol Violation|0|||
161934891|NCT02037984|584810127|FG000|Overall Study|Technical Problems|0|||
161934892|NCT02037984|584810128|FG001|Overall Study|Technical Problems|0|||
161934893|NCT02037984|584810129|FG002|Overall Study|Technical Problems|3|||
161934894|NCT02037984|584810130|FG003|Overall Study|Technical Problems|3|||
161934895|NCT02037984|584810131|FG004|Overall Study|Technical Problems|2|||
161934896|NCT02037984|584810132|FG005|Overall Study|Technical Problems|3|||
161934897|NCT02037984|584810133|FG006|Overall Study|Technical Problems|4|||
161934898|NCT02037984|584810134|FG007|Overall Study|Technical Problems|2|||
161934899|NCT02037984|584810127|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161934900|NCT02037984|584810128|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161934901|NCT02037984|584810129|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
161934902|NCT02037984|584810130|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
161934903|NCT02037984|584810131|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
161934904|NCT02037984|584810132|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
161523845|NCT04004611|583304005|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161934905|NCT02037984|584810133|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
161934906|NCT02037984|584810134|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
161934907|NCT02037984|584810127|FG000|Overall Study|Withdrawal by Subject|0|||
161934908|NCT02037984|584810128|FG001|Overall Study|Withdrawal by Subject|0|||
161934909|NCT02037984|584810129|FG002|Overall Study|Withdrawal by Subject|0|||
161934910|NCT02037984|584810130|FG003|Overall Study|Withdrawal by Subject|1|||
161934911|NCT02037984|584810131|FG004|Overall Study|Withdrawal by Subject|1|||
161934912|NCT02037984|584810132|FG005|Overall Study|Withdrawal by Subject|3|||
161934913|NCT02037984|584810133|FG006|Overall Study|Withdrawal by Subject|0|||
161934914|NCT02037984|584810134|FG007|Overall Study|Withdrawal by Subject|1|||
161934915|NCT00581100|584811381|FG000|Overall Study|Death|1|||
161934916|NCT00581100|584811382|FG001|Overall Study|Death|0|||
161934917|NCT00581100|584811381|FG000|Overall Study|Adverse Event|2|||
161934918|NCT00581100|584811382|FG001|Overall Study|Adverse Event|1|||
161934919|NCT00581100|584811381|FG000|Overall Study|Withdrawal by Subject|1|||
161934920|NCT00581100|584811382|FG001|Overall Study|Withdrawal by Subject|4|||
161934921|NCT00581100|584811381|FG000|Overall Study|Other|3|||
161934922|NCT00581100|584811382|FG001|Overall Study|Other|0|||
161934923|NCT04129398|584811383|FG000|Overall Study|Physician Decision|2|||
161934924|NCT00590317|584811384|FG000|Overall Study|Lack of Efficacy|1|||
161523846|NCT04004611|583304006|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161523847|NCT04004611|583304007|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161523848|NCT04004611|583304008|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161523849|NCT04004611|583304009|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
161523850|NCT00304070|583304010|FG000|Overall Study|Death|0|||
161523851|NCT00304070|583304011|FG001|Overall Study|Death|0|||
161523852|NCT00304070|583304012|FG002|Overall Study|Death|3|||
161523853|NCT00304070|583304010|FG000|Overall Study|Lost to Follow-up|0|||
161523854|NCT00304070|583304011|FG001|Overall Study|Lost to Follow-up|0|||
161523855|NCT00304070|583304012|FG002|Overall Study|Lost to Follow-up|1|||
161523856|NCT00304070|583304010|FG000|Overall Study|Physician Decision|0|||
161523857|NCT00304070|583304011|FG001|Overall Study|Physician Decision|0|||
161523858|NCT00304070|583304012|FG002|Overall Study|Physician Decision|3|||
161523859|NCT00304070|583304010|FG000|Overall Study|Withdrawal by Subject|0|||
161523860|NCT00304070|583304011|FG001|Overall Study|Withdrawal by Subject|0|||
161523861|NCT00304070|583304012|FG002|Overall Study|Withdrawal by Subject|1|||
161523862|NCT00304070|583304010|FG000|Overall Study|Progressive Disease|3|||
161523863|NCT00304070|583304011|FG001|Overall Study|Progressive Disease|7|||
161523864|NCT00304070|583304012|FG002|Overall Study|Progressive Disease|4|||
161523865|NCT00320216|583304013|FG000|Overall Study|Adverse Event|0|||
161523866|NCT00320216|583304014|FG001|Overall Study|Adverse Event|6|||
161523867|NCT00320216|583304015|FG002|Overall Study|Adverse Event|0|||
161523868|NCT00320216|583304016|FG003|Overall Study|Adverse Event|2|||
161523869|NCT00320216|583304017|FG004|Overall Study|Adverse Event|2|||
161523870|NCT00320216|583304013|FG000|Overall Study|Lack of Efficacy|6|||
161523871|NCT00320216|583304014|FG001|Overall Study|Lack of Efficacy|2|||
161523872|NCT00320216|583304015|FG002|Overall Study|Lack of Efficacy|1|||
161523873|NCT00320216|583304016|FG003|Overall Study|Lack of Efficacy|0|||
161523874|NCT00320216|583304017|FG004|Overall Study|Lack of Efficacy|1|||
161523875|NCT00320216|583304013|FG000|Overall Study|Lost to Follow-up|3|||
161523876|NCT00320216|583304014|FG001|Overall Study|Lost to Follow-up|0|||
161934925|NCT00590317|584811385|FG001|Overall Study|Lack of Efficacy|5|||
161934926|NCT00993473|584811389|FG000|Overall Study|Adverse Event|0|||
161934927|NCT00993473|584811390|FG001|Overall Study|Adverse Event|2|||
161934928|NCT00993473|584811389|FG000|Overall Study|Protocol Violation|1|||
161523877|NCT00320216|583304015|FG002|Overall Study|Lost to Follow-up|0|||
161523878|NCT00320216|583304016|FG003|Overall Study|Lost to Follow-up|0|||
161523879|NCT00320216|583304017|FG004|Overall Study|Lost to Follow-up|0|||
161934929|NCT00993473|584811390|FG001|Overall Study|Protocol Violation|2|||
161934930|NCT00993473|584811389|FG000|Overall Study|Lost to Follow-up|1|||
161523880|NCT00320216|583304013|FG000|Overall Study|Other|7|||
161523881|NCT00320216|583304014|FG001|Overall Study|Other|2|||
161523882|NCT00320216|583304015|FG002|Overall Study|Other|5|||
161523883|NCT00320216|583304016|FG003|Overall Study|Other|1|||
161523884|NCT00320216|583304017|FG004|Overall Study|Other|3|||
161523885|NCT00779246|583304026|FG000|Overall Study|Missing sufficient data for analysis|33|||
161549277|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Death|188|||
161549278|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Death|107|||
161549279|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Death|0|||
161549280|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Death|1|||
161549281|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Death|1|||
161549282|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Death|0|||
161549283|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Death|46|||
161549284|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Death|19|||
161523886|NCT00779246|583304027|FG001|Overall Study|Missing sufficient data for analysis|53|||
161523887|NCT02844946|583304029|FG000|Overall Study|Lost to Follow-up|7|||
161523888|NCT02844946|583304030|FG001|Overall Study|Lost to Follow-up|0|||
161523889|NCT02806986|583304031|FG000|Treatment Stage 1|Adverse Event|1|||
161523890|NCT02806986|583304031|FG000|Treatment Stage 2|Adverse Event|3|||
161523891|NCT02806986|583304031|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
161523892|NCT03950739|583304033|FG000|Treatment Phase|Adverse Event|2|||
161523893|NCT03950739|583304033|FG000|Optional Extension Phase|Death|1|||
161523894|NCT03950739|583304033|FG000|Optional Extension Phase|Progressive Disease|5|||
161523895|NCT03950739|583304033|FG000|Optional Extension Phase|Adverse Event|7|||
161523896|NCT03950739|583304033|FG000|Optional Extension Phase|Lost to Follow-up|2|||
161523897|NCT03950739|583304033|FG000|Optional Extension Phase|Site Closure|2|||
161523898|NCT03950739|583304033|FG000|Optional Extension Phase|Pregnancy|1|||
161523899|NCT03625570|583304034|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
161523900|NCT03625570|583304035|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
161523901|NCT03625570|583304034|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
161523902|NCT03625570|583304035|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
161523903|NCT03625570|583304034|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
161523904|NCT03625570|583304035|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
161523905|NCT02334748|583304036|FG000|Overall Study|Adverse Event|1|||
161523906|NCT02334748|583304036|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
161523907|NCT02334748|583304036|FG000|Overall Study|Patient no longer required study drug|2|||
161523908|NCT02334748|583304036|FG000|Overall Study|Lack of Efficacy|4|||
161523909|NCT01046643|583304037|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
161523910|NCT01046643|583304038|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
161523911|NCT01046643|583304039|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
161523912|NCT01046643|583304040|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
161523913|NCT00093145|583304041|FG000|Overall Study|Unacceptable Toxicity Only|2|||
161523914|NCT00093145|583304041|FG000|Overall Study|Physician Decision|5|||
161523915|NCT00093145|583304041|FG000|Overall Study|Withdrawal by Subject|9|||
161523916|NCT00093145|583304041|FG000|Overall Study|Other|1|||
161523917|NCT01310036|583304042|FG000|Overall Study|Administrative/other|10|||
161523918|NCT01310036|583304042|FG000|Overall Study|Withdrew Consent|11|||
161523919|NCT01310036|583304042|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
161523920|NCT01310036|583304042|FG000|Overall Study|Progression of Disease|164|||
161523921|NCT01310036|583304042|FG000|Overall Study|Death|1|||
161934931|NCT00993473|584811390|FG001|Overall Study|Lost to Follow-up|0|||
161934932|NCT00993473|584811389|FG000|Overall Study|Withdrawal by Subject|1|||
161934933|NCT00993473|584811390|FG001|Overall Study|Withdrawal by Subject|5|||
161934934|NCT00993473|584811389|FG000|Overall Study|Technical problem with CGM device|0|||
161934935|NCT00993473|584811390|FG001|Overall Study|Technical problem with CGM device|1|||
161934936|NCT00993473|584811389|FG000|Overall Study|Family event|1|||
161934937|NCT00993473|584811390|FG001|Overall Study|Family event|0|||
161934938|NCT00770679|584811399|FG000|Overall Study|Lost to Follow-up|3|||
161934939|NCT00770679|584811399|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
161934940|NCT05451329|584811405|FG000|Overall Study|Adverse Event|1|||
161934941|NCT05451329|584811406|FG001|Overall Study|Adverse Event|1|||
161934942|NCT05451329|584811407|FG002|Overall Study|Adverse Event|0|||
161934943|NCT05451329|584811405|FG000|Overall Study|Withdrawal by Subject|1|||
161934944|NCT05451329|584811406|FG001|Overall Study|Withdrawal by Subject|0|||
161523922|NCT01310036|583304042|FG000|Overall Study|Adverse event or intercurrent illness|12|||
161523923|NCT01175668|583304043|FG000|Overall Study|Withdrawal by Subject|2|||
161523924|NCT01175668|583304044|FG001|Overall Study|Withdrawal by Subject|0|||
161523925|NCT00817089|583304045|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
161523926|NCT00817089|583304046|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
161523927|NCT00817089|583304047|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
161523928|NCT00817089|583304048|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
161523929|NCT00817089|583304045|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
161523930|NCT00817089|583304046|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
161523931|NCT00817089|583304047|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
161523932|NCT00817089|583304048|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
161523933|NCT00709722|583304049|FG000|Overall Study|Adverse Event|1|||
161523934|NCT04667117|583304050|FG000|Investigational Period|Lost to Follow-up|0|||
161523935|NCT04667117|583304051|FG001|Investigational Period|Lost to Follow-up|0|||
161523936|NCT04667117|583304052|FG002|Investigational Period|Lost to Follow-up|1|||
161523937|NCT04667117|583304050|FG000|Investigational Period|Protocol Deviation|0|||
161934945|NCT05451329|584811407|FG002|Overall Study|Withdrawal by Subject|0|||
161523938|NCT04667117|583304051|FG001|Investigational Period|Protocol Deviation|1|||
161934946|NCT05451329|584811405|FG000|Overall Study|Investigational Product Lot exchange|1|||
161934947|NCT05451329|584811406|FG001|Overall Study|Investigational Product Lot exchange|1|||
161523939|NCT04667117|583304052|FG002|Investigational Period|Protocol Deviation|0|||
161523940|NCT04667117|583304050|FG000|Extension Period|Lost to Follow-up|1|||
161934948|NCT05451329|584811407|FG002|Overall Study|Investigational Product Lot exchange|0|||
161523941|NCT04667117|583304051|FG001|Extension Period|Lost to Follow-up|0|||
161523942|NCT04667117|583304052|FG002|Extension Period|Lost to Follow-up|0|||
161523943|NCT03359096|583304053|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
161523944|NCT03359096|583304054|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
161523945|NCT03359096|583304053|FG000|First Intervention (4 Weeks)|Death|1|||
161523946|NCT03359096|583304054|FG001|First Intervention (4 Weeks)|Death|0|||
161523947|NCT03359096|583304053|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
161523948|NCT03359096|583304054|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
161523949|NCT01953926|583304065|FG000|Overall Study|Withdrawal by Subject|23|||
161523950|NCT01953926|583304066|FG001|Overall Study|Withdrawal by Subject|3|||
161523951|NCT01953926|583304067|FG002|Overall Study|Withdrawal by Subject|3|||
161523952|NCT01953926|583304068|FG003|Overall Study|Withdrawal by Subject|5|||
161523953|NCT01953926|583304069|FG004|Overall Study|Withdrawal by Subject|6|||
161523954|NCT01953926|583304070|FG005|Overall Study|Withdrawal by Subject|0|||
161523955|NCT01953926|583304071|FG006|Overall Study|Withdrawal by Subject|1|||
161523956|NCT01953926|583304065|FG000|Overall Study|Physician Decision|1|||
161523957|NCT01953926|583304066|FG001|Overall Study|Physician Decision|0|||
161523958|NCT01953926|583304067|FG002|Overall Study|Physician Decision|0|||
161523959|NCT01953926|583304068|FG003|Overall Study|Physician Decision|0|||
161523960|NCT01953926|583304069|FG004|Overall Study|Physician Decision|2|||
161523961|NCT01953926|583304070|FG005|Overall Study|Physician Decision|0|||
161523962|NCT01953926|583304071|FG006|Overall Study|Physician Decision|0|||
161523963|NCT01953926|583304065|FG000|Overall Study|Lost to Follow-up|18|||
161523964|NCT01953926|583304066|FG001|Overall Study|Lost to Follow-up|3|||
161523965|NCT01953926|583304067|FG002|Overall Study|Lost to Follow-up|0|||
161523966|NCT01953926|583304068|FG003|Overall Study|Lost to Follow-up|5|||
161523967|NCT01953926|583304069|FG004|Overall Study|Lost to Follow-up|3|||
161523968|NCT01953926|583304070|FG005|Overall Study|Lost to Follow-up|0|||
161523969|NCT01953926|583304071|FG006|Overall Study|Lost to Follow-up|0|||
161523970|NCT01953926|583304065|FG000|Overall Study|Protocol Violation|1|||
161523971|NCT01953926|583304066|FG001|Overall Study|Protocol Violation|0|||
161523972|NCT01953926|583304067|FG002|Overall Study|Protocol Violation|0|||
161934949|NCT00069953|584811408|FG000|Overall Study|Protocol Violation|2|||
161934950|NCT00113373|584811411|FG000|Overall Study|Ineligible: wrong primary|1|||
161934951|NCT00113373|584811411|FG000|Overall Study|Ineligible: second primary|1|||
161934952|NCT00113373|584811411|FG000|Overall Study|Never Treated|1|||
161523973|NCT01953926|583304068|FG003|Overall Study|Protocol Violation|0|||
161523974|NCT01953926|583304069|FG004|Overall Study|Protocol Violation|0|||
161934953|NCT02395627|584811412|FG000|Overall Study|Withdrawal by Subject|0|||
161934954|NCT02395627|584811413|FG001|Overall Study|Withdrawal by Subject|2|||
161523975|NCT01953926|583304070|FG005|Overall Study|Protocol Violation|0|||
161523976|NCT01953926|583304071|FG006|Overall Study|Protocol Violation|0|||
161523977|NCT01953926|583304065|FG000|Overall Study|Other, Disease progression|2|||
161523978|NCT01953926|583304066|FG001|Overall Study|Other, Disease progression|1|||
161523979|NCT01953926|583304067|FG002|Overall Study|Other, Disease progression|0|||
161523980|NCT01953926|583304068|FG003|Overall Study|Other, Disease progression|0|||
161523981|NCT01953926|583304069|FG004|Overall Study|Other, Disease progression|1|||
161523982|NCT01953926|583304070|FG005|Overall Study|Other, Disease progression|0|||
161523983|NCT01953926|583304071|FG006|Overall Study|Other, Disease progression|0|||
161523984|NCT01953926|583304065|FG000|Overall Study|Discontinuation of study by sponsor|41|||
161523985|NCT01953926|583304066|FG001|Overall Study|Discontinuation of study by sponsor|7|||
161523986|NCT01953926|583304067|FG002|Overall Study|Discontinuation of study by sponsor|5|||
161523987|NCT01953926|583304068|FG003|Overall Study|Discontinuation of study by sponsor|12|||
161523988|NCT01953926|583304069|FG004|Overall Study|Discontinuation of study by sponsor|46|||
161523989|NCT01953926|583304070|FG005|Overall Study|Discontinuation of study by sponsor|5|||
161523990|NCT01953926|583304071|FG006|Overall Study|Discontinuation of study by sponsor|6|||
161523991|NCT01953926|583304065|FG000|Overall Study|Not Treated|1|||
161934955|NCT02395627|584811414|FG002|Overall Study|Withdrawal by Subject|0|||
161934956|NCT02395627|584811412|FG000|Overall Study|Did not receive pembrolizumab|3|||
161523992|NCT01953926|583304066|FG001|Overall Study|Not Treated|0|||
161523993|NCT01953926|583304067|FG002|Overall Study|Not Treated|1|||
161523994|NCT01953926|583304068|FG003|Overall Study|Not Treated|0|||
161523995|NCT01953926|583304069|FG004|Overall Study|Not Treated|0|||
161523996|NCT01953926|583304070|FG005|Overall Study|Not Treated|0|||
161523997|NCT01953926|583304071|FG006|Overall Study|Not Treated|0|||
161523998|NCT04102501|583304075|FG000|Overall Study|Withdrawal by Subject|7|||
161523999|NCT04102501|583304076|FG001|Overall Study|Withdrawal by Subject|9|||
161524000|NCT04102501|583304075|FG000|Overall Study|Adverse Event|1|||
161524001|NCT04102501|583304076|FG001|Overall Study|Adverse Event|3|||
161524002|NCT00968617|583304077|FG000|Overall Study|Study terminated by sponsor|6|||
161524003|NCT04433767|583304078|FG000|Overall Study|Adverse Event|1|||
161524004|NCT04964089|583304081|FG000|Overall Study|Adverse Event|8|||
161524005|NCT04964089|583304082|FG001|Overall Study|Adverse Event|6|||
161524006|NCT04964089|583304081|FG000|Overall Study|Non-compliance with study schedule|1|||
161524007|NCT04964089|583304082|FG001|Overall Study|Non-compliance with study schedule|0|||
161524008|NCT04964089|583304081|FG000|Overall Study|Withdrawal by Subject|6|||
161524009|NCT04964089|583304082|FG001|Overall Study|Withdrawal by Subject|5|||
161934957|NCT02395627|584811413|FG001|Overall Study|Did not receive pembrolizumab|1|||
161934958|NCT02395627|584811414|FG002|Overall Study|Did not receive pembrolizumab|0|||
161934959|NCT03253627|584811415|FG000|Overall Study|Lost to Follow-up|1|||
161934960|NCT03253627|584811416|FG001|Overall Study|Lost to Follow-up|2|||
161934961|NCT03253627|584811415|FG000|Overall Study|Withdrawal by Subject|0|||
161934962|NCT03253627|584811416|FG001|Overall Study|Withdrawal by Subject|2|||
161677861|NCT01994382|583873590|FG006|Overall Study|Progressive disease|3|||
161677862|NCT01994382|583873591|FG007|Overall Study|Progressive disease|6|||
161677863|NCT01994382|583873592|FG008|Overall Study|Progressive disease|2|||
161677864|NCT01994382|583873593|FG009|Overall Study|Progressive disease|2|||
161677865|NCT01994382|583873594|FG010|Overall Study|Progressive disease|13|||
161677866|NCT01994382|583873595|FG011|Overall Study|Progressive disease|8|||
161677867|NCT01994382|583873596|FG012|Overall Study|Progressive disease|7|||
161677868|NCT01994382|583873597|FG013|Overall Study|Progressive disease|3|||
161677869|NCT01994382|583873598|FG014|Overall Study|Progressive disease|6|||
161934963|NCT03253627|584811415|FG000|Overall Study|Inability to complete MRI|1|||
161934964|NCT03253627|584811416|FG001|Overall Study|Inability to complete MRI|0|||
161934965|NCT04629521|584811423|FG000|Overall Study|Death|1|||
161934966|NCT04629521|584811423|FG000|Overall Study|Lost to Follow-up|3|||
161934967|NCT04629521|584811423|FG000|Overall Study|Subject withdrew consent|3|||
161934968|NCT04629521|584811423|FG000|Overall Study|Enrolled in error|1|||
161934969|NCT03163667|584811424|FG000|Overall Study|Death|15|||
161934970|NCT03163667|584811425|FG001|Overall Study|Death|27|||
161524010|NCT04964089|583304081|FG000|Overall Study|Lost to Follow-up|1|||
161524011|NCT04964089|583304082|FG001|Overall Study|Lost to Follow-up|1|||
161524012|NCT04964089|583304081|FG000|Overall Study|Progressive disease|4|||
161524013|NCT04964089|583304082|FG001|Overall Study|Progressive disease|0|||
161524014|NCT04964089|583304081|FG000|Overall Study|Physician Decision|1|||
161524015|NCT04964089|583304082|FG001|Overall Study|Physician Decision|0|||
161524016|NCT04964089|583304081|FG000|Overall Study|Participant did not want to continue study treatment|1|||
161524017|NCT04964089|583304082|FG001|Overall Study|Participant did not want to continue study treatment|0|||
161524018|NCT04964089|583304081|FG000|Overall Study|Participant moved to different state|1|||
161524019|NCT04964089|583304082|FG001|Overall Study|Participant moved to different state|0|||
161524020|NCT04964089|583304081|FG000|Overall Study|Participant decided to discontinue|0|||
161677870|NCT01994382|583873599|FG015|Overall Study|Progressive disease|44|||
161677871|NCT01994382|583873600|FG016|Overall Study|Progressive disease|28|||
161677872|NCT01994382|583873584|FG000|Overall Study|Physician Decision|0|||
161677873|NCT01994382|583873585|FG001|Overall Study|Physician Decision|1|||
161677874|NCT01994382|583873586|FG002|Overall Study|Physician Decision|0|||
161934971|NCT03163667|584811424|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
161934972|NCT03163667|584811425|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
161934973|NCT00979407|584811426|FG000|Overall Study|Withdrawal by Subject|3|||
161934974|NCT00979407|584811427|FG001|Overall Study|Withdrawal by Subject|4|||
161934975|NCT00979407|584811426|FG000|Overall Study|Lost to Follow-up|3|||
161934976|NCT00979407|584811427|FG001|Overall Study|Lost to Follow-up|3|||
161934977|NCT00855166|584811428|FG000|Overall Study|Adverse Event|0|||
161934978|NCT00855166|584811429|FG001|Overall Study|Adverse Event|2|||
161677875|NCT01994382|583873587|FG003|Overall Study|Physician Decision|0|||
161677876|NCT01994382|583873588|FG004|Overall Study|Physician Decision|0|||
161934979|NCT00855166|584811428|FG000|Overall Study|Death|0|||
161934980|NCT00855166|584811429|FG001|Overall Study|Death|1|||
161934981|NCT00855166|584811428|FG000|Overall Study|Withdrawal by Subject|1|||
161934982|NCT00855166|584811429|FG001|Overall Study|Withdrawal by Subject|4|||
161934983|NCT00855166|584811428|FG000|Overall Study|Poor/non-compliance|2|||
161934984|NCT00855166|584811429|FG001|Overall Study|Poor/non-compliance|0|||
161934985|NCT00855166|584811428|FG000|Overall Study|Administrative reasons by sponsor|1|||
161934986|NCT00855166|584811429|FG001|Overall Study|Administrative reasons by sponsor|0|||
161934987|NCT00855166|584811428|FG000|Overall Study|Subject no longer meets study criteria|1|||
161934988|NCT00855166|584811429|FG001|Overall Study|Subject no longer meets study criteria|1|||
161524021|NCT04964089|583304082|FG001|Overall Study|Participant decided to discontinue|1|||
161934989|NCT02940223|584811430|FG000|Overall Study|Failed Requirement|2|||
161934990|NCT02940223|584811431|FG001|Overall Study|Failed Requirement|0|||
161934991|NCT05810597|584811433|FG000|Period 1|Adverse Event|2|||
161934992|NCT05810597|584811434|FG001|Period 1|Adverse Event|0|||
161524022|NCT00927927|583304083|FG000|Overall Study|Withdrawal by Subject|0|||
161524023|NCT00927927|583304084|FG001|Overall Study|Withdrawal by Subject|0|||
161524024|NCT00927927|583304085|FG002|Overall Study|Withdrawal by Subject|0|||
161524025|NCT00927927|583304086|FG003|Overall Study|Withdrawal by Subject|0|||
161677877|NCT01994382|583873589|FG005|Overall Study|Physician Decision|0|||
161677878|NCT01994382|583873590|FG006|Overall Study|Physician Decision|0|||
161677879|NCT01994382|583873591|FG007|Overall Study|Physician Decision|0|||
161677880|NCT01994382|583873592|FG008|Overall Study|Physician Decision|0|||
161677881|NCT01994382|583873593|FG009|Overall Study|Physician Decision|0|||
161934993|NCT05810597|584811433|FG000|Period 1|Physician Decision|1|||
161934994|NCT05810597|584811434|FG001|Period 1|Physician Decision|0|||
161934995|NCT01450631|584811435|FG000|Overall Study|Lost to Follow-up|2|||
161524026|NCT00927927|583304087|FG004|Overall Study|Withdrawal by Subject|0|||
161524027|NCT00927927|583304088|FG005|Overall Study|Withdrawal by Subject|0|||
161524028|NCT00927927|583304089|FG006|Overall Study|Withdrawal by Subject|0|||
161524029|NCT00927927|583304090|FG007|Overall Study|Withdrawal by Subject|2|||
161524030|NCT00927927|583304091|FG008|Overall Study|Withdrawal by Subject|0|||
161524031|NCT00927927|583304092|FG009|Overall Study|Withdrawal by Subject|0|||
161524032|NCT00927927|583304093|FG010|Overall Study|Withdrawal by Subject|0|||
161524033|NCT00927927|583304094|FG011|Overall Study|Withdrawal by Subject|2|||
161524034|NCT00927927|583304095|FG012|Overall Study|Withdrawal by Subject|0|||
161524035|NCT00927927|583304096|FG013|Overall Study|Withdrawal by Subject|0|||
161524036|NCT00927927|583304097|FG014|Overall Study|Withdrawal by Subject|0|||
161524037|NCT03135522|583304106|FG000|Overall Study|Adverse Event|1|||
161524038|NCT03135522|583304107|FG001|Overall Study|Adverse Event|0|||
161524039|NCT03403634|583304108|FG000|Overall Study|Disease progression|3|||
161524040|NCT03403634|583304108|FG000|Overall Study|Did not meet eligibility criteria|4|||
161524041|NCT00924287|583305989|FG000|Overall Study|Death|1|||
161524042|NCT00156065|583305996|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
161524043|NCT00156065|583305997|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
161524044|NCT00156065|583305998|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
161524045|NCT00156065|583305996|FG000|Overall Study|Adverse Event|8|||
161524046|NCT00156065|583305997|FG001|Overall Study|Adverse Event|11|||
161524047|NCT00156065|583305998|FG002|Overall Study|Adverse Event|4|||
161524048|NCT00156065|583305996|FG000|Overall Study|Lack of Efficacy|2|||
161524049|NCT00156065|583305997|FG001|Overall Study|Lack of Efficacy|9|||
161524050|NCT00156065|583305998|FG002|Overall Study|Lack of Efficacy|3|||
161524051|NCT00156065|583305996|FG000|Overall Study|Withdrawal by Subject|13|||
161524052|NCT00156065|583305997|FG001|Overall Study|Withdrawal by Subject|26|||
161524053|NCT00156065|583305998|FG002|Overall Study|Withdrawal by Subject|16|||
161524054|NCT00156065|583305996|FG000|Overall Study|Lost to Follow-up|5|||
161524055|NCT00156065|583305997|FG001|Overall Study|Lost to Follow-up|7|||
161524056|NCT00156065|583305998|FG002|Overall Study|Lost to Follow-up|1|||
161524057|NCT00156065|583305996|FG000|Overall Study|Other|2|||
161524058|NCT00156065|583305997|FG001|Overall Study|Other|9|||
161524059|NCT00156065|583305998|FG002|Overall Study|Other|3|||
161524060|NCT01432366|583305999|FG000|Overall Study|Non-Responder|7|||
161524061|NCT01432366|583305999|FG000|Overall Study|Adverse Event|8|||
161524062|NCT01432366|583305999|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
161524063|NCT01432366|583305999|FG000|Overall Study|Pregnancy|1|||
161524064|NCT01432366|583305999|FG000|Overall Study|Lost to Follow-up|13|||
161524065|NCT01432366|583305999|FG000|Overall Study|Lack of Efficacy|1|||
161524066|NCT01432366|583305999|FG000|Overall Study|Site Closed|20|||
161524067|NCT01432366|583305999|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
161826166|NCT03496298|584403805|FG000|Overall Study|Other|29|||
161524068|NCT01432366|583305999|FG000|Overall Study|Other|14|||
161524069|NCT02395120|583306000|FG000|Overall Study|Missed follow-up dental exam|57|||
161524070|NCT02395120|583306001|FG001|Overall Study|Missed follow-up dental exam|62|||
161524071|NCT02395120|583306002|FG002|Overall Study|Missed follow-up dental exam|6|||
161524072|NCT02395120|583306003|FG003|Overall Study|Missed follow-up dental exam|6|||
161524073|NCT02395120|583306004|FG004|Overall Study|Missed follow-up dental exam|51|||
161524074|NCT04546581|583306006|FG000|Overall Study|Adverse Event|9|||
161524075|NCT04546581|583306007|FG001|Overall Study|Adverse Event|3|||
161524076|NCT04546581|583306006|FG000|Overall Study|Physician Decision|0|||
161524077|NCT04546581|583306007|FG001|Overall Study|Physician Decision|1|||
161524078|NCT04546581|583306006|FG000|Overall Study|Protocol Violation|1|||
161524079|NCT04546581|583306007|FG001|Overall Study|Protocol Violation|2|||
161524080|NCT04546581|583306006|FG000|Overall Study|Withdrawal by Subject|3|||
161524081|NCT04546581|583306007|FG001|Overall Study|Withdrawal by Subject|7|||
161524082|NCT02526693|583306008|FG000|Overall Study|Physician Decision|3|||
161524083|NCT02526693|583306009|FG001|Overall Study|Physician Decision|1|||
161524084|NCT01798927|583306010|FG000|Overall Study|Withdrawal by Subject|1|||
161524085|NCT01159691|583306011|FG000|Overall Study|Lost to Follow-up|2|||
161826167|NCT03496298|584403806|FG001|Overall Study|Other|20|||
161524086|NCT01159691|583306011|FG000|Overall Study|Unknown reasons|1|||
161524087|NCT01159691|583306011|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
161524088|NCT01159691|583306011|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
161524089|NCT01159691|583306011|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
161524090|NCT01159691|583306011|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
161589856|NCT03763708|583548179|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
161826168|NCT03496298|584403807|FG002|Overall Study|Other|23|||
161826169|NCT03496298|584403805|FG000|Overall Study|Randomized and not treated|1|||
161826170|NCT03496298|584403806|FG001|Overall Study|Randomized and not treated|1|||
161826171|NCT03496298|584403807|FG002|Overall Study|Randomized and not treated|1|||
161524091|NCT01159691|583306011|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
161524092|NCT01159691|583306011|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
161524093|NCT04579757|583306022|FG000|Overall Study|Adverse Event|0|||
161524094|NCT04579757|583306023|FG001|Overall Study|Adverse Event|0|||
161524095|NCT04579757|583306024|FG002|Overall Study|Adverse Event|0|||
161934996|NCT01450631|584811436|FG001|Overall Study|Lost to Follow-up|4|||
161934997|NCT01450631|584811435|FG000|Overall Study|Withdrawal by Subject|1|||
161934998|NCT01450631|584811436|FG001|Overall Study|Withdrawal by Subject|0|||
161934999|NCT04903093|584811442|FG000|Overall Study|Withdrawal by Subject|0|||
161935000|NCT04903093|584811443|FG001|Overall Study|Withdrawal by Subject|0|||
161524096|NCT04579757|583306025|FG003|Overall Study|Adverse Event|2|||
161524097|NCT04579757|583306026|FG004|Overall Study|Adverse Event|1|||
161524098|NCT04579757|583306027|FG005|Overall Study|Adverse Event|1|||
161524099|NCT04579757|583306028|FG006|Overall Study|Adverse Event|0|||
161524100|NCT04579757|583306029|FG007|Overall Study|Adverse Event|0|||
161524101|NCT04579757|583306030|FG008|Overall Study|Adverse Event|0|||
161524102|NCT04579757|583306022|FG000|Overall Study|Death|4|||
161524103|NCT04579757|583306023|FG001|Overall Study|Death|1|||
161524104|NCT04579757|583306024|FG002|Overall Study|Death|14|||
161524105|NCT04579757|583306025|FG003|Overall Study|Death|3|||
161524106|NCT04579757|583306026|FG004|Overall Study|Death|2|||
161524107|NCT04579757|583306027|FG005|Overall Study|Death|7|||
161524108|NCT04579757|583306028|FG006|Overall Study|Death|0|||
161524109|NCT04579757|583306029|FG007|Overall Study|Death|1|||
161524110|NCT04579757|583306030|FG008|Overall Study|Death|3|||
161524111|NCT04579757|583306022|FG000|Overall Study|Physician Decision|0|||
161524112|NCT04579757|583306023|FG001|Overall Study|Physician Decision|0|||
161524113|NCT04579757|583306024|FG002|Overall Study|Physician Decision|0|||
161524114|NCT04579757|583306025|FG003|Overall Study|Physician Decision|2|||
161524115|NCT04579757|583306026|FG004|Overall Study|Physician Decision|1|||
161524116|NCT04579757|583306027|FG005|Overall Study|Physician Decision|1|||
161524117|NCT04579757|583306028|FG006|Overall Study|Physician Decision|1|||
161524118|NCT04579757|583306029|FG007|Overall Study|Physician Decision|0|||
161524119|NCT04579757|583306030|FG008|Overall Study|Physician Decision|0|||
161524120|NCT04579757|583306022|FG000|Overall Study|Study Terminated By Sponsor|0|||
161524121|NCT04579757|583306023|FG001|Overall Study|Study Terminated By Sponsor|0|||
161524122|NCT04579757|583306024|FG002|Overall Study|Study Terminated By Sponsor|0|||
161524123|NCT04579757|583306025|FG003|Overall Study|Study Terminated By Sponsor|0|||
161524124|NCT04579757|583306026|FG004|Overall Study|Study Terminated By Sponsor|2|||
161524125|NCT04579757|583306027|FG005|Overall Study|Study Terminated By Sponsor|0|||
161524126|NCT04579757|583306028|FG006|Overall Study|Study Terminated By Sponsor|0|||
161524127|NCT04579757|583306029|FG007|Overall Study|Study Terminated By Sponsor|2|||
161524128|NCT04579757|583306030|FG008|Overall Study|Study Terminated By Sponsor|0|||
161524129|NCT04579757|583306022|FG000|Overall Study|Withdrawal by Subject|1|||
161524130|NCT04579757|583306023|FG001|Overall Study|Withdrawal by Subject|1|||
161524131|NCT04579757|583306024|FG002|Overall Study|Withdrawal by Subject|0|||
161524132|NCT04579757|583306025|FG003|Overall Study|Withdrawal by Subject|0|||
161524133|NCT04579757|583306026|FG004|Overall Study|Withdrawal by Subject|2|||
161524134|NCT04579757|583306027|FG005|Overall Study|Withdrawal by Subject|1|||
161524135|NCT04579757|583306028|FG006|Overall Study|Withdrawal by Subject|0|||
161524136|NCT04579757|583306029|FG007|Overall Study|Withdrawal by Subject|3|||
161524137|NCT04579757|583306030|FG008|Overall Study|Withdrawal by Subject|0|||
161524138|NCT04579757|583306022|FG000|Overall Study|Radiological or Clinical PD|1|||
161524139|NCT04579757|583306023|FG001|Overall Study|Radiological or Clinical PD|4|||
161524140|NCT04579757|583306024|FG002|Overall Study|Radiological or Clinical PD|1|||
161524141|NCT04579757|583306025|FG003|Overall Study|Radiological or Clinical PD|3|||
161935001|NCT04903093|584811444|FG002|Overall Study|Withdrawal by Subject|0|||
161935002|NCT04903093|584811445|FG003|Overall Study|Withdrawal by Subject|1|||
161935003|NCT04903093|584811446|FG004|Overall Study|Withdrawal by Subject|0|||
161935004|NCT04903093|584811447|FG005|Overall Study|Withdrawal by Subject|0|||
161935005|NCT01390584|584811460|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
161935006|NCT01390584|584811461|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
161935007|NCT01390584|584811462|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
161524142|NCT04579757|583306026|FG004|Overall Study|Radiological or Clinical PD|9|||
161524143|NCT04579757|583306027|FG005|Overall Study|Radiological or Clinical PD|4|||
161524144|NCT04579757|583306028|FG006|Overall Study|Radiological or Clinical PD|2|||
161524145|NCT04579757|583306029|FG007|Overall Study|Radiological or Clinical PD|2|||
161524146|NCT04579757|583306030|FG008|Overall Study|Radiological or Clinical PD|0|||
161935008|NCT00025233|584811463|FG000|Overall Study|Ineligible: wrong cell type|1|||
161524147|NCT04579757|583306022|FG000|Overall Study|Start of New Therapy|0|||
161524148|NCT04579757|583306023|FG001|Overall Study|Start of New Therapy|0|||
161524149|NCT04579757|583306024|FG002|Overall Study|Start of New Therapy|0|||
161524150|NCT04579757|583306025|FG003|Overall Study|Start of New Therapy|0|||
161524151|NCT04579757|583306026|FG004|Overall Study|Start of New Therapy|2|||
161524152|NCT04579757|583306027|FG005|Overall Study|Start of New Therapy|1|||
161524153|NCT04579757|583306028|FG006|Overall Study|Start of New Therapy|0|||
161524154|NCT04579757|583306029|FG007|Overall Study|Start of New Therapy|0|||
161524155|NCT04579757|583306030|FG008|Overall Study|Start of New Therapy|0|||
161524156|NCT01153633|583306031|FG000|Overall Study|Protocol Violation|1|||
161524157|NCT01153633|583306032|FG001|Overall Study|Protocol Violation|1|||
161524158|NCT01153633|583306031|FG000|Overall Study|Therapeutic failure|3|||
161524159|NCT01153633|583306032|FG001|Overall Study|Therapeutic failure|3|||
161524160|NCT00384085|583306033|FG000|Overall Study|Adverse Event|5|||
161524161|NCT00384085|583306034|FG001|Overall Study|Adverse Event|5|||
161524162|NCT00384085|583306035|FG002|Overall Study|Adverse Event|4|||
161524163|NCT00384085|583306033|FG000|Overall Study|Lack of Efficacy|0|||
161524164|NCT00384085|583306034|FG001|Overall Study|Lack of Efficacy|3|||
161524165|NCT00384085|583306035|FG002|Overall Study|Lack of Efficacy|2|||
161524166|NCT00384085|583306033|FG000|Overall Study|No longer Requires Study Treatment|1|||
161524167|NCT00384085|583306034|FG001|Overall Study|No longer Requires Study Treatment|0|||
161524168|NCT00384085|583306035|FG002|Overall Study|No longer Requires Study Treatment|1|||
161524169|NCT00384085|583306033|FG000|Overall Study|Protocol Violation|2|||
161524170|NCT00384085|583306034|FG001|Overall Study|Protocol Violation|2|||
161524171|NCT00384085|583306035|FG002|Overall Study|Protocol Violation|2|||
161524172|NCT00384085|583306033|FG000|Overall Study|Lost to Follow-up|9|||
161524173|NCT00384085|583306034|FG001|Overall Study|Lost to Follow-up|9|||
161524174|NCT00384085|583306035|FG002|Overall Study|Lost to Follow-up|10|||
161524175|NCT00384085|583306033|FG000|Overall Study|Progressive Disease|0|||
161524176|NCT00384085|583306034|FG001|Overall Study|Progressive Disease|1|||
161524177|NCT00384085|583306035|FG002|Overall Study|Progressive Disease|0|||
161524178|NCT00384085|583306033|FG000|Overall Study|Withdrawal by Subject|14|||
161524179|NCT00384085|583306034|FG001|Overall Study|Withdrawal by Subject|19|||
161524180|NCT00384085|583306035|FG002|Overall Study|Withdrawal by Subject|29|||
161524181|NCT00384085|583306033|FG000|Overall Study|Patient non-compliant|4|||
161524182|NCT00384085|583306034|FG001|Overall Study|Patient non-compliant|4|||
161524183|NCT00384085|583306035|FG002|Overall Study|Patient non-compliant|5|||
161524184|NCT00384085|583306033|FG000|Overall Study|Physician Decision|1|||
161524185|NCT00384085|583306034|FG001|Overall Study|Physician Decision|0|||
161524186|NCT00384085|583306035|FG002|Overall Study|Physician Decision|0|||
161524187|NCT00384085|583306033|FG000|Overall Study|Loss of site personnel|1|||
161524188|NCT00384085|583306034|FG001|Overall Study|Loss of site personnel|0|||
161524189|NCT00384085|583306035|FG002|Overall Study|Loss of site personnel|1|||
161524190|NCT00384085|583306033|FG000|Overall Study|Sponsor decision|1|||
161524191|NCT00384085|583306034|FG001|Overall Study|Sponsor decision|2|||
161524192|NCT00384085|583306035|FG002|Overall Study|Sponsor decision|1|||
161524193|NCT00384085|583306033|FG000|Overall Study|Patient moved|1|||
161524194|NCT00384085|583306034|FG001|Overall Study|Patient moved|0|||
161524195|NCT00384085|583306035|FG002|Overall Study|Patient moved|1|||
161524196|NCT00384085|583306033|FG000|Overall Study|Patient required surgery|0|||
161524197|NCT00384085|583306034|FG001|Overall Study|Patient required surgery|1|||
161524198|NCT00384085|583306035|FG002|Overall Study|Patient required surgery|0|||
161524199|NCT05912400|583306036|FG000|Overall Study|Lost to Follow-up|1|||
161524200|NCT05912400|583306037|FG001|Overall Study|Lost to Follow-up|0|||
161524201|NCT05912400|583306036|FG000|Overall Study|Physician Decision|6|||
161524202|NCT05912400|583306037|FG001|Overall Study|Physician Decision|0|||
161524203|NCT05912400|583306036|FG000|Overall Study|Withdrawal by Subject|1|||
161524204|NCT05912400|583306037|FG001|Overall Study|Withdrawal by Subject|0|||
161524205|NCT01944631|583306041|FG000|Overall Study|Adverse Event|1|||
161524206|NCT01944631|583306042|FG001|Overall Study|Adverse Event|0|||
161826172|NCT00676494|584403810|FG000|Overall Study|Missed Visit|8|||
161524207|NCT01944631|583306041|FG000|Overall Study|Lost to Follow-up|3|||
161524208|NCT01944631|583306042|FG001|Overall Study|Lost to Follow-up|1|||
161524209|NCT01944631|583306041|FG000|Overall Study|Withdrawal by Subject|0|||
161524210|NCT01944631|583306042|FG001|Overall Study|Withdrawal by Subject|1|||
161524211|NCT01843192|583306043|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
161524212|NCT01843192|583306044|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
161524213|NCT01843192|583306045|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
161524214|NCT00328510|583306048|FG000|Overall Study|Gag disorder, could not use frame|4|||
161524215|NCT00328510|583306049|FG001|Overall Study|Gag disorder, could not use frame|0|||
161524216|NCT00328510|583306048|FG000|Overall Study|Dentition problems, could not use frame|1|||
161524217|NCT00328510|583306049|FG001|Overall Study|Dentition problems, could not use frame|0|||
161524218|NCT00328510|583306048|FG000|Overall Study|Withdrawal by Subject|4|||
161524219|NCT00328510|583306049|FG001|Overall Study|Withdrawal by Subject|2|||
161524220|NCT00328510|583306048|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
161524221|NCT00328510|583306049|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
161524222|NCT00328510|583306048|FG000|Overall Study|Treatment changed to a single fraction|1|||
161524223|NCT00328510|583306049|FG001|Overall Study|Treatment changed to a single fraction|1|||
161524224|NCT04726709|583306050|FG000|Overall Study|Withdrawal by Subject|2|||
161524225|NCT04726709|583306051|FG001|Overall Study|Withdrawal by Subject|2|||
161524226|NCT01949480|583306052|FG000|Overall Study|Physician Decision|5|||
161524227|NCT01949480|583306053|FG001|Overall Study|Physician Decision|8|||
161524228|NCT00144339|583306054|FG000|Overall Study|Adverse Event|746|||
161826173|NCT00676494|584403810|FG000|Overall Study|Withdrawal by Subject|6|||
161826174|NCT02608476|584403811|FG000|Overall Study|Withdrawal by Subject|30|||
161826175|NCT02608476|584403812|FG001|Overall Study|Withdrawal by Subject|37|||
161826176|NCT02608476|584403811|FG000|Overall Study|Lost to Follow-up|24|||
161826177|NCT02608476|584403812|FG001|Overall Study|Lost to Follow-up|24|||
161524229|NCT00144339|583306055|FG001|Overall Study|Adverse Event|627|||
161524230|NCT00144339|583306054|FG000|Overall Study|Protocol Violation|75|||
161524231|NCT00144339|583306055|FG001|Overall Study|Protocol Violation|48|||
161524232|NCT00144339|583306054|FG000|Overall Study|Withdrawal by Subject|403|||
161524233|NCT00144339|583306055|FG001|Overall Study|Withdrawal by Subject|300|||
161524234|NCT00144339|583306054|FG000|Overall Study|Lost to Follow-up|76|||
161524235|NCT00144339|583306055|FG001|Overall Study|Lost to Follow-up|64|||
161524236|NCT00144339|583306054|FG000|Overall Study|Other|58|||
161524237|NCT00144339|583306055|FG001|Overall Study|Other|60|||
161524238|NCT00305058|583306056|FG000|Overall Study|Participant too young|1|||
161524239|NCT00305058|583306057|FG001|Overall Study|Participant too young|0|||
161524240|NCT00305058|583306056|FG000|Overall Study|Missing data collection instrument|3|||
161524241|NCT00305058|583306057|FG001|Overall Study|Missing data collection instrument|2|||
161524242|NCT00305058|583306056|FG000|Overall Study|Missing outcome data|3|||
161524243|NCT00305058|583306057|FG001|Overall Study|Missing outcome data|2|||
161524244|NCT04798586|583306060|FG000|Overall Study|Death|2|||
161524245|NCT03538626|583306061|FG000|Overall Study|Withdrawal by Subject|0|||
161524246|NCT03538626|583306062|FG001|Overall Study|Withdrawal by Subject|1|||
161524247|NCT03538626|583306063|FG002|Overall Study|Withdrawal by Subject|0|||
161524248|NCT03538626|583306064|FG003|Overall Study|Withdrawal by Subject|0|||
161524249|NCT03538626|583306065|FG004|Overall Study|Withdrawal by Subject|0|||
161524250|NCT03538626|583306066|FG005|Overall Study|Withdrawal by Subject|0|||
161524251|NCT03538626|583306067|FG006|Overall Study|Withdrawal by Subject|0|||
161524252|NCT03538626|583306068|FG007|Overall Study|Withdrawal by Subject|0|||
161524253|NCT03538626|583306061|FG000|Overall Study|Lost to Follow-up|0|||
161524254|NCT03538626|583306062|FG001|Overall Study|Lost to Follow-up|0|||
161524255|NCT03538626|583306063|FG002|Overall Study|Lost to Follow-up|0|||
161524256|NCT03538626|583306064|FG003|Overall Study|Lost to Follow-up|0|||
161524257|NCT03538626|583306065|FG004|Overall Study|Lost to Follow-up|0|||
161524258|NCT03538626|583306066|FG005|Overall Study|Lost to Follow-up|0|||
161935009|NCT00025233|584811463|FG000|Overall Study|Ineligible: wrong primary|1|||
161524259|NCT03538626|583306067|FG006|Overall Study|Lost to Follow-up|1|||
161524260|NCT03538626|583306068|FG007|Overall Study|Lost to Follow-up|0|||
161524261|NCT00288587|583306069|FG000|Overall Study|Death|4|||
161524262|NCT00288587|583306070|FG001|Overall Study|Death|4|||
161524263|NCT00288587|583306069|FG000|Overall Study|Transplant|0|||
161524264|NCT00288587|583306070|FG001|Overall Study|Transplant|3|||
161524265|NCT00288587|583306069|FG000|Overall Study|Adverse Event|0|||
161524266|NCT00288587|583306070|FG001|Overall Study|Adverse Event|1|||
161524267|NCT00288587|583306069|FG000|Overall Study|Physician Decision|0|||
161524268|NCT00288587|583306070|FG001|Overall Study|Physician Decision|2|||
161524269|NCT00288587|583306069|FG000|Overall Study|Severe Aortic Stenosis|1|||
161524270|NCT00288587|583306070|FG001|Overall Study|Severe Aortic Stenosis|0|||
161524271|NCT02232893|583306076|FG000|Overall Study|Withdrawal by Subject|4|||
161524272|NCT02232893|583306077|FG001|Overall Study|Withdrawal by Subject|1|||
161524273|NCT02232893|583306076|FG000|Overall Study|Adverse Event|0|||
161935010|NCT00025233|584811463|FG000|Overall Study|Ineligible: improper prior treatment|1|||
161524274|NCT02232893|583306077|FG001|Overall Study|Adverse Event|1|||
161524275|NCT02232893|583306076|FG000|Overall Study|Sponsor request early termination|0|||
161524276|NCT02232893|583306077|FG001|Overall Study|Sponsor request early termination|1|||
161524277|NCT02232893|583306076|FG000|Overall Study|Developed exclusion criteria|0|||
161524278|NCT02232893|583306077|FG001|Overall Study|Developed exclusion criteria|1|||
161524279|NCT02232893|583306076|FG000|Overall Study|Other|0|||
161524280|NCT02232893|583306077|FG001|Overall Study|Other|3|||
161524281|NCT01764945|583306078|FG000|Overall Study|Adverse Event|0|||
161524282|NCT01764945|583306079|FG001|Overall Study|Adverse Event|1|||
161524283|NCT01764945|583306080|FG002|Overall Study|Adverse Event|0|||
161524284|NCT01764945|583306081|FG003|Overall Study|Adverse Event|0|||
161524285|NCT01764945|583306082|FG004|Overall Study|Adverse Event|0|||
161524286|NCT01764945|583306083|FG005|Overall Study|Adverse Event|0|||
161524287|NCT01764945|583306084|FG006|Overall Study|Adverse Event|1|||
161524288|NCT01764945|583306085|FG007|Overall Study|Adverse Event|0|||
161524289|NCT05077267|583306088|FG000|Treatment Period|Lost to Follow-up|0|||
161524290|NCT05077267|583306089|FG001|Treatment Period|Lost to Follow-up|1|||
161524291|NCT05077267|583306090|FG002|Treatment Period|Lost to Follow-up|0|||
161524292|NCT05077267|583306088|FG000|Treatment Period|Withdrawal by Subject|0|||
161524293|NCT05077267|583306089|FG001|Treatment Period|Withdrawal by Subject|1|||
161524294|NCT05077267|583306090|FG002|Treatment Period|Withdrawal by Subject|0|||
161524295|NCT05077267|583306088|FG000|Follow-up Period|Lost to Follow-up|0|||
161524296|NCT05077267|583306089|FG001|Follow-up Period|Lost to Follow-up|5|||
161524297|NCT05077267|583306090|FG002|Follow-up Period|Lost to Follow-up|7|||
161524298|NCT05077267|583306088|FG000|Follow-up Period|Withdrawal by Subject|0|||
161524299|NCT05077267|583306089|FG001|Follow-up Period|Withdrawal by Subject|2|||
161524300|NCT05077267|583306090|FG002|Follow-up Period|Withdrawal by Subject|5|||
161524301|NCT05077267|583306088|FG000|Follow-up Period|Study terminated by sponsor|0|||
161524302|NCT05077267|583306089|FG001|Follow-up Period|Study terminated by sponsor|27|||
161524303|NCT05077267|583306090|FG002|Follow-up Period|Study terminated by sponsor|23|||
161524304|NCT05077267|583306088|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
161524305|NCT05077267|583306089|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
161524306|NCT05077267|583306090|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
161524307|NCT05077267|583306088|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
161524308|NCT05077267|583306089|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
161524309|NCT05077267|583306090|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
161524310|NCT02911948|583306091|FG000|Overall Study|Protocol Violation|0|||
161524311|NCT02911948|583306092|FG001|Overall Study|Protocol Violation|1|||
161524312|NCT02911948|583306091|FG000|Overall Study|Withdrawal by Subject|0|||
161524313|NCT02911948|583306092|FG001|Overall Study|Withdrawal by Subject|2|||
161524314|NCT02911948|583306091|FG000|Overall Study|Lack of Efficacy|0|||
161524315|NCT02911948|583306092|FG001|Overall Study|Lack of Efficacy|1|||
161524316|NCT02911948|583306091|FG000|Overall Study|Unclassified|0|||
161524317|NCT02911948|583306092|FG001|Overall Study|Unclassified|3|||
161524318|NCT00586105|583306099|FG000|Overall Study|Adverse Event|4|||
161524319|NCT00586105|583306099|FG000|Overall Study|Death|2|||
161524320|NCT00586105|583306099|FG000|Overall Study|Protocol Violation|1|||
161524321|NCT00586105|583306099|FG000|Overall Study|Withdrawal by Subject|3|||
161524322|NCT00586105|583306099|FG000|Overall Study|Disease progression|19|||
161524323|NCT00586105|583306099|FG000|Overall Study|Switched to commercial drug|9|||
161524324|NCT00586105|583306099|FG000|Overall Study|Reason not reported|1|||
161524325|NCT01136291|583306103|FG000|Overall Study|Lost to Follow-up|1|||
161524326|NCT01136291|583306104|FG001|Overall Study|Lost to Follow-up|1|||
161524327|NCT03965052|583306105|FG000|Overall Study|Protocol Violation|1|||
161524328|NCT03965052|583306106|FG001|Overall Study|Protocol Violation|0|||
161524329|NCT02308033|583306116|FG000|Overall Study|Normal Gram stain at Baseline|13|||
161524330|NCT02308033|583306117|FG001|Overall Study|Normal Gram stain at Baseline|10|||
161524331|NCT02308033|583306116|FG000|Overall Study|Positive for STD at Baseline|7|||
161524332|NCT02308033|583306117|FG001|Overall Study|Positive for STD at Baseline|4|||
161524333|NCT02308033|583306116|FG000|Overall Study|Lost to Follow-up|6|||
161524334|NCT02308033|583306117|FG001|Overall Study|Lost to Follow-up|5|||
161524335|NCT03165045|583306118|FG000|Visit 1|No registration after visit 1|9|||
161524336|NCT03165045|583306118|FG000|Visit 1|No treatment documented|10|||
161826178|NCT02608476|584403811|FG000|Overall Study|Adverse Event|2|||
161524337|NCT03165045|583306118|FG000|Visit 1|No visit 1|10|||
161524338|NCT03165045|583306118|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
161524339|NCT03165045|583306118|FG000|Visit 2|No available total CCQ score at all|29|||
161524340|NCT03165045|583306118|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
161524341|NCT04323436|583306124|FG000|Overall Study|Adverse Event|7|||
161524342|NCT04323436|583306125|FG001|Overall Study|Adverse Event|0|||
161524343|NCT04323436|583306126|FG002|Overall Study|Adverse Event|0|||
161524344|NCT04323436|583306124|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
161524345|NCT04323436|583306125|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
161524346|NCT04323436|583306126|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
161524347|NCT04323436|583306124|FG000|Overall Study|Death|1|||
161524348|NCT04323436|583306125|FG001|Overall Study|Death|0|||
161524349|NCT04323436|583306126|FG002|Overall Study|Death|0|||
161524350|NCT04323436|583306124|FG000|Overall Study|Physician Decision|2|||
161524351|NCT04323436|583306125|FG001|Overall Study|Physician Decision|0|||
161524352|NCT04323436|583306126|FG002|Overall Study|Physician Decision|0|||
161524353|NCT04323436|583306124|FG000|Overall Study|Progressive disease|10|||
161524354|NCT04323436|583306125|FG001|Overall Study|Progressive disease|0|||
161524355|NCT04323436|583306126|FG002|Overall Study|Progressive disease|0|||
161524356|NCT04323436|583306124|FG000|Overall Study|Subject decision|3|||
161524357|NCT04323436|583306125|FG001|Overall Study|Subject decision|0|||
161524358|NCT04323436|583306126|FG002|Overall Study|Subject decision|0|||
161524359|NCT00142909|583306127|FG000|Randomization|Various Reasons|7|||
161524360|NCT00142909|583306128|FG001|Randomization|Various Reasons|10|||
161524361|NCT00142909|583306127|FG000|Medications Begin|Protocol Violation|2|||
161524362|NCT00142909|583306128|FG001|Medications Begin|Protocol Violation|0|||
161524363|NCT00142909|583306127|FG000|Medications Begin|Withdrawal by Subject|5|||
161524364|NCT00142909|583306128|FG001|Medications Begin|Withdrawal by Subject|3|||
161524365|NCT00142909|583306127|FG000|Medications Begin|Withdrawal by Subject|2|||
161524366|NCT00142909|583306128|FG001|Medications Begin|Withdrawal by Subject|0|||
161524367|NCT01682837|583306131|FG000|Baseline|Withdrawal by Subject|5|||
161524368|NCT03021187|583306134|FG000|Overall Study|Death|0|||
161524369|NCT03021187|583306135|FG001|Overall Study|Death|0|||
161524370|NCT03021187|583306136|FG002|Overall Study|Death|3|||
161524371|NCT03021187|583306137|FG003|Overall Study|Death|0|||
161524372|NCT03021187|583306134|FG000|Overall Study|Withdrawal by Subject|0|||
161524373|NCT03021187|583306135|FG001|Overall Study|Withdrawal by Subject|6|||
161524374|NCT03021187|583306136|FG002|Overall Study|Withdrawal by Subject|2|||
161524375|NCT03021187|583306137|FG003|Overall Study|Withdrawal by Subject|5|||
161524376|NCT03021187|583306134|FG000|Overall Study|Lost to Follow-up|10|||
161524377|NCT03021187|583306135|FG001|Overall Study|Lost to Follow-up|3|||
161524378|NCT03021187|583306136|FG002|Overall Study|Lost to Follow-up|1|||
161524379|NCT03021187|583306137|FG003|Overall Study|Lost to Follow-up|4|||
161524380|NCT01664078|583306138|FG000|Overall Study|Death|9|||
161524381|NCT01664078|583306138|FG000|Overall Study|Withdrawal by Subject|4|||
161589857|NCT03763708|583548180|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589858|NCT03763708|583548181|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589859|NCT03763708|583548182|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589860|NCT03763708|583548183|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161589861|NCT03763708|583548175|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589862|NCT03763708|583548176|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589863|NCT03763708|583548177|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589864|NCT03763708|583548178|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589865|NCT03763708|583548179|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589866|NCT03763708|583548180|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
161589867|NCT03763708|583548181|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589868|NCT03763708|583548182|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161589869|NCT03763708|583548183|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161677882|NCT01994382|583873594|FG010|Overall Study|Physician Decision|3|||
161677883|NCT01994382|583873595|FG011|Overall Study|Physician Decision|1|||
161677884|NCT01994382|583873596|FG012|Overall Study|Physician Decision|1|||
161677885|NCT01994382|583873597|FG013|Overall Study|Physician Decision|0|||
161677886|NCT01994382|583873598|FG014|Overall Study|Physician Decision|1|||
161677887|NCT01994382|583873599|FG015|Overall Study|Physician Decision|4|||
161677888|NCT01994382|583873600|FG016|Overall Study|Physician Decision|2|||
161677889|NCT01994382|583873584|FG000|Overall Study|Death|0|||
161677890|NCT01994382|583873585|FG001|Overall Study|Death|0|||
161677891|NCT01994382|583873586|FG002|Overall Study|Death|0|||
161677892|NCT01994382|583873587|FG003|Overall Study|Death|0|||
161677893|NCT01994382|583873588|FG004|Overall Study|Death|1|||
161677894|NCT01994382|583873589|FG005|Overall Study|Death|0|||
161677895|NCT01994382|583873590|FG006|Overall Study|Death|0|||
161677896|NCT01994382|583873591|FG007|Overall Study|Death|0|||
161677897|NCT01994382|583873592|FG008|Overall Study|Death|1|||
161677898|NCT01994382|583873593|FG009|Overall Study|Death|1|||
161677899|NCT01994382|583873594|FG010|Overall Study|Death|0|||
161677900|NCT01994382|583873595|FG011|Overall Study|Death|0|||
161677901|NCT01994382|583873596|FG012|Overall Study|Death|0|||
161677902|NCT01994382|583873597|FG013|Overall Study|Death|0|||
161677903|NCT01994382|583873598|FG014|Overall Study|Death|0|||
161677904|NCT01994382|583873599|FG015|Overall Study|Death|1|||
161677905|NCT01994382|583873600|FG016|Overall Study|Death|0|||
161677906|NCT01994382|583873584|FG000|Overall Study|Adverse Event|0|||
161677907|NCT01994382|583873585|FG001|Overall Study|Adverse Event|1|||
161677908|NCT01994382|583873586|FG002|Overall Study|Adverse Event|2|||
161677909|NCT01994382|583873587|FG003|Overall Study|Adverse Event|0|||
161677910|NCT01994382|583873588|FG004|Overall Study|Adverse Event|0|||
161677911|NCT01994382|583873589|FG005|Overall Study|Adverse Event|0|||
161677912|NCT01994382|583873590|FG006|Overall Study|Adverse Event|0|||
161677913|NCT01994382|583873591|FG007|Overall Study|Adverse Event|0|||
161677914|NCT01994382|583873592|FG008|Overall Study|Adverse Event|0|||
161677915|NCT01994382|583873593|FG009|Overall Study|Adverse Event|0|||
161677916|NCT01994382|583873594|FG010|Overall Study|Adverse Event|15|||
161677917|NCT01994382|583873595|FG011|Overall Study|Adverse Event|2|||
161677918|NCT01994382|583873596|FG012|Overall Study|Adverse Event|7|||
161677919|NCT01994382|583873597|FG013|Overall Study|Adverse Event|3|||
161677920|NCT01994382|583873598|FG014|Overall Study|Adverse Event|17|||
161677921|NCT01994382|583873599|FG015|Overall Study|Adverse Event|6|||
161677922|NCT01994382|583873600|FG016|Overall Study|Adverse Event|3|||
161677923|NCT01994382|583873584|FG000|Overall Study|Other than specified|0|||
161677924|NCT01994382|583873585|FG001|Overall Study|Other than specified|0|||
161677925|NCT01994382|583873586|FG002|Overall Study|Other than specified|0|||
161826179|NCT02608476|584403812|FG001|Overall Study|Adverse Event|8|||
161826180|NCT02608476|584403811|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
161589870|NCT03763708|583548175|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589871|NCT03763708|583548176|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589872|NCT03763708|583548177|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589873|NCT03763708|583548178|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161677926|NCT01994382|583873587|FG003|Overall Study|Other than specified|0|||
161677927|NCT01994382|583873588|FG004|Overall Study|Other than specified|0|||
161677928|NCT01994382|583873589|FG005|Overall Study|Other than specified|0|||
161677929|NCT01994382|583873590|FG006|Overall Study|Other than specified|0|||
161677930|NCT01994382|583873591|FG007|Overall Study|Other than specified|0|||
161677931|NCT01994382|583873592|FG008|Overall Study|Other than specified|0|||
161677932|NCT01994382|583873593|FG009|Overall Study|Other than specified|0|||
161677933|NCT01994382|583873594|FG010|Overall Study|Other than specified|2|||
161677934|NCT01994382|583873595|FG011|Overall Study|Other than specified|0|||
161677935|NCT01994382|583873596|FG012|Overall Study|Other than specified|2|||
161677936|NCT01994382|583873597|FG013|Overall Study|Other than specified|0|||
161826181|NCT02608476|584403812|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
161677937|NCT01994382|583873598|FG014|Overall Study|Other than specified|0|||
161677938|NCT01994382|583873599|FG015|Overall Study|Other than specified|4|||
161677939|NCT01994382|583873600|FG016|Overall Study|Other than specified|4|||
161524382|NCT01664078|583306138|FG000|Overall Study|Lost to Follow-up|2|||
161524383|NCT01664078|583306138|FG000|Overall Study|missed 5 year visit|1|||
161524384|NCT01664078|583306138|FG000|Overall Study|Other|53|||
161524385|NCT03351049|583306139|FG000|Overall Study|Withdrawal|26|||
161524386|NCT03351049|583306140|FG001|Overall Study|Withdrawal|22|||
161524387|NCT04095858|583306141|FG000|Overall Study|Death|1|||
161524388|NCT04095858|583306142|FG001|Overall Study|Death|0|||
161524389|NCT04095858|583306141|FG000|Overall Study|Study terminated by Sponsor|2|||
161524390|NCT04095858|583306142|FG001|Overall Study|Study terminated by Sponsor|4|||
161524391|NCT01344460|583306143|FG000|Overall Study|Withdrawal by Subject|1|||
161524392|NCT01344460|583306143|FG000|Overall Study|Lost to Follow-up|2|||
161524393|NCT02838017|583306145|FG000|Overall Study|Lost to Follow-up|14|||
161524394|NCT02838017|583306146|FG001|Overall Study|Lost to Follow-up|11|||
161524395|NCT01692197|583306147|FG000|Overall Study|Failed Screening|3|||
161524396|NCT02120924|583306148|FG000|Overall Study|Lack of Efficacy|1|||
161524397|NCT02120924|583306149|FG001|Overall Study|Lack of Efficacy|2|||
161524398|NCT02120924|583306150|FG002|Overall Study|Lack of Efficacy|3|||
161524399|NCT02120924|583306148|FG000|Overall Study|Adverse Event|0|||
161524400|NCT02120924|583306149|FG001|Overall Study|Adverse Event|1|||
161524401|NCT02120924|583306150|FG002|Overall Study|Adverse Event|3|||
161524402|NCT02120924|583306148|FG000|Overall Study|Withdrawal by Subject|16|||
161524403|NCT02120924|583306149|FG001|Overall Study|Withdrawal by Subject|20|||
161524404|NCT02120924|583306150|FG002|Overall Study|Withdrawal by Subject|8|||
161524405|NCT02120924|583306148|FG000|Overall Study|Lost to Follow-up|14|||
161524406|NCT02120924|583306149|FG001|Overall Study|Lost to Follow-up|14|||
161524407|NCT02120924|583306150|FG002|Overall Study|Lost to Follow-up|11|||
161524408|NCT02120924|583306148|FG000|Overall Study|Pregnancy|2|||
161524409|NCT02120924|583306149|FG001|Overall Study|Pregnancy|0|||
161524410|NCT02120924|583306150|FG002|Overall Study|Pregnancy|0|||
161524411|NCT02120924|583306148|FG000|Overall Study|Protocol Violation|3|||
161524412|NCT02120924|583306149|FG001|Overall Study|Protocol Violation|7|||
161524413|NCT02120924|583306150|FG002|Overall Study|Protocol Violation|2|||
161524414|NCT02120924|583306148|FG000|Overall Study|Physician Decision|0|||
161524415|NCT02120924|583306149|FG001|Overall Study|Physician Decision|1|||
161524416|NCT02120924|583306150|FG002|Overall Study|Physician Decision|1|||
161524417|NCT02120924|583306148|FG000|Overall Study|Death|1|||
161524418|NCT02120924|583306149|FG001|Overall Study|Death|0|||
161524419|NCT02120924|583306150|FG002|Overall Study|Death|0|||
161524420|NCT02120924|583306148|FG000|Overall Study|Compliance with IP|5|||
161524421|NCT02120924|583306149|FG001|Overall Study|Compliance with IP|1|||
161524422|NCT02120924|583306150|FG002|Overall Study|Compliance with IP|1|||
161524423|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
161524424|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
161524425|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
161524426|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
161524427|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
161524428|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
161524429|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
161524430|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
161524431|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
161524432|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
161524433|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
161589874|NCT03763708|583548179|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589875|NCT03763708|583548180|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589876|NCT03763708|583548181|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
161589877|NCT03763708|583548182|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589878|NCT03763708|583548183|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161589879|NCT03763708|583548175|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
161589880|NCT03763708|583548176|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
161589881|NCT03763708|583548177|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
161589882|NCT03763708|583548178|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
161524434|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
161524435|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
161524436|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
161589883|NCT03763708|583548179|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
161589884|NCT03763708|583548180|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
161589885|NCT03763708|583548181|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
161589886|NCT03763708|583548182|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
161935011|NCT00025233|584811463|FG000|Overall Study|Never treated|1|||
161524437|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
161524438|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
161524439|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
161524440|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
161524441|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
161935012|NCT00401830|584811464|FG000|Overall Study|Adverse Event|10|||
161935013|NCT00401830|584811465|FG001|Overall Study|Adverse Event|18|||
161935014|NCT00401830|584811464|FG000|Overall Study|Lack of Efficacy|11|||
161935015|NCT00401830|584811465|FG001|Overall Study|Lack of Efficacy|5|||
161935016|NCT00401830|584811464|FG000|Overall Study|Withdrawal by Subject|4|||
161935017|NCT00401830|584811465|FG001|Overall Study|Withdrawal by Subject|3|||
161935018|NCT00401830|584811464|FG000|Overall Study|Protocol Violation|3|||
161935019|NCT00401830|584811465|FG001|Overall Study|Protocol Violation|3|||
161935020|NCT00401830|584811464|FG000|Overall Study|Non-compliance with drug study|1|||
161935021|NCT00401830|584811465|FG001|Overall Study|Non-compliance with drug study|0|||
161935022|NCT00401830|584811464|FG000|Overall Study|Lost to Follow-up|1|||
161935023|NCT00401830|584811465|FG001|Overall Study|Lost to Follow-up|3|||
161935024|NCT00401830|584811464|FG000|Overall Study|Other: Personal / Family problems|1|||
161935025|NCT00401830|584811465|FG001|Overall Study|Other: Personal / Family problems|0|||
161935026|NCT01720602|584811466|FG000|Overall Study|Adverse Event|3|||
161935027|NCT01720602|584811466|FG000|Overall Study|Progressive disease on therapy|2|||
161935028|NCT01539525|584811467|FG000|Overall Study|Lost to Follow-up|19|||
161935029|NCT01539525|584811468|FG001|Overall Study|Lost to Follow-up|12|||
161935030|NCT01539525|584811469|FG002|Overall Study|Lost to Follow-up|11|||
161935031|NCT01539525|584811467|FG000|Overall Study|Withdrawal by Subject|0|||
161935032|NCT01539525|584811468|FG001|Overall Study|Withdrawal by Subject|3|||
161935033|NCT01539525|584811469|FG002|Overall Study|Withdrawal by Subject|2|||
161935034|NCT01539525|584811467|FG000|Overall Study|Protocol Violation|1|||
161935035|NCT01539525|584811468|FG001|Overall Study|Protocol Violation|1|||
161935036|NCT01539525|584811469|FG002|Overall Study|Protocol Violation|4|||
161935037|NCT02184442|584811470|FG000|Overall Study|Death|61|||
161935038|NCT02184442|584811471|FG001|Overall Study|Death|65|||
161935039|NCT02184442|584811470|FG000|Overall Study|Withdrawal by Subject|3|||
161935040|NCT02184442|584811471|FG001|Overall Study|Withdrawal by Subject|11|||
161935041|NCT01044459|584811472|FG000|Overall Study|Withdrawal by Subject|21|||
161935042|NCT01044459|584811473|FG001|Overall Study|Withdrawal by Subject|28|||
161935043|NCT01044459|584811472|FG000|Overall Study|Terminated by Sponsor|22|||
161935044|NCT01044459|584811473|FG001|Overall Study|Terminated by Sponsor|21|||
161524442|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
161524443|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
161524444|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
161524445|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
161524446|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
161524447|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
161524448|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
161524449|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
161524450|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
161524451|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
161524452|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
161524453|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
161524454|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
161524455|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
161524456|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
161524457|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
161524458|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
161524459|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
161524460|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
161524461|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
161524462|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
161524463|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
161524464|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
161524465|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
161524466|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
161524467|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
161524468|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
161524469|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
161524470|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
161524471|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
161524472|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
161935045|NCT01044459|584811472|FG000|Overall Study|Adverse Event|22|||
161935046|NCT01044459|584811473|FG001|Overall Study|Adverse Event|20|||
161935047|NCT01044459|584811472|FG000|Overall Study|Lack of Efficacy|23|||
161935048|NCT01044459|584811473|FG001|Overall Study|Lack of Efficacy|12|||
161935049|NCT01044459|584811472|FG000|Overall Study|Protocol Violation|11|||
161935050|NCT01044459|584811473|FG001|Overall Study|Protocol Violation|16|||
161524473|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
161524474|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
161524475|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
161524476|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
161524477|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
161524478|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
161524479|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
161524480|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
161524481|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
161524482|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
161524483|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
161524484|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
161524485|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
161524486|NCT01884350|583306151|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
161524487|NCT01884350|583306152|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
161524488|NCT01884350|583306153|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
161524489|NCT04447404|583307803|FG000|Overall Study|Death|2|||
161524490|NCT04447404|583307804|FG001|Overall Study|Death|0|||
161524491|NCT00574080|583307805|FG000|Overall Study|Death|10|||
161524492|NCT00574080|583307806|FG001|Overall Study|Death|10|||
161524493|NCT01221597|583307807|FG000|Overall Study|Adverse Event|4|||
161524494|NCT01221597|583307808|FG001|Overall Study|Adverse Event|1|||
161524495|NCT01221597|583307807|FG000|Overall Study|Withdrawal by Subject|20|||
161524496|NCT01221597|583307808|FG001|Overall Study|Withdrawal by Subject|6|||
161524497|NCT01221597|583307807|FG000|Overall Study|Lost to Follow-up|6|||
161524498|NCT01221597|583307808|FG001|Overall Study|Lost to Follow-up|5|||
161524499|NCT01221597|583307807|FG000|Overall Study|Protocol Violation|1|||
161524500|NCT01221597|583307808|FG001|Overall Study|Protocol Violation|0|||
161524501|NCT01221597|583307807|FG000|Overall Study|Other|3|||
161524502|NCT01221597|583307808|FG001|Overall Study|Other|4|||
161524503|NCT01221597|583307807|FG000|Overall Study|Death|2|||
161524504|NCT01221597|583307808|FG001|Overall Study|Death|0|||
161524505|NCT00148343|583307810|FG000|Overall Study|Withdrawal by Subject|12|||
161524506|NCT00148343|583307811|FG001|Overall Study|Withdrawal by Subject|7|||
161524507|NCT00148343|583307810|FG000|Overall Study|Physician Decision|3|||
161524508|NCT00148343|583307811|FG001|Overall Study|Physician Decision|4|||
161524509|NCT02384759|583307824|FG000|Overall Study|Patients not treated|3|||
161524510|NCT02384759|583307825|FG001|Overall Study|Patients not treated|2|||
161524511|NCT01605617|583307826|FG000|First Intervention|Adverse Event|0|||
161524512|NCT01605617|583307827|FG001|First Intervention|Adverse Event|1|||
161524513|NCT01605617|583307826|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
161524514|NCT01605617|583307827|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
161524515|NCT00121238|583307828|FG000|Overall Study|disease progression before intervention|1|||
161524516|NCT00121238|583307828|FG000|Overall Study|Protocol Violation|2|||
161524517|NCT01380327|583307829|FG000|Overall Study|Lost to Follow-up|0|||
161524518|NCT01380327|583307830|FG001|Overall Study|Lost to Follow-up|1|||
161524519|NCT01380327|583307831|FG002|Overall Study|Lost to Follow-up|1|||
161524520|NCT01380327|583307829|FG000|Overall Study|Protocol Violation|3|||
161524521|NCT01380327|583307830|FG001|Overall Study|Protocol Violation|2|||
161524522|NCT01380327|583307831|FG002|Overall Study|Protocol Violation|3|||
161524523|NCT01380327|583307829|FG000|Overall Study|Withdrawal by Subject|0|||
161524524|NCT01380327|583307830|FG001|Overall Study|Withdrawal by Subject|0|||
161524525|NCT01380327|583307831|FG002|Overall Study|Withdrawal by Subject|1|||
161524526|NCT01380327|583307829|FG000|Overall Study|Housing situation precluded ability to k|0|||
161524527|NCT01380327|583307830|FG001|Overall Study|Housing situation precluded ability to k|0|||
161524528|NCT01380327|583307831|FG002|Overall Study|Housing situation precluded ability to k|1|||
161524529|NCT01380327|583307829|FG000|Overall Study|Questionable onset of epilepsy|0|||
161524530|NCT01380327|583307830|FG001|Overall Study|Questionable onset of epilepsy|0|||
161524531|NCT01380327|583307831|FG002|Overall Study|Questionable onset of epilepsy|1|||
161589887|NCT03763708|583548183|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
161589888|NCT03763708|583548175|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
161589889|NCT03763708|583548176|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
161524532|NCT03043664|583307832|FG000|Overall Study|Lost to Follow-up|1|||
161524533|NCT01540851|583307833|FG000|Overall Study|Lost to Follow-up|14|||
161524534|NCT01540851|583307834|FG001|Overall Study|Lost to Follow-up|15|||
161524535|NCT01540851|583307833|FG000|Overall Study|Withdrawal by Subject|7|||
161524536|NCT01540851|583307834|FG001|Overall Study|Withdrawal by Subject|3|||
161589890|NCT03763708|583548177|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
161589891|NCT03763708|583548178|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
161935051|NCT01044459|584811472|FG000|Overall Study|Other Reason|7|||
161524537|NCT00325468|583307835|FG000|Overall Study|Adverse Event|1|||
161524538|NCT00325468|583307836|FG001|Overall Study|Adverse Event|1|||
161589892|NCT03763708|583548179|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
161524539|NCT00325468|583307837|FG002|Overall Study|Adverse Event|0|||
161524540|NCT00325468|583307838|FG003|Overall Study|Adverse Event|5|||
161524541|NCT00325468|583307839|FG004|Overall Study|Adverse Event|1|||
161524542|NCT00325468|583307835|FG000|Overall Study|Death|2|||
161524543|NCT00325468|583307836|FG001|Overall Study|Death|0|||
161524544|NCT00325468|583307837|FG002|Overall Study|Death|2|||
161524545|NCT00325468|583307838|FG003|Overall Study|Death|4|||
161524546|NCT00325468|583307839|FG004|Overall Study|Death|0|||
161524547|NCT00325468|583307835|FG000|Overall Study|Lost to Follow-up|0|||
161524548|NCT00325468|583307836|FG001|Overall Study|Lost to Follow-up|0|||
161524549|NCT00325468|583307837|FG002|Overall Study|Lost to Follow-up|1|||
161524550|NCT00325468|583307838|FG003|Overall Study|Lost to Follow-up|2|||
161524551|NCT00325468|583307839|FG004|Overall Study|Lost to Follow-up|2|||
161524552|NCT00325468|583307835|FG000|Overall Study|Physician Decision|1|||
161524553|NCT00325468|583307836|FG001|Overall Study|Physician Decision|1|||
161524554|NCT00325468|583307837|FG002|Overall Study|Physician Decision|0|||
161524555|NCT00325468|583307838|FG003|Overall Study|Physician Decision|1|||
161524556|NCT00325468|583307839|FG004|Overall Study|Physician Decision|0|||
161524557|NCT00325468|583307835|FG000|Overall Study|Withdrawal by Subject|3|||
161524558|NCT00325468|583307836|FG001|Overall Study|Withdrawal by Subject|1|||
161524559|NCT00325468|583307837|FG002|Overall Study|Withdrawal by Subject|0|||
161524560|NCT00325468|583307838|FG003|Overall Study|Withdrawal by Subject|14|||
161524561|NCT00325468|583307839|FG004|Overall Study|Withdrawal by Subject|4|||
161524562|NCT00325468|583307835|FG000|Overall Study|site closure etc|4|||
161524563|NCT00325468|583307836|FG001|Overall Study|site closure etc|2|||
161524564|NCT00325468|583307837|FG002|Overall Study|site closure etc|1|||
161524565|NCT00325468|583307838|FG003|Overall Study|site closure etc|8|||
161524566|NCT00325468|583307839|FG004|Overall Study|site closure etc|1|||
161524567|NCT03593655|583307840|FG000|First Product Use Period|Withdrawal by Subject|1|||
161524568|NCT03593655|583307841|FG001|First Product Use Period|Withdrawal by Subject|1|||
161524569|NCT03593655|583307840|FG000|First Product Use Period|Lost to Follow-up|1|||
161524570|NCT03593655|583307841|FG001|First Product Use Period|Lost to Follow-up|3|||
161524571|NCT03593655|583307840|FG000|Second Product Use Period|Withdrawal by Subject|1|||
161524572|NCT03593655|583307841|FG001|Second Product Use Period|Withdrawal by Subject|1|||
161524573|NCT03593655|583307840|FG000|Second Product Use Period|Lost to Follow-up|1|||
161524574|NCT03593655|583307841|FG001|Second Product Use Period|Lost to Follow-up|0|||
161524575|NCT03593655|583307840|FG000|Third Product Use Period|Lost to Follow-up|1|||
161524576|NCT03593655|583307841|FG001|Third Product Use Period|Lost to Follow-up|2|||
161677940|NCT01994382|583873584|FG000|Overall Study|Withdrawal by Subject|0|||
161677941|NCT01994382|583873585|FG001|Overall Study|Withdrawal by Subject|0|||
161677942|NCT01994382|583873586|FG002|Overall Study|Withdrawal by Subject|0|||
161677943|NCT01994382|583873587|FG003|Overall Study|Withdrawal by Subject|0|||
161677944|NCT01994382|583873588|FG004|Overall Study|Withdrawal by Subject|0|||
161677945|NCT01994382|583873589|FG005|Overall Study|Withdrawal by Subject|0|||
161677946|NCT01994382|583873590|FG006|Overall Study|Withdrawal by Subject|0|||
161677947|NCT01994382|583873591|FG007|Overall Study|Withdrawal by Subject|0|||
161677948|NCT01994382|583873592|FG008|Overall Study|Withdrawal by Subject|0|||
161826182|NCT02608476|584403811|FG000|Overall Study|Noncompliance with treatment|1|||
161826183|NCT02608476|584403812|FG001|Overall Study|Noncompliance with treatment|5|||
161826184|NCT02608476|584403811|FG000|Overall Study|Lack of Efficacy|3|||
161826185|NCT02608476|584403812|FG001|Overall Study|Lack of Efficacy|1|||
161826186|NCT02608476|584403811|FG000|Overall Study|Other|0|||
161826187|NCT02608476|584403812|FG001|Overall Study|Other|1|||
161826188|NCT02608476|584403811|FG000|Overall Study|Physician Decision|1|||
161935052|NCT01044459|584811473|FG001|Overall Study|Other Reason|14|||
161935053|NCT01044459|584811472|FG000|Overall Study|COPD exacerbation|9|||
161935054|NCT01044459|584811473|FG001|Overall Study|COPD exacerbation|8|||
161935055|NCT01044459|584811472|FG000|Overall Study|Lost to Follow-up|18|||
161524577|NCT03593655|583307840|FG000|Third Product Use Period|Physician Decision|0|||
161524578|NCT03593655|583307841|FG001|Third Product Use Period|Physician Decision|1|||
161524579|NCT03593655|583307840|FG000|Third Product Use Period|Withdrawal by Subject|0|||
161524580|NCT03593655|583307841|FG001|Third Product Use Period|Withdrawal by Subject|1|||
161524581|NCT03732209|583307842|FG000|Overall Study|Lost to Follow-up|4|||
161524582|NCT03732209|583307843|FG001|Overall Study|Lost to Follow-up|4|||
161524583|NCT03732209|583307842|FG000|Overall Study|Withdrawal by Subject|8|||
161524584|NCT03732209|583307843|FG001|Overall Study|Withdrawal by Subject|9|||
161826189|NCT02608476|584403812|FG001|Overall Study|Physician Decision|0|||
161524585|NCT05046795|583307844|FG000|Overall Study|Adverse Event|13|||
161935056|NCT01044459|584811473|FG001|Overall Study|Lost to Follow-up|12|||
161524586|NCT05046795|583307845|FG001|Overall Study|Adverse Event|15|||
161524587|NCT05046795|583307844|FG000|Overall Study|Withdrawal by Subject|4|||
161524588|NCT05046795|583307845|FG001|Overall Study|Withdrawal by Subject|7|||
161677949|NCT01994382|583873593|FG009|Overall Study|Withdrawal by Subject|0|||
161677950|NCT01994382|583873594|FG010|Overall Study|Withdrawal by Subject|6|||
161826190|NCT02608476|584403811|FG000|Overall Study|Pregnancy|0|||
161524589|NCT05046795|583307844|FG000|Overall Study|Physician Decision|1|||
161524590|NCT05046795|583307845|FG001|Overall Study|Physician Decision|2|||
161524591|NCT05046795|583307844|FG000|Overall Study|Protocol Violation|1|||
161524592|NCT05046795|583307845|FG001|Overall Study|Protocol Violation|2|||
161524593|NCT05046795|583307844|FG000|Overall Study|Death|1|||
161524594|NCT05046795|583307845|FG001|Overall Study|Death|0|||
161524595|NCT05046795|583307844|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
161524596|NCT05046795|583307845|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
161524597|NCT01127178|583307846|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
161524598|NCT01127178|583307847|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
161524599|NCT01127178|583307846|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
161524600|NCT01127178|583307847|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
161524601|NCT01127178|583307846|FG000|Dose Escalation: Treatment Phase|Other|2|||
161524602|NCT01127178|583307847|FG001|Dose Escalation: Treatment Phase|Other|0|||
161524603|NCT01127178|583307846|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
161524604|NCT01127178|583307847|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
161524605|NCT01127178|583307846|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
161524606|NCT01127178|583307847|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
161524607|NCT01127178|583307846|FG000|Dose Escalation: Extension Phase|Other|1|||
161524608|NCT01127178|583307847|FG001|Dose Escalation: Extension Phase|Other|0|||
161524609|NCT04139317|583307848|FG000|Overall Study|Adverse Event|10|||
161524610|NCT04139317|583307849|FG001|Overall Study|Adverse Event|2|||
161524611|NCT04139317|583307848|FG000|Overall Study|Death|6|||
161524612|NCT04139317|583307849|FG001|Overall Study|Death|4|||
161524613|NCT04139317|583307848|FG000|Overall Study|Lost to Follow-up|1|||
161524614|NCT04139317|583307849|FG001|Overall Study|Lost to Follow-up|0|||
161524615|NCT04139317|583307848|FG000|Overall Study|Physician Decision|3|||
161524616|NCT04139317|583307849|FG001|Overall Study|Physician Decision|1|||
161524617|NCT04139317|583307848|FG000|Overall Study|Progressive Disease|19|||
161524618|NCT04139317|583307849|FG001|Overall Study|Progressive Disease|9|||
161524619|NCT04139317|583307848|FG000|Overall Study|Subject Decision|2|||
161589893|NCT03763708|583548180|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
161589894|NCT03763708|583548181|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
161589895|NCT03763708|583548182|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
161589896|NCT03763708|583548183|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
161589897|NCT03763708|583548175|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
161589898|NCT03763708|583548176|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
161589899|NCT03763708|583548177|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
161589900|NCT03763708|583548178|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
161589901|NCT03763708|583548179|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
161589902|NCT03763708|583548180|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
161589903|NCT03763708|583548181|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
161589904|NCT03763708|583548182|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
161589905|NCT03763708|583548183|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
161589906|NCT04382404|583548186|FG000|Overall Study|Adverse Event|1|||
161589907|NCT04382404|583548186|FG000|Overall Study|Lost to Follow-up|2|||
161589908|NCT05687916|583548190|FG000|Overall Study|Adverse Event|1|||
161589909|NCT05687916|583548191|FG001|Overall Study|Adverse Event|2|||
161589910|NCT05687916|583548192|FG002|Overall Study|Adverse Event|0|||
161589911|NCT05687916|583548190|FG000|Overall Study|Withdrawal by Subject|1|||
161589912|NCT05687916|583548191|FG001|Overall Study|Withdrawal by Subject|0|||
161589913|NCT05687916|583548192|FG002|Overall Study|Withdrawal by Subject|1|||
161589914|NCT05687916|583548190|FG000|Overall Study|Protocol Violation|0|||
161589915|NCT05687916|583548191|FG001|Overall Study|Protocol Violation|2|||
161589916|NCT05687916|583548192|FG002|Overall Study|Protocol Violation|1|||
161524620|NCT04139317|583307849|FG001|Overall Study|Subject Decision|2|||
161524621|NCT00782340|583307852|FG000|Open Label Titration|Adverse Event|12|||
161524622|NCT00782340|583307853|FG001|Open Label Titration|Adverse Event|0|||
161524623|NCT00782340|583307854|FG002|Open Label Titration|Adverse Event|0|||
161524624|NCT00782340|583307852|FG000|Open Label Titration|Treatment failure|50|||
161524625|NCT00782340|583307853|FG001|Open Label Titration|Treatment failure|0|||
161524626|NCT00782340|583307854|FG002|Open Label Titration|Treatment failure|0|||
161589917|NCT05687916|583548190|FG000|Overall Study|Reason not Specified|1|||
161589918|NCT05687916|583548191|FG001|Overall Study|Reason not Specified|0|||
161589919|NCT05687916|583548192|FG002|Overall Study|Reason not Specified|0|||
161589920|NCT03406871|583548196|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
161589921|NCT03406871|583548197|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
161589922|NCT03406871|583548198|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
161589923|NCT03406871|583548196|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
161589924|NCT03406871|583548197|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
161524627|NCT00782340|583307852|FG000|Open Label Titration|Protocol Violation|5|||
161524628|NCT00782340|583307853|FG001|Open Label Titration|Protocol Violation|0|||
161524629|NCT00782340|583307854|FG002|Open Label Titration|Protocol Violation|0|||
161524630|NCT00782340|583307852|FG000|Open Label Titration|Withdrawal by Subject|5|||
161524631|NCT00782340|583307853|FG001|Open Label Titration|Withdrawal by Subject|0|||
161524632|NCT00782340|583307854|FG002|Open Label Titration|Withdrawal by Subject|0|||
161524633|NCT00782340|583307852|FG000|Open Label Titration|Enrollment capped|16|||
161935057|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
161935058|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
161935059|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
161935060|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161935061|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161935062|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
161935063|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Other|2|||
161935064|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Other|1|||
161935065|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Other|1|||
161935066|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
161935067|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
161935068|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
161935069|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161935070|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
161935071|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
161935072|NCT00787800|584811481|FG000|Overall Study|Withdrawal by Subject|3|||
161935073|NCT00787800|584811482|FG001|Overall Study|Withdrawal by Subject|5|||
161935074|NCT00787800|584811481|FG000|Overall Study|Death|0|||
161935075|NCT00787800|584811482|FG001|Overall Study|Death|2|||
161935076|NCT04634331|584811486|FG000|Overall Study|Withdrawal by Subject|2|||
161935077|NCT04634331|584811487|FG001|Overall Study|Withdrawal by Subject|2|||
161935078|NCT00461812|584811491|FG000|Overall Study|study terminated|10|||
161935079|NCT02916433|584811492|FG000|Overall Study|Withdrawal by Subject|1|||
161935080|NCT02916433|584811493|FG001|Overall Study|Withdrawal by Subject|0|||
161935081|NCT02916433|584811492|FG000|Overall Study|Physician Decision|1|||
161935082|NCT02916433|584811493|FG001|Overall Study|Physician Decision|0|||
161935083|NCT01694771|584811494|FG000|Overall Study|Adverse Event|18|||
161935084|NCT01694771|584811495|FG001|Overall Study|Adverse Event|16|||
161935085|NCT01694771|584811494|FG000|Overall Study|Lack of Efficacy|1|||
161935086|NCT01694771|584811495|FG001|Overall Study|Lack of Efficacy|0|||
161935087|NCT01694771|584811494|FG000|Overall Study|Non compliance protocol|7|||
161935088|NCT01694771|584811495|FG001|Overall Study|Non compliance protocol|6|||
161935089|NCT01694771|584811494|FG000|Overall Study|Lost to Follow-up|2|||
161935090|NCT01694771|584811495|FG001|Overall Study|Lost to Follow-up|3|||
161935091|NCT01694771|584811494|FG000|Overall Study|Consent withdrawn|7|||
161935092|NCT01694771|584811495|FG001|Overall Study|Consent withdrawn|9|||
161935093|NCT01694771|584811494|FG000|Overall Study|Other reasons|5|||
161935094|NCT01694771|584811495|FG001|Overall Study|Other reasons|6|||
161935095|NCT00890097|584811496|FG000|Overall Study|Adverse Event|21|||
161935096|NCT00890097|584811497|FG001|Overall Study|Adverse Event|32|||
161935097|NCT00890097|584811498|FG002|Overall Study|Adverse Event|28|||
161935098|NCT00890097|584811496|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
161935099|NCT00890097|584811497|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
161524634|NCT00782340|583307853|FG001|Open Label Titration|Enrollment capped|0|||
161524635|NCT00782340|583307854|FG002|Open Label Titration|Enrollment capped|0|||
161524636|NCT00782340|583307852|FG000|Open Label Titration|Did not meet responder criteria|2|||
161524637|NCT00782340|583307853|FG001|Open Label Titration|Did not meet responder criteria|0|||
161524638|NCT00782340|583307854|FG002|Open Label Titration|Did not meet responder criteria|0|||
161524639|NCT00782340|583307852|FG000|Open Label Titration|Lost to Follow-up|5|||
161524640|NCT00782340|583307853|FG001|Open Label Titration|Lost to Follow-up|0|||
161524641|NCT00782340|583307854|FG002|Open Label Titration|Lost to Follow-up|0|||
161524642|NCT00782340|583307852|FG000|Open Label Titration|Randomized in error|6|||
161524643|NCT00782340|583307853|FG001|Open Label Titration|Randomized in error|0|||
161524644|NCT00782340|583307854|FG002|Open Label Titration|Randomized in error|0|||
161524645|NCT02365467|583307855|FG000|Overall Study|Death|3|||
161524646|NCT01306162|583307856|FG000|Period 1|Adverse Event|0|||
161524647|NCT01306162|583307857|FG001|Period 1|Adverse Event|0|||
161826191|NCT02608476|584403812|FG001|Overall Study|Pregnancy|1|||
161524648|NCT01306162|583307858|FG002|Period 1|Adverse Event|0|||
161524649|NCT01306162|583307859|FG003|Period 1|Adverse Event|1|||
161524650|NCT01306162|583307856|FG000|Washout 1|Non-compliance to protocol|0|||
161826192|NCT02608476|584403811|FG000|Overall Study|Progressive disease|1|||
161826193|NCT02608476|584403812|FG001|Overall Study|Progressive disease|0|||
161826194|NCT02058160|584403813|FG000|Overall Study|Randomized but not treated|2|||
161826195|NCT02058160|584403814|FG001|Overall Study|Randomized but not treated|4|||
161826196|NCT02058160|584403813|FG000|Overall Study|Poor compliance to protocol|4|||
161826197|NCT02058160|584403814|FG001|Overall Study|Poor compliance to protocol|1|||
161826198|NCT02058160|584403813|FG000|Overall Study|Adverse Event|12|||
161826199|NCT02058160|584403814|FG001|Overall Study|Adverse Event|3|||
161826200|NCT02058160|584403813|FG000|Overall Study|Lost to Follow-up|1|||
161826201|NCT02058160|584403814|FG001|Overall Study|Lost to Follow-up|0|||
161826202|NCT02058160|584403813|FG000|Overall Study|Other than specified above|12|||
161826203|NCT02058160|584403814|FG001|Overall Study|Other than specified above|6|||
161826204|NCT01203917|584403816|FG000|Overall Study|Death|29|||
161826205|NCT01203917|584403816|FG000|Overall Study|Lost to Follow-up|2|||
161524651|NCT01306162|583307857|FG001|Washout 1|Non-compliance to protocol|1|||
161524652|NCT01306162|583307858|FG002|Washout 1|Non-compliance to protocol|0|||
161524653|NCT01306162|583307859|FG003|Washout 1|Non-compliance to protocol|0|||
161524654|NCT01109992|583307860|FG000|Overall Study|Withdrawal by Subject|0|||
161524655|NCT01109992|583307861|FG001|Overall Study|Withdrawal by Subject|1|||
161524656|NCT01109992|583307860|FG000|Overall Study|Movement during rest scan.|0|||
161524657|NCT01109992|583307861|FG001|Overall Study|Movement during rest scan.|1|||
161524658|NCT00690755|583307862|FG000|Overall Study|Physician Decision|2|||
161524659|NCT00690755|583307863|FG001|Overall Study|Physician Decision|0|||
161524660|NCT00690755|583307864|FG002|Overall Study|Physician Decision|46|||
161524661|NCT00690755|583307865|FG003|Overall Study|Physician Decision|5|||
161524662|NCT00690755|583307866|FG004|Overall Study|Physician Decision|0|||
161524663|NCT00690755|583307867|FG005|Overall Study|Physician Decision|4|||
161524664|NCT00690755|583307868|FG006|Overall Study|Physician Decision|0|||
161524665|NCT04287920|583307872|FG000|Overall Study|Lost to Follow-up|1|||
161524666|NCT04287920|583307873|FG001|Overall Study|Lost to Follow-up|1|||
161524667|NCT04287920|583307872|FG000|Overall Study|Withdrawal by Subject|0|||
161524668|NCT04287920|583307873|FG001|Overall Study|Withdrawal by Subject|3|||
161524669|NCT02952924|583307876|FG000|Overall Study|Protocol Violation|0|||
161524670|NCT02952924|583307877|FG001|Overall Study|Protocol Violation|0|||
161524671|NCT02952924|583307878|FG002|Overall Study|Protocol Violation|0|||
161826206|NCT01203917|584403816|FG000|Overall Study|Withdrawal by Subject|3|||
161826207|NCT01203917|584403816|FG000|Overall Study|Due to objective disease progression|1|||
161524672|NCT02952924|583307879|FG003|Overall Study|Protocol Violation|0|||
161524673|NCT02952924|583307880|FG004|Overall Study|Protocol Violation|0|||
161524674|NCT02952924|583307881|FG005|Overall Study|Protocol Violation|0|||
161524675|NCT02952924|583307882|FG006|Overall Study|Protocol Violation|0|||
161524676|NCT02952924|583307883|FG007|Overall Study|Protocol Violation|0|||
161524677|NCT02952924|583307884|FG008|Overall Study|Protocol Violation|0|||
161524678|NCT02952924|583307885|FG009|Overall Study|Protocol Violation|0|||
161524679|NCT02952924|583307886|FG010|Overall Study|Protocol Violation|0|||
161524680|NCT02952924|583307887|FG011|Overall Study|Protocol Violation|0|||
161524681|NCT02952924|583307888|FG012|Overall Study|Protocol Violation|0|||
161524682|NCT02952924|583307889|FG013|Overall Study|Protocol Violation|0|||
161524683|NCT02952924|583307890|FG014|Overall Study|Protocol Violation|0|||
161524684|NCT02952924|583307891|FG015|Overall Study|Protocol Violation|0|||
161524685|NCT02952924|583307892|FG016|Overall Study|Protocol Violation|0|||
161524686|NCT02952924|583307893|FG017|Overall Study|Protocol Violation|0|||
161524687|NCT02952924|583307894|FG018|Overall Study|Protocol Violation|0|||
161524688|NCT02952924|583307895|FG019|Overall Study|Protocol Violation|1|||
161524689|NCT02952924|583307896|FG020|Overall Study|Protocol Violation|0|||
161524690|NCT02952924|583307897|FG021|Overall Study|Protocol Violation|0|||
161524691|NCT02952924|583307876|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
161524692|NCT02952924|583307877|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
161524693|NCT02952924|583307878|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
161524694|NCT02952924|583307879|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
161524695|NCT02952924|583307880|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
161524696|NCT02952924|583307881|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
161524697|NCT02952924|583307882|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
161524698|NCT02952924|583307883|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
161524699|NCT02952924|583307884|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
161524700|NCT02952924|583307885|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
161524701|NCT02952924|583307886|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
161524702|NCT02952924|583307887|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
161524703|NCT02952924|583307888|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
161524704|NCT02952924|583307889|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
161524705|NCT02952924|583307890|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
161524706|NCT02952924|583307891|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
161524707|NCT02952924|583307892|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
161524708|NCT02952924|583307893|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
161524709|NCT02952924|583307894|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
161826208|NCT01203917|584403816|FG000|Overall Study|Due to EGFR M+I patient|1|||
161826209|NCT04106817|584403817|FG000|Overall Study|Lost to Follow-up|1|||
161826210|NCT04106817|584403818|FG001|Overall Study|Lost to Follow-up|0|||
161826211|NCT04106817|584403819|FG002|Overall Study|Lost to Follow-up|0|||
161826212|NCT02260635|584403820|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
161826213|NCT02260635|584403821|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
161826214|NCT02260635|584403820|FG000|Open-Label Extension|Study Termination|25|||
161826215|NCT02260635|584403821|FG001|Open-Label Extension|Study Termination|25|||
161826216|NCT02260635|584403820|FG000|Open-Label Extension|Withdrawal by Subject|1|||
161524710|NCT02952924|583307895|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
161524711|NCT02952924|583307896|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
161524712|NCT02952924|583307897|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
161524713|NCT02952924|583307876|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524714|NCT02952924|583307877|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524715|NCT02952924|583307878|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524716|NCT02952924|583307879|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524717|NCT02952924|583307880|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
161677951|NCT01994382|583873595|FG011|Overall Study|Withdrawal by Subject|0|||
161677952|NCT01994382|583873596|FG012|Overall Study|Withdrawal by Subject|2|||
161677953|NCT01994382|583873597|FG013|Overall Study|Withdrawal by Subject|0|||
161677954|NCT01994382|583873598|FG014|Overall Study|Withdrawal by Subject|4|||
161677955|NCT01994382|583873599|FG015|Overall Study|Withdrawal by Subject|3|||
161677956|NCT01994382|583873600|FG016|Overall Study|Withdrawal by Subject|0|||
161677957|NCT01994382|583873584|FG000|Overall Study|Lost to Follow-up|0|||
161677958|NCT01994382|583873585|FG001|Overall Study|Lost to Follow-up|0|||
161677959|NCT01994382|583873586|FG002|Overall Study|Lost to Follow-up|0|||
161677960|NCT01994382|583873587|FG003|Overall Study|Lost to Follow-up|0|||
161677961|NCT01994382|583873588|FG004|Overall Study|Lost to Follow-up|0|||
161677962|NCT01994382|583873589|FG005|Overall Study|Lost to Follow-up|0|||
161677963|NCT01994382|583873590|FG006|Overall Study|Lost to Follow-up|0|||
161677964|NCT01994382|583873591|FG007|Overall Study|Lost to Follow-up|0|||
161677965|NCT01994382|583873592|FG008|Overall Study|Lost to Follow-up|0|||
161677966|NCT01994382|583873593|FG009|Overall Study|Lost to Follow-up|0|||
161677967|NCT01994382|583873594|FG010|Overall Study|Lost to Follow-up|1|||
161677968|NCT01994382|583873595|FG011|Overall Study|Lost to Follow-up|0|||
161677969|NCT01994382|583873596|FG012|Overall Study|Lost to Follow-up|0|||
161677970|NCT01994382|583873597|FG013|Overall Study|Lost to Follow-up|0|||
161677971|NCT01994382|583873598|FG014|Overall Study|Lost to Follow-up|0|||
161677972|NCT01994382|583873599|FG015|Overall Study|Lost to Follow-up|0|||
161677973|NCT01994382|583873600|FG016|Overall Study|Lost to Follow-up|0|||
161677974|NCT01994382|583873584|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677975|NCT01994382|583873585|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677976|NCT01994382|583873586|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677977|NCT01994382|583873587|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677978|NCT01994382|583873588|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677979|NCT01994382|583873589|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677980|NCT01994382|583873590|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677981|NCT01994382|583873591|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677982|NCT01994382|583873592|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677983|NCT01994382|583873593|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677984|NCT01994382|583873594|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
161677985|NCT01994382|583873595|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677986|NCT01994382|583873596|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
161524718|NCT02952924|583307881|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524719|NCT02952924|583307882|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524720|NCT02952924|583307883|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
161677987|NCT01994382|583873597|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677988|NCT01994382|583873598|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677989|NCT01994382|583873599|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
161677990|NCT01994382|583873600|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
161677991|NCT01994382|583873584|FG000|Overall Study|Protocol violation/noncompliance|0|||
161677992|NCT01994382|583873585|FG001|Overall Study|Protocol violation/noncompliance|0|||
161677993|NCT01994382|583873586|FG002|Overall Study|Protocol violation/noncompliance|0|||
161677994|NCT01994382|583873587|FG003|Overall Study|Protocol violation/noncompliance|0|||
161677995|NCT01994382|583873588|FG004|Overall Study|Protocol violation/noncompliance|0|||
161677996|NCT01994382|583873589|FG005|Overall Study|Protocol violation/noncompliance|0|||
161677997|NCT01994382|583873590|FG006|Overall Study|Protocol violation/noncompliance|0|||
161677998|NCT01994382|583873591|FG007|Overall Study|Protocol violation/noncompliance|0|||
161677999|NCT01994382|583873592|FG008|Overall Study|Protocol violation/noncompliance|0|||
161935100|NCT00890097|584811498|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
161935101|NCT00890097|584811496|FG000|Overall Study|Withdrew Consent|9|||
161935102|NCT00890097|584811497|FG001|Overall Study|Withdrew Consent|6|||
161935103|NCT00890097|584811498|FG002|Overall Study|Withdrew Consent|9|||
161678000|NCT01994382|583873593|FG009|Overall Study|Protocol violation/noncompliance|0|||
161678001|NCT01994382|583873594|FG010|Overall Study|Protocol violation/noncompliance|0|||
161678002|NCT01994382|583873595|FG011|Overall Study|Protocol violation/noncompliance|1|||
161935104|NCT00890097|584811496|FG000|Overall Study|Lost to Follow-up|5|||
161935105|NCT00890097|584811497|FG001|Overall Study|Lost to Follow-up|5|||
161826217|NCT02260635|584403821|FG001|Open-Label Extension|Withdrawal by Subject|0|||
161826218|NCT03310619|584403822|FG000|Pre-Treatment Period|Death|1|||
161826219|NCT03310619|584403823|FG001|Pre-Treatment Period|Death|0|||
161826220|NCT03310619|584403824|FG002|Pre-Treatment Period|Death|0|||
161826221|NCT03310619|584403825|FG003|Pre-Treatment Period|Death|0|||
161826222|NCT03310619|584403826|FG004|Pre-Treatment Period|Death|1|||
161826223|NCT03310619|584403827|FG005|Pre-Treatment Period|Death|0|||
161826224|NCT03310619|584403828|FG006|Pre-Treatment Period|Death|0|||
161826225|NCT03310619|584403829|FG007|Pre-Treatment Period|Death|0|||
161826226|NCT03310619|584403822|FG000|Pre-Treatment Period|Other reasons|2|||
161826227|NCT03310619|584403823|FG001|Pre-Treatment Period|Other reasons|1|||
161826228|NCT03310619|584403824|FG002|Pre-Treatment Period|Other reasons|2|||
161826229|NCT03310619|584403825|FG003|Pre-Treatment Period|Other reasons|0|||
161826230|NCT03310619|584403826|FG004|Pre-Treatment Period|Other reasons|0|||
161826231|NCT03310619|584403827|FG005|Pre-Treatment Period|Other reasons|0|||
161826232|NCT03310619|584403828|FG006|Pre-Treatment Period|Other reasons|2|||
161826233|NCT03310619|584403829|FG007|Pre-Treatment Period|Other reasons|0|||
161826234|NCT03310619|584403822|FG000|Treatment Period|Death|1|||
161826235|NCT03310619|584403823|FG001|Treatment Period|Death|2|||
161826236|NCT03310619|584403824|FG002|Treatment Period|Death|0|||
161826237|NCT03310619|584403825|FG003|Treatment Period|Death|0|||
161826238|NCT03310619|584403826|FG004|Treatment Period|Death|1|||
161826239|NCT03310619|584403827|FG005|Treatment Period|Death|0|||
161826240|NCT03310619|584403828|FG006|Treatment Period|Death|2|||
161826241|NCT03310619|584403829|FG007|Treatment Period|Death|0|||
161826242|NCT03310619|584403822|FG000|Treatment Period|Adverse Event|0|||
161826243|NCT03310619|584403823|FG001|Treatment Period|Adverse Event|1|||
161826244|NCT03310619|584403824|FG002|Treatment Period|Adverse Event|4|||
161826245|NCT03310619|584403825|FG003|Treatment Period|Adverse Event|1|||
161826246|NCT03310619|584403826|FG004|Treatment Period|Adverse Event|0|||
161826247|NCT03310619|584403827|FG005|Treatment Period|Adverse Event|0|||
161826248|NCT03310619|584403828|FG006|Treatment Period|Adverse Event|0|||
161826249|NCT03310619|584403829|FG007|Treatment Period|Adverse Event|0|||
161826250|NCT03310619|584403822|FG000|Treatment Period|Withdrawal by participant|0|||
161826251|NCT03310619|584403823|FG001|Treatment Period|Withdrawal by participant|0|||
161826252|NCT03310619|584403824|FG002|Treatment Period|Withdrawal by participant|1|||
161826253|NCT03310619|584403825|FG003|Treatment Period|Withdrawal by participant|0|||
161826254|NCT03310619|584403826|FG004|Treatment Period|Withdrawal by participant|0|||
161826255|NCT03310619|584403827|FG005|Treatment Period|Withdrawal by participant|0|||
161826256|NCT03310619|584403828|FG006|Treatment Period|Withdrawal by participant|0|||
161826257|NCT03310619|584403829|FG007|Treatment Period|Withdrawal by participant|0|||
161826258|NCT03310619|584403822|FG000|Treatment Period|Lost to Follow-up|0|||
161826259|NCT03310619|584403823|FG001|Treatment Period|Lost to Follow-up|0|||
161826260|NCT03310619|584403824|FG002|Treatment Period|Lost to Follow-up|0|||
161826261|NCT03310619|584403825|FG003|Treatment Period|Lost to Follow-up|0|||
161826262|NCT03310619|584403826|FG004|Treatment Period|Lost to Follow-up|0|||
161826263|NCT03310619|584403827|FG005|Treatment Period|Lost to Follow-up|0|||
161826264|NCT03310619|584403828|FG006|Treatment Period|Lost to Follow-up|0|||
161826265|NCT03310619|584403829|FG007|Treatment Period|Lost to Follow-up|1|||
161826266|NCT03310619|584403822|FG000|Treatment Period|Study terminated by sponsor|0|||
161826267|NCT03310619|584403823|FG001|Treatment Period|Study terminated by sponsor|0|||
161826268|NCT03310619|584403824|FG002|Treatment Period|Study terminated by sponsor|0|||
161826269|NCT03310619|584403825|FG003|Treatment Period|Study terminated by sponsor|0|||
161826270|NCT03310619|584403826|FG004|Treatment Period|Study terminated by sponsor|0|||
161826271|NCT03310619|584403827|FG005|Treatment Period|Study terminated by sponsor|0|||
161826272|NCT03310619|584403828|FG006|Treatment Period|Study terminated by sponsor|0|||
161826273|NCT03310619|584403829|FG007|Treatment Period|Study terminated by sponsor|1|||
161524721|NCT02952924|583307884|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524722|NCT02952924|583307885|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524723|NCT02952924|583307886|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524724|NCT02952924|583307887|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
161826274|NCT03310619|584403822|FG000|Treatment Period|Physician Decision|0|||
161826275|NCT03310619|584403823|FG001|Treatment Period|Physician Decision|0|||
161826276|NCT03310619|584403824|FG002|Treatment Period|Physician Decision|0|||
161826277|NCT03310619|584403825|FG003|Treatment Period|Physician Decision|0|||
161549285|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Death|0|||
161826278|NCT03310619|584403826|FG004|Treatment Period|Physician Decision|3|||
161826279|NCT03310619|584403827|FG005|Treatment Period|Physician Decision|0|||
161826280|NCT03310619|584403828|FG006|Treatment Period|Physician Decision|0|||
161826281|NCT03310619|584403829|FG007|Treatment Period|Physician Decision|0|||
161826282|NCT03310619|584403822|FG000|Treatment Period|Other reasons|1|||
161826283|NCT03310619|584403823|FG001|Treatment Period|Other reasons|0|||
161826284|NCT03310619|584403824|FG002|Treatment Period|Other reasons|2|||
161826285|NCT03310619|584403825|FG003|Treatment Period|Other reasons|0|||
161826286|NCT03310619|584403826|FG004|Treatment Period|Other reasons|0|||
161826287|NCT03310619|584403827|FG005|Treatment Period|Other reasons|0|||
161935106|NCT00890097|584811498|FG002|Overall Study|Lost to Follow-up|5|||
161935107|NCT00890097|584811496|FG000|Overall Study|Noncompliance|0|||
161935108|NCT00890097|584811497|FG001|Overall Study|Noncompliance|4|||
161935109|NCT00890097|584811498|FG002|Overall Study|Noncompliance|4|||
161935110|NCT00890097|584811496|FG000|Overall Study|Sponsor Decision|7|||
161935111|NCT00890097|584811497|FG001|Overall Study|Sponsor Decision|11|||
161935112|NCT00890097|584811498|FG002|Overall Study|Sponsor Decision|7|||
161935113|NCT00890097|584811496|FG000|Overall Study|Did not attend final visit|2|||
161935114|NCT00890097|584811497|FG001|Overall Study|Did not attend final visit|3|||
161935115|NCT00890097|584811498|FG002|Overall Study|Did not attend final visit|0|||
161935116|NCT00890097|584811496|FG000|Overall Study|Subject Decision|3|||
161935117|NCT00890097|584811497|FG001|Overall Study|Subject Decision|2|||
161935118|NCT00890097|584811498|FG002|Overall Study|Subject Decision|6|||
161935119|NCT00890097|584811496|FG000|Overall Study|Randomization Error|2|||
161935120|NCT00890097|584811497|FG001|Overall Study|Randomization Error|0|||
161935121|NCT00890097|584811498|FG002|Overall Study|Randomization Error|0|||
161935122|NCT00890097|584811496|FG000|Overall Study|Failed inclusion criteria|3|||
161935123|NCT00890097|584811497|FG001|Overall Study|Failed inclusion criteria|4|||
161935124|NCT00890097|584811498|FG002|Overall Study|Failed inclusion criteria|0|||
161935125|NCT00890097|584811496|FG000|Overall Study|Transportation|0|||
161935126|NCT00890097|584811497|FG001|Overall Study|Transportation|2|||
161935127|NCT00890097|584811498|FG002|Overall Study|Transportation|0|||
161935128|NCT00890097|584811496|FG000|Overall Study|Subject Moved|0|||
161935129|NCT00890097|584811497|FG001|Overall Study|Subject Moved|4|||
161935130|NCT00890097|584811498|FG002|Overall Study|Subject Moved|0|||
161935131|NCT00890097|584811496|FG000|Overall Study|Protocol Deviation|1|||
161935132|NCT00890097|584811497|FG001|Overall Study|Protocol Deviation|1|||
161935133|NCT00890097|584811498|FG002|Overall Study|Protocol Deviation|1|||
161935134|NCT03878069|584811503|FG000|Overall Study|Death|0|||
161935135|NCT03878069|584811504|FG001|Overall Study|Death|1|||
161935136|NCT03878069|584811505|FG002|Overall Study|Death|0|||
161935137|NCT03810495|584811506|FG000|Overall Study|Lost to Follow-up|2|||
161935138|NCT03810495|584811506|FG000|Overall Study|Withdrawal by Subject|1|||
161935139|NCT03759379|584813857|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
161935140|NCT03759379|584813858|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
161935141|NCT03759379|584813857|FG000|Treatment Period|Death|2|||
161935142|NCT03759379|584813858|FG001|Treatment Period|Death|3|||
161935143|NCT03759379|584813857|FG000|Treatment Period|Lost to Follow-up|1|||
161935144|NCT03759379|584813858|FG001|Treatment Period|Lost to Follow-up|0|||
161935145|NCT03759379|584813857|FG000|Treatment Period|Physician Decision|0|||
161935146|NCT03759379|584813858|FG001|Treatment Period|Physician Decision|1|||
161935147|NCT04924608|584813859|FG000|Overall Study|Adverse Event|10|||
161935148|NCT04924608|584813860|FG001|Overall Study|Adverse Event|6|||
161524725|NCT02952924|583307888|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
161935149|NCT04924608|584813859|FG000|Overall Study|Lost to Follow-up|1|||
161935150|NCT04924608|584813860|FG001|Overall Study|Lost to Follow-up|1|||
161935151|NCT04924608|584813859|FG000|Overall Study|Ongoing at the data cut-off date|54|||
161935152|NCT04924608|584813860|FG001|Overall Study|Ongoing at the data cut-off date|60|||
161935153|NCT04924608|584813859|FG000|Overall Study|Progressive Disease|2|||
161524726|NCT02952924|583307889|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524727|NCT02952924|583307890|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524728|NCT02952924|583307891|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524729|NCT02952924|583307892|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524730|NCT02952924|583307893|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524731|NCT02952924|583307894|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524732|NCT02952924|583307895|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524733|NCT02952924|583307896|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
161524734|NCT02952924|583307897|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
161524735|NCT02952924|583307876|FG000|Overall Study|Noncompliance with study drug|0|||
161524736|NCT02952924|583307877|FG001|Overall Study|Noncompliance with study drug|0|||
161524737|NCT02952924|583307878|FG002|Overall Study|Noncompliance with study drug|0|||
161524738|NCT02952924|583307879|FG003|Overall Study|Noncompliance with study drug|0|||
161524739|NCT02952924|583307880|FG004|Overall Study|Noncompliance with study drug|0|||
161524740|NCT02952924|583307881|FG005|Overall Study|Noncompliance with study drug|0|||
161524741|NCT02952924|583307882|FG006|Overall Study|Noncompliance with study drug|0|||
161524742|NCT02952924|583307883|FG007|Overall Study|Noncompliance with study drug|0|||
161524743|NCT02952924|583307884|FG008|Overall Study|Noncompliance with study drug|0|||
161524744|NCT02952924|583307885|FG009|Overall Study|Noncompliance with study drug|0|||
161935154|NCT04924608|584813860|FG001|Overall Study|Progressive Disease|0|||
161935155|NCT04924608|584813859|FG000|Overall Study|Withdrawal by Subject|3|||
161935156|NCT04924608|584813860|FG001|Overall Study|Withdrawal by Subject|6|||
161935157|NCT04924608|584813859|FG000|Overall Study|Other reason|1|||
161935158|NCT04924608|584813860|FG001|Overall Study|Other reason|1|||
161935159|NCT05199571|584813861|FG000|Treatment period|Participant decision|3|||
161524745|NCT02952924|583307886|FG010|Overall Study|Noncompliance with study drug|0|||
161524746|NCT02952924|583307887|FG011|Overall Study|Noncompliance with study drug|0|||
161524747|NCT02952924|583307888|FG012|Overall Study|Noncompliance with study drug|0|||
161524748|NCT02952924|583307889|FG013|Overall Study|Noncompliance with study drug|0|||
161524749|NCT02952924|583307890|FG014|Overall Study|Noncompliance with study drug|0|||
161524750|NCT02952924|583307891|FG015|Overall Study|Noncompliance with study drug|0|||
161524751|NCT02952924|583307892|FG016|Overall Study|Noncompliance with study drug|0|||
161524752|NCT02952924|583307893|FG017|Overall Study|Noncompliance with study drug|0|||
161524753|NCT02952924|583307894|FG018|Overall Study|Noncompliance with study drug|0|||
161524754|NCT02952924|583307895|FG019|Overall Study|Noncompliance with study drug|0|||
161524755|NCT02952924|583307896|FG020|Overall Study|Noncompliance with study drug|0|||
161524756|NCT02952924|583307897|FG021|Overall Study|Noncompliance with study drug|1|||
161524757|NCT01435577|583307900|FG000|Overall Study|Adverse Event|10|||
161524758|NCT01435577|583307901|FG001|Overall Study|Adverse Event|0|||
161524759|NCT01435577|583307900|FG000|Overall Study|Lack of Efficacy|7|||
161524760|NCT01435577|583307901|FG001|Overall Study|Lack of Efficacy|51|||
161524761|NCT01435577|583307900|FG000|Overall Study|Alternative treatment started|0|||
161524762|NCT01435577|583307901|FG001|Overall Study|Alternative treatment started|1|||
161589925|NCT03406871|583548198|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
161589926|NCT03406871|583548196|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
161589927|NCT03406871|583548197|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
161589928|NCT03406871|583548198|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
161589929|NCT03406871|583548196|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
161589930|NCT03406871|583548197|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
161589931|NCT03406871|583548198|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
161589932|NCT03406871|583548196|FG000|Expansion Cohort(Final Analysis)|Death|0|||
161589933|NCT03406871|583548197|FG001|Expansion Cohort(Final Analysis)|Death|1|||
161589934|NCT03406871|583548198|FG002|Expansion Cohort(Final Analysis)|Death|0|||
161589935|NCT03406871|583548196|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
161589936|NCT03406871|583548197|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
161589937|NCT03406871|583548198|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
161589938|NCT04177823|583548206|FG000|Overall Study|Physician Decision|1|||
161589939|NCT04177823|583548206|FG000|Overall Study|Withdrawal by Subject|1|||
161589940|NCT02913872|583548208|FG000|Overall Study|Withdrawal by Subject|1|||
161589941|NCT03110315|583548211|FG000|Overall Study|Withdrawal by Subject|1|||
161589942|NCT03110315|583548212|FG001|Overall Study|Withdrawal by Subject|0|||
161589943|NCT03978871|583548213|FG000|Overall Study|Lost to Follow-up|11|||
161589944|NCT03978871|583548214|FG001|Overall Study|Lost to Follow-up|12|||
161589945|NCT05710107|583548215|FG000|Overall Study|Withdrawal by Subject|1|||
161589946|NCT05710107|583548216|FG001|Overall Study|Withdrawal by Subject|1|||
161589947|NCT05710107|583548215|FG000|Overall Study|Lost to Follow-up|8|||
161589948|NCT05710107|583548216|FG001|Overall Study|Lost to Follow-up|9|||
161589949|NCT05710107|583548215|FG000|Overall Study|Unable to place assigned block|2|||
161589950|NCT05710107|583548216|FG001|Overall Study|Unable to place assigned block|0|||
161589951|NCT05710107|583548215|FG000|Overall Study|Withdrawn by study team|0|||
161589952|NCT05710107|583548216|FG001|Overall Study|Withdrawn by study team|1|||
161589953|NCT04166773|583548217|FG000|Overall Study|Adverse Event|2|||
161589954|NCT04166773|583548218|FG001|Overall Study|Adverse Event|0|||
161589955|NCT04166773|583548219|FG002|Overall Study|Adverse Event|2|||
161589956|NCT04166773|583548220|FG003|Overall Study|Adverse Event|1|||
161589957|NCT04166773|583548217|FG000|Overall Study|Lost to Follow-up|4|||
161589958|NCT04166773|583548218|FG001|Overall Study|Lost to Follow-up|2|||
161589959|NCT04166773|583548219|FG002|Overall Study|Lost to Follow-up|1|||
161589960|NCT04166773|583548220|FG003|Overall Study|Lost to Follow-up|3|||
161589961|NCT04166773|583548217|FG000|Overall Study|Physician Decision|0|||
161826288|NCT03310619|584403828|FG006|Treatment Period|Other reasons|0|||
161524763|NCT01934218|583307903|FG000|Double-blind Phase|Adverse Event|8|||
161524764|NCT01934218|583307904|FG001|Double-blind Phase|Adverse Event|8|||
161524765|NCT01934218|583307903|FG000|Double-blind Phase|Lack of Efficacy|6|||
161524766|NCT01934218|583307904|FG001|Double-blind Phase|Lack of Efficacy|7|||
161524767|NCT01934218|583307903|FG000|Double-blind Phase|Lost to Follow-up|7|||
161524768|NCT01934218|583307904|FG001|Double-blind Phase|Lost to Follow-up|14|||
161524769|NCT01934218|583307903|FG000|Double-blind Phase|Physician Decision|1|||
161589962|NCT04166773|583548218|FG001|Overall Study|Physician Decision|0|||
161589963|NCT04166773|583548219|FG002|Overall Study|Physician Decision|0|||
161524770|NCT01934218|583307904|FG001|Double-blind Phase|Physician Decision|2|||
161524771|NCT01934218|583307903|FG000|Double-blind Phase|Protocol Violation|4|||
161524772|NCT01934218|583307904|FG001|Double-blind Phase|Protocol Violation|0|||
161589964|NCT04166773|583548220|FG003|Overall Study|Physician Decision|1|||
161589965|NCT04166773|583548217|FG000|Overall Study|Withdrawal by Subject|1|||
161826289|NCT03310619|584403829|FG007|Treatment Period|Other reasons|0|||
161826290|NCT00152516|584403834|FG000|Overall Study|Adverse Event|18|||
161524773|NCT01934218|583307903|FG000|Double-blind Phase|Withdrawal by Subject|16|||
161524774|NCT01934218|583307904|FG001|Double-blind Phase|Withdrawal by Subject|13|||
161524775|NCT01934218|583307903|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
161524776|NCT01934218|583307904|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
161524777|NCT01934218|583307903|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
161524778|NCT01934218|583307904|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
161524779|NCT01934218|583307903|FG000|Open-Label Phase|Adverse Event|2|||
161524780|NCT01934218|583307904|FG001|Open-Label Phase|Adverse Event|4|||
161524781|NCT01934218|583307903|FG000|Open-Label Phase|Lack of Efficacy|1|||
161524782|NCT01934218|583307904|FG001|Open-Label Phase|Lack of Efficacy|4|||
161524783|NCT01934218|583307903|FG000|Open-Label Phase|Lost to Follow-up|4|||
161524784|NCT01934218|583307904|FG001|Open-Label Phase|Lost to Follow-up|2|||
161524785|NCT01934218|583307903|FG000|Open-Label Phase|Physician Decision|1|||
161524786|NCT01934218|583307904|FG001|Open-Label Phase|Physician Decision|0|||
161524787|NCT01934218|583307903|FG000|Open-Label Phase|Protocol Violation|1|||
161524788|NCT01934218|583307904|FG001|Open-Label Phase|Protocol Violation|0|||
161524789|NCT01934218|583307903|FG000|Open-Label Phase|Withdrawal by Subject|13|||
161524790|NCT01934218|583307904|FG001|Open-Label Phase|Withdrawal by Subject|11|||
161524791|NCT01934218|583307903|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
161524792|NCT01934218|583307904|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
161524793|NCT01934218|583307903|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
161524794|NCT01934218|583307904|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
161524795|NCT03273946|583307908|FG000|Overall Study|Withdrawal by Subject|5|||
161524796|NCT03273946|583307908|FG000|Overall Study|Unwillingness of the guardian|1|||
161524797|NCT03273946|583307908|FG000|Overall Study|Participant refused to use the drug|2|||
161524798|NCT03273946|583307908|FG000|Overall Study|Participant relative refused to use drug|1|||
161524799|NCT01220557|583307909|FG000|Overall Study|Lost to Follow-up|5|||
161524800|NCT01220557|583307910|FG001|Overall Study|Lost to Follow-up|3|||
161524801|NCT01220557|583307909|FG000|Overall Study|attended less than 6 lessons|1|||
161524802|NCT01220557|583307910|FG001|Overall Study|attended less than 6 lessons|2|||
161524803|NCT01660763|583307918|FG000|Overall Study|Lack of Efficacy|45|||
161524804|NCT01660763|583307919|FG001|Overall Study|Lack of Efficacy|50|||
161524805|NCT01660763|583307918|FG000|Overall Study|Adverse Event|22|||
161524806|NCT01660763|583307919|FG001|Overall Study|Adverse Event|7|||
161524807|NCT01660763|583307918|FG000|Overall Study|Protocol Violation|1|||
161524808|NCT01660763|583307919|FG001|Overall Study|Protocol Violation|0|||
161524809|NCT01660763|583307918|FG000|Overall Study|Withdrawal by Subject|4|||
161524810|NCT01660763|583307919|FG001|Overall Study|Withdrawal by Subject|0|||
161524811|NCT01660763|583307918|FG000|Overall Study|Patient ready for early discharge|28|||
161524812|NCT01660763|583307919|FG001|Overall Study|Patient ready for early discharge|4|||
161524813|NCT00345397|583307920|FG000|Overall Study|Death|1|||
161524814|NCT04782323|583307921|FG000|Overall Study|Death|1|||
161524815|NCT04782323|583307922|FG001|Overall Study|Death|0|||
161524816|NCT04782323|583307923|FG002|Overall Study|Death|0|||
161524817|NCT04782323|583307924|FG003|Overall Study|Death|0|||
161524818|NCT04782323|583307925|FG004|Overall Study|Death|1|||
161524819|NCT04782323|583307926|FG005|Overall Study|Death|1|||
161524820|NCT04782323|583307927|FG006|Overall Study|Death|1|||
161524821|NCT04782323|583307928|FG007|Overall Study|Death|0|||
161524822|NCT04782323|583307921|FG000|Overall Study|Withdrawal by Subject|0|||
161524823|NCT04782323|583307922|FG001|Overall Study|Withdrawal by Subject|0|||
161524824|NCT04782323|583307923|FG002|Overall Study|Withdrawal by Subject|1|||
161524825|NCT04782323|583307924|FG003|Overall Study|Withdrawal by Subject|0|||
161524826|NCT04782323|583307925|FG004|Overall Study|Withdrawal by Subject|0|||
161524827|NCT04782323|583307926|FG005|Overall Study|Withdrawal by Subject|1|||
161524828|NCT04782323|583307927|FG006|Overall Study|Withdrawal by Subject|0|||
161524829|NCT04782323|583307928|FG007|Overall Study|Withdrawal by Subject|1|||
161524830|NCT04782323|583307921|FG000|Overall Study|Lost to Follow-up|0|||
161524831|NCT04782323|583307922|FG001|Overall Study|Lost to Follow-up|1|||
161524832|NCT04782323|583307923|FG002|Overall Study|Lost to Follow-up|1|||
161524833|NCT04782323|583307924|FG003|Overall Study|Lost to Follow-up|0|||
161524834|NCT04782323|583307925|FG004|Overall Study|Lost to Follow-up|0|||
161524835|NCT04782323|583307926|FG005|Overall Study|Lost to Follow-up|1|||
161524836|NCT04782323|583307927|FG006|Overall Study|Lost to Follow-up|1|||
161524837|NCT04782323|583307928|FG007|Overall Study|Lost to Follow-up|2|||
161524838|NCT04782323|583307921|FG000|Overall Study|randomization in error|1|||
161524839|NCT04782323|583307922|FG001|Overall Study|randomization in error|0|||
161524840|NCT04782323|583307923|FG002|Overall Study|randomization in error|0|||
161524841|NCT04782323|583307924|FG003|Overall Study|randomization in error|0|||
161524842|NCT04782323|583307925|FG004|Overall Study|randomization in error|0|||
161524843|NCT04782323|583307926|FG005|Overall Study|randomization in error|0|||
161524844|NCT04782323|583307927|FG006|Overall Study|randomization in error|0|||
161524845|NCT04782323|583307928|FG007|Overall Study|randomization in error|0|||
161524846|NCT04369469|583307929|FG000|Overall Study|Lost to Follow-up|2|||
161524847|NCT04369469|583307930|FG001|Overall Study|Lost to Follow-up|4|||
161524848|NCT04369469|583307929|FG000|Overall Study|Physician Decision|2|||
161524849|NCT04369469|583307930|FG001|Overall Study|Physician Decision|1|||
161524850|NCT04369469|583307929|FG000|Overall Study|Withdrawal by Subject|2|||
161826291|NCT00152516|584403834|FG000|Overall Study|Lack and Loss of Efficacy|30|||
161826292|NCT00152516|584403834|FG000|Overall Study|Lost to Follow-up|5|||
161826293|NCT00152516|584403834|FG000|Overall Study|Withdrawal by Subject|8|||
161826294|NCT00152516|584403834|FG000|Overall Study|Protocol Violation|3|||
161826295|NCT00152516|584403834|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
161826296|NCT00152516|584403834|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
161826297|NCT00152516|584403834|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
161826298|NCT00152516|584403834|FG000|Overall Study|Other: Non-Compliance|2|||
161826299|NCT00152516|584403834|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
161826300|NCT00152516|584403834|FG000|Overall Study|Other: Moved Out Of State|1|||
161826301|NCT00152516|584403834|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
161826302|NCT00152516|584403834|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
161826303|NCT04660032|584403837|FG000|Overall Study|Protocol Violation|1|||
161826304|NCT04660032|584403838|FG001|Overall Study|Protocol Violation|1|||
161826305|NCT00090753|584403839|FG000|First Treatment Period|Adverse Event|20|||
161826306|NCT00090753|584403840|FG001|First Treatment Period|Adverse Event|8|||
161826307|NCT00090753|584403839|FG000|First Treatment Period|Death|88|||
161826308|NCT00090753|584403840|FG001|First Treatment Period|Death|62|||
161826309|NCT00090753|584403839|FG000|First Treatment Period|Lack of Efficacy|2|||
161826310|NCT00090753|584403840|FG001|First Treatment Period|Lack of Efficacy|1|||
161826311|NCT00090753|584403839|FG000|First Treatment Period|Refused Treatment|32|||
161826312|NCT00090753|584403840|FG001|First Treatment Period|Refused Treatment|25|||
161826313|NCT00090753|584403839|FG000|First Treatment Period|Lost to Follow-up|4|||
161826314|NCT00090753|584403840|FG001|First Treatment Period|Lost to Follow-up|4|||
161826315|NCT00090753|584403839|FG000|First Treatment Period|Renal Transplant|70|||
161826316|NCT00090753|584403840|FG001|First Treatment Period|Renal Transplant|50|||
161826317|NCT00090753|584403839|FG000|First Treatment Period|Mircera Commercialization|1|||
161826318|NCT00090753|584403840|FG001|First Treatment Period|Mircera Commercialization|0|||
161826319|NCT00090753|584403839|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
161826320|NCT00090753|584403840|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
161826321|NCT00090753|584403839|FG000|Extended Treatment Period|Adverse Event|11|||
161826322|NCT00090753|584403840|FG001|Extended Treatment Period|Adverse Event|0|||
161826323|NCT00090753|584403839|FG000|Extended Treatment Period|Death|58|||
161826324|NCT00090753|584403840|FG001|Extended Treatment Period|Death|30|||
161826325|NCT00090753|584403839|FG000|Extended Treatment Period|Lack of Efficacy|1|||
161826326|NCT00090753|584403840|FG001|Extended Treatment Period|Lack of Efficacy|0|||
161826327|NCT00090753|584403839|FG000|Extended Treatment Period|Refused Treatment|18|||
161826328|NCT00090753|584403840|FG001|Extended Treatment Period|Refused Treatment|12|||
161935160|NCT05199571|584813861|FG000|Treatment period|Physician Decision|1|||
161935161|NCT05199571|584813861|FG000|Post-treatment follow up period|Participant decision|3|||
161935162|NCT02892344|584813862|FG000|Overall Study|Protocol deviation|3|||
161935163|NCT02892344|584813863|FG001|Overall Study|Protocol deviation|4|||
161935164|NCT02892344|584813862|FG000|Overall Study|Adverse Event|1|||
161935165|NCT02892344|584813863|FG001|Overall Study|Adverse Event|8|||
161935166|NCT02892344|584813862|FG000|Overall Study|Lost to Follow-up|0|||
161935167|NCT02892344|584813863|FG001|Overall Study|Lost to Follow-up|1|||
161935168|NCT02892344|584813862|FG000|Overall Study|Non-compliance with study treatment|0|||
161935169|NCT02892344|584813863|FG001|Overall Study|Non-compliance with study treatment|1|||
161935170|NCT02892344|584813862|FG000|Overall Study|Physician Decision|0|||
161524851|NCT04369469|583307930|FG001|Overall Study|Withdrawal by Subject|3|||
161524852|NCT04369469|583307929|FG000|Overall Study|Adverse Event|1|||
161524853|NCT04369469|583307930|FG001|Overall Study|Adverse Event|0|||
161524854|NCT04369469|583307929|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
161524855|NCT04369469|583307930|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
161524856|NCT04369469|583307929|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
161524857|NCT04369469|583307930|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
161524858|NCT04369469|583307929|FG000|Overall Study|Unable to Provide Consent|0|||
161524859|NCT04369469|583307930|FG001|Overall Study|Unable to Provide Consent|1|||
161524860|NCT03832192|583307933|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
161524861|NCT03832192|583307934|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
161524862|NCT03099382|583307937|FG000|Overall Study|Protocol Violation|2|||
161524863|NCT03099382|583307938|FG001|Overall Study|Protocol Violation|3|||
161524864|NCT00499369|583307939|FG000|Overall Study|Adverse Event|2|||
161524865|NCT00499369|583307940|FG001|Overall Study|Adverse Event|2|||
161524866|NCT00499369|583307941|FG002|Overall Study|Adverse Event|3|||
161524867|NCT00499369|583307942|FG003|Overall Study|Adverse Event|1|||
161826329|NCT00090753|584403839|FG000|Extended Treatment Period|Lost to Follow-up|3|||
161826330|NCT00090753|584403840|FG001|Extended Treatment Period|Lost to Follow-up|1|||
161826331|NCT00090753|584403839|FG000|Extended Treatment Period|Renal Transplant|15|||
161826332|NCT00090753|584403840|FG001|Extended Treatment Period|Renal Transplant|12|||
161826333|NCT00090753|584403839|FG000|Extended Treatment Period|Mircera Commercialization|188|||
161826334|NCT00090753|584403840|FG001|Extended Treatment Period|Mircera Commercialization|93|||
161935171|NCT02892344|584813863|FG001|Overall Study|Physician Decision|2|||
161935172|NCT02892344|584813862|FG000|Overall Study|Subject/guardian decision|0|||
161935173|NCT02892344|584813863|FG001|Overall Study|Subject/guardian decision|4|||
161935174|NCT02892344|584813862|FG000|Overall Study|Technical problems|0|||
161935175|NCT02892344|584813863|FG001|Overall Study|Technical problems|1|||
161935176|NCT04500769|584813864|FG000|Overall Study|Withdrawal by Subject|5|||
161935177|NCT01511562|584813865|FG000|Induction|Adverse Event|2|||
161935178|NCT01511562|584813866|FG001|Induction|Adverse Event|0|||
161935179|NCT01511562|584813865|FG000|Induction|Disease Progression|3|||
161935180|NCT01511562|584813866|FG001|Induction|Disease Progression|7|||
161935181|NCT01511562|584813865|FG000|Induction|Death|1|||
161935182|NCT01511562|584813866|FG001|Induction|Death|3|||
161935183|NCT01511562|584813865|FG000|Induction|Withdrawal by Subject|0|||
161935184|NCT01511562|584813866|FG001|Induction|Withdrawal by Subject|4|||
161935185|NCT01511562|584813865|FG000|Induction|Other|3|||
161935186|NCT01511562|584813866|FG001|Induction|Other|0|||
161935187|NCT01511562|584813865|FG000|Consolidation|Withdrawal by Subject|1|||
161935188|NCT01511562|584813866|FG001|Consolidation|Withdrawal by Subject|0|||
161935189|NCT01511562|584813865|FG000|Consolidation|Other|1|||
161935190|NCT01511562|584813866|FG001|Consolidation|Other|0|||
161935191|NCT03938454|584813867|FG000|Overall Study|Protocol Violation|1|||
161935192|NCT03938454|584813867|FG000|Overall Study|Withdrawal by Subject|2|||
161935193|NCT03938454|584813867|FG000|Overall Study|Lost to Follow-up|3|||
161935194|NCT04441905|584813868|FG000|Overall Study|Lost to Follow-up|1|||
161935195|NCT04441905|584813869|FG001|Overall Study|Lost to Follow-up|0|||
161935196|NCT04441905|584813870|FG002|Overall Study|Lost to Follow-up|0|||
161935197|NCT04441905|584813871|FG003|Overall Study|Lost to Follow-up|0|||
161935198|NCT04441905|584813872|FG004|Overall Study|Lost to Follow-up|0|||
161935199|NCT04441905|584813873|FG005|Overall Study|Lost to Follow-up|0|||
161935200|NCT04441905|584813868|FG000|Overall Study|Enrolled but treatment not administered|0|||
161935201|NCT04441905|584813869|FG001|Overall Study|Enrolled but treatment not administered|1|||
161935202|NCT04441905|584813870|FG002|Overall Study|Enrolled but treatment not administered|0|||
161935203|NCT04441905|584813871|FG003|Overall Study|Enrolled but treatment not administered|0|||
161935204|NCT04441905|584813872|FG004|Overall Study|Enrolled but treatment not administered|0|||
161935205|NCT04441905|584813873|FG005|Overall Study|Enrolled but treatment not administered|0|||
161935206|NCT04441905|584813868|FG000|Overall Study|Became ineligible after enrollment|0|||
161935207|NCT04441905|584813869|FG001|Overall Study|Became ineligible after enrollment|0|||
161935208|NCT04441905|584813870|FG002|Overall Study|Became ineligible after enrollment|0|||
161935209|NCT04441905|584813871|FG003|Overall Study|Became ineligible after enrollment|0|||
161935210|NCT04441905|584813872|FG004|Overall Study|Became ineligible after enrollment|1|||
161935211|NCT04441905|584813873|FG005|Overall Study|Became ineligible after enrollment|0|||
161935212|NCT05415215|584813874|FG000|Neoadjuvant Phase|Adverse Event|0|||
161935213|NCT05415215|584813875|FG001|Neoadjuvant Phase|Adverse Event|8|||
161935214|NCT05415215|584813876|FG002|Neoadjuvant Phase|Adverse Event|0|||
161935215|NCT05415215|584813877|FG003|Neoadjuvant Phase|Adverse Event|0|||
161935216|NCT05415215|584813878|FG004|Neoadjuvant Phase|Adverse Event|0|||
161935217|NCT05415215|584813879|FG005|Neoadjuvant Phase|Adverse Event|0|||
161935218|NCT05415215|584813880|FG006|Neoadjuvant Phase|Adverse Event|0|||
161935219|NCT05415215|584813881|FG007|Neoadjuvant Phase|Adverse Event|0|||
161935220|NCT05415215|584813874|FG000|Neoadjuvant Phase|Death|0|||
161935221|NCT05415215|584813875|FG001|Neoadjuvant Phase|Death|4|||
161935222|NCT05415215|584813876|FG002|Neoadjuvant Phase|Death|0|||
161935223|NCT05415215|584813877|FG003|Neoadjuvant Phase|Death|0|||
161935224|NCT05415215|584813878|FG004|Neoadjuvant Phase|Death|0|||
161935225|NCT05415215|584813879|FG005|Neoadjuvant Phase|Death|0|||
161935226|NCT05415215|584813880|FG006|Neoadjuvant Phase|Death|0|||
161935227|NCT05415215|584813881|FG007|Neoadjuvant Phase|Death|0|||
161524868|NCT00499369|583307943|FG004|Overall Study|Adverse Event|2|||
161524869|NCT00499369|583307939|FG000|Overall Study|Withdrawal by Subject|0|||
161524870|NCT00499369|583307940|FG001|Overall Study|Withdrawal by Subject|1|||
161524871|NCT00499369|583307941|FG002|Overall Study|Withdrawal by Subject|1|||
161524872|NCT00499369|583307942|FG003|Overall Study|Withdrawal by Subject|0|||
161524873|NCT00499369|583307943|FG004|Overall Study|Withdrawal by Subject|0|||
161935228|NCT05415215|584813874|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
161524874|NCT00499369|583307939|FG000|Overall Study|Progression|10|||
161935229|NCT05415215|584813875|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
161935230|NCT05415215|584813876|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935231|NCT05415215|584813877|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935232|NCT05415215|584813878|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935233|NCT05415215|584813879|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935234|NCT05415215|584813880|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
161524875|NCT00499369|583307940|FG001|Overall Study|Progression|12|||
161524876|NCT00499369|583307941|FG002|Overall Study|Progression|9|||
161524877|NCT00499369|583307942|FG003|Overall Study|Progression|6|||
161935235|NCT05415215|584813881|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935236|NCT05415215|584813874|FG000|Neoadjuvant Phase|Progressive Disease|0|||
161935237|NCT05415215|584813875|FG001|Neoadjuvant Phase|Progressive Disease|2|||
161935238|NCT05415215|584813876|FG002|Neoadjuvant Phase|Progressive Disease|0|||
161935239|NCT05415215|584813877|FG003|Neoadjuvant Phase|Progressive Disease|0|||
161524878|NCT00499369|583307943|FG004|Overall Study|Progression|10|||
161524879|NCT00499369|583307939|FG000|Overall Study|Death|0|||
161524880|NCT00499369|583307940|FG001|Overall Study|Death|1|||
161524881|NCT00499369|583307941|FG002|Overall Study|Death|0|||
161524882|NCT00499369|583307942|FG003|Overall Study|Death|0|||
161524883|NCT00499369|583307943|FG004|Overall Study|Death|0|||
161524884|NCT00499369|583307939|FG000|Overall Study|Not protocol specified|2|||
161524885|NCT00499369|583307940|FG001|Overall Study|Not protocol specified|0|||
161524886|NCT00499369|583307941|FG002|Overall Study|Not protocol specified|3|||
161524887|NCT00499369|583307942|FG003|Overall Study|Not protocol specified|1|||
161524888|NCT00499369|583307943|FG004|Overall Study|Not protocol specified|0|||
161524889|NCT00499369|583307939|FG000|Overall Study|Ineligible|2|||
161524890|NCT00499369|583307940|FG001|Overall Study|Ineligible|2|||
161524891|NCT00499369|583307941|FG002|Overall Study|Ineligible|1|||
161524892|NCT00499369|583307942|FG003|Overall Study|Ineligible|1|||
161826335|NCT00090753|584403839|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
161524893|NCT00499369|583307943|FG004|Overall Study|Ineligible|0|||
161826336|NCT00090753|584403840|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
161524894|NCT01898195|583307945|FG000|Smoking Abstinence|Did not have good measurements|35|||
161524895|NCT01898195|583307946|FG001|Smoking Abstinence|Did not have good measurements|38|||
161524896|NCT01898195|583307947|FG002|Smoking Abstinence|Did not have good measurements|36|||
161524897|NCT01802411|583307949|FG000|Overall Study|Death|2|||
161524898|NCT01802411|583307950|FG001|Overall Study|Death|1|||
161524899|NCT01802411|583307949|FG000|Overall Study|Adverse Event|2|||
161524900|NCT01802411|583307950|FG001|Overall Study|Adverse Event|7|||
161524901|NCT01802411|583307949|FG000|Overall Study|Lack of Efficacy|8|||
161524902|NCT01802411|583307950|FG001|Overall Study|Lack of Efficacy|10|||
161524903|NCT01802411|583307949|FG000|Overall Study|Withdrawal by Subject|0|||
161524904|NCT01802411|583307950|FG001|Overall Study|Withdrawal by Subject|2|||
161524905|NCT01802411|583307949|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
161524906|NCT01802411|583307950|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
161524907|NCT01802411|583307949|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
161524908|NCT01802411|583307950|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
161524909|NCT01802411|583307949|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
161524910|NCT01802411|583307950|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
161524911|NCT01337245|583307953|FG000|Overall Study|Lost to Follow-up|1|||
161524912|NCT03930745|583307954|FG000|Overall Study|Lost to Follow-up|10|||
161524913|NCT03930745|583307955|FG001|Overall Study|Lost to Follow-up|5|||
161524914|NCT03930745|583307954|FG000|Overall Study|Withdrawal by Subject|1|||
161524915|NCT03930745|583307955|FG001|Overall Study|Withdrawal by Subject|2|||
161524916|NCT03930745|583307954|FG000|Overall Study|Protocol Violation|2|||
161524917|NCT03930745|583307955|FG001|Overall Study|Protocol Violation|2|||
161524918|NCT03930745|583307954|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
161524919|NCT03930745|583307955|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
161524920|NCT03930745|583307954|FG000|Overall Study|Adverse Event|0|||
161524921|NCT03930745|583307955|FG001|Overall Study|Adverse Event|1|||
161524922|NCT03930745|583307954|FG000|Overall Study|Pregnancy|0|||
161524923|NCT03930745|583307955|FG001|Overall Study|Pregnancy|1|||
161524924|NCT02715765|583307956|FG000|Overall Study|Study Termination|3|||
161524925|NCT02715765|583307957|FG001|Overall Study|Study Termination|0|||
161524926|NCT02715765|583307958|FG002|Overall Study|Study Termination|0|||
161524927|NCT03483623|583307959|FG000|Overall Study|43 complete sets achieved|1|||
161524928|NCT03823651|583307960|FG000|Overall Study|Death|5|||
161524929|NCT03823651|583307961|FG001|Overall Study|Death|0|||
161524930|NCT03823651|583307960|FG000|Overall Study|Physician Decision|1|||
161524931|NCT03823651|583307961|FG001|Overall Study|Physician Decision|0|||
161524932|NCT03823651|583307960|FG000|Overall Study|Caregiver to patient who died|0|||
161524933|NCT03823651|583307961|FG001|Overall Study|Caregiver to patient who died|5|||
161524934|NCT03823651|583307960|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
161524935|NCT03823651|583307961|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
161524936|NCT03864614|583307965|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
161524937|NCT03864614|583307966|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
161524938|NCT03864614|583307967|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
161524939|NCT03864614|583307968|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
161524940|NCT03864614|583307965|FG000|Overall Study|Withdrawal by Subject|72|||
161524941|NCT03864614|583307966|FG001|Overall Study|Withdrawal by Subject|100|||
161524942|NCT03864614|583307967|FG002|Overall Study|Withdrawal by Subject|1|||
161524943|NCT03864614|583307968|FG003|Overall Study|Withdrawal by Subject|21|||
161524944|NCT03864614|583307965|FG000|Overall Study|Lost to Follow-up|45|||
161826337|NCT01266603|584403849|FG000|Overall Study|Adverse Event|1|||
161524945|NCT03864614|583307966|FG001|Overall Study|Lost to Follow-up|54|||
161524946|NCT03864614|583307967|FG002|Overall Study|Lost to Follow-up|0|||
161524947|NCT03864614|583307968|FG003|Overall Study|Lost to Follow-up|9|||
161524948|NCT03864614|583307965|FG000|Overall Study|Adverse Event|42|||
161826338|NCT01266603|584403849|FG000|Overall Study|Lack of Efficacy|14|||
161826339|NCT01266603|584403849|FG000|Overall Study|Withdrawal by Subject|1|||
161524949|NCT03864614|583307966|FG001|Overall Study|Adverse Event|30|||
161524950|NCT03864614|583307967|FG002|Overall Study|Adverse Event|1|||
161524951|NCT03864614|583307968|FG003|Overall Study|Adverse Event|9|||
161524952|NCT03864614|583307965|FG000|Overall Study|Protocol Deviation|6|||
161524953|NCT03864614|583307966|FG001|Overall Study|Protocol Deviation|26|||
161524954|NCT03864614|583307967|FG002|Overall Study|Protocol Deviation|0|||
161524955|NCT03864614|583307968|FG003|Overall Study|Protocol Deviation|1|||
161524956|NCT03864614|583307965|FG000|Overall Study|Physician Decision|7|||
161524957|NCT03864614|583307966|FG001|Overall Study|Physician Decision|10|||
161524958|NCT03864614|583307967|FG002|Overall Study|Physician Decision|1|||
161524959|NCT03864614|583307968|FG003|Overall Study|Physician Decision|5|||
161524960|NCT03864614|583307965|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
161524961|NCT03864614|583307966|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
161524962|NCT03864614|583307967|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
161524963|NCT03864614|583307968|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
161524964|NCT03864614|583307965|FG000|Overall Study|Sponsor Decision|1|||
161524965|NCT03864614|583307966|FG001|Overall Study|Sponsor Decision|2|||
161524966|NCT03864614|583307967|FG002|Overall Study|Sponsor Decision|0|||
161524967|NCT03864614|583307968|FG003|Overall Study|Sponsor Decision|0|||
161524968|NCT03864614|583307965|FG000|Overall Study|Pregnancy|0|||
161524969|NCT03864614|583307966|FG001|Overall Study|Pregnancy|1|||
161524970|NCT03864614|583307967|FG002|Overall Study|Pregnancy|0|||
161524971|NCT03864614|583307968|FG003|Overall Study|Pregnancy|0|||
161524972|NCT03864614|583307965|FG000|Overall Study|Other|7|||
161524973|NCT03864614|583307966|FG001|Overall Study|Other|9|||
161524974|NCT03864614|583307967|FG002|Overall Study|Other|1|||
161524975|NCT03864614|583307968|FG003|Overall Study|Other|4|||
161524976|NCT03864614|583307965|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
161524977|NCT03864614|583307966|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
161524978|NCT03864614|583307967|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
161524979|NCT03864614|583307968|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
161524980|NCT01850004|583307969|FG000|Overall Study|Poor/Non-compliance|1|||
161524981|NCT01850004|583307969|FG000|Overall Study|Participant Withdrew Consent|9|||
161524982|NCT01850004|583307969|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
161524983|NCT01850004|583307969|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161524984|NCT01850004|583307969|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
161524985|NCT01850004|583307969|FG000|Overall Study|Other Reasons|2|||
161524986|NCT01850004|583307969|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
161524987|NCT01850004|583307969|FG000|Overall Study|Maximum Clinical Benefit|4|||
161524988|NCT03147248|583309833|FG000|Overall Study|Adverse Event|0|||
161524989|NCT03147248|583309834|FG001|Overall Study|Adverse Event|2|||
161524990|NCT03147248|583309835|FG002|Overall Study|Adverse Event|2|||
161524991|NCT03147248|583309836|FG003|Overall Study|Adverse Event|2|||
161524992|NCT03147248|583309837|FG004|Overall Study|Adverse Event|6|||
161524993|NCT03147248|583309838|FG005|Overall Study|Adverse Event|11|||
161524994|NCT03147248|583309833|FG000|Overall Study|Disease progression|1|||
161524995|NCT03147248|583309834|FG001|Overall Study|Disease progression|0|||
161524996|NCT03147248|583309835|FG002|Overall Study|Disease progression|0|||
161524997|NCT03147248|583309836|FG003|Overall Study|Disease progression|0|||
161524998|NCT03147248|583309837|FG004|Overall Study|Disease progression|0|||
161524999|NCT03147248|583309838|FG005|Overall Study|Disease progression|2|||
161525000|NCT03147248|583309833|FG000|Overall Study|Withdrawal by Subject|0|||
161525001|NCT03147248|583309834|FG001|Overall Study|Withdrawal by Subject|0|||
161525002|NCT03147248|583309835|FG002|Overall Study|Withdrawal by Subject|0|||
161525003|NCT03147248|583309836|FG003|Overall Study|Withdrawal by Subject|0|||
161525004|NCT03147248|583309837|FG004|Overall Study|Withdrawal by Subject|12|||
161525005|NCT03147248|583309838|FG005|Overall Study|Withdrawal by Subject|9|||
161525006|NCT03147248|583309833|FG000|Overall Study|Protocol Violation|0|||
161525007|NCT03147248|583309834|FG001|Overall Study|Protocol Violation|0|||
161525008|NCT03147248|583309835|FG002|Overall Study|Protocol Violation|0|||
161525009|NCT03147248|583309836|FG003|Overall Study|Protocol Violation|0|||
161525010|NCT03147248|583309837|FG004|Overall Study|Protocol Violation|2|||
161525011|NCT03147248|583309838|FG005|Overall Study|Protocol Violation|0|||
161525012|NCT03147248|583309833|FG000|Overall Study|Lost to Follow-up|0|||
161525013|NCT03147248|583309834|FG001|Overall Study|Lost to Follow-up|0|||
161525014|NCT03147248|583309835|FG002|Overall Study|Lost to Follow-up|0|||
161525015|NCT03147248|583309836|FG003|Overall Study|Lost to Follow-up|0|||
161525016|NCT03147248|583309837|FG004|Overall Study|Lost to Follow-up|2|||
161525017|NCT03147248|583309838|FG005|Overall Study|Lost to Follow-up|0|||
161525018|NCT03147248|583309833|FG000|Overall Study|Pregnancy|0|||
161525019|NCT03147248|583309834|FG001|Overall Study|Pregnancy|0|||
161525020|NCT03147248|583309835|FG002|Overall Study|Pregnancy|0|||
161525021|NCT03147248|583309836|FG003|Overall Study|Pregnancy|0|||
161525022|NCT03147248|583309837|FG004|Overall Study|Pregnancy|1|||
161525023|NCT03147248|583309838|FG005|Overall Study|Pregnancy|0|||
161525024|NCT03147248|583309833|FG000|Overall Study|Death|0|||
161525025|NCT03147248|583309834|FG001|Overall Study|Death|0|||
161525026|NCT03147248|583309835|FG002|Overall Study|Death|0|||
161525027|NCT03147248|583309836|FG003|Overall Study|Death|0|||
161525028|NCT03147248|583309837|FG004|Overall Study|Death|0|||
161826340|NCT01266603|584403849|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
161525029|NCT03147248|583309838|FG005|Overall Study|Death|4|||
161525030|NCT03147248|583309833|FG000|Overall Study|Physician Decision|0|||
161525031|NCT03147248|583309834|FG001|Overall Study|Physician Decision|0|||
161525032|NCT03147248|583309835|FG002|Overall Study|Physician Decision|0|||
161525033|NCT03147248|583309836|FG003|Overall Study|Physician Decision|0|||
161525034|NCT03147248|583309837|FG004|Overall Study|Physician Decision|2|||
161525035|NCT03147248|583309838|FG005|Overall Study|Physician Decision|4|||
161525036|NCT03147248|583309833|FG000|Overall Study|Prolonged Dosing Interval|0|||
161525037|NCT03147248|583309834|FG001|Overall Study|Prolonged Dosing Interval|0|||
161525038|NCT03147248|583309835|FG002|Overall Study|Prolonged Dosing Interval|0|||
161525039|NCT03147248|583309836|FG003|Overall Study|Prolonged Dosing Interval|0|||
161525040|NCT03147248|583309837|FG004|Overall Study|Prolonged Dosing Interval|1|||
161525041|NCT03147248|583309838|FG005|Overall Study|Prolonged Dosing Interval|1|||
161525042|NCT01914926|583309840|FG000|Overall Study|Adverse Event|1|||
161525043|NCT01914926|583309841|FG001|Overall Study|Adverse Event|0|||
161525044|NCT01914926|583309840|FG000|Overall Study|uncooperative, agitated and removed|0|||
161525045|NCT01914926|583309841|FG001|Overall Study|uncooperative, agitated and removed|1|||
161525046|NCT02536508|583309842|FG000|Overall Study|Withdrawal by Subject|18|||
161525047|NCT02536508|583309843|FG001|Overall Study|Withdrawal by Subject|13|||
161525048|NCT02536508|583309844|FG002|Overall Study|Withdrawal by Subject|7|||
161525049|NCT02536508|583309842|FG000|Overall Study|Adverse Event|14|||
161525050|NCT02536508|583309843|FG001|Overall Study|Adverse Event|13|||
161525051|NCT02536508|583309844|FG002|Overall Study|Adverse Event|6|||
161525052|NCT02536508|583309842|FG000|Overall Study|Lost to Follow-up|12|||
161525053|NCT02536508|583309843|FG001|Overall Study|Lost to Follow-up|4|||
161525054|NCT02536508|583309844|FG002|Overall Study|Lost to Follow-up|0|||
161525055|NCT02536508|583309842|FG000|Overall Study|Lack of Efficacy|3|||
161525056|NCT02536508|583309843|FG001|Overall Study|Lack of Efficacy|5|||
161525057|NCT02536508|583309844|FG002|Overall Study|Lack of Efficacy|4|||
161525058|NCT02536508|583309842|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
161525059|NCT02536508|583309843|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
161826341|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
161826342|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
161826343|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
161826344|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
161826345|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
161826346|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
161525060|NCT02536508|583309844|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
161525061|NCT02536508|583309842|FG000|Overall Study|Physician Decision|0|||
161525062|NCT02536508|583309843|FG001|Overall Study|Physician Decision|4|||
161525063|NCT02536508|583309844|FG002|Overall Study|Physician Decision|2|||
161525064|NCT02536508|583309842|FG000|Overall Study|Major Protocol Deviation|2|||
161826347|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
161826348|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
161826349|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
161826350|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Other|1|||
161826351|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Other|4|||
161935240|NCT05415215|584813878|FG004|Neoadjuvant Phase|Progressive Disease|0|||
161935241|NCT05415215|584813879|FG005|Neoadjuvant Phase|Progressive Disease|0|||
161935242|NCT05415215|584813880|FG006|Neoadjuvant Phase|Progressive Disease|0|||
161525065|NCT02536508|583309843|FG001|Overall Study|Major Protocol Deviation|2|||
161525066|NCT02536508|583309844|FG002|Overall Study|Major Protocol Deviation|2|||
161525067|NCT02536508|583309842|FG000|Overall Study|Administrative Reasons|0|||
161525068|NCT02536508|583309843|FG001|Overall Study|Administrative Reasons|1|||
161525069|NCT02536508|583309844|FG002|Overall Study|Administrative Reasons|0|||
161935243|NCT05415215|584813881|FG007|Neoadjuvant Phase|Progressive Disease|0|||
161935244|NCT05415215|584813874|FG000|Neoadjuvant Phase|Reason not Specified|1|||
161935245|NCT05415215|584813875|FG001|Neoadjuvant Phase|Reason not Specified|4|||
161525070|NCT00856856|583309850|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
161525071|NCT00856856|583309850|FG000|4-year Clinical Follow-up|Missed visit|1|||
161525072|NCT00434057|583309851|FG000|Overall Study|Withdrawal by Subject|1|||
161525073|NCT03073603|583309853|FG000|Overall Study|Noncompliance|3|||
161525074|NCT03073603|583309854|FG001|Overall Study|Noncompliance|1|||
161826352|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Other|5|||
161826353|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
161826354|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
161826355|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
161935246|NCT05415215|584813876|FG002|Neoadjuvant Phase|Reason not Specified|0|||
161935247|NCT05415215|584813877|FG003|Neoadjuvant Phase|Reason not Specified|0|||
161525075|NCT03073603|583309853|FG000|Overall Study|Adverse Event|5|||
161525076|NCT03073603|583309854|FG001|Overall Study|Adverse Event|3|||
161826356|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
161525077|NCT03073603|583309853|FG000|Overall Study|Physician Decision|1|||
161525078|NCT03073603|583309854|FG001|Overall Study|Physician Decision|2|||
161826357|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
161826358|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
161826359|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
161826360|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
161826361|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
161826362|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
161826363|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
161826364|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
161826365|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
161826366|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
161826367|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
161826368|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Other|1|||
161826369|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Other|4|||
161826370|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Other|2|||
161826371|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161826372|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
161826373|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
161826374|NCT04307849|584403855|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161826375|NCT04307849|584403856|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161826376|NCT04307849|584403857|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
161826377|NCT04307849|584403858|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161826378|NCT04307849|584403859|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
161826379|NCT04307849|584403860|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
161826380|NCT04307849|584403855|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826381|NCT04307849|584403856|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826382|NCT04307849|584403857|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
161826383|NCT04307849|584403858|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826384|NCT04307849|584403859|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826385|NCT04307849|584403860|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826386|NCT04307849|584403855|FG000|Overall Study|Family member did not want them to continue|0|||
161826387|NCT04307849|584403856|FG001|Overall Study|Family member did not want them to continue|0|||
161826388|NCT04307849|584403857|FG002|Overall Study|Family member did not want them to continue|1|||
161826389|NCT04307849|584403858|FG003|Overall Study|Family member did not want them to continue|0|||
161826390|NCT04307849|584403859|FG004|Overall Study|Family member did not want them to continue|0|||
161826391|NCT04307849|584403860|FG005|Overall Study|Family member did not want them to continue|0|||
161826392|NCT04307849|584403855|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
161826393|NCT04307849|584403856|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
161826394|NCT04307849|584403857|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
161826395|NCT04307849|584403858|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
161826396|NCT04307849|584403859|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
161826397|NCT04307849|584403860|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
161826398|NCT00756717|584403861|FG000|Overall Study|Withdrawal by Subject|2|||
161826399|NCT02654015|584403862|FG000|Overall Study|Death|12|||
161826400|NCT02654015|584403862|FG000|Overall Study|Lost to Follow-up|3|||
161826401|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826402|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
161826403|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826404|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826405|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826406|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
161826407|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
161826408|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
161826409|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
161826410|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
161826411|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
161826412|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826413|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826414|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826415|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826416|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161826417|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
161826418|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
161826419|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161826420|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161826421|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161826422|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161826423|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
161826424|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161826425|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161525079|NCT03073603|583309853|FG000|Overall Study|Required treatment not allowed by protocol|1|||
161525080|NCT03073603|583309854|FG001|Overall Study|Required treatment not allowed by protocol|0|||
161525081|NCT03073603|583309853|FG000|Overall Study|Financial or insurance-related|8|||
161525082|NCT03073603|583309854|FG001|Overall Study|Financial or insurance-related|0|||
161525083|NCT03073603|583309853|FG000|Overall Study|Withdrawal by Subject|0|||
161525084|NCT03073603|583309854|FG001|Overall Study|Withdrawal by Subject|1|||
161525085|NCT03073603|583309853|FG000|Overall Study|Discontinued DMT|4|||
161525086|NCT03073603|583309854|FG001|Overall Study|Discontinued DMT|0|||
161525087|NCT03073603|583309853|FG000|Overall Study|Restarted DMT|0|||
161525088|NCT03073603|583309854|FG001|Overall Study|Restarted DMT|1|||
161589966|NCT04166773|583548218|FG001|Overall Study|Withdrawal by Subject|1|||
161589967|NCT04166773|583548219|FG002|Overall Study|Withdrawal by Subject|2|||
161589968|NCT04166773|583548220|FG003|Overall Study|Withdrawal by Subject|5|||
161589969|NCT04072822|583548221|FG000|Treatment|Adverse Event|9|||
161589970|NCT04072822|583548222|FG001|Treatment|Adverse Event|5|||
161589971|NCT04072822|583548221|FG000|Treatment|Met Stopping Criteria|13|||
161589972|NCT04072822|583548222|FG001|Treatment|Met Stopping Criteria|24|||
161589973|NCT04072822|583548221|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
161589974|NCT04072822|583548222|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
161589975|NCT04072822|583548221|FG000|Treatment|Withdrawal by Subject|0|||
161589976|NCT04072822|583548222|FG001|Treatment|Withdrawal by Subject|2|||
161589977|NCT04072822|583548221|FG000|Treatment|Death|0|||
161589978|NCT04072822|583548222|FG001|Treatment|Death|2|||
161589979|NCT04072822|583548221|FG000|Treatment|Lost to Follow-up|11|||
161589980|NCT04072822|583548222|FG001|Treatment|Lost to Follow-up|3|||
161589981|NCT04072822|583548221|FG000|Treatment|Physician Decision|1|||
161589982|NCT04072822|583548222|FG001|Treatment|Physician Decision|0|||
161589983|NCT04072822|583548221|FG000|Treatment|Other|7|||
161589984|NCT04072822|583548222|FG001|Treatment|Other|9|||
161589985|NCT04072822|583548221|FG000|Follow-up|Withdrawal by Subject|1|||
161589986|NCT04072822|583548222|FG001|Follow-up|Withdrawal by Subject|0|||
161589987|NCT04072822|583548221|FG000|Follow-up|Lost to Follow-up|5|||
161589988|NCT04072822|583548222|FG001|Follow-up|Lost to Follow-up|4|||
161589989|NCT03033576|583548223|FG000|Overall Study|Ineligible|1|||
161589990|NCT03033576|583548224|FG001|Overall Study|Ineligible|1|||
161589991|NCT03033576|583548223|FG000|Overall Study|Adverse Event|4|||
161589992|NCT03033576|583548224|FG001|Overall Study|Adverse Event|20|||
161589993|NCT03033576|583548223|FG000|Overall Study|Progression/relapse|9|||
161589994|NCT03033576|583548224|FG001|Overall Study|Progression/relapse|36|||
161589995|NCT03033576|583548223|FG000|Overall Study|Death|1|||
161589996|NCT03033576|583548224|FG001|Overall Study|Death|1|||
161589997|NCT03033576|583548223|FG000|Overall Study|Patient refusal|1|||
161589998|NCT03033576|583548224|FG001|Overall Study|Patient refusal|6|||
161589999|NCT03033576|583548223|FG000|Overall Study|Other, unspecified reasons|0|||
161590000|NCT03033576|583548224|FG001|Overall Study|Other, unspecified reasons|4|||
161590001|NCT03033576|583548223|FG000|Overall Study|Currently on protocol therapy|0|||
161590002|NCT03033576|583548224|FG001|Overall Study|Currently on protocol therapy|2|||
161590003|NCT01214616|583548225|FG000|Overall Study|Progressive disease|2|||
161590004|NCT01214616|583548226|FG001|Overall Study|Progressive disease|2|||
161590005|NCT01214616|583548227|FG002|Overall Study|Progressive disease|2|||
161590006|NCT01214616|583548228|FG003|Overall Study|Progressive disease|4|||
161590007|NCT01214616|583548225|FG000|Overall Study|Dose limiting toxicity|0|||
161590008|NCT01214616|583548226|FG001|Overall Study|Dose limiting toxicity|2|||
161590009|NCT01214616|583548227|FG002|Overall Study|Dose limiting toxicity|0|||
161590010|NCT01214616|583548228|FG003|Overall Study|Dose limiting toxicity|0|||
161590011|NCT01214616|583548225|FG000|Overall Study|Other adverse events|0|||
161590012|NCT01214616|583548226|FG001|Overall Study|Other adverse events|1|||
161590013|NCT01214616|583548227|FG002|Overall Study|Other adverse events|1|||
161826426|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
161826427|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
161826428|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
161525089|NCT02473952|583309855|FG000|Overall Study|Adverse Event|2|||
161525090|NCT02473952|583309856|FG001|Overall Study|Adverse Event|2|||
161525091|NCT02473952|583309855|FG000|Overall Study|Withdrawal by Subject|0|||
161590014|NCT01214616|583548228|FG003|Overall Study|Other adverse events|1|||
161590015|NCT01214616|583548225|FG000|Overall Study|Withdrawal by Subject|1|||
161590016|NCT01214616|583548226|FG001|Overall Study|Withdrawal by Subject|0|||
161590017|NCT01214616|583548227|FG002|Overall Study|Withdrawal by Subject|0|||
161590018|NCT01214616|583548228|FG003|Overall Study|Withdrawal by Subject|1|||
161590019|NCT02949362|583548229|FG000|Retrospective Period|Inform consent not signed by participant|4|||
161590020|NCT02949362|583548230|FG001|Retrospective Period|Inform consent not signed by participant|1|||
161590021|NCT02949362|583548231|FG002|Retrospective Period|Inform consent not signed by participant|0|||
161525092|NCT02473952|583309856|FG001|Overall Study|Withdrawal by Subject|6|||
161525093|NCT00823719|583309861|FG000|Overall Study|Adverse Event|1|||
161590022|NCT02949362|583548232|FG003|Retrospective Period|Inform consent not signed by participant|0|||
161590023|NCT02949362|583548229|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161525094|NCT00823719|583309862|FG001|Overall Study|Adverse Event|2|||
161525095|NCT00823719|583309861|FG000|Overall Study|Physician Decision|1|||
161525096|NCT00823719|583309862|FG001|Overall Study|Physician Decision|4|||
161525097|NCT00823719|583309861|FG000|Overall Study|Withdrawal by Subject|0|||
161525098|NCT00823719|583309862|FG001|Overall Study|Withdrawal by Subject|1|||
161525099|NCT00823719|583309861|FG000|Overall Study|Disease Progression|4|||
161525100|NCT00823719|583309862|FG001|Overall Study|Disease Progression|4|||
161525101|NCT02103439|583309865|FG000|Overall Study|Adverse Event|0|||
161525102|NCT02103439|583309866|FG001|Overall Study|Adverse Event|2|||
161525103|NCT02103439|583309865|FG000|Overall Study|Withdrawal by Subject|3|||
161525104|NCT02103439|583309866|FG001|Overall Study|Withdrawal by Subject|1|||
161525105|NCT02370602|583309867|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161525106|NCT02370602|583309868|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161525107|NCT02370602|583309869|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161590024|NCT02949362|583548230|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161590025|NCT02949362|583548231|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
161590026|NCT02949362|583548232|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161590027|NCT02949362|583548229|FG000|Prospective Period|Other|0|||
161590028|NCT02949362|583548230|FG001|Prospective Period|Other|0|||
161590029|NCT02949362|583548231|FG002|Prospective Period|Other|0|||
161590030|NCT02949362|583548232|FG003|Prospective Period|Other|4|||
161590031|NCT05268302|583548233|FG000|Overall Study|Death|0|||
161590032|NCT05268302|583548234|FG001|Overall Study|Death|1|||
161590033|NCT02811679|583548235|FG000|Overall Study|Adverse Event|1|||
161590034|NCT02811679|583548235|FG000|Overall Study|Lack of Efficacy|6|||
161590035|NCT02811679|583548235|FG000|Overall Study|Early study closure due to slow accrual|3|||
161590036|NCT05319860|583548236|FG000|Overall Study|Death|1|||
161590037|NCT05319860|583548237|FG001|Overall Study|Death|1|||
161590038|NCT05319860|583548236|FG000|Overall Study|Lost to Follow-up|3|||
161590039|NCT05319860|583548237|FG001|Overall Study|Lost to Follow-up|1|||
161590040|NCT05319860|583548236|FG000|Overall Study|Withdrawal by Subject|1|||
161590041|NCT05319860|583548237|FG001|Overall Study|Withdrawal by Subject|7|||
161590042|NCT04314895|583548238|FG000|Overall Study|Lost to Follow-up|1|||
161590043|NCT04314895|583548238|FG000|Overall Study|Death|10|||
161590044|NCT04314895|583548238|FG000|Overall Study|Physician Decision|2|||
161590045|NCT01361711|583548239|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
161590046|NCT01361711|583548239|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
161590047|NCT01361711|583548239|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
161590048|NCT01361711|583548239|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
161590049|NCT01361711|583548239|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
161590050|NCT01361711|583548239|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
161590051|NCT01361711|583548239|FG000|Completed Week 18 of Treatment|Other|9|||
161590052|NCT01361711|583548239|FG000|10 Year Follow-up|Still in follow-up|22|||
161590053|NCT01361711|583548239|FG000|10 Year Follow-up|Death|7|||
161590054|NCT01361711|583548239|FG000|10 Year Follow-up|Developed new cancer|1|||
161590055|NCT01361711|583548239|FG000|10 Year Follow-up|Lost to Follow-up|2|||
161590056|NCT01361711|583548239|FG000|10 Year Follow-up|New treatment started|6|||
161590057|NCT01361711|583548239|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
161590058|NCT01361711|583548239|FG000|10 Year Follow-up|Progressive Disease|1|||
161590059|NCT02187003|583550235|FG000|Overall Study|Adverse Event|2|||
161826429|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
161525108|NCT02370602|583309870|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
161525109|NCT02370602|583309871|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161525110|NCT02370602|583309872|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
161525111|NCT04827212|583309874|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
161525112|NCT04827212|583309875|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
161525113|NCT04827212|583309874|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
161525114|NCT04827212|583309875|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
161525115|NCT00599326|583309876|FG000|Overall Study|Lost to Follow-up|1|||
161525116|NCT00599326|583309876|FG000|Overall Study|Noncompliant|1|||
161590060|NCT02187003|583550236|FG001|Overall Study|Adverse Event|0|||
161590061|NCT02187003|583550235|FG000|Overall Study|Lost to Follow-up|14|||
161590062|NCT02187003|583550236|FG001|Overall Study|Lost to Follow-up|10|||
161590063|NCT02187003|583550235|FG000|Overall Study|Withdrawal by Subject|3|||
161590064|NCT02187003|583550236|FG001|Overall Study|Withdrawal by Subject|7|||
161590065|NCT02187003|583550235|FG000|Overall Study|Protocol Violation|2|||
161590066|NCT02187003|583550236|FG001|Overall Study|Protocol Violation|4|||
161826430|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
161826431|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
161826432|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826433|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826434|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826435|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826436|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
161525117|NCT00784810|583309877|FG000|Overall Study|Adverse Event|32|||
161525118|NCT00784810|583309878|FG001|Overall Study|Adverse Event|20|||
161525119|NCT00784810|583309877|FG000|Overall Study|Lack of Efficacy|14|||
161525120|NCT00784810|583309878|FG001|Overall Study|Lack of Efficacy|11|||
161525121|NCT00784810|583309877|FG000|Overall Study|Withdrawal by Subject|11|||
161525122|NCT00784810|583309878|FG001|Overall Study|Withdrawal by Subject|9|||
161525123|NCT00784810|583309877|FG000|Overall Study|Administrative|5|||
161525124|NCT00784810|583309878|FG001|Overall Study|Administrative|8|||
161525125|NCT00784810|583309877|FG000|Overall Study|Lost to Follow-up|1|||
161525126|NCT00784810|583309878|FG001|Overall Study|Lost to Follow-up|1|||
161525127|NCT03966157|583309879|FG000|Overall Study|Physician Decision|1|||
161525128|NCT03966157|583309880|FG001|Overall Study|Physician Decision|0|||
161525129|NCT04969250|583309885|FG000|Overall Study|Protocol Violation|0|||
161525130|NCT04969250|583309886|FG001|Overall Study|Protocol Violation|2|||
161525131|NCT04969250|583309887|FG002|Overall Study|Protocol Violation|3|||
161525132|NCT04969250|583309888|FG003|Overall Study|Protocol Violation|8|||
161525133|NCT04969250|583309885|FG000|Overall Study|Withdrawal by Subject|0|||
161525134|NCT04969250|583309886|FG001|Overall Study|Withdrawal by Subject|1|||
161525135|NCT04969250|583309887|FG002|Overall Study|Withdrawal by Subject|0|||
161525136|NCT04969250|583309888|FG003|Overall Study|Withdrawal by Subject|0|||
161525137|NCT03305016|583309889|FG000|Overall Study|Withdrawal by Subject|2|||
161525138|NCT02119416|583309890|FG000|Overall Study|Protocol Violation|1|||
161525139|NCT02119416|583309891|FG001|Overall Study|Protocol Violation|1|||
161525140|NCT02119416|583309892|FG002|Overall Study|Protocol Violation|1|||
161525141|NCT02119416|583309890|FG000|Overall Study|wrong pubertal stage|1|||
161525142|NCT02119416|583309891|FG001|Overall Study|wrong pubertal stage|0|||
161525143|NCT02119416|583309892|FG002|Overall Study|wrong pubertal stage|1|||
161525144|NCT04420689|583309893|FG000|Overall Study|COVID-19 related hospitalization|0|||
161525145|NCT04420689|583309894|FG001|Overall Study|COVID-19 related hospitalization|0|||
161525146|NCT04420689|583309895|FG002|Overall Study|COVID-19 related hospitalization|0|||
161525147|NCT04420689|583309896|FG003|Overall Study|COVID-19 related hospitalization|0|||
161525148|NCT04420689|583309897|FG004|Overall Study|COVID-19 related hospitalization|1|||
161525149|NCT04420689|583309898|FG005|Overall Study|COVID-19 related hospitalization|0|||
161525150|NCT04420689|583309899|FG006|Overall Study|COVID-19 related hospitalization|0|||
161525151|NCT04420689|583309893|FG000|Overall Study|Physician Decision|0|||
161525152|NCT04420689|583309894|FG001|Overall Study|Physician Decision|0|||
161525153|NCT04420689|583309895|FG002|Overall Study|Physician Decision|0|||
161525154|NCT04420689|583309896|FG003|Overall Study|Physician Decision|0|||
161525155|NCT04420689|583309897|FG004|Overall Study|Physician Decision|0|||
161525156|NCT04420689|583309898|FG005|Overall Study|Physician Decision|1|||
161525157|NCT04420689|583309899|FG006|Overall Study|Physician Decision|0|||
161525158|NCT03434119|583309900|FG000|Overall Study|Randomized but not treated|1|||
161525159|NCT03434119|583309901|FG001|Overall Study|Randomized but not treated|0|||
161525160|NCT03434119|583309900|FG000|Overall Study|Adverse Event|1|||
161525161|NCT03434119|583309901|FG001|Overall Study|Adverse Event|0|||
161525162|NCT03434119|583309900|FG000|Overall Study|Poor Compliance to Protocol|0|||
161525163|NCT03434119|583309901|FG001|Overall Study|Poor Compliance to Protocol|1|||
161525164|NCT03434119|583309900|FG000|Overall Study|Study Terminated by Sponsor|91|||
161525165|NCT03434119|583309901|FG001|Overall Study|Study Terminated by Sponsor|102|||
161525166|NCT03434119|583309900|FG000|Overall Study|Withdrawal by Subject|7|||
161525167|NCT03434119|583309901|FG001|Overall Study|Withdrawal by Subject|5|||
161525168|NCT03434119|583309900|FG000|Overall Study|Other than specified|7|||
161525169|NCT03434119|583309901|FG001|Overall Study|Other than specified|5|||
161525170|NCT04360824|583309904|FG000|Overall Study|Withdrawal by Subject|2|||
161525171|NCT04360824|583309905|FG001|Overall Study|Withdrawal by Subject|1|||
161525172|NCT04360824|583309904|FG000|Overall Study|Did not receive assigned treatment|1|||
161525173|NCT04360824|583309905|FG001|Overall Study|Did not receive assigned treatment|3|||
161525174|NCT02278328|583309909|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
161525175|NCT02278328|583309910|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
161525176|NCT02278328|583309911|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
161525177|NCT02278328|583309909|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
161525178|NCT02278328|583309910|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
161525179|NCT02278328|583309911|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
161935248|NCT05415215|584813878|FG004|Neoadjuvant Phase|Reason not Specified|0|||
161935249|NCT05415215|584813879|FG005|Neoadjuvant Phase|Reason not Specified|0|||
161525180|NCT02278328|583309909|FG000|Neuropsych Screening|incomplete consent|0|||
161525181|NCT02278328|583309910|FG001|Neuropsych Screening|incomplete consent|0|||
161525182|NCT02278328|583309911|FG002|Neuropsych Screening|incomplete consent|2|||
161525183|NCT00377676|583309912|FG000|Overall Study|Adverse Event|498|||
161525184|NCT00377676|583309913|FG001|Overall Study|Adverse Event|107|||
161525185|NCT00377676|583309912|FG000|Overall Study|Protocol Violation|33|||
161525186|NCT00377676|583309913|FG001|Overall Study|Protocol Violation|27|||
161525187|NCT00377676|583309912|FG000|Overall Study|Death|5|||
161525188|NCT00377676|583309913|FG001|Overall Study|Death|2|||
161525189|NCT00377676|583309912|FG000|Overall Study|Withdrawal by Subject|187|||
161525190|NCT00377676|583309913|FG001|Overall Study|Withdrawal by Subject|72|||
161935250|NCT05415215|584813880|FG006|Neoadjuvant Phase|Reason not Specified|0|||
161935251|NCT05415215|584813881|FG007|Neoadjuvant Phase|Reason not Specified|0|||
161525191|NCT00377676|583309912|FG000|Overall Study|Lost to Follow-up|120|||
161525192|NCT00377676|583309913|FG001|Overall Study|Lost to Follow-up|56|||
161525193|NCT00377676|583309912|FG000|Overall Study|Other|118|||
161525194|NCT00377676|583309913|FG001|Overall Study|Other|58|||
161525195|NCT03834779|583309919|FG000|Overall Study|Death|1|||
161525196|NCT03834779|583309920|FG001|Overall Study|Death|2|||
161525197|NCT03834779|583309919|FG000|Overall Study|Lost to Follow-up|6|||
161525198|NCT03834779|583309920|FG001|Overall Study|Lost to Follow-up|4|||
161525199|NCT03579459|583309921|FG000|Overall Study|Adverse Event|7|||
161525200|NCT03579459|583309922|FG001|Overall Study|Adverse Event|6|||
161525201|NCT03579459|583309923|FG002|Overall Study|Adverse Event|2|||
161935252|NCT05415215|584813874|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
161935253|NCT05415215|584813875|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
161525202|NCT03579459|583309924|FG003|Overall Study|Adverse Event|6|||
161525203|NCT03579459|583309921|FG000|Overall Study|Death|1|||
161525204|NCT03579459|583309922|FG001|Overall Study|Death|0|||
161525205|NCT03579459|583309923|FG002|Overall Study|Death|1|||
161935254|NCT05415215|584813876|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
161935255|NCT05415215|584813877|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
161935256|NCT05415215|584813878|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
161935257|NCT05415215|584813879|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
161935258|NCT05415215|584813880|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
161935259|NCT05415215|584813881|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
161935260|NCT05415215|584813874|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
161935261|NCT05415215|584813875|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161935262|NCT05415215|584813876|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
161935263|NCT05415215|584813877|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161935264|NCT05415215|584813878|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161935265|NCT05415215|584813879|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
161935266|NCT05415215|584813880|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
161935267|NCT05415215|584813881|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
161935268|NCT05415215|584813874|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935269|NCT05415215|584813875|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935270|NCT05415215|584813876|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935271|NCT05415215|584813877|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161935272|NCT05415215|584813878|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161525206|NCT03579459|583309924|FG003|Overall Study|Death|2|||
161525207|NCT03579459|583309921|FG000|Overall Study|Lost to Follow-up|6|||
161525208|NCT03579459|583309922|FG001|Overall Study|Lost to Follow-up|2|||
161525209|NCT03579459|583309923|FG002|Overall Study|Lost to Follow-up|4|||
161525210|NCT03579459|583309924|FG003|Overall Study|Lost to Follow-up|1|||
161525211|NCT03579459|583309921|FG000|Overall Study|Physician Decision|0|||
161525212|NCT03579459|583309922|FG001|Overall Study|Physician Decision|1|||
161525213|NCT03579459|583309923|FG002|Overall Study|Physician Decision|0|||
161525214|NCT03579459|583309924|FG003|Overall Study|Physician Decision|1|||
161525215|NCT03579459|583309921|FG000|Overall Study|Protocol Violation|1|||
161525216|NCT03579459|583309922|FG001|Overall Study|Protocol Violation|2|||
161525217|NCT03579459|583309923|FG002|Overall Study|Protocol Violation|3|||
161525218|NCT03579459|583309924|FG003|Overall Study|Protocol Violation|5|||
161525219|NCT03579459|583309921|FG000|Overall Study|Withdrawal by Subject|12|||
161525220|NCT03579459|583309922|FG001|Overall Study|Withdrawal by Subject|8|||
161525221|NCT03579459|583309923|FG002|Overall Study|Withdrawal by Subject|11|||
161525222|NCT03579459|583309924|FG003|Overall Study|Withdrawal by Subject|8|||
161525223|NCT03579459|583309921|FG000|Overall Study|Medication error without associated adverse event|2|||
161525224|NCT03579459|583309922|FG001|Overall Study|Medication error without associated adverse event|1|||
161525225|NCT03579459|583309923|FG002|Overall Study|Medication error without associated adverse event|1|||
161525226|NCT03579459|583309924|FG003|Overall Study|Medication error without associated adverse event|0|||
161525227|NCT03579459|583309921|FG000|Overall Study|Other|0|||
161525228|NCT03579459|583309922|FG001|Overall Study|Other|1|||
161525229|NCT03579459|583309923|FG002|Overall Study|Other|1|||
161525230|NCT03579459|583309924|FG003|Overall Study|Other|0|||
161525231|NCT03579459|583309921|FG000|Overall Study|Randomized not vaccinated|0|||
161525232|NCT03579459|583309922|FG001|Overall Study|Randomized not vaccinated|2|||
161525233|NCT03579459|583309923|FG002|Overall Study|Randomized not vaccinated|0|||
161525234|NCT03579459|583309924|FG003|Overall Study|Randomized not vaccinated|1|||
161525235|NCT02528214|583309925|FG000|Overall Study|Protocol Violation|0|||
161935273|NCT05415215|584813879|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935274|NCT05415215|584813880|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161525236|NCT02528214|583309926|FG001|Overall Study|Protocol Violation|1|||
161525237|NCT02528214|583309925|FG000|Overall Study|Adverse Event|0|||
161525238|NCT02528214|583309926|FG001|Overall Study|Adverse Event|1|||
161525239|NCT02528214|583309925|FG000|Overall Study|Other than specified above|0|||
161525240|NCT02528214|583309926|FG001|Overall Study|Other than specified above|1|||
161525241|NCT00407537|583309927|FG000|Overall Study|Death|5|||
161525242|NCT00407537|583309928|FG001|Overall Study|Death|2|||
161935275|NCT05415215|584813881|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161525243|NCT00407537|583309927|FG000|Overall Study|Adverse Event|36|||
161525244|NCT00407537|583309928|FG001|Overall Study|Adverse Event|0|||
161525245|NCT00407537|583309927|FG000|Overall Study|Lost to Follow-up|12|||
161525246|NCT00407537|583309928|FG001|Overall Study|Lost to Follow-up|19|||
161525247|NCT00407537|583309927|FG000|Overall Study|Other|6|||
161525248|NCT00407537|583309928|FG001|Overall Study|Other|7|||
161826437|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
161826438|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
161826439|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
161525249|NCT00407537|583309927|FG000|Overall Study|Withdrawal by Subject|34|||
161525250|NCT00407537|583309928|FG001|Overall Study|Withdrawal by Subject|16|||
161525251|NCT01090453|583309931|FG000|Overall Study|Withdrawal by Subject|1|||
161525252|NCT01090453|583309932|FG001|Overall Study|Withdrawal by Subject|2|||
161525253|NCT01090453|583309931|FG000|Overall Study|Lost to Follow-up|7|||
161525254|NCT01090453|583309932|FG001|Overall Study|Lost to Follow-up|7|||
161525255|NCT01090453|583309931|FG000|Overall Study|Non serious AEs|1|||
161525256|NCT01090453|583309932|FG001|Overall Study|Non serious AEs|0|||
161525257|NCT01090453|583309931|FG000|Overall Study|Protocol Violation|2|||
161525258|NCT01090453|583309932|FG001|Overall Study|Protocol Violation|0|||
161525259|NCT01090453|583309931|FG000|Overall Study|Other|2|||
161525260|NCT01090453|583309932|FG001|Overall Study|Other|4|||
161525261|NCT01090453|583309931|FG000|Overall Study|Eligibility Criteria|0|||
161525262|NCT01090453|583309932|FG001|Overall Study|Eligibility Criteria|1|||
161525263|NCT01870843|583309933|FG000|Overall Study|Adverse Event|10|||
161525264|NCT01870843|583309933|FG000|Overall Study|Lost to Follow-up|24|||
161525265|NCT01870843|583309933|FG000|Overall Study|Death|1|||
161525266|NCT01870843|583309933|FG000|Overall Study|Withdrawal by Subject|18|||
161525267|NCT01365494|583309935|FG000|Overall Study|Adverse Event|1|||
161525268|NCT01365494|583309936|FG001|Overall Study|Adverse Event|0|||
161525269|NCT01365494|583309935|FG000|Overall Study|Withdrawal by Subject|0|||
161525270|NCT01365494|583309936|FG001|Overall Study|Withdrawal by Subject|1|||
161525271|NCT01365494|583309935|FG000|Overall Study|Lost to Follow-up|1|||
161525272|NCT01365494|583309936|FG001|Overall Study|Lost to Follow-up|2|||
161525273|NCT00718718|583309937|FG000|Prior to Week 12|Adverse Event|0|||
161525274|NCT00718718|583309938|FG001|Prior to Week 12|Adverse Event|0|||
161525275|NCT00718718|583309939|FG002|Prior to Week 12|Adverse Event|0|||
161525276|NCT00718718|583309940|FG003|Prior to Week 12|Adverse Event|0|||
161525277|NCT00718718|583309941|FG004|Prior to Week 12|Adverse Event|0|||
161525278|NCT00718718|583309942|FG005|Prior to Week 12|Adverse Event|0|||
161525279|NCT00718718|583309943|FG006|Prior to Week 12|Adverse Event|0|||
161525280|NCT00718718|583309944|FG007|Prior to Week 12|Adverse Event|1|||
161525281|NCT00718718|583309945|FG008|Prior to Week 12|Adverse Event|1|||
161525282|NCT00718718|583309946|FG009|Prior to Week 12|Adverse Event|0|||
161525283|NCT00718718|583309937|FG000|Prior to Week 12|Withdrawal by Subject|0|||
161525284|NCT00718718|583309938|FG001|Prior to Week 12|Withdrawal by Subject|0|||
161525285|NCT00718718|583309939|FG002|Prior to Week 12|Withdrawal by Subject|0|||
161525286|NCT00718718|583309940|FG003|Prior to Week 12|Withdrawal by Subject|0|||
161590067|NCT02187003|583550235|FG000|Overall Study|Other|5|||
161590068|NCT02187003|583550236|FG001|Overall Study|Other|5|||
161590069|NCT02187003|583550235|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161590070|NCT02187003|583550236|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
161590071|NCT03648840|583550239|FG000|First IV Infusion Session|Adverse Event|0|||
161590072|NCT03648840|583550240|FG001|First IV Infusion Session|Adverse Event|2|||
161590073|NCT03648840|583550239|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
161590074|NCT03648840|583550240|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
161826440|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
161826441|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
161826442|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
161826443|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
161826444|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
161826445|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
161826446|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
161826447|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
161826448|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
161826449|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
161826450|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
161826451|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161826452|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
161826453|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161826454|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
161525287|NCT00718718|583309941|FG004|Prior to Week 12|Withdrawal by Subject|3|||
161525288|NCT00718718|583309942|FG005|Prior to Week 12|Withdrawal by Subject|0|||
161525289|NCT00718718|583309943|FG006|Prior to Week 12|Withdrawal by Subject|1|||
161935276|NCT05415215|584813874|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935277|NCT05415215|584813875|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935278|NCT05415215|584813876|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935279|NCT05415215|584813877|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161935280|NCT05415215|584813878|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161935281|NCT05415215|584813879|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935282|NCT05415215|584813880|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935283|NCT05415215|584813881|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935284|NCT05415215|584813874|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935285|NCT05415215|584813875|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935286|NCT05415215|584813876|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935287|NCT05415215|584813877|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935288|NCT05415215|584813878|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
161935289|NCT05415215|584813879|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935290|NCT05415215|584813880|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935291|NCT05415215|584813881|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935292|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935293|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935294|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935295|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935296|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935297|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935298|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
161935299|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935300|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935301|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935302|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935303|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161826455|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161826456|NCT00761176|584403872|FG000|Overall Study|Death|1|||
161826457|NCT00761176|584403873|FG001|Overall Study|Death|0|||
161826458|NCT00761176|584403872|FG000|Overall Study|Withdrawal by Subject|1|||
161935304|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935305|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
161826459|NCT00761176|584403873|FG001|Overall Study|Withdrawal by Subject|1|||
161826460|NCT02762994|584403874|FG000|Overall Study|Withdrawal by Subject|0|||
161826461|NCT02762994|584403875|FG001|Overall Study|Withdrawal by Subject|1|||
161826462|NCT02762994|584403876|FG002|Overall Study|Withdrawal by Subject|2|||
161826463|NCT02762994|584403877|FG003|Overall Study|Withdrawal by Subject|0|||
161826464|NCT02762994|584403874|FG000|Overall Study|Protocol Violation|1|||
161826465|NCT02762994|584403875|FG001|Overall Study|Protocol Violation|0|||
161826466|NCT02762994|584403876|FG002|Overall Study|Protocol Violation|0|||
161826467|NCT02762994|584403877|FG003|Overall Study|Protocol Violation|2|||
161826468|NCT05103657|584403880|FG000|Overall Study|Other reasons than listed|9|||
161826469|NCT05103657|584403881|FG001|Overall Study|Other reasons than listed|8|||
161826470|NCT05103657|584403880|FG000|Overall Study|Protocol deviation|2|||
161826471|NCT05103657|584403881|FG001|Overall Study|Protocol deviation|2|||
161826472|NCT05103657|584403880|FG000|Overall Study|No reason available|5|||
161826473|NCT05103657|584403881|FG001|Overall Study|No reason available|4|||
161826474|NCT05103657|584403880|FG000|Overall Study|Burden of study procedures|3|||
161826475|NCT05103657|584403881|FG001|Overall Study|Burden of study procedures|1|||
161826476|NCT05103657|584403880|FG000|Overall Study|Perceived lack of efficacy|1|||
161826477|NCT05103657|584403881|FG001|Overall Study|Perceived lack of efficacy|1|||
161826478|NCT05103657|584403880|FG000|Overall Study|Adverse Event|6|||
161826479|NCT05103657|584403881|FG001|Overall Study|Adverse Event|14|||
161826480|NCT05103657|584403880|FG000|Overall Study|Not Treated|1|||
161826481|NCT05103657|584403881|FG001|Overall Study|Not Treated|1|||
161826482|NCT02020967|584403882|FG000|Overall Study|Withdrawal by Subject|51|||
161826483|NCT02387762|584403885|FG000|Overall Study|Withdrawal by Subject|1|||
161826484|NCT02387762|584403886|FG001|Overall Study|Withdrawal by Subject|0|||
161935306|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935307|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935308|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935309|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935310|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161826485|NCT00642811|584403889|FG000|Overall Study|Adverse Event|2|||
161826486|NCT00642811|584403890|FG001|Overall Study|Adverse Event|3|||
161826487|NCT00642811|584403891|FG002|Overall Study|Adverse Event|0|||
161826488|NCT00642811|584403892|FG003|Overall Study|Adverse Event|0|||
161826489|NCT00642811|584403893|FG004|Overall Study|Adverse Event|0|||
161826490|NCT00642811|584403894|FG005|Overall Study|Adverse Event|1|||
161678003|NCT01994382|583873596|FG012|Overall Study|Protocol violation/noncompliance|0|||
161678004|NCT01994382|583873597|FG013|Overall Study|Protocol violation/noncompliance|0|||
161678005|NCT01994382|583873598|FG014|Overall Study|Protocol violation/noncompliance|0|||
161678006|NCT01994382|583873599|FG015|Overall Study|Protocol violation/noncompliance|0|||
161678007|NCT01994382|583873600|FG016|Overall Study|Protocol violation/noncompliance|2|||
161678008|NCT01994382|583873584|FG000|Overall Study|Rolled over to Phase 2a|0|||
161678009|NCT01994382|583873585|FG001|Overall Study|Rolled over to Phase 2a|0|||
161678010|NCT01994382|583873586|FG002|Overall Study|Rolled over to Phase 2a|1|||
161678011|NCT01994382|583873587|FG003|Overall Study|Rolled over to Phase 2a|0|||
161678012|NCT01994382|583873588|FG004|Overall Study|Rolled over to Phase 2a|0|||
161678013|NCT01994382|583873589|FG005|Overall Study|Rolled over to Phase 2a|0|||
161678014|NCT01994382|583873590|FG006|Overall Study|Rolled over to Phase 2a|0|||
161678015|NCT01994382|583873591|FG007|Overall Study|Rolled over to Phase 2a|0|||
161678016|NCT01994382|583873592|FG008|Overall Study|Rolled over to Phase 2a|0|||
161678017|NCT01994382|583873593|FG009|Overall Study|Rolled over to Phase 2a|2|||
161678018|NCT01994382|583873594|FG010|Overall Study|Rolled over to Phase 2a|0|||
161678019|NCT01994382|583873595|FG011|Overall Study|Rolled over to Phase 2a|0|||
161678020|NCT01994382|583873596|FG012|Overall Study|Rolled over to Phase 2a|0|||
161678021|NCT01994382|583873597|FG013|Overall Study|Rolled over to Phase 2a|0|||
161678022|NCT01994382|583873598|FG014|Overall Study|Rolled over to Phase 2a|0|||
161678023|NCT01994382|583873599|FG015|Overall Study|Rolled over to Phase 2a|0|||
161678024|NCT01994382|583873600|FG016|Overall Study|Rolled over to Phase 2a|0|||
161678025|NCT04667377|583873601|FG000|Dose Escalation Period|Other not specified below|3|||
161678026|NCT04667377|583873602|FG001|Dose Escalation Period|Other not specified below|3|||
161678027|NCT04667377|583873603|FG002|Dose Escalation Period|Other not specified below|2|||
161678028|NCT04667377|583873604|FG003|Dose Escalation Period|Other not specified below|1|||
161678029|NCT04667377|583873605|FG004|Dose Escalation Period|Other not specified below|3|||
161678030|NCT04667377|583873601|FG000|Dose Escalation Period|Protocol Violation|2|||
161678031|NCT04667377|583873602|FG001|Dose Escalation Period|Protocol Violation|2|||
161678032|NCT04667377|583873603|FG002|Dose Escalation Period|Protocol Violation|0|||
161678033|NCT04667377|583873604|FG003|Dose Escalation Period|Protocol Violation|2|||
161678034|NCT04667377|583873605|FG004|Dose Escalation Period|Protocol Violation|1|||
161678035|NCT04667377|583873601|FG000|Dose Escalation Period|Burden of study procedures|2|||
161678036|NCT04667377|583873602|FG001|Dose Escalation Period|Burden of study procedures|1|||
161678037|NCT04667377|583873603|FG002|Dose Escalation Period|Burden of study procedures|1|||
161678038|NCT04667377|583873604|FG003|Dose Escalation Period|Burden of study procedures|1|||
161678039|NCT04667377|583873605|FG004|Dose Escalation Period|Burden of study procedures|5|||
161678040|NCT04667377|583873601|FG000|Dose Escalation Period|Change of residence|0|||
161678041|NCT04667377|583873602|FG001|Dose Escalation Period|Change of residence|0|||
161826491|NCT00642811|584403889|FG000|Overall Study|Developement of discontinuation criteria|0|||
161826492|NCT00642811|584403890|FG001|Overall Study|Developement of discontinuation criteria|0|||
161826493|NCT00642811|584403891|FG002|Overall Study|Developement of discontinuation criteria|0|||
161826494|NCT00642811|584403892|FG003|Overall Study|Developement of discontinuation criteria|0|||
161826495|NCT00642811|584403893|FG004|Overall Study|Developement of discontinuation criteria|1|||
161826496|NCT00642811|584403894|FG005|Overall Study|Developement of discontinuation criteria|0|||
161826497|NCT00642811|584403889|FG000|Overall Study|Severe Non-compliance to protocol|1|||
161826498|NCT00642811|584403890|FG001|Overall Study|Severe Non-compliance to protocol|0|||
161826499|NCT00642811|584403891|FG002|Overall Study|Severe Non-compliance to protocol|0|||
161826500|NCT00642811|584403892|FG003|Overall Study|Severe Non-compliance to protocol|0|||
161826501|NCT00642811|584403893|FG004|Overall Study|Severe Non-compliance to protocol|0|||
161826502|NCT00642811|584403894|FG005|Overall Study|Severe Non-compliance to protocol|0|||
161826503|NCT00642811|584403889|FG000|Overall Study|Other|0|||
161826504|NCT00642811|584403890|FG001|Overall Study|Other|1|||
161826505|NCT00642811|584403891|FG002|Overall Study|Other|0|||
161826506|NCT00642811|584403892|FG003|Overall Study|Other|1|||
161826507|NCT00642811|584403893|FG004|Overall Study|Other|0|||
161826508|NCT00642811|584403894|FG005|Overall Study|Other|0|||
161826509|NCT02614898|584403895|FG000|Overall Study|Participated until study termination|10|||
161826510|NCT02614898|584403896|FG001|Overall Study|Participated until study termination|26|||
161826511|NCT02614898|584403895|FG000|Overall Study|Lost to Follow-up|0|||
161826512|NCT02614898|584403896|FG001|Overall Study|Lost to Follow-up|2|||
161826513|NCT02614898|584403895|FG000|Overall Study|Physician Decision|1|||
161826514|NCT02614898|584403896|FG001|Overall Study|Physician Decision|8|||
161826515|NCT02614898|584403895|FG000|Overall Study|Study Terminated by Sponsor|3|||
161826516|NCT02614898|584403896|FG001|Overall Study|Study Terminated by Sponsor|0|||
161826517|NCT02614898|584403895|FG000|Overall Study|Withdrawal by Subject|0|||
161826518|NCT02614898|584403896|FG001|Overall Study|Withdrawal by Subject|2|||
161826519|NCT02614898|584403895|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161826520|NCT02614898|584403896|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161826521|NCT02614898|584403895|FG000|Overall Study|Other-Additional Information Unavailable|0|||
161826522|NCT02614898|584403896|FG001|Overall Study|Other-Additional Information Unavailable|11|||
161826523|NCT02614898|584403895|FG000|Overall Study|Missing|0|||
161826524|NCT02614898|584403896|FG001|Overall Study|Missing|1|||
161525290|NCT00718718|583309944|FG007|Prior to Week 12|Withdrawal by Subject|1|||
161525291|NCT00718718|583309945|FG008|Prior to Week 12|Withdrawal by Subject|1|||
161525292|NCT00718718|583309946|FG009|Prior to Week 12|Withdrawal by Subject|0|||
161525293|NCT00718718|583309937|FG000|Prior to Week 12|Other|1|||
161525294|NCT00718718|583309938|FG001|Prior to Week 12|Other|0|||
161525295|NCT00718718|583309939|FG002|Prior to Week 12|Other|1|||
161525296|NCT00718718|583309940|FG003|Prior to Week 12|Other|0|||
161525297|NCT00718718|583309941|FG004|Prior to Week 12|Other|0|||
161525298|NCT00718718|583309942|FG005|Prior to Week 12|Other|0|||
161525299|NCT00718718|583309943|FG006|Prior to Week 12|Other|0|||
161525300|NCT00718718|583309944|FG007|Prior to Week 12|Other|0|||
161525301|NCT00718718|583309945|FG008|Prior to Week 12|Other|0|||
161525302|NCT00718718|583309946|FG009|Prior to Week 12|Other|0|||
161678042|NCT04667377|583873603|FG002|Dose Escalation Period|Change of residence|1|||
161826525|NCT00810602|584403899|FG000|Overall Study|Withdrawal by Subject|8|||
161826526|NCT00810602|584403900|FG001|Overall Study|Withdrawal by Subject|3|||
161826527|NCT00434590|584403901|FG000|Overall Study|Administrative problems|5|||
161525303|NCT00718718|583309937|FG000|Week 12 to End of Study|Adverse Event|0|||
161525304|NCT00718718|583309938|FG001|Week 12 to End of Study|Adverse Event|0|||
161525305|NCT00718718|583309939|FG002|Week 12 to End of Study|Adverse Event|0|||
161525306|NCT00718718|583309940|FG003|Week 12 to End of Study|Adverse Event|0|||
161525307|NCT00718718|583309941|FG004|Week 12 to End of Study|Adverse Event|0|||
161525308|NCT00718718|583309942|FG005|Week 12 to End of Study|Adverse Event|0|||
161525309|NCT00718718|583309943|FG006|Week 12 to End of Study|Adverse Event|0|||
161525310|NCT00718718|583309944|FG007|Week 12 to End of Study|Adverse Event|1|||
161525311|NCT00718718|583309945|FG008|Week 12 to End of Study|Adverse Event|0|||
161525312|NCT00718718|583309946|FG009|Week 12 to End of Study|Adverse Event|0|||
161525313|NCT00718718|583309937|FG000|Week 12 to End of Study|Death|0|||
161525314|NCT00718718|583309938|FG001|Week 12 to End of Study|Death|0|||
161525315|NCT00718718|583309939|FG002|Week 12 to End of Study|Death|0|||
161525316|NCT00718718|583309940|FG003|Week 12 to End of Study|Death|0|||
161525317|NCT00718718|583309941|FG004|Week 12 to End of Study|Death|0|||
161525318|NCT00718718|583309942|FG005|Week 12 to End of Study|Death|1|||
161525319|NCT00718718|583309943|FG006|Week 12 to End of Study|Death|0|||
161525320|NCT00718718|583309944|FG007|Week 12 to End of Study|Death|0|||
161525321|NCT00718718|583309945|FG008|Week 12 to End of Study|Death|0|||
161525322|NCT00718718|583309946|FG009|Week 12 to End of Study|Death|0|||
161525323|NCT00718718|583309937|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
161525324|NCT00718718|583309938|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
161525325|NCT00718718|583309939|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
161525326|NCT00718718|583309940|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
161525327|NCT00718718|583309941|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
161525328|NCT00718718|583309942|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
161525329|NCT00718718|583309943|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
161678043|NCT04667377|583873604|FG003|Dose Escalation Period|Change of residence|0|||
161826528|NCT00434590|584403902|FG001|Overall Study|Administrative problems|5|||
161826529|NCT00996437|584405987|FG000|Overall Study|Death|1|||
161826530|NCT00996437|584405988|FG001|Overall Study|Death|0|||
161826531|NCT00996437|584405987|FG000|Overall Study|Dropped|2|||
161826532|NCT00996437|584405988|FG001|Overall Study|Dropped|2|||
161826533|NCT00996437|584405987|FG000|Overall Study|Missed|2|||
161826534|NCT00996437|584405988|FG001|Overall Study|Missed|5|||
161826535|NCT02576717|584405989|FG000|Overall Study|Other Reasons|16|||
161826536|NCT02576717|584405990|FG001|Overall Study|Other Reasons|18|||
161826537|NCT02576717|584405991|FG002|Overall Study|Other Reasons|15|||
161826538|NCT02576717|584405989|FG000|Overall Study|Covid-19 Pandemic|0|||
161826539|NCT02576717|584405990|FG001|Overall Study|Covid-19 Pandemic|1|||
161826540|NCT02576717|584405991|FG002|Overall Study|Covid-19 Pandemic|1|||
161826541|NCT02576717|584405989|FG000|Overall Study|Sponsor Decision|0|||
161826542|NCT02576717|584405990|FG001|Overall Study|Sponsor Decision|0|||
161826543|NCT02576717|584405991|FG002|Overall Study|Sponsor Decision|1|||
161826544|NCT02576717|584405989|FG000|Overall Study|Physician Decision|3|||
161826545|NCT02576717|584405990|FG001|Overall Study|Physician Decision|8|||
161826546|NCT02576717|584405991|FG002|Overall Study|Physician Decision|9|||
161826547|NCT02576717|584405989|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
161826548|NCT02576717|584405990|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
161826549|NCT02576717|584405991|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
161826550|NCT02576717|584405989|FG000|Overall Study|Death|3|||
161826551|NCT02576717|584405990|FG001|Overall Study|Death|5|||
161826552|NCT02576717|584405991|FG002|Overall Study|Death|3|||
161826553|NCT02576717|584405989|FG000|Overall Study|Lost to Follow-up|9|||
161826554|NCT02576717|584405990|FG001|Overall Study|Lost to Follow-up|10|||
161525330|NCT00718718|583309944|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
161525331|NCT00718718|583309945|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
161525332|NCT00718718|583309946|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
161826555|NCT02576717|584405991|FG002|Overall Study|Lost to Follow-up|19|||
161826556|NCT02576717|584405989|FG000|Overall Study|Protocol Violation|4|||
161826557|NCT02576717|584405990|FG001|Overall Study|Protocol Violation|0|||
161826558|NCT02576717|584405991|FG002|Overall Study|Protocol Violation|5|||
161935311|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935312|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935313|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
161935314|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935315|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935316|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935317|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935318|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935319|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935320|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935321|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161935322|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161935323|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935324|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935325|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935326|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935327|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935328|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935329|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935330|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
161935331|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935332|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935333|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935334|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935335|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935336|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935337|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
161935338|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
161935339|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161525333|NCT00718718|583309937|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
161525334|NCT00718718|583309938|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
161525335|NCT00718718|583309939|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
161525336|NCT00718718|583309940|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
161525337|NCT00718718|583309941|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
161525338|NCT00718718|583309942|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
161525339|NCT00718718|583309943|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
161525340|NCT00718718|583309944|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
161525341|NCT00718718|583309945|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
161525342|NCT00718718|583309946|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
161525343|NCT00718718|583309937|FG000|Week 12 to End of Study|Other|0|||
161525344|NCT00718718|583309938|FG001|Week 12 to End of Study|Other|1|||
161525345|NCT00718718|583309939|FG002|Week 12 to End of Study|Other|0|||
161525346|NCT00718718|583309940|FG003|Week 12 to End of Study|Other|1|||
161525347|NCT00718718|583309941|FG004|Week 12 to End of Study|Other|0|||
161525348|NCT00718718|583309942|FG005|Week 12 to End of Study|Other|0|||
161525349|NCT00718718|583309943|FG006|Week 12 to End of Study|Other|1|||
161525350|NCT00718718|583309944|FG007|Week 12 to End of Study|Other|0|||
161525351|NCT00718718|583309945|FG008|Week 12 to End of Study|Other|0|||
161525352|NCT00718718|583309946|FG009|Week 12 to End of Study|Other|0|||
161525353|NCT03588572|583309952|FG000|Visitation 1|Lack of Efficacy|1|||
161525354|NCT03588572|583309953|FG001|Visitation 1|Lack of Efficacy|1|||
161525355|NCT03588572|583309952|FG000|Visitation 2|Lost to Follow-up|1|||
161525356|NCT03588572|583309953|FG001|Visitation 2|Lost to Follow-up|1|||
161525357|NCT03588572|583309952|FG000|Visitation 2|Lack of Efficacy|0|||
161590075|NCT03648840|583550239|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
161935340|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935341|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161525358|NCT03588572|583309953|FG001|Visitation 2|Lack of Efficacy|1|||
161525359|NCT03588572|583309952|FG000|Visitation 2|Withdrawal by Subject|1|||
161525360|NCT03588572|583309953|FG001|Visitation 2|Withdrawal by Subject|0|||
161525361|NCT03588572|583309952|FG000|Visitation 3|Lost to Follow-up|1|||
161525362|NCT03588572|583309953|FG001|Visitation 3|Lost to Follow-up|1|||
161525363|NCT03588572|583309952|FG000|Visitation 3|Physician Decision|1|||
161590076|NCT03648840|583550240|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
161525364|NCT03588572|583309953|FG001|Visitation 3|Physician Decision|1|||
161525365|NCT03588572|583309952|FG000|Visitation 3|Withdrawal by Subject|1|||
161525366|NCT03588572|583309953|FG001|Visitation 3|Withdrawal by Subject|0|||
161590077|NCT03648840|583550239|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
161935342|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161525367|NCT01165281|583309954|FG000|Overall Study|Adverse Event|12|||
161935343|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161525368|NCT01165281|583309955|FG001|Overall Study|Adverse Event|14|||
161525369|NCT01165281|583309954|FG000|Overall Study|Death|3|||
161525370|NCT01165281|583309955|FG001|Overall Study|Death|4|||
161525371|NCT01165281|583309954|FG000|Overall Study|Lack of Efficacy|4|||
161525372|NCT01165281|583309955|FG001|Overall Study|Lack of Efficacy|1|||
161525373|NCT01165281|583309954|FG000|Overall Study|Lost to Follow-up|0|||
161525374|NCT01165281|583309955|FG001|Overall Study|Lost to Follow-up|1|||
161525375|NCT01165281|583309954|FG000|Overall Study|Physician Decision|8|||
161525376|NCT01165281|583309955|FG001|Overall Study|Physician Decision|1|||
161525377|NCT01165281|583309954|FG000|Overall Study|Protocol Violation|6|||
161525378|NCT01165281|583309955|FG001|Overall Study|Protocol Violation|5|||
161525379|NCT01165281|583309954|FG000|Overall Study|Withdrawal by Subject|8|||
161525380|NCT01165281|583309955|FG001|Overall Study|Withdrawal by Subject|7|||
161525381|NCT01165281|583309954|FG000|Overall Study|Noncompliance with Study Drug|1|||
161525382|NCT01165281|583309955|FG001|Overall Study|Noncompliance with Study Drug|4|||
161525383|NCT01165281|583309954|FG000|Overall Study|Progressive Disease|10|||
161525384|NCT01165281|583309955|FG001|Overall Study|Progressive Disease|14|||
161525385|NCT01165281|583309954|FG000|Overall Study|Other|6|||
161525386|NCT01165281|583309955|FG001|Overall Study|Other|0|||
161525387|NCT02863991|583309956|FG000|Overall Study|Death|0|||
161525388|NCT02863991|583309957|FG001|Overall Study|Death|3|||
161525389|NCT02863991|583309956|FG000|Overall Study|Lack of Efficacy|0|||
161525390|NCT02863991|583309957|FG001|Overall Study|Lack of Efficacy|1|||
161525391|NCT02863991|583309956|FG000|Overall Study|Study Terminated|2|||
161525392|NCT02863991|583309957|FG001|Overall Study|Study Terminated|8|||
161525393|NCT00364858|583309958|FG000|Overall Study|Adverse Event|1|||
161525394|NCT00364858|583309959|FG001|Overall Study|Adverse Event|5|||
161525395|NCT00364858|583309958|FG000|Overall Study|Withdrawal by Subject|1|||
161525396|NCT00364858|583309959|FG001|Overall Study|Withdrawal by Subject|1|||
161525397|NCT00364858|583309958|FG000|Overall Study|Pregnancy|1|||
161525398|NCT00364858|583309959|FG001|Overall Study|Pregnancy|1|||
161525399|NCT00364858|583309958|FG000|Overall Study|Clinical failure|2|||
161525400|NCT00364858|583309959|FG001|Overall Study|Clinical failure|13|||
161525401|NCT00364858|583309958|FG000|Overall Study|Discontinuation at baseline|1|||
161525402|NCT00364858|583309959|FG001|Overall Study|Discontinuation at baseline|0|||
161525403|NCT00364858|583309958|FG000|Overall Study|Non-compliant|1|||
161525404|NCT00364858|583309959|FG001|Overall Study|Non-compliant|0|||
161525405|NCT00364858|583309958|FG000|Overall Study|Return to Q2 regimen|0|||
161525406|NCT00364858|583309959|FG001|Overall Study|Return to Q2 regimen|1|||
161525407|NCT00364858|583309958|FG000|Overall Study|Clinical baseline issue|0|||
161525408|NCT00364858|583309959|FG001|Overall Study|Clinical baseline issue|1|||
161525409|NCT00363766|583309960|FG000|Overall Study|Progressive Disease|15|||
161525410|NCT00363766|583309961|FG001|Overall Study|Progressive Disease|9|||
161525411|NCT00363766|583309960|FG000|Overall Study|Adverse Event|10|||
161525412|NCT00363766|583309961|FG001|Overall Study|Adverse Event|2|||
161525413|NCT00363766|583309960|FG000|Overall Study|Disease Related Death|1|||
161525414|NCT00363766|583309961|FG001|Overall Study|Disease Related Death|3|||
161525415|NCT00363766|583309960|FG000|Overall Study|Not Disease Related Death|3|||
161525416|NCT00363766|583309961|FG001|Overall Study|Not Disease Related Death|4|||
161525417|NCT00363766|583309960|FG000|Overall Study|Withdrawal by Subject|2|||
161525418|NCT00363766|583309961|FG001|Overall Study|Withdrawal by Subject|0|||
161525419|NCT00363766|583309960|FG000|Overall Study|Physician Decision|1|||
161525420|NCT00363766|583309961|FG001|Overall Study|Physician Decision|2|||
161525421|NCT00558285|583309962|FG000|Overall Study|Adverse Event|1|||
161525422|NCT00558285|583309963|FG001|Overall Study|Adverse Event|1|||
161525423|NCT00558285|583309964|FG002|Overall Study|Adverse Event|4|||
161525424|NCT00558285|583309965|FG003|Overall Study|Adverse Event|1|||
161525425|NCT00558285|583309966|FG004|Overall Study|Adverse Event|2|||
161525426|NCT00558285|583309962|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161525427|NCT00558285|583309963|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161525428|NCT00558285|583309964|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161525429|NCT00558285|583309965|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161525430|NCT00558285|583309966|FG004|Overall Study|Abnormal test procedure result(s)|0|||
161525431|NCT00558285|583309962|FG000|Overall Study|Subject withdrew consent|2|||
161525432|NCT00558285|583309963|FG001|Overall Study|Subject withdrew consent|0|||
161525433|NCT00558285|583309964|FG002|Overall Study|Subject withdrew consent|1|||
161525434|NCT00558285|583309965|FG003|Overall Study|Subject withdrew consent|1|||
161525435|NCT00558285|583309966|FG004|Overall Study|Subject withdrew consent|1|||
161525436|NCT00558285|583309962|FG000|Overall Study|Lost to Follow-up|1|||
161525437|NCT00558285|583309963|FG001|Overall Study|Lost to Follow-up|1|||
161525438|NCT00558285|583309964|FG002|Overall Study|Lost to Follow-up|0|||
161525439|NCT00558285|583309965|FG003|Overall Study|Lost to Follow-up|0|||
161525440|NCT00558285|583309966|FG004|Overall Study|Lost to Follow-up|0|||
161525441|NCT00558285|583309962|FG000|Overall Study|Administrative problems|0|||
161525442|NCT00558285|583309963|FG001|Overall Study|Administrative problems|0|||
161525443|NCT00558285|583309964|FG002|Overall Study|Administrative problems|0|||
161525444|NCT00558285|583309965|FG003|Overall Study|Administrative problems|1|||
161525445|NCT00558285|583309966|FG004|Overall Study|Administrative problems|1|||
161525446|NCT00558285|583309962|FG000|Overall Study|Protocol deviation|1|||
161935344|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935345|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935346|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935347|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
161935348|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935349|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935350|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935351|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935352|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935353|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935354|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935355|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
161935356|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935357|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935358|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935359|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935360|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935361|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935362|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935363|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
161935364|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935365|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935366|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935367|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935368|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935369|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935370|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935371|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
161935372|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935373|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935374|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935375|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935376|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935377|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935378|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935379|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
161935380|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935381|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935382|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935383|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161525447|NCT00558285|583309963|FG001|Overall Study|Protocol deviation|1|||
161525448|NCT00558285|583309964|FG002|Overall Study|Protocol deviation|0|||
161525449|NCT00558285|583309965|FG003|Overall Study|Protocol deviation|1|||
161525450|NCT00558285|583309966|FG004|Overall Study|Protocol deviation|0|||
161525451|NCT02730819|583309973|FG000|Overall Study|Lost to Follow-up|9|||
161525452|NCT02345512|583309974|FG000|Overall Study|Adverse Event|1|||
161525453|NCT02345512|583309974|FG000|Overall Study|Withdrawal by Subject|1|||
161525454|NCT02121847|583309975|FG000|Overall Study|Administrative Reasons|1|||
161525455|NCT02121847|583309975|FG000|Overall Study|Adverse Event|2|||
161525456|NCT01660906|583309976|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
161525457|NCT03478891|583309984|FG000|Overall Study|Enrolled, but product never administered|0|||
161525458|NCT03478891|583309985|FG001|Overall Study|Enrolled, but product never administered|0|||
161525459|NCT03478891|583309986|FG002|Overall Study|Enrolled, but product never administered|1|||
161525460|NCT03478891|583309984|FG000|Overall Study|Moved from area|0|||
161525461|NCT03478891|583309985|FG001|Overall Study|Moved from area|0|||
161525462|NCT03478891|583309986|FG002|Overall Study|Moved from area|1|||
161525463|NCT03478891|583309984|FG000|Overall Study|Lost to Follow-up|1|||
161525464|NCT03478891|583309985|FG001|Overall Study|Lost to Follow-up|0|||
161525465|NCT03478891|583309986|FG002|Overall Study|Lost to Follow-up|1|||
161525466|NCT01308580|583309988|FG000|Overall Study|Lost to Follow-up|12|||
161525467|NCT01308580|583309989|FG001|Overall Study|Lost to Follow-up|7|||
161525468|NCT01912612|583312461|FG000|Overall Study|Adverse Event|4|||
161525469|NCT01912612|583312462|FG001|Overall Study|Adverse Event|0|||
161525470|NCT01912612|583312463|FG002|Overall Study|Adverse Event|0|||
161525471|NCT01912612|583312461|FG000|Overall Study|Withdrew consent|1|||
161525472|NCT01912612|583312462|FG001|Overall Study|Withdrew consent|0|||
161935384|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935385|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935386|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935387|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
161935388|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935389|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935390|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935391|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935392|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935393|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935394|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935395|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
161935396|NCT05415215|584813874|FG000|Follow-up Period|Ongoing in Follow-up|0|||
161935397|NCT05415215|584813875|FG001|Follow-up Period|Ongoing in Follow-up|0|||
161935398|NCT05415215|584813876|FG002|Follow-up Period|Ongoing in Follow-up|0|||
161935399|NCT05415215|584813877|FG003|Follow-up Period|Ongoing in Follow-up|0|||
161935400|NCT05415215|584813878|FG004|Follow-up Period|Ongoing in Follow-up|0|||
161935401|NCT05415215|584813879|FG005|Follow-up Period|Ongoing in Follow-up|44|||
161935402|NCT05415215|584813880|FG006|Follow-up Period|Ongoing in Follow-up|45|||
161935403|NCT05415215|584813881|FG007|Follow-up Period|Ongoing in Follow-up|51|||
161935404|NCT05415215|584813874|FG000|Follow-up Period|Adverse Event|0|||
161935405|NCT05415215|584813875|FG001|Follow-up Period|Adverse Event|0|||
161935406|NCT05415215|584813876|FG002|Follow-up Period|Adverse Event|0|||
161935407|NCT05415215|584813877|FG003|Follow-up Period|Adverse Event|0|||
161935408|NCT05415215|584813878|FG004|Follow-up Period|Adverse Event|0|||
161935409|NCT05415215|584813879|FG005|Follow-up Period|Adverse Event|0|||
161935410|NCT05415215|584813880|FG006|Follow-up Period|Adverse Event|1|||
161935411|NCT05415215|584813881|FG007|Follow-up Period|Adverse Event|0|||
161935412|NCT05415215|584813874|FG000|Follow-up Period|Lost to Follow-up|0|||
161935413|NCT05415215|584813875|FG001|Follow-up Period|Lost to Follow-up|0|||
161935414|NCT05415215|584813876|FG002|Follow-up Period|Lost to Follow-up|0|||
161935415|NCT05415215|584813877|FG003|Follow-up Period|Lost to Follow-up|0|||
161935416|NCT05415215|584813878|FG004|Follow-up Period|Lost to Follow-up|0|||
161935417|NCT05415215|584813879|FG005|Follow-up Period|Lost to Follow-up|1|||
161935418|NCT05415215|584813880|FG006|Follow-up Period|Lost to Follow-up|1|||
161935419|NCT05415215|584813881|FG007|Follow-up Period|Lost to Follow-up|0|||
161935420|NCT05415215|584813874|FG000|Follow-up Period|Withdrawal by Subject|0|||
161935421|NCT05415215|584813875|FG001|Follow-up Period|Withdrawal by Subject|0|||
161935422|NCT05415215|584813876|FG002|Follow-up Period|Withdrawal by Subject|0|||
161935423|NCT05415215|584813877|FG003|Follow-up Period|Withdrawal by Subject|0|||
161935424|NCT05415215|584813878|FG004|Follow-up Period|Withdrawal by Subject|0|||
161935425|NCT05415215|584813879|FG005|Follow-up Period|Withdrawal by Subject|0|||
161935426|NCT05415215|584813880|FG006|Follow-up Period|Withdrawal by Subject|0|||
161935427|NCT05415215|584813881|FG007|Follow-up Period|Withdrawal by Subject|2|||
161935428|NCT03727022|584813882|FG000|Phase A|Lost to Follow-up|2|||
161935429|NCT03727022|584813883|FG001|Phase A|Lost to Follow-up|3|||
161935430|NCT03727022|584813882|FG000|Phase A|Withdrawal by Subject|10|||
161935431|NCT03727022|584813883|FG001|Phase A|Withdrawal by Subject|9|||
161935432|NCT03727022|584813882|FG000|Phase B|Lost to Follow-up|0|||
161935433|NCT03727022|584813883|FG001|Phase B|Lost to Follow-up|1|||
161935434|NCT03727022|584813882|FG000|Phase B|Subject Non-Compliance|1|||
161935435|NCT03727022|584813883|FG001|Phase B|Subject Non-Compliance|0|||
161935436|NCT03727022|584813882|FG000|Phase B|Withdrawal by Subject|3|||
161935437|NCT03727022|584813883|FG001|Phase B|Withdrawal by Subject|3|||
161935438|NCT03727022|584813882|FG000|Phase B|Site Closure|4|||
161935439|NCT03727022|584813883|FG001|Phase B|Site Closure|0|||
161935440|NCT04736199|584813884|FG000|Overall Study|Adverse Event|28|||
161935441|NCT04736199|584813885|FG001|Overall Study|Adverse Event|22|||
161935442|NCT04736199|584813884|FG000|Overall Study|Death|9|||
161935443|NCT04736199|584813885|FG001|Overall Study|Death|3|||
161525473|NCT01912612|583312463|FG002|Overall Study|Withdrew consent|0|||
161525474|NCT01912612|583312461|FG000|Overall Study|Study design change|0|||
161525475|NCT01912612|583312462|FG001|Overall Study|Study design change|0|||
161525476|NCT01912612|583312463|FG002|Overall Study|Study design change|3|||
161525477|NCT01588184|583312464|FG000|Overall Study|Death|1|||
161525478|NCT01588184|583312465|FG001|Overall Study|Death|0|||
161525479|NCT01588184|583312466|FG002|Overall Study|Death|0|||
161935444|NCT04736199|584813884|FG000|Overall Study|Lost to Follow-up|4|||
161935445|NCT04736199|584813885|FG001|Overall Study|Lost to Follow-up|1|||
161935446|NCT04736199|584813884|FG000|Overall Study|Physician Decision|5|||
161935447|NCT04736199|584813885|FG001|Overall Study|Physician Decision|9|||
161935448|NCT04736199|584813884|FG000|Overall Study|Withdrawal by Subject|21|||
161935449|NCT04736199|584813885|FG001|Overall Study|Withdrawal by Subject|9|||
161935450|NCT04736199|584813884|FG000|Overall Study|Progressive disease|120|||
161935451|NCT04736199|584813885|FG001|Overall Study|Progressive disease|101|||
161935452|NCT04736199|584813884|FG000|Overall Study|Subject decision|13|||
161525480|NCT01588184|583312467|FG003|Overall Study|Death|1|||
161525481|NCT01588184|583312468|FG004|Overall Study|Death|1|||
161935453|NCT04736199|584813885|FG001|Overall Study|Subject decision|13|||
161935454|NCT04736199|584813884|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
161935455|NCT04736199|584813885|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
161935456|NCT04736199|584813884|FG000|Overall Study|Additional primary malignancy|1|||
161935457|NCT04736199|584813885|FG001|Overall Study|Additional primary malignancy|0|||
161935458|NCT04736199|584813884|FG000|Overall Study|Non-compliance with study drug|0|||
161935459|NCT04736199|584813885|FG001|Overall Study|Non-compliance with study drug|1|||
161935460|NCT04736199|584813884|FG000|Overall Study|Other reason|0|||
161935461|NCT04736199|584813885|FG001|Overall Study|Other reason|1|||
161935462|NCT04736199|584813884|FG000|Overall Study|Ongoing with study drug|240|||
161935463|NCT04736199|584813885|FG001|Overall Study|Ongoing with study drug|63|||
161935464|NCT04736199|584813884|FG000|Overall Study|Study drug never administered|3|||
161935465|NCT04736199|584813885|FG001|Overall Study|Study drug never administered|0|||
161935466|NCT03922802|584813886|FG000|Overall Study|Withdrawal by Subject|4|||
161935467|NCT05550818|584813887|FG000|Overall Study|Protocol Violation|1|||
161935468|NCT05550818|584813888|FG001|Overall Study|Protocol Violation|1|||
161935469|NCT05550818|584813887|FG000|Overall Study|Withdrawal by Subject|2|||
161935470|NCT05550818|584813888|FG001|Overall Study|Withdrawal by Subject|1|||
161935471|NCT04770753|584813889|FG000|Overall Study|Randomized, never treated|1|||
161935472|NCT04770753|584813890|FG001|Overall Study|Randomized, never treated|1|||
161935473|NCT04770753|584813889|FG000|Overall Study|Withdrawal by Subject|3|||
161935474|NCT04770753|584813890|FG001|Overall Study|Withdrawal by Subject|1|||
161935475|NCT04770753|584813889|FG000|Overall Study|Adverse Event|2|||
161935476|NCT04770753|584813890|FG001|Overall Study|Adverse Event|0|||
161935477|NCT04770753|584813889|FG000|Overall Study|Pregnancy|1|||
161935478|NCT04770753|584813890|FG001|Overall Study|Pregnancy|0|||
161935479|NCT04770753|584813889|FG000|Overall Study|Other un-specified|1|||
161935480|NCT04770753|584813890|FG001|Overall Study|Other un-specified|0|||
161935481|NCT04486716|584813891|FG000|Core Phase|Subject decision|6|||
161935482|NCT04486716|584813891|FG000|Core Phase|Adverse Event|5|||
161935483|NCT04486716|584813891|FG000|Core Phase|Lost to Follow-up|1|||
161935484|NCT04486716|584813891|FG000|Core Phase|Physician Decision|1|||
161935485|NCT04486716|584813891|FG000|Core Phase|Enrolled subjects not treated|9|||
161935486|NCT05176847|584813892|FG000|Overall Study|Lost to Follow-up|23|||
161935487|NCT05176847|584813893|FG001|Overall Study|Lost to Follow-up|36|||
161935488|NCT05176847|584813892|FG000|Overall Study|Withdrawal by Subject|7|||
161935489|NCT05176847|584813893|FG001|Overall Study|Withdrawal by Subject|12|||
161935490|NCT05176847|584813892|FG000|Overall Study|Removed from analysis|1|||
161935491|NCT05176847|584813893|FG001|Overall Study|Removed from analysis|0|||
161935492|NCT02562235|584813894|FG000|Overall Study|Adverse Event|3|||
161935493|NCT02797522|584813895|FG000|Overall Study|Study Terminated by Sponsor|0|||
161935494|NCT02797522|584813896|FG001|Overall Study|Study Terminated by Sponsor|0|||
161935495|NCT02797522|584813897|FG002|Overall Study|Study Terminated by Sponsor|0|||
161935496|NCT02797522|584813898|FG003|Overall Study|Study Terminated by Sponsor|0|||
161935497|NCT02797522|584813899|FG004|Overall Study|Study Terminated by Sponsor|0|||
161935498|NCT02797522|584813900|FG005|Overall Study|Study Terminated by Sponsor|0|||
161935499|NCT02797522|584813901|FG006|Overall Study|Study Terminated by Sponsor|0|||
161935500|NCT02797522|584813902|FG007|Overall Study|Study Terminated by Sponsor|4|||
161525482|NCT01588184|583312469|FG005|Overall Study|Death|1|||
161525483|NCT01588184|583312464|FG000|Overall Study|Withdrawal by Subject|2|||
161525484|NCT01588184|583312465|FG001|Overall Study|Withdrawal by Subject|4|||
161525485|NCT01588184|583312466|FG002|Overall Study|Withdrawal by Subject|0|||
161525486|NCT01588184|583312467|FG003|Overall Study|Withdrawal by Subject|1|||
161935501|NCT02797522|584813903|FG008|Overall Study|Study Terminated by Sponsor|2|||
161935502|NCT02797522|584813904|FG009|Overall Study|Study Terminated by Sponsor|4|||
161935503|NCT02797522|584813905|FG010|Overall Study|Study Terminated by Sponsor|1|||
161935504|NCT04744831|584813906|FG000|Overall Study|Adverse Event|6|||
161525487|NCT01588184|583312468|FG004|Overall Study|Withdrawal by Subject|0|||
161525488|NCT01588184|583312469|FG005|Overall Study|Withdrawal by Subject|0|||
161525489|NCT01588184|583312464|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
161525490|NCT01588184|583312465|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
161525491|NCT01588184|583312466|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
161525492|NCT01588184|583312467|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
161678044|NCT04667377|583873605|FG004|Dose Escalation Period|Change of residence|0|||
161935505|NCT04744831|584813907|FG001|Overall Study|Adverse Event|4|||
161935506|NCT04744831|584813906|FG000|Overall Study|Clinical Progression|5|||
161935507|NCT04744831|584813907|FG001|Overall Study|Clinical Progression|5|||
161935508|NCT04744831|584813906|FG000|Overall Study|Death|2|||
161935509|NCT04744831|584813907|FG001|Overall Study|Death|1|||
161935510|NCT04744831|584813906|FG000|Overall Study|Other|5|||
161935511|NCT04744831|584813907|FG001|Overall Study|Other|1|||
161935512|NCT04744831|584813906|FG000|Overall Study|Progressive Disease|63|||
161935513|NCT04744831|584813907|FG001|Overall Study|Progressive Disease|29|||
161935514|NCT04744831|584813906|FG000|Overall Study|Withdrawal by Subject|1|||
161935515|NCT04744831|584813907|FG001|Overall Study|Withdrawal by Subject|0|||
161525493|NCT01588184|583312468|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
161935516|NCT05888103|584813908|FG000|Overall Study|Participant decision|3|||
161935517|NCT05888103|584813909|FG001|Overall Study|Participant decision|3|||
161935518|NCT04987307|584813910|FG000|Overall Study|Protocol-specified criteria|2|||
161935519|NCT04987307|584813911|FG001|Overall Study|Protocol-specified criteria|0|||
161935520|NCT04987307|584813912|FG002|Overall Study|Protocol-specified criteria|0|||
161935521|NCT04987307|584813913|FG003|Overall Study|Protocol-specified criteria|3|||
161935522|NCT04987307|584813910|FG000|Overall Study|Withdrawal by Subject|34|||
161935523|NCT04987307|584813911|FG001|Overall Study|Withdrawal by Subject|30|||
161935524|NCT04987307|584813912|FG002|Overall Study|Withdrawal by Subject|29|||
161935525|NCT04987307|584813913|FG003|Overall Study|Withdrawal by Subject|35|||
161525494|NCT01588184|583312469|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
161525495|NCT01588184|583312464|FG000|Overall Study|multiple reasons|0|||
161525496|NCT01588184|583312465|FG001|Overall Study|multiple reasons|3|||
161525497|NCT01588184|583312466|FG002|Overall Study|multiple reasons|0|||
161525498|NCT01588184|583312467|FG003|Overall Study|multiple reasons|1|||
161525499|NCT01588184|583312468|FG004|Overall Study|multiple reasons|0|||
161525500|NCT01588184|583312469|FG005|Overall Study|multiple reasons|0|||
161525501|NCT01983293|583312471|FG000|Overall Study|Withdrawal by Subject|29|||
161525502|NCT01983293|583312472|FG001|Overall Study|Withdrawal by Subject|15|||
161525503|NCT01983293|583312471|FG000|Overall Study|Missing 12-month visit|3|||
161525504|NCT01983293|583312472|FG001|Overall Study|Missing 12-month visit|3|||
161525505|NCT01983293|583312471|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
161525506|NCT01983293|583312472|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
161525507|NCT03750552|583312473|FG000|Overall Study|Adverse Event|5|||
161590078|NCT03648840|583550240|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
161590079|NCT05382936|583550241|FG000|Overall Study|Progressive Disease|3|||
161590080|NCT05382936|583550242|FG001|Overall Study|Progressive Disease|5|||
161590081|NCT05382936|583550243|FG002|Overall Study|Progressive Disease|2|||
161590082|NCT05382936|583550244|FG003|Overall Study|Progressive Disease|5|||
161590083|NCT05382936|583550241|FG000|Overall Study|Adverse Event|0|||
161590084|NCT05382936|583550242|FG001|Overall Study|Adverse Event|1|||
161590085|NCT05382936|583550243|FG002|Overall Study|Adverse Event|1|||
161590086|NCT05382936|583550244|FG003|Overall Study|Adverse Event|0|||
161590087|NCT05382936|583550241|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161590088|NCT05382936|583550242|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
161590089|NCT05382936|583550243|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161590090|NCT05382936|583550244|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161590091|NCT05382936|583550241|FG000|Overall Study|Withdrawal by Subject|0|||
161590092|NCT05382936|583550242|FG001|Overall Study|Withdrawal by Subject|0|||
161590093|NCT05382936|583550243|FG002|Overall Study|Withdrawal by Subject|1|||
161590094|NCT05382936|583550244|FG003|Overall Study|Withdrawal by Subject|1|||
161590095|NCT05063994|583550245|FG000|Cortef Run-In|Withdrawal of Consent|1|||
161590096|NCT05063994|583550246|FG001|Cortef Run-In|Withdrawal of Consent|0|||
161590097|NCT05063994|583550247|FG002|Cortef Run-In|Withdrawal of Consent|0|||
161590098|NCT05063994|583550245|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
161590099|NCT05063994|583550246|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
161590100|NCT05063994|583550247|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
161590101|NCT05063994|583550245|FG000|Treatment|Physician Decision|0|||
161590102|NCT05063994|583550246|FG001|Treatment|Physician Decision|0|||
161590103|NCT05063994|583550247|FG002|Treatment|Physician Decision|1|||
161590104|NCT05063994|583550245|FG000|Treatment|Withdrawal by Subject|0|||
161590105|NCT05063994|583550246|FG001|Treatment|Withdrawal by Subject|0|||
161590106|NCT05063994|583550247|FG002|Treatment|Withdrawal by Subject|1|||
161590107|NCT05063994|583550245|FG000|Treatment|Withdrawal of Consent|0|||
161590108|NCT05063994|583550246|FG001|Treatment|Withdrawal of Consent|0|||
161590109|NCT05063994|583550247|FG002|Treatment|Withdrawal of Consent|1|||
161590110|NCT00667251|583550251|FG000|Overall Study|Disease progression|232|||
161590111|NCT00667251|583550252|FG001|Overall Study|Disease progression|203|||
161678045|NCT04667377|583873601|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
161525508|NCT03750552|583312474|FG001|Overall Study|Adverse Event|1|||
161678046|NCT04667377|583873602|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
161678047|NCT04667377|583873603|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
161525509|NCT03750552|583312473|FG000|Overall Study|Withdrawal by Subject|1|||
161525510|NCT03750552|583312474|FG001|Overall Study|Withdrawal by Subject|1|||
161590112|NCT00667251|583550251|FG000|Overall Study|Toxicity|44|||
161590113|NCT00667251|583550252|FG001|Overall Study|Toxicity|23|||
161590114|NCT00667251|583550251|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
161935526|NCT04987307|584813910|FG000|Overall Study|Decision by sponsor|10|||
161935527|NCT04987307|584813911|FG001|Overall Study|Decision by sponsor|13|||
161525511|NCT03750552|583312473|FG000|Overall Study|Other|2|||
161590115|NCT00667251|583550252|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
161590116|NCT00667251|583550251|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
161678048|NCT04667377|583873604|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
161525512|NCT03750552|583312474|FG001|Overall Study|Other|0|||
161525513|NCT01259713|583312477|FG000|Overall Study|Adverse Event|54|||
161525514|NCT01259713|583312478|FG001|Overall Study|Adverse Event|23|||
161525515|NCT01259713|583312477|FG000|Overall Study|Death Not Related to IFI|8|||
161525516|NCT01259713|583312478|FG001|Overall Study|Death Not Related to IFI|1|||
161525517|NCT01259713|583312477|FG000|Overall Study|Investigators Discretion|14|||
161525518|NCT01259713|583312478|FG001|Overall Study|Investigators Discretion|6|||
161525519|NCT01259713|583312477|FG000|Overall Study|Lack of Efficacy|2|||
161525520|NCT01259713|583312478|FG001|Overall Study|Lack of Efficacy|0|||
161525521|NCT01259713|583312477|FG000|Overall Study|Protocol Violation|5|||
161525522|NCT01259713|583312478|FG001|Overall Study|Protocol Violation|4|||
161525523|NCT01259713|583312477|FG000|Overall Study|Subject Withdrew Consent|12|||
161525524|NCT01259713|583312478|FG001|Overall Study|Subject Withdrew Consent|7|||
161525525|NCT02091726|583312479|FG000|Overall Study|Lost to Follow-up|6|||
161525526|NCT06111742|583312486|FG000|Overall Study|Did not receive intervention|1|||
161525527|NCT06111742|583312487|FG001|Overall Study|Did not receive intervention|0|||
161525528|NCT06111742|583312488|FG002|Overall Study|Did not receive intervention|0|||
161590117|NCT00667251|583550252|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
161590118|NCT00667251|583550251|FG000|Overall Study|Symptomatic progression|8|||
161590119|NCT00667251|583550252|FG001|Overall Study|Symptomatic progression|4|||
161590120|NCT00667251|583550251|FG000|Overall Study|Death|6|||
161590121|NCT00667251|583550252|FG001|Overall Study|Death|11|||
161590122|NCT00667251|583550251|FG000|Overall Study|Intercurrent illness|5|||
161590123|NCT00667251|583550252|FG001|Overall Study|Intercurrent illness|6|||
161590124|NCT00667251|583550251|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
161590125|NCT00667251|583550252|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
161590126|NCT00667251|583550251|FG000|Overall Study|Randomized not Treated|4|||
161590127|NCT00667251|583550252|FG001|Overall Study|Randomized not Treated|1|||
161590128|NCT05034952|583550258|FG000|Overall Study|Adverse Event|1|||
161590129|NCT05034952|583550259|FG001|Overall Study|Adverse Event|0|||
161590130|NCT05034952|583550260|FG002|Overall Study|Adverse Event|0|||
161590131|NCT05034952|583550261|FG003|Overall Study|Adverse Event|0|||
161590132|NCT05034952|583550258|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161590133|NCT05034952|583550259|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161590134|NCT05034952|583550260|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
161590135|NCT05034952|583550261|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
161590136|NCT05034952|583550258|FG000|Overall Study|Lost to Follow-up|1|||
161590137|NCT05034952|583550259|FG001|Overall Study|Lost to Follow-up|4|||
161590138|NCT05034952|583550260|FG002|Overall Study|Lost to Follow-up|3|||
161590139|NCT05034952|583550261|FG003|Overall Study|Lost to Follow-up|3|||
161590140|NCT05034952|583550258|FG000|Overall Study|Other|0|||
161590141|NCT05034952|583550259|FG001|Overall Study|Other|0|||
161590142|NCT05034952|583550260|FG002|Overall Study|Other|0|||
161590143|NCT05034952|583550261|FG003|Overall Study|Other|1|||
161590144|NCT05273749|583550264|FG000|Overall Study|Adverse Event|14|||
161590145|NCT05273749|583550265|FG001|Overall Study|Adverse Event|8|||
161590146|NCT05273749|583550264|FG000|Overall Study|Lack of Efficacy|2|||
161590147|NCT05273749|583550265|FG001|Overall Study|Lack of Efficacy|8|||
161590148|NCT05273749|583550264|FG000|Overall Study|Physician Decision|0|||
161590149|NCT05273749|583550265|FG001|Overall Study|Physician Decision|2|||
161590150|NCT05273749|583550264|FG000|Overall Study|Withdrawal by Subject|14|||
161590151|NCT05273749|583550265|FG001|Overall Study|Withdrawal by Subject|16|||
161590152|NCT05273749|583550264|FG000|Overall Study|Lost to Follow-up|10|||
161590153|NCT05273749|583550265|FG001|Overall Study|Lost to Follow-up|10|||
161590154|NCT05273749|583550264|FG000|Overall Study|Pregnancy|1|||
161590155|NCT05273749|583550265|FG001|Overall Study|Pregnancy|0|||
161590156|NCT05273749|583550264|FG000|Overall Study|Non-Compliance|3|||
161590157|NCT05273749|583550265|FG001|Overall Study|Non-Compliance|2|||
161590158|NCT05273749|583550264|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
161590159|NCT05273749|583550265|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
161678049|NCT04667377|583873605|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
161590160|NCT02543281|583550274|FG000|Overall Study|Lost to Follow-up|0|||
161590161|NCT02543281|583550275|FG001|Overall Study|Lost to Follow-up|0|||
161590162|NCT02543281|583550276|FG002|Overall Study|Lost to Follow-up|1|||
161590163|NCT02530671|583550277|FG000|Overall Study|Lost to Follow-up|2|||
161678050|NCT04667377|583873601|FG000|Dose Escalation Period|Adverse Event|9|||
161590164|NCT02530671|583550278|FG001|Overall Study|Lost to Follow-up|0|||
161590165|NCT02530671|583550277|FG000|Overall Study|Withdrawal by Subject|1|||
161826559|NCT02576717|584405989|FG000|Overall Study|Lack of Efficacy|24|||
161826560|NCT02576717|584405990|FG001|Overall Study|Lack of Efficacy|28|||
161826561|NCT02576717|584405991|FG002|Overall Study|Lack of Efficacy|20|||
161826562|NCT02576717|584405989|FG000|Overall Study|Adverse Event|26|||
161826563|NCT02576717|584405990|FG001|Overall Study|Adverse Event|32|||
161826564|NCT02576717|584405991|FG002|Overall Study|Adverse Event|26|||
161826565|NCT00399893|584405992|FG000|Overall Study|Withdrawal by Subject|1|||
161826566|NCT00399893|584405993|FG001|Overall Study|Withdrawal by Subject|0|||
161826567|NCT00407745|584406005|FG000|Overall Study|Lack of Efficacy|1|||
161826568|NCT00407745|584406006|FG001|Overall Study|Lack of Efficacy|2|||
161826569|NCT00407745|584406005|FG000|Overall Study|Withdrawal by Subject|3|||
161826570|NCT00407745|584406006|FG001|Overall Study|Withdrawal by Subject|3|||
161826571|NCT00407745|584406005|FG000|Overall Study|Protocol Violation|5|||
161525529|NCT06111742|583312486|FG000|Overall Study|Withdrawal by Subject|2|||
161525530|NCT06111742|583312487|FG001|Overall Study|Withdrawal by Subject|0|||
161525531|NCT06111742|583312488|FG002|Overall Study|Withdrawal by Subject|0|||
161525532|NCT00922428|583312494|FG000|Overall Study|retrospective/extremely implausible data|2|||
161525533|NCT00922428|583312494|FG000|Overall Study|no medication use or questionable use|13|||
161525534|NCT03701555|583312496|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
161525535|NCT03701555|583312497|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
161525536|NCT03701555|583312498|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
161525537|NCT03701555|583312499|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
161525538|NCT03701555|583312500|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
161525539|NCT03701555|583312501|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
161525540|NCT03701555|583312502|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
161525541|NCT03701555|583312503|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
161525542|NCT03701555|583312504|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
161525543|NCT03701555|583312505|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
161525544|NCT03701555|583312506|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
161525545|NCT03701555|583312507|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
161525546|NCT03701555|583312508|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
161525547|NCT03701555|583312509|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
161525548|NCT03701555|583312510|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
161525549|NCT03701555|583312511|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
161525550|NCT03701555|583312512|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
161525551|NCT03701555|583312513|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
161525552|NCT03701555|583312514|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
161525553|NCT03701555|583312515|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
161525554|NCT03701555|583312516|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
161525555|NCT03701555|583312517|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
161525556|NCT03701555|583312518|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
161525557|NCT03701555|583312519|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
161525558|NCT03701555|583312520|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
161525559|NCT03701555|583312521|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
161525560|NCT03701555|583312522|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
161525561|NCT03701555|583312523|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
161525562|NCT03701555|583312524|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
161525563|NCT03701555|583312525|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
161525564|NCT03701555|583312526|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
161525565|NCT03701555|583312527|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
161525566|NCT03701555|583312528|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
161525567|NCT03701555|583312529|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
161525568|NCT03701555|583312530|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
161525569|NCT03701555|583312531|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
161525570|NCT03701555|583312496|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
161525571|NCT03701555|583312497|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
161525572|NCT03701555|583312498|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
161525573|NCT03701555|583312499|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
161525574|NCT03701555|583312500|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
161525575|NCT03701555|583312501|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
161525576|NCT03701555|583312502|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
161525577|NCT03701555|583312503|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
161525578|NCT03701555|583312504|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
161525579|NCT03701555|583312505|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
161525580|NCT03701555|583312506|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
161678051|NCT04667377|583873602|FG001|Dose Escalation Period|Adverse Event|10|||
161678052|NCT04667377|583873603|FG002|Dose Escalation Period|Adverse Event|12|||
161678053|NCT04667377|583873604|FG003|Dose Escalation Period|Adverse Event|17|||
161678054|NCT04667377|583873605|FG004|Dose Escalation Period|Adverse Event|3|||
161826572|NCT00407745|584406006|FG001|Overall Study|Protocol Violation|3|||
161826573|NCT00407745|584406005|FG000|Overall Study|Adverse Event|8|||
161826574|NCT00407745|584406006|FG001|Overall Study|Adverse Event|8|||
161826575|NCT00407745|584406005|FG000|Overall Study|Other|2|||
161826576|NCT00407745|584406006|FG001|Overall Study|Other|0|||
161826577|NCT00407745|584406005|FG000|Overall Study|Randomized, unknown if treated|0|||
161826578|NCT00407745|584406006|FG001|Overall Study|Randomized, unknown if treated|1|||
161826579|NCT02940730|584406009|FG000|Intervention 2|Physician Decision|7|||
161826580|NCT02940730|584406010|FG001|Intervention 2|Physician Decision|0|||
161826581|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
161826582|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
161826583|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
161826584|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
161826585|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
161525581|NCT03701555|583312507|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
161525582|NCT03701555|583312508|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
161525583|NCT03701555|583312509|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
161525584|NCT03701555|583312510|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
161525585|NCT03701555|583312511|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
161525586|NCT03701555|583312512|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
161525587|NCT03701555|583312513|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
161525588|NCT03701555|583312514|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
161525589|NCT03701555|583312515|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
161525590|NCT03701555|583312516|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
161525591|NCT03701555|583312517|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
161525592|NCT03701555|583312518|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
161525593|NCT03701555|583312519|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
161826586|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
161826587|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
161826588|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
161826589|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
161826590|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161826591|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161826592|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161826593|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
161826594|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
161826595|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
161826596|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
161826597|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161826598|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161826599|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
161826600|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161826601|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
161826602|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
161826603|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
161826604|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
161826605|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
161826606|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
161826607|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
161826608|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
161826609|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161826610|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161826611|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
161826612|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161826613|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161826614|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161826615|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
161826616|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161826617|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
161826618|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
161826619|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
161826620|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
161826621|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
161826622|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
161826623|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
161826624|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
161826625|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
161826626|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
161826627|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
161826628|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
161826629|NCT01522950|584406015|FG000|Overall Study|Withdrawal by Subject|3|||
161826630|NCT01522950|584406016|FG001|Overall Study|Withdrawal by Subject|2|||
161826631|NCT01522950|584406017|FG002|Overall Study|Withdrawal by Subject|1|||
161826632|NCT01522950|584406015|FG000|Overall Study|Adverse Event|3|||
161826633|NCT01522950|584406016|FG001|Overall Study|Adverse Event|1|||
161826634|NCT01522950|584406017|FG002|Overall Study|Adverse Event|1|||
161826635|NCT01522950|584406015|FG000|Overall Study|Protocol Violation|0|||
161826636|NCT01522950|584406016|FG001|Overall Study|Protocol Violation|0|||
161826637|NCT01522950|584406017|FG002|Overall Study|Protocol Violation|2|||
161935528|NCT04987307|584813912|FG002|Overall Study|Decision by sponsor|11|||
161935529|NCT04987307|584813913|FG003|Overall Study|Decision by sponsor|9|||
161935530|NCT04987307|584813910|FG000|Overall Study|Lost to Follow-up|1|||
161935531|NCT04987307|584813911|FG001|Overall Study|Lost to Follow-up|0|||
161826638|NCT01522950|584406015|FG000|Overall Study|Death|0|||
161826639|NCT01522950|584406016|FG001|Overall Study|Death|1|||
161826640|NCT01522950|584406017|FG002|Overall Study|Death|1|||
161826641|NCT01522950|584406015|FG000|Overall Study|Study Medication Sensitivity|0|||
161826642|NCT01522950|584406016|FG001|Overall Study|Study Medication Sensitivity|1|||
161826643|NCT01522950|584406017|FG002|Overall Study|Study Medication Sensitivity|0|||
161826644|NCT01064531|584406023|FG000|Overall Study|Lost to Follow-up|0|||
161826645|NCT01064531|584406024|FG001|Overall Study|Lost to Follow-up|2|||
161826646|NCT01064531|584406023|FG000|Overall Study|Physician Decision|0|||
161826647|NCT01064531|584406024|FG001|Overall Study|Physician Decision|1|||
161826648|NCT01064531|584406023|FG000|Overall Study|Withdrawal by Subject|2|||
161826649|NCT01064531|584406024|FG001|Overall Study|Withdrawal by Subject|2|||
161826650|NCT01064531|584406023|FG000|Overall Study|Revision due to femoral stem loosening|1|||
161826651|NCT01064531|584406024|FG001|Overall Study|Revision due to femoral stem loosening|0|||
161826652|NCT01064531|584406023|FG000|Overall Study|Revision due to dislocation|0|||
161826653|NCT01064531|584406024|FG001|Overall Study|Revision due to dislocation|1|||
161826654|NCT01064531|584406023|FG000|Overall Study|Death|0|||
161826655|NCT01064531|584406024|FG001|Overall Study|Death|1|||
161826656|NCT03449199|584406028|FG000|Overall Study|Lost to Follow-up|1|||
161826657|NCT03449199|584406029|FG001|Overall Study|Lost to Follow-up|1|||
161826658|NCT03449199|584406030|FG002|Overall Study|Lost to Follow-up|0|||
161826659|NCT03449199|584406028|FG000|Overall Study|Protocol Deviation|0|||
161826660|NCT03449199|584406029|FG001|Overall Study|Protocol Deviation|0|||
161826661|NCT03449199|584406030|FG002|Overall Study|Protocol Deviation|1|||
161826662|NCT03449199|584406028|FG000|Overall Study|Withdrawal by Subject|0|||
161826663|NCT03449199|584406029|FG001|Overall Study|Withdrawal by Subject|0|||
161826664|NCT03449199|584406030|FG002|Overall Study|Withdrawal by Subject|1|||
161826665|NCT03136406|584406031|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
161826666|NCT01201759|584406032|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
161826667|NCT01201759|584406033|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
161826668|NCT01201759|584406032|FG000|Visit 3 - Washout|Adverse Event|0|||
161826669|NCT01201759|584406033|FG001|Visit 3 - Washout|Adverse Event|3|||
161826670|NCT01201759|584406032|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
161826671|NCT01201759|584406033|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
161826672|NCT01201759|584406032|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
161826673|NCT01201759|584406033|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
161826674|NCT00906373|584406034|FG000|Overall Study|Withdrawal by Subject|0|||
161826675|NCT00906373|584406035|FG001|Overall Study|Withdrawal by Subject|5|||
161826676|NCT00906373|584406034|FG000|Overall Study|Other|0|||
161826677|NCT00906373|584406035|FG001|Overall Study|Other|1|||
161826678|NCT00906373|584406034|FG000|Overall Study|Still on treatment at cutoff date|0|||
161590166|NCT02530671|583550278|FG001|Overall Study|Withdrawal by Subject|0|||
161826679|NCT00906373|584406035|FG001|Overall Study|Still on treatment at cutoff date|2|||
161590167|NCT05247489|583550279|FG000|Overall Study|Lost to Follow-up|5|||
161590168|NCT05247489|583550280|FG001|Overall Study|Lost to Follow-up|1|||
161590169|NCT05247489|583550279|FG000|Overall Study|Withdrawal by Subject|6|||
161590170|NCT05247489|583550280|FG001|Overall Study|Withdrawal by Subject|7|||
161590171|NCT05247489|583550279|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
161590172|NCT05247489|583550280|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
161590173|NCT05247489|583550279|FG000|Overall Study|Left Country|1|||
161590174|NCT05247489|583550280|FG001|Overall Study|Left Country|0|||
161590175|NCT05247489|583550279|FG000|Overall Study|Noncompliance with Investigational Product|1|||
161590176|NCT05247489|583550280|FG001|Overall Study|Noncompliance with Investigational Product|0|||
161590177|NCT05247489|583550279|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
161590178|NCT05247489|583550280|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
161590179|NCT03126019|583550281|FG000|Overall Study|Death|5|||
161590180|NCT03126019|583550282|FG001|Overall Study|Death|27|||
161590181|NCT03126019|583550281|FG000|Overall Study|Lost to Follow-up|2|||
161826680|NCT00848042|584406036|FG000|Overall Study|Death|1|||
161826681|NCT00848042|584406037|FG001|Overall Study|Death|2|||
161826682|NCT00848042|584406038|FG002|Overall Study|Death|0|||
161826683|NCT00848042|584406036|FG000|Overall Study|Other Therapy|3|||
161826684|NCT00848042|584406037|FG001|Overall Study|Other Therapy|0|||
161826685|NCT00848042|584406038|FG002|Overall Study|Other Therapy|0|||
161826686|NCT01652729|584406039|FG000|Overall Study|Withdrawal by Subject|14|||
161826687|NCT01652729|584406040|FG001|Overall Study|Withdrawal by Subject|7|||
161826688|NCT01652729|584406041|FG002|Overall Study|Withdrawal by Subject|7|||
161826689|NCT01652729|584406039|FG000|Overall Study|Adverse Event|4|||
161826690|NCT01652729|584406040|FG001|Overall Study|Adverse Event|0|||
161826691|NCT01652729|584406041|FG002|Overall Study|Adverse Event|3|||
161826692|NCT01652729|584406039|FG000|Overall Study|Physician Decision|1|||
161826693|NCT01652729|584406040|FG001|Overall Study|Physician Decision|0|||
161826694|NCT01652729|584406041|FG002|Overall Study|Physician Decision|1|||
161826695|NCT01652729|584406039|FG000|Overall Study|Protocol Violation|1|||
161826696|NCT01652729|584406040|FG001|Overall Study|Protocol Violation|0|||
161826697|NCT01652729|584406041|FG002|Overall Study|Protocol Violation|0|||
161590182|NCT03126019|583550282|FG001|Overall Study|Lost to Follow-up|4|||
161525594|NCT03701555|583312520|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
161525595|NCT03701555|583312521|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
161525596|NCT03701555|583312522|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
161525597|NCT03701555|583312523|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
161525598|NCT03701555|583312524|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
161525599|NCT03701555|583312525|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
161525600|NCT03701555|583312526|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
161525601|NCT03701555|583312527|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
161525602|NCT03701555|583312528|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
161525603|NCT03701555|583312529|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
161525604|NCT03701555|583312530|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
161525605|NCT03701555|583312531|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
161525606|NCT03701555|583312496|FG000|Part 2 (Day 1)|Other|0|||
161525607|NCT03701555|583312497|FG001|Part 2 (Day 1)|Other|0|||
161525608|NCT03701555|583312498|FG002|Part 2 (Day 1)|Other|0|||
161525609|NCT03701555|583312499|FG003|Part 2 (Day 1)|Other|0|||
161525610|NCT03701555|583312500|FG004|Part 2 (Day 1)|Other|0|||
161525611|NCT03701555|583312501|FG005|Part 2 (Day 1)|Other|0|||
161525612|NCT03701555|583312502|FG006|Part 2 (Day 1)|Other|0|||
161525613|NCT03701555|583312503|FG007|Part 2 (Day 1)|Other|0|||
161525614|NCT03701555|583312504|FG008|Part 2 (Day 1)|Other|0|||
161826698|NCT01652729|584406039|FG000|Overall Study|Lost to Follow-up|6|||
161826699|NCT01652729|584406040|FG001|Overall Study|Lost to Follow-up|6|||
161525615|NCT03701555|583312505|FG009|Part 2 (Day 1)|Other|0|||
161678055|NCT04667377|583873601|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
161826700|NCT01652729|584406041|FG002|Overall Study|Lost to Follow-up|3|||
161826701|NCT01652729|584406039|FG000|Overall Study|Administrative|1|||
161826702|NCT01652729|584406040|FG001|Overall Study|Administrative|0|||
161826703|NCT01652729|584406041|FG002|Overall Study|Administrative|0|||
161826704|NCT00483548|584406042|FG000|Overall Study|Randomized; not treated with study drug|1|||
161525616|NCT03701555|583312506|FG010|Part 2 (Day 1)|Other|3|||
161525617|NCT03701555|583312507|FG011|Part 2 (Day 1)|Other|1|||
161525618|NCT03701555|583312508|FG012|Part 2 (Day 1)|Other|0|||
161525619|NCT03701555|583312509|FG013|Part 2 (Day 1)|Other|1|||
161826705|NCT00483548|584406043|FG001|Overall Study|Randomized; not treated with study drug|3|||
161826706|NCT00483548|584406042|FG000|Overall Study|Adverse Event|25|||
161826707|NCT00483548|584406043|FG001|Overall Study|Adverse Event|14|||
161826708|NCT00483548|584406042|FG000|Overall Study|Laboratory abnormality|1|||
161826709|NCT00483548|584406043|FG001|Overall Study|Laboratory abnormality|2|||
161826710|NCT00483548|584406042|FG000|Overall Study|Lack of Efficacy|4|||
161826711|NCT00483548|584406043|FG001|Overall Study|Lack of Efficacy|8|||
161826712|NCT00483548|584406042|FG000|Overall Study|Protocol Violation|11|||
161826713|NCT00483548|584406043|FG001|Overall Study|Protocol Violation|7|||
161826714|NCT00483548|584406042|FG000|Overall Study|Pregnancy|1|||
161826715|NCT00483548|584406043|FG001|Overall Study|Pregnancy|0|||
161826716|NCT00483548|584406042|FG000|Overall Study|Protocol required discontinuation|6|||
161826717|NCT00483548|584406043|FG001|Overall Study|Protocol required discontinuation|6|||
161826718|NCT00483548|584406042|FG000|Overall Study|Unable to comply with protocol schedule|1|||
161826719|NCT00483548|584406043|FG001|Overall Study|Unable to comply with protocol schedule|0|||
161826720|NCT00483548|584406042|FG000|Overall Study|Non-compliance with medication|2|||
161826721|NCT00483548|584406043|FG001|Overall Study|Non-compliance with medication|0|||
161826722|NCT00483548|584406042|FG000|Overall Study|Lost to Follow-up|3|||
161826723|NCT00483548|584406043|FG001|Overall Study|Lost to Follow-up|4|||
161826724|NCT00483548|584406042|FG000|Overall Study|Withdrawal by Subject|5|||
161826725|NCT00483548|584406043|FG001|Overall Study|Withdrawal by Subject|2|||
161826726|NCT04364737|584406047|FG000|Overall Study|Withdrawal by Subject|4|||
161826727|NCT04364737|584406048|FG001|Overall Study|Withdrawal by Subject|9|||
161826728|NCT04364737|584406047|FG000|Overall Study|Lost to Follow-up|1|||
161826729|NCT04364737|584406048|FG001|Overall Study|Lost to Follow-up|1|||
161826730|NCT01220609|584406049|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
161826731|NCT01220609|584406049|FG000|Overall Study|Ineligible- Wrong cell type|1|||
161826732|NCT01220609|584406049|FG000|Overall Study|Ineligible-Never treated|1|||
161826733|NCT00112294|584406050|FG000|Overall Study|Still on study|5|||
161826734|NCT00112294|584406051|FG001|Overall Study|Still on study|0|||
161826735|NCT05070754|584406061|FG000|Overall Study|Withdrawal by Subject|0|||
161826736|NCT05070754|584406062|FG001|Overall Study|Withdrawal by Subject|0|||
161826737|NCT05070754|584406063|FG002|Overall Study|Withdrawal by Subject|0|||
161826738|NCT05070754|584406064|FG003|Overall Study|Withdrawal by Subject|1|||
161826739|NCT05070754|584406061|FG000|Overall Study|Protocol Violation|0|||
161826740|NCT05070754|584406062|FG001|Overall Study|Protocol Violation|0|||
161826741|NCT05070754|584406063|FG002|Overall Study|Protocol Violation|0|||
161826742|NCT05070754|584406064|FG003|Overall Study|Protocol Violation|1|||
161826743|NCT01398787|584406065|FG000|Overall Study|Adverse Event|1|||
161826744|NCT00529217|584406068|FG000|Overall Study|Lack of Efficacy|2|||
161826745|NCT00529217|584406068|FG000|Overall Study|Unable to adhere to study schedule|2|||
161826746|NCT00372996|584406071|FG000|Overall Study|Death|11|||
161826747|NCT00372996|584406072|FG001|Overall Study|Death|4|||
161935532|NCT04987307|584813912|FG002|Overall Study|Lost to Follow-up|0|||
161935533|NCT04987307|584813913|FG003|Overall Study|Lost to Follow-up|0|||
161935534|NCT04562480|584813914|FG000|Overall Study|Withdrawal by Subject|1|||
161935535|NCT05369208|584813915|FG000|Core Phase|Prohibited Medication Required|2|||
161935536|NCT05369208|584813915|FG000|Core Phase|Adverse Event|1|||
161935537|NCT05369208|584813915|FG000|Core Phase|Lack of Efficacy|1|||
161935538|NCT03031912|584813917|FG000|Overall Study|Lost to Follow-up|1|||
161935539|NCT03031912|584813918|FG001|Overall Study|Lost to Follow-up|1|||
161935540|NCT03031912|584813919|FG002|Overall Study|Lost to Follow-up|0|||
161935541|NCT03031912|584813920|FG003|Overall Study|Lost to Follow-up|1|||
161935542|NCT03031912|584813921|FG004|Overall Study|Lost to Follow-up|0|||
161935543|NCT03031912|584813922|FG005|Overall Study|Lost to Follow-up|0|||
161935544|NCT03031912|584813923|FG006|Overall Study|Lost to Follow-up|0|||
161935545|NCT03031912|584813924|FG007|Overall Study|Lost to Follow-up|0|||
161935546|NCT03031912|584813925|FG008|Overall Study|Lost to Follow-up|0|||
161935547|NCT03031912|584813926|FG009|Overall Study|Lost to Follow-up|0|||
161935548|NCT02805725|584813927|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
161935549|NCT02805725|584813928|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
161935550|NCT02805725|584813929|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
161935551|NCT02805725|584813930|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
161935552|NCT02805725|584813931|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
161935553|NCT02805725|584813927|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
161525620|NCT03701555|583312510|FG014|Part 2 (Day 1)|Other|0|||
161525621|NCT03701555|583312511|FG015|Part 2 (Day 1)|Other|2|||
161525622|NCT03701555|583312512|FG016|Part 2 (Day 1)|Other|2|||
161935554|NCT02805725|584813928|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
161935555|NCT02805725|584813929|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
161935556|NCT02805725|584813930|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
161935557|NCT02805725|584813931|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
161935558|NCT02805725|584813927|FG000|Phase II|Protocol Violation|0|||
161935559|NCT02805725|584813928|FG001|Phase II|Protocol Violation|0|||
161935560|NCT02805725|584813929|FG002|Phase II|Protocol Violation|0|||
161525623|NCT03701555|583312513|FG017|Part 2 (Day 1)|Other|0|||
161525624|NCT03701555|583312514|FG018|Part 2 (Day 1)|Other|0|||
161525625|NCT03701555|583312515|FG019|Part 2 (Day 1)|Other|0|||
161525626|NCT03701555|583312516|FG020|Part 2 (Day 1)|Other|0|||
161525627|NCT03701555|583312517|FG021|Part 2 (Day 1)|Other|0|||
161525628|NCT03701555|583312518|FG022|Part 2 (Day 1)|Other|0|||
161525629|NCT03701555|583312519|FG023|Part 2 (Day 1)|Other|0|||
161525630|NCT03701555|583312520|FG024|Part 2 (Day 1)|Other|0|||
161525631|NCT03701555|583312521|FG025|Part 2 (Day 1)|Other|0|||
161525632|NCT03701555|583312522|FG026|Part 2 (Day 1)|Other|0|||
161525633|NCT03701555|583312523|FG027|Part 2 (Day 1)|Other|0|||
161525634|NCT03701555|583312524|FG028|Part 2 (Day 1)|Other|0|||
161525635|NCT03701555|583312525|FG029|Part 2 (Day 1)|Other|0|||
161525636|NCT03701555|583312526|FG030|Part 2 (Day 1)|Other|0|||
161525637|NCT03701555|583312527|FG031|Part 2 (Day 1)|Other|0|||
161525638|NCT03701555|583312528|FG032|Part 2 (Day 1)|Other|0|||
161525639|NCT03701555|583312529|FG033|Part 2 (Day 1)|Other|0|||
161525640|NCT03701555|583312530|FG034|Part 2 (Day 1)|Other|0|||
161525641|NCT03701555|583312531|FG035|Part 2 (Day 1)|Other|0|||
161525642|NCT03701555|583312496|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
161525643|NCT03701555|583312497|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
161525644|NCT03701555|583312498|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
161525645|NCT03701555|583312499|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
161525646|NCT03701555|583312500|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
161525647|NCT03701555|583312501|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
161525648|NCT03701555|583312502|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
161525649|NCT03701555|583312503|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
161525650|NCT03701555|583312504|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
161525651|NCT03701555|583312505|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
161525652|NCT03701555|583312506|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
161525653|NCT03701555|583312507|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
161525654|NCT03701555|583312508|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
161525655|NCT03701555|583312509|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
161935561|NCT02805725|584813930|FG003|Phase II|Protocol Violation|0|||
161935562|NCT02805725|584813931|FG004|Phase II|Protocol Violation|6|||
161935563|NCT03650400|584813934|FG000|Overall Study|Study terminated by sponsor|0|||
161525656|NCT03701555|583312510|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
161525657|NCT03701555|583312511|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
161525658|NCT03701555|583312512|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
161525659|NCT03701555|583312513|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
161935564|NCT03650400|584813935|FG001|Overall Study|Study terminated by sponsor|5|||
161935565|NCT04097743|584813938|FG000|Overall Study|Non-compliance of the study instruction.|1|||
161935566|NCT04097743|584813939|FG001|Overall Study|Non-compliance of the study instruction.|0|||
161525660|NCT03701555|583312514|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
161525661|NCT03701555|583312515|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
161935567|NCT06024096|584813948|FG000|Overall Study|Lost to Follow-up|2|||
161935568|NCT06024096|584813949|FG001|Overall Study|Lost to Follow-up|5|||
161935569|NCT06024096|584813948|FG000|Overall Study|Physician Decision|0|||
161935570|NCT06024096|584813949|FG001|Overall Study|Physician Decision|1|||
161935571|NCT06024096|584813948|FG000|Overall Study|Withdrawal by Subject|2|||
161935572|NCT06024096|584813949|FG001|Overall Study|Withdrawal by Subject|3|||
161935573|NCT05541861|584813950|FG000|Overall Study|Withdrawal by Subject|0|||
161935574|NCT05541861|584813951|FG001|Overall Study|Withdrawal by Subject|0|||
161935575|NCT05541861|584813952|FG002|Overall Study|Withdrawal by Subject|0|||
161935576|NCT05541861|584813953|FG003|Overall Study|Withdrawal by Subject|0|||
161935577|NCT05541861|584813954|FG004|Overall Study|Withdrawal by Subject|0|||
161935578|NCT05541861|584813955|FG005|Overall Study|Withdrawal by Subject|0|||
161935579|NCT05541861|584813956|FG006|Overall Study|Withdrawal by Subject|2|||
161935580|NCT05541861|584813957|FG007|Overall Study|Withdrawal by Subject|0|||
161935581|NCT05541861|584813958|FG008|Overall Study|Withdrawal by Subject|0|||
161935582|NCT05541861|584813950|FG000|Overall Study|Randomized but not dosed|0|||
161935583|NCT05541861|584813951|FG001|Overall Study|Randomized but not dosed|1|||
161935584|NCT05541861|584813952|FG002|Overall Study|Randomized but not dosed|1|||
161935585|NCT05541861|584813953|FG003|Overall Study|Randomized but not dosed|0|||
161935586|NCT05541861|584813954|FG004|Overall Study|Randomized but not dosed|0|||
161590183|NCT03126019|583550281|FG000|Overall Study|Withdrawal by Subject|1|||
161590184|NCT03126019|583550282|FG001|Overall Study|Withdrawal by Subject|9|||
161590185|NCT03126019|583550281|FG000|Overall Study|Physician Decision|1|||
161590186|NCT03126019|583550282|FG001|Overall Study|Physician Decision|0|||
161590187|NCT03126019|583550281|FG000|Overall Study|Transitioned to Rollover Study|0|||
161590188|NCT03126019|583550282|FG001|Overall Study|Transitioned to Rollover Study|11|||
161590189|NCT03126019|583550281|FG000|Overall Study|Did Not Return to Site for Care|0|||
161590190|NCT03126019|583550282|FG001|Overall Study|Did Not Return to Site for Care|1|||
161590191|NCT03126019|583550281|FG000|Overall Study|Site Closed|0|||
161590192|NCT03126019|583550282|FG001|Overall Study|Site Closed|1|||
161590193|NCT00170573|583550286|FG000|Overall Study|Violation of inclusion criteria|13|||
161590194|NCT05563246|583550321|FG000|Overall Study|Withdrawal by Subject|1|||
161590195|NCT05563246|583550322|FG001|Overall Study|Withdrawal by Subject|2|||
161590196|NCT05563246|583550323|FG002|Overall Study|Withdrawal by Subject|0|||
161590197|NCT05563246|583550324|FG003|Overall Study|Withdrawal by Subject|0|||
161590198|NCT05563246|583550321|FG000|Overall Study|Protocol Deviation|0|||
161590199|NCT05563246|583550322|FG001|Overall Study|Protocol Deviation|1|||
161590200|NCT05563246|583550323|FG002|Overall Study|Protocol Deviation|0|||
161590201|NCT05563246|583550324|FG003|Overall Study|Protocol Deviation|0|||
161590202|NCT05563246|583550321|FG000|Overall Study|Physician Decision|0|||
161590203|NCT05563246|583550322|FG001|Overall Study|Physician Decision|1|||
161590204|NCT05563246|583550323|FG002|Overall Study|Physician Decision|0|||
161590205|NCT05563246|583550324|FG003|Overall Study|Physician Decision|0|||
161590206|NCT05563246|583550321|FG000|Overall Study|Adverse Event|0|||
161590207|NCT05563246|583550322|FG001|Overall Study|Adverse Event|0|||
161590208|NCT05563246|583550323|FG002|Overall Study|Adverse Event|2|||
161590209|NCT05563246|583550324|FG003|Overall Study|Adverse Event|0|||
161590210|NCT05563246|583550321|FG000|Overall Study|Lost to Follow-up|0|||
161590211|NCT05563246|583550322|FG001|Overall Study|Lost to Follow-up|0|||
161590212|NCT05563246|583550323|FG002|Overall Study|Lost to Follow-up|1|||
161590213|NCT05563246|583550324|FG003|Overall Study|Lost to Follow-up|0|||
161590214|NCT03332017|583550326|FG000|Overall Study|Lost to Follow-up|1|||
161590215|NCT03332017|583550327|FG001|Overall Study|Lost to Follow-up|2|||
161590216|NCT03332017|583550326|FG000|Overall Study|Death|17|||
161590217|NCT03332017|583550327|FG001|Overall Study|Death|16|||
161590218|NCT03332017|583550326|FG000|Overall Study|Withdrawal by Subject|6|||
161590219|NCT03332017|583550327|FG001|Overall Study|Withdrawal by Subject|14|||
161590220|NCT03332017|583550326|FG000|Overall Study|Other|1|||
161590221|NCT03332017|583550327|FG001|Overall Study|Other|3|||
161590222|NCT03332017|583550326|FG000|Overall Study|Remained in Study (Ongoing)|47|||
161590223|NCT03332017|583550327|FG001|Overall Study|Remained in Study (Ongoing)|110|||
161590224|NCT01580488|583550331|FG000|Overall Study|Withdrawal by Subject|1|||
161590225|NCT02243709|583550337|FG000|Phase 1|Lost to Follow-up|0|||
161590226|NCT02243709|583550338|FG001|Phase 1|Lost to Follow-up|1|||
161590227|NCT02243709|583550337|FG000|Phase 1|Withdrawal by Subject|1|||
161590228|NCT02243709|583550338|FG001|Phase 1|Withdrawal by Subject|0|||
161590229|NCT02243709|583550337|FG000|Phase 1|Protocol Violation|0|||
161590230|NCT02243709|583550338|FG001|Phase 1|Protocol Violation|1|||
161590231|NCT02243709|583550337|FG000|Phase 1|Adverse Event|0|||
161590232|NCT02243709|583550338|FG001|Phase 1|Adverse Event|1|||
161590233|NCT01748448|583550339|FG000|Treatment Period|Consent withdrawn by subject|1|||
161590234|NCT01748448|583550340|FG001|Treatment Period|Consent withdrawn by subject|0|||
161590235|NCT01748448|583550339|FG000|Treatment Period|Adverse Event|1|||
161935587|NCT05541861|584813955|FG005|Overall Study|Randomized but not dosed|0|||
161935588|NCT05541861|584813956|FG006|Overall Study|Randomized but not dosed|1|||
161935589|NCT05541861|584813957|FG007|Overall Study|Randomized but not dosed|0|||
161935590|NCT05541861|584813958|FG008|Overall Study|Randomized but not dosed|1|||
161935591|NCT05441670|584813959|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
161590236|NCT01748448|583550340|FG001|Treatment Period|Adverse Event|0|||
161935592|NCT05441670|584813960|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
161935593|NCT04452877|584813967|FG000|Overall Study|Adverse Event|5|||
161935594|NCT04452877|584813967|FG000|Overall Study|Lost to Follow-up|1|||
161935595|NCT04452877|584813967|FG000|Overall Study|Physician Decision|4|||
161935596|NCT04452877|584813967|FG000|Overall Study|Progressive Disease|18|||
161935597|NCT04452877|584813967|FG000|Overall Study|Withdrawal by Subject|3|||
161935598|NCT04001829|584813970|FG000|Overall Study|Never start protocol therapy|5|||
161935599|NCT04001829|584813971|FG001|Overall Study|Never start protocol therapy|5|||
161935600|NCT04001829|584813970|FG000|Overall Study|Adverse Event|11|||
161935601|NCT04001829|584813971|FG001|Overall Study|Adverse Event|7|||
161935602|NCT04001829|584813970|FG000|Overall Study|Alternative therapy|1|||
161525662|NCT03701555|583312516|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
161525663|NCT03701555|583312517|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
161525664|NCT03701555|583312518|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
161525665|NCT03701555|583312519|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
161525666|NCT03701555|583312520|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
161525667|NCT03701555|583312521|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
161525668|NCT03701555|583312522|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
161525669|NCT03701555|583312523|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
161525670|NCT03701555|583312524|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
161525671|NCT03701555|583312525|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
161525672|NCT03701555|583312526|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
161525673|NCT03701555|583312527|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
161525674|NCT03701555|583312528|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
161525675|NCT03701555|583312529|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
161525676|NCT03701555|583312530|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
161525677|NCT03701555|583312531|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
161525678|NCT03701555|583312496|FG000|Part 3 (Day 1)|Subject Decision|0|||
161525679|NCT03701555|583312497|FG001|Part 3 (Day 1)|Subject Decision|0|||
161525680|NCT03701555|583312498|FG002|Part 3 (Day 1)|Subject Decision|0|||
161525681|NCT03701555|583312499|FG003|Part 3 (Day 1)|Subject Decision|0|||
161525682|NCT03701555|583312500|FG004|Part 3 (Day 1)|Subject Decision|0|||
161525683|NCT03701555|583312501|FG005|Part 3 (Day 1)|Subject Decision|0|||
161525684|NCT03701555|583312502|FG006|Part 3 (Day 1)|Subject Decision|0|||
161525685|NCT03701555|583312503|FG007|Part 3 (Day 1)|Subject Decision|0|||
161525686|NCT03701555|583312504|FG008|Part 3 (Day 1)|Subject Decision|0|||
161525687|NCT03701555|583312505|FG009|Part 3 (Day 1)|Subject Decision|0|||
161525688|NCT03701555|583312506|FG010|Part 3 (Day 1)|Subject Decision|0|||
161525689|NCT03701555|583312507|FG011|Part 3 (Day 1)|Subject Decision|0|||
161525690|NCT03701555|583312508|FG012|Part 3 (Day 1)|Subject Decision|0|||
161525691|NCT03701555|583312509|FG013|Part 3 (Day 1)|Subject Decision|0|||
161525692|NCT03701555|583312510|FG014|Part 3 (Day 1)|Subject Decision|0|||
161525693|NCT03701555|583312511|FG015|Part 3 (Day 1)|Subject Decision|0|||
161525694|NCT03701555|583312512|FG016|Part 3 (Day 1)|Subject Decision|0|||
161525695|NCT03701555|583312513|FG017|Part 3 (Day 1)|Subject Decision|0|||
161525696|NCT03701555|583312514|FG018|Part 3 (Day 1)|Subject Decision|0|||
161525697|NCT03701555|583312515|FG019|Part 3 (Day 1)|Subject Decision|0|||
161525698|NCT03701555|583312516|FG020|Part 3 (Day 1)|Subject Decision|0|||
161525699|NCT03701555|583312517|FG021|Part 3 (Day 1)|Subject Decision|0|||
161525700|NCT03701555|583312518|FG022|Part 3 (Day 1)|Subject Decision|0|||
161525701|NCT03701555|583312519|FG023|Part 3 (Day 1)|Subject Decision|0|||
161525702|NCT03701555|583312520|FG024|Part 3 (Day 1)|Subject Decision|0|||
161525703|NCT03701555|583312521|FG025|Part 3 (Day 1)|Subject Decision|0|||
161525704|NCT03701555|583312522|FG026|Part 3 (Day 1)|Subject Decision|1|||
161525705|NCT03701555|583312523|FG027|Part 3 (Day 1)|Subject Decision|0|||
161525706|NCT03701555|583312524|FG028|Part 3 (Day 1)|Subject Decision|0|||
161525707|NCT03701555|583312525|FG029|Part 3 (Day 1)|Subject Decision|0|||
161525708|NCT03701555|583312526|FG030|Part 3 (Day 1)|Subject Decision|0|||
161525709|NCT03701555|583312527|FG031|Part 3 (Day 1)|Subject Decision|2|||
161525710|NCT03701555|583312528|FG032|Part 3 (Day 1)|Subject Decision|1|||
161525711|NCT03701555|583312529|FG033|Part 3 (Day 1)|Subject Decision|1|||
161525712|NCT03701555|583312530|FG034|Part 3 (Day 1)|Subject Decision|0|||
161525713|NCT03701555|583312531|FG035|Part 3 (Day 1)|Subject Decision|0|||
161525714|NCT03701555|583312496|FG000|Part 3 (Day 1)|Other|0|||
161525715|NCT03701555|583312497|FG001|Part 3 (Day 1)|Other|0|||
161525716|NCT03701555|583312498|FG002|Part 3 (Day 1)|Other|0|||
161525717|NCT03701555|583312499|FG003|Part 3 (Day 1)|Other|0|||
161525718|NCT03701555|583312500|FG004|Part 3 (Day 1)|Other|0|||
161525719|NCT03701555|583312501|FG005|Part 3 (Day 1)|Other|0|||
161525720|NCT03701555|583312502|FG006|Part 3 (Day 1)|Other|0|||
161525721|NCT03701555|583312503|FG007|Part 3 (Day 1)|Other|0|||
161935603|NCT04001829|584813971|FG001|Overall Study|Alternative therapy|2|||
161935604|NCT04001829|584813970|FG000|Overall Study|Disease progression/relapse|2|||
161935605|NCT04001829|584813971|FG001|Overall Study|Disease progression/relapse|1|||
161525722|NCT03701555|583312504|FG008|Part 3 (Day 1)|Other|0|||
161525723|NCT03701555|583312505|FG009|Part 3 (Day 1)|Other|0|||
161525724|NCT03701555|583312506|FG010|Part 3 (Day 1)|Other|0|||
161935606|NCT04001829|584813970|FG000|Overall Study|Other complicating disease|1|||
161935607|NCT04001829|584813971|FG001|Overall Study|Other complicating disease|0|||
161935608|NCT04001829|584813970|FG000|Overall Study|Withdrawal by Subject|1|||
161935609|NCT04001829|584813971|FG001|Overall Study|Withdrawal by Subject|4|||
161935610|NCT04001829|584813970|FG000|Overall Study|Ineligible|2|||
161935611|NCT04001829|584813971|FG001|Overall Study|Ineligible|2|||
161935612|NCT04001829|584813970|FG000|Overall Study|Reason missing due to delinquent data|1|||
161935613|NCT04001829|584813971|FG001|Overall Study|Reason missing due to delinquent data|0|||
161935614|NCT05678959|584813972|FG000|Overall Study|Study Terminated by Sponsor|76|||
161935615|NCT05678959|584813973|FG001|Overall Study|Study Terminated by Sponsor|76|||
161935616|NCT05678959|584813972|FG000|Overall Study|Physician Decision|2|||
161935617|NCT05678959|584813973|FG001|Overall Study|Physician Decision|3|||
161935618|NCT05678959|584813972|FG000|Overall Study|Adverse Event|1|||
161935619|NCT05678959|584813973|FG001|Overall Study|Adverse Event|1|||
161935620|NCT05678959|584813972|FG000|Overall Study|Guardian Decision|1|||
161935621|NCT05678959|584813973|FG001|Overall Study|Guardian Decision|0|||
161935622|NCT05678959|584813972|FG000|Overall Study|Protocol Deviation|0|||
161935623|NCT05678959|584813973|FG001|Overall Study|Protocol Deviation|1|||
161935624|NCT05678959|584813972|FG000|Overall Study|Subject Decision|1|||
161935625|NCT05678959|584813973|FG001|Overall Study|Subject Decision|0|||
161525725|NCT03701555|583312507|FG011|Part 3 (Day 1)|Other|0|||
161525726|NCT03701555|583312508|FG012|Part 3 (Day 1)|Other|0|||
161525727|NCT03701555|583312509|FG013|Part 3 (Day 1)|Other|0|||
161525728|NCT03701555|583312510|FG014|Part 3 (Day 1)|Other|0|||
161525729|NCT03701555|583312511|FG015|Part 3 (Day 1)|Other|0|||
161525730|NCT03701555|583312512|FG016|Part 3 (Day 1)|Other|0|||
161525731|NCT03701555|583312513|FG017|Part 3 (Day 1)|Other|0|||
161525732|NCT03701555|583312514|FG018|Part 3 (Day 1)|Other|0|||
161826748|NCT00372996|584406073|FG002|Overall Study|Death|8|||
161826749|NCT00372996|584406074|FG003|Overall Study|Death|7|||
161826750|NCT00372996|584406071|FG000|Overall Study|Lost to Follow-up|0|||
161826751|NCT00372996|584406072|FG001|Overall Study|Lost to Follow-up|2|||
161826752|NCT00372996|584406073|FG002|Overall Study|Lost to Follow-up|0|||
161826753|NCT00372996|584406074|FG003|Overall Study|Lost to Follow-up|1|||
161826754|NCT00372996|584406071|FG000|Overall Study|Withdrawal by Subject|12|||
161826755|NCT00372996|584406072|FG001|Overall Study|Withdrawal by Subject|6|||
161826756|NCT00372996|584406073|FG002|Overall Study|Withdrawal by Subject|9|||
161826757|NCT00372996|584406074|FG003|Overall Study|Withdrawal by Subject|5|||
161826758|NCT00372996|584406071|FG000|Overall Study|Study Terminated by Sponsor|4|||
161826759|NCT00372996|584406072|FG001|Overall Study|Study Terminated by Sponsor|0|||
161826760|NCT00372996|584406073|FG002|Overall Study|Study Terminated by Sponsor|4|||
161826761|NCT00372996|584406074|FG003|Overall Study|Study Terminated by Sponsor|0|||
161826762|NCT00372996|584406071|FG000|Overall Study|Other|10|||
161826763|NCT00372996|584406072|FG001|Overall Study|Other|2|||
161826764|NCT00372996|584406073|FG002|Overall Study|Other|7|||
161826765|NCT00372996|584406074|FG003|Overall Study|Other|7|||
161826766|NCT01098539|584406075|FG000|Overall Study|Adverse Event|26|||
161826767|NCT01098539|584406076|FG001|Overall Study|Adverse Event|26|||
161826768|NCT01098539|584406075|FG000|Overall Study|Protocol Violation|1|||
161826769|NCT01098539|584406076|FG001|Overall Study|Protocol Violation|4|||
161826770|NCT01098539|584406075|FG000|Overall Study|Noncompliance|3|||
161826771|NCT01098539|584406076|FG001|Overall Study|Noncompliance|5|||
161826772|NCT01098539|584406075|FG000|Overall Study|Lost to Follow-up|4|||
161826773|NCT01098539|584406076|FG001|Overall Study|Lost to Follow-up|4|||
161826774|NCT01098539|584406075|FG000|Overall Study|Withdrawal by Subject|12|||
161826775|NCT01098539|584406076|FG001|Overall Study|Withdrawal by Subject|26|||
161826776|NCT01098539|584406075|FG000|Overall Study|Physician Decision|5|||
161826777|NCT01098539|584406076|FG001|Overall Study|Physician Decision|3|||
161826778|NCT03843125|584406077|FG000|Overall Study|Adverse Event|17|||
161826779|NCT03843125|584406078|FG001|Overall Study|Adverse Event|13|||
161826780|NCT03843125|584406079|FG002|Overall Study|Adverse Event|5|||
161826781|NCT03843125|584406080|FG003|Overall Study|Adverse Event|9|||
161826782|NCT03843125|584406077|FG000|Overall Study|Death|0|||
161826783|NCT03843125|584406078|FG001|Overall Study|Death|6|||
161826784|NCT03843125|584406079|FG002|Overall Study|Death|2|||
161826785|NCT03843125|584406080|FG003|Overall Study|Death|0|||
161935626|NCT05678959|584813972|FG000|Overall Study|Technical Problem|0|||
161935627|NCT05678959|584813973|FG001|Overall Study|Technical Problem|1|||
161935628|NCT02932410|584813974|FG000|Overall Study|Death|7|||
161935629|NCT02932410|584813975|FG001|Overall Study|Death|6|||
161935630|NCT02932410|584813976|FG002|Overall Study|Death|0|||
161935631|NCT02932410|584813977|FG003|Overall Study|Death|0|||
161525733|NCT03701555|583312515|FG019|Part 3 (Day 1)|Other|0|||
161826786|NCT03843125|584406077|FG000|Overall Study|Lack of Efficacy|14|||
161826787|NCT03843125|584406078|FG001|Overall Study|Lack of Efficacy|11|||
161826788|NCT03843125|584406079|FG002|Overall Study|Lack of Efficacy|9|||
161826789|NCT03843125|584406080|FG003|Overall Study|Lack of Efficacy|4|||
161826790|NCT03843125|584406077|FG000|Overall Study|Lost to Follow-up|3|||
161935632|NCT02932410|584813974|FG000|Overall Study|Lost to Follow-up|1|||
161935633|NCT02932410|584813975|FG001|Overall Study|Lost to Follow-up|2|||
161826791|NCT03843125|584406078|FG001|Overall Study|Lost to Follow-up|4|||
161826792|NCT03843125|584406079|FG002|Overall Study|Lost to Follow-up|0|||
161826793|NCT03843125|584406080|FG003|Overall Study|Lost to Follow-up|2|||
161826794|NCT03843125|584406077|FG000|Overall Study|Other|12|||
161826795|NCT03843125|584406078|FG001|Overall Study|Other|14|||
161590237|NCT01748448|583550339|FG000|Treatment Period|Personal|0|||
161590238|NCT01748448|583550340|FG001|Treatment Period|Personal|1|||
161590239|NCT03699709|583550343|FG000|Overall Study|Death|1|||
161590240|NCT03699709|583550344|FG001|Overall Study|Death|2|||
161590241|NCT03699709|583550343|FG000|Overall Study|Lost to Follow-up|10|||
161590242|NCT03699709|583550344|FG001|Overall Study|Lost to Follow-up|3|||
161826796|NCT03843125|584406079|FG002|Overall Study|Other|3|||
161826797|NCT03843125|584406080|FG003|Overall Study|Other|4|||
161826798|NCT03843125|584406077|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
161826799|NCT03843125|584406078|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
161826800|NCT03843125|584406079|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
161826801|NCT03843125|584406080|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
161826802|NCT03843125|584406077|FG000|Overall Study|Study Terminated by Sponsor|318|||
161826803|NCT03843125|584406078|FG001|Overall Study|Study Terminated by Sponsor|318|||
161826804|NCT03843125|584406079|FG002|Overall Study|Study Terminated by Sponsor|163|||
161826805|NCT03843125|584406080|FG003|Overall Study|Study Terminated by Sponsor|163|||
161826806|NCT03843125|584406077|FG000|Overall Study|Withdrawal by Subject|23|||
161826807|NCT03843125|584406078|FG001|Overall Study|Withdrawal by Subject|12|||
161826808|NCT03843125|584406079|FG002|Overall Study|Withdrawal by Subject|6|||
161826809|NCT03843125|584406080|FG003|Overall Study|Withdrawal by Subject|9|||
161826810|NCT03843125|584406077|FG000|Overall Study|Missing data|0|||
161826811|NCT03843125|584406078|FG001|Overall Study|Missing data|1|||
161826812|NCT03843125|584406079|FG002|Overall Study|Missing data|1|||
161826813|NCT03843125|584406080|FG003|Overall Study|Missing data|0|||
161826814|NCT03173560|584406081|FG000|Overall Study|Death|70|||
161826815|NCT03173560|584406082|FG001|Overall Study|Death|60|||
161826816|NCT03173560|584406081|FG000|Overall Study|Lost to Follow-up|1|||
161826817|NCT03173560|584406082|FG001|Overall Study|Lost to Follow-up|4|||
161826818|NCT03173560|584406081|FG000|Overall Study|Withdrawal by Subject|10|||
161826819|NCT03173560|584406082|FG001|Overall Study|Withdrawal by Subject|5|||
161826820|NCT03173560|584406081|FG000|Overall Study|Other|0|||
161826821|NCT03173560|584406082|FG001|Overall Study|Other|1|||
161826822|NCT02174276|584406083|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
161826823|NCT02174276|584406084|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161826824|NCT02174276|584406085|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161826825|NCT02174276|584406086|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161826826|NCT02174276|584406083|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161826827|NCT02174276|584406084|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161826828|NCT02174276|584406085|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
161826829|NCT02174276|584406086|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161826830|NCT02174276|584406083|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
161826831|NCT02174276|584406084|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
161826832|NCT02174276|584406085|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
161826833|NCT02174276|584406086|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
161826834|NCT02174276|584406083|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161826835|NCT02174276|584406084|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161826836|NCT02174276|584406085|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
161826837|NCT02174276|584406086|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161826838|NCT02174276|584406083|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161826839|NCT02174276|584406084|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161826840|NCT02174276|584406085|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
161826841|NCT02174276|584406086|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161826842|NCT02174276|584406083|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
161826843|NCT02174276|584406084|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
161826844|NCT02174276|584406085|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
161826845|NCT02174276|584406086|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
161826846|NCT00725764|584406088|FG000|Overall Study|Withdrawal by Subject|2|||
161826847|NCT00725764|584406088|FG000|Overall Study|Physician Decision|1|||
161826848|NCT00725764|584406088|FG000|Overall Study|Progressive Disease|7|||
161826849|NCT00725764|584406088|FG000|Overall Study|Lost to Follow-up|1|||
161826850|NCT00725764|584406088|FG000|Overall Study|Death|1|||
161826851|NCT00725764|584406088|FG000|Overall Study|Participant non compliant with protocol|1|||
161826852|NCT00725764|584406088|FG000|Overall Study|Decline in performance status|1|||
161826853|NCT00434837|584406091|FG000|Overall Study|Lost to Follow-up|20|||
161826854|NCT00434837|584406092|FG001|Overall Study|Lost to Follow-up|23|||
161826855|NCT00434837|584406093|FG002|Overall Study|Lost to Follow-up|30|||
161826856|NCT00250705|584406094|FG000|Overall Study|Lack of Efficacy|2|||
161826857|NCT00587431|584406095|FG000|Overall Study|Adverse Event|1|||
161826858|NCT00587431|584406096|FG001|Overall Study|Adverse Event|0|||
161826859|NCT00587431|584406095|FG000|Overall Study|Withdrawal by Subject|0|||
161935634|NCT02932410|584813976|FG002|Overall Study|Lost to Follow-up|0|||
161826860|NCT00587431|584406096|FG001|Overall Study|Withdrawal by Subject|1|||
161590243|NCT03699709|583550343|FG000|Overall Study|Withdrawal by Subject|5|||
161590244|NCT03699709|583550344|FG001|Overall Study|Withdrawal by Subject|0|||
161590245|NCT03699709|583550343|FG000|Overall Study|incarcerated|1|||
161590246|NCT03699709|583550344|FG001|Overall Study|incarcerated|0|||
161590247|NCT03699709|583550343|FG000|Overall Study|scheduled, but no show|0|||
161590248|NCT03699709|583550344|FG001|Overall Study|scheduled, but no show|1|||
161590249|NCT02907099|583550345|FG000|Overall Study|Adverse Event|1|||
161590250|NCT02907099|583550345|FG000|Overall Study|Withdrawal by Subject|2|||
161590251|NCT02907099|583550345|FG000|Overall Study|Screen Fail|2|||
161590252|NCT05784662|583550346|FG000|Overall Study|Lost to Follow-up|21|||
161590253|NCT05784662|583550347|FG001|Overall Study|Lost to Follow-up|17|||
161590255|NCT04739956|583550355|FG000|Overall Study|Withdrawal by Subject|1|||
161590256|NCT04739956|583550356|FG001|Overall Study|Withdrawal by Subject|1|||
161590257|NCT03920111|583550357|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
161590258|NCT03920111|583550358|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
161590259|NCT03920111|583550359|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
161590260|NCT03519581|583550360|FG000|Overall Study|Lost to Follow-up|3|||
161590261|NCT03519581|583550361|FG001|Overall Study|Lost to Follow-up|2|||
161590262|NCT03519581|583550360|FG000|Overall Study|Adverse Event|5|||
161590263|NCT03519581|583550361|FG001|Overall Study|Adverse Event|2|||
161590264|NCT03519581|583550360|FG000|Overall Study|Withdrawal by Subject|2|||
161590265|NCT03519581|583550361|FG001|Overall Study|Withdrawal by Subject|0|||
161590266|NCT03519581|583550360|FG000|Overall Study|Change to insurance|2|||
161590267|NCT03519581|583550361|FG001|Overall Study|Change to insurance|1|||
161590268|NCT03519581|583550360|FG000|Overall Study|Other|2|||
161590269|NCT03519581|583550361|FG001|Overall Study|Other|4|||
161590270|NCT05177848|583550362|FG000|Overall Study|Lost to Follow-up|1|||
161590271|NCT05177848|583550363|FG001|Overall Study|Lost to Follow-up|4|||
161590272|NCT05177848|583550362|FG000|Overall Study|Discontinued|2|||
161590273|NCT05177848|583550363|FG001|Overall Study|Discontinued|1|||
161590274|NCT06414213|583550364|FG000|Overall Study|Lost to Follow-up|1|||
161590275|NCT06414213|583550365|FG001|Overall Study|Lost to Follow-up|1|||
161590276|NCT06414213|583550366|FG002|Overall Study|Lost to Follow-up|3|||
161590277|NCT03720795|583550370|FG000|Phase 1|Lost to Follow-up|4|||
161590278|NCT03720795|583550370|FG000|Phase 1|Withdrawal by Subject|6|||
161590279|NCT03720795|583550370|FG000|Phase 1|Protocol Violation|1|||
161590280|NCT03720795|583550370|FG000|Phase 1|Other|1|||
161590281|NCT03720795|583550370|FG000|Phase 2|Lost to Follow-up|5|||
161590282|NCT03720795|583550370|FG000|Phase 2|Withdrawal by Subject|10|||
161590283|NCT03720795|583550370|FG000|Phase 2|Protocol Violation|2|||
161590284|NCT03720795|583550370|FG000|3 Month Follow Up|Lost to Follow-up|2|||
161590285|NCT04322643|583550371|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
161590286|NCT05486078|583550374|FG000|Overall Study|4 drop out and one withdrawn|5|||
161590287|NCT05134233|583550375|FG000|Overall Study|Pregnancy|1|||
161590288|NCT05134233|583550375|FG000|Overall Study|MEP value too low|2|||
161590289|NCT05134233|583550375|FG000|Overall Study|Lost to Follow-up|1|||
161590290|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Other|0|||
161590291|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Other|0|||
161590292|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Other|0|||
161590293|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Other|0|||
161590294|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Other|0|||
161590295|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Other|0|||
161590296|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Other|0|||
161590297|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Other|0|||
161590298|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Other|0|||
161590299|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Other|0|||
161590300|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Other|1|||
161590301|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Other|1|||
161590302|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Other|1|||
161590303|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Other|0|||
161590304|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Other|3|||
161590305|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Other|1|||
161590306|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Other|1|||
161590307|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Other|0|||
161590308|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590309|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
161826861|NCT05467982|584406097|FG000|Overall Study|Death|0|||
161826862|NCT05467982|584406098|FG001|Overall Study|Death|1|||
161590310|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590311|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590312|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590313|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590314|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
161590315|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590316|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
161590317|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
161826863|NCT05467982|584406097|FG000|Overall Study|Lost to Follow-up|3|||
161678056|NCT04667377|583873602|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
161678057|NCT04667377|583873603|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
161678058|NCT04667377|583873604|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
161678059|NCT04667377|583873605|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
161678060|NCT04667377|583873601|FG000|Dose Escalation Period|Not treated|1|||
161678061|NCT04667377|583873602|FG001|Dose Escalation Period|Not treated|0|||
161678062|NCT04667377|583873603|FG002|Dose Escalation Period|Not treated|0|||
161678063|NCT04667377|583873604|FG003|Dose Escalation Period|Not treated|0|||
161678064|NCT04667377|583873605|FG004|Dose Escalation Period|Not treated|0|||
161678065|NCT04667377|583873601|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
161678066|NCT04667377|583873602|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
161678067|NCT04667377|583873603|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
161678068|NCT04667377|583873604|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
161678069|NCT04667377|583873605|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
161678070|NCT04667377|583873601|FG000|Dose Escalation Period|Lost to Follow-up|0|||
161678071|NCT04667377|583873602|FG001|Dose Escalation Period|Lost to Follow-up|1|||
161678072|NCT04667377|583873603|FG002|Dose Escalation Period|Lost to Follow-up|0|||
161678073|NCT04667377|583873604|FG003|Dose Escalation Period|Lost to Follow-up|0|||
161678074|NCT04667377|583873605|FG004|Dose Escalation Period|Lost to Follow-up|0|||
161678075|NCT04667377|583873601|FG000|Maintenance Period|Perceived lack of efficacy|0|||
161678076|NCT04667377|583873602|FG001|Maintenance Period|Perceived lack of efficacy|2|||
161678077|NCT04667377|583873603|FG002|Maintenance Period|Perceived lack of efficacy|1|||
161678078|NCT04667377|583873604|FG003|Maintenance Period|Perceived lack of efficacy|0|||
161678079|NCT04667377|583873605|FG004|Maintenance Period|Perceived lack of efficacy|1|||
161678080|NCT04667377|583873601|FG000|Maintenance Period|Adverse Event|2|||
161678081|NCT04667377|583873602|FG001|Maintenance Period|Adverse Event|8|||
161678082|NCT04667377|583873603|FG002|Maintenance Period|Adverse Event|5|||
161678083|NCT04667377|583873604|FG003|Maintenance Period|Adverse Event|4|||
161678084|NCT04667377|583873605|FG004|Maintenance Period|Adverse Event|1|||
161678085|NCT04667377|583873601|FG000|Maintenance Period|Adverse event: COVID infection|0|||
161678086|NCT04667377|583873602|FG001|Maintenance Period|Adverse event: COVID infection|1|||
161678087|NCT04667377|583873603|FG002|Maintenance Period|Adverse event: COVID infection|0|||
161678088|NCT04667377|583873604|FG003|Maintenance Period|Adverse event: COVID infection|0|||
161678089|NCT04667377|583873605|FG004|Maintenance Period|Adverse event: COVID infection|0|||
161935635|NCT02932410|584813977|FG003|Overall Study|Lost to Follow-up|0|||
161935636|NCT02932410|584813974|FG000|Overall Study|Parent/Subjects decision|6|||
161935637|NCT02932410|584813975|FG001|Overall Study|Parent/Subjects decision|6|||
161935638|NCT02932410|584813976|FG002|Overall Study|Parent/Subjects decision|1|||
161525734|NCT03701555|583312516|FG020|Part 3 (Day 1)|Other|0|||
161525735|NCT03701555|583312517|FG021|Part 3 (Day 1)|Other|0|||
161525736|NCT03701555|583312518|FG022|Part 3 (Day 1)|Other|0|||
161525737|NCT03701555|583312519|FG023|Part 3 (Day 1)|Other|0|||
161525738|NCT03701555|583312520|FG024|Part 3 (Day 1)|Other|1|||
161525739|NCT03701555|583312521|FG025|Part 3 (Day 1)|Other|1|||
161525740|NCT03701555|583312522|FG026|Part 3 (Day 1)|Other|0|||
161525741|NCT03701555|583312523|FG027|Part 3 (Day 1)|Other|0|||
161525742|NCT03701555|583312524|FG028|Part 3 (Day 1)|Other|0|||
161525743|NCT03701555|583312525|FG029|Part 3 (Day 1)|Other|1|||
161525744|NCT03701555|583312526|FG030|Part 3 (Day 1)|Other|1|||
161525745|NCT03701555|583312527|FG031|Part 3 (Day 1)|Other|0|||
161525746|NCT03701555|583312528|FG032|Part 3 (Day 1)|Other|1|||
161678090|NCT04667377|583873601|FG000|Maintenance Period|COVID-related|0|||
161678091|NCT04667377|583873602|FG001|Maintenance Period|COVID-related|0|||
161678092|NCT04667377|583873603|FG002|Maintenance Period|COVID-related|1|||
161678093|NCT04667377|583873604|FG003|Maintenance Period|COVID-related|1|||
161678094|NCT04667377|583873605|FG004|Maintenance Period|COVID-related|0|||
161678095|NCT04667377|583873601|FG000|Maintenance Period|Protocol Violation|1|||
161678096|NCT04667377|583873602|FG001|Maintenance Period|Protocol Violation|0|||
161678097|NCT04667377|583873603|FG002|Maintenance Period|Protocol Violation|0|||
161678098|NCT04667377|583873604|FG003|Maintenance Period|Protocol Violation|0|||
161678099|NCT04667377|583873605|FG004|Maintenance Period|Protocol Violation|1|||
161678100|NCT04667377|583873601|FG000|Maintenance Period|Burden of study procedures|1|||
161935639|NCT02932410|584813977|FG003|Overall Study|Parent/Subjects decision|0|||
161525747|NCT03701555|583312529|FG033|Part 3 (Day 1)|Other|1|||
161525748|NCT03701555|583312530|FG034|Part 3 (Day 1)|Other|0|||
161525749|NCT03701555|583312531|FG035|Part 3 (Day 1)|Other|0|||
161590318|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590319|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590320|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
161590321|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590322|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590323|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590324|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
161935640|NCT02932410|584813974|FG000|Overall Study|Physician Decision|0|||
161935641|NCT02932410|584813975|FG001|Overall Study|Physician Decision|1|||
161525750|NCT04757649|583312532|FG000|Overall Study|Withdrawal by Subject|1|||
161590325|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
161590326|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590327|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590328|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590329|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590330|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590331|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590332|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590333|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
161590334|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590335|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590336|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590337|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590338|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590339|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590340|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590341|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590342|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590343|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161590344|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590345|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590346|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590347|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590348|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590349|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590350|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590351|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590352|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590353|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
161590354|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590355|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590356|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590357|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590358|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590359|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590360|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590361|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
161590362|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Death|0|||
161590363|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Death|0|||
161590364|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Death|0|||
161590365|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Death|0|||
161590366|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Death|0|||
161590367|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Death|0|||
161590368|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Death|0|||
161590369|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Death|0|||
161590370|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Death|0|||
161590371|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Death|1|||
161590372|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Death|0|||
161590373|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Death|1|||
161590374|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Death|0|||
161590375|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Death|1|||
161590376|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Death|0|||
161590377|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Death|0|||
161590378|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Death|2|||
161590379|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Death|0|||
161590380|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
161590381|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
161590382|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
161590383|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
161590384|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
161590385|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
161590386|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
161590387|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
161590388|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
161590389|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
161590390|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
161590391|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
161590392|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
161590393|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
161590394|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
161590395|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
161678101|NCT04667377|583873602|FG001|Maintenance Period|Burden of study procedures|2|||
161525751|NCT04757649|583312532|FG000|Overall Study|Adverse Event|1|||
161525752|NCT02508311|583312540|FG000|Overall Study|Withdrawal by Subject|1|||
161525753|NCT02508311|583312541|FG001|Overall Study|Withdrawal by Subject|0|||
161525754|NCT04862143|583312542|FG000|Overall Study|Adverse Event|1|||
161525755|NCT04862143|583312542|FG000|Overall Study|Study terminated by sponsor|1|||
161525756|NCT04955639|583312543|FG000|Overall Study|Withdrawal by Subject|2|||
161525757|NCT04955639|583312544|FG001|Overall Study|Withdrawal by Subject|2|||
161525758|NCT04955639|583312543|FG000|Overall Study|Week 26 survey not completed|2|||
161525759|NCT04955639|583312544|FG001|Overall Study|Week 26 survey not completed|2|||
161525760|NCT00413153|583312545|FG000|Overall Study|Withdrawal by Subject|1|||
161678102|NCT04667377|583873603|FG002|Maintenance Period|Burden of study procedures|0|||
161678103|NCT04667377|583873604|FG003|Maintenance Period|Burden of study procedures|1|||
161678104|NCT04667377|583873605|FG004|Maintenance Period|Burden of study procedures|0|||
161678105|NCT04667377|583873601|FG000|Maintenance Period|Change of residence|0|||
161678106|NCT04667377|583873602|FG001|Maintenance Period|Change of residence|1|||
161678107|NCT04667377|583873603|FG002|Maintenance Period|Change of residence|0|||
161678108|NCT04667377|583873604|FG003|Maintenance Period|Change of residence|0|||
161678109|NCT04667377|583873605|FG004|Maintenance Period|Change of residence|1|||
161678110|NCT04667377|583873601|FG000|Maintenance Period|Missing|1|||
161678111|NCT04667377|583873602|FG001|Maintenance Period|Missing|0|||
161678112|NCT04667377|583873603|FG002|Maintenance Period|Missing|0|||
161678113|NCT04667377|583873604|FG003|Maintenance Period|Missing|0|||
161678114|NCT04667377|583873605|FG004|Maintenance Period|Missing|0|||
161678115|NCT04667377|583873601|FG000|Maintenance Period|Other than listed above|2|||
161678116|NCT04667377|583873602|FG001|Maintenance Period|Other than listed above|0|||
161678117|NCT04667377|583873603|FG002|Maintenance Period|Other than listed above|3|||
161678118|NCT04667377|583873604|FG003|Maintenance Period|Other than listed above|2|||
161678119|NCT04667377|583873605|FG004|Maintenance Period|Other than listed above|6|||
161678120|NCT04667377|583873601|FG000|Maintenance Period|Withdrawal by Subject|0|||
161678121|NCT04667377|583873602|FG001|Maintenance Period|Withdrawal by Subject|1|||
161678122|NCT04667377|583873603|FG002|Maintenance Period|Withdrawal by Subject|0|||
161678123|NCT04667377|583873604|FG003|Maintenance Period|Withdrawal by Subject|0|||
161678124|NCT04667377|583873605|FG004|Maintenance Period|Withdrawal by Subject|0|||
161678125|NCT04667377|583873601|FG000|Maintenance Period|Lost to Follow-up|1|||
161678126|NCT04667377|583873602|FG001|Maintenance Period|Lost to Follow-up|0|||
161678127|NCT04667377|583873603|FG002|Maintenance Period|Lost to Follow-up|1|||
161678128|NCT04667377|583873604|FG003|Maintenance Period|Lost to Follow-up|0|||
161678129|NCT04667377|583873605|FG004|Maintenance Period|Lost to Follow-up|1|||
161678130|NCT00359021|583873606|FG000|Overall Study|Adverse Event|26|||
161678131|NCT00359021|583873607|FG001|Overall Study|Adverse Event|8|||
161678132|NCT00359021|583873606|FG000|Overall Study|Subject Non-Compliant|1|||
161678133|NCT00359021|583873607|FG001|Overall Study|Subject Non-Compliant|2|||
161678134|NCT00359021|583873606|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
161678135|NCT00359021|583873607|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
161678136|NCT00359021|583873606|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
161678137|NCT00359021|583873607|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
161678138|NCT00359021|583873606|FG000|Overall Study|Withdrawal by Subject|2|||
161678139|NCT00359021|583873607|FG001|Overall Study|Withdrawal by Subject|9|||
161678140|NCT00359021|583873606|FG000|Overall Study|Lost to Follow-up|1|||
161678141|NCT00359021|583873607|FG001|Overall Study|Lost to Follow-up|0|||
161678142|NCT00359021|583873606|FG000|Overall Study|Other|4|||
161678143|NCT00359021|583873607|FG001|Overall Study|Other|1|||
161678144|NCT00359021|583873606|FG000|Overall Study|Pregnancy|1|||
161678145|NCT00359021|583873607|FG001|Overall Study|Pregnancy|0|||
161678146|NCT03861936|583873608|FG000|Overall Study|Withdrawal by Subject|4|||
161678147|NCT03861936|583873609|FG001|Overall Study|Withdrawal by Subject|1|||
161826864|NCT05467982|584406098|FG001|Overall Study|Lost to Follow-up|1|||
161826865|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
161826866|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
161826867|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
161826868|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
161525761|NCT00413153|583312546|FG001|Overall Study|Withdrawal by Subject|1|||
161525762|NCT00413153|583312545|FG000|Overall Study|Adverse Event|1|||
161525763|NCT00413153|583312546|FG001|Overall Study|Adverse Event|0|||
161525764|NCT03204279|583312547|FG000|Overall Study|Withdrawal by Subject|0|||
161525765|NCT03204279|583312548|FG001|Overall Study|Withdrawal by Subject|1|||
161525766|NCT02862106|583312553|FG000|Overall Study|Adverse Event|4|||
161525767|NCT02862106|583312554|FG001|Overall Study|Adverse Event|0|||
161525768|NCT02862106|583312553|FG000|Overall Study|Protocol Violation|16|||
161678148|NCT03861936|583873610|FG002|Overall Study|Withdrawal by Subject|3|||
161678149|NCT03861936|583873608|FG000|Overall Study|Lost to Follow-up|5|||
161826869|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
161935642|NCT02932410|584813976|FG002|Overall Study|Physician Decision|0|||
161678150|NCT03861936|583873609|FG001|Overall Study|Lost to Follow-up|3|||
161678151|NCT03861936|583873610|FG002|Overall Study|Lost to Follow-up|3|||
161525769|NCT02862106|583312554|FG001|Overall Study|Protocol Violation|1|||
161525770|NCT02862106|583312553|FG000|Overall Study|Lost to Follow-up|15|||
161525771|NCT02862106|583312554|FG001|Overall Study|Lost to Follow-up|5|||
161525772|NCT02862106|583312553|FG000|Overall Study|Withdrawal by Subject|2|||
161525773|NCT02862106|583312554|FG001|Overall Study|Withdrawal by Subject|0|||
161525774|NCT02862106|583312553|FG000|Overall Study|Subjects moved to other city|1|||
161525775|NCT02862106|583312554|FG001|Overall Study|Subjects moved to other city|0|||
161525776|NCT03526250|583312555|FG000|Overall Study|Adverse Event|4|||
161525777|NCT03526250|583312555|FG000|Overall Study|Progressive Disease|16|||
161525778|NCT03526250|583312555|FG000|Overall Study|No Treatment|3|||
161525779|NCT04420221|583312556|FG000|Overall Study|Withdrawal by Subject|0|||
161525780|NCT04420221|583312557|FG001|Overall Study|Withdrawal by Subject|0|||
161525781|NCT04420221|583312558|FG002|Overall Study|Withdrawal by Subject|0|||
161525782|NCT04420221|583312559|FG003|Overall Study|Withdrawal by Subject|0|||
161525783|NCT04420221|583312560|FG004|Overall Study|Withdrawal by Subject|0|||
161525784|NCT04420221|583312561|FG005|Overall Study|Withdrawal by Subject|20|||
161525785|NCT04420221|583312562|FG006|Overall Study|Withdrawal by Subject|5|||
161525786|NCT04420221|583312556|FG000|Overall Study|Other|0|||
161525787|NCT04420221|583312557|FG001|Overall Study|Other|0|||
161525788|NCT04420221|583312558|FG002|Overall Study|Other|0|||
161525789|NCT04420221|583312559|FG003|Overall Study|Other|0|||
161525790|NCT04420221|583312560|FG004|Overall Study|Other|0|||
161678152|NCT03861936|583873608|FG000|Overall Study|Physician Decision|0|||
161826870|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
161826871|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
161826872|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
161826873|NCT03507686|584406107|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
161826874|NCT03507686|584406108|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
161826875|NCT03507686|584406107|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
161826876|NCT03507686|584406108|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
161826877|NCT00585312|584406109|FG000|Overall Study|Adverse Event|3|||
161826878|NCT00585312|584406110|FG001|Overall Study|Adverse Event|0|||
161826879|NCT00585312|584406109|FG000|Overall Study|Lack of Efficacy|6|||
161826880|NCT00585312|584406110|FG001|Overall Study|Lack of Efficacy|11|||
161826881|NCT00585312|584406109|FG000|Overall Study|Lost to Follow-up|1|||
161826882|NCT00585312|584406110|FG001|Overall Study|Lost to Follow-up|1|||
161826883|NCT00585312|584406109|FG000|Overall Study|Reason not specified|2|||
161826884|NCT00585312|584406110|FG001|Overall Study|Reason not specified|0|||
161826885|NCT00585312|584406109|FG000|Overall Study|Withdrawal by Subject|5|||
161826886|NCT00585312|584406110|FG001|Overall Study|Withdrawal by Subject|1|||
161826887|NCT00585312|584406109|FG000|Overall Study|Study terminated by the sponsor|34|||
161826888|NCT00585312|584406110|FG001|Overall Study|Study terminated by the sponsor|31|||
161826889|NCT01263561|584406111|FG000|Overall Study|Death|1|||
161826890|NCT01263561|584406112|FG001|Overall Study|Death|2|||
161826891|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
161826892|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
161826893|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
161826894|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
161826895|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
161826896|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
161826897|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
161826898|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
161826899|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
161826900|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
161826901|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
161826902|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
161826903|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
161826904|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
161826905|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826906|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826907|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
161826908|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
161826909|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826910|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826911|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826912|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Death|0|||
161826913|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Death|0|||
161826914|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Death|1|||
161525791|NCT04420221|583312561|FG005|Overall Study|Other|1|||
161525792|NCT04420221|583312562|FG006|Overall Study|Other|1|||
161525793|NCT04420221|583312556|FG000|Overall Study|Lost to Follow-up|0|||
161935643|NCT02932410|584813977|FG003|Overall Study|Physician Decision|0|||
161935644|NCT05859698|584813978|FG000|Overall Study|Adverse Event|1|||
161935645|NCT05859698|584813978|FG000|Overall Study|Death|1|||
161935646|NCT05859698|584813978|FG000|Overall Study|Physician Decision|1|||
161525794|NCT04420221|583312557|FG001|Overall Study|Lost to Follow-up|0|||
161525795|NCT04420221|583312558|FG002|Overall Study|Lost to Follow-up|0|||
161525796|NCT04420221|583312559|FG003|Overall Study|Lost to Follow-up|0|||
161525797|NCT04420221|583312560|FG004|Overall Study|Lost to Follow-up|0|||
161525798|NCT04420221|583312561|FG005|Overall Study|Lost to Follow-up|3|||
161525799|NCT04420221|583312562|FG006|Overall Study|Lost to Follow-up|2|||
161525800|NCT04420221|583312556|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
161525801|NCT04420221|583312557|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
161525802|NCT04420221|583312558|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
161525803|NCT04420221|583312559|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
161525804|NCT04420221|583312560|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
161525805|NCT04420221|583312561|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
161525806|NCT04420221|583312562|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
161935647|NCT05859698|584813978|FG000|Overall Study|Lost to Follow-up|2|||
161935648|NCT05859698|584813978|FG000|Overall Study|Other Than Specified|2|||
161935649|NCT05859698|584813978|FG000|Overall Study|Withdrawal by Subject|1|||
161935650|NCT05818137|584813981|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
161935651|NCT05818137|584813981|FG000|Extension Treatment Period|Ongoing participants|44|||
161935652|NCT05248945|584813982|FG000|Overall Study|Adverse Event|1|||
161935653|NCT05248945|584813982|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
161935654|NCT05525975|584813983|FG000|Overall Study|Surgery cancellation|4|||
161935655|NCT05525975|584813984|FG001|Overall Study|Surgery cancellation|5|||
161525807|NCT05348681|583312563|FG000|Overall Study|Study terminated by Sponsor|8|||
161525808|NCT05348681|583312564|FG001|Overall Study|Study terminated by Sponsor|3|||
161525809|NCT05348681|583312563|FG000|Overall Study|Withdrawal by Subject|1|||
161525810|NCT05348681|583312564|FG001|Overall Study|Withdrawal by Subject|1|||
161525811|NCT05348681|583312563|FG000|Overall Study|Lost to Follow-up|1|||
161525812|NCT05348681|583312564|FG001|Overall Study|Lost to Follow-up|1|||
161525813|NCT05348681|583312563|FG000|Overall Study|Adverse Event|1|||
161525814|NCT05348681|583312564|FG001|Overall Study|Adverse Event|0|||
161525815|NCT05348681|583312563|FG000|Overall Study|Other|2|||
161525816|NCT05348681|583312564|FG001|Overall Study|Other|1|||
161525817|NCT01040130|583312565|FG000|Overall Study|Adverse Event|1|||
161525818|NCT01040130|583312566|FG001|Overall Study|Adverse Event|1|||
161525819|NCT01040130|583312567|FG002|Overall Study|Adverse Event|0|||
161525820|NCT01040130|583312568|FG003|Overall Study|Adverse Event|5|||
161525821|NCT01040130|583312569|FG004|Overall Study|Adverse Event|0|||
161525822|NCT01040130|583312570|FG005|Overall Study|Adverse Event|3|||
161525823|NCT01040130|583312565|FG000|Overall Study|Protocol Violation|0|||
161525824|NCT01040130|583312566|FG001|Overall Study|Protocol Violation|0|||
161525825|NCT01040130|583312567|FG002|Overall Study|Protocol Violation|2|||
161525826|NCT01040130|583312568|FG003|Overall Study|Protocol Violation|0|||
161525827|NCT01040130|583312569|FG004|Overall Study|Protocol Violation|0|||
161525828|NCT01040130|583312570|FG005|Overall Study|Protocol Violation|0|||
161525829|NCT01040130|583312565|FG000|Overall Study|Withdrawal by Subject|0|||
161525830|NCT01040130|583312566|FG001|Overall Study|Withdrawal by Subject|2|||
161525831|NCT01040130|583312567|FG002|Overall Study|Withdrawal by Subject|0|||
161525832|NCT01040130|583312568|FG003|Overall Study|Withdrawal by Subject|0|||
161525833|NCT01040130|583312569|FG004|Overall Study|Withdrawal by Subject|0|||
161525834|NCT01040130|583312570|FG005|Overall Study|Withdrawal by Subject|1|||
161525835|NCT01040130|583312565|FG000|Overall Study|Other reasons not listed above|2|||
161525836|NCT01040130|583312566|FG001|Overall Study|Other reasons not listed above|0|||
161525837|NCT01040130|583312567|FG002|Overall Study|Other reasons not listed above|0|||
161525838|NCT01040130|583312568|FG003|Overall Study|Other reasons not listed above|0|||
161525839|NCT01040130|583312569|FG004|Overall Study|Other reasons not listed above|0|||
161525840|NCT01040130|583312570|FG005|Overall Study|Other reasons not listed above|0|||
161525841|NCT00553267|583312575|FG000|Overall Study|Adverse Event|8|||
161525842|NCT00553267|583312576|FG001|Overall Study|Adverse Event|10|||
161525843|NCT00553267|583312577|FG002|Overall Study|Adverse Event|5|||
161590396|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
161590397|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
161525844|NCT00553267|583312575|FG000|Overall Study|Non compliant with protocol|3|||
161525845|NCT00553267|583312576|FG001|Overall Study|Non compliant with protocol|3|||
161525846|NCT00553267|583312577|FG002|Overall Study|Non compliant with protocol|2|||
161525847|NCT00553267|583312575|FG000|Overall Study|Lost to Follow-up|0|||
161525848|NCT00553267|583312576|FG001|Overall Study|Lost to Follow-up|0|||
161525849|NCT00553267|583312577|FG002|Overall Study|Lost to Follow-up|1|||
161525850|NCT00553267|583312575|FG000|Overall Study|Consent withdrawn|2|||
161525851|NCT00553267|583312576|FG001|Overall Study|Consent withdrawn|3|||
161525852|NCT00553267|583312577|FG002|Overall Study|Consent withdrawn|1|||
161935656|NCT05525975|584813983|FG000|Overall Study|didn't fill prescription|1|||
161935657|NCT05525975|584813984|FG001|Overall Study|didn't fill prescription|0|||
161935658|NCT05525975|584813983|FG000|Overall Study|Withdrawal by Subject|0|||
161935659|NCT05525975|584813984|FG001|Overall Study|Withdrawal by Subject|3|||
161935660|NCT02065336|584813985|FG000|Extension Phase|Study Terminated by Sponsor|0|||
161935661|NCT02065336|584813986|FG001|Extension Phase|Study Terminated by Sponsor|0|||
161935662|NCT02065336|584813987|FG002|Extension Phase|Study Terminated by Sponsor|0|||
161525853|NCT00553267|583312575|FG000|Overall Study|Specified category|1|||
161525854|NCT00553267|583312576|FG001|Overall Study|Specified category|2|||
161525855|NCT00553267|583312577|FG002|Overall Study|Specified category|1|||
161525856|NCT04389840|583312578|FG000|Overall Study|Adverse Event|0|||
161525857|NCT04389840|583312579|FG001|Overall Study|Adverse Event|0|||
161525858|NCT04389840|583312580|FG002|Overall Study|Adverse Event|0|||
161525859|NCT04389840|583312581|FG003|Overall Study|Adverse Event|1|||
161525860|NCT04389840|583312582|FG004|Overall Study|Adverse Event|0|||
161525861|NCT04389840|583312583|FG005|Overall Study|Adverse Event|0|||
161525862|NCT04389840|583312578|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
161525863|NCT04389840|583312579|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
161525864|NCT04389840|583312580|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
161525865|NCT04389840|583312581|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
161525866|NCT04389840|583312582|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
161525867|NCT04389840|583312583|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
161525868|NCT04389840|583312578|FG000|Overall Study|Death|0|||
161525869|NCT04389840|583312579|FG001|Overall Study|Death|1|||
161525870|NCT04389840|583312580|FG002|Overall Study|Death|0|||
161525871|NCT04389840|583312581|FG003|Overall Study|Death|0|||
161525872|NCT04389840|583312582|FG004|Overall Study|Death|0|||
161525873|NCT04389840|583312583|FG005|Overall Study|Death|0|||
161525874|NCT01618864|583312584|FG000|Overall Study|Withdrawal by Subject|2|||
161525875|NCT01618864|583312584|FG000|Overall Study|Lost to Follow-up|2|||
161525876|NCT00096135|583312590|FG000|Overall Study|Physician Decision|20|||
161525877|NCT00096135|583312591|FG001|Overall Study|Physician Decision|4|||
161525878|NCT00096135|583312590|FG000|Overall Study|Refusal of further protocol therapy|4|||
161525879|NCT00096135|583312591|FG001|Overall Study|Refusal of further protocol therapy|1|||
161525880|NCT00096135|583312590|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
161525881|NCT00096135|583312591|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
161525882|NCT00096135|583312590|FG000|Overall Study|Other, specify|15|||
161525883|NCT00096135|583312591|FG001|Overall Study|Other, specify|3|||
161525884|NCT00096135|583312590|FG000|Overall Study|Ineligible|2|||
161525885|NCT00096135|583312591|FG001|Overall Study|Ineligible|0|||
161525886|NCT00833989|583312600|FG000|Overall Study|Physician Decision|0|||
161525887|NCT00833989|583312601|FG001|Overall Study|Physician Decision|0|||
161525888|NCT00833989|583312602|FG002|Overall Study|Physician Decision|0|||
161525889|NCT00833989|583312603|FG003|Overall Study|Physician Decision|1|||
161525890|NCT00833989|583312600|FG000|Overall Study|Withdrawal by Subject|3|||
161525891|NCT00833989|583312601|FG001|Overall Study|Withdrawal by Subject|0|||
161525892|NCT00833989|583312602|FG002|Overall Study|Withdrawal by Subject|1|||
161525893|NCT00833989|583312603|FG003|Overall Study|Withdrawal by Subject|1|||
161525894|NCT02310750|583312606|FG000|HP Period 1|Lost to Follow-up|0|||
161525895|NCT02310750|583312607|FG001|HP Period 1|Lost to Follow-up|0|||
161525896|NCT02310750|583312608|FG002|HP Period 1|Lost to Follow-up|0|||
161525897|NCT02310750|583312609|FG003|HP Period 1|Lost to Follow-up|0|||
161525898|NCT02310750|583312610|FG004|HP Period 1|Lost to Follow-up|0|||
161525899|NCT02310750|583312611|FG005|HP Period 1|Lost to Follow-up|0|||
161525900|NCT02310750|583312612|FG006|HP Period 1|Lost to Follow-up|1|||
161525901|NCT02310750|583312613|FG007|HP Period 1|Lost to Follow-up|0|||
161525902|NCT02310750|583312614|FG008|HP Period 1|Lost to Follow-up|0|||
161525903|NCT02310750|583312615|FG009|HP Period 1|Lost to Follow-up|0|||
161525904|NCT02310750|583312616|FG010|HP Period 1|Lost to Follow-up|0|||
161525905|NCT02310750|583312617|FG011|HP Period 1|Lost to Follow-up|0|||
161525906|NCT02310750|583312618|FG012|HP Period 1|Lost to Follow-up|0|||
161525907|NCT02310750|583312619|FG013|HP Period 1|Lost to Follow-up|0|||
161525908|NCT02310750|583312620|FG014|HP Period 1|Lost to Follow-up|0|||
161525909|NCT02310750|583312621|FG015|HP Period 1|Lost to Follow-up|0|||
161525910|NCT02310750|583312606|FG000|HP Period 1|Withdrawal by Subject|1|||
161525911|NCT02310750|583312607|FG001|HP Period 1|Withdrawal by Subject|0|||
161525912|NCT02310750|583312608|FG002|HP Period 1|Withdrawal by Subject|0|||
161525913|NCT02310750|583312609|FG003|HP Period 1|Withdrawal by Subject|1|||
161525914|NCT02310750|583312610|FG004|HP Period 1|Withdrawal by Subject|0|||
161525915|NCT02310750|583312611|FG005|HP Period 1|Withdrawal by Subject|0|||
161525916|NCT02310750|583312612|FG006|HP Period 1|Withdrawal by Subject|0|||
161525917|NCT02310750|583312613|FG007|HP Period 1|Withdrawal by Subject|0|||
161590398|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Adverse Event|0|||
161935663|NCT02065336|584813988|FG003|Extension Phase|Study Terminated by Sponsor|0|||
161525918|NCT02310750|583312614|FG008|HP Period 1|Withdrawal by Subject|0|||
161525919|NCT02310750|583312615|FG009|HP Period 1|Withdrawal by Subject|0|||
161525920|NCT02310750|583312616|FG010|HP Period 1|Withdrawal by Subject|0|||
161525921|NCT02310750|583312617|FG011|HP Period 1|Withdrawal by Subject|0|||
161525922|NCT02310750|583312618|FG012|HP Period 1|Withdrawal by Subject|0|||
161590399|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Adverse Event|0|||
161590400|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Adverse Event|0|||
161590401|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Adverse Event|0|||
161590402|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Adverse Event|0|||
161590403|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Adverse Event|0|||
161590404|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Adverse Event|2|||
161590405|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Adverse Event|0|||
161590406|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Adverse Event|0|||
161590407|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Adverse Event|0|||
161590408|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Adverse Event|1|||
161590409|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Adverse Event|2|||
161590410|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Adverse Event|0|||
161590411|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Adverse Event|1|||
161590412|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Adverse Event|0|||
161590413|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Adverse Event|0|||
161590414|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Adverse Event|1|||
161590415|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Adverse Event|0|||
161590416|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
161590417|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
161590418|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
161590419|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
161590420|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
161590421|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
161590422|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
161590423|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
161590424|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
161590425|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
161590426|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
161590427|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
161590428|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
161590429|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
161590430|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
161590431|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
161590432|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
161590433|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
161590434|NCT03269136|583550380|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161525923|NCT02310750|583312619|FG013|HP Period 1|Withdrawal by Subject|0|||
161525924|NCT02310750|583312620|FG014|HP Period 1|Withdrawal by Subject|0|||
161525925|NCT02310750|583312621|FG015|HP Period 1|Withdrawal by Subject|0|||
161525926|NCT02310750|583312606|FG000|HP Washout 1|Lost to Follow-up|0|||
161525927|NCT02310750|583312607|FG001|HP Washout 1|Lost to Follow-up|0|||
161525928|NCT02310750|583312608|FG002|HP Washout 1|Lost to Follow-up|1|||
161525929|NCT02310750|583312609|FG003|HP Washout 1|Lost to Follow-up|1|||
161525930|NCT02310750|583312610|FG004|HP Washout 1|Lost to Follow-up|2|||
161525931|NCT02310750|583312611|FG005|HP Washout 1|Lost to Follow-up|2|||
161525932|NCT02310750|583312612|FG006|HP Washout 1|Lost to Follow-up|3|||
161525933|NCT02310750|583312613|FG007|HP Washout 1|Lost to Follow-up|0|||
161525934|NCT02310750|583312614|FG008|HP Washout 1|Lost to Follow-up|0|||
161525935|NCT02310750|583312615|FG009|HP Washout 1|Lost to Follow-up|0|||
161525936|NCT02310750|583312616|FG010|HP Washout 1|Lost to Follow-up|0|||
161525937|NCT02310750|583312617|FG011|HP Washout 1|Lost to Follow-up|0|||
161525938|NCT02310750|583312618|FG012|HP Washout 1|Lost to Follow-up|0|||
161525939|NCT02310750|583312619|FG013|HP Washout 1|Lost to Follow-up|0|||
161525940|NCT02310750|583312620|FG014|HP Washout 1|Lost to Follow-up|0|||
161525941|NCT02310750|583312621|FG015|HP Washout 1|Lost to Follow-up|0|||
161525942|NCT02310750|583312606|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525943|NCT02310750|583312607|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161590435|NCT03269136|583550381|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161826915|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Death|0|||
161826916|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Death|0|||
161826917|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Death|0|||
161826918|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Death|0|||
161826919|NCT00879684|584406113|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826920|NCT00879684|584406114|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826921|NCT00879684|584406115|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826922|NCT00879684|584406116|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826923|NCT00879684|584406117|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826924|NCT00879684|584406118|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826925|NCT00879684|584406119|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
161525944|NCT02310750|583312608|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161590436|NCT03269136|583550382|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590437|NCT03269136|583550383|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590438|NCT03269136|583550384|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161525945|NCT02310750|583312609|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
161525946|NCT02310750|583312610|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525947|NCT02310750|583312611|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
161525948|NCT02310750|583312612|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525949|NCT02310750|583312613|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525950|NCT02310750|583312614|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
161525951|NCT02310750|583312615|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
161525952|NCT02310750|583312616|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525953|NCT02310750|583312617|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525954|NCT02310750|583312618|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525955|NCT02310750|583312619|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525956|NCT02310750|583312620|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525957|NCT02310750|583312621|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
161525958|NCT02310750|583312606|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525959|NCT02310750|583312607|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525960|NCT02310750|583312608|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525961|NCT02310750|583312609|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525962|NCT02310750|583312610|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525963|NCT02310750|583312611|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525964|NCT02310750|583312612|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525965|NCT02310750|583312613|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525966|NCT02310750|583312614|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525967|NCT02310750|583312615|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
161525968|NCT02310750|583312616|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525969|NCT02310750|583312617|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525970|NCT02310750|583312618|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525971|NCT02310750|583312619|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525972|NCT02310750|583312620|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525973|NCT02310750|583312621|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
161525974|NCT02310750|583312606|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525975|NCT02310750|583312607|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525976|NCT02310750|583312608|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525977|NCT02310750|583312609|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525978|NCT02310750|583312610|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525979|NCT02310750|583312611|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525980|NCT02310750|583312612|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525981|NCT02310750|583312613|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
161525982|NCT02310750|583312614|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
161826926|NCT00879684|584406113|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
161525983|NCT02310750|583312615|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
161525984|NCT02310750|583312616|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525985|NCT02310750|583312617|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525986|NCT02310750|583312618|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161826927|NCT00879684|584406114|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826928|NCT00879684|584406115|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826929|NCT00879684|584406116|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826930|NCT00879684|584406117|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826931|NCT00879684|584406118|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826932|NCT00879684|584406119|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
161826933|NCT00879684|584406113|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826934|NCT00879684|584406114|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826935|NCT00879684|584406115|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826936|NCT00879684|584406116|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826937|NCT00879684|584406117|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826938|NCT00879684|584406118|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826939|NCT00879684|584406119|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
161826940|NCT03185741|584406124|FG000|Baseline|Withdrawal by Subject|1|||
161826941|NCT03185741|584406125|FG001|Baseline|Withdrawal by Subject|3|||
161826942|NCT03185741|584406126|FG002|Baseline|Withdrawal by Subject|2|||
161826943|NCT03185741|584406124|FG000|Baseline|Lost to Follow-up|1|||
161826944|NCT03185741|584406125|FG001|Baseline|Lost to Follow-up|2|||
161826945|NCT03185741|584406126|FG002|Baseline|Lost to Follow-up|3|||
161826946|NCT03185741|584406124|FG000|3Month|Death|1|||
161826947|NCT03185741|584406125|FG001|3Month|Death|1|||
161826948|NCT03185741|584406126|FG002|3Month|Death|2|||
161826949|NCT03185741|584406124|FG000|3Month|Withdrawal by Subject|1|||
161826950|NCT03185741|584406125|FG001|3Month|Withdrawal by Subject|5|||
161826951|NCT03185741|584406126|FG002|3Month|Withdrawal by Subject|1|||
161826952|NCT03185741|584406124|FG000|3Month|Lost to Follow-up|7|||
161935664|NCT02065336|584813989|FG004|Extension Phase|Study Terminated by Sponsor|0|||
161935665|NCT02065336|584813990|FG005|Extension Phase|Study Terminated by Sponsor|0|||
161935666|NCT02065336|584813991|FG006|Extension Phase|Study Terminated by Sponsor|0|||
161935667|NCT02065336|584813992|FG007|Extension Phase|Study Terminated by Sponsor|0|||
161935668|NCT02065336|584813993|FG008|Extension Phase|Study Terminated by Sponsor|2|||
161935669|NCT02065336|584813994|FG009|Extension Phase|Study Terminated by Sponsor|8|||
161935670|NCT05925374|584813995|FG000|Overall Study|Lost to Follow-up|13|||
161525987|NCT02310750|583312619|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525988|NCT02310750|583312620|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525989|NCT02310750|583312621|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
161525990|NCT02310750|583312606|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161525991|NCT02310750|583312607|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161525992|NCT02310750|583312608|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161525993|NCT02310750|583312609|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161590439|NCT03269136|583550385|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590440|NCT03269136|583550386|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590441|NCT03269136|583550387|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161935671|NCT03226392|584813996|FG000|Overall Study|Protocol Deviation|1|||
161935672|NCT03226392|584813997|FG001|Overall Study|Protocol Deviation|0|||
161935673|NCT03226392|584813996|FG000|Overall Study|Physician Decision|1|||
161935674|NCT03226392|584813997|FG001|Overall Study|Physician Decision|0|||
161935675|NCT03226392|584813996|FG000|Overall Study|Lost to Follow-up|1|||
161935676|NCT03226392|584813997|FG001|Overall Study|Lost to Follow-up|0|||
161935677|NCT03226392|584813996|FG000|Overall Study|Adverse Event|1|||
161935678|NCT03226392|584813997|FG001|Overall Study|Adverse Event|0|||
161935679|NCT03226392|584813996|FG000|Overall Study|Technical Problems|0|||
161935680|NCT03226392|584813997|FG001|Overall Study|Technical Problems|2|||
161935681|NCT03226392|584813996|FG000|Overall Study|Subject/Guardian Decision|7|||
161935682|NCT03226392|584813997|FG001|Overall Study|Subject/Guardian Decision|6|||
161935683|NCT05900999|584813998|FG000|Overall Study|Withdrawal by Subject|9|||
161935684|NCT05900999|584813998|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
161935685|NCT05090423|584813999|FG000|Overall Study|Because of the covid-19|3|||
161935686|NCT05090423|584814000|FG001|Overall Study|Because of the covid-19|2|||
161935687|NCT05090423|584813999|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
161935688|NCT05090423|584814000|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
161935689|NCT03056755|584814001|FG000|Core Phase|Progressive disease|89|||
161935690|NCT03056755|584814002|FG001|Core Phase|Progressive disease|88|||
161935691|NCT03056755|584814003|FG002|Core Phase|Progressive disease|90|||
161935692|NCT03056755|584814001|FG000|Core Phase|Adverse Event|20|||
161935693|NCT03056755|584814002|FG001|Core Phase|Adverse Event|14|||
161935694|NCT03056755|584814003|FG002|Core Phase|Adverse Event|13|||
161935695|NCT03056755|584814001|FG000|Core Phase|Physician Decision|7|||
161935696|NCT03056755|584814002|FG001|Core Phase|Physician Decision|13|||
161525994|NCT02310750|583312610|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161590442|NCT03269136|583550388|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590443|NCT03269136|583550389|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590444|NCT03269136|583550390|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590445|NCT03269136|583550391|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590446|NCT03269136|583550392|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161590447|NCT03269136|583550393|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161590448|NCT03269136|583550394|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161590449|NCT03269136|583550395|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161590450|NCT03269136|583550396|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161590451|NCT03269136|583550397|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161935697|NCT03056755|584814003|FG002|Core Phase|Physician Decision|5|||
161935698|NCT03056755|584814001|FG000|Core Phase|Subject/guardian decision|5|||
161935699|NCT03056755|584814002|FG001|Core Phase|Subject/guardian decision|8|||
161935700|NCT03056755|584814003|FG002|Core Phase|Subject/guardian decision|4|||
161935701|NCT03056755|584814001|FG000|Core Phase|Death|3|||
161935702|NCT03056755|584814002|FG001|Core Phase|Death|2|||
161590452|NCT03269136|583550380|FG000|Part 2A: Dose Expansion|Other|0|||
161590453|NCT03269136|583550381|FG001|Part 2A: Dose Expansion|Other|0|||
161590454|NCT03269136|583550382|FG002|Part 2A: Dose Expansion|Other|0|||
161590455|NCT03269136|583550383|FG003|Part 2A: Dose Expansion|Other|0|||
161590456|NCT03269136|583550384|FG004|Part 2A: Dose Expansion|Other|0|||
161935703|NCT03056755|584814003|FG002|Core Phase|Death|4|||
161590457|NCT03269136|583550385|FG005|Part 2A: Dose Expansion|Other|0|||
161935704|NCT03056755|584814001|FG000|Core Phase|Protocol deviation|1|||
161935705|NCT03056755|584814002|FG001|Core Phase|Protocol deviation|1|||
161935706|NCT03056755|584814003|FG002|Core Phase|Protocol deviation|0|||
161935707|NCT03056755|584814001|FG000|Core Phase|Technical problems|1|||
161590458|NCT03269136|583550386|FG006|Part 2A: Dose Expansion|Other|0|||
161935708|NCT03056755|584814002|FG001|Core Phase|Technical problems|0|||
161935709|NCT03056755|584814003|FG002|Core Phase|Technical problems|0|||
161935710|NCT03056755|584814001|FG000|Extension Phase|Physician Decision|1|||
161935711|NCT03056755|584814002|FG001|Extension Phase|Physician Decision|0|||
161935712|NCT03056755|584814003|FG002|Extension Phase|Physician Decision|3|||
161935713|NCT03056755|584814001|FG000|Extension Phase|Adverse Event|0|||
161935714|NCT03056755|584814002|FG001|Extension Phase|Adverse Event|0|||
161935715|NCT03056755|584814003|FG002|Extension Phase|Adverse Event|1|||
161525995|NCT02310750|583312611|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161525996|NCT02310750|583312612|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161525997|NCT02310750|583312613|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
161525998|NCT02310750|583312614|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
161525999|NCT02310750|583312615|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526000|NCT02310750|583312616|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526001|NCT02310750|583312617|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526002|NCT02310750|583312618|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526003|NCT02310750|583312619|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526004|NCT02310750|583312620|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526005|NCT02310750|583312621|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
161526006|NCT02310750|583312606|FG000|HP Washout 2|Lost to Follow-up|0|||
161526007|NCT02310750|583312607|FG001|HP Washout 2|Lost to Follow-up|0|||
161526008|NCT02310750|583312608|FG002|HP Washout 2|Lost to Follow-up|0|||
161526009|NCT02310750|583312609|FG003|HP Washout 2|Lost to Follow-up|0|||
161678153|NCT03861936|583873609|FG001|Overall Study|Physician Decision|1|||
161678154|NCT03861936|583873610|FG002|Overall Study|Physician Decision|0|||
161678155|NCT03861936|583873608|FG000|Overall Study|Protocol Deviation|0|||
161678156|NCT03861936|583873609|FG001|Overall Study|Protocol Deviation|0|||
161678157|NCT03861936|583873610|FG002|Overall Study|Protocol Deviation|1|||
161678158|NCT03861936|583873608|FG000|Overall Study|Reason not Specified|5|||
161678159|NCT03861936|583873609|FG001|Overall Study|Reason not Specified|5|||
161678160|NCT03861936|583873610|FG002|Overall Study|Reason not Specified|3|||
161678161|NCT03198520|583873615|FG000|Overall Study|Physician Decision|2|||
161678162|NCT03198520|583873615|FG000|Overall Study|Protocol Violation|2|||
161526010|NCT02310750|583312610|FG004|HP Washout 2|Lost to Follow-up|1|||
161526011|NCT02310750|583312611|FG005|HP Washout 2|Lost to Follow-up|0|||
161526012|NCT02310750|583312612|FG006|HP Washout 2|Lost to Follow-up|7|||
161526013|NCT02310750|583312613|FG007|HP Washout 2|Lost to Follow-up|0|||
161526014|NCT02310750|583312614|FG008|HP Washout 2|Lost to Follow-up|0|||
161526015|NCT02310750|583312615|FG009|HP Washout 2|Lost to Follow-up|0|||
161526016|NCT02310750|583312616|FG010|HP Washout 2|Lost to Follow-up|0|||
161526017|NCT02310750|583312617|FG011|HP Washout 2|Lost to Follow-up|0|||
161526018|NCT02310750|583312618|FG012|HP Washout 2|Lost to Follow-up|0|||
161526019|NCT02310750|583312619|FG013|HP Washout 2|Lost to Follow-up|0|||
161526020|NCT02310750|583312620|FG014|HP Washout 2|Lost to Follow-up|0|||
161526021|NCT02310750|583312621|FG015|HP Washout 2|Lost to Follow-up|0|||
161526022|NCT03585244|583312622|FG000|Overall Study|Withdrawal by Subject|15|||
161526023|NCT02199028|583312627|FG000|Week 1|Adverse Event|1|||
161526024|NCT02199028|583312628|FG001|Week 1|Adverse Event|0|||
161526025|NCT02199028|583312627|FG000|Week 3|Adverse Event|1|||
161526026|NCT02199028|583312628|FG001|Week 3|Adverse Event|0|||
161526027|NCT01881126|583312629|FG000|Overall Study|Non-compliance|1|||
161526028|NCT01881126|583312630|FG001|Overall Study|Non-compliance|1|||
161526029|NCT01881126|583312629|FG000|Overall Study|Adverse Event|0|||
161526030|NCT01881126|583312630|FG001|Overall Study|Adverse Event|1|||
161526031|NCT05045625|583312633|FG000|Overall Study|Lost to Follow-up|3|||
161526032|NCT03867734|583312634|FG000|Overall Study|Lost to Follow-up|2|||
161526033|NCT01827904|583312635|FG000|Main Study|Withdrawal by Subject|1|||
161526034|NCT01827904|583312636|FG001|Main Study|Withdrawal by Subject|0|||
161526035|NCT01827904|583312637|FG002|Main Study|Withdrawal by Subject|0|||
161678163|NCT03198520|583873615|FG000|Overall Study|Withdrawal by Subject|1|||
161678164|NCT03198520|583873615|FG000|Overall Study|Study Ended|1|||
161678165|NCT01670539|583873616|FG000|Overall Study|Death|3|||
161678166|NCT01670539|583873617|FG001|Overall Study|Death|5|||
161935716|NCT03056755|584814001|FG000|Extension Phase|Subject/guardian decision|0|||
161935717|NCT03056755|584814002|FG001|Extension Phase|Subject/guardian decision|0|||
161526036|NCT01827904|583312635|FG000|Main Study|Adverse Event|1|||
161526037|NCT01827904|583312636|FG001|Main Study|Adverse Event|0|||
161526038|NCT01827904|583312637|FG002|Main Study|Adverse Event|0|||
161526039|NCT01827904|583312635|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
161526040|NCT01827904|583312636|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
161526041|NCT01827904|583312637|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
161526042|NCT01827904|583312635|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
161678167|NCT01670539|583873616|FG000|Overall Study|Withdrawal by Subject|3|||
161678168|NCT01670539|583873617|FG001|Overall Study|Withdrawal by Subject|0|||
161678169|NCT04353596|583873618|FG000|Overall Study|Protocol Violation|4|||
161678170|NCT04353596|583873619|FG001|Overall Study|Protocol Violation|4|||
161935718|NCT03056755|584814003|FG002|Extension Phase|Subject/guardian decision|1|||
161526043|NCT01827904|583312636|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
161526044|NCT01827904|583312637|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
161526045|NCT01827904|583312635|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
161526046|NCT01827904|583312636|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
161526047|NCT01827904|583312637|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
161526048|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
161935719|NCT04693715|584814010|FG000|Overall Study|Adverse Events Leading to Death|2|||
161935720|NCT04693715|584814011|FG001|Overall Study|Adverse Events Leading to Death|2|||
161935721|NCT04693715|584814012|FG002|Overall Study|Adverse Events Leading to Death|4|||
161935722|NCT04693715|584814010|FG000|Overall Study|Lost to Follow-up|0|||
161935723|NCT04693715|584814011|FG001|Overall Study|Lost to Follow-up|2|||
161935724|NCT04693715|584814012|FG002|Overall Study|Lost to Follow-up|2|||
161935725|NCT04693715|584814010|FG000|Overall Study|Physician Decision|0|||
161935726|NCT04693715|584814011|FG001|Overall Study|Physician Decision|1|||
161935727|NCT04693715|584814012|FG002|Overall Study|Physician Decision|0|||
161935728|NCT04693715|584814010|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161935729|NCT04693715|584814011|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
161935730|NCT04693715|584814012|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161935731|NCT04693715|584814010|FG000|Overall Study|Withdrawal by Subject|0|||
161935732|NCT04693715|584814011|FG001|Overall Study|Withdrawal by Subject|0|||
161935733|NCT04693715|584814012|FG002|Overall Study|Withdrawal by Subject|1|||
161935734|NCT04667949|584814020|FG000|Overall Study|Adverse Event|0|||
161935735|NCT04667949|584814021|FG001|Overall Study|Adverse Event|2|||
161935736|NCT04667949|584814020|FG000|Overall Study|Lost to Follow-up|0|||
161935737|NCT04667949|584814021|FG001|Overall Study|Lost to Follow-up|1|||
161935738|NCT04667949|584814020|FG000|Overall Study|Physician Decision|0|||
161935739|NCT04667949|584814021|FG001|Overall Study|Physician Decision|2|||
161935740|NCT04667949|584814020|FG000|Overall Study|Subject decision|1|||
161935741|NCT04667949|584814021|FG001|Overall Study|Subject decision|7|||
161935742|NCT05206370|584814022|FG000|Overall Study|Adverse Event|3|||
161935743|NCT05206370|584814023|FG001|Overall Study|Adverse Event|4|||
161935744|NCT05206370|584814024|FG002|Overall Study|Adverse Event|5|||
161935745|NCT05206370|584814022|FG000|Overall Study|Withdrawal by Subject|27|||
161935746|NCT05206370|584814023|FG001|Overall Study|Withdrawal by Subject|30|||
161935747|NCT05206370|584814024|FG002|Overall Study|Withdrawal by Subject|24|||
161935748|NCT05206370|584814022|FG000|Overall Study|Physician Decision|1|||
161935749|NCT05206370|584814023|FG001|Overall Study|Physician Decision|3|||
161935750|NCT05206370|584814024|FG002|Overall Study|Physician Decision|2|||
161935751|NCT05206370|584814022|FG000|Overall Study|Death|0|||
161935752|NCT05206370|584814023|FG001|Overall Study|Death|1|||
161935753|NCT05206370|584814024|FG002|Overall Study|Death|3|||
161935754|NCT05206370|584814022|FG000|Overall Study|Lost to Follow-up|23|||
161935755|NCT05206370|584814023|FG001|Overall Study|Lost to Follow-up|16|||
161935756|NCT05206370|584814024|FG002|Overall Study|Lost to Follow-up|14|||
161935757|NCT05206370|584814022|FG000|Overall Study|Other, Nor Specified|2|||
161935758|NCT05206370|584814023|FG001|Overall Study|Other, Nor Specified|2|||
161935759|NCT05206370|584814024|FG002|Overall Study|Other, Nor Specified|4|||
161935760|NCT05388058|584814025|FG000|Initial Treatment|Withdrawal by Subject|0|||
161935761|NCT05388058|584814026|FG001|Initial Treatment|Withdrawal by Subject|1|||
161935762|NCT05388058|584814025|FG000|Initial Treatment|Ineligible|0|||
161935763|NCT05388058|584814026|FG001|Initial Treatment|Ineligible|1|||
161935764|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
161935765|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
161935766|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Death|5|||
161935767|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
161935768|NCT04557735|584814027|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
161935769|NCT04557735|584814027|FG000|Follow-Up Period (26 Weeks)|Death|4|||
161935770|NCT04998851|584814029|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
161935771|NCT04998851|584814030|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
161935772|NCT04998851|584814029|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
161935773|NCT04998851|584814030|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
161935774|NCT04504630|584814031|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
161935775|NCT04504630|584814032|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
161935776|NCT04504630|584814031|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
161935777|NCT04504630|584814032|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
161935778|NCT05562934|584814033|FG000|Overall Study|Adverse Event|0|||
161935779|NCT05562934|584814034|FG001|Overall Study|Adverse Event|2|||
161935780|NCT05562934|584814035|FG002|Overall Study|Adverse Event|0|||
161935781|NCT05562934|584814036|FG003|Overall Study|Adverse Event|0|||
161526049|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
161935782|NCT05562934|584814037|FG004|Overall Study|Adverse Event|2|||
161935783|NCT05562934|584814033|FG000|Overall Study|Lost to Follow-up|0|||
161935784|NCT05562934|584814034|FG001|Overall Study|Lost to Follow-up|0|||
161935785|NCT05562934|584814035|FG002|Overall Study|Lost to Follow-up|0|||
161935786|NCT05562934|584814036|FG003|Overall Study|Lost to Follow-up|0|||
161935787|NCT05562934|584814037|FG004|Overall Study|Lost to Follow-up|1|||
161935788|NCT05562934|584814033|FG000|Overall Study|Protocol Violation|0|||
161935789|NCT05562934|584814034|FG001|Overall Study|Protocol Violation|0|||
161935790|NCT05562934|584814035|FG002|Overall Study|Protocol Violation|0|||
161935791|NCT05562934|584814036|FG003|Overall Study|Protocol Violation|1|||
161935792|NCT05562934|584814037|FG004|Overall Study|Protocol Violation|1|||
161935793|NCT05562934|584814033|FG000|Overall Study|Withdrawal by Subject|0|||
161935794|NCT05562934|584814034|FG001|Overall Study|Withdrawal by Subject|0|||
161935795|NCT05562934|584814035|FG002|Overall Study|Withdrawal by Subject|1|||
161935796|NCT05562934|584814036|FG003|Overall Study|Withdrawal by Subject|1|||
161935797|NCT05562934|584814037|FG004|Overall Study|Withdrawal by Subject|0|||
161935798|NCT05365217|584814038|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161935799|NCT05365217|584814039|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161935800|NCT04266301|584814042|FG000|Overall Study|Progressive Disease|111|||
161935801|NCT04266301|584814043|FG001|Overall Study|Progressive Disease|92|||
161935802|NCT04266301|584814042|FG000|Overall Study|Adverse Event|41|||
161935803|NCT04266301|584814043|FG001|Overall Study|Adverse Event|43|||
161526050|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
161526051|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
161526052|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
161526053|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
161526054|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
161526055|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
161526056|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
161935804|NCT04266301|584814042|FG000|Overall Study|Death|26|||
161935805|NCT04266301|584814043|FG001|Overall Study|Death|35|||
161590459|NCT03269136|583550387|FG007|Part 2A: Dose Expansion|Other|0|||
161590460|NCT03269136|583550388|FG008|Part 2A: Dose Expansion|Other|0|||
161935806|NCT04266301|584814042|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
161590461|NCT03269136|583550389|FG009|Part 2A: Dose Expansion|Other|0|||
161590462|NCT03269136|583550390|FG010|Part 2A: Dose Expansion|Other|0|||
161935807|NCT04266301|584814043|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
161935808|NCT04266301|584814042|FG000|Overall Study|Study Terminated by Sponsor|22|||
161935809|NCT04266301|584814043|FG001|Overall Study|Study Terminated by Sponsor|27|||
161935810|NCT04266301|584814042|FG000|Overall Study|Participant Decision|22|||
161935811|NCT04266301|584814043|FG001|Overall Study|Participant Decision|28|||
161935812|NCT04266301|584814042|FG000|Overall Study|Physician Decision|14|||
161935813|NCT04266301|584814043|FG001|Overall Study|Physician Decision|9|||
161935814|NCT04266301|584814042|FG000|Overall Study|New Therapy for Study Indication|2|||
161935815|NCT04266301|584814043|FG001|Overall Study|New Therapy for Study Indication|4|||
161935816|NCT04266301|584814042|FG000|Overall Study|Protocol Deviation|2|||
161935817|NCT04266301|584814043|FG001|Overall Study|Protocol Deviation|4|||
161935818|NCT04266301|584814042|FG000|Overall Study|Guardian Decision|1|||
161935819|NCT04266301|584814043|FG001|Overall Study|Guardian Decision|0|||
161935820|NCT04266301|584814042|FG000|Overall Study|Lost to Follow-up|1|||
161935821|NCT04266301|584814043|FG001|Overall Study|Lost to Follow-up|0|||
161935822|NCT04266301|584814042|FG000|Overall Study|Participants Not Treated|1|||
161935823|NCT04266301|584814043|FG001|Overall Study|Participants Not Treated|1|||
161935824|NCT03215758|584814046|FG000|Overall Study|Technical Problems|1|||
161935825|NCT03215758|584814047|FG001|Overall Study|Technical Problems|0|||
161935826|NCT03215758|584814046|FG000|Overall Study|Protocol deviation|0|||
161935827|NCT03215758|584814047|FG001|Overall Study|Protocol deviation|1|||
161935828|NCT03215758|584814046|FG000|Overall Study|Physician Decision|0|||
161935829|NCT03215758|584814047|FG001|Overall Study|Physician Decision|1|||
161935830|NCT03215758|584814046|FG000|Overall Study|Death|0|||
161935831|NCT03215758|584814047|FG001|Overall Study|Death|1|||
161935832|NCT03215758|584814046|FG000|Overall Study|Adverse Event|1|||
161935833|NCT03215758|584814047|FG001|Overall Study|Adverse Event|2|||
161935834|NCT03215758|584814046|FG000|Overall Study|Subject/Guardian Decision|3|||
161935835|NCT03215758|584814047|FG001|Overall Study|Subject/Guardian Decision|3|||
161935836|NCT05733286|584814049|FG000|Overall Study|Never received study drug|2|||
161935837|NCT05733286|584814050|FG001|Overall Study|Never received study drug|3|||
161935838|NCT04527549|584814054|FG000|Overall Study|Withdrawal by Subject|1|||
161935839|NCT04527549|584814055|FG001|Overall Study|Withdrawal by Subject|1|||
161935840|NCT03997383|584814060|FG000|Double-blind Treatment Period|Adverse Event|4|||
161935841|NCT03997383|584814061|FG001|Double-blind Treatment Period|Adverse Event|3|||
161935842|NCT03997383|584814060|FG000|Double-blind Treatment Period|Death|4|||
161935843|NCT03997383|584814061|FG001|Double-blind Treatment Period|Death|4|||
161935844|NCT03997383|584814060|FG000|Double-blind Treatment Period|Physician Decision|2|||
161935845|NCT03997383|584814061|FG001|Double-blind Treatment Period|Physician Decision|0|||
161935846|NCT03997383|584814060|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
161935847|NCT03997383|584814061|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
161935848|NCT03997383|584814060|FG000|Open-label Extension Period|Ongoing|148|||
161590463|NCT03269136|583550391|FG011|Part 2A: Dose Expansion|Other|0|||
161590464|NCT03269136|583550392|FG012|Part 2A: Dose Expansion|Other|0|||
161526057|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
161526058|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
161526059|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
161526060|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Physician Decision|1|||
161526061|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Physician Decision|0|||
161526062|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Physician Decision|0|||
161526063|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
161526064|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
161526065|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
161526066|NCT01827904|583312635|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
161526067|NCT01827904|583312636|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
161526068|NCT01827904|583312637|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
161526069|NCT01910519|583312638|FG000|Overall Study|Withdrawal by Subject|2|||
161526070|NCT01910519|583312639|FG001|Overall Study|Withdrawal by Subject|0|||
161526071|NCT01910519|583312638|FG000|Overall Study|Adverse Event|2|||
161526072|NCT01910519|583312639|FG001|Overall Study|Adverse Event|0|||
161526073|NCT04266028|583312640|FG000|Overall Study|Adverse Event|0|||
161526074|NCT04266028|583312641|FG001|Overall Study|Adverse Event|0|||
161526075|NCT04266028|583312642|FG002|Overall Study|Adverse Event|1|||
161526076|NCT04266028|583312643|FG003|Overall Study|Adverse Event|0|||
161526077|NCT04266028|583312644|FG004|Overall Study|Adverse Event|1|||
161526078|NCT04266028|583312645|FG005|Overall Study|Adverse Event|0|||
161526079|NCT04266028|583312646|FG006|Overall Study|Adverse Event|2|||
161526080|NCT04266028|583312647|FG007|Overall Study|Adverse Event|0|||
161526081|NCT04266028|583312640|FG000|Overall Study|temporary halt of the study|0|||
161526082|NCT04266028|583312641|FG001|Overall Study|temporary halt of the study|0|||
161526083|NCT04266028|583312642|FG002|Overall Study|temporary halt of the study|0|||
161526084|NCT04266028|583312643|FG003|Overall Study|temporary halt of the study|0|||
161590465|NCT03269136|583550393|FG013|Part 2A: Dose Expansion|Other|0|||
161678171|NCT04353596|583873618|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
161678172|NCT04353596|583873619|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
161678173|NCT01236573|583873620|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678174|NCT01236573|583873621|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678175|NCT01236573|583873622|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678176|NCT01236573|583873623|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161590466|NCT03269136|583550394|FG014|Part 2A: Dose Expansion|Other|0|||
161590467|NCT03269136|583550395|FG015|Part 2A: Dose Expansion|Other|0|||
161590468|NCT03269136|583550396|FG016|Part 2A: Dose Expansion|Other|0|||
161590469|NCT03269136|583550397|FG017|Part 2A: Dose Expansion|Other|1|||
161590470|NCT03269136|583550380|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590471|NCT03269136|583550381|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590472|NCT03269136|583550382|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590473|NCT03269136|583550383|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590474|NCT03269136|583550384|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590475|NCT03269136|583550385|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590476|NCT03269136|583550386|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590477|NCT03269136|583550387|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590478|NCT03269136|583550388|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590479|NCT03269136|583550389|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590480|NCT03269136|583550390|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590481|NCT03269136|583550391|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590482|NCT03269136|583550392|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590483|NCT03269136|583550393|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590484|NCT03269136|583550394|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590485|NCT03269136|583550395|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590486|NCT03269136|583550396|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161590487|NCT03269136|583550397|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
161590488|NCT03269136|583550380|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
161590489|NCT03269136|583550381|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
161590490|NCT03269136|583550382|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
161590491|NCT03269136|583550383|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
161590492|NCT03269136|583550384|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
161590493|NCT03269136|583550385|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
161590494|NCT03269136|583550386|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
161590495|NCT03269136|583550387|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
161826953|NCT03185741|584406125|FG001|3Month|Lost to Follow-up|9|||
161826954|NCT03185741|584406126|FG002|3Month|Lost to Follow-up|8|||
161526085|NCT04266028|583312644|FG004|Overall Study|temporary halt of the study|0|||
161526086|NCT04266028|583312645|FG005|Overall Study|temporary halt of the study|0|||
161526087|NCT04266028|583312646|FG006|Overall Study|temporary halt of the study|2|||
161526088|NCT04266028|583312647|FG007|Overall Study|temporary halt of the study|1|||
161526089|NCT04266028|583312640|FG000|Overall Study|Onset of birch pollen season|0|||
161526090|NCT04266028|583312641|FG001|Overall Study|Onset of birch pollen season|0|||
161526091|NCT04266028|583312642|FG002|Overall Study|Onset of birch pollen season|0|||
161526092|NCT04266028|583312643|FG003|Overall Study|Onset of birch pollen season|0|||
161526093|NCT04266028|583312644|FG004|Overall Study|Onset of birch pollen season|1|||
161526094|NCT04266028|583312645|FG005|Overall Study|Onset of birch pollen season|0|||
161526095|NCT04266028|583312646|FG006|Overall Study|Onset of birch pollen season|0|||
161526096|NCT04266028|583312647|FG007|Overall Study|Onset of birch pollen season|0|||
161526097|NCT01458574|583312648|FG000|Overall Study|Adverse Event|5|||
161526098|NCT01458574|583312649|FG001|Overall Study|Adverse Event|9|||
161826955|NCT03185741|584406124|FG000|3Month|Unavailable for 3Month|11|||
161826956|NCT03185741|584406125|FG001|3Month|Unavailable for 3Month|10|||
161826957|NCT03185741|584406126|FG002|3Month|Unavailable for 3Month|11|||
161826958|NCT03185741|584406124|FG000|3Month|Protocol Violation|0|||
161826959|NCT03185741|584406125|FG001|3Month|Protocol Violation|0|||
161826960|NCT03185741|584406126|FG002|3Month|Protocol Violation|3|||
161826961|NCT03185741|584406124|FG000|6Month|Death|1|||
161826962|NCT03185741|584406125|FG001|6Month|Death|1|||
161826963|NCT03185741|584406126|FG002|6Month|Death|2|||
161826964|NCT03185741|584406124|FG000|6Month|Withdrawal by Subject|2|||
161826965|NCT03185741|584406125|FG001|6Month|Withdrawal by Subject|3|||
161826966|NCT03185741|584406126|FG002|6Month|Withdrawal by Subject|1|||
161826967|NCT03185741|584406124|FG000|6Month|Lost to Follow-up|16|||
161826968|NCT03185741|584406125|FG001|6Month|Lost to Follow-up|15|||
161826969|NCT03185741|584406126|FG002|6Month|Lost to Follow-up|16|||
161826970|NCT03573336|584406129|FG000|Overall Study|Study terminated|2|||
161826971|NCT03573336|584406130|FG001|Overall Study|Study terminated|4|||
161826972|NCT03573336|584406131|FG002|Overall Study|Study terminated|2|||
161826973|NCT03108820|584406132|FG000|Overall Study|Lost to Follow-up|30|||
161526099|NCT01458574|583312650|FG002|Overall Study|Adverse Event|7|||
161826974|NCT03108820|584406133|FG001|Overall Study|Lost to Follow-up|28|||
161526100|NCT01458574|583312648|FG000|Overall Study|Lack of Efficacy|70|||
161526101|NCT01458574|583312649|FG001|Overall Study|Lack of Efficacy|53|||
161526102|NCT01458574|583312650|FG002|Overall Study|Lack of Efficacy|132|||
161526103|NCT01458574|583312648|FG000|Overall Study|Lost to Follow-up|3|||
161526104|NCT01458574|583312649|FG001|Overall Study|Lost to Follow-up|2|||
161526105|NCT01458574|583312650|FG002|Overall Study|Lost to Follow-up|1|||
161526106|NCT01458574|583312648|FG000|Overall Study|Pregnancy|1|||
161526107|NCT01458574|583312649|FG001|Overall Study|Pregnancy|1|||
161526108|NCT01458574|583312650|FG002|Overall Study|Pregnancy|0|||
161526109|NCT01458574|583312648|FG000|Overall Study|Protocol Violation|0|||
161526110|NCT01458574|583312649|FG001|Overall Study|Protocol Violation|1|||
161526111|NCT01458574|583312650|FG002|Overall Study|Protocol Violation|0|||
161526112|NCT01458574|583312648|FG000|Overall Study|Withdrawal by Subject|6|||
161526113|NCT01458574|583312649|FG001|Overall Study|Withdrawal by Subject|3|||
161526114|NCT01458574|583312650|FG002|Overall Study|Withdrawal by Subject|5|||
161526115|NCT01458574|583312648|FG000|Overall Study|Other|2|||
161526116|NCT01458574|583312649|FG001|Overall Study|Other|1|||
161590496|NCT03269136|583550388|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
161826975|NCT03108820|584406132|FG000|Overall Study|Withdrawal by Subject|32|||
161826976|NCT03108820|584406133|FG001|Overall Study|Withdrawal by Subject|24|||
161826977|NCT03108820|584406132|FG000|Overall Study|Death|6|||
161826978|NCT03108820|584406133|FG001|Overall Study|Death|11|||
161826979|NCT01488448|584406139|FG000|Overall Study|Withdrawal by Subject|3|||
161526117|NCT01458574|583312650|FG002|Overall Study|Other|0|||
161526118|NCT01458574|583312648|FG000|Overall Study|Randomized but not treated|0|||
161526119|NCT01458574|583312649|FG001|Overall Study|Randomized but not treated|1|||
161826980|NCT01488448|584406140|FG001|Overall Study|Withdrawal by Subject|1|||
161526120|NCT01458574|583312650|FG002|Overall Study|Randomized but not treated|0|||
161526121|NCT02125786|583312651|FG000|Overall Study|Still in Follow-up|3|||
161526122|NCT02125786|583312651|FG000|Overall Study|Screen Failure|2|||
161526123|NCT02125786|583312651|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
161526124|NCT02125786|583312651|FG000|Overall Study|Progressive Disease|44|||
161526125|NCT02125786|583312651|FG000|Overall Study|Death|8|||
161526126|NCT02663128|583312652|FG000|Period 2|Physician Decision|0|||
161526127|NCT02663128|583312653|FG001|Period 2|Physician Decision|0|||
161590497|NCT03269136|583550389|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
161826981|NCT01488448|584406139|FG000|Overall Study|Adverse Event|9|||
161826982|NCT01488448|584406140|FG001|Overall Study|Adverse Event|4|||
161826983|NCT01488448|584406139|FG000|Overall Study|Physician Decision|4|||
161826984|NCT01488448|584406140|FG001|Overall Study|Physician Decision|9|||
161826985|NCT01488448|584406139|FG000|Overall Study|Protocol Violation|4|||
161826986|NCT01488448|584406140|FG001|Overall Study|Protocol Violation|3|||
161826987|NCT00654641|584406141|FG000|Overall Study|Lost to Follow-up|2|||
161826988|NCT00654641|584406142|FG001|Overall Study|Lost to Follow-up|3|||
161826989|NCT01992094|584406143|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
161826990|NCT01992094|584406144|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
161826991|NCT01992094|584406145|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
161826992|NCT01992094|584406143|FG000|Overall Study|Adverse Event|1|||
161590498|NCT03269136|583550390|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
161590499|NCT03269136|583550391|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
161590500|NCT03269136|583550392|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
161590501|NCT03269136|583550393|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
161590502|NCT03269136|583550394|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
161526128|NCT02663128|583312654|FG002|Period 2|Physician Decision|0|||
161526129|NCT02663128|583312655|FG003|Period 2|Physician Decision|0|||
161526130|NCT02663128|583312656|FG004|Period 2|Physician Decision|1|||
161526131|NCT02663128|583312657|FG005|Period 2|Physician Decision|0|||
161526132|NCT02720484|583312658|FG000|Treatment on Study|Adverse Event|1|||
161526133|NCT02720484|583312658|FG000|Treatment on Study|Withdrawal by Subject|1|||
161526134|NCT02720484|583312658|FG000|Treatment on Study|Progressive Disease|4|||
161526135|NCT02720484|583312658|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
161526136|NCT02720484|583312658|FG000|Follow Up for 2 Years|Death|3|||
161526137|NCT02720484|583312658|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
161526138|NCT05070897|583312659|FG000|Overall Study|Protocol Violation|123|||
161526139|NCT05070897|583312660|FG001|Overall Study|Protocol Violation|68|||
161526140|NCT01617629|583312663|FG000|Overall Study|Death|2|||
161526141|NCT01617629|583312663|FG000|Overall Study|Investigator's Clinical Judgement|1|||
161526142|NCT01617629|583312663|FG000|Overall Study|Reason Not Specified|1|||
161526143|NCT01617629|583312663|FG000|Overall Study|Participant Withdrew Consent|2|||
161526144|NCT01663636|583312664|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
161526145|NCT01663636|583312665|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
161526146|NCT03832946|583312666|FG000|Overall Study|Adverse Event|3|||
161526147|NCT03832946|583312667|FG001|Overall Study|Adverse Event|1|||
161526148|NCT03832946|583312666|FG000|Overall Study|Lost to Follow-up|1|||
161526149|NCT03832946|583312667|FG001|Overall Study|Lost to Follow-up|0|||
161526150|NCT03832946|583312666|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
161526151|NCT03832946|583312667|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
161526152|NCT03832946|583312666|FG000|Overall Study|Lack of Efficacy|1|||
161526153|NCT03832946|583312667|FG001|Overall Study|Lack of Efficacy|0|||
161526154|NCT03832946|583312666|FG000|Overall Study|Withdrawal by Subject|12|||
161590503|NCT03269136|583550395|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
161590504|NCT03269136|583550396|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
161526155|NCT03832946|583312667|FG001|Overall Study|Withdrawal by Subject|9|||
161526156|NCT03394924|583312670|FG000|Overall Study|Adverse Event|0|||
161590505|NCT03269136|583550397|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
161590506|NCT03269136|583550380|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
161590507|NCT03269136|583550381|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
161590508|NCT03269136|583550382|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
161590509|NCT03269136|583550383|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
161590510|NCT03269136|583550384|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
161590511|NCT03269136|583550385|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
161590512|NCT03269136|583550386|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
161590513|NCT03269136|583550387|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
161590514|NCT03269136|583550388|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
161678177|NCT01236573|583873624|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678178|NCT01236573|583873625|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678179|NCT01236573|583873626|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161678180|NCT01236573|583873627|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678181|NCT01236573|583873628|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161678182|NCT01236573|583873629|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161678183|NCT01236573|583873630|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678184|NCT01236573|583873620|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678185|NCT01236573|583873621|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678186|NCT01236573|583873622|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678187|NCT01236573|583873623|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678188|NCT01236573|583873624|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678189|NCT01236573|583873625|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678190|NCT01236573|583873626|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678191|NCT01236573|583873627|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678192|NCT01236573|583873628|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
161678193|NCT01236573|583873629|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161590515|NCT03269136|583550389|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
161826993|NCT01992094|584406144|FG001|Overall Study|Adverse Event|0|||
161526157|NCT03394924|583312671|FG001|Overall Study|Adverse Event|5|||
161526158|NCT03394924|583312672|FG002|Overall Study|Adverse Event|0|||
161526159|NCT03394924|583312670|FG000|Overall Study|Withdrawal by Subject|2|||
161526160|NCT03394924|583312671|FG001|Overall Study|Withdrawal by Subject|0|||
161526161|NCT03394924|583312672|FG002|Overall Study|Withdrawal by Subject|0|||
161590516|NCT03269136|583550390|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
161678194|NCT01236573|583873630|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161826994|NCT01992094|584406145|FG002|Overall Study|Adverse Event|0|||
161526162|NCT03394924|583312670|FG000|Overall Study|Lost to Follow-up|0|||
161526163|NCT03394924|583312671|FG001|Overall Study|Lost to Follow-up|1|||
161526164|NCT03394924|583312672|FG002|Overall Study|Lost to Follow-up|0|||
161526165|NCT03394924|583312670|FG000|Overall Study|Did not meet all inclusion criteria|1|||
161526166|NCT03394924|583312671|FG001|Overall Study|Did not meet all inclusion criteria|0|||
161526167|NCT03394924|583312672|FG002|Overall Study|Did not meet all inclusion criteria|0|||
161526168|NCT03277313|583312682|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
161526169|NCT03277313|583312683|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
161526170|NCT03277313|583312682|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
161526171|NCT03277313|583312683|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
161526172|NCT03277313|583312682|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
161526173|NCT03277313|583312683|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
161526174|NCT03277313|583312682|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
161526175|NCT03277313|583312683|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
161526176|NCT03277313|583312682|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
161526177|NCT03277313|583312683|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
161526178|NCT02005471|583312688|FG000|Main Study|Adverse Event|0|||
161526179|NCT02005471|583312689|FG001|Main Study|Adverse Event|1|||
161526180|NCT02005471|583312690|FG002|Main Study|Adverse Event|0|||
161526181|NCT02005471|583312691|FG003|Main Study|Adverse Event|0|||
161526182|NCT02005471|583312688|FG000|Main Study|Death|83|||
161526183|NCT02005471|583312689|FG001|Main Study|Death|52|||
161526184|NCT02005471|583312690|FG002|Main Study|Death|0|||
161526185|NCT02005471|583312691|FG003|Main Study|Death|0|||
161526186|NCT02005471|583312688|FG000|Main Study|Lost to Follow-up|4|||
161526187|NCT02005471|583312689|FG001|Main Study|Lost to Follow-up|5|||
161526188|NCT02005471|583312690|FG002|Main Study|Lost to Follow-up|0|||
161526189|NCT02005471|583312691|FG003|Main Study|Lost to Follow-up|0|||
161526190|NCT02005471|583312688|FG000|Main Study|Physician Decision|3|||
161526191|NCT02005471|583312689|FG001|Main Study|Physician Decision|1|||
161678195|NCT01236573|583873620|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678196|NCT01236573|583873621|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161826995|NCT01992094|584406143|FG000|Overall Study|Death|5|||
161826996|NCT01992094|584406144|FG001|Overall Study|Death|5|||
161826997|NCT01992094|584406145|FG002|Overall Study|Death|2|||
161826998|NCT01992094|584406143|FG000|Overall Study|Lost to Follow-up|26|||
161826999|NCT01992094|584406144|FG001|Overall Study|Lost to Follow-up|9|||
161827000|NCT01992094|584406145|FG002|Overall Study|Lost to Follow-up|13|||
161827001|NCT01992094|584406143|FG000|Overall Study|OTHER|4|||
161827002|NCT01992094|584406144|FG001|Overall Study|OTHER|0|||
161827003|NCT01992094|584406145|FG002|Overall Study|OTHER|0|||
161827004|NCT01992094|584406143|FG000|Overall Study|Protocol Violation|1|||
161827005|NCT01992094|584406144|FG001|Overall Study|Protocol Violation|0|||
161827006|NCT01992094|584406145|FG002|Overall Study|Protocol Violation|1|||
161827007|NCT01992094|584406143|FG000|Overall Study|Withdrawal by Subject|7|||
161827008|NCT01992094|584406144|FG001|Overall Study|Withdrawal by Subject|3|||
161827009|NCT01992094|584406145|FG002|Overall Study|Withdrawal by Subject|4|||
161827010|NCT03168906|584406146|FG000|Overall Study|Lack of Efficacy|6|||
161827011|NCT03168906|584406147|FG001|Overall Study|Lack of Efficacy|6|||
161827012|NCT01214239|584406148|FG000|Overall Study|Adverse Event|3|||
161827013|NCT01214239|584406149|FG001|Overall Study|Adverse Event|4|||
161827014|NCT01214239|584406148|FG000|Overall Study|Protocol Violation|2|||
161827015|NCT01214239|584406149|FG001|Overall Study|Protocol Violation|1|||
161827016|NCT01214239|584406148|FG000|Overall Study|Lost to Follow-up|1|||
161827017|NCT01214239|584406149|FG001|Overall Study|Lost to Follow-up|1|||
161827018|NCT01214239|584406148|FG000|Overall Study|Withdrawal by Subject|4|||
161827019|NCT01214239|584406149|FG001|Overall Study|Withdrawal by Subject|9|||
161827020|NCT01214239|584406148|FG000|Overall Study|Lack of Efficacy|1|||
161827021|NCT01214239|584406149|FG001|Overall Study|Lack of Efficacy|2|||
161827022|NCT01214239|584406148|FG000|Overall Study|patient's private reason|1|||
161827023|NCT01214239|584406149|FG001|Overall Study|patient's private reason|1|||
161827024|NCT03840382|584406150|FG000|Overall Study|Lost to Follow-up|11|||
161827025|NCT01142661|584406151|FG000|Overall Study|Adverse Event|2|||
161827026|NCT01142661|584406151|FG000|Overall Study|Withdrawal by Subject|1|||
161827027|NCT01142661|584406151|FG000|Overall Study|Physician Decision|1|||
161827028|NCT00965731|584406154|FG000|Overall Study|Death|0|||
161827029|NCT00965731|584406155|FG001|Overall Study|Death|4|||
161827030|NCT00965731|584406154|FG000|Overall Study|Withdrawal by Subject|0|||
161827031|NCT00965731|584406155|FG001|Overall Study|Withdrawal by Subject|1|||
161827032|NCT00965731|584406154|FG000|Overall Study|Other|7|||
161827033|NCT00965731|584406155|FG001|Overall Study|Other|15|||
161827034|NCT04773600|584406156|FG000|Overall Study|Withdrawal by Subject|15|||
161827035|NCT04773600|584406157|FG001|Overall Study|Withdrawal by Subject|9|||
161827036|NCT04773600|584406156|FG000|Overall Study|Lost to Follow-up|10|||
161827037|NCT04773600|584406157|FG001|Overall Study|Lost to Follow-up|6|||
161827038|NCT04773600|584406156|FG000|Overall Study|Adverse Event|8|||
161827039|NCT04773600|584406157|FG001|Overall Study|Adverse Event|2|||
161827040|NCT04773600|584406156|FG000|Overall Study|Lack of Efficacy|2|||
161590517|NCT03269136|583550391|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
161590518|NCT03269136|583550392|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
161590519|NCT03269136|583550393|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
161590520|NCT03269136|583550394|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
161590521|NCT03269136|583550395|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
161590522|NCT03269136|583550396|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
161590523|NCT03269136|583550397|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
161590524|NCT03269136|583550380|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
161590525|NCT03269136|583550381|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
161590526|NCT03269136|583550382|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
161590527|NCT03269136|583550383|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
161590528|NCT03269136|583550384|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
161590529|NCT03269136|583550385|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
161590530|NCT03269136|583550386|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
161590531|NCT03269136|583550387|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
161590532|NCT03269136|583550388|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
161590533|NCT03269136|583550389|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
161590534|NCT03269136|583550390|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
161590535|NCT03269136|583550391|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
161590536|NCT03269136|583550392|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
161590537|NCT03269136|583550393|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
161590538|NCT03269136|583550394|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
161590539|NCT03269136|583550395|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
161590540|NCT03269136|583550396|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
161590541|NCT03269136|583550397|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
161590542|NCT04856163|583550404|FG000|Overall Study|Lost to Follow-up|97|||
161590543|NCT04856163|583550405|FG001|Overall Study|Lost to Follow-up|100|||
161590544|NCT03468218|583550408|FG000|Overall Study|Adverse Event|5|||
161590545|NCT03468218|583550408|FG000|Overall Study|Progressive Disease|16|||
161590546|NCT03468218|583550408|FG000|Overall Study|Death|1|||
161590547|NCT03468218|583550408|FG000|Overall Study|Alternate therapy|1|||
161590548|NCT03468218|583550408|FG000|Overall Study|Withdrawal by Subject|2|||
161590549|NCT03719443|583550409|FG000|Overall Study|Lost to Follow-up|0|||
161590550|NCT03719443|583550410|FG001|Overall Study|Lost to Follow-up|0|||
161590551|NCT03719443|583550411|FG002|Overall Study|Lost to Follow-up|1|||
161590552|NCT03719443|583550412|FG003|Overall Study|Lost to Follow-up|0|||
161590553|NCT03719443|583550413|FG004|Overall Study|Lost to Follow-up|1|||
161590554|NCT03719443|583550414|FG005|Overall Study|Lost to Follow-up|0|||
161590555|NCT03719443|583550415|FG006|Overall Study|Lost to Follow-up|1|||
161590556|NCT03719443|583550409|FG000|Overall Study|Withdrawal by Subject|0|||
161590557|NCT03719443|583550410|FG001|Overall Study|Withdrawal by Subject|0|||
161590558|NCT03719443|583550411|FG002|Overall Study|Withdrawal by Subject|1|||
161590559|NCT03719443|583550412|FG003|Overall Study|Withdrawal by Subject|0|||
161590560|NCT03719443|583550413|FG004|Overall Study|Withdrawal by Subject|0|||
161590561|NCT03719443|583550414|FG005|Overall Study|Withdrawal by Subject|0|||
161590562|NCT03719443|583550415|FG006|Overall Study|Withdrawal by Subject|0|||
161590563|NCT03447470|583550420|FG000|Overall Study|Death|0|||
161590564|NCT03447470|583550421|FG001|Overall Study|Death|1|||
161590565|NCT03447470|583550422|FG002|Overall Study|Death|3|||
161590566|NCT03447470|583550423|FG003|Overall Study|Death|0|||
161590567|NCT03447470|583550424|FG004|Overall Study|Death|1|||
161590568|NCT03447470|583550425|FG005|Overall Study|Death|0|||
161590569|NCT03447470|583550426|FG006|Overall Study|Death|3|||
161590570|NCT03447470|583550427|FG007|Overall Study|Death|3|||
161590571|NCT03447470|583550428|FG008|Overall Study|Death|1|||
161590572|NCT03447470|583550420|FG000|Overall Study|Withdrawal by Subject|1|||
161590573|NCT03447470|583550421|FG001|Overall Study|Withdrawal by Subject|0|||
161590574|NCT03447470|583550422|FG002|Overall Study|Withdrawal by Subject|0|||
161590575|NCT03447470|583550423|FG003|Overall Study|Withdrawal by Subject|0|||
161590576|NCT03447470|583550424|FG004|Overall Study|Withdrawal by Subject|1|||
161590577|NCT03447470|583550425|FG005|Overall Study|Withdrawal by Subject|0|||
161590578|NCT03447470|583550426|FG006|Overall Study|Withdrawal by Subject|1|||
161590579|NCT03447470|583550427|FG007|Overall Study|Withdrawal by Subject|1|||
161590580|NCT03447470|583550428|FG008|Overall Study|Withdrawal by Subject|3|||
161590581|NCT03447470|583550420|FG000|Overall Study|Treatment discontinued|3|||
161590582|NCT03447470|583550421|FG001|Overall Study|Treatment discontinued|2|||
161590583|NCT03447470|583550422|FG002|Overall Study|Treatment discontinued|4|||
161590584|NCT03447470|583550423|FG003|Overall Study|Treatment discontinued|6|||
161590585|NCT03447470|583550424|FG004|Overall Study|Treatment discontinued|2|||
161590586|NCT03447470|583550425|FG005|Overall Study|Treatment discontinued|1|||
161590587|NCT03447470|583550426|FG006|Overall Study|Treatment discontinued|2|||
161590588|NCT03447470|583550427|FG007|Overall Study|Treatment discontinued|4|||
161590589|NCT03447470|583550428|FG008|Overall Study|Treatment discontinued|3|||
161590590|NCT02471638|583550431|FG000|Overall Study|Early Term Withdrawal|10|||
161590591|NCT05816551|583552649|FG000|Overall Study|Withdrawal by Subject|0|||
161590592|NCT05816551|583552650|FG001|Overall Study|Withdrawal by Subject|1|||
161590593|NCT05816551|583552649|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
161526192|NCT02005471|583312690|FG002|Main Study|Physician Decision|0|||
161526193|NCT02005471|583312691|FG003|Main Study|Physician Decision|0|||
161526194|NCT02005471|583312688|FG000|Main Study|Withdrawal by Subject|26|||
161526195|NCT02005471|583312689|FG001|Main Study|Withdrawal by Subject|11|||
161526196|NCT02005471|583312690|FG002|Main Study|Withdrawal by Subject|0|||
161526197|NCT02005471|583312691|FG003|Main Study|Withdrawal by Subject|0|||
161526198|NCT02005471|583312688|FG000|Main Study|Reason not Specified|0|||
161526199|NCT02005471|583312689|FG001|Main Study|Reason not Specified|6|||
161526200|NCT02005471|583312690|FG002|Main Study|Reason not Specified|0|||
161526201|NCT02005471|583312691|FG003|Main Study|Reason not Specified|0|||
161526202|NCT02005471|583312688|FG000|Main Study|Randomized but not Dosed|8|||
161526203|NCT02005471|583312689|FG001|Main Study|Randomized but not Dosed|0|||
161526204|NCT02005471|583312690|FG002|Main Study|Randomized but not Dosed|0|||
161526205|NCT02005471|583312691|FG003|Main Study|Randomized but not Dosed|0|||
161526206|NCT02005471|583312688|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
161526207|NCT02005471|583312689|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
161526208|NCT02005471|583312690|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
161526209|NCT02005471|583312691|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
161526210|NCT02005471|583312688|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
161526211|NCT02005471|583312689|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
161526212|NCT02005471|583312690|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
161526213|NCT02005471|583312691|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
161526214|NCT02005471|583312688|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
161526215|NCT02005471|583312689|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
161526216|NCT02005471|583312690|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
161526217|NCT02005471|583312691|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
161526218|NCT02663817|583312692|FG000|Overall Study|Screen failure|2|||
161526219|NCT00932893|583312697|FG000|Overall Study|Death|115|||
161526220|NCT00932893|583312698|FG001|Overall Study|Death|24|||
161526221|NCT00932893|583312697|FG000|Overall Study|Lost to Follow-up|8|||
161526222|NCT00932893|583312698|FG001|Overall Study|Lost to Follow-up|0|||
161526223|NCT00932893|583312697|FG000|Overall Study|Withdrawal by Subject|5|||
161526224|NCT00932893|583312698|FG001|Overall Study|Withdrawal by Subject|2|||
161526225|NCT00932893|583312697|FG000|Overall Study|Other|5|||
161526226|NCT00932893|583312698|FG001|Overall Study|Other|144|||
161526227|NCT05350449|583312699|FG000|Overall Study|Withdrawal by Subject|4|||
161526228|NCT05350449|583312700|FG001|Overall Study|Withdrawal by Subject|8|||
161526229|NCT02062632|583314777|FG000|Overall Study|No treatment data|1|||
161526230|NCT00773968|583314780|FG000|Overall Study|Adverse Event|2|||
161526231|NCT00773968|583314780|FG000|Overall Study|Death|1|||
161526232|NCT00773968|583314780|FG000|Overall Study|Failure to Return|2|||
161526233|NCT00773968|583314780|FG000|Overall Study|Lack of Efficacy|3|||
161526234|NCT00773968|583314780|FG000|Overall Study|Protocol Violation|1|||
161526235|NCT00773968|583314780|FG000|Overall Study|Withdrawal by Subject|11|||
161526236|NCT00773968|583314780|FG000|Overall Study|Screen Failure|17|||
161526237|NCT00773968|583314780|FG000|Overall Study|Other|8|||
161526238|NCT02008890|583314783|FG000|Period 1|Withdrawal by Subject|7|||
161526239|NCT02008890|583314784|FG001|Period 1|Withdrawal by Subject|7|||
161526240|NCT02008890|583314785|FG002|Period 1|Withdrawal by Subject|5|||
161526241|NCT02008890|583314786|FG003|Period 1|Withdrawal by Subject|0|||
161526242|NCT02008890|583314787|FG004|Period 1|Withdrawal by Subject|0|||
161526243|NCT02008890|583314783|FG000|Period 1|Pregnancy|1|||
161526244|NCT02008890|583314784|FG001|Period 1|Pregnancy|0|||
161526245|NCT02008890|583314785|FG002|Period 1|Pregnancy|0|||
161526246|NCT02008890|583314786|FG003|Period 1|Pregnancy|0|||
161827041|NCT04773600|584406157|FG001|Overall Study|Lack of Efficacy|3|||
161827042|NCT04773600|584406156|FG000|Overall Study|Noncompliance|2|||
161827043|NCT04773600|584406157|FG001|Overall Study|Noncompliance|0|||
161526247|NCT02008890|583314787|FG004|Period 1|Pregnancy|0|||
161526248|NCT02008890|583314783|FG000|Period 1|Physician Decision|1|||
161526249|NCT02008890|583314784|FG001|Period 1|Physician Decision|0|||
161526250|NCT02008890|583314785|FG002|Period 1|Physician Decision|1|||
161827044|NCT04773600|584406156|FG000|Overall Study|Protocol Violation|2|||
161827045|NCT04773600|584406157|FG001|Overall Study|Protocol Violation|0|||
161827046|NCT04773600|584406156|FG000|Overall Study|Physician Decision|0|||
161827047|NCT04773600|584406157|FG001|Overall Study|Physician Decision|1|||
161827048|NCT04773600|584406156|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
161827049|NCT04773600|584406157|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
161827050|NCT04773600|584406156|FG000|Overall Study|Emergency Travel Out of Country|1|||
161827051|NCT04773600|584406157|FG001|Overall Study|Emergency Travel Out of Country|0|||
161827052|NCT02839798|584407932|FG000|Overall Study|Withdrawal by Subject|2|||
161827053|NCT03180528|584407933|FG000|Overall Study|Adverse Event|1|||
161827054|NCT03180528|584407933|FG000|Overall Study|Withdrawal by Subject|1|||
161827055|NCT03180528|584407933|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
161827056|NCT02447887|584407934|FG000|Overall Study|Study was terminated|3|||
161827057|NCT03429049|584407935|FG000|Overall Study|Adverse Event|2|||
161827058|NCT03429049|584407936|FG001|Overall Study|Adverse Event|3|||
161526251|NCT02008890|583314786|FG003|Period 1|Physician Decision|0|||
161526252|NCT02008890|583314787|FG004|Period 1|Physician Decision|0|||
161526253|NCT02008890|583314783|FG000|Period 1|Adverse Event|6|||
161526254|NCT02008890|583314784|FG001|Period 1|Adverse Event|8|||
161526255|NCT02008890|583314785|FG002|Period 1|Adverse Event|6|||
161526256|NCT02008890|583314786|FG003|Period 1|Adverse Event|0|||
161526257|NCT02008890|583314787|FG004|Period 1|Adverse Event|0|||
161526258|NCT02008890|583314783|FG000|Period 2|Adverse Event|12|||
161526259|NCT02008890|583314784|FG001|Period 2|Adverse Event|7|||
161526260|NCT02008890|583314785|FG002|Period 2|Adverse Event|0|||
161526261|NCT02008890|583314786|FG003|Period 2|Adverse Event|5|||
161526262|NCT02008890|583314787|FG004|Period 2|Adverse Event|5|||
161526263|NCT02008890|583314783|FG000|Period 2|Withdrawal by Subject|11|||
161526264|NCT02008890|583314784|FG001|Period 2|Withdrawal by Subject|8|||
161526265|NCT02008890|583314785|FG002|Period 2|Withdrawal by Subject|0|||
161526266|NCT02008890|583314786|FG003|Period 2|Withdrawal by Subject|7|||
161526267|NCT02008890|583314787|FG004|Period 2|Withdrawal by Subject|2|||
161526268|NCT02008890|583314783|FG000|Period 2|Physician Decision|4|||
161526269|NCT02008890|583314784|FG001|Period 2|Physician Decision|0|||
161526270|NCT02008890|583314785|FG002|Period 2|Physician Decision|0|||
161526271|NCT02008890|583314786|FG003|Period 2|Physician Decision|2|||
161526272|NCT02008890|583314787|FG004|Period 2|Physician Decision|1|||
161526273|NCT02008890|583314783|FG000|Period 2|Lost to Follow-up|0|||
161526274|NCT02008890|583314784|FG001|Period 2|Lost to Follow-up|0|||
161526275|NCT02008890|583314785|FG002|Period 2|Lost to Follow-up|1|||
161526276|NCT02008890|583314786|FG003|Period 2|Lost to Follow-up|0|||
161526277|NCT02008890|583314787|FG004|Period 2|Lost to Follow-up|0|||
161526278|NCT02008890|583314783|FG000|Extension Period|Withdrawal by Subject|3|||
161526279|NCT02008890|583314784|FG001|Extension Period|Withdrawal by Subject|2|||
161526280|NCT02008890|583314785|FG002|Extension Period|Withdrawal by Subject|0|||
161526281|NCT02008890|583314786|FG003|Extension Period|Withdrawal by Subject|4|||
161526282|NCT02008890|583314787|FG004|Extension Period|Withdrawal by Subject|2|||
161526283|NCT02008890|583314783|FG000|Extension Period|Lost to Follow-up|1|||
161526284|NCT02008890|583314784|FG001|Extension Period|Lost to Follow-up|0|||
161526285|NCT02008890|583314785|FG002|Extension Period|Lost to Follow-up|0|||
161526286|NCT02008890|583314786|FG003|Extension Period|Lost to Follow-up|0|||
161526287|NCT02008890|583314787|FG004|Extension Period|Lost to Follow-up|0|||
161526288|NCT02008890|583314783|FG000|Extension Period|Adverse Event|1|||
161526289|NCT02008890|583314784|FG001|Extension Period|Adverse Event|3|||
161526290|NCT02008890|583314785|FG002|Extension Period|Adverse Event|0|||
161526291|NCT02008890|583314786|FG003|Extension Period|Adverse Event|0|||
161526292|NCT02008890|583314787|FG004|Extension Period|Adverse Event|2|||
161526293|NCT02207816|583314788|FG000|Overall Study|Serious Adverse Event|0|||
161526294|NCT02207816|583314789|FG001|Overall Study|Serious Adverse Event|5|||
161526295|NCT02207816|583314790|FG002|Overall Study|Serious Adverse Event|2|||
161526296|NCT02207816|583314788|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
161526297|NCT02207816|583314789|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
161526298|NCT02207816|583314790|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
161526299|NCT02207816|583314788|FG000|Overall Study|Withdrawal by Subject|4|||
161526300|NCT02207816|583314789|FG001|Overall Study|Withdrawal by Subject|9|||
161526301|NCT02207816|583314790|FG002|Overall Study|Withdrawal by Subject|7|||
161526302|NCT02207816|583314788|FG000|Overall Study|Migrated/Moved From Study Area|41|||
161526303|NCT02207816|583314789|FG001|Overall Study|Migrated/Moved From Study Area|60|||
161526304|NCT02207816|583314790|FG002|Overall Study|Migrated/Moved From Study Area|51|||
161526305|NCT02207816|583314788|FG000|Overall Study|Lost to Follow-up|3|||
161526306|NCT02207816|583314789|FG001|Overall Study|Lost to Follow-up|9|||
161526307|NCT02207816|583314790|FG002|Overall Study|Lost to Follow-up|1|||
161526308|NCT02207816|583314788|FG000|Overall Study|Other|1|||
161526309|NCT02207816|583314789|FG001|Overall Study|Other|2|||
161526310|NCT02207816|583314790|FG002|Overall Study|Other|4|||
161526311|NCT02522494|583314791|FG000|Overall Study|Lost to Follow-up|6|||
161526312|NCT02522494|583314792|FG001|Overall Study|Lost to Follow-up|2|||
161526313|NCT02522494|583314791|FG000|Overall Study|Withdrawal by Subject|1|||
161526314|NCT02522494|583314792|FG001|Overall Study|Withdrawal by Subject|0|||
161526315|NCT02522494|583314791|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
161827059|NCT03429049|584407935|FG000|Overall Study|Death|0|||
161526316|NCT02522494|583314792|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
161526317|NCT02522494|583314791|FG000|Overall Study|Participant did not watch the video|1|||
161526318|NCT02522494|583314792|FG001|Overall Study|Participant did not watch the video|0|||
161526319|NCT02522494|583314791|FG000|Overall Study|Death|0|||
161526320|NCT02522494|583314792|FG001|Overall Study|Death|1|||
161526321|NCT02349295|583314795|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
161827060|NCT03429049|584407936|FG001|Overall Study|Death|1|||
161827061|NCT03429049|584407935|FG000|Overall Study|Lack of Efficacy|4|||
161827062|NCT03429049|584407936|FG001|Overall Study|Lack of Efficacy|2|||
161827063|NCT03429049|584407935|FG000|Overall Study|Lost to Follow-up|9|||
161827064|NCT03429049|584407936|FG001|Overall Study|Lost to Follow-up|8|||
161827065|NCT03429049|584407935|FG000|Overall Study|Physician Decision|1|||
161827066|NCT03429049|584407936|FG001|Overall Study|Physician Decision|0|||
161526322|NCT02349295|583314796|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
161526323|NCT02349295|583314797|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
161526324|NCT02349295|583314798|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526325|NCT02349295|583314799|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526326|NCT02349295|583314800|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526327|NCT02349295|583314801|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526328|NCT02349295|583314802|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526329|NCT02349295|583314803|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526330|NCT02349295|583314804|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526331|NCT02349295|583314805|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526332|NCT02349295|583314806|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526333|NCT02349295|583314807|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526334|NCT02349295|583314808|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
161526335|NCT02349295|583314795|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
161526336|NCT02349295|583314796|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
161526337|NCT02349295|583314797|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
161526338|NCT02349295|583314798|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526339|NCT02349295|583314799|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526340|NCT02349295|583314800|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526341|NCT02349295|583314801|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161827067|NCT03429049|584407935|FG000|Overall Study|Protocol Violation|3|||
161827068|NCT03429049|584407936|FG001|Overall Study|Protocol Violation|0|||
161827069|NCT03429049|584407935|FG000|Overall Study|Sponsor Decision|2|||
161827070|NCT03429049|584407936|FG001|Overall Study|Sponsor Decision|0|||
161526342|NCT02349295|583314802|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526343|NCT02349295|583314803|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526344|NCT02349295|583314804|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526345|NCT02349295|583314805|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526346|NCT02349295|583314806|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526347|NCT02349295|583314807|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526348|NCT02349295|583314808|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
161526349|NCT02349295|583314795|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
161526350|NCT02349295|583314796|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
161526351|NCT02349295|583314797|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
161526352|NCT02349295|583314798|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526353|NCT02349295|583314799|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526354|NCT02349295|583314800|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526355|NCT02349295|583314801|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526356|NCT02349295|583314802|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526357|NCT02349295|583314803|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526358|NCT02349295|583314804|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526359|NCT02349295|583314805|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526360|NCT02349295|583314806|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526361|NCT02349295|583314807|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526362|NCT02349295|583314808|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161526363|NCT02349295|583314795|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
161526364|NCT02349295|583314796|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
161526365|NCT02349295|583314797|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
161526366|NCT02349295|583314798|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161827071|NCT03429049|584407935|FG000|Overall Study|Withdrawal by Subject|4|||
161827072|NCT03429049|584407936|FG001|Overall Study|Withdrawal by Subject|20|||
161827073|NCT03429049|584407935|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
161827074|NCT03429049|584407936|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
161827075|NCT04703855|584407937|FG000|Overall Study|Heart Transplant|1|||
161827076|NCT02418455|584407940|FG000|48-Week Treatment Period|Other- Not Specified|1|||
161827077|NCT02418455|584407940|FG000|Continuation Period|Sponsor Decision|7|||
161827078|NCT02001051|584407943|FG000|Overall Study|Deemed not eligible following enrollment|0|||
161827079|NCT02001051|584407944|FG001|Overall Study|Deemed not eligible following enrollment|1|||
161827080|NCT04205162|584407954|FG000|Overall Study|Lost to Follow-up|1|||
161827081|NCT04205162|584407955|FG001|Overall Study|Lost to Follow-up|0|||
161827082|NCT04205162|584407954|FG000|Overall Study|Withdrawal by Subject|2|||
161827083|NCT04205162|584407955|FG001|Overall Study|Withdrawal by Subject|0|||
161827084|NCT04205162|584407954|FG000|Overall Study|University closure due to COVID-19|1|||
161827085|NCT04205162|584407955|FG001|Overall Study|University closure due to COVID-19|0|||
161827086|NCT01999894|584407956|FG000|Overall Study|Adverse Event|9|||
161827087|NCT01999894|584407956|FG000|Overall Study|Lack of Efficacy|5|||
161827088|NCT01999894|584407956|FG000|Overall Study|Protocol Violation|1|||
161827089|NCT01999894|584407956|FG000|Overall Study|Withdrawal by Subject|7|||
161827090|NCT01999894|584407956|FG000|Overall Study|Lost to Follow-up|10|||
161827091|NCT01999894|584407956|FG000|Overall Study|Other Reason|3|||
161827092|NCT01999894|584407956|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
161526367|NCT02349295|583314799|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526368|NCT02349295|583314800|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526369|NCT02349295|583314801|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526370|NCT02349295|583314802|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526371|NCT02349295|583314803|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526372|NCT02349295|583314804|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526373|NCT02349295|583314805|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526374|NCT02349295|583314806|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526375|NCT02349295|583314807|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526376|NCT02349295|583314808|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
161526377|NCT02349295|583314795|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526378|NCT02349295|583314796|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
161526379|NCT02349295|583314797|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
161526380|NCT02349295|583314798|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526381|NCT02349295|583314799|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526382|NCT02349295|583314800|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526383|NCT02349295|583314801|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526384|NCT02349295|583314802|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526385|NCT02349295|583314803|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526386|NCT02349295|583314804|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526387|NCT02349295|583314805|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161827093|NCT01546519|584407958|FG000|Overall Study|Adverse Event|0|||
161827094|NCT01546519|584407959|FG001|Overall Study|Adverse Event|0|||
161827095|NCT01546519|584407960|FG002|Overall Study|Adverse Event|1|||
161827096|NCT01546519|584407961|FG003|Overall Study|Adverse Event|1|||
161827097|NCT01546519|584407958|FG000|Overall Study|Death|0|||
161827098|NCT01546519|584407959|FG001|Overall Study|Death|1|||
161827099|NCT01546519|584407960|FG002|Overall Study|Death|3|||
161827100|NCT01546519|584407961|FG003|Overall Study|Death|1|||
161827101|NCT01546519|584407958|FG000|Overall Study|related to disease progression|2|||
161827102|NCT01546519|584407959|FG001|Overall Study|related to disease progression|2|||
161827103|NCT01546519|584407960|FG002|Overall Study|related to disease progression|2|||
161827104|NCT01546519|584407961|FG003|Overall Study|related to disease progression|1|||
161827105|NCT01546519|584407958|FG000|Overall Study|Physician Decision|6|||
161827106|NCT01546519|584407959|FG001|Overall Study|Physician Decision|5|||
161827107|NCT01546519|584407960|FG002|Overall Study|Physician Decision|2|||
161827108|NCT01546519|584407961|FG003|Overall Study|Physician Decision|3|||
161827109|NCT01546519|584407958|FG000|Overall Study|Withdrawal by Subject|1|||
161827110|NCT01546519|584407959|FG001|Overall Study|Withdrawal by Subject|0|||
161827111|NCT01546519|584407960|FG002|Overall Study|Withdrawal by Subject|0|||
161827112|NCT01546519|584407961|FG003|Overall Study|Withdrawal by Subject|0|||
161827113|NCT00779402|584407962|FG000|Treatment Phase 1|Disease Progression|1|||
161827114|NCT00779402|584407963|FG001|Treatment Phase 1|Disease Progression|0|||
161827115|NCT00779402|584407962|FG000|Treatment Phase 1|Adverse Event|2|||
161827116|NCT00779402|584407963|FG001|Treatment Phase 1|Adverse Event|0|||
161827117|NCT00779402|584407962|FG000|Treatment Phase 1|Protocol Violation|1|||
161827118|NCT00779402|584407963|FG001|Treatment Phase 1|Protocol Violation|0|||
161827119|NCT00779402|584407962|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
161827120|NCT00779402|584407963|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
161827121|NCT00779402|584407962|FG000|Treatment Phase 1|Lost to Follow-up|0|||
161827122|NCT00779402|584407963|FG001|Treatment Phase 1|Lost to Follow-up|1|||
161827123|NCT00779402|584407962|FG000|Treatment Phase 1|Death|0|||
161827124|NCT00779402|584407963|FG001|Treatment Phase 1|Death|1|||
161827125|NCT00779402|584407962|FG000|Treatment Phase 1|Intercurrent Illness|1|||
161827126|NCT00779402|584407963|FG001|Treatment Phase 1|Intercurrent Illness|1|||
161827127|NCT00779402|584407962|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
161827128|NCT00779402|584407963|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
161827129|NCT00779402|584407962|FG000|Treatment Phase 1|Other|4|||
161827130|NCT00779402|584407963|FG001|Treatment Phase 1|Other|2|||
161827131|NCT00779402|584407962|FG000|Treatment Phase 1|Closure of Study|3|||
161827132|NCT00779402|584407963|FG001|Treatment Phase 1|Closure of Study|2|||
161827133|NCT00779402|584407962|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
161827134|NCT00779402|584407963|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
161827135|NCT00779402|584407962|FG000|Surveillance Phase|Protocol Violation|0|||
161827136|NCT00779402|584407963|FG001|Surveillance Phase|Protocol Violation|1|||
161827137|NCT00779402|584407962|FG000|Surveillance Phase|Patient refused to continue|22|||
161827138|NCT00779402|584407963|FG001|Surveillance Phase|Patient refused to continue|14|||
161827139|NCT00779402|584407962|FG000|Surveillance Phase|Lost to Follow-up|2|||
161827140|NCT00779402|584407963|FG001|Surveillance Phase|Lost to Follow-up|1|||
161827141|NCT00779402|584407962|FG000|Surveillance Phase|Death|0|||
161827142|NCT00779402|584407963|FG001|Surveillance Phase|Death|1|||
161526388|NCT02349295|583314806|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526389|NCT02349295|583314807|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526390|NCT02349295|583314808|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
161526391|NCT02349295|583314795|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
161526392|NCT02349295|583314796|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
161526393|NCT02349295|583314797|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
161526394|NCT02349295|583314798|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
161526395|NCT02349295|583314799|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
161526396|NCT02349295|583314800|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
161526397|NCT02349295|583314801|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
161526398|NCT02349295|583314802|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
161526399|NCT02349295|583314803|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
161526400|NCT02349295|583314804|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
161526401|NCT02349295|583314805|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
161526402|NCT02349295|583314806|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
161526403|NCT02349295|583314807|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
161526404|NCT02349295|583314808|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
161526405|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526406|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526407|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526408|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526409|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526410|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526411|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526412|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
161526413|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
161526414|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
161526415|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
161526416|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526417|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526418|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161526419|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526420|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526421|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526422|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526423|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526424|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526425|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526426|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
161526427|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
161526428|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
161526429|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
161526430|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526431|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526432|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
161526433|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526434|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526435|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526436|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526437|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526438|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526439|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526440|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
161526441|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526442|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
161526443|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161590594|NCT05816551|583552650|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
161590595|NCT04593472|583552653|FG000|Overall Study|Death|31|||
161590596|NCT04593472|583552654|FG001|Overall Study|Death|27|||
161590597|NCT04593472|583552653|FG000|Overall Study|Withdrawal by Subject|12|||
161590598|NCT04593472|583552654|FG001|Overall Study|Withdrawal by Subject|12|||
161590599|NCT04593472|583552653|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
161590600|NCT04593472|583552654|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
161526444|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526445|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526446|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
161526447|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
161678197|NCT01236573|583873622|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161526448|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
161827143|NCT00779402|584407962|FG000|Surveillance Phase|Intercurrent Illness|2|||
161827144|NCT00779402|584407963|FG001|Surveillance Phase|Intercurrent Illness|0|||
161827145|NCT00779402|584407962|FG000|Surveillance Phase|Other|5|||
161827146|NCT00779402|584407963|FG001|Surveillance Phase|Other|5|||
161827147|NCT00779402|584407962|FG000|Surveillance Phase|Withdrawal by Subject|4|||
161827148|NCT00779402|584407963|FG001|Surveillance Phase|Withdrawal by Subject|1|||
161827149|NCT00779402|584407962|FG000|Surveillance Phase|Closure of study|5|||
161827150|NCT00779402|584407963|FG001|Surveillance Phase|Closure of study|6|||
161827151|NCT00779402|584407962|FG000|Surveillance Phase|Completed Protocol Visits|3|||
161827152|NCT00779402|584407963|FG001|Surveillance Phase|Completed Protocol Visits|2|||
161827153|NCT00779402|584407962|FG000|Long-term Follow-up|Patient refused to continue|2|||
161827154|NCT00779402|584407963|FG001|Long-term Follow-up|Patient refused to continue|0|||
161827155|NCT00779402|584407962|FG000|Long-term Follow-up|Other|5|||
161827156|NCT00779402|584407963|FG001|Long-term Follow-up|Other|0|||
161827157|NCT00779402|584407962|FG000|Long-term Follow-up|Closure of Study|8|||
161935849|NCT03997383|584814061|FG001|Open-label Extension Period|Ongoing|151|||
161526449|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
161526450|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
161526451|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
161526452|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
161526453|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
161526454|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
161526455|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
161526456|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
161526457|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
161526458|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
161526459|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
161526460|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
161526461|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161935850|NCT03997383|584814060|FG000|Open-label Extension Period|Adverse Event|4|||
161935851|NCT03997383|584814061|FG001|Open-label Extension Period|Adverse Event|1|||
161935852|NCT03997383|584814060|FG000|Open-label Extension Period|Death|8|||
161935853|NCT03997383|584814061|FG001|Open-label Extension Period|Death|9|||
161935854|NCT03997383|584814060|FG000|Open-label Extension Period|Physician Decision|1|||
161935855|NCT03997383|584814061|FG001|Open-label Extension Period|Physician Decision|1|||
161935856|NCT03997383|584814060|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
161935857|NCT03997383|584814061|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
161935858|NCT03997383|584814060|FG000|Open-label Extension Period|Reason Not Specified|2|||
161935859|NCT03997383|584814061|FG001|Open-label Extension Period|Reason Not Specified|0|||
161935860|NCT02977988|584814067|FG000|Overall Study|Lost to Follow-up|13|||
161935861|NCT02977988|584814068|FG001|Overall Study|Lost to Follow-up|7|||
161935862|NCT05098015|584814069|FG000|Overall Study|Death|1|||
161935863|NCT05098015|584814070|FG001|Overall Study|Death|1|||
161935864|NCT05098015|584814071|FG002|Overall Study|Death|3|||
161935865|NCT05098015|584814072|FG003|Overall Study|Death|0|||
161935866|NCT05098015|584814069|FG000|Overall Study|Lost to Follow-up|1|||
161935867|NCT05098015|584814070|FG001|Overall Study|Lost to Follow-up|1|||
161935868|NCT05098015|584814071|FG002|Overall Study|Lost to Follow-up|3|||
161935869|NCT05098015|584814072|FG003|Overall Study|Lost to Follow-up|3|||
161935870|NCT05098015|584814069|FG000|Overall Study|Withdrawal by Subject|0|||
161935871|NCT05098015|584814070|FG001|Overall Study|Withdrawal by Subject|1|||
161935872|NCT05098015|584814071|FG002|Overall Study|Withdrawal by Subject|0|||
161935873|NCT05098015|584814072|FG003|Overall Study|Withdrawal by Subject|2|||
161935874|NCT04831216|584814073|FG000|Overall Study|Lost to Follow-up|32|||
161935875|NCT05341115|584814074|FG000|Overall Study|Adverse Event|1|||
161827158|NCT00779402|584407963|FG001|Long-term Follow-up|Closure of Study|4|||
161526462|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526463|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526464|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526465|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526466|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161827159|NCT00779402|584407962|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
161935876|NCT05341115|584814074|FG000|Overall Study|Lost to Follow-up|1|||
161935877|NCT06038123|584814080|FG000|Overall Study|Withdrawal by Subject|1|||
161935878|NCT06038123|584814080|FG000|Overall Study|not return due to femur fracture|1|||
161935879|NCT05630001|584814082|FG000|Overall Study|Adverse Event|1|||
161935880|NCT05218499|584814083|FG000|Overall Study|Not treated|1|||
161935881|NCT05218499|584814084|FG001|Overall Study|Not treated|1|||
161935882|NCT05218499|584814085|FG002|Overall Study|Not treated|8|||
161935883|NCT05218499|584814083|FG000|Overall Study|Death|2|||
161827160|NCT00779402|584407963|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
161935884|NCT05218499|584814084|FG001|Overall Study|Death|0|||
161935885|NCT05218499|584814085|FG002|Overall Study|Death|0|||
161935886|NCT05218499|584814083|FG000|Overall Study|Other than listed|3|||
161935887|NCT05218499|584814084|FG001|Overall Study|Other than listed|7|||
161935888|NCT05218499|584814085|FG002|Overall Study|Other than listed|10|||
161935889|NCT05218499|584814083|FG000|Overall Study|Protocol deviation|5|||
161935890|NCT05218499|584814084|FG001|Overall Study|Protocol deviation|6|||
161935891|NCT05218499|584814085|FG002|Overall Study|Protocol deviation|4|||
161935892|NCT05218499|584814083|FG000|Overall Study|Technical problems|0|||
161935893|NCT05218499|584814084|FG001|Overall Study|Technical problems|1|||
161935894|NCT05218499|584814085|FG002|Overall Study|Technical problems|0|||
161935895|NCT05218499|584814083|FG000|Overall Study|Burden of trial procedures|0|||
161935896|NCT05218499|584814084|FG001|Overall Study|Burden of trial procedures|1|||
161935897|NCT05218499|584814085|FG002|Overall Study|Burden of trial procedures|2|||
161935898|NCT05218499|584814083|FG000|Overall Study|Clinical disease progression|6|||
161935899|NCT05218499|584814084|FG001|Overall Study|Clinical disease progression|6|||
161935900|NCT05218499|584814085|FG002|Overall Study|Clinical disease progression|11|||
161935901|NCT05218499|584814083|FG000|Overall Study|Objective disease progression|44|||
161935902|NCT05218499|584814084|FG001|Overall Study|Objective disease progression|61|||
161935903|NCT05218499|584814085|FG002|Overall Study|Objective disease progression|42|||
161935904|NCT05218499|584814083|FG000|Overall Study|Adverse Event|11|||
161935905|NCT05218499|584814084|FG001|Overall Study|Adverse Event|36|||
161935906|NCT05218499|584814085|FG002|Overall Study|Adverse Event|9|||
161935907|NCT05218499|584814083|FG000|Overall Study|On treatment at time of snapshot|18|||
161935908|NCT05218499|584814084|FG001|Overall Study|On treatment at time of snapshot|29|||
161935909|NCT05218499|584814085|FG002|Overall Study|On treatment at time of snapshot|0|||
161935910|NCT05386680|584817512|FG000|Overall Study|Guardian decision|2|||
161935911|NCT05655832|584817513|FG000|Overall Study|Not mentioned|0|||
161935912|NCT05655832|584817514|FG001|Overall Study|Not mentioned|1|||
161935913|NCT05655832|584817513|FG000|Overall Study|Withdrawal by Subject|0|||
161935914|NCT05655832|584817514|FG001|Overall Study|Withdrawal by Subject|1|||
161935915|NCT05655832|584817513|FG000|Overall Study|Protocol non-compliance|0|||
161935916|NCT05655832|584817514|FG001|Overall Study|Protocol non-compliance|1|||
161935917|NCT03946670|584817515|FG000|Overall Study|Progressive Disease|34|||
161935918|NCT03946670|584817516|FG001|Overall Study|Progressive Disease|27|||
161935919|NCT03946670|584817515|FG000|Overall Study|Adverse Event|7|||
161935920|NCT03946670|584817516|FG001|Overall Study|Adverse Event|10|||
161935921|NCT03946670|584817515|FG000|Overall Study|Physician Decision|6|||
161935922|NCT03946670|584817516|FG001|Overall Study|Physician Decision|5|||
161935923|NCT03946670|584817515|FG000|Overall Study|Death|5|||
161935924|NCT03946670|584817516|FG001|Overall Study|Death|8|||
161935925|NCT03946670|584817515|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
161935926|NCT03946670|584817516|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
161935927|NCT03946670|584817515|FG000|Overall Study|Subject Decision|4|||
161935928|NCT03946670|584817516|FG001|Overall Study|Subject Decision|5|||
161935929|NCT03946670|584817515|FG000|Overall Study|Study Terminated By Sponsor|2|||
161935930|NCT03946670|584817516|FG001|Overall Study|Study Terminated By Sponsor|0|||
161935931|NCT03946670|584817515|FG000|Overall Study|New Therapy For Study Indication|1|||
161935932|NCT03946670|584817516|FG001|Overall Study|New Therapy For Study Indication|0|||
161935933|NCT03946670|584817515|FG000|Overall Study|Not Treated|1|||
161678198|NCT01236573|583873623|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161827161|NCT01519947|584407964|FG000|Overall Study|Death|0|||
161827162|NCT01519947|584407965|FG001|Overall Study|Death|0|||
161827163|NCT01519947|584407966|FG002|Overall Study|Death|0|||
161827164|NCT01519947|584407967|FG003|Overall Study|Death|1|||
161827165|NCT01519947|584407964|FG000|Overall Study|Protocol Violation|0|||
161827166|NCT01519947|584407965|FG001|Overall Study|Protocol Violation|0|||
161827167|NCT01519947|584407966|FG002|Overall Study|Protocol Violation|2|||
161827168|NCT01519947|584407967|FG003|Overall Study|Protocol Violation|1|||
161827169|NCT01519947|584407964|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
161827170|NCT01519947|584407965|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
161827171|NCT01519947|584407966|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
161827172|NCT01519947|584407967|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
161827173|NCT01519947|584407964|FG000|Overall Study|Development of Anemia|0|||
161827174|NCT01519947|584407965|FG001|Overall Study|Development of Anemia|1|||
161827175|NCT01519947|584407966|FG002|Overall Study|Development of Anemia|0|||
161827176|NCT01519947|584407967|FG003|Overall Study|Development of Anemia|1|||
161827177|NCT01519947|584407964|FG000|Overall Study|Blood Transfusion|0|||
161827178|NCT01519947|584407965|FG001|Overall Study|Blood Transfusion|1|||
161827179|NCT01519947|584407966|FG002|Overall Study|Blood Transfusion|1|||
161827180|NCT01519947|584407967|FG003|Overall Study|Blood Transfusion|0|||
161827181|NCT01519947|584407964|FG000|Overall Study|Withdrawal by Subject|0|||
161827182|NCT01519947|584407965|FG001|Overall Study|Withdrawal by Subject|1|||
161827183|NCT01519947|584407966|FG002|Overall Study|Withdrawal by Subject|0|||
161827184|NCT01519947|584407967|FG003|Overall Study|Withdrawal by Subject|1|||
161827185|NCT01519947|584407964|FG000|Overall Study|Lost to Follow-up|0|||
161827186|NCT01519947|584407965|FG001|Overall Study|Lost to Follow-up|0|||
161526467|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526468|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
161526469|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
161526470|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
161526471|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
161526472|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526473|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526474|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161526475|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526476|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526477|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526478|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526479|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526480|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526481|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526482|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
161526483|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
161526484|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526485|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526486|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526487|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526488|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
161526489|NCT02349295|583314795|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526490|NCT02349295|583314796|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526491|NCT02349295|583314797|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526492|NCT02349295|583314798|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161590601|NCT04593472|583552653|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
161590602|NCT04593472|583552654|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
161590603|NCT04593472|583552653|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
161590604|NCT04593472|583552654|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
161590605|NCT04593472|583552653|FG000|Overall Study|Lost to Follow-up|0|||
161590606|NCT04593472|583552654|FG001|Overall Study|Lost to Follow-up|2|||
161590607|NCT04593472|583552653|FG000|Overall Study|Still collecting 24-month assessment|17|||
161590608|NCT04593472|583552654|FG001|Overall Study|Still collecting 24-month assessment|10|||
161590609|NCT04353661|583552658|FG000|Overall Study|Protocol Violation|0|||
161590610|NCT04353661|583552659|FG001|Overall Study|Protocol Violation|0|||
161590611|NCT04353661|583552660|FG002|Overall Study|Protocol Violation|1|||
161590612|NCT04353661|583552658|FG000|Overall Study|Study termination by the Sponsor|1|||
161590613|NCT04353661|583552659|FG001|Overall Study|Study termination by the Sponsor|1|||
161590614|NCT04353661|583552660|FG002|Overall Study|Study termination by the Sponsor|1|||
161590615|NCT02671903|583552666|FG000|Period 0 (Run-In)|Death|0|||
161590616|NCT02671903|583552667|FG001|Period 0 (Run-In)|Death|0|||
161590617|NCT02671903|583552668|FG002|Period 0 (Run-In)|Death|3|||
161590618|NCT02671903|583552666|FG000|Period 0 (Run-In)|Physician Decision|0|||
161590619|NCT02671903|583552667|FG001|Period 0 (Run-In)|Physician Decision|0|||
161590620|NCT02671903|583552668|FG002|Period 0 (Run-In)|Physician Decision|4|||
161590621|NCT02671903|583552666|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
161590622|NCT02671903|583552667|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
161590623|NCT02671903|583552668|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
161590624|NCT02671903|583552666|FG000|Period 0 (Run-In)|Protocol Violation|0|||
161590625|NCT02671903|583552667|FG001|Period 0 (Run-In)|Protocol Violation|0|||
161590626|NCT02671903|583552668|FG002|Period 0 (Run-In)|Protocol Violation|1|||
161590627|NCT02671903|583552666|FG000|Period 0 (Run-In)|Adverse Event|0|||
161590628|NCT02671903|583552667|FG001|Period 0 (Run-In)|Adverse Event|0|||
161590629|NCT02671903|583552668|FG002|Period 0 (Run-In)|Adverse Event|1|||
161590630|NCT02671903|583552666|FG000|Period 0 (Run-In)|Implantation Failure|0|||
161590631|NCT02671903|583552667|FG001|Period 0 (Run-In)|Implantation Failure|0|||
161590632|NCT02671903|583552668|FG002|Period 0 (Run-In)|Implantation Failure|2|||
161590633|NCT02671903|583552666|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
161590634|NCT02671903|583552667|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
161590635|NCT02671903|583552668|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
161590636|NCT03376321|583552669|FG000|Overall Study|Other|5|||
161590637|NCT03376321|583552670|FG001|Overall Study|Other|1|||
161590638|NCT03376321|583552669|FG000|Overall Study|Withdrawal by Subject|8|||
161590639|NCT03376321|583552670|FG001|Overall Study|Withdrawal by Subject|14|||
161590640|NCT03376321|583552669|FG000|Overall Study|Lost to Follow-up|1|||
161590641|NCT03376321|583552670|FG001|Overall Study|Lost to Follow-up|7|||
161590642|NCT03376321|583552669|FG000|Overall Study|Death|4|||
161590643|NCT03376321|583552670|FG001|Overall Study|Death|0|||
161935934|NCT03946670|584817516|FG001|Overall Study|Not Treated|1|||
161935935|NCT06433908|584817517|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
161935936|NCT06433908|584817518|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161526493|NCT02349295|583314799|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526494|NCT02349295|583314800|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526495|NCT02349295|583314801|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526496|NCT02349295|583314802|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
161526497|NCT02349295|583314803|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
161526498|NCT02349295|583314804|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526499|NCT02349295|583314805|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526500|NCT02349295|583314806|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526501|NCT02349295|583314807|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526502|NCT02349295|583314808|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
161526503|NCT02349295|583314795|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526504|NCT02349295|583314796|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526505|NCT02349295|583314797|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526506|NCT02349295|583314798|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526507|NCT02349295|583314799|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526508|NCT02349295|583314800|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526509|NCT02349295|583314801|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526510|NCT02349295|583314802|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526511|NCT02349295|583314803|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526512|NCT02349295|583314804|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526513|NCT02349295|583314805|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161526514|NCT02349295|583314806|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
161526515|NCT02349295|583314807|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
161526516|NCT02349295|583314808|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
161526517|NCT02349295|583314795|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526518|NCT02349295|583314796|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526519|NCT02349295|583314797|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526520|NCT02349295|583314798|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526521|NCT02349295|583314799|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526522|NCT02349295|583314800|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161590644|NCT03376321|583552669|FG000|Overall Study|Randomized, not treated|5|||
161590645|NCT03376321|583552670|FG001|Overall Study|Randomized, not treated|3|||
161590646|NCT02995434|583552671|FG000|Overall Study|Adverse Event|1|||
161590647|NCT02995434|583552672|FG001|Overall Study|Adverse Event|0|||
161590648|NCT02995434|583552671|FG000|Overall Study|Withdrawal by Subject|6|||
161590649|NCT02995434|583552672|FG001|Overall Study|Withdrawal by Subject|3|||
161590650|NCT04150718|583552673|FG000|Overall Study|Withdrawal by Subject|2|||
161590651|NCT04150718|583552674|FG001|Overall Study|Withdrawal by Subject|7|||
161590652|NCT04150718|583552675|FG002|Overall Study|Withdrawal by Subject|1|||
161590653|NCT04150718|583552673|FG000|Overall Study|Lost to Follow-up|1|||
161590654|NCT04150718|583552674|FG001|Overall Study|Lost to Follow-up|2|||
161590655|NCT04150718|583552675|FG002|Overall Study|Lost to Follow-up|0|||
161590656|NCT04150718|583552673|FG000|Overall Study|Ineligible|1|||
161590657|NCT04150718|583552674|FG001|Overall Study|Ineligible|0|||
161590658|NCT04150718|583552675|FG002|Overall Study|Ineligible|10|||
161590659|NCT04034251|583552676|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
161590660|NCT04034251|583552677|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
161590661|NCT04034251|583552678|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
161590662|NCT03673111|583552712|FG000|Overall Study|Protocol Violation|0|||
161590663|NCT03673111|583552713|FG001|Overall Study|Protocol Violation|0|||
161590664|NCT03673111|583552714|FG002|Overall Study|Protocol Violation|0|||
161590665|NCT03673111|583552715|FG003|Overall Study|Protocol Violation|0|||
161590666|NCT03673111|583552716|FG004|Overall Study|Protocol Violation|0|||
161590667|NCT03673111|583552717|FG005|Overall Study|Protocol Violation|0|||
161590668|NCT03673111|583552718|FG006|Overall Study|Protocol Violation|0|||
161590669|NCT03673111|583552719|FG007|Overall Study|Protocol Violation|0|||
161590670|NCT03673111|583552720|FG008|Overall Study|Protocol Violation|0|||
161590671|NCT03673111|583552721|FG009|Overall Study|Protocol Violation|0|||
161590672|NCT03673111|583552722|FG010|Overall Study|Protocol Violation|1|||
161590673|NCT03673111|583552723|FG011|Overall Study|Protocol Violation|0|||
161590674|NCT03673111|583552724|FG012|Overall Study|Protocol Violation|0|||
161590675|NCT03673111|583552725|FG013|Overall Study|Protocol Violation|0|||
161590676|NCT03673111|583552712|FG000|Overall Study|Adverse Event|1|||
161678199|NCT01236573|583873624|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161935937|NCT06433908|584817519|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161526523|NCT02349295|583314801|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526524|NCT02349295|583314802|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526525|NCT02349295|583314803|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526526|NCT02349295|583314804|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526527|NCT02349295|583314805|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526528|NCT02349295|583314806|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
161526529|NCT02349295|583314807|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
161526530|NCT02349295|583314808|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
161526531|NCT02349295|583314795|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526532|NCT02349295|583314796|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526533|NCT02349295|583314797|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526534|NCT02349295|583314798|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526535|NCT02349295|583314799|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526536|NCT02349295|583314800|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161827187|NCT01519947|584407966|FG002|Overall Study|Lost to Follow-up|3|||
161827188|NCT01519947|584407967|FG003|Overall Study|Lost to Follow-up|2|||
161827189|NCT01519947|584407964|FG000|Overall Study|Poor Response|1|||
161827190|NCT01519947|584407965|FG001|Overall Study|Poor Response|0|||
161827191|NCT01519947|584407966|FG002|Overall Study|Poor Response|0|||
161827192|NCT01519947|584407967|FG003|Overall Study|Poor Response|1|||
161827193|NCT01519947|584407964|FG000|Overall Study|Adverse Event|1|||
161827194|NCT01519947|584407965|FG001|Overall Study|Adverse Event|0|||
161827195|NCT01519947|584407966|FG002|Overall Study|Adverse Event|1|||
161827196|NCT01519947|584407967|FG003|Overall Study|Adverse Event|1|||
161827197|NCT00693225|584407968|FG000|Overall Study|Lost to Follow-up|1|||
161827198|NCT00693225|584407969|FG001|Overall Study|Lost to Follow-up|2|||
161827199|NCT00693225|584407968|FG000|Overall Study|Adverse Event|1|||
161827200|NCT00693225|584407969|FG001|Overall Study|Adverse Event|3|||
161827201|NCT03585959|584407974|FG000|Overall Study|Physician Decision|1|||
161827202|NCT03585959|584407974|FG000|Overall Study|Unsuccessful Procedure|2|||
161827203|NCT01186016|584407976|FG000|Overall Study|Withdrawal by Subject|46|||
161827204|NCT01186016|584407977|FG001|Overall Study|Withdrawal by Subject|29|||
161827205|NCT03750695|584407979|FG000|Overall Study|Lost to Follow-up|0|||
161827206|NCT03750695|584407980|FG001|Overall Study|Lost to Follow-up|1|||
161827207|NCT01386125|584407981|FG000|Overall Study|Lost to Follow-up|3|||
161827208|NCT01386125|584407982|FG001|Overall Study|Lost to Follow-up|9|||
161827209|NCT01386125|584407981|FG000|Overall Study|Physician Decision|0|||
161827210|NCT01386125|584407982|FG001|Overall Study|Physician Decision|1|||
161827211|NCT01386125|584407981|FG000|Overall Study|Protocol Violation|5|||
161827212|NCT01386125|584407982|FG001|Overall Study|Protocol Violation|7|||
161827213|NCT01386125|584407981|FG000|Overall Study|Disease Progress|1|||
161827214|NCT01386125|584407982|FG001|Overall Study|Disease Progress|2|||
161827215|NCT01386125|584407981|FG000|Overall Study|Withdrawal by Subject|13|||
161827216|NCT01386125|584407982|FG001|Overall Study|Withdrawal by Subject|12|||
161827217|NCT01386125|584407981|FG000|Overall Study|Adverse Event|2|||
161827218|NCT01386125|584407982|FG001|Overall Study|Adverse Event|5|||
161827219|NCT01386125|584407981|FG000|Overall Study|Lack of Efficacy|0|||
161827220|NCT01386125|584407982|FG001|Overall Study|Lack of Efficacy|1|||
161827221|NCT01386125|584407981|FG000|Overall Study|Participant Leaving Country|1|||
161827222|NCT01386125|584407982|FG001|Overall Study|Participant Leaving Country|0|||
161827223|NCT01292837|584407983|FG000|Overall Study|Adverse Event|1|||
161827224|NCT01292837|584407983|FG000|Overall Study|Further treatment determined|1|||
161827225|NCT02661022|584407986|FG000|Overall Study|Withdrawal by Subject|3|||
161827226|NCT02661022|584407987|FG001|Overall Study|Withdrawal by Subject|0|||
161827227|NCT02661022|584407986|FG000|Overall Study|Adverse Event|1|||
161827228|NCT02661022|584407987|FG001|Overall Study|Adverse Event|1|||
161827229|NCT02661022|584407986|FG000|Overall Study|Physician Decision|1|||
161827230|NCT02661022|584407987|FG001|Overall Study|Physician Decision|0|||
161827231|NCT02661022|584407986|FG000|Overall Study|Progressive Disease|2|||
161827232|NCT02661022|584407987|FG001|Overall Study|Progressive Disease|1|||
161526537|NCT02349295|583314801|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526538|NCT02349295|583314802|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526539|NCT02349295|583314803|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161827233|NCT02359864|584407988|FG000|Overall Study|Withdrawal by Subject|1|||
161827234|NCT02359864|584407989|FG001|Overall Study|Withdrawal by Subject|0|||
161827235|NCT04480307|584407991|FG000|Overall Study|Withdrawal by Subject|0|||
161827236|NCT04480307|584407992|FG001|Overall Study|Withdrawal by Subject|1|||
161827237|NCT04480307|584407993|FG002|Overall Study|Withdrawal by Subject|0|||
161827238|NCT04480307|584407994|FG003|Overall Study|Withdrawal by Subject|0|||
161526540|NCT02349295|583314804|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161678200|NCT01236573|583873625|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161827239|NCT04480307|584407991|FG000|Overall Study|Adverse Event|0|||
161827240|NCT04480307|584407992|FG001|Overall Study|Adverse Event|0|||
161827241|NCT04480307|584407993|FG002|Overall Study|Adverse Event|0|||
161827242|NCT04480307|584407994|FG003|Overall Study|Adverse Event|1|||
161526541|NCT02349295|583314805|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526542|NCT02349295|583314806|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
161526543|NCT02349295|583314807|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
161526544|NCT02349295|583314808|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
161526545|NCT02349295|583314795|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526546|NCT02349295|583314796|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526547|NCT02349295|583314797|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526548|NCT02349295|583314798|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526549|NCT02349295|583314799|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526550|NCT02349295|583314800|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526551|NCT02349295|583314801|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526552|NCT02349295|583314802|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526553|NCT02349295|583314803|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526554|NCT02349295|583314804|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526555|NCT02349295|583314805|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526556|NCT02349295|583314806|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
161526557|NCT02349295|583314807|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526558|NCT02349295|583314808|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161526559|NCT02349295|583314795|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526560|NCT02349295|583314796|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526561|NCT02349295|583314797|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526562|NCT02349295|583314798|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526563|NCT02349295|583314799|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526564|NCT02349295|583314800|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526565|NCT02349295|583314801|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526566|NCT02349295|583314802|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526567|NCT02349295|583314803|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526568|NCT02349295|583314804|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526569|NCT02349295|583314805|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526570|NCT02349295|583314806|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
161526571|NCT02349295|583314807|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526572|NCT02349295|583314808|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161526573|NCT03240588|583314809|FG000|Overall Study|Death|3|||
161526574|NCT03240588|583314810|FG001|Overall Study|Death|0|||
161526575|NCT03240588|583314811|FG002|Overall Study|Death|0|||
161526576|NCT03240588|583314809|FG000|Overall Study|Adverse Event|5|||
161526577|NCT03240588|583314810|FG001|Overall Study|Adverse Event|4|||
161526578|NCT03240588|583314811|FG002|Overall Study|Adverse Event|0|||
161526579|NCT03240588|583314809|FG000|Overall Study|Lost to Follow-up|9|||
161526580|NCT03240588|583314810|FG001|Overall Study|Lost to Follow-up|4|||
161526581|NCT03240588|583314811|FG002|Overall Study|Lost to Follow-up|0|||
161526582|NCT03240588|583314809|FG000|Overall Study|Physician Decision|3|||
161526583|NCT03240588|583314810|FG001|Overall Study|Physician Decision|2|||
161526584|NCT03240588|583314811|FG002|Overall Study|Physician Decision|0|||
161526585|NCT03240588|583314809|FG000|Overall Study|Did not meet eligibility criteria|0|||
161590677|NCT03673111|583552713|FG001|Overall Study|Adverse Event|0|||
161590678|NCT03673111|583552714|FG002|Overall Study|Adverse Event|0|||
161590679|NCT03673111|583552715|FG003|Overall Study|Adverse Event|0|||
161590680|NCT03673111|583552716|FG004|Overall Study|Adverse Event|0|||
161590681|NCT03673111|583552717|FG005|Overall Study|Adverse Event|0|||
161827243|NCT00609154|584407995|FG000|Overall Study|Protocol Violation|1|||
161827244|NCT00609154|584407996|FG001|Overall Study|Protocol Violation|2|||
161827245|NCT00609154|584407995|FG000|Overall Study|Unable to establish IV access|0|||
161827246|NCT00609154|584407996|FG001|Overall Study|Unable to establish IV access|4|||
161827247|NCT00609154|584407995|FG000|Overall Study|Adverse Event|0|||
161827248|NCT00609154|584407996|FG001|Overall Study|Adverse Event|2|||
161827249|NCT00515216|584407997|FG000|Overall Study|Withdrawal by Subject|1|||
161827250|NCT03023137|584408009|FG000|Overall Study|Multiple pregnancy|2|||
161827251|NCT03023137|584408010|FG001|Overall Study|Multiple pregnancy|4|||
161827252|NCT03023137|584408009|FG000|Overall Study|Lost to Follow-up|1|||
161827253|NCT03023137|584408010|FG001|Overall Study|Lost to Follow-up|1|||
161827254|NCT03023137|584408009|FG000|Overall Study|Protocol Violation|0|||
161827255|NCT03023137|584408010|FG001|Overall Study|Protocol Violation|4|||
161827256|NCT03023137|584408009|FG000|Overall Study|Lost the baby in a car accident|1|||
161827257|NCT03023137|584408010|FG001|Overall Study|Lost the baby in a car accident|0|||
161827258|NCT01450800|584408011|FG000|Overall Study|Protocol Violation|1|||
161827259|NCT01450800|584408012|FG001|Overall Study|Protocol Violation|3|||
161827260|NCT02795676|584408016|FG000|Overall Study|Adverse Event|2|||
161827261|NCT02795676|584408017|FG001|Overall Study|Adverse Event|0|||
161827262|NCT02795676|584408016|FG000|Overall Study|Withdrawal by Subject|3|||
161827263|NCT02795676|584408017|FG001|Overall Study|Withdrawal by Subject|1|||
161827264|NCT00732160|584408022|FG000|Overall Study|Adverse Event|1|||
161827265|NCT00732160|584408023|FG001|Overall Study|Adverse Event|0|||
161526586|NCT03240588|583314810|FG001|Overall Study|Did not meet eligibility criteria|6|||
161526587|NCT03240588|583314811|FG002|Overall Study|Did not meet eligibility criteria|0|||
161526588|NCT03240588|583314809|FG000|Overall Study|No longer meets protocol criteria|12|||
161526589|NCT03240588|583314810|FG001|Overall Study|No longer meets protocol criteria|7|||
161526590|NCT03240588|583314811|FG002|Overall Study|No longer meets protocol criteria|0|||
161526591|NCT03240588|583314809|FG000|Overall Study|Withdrawal by Subject|60|||
161526592|NCT03240588|583314810|FG001|Overall Study|Withdrawal by Subject|52|||
161526593|NCT03240588|583314811|FG002|Overall Study|Withdrawal by Subject|7|||
161526594|NCT03240588|583314809|FG000|Overall Study|Other, additional details not available.|0|||
161526595|NCT03240588|583314810|FG001|Overall Study|Other, additional details not available.|12|||
161526596|NCT03240588|583314811|FG002|Overall Study|Other, additional details not available.|1|||
161526597|NCT03240588|583314809|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
161526598|NCT03240588|583314810|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
161526599|NCT03240588|583314811|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
161526600|NCT03240588|583314809|FG000|Overall Study|Closure of study|55|||
161526601|NCT03240588|583314810|FG001|Overall Study|Closure of study|3|||
161526602|NCT03240588|583314811|FG002|Overall Study|Closure of study|0|||
161526603|NCT03240588|583314809|FG000|Overall Study|Subject non-compliance|23|||
161526604|NCT03240588|583314810|FG001|Overall Study|Subject non-compliance|2|||
161526605|NCT03240588|583314811|FG002|Overall Study|Subject non-compliance|1|||
161526606|NCT03240588|583314809|FG000|Overall Study|Device Deficiency|1|||
161526607|NCT03240588|583314810|FG001|Overall Study|Device Deficiency|0|||
161526608|NCT03240588|583314811|FG002|Overall Study|Device Deficiency|0|||
161526609|NCT03240588|583314809|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
161526610|NCT03240588|583314810|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
161526611|NCT03240588|583314811|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
161526612|NCT03461003|583314813|FG000|Overall Study|Lost to Follow-up|2|||
161526613|NCT03461003|583314814|FG001|Overall Study|Lost to Follow-up|2|||
161526614|NCT03461003|583314813|FG000|Overall Study|Withdrawal by Subject|3|||
161526615|NCT03461003|583314814|FG001|Overall Study|Withdrawal by Subject|1|||
161526616|NCT00620750|583314815|FG000|Overall Study|Lost to Follow-up|25|||
161526617|NCT04477187|583314816|FG000|Overall Study|Lost to Follow-up|2|||
161526618|NCT02047045|583314817|FG000|Baseline|Withdrawal by Subject|3|||
161526619|NCT02047045|583314818|FG001|Baseline|Withdrawal by Subject|2|||
161526620|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
161526621|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
161526622|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
161526623|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
161526624|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
161526625|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
161526626|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
161526627|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
161526628|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
161526629|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
161526630|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
161526631|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
161526632|NCT02047045|583314817|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
161526633|NCT02047045|583314818|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
161526634|NCT02047045|583314817|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
161526635|NCT02047045|583314818|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
161526636|NCT03508843|583314820|FG000|Overall Study|Withdrawal by Subject|1|||
161526637|NCT03508843|583314820|FG000|Overall Study|technical difficulties|2|||
161526638|NCT04717596|583314821|FG000|Overall Study|Withdrawal by Subject|4|||
161526639|NCT00765843|583314822|FG000|Overall Study|Lost to Follow-up|1|||
161526640|NCT00765843|583314823|FG001|Overall Study|Lost to Follow-up|3|||
161526641|NCT00765843|583314824|FG002|Overall Study|Lost to Follow-up|2|||
161526642|NCT00765843|583314822|FG000|Overall Study|did not return to receive intervention|0|||
161526643|NCT00765843|583314823|FG001|Overall Study|did not return to receive intervention|1|||
161526644|NCT00765843|583314824|FG002|Overall Study|did not return to receive intervention|0|||
161526645|NCT00765843|583314822|FG000|Overall Study|Adverse Event|0|||
161526646|NCT00765843|583314823|FG001|Overall Study|Adverse Event|0|||
161526647|NCT00765843|583314824|FG002|Overall Study|Adverse Event|1|||
161935938|NCT06433908|584817520|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161526648|NCT03555396|583314825|FG000|Overall Study|Death|3|||
161526649|NCT03555396|583314826|FG001|Overall Study|Death|1|||
161526650|NCT03555396|583314825|FG000|Overall Study|Lost to Follow-up|0|||
161526651|NCT03555396|583314826|FG001|Overall Study|Lost to Follow-up|2|||
161526652|NCT04066114|583314827|FG000|Overall Study|Adverse Event|1|||
161526653|NCT04066114|583314828|FG001|Overall Study|Adverse Event|0|||
161526654|NCT04066114|583314829|FG002|Overall Study|Adverse Event|0|||
161526655|NCT04066114|583314827|FG000|Overall Study|Withdrawal by Subject|1|||
161827266|NCT00732160|584408024|FG002|Overall Study|Adverse Event|1|||
161827267|NCT00732160|584408025|FG003|Overall Study|Adverse Event|1|||
161827268|NCT00732160|584408022|FG000|Overall Study|scheduling|4|||
161827269|NCT00732160|584408023|FG001|Overall Study|scheduling|4|||
161827270|NCT00732160|584408024|FG002|Overall Study|scheduling|2|||
161827271|NCT00732160|584408025|FG003|Overall Study|scheduling|1|||
161827272|NCT02427399|584408028|FG000|Overall Study|Protocol Violation|14|||
161827273|NCT02427399|584408029|FG001|Overall Study|Protocol Violation|16|||
161827274|NCT02427399|584408030|FG002|Overall Study|Protocol Violation|12|||
161827275|NCT02427399|584408031|FG003|Overall Study|Protocol Violation|18|||
161827276|NCT02427399|584408032|FG004|Overall Study|Protocol Violation|15|||
161827277|NCT01115933|584408033|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
161827278|NCT00605176|584408036|FG000|Overall Study|Adverse Event|2|||
161827279|NCT00605176|584408037|FG001|Overall Study|Adverse Event|1|||
161827280|NCT00605176|584408038|FG002|Overall Study|Adverse Event|3|||
161827281|NCT00605176|584408036|FG000|Overall Study|Withdrawal by Subject|4|||
161827282|NCT00605176|584408037|FG001|Overall Study|Withdrawal by Subject|2|||
161526656|NCT04066114|583314828|FG001|Overall Study|Withdrawal by Subject|0|||
161526657|NCT04066114|583314829|FG002|Overall Study|Withdrawal by Subject|0|||
161526658|NCT04066114|583314827|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161526659|NCT04066114|583314828|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
161526660|NCT04066114|583314829|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
161526661|NCT02460991|583314830|FG000|Overall Study|Withdrawal by Subject|0|||
161526662|NCT02460991|583314831|FG001|Overall Study|Withdrawal by Subject|2|||
161526663|NCT02564523|583314832|FG000|Overall Study|Withdrawal by Subject|3|||
161526664|NCT02564523|583314833|FG001|Overall Study|Withdrawal by Subject|0|||
161526665|NCT02564523|583314834|FG002|Overall Study|Withdrawal by Subject|1|||
161526666|NCT02564523|583314835|FG003|Overall Study|Withdrawal by Subject|0|||
161526667|NCT02564523|583314836|FG004|Overall Study|Withdrawal by Subject|1|||
161526668|NCT02564523|583314837|FG005|Overall Study|Withdrawal by Subject|0|||
161526669|NCT02564523|583314838|FG006|Overall Study|Withdrawal by Subject|1|||
161526670|NCT02564523|583314839|FG007|Overall Study|Withdrawal by Subject|0|||
161526671|NCT02564523|583314840|FG008|Overall Study|Withdrawal by Subject|0|||
161526672|NCT02564523|583314841|FG009|Overall Study|Withdrawal by Subject|0|||
161526673|NCT02564523|583314842|FG010|Overall Study|Withdrawal by Subject|1|||
161526674|NCT02564523|583314843|FG011|Overall Study|Withdrawal by Subject|0|||
161526675|NCT02564523|583314844|FG012|Overall Study|Withdrawal by Subject|1|||
161526676|NCT02564523|583314845|FG013|Overall Study|Withdrawal by Subject|0|||
161526677|NCT02564523|583314846|FG014|Overall Study|Withdrawal by Subject|0|||
161526678|NCT02564523|583314847|FG015|Overall Study|Withdrawal by Subject|0|||
161526679|NCT02564523|583314848|FG016|Overall Study|Withdrawal by Subject|0|||
161526680|NCT02564523|583314849|FG017|Overall Study|Withdrawal by Subject|0|||
161526681|NCT02564523|583314832|FG000|Overall Study|Adverse Event|0|||
161526682|NCT02564523|583314833|FG001|Overall Study|Adverse Event|0|||
161526683|NCT02564523|583314834|FG002|Overall Study|Adverse Event|0|||
161526684|NCT02564523|583314835|FG003|Overall Study|Adverse Event|0|||
161526685|NCT02564523|583314836|FG004|Overall Study|Adverse Event|0|||
161526686|NCT02564523|583314837|FG005|Overall Study|Adverse Event|0|||
161526687|NCT02564523|583314838|FG006|Overall Study|Adverse Event|0|||
161526688|NCT02564523|583314839|FG007|Overall Study|Adverse Event|0|||
161526689|NCT02564523|583314840|FG008|Overall Study|Adverse Event|0|||
161526690|NCT02564523|583314841|FG009|Overall Study|Adverse Event|0|||
161526691|NCT02564523|583314842|FG010|Overall Study|Adverse Event|0|||
161827283|NCT00605176|584408038|FG002|Overall Study|Withdrawal by Subject|4|||
161935939|NCT06433908|584817517|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161935940|NCT06433908|584817518|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
161935941|NCT06433908|584817519|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161935942|NCT06433908|584817520|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161935943|NCT06433908|584817517|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161935944|NCT06433908|584817518|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161935945|NCT06433908|584817519|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
161935946|NCT06433908|584817520|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161935947|NCT04516967|584817521|FG000|Core Phase|Adverse Event|2|||
161526692|NCT02564523|583314843|FG011|Overall Study|Adverse Event|0|||
161827284|NCT00605176|584408036|FG000|Overall Study|Lost to Follow-up|2|||
161526693|NCT02564523|583314844|FG012|Overall Study|Adverse Event|0|||
161526694|NCT02564523|583314845|FG013|Overall Study|Adverse Event|0|||
161526695|NCT02564523|583314846|FG014|Overall Study|Adverse Event|0|||
161526696|NCT02564523|583314847|FG015|Overall Study|Adverse Event|0|||
161526697|NCT02564523|583314848|FG016|Overall Study|Adverse Event|0|||
161526698|NCT02564523|583314849|FG017|Overall Study|Adverse Event|1|||
161526699|NCT02564523|583314832|FG000|Overall Study|Death|0|||
161827285|NCT00605176|584408037|FG001|Overall Study|Lost to Follow-up|2|||
161827286|NCT00605176|584408038|FG002|Overall Study|Lost to Follow-up|1|||
161827287|NCT00605176|584408036|FG000|Overall Study|Non-complicance with study procedures|1|||
161827288|NCT00605176|584408037|FG001|Overall Study|Non-complicance with study procedures|0|||
161935948|NCT04516967|584817522|FG001|Core Phase|Adverse Event|1|||
161935949|NCT04516967|584817523|FG002|Core Phase|Adverse Event|0|||
161935950|NCT04516967|584817521|FG000|Core Phase|Physician Decision|1|||
161935951|NCT04516967|584817522|FG001|Core Phase|Physician Decision|1|||
161935952|NCT04516967|584817523|FG002|Core Phase|Physician Decision|0|||
161935953|NCT04516967|584817521|FG000|Core Phase|Lack of Efficacy|7|||
161935954|NCT04516967|584817522|FG001|Core Phase|Lack of Efficacy|18|||
161935955|NCT04516967|584817523|FG002|Core Phase|Lack of Efficacy|0|||
161935956|NCT04403880|584817524|FG000|Overall Study|Death|1|||
161935957|NCT04403880|584817525|FG001|Overall Study|Death|0|||
161935958|NCT04403880|584817526|FG002|Overall Study|Death|2|||
161935959|NCT04403880|584817527|FG003|Overall Study|Death|0|||
161935960|NCT04403880|584817528|FG004|Overall Study|Death|0|||
161935961|NCT04403880|584817529|FG005|Overall Study|Death|0|||
161935962|NCT04403880|584817530|FG006|Overall Study|Death|0|||
161935963|NCT04403880|584817524|FG000|Overall Study|Physician Decision|0|||
161935964|NCT04403880|584817525|FG001|Overall Study|Physician Decision|0|||
161935965|NCT04403880|584817526|FG002|Overall Study|Physician Decision|0|||
161935966|NCT04403880|584817527|FG003|Overall Study|Physician Decision|0|||
161935967|NCT04403880|584817528|FG004|Overall Study|Physician Decision|1|||
161935968|NCT04403880|584817529|FG005|Overall Study|Physician Decision|0|||
161935969|NCT04403880|584817530|FG006|Overall Study|Physician Decision|0|||
161935970|NCT04403880|584817524|FG000|Overall Study|Lost to Follow-up|4|||
161935971|NCT04403880|584817525|FG001|Overall Study|Lost to Follow-up|3|||
161935972|NCT04403880|584817526|FG002|Overall Study|Lost to Follow-up|8|||
161935973|NCT04403880|584817527|FG003|Overall Study|Lost to Follow-up|7|||
161935974|NCT04403880|584817528|FG004|Overall Study|Lost to Follow-up|8|||
161935975|NCT04403880|584817529|FG005|Overall Study|Lost to Follow-up|1|||
161935976|NCT04403880|584817530|FG006|Overall Study|Lost to Follow-up|8|||
161935977|NCT04403880|584817524|FG000|Overall Study|Withdrawal by Subject|8|||
161935978|NCT04403880|584817525|FG001|Overall Study|Withdrawal by Subject|9|||
161935979|NCT04403880|584817526|FG002|Overall Study|Withdrawal by Subject|22|||
161935980|NCT04403880|584817527|FG003|Overall Study|Withdrawal by Subject|16|||
161935981|NCT04403880|584817528|FG004|Overall Study|Withdrawal by Subject|16|||
161678201|NCT01236573|583873626|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678202|NCT01236573|583873627|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678203|NCT01236573|583873628|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678204|NCT01236573|583873629|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678205|NCT01236573|583873630|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
161678206|NCT05418673|583873633|FG000|Overall Study|Study Terminated by Sponsor|2|||
161678207|NCT05418673|583873634|FG001|Overall Study|Study Terminated by Sponsor|4|||
161678208|NCT05418673|583873633|FG000|Overall Study|Lost to Follow-up|1|||
161678209|NCT05418673|583873634|FG001|Overall Study|Lost to Follow-up|0|||
161678210|NCT02665052|583873635|FG000|Overall Study|Lost to Follow-up|1|||
161678211|NCT02665052|583873636|FG001|Overall Study|Lost to Follow-up|0|||
161678212|NCT02665052|583873637|FG002|Overall Study|Lost to Follow-up|0|||
161678213|NCT02665052|583873638|FG003|Overall Study|Lost to Follow-up|0|||
161678214|NCT02665052|583873635|FG000|Overall Study|Withdrawal by Subject|1|||
161678215|NCT02665052|583873636|FG001|Overall Study|Withdrawal by Subject|1|||
161678216|NCT02665052|583873637|FG002|Overall Study|Withdrawal by Subject|0|||
161935982|NCT04403880|584817529|FG005|Overall Study|Withdrawal by Subject|8|||
161935983|NCT04403880|584817530|FG006|Overall Study|Withdrawal by Subject|11|||
161935984|NCT04403880|584817524|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161935985|NCT04403880|584817525|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
161935986|NCT04403880|584817526|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
161935987|NCT04403880|584817527|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161935988|NCT04403880|584817528|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
161935989|NCT04403880|584817529|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161935990|NCT04403880|584817530|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161935991|NCT04403880|584817524|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161678217|NCT02665052|583873638|FG003|Overall Study|Withdrawal by Subject|5|||
161935992|NCT04403880|584817525|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
161935993|NCT04403880|584817526|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161935994|NCT04403880|584817527|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
161678218|NCT02665052|583873635|FG000|Overall Study|Adverse Event|1|||
161678219|NCT02665052|583873636|FG001|Overall Study|Adverse Event|1|||
161935995|NCT04403880|584817528|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161526700|NCT02564523|583314833|FG001|Overall Study|Death|0|||
161935996|NCT04403880|584817529|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161935997|NCT04403880|584817530|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
161935998|NCT04403880|584817524|FG000|Overall Study|Pregnancy|2|||
161526701|NCT02564523|583314834|FG002|Overall Study|Death|0|||
161678220|NCT02665052|583873637|FG002|Overall Study|Adverse Event|0|||
161678221|NCT02665052|583873638|FG003|Overall Study|Adverse Event|0|||
161678222|NCT00823823|583873639|FG000|Overall Study|Lost to Follow-up|3|||
161935999|NCT04403880|584817525|FG001|Overall Study|Pregnancy|0|||
161936000|NCT04403880|584817526|FG002|Overall Study|Pregnancy|5|||
161936001|NCT04403880|584817527|FG003|Overall Study|Pregnancy|0|||
161936002|NCT04403880|584817528|FG004|Overall Study|Pregnancy|1|||
161936003|NCT04403880|584817529|FG005|Overall Study|Pregnancy|0|||
161936004|NCT04403880|584817530|FG006|Overall Study|Pregnancy|1|||
161936005|NCT04403880|584817524|FG000|Overall Study|Sponsor Decision|2|||
161936006|NCT04403880|584817525|FG001|Overall Study|Sponsor Decision|0|||
161936007|NCT04403880|584817526|FG002|Overall Study|Sponsor Decision|14|||
161936008|NCT04403880|584817527|FG003|Overall Study|Sponsor Decision|1|||
161936009|NCT04403880|584817528|FG004|Overall Study|Sponsor Decision|1|||
161936010|NCT04403880|584817529|FG005|Overall Study|Sponsor Decision|0|||
161936011|NCT04403880|584817530|FG006|Overall Study|Sponsor Decision|2|||
161936012|NCT04403880|584817524|FG000|Overall Study|Other|18|||
161526702|NCT02564523|583314835|FG003|Overall Study|Death|0|||
161526703|NCT02564523|583314836|FG004|Overall Study|Death|0|||
161526704|NCT02564523|583314837|FG005|Overall Study|Death|0|||
161936013|NCT04403880|584817525|FG001|Overall Study|Other|9|||
161936014|NCT04403880|584817526|FG002|Overall Study|Other|14|||
161936015|NCT04403880|584817527|FG003|Overall Study|Other|10|||
161936016|NCT04403880|584817528|FG004|Overall Study|Other|11|||
161526705|NCT02564523|583314838|FG006|Overall Study|Death|1|||
161526706|NCT02564523|583314839|FG007|Overall Study|Death|0|||
161526707|NCT02564523|583314840|FG008|Overall Study|Death|0|||
161936017|NCT04403880|584817529|FG005|Overall Study|Other|12|||
161936018|NCT04403880|584817530|FG006|Overall Study|Other|15|||
161936019|NCT04652726|584817531|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
161936020|NCT04652726|584817532|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
161936021|NCT04652726|584817533|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
161936022|NCT04652726|584817531|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
161936023|NCT04652726|584817532|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
161936024|NCT04652726|584817533|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
161936025|NCT03199469|584817534|FG000|Overall Study|Randomized, not treated|0|||
161936026|NCT03199469|584817535|FG001|Overall Study|Randomized, not treated|3|||
161936027|NCT03199469|584817534|FG000|Overall Study|Withdrawal by Subject|1|||
161936028|NCT03199469|584817535|FG001|Overall Study|Withdrawal by Subject|0|||
161936029|NCT03199469|584817534|FG000|Overall Study|Death|1|||
161936030|NCT03199469|584817535|FG001|Overall Study|Death|3|||
161936031|NCT03199469|584817534|FG000|Overall Study|Ongoing|5|||
161936032|NCT03199469|584817535|FG001|Overall Study|Ongoing|14|||
161936033|NCT03470441|584817538|FG000|Overall Study|Death|0|||
161936034|NCT03470441|584817539|FG001|Overall Study|Death|1|||
161526708|NCT02564523|583314841|FG009|Overall Study|Death|0|||
161526709|NCT02564523|583314842|FG010|Overall Study|Death|1|||
161526710|NCT02564523|583314843|FG011|Overall Study|Death|0|||
161526711|NCT02564523|583314844|FG012|Overall Study|Death|0|||
161526712|NCT02564523|583314845|FG013|Overall Study|Death|0|||
161526713|NCT02564523|583314846|FG014|Overall Study|Death|0|||
161526714|NCT02564523|583314847|FG015|Overall Study|Death|0|||
161526715|NCT02564523|583314848|FG016|Overall Study|Death|0|||
161526716|NCT02564523|583314849|FG017|Overall Study|Death|0|||
161526717|NCT02564523|583314832|FG000|Overall Study|Lost to Follow-up|2|||
161526718|NCT02564523|583314833|FG001|Overall Study|Lost to Follow-up|1|||
161526719|NCT02564523|583314834|FG002|Overall Study|Lost to Follow-up|4|||
161526720|NCT02564523|583314835|FG003|Overall Study|Lost to Follow-up|0|||
161526721|NCT02564523|583314836|FG004|Overall Study|Lost to Follow-up|1|||
161526722|NCT02564523|583314837|FG005|Overall Study|Lost to Follow-up|0|||
161526723|NCT02564523|583314838|FG006|Overall Study|Lost to Follow-up|1|||
161526724|NCT02564523|583314839|FG007|Overall Study|Lost to Follow-up|0|||
161526725|NCT02564523|583314840|FG008|Overall Study|Lost to Follow-up|0|||
161526726|NCT02564523|583314841|FG009|Overall Study|Lost to Follow-up|0|||
161526727|NCT02564523|583314842|FG010|Overall Study|Lost to Follow-up|0|||
161526728|NCT02564523|583314843|FG011|Overall Study|Lost to Follow-up|1|||
161936035|NCT03470441|584817540|FG002|Overall Study|Death|1|||
161526729|NCT02564523|583314844|FG012|Overall Study|Lost to Follow-up|1|||
161526730|NCT02564523|583314845|FG013|Overall Study|Lost to Follow-up|0|||
161526731|NCT02564523|583314846|FG014|Overall Study|Lost to Follow-up|0|||
161526732|NCT02564523|583314847|FG015|Overall Study|Lost to Follow-up|0|||
161526733|NCT02564523|583314848|FG016|Overall Study|Lost to Follow-up|0|||
161526734|NCT02564523|583314849|FG017|Overall Study|Lost to Follow-up|0|||
161936036|NCT03470441|584817541|FG003|Overall Study|Death|0|||
161936037|NCT03470441|584817538|FG000|Overall Study|Adverse Event|0|||
161936038|NCT03470441|584817539|FG001|Overall Study|Adverse Event|0|||
161936039|NCT03470441|584817540|FG002|Overall Study|Adverse Event|0|||
161936040|NCT03470441|584817541|FG003|Overall Study|Adverse Event|1|||
161936041|NCT03470441|584817538|FG000|Overall Study|Withdrawal by Subject|1|||
161936042|NCT03470441|584817539|FG001|Overall Study|Withdrawal by Subject|4|||
161936043|NCT03470441|584817540|FG002|Overall Study|Withdrawal by Subject|1|||
161936044|NCT03470441|584817541|FG003|Overall Study|Withdrawal by Subject|3|||
161526735|NCT02564523|583314832|FG000|Overall Study|Physician Decision|0|||
161526736|NCT02564523|583314833|FG001|Overall Study|Physician Decision|0|||
161526737|NCT02564523|583314834|FG002|Overall Study|Physician Decision|0|||
161526738|NCT02564523|583314835|FG003|Overall Study|Physician Decision|0|||
161526739|NCT02564523|583314836|FG004|Overall Study|Physician Decision|1|||
161526740|NCT02564523|583314837|FG005|Overall Study|Physician Decision|0|||
161526741|NCT02564523|583314838|FG006|Overall Study|Physician Decision|0|||
161526742|NCT02564523|583314839|FG007|Overall Study|Physician Decision|0|||
161526743|NCT02564523|583314840|FG008|Overall Study|Physician Decision|0|||
161526744|NCT02564523|583314841|FG009|Overall Study|Physician Decision|0|||
161526745|NCT02564523|583314842|FG010|Overall Study|Physician Decision|1|||
161526746|NCT02564523|583314843|FG011|Overall Study|Physician Decision|0|||
161526747|NCT02564523|583314844|FG012|Overall Study|Physician Decision|0|||
161526748|NCT02564523|583314845|FG013|Overall Study|Physician Decision|0|||
161526749|NCT02564523|583314846|FG014|Overall Study|Physician Decision|0|||
161526750|NCT02564523|583314847|FG015|Overall Study|Physician Decision|0|||
161526751|NCT02564523|583314848|FG016|Overall Study|Physician Decision|0|||
161526752|NCT02564523|583314849|FG017|Overall Study|Physician Decision|0|||
161526753|NCT02564523|583314832|FG000|Overall Study|Protocol Violation|2|||
161827289|NCT00605176|584408038|FG002|Overall Study|Non-complicance with study procedures|0|||
161590682|NCT03673111|583552718|FG006|Overall Study|Adverse Event|0|||
161590683|NCT03673111|583552719|FG007|Overall Study|Adverse Event|0|||
161590684|NCT03673111|583552720|FG008|Overall Study|Adverse Event|0|||
161590685|NCT03673111|583552721|FG009|Overall Study|Adverse Event|0|||
161590686|NCT03673111|583552722|FG010|Overall Study|Adverse Event|0|||
161590687|NCT03673111|583552723|FG011|Overall Study|Adverse Event|0|||
161590688|NCT03673111|583552724|FG012|Overall Study|Adverse Event|0|||
161590689|NCT03673111|583552725|FG013|Overall Study|Adverse Event|0|||
161590690|NCT04485039|583552726|FG000|TPOXX Only|Adverse Event|2|||
161590691|NCT04485039|583552726|FG000|TPOXX Only|Physician Decision|1|||
161590692|NCT04485039|583552726|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
161590693|NCT04485039|583552726|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
161590694|NCT04005716|583552727|FG000|Overall Study|Death|175|||
161590695|NCT04005716|583552728|FG001|Overall Study|Death|196|||
161590696|NCT04005716|583552727|FG000|Overall Study|Withdrawal by Subject|1|||
161590697|NCT04005716|583552728|FG001|Overall Study|Withdrawal by Subject|6|||
161590698|NCT04005716|583552727|FG000|Overall Study|Lost to Follow-up|2|||
161590699|NCT04005716|583552728|FG001|Overall Study|Lost to Follow-up|2|||
161590700|NCT02783300|583552729|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590701|NCT02783300|583552730|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590702|NCT02783300|583552731|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590703|NCT02783300|583552732|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590704|NCT02783300|583552733|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590705|NCT02783300|583552734|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590706|NCT02783300|583552735|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
161590707|NCT02783300|583552736|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590708|NCT02783300|583552737|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590709|NCT02783300|583552738|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590710|NCT02783300|583552739|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590711|NCT02783300|583552740|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590712|NCT02783300|583552741|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590713|NCT02783300|583552742|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590714|NCT02783300|583552743|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590715|NCT02783300|583552744|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590716|NCT02783300|583552745|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590717|NCT02783300|583552746|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590718|NCT02783300|583552747|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590719|NCT02783300|583552748|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590720|NCT02783300|583552749|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590721|NCT02783300|583552750|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590722|NCT02783300|583552751|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590723|NCT02783300|583552752|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590724|NCT02783300|583552753|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590725|NCT02783300|583552754|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590726|NCT02783300|583552755|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161590727|NCT02783300|583552729|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590728|NCT02783300|583552730|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590729|NCT02783300|583552731|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161827290|NCT00605176|584408036|FG000|Overall Study|Use of concomitant therapy|1|||
161827291|NCT00605176|584408037|FG001|Overall Study|Use of concomitant therapy|0|||
161827292|NCT00605176|584408038|FG002|Overall Study|Use of concomitant therapy|1|||
161827293|NCT00605176|584408036|FG000|Overall Study|Other (not due to AE)|1|||
161827294|NCT00605176|584408037|FG001|Overall Study|Other (not due to AE)|1|||
161827295|NCT00605176|584408038|FG002|Overall Study|Other (not due to AE)|0|||
161827296|NCT01086969|584408039|FG000|Overall Study|Withdrawal by Subject|1|||
161526754|NCT02564523|583314833|FG001|Overall Study|Protocol Violation|2|||
161936045|NCT03780725|584817542|FG000|Overall Study|Progression of disease|3|||
161526755|NCT02564523|583314834|FG002|Overall Study|Protocol Violation|5|||
161526756|NCT02564523|583314835|FG003|Overall Study|Protocol Violation|0|||
161526757|NCT02564523|583314836|FG004|Overall Study|Protocol Violation|1|||
161526758|NCT02564523|583314837|FG005|Overall Study|Protocol Violation|0|||
161526759|NCT02564523|583314838|FG006|Overall Study|Protocol Violation|0|||
161526760|NCT02564523|583314839|FG007|Overall Study|Protocol Violation|0|||
161526761|NCT02564523|583314840|FG008|Overall Study|Protocol Violation|0|||
161526762|NCT02564523|583314841|FG009|Overall Study|Protocol Violation|0|||
161526763|NCT02564523|583314842|FG010|Overall Study|Protocol Violation|0|||
161526764|NCT02564523|583314843|FG011|Overall Study|Protocol Violation|0|||
161936046|NCT03780725|584817543|FG001|Overall Study|Progression of disease|4|||
161936047|NCT03780725|584817542|FG000|Overall Study|Adverse Event|0|||
161936048|NCT03780725|584817543|FG001|Overall Study|Adverse Event|1|||
161936049|NCT05916170|584817544|FG000|No Warning Control|Lost to Follow-up|12|||
161936050|NCT05916170|584817544|FG000|No Warning Control|Withdrawal by Subject|15|||
161526765|NCT02564523|583314844|FG012|Overall Study|Protocol Violation|0|||
161526766|NCT02564523|583314845|FG013|Overall Study|Protocol Violation|0|||
161526767|NCT02564523|583314846|FG014|Overall Study|Protocol Violation|0|||
161526768|NCT02564523|583314847|FG015|Overall Study|Protocol Violation|0|||
161526769|NCT02564523|583314848|FG016|Overall Study|Protocol Violation|0|||
161526770|NCT02564523|583314849|FG017|Overall Study|Protocol Violation|0|||
161526771|NCT02564523|583314832|FG000|Overall Study|Other|3|||
161526772|NCT02564523|583314833|FG001|Overall Study|Other|0|||
161526773|NCT02564523|583314834|FG002|Overall Study|Other|0|||
161526774|NCT02564523|583314835|FG003|Overall Study|Other|1|||
161526775|NCT02564523|583314836|FG004|Overall Study|Other|0|||
161526776|NCT02564523|583314837|FG005|Overall Study|Other|0|||
161526777|NCT02564523|583314838|FG006|Overall Study|Other|0|||
161526778|NCT02564523|583314839|FG007|Overall Study|Other|0|||
161526779|NCT02564523|583314840|FG008|Overall Study|Other|0|||
161526780|NCT02564523|583314841|FG009|Overall Study|Other|0|||
161526781|NCT02564523|583314842|FG010|Overall Study|Other|0|||
161526782|NCT02564523|583314843|FG011|Overall Study|Other|0|||
161526783|NCT02564523|583314844|FG012|Overall Study|Other|0|||
161526784|NCT02564523|583314845|FG013|Overall Study|Other|0|||
161526785|NCT02564523|583314846|FG014|Overall Study|Other|0|||
161526786|NCT02564523|583314847|FG015|Overall Study|Other|0|||
161526787|NCT02564523|583314848|FG016|Overall Study|Other|0|||
161526788|NCT02564523|583314849|FG017|Overall Study|Other|0|||
161526789|NCT00448539|583314852|FG000|Overall Study|Medication non-compliance|4|||
161526790|NCT00448539|583314853|FG001|Overall Study|Medication non-compliance|1|||
161526791|NCT00448539|583314852|FG000|Overall Study|Protocol Violation|1|||
161526792|NCT00448539|583314853|FG001|Overall Study|Protocol Violation|0|||
161526793|NCT00448539|583314852|FG000|Overall Study|Request of the investigator or sponsor|67|||
161526794|NCT00448539|583314853|FG001|Overall Study|Request of the investigator or sponsor|54|||
161526795|NCT00448539|583314852|FG000|Overall Study|Withdrawal by Subject|20|||
161526796|NCT00448539|583314853|FG001|Overall Study|Withdrawal by Subject|24|||
161526797|NCT00448539|583314852|FG000|Overall Study|Diary non-compliance|1|||
161526798|NCT00448539|583314853|FG001|Overall Study|Diary non-compliance|0|||
161526799|NCT00448539|583314852|FG000|Overall Study|Adverse Event|9|||
161526800|NCT00448539|583314853|FG001|Overall Study|Adverse Event|26|||
161526801|NCT00448539|583314852|FG000|Overall Study|Lack of Efficacy|27|||
161526802|NCT00448539|583314853|FG001|Overall Study|Lack of Efficacy|40|||
161526803|NCT00448539|583314852|FG000|Overall Study|Miscellaneous|2|||
161526804|NCT00448539|583314853|FG001|Overall Study|Miscellaneous|1|||
161526805|NCT00448539|583314852|FG000|Overall Study|Change of meds|2|||
161526806|NCT00448539|583314853|FG001|Overall Study|Change of meds|3|||
161526807|NCT00448539|583314852|FG000|Overall Study|Lost to Follow-up|1|||
161526808|NCT00448539|583314853|FG001|Overall Study|Lost to Follow-up|3|||
161526809|NCT03349710|583314854|FG000|Treatment Period|Death|0|||
161936051|NCT05916170|584817544|FG000|No Warning Control|Noncompliance with protocol|1|||
161936052|NCT05916170|584817544|FG000|Health Warning Intervention|Lost to Follow-up|15|||
161936053|NCT05916170|584817544|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
161526810|NCT03349710|583314855|FG001|Treatment Period|Death|0|||
161526811|NCT03349710|583314856|FG002|Treatment Period|Death|1|||
161526812|NCT03349710|583314857|FG003|Treatment Period|Death|0|||
161526813|NCT03349710|583314854|FG000|Treatment Period|Disease Progression|0|||
161526814|NCT03349710|583314855|FG001|Treatment Period|Disease Progression|2|||
161526815|NCT03349710|583314856|FG002|Treatment Period|Disease Progression|0|||
161526816|NCT03349710|583314857|FG003|Treatment Period|Disease Progression|1|||
161526817|NCT03349710|583314854|FG000|Treatment Period|Study Drug Toxicity|1|||
161526818|NCT03349710|583314855|FG001|Treatment Period|Study Drug Toxicity|0|||
161526819|NCT03349710|583314856|FG002|Treatment Period|Study Drug Toxicity|1|||
161526820|NCT03349710|583314857|FG003|Treatment Period|Study Drug Toxicity|1|||
161526821|NCT03349710|583314854|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
161526822|NCT03349710|583314855|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
161526823|NCT03349710|583314856|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
161526824|NCT03349710|583314857|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
161936054|NCT05916170|584817544|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
161936055|NCT04138277|584817545|FG000|Pretreatment|Withdrawal by Subject|1|||
161936056|NCT04138277|584817546|FG001|Pretreatment|Withdrawal by Subject|0|||
161936057|NCT04138277|584817545|FG000|Treatment|Adverse Event|6|||
161936058|NCT04138277|584817546|FG001|Treatment|Adverse Event|2|||
161936059|NCT04138277|584817545|FG000|Treatment|Lost to Follow-up|1|||
161936060|NCT04138277|584817546|FG001|Treatment|Lost to Follow-up|0|||
161936061|NCT04138277|584817545|FG000|Treatment|Pregnancy|3|||
161936062|NCT04138277|584817546|FG001|Treatment|Pregnancy|0|||
161936063|NCT04138277|584817545|FG000|Treatment|COVID-19 pandemic|1|||
161936064|NCT04138277|584817546|FG001|Treatment|COVID-19 pandemic|0|||
161936065|NCT04138277|584817545|FG000|Treatment|Withdrawal by Subject|9|||
161936066|NCT04138277|584817546|FG001|Treatment|Withdrawal by Subject|3|||
161936067|NCT04138277|584817545|FG000|Treatment|Sponsor decision|1|||
161936068|NCT04138277|584817546|FG001|Treatment|Sponsor decision|0|||
161936069|NCT04138277|584817545|FG000|Treatment|Physician Decision|1|||
161936070|NCT04138277|584817546|FG001|Treatment|Physician Decision|0|||
161936071|NCT04138277|584817545|FG000|Treatment|Worsening of condition|1|||
161936072|NCT04138277|584817546|FG001|Treatment|Worsening of condition|2|||
161936073|NCT03768414|584817547|FG000|Overall Study|Adverse Event or side effects|72|||
161936074|NCT03768414|584817548|FG001|Overall Study|Adverse Event or side effects|28|||
161936075|NCT03768414|584817547|FG000|Overall Study|Refusal unrelated to adverse event|33|||
161936076|NCT03768414|584817548|FG001|Overall Study|Refusal unrelated to adverse event|33|||
161936077|NCT03768414|584817547|FG000|Overall Study|Progression/relapse|132|||
161936078|NCT03768414|584817548|FG001|Overall Study|Progression/relapse|60|||
161936079|NCT03768414|584817547|FG000|Overall Study|Death|9|||
161936080|NCT03768414|584817548|FG001|Overall Study|Death|6|||
161936081|NCT03768414|584817547|FG000|Overall Study|Other - not protocol specified|45|||
161936082|NCT03768414|584817548|FG001|Overall Study|Other - not protocol specified|18|||
161936083|NCT03768414|584817547|FG000|Overall Study|Reason under review|3|||
161936084|NCT03768414|584817548|FG001|Overall Study|Reason under review|2|||
161936085|NCT04576949|584817549|FG000|Overall Study|Adverse Event|1|||
161936086|NCT04576949|584817550|FG001|Overall Study|Adverse Event|3|||
161936087|NCT04576949|584817551|FG002|Overall Study|Adverse Event|2|||
161936088|NCT04576949|584817549|FG000|Overall Study|Withdrawal by Subject|41|||
161936089|NCT04576949|584817550|FG001|Overall Study|Withdrawal by Subject|26|||
161936090|NCT04576949|584817551|FG002|Overall Study|Withdrawal by Subject|18|||
161936091|NCT04576949|584817549|FG000|Overall Study|Physician Decision|3|||
161936092|NCT04576949|584817550|FG001|Overall Study|Physician Decision|0|||
161936093|NCT04576949|584817551|FG002|Overall Study|Physician Decision|0|||
161936094|NCT04576949|584817549|FG000|Overall Study|Death|0|||
161936095|NCT04576949|584817550|FG001|Overall Study|Death|1|||
161936096|NCT04576949|584817551|FG002|Overall Study|Death|0|||
161936097|NCT04576949|584817549|FG000|Overall Study|Lost to Follow-up|29|||
161936098|NCT04576949|584817550|FG001|Overall Study|Lost to Follow-up|37|||
161936099|NCT04576949|584817551|FG002|Overall Study|Lost to Follow-up|24|||
161936100|NCT04576949|584817549|FG000|Overall Study|Other, Not Specified|2|||
161936101|NCT04576949|584817550|FG001|Overall Study|Other, Not Specified|3|||
161936102|NCT04576949|584817551|FG002|Overall Study|Other, Not Specified|1|||
161936103|NCT04576949|584817549|FG000|Overall Study|Other|1|||
161936104|NCT04576949|584817550|FG001|Overall Study|Other|0|||
161936105|NCT04576949|584817551|FG002|Overall Study|Other|0|||
161936106|NCT02738008|584817556|FG000|Overall Study|Study Terminated by Sponsor|1|||
161936107|NCT02738008|584817557|FG001|Overall Study|Study Terminated by Sponsor|5|||
161936108|NCT02738008|584817558|FG002|Overall Study|Study Terminated by Sponsor|3|||
161936109|NCT02738008|584817556|FG000|Overall Study|Adverse Event|0|||
161936110|NCT02738008|584817557|FG001|Overall Study|Adverse Event|1|||
161936111|NCT02738008|584817558|FG002|Overall Study|Adverse Event|2|||
161936112|NCT03437278|584817559|FG000|Overall Study|Adverse Event|0|||
161936113|NCT03437278|584817560|FG001|Overall Study|Adverse Event|0|||
161936114|NCT03437278|584817561|FG002|Overall Study|Adverse Event|1|||
161936115|NCT03437278|584817559|FG000|Overall Study|Progressive disease|1|||
161936116|NCT03437278|584817560|FG001|Overall Study|Progressive disease|0|||
161936117|NCT03437278|584817561|FG002|Overall Study|Progressive disease|0|||
161936118|NCT03437278|584817559|FG000|Overall Study|Physician Decision|1|||
161936119|NCT03437278|584817560|FG001|Overall Study|Physician Decision|0|||
161936120|NCT03437278|584817561|FG002|Overall Study|Physician Decision|1|||
161936121|NCT03556904|584817562|FG000|Overall Study|Disease Progression after treatment started|3|||
161936122|NCT03556904|584817563|FG001|Overall Study|Disease Progression after treatment started|3|||
161936123|NCT03556904|584817562|FG000|Overall Study|Sponsor Termination|2|||
161936124|NCT03556904|584817563|FG001|Overall Study|Sponsor Termination|2|||
161936125|NCT03556904|584817562|FG000|Overall Study|Physician Decision|2|||
161936126|NCT03556904|584817563|FG001|Overall Study|Physician Decision|0|||
161936127|NCT03556904|584817562|FG000|Overall Study|Withdrawal by Subject|1|||
161936128|NCT03556904|584817563|FG001|Overall Study|Withdrawal by Subject|0|||
161936129|NCT05192382|584817564|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
161936130|NCT05192382|584817565|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
161526825|NCT03349710|583314854|FG000|Treatment Period|admin reason by sponsor|0|||
161526826|NCT03349710|583314855|FG001|Treatment Period|admin reason by sponsor|7|||
161526827|NCT03349710|583314856|FG002|Treatment Period|admin reason by sponsor|0|||
161526828|NCT03349710|583314857|FG003|Treatment Period|admin reason by sponsor|19|||
161526829|NCT03349710|583314854|FG000|Treatment Period|Other Reason|2|||
161526830|NCT03349710|583314855|FG001|Treatment Period|Other Reason|0|||
161526831|NCT03349710|583314856|FG002|Treatment Period|Other Reason|2|||
161526832|NCT03349710|583314857|FG003|Treatment Period|Other Reason|1|||
161526833|NCT03349710|583314854|FG000|Treatment Period|completed|6|||
161526834|NCT03349710|583314855|FG001|Treatment Period|completed|0|||
161526835|NCT03349710|583314856|FG002|Treatment Period|completed|18|||
161526836|NCT03349710|583314857|FG003|Treatment Period|completed|1|||
161526837|NCT03349710|583314854|FG000|Treatment Period|participant request to discontinue|0|||
161526838|NCT03349710|583314855|FG001|Treatment Period|participant request to discontinue|0|||
161526839|NCT03349710|583314856|FG002|Treatment Period|participant request to discontinue|4|||
161526840|NCT03349710|583314857|FG003|Treatment Period|participant request to discontinue|0|||
161526841|NCT03349710|583314854|FG000|Treatment Period|participant withdrew consent|1|||
161526842|NCT03349710|583314855|FG001|Treatment Period|participant withdrew consent|0|||
161526843|NCT03349710|583314856|FG002|Treatment Period|participant withdrew consent|0|||
161526844|NCT03349710|583314857|FG003|Treatment Period|participant withdrew consent|0|||
161526845|NCT00695903|583314858|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
161526846|NCT00695903|583314859|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
161526847|NCT00695903|583314858|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
161526848|NCT00695903|583314859|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
161526849|NCT00695903|583314858|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
161526850|NCT00695903|583314859|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
161526851|NCT00695903|583314858|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
161526852|NCT00695903|583314859|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
161526853|NCT00695903|583314858|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
161526854|NCT00695903|583314859|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
161526855|NCT00695903|583314858|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
161526856|NCT00695903|583314859|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
161526857|NCT00695903|583314858|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
161590730|NCT02783300|583552732|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
161590731|NCT02783300|583552733|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161526858|NCT00695903|583314859|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
161526859|NCT00695903|583314858|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
161590732|NCT02783300|583552734|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590733|NCT02783300|583552735|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590734|NCT02783300|583552736|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590735|NCT02783300|583552737|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590736|NCT02783300|583552738|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590737|NCT02783300|583552739|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590738|NCT02783300|583552740|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590739|NCT02783300|583552741|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590740|NCT02783300|583552742|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590741|NCT02783300|583552743|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590742|NCT02783300|583552744|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590743|NCT02783300|583552745|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590744|NCT02783300|583552746|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590745|NCT02783300|583552747|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590746|NCT02783300|583552748|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590747|NCT02783300|583552749|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590748|NCT02783300|583552750|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590749|NCT02783300|583552751|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590750|NCT02783300|583552752|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590751|NCT02783300|583552753|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590752|NCT02783300|583552754|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590753|NCT02783300|583552755|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161590754|NCT02783300|583552729|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
161590755|NCT02783300|583552730|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
161590756|NCT02783300|583552731|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
161590757|NCT02783300|583552732|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
161590758|NCT02783300|583552733|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
161526860|NCT00695903|583314859|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
161526861|NCT00695903|583314858|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
161590759|NCT02783300|583552734|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
161590760|NCT02783300|583552735|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
161590761|NCT02783300|583552736|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
161590762|NCT02783300|583552737|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
161936131|NCT05192382|584817566|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
161526862|NCT00695903|583314859|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
161526863|NCT01296568|583314862|FG000|Continued Access Phase|Lost to Follow-up|1|||
161526864|NCT01296568|583314862|FG000|Continued Access Phase|Withdrawal by Subject|1|||
161526865|NCT01296568|583314862|FG000|Continued Access Phase|Disease Progression|1|||
161526866|NCT00321854|583314868|FG000|Overall Study|Adverse Event|41|||
161526867|NCT00321854|583314869|FG001|Overall Study|Adverse Event|43|||
161526868|NCT00321854|583314868|FG000|Overall Study|Lack of Efficacy|9|||
161526869|NCT00321854|583314869|FG001|Overall Study|Lack of Efficacy|14|||
161526870|NCT00321854|583314868|FG000|Overall Study|Protocol Violation|6|||
161526871|NCT00321854|583314869|FG001|Overall Study|Protocol Violation|5|||
161526872|NCT00321854|583314868|FG000|Overall Study|Lost to Follow-up|0|||
161526873|NCT00321854|583314869|FG001|Overall Study|Lost to Follow-up|2|||
161526874|NCT00321854|583314868|FG000|Overall Study|Withdrawal by Subject|6|||
161526875|NCT00321854|583314869|FG001|Overall Study|Withdrawal by Subject|17|||
161526876|NCT00321854|583314868|FG000|Overall Study|Other|1|||
161526877|NCT00321854|583314869|FG001|Overall Study|Other|1|||
161526878|NCT01369342|583314870|FG000|Overall Study|Withdrawal by Subject|7|||
161526879|NCT01369342|583314871|FG001|Overall Study|Withdrawal by Subject|7|||
161526880|NCT01369342|583314872|FG002|Overall Study|Withdrawal by Subject|2|||
161526881|NCT01369342|583314870|FG000|Overall Study|Lost to Follow-up|5|||
161526882|NCT01369342|583314871|FG001|Overall Study|Lost to Follow-up|2|||
161526883|NCT01369342|583314872|FG002|Overall Study|Lost to Follow-up|1|||
161526884|NCT01369342|583314870|FG000|Overall Study|Not Treated|1|||
161526885|NCT01369342|583314871|FG001|Overall Study|Not Treated|0|||
161526886|NCT01369342|583314872|FG002|Overall Study|Not Treated|0|||
161526887|NCT01816594|583314873|FG000|Overall Study|Local Progress|0|||
161526888|NCT01816594|583314874|FG001|Overall Study|Local Progress|2|||
161526889|NCT01816594|583314873|FG000|Overall Study|Adverse Event|9|||
161526890|NCT01816594|583314874|FG001|Overall Study|Adverse Event|0|||
161526891|NCT01816594|583314873|FG000|Overall Study|Withdrawal by Subject|1|||
161526892|NCT01816594|583314874|FG001|Overall Study|Withdrawal by Subject|0|||
161526893|NCT01816594|583314873|FG000|Overall Study|Physician Decision|1|||
161526894|NCT01816594|583314874|FG001|Overall Study|Physician Decision|0|||
161526895|NCT03905655|583314875|FG000|Overall Study|Adverse Event|1|||
161526896|NCT03905655|583314876|FG001|Overall Study|Adverse Event|0|||
161526897|NCT03905655|583314877|FG002|Overall Study|Adverse Event|1|||
161526898|NCT03905655|583314878|FG003|Overall Study|Adverse Event|1|||
161526899|NCT04723576|583314879|FG000|Overall Study|Withdrawal by Subject|2133|||
161526900|NCT04723576|583314880|FG001|Overall Study|Withdrawal by Subject|3234|||
161526901|NCT03927950|583314889|FG000|Overall Study|Adverse Event|9|||
161526902|NCT03263429|583314890|FG000|Overall Study|Withdrawal by Subject|0|||
161526903|NCT03263429|583314891|FG001|Overall Study|Withdrawal by Subject|1|||
161526904|NCT03263429|583314892|FG002|Overall Study|Withdrawal by Subject|0|||
161526905|NCT03263429|583314890|FG000|Overall Study|Follow-Up Period Completed|0|||
161526906|NCT03263429|583314891|FG001|Overall Study|Follow-Up Period Completed|2|||
161526907|NCT03263429|583314892|FG002|Overall Study|Follow-Up Period Completed|0|||
161526908|NCT03263429|583314890|FG000|Overall Study|Death|3|||
161526909|NCT03263429|583314891|FG001|Overall Study|Death|5|||
161526910|NCT03263429|583314892|FG002|Overall Study|Death|16|||
161526911|NCT03263429|583314890|FG000|Overall Study|Participant unable to return|0|||
161526912|NCT03263429|583314891|FG001|Overall Study|Participant unable to return|0|||
161526913|NCT03263429|583314892|FG002|Overall Study|Participant unable to return|1|||
161526914|NCT03263429|583314890|FG000|Overall Study|Study Closed|0|||
161526915|NCT03263429|583314891|FG001|Overall Study|Study Closed|0|||
161526916|NCT03263429|583314892|FG002|Overall Study|Study Closed|1|||
161526917|NCT04530448|583314893|FG000|Overall Study|Physician Decision|3|||
161526918|NCT04530448|583314894|FG001|Overall Study|Physician Decision|0|||
161526919|NCT01519206|583314895|FG000|Overall Study|Lost to Follow-up|3|||
161526920|NCT01519206|583314895|FG000|Overall Study|Missed Visit|2|||
161526921|NCT02014116|583314896|FG000|Overall Study|Progressive Disease|3|||
161526922|NCT02014116|583314897|FG001|Overall Study|Progressive Disease|4|||
161526923|NCT02014116|583314898|FG002|Overall Study|Progressive Disease|2|||
161526924|NCT02014116|583314899|FG003|Overall Study|Progressive Disease|6|||
161590763|NCT02783300|583552738|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
161590764|NCT02783300|583552739|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
161590765|NCT02783300|583552740|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
161590766|NCT02783300|583552741|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
161936132|NCT05192382|584817564|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
161936133|NCT05192382|584817565|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
161526925|NCT02014116|583314900|FG004|Overall Study|Progressive Disease|1|||
161526926|NCT02014116|583314901|FG005|Overall Study|Progressive Disease|13|||
161526927|NCT02014116|583314902|FG006|Overall Study|Progressive Disease|1|||
161526928|NCT02014116|583314903|FG007|Overall Study|Progressive Disease|3|||
161526929|NCT02014116|583314904|FG008|Overall Study|Progressive Disease|7|||
161526930|NCT02014116|583314896|FG000|Overall Study|Adverse Event|0|||
161590767|NCT02783300|583552742|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
161526931|NCT02014116|583314897|FG001|Overall Study|Adverse Event|0|||
161936134|NCT05192382|584817566|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
161936135|NCT05192382|584817564|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
161936136|NCT05192382|584817565|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
161936137|NCT05192382|584817566|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
161936138|NCT05192382|584817564|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
161936139|NCT05192382|584817565|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
161936140|NCT05192382|584817566|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
161936141|NCT04328727|584817569|FG000|Overall Study|Guardian Decision|1|||
161936142|NCT04328727|584817569|FG000|Overall Study|Participant decision|4|||
161936143|NCT04328727|584817569|FG000|Overall Study|Death|3|||
161936144|NCT02604199|584817570|FG000|Overall Study|Pregnancy|0|||
161936145|NCT02604199|584817571|FG001|Overall Study|Pregnancy|0|||
161936146|NCT02604199|584817572|FG002|Overall Study|Pregnancy|0|||
161936147|NCT02604199|584817573|FG003|Overall Study|Pregnancy|1|||
161936148|NCT02604199|584817570|FG000|Overall Study|Study terminated by sponsor|0|||
161936149|NCT02604199|584817571|FG001|Overall Study|Study terminated by sponsor|2|||
161936150|NCT02604199|584817572|FG002|Overall Study|Study terminated by sponsor|0|||
161936151|NCT02604199|584817573|FG003|Overall Study|Study terminated by sponsor|2|||
161936152|NCT02604199|584817570|FG000|Overall Study|Withdrawal by Subject|0|||
161936153|NCT02604199|584817571|FG001|Overall Study|Withdrawal by Subject|1|||
161936154|NCT02604199|584817572|FG002|Overall Study|Withdrawal by Subject|0|||
161936155|NCT02604199|584817573|FG003|Overall Study|Withdrawal by Subject|0|||
161936156|NCT05411367|584817574|FG000|Overall Study|Adverse Event|9|||
161936157|NCT05411367|584817575|FG001|Overall Study|Adverse Event|3|||
161936158|NCT05411367|584817574|FG000|Overall Study|Protocol Violation|0|||
161936159|NCT05411367|584817575|FG001|Overall Study|Protocol Violation|2|||
161936160|NCT05411367|584817574|FG000|Overall Study|Administrative Reasons|2|||
161936161|NCT05411367|584817575|FG001|Overall Study|Administrative Reasons|1|||
161936162|NCT05411367|584817574|FG000|Overall Study|Withdrawal by Subject|3|||
161936163|NCT05411367|584817575|FG001|Overall Study|Withdrawal by Subject|4|||
161936164|NCT05411367|584817574|FG000|Overall Study|Inclusion Criteria Not Met|0|||
161936165|NCT05411367|584817575|FG001|Overall Study|Inclusion Criteria Not Met|1|||
161936166|NCT02604212|584817576|FG000|Overall Study|Study Terminated by Sponsor|2|||
161936167|NCT02604212|584817577|FG001|Overall Study|Study Terminated by Sponsor|1|||
161936168|NCT02604212|584817578|FG002|Overall Study|Study Terminated by Sponsor|3|||
161936169|NCT02604212|584817579|FG003|Overall Study|Study Terminated by Sponsor|3|||
161526932|NCT02014116|583314898|FG002|Overall Study|Adverse Event|0|||
161526933|NCT02014116|583314899|FG003|Overall Study|Adverse Event|0|||
161526934|NCT02014116|583314900|FG004|Overall Study|Adverse Event|1|||
161526935|NCT02014116|583314901|FG005|Overall Study|Adverse Event|0|||
161526936|NCT02014116|583314902|FG006|Overall Study|Adverse Event|0|||
161526937|NCT02014116|583314903|FG007|Overall Study|Adverse Event|1|||
161526938|NCT02014116|583314904|FG008|Overall Study|Adverse Event|0|||
161526939|NCT02014116|583314896|FG000|Overall Study|Lost to Follow-up|0|||
161526940|NCT02014116|583314897|FG001|Overall Study|Lost to Follow-up|0|||
161526941|NCT02014116|583314898|FG002|Overall Study|Lost to Follow-up|0|||
161526942|NCT02014116|583314899|FG003|Overall Study|Lost to Follow-up|0|||
161526943|NCT02014116|583314900|FG004|Overall Study|Lost to Follow-up|0|||
161526944|NCT02014116|583314901|FG005|Overall Study|Lost to Follow-up|1|||
161526945|NCT02014116|583314902|FG006|Overall Study|Lost to Follow-up|0|||
161526946|NCT02014116|583314903|FG007|Overall Study|Lost to Follow-up|0|||
161526947|NCT02014116|583314904|FG008|Overall Study|Lost to Follow-up|1|||
161526948|NCT02014116|583314896|FG000|Overall Study|Death|0|||
161526949|NCT02014116|583314897|FG001|Overall Study|Death|0|||
161526950|NCT02014116|583314898|FG002|Overall Study|Death|0|||
161526951|NCT02014116|583314899|FG003|Overall Study|Death|0|||
161526952|NCT02014116|583314900|FG004|Overall Study|Death|0|||
161936170|NCT02604212|584817576|FG000|Overall Study|Withdrawal by Subject|0|||
161936171|NCT02604212|584817577|FG001|Overall Study|Withdrawal by Subject|0|||
161936172|NCT02604212|584817578|FG002|Overall Study|Withdrawal by Subject|1|||
161936173|NCT02604212|584817579|FG003|Overall Study|Withdrawal by Subject|0|||
161936174|NCT03019406|584817580|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
161936175|NCT03019406|584817581|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
161526953|NCT02014116|583314901|FG005|Overall Study|Death|0|||
161526954|NCT02014116|583314902|FG006|Overall Study|Death|0|||
161526955|NCT02014116|583314903|FG007|Overall Study|Death|1|||
161526956|NCT02014116|583314904|FG008|Overall Study|Death|1|||
161936176|NCT03019406|584817582|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
161526957|NCT02014116|583314896|FG000|Overall Study|Withdrawal by Subject|0|||
161526958|NCT02014116|583314897|FG001|Overall Study|Withdrawal by Subject|0|||
161526959|NCT02014116|583314898|FG002|Overall Study|Withdrawal by Subject|1|||
161526960|NCT02014116|583314899|FG003|Overall Study|Withdrawal by Subject|1|||
161526961|NCT02014116|583314900|FG004|Overall Study|Withdrawal by Subject|0|||
161526962|NCT02014116|583314901|FG005|Overall Study|Withdrawal by Subject|1|||
161526963|NCT02014116|583314902|FG006|Overall Study|Withdrawal by Subject|0|||
161526964|NCT02014116|583314903|FG007|Overall Study|Withdrawal by Subject|0|||
161526965|NCT02014116|583314904|FG008|Overall Study|Withdrawal by Subject|0|||
161936177|NCT03019406|584817583|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
161526966|NCT02014116|583314896|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
161526967|NCT02014116|583314897|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
161526968|NCT02014116|583314898|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
161526969|NCT02014116|583314899|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
161526970|NCT02014116|583314900|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
161526971|NCT02014116|583314901|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
161526972|NCT02014116|583314902|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
161526973|NCT02014116|583314903|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
161526974|NCT02014116|583314904|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
161526975|NCT02014116|583314896|FG000|Overall Study|Physician Decision|0|||
161526976|NCT02014116|583314897|FG001|Overall Study|Physician Decision|0|||
161526977|NCT02014116|583314898|FG002|Overall Study|Physician Decision|0|||
161526978|NCT02014116|583314899|FG003|Overall Study|Physician Decision|0|||
161526979|NCT02014116|583314900|FG004|Overall Study|Physician Decision|0|||
161526980|NCT02014116|583314901|FG005|Overall Study|Physician Decision|0|||
161526981|NCT02014116|583314902|FG006|Overall Study|Physician Decision|0|||
161526982|NCT02014116|583314903|FG007|Overall Study|Physician Decision|0|||
161526983|NCT02014116|583314904|FG008|Overall Study|Physician Decision|1|||
161526984|NCT01491854|583314905|FG000|Overall Study|mainly due to premature termination|93|||
161526985|NCT01491854|583314905|FG000|Overall Study|Death|1|||
161526986|NCT01491854|583314905|FG000|Overall Study|Withdrawal by Subject|3|||
161526987|NCT01491854|583314905|FG000|Overall Study|Lost to Follow-up|33|||
161526988|NCT02395042|583314907|FG000|Treatment 1 Period|Adverse Event|1|||
161526989|NCT02395042|583314908|FG001|Treatment 1 Period|Adverse Event|3|||
161526990|NCT02395042|583314909|FG002|Treatment 1 Period|Adverse Event|1|||
161526991|NCT02395042|583314907|FG000|Treatment 1 Period|Lack of Efficacy|1|||
161526992|NCT02395042|583314908|FG001|Treatment 1 Period|Lack of Efficacy|1|||
161526993|NCT02395042|583314909|FG002|Treatment 1 Period|Lack of Efficacy|0|||
161526994|NCT02395042|583314907|FG000|Treatment 1 Period|Lost to Follow-up|1|||
161526995|NCT02395042|583314908|FG001|Treatment 1 Period|Lost to Follow-up|0|||
161526996|NCT02395042|583314909|FG002|Treatment 1 Period|Lost to Follow-up|0|||
161526997|NCT02395042|583314907|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
161526998|NCT02395042|583314908|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
161526999|NCT02395042|583314909|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
161527000|NCT02395042|583314907|FG000|Treatment 2 Period|Lack of Efficacy|1|||
161527001|NCT02395042|583314908|FG001|Treatment 2 Period|Lack of Efficacy|1|||
161527002|NCT02395042|583314909|FG002|Treatment 2 Period|Lack of Efficacy|0|||
161527003|NCT03638141|583314910|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
161527004|NCT03579563|583314911|FG000|Overall Study|Lost to Follow-up|0|||
161527005|NCT03579563|583314912|FG001|Overall Study|Lost to Follow-up|0|||
161527006|NCT03579563|583314913|FG002|Overall Study|Lost to Follow-up|0|||
161527007|NCT03579563|583314914|FG003|Overall Study|Lost to Follow-up|0|||
161527008|NCT03579563|583314915|FG004|Overall Study|Lost to Follow-up|1|||
161527009|NCT03579563|583314916|FG005|Overall Study|Lost to Follow-up|0|||
161527010|NCT03579563|583314911|FG000|Overall Study|Lack of Efficacy|1|||
161527011|NCT03579563|583314912|FG001|Overall Study|Lack of Efficacy|1|||
161527012|NCT03579563|583314913|FG002|Overall Study|Lack of Efficacy|4|||
161527013|NCT03579563|583314914|FG003|Overall Study|Lack of Efficacy|1|||
161527014|NCT03579563|583314915|FG004|Overall Study|Lack of Efficacy|2|||
161527015|NCT03579563|583314916|FG005|Overall Study|Lack of Efficacy|3|||
161527016|NCT03579563|583314911|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
161527017|NCT03579563|583314912|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161527018|NCT03579563|583314913|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161527019|NCT03579563|583314914|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
161527020|NCT03579563|583314915|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
161527021|NCT03579563|583314916|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
161527022|NCT03579563|583314911|FG000|Overall Study|Time/distance concern|0|||
161527023|NCT03579563|583314912|FG001|Overall Study|Time/distance concern|0|||
161527024|NCT03579563|583314913|FG002|Overall Study|Time/distance concern|1|||
161527025|NCT03579563|583314914|FG003|Overall Study|Time/distance concern|0|||
161527026|NCT03579563|583314915|FG004|Overall Study|Time/distance concern|0|||
161527027|NCT03579563|583314916|FG005|Overall Study|Time/distance concern|1|||
161527028|NCT03579563|583314911|FG000|Overall Study|COVID shutdown|2|||
161527029|NCT03579563|583314912|FG001|Overall Study|COVID shutdown|3|||
161527030|NCT03579563|583314913|FG002|Overall Study|COVID shutdown|4|||
161527031|NCT03579563|583314914|FG003|Overall Study|COVID shutdown|3|||
161527032|NCT03579563|583314915|FG004|Overall Study|COVID shutdown|1|||
161527033|NCT03579563|583314916|FG005|Overall Study|COVID shutdown|2|||
161527034|NCT03579563|583314911|FG000|Overall Study|Protocol administration error|1|||
161527035|NCT03579563|583314912|FG001|Overall Study|Protocol administration error|0|||
161527036|NCT03579563|583314913|FG002|Overall Study|Protocol administration error|1|||
161527037|NCT03579563|583314914|FG003|Overall Study|Protocol administration error|0|||
161527038|NCT03579563|583314915|FG004|Overall Study|Protocol administration error|1|||
161527039|NCT03579563|583314916|FG005|Overall Study|Protocol administration error|5|||
161527040|NCT03621696|583314917|FG000|Overall Study|Not eligible|0|||
161527041|NCT03621696|583314918|FG001|Overall Study|Not eligible|0|||
161527042|NCT03621696|583314919|FG002|Overall Study|Not eligible|0|||
161527043|NCT03621696|583314920|FG003|Overall Study|Not eligible|5|||
161527044|NCT03621696|583314917|FG000|Overall Study|Withdrawal by Subject|1|||
161527045|NCT03621696|583314918|FG001|Overall Study|Withdrawal by Subject|1|||
161527046|NCT03621696|583314919|FG002|Overall Study|Withdrawal by Subject|1|||
161527047|NCT03621696|583314920|FG003|Overall Study|Withdrawal by Subject|0|||
161527048|NCT03621696|583314917|FG000|Overall Study|Physician Decision|0|||
161527049|NCT03621696|583314918|FG001|Overall Study|Physician Decision|0|||
161527050|NCT03621696|583314919|FG002|Overall Study|Physician Decision|1|||
161527051|NCT03621696|583314920|FG003|Overall Study|Physician Decision|0|||
161527052|NCT01003249|583314926|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161527053|NCT01003249|583314927|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161527054|NCT01003249|583314926|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
161527055|NCT01003249|583314927|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
161527056|NCT01003249|583314926|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161527057|NCT01003249|583314927|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161527058|NCT01003249|583314926|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
161527059|NCT01003249|583314927|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
161527060|NCT01962974|583314928|FG000|Overall Study|Study termination|7|||
161527061|NCT00627705|583314930|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
161527062|NCT00627705|583314931|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
161527063|NCT00627705|583314930|FG000|Overall Study|Adverse Event|1|||
161527064|NCT00627705|583314931|FG001|Overall Study|Adverse Event|0|||
161527065|NCT00627705|583314930|FG000|Overall Study|Withdrawal by Subject|0|||
161527066|NCT00627705|583314931|FG001|Overall Study|Withdrawal by Subject|2|||
161527067|NCT00627705|583314930|FG000|Overall Study|Lost to Follow-up|0|||
161527068|NCT00627705|583314931|FG001|Overall Study|Lost to Follow-up|1|||
161527069|NCT02535065|583314934|FG000|Overall Study|Death|13|||
161527070|NCT02535065|583314934|FG000|Overall Study|Lost to Follow-up|1|||
161527071|NCT02535065|583314934|FG000|Overall Study|Withdrawal by Subject|6|||
161527072|NCT03712917|583314935|FG000|Overall Study|Pregnancy|0|||
161527073|NCT03712917|583314936|FG001|Overall Study|Pregnancy|0|||
161527074|NCT03712917|583314937|FG002|Overall Study|Pregnancy|1|||
161527075|NCT03712917|583314935|FG000|Overall Study|Adverse Event|0|||
161527076|NCT03712917|583314936|FG001|Overall Study|Adverse Event|4|||
161527077|NCT03712917|583314937|FG002|Overall Study|Adverse Event|3|||
161527078|NCT03712917|583314935|FG000|Overall Study|Lost to Follow-up|9|||
161527079|NCT03712917|583314936|FG001|Overall Study|Lost to Follow-up|4|||
161527080|NCT03712917|583314937|FG002|Overall Study|Lost to Follow-up|5|||
161527081|NCT00110617|583314938|FG000|Overall Study|Adverse Event|2|||
161527082|NCT00110617|583314939|FG001|Overall Study|Adverse Event|4|||
161527083|NCT00110617|583314938|FG000|Overall Study|Abnormal Laboratory Value|4|||
161527084|NCT00110617|583314939|FG001|Overall Study|Abnormal Laboratory Value|2|||
161527085|NCT00110617|583314938|FG000|Overall Study|Lack of Efficacy|1|||
161527086|NCT00110617|583314939|FG001|Overall Study|Lack of Efficacy|0|||
161527087|NCT00110617|583314938|FG000|Overall Study|Patient no longer requires study drug|1|||
161527088|NCT00110617|583314939|FG001|Overall Study|Patient no longer requires study drug|0|||
161527089|NCT00110617|583314938|FG000|Overall Study|Protocol Violation|5|||
161527090|NCT00110617|583314939|FG001|Overall Study|Protocol Violation|0|||
161527091|NCT00110617|583314938|FG000|Overall Study|Withdrawal by Subject|10|||
161527092|NCT00110617|583314939|FG001|Overall Study|Withdrawal by Subject|4|||
161527093|NCT00110617|583314938|FG000|Overall Study|Lost to Follow-up|9|||
161527094|NCT00110617|583314939|FG001|Overall Study|Lost to Follow-up|1|||
161527095|NCT00110617|583314938|FG000|Overall Study|Administrative problems|6|||
161527096|NCT00110617|583314939|FG001|Overall Study|Administrative problems|5|||
161527097|NCT00110617|583314938|FG000|Overall Study|Death|1|||
161527098|NCT00110617|583314939|FG001|Overall Study|Death|1|||
161527099|NCT00110617|583314938|FG000|Overall Study|Did not receive study drug|0|||
161527100|NCT00110617|583314939|FG001|Overall Study|Did not receive study drug|12|||
161527101|NCT04764396|583314941|FG000|Overall Study|Physician Decision|1|||
161527102|NCT04764396|583314942|FG001|Overall Study|Physician Decision|0|||
161527103|NCT03230916|583314943|FG000|Overall Study|Withdrawal by Subject|0|||
161936178|NCT04702776|584817587|FG000|Overall Study|Adverse Event|1|||
161936179|NCT04702776|584817588|FG001|Overall Study|Adverse Event|2|||
161527104|NCT03230916|583314944|FG001|Overall Study|Withdrawal by Subject|0|||
161527105|NCT03230916|583314945|FG002|Overall Study|Withdrawal by Subject|0|||
161527106|NCT03230916|583314946|FG003|Overall Study|Withdrawal by Subject|0|||
161936180|NCT04702776|584817589|FG002|Overall Study|Adverse Event|1|||
161936181|NCT04702776|584817587|FG000|Overall Study|Lost to Follow-up|2|||
161527107|NCT03230916|583314947|FG004|Overall Study|Withdrawal by Subject|0|||
161527108|NCT03230916|583314948|FG005|Overall Study|Withdrawal by Subject|1|||
161527109|NCT03230916|583314949|FG006|Overall Study|Withdrawal by Subject|0|||
161936182|NCT04702776|584817588|FG001|Overall Study|Lost to Follow-up|1|||
161527110|NCT03230916|583314950|FG007|Overall Study|Withdrawal by Subject|0|||
161527111|NCT03230916|583314951|FG008|Overall Study|Withdrawal by Subject|0|||
161527112|NCT03230916|583314952|FG009|Overall Study|Withdrawal by Subject|0|||
161527113|NCT03230916|583314953|FG010|Overall Study|Withdrawal by Subject|0|||
161527114|NCT01438541|583314956|FG000|Overall Study|Physician Decision|1|||
161527115|NCT01438541|583314956|FG000|Overall Study|Withdrawal by Subject|1|||
161527116|NCT01438541|583314956|FG000|Overall Study|discharge from the hospital|5|||
161527117|NCT02091167|583314957|FG000|Overall Study|Lost to Follow-up|0|||
161527118|NCT02091167|583314958|FG001|Overall Study|Lost to Follow-up|2|||
161527119|NCT01218646|583314959|FG000|Overall Study|Adverse Event|0|||
161527120|NCT01218646|583314960|FG001|Overall Study|Adverse Event|0|||
161527121|NCT01218646|583314961|FG002|Overall Study|Adverse Event|1|||
161527122|NCT01218646|583314962|FG003|Overall Study|Adverse Event|0|||
161527123|NCT01218646|583314959|FG000|Overall Study|Lost to Follow-up|1|||
161527124|NCT01218646|583314960|FG001|Overall Study|Lost to Follow-up|0|||
161527125|NCT01218646|583314961|FG002|Overall Study|Lost to Follow-up|0|||
161527126|NCT01218646|583314962|FG003|Overall Study|Lost to Follow-up|0|||
161527127|NCT01218646|583314959|FG000|Overall Study|Protocol Violation|0|||
161527128|NCT01218646|583314960|FG001|Overall Study|Protocol Violation|0|||
161527129|NCT01218646|583314961|FG002|Overall Study|Protocol Violation|1|||
161527130|NCT01218646|583314962|FG003|Overall Study|Protocol Violation|1|||
161527131|NCT00722761|583314963|FG000|Overall Study|Lost to Follow-up|1|||
161527132|NCT00722761|583314964|FG001|Overall Study|Lost to Follow-up|4|||
161527133|NCT00722761|583314963|FG000|Overall Study|Withdrawal by Subject|5|||
161527134|NCT00722761|583314964|FG001|Overall Study|Withdrawal by Subject|2|||
161527135|NCT02693665|583314970|FG000|Overall Study|Death|3|||
161527136|NCT02693665|583314971|FG001|Overall Study|Death|2|||
161527137|NCT02693665|583314970|FG000|Overall Study|Lost to Follow-up|7|||
161527138|NCT02693665|583314971|FG001|Overall Study|Lost to Follow-up|3|||
161527139|NCT02693665|583314970|FG000|Overall Study|Protocol Violation|1|||
161527140|NCT02693665|583314971|FG001|Overall Study|Protocol Violation|0|||
161527141|NCT02693665|583314970|FG000|Overall Study|Withdrawal by Subject|2|||
161527142|NCT02693665|583314971|FG001|Overall Study|Withdrawal by Subject|0|||
161527143|NCT02693665|583314970|FG000|Overall Study|patient wanted to leave it behind|1|||
161527144|NCT02693665|583314971|FG001|Overall Study|patient wanted to leave it behind|0|||
161527145|NCT02693665|583314970|FG000|Overall Study|anxiety|1|||
161527146|NCT02693665|583314971|FG001|Overall Study|anxiety|0|||
161527147|NCT02693665|583314970|FG000|Overall Study|family issues|1|||
161527148|NCT02693665|583314971|FG001|Overall Study|family issues|0|||
161527149|NCT02693665|583314970|FG000|Overall Study|no reason given|1|||
161527150|NCT02693665|583314971|FG001|Overall Study|no reason given|0|||
161527151|NCT03156023|583314972|FG000|Overall Study|Withdrawal by Subject|1|||
161527152|NCT03156023|583314973|FG001|Overall Study|Withdrawal by Subject|0|||
161527153|NCT03156023|583314974|FG002|Overall Study|Withdrawal by Subject|2|||
161527154|NCT03156023|583314975|FG003|Overall Study|Withdrawal by Subject|1|||
161527155|NCT03156023|583314976|FG004|Overall Study|Withdrawal by Subject|1|||
161527156|NCT03156023|583314972|FG000|Overall Study|Lost to Follow-up|0|||
161527157|NCT03156023|583314973|FG001|Overall Study|Lost to Follow-up|0|||
161527158|NCT03156023|583314974|FG002|Overall Study|Lost to Follow-up|0|||
161527159|NCT03156023|583314975|FG003|Overall Study|Lost to Follow-up|0|||
161527160|NCT03156023|583314976|FG004|Overall Study|Lost to Follow-up|1|||
161527161|NCT03069482|583318149|FG000|Overall Study|Lost to Follow-up|0|||
161527162|NCT03069482|583318150|FG001|Overall Study|Lost to Follow-up|1|||
161527163|NCT03069482|583318149|FG000|Overall Study|Physician Decision|1|||
161527164|NCT03069482|583318150|FG001|Overall Study|Physician Decision|0|||
161527165|NCT01949311|583318158|FG000|Overall Study|Lost to Follow-up|73|||
161527166|NCT01949311|583318158|FG000|Overall Study|Terminated by Sponsor|708|||
161527167|NCT01949311|583318158|FG000|Overall Study|Withdrawal by Subject|375|||
161527168|NCT01949311|583318158|FG000|Overall Study|Lack of Efficacy|50|||
161527169|NCT01949311|583318158|FG000|Overall Study|Protocol Deviation|34|||
161527170|NCT01949311|583318158|FG000|Overall Study|Pregnancy|20|||
161527171|NCT01949311|583318158|FG000|Overall Study|Physician Decision|9|||
161527172|NCT01949311|583318158|FG000|Overall Study|Other|4|||
161527173|NCT01949311|583318158|FG000|Overall Study|Adverse Event|107|||
161527174|NCT02338154|583318159|FG000|Overall Study|Death|46|||
161527175|NCT02338154|583318159|FG000|Overall Study|Valve Implant Failure|17|||
161590768|NCT02783300|583552743|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
161590769|NCT02783300|583552744|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
161590770|NCT02783300|583552745|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
161827297|NCT01086969|584408040|FG001|Overall Study|Withdrawal by Subject|2|||
161827298|NCT01086969|584408041|FG002|Overall Study|Withdrawal by Subject|0|||
161827299|NCT01609582|584408046|FG000|Overall Study|Adverse Event|20|||
161827300|NCT01609582|584408047|FG001|Overall Study|Adverse Event|18|||
161527176|NCT02338154|583318159|FG000|Overall Study|Valve Explant|11|||
161527177|NCT02338154|583318159|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
161527178|NCT02338154|583318159|FG000|Overall Study|Lost to Follow-up|8|||
161527179|NCT02338154|583318159|FG000|Overall Study|Other Reason|3|||
161527180|NCT02338154|583318159|FG000|Overall Study|Patients Without Exit Form|47|||
161527181|NCT02338154|583318159|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
161527182|NCT01559844|583318164|FG000|Overall Study|Consent Withdrawn|7|||
161527183|NCT01559844|583318164|FG000|Overall Study|Death|5|||
161527184|NCT01559844|583318164|FG000|Overall Study|Efficacy Failure|10|||
161936183|NCT04702776|584817589|FG002|Overall Study|Lost to Follow-up|4|||
161936184|NCT04702776|584817587|FG000|Overall Study|Protocol Violation|2|||
161936185|NCT04702776|584817588|FG001|Overall Study|Protocol Violation|2|||
161527185|NCT01559844|583318164|FG000|Overall Study|No Longer A Transplant Candidate|3|||
161527186|NCT00951041|583318166|FG000|Overall Study|Withdrawal by Subject|1|||
161527187|NCT00951041|583318167|FG001|Overall Study|Withdrawal by Subject|1|||
161527188|NCT00951041|583318166|FG000|Overall Study|Lost to Follow-up|1|||
161527189|NCT00951041|583318167|FG001|Overall Study|Lost to Follow-up|0|||
161527190|NCT00951041|583318166|FG000|Overall Study|Other|3|||
161936186|NCT04702776|584817589|FG002|Overall Study|Protocol Violation|3|||
161936187|NCT02556736|584817590|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
161936188|NCT02556736|584817591|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
161936189|NCT02556736|584817592|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
161936190|NCT02556736|584817593|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
161936191|NCT02556736|584817590|FG000|Open Label Treatment Period|Adverse Event|0|||
161936192|NCT02556736|584817591|FG001|Open Label Treatment Period|Adverse Event|0|||
161936193|NCT02556736|584817592|FG002|Open Label Treatment Period|Adverse Event|0|||
161936194|NCT02556736|584817593|FG003|Open Label Treatment Period|Adverse Event|1|||
161936195|NCT02556736|584817590|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
161936196|NCT02556736|584817591|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
161936197|NCT02556736|584817592|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
161936198|NCT02556736|584817593|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
161936199|NCT02032823|584817606|FG000|Overall Study|Death|75|||
161936200|NCT02032823|584817607|FG001|Overall Study|Death|109|||
161936201|NCT02032823|584817606|FG000|Overall Study|Lost to Follow-up|18|||
161936202|NCT02032823|584817607|FG001|Overall Study|Lost to Follow-up|17|||
161936203|NCT02032823|584817606|FG000|Overall Study|Withdrawal by Subject|70|||
161936204|NCT02032823|584817607|FG001|Overall Study|Withdrawal by Subject|53|||
161936205|NCT02032823|584817606|FG000|Overall Study|Ongoing study at data cut-off|755|||
161936206|NCT02032823|584817607|FG001|Overall Study|Ongoing study at data cut-off|731|||
161936207|NCT02032823|584817606|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
161936208|NCT02032823|584817607|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
161936209|NCT05431387|584817608|FG000|Overall Study|Adverse Event|1|||
161936210|NCT05431387|584817609|FG001|Overall Study|Adverse Event|0|||
161936211|NCT05431387|584817608|FG000|Overall Study|Withdrawal by Subject|4|||
161936212|NCT05431387|584817609|FG001|Overall Study|Withdrawal by Subject|4|||
161936213|NCT05431387|584817608|FG000|Overall Study|Physician Decision|0|||
161936214|NCT05431387|584817609|FG001|Overall Study|Physician Decision|1|||
161936215|NCT05431387|584817608|FG000|Overall Study|Lost to Follow-up|5|||
161936216|NCT05431387|584817609|FG001|Overall Study|Lost to Follow-up|9|||
161936217|NCT05431387|584817608|FG000|Overall Study|Other, Not Specified|1|||
161936218|NCT05431387|584817609|FG001|Overall Study|Other, Not Specified|4|||
161936219|NCT05243680|584817610|FG000|Overall Study|Adverse Event|1|||
161936220|NCT05243680|584817611|FG001|Overall Study|Adverse Event|1|||
161936221|NCT05243680|584817610|FG000|Overall Study|Lack of Efficacy|1|||
161936222|NCT05243680|584817611|FG001|Overall Study|Lack of Efficacy|1|||
161936223|NCT05243680|584817610|FG000|Overall Study|Lost to Follow-up|5|||
161936224|NCT05243680|584817611|FG001|Overall Study|Lost to Follow-up|4|||
161936225|NCT05243680|584817610|FG000|Overall Study|Physician Decision|1|||
161936226|NCT05243680|584817611|FG001|Overall Study|Physician Decision|0|||
161936227|NCT05243680|584817610|FG000|Overall Study|Withdrawal by Subject|3|||
161936228|NCT05243680|584817611|FG001|Overall Study|Withdrawal by Subject|10|||
161936229|NCT05243680|584817610|FG000|Overall Study|Data integrity and GCP violations|4|||
161936230|NCT05243680|584817611|FG001|Overall Study|Data integrity and GCP violations|8|||
161936231|NCT05358717|584817612|FG000|Overall Study|Adverse Event|0|||
161936232|NCT05358717|584817613|FG001|Overall Study|Adverse Event|1|||
161936233|NCT05358717|584817614|FG002|Overall Study|Adverse Event|1|||
161936234|NCT05358717|584817612|FG000|Overall Study|Death|1|||
161527191|NCT00951041|583318167|FG001|Overall Study|Other|0|||
161527192|NCT02388724|583318170|FG000|Overall Study|Reason not Specified|0|||
161527193|NCT02388724|583318171|FG001|Overall Study|Reason not Specified|1|||
161936235|NCT05358717|584817613|FG001|Overall Study|Death|1|||
161936236|NCT05358717|584817614|FG002|Overall Study|Death|0|||
161936237|NCT05358717|584817612|FG000|Overall Study|Withdrawal by Subject|1|||
161936238|NCT05358717|584817613|FG001|Overall Study|Withdrawal by Subject|1|||
161936239|NCT05358717|584817614|FG002|Overall Study|Withdrawal by Subject|2|||
161527194|NCT02388724|583318170|FG000|Overall Study|Major Protocol Deviation|3|||
161527195|NCT02388724|583318171|FG001|Overall Study|Major Protocol Deviation|3|||
161936240|NCT05358717|584817612|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
161936241|NCT05358717|584817613|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
161936242|NCT05358717|584817614|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
161936243|NCT02411448|584817615|FG000|Overall Study|Withdrawal by Subject|1|||
161936244|NCT02411448|584817616|FG001|Overall Study|Withdrawal by Subject|14|||
161936245|NCT02411448|584817617|FG002|Overall Study|Withdrawal by Subject|9|||
161527196|NCT02388724|583318170|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
161527197|NCT02388724|583318171|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
161527198|NCT02388724|583318170|FG000|Overall Study|Voluntary Withdrawal|6|||
161527199|NCT02388724|583318171|FG001|Overall Study|Voluntary Withdrawal|5|||
161527200|NCT02388724|583318170|FG000|Overall Study|Randomized but not Treated|0|||
161527201|NCT02388724|583318171|FG001|Overall Study|Randomized but not Treated|2|||
161936246|NCT02411448|584817615|FG000|Overall Study|Other|0|||
161936247|NCT02411448|584817616|FG001|Overall Study|Other|2|||
161936248|NCT02411448|584817617|FG002|Overall Study|Other|0|||
161936249|NCT02411448|584817615|FG000|Overall Study|Did not receive study treatment|0|||
161936250|NCT02411448|584817616|FG001|Overall Study|Did not receive study treatment|3|||
161936251|NCT02411448|584817617|FG002|Overall Study|Did not receive study treatment|0|||
161936252|NCT02411448|584817615|FG000|Overall Study|Alive on study treatment|3|||
161936253|NCT02411448|584817616|FG001|Overall Study|Alive on study treatment|64|||
161936254|NCT02411448|584817617|FG002|Overall Study|Alive on study treatment|43|||
161936255|NCT01302834|584817618|FG000|Overall Study|Protocol Violation|17|||
161936256|NCT01302834|584817619|FG001|Overall Study|Protocol Violation|23|||
161936257|NCT01302834|584817618|FG000|Overall Study|HIV positive|1|||
161936258|NCT01302834|584817619|FG001|Overall Study|HIV positive|3|||
161936259|NCT04257929|584817620|FG000|Overall Study|Adverse Event|1|||
161936260|NCT04257929|584817621|FG001|Overall Study|Adverse Event|0|||
161936261|NCT04257929|584817622|FG002|Overall Study|Adverse Event|1|||
161936262|NCT04257929|584817620|FG000|Overall Study|Withdrawal by Subject|1|||
161936263|NCT04257929|584817621|FG001|Overall Study|Withdrawal by Subject|0|||
161936264|NCT04257929|584817622|FG002|Overall Study|Withdrawal by Subject|0|||
161936265|NCT04257929|584817620|FG000|Overall Study|COVID-19|0|||
161936266|NCT04257929|584817621|FG001|Overall Study|COVID-19|1|||
161936267|NCT04257929|584817622|FG002|Overall Study|COVID-19|1|||
161936268|NCT04257929|584817620|FG000|Overall Study|Lost to Follow-up|0|||
161936269|NCT04257929|584817621|FG001|Overall Study|Lost to Follow-up|0|||
161936270|NCT04257929|584817622|FG002|Overall Study|Lost to Follow-up|1|||
161936271|NCT05642442|584817623|FG000|Overall Study|Adverse Event|0|||
161936272|NCT05642442|584817624|FG001|Overall Study|Adverse Event|1|||
161936273|NCT05642442|584817623|FG000|Overall Study|Lack of Efficacy|0|||
161936274|NCT05642442|584817624|FG001|Overall Study|Lack of Efficacy|1|||
161936275|NCT05642442|584817623|FG000|Overall Study|Withdrawal by Subject|13|||
161936276|NCT05642442|584817624|FG001|Overall Study|Withdrawal by Subject|9|||
161936277|NCT05642442|584817623|FG000|Overall Study|Other|5|||
161936278|NCT05642442|584817624|FG001|Overall Study|Other|2|||
161936279|NCT05642442|584817623|FG000|Overall Study|Lost to Follow-up|0|||
161936280|NCT05642442|584817624|FG001|Overall Study|Lost to Follow-up|1|||
161936281|NCT05528510|584817625|FG000|Overall Study|Death|1|||
161936282|NCT05528510|584817626|FG001|Overall Study|Death|0|||
161936283|NCT05528510|584817627|FG002|Overall Study|Death|0|||
161936284|NCT05528510|584817625|FG000|Overall Study|Lost to Follow-up|1|||
161936285|NCT05528510|584817626|FG001|Overall Study|Lost to Follow-up|0|||
161936286|NCT05528510|584817627|FG002|Overall Study|Lost to Follow-up|0|||
161936287|NCT05528510|584817625|FG000|Overall Study|Withdrawal by Subject|4|||
161936288|NCT05528510|584817626|FG001|Overall Study|Withdrawal by Subject|1|||
161936289|NCT05528510|584817627|FG002|Overall Study|Withdrawal by Subject|3|||
161936290|NCT05528510|584817625|FG000|Overall Study|Other|2|||
161936291|NCT05528510|584817626|FG001|Overall Study|Other|2|||
161936292|NCT05528510|584817627|FG002|Overall Study|Other|1|||
161936293|NCT06066697|584817628|FG000|Overall Study|Lost to Follow-up|5|||
161936294|NCT06066697|584817629|FG001|Overall Study|Lost to Follow-up|0|||
161936295|NCT06036914|584817631|FG000|Overall Study|Withdrawal by Subject|1|||
161936296|NCT06036914|584817632|FG001|Overall Study|Withdrawal by Subject|0|||
161527202|NCT02277106|583318172|FG000|Stage 2|Adverse Event|0|||
161527203|NCT02277106|583318173|FG001|Stage 2|Adverse Event|0|||
161527204|NCT02277106|583318174|FG002|Stage 2|Adverse Event|1|||
161527205|NCT01064739|583318175|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
161527206|NCT02479412|583318176|FG000|Overall Study|Adverse Event|0|||
161527207|NCT02479412|583318177|FG001|Overall Study|Adverse Event|0|||
161936297|NCT02616562|584817635|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936298|NCT02616562|584817636|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
161936299|NCT02616562|584817637|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936300|NCT02616562|584817638|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936301|NCT02616562|584817639|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936302|NCT02616562|584817640|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936303|NCT02616562|584817641|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936304|NCT02616562|584817642|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936305|NCT02616562|584817643|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936306|NCT02616562|584817644|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936307|NCT02616562|584817645|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936308|NCT02616562|584817646|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936309|NCT02616562|584817647|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936310|NCT02616562|584817648|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161527208|NCT02479412|583318178|FG002|Overall Study|Adverse Event|1|||
161527209|NCT02479412|583318179|FG003|Overall Study|Adverse Event|0|||
161527210|NCT02479412|583318180|FG004|Overall Study|Adverse Event|0|||
161527211|NCT02479412|583318181|FG005|Overall Study|Adverse Event|0|||
161527212|NCT02479412|583318182|FG006|Overall Study|Adverse Event|0|||
161527213|NCT02479412|583318183|FG007|Overall Study|Adverse Event|0|||
161527214|NCT02479412|583318184|FG008|Overall Study|Adverse Event|0|||
161527215|NCT02479412|583318176|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161527216|NCT02479412|583318177|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161527217|NCT02479412|583318178|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161527218|NCT02479412|583318179|FG003|Overall Study|Study-specific withdrawal criteria|1|||
161527219|NCT02479412|583318180|FG004|Overall Study|Study-specific withdrawal criteria|0|||
161527220|NCT02479412|583318181|FG005|Overall Study|Study-specific withdrawal criteria|0|||
161527221|NCT02479412|583318182|FG006|Overall Study|Study-specific withdrawal criteria|0|||
161527222|NCT02479412|583318183|FG007|Overall Study|Study-specific withdrawal criteria|1|||
161527223|NCT02479412|583318184|FG008|Overall Study|Study-specific withdrawal criteria|1|||
161527224|NCT02479412|583318176|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
161527225|NCT02479412|583318177|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
161527226|NCT02479412|583318178|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
161527227|NCT02479412|583318179|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
161527228|NCT02479412|583318180|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
161527229|NCT02479412|583318181|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
161527230|NCT02479412|583318182|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
161936311|NCT02616562|584817649|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936312|NCT02616562|584817650|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936313|NCT02616562|584817651|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
161936314|NCT02616562|584817635|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936315|NCT02616562|584817636|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936316|NCT02616562|584817637|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936317|NCT02616562|584817638|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936318|NCT02616562|584817639|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936319|NCT02616562|584817640|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936320|NCT02616562|584817641|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936321|NCT02616562|584817642|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936322|NCT02616562|584817643|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936323|NCT02616562|584817644|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
161936324|NCT02616562|584817645|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936325|NCT02616562|584817646|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936326|NCT02616562|584817647|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936327|NCT02616562|584817648|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936328|NCT02616562|584817649|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936329|NCT02616562|584817650|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936330|NCT02616562|584817651|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
161936331|NCT02616562|584817635|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936332|NCT02616562|584817636|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936333|NCT02616562|584817637|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936334|NCT02616562|584817638|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936335|NCT02616562|584817639|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936336|NCT02616562|584817640|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936337|NCT02616562|584817641|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936338|NCT02616562|584817642|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161527231|NCT02479412|583318183|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
161527232|NCT02479412|583318184|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
161527233|NCT00454051|583318185|FG000|Overall Study|Adverse Event|1|||
161527234|NCT00454051|583318186|FG001|Overall Study|Adverse Event|2|||
161527235|NCT00454051|583318185|FG000|Overall Study|Withdrawal by Subject|1|||
161527236|NCT00454051|583318186|FG001|Overall Study|Withdrawal by Subject|0|||
161527237|NCT00454051|583318185|FG000|Overall Study|Protocol Violation|1|||
161527238|NCT00454051|583318186|FG001|Overall Study|Protocol Violation|1|||
161527239|NCT01571362|583318187|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
161527240|NCT01571362|583318188|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
161527241|NCT01571362|583318189|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
161527242|NCT01571362|583318187|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
161527243|NCT01571362|583318188|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
161527244|NCT01571362|583318189|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
161527245|NCT01571362|583318187|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
161527246|NCT01571362|583318188|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
161527247|NCT01571362|583318189|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
161527248|NCT01571362|583318187|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
161527249|NCT01571362|583318188|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
161527250|NCT01571362|583318189|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
161936339|NCT02616562|584817643|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
161936340|NCT02616562|584817644|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
161936341|NCT02616562|584817645|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936342|NCT02616562|584817646|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936343|NCT02616562|584817647|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936344|NCT02616562|584817648|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936345|NCT02616562|584817649|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936346|NCT02616562|584817650|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936347|NCT02616562|584817651|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161936348|NCT02616562|584817635|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936349|NCT02616562|584817636|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936350|NCT02616562|584817637|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936351|NCT02616562|584817638|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936352|NCT02616562|584817639|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936353|NCT02616562|584817640|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936354|NCT02616562|584817641|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936355|NCT02616562|584817642|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936356|NCT02616562|584817643|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936357|NCT02616562|584817644|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
161936358|NCT02616562|584817645|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936359|NCT02616562|584817646|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936360|NCT02616562|584817647|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936361|NCT02616562|584817648|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936362|NCT02616562|584817649|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936363|NCT02616562|584817650|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936364|NCT02616562|584817651|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
161936365|NCT02616562|584817635|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936366|NCT02616562|584817636|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936367|NCT02616562|584817637|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936368|NCT02616562|584817638|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936369|NCT02616562|584817639|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936370|NCT02616562|584817640|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936371|NCT02616562|584817641|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936372|NCT02616562|584817642|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936373|NCT02616562|584817643|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
161936374|NCT02616562|584817644|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936375|NCT02616562|584817645|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936376|NCT02616562|584817646|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936377|NCT02616562|584817647|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936378|NCT02616562|584817648|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936379|NCT02616562|584817649|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936380|NCT02616562|584817650|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936381|NCT02616562|584817651|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161936382|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936383|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936384|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936385|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936386|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936387|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936388|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936389|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936390|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936391|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936392|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936393|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
161936394|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936395|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936396|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
161936397|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936398|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161936399|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936400|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936401|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936402|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936403|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936404|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936405|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936406|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936407|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936408|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936409|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936410|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
161936411|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936412|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936413|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936414|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936415|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
161936416|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936417|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936418|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936419|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936420|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936421|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936422|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936423|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936424|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936425|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936426|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936427|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
161527251|NCT01571362|583318187|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
161527252|NCT01571362|583318188|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
161527253|NCT01571362|583318189|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
161527254|NCT01571362|583318187|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
161527255|NCT01571362|583318188|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
161527256|NCT01571362|583318189|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
161527257|NCT01571362|583318187|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161527258|NCT01571362|583318188|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
161527259|NCT01571362|583318189|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
161527260|NCT01571362|583318187|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161527261|NCT01571362|583318188|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
161527262|NCT01571362|583318189|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
161527263|NCT01571362|583318187|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161527264|NCT01571362|583318188|FG001|Double-Blind Treatment Period|Adverse Event|9|||
161527265|NCT01571362|583318189|FG002|Double-Blind Treatment Period|Adverse Event|14|||
161527266|NCT01571362|583318187|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161527267|NCT01571362|583318188|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
161527268|NCT01571362|583318189|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
161527269|NCT01571362|583318187|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
161527270|NCT01571362|583318188|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
161527271|NCT01571362|583318189|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
161527272|NCT01571362|583318187|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
161527273|NCT01571362|583318188|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
161527274|NCT01571362|583318189|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
161936428|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936429|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936430|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936431|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936432|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
161936433|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936434|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161527275|NCT04258020|583318190|FG000|Overall Study|Withdrawal by Subject|1|||
161527276|NCT04258020|583318191|FG001|Overall Study|Withdrawal by Subject|0|||
161527277|NCT02097472|583318194|FG000|Received Vaccination 2|Adverse Event|0|||
161527278|NCT02097472|583318195|FG001|Received Vaccination 2|Adverse Event|0|||
161527279|NCT02097472|583318196|FG002|Received Vaccination 2|Adverse Event|0|||
161527280|NCT02097472|583318197|FG003|Received Vaccination 2|Adverse Event|0|||
161527281|NCT02097472|583318198|FG004|Received Vaccination 2|Adverse Event|0|||
161527282|NCT02097472|583318199|FG005|Received Vaccination 2|Adverse Event|0|||
161527283|NCT02097472|583318200|FG006|Received Vaccination 2|Adverse Event|1|||
161527284|NCT02097472|583318201|FG007|Received Vaccination 2|Adverse Event|0|||
161527285|NCT03117738|583318202|FG000|Overall Study|Withdrawal by Subject|3|||
161527286|NCT03117738|583318203|FG001|Overall Study|Withdrawal by Subject|1|||
161527287|NCT03117738|583318202|FG000|Overall Study|Lost to Follow-up|1|||
161527288|NCT03117738|583318203|FG001|Overall Study|Lost to Follow-up|4|||
161527289|NCT01669629|583318204|FG000|Period 1|protocol deviation|1|||
161527290|NCT01669629|583318205|FG001|Period 1|protocol deviation|2|||
161527291|NCT04402866|583318208|FG000|Overall Study|Discontinued Prior to Treatment|0|||
161527292|NCT04402866|583318209|FG001|Overall Study|Discontinued Prior to Treatment|0|||
161527293|NCT04402866|583318210|FG002|Overall Study|Discontinued Prior to Treatment|0|||
161527294|NCT04402866|583318211|FG003|Overall Study|Discontinued Prior to Treatment|0|||
161527295|NCT04402866|583318212|FG004|Overall Study|Discontinued Prior to Treatment|2|||
161527296|NCT04402866|583318213|FG005|Overall Study|Discontinued Prior to Treatment|3|||
161527297|NCT04402866|583318208|FG000|Overall Study|Adverse Event|2|||
161527298|NCT04402866|583318209|FG001|Overall Study|Adverse Event|1|||
161527299|NCT04402866|583318210|FG002|Overall Study|Adverse Event|0|||
161527300|NCT04402866|583318211|FG003|Overall Study|Adverse Event|0|||
161527301|NCT04402866|583318212|FG004|Overall Study|Adverse Event|13|||
161527302|NCT04402866|583318213|FG005|Overall Study|Adverse Event|8|||
161527303|NCT04402866|583318208|FG000|Overall Study|Miscellaneous|0|||
161527304|NCT04402866|583318209|FG001|Overall Study|Miscellaneous|0|||
161527305|NCT04402866|583318210|FG002|Overall Study|Miscellaneous|1|||
161527306|NCT04402866|583318211|FG003|Overall Study|Miscellaneous|0|||
161527307|NCT04402866|583318212|FG004|Overall Study|Miscellaneous|0|||
161527308|NCT04402866|583318213|FG005|Overall Study|Miscellaneous|0|||
161527309|NCT04402866|583318208|FG000|Overall Study|Lost to Follow-up|0|||
161527310|NCT04402866|583318209|FG001|Overall Study|Lost to Follow-up|0|||
161527311|NCT04402866|583318210|FG002|Overall Study|Lost to Follow-up|0|||
161527312|NCT04402866|583318211|FG003|Overall Study|Lost to Follow-up|0|||
161527313|NCT04402866|583318212|FG004|Overall Study|Lost to Follow-up|0|||
161527314|NCT04402866|583318213|FG005|Overall Study|Lost to Follow-up|1|||
161527315|NCT04402866|583318208|FG000|Overall Study|Withdrawal by Subject|0|||
161527316|NCT04402866|583318209|FG001|Overall Study|Withdrawal by Subject|0|||
161527317|NCT04402866|583318210|FG002|Overall Study|Withdrawal by Subject|0|||
161527318|NCT04402866|583318211|FG003|Overall Study|Withdrawal by Subject|0|||
161527319|NCT04402866|583318212|FG004|Overall Study|Withdrawal by Subject|0|||
161527320|NCT04402866|583318213|FG005|Overall Study|Withdrawal by Subject|2|||
161527321|NCT03667053|583318214|FG000|Overall Study|Withdrawal by Subject|1|||
161678223|NCT00823823|583873640|FG001|Overall Study|Lost to Follow-up|1|||
161678224|NCT00823823|583873639|FG000|Overall Study|Protocol Violation|5|||
161527322|NCT03667053|583318215|FG001|Overall Study|Withdrawal by Subject|0|||
161527323|NCT03667053|583318216|FG002|Overall Study|Withdrawal by Subject|0|||
161527324|NCT01292928|583318218|FG000|Overall Study|Death|8|||
161527325|NCT01292928|583318218|FG000|Overall Study|Withdrawal by Subject|8|||
161527326|NCT01292928|583318218|FG000|Overall Study|Lost to Follow-up|6|||
161527327|NCT01292928|583318218|FG000|Overall Study|Physician Decision|2|||
161527328|NCT00130533|583318219|FG000|Overall Study|Withdrawal by Subject|33|||
161527329|NCT00130533|583318220|FG001|Overall Study|Withdrawal by Subject|6|||
161527330|NCT00130533|583318219|FG000|Overall Study|Adverse Event|34|||
161527331|NCT00130533|583318220|FG001|Overall Study|Adverse Event|1|||
161527332|NCT00130533|583318219|FG000|Overall Study|Disease relapse|9|||
161527333|NCT00130533|583318220|FG001|Overall Study|Disease relapse|13|||
161527334|NCT00130533|583318219|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
161527335|NCT00130533|583318220|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
161527336|NCT00130533|583318219|FG000|Overall Study|Death|4|||
161527337|NCT00130533|583318220|FG001|Overall Study|Death|2|||
161527338|NCT00130533|583318219|FG000|Overall Study|Protocol Violation|5|||
161527339|NCT00130533|583318220|FG001|Overall Study|Protocol Violation|1|||
161527340|NCT00130533|583318219|FG000|Overall Study|Lost to Follow-up|1|||
161678225|NCT00823823|583873640|FG001|Overall Study|Protocol Violation|5|||
161527341|NCT00130533|583318220|FG001|Overall Study|Lost to Follow-up|1|||
161527342|NCT00130533|583318219|FG000|Overall Study|Sponsor´s decision|2|||
161527343|NCT00130533|583318220|FG001|Overall Study|Sponsor´s decision|0|||
161527344|NCT00130533|583318219|FG000|Overall Study|Second Primary Malignancy|0|||
161527345|NCT00130533|583318220|FG001|Overall Study|Second Primary Malignancy|1|||
161527346|NCT00130533|583318219|FG000|Overall Study|Other|12|||
161527347|NCT00130533|583318220|FG001|Overall Study|Other|5|||
161527348|NCT01059565|583318221|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
161527349|NCT01059565|583318222|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
161527350|NCT01059565|583318221|FG000|24-Week Randomized Phase|Adverse Event|5|||
161527351|NCT01059565|583318222|FG001|24-Week Randomized Phase|Adverse Event|0|||
161678226|NCT02234284|583873641|FG000|Overall Study|Death|4|||
161527352|NCT01059565|583318221|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
161527353|NCT01059565|583318222|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
161527354|NCT01059565|583318221|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
161527355|NCT01059565|583318222|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
161527356|NCT01059565|583318221|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
161527357|NCT01059565|583318222|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
161527358|NCT01059565|583318221|FG000|24-Week Open-Label Phase|Adverse Event|2|||
161527359|NCT01059565|583318222|FG001|24-Week Open-Label Phase|Adverse Event|0|||
161527360|NCT01059565|583318221|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
161527361|NCT01059565|583318222|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
161527362|NCT01059565|583318221|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
161527363|NCT01059565|583318222|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
161527364|NCT01059565|583318221|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
161527365|NCT01059565|583318222|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
161527366|NCT01059565|583318221|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
161527367|NCT01059565|583318222|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
161527368|NCT01059565|583318221|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
161527369|NCT01059565|583318222|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
161527370|NCT02732938|583318223|FG000|Overall Study|Death|0|||
161527371|NCT02732938|583318224|FG001|Overall Study|Death|11|||
161527372|NCT02732938|583318225|FG002|Overall Study|Death|0|||
161527373|NCT02732938|583318223|FG000|Overall Study|Randomized but did not receive treatment|0|||
161527374|NCT02732938|583318224|FG001|Overall Study|Randomized but did not receive treatment|1|||
161527375|NCT02732938|583318225|FG002|Overall Study|Randomized but did not receive treatment|0|||
161527376|NCT02732938|583318223|FG000|Overall Study|Refused further follow-up|1|||
161527377|NCT02732938|583318224|FG001|Overall Study|Refused further follow-up|0|||
161527378|NCT02732938|583318225|FG002|Overall Study|Refused further follow-up|0|||
161527379|NCT02732938|583318223|FG000|Overall Study|Study terminated by sponsor|3|||
161527380|NCT02732938|583318224|FG001|Overall Study|Study terminated by sponsor|6|||
161527381|NCT02732938|583318225|FG002|Overall Study|Study terminated by sponsor|0|||
161527382|NCT01026974|583318236|FG000|Overall Study|Withdrawal by Subject|0|||
161527383|NCT01026974|583318237|FG001|Overall Study|Withdrawal by Subject|1|||
161527384|NCT01026974|583318238|FG002|Overall Study|Withdrawal by Subject|7|||
161527385|NCT01026974|583318239|FG003|Overall Study|Withdrawal by Subject|2|||
161527386|NCT01026974|583318236|FG000|Overall Study|Lost to Follow-up|1|||
161527387|NCT01026974|583318237|FG001|Overall Study|Lost to Follow-up|1|||
161527388|NCT01026974|583318238|FG002|Overall Study|Lost to Follow-up|4|||
161527389|NCT01026974|583318239|FG003|Overall Study|Lost to Follow-up|0|||
161527390|NCT01026974|583318236|FG000|Overall Study|Adverse Event|0|||
161527391|NCT01026974|583318237|FG001|Overall Study|Adverse Event|0|||
161527392|NCT01026974|583318238|FG002|Overall Study|Adverse Event|0|||
161527393|NCT01026974|583318239|FG003|Overall Study|Adverse Event|1|||
161527394|NCT01026974|583318236|FG000|Overall Study|Inappropriate enrollment|0|||
161527395|NCT01026974|583318237|FG001|Overall Study|Inappropriate enrollment|0|||
161527396|NCT01026974|583318238|FG002|Overall Study|Inappropriate enrollment|1|||
161527397|NCT01026974|583318239|FG003|Overall Study|Inappropriate enrollment|0|||
161527398|NCT02864082|583318246|FG000|Overall Study|Adverse Event|1|||
161527399|NCT02864082|583318247|FG001|Overall Study|Adverse Event|1|||
161527400|NCT02864082|583318246|FG000|Overall Study|Lost to Follow-up|0|||
161527401|NCT02864082|583318247|FG001|Overall Study|Lost to Follow-up|1|||
161527402|NCT02864082|583318246|FG000|Overall Study|Withdrawal by Subject|2|||
161527403|NCT02864082|583318247|FG001|Overall Study|Withdrawal by Subject|2|||
161527404|NCT05545072|583318255|FG000|Overall Study|Lost to Follow-up|1|||
161527405|NCT05545072|583318256|FG001|Overall Study|Lost to Follow-up|0|||
161527406|NCT05545072|583318255|FG000|Overall Study|Study ended prematurely due to funding|2|||
161527407|NCT05545072|583318256|FG001|Overall Study|Study ended prematurely due to funding|2|||
161527408|NCT03996473|583318257|FG000|Treatment Assignment|Withdrawal by Subject|1|||
161527409|NCT03996473|583318257|FG000|Treatment Assignment|Progressive disease|6|||
161527410|NCT03996473|583318257|FG000|Treatment Assignment|Study drug never administered|1|||
161827301|NCT01609582|584408046|FG000|Overall Study|Lost to Follow-up|10|||
161827302|NCT01609582|584408047|FG001|Overall Study|Lost to Follow-up|10|||
161527411|NCT03996473|583318257|FG000|Active Follow-up|Death|1|||
161527412|NCT03996473|583318257|FG000|Long-term Follow-up|Death|5|||
161527413|NCT03759873|583318258|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
161827303|NCT01609582|584408046|FG000|Overall Study|Withdrawal by Subject|21|||
161827304|NCT01609582|584408047|FG001|Overall Study|Withdrawal by Subject|15|||
161827305|NCT01609582|584408046|FG000|Overall Study|Study Terminated by Sponsor|1543|||
161827306|NCT01609582|584408047|FG001|Overall Study|Study Terminated by Sponsor|1548|||
161827307|NCT01609582|584408046|FG000|Overall Study|Other|9|||
161827308|NCT01609582|584408047|FG001|Overall Study|Other|10|||
161827309|NCT01609582|584408046|FG000|Overall Study|Randomized, but not treated|0|||
161827310|NCT01609582|584408047|FG001|Overall Study|Randomized, but not treated|3|||
161827311|NCT00819767|584408048|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161827312|NCT00819767|584408049|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161590771|NCT02783300|583552746|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
161590772|NCT02783300|583552747|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
161590773|NCT02783300|583552748|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
161590774|NCT02783300|583552749|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
161590775|NCT02783300|583552750|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
161590776|NCT02783300|583552751|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
161590777|NCT02783300|583552752|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
161590778|NCT02783300|583552753|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
161590779|NCT02783300|583552754|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
161590780|NCT02783300|583552755|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
161590781|NCT02783300|583552729|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590782|NCT02783300|583552730|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590783|NCT02783300|583552731|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590784|NCT02783300|583552732|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590785|NCT02783300|583552733|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590786|NCT02783300|583552734|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590787|NCT02783300|583552735|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
161590788|NCT02783300|583552736|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590789|NCT02783300|583552737|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590790|NCT02783300|583552738|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590791|NCT02783300|583552739|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590792|NCT02783300|583552740|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590793|NCT02783300|583552741|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
161590794|NCT02783300|583552742|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590795|NCT02783300|583552743|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590796|NCT02783300|583552744|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590797|NCT02783300|583552745|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590798|NCT02783300|583552746|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590799|NCT02783300|583552747|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590800|NCT02783300|583552748|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590801|NCT02783300|583552749|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590802|NCT02783300|583552750|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590803|NCT02783300|583552751|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590804|NCT02783300|583552752|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590805|NCT02783300|583552753|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590806|NCT02783300|583552754|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590807|NCT02783300|583552755|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161590808|NCT02783300|583552729|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590809|NCT02783300|583552730|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590810|NCT02783300|583552731|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590811|NCT02783300|583552732|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590812|NCT02783300|583552733|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161590813|NCT02783300|583552734|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590814|NCT02783300|583552735|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161590815|NCT02783300|583552736|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590816|NCT02783300|583552737|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590817|NCT02783300|583552738|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161590818|NCT02783300|583552739|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590819|NCT02783300|583552740|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590820|NCT02783300|583552741|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
161590821|NCT02783300|583552742|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590822|NCT02783300|583552743|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590823|NCT02783300|583552744|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590824|NCT02783300|583552745|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590825|NCT02783300|583552746|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590826|NCT02783300|583552747|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590827|NCT02783300|583552748|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590828|NCT02783300|583552749|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590829|NCT02783300|583552750|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590830|NCT02783300|583552751|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590831|NCT02783300|583552752|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590832|NCT02783300|583552753|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590833|NCT02783300|583552754|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590834|NCT02783300|583552755|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161590835|NCT02783300|583552729|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590836|NCT02783300|583552730|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161527414|NCT03759873|583318259|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
161936435|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936436|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936437|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936438|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161527415|NCT03759873|583318260|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
161527416|NCT03759873|583318261|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
161527417|NCT03759873|583318258|FG000|Overall Study|Moved outside eligible area|0|||
161527418|NCT03759873|583318259|FG001|Overall Study|Moved outside eligible area|2|||
161936439|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936440|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936441|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936442|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936443|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
161936444|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936445|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936446|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
161936447|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
161936448|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936449|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
161936450|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936451|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936452|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936453|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936454|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936455|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936456|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936457|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936458|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936459|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936460|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
161936461|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936462|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936463|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936464|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936465|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161936466|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161527419|NCT03759873|583318260|FG002|Overall Study|Moved outside eligible area|0|||
161527420|NCT03759873|583318261|FG003|Overall Study|Moved outside eligible area|0|||
161527421|NCT03759873|583318258|FG000|Overall Study|Withdrawal by Subject|0|||
161527422|NCT03759873|583318259|FG001|Overall Study|Withdrawal by Subject|0|||
161527423|NCT03759873|583318260|FG002|Overall Study|Withdrawal by Subject|1|||
161527424|NCT03759873|583318261|FG003|Overall Study|Withdrawal by Subject|0|||
161527425|NCT04349553|583318264|FG000|Overall Study|Withdrawal by Subject|1|||
161590837|NCT02783300|583552731|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161527426|NCT04349553|583318265|FG001|Overall Study|Withdrawal by Subject|0|||
161527427|NCT04349553|583318266|FG002|Overall Study|Withdrawal by Subject|1|||
161527428|NCT04349553|583318267|FG003|Overall Study|Withdrawal by Subject|0|||
161527429|NCT01869491|583318270|FG000|Overall Study|Adverse Event|3|||
161527430|NCT01869491|583318271|FG001|Overall Study|Adverse Event|5|||
161590838|NCT02783300|583552732|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590839|NCT02783300|583552733|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590840|NCT02783300|583552734|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590841|NCT02783300|583552735|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590842|NCT02783300|583552736|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590843|NCT02783300|583552737|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161527431|NCT01869491|583318270|FG000|Overall Study|Lack of Efficacy|0|||
161527432|NCT01869491|583318271|FG001|Overall Study|Lack of Efficacy|3|||
161527433|NCT01869491|583318270|FG000|Overall Study|Withdrawal by Subject|6|||
161527434|NCT01869491|583318271|FG001|Overall Study|Withdrawal by Subject|7|||
161527435|NCT01869491|583318270|FG000|Overall Study|Lost to Follow-up|11|||
161527436|NCT01869491|583318271|FG001|Overall Study|Lost to Follow-up|9|||
161936467|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936468|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936469|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936470|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936471|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936472|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936473|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936474|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936475|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936476|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936477|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936478|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
161936479|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936480|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936481|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936482|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936483|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
161936484|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936485|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936486|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936487|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936488|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936489|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936490|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936491|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936492|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936493|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936494|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936495|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
161936496|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936497|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936498|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936499|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936500|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161936501|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936502|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936503|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936504|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936505|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936506|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936507|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936508|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161527437|NCT01869491|583318270|FG000|Overall Study|No further need of investigational product|1|||
161527438|NCT01869491|583318271|FG001|Overall Study|No further need of investigational product|0|||
161527439|NCT05177770|583318272|FG000|Overall Study|Death|4|||
161527440|NCT05177770|583318272|FG000|Overall Study|Withdrawal by Subject|1|||
161527441|NCT05177770|583318272|FG000|Overall Study|Adverse Event prior to dosing|1|||
161527442|NCT01272934|583318276|FG000|Overall Study|Adverse Event|0|||
161527443|NCT01272934|583318277|FG001|Overall Study|Adverse Event|1|||
161527444|NCT01272934|583318276|FG000|Overall Study|Abnormal Laboratory Value|0|||
161527445|NCT01272934|583318277|FG001|Overall Study|Abnormal Laboratory Value|1|||
161527446|NCT00214136|583318278|FG000|Overall Study|Death|5|||
161527447|NCT04313634|583318279|FG000|Overall Study|Adverse Event|2|||
161527448|NCT04313634|583318280|FG001|Overall Study|Adverse Event|2|||
161527449|NCT04313634|583318281|FG002|Overall Study|Adverse Event|0|||
161527450|NCT04313634|583318279|FG000|Overall Study|Withdrawal by Subject|1|||
161527451|NCT04313634|583318280|FG001|Overall Study|Withdrawal by Subject|0|||
161527452|NCT04313634|583318281|FG002|Overall Study|Withdrawal by Subject|1|||
161678227|NCT02234284|583873642|FG001|Overall Study|Death|2|||
161527453|NCT04313634|583318279|FG000|Overall Study|Protocol Violation|0|||
161527454|NCT04313634|583318280|FG001|Overall Study|Protocol Violation|0|||
161527455|NCT04313634|583318281|FG002|Overall Study|Protocol Violation|1|||
161678228|NCT02234284|583873641|FG000|Overall Study|Withdrawal by Subject|1|||
161527456|NCT00319098|583318284|FG000|Overall Study|Serious adverse event|3|||
161527457|NCT00319098|583318285|FG001|Overall Study|Serious adverse event|0|||
161527458|NCT00319098|583318284|FG000|Overall Study|Adverse Event|20|||
161527459|NCT00319098|583318285|FG001|Overall Study|Adverse Event|1|||
161527460|NCT00319098|583318284|FG000|Overall Study|Withdrawal by Subject|37|||
161527461|NCT00319098|583318285|FG001|Overall Study|Withdrawal by Subject|8|||
161527462|NCT00319098|583318284|FG000|Overall Study|Migrated/moved from study area|2|||
161527463|NCT00319098|583318285|FG001|Overall Study|Migrated/moved from study area|1|||
161527464|NCT00319098|583318284|FG000|Overall Study|Lost to Follow-up|37|||
161527465|NCT00319098|583318285|FG001|Overall Study|Lost to Follow-up|13|||
161527466|NCT00319098|583318284|FG000|Overall Study|Others|33|||
161527467|NCT00319098|583318285|FG001|Overall Study|Others|8|||
161527468|NCT00319098|583318284|FG000|Overall Study|Protocol Violation|3|||
161527469|NCT00319098|583318285|FG001|Overall Study|Protocol Violation|1|||
161527470|NCT03449030|583318286|FG000|Overall Study|Withdrawal by Subject|0|||
161527471|NCT03449030|583318287|FG001|Overall Study|Withdrawal by Subject|0|||
161527472|NCT03449030|583318288|FG002|Overall Study|Withdrawal by Subject|0|||
161527473|NCT03449030|583318289|FG003|Overall Study|Withdrawal by Subject|1|||
161527474|NCT03449030|583318290|FG004|Overall Study|Withdrawal by Subject|1|||
161527475|NCT03449030|583318291|FG005|Overall Study|Withdrawal by Subject|1|||
161527476|NCT03449030|583318292|FG006|Overall Study|Withdrawal by Subject|1|||
161527477|NCT03449030|583318293|FG007|Overall Study|Withdrawal by Subject|2|||
161527478|NCT03449030|583318294|FG008|Overall Study|Withdrawal by Subject|0|||
161527479|NCT03449030|583318295|FG009|Overall Study|Withdrawal by Subject|0|||
161527480|NCT03449030|583318286|FG000|Overall Study|Symptomatic Deterioration|0|||
161527481|NCT03449030|583318287|FG001|Overall Study|Symptomatic Deterioration|1|||
161527482|NCT03449030|583318288|FG002|Overall Study|Symptomatic Deterioration|0|||
161527483|NCT03449030|583318289|FG003|Overall Study|Symptomatic Deterioration|0|||
161527484|NCT03449030|583318290|FG004|Overall Study|Symptomatic Deterioration|0|||
161527485|NCT03449030|583318291|FG005|Overall Study|Symptomatic Deterioration|1|||
161527486|NCT03449030|583318292|FG006|Overall Study|Symptomatic Deterioration|1|||
161527487|NCT03449030|583318293|FG007|Overall Study|Symptomatic Deterioration|0|||
161527488|NCT03449030|583318294|FG008|Overall Study|Symptomatic Deterioration|2|||
161527489|NCT03449030|583318295|FG009|Overall Study|Symptomatic Deterioration|0|||
161527490|NCT03449030|583318286|FG000|Overall Study|Progressive Disease|1|||
161527491|NCT03449030|583318287|FG001|Overall Study|Progressive Disease|0|||
161527492|NCT03449030|583318288|FG002|Overall Study|Progressive Disease|1|||
161527493|NCT03449030|583318289|FG003|Overall Study|Progressive Disease|4|||
161527494|NCT03449030|583318290|FG004|Overall Study|Progressive Disease|5|||
161527495|NCT03449030|583318291|FG005|Overall Study|Progressive Disease|3|||
161527496|NCT03449030|583318292|FG006|Overall Study|Progressive Disease|0|||
161527497|NCT03449030|583318293|FG007|Overall Study|Progressive Disease|1|||
161527498|NCT03449030|583318294|FG008|Overall Study|Progressive Disease|1|||
161527499|NCT03449030|583318295|FG009|Overall Study|Progressive Disease|1|||
161527500|NCT03449030|583318286|FG000|Overall Study|Adverse Event|0|||
161527501|NCT03449030|583318287|FG001|Overall Study|Adverse Event|0|||
161527502|NCT03449030|583318288|FG002|Overall Study|Adverse Event|0|||
161527503|NCT03449030|583318289|FG003|Overall Study|Adverse Event|0|||
161527504|NCT03449030|583318290|FG004|Overall Study|Adverse Event|0|||
161527505|NCT03449030|583318291|FG005|Overall Study|Adverse Event|2|||
161527506|NCT03449030|583318292|FG006|Overall Study|Adverse Event|0|||
161527507|NCT03449030|583318293|FG007|Overall Study|Adverse Event|0|||
161527508|NCT03449030|583318294|FG008|Overall Study|Adverse Event|0|||
161527509|NCT03449030|583318295|FG009|Overall Study|Adverse Event|0|||
161527510|NCT03449030|583318286|FG000|Overall Study|Death|0|||
161527511|NCT03449030|583318287|FG001|Overall Study|Death|0|||
161527512|NCT03449030|583318288|FG002|Overall Study|Death|0|||
161527513|NCT03449030|583318289|FG003|Overall Study|Death|0|||
161527514|NCT03449030|583318290|FG004|Overall Study|Death|1|||
161936509|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161527515|NCT03449030|583318291|FG005|Overall Study|Death|0|||
161527516|NCT03449030|583318292|FG006|Overall Study|Death|0|||
161527517|NCT03449030|583318293|FG007|Overall Study|Death|0|||
161527518|NCT03449030|583318294|FG008|Overall Study|Death|0|||
161527519|NCT03449030|583318295|FG009|Overall Study|Death|0|||
161527520|NCT02105948|583318296|FG000|Overall Study|Adverse Event|10|||
161527521|NCT02105948|583318297|FG001|Overall Study|Adverse Event|7|||
161527522|NCT02105948|583318298|FG002|Overall Study|Adverse Event|11|||
161527523|NCT02105948|583318299|FG003|Overall Study|Adverse Event|11|||
161527524|NCT02105948|583318296|FG000|Overall Study|Lack of Efficacy|0|||
161527525|NCT02105948|583318297|FG001|Overall Study|Lack of Efficacy|1|||
161527526|NCT02105948|583318298|FG002|Overall Study|Lack of Efficacy|3|||
161527527|NCT02105948|583318299|FG003|Overall Study|Lack of Efficacy|2|||
161527528|NCT02105948|583318296|FG000|Overall Study|Lost to Follow-up|0|||
161527529|NCT02105948|583318297|FG001|Overall Study|Lost to Follow-up|0|||
161527530|NCT02105948|583318298|FG002|Overall Study|Lost to Follow-up|2|||
161527531|NCT02105948|583318299|FG003|Overall Study|Lost to Follow-up|1|||
161527532|NCT02105948|583318296|FG000|Overall Study|Physician Decision|2|||
161527533|NCT02105948|583318297|FG001|Overall Study|Physician Decision|2|||
161527534|NCT02105948|583318298|FG002|Overall Study|Physician Decision|2|||
161527535|NCT02105948|583318299|FG003|Overall Study|Physician Decision|2|||
161527536|NCT02105948|583318296|FG000|Overall Study|Withdrawal by Subject|15|||
161527537|NCT02105948|583318297|FG001|Overall Study|Withdrawal by Subject|10|||
161527538|NCT02105948|583318298|FG002|Overall Study|Withdrawal by Subject|10|||
161527539|NCT02105948|583318299|FG003|Overall Study|Withdrawal by Subject|11|||
161527540|NCT00522275|583318300|FG000|Overall Study|Adverse Event|35|||
161527541|NCT00522275|583318300|FG000|Overall Study|Lack of Efficacy|80|||
161527542|NCT00522275|583318300|FG000|Overall Study|Subject withdrew consent|16|||
161527543|NCT00522275|583318300|FG000|Overall Study|Protocol deviation|1|||
161527544|NCT00522275|583318300|FG000|Overall Study|Unsatisfactory compliance|11|||
161527545|NCT00522275|583318300|FG000|Overall Study|Lost to Follow-up|8|||
161527546|NCT00522275|583318300|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
161527547|NCT00522275|583318300|FG000|Overall Study|Other: Subject is pregnant|2|||
161527548|NCT00522275|583318300|FG000|Overall Study|Other: Subject relocated|2|||
161527549|NCT00522275|583318300|FG000|Overall Study|Other: Subject arrested|1|||
161527550|NCT00522275|583318300|FG000|Overall Study|Other: Site / clinic closed|4|||
161527551|NCT00522275|583318300|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
161527552|NCT00522275|583318300|FG000|Overall Study|Other: Sponsor request|2|||
161527553|NCT00522275|583318300|FG000|Overall Study|Other: Subject ran out of medication|1|||
161527554|NCT00522275|583318300|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
161527555|NCT04558346|583318309|FG000|Overall Study|Withdrawal by Subject|2|||
161527556|NCT04558346|583318310|FG001|Overall Study|Withdrawal by Subject|0|||
161527557|NCT04558346|583318309|FG000|Overall Study|Lost to Follow-up|0|||
161527558|NCT04558346|583318310|FG001|Overall Study|Lost to Follow-up|1|||
161527559|NCT04558346|583318309|FG000|Overall Study|Adverse Event|0|||
161527560|NCT04558346|583318310|FG001|Overall Study|Adverse Event|1|||
161527561|NCT00724971|583318313|FG000|Overall Study|Adverse Event|5|||
161527562|NCT00724971|583318313|FG000|Overall Study|Withdrawal by Subject|1|||
161527563|NCT01462344|583318314|FG000|Overall Study|Withdrawal by Subject|245|||
161527564|NCT01462344|583318315|FG001|Overall Study|Withdrawal by Subject|226|||
161527565|NCT01462344|583318314|FG000|Overall Study|Adverse Event|24|||
161527566|NCT01462344|583318315|FG001|Overall Study|Adverse Event|23|||
161527567|NCT01462344|583318314|FG000|Overall Study|Asthma Exacerbation|34|||
161527568|NCT01462344|583318315|FG001|Overall Study|Asthma Exacerbation|35|||
161590844|NCT02783300|583552738|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590845|NCT02783300|583552739|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590846|NCT02783300|583552740|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590847|NCT02783300|583552741|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590848|NCT02783300|583552742|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590849|NCT02783300|583552743|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590850|NCT02783300|583552744|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161936510|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936511|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936512|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936513|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936514|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
161590851|NCT02783300|583552745|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590852|NCT02783300|583552746|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
161590853|NCT02783300|583552747|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
161590854|NCT02783300|583552748|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161936515|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936516|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936517|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161936518|NCT02616562|584817635|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936519|NCT02616562|584817636|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936520|NCT02616562|584817637|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161590855|NCT02783300|583552749|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590856|NCT02783300|583552750|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161527569|NCT01462344|583318314|FG000|Overall Study|Lack of Efficacy|5|||
161527570|NCT01462344|583318315|FG001|Overall Study|Lack of Efficacy|6|||
161527571|NCT01462344|583318314|FG000|Overall Study|Protocol Violation|68|||
161527572|NCT01462344|583318315|FG001|Overall Study|Protocol Violation|53|||
161527573|NCT01462344|583318314|FG000|Overall Study|Lost to Follow-up|7|||
161527574|NCT01462344|583318315|FG001|Overall Study|Lost to Follow-up|7|||
161527575|NCT02276482|583318316|FG000|Overall Study|Adverse Event|1|||
161527576|NCT02276482|583318317|FG001|Overall Study|Adverse Event|0|||
161527577|NCT02276482|583318316|FG000|Overall Study|Withdrawal by Subject|1|||
161527578|NCT02276482|583318317|FG001|Overall Study|Withdrawal by Subject|0|||
161527579|NCT02276482|583318316|FG000|Overall Study|Gram-negative infection|1|||
161527580|NCT02276482|583318317|FG001|Overall Study|Gram-negative infection|0|||
161936521|NCT02616562|584817638|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936522|NCT02616562|584817639|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936523|NCT02616562|584817640|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936524|NCT02616562|584817641|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936525|NCT02616562|584817642|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936526|NCT02616562|584817643|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936527|NCT02616562|584817644|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936528|NCT02616562|584817645|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936529|NCT02616562|584817646|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936530|NCT02616562|584817647|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936531|NCT02616562|584817648|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936532|NCT02616562|584817649|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
161936533|NCT02616562|584817650|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161527581|NCT02276482|583318316|FG000|Overall Study|Reason not specified|0|||
161527582|NCT02276482|583318317|FG001|Overall Study|Reason not specified|1|||
161936534|NCT02616562|584817651|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
161936535|NCT02616562|584817635|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936536|NCT02616562|584817636|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936537|NCT02616562|584817637|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936538|NCT02616562|584817638|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936539|NCT02616562|584817639|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936540|NCT02616562|584817640|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936541|NCT02616562|584817641|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936542|NCT02616562|584817642|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936543|NCT02616562|584817643|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936544|NCT02616562|584817644|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936545|NCT02616562|584817645|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936546|NCT02616562|584817646|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936547|NCT02616562|584817647|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161527583|NCT01410448|583318323|FG000|Overall Study|No conversion to everolimus|0|||
161527584|NCT01410448|583318324|FG001|Overall Study|No conversion to everolimus|24|||
161527585|NCT01410448|583318323|FG000|Overall Study|Graft loss|4|||
161527586|NCT01410448|583318324|FG001|Overall Study|Graft loss|1|||
161527587|NCT01410448|583318323|FG000|Overall Study|Administrative issues|2|||
161527588|NCT01410448|583318324|FG001|Overall Study|Administrative issues|1|||
161527589|NCT01410448|583318323|FG000|Overall Study|Lost to Follow-up|1|||
161527590|NCT01410448|583318324|FG001|Overall Study|Lost to Follow-up|0|||
161527591|NCT01410448|583318323|FG000|Overall Study|Withdrawal by Subject|3|||
161527592|NCT01410448|583318324|FG001|Overall Study|Withdrawal by Subject|2|||
161527593|NCT01410448|583318323|FG000|Overall Study|Protocol Violation|0|||
161527594|NCT01410448|583318324|FG001|Overall Study|Protocol Violation|4|||
161678229|NCT02234284|583873642|FG001|Overall Study|Withdrawal by Subject|0|||
161678230|NCT02234284|583873641|FG000|Overall Study|Lost to Follow-up|20|||
161678231|NCT02234284|583873642|FG001|Overall Study|Lost to Follow-up|7|||
161678232|NCT01986920|583873645|FG000|A- 101 25%|Withdrawal by Subject|1|||
161678233|NCT01986920|583873646|FG001|A- 101 25%|Withdrawal by Subject|0|||
161678234|NCT01986920|583873647|FG002|A- 101 25%|Withdrawal by Subject|0|||
161678235|NCT01986920|583873648|FG003|A- 101 25%|Withdrawal by Subject|0|||
161527595|NCT01410448|583318323|FG000|Overall Study|Death|2|||
161527596|NCT01410448|583318324|FG001|Overall Study|Death|3|||
161527597|NCT01218438|583318326|FG000|Epoch 1|Physician Decision|2|||
161527598|NCT01218438|583318326|FG000|Epoch 1|Adverse Event|1|||
161527599|NCT01218438|583318326|FG000|Epoch 3|Withdrawal by Subject|3|||
161527600|NCT01218438|583318326|FG000|Epoch 3|Adverse Event|1|||
161527601|NCT01218438|583318326|FG000|Epoch 4|Physician Decision|1|||
161527602|NCT01218438|583318326|FG000|Epoch 4|Withdrawal by Subject|2|||
161527603|NCT03096782|583318329|FG000|Overall Study|Death|1|||
161527604|NCT03096782|583318329|FG000|Overall Study|Participant Relapsed|1|||
161678236|NCT01986920|583873645|FG000|A-101 32.5%|Withdrawal by Subject|0|||
161678237|NCT01986920|583873646|FG001|A-101 32.5%|Withdrawal by Subject|1|||
161678238|NCT01986920|583873647|FG002|A-101 32.5%|Withdrawal by Subject|0|||
161678239|NCT01986920|583873648|FG003|A-101 32.5%|Withdrawal by Subject|0|||
161527605|NCT02075593|583318330|FG000|Overall Study|Withdrawal by Subject|1|||
161678240|NCT01986920|583873645|FG000|A-101 40%|Withdrawal by Subject|0|||
161678241|NCT01986920|583873646|FG001|A-101 40%|Withdrawal by Subject|0|||
161678242|NCT01986920|583873647|FG002|A-101 40%|Withdrawal by Subject|1|||
161527606|NCT05819749|583318335|FG000|Overall Study|Lost to Follow-up|1|||
161527607|NCT00844857|583320247|FG000|Overall Study|Adverse Event|24|||
161678243|NCT01986920|583873648|FG003|A-101 40%|Withdrawal by Subject|0|||
161527608|NCT00844857|583320248|FG001|Overall Study|Adverse Event|5|||
161527609|NCT00844857|583320247|FG000|Overall Study|Sponsor Decision|1|||
161527610|NCT00844857|583320248|FG001|Overall Study|Sponsor Decision|1|||
161527611|NCT00844857|583320247|FG000|Overall Study|Physician Decision|2|||
161527612|NCT00844857|583320248|FG001|Overall Study|Physician Decision|0|||
161527613|NCT00844857|583320247|FG000|Overall Study|Parent/Caregiver Decision|6|||
161527614|NCT00844857|583320248|FG001|Overall Study|Parent/Caregiver Decision|2|||
161527615|NCT00844857|583320247|FG000|Overall Study|Withdrawal by Subject|8|||
161590857|NCT02783300|583552751|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590858|NCT02783300|583552752|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590859|NCT02783300|583552753|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161590860|NCT02783300|583552754|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161590861|NCT02783300|583552755|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161527616|NCT00844857|583320248|FG001|Overall Study|Withdrawal by Subject|7|||
161527617|NCT00844857|583320247|FG000|Overall Study|Protocol Violation|6|||
161527618|NCT00844857|583320248|FG001|Overall Study|Protocol Violation|0|||
161527619|NCT00844857|583320247|FG000|Overall Study|Lack of Efficacy|5|||
161527620|NCT00844857|583320248|FG001|Overall Study|Lack of Efficacy|5|||
161527621|NCT00844857|583320247|FG000|Overall Study|Clinical Relapse|0|||
161527622|NCT00844857|583320248|FG001|Overall Study|Clinical Relapse|1|||
161527623|NCT00844857|583320247|FG000|Overall Study|Entry Criteria Not Met|0|||
161527624|NCT00844857|583320248|FG001|Overall Study|Entry Criteria Not Met|1|||
161527625|NCT00844857|583320247|FG000|Overall Study|Lost to Follow-up|2|||
161527626|NCT00844857|583320248|FG001|Overall Study|Lost to Follow-up|3|||
161527627|NCT00844857|583320247|FG000|Overall Study|Did Not Take Study Drug|3|||
161527628|NCT00844857|583320248|FG001|Overall Study|Did Not Take Study Drug|1|||
161527629|NCT00844857|583320247|FG000|Overall Study|Good Clinical Practice Violations|21|||
161527630|NCT00844857|583320248|FG001|Overall Study|Good Clinical Practice Violations|11|||
161527631|NCT00570674|583320249|FG000|Overall Study|Withdrawal by Subject|0|||
161527632|NCT00570674|583320250|FG001|Overall Study|Withdrawal by Subject|0|||
161527633|NCT00570674|583320251|FG002|Overall Study|Withdrawal by Subject|1|||
161527634|NCT00570674|583320252|FG003|Overall Study|Withdrawal by Subject|0|||
161527635|NCT00570674|583320253|FG004|Overall Study|Withdrawal by Subject|0|||
161527636|NCT00570674|583320254|FG005|Overall Study|Withdrawal by Subject|0|||
161527637|NCT00570674|583320255|FG006|Overall Study|Withdrawal by Subject|0|||
161527638|NCT03393000|583320263|FG000|Overall Study|Death|11|||
161527639|NCT03393000|583320263|FG000|Overall Study|Withdrawal by Subject|2|||
161527640|NCT03393000|583320263|FG000|Overall Study|Physician Decision|1|||
161527641|NCT01773070|583320264|FG000|Overall Study|Withdrawal by Subject|24|||
161527642|NCT01773070|583320264|FG000|Overall Study|Lost to Follow-up|39|||
161527643|NCT01773070|583320264|FG000|Overall Study|Other|15|||
161527644|NCT01773070|583320264|FG000|Overall Study|Death (unrelated to study procedures)|3|||
161527645|NCT02181803|583320265|FG000|Overall Study|Withdrawal by Subject|0|||
161527646|NCT02181803|583320266|FG001|Overall Study|Withdrawal by Subject|2|||
161527647|NCT02181803|583320267|FG002|Overall Study|Withdrawal by Subject|0|||
161527648|NCT02181803|583320268|FG003|Overall Study|Withdrawal by Subject|0|||
161527649|NCT02181803|583320269|FG004|Overall Study|Withdrawal by Subject|0|||
161527650|NCT02181803|583320270|FG005|Overall Study|Withdrawal by Subject|0|||
161527651|NCT02181803|583320271|FG006|Overall Study|Withdrawal by Subject|0|||
161527652|NCT02181803|583320272|FG007|Overall Study|Withdrawal by Subject|0|||
161527653|NCT02181803|583320273|FG008|Overall Study|Withdrawal by Subject|0|||
161527654|NCT02181803|583320265|FG000|Overall Study|Physician Decision|0|||
161527655|NCT02181803|583320266|FG001|Overall Study|Physician Decision|0|||
161527656|NCT02181803|583320267|FG002|Overall Study|Physician Decision|0|||
161527657|NCT02181803|583320268|FG003|Overall Study|Physician Decision|1|||
161527658|NCT02181803|583320269|FG004|Overall Study|Physician Decision|0|||
161527659|NCT02181803|583320270|FG005|Overall Study|Physician Decision|0|||
161527660|NCT02181803|583320271|FG006|Overall Study|Physician Decision|0|||
161590862|NCT02783300|583552729|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590863|NCT02783300|583552730|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590864|NCT02783300|583552731|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590865|NCT02783300|583552732|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590866|NCT02783300|583552733|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590867|NCT02783300|583552734|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590868|NCT02783300|583552735|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590869|NCT02783300|583552736|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161527661|NCT02181803|583320272|FG007|Overall Study|Physician Decision|1|||
161527662|NCT02181803|583320273|FG008|Overall Study|Physician Decision|0|||
161527663|NCT02181803|583320265|FG000|Overall Study|Adverse Event|0|||
161527664|NCT02181803|583320266|FG001|Overall Study|Adverse Event|2|||
161527665|NCT02181803|583320267|FG002|Overall Study|Adverse Event|0|||
161527666|NCT02181803|583320268|FG003|Overall Study|Adverse Event|1|||
161527667|NCT02181803|583320269|FG004|Overall Study|Adverse Event|0|||
161527668|NCT02181803|583320270|FG005|Overall Study|Adverse Event|0|||
161527669|NCT02181803|583320271|FG006|Overall Study|Adverse Event|1|||
161527670|NCT02181803|583320272|FG007|Overall Study|Adverse Event|0|||
161527671|NCT02181803|583320273|FG008|Overall Study|Adverse Event|0|||
161527672|NCT04786444|583320275|FG000|Overall Study|Withdrawal by Subject|4|||
161527673|NCT04786444|583320276|FG001|Overall Study|Withdrawal by Subject|7|||
161527674|NCT04786444|583320277|FG002|Overall Study|Withdrawal by Subject|2|||
161527675|NCT04786444|583320275|FG000|Overall Study|Lost to Follow-up|11|||
161527676|NCT04786444|583320276|FG001|Overall Study|Lost to Follow-up|9|||
161527677|NCT04786444|583320277|FG002|Overall Study|Lost to Follow-up|10|||
161527678|NCT04786444|583320275|FG000|Overall Study|Subject would like to become pregnant|0|||
161678244|NCT01986920|583873645|FG000|Placebo|Withdrawal by Subject|0|||
161527679|NCT04786444|583320276|FG001|Overall Study|Subject would like to become pregnant|1|||
161527680|NCT04786444|583320277|FG002|Overall Study|Subject would like to become pregnant|0|||
161527681|NCT03166618|583320278|FG000|Overall Study|Study was Terminated|0|||
161527682|NCT03166618|583320279|FG001|Overall Study|Study was Terminated|1|||
161527683|NCT01925950|583320280|FG000|Part 2|Withdrawal by Subject|1|||
161527684|NCT01925950|583320281|FG001|Part 2|Withdrawal by Subject|0|||
161527685|NCT03137303|583320283|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
161527686|NCT03137303|583320284|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
161527687|NCT03137303|583320283|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
161527688|NCT03137303|583320284|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
161527689|NCT03137303|583320283|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
161527690|NCT03137303|583320284|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
161527691|NCT03137303|583320283|FG000|T3: 9-month Follow-up|Death|1|||
161527692|NCT03137303|583320284|FG001|T3: 9-month Follow-up|Death|0|||
161527693|NCT03137303|583320283|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
161527694|NCT03137303|583320284|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
161527695|NCT03137303|583320283|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
161527696|NCT03137303|583320284|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
161527697|NCT03137303|583320283|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
161527698|NCT03137303|583320284|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
161527699|NCT01217073|583320285|FG000|Base Period|Adverse Event|1|||
161527700|NCT01217073|583320286|FG001|Base Period|Adverse Event|0|||
161527701|NCT01217073|583320287|FG002|Base Period|Adverse Event|1|||
161527702|NCT01217073|583320288|FG003|Base Period|Adverse Event|0|||
161527703|NCT01217073|583320289|FG004|Base Period|Adverse Event|4|||
161527704|NCT01217073|583320290|FG005|Base Period|Adverse Event|1|||
161527705|NCT01217073|583320291|FG006|Base Period|Adverse Event|0|||
161527706|NCT01217073|583320292|FG007|Base Period|Adverse Event|0|||
161527707|NCT01217073|583320285|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
161527708|NCT01217073|583320286|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527709|NCT01217073|583320287|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527710|NCT01217073|583320288|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527711|NCT01217073|583320289|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527712|NCT01217073|583320290|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527713|NCT01217073|583320291|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527714|NCT01217073|583320292|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161527715|NCT01217073|583320285|FG000|Base Period|Excluded medication|0|||
161527716|NCT01217073|583320286|FG001|Base Period|Excluded medication|0|||
161527717|NCT01217073|583320287|FG002|Base Period|Excluded medication|0|||
161527718|NCT01217073|583320288|FG003|Base Period|Excluded medication|0|||
161527719|NCT01217073|583320289|FG004|Base Period|Excluded medication|1|||
161527720|NCT01217073|583320290|FG005|Base Period|Excluded medication|0|||
161527721|NCT01217073|583320291|FG006|Base Period|Excluded medication|0|||
161527722|NCT01217073|583320292|FG007|Base Period|Excluded medication|0|||
161527723|NCT01217073|583320285|FG000|Base Period|Lack of Efficacy|0|||
161527724|NCT01217073|583320286|FG001|Base Period|Lack of Efficacy|0|||
161527725|NCT01217073|583320287|FG002|Base Period|Lack of Efficacy|0|||
161936548|NCT02616562|584817648|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161936549|NCT02616562|584817649|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
161527726|NCT01217073|583320288|FG003|Base Period|Lack of Efficacy|0|||
161678245|NCT01986920|583873646|FG001|Placebo|Withdrawal by Subject|0|||
161678246|NCT01986920|583873647|FG002|Placebo|Withdrawal by Subject|0|||
161936550|NCT02616562|584817650|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
161527727|NCT01217073|583320289|FG004|Base Period|Lack of Efficacy|0|||
161527728|NCT01217073|583320290|FG005|Base Period|Lack of Efficacy|1|||
161527729|NCT01217073|583320291|FG006|Base Period|Lack of Efficacy|0|||
161527730|NCT01217073|583320292|FG007|Base Period|Lack of Efficacy|0|||
161527731|NCT01217073|583320285|FG000|Base Period|Lost to Follow-up|0|||
161527732|NCT01217073|583320286|FG001|Base Period|Lost to Follow-up|0|||
161527733|NCT01217073|583320287|FG002|Base Period|Lost to Follow-up|1|||
161527734|NCT01217073|583320288|FG003|Base Period|Lost to Follow-up|1|||
161527735|NCT01217073|583320289|FG004|Base Period|Lost to Follow-up|3|||
161527736|NCT01217073|583320290|FG005|Base Period|Lost to Follow-up|0|||
161527737|NCT01217073|583320291|FG006|Base Period|Lost to Follow-up|0|||
161527738|NCT01217073|583320292|FG007|Base Period|Lost to Follow-up|0|||
161527739|NCT01217073|583320285|FG000|Base Period|Physician Decision|0|||
161527740|NCT01217073|583320286|FG001|Base Period|Physician Decision|0|||
161527741|NCT01217073|583320287|FG002|Base Period|Physician Decision|0|||
161527742|NCT01217073|583320288|FG003|Base Period|Physician Decision|0|||
161527743|NCT01217073|583320289|FG004|Base Period|Physician Decision|1|||
161527744|NCT01217073|583320290|FG005|Base Period|Physician Decision|0|||
161527745|NCT01217073|583320291|FG006|Base Period|Physician Decision|0|||
161527746|NCT01217073|583320292|FG007|Base Period|Physician Decision|0|||
161527747|NCT01217073|583320285|FG000|Base Period|Protocol Violation|1|||
161527748|NCT01217073|583320286|FG001|Base Period|Protocol Violation|0|||
161527749|NCT01217073|583320287|FG002|Base Period|Protocol Violation|0|||
161527750|NCT01217073|583320288|FG003|Base Period|Protocol Violation|0|||
161527751|NCT01217073|583320289|FG004|Base Period|Protocol Violation|1|||
161527752|NCT01217073|583320290|FG005|Base Period|Protocol Violation|2|||
161527753|NCT01217073|583320291|FG006|Base Period|Protocol Violation|0|||
161527754|NCT01217073|583320292|FG007|Base Period|Protocol Violation|0|||
161527755|NCT01217073|583320285|FG000|Base Period|Withdrawal by Subject|4|||
161527756|NCT01217073|583320286|FG001|Base Period|Withdrawal by Subject|5|||
161527757|NCT01217073|583320287|FG002|Base Period|Withdrawal by Subject|5|||
161527758|NCT01217073|583320288|FG003|Base Period|Withdrawal by Subject|1|||
161527759|NCT01217073|583320289|FG004|Base Period|Withdrawal by Subject|5|||
161527760|NCT01217073|583320290|FG005|Base Period|Withdrawal by Subject|5|||
161527761|NCT01217073|583320291|FG006|Base Period|Withdrawal by Subject|0|||
161527762|NCT01217073|583320292|FG007|Base Period|Withdrawal by Subject|0|||
161527763|NCT01217073|583320285|FG000|Extension Period|Adverse Event|0|||
161527764|NCT01217073|583320286|FG001|Extension Period|Adverse Event|0|||
161527765|NCT01217073|583320287|FG002|Extension Period|Adverse Event|0|||
161678247|NCT01986920|583873648|FG003|Placebo|Withdrawal by Subject|1|||
161936551|NCT02616562|584817651|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
161527766|NCT01217073|583320288|FG003|Extension Period|Adverse Event|0|||
161527767|NCT01217073|583320289|FG004|Extension Period|Adverse Event|0|||
161527768|NCT01217073|583320290|FG005|Extension Period|Adverse Event|0|||
161527769|NCT01217073|583320291|FG006|Extension Period|Adverse Event|19|||
161527770|NCT01217073|583320292|FG007|Extension Period|Adverse Event|5|||
161678248|NCT03023059|583873651|FG000|Overall Study|Withdrawal by Subject|5|||
161678249|NCT01526551|583873654|FG000|Overall Study|Lack of returned parental consent form|424|||
161678250|NCT00874770|583873655|FG000|Overall Study|Lack of Efficacy|2|||
161678251|NCT00874770|583873656|FG001|Overall Study|Lack of Efficacy|0|||
161678252|NCT00874770|583873657|FG002|Overall Study|Lack of Efficacy|0|||
161678253|NCT00874770|583873658|FG003|Overall Study|Lack of Efficacy|2|||
161678254|NCT00874770|583873655|FG000|Overall Study|Adverse Event|1|||
161678255|NCT00874770|583873656|FG001|Overall Study|Adverse Event|1|||
161678256|NCT00874770|583873657|FG002|Overall Study|Adverse Event|4|||
161678257|NCT00874770|583873658|FG003|Overall Study|Adverse Event|2|||
161678258|NCT00874770|583873655|FG000|Overall Study|Lost to Follow-up|1|||
161678259|NCT00874770|583873656|FG001|Overall Study|Lost to Follow-up|0|||
161678260|NCT00874770|583873657|FG002|Overall Study|Lost to Follow-up|0|||
161678261|NCT00874770|583873658|FG003|Overall Study|Lost to Follow-up|1|||
161678262|NCT00874770|583873655|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
161678263|NCT00874770|583873656|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
161678264|NCT00874770|583873657|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
161678265|NCT00874770|583873658|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
161678266|NCT01353508|583873659|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161678267|NCT01353508|583873660|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161678268|NCT01353508|583873661|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161678269|NCT01353508|583873662|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
161678270|NCT01353508|583873659|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
161678271|NCT01353508|583873660|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161678272|NCT01353508|583873661|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161678273|NCT01353508|583873662|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161678274|NCT00873366|583873663|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
161678275|NCT00873366|583873663|FG000|Overall Study|Off tamoxifen due to side effects|2|||
161678276|NCT00873366|583873663|FG000|Overall Study|Refused to continue DM-BT testing|3|||
161678277|NCT01576172|583873664|FG000|Overall Study|Ineligible|2|||
161678278|NCT01576172|583873665|FG001|Overall Study|Ineligible|1|||
161936552|NCT04697381|584817652|FG000|Extension Period|Adverse Event|0|||
161527771|NCT01217073|583320285|FG000|Extension Period|ALT/AST|0|||
161527772|NCT01217073|583320286|FG001|Extension Period|ALT/AST|0|||
161527773|NCT01217073|583320287|FG002|Extension Period|ALT/AST|0|||
161527774|NCT01217073|583320288|FG003|Extension Period|ALT/AST|0|||
161678279|NCT01576172|583873664|FG000|Overall Study|Withdrawal by Subject|2|||
161678280|NCT01576172|583873665|FG001|Overall Study|Withdrawal by Subject|0|||
161527775|NCT01217073|583320289|FG004|Extension Period|ALT/AST|0|||
161678281|NCT01576172|583873664|FG000|Overall Study|Insurance issue|1|||
161527776|NCT01217073|583320290|FG005|Extension Period|ALT/AST|0|||
161527777|NCT01217073|583320291|FG006|Extension Period|ALT/AST|2|||
161527778|NCT01217073|583320292|FG007|Extension Period|ALT/AST|0|||
161936553|NCT04697381|584817653|FG001|Extension Period|Adverse Event|0|||
161678282|NCT01576172|583873665|FG001|Overall Study|Insurance issue|0|||
161678283|NCT02092350|583873670|FG000|Overall Study|Adverse Event|0|||
161678284|NCT02092350|583873671|FG001|Overall Study|Adverse Event|3|||
161678285|NCT02092350|583873670|FG000|Overall Study|Death|2|||
161678286|NCT02092350|583873671|FG001|Overall Study|Death|5|||
161678287|NCT02092350|583873670|FG000|Overall Study|Lost to Follow-up|3|||
161678288|NCT02092350|583873671|FG001|Overall Study|Lost to Follow-up|1|||
161678289|NCT02092350|583873670|FG000|Overall Study|Protocol Violation|1|||
161678290|NCT02092350|583873671|FG001|Overall Study|Protocol Violation|0|||
161678291|NCT02092350|583873670|FG000|Overall Study|Physician Decision|1|||
161678292|NCT02092350|583873671|FG001|Overall Study|Physician Decision|1|||
161678293|NCT02092350|583873670|FG000|Overall Study|Screen Failure|1|||
161678294|NCT02092350|583873671|FG001|Overall Study|Screen Failure|0|||
161678295|NCT02092350|583873670|FG000|Overall Study|Withdrawal by Subject|2|||
161678296|NCT02092350|583873671|FG001|Overall Study|Withdrawal by Subject|2|||
161678297|NCT00646906|583873673|FG000|Crossover Period 1|Withdrawal by Subject|1|||
161678298|NCT00646906|583873674|FG001|Crossover Period 1|Withdrawal by Subject|0|||
161678299|NCT00646906|583873675|FG002|Crossover Period 1|Withdrawal by Subject|0|||
161678300|NCT00646906|583873676|FG003|Crossover Period 1|Withdrawal by Subject|0|||
161678301|NCT00646906|583873677|FG004|Crossover Period 1|Withdrawal by Subject|0|||
161678302|NCT00646906|583873678|FG005|Crossover Period 1|Withdrawal by Subject|1|||
161678303|NCT00646906|583873679|FG006|Crossover Period 1|Withdrawal by Subject|0|||
161678304|NCT00646906|583873673|FG000|Crossover Period 2|Withdrawal by Subject|0|||
161678305|NCT00646906|583873674|FG001|Crossover Period 2|Withdrawal by Subject|1|||
161678306|NCT00646906|583873675|FG002|Crossover Period 2|Withdrawal by Subject|2|||
161678307|NCT00646906|583873676|FG003|Crossover Period 2|Withdrawal by Subject|1|||
161678308|NCT00646906|583873677|FG004|Crossover Period 2|Withdrawal by Subject|0|||
161678309|NCT00646906|583873678|FG005|Crossover Period 2|Withdrawal by Subject|0|||
161678310|NCT00646906|583873679|FG006|Crossover Period 2|Withdrawal by Subject|0|||
161678311|NCT00646906|583873673|FG000|Crossover Period 2|Physician Decision|0|||
161678312|NCT00646906|583873674|FG001|Crossover Period 2|Physician Decision|0|||
161678313|NCT00646906|583873675|FG002|Crossover Period 2|Physician Decision|0|||
161678314|NCT00646906|583873676|FG003|Crossover Period 2|Physician Decision|0|||
161678315|NCT00646906|583873677|FG004|Crossover Period 2|Physician Decision|0|||
161678316|NCT00646906|583873678|FG005|Crossover Period 2|Physician Decision|0|||
161678317|NCT00646906|583873679|FG006|Crossover Period 2|Physician Decision|1|||
161678318|NCT02844920|583873683|FG000|Overall Study|Lost to Follow-up|2|||
161678319|NCT04534491|583873684|FG000|Overall Study|Not completed end-of-study interview|24|||
161678320|NCT04534491|583873684|FG000|Overall Study|Non-users|70|||
161678321|NCT04534491|583873684|FG000|Overall Study|Non-verifiable users|58|||
161678322|NCT00369785|583873690|FG000|Overall Study|Physician Decision|3|||
161678323|NCT00369785|583873691|FG001|Overall Study|Physician Decision|2|||
161678324|NCT00369785|583873690|FG000|Overall Study|Death|1|||
161678325|NCT00369785|583873691|FG001|Overall Study|Death|2|||
161678326|NCT00369785|583873690|FG000|Overall Study|Withdrawal by Subject|7|||
161678327|NCT00369785|583873691|FG001|Overall Study|Withdrawal by Subject|6|||
161678328|NCT00369785|583873690|FG000|Overall Study|Toxicity|6|||
161678329|NCT00369785|583873691|FG001|Overall Study|Toxicity|4|||
161678330|NCT00369785|583873690|FG000|Overall Study|Never started|0|||
161678331|NCT00369785|583873691|FG001|Overall Study|Never started|2|||
161678332|NCT00369785|583873690|FG000|Overall Study|Progression|4|||
161678333|NCT00369785|583873691|FG001|Overall Study|Progression|4|||
161678334|NCT00369785|583873690|FG000|Overall Study|Multiple reasons|6|||
161678335|NCT00369785|583873691|FG001|Overall Study|Multiple reasons|5|||
161678336|NCT00800683|583873692|FG000|Overall Study|Adverse Event|11|||
161678337|NCT00800683|583873693|FG001|Overall Study|Adverse Event|8|||
161678338|NCT00800683|583873692|FG000|Overall Study|Lost to Follow-up|3|||
161678339|NCT00800683|583873693|FG001|Overall Study|Lost to Follow-up|1|||
161678340|NCT00800683|583873692|FG000|Overall Study|Withdrawal by Subject|1|||
161678341|NCT00800683|583873693|FG001|Overall Study|Withdrawal by Subject|7|||
161678342|NCT00800683|583873692|FG000|Overall Study|Lack of Efficacy|1|||
161678343|NCT00800683|583873693|FG001|Overall Study|Lack of Efficacy|1|||
161678344|NCT00800683|583873692|FG000|Overall Study|Other|1|||
161678345|NCT00800683|583873693|FG001|Overall Study|Other|2|||
161936554|NCT04697381|584817654|FG002|Extension Period|Adverse Event|3|||
161936555|NCT04697381|584817652|FG000|Extension Period|Physician Decision|0|||
161678346|NCT02247960|583873695|FG000|Patient Consent and Randomization|Physician Decision|2|||
161678347|NCT02247960|583873696|FG001|Patient Consent and Randomization|Physician Decision|2|||
161678348|NCT02247960|583873695|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
161678349|NCT02247960|583873696|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
161936556|NCT04697381|584817653|FG001|Extension Period|Physician Decision|0|||
161678350|NCT02247960|583873695|FG000|Catheter Removed|Lost to Follow-up|7|||
161678351|NCT02247960|583873696|FG001|Catheter Removed|Lost to Follow-up|10|||
161678352|NCT02678416|583873697|FG000|Part 1|Withdrawal by Subject|1|||
161678353|NCT02678416|583873697|FG000|Part 2|Adverse Event|2|||
161678354|NCT02678416|583873697|FG000|Part 2|Withdrawal by Subject|1|||
161678355|NCT01848353|583873698|FG000|Phase 1|Withdrawal by Subject|3|||
161527779|NCT01217073|583320285|FG000|Extension Period|Contraindication to study medication|0|||
161527780|NCT01217073|583320286|FG001|Extension Period|Contraindication to study medication|0|||
161527781|NCT01217073|583320287|FG002|Extension Period|Contraindication to study medication|0|||
161527782|NCT01217073|583320288|FG003|Extension Period|Contraindication to study medication|0|||
161527783|NCT01217073|583320289|FG004|Extension Period|Contraindication to study medication|0|||
161527784|NCT01217073|583320290|FG005|Extension Period|Contraindication to study medication|0|||
161527785|NCT01217073|583320291|FG006|Extension Period|Contraindication to study medication|1|||
161527786|NCT01217073|583320292|FG007|Extension Period|Contraindication to study medication|0|||
161527787|NCT01217073|583320285|FG000|Extension Period|Creatinine/eGFR|0|||
161527788|NCT01217073|583320286|FG001|Extension Period|Creatinine/eGFR|0|||
161527789|NCT01217073|583320287|FG002|Extension Period|Creatinine/eGFR|0|||
161527790|NCT01217073|583320288|FG003|Extension Period|Creatinine/eGFR|0|||
161527791|NCT01217073|583320289|FG004|Extension Period|Creatinine/eGFR|0|||
161527792|NCT01217073|583320290|FG005|Extension Period|Creatinine/eGFR|0|||
161527793|NCT01217073|583320291|FG006|Extension Period|Creatinine/eGFR|11|||
161527794|NCT01217073|583320292|FG007|Extension Period|Creatinine/eGFR|1|||
161527795|NCT01217073|583320285|FG000|Extension Period|Death|0|||
161827313|NCT00685750|584408050|FG000|Overall Study|Tumor sampling failure|0|||
161827314|NCT00685750|584408051|FG001|Overall Study|Tumor sampling failure|0|||
161827315|NCT00685750|584408052|FG002|Overall Study|Tumor sampling failure|1|||
161827316|NCT00685750|584408053|FG003|Overall Study|Tumor sampling failure|0|||
161827317|NCT00685750|584408054|FG004|Overall Study|Tumor sampling failure|0|||
161527796|NCT01217073|583320286|FG001|Extension Period|Death|0|||
161527797|NCT01217073|583320287|FG002|Extension Period|Death|0|||
161527798|NCT01217073|583320288|FG003|Extension Period|Death|0|||
161527799|NCT01217073|583320289|FG004|Extension Period|Death|0|||
161527800|NCT01217073|583320290|FG005|Extension Period|Death|0|||
161527801|NCT01217073|583320291|FG006|Extension Period|Death|1|||
161527802|NCT01217073|583320292|FG007|Extension Period|Death|0|||
161527803|NCT01217073|583320285|FG000|Extension Period|Excluded medication|0|||
161527804|NCT01217073|583320286|FG001|Extension Period|Excluded medication|0|||
161527805|NCT01217073|583320287|FG002|Extension Period|Excluded medication|0|||
161527806|NCT01217073|583320288|FG003|Extension Period|Excluded medication|0|||
161527807|NCT01217073|583320289|FG004|Extension Period|Excluded medication|0|||
161527808|NCT01217073|583320290|FG005|Extension Period|Excluded medication|0|||
161527809|NCT01217073|583320291|FG006|Extension Period|Excluded medication|2|||
161527810|NCT01217073|583320292|FG007|Extension Period|Excluded medication|0|||
161527811|NCT01217073|583320285|FG000|Extension Period|Lack of Efficacy|0|||
161527812|NCT01217073|583320286|FG001|Extension Period|Lack of Efficacy|0|||
161527813|NCT01217073|583320287|FG002|Extension Period|Lack of Efficacy|0|||
161527814|NCT01217073|583320288|FG003|Extension Period|Lack of Efficacy|0|||
161527815|NCT01217073|583320289|FG004|Extension Period|Lack of Efficacy|0|||
161527816|NCT01217073|583320290|FG005|Extension Period|Lack of Efficacy|0|||
161527817|NCT01217073|583320291|FG006|Extension Period|Lack of Efficacy|3|||
161527818|NCT01217073|583320292|FG007|Extension Period|Lack of Efficacy|0|||
161527819|NCT01217073|583320285|FG000|Extension Period|Lost to Follow-up|0|||
161527820|NCT01217073|583320286|FG001|Extension Period|Lost to Follow-up|0|||
161527821|NCT01217073|583320287|FG002|Extension Period|Lost to Follow-up|0|||
161527822|NCT01217073|583320288|FG003|Extension Period|Lost to Follow-up|0|||
161527823|NCT01217073|583320289|FG004|Extension Period|Lost to Follow-up|0|||
161527824|NCT01217073|583320290|FG005|Extension Period|Lost to Follow-up|0|||
161527825|NCT01217073|583320291|FG006|Extension Period|Lost to Follow-up|9|||
161527826|NCT01217073|583320292|FG007|Extension Period|Lost to Follow-up|1|||
161527827|NCT01217073|583320285|FG000|Extension Period|Non-compliance with study drug|0|||
161527828|NCT01217073|583320286|FG001|Extension Period|Non-compliance with study drug|0|||
161527829|NCT01217073|583320287|FG002|Extension Period|Non-compliance with study drug|0|||
161527830|NCT01217073|583320288|FG003|Extension Period|Non-compliance with study drug|0|||
161527831|NCT01217073|583320289|FG004|Extension Period|Non-compliance with study drug|0|||
161527832|NCT01217073|583320290|FG005|Extension Period|Non-compliance with study drug|0|||
161527833|NCT01217073|583320291|FG006|Extension Period|Non-compliance with study drug|0|||
161527834|NCT01217073|583320292|FG007|Extension Period|Non-compliance with study drug|1|||
161527835|NCT01217073|583320285|FG000|Extension Period|Physician Decision|0|||
161527836|NCT01217073|583320286|FG001|Extension Period|Physician Decision|0|||
161527837|NCT01217073|583320287|FG002|Extension Period|Physician Decision|0|||
161527838|NCT01217073|583320288|FG003|Extension Period|Physician Decision|0|||
161527839|NCT01217073|583320289|FG004|Extension Period|Physician Decision|0|||
161527840|NCT01217073|583320290|FG005|Extension Period|Physician Decision|0|||
161527841|NCT01217073|583320291|FG006|Extension Period|Physician Decision|4|||
161527842|NCT01217073|583320292|FG007|Extension Period|Physician Decision|1|||
161527843|NCT01217073|583320285|FG000|Extension Period|Protocol Violation|0|||
161527844|NCT01217073|583320286|FG001|Extension Period|Protocol Violation|0|||
161827318|NCT00685750|584408055|FG005|Overall Study|Tumor sampling failure|0|||
161827319|NCT00685750|584408056|FG006|Overall Study|Tumor sampling failure|0|||
161827320|NCT00685750|584408050|FG000|Overall Study|Patient didn't receive the treatment|0|||
161827321|NCT00685750|584408051|FG001|Overall Study|Patient didn't receive the treatment|0|||
161936557|NCT04697381|584817654|FG002|Extension Period|Physician Decision|2|||
161936558|NCT04697381|584817652|FG000|Extension Period|Other|0|||
161936559|NCT04697381|584817653|FG001|Extension Period|Other|0|||
161936560|NCT04697381|584817654|FG002|Extension Period|Other|1|||
161936561|NCT04837040|584817658|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
161936562|NCT04837040|584817659|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
161936563|NCT02961218|584817661|FG000|Overall Study|Lost to Follow-up|0|||
161936564|NCT02961218|584817662|FG001|Overall Study|Lost to Follow-up|2|||
161936565|NCT02961218|584817661|FG000|Overall Study|Physician Decision|0|||
161527845|NCT01217073|583320287|FG002|Extension Period|Protocol Violation|0|||
161527846|NCT01217073|583320288|FG003|Extension Period|Protocol Violation|0|||
161527847|NCT01217073|583320289|FG004|Extension Period|Protocol Violation|0|||
161527848|NCT01217073|583320290|FG005|Extension Period|Protocol Violation|0|||
161936566|NCT02961218|584817662|FG001|Overall Study|Physician Decision|2|||
161936567|NCT02961218|584817661|FG000|Overall Study|Subject/Guardian Decision|3|||
161936568|NCT02961218|584817662|FG001|Overall Study|Subject/Guardian Decision|1|||
161936569|NCT01856478|584817663|FG000|Overall Study|Not treated|0|||
161936570|NCT01856478|584817664|FG001|Overall Study|Not treated|8|||
161936571|NCT01856478|584817663|FG000|Overall Study|Progressive disease per RECIST|146|||
161936572|NCT01856478|584817664|FG001|Overall Study|Progressive disease per RECIST|49|||
161936573|NCT01856478|584817663|FG000|Overall Study|Worsening of underlying cancer|6|||
161936574|NCT01856478|584817664|FG001|Overall Study|Worsening of underlying cancer|2|||
161936575|NCT01856478|584817663|FG000|Overall Study|Adverse events|57|||
161936576|NCT01856478|584817664|FG001|Overall Study|Adverse events|30|||
161936577|NCT01856478|584817663|FG000|Overall Study|Non-compliant with protocol|1|||
161936578|NCT01856478|584817664|FG001|Overall Study|Non-compliant with protocol|1|||
161936579|NCT01856478|584817663|FG000|Overall Study|Lost to Follow-up|1|||
161936580|NCT01856478|584817664|FG001|Overall Study|Lost to Follow-up|1|||
161936581|NCT01856478|584817663|FG000|Overall Study|Refused to continue trial medication|13|||
161936582|NCT01856478|584817664|FG001|Overall Study|Refused to continue trial medication|11|||
161936583|NCT01856478|584817663|FG000|Overall Study|Other reason than listed|4|||
161936584|NCT01856478|584817664|FG001|Overall Study|Other reason than listed|10|||
161527849|NCT01217073|583320291|FG006|Extension Period|Protocol Violation|2|||
161527850|NCT01217073|583320292|FG007|Extension Period|Protocol Violation|1|||
161527851|NCT01217073|583320285|FG000|Extension Period|Site discontinued study participation|0|||
161527852|NCT01217073|583320286|FG001|Extension Period|Site discontinued study participation|0|||
161527853|NCT01217073|583320287|FG002|Extension Period|Site discontinued study participation|0|||
161527854|NCT01217073|583320288|FG003|Extension Period|Site discontinued study participation|0|||
161527855|NCT01217073|583320289|FG004|Extension Period|Site discontinued study participation|0|||
161527856|NCT01217073|583320290|FG005|Extension Period|Site discontinued study participation|0|||
161527857|NCT01217073|583320291|FG006|Extension Period|Site discontinued study participation|7|||
161527858|NCT01217073|583320292|FG007|Extension Period|Site discontinued study participation|2|||
161527859|NCT01217073|583320285|FG000|Extension Period|Withdrawal by Subject|0|||
161527860|NCT01217073|583320286|FG001|Extension Period|Withdrawal by Subject|0|||
161527861|NCT01217073|583320287|FG002|Extension Period|Withdrawal by Subject|0|||
161527862|NCT01217073|583320288|FG003|Extension Period|Withdrawal by Subject|0|||
161527863|NCT01217073|583320289|FG004|Extension Period|Withdrawal by Subject|0|||
161527864|NCT01217073|583320290|FG005|Extension Period|Withdrawal by Subject|0|||
161527865|NCT01217073|583320291|FG006|Extension Period|Withdrawal by Subject|30|||
161527866|NCT01217073|583320292|FG007|Extension Period|Withdrawal by Subject|8|||
161527867|NCT03561090|583320293|FG000|Overall Study|Adverse Event|11|||
161527868|NCT03561090|583320294|FG001|Overall Study|Adverse Event|7|||
161527869|NCT03561090|583320293|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161527870|NCT03561090|583320294|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161527871|NCT03561090|583320293|FG000|Overall Study|Protocol Violation|2|||
161527872|NCT03561090|583320294|FG001|Overall Study|Protocol Violation|2|||
161527873|NCT03561090|583320293|FG000|Overall Study|Withdrawal by Subject|7|||
161527874|NCT03561090|583320294|FG001|Overall Study|Withdrawal by Subject|7|||
161527875|NCT03561090|583320293|FG000|Overall Study|Lost to Follow-up|7|||
161527876|NCT03561090|583320294|FG001|Overall Study|Lost to Follow-up|2|||
161527877|NCT03561090|583320293|FG000|Overall Study|Study Terminated by Sponsor|10|||
161527878|NCT03561090|583320294|FG001|Overall Study|Study Terminated by Sponsor|15|||
161590870|NCT02783300|583552737|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161936585|NCT05032820|584817665|FG000|Overall Study|Lost to Follow-up|1|||
161936586|NCT05032820|584817665|FG000|Overall Study|Withdrawal by Subject|1|||
161936587|NCT02486718|584817668|FG000|Enrollment Phase|Death|19|||
161527879|NCT03561090|583320293|FG000|Overall Study|Randomized by Mistake|1|||
161527880|NCT03561090|583320294|FG001|Overall Study|Randomized by Mistake|1|||
161527881|NCT03561090|583320293|FG000|Overall Study|Other Not Specified|0|||
161527882|NCT03561090|583320294|FG001|Overall Study|Other Not Specified|2|||
161590871|NCT02783300|583552738|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161936588|NCT02486718|584817669|FG001|Enrollment Phase|Death|0|||
161936589|NCT02486718|584817670|FG002|Enrollment Phase|Death|0|||
161936590|NCT02486718|584817668|FG000|Enrollment Phase|Symptomatic deterioration|1|||
161936591|NCT02486718|584817669|FG001|Enrollment Phase|Symptomatic deterioration|0|||
161527883|NCT00725452|583320303|FG000|Overall Study|Adverse Event|3|||
161527884|NCT00725452|583320303|FG000|Overall Study|Lack of Efficacy|2|||
161527885|NCT00725452|583320303|FG000|Overall Study|Reason not specified|1|||
161527886|NCT00725452|583320303|FG000|Overall Study|Physician Decision|1|||
161527887|NCT00725452|583320303|FG000|Overall Study|Withdrawal by Subject|3|||
161527888|NCT00725452|583320303|FG000|Overall Study|Lost to Follow-up|1|||
161527889|NCT02696317|583320307|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
161527890|NCT02696317|583320308|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
161527891|NCT02696317|583320307|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
161527892|NCT02696317|583320308|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
161527893|NCT01343368|583320309|FG000|Overall Study|Death|1|||
161527894|NCT01343368|583320310|FG001|Overall Study|Death|0|||
161527895|NCT01343368|583320309|FG000|Overall Study|Lost to Follow-up|1|||
161527896|NCT01343368|583320310|FG001|Overall Study|Lost to Follow-up|0|||
161527897|NCT00237744|583320311|FG000|Overall Study|Withdrawal by Subject|3|||
161527898|NCT00237744|583320312|FG001|Overall Study|Withdrawal by Subject|1|||
161527899|NCT00237744|583320313|FG002|Overall Study|Withdrawal by Subject|0|||
161527900|NCT02015676|583320314|FG000|Overall Study|Adverse Event|2|||
161527901|NCT02015676|583320315|FG001|Overall Study|Adverse Event|18|||
161527902|NCT02015676|583320316|FG002|Overall Study|Adverse Event|0|||
161527903|NCT02015676|583320314|FG000|Overall Study|Lack of Efficacy|2|||
161527904|NCT02015676|583320315|FG001|Overall Study|Lack of Efficacy|4|||
161527905|NCT02015676|583320316|FG002|Overall Study|Lack of Efficacy|0|||
161527906|NCT02015676|583320314|FG000|Overall Study|Protocol Violation|1|||
161527907|NCT02015676|583320315|FG001|Overall Study|Protocol Violation|0|||
161527908|NCT02015676|583320316|FG002|Overall Study|Protocol Violation|0|||
161527909|NCT02015676|583320314|FG000|Overall Study|Withdrawal by Subject|1|||
161527910|NCT02015676|583320315|FG001|Overall Study|Withdrawal by Subject|7|||
161527911|NCT02015676|583320316|FG002|Overall Study|Withdrawal by Subject|1|||
161527912|NCT02015676|583320314|FG000|Overall Study|Administrative reasons|0|||
161527913|NCT02015676|583320315|FG001|Overall Study|Administrative reasons|3|||
161527914|NCT02015676|583320316|FG002|Overall Study|Administrative reasons|1|||
161527915|NCT02015676|583320314|FG000|Overall Study|Death|0|||
161527916|NCT02015676|583320315|FG001|Overall Study|Death|1|||
161527917|NCT02015676|583320316|FG002|Overall Study|Death|0|||
161527918|NCT02015676|583320314|FG000|Overall Study|Disease progression|3|||
161527919|NCT02015676|583320315|FG001|Overall Study|Disease progression|1|||
161527920|NCT02015676|583320316|FG002|Overall Study|Disease progression|1|||
161527921|NCT00476476|583320317|FG000|Overall Study|Adverse Event|2|||
161527922|NCT00476476|583320318|FG001|Overall Study|Adverse Event|7|||
161527923|NCT00476476|583320317|FG000|Overall Study|Progressive Disease|0|||
161527924|NCT00476476|583320318|FG001|Overall Study|Progressive Disease|17|||
161527925|NCT00971048|583320323|FG000|Overall Study|Protocol Violation|1|||
161527926|NCT00971048|583320324|FG001|Overall Study|Protocol Violation|2|||
161527927|NCT00971048|583320325|FG002|Overall Study|Protocol Violation|0|||
161527928|NCT00971048|583320326|FG003|Overall Study|Protocol Violation|1|||
161527929|NCT00971048|583320323|FG000|Overall Study|Adverse Event|0|||
161527930|NCT00971048|583320324|FG001|Overall Study|Adverse Event|0|||
161527931|NCT00971048|583320325|FG002|Overall Study|Adverse Event|1|||
161527932|NCT00971048|583320326|FG003|Overall Study|Adverse Event|0|||
161527933|NCT00971048|583320323|FG000|Overall Study|Physician Decision|0|||
161527934|NCT00971048|583320324|FG001|Overall Study|Physician Decision|0|||
161527935|NCT00971048|583320325|FG002|Overall Study|Physician Decision|0|||
161527936|NCT00971048|583320326|FG003|Overall Study|Physician Decision|1|||
161527937|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
161527938|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
161527939|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
161527940|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
161527941|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
161527942|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
161527943|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
161527944|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
161527945|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
161527946|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
161590872|NCT02783300|583552739|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590873|NCT02783300|583552740|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161936592|NCT02486718|584817670|FG002|Enrollment Phase|Symptomatic deterioration|0|||
161527947|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
161527948|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
161527949|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
161527950|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
161527951|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
161527952|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
161527953|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
161527954|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
161936593|NCT02486718|584817668|FG000|Enrollment Phase|Withdrawal by Subject|86|||
161936594|NCT02486718|584817669|FG001|Enrollment Phase|Withdrawal by Subject|0|||
161936595|NCT02486718|584817670|FG002|Enrollment Phase|Withdrawal by Subject|0|||
161936596|NCT02486718|584817668|FG000|Enrollment Phase|Protocol Violation|18|||
161936597|NCT02486718|584817669|FG001|Enrollment Phase|Protocol Violation|0|||
161936598|NCT02486718|584817670|FG002|Enrollment Phase|Protocol Violation|0|||
161936599|NCT02486718|584817668|FG000|Enrollment Phase|Physician Decision|18|||
161936600|NCT02486718|584817669|FG001|Enrollment Phase|Physician Decision|0|||
161936601|NCT02486718|584817670|FG002|Enrollment Phase|Physician Decision|0|||
161936602|NCT02486718|584817668|FG000|Enrollment Phase|Reason not provided|41|||
161936603|NCT02486718|584817669|FG001|Enrollment Phase|Reason not provided|0|||
161936604|NCT02486718|584817670|FG002|Enrollment Phase|Reason not provided|0|||
161936605|NCT02486718|584817668|FG000|Enrollment Phase|Disease relapse|54|||
161936606|NCT02486718|584817669|FG001|Enrollment Phase|Disease relapse|0|||
161936607|NCT02486718|584817670|FG002|Enrollment Phase|Disease relapse|0|||
161936608|NCT02486718|584817668|FG000|Enrollment Phase|Lost to Follow-up|4|||
161936609|NCT02486718|584817669|FG001|Enrollment Phase|Lost to Follow-up|0|||
161936610|NCT02486718|584817670|FG002|Enrollment Phase|Lost to Follow-up|0|||
161936611|NCT02486718|584817668|FG000|Enrollment Phase|Adverse Event|34|||
161936612|NCT02486718|584817669|FG001|Enrollment Phase|Adverse Event|0|||
161936613|NCT02486718|584817670|FG002|Enrollment Phase|Adverse Event|0|||
161936614|NCT02486718|584817668|FG000|Randomized Phase|Withdrawal by Subject|0|||
161936615|NCT02486718|584817669|FG001|Randomized Phase|Withdrawal by Subject|44|||
161936616|NCT02486718|584817670|FG002|Randomized Phase|Withdrawal by Subject|47|||
161936617|NCT02486718|584817668|FG000|Randomized Phase|Protocol Violation|0|||
161936618|NCT02486718|584817669|FG001|Randomized Phase|Protocol Violation|2|||
161936619|NCT02486718|584817670|FG002|Randomized Phase|Protocol Violation|0|||
161936620|NCT02486718|584817668|FG000|Randomized Phase|Physician Decision|0|||
161936621|NCT02486718|584817669|FG001|Randomized Phase|Physician Decision|0|||
161936622|NCT02486718|584817670|FG002|Randomized Phase|Physician Decision|3|||
161936623|NCT02486718|584817668|FG000|Randomized Phase|Lost to Follow-up|0|||
161936624|NCT02486718|584817669|FG001|Randomized Phase|Lost to Follow-up|5|||
161936625|NCT02486718|584817670|FG002|Randomized Phase|Lost to Follow-up|11|||
161936626|NCT02486718|584817668|FG000|Randomized Phase|Disease Relapse|0|||
161936627|NCT02486718|584817669|FG001|Randomized Phase|Disease Relapse|1|||
161936628|NCT02486718|584817670|FG002|Randomized Phase|Disease Relapse|0|||
161936629|NCT02486718|584817668|FG000|Randomized Phase|Death|0|||
161936630|NCT02486718|584817669|FG001|Randomized Phase|Death|154|||
161936631|NCT02486718|584817670|FG002|Randomized Phase|Death|155|||
161936632|NCT02486718|584817668|FG000|Randomized Phase|Ongoing|0|||
161936633|NCT02486718|584817669|FG001|Randomized Phase|Ongoing|301|||
161936634|NCT02486718|584817670|FG002|Randomized Phase|Ongoing|282|||
161936635|NCT04108208|584817671|FG000|Overall Study|Withdrawal by Subject|2|||
161936636|NCT04108208|584817672|FG001|Overall Study|Withdrawal by Subject|6|||
161936637|NCT04108208|584817671|FG000|Overall Study|other-ongoing|20|||
161936638|NCT04108208|584817672|FG001|Overall Study|other-ongoing|40|||
161936639|NCT04108208|584817671|FG000|Overall Study|Death|1|||
161527955|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
161527956|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
161527957|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
161527958|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
161527959|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
161527960|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
161527961|NCT01715805|583320330|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
161936640|NCT04108208|584817672|FG001|Overall Study|Death|4|||
161936641|NCT04108208|584817671|FG000|Overall Study|Lost to Follow-up|2|||
161527962|NCT01715805|583320331|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
161527963|NCT01715805|583320332|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
161527964|NCT01715805|583320333|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
161527965|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
161527966|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
161527967|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
161527968|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
161527969|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
161527970|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
161527971|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
161527972|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
161527973|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
161527974|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
161527975|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
161936642|NCT04108208|584817672|FG001|Overall Study|Lost to Follow-up|0|||
161936643|NCT04936308|584817673|FG000|Overall Study|Death|0|||
161936644|NCT04936308|584817674|FG001|Overall Study|Death|0|||
161936645|NCT04936308|584817675|FG002|Overall Study|Death|1|||
161936646|NCT04936308|584817673|FG000|Overall Study|Withdrawal by Subject|6|||
161936647|NCT04936308|584817674|FG001|Overall Study|Withdrawal by Subject|3|||
161936648|NCT04936308|584817675|FG002|Overall Study|Withdrawal by Subject|0|||
161936649|NCT04936308|584817673|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
161936650|NCT04936308|584817674|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161936651|NCT04936308|584817675|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161936652|NCT04936308|584817673|FG000|Overall Study|Completed protocol-required follow-up|1|||
161527976|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
161527977|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
161527978|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
161527979|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
161527980|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
161527981|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
161527982|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
161527983|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
161527984|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
161527985|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
161527986|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
161527987|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
161527988|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
161527989|NCT01715805|583320330|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
161527990|NCT01715805|583320331|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
161527991|NCT01715805|583320332|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
161527992|NCT01715805|583320333|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
161527993|NCT02647359|583320336|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
161590874|NCT02783300|583552741|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590875|NCT02783300|583552742|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590876|NCT02783300|583552743|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590877|NCT02783300|583552744|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590878|NCT02783300|583552745|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
161590879|NCT02783300|583552746|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590880|NCT02783300|583552747|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
161678356|NCT01848353|583873699|FG001|Phase 1|Withdrawal by Subject|1|||
161678357|NCT01848353|583873700|FG002|Phase 1|Withdrawal by Subject|0|||
161678358|NCT01848353|583873701|FG003|Phase 1|Withdrawal by Subject|0|||
161678359|NCT01848353|583873698|FG000|Phase 2|Withdrawal by Subject|3|||
161678360|NCT01848353|583873699|FG001|Phase 2|Withdrawal by Subject|2|||
161678361|NCT01848353|583873700|FG002|Phase 2|Withdrawal by Subject|0|||
161678362|NCT01848353|583873701|FG003|Phase 2|Withdrawal by Subject|0|||
161678363|NCT01848353|583873698|FG000|Phase 3|Withdrawal by Subject|1|||
161678364|NCT01848353|583873699|FG001|Phase 3|Withdrawal by Subject|1|||
161678365|NCT01848353|583873700|FG002|Phase 3|Withdrawal by Subject|0|||
161678366|NCT01848353|583873701|FG003|Phase 3|Withdrawal by Subject|0|||
161678367|NCT00736034|583873711|FG000|Overall Study|Adverse Event|2|||
161678368|NCT01910116|583873712|FG000|Overall Study|Adverse Event|0|||
161678369|NCT01910116|583873713|FG001|Overall Study|Adverse Event|3|||
161678370|NCT01910116|583873712|FG000|Overall Study|Lack of Efficacy|3|||
161678371|NCT01910116|583873713|FG001|Overall Study|Lack of Efficacy|4|||
161678372|NCT01910116|583873712|FG000|Overall Study|Lost to Follow-up|1|||
161678373|NCT01910116|583873713|FG001|Overall Study|Lost to Follow-up|0|||
161678374|NCT01910116|583873712|FG000|Overall Study|Protocol Violation|1|||
161678375|NCT01910116|583873713|FG001|Overall Study|Protocol Violation|2|||
161936653|NCT04936308|584817674|FG001|Overall Study|Completed protocol-required follow-up|2|||
161590881|NCT02783300|583552748|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
161590882|NCT02783300|583552749|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590883|NCT02783300|583552750|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590884|NCT02783300|583552751|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590885|NCT02783300|583552752|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590886|NCT02783300|583552753|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590887|NCT02783300|583552754|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161590888|NCT02783300|583552755|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161678376|NCT01910116|583873712|FG000|Overall Study|Withdrawal by Subject|8|||
161678377|NCT01910116|583873713|FG001|Overall Study|Withdrawal by Subject|3|||
161678378|NCT01910116|583873712|FG000|Overall Study|uncertain allocation|1|||
161678379|NCT01910116|583873713|FG001|Overall Study|uncertain allocation|3|||
161678380|NCT01910116|583873712|FG000|Overall Study|incomplete data|0|||
161678381|NCT01910116|583873713|FG001|Overall Study|incomplete data|1|||
161527994|NCT02647359|583320337|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
161527995|NCT02647359|583320336|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
161527996|NCT02647359|583320337|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
161527997|NCT02647359|583320336|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
161527998|NCT02647359|583320337|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
161527999|NCT02647359|583320336|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
161528000|NCT02647359|583320337|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
161528001|NCT02647359|583320336|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
161590889|NCT02783300|583552729|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590890|NCT02783300|583552730|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590891|NCT02783300|583552731|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590892|NCT02783300|583552732|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590893|NCT02783300|583552733|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590894|NCT02783300|583552734|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590895|NCT02783300|583552735|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590896|NCT02783300|583552736|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590897|NCT02783300|583552737|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590898|NCT02783300|583552738|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590899|NCT02783300|583552739|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590900|NCT02783300|583552740|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590901|NCT02783300|583552741|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590902|NCT02783300|583552742|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590903|NCT02783300|583552743|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590904|NCT02783300|583552744|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590905|NCT02783300|583552745|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161590906|NCT02783300|583552746|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590907|NCT02783300|583552747|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161590908|NCT02783300|583552748|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
161590909|NCT02783300|583552749|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161590910|NCT02783300|583552750|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590911|NCT02783300|583552751|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590912|NCT02783300|583552752|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590913|NCT02783300|583552753|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590914|NCT02783300|583552754|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590915|NCT02783300|583552755|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161590916|NCT02783300|583552729|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590917|NCT02783300|583552730|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590918|NCT02783300|583552731|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590919|NCT02783300|583552732|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590920|NCT02783300|583552733|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590921|NCT02783300|583552734|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590922|NCT02783300|583552735|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590923|NCT02783300|583552736|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590924|NCT02783300|583552737|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590925|NCT02783300|583552738|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590926|NCT02783300|583552739|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590927|NCT02783300|583552740|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590928|NCT02783300|583552741|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590929|NCT02783300|583552742|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590930|NCT02783300|583552743|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590931|NCT02783300|583552744|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
161590932|NCT02783300|583552745|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590933|NCT02783300|583552746|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590934|NCT02783300|583552747|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590935|NCT02783300|583552748|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590936|NCT02783300|583552749|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590937|NCT02783300|583552750|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590938|NCT02783300|583552751|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
161590939|NCT02783300|583552752|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161678382|NCT02289352|583873716|FG000|Overall Study|Withdrawal by Subject|1|||
161678383|NCT02289352|583873717|FG001|Overall Study|Withdrawal by Subject|1|||
161590940|NCT02783300|583552753|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161678384|NCT02289352|583873718|FG002|Overall Study|Withdrawal by Subject|0|||
161528002|NCT02647359|583320337|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
161936654|NCT04936308|584817675|FG002|Overall Study|Completed protocol-required follow-up|2|||
161936655|NCT04936308|584817673|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
161936656|NCT04936308|584817674|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
161936657|NCT04936308|584817675|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
161528003|NCT02647359|583320336|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
161528004|NCT02647359|583320337|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
161528005|NCT00413413|583320338|FG000|Single-Blind|Adverse Event|0|||
161528006|NCT00413413|583320339|FG001|Single-Blind|Adverse Event|9|||
161936658|NCT04936308|584817673|FG000|Overall Study|Other|3|||
161936659|NCT04936308|584817674|FG001|Overall Study|Other|0|||
161936660|NCT04936308|584817675|FG002|Overall Study|Other|2|||
161936661|NCT04770272|584817676|FG000|Overall Study|Death|1|||
161936662|NCT04770272|584817677|FG001|Overall Study|Death|0|||
161936663|NCT04770272|584817676|FG000|Overall Study|Withdrawal by Subject|11|||
161936664|NCT04770272|584817677|FG001|Overall Study|Withdrawal by Subject|12|||
161936665|NCT04770272|584817676|FG000|Overall Study|Protocol Violation|0|||
161936666|NCT04770272|584817677|FG001|Overall Study|Protocol Violation|2|||
161936667|NCT04770272|584817676|FG000|Overall Study|Adverse Event|23|||
161936668|NCT04770272|584817677|FG001|Overall Study|Adverse Event|21|||
161936669|NCT04770272|584817676|FG000|Overall Study|Physician Decision|7|||
161936670|NCT04770272|584817677|FG001|Overall Study|Physician Decision|3|||
161936671|NCT04770272|584817676|FG000|Overall Study|Disease progression|4|||
161936672|NCT04770272|584817677|FG001|Overall Study|Disease progression|8|||
161936673|NCT04770272|584817676|FG000|Overall Study|Switched to other therapy.|0|||
161936674|NCT04770272|584817677|FG001|Overall Study|Switched to other therapy.|2|||
161936675|NCT00602667|584817678|FG000|Overall Study|Still on Therapy|0|||
161936676|NCT00602667|584817679|FG001|Overall Study|Still on Therapy|2|||
161936677|NCT00602667|584817680|FG002|Overall Study|Still on Therapy|2|||
161936678|NCT00602667|584817678|FG000|Overall Study|Death|0|||
161936679|NCT00602667|584817679|FG001|Overall Study|Death|1|||
161936680|NCT00602667|584817680|FG002|Overall Study|Death|1|||
161936681|NCT00602667|584817678|FG000|Overall Study|Family request|3|||
161936682|NCT00602667|584817679|FG001|Overall Study|Family request|25|||
161936683|NCT00602667|584817680|FG002|Overall Study|Family request|6|||
161936684|NCT00602667|584817678|FG000|Overall Study|Excessive toxicity|1|||
161936685|NCT00602667|584817679|FG001|Overall Study|Excessive toxicity|1|||
161936686|NCT00602667|584817680|FG002|Overall Study|Excessive toxicity|0|||
161936687|NCT00602667|584817678|FG000|Overall Study|Second malignancy|0|||
161936688|NCT00602667|584817679|FG001|Overall Study|Second malignancy|1|||
161936689|NCT00602667|584817680|FG002|Overall Study|Second malignancy|0|||
161936690|NCT00602667|584817678|FG000|Overall Study|Physician Decision|2|||
161936691|NCT00602667|584817679|FG001|Overall Study|Physician Decision|3|||
161936692|NCT00602667|584817680|FG002|Overall Study|Physician Decision|8|||
161936693|NCT00602667|584817678|FG000|Overall Study|Progressive disease|13|||
161936694|NCT00602667|584817679|FG001|Overall Study|Progressive disease|48|||
161936695|NCT00602667|584817680|FG002|Overall Study|Progressive disease|45|||
161936696|NCT00602667|584817678|FG000|Overall Study|Progressive disease prior to therapy|0|||
161936697|NCT00602667|584817679|FG001|Overall Study|Progressive disease prior to therapy|0|||
161936698|NCT00602667|584817680|FG002|Overall Study|Progressive disease prior to therapy|1|||
161936699|NCT02363946|584817682|FG000|Overall Study|Lost to Follow-up|0|||
161936700|NCT02363946|584817683|FG001|Overall Study|Lost to Follow-up|0|||
161936701|NCT02363946|584817684|FG002|Overall Study|Lost to Follow-up|0|||
161936702|NCT02363946|584817685|FG003|Overall Study|Lost to Follow-up|0|||
161936703|NCT02363946|584817686|FG004|Overall Study|Lost to Follow-up|0|||
161936704|NCT02363946|584817687|FG005|Overall Study|Lost to Follow-up|0|||
161936705|NCT02363946|584817688|FG006|Overall Study|Lost to Follow-up|0|||
161528007|NCT00413413|583320340|FG002|Single-Blind|Adverse Event|0|||
161936706|NCT02363946|584817689|FG007|Overall Study|Lost to Follow-up|1|||
161936707|NCT02363946|584817690|FG008|Overall Study|Lost to Follow-up|0|||
161936708|NCT02363946|584817691|FG009|Overall Study|Lost to Follow-up|0|||
161936709|NCT02363946|584817692|FG010|Overall Study|Lost to Follow-up|0|||
161936710|NCT02363946|584817693|FG011|Overall Study|Lost to Follow-up|0|||
161936711|NCT02363946|584817694|FG012|Overall Study|Lost to Follow-up|0|||
161936712|NCT02975700|584817697|FG000|Overall Study|Adverse Event|1|||
161936713|NCT02975700|584817697|FG000|Overall Study|Progressive disease|3|||
161936714|NCT02975700|584817697|FG000|Overall Study|Failed screening criteria|2|||
161936715|NCT05702918|584817698|FG000|Overall Study|Withdrawal by Subject|0|||
161528008|NCT00413413|583320338|FG000|Single-Blind|Lack of Efficacy|0|||
161936716|NCT05702918|584817699|FG001|Overall Study|Withdrawal by Subject|2|||
161936717|NCT05702918|584817698|FG000|Overall Study|Lost to Follow-up|0|||
161936718|NCT05702918|584817699|FG001|Overall Study|Lost to Follow-up|2|||
161936719|NCT05702918|584817698|FG000|Overall Study|Unrelated injury|2|||
161936720|NCT05702918|584817699|FG001|Overall Study|Unrelated injury|0|||
161936721|NCT03030261|584817702|FG000|Overall Study|Still receiving continuation therapy|5|||
161936722|NCT05270265|584817703|FG000|Overall Study|Lost to Follow-up|0|||
161936723|NCT05270265|584817704|FG001|Overall Study|Lost to Follow-up|1|||
161936724|NCT05270265|584817705|FG002|Overall Study|Lost to Follow-up|0|||
161936725|NCT04765059|584817706|FG000|Overall Study|Failure to meet randomization criteria|1|||
161678385|NCT03606980|583873719|FG000|Overall Study|Lost to Follow-up|3|||
161678386|NCT03606980|583873720|FG001|Overall Study|Lost to Follow-up|2|||
161678387|NCT03606980|583873721|FG002|Overall Study|Lost to Follow-up|3|||
161678388|NCT03606980|583873719|FG000|Overall Study|Withdrawal by Subject|1|||
161678389|NCT03606980|583873720|FG001|Overall Study|Withdrawal by Subject|0|||
161936726|NCT04765059|584817707|FG001|Overall Study|Failure to meet randomization criteria|0|||
161936727|NCT04765059|584817706|FG000|Overall Study|Withdrawal by Subject|1|||
161936728|NCT04765059|584817707|FG001|Overall Study|Withdrawal by Subject|4|||
161936729|NCT04765059|584817706|FG000|Overall Study|Lost to Follow-up|1|||
161936730|NCT04765059|584817707|FG001|Overall Study|Lost to Follow-up|1|||
161936731|NCT04765059|584817706|FG000|Overall Study|Death|25|||
161936732|NCT04765059|584817707|FG001|Overall Study|Death|28|||
161936733|NCT04765059|584817706|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
161936734|NCT04765059|584817707|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
161936735|NCT01615029|584817709|FG000|Overall Study|Adverse Event|1|||
161936736|NCT01615029|584817710|FG001|Overall Study|Adverse Event|0|||
161936737|NCT01615029|584817711|FG002|Overall Study|Adverse Event|3|||
161936738|NCT01615029|584817712|FG003|Overall Study|Adverse Event|0|||
161936739|NCT01615029|584817713|FG004|Overall Study|Adverse Event|4|||
161936740|NCT01615029|584817709|FG000|Overall Study|Progressive disease|1|||
161936741|NCT01615029|584817710|FG001|Overall Study|Progressive disease|1|||
161936742|NCT01615029|584817711|FG002|Overall Study|Progressive disease|1|||
161936743|NCT01615029|584817712|FG003|Overall Study|Progressive disease|1|||
161936744|NCT01615029|584817713|FG004|Overall Study|Progressive disease|10|||
161936745|NCT01615029|584817709|FG000|Overall Study|Physician Decision|0|||
161936746|NCT01615029|584817710|FG001|Overall Study|Physician Decision|0|||
161528009|NCT00413413|583320339|FG001|Single-Blind|Lack of Efficacy|5|||
161528010|NCT00413413|583320340|FG002|Single-Blind|Lack of Efficacy|0|||
161528011|NCT00413413|583320338|FG000|Single-Blind|Subject no longer requires study drug|0|||
161528012|NCT00413413|583320339|FG001|Single-Blind|Subject no longer requires study drug|151|||
161528013|NCT00413413|583320340|FG002|Single-Blind|Subject no longer requires study drug|0|||
161528014|NCT00413413|583320338|FG000|Single-Blind|Protocol Violation|0|||
161528015|NCT00413413|583320339|FG001|Single-Blind|Protocol Violation|16|||
161528016|NCT00413413|583320340|FG002|Single-Blind|Protocol Violation|0|||
161528017|NCT00413413|583320338|FG000|Single-Blind|Withdrawal by Subject|0|||
161528018|NCT00413413|583320339|FG001|Single-Blind|Withdrawal by Subject|27|||
161528019|NCT00413413|583320340|FG002|Single-Blind|Withdrawal by Subject|0|||
161528020|NCT00413413|583320338|FG000|Single-Blind|Lost to Follow-up|0|||
161528021|NCT00413413|583320339|FG001|Single-Blind|Lost to Follow-up|8|||
161528022|NCT00413413|583320340|FG002|Single-Blind|Lost to Follow-up|0|||
161528023|NCT00413413|583320338|FG000|Double-Blind|Adverse Event|6|||
161528024|NCT00413413|583320339|FG001|Double-Blind|Adverse Event|0|||
161528025|NCT00413413|583320340|FG002|Double-Blind|Adverse Event|5|||
161528026|NCT00413413|583320338|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
161528027|NCT00413413|583320339|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
161528028|NCT00413413|583320340|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
161528029|NCT00413413|583320338|FG000|Double-Blind|Protocol deviation|1|||
161528030|NCT00413413|583320339|FG001|Double-Blind|Protocol deviation|2|||
161528031|NCT00413413|583320340|FG002|Double-Blind|Protocol deviation|1|||
161528032|NCT00413413|583320338|FG000|Double-Blind|Subject withdrew consent|4|||
161528033|NCT00413413|583320339|FG001|Double-Blind|Subject withdrew consent|6|||
161528034|NCT00413413|583320340|FG002|Double-Blind|Subject withdrew consent|9|||
161528035|NCT00413413|583320338|FG000|Double-Blind|Lost to Follow-up|3|||
161528036|NCT00413413|583320339|FG001|Double-Blind|Lost to Follow-up|4|||
161528037|NCT00413413|583320340|FG002|Double-Blind|Lost to Follow-up|2|||
161528038|NCT02219932|583320347|FG000|Overall Study|Other|5|||
161528039|NCT02219932|583320348|FG001|Overall Study|Other|11|||
161528040|NCT02219932|583320347|FG000|Overall Study|Death|1|||
161528041|NCT02219932|583320348|FG001|Overall Study|Death|1|||
161528042|NCT02219932|583320347|FG000|Overall Study|Investigator Decision|0|||
161528043|NCT02219932|583320348|FG001|Overall Study|Investigator Decision|1|||
161528044|NCT02219932|583320347|FG000|Overall Study|Consent Withdrawn|11|||
161678390|NCT03606980|583873721|FG002|Overall Study|Withdrawal by Subject|4|||
161678391|NCT02374021|583873723|FG000|Overall Study|Adverse Event|1|||
161678392|NCT02374021|583873724|FG001|Overall Study|Adverse Event|0|||
161678393|NCT02374021|583873723|FG000|Overall Study|Lost to Follow-up|3|||
161678394|NCT02374021|583873724|FG001|Overall Study|Lost to Follow-up|2|||
161528045|NCT02219932|583320348|FG001|Overall Study|Consent Withdrawn|7|||
161936747|NCT01615029|584817711|FG002|Overall Study|Physician Decision|0|||
161936748|NCT01615029|584817712|FG003|Overall Study|Physician Decision|0|||
161936749|NCT01615029|584817713|FG004|Overall Study|Physician Decision|2|||
161936750|NCT04088331|584817714|FG000|Overall Study|Lost to Follow-up|3|||
161528046|NCT02219932|583320347|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
161528047|NCT02219932|583320348|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
161528048|NCT02219932|583320347|FG000|Overall Study|Protocol Violation|10|||
161936751|NCT04088331|584817714|FG000|Overall Study|Withdrawal by Subject|7|||
161936752|NCT04088331|584817714|FG000|Overall Study|Adverse Event|4|||
161936753|NCT03500172|584817721|FG000|Period 1: Baseline Randomization|Death|0|||
161528049|NCT02219932|583320348|FG001|Overall Study|Protocol Violation|6|||
161528050|NCT02219932|583320347|FG000|Overall Study|Pregnancy|1|||
161528051|NCT02219932|583320348|FG001|Overall Study|Pregnancy|0|||
161528052|NCT02219932|583320347|FG000|Overall Study|Lost to Follow-up|4|||
161528053|NCT02219932|583320348|FG001|Overall Study|Lost to Follow-up|2|||
161528054|NCT02219932|583320347|FG000|Overall Study|Adverse Event|23|||
161528055|NCT02219932|583320348|FG001|Overall Study|Adverse Event|21|||
161528056|NCT04642638|583320351|FG000|Overall Study|Withdrawal by Subject|23|||
161528057|NCT04642638|583320352|FG001|Overall Study|Withdrawal by Subject|29|||
161528058|NCT04642638|583320353|FG002|Overall Study|Withdrawal by Subject|9|||
161528059|NCT04642638|583320354|FG003|Overall Study|Withdrawal by Subject|7|||
161528060|NCT04642638|583320355|FG004|Overall Study|Withdrawal by Subject|61|||
161528061|NCT04642638|583320356|FG005|Overall Study|Withdrawal by Subject|27|||
161528062|NCT04642638|583320351|FG000|Overall Study|Lost to Follow-up|17|||
161528063|NCT04642638|583320352|FG001|Overall Study|Lost to Follow-up|18|||
161528064|NCT04642638|583320353|FG002|Overall Study|Lost to Follow-up|5|||
161528065|NCT04642638|583320354|FG003|Overall Study|Lost to Follow-up|5|||
161528066|NCT04642638|583320355|FG004|Overall Study|Lost to Follow-up|6|||
161528067|NCT04642638|583320356|FG005|Overall Study|Lost to Follow-up|3|||
161528068|NCT04642638|583320351|FG000|Overall Study|Adverse Event|0|||
161528069|NCT04642638|583320352|FG001|Overall Study|Adverse Event|0|||
161528070|NCT04642638|583320353|FG002|Overall Study|Adverse Event|1|||
161528071|NCT04642638|583320354|FG003|Overall Study|Adverse Event|0|||
161528072|NCT04642638|583320355|FG004|Overall Study|Adverse Event|10|||
161528073|NCT04642638|583320356|FG005|Overall Study|Adverse Event|3|||
161528074|NCT04642638|583320351|FG000|Overall Study|Reason Not Specified|1|||
161528075|NCT04642638|583320352|FG001|Overall Study|Reason Not Specified|4|||
161528076|NCT04642638|583320353|FG002|Overall Study|Reason Not Specified|0|||
161528077|NCT04642638|583320354|FG003|Overall Study|Reason Not Specified|0|||
161528078|NCT04642638|583320355|FG004|Overall Study|Reason Not Specified|38|||
161528079|NCT04642638|583320356|FG005|Overall Study|Reason Not Specified|16|||
161528080|NCT04642638|583320351|FG000|Overall Study|Physician Decision|0|||
161528081|NCT04642638|583320352|FG001|Overall Study|Physician Decision|0|||
161528082|NCT04642638|583320353|FG002|Overall Study|Physician Decision|0|||
161528083|NCT04642638|583320354|FG003|Overall Study|Physician Decision|0|||
161528084|NCT04642638|583320355|FG004|Overall Study|Physician Decision|2|||
161528085|NCT04642638|583320356|FG005|Overall Study|Physician Decision|1|||
161528086|NCT04642638|583320351|FG000|Overall Study|Protocol Deviation|0|||
161528087|NCT04642638|583320352|FG001|Overall Study|Protocol Deviation|0|||
161590941|NCT02783300|583552754|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590942|NCT02783300|583552755|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161590943|NCT02783300|583552729|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590944|NCT02783300|583552730|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590945|NCT02783300|583552731|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590946|NCT02783300|583552732|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590947|NCT02783300|583552733|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590948|NCT02783300|583552734|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590949|NCT02783300|583552735|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590950|NCT02783300|583552736|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590951|NCT02783300|583552737|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590952|NCT02783300|583552738|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590953|NCT02783300|583552739|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590954|NCT02783300|583552740|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590955|NCT02783300|583552741|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590956|NCT02783300|583552742|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
161590957|NCT02783300|583552743|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
161590958|NCT02783300|583552744|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
161590959|NCT02783300|583552745|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
161590960|NCT02783300|583552746|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590961|NCT02783300|583552747|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
161590962|NCT02783300|583552748|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
161590963|NCT02783300|583552749|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590964|NCT02783300|583552750|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590965|NCT02783300|583552751|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161528088|NCT04642638|583320353|FG002|Overall Study|Protocol Deviation|0|||
161528089|NCT04642638|583320354|FG003|Overall Study|Protocol Deviation|0|||
161528090|NCT04642638|583320355|FG004|Overall Study|Protocol Deviation|1|||
161528091|NCT04642638|583320356|FG005|Overall Study|Protocol Deviation|3|||
161528092|NCT04642638|583320351|FG000|Overall Study|Study Terminated|0|||
161528093|NCT04642638|583320352|FG001|Overall Study|Study Terminated|0|||
161528094|NCT04642638|583320353|FG002|Overall Study|Study Terminated|0|||
161528095|NCT04642638|583320354|FG003|Overall Study|Study Terminated|0|||
161528096|NCT04642638|583320355|FG004|Overall Study|Study Terminated|484|||
161528097|NCT04642638|583320356|FG005|Overall Study|Study Terminated|250|||
161528098|NCT04642638|583320351|FG000|Overall Study|Pregnancy|0|||
161528099|NCT04642638|583320352|FG001|Overall Study|Pregnancy|0|||
161528100|NCT04642638|583320353|FG002|Overall Study|Pregnancy|0|||
161528101|NCT04642638|583320354|FG003|Overall Study|Pregnancy|0|||
161528102|NCT04642638|583320355|FG004|Overall Study|Pregnancy|1|||
161528103|NCT04642638|583320356|FG005|Overall Study|Pregnancy|0|||
161528104|NCT00511004|583320357|FG000|Overall Study|Lost to Follow-up|0|||
161528105|NCT00511004|583320358|FG001|Overall Study|Lost to Follow-up|0|||
161528106|NCT00511004|583320359|FG002|Overall Study|Lost to Follow-up|4|||
161528107|NCT00990652|583320360|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
161528108|NCT00990652|583320360|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
161528109|NCT01672801|583320362|FG000|Overall Study|Screen Failure|0|||
161528110|NCT01672801|583320363|FG001|Overall Study|Screen Failure|1|||
161528111|NCT06476366|583320364|FG000|Overall Study|Lost to Follow-up|1|||
161528112|NCT06476366|583320365|FG001|Overall Study|Lost to Follow-up|3|||
161528113|NCT06476366|583320364|FG000|Overall Study|Adverse Event|1|||
161528114|NCT06476366|583320365|FG001|Overall Study|Adverse Event|0|||
161528115|NCT04313881|583320370|FG000|Overall Study|Death|138|||
161528116|NCT04313881|583320371|FG001|Overall Study|Death|126|||
161528117|NCT04313881|583320370|FG000|Overall Study|Study terminated by sponsor|108|||
161528118|NCT04313881|583320371|FG001|Overall Study|Study terminated by sponsor|129|||
161528119|NCT04313881|583320370|FG000|Overall Study|Consent withdrawn|19|||
161528120|NCT04313881|583320371|FG001|Overall Study|Consent withdrawn|15|||
161528121|NCT04313881|583320370|FG000|Overall Study|Reason not Specified|3|||
161528122|NCT04313881|583320371|FG001|Overall Study|Reason not Specified|1|||
161528123|NCT00727272|583320372|FG000|Washout Period A|Adverse Event|0|||
161528124|NCT00727272|583320373|FG001|Washout Period A|Adverse Event|0|||
161936754|NCT03500172|584817722|FG001|Period 1: Baseline Randomization|Death|0|||
161936755|NCT03500172|584817723|FG002|Period 1: Baseline Randomization|Death|0|||
161936756|NCT03500172|584817724|FG003|Period 1: Baseline Randomization|Death|0|||
161936757|NCT03500172|584817725|FG004|Period 1: Baseline Randomization|Death|0|||
161936758|NCT03500172|584817726|FG005|Period 1: Baseline Randomization|Death|0|||
161936759|NCT03500172|584817727|FG006|Period 1: Baseline Randomization|Death|0|||
161936760|NCT03500172|584817728|FG007|Period 1: Baseline Randomization|Death|0|||
161936761|NCT03500172|584817729|FG008|Period 1: Baseline Randomization|Death|0|||
161936762|NCT03500172|584817730|FG009|Period 1: Baseline Randomization|Death|2|||
161528125|NCT00727272|583320374|FG002|Washout Period A|Adverse Event|1|||
161528126|NCT00727272|583320372|FG000|Washout Period B|Withdrawal by Subject|0|||
161528127|NCT00727272|583320373|FG001|Washout Period B|Withdrawal by Subject|0|||
161528128|NCT00727272|583320374|FG002|Washout Period B|Withdrawal by Subject|1|||
161528129|NCT00651664|583320375|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
161528130|NCT00651664|583320376|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
161528131|NCT00651664|583320377|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
161528132|NCT00651664|583320378|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
161528133|NCT00651664|583320379|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
161528134|NCT00651664|583320380|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
161528135|NCT00651664|583320381|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
161528136|NCT00651664|583320382|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
161528137|NCT00651664|583320383|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
161528138|NCT00651664|583320384|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
161528139|NCT00651664|583320375|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
161528140|NCT00651664|583320376|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
161528141|NCT00651664|583320377|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161528142|NCT00651664|583320378|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
161528143|NCT00651664|583320379|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
161528144|NCT00651664|583320380|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
161528145|NCT00651664|583320381|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
161528146|NCT00651664|583320382|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
161528147|NCT00651664|583320383|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
161528148|NCT00651664|583320384|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
161936763|NCT03500172|584817731|FG010|Period 1: Baseline Randomization|Death|0|||
161936764|NCT03500172|584817721|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
161936765|NCT03500172|584817722|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
161936766|NCT03500172|584817723|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
161936767|NCT03500172|584817724|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
161528149|NCT00651664|583320375|FG000|Overall Study|Progressive Disease|3|||
161528150|NCT00651664|583320376|FG001|Overall Study|Progressive Disease|3|||
161528151|NCT00651664|583320377|FG002|Overall Study|Progressive Disease|3|||
161528152|NCT00651664|583320378|FG003|Overall Study|Progressive Disease|12|||
161528153|NCT00651664|583320379|FG004|Overall Study|Progressive Disease|4|||
161528154|NCT00651664|583320380|FG005|Overall Study|Progressive Disease|1|||
161528155|NCT00651664|583320381|FG006|Overall Study|Progressive Disease|3|||
161528156|NCT00651664|583320382|FG007|Overall Study|Progressive Disease|6|||
161936768|NCT03500172|584817725|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
161528157|NCT00651664|583320383|FG008|Overall Study|Progressive Disease|5|||
161528158|NCT00651664|583320384|FG009|Overall Study|Progressive Disease|5|||
161528159|NCT00651664|583320375|FG000|Overall Study|Patient Declined Further Treatment|0|||
161528160|NCT00651664|583320376|FG001|Overall Study|Patient Declined Further Treatment|0|||
161528161|NCT00651664|583320377|FG002|Overall Study|Patient Declined Further Treatment|0|||
161528162|NCT00651664|583320378|FG003|Overall Study|Patient Declined Further Treatment|1|||
161528163|NCT00651664|583320379|FG004|Overall Study|Patient Declined Further Treatment|1|||
161528164|NCT00651664|583320380|FG005|Overall Study|Patient Declined Further Treatment|1|||
161528165|NCT00651664|583320381|FG006|Overall Study|Patient Declined Further Treatment|0|||
161528166|NCT00651664|583320382|FG007|Overall Study|Patient Declined Further Treatment|0|||
161528167|NCT00651664|583320383|FG008|Overall Study|Patient Declined Further Treatment|0|||
161528168|NCT00651664|583320384|FG009|Overall Study|Patient Declined Further Treatment|1|||
161528169|NCT00651664|583320375|FG000|Overall Study|Symptomatic Deterioration|0|||
161528170|NCT00651664|583320376|FG001|Overall Study|Symptomatic Deterioration|0|||
161528171|NCT00651664|583320377|FG002|Overall Study|Symptomatic Deterioration|0|||
161528172|NCT00651664|583320378|FG003|Overall Study|Symptomatic Deterioration|1|||
161528173|NCT00651664|583320379|FG004|Overall Study|Symptomatic Deterioration|0|||
161528174|NCT00651664|583320380|FG005|Overall Study|Symptomatic Deterioration|0|||
161528175|NCT00651664|583320381|FG006|Overall Study|Symptomatic Deterioration|1|||
161528176|NCT00651664|583320382|FG007|Overall Study|Symptomatic Deterioration|0|||
161528177|NCT00651664|583320383|FG008|Overall Study|Symptomatic Deterioration|1|||
161528178|NCT00651664|583320384|FG009|Overall Study|Symptomatic Deterioration|0|||
161528179|NCT00651664|583320375|FG000|Overall Study|Reason not Specified|0|||
161528180|NCT00651664|583320376|FG001|Overall Study|Reason not Specified|0|||
161528181|NCT00651664|583320377|FG002|Overall Study|Reason not Specified|0|||
161528182|NCT00651664|583320378|FG003|Overall Study|Reason not Specified|0|||
161528183|NCT00651664|583320379|FG004|Overall Study|Reason not Specified|0|||
161528184|NCT00651664|583320380|FG005|Overall Study|Reason not Specified|0|||
161528185|NCT00651664|583320381|FG006|Overall Study|Reason not Specified|1|||
161528186|NCT00651664|583320382|FG007|Overall Study|Reason not Specified|0|||
161528187|NCT00651664|583320383|FG008|Overall Study|Reason not Specified|0|||
161528188|NCT00651664|583320384|FG009|Overall Study|Reason not Specified|0|||
161528189|NCT00965523|583320387|FG000|Study 221|Progressive Disease|4|||
161528190|NCT00965523|583320387|FG000|Study 221|Physician Decision|3|||
161528191|NCT00965523|583320387|FG000|Study 224|Progressive Disease|5|||
161528192|NCT00965523|583320387|FG000|Study 224|Physician Decision|1|||
161528193|NCT03595904|583320392|FG000|Overall Study|Protocol Violation|3|||
161528194|NCT03595904|583320393|FG001|Overall Study|Protocol Violation|1|||
161528195|NCT03595904|583320392|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
161528196|NCT03595904|583320393|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
161528197|NCT03595904|583320392|FG000|Overall Study|Insurance complications|1|||
161528198|NCT03595904|583320393|FG001|Overall Study|Insurance complications|0|||
161528199|NCT03595904|583320392|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
161528200|NCT03595904|583320393|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
161528201|NCT01581281|583320394|FG000|Overall Study|Early Study Closure|15|||
161528202|NCT01581281|583320395|FG001|Overall Study|Early Study Closure|6|||
161528203|NCT01581281|583320396|FG002|Overall Study|Early Study Closure|12|||
161528204|NCT02187991|583320399|FG000|Overall Study|Adverse Event|13|||
161528205|NCT02187991|583320400|FG001|Overall Study|Adverse Event|14|||
161528206|NCT02187991|583320401|FG002|Overall Study|Adverse Event|3|||
161528207|NCT02187991|583320402|FG003|Overall Study|Adverse Event|2|||
161528208|NCT02187991|583320399|FG000|Overall Study|Withdrawal by Subject|9|||
161528209|NCT02187991|583320400|FG001|Overall Study|Withdrawal by Subject|6|||
161528210|NCT02187991|583320401|FG002|Overall Study|Withdrawal by Subject|3|||
161528211|NCT02187991|583320402|FG003|Overall Study|Withdrawal by Subject|2|||
161528212|NCT02187991|583320399|FG000|Overall Study|Physician Decision|4|||
161678395|NCT02374021|583873723|FG000|Overall Study|Physician Decision|0|||
161678396|NCT02374021|583873724|FG001|Overall Study|Physician Decision|3|||
161678397|NCT02374021|583873723|FG000|Overall Study|Withdrawal by Subject|6|||
161678398|NCT02374021|583873724|FG001|Overall Study|Withdrawal by Subject|5|||
161678399|NCT02374021|583873723|FG000|Overall Study|Poor Adherence|0|||
161678400|NCT02374021|583873724|FG001|Overall Study|Poor Adherence|1|||
161678401|NCT02374021|583873723|FG000|Overall Study|Scan protocol not followed|0|||
161678402|NCT02374021|583873724|FG001|Overall Study|Scan protocol not followed|1|||
161678403|NCT02374021|583873723|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
161528213|NCT02187991|583320400|FG001|Overall Study|Physician Decision|4|||
161528214|NCT02187991|583320401|FG002|Overall Study|Physician Decision|0|||
161528215|NCT02187991|583320402|FG003|Overall Study|Physician Decision|2|||
161528216|NCT02187991|583320399|FG000|Overall Study|Other, unrelated complication|7|||
161528217|NCT02187991|583320400|FG001|Overall Study|Other, unrelated complication|1|||
161528218|NCT02187991|583320401|FG002|Overall Study|Other, unrelated complication|1|||
161528219|NCT02187991|583320402|FG003|Overall Study|Other, unrelated complication|2|||
161528220|NCT02187991|583320399|FG000|Overall Study|Death|1|||
161528221|NCT02187991|583320400|FG001|Overall Study|Death|3|||
161528222|NCT02187991|583320401|FG002|Overall Study|Death|0|||
161528223|NCT02187991|583320402|FG003|Overall Study|Death|0|||
161528224|NCT01392560|583320403|FG000|Overall Study|Adverse Event|2|||
161528225|NCT01392560|583320403|FG000|Overall Study|not entered|8|||
161528226|NCT01392560|583320403|FG000|Overall Study|discontinued during placebo run-in|2|||
161528227|NCT04656847|583320410|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
161528228|NCT03301051|583320411|FG000|Overall Study|Adverse Event|0|||
161528229|NCT03301051|583320412|FG001|Overall Study|Adverse Event|4|||
161528230|NCT03301051|583320411|FG000|Overall Study|Withdrawal by Subject|59|||
161528231|NCT03301051|583320412|FG001|Overall Study|Withdrawal by Subject|65|||
161528232|NCT03301051|583320411|FG000|Overall Study|Lost to Follow-up|263|||
161528233|NCT03301051|583320412|FG001|Overall Study|Lost to Follow-up|282|||
161528234|NCT03301051|583320411|FG000|Overall Study|Protocol Violation|1|||
161528235|NCT03301051|583320412|FG001|Overall Study|Protocol Violation|3|||
161528236|NCT03301051|583320411|FG000|Overall Study|Physician Decision|1|||
161528237|NCT03301051|583320412|FG001|Overall Study|Physician Decision|3|||
161528238|NCT03301051|583320411|FG000|Overall Study|Death|1|||
161528239|NCT03301051|583320412|FG001|Overall Study|Death|1|||
161528240|NCT03301051|583320411|FG000|Overall Study|Miscellaneous|8|||
161528241|NCT03301051|583320412|FG001|Overall Study|Miscellaneous|4|||
161528242|NCT03301051|583320411|FG000|Overall Study|Randomized, not vaccinated|13|||
161528243|NCT03301051|583320412|FG001|Overall Study|Randomized, not vaccinated|10|||
161528244|NCT00047879|583320413|FG000|Overall Study|Progressive disease|4|||
161528245|NCT00047879|583320414|FG001|Overall Study|Progressive disease|3|||
161528246|NCT01196975|583320415|FG000|Overall Study|Adverse Event|2|||
161528247|NCT01196975|583320416|FG001|Overall Study|Adverse Event|2|||
161528248|NCT01196975|583320417|FG002|Overall Study|Adverse Event|0|||
161528249|NCT01196975|583320418|FG003|Overall Study|Adverse Event|0|||
161528250|NCT01196975|583320419|FG004|Overall Study|Adverse Event|2|||
161528251|NCT01196975|583320415|FG000|Overall Study|Withdrawal by Subject|2|||
161528252|NCT01196975|583320416|FG001|Overall Study|Withdrawal by Subject|1|||
161528253|NCT01196975|583320417|FG002|Overall Study|Withdrawal by Subject|0|||
161528254|NCT01196975|583320418|FG003|Overall Study|Withdrawal by Subject|1|||
161528255|NCT01196975|583320419|FG004|Overall Study|Withdrawal by Subject|0|||
161528256|NCT01196975|583320415|FG000|Overall Study|Lost to Follow-up|11|||
161528257|NCT01196975|583320416|FG001|Overall Study|Lost to Follow-up|6|||
161528258|NCT01196975|583320417|FG002|Overall Study|Lost to Follow-up|5|||
161528259|NCT01196975|583320418|FG003|Overall Study|Lost to Follow-up|5|||
161528260|NCT01196975|583320419|FG004|Overall Study|Lost to Follow-up|11|||
161528261|NCT01358526|583320427|FG000|Open-label Titration Period|Adverse Event|95|||
161528262|NCT01358526|583320428|FG001|Open-label Titration Period|Adverse Event|0|||
161528263|NCT01358526|583320429|FG002|Open-label Titration Period|Adverse Event|0|||
161528264|NCT01358526|583320427|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
161528265|NCT01358526|583320428|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
161528266|NCT01358526|583320429|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
161528267|NCT01358526|583320427|FG000|Open-label Titration Period|Lost to Follow-up|25|||
161528268|NCT01358526|583320428|FG001|Open-label Titration Period|Lost to Follow-up|0|||
161528269|NCT01358526|583320429|FG002|Open-label Titration Period|Lost to Follow-up|0|||
161528270|NCT01358526|583320427|FG000|Open-label Titration Period|Lack of Efficacy|107|||
161528271|NCT01358526|583320428|FG001|Open-label Titration Period|Lack of Efficacy|0|||
161528272|NCT01358526|583320429|FG002|Open-label Titration Period|Lack of Efficacy|0|||
161590966|NCT02783300|583552752|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590967|NCT02783300|583552753|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590968|NCT02783300|583552754|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590969|NCT02783300|583552755|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161590970|NCT02783300|583552729|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590971|NCT02783300|583552730|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590972|NCT02783300|583552731|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590973|NCT02783300|583552732|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590974|NCT02783300|583552733|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590975|NCT02783300|583552734|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590976|NCT02783300|583552735|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590977|NCT02783300|583552736|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161528273|NCT01358526|583320427|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
161528274|NCT01358526|583320428|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
161528275|NCT01358526|583320429|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
161528276|NCT01358526|583320427|FG000|Open-label Titration Period|Administrative|8|||
161528277|NCT01358526|583320428|FG001|Open-label Titration Period|Administrative|0|||
161528278|NCT01358526|583320429|FG002|Open-label Titration Period|Administrative|0|||
161528279|NCT01358526|583320427|FG000|Open-label Titration Period|Did not qualify|178|||
161528280|NCT01358526|583320428|FG001|Open-label Titration Period|Did not qualify|0|||
161528281|NCT01358526|583320429|FG002|Open-label Titration Period|Did not qualify|0|||
161528282|NCT01358526|583320427|FG000|Double-blind Phase|Adverse Event|0|||
161528283|NCT01358526|583320428|FG001|Double-blind Phase|Adverse Event|24|||
161528284|NCT01358526|583320429|FG002|Double-blind Phase|Adverse Event|23|||
161528285|NCT01358526|583320427|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161528286|NCT01358526|583320428|FG001|Double-blind Phase|Withdrawal by Subject|10|||
161528287|NCT01358526|583320429|FG002|Double-blind Phase|Withdrawal by Subject|8|||
161528288|NCT01358526|583320427|FG000|Double-blind Phase|Lost to Follow-up|0|||
161528289|NCT01358526|583320428|FG001|Double-blind Phase|Lost to Follow-up|4|||
161528290|NCT01358526|583320429|FG002|Double-blind Phase|Lost to Follow-up|1|||
161528291|NCT01358526|583320427|FG000|Double-blind Phase|Lack of Efficacy|0|||
161528292|NCT01358526|583320428|FG001|Double-blind Phase|Lack of Efficacy|31|||
161528293|NCT01358526|583320429|FG002|Double-blind Phase|Lack of Efficacy|73|||
161528294|NCT01358526|583320427|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
161528295|NCT01358526|583320428|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
161528296|NCT01358526|583320429|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
161528297|NCT01358526|583320427|FG000|Double-blind Phase|Administrative|0|||
161528298|NCT01358526|583320428|FG001|Double-blind Phase|Administrative|6|||
161528299|NCT01358526|583320429|FG002|Double-blind Phase|Administrative|10|||
161528300|NCT00360529|583320430|FG000|Overall Study|Adverse Event|10|||
161528301|NCT00360529|583320431|FG001|Overall Study|Adverse Event|23|||
161528302|NCT00360529|583320432|FG002|Overall Study|Adverse Event|33|||
161528303|NCT00360529|583320430|FG000|Overall Study|Protocol Violation|3|||
161528304|NCT00360529|583320431|FG001|Overall Study|Protocol Violation|3|||
161528305|NCT00360529|583320432|FG002|Overall Study|Protocol Violation|11|||
161528306|NCT00360529|583320430|FG000|Overall Study|Lost to Follow-up|14|||
161528307|NCT00360529|583320431|FG001|Overall Study|Lost to Follow-up|10|||
161528308|NCT00360529|583320432|FG002|Overall Study|Lost to Follow-up|13|||
161528309|NCT00360529|583320430|FG000|Overall Study|Withdrawal by Subject|22|||
161528310|NCT00360529|583320431|FG001|Overall Study|Withdrawal by Subject|14|||
161528311|NCT00360529|583320432|FG002|Overall Study|Withdrawal by Subject|18|||
161528312|NCT00360529|583320430|FG000|Overall Study|Lack of Efficacy|8|||
161528313|NCT00360529|583320431|FG001|Overall Study|Lack of Efficacy|6|||
161528314|NCT00360529|583320432|FG002|Overall Study|Lack of Efficacy|5|||
161528315|NCT00360529|583320430|FG000|Overall Study|Reason discontinued not explained above|4|||
161528316|NCT00360529|583320431|FG001|Overall Study|Reason discontinued not explained above|9|||
161528317|NCT00360529|583320432|FG002|Overall Study|Reason discontinued not explained above|11|||
161528318|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
161528319|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
161528320|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
161528321|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
161528322|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
161528323|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
161528324|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
161528325|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
161528326|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
161528327|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
161528328|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
161528329|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
161528330|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
161528331|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
161528332|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
161528333|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
161528334|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
161528335|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
161528336|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
161528337|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
161528338|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
161528339|NCT01781572|583320437|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
161528340|NCT01781572|583320438|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
161528341|NCT01781572|583320439|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
161528342|NCT01781572|583320437|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
161528343|NCT01781572|583320438|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
161528344|NCT01781572|583320439|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
161528345|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
161528346|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
161528347|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
161528348|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
161528349|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
161528350|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
161528351|NCT01781572|583320437|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
161528352|NCT01781572|583320438|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
161678404|NCT02374021|583873724|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
161528353|NCT01781572|583320439|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
161936769|NCT03500172|584817726|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
161936770|NCT03500172|584817727|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
161936771|NCT03500172|584817728|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
161936772|NCT03500172|584817729|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
161528354|NCT01781572|583320437|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
161528355|NCT01781572|583320438|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
161528356|NCT01781572|583320439|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
161528357|NCT01781572|583320437|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
161528358|NCT01781572|583320438|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
161528359|NCT01781572|583320439|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
161528360|NCT01781572|583320437|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
161528361|NCT01781572|583320438|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
161590978|NCT02783300|583552737|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590979|NCT02783300|583552738|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161936773|NCT03500172|584817730|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
161936774|NCT03500172|584817731|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
161936775|NCT03500172|584817721|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
161936776|NCT03500172|584817722|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
161936777|NCT03500172|584817723|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
161936778|NCT03500172|584817724|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
161936779|NCT03500172|584817725|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
161936780|NCT03500172|584817726|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
161936781|NCT03500172|584817727|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
161936782|NCT03500172|584817728|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
161936783|NCT03500172|584817729|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
161936784|NCT03500172|584817730|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
161936785|NCT03500172|584817731|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
161936786|NCT03500172|584817721|FG000|Period 2: Re-Randomization|Death|0|||
161936787|NCT03500172|584817722|FG001|Period 2: Re-Randomization|Death|0|||
161936788|NCT03500172|584817723|FG002|Period 2: Re-Randomization|Death|0|||
161936789|NCT03500172|584817724|FG003|Period 2: Re-Randomization|Death|4|||
161936790|NCT03500172|584817725|FG004|Period 2: Re-Randomization|Death|2|||
161936791|NCT03500172|584817726|FG005|Period 2: Re-Randomization|Death|0|||
161936792|NCT03500172|584817727|FG006|Period 2: Re-Randomization|Death|5|||
161936793|NCT03500172|584817728|FG007|Period 2: Re-Randomization|Death|2|||
161936794|NCT03500172|584817729|FG008|Period 2: Re-Randomization|Death|0|||
161936795|NCT03500172|584817730|FG009|Period 2: Re-Randomization|Death|0|||
161936796|NCT03500172|584817731|FG010|Period 2: Re-Randomization|Death|0|||
161936797|NCT04300309|584817732|FG000|Overall Study|Lost to Follow-up|1|||
161936798|NCT04300309|584817733|FG001|Overall Study|Lost to Follow-up|0|||
161936799|NCT03171545|584817736|FG000|Baseline|Withdrawal by Subject|0|||
161936800|NCT03171545|584817737|FG001|Baseline|Withdrawal by Subject|0|||
161936801|NCT03171545|584817738|FG002|Baseline|Withdrawal by Subject|1|||
161936802|NCT03171545|584817739|FG003|Baseline|Withdrawal by Subject|2|||
161936803|NCT03171545|584817736|FG000|Baseline|Transferred out of clinic|4|||
161936804|NCT03171545|584817737|FG001|Baseline|Transferred out of clinic|0|||
161936805|NCT03171545|584817738|FG002|Baseline|Transferred out of clinic|2|||
161936806|NCT03171545|584817739|FG003|Baseline|Transferred out of clinic|0|||
161936807|NCT03171545|584817736|FG000|Baseline|Death|1|||
161936808|NCT03171545|584817737|FG001|Baseline|Death|2|||
161936809|NCT03171545|584817738|FG002|Baseline|Death|1|||
161936810|NCT03171545|584817739|FG003|Baseline|Death|5|||
161936811|NCT03171545|584817736|FG000|Baseline|Recovered renal function|0|||
161936812|NCT03171545|584817737|FG001|Baseline|Recovered renal function|0|||
161936813|NCT03171545|584817738|FG002|Baseline|Recovered renal function|1|||
161936814|NCT03171545|584817739|FG003|Baseline|Recovered renal function|0|||
161936815|NCT03171545|584817736|FG000|Baseline|Received transplant|0|||
161936816|NCT03171545|584817737|FG001|Baseline|Received transplant|0|||
161936817|NCT03171545|584817738|FG002|Baseline|Received transplant|1|||
161936818|NCT03171545|584817739|FG003|Baseline|Received transplant|0|||
161936819|NCT03171545|584817736|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
161936820|NCT03171545|584817737|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
161936821|NCT03171545|584817738|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
161936822|NCT03171545|584817739|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
161936823|NCT03171545|584817736|FG000|Intervention|Withdrawal by Subject|2|||
161936824|NCT03171545|584817737|FG001|Intervention|Withdrawal by Subject|0|||
161936825|NCT03171545|584817738|FG002|Intervention|Withdrawal by Subject|0|||
161936826|NCT03171545|584817739|FG003|Intervention|Withdrawal by Subject|4|||
161936827|NCT03171545|584817736|FG000|Intervention|Transferred out of clinic|12|||
161936828|NCT03171545|584817737|FG001|Intervention|Transferred out of clinic|9|||
161528362|NCT01781572|583320439|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
161528363|NCT01781572|583320437|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
161936829|NCT03171545|584817738|FG002|Intervention|Transferred out of clinic|17|||
161936830|NCT03171545|584817739|FG003|Intervention|Transferred out of clinic|9|||
161936831|NCT03171545|584817736|FG000|Intervention|Death|26|||
161936832|NCT03171545|584817737|FG001|Intervention|Death|16|||
161936833|NCT03171545|584817738|FG002|Intervention|Death|29|||
161936834|NCT03171545|584817739|FG003|Intervention|Death|14|||
161936835|NCT03171545|584817736|FG000|Intervention|Received transplant|7|||
161528364|NCT01781572|583320438|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
161528365|NCT01781572|583320439|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
161528366|NCT01781572|583320437|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
161528367|NCT01781572|583320438|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
161528368|NCT01781572|583320439|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
161528369|NCT01781572|583320437|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
161528370|NCT01781572|583320438|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
161528371|NCT01781572|583320439|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
161528372|NCT06167031|583320442|FG000|Overall Study|Lost to Follow-up|5|||
161528373|NCT06167031|583320443|FG001|Overall Study|Lost to Follow-up|1|||
161528374|NCT00907153|583322291|FG000|Overall Study|Lost to Follow-up|1|||
161528375|NCT00907153|583322292|FG001|Overall Study|Lost to Follow-up|1|||
161528376|NCT00907153|583322291|FG000|Overall Study|Withdrawal by Subject|1|||
161528377|NCT00907153|583322292|FG001|Overall Study|Withdrawal by Subject|3|||
161528378|NCT00713648|583322298|FG000|Overall Study|Adverse Event|1|||
161528379|NCT00713648|583322298|FG000|Overall Study|Unclassified|2|||
161528380|NCT00713648|583322298|FG000|Overall Study|According to Protocol|2|||
161528381|NCT00713648|583322298|FG000|Overall Study|Development of antibodies|3|||
161528382|NCT02566031|583322301|FG000|Overall Study|Patient/guardian decision|14|||
161528383|NCT02566031|583322302|FG001|Overall Study|Patient/guardian decision|7|||
161528384|NCT02566031|583322301|FG000|Overall Study|Protocol deviation|2|||
161528385|NCT02566031|583322302|FG001|Overall Study|Protocol deviation|3|||
161528386|NCT02566031|583322301|FG000|Overall Study|Adverse Event|3|||
161528387|NCT02566031|583322302|FG001|Overall Study|Adverse Event|1|||
161528388|NCT02566031|583322301|FG000|Overall Study|Lost to Follow-up|1|||
161528389|NCT02566031|583322302|FG001|Overall Study|Lost to Follow-up|1|||
161528390|NCT03031938|583322303|FG000|Overall Study|Death|1|||
161528391|NCT03031938|583322304|FG001|Overall Study|Death|0|||
161528392|NCT01910129|583322313|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
161528393|NCT01910129|583322314|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
161528394|NCT01910129|583322315|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
161528395|NCT01910129|583322313|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
161528396|NCT01910129|583322314|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
161528397|NCT01910129|583322315|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
161528398|NCT02415400|583322317|FG000|Overall Study|Adverse Event|0|||
161528399|NCT02415400|583322318|FG001|Overall Study|Adverse Event|1|||
161528400|NCT02415400|583322319|FG002|Overall Study|Adverse Event|1|||
161528401|NCT02415400|583322320|FG003|Overall Study|Adverse Event|2|||
161528402|NCT02415400|583322317|FG000|Overall Study|Participant request to stop therapy|4|||
161528403|NCT02415400|583322318|FG001|Overall Study|Participant request to stop therapy|3|||
161528404|NCT02415400|583322319|FG002|Overall Study|Participant request to stop therapy|8|||
161528405|NCT02415400|583322320|FG003|Overall Study|Participant request to stop therapy|6|||
161528406|NCT02415400|583322317|FG000|Overall Study|Participant withdrew consent|14|||
161528407|NCT02415400|583322318|FG001|Overall Study|Participant withdrew consent|12|||
161528408|NCT02415400|583322319|FG002|Overall Study|Participant withdrew consent|30|||
161528409|NCT02415400|583322320|FG003|Overall Study|Participant withdrew consent|21|||
161528410|NCT02415400|583322317|FG000|Overall Study|Death|39|||
161528411|NCT02415400|583322318|FG001|Overall Study|Death|41|||
161528412|NCT02415400|583322319|FG002|Overall Study|Death|35|||
161528413|NCT02415400|583322320|FG003|Overall Study|Death|42|||
161528414|NCT02415400|583322317|FG000|Overall Study|Lost to Follow-up|3|||
161528415|NCT02415400|583322318|FG001|Overall Study|Lost to Follow-up|3|||
161528416|NCT02415400|583322319|FG002|Overall Study|Lost to Follow-up|2|||
161528417|NCT02415400|583322320|FG003|Overall Study|Lost to Follow-up|5|||
161528418|NCT02415400|583322317|FG000|Overall Study|Poor/Non-Compliance|0|||
161528419|NCT02415400|583322318|FG001|Overall Study|Poor/Non-Compliance|1|||
161528420|NCT02415400|583322319|FG002|Overall Study|Poor/Non-Compliance|3|||
161528421|NCT02415400|583322320|FG003|Overall Study|Poor/Non-Compliance|4|||
161528422|NCT02415400|583322317|FG000|Overall Study|Participant no longer meets criteria|2|||
161528423|NCT02415400|583322318|FG001|Overall Study|Participant no longer meets criteria|0|||
161528424|NCT02415400|583322319|FG002|Overall Study|Participant no longer meets criteria|0|||
161528425|NCT02415400|583322320|FG003|Overall Study|Participant no longer meets criteria|1|||
161528426|NCT02415400|583322317|FG000|Overall Study|Participant doesn't answer phone|1|||
161528427|NCT02415400|583322318|FG001|Overall Study|Participant doesn't answer phone|0|||
161528428|NCT02415400|583322319|FG002|Overall Study|Participant doesn't answer phone|0|||
161528429|NCT02415400|583322320|FG003|Overall Study|Participant doesn't answer phone|0|||
161528430|NCT02415400|583322317|FG000|Overall Study|Participant wanted home visits|1|||
161528431|NCT02415400|583322318|FG001|Overall Study|Participant wanted home visits|0|||
161528432|NCT02415400|583322319|FG002|Overall Study|Participant wanted home visits|0|||
161528433|NCT02415400|583322320|FG003|Overall Study|Participant wanted home visits|0|||
161528434|NCT02415400|583322317|FG000|Overall Study|Randomized in error|2|||
161528435|NCT02415400|583322318|FG001|Overall Study|Randomized in error|0|||
161528436|NCT02415400|583322319|FG002|Overall Study|Randomized in error|0|||
161528437|NCT02415400|583322320|FG003|Overall Study|Randomized in error|0|||
161528438|NCT02415400|583322317|FG000|Overall Study|No study drug on site|0|||
161528439|NCT02415400|583322318|FG001|Overall Study|No study drug on site|1|||
161528440|NCT02415400|583322319|FG002|Overall Study|No study drug on site|0|||
161528441|NCT02415400|583322320|FG003|Overall Study|No study drug on site|0|||
161528442|NCT02415400|583322317|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
161528443|NCT02415400|583322318|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
161528444|NCT02415400|583322319|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
161528445|NCT02415400|583322320|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
161528446|NCT02415400|583322317|FG000|Overall Study|Coagulation values cannot be set|0|||
161528447|NCT02415400|583322318|FG001|Overall Study|Coagulation values cannot be set|0|||
161528448|NCT02415400|583322319|FG002|Overall Study|Coagulation values cannot be set|1|||
161528449|NCT02415400|583322320|FG003|Overall Study|Coagulation values cannot be set|0|||
161528450|NCT02415400|583322317|FG000|Overall Study|State regulations prevent participation|0|||
161528451|NCT02415400|583322318|FG001|Overall Study|State regulations prevent participation|0|||
161528452|NCT02415400|583322319|FG002|Overall Study|State regulations prevent participation|1|||
161528453|NCT02415400|583322320|FG003|Overall Study|State regulations prevent participation|0|||
161528454|NCT02415400|583322317|FG000|Overall Study|Poor treatment monitoring|0|||
161528455|NCT02415400|583322318|FG001|Overall Study|Poor treatment monitoring|0|||
161528456|NCT02415400|583322319|FG002|Overall Study|Poor treatment monitoring|1|||
161528457|NCT02415400|583322320|FG003|Overall Study|Poor treatment monitoring|0|||
161528458|NCT02415400|583322317|FG000|Overall Study|Participant in jail|0|||
161528459|NCT02415400|583322318|FG001|Overall Study|Participant in jail|0|||
161528460|NCT02415400|583322319|FG002|Overall Study|Participant in jail|1|||
161528461|NCT02415400|583322320|FG003|Overall Study|Participant in jail|0|||
161528462|NCT02415400|583322317|FG000|Overall Study|Investigator decision|0|||
161528463|NCT02415400|583322318|FG001|Overall Study|Investigator decision|0|||
161528464|NCT02415400|583322319|FG002|Overall Study|Investigator decision|1|||
161528465|NCT02415400|583322320|FG003|Overall Study|Investigator decision|1|||
161528466|NCT02415400|583322317|FG000|Overall Study|Site closure; participant won't transfer|0|||
161528467|NCT02415400|583322318|FG001|Overall Study|Site closure; participant won't transfer|0|||
161528468|NCT02415400|583322319|FG002|Overall Study|Site closure; participant won't transfer|0|||
161528469|NCT02415400|583322320|FG003|Overall Study|Site closure; participant won't transfer|1|||
161528470|NCT01226745|583322323|FG000|Overall Study|Did not complete schedule of assessments|8|||
161528471|NCT01226745|583322324|FG001|Overall Study|Did not complete schedule of assessments|3|||
161528472|NCT01226745|583322325|FG002|Overall Study|Did not complete schedule of assessments|6|||
161528473|NCT01226745|583322326|FG003|Overall Study|Did not complete schedule of assessments|0|||
161528474|NCT01226745|583322327|FG004|Overall Study|Did not complete schedule of assessments|0|||
161590980|NCT02783300|583552739|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590981|NCT02783300|583552740|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590982|NCT02783300|583552741|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590983|NCT02783300|583552742|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
161590984|NCT02783300|583552743|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161590985|NCT02783300|583552744|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161590986|NCT02783300|583552745|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161590987|NCT02783300|583552746|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161827322|NCT00685750|584408052|FG002|Overall Study|Patient didn't receive the treatment|0|||
161827323|NCT00685750|584408053|FG003|Overall Study|Patient didn't receive the treatment|0|||
161827324|NCT00685750|584408054|FG004|Overall Study|Patient didn't receive the treatment|0|||
161827325|NCT00685750|584408055|FG005|Overall Study|Patient didn't receive the treatment|0|||
161827326|NCT00685750|584408056|FG006|Overall Study|Patient didn't receive the treatment|1|||
161827327|NCT00685750|584408050|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161827328|NCT00685750|584408051|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161827329|NCT00685750|584408052|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161827330|NCT00685750|584408053|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
161827331|NCT00685750|584408054|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161827332|NCT00685750|584408055|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
161827333|NCT00685750|584408056|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
161827334|NCT00129116|584408059|FG000|Primary Phase|Lost to Follow-up|1|||
161827335|NCT00129116|584408060|FG001|Primary Phase|Lost to Follow-up|1|||
161827336|NCT00129116|584408061|FG002|Primary Phase|Lost to Follow-up|0|||
161827337|NCT00129116|584408062|FG003|Primary Phase|Lost to Follow-up|1|||
161827338|NCT00129116|584408063|FG004|Primary Phase|Lost to Follow-up|1|||
161827339|NCT00129116|584408059|FG000|Primary Phase|Protocol Violation|0|||
161827340|NCT00129116|584408060|FG001|Primary Phase|Protocol Violation|1|||
161827341|NCT00129116|584408061|FG002|Primary Phase|Protocol Violation|0|||
161827342|NCT00129116|584408062|FG003|Primary Phase|Protocol Violation|0|||
161827343|NCT00129116|584408063|FG004|Primary Phase|Protocol Violation|0|||
161827344|NCT00129116|584408059|FG000|Primary Phase|Adverse Event|1|||
161827345|NCT00129116|584408060|FG001|Primary Phase|Adverse Event|1|||
161528475|NCT01226745|583322328|FG005|Overall Study|Did not complete schedule of assessments|1|||
161528476|NCT01226745|583322323|FG000|Overall Study|Lost to Follow-up|2|||
161528477|NCT01226745|583322324|FG001|Overall Study|Lost to Follow-up|6|||
161528478|NCT01226745|583322325|FG002|Overall Study|Lost to Follow-up|6|||
161528479|NCT01226745|583322326|FG003|Overall Study|Lost to Follow-up|1|||
161528480|NCT01226745|583322327|FG004|Overall Study|Lost to Follow-up|1|||
161528481|NCT01226745|583322328|FG005|Overall Study|Lost to Follow-up|2|||
161528482|NCT01226745|583322323|FG000|Overall Study|Death|1|||
161528483|NCT01226745|583322324|FG001|Overall Study|Death|0|||
161528484|NCT01226745|583322325|FG002|Overall Study|Death|0|||
161528485|NCT01226745|583322326|FG003|Overall Study|Death|0|||
161528486|NCT01226745|583322327|FG004|Overall Study|Death|0|||
161528487|NCT01226745|583322328|FG005|Overall Study|Death|1|||
161528488|NCT01226745|583322323|FG000|Overall Study|Other|6|||
161827346|NCT00129116|584408061|FG002|Primary Phase|Adverse Event|0|||
161827347|NCT00129116|584408062|FG003|Primary Phase|Adverse Event|0|||
161827348|NCT00129116|584408063|FG004|Primary Phase|Adverse Event|0|||
161827349|NCT00129116|584408059|FG000|Primary Phase|Withdrawal by Subject|0|||
161827350|NCT00129116|584408060|FG001|Primary Phase|Withdrawal by Subject|1|||
161827351|NCT00129116|584408061|FG002|Primary Phase|Withdrawal by Subject|0|||
161827352|NCT00129116|584408062|FG003|Primary Phase|Withdrawal by Subject|0|||
161827353|NCT00129116|584408063|FG004|Primary Phase|Withdrawal by Subject|0|||
161827354|NCT00129116|584408059|FG000|Primary Phase|Other|0|||
161827355|NCT00129116|584408060|FG001|Primary Phase|Other|0|||
161827356|NCT00129116|584408061|FG002|Primary Phase|Other|1|||
161827357|NCT00129116|584408062|FG003|Primary Phase|Other|0|||
161528489|NCT01226745|583322324|FG001|Overall Study|Other|7|||
161528490|NCT01226745|583322325|FG002|Overall Study|Other|8|||
161528491|NCT01226745|583322326|FG003|Overall Study|Other|4|||
161528492|NCT01226745|583322327|FG004|Overall Study|Other|3|||
161528493|NCT01226745|583322328|FG005|Overall Study|Other|1|||
161528494|NCT00295750|583322333|FG000|Overall Study|Adverse Event|19|||
161528495|NCT00295750|583322334|FG001|Overall Study|Adverse Event|15|||
161528496|NCT00295750|583322335|FG002|Overall Study|Adverse Event|12|||
161528497|NCT00295750|583322333|FG000|Overall Study|Lack of Efficacy|1|||
161528498|NCT00295750|583322334|FG001|Overall Study|Lack of Efficacy|1|||
161528499|NCT00295750|583322335|FG002|Overall Study|Lack of Efficacy|0|||
161528500|NCT00295750|583322333|FG000|Overall Study|Lost to Follow-up|1|||
161528501|NCT00295750|583322334|FG001|Overall Study|Lost to Follow-up|4|||
161528502|NCT00295750|583322335|FG002|Overall Study|Lost to Follow-up|1|||
161528503|NCT00295750|583322333|FG000|Overall Study|Taking prohibited therapy|2|||
161528504|NCT00295750|583322334|FG001|Overall Study|Taking prohibited therapy|3|||
161528505|NCT00295750|583322335|FG002|Overall Study|Taking prohibited therapy|2|||
161528506|NCT00295750|583322333|FG000|Overall Study|Administrative errors|2|||
161528507|NCT00295750|583322334|FG001|Overall Study|Administrative errors|4|||
161528508|NCT00295750|583322335|FG002|Overall Study|Administrative errors|5|||
161528509|NCT00295750|583322333|FG000|Overall Study|Trial drug errors|1|||
161528510|NCT00295750|583322334|FG001|Overall Study|Trial drug errors|1|||
161528511|NCT00295750|583322335|FG002|Overall Study|Trial drug errors|0|||
161528512|NCT00295750|583322333|FG000|Overall Study|Disease progression|2|||
161528513|NCT00295750|583322334|FG001|Overall Study|Disease progression|1|||
161528514|NCT00295750|583322335|FG002|Overall Study|Disease progression|0|||
161528515|NCT00295750|583322333|FG000|Overall Study|Personal reasons|0|||
161528516|NCT00295750|583322334|FG001|Overall Study|Personal reasons|1|||
161528517|NCT00295750|583322335|FG002|Overall Study|Personal reasons|0|||
161528518|NCT00295750|583322333|FG000|Overall Study|Randomized but never received trial drug|4|||
161528519|NCT00295750|583322334|FG001|Overall Study|Randomized but never received trial drug|3|||
161528520|NCT00295750|583322335|FG002|Overall Study|Randomized but never received trial drug|3|||
161528521|NCT00295750|583322333|FG000|Overall Study|Withdrawal by Subject|9|||
161528522|NCT00295750|583322334|FG001|Overall Study|Withdrawal by Subject|4|||
161528523|NCT00295750|583322335|FG002|Overall Study|Withdrawal by Subject|7|||
161528524|NCT00295750|583322333|FG000|Overall Study|Protocol Violation|2|||
161528525|NCT00295750|583322334|FG001|Overall Study|Protocol Violation|4|||
161528526|NCT00295750|583322335|FG002|Overall Study|Protocol Violation|2|||
161528527|NCT01650259|583322336|FG000|Overall Study|Improvement|105|||
161528528|NCT01650259|583322337|FG001|Overall Study|Improvement|0|||
161528529|NCT01650259|583322336|FG000|Overall Study|Adverse Event|127|||
161528530|NCT01650259|583322337|FG001|Overall Study|Adverse Event|0|||
161827358|NCT00129116|584408063|FG004|Primary Phase|Other|0|||
161827359|NCT00129116|584408059|FG000|Booster Phase|Lost to Follow-up|2|||
161827360|NCT00129116|584408060|FG001|Booster Phase|Lost to Follow-up|0|||
161528531|NCT01650259|583322336|FG000|Overall Study|Lack of Efficacy|143|||
161528532|NCT01650259|583322337|FG001|Overall Study|Lack of Efficacy|0|||
161528533|NCT01650259|583322336|FG000|Overall Study|Lost to Follow-up|435|||
161528534|NCT01650259|583322337|FG001|Overall Study|Lost to Follow-up|0|||
161528535|NCT01650259|583322336|FG000|Overall Study|Patients had no visit after entry|70|||
161528536|NCT01650259|583322337|FG001|Overall Study|Patients had no visit after entry|0|||
161528537|NCT01650259|583322336|FG000|Overall Study|CRF not collected|98|||
161528538|NCT01650259|583322337|FG001|Overall Study|CRF not collected|82|||
161528539|NCT01650259|583322336|FG000|Overall Study|Not treated|1|||
161827361|NCT00129116|584408061|FG002|Booster Phase|Lost to Follow-up|0|||
161528540|NCT01650259|583322337|FG001|Overall Study|Not treated|7|||
161528541|NCT01650259|583322336|FG000|Overall Study|Other than listed|64|||
161528542|NCT01650259|583322337|FG001|Overall Study|Other than listed|146|||
161528543|NCT00584727|583322346|FG000|First Intervention|Discontinuation|0|||
161528544|NCT00584727|583322347|FG001|First Intervention|Discontinuation|0|||
161528545|NCT00584727|583322348|FG002|First Intervention|Discontinuation|1|||
161528546|NCT00584727|583322349|FG003|First Intervention|Discontinuation|0|||
161528547|NCT00584727|583322350|FG004|First Intervention|Discontinuation|0|||
161528548|NCT00584727|583322351|FG005|First Intervention|Discontinuation|0|||
161528549|NCT00584727|583322346|FG000|Third Intervention|Protocol Violation|0|||
161528550|NCT00584727|583322347|FG001|Third Intervention|Protocol Violation|0|||
161528551|NCT00584727|583322348|FG002|Third Intervention|Protocol Violation|1|||
161528552|NCT00584727|583322349|FG003|Third Intervention|Protocol Violation|0|||
161528553|NCT00584727|583322350|FG004|Third Intervention|Protocol Violation|4|||
161528554|NCT00584727|583322351|FG005|Third Intervention|Protocol Violation|2|||
161528555|NCT04072159|583322352|FG000|Overall Study|Lost to Follow-up|6|||
161528556|NCT04072159|583322353|FG001|Overall Study|Lost to Follow-up|6|||
161528557|NCT04072159|583322352|FG000|Overall Study|Withdrawal by Subject|2|||
161528558|NCT04072159|583322353|FG001|Overall Study|Withdrawal by Subject|0|||
161528559|NCT00989287|583322357|FG000|Overall Study|Adverse Event|1|||
161528560|NCT00989287|583322358|FG001|Overall Study|Adverse Event|0|||
161528561|NCT00989287|583322357|FG000|Overall Study|Lost to Follow-up|0|||
161528562|NCT00989287|583322358|FG001|Overall Study|Lost to Follow-up|1|||
161528563|NCT00695669|583322359|FG000|Overall Study|Adverse Event|0|||
161528564|NCT00695669|583322360|FG001|Overall Study|Adverse Event|0|||
161528565|NCT00695669|583322361|FG002|Overall Study|Adverse Event|2|||
161528566|NCT00695669|583322362|FG003|Overall Study|Adverse Event|0|||
161528567|NCT00695669|583322359|FG000|Overall Study|Lost to Follow-up|4|||
161528568|NCT00695669|583322360|FG001|Overall Study|Lost to Follow-up|4|||
161528569|NCT00695669|583322361|FG002|Overall Study|Lost to Follow-up|1|||
161528570|NCT00695669|583322362|FG003|Overall Study|Lost to Follow-up|4|||
161528571|NCT00092131|583322363|FG000|Treatment Period I|Adverse Event|1|||
161590988|NCT02783300|583552747|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161590989|NCT02783300|583552748|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
161590990|NCT02783300|583552749|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161590991|NCT02783300|583552750|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161590992|NCT02783300|583552751|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
161590993|NCT02783300|583552752|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161590994|NCT02783300|583552753|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161590995|NCT02783300|583552754|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
161590996|NCT02783300|583552755|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161590997|NCT02783300|583552729|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161590998|NCT02783300|583552730|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161590999|NCT02783300|583552731|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591000|NCT02783300|583552732|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591001|NCT02783300|583552733|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591002|NCT02783300|583552734|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591003|NCT02783300|583552735|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591004|NCT02783300|583552736|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591005|NCT02783300|583552737|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591006|NCT02783300|583552738|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591007|NCT02783300|583552739|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591008|NCT02783300|583552740|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591009|NCT02783300|583552741|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591010|NCT02783300|583552742|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161528572|NCT00092131|583322364|FG001|Treatment Period I|Adverse Event|0|||
161528573|NCT00092131|583322363|FG000|Treatment Period II|Adverse Event|0|||
161528574|NCT00092131|583322364|FG001|Treatment Period II|Adverse Event|1|||
161528575|NCT02341417|583322365|FG000|Overall Study|Withdrawal by Subject|0|||
161528576|NCT02341417|583322366|FG001|Overall Study|Withdrawal by Subject|2|||
161528577|NCT02341417|583322367|FG002|Overall Study|Withdrawal by Subject|0|||
161591011|NCT02783300|583552743|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161827362|NCT00129116|584408062|FG003|Booster Phase|Lost to Follow-up|0|||
161827363|NCT00129116|584408063|FG004|Booster Phase|Lost to Follow-up|1|||
161827364|NCT02539368|584408064|FG000|Overall Study|Death|4|||
161528578|NCT02341417|583322365|FG000|Overall Study|Decision by sponsor|2|||
161528579|NCT02341417|583322366|FG001|Overall Study|Decision by sponsor|0|||
161528580|NCT02341417|583322367|FG002|Overall Study|Decision by sponsor|0|||
161528581|NCT02341417|583322365|FG000|Overall Study|Death|0|||
161528582|NCT02341417|583322366|FG001|Overall Study|Death|0|||
161528583|NCT02341417|583322367|FG002|Overall Study|Death|1|||
161528584|NCT03570619|583322383|FG000|Overall Study|Adverse Event|2|||
161528585|NCT03570619|583322384|FG001|Overall Study|Adverse Event|0|||
161591012|NCT02783300|583552744|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591013|NCT02783300|583552745|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591014|NCT02783300|583552746|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591015|NCT02783300|583552747|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591016|NCT02783300|583552748|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591017|NCT02783300|583552749|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591018|NCT02783300|583552750|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591019|NCT02783300|583552751|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591020|NCT02783300|583552752|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591021|NCT02783300|583552753|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591022|NCT02783300|583552754|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161591023|NCT02783300|583552755|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
161591024|NCT02783300|583552729|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591025|NCT02783300|583552730|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591026|NCT02783300|583552731|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591027|NCT02783300|583552732|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591028|NCT02783300|583552733|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591029|NCT02783300|583552734|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591030|NCT02783300|583552735|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591031|NCT02783300|583552736|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591032|NCT02783300|583552737|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591033|NCT02783300|583552738|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591034|NCT02783300|583552739|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591035|NCT02783300|583552740|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591036|NCT02783300|583552741|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591037|NCT02783300|583552742|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591038|NCT02783300|583552743|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591039|NCT02783300|583552744|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591040|NCT02783300|583552745|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591041|NCT02783300|583552746|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591042|NCT02783300|583552747|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591043|NCT02783300|583552748|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
161936836|NCT03171545|584817737|FG001|Intervention|Received transplant|5|||
161936837|NCT03171545|584817738|FG002|Intervention|Received transplant|3|||
161936838|NCT03171545|584817739|FG003|Intervention|Received transplant|6|||
161591044|NCT02783300|583552749|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591045|NCT02783300|583552750|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591046|NCT02783300|583552751|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591047|NCT02783300|583552752|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591048|NCT02783300|583552753|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591049|NCT02783300|583552754|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
161591050|NCT02783300|583552755|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
161936839|NCT03171545|584817736|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
161528586|NCT03570619|583322385|FG002|Overall Study|Adverse Event|1|||
161528587|NCT03570619|583322383|FG000|Overall Study|new diagnosis of new malignancy|1|||
161528588|NCT03570619|583322384|FG001|Overall Study|new diagnosis of new malignancy|0|||
161528589|NCT03570619|583322385|FG002|Overall Study|new diagnosis of new malignancy|0|||
161528590|NCT03570619|583322383|FG000|Overall Study|Physician Decision|1|||
161528591|NCT03570619|583322384|FG001|Overall Study|Physician Decision|1|||
161528592|NCT03570619|583322385|FG002|Overall Study|Physician Decision|0|||
161528593|NCT03570619|583322383|FG000|Overall Study|Withdrawal by Subject|0|||
161528594|NCT03570619|583322384|FG001|Overall Study|Withdrawal by Subject|2|||
161528595|NCT03570619|583322385|FG002|Overall Study|Withdrawal by Subject|0|||
161528596|NCT04773587|583322386|FG000|Overall Study|Lost to Follow-up|11|||
161528597|NCT04773587|583322387|FG001|Overall Study|Lost to Follow-up|3|||
161528598|NCT04773587|583322386|FG000|Overall Study|Adverse Event|6|||
161528599|NCT04773587|583322387|FG001|Overall Study|Adverse Event|3|||
161528600|NCT04773587|583322386|FG000|Overall Study|Lack of Efficacy|5|||
161528601|NCT04773587|583322387|FG001|Overall Study|Lack of Efficacy|2|||
161528602|NCT04773587|583322386|FG000|Overall Study|Withdrawal by Subject|4|||
161528603|NCT04773587|583322387|FG001|Overall Study|Withdrawal by Subject|5|||
161528604|NCT04773587|583322386|FG000|Overall Study|Noncompliance|1|||
161528605|NCT04773587|583322387|FG001|Overall Study|Noncompliance|0|||
161528606|NCT04773587|583322386|FG000|Overall Study|Protocol Violation|1|||
161528607|NCT04773587|583322387|FG001|Overall Study|Protocol Violation|0|||
161528608|NCT04773587|583322386|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
161528609|NCT04773587|583322387|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
161528610|NCT02372409|583322388|FG000|Overall Study|Lost to Follow-up|1|||
161528611|NCT02372409|583322389|FG001|Overall Study|Lost to Follow-up|0|||
161528612|NCT02372409|583322388|FG000|Overall Study|Disease progression|1|||
161528613|NCT02372409|583322389|FG001|Overall Study|Disease progression|1|||
161528614|NCT01808313|583322390|FG000|Overall Study|Adverse Event|5|||
161528615|NCT01808313|583322390|FG000|Overall Study|Protocol Violation|2|||
161528616|NCT01808313|583322390|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161528617|NCT01808313|583322390|FG000|Overall Study|Lost to Follow-up|1|||
161528618|NCT01808313|583322390|FG000|Overall Study|Physician Decision|1|||
161528619|NCT03086447|583322396|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161528620|NCT03086447|583322397|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161528621|NCT03086447|583322396|FG000|Overall Study|Lost Lens|2|||
161528622|NCT03086447|583322397|FG001|Overall Study|Lost Lens|5|||
161528623|NCT03086447|583322396|FG000|Overall Study|Product quality complaint|0|||
161528624|NCT03086447|583322397|FG001|Overall Study|Product quality complaint|1|||
161528625|NCT03086447|583322396|FG000|Overall Study|Lens Damage|1|||
161528626|NCT03086447|583322397|FG001|Overall Study|Lens Damage|6|||
161528627|NCT03086447|583322396|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
161528628|NCT03086447|583322397|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
161528629|NCT03086447|583322396|FG000|Overall Study|Test Article No Longer Available|1|||
161528630|NCT03086447|583322397|FG001|Overall Study|Test Article No Longer Available|0|||
161528631|NCT03086447|583322396|FG000|Overall Study|Protocol Violation|2|||
161528632|NCT03086447|583322397|FG001|Overall Study|Protocol Violation|4|||
161528633|NCT03086447|583322396|FG000|Overall Study|Lost to Follow-up|0|||
161528634|NCT03086447|583322397|FG001|Overall Study|Lost to Follow-up|1|||
161528635|NCT03086447|583322396|FG000|Overall Study|Adverse Event|3|||
161528636|NCT03086447|583322397|FG001|Overall Study|Adverse Event|0|||
161528637|NCT03086447|583322396|FG000|Overall Study|Lens Discomfort|2|||
161528638|NCT03086447|583322397|FG001|Overall Study|Lens Discomfort|1|||
161528639|NCT00435370|583322402|FG000|Overall Study|Adverse Event|8|||
161528640|NCT00435370|583322403|FG001|Overall Study|Adverse Event|8|||
161528641|NCT00435370|583322402|FG000|Overall Study|Withdrawal by Subject|10|||
161528642|NCT00435370|583322403|FG001|Overall Study|Withdrawal by Subject|10|||
161528643|NCT00435370|583322402|FG000|Overall Study|Antipsychotic medication changed|4|||
161528644|NCT00435370|583322403|FG001|Overall Study|Antipsychotic medication changed|2|||
161528645|NCT00659334|583322409|FG000|Overall Study|Screen Failure|8|||
161528646|NCT00659334|583322410|FG001|Overall Study|Screen Failure|5|||
161528647|NCT00659334|583322411|FG002|Overall Study|Screen Failure|0|||
161528648|NCT00659334|583322412|FG003|Overall Study|Screen Failure|0|||
161528649|NCT00659334|583322413|FG004|Overall Study|Screen Failure|0|||
161528650|NCT00659334|583322414|FG005|Overall Study|Screen Failure|0|||
161528651|NCT00659334|583322415|FG006|Overall Study|Screen Failure|1|||
161528652|NCT03034577|583322416|FG000|Overall Study|Withdrawal by Subject|6|||
161528653|NCT03034577|583322417|FG001|Overall Study|Withdrawal by Subject|9|||
161528654|NCT03034577|583322416|FG000|Overall Study|Lost to Follow-up|25|||
161528655|NCT03034577|583322417|FG001|Overall Study|Lost to Follow-up|26|||
161528656|NCT01174342|583322418|FG000|Overall Study|Conversion to cesarean section|4|||
161936840|NCT03171545|584817737|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
161936841|NCT03171545|584817738|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
161528657|NCT02625623|583322419|FG000|Overall Study|Participants randomized but not treated|9|||
161528658|NCT02625623|583322420|FG001|Overall Study|Participants randomized but not treated|1|||
161528659|NCT00744653|583322424|FG000|Overall Study|antineoplastic treatment|11|||
161528660|NCT00744653|583322424|FG000|Overall Study|Death|1|||
161528661|NCT00744653|583322424|FG000|Overall Study|Lost to Follow-up|1|||
161528662|NCT00744653|583322424|FG000|Overall Study|Physician Decision|3|||
161528663|NCT03826667|583322427|FG000|Overall Study|Protocol deviation|21|||
161528664|NCT00808808|583322428|FG000|Overall Study|Vaccinated; survey not completed|131|||
161528665|NCT00808808|583322429|FG001|Overall Study|Vaccinated; survey not completed|169|||
161528666|NCT00808808|583322430|FG002|Overall Study|Vaccinated; survey not completed|302|||
161528667|NCT00808808|583322428|FG000|Overall Study|Employee was not vaccinated.|2686|||
161528668|NCT00808808|583322429|FG001|Overall Study|Employee was not vaccinated.|2268|||
161528669|NCT00808808|583322430|FG002|Overall Study|Employee was not vaccinated.|2255|||
161528670|NCT02298192|583322431|FG000|Overall Study|Unclassified|3|||
161528671|NCT02298192|583322432|FG001|Overall Study|Unclassified|2|||
161528672|NCT02298192|583322431|FG000|Overall Study|Withdrawal criteria|2|||
161936842|NCT03171545|584817739|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
161528673|NCT02298192|583322432|FG001|Overall Study|Withdrawal criteria|0|||
161528674|NCT02298192|583322431|FG000|Overall Study|Withdrawal by Subject|6|||
161528675|NCT02298192|583322432|FG001|Overall Study|Withdrawal by Subject|1|||
161528676|NCT02298192|583322431|FG000|Overall Study|Lost to Follow-up|2|||
161528677|NCT02298192|583322432|FG001|Overall Study|Lost to Follow-up|1|||
161528678|NCT02298192|583322431|FG000|Overall Study|Adverse Event|6|||
161528679|NCT02298192|583322432|FG001|Overall Study|Adverse Event|2|||
161528680|NCT02352948|583322437|FG000|Overall Study|Death|47|||
161528681|NCT02352948|583322438|FG001|Overall Study|Death|48|||
161528682|NCT02352948|583322439|FG002|Overall Study|Death|114|||
161528683|NCT02352948|583322440|FG003|Overall Study|Death|74|||
161528684|NCT02352948|583322441|FG004|Overall Study|Death|77|||
161528685|NCT02352948|583322442|FG005|Overall Study|Death|44|||
161528686|NCT02352948|583322437|FG000|Overall Study|Lost to Follow-up|1|||
161528687|NCT02352948|583322438|FG001|Overall Study|Lost to Follow-up|0|||
161528688|NCT02352948|583322439|FG002|Overall Study|Lost to Follow-up|2|||
161528689|NCT02352948|583322440|FG003|Overall Study|Lost to Follow-up|1|||
161528690|NCT02352948|583322441|FG004|Overall Study|Lost to Follow-up|2|||
161528691|NCT02352948|583322442|FG005|Overall Study|Lost to Follow-up|1|||
161528692|NCT02352948|583322437|FG000|Overall Study|Withdrawal by Subject|1|||
161528693|NCT02352948|583322438|FG001|Overall Study|Withdrawal by Subject|10|||
161528694|NCT02352948|583322439|FG002|Overall Study|Withdrawal by Subject|11|||
161528695|NCT02352948|583322440|FG003|Overall Study|Withdrawal by Subject|23|||
161528696|NCT02352948|583322441|FG004|Overall Study|Withdrawal by Subject|9|||
161528697|NCT02352948|583322442|FG005|Overall Study|Withdrawal by Subject|4|||
161528698|NCT02352948|583322437|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161528699|NCT02352948|583322438|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161528700|NCT02352948|583322439|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161528701|NCT02352948|583322440|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161528702|NCT02352948|583322441|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161528703|NCT02352948|583322442|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
161528704|NCT02352948|583322437|FG000|Overall Study|Other|0|||
161528705|NCT02352948|583322438|FG001|Overall Study|Other|0|||
161528706|NCT02352948|583322439|FG002|Overall Study|Other|2|||
161528707|NCT02352948|583322440|FG003|Overall Study|Other|0|||
161528708|NCT02352948|583322441|FG004|Overall Study|Other|0|||
161528709|NCT02352948|583322442|FG005|Overall Study|Other|0|||
161528710|NCT01453595|583322448|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161528711|NCT01453595|583322449|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161528712|NCT01453595|583322450|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161528713|NCT03762473|583322455|FG000|Overall Study|Death|1|||
161528714|NCT03762473|583322456|FG001|Overall Study|Death|0|||
161528715|NCT01128413|583322457|FG000|Overall Study|Withdrawal by Subject|1|||
161528716|NCT01128413|583322458|FG001|Overall Study|Withdrawal by Subject|0|||
161528717|NCT01128413|583322457|FG000|Overall Study|NICOM Monitor Problems|2|||
161528718|NCT01128413|583322458|FG001|Overall Study|NICOM Monitor Problems|1|||
161528719|NCT01128413|583322457|FG000|Overall Study|Pt made DNR|1|||
161528720|NCT01128413|583322458|FG001|Overall Study|Pt made DNR|0|||
161528721|NCT00045110|583322459|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
161528722|NCT00045110|583322460|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
161528723|NCT00045110|583322461|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
161528724|NCT00045110|583322459|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
161528725|NCT00045110|583322460|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
161528726|NCT00045110|583322461|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
161528727|NCT00045110|583322459|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
161528728|NCT00045110|583322460|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
161528729|NCT00045110|583322461|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
161528730|NCT03662750|583322463|FG000|Overall Study|Withdrawal by Subject|1|||
161528731|NCT02010060|583322464|FG000|Overall Study|Lost to Follow-up|1|||
161528732|NCT02010060|583322465|FG001|Overall Study|Lost to Follow-up|2|||
161528733|NCT02010060|583322466|FG002|Overall Study|Lost to Follow-up|2|||
161528734|NCT02010060|583322464|FG000|Overall Study|Injury|0|||
161528735|NCT02010060|583322465|FG001|Overall Study|Injury|1|||
161528736|NCT02010060|583322466|FG002|Overall Study|Injury|0|||
161528737|NCT04414696|583322467|FG000|3-month Follow up|Withdrawal by Subject|1|||
161528738|NCT04414696|583322468|FG001|3-month Follow up|Withdrawal by Subject|0|||
161528739|NCT04414696|583322467|FG000|3-month Follow up|Lost to Follow-up|22|||
161528740|NCT04414696|583322468|FG001|3-month Follow up|Lost to Follow-up|23|||
161528741|NCT04414696|583322467|FG000|6-month Follow up|Withdrawal by Subject|1|||
161528742|NCT04414696|583322468|FG001|6-month Follow up|Withdrawal by Subject|2|||
161528743|NCT04414696|583322467|FG000|6-month Follow up|Lost to Follow-up|5|||
161528744|NCT04414696|583322468|FG001|6-month Follow up|Lost to Follow-up|2|||
161528745|NCT00660010|583322471|FG000|Overall Study|Withdrawal by Subject|2|||
161528746|NCT00660010|583322471|FG000|Overall Study|Lost to Follow-up|3|||
161528747|NCT00660010|583322471|FG000|Overall Study|Adverse Event|1|||
161528748|NCT00660010|583322471|FG000|Overall Study|Noncompliance with visit schedule|3|||
161528749|NCT00726752|583322472|FG000|Overall Study|Lack of Efficacy|6|||
161528750|NCT01292603|583324755|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
161528751|NCT01292603|583324756|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
161528752|NCT01292603|583324757|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
161528753|NCT01292603|583324758|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
161528754|NCT01292603|583324759|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
161528755|NCT01292603|583324760|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
161528756|NCT01292603|583324755|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
161528757|NCT01292603|583324756|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
161528758|NCT01292603|583324757|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
161528759|NCT01292603|583324758|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
161528760|NCT01292603|583324759|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
161528761|NCT01292603|583324760|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
161528762|NCT01292603|583324755|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
161528763|NCT01292603|583324756|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
161528764|NCT01292603|583324757|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
161528765|NCT01292603|583324758|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
161528766|NCT01292603|583324759|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
161528767|NCT01292603|583324760|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
161528768|NCT01292603|583324755|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
161528769|NCT01292603|583324756|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
161528770|NCT01292603|583324757|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
161528771|NCT01292603|583324758|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
161528772|NCT01292603|583324759|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
161528773|NCT01292603|583324760|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
161528774|NCT01292603|583324755|FG000|Part 1: Regular Follow-Up Period|Death|3|||
161528775|NCT01292603|583324756|FG001|Part 1: Regular Follow-Up Period|Death|1|||
161528776|NCT01292603|583324757|FG002|Part 1: Regular Follow-Up Period|Death|3|||
161528777|NCT01292603|583324758|FG003|Part 1: Regular Follow-Up Period|Death|1|||
161528778|NCT01292603|583324759|FG004|Part 1: Regular Follow-Up Period|Death|0|||
161528779|NCT01292603|583324760|FG005|Part 1: Regular Follow-Up Period|Death|0|||
161528780|NCT01292603|583324755|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
161528781|NCT01292603|583324756|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
161528782|NCT01292603|583324757|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
161528783|NCT01292603|583324758|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
161528784|NCT01292603|583324759|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
161528785|NCT01292603|583324760|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
161528786|NCT01292603|583324755|FG000|Part 2: Dose Confirmation Period|Death|0|||
161528787|NCT01292603|583324756|FG001|Part 2: Dose Confirmation Period|Death|0|||
161528788|NCT01292603|583324757|FG002|Part 2: Dose Confirmation Period|Death|0|||
161528789|NCT01292603|583324758|FG003|Part 2: Dose Confirmation Period|Death|0|||
161528790|NCT01292603|583324759|FG004|Part 2: Dose Confirmation Period|Death|1|||
161528791|NCT01292603|583324760|FG005|Part 2: Dose Confirmation Period|Death|0|||
161528792|NCT01292603|583324755|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
161528793|NCT01292603|583324756|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
161528794|NCT01292603|583324757|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
161528795|NCT01292603|583324758|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
161528796|NCT01292603|583324759|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
161528797|NCT01292603|583324760|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
161528798|NCT01292603|583324755|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
161528799|NCT01292603|583324756|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
161528800|NCT01292603|583324757|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
161528801|NCT01292603|583324758|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
161528802|NCT01292603|583324759|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
161528803|NCT01292603|583324760|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
161528804|NCT01292603|583324755|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
161528805|NCT01292603|583324756|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
161528806|NCT01292603|583324757|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
161528807|NCT01292603|583324758|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
161528808|NCT01292603|583324759|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
161528809|NCT01292603|583324760|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
161528810|NCT01292603|583324755|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
161528811|NCT01292603|583324756|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
161528812|NCT01292603|583324757|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
161528813|NCT01292603|583324758|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
161528814|NCT01292603|583324759|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
161528815|NCT01292603|583324760|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
161528816|NCT01292603|583324755|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
161528817|NCT01292603|583324756|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
161528818|NCT01292603|583324757|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
161591051|NCT01744782|583552756|FG000|Overall Study|Death|1|||
161591052|NCT00378105|583552757|FG000|Overall Study|Adverse Event|3|||
161591053|NCT00378105|583552758|FG001|Overall Study|Adverse Event|1|||
161528819|NCT01292603|583324758|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
161528820|NCT01292603|583324759|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
161528821|NCT01292603|583324760|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
161528822|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Death|0|||
161528823|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Death|0|||
161528824|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Death|0|||
161528825|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Death|0|||
161591054|NCT00378105|583552757|FG000|Overall Study|Withdrawal by Subject|3|||
161936843|NCT03171545|584817736|FG000|Intervention|Lost to Follow-up|0|||
161936844|NCT03171545|584817737|FG001|Intervention|Lost to Follow-up|1|||
161936845|NCT03171545|584817738|FG002|Intervention|Lost to Follow-up|0|||
161936846|NCT03171545|584817739|FG003|Intervention|Lost to Follow-up|0|||
161528826|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Death|6|||
161528827|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Death|3|||
161528828|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
161528829|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
161528830|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
161528831|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
161528832|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
161528833|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
161528834|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
161528835|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
161528836|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
161528837|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
161528838|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
161528839|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
161528840|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
161528841|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
161528842|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
161528843|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
161528844|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
161528845|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
161528846|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
161528847|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
161528848|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
161528849|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
161528850|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
161528851|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
161528852|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
161528853|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
161528854|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
161528855|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
161528856|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
161528857|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
161528858|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
161528859|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
161528860|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
161528861|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
161528862|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
161528863|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
161528864|NCT01292603|583324755|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
161528865|NCT01292603|583324756|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
161528866|NCT01292603|583324757|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
161528867|NCT01292603|583324758|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
161528868|NCT01292603|583324759|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
161528869|NCT01292603|583324760|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
161528870|NCT01292603|583324755|FG000|Overall Survival Status|Death|3|||
161528871|NCT01292603|583324756|FG001|Overall Survival Status|Death|1|||
161528872|NCT01292603|583324757|FG002|Overall Survival Status|Death|3|||
161528873|NCT01292603|583324758|FG003|Overall Survival Status|Death|1|||
161528874|NCT01292603|583324759|FG004|Overall Survival Status|Death|16|||
161528875|NCT01292603|583324760|FG005|Overall Survival Status|Death|10|||
161528876|NCT02120027|583324761|FG000|Overall Study|Adverse Event|4|||
161528877|NCT02120027|583324762|FG001|Overall Study|Adverse Event|5|||
161528878|NCT02120027|583324761|FG000|Overall Study|Lack of Efficacy|3|||
161528879|NCT02120027|583324762|FG001|Overall Study|Lack of Efficacy|5|||
161528880|NCT02120027|583324761|FG000|Overall Study|Lost to Follow-up|5|||
161528881|NCT02120027|583324762|FG001|Overall Study|Lost to Follow-up|13|||
161528882|NCT02120027|583324761|FG000|Overall Study|Other|4|||
161528883|NCT02120027|583324762|FG001|Overall Study|Other|0|||
161528884|NCT02120027|583324761|FG000|Overall Study|Physician Decision|4|||
161528885|NCT02120027|583324762|FG001|Overall Study|Physician Decision|3|||
161528886|NCT02120027|583324761|FG000|Overall Study|Protocol Violation|18|||
161528887|NCT02120027|583324762|FG001|Overall Study|Protocol Violation|21|||
161528888|NCT02120027|583324761|FG000|Overall Study|Study terminated by Sponsor|45|||
161936847|NCT03171545|584817736|FG000|Follow up|Withdrawal by Subject|1|||
161936848|NCT03171545|584817737|FG001|Follow up|Withdrawal by Subject|1|||
161528889|NCT02120027|583324762|FG001|Overall Study|Study terminated by Sponsor|47|||
161528890|NCT02120027|583324761|FG000|Overall Study|Withdrawal by Subject|33|||
161528891|NCT02120027|583324762|FG001|Overall Study|Withdrawal by Subject|25|||
161528892|NCT03162224|583324763|FG000|Overall Study|Death|4|||
161528893|NCT03162224|583324764|FG001|Overall Study|Death|5|||
161528894|NCT03162224|583324765|FG002|Overall Study|Death|8|||
161936849|NCT03171545|584817738|FG002|Follow up|Withdrawal by Subject|0|||
161528895|NCT03162224|583324763|FG000|Overall Study|Withdrawal by Subject|1|||
161528896|NCT03162224|583324764|FG001|Overall Study|Withdrawal by Subject|0|||
161528897|NCT03162224|583324765|FG002|Overall Study|Withdrawal by Subject|1|||
161528898|NCT03162224|583324763|FG000|Overall Study|Lost to Follow-up|0|||
161528899|NCT03162224|583324764|FG001|Overall Study|Lost to Follow-up|1|||
161528900|NCT03162224|583324765|FG002|Overall Study|Lost to Follow-up|0|||
161528901|NCT03162224|583324763|FG000|Overall Study|Other|6|||
161528902|NCT03162224|583324764|FG001|Overall Study|Other|2|||
161528903|NCT03162224|583324765|FG002|Overall Study|Other|1|||
161528904|NCT04162769|583324766|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
161528905|NCT04162769|583324767|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
161528906|NCT04162769|583324768|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
161528907|NCT04162769|583324769|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
161528908|NCT04162769|583324766|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
161528909|NCT04162769|583324767|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
161528910|NCT04162769|583324768|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
161528911|NCT04162769|583324769|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
161528912|NCT04162769|583324766|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
161528913|NCT04162769|583324767|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
161528914|NCT04162769|583324768|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
161528915|NCT04162769|583324769|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
161528916|NCT04162769|583324766|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
161528917|NCT04162769|583324767|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
161528918|NCT04162769|583324768|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
161528919|NCT04162769|583324769|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
161528920|NCT04162769|583324766|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
161528921|NCT04162769|583324767|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
161528922|NCT04162769|583324768|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
161528923|NCT04162769|583324769|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
161528924|NCT04162769|583324766|FG000|Double-blind Treatment (12-Week)|Other|0|||
161528925|NCT04162769|583324767|FG001|Double-blind Treatment (12-Week)|Other|1|||
161528926|NCT04162769|583324768|FG002|Double-blind Treatment (12-Week)|Other|1|||
161528927|NCT04162769|583324769|FG003|Double-blind Treatment (12-Week)|Other|0|||
161528928|NCT04162769|583324766|FG000|OLE Period (52-Week)|Adverse Event|0|||
161528929|NCT04162769|583324767|FG001|OLE Period (52-Week)|Adverse Event|0|||
161528930|NCT04162769|583324768|FG002|OLE Period (52-Week)|Adverse Event|0|||
161528931|NCT04162769|583324769|FG003|OLE Period (52-Week)|Adverse Event|5|||
161528932|NCT04162769|583324766|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
161528933|NCT04162769|583324767|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
161528934|NCT04162769|583324768|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
161528935|NCT04162769|583324769|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
161528936|NCT04162769|583324766|FG000|OLE Period (52-Week)|Physician Decision|0|||
161528937|NCT04162769|583324767|FG001|OLE Period (52-Week)|Physician Decision|0|||
161528938|NCT04162769|583324768|FG002|OLE Period (52-Week)|Physician Decision|0|||
161528939|NCT04162769|583324769|FG003|OLE Period (52-Week)|Physician Decision|1|||
161528940|NCT04162769|583324766|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
161528941|NCT04162769|583324767|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
161528942|NCT04162769|583324768|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
161528943|NCT04162769|583324769|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
161528944|NCT04162769|583324766|FG000|OLE Period (52-Week)|Protocol deviation|0|||
161528945|NCT04162769|583324767|FG001|OLE Period (52-Week)|Protocol deviation|0|||
161528946|NCT04162769|583324768|FG002|OLE Period (52-Week)|Protocol deviation|0|||
161528947|NCT04162769|583324769|FG003|OLE Period (52-Week)|Protocol deviation|2|||
161528948|NCT00082173|583324770|FG000|Overall Study|Withdrawal by Subject|3|||
161528949|NCT00082173|583324771|FG001|Overall Study|Withdrawal by Subject|5|||
161528950|NCT00082173|583324770|FG000|Overall Study|Lost to Follow-up|1|||
161528951|NCT00082173|583324771|FG001|Overall Study|Lost to Follow-up|0|||
161528952|NCT00082173|583324770|FG000|Overall Study|Adverse Event|1|||
161528953|NCT00082173|583324771|FG001|Overall Study|Adverse Event|0|||
161528954|NCT00082173|583324770|FG000|Overall Study|Culture negative or resistant at baselin|5|||
161528955|NCT00082173|583324771|FG001|Overall Study|Culture negative or resistant at baselin|6|||
161528956|NCT02633137|583324780|FG000|Overall Study|Adverse Event|1|||
161528957|NCT02633137|583324780|FG000|Overall Study|Lack of Efficacy|2|||
161528958|NCT02633137|583324780|FG000|Overall Study|Withdrawal by Subject|1|||
161528959|NCT04307004|583324781|FG000|Randomization 1|Withdrawal by Subject|25|||
161528960|NCT04307004|583324782|FG001|Randomization 1|Withdrawal by Subject|26|||
161528961|NCT04307004|583324783|FG002|Randomization 1|Withdrawal by Subject|0|||
161528962|NCT04307004|583324784|FG003|Randomization 1|Withdrawal by Subject|0|||
161528963|NCT04307004|583324781|FG000|Randomization 2|Withdrawal by Subject|0|||
161528964|NCT04307004|583324782|FG001|Randomization 2|Withdrawal by Subject|0|||
161528965|NCT04307004|583324783|FG002|Randomization 2|Withdrawal by Subject|28|||
161528966|NCT04307004|583324784|FG003|Randomization 2|Withdrawal by Subject|23|||
161528967|NCT01324271|583324785|FG000|Overall Study|Lost to Follow-up|3|||
161528968|NCT01324271|583324786|FG001|Overall Study|Lost to Follow-up|0|||
161528969|NCT01324271|583324785|FG000|Overall Study|Physician Decision|1|||
161528970|NCT01324271|583324786|FG001|Overall Study|Physician Decision|0|||
161528971|NCT02807558|583324787|FG000|Overall Study|Consent withdrawn by participant|4|||
161528972|NCT02807558|583324788|FG001|Overall Study|Consent withdrawn by participant|0|||
161528973|NCT02807558|583324789|FG002|Overall Study|Consent withdrawn by participant|4|||
161528974|NCT02807558|583324790|FG003|Overall Study|Consent withdrawn by participant|2|||
161528975|NCT02807558|583324791|FG004|Overall Study|Consent withdrawn by participant|1|||
161528976|NCT02807558|583324792|FG005|Overall Study|Consent withdrawn by participant|0|||
161528977|NCT02807558|583324787|FG000|Overall Study|Non-compliance with Study Drug|0|||
161528978|NCT02807558|583324788|FG001|Overall Study|Non-compliance with Study Drug|0|||
161528979|NCT02807558|583324789|FG002|Overall Study|Non-compliance with Study Drug|1|||
161528980|NCT02807558|583324790|FG003|Overall Study|Non-compliance with Study Drug|0|||
161528981|NCT02807558|583324791|FG004|Overall Study|Non-compliance with Study Drug|0|||
161528982|NCT02807558|583324792|FG005|Overall Study|Non-compliance with Study Drug|0|||
161528983|NCT02807558|583324787|FG000|Overall Study|Adverse Event|0|||
161528984|NCT02807558|583324788|FG001|Overall Study|Adverse Event|0|||
161528985|NCT02807558|583324789|FG002|Overall Study|Adverse Event|9|||
161528986|NCT02807558|583324790|FG003|Overall Study|Adverse Event|0|||
161528987|NCT02807558|583324791|FG004|Overall Study|Adverse Event|0|||
161528988|NCT02807558|583324792|FG005|Overall Study|Adverse Event|0|||
161528989|NCT02807558|583324787|FG000|Overall Study|Death|23|||
161528990|NCT02807558|583324788|FG001|Overall Study|Death|2|||
161528991|NCT02807558|583324789|FG002|Overall Study|Death|3|||
161528992|NCT02807558|583324790|FG003|Overall Study|Death|43|||
161528993|NCT02807558|583324791|FG004|Overall Study|Death|24|||
161528994|NCT02807558|583324792|FG005|Overall Study|Death|15|||
161528995|NCT02807558|583324787|FG000|Overall Study|Progressive Disease|0|||
161528996|NCT02807558|583324788|FG001|Overall Study|Progressive Disease|0|||
161528997|NCT02807558|583324789|FG002|Overall Study|Progressive Disease|1|||
161528998|NCT02807558|583324790|FG003|Overall Study|Progressive Disease|0|||
161528999|NCT02807558|583324791|FG004|Overall Study|Progressive Disease|0|||
161529000|NCT02807558|583324792|FG005|Overall Study|Progressive Disease|0|||
161529001|NCT02807558|583324787|FG000|Overall Study|Other than specified|1|||
161529002|NCT02807558|583324788|FG001|Overall Study|Other than specified|0|||
161529003|NCT02807558|583324789|FG002|Overall Study|Other than specified|2|||
161529004|NCT02807558|583324790|FG003|Overall Study|Other than specified|0|||
161529005|NCT02807558|583324791|FG004|Overall Study|Other than specified|1|||
161529006|NCT02807558|583324792|FG005|Overall Study|Other than specified|1|||
161529007|NCT02807558|583324787|FG000|Overall Study|Lack of Efficacy|0|||
161529008|NCT02807558|583324788|FG001|Overall Study|Lack of Efficacy|0|||
161529009|NCT02807558|583324789|FG002|Overall Study|Lack of Efficacy|9|||
161529010|NCT02807558|583324790|FG003|Overall Study|Lack of Efficacy|0|||
161529011|NCT02807558|583324791|FG004|Overall Study|Lack of Efficacy|0|||
161529012|NCT02807558|583324792|FG005|Overall Study|Lack of Efficacy|0|||
161529013|NCT06116591|583324793|FG000|Overall Study|No longer met eligibility criteria|0|||
161529014|NCT06116591|583324794|FG001|Overall Study|No longer met eligibility criteria|1|||
161529015|NCT06116591|583324793|FG000|Overall Study|Other: Change in life situation|0|||
161529016|NCT06116591|583324794|FG001|Overall Study|Other: Change in life situation|1|||
161529017|NCT05585307|583324795|FG000|Overall Study|Lost to Follow-up|0|||
161529018|NCT05585307|583324796|FG001|Overall Study|Lost to Follow-up|0|||
161529019|NCT05585307|583324797|FG002|Overall Study|Lost to Follow-up|0|||
161529020|NCT05585307|583324798|FG003|Overall Study|Lost to Follow-up|0|||
161529021|NCT05585307|583324799|FG004|Overall Study|Lost to Follow-up|0|||
161529022|NCT05585307|583324800|FG005|Overall Study|Lost to Follow-up|0|||
161529023|NCT05585307|583324801|FG006|Overall Study|Lost to Follow-up|1|||
161529024|NCT05585307|583324802|FG007|Overall Study|Lost to Follow-up|0|||
161529025|NCT01972841|583324803|FG000|Overall Study|Randomized but Never Received Treatment|2|||
161529026|NCT01972841|583324804|FG001|Overall Study|Randomized but Never Received Treatment|5|||
161529027|NCT01972841|583324805|FG002|Overall Study|Randomized but Never Received Treatment|4|||
161529028|NCT01972841|583324806|FG003|Overall Study|Randomized but Never Received Treatment|2|||
161529029|NCT01972841|583324807|FG004|Overall Study|Randomized but Never Received Treatment|6|||
161529030|NCT01972841|583324808|FG005|Overall Study|Randomized but Never Received Treatment|13|||
161529031|NCT01972841|583324803|FG000|Overall Study|Adverse Event|13|||
161529032|NCT01972841|583324804|FG001|Overall Study|Adverse Event|8|||
161529033|NCT01972841|583324805|FG002|Overall Study|Adverse Event|12|||
161529034|NCT01972841|583324806|FG003|Overall Study|Adverse Event|9|||
161529035|NCT01972841|583324807|FG004|Overall Study|Adverse Event|21|||
161529036|NCT01972841|583324808|FG005|Overall Study|Adverse Event|26|||
161529037|NCT01972841|583324803|FG000|Overall Study|Lack of Efficacy|1|||
161591055|NCT00378105|583552758|FG001|Overall Study|Withdrawal by Subject|3|||
161591056|NCT00378105|583552757|FG000|Overall Study|Death|1|||
161591057|NCT00378105|583552758|FG001|Overall Study|Death|0|||
161591058|NCT00378105|583552757|FG000|Overall Study|Going to transplant|7|||
161591059|NCT00378105|583552758|FG001|Overall Study|Going to transplant|8|||
161591060|NCT00378105|583552757|FG000|Overall Study|Progressive disease|3|||
161591061|NCT00378105|583552758|FG001|Overall Study|Progressive disease|3|||
161591062|NCT00378105|583552757|FG000|Overall Study|remain on study|3|||
161591063|NCT00378105|583552758|FG001|Overall Study|remain on study|11|||
161827365|NCT02539368|584408065|FG001|Overall Study|Death|2|||
161827366|NCT02539368|584408066|FG002|Overall Study|Death|1|||
161827367|NCT02539368|584408067|FG003|Overall Study|Death|0|||
161827368|NCT02539368|584408068|FG004|Overall Study|Death|0|||
161936850|NCT03171545|584817739|FG003|Follow up|Withdrawal by Subject|0|||
161936851|NCT03171545|584817736|FG000|Follow up|Transferred out of clinic|4|||
161936852|NCT03171545|584817737|FG001|Follow up|Transferred out of clinic|4|||
161936853|NCT03171545|584817738|FG002|Follow up|Transferred out of clinic|12|||
161936854|NCT03171545|584817739|FG003|Follow up|Transferred out of clinic|7|||
161936855|NCT03171545|584817736|FG000|Follow up|Death|18|||
161936856|NCT03171545|584817737|FG001|Follow up|Death|12|||
161936857|NCT03171545|584817738|FG002|Follow up|Death|5|||
161936858|NCT03171545|584817739|FG003|Follow up|Death|8|||
161936859|NCT03171545|584817736|FG000|Follow up|Received transplant|4|||
161936860|NCT03171545|584817737|FG001|Follow up|Received transplant|1|||
161936861|NCT03171545|584817738|FG002|Follow up|Received transplant|0|||
161936862|NCT03171545|584817739|FG003|Follow up|Received transplant|1|||
161936863|NCT03171545|584817736|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
161936864|NCT03171545|584817737|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
161936865|NCT03171545|584817738|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
161529038|NCT01972841|583324804|FG001|Overall Study|Lack of Efficacy|0|||
161529039|NCT01972841|583324805|FG002|Overall Study|Lack of Efficacy|0|||
161529040|NCT01972841|583324806|FG003|Overall Study|Lack of Efficacy|2|||
161529041|NCT01972841|583324807|FG004|Overall Study|Lack of Efficacy|4|||
161529042|NCT01972841|583324808|FG005|Overall Study|Lack of Efficacy|1|||
161529043|NCT01972841|583324803|FG000|Overall Study|Lost to Follow-up|4|||
161529044|NCT01972841|583324804|FG001|Overall Study|Lost to Follow-up|2|||
161529045|NCT01972841|583324805|FG002|Overall Study|Lost to Follow-up|4|||
161529046|NCT01972841|583324806|FG003|Overall Study|Lost to Follow-up|2|||
161529047|NCT01972841|583324807|FG004|Overall Study|Lost to Follow-up|9|||
161529048|NCT01972841|583324808|FG005|Overall Study|Lost to Follow-up|3|||
161529049|NCT01972841|583324803|FG000|Overall Study|Protocol Violation|2|||
161529050|NCT01972841|583324804|FG001|Overall Study|Protocol Violation|2|||
161529051|NCT01972841|583324805|FG002|Overall Study|Protocol Violation|3|||
161529052|NCT01972841|583324806|FG003|Overall Study|Protocol Violation|5|||
161529053|NCT01972841|583324807|FG004|Overall Study|Protocol Violation|9|||
161529054|NCT01972841|583324808|FG005|Overall Study|Protocol Violation|4|||
161529055|NCT01972841|583324803|FG000|Overall Study|Withdrawal by participants|21|||
161529056|NCT01972841|583324804|FG001|Overall Study|Withdrawal by participants|27|||
161529057|NCT01972841|583324805|FG002|Overall Study|Withdrawal by participants|23|||
161529058|NCT01972841|583324806|FG003|Overall Study|Withdrawal by participants|16|||
161529059|NCT01972841|583324807|FG004|Overall Study|Withdrawal by participants|33|||
161529060|NCT01972841|583324808|FG005|Overall Study|Withdrawal by participants|34|||
161529061|NCT01972841|583324803|FG000|Overall Study|Miscellaneous|0|||
161529062|NCT01972841|583324804|FG001|Overall Study|Miscellaneous|0|||
161529063|NCT01972841|583324805|FG002|Overall Study|Miscellaneous|4|||
161529064|NCT01972841|583324806|FG003|Overall Study|Miscellaneous|1|||
161591064|NCT00378105|583552757|FG000|Overall Study|Physician Decision|0|||
161591065|NCT00378105|583552758|FG001|Overall Study|Physician Decision|2|||
161591066|NCT00378105|583552757|FG000|Overall Study|Going non-protocol therapy|0|||
161591067|NCT00378105|583552758|FG001|Overall Study|Going non-protocol therapy|1|||
161827369|NCT02539368|584408064|FG000|Overall Study|Withdrawal by Subject|44|||
161827370|NCT02539368|584408065|FG001|Overall Study|Withdrawal by Subject|35|||
161529065|NCT01972841|583324807|FG004|Overall Study|Miscellaneous|0|||
161529066|NCT01972841|583324808|FG005|Overall Study|Miscellaneous|4|||
161529067|NCT01972841|583324803|FG000|Overall Study|Did not have end of treatment page|0|||
161591068|NCT00378105|583552757|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
161529068|NCT01972841|583324804|FG001|Overall Study|Did not have end of treatment page|0|||
161529069|NCT01972841|583324805|FG002|Overall Study|Did not have end of treatment page|0|||
161529070|NCT01972841|583324806|FG003|Overall Study|Did not have end of treatment page|0|||
161529071|NCT01972841|583324807|FG004|Overall Study|Did not have end of treatment page|1|||
161591069|NCT00378105|583552758|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
161827371|NCT02539368|584408066|FG002|Overall Study|Withdrawal by Subject|9|||
161827372|NCT02539368|584408067|FG003|Overall Study|Withdrawal by Subject|1|||
161936866|NCT03171545|584817739|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
161936867|NCT03171545|584817736|FG000|Follow up|Lost to Follow-up|1|||
161936868|NCT03171545|584817737|FG001|Follow up|Lost to Follow-up|2|||
161936869|NCT03171545|584817738|FG002|Follow up|Lost to Follow-up|3|||
161529072|NCT01972841|583324808|FG005|Overall Study|Did not have end of treatment page|0|||
161529073|NCT02085408|583324811|FG000|Step 1: Induction|Disease Progression|19|||
161529074|NCT02085408|583324812|FG001|Step 1: Induction|Disease Progression|19|||
161529075|NCT02085408|583324811|FG000|Step 1: Induction|Adverse Event|18|||
161529076|NCT02085408|583324812|FG001|Step 1: Induction|Adverse Event|17|||
161529077|NCT02085408|583324811|FG000|Step 1: Induction|Death|33|||
161529078|NCT02085408|583324812|FG001|Step 1: Induction|Death|30|||
161529079|NCT02085408|583324811|FG000|Step 1: Induction|Withdrawal by Subject|16|||
161591070|NCT03623321|583552759|FG000|Overall Study|Adverse Event|32|||
161591071|NCT03623321|583552759|FG000|Overall Study|Death|9|||
161591072|NCT03623321|583552759|FG000|Overall Study|Lack of Efficacy|9|||
161591073|NCT03623321|583552759|FG000|Overall Study|Lost to Follow-up|6|||
161591074|NCT03623321|583552759|FG000|Overall Study|Noncompliance with study drug|6|||
161591075|NCT03623321|583552759|FG000|Overall Study|Use of prohibited medication|3|||
161529080|NCT02085408|583324812|FG001|Step 1: Induction|Withdrawal by Subject|8|||
161529081|NCT02085408|583324811|FG000|Step 1: Induction|Alternative Therapy|15|||
161529082|NCT02085408|583324812|FG001|Step 1: Induction|Alternative Therapy|19|||
161529083|NCT02085408|583324811|FG000|Step 1: Induction|Complicating Disease|2|||
161529084|NCT02085408|583324812|FG001|Step 1: Induction|Complicating Disease|3|||
161529085|NCT02085408|583324811|FG000|Step 1: Induction|Other|27|||
161529086|NCT02085408|583324812|FG001|Step 1: Induction|Other|39|||
161591076|NCT03623321|583552759|FG000|Overall Study|Physician Decision|5|||
161591077|NCT03623321|583552759|FG000|Overall Study|Protocol Violation|1|||
161591078|NCT03623321|583552759|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
161591079|NCT03623321|583552759|FG000|Overall Study|Not further specified|43|||
161591080|NCT04241068|583552760|FG000|Core Treatment Period|Adverse Event|91|||
161591081|NCT04241068|583552760|FG000|Core Treatment Period|Change of Treatment|4|||
161591082|NCT04241068|583552760|FG000|Core Treatment Period|Consent Withdrawn|143|||
161591083|NCT04241068|583552760|FG000|Core Treatment Period|Death|26|||
161591084|NCT04241068|583552760|FG000|Core Treatment Period|Disease Progression|67|||
161591085|NCT04241068|583552760|FG000|Core Treatment Period|Investigator Decision|40|||
161591086|NCT04241068|583552760|FG000|Core Treatment Period|Loss of Capacity|9|||
161678405|NCT00732251|583873725|FG000|Overall Study|Lost to Follow-up|3|||
161678406|NCT00732251|583873725|FG000|Overall Study|Withdrawal by Subject|3|||
161678407|NCT00732251|583873725|FG000|Overall Study|Early Term due to Site Closure|1|||
161678408|NCT02737852|583875949|FG000|Overall Study|Withdrawal by Subject|2|||
161678409|NCT03688880|583875950|FG000|Overall Study|Withdrawal by Subject|0|||
161678410|NCT03688880|583875951|FG001|Overall Study|Withdrawal by Subject|2|||
161678411|NCT03688880|583875950|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
161678412|NCT03688880|583875951|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
161678413|NCT03688880|583875950|FG000|Overall Study|Lost to Follow-up|4|||
161678414|NCT03688880|583875951|FG001|Overall Study|Lost to Follow-up|7|||
161678415|NCT03688880|583875950|FG000|Overall Study|Adverse Event|0|||
161678416|NCT03688880|583875951|FG001|Overall Study|Adverse Event|2|||
161678417|NCT03688880|583875950|FG000|Overall Study|Device deficiencies|0|||
161678418|NCT03688880|583875951|FG001|Overall Study|Device deficiencies|2|||
161678419|NCT03688880|583875950|FG000|Overall Study|Other|10|||
161678420|NCT03688880|583875951|FG001|Overall Study|Other|16|||
161678421|NCT02807480|583875955|FG000|Overall Study|Withdrawal by Subject|14|||
161678422|NCT02807480|583875956|FG001|Overall Study|Withdrawal by Subject|10|||
161678423|NCT02163187|583875959|FG000|Overall Study|Device removed|1|||
161678424|NCT02163187|583875960|FG001|Overall Study|Device removed|0|||
161678425|NCT02163187|583875959|FG000|Overall Study|Progressive disease|1|||
161678426|NCT02163187|583875960|FG001|Overall Study|Progressive disease|0|||
161678427|NCT02369848|583875961|FG000|Overall Study|Death|1|||
161678428|NCT02369848|583875961|FG000|Overall Study|Withdrawal by Subject|2|||
161529087|NCT02085408|583324811|FG000|Step 1: Induction|Never started treatment|6|||
161529088|NCT02085408|583324812|FG001|Step 1: Induction|Never started treatment|4|||
161529089|NCT02085408|583324811|FG000|Step 2: Consolidation|Disease Progression|5|||
161591087|NCT04241068|583552760|FG000|Core Treatment Period|Lost to Follow-up|11|||
161591088|NCT04241068|583552760|FG000|Core Treatment Period|Relocation|4|||
161591089|NCT04241068|583552760|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
161591090|NCT04241068|583552760|FG000|Core Treatment Period|Study Visit Burden|40|||
161591091|NCT04241068|583552760|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
161678429|NCT02369848|583875961|FG000|Overall Study|Lost to Follow-up|1|||
161678430|NCT03281668|583875964|FG000|Overall Study|Physician Decision|1|||
161678431|NCT03281668|583875964|FG000|Overall Study|scheduling conflict, family circumstance|2|||
161529090|NCT02085408|583324812|FG001|Step 2: Consolidation|Disease Progression|20|||
161529091|NCT02085408|583324811|FG000|Step 2: Consolidation|Adverse Event|9|||
161529092|NCT02085408|583324812|FG001|Step 2: Consolidation|Adverse Event|8|||
161529093|NCT02085408|583324811|FG000|Step 2: Consolidation|Death|4|||
161591092|NCT04241068|583552760|FG000|Core Treatment Period|Missing|2|||
161591093|NCT04241068|583552760|FG000|Core Treatment Period|Reason Not Specified|41|||
161591094|NCT04241068|583552760|FG000|LTE Period|Adverse Event|19|||
161591095|NCT04241068|583552760|FG000|LTE Period|Change of Treatment|1|||
161591096|NCT04241068|583552760|FG000|LTE Period|Consent Withdrawn|71|||
161591097|NCT04241068|583552760|FG000|LTE Period|Death|8|||
161529094|NCT02085408|583324812|FG001|Step 2: Consolidation|Death|3|||
161529095|NCT02085408|583324811|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
161529096|NCT02085408|583324812|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
161529097|NCT02085408|583324811|FG000|Step 2: Consolidation|Alternative Therapy|9|||
161529098|NCT02085408|583324812|FG001|Step 2: Consolidation|Alternative Therapy|3|||
161529099|NCT02085408|583324811|FG000|Step 2: Consolidation|Complicating Disease|0|||
161529100|NCT02085408|583324812|FG001|Step 2: Consolidation|Complicating Disease|2|||
161529101|NCT02085408|583324811|FG000|Step 2: Consolidation|Other|6|||
161529102|NCT02085408|583324812|FG001|Step 2: Consolidation|Other|6|||
161529103|NCT02085408|583324811|FG000|Step 2: Consolidation|Never started treatment|4|||
161529104|NCT02085408|583324812|FG001|Step 2: Consolidation|Never started treatment|3|||
161529105|NCT02085408|583324811|FG000|Step 3: Maintenance|Disease Progression|13|||
161529106|NCT02085408|583324812|FG001|Step 3: Maintenance|Disease Progression|11|||
161529107|NCT02085408|583324811|FG000|Step 3: Maintenance|Adverse Event|2|||
161529108|NCT02085408|583324812|FG001|Step 3: Maintenance|Adverse Event|4|||
161529109|NCT02085408|583324811|FG000|Step 3: Maintenance|Death|1|||
161529110|NCT02085408|583324812|FG001|Step 3: Maintenance|Death|2|||
161529111|NCT02085408|583324811|FG000|Step 3: Maintenance|Alternative Therapy|1|||
161529112|NCT02085408|583324812|FG001|Step 3: Maintenance|Alternative Therapy|1|||
161529113|NCT02085408|583324811|FG000|Step 3: Maintenance|Complicating Disease|0|||
161529114|NCT02085408|583324812|FG001|Step 3: Maintenance|Complicating Disease|1|||
161529115|NCT02085408|583324811|FG000|Step 3: Maintenance|Other|3|||
161529116|NCT02085408|583324812|FG001|Step 3: Maintenance|Other|2|||
161529117|NCT02085408|583324811|FG000|Step 3: Maintenance|Never started treatment|5|||
161529118|NCT02085408|583324812|FG001|Step 3: Maintenance|Never started treatment|1|||
161529119|NCT02734212|583324813|FG000|Overall Study|Lost to Follow-up|5|||
161529120|NCT02734212|583324814|FG001|Overall Study|Lost to Follow-up|10|||
161529121|NCT00688636|583324817|FG000|Overall Study|Adverse Event|2|||
161529122|NCT00688636|583324818|FG001|Overall Study|Adverse Event|1|||
161529123|NCT01572727|583324819|FG000|Overall Study|Adverse Event|43|||
161529124|NCT01572727|583324820|FG001|Overall Study|Adverse Event|15|||
161529125|NCT01572727|583324819|FG000|Overall Study|Lost to Follow-up|1|||
161529126|NCT01572727|583324820|FG001|Overall Study|Lost to Follow-up|1|||
161529127|NCT01572727|583324819|FG000|Overall Study|Physician Decision|23|||
161529128|NCT01572727|583324820|FG001|Overall Study|Physician Decision|9|||
161529129|NCT01572727|583324819|FG000|Overall Study|Progressive disease|59|||
161529130|NCT01572727|583324820|FG001|Overall Study|Progressive disease|82|||
161529131|NCT01572727|583324819|FG000|Overall Study|Protocol Violation|0|||
161529132|NCT01572727|583324820|FG001|Overall Study|Protocol Violation|1|||
161529133|NCT01572727|583324819|FG000|Overall Study|Study terminated by sponsor|61|||
161529134|NCT01572727|583324820|FG001|Overall Study|Study terminated by sponsor|83|||
161529135|NCT01572727|583324819|FG000|Overall Study|Parent/guardian decision|14|||
161529136|NCT01572727|583324820|FG001|Overall Study|Parent/guardian decision|9|||
161529137|NCT01572727|583324819|FG000|Overall Study|Death|2|||
161529138|NCT01572727|583324820|FG001|Overall Study|Death|2|||
161529139|NCT01572727|583324819|FG000|Overall Study|Untreated|4|||
161529140|NCT01572727|583324820|FG001|Overall Study|Untreated|7|||
161529141|NCT04053764|583324821|FG000|Overall Study|Withdrawal by Subject|6|||
161529142|NCT04053764|583324822|FG001|Overall Study|Withdrawal by Subject|2|||
161529143|NCT04053764|583324821|FG000|Overall Study|Physician Decision|2|||
161529144|NCT04053764|583324822|FG001|Overall Study|Physician Decision|1|||
161529145|NCT04053764|583324821|FG000|Overall Study|Adverse Event|1|||
161529146|NCT04053764|583324822|FG001|Overall Study|Adverse Event|0|||
161529147|NCT04053764|583324821|FG000|Overall Study|Pregnancy|1|||
161529148|NCT04053764|583324822|FG001|Overall Study|Pregnancy|0|||
161529149|NCT02384954|583324826|FG000|Phase 1|Progressive Disease|2|||
161529150|NCT02384954|583324827|FG001|Phase 1|Progressive Disease|0|||
161529151|NCT02384954|583324828|FG002|Phase 1|Progressive Disease|1|||
161827373|NCT02539368|584408068|FG004|Overall Study|Withdrawal by Subject|3|||
161529152|NCT02384954|583324829|FG003|Phase 1|Progressive Disease|1|||
161529153|NCT02384954|583324830|FG004|Phase 1|Progressive Disease|0|||
161529154|NCT02384954|583324831|FG005|Phase 1|Progressive Disease|0|||
161529155|NCT02384954|583324832|FG006|Phase 1|Progressive Disease|0|||
161529156|NCT02384954|583324833|FG007|Phase 1|Progressive Disease|0|||
161827374|NCT02539368|584408064|FG000|Overall Study|Physician Decision|49|||
161827375|NCT02539368|584408065|FG001|Overall Study|Physician Decision|15|||
161827376|NCT02539368|584408066|FG002|Overall Study|Physician Decision|7|||
161827377|NCT02539368|584408067|FG003|Overall Study|Physician Decision|0|||
161827378|NCT02539368|584408068|FG004|Overall Study|Physician Decision|2|||
161827379|NCT02539368|584408064|FG000|Overall Study|Lost to Follow-up|96|||
161827380|NCT02539368|584408065|FG001|Overall Study|Lost to Follow-up|21|||
161827381|NCT02539368|584408066|FG002|Overall Study|Lost to Follow-up|16|||
161827382|NCT02539368|584408067|FG003|Overall Study|Lost to Follow-up|4|||
161827383|NCT02539368|584408068|FG004|Overall Study|Lost to Follow-up|3|||
161827384|NCT02539368|584408064|FG000|Overall Study|Adverse Event|44|||
161529157|NCT02384954|583324834|FG008|Phase 1|Progressive Disease|0|||
161529158|NCT02384954|583324826|FG000|Phase 1|Adverse Event|0|||
161529159|NCT02384954|583324827|FG001|Phase 1|Adverse Event|0|||
161529160|NCT02384954|583324828|FG002|Phase 1|Adverse Event|1|||
161529161|NCT02384954|583324829|FG003|Phase 1|Adverse Event|0|||
161529162|NCT02384954|583324830|FG004|Phase 1|Adverse Event|0|||
161529163|NCT02384954|583324831|FG005|Phase 1|Adverse Event|0|||
161529164|NCT02384954|583324832|FG006|Phase 1|Adverse Event|0|||
161529165|NCT02384954|583324833|FG007|Phase 1|Adverse Event|0|||
161529166|NCT02384954|583324834|FG008|Phase 1|Adverse Event|0|||
161529167|NCT02384954|583324826|FG000|Phase 2|Progressive Disease|0|||
161529168|NCT02384954|583324827|FG001|Phase 2|Progressive Disease|0|||
161529169|NCT02384954|583324828|FG002|Phase 2|Progressive Disease|0|||
161529170|NCT02384954|583324829|FG003|Phase 2|Progressive Disease|0|||
161529171|NCT02384954|583324830|FG004|Phase 2|Progressive Disease|0|||
161529172|NCT02384954|583324831|FG005|Phase 2|Progressive Disease|0|||
161529173|NCT02384954|583324832|FG006|Phase 2|Progressive Disease|0|||
161529174|NCT02384954|583324833|FG007|Phase 2|Progressive Disease|1|||
161529175|NCT02384954|583324834|FG008|Phase 2|Progressive Disease|2|||
161529176|NCT02384954|583324826|FG000|Phase 2|Adverse Event|0|||
161529177|NCT02384954|583324827|FG001|Phase 2|Adverse Event|0|||
161529178|NCT02384954|583324828|FG002|Phase 2|Adverse Event|0|||
161529179|NCT02384954|583324829|FG003|Phase 2|Adverse Event|0|||
161529180|NCT02384954|583324830|FG004|Phase 2|Adverse Event|0|||
161529181|NCT02384954|583324831|FG005|Phase 2|Adverse Event|0|||
161529182|NCT02384954|583324832|FG006|Phase 2|Adverse Event|0|||
161529183|NCT02384954|583324833|FG007|Phase 2|Adverse Event|1|||
161529184|NCT02384954|583324834|FG008|Phase 2|Adverse Event|1|||
161529185|NCT02384954|583324826|FG000|Phase 2|Failure to meet continuation criteria|0|||
161529186|NCT02384954|583324827|FG001|Phase 2|Failure to meet continuation criteria|0|||
161529187|NCT02384954|583324828|FG002|Phase 2|Failure to meet continuation criteria|0|||
161529188|NCT02384954|583324829|FG003|Phase 2|Failure to meet continuation criteria|0|||
161529189|NCT02384954|583324830|FG004|Phase 2|Failure to meet continuation criteria|0|||
161529190|NCT02384954|583324831|FG005|Phase 2|Failure to meet continuation criteria|0|||
161529191|NCT02384954|583324832|FG006|Phase 2|Failure to meet continuation criteria|0|||
161529192|NCT02384954|583324833|FG007|Phase 2|Failure to meet continuation criteria|1|||
161529193|NCT02384954|583324834|FG008|Phase 2|Failure to meet continuation criteria|0|||
161529194|NCT04732286|583324835|FG000|Overall Study|Progressive Disease|2|||
161529195|NCT04732286|583324835|FG000|Overall Study|Physician Decision|1|||
161529196|NCT04732286|583324835|FG000|Overall Study|Study Terminated by Sponsor|31|||
161529197|NCT04732286|583324835|FG000|Overall Study|Withdrawal by Subject|10|||
161529198|NCT04732286|583324835|FG000|Overall Study|Non-compliance With Study Drug|1|||
161529199|NCT04732286|583324835|FG000|Overall Study|Lost to Follow-up|4|||
161529200|NCT04732286|583324835|FG000|Overall Study|Death|51|||
161529201|NCT01474681|583324839|FG000|Overall Study|Death|0|||
161529202|NCT01474681|583324840|FG001|Overall Study|Death|3|||
161529203|NCT01474681|583324841|FG002|Overall Study|Death|2|||
161529204|NCT01474681|583324842|FG003|Overall Study|Death|6|||
161529205|NCT02372396|583324848|FG000|Overall Study|Lost to Follow-up|7|||
161529206|NCT02372396|583324849|FG001|Overall Study|Lost to Follow-up|9|||
161529207|NCT01483924|583324852|FG000|Overall Study|Withdrawal by Subject|2|||
161529208|NCT01483924|583324853|FG001|Overall Study|Withdrawal by Subject|0|||
161529209|NCT01483924|583324854|FG002|Overall Study|Withdrawal by Subject|0|||
161529210|NCT01483924|583324855|FG003|Overall Study|Withdrawal by Subject|1|||
161529211|NCT01483924|583324856|FG004|Overall Study|Withdrawal by Subject|1|||
161529212|NCT01483924|583324852|FG000|Overall Study|Adverse Event|0|||
161529213|NCT01483924|583324853|FG001|Overall Study|Adverse Event|0|||
161529214|NCT01483924|583324854|FG002|Overall Study|Adverse Event|1|||
161529215|NCT01483924|583324855|FG003|Overall Study|Adverse Event|1|||
161529216|NCT01483924|583324856|FG004|Overall Study|Adverse Event|0|||
161529217|NCT01483924|583324852|FG000|Overall Study|Non-compliance|0|||
161529218|NCT01483924|583324853|FG001|Overall Study|Non-compliance|0|||
161529219|NCT01483924|583324854|FG002|Overall Study|Non-compliance|0|||
161529220|NCT01483924|583324855|FG003|Overall Study|Non-compliance|1|||
161529221|NCT01483924|583324856|FG004|Overall Study|Non-compliance|1|||
161529222|NCT01483924|583324852|FG000|Overall Study|Sponsor concern over ECG result|0|||
161529223|NCT01483924|583324853|FG001|Overall Study|Sponsor concern over ECG result|0|||
161529224|NCT01483924|583324854|FG002|Overall Study|Sponsor concern over ECG result|0|||
161529225|NCT01483924|583324855|FG003|Overall Study|Sponsor concern over ECG result|1|||
161529226|NCT01483924|583324856|FG004|Overall Study|Sponsor concern over ECG result|0|||
161529227|NCT00003298|583324857|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
161529228|NCT00003298|583324857|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
161529229|NCT00003298|583324857|FG000|Surgery|Unresectable at surgery|3|||
161529230|NCT00003298|583324857|FG000|Surgery|Progression before surgery|2|||
161529231|NCT00003298|583324857|FG000|Surgery|Unevaluable and off study|2|||
161529232|NCT00003298|583324857|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
161529233|NCT00003298|583324857|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
161529234|NCT00003298|583324857|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
161529235|NCT00003298|583324857|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
161529236|NCT00003298|583324857|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
161529237|NCT00003298|583324857|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
161529238|NCT00003298|583324857|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
161936870|NCT03171545|584817739|FG003|Follow up|Lost to Follow-up|1|||
161936871|NCT05213624|584817740|FG000|Overall Study|Adverse Event|0|||
161936872|NCT05213624|584817741|FG001|Overall Study|Adverse Event|3|||
161936873|NCT05213624|584817742|FG002|Overall Study|Adverse Event|0|||
161936874|NCT05213624|584817743|FG003|Overall Study|Adverse Event|0|||
161936875|NCT05213624|584817740|FG000|Overall Study|Protocol deviation|0|||
161936876|NCT05213624|584817741|FG001|Overall Study|Protocol deviation|2|||
161936877|NCT05213624|584817742|FG002|Overall Study|Protocol deviation|0|||
161936878|NCT05213624|584817743|FG003|Overall Study|Protocol deviation|0|||
161936879|NCT05213624|584817740|FG000|Overall Study|Withdrawal by Subject|0|||
161936880|NCT05213624|584817741|FG001|Overall Study|Withdrawal by Subject|0|||
161936881|NCT05213624|584817742|FG002|Overall Study|Withdrawal by Subject|0|||
161936882|NCT05213624|584817743|FG003|Overall Study|Withdrawal by Subject|1|||
161936883|NCT05213624|584817740|FG000|Overall Study|Not treated|0|||
161936884|NCT05213624|584817741|FG001|Overall Study|Not treated|1|||
161936885|NCT05213624|584817742|FG002|Overall Study|Not treated|2|||
161936886|NCT05213624|584817743|FG003|Overall Study|Not treated|2|||
161936887|NCT04770779|584817744|FG000|Overall Study|Randomized, never treated|0|||
161936888|NCT04770779|584817745|FG001|Overall Study|Randomized, never treated|1|||
161936889|NCT04770779|584817744|FG000|Overall Study|Adverse Event|9|||
161936890|NCT04770779|584817745|FG001|Overall Study|Adverse Event|1|||
161936891|NCT04770779|584817744|FG000|Overall Study|Withdrawal by Subject|7|||
161936892|NCT04770779|584817745|FG001|Overall Study|Withdrawal by Subject|1|||
161936893|NCT04770779|584817744|FG000|Overall Study|Pregnancy|0|||
161936894|NCT04770779|584817745|FG001|Overall Study|Pregnancy|1|||
161936895|NCT03692052|584817746|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
161936896|NCT03692052|584817746|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
161936897|NCT03692052|584817746|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
161936898|NCT03692052|584817746|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
161936899|NCT02656706|584819089|FG000|Overall Study|Insurance Denial|1|||
161529239|NCT00003298|583324857|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
161529240|NCT00003298|583324857|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
161529241|NCT00003298|583324857|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
161529242|NCT00335322|583324861|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
161529243|NCT00335322|583324862|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
161529244|NCT00335322|583324863|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
161529245|NCT02195986|583324864|FG000|Overall Study|Adverse Event|3|||
161529246|NCT02195986|583324865|FG001|Overall Study|Adverse Event|0|||
161529247|NCT02195986|583324866|FG002|Overall Study|Adverse Event|0|||
161529248|NCT02195986|583324864|FG000|Overall Study|Withdrawal by Subject|0|||
161529249|NCT02195986|583324865|FG001|Overall Study|Withdrawal by Subject|3|||
161529250|NCT02195986|583324866|FG002|Overall Study|Withdrawal by Subject|0|||
161529251|NCT02195986|583324864|FG000|Overall Study|Family Emergency|0|||
161529252|NCT02195986|583324865|FG001|Overall Study|Family Emergency|0|||
161529253|NCT02195986|583324866|FG002|Overall Study|Family Emergency|1|||
161529254|NCT02195986|583324864|FG000|Overall Study|Protocol Violation|0|||
161529255|NCT02195986|583324865|FG001|Overall Study|Protocol Violation|1|||
161529256|NCT02195986|583324866|FG002|Overall Study|Protocol Violation|1|||
161529257|NCT02195986|583324864|FG000|Overall Study|Non-compliance|0|||
161529258|NCT02195986|583324865|FG001|Overall Study|Non-compliance|1|||
161529259|NCT02195986|583324866|FG002|Overall Study|Non-compliance|0|||
161529260|NCT02834780|583324869|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
161529261|NCT02834780|583324870|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
161529262|NCT02834780|583324871|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
161529263|NCT02834780|583324872|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
161529264|NCT02834780|583324873|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
161529265|NCT02834780|583324874|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
161529266|NCT02834780|583324875|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
161529267|NCT02834780|583324876|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
161529268|NCT02834780|583324877|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
161529269|NCT02834780|583324878|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
161529270|NCT02834780|583324879|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
161529271|NCT02834780|583324880|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
161529272|NCT02834780|583324881|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
161591098|NCT04241068|583552760|FG000|LTE Period|Disease Progression|11|||
161936900|NCT02441686|584819092|FG000|Induction|Adverse Event|4|||
161936901|NCT02441686|584819092|FG000|Induction|Complicating disease|1|||
161936902|NCT02441686|584819092|FG000|Induction|Physician Decision|1|||
161936903|NCT02441686|584819092|FG000|Induction|Withdrawal by Subject|1|||
161936904|NCT02441686|584819092|FG000|Induction|Did not receive treatment|1|||
161936905|NCT02441686|584819092|FG000|Maintenance|Remaining on Treatment|23|||
161936906|NCT02441686|584819092|FG000|Maintenance|Physician Decision|1|||
161936907|NCT02441686|584819092|FG000|Maintenance|Adverse Event|3|||
161529273|NCT02834780|583324869|FG000|Overall Study|Withdrawal by Subject|0|||
161529274|NCT02834780|583324870|FG001|Overall Study|Withdrawal by Subject|0|||
161529275|NCT02834780|583324871|FG002|Overall Study|Withdrawal by Subject|1|||
161529276|NCT02834780|583324872|FG003|Overall Study|Withdrawal by Subject|0|||
161529277|NCT02834780|583324873|FG004|Overall Study|Withdrawal by Subject|0|||
161529278|NCT02834780|583324874|FG005|Overall Study|Withdrawal by Subject|0|||
161529279|NCT02834780|583324875|FG006|Overall Study|Withdrawal by Subject|0|||
161529280|NCT02834780|583324876|FG007|Overall Study|Withdrawal by Subject|0|||
161529281|NCT02834780|583324877|FG008|Overall Study|Withdrawal by Subject|0|||
161529282|NCT02834780|583324878|FG009|Overall Study|Withdrawal by Subject|0|||
161529283|NCT02834780|583324879|FG010|Overall Study|Withdrawal by Subject|1|||
161529284|NCT02834780|583324880|FG011|Overall Study|Withdrawal by Subject|0|||
161529285|NCT02834780|583324881|FG012|Overall Study|Withdrawal by Subject|0|||
161529286|NCT02834780|583324869|FG000|Overall Study|Adverse Event|0|||
161529287|NCT02834780|583324870|FG001|Overall Study|Adverse Event|0|||
161529288|NCT02834780|583324871|FG002|Overall Study|Adverse Event|0|||
161529289|NCT02834780|583324872|FG003|Overall Study|Adverse Event|0|||
161529290|NCT02834780|583324873|FG004|Overall Study|Adverse Event|1|||
161529291|NCT02834780|583324874|FG005|Overall Study|Adverse Event|0|||
161529292|NCT02834780|583324875|FG006|Overall Study|Adverse Event|1|||
161529293|NCT02834780|583324876|FG007|Overall Study|Adverse Event|1|||
161529294|NCT02834780|583324877|FG008|Overall Study|Adverse Event|0|||
161529295|NCT02834780|583324878|FG009|Overall Study|Adverse Event|2|||
161529296|NCT02834780|583324879|FG010|Overall Study|Adverse Event|0|||
161529297|NCT02834780|583324880|FG011|Overall Study|Adverse Event|3|||
161529298|NCT02834780|583324881|FG012|Overall Study|Adverse Event|2|||
161529299|NCT02834780|583324869|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
161529300|NCT02834780|583324870|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
161529301|NCT02834780|583324871|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
161529302|NCT02834780|583324872|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
161529303|NCT02834780|583324873|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
161529304|NCT02834780|583324874|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
161529305|NCT02834780|583324875|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
161529306|NCT02834780|583324876|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
161529307|NCT02834780|583324877|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
161529308|NCT02834780|583324878|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
161529309|NCT02834780|583324879|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
161529310|NCT02834780|583324880|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
161529311|NCT02834780|583324881|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
161529312|NCT02834780|583324869|FG000|Overall Study|Other|1|||
161529313|NCT02834780|583324870|FG001|Overall Study|Other|0|||
161529314|NCT02834780|583324871|FG002|Overall Study|Other|1|||
161529315|NCT02834780|583324872|FG003|Overall Study|Other|2|||
161529316|NCT02834780|583324873|FG004|Overall Study|Other|0|||
161529317|NCT02834780|583324874|FG005|Overall Study|Other|0|||
161529318|NCT02834780|583324875|FG006|Overall Study|Other|0|||
161529319|NCT02834780|583324876|FG007|Overall Study|Other|0|||
161529320|NCT02834780|583324877|FG008|Overall Study|Other|0|||
161529321|NCT02834780|583324878|FG009|Overall Study|Other|0|||
161529322|NCT02834780|583324879|FG010|Overall Study|Other|0|||
161529323|NCT02834780|583324880|FG011|Overall Study|Other|0|||
161529324|NCT02834780|583324881|FG012|Overall Study|Other|1|||
161529325|NCT03150056|583324882|FG000|Overall Study|Withdrawal by Subject|0|||
161529326|NCT03150056|583324883|FG001|Overall Study|Withdrawal by Subject|0|||
161529327|NCT03150056|583324884|FG002|Overall Study|Withdrawal by Subject|0|||
161529328|NCT03150056|583324885|FG003|Overall Study|Withdrawal by Subject|0|||
161529329|NCT03150056|583324886|FG004|Overall Study|Withdrawal by Subject|0|||
161529330|NCT03150056|583324887|FG005|Overall Study|Withdrawal by Subject|2|||
161529331|NCT03150056|583324882|FG000|Overall Study|Study terminated by Sponsor|1|||
161529332|NCT03150056|583324883|FG001|Overall Study|Study terminated by Sponsor|3|||
161529333|NCT03150056|583324884|FG002|Overall Study|Study terminated by Sponsor|1|||
161529334|NCT03150056|583324885|FG003|Overall Study|Study terminated by Sponsor|1|||
161529335|NCT03150056|583324886|FG004|Overall Study|Study terminated by Sponsor|5|||
161936908|NCT02441686|584819092|FG000|Maintenance|Progressive Disease|10|||
161529336|NCT03150056|583324887|FG005|Overall Study|Study terminated by Sponsor|6|||
161529337|NCT03150056|583324882|FG000|Overall Study|Death|9|||
161529338|NCT03150056|583324883|FG001|Overall Study|Death|2|||
161529339|NCT03150056|583324884|FG002|Overall Study|Death|2|||
161529340|NCT03150056|583324885|FG003|Overall Study|Death|7|||
161529341|NCT03150056|583324886|FG004|Overall Study|Death|8|||
161529342|NCT03150056|583324887|FG005|Overall Study|Death|10|||
161529343|NCT02270450|583324892|FG000|Overall Study|Refusal unrelated to adverse event|3|||
161529344|NCT02270450|583324893|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161529345|NCT02270450|583324894|FG002|Overall Study|Refusal unrelated to adverse event|5|||
161529346|NCT02270450|583324895|FG003|Overall Study|Refusal unrelated to adverse event|14|||
161529347|NCT02270450|583324892|FG000|Overall Study|Progression/relapse|1|||
161936909|NCT02441686|584819092|FG000|Maintenance|Withdrawal by Subject|1|||
161529348|NCT02270450|583324893|FG001|Overall Study|Progression/relapse|2|||
161529349|NCT02270450|583324894|FG002|Overall Study|Progression/relapse|4|||
161529350|NCT02270450|583324895|FG003|Overall Study|Progression/relapse|9|||
161529351|NCT02270450|583324892|FG000|Overall Study|Death|19|||
161529352|NCT02270450|583324893|FG001|Overall Study|Death|19|||
161529353|NCT02270450|583324894|FG002|Overall Study|Death|31|||
161529354|NCT02270450|583324895|FG003|Overall Study|Death|59|||
161529355|NCT02363738|583324896|FG000|Overall Study|Adverse Event|5|||
161529356|NCT02363738|583324897|FG001|Overall Study|Adverse Event|2|||
161529357|NCT02363738|583324896|FG000|Overall Study|Lack of Efficacy|1|||
161529358|NCT02363738|583324897|FG001|Overall Study|Lack of Efficacy|2|||
161529359|NCT02363738|583324896|FG000|Overall Study|Lost to Follow-up|2|||
161529360|NCT02363738|583324897|FG001|Overall Study|Lost to Follow-up|1|||
161529361|NCT02081846|583324902|FG000|Overall Study|Withdrawal by Subject|1|||
161529362|NCT02081846|583324903|FG001|Overall Study|Withdrawal by Subject|0|||
161529363|NCT02081846|583324902|FG000|Overall Study|invalid consent|1|||
161529364|NCT02081846|583324903|FG001|Overall Study|invalid consent|0|||
161529365|NCT03265600|583324904|FG000|Overall Study|Lost to Follow-up|17|||
161529366|NCT03265600|583324905|FG001|Overall Study|Lost to Follow-up|5|||
161529367|NCT03265600|583324904|FG000|Overall Study|Withdrawal by Subject|4|||
161529368|NCT03265600|583324905|FG001|Overall Study|Withdrawal by Subject|2|||
161529369|NCT03265600|583324904|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
161529370|NCT03265600|583324905|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
161529371|NCT00535730|583324906|FG000|Overall Study|Adverse Event|1|||
161529372|NCT00535730|583324907|FG001|Overall Study|Adverse Event|1|||
161529373|NCT00535730|583324906|FG000|Overall Study|Lost to Follow-up|0|||
161529374|NCT00535730|583324907|FG001|Overall Study|Lost to Follow-up|1|||
161529375|NCT00535730|583324906|FG000|Overall Study|Physician Decision|0|||
161529376|NCT00535730|583324907|FG001|Overall Study|Physician Decision|1|||
161529377|NCT00535730|583324906|FG000|Overall Study|Protocol Violation|1|||
161529378|NCT00535730|583324907|FG001|Overall Study|Protocol Violation|0|||
161529379|NCT00535730|583324906|FG000|Overall Study|Withdrawal by Subject|0|||
161529380|NCT00535730|583324907|FG001|Overall Study|Withdrawal by Subject|4|||
161529381|NCT00936858|583324908|FG000|Overall Study|Death|3|||
161529382|NCT00936858|583324908|FG000|Overall Study|Progression|29|||
161529383|NCT00936858|583324908|FG000|Overall Study|Withdrawal by Subject|5|||
161529384|NCT00936858|583324908|FG000|Overall Study|Adverse Event|1|||
161529385|NCT00936858|583324908|FG000|Overall Study|Physician Decision|7|||
161529386|NCT00936858|583324908|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
161529387|NCT00936858|583324908|FG000|Overall Study|Lost to Follow-up|1|||
161529388|NCT02132611|583324913|FG000|Overall Study|Death|2|||
161529389|NCT01965834|583324914|FG000|Overall Study|Lack of Efficacy|4|||
161529390|NCT03674177|583324918|FG000|Overall Study|Lost to Follow-up|2|||
161529391|NCT03674177|583324919|FG001|Overall Study|Lost to Follow-up|1|||
161529392|NCT03674177|583324920|FG002|Overall Study|Lost to Follow-up|0|||
161529393|NCT03674177|583324921|FG003|Overall Study|Lost to Follow-up|2|||
161529394|NCT03387852|583324922|FG000|Overall Study|Adverse event (AE)|3|||
161529395|NCT03387852|583324923|FG001|Overall Study|Adverse event (AE)|0|||
161529396|NCT03387852|583324924|FG002|Overall Study|Adverse event (AE)|2|||
161529397|NCT03387852|583324925|FG003|Overall Study|Adverse event (AE)|0|||
161529398|NCT03387852|583324922|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
161529399|NCT03387852|583324923|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
161936910|NCT02296684|584819093|FG000|Overall Study|Withdrawal by Subject|0|||
161936911|NCT02296684|584819094|FG001|Overall Study|Withdrawal by Subject|1|||
161529400|NCT03387852|583324924|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
161529401|NCT03387852|583324925|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
161529402|NCT03387852|583324922|FG000|Overall Study|Withdrawal by participant|1|||
161529403|NCT03387852|583324923|FG001|Overall Study|Withdrawal by participant|1|||
161529404|NCT03387852|583324924|FG002|Overall Study|Withdrawal by participant|3|||
161529405|NCT03387852|583324925|FG003|Overall Study|Withdrawal by participant|2|||
161529406|NCT03387852|583324922|FG000|Overall Study|Other- Unspecified|1|||
161529407|NCT03387852|583324923|FG001|Overall Study|Other- Unspecified|1|||
161529408|NCT03387852|583324924|FG002|Overall Study|Other- Unspecified|2|||
161529409|NCT03387852|583324925|FG003|Overall Study|Other- Unspecified|1|||
161936912|NCT02296684|584819095|FG002|Overall Study|Withdrawal by Subject|1|||
161936913|NCT02296684|584819093|FG000|Overall Study|Death|2|||
161591099|NCT04241068|583552760|FG000|LTE Period|Investigator Decision|12|||
161936914|NCT02296684|584819094|FG001|Overall Study|Death|0|||
161936915|NCT02296684|584819095|FG002|Overall Study|Death|0|||
161529410|NCT03387852|583324922|FG000|Overall Study|Poor compliance to protocol|0|||
161529411|NCT03387852|583324923|FG001|Overall Study|Poor compliance to protocol|0|||
161529412|NCT03387852|583324924|FG002|Overall Study|Poor compliance to protocol|0|||
161529413|NCT03387852|583324925|FG003|Overall Study|Poor compliance to protocol|1|||
161529414|NCT03387852|583324922|FG000|Overall Study|Randomized and not treated|0|||
161529415|NCT03387852|583324923|FG001|Overall Study|Randomized and not treated|0|||
161529416|NCT03387852|583324924|FG002|Overall Study|Randomized and not treated|0|||
161529417|NCT03387852|583324925|FG003|Overall Study|Randomized and not treated|1|||
161529418|NCT02194621|583324933|FG000|Overall Study|6 withdrew prior to randomization|2|||
161591100|NCT04241068|583552760|FG000|LTE Period|Loss of Capacity|2|||
161591101|NCT04241068|583552760|FG000|LTE Period|Lost to Follow-up|7|||
161529419|NCT02194621|583324934|FG001|Overall Study|6 withdrew prior to randomization|2|||
161529420|NCT02194621|583324935|FG002|Overall Study|6 withdrew prior to randomization|2|||
161529421|NCT02194621|583324933|FG000|Overall Study|Withdrawal by Subject|4|||
161529422|NCT02194621|583324934|FG001|Overall Study|Withdrawal by Subject|4|||
161591102|NCT04241068|583552760|FG000|LTE Period|Relocation|6|||
161591103|NCT04241068|583552760|FG000|LTE Period|Site Terminated by Sponsor|26|||
161591104|NCT04241068|583552760|FG000|LTE Period|Study Terminated by Sponsor|276|||
161591105|NCT04241068|583552760|FG000|LTE Period|Study Visit Burden|10|||
161591106|NCT04241068|583552760|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
161591107|NCT04241068|583552760|FG000|LTE Period|Reason Not Specified|65|||
161591108|NCT04229992|583552765|FG000|Overall Study|Withdrawal by Subject|0|||
161591109|NCT04229992|583552766|FG001|Overall Study|Withdrawal by Subject|2|||
161591110|NCT04229992|583552767|FG002|Overall Study|Withdrawal by Subject|1|||
161591111|NCT04229992|583552768|FG003|Overall Study|Withdrawal by Subject|1|||
161591112|NCT04229992|583552765|FG000|Overall Study|Adverse Event|1|||
161591113|NCT04229992|583552766|FG001|Overall Study|Adverse Event|1|||
161591114|NCT04229992|583552767|FG002|Overall Study|Adverse Event|3|||
161591115|NCT04229992|583552768|FG003|Overall Study|Adverse Event|1|||
161591116|NCT04229992|583552765|FG000|Overall Study|Lost to Follow-up|0|||
161591117|NCT04229992|583552766|FG001|Overall Study|Lost to Follow-up|0|||
161591118|NCT04229992|583552767|FG002|Overall Study|Lost to Follow-up|0|||
161591119|NCT04229992|583552768|FG003|Overall Study|Lost to Follow-up|1|||
161591120|NCT05178316|583552769|FG000|Overall Study|Adverse Event|5|||
161591121|NCT05178316|583552770|FG001|Overall Study|Adverse Event|4|||
161529423|NCT02194621|583324935|FG002|Overall Study|Withdrawal by Subject|7|||
161529424|NCT02493127|583324936|FG000|Overall Study|Lost to Follow-up|1|||
161529425|NCT02493127|583324937|FG001|Overall Study|Lost to Follow-up|1|||
161529426|NCT00714168|583324938|FG000|Overall Study|Pregnancy|5|||
161529427|NCT00714168|583324939|FG001|Overall Study|Pregnancy|4|||
161529428|NCT00714168|583324938|FG000|Overall Study|Lost to Follow-up|32|||
161529429|NCT00714168|583324939|FG001|Overall Study|Lost to Follow-up|50|||
161529430|NCT00714168|583324938|FG000|Overall Study|Relocation|4|||
161529431|NCT00714168|583324939|FG001|Overall Study|Relocation|3|||
161529432|NCT00714168|583324938|FG000|Overall Study|Non-study medical condition|3|||
161529433|NCT00714168|583324939|FG001|Overall Study|Non-study medical condition|2|||
161529434|NCT00809757|583324940|FG000|Overall Study|Adverse Event|2|||
161529435|NCT00809757|583324941|FG001|Overall Study|Adverse Event|3|||
161529436|NCT00809757|583324942|FG002|Overall Study|Adverse Event|3|||
161529437|NCT00809757|583324940|FG000|Overall Study|Lost to Follow-up|0|||
161591122|NCT05178316|583552771|FG002|Overall Study|Adverse Event|9|||
161591123|NCT05178316|583552769|FG000|Overall Study|Enrolled in Error|1|||
161591124|NCT05178316|583552770|FG001|Overall Study|Enrolled in Error|2|||
161591125|NCT05178316|583552771|FG002|Overall Study|Enrolled in Error|1|||
161591126|NCT05178316|583552769|FG000|Overall Study|Lost to Follow-up|3|||
161591127|NCT05178316|583552770|FG001|Overall Study|Lost to Follow-up|15|||
161591128|NCT05178316|583552771|FG002|Overall Study|Lost to Follow-up|11|||
161591129|NCT05178316|583552769|FG000|Overall Study|Noncompliance|1|||
161591130|NCT05178316|583552770|FG001|Overall Study|Noncompliance|3|||
161591131|NCT05178316|583552771|FG002|Overall Study|Noncompliance|1|||
161591132|NCT05178316|583552769|FG000|Overall Study|Other|0|||
161591133|NCT05178316|583552770|FG001|Overall Study|Other|1|||
161591134|NCT05178316|583552771|FG002|Overall Study|Other|0|||
161591135|NCT05178316|583552769|FG000|Overall Study|Physician Decision|0|||
161591136|NCT05178316|583552770|FG001|Overall Study|Physician Decision|3|||
161591137|NCT05178316|583552771|FG002|Overall Study|Physician Decision|2|||
161591138|NCT05178316|583552769|FG000|Overall Study|Protocol deviation|1|||
161936916|NCT04647526|584819096|FG000|Overall Study|Death|13|||
161936917|NCT04647526|584819097|FG001|Overall Study|Death|76|||
161936918|NCT04647526|584819098|FG002|Overall Study|Death|32|||
161936919|NCT04647526|584819099|FG003|Overall Study|Death|0|||
161936920|NCT04647526|584819096|FG000|Overall Study|Lost to Follow-up|1|||
161936921|NCT04647526|584819097|FG001|Overall Study|Lost to Follow-up|0|||
161936922|NCT04647526|584819098|FG002|Overall Study|Lost to Follow-up|1|||
161936923|NCT04647526|584819099|FG003|Overall Study|Lost to Follow-up|0|||
161591139|NCT05178316|583552770|FG001|Overall Study|Protocol deviation|0|||
161591140|NCT05178316|583552771|FG002|Overall Study|Protocol deviation|1|||
161591141|NCT05178316|583552769|FG000|Overall Study|Sponsor decision|1|||
161936924|NCT04647526|584819096|FG000|Overall Study|Withdrawal by Subject|4|||
161529438|NCT00809757|583324941|FG001|Overall Study|Lost to Follow-up|0|||
161529439|NCT00809757|583324942|FG002|Overall Study|Lost to Follow-up|1|||
161529440|NCT00809757|583324940|FG000|Overall Study|Protocol Violation|1|||
161591142|NCT05178316|583552770|FG001|Overall Study|Sponsor decision|0|||
161529441|NCT00809757|583324941|FG001|Overall Study|Protocol Violation|1|||
161529442|NCT00809757|583324942|FG002|Overall Study|Protocol Violation|1|||
161529443|NCT00809757|583324940|FG000|Overall Study|Withdrawal by Subject|2|||
161529444|NCT00809757|583324941|FG001|Overall Study|Withdrawal by Subject|1|||
161529445|NCT00809757|583324942|FG002|Overall Study|Withdrawal by Subject|3|||
161591143|NCT05178316|583552771|FG002|Overall Study|Sponsor decision|1|||
161529446|NCT00809757|583324940|FG000|Overall Study|Subject Uncooperative|1|||
161529447|NCT00809757|583324941|FG001|Overall Study|Subject Uncooperative|0|||
161529448|NCT00809757|583324942|FG002|Overall Study|Subject Uncooperative|2|||
161529449|NCT00809757|583324940|FG000|Overall Study|Noncompliance with Medication|0|||
161529450|NCT00809757|583324941|FG001|Overall Study|Noncompliance with Medication|0|||
161529451|NCT00809757|583324942|FG002|Overall Study|Noncompliance with Medication|1|||
161529452|NCT00253864|583324943|FG000|Overall Study|Lost to Follow-up|5|||
161529453|NCT00253864|583324944|FG001|Overall Study|Lost to Follow-up|8|||
161529454|NCT01864564|583324945|FG000|Overall Study|Lost to Follow-up|17|||
161529455|NCT01864564|583324946|FG001|Overall Study|Lost to Follow-up|23|||
161529456|NCT01864564|583324945|FG000|Overall Study|Withdrawal by Subject|20|||
161529457|NCT01864564|583324946|FG001|Overall Study|Withdrawal by Subject|11|||
161529458|NCT01864564|583324945|FG000|Overall Study|Protocol Violation|0|||
161529459|NCT01864564|583324946|FG001|Overall Study|Protocol Violation|27|||
161529460|NCT01864564|583324945|FG000|Overall Study|not reported|0|||
161529461|NCT01864564|583324946|FG001|Overall Study|not reported|34|||
161529462|NCT03077724|583324947|FG000|Overall Study|Lost to Follow-up|5|||
161529463|NCT03077724|583324948|FG001|Overall Study|Lost to Follow-up|1|||
161529464|NCT03077724|583324947|FG000|Overall Study|Withdrawal by Subject|3|||
161529465|NCT03077724|583324948|FG001|Overall Study|Withdrawal by Subject|1|||
161529466|NCT02269670|583324949|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
161529467|NCT00234065|583324950|FG000|Overall Study|Adverse Event|268|||
161529468|NCT00234065|583324951|FG001|Overall Study|Adverse Event|166|||
161529469|NCT00234065|583324950|FG000|Overall Study|Withdrawal by Subject|73|||
161529470|NCT00234065|583324951|FG001|Overall Study|Withdrawal by Subject|56|||
161529471|NCT00234065|583324950|FG000|Overall Study|Physician Decision|23|||
161529472|NCT00234065|583324951|FG001|Overall Study|Physician Decision|22|||
161529473|NCT00234065|583324950|FG000|Overall Study|Not Classified|111|||
161529474|NCT00234065|583324951|FG001|Overall Study|Not Classified|112|||
161529475|NCT00126438|583324952|FG000|Overall Study|Withdrawal due to adverse event|1|||
161529476|NCT00126438|583324953|FG001|Overall Study|Withdrawal due to adverse event|0|||
161529477|NCT00126438|583324952|FG000|Overall Study|Lost to Follow-up|22|||
161529478|NCT00126438|583324953|FG001|Overall Study|Lost to Follow-up|0|||
161529479|NCT00126438|583324952|FG000|Overall Study|Protocol Violation|8|||
161529480|NCT00126438|583324953|FG001|Overall Study|Protocol Violation|8|||
161529481|NCT00126438|583324952|FG000|Overall Study|Withdrawal by Subject|3|||
161529482|NCT00126438|583324953|FG001|Overall Study|Withdrawal by Subject|2|||
161529483|NCT02313428|583324954|FG000|Overall Study|Lost to Follow-up|1|||
161529484|NCT02313428|583324955|FG001|Overall Study|Lost to Follow-up|1|||
161529485|NCT05374421|583324956|FG000|Overall Study|Withdrawal by Subject|3|||
161529486|NCT05374421|583324957|FG001|Overall Study|Withdrawal by Subject|4|||
161529487|NCT00003508|583326585|FG000|Overall Study|Not evaluable|5|||
161529488|NCT02160314|583326586|FG000|Overall Study|Adverse Event|0|||
161529489|NCT02160314|583326587|FG001|Overall Study|Adverse Event|6|||
161529490|NCT02160314|583326586|FG000|Overall Study|Protocol Violation|0|||
161529491|NCT02160314|583326587|FG001|Overall Study|Protocol Violation|4|||
161529492|NCT02160314|583326586|FG000|Overall Study|Withdrawal by Subject|1|||
161529493|NCT02160314|583326587|FG001|Overall Study|Withdrawal by Subject|2|||
161529494|NCT02160314|583326586|FG000|Overall Study|Lost to Follow-up|0|||
161529495|NCT02160314|583326587|FG001|Overall Study|Lost to Follow-up|1|||
161529496|NCT00593567|583326588|FG000|Overall Study|Adverse Event|2|||
161529497|NCT00593567|583326589|FG001|Overall Study|Adverse Event|0|||
161529498|NCT00593567|583326588|FG000|Overall Study|Physician Decision|2|||
161529499|NCT00593567|583326589|FG001|Overall Study|Physician Decision|0|||
161529500|NCT00593567|583326588|FG000|Overall Study|Protocol Violation|13|||
161529501|NCT00593567|583326589|FG001|Overall Study|Protocol Violation|7|||
161529502|NCT00593567|583326588|FG000|Overall Study|Lack of Efficacy|2|||
161529503|NCT00593567|583326589|FG001|Overall Study|Lack of Efficacy|1|||
161936925|NCT04647526|584819097|FG001|Overall Study|Withdrawal by Subject|15|||
161936926|NCT04647526|584819098|FG002|Overall Study|Withdrawal by Subject|8|||
161936927|NCT04647526|584819099|FG003|Overall Study|Withdrawal by Subject|1|||
161936928|NCT04647526|584819096|FG000|Overall Study|Incorrect enrollment|0|||
161529504|NCT00593567|583326588|FG000|Overall Study|Withdrawal by Subject|1|||
161529505|NCT00593567|583326589|FG001|Overall Study|Withdrawal by Subject|2|||
161529506|NCT03576768|583326595|FG000|Overall Study|Lost to Follow-up|3|||
161529507|NCT03576768|583326596|FG001|Overall Study|Lost to Follow-up|3|||
161529508|NCT03576768|583326597|FG002|Overall Study|Lost to Follow-up|0|||
161529509|NCT03576768|583326598|FG003|Overall Study|Lost to Follow-up|0|||
161529510|NCT00590902|583326599|FG000|Overall Study|Death|1|||
161529511|NCT00785291|583326600|FG000|Overall Study|Never began treatment|8|||
161529512|NCT00785291|583326601|FG001|Overall Study|Never began treatment|4|||
161529513|NCT00785291|583326602|FG002|Overall Study|Never began treatment|4|||
161529514|NCT00785291|583326600|FG000|Overall Study|Adverse Event|39|||
161529515|NCT00785291|583326601|FG001|Overall Study|Adverse Event|70|||
161529516|NCT00785291|583326602|FG002|Overall Study|Adverse Event|56|||
161529517|NCT00785291|583326600|FG000|Overall Study|Death|7|||
161529518|NCT00785291|583326601|FG001|Overall Study|Death|4|||
161529519|NCT00785291|583326602|FG002|Overall Study|Death|3|||
161529520|NCT00785291|583326600|FG000|Overall Study|Withdrawal by Subject|35|||
161529521|NCT00785291|583326601|FG001|Overall Study|Withdrawal by Subject|36|||
161529522|NCT00785291|583326602|FG002|Overall Study|Withdrawal by Subject|17|||
161529523|NCT00785291|583326600|FG000|Overall Study|Alternative Therapy|12|||
161529524|NCT00785291|583326601|FG001|Overall Study|Alternative Therapy|6|||
161529525|NCT00785291|583326602|FG002|Overall Study|Alternative Therapy|7|||
161529526|NCT00785291|583326600|FG000|Overall Study|Complicating illness|6|||
161529527|NCT00785291|583326601|FG001|Overall Study|Complicating illness|4|||
161529528|NCT00785291|583326602|FG002|Overall Study|Complicating illness|4|||
161529529|NCT00785291|583326600|FG000|Overall Study|Other Medical Reasons|29|||
161529530|NCT00785291|583326601|FG001|Overall Study|Other Medical Reasons|25|||
161529531|NCT00785291|583326602|FG002|Overall Study|Other Medical Reasons|15|||
161529532|NCT02119260|583326603|FG000|Overall Study|Adverse Event|1|||
161529533|NCT02119260|583326604|FG001|Overall Study|Adverse Event|0|||
161529534|NCT02119260|583326605|FG002|Overall Study|Adverse Event|0|||
161529535|NCT02119260|583326606|FG003|Overall Study|Adverse Event|0|||
161529536|NCT02119260|583326607|FG004|Overall Study|Adverse Event|0|||
161529537|NCT02119260|583326608|FG005|Overall Study|Adverse Event|0|||
161529538|NCT02119260|583326609|FG006|Overall Study|Adverse Event|0|||
161529539|NCT02119260|583326603|FG000|Overall Study|Withdrew consent|0|||
161529540|NCT02119260|583326604|FG001|Overall Study|Withdrew consent|1|||
161529541|NCT02119260|583326605|FG002|Overall Study|Withdrew consent|1|||
161529542|NCT02119260|583326606|FG003|Overall Study|Withdrew consent|0|||
161529543|NCT02119260|583326607|FG004|Overall Study|Withdrew consent|0|||
161529544|NCT02119260|583326608|FG005|Overall Study|Withdrew consent|0|||
161529545|NCT02119260|583326609|FG006|Overall Study|Withdrew consent|0|||
161529546|NCT02979639|583326611|FG000|Overall Study|Withdrawal based on medical judgement|1|||
161529547|NCT02979639|583326611|FG000|Overall Study|Lost to Follow-up|8|||
161529548|NCT02979639|583326611|FG000|Overall Study|Withdrawal by Subject|3|||
161529549|NCT02979639|583326611|FG000|Overall Study|Adverse Event|2|||
161529550|NCT01877408|583326615|FG000|Overall Study|Lost to Follow-up|0|||
161529551|NCT01877408|583326616|FG001|Overall Study|Lost to Follow-up|2|||
161529552|NCT03870763|583326619|FG000|Overall Study|Study terminated by sponsor|0|||
161529553|NCT03870763|583326620|FG001|Overall Study|Study terminated by sponsor|2|||
161529554|NCT03870763|583326621|FG002|Overall Study|Study terminated by sponsor|0|||
161529555|NCT03870763|583326619|FG000|Overall Study|Withdrawal by Subject|0|||
161529556|NCT03870763|583326620|FG001|Overall Study|Withdrawal by Subject|1|||
161529557|NCT03870763|583326621|FG002|Overall Study|Withdrawal by Subject|0|||
161529558|NCT03870763|583326619|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
161529559|NCT03870763|583326620|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
161529560|NCT03870763|583326621|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
161529561|NCT04279314|583326622|FG000|Overall Study|Adverse Event|55|||
161529562|NCT04279314|583326622|FG000|Overall Study|Withdrawal by Subject|5|||
161529563|NCT04279314|583326622|FG000|Overall Study|Lack of Efficacy|5|||
161529564|NCT04279314|583326622|FG000|Overall Study|Protocol Violation|3|||
161529565|NCT04279314|583326622|FG000|Overall Study|Other (not COVID-19 related)|2|||
161529566|NCT01471054|583326627|FG000|Overall Study|Study terminated prematurely|4|||
161529567|NCT01471054|583326628|FG001|Overall Study|Study terminated prematurely|0|||
161529568|NCT00360308|583326629|FG000|Overall Study|Adverse Event|15|||
161529569|NCT00360308|583326630|FG001|Overall Study|Adverse Event|14|||
161529570|NCT00360308|583326631|FG002|Overall Study|Adverse Event|25|||
161529571|NCT00360308|583326629|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
161529572|NCT00360308|583326630|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
161529573|NCT00360308|583326631|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161529574|NCT00360308|583326629|FG000|Overall Study|Protocol Violation|2|||
161529575|NCT00360308|583326630|FG001|Overall Study|Protocol Violation|1|||
161529576|NCT00360308|583326631|FG002|Overall Study|Protocol Violation|2|||
161529577|NCT00360308|583326629|FG000|Overall Study|Withdrawal by Subject|11|||
161529578|NCT00360308|583326630|FG001|Overall Study|Withdrawal by Subject|7|||
161529579|NCT00360308|583326631|FG002|Overall Study|Withdrawal by Subject|14|||
161529580|NCT00360308|583326629|FG000|Overall Study|Lack of Efficacy|3|||
161529581|NCT00360308|583326630|FG001|Overall Study|Lack of Efficacy|0|||
161529582|NCT00360308|583326631|FG002|Overall Study|Lack of Efficacy|2|||
161529583|NCT00360308|583326629|FG000|Overall Study|Other|2|||
161529584|NCT00360308|583326630|FG001|Overall Study|Other|1|||
161529585|NCT00360308|583326631|FG002|Overall Study|Other|1|||
161529586|NCT00360308|583326629|FG000|Overall Study|Study termination by sponsor|43|||
161529587|NCT00360308|583326630|FG001|Overall Study|Study termination by sponsor|55|||
161529588|NCT00360308|583326631|FG002|Overall Study|Study termination by sponsor|44|||
161529589|NCT01733732|583326632|FG000|Overall Study|Adverse Event|1|||
161529590|NCT01733732|583326633|FG001|Overall Study|Adverse Event|0|||
161529591|NCT01733732|583326632|FG000|Overall Study|Did not attend all study visits|1|||
161827385|NCT02539368|584408065|FG001|Overall Study|Adverse Event|5|||
161827386|NCT02539368|584408066|FG002|Overall Study|Adverse Event|9|||
161827387|NCT02539368|584408067|FG003|Overall Study|Adverse Event|0|||
161827388|NCT02539368|584408068|FG004|Overall Study|Adverse Event|3|||
161827389|NCT02539368|584408064|FG000|Overall Study|Participant Non-compliant|13|||
161529592|NCT01733732|583326633|FG001|Overall Study|Did not attend all study visits|0|||
161529593|NCT03280121|583326637|FG000|Overall Study|Physician Decision|1|||
161529594|NCT03280121|583326637|FG000|Overall Study|Lost to Follow-up|1|||
161529595|NCT03280121|583326637|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
161529596|NCT04391023|583326648|FG000|Overall Study|Withdrawal by Subject|2|||
161529597|NCT04391023|583326649|FG001|Overall Study|Withdrawal by Subject|2|||
161529598|NCT01270347|583326651|FG000|Core Phase|Adverse Event|1|||
161529599|NCT01270347|583326652|FG001|Core Phase|Adverse Event|6|||
161529600|NCT01270347|583326651|FG000|Core Phase|Withdrawal by Subject|1|||
161529601|NCT01270347|583326652|FG001|Core Phase|Withdrawal by Subject|2|||
161529602|NCT01270347|583326651|FG000|Core Phase|Lost to Follow-up|0|||
161529603|NCT01270347|583326652|FG001|Core Phase|Lost to Follow-up|1|||
161529604|NCT01270347|583326651|FG000|Core Phase|Miscellaneous|8|||
161529605|NCT01270347|583326652|FG001|Core Phase|Miscellaneous|14|||
161529606|NCT01270347|583326651|FG000|Extension Phase|Adverse Event|1|||
161529607|NCT01270347|583326652|FG001|Extension Phase|Adverse Event|3|||
161529608|NCT01270347|583326651|FG000|Extension Phase|Withdrawal by Subject|3|||
161529609|NCT01270347|583326652|FG001|Extension Phase|Withdrawal by Subject|4|||
161529610|NCT01270347|583326651|FG000|Extension Phase|Miscellaneous|2|||
161529611|NCT01270347|583326652|FG001|Extension Phase|Miscellaneous|2|||
161529612|NCT00492284|583326653|FG000|Overall Study|Adverse Event|0|||
161529613|NCT00492284|583326654|FG001|Overall Study|Adverse Event|1|||
161529614|NCT00492284|583326655|FG002|Overall Study|Adverse Event|1|||
161529615|NCT00492284|583326656|FG003|Overall Study|Adverse Event|2|||
161529616|NCT00492284|583326653|FG000|Overall Study|Lost to Follow-up|0|||
161529617|NCT00492284|583326654|FG001|Overall Study|Lost to Follow-up|0|||
161529618|NCT00492284|583326655|FG002|Overall Study|Lost to Follow-up|3|||
161529619|NCT00492284|583326656|FG003|Overall Study|Lost to Follow-up|1|||
161529620|NCT00492284|583326653|FG000|Overall Study|Death|0|||
161529621|NCT00492284|583326654|FG001|Overall Study|Death|3|||
161529622|NCT00492284|583326655|FG002|Overall Study|Death|2|||
161529623|NCT00492284|583326656|FG003|Overall Study|Death|5|||
161529624|NCT00492284|583326653|FG000|Overall Study|Withdrawal by Subject|1|||
161529625|NCT00492284|583326654|FG001|Overall Study|Withdrawal by Subject|0|||
161529626|NCT00492284|583326655|FG002|Overall Study|Withdrawal by Subject|0|||
161529627|NCT00492284|583326656|FG003|Overall Study|Withdrawal by Subject|2|||
161529628|NCT01939028|583326661|FG000|Overall Study|Withdrawal by Subject|5|||
161529629|NCT01939028|583326661|FG000|Overall Study|Physician Decision|7|||
161529630|NCT03282227|583326662|FG000|Overall Study|Exposure Goals Achieved|60|||
161529631|NCT03282227|583326662|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
161529632|NCT03282227|583326662|FG000|Overall Study|Adverse Event|15|||
161529633|NCT03282227|583326662|FG000|Overall Study|Lost to Follow-up|21|||
161529634|NCT03282227|583326662|FG000|Overall Study|Withdrawal by Subject|20|||
161529635|NCT03282227|583326662|FG000|Overall Study|Lack of Efficacy|12|||
161529636|NCT03282227|583326662|FG000|Overall Study|Sponsor decision|3|||
161529637|NCT03282227|583326662|FG000|Overall Study|Physician Decision|2|||
161529638|NCT03282227|583326662|FG000|Overall Study|Pregnancy|2|||
161529639|NCT03282227|583326662|FG000|Overall Study|Other|1|||
161529640|NCT02576678|583326663|FG000|Overall Study|Adverse Event|0|||
161529641|NCT02576678|583326664|FG001|Overall Study|Adverse Event|0|||
161529642|NCT02576678|583326665|FG002|Overall Study|Adverse Event|2|||
161529643|NCT02576678|583326663|FG000|Overall Study|Withdrawal by Subject|3|||
161827390|NCT02539368|584408065|FG001|Overall Study|Participant Non-compliant|2|||
161827391|NCT02539368|584408066|FG002|Overall Study|Participant Non-compliant|1|||
161827392|NCT02539368|584408067|FG003|Overall Study|Participant Non-compliant|1|||
161827393|NCT02539368|584408068|FG004|Overall Study|Participant Non-compliant|0|||
161827394|NCT02539368|584408064|FG000|Overall Study|Other|145|||
161827395|NCT02539368|584408065|FG001|Overall Study|Other|18|||
161827396|NCT02539368|584408066|FG002|Overall Study|Other|24|||
161827397|NCT02539368|584408067|FG003|Overall Study|Other|1|||
161827398|NCT02539368|584408068|FG004|Overall Study|Other|3|||
161827399|NCT02539368|584408064|FG000|Overall Study|Missing|10|||
161827400|NCT02539368|584408065|FG001|Overall Study|Missing|3|||
161827401|NCT02539368|584408066|FG002|Overall Study|Missing|0|||
161529644|NCT02576678|583326664|FG001|Overall Study|Withdrawal by Subject|1|||
161529645|NCT02576678|583326665|FG002|Overall Study|Withdrawal by Subject|2|||
161529646|NCT02576678|583326663|FG000|Overall Study|Lost to Follow-up|0|||
161529647|NCT02576678|583326664|FG001|Overall Study|Lost to Follow-up|0|||
161529648|NCT02576678|583326665|FG002|Overall Study|Lost to Follow-up|1|||
161529649|NCT02576678|583326663|FG000|Overall Study|Miscellaneous|2|||
161529650|NCT02576678|583326664|FG001|Overall Study|Miscellaneous|0|||
161529651|NCT02576678|583326665|FG002|Overall Study|Miscellaneous|0|||
161529652|NCT00700401|583326676|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
161529653|NCT00700401|583326676|FG000|Overall Study|Adverse Event|5|||
161529654|NCT00700401|583326676|FG000|Overall Study|Refused Treatment|2|||
161529655|NCT00700401|583326676|FG000|Overall Study|Lost to Follow-up|1|||
161529656|NCT00700401|583326676|FG000|Overall Study|Treatment never started|1|||
161529657|NCT00700401|583326676|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
161529658|NCT00700401|583326676|FG000|Overall Study|Withdrawal by Subject|2|||
161827402|NCT02539368|584408067|FG003|Overall Study|Missing|0|||
161529659|NCT02491671|583326677|FG000|Overall Study|Adverse Event|6|||
161529660|NCT02491671|583326678|FG001|Overall Study|Adverse Event|8|||
161529661|NCT02491671|583326677|FG000|Overall Study|Death|0|||
161529662|NCT02491671|583326678|FG001|Overall Study|Death|2|||
161529663|NCT02491671|583326677|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
161529664|NCT02491671|583326678|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
161529665|NCT02251990|583326682|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
161529666|NCT02251990|583326683|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
161529667|NCT02251990|583326682|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
161529668|NCT02251990|583326683|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
161529669|NCT02251990|583326682|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
161529670|NCT02251990|583326683|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
161529671|NCT02251990|583326682|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
161529672|NCT02251990|583326683|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
161529673|NCT02251990|583326682|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
161529674|NCT02251990|583326683|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
161529675|NCT02251990|583326682|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
161529676|NCT02251990|583326683|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
161529677|NCT02293538|583326684|FG000|Overall Study|Adverse Event|0|||
161529678|NCT02293538|583326685|FG001|Overall Study|Adverse Event|1|||
161529679|NCT02293538|583326684|FG000|Overall Study|Lost to Follow-up|1|||
161529680|NCT02293538|583326685|FG001|Overall Study|Lost to Follow-up|0|||
161529681|NCT02293538|583326684|FG000|Overall Study|Withdrawal by Subject|0|||
161529682|NCT02293538|583326685|FG001|Overall Study|Withdrawal by Subject|1|||
161529683|NCT00322348|583326686|FG000|Overall Study|Adverse Event|0|||
161529684|NCT00322348|583326687|FG001|Overall Study|Adverse Event|1|||
161529685|NCT00322348|583326686|FG000|Overall Study|Withdrawal by Subject|1|||
161529686|NCT00322348|583326687|FG001|Overall Study|Withdrawal by Subject|4|||
161529687|NCT00322348|583326686|FG000|Overall Study|Lost to Follow-up|1|||
161529688|NCT00322348|583326687|FG001|Overall Study|Lost to Follow-up|0|||
161529689|NCT00322348|583326686|FG000|Overall Study|Death|0|||
161529690|NCT00322348|583326687|FG001|Overall Study|Death|2|||
161529691|NCT00322348|583326686|FG000|Overall Study|Disease Progression|30|||
161529692|NCT00322348|583326687|FG001|Overall Study|Disease Progression|25|||
161529693|NCT00322348|583326686|FG000|Overall Study|Reasons not specified|5|||
161529694|NCT00322348|583326687|FG001|Overall Study|Reasons not specified|1|||
161529695|NCT01041638|583326689|FG000|Overall Study|Adverse Event|4|||
161529696|NCT01041638|583326689|FG000|Overall Study|Death|1|||
161827403|NCT02539368|584408068|FG004|Overall Study|Missing|0|||
161827404|NCT00251316|584408071|FG000|Overall Study|Physician Decision|2|||
161529697|NCT01041638|583326689|FG000|Overall Study|Lack of Efficacy|7|||
161529698|NCT01041638|583326689|FG000|Overall Study|Physician Decision|4|||
161529699|NCT01041638|583326689|FG000|Overall Study|Withdrawal by Subject|11|||
161529700|NCT03152552|583326690|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
161529701|NCT03152552|583326691|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
161529702|NCT03152552|583326692|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
161529703|NCT03152552|583326693|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
161529704|NCT03152552|583326694|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
161529705|NCT03152552|583326690|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161529706|NCT03152552|583326691|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
161529707|NCT03152552|583326692|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161529708|NCT03152552|583326693|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161529709|NCT03152552|583326694|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161529710|NCT03152552|583326690|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
161529711|NCT03152552|583326691|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
161529712|NCT03152552|583326692|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
161529713|NCT03152552|583326693|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
161529714|NCT03152552|583326694|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
161529715|NCT03152552|583326690|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161529716|NCT03152552|583326691|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161529717|NCT03152552|583326692|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161529718|NCT03152552|583326693|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161529719|NCT03152552|583326694|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161529720|NCT03152552|583326690|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
161529721|NCT03152552|583326691|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
161529722|NCT03152552|583326692|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
161529723|NCT03152552|583326693|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
161529724|NCT03152552|583326694|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
161529725|NCT03152552|583326690|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
161529726|NCT03152552|583326691|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
161529727|NCT03152552|583326692|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
161529728|NCT03152552|583326693|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
161529729|NCT03152552|583326694|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
161936929|NCT04647526|584819097|FG001|Overall Study|Incorrect enrollment|1|||
161936930|NCT04647526|584819098|FG002|Overall Study|Incorrect enrollment|1|||
161936931|NCT04647526|584819099|FG003|Overall Study|Incorrect enrollment|0|||
161936932|NCT04647526|584819096|FG000|Overall Study|Physician Decision|0|||
161936933|NCT04647526|584819097|FG001|Overall Study|Physician Decision|1|||
161936934|NCT04647526|584819098|FG002|Overall Study|Physician Decision|1|||
161936935|NCT04647526|584819099|FG003|Overall Study|Physician Decision|0|||
161529730|NCT03152552|583326690|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
161936936|NCT04647526|584819096|FG000|Overall Study|Ongoing|9|||
161936937|NCT04647526|584819097|FG001|Overall Study|Ongoing|183|||
161529731|NCT03152552|583326691|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
161529732|NCT03152552|583326692|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
161529733|NCT03152552|583326693|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
161529734|NCT03152552|583326694|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
161529735|NCT01922076|583326696|FG000|Overall Study|Adverse Event|0|||
161529736|NCT01922076|583326697|FG001|Overall Study|Adverse Event|0|||
161529737|NCT01922076|583326698|FG002|Overall Study|Adverse Event|0|||
161529738|NCT01922076|583326699|FG003|Overall Study|Adverse Event|0|||
161529739|NCT01922076|583326700|FG004|Overall Study|Adverse Event|1|||
161529740|NCT01922076|583326701|FG005|Overall Study|Adverse Event|0|||
161529741|NCT01922076|583326702|FG006|Overall Study|Adverse Event|0|||
161529742|NCT01922076|583326696|FG000|Overall Study|Physician Decision|0|||
161529743|NCT01922076|583326697|FG001|Overall Study|Physician Decision|0|||
161529744|NCT01922076|583326698|FG002|Overall Study|Physician Decision|1|||
161529745|NCT01922076|583326699|FG003|Overall Study|Physician Decision|0|||
161529746|NCT01922076|583326700|FG004|Overall Study|Physician Decision|0|||
161529747|NCT01922076|583326701|FG005|Overall Study|Physician Decision|0|||
161529748|NCT01922076|583326702|FG006|Overall Study|Physician Decision|0|||
161529749|NCT01922076|583326696|FG000|Overall Study|Withdrawal by Subject|0|||
161529750|NCT01922076|583326697|FG001|Overall Study|Withdrawal by Subject|0|||
161529751|NCT01922076|583326698|FG002|Overall Study|Withdrawal by Subject|0|||
161529752|NCT01922076|583326699|FG003|Overall Study|Withdrawal by Subject|1|||
161529753|NCT01922076|583326700|FG004|Overall Study|Withdrawal by Subject|0|||
161529754|NCT01922076|583326701|FG005|Overall Study|Withdrawal by Subject|1|||
161529755|NCT01922076|583326702|FG006|Overall Study|Withdrawal by Subject|1|||
161529756|NCT00683644|583326710|FG000|Overall Study|Withdrawal by Subject|4|||
161529757|NCT00683644|583326711|FG001|Overall Study|Withdrawal by Subject|2|||
161529758|NCT00683644|583326710|FG000|Overall Study|Lost to Follow-up|1|||
161529759|NCT00683644|583326711|FG001|Overall Study|Lost to Follow-up|4|||
161529760|NCT00683644|583326710|FG000|Overall Study|Adverse Event|1|||
161529761|NCT00683644|583326711|FG001|Overall Study|Adverse Event|2|||
161529762|NCT00683644|583326710|FG000|Overall Study|Low copper, other health problems,|7|||
161529763|NCT00683644|583326711|FG001|Overall Study|Low copper, other health problems,|6|||
161529764|NCT03240692|583326712|FG000|Overall Study|Physician Decision|1|||
161529765|NCT03240692|583326712|FG000|Overall Study|Withdrawal by Subject|1|||
161529766|NCT01857531|583326713|FG000|Overall Study|Withdrawal by Subject|4|||
161529767|NCT00355082|583326714|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
161529768|NCT00355082|583326715|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
161529769|NCT00355082|583326716|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
161529770|NCT00355082|583326714|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
161529771|NCT00355082|583326715|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
161529772|NCT00355082|583326716|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
161529773|NCT00355082|583326714|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
161529774|NCT00355082|583326715|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
161529775|NCT00355082|583326716|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
161529776|NCT00355082|583326714|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
161936938|NCT04647526|584819098|FG002|Overall Study|Ongoing|93|||
161529777|NCT00355082|583326715|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
161529778|NCT00355082|583326716|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
161529779|NCT00355082|583326714|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
161529780|NCT00355082|583326715|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
161529781|NCT00355082|583326716|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
161529782|NCT00355082|583326714|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
161529783|NCT00355082|583326715|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
161529784|NCT00355082|583326716|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
161529785|NCT00355082|583326714|FG000|Continuation Phase|Adverse Event|2|||
161529786|NCT00355082|583326715|FG001|Continuation Phase|Adverse Event|0|||
161529787|NCT00355082|583326716|FG002|Continuation Phase|Adverse Event|1|||
161936939|NCT04647526|584819099|FG003|Overall Study|Ongoing|15|||
161529788|NCT00355082|583326714|FG000|Continuation Phase|Lost to Follow-up|2|||
161529789|NCT00355082|583326715|FG001|Continuation Phase|Lost to Follow-up|0|||
161529790|NCT00355082|583326716|FG002|Continuation Phase|Lost to Follow-up|1|||
161529791|NCT00355082|583326714|FG000|Continuation Phase|Protocol Violation|1|||
161529792|NCT00355082|583326715|FG001|Continuation Phase|Protocol Violation|0|||
161529793|NCT00355082|583326716|FG002|Continuation Phase|Protocol Violation|1|||
161529794|NCT00355082|583326714|FG000|Continuation Phase|Withdrawal by Subject|4|||
161936940|NCT03298451|584819100|FG000|Overall Study|Death|275|||
161936941|NCT03298451|584819101|FG001|Overall Study|Death|260|||
161936942|NCT03298451|584819102|FG002|Overall Study|Death|122|||
161936943|NCT03298451|584819103|FG003|Overall Study|Death|280|||
161936944|NCT03298451|584819100|FG000|Overall Study|Lost to Follow-up|1|||
161936945|NCT03298451|584819101|FG001|Overall Study|Lost to Follow-up|1|||
161936946|NCT03298451|584819102|FG002|Overall Study|Lost to Follow-up|0|||
161936947|NCT03298451|584819103|FG003|Overall Study|Lost to Follow-up|7|||
161936948|NCT03298451|584819100|FG000|Overall Study|Withdrawal by Subject|9|||
161936949|NCT03298451|584819101|FG001|Overall Study|Withdrawal by Subject|7|||
161936950|NCT03298451|584819102|FG002|Overall Study|Withdrawal by Subject|1|||
161936951|NCT03298451|584819103|FG003|Overall Study|Withdrawal by Subject|20|||
161936952|NCT04150029|584819104|FG000|Overall Study|Disease Relapse|0|||
161529795|NCT00355082|583326715|FG001|Continuation Phase|Withdrawal by Subject|0|||
161529796|NCT00355082|583326716|FG002|Continuation Phase|Withdrawal by Subject|0|||
161529797|NCT00355082|583326714|FG000|Continuation Phase|Lack of Efficacy|5|||
161529798|NCT00355082|583326715|FG001|Continuation Phase|Lack of Efficacy|0|||
161529799|NCT00355082|583326716|FG002|Continuation Phase|Lack of Efficacy|0|||
161529800|NCT00355082|583326714|FG000|Continuation Phase|Site Closed by Sponsor|8|||
161529801|NCT00355082|583326715|FG001|Continuation Phase|Site Closed by Sponsor|0|||
161529802|NCT00355082|583326716|FG002|Continuation Phase|Site Closed by Sponsor|0|||
161529803|NCT00355082|583326714|FG000|Continuation Phase|Scheduling Error|1|||
161529804|NCT00355082|583326715|FG001|Continuation Phase|Scheduling Error|0|||
161529805|NCT00355082|583326716|FG002|Continuation Phase|Scheduling Error|0|||
161529806|NCT00355082|583326714|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
161936953|NCT04150029|584819105|FG001|Overall Study|Disease Relapse|18|||
161936954|NCT04150029|584819104|FG000|Overall Study|Progressive Disease|2|||
161529807|NCT00355082|583326715|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
161529808|NCT00355082|583326716|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
161529809|NCT02576067|583326717|FG000|Overall Study|Death|0|||
161529810|NCT02576067|583326718|FG001|Overall Study|Death|1|||
161529811|NCT02576067|583326717|FG000|Overall Study|Lack of Efficacy|1|||
161529812|NCT02576067|583326718|FG001|Overall Study|Lack of Efficacy|0|||
161529813|NCT02576067|583326717|FG000|Overall Study|Lost to Follow-up|11|||
161529814|NCT02576067|583326718|FG001|Overall Study|Lost to Follow-up|0|||
161529815|NCT02576067|583326717|FG000|Overall Study|Withdrawal by Subject|11|||
161529816|NCT02576067|583326718|FG001|Overall Study|Withdrawal by Subject|2|||
161529817|NCT02576067|583326717|FG000|Overall Study|study closure of main CIRT trial)|0|||
161529818|NCT02576067|583326718|FG001|Overall Study|study closure of main CIRT trial)|8|||
161529819|NCT02576067|583326717|FG000|Overall Study|not randomized, failed run-in|7|||
161529820|NCT02576067|583326718|FG001|Overall Study|not randomized, failed run-in|0|||
161529821|NCT02576067|583326717|FG000|Overall Study|screen failure/ re-enrolled|0|||
161529822|NCT02576067|583326718|FG001|Overall Study|screen failure/ re-enrolled|25|||
161529823|NCT02576067|583326717|FG000|Overall Study|Physician Decision|4|||
161529824|NCT02576067|583326718|FG001|Overall Study|Physician Decision|0|||
161529825|NCT04084314|583326719|FG000|Overall Study|Subject/guardian decision|91|||
161529826|NCT04084314|583326719|FG000|Overall Study|Adverse Event|24|||
161529827|NCT04084314|583326719|FG000|Overall Study|Lost to Follow-up|19|||
161529828|NCT04084314|583326719|FG000|Overall Study|New therapy for study indication|9|||
161529829|NCT04084314|583326719|FG000|Overall Study|Pregnancy|9|||
161529830|NCT04084314|583326719|FG000|Overall Study|Withdrawal of informed consent|8|||
161529831|NCT04084314|583326719|FG000|Overall Study|Physician Decision|4|||
161529832|NCT04084314|583326719|FG000|Overall Study|Protocol Deviation|3|||
161529833|NCT00622167|583326720|FG000|Overall Study|Did not meet angiographic criteria|20|||
161529834|NCT03738150|583326729|FG000|Base Study|Withdrawal by Subject|1|||
161529835|NCT03738150|583326729|FG000|Extension Study|Withdrawal by Subject|1|||
161529836|NCT04598152|583326732|FG000|Overall Study|Lost to Follow-up|0|||
161529837|NCT04598152|583326733|FG001|Overall Study|Lost to Follow-up|1|||
161529838|NCT03346759|583326734|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
161529839|NCT03346759|583326735|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
161529840|NCT03346759|583326734|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
161529841|NCT03346759|583326735|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
161529842|NCT03346759|583326734|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
161529843|NCT03346759|583326735|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
161529844|NCT03943095|583326736|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
161529845|NCT03943095|583326737|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
161936955|NCT04150029|584819105|FG001|Overall Study|Progressive Disease|16|||
161936956|NCT04150029|584819104|FG000|Overall Study|Adverse Event|1|||
161936957|NCT04150029|584819105|FG001|Overall Study|Adverse Event|11|||
161529846|NCT03943095|583326736|FG000|Overall Study|Withdrawal by Subject|1|||
161529847|NCT03943095|583326737|FG001|Overall Study|Withdrawal by Subject|0|||
161529848|NCT04988308|583326738|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
161529849|NCT04988308|583326739|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
161529850|NCT04988308|583326740|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
161529851|NCT04988308|583326741|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
161529852|NCT04988308|583326742|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
161529853|NCT04988308|583326743|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
161529854|NCT04988308|583326738|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
161529855|NCT04988308|583326739|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
161529856|NCT04988308|583326740|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
161529857|NCT04988308|583326741|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
161529858|NCT04988308|583326742|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
161529859|NCT04988308|583326743|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
161529860|NCT04988308|583326738|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
161529861|NCT04988308|583326739|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
161529862|NCT04988308|583326740|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
161529863|NCT04988308|583326741|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
161529864|NCT04988308|583326742|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
161529865|NCT04988308|583326743|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
161529866|NCT04988308|583326738|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
161529867|NCT04988308|583326739|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
161529868|NCT04988308|583326740|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
161529869|NCT04988308|583326741|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
161529870|NCT04988308|583326742|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
161529871|NCT04988308|583326743|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
161529872|NCT04988308|583326738|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
161529873|NCT04988308|583326739|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
161529874|NCT04988308|583326740|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
161529875|NCT04988308|583326741|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
161591144|NCT05178316|583552769|FG000|Overall Study|Withdrawal by Subject|5|||
161591145|NCT05178316|583552770|FG001|Overall Study|Withdrawal by Subject|11|||
161591146|NCT05178316|583552771|FG002|Overall Study|Withdrawal by Subject|5|||
161591147|NCT04347161|583552772|FG000|Overall Study|Death|0|||
161591148|NCT04347161|583552773|FG001|Overall Study|Death|2|||
161591149|NCT04347161|583552772|FG000|Overall Study|Withdrawal by Subject|1|||
161591150|NCT04347161|583552773|FG001|Overall Study|Withdrawal by Subject|0|||
161936958|NCT04150029|584819104|FG000|Overall Study|Physician Decision|0|||
161591151|NCT04347161|583552772|FG000|Overall Study|Lost to Follow-up|0|||
161591152|NCT04347161|583552773|FG001|Overall Study|Lost to Follow-up|1|||
161591153|NCT04347161|583552772|FG000|Overall Study|No longer on study medication|1|||
161591154|NCT04347161|583552773|FG001|Overall Study|No longer on study medication|1|||
161591155|NCT04169373|583552774|FG000|Week 1 to Week 14|Adverse Event|1|||
161591156|NCT04169373|583552775|FG001|Week 1 to Week 14|Adverse Event|0|||
161591157|NCT04169373|583552776|FG002|Week 1 to Week 14|Adverse Event|1|||
161591158|NCT04169373|583552777|FG003|Week 1 to Week 14|Adverse Event|2|||
161591159|NCT04169373|583552774|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
161591160|NCT04169373|583552775|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
161591161|NCT04169373|583552776|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
161591162|NCT04169373|583552777|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
161591163|NCT04169373|583552774|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
161591164|NCT04169373|583552775|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
161591165|NCT04169373|583552776|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
161591166|NCT04169373|583552777|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
161591167|NCT04169373|583552774|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161591168|NCT04169373|583552775|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
161591169|NCT04169373|583552776|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161591170|NCT04169373|583552777|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161529876|NCT04988308|583326742|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
161529877|NCT04988308|583326743|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
161529878|NCT04988308|583326738|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
161529879|NCT04988308|583326739|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
161529880|NCT04988308|583326740|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
161591171|NCT04169373|583552774|FG000|Week 1 to Week 14|Other|1|||
161591172|NCT04169373|583552775|FG001|Week 1 to Week 14|Other|3|||
161591173|NCT04169373|583552776|FG002|Week 1 to Week 14|Other|3|||
161591174|NCT04169373|583552777|FG003|Week 1 to Week 14|Other|5|||
161678432|NCT03281668|583875964|FG000|Overall Study|Withdrawal by Subject|4|||
161678433|NCT03281668|583875964|FG000|Overall Study|Lost to Follow-up|1|||
161529881|NCT04988308|583326741|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
161529882|NCT04988308|583326742|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
161529883|NCT04988308|583326743|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
161529884|NCT04988308|583326738|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
161529885|NCT04988308|583326739|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
161529886|NCT04988308|583326740|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
161529887|NCT04988308|583326741|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
161529888|NCT04988308|583326742|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
161529889|NCT04988308|583326743|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
161529890|NCT04988308|583326738|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161529891|NCT04988308|583326739|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161529892|NCT04988308|583326740|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
161529893|NCT04988308|583326741|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
161529894|NCT04988308|583326742|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
161529895|NCT04988308|583326743|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
161529896|NCT04988308|583326738|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
161529897|NCT04988308|583326739|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
161529898|NCT04988308|583326740|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
161529899|NCT04988308|583326741|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
161529900|NCT04988308|583326742|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
161529901|NCT04988308|583326743|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
161529902|NCT04177758|583326753|FG000|Overall Study|Lost to Follow-up|19|||
161529903|NCT04177758|583326754|FG001|Overall Study|Lost to Follow-up|11|||
161529904|NCT02763384|583326755|FG000|Overall Study|Physician Decision|1|||
161529905|NCT02763384|583326755|FG000|Overall Study|Rapid decline - went on hospice|1|||
161529906|NCT02057874|583328880|FG000|Overall Study|participant did not return for scan|1|||
161529907|NCT01738984|583328883|FG000|Overall Study|Pregnancy|4|||
161529908|NCT01738984|583328884|FG001|Overall Study|Pregnancy|0|||
161529909|NCT01738984|583328883|FG000|Overall Study|Withdrawal by Subject|1|||
161529910|NCT01738984|583328884|FG001|Overall Study|Withdrawal by Subject|0|||
161529911|NCT01738984|583328883|FG000|Overall Study|Lost to Follow-up|59|||
161529912|NCT01738984|583328884|FG001|Overall Study|Lost to Follow-up|39|||
161529913|NCT02621931|583328889|FG000|Overall Study|Death|0|||
161529914|NCT02621931|583328890|FG001|Overall Study|Death|1|||
161529915|NCT02621931|583328891|FG002|Overall Study|Death|0|||
161529916|NCT02621931|583328889|FG000|Overall Study|Adverse Event|8|||
161529917|NCT02621931|583328890|FG001|Overall Study|Adverse Event|5|||
161529918|NCT02621931|583328891|FG002|Overall Study|Adverse Event|7|||
161529919|NCT02621931|583328889|FG000|Overall Study|Withdrawal by Subject|12|||
161529920|NCT02621931|583328890|FG001|Overall Study|Withdrawal by Subject|10|||
161529921|NCT02621931|583328891|FG002|Overall Study|Withdrawal by Subject|11|||
161529922|NCT02621931|583328889|FG000|Overall Study|Protocol Violation|2|||
161529923|NCT02621931|583328890|FG001|Overall Study|Protocol Violation|2|||
161529924|NCT02621931|583328891|FG002|Overall Study|Protocol Violation|2|||
161529925|NCT02621931|583328889|FG000|Overall Study|Pregnancy|2|||
161529926|NCT02621931|583328890|FG001|Overall Study|Pregnancy|0|||
161529927|NCT02621931|583328891|FG002|Overall Study|Pregnancy|0|||
161529928|NCT02621931|583328889|FG000|Overall Study|Noncompliance to study procedures|0|||
161529929|NCT02621931|583328890|FG001|Overall Study|Noncompliance to study procedures|1|||
161529930|NCT02621931|583328891|FG002|Overall Study|Noncompliance to study procedures|2|||
161529931|NCT02621931|583328889|FG000|Overall Study|Lost to Follow-up|8|||
161529932|NCT02621931|583328890|FG001|Overall Study|Lost to Follow-up|7|||
161529933|NCT02621931|583328891|FG002|Overall Study|Lost to Follow-up|10|||
161529934|NCT02621931|583328889|FG000|Overall Study|Lack of Efficacy|0|||
161529935|NCT02621931|583328890|FG001|Overall Study|Lack of Efficacy|0|||
161529936|NCT02621931|583328891|FG002|Overall Study|Lack of Efficacy|1|||
161936959|NCT04150029|584819105|FG001|Overall Study|Physician Decision|10|||
161936960|NCT04150029|584819104|FG000|Overall Study|Study Terminated by Sponsor|1|||
161936961|NCT04150029|584819105|FG001|Overall Study|Study Terminated by Sponsor|10|||
161936962|NCT04150029|584819104|FG000|Overall Study|Death|0|||
161936963|NCT04150029|584819105|FG001|Overall Study|Death|8|||
161936964|NCT04150029|584819104|FG000|Overall Study|Participant Decision|0|||
161936965|NCT04150029|584819105|FG001|Overall Study|Participant Decision|7|||
161936966|NCT04150029|584819104|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
161529937|NCT02621931|583328889|FG000|Overall Study|Other|1|||
161529938|NCT02621931|583328890|FG001|Overall Study|Other|1|||
161529939|NCT02621931|583328891|FG002|Overall Study|Other|3|||
161529940|NCT00920426|583328892|FG000|ITZ111451|Adverse Event|1|||
161529941|NCT00920426|583328893|FG001|ITZ111451|Adverse Event|0|||
161936967|NCT04150029|584819105|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
161529942|NCT00920426|583328894|FG002|ITZ111451|Adverse Event|0|||
161529943|NCT00920426|583328895|FG003|ITZ111451|Adverse Event|0|||
161529944|NCT00955357|583328900|FG000|Titration Phase|Adverse Event|9|||
161529945|NCT00955357|583328901|FG001|Titration Phase|Adverse Event|46|||
161529946|NCT00955357|583328900|FG000|Titration Phase|Lack of Efficacy|0|||
161529947|NCT00955357|583328901|FG001|Titration Phase|Lack of Efficacy|2|||
161529948|NCT00955357|583328900|FG000|Titration Phase|Protocol Violation|3|||
161529949|NCT00955357|583328901|FG001|Titration Phase|Protocol Violation|7|||
161529950|NCT00955357|583328900|FG000|Titration Phase|Lost to Follow-up|1|||
161529951|NCT00955357|583328901|FG001|Titration Phase|Lost to Follow-up|3|||
161529952|NCT00955357|583328900|FG000|Titration Phase|Withdrawal by Subject|3|||
161529953|NCT00955357|583328901|FG001|Titration Phase|Withdrawal by Subject|5|||
161529954|NCT00955357|583328900|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
161529955|NCT00955357|583328901|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
161529956|NCT00955357|583328900|FG000|Titration Phase|Study medication not tolerated|0|||
161529957|NCT00955357|583328901|FG001|Titration Phase|Study medication not tolerated|1|||
161529958|NCT00955357|583328900|FG000|Titration Phase|Non compliance to study procedures|0|||
161529959|NCT00955357|583328901|FG001|Titration Phase|Non compliance to study procedures|1|||
161529960|NCT00955357|583328900|FG000|Maintenance Phase|Adverse Event|3|||
161529961|NCT00955357|583328901|FG001|Maintenance Phase|Adverse Event|23|||
161529962|NCT00955357|583328900|FG000|Maintenance Phase|Lack of Efficacy|0|||
161529963|NCT00955357|583328901|FG001|Maintenance Phase|Lack of Efficacy|4|||
161529964|NCT00955357|583328900|FG000|Maintenance Phase|Protocol Violation|2|||
161529965|NCT00955357|583328901|FG001|Maintenance Phase|Protocol Violation|6|||
161529966|NCT00955357|583328900|FG000|Maintenance Phase|Lost to Follow-up|2|||
161529967|NCT00955357|583328901|FG001|Maintenance Phase|Lost to Follow-up|7|||
161529968|NCT00955357|583328900|FG000|Maintenance Phase|Withdrawal by Subject|4|||
161529969|NCT00955357|583328901|FG001|Maintenance Phase|Withdrawal by Subject|4|||
161529970|NCT00955357|583328900|FG000|Maintenance Phase|Patient moving out of area|0|||
161529971|NCT00955357|583328901|FG001|Maintenance Phase|Patient moving out of area|1|||
161529972|NCT00955357|583328900|FG000|Maintenance Phase|Non compliance to study procedures|1|||
161529973|NCT00955357|583328901|FG001|Maintenance Phase|Non compliance to study procedures|0|||
161529974|NCT00886340|583328902|FG000|Overall Study|Withdrawal by Subject|0|||
161529975|NCT00886340|583328903|FG001|Overall Study|Withdrawal by Subject|7|||
161529976|NCT02985866|583328904|FG000|Overall Study|Poor CGM data|1|||
161529977|NCT02985866|583328905|FG001|Overall Study|Poor CGM data|1|||
161529978|NCT03224182|583328906|FG000|Overall Study|Study Drug Not Instilled|6|||
161529979|NCT03224182|583328907|FG001|Overall Study|Study Drug Not Instilled|1|||
161529980|NCT03224182|583328906|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
161529981|NCT03224182|583328907|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
161529982|NCT03224182|583328906|FG000|Overall Study|Withdrew of Consent|4|||
161529983|NCT03224182|583328907|FG001|Overall Study|Withdrew of Consent|2|||
161529984|NCT03224182|583328906|FG000|Overall Study|Investigator Decision|3|||
161529985|NCT03224182|583328907|FG001|Overall Study|Investigator Decision|1|||
161529986|NCT03224182|583328906|FG000|Overall Study|Sponsor Decision|26|||
161529987|NCT03224182|583328907|FG001|Overall Study|Sponsor Decision|12|||
161529988|NCT03224182|583328906|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
161529989|NCT03224182|583328907|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
161529990|NCT03224182|583328906|FG000|Overall Study|Lost to Follow-up|1|||
161529991|NCT03224182|583328907|FG001|Overall Study|Lost to Follow-up|0|||
161529992|NCT03224182|583328906|FG000|Overall Study|Participant Had Recurrence|11|||
161529993|NCT03224182|583328907|FG001|Overall Study|Participant Had Recurrence|5|||
161529994|NCT03224182|583328906|FG000|Overall Study|Death|0|||
161529995|NCT03224182|583328907|FG001|Overall Study|Death|1|||
161529996|NCT03224182|583328906|FG000|Overall Study|Reason not Specified|3|||
161529997|NCT03224182|583328907|FG001|Overall Study|Reason not Specified|3|||
161529998|NCT03224182|583328906|FG000|Overall Study|Other|1|||
161529999|NCT03224182|583328907|FG001|Overall Study|Other|0|||
161530000|NCT02925455|583328911|FG000|Overall Study|Withdrawal by Subject|2|||
161530001|NCT02925455|583328912|FG001|Overall Study|Withdrawal by Subject|0|||
161530002|NCT00686166|583328916|FG000|Overall Study|Adverse Event|7|||
161530003|NCT00686166|583328916|FG000|Overall Study|Withdrawal by Subject|1|||
161530004|NCT00686166|583328916|FG000|Overall Study|Progression/Relapse|1|||
161530005|NCT00686166|583328916|FG000|Overall Study|Death|1|||
161591175|NCT04169373|583552774|FG000|Week 14 to Week 52|Adverse Event|1|||
161591176|NCT04169373|583552775|FG001|Week 14 to Week 52|Adverse Event|0|||
161591177|NCT04169373|583552776|FG002|Week 14 to Week 52|Adverse Event|0|||
161591178|NCT04169373|583552777|FG003|Week 14 to Week 52|Adverse Event|1|||
161530006|NCT00686166|583328916|FG000|Overall Study|Not Protocol Specified|1|||
161530007|NCT00686166|583328916|FG000|Overall Study|Ineligible|5|||
161530008|NCT00686166|583328916|FG000|Overall Study|Did not begin protocol therapy|4|||
161530009|NCT00985725|583328917|FG000|Overall Study|Adverse Event|4|||
161591179|NCT04169373|583552774|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
161530010|NCT00985725|583328918|FG001|Overall Study|Adverse Event|1|||
161591180|NCT04169373|583552775|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
161530011|NCT00985725|583328917|FG000|Overall Study|Protocol Violation|1|||
161530012|NCT00985725|583328918|FG001|Overall Study|Protocol Violation|3|||
161530013|NCT00985725|583328917|FG000|Overall Study|Withdrawal by Subject|4|||
161530014|NCT00985725|583328918|FG001|Overall Study|Withdrawal by Subject|4|||
161530015|NCT00985725|583328917|FG000|Overall Study|Lost to Follow-up|1|||
161591181|NCT04169373|583552776|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
161591182|NCT04169373|583552777|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
161591183|NCT04169373|583552774|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
161591184|NCT04169373|583552775|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
161591185|NCT04169373|583552776|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
161591186|NCT04169373|583552777|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
161591187|NCT04169373|583552774|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
161591188|NCT04169373|583552775|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161591189|NCT04169373|583552776|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161591190|NCT04169373|583552777|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161530016|NCT00985725|583328918|FG001|Overall Study|Lost to Follow-up|1|||
161591191|NCT04169373|583552774|FG000|Week 14 to Week 52|Other|4|||
161591192|NCT04169373|583552775|FG001|Week 14 to Week 52|Other|5|||
161591193|NCT04169373|583552776|FG002|Week 14 to Week 52|Other|4|||
161591194|NCT04169373|583552777|FG003|Week 14 to Week 52|Other|5|||
161591195|NCT04169373|583552774|FG000|Week 14 to Week 52|Ongoing|0|||
161591196|NCT04169373|583552775|FG001|Week 14 to Week 52|Ongoing|1|||
161591197|NCT04169373|583552776|FG002|Week 14 to Week 52|Ongoing|0|||
161591198|NCT04169373|583552777|FG003|Week 14 to Week 52|Ongoing|0|||
161591199|NCT04610892|583552778|FG000|Overall Study|Adverse Event|1|||
161591200|NCT04610892|583552779|FG001|Overall Study|Adverse Event|0|||
161591201|NCT04610892|583552780|FG002|Overall Study|Adverse Event|0|||
161591202|NCT04610892|583552781|FG003|Overall Study|Adverse Event|1|||
161591203|NCT04610892|583552782|FG004|Overall Study|Adverse Event|3|||
161591204|NCT04610892|583552778|FG000|Overall Study|Death|0|||
161591205|NCT04610892|583552779|FG001|Overall Study|Death|1|||
161530017|NCT00985725|583328917|FG000|Overall Study|Lack of Efficacy|0|||
161530018|NCT00985725|583328918|FG001|Overall Study|Lack of Efficacy|1|||
161530019|NCT00985725|583328917|FG000|Overall Study|Non-compliance|1|||
161530020|NCT00985725|583328918|FG001|Overall Study|Non-compliance|2|||
161530021|NCT00985725|583328917|FG000|Overall Study|Out-of-window visits|0|||
161530022|NCT00985725|583328918|FG001|Overall Study|Out-of-window visits|1|||
161530023|NCT02314624|583328922|FG000|Overall Study|No participating patient|16|||
161530024|NCT02314624|583328923|FG001|Overall Study|No participating patient|13|||
161530025|NCT02314624|583328922|FG000|Overall Study|Participant withdrew|7|||
161591206|NCT04610892|583552780|FG002|Overall Study|Death|0|||
161591207|NCT04610892|583552781|FG003|Overall Study|Death|1|||
161591208|NCT04610892|583552782|FG004|Overall Study|Death|0|||
161591209|NCT04610892|583552778|FG000|Overall Study|Withdrawal by Subject|3|||
161591210|NCT04610892|583552779|FG001|Overall Study|Withdrawal by Subject|2|||
161591211|NCT04610892|583552780|FG002|Overall Study|Withdrawal by Subject|0|||
161591212|NCT04610892|583552781|FG003|Overall Study|Withdrawal by Subject|6|||
161591213|NCT04610892|583552782|FG004|Overall Study|Withdrawal by Subject|6|||
161591214|NCT04610892|583552778|FG000|Overall Study|Subjects who did not receive treatment|1|||
161591215|NCT04610892|583552779|FG001|Overall Study|Subjects who did not receive treatment|0|||
161591216|NCT04610892|583552780|FG002|Overall Study|Subjects who did not receive treatment|0|||
161591217|NCT04610892|583552781|FG003|Overall Study|Subjects who did not receive treatment|0|||
161591218|NCT04610892|583552782|FG004|Overall Study|Subjects who did not receive treatment|2|||
161591219|NCT01413100|583552783|FG000|Overall Study|Withdrawal by Subject|1|||
161591220|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
161591221|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
161591222|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
161591223|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
161591224|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
161591225|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
161591226|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
161591227|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
161591228|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
161591229|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
161591230|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
161591231|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
161591232|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
161591233|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
161591234|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
161591235|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
161530026|NCT02314624|583328923|FG001|Overall Study|Participant withdrew|2|||
161530027|NCT02314624|583328922|FG000|Overall Study|Lost to Follow-up|2|||
161530028|NCT02314624|583328923|FG001|Overall Study|Lost to Follow-up|5|||
161591236|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
161591237|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
161591238|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
161530029|NCT02314624|583328922|FG000|Overall Study|Dropped/Excluded by PI|6|||
161530030|NCT02314624|583328923|FG001|Overall Study|Dropped/Excluded by PI|6|||
161530031|NCT03151005|583328924|FG000|Overall Study|Lost to Follow-up|5|||
161530032|NCT03151005|583328925|FG001|Overall Study|Lost to Follow-up|5|||
161530033|NCT03912259|583328926|FG000|Overall Study|Adverse Event (AE)|2|||
161530034|NCT03912259|583328927|FG001|Overall Study|Adverse Event (AE)|4|||
161530035|NCT03912259|583328926|FG000|Overall Study|Lack of Efficacy|4|||
161530036|NCT03912259|583328927|FG001|Overall Study|Lack of Efficacy|1|||
161530037|NCT03912259|583328926|FG000|Overall Study|Withdrawal by Subject|11|||
161530038|NCT03912259|583328927|FG001|Overall Study|Withdrawal by Subject|1|||
161530039|NCT01549613|583328930|FG000|Overall Study|Lost to Follow-up|11|||
161530040|NCT01549613|583328931|FG001|Overall Study|Lost to Follow-up|11|||
161530041|NCT02131272|583328932|FG000|Overall Study|Withdrawal by parent|0|||
161530042|NCT02131272|583328933|FG001|Overall Study|Withdrawal by parent|1|||
161530043|NCT02131272|583328932|FG000|Overall Study|Withdrawal by Subject|0|||
161530044|NCT02131272|583328933|FG001|Overall Study|Withdrawal by Subject|1|||
161530045|NCT02131272|583328932|FG000|Overall Study|Withdrawal Criteria|1|||
161530046|NCT02131272|583328933|FG001|Overall Study|Withdrawal Criteria|0|||
161530047|NCT00381940|583328934|FG000|Overall Study|Lack of Efficacy|3|||
161530048|NCT00381940|583328934|FG000|Overall Study|Protocol Violation|1|||
161530049|NCT00381940|583328934|FG000|Overall Study|Ineligible|1|||
161530050|NCT00464815|583328935|FG000|Overall Study|Withdrawal by Subject|6|||
161530051|NCT00464815|583328936|FG001|Overall Study|Withdrawal by Subject|3|||
161530052|NCT03643952|583328940|FG000|Overall Study|Lack of Efficacy|1|||
161530053|NCT01358968|583328941|FG000|Period 2|Adverse Event|0|||
161530054|NCT01358968|583328942|FG001|Period 2|Adverse Event|1|||
161530055|NCT01358968|583328943|FG002|Period 2|Adverse Event|0|||
161530056|NCT01358968|583328944|FG003|Period 2|Adverse Event|0|||
161530057|NCT01358968|583328941|FG000|Continued Access Phase|Progression of Disease|0|||
161530058|NCT01358968|583328942|FG001|Continued Access Phase|Progression of Disease|0|||
161530059|NCT01358968|583328943|FG002|Continued Access Phase|Progression of Disease|8|||
161530060|NCT01358968|583328944|FG003|Continued Access Phase|Progression of Disease|4|||
161530061|NCT01358968|583328941|FG000|Continued Access Phase|Protocol Violation|0|||
161530062|NCT01358968|583328942|FG001|Continued Access Phase|Protocol Violation|0|||
161530063|NCT01358968|583328943|FG002|Continued Access Phase|Protocol Violation|0|||
161530064|NCT01358968|583328944|FG003|Continued Access Phase|Protocol Violation|2|||
161530065|NCT01358968|583328941|FG000|Continued Access Phase|Withdrawal by Subject|0|||
161530066|NCT01358968|583328942|FG001|Continued Access Phase|Withdrawal by Subject|0|||
161530067|NCT01358968|583328943|FG002|Continued Access Phase|Withdrawal by Subject|3|||
161530068|NCT01358968|583328944|FG003|Continued Access Phase|Withdrawal by Subject|0|||
161530069|NCT01358968|583328941|FG000|Continued Access Phase|Death|0|||
161530070|NCT01358968|583328942|FG001|Continued Access Phase|Death|0|||
161530071|NCT01358968|583328943|FG002|Continued Access Phase|Death|1|||
161530072|NCT01358968|583328944|FG003|Continued Access Phase|Death|1|||
161530073|NCT01597050|583328945|FG000|Overall Study|Withdrawal by Subject|1|||
161530074|NCT01597050|583328946|FG001|Overall Study|Withdrawal by Subject|0|||
161530075|NCT00483184|583328947|FG000|Overall Study|Withdrawal by Subject|2|||
161530076|NCT00483184|583328948|FG001|Overall Study|Withdrawal by Subject|2|||
161530077|NCT00483184|583328949|FG002|Overall Study|Withdrawal by Subject|0|||
161530078|NCT00483184|583328947|FG000|Overall Study|Lost to Follow-up|1|||
161530079|NCT00483184|583328948|FG001|Overall Study|Lost to Follow-up|0|||
161530080|NCT00483184|583328949|FG002|Overall Study|Lost to Follow-up|0|||
161530081|NCT00483184|583328947|FG000|Overall Study|Adverse Event|1|||
161530082|NCT00483184|583328948|FG001|Overall Study|Adverse Event|2|||
161530083|NCT00483184|583328949|FG002|Overall Study|Adverse Event|2|||
161530084|NCT00483184|583328947|FG000|Overall Study|Protocol Violation|1|||
161530085|NCT00483184|583328948|FG001|Overall Study|Protocol Violation|0|||
161530086|NCT00483184|583328949|FG002|Overall Study|Protocol Violation|1|||
161530087|NCT00515502|583328957|FG000|Treatment Period 1|Adverse Event|0|||
161530088|NCT00515502|583328958|FG001|Treatment Period 1|Adverse Event|0|||
161530089|NCT00515502|583328959|FG002|Treatment Period 1|Adverse Event|0|||
161530090|NCT00515502|583328960|FG003|Treatment Period 1|Adverse Event|0|||
161530091|NCT00515502|583328961|FG004|Treatment Period 1|Adverse Event|0|||
161530092|NCT00515502|583328962|FG005|Treatment Period 1|Adverse Event|0|||
161530093|NCT00515502|583328963|FG006|Treatment Period 1|Adverse Event|1|||
161530094|NCT00515502|583328964|FG007|Treatment Period 1|Adverse Event|0|||
161530095|NCT00515502|583328965|FG008|Treatment Period 1|Adverse Event|1|||
161530096|NCT00515502|583328966|FG009|Treatment Period 1|Adverse Event|0|||
161530097|NCT00515502|583328967|FG010|Treatment Period 1|Adverse Event|0|||
161530098|NCT00515502|583328968|FG011|Treatment Period 1|Adverse Event|1|||
161530099|NCT00515502|583328957|FG000|Treatment Period 2|Adverse Event|0|||
161530100|NCT00515502|583328958|FG001|Treatment Period 2|Adverse Event|1|||
161530101|NCT00515502|583328959|FG002|Treatment Period 2|Adverse Event|0|||
161530102|NCT00515502|583328960|FG003|Treatment Period 2|Adverse Event|0|||
161530103|NCT00515502|583328961|FG004|Treatment Period 2|Adverse Event|0|||
161530104|NCT00515502|583328962|FG005|Treatment Period 2|Adverse Event|0|||
161530105|NCT00515502|583328963|FG006|Treatment Period 2|Adverse Event|0|||
161678434|NCT01858532|583875967|FG000|Overall Study|Adverse Event|58|||
161530106|NCT00515502|583328964|FG007|Treatment Period 2|Adverse Event|0|||
161530107|NCT00515502|583328965|FG008|Treatment Period 2|Adverse Event|0|||
161530108|NCT00515502|583328966|FG009|Treatment Period 2|Adverse Event|0|||
161530109|NCT00515502|583328967|FG010|Treatment Period 2|Adverse Event|0|||
161530110|NCT00515502|583328968|FG011|Treatment Period 2|Adverse Event|0|||
161530111|NCT03252587|583328971|FG000|Overall Study|Adverse Event|3|||
161530112|NCT03252587|583328972|FG001|Overall Study|Adverse Event|8|||
161530113|NCT03252587|583328973|FG002|Overall Study|Adverse Event|6|||
161530114|NCT03252587|583328974|FG003|Overall Study|Adverse Event|12|||
161530115|NCT03252587|583328971|FG000|Overall Study|Lack of Efficacy|7|||
161530116|NCT03252587|583328972|FG001|Overall Study|Lack of Efficacy|2|||
161530117|NCT03252587|583328973|FG002|Overall Study|Lack of Efficacy|2|||
161530118|NCT03252587|583328974|FG003|Overall Study|Lack of Efficacy|4|||
161530119|NCT03252587|583328971|FG000|Overall Study|Lost to Follow-up|2|||
161530120|NCT03252587|583328972|FG001|Overall Study|Lost to Follow-up|0|||
161530121|NCT03252587|583328973|FG002|Overall Study|Lost to Follow-up|0|||
161530122|NCT03252587|583328974|FG003|Overall Study|Lost to Follow-up|2|||
161530123|NCT03252587|583328971|FG000|Overall Study|Pregnancy|2|||
161530124|NCT03252587|583328972|FG001|Overall Study|Pregnancy|1|||
161530125|NCT03252587|583328973|FG002|Overall Study|Pregnancy|0|||
161530126|NCT03252587|583328974|FG003|Overall Study|Pregnancy|1|||
161530127|NCT03252587|583328971|FG000|Overall Study|Withdrawal by Subject|8|||
161530128|NCT03252587|583328972|FG001|Overall Study|Withdrawal by Subject|4|||
161530129|NCT03252587|583328973|FG002|Overall Study|Withdrawal by Subject|4|||
161530130|NCT03252587|583328974|FG003|Overall Study|Withdrawal by Subject|4|||
161530131|NCT03252587|583328971|FG000|Overall Study|Other Reasons|2|||
161530132|NCT03252587|583328972|FG001|Overall Study|Other Reasons|5|||
161530133|NCT03252587|583328973|FG002|Overall Study|Other Reasons|5|||
161530134|NCT03252587|583328974|FG003|Overall Study|Other Reasons|4|||
161530135|NCT04052204|583328975|FG000|Overall Study|Death|1|||
161530136|NCT04052204|583328976|FG001|Overall Study|Death|0|||
161530137|NCT04052204|583328977|FG002|Overall Study|Death|0|||
161530138|NCT04052204|583328975|FG000|Overall Study|Progressive disease|1|||
161530139|NCT04052204|583328976|FG001|Overall Study|Progressive disease|0|||
161530140|NCT04052204|583328977|FG002|Overall Study|Progressive disease|0|||
161530141|NCT04052204|583328975|FG000|Overall Study|Other|1|||
161530142|NCT04052204|583328976|FG001|Overall Study|Other|0|||
161530143|NCT04052204|583328977|FG002|Overall Study|Other|0|||
161530144|NCT03647501|583328978|FG000|Overall Study|Lost to Follow-up|1|||
161530145|NCT03647501|583328979|FG001|Overall Study|Lost to Follow-up|1|||
161530146|NCT03647501|583328978|FG000|Overall Study|Withdrawal by Subject|0|||
161530147|NCT03647501|583328979|FG001|Overall Study|Withdrawal by Subject|1|||
161530148|NCT03945188|583328980|FG000|Overall Study|Protocol Violation|1|||
161530149|NCT03945188|583328981|FG001|Overall Study|Protocol Violation|0|||
161530150|NCT03945188|583328980|FG000|Overall Study|Disease worsening|79|||
161530151|NCT03945188|583328981|FG001|Overall Study|Disease worsening|73|||
161530152|NCT03945188|583328980|FG000|Overall Study|Physician Decision|2|||
161530153|NCT03945188|583328981|FG001|Overall Study|Physician Decision|2|||
161530154|NCT03945188|583328980|FG000|Overall Study|Lack of Efficacy|7|||
161530155|NCT03945188|583328981|FG001|Overall Study|Lack of Efficacy|4|||
161530156|NCT03945188|583328980|FG000|Overall Study|Pregnancy|2|||
161530157|NCT03945188|583328981|FG001|Overall Study|Pregnancy|0|||
161530158|NCT03945188|583328980|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
161530159|NCT03945188|583328981|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
161530160|NCT03945188|583328980|FG000|Overall Study|Adverse Event|10|||
161530161|NCT03945188|583328981|FG001|Overall Study|Adverse Event|5|||
161530162|NCT03945188|583328980|FG000|Overall Study|Other|2|||
161530163|NCT03945188|583328981|FG001|Overall Study|Other|2|||
161530164|NCT03945188|583328980|FG000|Overall Study|Lost to Follow-up|1|||
161530165|NCT03945188|583328981|FG001|Overall Study|Lost to Follow-up|2|||
161530166|NCT01613248|583328982|FG000|Overall Study|Adverse Event|0|||
161530167|NCT01613248|583328983|FG001|Overall Study|Adverse Event|0|||
161530168|NCT01613248|583328984|FG002|Overall Study|Adverse Event|0|||
161530169|NCT01613248|583328985|FG003|Overall Study|Adverse Event|1|||
161530170|NCT01613248|583328986|FG004|Overall Study|Adverse Event|0|||
161530171|NCT01613248|583328987|FG005|Overall Study|Adverse Event|0|||
161530172|NCT01613248|583328982|FG000|Overall Study|Withdrawal by Subject|3|||
161530173|NCT01613248|583328983|FG001|Overall Study|Withdrawal by Subject|2|||
161530174|NCT01613248|583328984|FG002|Overall Study|Withdrawal by Subject|2|||
161530175|NCT01613248|583328985|FG003|Overall Study|Withdrawal by Subject|5|||
161530176|NCT01613248|583328986|FG004|Overall Study|Withdrawal by Subject|0|||
161530177|NCT01613248|583328987|FG005|Overall Study|Withdrawal by Subject|1|||
161530178|NCT01613248|583328982|FG000|Overall Study|Lost to Follow-up|5|||
161530179|NCT01613248|583328983|FG001|Overall Study|Lost to Follow-up|7|||
161530180|NCT01613248|583328984|FG002|Overall Study|Lost to Follow-up|4|||
161530181|NCT01613248|583328985|FG003|Overall Study|Lost to Follow-up|8|||
161591239|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
161530182|NCT01613248|583328986|FG004|Overall Study|Lost to Follow-up|4|||
161530183|NCT01613248|583328987|FG005|Overall Study|Lost to Follow-up|2|||
161530184|NCT01613248|583328982|FG000|Overall Study|Study Terminated by Sponsor|4|||
161530185|NCT01613248|583328983|FG001|Overall Study|Study Terminated by Sponsor|6|||
161530186|NCT01613248|583328984|FG002|Overall Study|Study Terminated by Sponsor|8|||
161530187|NCT01613248|583328985|FG003|Overall Study|Study Terminated by Sponsor|8|||
161936968|NCT01602380|584819106|FG000|Overall Study|Death|147|||
161530188|NCT01613248|583328986|FG004|Overall Study|Study Terminated by Sponsor|9|||
161530189|NCT01613248|583328987|FG005|Overall Study|Study Terminated by Sponsor|11|||
161530190|NCT01613248|583328982|FG000|Overall Study|Physician Decision|8|||
161530191|NCT01613248|583328983|FG001|Overall Study|Physician Decision|8|||
161530192|NCT01613248|583328984|FG002|Overall Study|Physician Decision|9|||
161530193|NCT01613248|583328985|FG003|Overall Study|Physician Decision|4|||
161530194|NCT01613248|583328986|FG004|Overall Study|Physician Decision|7|||
161530195|NCT01613248|583328987|FG005|Overall Study|Physician Decision|6|||
161530196|NCT01613248|583328982|FG000|Overall Study|Lack of Qualifying Event|9|||
161530197|NCT01613248|583328983|FG001|Overall Study|Lack of Qualifying Event|11|||
161530198|NCT01613248|583328984|FG002|Overall Study|Lack of Qualifying Event|10|||
161530199|NCT01613248|583328985|FG003|Overall Study|Lack of Qualifying Event|11|||
161530200|NCT01613248|583328986|FG004|Overall Study|Lack of Qualifying Event|15|||
161530201|NCT01613248|583328987|FG005|Overall Study|Lack of Qualifying Event|18|||
161530202|NCT01613248|583328982|FG000|Overall Study|Pregnancy|0|||
161530203|NCT01613248|583328983|FG001|Overall Study|Pregnancy|0|||
161530204|NCT01613248|583328984|FG002|Overall Study|Pregnancy|0|||
161530205|NCT01613248|583328985|FG003|Overall Study|Pregnancy|1|||
161530206|NCT01613248|583328986|FG004|Overall Study|Pregnancy|0|||
161530207|NCT01613248|583328987|FG005|Overall Study|Pregnancy|0|||
161530208|NCT01433354|583328988|FG000|Overall Study|Adverse Event|6|||
161530209|NCT01433354|583328988|FG000|Overall Study|Lost to Follow-up|1|||
161530210|NCT01433354|583328988|FG000|Overall Study|Administrative problems|90|||
161530211|NCT01433354|583328988|FG000|Overall Study|Protocol Violation|2|||
161530212|NCT01433354|583328988|FG000|Overall Study|Lack of Efficacy|17|||
161530213|NCT01433354|583328988|FG000|Overall Study|Subject Withdrew Consent|3|||
161530214|NCT01618162|583328997|FG000|Overall Study|Protocol Violation|13|||
161530215|NCT01618162|583328998|FG001|Overall Study|Protocol Violation|10|||
161530216|NCT01618162|583328997|FG000|Overall Study|Adverse Event|9|||
161530217|NCT01618162|583328998|FG001|Overall Study|Adverse Event|2|||
161530218|NCT01618162|583328997|FG000|Overall Study|Withdrawal Criteria|2|||
161530219|NCT01618162|583328998|FG001|Overall Study|Withdrawal Criteria|10|||
161530220|NCT01618162|583328997|FG000|Overall Study|Unclassified|14|||
161530221|NCT01618162|583328998|FG001|Overall Study|Unclassified|13|||
161530222|NCT04794803|583328999|FG000|Overall Study|Death|1|||
161530223|NCT04794803|583329000|FG001|Overall Study|Death|3|||
161530224|NCT04794803|583328999|FG000|Overall Study|Lost to Follow-up|2|||
161530225|NCT04794803|583329000|FG001|Overall Study|Lost to Follow-up|2|||
161530226|NCT04794803|583328999|FG000|Overall Study|Withdrawal by Subject|1|||
161530227|NCT04794803|583329000|FG001|Overall Study|Withdrawal by Subject|0|||
161530228|NCT04794803|583328999|FG000|Overall Study|Physician Decision|1|||
161530229|NCT04794803|583329000|FG001|Overall Study|Physician Decision|1|||
161530230|NCT04794803|583328999|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
161530231|NCT04794803|583329000|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
161530232|NCT04794803|583328999|FG000|Overall Study|Refused to continue the treatment|1|||
161530233|NCT04794803|583329000|FG001|Overall Study|Refused to continue the treatment|0|||
161530234|NCT04794803|583328999|FG000|Overall Study|Patient admitted to ICU|0|||
161530235|NCT04794803|583329000|FG001|Overall Study|Patient admitted to ICU|1|||
161530236|NCT04124926|583329005|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
161530237|NCT04124926|583329006|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
161530238|NCT04124926|583329007|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
161530239|NCT04124926|583329008|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
161530240|NCT04124926|583329009|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
161530241|NCT04124926|583329005|FG000|Healing Phase|Protocol Violation|0|||
161530242|NCT04124926|583329006|FG001|Healing Phase|Protocol Violation|1|||
161530243|NCT04124926|583329007|FG002|Healing Phase|Protocol Violation|0|||
161530244|NCT04124926|583329008|FG003|Healing Phase|Protocol Violation|0|||
161936969|NCT01602380|584819107|FG001|Overall Study|Death|145|||
161530245|NCT04124926|583329009|FG004|Healing Phase|Protocol Violation|0|||
161530246|NCT04124926|583329005|FG000|Healing Phase|Lost to Follow-up|5|||
161591240|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
161591241|NCT05369403|583552784|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
161591242|NCT05369403|583552785|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
161936970|NCT01602380|584819106|FG000|Overall Study|Withdrawal by Subject|39|||
161936971|NCT01602380|584819107|FG001|Overall Study|Withdrawal by Subject|41|||
161530247|NCT04124926|583329006|FG001|Healing Phase|Lost to Follow-up|4|||
161530248|NCT04124926|583329007|FG002|Healing Phase|Lost to Follow-up|0|||
161530249|NCT04124926|583329008|FG003|Healing Phase|Lost to Follow-up|0|||
161530250|NCT04124926|583329009|FG004|Healing Phase|Lost to Follow-up|0|||
161530251|NCT04124926|583329005|FG000|Healing Phase|Voluntary Withdrawal|10|||
161530252|NCT04124926|583329006|FG001|Healing Phase|Voluntary Withdrawal|7|||
161530253|NCT04124926|583329007|FG002|Healing Phase|Voluntary Withdrawal|0|||
161678435|NCT01858532|583875968|FG001|Overall Study|Adverse Event|50|||
161936972|NCT01602380|584819106|FG000|Overall Study|Lost to Follow-up|15|||
161530254|NCT04124926|583329008|FG003|Healing Phase|Voluntary Withdrawal|0|||
161530255|NCT04124926|583329009|FG004|Healing Phase|Voluntary Withdrawal|0|||
161530256|NCT04124926|583329005|FG000|Healing Phase|Withdrawal of Consent|5|||
161530257|NCT04124926|583329006|FG001|Healing Phase|Withdrawal of Consent|3|||
161530258|NCT04124926|583329007|FG002|Healing Phase|Withdrawal of Consent|0|||
161530259|NCT04124926|583329008|FG003|Healing Phase|Withdrawal of Consent|0|||
161530260|NCT04124926|583329009|FG004|Healing Phase|Withdrawal of Consent|0|||
161530261|NCT04124926|583329005|FG000|Healing Phase|Miscellaneous|8|||
161936973|NCT01602380|584819107|FG001|Overall Study|Lost to Follow-up|12|||
161936974|NCT01602380|584819106|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161936975|NCT01602380|584819107|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
161936976|NCT01602380|584819106|FG000|Overall Study|Other|2|||
161530262|NCT04124926|583329006|FG001|Healing Phase|Miscellaneous|7|||
161530263|NCT04124926|583329007|FG002|Healing Phase|Miscellaneous|0|||
161530264|NCT04124926|583329008|FG003|Healing Phase|Miscellaneous|0|||
161530265|NCT04124926|583329009|FG004|Healing Phase|Miscellaneous|0|||
161530266|NCT04124926|583329005|FG000|Healing Phase|Randomized but not Treated|0|||
161530267|NCT04124926|583329006|FG001|Healing Phase|Randomized but not Treated|3|||
161530268|NCT04124926|583329007|FG002|Healing Phase|Randomized but not Treated|0|||
161530269|NCT04124926|583329008|FG003|Healing Phase|Randomized but not Treated|0|||
161530270|NCT04124926|583329009|FG004|Healing Phase|Randomized but not Treated|0|||
161530271|NCT04124926|583329005|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
161530272|NCT04124926|583329006|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
161530273|NCT04124926|583329007|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
161530274|NCT04124926|583329008|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
161530275|NCT04124926|583329009|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
161530276|NCT04124926|583329005|FG000|Maintenance Phase|Protocol Violation|0|||
161530277|NCT04124926|583329006|FG001|Maintenance Phase|Protocol Violation|0|||
161530278|NCT04124926|583329007|FG002|Maintenance Phase|Protocol Violation|3|||
161530279|NCT04124926|583329008|FG003|Maintenance Phase|Protocol Violation|0|||
161530280|NCT04124926|583329009|FG004|Maintenance Phase|Protocol Violation|0|||
161530281|NCT04124926|583329005|FG000|Maintenance Phase|Lost to Follow-up|0|||
161530282|NCT04124926|583329006|FG001|Maintenance Phase|Lost to Follow-up|0|||
161530283|NCT04124926|583329007|FG002|Maintenance Phase|Lost to Follow-up|7|||
161530284|NCT04124926|583329008|FG003|Maintenance Phase|Lost to Follow-up|8|||
161530285|NCT04124926|583329009|FG004|Maintenance Phase|Lost to Follow-up|9|||
161530286|NCT04124926|583329005|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
161530287|NCT04124926|583329006|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
161530288|NCT04124926|583329007|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
161530289|NCT04124926|583329008|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
161530290|NCT04124926|583329009|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
161530291|NCT04124926|583329005|FG000|Maintenance Phase|Pregnancy|0|||
161530292|NCT04124926|583329006|FG001|Maintenance Phase|Pregnancy|0|||
161530293|NCT04124926|583329007|FG002|Maintenance Phase|Pregnancy|0|||
161530294|NCT04124926|583329008|FG003|Maintenance Phase|Pregnancy|1|||
161530295|NCT04124926|583329009|FG004|Maintenance Phase|Pregnancy|0|||
161530296|NCT04124926|583329005|FG000|Maintenance Phase|Lack of Efficacy|0|||
161530297|NCT04124926|583329006|FG001|Maintenance Phase|Lack of Efficacy|0|||
161530298|NCT04124926|583329007|FG002|Maintenance Phase|Lack of Efficacy|0|||
161530299|NCT04124926|583329008|FG003|Maintenance Phase|Lack of Efficacy|0|||
161530300|NCT04124926|583329009|FG004|Maintenance Phase|Lack of Efficacy|1|||
161530301|NCT04124926|583329005|FG000|Maintenance Phase|Withdrawal of Consent|0|||
161936977|NCT01602380|584819107|FG001|Overall Study|Other|0|||
161530302|NCT04124926|583329006|FG001|Maintenance Phase|Withdrawal of Consent|0|||
161530303|NCT04124926|583329007|FG002|Maintenance Phase|Withdrawal of Consent|5|||
161530304|NCT04124926|583329008|FG003|Maintenance Phase|Withdrawal of Consent|5|||
161530305|NCT04124926|583329009|FG004|Maintenance Phase|Withdrawal of Consent|5|||
161530306|NCT04124926|583329005|FG000|Maintenance Phase|Miscellaneous|0|||
161530307|NCT04124926|583329006|FG001|Maintenance Phase|Miscellaneous|0|||
161530308|NCT04124926|583329007|FG002|Maintenance Phase|Miscellaneous|1|||
161530309|NCT04124926|583329008|FG003|Maintenance Phase|Miscellaneous|2|||
161530310|NCT04124926|583329009|FG004|Maintenance Phase|Miscellaneous|4|||
161530311|NCT04124926|583329005|FG000|Maintenance Phase|Randomized but not Treated|0|||
161530312|NCT04124926|583329006|FG001|Maintenance Phase|Randomized but not Treated|0|||
161530313|NCT04124926|583329007|FG002|Maintenance Phase|Randomized but not Treated|2|||
161530314|NCT04124926|583329008|FG003|Maintenance Phase|Randomized but not Treated|2|||
161530315|NCT04124926|583329009|FG004|Maintenance Phase|Randomized but not Treated|0|||
161530316|NCT03321396|583329012|FG000|Overall Study|Physician Decision|1|||
161530317|NCT01654549|583329016|FG000|Overall Study|H.pylori eradication not successful|0|||
161530318|NCT01654549|583329017|FG001|Overall Study|H.pylori eradication not successful|1|||
161530319|NCT02013622|583329020|FG000|Overall Study|Lost to Follow-up|10|||
161530320|NCT02013622|583329020|FG000|Overall Study|Adverse Event|3|||
161530321|NCT02013622|583329020|FG000|Overall Study|Met Withdrawal Criteria|3|||
161530322|NCT02013622|583329020|FG000|Overall Study|Withdrawal by Subject|6|||
161530323|NCT02013622|583329020|FG000|Overall Study|Protocol Deviation|1|||
161530324|NCT02013622|583329020|FG000|Overall Study|Lack of Efficacy|1|||
161530325|NCT00937924|583329021|FG000|Overall Study|Lost to Follow-up|44|||
161530326|NCT00937924|583329022|FG001|Overall Study|Lost to Follow-up|44|||
161530327|NCT00937924|583329023|FG002|Overall Study|Lost to Follow-up|41|||
161530328|NCT00224874|583329024|FG000|Overall Study|Withdrawal by Subject|0|||
161530329|NCT00224874|583329025|FG001|Overall Study|Withdrawal by Subject|0|||
161530330|NCT00224874|583329026|FG002|Overall Study|Withdrawal by Subject|1|||
161530331|NCT00224874|583329027|FG003|Overall Study|Withdrawal by Subject|0|||
161530332|NCT02355002|583329030|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
161530333|NCT02355002|583329031|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
161530334|NCT02355002|583329030|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
161530335|NCT02355002|583329031|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
161530336|NCT02355002|583329030|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
161530337|NCT02355002|583329031|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
161530338|NCT02355002|583329030|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
161530339|NCT02355002|583329031|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
161530340|NCT02355002|583329030|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
161530341|NCT02355002|583329031|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
161530342|NCT02355002|583329030|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
161530343|NCT02355002|583329031|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
161530344|NCT02355002|583329030|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
161530345|NCT02355002|583329031|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
161530346|NCT03644186|583329032|FG000|Overall Study|Withdrawal by Subject|1|||
161530347|NCT03644186|583329033|FG001|Overall Study|Withdrawal by Subject|1|||
161530348|NCT04009291|583329034|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
161530349|NCT04009291|583329035|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
161530350|NCT04009291|583329036|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
161530351|NCT04009291|583329037|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
161530352|NCT04009291|583329038|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
161530353|NCT04009291|583329034|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
161530354|NCT04009291|583329035|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
161530355|NCT04009291|583329036|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
161530356|NCT04009291|583329037|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
161530357|NCT04009291|583329038|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
161530358|NCT01687257|583329044|FG000|Overall Study|Efficacy Failure|6|||
161530359|NCT01687257|583329045|FG001|Overall Study|Efficacy Failure|0|||
161827405|NCT00251316|584408072|FG001|Overall Study|Physician Decision|3|||
161530360|NCT01687257|583329046|FG002|Overall Study|Efficacy Failure|5|||
161530361|NCT01687257|583329044|FG000|Overall Study|Subject Withdrew Consent|1|||
161530362|NCT01687257|583329045|FG001|Overall Study|Subject Withdrew Consent|1|||
161530363|NCT01687257|583329046|FG002|Overall Study|Subject Withdrew Consent|1|||
161530364|NCT01687257|583329044|FG000|Overall Study|Adverse Event|1|||
161530365|NCT01687257|583329045|FG001|Overall Study|Adverse Event|0|||
161530366|NCT01687257|583329046|FG002|Overall Study|Adverse Event|0|||
161530367|NCT01687257|583329044|FG000|Overall Study|Investigator's Discretion|0|||
161530368|NCT01687257|583329045|FG001|Overall Study|Investigator's Discretion|3|||
161530369|NCT01687257|583329046|FG002|Overall Study|Investigator's Discretion|0|||
161530370|NCT01300546|583329049|FG000|Overall Study|Withdrawal by Subject|1|||
161530371|NCT01300546|583329050|FG001|Overall Study|Withdrawal by Subject|0|||
161530372|NCT01300546|583329049|FG000|Overall Study|Lost to Follow-up|0|||
161530373|NCT01300546|583329050|FG001|Overall Study|Lost to Follow-up|2|||
161530374|NCT01300546|583329049|FG000|Overall Study|Lack of Efficacy|0|||
161530375|NCT01300546|583329050|FG001|Overall Study|Lack of Efficacy|3|||
161530376|NCT01300546|583329049|FG000|Overall Study|Adverse Event|0|||
161530377|NCT01300546|583329050|FG001|Overall Study|Adverse Event|1|||
161530378|NCT05207813|583329053|FG000|Overall Study|Lost to Follow-up|2|||
161530379|NCT01954017|583329054|FG000|Overall Study|Adverse Event|0|||
161530380|NCT01954017|583329055|FG001|Overall Study|Adverse Event|0|||
161530381|NCT01954017|583329056|FG002|Overall Study|Adverse Event|1|||
161530382|NCT01954017|583329054|FG000|Overall Study|Death|2|||
161591243|NCT05369403|583552786|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
161530383|NCT01954017|583329055|FG001|Overall Study|Death|1|||
161530384|NCT01954017|583329056|FG002|Overall Study|Death|1|||
161530385|NCT01954017|583329054|FG000|Overall Study|Withdrawal by Subject|0|||
161530386|NCT01954017|583329055|FG001|Overall Study|Withdrawal by Subject|1|||
161530387|NCT01954017|583329056|FG002|Overall Study|Withdrawal by Subject|0|||
161530388|NCT01954017|583329054|FG000|Overall Study|Protocol Violation|0|||
161530389|NCT01954017|583329055|FG001|Overall Study|Protocol Violation|3|||
161530390|NCT01954017|583329056|FG002|Overall Study|Protocol Violation|2|||
161530391|NCT01954017|583329054|FG000|Overall Study|Necrotizing enterocolitis|1|||
161530392|NCT01954017|583329055|FG001|Overall Study|Necrotizing enterocolitis|0|||
161678436|NCT01858532|583875969|FG002|Overall Study|Adverse Event|23|||
161530393|NCT01954017|583329056|FG002|Overall Study|Necrotizing enterocolitis|1|||
161530394|NCT01954017|583329054|FG000|Overall Study|Enteral intake stopped >7 days|0|||
161530395|NCT01954017|583329055|FG001|Overall Study|Enteral intake stopped >7 days|1|||
161530396|NCT01954017|583329056|FG002|Overall Study|Enteral intake stopped >7 days|1|||
161530397|NCT01954017|583329054|FG000|Overall Study|All other reasons|2|||
161530398|NCT01954017|583329055|FG001|Overall Study|All other reasons|2|||
161530399|NCT01954017|583329056|FG002|Overall Study|All other reasons|7|||
161530400|NCT00679939|583329061|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
161530401|NCT00679939|583329062|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
161530402|NCT00679939|583329061|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
161530403|NCT00679939|583329062|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
161530404|NCT00679939|583329061|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
161530405|NCT00679939|583329062|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
161530406|NCT00679939|583329061|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
161678437|NCT01858532|583875970|FG003|Overall Study|Adverse Event|28|||
161530407|NCT00679939|583329062|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
161530408|NCT00679939|583329061|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
161530409|NCT00679939|583329062|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
161530410|NCT00679939|583329061|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
161530411|NCT00679939|583329062|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
161530412|NCT00679939|583329061|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
161530413|NCT00679939|583329062|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
161530414|NCT00679939|583329061|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
161530415|NCT00679939|583329062|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
161530416|NCT00679939|583329061|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
161530417|NCT00679939|583329062|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
161530418|NCT00679939|583329061|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
161530419|NCT00679939|583329062|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
161530420|NCT04657211|583329065|FG000|Overall Study|Withdrawal by Subject|21|||
161530421|NCT04657211|583329065|FG000|Overall Study|Lost to Follow-up|113|||
161530422|NCT04657211|583329065|FG000|Overall Study|Death|47|||
161530423|NCT04657211|583329065|FG000|Overall Study|Transfer to another institution|21|||
161530424|NCT04657211|583329065|FG000|Overall Study|Other|29|||
161530425|NCT06273774|583329066|FG000|Overall Study|Participant was out of state.|0|||
161530426|NCT06273774|583329067|FG001|Overall Study|Participant was out of state.|0|||
161530427|NCT06273774|583329068|FG002|Overall Study|Participant was out of state.|0|||
161530428|NCT06273774|583329069|FG003|Overall Study|Participant was out of state.|0|||
161530429|NCT06273774|583329070|FG004|Overall Study|Participant was out of state.|0|||
161530430|NCT06273774|583329071|FG005|Overall Study|Participant was out of state.|1|||
161530431|NCT06273774|583329066|FG000|Overall Study|Lost to Follow-up|0|||
161530432|NCT06273774|583329067|FG001|Overall Study|Lost to Follow-up|0|||
161530433|NCT06273774|583329068|FG002|Overall Study|Lost to Follow-up|0|||
161678438|NCT01858532|583875967|FG000|Overall Study|Withdrew consent|71|||
161678439|NCT01858532|583875968|FG001|Overall Study|Withdrew consent|93|||
161678440|NCT01858532|583875969|FG002|Overall Study|Withdrew consent|46|||
161678441|NCT01858532|583875970|FG003|Overall Study|Withdrew consent|27|||
161678442|NCT01858532|583875967|FG000|Overall Study|Lost to Follow-up|17|||
161678443|NCT01858532|583875968|FG001|Overall Study|Lost to Follow-up|26|||
161678444|NCT01858532|583875969|FG002|Overall Study|Lost to Follow-up|11|||
161678445|NCT01858532|583875970|FG003|Overall Study|Lost to Follow-up|14|||
161678446|NCT01858532|583875967|FG000|Overall Study|Deterioration of medical status|3|||
161678447|NCT01858532|583875968|FG001|Overall Study|Deterioration of medical status|4|||
161678448|NCT01858532|583875969|FG002|Overall Study|Deterioration of medical status|3|||
161678449|NCT01858532|583875970|FG003|Overall Study|Deterioration of medical status|7|||
161678450|NCT01858532|583875967|FG000|Overall Study|Investigator request|3|||
161678451|NCT01858532|583875968|FG001|Overall Study|Investigator request|4|||
161678452|NCT01858532|583875969|FG002|Overall Study|Investigator request|2|||
161530434|NCT06273774|583329069|FG003|Overall Study|Lost to Follow-up|0|||
161530435|NCT06273774|583329070|FG004|Overall Study|Lost to Follow-up|1|||
161678453|NCT01858532|583875970|FG003|Overall Study|Investigator request|6|||
161678454|NCT01858532|583875967|FG000|Overall Study|Other, not specified|29|||
161678455|NCT01858532|583875968|FG001|Overall Study|Other, not specified|15|||
161678456|NCT01858532|583875969|FG002|Overall Study|Other, not specified|13|||
161678457|NCT01858532|583875970|FG003|Overall Study|Other, not specified|11|||
161530436|NCT06273774|583329071|FG005|Overall Study|Lost to Follow-up|0|||
161678458|NCT02081534|583875976|FG000|Overall Study|Adverse Event|5|||
161530437|NCT02943408|583331002|FG000|Overall Study|Lost to Follow-up|7|||
161530438|NCT02943408|583331003|FG001|Overall Study|Lost to Follow-up|1|||
161530439|NCT02943408|583331002|FG000|Overall Study|Withdrawal by Subject|0|||
161530440|NCT02943408|583331003|FG001|Overall Study|Withdrawal by Subject|1|||
161530441|NCT01621126|583331006|FG000|Overall Study|Physician Decision|6|||
161530442|NCT03751631|583331007|FG000|Overall Study|Withdrawal by Subject|0|||
161678459|NCT02081534|583875977|FG001|Overall Study|Adverse Event|4|||
161530443|NCT03751631|583331008|FG001|Overall Study|Withdrawal by Subject|0|||
161530444|NCT03751631|583331009|FG002|Overall Study|Withdrawal by Subject|1|||
161530445|NCT03751631|583331010|FG003|Overall Study|Withdrawal by Subject|1|||
161530446|NCT03751631|583331011|FG004|Overall Study|Withdrawal by Subject|0|||
161530447|NCT03751631|583331012|FG005|Overall Study|Withdrawal by Subject|0|||
161530448|NCT02481310|583331013|FG000|Follow up|Still in follow up|0|||
161530449|NCT02481310|583331014|FG001|Follow up|Still in follow up|3|||
161530450|NCT02481310|583331015|FG002|Follow up|Still in follow up|0|||
161530451|NCT00643916|583331017|FG000|Overall Study|Protocol Violation|0|||
161530452|NCT00643916|583331018|FG001|Overall Study|Protocol Violation|1|||
161530453|NCT00643916|583331019|FG002|Overall Study|Protocol Violation|1|||
161530454|NCT00643916|583331020|FG003|Overall Study|Protocol Violation|1|||
161530455|NCT00643916|583331021|FG004|Overall Study|Protocol Violation|0|||
161530456|NCT00643916|583331022|FG005|Overall Study|Protocol Violation|0|||
161530457|NCT00643916|583331017|FG000|Overall Study|Lost to Follow-up|0|||
161530458|NCT00643916|583331018|FG001|Overall Study|Lost to Follow-up|1|||
161530459|NCT00643916|583331019|FG002|Overall Study|Lost to Follow-up|0|||
161530460|NCT00643916|583331020|FG003|Overall Study|Lost to Follow-up|0|||
161530461|NCT00643916|583331021|FG004|Overall Study|Lost to Follow-up|0|||
161530462|NCT00643916|583331022|FG005|Overall Study|Lost to Follow-up|0|||
161530463|NCT00643916|583331017|FG000|Overall Study|Withdrawal by Subject|2|||
161530464|NCT00643916|583331018|FG001|Overall Study|Withdrawal by Subject|2|||
161530465|NCT00643916|583331019|FG002|Overall Study|Withdrawal by Subject|2|||
161530466|NCT00643916|583331020|FG003|Overall Study|Withdrawal by Subject|1|||
161530467|NCT00643916|583331021|FG004|Overall Study|Withdrawal by Subject|0|||
161530468|NCT00643916|583331022|FG005|Overall Study|Withdrawal by Subject|1|||
161530469|NCT00643916|583331017|FG000|Overall Study|Not Vaccinated|2|||
161530470|NCT00643916|583331018|FG001|Overall Study|Not Vaccinated|2|||
161530471|NCT00643916|583331019|FG002|Overall Study|Not Vaccinated|3|||
161530472|NCT00643916|583331020|FG003|Overall Study|Not Vaccinated|0|||
161530473|NCT00643916|583331021|FG004|Overall Study|Not Vaccinated|2|||
161530474|NCT00643916|583331022|FG005|Overall Study|Not Vaccinated|0|||
161530475|NCT00447057|583331024|FG000|Overall Study|Adverse Event|4|||
161530476|NCT00447057|583331025|FG001|Overall Study|Adverse Event|10|||
161530477|NCT00447057|583331026|FG002|Overall Study|Adverse Event|0|||
161530478|NCT00447057|583331027|FG003|Overall Study|Adverse Event|3|||
161530479|NCT00447057|583331024|FG000|Overall Study|Death due to study disease|6|||
161530480|NCT00447057|583331025|FG001|Overall Study|Death due to study disease|4|||
161530481|NCT00447057|583331026|FG002|Overall Study|Death due to study disease|1|||
161530482|NCT00447057|583331027|FG003|Overall Study|Death due to study disease|1|||
161530483|NCT00447057|583331024|FG000|Overall Study|Lost to Follow-up|0|||
161530484|NCT00447057|583331025|FG001|Overall Study|Lost to Follow-up|1|||
161530485|NCT00447057|583331026|FG002|Overall Study|Lost to Follow-up|0|||
161530486|NCT00447057|583331027|FG003|Overall Study|Lost to Follow-up|0|||
161530487|NCT00447057|583331024|FG000|Overall Study|Entry criteria not met|1|||
161530488|NCT00447057|583331025|FG001|Overall Study|Entry criteria not met|1|||
161530489|NCT00447057|583331026|FG002|Overall Study|Entry criteria not met|0|||
161530490|NCT00447057|583331027|FG003|Overall Study|Entry criteria not met|0|||
161530491|NCT00447057|583331024|FG000|Overall Study|Protocol Violation|0|||
161530492|NCT00447057|583331025|FG001|Overall Study|Protocol Violation|1|||
161530493|NCT00447057|583331026|FG002|Overall Study|Protocol Violation|0|||
161530494|NCT00447057|583331027|FG003|Overall Study|Protocol Violation|0|||
161530495|NCT00447057|583331024|FG000|Overall Study|Withdrawal by Subject|4|||
161530496|NCT00447057|583331025|FG001|Overall Study|Withdrawal by Subject|5|||
161530497|NCT00447057|583331026|FG002|Overall Study|Withdrawal by Subject|1|||
161530498|NCT00447057|583331027|FG003|Overall Study|Withdrawal by Subject|1|||
161530499|NCT00447057|583331024|FG000|Overall Study|Physician Decision|9|||
161530500|NCT00447057|583331025|FG001|Overall Study|Physician Decision|6|||
161530501|NCT00447057|583331026|FG002|Overall Study|Physician Decision|3|||
161530502|NCT00447057|583331027|FG003|Overall Study|Physician Decision|1|||
161530503|NCT00447057|583331024|FG000|Overall Study|Sponsor decision|1|||
161530504|NCT00447057|583331025|FG001|Overall Study|Sponsor decision|1|||
161827406|NCT00398073|584408073|FG000|Overall Study|Withdrawal by Subject|1|||
161827407|NCT00398073|584408074|FG001|Overall Study|Withdrawal by Subject|0|||
161827408|NCT00708682|584408075|FG000|Infant Series|Adverse Event|1|||
161827409|NCT00708682|584408075|FG000|Infant Series|Lost to Follow-up|4|||
161827410|NCT00708682|584408075|FG000|Infant Series|Protocol Violation|1|||
161827411|NCT00708682|584408075|FG000|Infant Series|Parent/legal guardian request|6|||
161827412|NCT00708682|584408075|FG000|Infant Series|Failed to return|2|||
161530505|NCT00447057|583331026|FG002|Overall Study|Sponsor decision|0|||
161530506|NCT00447057|583331027|FG003|Overall Study|Sponsor decision|0|||
161530507|NCT00447057|583331024|FG000|Overall Study|Progressive disease|58|||
161530508|NCT00447057|583331025|FG001|Overall Study|Progressive disease|43|||
161530509|NCT00447057|583331026|FG002|Overall Study|Progressive disease|13|||
161530510|NCT00447057|583331027|FG003|Overall Study|Progressive disease|18|||
161530511|NCT00447057|583331024|FG000|Overall Study|Death due to adverse event|0|||
161530512|NCT00447057|583331025|FG001|Overall Study|Death due to adverse event|0|||
161530513|NCT00447057|583331026|FG002|Overall Study|Death due to adverse event|1|||
161530514|NCT00447057|583331027|FG003|Overall Study|Death due to adverse event|2|||
161936978|NCT05076266|584819108|FG000|Overall Study|Survey not complete - Participant refusal|2|||
161936979|NCT05076266|584819109|FG001|Overall Study|Survey not complete - Participant refusal|0|||
161936980|NCT05169567|584819114|FG000|Overall Study|On study treatment|116|||
161936981|NCT05169567|584819115|FG001|Overall Study|On study treatment|128|||
161936982|NCT05169567|584819114|FG000|Overall Study|Lost to Follow-up|1|||
161936983|NCT05169567|584819115|FG001|Overall Study|Lost to Follow-up|0|||
161936984|NCT05169567|584819114|FG000|Overall Study|Withdrawal by Subject|25|||
161936985|NCT05169567|584819115|FG001|Overall Study|Withdrawal by Subject|21|||
161936986|NCT04409457|584819118|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
161936987|NCT04409457|584819119|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
161936988|NCT04409457|584819120|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161936989|NCT04409457|584819121|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161936990|NCT04409457|584819122|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161936991|NCT04409457|584819123|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161936992|NCT04409457|584819118|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
161936993|NCT04409457|584819119|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
161936994|NCT04409457|584819120|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
161936995|NCT04409457|584819121|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
161936996|NCT04409457|584819122|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
161936997|NCT04409457|584819123|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
161936998|NCT04409457|584819118|FG000|Randomization|Withdrawal by Subject|0|||
161936999|NCT04409457|584819119|FG001|Randomization|Withdrawal by Subject|0|||
161937000|NCT04409457|584819120|FG002|Randomization|Withdrawal by Subject|0|||
161937001|NCT04409457|584819121|FG003|Randomization|Withdrawal by Subject|0|||
161937002|NCT04409457|584819122|FG004|Randomization|Withdrawal by Subject|1|||
161937003|NCT04409457|584819123|FG005|Randomization|Withdrawal by Subject|0|||
161937004|NCT04409457|584819118|FG000|Randomization|Incidental MRI finding at scan 1|0|||
161937005|NCT04409457|584819119|FG001|Randomization|Incidental MRI finding at scan 1|0|||
161937006|NCT04409457|584819120|FG002|Randomization|Incidental MRI finding at scan 1|0|||
161937007|NCT04409457|584819121|FG003|Randomization|Incidental MRI finding at scan 1|1|||
161937008|NCT04409457|584819122|FG004|Randomization|Incidental MRI finding at scan 1|0|||
161937009|NCT04409457|584819123|FG005|Randomization|Incidental MRI finding at scan 1|1|||
161937010|NCT04409457|584819118|FG000|Randomization|Technical/equipment error at scan 1|0|||
161937011|NCT04409457|584819119|FG001|Randomization|Technical/equipment error at scan 1|0|||
161937012|NCT04409457|584819120|FG002|Randomization|Technical/equipment error at scan 1|0|||
161937013|NCT04409457|584819121|FG003|Randomization|Technical/equipment error at scan 1|0|||
161937014|NCT04409457|584819122|FG004|Randomization|Technical/equipment error at scan 1|0|||
161937015|NCT04409457|584819123|FG005|Randomization|Technical/equipment error at scan 1|1|||
161937016|NCT04865770|584819124|FG000|Overall Study|Withdrawal by Subject|3|||
161937017|NCT04865770|584819125|FG001|Overall Study|Withdrawal by Subject|0|||
161937018|NCT04865770|584819124|FG000|Overall Study|Physician Decision|9|||
161937019|NCT04865770|584819125|FG001|Overall Study|Physician Decision|0|||
161937020|NCT04865770|584819124|FG000|Overall Study|Death|1|||
161937021|NCT04865770|584819125|FG001|Overall Study|Death|1|||
161937022|NCT05497284|584819126|FG000|Overall Study|Adverse Event|1|||
161937023|NCT05497284|584819127|FG001|Overall Study|Adverse Event|0|||
161937024|NCT05497284|584819126|FG000|Overall Study|Physician Decision|0|||
161937025|NCT05497284|584819127|FG001|Overall Study|Physician Decision|1|||
161937026|NCT05497284|584819126|FG000|Overall Study|Study terminated by sponsor|7|||
161937027|NCT05497284|584819127|FG001|Overall Study|Study terminated by sponsor|4|||
161937028|NCT05497284|584819126|FG000|Overall Study|Subject Decision|0|||
161530515|NCT00447057|583331024|FG000|Overall Study|Death, study drug related|0|||
161530516|NCT00447057|583331025|FG001|Overall Study|Death, study drug related|1|||
161530517|NCT00447057|583331026|FG002|Overall Study|Death, study drug related|0|||
161530518|NCT00447057|583331027|FG003|Overall Study|Death, study drug related|0|||
161530519|NCT00677833|583331028|FG000|Overall Study|Withdrawal by Subject|4|||
161530520|NCT00677833|583331029|FG001|Overall Study|Withdrawal by Subject|0|||
161530521|NCT00677833|583331030|FG002|Overall Study|Withdrawal by Subject|1|||
161530522|NCT00677833|583331031|FG003|Overall Study|Withdrawal by Subject|3|||
161530523|NCT00677833|583331028|FG000|Overall Study|Lost to Follow-up|0|||
161530524|NCT00677833|583331029|FG001|Overall Study|Lost to Follow-up|0|||
161937029|NCT05497284|584819127|FG001|Overall Study|Subject Decision|1|||
161937030|NCT03816891|584819130|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161937031|NCT03816891|584819131|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161937032|NCT03816891|584819132|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161530525|NCT00677833|583331030|FG002|Overall Study|Lost to Follow-up|1|||
161937033|NCT03816891|584819133|FG003|Double-Blind Period|Withdrawal by Subject|2|||
161937034|NCT03816891|584819134|FG004|Double-Blind Period|Withdrawal by Subject|0|||
161937035|NCT03816891|584819135|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161530526|NCT00677833|583331031|FG003|Overall Study|Lost to Follow-up|0|||
161530527|NCT02606279|583331036|FG000|Overall Study|Lost to Follow-up|0|||
161530528|NCT02606279|583331037|FG001|Overall Study|Lost to Follow-up|1|||
161530529|NCT02184611|583331038|FG000|Overall Study|Lack of Efficacy|11|||
161937036|NCT03816891|584819130|FG000|Double-Blind Period|Adverse Event|0|||
161937037|NCT03816891|584819131|FG001|Double-Blind Period|Adverse Event|0|||
161937038|NCT03816891|584819132|FG002|Double-Blind Period|Adverse Event|2|||
161937039|NCT03816891|584819133|FG003|Double-Blind Period|Adverse Event|0|||
161937040|NCT03816891|584819134|FG004|Double-Blind Period|Adverse Event|0|||
161937041|NCT03816891|584819135|FG005|Double-Blind Period|Adverse Event|0|||
161937042|NCT03816891|584819130|FG000|Double-Blind Period|Lost to Follow-up|2|||
161937043|NCT03816891|584819131|FG001|Double-Blind Period|Lost to Follow-up|0|||
161937044|NCT03816891|584819132|FG002|Double-Blind Period|Lost to Follow-up|0|||
161937045|NCT03816891|584819133|FG003|Double-Blind Period|Lost to Follow-up|0|||
161937046|NCT03816891|584819134|FG004|Double-Blind Period|Lost to Follow-up|0|||
161937047|NCT03816891|584819135|FG005|Double-Blind Period|Lost to Follow-up|1|||
161937048|NCT03816891|584819130|FG000|Double-Blind Period|Physician Decision|0|||
161937049|NCT03816891|584819131|FG001|Double-Blind Period|Physician Decision|0|||
161937050|NCT03816891|584819132|FG002|Double-Blind Period|Physician Decision|0|||
161937051|NCT03816891|584819133|FG003|Double-Blind Period|Physician Decision|1|||
161937052|NCT03816891|584819134|FG004|Double-Blind Period|Physician Decision|0|||
161937053|NCT03816891|584819135|FG005|Double-Blind Period|Physician Decision|0|||
161937054|NCT03816891|584819130|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161530530|NCT02184611|583331039|FG001|Overall Study|Lack of Efficacy|15|||
161530531|NCT02184611|583331038|FG000|Overall Study|Withdrawal by Subject|5|||
161530532|NCT02184611|583331039|FG001|Overall Study|Withdrawal by Subject|6|||
161530533|NCT02184611|583331038|FG000|Overall Study|Adverse Event|4|||
161530534|NCT02184611|583331039|FG001|Overall Study|Adverse Event|5|||
161530535|NCT02184611|583331038|FG000|Overall Study|Protocol Violation|1|||
161530536|NCT02184611|583331039|FG001|Overall Study|Protocol Violation|1|||
161530537|NCT02184611|583331038|FG000|Overall Study|Protocol defined stopping criteria|0|||
161530538|NCT02184611|583331039|FG001|Overall Study|Protocol defined stopping criteria|1|||
161530539|NCT01514448|583331042|FG000|Overall Study|Death|7|||
161530540|NCT01514448|583331043|FG001|Overall Study|Death|8|||
161530541|NCT01514448|583331042|FG000|Overall Study|Withdrawal by Subject|2|||
161530542|NCT01514448|583331043|FG001|Overall Study|Withdrawal by Subject|0|||
161530543|NCT01514448|583331042|FG000|Overall Study|Lost to Follow-up|2|||
161530544|NCT01514448|583331043|FG001|Overall Study|Lost to Follow-up|0|||
161530545|NCT01514448|583331042|FG000|Overall Study|New Cancer Therapy|1|||
161530546|NCT01514448|583331043|FG001|Overall Study|New Cancer Therapy|0|||
161530547|NCT05159622|583331044|FG000|Overall Study|Lost to Follow-up|4|||
161530548|NCT05159622|583331045|FG001|Overall Study|Lost to Follow-up|5|||
161530549|NCT03318523|583331046|FG000|PC Period: Up to Year 1|Adverse Event|1|||
161530550|NCT03318523|583331047|FG001|PC Period: Up to Year 1|Adverse Event|0|||
161530551|NCT03318523|583331048|FG002|PC Period: Up to Year 1|Adverse Event|2|||
161530552|NCT03318523|583331049|FG003|PC Period: Up to Year 1|Adverse Event|0|||
161530553|NCT03318523|583331050|FG004|PC Period: Up to Year 1|Adverse Event|0|||
161530554|NCT03318523|583331051|FG005|PC Period: Up to Year 1|Adverse Event|0|||
161530555|NCT03318523|583331052|FG006|PC Period: Up to Year 1|Adverse Event|0|||
161530556|NCT03318523|583331053|FG007|PC Period: Up to Year 1|Adverse Event|0|||
161530557|NCT03318523|583331054|FG008|PC Period: Up to Year 1|Adverse Event|0|||
161530558|NCT03318523|583331055|FG009|PC Period: Up to Year 1|Adverse Event|0|||
161530559|NCT03318523|583331046|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
161530560|NCT03318523|583331047|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
161530561|NCT03318523|583331048|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
161530562|NCT03318523|583331049|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
161530563|NCT03318523|583331050|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
161530564|NCT03318523|583331051|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
161530565|NCT03318523|583331052|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
161530566|NCT03318523|583331053|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
161530567|NCT03318523|583331054|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
161591244|NCT05369403|583552784|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
161937055|NCT03816891|584819131|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161937056|NCT03816891|584819132|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161591245|NCT05369403|583552785|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
161937057|NCT03816891|584819133|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161937058|NCT03816891|584819134|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161530568|NCT03318523|583331055|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
161530569|NCT03318523|583331046|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161937059|NCT03816891|584819135|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
161937060|NCT03816891|584819130|FG000|Double-Blind Period|Other|1|||
161530570|NCT03318523|583331047|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161937061|NCT03816891|584819131|FG001|Double-Blind Period|Other|0|||
161530571|NCT03318523|583331048|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161530572|NCT03318523|583331049|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161530573|NCT03318523|583331050|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
161530574|NCT03318523|583331051|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161530575|NCT03318523|583331052|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161937062|NCT03816891|584819132|FG002|Double-Blind Period|Other|0|||
161530576|NCT03318523|583331053|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
161530577|NCT03318523|583331054|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
161530578|NCT03318523|583331055|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
161530579|NCT03318523|583331046|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161530580|NCT03318523|583331047|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161530581|NCT03318523|583331048|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161530582|NCT03318523|583331049|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161530583|NCT03318523|583331050|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
161530584|NCT03318523|583331051|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161530585|NCT03318523|583331052|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161530586|NCT03318523|583331053|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
161530587|NCT03318523|583331054|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
161530588|NCT03318523|583331055|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
161530589|NCT03318523|583331046|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530590|NCT03318523|583331047|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530591|NCT03318523|583331048|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530592|NCT03318523|583331049|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530593|NCT03318523|583331050|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530594|NCT03318523|583331051|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
161530595|NCT03318523|583331052|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530596|NCT03318523|583331053|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530597|NCT03318523|583331054|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530598|NCT03318523|583331055|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
161530599|NCT03318523|583331046|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530600|NCT03318523|583331047|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530601|NCT03318523|583331048|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530602|NCT03318523|583331049|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530603|NCT03318523|583331050|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530604|NCT03318523|583331051|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530605|NCT03318523|583331052|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530606|NCT03318523|583331053|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530607|NCT03318523|583331054|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
161530608|NCT03318523|583331055|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
161530609|NCT03318523|583331046|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
161530610|NCT03318523|583331047|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
161530611|NCT03318523|583331048|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
161530612|NCT03318523|583331049|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
161530613|NCT03318523|583331050|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
161530614|NCT03318523|583331051|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
161530615|NCT03318523|583331052|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
161530616|NCT03318523|583331053|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
161530617|NCT03318523|583331054|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
161530618|NCT03318523|583331055|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
161530619|NCT03318523|583331046|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161937063|NCT03816891|584819133|FG003|Double-Blind Period|Other|0|||
161530620|NCT03318523|583331047|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161530621|NCT03318523|583331048|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161530622|NCT03318523|583331049|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161530623|NCT03318523|583331050|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
161530624|NCT03318523|583331051|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161530625|NCT03318523|583331052|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161530626|NCT03318523|583331053|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
161530627|NCT03318523|583331054|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
161530628|NCT03318523|583331055|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
161530629|NCT02163733|583331056|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
161530630|NCT02163733|583331057|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
161937064|NCT03816891|584819134|FG004|Double-Blind Period|Other|0|||
161530631|NCT02163733|583331058|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
161530632|NCT02163733|583331056|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
161530633|NCT02163733|583331057|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
161937065|NCT03816891|584819135|FG005|Double-Blind Period|Other|0|||
161937066|NCT03816891|584819130|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161937067|NCT03816891|584819131|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161591246|NCT05369403|583552786|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
161937068|NCT03816891|584819132|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
161591247|NCT05369403|583552784|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
161591248|NCT05369403|583552785|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
161591249|NCT05369403|583552786|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
161591250|NCT05369403|583552784|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
161591251|NCT05369403|583552785|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
161591252|NCT05369403|583552786|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
161591253|NCT03792256|583552787|FG000|Overall Study|Death|0|||
161591254|NCT03792256|583552788|FG001|Overall Study|Death|1|||
161591255|NCT03792256|583552787|FG000|Overall Study|Lack of Efficacy|0|||
161591256|NCT03792256|583552788|FG001|Overall Study|Lack of Efficacy|1|||
161591257|NCT03792256|583552787|FG000|Overall Study|Withdrawal by Subject|0|||
161591258|NCT03792256|583552788|FG001|Overall Study|Withdrawal by Subject|1|||
161591259|NCT04760678|583552791|FG000|Overall Study|Death|13|||
161591260|NCT04760678|583552791|FG000|Overall Study|Lost to Follow-up|48|||
161591261|NCT04760678|583552791|FG000|Overall Study|Withdrawal by Subject|1|||
161591262|NCT01573442|583552804|FG000|Overall Study|Cancels|9|||
161591263|NCT01573442|583552805|FG001|Overall Study|Cancels|10|||
161591264|NCT04763265|583552806|FG000|Overall Study|Adverse Event|1|||
161591265|NCT04763265|583552807|FG001|Overall Study|Adverse Event|0|||
161591266|NCT04763265|583552806|FG000|Overall Study|Lost to Follow-up|2|||
161591267|NCT04763265|583552807|FG001|Overall Study|Lost to Follow-up|4|||
161591268|NCT04763265|583552806|FG000|Overall Study|Withdrawal by Subject|0|||
161591269|NCT04763265|583552807|FG001|Overall Study|Withdrawal by Subject|1|||
161591270|NCT05308004|583552815|FG000|Overall Study|Not seen by Palliative Care NP|0|||
161591271|NCT05308004|583552816|FG001|Overall Study|Not seen by Palliative Care NP|1|||
161591272|NCT04552223|583552817|FG000|Overall Study|Withdrawal by Subject|1|||
161591273|NCT04359108|583552818|FG000|Overall Study|Withdrawal by Subject|1|||
161591274|NCT04359108|583552819|FG001|Overall Study|Withdrawal by Subject|0|||
161591275|NCT04359108|583552818|FG000|Overall Study|Unable or too feeble to walk independently|0|||
161591276|NCT04359108|583552819|FG001|Overall Study|Unable or too feeble to walk independently|2|||
161591277|NCT04359108|583552818|FG000|Overall Study|Argus II system stopped functioning|0|||
161591278|NCT04359108|583552819|FG001|Overall Study|Argus II system stopped functioning|1|||
161591279|NCT04359108|583552818|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
161591280|NCT04359108|583552819|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
161591281|NCT02515773|583552820|FG000|Overall Study|Withdrawal by Subject|12|||
161591282|NCT02515773|583552821|FG001|Overall Study|Withdrawal by Subject|2|||
161591283|NCT02515773|583552820|FG000|Overall Study|Lost to Follow-up|119|||
161591284|NCT02515773|583552821|FG001|Overall Study|Lost to Follow-up|126|||
161591285|NCT02515773|583552820|FG000|Overall Study|Discharged from Clinic Services|53|||
161591286|NCT02515773|583552821|FG001|Overall Study|Discharged from Clinic Services|84|||
161591287|NCT02515773|583552820|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
161591288|NCT02515773|583552821|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
161591289|NCT02515773|583552820|FG000|Overall Study|Follow-up at non-study site|8|||
161591290|NCT02515773|583552821|FG001|Overall Study|Follow-up at non-study site|16|||
161591291|NCT02515773|583552820|FG000|Overall Study|Moved from area|9|||
161591292|NCT02515773|583552821|FG001|Overall Study|Moved from area|14|||
161591293|NCT04176965|583552822|FG000|Overall Study|Death|1|||
161591294|NCT04176965|583552823|FG001|Overall Study|Death|2|||
161591295|NCT04176965|583552822|FG000|Overall Study|Lost to Follow-up|10|||
161591296|NCT04176965|583552823|FG001|Overall Study|Lost to Follow-up|2|||
161591297|NCT04176965|583552822|FG000|Overall Study|Withdrawal by Subject|6|||
161591298|NCT04176965|583552823|FG001|Overall Study|Withdrawal by Subject|1|||
161591299|NCT05434078|583552825|FG000|Overall Study|Lost to Follow-up|2|||
161591300|NCT05434078|583552826|FG001|Overall Study|Lost to Follow-up|1|||
161591301|NCT05434078|583552825|FG000|Overall Study|Withdrawal by Subject|1|||
161591302|NCT05434078|583552826|FG001|Overall Study|Withdrawal by Subject|0|||
161591303|NCT04072380|583552827|FG000|Overall Study|Adverse Event|4|||
161591304|NCT04072380|583552828|FG001|Overall Study|Adverse Event|6|||
161591305|NCT04072380|583552829|FG002|Overall Study|Adverse Event|0|||
161591306|NCT04072380|583552827|FG000|Overall Study|Withdrawal by Subject|3|||
161591307|NCT04072380|583552828|FG001|Overall Study|Withdrawal by Subject|1|||
161591308|NCT04072380|583552829|FG002|Overall Study|Withdrawal by Subject|1|||
161591309|NCT04072380|583552827|FG000|Overall Study|Physician Decision|2|||
161591310|NCT04072380|583552828|FG001|Overall Study|Physician Decision|0|||
161591311|NCT04072380|583552829|FG002|Overall Study|Physician Decision|0|||
161591312|NCT04072380|583552827|FG000|Overall Study|Protocol Violation|0|||
161591313|NCT04072380|583552828|FG001|Overall Study|Protocol Violation|2|||
161591314|NCT04072380|583552829|FG002|Overall Study|Protocol Violation|3|||
161591315|NCT04072380|583552827|FG000|Overall Study|Intercurrent Illness and Others|3|||
161591316|NCT04072380|583552828|FG001|Overall Study|Intercurrent Illness and Others|5|||
161591317|NCT04072380|583552829|FG002|Overall Study|Intercurrent Illness and Others|6|||
161591318|NCT03652688|583552830|FG000|Baseline|Withdrawal by Subject|0|||
161591319|NCT03652688|583552831|FG001|Baseline|Withdrawal by Subject|3|||
161591320|NCT03652688|583552830|FG000|Follow-up|Lost to Follow-up|56|||
161530634|NCT02163733|583331058|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
161530635|NCT02723864|583331059|FG000|Overall Study|Refused further treatment|1|||
161530636|NCT02723864|583331060|FG001|Overall Study|Refused further treatment|0|||
161530637|NCT02723864|583331061|FG002|Overall Study|Refused further treatment|0|||
161530638|NCT02723864|583331062|FG003|Overall Study|Refused further treatment|0|||
161530639|NCT02723864|583331063|FG004|Overall Study|Refused further treatment|1|||
161530640|NCT02723864|583331064|FG005|Overall Study|Refused further treatment|2|||
161530641|NCT02723864|583331065|FG006|Overall Study|Refused further treatment|0|||
161530642|NCT02723864|583331059|FG000|Overall Study|Exceed treatment hold time|0|||
161530643|NCT02723864|583331060|FG001|Overall Study|Exceed treatment hold time|1|||
161530644|NCT02723864|583331061|FG002|Overall Study|Exceed treatment hold time|0|||
161530645|NCT02723864|583331062|FG003|Overall Study|Exceed treatment hold time|0|||
161530646|NCT02723864|583331063|FG004|Overall Study|Exceed treatment hold time|0|||
161530647|NCT02723864|583331064|FG005|Overall Study|Exceed treatment hold time|0|||
161530648|NCT02723864|583331065|FG006|Overall Study|Exceed treatment hold time|0|||
161530649|NCT02723864|583331059|FG000|Overall Study|Clinical progression|0|||
161530650|NCT02723864|583331060|FG001|Overall Study|Clinical progression|0|||
161530651|NCT02723864|583331061|FG002|Overall Study|Clinical progression|1|||
161530652|NCT02723864|583331062|FG003|Overall Study|Clinical progression|0|||
161530653|NCT02723864|583331063|FG004|Overall Study|Clinical progression|0|||
161530654|NCT02723864|583331064|FG005|Overall Study|Clinical progression|3|||
161530655|NCT02723864|583331065|FG006|Overall Study|Clinical progression|1|||
161530656|NCT02723864|583331059|FG000|Overall Study|Physician Decision|0|||
161530657|NCT02723864|583331060|FG001|Overall Study|Physician Decision|0|||
161530658|NCT02723864|583331061|FG002|Overall Study|Physician Decision|0|||
161530659|NCT02723864|583331062|FG003|Overall Study|Physician Decision|0|||
161530660|NCT02723864|583331063|FG004|Overall Study|Physician Decision|0|||
161530661|NCT02723864|583331064|FG005|Overall Study|Physician Decision|0|||
161530662|NCT02723864|583331065|FG006|Overall Study|Physician Decision|1|||
161530663|NCT02723864|583331059|FG000|Overall Study|Changes in patient condition|0|||
161530664|NCT02723864|583331060|FG001|Overall Study|Changes in patient condition|0|||
161530665|NCT02723864|583331061|FG002|Overall Study|Changes in patient condition|0|||
161530666|NCT02723864|583331062|FG003|Overall Study|Changes in patient condition|0|||
161530667|NCT02723864|583331063|FG004|Overall Study|Changes in patient condition|0|||
161530668|NCT02723864|583331064|FG005|Overall Study|Changes in patient condition|1|||
161530669|NCT02723864|583331065|FG006|Overall Study|Changes in patient condition|0|||
161530670|NCT02723864|583331059|FG000|Overall Study|Patient choice|0|||
161530671|NCT02723864|583331060|FG001|Overall Study|Patient choice|0|||
161530672|NCT02723864|583331061|FG002|Overall Study|Patient choice|0|||
161530673|NCT02723864|583331062|FG003|Overall Study|Patient choice|0|||
161530674|NCT02723864|583331063|FG004|Overall Study|Patient choice|0|||
161530675|NCT02723864|583331064|FG005|Overall Study|Patient choice|1|||
161530676|NCT02723864|583331065|FG006|Overall Study|Patient choice|0|||
161530677|NCT02723864|583331059|FG000|Overall Study|Adverse Event|0|||
161530678|NCT02723864|583331060|FG001|Overall Study|Adverse Event|0|||
161530679|NCT02723864|583331061|FG002|Overall Study|Adverse Event|0|||
161530680|NCT02723864|583331062|FG003|Overall Study|Adverse Event|0|||
161530681|NCT02723864|583331063|FG004|Overall Study|Adverse Event|0|||
161530682|NCT02723864|583331064|FG005|Overall Study|Adverse Event|1|||
161530683|NCT02723864|583331065|FG006|Overall Study|Adverse Event|0|||
161530684|NCT02723864|583331059|FG000|Overall Study|Started new treatment|0|||
161530685|NCT02723864|583331060|FG001|Overall Study|Started new treatment|0|||
161530686|NCT02723864|583331061|FG002|Overall Study|Started new treatment|0|||
161530687|NCT02723864|583331062|FG003|Overall Study|Started new treatment|0|||
161530688|NCT02723864|583331063|FG004|Overall Study|Started new treatment|0|||
161530689|NCT02723864|583331064|FG005|Overall Study|Started new treatment|1|||
161591321|NCT03652688|583552831|FG001|Follow-up|Lost to Follow-up|54|||
161530690|NCT02723864|583331065|FG006|Overall Study|Started new treatment|0|||
161530691|NCT02723864|583331059|FG000|Overall Study|Switched to alternative treatment|0|||
161530692|NCT02723864|583331060|FG001|Overall Study|Switched to alternative treatment|0|||
161530693|NCT02723864|583331061|FG002|Overall Study|Switched to alternative treatment|0|||
161530694|NCT02723864|583331062|FG003|Overall Study|Switched to alternative treatment|0|||
161530695|NCT02723864|583331063|FG004|Overall Study|Switched to alternative treatment|0|||
161591322|NCT00554788|583552837|FG000|Overall Study|Adverse Event|0|||
161591323|NCT00554788|583552838|FG001|Overall Study|Adverse Event|1|||
161827413|NCT00708682|584408075|FG000|Infant Series|Other|19|||
161827414|NCT00708682|584408075|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
161827415|NCT00708682|584408075|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
161827416|NCT00708682|584408075|FG000|Toddler Dose|Lost to Follow-up|3|||
161827417|NCT00708682|584408075|FG000|Toddler Dose|Failed to Return|4|||
161827418|NCT00569777|584408078|FG000|Overall Study|Withdrawal by Subject|4|||
161827419|NCT00569777|584408079|FG001|Overall Study|Withdrawal by Subject|0|||
161827420|NCT00569777|584408078|FG000|Overall Study|Adverse Event|3|||
161827421|NCT00569777|584408079|FG001|Overall Study|Adverse Event|0|||
161827422|NCT00569777|584408078|FG000|Overall Study|Lost to Follow-up|1|||
161827423|NCT00569777|584408079|FG001|Overall Study|Lost to Follow-up|0|||
161530696|NCT02723864|583331064|FG005|Overall Study|Switched to alternative treatment|1|||
161530697|NCT02723864|583331065|FG006|Overall Study|Switched to alternative treatment|0|||
161530698|NCT02723864|583331059|FG000|Overall Study|Late determination of ineligibility|0|||
161530699|NCT02723864|583331060|FG001|Overall Study|Late determination of ineligibility|0|||
161530700|NCT02723864|583331061|FG002|Overall Study|Late determination of ineligibility|0|||
161530701|NCT02723864|583331062|FG003|Overall Study|Late determination of ineligibility|0|||
161530702|NCT02723864|583331063|FG004|Overall Study|Late determination of ineligibility|0|||
161530703|NCT02723864|583331064|FG005|Overall Study|Late determination of ineligibility|1|||
161530704|NCT02723864|583331065|FG006|Overall Study|Late determination of ineligibility|0|||
161530705|NCT03232983|583331066|FG000|Period 1|Physician Decision|0|||
161530706|NCT03232983|583331067|FG001|Period 1|Physician Decision|0|||
161530707|NCT03232983|583331068|FG002|Period 1|Physician Decision|1|||
161530708|NCT03232983|583331069|FG003|Period 1|Physician Decision|0|||
161530709|NCT03232983|583331066|FG000|Washout Period 2|Physician Decision|0|||
161530710|NCT03232983|583331067|FG001|Washout Period 2|Physician Decision|0|||
161530711|NCT03232983|583331068|FG002|Washout Period 2|Physician Decision|1|||
161530712|NCT03232983|583331069|FG003|Washout Period 2|Physician Decision|0|||
161530713|NCT03232983|583331066|FG000|Washout Period 2|Withdrawal by Subject|0|||
161530714|NCT03232983|583331067|FG001|Washout Period 2|Withdrawal by Subject|0|||
161530715|NCT03232983|583331068|FG002|Washout Period 2|Withdrawal by Subject|0|||
161530716|NCT03232983|583331069|FG003|Washout Period 2|Withdrawal by Subject|1|||
161530717|NCT03232983|583331066|FG000|Period 4|Withdrawal by Subject|1|||
161530718|NCT03232983|583331067|FG001|Period 4|Withdrawal by Subject|0|||
161530719|NCT03232983|583331068|FG002|Period 4|Withdrawal by Subject|0|||
161530720|NCT03232983|583331069|FG003|Period 4|Withdrawal by Subject|0|||
161530721|NCT00746590|583331070|FG000|Overall Study|Death|1|||
161530722|NCT02633800|583331073|FG000|Overall Study|Death|3|||
161530723|NCT02633800|583331074|FG001|Overall Study|Death|3|||
161530724|NCT02633800|583331073|FG000|Overall Study|Reason not provided|1|||
161530725|NCT02633800|583331074|FG001|Overall Study|Reason not provided|0|||
161530726|NCT02633800|583331073|FG000|Overall Study|Radiologic(al) progression|23|||
161530727|NCT02633800|583331074|FG001|Overall Study|Radiologic(al) progression|23|||
161530728|NCT02633800|583331073|FG000|Overall Study|Clinical progression|3|||
161530729|NCT02633800|583331074|FG001|Overall Study|Clinical progression|6|||
161530730|NCT02633800|583331073|FG000|Overall Study|Study terminated by sponsor|6|||
161530731|NCT02633800|583331074|FG001|Overall Study|Study terminated by sponsor|5|||
161530732|NCT02633800|583331073|FG000|Overall Study|Adverse event, non-fatal|7|||
161530733|NCT02633800|583331074|FG001|Overall Study|Adverse event, non-fatal|2|||
161530734|NCT02633800|583331073|FG000|Overall Study|Withdrawal by Subject|0|||
161530735|NCT02633800|583331074|FG001|Overall Study|Withdrawal by Subject|3|||
161530736|NCT02633800|583331073|FG000|Overall Study|Patient Request|1|||
161530737|NCT02633800|583331074|FG001|Overall Study|Patient Request|1|||
161530738|NCT00530855|583331078|FG000|Overall Study|Lack of Efficacy|20|||
161530739|NCT00530855|583331078|FG000|Overall Study|Withdrawal by Subject|30|||
161530740|NCT00530855|583331078|FG000|Overall Study|Fatal Serious AE|3|||
161530741|NCT00530855|583331078|FG000|Overall Study|Non Fatal Serious AE|7|||
161530742|NCT00530855|583331078|FG000|Overall Study|Non Fatal Non Serious AE|12|||
161530743|NCT00530855|583331078|FG000|Overall Study|Protocol Violation|3|||
161530744|NCT00530855|583331078|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
161530745|NCT00530855|583331078|FG000|Overall Study|Lost to Follow-up|9|||
161678460|NCT02081534|583875978|FG002|Overall Study|Adverse Event|3|||
161678461|NCT02081534|583875979|FG003|Overall Study|Adverse Event|10|||
161678462|NCT02081534|583875980|FG004|Overall Study|Adverse Event|2|||
161678463|NCT02081534|583875981|FG005|Overall Study|Adverse Event|8|||
161678464|NCT02081534|583875982|FG006|Overall Study|Adverse Event|2|||
161678465|NCT02081534|583875976|FG000|Overall Study|Withdrawal by Subject|0|||
161678466|NCT02081534|583875977|FG001|Overall Study|Withdrawal by Subject|1|||
161678467|NCT02081534|583875978|FG002|Overall Study|Withdrawal by Subject|1|||
161827424|NCT00569777|584408078|FG000|Overall Study|scheduled eye surgery|0|||
161530746|NCT00530855|583331078|FG000|Overall Study|Other reason for premature termination|17|||
161530747|NCT00815295|583331079|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
161530748|NCT00815295|583331080|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
161530749|NCT00815295|583331081|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
161530750|NCT03152526|583331100|FG000|Overall Study|Withdrawal by Subject|0|||
161827425|NCT00569777|584408079|FG001|Overall Study|scheduled eye surgery|1|||
161827426|NCT00569777|584408078|FG000|Overall Study|did not meet exclusion criteria|1|||
161530751|NCT03152526|583331101|FG001|Overall Study|Withdrawal by Subject|1|||
161530752|NCT05554237|583331102|FG000|Part 2 (7 Days)|Adverse Event|0|||
161530753|NCT05554237|583331103|FG001|Part 2 (7 Days)|Adverse Event|0|||
161530754|NCT05554237|583331104|FG002|Part 2 (7 Days)|Adverse Event|0|||
161530755|NCT05554237|583331105|FG003|Part 2 (7 Days)|Adverse Event|0|||
161530756|NCT05554237|583331106|FG004|Part 2 (7 Days)|Adverse Event|2|||
161530757|NCT05554237|583331107|FG005|Part 2 (7 Days)|Adverse Event|0|||
161827427|NCT00569777|584408079|FG001|Overall Study|did not meet exclusion criteria|2|||
161678468|NCT02081534|583875979|FG003|Overall Study|Withdrawal by Subject|1|||
161678469|NCT02081534|583875980|FG004|Overall Study|Withdrawal by Subject|1|||
161530758|NCT05554237|583331108|FG006|Part 2 (7 Days)|Adverse Event|0|||
161530759|NCT05554237|583331109|FG007|Part 2 (7 Days)|Adverse Event|0|||
161530760|NCT05554237|583331110|FG008|Part 2 (7 Days)|Adverse Event|0|||
161530761|NCT05554237|583331111|FG009|Part 2 (7 Days)|Adverse Event|1|||
161530762|NCT05554237|583331112|FG010|Part 2 (7 Days)|Adverse Event|0|||
161530763|NCT05554237|583331113|FG011|Part 2 (7 Days)|Adverse Event|0|||
161530764|NCT05554237|583331114|FG012|Part 2 (7 Days)|Adverse Event|1|||
161530765|NCT05554237|583331115|FG013|Part 2 (7 Days)|Adverse Event|0|||
161530766|NCT05130970|583331116|FG000|Overall Study|Adverse Event|1|||
161530767|NCT05130970|583331117|FG001|Overall Study|Adverse Event|1|||
161530768|NCT05130970|583331116|FG000|Overall Study|Death|0|||
161530769|NCT05130970|583331117|FG001|Overall Study|Death|1|||
161530770|NCT05130970|583331116|FG000|Overall Study|Lost to Follow-up|0|||
161530771|NCT05130970|583331117|FG001|Overall Study|Lost to Follow-up|1|||
161530772|NCT05130970|583331116|FG000|Overall Study|Physician Decision|0|||
161530773|NCT05130970|583331117|FG001|Overall Study|Physician Decision|1|||
161530774|NCT05130970|583331116|FG000|Overall Study|Withdrawal by Subject|1|||
161530775|NCT05130970|583331117|FG001|Overall Study|Withdrawal by Subject|1|||
161530776|NCT04969198|583331118|FG000|Overall Study|Withdrawal by Subject|20|||
161530777|NCT04969198|583331118|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
161530778|NCT04969198|583331118|FG000|Overall Study|Lost to Follow-up|20|||
161530779|NCT02701985|583331119|FG000|Overall Study|Withdrawal by Subject|1|||
161530780|NCT02701985|583331120|FG001|Overall Study|Withdrawal by Subject|1|||
161530781|NCT02701985|583331119|FG000|Overall Study|Lost to Follow-up|1|||
161530782|NCT02701985|583331120|FG001|Overall Study|Lost to Follow-up|0|||
161530783|NCT02701985|583331119|FG000|Overall Study|Death|1|||
161530784|NCT02701985|583331120|FG001|Overall Study|Death|0|||
161530785|NCT02701985|583331119|FG000|Overall Study|Adverse Event|0|||
161530786|NCT02701985|583331120|FG001|Overall Study|Adverse Event|5|||
161530787|NCT01640808|583331122|FG000|Overall Study|Unable to continue dynamic CT|14|||
161530788|NCT01640808|583331123|FG001|Overall Study|Unable to continue dynamic CT|4|||
161530789|NCT01640808|583331122|FG000|Overall Study|Withdrawal by Subject|12|||
161530790|NCT01640808|583331123|FG001|Overall Study|Withdrawal by Subject|4|||
161530791|NCT01640808|583331122|FG000|Overall Study|Lost to Follow-up|4|||
161530792|NCT01640808|583331123|FG001|Overall Study|Lost to Follow-up|0|||
161530793|NCT01640808|583331122|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
161530794|NCT01640808|583331123|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
161530795|NCT01640808|583331122|FG000|Overall Study|Administration of anticancer drugs|2|||
161530796|NCT01640808|583331123|FG001|Overall Study|Administration of anticancer drugs|1|||
161530797|NCT01640808|583331122|FG000|Overall Study|Physician Decision|19|||
161530798|NCT01640808|583331123|FG001|Overall Study|Physician Decision|5|||
161530799|NCT01640808|583331122|FG000|Overall Study|Randomized but not treated|4|||
161530800|NCT01640808|583331123|FG001|Overall Study|Randomized but not treated|2|||
161530801|NCT02477111|583331124|FG000|Overall Study|Death|28|||
161530802|NCT02477111|583331124|FG000|Overall Study|Withdrawal by Subject|19|||
161530803|NCT02477111|583331124|FG000|Overall Study|Lost to Follow-up|4|||
161530804|NCT02192502|583331126|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
161530805|NCT02192502|583331127|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
161530806|NCT02192502|583331126|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
161530807|NCT02192502|583331127|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
161530808|NCT02192502|583331126|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
161530809|NCT02192502|583331127|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
161530810|NCT01381692|583331128|FG000|Overall Study|Adverse Event|1|||
161530811|NCT01381692|583331129|FG001|Overall Study|Adverse Event|0|||
161530812|NCT01381692|583331130|FG002|Overall Study|Adverse Event|0|||
161530813|NCT01381692|583331131|FG003|Overall Study|Adverse Event|0|||
161530814|NCT01381692|583331132|FG004|Overall Study|Adverse Event|0|||
161530815|NCT01381692|583331133|FG005|Overall Study|Adverse Event|0|||
161530816|NCT02189798|583331134|FG000|Extended Use Phase|Withdrawal by Subject|0|||
161530817|NCT02189798|583331135|FG001|Extended Use Phase|Withdrawal by Subject|4|||
161530818|NCT02189798|583331134|FG000|Extended Use Phase|Physician Decision|1|||
161530819|NCT02189798|583331135|FG001|Extended Use Phase|Physician Decision|0|||
161530820|NCT02189798|583331134|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
161530821|NCT02189798|583331135|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
161530822|NCT02189798|583331134|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
161530823|NCT02189798|583331135|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
161530824|NCT02189798|583331134|FG000|Extended Use Phase|Travel Issues|2|||
161530825|NCT02189798|583331135|FG001|Extended Use Phase|Travel Issues|1|||
161530826|NCT02189798|583331134|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
161530827|NCT02189798|583331135|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
161530828|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
161530829|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
161530830|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
161530831|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
161530832|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
161530833|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
161530834|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
161530835|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
161530836|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
161530837|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
161530838|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
161530839|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
161530840|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
161530841|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
161530842|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
161530843|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
161530844|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
161530845|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
161530846|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
161530847|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
161530848|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
161530849|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
161530850|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
161530851|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
161530852|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
161530853|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
161530854|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
161530855|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
161530856|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
161530857|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
161530858|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
161530859|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
161530860|NCT04818346|583331139|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
161530861|NCT04818346|583331140|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
161530862|NCT04818346|583331141|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
161530863|NCT04818346|583331142|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
161530864|NCT04818346|583331139|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
161530865|NCT04818346|583331140|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
161530866|NCT04818346|583331141|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
161530867|NCT04818346|583331142|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
161530868|NCT04818346|583331139|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
161530869|NCT04818346|583331140|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
161530870|NCT04818346|583331141|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
161530871|NCT04818346|583331142|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
161530872|NCT04818346|583331139|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
161530873|NCT04818346|583331140|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
161530874|NCT04818346|583331141|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
161530875|NCT04818346|583331142|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
161530876|NCT04818346|583331139|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
161530877|NCT04818346|583331140|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
161530878|NCT04818346|583331141|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
161530879|NCT04818346|583331142|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
161530880|NCT04818346|583331139|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
161530881|NCT04818346|583331140|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
161530882|NCT04818346|583331141|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
161530883|NCT04818346|583331142|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
161530884|NCT04818346|583331139|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
161530885|NCT04818346|583331140|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
161591324|NCT00554788|583552839|FG002|Overall Study|Adverse Event|2|||
161591325|NCT00554788|583552837|FG000|Overall Study|Lost to Follow-up|4|||
161591326|NCT00554788|583552838|FG001|Overall Study|Lost to Follow-up|3|||
161827428|NCT00569777|584408078|FG000|Overall Study|pregnant|1|||
161827429|NCT00569777|584408079|FG001|Overall Study|pregnant|0|||
161530886|NCT04818346|583331141|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
161530887|NCT04818346|583331142|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
161530888|NCT05553808|583331143|FG000|Overall Study|Death|25|||
161530889|NCT05553808|583331144|FG001|Overall Study|Death|62|||
161530890|NCT05553808|583331143|FG000|Overall Study|Site Closed|6|||
161530891|NCT05553808|583331144|FG001|Overall Study|Site Closed|6|||
161530892|NCT05553808|583331143|FG000|Overall Study|Lost to Follow-up|1|||
161530893|NCT05553808|583331144|FG001|Overall Study|Lost to Follow-up|0|||
161530894|NCT05553808|583331143|FG000|Overall Study|Withdrawal by Subject|3|||
161530895|NCT05553808|583331144|FG001|Overall Study|Withdrawal by Subject|2|||
161530896|NCT02273141|583331145|FG000|Overall Study|Adverse Event|0|||
161530897|NCT02273141|583331146|FG001|Overall Study|Adverse Event|1|||
161530898|NCT02273141|583331145|FG000|Overall Study|Lost to Follow-up|1|||
161530899|NCT02273141|583331146|FG001|Overall Study|Lost to Follow-up|3|||
161530900|NCT02273141|583331145|FG000|Overall Study|Withdrawal by Subject|10|||
161530901|NCT02273141|583331146|FG001|Overall Study|Withdrawal by Subject|15|||
161530902|NCT02273141|583331145|FG000|Overall Study|Various|6|||
161530903|NCT02273141|583331146|FG001|Overall Study|Various|6|||
161530904|NCT00529399|583331149|FG000|Overall Study|Lost to Follow-up|1|||
161530905|NCT00529399|583331150|FG001|Overall Study|Lost to Follow-up|0|||
161530906|NCT00529399|583331151|FG002|Overall Study|Lost to Follow-up|1|||
161530907|NCT00529399|583331149|FG000|Overall Study|Withdrawal by Subject|1|||
161530908|NCT00529399|583331150|FG001|Overall Study|Withdrawal by Subject|0|||
161530909|NCT00529399|583331151|FG002|Overall Study|Withdrawal by Subject|1|||
161530910|NCT00529399|583331149|FG000|Overall Study|Non-compliant|0|||
161530911|NCT00529399|583331150|FG001|Overall Study|Non-compliant|1|||
161530912|NCT00529399|583331151|FG002|Overall Study|Non-compliant|0|||
161530913|NCT03695172|583331152|FG000|Overall Study|Withdrawal by Subject|1|||
161530914|NCT03695172|583331153|FG001|Overall Study|Withdrawal by Subject|1|||
161530915|NCT03695172|583331154|FG002|Overall Study|Withdrawal by Subject|0|||
161530916|NCT01506193|583331155|FG000|Overall Study|Protocol Violation|1|||
161530917|NCT01506193|583331156|FG001|Overall Study|Protocol Violation|0|||
161530918|NCT01506193|583331157|FG002|Overall Study|Protocol Violation|1|||
161530919|NCT01506193|583331155|FG000|Overall Study|Migrated/moved from study area|0|||
161530920|NCT01506193|583331156|FG001|Overall Study|Migrated/moved from study area|0|||
161530921|NCT01506193|583331157|FG002|Overall Study|Migrated/moved from study area|1|||
161530922|NCT01506193|583331155|FG000|Overall Study|Adverse event, non-fatal|0|||
161530923|NCT01506193|583331156|FG001|Overall Study|Adverse event, non-fatal|0|||
161530924|NCT01506193|583331157|FG002|Overall Study|Adverse event, non-fatal|1|||
161530925|NCT01506193|583331155|FG000|Overall Study|Withdrawal by Subject|5|||
161530926|NCT01506193|583331156|FG001|Overall Study|Withdrawal by Subject|1|||
161530927|NCT01506193|583331157|FG002|Overall Study|Withdrawal by Subject|8|||
161530928|NCT01506193|583331155|FG000|Overall Study|Lost to Follow-up|8|||
161530929|NCT01506193|583331156|FG001|Overall Study|Lost to Follow-up|3|||
161530930|NCT01506193|583331157|FG002|Overall Study|Lost to Follow-up|3|||
161530931|NCT04575467|583331174|FG000|Overall Study|Adverse Event|0|||
161530932|NCT04575467|583331175|FG001|Overall Study|Adverse Event|1|||
161530933|NCT04575467|583331176|FG002|Overall Study|Adverse Event|0|||
161530934|NCT04575467|583331177|FG003|Overall Study|Adverse Event|0|||
161530935|NCT00729833|583331180|FG000|Overall Study|Death|5|||
161530936|NCT00729833|583331181|FG001|Overall Study|Death|1|||
161530937|NCT00729833|583331182|FG002|Overall Study|Death|3|||
161530938|NCT00729833|583331183|FG003|Overall Study|Death|5|||
161530939|NCT00729833|583331180|FG000|Overall Study|Study Terminated by Sponsor|0|||
161530940|NCT00729833|583331181|FG001|Overall Study|Study Terminated by Sponsor|0|||
161530941|NCT00729833|583331182|FG002|Overall Study|Study Terminated by Sponsor|1|||
161530942|NCT00729833|583331183|FG003|Overall Study|Study Terminated by Sponsor|0|||
161530943|NCT00729833|583331180|FG000|Overall Study|Lost to Follow-up|1|||
161530944|NCT00729833|583331181|FG001|Overall Study|Lost to Follow-up|0|||
161530945|NCT00729833|583331182|FG002|Overall Study|Lost to Follow-up|0|||
161530946|NCT00729833|583331183|FG003|Overall Study|Lost to Follow-up|0|||
161530947|NCT00729833|583331180|FG000|Overall Study|Withdrawal by Subject|3|||
161530948|NCT00729833|583331181|FG001|Overall Study|Withdrawal by Subject|1|||
161530949|NCT00729833|583331182|FG002|Overall Study|Withdrawal by Subject|3|||
161678470|NCT02081534|583875981|FG005|Overall Study|Withdrawal by Subject|0|||
161678471|NCT02081534|583875982|FG006|Overall Study|Withdrawal by Subject|1|||
161530950|NCT00729833|583331183|FG003|Overall Study|Withdrawal by Subject|0|||
161530951|NCT00729833|583331180|FG000|Overall Study|Unspecified Reasons|11|||
161530952|NCT00729833|583331181|FG001|Overall Study|Unspecified Reasons|5|||
161530953|NCT00729833|583331182|FG002|Overall Study|Unspecified Reasons|5|||
161530954|NCT00729833|583331183|FG003|Overall Study|Unspecified Reasons|1|||
161530955|NCT04899349|583331184|FG000|Overall Study|Study terminated by Sponsor|2|||
161530956|NCT04899349|583331185|FG001|Overall Study|Study terminated by Sponsor|0|||
161530957|NCT03336619|583331187|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
161530958|NCT03336619|583331188|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
161530959|NCT03336619|583331187|FG000|Overall Study|Withdrawal by Subject|17|||
161530960|NCT03336619|583331188|FG001|Overall Study|Withdrawal by Subject|16|||
161530961|NCT03336619|583331187|FG000|Overall Study|Adverse Event|2|||
161530962|NCT03336619|583331188|FG001|Overall Study|Adverse Event|5|||
161530963|NCT03336619|583331187|FG000|Overall Study|Physician Decision|3|||
161530964|NCT03336619|583331188|FG001|Overall Study|Physician Decision|0|||
161530965|NCT02820623|583331189|FG000|Overall Study|Withdrawal by Subject|1|||
161530966|NCT02820623|583331190|FG001|Overall Study|Withdrawal by Subject|3|||
161530967|NCT02820623|583331191|FG002|Overall Study|Withdrawal by Subject|3|||
161530968|NCT02820623|583331189|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
161530969|NCT02820623|583331190|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
161530970|NCT02820623|583331191|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
161530971|NCT02820623|583331189|FG000|Overall Study|Therapist unable to enroll clients|1|||
161530972|NCT02820623|583331190|FG001|Overall Study|Therapist unable to enroll clients|1|||
161530973|NCT02820623|583331191|FG002|Overall Study|Therapist unable to enroll clients|3|||
161530974|NCT02820623|583331189|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
161530975|NCT02820623|583331190|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
161530976|NCT02820623|583331191|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
161530977|NCT02653482|583331192|FG000|Overall Study|Death|1|||
161530978|NCT02653482|583331193|FG001|Overall Study|Death|1|||
161530979|NCT05132699|583331195|FG000|Overall Study|Withdrawal by Subject|3|||
161530980|NCT05132699|583331196|FG001|Overall Study|Withdrawal by Subject|0|||
161530981|NCT04370054|583331197|FG000|Treatment Phase|Lost to Follow-up|1|||
161530982|NCT04370054|583331197|FG000|Treatment Phase|Withdrawal by Subject|1|||
161530983|NCT04370054|583331197|FG000|Follow-Up Phase|Ongoing|75|||
161530984|NCT02096900|583331198|FG000|Overall Study|Did not receive medication|3|||
161530985|NCT02096900|583331199|FG001|Overall Study|Did not receive medication|1|||
161530986|NCT02096900|583331198|FG000|Overall Study|Surgery cancelled- medication received|1|||
161530987|NCT02096900|583331199|FG001|Overall Study|Surgery cancelled- medication received|1|||
161530988|NCT00710424|583331202|FG000|Overall Study|Adverse Event|30|||
161530989|NCT00710424|583331203|FG001|Overall Study|Adverse Event|12|||
161530990|NCT00710424|583331202|FG000|Overall Study|Lack of Efficacy|4|||
161530991|NCT00710424|583331203|FG001|Overall Study|Lack of Efficacy|5|||
161530992|NCT00710424|583331202|FG000|Overall Study|Withdrawal by Subject|5|||
161530993|NCT00710424|583331203|FG001|Overall Study|Withdrawal by Subject|3|||
161530994|NCT00710424|583331202|FG000|Overall Study|Lost to Follow-up|0|||
161530995|NCT00710424|583331203|FG001|Overall Study|Lost to Follow-up|1|||
161530996|NCT00710424|583331202|FG000|Overall Study|Refused medication, no side effects|1|||
161530997|NCT00710424|583331203|FG001|Overall Study|Refused medication, no side effects|0|||
161530998|NCT00710424|583331202|FG000|Overall Study|Non-compliance with stable analgesia|1|||
161530999|NCT00710424|583331203|FG001|Overall Study|Non-compliance with stable analgesia|0|||
161531000|NCT00710424|583331202|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
161531001|NCT00710424|583331203|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
161531002|NCT00710424|583331202|FG000|Overall Study|Subject thought medication changed|1|||
161531003|NCT00710424|583331203|FG001|Overall Study|Subject thought medication changed|0|||
161531004|NCT00710424|583331202|FG000|Overall Study|Ceased treatment due to travel|1|||
161531005|NCT00710424|583331203|FG001|Overall Study|Ceased treatment due to travel|0|||
161531006|NCT00710424|583331202|FG000|Overall Study|Subject preferred paracetamol|0|||
161531007|NCT00710424|583331203|FG001|Overall Study|Subject preferred paracetamol|1|||
161531008|NCT00710424|583331202|FG000|Overall Study|Felt good so stopped treatment|0|||
161531009|NCT00710424|583331203|FG001|Overall Study|Felt good so stopped treatment|1|||
161531010|NCT04918784|583333050|FG000|Overall Study|Amputation - no longer eligible|1|||
161531011|NCT04918784|583333051|FG001|Overall Study|Amputation - no longer eligible|2|||
161531012|NCT04918784|583333050|FG000|Overall Study|Death|1|||
161531013|NCT04918784|583333051|FG001|Overall Study|Death|0|||
161531014|NCT04918784|583333050|FG000|Overall Study|patient non-compliance|3|||
161531015|NCT04918784|583333051|FG001|Overall Study|patient non-compliance|1|||
161531016|NCT04918784|583333050|FG000|Overall Study|Adverse Event|1|||
161531017|NCT04918784|583333051|FG001|Overall Study|Adverse Event|0|||
161531018|NCT01986881|583333052|FG000|Overall Study|Death|228|||
161827430|NCT02056652|584408080|FG000|Overall Study|Withdrawal by Subject|1|||
161827431|NCT02056652|584408081|FG001|Overall Study|Withdrawal by Subject|0|||
161827432|NCT02056652|584408080|FG000|Overall Study|Lost to Follow-up|0|||
161531019|NCT01986881|583333053|FG001|Overall Study|Death|233|||
161531020|NCT01986881|583333054|FG002|Overall Study|Death|247|||
161531021|NCT01986881|583333052|FG000|Overall Study|Lost to Follow-up|51|||
161531022|NCT01986881|583333053|FG001|Overall Study|Lost to Follow-up|44|||
161531023|NCT01986881|583333054|FG002|Overall Study|Lost to Follow-up|55|||
161531024|NCT01986881|583333052|FG000|Overall Study|Physician Decision|7|||
161531025|NCT01986881|583333053|FG001|Overall Study|Physician Decision|4|||
161531026|NCT01986881|583333054|FG002|Overall Study|Physician Decision|6|||
161531027|NCT01986881|583333052|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
161531028|NCT01986881|583333053|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
161531029|NCT01986881|583333054|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
161531030|NCT01986881|583333052|FG000|Overall Study|Withdrawal by Subject|41|||
161591327|NCT00554788|583552839|FG002|Overall Study|Lost to Follow-up|3|||
161591328|NCT00554788|583552837|FG000|Overall Study|Physician Decision|1|||
161591329|NCT00554788|583552838|FG001|Overall Study|Physician Decision|1|||
161591330|NCT00554788|583552839|FG002|Overall Study|Physician Decision|3|||
161591331|NCT00554788|583552837|FG000|Overall Study|Withdrawal by Subject|0|||
161591332|NCT00554788|583552838|FG001|Overall Study|Withdrawal by Subject|0|||
161591333|NCT00554788|583552839|FG002|Overall Study|Withdrawal by Subject|1|||
161591334|NCT00554788|583552837|FG000|Overall Study|Refusal of further protocol therapy|0|||
161591335|NCT00554788|583552838|FG001|Overall Study|Refusal of further protocol therapy|1|||
161591336|NCT00554788|583552839|FG002|Overall Study|Refusal of further protocol therapy|1|||
161591337|NCT00554788|583552837|FG000|Overall Study|Progressive disease|0|||
161591338|NCT00554788|583552838|FG001|Overall Study|Progressive disease|0|||
161591339|NCT00554788|583552839|FG002|Overall Study|Progressive disease|3|||
161591340|NCT00554788|583552837|FG000|Overall Study|Ineligible|2|||
161591341|NCT00554788|583552838|FG001|Overall Study|Ineligible|0|||
161591342|NCT00554788|583552839|FG002|Overall Study|Ineligible|1|||
161591343|NCT03640312|583552850|FG000|Overall Study|Lost to Follow-up|3|||
161591344|NCT03640312|583552851|FG001|Overall Study|Lost to Follow-up|6|||
161591345|NCT05008835|583552855|FG000|Overall Study|Adverse Event|5|||
161591346|NCT05008835|583552856|FG001|Overall Study|Adverse Event|2|||
161591347|NCT05008835|583552857|FG002|Overall Study|Adverse Event|1|||
161591348|NCT05008835|583552855|FG000|Overall Study|Lack of Efficacy|0|||
161591349|NCT05008835|583552856|FG001|Overall Study|Lack of Efficacy|0|||
161591350|NCT05008835|583552857|FG002|Overall Study|Lack of Efficacy|1|||
161591351|NCT05008835|583552855|FG000|Overall Study|Study terminated by sponsor|0|||
161591352|NCT05008835|583552856|FG001|Overall Study|Study terminated by sponsor|0|||
161591353|NCT05008835|583552857|FG002|Overall Study|Study terminated by sponsor|1|||
161591354|NCT05008835|583552855|FG000|Overall Study|Not further specified|3|||
161591355|NCT05008835|583552856|FG001|Overall Study|Not further specified|2|||
161591356|NCT05008835|583552857|FG002|Overall Study|Not further specified|1|||
161591357|NCT04876118|583552858|FG000|Overall Study|Pregnancy|1|||
161591358|NCT04876118|583552858|FG000|Overall Study|Withdrawal by Subject|14|||
161591359|NCT05089734|583552859|FG000|Overall Study|Still on study|122|||
161591360|NCT05089734|583552860|FG001|Overall Study|Still on study|101|||
161591361|NCT05089734|583552859|FG000|Overall Study|Death|161|||
161591362|NCT05089734|583552860|FG001|Overall Study|Death|179|||
161591363|NCT05089734|583552859|FG000|Overall Study|Withdrew consent|11|||
161591364|NCT05089734|583552860|FG001|Overall Study|Withdrew consent|24|||
161591365|NCT05089734|583552859|FG000|Overall Study|Lost to Follow-up|5|||
161591366|NCT05089734|583552860|FG001|Overall Study|Lost to Follow-up|0|||
161591367|NCT05215314|583554620|FG000|Overall Study|Lost to Follow-up|2|||
161591368|NCT05215314|583554621|FG001|Overall Study|Lost to Follow-up|2|||
161591369|NCT05215314|583554620|FG000|Overall Study|Withdrawal by Subject|2|||
161591370|NCT05215314|583554621|FG001|Overall Study|Withdrawal by Subject|0|||
161591371|NCT05215314|583554620|FG000|Overall Study|Physician Decision|1|||
161591372|NCT05215314|583554621|FG001|Overall Study|Physician Decision|0|||
161591373|NCT04179500|583554622|FG000|Treatment|Withdrawal by Subject|1|||
161591374|NCT04179500|583554622|FG000|Treatment|Adverse Event|2|||
161591375|NCT04179500|583554622|FG000|Treatment|pyrazinamide resistance|1|||
161827433|NCT02056652|584408081|FG001|Overall Study|Lost to Follow-up|3|||
161827434|NCT00239005|584408086|FG000|Overall Study|Adverse Event|6|||
161827435|NCT00239005|584408087|FG001|Overall Study|Adverse Event|6|||
161827436|NCT00239005|584408086|FG000|Overall Study|Withdrawal by Subject|3|||
161827437|NCT00239005|584408087|FG001|Overall Study|Withdrawal by Subject|4|||
161827438|NCT00239005|584408086|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
161827439|NCT00239005|584408087|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
161827440|NCT00239005|584408086|FG000|Overall Study|Protocol Violation|1|||
161827441|NCT00239005|584408087|FG001|Overall Study|Protocol Violation|0|||
161827442|NCT00239005|584408086|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
161827443|NCT00239005|584408087|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
161827444|NCT00239005|584408086|FG000|Overall Study|Lost to Follow-up|0|||
161827445|NCT00239005|584408087|FG001|Overall Study|Lost to Follow-up|1|||
161827446|NCT00987831|584408089|FG000|Overall Study|Never flared in 12 months|1|||
161827447|NCT00987831|584408090|FG001|Overall Study|Never flared in 12 months|0|||
161827448|NCT00987831|584408091|FG002|Overall Study|Never flared in 12 months|0|||
161827449|NCT00987831|584408089|FG000|Overall Study|Lost to Follow-up|0|||
161827450|NCT00987831|584408090|FG001|Overall Study|Lost to Follow-up|3|||
161827451|NCT00987831|584408091|FG002|Overall Study|Lost to Follow-up|0|||
161827452|NCT03253094|584408092|FG000|Overall Study|Adverse Event|2|||
161827453|NCT03253094|584408093|FG001|Overall Study|Adverse Event|0|||
161827454|NCT03253094|584408094|FG002|Overall Study|Adverse Event|0|||
161827455|NCT03253094|584408095|FG003|Overall Study|Adverse Event|0|||
161827456|NCT03253094|584408096|FG004|Overall Study|Adverse Event|0|||
161827457|NCT03253094|584408097|FG005|Overall Study|Adverse Event|0|||
161827458|NCT03253094|584408092|FG000|Overall Study|Lack of Efficacy|0|||
161827459|NCT03253094|584408093|FG001|Overall Study|Lack of Efficacy|0|||
161827460|NCT03253094|584408094|FG002|Overall Study|Lack of Efficacy|2|||
161827461|NCT03253094|584408095|FG003|Overall Study|Lack of Efficacy|1|||
161827462|NCT03253094|584408096|FG004|Overall Study|Lack of Efficacy|2|||
161827463|NCT03253094|584408097|FG005|Overall Study|Lack of Efficacy|1|||
161827464|NCT03253094|584408092|FG000|Overall Study|Lost to Follow-up|0|||
161827465|NCT03253094|584408093|FG001|Overall Study|Lost to Follow-up|0|||
161827466|NCT03253094|584408094|FG002|Overall Study|Lost to Follow-up|1|||
161827467|NCT03253094|584408095|FG003|Overall Study|Lost to Follow-up|1|||
161827468|NCT03253094|584408096|FG004|Overall Study|Lost to Follow-up|0|||
161827469|NCT03253094|584408097|FG005|Overall Study|Lost to Follow-up|1|||
161827470|NCT03253094|584408092|FG000|Overall Study|Physician Decision|1|||
161827471|NCT03253094|584408093|FG001|Overall Study|Physician Decision|0|||
161827472|NCT03253094|584408094|FG002|Overall Study|Physician Decision|0|||
161827473|NCT03253094|584408095|FG003|Overall Study|Physician Decision|1|||
161827474|NCT03253094|584408096|FG004|Overall Study|Physician Decision|0|||
161827475|NCT03253094|584408097|FG005|Overall Study|Physician Decision|2|||
161827476|NCT03253094|584408092|FG000|Overall Study|Withdrawal by Subject|1|||
161827477|NCT03253094|584408093|FG001|Overall Study|Withdrawal by Subject|2|||
161827478|NCT03253094|584408094|FG002|Overall Study|Withdrawal by Subject|1|||
161827479|NCT03253094|584408095|FG003|Overall Study|Withdrawal by Subject|0|||
161827480|NCT03253094|584408096|FG004|Overall Study|Withdrawal by Subject|3|||
161827481|NCT03253094|584408097|FG005|Overall Study|Withdrawal by Subject|0|||
161827482|NCT03253094|584408092|FG000|Overall Study|Other|0|||
161827483|NCT03253094|584408093|FG001|Overall Study|Other|1|||
161827484|NCT03253094|584408094|FG002|Overall Study|Other|2|||
161937069|NCT03816891|584819133|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
161937070|NCT03816891|584819134|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
161937071|NCT03816891|584819135|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161937072|NCT03816891|584819130|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
161531031|NCT01986881|583333053|FG001|Overall Study|Withdrawal by Subject|60|||
161531032|NCT01986881|583333054|FG002|Overall Study|Withdrawal by Subject|45|||
161531033|NCT01986881|583333052|FG000|Overall Study|Subject Moved|0|||
161531034|NCT01986881|583333053|FG001|Overall Study|Subject Moved|1|||
161531035|NCT01986881|583333054|FG002|Overall Study|Subject Moved|0|||
161531036|NCT01986881|583333052|FG000|Overall Study|Other|1|||
161531037|NCT01986881|583333053|FG001|Overall Study|Other|2|||
161531038|NCT01986881|583333054|FG002|Overall Study|Other|2|||
161531039|NCT04050865|583333055|FG000|Overall Study|Adverse Event|1|||
161531040|NCT04050865|583333056|FG001|Overall Study|Adverse Event|0|||
161531041|NCT04050865|583333055|FG000|Overall Study|no insert|1|||
161531042|NCT04050865|583333056|FG001|Overall Study|no insert|0|||
161531043|NCT04050865|583333055|FG000|Overall Study|Only 1 insert|2|||
161531044|NCT04050865|583333056|FG001|Overall Study|Only 1 insert|3|||
161531045|NCT04050865|583333055|FG000|Overall Study|Physician Decision|0|||
161531046|NCT04050865|583333056|FG001|Overall Study|Physician Decision|1|||
161531047|NCT04050865|583333055|FG000|Overall Study|Withdrawal by Subject|0|||
161531048|NCT04050865|583333056|FG001|Overall Study|Withdrawal by Subject|1|||
161531049|NCT02035332|583333057|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
161531050|NCT01258608|583333058|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
161531051|NCT01258608|583333059|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
161531052|NCT01258608|583333058|FG000|Overall Study|Clinical progression|1|||
161531053|NCT01258608|583333059|FG001|Overall Study|Clinical progression|0|||
161531054|NCT01258608|583333058|FG000|Overall Study|Sponsor decision|0|||
161531055|NCT01258608|583333059|FG001|Overall Study|Sponsor decision|1|||
161531056|NCT01258608|583333058|FG000|Overall Study|Physician Decision|6|||
161531057|NCT01258608|583333059|FG001|Overall Study|Physician Decision|1|||
161531058|NCT01258608|583333058|FG000|Overall Study|Lost to Follow-up|0|||
161531059|NCT01258608|583333059|FG001|Overall Study|Lost to Follow-up|1|||
161531060|NCT01258608|583333058|FG000|Overall Study|Lack of compliance|1|||
161531061|NCT01258608|583333059|FG001|Overall Study|Lack of compliance|0|||
161531062|NCT01258608|583333058|FG000|Overall Study|Lack of Efficacy|0|||
161531063|NCT01258608|583333059|FG001|Overall Study|Lack of Efficacy|1|||
161531064|NCT01258608|583333058|FG000|Overall Study|Adverse Event|6|||
161531065|NCT01258608|583333059|FG001|Overall Study|Adverse Event|10|||
161827485|NCT03253094|584408095|FG003|Overall Study|Other|1|||
161827486|NCT03253094|584408096|FG004|Overall Study|Other|0|||
161937073|NCT03816891|584819131|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
161937074|NCT03816891|584819132|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161937075|NCT03816891|584819133|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161937076|NCT03816891|584819134|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161531066|NCT01258608|583333058|FG000|Overall Study|Withdrawal by Subject|6|||
161531067|NCT01258608|583333059|FG001|Overall Study|Withdrawal by Subject|5|||
161531068|NCT04205630|583333060|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
161827487|NCT03253094|584408097|FG005|Overall Study|Other|0|||
161531069|NCT04205630|583333060|FG000|Overall Study|Disease clinical progression|7|||
161531070|NCT04205630|583333060|FG000|Overall Study|Withdrawal by Subject|2|||
161827488|NCT00824369|584408098|FG000|Overall Study|Nolonger willing to participate in study|1|||
161827489|NCT00824369|584408099|FG001|Overall Study|Nolonger willing to participate in study|0|||
161827490|NCT00824369|584408100|FG002|Overall Study|Nolonger willing to participate in study|1|||
161531071|NCT04205630|583333060|FG000|Overall Study|Adverse Event|17|||
161827491|NCT00824369|584408101|FG003|Overall Study|Nolonger willing to participate in study|2|||
161937077|NCT03816891|584819135|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
161937078|NCT03816891|584819130|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161937079|NCT03816891|584819131|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161937080|NCT03816891|584819132|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
161937081|NCT03816891|584819133|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161937082|NCT03816891|584819134|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
161937083|NCT03816891|584819135|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161937084|NCT03816891|584819130|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161937085|NCT03816891|584819131|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161937086|NCT03816891|584819132|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161937087|NCT03816891|584819133|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161937088|NCT03816891|584819134|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
161937089|NCT03816891|584819135|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
161937090|NCT03816891|584819130|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
161937091|NCT03816891|584819131|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
161937092|NCT03816891|584819132|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
161937093|NCT03816891|584819133|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
161937094|NCT03816891|584819134|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
161937095|NCT03816891|584819135|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
161937096|NCT04576455|584819138|FG000|Overall Study|Ongoing in the Study|48|||
161937097|NCT04576455|584819139|FG001|Overall Study|Ongoing in the Study|58|||
161937098|NCT04576455|584819138|FG000|Overall Study|Death|83|||
161937099|NCT04576455|584819139|FG001|Overall Study|Death|77|||
161937100|NCT04576455|584819138|FG000|Overall Study|Lost to Follow-up|4|||
161937101|NCT04576455|584819139|FG001|Overall Study|Lost to Follow-up|5|||
161531072|NCT04205630|583333060|FG000|Overall Study|Other|1|||
161531073|NCT00160680|583333067|FG000|Overall Study|Adverse Event|0|||
161531074|NCT00160680|583333068|FG001|Overall Study|Adverse Event|1|||
161531075|NCT00160680|583333067|FG000|Overall Study|Lack of Efficacy|2|||
161531076|NCT00160680|583333068|FG001|Overall Study|Lack of Efficacy|1|||
161531077|NCT00160680|583333067|FG000|Overall Study|Lost to Follow-up|3|||
161531078|NCT00160680|583333068|FG001|Overall Study|Lost to Follow-up|2|||
161531079|NCT00160680|583333067|FG000|Overall Study|Withdrawal by Subject|4|||
161531080|NCT00160680|583333068|FG001|Overall Study|Withdrawal by Subject|9|||
161531081|NCT04493216|583333069|FG000|Overall Study|Study terminated by sponsor|30|||
161531082|NCT04493216|583333070|FG001|Overall Study|Study terminated by sponsor|33|||
161531083|NCT04493216|583333071|FG002|Overall Study|Study terminated by sponsor|28|||
161531084|NCT04493216|583333072|FG003|Overall Study|Study terminated by sponsor|27|||
161531085|NCT04493216|583333069|FG000|Overall Study|Withdrawal by Subject|2|||
161531086|NCT04493216|583333070|FG001|Overall Study|Withdrawal by Subject|1|||
161531087|NCT04493216|583333071|FG002|Overall Study|Withdrawal by Subject|1|||
161827492|NCT00824369|584408102|FG004|Overall Study|Nolonger willing to participate in study|0|||
161827493|NCT00824369|584408103|FG005|Overall Study|Nolonger willing to participate in study|1|||
161827494|NCT00824369|584408098|FG000|Overall Study|Lost to Follow-up|0|||
161531088|NCT04493216|583333072|FG003|Overall Study|Withdrawal by Subject|2|||
161531089|NCT04493216|583333069|FG000|Overall Study|Protocol Violation|1|||
161678472|NCT02081534|583875976|FG000|Overall Study|Protocol Violation|0|||
161678473|NCT02081534|583875977|FG001|Overall Study|Protocol Violation|3|||
161678474|NCT02081534|583875978|FG002|Overall Study|Protocol Violation|0|||
161827495|NCT00824369|584408099|FG001|Overall Study|Lost to Follow-up|0|||
161827496|NCT00824369|584408100|FG002|Overall Study|Lost to Follow-up|0|||
161827497|NCT00824369|584408101|FG003|Overall Study|Lost to Follow-up|0|||
161827498|NCT00824369|584408102|FG004|Overall Study|Lost to Follow-up|1|||
161827499|NCT00824369|584408103|FG005|Overall Study|Lost to Follow-up|0|||
161827500|NCT02413294|584408104|FG000|Overall Study|Withdrawal by Subject|1|||
161827501|NCT02625974|584408105|FG000|Part 1|Lost to Follow-up|9|||
161827502|NCT02625974|584408106|FG001|Part 1|Lost to Follow-up|3|||
161827503|NCT02625974|584408105|FG000|Part 2|Lost to Follow-up|4|||
161827504|NCT02625974|584408106|FG001|Part 2|Lost to Follow-up|6|||
161827505|NCT02625974|584408105|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
161827506|NCT02625974|584408106|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
161827507|NCT01923311|584409324|FG000|Overall Study|Pregnancy|1|||
161827508|NCT01923311|584409325|FG001|Overall Study|Pregnancy|0|||
161827509|NCT01923311|584409324|FG000|Overall Study|Investigator's Discretion|1|||
161827510|NCT01923311|584409325|FG001|Overall Study|Investigator's Discretion|0|||
161827511|NCT01923311|584409324|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161827512|NCT01923311|584409325|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161827513|NCT01923311|584409324|FG000|Overall Study|Withdrew Consent|1|||
161827514|NCT01923311|584409325|FG001|Overall Study|Withdrew Consent|0|||
161827515|NCT01923311|584409324|FG000|Overall Study|Study Terminated by Sponsor|12|||
161827516|NCT01923311|584409325|FG001|Overall Study|Study Terminated by Sponsor|0|||
161937102|NCT04576455|584819138|FG000|Overall Study|Withdrawal by Subject|16|||
161937103|NCT04576455|584819139|FG001|Overall Study|Withdrawal by Subject|12|||
161937104|NCT04449055|584819140|FG000|Overall Study|Lost to Follow-up|2|||
161531090|NCT04493216|583333070|FG001|Overall Study|Protocol Violation|2|||
161531091|NCT04493216|583333071|FG002|Overall Study|Protocol Violation|0|||
161531092|NCT04493216|583333072|FG003|Overall Study|Protocol Violation|2|||
161531093|NCT04493216|583333069|FG000|Overall Study|Physician Decision|0|||
161531094|NCT04493216|583333070|FG001|Overall Study|Physician Decision|0|||
161531095|NCT04493216|583333071|FG002|Overall Study|Physician Decision|1|||
161531096|NCT04493216|583333072|FG003|Overall Study|Physician Decision|0|||
161531097|NCT04493216|583333069|FG000|Overall Study|Lost to Follow-up|2|||
161531098|NCT04493216|583333070|FG001|Overall Study|Lost to Follow-up|1|||
161531099|NCT04493216|583333071|FG002|Overall Study|Lost to Follow-up|0|||
161531100|NCT04493216|583333072|FG003|Overall Study|Lost to Follow-up|1|||
161531101|NCT04493216|583333069|FG000|Overall Study|Adverse Event|1|||
161531102|NCT04493216|583333070|FG001|Overall Study|Adverse Event|4|||
161531103|NCT04493216|583333071|FG002|Overall Study|Adverse Event|5|||
161678475|NCT02081534|583875979|FG003|Overall Study|Protocol Violation|0|||
161678476|NCT02081534|583875980|FG004|Overall Study|Protocol Violation|0|||
161678477|NCT02081534|583875981|FG005|Overall Study|Protocol Violation|0|||
161678478|NCT02081534|583875982|FG006|Overall Study|Protocol Violation|1|||
161678479|NCT02081534|583875976|FG000|Overall Study|Lost to Follow-up|0|||
161678480|NCT02081534|583875977|FG001|Overall Study|Lost to Follow-up|0|||
161678481|NCT02081534|583875978|FG002|Overall Study|Lost to Follow-up|0|||
161678482|NCT02081534|583875979|FG003|Overall Study|Lost to Follow-up|2|||
161678483|NCT02081534|583875980|FG004|Overall Study|Lost to Follow-up|1|||
161678484|NCT02081534|583875981|FG005|Overall Study|Lost to Follow-up|1|||
161678485|NCT02081534|583875982|FG006|Overall Study|Lost to Follow-up|0|||
161678486|NCT01848288|583875987|FG000|Overall Study|Death|1|||
161678487|NCT01848288|583875987|FG000|Overall Study|Protocol Violation|1|||
161678488|NCT01848288|583875987|FG000|Overall Study|Withdrawal by Subject|1|||
161678489|NCT01007032|583875989|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
161531104|NCT04493216|583333072|FG003|Overall Study|Adverse Event|2|||
161531105|NCT04493216|583333069|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
161531106|NCT04493216|583333070|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
161531107|NCT04493216|583333071|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
161531108|NCT04493216|583333072|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
161531109|NCT04605978|583333085|FG000|Overall Study|Adverse Event|2|||
161531110|NCT04605978|583333086|FG001|Overall Study|Adverse Event|1|||
161531111|NCT04605978|583333085|FG000|Overall Study|Withdrawal nonmedical reason|1|||
161531112|NCT04605978|583333086|FG001|Overall Study|Withdrawal nonmedical reason|1|||
161531113|NCT02583425|583333087|FG000|Screening|Did not meet entry criteria|12|||
161531114|NCT02583425|583333087|FG000|Baseline|Did not meet continued criteria|5|||
161531115|NCT02583425|583333087|FG000|Treatment Period|Adverse Event|1|||
161531116|NCT01690130|583333088|FG000|Overall Study|Subject have cancelled visit.|1|||
161531117|NCT01690130|583333089|FG001|Overall Study|Subject have cancelled visit.|0|||
161531118|NCT01644734|583333090|FG000|Overall Study|Adverse Event|4|||
161531119|NCT01644734|583333090|FG000|Overall Study|Lost to Follow-up|17|||
161531120|NCT01644734|583333090|FG000|Overall Study|Reasons other than stated above|7|||
161531121|NCT01644734|583333090|FG000|Overall Study|Missing documentation|238|||
161531122|NCT02216123|583333091|FG000|Overall Study|Lost to Follow-up|4|||
161678490|NCT01007032|583875990|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
161678491|NCT01007032|583875991|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
161678492|NCT01007032|583875992|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
161678493|NCT01007032|583875989|FG000|Overall Study|Withdrawal by Subject|0|||
161678494|NCT01007032|583875990|FG001|Overall Study|Withdrawal by Subject|0|||
161678495|NCT01007032|583875991|FG002|Overall Study|Withdrawal by Subject|0|||
161531123|NCT02216123|583333092|FG001|Overall Study|Lost to Follow-up|2|||
161531124|NCT02216123|583333091|FG000|Overall Study|Withdrawal by Subject|2|||
161531125|NCT02216123|583333092|FG001|Overall Study|Withdrawal by Subject|0|||
161531126|NCT01615328|583333099|FG000|Overall Study|Lost to Follow-up|3|||
161531127|NCT01615328|583333100|FG001|Overall Study|Lost to Follow-up|5|||
161531128|NCT02157779|583333101|FG000|Overall Study|Logistical|9|||
161531129|NCT02157779|583333102|FG001|Overall Study|Logistical|3|||
161531130|NCT02157779|583333101|FG000|Overall Study|Stopped attending, reason unknown|11|||
161827517|NCT04129944|584409328|FG000|Overall Study|Death|0|||
161827518|NCT04129944|584409329|FG001|Overall Study|Death|0|||
161827519|NCT04129944|584409330|FG002|Overall Study|Death|0|||
161531131|NCT02157779|583333102|FG001|Overall Study|Stopped attending, reason unknown|7|||
161531132|NCT02157779|583333101|FG000|Overall Study|No response to outreach after Baseline|1|||
161531133|NCT02157779|583333102|FG001|Overall Study|No response to outreach after Baseline|1|||
161531134|NCT02157779|583333101|FG000|Overall Study|Moved|1|||
161531135|NCT02157779|583333102|FG001|Overall Study|Moved|0|||
161678496|NCT01007032|583875992|FG003|Overall Study|Withdrawal by Subject|1|||
161678497|NCT01841749|583875993|FG000|Overall Study|Protocol Violation|1|||
161678498|NCT02285920|583875994|FG000|Overall Study|Kidney transplantation|2|||
161678499|NCT02285920|583875995|FG001|Overall Study|Kidney transplantation|2|||
161827520|NCT04129944|584409331|FG003|Overall Study|Death|1|||
161827521|NCT04129944|584409328|FG000|Overall Study|Lost to Follow-up|1|||
161531136|NCT02157779|583333101|FG000|Overall Study|Medical|1|||
161531137|NCT02157779|583333102|FG001|Overall Study|Medical|0|||
161531138|NCT02157779|583333101|FG000|Overall Study|Legal issue|1|||
161531139|NCT02157779|583333102|FG001|Overall Study|Legal issue|0|||
161531140|NCT02548455|583333103|FG000|Overall Study|Withdrawal by Subject|27|||
161531141|NCT02548455|583333103|FG000|Overall Study|Death|26|||
161531142|NCT02548455|583333103|FG000|Overall Study|Lost to Follow-up|14|||
161531143|NCT02548455|583333103|FG000|Overall Study|Visit not completed|173|||
161531144|NCT00487162|583333105|FG000|Overall Study|Adverse Event|0|||
161531145|NCT00487162|583333106|FG001|Overall Study|Adverse Event|1|||
161531146|NCT00487162|583333105|FG000|Overall Study|Physician Decision|0|||
161531147|NCT00487162|583333106|FG001|Overall Study|Physician Decision|1|||
161531148|NCT00487162|583333105|FG000|Overall Study|Withdrawal by Subject|2|||
161531149|NCT00487162|583333106|FG001|Overall Study|Withdrawal by Subject|3|||
161531150|NCT02794285|583333109|FG000|Overall Study|Adverse Event|11|||
161531151|NCT02794285|583333110|FG001|Overall Study|Adverse Event|4|||
161531152|NCT02794285|583333111|FG002|Overall Study|Adverse Event|5|||
161531153|NCT02794285|583333112|FG003|Overall Study|Adverse Event|8|||
161531154|NCT02794285|583333109|FG000|Overall Study|Condition Under Investigation Improved|1|||
161531155|NCT02794285|583333110|FG001|Overall Study|Condition Under Investigation Improved|0|||
161531156|NCT02794285|583333111|FG002|Overall Study|Condition Under Investigation Improved|0|||
161531157|NCT02794285|583333112|FG003|Overall Study|Condition Under Investigation Improved|0|||
161531158|NCT02794285|583333109|FG000|Overall Study|Condition Under Investigation Worsened|0|||
161531159|NCT02794285|583333110|FG001|Overall Study|Condition Under Investigation Worsened|2|||
161531160|NCT02794285|583333111|FG002|Overall Study|Condition Under Investigation Worsened|1|||
161531161|NCT02794285|583333112|FG003|Overall Study|Condition Under Investigation Worsened|0|||
161678500|NCT02285920|583875996|FG002|Overall Study|Kidney transplantation|2|||
161678501|NCT02285920|583875997|FG003|Overall Study|Kidney transplantation|0|||
161678502|NCT02285920|583875994|FG000|Overall Study|Change to peritoneal dialysis|0|||
161678503|NCT02285920|583875995|FG001|Overall Study|Change to peritoneal dialysis|0|||
161678504|NCT02285920|583875996|FG002|Overall Study|Change to peritoneal dialysis|1|||
161678505|NCT02285920|583875997|FG003|Overall Study|Change to peritoneal dialysis|0|||
161678506|NCT02285920|583875994|FG000|Overall Study|Transfer to non-participating unit|0|||
161827522|NCT04129944|584409329|FG001|Overall Study|Lost to Follow-up|0|||
161531162|NCT02794285|583333109|FG000|Overall Study|Death|2|||
161531163|NCT02794285|583333110|FG001|Overall Study|Death|1|||
161531164|NCT02794285|583333111|FG002|Overall Study|Death|2|||
161531165|NCT02794285|583333112|FG003|Overall Study|Death|0|||
161531166|NCT02794285|583333109|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
161531167|NCT02794285|583333110|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
161531168|NCT02794285|583333111|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
161591376|NCT03792555|583554627|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
161591377|NCT03792555|583554628|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
161591378|NCT03792555|583554629|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
161591379|NCT03792555|583554627|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
161591380|NCT03792555|583554628|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
161591381|NCT03792555|583554629|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
161591382|NCT03792555|583554627|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
161591383|NCT03792555|583554628|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
161591384|NCT03792555|583554629|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
161591385|NCT03535272|583554633|FG000|Overall Study|Lost to Follow-up|71|||
161591386|NCT03535272|583554634|FG001|Overall Study|Lost to Follow-up|73|||
161591387|NCT00418886|583554642|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
161591388|NCT00418886|583554643|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
161827523|NCT04129944|584409330|FG002|Overall Study|Lost to Follow-up|0|||
161591389|NCT00418886|583554642|FG000|Randomized Period|Death|122|||
161591390|NCT00418886|583554643|FG001|Randomized Period|Death|147|||
161591391|NCT00418886|583554642|FG000|Randomized Period|Withdrawal by Subject|9|||
161591392|NCT00418886|583554643|FG001|Randomized Period|Withdrawal by Subject|10|||
161591393|NCT00418886|583554642|FG000|Randomized Period|Lost to Follow-up|4|||
161591394|NCT00418886|583554643|FG001|Randomized Period|Lost to Follow-up|6|||
161827524|NCT04129944|584409331|FG003|Overall Study|Lost to Follow-up|0|||
161827525|NCT04129944|584409328|FG000|Overall Study|Withdrawal by Subject|1|||
161827526|NCT04129944|584409329|FG001|Overall Study|Withdrawal by Subject|0|||
161827527|NCT04129944|584409330|FG002|Overall Study|Withdrawal by Subject|1|||
161827528|NCT04129944|584409331|FG003|Overall Study|Withdrawal by Subject|2|||
161827529|NCT03941834|584409332|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
161827530|NCT03941834|584409333|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
161827531|NCT03941834|584409334|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
161827532|NCT03941834|584409332|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
161827533|NCT03941834|584409333|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
161678507|NCT02285920|583875995|FG001|Overall Study|Transfer to non-participating unit|1|||
161678508|NCT02285920|583875996|FG002|Overall Study|Transfer to non-participating unit|0|||
161678509|NCT02285920|583875997|FG003|Overall Study|Transfer to non-participating unit|0|||
161531169|NCT02794285|583333112|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
161531170|NCT02794285|583333109|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
161531171|NCT02794285|583333110|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
161531172|NCT02794285|583333111|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
161531173|NCT02794285|583333112|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
161531174|NCT02794285|583333109|FG000|Overall Study|Lack of Efficacy|10|||
161678510|NCT02285920|583875994|FG000|Overall Study|Dialysis discontinuation|0|||
161678511|NCT02285920|583875995|FG001|Overall Study|Dialysis discontinuation|1|||
161678512|NCT02285920|583875996|FG002|Overall Study|Dialysis discontinuation|0|||
161531175|NCT02794285|583333110|FG001|Overall Study|Lack of Efficacy|6|||
161531176|NCT02794285|583333111|FG002|Overall Study|Lack of Efficacy|3|||
161531177|NCT02794285|583333112|FG003|Overall Study|Lack of Efficacy|3|||
161531178|NCT02794285|583333109|FG000|Overall Study|Lost to Follow-up|5|||
161531179|NCT02794285|583333110|FG001|Overall Study|Lost to Follow-up|6|||
161531180|NCT02794285|583333111|FG002|Overall Study|Lost to Follow-up|3|||
161531181|NCT02794285|583333112|FG003|Overall Study|Lost to Follow-up|1|||
161531182|NCT02794285|583333109|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
161531183|NCT02794285|583333110|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
161531184|NCT02794285|583333111|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
161531185|NCT02794285|583333112|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
161531186|NCT02794285|583333109|FG000|Overall Study|Withdrawal by Subject|38|||
161531187|NCT02794285|583333110|FG001|Overall Study|Withdrawal by Subject|29|||
161531188|NCT02794285|583333111|FG002|Overall Study|Withdrawal by Subject|20|||
161531189|NCT02794285|583333112|FG003|Overall Study|Withdrawal by Subject|12|||
161531190|NCT02794285|583333109|FG000|Overall Study|Missing|1|||
161531191|NCT02794285|583333110|FG001|Overall Study|Missing|0|||
161531192|NCT02794285|583333111|FG002|Overall Study|Missing|0|||
161531193|NCT02794285|583333112|FG003|Overall Study|Missing|0|||
161531194|NCT02794285|583333109|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
161531195|NCT02794285|583333110|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
161531196|NCT02794285|583333111|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
161531197|NCT02794285|583333112|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
161531198|NCT02794285|583333109|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
161531199|NCT02794285|583333110|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
161531200|NCT02794285|583333111|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
161531201|NCT02794285|583333112|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
161531202|NCT03896035|583333113|FG000|Overall Study|Lost to Follow-up|2|||
161531203|NCT03896035|583333114|FG001|Overall Study|Lost to Follow-up|6|||
161531204|NCT03896035|583333113|FG000|Overall Study|Withdrawal by Subject|0|||
161531205|NCT03896035|583333114|FG001|Overall Study|Withdrawal by Subject|1|||
161531206|NCT03896035|583333113|FG000|Overall Study|Health/family health issues during COVID|0|||
161531207|NCT03896035|583333114|FG001|Overall Study|Health/family health issues during COVID|4|||
161531208|NCT01362140|583333115|FG000|Overall Study|Noncompliance|1|||
161531209|NCT01362140|583333116|FG001|Overall Study|Noncompliance|0|||
161531210|NCT01362140|583333115|FG000|Overall Study|Adverse Event|2|||
161531211|NCT01362140|583333116|FG001|Overall Study|Adverse Event|2|||
161531212|NCT01362140|583333115|FG000|Overall Study|Withdrawal by Subject|3|||
161531213|NCT01362140|583333116|FG001|Overall Study|Withdrawal by Subject|3|||
161531214|NCT01362140|583333115|FG000|Overall Study|Administrative Decision|0|||
161531215|NCT01362140|583333116|FG001|Overall Study|Administrative Decision|1|||
161531216|NCT01362140|583333115|FG000|Overall Study|Death|2|||
161531217|NCT01362140|583333116|FG001|Overall Study|Death|1|||
161531218|NCT01362140|583333115|FG000|Overall Study|Other|1|||
161531219|NCT01362140|583333116|FG001|Overall Study|Other|1|||
161531220|NCT01362140|583333115|FG000|Overall Study|Protocol-specified Criteria|1|||
161531221|NCT01362140|583333116|FG001|Overall Study|Protocol-specified Criteria|2|||
161531222|NCT01362140|583333115|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
161531223|NCT01362140|583333116|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
161531224|NCT01556438|583333119|FG000|Overall Study|Adverse Event|4|||
161678513|NCT02285920|583875997|FG003|Overall Study|Dialysis discontinuation|0|||
161678514|NCT02285920|583875994|FG000|Overall Study|Death|2|||
161678515|NCT02285920|583875995|FG001|Overall Study|Death|0|||
161678516|NCT02285920|583875996|FG002|Overall Study|Death|2|||
161937105|NCT04449055|584819141|FG001|Overall Study|Lost to Follow-up|1|||
161531225|NCT01556438|583333120|FG001|Overall Study|Adverse Event|2|||
161531226|NCT01556438|583333119|FG000|Overall Study|Sponsor Decision|0|||
161531227|NCT01556438|583333120|FG001|Overall Study|Sponsor Decision|2|||
161531228|NCT01556438|583333119|FG000|Overall Study|Progressive Disease|0|||
161531229|NCT01556438|583333120|FG001|Overall Study|Progressive Disease|6|||
161531230|NCT01556438|583333119|FG000|Overall Study|Death|0|||
161531231|NCT01556438|583333120|FG001|Overall Study|Death|1|||
161531232|NCT01388816|583333122|FG000|Overall Study|Adverse Event|0|||
161531233|NCT01388816|583333123|FG001|Overall Study|Adverse Event|2|||
161531234|NCT01388816|583333124|FG002|Overall Study|Adverse Event|0|||
161531235|NCT01388816|583333125|FG003|Overall Study|Adverse Event|0|||
161531236|NCT01388816|583333122|FG000|Overall Study|Lost to Follow-up|0|||
161531237|NCT01388816|583333123|FG001|Overall Study|Lost to Follow-up|1|||
161531238|NCT01388816|583333124|FG002|Overall Study|Lost to Follow-up|0|||
161531239|NCT01388816|583333125|FG003|Overall Study|Lost to Follow-up|0|||
161531240|NCT01388816|583333122|FG000|Overall Study|Withdrawal by Subject|2|||
161531241|NCT01388816|583333123|FG001|Overall Study|Withdrawal by Subject|1|||
161531242|NCT01388816|583333124|FG002|Overall Study|Withdrawal by Subject|1|||
161531243|NCT01388816|583333125|FG003|Overall Study|Withdrawal by Subject|0|||
161531244|NCT01388816|583333122|FG000|Overall Study|Protocol Violation|0|||
161827534|NCT03941834|584409334|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
161827535|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
161827536|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
161827537|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
161827538|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
161827539|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
161827540|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
161827541|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
161827542|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
161827543|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
161827544|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
161827545|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
161827546|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
161827547|NCT01560819|584409335|FG000|Overall Study|Physician Decision|1|||
161827548|NCT01560819|584409336|FG001|Overall Study|Physician Decision|0|||
161827549|NCT02012452|584409339|FG000|Overall Study|Lost to Follow-up|2|||
161827550|NCT02012452|584409340|FG001|Overall Study|Lost to Follow-up|1|||
161827551|NCT02012452|584409339|FG000|Overall Study|Withdrawal by Subject|4|||
161827552|NCT02012452|584409340|FG001|Overall Study|Withdrawal by Subject|0|||
161827553|NCT04403399|584409341|FG000|Period 2|Physician Decision|0|||
161531245|NCT01388816|583333123|FG001|Overall Study|Protocol Violation|0|||
161531246|NCT01388816|583333124|FG002|Overall Study|Protocol Violation|2|||
161531247|NCT01388816|583333125|FG003|Overall Study|Protocol Violation|0|||
161531248|NCT00743366|583333126|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
161531249|NCT00743366|583333127|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
161531250|NCT01328574|583333128|FG000|Overall Study|Refused further treatment|1|||
161531251|NCT03206203|583333129|FG000|Treatment|Death|38|||
161531252|NCT03206203|583333130|FG001|Treatment|Death|26|||
161531253|NCT03206203|583333131|FG002|Treatment|Death|0|||
161531254|NCT03206203|583333129|FG000|Treatment|Withdrawal by Subject|1|||
161531255|NCT03206203|583333130|FG001|Treatment|Withdrawal by Subject|0|||
161531256|NCT03206203|583333131|FG002|Treatment|Withdrawal by Subject|0|||
161531257|NCT03206203|583333129|FG000|Treatment|Lost to Follow-up|4|||
161531258|NCT03206203|583333130|FG001|Treatment|Lost to Follow-up|0|||
161531259|NCT03206203|583333131|FG002|Treatment|Lost to Follow-up|0|||
161827554|NCT04403399|584409342|FG001|Period 2|Physician Decision|1|||
161827555|NCT00831233|584409345|FG000|Overall Study|Adverse Event|0|||
161827556|NCT00831233|584409346|FG001|Overall Study|Adverse Event|1|||
161827557|NCT00831233|584409345|FG000|Overall Study|Protocol Violation|1|||
161827558|NCT00831233|584409346|FG001|Overall Study|Protocol Violation|0|||
161827559|NCT00831233|584409345|FG000|Overall Study|Selection Criteria Not Met|2|||
161827560|NCT00831233|584409346|FG001|Overall Study|Selection Criteria Not Met|0|||
161827561|NCT00991510|584409347|FG000|Period I (Days 1-14)|Adverse Event|1|||
161827562|NCT00991510|584409348|FG001|Period I (Days 1-14)|Adverse Event|0|||
161827563|NCT00991510|584409347|FG000|Period III (Days 29-112)|Adverse Event|1|||
161827564|NCT00991510|584409348|FG001|Period III (Days 29-112)|Adverse Event|1|||
161827565|NCT03710590|584409349|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
161827566|NCT03710590|584409350|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
161827567|NCT02488824|584409351|FG000|Overall Study|Adverse Event|1|||
161827568|NCT02488824|584409352|FG001|Overall Study|Adverse Event|1|||
161827569|NCT01976728|584409353|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
161827570|NCT01976728|584409354|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
161827571|NCT01976728|584409355|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
161531260|NCT03206203|583333129|FG000|Treatment|N/A in Follow-Up|8|||
161531261|NCT03206203|583333130|FG001|Treatment|N/A in Follow-Up|1|||
161531262|NCT03206203|583333131|FG002|Treatment|N/A in Follow-Up|0|||
161531263|NCT03206203|583333129|FG000|Treatment|Disease progression|0|||
161531264|NCT03206203|583333130|FG001|Treatment|Disease progression|1|||
161531265|NCT03206203|583333131|FG002|Treatment|Disease progression|0|||
161531266|NCT03206203|583333129|FG000|Treatment|Refused follow-up|0|||
161531267|NCT03206203|583333130|FG001|Treatment|Refused follow-up|1|||
161827572|NCT01976728|584409356|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
161827573|NCT02356211|584409357|FG000|Overall Study|Withdrawal by Subject|2|||
161827574|NCT02356211|584409358|FG001|Overall Study|Withdrawal by Subject|2|||
161827575|NCT02356211|584409357|FG000|Overall Study|ineligible|1|||
161827576|NCT02356211|584409358|FG001|Overall Study|ineligible|8|||
161531268|NCT03206203|583333131|FG002|Treatment|Refused follow-up|0|||
161531269|NCT03206203|583333129|FG000|Treatment|Cross over to Arm 1|0|||
161531270|NCT03206203|583333130|FG001|Treatment|Cross over to Arm 1|19|||
161531271|NCT03206203|583333131|FG002|Treatment|Cross over to Arm 1|0|||
161531272|NCT03206203|583333129|FG000|Optional Cross-Over|Death|0|||
161531273|NCT03206203|583333130|FG001|Optional Cross-Over|Death|0|||
161531274|NCT03206203|583333131|FG002|Optional Cross-Over|Death|14|||
161531275|NCT03206203|583333129|FG000|Optional Cross-Over|Refused follow-up|0|||
161531276|NCT03206203|583333130|FG001|Optional Cross-Over|Refused follow-up|0|||
161531277|NCT03206203|583333131|FG002|Optional Cross-Over|Refused follow-up|2|||
161531278|NCT03998618|583333134|FG000|Overall Study|Death|7|||
161531279|NCT03998618|583333135|FG001|Overall Study|Death|11|||
161531280|NCT03998618|583333134|FG000|Overall Study|hospice enrollment|3|||
161531281|NCT03998618|583333135|FG001|Overall Study|hospice enrollment|3|||
161531282|NCT03998618|583333134|FG000|Overall Study|Not feeling well/health problems|3|||
161531283|NCT03998618|583333135|FG001|Overall Study|Not feeling well/health problems|5|||
161531284|NCT03998618|583333134|FG000|Overall Study|Lost to Follow-up|6|||
161531285|NCT03998618|583333135|FG001|Overall Study|Lost to Follow-up|6|||
161531286|NCT03998618|583333134|FG000|Overall Study|Withdrawal by Subject|0|||
161531287|NCT03998618|583333135|FG001|Overall Study|Withdrawal by Subject|4|||
161531288|NCT02308748|583333140|FG000|Period 1|Withdrawal by Subject|0|||
161531289|NCT02308748|583333141|FG001|Period 1|Withdrawal by Subject|0|||
161531290|NCT02308748|583333142|FG002|Period 1|Withdrawal by Subject|1|||
161531291|NCT02308748|583333143|FG003|Period 1|Withdrawal by Subject|0|||
161531292|NCT02308748|583333144|FG004|Period 1|Withdrawal by Subject|0|||
161531293|NCT02308748|583333145|FG005|Period 1|Withdrawal by Subject|0|||
161531294|NCT02308748|583333146|FG006|Period 1|Withdrawal by Subject|0|||
161531295|NCT02308748|583333147|FG007|Period 1|Withdrawal by Subject|0|||
161531296|NCT02308748|583333148|FG008|Period 1|Withdrawal by Subject|0|||
161531297|NCT02308748|583333149|FG009|Period 1|Withdrawal by Subject|0|||
161531298|NCT02308748|583333140|FG000|Period 2|Adverse Event|0|||
161531299|NCT02308748|583333141|FG001|Period 2|Adverse Event|0|||
161531300|NCT02308748|583333142|FG002|Period 2|Adverse Event|0|||
161531301|NCT02308748|583333143|FG003|Period 2|Adverse Event|0|||
161531302|NCT02308748|583333144|FG004|Period 2|Adverse Event|0|||
161531303|NCT02308748|583333145|FG005|Period 2|Adverse Event|0|||
161531304|NCT02308748|583333146|FG006|Period 2|Adverse Event|0|||
161531305|NCT02308748|583333147|FG007|Period 2|Adverse Event|1|||
161531306|NCT02308748|583333148|FG008|Period 2|Adverse Event|0|||
161531307|NCT02308748|583333149|FG009|Period 2|Adverse Event|0|||
161531308|NCT02308748|583333140|FG000|Period 3|Protocol Violation|0|||
161531309|NCT02308748|583333141|FG001|Period 3|Protocol Violation|0|||
161531310|NCT02308748|583333142|FG002|Period 3|Protocol Violation|0|||
161678517|NCT02285920|583875997|FG003|Overall Study|Death|1|||
161827577|NCT01563237|584409360|FG000|Overall Study|Lost to Follow-up|6|||
161827578|NCT01563237|584409361|FG001|Overall Study|Lost to Follow-up|0|||
161827579|NCT01563237|584409360|FG000|Overall Study|Withdrawal by Subject|1|||
161827580|NCT01563237|584409361|FG001|Overall Study|Withdrawal by Subject|0|||
161827581|NCT01563237|584409360|FG000|Overall Study|Adverse Event|1|||
161827582|NCT01563237|584409361|FG001|Overall Study|Adverse Event|0|||
161827583|NCT01563237|584409360|FG000|Overall Study|Medical Reasons|1|||
161827584|NCT01563237|584409361|FG001|Overall Study|Medical Reasons|0|||
161827585|NCT01563237|584409360|FG000|Overall Study|Death|1|||
161827586|NCT01563237|584409361|FG001|Overall Study|Death|0|||
161827587|NCT02211014|584409362|FG000|Overall Study|Adverse Event|0|||
161827588|NCT02211014|584409363|FG001|Overall Study|Adverse Event|2|||
161827589|NCT02211014|584409362|FG000|Overall Study|Physician Decision|1|||
161827590|NCT02211014|584409363|FG001|Overall Study|Physician Decision|2|||
161827591|NCT02211014|584409362|FG000|Overall Study|Started another cancer therapy|1|||
161827592|NCT02211014|584409363|FG001|Overall Study|Started another cancer therapy|0|||
161827593|NCT02211014|584409362|FG000|Overall Study|Withdrawal by Subject|0|||
161827594|NCT02211014|584409363|FG001|Overall Study|Withdrawal by Subject|1|||
161827595|NCT02211014|584409362|FG000|Overall Study|In agreement with patient, no benefit|0|||
161827596|NCT02211014|584409363|FG001|Overall Study|In agreement with patient, no benefit|1|||
161827597|NCT01124695|584409364|FG000|Overall Study|Disease progression|77|||
161827598|NCT01124695|584409364|FG000|Overall Study|Adverse Event|11|||
161531311|NCT02308748|583333143|FG003|Period 3|Protocol Violation|0|||
161531312|NCT02308748|583333144|FG004|Period 3|Protocol Violation|0|||
161531313|NCT02308748|583333145|FG005|Period 3|Protocol Violation|0|||
161531314|NCT02308748|583333146|FG006|Period 3|Protocol Violation|0|||
161531315|NCT02308748|583333147|FG007|Period 3|Protocol Violation|0|||
161531316|NCT02308748|583333148|FG008|Period 3|Protocol Violation|0|||
161531317|NCT02308748|583333149|FG009|Period 3|Protocol Violation|1|||
161531318|NCT02308748|583333140|FG000|Period 5|Adverse Event|1|||
161531319|NCT02308748|583333141|FG001|Period 5|Adverse Event|0|||
161827599|NCT01124695|584409364|FG000|Overall Study|Death|1|||
161827600|NCT01124695|584409364|FG000|Overall Study|Withdrawal by Subject|7|||
161827601|NCT01124695|584409364|FG000|Overall Study|Physician Decision|3|||
161827602|NCT01124695|584409364|FG000|Overall Study|Alternative therapy|9|||
161827603|NCT01124695|584409364|FG000|Overall Study|No documentation that patient went off treatment|4|||
161827604|NCT01124695|584409364|FG000|Overall Study|Ineligible|9|||
161937106|NCT04449055|584819140|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
161937107|NCT04449055|584819141|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
161937108|NCT04449055|584819140|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
161937109|NCT04449055|584819141|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
161937110|NCT04449055|584819140|FG000|Overall Study|Incarcerated|1|||
161937111|NCT04449055|584819141|FG001|Overall Study|Incarcerated|0|||
161937112|NCT02577029|584819142|FG000|Overall Study|Adverse Event|1|||
161937113|NCT02577029|584819143|FG001|Overall Study|Adverse Event|0|||
161937114|NCT02577029|584819144|FG002|Overall Study|Adverse Event|2|||
161937115|NCT02577029|584819145|FG003|Overall Study|Adverse Event|0|||
161937116|NCT02577029|584819146|FG004|Overall Study|Adverse Event|1|||
161937117|NCT02577029|584819147|FG005|Overall Study|Adverse Event|0|||
161937118|NCT02577029|584819148|FG006|Overall Study|Adverse Event|0|||
161937119|NCT02577029|584819149|FG007|Overall Study|Adverse Event|0|||
161937120|NCT02577029|584819142|FG000|Overall Study|Withdrawal by Subject|0|||
161937121|NCT02577029|584819143|FG001|Overall Study|Withdrawal by Subject|0|||
161937122|NCT02577029|584819144|FG002|Overall Study|Withdrawal by Subject|0|||
161937123|NCT02577029|584819145|FG003|Overall Study|Withdrawal by Subject|0|||
161937124|NCT02577029|584819146|FG004|Overall Study|Withdrawal by Subject|0|||
161937125|NCT02577029|584819147|FG005|Overall Study|Withdrawal by Subject|1|||
161937126|NCT02577029|584819148|FG006|Overall Study|Withdrawal by Subject|0|||
161937127|NCT02577029|584819149|FG007|Overall Study|Withdrawal by Subject|0|||
161937128|NCT02577029|584819142|FG000|Overall Study|Sponsor Termination of the Study|9|||
161937129|NCT02577029|584819143|FG001|Overall Study|Sponsor Termination of the Study|2|||
161937130|NCT02577029|584819144|FG002|Overall Study|Sponsor Termination of the Study|5|||
161937131|NCT02577029|584819145|FG003|Overall Study|Sponsor Termination of the Study|12|||
161937132|NCT02577029|584819146|FG004|Overall Study|Sponsor Termination of the Study|10|||
161937133|NCT02577029|584819147|FG005|Overall Study|Sponsor Termination of the Study|12|||
161937134|NCT02577029|584819148|FG006|Overall Study|Sponsor Termination of the Study|12|||
161937135|NCT02577029|584819149|FG007|Overall Study|Sponsor Termination of the Study|12|||
161937136|NCT00124306|584819167|FG000|Overall Study|Adverse Event|7|||
161937137|NCT00124306|584819168|FG001|Overall Study|Adverse Event|2|||
161937138|NCT00124306|584819167|FG000|Overall Study|Lost to Follow-up|10|||
161937139|NCT00124306|584819168|FG001|Overall Study|Lost to Follow-up|6|||
161937140|NCT00124306|584819167|FG000|Overall Study|Lack of Efficacy|3|||
161937141|NCT00124306|584819168|FG001|Overall Study|Lack of Efficacy|6|||
161937142|NCT00124306|584819167|FG000|Overall Study|Personal constraints|0|||
161937143|NCT00124306|584819168|FG001|Overall Study|Personal constraints|2|||
161827605|NCT01124695|584409364|FG000|Overall Study|Ineligible and never start treatment|2|||
161827606|NCT00097786|584409368|FG000|Overall Study|lost to follow-up for all-cause death|296|||
161827607|NCT00097786|584409369|FG001|Overall Study|lost to follow-up for all-cause death|292|||
161591395|NCT00418886|583554642|FG000|Randomized Period|withdrawn due to other reason|1|||
161827608|NCT00097786|584409370|FG002|Overall Study|lost to follow-up for all-cause death|313|||
161827609|NCT00097786|584409371|FG003|Overall Study|lost to follow-up for all-cause death|310|||
161827610|NCT02668822|584409372|FG000|Overall Study|Protocol Violation|2|||
161827611|NCT02668822|584409373|FG001|Overall Study|Protocol Violation|0|||
161827612|NCT02668822|584409372|FG000|Overall Study|Study Terminated by Sponsor|7|||
161827613|NCT02668822|584409373|FG001|Overall Study|Study Terminated by Sponsor|9|||
161827614|NCT01647711|584409376|FG000|Overall Study|Progressive disease|6|||
161827615|NCT01647711|584409377|FG001|Overall Study|Progressive disease|2|||
161827616|NCT01647711|584409378|FG002|Overall Study|Progressive disease|6|||
161827617|NCT01647711|584409379|FG003|Overall Study|Progressive disease|8|||
161827618|NCT01647711|584409380|FG004|Overall Study|Progressive disease|2|||
161591396|NCT00418886|583554643|FG001|Randomized Period|withdrawn due to other reason|0|||
161591397|NCT00418886|583554642|FG000|Randomized Period|randomised but no treatment received|0|||
161591398|NCT00418886|583554643|FG001|Randomized Period|randomised but no treatment received|1|||
161591399|NCT05948670|583554645|FG000|Overall Study|Protocol Violation|6|||
161591400|NCT05948670|583554646|FG001|Overall Study|Protocol Violation|8|||
161591401|NCT05948670|583554645|FG000|Overall Study|Withdrawal by Subject|0|||
161591402|NCT05948670|583554646|FG001|Overall Study|Withdrawal by Subject|1|||
161591403|NCT04562649|583554648|FG000|Overall Study|Withdrawal by Subject|11|||
161591404|NCT04562649|583554649|FG001|Overall Study|Withdrawal by Subject|8|||
161591405|NCT04562649|583554648|FG000|Overall Study|Lost to Follow-up|26|||
161591406|NCT04562649|583554649|FG001|Overall Study|Lost to Follow-up|20|||
161937144|NCT00124306|584819167|FG000|Overall Study|Use of unacceptable medication|1|||
161937145|NCT00124306|584819168|FG001|Overall Study|Use of unacceptable medication|0|||
161827619|NCT01647711|584409376|FG000|Overall Study|Other adverse event|0|||
161937146|NCT00124306|584819167|FG000|Overall Study|Abnormal lab result|0|||
161937147|NCT00124306|584819168|FG001|Overall Study|Abnormal lab result|1|||
161827620|NCT01647711|584409377|FG001|Overall Study|Other adverse event|0|||
161827621|NCT01647711|584409378|FG002|Overall Study|Other adverse event|2|||
161678518|NCT00677820|583875998|FG000|Overall Study|Lost to Follow-up|1|||
161591407|NCT05368103|583554650|FG000|Overall Study|Withdrawal by Subject|4|||
161827622|NCT01647711|584409379|FG003|Overall Study|Other adverse event|0|||
161827623|NCT01647711|584409380|FG004|Overall Study|Other adverse event|2|||
161827624|NCT01647711|584409376|FG000|Overall Study|Protocol Violation|0|||
161827625|NCT01647711|584409377|FG001|Overall Study|Protocol Violation|0|||
161827626|NCT01647711|584409378|FG002|Overall Study|Protocol Violation|0|||
161827627|NCT01647711|584409379|FG003|Overall Study|Protocol Violation|0|||
161827628|NCT01647711|584409380|FG004|Overall Study|Protocol Violation|1|||
161827629|NCT01647711|584409376|FG000|Overall Study|Refused to continue taking medication|0|||
161827630|NCT01647711|584409377|FG001|Overall Study|Refused to continue taking medication|0|||
161827631|NCT01647711|584409378|FG002|Overall Study|Refused to continue taking medication|0|||
161827632|NCT01647711|584409379|FG003|Overall Study|Refused to continue taking medication|2|||
161827633|NCT01647711|584409380|FG004|Overall Study|Refused to continue taking medication|1|||
161827634|NCT01647711|584409376|FG000|Overall Study|Other reason not defined|0|||
161827635|NCT01647711|584409377|FG001|Overall Study|Other reason not defined|1|||
161827636|NCT01647711|584409378|FG002|Overall Study|Other reason not defined|1|||
161591408|NCT05368103|583554650|FG000|Overall Study|Lost to Follow-up|1|||
161591409|NCT05368103|583554650|FG000|Overall Study|Lack of Efficacy|3|||
161591410|NCT03675282|583554653|FG000|Overall Study|Lost to Follow-up|4|||
161591411|NCT03675282|583554654|FG001|Overall Study|Lost to Follow-up|8|||
161591412|NCT03675282|583554655|FG002|Overall Study|Lost to Follow-up|1|||
161827637|NCT01647711|584409379|FG003|Overall Study|Other reason not defined|1|||
161827638|NCT01647711|584409380|FG004|Overall Study|Other reason not defined|0|||
161827639|NCT03036839|584409381|FG000|Overall Study|Adverse Event|0|||
161827640|NCT03036839|584409382|FG001|Overall Study|Adverse Event|0|||
161827641|NCT03036839|584409383|FG002|Overall Study|Adverse Event|1|||
161591413|NCT03675282|583554656|FG003|Overall Study|Lost to Follow-up|0|||
161591414|NCT03675282|583554657|FG004|Overall Study|Lost to Follow-up|2|||
161591415|NCT03675282|583554658|FG005|Overall Study|Lost to Follow-up|7|||
161591416|NCT03675282|583554653|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
161591417|NCT03675282|583554654|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
161591418|NCT03675282|583554655|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
161591419|NCT03675282|583554656|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
161591420|NCT03675282|583554657|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
161591421|NCT03675282|583554658|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
161591422|NCT03675282|583554653|FG000|Overall Study|Physician Decision|1|||
161591423|NCT03675282|583554654|FG001|Overall Study|Physician Decision|0|||
161591424|NCT03675282|583554655|FG002|Overall Study|Physician Decision|0|||
161591425|NCT03675282|583554656|FG003|Overall Study|Physician Decision|0|||
161591426|NCT03675282|583554657|FG004|Overall Study|Physician Decision|0|||
161591427|NCT03675282|583554658|FG005|Overall Study|Physician Decision|0|||
161591428|NCT03056040|583554662|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
161591429|NCT03056040|583554663|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
161591430|NCT03056040|583554662|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
161591431|NCT03056040|583554663|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
161827642|NCT03036839|584409381|FG000|Overall Study|Death|3|||
161591432|NCT03056040|583554662|FG000|Primary Evaluation Period|Pregnancy|0|||
161591433|NCT03056040|583554663|FG001|Primary Evaluation Period|Pregnancy|1|||
161591434|NCT03056040|583554662|FG000|Primary Evaluation Period|Randomized, not treated|1|||
161827643|NCT03036839|584409382|FG001|Overall Study|Death|0|||
161591435|NCT03056040|583554663|FG001|Primary Evaluation Period|Randomized, not treated|1|||
161591436|NCT03056040|583554662|FG000|Extension Period|Physician Decision|3|||
161591437|NCT03056040|583554663|FG001|Extension Period|Physician Decision|3|||
161531320|NCT02308748|583333142|FG002|Period 5|Adverse Event|0|||
161531321|NCT02308748|583333143|FG003|Period 5|Adverse Event|0|||
161531322|NCT02308748|583333144|FG004|Period 5|Adverse Event|0|||
161531323|NCT02308748|583333145|FG005|Period 5|Adverse Event|0|||
161937148|NCT00124306|584819167|FG000|Overall Study|Other|2|||
161531324|NCT02308748|583333146|FG006|Period 5|Adverse Event|0|||
161531325|NCT02308748|583333147|FG007|Period 5|Adverse Event|0|||
161531326|NCT02308748|583333148|FG008|Period 5|Adverse Event|1|||
161937149|NCT00124306|584819168|FG001|Overall Study|Other|0|||
161531327|NCT02308748|583333149|FG009|Period 5|Adverse Event|0|||
161531328|NCT01152580|583333150|FG000|Overall Study|Withdrawal by Subject|0|||
161678519|NCT00677820|583875999|FG001|Overall Study|Lost to Follow-up|0|||
161937150|NCT06596005|584819170|FG000|Overall Study|Withdrawal by Subject|2|||
161937151|NCT06596005|584819171|FG001|Overall Study|Withdrawal by Subject|2|||
161937152|NCT06596005|584819172|FG002|Overall Study|Withdrawal by Subject|1|||
161937153|NCT06596005|584819170|FG000|Overall Study|Other|0|||
161937154|NCT06596005|584819171|FG001|Overall Study|Other|2|||
161937155|NCT06596005|584819172|FG002|Overall Study|Other|0|||
161937156|NCT03734666|584819173|FG000|Overall Study|Other|7|||
161937157|NCT03734666|584819174|FG001|Overall Study|Other|4|||
161937158|NCT03734666|584819173|FG000|Overall Study|Lost to Follow-up|12|||
161937159|NCT03734666|584819174|FG001|Overall Study|Lost to Follow-up|12|||
161937160|NCT05866185|584819175|FG000|Overall Study|Lost to Follow-up|2|||
161937161|NCT05866185|584819176|FG001|Overall Study|Lost to Follow-up|4|||
161937162|NCT05866185|584819177|FG002|Overall Study|Lost to Follow-up|4|||
161937163|NCT05866185|584819178|FG003|Overall Study|Lost to Follow-up|6|||
161937164|NCT03369704|584819179|FG000|Treatment Epoch|technical problems|1|||
161937165|NCT03369704|584819180|FG001|Treatment Epoch|technical problems|0|||
161937166|NCT03369704|584819179|FG000|Treatment Epoch|Protocol Violation|1|||
161937167|NCT03369704|584819180|FG001|Treatment Epoch|Protocol Violation|0|||
161937168|NCT03369704|584819179|FG000|Treatment Epoch|Lost to Follow-up|0|||
161937169|NCT03369704|584819180|FG001|Treatment Epoch|Lost to Follow-up|1|||
161937170|NCT03369704|584819179|FG000|Treatment Epoch|Lack of Efficacy|0|||
161937171|NCT03369704|584819180|FG001|Treatment Epoch|Lack of Efficacy|2|||
161937172|NCT03369704|584819179|FG000|Treatment Epoch|Adverse Event|2|||
161937173|NCT03369704|584819180|FG001|Treatment Epoch|Adverse Event|0|||
161937174|NCT03369704|584819179|FG000|Follow-up Epoch|Lost to Follow-up|1|||
161937175|NCT03369704|584819180|FG001|Follow-up Epoch|Lost to Follow-up|0|||
161937176|NCT02445391|584819182|FG000|Overall Study|No active protocol treatment|3|||
161937177|NCT02445391|584819183|FG001|Overall Study|No active protocol treatment|0|||
161937178|NCT02445391|584819184|FG002|Overall Study|No active protocol treatment|0|||
161937179|NCT02445391|584819182|FG000|Overall Study|Adverse Event|0|||
161937180|NCT02445391|584819183|FG001|Overall Study|Adverse Event|21|||
161937181|NCT02445391|584819184|FG002|Overall Study|Adverse Event|12|||
161937182|NCT02445391|584819182|FG000|Overall Study|Alternative therapy|0|||
161937183|NCT02445391|584819183|FG001|Overall Study|Alternative therapy|0|||
161937184|NCT02445391|584819184|FG002|Overall Study|Alternative therapy|1|||
161937185|NCT02445391|584819182|FG000|Overall Study|Disease progression|0|||
161937186|NCT02445391|584819183|FG001|Overall Study|Disease progression|7|||
161937187|NCT02445391|584819184|FG002|Overall Study|Disease progression|22|||
161937188|NCT02445391|584819182|FG000|Overall Study|Complicating disease|0|||
161937189|NCT02445391|584819183|FG001|Overall Study|Complicating disease|2|||
161937190|NCT02445391|584819184|FG002|Overall Study|Complicating disease|1|||
161937191|NCT02445391|584819182|FG000|Overall Study|Withdrawal by Subject|0|||
161937192|NCT02445391|584819183|FG001|Overall Study|Withdrawal by Subject|4|||
161937193|NCT02445391|584819184|FG002|Overall Study|Withdrawal by Subject|9|||
161937194|NCT02445391|584819182|FG000|Overall Study|Financial issue|0|||
161937195|NCT02445391|584819183|FG001|Overall Study|Financial issue|0|||
161937196|NCT02445391|584819184|FG002|Overall Study|Financial issue|2|||
161937197|NCT02445391|584819182|FG000|Overall Study|Still on treatment|0|||
161937198|NCT02445391|584819183|FG001|Overall Study|Still on treatment|7|||
161937199|NCT02445391|584819184|FG002|Overall Study|Still on treatment|16|||
161937200|NCT02445391|584819182|FG000|Overall Study|Not start protocol therapy|0|||
161937201|NCT02445391|584819183|FG001|Overall Study|Not start protocol therapy|12|||
161937202|NCT02445391|584819184|FG002|Overall Study|Not start protocol therapy|9|||
161937203|NCT03246529|584819186|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
161937204|NCT03246529|584819187|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
161937205|NCT03246529|584819188|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
161937206|NCT03246529|584819186|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
161937207|NCT03246529|584819187|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
161937208|NCT03246529|584819188|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
161937209|NCT03246529|584819186|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
161937210|NCT03246529|584819187|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
161937211|NCT03246529|584819188|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
161937212|NCT03246529|584819186|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
161531329|NCT01152580|583333151|FG001|Overall Study|Withdrawal by Subject|1|||
161531330|NCT01994954|583333153|FG000|Overall Study|Death|1|||
161531331|NCT01994954|583333154|FG001|Overall Study|Death|0|||
161827644|NCT03036839|584409383|FG002|Overall Study|Death|3|||
161827645|NCT03036839|584409381|FG000|Overall Study|Withdrew Consent|0|||
161827646|NCT03036839|584409382|FG001|Overall Study|Withdrew Consent|0|||
161827647|NCT03036839|584409383|FG002|Overall Study|Withdrew Consent|1|||
161531332|NCT01994954|583333153|FG000|Overall Study|Withdrawal by Subject|9|||
161531333|NCT01994954|583333154|FG001|Overall Study|Withdrawal by Subject|14|||
161531334|NCT01994954|583333153|FG000|Overall Study|Physician Decision|2|||
161531335|NCT01994954|583333154|FG001|Overall Study|Physician Decision|2|||
161531336|NCT01994954|583333153|FG000|Overall Study|Lost to Follow-up|8|||
161531337|NCT01994954|583333154|FG001|Overall Study|Lost to Follow-up|10|||
161531338|NCT01994954|583333153|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
161531339|NCT01994954|583333154|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
161531340|NCT00449176|583333155|FG000|Overall Study|Withdrawal by Subject|39|||
161531341|NCT00449176|583333156|FG001|Overall Study|Withdrawal by Subject|43|||
161827648|NCT01316419|584409384|FG000|Overall Study|Not treated|103|||
161827649|NCT01316419|584409384|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
161827650|NCT01316419|584409384|FG000|Overall Study|Lost to Follow-up|19|||
161827651|NCT00412737|584409386|FG000|Overall Study|Death|1|||
161827652|NCT00412737|584409387|FG001|Overall Study|Death|0|||
161827653|NCT00412737|584409386|FG000|Overall Study|Adverse Event|3|||
161827654|NCT00412737|584409387|FG001|Overall Study|Adverse Event|2|||
161827655|NCT00412737|584409386|FG000|Overall Study|Refused Treatment|6|||
161827656|NCT00412737|584409387|FG001|Overall Study|Refused Treatment|2|||
161591438|NCT03056040|583554662|FG000|Extension Period|Lost to Follow-up|0|||
161591439|NCT03056040|583554663|FG001|Extension Period|Lost to Follow-up|1|||
161827657|NCT00412737|584409386|FG000|Overall Study|Failure to Return|6|||
161827658|NCT00412737|584409387|FG001|Overall Study|Failure to Return|2|||
161827659|NCT03180801|584409389|FG000|Overall Study|Physician Decision|3|||
161827660|NCT03180801|584409390|FG001|Overall Study|Physician Decision|3|||
161827661|NCT03180801|584409391|FG002|Overall Study|Physician Decision|1|||
161827662|NCT03180801|584409389|FG000|Overall Study|Non-compliance|1|||
161827663|NCT03180801|584409390|FG001|Overall Study|Non-compliance|4|||
161827664|NCT03180801|584409391|FG002|Overall Study|Non-compliance|0|||
161827665|NCT03180801|584409389|FG000|Overall Study|Inoculation Target Reached|1|||
161827666|NCT03180801|584409390|FG001|Overall Study|Inoculation Target Reached|1|||
161827667|NCT03180801|584409391|FG002|Overall Study|Inoculation Target Reached|3|||
161827668|NCT03180801|584409389|FG000|Overall Study|Adverse Event|1|||
161827669|NCT03180801|584409390|FG001|Overall Study|Adverse Event|0|||
161827670|NCT03180801|584409391|FG002|Overall Study|Adverse Event|2|||
161827671|NCT03180801|584409389|FG000|Overall Study|Withdrawal by Subject|2|||
161827672|NCT03180801|584409390|FG001|Overall Study|Withdrawal by Subject|2|||
161827673|NCT03180801|584409391|FG002|Overall Study|Withdrawal by Subject|1|||
161827674|NCT03180801|584409389|FG000|Overall Study|Lost to Follow-up|0|||
161827675|NCT03180801|584409390|FG001|Overall Study|Lost to Follow-up|2|||
161827676|NCT03180801|584409391|FG002|Overall Study|Lost to Follow-up|3|||
161827677|NCT01049412|584409392|FG000|Period I|Withdrawal by Subject|4|||
161827678|NCT01049412|584409393|FG001|Period I|Withdrawal by Subject|6|||
161827679|NCT01049412|584409392|FG000|Period I|Lost to Follow-up|2|||
161827680|NCT01049412|584409393|FG001|Period I|Lost to Follow-up|2|||
161827681|NCT01049412|584409392|FG000|Period I|Physician Decision|0|||
161827682|NCT01049412|584409393|FG001|Period I|Physician Decision|3|||
161827683|NCT01049412|584409392|FG000|Period I|Protocol Violation|1|||
161827684|NCT01049412|584409393|FG001|Period I|Protocol Violation|2|||
161827685|NCT01049412|584409392|FG000|Period I|Adverse Event|1|||
161827686|NCT01049412|584409393|FG001|Period I|Adverse Event|0|||
161827687|NCT01049412|584409392|FG000|Period II|Withdrawal by Subject|2|||
161827688|NCT01049412|584409393|FG001|Period II|Withdrawal by Subject|3|||
161827689|NCT01049412|584409392|FG000|Period II|Adverse Event|1|||
161827690|NCT01049412|584409393|FG001|Period II|Adverse Event|0|||
161827691|NCT01049412|584409392|FG000|Period II|Lost to Follow-up|1|||
161827692|NCT01049412|584409393|FG001|Period II|Lost to Follow-up|0|||
161827693|NCT00868296|584409396|FG000|Overall Study|Adverse Event|0|||
161827694|NCT00868296|584409397|FG001|Overall Study|Adverse Event|2|||
161827695|NCT00868296|584409396|FG000|Overall Study|Withdrawal by Subject|0|||
161827696|NCT00868296|584409397|FG001|Overall Study|Withdrawal by Subject|1|||
161827697|NCT00573170|584409398|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
161827698|NCT00573170|584409399|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
161827699|NCT00573170|584409400|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
161827700|NCT00573170|584409401|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
161827701|NCT00573170|584409402|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
161827702|NCT00573170|584409403|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
161827703|NCT00573170|584409398|FG000|First Washout Period|Adverse Event|1|||
161827704|NCT00573170|584409399|FG001|First Washout Period|Adverse Event|1|||
161827705|NCT00573170|584409400|FG002|First Washout Period|Adverse Event|0|||
161827706|NCT00573170|584409401|FG003|First Washout Period|Adverse Event|0|||
161827707|NCT00573170|584409402|FG004|First Washout Period|Adverse Event|0|||
161827708|NCT00573170|584409403|FG005|First Washout Period|Adverse Event|1|||
161827709|NCT00573170|584409398|FG000|First Washout Period|Lack of Efficacy|0|||
161827710|NCT00573170|584409399|FG001|First Washout Period|Lack of Efficacy|0|||
161827711|NCT00573170|584409400|FG002|First Washout Period|Lack of Efficacy|0|||
161827712|NCT00573170|584409401|FG003|First Washout Period|Lack of Efficacy|0|||
161827713|NCT00573170|584409402|FG004|First Washout Period|Lack of Efficacy|0|||
161827714|NCT00573170|584409403|FG005|First Washout Period|Lack of Efficacy|1|||
161827715|NCT00573170|584409398|FG000|First Washout Period|Lost to Follow-up|1|||
161827716|NCT00573170|584409399|FG001|First Washout Period|Lost to Follow-up|1|||
161827717|NCT00573170|584409400|FG002|First Washout Period|Lost to Follow-up|0|||
161827718|NCT00573170|584409401|FG003|First Washout Period|Lost to Follow-up|2|||
161827719|NCT00573170|584409402|FG004|First Washout Period|Lost to Follow-up|0|||
161827720|NCT00573170|584409403|FG005|First Washout Period|Lost to Follow-up|2|||
161827721|NCT00573170|584409398|FG000|First Washout Period|Withdrawal by Subject|2|||
161827722|NCT00573170|584409399|FG001|First Washout Period|Withdrawal by Subject|0|||
161827723|NCT00573170|584409400|FG002|First Washout Period|Withdrawal by Subject|0|||
161827724|NCT00573170|584409401|FG003|First Washout Period|Withdrawal by Subject|2|||
161827725|NCT00573170|584409402|FG004|First Washout Period|Withdrawal by Subject|3|||
161827726|NCT00573170|584409403|FG005|First Washout Period|Withdrawal by Subject|3|||
161827727|NCT00573170|584409398|FG000|First Washout Period|Other|4|||
161827728|NCT00573170|584409399|FG001|First Washout Period|Other|0|||
161827729|NCT00573170|584409400|FG002|First Washout Period|Other|1|||
161827730|NCT00573170|584409401|FG003|First Washout Period|Other|1|||
161827731|NCT00573170|584409402|FG004|First Washout Period|Other|0|||
161827732|NCT00573170|584409403|FG005|First Washout Period|Other|0|||
161827733|NCT00573170|584409398|FG000|Second Washout Period|Adverse Event|1|||
161827734|NCT00573170|584409399|FG001|Second Washout Period|Adverse Event|0|||
161827735|NCT00573170|584409400|FG002|Second Washout Period|Adverse Event|0|||
161827736|NCT00573170|584409401|FG003|Second Washout Period|Adverse Event|0|||
161827737|NCT00573170|584409402|FG004|Second Washout Period|Adverse Event|1|||
161827738|NCT00573170|584409403|FG005|Second Washout Period|Adverse Event|0|||
161827739|NCT00573170|584409398|FG000|Second Washout Period|Protocol Violation|2|||
161827740|NCT00573170|584409399|FG001|Second Washout Period|Protocol Violation|1|||
161827741|NCT00573170|584409400|FG002|Second Washout Period|Protocol Violation|1|||
161827742|NCT00573170|584409401|FG003|Second Washout Period|Protocol Violation|0|||
161827743|NCT00573170|584409402|FG004|Second Washout Period|Protocol Violation|0|||
161827744|NCT00573170|584409403|FG005|Second Washout Period|Protocol Violation|0|||
161827745|NCT00573170|584409398|FG000|Second Washout Period|Withdrawal by Subject|1|||
161827746|NCT00573170|584409399|FG001|Second Washout Period|Withdrawal by Subject|1|||
161827747|NCT00573170|584409400|FG002|Second Washout Period|Withdrawal by Subject|2|||
161827748|NCT00573170|584409401|FG003|Second Washout Period|Withdrawal by Subject|0|||
161827749|NCT00573170|584409402|FG004|Second Washout Period|Withdrawal by Subject|1|||
161827750|NCT00573170|584409403|FG005|Second Washout Period|Withdrawal by Subject|0|||
161827751|NCT00573170|584409398|FG000|Second Washout Period|Lost to Follow-up|0|||
161827752|NCT00573170|584409399|FG001|Second Washout Period|Lost to Follow-up|0|||
161827753|NCT00573170|584409400|FG002|Second Washout Period|Lost to Follow-up|0|||
161827754|NCT00573170|584409401|FG003|Second Washout Period|Lost to Follow-up|1|||
161827755|NCT00573170|584409402|FG004|Second Washout Period|Lost to Follow-up|0|||
161827756|NCT00573170|584409403|FG005|Second Washout Period|Lost to Follow-up|0|||
161827757|NCT00573170|584409398|FG000|Second Washout Period|Other|1|||
161827758|NCT00573170|584409399|FG001|Second Washout Period|Other|2|||
161827759|NCT00573170|584409400|FG002|Second Washout Period|Other|1|||
161827760|NCT00573170|584409401|FG003|Second Washout Period|Other|4|||
161827761|NCT00573170|584409402|FG004|Second Washout Period|Other|6|||
161827762|NCT00573170|584409403|FG005|Second Washout Period|Other|2|||
161827763|NCT00573170|584409398|FG000|Third Treatment Period|Withdrawal by Subject|1|||
161827764|NCT00573170|584409399|FG001|Third Treatment Period|Withdrawal by Subject|0|||
161827765|NCT00573170|584409400|FG002|Third Treatment Period|Withdrawal by Subject|0|||
161827766|NCT00573170|584409401|FG003|Third Treatment Period|Withdrawal by Subject|0|||
161827767|NCT00573170|584409402|FG004|Third Treatment Period|Withdrawal by Subject|0|||
161827768|NCT00573170|584409403|FG005|Third Treatment Period|Withdrawal by Subject|0|||
161827769|NCT00573170|584409398|FG000|Third Treatment Period|Lost to Follow-up|0|||
161827770|NCT00573170|584409399|FG001|Third Treatment Period|Lost to Follow-up|0|||
161827771|NCT00573170|584409400|FG002|Third Treatment Period|Lost to Follow-up|0|||
161827772|NCT00573170|584409401|FG003|Third Treatment Period|Lost to Follow-up|0|||
161827773|NCT00573170|584409402|FG004|Third Treatment Period|Lost to Follow-up|0|||
161827774|NCT00573170|584409403|FG005|Third Treatment Period|Lost to Follow-up|2|||
161827775|NCT05966090|584409404|FG000|Overall Study|Lost to Follow-up|6|||
161827776|NCT05966090|584409405|FG001|Overall Study|Lost to Follow-up|6|||
161827777|NCT05966090|584409404|FG000|Overall Study|Adverse Event|1|||
161827778|NCT05966090|584409405|FG001|Overall Study|Adverse Event|1|||
161827779|NCT05966090|584409404|FG000|Overall Study|Withdrawal by Subject|1|||
161827780|NCT05966090|584409405|FG001|Overall Study|Withdrawal by Subject|1|||
161827781|NCT05966090|584409404|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161827782|NCT05966090|584409405|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161827783|NCT05966090|584409404|FG000|Overall Study|Other|1|||
161827784|NCT05966090|584409405|FG001|Overall Study|Other|1|||
161827785|NCT00804141|584409406|FG000|Overall Study|Adverse Event|157|||
161827786|NCT00804141|584409406|FG000|Overall Study|Death|4|||
161827787|NCT00804141|584409406|FG000|Overall Study|Failed to return|96|||
161827788|NCT00804141|584409406|FG000|Overall Study|Investigator request|8|||
161827789|NCT00804141|584409406|FG000|Overall Study|Protocol Violation|85|||
161827790|NCT00804141|584409406|FG000|Overall Study|Withdrawal by Subject|131|||
161827791|NCT00804141|584409406|FG000|Overall Study|Lack of Efficacy|46|||
161827792|NCT00804141|584409406|FG000|Overall Study|Other than specified|30|||
161827793|NCT00804141|584409406|FG000|Overall Study|Enrolled but not treated|6|||
161827794|NCT01142908|584409407|FG000|Overall Study|Lost to Follow-up|19|||
161827795|NCT01142908|584409408|FG001|Overall Study|Lost to Follow-up|13|||
161827796|NCT01142908|584409407|FG000|Overall Study|Death|1|||
161827797|NCT01142908|584409408|FG001|Overall Study|Death|4|||
161827798|NCT01142908|584409407|FG000|Overall Study|Excluded - did not meet criteria|9|||
161827799|NCT01142908|584409408|FG001|Overall Study|Excluded - did not meet criteria|5|||
161827800|NCT01142908|584409407|FG000|Overall Study|Withdrawal by Subject|3|||
161827801|NCT01142908|584409408|FG001|Overall Study|Withdrawal by Subject|0|||
161827802|NCT03235479|584409410|FG000|Overall Study|Lost to Follow-up|8|||
161827803|NCT03235479|584409411|FG001|Overall Study|Lost to Follow-up|11|||
161827804|NCT03235479|584409410|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
161827805|NCT03235479|584409411|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
161827806|NCT03235479|584409410|FG000|Overall Study|Pregnancy|1|||
161827807|NCT03235479|584409411|FG001|Overall Study|Pregnancy|0|||
161827808|NCT03235479|584409410|FG000|Overall Study|Protocol Deviation|1|||
161827809|NCT03235479|584409411|FG001|Overall Study|Protocol Deviation|3|||
161827810|NCT03235479|584409410|FG000|Overall Study|Technical Problems|3|||
161827811|NCT03235479|584409411|FG001|Overall Study|Technical Problems|2|||
161827812|NCT03235479|584409410|FG000|Overall Study|Withdrawal by Subject|2|||
161937213|NCT03246529|584819187|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
161937214|NCT03246529|584819188|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
161937215|NCT03246529|584819186|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
161827813|NCT03235479|584409411|FG001|Overall Study|Withdrawal by Subject|2|||
161827814|NCT03235479|584409410|FG000|Overall Study|Other Reasons|3|||
161827815|NCT03235479|584409411|FG001|Overall Study|Other Reasons|5|||
161827816|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
161827817|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
161827818|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161827819|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161827820|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161827821|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
161827822|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161827823|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161827824|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
161827825|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161827826|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161827827|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161827828|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
161827829|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
161827830|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161827831|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161827832|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Death|2|||
161827833|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Death|1|||
161827834|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Death|0|||
161827835|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Death|0|||
161937216|NCT03246529|584819187|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
161937217|NCT03246529|584819188|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
161937218|NCT03246529|584819186|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
161937219|NCT03246529|584819187|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
161937220|NCT03246529|584819188|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
161937221|NCT03246529|584819186|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
161937222|NCT03246529|584819187|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
161937223|NCT03246529|584819188|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
161937224|NCT03246529|584819186|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
161827836|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
161827837|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
161827838|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
161827839|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
161827840|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
161827841|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161827842|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161827843|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161827844|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161827845|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
161827846|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161827847|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161827848|NCT03110380|584409421|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161827849|NCT03110380|584409422|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161827850|NCT03110380|584409423|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
161827851|NCT03110380|584409424|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
161827852|NCT03110380|584409421|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
161827853|NCT03110380|584409422|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
161827854|NCT03110380|584409423|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
161827855|NCT03110380|584409424|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
161827856|NCT03110380|584409421|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161827857|NCT03110380|584409422|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161937225|NCT03246529|584819187|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
161827858|NCT03110380|584409423|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161827859|NCT03110380|584409424|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
161827860|NCT01206439|584409427|FG000|Overall Study|subject did not meet inclusion criteria|1|||
161827861|NCT05889039|584409429|FG000|Overall Study|error in completing survey|0|||
161827862|NCT05889039|584409430|FG001|Overall Study|error in completing survey|2|||
161827863|NCT05889039|584409431|FG002|Overall Study|error in completing survey|0|||
161827864|NCT05889039|584409432|FG003|Overall Study|error in completing survey|0|||
161827865|NCT05889039|584409429|FG000|Overall Study|Lost to Follow-up|4|||
161937226|NCT03246529|584819188|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
161937227|NCT03246529|584819186|FG000|Follow-up period at 1 year FU Completion|Death|0|||
161937228|NCT03246529|584819187|FG001|Follow-up period at 1 year FU Completion|Death|0|||
161937229|NCT03246529|584819188|FG002|Follow-up period at 1 year FU Completion|Death|1|||
161937230|NCT04379518|584819189|FG000|Overall Study|Physician Decision|2|||
161937231|NCT04379518|584819190|FG001|Overall Study|Physician Decision|0|||
161937232|NCT04379518|584819191|FG002|Overall Study|Physician Decision|0|||
161937233|NCT04379518|584819192|FG003|Overall Study|Physician Decision|0|||
161937234|NCT04379518|584819193|FG004|Overall Study|Physician Decision|0|||
161937235|NCT04379518|584819189|FG000|Overall Study|Withdrawal by Subject|1|||
161827866|NCT05889039|584409430|FG001|Overall Study|Lost to Follow-up|0|||
161827867|NCT05889039|584409431|FG002|Overall Study|Lost to Follow-up|0|||
161937236|NCT04379518|584819190|FG001|Overall Study|Withdrawal by Subject|0|||
161678520|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
161827868|NCT05889039|584409432|FG003|Overall Study|Lost to Follow-up|0|||
161827869|NCT01808248|584409435|FG000|Overall Study|Lack of Efficacy|3|||
161827870|NCT01808248|584409435|FG000|Overall Study|Withdrawal by Subject|1|||
161827871|NCT01808248|584409435|FG000|Overall Study|Lost to Follow-up|1|||
161827872|NCT04974580|584409438|FG000|Overall Study|Lost to Follow-up|33|||
161827873|NCT04974580|584409439|FG001|Overall Study|Lost to Follow-up|39|||
161827874|NCT04974580|584409440|FG002|Overall Study|Lost to Follow-up|30|||
161827875|NCT04974580|584409441|FG003|Overall Study|Lost to Follow-up|29|||
161827876|NCT02941523|584409445|FG000|Monotherapy|Withdrawal by Subject|0|||
161827877|NCT02941523|584409446|FG001|Monotherapy|Withdrawal by Subject|1|||
161827878|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
161827879|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
161827880|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Death|1|||
161827881|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Death|2|||
161827882|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Disease progression|2|||
161827883|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Disease progression|0|||
161591440|NCT03056040|583554662|FG000|Extension Period|Death|0|||
161591441|NCT03056040|583554663|FG001|Extension Period|Death|3|||
161591442|NCT03056040|583554662|FG000|Extension Period|Withdrawal by Subject|1|||
161591443|NCT03056040|583554663|FG001|Extension Period|Withdrawal by Subject|0|||
161591444|NCT03232138|583554669|FG000|Overall Study|Physician Decision|1|||
161591445|NCT03232138|583554670|FG001|Overall Study|Physician Decision|0|||
161591446|NCT03232138|583554669|FG000|Overall Study|Adverse Event|2|||
161591447|NCT03232138|583554670|FG001|Overall Study|Adverse Event|0|||
161591448|NCT03232138|583554669|FG000|Overall Study|Withdrawal by Subject|1|||
161591449|NCT03232138|583554670|FG001|Overall Study|Withdrawal by Subject|2|||
161591450|NCT03853746|583554672|FG000|Overall Study|Withdrawal by Subject|1|||
161591451|NCT05028634|583554673|FG000|Overall Study|Withdrawal by Subject|0|||
161591452|NCT05028634|583554674|FG001|Overall Study|Withdrawal by Subject|1|||
161591453|NCT01997840|583554675|FG000|Overall Study|Lost to Follow-up|0|||
161591454|NCT01997840|583554676|FG001|Overall Study|Lost to Follow-up|0|||
161591455|NCT01997840|583554677|FG002|Overall Study|Lost to Follow-up|1|||
161591456|NCT01997840|583554678|FG003|Overall Study|Lost to Follow-up|0|||
161591457|NCT01997840|583554675|FG000|Overall Study|Withdrawal by participant|0|||
161591458|NCT01997840|583554676|FG001|Overall Study|Withdrawal by participant|0|||
161591459|NCT01997840|583554677|FG002|Overall Study|Withdrawal by participant|8|||
161591460|NCT01997840|583554678|FG003|Overall Study|Withdrawal by participant|1|||
161591461|NCT01997840|583554675|FG000|Overall Study|Physician Decision|0|||
161591462|NCT01997840|583554676|FG001|Overall Study|Physician Decision|0|||
161591463|NCT01997840|583554677|FG002|Overall Study|Physician Decision|3|||
161591464|NCT01997840|583554678|FG003|Overall Study|Physician Decision|0|||
161591465|NCT01997840|583554675|FG000|Overall Study|Progressive disease|3|||
161591466|NCT01997840|583554676|FG001|Overall Study|Progressive disease|4|||
161591467|NCT01997840|583554677|FG002|Overall Study|Progressive disease|57|||
161591468|NCT01997840|583554678|FG003|Overall Study|Progressive disease|8|||
161591469|NCT01997840|583554675|FG000|Overall Study|Other reasons|0|||
161591470|NCT01997840|583554676|FG001|Overall Study|Other reasons|0|||
161937237|NCT04379518|584819191|FG002|Overall Study|Withdrawal by Subject|0|||
161937238|NCT04379518|584819192|FG003|Overall Study|Withdrawal by Subject|0|||
161937239|NCT04379518|584819193|FG004|Overall Study|Withdrawal by Subject|0|||
161937240|NCT05666505|584819194|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
161937241|NCT05135000|584820002|FG000|Overall Study|Adverse Event|2|||
161937242|NCT05135000|584820003|FG001|Overall Study|Adverse Event|0|||
161937243|NCT05135000|584820002|FG000|Overall Study|Lost to Follow-up|1|||
161937244|NCT05135000|584820003|FG001|Overall Study|Lost to Follow-up|0|||
161937245|NCT05135000|584820002|FG000|Overall Study|Study Terminated by Sponsor|6|||
161937246|NCT05135000|584820003|FG001|Overall Study|Study Terminated by Sponsor|3|||
161937247|NCT05561673|584820008|FG000|Overall Study|Lost to Follow-up|0|||
161937248|NCT05561673|584820009|FG001|Overall Study|Lost to Follow-up|1|||
161937249|NCT05561673|584820010|FG002|Overall Study|Lost to Follow-up|0|||
161937250|NCT05561673|584820011|FG003|Overall Study|Lost to Follow-up|1|||
161937251|NCT05561673|584820012|FG004|Overall Study|Lost to Follow-up|0|||
161937252|NCT05561673|584820008|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
161937253|NCT05561673|584820009|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
161937254|NCT05561673|584820010|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
161937255|NCT05561673|584820011|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
161937256|NCT05561673|584820012|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
161937257|NCT05561673|584820008|FG000|Overall Study|Other|1|||
161937258|NCT05561673|584820009|FG001|Overall Study|Other|0|||
161937259|NCT05561673|584820010|FG002|Overall Study|Other|1|||
161937260|NCT05561673|584820011|FG003|Overall Study|Other|0|||
161937261|NCT05561673|584820012|FG004|Overall Study|Other|0|||
161937262|NCT03596645|584820015|FG000|Overall Study|Adverse Event|17|||
161937263|NCT03596645|584820016|FG001|Overall Study|Adverse Event|0|||
161937264|NCT03596645|584820015|FG000|Overall Study|Lack of Efficacy|8|||
161937265|NCT03596645|584820016|FG001|Overall Study|Lack of Efficacy|0|||
161937266|NCT03596645|584820015|FG000|Overall Study|Lost to Follow-up|1|||
161937267|NCT03596645|584820016|FG001|Overall Study|Lost to Follow-up|1|||
161937268|NCT03596645|584820015|FG000|Overall Study|Physician Decision|1|||
161937269|NCT03596645|584820016|FG001|Overall Study|Physician Decision|1|||
161937270|NCT03596645|584820015|FG000|Overall Study|Protocol Violation|1|||
161937271|NCT03596645|584820016|FG001|Overall Study|Protocol Violation|0|||
161937272|NCT03596645|584820015|FG000|Overall Study|Initiated Prohibited Medication|1|||
161937273|NCT03596645|584820016|FG001|Overall Study|Initiated Prohibited Medication|0|||
161937274|NCT03596645|584820015|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161937275|NCT03596645|584820016|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161937276|NCT03596645|584820015|FG000|Overall Study|No mucosal healing achieved|1|||
161937277|NCT03596645|584820016|FG001|Overall Study|No mucosal healing achieved|0|||
161937278|NCT03596645|584820015|FG000|Overall Study|Disease progression|1|||
161937279|NCT03596645|584820016|FG001|Overall Study|Disease progression|0|||
161937280|NCT03596645|584820015|FG000|Overall Study|Ongoing|37|||
161937281|NCT03596645|584820016|FG001|Overall Study|Ongoing|12|||
161937282|NCT03596645|584820015|FG000|Overall Study|Randomized but not treated|0|||
161937283|NCT03596645|584820016|FG001|Overall Study|Randomized but not treated|1|||
161937284|NCT03961555|584820017|FG000|Overall Study|Lost to Follow-up|0|||
161937285|NCT03961555|584820018|FG001|Overall Study|Lost to Follow-up|0|||
161937286|NCT03961555|584820019|FG002|Overall Study|Lost to Follow-up|1|||
161937287|NCT03961555|584820020|FG003|Overall Study|Lost to Follow-up|0|||
161937288|NCT03961555|584820017|FG000|Overall Study|Withdrawal by Subject|0|||
161937289|NCT03961555|584820018|FG001|Overall Study|Withdrawal by Subject|0|||
161937290|NCT03961555|584820019|FG002|Overall Study|Withdrawal by Subject|2|||
161937291|NCT03961555|584820020|FG003|Overall Study|Withdrawal by Subject|4|||
161937292|NCT03961555|584820017|FG000|Overall Study|Death|0|||
161937293|NCT03961555|584820018|FG001|Overall Study|Death|1|||
161937294|NCT03961555|584820019|FG002|Overall Study|Death|0|||
161937295|NCT03961555|584820020|FG003|Overall Study|Death|0|||
161937296|NCT03961555|584820017|FG000|Overall Study|Other|0|||
161937297|NCT03961555|584820018|FG001|Overall Study|Other|0|||
161937298|NCT03961555|584820019|FG002|Overall Study|Other|2|||
161937299|NCT03961555|584820020|FG003|Overall Study|Other|2|||
161937300|NCT03961555|584820017|FG000|Overall Study|No treatment received|0|||
161937301|NCT03961555|584820018|FG001|Overall Study|No treatment received|0|||
161937302|NCT03961555|584820019|FG002|Overall Study|No treatment received|1|||
161937303|NCT03961555|584820020|FG003|Overall Study|No treatment received|0|||
161937304|NCT04153149|584820021|FG000|Double Blind Period|Death|63|||
161937305|NCT04153149|584820022|FG001|Double Blind Period|Death|49|||
161937306|NCT04153149|584820023|FG002|Double Blind Period|Death|0|||
161937307|NCT04153149|584820024|FG003|Double Blind Period|Death|0|||
161937308|NCT04153149|584820021|FG000|Double Blind Period|Withdrawal by Subject|16|||
161937309|NCT04153149|584820022|FG001|Double Blind Period|Withdrawal by Subject|11|||
161937310|NCT04153149|584820023|FG002|Double Blind Period|Withdrawal by Subject|0|||
161937311|NCT04153149|584820024|FG003|Double Blind Period|Withdrawal by Subject|0|||
161937312|NCT04153149|584820021|FG000|Double Blind Period|Adverse Event|6|||
161937313|NCT04153149|584820022|FG001|Double Blind Period|Adverse Event|2|||
161937314|NCT04153149|584820023|FG002|Double Blind Period|Adverse Event|0|||
161937315|NCT04153149|584820024|FG003|Double Blind Period|Adverse Event|0|||
161827884|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
161827885|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
161827886|NCT04330157|584409447|FG000|Overall Study|Protocol Violation|4|||
161827887|NCT04330157|584409447|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
161827888|NCT03558139|584409448|FG000|Overall Study|Consent Withdrawn|1|||
161827889|NCT03558139|584409449|FG001|Overall Study|Consent Withdrawn|1|||
161827890|NCT03558139|584409450|FG002|Overall Study|Consent Withdrawn|4|||
161827891|NCT03558139|584409448|FG000|Overall Study|Death|5|||
161827892|NCT03558139|584409449|FG001|Overall Study|Death|3|||
161827893|NCT03558139|584409450|FG002|Overall Study|Death|8|||
161827894|NCT03558139|584409448|FG000|Overall Study|Lost to Follow-up|0|||
161827895|NCT03558139|584409449|FG001|Overall Study|Lost to Follow-up|0|||
161827896|NCT03558139|584409450|FG002|Overall Study|Lost to Follow-up|3|||
161827897|NCT03558139|584409448|FG000|Overall Study|Study Ended Per Protocol|0|||
161827898|NCT03558139|584409449|FG001|Overall Study|Study Ended Per Protocol|3|||
161827899|NCT03558139|584409450|FG002|Overall Study|Study Ended Per Protocol|6|||
161827900|NCT02752802|584409451|FG000|Overall Study|Contrast Volume Not Collected|1|||
161827901|NCT02752802|584409452|FG001|Overall Study|Contrast Volume Not Collected|0|||
161827902|NCT03689894|584409453|FG000|Overall Study|Adverse Event|1|||
161827903|NCT01378962|584409459|FG000|Overall Study|Death|14|||
161827904|NCT01378962|584409459|FG000|Overall Study|Lost to Follow-up|1|||
161827905|NCT01378962|584409459|FG000|Overall Study|Other|2|||
161827906|NCT00983918|584411426|FG000|Overall Study|conversion to open cholecystectomy|0|||
161827907|NCT00983918|584411427|FG001|Overall Study|conversion to open cholecystectomy|2|||
161827908|NCT00983918|584411428|FG002|Overall Study|conversion to open cholecystectomy|2|||
161827909|NCT00983918|584411429|FG003|Overall Study|conversion to open cholecystectomy|2|||
161937316|NCT04153149|584820021|FG000|Double Blind Period|Lost to Follow-up|2|||
161937317|NCT04153149|584820022|FG001|Double Blind Period|Lost to Follow-up|1|||
161937318|NCT04153149|584820023|FG002|Double Blind Period|Lost to Follow-up|0|||
161937319|NCT04153149|584820024|FG003|Double Blind Period|Lost to Follow-up|0|||
161827910|NCT01796964|584411435|FG000|Overall Study|Adverse Event|1|||
161827911|NCT01796964|584411436|FG001|Overall Study|Adverse Event|1|||
161827912|NCT01796964|584411435|FG000|Overall Study|Death|1|||
161827913|NCT01796964|584411436|FG001|Overall Study|Death|0|||
161827914|NCT01796964|584411435|FG000|Overall Study|Protocol Violation|0|||
161827915|NCT01796964|584411436|FG001|Overall Study|Protocol Violation|1|||
161827916|NCT01796964|584411435|FG000|Overall Study|Withdrawal by Subject|1|||
161827917|NCT01796964|584411436|FG001|Overall Study|Withdrawal by Subject|1|||
161827918|NCT01345318|584411457|FG000|Overall Study|Adverse Event|16|||
161827919|NCT01345318|584411457|FG000|Overall Study|Lack of Efficacy|17|||
161937320|NCT04153149|584820021|FG000|Double Blind Period|Withdrawal by guardian|0|||
161937321|NCT04153149|584820022|FG001|Double Blind Period|Withdrawal by guardian|2|||
161937322|NCT04153149|584820023|FG002|Double Blind Period|Withdrawal by guardian|0|||
161937323|NCT04153149|584820024|FG003|Double Blind Period|Withdrawal by guardian|0|||
161827920|NCT01345318|584411457|FG000|Overall Study|Lost to Follow-up|2|||
161827921|NCT01345318|584411457|FG000|Overall Study|Protocol Violation|1|||
161827922|NCT01345318|584411457|FG000|Overall Study|Withdrawal by Subject|41|||
161827923|NCT01345318|584411457|FG000|Overall Study|Other|3|||
161827924|NCT01685073|584411458|FG000|Overall Study|Lost to Follow-up|6|||
161827925|NCT01685073|584411459|FG001|Overall Study|Lost to Follow-up|8|||
161827926|NCT01685073|584411458|FG000|Overall Study|Withdrawal by Subject|24|||
161827927|NCT01685073|584411459|FG001|Overall Study|Withdrawal by Subject|24|||
161827928|NCT01239472|584411462|FG000|Overall Study|Withdrawal by Subject|5|||
161827929|NCT01239472|584411463|FG001|Overall Study|Withdrawal by Subject|1|||
161827930|NCT01239472|584411462|FG000|Overall Study|Adverse Event|0|||
161827931|NCT01239472|584411463|FG001|Overall Study|Adverse Event|1|||
161827932|NCT01239472|584411462|FG000|Overall Study|Lack of Efficacy|0|||
161827933|NCT01239472|584411463|FG001|Overall Study|Lack of Efficacy|1|||
161827934|NCT02695719|584411467|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
161827935|NCT02695719|584411468|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
161827936|NCT02695719|584411467|FG000|Overall Study|Significant Protocol Deviation|0|||
161827937|NCT02695719|584411468|FG001|Overall Study|Significant Protocol Deviation|1|||
161827938|NCT02695719|584411467|FG000|Overall Study|Voluntary Withdrawal|1|||
161827939|NCT02695719|584411468|FG001|Overall Study|Voluntary Withdrawal|0|||
161827940|NCT01714739|584411471|FG000|Overall Study|Disease progression|3|||
161827941|NCT01714739|584411472|FG001|Overall Study|Disease progression|5|||
161827942|NCT01714739|584411473|FG002|Overall Study|Disease progression|5|||
161827943|NCT01714739|584411474|FG003|Overall Study|Disease progression|204|||
161827944|NCT01714739|584411475|FG004|Overall Study|Disease progression|1|||
161827945|NCT01714739|584411476|FG005|Overall Study|Disease progression|3|||
161827946|NCT01714739|584411477|FG006|Overall Study|Disease progression|5|||
161827947|NCT01714739|584411471|FG000|Overall Study|Study drug toxicity|1|||
161827948|NCT01714739|584411472|FG001|Overall Study|Study drug toxicity|1|||
161827949|NCT01714739|584411473|FG002|Overall Study|Study drug toxicity|1|||
161827950|NCT01714739|584411474|FG003|Overall Study|Study drug toxicity|15|||
161531342|NCT00449176|583333157|FG002|Overall Study|Withdrawal by Subject|59|||
161531343|NCT00449176|583333155|FG000|Overall Study|Lost to Follow-up|13|||
161531344|NCT00449176|583333156|FG001|Overall Study|Lost to Follow-up|8|||
161531345|NCT00449176|583333157|FG002|Overall Study|Lost to Follow-up|12|||
161531346|NCT00449176|583333155|FG000|Overall Study|Adverse Event|51|||
161531347|NCT00449176|583333156|FG001|Overall Study|Adverse Event|107|||
161531348|NCT00449176|583333157|FG002|Overall Study|Adverse Event|15|||
161531349|NCT00449176|583333155|FG000|Overall Study|Lack of Efficacy|13|||
161531350|NCT00449176|583333156|FG001|Overall Study|Lack of Efficacy|7|||
161937324|NCT04153149|584820021|FG000|Double Blind Period|Reason Not Specified|5|||
161531351|NCT00449176|583333157|FG002|Overall Study|Lack of Efficacy|50|||
161937325|NCT04153149|584820022|FG001|Double Blind Period|Reason Not Specified|4|||
161937326|NCT04153149|584820023|FG002|Double Blind Period|Reason Not Specified|0|||
161937327|NCT04153149|584820024|FG003|Double Blind Period|Reason Not Specified|0|||
161937328|NCT04153149|584820021|FG000|Double Blind Period|Physician Decision|2|||
161937329|NCT04153149|584820022|FG001|Double Blind Period|Physician Decision|0|||
161937330|NCT04153149|584820023|FG002|Double Blind Period|Physician Decision|0|||
161937331|NCT04153149|584820024|FG003|Double Blind Period|Physician Decision|0|||
161937332|NCT04153149|584820021|FG000|Open Label Extension Period|Death|0|||
161937333|NCT04153149|584820022|FG001|Open Label Extension Period|Death|0|||
161937334|NCT04153149|584820023|FG002|Open Label Extension Period|Death|7|||
161937335|NCT04153149|584820024|FG003|Open Label Extension Period|Death|3|||
161937336|NCT04153149|584820021|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
161937337|NCT04153149|584820022|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
161937338|NCT04153149|584820023|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
161937339|NCT04153149|584820024|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
161937340|NCT04153149|584820021|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161937341|NCT04153149|584820022|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161937342|NCT04153149|584820023|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161937343|NCT04153149|584820024|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
161937344|NCT04153149|584820021|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
161937345|NCT04153149|584820022|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
161937346|NCT04153149|584820023|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
161937347|NCT04153149|584820024|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
161937348|NCT04522973|584820025|FG000|Overall Study|Lost to Follow-up|4|||
161937349|NCT04522973|584820025|FG000|Overall Study|Could not adhere to study schedule|1|||
161937350|NCT04007796|584820028|FG000|Overall Study|Exclusion criterion met during the trial|1|||
161937351|NCT04007796|584820029|FG001|Overall Study|Exclusion criterion met during the trial|1|||
161937352|NCT04007796|584820028|FG000|Overall Study|Withdrawal by Subject|1|||
161937353|NCT04007796|584820029|FG001|Overall Study|Withdrawal by Subject|0|||
161937354|NCT03573401|584820030|FG000|Overall Study|Withdrawal by Subject|2|||
161937355|NCT03573401|584820031|FG001|Overall Study|Withdrawal by Subject|0|||
161937356|NCT03573401|584820030|FG000|Overall Study|Subject non-compliance with study schedule|1|||
161937357|NCT03573401|584820031|FG001|Overall Study|Subject non-compliance with study schedule|0|||
161937358|NCT03573401|584820030|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
161937359|NCT03573401|584820031|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
161937360|NCT03573401|584820030|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
161937361|NCT03573401|584820031|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
161937362|NCT05579249|584820032|FG000|Overall Study|Withdrawal by Subject|1|||
161937363|NCT05579249|584820033|FG001|Overall Study|Withdrawal by Subject|3|||
161937364|NCT05579249|584820032|FG000|Overall Study|Lost to Follow-up|33|||
161937365|NCT05579249|584820033|FG001|Overall Study|Lost to Follow-up|52|||
161937366|NCT05579249|584820032|FG000|Overall Study|Physician Decision|2|||
161937367|NCT05579249|584820033|FG001|Overall Study|Physician Decision|2|||
161937368|NCT05579249|584820032|FG000|Overall Study|Death|0|||
161937369|NCT05579249|584820033|FG001|Overall Study|Death|2|||
161937370|NCT05222555|584820304|FG000|Overall Study|Ongoing|2|||
161937371|NCT05222555|584820305|FG001|Overall Study|Ongoing|18|||
161937372|NCT05222555|584820304|FG000|Overall Study|Adverse Event|1|||
161937373|NCT05222555|584820305|FG001|Overall Study|Adverse Event|1|||
161937374|NCT05222555|584820304|FG000|Overall Study|Death|0|||
161937375|NCT05222555|584820305|FG001|Overall Study|Death|6|||
161937376|NCT05222555|584820304|FG000|Overall Study|Withdrawal by Subject|0|||
161937377|NCT05222555|584820305|FG001|Overall Study|Withdrawal by Subject|11|||
161937378|NCT03516942|584820312|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
161937379|NCT03516942|584820312|FG000|Registration through baseline survey com|Death|8|||
161937380|NCT03516942|584820312|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
161937381|NCT03516942|584820312|FG000|T0: Baseline|LOST|13|||
161937382|NCT03516942|584820312|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
161937383|NCT03516942|584820312|FG000|T1: 3 Months Survey|Death|10|||
161937384|NCT03516942|584820312|FG000|T1: 3 Months Survey|Lost|163|||
161531352|NCT00449176|583333155|FG000|Overall Study|Study drug non-compliant|14|||
161827951|NCT01714739|584411475|FG004|Overall Study|Study drug toxicity|0|||
161827952|NCT01714739|584411476|FG005|Overall Study|Study drug toxicity|0|||
161827953|NCT01714739|584411477|FG006|Overall Study|Study drug toxicity|5|||
161827954|NCT01714739|584411471|FG000|Overall Study|Death|0|||
161827955|NCT01714739|584411472|FG001|Overall Study|Death|0|||
161827956|NCT01714739|584411473|FG002|Overall Study|Death|0|||
161827957|NCT01714739|584411474|FG003|Overall Study|Death|1|||
161827958|NCT01714739|584411475|FG004|Overall Study|Death|0|||
161827959|NCT01714739|584411476|FG005|Overall Study|Death|0|||
161827960|NCT01714739|584411477|FG006|Overall Study|Death|0|||
161827961|NCT01714739|584411471|FG000|Overall Study|Adverse Event unrelated to drug|0|||
161827962|NCT01714739|584411472|FG001|Overall Study|Adverse Event unrelated to drug|0|||
161827963|NCT01714739|584411473|FG002|Overall Study|Adverse Event unrelated to drug|3|||
161827964|NCT01714739|584411474|FG003|Overall Study|Adverse Event unrelated to drug|21|||
161827965|NCT01714739|584411475|FG004|Overall Study|Adverse Event unrelated to drug|0|||
161827966|NCT01714739|584411476|FG005|Overall Study|Adverse Event unrelated to drug|0|||
161827967|NCT01714739|584411477|FG006|Overall Study|Adverse Event unrelated to drug|0|||
161827968|NCT01714739|584411471|FG000|Overall Study|Participant request to stop therapy|0|||
161827969|NCT01714739|584411472|FG001|Overall Study|Participant request to stop therapy|1|||
161827970|NCT01714739|584411473|FG002|Overall Study|Participant request to stop therapy|0|||
161827971|NCT01714739|584411474|FG003|Overall Study|Participant request to stop therapy|6|||
161827972|NCT01714739|584411475|FG004|Overall Study|Participant request to stop therapy|0|||
161827973|NCT01714739|584411476|FG005|Overall Study|Participant request to stop therapy|0|||
161827974|NCT01714739|584411477|FG006|Overall Study|Participant request to stop therapy|0|||
161827975|NCT01714739|584411471|FG000|Overall Study|Participant withdrew consent|0|||
161827976|NCT01714739|584411472|FG001|Overall Study|Participant withdrew consent|1|||
161827977|NCT01714739|584411473|FG002|Overall Study|Participant withdrew consent|0|||
161827978|NCT01714739|584411474|FG003|Overall Study|Participant withdrew consent|8|||
161827979|NCT01714739|584411475|FG004|Overall Study|Participant withdrew consent|0|||
161827980|NCT01714739|584411476|FG005|Overall Study|Participant withdrew consent|0|||
161827981|NCT01714739|584411477|FG006|Overall Study|Participant withdrew consent|0|||
161827982|NCT01714739|584411471|FG000|Overall Study|Lost to Follow-up|0|||
161827983|NCT01714739|584411472|FG001|Overall Study|Lost to Follow-up|0|||
161827984|NCT01714739|584411473|FG002|Overall Study|Lost to Follow-up|0|||
161827985|NCT01714739|584411474|FG003|Overall Study|Lost to Follow-up|1|||
161827986|NCT01714739|584411475|FG004|Overall Study|Lost to Follow-up|0|||
161827987|NCT01714739|584411476|FG005|Overall Study|Lost to Follow-up|0|||
161827988|NCT01714739|584411477|FG006|Overall Study|Lost to Follow-up|0|||
161827989|NCT01714739|584411471|FG000|Overall Study|Maximum clinical benefit|0|||
161827990|NCT01714739|584411472|FG001|Overall Study|Maximum clinical benefit|1|||
161827991|NCT01714739|584411473|FG002|Overall Study|Maximum clinical benefit|1|||
161827992|NCT01714739|584411474|FG003|Overall Study|Maximum clinical benefit|3|||
161827993|NCT01714739|584411475|FG004|Overall Study|Maximum clinical benefit|0|||
161827994|NCT01714739|584411476|FG005|Overall Study|Maximum clinical benefit|0|||
161827995|NCT01714739|584411477|FG006|Overall Study|Maximum clinical benefit|0|||
161827996|NCT01714739|584411471|FG000|Overall Study|Poor/non-comliance|0|||
161827997|NCT01714739|584411472|FG001|Overall Study|Poor/non-comliance|1|||
161827998|NCT01714739|584411473|FG002|Overall Study|Poor/non-comliance|0|||
161827999|NCT01714739|584411474|FG003|Overall Study|Poor/non-comliance|1|||
161828000|NCT01714739|584411475|FG004|Overall Study|Poor/non-comliance|0|||
161828001|NCT01714739|584411476|FG005|Overall Study|Poor/non-comliance|0|||
161678521|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
161828002|NCT01714739|584411477|FG006|Overall Study|Poor/non-comliance|0|||
161828003|NCT01714739|584411471|FG000|Overall Study|No longer meets study criteria|0|||
161828004|NCT01714739|584411472|FG001|Overall Study|No longer meets study criteria|0|||
161828005|NCT01714739|584411473|FG002|Overall Study|No longer meets study criteria|0|||
161828006|NCT01714739|584411474|FG003|Overall Study|No longer meets study criteria|1|||
161531353|NCT00449176|583333156|FG001|Overall Study|Study drug non-compliant|11|||
161531354|NCT00449176|583333157|FG002|Overall Study|Study drug non-compliant|11|||
161531355|NCT00449176|583333155|FG000|Overall Study|all other|22|||
161531356|NCT00449176|583333156|FG001|Overall Study|all other|19|||
161531357|NCT00449176|583333157|FG002|Overall Study|all other|20|||
161531358|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
161531359|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
161531360|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|disease progression|58|||
161828007|NCT01714739|584411475|FG004|Overall Study|No longer meets study criteria|0|||
161828008|NCT01714739|584411476|FG005|Overall Study|No longer meets study criteria|0|||
161828009|NCT01714739|584411477|FG006|Overall Study|No longer meets study criteria|0|||
161828010|NCT01714739|584411471|FG000|Overall Study|Other reason|0|||
161828011|NCT01714739|584411472|FG001|Overall Study|Other reason|0|||
161828012|NCT01714739|584411473|FG002|Overall Study|Other reason|0|||
161828013|NCT01714739|584411474|FG003|Overall Study|Other reason|3|||
161828014|NCT01714739|584411475|FG004|Overall Study|Other reason|1|||
161828015|NCT01714739|584411476|FG005|Overall Study|Other reason|0|||
161828016|NCT01714739|584411477|FG006|Overall Study|Other reason|0|||
161828017|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
161828018|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
161828019|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
161828020|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
161828021|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161828022|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161828023|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
161828024|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
161828025|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
161828026|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
161828027|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
161828028|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
161828029|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
161828030|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
161937385|NCT03516942|584820312|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
161937386|NCT03516942|584820312|FG000|T2: 6 Month Survey|Death|14|||
161937387|NCT03516942|584820312|FG000|T2: 6 Month Survey|Lost|180|||
161937388|NCT03516942|584820312|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
161937389|NCT03516942|584820312|FG000|T3: 12 Month Survey|Death|19|||
161937390|NCT03516942|584820312|FG000|T3: 12 Month Survey|Lost|209|||
161937391|NCT05028517|584820313|FG000|Overall Study|Lost to Follow-up|13|||
161937392|NCT05028517|584820314|FG001|Overall Study|Lost to Follow-up|20|||
161937393|NCT05028517|584820315|FG002|Overall Study|Lost to Follow-up|12|||
161937394|NCT05028517|584820313|FG000|Overall Study|Withdrawal by Subject|0|||
161937395|NCT05028517|584820314|FG001|Overall Study|Withdrawal by Subject|0|||
161937396|NCT05028517|584820315|FG002|Overall Study|Withdrawal by Subject|1|||
161937397|NCT05089656|584820316|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
161937398|NCT05089656|584820317|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
161937399|NCT05089656|584820316|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
161937400|NCT05089656|584820317|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
161937401|NCT05089656|584820316|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
161937402|NCT05089656|584820317|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
161937403|NCT05089656|584820316|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
161937404|NCT05089656|584820317|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
161937405|NCT02535416|584820322|FG000|Overall Study|Family bereavement overseas|1|||
161937406|NCT02535416|584820323|FG001|Overall Study|Family bereavement overseas|0|||
161591471|NCT01997840|583554677|FG002|Overall Study|Other reasons|1|||
161591472|NCT01997840|583554678|FG003|Overall Study|Other reasons|0|||
161591473|NCT01997840|583554675|FG000|Overall Study|Adverse Event|0|||
161591474|NCT01997840|583554676|FG001|Overall Study|Adverse Event|0|||
161591475|NCT01997840|583554677|FG002|Overall Study|Adverse Event|15|||
161591476|NCT01997840|583554678|FG003|Overall Study|Adverse Event|2|||
161591477|NCT03850678|583554679|FG000|Overall Study|Withdrawal by Subject|3|||
161591478|NCT03850678|583554680|FG001|Overall Study|Withdrawal by Subject|0|||
161591479|NCT03850678|583554679|FG000|Overall Study|Experimenter Error|1|||
161591480|NCT03850678|583554680|FG001|Overall Study|Experimenter Error|1|||
161591481|NCT03850678|583554679|FG000|Overall Study|Did Not Condition To Experiment|7|||
161591482|NCT03850678|583554680|FG001|Overall Study|Did Not Condition To Experiment|2|||
161591483|NCT02724631|583554690|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
161591484|NCT02908477|583554691|FG000|Overall Study|Withdrawal by Subject|8|||
161591485|NCT02908477|583554692|FG001|Overall Study|Withdrawal by Subject|28|||
161591486|NCT03766009|583554700|FG000|Usual Care|Death|0|||
161591487|NCT03766009|583554701|FG001|Usual Care|Death|0|||
161591488|NCT03766009|583554702|FG002|Usual Care|Death|0|||
161591489|NCT03766009|583554703|FG003|Usual Care|Death|1|||
161591490|NCT03766009|583554704|FG004|Usual Care|Death|0|||
161591491|NCT03766009|583554705|FG005|Usual Care|Death|0|||
161591492|NCT03766009|583554700|FG000|Usual Care|Lost to Follow-up|0|||
161591493|NCT03766009|583554701|FG001|Usual Care|Lost to Follow-up|0|||
161591494|NCT03766009|583554702|FG002|Usual Care|Lost to Follow-up|0|||
161591495|NCT03766009|583554703|FG003|Usual Care|Lost to Follow-up|1|||
161591496|NCT03766009|583554704|FG004|Usual Care|Lost to Follow-up|0|||
161591497|NCT03766009|583554705|FG005|Usual Care|Lost to Follow-up|0|||
161937407|NCT02535416|584820324|FG002|Overall Study|Family bereavement overseas|0|||
161937408|NCT02535416|584820325|FG003|Overall Study|Family bereavement overseas|0|||
161937409|NCT02535416|584820326|FG004|Overall Study|Family bereavement overseas|0|||
161937410|NCT02535416|584820327|FG005|Overall Study|Family bereavement overseas|0|||
161937411|NCT02535416|584820328|FG006|Overall Study|Family bereavement overseas|0|||
161937412|NCT02535416|584820329|FG007|Overall Study|Family bereavement overseas|0|||
161937413|NCT02535416|584820330|FG008|Overall Study|Family bereavement overseas|0|||
161937414|NCT04514341|584820331|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
161937415|NCT04514341|584820332|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
161937416|NCT04514341|584820331|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
161937417|NCT04514341|584820332|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
161937418|NCT04573881|584820333|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
161591498|NCT03766009|583554700|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
161591499|NCT03766009|583554701|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
161591500|NCT03766009|583554702|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
161591501|NCT03766009|583554703|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
161591502|NCT03766009|583554704|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
161591503|NCT03766009|583554705|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
161531361|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|disease progression|47|||
161531362|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|Death|3|||
161531363|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|Death|6|||
161531364|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
161531365|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
161531366|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
161531367|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
161531368|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
161531369|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
161531370|NCT02472964|583333158|FG000|Part 1 (up to Week 24)|Other|2|||
161591504|NCT03766009|583554700|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161591505|NCT03766009|583554701|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161591506|NCT03766009|583554702|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161591507|NCT03766009|583554703|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161591508|NCT03766009|583554704|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161591509|NCT03766009|583554705|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161531371|NCT02472964|583333159|FG001|Part 1 (up to Week 24)|Other|1|||
161591510|NCT03766009|583554700|FG000|Usual Care|No treatment or declined surgery|0|||
161828031|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
161828032|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
161828033|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
161828034|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
161828035|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
161828036|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
161828037|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
161828038|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
161828039|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
161828040|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
161828041|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
161828042|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
161828043|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
161828044|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
161828045|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
161828046|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
161828047|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
161531372|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
161531373|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
161531374|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
161531375|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
161531376|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Death|0|||
161531377|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Death|1|||
161531378|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
161531379|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
161531380|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
161531381|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
161531382|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
161531383|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
161531384|NCT02472964|583333158|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
161531385|NCT02472964|583333159|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
161531386|NCT01454583|583333160|FG000|1st Year|Lost to Follow-up|1057|||
161531387|NCT01454583|583333161|FG001|1st Year|Lost to Follow-up|318|||
161828048|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
161828049|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
161828050|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
161828051|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
161828052|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
161828053|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
161828054|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
161828055|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
161828056|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
161828057|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
161828058|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
161828059|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
161828060|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
161828061|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
161828062|NCT01264835|584411481|FG000|Overall Study|Lost to Follow-up|1|||
161828063|NCT01557920|584411486|FG000|Overall Study|Withdrawal by Subject|2|||
161828064|NCT01557920|584411487|FG001|Overall Study|Withdrawal by Subject|3|||
161828065|NCT01557920|584411486|FG000|Overall Study|Lack of Efficacy|1|||
161828066|NCT01557920|584411487|FG001|Overall Study|Lack of Efficacy|0|||
161828067|NCT01466036|584411488|FG000|Overall Study|Death|1|||
161828068|NCT01466036|584411489|FG001|Overall Study|Death|1|||
161828069|NCT01466036|584411488|FG000|Overall Study|Physician Decision|0|||
161828070|NCT01466036|584411489|FG001|Overall Study|Physician Decision|4|||
161828071|NCT01466036|584411488|FG000|Overall Study|Adverse Event|2|||
161828072|NCT01466036|584411489|FG001|Overall Study|Adverse Event|6|||
161828073|NCT01466036|584411488|FG000|Overall Study|Withdrawal by Subject|2|||
161828074|NCT01466036|584411489|FG001|Overall Study|Withdrawal by Subject|8|||
161828075|NCT01466036|584411488|FG000|Overall Study|progression/relapse|14|||
161828076|NCT01466036|584411489|FG001|Overall Study|progression/relapse|21|||
161828077|NCT01466036|584411488|FG000|Overall Study|prolonged treatment delay|1|||
161828078|NCT01466036|584411489|FG001|Overall Study|prolonged treatment delay|1|||
161828079|NCT00220727|584411518|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
161828080|NCT00220727|584411519|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
161828081|NCT02508116|584411522|FG000|Overall Study|Lost to Follow-up|2|||
161828082|NCT02508116|584411523|FG001|Overall Study|Lost to Follow-up|3|||
161828083|NCT02508116|584411522|FG000|Overall Study|Withdrawal by Subject|3|||
161828084|NCT02508116|584411523|FG001|Overall Study|Withdrawal by Subject|2|||
161828085|NCT02508116|584411522|FG000|Overall Study|Protocol Violation|1|||
161828086|NCT02508116|584411523|FG001|Overall Study|Protocol Violation|2|||
161828087|NCT02508116|584411522|FG000|Overall Study|Physician Decision|2|||
161828088|NCT02508116|584411523|FG001|Overall Study|Physician Decision|0|||
161828089|NCT00109850|584411527|FG000|Overall Study|Adverse Event|1|||
161828090|NCT00109850|584411527|FG000|Overall Study|Death|2|||
161828091|NCT00109850|584411527|FG000|Overall Study|Ineligible|1|||
161828092|NCT00476593|584411528|FG000|Overall Study|Lost to Follow-up|10|||
161828093|NCT00476593|584411529|FG001|Overall Study|Lost to Follow-up|2|||
161828094|NCT00476593|584411530|FG002|Overall Study|Lost to Follow-up|8|||
161828095|NCT00476593|584411531|FG003|Overall Study|Lost to Follow-up|22|||
161828096|NCT03430011|584411532|FG000|Pre-Treatment|Death|1|||
161828097|NCT03430011|584411533|FG001|Pre-Treatment|Death|0|||
161828098|NCT03430011|584411534|FG002|Pre-Treatment|Death|0|||
161828099|NCT03430011|584411535|FG003|Pre-Treatment|Death|0|||
161828100|NCT03430011|584411536|FG004|Pre-Treatment|Death|1|||
161828101|NCT03430011|584411537|FG005|Pre-Treatment|Death|0|||
161828102|NCT03430011|584411538|FG006|Pre-Treatment|Death|1|||
161828103|NCT03430011|584411539|FG007|Pre-Treatment|Death|0|||
161828104|NCT03430011|584411532|FG000|Pre-Treatment|Screen Fail|0|||
161828105|NCT03430011|584411533|FG001|Pre-Treatment|Screen Fail|0|||
161828106|NCT03430011|584411534|FG002|Pre-Treatment|Screen Fail|0|||
161828107|NCT03430011|584411535|FG003|Pre-Treatment|Screen Fail|0|||
161828108|NCT03430011|584411536|FG004|Pre-Treatment|Screen Fail|1|||
161828109|NCT03430011|584411537|FG005|Pre-Treatment|Screen Fail|0|||
161828110|NCT03430011|584411538|FG006|Pre-Treatment|Screen Fail|0|||
161828111|NCT03430011|584411539|FG007|Pre-Treatment|Screen Fail|0|||
161828112|NCT03430011|584411532|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828113|NCT03430011|584411533|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828114|NCT03430011|584411534|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
161828115|NCT03430011|584411535|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828116|NCT03430011|584411536|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828117|NCT03430011|584411537|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828118|NCT03430011|584411538|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828119|NCT03430011|584411539|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828120|NCT03430011|584411532|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
161828121|NCT03430011|584411533|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
161828122|NCT03430011|584411534|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
161828123|NCT03430011|584411535|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
161828124|NCT03430011|584411536|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
161828125|NCT03430011|584411537|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
161531388|NCT01454583|583333162|FG002|1st Year|Lost to Follow-up|180|||
161531389|NCT01454583|583333160|FG000|2nd Year|Lost to Follow-up|3965|||
161531390|NCT01454583|583333161|FG001|2nd Year|Lost to Follow-up|1049|||
161531391|NCT01454583|583333162|FG002|2nd Year|Lost to Follow-up|737|||
161531392|NCT01454583|583333160|FG000|3rd Year|Lost to Follow-up|1959|||
161531393|NCT01454583|583333161|FG001|3rd Year|Lost to Follow-up|512|||
161531394|NCT01454583|583333162|FG002|3rd Year|Lost to Follow-up|297|||
161531395|NCT04330638|583333165|FG000|Overall Study|Adverse Event|9|||
161531396|NCT04330638|583333166|FG001|Overall Study|Adverse Event|10|||
161531397|NCT04330638|583333167|FG002|Overall Study|Adverse Event|15|||
161531398|NCT04330638|583333168|FG003|Overall Study|Adverse Event|6|||
161531399|NCT04330638|583333169|FG004|Overall Study|Adverse Event|10|||
161531400|NCT04330638|583333170|FG005|Overall Study|Adverse Event|5|||
161531401|NCT04330638|583333165|FG000|Overall Study|Other|2|||
161531402|NCT04330638|583333166|FG001|Overall Study|Other|2|||
161531403|NCT04330638|583333167|FG002|Overall Study|Other|5|||
161531404|NCT04330638|583333168|FG003|Overall Study|Other|1|||
161531405|NCT04330638|583333169|FG004|Overall Study|Other|3|||
161531406|NCT04330638|583333170|FG005|Overall Study|Other|2|||
161531407|NCT04330638|583333165|FG000|Overall Study|Withdrawal by Subject|4|||
161828126|NCT03430011|584411538|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
161828127|NCT03430011|584411539|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
161828128|NCT03430011|584411532|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
161828129|NCT03430011|584411533|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
161828130|NCT03430011|584411534|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
161828131|NCT03430011|584411535|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
161828132|NCT03430011|584411536|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
161828133|NCT03430011|584411537|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
161828134|NCT03430011|584411538|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
161828135|NCT03430011|584411539|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
161828136|NCT03430011|584411532|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
161828137|NCT03430011|584411533|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
161828138|NCT03430011|584411534|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
161828139|NCT03430011|584411535|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
161828140|NCT03430011|584411536|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
161828141|NCT03430011|584411537|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
161828142|NCT03430011|584411538|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
161828143|NCT03430011|584411539|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
161828144|NCT03430011|584411532|FG000|JCARH125 Treatment|Death|4|||
161828145|NCT03430011|584411533|FG001|JCARH125 Treatment|Death|19|||
161828146|NCT03430011|584411534|FG002|JCARH125 Treatment|Death|10|||
161828147|NCT03430011|584411535|FG003|JCARH125 Treatment|Death|8|||
161828148|NCT03430011|584411536|FG004|JCARH125 Treatment|Death|5|||
161828149|NCT03430011|584411537|FG005|JCARH125 Treatment|Death|3|||
161828150|NCT03430011|584411538|FG006|JCARH125 Treatment|Death|4|||
161828151|NCT03430011|584411539|FG007|JCARH125 Treatment|Death|2|||
161828152|NCT03430011|584411532|FG000|JCARH125 Treatment|Other reasons|1|||
161828153|NCT03430011|584411533|FG001|JCARH125 Treatment|Other reasons|0|||
161828154|NCT03430011|584411534|FG002|JCARH125 Treatment|Other reasons|4|||
161828155|NCT03430011|584411535|FG003|JCARH125 Treatment|Other reasons|2|||
161828156|NCT03430011|584411536|FG004|JCARH125 Treatment|Other reasons|2|||
161828157|NCT03430011|584411537|FG005|JCARH125 Treatment|Other reasons|1|||
161828158|NCT03430011|584411538|FG006|JCARH125 Treatment|Other reasons|3|||
161828159|NCT03430011|584411539|FG007|JCARH125 Treatment|Other reasons|2|||
161828160|NCT00559364|584411541|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
161828161|NCT00559364|584411542|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
161828162|NCT04126343|584411543|FG000|Overall Study|Adverse Event|0|||
161828163|NCT04126343|584411544|FG001|Overall Study|Adverse Event|0|||
161828164|NCT04126343|584411545|FG002|Overall Study|Adverse Event|0|||
161828165|NCT04126343|584411546|FG003|Overall Study|Adverse Event|0|||
161828166|NCT04126343|584411547|FG004|Overall Study|Adverse Event|0|||
161828167|NCT04126343|584411548|FG005|Overall Study|Adverse Event|1|||
161828168|NCT04126343|584411543|FG000|Overall Study|Withdrawal by Subject|0|||
161828169|NCT04126343|584411544|FG001|Overall Study|Withdrawal by Subject|0|||
161828170|NCT04126343|584411545|FG002|Overall Study|Withdrawal by Subject|0|||
161828171|NCT04126343|584411546|FG003|Overall Study|Withdrawal by Subject|1|||
161828172|NCT04126343|584411547|FG004|Overall Study|Withdrawal by Subject|0|||
161828173|NCT04126343|584411548|FG005|Overall Study|Withdrawal by Subject|0|||
161828174|NCT04126343|584411543|FG000|Overall Study|Related to COVID-19 pandemic|3|||
161828175|NCT04126343|584411544|FG001|Overall Study|Related to COVID-19 pandemic|4|||
161828176|NCT04126343|584411545|FG002|Overall Study|Related to COVID-19 pandemic|3|||
161828177|NCT04126343|584411546|FG003|Overall Study|Related to COVID-19 pandemic|3|||
161828178|NCT04126343|584411547|FG004|Overall Study|Related to COVID-19 pandemic|3|||
161828179|NCT04126343|584411548|FG005|Overall Study|Related to COVID-19 pandemic|3|||
161828180|NCT01235442|584411549|FG000|Overall Study|Lost to Follow-up|12|||
161828181|NCT01235442|584411550|FG001|Overall Study|Lost to Follow-up|10|||
161828182|NCT01235442|584411549|FG000|Overall Study|Death|0|||
161828183|NCT01235442|584411550|FG001|Overall Study|Death|2|||
161828184|NCT01235442|584411549|FG000|Overall Study|Pregnancy|1|||
161828185|NCT01235442|584411550|FG001|Overall Study|Pregnancy|1|||
161828186|NCT01235442|584411549|FG000|Overall Study|Ineligibility determined|5|||
161828187|NCT01235442|584411550|FG001|Overall Study|Ineligibility determined|4|||
161828188|NCT01235442|584411549|FG000|Overall Study|Protocol Violation|3|||
161828189|NCT01235442|584411550|FG001|Overall Study|Protocol Violation|3|||
161828190|NCT01235442|584411549|FG000|Overall Study|Adverse Event|4|||
161828191|NCT01235442|584411550|FG001|Overall Study|Adverse Event|6|||
161828192|NCT01235442|584411549|FG000|Overall Study|Withdrawal by Subject|15|||
161828193|NCT01235442|584411550|FG001|Overall Study|Withdrawal by Subject|9|||
161828194|NCT01235442|584411549|FG000|Overall Study|Lack of Efficacy|1|||
161828195|NCT01235442|584411550|FG001|Overall Study|Lack of Efficacy|3|||
161828196|NCT01235442|584411549|FG000|Overall Study|Noncompliance|1|||
161828197|NCT01235442|584411550|FG001|Overall Study|Noncompliance|2|||
161828198|NCT01235442|584411549|FG000|Overall Study|Administrative decision|1|||
161828199|NCT01235442|584411550|FG001|Overall Study|Administrative decision|2|||
161828200|NCT01235442|584411549|FG000|Overall Study|Other unspecified|1|||
161828201|NCT01235442|584411550|FG001|Overall Study|Other unspecified|2|||
161828202|NCT00330460|584411555|FG000|Overall Study|Physician Decision|1|||
161828203|NCT00330460|584411556|FG001|Overall Study|Physician Decision|0|||
161828204|NCT00330460|584411555|FG000|Overall Study|Adverse Event|10|||
161828205|NCT00330460|584411556|FG001|Overall Study|Adverse Event|8|||
161828206|NCT00330460|584411555|FG000|Overall Study|Withdrawal by Subject|18|||
161828207|NCT00330460|584411556|FG001|Overall Study|Withdrawal by Subject|17|||
161828208|NCT00330460|584411555|FG000|Overall Study|Death|1|||
161828209|NCT00330460|584411556|FG001|Overall Study|Death|1|||
161828210|NCT00330460|584411555|FG000|Overall Study|Ineligibility determined|1|||
161828211|NCT00330460|584411556|FG001|Overall Study|Ineligibility determined|3|||
161828212|NCT00330460|584411555|FG000|Overall Study|Lost to Follow-up|8|||
161828213|NCT00330460|584411556|FG001|Overall Study|Lost to Follow-up|3|||
161828214|NCT00330460|584411555|FG000|Overall Study|Noncompliance|2|||
161828215|NCT00330460|584411556|FG001|Overall Study|Noncompliance|1|||
161828216|NCT00330460|584411555|FG000|Overall Study|Other|1|||
161828217|NCT00330460|584411556|FG001|Overall Study|Other|0|||
161828218|NCT01857973|584411561|FG000|Overall Study|Subject did not meet required BG range|3|||
161828219|NCT01857973|584411561|FG000|Overall Study|drop out after 3 failed attempts|1|||
161828220|NCT01857973|584411561|FG000|Overall Study|Physician Decision|1|||
161828221|NCT01701973|584411564|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828222|NCT01701973|584411565|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
161828223|NCT01701973|584411566|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828224|NCT01701973|584411567|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828225|NCT01701973|584411568|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828226|NCT01701973|584411569|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828227|NCT01701973|584411570|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828228|NCT01701973|584411571|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828229|NCT02663882|584411572|FG000|Overall Study|Lost to Follow-up|4|||
161828230|NCT02663882|584411573|FG001|Overall Study|Lost to Follow-up|2|||
161828231|NCT03712124|584411576|FG000|Overall Study|Protocol Violation|1|||
161828232|NCT03712124|584411577|FG001|Overall Study|Protocol Violation|0|||
161828233|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
161828234|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
161828235|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
161828236|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
161828237|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
161828238|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
161828239|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
161828240|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
161828241|NCT00602537|584411581|FG000|Follow Up Study Comparison|Adverse Event|1|||
161828242|NCT00602537|584411582|FG001|Follow Up Study Comparison|Adverse Event|0|||
161828243|NCT00602537|584411581|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
161828244|NCT00602537|584411582|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
161828245|NCT00602537|584411581|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
161828246|NCT00602537|584411582|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
161828247|NCT00388037|584411583|FG000|Overall Study|Protocol Violation|1|||
161828248|NCT04314843|584411584|FG000|Overall Study|Death|2|||
161828249|NCT04314843|584411585|FG001|Overall Study|Death|2|||
161828250|NCT04314843|584411584|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
161828251|NCT04314843|584411585|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
161828252|NCT00869440|584411586|FG000|Overall Study|Withdrawal by Subject|1|||
161828253|NCT00869440|584411587|FG001|Overall Study|Withdrawal by Subject|0|||
161828254|NCT00869440|584411588|FG002|Overall Study|Withdrawal by Subject|0|||
161828255|NCT00869440|584411589|FG003|Overall Study|Withdrawal by Subject|0|||
161828256|NCT00869440|584411586|FG000|Overall Study|Physician Decision|1|||
161828257|NCT00869440|584411587|FG001|Overall Study|Physician Decision|1|||
161828258|NCT00869440|584411588|FG002|Overall Study|Physician Decision|0|||
161828259|NCT00869440|584411589|FG003|Overall Study|Physician Decision|0|||
161828260|NCT01899326|584411591|FG000|Overall Study|Withdrawal by Subject|1|||
161828261|NCT01899326|584411591|FG000|Overall Study|Adverse Event|2|||
161828262|NCT01899326|584411591|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
161828263|NCT01435031|584411592|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
161828264|NCT01435031|584411592|FG000|ITT at 1 Month|Death|1|||
161828265|NCT01435031|584411592|FG000|ITT at 1 Month|Lost to Follow-up|4|||
161828266|NCT01435031|584411592|FG000|ITT at 6 Months|Death|2|||
161828267|NCT01435031|584411592|FG000|ITT at 6 Months|Lost to Follow-up|3|||
161828268|NCT01435031|584411592|FG000|ITT at 1 Year|Death|1|||
161828269|NCT01435031|584411592|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
161828270|NCT01435031|584411592|FG000|ITT at 1 Year|Lost to Follow-up|6|||
161828271|NCT01435031|584411592|FG000|ITT at 2 Years|Death|7|||
161828272|NCT01435031|584411592|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
161828273|NCT01435031|584411592|FG000|ITT at 2 Years|Lost to Follow-up|4|||
161828274|NCT01435031|584411592|FG000|ITT at 3 Years|Death|5|||
161828275|NCT01435031|584411592|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
161828276|NCT01435031|584411592|FG000|ITT at 3 Years|Lost to Follow-up|4|||
161678522|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
161678523|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
161678524|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Ineligible|3|||
161678525|NCT00066742|583876000|FG000|Consolidation Chemotherapy|not protocol specified|1|||
161678526|NCT00066742|583876000|FG000|Consolidation Chemotherapy|Ineligible|2|||
161678527|NCT02357134|583876001|FG000|Overall Study|Lost to Follow-up|1|||
161678528|NCT02357134|583876002|FG001|Overall Study|Lost to Follow-up|0|||
161678529|NCT02357134|583876003|FG002|Overall Study|Lost to Follow-up|0|||
161678530|NCT02357134|583876004|FG003|Overall Study|Lost to Follow-up|0|||
161678531|NCT02716675|583876005|FG000|Overall Study|Death|2|||
161678532|NCT02716675|583876006|FG001|Overall Study|Death|3|||
161678533|NCT02716675|583876007|FG002|Overall Study|Death|0|||
161678534|NCT02716675|583876005|FG000|Overall Study|Physician Decision|2|||
161678535|NCT02716675|583876006|FG001|Overall Study|Physician Decision|1|||
161678536|NCT02716675|583876007|FG002|Overall Study|Physician Decision|1|||
161828277|NCT01435031|584411592|FG000|ITT at 4 Years|Death|4|||
161828278|NCT01435031|584411592|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
161828279|NCT01435031|584411592|FG000|ITT at 4 Years|Lost to Follow-up|1|||
161678537|NCT02716675|583876005|FG000|Overall Study|Lost to Follow-up|100|||
161678538|NCT02716675|583876006|FG001|Overall Study|Lost to Follow-up|87|||
161678539|NCT02716675|583876007|FG002|Overall Study|Lost to Follow-up|99|||
161678540|NCT02716675|583876005|FG000|Overall Study|Withdrawal by Subject|22|||
161678541|NCT02716675|583876006|FG001|Overall Study|Withdrawal by Subject|25|||
161828280|NCT00104247|584411593|FG000|Overall Study|Withdrawal by Subject|1|||
161828281|NCT00104247|584411594|FG001|Overall Study|Withdrawal by Subject|0|||
161828282|NCT00104247|584411593|FG000|Overall Study|Noncompliant with dosing|0|||
161828283|NCT00104247|584411594|FG001|Overall Study|Noncompliant with dosing|1|||
161828284|NCT03718117|584411596|FG000|Overall Study|Death|12|||
161828285|NCT03718117|584411597|FG001|Overall Study|Death|11|||
161828286|NCT03718117|584411598|FG002|Overall Study|Death|0|||
161828287|NCT03718117|584411596|FG000|Overall Study|Other|0|||
161828288|NCT03718117|584411597|FG001|Overall Study|Other|1|||
161828289|NCT03718117|584411598|FG002|Overall Study|Other|0|||
161828290|NCT03718117|584411596|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
161828291|NCT03718117|584411597|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
161828292|NCT03718117|584411598|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
161828293|NCT03718117|584411596|FG000|Overall Study|Participant not met eligibility criteria|0|||
161828294|NCT03718117|584411597|FG001|Overall Study|Participant not met eligibility criteria|0|||
161828295|NCT03718117|584411598|FG002|Overall Study|Participant not met eligibility criteria|2|||
161828296|NCT02030535|584411599|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
161828297|NCT01588548|584411600|FG000|Overall Study|Withdrawal by Subject|0|||
161828298|NCT01588548|584411601|FG001|Overall Study|Withdrawal by Subject|1|||
161828299|NCT01588548|584411602|FG002|Overall Study|Withdrawal by Subject|1|||
161828300|NCT01588548|584411603|FG003|Overall Study|Withdrawal by Subject|1|||
161828301|NCT01588548|584411604|FG004|Overall Study|Withdrawal by Subject|2|||
161828302|NCT01588548|584411605|FG005|Overall Study|Withdrawal by Subject|3|||
161828303|NCT01588548|584411600|FG000|Overall Study|Adverse Event|0|||
161828304|NCT01588548|584411601|FG001|Overall Study|Adverse Event|0|||
161828305|NCT01588548|584411602|FG002|Overall Study|Adverse Event|1|||
161828306|NCT01588548|584411603|FG003|Overall Study|Adverse Event|2|||
161828307|NCT01588548|584411604|FG004|Overall Study|Adverse Event|1|||
161828308|NCT01588548|584411605|FG005|Overall Study|Adverse Event|0|||
161828309|NCT01588548|584411600|FG000|Overall Study|Condition Under Investigation Worsened|3|||
161828310|NCT01588548|584411601|FG001|Overall Study|Condition Under Investigation Worsened|6|||
161828311|NCT01588548|584411602|FG002|Overall Study|Condition Under Investigation Worsened|4|||
161828312|NCT01588548|584411603|FG003|Overall Study|Condition Under Investigation Worsened|4|||
161828313|NCT01588548|584411604|FG004|Overall Study|Condition Under Investigation Worsened|3|||
161828314|NCT01588548|584411605|FG005|Overall Study|Condition Under Investigation Worsened|3|||
161828315|NCT01835548|584411608|FG000|Dose Optimization Period|Adverse Event|0|||
161828316|NCT01835548|584411609|FG001|Dose Optimization Period|Adverse Event|0|||
161828317|NCT01835548|584411610|FG002|Dose Optimization Period|Adverse Event|1|||
161828318|NCT01835548|584411608|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
161828319|NCT01835548|584411609|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
161828320|NCT01835548|584411610|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
161828321|NCT01835548|584411608|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161828322|NCT01835548|584411609|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161828323|NCT01835548|584411610|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161828324|NCT01835548|584411608|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161828325|NCT01835548|584411609|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161828326|NCT01835548|584411610|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161828327|NCT01169038|584411611|FG000|Overall Study|Death|1|||
161828328|NCT01169038|584411611|FG000|Overall Study|Adverse Event|5|||
161828329|NCT01169038|584411611|FG000|Overall Study|Required antibiotic administration|1|||
161828330|NCT01634854|584411612|FG000|Overall Study|Cesarean delivery|2|||
161828331|NCT01634854|584411613|FG001|Overall Study|Cesarean delivery|7|||
161828332|NCT02490800|584411614|FG000|Overall Study|Adverse Event|0|||
161828333|NCT02490800|584411615|FG001|Overall Study|Adverse Event|0|||
161828334|NCT02490800|584411616|FG002|Overall Study|Adverse Event|0|||
161828335|NCT02490800|584411617|FG003|Overall Study|Adverse Event|2|||
161828336|NCT02490800|584411618|FG004|Overall Study|Adverse Event|3|||
161828337|NCT02490800|584411619|FG005|Overall Study|Adverse Event|2|||
161828338|NCT02490800|584411620|FG006|Overall Study|Adverse Event|0|||
161828339|NCT02490800|584411621|FG007|Overall Study|Adverse Event|0|||
161828340|NCT02490800|584411622|FG008|Overall Study|Adverse Event|0|||
161828341|NCT02490800|584411623|FG009|Overall Study|Adverse Event|0|||
161828342|NCT02490800|584411624|FG010|Overall Study|Adverse Event|0|||
161828343|NCT02490800|584411625|FG011|Overall Study|Adverse Event|2|||
161828344|NCT02490800|584411626|FG012|Overall Study|Adverse Event|2|||
161828345|NCT02490800|584411614|FG000|Overall Study|Withdrawal by Subject|0|||
161828346|NCT02490800|584411615|FG001|Overall Study|Withdrawal by Subject|0|||
161828347|NCT02490800|584411616|FG002|Overall Study|Withdrawal by Subject|0|||
161828348|NCT02490800|584411617|FG003|Overall Study|Withdrawal by Subject|1|||
161828349|NCT02490800|584411618|FG004|Overall Study|Withdrawal by Subject|0|||
161828350|NCT02490800|584411619|FG005|Overall Study|Withdrawal by Subject|0|||
161828351|NCT02490800|584411620|FG006|Overall Study|Withdrawal by Subject|0|||
161828352|NCT02490800|584411621|FG007|Overall Study|Withdrawal by Subject|0|||
161828353|NCT02490800|584411622|FG008|Overall Study|Withdrawal by Subject|1|||
161828354|NCT02490800|584411623|FG009|Overall Study|Withdrawal by Subject|0|||
161828355|NCT02490800|584411624|FG010|Overall Study|Withdrawal by Subject|0|||
161828356|NCT02490800|584411625|FG011|Overall Study|Withdrawal by Subject|0|||
161531408|NCT04330638|583333166|FG001|Overall Study|Withdrawal by Subject|0|||
161531409|NCT04330638|583333167|FG002|Overall Study|Withdrawal by Subject|0|||
161531410|NCT04330638|583333168|FG003|Overall Study|Withdrawal by Subject|0|||
161531411|NCT04330638|583333169|FG004|Overall Study|Withdrawal by Subject|0|||
161531412|NCT04330638|583333170|FG005|Overall Study|Withdrawal by Subject|0|||
161531413|NCT04330638|583333165|FG000|Overall Study|Lost to Follow-up|3|||
161531414|NCT04330638|583333166|FG001|Overall Study|Lost to Follow-up|2|||
161531415|NCT04330638|583333167|FG002|Overall Study|Lost to Follow-up|3|||
161531416|NCT04330638|583333168|FG003|Overall Study|Lost to Follow-up|2|||
161531417|NCT04330638|583333169|FG004|Overall Study|Lost to Follow-up|3|||
161531418|NCT04330638|583333170|FG005|Overall Study|Lost to Follow-up|0|||
161531419|NCT01967732|583333172|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
161531420|NCT01967732|583333173|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
161531421|NCT01967732|583333174|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
161531422|NCT01967732|583333175|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
161531423|NCT01967732|583333172|FG000|First Intervention (Day 1)|Poor venous access|0|||
161531424|NCT01967732|583333173|FG001|First Intervention (Day 1)|Poor venous access|1|||
161531425|NCT01967732|583333174|FG002|First Intervention (Day 1)|Poor venous access|0|||
161531426|NCT01967732|583333175|FG003|First Intervention (Day 1)|Poor venous access|0|||
161531427|NCT01988779|583333184|FG000|Overall Study|Withdrawal by Subject|2|||
161531428|NCT01988779|583333185|FG001|Overall Study|Withdrawal by Subject|2|||
161828357|NCT02490800|584411626|FG012|Overall Study|Withdrawal by Subject|0|||
161828358|NCT02490800|584411614|FG000|Overall Study|Progressive disease|3|||
161828359|NCT02490800|584411615|FG001|Overall Study|Progressive disease|3|||
161828360|NCT02490800|584411616|FG002|Overall Study|Progressive disease|3|||
161828361|NCT02490800|584411617|FG003|Overall Study|Progressive disease|4|||
161828362|NCT02490800|584411618|FG004|Overall Study|Progressive disease|4|||
161828363|NCT02490800|584411619|FG005|Overall Study|Progressive disease|1|||
161828364|NCT02490800|584411620|FG006|Overall Study|Progressive disease|4|||
161828365|NCT02490800|584411621|FG007|Overall Study|Progressive disease|3|||
161828366|NCT02490800|584411622|FG008|Overall Study|Progressive disease|6|||
161828367|NCT02490800|584411623|FG009|Overall Study|Progressive disease|2|||
161531429|NCT01988779|583333184|FG000|Overall Study|Protocol Violation|1|||
161531430|NCT01988779|583333185|FG001|Overall Study|Protocol Violation|0|||
161531431|NCT00377403|583333186|FG000|Overall Study|Unable to contact for telephone intervie|4|||
161531432|NCT00377403|583333187|FG001|Overall Study|Unable to contact for telephone intervie|7|||
161531433|NCT02275065|583333188|FG000|Overall Study|Randomized but not treated|1|||
161531434|NCT02275065|583333189|FG001|Overall Study|Randomized but not treated|0|||
161531435|NCT02275065|583333190|FG002|Overall Study|Randomized but not treated|1|||
161531436|NCT02275065|583333191|FG003|Overall Study|Randomized but not treated|1|||
161531437|NCT02275065|583333192|FG004|Overall Study|Randomized but not treated|0|||
161531438|NCT00417079|583333194|FG000|Overall Study|Disease progression|267|||
161531439|NCT00417079|583333195|FG001|Overall Study|Disease progression|180|||
161531440|NCT00417079|583333194|FG000|Overall Study|Adverse Event|32|||
161531441|NCT00417079|583333195|FG001|Overall Study|Adverse Event|67|||
161531442|NCT00417079|583333194|FG000|Overall Study|Non-compliance to protocol|0|||
161531443|NCT00417079|583333195|FG001|Overall Study|Non-compliance to protocol|1|||
161531444|NCT00417079|583333194|FG000|Overall Study|Lost to Follow-up|2|||
161531445|NCT00417079|583333195|FG001|Overall Study|Lost to Follow-up|0|||
161828368|NCT02490800|584411624|FG010|Overall Study|Progressive disease|7|||
161828369|NCT02490800|584411625|FG011|Overall Study|Progressive disease|1|||
161828370|NCT02490800|584411626|FG012|Overall Study|Progressive disease|10|||
161531446|NCT00417079|583333194|FG000|Overall Study|Withdrawal by Subject|17|||
161531447|NCT00417079|583333195|FG001|Overall Study|Withdrawal by Subject|8|||
161531448|NCT00417079|583333194|FG000|Overall Study|Not treated|6|||
161531449|NCT00417079|583333195|FG001|Overall Study|Not treated|7|||
161531450|NCT00417079|583333194|FG000|Overall Study|Screened failure|2|||
161531451|NCT00417079|583333195|FG001|Overall Study|Screened failure|1|||
161531452|NCT00417079|583333194|FG000|Overall Study|Investigator's decision|1|||
161531453|NCT00417079|583333195|FG001|Overall Study|Investigator's decision|4|||
161531454|NCT00417079|583333194|FG000|Overall Study|Non-confirmed Disease progression|1|||
161531455|NCT00417079|583333195|FG001|Overall Study|Non-confirmed Disease progression|1|||
161531456|NCT00417079|583333194|FG000|Overall Study|Clinical deterioration|1|||
161531457|NCT00417079|583333195|FG001|Overall Study|Clinical deterioration|0|||
161531458|NCT00417079|583333194|FG000|Overall Study|Screening error|2|||
161531459|NCT00417079|583333195|FG001|Overall Study|Screening error|1|||
161531460|NCT00417079|583333194|FG000|Overall Study|Withdrawal by subject's family|0|||
161531461|NCT00417079|583333195|FG001|Overall Study|Withdrawal by subject's family|1|||
161531462|NCT00417079|583333194|FG000|Overall Study|Patient unable to come to the clinic|0|||
161531463|NCT00417079|583333195|FG001|Overall Study|Patient unable to come to the clinic|1|||
161531464|NCT00417079|583333194|FG000|Overall Study|abnormal liver function tests|0|||
161531465|NCT00417079|583333195|FG001|Overall Study|abnormal liver function tests|1|||
161531466|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
161531467|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
161531468|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
161531469|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
161531470|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
161531471|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
161531472|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
161531473|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
161531474|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
161531475|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
161531476|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
161828371|NCT02490800|584411614|FG000|Overall Study|Patient enrolled in post-trial access|0|||
161531477|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
161531478|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
161531479|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
161531480|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
161531481|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
161531482|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
161531483|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
161828372|NCT02490800|584411615|FG001|Overall Study|Patient enrolled in post-trial access|0|||
161828373|NCT02490800|584411616|FG002|Overall Study|Patient enrolled in post-trial access|0|||
161828374|NCT02490800|584411617|FG003|Overall Study|Patient enrolled in post-trial access|0|||
161828375|NCT02490800|584411618|FG004|Overall Study|Patient enrolled in post-trial access|0|||
161828376|NCT02490800|584411619|FG005|Overall Study|Patient enrolled in post-trial access|0|||
161828377|NCT02490800|584411620|FG006|Overall Study|Patient enrolled in post-trial access|0|||
161828378|NCT02490800|584411621|FG007|Overall Study|Patient enrolled in post-trial access|0|||
161828379|NCT02490800|584411622|FG008|Overall Study|Patient enrolled in post-trial access|0|||
161828380|NCT02490800|584411623|FG009|Overall Study|Patient enrolled in post-trial access|1|||
161828381|NCT02490800|584411624|FG010|Overall Study|Patient enrolled in post-trial access|1|||
161828382|NCT02490800|584411625|FG011|Overall Study|Patient enrolled in post-trial access|0|||
161828383|NCT02490800|584411626|FG012|Overall Study|Patient enrolled in post-trial access|6|||
161828384|NCT03257254|584411627|FG000|Overall Study|Withdrawal by Subject|7|||
161828385|NCT03257254|584411627|FG000|Overall Study|Lost to Follow-up|9|||
161828386|NCT03257254|584411627|FG000|Overall Study|Study discontinued by sponsor|5|||
161828387|NCT02219308|584411628|FG000|Overall Study|Withdrawal by Subject|1|||
161828388|NCT02219308|584411629|FG001|Overall Study|Withdrawal by Subject|2|||
161531484|NCT00833638|583333196|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
161531485|NCT00833638|583333197|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
161531486|NCT00833638|583333198|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
161531487|NCT00833638|583333196|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
161531488|NCT00833638|583333197|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
161531489|NCT00833638|583333198|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
161531490|NCT00833638|583333196|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
161828389|NCT03581188|584413531|FG000|Overall Study|Inclusion criteria not met|3|||
161828390|NCT03581188|584413532|FG001|Overall Study|Inclusion criteria not met|2|||
161828391|NCT03581188|584413531|FG000|Overall Study|Lost to Follow-up|5|||
161828392|NCT03581188|584413532|FG001|Overall Study|Lost to Follow-up|5|||
161828393|NCT03581188|584413531|FG000|Overall Study|Discontinued intervention|11|||
161828394|NCT03581188|584413532|FG001|Overall Study|Discontinued intervention|8|||
161828395|NCT00109837|584413535|FG000|Overall Study|Adverse Event|2|||
161828396|NCT00109837|584413535|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
161828397|NCT00109837|584413535|FG000|Overall Study|Death|1|||
161828398|NCT00109837|584413535|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
161828399|NCT00109837|584413535|FG000|Overall Study|Not treated|1|||
161828400|NCT00109837|584413535|FG000|Overall Study|Ineligible|1|||
161828401|NCT01989676|584413536|FG000|Overall Study|Death|52|||
161828402|NCT01989676|584413537|FG001|Overall Study|Death|60|||
161828403|NCT01989676|584413536|FG000|Overall Study|Protocol Violation|2|||
161828404|NCT01989676|584413537|FG001|Overall Study|Protocol Violation|1|||
161828405|NCT01989676|584413536|FG000|Overall Study|Lost to Follow-up|8|||
161828406|NCT01989676|584413537|FG001|Overall Study|Lost to Follow-up|18|||
161828407|NCT01989676|584413536|FG000|Overall Study|No longer willing to participate in study|26|||
161828408|NCT01989676|584413537|FG001|Overall Study|No longer willing to participate in study|26|||
161828409|NCT01989676|584413536|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
161828410|NCT01989676|584413537|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
161828411|NCT01989676|584413536|FG000|Overall Study|Other|4|||
161828412|NCT01989676|584413537|FG001|Overall Study|Other|3|||
161828413|NCT01619579|584413538|FG000|Overall Study|Withdrawal by Subject|0|||
161828414|NCT01619579|584413539|FG001|Overall Study|Withdrawal by Subject|3|||
161828415|NCT02190279|584413541|FG000|Overall Study|Withdrawal consent|1|||
161828416|NCT02190279|584413542|FG001|Overall Study|Withdrawal consent|0|||
161828417|NCT02190279|584413543|FG002|Overall Study|Withdrawal consent|1|||
161828418|NCT02190279|584413541|FG000|Overall Study|Lost to Follow-up|2|||
161828419|NCT02190279|584413542|FG001|Overall Study|Lost to Follow-up|0|||
161828420|NCT02190279|584413543|FG002|Overall Study|Lost to Follow-up|0|||
161828421|NCT02190279|584413541|FG000|Overall Study|Refused further treatment|0|||
161828422|NCT02190279|584413542|FG001|Overall Study|Refused further treatment|0|||
161828423|NCT02190279|584413543|FG002|Overall Study|Refused further treatment|1|||
161828424|NCT02190279|584413541|FG000|Overall Study|Screening failure|0|||
161828425|NCT02190279|584413542|FG001|Overall Study|Screening failure|0|||
161828426|NCT02190279|584413543|FG002|Overall Study|Screening failure|1|||
161828427|NCT02688387|584413544|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828428|NCT02688387|584413545|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828429|NCT02688387|584413546|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
161828430|NCT02688387|584413547|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828431|NCT02688387|584413548|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828432|NCT02688387|584413549|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828433|NCT02688387|584413550|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828434|NCT02688387|584413551|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828435|NCT02688387|584413552|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828436|NCT02688387|584413553|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828437|NCT02688387|584413554|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828438|NCT02688387|584413555|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828439|NCT02688387|584413556|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828440|NCT02688387|584413557|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828441|NCT02688387|584413558|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828442|NCT02688387|584413559|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828443|NCT02688387|584413560|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828444|NCT02688387|584413561|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828445|NCT02688387|584413562|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828446|NCT02688387|584413563|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828447|NCT02688387|584413564|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828448|NCT02688387|584413565|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828449|NCT02688387|584413544|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828450|NCT02688387|584413545|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828451|NCT02688387|584413546|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828452|NCT02688387|584413547|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
161828453|NCT02688387|584413548|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828454|NCT02688387|584413549|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828455|NCT02688387|584413550|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828456|NCT02688387|584413551|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828457|NCT02688387|584413552|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828458|NCT02688387|584413553|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161678542|NCT02716675|583876007|FG002|Overall Study|Withdrawal by Subject|20|||
161678543|NCT02716675|583876005|FG000|Overall Study|Protocol Violation|0|||
161678544|NCT02716675|583876006|FG001|Overall Study|Protocol Violation|3|||
161678545|NCT02716675|583876007|FG002|Overall Study|Protocol Violation|1|||
161678546|NCT02716675|583876005|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
161678547|NCT02716675|583876006|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
161678548|NCT02716675|583876007|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
161828459|NCT02688387|584413554|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828460|NCT02688387|584413555|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828461|NCT02688387|584413556|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828462|NCT02688387|584413557|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828463|NCT02688387|584413558|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828464|NCT02688387|584413559|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828465|NCT02688387|584413560|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828466|NCT02688387|584413561|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828467|NCT02688387|584413562|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828468|NCT02688387|584413563|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828469|NCT02688387|584413564|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828470|NCT02688387|584413565|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828471|NCT02688387|584413544|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828472|NCT02688387|584413545|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
161828473|NCT02688387|584413546|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828474|NCT02688387|584413547|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828475|NCT02688387|584413548|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828476|NCT02688387|584413549|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828477|NCT02688387|584413550|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828478|NCT02688387|584413551|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828479|NCT02688387|584413552|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828480|NCT02688387|584413553|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828481|NCT02688387|584413554|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161591511|NCT03766009|583554701|FG001|Usual Care|No treatment or declined surgery|0|||
161591512|NCT03766009|583554702|FG002|Usual Care|No treatment or declined surgery|0|||
161591513|NCT03766009|583554703|FG003|Usual Care|No treatment or declined surgery|2|||
161678549|NCT02716675|583876005|FG000|Overall Study|Other|38|||
161678550|NCT02716675|583876006|FG001|Overall Study|Other|47|||
161678551|NCT02716675|583876007|FG002|Overall Study|Other|48|||
161678552|NCT00290290|583876012|FG000|Overall Study|Death|3|||
161678553|NCT00290290|583876013|FG001|Overall Study|Death|4|||
161678554|NCT00290290|583876012|FG000|Overall Study|Withdrawal by Subject|2|||
161678555|NCT00290290|583876013|FG001|Overall Study|Withdrawal by Subject|2|||
161678556|NCT00290290|583876012|FG000|Overall Study|Underwent clean surgical procedure|13|||
161678557|NCT00290290|583876013|FG001|Overall Study|Underwent clean surgical procedure|12|||
161678558|NCT00003895|583876018|FG000|Overall Study|Adverse Event|4|||
161678559|NCT00003895|583876019|FG001|Overall Study|Adverse Event|0|||
161678560|NCT00003895|583876018|FG000|Overall Study|Lack of Efficacy|1|||
161678561|NCT00003895|583876019|FG001|Overall Study|Lack of Efficacy|1|||
161678562|NCT00003895|583876018|FG000|Overall Study|Patient Vacation|2|||
161678563|NCT00003895|583876019|FG001|Overall Study|Patient Vacation|0|||
161828482|NCT02688387|584413555|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828483|NCT02688387|584413556|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828484|NCT02688387|584413557|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828485|NCT02688387|584413558|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161531491|NCT00833638|583333197|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
161531492|NCT00833638|583333198|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
161531493|NCT01178086|583333199|FG000|Overall Study|Participant refusal|7|||
161531494|NCT01178086|583333199|FG000|Overall Study|Physician Decision|44|||
161531495|NCT01178086|583333199|FG000|Overall Study|Switch to other CLL therapy|113|||
161531496|NCT01178086|583333199|FG000|Overall Study|Death|59|||
161531497|NCT01178086|583333199|FG000|Overall Study|Other unspecified|89|||
161531498|NCT01178086|583333199|FG000|Overall Study|Excluded from EAS|20|||
161531499|NCT04348604|583333202|FG000|Week 8|Withdrawal by Subject|1|||
161531500|NCT04348604|583333203|FG001|Week 8|Withdrawal by Subject|1|||
161531501|NCT04348604|583333202|FG000|Week 8|Lost to Follow-up|1|||
161531502|NCT04348604|583333203|FG001|Week 8|Lost to Follow-up|2|||
161531503|NCT04348604|583333202|FG000|Week 8|Suspended|0|||
161678564|NCT00003895|583876018|FG000|Overall Study|Withdrawal by Subject|0|||
161531504|NCT04348604|583333203|FG001|Week 8|Suspended|1|||
161531505|NCT04348604|583333202|FG000|Week 12|Lost to Follow-up|1|||
161531506|NCT04348604|583333203|FG001|Week 12|Lost to Follow-up|2|||
161531507|NCT04348604|583333202|FG000|Week 12|Withdrawal by Subject|1|||
161531508|NCT04348604|583333203|FG001|Week 12|Withdrawal by Subject|0|||
161531509|NCT04348604|583333202|FG000|Week 24|Lost to Follow-up|2|||
161531510|NCT04348604|583333203|FG001|Week 24|Lost to Follow-up|1|||
161531511|NCT02097108|583333204|FG000|Overall Study|Adverse Event|1|||
161531512|NCT02097108|583333204|FG000|Overall Study|patient was abroad for 6 months|1|||
161531513|NCT00127608|583333207|FG000|Overall Study|VZV DNA negative|1|||
161531514|NCT01712009|583334396|FG000|Overall Study|Withdrawal by Subject|24|||
161531515|NCT01712009|583334397|FG001|Overall Study|Withdrawal by Subject|15|||
161531516|NCT01712009|583334398|FG002|Overall Study|Withdrawal by Subject|8|||
161531517|NCT01712009|583334396|FG000|Overall Study|Lost to Follow-up|2|||
161531518|NCT01712009|583334397|FG001|Overall Study|Lost to Follow-up|0|||
161531519|NCT01712009|583334398|FG002|Overall Study|Lost to Follow-up|1|||
161531520|NCT01712009|583334396|FG000|Overall Study|Decision by Sponsor|12|||
161531521|NCT01712009|583334397|FG001|Overall Study|Decision by Sponsor|14|||
161531522|NCT01712009|583334398|FG002|Overall Study|Decision by Sponsor|12|||
161531523|NCT01111123|583334400|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
161531524|NCT01111123|583334401|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
161531525|NCT01111123|583334400|FG000|Maintenance Phase|Lost to Follow-up|0|||
161531526|NCT01111123|583334401|FG001|Maintenance Phase|Lost to Follow-up|2|||
161531527|NCT01292876|583334409|FG000|Overall Study|Physician Decision|4|||
161531528|NCT01627327|583334410|FG000|Overall Study|Adverse Event|6|||
161531529|NCT01627327|583334411|FG001|Overall Study|Adverse Event|12|||
161531530|NCT01627327|583334410|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
161531531|NCT01627327|583334411|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
161828486|NCT02688387|584413559|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828487|NCT02688387|584413560|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828488|NCT02688387|584413561|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828489|NCT02688387|584413562|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828490|NCT02688387|584413563|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828491|NCT02688387|584413564|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828492|NCT02688387|584413565|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828493|NCT02688387|584413544|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828494|NCT02688387|584413545|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828495|NCT02688387|584413546|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
161828496|NCT02688387|584413547|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828497|NCT02688387|584413548|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
161828498|NCT02688387|584413549|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828499|NCT02688387|584413550|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828500|NCT02688387|584413551|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828501|NCT02688387|584413552|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828502|NCT02688387|584413553|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828503|NCT02688387|584413554|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828504|NCT02688387|584413555|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828505|NCT02688387|584413556|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828506|NCT02688387|584413557|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828507|NCT02688387|584413558|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828508|NCT02688387|584413559|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828509|NCT02688387|584413560|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828510|NCT02688387|584413561|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828511|NCT02688387|584413562|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828512|NCT02688387|584413563|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828513|NCT02688387|584413564|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828514|NCT02688387|584413565|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828515|NCT02688387|584413544|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
161828516|NCT02688387|584413545|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828517|NCT02688387|584413546|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828518|NCT02688387|584413547|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828519|NCT02688387|584413548|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828520|NCT02688387|584413549|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161531532|NCT01627327|583334410|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
161531533|NCT01627327|583334411|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
161828521|NCT02688387|584413550|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828522|NCT02688387|584413551|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161531534|NCT01627327|583334410|FG000|Overall Study|Protocol Violation|4|||
161531535|NCT01627327|583334411|FG001|Overall Study|Protocol Violation|10|||
161531536|NCT01627327|583334410|FG000|Overall Study|Lost to Follow-up|1|||
161531537|NCT01627327|583334411|FG001|Overall Study|Lost to Follow-up|3|||
161531538|NCT01627327|583334410|FG000|Overall Study|Physician Decision|1|||
161531539|NCT01627327|583334411|FG001|Overall Study|Physician Decision|0|||
161531540|NCT01627327|583334410|FG000|Overall Study|Withdrawal by Subject|3|||
161531541|NCT01627327|583334411|FG001|Overall Study|Withdrawal by Subject|3|||
161531542|NCT01137474|583334417|FG000|Overall Study|Adverse Event|3|||
161531543|NCT01137474|583334418|FG001|Overall Study|Adverse Event|5|||
161828523|NCT02688387|584413552|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828524|NCT02688387|584413553|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828525|NCT02688387|584413554|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828526|NCT02688387|584413555|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828527|NCT02688387|584413556|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828528|NCT02688387|584413557|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828529|NCT02688387|584413558|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828530|NCT02688387|584413559|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828531|NCT02688387|584413560|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828532|NCT02688387|584413561|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828533|NCT02688387|584413562|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828534|NCT02688387|584413563|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828535|NCT02688387|584413564|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828536|NCT02688387|584413565|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828537|NCT02688387|584413544|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828538|NCT02688387|584413545|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828539|NCT02688387|584413546|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828540|NCT02688387|584413547|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828541|NCT02688387|584413548|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828542|NCT02688387|584413549|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828543|NCT02688387|584413550|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828544|NCT02688387|584413551|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828545|NCT02688387|584413552|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828546|NCT02688387|584413553|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828547|NCT02688387|584413554|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
161828548|NCT02688387|584413555|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828549|NCT02688387|584413556|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828550|NCT02688387|584413557|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161678565|NCT00003895|583876019|FG001|Overall Study|Withdrawal by Subject|3|||
161828551|NCT02688387|584413558|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828552|NCT02688387|584413559|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828553|NCT02688387|584413560|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828554|NCT02688387|584413561|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161678566|NCT01380730|583876020|FG000|Overall Study|Death|0|||
161828555|NCT02688387|584413562|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161591514|NCT03766009|583554704|FG004|Usual Care|No treatment or declined surgery|0|||
161828556|NCT02688387|584413563|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828557|NCT02688387|584413564|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828558|NCT02688387|584413565|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828559|NCT02688387|584413544|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828560|NCT02688387|584413545|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828561|NCT02688387|584413546|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828562|NCT02688387|584413547|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828563|NCT02688387|584413548|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828564|NCT02688387|584413549|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828565|NCT02688387|584413550|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828566|NCT02688387|584413551|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161531544|NCT01137474|583334419|FG002|Overall Study|Adverse Event|1|||
161531545|NCT01137474|583334420|FG003|Overall Study|Adverse Event|3|||
161531546|NCT01137474|583334417|FG000|Overall Study|Withdrawal by Subject|7|||
161531547|NCT01137474|583334418|FG001|Overall Study|Withdrawal by Subject|2|||
161531548|NCT01137474|583334419|FG002|Overall Study|Withdrawal by Subject|6|||
161531549|NCT01137474|583334420|FG003|Overall Study|Withdrawal by Subject|9|||
161531550|NCT01137474|583334417|FG000|Overall Study|No longer met study criteria|6|||
161531551|NCT01137474|583334418|FG001|Overall Study|No longer met study criteria|1|||
161531552|NCT01137474|583334419|FG002|Overall Study|No longer met study criteria|0|||
161531553|NCT01137474|583334420|FG003|Overall Study|No longer met study criteria|5|||
161531554|NCT01137474|583334417|FG000|Overall Study|Lost to Follow-up|5|||
161531555|NCT01137474|583334418|FG001|Overall Study|Lost to Follow-up|1|||
161531556|NCT01137474|583334419|FG002|Overall Study|Lost to Follow-up|0|||
161531557|NCT01137474|583334420|FG003|Overall Study|Lost to Follow-up|2|||
161531558|NCT01137474|583334417|FG000|Overall Study|Lack of Efficacy|0|||
161531559|NCT01137474|583334418|FG001|Overall Study|Lack of Efficacy|0|||
161531560|NCT01137474|583334419|FG002|Overall Study|Lack of Efficacy|0|||
161531561|NCT01137474|583334420|FG003|Overall Study|Lack of Efficacy|2|||
161531562|NCT01137474|583334417|FG000|Overall Study|Other|3|||
161531563|NCT01137474|583334418|FG001|Overall Study|Other|1|||
161531564|NCT01137474|583334419|FG002|Overall Study|Other|0|||
161531565|NCT01137474|583334420|FG003|Overall Study|Other|0|||
161531566|NCT01137474|583334417|FG000|Overall Study|Pregnancy|0|||
161531567|NCT01137474|583334418|FG001|Overall Study|Pregnancy|1|||
161531568|NCT01137474|583334419|FG002|Overall Study|Pregnancy|0|||
161531569|NCT01137474|583334420|FG003|Overall Study|Pregnancy|0|||
161531570|NCT01137474|583334417|FG000|Overall Study|Administrative reason by sponsor|0|||
161531571|NCT01137474|583334418|FG001|Overall Study|Administrative reason by sponsor|1|||
161828567|NCT02688387|584413552|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828568|NCT02688387|584413553|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828569|NCT02688387|584413554|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828570|NCT02688387|584413555|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828571|NCT02688387|584413556|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828572|NCT02688387|584413557|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828573|NCT02688387|584413558|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
161828574|NCT02688387|584413559|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828575|NCT02688387|584413560|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828576|NCT02688387|584413561|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828577|NCT02688387|584413562|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828578|NCT02688387|584413563|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828579|NCT02688387|584413564|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161591515|NCT03766009|583554705|FG005|Usual Care|No treatment or declined surgery|0|||
161591516|NCT03766009|583554700|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
161591517|NCT03766009|583554701|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
161591518|NCT03766009|583554702|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
161591519|NCT03766009|583554703|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
161591520|NCT03766009|583554704|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
161591521|NCT03766009|583554705|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
161591522|NCT03766009|583554700|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161591523|NCT03766009|583554701|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
161591524|NCT03766009|583554702|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161591525|NCT03766009|583554703|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161591526|NCT03766009|583554704|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161591527|NCT03766009|583554705|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161591528|NCT03766009|583554700|FG000|Usual Care|Ineligible|0|||
161591529|NCT03766009|583554701|FG001|Usual Care|Ineligible|1|||
161591530|NCT03766009|583554702|FG002|Usual Care|Ineligible|0|||
161591531|NCT03766009|583554703|FG003|Usual Care|Ineligible|0|||
161591532|NCT03766009|583554704|FG004|Usual Care|Ineligible|0|||
161591533|NCT03766009|583554705|FG005|Usual Care|Ineligible|0|||
161591534|NCT03766009|583554700|FG000|Usual Care|Other: Staff turnover|0|||
161591535|NCT03766009|583554701|FG001|Usual Care|Other: Staff turnover|0|||
161591536|NCT03766009|583554702|FG002|Usual Care|Other: Staff turnover|0|||
161678567|NCT01380730|583876021|FG001|Overall Study|Death|0|||
161678568|NCT01380730|583876022|FG002|Overall Study|Death|0|||
161591537|NCT03766009|583554703|FG003|Usual Care|Other: Staff turnover|0|||
161591538|NCT03766009|583554704|FG004|Usual Care|Other: Staff turnover|0|||
161591539|NCT03766009|583554705|FG005|Usual Care|Other: Staff turnover|2|||
161591540|NCT05071807|583554709|FG000|Overall Study|Withdrawal by Subject|4|||
161591541|NCT05071807|583554710|FG001|Overall Study|Withdrawal by Subject|0|||
161591542|NCT05071807|583554709|FG000|Overall Study|Unrelated medical issues|3|||
161591543|NCT05071807|583554710|FG001|Overall Study|Unrelated medical issues|0|||
161591544|NCT05071807|583554709|FG000|Overall Study|Relocated|0|||
161591545|NCT05071807|583554710|FG001|Overall Study|Relocated|1|||
161591546|NCT04952909|583554711|FG000|Overall Study|Death|3|||
161591547|NCT00881621|583554718|FG000|Overall Study|Physician Decision|34|||
161591548|NCT03903146|583554722|FG000|Overall Study|Lost to Follow-up|6|||
161591549|NCT03903146|583554723|FG001|Overall Study|Lost to Follow-up|4|||
161591550|NCT03903146|583554722|FG000|Overall Study|Withdrawal by Subject|0|||
161591551|NCT03903146|583554723|FG001|Overall Study|Withdrawal by Subject|1|||
161828580|NCT02688387|584413565|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828581|NCT02688387|584413544|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828582|NCT02688387|584413545|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828583|NCT02688387|584413546|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828584|NCT02688387|584413547|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828585|NCT02688387|584413548|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828586|NCT02688387|584413549|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828587|NCT02688387|584413550|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828588|NCT02688387|584413551|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828589|NCT02688387|584413552|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828590|NCT02688387|584413553|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828591|NCT02688387|584413554|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828592|NCT02688387|584413555|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828593|NCT02688387|584413556|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828594|NCT02688387|584413557|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828595|NCT02688387|584413558|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828596|NCT02688387|584413559|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828597|NCT02688387|584413560|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828598|NCT02688387|584413561|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828599|NCT02688387|584413562|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828600|NCT02688387|584413563|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828601|NCT02688387|584413564|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
161828602|NCT02688387|584413565|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828603|NCT02688387|584413544|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828604|NCT02688387|584413545|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828605|NCT02688387|584413546|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828606|NCT02688387|584413547|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828607|NCT02688387|584413548|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828608|NCT02688387|584413549|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828609|NCT02688387|584413550|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828610|NCT02688387|584413551|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828611|NCT02688387|584413552|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828612|NCT02688387|584413553|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828613|NCT02688387|584413554|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828614|NCT02688387|584413555|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828615|NCT02688387|584413556|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828616|NCT02688387|584413557|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828617|NCT02688387|584413558|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828618|NCT02688387|584413559|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828619|NCT02688387|584413560|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828620|NCT02688387|584413561|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828621|NCT02688387|584413562|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
161828622|NCT02688387|584413563|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828623|NCT02688387|584413564|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
161828624|NCT02688387|584413565|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828625|NCT02688387|584413544|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828626|NCT02688387|584413545|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828627|NCT02688387|584413546|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828628|NCT02688387|584413547|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161678569|NCT01380730|583876023|FG003|Overall Study|Death|0|||
161591552|NCT05551637|583554724|FG000|Overall Study|Lack of Efficacy|0|||
161591553|NCT05551637|583554725|FG001|Overall Study|Lack of Efficacy|6|||
161591554|NCT05551637|583554724|FG000|Overall Study|Lost to Follow-up|1|||
161591555|NCT05551637|583554725|FG001|Overall Study|Lost to Follow-up|1|||
161591556|NCT05179837|583554728|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
161591557|NCT05179837|583554728|FG000|Overall Study|Device malfunctioned|1|||
161591558|NCT05179837|583554728|FG000|Overall Study|Image quality too low|2|||
161591559|NCT04924660|583554729|FG000|United States|Death|29|||
161591560|NCT04924660|583554730|FG001|United States|Death|32|||
161591561|NCT04924660|583554731|FG002|United States|Death|34|||
161591562|NCT04924660|583554732|FG003|United States|Death|25|||
161591563|NCT04924660|583554733|FG004|United States|Death|26|||
161591564|NCT04924660|583554734|FG005|United States|Death|23|||
161591565|NCT04924660|583554729|FG000|United States|Lost to Follow-up|15|||
161591566|NCT04924660|583554730|FG001|United States|Lost to Follow-up|10|||
161531572|NCT01137474|583334419|FG002|Overall Study|Administrative reason by sponsor|0|||
161531573|NCT01137474|583334420|FG003|Overall Study|Administrative reason by sponsor|0|||
161531574|NCT02525874|583334421|FG000|Overall Study|Other|1|||
161531575|NCT02525874|583334421|FG000|Overall Study|Investigator Decision|1|||
161531576|NCT02525874|583334421|FG000|Overall Study|Consent withdrawn|22|||
161531577|NCT02525874|583334421|FG000|Overall Study|Non-compliance with study drug|3|||
161531578|NCT02525874|583334421|FG000|Overall Study|Adverse Event|17|||
161531579|NCT02525874|583334421|FG000|Overall Study|Lost to Follow-up|7|||
161531580|NCT02525874|583334421|FG000|Overall Study|Disease progression, defined by protocol|2|||
161531581|NCT02525874|583334421|FG000|Overall Study|Disease relapse|4|||
161531582|NCT02525874|583334421|FG000|Overall Study|Alternative Treatment for MS|2|||
161531583|NCT02525874|583334421|FG000|Overall Study|New lesions in Brain|1|||
161531584|NCT00423176|583334424|FG000|Overall Study|Adverse Event|4|||
161531585|NCT00423176|583334425|FG001|Overall Study|Adverse Event|6|||
161531586|NCT00423176|583334424|FG000|Overall Study|Treatment Failure|1|||
161531587|NCT00423176|583334425|FG001|Overall Study|Treatment Failure|6|||
161531588|NCT00423176|583334424|FG000|Overall Study|Lost to Follow-up|4|||
161531589|NCT00423176|583334425|FG001|Overall Study|Lost to Follow-up|7|||
161531590|NCT00423176|583334424|FG000|Overall Study|Withdrawal by Subject|4|||
161531591|NCT00423176|583334425|FG001|Overall Study|Withdrawal by Subject|3|||
161531592|NCT00423176|583334424|FG000|Overall Study|Protocol Violation|1|||
161531593|NCT00423176|583334425|FG001|Overall Study|Protocol Violation|3|||
161531594|NCT00423176|583334424|FG000|Overall Study|Did not meet protocol eligibility|2|||
161531595|NCT00423176|583334425|FG001|Overall Study|Did not meet protocol eligibility|4|||
161531596|NCT04535947|583334426|FG000|Overall Study|Adverse Event|1|||
161531597|NCT04535947|583334427|FG001|Overall Study|Adverse Event|4|||
161531598|NCT04535947|583334426|FG000|Overall Study|Other reasons not specified|2|||
161531599|NCT04535947|583334427|FG001|Overall Study|Other reasons not specified|0|||
161531600|NCT04535947|583334426|FG000|Overall Study|Withdrawal by Subject|1|||
161531601|NCT04535947|583334427|FG001|Overall Study|Withdrawal by Subject|1|||
161531602|NCT04867369|583334433|FG000|Overall Study|Withdrawal by Subject|1|||
161531603|NCT04867369|583334434|FG001|Overall Study|Withdrawal by Subject|0|||
161531604|NCT03492281|583334440|FG000|Overall Study|Withdrawal by Subject|21|||
161531605|NCT03492281|583334441|FG001|Overall Study|Withdrawal by Subject|14|||
161531606|NCT03492281|583334442|FG002|Overall Study|Withdrawal by Subject|13|||
161531607|NCT03492281|583334440|FG000|Overall Study|Lost to Follow-up|14|||
161531608|NCT03492281|583334441|FG001|Overall Study|Lost to Follow-up|15|||
161531609|NCT03492281|583334442|FG002|Overall Study|Lost to Follow-up|10|||
161531610|NCT03492281|583334440|FG000|Overall Study|Adverse Event|6|||
161531611|NCT03492281|583334441|FG001|Overall Study|Adverse Event|8|||
161531612|NCT03492281|583334442|FG002|Overall Study|Adverse Event|13|||
161531613|NCT03492281|583334440|FG000|Overall Study|Lack of Efficacy|3|||
161531614|NCT03492281|583334441|FG001|Overall Study|Lack of Efficacy|0|||
161531615|NCT03492281|583334442|FG002|Overall Study|Lack of Efficacy|1|||
161531616|NCT03492281|583334440|FG000|Overall Study|Physician Decision|1|||
161531617|NCT03492281|583334441|FG001|Overall Study|Physician Decision|0|||
161531618|NCT03492281|583334442|FG002|Overall Study|Physician Decision|3|||
161531619|NCT03492281|583334440|FG000|Overall Study|Protocol Violation|0|||
161531620|NCT03492281|583334441|FG001|Overall Study|Protocol Violation|2|||
161531621|NCT03492281|583334442|FG002|Overall Study|Protocol Violation|1|||
161531622|NCT03492281|583334440|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
161531623|NCT03492281|583334441|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
161531624|NCT03492281|583334442|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
161531625|NCT03492281|583334440|FG000|Overall Study|Death|0|||
161531626|NCT03492281|583334441|FG001|Overall Study|Death|0|||
161531627|NCT03492281|583334442|FG002|Overall Study|Death|1|||
161531628|NCT03492281|583334440|FG000|Overall Study|Captured as Other in Database|8|||
161531629|NCT03492281|583334441|FG001|Overall Study|Captured as Other in Database|6|||
161531630|NCT03492281|583334442|FG002|Overall Study|Captured as Other in Database|3|||
161531631|NCT00675766|583334449|FG000|Overall Study|Lost to Follow-up|6|||
161531632|NCT00675766|583334450|FG001|Overall Study|Lost to Follow-up|5|||
161531633|NCT00675766|583334451|FG002|Overall Study|Lost to Follow-up|21|||
161531634|NCT00675766|583334452|FG003|Overall Study|Lost to Follow-up|26|||
161531635|NCT01749982|583334455|FG000|Overall Study|Physician Decision|0|||
161531636|NCT01749982|583334456|FG001|Overall Study|Physician Decision|0|||
161531637|NCT01749982|583334457|FG002|Overall Study|Physician Decision|0|||
161531638|NCT01749982|583334458|FG003|Overall Study|Physician Decision|1|||
161531639|NCT01749982|583334455|FG000|Overall Study|Lost to Follow-up|0|||
161531640|NCT01749982|583334456|FG001|Overall Study|Lost to Follow-up|0|||
161531641|NCT01749982|583334457|FG002|Overall Study|Lost to Follow-up|0|||
161531642|NCT01749982|583334458|FG003|Overall Study|Lost to Follow-up|1|||
161531643|NCT01749982|583334455|FG000|Overall Study|Withdrawal by Subject|0|||
161531644|NCT01749982|583334456|FG001|Overall Study|Withdrawal by Subject|0|||
161531645|NCT01749982|583334457|FG002|Overall Study|Withdrawal by Subject|0|||
161531646|NCT01749982|583334458|FG003|Overall Study|Withdrawal by Subject|1|||
161531647|NCT02677116|583334459|FG000|Overall Study|Adverse Event|0|||
161531648|NCT02677116|583334460|FG001|Overall Study|Adverse Event|1|||
161531649|NCT02677116|583334461|FG002|Overall Study|Adverse Event|0|||
161531650|NCT02677116|583334462|FG003|Overall Study|Adverse Event|0|||
161531651|NCT02677116|583334463|FG004|Overall Study|Adverse Event|0|||
161531652|NCT02677116|583334464|FG005|Overall Study|Adverse Event|1|||
161531653|NCT02677116|583334465|FG006|Overall Study|Adverse Event|1|||
161531654|NCT02677116|583334466|FG007|Overall Study|Adverse Event|0|||
161531655|NCT02677116|583334467|FG008|Overall Study|Adverse Event|0|||
161531656|NCT02677116|583334459|FG000|Overall Study|Physician Decision|0|||
161531657|NCT02677116|583334460|FG001|Overall Study|Physician Decision|2|||
161531658|NCT02677116|583334461|FG002|Overall Study|Physician Decision|3|||
161531659|NCT02677116|583334462|FG003|Overall Study|Physician Decision|2|||
161531660|NCT02677116|583334463|FG004|Overall Study|Physician Decision|1|||
161531661|NCT02677116|583334464|FG005|Overall Study|Physician Decision|3|||
161531662|NCT02677116|583334465|FG006|Overall Study|Physician Decision|1|||
161531663|NCT02677116|583334466|FG007|Overall Study|Physician Decision|1|||
161531664|NCT02677116|583334467|FG008|Overall Study|Physician Decision|2|||
161531665|NCT02677116|583334459|FG000|Overall Study|Withdrawal by parent or guardian|2|||
161531666|NCT02677116|583334460|FG001|Overall Study|Withdrawal by parent or guardian|1|||
161531667|NCT02677116|583334461|FG002|Overall Study|Withdrawal by parent or guardian|0|||
161531668|NCT02677116|583334462|FG003|Overall Study|Withdrawal by parent or guardian|1|||
161531669|NCT02677116|583334463|FG004|Overall Study|Withdrawal by parent or guardian|0|||
161531670|NCT02677116|583334464|FG005|Overall Study|Withdrawal by parent or guardian|0|||
161531671|NCT02677116|583334465|FG006|Overall Study|Withdrawal by parent or guardian|2|||
161531672|NCT02677116|583334466|FG007|Overall Study|Withdrawal by parent or guardian|1|||
161531673|NCT02677116|583334467|FG008|Overall Study|Withdrawal by parent or guardian|0|||
161531674|NCT02677116|583334459|FG000|Overall Study|Withdrawal by Subject|1|||
161531675|NCT02677116|583334460|FG001|Overall Study|Withdrawal by Subject|0|||
161828629|NCT02688387|584413548|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828630|NCT02688387|584413549|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828631|NCT02688387|584413550|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828632|NCT02688387|584413551|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828633|NCT02688387|584413552|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828634|NCT02688387|584413553|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161531676|NCT02677116|583334461|FG002|Overall Study|Withdrawal by Subject|0|||
161531677|NCT02677116|583334462|FG003|Overall Study|Withdrawal by Subject|0|||
161531678|NCT02677116|583334463|FG004|Overall Study|Withdrawal by Subject|0|||
161531679|NCT02677116|583334464|FG005|Overall Study|Withdrawal by Subject|0|||
161531680|NCT02677116|583334465|FG006|Overall Study|Withdrawal by Subject|0|||
161531681|NCT02677116|583334466|FG007|Overall Study|Withdrawal by Subject|0|||
161531682|NCT02677116|583334467|FG008|Overall Study|Withdrawal by Subject|0|||
161531683|NCT01207102|583334472|FG000|Overall Study|Withdrawal by Subject|5|||
161531684|NCT01207102|583334472|FG000|Overall Study|Adverse Event|2|||
161531685|NCT01207102|583334472|FG000|Overall Study|progression|2|||
161531686|NCT01207102|583334472|FG000|Overall Study|Withdrawal by Treating Physician|1|||
161531687|NCT01018394|583334473|FG000|Overall Study|Withdrawal by Subject|5|||
161531688|NCT01018394|583334474|FG001|Overall Study|Withdrawal by Subject|5|||
161531689|NCT01018394|583334473|FG000|Overall Study|Lost to Follow-up|4|||
161531690|NCT01018394|583334474|FG001|Overall Study|Lost to Follow-up|3|||
161531691|NCT03792126|583334475|FG000|Overall Study|Adverse Event|1|||
161531692|NCT03792126|583334476|FG001|Overall Study|Adverse Event|2|||
161531693|NCT03792126|583334475|FG000|Overall Study|Death|0|||
161531694|NCT03792126|583334476|FG001|Overall Study|Death|1|||
161531695|NCT03792126|583334475|FG000|Overall Study|Lost to Follow-up|1|||
161531696|NCT03792126|583334476|FG001|Overall Study|Lost to Follow-up|0|||
161531697|NCT03792126|583334475|FG000|Overall Study|Withdrawal by Subject|0|||
161531698|NCT03792126|583334476|FG001|Overall Study|Withdrawal by Subject|1|||
161531699|NCT03792126|583334475|FG000|Overall Study|COVID-19 Restrictions|1|||
161531700|NCT03792126|583334476|FG001|Overall Study|COVID-19 Restrictions|3|||
161531701|NCT03792126|583334475|FG000|Overall Study|Symptoms resolved|0|||
161531702|NCT03792126|583334476|FG001|Overall Study|Symptoms resolved|3|||
161531703|NCT00617344|583334478|FG000|Overall Study|Serious adverse event|1|||
161531704|NCT00617344|583334479|FG001|Overall Study|Serious adverse event|0|||
161531705|NCT00617344|583334480|FG002|Overall Study|Serious adverse event|0|||
161531706|NCT00617344|583334478|FG000|Overall Study|Other Adverse Event|1|||
161828635|NCT02688387|584413554|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161531707|NCT00617344|583334479|FG001|Overall Study|Other Adverse Event|1|||
161531708|NCT00617344|583334480|FG002|Overall Study|Other Adverse Event|0|||
161531709|NCT00617344|583334478|FG000|Overall Study|Protocol Violation|10|||
161531710|NCT00617344|583334479|FG001|Overall Study|Protocol Violation|8|||
161531711|NCT00617344|583334480|FG002|Overall Study|Protocol Violation|5|||
161531712|NCT00617344|583334478|FG000|Overall Study|Lost to Follow-up|5|||
161531713|NCT00617344|583334479|FG001|Overall Study|Lost to Follow-up|4|||
161531714|NCT00617344|583334480|FG002|Overall Study|Lost to Follow-up|1|||
161531715|NCT00617344|583334478|FG000|Overall Study|Withdrawal by Subject|8|||
161531716|NCT00617344|583334479|FG001|Overall Study|Withdrawal by Subject|9|||
161531717|NCT00617344|583334480|FG002|Overall Study|Withdrawal by Subject|2|||
161531718|NCT00490646|583334481|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
161531719|NCT00490646|583334482|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
161531720|NCT00490646|583334481|FG000|Overall Study|Never Treated (had an adverse event)|1|||
161531721|NCT00490646|583334482|FG001|Overall Study|Never Treated (had an adverse event)|0|||
161531722|NCT00490646|583334481|FG000|Overall Study|Never Treated (withdrew consent)|0|||
161531723|NCT00490646|583334482|FG001|Overall Study|Never Treated (withdrew consent)|1|||
161531724|NCT01400503|583334484|FG000|Overall Study|Withdrawal by Subject|1|||
161531725|NCT01400503|583334484|FG000|Overall Study|Study Terminated by Sponsor|58|||
161531726|NCT01400503|583334484|FG000|Overall Study|Other|1|||
161531727|NCT00983073|583334485|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
161828636|NCT02688387|584413555|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828637|NCT02688387|584413556|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828638|NCT02688387|584413557|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828639|NCT02688387|584413558|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828640|NCT02688387|584413559|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828641|NCT02688387|584413560|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828642|NCT02688387|584413561|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828643|NCT02688387|584413562|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828644|NCT02688387|584413563|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
161828645|NCT02688387|584413564|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828646|NCT02688387|584413565|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828647|NCT02938442|584413566|FG000|Overall Study|Death|0|||
161828648|NCT02938442|584413567|FG001|Overall Study|Death|1|||
161828649|NCT02938442|584413566|FG000|Overall Study|Lost to Follow-up|0|||
161531728|NCT00983073|583334485|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
161531729|NCT00983073|583334485|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
161531730|NCT00983073|583334485|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
161531731|NCT00983073|583334485|FG000|Titration and Optimal Dose Period|Other reason|4|||
161531732|NCT00983073|583334485|FG000|Maintenance Period|Adverse Event|5|||
161531733|NCT00983073|583334485|FG000|Maintenance Period|Withdrawal by Subject|2|||
161531734|NCT00983073|583334485|FG000|Maintenance Period|Lack of Efficacy|2|||
161531735|NCT00983073|583334485|FG000|Maintenance Period|Other Reason|7|||
161531736|NCT01669122|583334488|FG000|Period I|Lost to Follow-up|1|||
161531737|NCT01669122|583334488|FG000|Washout Period II|Protocol Violation|2|||
161531738|NCT02962908|583334489|FG000|Overall Study|Lost to Follow-up|0|||
161531739|NCT02962908|583334490|FG001|Overall Study|Lost to Follow-up|3|||
161531740|NCT02962908|583334491|FG002|Overall Study|Lost to Follow-up|0|||
161531741|NCT02962908|583334492|FG003|Overall Study|Lost to Follow-up|1|||
161531742|NCT02962908|583334489|FG000|Overall Study|Withdrawal by Subject|0|||
161531743|NCT02962908|583334490|FG001|Overall Study|Withdrawal by Subject|3|||
161531744|NCT02962908|583334491|FG002|Overall Study|Withdrawal by Subject|0|||
161531745|NCT02962908|583334492|FG003|Overall Study|Withdrawal by Subject|2|||
161531746|NCT02962908|583334489|FG000|Overall Study|Protocol Violation|0|||
161531747|NCT02962908|583334490|FG001|Overall Study|Protocol Violation|1|||
161828650|NCT02938442|584413567|FG001|Overall Study|Lost to Follow-up|1|||
161828651|NCT02938442|584413566|FG000|Overall Study|Physician Decision|0|||
161828652|NCT02938442|584413567|FG001|Overall Study|Physician Decision|1|||
161828653|NCT02938442|584413566|FG000|Overall Study|Withdrawal by Subject|2|||
161828654|NCT02938442|584413567|FG001|Overall Study|Withdrawal by Subject|0|||
161828655|NCT00802178|584413568|FG000|Overall Study|Lack of Efficacy|36|||
161828656|NCT00802178|584413568|FG000|Overall Study|Insufficient tolerability (IT)|17|||
161828657|NCT00802178|584413568|FG000|Overall Study|Withdrawal by Subject|18|||
161828658|NCT00802178|584413568|FG000|Overall Study|Other|32|||
161828659|NCT00802178|584413568|FG000|Overall Study|Lack of efficacy and patient wish|1|||
161828660|NCT00802178|584413568|FG000|Overall Study|IT and patient wish|8|||
161828661|NCT00802178|584413568|FG000|Overall Study|Patients wish and other reason|1|||
161828662|NCT01606228|584413569|FG000|Overall Study|Lost to Follow-up|20|||
161828663|NCT01606228|584413569|FG000|Overall Study|Withdrawal by Subject|3|||
161828664|NCT01606228|584413569|FG000|Overall Study|Non-compliant|3|||
161828665|NCT01606228|584413569|FG000|Overall Study|Lack of Efficacy|2|||
161828666|NCT01606228|584413569|FG000|Overall Study|Adverse Event|1|||
161828667|NCT01115855|584413570|FG000|Overall Study|Adverse Event|16|||
161828668|NCT01115855|584413571|FG001|Overall Study|Adverse Event|18|||
161828669|NCT01115855|584413570|FG000|Overall Study|Death|6|||
161828670|NCT01115855|584413571|FG001|Overall Study|Death|5|||
161828671|NCT01115855|584413570|FG000|Overall Study|Lab Abnormality|1|||
161828672|NCT01115855|584413571|FG001|Overall Study|Lab Abnormality|1|||
161828673|NCT01115855|584413570|FG000|Overall Study|Protocol Violation|0|||
161828674|NCT01115855|584413571|FG001|Overall Study|Protocol Violation|1|||
161828675|NCT01115855|584413570|FG000|Overall Study|Withdrawal by Subject|5|||
161828676|NCT01115855|584413571|FG001|Overall Study|Withdrawal by Subject|5|||
161531748|NCT02962908|583334491|FG002|Overall Study|Protocol Violation|0|||
161531749|NCT02962908|583334492|FG003|Overall Study|Protocol Violation|0|||
161531750|NCT02962908|583334489|FG000|Overall Study|Physician Decision|0|||
161531751|NCT02962908|583334490|FG001|Overall Study|Physician Decision|1|||
161531752|NCT02962908|583334491|FG002|Overall Study|Physician Decision|0|||
161531753|NCT02962908|583334492|FG003|Overall Study|Physician Decision|0|||
161531754|NCT03543254|583334493|FG000|Overall Study|Lost to Follow-up|1|||
161531755|NCT02077166|583334494|FG000|Overall Study|Death|6|||
161828677|NCT01115855|584413570|FG000|Overall Study|Other|8|||
161828678|NCT01115855|584413571|FG001|Overall Study|Other|6|||
161828679|NCT04100096|584413572|FG000|Overall Study|Adverse Event|19|||
161828680|NCT04100096|584413573|FG001|Overall Study|Adverse Event|7|||
161828681|NCT04100096|584413572|FG000|Overall Study|Lack of Efficacy|0|||
161828682|NCT04100096|584413573|FG001|Overall Study|Lack of Efficacy|1|||
161828683|NCT04100096|584413572|FG000|Overall Study|Lost to Follow-up|13|||
161531756|NCT02077166|583334495|FG001|Overall Study|Death|7|||
161531757|NCT02077166|583334496|FG002|Overall Study|Death|5|||
161828684|NCT04100096|584413573|FG001|Overall Study|Lost to Follow-up|11|||
161531758|NCT02077166|583334497|FG003|Overall Study|Death|6|||
161531759|NCT02077166|583334498|FG004|Overall Study|Death|4|||
161531760|NCT02077166|583334499|FG005|Overall Study|Death|32|||
161531761|NCT02077166|583334500|FG006|Overall Study|Death|22|||
161531762|NCT02077166|583334494|FG000|Overall Study|Study Closure by Sponsor|3|||
161531763|NCT02077166|583334495|FG001|Overall Study|Study Closure by Sponsor|0|||
161531764|NCT02077166|583334496|FG002|Overall Study|Study Closure by Sponsor|2|||
161531765|NCT02077166|583334497|FG003|Overall Study|Study Closure by Sponsor|2|||
161531766|NCT02077166|583334498|FG004|Overall Study|Study Closure by Sponsor|2|||
161531767|NCT02077166|583334499|FG005|Overall Study|Study Closure by Sponsor|12|||
161531768|NCT02077166|583334500|FG006|Overall Study|Study Closure by Sponsor|4|||
161531769|NCT02077166|583334494|FG000|Overall Study|Lost to Follow-up|0|||
161531770|NCT02077166|583334495|FG001|Overall Study|Lost to Follow-up|0|||
161531771|NCT02077166|583334496|FG002|Overall Study|Lost to Follow-up|0|||
161531772|NCT02077166|583334497|FG003|Overall Study|Lost to Follow-up|0|||
161531773|NCT02077166|583334498|FG004|Overall Study|Lost to Follow-up|0|||
161531774|NCT02077166|583334499|FG005|Overall Study|Lost to Follow-up|1|||
161531775|NCT02077166|583334500|FG006|Overall Study|Lost to Follow-up|0|||
161531776|NCT02077166|583334494|FG000|Overall Study|Withdrawal by Subject|3|||
161531777|NCT02077166|583334495|FG001|Overall Study|Withdrawal by Subject|0|||
161531778|NCT02077166|583334496|FG002|Overall Study|Withdrawal by Subject|1|||
161531779|NCT02077166|583334497|FG003|Overall Study|Withdrawal by Subject|1|||
161531780|NCT02077166|583334498|FG004|Overall Study|Withdrawal by Subject|1|||
161531781|NCT02077166|583334499|FG005|Overall Study|Withdrawal by Subject|3|||
161531782|NCT02077166|583334500|FG006|Overall Study|Withdrawal by Subject|0|||
161531783|NCT02077166|583334494|FG000|Overall Study|Other, Not Specified|0|||
161531784|NCT02077166|583334495|FG001|Overall Study|Other, Not Specified|0|||
161531785|NCT02077166|583334496|FG002|Overall Study|Other, Not Specified|1|||
161531786|NCT02077166|583334497|FG003|Overall Study|Other, Not Specified|0|||
161531787|NCT02077166|583334498|FG004|Overall Study|Other, Not Specified|1|||
161531788|NCT02077166|583334499|FG005|Overall Study|Other, Not Specified|7|||
161531789|NCT02077166|583334500|FG006|Overall Study|Other, Not Specified|8|||
161531790|NCT01261338|583334501|FG000|Overall Study|Withdrawal by Subject|3|||
161531791|NCT01261338|583334502|FG001|Overall Study|Withdrawal by Subject|2|||
161531792|NCT02899728|583334508|FG000|Overall Study|Withdrawal by Subject|1|||
161531793|NCT02899728|583334509|FG001|Overall Study|Withdrawal by Subject|1|||
161531794|NCT05557942|583334510|FG000|Overall Study|Death|0|||
161531795|NCT05557942|583334511|FG001|Overall Study|Death|0|||
161531796|NCT05557942|583334512|FG002|Overall Study|Death|0|||
161531797|NCT05557942|583334513|FG003|Overall Study|Death|2|||
161531798|NCT05557942|583334514|FG004|Overall Study|Death|1|||
161531799|NCT05557942|583334515|FG005|Overall Study|Death|1|||
161531800|NCT05557942|583334510|FG000|Overall Study|Physician Decision|1|||
161531801|NCT05557942|583334511|FG001|Overall Study|Physician Decision|1|||
161531802|NCT05557942|583334512|FG002|Overall Study|Physician Decision|2|||
161531803|NCT05557942|583334513|FG003|Overall Study|Physician Decision|3|||
161531804|NCT05557942|583334514|FG004|Overall Study|Physician Decision|0|||
161531805|NCT05557942|583334515|FG005|Overall Study|Physician Decision|2|||
161531806|NCT05557942|583334510|FG000|Overall Study|Study terminated by sponsor|17|||
161531807|NCT05557942|583334511|FG001|Overall Study|Study terminated by sponsor|17|||
161531808|NCT05557942|583334512|FG002|Overall Study|Study terminated by sponsor|14|||
161531809|NCT05557942|583334513|FG003|Overall Study|Study terminated by sponsor|40|||
161678570|NCT01380730|583876024|FG004|Overall Study|Death|1|||
161678571|NCT01380730|583876025|FG005|Overall Study|Death|0|||
161678572|NCT01380730|583876026|FG006|Overall Study|Death|0|||
161678573|NCT01380730|583876027|FG007|Overall Study|Death|0|||
161678574|NCT00962390|583876037|FG000|Overall Study|Adverse Event|0|||
161678575|NCT00962390|583876038|FG001|Overall Study|Adverse Event|0|||
161678576|NCT00962390|583876039|FG002|Overall Study|Adverse Event|3|||
161678577|NCT00962390|583876040|FG003|Overall Study|Adverse Event|1|||
161678578|NCT00962390|583876037|FG000|Overall Study|Lost to Follow-up|2|||
161531810|NCT05557942|583334514|FG004|Overall Study|Study terminated by sponsor|45|||
161531811|NCT05557942|583334515|FG005|Overall Study|Study terminated by sponsor|37|||
161531812|NCT05557942|583334510|FG000|Overall Study|Protocol Violation|0|||
161531813|NCT05557942|583334511|FG001|Overall Study|Protocol Violation|0|||
161531814|NCT05557942|583334512|FG002|Overall Study|Protocol Violation|0|||
161531815|NCT05557942|583334513|FG003|Overall Study|Protocol Violation|0|||
161531816|NCT05557942|583334514|FG004|Overall Study|Protocol Violation|0|||
161678579|NCT00962390|583876038|FG001|Overall Study|Lost to Follow-up|2|||
161531817|NCT05557942|583334515|FG005|Overall Study|Protocol Violation|1|||
161531818|NCT05557942|583334510|FG000|Overall Study|Withdrawal by Subject|0|||
161531819|NCT05557942|583334511|FG001|Overall Study|Withdrawal by Subject|0|||
161531820|NCT05557942|583334512|FG002|Overall Study|Withdrawal by Subject|0|||
161531821|NCT05557942|583334513|FG003|Overall Study|Withdrawal by Subject|0|||
161678580|NCT00962390|583876039|FG002|Overall Study|Lost to Follow-up|0|||
161678581|NCT00962390|583876040|FG003|Overall Study|Lost to Follow-up|0|||
161531822|NCT05557942|583334514|FG004|Overall Study|Withdrawal by Subject|2|||
161531823|NCT05557942|583334515|FG005|Overall Study|Withdrawal by Subject|0|||
161531824|NCT01962493|583334516|FG000|Overall Study|Adverse Event|1|||
161531825|NCT01962493|583334517|FG001|Overall Study|Adverse Event|2|||
161531826|NCT01962493|583334516|FG000|Overall Study|Protocol Violation|0|||
161531827|NCT01962493|583334517|FG001|Overall Study|Protocol Violation|1|||
161531828|NCT01962493|583334516|FG000|Overall Study|Withdrawal by Subject|4|||
161531829|NCT01962493|583334517|FG001|Overall Study|Withdrawal by Subject|2|||
161531830|NCT01951625|583334518|FG000|Treatment Period|Protocol Violation|2|||
161531831|NCT01951625|583334519|FG001|Treatment Period|Protocol Violation|0|||
161531832|NCT01951625|583334520|FG002|Treatment Period|Protocol Violation|1|||
161531833|NCT01951625|583334521|FG003|Treatment Period|Protocol Violation|3|||
161531834|NCT01951625|583334522|FG004|Treatment Period|Protocol Violation|2|||
161531835|NCT01951625|583334518|FG000|Treatment Period|Physician Decision|0|||
161531836|NCT01951625|583334519|FG001|Treatment Period|Physician Decision|0|||
161531837|NCT01951625|583334520|FG002|Treatment Period|Physician Decision|0|||
161531838|NCT01951625|583334521|FG003|Treatment Period|Physician Decision|0|||
161531839|NCT01951625|583334522|FG004|Treatment Period|Physician Decision|1|||
161531840|NCT01951625|583334518|FG000|Treatment Period|Protocol driven decision point|0|||
161531841|NCT01951625|583334519|FG001|Treatment Period|Protocol driven decision point|5|||
161531842|NCT01951625|583334520|FG002|Treatment Period|Protocol driven decision point|0|||
161531843|NCT01951625|583334521|FG003|Treatment Period|Protocol driven decision point|2|||
161531844|NCT01951625|583334522|FG004|Treatment Period|Protocol driven decision point|1|||
161531845|NCT01951625|583334518|FG000|Treatment Period|Non compliance with study drug|1|||
161531846|NCT01951625|583334519|FG001|Treatment Period|Non compliance with study drug|2|||
161531847|NCT01951625|583334520|FG002|Treatment Period|Non compliance with study drug|2|||
161531848|NCT01951625|583334521|FG003|Treatment Period|Non compliance with study drug|0|||
161531849|NCT01951625|583334522|FG004|Treatment Period|Non compliance with study drug|0|||
161531850|NCT01951625|583334518|FG000|Treatment Period|Death|3|||
161531851|NCT01951625|583334519|FG001|Treatment Period|Death|2|||
161531852|NCT01951625|583334520|FG002|Treatment Period|Death|2|||
161531853|NCT01951625|583334521|FG003|Treatment Period|Death|1|||
161531854|NCT01951625|583334522|FG004|Treatment Period|Death|2|||
161531855|NCT01951625|583334518|FG000|Treatment Period|Adverse Event|7|||
161531856|NCT01951625|583334519|FG001|Treatment Period|Adverse Event|10|||
161531857|NCT01951625|583334520|FG002|Treatment Period|Adverse Event|9|||
161531858|NCT01951625|583334521|FG003|Treatment Period|Adverse Event|8|||
161531859|NCT01951625|583334522|FG004|Treatment Period|Adverse Event|8|||
161531860|NCT01951625|583334518|FG000|Treatment Period|Withdrawal by Subject|5|||
161531861|NCT01951625|583334519|FG001|Treatment Period|Withdrawal by Subject|2|||
161531862|NCT01951625|583334520|FG002|Treatment Period|Withdrawal by Subject|1|||
161531863|NCT01951625|583334521|FG003|Treatment Period|Withdrawal by Subject|7|||
161531864|NCT01951625|583334522|FG004|Treatment Period|Withdrawal by Subject|3|||
161531865|NCT01951625|583334518|FG000|Treatment Period|Lost to Follow-up|1|||
161531866|NCT01951625|583334519|FG001|Treatment Period|Lost to Follow-up|0|||
161531867|NCT01951625|583334520|FG002|Treatment Period|Lost to Follow-up|0|||
161531868|NCT01951625|583334521|FG003|Treatment Period|Lost to Follow-up|1|||
161531869|NCT01951625|583334522|FG004|Treatment Period|Lost to Follow-up|0|||
161531870|NCT01951625|583334518|FG000|Follow Up Period|Non-compliance with study drug|1|||
161531871|NCT01951625|583334519|FG001|Follow Up Period|Non-compliance with study drug|0|||
161531872|NCT01951625|583334520|FG002|Follow Up Period|Non-compliance with study drug|0|||
161531873|NCT01951625|583334521|FG003|Follow Up Period|Non-compliance with study drug|0|||
161531874|NCT01951625|583334522|FG004|Follow Up Period|Non-compliance with study drug|0|||
161531875|NCT01951625|583334518|FG000|Follow Up Period|Death|1|||
161531876|NCT01951625|583334519|FG001|Follow Up Period|Death|3|||
161531877|NCT01951625|583334520|FG002|Follow Up Period|Death|2|||
161531878|NCT01951625|583334521|FG003|Follow Up Period|Death|2|||
161531879|NCT01951625|583334522|FG004|Follow Up Period|Death|1|||
161531880|NCT01951625|583334518|FG000|Follow Up Period|Logistical difficulties|1|||
161531881|NCT01951625|583334519|FG001|Follow Up Period|Logistical difficulties|2|||
161531882|NCT01951625|583334520|FG002|Follow Up Period|Logistical difficulties|0|||
161531883|NCT01951625|583334521|FG003|Follow Up Period|Logistical difficulties|0|||
161531884|NCT01951625|583334522|FG004|Follow Up Period|Logistical difficulties|0|||
161531885|NCT01951625|583334518|FG000|Follow Up Period|Adverse Event|0|||
161531886|NCT01951625|583334519|FG001|Follow Up Period|Adverse Event|3|||
161531887|NCT01951625|583334520|FG002|Follow Up Period|Adverse Event|2|||
161531888|NCT01951625|583334521|FG003|Follow Up Period|Adverse Event|3|||
161531889|NCT01951625|583334522|FG004|Follow Up Period|Adverse Event|5|||
161531890|NCT01951625|583334518|FG000|Follow Up Period|Withdrawal by Subject|4|||
161531891|NCT01951625|583334519|FG001|Follow Up Period|Withdrawal by Subject|1|||
161531892|NCT01951625|583334520|FG002|Follow Up Period|Withdrawal by Subject|0|||
161531893|NCT01951625|583334521|FG003|Follow Up Period|Withdrawal by Subject|5|||
161531894|NCT01951625|583334522|FG004|Follow Up Period|Withdrawal by Subject|3|||
161531895|NCT01951625|583334518|FG000|Follow Up Period|Lost to Follow-up|1|||
161531896|NCT01951625|583334519|FG001|Follow Up Period|Lost to Follow-up|0|||
161531897|NCT01951625|583334520|FG002|Follow Up Period|Lost to Follow-up|0|||
161531898|NCT01951625|583334521|FG003|Follow Up Period|Lost to Follow-up|1|||
161531899|NCT01951625|583334522|FG004|Follow Up Period|Lost to Follow-up|1|||
161531900|NCT03754803|583334529|FG000|Overall Study|Withdrawal by Subject|2|||
161531901|NCT05338333|583334530|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
161531902|NCT05338333|583334531|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
161531903|NCT05245864|583334532|FG000|Overall Study|Withdrawal by Subject|1|||
161531904|NCT05245864|583334533|FG001|Overall Study|Withdrawal by Subject|1|||
161531905|NCT00857207|583336054|FG000|Overall Study|Withdrawal by Subject|13|||
161531906|NCT00857207|583336055|FG001|Overall Study|Withdrawal by Subject|0|||
161531907|NCT00857207|583336054|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
161531908|NCT00857207|583336055|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
161531909|NCT00857207|583336054|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
161531910|NCT00857207|583336055|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
161531911|NCT02030015|583336056|FG000|Overall Study|Withdrawal by Subject|3|||
161531912|NCT02030015|583336056|FG000|Overall Study|Death|13|||
161531913|NCT03014674|583336058|FG000|Overall Study|Withdrawal by Subject|1|||
161531914|NCT03014674|583336059|FG001|Overall Study|Withdrawal by Subject|0|||
161531915|NCT03014674|583336060|FG002|Overall Study|Withdrawal by Subject|0|||
161531916|NCT01332227|583336062|FG000|Overall Study|Adverse Event|4|||
161531917|NCT01332227|583336063|FG001|Overall Study|Adverse Event|1|||
161531918|NCT01332227|583336062|FG000|Overall Study|Withdrawal by Subject|5|||
161531919|NCT01332227|583336063|FG001|Overall Study|Withdrawal by Subject|1|||
161531920|NCT01332227|583336062|FG000|Overall Study|Lost to Follow-up|2|||
161531921|NCT01332227|583336063|FG001|Overall Study|Lost to Follow-up|0|||
161531922|NCT01332227|583336062|FG000|Overall Study|Lack of Efficacy|3|||
161531923|NCT01332227|583336063|FG001|Overall Study|Lack of Efficacy|1|||
161531924|NCT01332227|583336062|FG000|Overall Study|Poor compliance/noncompliance|1|||
161531925|NCT01332227|583336063|FG001|Overall Study|Poor compliance/noncompliance|1|||
161531926|NCT01332227|583336062|FG000|Overall Study|Patient moved from area|1|||
161531927|NCT01332227|583336063|FG001|Overall Study|Patient moved from area|0|||
161531928|NCT01332227|583336062|FG000|Overall Study|Patient began prohibited medication|0|||
161531929|NCT01332227|583336063|FG001|Overall Study|Patient began prohibited medication|1|||
161531930|NCT02822222|583336072|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
161531931|NCT02822222|583336073|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
161531932|NCT00833560|583336074|FG000|Overall Study|Toxicity|13|||
161531933|NCT00833560|583336074|FG000|Overall Study|Adverse Event|11|||
161531934|NCT00833560|583336074|FG000|Overall Study|Protocol Violation|6|||
161531935|NCT00833560|583336074|FG000|Overall Study|Lack of Efficacy|4|||
161531936|NCT00833560|583336074|FG000|Overall Study|Death|2|||
161531937|NCT00833560|583336074|FG000|Overall Study|Pregression of other disease|1|||
161531938|NCT00833560|583336074|FG000|Overall Study|Other|5|||
161531939|NCT00440531|583336078|FG000|Overall Study|Adverse Event|1|||
161531940|NCT00440531|583336079|FG001|Overall Study|Adverse Event|0|||
161531941|NCT00440531|583336080|FG002|Overall Study|Adverse Event|2|||
161531942|NCT00440531|583336078|FG000|Overall Study|Withdrawal by Subject|2|||
161531943|NCT00440531|583336079|FG001|Overall Study|Withdrawal by Subject|0|||
161531944|NCT00440531|583336080|FG002|Overall Study|Withdrawal by Subject|0|||
161531945|NCT00440531|583336078|FG000|Overall Study|Protocol Violation|1|||
161531946|NCT00440531|583336079|FG001|Overall Study|Protocol Violation|2|||
161531947|NCT00440531|583336080|FG002|Overall Study|Protocol Violation|0|||
161531948|NCT00440531|583336078|FG000|Overall Study|Lost to Follow-up|4|||
161531949|NCT00440531|583336079|FG001|Overall Study|Lost to Follow-up|3|||
161531950|NCT00440531|583336080|FG002|Overall Study|Lost to Follow-up|5|||
161531951|NCT00440531|583336078|FG000|Overall Study|see pre-assignment details|2|||
161531952|NCT00440531|583336079|FG001|Overall Study|see pre-assignment details|0|||
161531953|NCT00440531|583336080|FG002|Overall Study|see pre-assignment details|0|||
161531954|NCT01791725|583336081|FG000|Overall Study|Withdrawal by Subject|0|||
161531955|NCT01791725|583336082|FG001|Overall Study|Withdrawal by Subject|1|||
161531956|NCT01791725|583336083|FG002|Overall Study|Withdrawal by Subject|0|||
161591567|NCT04924660|583554731|FG002|United States|Lost to Follow-up|13|||
161591568|NCT04924660|583554732|FG003|United States|Lost to Follow-up|5|||
161591569|NCT04924660|583554733|FG004|United States|Lost to Follow-up|19|||
161591570|NCT04924660|583554734|FG005|United States|Lost to Follow-up|20|||
161591571|NCT04924660|583554729|FG000|United States|Withdrawal by Subject|8|||
161591572|NCT04924660|583554730|FG001|United States|Withdrawal by Subject|3|||
161591573|NCT04924660|583554731|FG002|United States|Withdrawal by Subject|3|||
161591574|NCT04924660|583554732|FG003|United States|Withdrawal by Subject|3|||
161591575|NCT04924660|583554733|FG004|United States|Withdrawal by Subject|8|||
161591576|NCT04924660|583554734|FG005|United States|Withdrawal by Subject|4|||
161591577|NCT04924660|583554729|FG000|Spain|Death|0|||
161591578|NCT04924660|583554730|FG001|Spain|Death|0|||
161591579|NCT04924660|583554731|FG002|Spain|Death|0|||
161591580|NCT04924660|583554732|FG003|Spain|Death|0|||
161678582|NCT00962390|583876037|FG000|Overall Study|Protocol Violation|1|||
161678583|NCT00962390|583876038|FG001|Overall Study|Protocol Violation|0|||
161678584|NCT00962390|583876039|FG002|Overall Study|Protocol Violation|0|||
161678585|NCT00962390|583876040|FG003|Overall Study|Protocol Violation|0|||
161678586|NCT00962390|583876037|FG000|Overall Study|Withdrawal by Subject|1|||
161678587|NCT00962390|583876038|FG001|Overall Study|Withdrawal by Subject|1|||
161678588|NCT00962390|583876039|FG002|Overall Study|Withdrawal by Subject|1|||
161678589|NCT00962390|583876040|FG003|Overall Study|Withdrawal by Subject|0|||
161678590|NCT02613884|583876041|FG000|Overall Study|Death|1|||
161678591|NCT02613884|583876041|FG000|Overall Study|Lost to Follow-up|1|||
161678592|NCT00433914|583876044|FG000|Overall Study|Withdrawal by Subject|0|||
161678593|NCT00433914|583876045|FG001|Overall Study|Withdrawal by Subject|2|||
161678594|NCT00433914|583876044|FG000|Overall Study|Lost to Follow-up|0|||
161678595|NCT00433914|583876045|FG001|Overall Study|Lost to Follow-up|1|||
161678596|NCT00766090|583876046|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678597|NCT00766090|583876047|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678598|NCT00766090|583876048|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678599|NCT00766090|583876049|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678600|NCT00766090|583876050|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678601|NCT00766090|583876051|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678602|NCT00766090|583876052|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161531957|NCT02690974|583336086|FG000|Overall Study|Adverse Event|16|||
161531958|NCT02690974|583336086|FG000|Overall Study|Death|9|||
161531959|NCT02690974|583336086|FG000|Overall Study|Subject/guardian decision|4|||
161531960|NCT02690974|583336086|FG000|Overall Study|Lost to Follow-up|3|||
161531961|NCT02690974|583336086|FG000|Overall Study|Withdrawal of Informed Consent|3|||
161531962|NCT02690974|583336086|FG000|Overall Study|Physician Decision|2|||
161591581|NCT04924660|583554733|FG004|Spain|Death|0|||
161591582|NCT04924660|583554734|FG005|Spain|Death|2|||
161591583|NCT04924660|583554729|FG000|Spain|Lost to Follow-up|0|||
161678603|NCT00766090|583876053|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161531963|NCT02690974|583336086|FG000|Overall Study|Non-compliance with study treatment|1|||
161531964|NCT02690974|583336086|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161531965|NCT02690974|583336086|FG000|Overall Study|Protocol Deviation|1|||
161531966|NCT01666951|583336089|FG000|Overall Study|Not dosed|1|||
161531967|NCT01666951|583336090|FG001|Overall Study|Not dosed|1|||
161531968|NCT00420199|583336096|FG000|Overall Study|Participant no longer met study criteria|1|||
161531969|NCT00420199|583336097|FG001|Overall Study|Participant no longer met study criteria|0|||
161531970|NCT00254982|583336108|FG000|Overall Study|Other|2|||
161531971|NCT00254982|583336109|FG001|Overall Study|Other|1|||
161531972|NCT00254982|583336108|FG000|Overall Study|Lack of Efficacy|5|||
161531973|NCT00254982|583336109|FG001|Overall Study|Lack of Efficacy|3|||
161531974|NCT00254982|583336108|FG000|Overall Study|Lost to Follow-up|5|||
161591584|NCT04924660|583554730|FG001|Spain|Lost to Follow-up|0|||
161591585|NCT04924660|583554731|FG002|Spain|Lost to Follow-up|0|||
161678604|NCT00766090|583876054|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
161678605|NCT00766090|583876055|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678606|NCT00766090|583876056|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678607|NCT00766090|583876057|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678608|NCT00766090|583876046|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
161531975|NCT00254982|583336109|FG001|Overall Study|Lost to Follow-up|3|||
161591586|NCT04924660|583554732|FG003|Spain|Lost to Follow-up|0|||
161591587|NCT04924660|583554733|FG004|Spain|Lost to Follow-up|1|||
161591588|NCT04924660|583554734|FG005|Spain|Lost to Follow-up|0|||
161591589|NCT04924660|583554729|FG000|Brazil|Death|0|||
161531976|NCT00254982|583336108|FG000|Overall Study|Adverse Event|18|||
161531977|NCT00254982|583336109|FG001|Overall Study|Adverse Event|16|||
161531978|NCT00254982|583336108|FG000|Overall Study|Withdrawal by Subject|1|||
161531979|NCT00254982|583336109|FG001|Overall Study|Withdrawal by Subject|1|||
161531980|NCT00254982|583336108|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
161531981|NCT00254982|583336109|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
161531982|NCT00254982|583336108|FG000|Overall Study|Protocol deviation|1|||
161531983|NCT00254982|583336109|FG001|Overall Study|Protocol deviation|1|||
161531984|NCT00254982|583336108|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
161531985|NCT00254982|583336109|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
161531986|NCT00254982|583336108|FG000|Overall Study|Malignancy|0|||
161531987|NCT00254982|583336109|FG001|Overall Study|Malignancy|2|||
161531988|NCT00254982|583336108|FG000|Overall Study|Opportunistic infection|1|||
161531989|NCT00254982|583336109|FG001|Overall Study|Opportunistic infection|0|||
161531990|NCT00254982|583336108|FG000|Overall Study|Abnormal liver function tests|2|||
161531991|NCT00254982|583336109|FG001|Overall Study|Abnormal liver function tests|1|||
161531992|NCT02570126|583336110|FG000|Overall Study|Lost to Follow-up|2|||
161531993|NCT02570126|583336111|FG001|Overall Study|Lost to Follow-up|0|||
161531994|NCT02570126|583336110|FG000|Overall Study|Unable To Arrange Visit 3|1|||
161531995|NCT02570126|583336111|FG001|Overall Study|Unable To Arrange Visit 3|0|||
161531996|NCT02570126|583336110|FG000|Overall Study|Violation Of Procedures GSK|0|||
161531997|NCT02570126|583336111|FG001|Overall Study|Violation Of Procedures GSK|1|||
161531998|NCT02570126|583336110|FG000|Overall Study|Protocol Violation|0|||
161531999|NCT02570126|583336111|FG001|Overall Study|Protocol Violation|1|||
161532000|NCT02570126|583336110|FG000|Overall Study|Withdrawal by Subject|3|||
161532001|NCT02570126|583336111|FG001|Overall Study|Withdrawal by Subject|7|||
161532002|NCT00626028|583336112|FG000|Overall Study|Adverse Event|1|||
161532003|NCT00626028|583336113|FG001|Overall Study|Adverse Event|1|||
161532004|NCT00626028|583336112|FG000|Overall Study|Device Failure|0|||
161532005|NCT00626028|583336113|FG001|Overall Study|Device Failure|1|||
161532006|NCT00626028|583336112|FG000|Overall Study|Physician Decision|2|||
161532007|NCT00626028|583336113|FG001|Overall Study|Physician Decision|1|||
161532008|NCT00626028|583336112|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
161532009|NCT00626028|583336113|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
161532010|NCT05224050|583336115|FG000|Overall Study|Withdrawal by Subject|9|||
161532011|NCT05224050|583336115|FG000|Overall Study|Lost to Follow-up|3|||
161532012|NCT00917579|583336116|FG000|Washout >= 2 Weeks|Adverse Event|1|||
161532013|NCT00917579|583336117|FG001|Washout >= 2 Weeks|Adverse Event|0|||
161532014|NCT00917579|583336116|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
161532015|NCT00917579|583336117|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
161532016|NCT05763628|583336118|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
161532017|NCT05763628|583336119|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
161532018|NCT05763628|583336118|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
161532019|NCT05763628|583336119|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
161532020|NCT05763628|583336118|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
161532021|NCT05763628|583336119|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
161532022|NCT00868439|583336125|FG000|Overall Study|Adverse Event|4|||
161532023|NCT00868439|583336126|FG001|Overall Study|Adverse Event|3|||
161591590|NCT04924660|583554730|FG001|Brazil|Death|0|||
161532024|NCT00868439|583336125|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
161532025|NCT00868439|583336126|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
161532026|NCT00868439|583336125|FG000|Overall Study|Death|0|||
161532027|NCT00868439|583336126|FG001|Overall Study|Death|1|||
161532028|NCT00868439|583336125|FG000|Overall Study|Protocol Violation|1|||
161532029|NCT00868439|583336126|FG001|Overall Study|Protocol Violation|1|||
161532030|NCT00868439|583336125|FG000|Overall Study|Physician Decision|1|||
161532031|NCT00868439|583336126|FG001|Overall Study|Physician Decision|0|||
161532032|NCT00868439|583336125|FG000|Overall Study|Withdrawal by Subject|0|||
161532033|NCT00868439|583336126|FG001|Overall Study|Withdrawal by Subject|1|||
161532034|NCT01132326|583336127|FG000|Overall Study|Lack of Efficacy|25|||
161532035|NCT01132326|583336127|FG000|Overall Study|Adverse Event|37|||
161532036|NCT01132326|583336127|FG000|Overall Study|Protocol Violation|1|||
161532037|NCT01132326|583336127|FG000|Overall Study|Lost to Follow-up|16|||
161532038|NCT01132326|583336127|FG000|Overall Study|Withdrawal by Subject|40|||
161532039|NCT01132326|583336127|FG000|Overall Study|Physician Decision|10|||
161532040|NCT01132326|583336127|FG000|Overall Study|Study Termination|80|||
161532041|NCT01132326|583336127|FG000|Overall Study|Declining Health|1|||
161532042|NCT01132326|583336127|FG000|Overall Study|Pregnancy|1|||
161532043|NCT01132326|583336127|FG000|Overall Study|Caregiver Withdrew Consent|1|||
161828685|NCT04100096|584413572|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161828686|NCT04100096|584413573|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161828687|NCT04100096|584413572|FG000|Overall Study|Protocol Deviation|1|||
161828688|NCT04100096|584413573|FG001|Overall Study|Protocol Deviation|1|||
161828689|NCT04100096|584413572|FG000|Overall Study|Withdrawal by Participant|13|||
161828690|NCT04100096|584413573|FG001|Overall Study|Withdrawal by Participant|15|||
161828691|NCT01684215|584413574|FG000|Phase 1, Part 1|Adverse Event|1|||
161828692|NCT01684215|584413575|FG001|Phase 1, Part 1|Adverse Event|0|||
161828693|NCT01684215|584413576|FG002|Phase 1, Part 1|Adverse Event|0|||
161828694|NCT01684215|584413577|FG003|Phase 1, Part 1|Adverse Event|0|||
161828695|NCT01684215|584413574|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
161828696|NCT01684215|584413575|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
161828697|NCT01684215|584413576|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
161828698|NCT01684215|584413577|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
161828699|NCT01684215|584413574|FG000|Phase 1, Part 2|Adverse Event|0|||
161828700|NCT01684215|584413575|FG001|Phase 1, Part 2|Adverse Event|0|||
161828701|NCT01684215|584413576|FG002|Phase 1, Part 2|Adverse Event|1|||
161828702|NCT01684215|584413577|FG003|Phase 1, Part 2|Adverse Event|0|||
161828703|NCT01684215|584413574|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161828704|NCT01684215|584413575|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161828705|NCT01684215|584413576|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
161828706|NCT01684215|584413577|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161828707|NCT01684215|584413574|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
161828708|NCT01684215|584413575|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
161828709|NCT01684215|584413576|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
161828710|NCT01684215|584413577|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
161828711|NCT01684215|584413574|FG000|Phase 2|Death|0|||
161828712|NCT01684215|584413575|FG001|Phase 2|Death|0|||
161828713|NCT01684215|584413576|FG002|Phase 2|Death|0|||
161828714|NCT01684215|584413577|FG003|Phase 2|Death|8|||
161828715|NCT01684215|584413574|FG000|Phase 2|Study terminated by sponsor|0|||
161828716|NCT01684215|584413575|FG001|Phase 2|Study terminated by sponsor|0|||
161828717|NCT01684215|584413576|FG002|Phase 2|Study terminated by sponsor|0|||
161828718|NCT01684215|584413577|FG003|Phase 2|Study terminated by sponsor|30|||
161828719|NCT01684215|584413574|FG000|Phase 2|Enrolled but not treated|0|||
161828720|NCT01684215|584413575|FG001|Phase 2|Enrolled but not treated|0|||
161828721|NCT01684215|584413576|FG002|Phase 2|Enrolled but not treated|0|||
161828722|NCT01684215|584413577|FG003|Phase 2|Enrolled but not treated|1|||
161828723|NCT01684215|584413574|FG000|Phase 2|Lost to Follow-up|0|||
161828724|NCT01684215|584413575|FG001|Phase 2|Lost to Follow-up|0|||
161828725|NCT01684215|584413576|FG002|Phase 2|Lost to Follow-up|0|||
161828726|NCT01684215|584413577|FG003|Phase 2|Lost to Follow-up|4|||
161828727|NCT00480324|584413578|FG000|Overall Study|Adverse Event|1|||
161828728|NCT00480324|584413579|FG001|Overall Study|Adverse Event|1|||
161828729|NCT00480324|584413578|FG000|Overall Study|Protocol Violation|0|||
161828730|NCT00480324|584413579|FG001|Overall Study|Protocol Violation|1|||
161828731|NCT00480324|584413578|FG000|Overall Study|Withdrawal by Subject|14|||
161828732|NCT00480324|584413579|FG001|Overall Study|Withdrawal by Subject|5|||
161828733|NCT00480324|584413578|FG000|Overall Study|Lost to Follow-up|17|||
161828734|NCT00480324|584413579|FG001|Overall Study|Lost to Follow-up|8|||
161828735|NCT00480324|584413578|FG000|Overall Study|Subject's mother pregnant|0|||
161828736|NCT00480324|584413579|FG001|Overall Study|Subject's mother pregnant|1|||
161828737|NCT00784134|584413580|FG000|Overall Study|Lost to Follow-up|3|||
161828738|NCT00784134|584413581|FG001|Overall Study|Lost to Follow-up|6|||
161828739|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
161828740|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
161828741|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
161828742|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
161828743|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
161828744|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
161532044|NCT01132326|583336127|FG000|Overall Study|Death|5|||
161532045|NCT01132326|583336127|FG000|Overall Study|Subject Unable to Come To Visits|1|||
161532046|NCT00338884|583336130|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
161532047|NCT00338884|583336130|FG000|Overall Study|Adverse Event|14|||
161532048|NCT00338884|583336130|FG000|Overall Study|Death|8|||
161532049|NCT00338884|583336130|FG000|Overall Study|Other|4|||
161532050|NCT00338884|583336130|FG000|Overall Study|Global Deterioration of Health Status|3|||
161532051|NCT00338884|583336130|FG000|Overall Study|Withdrawal by Subject|3|||
161532052|NCT00338884|583336130|FG000|Overall Study|Lost to Follow-up|1|||
161532053|NCT00338884|583336130|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
161828745|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
161828746|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
161532054|NCT00911534|583336131|FG000|Overall Study|Adverse Event|4|||
161532055|NCT00911534|583336132|FG001|Overall Study|Adverse Event|4|||
161532056|NCT00911534|583336131|FG000|Overall Study|Lost to Follow-up|2|||
161828747|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
161828748|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
161828749|NCT03785145|584413582|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
161828750|NCT03785145|584413583|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
161828751|NCT03785145|584413582|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
161828752|NCT03785145|584413583|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
161828753|NCT03785145|584413582|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
161828754|NCT03785145|584413583|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
161828755|NCT03785145|584413582|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
161828756|NCT03785145|584413583|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
161828757|NCT03785145|584413582|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
161828758|NCT03785145|584413583|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
161828759|NCT03785145|584413582|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
161828760|NCT03785145|584413583|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
161828761|NCT00966381|584413584|FG000|Overall Study|Withdrawal by Subject|2|||
161828762|NCT00966381|584413585|FG001|Overall Study|Withdrawal by Subject|2|||
161828763|NCT01915940|584413586|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
161828764|NCT01915940|584413587|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
161828765|NCT01915940|584413588|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
161828766|NCT01915940|584413586|FG000|Treatment Period|Decision of Participant|0|||
161828767|NCT01915940|584413587|FG001|Treatment Period|Decision of Participant|1|||
161828768|NCT01915940|584413588|FG002|Treatment Period|Decision of Participant|3|||
161828769|NCT01915940|584413586|FG000|Treatment Period|Adverse Event|0|||
161828770|NCT01915940|584413587|FG001|Treatment Period|Adverse Event|9|||
161828771|NCT01915940|584413588|FG002|Treatment Period|Adverse Event|1|||
161828772|NCT01915940|584413586|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161828773|NCT01915940|584413587|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
161828774|NCT01915940|584413588|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
161828775|NCT03686150|584413589|FG000|Overall Study|Withdrawal by Subject|1|||
161828776|NCT03686150|584413590|FG001|Overall Study|Withdrawal by Subject|1|||
161828777|NCT03686150|584413591|FG002|Overall Study|Withdrawal by Subject|1|||
161828778|NCT03686150|584413592|FG003|Overall Study|Withdrawal by Subject|0|||
161828779|NCT03686150|584413593|FG004|Overall Study|Withdrawal by Subject|1|||
161828780|NCT03686150|584413594|FG005|Overall Study|Withdrawal by Subject|2|||
161828781|NCT03686150|584413589|FG000|Overall Study|Physician Decision|1|||
161828782|NCT03686150|584413590|FG001|Overall Study|Physician Decision|0|||
161828783|NCT03686150|584413591|FG002|Overall Study|Physician Decision|0|||
161828784|NCT03686150|584413592|FG003|Overall Study|Physician Decision|0|||
161828785|NCT03686150|584413593|FG004|Overall Study|Physician Decision|0|||
161828786|NCT03686150|584413594|FG005|Overall Study|Physician Decision|1|||
161828787|NCT03686150|584413589|FG000|Overall Study|Lost to Follow-up|0|||
161828788|NCT03686150|584413590|FG001|Overall Study|Lost to Follow-up|1|||
161828789|NCT03686150|584413591|FG002|Overall Study|Lost to Follow-up|0|||
161828790|NCT03686150|584413592|FG003|Overall Study|Lost to Follow-up|0|||
161828791|NCT03686150|584413593|FG004|Overall Study|Lost to Follow-up|0|||
161828792|NCT03686150|584413594|FG005|Overall Study|Lost to Follow-up|0|||
161828793|NCT02443324|584413595|FG000|Overall Study|Death|4|||
161828794|NCT02443324|584413596|FG001|Overall Study|Death|1|||
161828795|NCT02443324|584413597|FG002|Overall Study|Death|0|||
161828796|NCT02443324|584413598|FG003|Overall Study|Death|3|||
161828797|NCT02443324|584413599|FG004|Overall Study|Death|1|||
161828798|NCT02443324|584413600|FG005|Overall Study|Death|3|||
161828799|NCT02443324|584413601|FG006|Overall Study|Death|2|||
161532057|NCT00911534|583336132|FG001|Overall Study|Lost to Follow-up|4|||
161532058|NCT00911534|583336131|FG000|Overall Study|Withdrawal by Subject|2|||
161532059|NCT00911534|583336132|FG001|Overall Study|Withdrawal by Subject|1|||
161532060|NCT00911534|583336131|FG000|Overall Study|Lack of Efficacy|4|||
161532061|NCT00911534|583336132|FG001|Overall Study|Lack of Efficacy|1|||
161532062|NCT00911534|583336131|FG000|Overall Study|Withdrawal of consent|1|||
161532063|NCT00911534|583336132|FG001|Overall Study|Withdrawal of consent|4|||
161532064|NCT00911534|583336131|FG000|Overall Study|Other|2|||
161532065|NCT00911534|583336132|FG001|Overall Study|Other|2|||
161532066|NCT05072080|583336136|FG000|Overall Study|Death|0|||
161532067|NCT05072080|583336137|FG001|Overall Study|Death|0|||
161532068|NCT05072080|583336138|FG002|Overall Study|Death|1|||
161532069|NCT05072080|583336139|FG003|Overall Study|Death|0|||
161532070|NCT05072080|583336136|FG000|Overall Study|Lost to Follow-up|65|||
161532071|NCT05072080|583336137|FG001|Overall Study|Lost to Follow-up|70|||
161532072|NCT05072080|583336138|FG002|Overall Study|Lost to Follow-up|58|||
161532073|NCT05072080|583336139|FG003|Overall Study|Lost to Follow-up|23|||
161532074|NCT05072080|583336136|FG000|Overall Study|Physician Decision|2|||
161532075|NCT05072080|583336137|FG001|Overall Study|Physician Decision|1|||
161532076|NCT05072080|583336138|FG002|Overall Study|Physician Decision|1|||
161532077|NCT05072080|583336139|FG003|Overall Study|Physician Decision|0|||
161532078|NCT05072080|583336136|FG000|Overall Study|Withdrawal by Subject|45|||
161532079|NCT05072080|583336137|FG001|Overall Study|Withdrawal by Subject|30|||
161532080|NCT05072080|583336138|FG002|Overall Study|Withdrawal by Subject|27|||
161532081|NCT05072080|583336139|FG003|Overall Study|Withdrawal by Subject|7|||
161532082|NCT05072080|583336136|FG000|Overall Study|Sponsor Decision|0|||
161532083|NCT05072080|583336137|FG001|Overall Study|Sponsor Decision|1|||
161532084|NCT05072080|583336138|FG002|Overall Study|Sponsor Decision|0|||
161532085|NCT05072080|583336139|FG003|Overall Study|Sponsor Decision|0|||
161532086|NCT05072080|583336136|FG000|Overall Study|Subject moved|1|||
161532087|NCT05072080|583336137|FG001|Overall Study|Subject moved|3|||
161532088|NCT05072080|583336138|FG002|Overall Study|Subject moved|5|||
161532089|NCT05072080|583336139|FG003|Overall Study|Subject moved|2|||
161532090|NCT05072080|583336136|FG000|Overall Study|Withdrawal by parent|0|||
161532091|NCT05072080|583336137|FG001|Overall Study|Withdrawal by parent|0|||
161532092|NCT05072080|583336138|FG002|Overall Study|Withdrawal by parent|1|||
161532093|NCT05072080|583336139|FG003|Overall Study|Withdrawal by parent|0|||
161532094|NCT05072080|583336136|FG000|Overall Study|Subject was deployed|0|||
161532095|NCT05072080|583336137|FG001|Overall Study|Subject was deployed|1|||
161532096|NCT05072080|583336138|FG002|Overall Study|Subject was deployed|0|||
161532097|NCT05072080|583336139|FG003|Overall Study|Subject was deployed|0|||
161532098|NCT05072080|583336136|FG000|Overall Study|Subject left site without receiving dose|0|||
161532099|NCT05072080|583336137|FG001|Overall Study|Subject left site without receiving dose|1|||
161532100|NCT05072080|583336138|FG002|Overall Study|Subject left site without receiving dose|0|||
161532101|NCT05072080|583336139|FG003|Overall Study|Subject left site without receiving dose|0|||
161532102|NCT05072080|583336136|FG000|Overall Study|Subject incarcerated|0|||
161532103|NCT05072080|583336137|FG001|Overall Study|Subject incarcerated|1|||
161532104|NCT05072080|583336138|FG002|Overall Study|Subject incarcerated|0|||
161532105|NCT05072080|583336139|FG003|Overall Study|Subject incarcerated|1|||
161532106|NCT05072080|583336136|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
161532107|NCT05072080|583336137|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
161532108|NCT05072080|583336138|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
161532109|NCT05072080|583336139|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
161532110|NCT05072080|583336136|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
161828800|NCT02443324|584413595|FG000|Overall Study|Lost to Follow-up|0|||
161828801|NCT02443324|584413596|FG001|Overall Study|Lost to Follow-up|0|||
161828802|NCT02443324|584413597|FG002|Overall Study|Lost to Follow-up|0|||
161828803|NCT02443324|584413598|FG003|Overall Study|Lost to Follow-up|1|||
161828804|NCT02443324|584413599|FG004|Overall Study|Lost to Follow-up|0|||
161828805|NCT02443324|584413600|FG005|Overall Study|Lost to Follow-up|1|||
161828806|NCT02443324|584413601|FG006|Overall Study|Lost to Follow-up|0|||
161828807|NCT02443324|584413595|FG000|Overall Study|Physician Decision|0|||
161828808|NCT02443324|584413596|FG001|Overall Study|Physician Decision|3|||
161828809|NCT02443324|584413597|FG002|Overall Study|Physician Decision|5|||
161828810|NCT02443324|584413598|FG003|Overall Study|Physician Decision|1|||
161828811|NCT02443324|584413599|FG004|Overall Study|Physician Decision|1|||
161828812|NCT02443324|584413600|FG005|Overall Study|Physician Decision|0|||
161828813|NCT02443324|584413601|FG006|Overall Study|Physician Decision|2|||
161828814|NCT02443324|584413595|FG000|Overall Study|Progressive Disease|20|||
161828815|NCT02443324|584413596|FG001|Overall Study|Progressive Disease|20|||
161828816|NCT02443324|584413597|FG002|Overall Study|Progressive Disease|13|||
161828817|NCT02443324|584413598|FG003|Overall Study|Progressive Disease|10|||
161828818|NCT02443324|584413599|FG004|Overall Study|Progressive Disease|13|||
161828819|NCT02443324|584413600|FG005|Overall Study|Progressive Disease|17|||
161591591|NCT04924660|583554731|FG002|Brazil|Death|0|||
161591592|NCT04924660|583554732|FG003|Brazil|Death|0|||
161591593|NCT04924660|583554733|FG004|Brazil|Death|1|||
161591594|NCT04924660|583554734|FG005|Brazil|Death|0|||
161591595|NCT04924660|583554729|FG000|Italy|Lost to Follow-up|0|||
161591596|NCT04924660|583554730|FG001|Italy|Lost to Follow-up|0|||
161591597|NCT04924660|583554731|FG002|Italy|Lost to Follow-up|0|||
161591598|NCT04924660|583554732|FG003|Italy|Lost to Follow-up|0|||
161532111|NCT05072080|583336137|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
161532112|NCT05072080|583336138|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
161532113|NCT05072080|583336139|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
161532114|NCT03342638|583336140|FG000|Overall Study|Withdrawal by Subject|1|||
161532115|NCT03342638|583336141|FG001|Overall Study|Withdrawal by Subject|0|||
161532116|NCT03342638|583336140|FG000|Overall Study|Physician Decision|0|||
161532117|NCT03342638|583336141|FG001|Overall Study|Physician Decision|1|||
161532118|NCT00113568|583336157|FG000|Overall Study|Adverse Event|97|||
161532119|NCT00113568|583336157|FG000|Overall Study|Death|1|||
161532120|NCT00113568|583336157|FG000|Overall Study|Lack of Efficacy|30|||
161532121|NCT00113568|583336157|FG000|Overall Study|Lost to Follow-up|156|||
161532122|NCT00113568|583336157|FG000|Overall Study|Protocol Violation|32|||
161532123|NCT00113568|583336157|FG000|Overall Study|Withdrawal by Subject|117|||
161532124|NCT00113568|583336157|FG000|Overall Study|Other|112|||
161532125|NCT02191267|583336159|FG000|Overall Study|Withdrawal by Subject|1|||
161532126|NCT02191267|583336160|FG001|Overall Study|Withdrawal by Subject|0|||
161532127|NCT02191267|583336161|FG002|Overall Study|Withdrawal by Subject|0|||
161532128|NCT03213158|583336164|FG000|Overall Study|Withdrawal by Subject|1|||
161532129|NCT03213158|583336164|FG000|Overall Study|Physician Decision|2|||
161532130|NCT00587964|583336168|FG000|Overall Study|Withdrawal by Subject|1|||
161532131|NCT00587964|583336168|FG000|Overall Study|Lost to Follow-up|1|||
161532132|NCT00587964|583336168|FG000|Overall Study|Patient found to be ineligible|1|||
161532133|NCT00587964|583336168|FG000|Overall Study|Patient did not receive intervention|5|||
161532134|NCT00587964|583336168|FG000|Overall Study|Progression of Disease|4|||
161532135|NCT01569438|583336170|FG000|Overall Study|Lack of Efficacy|1|||
161532136|NCT01569438|583336171|FG001|Overall Study|Lack of Efficacy|2|||
161532137|NCT01569438|583336170|FG000|Overall Study|Withdrawal by Subject|0|||
161532138|NCT01569438|583336171|FG001|Overall Study|Withdrawal by Subject|3|||
161532139|NCT01569438|583336170|FG000|Overall Study|Adverse Event|2|||
161532140|NCT01569438|583336171|FG001|Overall Study|Adverse Event|15|||
161532141|NCT01569438|583336170|FG000|Overall Study|Protocol Violation|2|||
161532142|NCT01569438|583336171|FG001|Overall Study|Protocol Violation|0|||
161532143|NCT01569438|583336170|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
161532144|NCT01569438|583336171|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
161532145|NCT01569438|583336170|FG000|Overall Study|Sponsor/Physician decision|1|||
161532146|NCT01569438|583336171|FG001|Overall Study|Sponsor/Physician decision|1|||
161532147|NCT01569438|583336170|FG000|Overall Study|Unable to adhere to study schedule|0|||
161532148|NCT01569438|583336171|FG001|Overall Study|Unable to adhere to study schedule|1|||
161532149|NCT03649230|583336173|FG000|Overall Study|Adverse Event|12|||
161532150|NCT03649230|583336173|FG000|Overall Study|Death|8|||
161532151|NCT03649230|583336173|FG000|Overall Study|Withdrawal by Subject|6|||
161532152|NCT03649230|583336173|FG000|Overall Study|Physician Decision|5|||
161532153|NCT03649230|583336173|FG000|Overall Study|Disease progression|5|||
161532154|NCT03649230|583336173|FG000|Overall Study|Switched to non-HEC|5|||
161532155|NCT03649230|583336173|FG000|Overall Study|Chemotherapy discontinued|4|||
161532156|NCT03649230|583336173|FG000|Overall Study|Received only 3 HEC cycles|4|||
161532157|NCT03649230|583336173|FG000|Overall Study|Screen Failure|3|||
161532158|NCT03649230|583336173|FG000|Overall Study|Patient stopped treatment|2|||
161532159|NCT03649230|583336173|FG000|Overall Study|Protocol Violation|1|||
161532160|NCT03649230|583336173|FG000|Overall Study|Non-compliance|1|||
161532161|NCT03649230|583336173|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
161532162|NCT01693068|583336177|FG000|Randomization Period|On-study|2|||
161532163|NCT01693068|583336178|FG001|Randomization Period|On-study|5|||
161532164|NCT01693068|583336179|FG002|Randomization Period|On-study|0|||
161532165|NCT01693068|583336177|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
161532166|NCT01693068|583336178|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
161532167|NCT01693068|583336179|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
161532168|NCT00736645|583336183|FG000|Overall Study|Adverse Event|0|||
161532169|NCT00736645|583336184|FG001|Overall Study|Adverse Event|2|||
161532170|NCT00736645|583336185|FG002|Overall Study|Adverse Event|0|||
161532171|NCT00736645|583336186|FG003|Overall Study|Adverse Event|0|||
161532172|NCT04302350|583336187|FG000|Overall Study|Physician Decision|1|||
161532173|NCT04302350|583336188|FG001|Overall Study|Physician Decision|1|||
161532174|NCT04302350|583336189|FG002|Overall Study|Physician Decision|2|||
161532175|NCT04302350|583336187|FG000|Overall Study|Lack of Efficacy|1|||
161532176|NCT04302350|583336188|FG001|Overall Study|Lack of Efficacy|1|||
161532177|NCT04302350|583336189|FG002|Overall Study|Lack of Efficacy|4|||
161532178|NCT04302350|583336187|FG000|Overall Study|Adverse Event|0|||
161532179|NCT04302350|583336188|FG001|Overall Study|Adverse Event|1|||
161532180|NCT04302350|583336189|FG002|Overall Study|Adverse Event|2|||
161532181|NCT02137369|583336192|FG000|Overall Study|Withdrawal by Subject|3|||
161532182|NCT02137369|583336193|FG001|Overall Study|Withdrawal by Subject|2|||
161532183|NCT02137369|583336192|FG000|Overall Study|Adverse Event|2|||
161532184|NCT02137369|583336193|FG001|Overall Study|Adverse Event|0|||
161532185|NCT02137369|583336192|FG000|Overall Study|Lost to Follow-up|1|||
161532186|NCT02137369|583336193|FG001|Overall Study|Lost to Follow-up|0|||
161532187|NCT02137369|583336192|FG000|Overall Study|Moved away|2|||
161532188|NCT02137369|583336193|FG001|Overall Study|Moved away|0|||
161532189|NCT02747238|583336203|FG000|Overall Study|Lack of Efficacy|0|||
161532190|NCT02747238|583336204|FG001|Overall Study|Lack of Efficacy|1|||
161532191|NCT02747238|583336203|FG000|Overall Study|Data lost|3|||
161532192|NCT02747238|583336204|FG001|Overall Study|Data lost|5|||
161678609|NCT00766090|583876047|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678610|NCT00766090|583876048|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161532193|NCT01475136|583336208|FG000|Overall Study|Sponsor Decision|0|||
161532194|NCT01475136|583336209|FG001|Overall Study|Sponsor Decision|1|||
161532195|NCT01475136|583336210|FG002|Overall Study|Sponsor Decision|0|||
161678611|NCT00766090|583876049|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161532196|NCT01475136|583336211|FG003|Overall Study|Sponsor Decision|0|||
161532197|NCT01475136|583336208|FG000|Overall Study|Entry Criteria Not Met|0|||
161532198|NCT01475136|583336209|FG001|Overall Study|Entry Criteria Not Met|2|||
161532199|NCT01475136|583336210|FG002|Overall Study|Entry Criteria Not Met|3|||
161532200|NCT01475136|583336211|FG003|Overall Study|Entry Criteria Not Met|1|||
161532201|NCT01475136|583336208|FG000|Overall Study|Withdrawal by Subject|0|||
161532202|NCT01475136|583336209|FG001|Overall Study|Withdrawal by Subject|0|||
161532203|NCT01475136|583336210|FG002|Overall Study|Withdrawal by Subject|0|||
161532204|NCT01475136|583336211|FG003|Overall Study|Withdrawal by Subject|2|||
161532205|NCT01475136|583336208|FG000|Overall Study|Adverse Event|1|||
161532206|NCT01475136|583336209|FG001|Overall Study|Adverse Event|0|||
161532207|NCT01475136|583336210|FG002|Overall Study|Adverse Event|0|||
161532208|NCT01475136|583336211|FG003|Overall Study|Adverse Event|1|||
161532209|NCT01475136|583336208|FG000|Overall Study|Death|0|||
161532210|NCT01475136|583336209|FG001|Overall Study|Death|0|||
161532211|NCT01475136|583336210|FG002|Overall Study|Death|0|||
161532212|NCT01475136|583336211|FG003|Overall Study|Death|1|||
161532213|NCT01329029|583336212|FG000|Overall Study|Withdrawal by Subject|117|||
161532214|NCT01329029|583336213|FG001|Overall Study|Withdrawal by Subject|87|||
161532215|NCT01329029|583336212|FG000|Overall Study|Adverse Event|82|||
161532216|NCT01329029|583336213|FG001|Overall Study|Adverse Event|29|||
161532217|NCT01329029|583336212|FG000|Overall Study|Death|16|||
161532218|NCT01329029|583336213|FG001|Overall Study|Death|19|||
161532219|NCT01329029|583336212|FG000|Overall Study|Other|14|||
161532220|NCT01329029|583336213|FG001|Overall Study|Other|20|||
161532221|NCT01329029|583336212|FG000|Overall Study|COPD Exacerbation|11|||
161532222|NCT01329029|583336213|FG001|Overall Study|COPD Exacerbation|18|||
161532223|NCT01329029|583336212|FG000|Overall Study|Physician Decision|16|||
161532224|NCT01329029|583336213|FG001|Overall Study|Physician Decision|13|||
161532225|NCT01329029|583336212|FG000|Overall Study|Lost to Follow-up|8|||
161532226|NCT01329029|583336213|FG001|Overall Study|Lost to Follow-up|5|||
161532227|NCT01329029|583336212|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
161532228|NCT01329029|583336213|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
161532229|NCT01323530|583338629|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
161532230|NCT01323530|583338630|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161532231|NCT01323530|583338631|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161532232|NCT01323530|583338632|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161532233|NCT01323530|583338633|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161532234|NCT01323530|583338634|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
161532235|NCT01323530|583338635|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161532236|NCT01323530|583338629|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
161532237|NCT01323530|583338630|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
161532238|NCT01323530|583338631|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
161532239|NCT01323530|583338632|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161532240|NCT01323530|583338633|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
161532241|NCT01323530|583338634|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161532242|NCT01323530|583338635|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161532243|NCT01323530|583338629|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
161532244|NCT01323530|583338630|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
161532245|NCT01323530|583338631|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
161532246|NCT01323530|583338632|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
161532247|NCT01323530|583338633|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
161532248|NCT01323530|583338634|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
161532249|NCT01323530|583338635|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
161532250|NCT01323530|583338629|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161532251|NCT01323530|583338630|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161532252|NCT01323530|583338631|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161532253|NCT01323530|583338632|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161532254|NCT01323530|583338633|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161532255|NCT01323530|583338634|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161532256|NCT01323530|583338635|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
161532257|NCT01323530|583338629|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
161532258|NCT01323530|583338630|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
161532259|NCT01323530|583338631|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
161532260|NCT01323530|583338632|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
161532261|NCT01323530|583338633|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
161532262|NCT01323530|583338634|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
161532263|NCT01323530|583338635|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
161532264|NCT01323530|583338629|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
161532265|NCT01323530|583338630|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
161532266|NCT01323530|583338631|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
161532267|NCT01323530|583338632|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
161532268|NCT01323530|583338633|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
161532269|NCT01323530|583338634|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
161532270|NCT01323530|583338635|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
161532271|NCT01323530|583338629|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
161532272|NCT01323530|583338630|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
161532273|NCT01323530|583338631|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
161532274|NCT01323530|583338632|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
161532275|NCT01323530|583338633|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
161532276|NCT01323530|583338634|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
161532277|NCT01323530|583338635|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
161532278|NCT01323530|583338629|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
161532279|NCT01323530|583338630|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
161532280|NCT01323530|583338631|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
161532281|NCT01323530|583338632|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
161532282|NCT01323530|583338633|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
161532283|NCT01323530|583338634|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
161532284|NCT01323530|583338635|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
161532285|NCT01194570|583338638|FG000|Overall Study|Adverse Event|22|||
161828820|NCT02443324|584413601|FG006|Overall Study|Progressive Disease|10|||
161828821|NCT02443324|584413595|FG000|Overall Study|Withdrawal by Subject|0|||
161828822|NCT02443324|584413596|FG001|Overall Study|Withdrawal by Subject|0|||
161828823|NCT02443324|584413597|FG002|Overall Study|Withdrawal by Subject|3|||
161828824|NCT02443324|584413598|FG003|Overall Study|Withdrawal by Subject|1|||
161828825|NCT02443324|584413599|FG004|Overall Study|Withdrawal by Subject|1|||
161828826|NCT02443324|584413600|FG005|Overall Study|Withdrawal by Subject|0|||
161828827|NCT02443324|584413601|FG006|Overall Study|Withdrawal by Subject|1|||
161828828|NCT02443324|584413595|FG000|Overall Study|Adverse Event|0|||
161828829|NCT02443324|584413596|FG001|Overall Study|Adverse Event|1|||
161828830|NCT02443324|584413597|FG002|Overall Study|Adverse Event|3|||
161828831|NCT02443324|584413598|FG003|Overall Study|Adverse Event|0|||
161828832|NCT02443324|584413599|FG004|Overall Study|Adverse Event|4|||
161828833|NCT02443324|584413600|FG005|Overall Study|Adverse Event|3|||
161828834|NCT02443324|584413601|FG006|Overall Study|Adverse Event|3|||
161828835|NCT02443324|584413595|FG000|Overall Study|Enrolled but Never Treated|0|||
161828836|NCT02443324|584413596|FG001|Overall Study|Enrolled but Never Treated|0|||
161828837|NCT02443324|584413597|FG002|Overall Study|Enrolled but Never Treated|1|||
161828838|NCT02443324|584413598|FG003|Overall Study|Enrolled but Never Treated|0|||
161828839|NCT02443324|584413599|FG004|Overall Study|Enrolled but Never Treated|1|||
161828840|NCT02443324|584413600|FG005|Overall Study|Enrolled but Never Treated|0|||
161828841|NCT02443324|584413601|FG006|Overall Study|Enrolled but Never Treated|1|||
161828842|NCT04025684|584413612|FG000|Overall Study|Withdrawal by Subject|1|||
161828843|NCT04025684|584413613|FG001|Overall Study|Withdrawal by Subject|1|||
161828844|NCT04025684|584413614|FG002|Overall Study|Withdrawal by Subject|0|||
161828845|NCT04025684|584413615|FG003|Overall Study|Withdrawal by Subject|0|||
161828846|NCT04025684|584413612|FG000|Overall Study|Multiple reasons|1|||
161828847|NCT04025684|584413613|FG001|Overall Study|Multiple reasons|3|||
161828848|NCT04025684|584413614|FG002|Overall Study|Multiple reasons|0|||
161828849|NCT04025684|584413615|FG003|Overall Study|Multiple reasons|1|||
161828850|NCT01844531|584413616|FG000|Overall Study|Withdrawal by Subject|0|||
161828851|NCT01844531|584413617|FG001|Overall Study|Withdrawal by Subject|1|||
161828852|NCT01844531|584413618|FG002|Overall Study|Withdrawal by Subject|0|||
161828853|NCT01844531|584413619|FG003|Overall Study|Withdrawal by Subject|0|||
161828854|NCT01546922|584413620|FG000|First Period of 10 Weeks|Protocol Violation|3|||
161828855|NCT01546922|584413621|FG001|First Period of 10 Weeks|Protocol Violation|1|||
161828856|NCT01546922|584413620|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
161828857|NCT01546922|584413621|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
161828858|NCT01546922|584413620|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
161532286|NCT01194570|583338639|FG001|Overall Study|Adverse Event|40|||
161532287|NCT01194570|583338638|FG000|Overall Study|Death|6|||
161532288|NCT01194570|583338639|FG001|Overall Study|Death|20|||
161532289|NCT01194570|583338638|FG000|Overall Study|Lack of Efficacy|32|||
161532290|NCT01194570|583338639|FG001|Overall Study|Lack of Efficacy|33|||
161532291|NCT01194570|583338638|FG000|Overall Study|Lost to Follow-up|4|||
161532292|NCT01194570|583338639|FG001|Overall Study|Lost to Follow-up|15|||
161532293|NCT01194570|583338638|FG000|Overall Study|Non-Compliance|2|||
161532294|NCT01194570|583338639|FG001|Overall Study|Non-Compliance|2|||
161532295|NCT01194570|583338638|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161532296|NCT01194570|583338639|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161532297|NCT01194570|583338638|FG000|Overall Study|Other|18|||
161532298|NCT01194570|583338639|FG001|Overall Study|Other|47|||
161532299|NCT01194570|583338638|FG000|Overall Study|Physician Decision|10|||
161532300|NCT01194570|583338639|FG001|Overall Study|Physician Decision|25|||
161532301|NCT01194570|583338638|FG000|Overall Study|Protocol Violation|1|||
161532302|NCT01194570|583338639|FG001|Overall Study|Protocol Violation|2|||
161532303|NCT01194570|583338638|FG000|Overall Study|Study Terminated By Sponsor|0|||
161532304|NCT01194570|583338639|FG001|Overall Study|Study Terminated By Sponsor|1|||
161532305|NCT01194570|583338638|FG000|Overall Study|Withdrawal by Subject|57|||
161532306|NCT01194570|583338639|FG001|Overall Study|Withdrawal by Subject|82|||
161532307|NCT01194570|583338638|FG000|Overall Study|Pregnancy|1|||
161532308|NCT01194570|583338639|FG001|Overall Study|Pregnancy|1|||
161532309|NCT01377480|583338646|FG000|Overall Study|Protocol Violation|0|||
161532310|NCT01377480|583338647|FG001|Overall Study|Protocol Violation|0|||
161532311|NCT01377480|583338648|FG002|Overall Study|Protocol Violation|0|||
161532312|NCT01377480|583338649|FG003|Overall Study|Protocol Violation|4|||
161532313|NCT01377480|583338646|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
161532314|NCT01377480|583338647|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
161532315|NCT01377480|583338648|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
161532316|NCT01377480|583338649|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
161532317|NCT01377480|583338646|FG000|Overall Study|Withdrawal by Subject|0|||
161532318|NCT01377480|583338647|FG001|Overall Study|Withdrawal by Subject|0|||
161532319|NCT01377480|583338648|FG002|Overall Study|Withdrawal by Subject|1|||
161532320|NCT01377480|583338649|FG003|Overall Study|Withdrawal by Subject|0|||
161532321|NCT01377480|583338646|FG000|Overall Study|Serious adverse event|0|||
161532322|NCT01377480|583338647|FG001|Overall Study|Serious adverse event|0|||
161828859|NCT01546922|584413621|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
161591599|NCT04924660|583554733|FG004|Italy|Lost to Follow-up|0|||
161591600|NCT04924660|583554734|FG005|Italy|Lost to Follow-up|1|||
161532323|NCT01377480|583338648|FG002|Overall Study|Serious adverse event|1|||
161532324|NCT01377480|583338649|FG003|Overall Study|Serious adverse event|1|||
161591601|NCT04924660|583554729|FG000|South Africa|Death|0|||
161532325|NCT01377480|583338646|FG000|Overall Study|Other|0|||
161532326|NCT01377480|583338647|FG001|Overall Study|Other|0|||
161532327|NCT01377480|583338648|FG002|Overall Study|Other|7|||
161532328|NCT01377480|583338649|FG003|Overall Study|Other|6|||
161591602|NCT04924660|583554730|FG001|South Africa|Death|0|||
161532329|NCT01203930|583338654|FG000|Overall Study|Disease Progression|0|||
161532330|NCT01203930|583338655|FG001|Overall Study|Disease Progression|4|||
161532331|NCT01203930|583338654|FG000|Overall Study|Death|3|||
161532332|NCT01203930|583338655|FG001|Overall Study|Death|1|||
161532333|NCT01203930|583338654|FG000|Overall Study|Withdrew Consent|1|||
161532334|NCT01203930|583338655|FG001|Overall Study|Withdrew Consent|10|||
161678612|NCT00766090|583876050|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678613|NCT00766090|583876051|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678614|NCT00766090|583876052|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678615|NCT00766090|583876053|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678616|NCT00766090|583876054|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678617|NCT00766090|583876055|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678618|NCT00766090|583876056|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678619|NCT00766090|583876057|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678620|NCT00766090|583876046|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161678621|NCT00766090|583876047|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678622|NCT00766090|583876048|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678623|NCT00766090|583876049|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161532335|NCT01203930|583338654|FG000|Overall Study|Investigator Request|0|||
161532336|NCT01203930|583338655|FG001|Overall Study|Investigator Request|8|||
161678624|NCT00766090|583876050|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161828860|NCT01546922|584413620|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
161828861|NCT01546922|584413621|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
161828862|NCT01546922|584413620|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
161828863|NCT01546922|584413621|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
161828864|NCT01613378|584413629|FG000|Overall Study|Lack of Efficacy|13|||
161828865|NCT01613378|584413629|FG000|Overall Study|Adverse Event|11|||
161828866|NCT01613378|584413629|FG000|Overall Study|Withdrawal by Subject|8|||
161828867|NCT01613378|584413629|FG000|Overall Study|Death|2|||
161828868|NCT01613378|584413629|FG000|Overall Study|Lost to Follow-up|1|||
161828869|NCT01613378|584413629|FG000|Overall Study|Other Reason|4|||
161828870|NCT00418522|584413630|FG000|Overall Study|Adverse Event|7|||
161828871|NCT00418522|584413631|FG001|Overall Study|Adverse Event|1|||
161828872|NCT00418522|584413630|FG000|Overall Study|Lack of Efficacy|1|||
161828873|NCT00418522|584413631|FG001|Overall Study|Lack of Efficacy|3|||
161828874|NCT00418522|584413630|FG000|Overall Study|Lost to Follow-up|10|||
161828875|NCT00418522|584413631|FG001|Overall Study|Lost to Follow-up|4|||
161828876|NCT00418522|584413630|FG000|Overall Study|Withdrawal by Subject|31|||
161828877|NCT00418522|584413631|FG001|Overall Study|Withdrawal by Subject|7|||
161532337|NCT01203930|583338654|FG000|Overall Study|Study Terminated by Sponsor|0|||
161532338|NCT01203930|583338655|FG001|Overall Study|Study Terminated by Sponsor|12|||
161532339|NCT01203930|583338654|FG000|Overall Study|Poor tolerance of study drug|0|||
161532340|NCT01203930|583338655|FG001|Overall Study|Poor tolerance of study drug|1|||
161532341|NCT01203930|583338654|FG000|Overall Study|Adverse Event|17|||
161532342|NCT01203930|583338655|FG001|Overall Study|Adverse Event|5|||
161532343|NCT01266850|583338656|FG000|Overall Study|Lost to Follow-up|19|||
161532344|NCT01266850|583338657|FG001|Overall Study|Lost to Follow-up|19|||
161532345|NCT01266850|583338658|FG002|Overall Study|Lost to Follow-up|13|||
161532346|NCT01266850|583338659|FG003|Overall Study|Lost to Follow-up|13|||
161532347|NCT01266850|583338660|FG004|Overall Study|Lost to Follow-up|12|||
161532348|NCT01266850|583338656|FG000|Overall Study|Withdrawal by Subject|8|||
161532349|NCT01266850|583338657|FG001|Overall Study|Withdrawal by Subject|9|||
161532350|NCT01266850|583338658|FG002|Overall Study|Withdrawal by Subject|6|||
161532351|NCT01266850|583338659|FG003|Overall Study|Withdrawal by Subject|9|||
161532352|NCT01266850|583338660|FG004|Overall Study|Withdrawal by Subject|12|||
161532353|NCT01266850|583338656|FG000|Overall Study|Physician Decision|3|||
161532354|NCT01266850|583338657|FG001|Overall Study|Physician Decision|6|||
161532355|NCT01266850|583338658|FG002|Overall Study|Physician Decision|4|||
161532356|NCT01266850|583338659|FG003|Overall Study|Physician Decision|4|||
161532357|NCT01266850|583338660|FG004|Overall Study|Physician Decision|3|||
161532358|NCT01266850|583338656|FG000|Overall Study|Protocol Violation|0|||
161532359|NCT01266850|583338657|FG001|Overall Study|Protocol Violation|1|||
161532360|NCT01266850|583338658|FG002|Overall Study|Protocol Violation|0|||
161532361|NCT01266850|583338659|FG003|Overall Study|Protocol Violation|1|||
161532362|NCT01266850|583338660|FG004|Overall Study|Protocol Violation|2|||
161532363|NCT01266850|583338656|FG000|Overall Study|Adverse Event|0|||
161532364|NCT01266850|583338657|FG001|Overall Study|Adverse Event|0|||
161532365|NCT01266850|583338658|FG002|Overall Study|Adverse Event|0|||
161532366|NCT01266850|583338659|FG003|Overall Study|Adverse Event|0|||
161532367|NCT01266850|583338660|FG004|Overall Study|Adverse Event|1|||
161532368|NCT01266850|583338656|FG000|Overall Study|Site Closure|0|||
161532369|NCT01266850|583338657|FG001|Overall Study|Site Closure|1|||
161532370|NCT01266850|583338658|FG002|Overall Study|Site Closure|1|||
161532371|NCT01266850|583338659|FG003|Overall Study|Site Closure|1|||
161532372|NCT01266850|583338660|FG004|Overall Study|Site Closure|0|||
161532373|NCT04098406|583338664|FG000|Overall Study|Adverse Event|2|||
161591603|NCT04924660|583554731|FG002|South Africa|Death|0|||
161532374|NCT04098406|583338665|FG001|Overall Study|Adverse Event|1|||
161532375|NCT04098406|583338664|FG000|Overall Study|Withdrawal by Subject|1|||
161532376|NCT04098406|583338665|FG001|Overall Study|Withdrawal by Subject|0|||
161532377|NCT03382782|583338668|FG000|Cohort 1|Withdrawal by Subject|11|||
161532378|NCT03382782|583338669|FG001|Cohort 1|Withdrawal by Subject|5|||
161532379|NCT03382782|583338670|FG002|Cohort 1|Withdrawal by Subject|0|||
161532380|NCT03382782|583338668|FG000|Cohort 2|Withdrawal by Subject|1|||
161532381|NCT03382782|583338669|FG001|Cohort 2|Withdrawal by Subject|1|||
161532382|NCT03382782|583338670|FG002|Cohort 2|Withdrawal by Subject|0|||
161532383|NCT03382782|583338668|FG000|Cohort 3|Withdrawal by Subject|1|||
161532384|NCT03382782|583338669|FG001|Cohort 3|Withdrawal by Subject|2|||
161532385|NCT03382782|583338670|FG002|Cohort 3|Withdrawal by Subject|0|||
161532386|NCT00428090|583338675|FG000|Overall Study|Adverse Event|10|||
161532387|NCT00428090|583338676|FG001|Overall Study|Adverse Event|8|||
161532388|NCT00428090|583338677|FG002|Overall Study|Adverse Event|10|||
161532389|NCT00428090|583338678|FG003|Overall Study|Adverse Event|11|||
161532390|NCT00428090|583338675|FG000|Overall Study|Lost to Follow-up|3|||
161532391|NCT00428090|583338676|FG001|Overall Study|Lost to Follow-up|6|||
161532392|NCT00428090|583338677|FG002|Overall Study|Lost to Follow-up|1|||
161532393|NCT00428090|583338678|FG003|Overall Study|Lost to Follow-up|4|||
161532394|NCT00428090|583338675|FG000|Overall Study|Protocol Violation|3|||
161532395|NCT00428090|583338676|FG001|Overall Study|Protocol Violation|1|||
161532396|NCT00428090|583338677|FG002|Overall Study|Protocol Violation|3|||
161532397|NCT00428090|583338678|FG003|Overall Study|Protocol Violation|3|||
161532398|NCT00428090|583338675|FG000|Overall Study|Withdrawal by Subject|10|||
161532399|NCT00428090|583338676|FG001|Overall Study|Withdrawal by Subject|12|||
161532400|NCT00428090|583338677|FG002|Overall Study|Withdrawal by Subject|15|||
161532401|NCT00428090|583338678|FG003|Overall Study|Withdrawal by Subject|5|||
161532402|NCT00428090|583338675|FG000|Overall Study|Sponsor terminated study|0|||
161532403|NCT00428090|583338676|FG001|Overall Study|Sponsor terminated study|1|||
161532404|NCT00428090|583338677|FG002|Overall Study|Sponsor terminated study|0|||
161532405|NCT00428090|583338678|FG003|Overall Study|Sponsor terminated study|0|||
161532406|NCT00428090|583338675|FG000|Overall Study|Non-compliance|4|||
161532407|NCT00428090|583338676|FG001|Overall Study|Non-compliance|0|||
161532408|NCT00428090|583338677|FG002|Overall Study|Non-compliance|1|||
161532409|NCT00428090|583338678|FG003|Overall Study|Non-compliance|3|||
161532410|NCT00428090|583338675|FG000|Overall Study|Par. did not returned to visit|1|||
161532411|NCT00428090|583338676|FG001|Overall Study|Par. did not returned to visit|0|||
161532412|NCT00428090|583338677|FG002|Overall Study|Par. did not returned to visit|0|||
161532413|NCT00428090|583338678|FG003|Overall Study|Par. did not returned to visit|1|||
161532414|NCT00428090|583338675|FG000|Overall Study|Follow-Up visit not possible|1|||
161532415|NCT00428090|583338676|FG001|Overall Study|Follow-Up visit not possible|0|||
161532416|NCT00428090|583338677|FG002|Overall Study|Follow-Up visit not possible|0|||
161532417|NCT00428090|583338678|FG003|Overall Study|Follow-Up visit not possible|0|||
161532418|NCT00428090|583338675|FG000|Overall Study|Prohibited medication used for SAE|1|||
161532419|NCT00428090|583338676|FG001|Overall Study|Prohibited medication used for SAE|0|||
161532420|NCT00428090|583338677|FG002|Overall Study|Prohibited medication used for SAE|0|||
161532421|NCT00428090|583338678|FG003|Overall Study|Prohibited medication used for SAE|0|||
161532422|NCT00428090|583338675|FG000|Overall Study|Death of par.|1|||
161532423|NCT00428090|583338676|FG001|Overall Study|Death of par.|0|||
161532424|NCT00428090|583338677|FG002|Overall Study|Death of par.|1|||
161532425|NCT00428090|583338678|FG003|Overall Study|Death of par.|0|||
161532426|NCT00428090|583338675|FG000|Overall Study|Visit 7 exceed the visit window|0|||
161532427|NCT00428090|583338676|FG001|Overall Study|Visit 7 exceed the visit window|1|||
161532428|NCT00428090|583338677|FG002|Overall Study|Visit 7 exceed the visit window|0|||
161532429|NCT00428090|583338678|FG003|Overall Study|Visit 7 exceed the visit window|0|||
161532430|NCT00428090|583338675|FG000|Overall Study|Medical monitor terminated par.|0|||
161532431|NCT00428090|583338676|FG001|Overall Study|Medical monitor terminated par.|1|||
161532432|NCT00428090|583338677|FG002|Overall Study|Medical monitor terminated par.|0|||
161532433|NCT00428090|583338678|FG003|Overall Study|Medical monitor terminated par.|0|||
161532434|NCT00428090|583338675|FG000|Overall Study|Mental status of par. was|0|||
161532435|NCT00428090|583338676|FG001|Overall Study|Mental status of par. was|1|||
161532436|NCT00428090|583338677|FG002|Overall Study|Mental status of par. was|0|||
161532437|NCT00428090|583338678|FG003|Overall Study|Mental status of par. was|0|||
161532438|NCT00428090|583338675|FG000|Overall Study|Worsening of AD|0|||
161532439|NCT00428090|583338676|FG001|Overall Study|Worsening of AD|0|||
161532440|NCT00428090|583338677|FG002|Overall Study|Worsening of AD|1|||
161532441|NCT00428090|583338678|FG003|Overall Study|Worsening of AD|0|||
161532442|NCT00428090|583338675|FG000|Overall Study|Excluded for concerning QTc value|0|||
161532443|NCT00428090|583338676|FG001|Overall Study|Excluded for concerning QTc value|0|||
161532444|NCT00428090|583338677|FG002|Overall Study|Excluded for concerning QTc value|1|||
161532445|NCT00428090|583338678|FG003|Overall Study|Excluded for concerning QTc value|0|||
161532446|NCT00428090|583338675|FG000|Overall Study|Insufficient AD documentation|0|||
161532447|NCT00428090|583338676|FG001|Overall Study|Insufficient AD documentation|0|||
161532448|NCT00428090|583338677|FG002|Overall Study|Insufficient AD documentation|1|||
161532449|NCT00428090|583338678|FG003|Overall Study|Insufficient AD documentation|0|||
161532450|NCT00428090|583338675|FG000|Overall Study|High MMSE scores|0|||
161532451|NCT00428090|583338676|FG001|Overall Study|High MMSE scores|0|||
161532452|NCT00428090|583338677|FG002|Overall Study|High MMSE scores|1|||
161532453|NCT00428090|583338678|FG003|Overall Study|High MMSE scores|0|||
161532454|NCT00428090|583338675|FG000|Overall Study|Deterioration of cognitive status|0|||
161532455|NCT00428090|583338676|FG001|Overall Study|Deterioration of cognitive status|0|||
161532456|NCT00428090|583338677|FG002|Overall Study|Deterioration of cognitive status|1|||
161532457|NCT00428090|583338678|FG003|Overall Study|Deterioration of cognitive status|0|||
161532458|NCT00428090|583338675|FG000|Overall Study|Serious adverse event|0|||
161532459|NCT00428090|583338676|FG001|Overall Study|Serious adverse event|0|||
161532460|NCT00428090|583338677|FG002|Overall Study|Serious adverse event|1|||
161532461|NCT00428090|583338678|FG003|Overall Study|Serious adverse event|0|||
161532462|NCT00428090|583338675|FG000|Overall Study|Excluded for heart insufficiency|0|||
161532463|NCT00428090|583338676|FG001|Overall Study|Excluded for heart insufficiency|0|||
161532464|NCT00428090|583338677|FG002|Overall Study|Excluded for heart insufficiency|1|||
161532465|NCT00428090|583338678|FG003|Overall Study|Excluded for heart insufficiency|0|||
161532466|NCT00428090|583338675|FG000|Overall Study|Raised Creatinine Value|0|||
161532467|NCT00428090|583338676|FG001|Overall Study|Raised Creatinine Value|0|||
161532468|NCT00428090|583338677|FG002|Overall Study|Raised Creatinine Value|0|||
161828878|NCT00418522|584413630|FG000|Overall Study|Other|27|||
161828879|NCT00418522|584413631|FG001|Overall Study|Other|23|||
161828880|NCT00418522|584413630|FG000|Overall Study|Randomized but did not receive treatment|7|||
161532469|NCT00428090|583338678|FG003|Overall Study|Raised Creatinine Value|1|||
161532470|NCT03409666|583338679|FG000|Overall Study|Physician Decision|0|||
161532471|NCT03409666|583338680|FG001|Overall Study|Physician Decision|1|||
161828881|NCT00418522|584413631|FG001|Overall Study|Randomized but did not receive treatment|4|||
161828882|NCT01005329|584413632|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
161828883|NCT02147587|584413633|FG000|Overall Study|Adverse Event|9|||
161828884|NCT02147587|584413634|FG001|Overall Study|Adverse Event|4|||
161828885|NCT02147587|584413633|FG000|Overall Study|Lack of Efficacy|2|||
161828886|NCT02147587|584413634|FG001|Overall Study|Lack of Efficacy|1|||
161828887|NCT01315028|584413639|FG000|Overall Study|Lost to Follow-up|1|||
161828888|NCT01315028|584413640|FG001|Overall Study|Lost to Follow-up|0|||
161828889|NCT01315028|584413639|FG000|Overall Study|Death|0|||
161828890|NCT01315028|584413640|FG001|Overall Study|Death|1|||
161828891|NCT02531594|584413641|FG000|Overall Study|Withdrawal by Subject|7|||
161828892|NCT02531594|584413642|FG001|Overall Study|Withdrawal by Subject|8|||
161828893|NCT01175473|584413656|FG000|Overall Study|Adverse Event|2|||
161828894|NCT01175473|584413657|FG001|Overall Study|Adverse Event|2|||
161828895|NCT04234464|584413660|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
161831521|NCT03135899|584424796|FG004|Overall Study|Withdrawal by Subject|0|||
161831522|NCT03135899|584424797|FG005|Overall Study|Withdrawal by Subject|2|||
161831523|NCT03135899|584424798|FG006|Overall Study|Withdrawal by Subject|0|||
161831524|NCT03135899|584424799|FG007|Overall Study|Withdrawal by Subject|0|||
161831525|NCT04373551|584424800|FG000|Overall Study|Lost to Follow-up|15|||
161831526|NCT04373551|584424800|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
161831527|NCT02914236|584424801|FG000|Overall Study|Lost to Follow-up|1|||
161831528|NCT01042535|584424802|FG000|Overall Study|disease progression prior to treatment|3|||
161831529|NCT01042535|584424802|FG000|Overall Study|disease progression during treatment|3|||
161831530|NCT01042535|584424802|FG000|Overall Study|complications from other disease|2|||
161831531|NCT03438539|584424809|FG000|Overall Study|Lost to Follow-up|8|||
161831532|NCT03438539|584424810|FG001|Overall Study|Lost to Follow-up|4|||
161831533|NCT03438539|584424811|FG002|Overall Study|Lost to Follow-up|10|||
161828896|NCT04234464|584413661|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
161828897|NCT00983528|584413662|FG000|Overall Study|Death|4|||
161828898|NCT00983528|584413662|FG000|Overall Study|Lost to Follow-up|1|||
161828899|NCT00983528|584413662|FG000|Overall Study|Study Terminated|1|||
161828900|NCT03635983|584413663|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161828901|NCT03635983|584413664|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
161828902|NCT03635983|584413663|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161828903|NCT03635983|584413664|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161828904|NCT03635983|584413663|FG000|Pre-Treatment Period|Other reasons|0|||
161828905|NCT03635983|584413664|FG001|Pre-Treatment Period|Other reasons|1|||
161828906|NCT03635983|584413663|FG000|Pre-Treatment Period|Disease Progression|0|||
161828907|NCT03635983|584413664|FG001|Pre-Treatment Period|Disease Progression|1|||
161828908|NCT03635983|584413663|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
161828909|NCT03635983|584413664|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
161828910|NCT03635983|584413663|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
161828911|NCT03635983|584413664|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
161828912|NCT03635983|584413663|FG000|Treatment Period|Withdrawal by Subject|3|||
161828913|NCT03635983|584413664|FG001|Treatment Period|Withdrawal by Subject|5|||
161828914|NCT03635983|584413663|FG000|Treatment Period|Death|3|||
161828915|NCT03635983|584413664|FG001|Treatment Period|Death|5|||
161828916|NCT03635983|584413663|FG000|Treatment Period|Poor/Non-compliance|2|||
161828917|NCT03635983|584413664|FG001|Treatment Period|Poor/Non-compliance|1|||
161828918|NCT03635983|584413663|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
161828919|NCT03635983|584413664|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
161828920|NCT03635983|584413663|FG000|Treatment Period|Other reasons|7|||
161828921|NCT03635983|584413664|FG001|Treatment Period|Other reasons|4|||
161828922|NCT03635983|584413663|FG000|Treatment Period|Disease progression|230|||
161828923|NCT03635983|584413664|FG001|Treatment Period|Disease progression|201|||
161828924|NCT03635983|584413663|FG000|Treatment Period|Study drug toxicity|35|||
161828925|NCT03635983|584413664|FG001|Treatment Period|Study drug toxicity|36|||
161828926|NCT03635983|584413663|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
161828927|NCT03635983|584413664|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
161828928|NCT03635983|584413663|FG000|Treatment Period|Maximum clinical benefit|3|||
161828929|NCT03635983|584413664|FG001|Treatment Period|Maximum clinical benefit|5|||
161828930|NCT03635983|584413663|FG000|Treatment Period|Administrative reason by the sponsor|1|||
161828931|NCT03635983|584413664|FG001|Treatment Period|Administrative reason by the sponsor|2|||
161828932|NCT03635983|584413663|FG000|Treatment Period|Lost to Follow-up|0|||
161828933|NCT03635983|584413664|FG001|Treatment Period|Lost to Follow-up|1|||
161828934|NCT03365791|584413666|FG000|Overall Study|Adverse Event|5|||
161828935|NCT03365791|584413666|FG000|Overall Study|Death|1|||
161828936|NCT03365791|584413666|FG000|Overall Study|Lost to Follow-up|1|||
161828937|NCT03365791|584413666|FG000|Overall Study|Physician Decision|9|||
161532472|NCT03409666|583338679|FG000|Overall Study|Protocol Violation|0|||
161532473|NCT03409666|583338680|FG001|Overall Study|Protocol Violation|3|||
161532474|NCT00512148|583338684|FG000|Primay Study Period|Withdrawal by Subject|1|||
161532475|NCT02623322|583338685|FG000|Overall Study|Lost to Follow-up|2|||
161532476|NCT02623322|583338686|FG001|Overall Study|Lost to Follow-up|1|||
161532477|NCT02623322|583338687|FG002|Overall Study|Lost to Follow-up|0|||
161828938|NCT03365791|584413666|FG000|Overall Study|Progressive disease|51|||
161532478|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
161532479|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
161828939|NCT03365791|584413666|FG000|Overall Study|Subject/guardian decision|5|||
161828940|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
161828941|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828942|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828943|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828944|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828945|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828946|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828947|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161532480|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
161532481|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
161532482|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
161532483|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161532484|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
161532485|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
161532486|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
161532487|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
161532488|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
161532489|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
161532490|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Death|6|||
161532491|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Death|3|||
161532492|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Death|0|||
161532493|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Death|1|||
161532494|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Death|1|||
161532495|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Death|0|||
161532496|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
161532497|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
161532498|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
161532499|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
161532500|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
161532501|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
161532502|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
161532503|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
161532504|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
161532505|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
161532506|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
161532507|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
161532508|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
161532509|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
161532510|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
161532511|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
161532512|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
161532513|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
161532514|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
161532515|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
161532516|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
161532517|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
161591604|NCT04924660|583554732|FG003|South Africa|Death|0|||
161532518|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
161532519|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
161532520|NCT03104699|583338688|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
161532521|NCT03104699|583338689|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
161532522|NCT03104699|583338690|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
161532523|NCT03104699|583338691|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
161532524|NCT03104699|583338692|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
161532525|NCT03104699|583338693|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
161532526|NCT03104699|583338688|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161532527|NCT03104699|583338689|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161532528|NCT03104699|583338690|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161532529|NCT03104699|583338691|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161532530|NCT03104699|583338692|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
161532531|NCT03104699|583338693|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
161532532|NCT03104699|583338688|FG000|Phase 2: Dose Expansion|Death|0|||
161532533|NCT03104699|583338689|FG001|Phase 2: Dose Expansion|Death|0|||
161532534|NCT03104699|583338690|FG002|Phase 2: Dose Expansion|Death|0|||
161532535|NCT03104699|583338691|FG003|Phase 2: Dose Expansion|Death|0|||
161532536|NCT03104699|583338692|FG004|Phase 2: Dose Expansion|Death|0|||
161532537|NCT03104699|583338693|FG005|Phase 2: Dose Expansion|Death|107|||
161532538|NCT03104699|583338688|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
161532539|NCT03104699|583338689|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
161532540|NCT03104699|583338690|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
161532541|NCT03104699|583338691|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
161532542|NCT03104699|583338692|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
161532543|NCT03104699|583338693|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
161532544|NCT03104699|583338688|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
161532545|NCT03104699|583338689|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
161532546|NCT03104699|583338690|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
161532547|NCT03104699|583338691|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
161532548|NCT03104699|583338692|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
161532549|NCT03104699|583338693|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
161532550|NCT03104699|583338688|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161532551|NCT03104699|583338689|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161532552|NCT03104699|583338690|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161532553|NCT03104699|583338691|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161532554|NCT03104699|583338692|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
161532555|NCT03104699|583338693|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
161532556|NCT03104699|583338688|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
161532557|NCT03104699|583338689|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
161532558|NCT03104699|583338690|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
161532559|NCT03104699|583338691|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
161532560|NCT03104699|583338692|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
161532561|NCT03104699|583338693|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
161532562|NCT02450331|583338694|FG000|Overall Study|Death|162|||
161532563|NCT02450331|583338695|FG001|Overall Study|Death|171|||
161532564|NCT02450331|583338694|FG000|Overall Study|Lost to Follow-up|14|||
161532565|NCT02450331|583338695|FG001|Overall Study|Lost to Follow-up|12|||
161532566|NCT02450331|583338694|FG000|Overall Study|Withdrawal by Subject|55|||
161532567|NCT02450331|583338695|FG001|Overall Study|Withdrawal by Subject|44|||
161532568|NCT02450331|583338694|FG000|Overall Study|Non-specified other|1|||
161532569|NCT02450331|583338695|FG001|Overall Study|Non-specified other|1|||
161532570|NCT02080871|583338696|FG000|Overall Study|Death|1|||
161532571|NCT02080871|583338696|FG000|Overall Study|Lost to Follow-up|1|||
161532572|NCT00234052|583338697|FG000|Treatment|Withdrawal by Subject|3|||
161532573|NCT00234052|583338697|FG000|Treatment|Adverse Event|5|||
161532574|NCT00234052|583338697|FG000|Treatment|Death|2|||
161532575|NCT00234052|583338697|FG000|Treatment|Progressive Disease|11|||
161532576|NCT00234052|583338697|FG000|Follow-up for 5 Years|Death|41|||
161532577|NCT00234052|583338697|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
161532578|NCT00234052|583338697|FG000|Follow-up for 5 Years|Other|7|||
161532579|NCT01410474|583338698|FG000|Overall Study|Withdrawal by Subject|0|||
161532580|NCT01410474|583338699|FG001|Overall Study|Withdrawal by Subject|1|||
161532581|NCT02428296|583338700|FG000|Overall Study|Adverse Event|7|||
161591605|NCT04924660|583554733|FG004|South Africa|Death|0|||
161591606|NCT04924660|583554734|FG005|South Africa|Death|1|||
161591607|NCT04924660|583554729|FG000|South Africa|Lost to Follow-up|0|||
161591608|NCT04924660|583554730|FG001|South Africa|Lost to Follow-up|0|||
161591609|NCT04924660|583554731|FG002|South Africa|Lost to Follow-up|0|||
161532582|NCT02428296|583338700|FG000|Overall Study|Withdrawal by Subject|2|||
161532583|NCT04493931|583338704|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
161532584|NCT04493931|583338705|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
161532585|NCT04493931|583338706|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
161532586|NCT04493931|583338707|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
161532587|NCT04493931|583338708|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
161532588|NCT04493931|583338709|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
161532589|NCT04493931|583338710|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
161532590|NCT04493931|583338704|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
161532591|NCT04493931|583338705|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
161532592|NCT04493931|583338706|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
161532593|NCT04493931|583338707|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
161532594|NCT04493931|583338708|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
161532595|NCT04493931|583338709|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
161532596|NCT04493931|583338710|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
161532597|NCT04493931|583338704|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
161532598|NCT04493931|583338705|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
161532599|NCT04493931|583338706|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
161532600|NCT04493931|583338707|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
161532601|NCT04493931|583338708|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
161532602|NCT04493931|583338709|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
161532603|NCT04493931|583338710|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
161532604|NCT04493931|583338704|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
161532605|NCT04493931|583338705|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
161532606|NCT04493931|583338706|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
161532607|NCT04493931|583338707|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
161532608|NCT04493931|583338708|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
161532609|NCT04493931|583338709|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
161532610|NCT04493931|583338710|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
161532611|NCT03338894|583338711|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
161532612|NCT02261493|583338713|FG000|Overall Study|Noncompliance|0|||
161532613|NCT02261493|583338714|FG001|Overall Study|Noncompliance|0|||
161532614|NCT02261493|583338715|FG002|Overall Study|Noncompliance|2|||
161532615|NCT02261493|583338713|FG000|Overall Study|Physician Decision|0|||
161532616|NCT02261493|583338714|FG001|Overall Study|Physician Decision|1|||
161532617|NCT02261493|583338715|FG002|Overall Study|Physician Decision|0|||
161532618|NCT02261493|583338713|FG000|Overall Study|Undisclosed alcohol abuse|0|||
161532619|NCT02261493|583338714|FG001|Overall Study|Undisclosed alcohol abuse|1|||
161532620|NCT02261493|583338715|FG002|Overall Study|Undisclosed alcohol abuse|0|||
161532621|NCT02261493|583338713|FG000|Overall Study|Protocol Violation|1|||
161532622|NCT02261493|583338714|FG001|Overall Study|Protocol Violation|0|||
161532623|NCT02261493|583338715|FG002|Overall Study|Protocol Violation|0|||
161532624|NCT02261493|583338713|FG000|Overall Study|Personal Reasons|14|||
161532625|NCT02261493|583338714|FG001|Overall Study|Personal Reasons|14|||
161532626|NCT02261493|583338715|FG002|Overall Study|Personal Reasons|16|||
161532627|NCT02261493|583338713|FG000|Overall Study|Lost to Follow-up|14|||
161532628|NCT02261493|583338714|FG001|Overall Study|Lost to Follow-up|27|||
161532629|NCT02261493|583338715|FG002|Overall Study|Lost to Follow-up|8|||
161532630|NCT02261493|583338713|FG000|Overall Study|Pregnancy|1|||
161532631|NCT02261493|583338714|FG001|Overall Study|Pregnancy|2|||
161532632|NCT02261493|583338715|FG002|Overall Study|Pregnancy|0|||
161532633|NCT02261493|583338713|FG000|Overall Study|Lack of Efficacy|0|||
161532634|NCT02261493|583338714|FG001|Overall Study|Lack of Efficacy|1|||
161532635|NCT02261493|583338715|FG002|Overall Study|Lack of Efficacy|0|||
161532636|NCT02261493|583338713|FG000|Overall Study|Adverse Event|0|||
161532637|NCT02261493|583338714|FG001|Overall Study|Adverse Event|1|||
161532638|NCT02261493|583338715|FG002|Overall Study|Adverse Event|0|||
161532639|NCT00558428|583338716|FG000|Overall Study|Adverse Event|6|||
161532640|NCT00558428|583338717|FG001|Overall Study|Adverse Event|22|||
161532641|NCT00558428|583338718|FG002|Overall Study|Adverse Event|3|||
161532642|NCT00558428|583338719|FG003|Overall Study|Adverse Event|4|||
161532643|NCT00558428|583338716|FG000|Overall Study|Lost to Follow-up|0|||
161532644|NCT00558428|583338717|FG001|Overall Study|Lost to Follow-up|1|||
161532645|NCT00558428|583338718|FG002|Overall Study|Lost to Follow-up|0|||
161532646|NCT00558428|583338719|FG003|Overall Study|Lost to Follow-up|0|||
161532647|NCT00558428|583338716|FG000|Overall Study|Lack of Efficacy|0|||
161532648|NCT00558428|583338717|FG001|Overall Study|Lack of Efficacy|0|||
161532649|NCT00558428|583338718|FG002|Overall Study|Lack of Efficacy|1|||
161532650|NCT00558428|583338719|FG003|Overall Study|Lack of Efficacy|2|||
161532651|NCT00558428|583338716|FG000|Overall Study|Non compliant with protocol|1|||
161532652|NCT00558428|583338717|FG001|Overall Study|Non compliant with protocol|0|||
161532653|NCT00558428|583338718|FG002|Overall Study|Non compliant with protocol|0|||
161532654|NCT00558428|583338719|FG003|Overall Study|Non compliant with protocol|3|||
161532655|NCT00558428|583338716|FG000|Overall Study|Consent withdrawn|2|||
161532656|NCT00558428|583338717|FG001|Overall Study|Consent withdrawn|1|||
161532657|NCT00558428|583338718|FG002|Overall Study|Consent withdrawn|0|||
161532658|NCT00558428|583338719|FG003|Overall Study|Consent withdrawn|1|||
161532659|NCT00558428|583338716|FG000|Overall Study|Other|3|||
161532660|NCT00558428|583338717|FG001|Overall Study|Other|0|||
161532661|NCT00558428|583338718|FG002|Overall Study|Other|0|||
161532662|NCT00558428|583338719|FG003|Overall Study|Other|1|||
161532663|NCT00754338|583338720|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
161532664|NCT00754338|583338721|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
161532665|NCT00754338|583338722|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
161532666|NCT00754338|583338723|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
161532667|NCT00754338|583338720|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
161532668|NCT00754338|583338721|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
161532669|NCT00754338|583338722|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
161532670|NCT00754338|583338723|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
161532671|NCT00831779|583338726|FG000|Overall Study|Lost to Follow-up|1|||
161532672|NCT00831779|583338727|FG001|Overall Study|Lost to Follow-up|0|||
161532673|NCT00831779|583338726|FG000|Overall Study|No longer met criteria|0|||
161828948|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161591610|NCT04924660|583554732|FG003|South Africa|Lost to Follow-up|0|||
161591611|NCT04924660|583554733|FG004|South Africa|Lost to Follow-up|0|||
161591612|NCT04924660|583554734|FG005|South Africa|Lost to Follow-up|1|||
161591613|NCT03557697|583554735|FG000|Overall Study|Withdrawal by Subject|2|||
161591614|NCT03557697|583554736|FG001|Overall Study|Withdrawal by Subject|4|||
161591615|NCT03197662|583554737|FG000|Overall Study|Withdrawn by family|0|||
161591616|NCT03197662|583554738|FG001|Overall Study|Withdrawn by family|2|||
161591617|NCT03721952|583554739|FG000|Overall Study|Lost to Follow-up|0|||
161591618|NCT03721952|583554740|FG001|Overall Study|Lost to Follow-up|0|||
161591619|NCT03721952|583554741|FG002|Overall Study|Lost to Follow-up|2|||
161591620|NCT03721952|583554742|FG003|Overall Study|Lost to Follow-up|0|||
161591621|NCT03721952|583554743|FG004|Overall Study|Lost to Follow-up|0|||
161591622|NCT03721952|583554739|FG000|Overall Study|Protocol Violation|0|||
161591623|NCT03721952|583554740|FG001|Overall Study|Protocol Violation|1|||
161591624|NCT03721952|583554741|FG002|Overall Study|Protocol Violation|0|||
161591625|NCT03721952|583554742|FG003|Overall Study|Protocol Violation|0|||
161591626|NCT03721952|583554743|FG004|Overall Study|Protocol Violation|0|||
161591627|NCT03721952|583554739|FG000|Overall Study|Withdrawal by Subject|1|||
161591628|NCT03721952|583554740|FG001|Overall Study|Withdrawal by Subject|0|||
161591629|NCT03721952|583554741|FG002|Overall Study|Withdrawal by Subject|40|||
161591630|NCT03721952|583554742|FG003|Overall Study|Withdrawal by Subject|28|||
161591631|NCT03721952|583554743|FG004|Overall Study|Withdrawal by Subject|0|||
161591632|NCT03364647|583554744|FG000|Overall Study|Withdrawal by Subject|3|||
161591633|NCT03364647|583554745|FG001|Overall Study|Withdrawal by Subject|1|||
161591634|NCT03476460|583554746|FG000|Overall Study|Withdrawal by Subject|3|||
161591635|NCT03476460|583554747|FG001|Overall Study|Withdrawal by Subject|2|||
161591636|NCT03476460|583554746|FG000|Overall Study|Non-compliance with treatment|3|||
161591637|NCT03476460|583554747|FG001|Overall Study|Non-compliance with treatment|0|||
161828949|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
161828950|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828951|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828952|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828953|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828954|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828955|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828956|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828957|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828958|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
161828959|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828960|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828961|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828962|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828963|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828964|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828965|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828966|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828967|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
161828968|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828969|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161532674|NCT00831779|583338727|FG001|Overall Study|No longer met criteria|1|||
161532675|NCT04020341|583338728|FG000|Overall Study|Adverse Event|8|||
161532676|NCT04020341|583338729|FG001|Overall Study|Adverse Event|6|||
161532677|NCT04020341|583338728|FG000|Overall Study|Lost to Follow-up|8|||
161532678|NCT04020341|583338729|FG001|Overall Study|Lost to Follow-up|2|||
161532679|NCT04020341|583338728|FG000|Overall Study|Withdrawal by Subject|16|||
161532680|NCT04020341|583338729|FG001|Overall Study|Withdrawal by Subject|16|||
161532681|NCT04020341|583338728|FG000|Overall Study|Participant not able to swallow the tablet|1|||
161532682|NCT04020341|583338729|FG001|Overall Study|Participant not able to swallow the tablet|0|||
161532683|NCT04020341|583338728|FG000|Overall Study|Physician Decision|0|||
161532684|NCT04020341|583338729|FG001|Overall Study|Physician Decision|2|||
161532685|NCT04020341|583338728|FG000|Overall Study|Protocol Deviation|0|||
161532686|NCT04020341|583338729|FG001|Overall Study|Protocol Deviation|2|||
161532687|NCT04528069|583338730|FG000|Overall Study|Adverse Event|1|||
161532688|NCT04528069|583338730|FG000|Overall Study|Lost to Follow-up|1|||
161532689|NCT04528069|583338730|FG000|Overall Study|Patient Unable to Come|1|||
161532690|NCT04528069|583338730|FG000|Overall Study|Patient Unable to Attend|1|||
161532691|NCT01814371|583338732|FG000|Overall Study|Lost to Follow-up|30|||
161532692|NCT01814371|583338733|FG001|Overall Study|Lost to Follow-up|27|||
161532693|NCT04683926|583338734|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
161532694|NCT04683926|583338735|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
161532695|NCT04683926|583338736|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
161532696|NCT04683926|583338737|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
161532697|NCT01692782|583338739|FG000|Overall Study|Adverse Event|12|||
161532698|NCT01692782|583338740|FG001|Overall Study|Adverse Event|32|||
161532699|NCT01692782|583338741|FG002|Overall Study|Adverse Event|2|||
161532700|NCT01692782|583338739|FG000|Overall Study|Lack of Efficacy|1|||
161532701|NCT01692782|583338740|FG001|Overall Study|Lack of Efficacy|2|||
161532702|NCT01692782|583338741|FG002|Overall Study|Lack of Efficacy|0|||
161532703|NCT01692782|583338739|FG000|Overall Study|Lost to Follow-up|2|||
161532704|NCT01692782|583338740|FG001|Overall Study|Lost to Follow-up|7|||
161532705|NCT01692782|583338741|FG002|Overall Study|Lost to Follow-up|1|||
161532706|NCT01692782|583338739|FG000|Overall Study|Pregnancy|1|||
161532707|NCT01692782|583338740|FG001|Overall Study|Pregnancy|0|||
161532708|NCT01692782|583338741|FG002|Overall Study|Pregnancy|0|||
161532709|NCT01692782|583338739|FG000|Overall Study|Protocol Violation|1|||
161532710|NCT01692782|583338740|FG001|Overall Study|Protocol Violation|0|||
161532711|NCT01692782|583338741|FG002|Overall Study|Protocol Violation|2|||
161532712|NCT01692782|583338739|FG000|Overall Study|Non-complance with study drug|0|||
161532713|NCT01692782|583338740|FG001|Overall Study|Non-complance with study drug|4|||
161532714|NCT01692782|583338741|FG002|Overall Study|Non-complance with study drug|1|||
161532715|NCT01692782|583338739|FG000|Overall Study|Non-compliant with study visits|0|||
161532716|NCT01692782|583338740|FG001|Overall Study|Non-compliant with study visits|0|||
161532717|NCT01692782|583338741|FG002|Overall Study|Non-compliant with study visits|1|||
161532718|NCT01692782|583338739|FG000|Overall Study|SAE not related to study drug|0|||
161532719|NCT01692782|583338740|FG001|Overall Study|SAE not related to study drug|1|||
161532720|NCT01692782|583338741|FG002|Overall Study|SAE not related to study drug|0|||
161532721|NCT01692782|583338739|FG000|Overall Study|Withdrawal by Subject|3|||
161532722|NCT01692782|583338740|FG001|Overall Study|Withdrawal by Subject|10|||
161532723|NCT01692782|583338741|FG002|Overall Study|Withdrawal by Subject|3|||
161532724|NCT00952367|583338750|FG000|Overall Study|Withdrawal by Subject|2|||
161532725|NCT00952367|583338750|FG000|Overall Study|Noncoordination|1|||
161532726|NCT00952367|583338750|FG000|Overall Study|Protocol Violation|3|||
161532727|NCT02300220|583338754|FG000|Overall Study|Lost to Follow-up|1|||
161532728|NCT02300220|583338755|FG001|Overall Study|Lost to Follow-up|2|||
161532729|NCT02300220|583338754|FG000|Overall Study|Death|1|||
161532730|NCT02300220|583338755|FG001|Overall Study|Death|1|||
161532731|NCT02300220|583338754|FG000|Overall Study|Adverse Event|1|||
161532732|NCT02300220|583338755|FG001|Overall Study|Adverse Event|1|||
161532733|NCT02300220|583338754|FG000|Overall Study|Protocol Violation|1|||
161532734|NCT02300220|583338755|FG001|Overall Study|Protocol Violation|0|||
161532735|NCT02300220|583338754|FG000|Overall Study|Withdrawal by Subject|0|||
161532736|NCT02300220|583338755|FG001|Overall Study|Withdrawal by Subject|2|||
161532737|NCT02300220|583338754|FG000|Overall Study|Did not tolerate IMP|0|||
161532738|NCT02300220|583338755|FG001|Overall Study|Did not tolerate IMP|1|||
161532739|NCT04322682|583338756|FG000|Overall Study|Withdrawal by Subject|33|||
161532740|NCT04322682|583338757|FG001|Overall Study|Withdrawal by Subject|47|||
161532741|NCT04322682|583338756|FG000|Overall Study|Death|5|||
161532742|NCT04322682|583338757|FG001|Overall Study|Death|9|||
161532743|NCT04322682|583338756|FG000|Overall Study|Lost to Follow-up|4|||
161532744|NCT04322682|583338757|FG001|Overall Study|Lost to Follow-up|8|||
161532745|NCT04322682|583338756|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
161532746|NCT04322682|583338757|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
161532747|NCT04123067|583338758|FG000|Overall Study|Lost to Follow-up|0|||
161532748|NCT04123067|583338759|FG001|Overall Study|Lost to Follow-up|1|||
161532749|NCT02238379|583338760|FG000|Overall Study|Lost to Follow-up|1|||
161532750|NCT02238379|583338761|FG001|Overall Study|Lost to Follow-up|0|||
161591638|NCT03476460|583554746|FG000|Overall Study|Missing laboratory tests|5|||
161591639|NCT03476460|583554747|FG001|Overall Study|Missing laboratory tests|5|||
161591640|NCT03476460|583554746|FG000|Overall Study|Adverse Event|0|||
161591641|NCT03476460|583554747|FG001|Overall Study|Adverse Event|1|||
161591642|NCT04624633|583554751|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
161591643|NCT04624633|583554752|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
161591644|NCT04624633|583554751|FG000|Overall Study|Death|1|||
161591645|NCT04624633|583554752|FG001|Overall Study|Death|0|||
161591646|NCT01902173|583554753|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
161591647|NCT01902173|583554754|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161591648|NCT01902173|583554755|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161591649|NCT01902173|583554756|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161532751|NCT03085485|583338762|FG000|Overall Study|Death|1|||
161591650|NCT01902173|583554757|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161532752|NCT03085485|583338763|FG001|Overall Study|Death|0|||
161532753|NCT03085485|583338762|FG000|Overall Study|Lost to Follow-up|1|||
161532754|NCT03085485|583338763|FG001|Overall Study|Lost to Follow-up|0|||
161532755|NCT00605280|583338764|FG000|Year 1|Protocol Violation|0|||
161532756|NCT00605280|583338765|FG001|Year 1|Protocol Violation|0|||
161532757|NCT00605280|583338766|FG002|Year 1|Protocol Violation|0|||
161532758|NCT00605280|583338767|FG003|Year 1|Protocol Violation|1|||
161532759|NCT00605280|583338764|FG000|Year 1|Adverse Event|3|||
161532760|NCT00605280|583338765|FG001|Year 1|Adverse Event|1|||
161532761|NCT00605280|583338766|FG002|Year 1|Adverse Event|1|||
161532762|NCT00605280|583338767|FG003|Year 1|Adverse Event|5|||
161532763|NCT00605280|583338764|FG000|Year 1|Physician Decision|7|||
161532764|NCT00605280|583338765|FG001|Year 1|Physician Decision|4|||
161532765|NCT00605280|583338766|FG002|Year 1|Physician Decision|0|||
161532766|NCT00605280|583338767|FG003|Year 1|Physician Decision|6|||
161532767|NCT00605280|583338764|FG000|Year 1|Withdrawal by Subject|2|||
161532768|NCT00605280|583338765|FG001|Year 1|Withdrawal by Subject|4|||
161532769|NCT00605280|583338766|FG002|Year 1|Withdrawal by Subject|0|||
161532770|NCT00605280|583338767|FG003|Year 1|Withdrawal by Subject|4|||
161532771|NCT00605280|583338764|FG000|Year 1|Other|2|||
161532772|NCT00605280|583338765|FG001|Year 1|Other|1|||
161532773|NCT00605280|583338766|FG002|Year 1|Other|0|||
161532774|NCT00605280|583338767|FG003|Year 1|Other|1|||
161532775|NCT00605280|583338764|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
161532776|NCT00605280|583338765|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
161532777|NCT00605280|583338766|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
161532778|NCT00605280|583338767|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
161532779|NCT00605280|583338764|FG000|Year 2|Adverse Event|4|||
161532780|NCT00605280|583338765|FG001|Year 2|Adverse Event|0|||
161532781|NCT00605280|583338766|FG002|Year 2|Adverse Event|2|||
161532782|NCT00605280|583338767|FG003|Year 2|Adverse Event|4|||
161532783|NCT00605280|583338764|FG000|Year 2|Physician Decision|11|||
161532784|NCT00605280|583338765|FG001|Year 2|Physician Decision|6|||
161532785|NCT00605280|583338766|FG002|Year 2|Physician Decision|4|||
161532786|NCT00605280|583338767|FG003|Year 2|Physician Decision|11|||
161532787|NCT00605280|583338764|FG000|Year 2|Withdrawal by Subject|4|||
161532788|NCT00605280|583338765|FG001|Year 2|Withdrawal by Subject|0|||
161532789|NCT00605280|583338766|FG002|Year 2|Withdrawal by Subject|0|||
161532790|NCT00605280|583338767|FG003|Year 2|Withdrawal by Subject|4|||
161532791|NCT00605280|583338764|FG000|Year 2|Other|1|||
161532792|NCT00605280|583338765|FG001|Year 2|Other|0|||
161591651|NCT01902173|583554758|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161532793|NCT00605280|583338766|FG002|Year 2|Other|0|||
161532794|NCT00605280|583338767|FG003|Year 2|Other|1|||
161532795|NCT00605280|583338764|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
161532796|NCT00605280|583338765|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
161532797|NCT00605280|583338766|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
161532798|NCT00605280|583338767|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
161532799|NCT00605280|583338764|FG000|Year 3 Extension|Adverse Event|2|||
161678625|NCT00766090|583876051|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678626|NCT00766090|583876052|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678627|NCT00766090|583876053|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161828970|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828971|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828972|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161532800|NCT00605280|583338765|FG001|Year 3 Extension|Adverse Event|0|||
161532801|NCT00605280|583338766|FG002|Year 3 Extension|Adverse Event|0|||
161828973|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828974|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161532802|NCT00605280|583338767|FG003|Year 3 Extension|Adverse Event|2|||
161532803|NCT00605280|583338764|FG000|Year 3 Extension|Physician Decision|0|||
161532804|NCT00605280|583338765|FG001|Year 3 Extension|Physician Decision|0|||
161532805|NCT00605280|583338766|FG002|Year 3 Extension|Physician Decision|0|||
161532806|NCT00605280|583338767|FG003|Year 3 Extension|Physician Decision|2|||
161532807|NCT00605280|583338764|FG000|Year 3 Extension|Withdrawal by Subject|2|||
161532808|NCT00605280|583338765|FG001|Year 3 Extension|Withdrawal by Subject|0|||
161532809|NCT00605280|583338766|FG002|Year 3 Extension|Withdrawal by Subject|0|||
161532810|NCT00605280|583338767|FG003|Year 3 Extension|Withdrawal by Subject|5|||
161532811|NCT00605280|583338764|FG000|Year 3 Extension|Other|2|||
161532812|NCT00605280|583338765|FG001|Year 3 Extension|Other|0|||
161532813|NCT00605280|583338766|FG002|Year 3 Extension|Other|0|||
161532814|NCT00605280|583338767|FG003|Year 3 Extension|Other|0|||
161532815|NCT00605280|583338764|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
161532816|NCT00605280|583338765|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
161532817|NCT00605280|583338766|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
161532818|NCT00605280|583338767|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
161532819|NCT01775904|583338771|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
161532820|NCT01775904|583338771|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
161532821|NCT00518115|583338772|FG000|Overall Study|Adverse Event|6|||
161532822|NCT00518115|583338773|FG001|Overall Study|Adverse Event|1|||
161532823|NCT00518115|583338774|FG002|Overall Study|Adverse Event|5|||
161532824|NCT00518115|583338775|FG003|Overall Study|Adverse Event|6|||
161532825|NCT00518115|583338776|FG004|Overall Study|Adverse Event|5|||
161532826|NCT00518115|583338777|FG005|Overall Study|Adverse Event|5|||
161532827|NCT00518115|583338778|FG006|Overall Study|Adverse Event|5|||
161532828|NCT00518115|583338779|FG007|Overall Study|Adverse Event|10|||
161532829|NCT00518115|583338780|FG008|Overall Study|Adverse Event|2|||
161532830|NCT00518115|583338781|FG009|Overall Study|Adverse Event|9|||
161532831|NCT00518115|583338772|FG000|Overall Study|Lost to Follow-up|0|||
161532832|NCT00518115|583338773|FG001|Overall Study|Lost to Follow-up|0|||
161828975|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161532833|NCT00518115|583338774|FG002|Overall Study|Lost to Follow-up|2|||
161532834|NCT00518115|583338775|FG003|Overall Study|Lost to Follow-up|3|||
161532835|NCT00518115|583338776|FG004|Overall Study|Lost to Follow-up|1|||
161532836|NCT00518115|583338777|FG005|Overall Study|Lost to Follow-up|3|||
161532837|NCT00518115|583338778|FG006|Overall Study|Lost to Follow-up|0|||
161532838|NCT00518115|583338779|FG007|Overall Study|Lost to Follow-up|1|||
161532839|NCT00518115|583338780|FG008|Overall Study|Lost to Follow-up|1|||
161532840|NCT00518115|583338781|FG009|Overall Study|Lost to Follow-up|1|||
161532841|NCT00518115|583338772|FG000|Overall Study|Protocol Violation|1|||
161532842|NCT00518115|583338773|FG001|Overall Study|Protocol Violation|3|||
161532843|NCT00518115|583338774|FG002|Overall Study|Protocol Violation|1|||
161532844|NCT00518115|583338775|FG003|Overall Study|Protocol Violation|0|||
161532845|NCT00518115|583338776|FG004|Overall Study|Protocol Violation|0|||
161532846|NCT00518115|583338777|FG005|Overall Study|Protocol Violation|0|||
161532847|NCT00518115|583338778|FG006|Overall Study|Protocol Violation|0|||
161532848|NCT00518115|583338779|FG007|Overall Study|Protocol Violation|0|||
161532849|NCT00518115|583338780|FG008|Overall Study|Protocol Violation|0|||
161532850|NCT00518115|583338781|FG009|Overall Study|Protocol Violation|0|||
161532851|NCT00518115|583338772|FG000|Overall Study|Withdrawal by Subject|1|||
161532852|NCT00518115|583338773|FG001|Overall Study|Withdrawal by Subject|1|||
161532853|NCT00518115|583338774|FG002|Overall Study|Withdrawal by Subject|5|||
161532854|NCT00518115|583338775|FG003|Overall Study|Withdrawal by Subject|0|||
161532855|NCT00518115|583338776|FG004|Overall Study|Withdrawal by Subject|2|||
161532856|NCT00518115|583338777|FG005|Overall Study|Withdrawal by Subject|1|||
161532857|NCT00518115|583338778|FG006|Overall Study|Withdrawal by Subject|0|||
161532858|NCT00518115|583338779|FG007|Overall Study|Withdrawal by Subject|2|||
161532859|NCT00518115|583338780|FG008|Overall Study|Withdrawal by Subject|1|||
161532860|NCT00518115|583338781|FG009|Overall Study|Withdrawal by Subject|3|||
161532861|NCT00518115|583338772|FG000|Overall Study|Lack of Efficacy|1|||
161532862|NCT00518115|583338773|FG001|Overall Study|Lack of Efficacy|0|||
161532863|NCT00518115|583338774|FG002|Overall Study|Lack of Efficacy|1|||
161532864|NCT00518115|583338775|FG003|Overall Study|Lack of Efficacy|1|||
161532865|NCT00518115|583338776|FG004|Overall Study|Lack of Efficacy|0|||
161532866|NCT00518115|583338777|FG005|Overall Study|Lack of Efficacy|0|||
161532867|NCT00518115|583338778|FG006|Overall Study|Lack of Efficacy|0|||
161532868|NCT00518115|583338779|FG007|Overall Study|Lack of Efficacy|1|||
161532869|NCT00518115|583338780|FG008|Overall Study|Lack of Efficacy|0|||
161532870|NCT00518115|583338781|FG009|Overall Study|Lack of Efficacy|0|||
161532871|NCT00518115|583338772|FG000|Overall Study|Non-Compliance|1|||
161532872|NCT00518115|583338773|FG001|Overall Study|Non-Compliance|0|||
161532873|NCT00518115|583338774|FG002|Overall Study|Non-Compliance|1|||
161532874|NCT00518115|583338775|FG003|Overall Study|Non-Compliance|0|||
161532875|NCT00518115|583338776|FG004|Overall Study|Non-Compliance|1|||
161532876|NCT00518115|583338777|FG005|Overall Study|Non-Compliance|1|||
161532877|NCT00518115|583338778|FG006|Overall Study|Non-Compliance|1|||
161532878|NCT00518115|583338779|FG007|Overall Study|Non-Compliance|1|||
161532879|NCT00518115|583338780|FG008|Overall Study|Non-Compliance|0|||
161532880|NCT00518115|583338781|FG009|Overall Study|Non-Compliance|1|||
161532881|NCT00518115|583338772|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
161532882|NCT00518115|583338773|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
161591652|NCT01902173|583554753|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
161591653|NCT01902173|583554754|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161591654|NCT01902173|583554755|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161591655|NCT01902173|583554756|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161591656|NCT01902173|583554757|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161591657|NCT01902173|583554758|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161591658|NCT01902173|583554753|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161591659|NCT01902173|583554754|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
161591660|NCT01902173|583554755|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161591661|NCT01902173|583554756|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161591662|NCT01902173|583554757|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161591663|NCT01902173|583554758|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161591664|NCT01902173|583554753|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161591665|NCT01902173|583554754|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
161591666|NCT01902173|583554755|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161591667|NCT01902173|583554756|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161591668|NCT01902173|583554757|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161591669|NCT01902173|583554758|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161591670|NCT01902173|583554753|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161591671|NCT01902173|583554754|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
161591672|NCT01902173|583554755|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161591673|NCT01902173|583554756|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161591674|NCT01902173|583554757|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161591675|NCT01902173|583554758|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161591676|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161591677|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161591678|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
161591679|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161591680|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161591681|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161591682|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161591683|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161591684|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
161591685|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161591686|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161591687|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161591688|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161678628|NCT00766090|583876054|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678629|NCT00766090|583876055|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678630|NCT00766090|583876056|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678631|NCT00766090|583876057|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678632|NCT00766090|583876046|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678633|NCT00766090|583876047|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678634|NCT00766090|583876048|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
161678635|NCT00766090|583876049|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678636|NCT00766090|583876050|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678637|NCT00766090|583876051|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678638|NCT00766090|583876052|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678639|NCT00766090|583876053|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678640|NCT00766090|583876054|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678641|NCT00766090|583876055|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678642|NCT00766090|583876056|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678643|NCT00766090|583876057|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678644|NCT00766090|583876046|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678645|NCT00766090|583876047|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678646|NCT00766090|583876048|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678647|NCT00766090|583876049|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678648|NCT00766090|583876050|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
161532883|NCT00518115|583338774|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161532884|NCT00518115|583338775|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161532885|NCT00518115|583338776|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161532886|NCT00518115|583338777|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
161532887|NCT00518115|583338778|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161678649|NCT00766090|583876051|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161532888|NCT00518115|583338779|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161532889|NCT00518115|583338780|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161532890|NCT00518115|583338781|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161532891|NCT00518115|583338772|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
161532892|NCT00518115|583338773|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532893|NCT00518115|583338774|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532894|NCT00518115|583338775|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532895|NCT00518115|583338776|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532896|NCT00518115|583338777|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532897|NCT00518115|583338778|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532898|NCT00518115|583338779|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532899|NCT00518115|583338780|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161532900|NCT00518115|583338781|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
161678650|NCT00766090|583876052|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161828976|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
161828977|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828978|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828979|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828980|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828981|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828982|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828983|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828984|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828985|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
161828986|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828987|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828988|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828989|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828990|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828991|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828992|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828993|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161532901|NCT00518115|583338772|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532902|NCT00518115|583338773|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532903|NCT00518115|583338774|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
161532904|NCT00518115|583338775|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532905|NCT00518115|583338776|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532906|NCT00518115|583338777|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532907|NCT00518115|583338778|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532908|NCT00518115|583338779|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532909|NCT00518115|583338780|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
161532910|NCT00518115|583338781|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
161532911|NCT00518115|583338772|FG000|Overall Study|Wrong Monotherapy Administered|0|||
161532912|NCT00518115|583338773|FG001|Overall Study|Wrong Monotherapy Administered|0|||
161532913|NCT00518115|583338774|FG002|Overall Study|Wrong Monotherapy Administered|1|||
161532914|NCT00518115|583338775|FG003|Overall Study|Wrong Monotherapy Administered|0|||
161591689|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161591690|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161591691|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
161591692|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161591693|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161591694|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161591695|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161591696|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161591697|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
161591698|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161591699|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161591700|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161591701|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161591702|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161591703|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161532915|NCT00518115|583338776|FG004|Overall Study|Wrong Monotherapy Administered|0|||
161532916|NCT00518115|583338777|FG005|Overall Study|Wrong Monotherapy Administered|0|||
161591704|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
161591705|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161828994|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
161828995|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828996|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828997|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828998|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828999|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829000|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829001|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829002|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829003|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161829004|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161829005|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
161829006|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
161829007|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
161829008|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161829009|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
161829010|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
161829011|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
161829012|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829013|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829014|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829015|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829016|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
161829017|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829018|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829019|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
161829020|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829021|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
161829022|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
161532917|NCT00518115|583338778|FG006|Overall Study|Wrong Monotherapy Administered|1|||
161532918|NCT00518115|583338779|FG007|Overall Study|Wrong Monotherapy Administered|0|||
161532919|NCT00518115|583338780|FG008|Overall Study|Wrong Monotherapy Administered|0|||
161532920|NCT00518115|583338781|FG009|Overall Study|Wrong Monotherapy Administered|0|||
161532921|NCT00518115|583338772|FG000|Overall Study|Violation of Exclusion Criteria|0|||
161532922|NCT00518115|583338773|FG001|Overall Study|Violation of Exclusion Criteria|0|||
161532923|NCT00518115|583338774|FG002|Overall Study|Violation of Exclusion Criteria|0|||
161532924|NCT00518115|583338775|FG003|Overall Study|Violation of Exclusion Criteria|1|||
161829023|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829024|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829025|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829026|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829027|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829028|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829029|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829030|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
161829031|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
161829032|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
161829033|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
161829034|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161829035|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161829036|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
161829037|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
161829038|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161829039|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829040|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829041|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
161829042|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829043|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829044|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829045|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829046|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829047|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829048|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829049|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
161829050|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829051|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
161829052|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829053|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829054|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
161829055|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
161829056|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829057|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
161829058|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161829059|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
161829060|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
161829061|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161829062|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161829063|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
161829064|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
161829065|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
161829066|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829067|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829068|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829069|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829070|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829071|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829072|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
161532925|NCT00518115|583338776|FG004|Overall Study|Violation of Exclusion Criteria|0|||
161532926|NCT00518115|583338777|FG005|Overall Study|Violation of Exclusion Criteria|0|||
161532927|NCT00518115|583338778|FG006|Overall Study|Violation of Exclusion Criteria|1|||
161532928|NCT00518115|583338779|FG007|Overall Study|Violation of Exclusion Criteria|0|||
161532929|NCT00518115|583338780|FG008|Overall Study|Violation of Exclusion Criteria|0|||
161532930|NCT00518115|583338781|FG009|Overall Study|Violation of Exclusion Criteria|0|||
161532931|NCT00518115|583338772|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
161532932|NCT00518115|583338773|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
161532933|NCT00518115|583338774|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
161532934|NCT00518115|583338775|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
161532935|NCT00518115|583338776|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
161532936|NCT00518115|583338777|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
161532937|NCT00518115|583338778|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
161532938|NCT00518115|583338779|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
161532939|NCT00518115|583338780|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
161532940|NCT00518115|583338781|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
161532941|NCT00518115|583338772|FG000|Overall Study|Withdrew Consent|0|||
161532942|NCT00518115|583338773|FG001|Overall Study|Withdrew Consent|0|||
161532943|NCT00518115|583338774|FG002|Overall Study|Withdrew Consent|0|||
161532944|NCT00518115|583338775|FG003|Overall Study|Withdrew Consent|0|||
161532945|NCT00518115|583338776|FG004|Overall Study|Withdrew Consent|0|||
161532946|NCT00518115|583338777|FG005|Overall Study|Withdrew Consent|1|||
161532947|NCT00518115|583338778|FG006|Overall Study|Withdrew Consent|0|||
161532948|NCT00518115|583338779|FG007|Overall Study|Withdrew Consent|0|||
161532949|NCT00518115|583338780|FG008|Overall Study|Withdrew Consent|0|||
161532950|NCT00518115|583338781|FG009|Overall Study|Withdrew Consent|0|||
161532951|NCT00518115|583338772|FG000|Overall Study|Moved Out of State|0|||
161532952|NCT00518115|583338773|FG001|Overall Study|Moved Out of State|0|||
161532953|NCT00518115|583338774|FG002|Overall Study|Moved Out of State|0|||
161591706|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161591707|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161591708|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161532954|NCT00518115|583338775|FG003|Overall Study|Moved Out of State|0|||
161532955|NCT00518115|583338776|FG004|Overall Study|Moved Out of State|0|||
161532956|NCT00518115|583338777|FG005|Overall Study|Moved Out of State|0|||
161532957|NCT00518115|583338778|FG006|Overall Study|Moved Out of State|0|||
161532958|NCT00518115|583338779|FG007|Overall Study|Moved Out of State|0|||
161532959|NCT00518115|583338780|FG008|Overall Study|Moved Out of State|0|||
161532960|NCT00518115|583338781|FG009|Overall Study|Moved Out of State|1|||
161532961|NCT04891419|583338782|FG000|Overall Study|Withdrawal by Subject|4|||
161532962|NCT04891419|583338783|FG001|Overall Study|Withdrawal by Subject|0|||
161532963|NCT04891419|583338782|FG000|Overall Study|Lost to Follow-up|1|||
161532964|NCT04891419|583338783|FG001|Overall Study|Lost to Follow-up|3|||
161532965|NCT00827918|583338787|FG000|Overall Study|Adverse Event|4|||
161532966|NCT00827918|583338788|FG001|Overall Study|Adverse Event|0|||
161532967|NCT00827918|583338789|FG002|Overall Study|Adverse Event|0|||
161532968|NCT00827918|583338787|FG000|Overall Study|Lack of Efficacy|16|||
161532969|NCT00827918|583338788|FG001|Overall Study|Lack of Efficacy|4|||
161532970|NCT00827918|583338789|FG002|Overall Study|Lack of Efficacy|15|||
161532971|NCT00827918|583338787|FG000|Overall Study|Physician Decision|1|||
161532972|NCT00827918|583338788|FG001|Overall Study|Physician Decision|0|||
161532973|NCT00827918|583338789|FG002|Overall Study|Physician Decision|0|||
161532974|NCT00827918|583338787|FG000|Overall Study|Pregnancy|0|||
161532975|NCT00827918|583338788|FG001|Overall Study|Pregnancy|1|||
161532976|NCT00827918|583338789|FG002|Overall Study|Pregnancy|0|||
161532977|NCT00827918|583338787|FG000|Overall Study|Progressive Disease|1|||
161532978|NCT00827918|583338788|FG001|Overall Study|Progressive Disease|1|||
161532979|NCT00827918|583338789|FG002|Overall Study|Progressive Disease|0|||
161532980|NCT00827918|583338787|FG000|Overall Study|Protocol Violation|0|||
161532981|NCT00827918|583338788|FG001|Overall Study|Protocol Violation|1|||
161532982|NCT00827918|583338789|FG002|Overall Study|Protocol Violation|0|||
161532983|NCT00827918|583338787|FG000|Overall Study|Withdrawal by Subject|6|||
161532984|NCT00827918|583338788|FG001|Overall Study|Withdrawal by Subject|2|||
161532985|NCT00827918|583338789|FG002|Overall Study|Withdrawal by Subject|6|||
161532986|NCT00802074|583338790|FG000|Overall Study|Adverse Event|1|||
161532987|NCT00802074|583338791|FG001|Overall Study|Adverse Event|1|||
161532988|NCT00802074|583338792|FG002|Overall Study|Adverse Event|1|||
161532989|NCT00802074|583338793|FG003|Overall Study|Adverse Event|0|||
161532990|NCT00802074|583338794|FG004|Overall Study|Adverse Event|0|||
161532991|NCT00802074|583338795|FG005|Overall Study|Adverse Event|0|||
161532992|NCT00802074|583338790|FG000|Overall Study|Withdrawal by Subject|1|||
161532993|NCT00802074|583338791|FG001|Overall Study|Withdrawal by Subject|0|||
161532994|NCT00802074|583338792|FG002|Overall Study|Withdrawal by Subject|0|||
161532995|NCT00802074|583338793|FG003|Overall Study|Withdrawal by Subject|0|||
161532996|NCT00802074|583338794|FG004|Overall Study|Withdrawal by Subject|0|||
161532997|NCT00802074|583338795|FG005|Overall Study|Withdrawal by Subject|0|||
161532998|NCT00127101|583338798|FG000|Base Protocol|Adverse Event|0|||
161532999|NCT00127101|583338799|FG001|Base Protocol|Adverse Event|2|||
161533000|NCT00127101|583338800|FG002|Base Protocol|Adverse Event|1|||
161533001|NCT00127101|583338801|FG003|Base Protocol|Adverse Event|0|||
161533002|NCT00127101|583338802|FG004|Base Protocol|Adverse Event|0|||
161533003|NCT00127101|583338803|FG005|Base Protocol|Adverse Event|0|||
161533004|NCT00127101|583338798|FG000|Base Protocol|Lack of Efficacy|1|||
161533005|NCT00127101|583338799|FG001|Base Protocol|Lack of Efficacy|0|||
161533006|NCT00127101|583338800|FG002|Base Protocol|Lack of Efficacy|0|||
161533007|NCT00127101|583338801|FG003|Base Protocol|Lack of Efficacy|0|||
161533008|NCT00127101|583338802|FG004|Base Protocol|Lack of Efficacy|2|||
161533009|NCT00127101|583338803|FG005|Base Protocol|Lack of Efficacy|0|||
161533010|NCT00127101|583338798|FG000|Base Protocol|Withdrawal by Subject|1|||
161533011|NCT00127101|583338799|FG001|Base Protocol|Withdrawal by Subject|2|||
161533012|NCT00127101|583338800|FG002|Base Protocol|Withdrawal by Subject|1|||
161533013|NCT00127101|583338801|FG003|Base Protocol|Withdrawal by Subject|0|||
161533014|NCT00127101|583338802|FG004|Base Protocol|Withdrawal by Subject|0|||
161533015|NCT00127101|583338803|FG005|Base Protocol|Withdrawal by Subject|1|||
161533016|NCT00127101|583338798|FG000|Continuation Phase|Adverse Event|0|||
161533017|NCT00127101|583338799|FG001|Continuation Phase|Adverse Event|0|||
161533018|NCT00127101|583338800|FG002|Continuation Phase|Adverse Event|0|||
161533019|NCT00127101|583338801|FG003|Continuation Phase|Adverse Event|0|||
161533020|NCT00127101|583338802|FG004|Continuation Phase|Adverse Event|1|||
161533021|NCT00127101|583338803|FG005|Continuation Phase|Adverse Event|1|||
161533022|NCT00127101|583338798|FG000|Continuation Phase|Lack of Efficacy|0|||
161533023|NCT00127101|583338799|FG001|Continuation Phase|Lack of Efficacy|0|||
161533024|NCT00127101|583338800|FG002|Continuation Phase|Lack of Efficacy|0|||
161591709|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161591710|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
161591711|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161591712|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161591713|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161591714|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161591715|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161591716|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161533025|NCT00127101|583338801|FG003|Continuation Phase|Lack of Efficacy|0|||
161533026|NCT00127101|583338802|FG004|Continuation Phase|Lack of Efficacy|0|||
161533027|NCT00127101|583338803|FG005|Continuation Phase|Lack of Efficacy|1|||
161533028|NCT00127101|583338798|FG000|Continuation Phase|Withdrawal by Subject|0|||
161533029|NCT00127101|583338799|FG001|Continuation Phase|Withdrawal by Subject|0|||
161533030|NCT00127101|583338800|FG002|Continuation Phase|Withdrawal by Subject|1|||
161533031|NCT00127101|583338801|FG003|Continuation Phase|Withdrawal by Subject|0|||
161533032|NCT00127101|583338802|FG004|Continuation Phase|Withdrawal by Subject|2|||
161533033|NCT00127101|583338803|FG005|Continuation Phase|Withdrawal by Subject|1|||
161533034|NCT00843167|583338804|FG000|Treatment Period|Adverse Event|1|||
161533035|NCT00843167|583338805|FG001|Treatment Period|Adverse Event|5|||
161533036|NCT00843167|583338804|FG000|Treatment Period|Withdrawal by Subject|2|||
161533037|NCT00843167|583338805|FG001|Treatment Period|Withdrawal by Subject|3|||
161533038|NCT02291614|583338806|FG000|Overall Study|Lost to Follow-up|0|||
161533039|NCT02291614|583338807|FG001|Overall Study|Lost to Follow-up|0|||
161533040|NCT02291614|583338808|FG002|Overall Study|Lost to Follow-up|0|||
161533041|NCT02291614|583338809|FG003|Overall Study|Lost to Follow-up|0|||
161533042|NCT02291614|583338810|FG004|Overall Study|Lost to Follow-up|0|||
161533043|NCT02291614|583338811|FG005|Overall Study|Lost to Follow-up|0|||
161533044|NCT02291614|583338812|FG006|Overall Study|Lost to Follow-up|0|||
161533045|NCT02291614|583338813|FG007|Overall Study|Lost to Follow-up|1|||
161533046|NCT02291614|583338814|FG008|Overall Study|Lost to Follow-up|0|||
161533047|NCT02291614|583338815|FG009|Overall Study|Lost to Follow-up|0|||
161533048|NCT02291614|583338816|FG010|Overall Study|Lost to Follow-up|0|||
161533049|NCT02291614|583338806|FG000|Overall Study|Withdrawal by Subject|0|||
161533050|NCT02291614|583338807|FG001|Overall Study|Withdrawal by Subject|1|||
161533051|NCT02291614|583338808|FG002|Overall Study|Withdrawal by Subject|0|||
161831534|NCT03438539|584424812|FG003|Overall Study|Lost to Follow-up|9|||
161533052|NCT02291614|583338809|FG003|Overall Study|Withdrawal by Subject|0|||
161831535|NCT03438539|584424813|FG004|Overall Study|Lost to Follow-up|3|||
161831536|NCT03438539|584424814|FG005|Overall Study|Lost to Follow-up|8|||
161831537|NCT00655850|584424815|FG000|Overall Study|Death|2|||
161831538|NCT00655850|584424815|FG000|Overall Study|Withdrawal by Subject|1|||
161831539|NCT00918463|584424816|FG000|Overall Study|Death|1|||
161831540|NCT00918463|584424816|FG000|Overall Study|Lack of Efficacy|1|||
161831541|NCT01715896|584424817|FG000|Overall Study|Lost to Follow-up|0|||
161831542|NCT01715896|584424818|FG001|Overall Study|Lost to Follow-up|2|||
161831543|NCT01715896|584424817|FG000|Overall Study|Withdrawal by Subject|1|||
161831544|NCT01715896|584424818|FG001|Overall Study|Withdrawal by Subject|4|||
161831545|NCT01715896|584424817|FG000|Overall Study|Other|2|||
161831546|NCT01715896|584424818|FG001|Overall Study|Other|5|||
161831547|NCT01045993|584424820|FG000|Overall Study|Treated-later found eligibility not met|0|||
161831548|NCT01045993|584424821|FG001|Overall Study|Treated-later found eligibility not met|1|||
161831549|NCT01045993|584424822|FG002|Overall Study|Treated-later found eligibility not met|0|||
161831550|NCT01045993|584424823|FG003|Overall Study|Treated-later found eligibility not met|0|||
161831551|NCT01659736|584424824|FG000|Treatment Period|Adverse Event|1|||
161831552|NCT01659736|584424825|FG001|Treatment Period|Adverse Event|1|||
161831553|NCT01659736|584424824|FG000|Treatment Period|Protocol Violation|3|||
161831554|NCT01659736|584424825|FG001|Treatment Period|Protocol Violation|1|||
161831555|NCT01659736|584424824|FG000|Treatment Period|Withdrawal by Subject|1|||
161831556|NCT01659736|584424825|FG001|Treatment Period|Withdrawal by Subject|0|||
161831557|NCT01659736|584424824|FG000|3-month Follow-up|Lost to Follow-up|0|||
161831558|NCT01659736|584424825|FG001|3-month Follow-up|Lost to Follow-up|1|||
161831559|NCT00685802|584424832|FG000|Washout Period of 7 Days|Protocol Violation|2|||
161831560|NCT00685802|584424833|FG001|Washout Period of 7 Days|Protocol Violation|0|||
161831561|NCT00685802|584424832|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161831562|NCT00685802|584424833|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161831563|NCT03336242|584424834|FG000|Overall Study|Adverse Event|0|||
161831564|NCT03336242|584424835|FG001|Overall Study|Adverse Event|1|||
161831565|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
161831566|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
161831567|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
161831568|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
161831569|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
161831570|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
161831571|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
161831572|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
161831573|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
161831574|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
161831575|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
161831576|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
161831577|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
161831578|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
161533053|NCT02291614|583338810|FG004|Overall Study|Withdrawal by Subject|0|||
161533054|NCT02291614|583338811|FG005|Overall Study|Withdrawal by Subject|0|||
161533055|NCT02291614|583338812|FG006|Overall Study|Withdrawal by Subject|0|||
161533056|NCT02291614|583338813|FG007|Overall Study|Withdrawal by Subject|0|||
161533057|NCT02291614|583338814|FG008|Overall Study|Withdrawal by Subject|0|||
161533058|NCT02291614|583338815|FG009|Overall Study|Withdrawal by Subject|2|||
161533059|NCT02291614|583338816|FG010|Overall Study|Withdrawal by Subject|2|||
161533060|NCT02291614|583338806|FG000|Overall Study|Decision by sponsor|0|||
161533061|NCT02291614|583338807|FG001|Overall Study|Decision by sponsor|0|||
161533062|NCT02291614|583338808|FG002|Overall Study|Decision by sponsor|0|||
161533063|NCT02291614|583338809|FG003|Overall Study|Decision by sponsor|1|||
161533064|NCT02291614|583338810|FG004|Overall Study|Decision by sponsor|0|||
161533065|NCT02291614|583338811|FG005|Overall Study|Decision by sponsor|0|||
161533066|NCT02291614|583338812|FG006|Overall Study|Decision by sponsor|0|||
161533067|NCT02291614|583338813|FG007|Overall Study|Decision by sponsor|0|||
161533068|NCT02291614|583338814|FG008|Overall Study|Decision by sponsor|0|||
161533069|NCT02291614|583338815|FG009|Overall Study|Decision by sponsor|0|||
161533070|NCT02291614|583338816|FG010|Overall Study|Decision by sponsor|0|||
161533071|NCT02291614|583338806|FG000|Overall Study|Death|0|||
161533072|NCT02291614|583338807|FG001|Overall Study|Death|0|||
161533073|NCT02291614|583338808|FG002|Overall Study|Death|1|||
161533074|NCT02291614|583338809|FG003|Overall Study|Death|0|||
161533075|NCT02291614|583338810|FG004|Overall Study|Death|1|||
161533076|NCT02291614|583338811|FG005|Overall Study|Death|1|||
161533077|NCT02291614|583338812|FG006|Overall Study|Death|1|||
161533078|NCT02291614|583338813|FG007|Overall Study|Death|0|||
161533079|NCT02291614|583338814|FG008|Overall Study|Death|0|||
161533080|NCT02291614|583338815|FG009|Overall Study|Death|0|||
161533081|NCT02291614|583338816|FG010|Overall Study|Death|0|||
161533082|NCT03743038|583338817|FG000|Overall Study|Physician Decision|1|||
161533083|NCT01830127|583338819|FG000|Overall Study|Adverse Event|1|||
161533084|NCT01830127|583338820|FG001|Overall Study|Adverse Event|6|||
161533085|NCT01830127|583338819|FG000|Overall Study|Lack of Efficacy|3|||
161533086|NCT01830127|583338820|FG001|Overall Study|Lack of Efficacy|0|||
161533087|NCT01830127|583338819|FG000|Overall Study|Withdrawal by Subject|1|||
161533088|NCT01830127|583338820|FG001|Overall Study|Withdrawal by Subject|1|||
161533089|NCT01830127|583338819|FG000|Overall Study|Other reason not defined above|0|||
161533090|NCT01830127|583338820|FG001|Overall Study|Other reason not defined above|2|||
161533091|NCT01302847|583338823|FG000|Overall Study|Death|0|||
161533092|NCT01302847|583338824|FG001|Overall Study|Death|1|||
161533093|NCT01302847|583338825|FG002|Overall Study|Death|0|||
161533094|NCT01302847|583338826|FG003|Overall Study|Death|0|||
161533095|NCT01302847|583338827|FG004|Overall Study|Death|0|||
161533096|NCT01302847|583338828|FG005|Overall Study|Death|1|||
161533097|NCT01302847|583338829|FG006|Overall Study|Death|1|||
161533098|NCT01302847|583338830|FG007|Overall Study|Death|0|||
161533099|NCT01302847|583338823|FG000|Overall Study|Pregnancy|2|||
161533100|NCT01302847|583338824|FG001|Overall Study|Pregnancy|0|||
161533101|NCT01302847|583338825|FG002|Overall Study|Pregnancy|0|||
161533102|NCT01302847|583338826|FG003|Overall Study|Pregnancy|0|||
161533103|NCT01302847|583338827|FG004|Overall Study|Pregnancy|0|||
161533104|NCT01302847|583338828|FG005|Overall Study|Pregnancy|0|||
161533105|NCT01302847|583338829|FG006|Overall Study|Pregnancy|0|||
161533106|NCT01302847|583338830|FG007|Overall Study|Pregnancy|0|||
161533107|NCT01302847|583338823|FG000|Overall Study|Virologic failure|0|||
161533108|NCT01302847|583338824|FG001|Overall Study|Virologic failure|2|||
161533109|NCT01302847|583338825|FG002|Overall Study|Virologic failure|0|||
161533110|NCT01302847|583338826|FG003|Overall Study|Virologic failure|2|||
161533111|NCT01302847|583338827|FG004|Overall Study|Virologic failure|1|||
161533112|NCT01302847|583338828|FG005|Overall Study|Virologic failure|3|||
161533113|NCT01302847|583338829|FG006|Overall Study|Virologic failure|1|||
161533114|NCT01302847|583338830|FG007|Overall Study|Virologic failure|2|||
161533115|NCT01302847|583338823|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161533116|NCT01302847|583338824|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161533117|NCT01302847|583338825|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161533118|NCT01302847|583338826|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161533119|NCT01302847|583338827|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161533120|NCT01302847|583338828|FG005|Overall Study|Severe debilitation, unable to continue|1|||
161533121|NCT01302847|583338829|FG006|Overall Study|Severe debilitation, unable to continue|1|||
161533122|NCT01302847|583338830|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161533123|NCT01302847|583338823|FG000|Overall Study|Not able to get to clinic|1|||
161533124|NCT01302847|583338824|FG001|Overall Study|Not able to get to clinic|1|||
161533125|NCT01302847|583338825|FG002|Overall Study|Not able to get to clinic|0|||
161533126|NCT01302847|583338826|FG003|Overall Study|Not able to get to clinic|0|||
161533127|NCT01302847|583338827|FG004|Overall Study|Not able to get to clinic|0|||
161533128|NCT01302847|583338828|FG005|Overall Study|Not able to get to clinic|0|||
161533129|NCT01302847|583338829|FG006|Overall Study|Not able to get to clinic|0|||
161533130|NCT01302847|583338830|FG007|Overall Study|Not able to get to clinic|0|||
161533131|NCT01302847|583338823|FG000|Overall Study|Site closing|2|||
161533132|NCT01302847|583338824|FG001|Overall Study|Site closing|2|||
161533133|NCT01302847|583338825|FG002|Overall Study|Site closing|0|||
161533134|NCT01302847|583338826|FG003|Overall Study|Site closing|0|||
161533135|NCT01302847|583338827|FG004|Overall Study|Site closing|0|||
161533136|NCT01302847|583338828|FG005|Overall Study|Site closing|0|||
161533137|NCT01302847|583338829|FG006|Overall Study|Site closing|0|||
161533138|NCT01302847|583338830|FG007|Overall Study|Site closing|0|||
161533139|NCT01302847|583338823|FG000|Overall Study|Withdrawal by Subject|1|||
161533140|NCT01302847|583338824|FG001|Overall Study|Withdrawal by Subject|0|||
161533141|NCT01302847|583338825|FG002|Overall Study|Withdrawal by Subject|0|||
161533142|NCT01302847|583338826|FG003|Overall Study|Withdrawal by Subject|0|||
161829073|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829074|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161533143|NCT01302847|583338827|FG004|Overall Study|Withdrawal by Subject|1|||
161533144|NCT01302847|583338828|FG005|Overall Study|Withdrawal by Subject|0|||
161533145|NCT01302847|583338829|FG006|Overall Study|Withdrawal by Subject|0|||
161533146|NCT01302847|583338830|FG007|Overall Study|Withdrawal by Subject|1|||
161533147|NCT01302847|583338823|FG000|Overall Study|Not willing to adhere to requirements|5|||
161533148|NCT01302847|583338824|FG001|Overall Study|Not willing to adhere to requirements|0|||
161533149|NCT01302847|583338825|FG002|Overall Study|Not willing to adhere to requirements|1|||
161533150|NCT01302847|583338826|FG003|Overall Study|Not willing to adhere to requirements|0|||
161533151|NCT01302847|583338827|FG004|Overall Study|Not willing to adhere to requirements|0|||
161533152|NCT01302847|583338828|FG005|Overall Study|Not willing to adhere to requirements|0|||
161533153|NCT01302847|583338829|FG006|Overall Study|Not willing to adhere to requirements|0|||
161533154|NCT01302847|583338830|FG007|Overall Study|Not willing to adhere to requirements|2|||
161533155|NCT01302847|583338823|FG000|Overall Study|Site unable to contact participant|2|||
161533156|NCT01302847|583338824|FG001|Overall Study|Site unable to contact participant|1|||
161533157|NCT01302847|583338825|FG002|Overall Study|Site unable to contact participant|0|||
161533158|NCT01302847|583338826|FG003|Overall Study|Site unable to contact participant|0|||
161533159|NCT01302847|583338827|FG004|Overall Study|Site unable to contact participant|0|||
161533160|NCT01302847|583338828|FG005|Overall Study|Site unable to contact participant|0|||
161533161|NCT01302847|583338829|FG006|Overall Study|Site unable to contact participant|2|||
161533162|NCT01302847|583338830|FG007|Overall Study|Site unable to contact participant|0|||
161533163|NCT03776136|583338832|FG000|Overall Study|Death|85|||
161533164|NCT03776136|583338832|FG000|Overall Study|Withdrawal by Subject|3|||
161533165|NCT03776136|583338832|FG000|Overall Study|Sponsor Decision|15|||
161533166|NCT00680407|583338840|FG000|Overall Study|Lost to Follow-up|3|||
161533167|NCT00680407|583338841|FG001|Overall Study|Lost to Follow-up|3|||
161533168|NCT00680407|583338842|FG002|Overall Study|Lost to Follow-up|1|||
161533169|NCT00680407|583338840|FG000|Overall Study|Withdrawal by Subject|5|||
161533170|NCT00680407|583338841|FG001|Overall Study|Withdrawal by Subject|2|||
161533171|NCT00680407|583338842|FG002|Overall Study|Withdrawal by Subject|2|||
161533172|NCT01735201|583341279|FG000|Overall Study|Adverse Event|1|||
161533173|NCT01735201|583341280|FG001|Overall Study|Adverse Event|1|||
161533174|NCT01735201|583341281|FG002|Overall Study|Adverse Event|0|||
161533175|NCT01735201|583341282|FG003|Overall Study|Adverse Event|1|||
161533176|NCT01735201|583341283|FG004|Overall Study|Adverse Event|1|||
161533177|NCT01735201|583341284|FG005|Overall Study|Adverse Event|3|||
161533178|NCT01735201|583341285|FG006|Overall Study|Adverse Event|2|||
161533179|NCT01735201|583341286|FG007|Overall Study|Adverse Event|1|||
161533180|NCT01735201|583341279|FG000|Overall Study|Personal Reasons|1|||
161533181|NCT01735201|583341280|FG001|Overall Study|Personal Reasons|0|||
161533182|NCT01735201|583341281|FG002|Overall Study|Personal Reasons|0|||
161533183|NCT01735201|583341282|FG003|Overall Study|Personal Reasons|0|||
161533184|NCT01735201|583341283|FG004|Overall Study|Personal Reasons|0|||
161533185|NCT01735201|583341284|FG005|Overall Study|Personal Reasons|0|||
161533186|NCT01735201|583341285|FG006|Overall Study|Personal Reasons|0|||
161533187|NCT01735201|583341286|FG007|Overall Study|Personal Reasons|0|||
161533188|NCT01735201|583341279|FG000|Overall Study|Protocol Violation|1|||
161533189|NCT01735201|583341280|FG001|Overall Study|Protocol Violation|0|||
161533190|NCT01735201|583341281|FG002|Overall Study|Protocol Violation|0|||
161533191|NCT01735201|583341282|FG003|Overall Study|Protocol Violation|0|||
161533192|NCT01735201|583341283|FG004|Overall Study|Protocol Violation|0|||
161533193|NCT01735201|583341284|FG005|Overall Study|Protocol Violation|0|||
161533194|NCT01735201|583341285|FG006|Overall Study|Protocol Violation|0|||
161533195|NCT01735201|583341286|FG007|Overall Study|Protocol Violation|0|||
161533196|NCT01735201|583341279|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161533197|NCT01735201|583341280|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161533198|NCT01735201|583341281|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161533199|NCT01735201|583341282|FG003|Overall Study|Other Miscellaneous Reasons|1|||
161533200|NCT01735201|583341283|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161533201|NCT01735201|583341284|FG005|Overall Study|Other Miscellaneous Reasons|2|||
161533202|NCT01735201|583341285|FG006|Overall Study|Other Miscellaneous Reasons|1|||
161533203|NCT01735201|583341286|FG007|Overall Study|Other Miscellaneous Reasons|1|||
161533204|NCT02178059|583341292|FG000|Washout|Physician Decision|1|||
161533205|NCT02178059|583341293|FG001|Washout|Physician Decision|0|||
161533206|NCT04128293|583341294|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
161533207|NCT04128293|583341295|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
161533208|NCT04128293|583341296|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
161533209|NCT04128293|583341297|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
161533210|NCT00514943|583341300|FG000|Stage 1|Progressive disease|4|||
161533211|NCT00514943|583341301|FG001|Stage 1|Progressive disease|8|||
161533212|NCT00514943|583341300|FG000|Stage 1|Other Adverse Event|16|||
161533213|NCT00514943|583341301|FG001|Stage 1|Other Adverse Event|6|||
161533214|NCT00514943|583341300|FG000|Stage 1|Not treated|1|||
161533215|NCT00514943|583341301|FG001|Stage 1|Not treated|2|||
161533216|NCT00514943|583341300|FG000|Stage 1|Patient refused to continue study meds|8|||
161533217|NCT00514943|583341301|FG001|Stage 1|Patient refused to continue study meds|3|||
161533218|NCT00514943|583341300|FG000|Stage 1|Other than stated above|1|||
161533219|NCT00514943|583341301|FG001|Stage 1|Other than stated above|7|||
161533220|NCT00514943|583341300|FG000|Stage 2|Progressive disease|27|||
161533221|NCT00514943|583341301|FG001|Stage 2|Progressive disease|24|||
161533222|NCT00514943|583341300|FG000|Stage 2|Other Adverse Event|3|||
161533223|NCT00514943|583341301|FG001|Stage 2|Other Adverse Event|10|||
161533224|NCT00514943|583341300|FG000|Stage 2|Patient refused to continue study meds|2|||
161533225|NCT00514943|583341301|FG001|Stage 2|Patient refused to continue study meds|0|||
161533226|NCT00514943|583341300|FG000|Stage 2|Other than stated above|0|||
161533227|NCT00514943|583341301|FG001|Stage 2|Other than stated above|2|||
161533228|NCT00499031|583341302|FG000|Overall Study|Improper pre-protocol treatment|1|||
161533229|NCT00499031|583341302|FG000|Overall Study|Required test not done|1|||
161533230|NCT00499031|583341302|FG000|Overall Study|Never treated|1|||
161533231|NCT02001194|583341304|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
161829075|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
161533232|NCT02001194|583341305|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
161533233|NCT02001194|583341306|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
161533234|NCT02001194|583341307|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
161533235|NCT02001194|583341304|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
161533236|NCT02001194|583341305|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
161533237|NCT02001194|583341306|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
161533238|NCT02001194|583341307|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
161533239|NCT02366910|583341312|FG000|Overall Study|Withdrawal by Subject|2|||
161533240|NCT02366910|583341312|FG000|Overall Study|Screen Failure|3|||
161533241|NCT03284788|583341313|FG000|Overall Study|Withdrawal by Subject|2|||
161533242|NCT01786512|583341314|FG000|Overall Study|Lost to Follow-up|0|||
161533243|NCT01786512|583341315|FG001|Overall Study|Lost to Follow-up|0|||
161533244|NCT01786512|583341316|FG002|Overall Study|Lost to Follow-up|0|||
161533245|NCT01786512|583341317|FG003|Overall Study|Lost to Follow-up|0|||
161533246|NCT01786512|583341318|FG004|Overall Study|Lost to Follow-up|0|||
161533247|NCT01786512|583341319|FG005|Overall Study|Lost to Follow-up|0|||
161533248|NCT01786512|583341320|FG006|Overall Study|Lost to Follow-up|0|||
161533249|NCT01786512|583341321|FG007|Overall Study|Lost to Follow-up|0|||
161533250|NCT01786512|583341322|FG008|Overall Study|Lost to Follow-up|0|||
161533251|NCT01786512|583341323|FG009|Overall Study|Lost to Follow-up|1|||
161533252|NCT01786512|583341324|FG010|Overall Study|Lost to Follow-up|0|||
161533253|NCT01786512|583341314|FG000|Overall Study|Decision by sponsor|0|||
161533254|NCT01786512|583341315|FG001|Overall Study|Decision by sponsor|0|||
161533255|NCT01786512|583341316|FG002|Overall Study|Decision by sponsor|0|||
161533256|NCT01786512|583341317|FG003|Overall Study|Decision by sponsor|0|||
161533257|NCT01786512|583341318|FG004|Overall Study|Decision by sponsor|0|||
161533258|NCT01786512|583341319|FG005|Overall Study|Decision by sponsor|0|||
161533259|NCT01786512|583341320|FG006|Overall Study|Decision by sponsor|0|||
161533260|NCT01786512|583341321|FG007|Overall Study|Decision by sponsor|0|||
161533261|NCT01786512|583341322|FG008|Overall Study|Decision by sponsor|0|||
161533262|NCT01786512|583341323|FG009|Overall Study|Decision by sponsor|0|||
161533263|NCT01786512|583341324|FG010|Overall Study|Decision by sponsor|2|||
161533264|NCT01786512|583341314|FG000|Overall Study|Withdrawal by Subject|0|||
161533265|NCT01786512|583341315|FG001|Overall Study|Withdrawal by Subject|1|||
161533266|NCT01786512|583341316|FG002|Overall Study|Withdrawal by Subject|0|||
161533267|NCT01786512|583341317|FG003|Overall Study|Withdrawal by Subject|0|||
161533268|NCT01786512|583341318|FG004|Overall Study|Withdrawal by Subject|0|||
161533269|NCT01786512|583341319|FG005|Overall Study|Withdrawal by Subject|0|||
161533270|NCT01786512|583341320|FG006|Overall Study|Withdrawal by Subject|1|||
161533271|NCT01786512|583341321|FG007|Overall Study|Withdrawal by Subject|0|||
161533272|NCT01786512|583341322|FG008|Overall Study|Withdrawal by Subject|0|||
161533273|NCT01786512|583341323|FG009|Overall Study|Withdrawal by Subject|3|||
161533274|NCT01786512|583341324|FG010|Overall Study|Withdrawal by Subject|7|||
161533275|NCT01786512|583341314|FG000|Overall Study|Death|0|||
161533276|NCT01786512|583341315|FG001|Overall Study|Death|0|||
161533277|NCT01786512|583341316|FG002|Overall Study|Death|0|||
161533278|NCT01786512|583341317|FG003|Overall Study|Death|0|||
161533279|NCT01786512|583341318|FG004|Overall Study|Death|0|||
161533280|NCT01786512|583341319|FG005|Overall Study|Death|0|||
161533281|NCT01786512|583341320|FG006|Overall Study|Death|0|||
161533282|NCT01786512|583341321|FG007|Overall Study|Death|0|||
161533283|NCT01786512|583341322|FG008|Overall Study|Death|4|||
161533284|NCT01786512|583341323|FG009|Overall Study|Death|1|||
161533285|NCT01786512|583341324|FG010|Overall Study|Death|3|||
161533286|NCT00605293|583341325|FG000|Overall Study|Death|2|||
161533287|NCT00605293|583341326|FG001|Overall Study|Death|1|||
161533288|NCT00605293|583341325|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161533289|NCT00605293|583341326|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161533290|NCT00605293|583341325|FG000|Overall Study|Adverse Event|1|||
161533291|NCT00605293|583341326|FG001|Overall Study|Adverse Event|0|||
161533292|NCT00605293|583341325|FG000|Overall Study|Holidays Dialysis Out|1|||
161533293|NCT00605293|583341326|FG001|Overall Study|Holidays Dialysis Out|0|||
161533294|NCT00605293|583341325|FG000|Overall Study|Blood Transfusion|7|||
161533295|NCT00605293|583341326|FG001|Overall Study|Blood Transfusion|1|||
161533296|NCT00605293|583341325|FG000|Overall Study|Renal Transplantation|3|||
161533297|NCT00605293|583341326|FG001|Overall Study|Renal Transplantation|1|||
161533298|NCT00605293|583341325|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
161533299|NCT00605293|583341326|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
161533300|NCT00605293|583341325|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
161533301|NCT00605293|583341326|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
161533302|NCT00605293|583341325|FG000|Overall Study|Principal Investigator Decision|0|||
161533303|NCT00605293|583341326|FG001|Overall Study|Principal Investigator Decision|1|||
161533304|NCT00781391|583341329|FG000|Overall Study|never received study drug|24|||
161533305|NCT00781391|583341330|FG001|Overall Study|never received study drug|23|||
161533306|NCT00781391|583341331|FG002|Overall Study|never received study drug|32|||
161533307|NCT00781391|583341329|FG000|Overall Study|Protocol Violation|19|||
161829076|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161829077|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
161829078|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161533308|NCT00781391|583341330|FG001|Overall Study|Protocol Violation|17|||
161533309|NCT00781391|583341331|FG002|Overall Study|Protocol Violation|20|||
161533310|NCT00781391|583341329|FG000|Overall Study|Death|789|||
161533311|NCT00781391|583341330|FG001|Overall Study|Death|730|||
161533312|NCT00781391|583341331|FG002|Overall Study|Death|706|||
161533313|NCT00781391|583341329|FG000|Overall Study|Withdrawal by Subject|47|||
161533314|NCT00781391|583341330|FG001|Overall Study|Withdrawal by Subject|37|||
161533315|NCT00781391|583341331|FG002|Overall Study|Withdrawal by Subject|25|||
161533316|NCT00781391|583341329|FG000|Overall Study|Lost to Follow-up|0|||
161533317|NCT00781391|583341330|FG001|Overall Study|Lost to Follow-up|0|||
161533318|NCT00781391|583341331|FG002|Overall Study|Lost to Follow-up|1|||
161533319|NCT01984684|583341332|FG000|Overall Study|Lost to Follow-up|25|||
161533320|NCT01984684|583341333|FG001|Overall Study|Lost to Follow-up|24|||
161533321|NCT01984684|583341332|FG000|Overall Study|Adverse Event|8|||
161533322|NCT01984684|583341333|FG001|Overall Study|Adverse Event|12|||
161533323|NCT01984684|583341332|FG000|Overall Study|Withdrawal by Subject|9|||
161533324|NCT01984684|583341333|FG001|Overall Study|Withdrawal by Subject|9|||
161533325|NCT01984684|583341332|FG000|Overall Study|Lack of Efficacy|3|||
161533326|NCT01984684|583341333|FG001|Overall Study|Lack of Efficacy|6|||
161533327|NCT01984684|583341332|FG000|Overall Study|Physician Decision|4|||
161533328|NCT01984684|583341333|FG001|Overall Study|Physician Decision|2|||
161533329|NCT01984684|583341332|FG000|Overall Study|Protocol Violation|4|||
161533330|NCT01984684|583341333|FG001|Overall Study|Protocol Violation|2|||
161533331|NCT01984684|583341332|FG000|Overall Study|Death|0|||
161533332|NCT01984684|583341333|FG001|Overall Study|Death|1|||
161533333|NCT01984684|583341332|FG000|Overall Study|Noncompliance with study drug|2|||
161533334|NCT01984684|583341333|FG001|Overall Study|Noncompliance with study drug|1|||
161533335|NCT01984684|583341332|FG000|Overall Study|Subject incarcerated|1|||
161533336|NCT01984684|583341333|FG001|Overall Study|Subject incarcerated|0|||
161533337|NCT01984684|583341332|FG000|Overall Study|Study drug not available at site|1|||
161533338|NCT01984684|583341333|FG001|Overall Study|Study drug not available at site|1|||
161533339|NCT01984684|583341332|FG000|Overall Study|Subject had inadequate IV access|0|||
161533340|NCT01984684|583341333|FG001|Overall Study|Subject had inadequate IV access|1|||
161533341|NCT03205371|583341343|FG000|Overall Study|Withdrawal by Subject|4|||
161533342|NCT03205371|583341344|FG001|Overall Study|Withdrawal by Subject|1|||
161533343|NCT03205371|583341345|FG002|Overall Study|Withdrawal by Subject|0|||
161533344|NCT03205371|583341346|FG003|Overall Study|Withdrawal by Subject|0|||
161533345|NCT03205371|583341347|FG004|Overall Study|Withdrawal by Subject|0|||
161533346|NCT03205371|583341348|FG005|Overall Study|Withdrawal by Subject|0|||
161533347|NCT03205371|583341349|FG006|Overall Study|Withdrawal by Subject|4|||
161533348|NCT03205371|583341350|FG007|Overall Study|Withdrawal by Subject|0|||
161533349|NCT03205371|583341351|FG008|Overall Study|Withdrawal by Subject|2|||
161829079|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161829080|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
161829081|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161829082|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161829083|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161829084|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829085|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
161829086|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161533350|NCT03205371|583341352|FG009|Overall Study|Withdrawal by Subject|0|||
161533351|NCT03205371|583341353|FG010|Overall Study|Withdrawal by Subject|0|||
161533352|NCT03205371|583341354|FG011|Overall Study|Withdrawal by Subject|1|||
161533353|NCT03205371|583341343|FG000|Overall Study|Lost to Follow-up|0|||
161533354|NCT03205371|583341344|FG001|Overall Study|Lost to Follow-up|0|||
161533355|NCT03205371|583341345|FG002|Overall Study|Lost to Follow-up|0|||
161533356|NCT03205371|583341346|FG003|Overall Study|Lost to Follow-up|0|||
161533357|NCT03205371|583341347|FG004|Overall Study|Lost to Follow-up|0|||
161533358|NCT03205371|583341348|FG005|Overall Study|Lost to Follow-up|0|||
161533359|NCT03205371|583341349|FG006|Overall Study|Lost to Follow-up|5|||
161533360|NCT03205371|583341350|FG007|Overall Study|Lost to Follow-up|2|||
161533361|NCT03205371|583341351|FG008|Overall Study|Lost to Follow-up|3|||
161533362|NCT03205371|583341352|FG009|Overall Study|Lost to Follow-up|0|||
161533363|NCT03205371|583341353|FG010|Overall Study|Lost to Follow-up|0|||
161533364|NCT03205371|583341354|FG011|Overall Study|Lost to Follow-up|0|||
161533365|NCT03205371|583341343|FG000|Overall Study|Protocol Violation|0|||
161533366|NCT03205371|583341344|FG001|Overall Study|Protocol Violation|0|||
161533367|NCT03205371|583341345|FG002|Overall Study|Protocol Violation|0|||
161533368|NCT03205371|583341346|FG003|Overall Study|Protocol Violation|0|||
161533369|NCT03205371|583341347|FG004|Overall Study|Protocol Violation|0|||
161533370|NCT03205371|583341348|FG005|Overall Study|Protocol Violation|0|||
161533371|NCT03205371|583341349|FG006|Overall Study|Protocol Violation|1|||
161533372|NCT03205371|583341350|FG007|Overall Study|Protocol Violation|0|||
161533373|NCT03205371|583341351|FG008|Overall Study|Protocol Violation|0|||
161533374|NCT03205371|583341352|FG009|Overall Study|Protocol Violation|0|||
161533375|NCT03205371|583341353|FG010|Overall Study|Protocol Violation|0|||
161533376|NCT03205371|583341354|FG011|Overall Study|Protocol Violation|0|||
161533377|NCT03205371|583341343|FG000|Overall Study|Adverse Event|0|||
161533378|NCT03205371|583341344|FG001|Overall Study|Adverse Event|0|||
161533379|NCT03205371|583341345|FG002|Overall Study|Adverse Event|0|||
161533380|NCT03205371|583341346|FG003|Overall Study|Adverse Event|0|||
161533381|NCT03205371|583341347|FG004|Overall Study|Adverse Event|0|||
161533382|NCT03205371|583341348|FG005|Overall Study|Adverse Event|0|||
161533383|NCT03205371|583341349|FG006|Overall Study|Adverse Event|0|||
161533384|NCT03205371|583341350|FG007|Overall Study|Adverse Event|1|||
161533385|NCT03205371|583341351|FG008|Overall Study|Adverse Event|0|||
161533386|NCT03205371|583341352|FG009|Overall Study|Adverse Event|0|||
161533387|NCT03205371|583341353|FG010|Overall Study|Adverse Event|0|||
161533388|NCT03205371|583341354|FG011|Overall Study|Adverse Event|0|||
161533389|NCT02835339|583341355|FG000|Overall Study|Did not receive allocated intervention|13|||
161533390|NCT02835339|583341356|FG001|Overall Study|Did not receive allocated intervention|16|||
161533391|NCT01077544|583341357|FG000|Overall Study|New Cancer Therapy|3|||
161533392|NCT01077544|583341358|FG001|Overall Study|New Cancer Therapy|3|||
161533393|NCT01077544|583341357|FG000|Overall Study|Adverse Event|0|||
161533394|NCT01077544|583341358|FG001|Overall Study|Adverse Event|1|||
161533395|NCT01077544|583341357|FG000|Overall Study|Disease Progression|0|||
161533396|NCT01077544|583341358|FG001|Overall Study|Disease Progression|1|||
161533397|NCT03923959|583341359|FG000|Overall Study|Death|16|||
161533398|NCT03923959|583341360|FG001|Overall Study|Death|12|||
161533399|NCT03923959|583341359|FG000|Overall Study|Lost to Follow-up|56|||
161533400|NCT03923959|583341360|FG001|Overall Study|Lost to Follow-up|56|||
161533401|NCT03923959|583341359|FG000|Overall Study|Withdrawal by Subject|1|||
161533402|NCT03923959|583341360|FG001|Overall Study|Withdrawal by Subject|1|||
161533403|NCT03923959|583341359|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
161533404|NCT03923959|583341360|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
161533405|NCT04212091|583341362|FG000|Overall Study|Lost to Follow-up|0|||
161533406|NCT04212091|583341363|FG001|Overall Study|Lost to Follow-up|0|||
161533407|NCT04212091|583341364|FG002|Overall Study|Lost to Follow-up|0|||
161533408|NCT04212091|583341365|FG003|Overall Study|Lost to Follow-up|0|||
161533409|NCT04212091|583341366|FG004|Overall Study|Lost to Follow-up|1|||
161533410|NCT04212091|583341367|FG005|Overall Study|Lost to Follow-up|1|||
161533411|NCT04212091|583341362|FG000|Overall Study|Participant unable to adhere to visit|0|||
161533412|NCT04212091|583341363|FG001|Overall Study|Participant unable to adhere to visit|0|||
161533413|NCT04212091|583341364|FG002|Overall Study|Participant unable to adhere to visit|0|||
161533414|NCT04212091|583341365|FG003|Overall Study|Participant unable to adhere to visit|0|||
161533415|NCT04212091|583341366|FG004|Overall Study|Participant unable to adhere to visit|1|||
161533416|NCT04212091|583341367|FG005|Overall Study|Participant unable to adhere to visit|0|||
161533417|NCT04575051|583341368|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
161533418|NCT04575051|583341369|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
161533419|NCT04575051|583341370|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
161533420|NCT04575051|583341371|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
161533421|NCT04575051|583341372|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
161533422|NCT04575051|583341368|FG000|Time Period 1|Missing follow up|1|||
161533423|NCT04575051|583341369|FG001|Time Period 1|Missing follow up|3|||
161533424|NCT04575051|583341370|FG002|Time Period 1|Missing follow up|1|||
161533425|NCT04575051|583341371|FG003|Time Period 1|Missing follow up|3|||
161533426|NCT04575051|583341372|FG004|Time Period 1|Missing follow up|2|||
161533427|NCT04575051|583341368|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
161533428|NCT04575051|583341369|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
161533429|NCT04575051|583341370|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
161533430|NCT04575051|583341371|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
161533431|NCT04575051|583341372|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
161533432|NCT04575051|583341368|FG000|Time Period 2|Missing follow up|1|||
161533433|NCT04575051|583341369|FG001|Time Period 2|Missing follow up|8|||
161533434|NCT04575051|583341370|FG002|Time Period 2|Missing follow up|7|||
161533435|NCT04575051|583341371|FG003|Time Period 2|Missing follow up|0|||
161533436|NCT04575051|583341372|FG004|Time Period 2|Missing follow up|1|||
161533437|NCT04575051|583341368|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
161533438|NCT04575051|583341369|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
161533439|NCT04575051|583341370|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
161533440|NCT04575051|583341371|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
161533441|NCT04575051|583341372|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
161533442|NCT04575051|583341368|FG000|Time Period 3|Missing follow up|8|||
161533443|NCT04575051|583341369|FG001|Time Period 3|Missing follow up|6|||
161533444|NCT04575051|583341370|FG002|Time Period 3|Missing follow up|4|||
161533445|NCT04575051|583341371|FG003|Time Period 3|Missing follow up|3|||
161533446|NCT04575051|583341372|FG004|Time Period 3|Missing follow up|0|||
161533447|NCT04575051|583341368|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
161533448|NCT04575051|583341369|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
161533449|NCT04575051|583341370|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
161533450|NCT04575051|583341371|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
161533451|NCT04575051|583341372|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
161533452|NCT04575051|583341368|FG000|Time Period 4|Missing follow up|17|||
161533453|NCT04575051|583341369|FG001|Time Period 4|Missing follow up|3|||
161533454|NCT04575051|583341370|FG002|Time Period 4|Missing follow up|4|||
161533455|NCT04575051|583341371|FG003|Time Period 4|Missing follow up|2|||
161533456|NCT04575051|583341372|FG004|Time Period 4|Missing follow up|1|||
161533457|NCT04575051|583341368|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
161533458|NCT04575051|583341369|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
161533459|NCT04575051|583341370|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
161533460|NCT04575051|583341371|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
161533461|NCT04575051|583341372|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
161533462|NCT04575051|583341368|FG000|Time Period 5|Missing follow up|11|||
161533463|NCT04575051|583341369|FG001|Time Period 5|Missing follow up|8|||
161533464|NCT04575051|583341370|FG002|Time Period 5|Missing follow up|12|||
161533465|NCT04575051|583341371|FG003|Time Period 5|Missing follow up|3|||
161533466|NCT04575051|583341372|FG004|Time Period 5|Missing follow up|11|||
161533467|NCT03182868|583341373|FG000|Overall Study|Protocol Violation|3|||
161533468|NCT03182868|583341374|FG001|Overall Study|Protocol Violation|0|||
161533469|NCT03182868|583341375|FG002|Overall Study|Protocol Violation|4|||
161533470|NCT03182868|583341376|FG003|Overall Study|Protocol Violation|1|||
161533471|NCT03182868|583341377|FG004|Overall Study|Protocol Violation|8|||
161533472|NCT00295022|583341378|FG000|Overall Study|Adverse Event|1|||
161533473|NCT00295022|583341379|FG001|Overall Study|Adverse Event|1|||
161533474|NCT00295022|583341380|FG002|Overall Study|Adverse Event|2|||
161533475|NCT00295022|583341378|FG000|Overall Study|Lost to Follow-up|0|||
161533476|NCT00295022|583341379|FG001|Overall Study|Lost to Follow-up|0|||
161533477|NCT00295022|583341380|FG002|Overall Study|Lost to Follow-up|1|||
161533478|NCT00295022|583341378|FG000|Overall Study|Withdrawal by Subject|0|||
161533479|NCT00295022|583341379|FG001|Overall Study|Withdrawal by Subject|0|||
161533480|NCT00295022|583341380|FG002|Overall Study|Withdrawal by Subject|2|||
161533481|NCT00734630|583341382|FG000|Overall Study|Lack of Efficacy|4|||
161533482|NCT00734630|583341383|FG001|Overall Study|Lack of Efficacy|4|||
161533483|NCT00734630|583341382|FG000|Overall Study|Withdrawal by Subject|7|||
161533484|NCT00734630|583341383|FG001|Overall Study|Withdrawal by Subject|9|||
161533485|NCT00734630|583341382|FG000|Overall Study|Lost to Follow-up|13|||
161533486|NCT00734630|583341383|FG001|Overall Study|Lost to Follow-up|7|||
161533487|NCT00734630|583341382|FG000|Overall Study|Protocol Violation|0|||
161533488|NCT00734630|583341383|FG001|Overall Study|Protocol Violation|3|||
161533489|NCT00734630|583341382|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161533490|NCT00734630|583341383|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
161533491|NCT00734630|583341382|FG000|Overall Study|Adverse Event|3|||
161533492|NCT00734630|583341383|FG001|Overall Study|Adverse Event|6|||
161533493|NCT00734630|583341382|FG000|Overall Study|Randomized in Error|0|||
161829087|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829088|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161533494|NCT00734630|583341383|FG001|Overall Study|Randomized in Error|1|||
161533495|NCT00734630|583341382|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
161533496|NCT00734630|583341383|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
161533497|NCT00734630|583341382|FG000|Overall Study|Poor Compliance|1|||
161533498|NCT00734630|583341383|FG001|Overall Study|Poor Compliance|1|||
161533499|NCT01239030|583341384|FG000|Double Blind|Adverse Event|0|||
161533500|NCT01239030|583341385|FG001|Double Blind|Adverse Event|1|||
161533501|NCT01239030|583341386|FG002|Double Blind|Adverse Event|0|||
161533502|NCT01239030|583341387|FG003|Double Blind|Adverse Event|2|||
161533503|NCT01239030|583341388|FG004|Double Blind|Adverse Event|0|||
161533504|NCT01239030|583341384|FG000|Double Blind|Withdrawal by Subject|0|||
161533505|NCT01239030|583341385|FG001|Double Blind|Withdrawal by Subject|1|||
161533506|NCT01239030|583341386|FG002|Double Blind|Withdrawal by Subject|1|||
161533507|NCT01239030|583341387|FG003|Double Blind|Withdrawal by Subject|0|||
161533508|NCT01239030|583341388|FG004|Double Blind|Withdrawal by Subject|1|||
161533509|NCT01239030|583341384|FG000|Double Blind|Lost to Follow-up|1|||
161533510|NCT01239030|583341385|FG001|Double Blind|Lost to Follow-up|1|||
161533511|NCT01239030|583341386|FG002|Double Blind|Lost to Follow-up|0|||
161533512|NCT01239030|583341387|FG003|Double Blind|Lost to Follow-up|0|||
161533513|NCT01239030|583341388|FG004|Double Blind|Lost to Follow-up|0|||
161533514|NCT01239030|583341384|FG000|Double Blind|Physician Decision|0|||
161533515|NCT01239030|583341385|FG001|Double Blind|Physician Decision|1|||
161533516|NCT01239030|583341386|FG002|Double Blind|Physician Decision|0|||
161533517|NCT01239030|583341387|FG003|Double Blind|Physician Decision|0|||
161533518|NCT01239030|583341388|FG004|Double Blind|Physician Decision|0|||
161533519|NCT01239030|583341384|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
161533520|NCT01239030|583341385|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
161533521|NCT01239030|583341386|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
161533522|NCT01239030|583341387|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
161533523|NCT01239030|583341388|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
161533524|NCT01239030|583341384|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
161533525|NCT01239030|583341385|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
161533526|NCT01239030|583341386|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
161533527|NCT01239030|583341387|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
161533528|NCT01239030|583341388|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
161533529|NCT01239030|583341384|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
161533530|NCT01239030|583341385|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
161533531|NCT01239030|583341386|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
161533532|NCT01239030|583341387|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
161533533|NCT01239030|583341388|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
161533534|NCT01239030|583341384|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
161533535|NCT01239030|583341385|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
161533536|NCT01239030|583341386|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
161533537|NCT01239030|583341387|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
161533538|NCT01239030|583341388|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
161533539|NCT04403698|583341389|FG000|Overall Study|Adverse Event|1|||
161533540|NCT04403698|583341390|FG001|Overall Study|Adverse Event|1|||
161533541|NCT04403698|583341389|FG000|Overall Study|Lost to Follow-up|1|||
161533542|NCT04403698|583341390|FG001|Overall Study|Lost to Follow-up|0|||
161533543|NCT04403698|583341389|FG000|Overall Study|Protocol Violation|0|||
161533544|NCT04403698|583341390|FG001|Overall Study|Protocol Violation|1|||
161533545|NCT00977665|583341391|FG000|Overall Study|Withdrawal by Subject|1|||
161533546|NCT00977665|583341392|FG001|Overall Study|Withdrawal by Subject|3|||
161533547|NCT00977665|583341391|FG000|Overall Study|Physician Decision|2|||
161533548|NCT00977665|583341392|FG001|Overall Study|Physician Decision|1|||
161533549|NCT00977665|583341391|FG000|Overall Study|Sponsor requested withdrawal|0|||
161533550|NCT00977665|583341392|FG001|Overall Study|Sponsor requested withdrawal|1|||
161533551|NCT00977665|583341391|FG000|Overall Study|Lost to Follow-up|1|||
161533552|NCT00977665|583341392|FG001|Overall Study|Lost to Follow-up|0|||
161533553|NCT00977665|583341391|FG000|Overall Study|Death|3|||
161533554|NCT00977665|583341392|FG001|Overall Study|Death|2|||
161533555|NCT00977665|583341391|FG000|Overall Study|Adverse Event|14|||
161533556|NCT00977665|583341392|FG001|Overall Study|Adverse Event|7|||
161533557|NCT00977665|583341391|FG000|Overall Study|Treatment failure|0|||
161533558|NCT00977665|583341392|FG001|Overall Study|Treatment failure|1|||
161533559|NCT01330433|583341393|FG000|Overall Study|Death|1|||
161533560|NCT01330433|583341394|FG001|Overall Study|Death|3|||
161533561|NCT01330433|583341393|FG000|Overall Study|Lost to Follow-up|1|||
161533562|NCT01330433|583341394|FG001|Overall Study|Lost to Follow-up|0|||
161533563|NCT00441090|583341397|FG000|Overall Study|Adverse Event|0|||
161533564|NCT00441090|583341398|FG001|Overall Study|Adverse Event|1|||
161533565|NCT00441090|583341399|FG002|Overall Study|Adverse Event|1|||
161533566|NCT00441090|583341400|FG003|Overall Study|Adverse Event|0|||
161533567|NCT00441090|583341401|FG004|Overall Study|Adverse Event|0|||
161533568|NCT00441090|583341397|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
161533569|NCT00441090|583341398|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
161533570|NCT00441090|583341399|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
161533571|NCT00441090|583341400|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
161533572|NCT00441090|583341401|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
161533573|NCT00441090|583341397|FG000|Overall Study|Withdrawal by Subject|1|||
161533574|NCT00441090|583341398|FG001|Overall Study|Withdrawal by Subject|0|||
161533575|NCT00441090|583341399|FG002|Overall Study|Withdrawal by Subject|1|||
161678651|NCT00766090|583876053|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161533576|NCT00441090|583341400|FG003|Overall Study|Withdrawal by Subject|0|||
161533577|NCT00441090|583341401|FG004|Overall Study|Withdrawal by Subject|0|||
161533578|NCT00441090|583341397|FG000|Overall Study|Lack of Efficacy|1|||
161533579|NCT00441090|583341398|FG001|Overall Study|Lack of Efficacy|0|||
161533580|NCT00441090|583341399|FG002|Overall Study|Lack of Efficacy|0|||
161533581|NCT00441090|583341400|FG003|Overall Study|Lack of Efficacy|0|||
161533582|NCT00441090|583341401|FG004|Overall Study|Lack of Efficacy|0|||
161533583|NCT01441102|583341402|FG000|Overall Study|Adverse Event|1|||
161533584|NCT01441102|583341402|FG000|Overall Study|Withdrawal by Subject|2|||
161533585|NCT01022762|583341403|FG000|Overall Study|Adverse Event|3|||
161533586|NCT01022762|583341404|FG001|Overall Study|Adverse Event|1|||
161533587|NCT01022762|583341403|FG000|Overall Study|Lack of Efficacy|0|||
161533588|NCT01022762|583341404|FG001|Overall Study|Lack of Efficacy|1|||
161533589|NCT01022762|583341403|FG000|Overall Study|Protocol Violation|7|||
161533590|NCT01022762|583341404|FG001|Overall Study|Protocol Violation|6|||
161533591|NCT01022762|583341403|FG000|Overall Study|Unclassified|12|||
161533592|NCT01022762|583341404|FG001|Overall Study|Unclassified|20|||
161533593|NCT01565707|583341407|FG000|Overall Study|Adverse Event|1|||
161533594|NCT01565707|583341408|FG001|Overall Study|Adverse Event|6|||
161533595|NCT01565707|583341409|FG002|Overall Study|Adverse Event|2|||
161533596|NCT01565707|583341410|FG003|Overall Study|Adverse Event|1|||
161533597|NCT01565707|583341407|FG000|Overall Study|Lost to Follow-up|1|||
161533598|NCT01565707|583341408|FG001|Overall Study|Lost to Follow-up|0|||
161533599|NCT01565707|583341409|FG002|Overall Study|Lost to Follow-up|0|||
161533600|NCT01565707|583341410|FG003|Overall Study|Lost to Follow-up|0|||
161533601|NCT01565707|583341407|FG000|Overall Study|Protocol Violation|1|||
161533602|NCT01565707|583341408|FG001|Overall Study|Protocol Violation|0|||
161533603|NCT01565707|583341409|FG002|Overall Study|Protocol Violation|0|||
161533604|NCT01565707|583341410|FG003|Overall Study|Protocol Violation|1|||
161533605|NCT01565707|583341407|FG000|Overall Study|Withdrawal by Subject|3|||
161533606|NCT01565707|583341408|FG001|Overall Study|Withdrawal by Subject|1|||
161533607|NCT01565707|583341409|FG002|Overall Study|Withdrawal by Subject|1|||
161533608|NCT01565707|583341410|FG003|Overall Study|Withdrawal by Subject|1|||
161533609|NCT01565707|583341407|FG000|Overall Study|Randomized but not evaluable|2|||
161533610|NCT01565707|583341408|FG001|Overall Study|Randomized but not evaluable|0|||
161533611|NCT01565707|583341409|FG002|Overall Study|Randomized but not evaluable|0|||
161533612|NCT01565707|583341410|FG003|Overall Study|Randomized but not evaluable|0|||
161533613|NCT01565707|583341407|FG000|Overall Study|Miscellaneous|1|||
161533614|NCT01565707|583341408|FG001|Overall Study|Miscellaneous|1|||
161533615|NCT01565707|583341409|FG002|Overall Study|Miscellaneous|0|||
161533616|NCT01565707|583341410|FG003|Overall Study|Miscellaneous|2|||
161533617|NCT01371851|583341411|FG000|Overall Study|Lost to Follow-up|5|||
161533618|NCT01371851|583341412|FG001|Overall Study|Lost to Follow-up|8|||
161678652|NCT00766090|583876054|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678653|NCT00766090|583876055|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678654|NCT00766090|583876056|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678655|NCT00766090|583876057|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161533619|NCT01371851|583341411|FG000|Overall Study|was arrested and put in jail|0|||
161533620|NCT01371851|583341412|FG001|Overall Study|was arrested and put in jail|1|||
161533621|NCT01371851|583341411|FG000|Overall Study|non study related adverse event|1|||
161533622|NCT01371851|583341412|FG001|Overall Study|non study related adverse event|0|||
161533623|NCT01371851|583341411|FG000|Overall Study|Blood Pressure outside study parameters|2|||
161533624|NCT01371851|583341412|FG001|Overall Study|Blood Pressure outside study parameters|0|||
161533625|NCT00450411|583341413|FG000|Overall Study|Protocol Violation|6|||
161533626|NCT00450411|583341413|FG000|Overall Study|No protocol treatment|2|||
161533627|NCT03969719|583341424|FG000|Overall Study|Other reasons not specified|1|||
161533628|NCT03969719|583341425|FG001|Overall Study|Other reasons not specified|1|||
161533629|NCT03969719|583341426|FG002|Overall Study|Other reasons not specified|3|||
161533630|NCT03969719|583341424|FG000|Overall Study|Withdrawal by Subject|2|||
161533631|NCT03969719|583341425|FG001|Overall Study|Withdrawal by Subject|3|||
161533632|NCT03969719|583341426|FG002|Overall Study|Withdrawal by Subject|2|||
161533633|NCT03969719|583341424|FG000|Overall Study|Protocol Violation|1|||
161533634|NCT03969719|583341425|FG001|Overall Study|Protocol Violation|2|||
161533635|NCT03969719|583341426|FG002|Overall Study|Protocol Violation|0|||
161533636|NCT03969719|583341424|FG000|Overall Study|Adverse Event|0|||
161533637|NCT03969719|583341425|FG001|Overall Study|Adverse Event|2|||
161533638|NCT03969719|583341426|FG002|Overall Study|Adverse Event|0|||
161533639|NCT03969719|583341424|FG000|Overall Study|Lost to Follow-up|0|||
161533640|NCT03969719|583341425|FG001|Overall Study|Lost to Follow-up|1|||
161533641|NCT03969719|583341426|FG002|Overall Study|Lost to Follow-up|0|||
161533642|NCT05608629|583341427|FG000|Overall Study|Lost to Follow-up|2|||
161533643|NCT02130193|583341428|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
161533644|NCT02130193|583341429|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
161533645|NCT02130193|583341430|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
161533646|NCT02130193|583341428|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
161533647|NCT02130193|583341429|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
161533648|NCT02130193|583341430|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
161533649|NCT02130193|583341428|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
161533650|NCT02130193|583341429|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
161533651|NCT02130193|583341430|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
161533652|NCT02130193|583341428|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
161533653|NCT02130193|583341429|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
161533654|NCT02130193|583341430|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
161533655|NCT01297959|583341431|FG000|Overall Study|Adverse Event|0|||
161533656|NCT01297959|583341432|FG001|Overall Study|Adverse Event|1|||
161533657|NCT01297959|583341431|FG000|Overall Study|Protocol Violation|2|||
161533658|NCT01297959|583341432|FG001|Overall Study|Protocol Violation|1|||
161533659|NCT01297959|583341431|FG000|Overall Study|Withdrawal by Subject|5|||
161533660|NCT01297959|583341432|FG001|Overall Study|Withdrawal by Subject|4|||
161533661|NCT01297959|583341431|FG000|Overall Study|Physician Decision|0|||
161533662|NCT01297959|583341432|FG001|Overall Study|Physician Decision|1|||
161533663|NCT01297959|583341431|FG000|Overall Study|Unrelated medical illness / complication|0|||
161533664|NCT01297959|583341432|FG001|Overall Study|Unrelated medical illness / complication|2|||
161533665|NCT01297959|583341431|FG000|Overall Study|Other|13|||
161533666|NCT01297959|583341432|FG001|Overall Study|Other|7|||
161533667|NCT01212770|583341433|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
161533668|NCT01212770|583341434|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
161533669|NCT01212770|583341435|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
161533670|NCT01212770|583341436|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161533671|NCT01212770|583341437|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161533672|NCT01212770|583341438|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161533673|NCT01212770|583341439|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161533674|NCT01212770|583341440|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161533675|NCT01212770|583341441|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161533676|NCT01212770|583341433|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
161533677|NCT01212770|583341434|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
161533678|NCT01212770|583341435|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
161533679|NCT01212770|583341436|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161533680|NCT01212770|583341437|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161533681|NCT01212770|583341438|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161533682|NCT01212770|583341439|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161533683|NCT01212770|583341440|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161591717|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
161591718|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161591719|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161591720|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161591721|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161591722|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161591723|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
161591724|NCT01902173|583554753|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161591725|NCT01902173|583554754|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161591726|NCT01902173|583554755|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161591727|NCT01902173|583554756|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161591728|NCT01902173|583554757|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161591729|NCT01902173|583554758|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
161591730|NCT03536754|583554761|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
161591731|NCT03536754|583554762|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
161591732|NCT03536754|583554763|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
161591733|NCT03536754|583554764|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
161591734|NCT03536754|583554765|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
161591735|NCT03536754|583554761|FG000|Open Label Extension|Other|0|||
161591736|NCT03536754|583554762|FG001|Open Label Extension|Other|0|||
161591737|NCT03536754|583554763|FG002|Open Label Extension|Other|0|||
161591738|NCT03536754|583554764|FG003|Open Label Extension|Other|0|||
161591739|NCT03536754|583554765|FG004|Open Label Extension|Other|1|||
161591740|NCT03382652|583554768|FG000|Overall Study|Lost to Follow-up|6|||
161533684|NCT01212770|583341441|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161533685|NCT01212770|583341433|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
161533686|NCT01212770|583341434|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
161533687|NCT01212770|583341435|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
161591741|NCT03382652|583554768|FG000|Overall Study|Death|4|||
161591742|NCT03382652|583554768|FG000|Overall Study|Revision|5|||
161533688|NCT01212770|583341436|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161533689|NCT01212770|583341437|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161533690|NCT01212770|583341438|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161533691|NCT01212770|583341439|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161533692|NCT01212770|583341440|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161533693|NCT01212770|583341441|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161533694|NCT01212770|583341433|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161533695|NCT01212770|583341434|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533696|NCT01212770|583341435|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
161533697|NCT01212770|583341436|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533698|NCT01212770|583341437|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533699|NCT01212770|583341438|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533700|NCT01212770|583341439|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533701|NCT01212770|583341440|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533702|NCT01212770|583341441|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161533703|NCT01212770|583341433|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533704|NCT01212770|583341434|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533705|NCT01212770|583341435|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161533706|NCT01212770|583341436|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533707|NCT01212770|583341437|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533708|NCT01212770|583341438|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533709|NCT01212770|583341439|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533710|NCT01212770|583341440|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533711|NCT01212770|583341441|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161533712|NCT01212770|583341433|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
161533713|NCT01212770|583341434|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
161533714|NCT01212770|583341435|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
161533715|NCT01212770|583341436|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
161533716|NCT01212770|583341437|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
161533717|NCT01212770|583341438|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
161533718|NCT01212770|583341439|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
161533719|NCT01212770|583341440|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
161533720|NCT01212770|583341441|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
161533721|NCT01212770|583341433|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
161533722|NCT01212770|583341434|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
161533723|NCT01212770|583341435|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
161533724|NCT01212770|583341436|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
161533725|NCT01212770|583341437|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
161533726|NCT01212770|583341438|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
161533727|NCT01212770|583341439|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
161533728|NCT01212770|583341440|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
161533729|NCT01212770|583341441|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
161533730|NCT01212770|583341433|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
161533731|NCT01212770|583341434|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
161533732|NCT01212770|583341435|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
161533733|NCT01212770|583341436|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
161533734|NCT01212770|583341437|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
161533735|NCT01212770|583341438|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
161533736|NCT01212770|583341439|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
161533737|NCT01212770|583341440|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
161533738|NCT01212770|583341441|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
161533739|NCT01212770|583341433|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
161533740|NCT01212770|583341434|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
161533741|NCT01212770|583341435|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
161591743|NCT03382652|583554768|FG000|Overall Study|Patient withdrew|3|||
161533742|NCT01212770|583341436|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
161533743|NCT01212770|583341437|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
161533744|NCT01212770|583341438|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
161533745|NCT01212770|583341439|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
161533746|NCT01212770|583341440|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
161533747|NCT01212770|583341441|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
161533748|NCT01212770|583341433|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533749|NCT01212770|583341434|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533750|NCT01212770|583341435|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
161591744|NCT03382652|583554768|FG000|Overall Study|Other reasons|21|||
161533751|NCT01212770|583341436|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533752|NCT01212770|583341437|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533753|NCT01212770|583341438|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533754|NCT01212770|583341439|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533755|NCT01212770|583341440|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533756|NCT01212770|583341441|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
161533757|NCT01212770|583341433|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533758|NCT01212770|583341434|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533759|NCT01212770|583341435|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533760|NCT01212770|583341436|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
161533761|NCT01212770|583341437|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533762|NCT01212770|583341438|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533763|NCT01212770|583341439|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533764|NCT01212770|583341440|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533765|NCT01212770|583341441|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
161533766|NCT01212770|583341433|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161533767|NCT01212770|583341434|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161533768|NCT01212770|583341435|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
161533769|NCT01212770|583341436|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
161533770|NCT01212770|583341437|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161533771|NCT01212770|583341438|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161591745|NCT04806594|583556583|FG000|Overall Study|Withdrawal by Subject|2|||
161591746|NCT04806594|583556583|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
161591747|NCT04390048|583556584|FG000|Overall Study|Withdrawal by Subject|1|||
161591748|NCT04390048|583556585|FG001|Overall Study|Withdrawal by Subject|3|||
161591749|NCT06283173|583556586|FG000|Overall Study|Did not show for first visit|10|||
161591750|NCT06283173|583556586|FG000|Overall Study|Lost to Follow-up|12|||
161591751|NCT06283173|583556586|FG000|Overall Study|Physician Decision|7|||
161591752|NCT03138512|583556587|FG000|Randomization|Participants withdrew consent|0|||
161591753|NCT03138512|583556588|FG001|Randomization|Participants withdrew consent|1|||
161591754|NCT03138512|583556589|FG002|Randomization|Participants withdrew consent|1|||
161591755|NCT03138512|583556590|FG003|Randomization|Participants withdrew consent|0|||
161591756|NCT03138512|583556591|FG004|Randomization|Participants withdrew consent|0|||
161591757|NCT03138512|583556587|FG000|Randomization|Participant no longer meets study criteria|0|||
161591758|NCT03138512|583556588|FG001|Randomization|Participant no longer meets study criteria|3|||
161591759|NCT03138512|583556589|FG002|Randomization|Participant no longer meets study criteria|1|||
161591760|NCT03138512|583556590|FG003|Randomization|Participant no longer meets study criteria|1|||
161591761|NCT03138512|583556591|FG004|Randomization|Participant no longer meets study criteria|3|||
161591762|NCT03138512|583556587|FG000|Randomization|Other reasons|1|||
161591763|NCT03138512|583556588|FG001|Randomization|Other reasons|0|||
161591764|NCT03138512|583556589|FG002|Randomization|Other reasons|0|||
161591765|NCT03138512|583556590|FG003|Randomization|Other reasons|0|||
161591766|NCT03138512|583556591|FG004|Randomization|Other reasons|0|||
161591767|NCT03138512|583556587|FG000|Treatment Part A|Disease recurrence|10|||
161591768|NCT03138512|583556588|FG001|Treatment Part A|Disease recurrence|20|||
161591769|NCT03138512|583556589|FG002|Treatment Part A|Disease recurrence|0|||
161591770|NCT03138512|583556590|FG003|Treatment Part A|Disease recurrence|0|||
161591771|NCT03138512|583556591|FG004|Treatment Part A|Disease recurrence|0|||
161591772|NCT03138512|583556587|FG000|Treatment Part A|Study Drug Toxicity|132|||
161591773|NCT03138512|583556588|FG001|Treatment Part A|Study Drug Toxicity|5|||
161591774|NCT03138512|583556589|FG002|Treatment Part A|Study Drug Toxicity|0|||
161591775|NCT03138512|583556590|FG003|Treatment Part A|Study Drug Toxicity|0|||
161591776|NCT03138512|583556591|FG004|Treatment Part A|Study Drug Toxicity|0|||
161591777|NCT03138512|583556587|FG000|Treatment Part A|Death|1|||
161591778|NCT03138512|583556588|FG001|Treatment Part A|Death|0|||
161591779|NCT03138512|583556589|FG002|Treatment Part A|Death|0|||
161533772|NCT01212770|583341439|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161591780|NCT03138512|583556590|FG003|Treatment Part A|Death|0|||
161591781|NCT03138512|583556591|FG004|Treatment Part A|Death|0|||
161591782|NCT03138512|583556587|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
161591783|NCT03138512|583556588|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
161591784|NCT03138512|583556589|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
161591785|NCT03138512|583556590|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
161533773|NCT01212770|583341440|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161533774|NCT01212770|583341441|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
161533775|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161533776|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
161533777|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
161533778|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161533779|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161533780|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161533781|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161533782|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161533783|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
161533784|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161533785|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
161533786|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
161533787|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161533788|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161533789|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161533790|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161533791|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
161533792|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
161533793|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533794|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
161533795|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533796|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533797|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533798|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533799|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533800|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533801|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
161533802|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161533803|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
161533804|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
161533805|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161533806|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161533807|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161533808|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161533809|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
161533810|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
161533811|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
161533812|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
161533813|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
161533814|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
161533815|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
161533816|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
161533817|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
161533818|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
161533819|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
161533820|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161533821|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
161533822|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161533823|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161533824|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161533825|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161533826|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161533827|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161533828|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161533829|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161533830|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161533831|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161533832|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161533833|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161533834|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161533835|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161533836|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161533837|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
161533838|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161533839|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
161678656|NCT00766090|583876046|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678657|NCT00766090|583876047|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678658|NCT00766090|583876048|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
161678659|NCT00766090|583876049|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161533840|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
161533841|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161533842|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161533843|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161533844|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161533845|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161533846|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161533847|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161533848|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
161533849|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
161533850|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161533851|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161533852|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161533853|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161533854|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
161533855|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
161533856|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161533857|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161533858|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161533859|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161678660|NCT00766090|583876050|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161533860|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161678661|NCT00766090|583876051|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161829089|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829090|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
161829091|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829092|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829093|NCT04149535|584413676|FG000|Overall Study|Death|11|||
161829094|NCT04149535|584413677|FG001|Overall Study|Death|7|||
161829095|NCT04149535|584413676|FG000|Overall Study|Physician Decision|10|||
161829096|NCT04149535|584413677|FG001|Overall Study|Physician Decision|4|||
161829097|NCT04149535|584413676|FG000|Overall Study|Withdrawal by Subject|6|||
161829098|NCT04149535|584413677|FG001|Overall Study|Withdrawal by Subject|7|||
161829099|NCT04149535|584413676|FG000|Overall Study|Not described|2|||
161829100|NCT04149535|584413677|FG001|Overall Study|Not described|0|||
161829101|NCT02175368|584413678|FG000|Overall Study|Lost to Follow-up|1|||
161829102|NCT02875028|584413679|FG000|Washout Period|Withdrawal by Subject|0|||
161829103|NCT02875028|584413680|FG001|Washout Period|Withdrawal by Subject|1|||
161829104|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
161829105|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
161829106|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829107|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829108|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829109|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829110|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829111|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829112|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829113|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161533861|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161533862|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161533863|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161533864|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161533865|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533866|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533867|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533868|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533869|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533870|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533871|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533872|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
161533873|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
161533874|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161533875|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
161533876|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161533877|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161533878|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161533879|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161533880|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161533881|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161533882|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161533883|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161533884|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
161533885|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
161533886|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161533887|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161533888|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161829114|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
161829115|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161533889|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161533890|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161533891|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
161533892|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161533893|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161533894|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
161533895|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161533896|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161533897|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161533898|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161533899|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
161533900|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161533901|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
161533902|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
161533903|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
161533904|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
161533905|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
161533906|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
161533907|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
161533908|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
161533909|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
161533910|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533911|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
161533912|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
161533913|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533914|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533915|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533916|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533917|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533918|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161533919|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533920|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533921|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
161533922|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533923|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533924|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533925|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533926|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533927|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161533928|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161533929|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
161533930|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161533931|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161678662|NCT00766090|583876052|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678663|NCT00766090|583876053|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678664|NCT00766090|583876054|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678665|NCT00766090|583876055|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678666|NCT00766090|583876056|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678667|NCT00766090|583876057|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678668|NCT00766090|583876046|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
161678669|NCT00766090|583876047|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
161829116|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829117|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829118|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829119|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829120|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
161829121|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
161829122|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
161829123|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
161829124|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
161829125|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161829126|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161829127|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161829128|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829129|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829130|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
161829131|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829132|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
161533932|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161533933|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161533934|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161533935|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161533936|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
161533937|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
161533938|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
161533939|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
161533940|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
161533941|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
161533942|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
161533943|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
161533944|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
161533945|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
161533946|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533947|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533948|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
161533949|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533950|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533951|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533952|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533953|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533954|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161533955|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533956|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533957|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
161533958|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533959|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533960|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533961|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533962|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161533963|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161533964|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533965|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533966|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
161533967|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533968|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533969|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533970|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533971|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533972|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161533973|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161533974|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
161533975|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161533976|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161533977|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161533978|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161533979|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161591786|NCT03138512|583556591|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
161591787|NCT03138512|583556587|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
161533980|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161533981|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161533982|NCT01212770|583341433|FG000|Long-term Safety Phase (Year 5)|Death|0|||
161533983|NCT01212770|583341434|FG001|Long-term Safety Phase (Year 5)|Death|0|||
161533984|NCT01212770|583341435|FG002|Long-term Safety Phase (Year 5)|Death|0|||
161533985|NCT01212770|583341436|FG003|Long-term Safety Phase (Year 5)|Death|0|||
161533986|NCT01212770|583341437|FG004|Long-term Safety Phase (Year 5)|Death|0|||
161533987|NCT01212770|583341438|FG005|Long-term Safety Phase (Year 5)|Death|0|||
161533988|NCT01212770|583341439|FG006|Long-term Safety Phase (Year 5)|Death|0|||
161533989|NCT01212770|583341440|FG007|Long-term Safety Phase (Year 5)|Death|1|||
161533990|NCT01212770|583341441|FG008|Long-term Safety Phase (Year 5)|Death|0|||
161533991|NCT00829387|583341444|FG000|Overall Study|Withdrawal by Subject|2|||
161533992|NCT00829387|583341445|FG001|Overall Study|Withdrawal by Subject|3|||
161533993|NCT00829387|583341444|FG000|Overall Study|Disqualified by PI|1|||
161533994|NCT00829387|583341445|FG001|Overall Study|Disqualified by PI|0|||
161533995|NCT00707031|583341446|FG000|Overall Study|Adverse Event|45|||
161533996|NCT00707031|583341447|FG001|Overall Study|Adverse Event|45|||
161533997|NCT00707031|583341446|FG000|Overall Study|Lack of Efficacy|19|||
161533998|NCT00707031|583341447|FG001|Overall Study|Lack of Efficacy|6|||
161533999|NCT00707031|583341446|FG000|Overall Study|Lost to Follow-up|2|||
161534000|NCT00707031|583341447|FG001|Overall Study|Lost to Follow-up|1|||
161534001|NCT00707031|583341446|FG000|Overall Study|Protocol Violation|1|||
161534002|NCT00707031|583341447|FG001|Overall Study|Protocol Violation|0|||
161534003|NCT00707031|583341446|FG000|Overall Study|Withdrawal by Subject|7|||
161534004|NCT00707031|583341447|FG001|Overall Study|Withdrawal by Subject|8|||
161534005|NCT00707031|583341446|FG000|Overall Study|Poor Compliance to Protocol|7|||
161534006|NCT00707031|583341447|FG001|Overall Study|Poor Compliance to Protocol|13|||
161534007|NCT00707031|583341446|FG000|Overall Study|Familial or Personal Reasons|12|||
161534008|NCT00707031|583341447|FG001|Overall Study|Familial or Personal Reasons|15|||
161534009|NCT00707031|583341446|FG000|Overall Study|Serious Noncompliance|2|||
161534010|NCT00707031|583341447|FG001|Overall Study|Serious Noncompliance|3|||
161534011|NCT00707031|583341446|FG000|Overall Study|Sponsor Decision|9|||
161534012|NCT00707031|583341447|FG001|Overall Study|Sponsor Decision|8|||
161534013|NCT03519854|583341448|FG000|Overall Study|Technical Error|0|||
161534014|NCT03519854|583341449|FG001|Overall Study|Technical Error|0|||
161534015|NCT03519854|583341450|FG002|Overall Study|Technical Error|1|||
161534016|NCT03519854|583341451|FG003|Overall Study|Technical Error|0|||
161534017|NCT03519854|583341452|FG004|Overall Study|Technical Error|0|||
161534018|NCT03519854|583341453|FG005|Overall Study|Technical Error|0|||
161534019|NCT03519854|583341454|FG006|Overall Study|Technical Error|0|||
161591788|NCT03138512|583556588|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
161591789|NCT03138512|583556589|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
161591790|NCT03138512|583556590|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
161591791|NCT03138512|583556591|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
161591792|NCT03138512|583556587|FG000|Treatment Part A|Participant withdrew consent|2|||
161591793|NCT03138512|583556588|FG001|Treatment Part A|Participant withdrew consent|4|||
161591794|NCT03138512|583556589|FG002|Treatment Part A|Participant withdrew consent|0|||
161534020|NCT03519854|583341455|FG007|Overall Study|Technical Error|0|||
161534021|NCT03519854|583341456|FG008|Overall Study|Technical Error|0|||
161534022|NCT03519854|583341457|FG009|Overall Study|Technical Error|0|||
161534023|NCT03519854|583341458|FG010|Overall Study|Technical Error|0|||
161534024|NCT03519854|583341459|FG011|Overall Study|Technical Error|0|||
161534025|NCT03519854|583341460|FG012|Overall Study|Technical Error|0|||
161534026|NCT03519854|583341461|FG013|Overall Study|Technical Error|0|||
161534027|NCT03519854|583341462|FG014|Overall Study|Technical Error|0|||
161534028|NCT03519854|583341463|FG015|Overall Study|Technical Error|0|||
161534029|NCT03519854|583341464|FG016|Overall Study|Technical Error|0|||
161534030|NCT03519854|583341465|FG017|Overall Study|Technical Error|0|||
161534031|NCT00951275|583341467|FG000|Overall Study|Administrative Reason|1|||
161534032|NCT00951275|583341467|FG000|Overall Study|Adverse Event|7|||
161534033|NCT00951275|583341467|FG000|Overall Study|Withdrawal by Subject|4|||
161534034|NCT00951275|583341467|FG000|Overall Study|Protocol Violation|1|||
161534035|NCT03260868|583341468|FG000|Overall Study|Poor Compliance to Protocol|0|||
161534036|NCT03260868|583341469|FG001|Overall Study|Poor Compliance to Protocol|2|||
161534037|NCT03260868|583341468|FG000|Overall Study|Study Terminated By Sponsor|2|||
161534038|NCT03260868|583341469|FG001|Overall Study|Study Terminated By Sponsor|1|||
161534039|NCT03260868|583341468|FG000|Overall Study|Other than specified above|1|||
161591795|NCT03138512|583556590|FG003|Treatment Part A|Participant withdrew consent|0|||
161591796|NCT03138512|583556591|FG004|Treatment Part A|Participant withdrew consent|0|||
161534040|NCT03260868|583341469|FG001|Overall Study|Other than specified above|0|||
161534041|NCT02925676|583341470|FG000|Overall Study|Withdrawal by Subject|1|||
161534042|NCT02048072|583341474|FG000|Overall Study|Adverse Event|3|||
161534043|NCT02048072|583341474|FG000|Overall Study|Lost to Follow-up|1|||
161534044|NCT02693743|583341477|FG000|Overall Study|Physician Decision|1|||
161534045|NCT02693743|583341478|FG001|Overall Study|Physician Decision|0|||
161534046|NCT02626780|583341479|FG000|Overall Study|Withdrawal by Subject|3|||
161534047|NCT04304833|583341480|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
161534048|NCT04304833|583341481|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
161534049|NCT02858895|583341482|FG000|Overall Study|Disease progression|31|||
161534050|NCT02858895|583341482|FG000|Overall Study|Death|2|||
161534051|NCT02858895|583341482|FG000|Overall Study|Adverse Event|1|||
161534052|NCT02858895|583341482|FG000|Overall Study|Withdrawal by Subject|3|||
161534053|NCT02858895|583341482|FG000|Overall Study|hospice,|1|||
161534054|NCT02858895|583341482|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
161534055|NCT05540522|583341483|FG000|Overall Study|Adverse Event|1|||
161534056|NCT05540522|583341484|FG001|Overall Study|Adverse Event|0|||
161534057|NCT05540522|583341485|FG002|Overall Study|Adverse Event|2|||
161534058|NCT05540522|583341486|FG003|Overall Study|Adverse Event|5|||
161534059|NCT05540522|583341483|FG000|Overall Study|Lost to Follow-up|487|||
161534060|NCT05540522|583341484|FG001|Overall Study|Lost to Follow-up|427|||
161534061|NCT05540522|583341485|FG002|Overall Study|Lost to Follow-up|146|||
161534062|NCT05540522|583341486|FG003|Overall Study|Lost to Follow-up|166|||
161534063|NCT05540522|583341483|FG000|Overall Study|Physician Decision|11|||
161534064|NCT05540522|583341484|FG001|Overall Study|Physician Decision|19|||
161534065|NCT05540522|583341485|FG002|Overall Study|Physician Decision|8|||
161534066|NCT05540522|583341486|FG003|Overall Study|Physician Decision|13|||
161534067|NCT05540522|583341483|FG000|Overall Study|Pregnancy|1|||
161534068|NCT05540522|583341484|FG001|Overall Study|Pregnancy|0|||
161534069|NCT05540522|583341485|FG002|Overall Study|Pregnancy|0|||
161534070|NCT05540522|583341486|FG003|Overall Study|Pregnancy|0|||
161534071|NCT05540522|583341483|FG000|Overall Study|Protocol Violation|3|||
161534072|NCT05540522|583341484|FG001|Overall Study|Protocol Violation|1|||
161534073|NCT05540522|583341485|FG002|Overall Study|Protocol Violation|9|||
161534074|NCT05540522|583341486|FG003|Overall Study|Protocol Violation|7|||
161534075|NCT05540522|583341483|FG000|Overall Study|Withdrawal by Subject|168|||
161534076|NCT05540522|583341484|FG001|Overall Study|Withdrawal by Subject|134|||
161534077|NCT05540522|583341485|FG002|Overall Study|Withdrawal by Subject|331|||
161534078|NCT05540522|583341486|FG003|Overall Study|Withdrawal by Subject|322|||
161534079|NCT05540522|583341483|FG000|Overall Study|Death|7|||
161534080|NCT05540522|583341484|FG001|Overall Study|Death|9|||
161534081|NCT05540522|583341485|FG002|Overall Study|Death|49|||
161534082|NCT05540522|583341486|FG003|Overall Study|Death|46|||
161534083|NCT05540522|583341483|FG000|Overall Study|Not vaccinated|34|||
161534084|NCT05540522|583341484|FG001|Overall Study|Not vaccinated|53|||
161534085|NCT05540522|583341485|FG002|Overall Study|Not vaccinated|57|||
161534086|NCT05540522|583341486|FG003|Overall Study|Not vaccinated|50|||
161534087|NCT05540522|583341483|FG000|Overall Study|No longer meets eligibility criteria|0|||
161534088|NCT05540522|583341484|FG001|Overall Study|No longer meets eligibility criteria|0|||
161534089|NCT05540522|583341485|FG002|Overall Study|No longer meets eligibility criteria|3|||
161534090|NCT05540522|583341486|FG003|Overall Study|No longer meets eligibility criteria|2|||
161534091|NCT05540522|583341483|FG000|Overall Study|Other (Unspecified)|8|||
161534092|NCT05540522|583341484|FG001|Overall Study|Other (Unspecified)|10|||
161534093|NCT05540522|583341485|FG002|Overall Study|Other (Unspecified)|4|||
161534094|NCT05540522|583341486|FG003|Overall Study|Other (Unspecified)|2|||
161534095|NCT02543658|583342989|FG000|Overall Study|Lack of Efficacy|0|||
161534096|NCT02543658|583342990|FG001|Overall Study|Lack of Efficacy|4|||
161534097|NCT00789815|583342991|FG000|Overall Study|Protocol Violation|6|||
161534098|NCT00789815|583342992|FG001|Overall Study|Protocol Violation|1|||
161534099|NCT00789815|583342991|FG000|Overall Study|Intubation due to massive bleeding|1|||
161534100|NCT00789815|583342992|FG001|Overall Study|Intubation due to massive bleeding|0|||
161534101|NCT01699022|583343005|FG000|Overall Study|Early discontinuation from the study|3|||
161534102|NCT03563716|583343006|FG000|Overall Study|Death|20|||
161534103|NCT03563716|583343007|FG001|Overall Study|Death|14|||
161534104|NCT03563716|583343006|FG000|Overall Study|Withdrawal by Subject|3|||
161534105|NCT03563716|583343007|FG001|Overall Study|Withdrawal by Subject|3|||
161534106|NCT03563716|583343006|FG000|Overall Study|Still on Study|45|||
161534107|NCT03563716|583343007|FG001|Overall Study|Still on Study|50|||
161534108|NCT04539821|583343008|FG000|Overall Study|Withdrawal by Subject|2|||
161534109|NCT04539821|583343008|FG000|Overall Study|continued care with their physician|20|||
161534110|NCT04539821|583343008|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
161534111|NCT03813238|583343015|FG000|Overall Study|Adverse Event|0|||
161534112|NCT03813238|583343016|FG001|Overall Study|Adverse Event|6|||
161534113|NCT03813238|583343015|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161534114|NCT03813238|583343016|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161534115|NCT03813238|583343015|FG000|Overall Study|Lost to Follow-up|0|||
161534116|NCT03813238|583343016|FG001|Overall Study|Lost to Follow-up|1|||
161534117|NCT03813238|583343015|FG000|Overall Study|Other than specified|1|||
161534118|NCT03813238|583343016|FG001|Overall Study|Other than specified|2|||
161534119|NCT02066402|583343017|FG000|Overall Study|Adverse Event|1|||
161534120|NCT02066402|583343018|FG001|Overall Study|Adverse Event|2|||
161534121|NCT02066402|583343017|FG000|Overall Study|Lost to Follow-up|11|||
161534122|NCT02066402|583343018|FG001|Overall Study|Lost to Follow-up|8|||
161534123|NCT02066402|583343017|FG000|Overall Study|Withdrawal by Subject|14|||
161534124|NCT02066402|583343018|FG001|Overall Study|Withdrawal by Subject|11|||
161534125|NCT02066402|583343017|FG000|Overall Study|Progressive disease-clinical progression|0|||
161534126|NCT02066402|583343018|FG001|Overall Study|Progressive disease-clinical progression|1|||
161534127|NCT02066402|583343017|FG000|Overall Study|Protocol driven decision point|0|||
161534128|NCT02066402|583343018|FG001|Overall Study|Protocol driven decision point|1|||
161534129|NCT00152464|583343019|FG000|Overall Study|Adverse Event|3|||
161534130|NCT00152464|583343020|FG001|Overall Study|Adverse Event|6|||
161534131|NCT00152464|583343019|FG000|Overall Study|Lost to Follow-up|8|||
161534132|NCT00152464|583343020|FG001|Overall Study|Lost to Follow-up|4|||
161534133|NCT00152464|583343019|FG000|Overall Study|Protocol Violation|3|||
161534134|NCT00152464|583343020|FG001|Overall Study|Protocol Violation|1|||
161534135|NCT00152464|583343019|FG000|Overall Study|Withdrawal by Subject|21|||
161534136|NCT00152464|583343020|FG001|Overall Study|Withdrawal by Subject|22|||
161829133|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829134|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161534137|NCT00152464|583343019|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
161534138|NCT00152464|583343020|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
161534139|NCT00152464|583343019|FG000|Overall Study|Eczema deterioration|0|||
161534140|NCT00152464|583343020|FG001|Overall Study|Eczema deterioration|1|||
161534141|NCT00152464|583343019|FG000|Overall Study|Parent decision|1|||
161534142|NCT00152464|583343020|FG001|Overall Study|Parent decision|1|||
161534143|NCT00152464|583343019|FG000|Overall Study|Investigator decision|1|||
161534144|NCT00152464|583343020|FG001|Overall Study|Investigator decision|0|||
161534145|NCT00152464|583343019|FG000|Overall Study|Lack of Efficacy|1|||
161534146|NCT00152464|583343020|FG001|Overall Study|Lack of Efficacy|0|||
161534147|NCT00152464|583343019|FG000|Overall Study|Eczema poorly controlled|1|||
161534148|NCT00152464|583343020|FG001|Overall Study|Eczema poorly controlled|0|||
161534149|NCT00152464|583343019|FG000|Overall Study|Patient relocated|1|||
161534150|NCT00152464|583343020|FG001|Overall Study|Patient relocated|0|||
161534151|NCT02462876|583343021|FG000|Overall Study|Death|3|||
161534152|NCT02462876|583343021|FG000|Overall Study|Lost to Follow-up|7|||
161534153|NCT02462876|583343021|FG000|Overall Study|Surgical Bypass|9|||
161534154|NCT02462876|583343021|FG000|Overall Study|Amputation Above the Metatarsals|1|||
161534155|NCT02462876|583343021|FG000|Overall Study|36 months follow-up visit missed|1|||
161534156|NCT02462876|583343021|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
161534157|NCT02462876|583343021|FG000|Overall Study|Patient did not come back to the vascular department|1|||
161534158|NCT02462876|583343021|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
161534159|NCT02462876|583343021|FG000|Overall Study|Patient refused to come back|1|||
161534160|NCT02462876|583343021|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
161534161|NCT02462876|583343021|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
161534162|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
161534163|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
161534164|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
161534165|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
161534166|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
161534167|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
161534168|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
161534169|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
161534170|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Other|18|||
161534171|NCT02565914|583343022|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
161534172|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
161534173|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Other|1|||
161534174|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
161534175|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
161534176|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
161534177|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
161534178|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
161534179|NCT02565914|583343022|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
161534180|NCT02565914|583343022|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
161534181|NCT02565914|583343022|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
161534182|NCT02565914|583343022|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
161534183|NCT02565914|583343022|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
161534184|NCT02565914|583343022|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
161534185|NCT02565914|583343022|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
161534186|NCT03581981|583343023|FG000|Overall Study|Withdrawal by Subject|12|||
161534187|NCT03581981|583343024|FG001|Overall Study|Withdrawal by Subject|13|||
161534188|NCT03581981|583343023|FG000|Overall Study|Physician Decision|1|||
161534189|NCT03581981|583343024|FG001|Overall Study|Physician Decision|2|||
161534190|NCT03581981|583343023|FG000|Overall Study|Lost to Follow-up|0|||
161534191|NCT03581981|583343024|FG001|Overall Study|Lost to Follow-up|4|||
161534192|NCT00828984|583343025|FG000|Overall Study|Adverse Event|2|||
161534193|NCT00828984|583343026|FG001|Overall Study|Adverse Event|3|||
161534194|NCT00828984|583343027|FG002|Overall Study|Adverse Event|0|||
161534195|NCT00828984|583343025|FG000|Overall Study|Lost to Follow-up|5|||
161534196|NCT00828984|583343026|FG001|Overall Study|Lost to Follow-up|3|||
161534197|NCT00828984|583343027|FG002|Overall Study|Lost to Follow-up|1|||
161534198|NCT00828984|583343025|FG000|Overall Study|Withdrawal by Subject|4|||
161534199|NCT00828984|583343026|FG001|Overall Study|Withdrawal by Subject|4|||
161534200|NCT00828984|583343027|FG002|Overall Study|Withdrawal by Subject|4|||
161534201|NCT00828984|583343025|FG000|Overall Study|Ineligable|1|||
161534202|NCT00828984|583343026|FG001|Overall Study|Ineligable|2|||
161534203|NCT00828984|583343027|FG002|Overall Study|Ineligable|0|||
161534204|NCT00828984|583343025|FG000|Overall Study|Medical Contraindication|0|||
161534205|NCT00828984|583343026|FG001|Overall Study|Medical Contraindication|1|||
161534206|NCT00828984|583343027|FG002|Overall Study|Medical Contraindication|0|||
161534207|NCT00828984|583343025|FG000|Overall Study|Noncompliant|1|||
161534208|NCT00828984|583343026|FG001|Overall Study|Noncompliant|2|||
161534209|NCT00828984|583343027|FG002|Overall Study|Noncompliant|3|||
161534210|NCT00828984|583343025|FG000|Overall Study|ConMed|1|||
161534211|NCT00828984|583343026|FG001|Overall Study|ConMed|1|||
161534212|NCT00828984|583343027|FG002|Overall Study|ConMed|1|||
161534213|NCT04465357|583343030|FG000|Overall Study|Adverse Event|2|||
161534214|NCT04465357|583343030|FG000|Overall Study|Lack of Efficacy|1|||
161534215|NCT04465357|583343030|FG000|Overall Study|Lost to Follow-up|2|||
161591797|NCT03138512|583556587|FG000|Treatment Part A|Lost to Follow-up|0|||
161591798|NCT03138512|583556588|FG001|Treatment Part A|Lost to Follow-up|1|||
161591799|NCT03138512|583556589|FG002|Treatment Part A|Lost to Follow-up|0|||
161591800|NCT03138512|583556590|FG003|Treatment Part A|Lost to Follow-up|0|||
161591801|NCT03138512|583556591|FG004|Treatment Part A|Lost to Follow-up|0|||
161591802|NCT03138512|583556587|FG000|Treatment Part A|Poor/non-compliance|1|||
161591803|NCT03138512|583556588|FG001|Treatment Part A|Poor/non-compliance|0|||
161591804|NCT03138512|583556589|FG002|Treatment Part A|Poor/non-compliance|0|||
161591805|NCT03138512|583556590|FG003|Treatment Part A|Poor/non-compliance|0|||
161591806|NCT03138512|583556591|FG004|Treatment Part A|Poor/non-compliance|0|||
161591807|NCT03138512|583556587|FG000|Treatment Part A|Pregnancy|0|||
161591808|NCT03138512|583556588|FG001|Treatment Part A|Pregnancy|1|||
161591809|NCT03138512|583556589|FG002|Treatment Part A|Pregnancy|0|||
161591810|NCT03138512|583556590|FG003|Treatment Part A|Pregnancy|0|||
161591811|NCT03138512|583556591|FG004|Treatment Part A|Pregnancy|0|||
161591812|NCT03138512|583556587|FG000|Treatment Part A|Other reasons|11|||
161591813|NCT03138512|583556588|FG001|Treatment Part A|Other reasons|8|||
161591814|NCT03138512|583556589|FG002|Treatment Part A|Other reasons|0|||
161591815|NCT03138512|583556590|FG003|Treatment Part A|Other reasons|0|||
161591816|NCT03138512|583556591|FG004|Treatment Part A|Other reasons|0|||
161591817|NCT03138512|583556587|FG000|Treatment Part B|Disease recurrence|0|||
161591818|NCT03138512|583556588|FG001|Treatment Part B|Disease recurrence|0|||
161534216|NCT04465357|583343030|FG000|Overall Study|Withdrawal by Subject|6|||
161534217|NCT04465357|583343030|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
161534218|NCT00863655|583343031|FG000|Overall Study|Protocol Violation|4|||
161591819|NCT03138512|583556589|FG002|Treatment Part B|Disease recurrence|6|||
161591820|NCT03138512|583556590|FG003|Treatment Part B|Disease recurrence|12|||
161591821|NCT03138512|583556591|FG004|Treatment Part B|Disease recurrence|10|||
161534219|NCT00863655|583343032|FG001|Overall Study|Protocol Violation|0|||
161534220|NCT00863655|583343031|FG000|Overall Study|Adverse Event|52|||
161534221|NCT00863655|583343032|FG001|Overall Study|Adverse Event|8|||
161534222|NCT00863655|583343031|FG000|Overall Study|Withdrawal by Subject|47|||
161534223|NCT00863655|583343032|FG001|Overall Study|Withdrawal by Subject|7|||
161534224|NCT00863655|583343031|FG000|Overall Study|Administrative problems|1|||
161534225|NCT00863655|583343032|FG001|Overall Study|Administrative problems|0|||
161534226|NCT00863655|583343031|FG000|Overall Study|Death|7|||
161534227|NCT00863655|583343032|FG001|Overall Study|Death|1|||
161534228|NCT00863655|583343031|FG000|Overall Study|New cancer therapy|5|||
161534229|NCT00863655|583343032|FG001|Overall Study|New cancer therapy|1|||
161534230|NCT00863655|583343031|FG000|Overall Study|Disease progression|364|||
161534231|NCT00863655|583343032|FG001|Overall Study|Disease progression|221|||
161534232|NCT00863655|583343031|FG000|Overall Study|Treatment completed as per protocol|5|||
161534233|NCT00863655|583343032|FG001|Overall Study|Treatment completed as per protocol|1|||
161534234|NCT04385368|583343049|FG000|Overall Study|Death|5|||
161534235|NCT04385368|583343050|FG001|Overall Study|Death|5|||
161534236|NCT04385368|583343049|FG000|Overall Study|Physician Decision|3|||
161534237|NCT04385368|583343050|FG001|Overall Study|Physician Decision|0|||
161534238|NCT04385368|583343049|FG000|Overall Study|Withdrawal by Subject|4|||
161534239|NCT04385368|583343050|FG001|Overall Study|Withdrawal by Subject|3|||
161534240|NCT00716092|583343055|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
161534241|NCT00716092|583343056|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
161534242|NCT00716092|583343057|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
161534243|NCT02436330|583343058|FG000|Cohort 1|Lost to Follow-up|5|||
161534244|NCT02436330|583343059|FG001|Cohort 1|Lost to Follow-up|2|||
161534245|NCT02436330|583343058|FG000|Cohort 1|Withdrawal by Subject|0|||
161534246|NCT02436330|583343059|FG001|Cohort 1|Withdrawal by Subject|1|||
161534247|NCT02436330|583343058|FG000|Cohort 2|Lost to Follow-up|2|||
161534248|NCT02436330|583343059|FG001|Cohort 2|Lost to Follow-up|0|||
161534249|NCT02436330|583343058|FG000|Cohort 2|Withdrawal by Subject|2|||
161534250|NCT02436330|583343059|FG001|Cohort 2|Withdrawal by Subject|3|||
161534251|NCT02436330|583343058|FG000|Cohort 3|Lost to Follow-up|1|||
161534252|NCT02436330|583343059|FG001|Cohort 3|Lost to Follow-up|0|||
161534253|NCT02436330|583343058|FG000|Cohort 3|Withdrawal by Subject|4|||
161534254|NCT02436330|583343059|FG001|Cohort 3|Withdrawal by Subject|0|||
161534255|NCT02436330|583343058|FG000|Cohort 4|Lost to Follow-up|1|||
161534256|NCT02436330|583343059|FG001|Cohort 4|Lost to Follow-up|0|||
161534257|NCT02436330|583343058|FG000|Cohort 4|Withdrawal by Subject|1|||
161534258|NCT02436330|583343059|FG001|Cohort 4|Withdrawal by Subject|0|||
161534259|NCT02436330|583343058|FG000|Cohort 5|Lost to Follow-up|3|||
161534260|NCT02436330|583343059|FG001|Cohort 5|Lost to Follow-up|2|||
161534261|NCT02436330|583343058|FG000|Cohort 5|Withdrawal by Subject|3|||
161534262|NCT02436330|583343059|FG001|Cohort 5|Withdrawal by Subject|2|||
161534263|NCT02436330|583343058|FG000|Cohort 6|Lost to Follow-up|2|||
161534264|NCT02436330|583343059|FG001|Cohort 6|Lost to Follow-up|0|||
161534265|NCT02436330|583343058|FG000|Cohort 6|Withdrawal by Subject|1|||
161534266|NCT02436330|583343059|FG001|Cohort 6|Withdrawal by Subject|1|||
161534267|NCT02054806|583343060|FG000|Overall Study|Sponsor Decision|31|||
161534268|NCT02054806|583343060|FG000|Overall Study|Withdrawal by Subject|43|||
161534269|NCT02054806|583343060|FG000|Overall Study|Protocol Violation|2|||
161534270|NCT02054806|583343060|FG000|Overall Study|Lost to Follow-up|10|||
161591822|NCT03138512|583556587|FG000|Treatment Part B|Study drug toxicity|0|||
161591823|NCT03138512|583556588|FG001|Treatment Part B|Study drug toxicity|0|||
161591824|NCT03138512|583556589|FG002|Treatment Part B|Study drug toxicity|63|||
161591825|NCT03138512|583556590|FG003|Treatment Part B|Study drug toxicity|3|||
161591826|NCT03138512|583556591|FG004|Treatment Part B|Study drug toxicity|45|||
161591827|NCT03138512|583556587|FG000|Treatment Part B|Death|0|||
161591828|NCT03138512|583556588|FG001|Treatment Part B|Death|0|||
161591829|NCT03138512|583556589|FG002|Treatment Part B|Death|1|||
161591830|NCT03138512|583556590|FG003|Treatment Part B|Death|0|||
161534271|NCT02054806|583343060|FG000|Overall Study|Death|391|||
161534272|NCT00677235|583343061|FG000|Overall Study|Withdrawal by Subject|1|||
161591831|NCT03138512|583556591|FG004|Treatment Part B|Death|0|||
161591832|NCT03138512|583556587|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
161591833|NCT03138512|583556588|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
161534273|NCT00677235|583343062|FG001|Overall Study|Withdrawal by Subject|1|||
161534274|NCT00677235|583343061|FG000|Overall Study|Lost to Follow-up|2|||
161534275|NCT00677235|583343062|FG001|Overall Study|Lost to Follow-up|1|||
161534276|NCT00677235|583343061|FG000|Overall Study|Death|37|||
161534277|NCT00677235|583343062|FG001|Overall Study|Death|36|||
161534278|NCT00677235|583343061|FG000|Overall Study|Adverse Experience|1|||
161534279|NCT00677235|583343062|FG001|Overall Study|Adverse Experience|0|||
161534280|NCT01040260|583343063|FG000|Overall Study|Withdrawal by Subject|12|||
161534281|NCT01040260|583343064|FG001|Overall Study|Withdrawal by Subject|6|||
161534282|NCT01040260|583343063|FG000|Overall Study|Lost to Follow-up|3|||
161534283|NCT01040260|583343064|FG001|Overall Study|Lost to Follow-up|5|||
161534284|NCT00708916|583343077|FG000|Overall Study|Subject Noncompliance|2|||
161534285|NCT00708916|583343077|FG000|Overall Study|Adverse Event|2|||
161534286|NCT00951483|583343080|FG000|Overall Study|Physician Decision|4|||
161534287|NCT00951483|583343081|FG001|Overall Study|Physician Decision|0|||
161534288|NCT00951483|583343080|FG000|Overall Study|Withdrawal by Subject|15|||
161534289|NCT00951483|583343081|FG001|Overall Study|Withdrawal by Subject|0|||
161534290|NCT03565887|583343082|FG000|Overall Study|Adverse Event|1|||
161534291|NCT03565887|583343083|FG001|Overall Study|Adverse Event|0|||
161534292|NCT03565887|583343082|FG000|Overall Study|Withdrawal by Subject|0|||
161534293|NCT03565887|583343083|FG001|Overall Study|Withdrawal by Subject|2|||
161534294|NCT00689221|583343084|FG000|Overall Study|Ongoing at cut-off date|39|||
161534295|NCT00689221|583343085|FG001|Overall Study|Ongoing at cut-off date|36|||
161534296|NCT01292239|583343086|FG000|Overall Study|Other|1|||
161534297|NCT01292239|583343087|FG001|Overall Study|Other|1|||
161534298|NCT01292239|583343086|FG000|Overall Study|Withdrawal by Subject|3|||
161534299|NCT01292239|583343087|FG001|Overall Study|Withdrawal by Subject|6|||
161534300|NCT00262821|583343088|FG000|Overall Study|Ineligible - wrong stage|0|||
161534301|NCT00262821|583343089|FG001|Overall Study|Ineligible - wrong stage|3|||
161534302|NCT00262821|583343088|FG000|Overall Study|Ineligible - wrong cell type|2|||
161534303|NCT00262821|583343089|FG001|Overall Study|Ineligible - wrong cell type|2|||
161534304|NCT00262821|583343088|FG000|Overall Study|Ineligible - wrong primary|0|||
161534305|NCT00262821|583343089|FG001|Overall Study|Ineligible - wrong primary|1|||
161534306|NCT00262821|583343088|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161534307|NCT00262821|583343089|FG001|Overall Study|Ineligible - inadequate pathology|3|||
161534308|NCT00262821|583343088|FG000|Overall Study|Ineligible - elevated creatinine|0|||
161534309|NCT00262821|583343089|FG001|Overall Study|Ineligible - elevated creatinine|2|||
161534310|NCT00262821|583343088|FG000|Overall Study|Ineligible - required test not done|1|||
161534311|NCT00262821|583343089|FG001|Overall Study|Ineligible - required test not done|4|||
161534312|NCT00262821|583343088|FG000|Overall Study|Inevaluable - inadequate data|0|||
161534313|NCT00262821|583343089|FG001|Overall Study|Inevaluable - inadequate data|4|||
161534314|NCT00765388|583343090|FG000|Period 1|Lack of Efficacy|1|||
161534315|NCT00765388|583343091|FG001|Period 1|Lack of Efficacy|2|||
161534316|NCT00765388|583343090|FG000|Period 1|Lost to Follow-up|0|||
161534317|NCT00765388|583343091|FG001|Period 1|Lost to Follow-up|1|||
161534318|NCT00765388|583343090|FG000|Period 1|Herpes Zoster|0|||
161534319|NCT00765388|583343091|FG001|Period 1|Herpes Zoster|1|||
161534320|NCT00765388|583343090|FG000|Period 1|Hip operation|0|||
161534321|NCT00765388|583343091|FG001|Period 1|Hip operation|1|||
161534322|NCT03923933|583343092|FG000|Overall Study|Lost to Follow-up|1|||
161534323|NCT03923933|583343093|FG001|Overall Study|Lost to Follow-up|0|||
161534324|NCT03923933|583343092|FG000|Overall Study|Withdrawal by Subject|0|||
161534325|NCT03923933|583343093|FG001|Overall Study|Withdrawal by Subject|1|||
161534326|NCT01995461|583343094|FG000|Overall Study|Death|1|||
161534327|NCT01995461|583343094|FG000|Overall Study|Lost to Follow-up|2|||
161534328|NCT01995461|583343094|FG000|Overall Study|Withdrawal by Subject|2|||
161534329|NCT01777854|583343096|FG000|Overall Study|Physician Decision|3|||
161534330|NCT01777854|583343097|FG001|Overall Study|Physician Decision|3|||
161534331|NCT01939548|583343098|FG000|Overall Study|Non compliance|0|||
161534332|NCT01939548|583343099|FG001|Overall Study|Non compliance|2|||
161534333|NCT01939548|583343100|FG002|Overall Study|Non compliance|0|||
161534334|NCT01939548|583343098|FG000|Overall Study|Study Terminated by Sponsor|17|||
161534335|NCT01939548|583343099|FG001|Overall Study|Study Terminated by Sponsor|19|||
161534336|NCT01939548|583343100|FG002|Overall Study|Study Terminated by Sponsor|12|||
161534337|NCT01939548|583343098|FG000|Overall Study|Insufficient Clinical Response|1|||
161534338|NCT01939548|583343099|FG001|Overall Study|Insufficient Clinical Response|0|||
161534339|NCT01939548|583343100|FG002|Overall Study|Insufficient Clinical Response|0|||
161534340|NCT01939548|583343098|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161534341|NCT01939548|583343099|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161534342|NCT01939548|583343100|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
161534343|NCT01939548|583343098|FG000|Overall Study|Withdrawal by Subject|4|||
161534344|NCT01939548|583343099|FG001|Overall Study|Withdrawal by Subject|4|||
161829135|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829136|NCT05068284|584413681|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161534345|NCT01939548|583343100|FG002|Overall Study|Withdrawal by Subject|1|||
161534346|NCT01939548|583343098|FG000|Overall Study|Protocol Violation|7|||
161534347|NCT01939548|583343099|FG001|Overall Study|Protocol Violation|6|||
161534348|NCT01939548|583343100|FG002|Overall Study|Protocol Violation|5|||
161534349|NCT01939548|583343098|FG000|Overall Study|Lost to Follow-up|5|||
161534350|NCT01939548|583343099|FG001|Overall Study|Lost to Follow-up|5|||
161534351|NCT01939548|583343100|FG002|Overall Study|Lost to Follow-up|3|||
161534352|NCT01939548|583343098|FG000|Overall Study|Adverse Event|2|||
161534353|NCT01939548|583343099|FG001|Overall Study|Adverse Event|9|||
161534354|NCT01939548|583343100|FG002|Overall Study|Adverse Event|7|||
161829137|NCT05068284|584413682|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161534355|NCT01939548|583343098|FG000|Overall Study|Death|0|||
161829138|NCT05068284|584413683|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829139|NCT05068284|584413684|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
161534356|NCT01939548|583343099|FG001|Overall Study|Death|0|||
161534357|NCT01939548|583343100|FG002|Overall Study|Death|1|||
161534358|NCT01939548|583343098|FG000|Overall Study|Participant dropped|0|||
161534359|NCT01939548|583343099|FG001|Overall Study|Participant dropped|0|||
161534360|NCT01939548|583343100|FG002|Overall Study|Participant dropped|1|||
161534361|NCT01939548|583343098|FG000|Overall Study|Participant unwilling to continue|0|||
161534362|NCT01939548|583343099|FG001|Overall Study|Participant unwilling to continue|1|||
161534363|NCT01939548|583343100|FG002|Overall Study|Participant unwilling to continue|0|||
161534364|NCT01939548|583343098|FG000|Overall Study|Participant withdrew consent|0|||
161534365|NCT01939548|583343099|FG001|Overall Study|Participant withdrew consent|2|||
161534366|NCT01939548|583343100|FG002|Overall Study|Participant withdrew consent|0|||
161534367|NCT01939548|583343098|FG000|Overall Study|Did not complete follow-up|0|||
161534368|NCT01939548|583343099|FG001|Overall Study|Did not complete follow-up|1|||
161534369|NCT01939548|583343100|FG002|Overall Study|Did not complete follow-up|0|||
161534370|NCT03311373|583343101|FG000|Overall Study|Adverse Event|1|||
161534371|NCT03311373|583343101|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
161534372|NCT03311373|583343101|FG000|Overall Study|Lost to Follow-up|1|||
161534373|NCT03311373|583343101|FG000|Overall Study|Physician Decision|1|||
161534374|NCT03311373|583343101|FG000|Overall Study|Withdrawal by Subject|3|||
161534375|NCT01302119|583343104|FG000|Overall Study|Withdrawal by Subject|30|||
161534376|NCT01302119|583343105|FG001|Overall Study|Withdrawal by Subject|20|||
161534377|NCT01302119|583343104|FG000|Overall Study|Lost to Follow-up|10|||
161534378|NCT01302119|583343105|FG001|Overall Study|Lost to Follow-up|4|||
161534379|NCT01302119|583343104|FG000|Overall Study|Adverse Event|2|||
161534380|NCT01302119|583343105|FG001|Overall Study|Adverse Event|1|||
161534381|NCT01302119|583343104|FG000|Overall Study|Non-compliance|4|||
161534382|NCT01302119|583343105|FG001|Overall Study|Non-compliance|2|||
161534383|NCT01302119|583343104|FG000|Overall Study|Non-specific|4|||
161534384|NCT01302119|583343105|FG001|Overall Study|Non-specific|1|||
161534385|NCT01662310|583343108|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
161534386|NCT01662310|583343109|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
161534387|NCT01662310|583343110|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
161534388|NCT01662310|583343111|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
161534389|NCT01662310|583343112|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
161534390|NCT01662310|583343108|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
161534391|NCT01662310|583343109|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
161534392|NCT01662310|583343110|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
161534393|NCT01662310|583343111|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
161534394|NCT01662310|583343112|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
161534395|NCT01662310|583343108|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
161534396|NCT01662310|583343109|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
161534397|NCT01662310|583343110|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
161534398|NCT01662310|583343111|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
161534399|NCT01662310|583343112|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
161534400|NCT01662310|583343108|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
161534401|NCT01662310|583343109|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
161534402|NCT01662310|583343110|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
161534403|NCT01662310|583343111|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
161534404|NCT01662310|583343112|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
161534405|NCT01662310|583343108|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
161534406|NCT01662310|583343109|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
161534407|NCT01662310|583343110|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
161534408|NCT01662310|583343111|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
161534409|NCT01662310|583343112|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
161534410|NCT01662310|583343108|FG000|Run-In or Stabilization Phase|Other|1|||
161534411|NCT01662310|583343109|FG001|Run-In or Stabilization Phase|Other|0|||
161534412|NCT01662310|583343110|FG002|Run-In or Stabilization Phase|Other|0|||
161534413|NCT01662310|583343111|FG003|Run-In or Stabilization Phase|Other|0|||
161534414|NCT01662310|583343112|FG004|Run-In or Stabilization Phase|Other|0|||
161534415|NCT01662310|583343108|FG000|Double-Blind Phase|Adverse Event|0|||
161534416|NCT01662310|583343109|FG001|Double-Blind Phase|Adverse Event|0|||
161534417|NCT01662310|583343110|FG002|Double-Blind Phase|Adverse Event|1|||
161534418|NCT01662310|583343111|FG003|Double-Blind Phase|Adverse Event|0|||
161534419|NCT01662310|583343112|FG004|Double-Blind Phase|Adverse Event|0|||
161534420|NCT01662310|583343108|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161534421|NCT01662310|583343109|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161534422|NCT01662310|583343110|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161534423|NCT01662310|583343111|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161534424|NCT01662310|583343112|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161534425|NCT01662310|583343108|FG000|Double-Blind Phase|Pregnancy|0|||
161534426|NCT01662310|583343109|FG001|Double-Blind Phase|Pregnancy|2|||
161534427|NCT01662310|583343110|FG002|Double-Blind Phase|Pregnancy|0|||
161534428|NCT01662310|583343111|FG003|Double-Blind Phase|Pregnancy|0|||
161534429|NCT01662310|583343112|FG004|Double-Blind Phase|Pregnancy|0|||
161534430|NCT01662310|583343108|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161534431|NCT01662310|583343109|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
161534432|NCT01662310|583343110|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
161534433|NCT01662310|583343111|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161534434|NCT01662310|583343112|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161534435|NCT01662310|583343108|FG000|Double-Blind Phase|Other|0|||
161534436|NCT01662310|583343109|FG001|Double-Blind Phase|Other|0|||
161534437|NCT01662310|583343110|FG002|Double-Blind Phase|Other|1|||
161534438|NCT01662310|583343111|FG003|Double-Blind Phase|Other|0|||
161534439|NCT01662310|583343112|FG004|Double-Blind Phase|Other|0|||
161534440|NCT01662310|583343108|FG000|Double-Blind Phase|Randomized but not treated|0|||
161534441|NCT01662310|583343109|FG001|Double-Blind Phase|Randomized but not treated|1|||
161534442|NCT01662310|583343110|FG002|Double-Blind Phase|Randomized but not treated|0|||
161534443|NCT01662310|583343111|FG003|Double-Blind Phase|Randomized but not treated|0|||
161534444|NCT01662310|583343112|FG004|Double-Blind Phase|Randomized but not treated|0|||
161534445|NCT01662310|583343108|FG000|Open-Label Extension Phase|Adverse Event|0|||
161534446|NCT01662310|583343109|FG001|Open-Label Extension Phase|Adverse Event|0|||
161534447|NCT01662310|583343110|FG002|Open-Label Extension Phase|Adverse Event|0|||
161534448|NCT01662310|583343111|FG003|Open-Label Extension Phase|Adverse Event|3|||
161534449|NCT01662310|583343112|FG004|Open-Label Extension Phase|Adverse Event|0|||
161534450|NCT01662310|583343108|FG000|Open-Label Extension Phase|Death|0|||
161534451|NCT01662310|583343109|FG001|Open-Label Extension Phase|Death|0|||
161534452|NCT01662310|583343110|FG002|Open-Label Extension Phase|Death|0|||
161534453|NCT01662310|583343111|FG003|Open-Label Extension Phase|Death|1|||
161534454|NCT01662310|583343112|FG004|Open-Label Extension Phase|Death|0|||
161534455|NCT01662310|583343108|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
161534456|NCT01662310|583343109|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
161534457|NCT01662310|583343110|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
161534458|NCT01662310|583343111|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
161534459|NCT01662310|583343112|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
161534460|NCT01662310|583343108|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161534461|NCT01662310|583343109|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161534462|NCT01662310|583343110|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161534463|NCT01662310|583343111|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
161534464|NCT01662310|583343112|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
161534465|NCT01662310|583343108|FG000|Open-Label Extension Phase|Pregnancy|0|||
161534466|NCT01662310|583343109|FG001|Open-Label Extension Phase|Pregnancy|0|||
161534467|NCT01662310|583343110|FG002|Open-Label Extension Phase|Pregnancy|0|||
161534468|NCT01662310|583343111|FG003|Open-Label Extension Phase|Pregnancy|1|||
161534469|NCT01662310|583343112|FG004|Open-Label Extension Phase|Pregnancy|0|||
161534470|NCT01662310|583343108|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
161534471|NCT01662310|583343109|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
161534472|NCT01662310|583343110|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
161534473|NCT01662310|583343111|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
161534474|NCT01662310|583343112|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
161534475|NCT02432105|583343116|FG000|Overall Study|Lost to Follow-up|1|||
161534476|NCT02432105|583343117|FG001|Overall Study|Lost to Follow-up|1|||
161534477|NCT02432105|583343118|FG002|Overall Study|Lost to Follow-up|0|||
161534478|NCT02432105|583343116|FG000|Overall Study|Withdrawal by Subject|1|||
161534479|NCT02432105|583343117|FG001|Overall Study|Withdrawal by Subject|0|||
161534480|NCT02432105|583343118|FG002|Overall Study|Withdrawal by Subject|1|||
161534481|NCT02432105|583343116|FG000|Overall Study|Culture positive for yeast|0|||
161534482|NCT02432105|583343117|FG001|Overall Study|Culture positive for yeast|1|||
161534483|NCT02432105|583343118|FG002|Overall Study|Culture positive for yeast|0|||
161534484|NCT02432105|583343116|FG000|Overall Study|Randomized in error|0|||
161534485|NCT02432105|583343117|FG001|Overall Study|Randomized in error|0|||
161534486|NCT02432105|583343118|FG002|Overall Study|Randomized in error|2|||
161534487|NCT02085252|583343121|FG000|Overall Study|Withdrawal of Consent|1|||
161534488|NCT02085252|583343122|FG001|Overall Study|Withdrawal of Consent|0|||
161534489|NCT02085252|583343121|FG000|Overall Study|Adverse Event|0|||
161534490|NCT02085252|583343122|FG001|Overall Study|Adverse Event|1|||
161534491|NCT02085252|583343121|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
161534492|NCT02085252|583343122|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
161534493|NCT02085252|583343121|FG000|Overall Study|Reason Not Specified|0|||
161534494|NCT02085252|583343122|FG001|Overall Study|Reason Not Specified|1|||
161534495|NCT02085252|583343121|FG000|Overall Study|Reason Unknown|0|||
161534496|NCT02085252|583343122|FG001|Overall Study|Reason Unknown|1|||
161534497|NCT03645759|583343126|FG000|Overall Study|Lost to Follow-up|3|||
161534498|NCT03645759|583343127|FG001|Overall Study|Lost to Follow-up|2|||
161534499|NCT00251745|583343132|FG000|Overall Study|Adverse Event|7|||
161534500|NCT00251745|583343133|FG001|Overall Study|Adverse Event|9|||
161534501|NCT00251745|583343134|FG002|Overall Study|Adverse Event|11|||
161534502|NCT00251745|583343132|FG000|Overall Study|Lost to Follow-up|4|||
161534503|NCT00251745|583343133|FG001|Overall Study|Lost to Follow-up|2|||
161534504|NCT00251745|583343134|FG002|Overall Study|Lost to Follow-up|5|||
161534505|NCT00251745|583343132|FG000|Overall Study|Withdrawal by Subject|13|||
161534506|NCT00251745|583343133|FG001|Overall Study|Withdrawal by Subject|7|||
161534507|NCT00251745|583343134|FG002|Overall Study|Withdrawal by Subject|3|||
161534508|NCT00251745|583343132|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161534509|NCT00251745|583343133|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
161534510|NCT00251745|583343134|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
161534511|NCT00251745|583343132|FG000|Overall Study|Lack of Efficacy|3|||
161534512|NCT00251745|583343133|FG001|Overall Study|Lack of Efficacy|0|||
161534513|NCT00251745|583343134|FG002|Overall Study|Lack of Efficacy|0|||
161534514|NCT00251745|583343132|FG000|Overall Study|Noncompliant|0|||
161534515|NCT00251745|583343133|FG001|Overall Study|Noncompliant|2|||
161534516|NCT00251745|583343134|FG002|Overall Study|Noncompliant|2|||
161534517|NCT00251745|583343132|FG000|Overall Study|Pregnancy|0|||
161534518|NCT00251745|583343133|FG001|Overall Study|Pregnancy|1|||
161534519|NCT00251745|583343134|FG002|Overall Study|Pregnancy|0|||
161534520|NCT00251745|583343132|FG000|Overall Study|Per Subject Request|0|||
161534521|NCT00251745|583343133|FG001|Overall Study|Per Subject Request|0|||
161534522|NCT00251745|583343134|FG002|Overall Study|Per Subject Request|1|||
161534523|NCT00251745|583343132|FG000|Overall Study|Per Investigator Request|1|||
161534524|NCT00251745|583343133|FG001|Overall Study|Per Investigator Request|0|||
161534525|NCT00251745|583343134|FG002|Overall Study|Per Investigator Request|0|||
161534526|NCT04508699|583343139|FG000|Overall Study|Lack of Efficacy|2|||
161534527|NCT04508699|583343140|FG001|Overall Study|Lack of Efficacy|15|||
161534528|NCT04508699|583343139|FG000|Overall Study|Withdrawal by Subject|0|||
161534529|NCT04508699|583343140|FG001|Overall Study|Withdrawal by Subject|2|||
161534530|NCT02586025|583344816|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
161534531|NCT02586025|583344817|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
161534532|NCT02586025|583344816|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
161534533|NCT02586025|583344817|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
161534534|NCT02586025|583344816|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
161534535|NCT02586025|583344817|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
161534536|NCT02586025|583344816|FG000|Neoadjuvant Treatment|Death|1|||
161534537|NCT02586025|583344817|FG001|Neoadjuvant Treatment|Death|0|||
161534538|NCT02586025|583344816|FG000|Neoadjuvant Treatment|Adverse Event|1|||
161534539|NCT02586025|583344817|FG001|Neoadjuvant Treatment|Adverse Event|0|||
161534540|NCT02586025|583344816|FG000|Neoadjuvant Treatment|Physician Decision|2|||
161534541|NCT02586025|583344817|FG001|Neoadjuvant Treatment|Physician Decision|1|||
161534542|NCT02586025|583344816|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
161534543|NCT02586025|583344817|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
161534544|NCT02586025|583344816|FG000|Adjuvant Treatment|Recurrent Disease|4|||
161534545|NCT02586025|583344817|FG001|Adjuvant Treatment|Recurrent Disease|5|||
161534546|NCT02586025|583344816|FG000|Adjuvant Treatment|Physician Decision|0|||
161534547|NCT02586025|583344817|FG001|Adjuvant Treatment|Physician Decision|1|||
161534548|NCT02586025|583344816|FG000|Adjuvant Treatment|Pregnancy|1|||
161534549|NCT02586025|583344817|FG001|Adjuvant Treatment|Pregnancy|0|||
161534550|NCT02586025|583344816|FG000|Treatment-Free Follow-Up|Death|11|||
161534551|NCT02586025|583344817|FG001|Treatment-Free Follow-Up|Death|11|||
161534552|NCT02586025|583344816|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
161534553|NCT02586025|583344817|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
161534554|NCT02586025|583344816|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
161534555|NCT02586025|583344817|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
161534556|NCT02586025|583344816|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
161534557|NCT02586025|583344817|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
161534558|NCT02586025|583344816|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
161534559|NCT02586025|583344817|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
161534560|NCT00175825|583344818|FG000|Overall Study|Adverse Event|3|||
161534561|NCT00175825|583344819|FG001|Overall Study|Adverse Event|2|||
161534562|NCT00175825|583344820|FG002|Overall Study|Adverse Event|1|||
161534563|NCT00175825|583344821|FG003|Overall Study|Adverse Event|1|||
161534564|NCT00175825|583344818|FG000|Overall Study|Lost to Follow-up|1|||
161534565|NCT00175825|583344819|FG001|Overall Study|Lost to Follow-up|2|||
161534566|NCT00175825|583344820|FG002|Overall Study|Lost to Follow-up|0|||
161534567|NCT00175825|583344821|FG003|Overall Study|Lost to Follow-up|0|||
161534568|NCT00175825|583344818|FG000|Overall Study|Withdrawal by Subject|1|||
161534569|NCT00175825|583344819|FG001|Overall Study|Withdrawal by Subject|0|||
161534570|NCT00175825|583344820|FG002|Overall Study|Withdrawal by Subject|0|||
161534571|NCT00175825|583344821|FG003|Overall Study|Withdrawal by Subject|0|||
161534572|NCT03704584|583344822|FG000|Overall Study|Withdrawal by Subject|1|||
161534573|NCT03704584|583344823|FG001|Overall Study|Withdrawal by Subject|0|||
161534574|NCT03412812|583344824|FG000|Level 1|Death|3|||
161534575|NCT03412812|583344825|FG001|Level 1|Death|0|||
161534576|NCT03412812|583344824|FG000|Level 1|Adverse Event|0|||
161534577|NCT03412812|583344825|FG001|Level 1|Adverse Event|1|||
161534578|NCT03548207|583344828|FG000|Overall Study|Death|10|||
161534579|NCT03548207|583344829|FG001|Overall Study|Death|23|||
161534580|NCT03548207|583344830|FG002|Overall Study|Death|3|||
161534581|NCT03548207|583344828|FG000|Overall Study|Lost to Follow-up|0|||
161534582|NCT03548207|583344829|FG001|Overall Study|Lost to Follow-up|2|||
161534583|NCT03548207|583344830|FG002|Overall Study|Lost to Follow-up|0|||
161534584|NCT03548207|583344828|FG000|Overall Study|Withdrawal by Subject|0|||
161534585|NCT03548207|583344829|FG001|Overall Study|Withdrawal by Subject|3|||
161534586|NCT03548207|583344830|FG002|Overall Study|Withdrawal by Subject|0|||
161534587|NCT03548207|583344828|FG000|Overall Study|Sponsor decision|19|||
161534588|NCT03548207|583344829|FG001|Overall Study|Sponsor decision|40|||
161534589|NCT03548207|583344830|FG002|Overall Study|Sponsor decision|6|||
161534590|NCT03548207|583344828|FG000|Overall Study|Randomized but not treated|6|||
161534591|NCT03548207|583344829|FG001|Overall Study|Randomized but not treated|10|||
161534592|NCT03548207|583344830|FG002|Overall Study|Randomized but not treated|4|||
161534593|NCT01756352|583344831|FG000|Overall Study|moved away and lost to followup|1|||
161534594|NCT03822117|583344832|FG000|Overall Study|Death|18|||
161534595|NCT03822117|583344833|FG001|Overall Study|Death|17|||
161534596|NCT03822117|583344834|FG002|Overall Study|Death|12|||
161534597|NCT03822117|583344835|FG003|Overall Study|Death|4|||
161534598|NCT03822117|583344832|FG000|Overall Study|Lost to Follow-up|1|||
161534599|NCT03822117|583344833|FG001|Overall Study|Lost to Follow-up|2|||
161829140|NCT05068284|584413685|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161534600|NCT03822117|583344834|FG002|Overall Study|Lost to Follow-up|3|||
161534601|NCT03822117|583344835|FG003|Overall Study|Lost to Follow-up|0|||
161534602|NCT03822117|583344832|FG000|Overall Study|Study Terminated by Sponsor|25|||
161534603|NCT03822117|583344833|FG001|Overall Study|Study Terminated by Sponsor|11|||
161534604|NCT03822117|583344834|FG002|Overall Study|Study Terminated by Sponsor|6|||
161534605|NCT03822117|583344835|FG003|Overall Study|Study Terminated by Sponsor|0|||
161534606|NCT03822117|583344832|FG000|Overall Study|Withdrawal by Subject|4|||
161534607|NCT03822117|583344833|FG001|Overall Study|Withdrawal by Subject|0|||
161534608|NCT03822117|583344834|FG002|Overall Study|Withdrawal by Subject|3|||
161534609|NCT03822117|583344835|FG003|Overall Study|Withdrawal by Subject|0|||
161534610|NCT03822117|583344832|FG000|Overall Study|Disease Progression|1|||
161534611|NCT03822117|583344833|FG001|Overall Study|Disease Progression|2|||
161534612|NCT03822117|583344834|FG002|Overall Study|Disease Progression|1|||
161534613|NCT03822117|583344835|FG003|Overall Study|Disease Progression|0|||
161534614|NCT03822117|583344832|FG000|Overall Study|Never Returned to Hospital|0|||
161534615|NCT03822117|583344833|FG001|Overall Study|Never Returned to Hospital|0|||
161534616|NCT03822117|583344834|FG002|Overall Study|Never Returned to Hospital|1|||
161534617|NCT03822117|583344835|FG003|Overall Study|Never Returned to Hospital|0|||
161534618|NCT00415610|583344837|FG000|Overall Study|Death|3|||
161534619|NCT00415610|583344838|FG001|Overall Study|Death|2|||
161534620|NCT00415610|583344839|FG002|Overall Study|Death|5|||
161534621|NCT01357616|583344843|FG000|Overall Study|Adverse Event|1|||
161534622|NCT01357616|583344844|FG001|Overall Study|Adverse Event|1|||
161534623|NCT01357616|583344843|FG000|Overall Study|Lost to Follow-up|4|||
161534624|NCT01357616|583344844|FG001|Overall Study|Lost to Follow-up|3|||
161534625|NCT01357616|583344843|FG000|Overall Study|Protocol Violation|0|||
161534626|NCT01357616|583344844|FG001|Overall Study|Protocol Violation|2|||
161534627|NCT01357616|583344843|FG000|Overall Study|Inadequate Control of IOP|1|||
161534628|NCT01357616|583344844|FG001|Overall Study|Inadequate Control of IOP|2|||
161534629|NCT01357616|583344843|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
161534630|NCT01357616|583344844|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
161534631|NCT01357616|583344843|FG000|Overall Study|Withdrawal by Subject|1|||
161534632|NCT01357616|583344844|FG001|Overall Study|Withdrawal by Subject|0|||
161534633|NCT03255824|583344853|FG000|Overall Study|Under-sedation|2|||
161534634|NCT03255824|583344854|FG001|Overall Study|Under-sedation|1|||
161534635|NCT03432364|583344857|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
161534636|NCT00522301|583344858|FG000|Overall Study|Withdrawal by Subject|1|||
161534637|NCT00522301|583344858|FG000|Overall Study|Adverse Event|5|||
161534638|NCT03040713|583344859|FG000|Overall Study|Positive amyloid scan|3|||
161534639|NCT02641392|583344864|FG000|Overall Study|Lost to Follow-up|0|||
161534640|NCT02641392|583344865|FG001|Overall Study|Lost to Follow-up|0|||
161534641|NCT02641392|583344866|FG002|Overall Study|Lost to Follow-up|2|||
161534642|NCT02641392|583344864|FG000|Overall Study|Withdrawal by Subject|0|||
161534643|NCT02641392|583344865|FG001|Overall Study|Withdrawal by Subject|0|||
161534644|NCT02641392|583344866|FG002|Overall Study|Withdrawal by Subject|17|||
161534645|NCT02641392|583344864|FG000|Overall Study|Adverse Event|0|||
161534646|NCT02641392|583344865|FG001|Overall Study|Adverse Event|1|||
161534647|NCT02641392|583344866|FG002|Overall Study|Adverse Event|25|||
161534648|NCT02641392|583344864|FG000|Overall Study|Study Terminated by Sponsor|4|||
161534649|NCT02641392|583344865|FG001|Overall Study|Study Terminated by Sponsor|12|||
161591834|NCT03138512|583556589|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
161591835|NCT03138512|583556590|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
161591836|NCT03138512|583556591|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
161591837|NCT03138512|583556587|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
161534650|NCT02641392|583344866|FG002|Overall Study|Study Terminated by Sponsor|144|||
161591838|NCT03138512|583556588|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
161591839|NCT03138512|583556589|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
161534651|NCT02641392|583344864|FG000|Overall Study|Lack of Efficacy|0|||
161534652|NCT02641392|583344865|FG001|Overall Study|Lack of Efficacy|0|||
161591840|NCT03138512|583556590|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
161534653|NCT02641392|583344866|FG002|Overall Study|Lack of Efficacy|101|||
161534654|NCT02641392|583344864|FG000|Overall Study|Miscellaneous|0|||
161534655|NCT02641392|583344865|FG001|Overall Study|Miscellaneous|0|||
161534656|NCT02641392|583344866|FG002|Overall Study|Miscellaneous|3|||
161534657|NCT02641392|583344864|FG000|Overall Study|Death|0|||
161534658|NCT02641392|583344865|FG001|Overall Study|Death|0|||
161534659|NCT02641392|583344866|FG002|Overall Study|Death|1|||
161534660|NCT00430248|583344867|FG000|Overall Study|Adverse Event|49|||
161534661|NCT00430248|583344868|FG001|Overall Study|Adverse Event|61|||
161534662|NCT00430248|583344869|FG002|Overall Study|Adverse Event|64|||
161534663|NCT00430248|583344867|FG000|Overall Study|Protocol Violation|10|||
161534664|NCT00430248|583344868|FG001|Overall Study|Protocol Violation|2|||
161534665|NCT00430248|583344869|FG002|Overall Study|Protocol Violation|4|||
161534666|NCT00430248|583344867|FG000|Overall Study|Personal Reasons|12|||
161534667|NCT00430248|583344868|FG001|Overall Study|Personal Reasons|24|||
161534668|NCT00430248|583344869|FG002|Overall Study|Personal Reasons|9|||
161534669|NCT00430248|583344867|FG000|Overall Study|Lost to Follow-up|28|||
161534670|NCT00430248|583344868|FG001|Overall Study|Lost to Follow-up|33|||
161534671|NCT00430248|583344869|FG002|Overall Study|Lost to Follow-up|28|||
161534672|NCT00430248|583344867|FG000|Overall Study|Therapeutic Failure|1|||
161534673|NCT00430248|583344868|FG001|Overall Study|Therapeutic Failure|1|||
161534674|NCT00430248|583344869|FG002|Overall Study|Therapeutic Failure|1|||
161534675|NCT00430248|583344867|FG000|Overall Study|Withdrawal by Subject|14|||
161534676|NCT00430248|583344868|FG001|Overall Study|Withdrawal by Subject|20|||
161534677|NCT00430248|583344869|FG002|Overall Study|Withdrawal by Subject|16|||
161534678|NCT00430248|583344867|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161534679|NCT00430248|583344868|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
161534680|NCT00430248|583344869|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161534681|NCT00430248|583344867|FG000|Overall Study|Gout Flare|3|||
161534682|NCT00430248|583344868|FG001|Overall Study|Gout Flare|7|||
161534683|NCT00430248|583344869|FG002|Overall Study|Gout Flare|2|||
161534684|NCT00430248|583344867|FG000|Overall Study|Reason Not Specified|8|||
161534685|NCT00430248|583344868|FG001|Overall Study|Reason Not Specified|8|||
161534686|NCT00430248|583344869|FG002|Overall Study|Reason Not Specified|11|||
161534687|NCT03466086|583344872|FG000|Period 1|Sponsor decision due to study timeline|1|||
161534688|NCT03466086|583344873|FG001|Period 1|Sponsor decision due to study timeline|0|||
161534689|NCT03466086|583344872|FG000|Period 1|Withdrawal by Subject|1|||
161534690|NCT03466086|583344873|FG001|Period 1|Withdrawal by Subject|0|||
161534691|NCT00002558|583344874|FG000|Overall Study|Withdrawal by Subject|0|||
161534692|NCT00002558|583344875|FG001|Overall Study|Withdrawal by Subject|1|||
161534693|NCT01260350|583344877|FG000|Overall Study|Lack of Efficacy|0|||
161534694|NCT01260350|583344878|FG001|Overall Study|Lack of Efficacy|0|||
161534695|NCT01260350|583344879|FG002|Overall Study|Lack of Efficacy|0|||
161534696|NCT01260350|583344880|FG003|Overall Study|Lack of Efficacy|0|||
161534697|NCT01260350|583344881|FG004|Overall Study|Lack of Efficacy|0|||
161534698|NCT01260350|583344882|FG005|Overall Study|Lack of Efficacy|0|||
161534699|NCT01260350|583344883|FG006|Overall Study|Lack of Efficacy|0|||
161534700|NCT01260350|583344884|FG007|Overall Study|Lack of Efficacy|0|||
161534701|NCT01260350|583344885|FG008|Overall Study|Lack of Efficacy|0|||
161534702|NCT01260350|583344886|FG009|Overall Study|Lack of Efficacy|0|||
161534703|NCT01260350|583344887|FG010|Overall Study|Lack of Efficacy|0|||
161534704|NCT01260350|583344888|FG011|Overall Study|Lack of Efficacy|0|||
161534705|NCT01260350|583344889|FG012|Overall Study|Lack of Efficacy|0|||
161534706|NCT01260350|583344890|FG013|Overall Study|Lack of Efficacy|0|||
161534707|NCT01260350|583344891|FG014|Overall Study|Lack of Efficacy|0|||
161534708|NCT01260350|583344892|FG015|Overall Study|Lack of Efficacy|0|||
161534709|NCT01260350|583344893|FG016|Overall Study|Lack of Efficacy|0|||
161534710|NCT01260350|583344894|FG017|Overall Study|Lack of Efficacy|1|||
161534711|NCT01260350|583344895|FG018|Overall Study|Lack of Efficacy|0|||
161534712|NCT01260350|583344896|FG019|Overall Study|Lack of Efficacy|0|||
161534713|NCT01260350|583344897|FG020|Overall Study|Lack of Efficacy|3|||
161534714|NCT01260350|583344898|FG021|Overall Study|Lack of Efficacy|0|||
161534715|NCT01260350|583344877|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534716|NCT01260350|583344878|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534717|NCT01260350|583344879|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534718|NCT01260350|583344880|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534719|NCT01260350|583344881|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534720|NCT01260350|583344882|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534721|NCT01260350|583344883|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534722|NCT01260350|583344884|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534723|NCT01260350|583344885|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
161829141|NCT05068284|584413686|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829142|NCT05068284|584413687|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829143|NCT05068284|584413688|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161534724|NCT01260350|583344886|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534725|NCT01260350|583344887|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534726|NCT01260350|583344888|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534727|NCT01260350|583344889|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534728|NCT01260350|583344890|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534729|NCT01260350|583344891|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534730|NCT01260350|583344892|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534731|NCT01260350|583344893|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534732|NCT01260350|583344894|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534733|NCT01260350|583344895|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161829144|NCT05068284|584413681|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829145|NCT05068284|584413682|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829146|NCT05068284|584413683|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
161829147|NCT05068284|584413684|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
161829148|NCT05068284|584413685|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829149|NCT05068284|584413686|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829150|NCT05068284|584413687|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161534734|NCT01260350|583344896|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534735|NCT01260350|583344897|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534736|NCT01260350|583344898|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161534737|NCT02123108|583344901|FG000|Overall Study|Death|2|||
161534738|NCT02123108|583344902|FG001|Overall Study|Death|3|||
161534739|NCT02219048|583344906|FG000|Overall Study|Adverse Event|2|||
161534740|NCT02219048|583344907|FG001|Overall Study|Adverse Event|5|||
161534741|NCT02219048|583344906|FG000|Overall Study|No longer meets eligibility criteria|1|||
161534742|NCT02219048|583344907|FG001|Overall Study|No longer meets eligibility criteria|0|||
161534743|NCT02219048|583344906|FG000|Overall Study|Study terminated by sponsor|16|||
161534744|NCT02219048|583344907|FG001|Overall Study|Study terminated by sponsor|15|||
161534745|NCT02219048|583344906|FG000|Overall Study|Withdrawal by Subject|2|||
161534746|NCT02219048|583344907|FG001|Overall Study|Withdrawal by Subject|0|||
161534747|NCT02219048|583344906|FG000|Overall Study|Other|0|||
161534748|NCT02219048|583344907|FG001|Overall Study|Other|1|||
161534749|NCT04721925|583344908|FG000|2-Month Assessment|Lost to Follow-up|5|||
161534750|NCT04721925|583344909|FG001|2-Month Assessment|Lost to Follow-up|3|||
161534751|NCT04721925|583344908|FG000|4-Month Assessment|Lost to Follow-up|3|||
161534752|NCT04721925|583344909|FG001|4-Month Assessment|Lost to Follow-up|6|||
161534753|NCT01274182|583344910|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161534754|NCT01274182|583344911|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161534755|NCT01274182|583344912|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
161534756|NCT01274182|583344910|FG000|Overall Study|Adverse Event|4|||
161534757|NCT01274182|583344911|FG001|Overall Study|Adverse Event|5|||
161534758|NCT01274182|583344912|FG002|Overall Study|Adverse Event|3|||
161534759|NCT01274182|583344910|FG000|Overall Study|Withdrawal by Subject|5|||
161678670|NCT00766090|583876048|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
161534760|NCT01274182|583344911|FG001|Overall Study|Withdrawal by Subject|5|||
161534761|NCT01274182|583344912|FG002|Overall Study|Withdrawal by Subject|3|||
161534762|NCT01274182|583344910|FG000|Overall Study|Lost to Follow-up|2|||
161534763|NCT01274182|583344911|FG001|Overall Study|Lost to Follow-up|3|||
161534764|NCT01274182|583344912|FG002|Overall Study|Lost to Follow-up|1|||
161678671|NCT00766090|583876049|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
161678672|NCT00766090|583876050|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
161678673|NCT00766090|583876051|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
161678674|NCT00766090|583876052|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
161678675|NCT00766090|583876053|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
161678676|NCT00766090|583876054|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
161678677|NCT00766090|583876055|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
161534765|NCT01274182|583344910|FG000|Overall Study|Protocol Violation|3|||
161534766|NCT01274182|583344911|FG001|Overall Study|Protocol Violation|2|||
161534767|NCT01274182|583344912|FG002|Overall Study|Protocol Violation|0|||
161534768|NCT01274182|583344910|FG000|Overall Study|Death|1|||
161534769|NCT01274182|583344911|FG001|Overall Study|Death|0|||
161534770|NCT01274182|583344912|FG002|Overall Study|Death|1|||
161534771|NCT01970982|583344913|FG000|Overall Study|Withdrawal by Subject|0|||
161534772|NCT01970982|583344914|FG001|Overall Study|Withdrawal by Subject|0|||
161534773|NCT01970982|583344915|FG002|Overall Study|Withdrawal by Subject|2|||
161534774|NCT04040751|583344920|FG000|Overall Study|Withdrawal by Subject|2|||
161534775|NCT04040751|583344921|FG001|Overall Study|Withdrawal by Subject|0|||
161534776|NCT04040751|583344922|FG002|Overall Study|Withdrawal by Subject|2|||
161534777|NCT04040751|583344923|FG003|Overall Study|Withdrawal by Subject|0|||
161534778|NCT02862457|583344924|FG000|Overall Study|Death|1|||
161534779|NCT02862457|583344925|FG001|Overall Study|Death|3|||
161534780|NCT02862457|583344926|FG002|Overall Study|Death|2|||
161534781|NCT02862457|583344927|FG003|Overall Study|Death|3|||
161534782|NCT02862457|583344928|FG004|Overall Study|Death|0|||
161534783|NCT02862457|583344929|FG005|Overall Study|Death|2|||
161534784|NCT02862457|583344930|FG006|Overall Study|Death|1|||
161534785|NCT02862457|583344924|FG000|Overall Study|Lost to Follow-up|1|||
161534786|NCT02862457|583344925|FG001|Overall Study|Lost to Follow-up|0|||
161534787|NCT02862457|583344926|FG002|Overall Study|Lost to Follow-up|0|||
161534788|NCT02862457|583344927|FG003|Overall Study|Lost to Follow-up|1|||
161534789|NCT02862457|583344928|FG004|Overall Study|Lost to Follow-up|0|||
161534790|NCT02862457|583344929|FG005|Overall Study|Lost to Follow-up|0|||
161534791|NCT02862457|583344930|FG006|Overall Study|Lost to Follow-up|0|||
161534792|NCT02862457|583344924|FG000|Overall Study|Withdrawal by Subject|0|||
161534793|NCT02862457|583344925|FG001|Overall Study|Withdrawal by Subject|0|||
161534794|NCT02862457|583344926|FG002|Overall Study|Withdrawal by Subject|1|||
161534795|NCT02862457|583344927|FG003|Overall Study|Withdrawal by Subject|0|||
161534796|NCT02862457|583344928|FG004|Overall Study|Withdrawal by Subject|0|||
161534797|NCT02862457|583344929|FG005|Overall Study|Withdrawal by Subject|1|||
161534798|NCT02862457|583344930|FG006|Overall Study|Withdrawal by Subject|0|||
161534799|NCT03364751|583344931|FG000|Overall Study|Withdrawal by Subject|1|||
161534800|NCT03364751|583344932|FG001|Overall Study|Withdrawal by Subject|0|||
161534801|NCT03364751|583344933|FG002|Overall Study|Withdrawal by Subject|0|||
161591841|NCT03138512|583556591|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
161591842|NCT03138512|583556587|FG000|Treatment Part B|Participant withdrew consent|0|||
161591843|NCT03138512|583556588|FG001|Treatment Part B|Participant withdrew consent|0|||
161591844|NCT03138512|583556589|FG002|Treatment Part B|Participant withdrew consent|1|||
161591845|NCT03138512|583556590|FG003|Treatment Part B|Participant withdrew consent|1|||
161591846|NCT03138512|583556591|FG004|Treatment Part B|Participant withdrew consent|2|||
161591847|NCT03138512|583556587|FG000|Treatment Part B|Lost to Follow-up|0|||
161591848|NCT03138512|583556588|FG001|Treatment Part B|Lost to Follow-up|0|||
161591849|NCT03138512|583556589|FG002|Treatment Part B|Lost to Follow-up|0|||
161591850|NCT03138512|583556590|FG003|Treatment Part B|Lost to Follow-up|1|||
161591851|NCT03138512|583556591|FG004|Treatment Part B|Lost to Follow-up|0|||
161591852|NCT03138512|583556587|FG000|Treatment Part B|Poor/non-compliance|0|||
161591853|NCT03138512|583556588|FG001|Treatment Part B|Poor/non-compliance|0|||
161591854|NCT03138512|583556589|FG002|Treatment Part B|Poor/non-compliance|1|||
161591855|NCT03138512|583556590|FG003|Treatment Part B|Poor/non-compliance|1|||
161591856|NCT03138512|583556591|FG004|Treatment Part B|Poor/non-compliance|1|||
161591857|NCT03138512|583556587|FG000|Treatment Part B|Other reasons|0|||
161591858|NCT03138512|583556588|FG001|Treatment Part B|Other reasons|0|||
161591859|NCT03138512|583556589|FG002|Treatment Part B|Other reasons|3|||
161591860|NCT03138512|583556590|FG003|Treatment Part B|Other reasons|1|||
161591861|NCT03138512|583556591|FG004|Treatment Part B|Other reasons|5|||
161591862|NCT02120456|583556598|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591863|NCT02120456|583556599|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591864|NCT02120456|583556600|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591865|NCT02120456|583556601|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591866|NCT02120456|583556602|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591867|NCT02120456|583556603|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591868|NCT02120456|583556604|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
161591869|NCT02120456|583556605|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591870|NCT02120456|583556606|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161591871|NCT02120456|583556598|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591872|NCT02120456|583556599|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591873|NCT02120456|583556600|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591874|NCT02120456|583556601|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591875|NCT02120456|583556602|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591876|NCT02120456|583556603|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591877|NCT02120456|583556604|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
161591878|NCT02120456|583556605|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591879|NCT02120456|583556606|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161591880|NCT02120456|583556598|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161591881|NCT02120456|583556599|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161534802|NCT03364751|583344934|FG003|Overall Study|Withdrawal by Subject|0|||
161829151|NCT05068284|584413688|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829152|NCT05068284|584413681|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829153|NCT05068284|584413682|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829154|NCT05068284|584413683|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
161829155|NCT05068284|584413684|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829156|NCT05068284|584413685|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829157|NCT05068284|584413686|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829158|NCT05068284|584413687|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829159|NCT05068284|584413688|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829160|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
161534803|NCT03364751|583344931|FG000|Overall Study|Lost to Follow-up|0|||
161534804|NCT03364751|583344932|FG001|Overall Study|Lost to Follow-up|1|||
161829161|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829162|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829163|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829164|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829165|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161534805|NCT03364751|583344933|FG002|Overall Study|Lost to Follow-up|0|||
161534806|NCT03364751|583344934|FG003|Overall Study|Lost to Follow-up|0|||
161534807|NCT02342886|583344936|FG000|Overall Study|Treatment non-compliance|1|||
161534808|NCT02342886|583344937|FG001|Overall Study|Treatment non-compliance|0|||
161534809|NCT02342886|583344938|FG002|Overall Study|Treatment non-compliance|0|||
161534810|NCT02342886|583344939|FG003|Overall Study|Treatment non-compliance|1|||
161534811|NCT02342886|583344940|FG004|Overall Study|Treatment non-compliance|0|||
161534812|NCT02342886|583344936|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
161534813|NCT02342886|583344937|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
161534814|NCT02342886|583344938|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
161534815|NCT02342886|583344939|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
161534816|NCT02342886|583344940|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
161534817|NCT02342886|583344936|FG000|Overall Study|Adverse event/specific toxicity|4|||
161534818|NCT02342886|583344937|FG001|Overall Study|Adverse event/specific toxicity|3|||
161534819|NCT02342886|583344938|FG002|Overall Study|Adverse event/specific toxicity|11|||
161534820|NCT02342886|583344939|FG003|Overall Study|Adverse event/specific toxicity|2|||
161534821|NCT02342886|583344940|FG004|Overall Study|Adverse event/specific toxicity|1|||
161534822|NCT02342886|583344936|FG000|Overall Study|Lost to Follow-up|1|||
161534823|NCT02342886|583344937|FG001|Overall Study|Lost to Follow-up|0|||
161534824|NCT02342886|583344938|FG002|Overall Study|Lost to Follow-up|0|||
161534825|NCT02342886|583344939|FG003|Overall Study|Lost to Follow-up|0|||
161534826|NCT02342886|583344940|FG004|Overall Study|Lost to Follow-up|0|||
161534827|NCT02342886|583344936|FG000|Overall Study|Death|1|||
161534828|NCT02342886|583344937|FG001|Overall Study|Death|2|||
161534829|NCT02342886|583344938|FG002|Overall Study|Death|1|||
161534830|NCT02342886|583344939|FG003|Overall Study|Death|0|||
161534831|NCT02342886|583344940|FG004|Overall Study|Death|1|||
161534832|NCT02342886|583344936|FG000|Overall Study|Withdrawal by Subject|0|||
161534833|NCT02342886|583344937|FG001|Overall Study|Withdrawal by Subject|1|||
161534834|NCT02342886|583344938|FG002|Overall Study|Withdrawal by Subject|0|||
161534835|NCT02342886|583344939|FG003|Overall Study|Withdrawal by Subject|1|||
161534836|NCT02342886|583344940|FG004|Overall Study|Withdrawal by Subject|0|||
161534837|NCT02342886|583344936|FG000|Overall Study|Investigator/sponsor decision|0|||
161534838|NCT02342886|583344937|FG001|Overall Study|Investigator/sponsor decision|2|||
161534839|NCT02342886|583344938|FG002|Overall Study|Investigator/sponsor decision|0|||
161534840|NCT02342886|583344939|FG003|Overall Study|Investigator/sponsor decision|3|||
161534841|NCT02342886|583344940|FG004|Overall Study|Investigator/sponsor decision|1|||
161534842|NCT02342886|583344936|FG000|Overall Study|Pregnancy|0|||
161534843|NCT02342886|583344937|FG001|Overall Study|Pregnancy|0|||
161534844|NCT02342886|583344938|FG002|Overall Study|Pregnancy|2|||
161534845|NCT02342886|583344939|FG003|Overall Study|Pregnancy|0|||
161534846|NCT02342886|583344940|FG004|Overall Study|Pregnancy|0|||
161534847|NCT02342886|583344936|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
161534848|NCT02342886|583344937|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
161534849|NCT02342886|583344938|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
161829166|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829167|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829168|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
161829169|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829170|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829171|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829172|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829173|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
161829174|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
161829175|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829176|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
161829177|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829178|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829179|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829180|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829181|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829182|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
161829183|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829184|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
161829185|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829186|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829187|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829188|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829189|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829190|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161534850|NCT02342886|583344939|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
161534851|NCT02342886|583344940|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
161534852|NCT02342886|583344936|FG000|Overall Study|Protocol Violation|0|||
161534853|NCT02342886|583344937|FG001|Overall Study|Protocol Violation|0|||
161534854|NCT02342886|583344938|FG002|Overall Study|Protocol Violation|0|||
161534855|NCT02342886|583344939|FG003|Overall Study|Protocol Violation|2|||
161534856|NCT02342886|583344940|FG004|Overall Study|Protocol Violation|0|||
161534857|NCT00862134|583344944|FG000|Overall Study|Death|1|||
161534858|NCT00862134|583344945|FG001|Overall Study|Death|0|||
161534859|NCT00862134|583344944|FG000|Overall Study|Physician Decision|0|||
161534860|NCT00862134|583344945|FG001|Overall Study|Physician Decision|1|||
161534861|NCT00862134|583344944|FG000|Overall Study|Withdrawal by Subject|1|||
161534862|NCT00862134|583344945|FG001|Overall Study|Withdrawal by Subject|2|||
161534863|NCT00862134|583344944|FG000|Overall Study|Sponsor terminated study|5|||
161534864|NCT00862134|583344945|FG001|Overall Study|Sponsor terminated study|7|||
161534865|NCT00862134|583344944|FG000|Overall Study|Adverse Event|2|||
161534866|NCT00862134|583344945|FG001|Overall Study|Adverse Event|2|||
161534867|NCT00862134|583344944|FG000|Overall Study|Withdrew prior to dosing|2|||
161534868|NCT00862134|583344945|FG001|Overall Study|Withdrew prior to dosing|0|||
161534869|NCT00765674|583344946|FG000|Overall Study|Adverse Event|7|||
161534870|NCT00765674|583344947|FG001|Overall Study|Adverse Event|2|||
161534871|NCT00765674|583344948|FG002|Overall Study|Adverse Event|8|||
161534872|NCT00765674|583344949|FG003|Overall Study|Adverse Event|11|||
161534873|NCT00765674|583344946|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
161534874|NCT00765674|583344947|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
161534875|NCT00765674|583344948|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
161534876|NCT00765674|583344949|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
161534877|NCT00765674|583344946|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
161534878|NCT00765674|583344947|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
161534879|NCT00765674|583344948|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
161534880|NCT00765674|583344949|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
161534881|NCT00765674|583344946|FG000|Overall Study|Lack of Efficacy|2|||
161534882|NCT00765674|583344947|FG001|Overall Study|Lack of Efficacy|3|||
161534883|NCT00765674|583344948|FG002|Overall Study|Lack of Efficacy|1|||
161534884|NCT00765674|583344949|FG003|Overall Study|Lack of Efficacy|2|||
161534885|NCT00765674|583344946|FG000|Overall Study|Protocol Violation|2|||
161534886|NCT00765674|583344947|FG001|Overall Study|Protocol Violation|0|||
161534887|NCT00765674|583344948|FG002|Overall Study|Protocol Violation|1|||
161534888|NCT00765674|583344949|FG003|Overall Study|Protocol Violation|0|||
161534889|NCT00765674|583344946|FG000|Overall Study|Withdrawal by Subject|5|||
161534890|NCT00765674|583344947|FG001|Overall Study|Withdrawal by Subject|7|||
161534891|NCT00765674|583344948|FG002|Overall Study|Withdrawal by Subject|3|||
161534892|NCT00765674|583344949|FG003|Overall Study|Withdrawal by Subject|8|||
161534893|NCT00765674|583344946|FG000|Overall Study|Lost to Follow-up|4|||
161534894|NCT00765674|583344947|FG001|Overall Study|Lost to Follow-up|6|||
161534895|NCT00765674|583344948|FG002|Overall Study|Lost to Follow-up|2|||
161534896|NCT00765674|583344949|FG003|Overall Study|Lost to Follow-up|1|||
161534897|NCT00765674|583344946|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
161534898|NCT00765674|583344947|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
161534899|NCT00765674|583344948|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
161534900|NCT00765674|583344949|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
161534901|NCT01813474|583344950|FG000|Overall Study|Withdrawal by Subject|0|||
161534902|NCT01813474|583344951|FG001|Overall Study|Withdrawal by Subject|0|||
161534903|NCT01813474|583344952|FG002|Overall Study|Withdrawal by Subject|1|||
161534904|NCT01813474|583344950|FG000|Overall Study|Adverse Event|1|||
161534905|NCT01813474|583344951|FG001|Overall Study|Adverse Event|1|||
161534906|NCT01813474|583344952|FG002|Overall Study|Adverse Event|0|||
161534907|NCT01813474|583344950|FG000|Overall Study|Lack of Efficacy|2|||
161534908|NCT01813474|583344951|FG001|Overall Study|Lack of Efficacy|6|||
161678678|NCT00766090|583876056|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
161678679|NCT00766090|583876057|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
161534909|NCT01813474|583344952|FG002|Overall Study|Lack of Efficacy|9|||
161534910|NCT01813474|583344950|FG000|Overall Study|Death|0|||
161534911|NCT01813474|583344951|FG001|Overall Study|Death|0|||
161534912|NCT01813474|583344952|FG002|Overall Study|Death|1|||
161534913|NCT03015402|583344953|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161534914|NCT03015402|583344954|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
161534915|NCT03015402|583344953|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161534916|NCT03015402|583344954|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
161534917|NCT00316082|583344960|FG000|Overall Study|Lack of Efficacy|2|||
161534918|NCT00316082|583344961|FG001|Overall Study|Lack of Efficacy|3|||
161534919|NCT00316082|583344962|FG002|Overall Study|Lack of Efficacy|3|||
161534920|NCT00316082|583344963|FG003|Overall Study|Lack of Efficacy|4|||
161534921|NCT00316082|583344964|FG004|Overall Study|Lack of Efficacy|6|||
161534922|NCT00316082|583344960|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
161534923|NCT00316082|583344961|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
161534924|NCT00316082|583344962|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
161534925|NCT00316082|583344963|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
161534926|NCT00316082|583344964|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
161534927|NCT00316082|583344960|FG000|Overall Study|Lost to Follow-up|7|||
161534928|NCT00316082|583344961|FG001|Overall Study|Lost to Follow-up|6|||
161534929|NCT00316082|583344962|FG002|Overall Study|Lost to Follow-up|7|||
161534930|NCT00316082|583344963|FG003|Overall Study|Lost to Follow-up|8|||
161534931|NCT00316082|583344964|FG004|Overall Study|Lost to Follow-up|6|||
161534932|NCT00316082|583344960|FG000|Overall Study|Poor/noncompliance|6|||
161534933|NCT00316082|583344961|FG001|Overall Study|Poor/noncompliance|1|||
161534934|NCT00316082|583344962|FG002|Overall Study|Poor/noncompliance|4|||
161534935|NCT00316082|583344963|FG003|Overall Study|Poor/noncompliance|1|||
161534936|NCT00316082|583344964|FG004|Overall Study|Poor/noncompliance|4|||
161678680|NCT00766090|583876046|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161534937|NCT00316082|583344960|FG000|Overall Study|Adverse Event|4|||
161534938|NCT00316082|583344961|FG001|Overall Study|Adverse Event|2|||
161534939|NCT00316082|583344962|FG002|Overall Study|Adverse Event|5|||
161534940|NCT00316082|583344963|FG003|Overall Study|Adverse Event|1|||
161534941|NCT00316082|583344964|FG004|Overall Study|Adverse Event|3|||
161678681|NCT00766090|583876047|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161534942|NCT00316082|583344960|FG000|Overall Study|Subject no longer meets study criteria|3|||
161534943|NCT00316082|583344961|FG001|Overall Study|Subject no longer meets study criteria|1|||
161534944|NCT00316082|583344962|FG002|Overall Study|Subject no longer meets study criteria|2|||
161534945|NCT00316082|583344963|FG003|Overall Study|Subject no longer meets study criteria|2|||
161534946|NCT00316082|583344964|FG004|Overall Study|Subject no longer meets study criteria|1|||
161534947|NCT00316082|583344960|FG000|Overall Study|Physician Decision|1|||
161534948|NCT00316082|583344961|FG001|Overall Study|Physician Decision|1|||
161534949|NCT00316082|583344962|FG002|Overall Study|Physician Decision|2|||
161534950|NCT00316082|583344963|FG003|Overall Study|Physician Decision|1|||
161534951|NCT00316082|583344964|FG004|Overall Study|Physician Decision|1|||
161534952|NCT00316082|583344960|FG000|Overall Study|Death|0|||
161534953|NCT00316082|583344961|FG001|Overall Study|Death|0|||
161534954|NCT00316082|583344962|FG002|Overall Study|Death|1|||
161534955|NCT00316082|583344963|FG003|Overall Study|Death|0|||
161534956|NCT00316082|583344964|FG004|Overall Study|Death|0|||
161534957|NCT00316082|583344960|FG000|Overall Study|Administrative reason by sponsor|0|||
161534958|NCT00316082|583344961|FG001|Overall Study|Administrative reason by sponsor|0|||
161534959|NCT00316082|583344962|FG002|Overall Study|Administrative reason by sponsor|1|||
161534960|NCT00316082|583344963|FG003|Overall Study|Administrative reason by sponsor|0|||
161534961|NCT00316082|583344964|FG004|Overall Study|Administrative reason by sponsor|0|||
161534962|NCT02216773|583344965|FG000|Overall Study|Disease progression|4|||
161534963|NCT02216773|583344966|FG001|Overall Study|Disease progression|2|||
161534964|NCT02216773|583344965|FG000|Overall Study|Insufficient FLRV|4|||
161534965|NCT02216773|583344966|FG001|Overall Study|Insufficient FLRV|0|||
161534966|NCT02216773|583344965|FG000|Overall Study|Abandoned|4|||
161534967|NCT02216773|583344966|FG001|Overall Study|Abandoned|3|||
161534968|NCT00528775|583344967|FG000|Overall Study|Other not specified|1|||
161534969|NCT02012491|583344980|FG000|Overall Study|Lost to Follow-up|1|||
161534970|NCT02012491|583344981|FG001|Overall Study|Lost to Follow-up|0|||
161534971|NCT02012491|583344980|FG000|Overall Study|Protocol Violation|0|||
161534972|NCT02012491|583344981|FG001|Overall Study|Protocol Violation|1|||
161534973|NCT02012491|583344980|FG000|Overall Study|Withdrawal by Subject|1|||
161534974|NCT02012491|583344981|FG001|Overall Study|Withdrawal by Subject|0|||
161534975|NCT00941330|583344985|FG000|Overall Study|Other|1|||
161534976|NCT00941330|583344986|FG001|Overall Study|Other|0|||
161678682|NCT00766090|583876048|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678683|NCT00766090|583876049|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678684|NCT00766090|583876050|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678685|NCT00766090|583876051|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
161678686|NCT00766090|583876052|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678687|NCT00766090|583876053|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678688|NCT00766090|583876054|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678689|NCT00766090|583876055|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678690|NCT00766090|583876056|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678691|NCT00766090|583876057|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678692|NCT00766090|583876046|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678693|NCT00766090|583876047|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161678694|NCT00766090|583876048|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678695|NCT00766090|583876049|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161678696|NCT00766090|583876050|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678697|NCT00766090|583876051|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678698|NCT00766090|583876052|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678699|NCT00766090|583876053|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678700|NCT00766090|583876054|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678701|NCT00766090|583876055|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678702|NCT00766090|583876056|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678703|NCT00766090|583876057|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161678704|NCT00766090|583876046|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678705|NCT00766090|583876047|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678706|NCT00766090|583876048|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678707|NCT00766090|583876049|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678708|NCT00766090|583876050|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
161678709|NCT00766090|583876051|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678710|NCT00766090|583876052|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678711|NCT00766090|583876053|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678712|NCT00766090|583876054|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678713|NCT00766090|583876055|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678714|NCT00766090|583876056|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161534977|NCT00941330|583344985|FG000|Overall Study|Physician Decision|0|||
161534978|NCT00941330|583344986|FG001|Overall Study|Physician Decision|2|||
161678715|NCT00766090|583876057|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678716|NCT03024970|583876061|FG000|First Intervention|Adverse Event|1|||
161678717|NCT03024970|583876062|FG001|First Intervention|Adverse Event|0|||
161534979|NCT00541450|583344987|FG000|Phase A|Adverse Event|3|||
161534980|NCT00541450|583344988|FG001|Phase A|Adverse Event|0|||
161534981|NCT00541450|583344987|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
161534982|NCT00541450|583344988|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
161534983|NCT00541450|583344987|FG000|Phase A|Hyperglycemia|0|||
161829191|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829192|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
161829193|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829194|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829195|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829196|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829197|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829198|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829199|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829200|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
161829201|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161829202|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161534984|NCT00541450|583344988|FG001|Phase A|Hyperglycemia|1|||
161534985|NCT00541450|583344987|FG000|Phase A|Lost to Follow-up|6|||
161534986|NCT00541450|583344988|FG001|Phase A|Lost to Follow-up|4|||
161534987|NCT00541450|583344987|FG000|Phase A|Physician Decision|2|||
161534988|NCT00541450|583344988|FG001|Phase A|Physician Decision|0|||
161534989|NCT00541450|583344987|FG000|Phase A|Protocol Violation|2|||
161534990|NCT00541450|583344988|FG001|Phase A|Protocol Violation|3|||
161534991|NCT00541450|583344987|FG000|Phase A|Withdrawal by Subject|7|||
161534992|NCT00541450|583344988|FG001|Phase A|Withdrawal by Subject|7|||
161534993|NCT00541450|583344987|FG000|Phase B|Adverse Event|6|||
161534994|NCT00541450|583344988|FG001|Phase B|Adverse Event|6|||
161534995|NCT00541450|583344987|FG000|Phase B|Hyperglycemia|10|||
161534996|NCT00541450|583344988|FG001|Phase B|Hyperglycemia|9|||
161534997|NCT00541450|583344987|FG000|Phase B|Lost to Follow-up|6|||
161534998|NCT00541450|583344988|FG001|Phase B|Lost to Follow-up|4|||
161534999|NCT00541450|583344987|FG000|Phase B|Physician Decision|4|||
161535000|NCT00541450|583344988|FG001|Phase B|Physician Decision|2|||
161535001|NCT00541450|583344987|FG000|Phase B|Pregnancy|0|||
161535002|NCT00541450|583344988|FG001|Phase B|Pregnancy|1|||
161535003|NCT00541450|583344987|FG000|Phase B|Protocol Violation|3|||
161535004|NCT00541450|583344988|FG001|Phase B|Protocol Violation|3|||
161535005|NCT00541450|583344987|FG000|Phase B|Withdrawal by Subject|8|||
161535006|NCT00541450|583344988|FG001|Phase B|Withdrawal by Subject|6|||
161535007|NCT02816138|583344989|FG000|Overall Study|Adverse Event|1|||
161535008|NCT00981084|583344990|FG000|Post Intervention (Data Analysis)|poor effort|1|||
161535009|NCT00981084|583344991|FG001|Post Intervention (Data Analysis)|poor effort|1|||
161535010|NCT00981084|583344990|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
161535011|NCT00981084|583344991|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
161535012|NCT01112579|583344992|FG000|Overall Study|Missed Visit|1|||
161535013|NCT01112579|583344993|FG001|Overall Study|Missed Visit|1|||
161535014|NCT01112579|583344992|FG000|Overall Study|Death|0|||
161591882|NCT02120456|583556600|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161591883|NCT02120456|583556601|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161591884|NCT02120456|583556602|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161591885|NCT02120456|583556603|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161829203|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161829204|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161829205|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
161829206|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
161829207|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
161535015|NCT01112579|583344993|FG001|Overall Study|Death|2|||
161535016|NCT01648270|583344994|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
161535017|NCT00818753|583344995|FG000|Overall Study|Protocol Violation|1|||
161535018|NCT00818753|583344996|FG001|Overall Study|Protocol Violation|0|||
161535019|NCT00818753|583344997|FG002|Overall Study|Protocol Violation|0|||
161535020|NCT00818753|583344995|FG000|Overall Study|Other reason (not specified)|0|||
161535021|NCT00818753|583344996|FG001|Overall Study|Other reason (not specified)|0|||
161535022|NCT00818753|583344997|FG002|Overall Study|Other reason (not specified)|1|||
161535023|NCT00818753|583344995|FG000|Overall Study|Randomised and not treated|2|||
161535024|NCT00818753|583344996|FG001|Overall Study|Randomised and not treated|0|||
161535025|NCT00818753|583344997|FG002|Overall Study|Randomised and not treated|0|||
161535026|NCT01389973|583344998|FG000|Overall Study|Lost to Follow-up|1|||
161535027|NCT01389973|583344998|FG000|Overall Study|Trial Stopped by Sponsor|9|||
161535028|NCT01389973|583344998|FG000|Overall Study|Other|10|||
161535029|NCT00725296|583344999|FG000|Overall Study|Adverse Event|11|||
161535030|NCT00725296|583344999|FG000|Overall Study|Lack of Efficacy|7|||
161535031|NCT00725296|583344999|FG000|Overall Study|Withdrawal by Subject|3|||
161535032|NCT00725296|583344999|FG000|Overall Study|Non-Compliance|2|||
161535033|NCT00725296|583344999|FG000|Overall Study|Lost to Follow-up|1|||
161535034|NCT00725296|583344999|FG000|Overall Study|Other|38|||
161535035|NCT03360942|583345000|FG000|Overall Study|Device explanted|2|||
161535036|NCT03360942|583345000|FG000|Overall Study|Study closure|1|||
161535037|NCT03360942|583345000|FG000|Overall Study|Withdrawal by Subject|2|||
161535038|NCT03456700|583345001|FG000|Overall Study|Withdrawal by Subject|1|||
161535039|NCT00613951|583345005|FG000|Overall Study|Adverse Event|1|||
161535040|NCT00613951|583345006|FG001|Overall Study|Adverse Event|0|||
161535041|NCT00613951|583345007|FG002|Overall Study|Adverse Event|1|||
161535042|NCT00613951|583345005|FG000|Overall Study|Lack of Efficacy|0|||
161535043|NCT00613951|583345006|FG001|Overall Study|Lack of Efficacy|1|||
161535044|NCT00613951|583345007|FG002|Overall Study|Lack of Efficacy|1|||
161535045|NCT00613951|583345005|FG000|Overall Study|Protocol Violation|1|||
161535046|NCT00613951|583345006|FG001|Overall Study|Protocol Violation|1|||
161535047|NCT00613951|583345007|FG002|Overall Study|Protocol Violation|1|||
161535048|NCT00613951|583345005|FG000|Overall Study|Unclassified|5|||
161535049|NCT00613951|583345006|FG001|Overall Study|Unclassified|3|||
161535050|NCT00613951|583345007|FG002|Overall Study|Unclassified|2|||
161535051|NCT03053050|583345008|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
161535052|NCT03053050|583345009|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
161535053|NCT03053050|583345010|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
161535054|NCT03053050|583345011|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
161535055|NCT03053050|583345008|FG000|Randomized Phase|Withdrew Consent|16|||
161535056|NCT03053050|583345009|FG001|Randomized Phase|Withdrew Consent|8|||
161535057|NCT03053050|583345010|FG002|Randomized Phase|Withdrew Consent|9|||
161535058|NCT03053050|583345011|FG003|Randomized Phase|Withdrew Consent|0|||
161535059|NCT03053050|583345008|FG000|Randomized Phase|Investigator's Discretion|6|||
161535060|NCT03053050|583345009|FG001|Randomized Phase|Investigator's Discretion|6|||
161535061|NCT03053050|583345010|FG002|Randomized Phase|Investigator's Discretion|3|||
161535062|NCT03053050|583345011|FG003|Randomized Phase|Investigator's Discretion|0|||
161535063|NCT03053050|583345008|FG000|Randomized Phase|Lost to Follow-up|5|||
161535064|NCT03053050|583345009|FG001|Randomized Phase|Lost to Follow-up|1|||
161535065|NCT03053050|583345010|FG002|Randomized Phase|Lost to Follow-up|1|||
161535066|NCT03053050|583345011|FG003|Randomized Phase|Lost to Follow-up|0|||
161535067|NCT03053050|583345008|FG000|Randomized Phase|Adverse Event|0|||
161535068|NCT03053050|583345009|FG001|Randomized Phase|Adverse Event|1|||
161535069|NCT03053050|583345010|FG002|Randomized Phase|Adverse Event|0|||
161535070|NCT03053050|583345011|FG003|Randomized Phase|Adverse Event|0|||
161535071|NCT03053050|583345008|FG000|Randomized Phase|Randomized but Never Treated|2|||
161535072|NCT03053050|583345009|FG001|Randomized Phase|Randomized but Never Treated|2|||
161535073|NCT03053050|583345010|FG002|Randomized Phase|Randomized but Never Treated|2|||
161535074|NCT03053050|583345011|FG003|Randomized Phase|Randomized but Never Treated|0|||
161535075|NCT03053050|583345008|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
161535076|NCT03053050|583345009|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
161535077|NCT03053050|583345010|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
161535078|NCT03053050|583345011|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
161535079|NCT03053050|583345008|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
161535080|NCT03053050|583345009|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
161535081|NCT03053050|583345010|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
161535082|NCT03053050|583345011|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
161535083|NCT03053050|583345008|FG000|Open-label Phase|Withdrew Consent|0|||
161535084|NCT03053050|583345009|FG001|Open-label Phase|Withdrew Consent|0|||
161535085|NCT03053050|583345010|FG002|Open-label Phase|Withdrew Consent|0|||
161535086|NCT03053050|583345011|FG003|Open-label Phase|Withdrew Consent|6|||
161535087|NCT03053050|583345008|FG000|Open-label Phase|Investigator's Discretion|0|||
161535088|NCT03053050|583345009|FG001|Open-label Phase|Investigator's Discretion|0|||
161535089|NCT03053050|583345010|FG002|Open-label Phase|Investigator's Discretion|0|||
161535090|NCT03053050|583345011|FG003|Open-label Phase|Investigator's Discretion|4|||
161535091|NCT00655980|583345012|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
161535092|NCT00655980|583345013|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
161535093|NCT00655980|583345014|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
161535094|NCT01553318|583346248|FG000|Overall Study|Protocol Violation|3|||
161535095|NCT01553318|583346249|FG001|Overall Study|Protocol Violation|2|||
161535096|NCT02293395|583346250|FG000|Overall Study|Lost to Follow-up|1|||
161535097|NCT02293395|583346251|FG001|Overall Study|Lost to Follow-up|0|||
161535098|NCT02293395|583346250|FG000|Overall Study|Withdrawal by Subject|8|||
161535099|NCT02293395|583346251|FG001|Overall Study|Withdrawal by Subject|7|||
161535100|NCT01464021|583346252|FG000|Overall Study|Withdrawal by Subject|13|||
161535101|NCT01464021|583346252|FG000|Overall Study|Lost to Follow-up|1|||
161535102|NCT01464021|583346252|FG000|Overall Study|Lack of Efficacy|1|||
161829208|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829209|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829210|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829211|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829212|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829213|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829214|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829215|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
161829216|NCT04039919|584415715|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161829217|NCT04039919|584415716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161829218|NCT04039919|584415717|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161535103|NCT01464021|583346252|FG000|Overall Study|various|11|||
161535104|NCT00224770|583346258|FG000|Overall Study|Lost to Follow-up|4|||
161535105|NCT00224770|583346259|FG001|Overall Study|Lost to Follow-up|2|||
161535106|NCT00224770|583346260|FG002|Overall Study|Lost to Follow-up|0|||
161535107|NCT01106430|583346261|FG000|Overall Study|Adverse Event|8|||
161535108|NCT01106430|583346262|FG001|Overall Study|Adverse Event|10|||
161535109|NCT01106430|583346261|FG000|Overall Study|Lack of Efficacy|2|||
161535110|NCT01106430|583346262|FG001|Overall Study|Lack of Efficacy|13|||
161535111|NCT01106430|583346261|FG000|Overall Study|Lost to Follow-up|5|||
161535112|NCT01106430|583346262|FG001|Overall Study|Lost to Follow-up|1|||
161535113|NCT01106430|583346261|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
161535114|NCT01106430|583346262|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
161535115|NCT01106430|583346261|FG000|Overall Study|Moved Out Of State|0|||
161829219|NCT04039919|584415718|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161829220|NCT04039919|584415719|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161829221|NCT04039919|584415715|FG000|Treatment Period 1|Sponsor's decision|0|||
161829222|NCT04039919|584415716|FG001|Treatment Period 1|Sponsor's decision|0|||
161829223|NCT04039919|584415717|FG002|Treatment Period 1|Sponsor's decision|0|||
161829224|NCT04039919|584415718|FG003|Treatment Period 1|Sponsor's decision|0|||
161829225|NCT04039919|584415719|FG004|Treatment Period 1|Sponsor's decision|16|||
161829226|NCT04039919|584415715|FG000|Treatment Period 5|Withdrawal by Subject|1|||
161829227|NCT04039919|584415716|FG001|Treatment Period 5|Withdrawal by Subject|0|||
161829228|NCT04039919|584415717|FG002|Treatment Period 5|Withdrawal by Subject|0|||
161829229|NCT04039919|584415718|FG003|Treatment Period 5|Withdrawal by Subject|0|||
161829230|NCT04039919|584415719|FG004|Treatment Period 5|Withdrawal by Subject|0|||
161535116|NCT01106430|583346262|FG001|Overall Study|Moved Out Of State|1|||
161829231|NCT03250299|584415727|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
161535117|NCT01106430|583346261|FG000|Overall Study|Refused To Take Medication|0|||
161535118|NCT01106430|583346262|FG001|Overall Study|Refused To Take Medication|1|||
161535119|NCT01106430|583346261|FG000|Overall Study|Noncompliance|0|||
161829232|NCT03250299|584415728|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
161829233|NCT03250299|584415729|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
161829234|NCT03250299|584415730|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
161829235|NCT03250299|584415731|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
161535120|NCT01106430|583346262|FG001|Overall Study|Noncompliance|1|||
161535121|NCT01106430|583346261|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
161829236|NCT03250299|584415727|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
161535122|NCT01106430|583346262|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
161535123|NCT01106430|583346261|FG000|Overall Study|Previous Use Of Marijuana|1|||
161535124|NCT01106430|583346262|FG001|Overall Study|Previous Use Of Marijuana|0|||
161535125|NCT01106430|583346261|FG000|Overall Study|Protocol Violation|7|||
161535126|NCT01106430|583346262|FG001|Overall Study|Protocol Violation|2|||
161535127|NCT01106430|583346261|FG000|Overall Study|Withdrawal by Subject|8|||
161535128|NCT01106430|583346262|FG001|Overall Study|Withdrawal by Subject|4|||
161535129|NCT00437645|583346263|FG000|Overall Study|Adverse Event|15|||
161535130|NCT00437645|583346264|FG001|Overall Study|Adverse Event|84|||
161535131|NCT00437645|583346263|FG000|Overall Study|Withdrawal by Subject|10|||
161535132|NCT00437645|583346264|FG001|Overall Study|Withdrawal by Subject|22|||
161535133|NCT00437645|583346263|FG000|Overall Study|Protocol Violation|3|||
161535134|NCT00437645|583346264|FG001|Overall Study|Protocol Violation|3|||
161535135|NCT00437645|583346263|FG000|Overall Study|Lost to Follow-up|2|||
161535136|NCT00437645|583346264|FG001|Overall Study|Lost to Follow-up|3|||
161535137|NCT00437645|583346263|FG000|Overall Study|Administrative problems|2|||
161535138|NCT00437645|583346264|FG001|Overall Study|Administrative problems|1|||
161535139|NCT00437645|583346263|FG000|Overall Study|Lack of Efficacy|2|||
161535140|NCT00437645|583346264|FG001|Overall Study|Lack of Efficacy|1|||
161535141|NCT00437645|583346263|FG000|Overall Study|Condition no longer requires study drug|1|||
161535142|NCT00437645|583346264|FG001|Overall Study|Condition no longer requires study drug|1|||
161535143|NCT00989092|583346269|FG000|Overall Study|Physician Decision|9|||
161535144|NCT00989092|583346270|FG001|Overall Study|Physician Decision|6|||
161535145|NCT00989092|583346269|FG000|Overall Study|Adverse Event|20|||
161535146|NCT00989092|583346270|FG001|Overall Study|Adverse Event|1|||
161535147|NCT00989092|583346269|FG000|Overall Study|Chemotherapy initiated|12|||
161535148|NCT00989092|583346270|FG001|Overall Study|Chemotherapy initiated|4|||
161535149|NCT00989092|583346269|FG000|Overall Study|Withdrawal by Subject|17|||
161535150|NCT00989092|583346270|FG001|Overall Study|Withdrawal by Subject|9|||
161535151|NCT00989092|583346269|FG000|Overall Study|Death|14|||
161535152|NCT00989092|583346270|FG001|Overall Study|Death|2|||
161535153|NCT00989092|583346269|FG000|Overall Study|Ineligibility determined|3|||
161535154|NCT00989092|583346270|FG001|Overall Study|Ineligibility determined|3|||
161535155|NCT00989092|583346269|FG000|Overall Study|Lost to Follow-up|6|||
161535156|NCT00989092|583346270|FG001|Overall Study|Lost to Follow-up|2|||
161535157|NCT00989092|583346269|FG000|Overall Study|Other|3|||
161535158|NCT00989092|583346270|FG001|Overall Study|Other|1|||
161535159|NCT00989092|583346269|FG000|Overall Study|Protocol deviation|2|||
161535160|NCT00989092|583346270|FG001|Overall Study|Protocol deviation|0|||
161535161|NCT00989092|583346269|FG000|Overall Study|Erythropoietin therapy initiated|2|||
161535162|NCT00989092|583346270|FG001|Overall Study|Erythropoietin therapy initiated|0|||
161535163|NCT00989092|583346269|FG000|Overall Study|Did not receive study drug|2|||
161535164|NCT00989092|583346270|FG001|Overall Study|Did not receive study drug|0|||
161535165|NCT02127372|583346275|FG000|Overall Study|Withdrawal by Subject|1|||
161535166|NCT02127372|583346276|FG001|Overall Study|Withdrawal by Subject|0|||
161535167|NCT03837509|583346277|FG000|Phase 1|Death|5|||
161535168|NCT03837509|583346278|FG001|Phase 1|Death|2|||
161535169|NCT03837509|583346279|FG002|Phase 1|Death|0|||
161535170|NCT03837509|583346280|FG003|Phase 1|Death|0|||
161535171|NCT03837509|583346281|FG004|Phase 1|Death|0|||
161535172|NCT03837509|583346277|FG000|Phase 2|Death|0|||
161535173|NCT03837509|583346278|FG001|Phase 2|Death|0|||
161535174|NCT03837509|583346279|FG002|Phase 2|Death|0|||
161535175|NCT03837509|583346280|FG003|Phase 2|Death|1|||
161535176|NCT03837509|583346281|FG004|Phase 2|Death|1|||
161535177|NCT01113502|583346286|FG000|Overall Study|Withdrawal by Subject|1|||
161535178|NCT01113502|583346287|FG001|Overall Study|Withdrawal by Subject|0|||
161829237|NCT03250299|584415728|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
161829238|NCT03250299|584415729|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
161535179|NCT01113502|583346288|FG002|Overall Study|Withdrawal by Subject|1|||
161535180|NCT01113502|583346289|FG003|Overall Study|Withdrawal by Subject|1|||
161535181|NCT01113502|583346290|FG004|Overall Study|Withdrawal by Subject|0|||
161535182|NCT01113502|583346286|FG000|Overall Study|Adverse Event|0|||
161535183|NCT01113502|583346287|FG001|Overall Study|Adverse Event|0|||
161535184|NCT01113502|583346288|FG002|Overall Study|Adverse Event|3|||
161535185|NCT01113502|583346289|FG003|Overall Study|Adverse Event|2|||
161535186|NCT01113502|583346290|FG004|Overall Study|Adverse Event|0|||
161535187|NCT03802123|583346293|FG000|Overall Study|Withdrawal by Subject|3|||
161535188|NCT03802123|583346293|FG000|Overall Study|Physician Decision|1|||
161535189|NCT03802123|583346293|FG000|Overall Study|Subject moved to hospice care|1|||
161535190|NCT03802123|583346293|FG000|Overall Study|technician error|1|||
161535191|NCT03802123|583346293|FG000|Overall Study|Death|3|||
161535192|NCT04555096|583346295|FG000|Overall Study|Death|4|||
161829239|NCT03250299|584415730|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
161535193|NCT04555096|583346296|FG001|Overall Study|Death|4|||
161829240|NCT03250299|584415731|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
161829241|NCT03250299|584415727|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829242|NCT03250299|584415728|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829243|NCT03250299|584415729|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
161829244|NCT03250299|584415730|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829245|NCT03250299|584415731|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829246|NCT03250299|584415727|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
161829247|NCT03250299|584415728|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
161829248|NCT03250299|584415729|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
161829249|NCT03250299|584415730|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
161829250|NCT03250299|584415731|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
161829251|NCT03346070|584415732|FG000|Overall Study|Death|0|||
161535194|NCT04555096|583346295|FG000|Overall Study|Withdrawal by Subject|1|||
161535195|NCT04555096|583346296|FG001|Overall Study|Withdrawal by Subject|0|||
161535196|NCT04555096|583346295|FG000|Overall Study|Other|0|||
161535197|NCT04555096|583346296|FG001|Overall Study|Other|1|||
161535198|NCT06134180|583346298|FG000|Overall Study|Lost to Follow-up|4|||
161535199|NCT01362439|583346299|FG000|Overall Study|Adverse Event|1|||
161535200|NCT01362439|583346299|FG000|Overall Study|Lack of Efficacy|3|||
161535201|NCT01362439|583346299|FG000|Overall Study|Lost to Follow-up|2|||
161535202|NCT01362439|583346299|FG000|Overall Study|Study medication non-compliant|1|||
161535203|NCT01362439|583346299|FG000|Overall Study|Participant who withdrew consent|8|||
161535204|NCT03575325|583346303|FG000|Overall Study|Death|1|||
161535205|NCT03440372|583346304|FG000|Treatment|Adverse Event|16|||
161535206|NCT03440372|583346305|FG001|Treatment|Adverse Event|8|||
161535207|NCT03440372|583346304|FG000|Treatment|Lack of Efficacy|4|||
161535208|NCT03440372|583346305|FG001|Treatment|Lack of Efficacy|2|||
161535209|NCT03440372|583346304|FG000|Treatment|Withdrawal by Subject|12|||
161535210|NCT03440372|583346305|FG001|Treatment|Withdrawal by Subject|8|||
161535211|NCT03440372|583346304|FG000|Treatment|Lost to Follow-up|1|||
161535212|NCT03440372|583346305|FG001|Treatment|Lost to Follow-up|0|||
161535213|NCT03440372|583346304|FG000|Treatment|Pregnancy|1|||
161535214|NCT03440372|583346305|FG001|Treatment|Pregnancy|0|||
161535215|NCT03440372|583346304|FG000|Treatment|Study Terminated by Sponsor|2|||
161535216|NCT03440372|583346305|FG001|Treatment|Study Terminated by Sponsor|1|||
161535217|NCT03440372|583346304|FG000|Treatment|Other Reason|2|||
161535218|NCT03440372|583346305|FG001|Treatment|Other Reason|3|||
161535219|NCT05711641|583346306|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
161535220|NCT05711641|583346307|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
161535221|NCT05711641|583346306|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
161535222|NCT05711641|583346307|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
161535223|NCT03574597|583346308|FG000|Overall Study|Withdrawal by Subject|67|||
161535224|NCT03574597|583346309|FG001|Overall Study|Withdrawal by Subject|96|||
161535225|NCT03574597|583346308|FG000|Overall Study|Lost to Follow-up|192|||
161535226|NCT03574597|583346309|FG001|Overall Study|Lost to Follow-up|188|||
161535227|NCT03804710|583346310|FG000|Overall Study|Adverse Event|0|||
161535228|NCT03804710|583346311|FG001|Overall Study|Adverse Event|3|||
161535229|NCT03804710|583346310|FG000|Overall Study|Withdrawal by Subject|2|||
161535230|NCT03804710|583346311|FG001|Overall Study|Withdrawal by Subject|1|||
161535231|NCT03804710|583346310|FG000|Overall Study|Other|0|||
161535232|NCT03804710|583346311|FG001|Overall Study|Other|1|||
161535233|NCT04542018|583346312|FG000|Overall Study|Withdrawal by Subject|0|||
161535234|NCT04542018|583346313|FG001|Overall Study|Withdrawal by Subject|0|||
161535235|NCT04542018|583346314|FG002|Overall Study|Withdrawal by Subject|4|||
161535236|NCT04542018|583346312|FG000|Overall Study|Protocol Violation|0|||
161535237|NCT04542018|583346313|FG001|Overall Study|Protocol Violation|0|||
161535238|NCT04542018|583346314|FG002|Overall Study|Protocol Violation|2|||
161535239|NCT03583554|583346315|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
161535240|NCT03583554|583346316|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
161535241|NCT03583554|583346317|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
161535242|NCT03178266|583346318|FG000|Overall Study|Death|0|||
161535243|NCT03178266|583346319|FG001|Overall Study|Death|1|||
161535244|NCT03178266|583346318|FG000|Overall Study|Disont. Early|0|||
161535245|NCT03178266|583346319|FG001|Overall Study|Disont. Early|1|||
161535246|NCT03178266|583346318|FG000|Overall Study|Withdrawal by Subject|0|||
161535247|NCT03178266|583346319|FG001|Overall Study|Withdrawal by Subject|2|||
161535248|NCT01596582|583346331|FG000|Overall Study|Deemed ineligible after study visit|3|||
161535249|NCT01596582|583346332|FG001|Overall Study|Deemed ineligible after study visit|6|||
161535250|NCT01596582|583346331|FG000|Overall Study|Missing all outcome data|1|||
161535251|NCT01596582|583346332|FG001|Overall Study|Missing all outcome data|1|||
161535252|NCT02454101|583346336|FG000|Overall Study|Adverse Event|2|||
161829252|NCT03346070|584415733|FG001|Overall Study|Death|0|||
161829253|NCT03346070|584415734|FG002|Overall Study|Death|0|||
161829254|NCT03346070|584415735|FG003|Overall Study|Death|0|||
161535253|NCT02454101|583346337|FG001|Overall Study|Adverse Event|3|||
161535254|NCT02454101|583346336|FG000|Overall Study|Lost to Follow-up|3|||
161535255|NCT02454101|583346337|FG001|Overall Study|Lost to Follow-up|4|||
161535256|NCT02124265|583346338|FG000|Overall Study|Adverse Event|1|||
161535257|NCT00058123|583346340|FG000|Overall Study|Wrong histology|9|||
161535258|NCT00058123|583346340|FG000|Overall Study|Received >3 prior treatments|1|||
161535259|NCT01667432|583346343|FG000|Overall Study|Premature Study Termination|26|||
161535260|NCT01667432|583346343|FG000|Overall Study|Failure to Return|10|||
161535261|NCT01667432|583346343|FG000|Overall Study|Moved to Another Center|3|||
161535262|NCT01667432|583346343|FG000|Overall Study|Lost to Follow-up|3|||
161535263|NCT01667432|583346343|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
161535264|NCT01667432|583346343|FG000|Overall Study|Insufficient Therapeutic Response|4|||
161535265|NCT01667432|583346343|FG000|Overall Study|Adverse Event|1|||
161535266|NCT01667432|583346343|FG000|Overall Study|Protocol Deviation|2|||
161535267|NCT01667432|583346343|FG000|Overall Study|Principal Investigator Decision|1|||
161535268|NCT01667432|583346343|FG000|Overall Study|Reason Not Specified|2|||
161535269|NCT01667432|583346343|FG000|Overall Study|Missing Information|4|||
161535270|NCT00344461|583346344|FG000|Overall Study|Adverse Event|6|||
161535271|NCT00344461|583346344|FG000|Overall Study|Death|1|||
161535272|NCT00344461|583346344|FG000|Overall Study|Lack of Efficacy|2|||
161535273|NCT00344461|583346344|FG000|Overall Study|Lost to Follow-up|2|||
161535274|NCT00344461|583346344|FG000|Overall Study|Physician Decision|2|||
161535275|NCT00344461|583346344|FG000|Overall Study|Protocol Violation|6|||
161535276|NCT00344461|583346344|FG000|Overall Study|Withdrawal by Subject|2|||
161535277|NCT00553696|583346353|FG000|Overall Study|Adverse Event|2|||
161535278|NCT00553696|583346354|FG001|Overall Study|Adverse Event|4|||
161535279|NCT00553696|583346355|FG002|Overall Study|Adverse Event|0|||
161535280|NCT00553696|583346356|FG003|Overall Study|Adverse Event|1|||
161535281|NCT00553696|583346353|FG000|Overall Study|Global deterioration of health status|0|||
161535282|NCT00553696|583346354|FG001|Overall Study|Global deterioration of health status|2|||
161535283|NCT00553696|583346355|FG002|Overall Study|Global deterioration of health status|0|||
161535284|NCT00553696|583346356|FG003|Overall Study|Global deterioration of health status|0|||
161535285|NCT00553696|583346353|FG000|Overall Study|Objective progression or relapse|2|||
161535286|NCT00553696|583346354|FG001|Overall Study|Objective progression or relapse|9|||
161591886|NCT02120456|583556604|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161591887|NCT02120456|583556605|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161591888|NCT02120456|583556606|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
161591889|NCT05192200|583556607|FG000|Treatment Period|Other|1|||
161591890|NCT05192200|583556607|FG000|Treatment Period|Lack of Efficacy|1|||
161591891|NCT05192200|583556607|FG000|Treatment Period|Withdrawal by Subject|1|||
161591892|NCT05192200|583556607|FG000|Follow-up|Withdrawal by Subject|1|||
161591893|NCT03443323|583556610|FG000|Overall Study|Lost to Follow-up|2|||
161591894|NCT03443323|583556611|FG001|Overall Study|Lost to Follow-up|2|||
161591895|NCT03443323|583556610|FG000|Overall Study|PI withdrawal|1|||
161591896|NCT03443323|583556611|FG001|Overall Study|PI withdrawal|0|||
161591897|NCT04492007|583556612|FG000|Overall Study|Lost to Follow-up|1|||
161591898|NCT04492007|583556613|FG001|Overall Study|Lost to Follow-up|1|||
161591899|NCT04492007|583556614|FG002|Overall Study|Lost to Follow-up|2|||
161591900|NCT04492007|583556615|FG003|Overall Study|Lost to Follow-up|2|||
161591901|NCT04492007|583556612|FG000|Overall Study|Protocol Violation|1|||
161591902|NCT04492007|583556613|FG001|Overall Study|Protocol Violation|1|||
161591903|NCT04492007|583556614|FG002|Overall Study|Protocol Violation|1|||
161591904|NCT04492007|583556615|FG003|Overall Study|Protocol Violation|1|||
161591905|NCT04492007|583556612|FG000|Overall Study|Withdrawal by Subject|0|||
161591906|NCT04492007|583556613|FG001|Overall Study|Withdrawal by Subject|0|||
161591907|NCT04492007|583556614|FG002|Overall Study|Withdrawal by Subject|1|||
161591908|NCT04492007|583556615|FG003|Overall Study|Withdrawal by Subject|1|||
161591909|NCT03457142|583556618|FG000|Overall Study|Death|1|||
161591910|NCT03770273|583556619|FG000|Overall Study|Adverse Event|2|||
161591911|NCT03770273|583556620|FG001|Overall Study|Adverse Event|0|||
161591912|NCT03770273|583556619|FG000|Overall Study|Lost to Follow-up|1|||
161591913|NCT03770273|583556620|FG001|Overall Study|Lost to Follow-up|1|||
161591914|NCT04060654|583556621|FG000|Overall Study|Withdrawal by Subject|1|||
161591915|NCT04060654|583556621|FG000|Overall Study|Lost to Follow-up|5|||
161591916|NCT03707951|583556622|FG000|Overall Study|Lost to Follow-up|8|||
161591917|NCT03707951|583556623|FG001|Overall Study|Lost to Follow-up|17|||
161591918|NCT03707951|583556622|FG000|Overall Study|Withdrawal by Subject|6|||
161591919|NCT03707951|583556623|FG001|Overall Study|Withdrawal by Subject|6|||
161829255|NCT03346070|584415736|FG004|Overall Study|Death|1|||
161535287|NCT00553696|583346355|FG002|Overall Study|Objective progression or relapse|6|||
161591920|NCT04887129|583556624|FG000|Overall Study|Lost to Follow-up|0|||
161591921|NCT04887129|583556625|FG001|Overall Study|Lost to Follow-up|24|||
161591922|NCT04887129|583556624|FG000|Overall Study|Withdrawal by Subject|9|||
161535288|NCT00553696|583346356|FG003|Overall Study|Objective progression or relapse|0|||
161535289|NCT00553696|583346353|FG000|Overall Study|Withdrawal by Subject|0|||
161535290|NCT00553696|583346354|FG001|Overall Study|Withdrawal by Subject|1|||
161535291|NCT00553696|583346355|FG002|Overall Study|Withdrawal by Subject|0|||
161535292|NCT00553696|583346356|FG003|Overall Study|Withdrawal by Subject|0|||
161535293|NCT00686881|583346357|FG000|Overall Study|Withdrawal by Subject|11|||
161535294|NCT00686881|583346358|FG001|Overall Study|Withdrawal by Subject|18|||
161535295|NCT00686881|583346357|FG000|Overall Study|Lost to Follow-up|0|||
161535296|NCT00686881|583346358|FG001|Overall Study|Lost to Follow-up|1|||
161535297|NCT00686881|583346357|FG000|Overall Study|Treatment-related adverse event|10|||
161535298|NCT00686881|583346358|FG001|Overall Study|Treatment-related adverse event|9|||
161535299|NCT00686881|583346357|FG000|Overall Study|Met discontinuation criteria|5|||
161535300|NCT00686881|583346358|FG001|Overall Study|Met discontinuation criteria|0|||
161535301|NCT00686881|583346357|FG000|Overall Study|Onset of malignant tumor|11|||
161535302|NCT00686881|583346358|FG001|Overall Study|Onset of malignant tumor|11|||
161535303|NCT00686881|583346357|FG000|Overall Study|Lack of Efficacy|4|||
161535304|NCT00686881|583346358|FG001|Overall Study|Lack of Efficacy|3|||
161535305|NCT00686881|583346357|FG000|Overall Study|Physician Decision|1|||
161535306|NCT00686881|583346358|FG001|Overall Study|Physician Decision|0|||
161535307|NCT00686881|583346357|FG000|Overall Study|Circumstances of site|1|||
161535308|NCT00686881|583346358|FG001|Overall Study|Circumstances of site|1|||
161535309|NCT00686881|583346357|FG000|Overall Study|Did not meet protocol eligibility|1|||
161535310|NCT00686881|583346358|FG001|Overall Study|Did not meet protocol eligibility|0|||
161535311|NCT00686881|583346357|FG000|Overall Study|Irregular visits|1|||
161535312|NCT00686881|583346358|FG001|Overall Study|Irregular visits|0|||
161535313|NCT00686881|583346357|FG000|Overall Study|Study discontinuation|35|||
161535314|NCT00686881|583346358|FG001|Overall Study|Study discontinuation|32|||
161535315|NCT00686881|583346357|FG000|Overall Study|Never received study drug|2|||
161535316|NCT00686881|583346358|FG001|Overall Study|Never received study drug|6|||
161535317|NCT00671931|583346361|FG000|Overall Study|Physician Decision|1|||
161535318|NCT00671931|583346362|FG001|Overall Study|Physician Decision|0|||
161535319|NCT00671931|583346363|FG002|Overall Study|Physician Decision|0|||
161535320|NCT00671931|583346364|FG003|Overall Study|Physician Decision|2|||
161535321|NCT00671931|583346365|FG004|Overall Study|Physician Decision|1|||
161535322|NCT01298999|583346366|FG000|Overall Study|Physician Decision|0|||
161535323|NCT01298999|583346367|FG001|Overall Study|Physician Decision|1|||
161535324|NCT01298999|583346366|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
161535325|NCT01298999|583346367|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
161535326|NCT00902694|583346368|FG000|Overall Study|Death|1|||
161535327|NCT00902694|583346369|FG001|Overall Study|Death|3|||
161535328|NCT00902694|583346368|FG000|Overall Study|Lost to Follow-up|1|||
161535329|NCT00902694|583346369|FG001|Overall Study|Lost to Follow-up|0|||
161535330|NCT00902694|583346368|FG000|Overall Study|Censored per protocol|3|||
161535331|NCT00902694|583346369|FG001|Overall Study|Censored per protocol|1|||
161535332|NCT00902694|583346368|FG000|Overall Study|Pregnancy|1|||
161535333|NCT00902694|583346369|FG001|Overall Study|Pregnancy|1|||
161535334|NCT00902694|583346368|FG000|Overall Study|Incarceration|1|||
161535335|NCT00902694|583346369|FG001|Overall Study|Incarceration|0|||
161535336|NCT04969263|583346370|FG000|Overall Study|Death|1|||
161535337|NCT04969263|583346370|FG000|Overall Study|Lost to Follow-up|2|||
161535338|NCT04969263|583346370|FG000|Overall Study|Withdrawal by Subject|5|||
161535339|NCT04969263|583346370|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
161535340|NCT04154787|583346371|FG000|Overall Study|Adverse Event|0|||
161535341|NCT04154787|583346372|FG001|Overall Study|Adverse Event|1|||
161535342|NCT04154787|583346373|FG002|Overall Study|Adverse Event|0|||
161535343|NCT04154787|583346371|FG000|Overall Study|Patient Requires Other Treatment|0|||
161535344|NCT04154787|583346372|FG001|Overall Study|Patient Requires Other Treatment|1|||
161535345|NCT04154787|583346373|FG002|Overall Study|Patient Requires Other Treatment|0|||
161535346|NCT04154787|583346371|FG000|Overall Study|Study Terminated By Sponsor|0|||
161535347|NCT04154787|583346372|FG001|Overall Study|Study Terminated By Sponsor|6|||
161535348|NCT04154787|583346373|FG002|Overall Study|Study Terminated By Sponsor|1|||
161535349|NCT04154787|583346371|FG000|Overall Study|Subject Decision|0|||
161535350|NCT04154787|583346372|FG001|Overall Study|Subject Decision|1|||
161591923|NCT04887129|583556625|FG001|Overall Study|Withdrawal by Subject|57|||
161591924|NCT04887129|583556624|FG000|Overall Study|Other|2|||
161535351|NCT04154787|583346373|FG002|Overall Study|Subject Decision|0|||
161591925|NCT04887129|583556625|FG001|Overall Study|Other|9|||
161591926|NCT04533347|583556627|FG000|Overall Study|Adverse Event|1|||
161591927|NCT04533347|583556628|FG001|Overall Study|Adverse Event|2|||
161591928|NCT04533347|583556627|FG000|Overall Study|Lost to Follow-up|2|||
161591929|NCT04533347|583556628|FG001|Overall Study|Lost to Follow-up|0|||
161535352|NCT04154787|583346371|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
161535353|NCT04154787|583346372|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
161535354|NCT04154787|583346373|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
161535355|NCT02459574|583346374|FG000|Overall Study|Withdrawal by Subject|6|||
161535356|NCT02459574|583346375|FG001|Overall Study|Withdrawal by Subject|6|||
161535357|NCT02459574|583346376|FG002|Overall Study|Withdrawal by Subject|2|||
161591930|NCT04533347|583556627|FG000|Overall Study|Withdrawal by Subject|1|||
161591931|NCT04533347|583556628|FG001|Overall Study|Withdrawal by Subject|0|||
161535358|NCT02459574|583346374|FG000|Overall Study|Lost to Follow-up|1|||
161535359|NCT02459574|583346375|FG001|Overall Study|Lost to Follow-up|1|||
161535360|NCT02459574|583346376|FG002|Overall Study|Lost to Follow-up|0|||
161535361|NCT02459574|583346374|FG000|Overall Study|Death|0|||
161535362|NCT02459574|583346375|FG001|Overall Study|Death|1|||
161535363|NCT02459574|583346376|FG002|Overall Study|Death|0|||
161535364|NCT04866017|583346377|FG000|Overall Study|Study Terminated by Sponsor|13|||
161535365|NCT04866017|583346378|FG001|Overall Study|Study Terminated by Sponsor|14|||
161535366|NCT04866017|583346379|FG002|Overall Study|Study Terminated by Sponsor|13|||
161535367|NCT04866017|583346377|FG000|Overall Study|Death|8|||
161535368|NCT04866017|583346378|FG001|Overall Study|Death|4|||
161535369|NCT04866017|583346379|FG002|Overall Study|Death|8|||
161535370|NCT04866017|583346377|FG000|Overall Study|Withdrawal by Subject|1|||
161535371|NCT04866017|583346378|FG001|Overall Study|Withdrawal by Subject|0|||
161535372|NCT04866017|583346379|FG002|Overall Study|Withdrawal by Subject|1|||
161535373|NCT04866017|583346377|FG000|Overall Study|Physician Decision|0|||
161535374|NCT04866017|583346378|FG001|Overall Study|Physician Decision|1|||
161535375|NCT04866017|583346379|FG002|Overall Study|Physician Decision|0|||
161535376|NCT01266642|583346380|FG000|Overall Study|Protocol Violation|0|||
161535377|NCT01266642|583346381|FG001|Overall Study|Protocol Violation|1|||
161535378|NCT01337674|583348121|FG000|Treatment Period 1|Adverse Event|0|||
161535379|NCT01337674|583348122|FG001|Treatment Period 1|Adverse Event|1|||
161535380|NCT01337674|583348123|FG002|Treatment Period 1|Adverse Event|0|||
161535381|NCT01337674|583348124|FG003|Treatment Period 1|Adverse Event|0|||
161535382|NCT01337674|583348121|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
161535383|NCT01337674|583348122|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
161535384|NCT01337674|583348123|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
161535385|NCT01337674|583348124|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
161535386|NCT01337674|583348121|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161535387|NCT01337674|583348122|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161535388|NCT01337674|583348123|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161535389|NCT01337674|583348124|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161535390|NCT00695786|583348125|FG000|Overall Study|Adverse Event|0|||
161535391|NCT00695786|583348126|FG001|Overall Study|Adverse Event|3|||
161535392|NCT00695786|583348127|FG002|Overall Study|Adverse Event|4|||
161535393|NCT00695786|583348128|FG003|Overall Study|Adverse Event|2|||
161535394|NCT00695786|583348125|FG000|Overall Study|Lost to Follow-up|0|||
161591932|NCT05520190|583556629|FG000|Overall Study|Lost to Follow-up|7|||
161591933|NCT05520190|583556629|FG000|Overall Study|Withdrawal by Subject|2|||
161591934|NCT01999075|583556630|FG000|Overall Study|Lost to Follow-up|0|||
161591935|NCT01999075|583556631|FG001|Overall Study|Lost to Follow-up|2|||
161591936|NCT01999075|583556630|FG000|Overall Study|Withdrawal by Subject|2|||
161591937|NCT01999075|583556631|FG001|Overall Study|Withdrawal by Subject|7|||
161591938|NCT01999075|583556630|FG000|Overall Study|Enrolled in drug trial|3|||
161591939|NCT01999075|583556631|FG001|Overall Study|Enrolled in drug trial|1|||
161591940|NCT01999075|583556630|FG000|Overall Study|Became ineligible|0|||
161591941|NCT01999075|583556631|FG001|Overall Study|Became ineligible|2|||
161591942|NCT03907397|583556634|FG000|Overall Study|Lost to Follow-up|0|||
161591943|NCT03907397|583556635|FG001|Overall Study|Lost to Follow-up|1|||
161591944|NCT03907397|583556634|FG000|Overall Study|Physician Decision|2|||
161591945|NCT03907397|583556635|FG001|Overall Study|Physician Decision|1|||
161591946|NCT03907397|583556634|FG000|Overall Study|Withdrawal by Subject|5|||
161591947|NCT03907397|583556635|FG001|Overall Study|Withdrawal by Subject|4|||
161591948|NCT03907397|583556634|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
161591949|NCT03907397|583556635|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
161591950|NCT04896476|583556647|FG000|Overall Study|Withdrawal by Subject|1|||
161591951|NCT04896476|583556647|FG000|Overall Study|Lost to Follow-up|2|||
161591952|NCT03476187|583556648|FG000|Overall Study|Protocol Violation|7|||
161591953|NCT03476187|583556648|FG000|Overall Study|Physician Decision|5|||
161591954|NCT02921230|583556649|FG000|Overall Study|Withdrawal by Subject|20|||
161591955|NCT02921230|583556650|FG001|Overall Study|Withdrawal by Subject|8|||
161591956|NCT02921230|583556649|FG000|Overall Study|Death|12|||
161591957|NCT02921230|583556650|FG001|Overall Study|Death|3|||
161591958|NCT02921230|583556649|FG000|Overall Study|Protocol Violation|17|||
161535395|NCT00695786|583348126|FG001|Overall Study|Lost to Follow-up|5|||
161535396|NCT00695786|583348127|FG002|Overall Study|Lost to Follow-up|1|||
161535397|NCT00695786|583348128|FG003|Overall Study|Lost to Follow-up|1|||
161591959|NCT02921230|583556650|FG001|Overall Study|Protocol Violation|6|||
161591960|NCT02921230|583556649|FG000|Overall Study|Early completion|5|||
161591961|NCT02921230|583556650|FG001|Overall Study|Early completion|1|||
161591962|NCT02921230|583556649|FG000|Overall Study|Pending data entry|1|||
161829256|NCT03346070|584415732|FG000|Overall Study|Lost to Follow-up|0|||
161829257|NCT03346070|584415733|FG001|Overall Study|Lost to Follow-up|1|||
161535398|NCT00695786|583348125|FG000|Overall Study|Withdrawal by Subject|0|||
161535399|NCT00695786|583348126|FG001|Overall Study|Withdrawal by Subject|4|||
161535400|NCT00695786|583348127|FG002|Overall Study|Withdrawal by Subject|3|||
161535401|NCT00695786|583348128|FG003|Overall Study|Withdrawal by Subject|1|||
161829258|NCT03346070|584415734|FG002|Overall Study|Lost to Follow-up|2|||
161535402|NCT00695786|583348125|FG000|Overall Study|Deemed Ineligible|1|||
161535403|NCT00695786|583348126|FG001|Overall Study|Deemed Ineligible|0|||
161535404|NCT00695786|583348127|FG002|Overall Study|Deemed Ineligible|0|||
161535405|NCT00695786|583348128|FG003|Overall Study|Deemed Ineligible|0|||
161535406|NCT00695786|583348125|FG000|Overall Study|Lack of Efficacy|0|||
161535407|NCT00695786|583348126|FG001|Overall Study|Lack of Efficacy|0|||
161535408|NCT00695786|583348127|FG002|Overall Study|Lack of Efficacy|0|||
161535409|NCT00695786|583348128|FG003|Overall Study|Lack of Efficacy|4|||
161535410|NCT04244396|583348132|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
161535411|NCT04244396|583348132|FG000|Overall Study|Withdrawal by Subject|2|||
161535412|NCT04244396|583348132|FG000|Overall Study|Study termination|37|||
161535413|NCT01787097|583348133|FG000|Overall Study|Withdrawal by Subject|1|||
161535414|NCT01787097|583348134|FG001|Overall Study|Withdrawal by Subject|0|||
161535415|NCT01787097|583348135|FG002|Overall Study|Withdrawal by Subject|0|||
161535416|NCT01787097|583348136|FG003|Overall Study|Withdrawal by Subject|0|||
161535417|NCT00245102|583348137|FG000|Overall Study|Not Treated|1|||
161535418|NCT00245102|583348138|FG001|Overall Study|Not Treated|0|||
161535419|NCT00245102|583348139|FG002|Overall Study|Not Treated|1|||
161535420|NCT00245102|583348140|FG003|Overall Study|Not Treated|0|||
161535421|NCT00245102|583348141|FG004|Overall Study|Not Treated|0|||
161535422|NCT00245102|583348142|FG005|Overall Study|Not Treated|0|||
161535423|NCT00245102|583348137|FG000|Overall Study|Protocol Violation|1|||
161535424|NCT00245102|583348138|FG001|Overall Study|Protocol Violation|0|||
161535425|NCT00245102|583348139|FG002|Overall Study|Protocol Violation|0|||
161535426|NCT00245102|583348140|FG003|Overall Study|Protocol Violation|0|||
161535427|NCT00245102|583348141|FG004|Overall Study|Protocol Violation|0|||
161535428|NCT00245102|583348142|FG005|Overall Study|Protocol Violation|0|||
161535429|NCT00245102|583348137|FG000|Overall Study|Death|0|||
161591963|NCT02921230|583556650|FG001|Overall Study|Pending data entry|0|||
161591964|NCT04274764|583556651|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
161591965|NCT04274764|583556652|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
161591966|NCT04142788|583556657|FG000|Overall Study|Trial terminated prematurely|2|||
161591967|NCT04142788|583556658|FG001|Overall Study|Trial terminated prematurely|2|||
161591968|NCT05268393|583556662|FG000|Overall Study|Withdrawal by Subject|2|||
161591969|NCT05268393|583556663|FG001|Overall Study|Withdrawal by Subject|1|||
161591970|NCT03396926|583556664|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
161591971|NCT03396926|583556665|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
161591972|NCT02035787|583556666|FG000|Overall Study- 12 Months|Adverse Event|3|||
161591973|NCT02035787|583556667|FG001|Overall Study- 12 Months|Adverse Event|0|||
161591974|NCT02035787|583556666|FG000|Overall Study- 12 Months|Complete response|4|||
161829259|NCT03346070|584415735|FG003|Overall Study|Lost to Follow-up|0|||
161535430|NCT00245102|583348138|FG001|Overall Study|Death|0|||
161535431|NCT00245102|583348139|FG002|Overall Study|Death|0|||
161535432|NCT00245102|583348140|FG003|Overall Study|Death|1|||
161535433|NCT00245102|583348141|FG004|Overall Study|Death|0|||
161535434|NCT00245102|583348142|FG005|Overall Study|Death|0|||
161535435|NCT00245102|583348137|FG000|Overall Study|Adverse Event|4|||
161535436|NCT00245102|583348138|FG001|Overall Study|Adverse Event|2|||
161535437|NCT00245102|583348139|FG002|Overall Study|Adverse Event|5|||
161535438|NCT00245102|583348140|FG003|Overall Study|Adverse Event|1|||
161535439|NCT00245102|583348141|FG004|Overall Study|Adverse Event|0|||
161535440|NCT00245102|583348142|FG005|Overall Study|Adverse Event|2|||
161535441|NCT00245102|583348137|FG000|Overall Study|Decline in performance|0|||
161535442|NCT00245102|583348138|FG001|Overall Study|Decline in performance|2|||
161535443|NCT00245102|583348139|FG002|Overall Study|Decline in performance|0|||
161535444|NCT00245102|583348140|FG003|Overall Study|Decline in performance|1|||
161535445|NCT00245102|583348141|FG004|Overall Study|Decline in performance|0|||
161535446|NCT00245102|583348142|FG005|Overall Study|Decline in performance|2|||
161535447|NCT00245102|583348137|FG000|Overall Study|Participant needed surgery|0|||
161535448|NCT00245102|583348138|FG001|Overall Study|Participant needed surgery|0|||
161535449|NCT00245102|583348139|FG002|Overall Study|Participant needed surgery|1|||
161535450|NCT00245102|583348140|FG003|Overall Study|Participant needed surgery|0|||
161535451|NCT00245102|583348141|FG004|Overall Study|Participant needed surgery|0|||
161535452|NCT00245102|583348142|FG005|Overall Study|Participant needed surgery|0|||
161535453|NCT00245102|583348137|FG000|Overall Study|Clinical progression|1|||
161535454|NCT00245102|583348138|FG001|Overall Study|Clinical progression|0|||
161535455|NCT00245102|583348139|FG002|Overall Study|Clinical progression|0|||
161535456|NCT00245102|583348140|FG003|Overall Study|Clinical progression|0|||
161535457|NCT00245102|583348141|FG004|Overall Study|Clinical progression|0|||
161535458|NCT00245102|583348142|FG005|Overall Study|Clinical progression|0|||
161535459|NCT00289887|583348143|FG000|Overall Study|Adverse Event|3|||
161535460|NCT00289887|583348144|FG001|Overall Study|Adverse Event|3|||
161535461|NCT00289887|583348143|FG000|Overall Study|Lack of Efficacy|3|||
161535462|NCT00289887|583348144|FG001|Overall Study|Lack of Efficacy|11|||
161535463|NCT00289887|583348143|FG000|Overall Study|Lost to Follow-up|3|||
161535464|NCT00289887|583348144|FG001|Overall Study|Lost to Follow-up|3|||
161535465|NCT00289887|583348143|FG000|Overall Study|Protocol Violation|3|||
161535466|NCT00289887|583348144|FG001|Overall Study|Protocol Violation|1|||
161535467|NCT00289887|583348143|FG000|Overall Study|Withdrawal by Subject|3|||
161535468|NCT00289887|583348144|FG001|Overall Study|Withdrawal by Subject|8|||
161535469|NCT00289887|583348143|FG000|Overall Study|Other|7|||
161535470|NCT00289887|583348144|FG001|Overall Study|Other|3|||
161535471|NCT02472652|583348151|FG000|Overall Study|Lost to Follow-up|1|||
161535472|NCT03185832|583348152|FG000|Overall Study|Death|9|||
161591975|NCT02035787|583556667|FG001|Overall Study- 12 Months|Complete response|1|||
161591976|NCT02035787|583556666|FG000|Overall Study- 12 Months|Protocol Violation|1|||
161591977|NCT02035787|583556667|FG001|Overall Study- 12 Months|Protocol Violation|1|||
161591978|NCT01396278|583556669|FG000|Overall Study|Adverse Event|0|||
161591979|NCT01396278|583556670|FG001|Overall Study|Adverse Event|0|||
161591980|NCT01396278|583556671|FG002|Overall Study|Adverse Event|0|||
161591981|NCT01396278|583556672|FG003|Overall Study|Adverse Event|2|||
161591982|NCT01396278|583556673|FG004|Overall Study|Adverse Event|0|||
161591983|NCT01396278|583556669|FG000|Overall Study|Withdraw due to trial termination|2|||
161591984|NCT01396278|583556670|FG001|Overall Study|Withdraw due to trial termination|1|||
161591985|NCT01396278|583556671|FG002|Overall Study|Withdraw due to trial termination|1|||
161591986|NCT01396278|583556672|FG003|Overall Study|Withdraw due to trial termination|0|||
161591987|NCT01396278|583556673|FG004|Overall Study|Withdraw due to trial termination|2|||
161591988|NCT00450658|583556674|FG000|Overall Study|Adverse Event|24|||
161591989|NCT00450658|583556675|FG001|Overall Study|Adverse Event|15|||
161591990|NCT00450658|583556674|FG000|Overall Study|Withdrawal by Subject|43|||
161591991|NCT00450658|583556675|FG001|Overall Study|Withdrawal by Subject|26|||
161591992|NCT00450658|583556674|FG000|Overall Study|Lost to Follow-up|22|||
161591993|NCT00450658|583556675|FG001|Overall Study|Lost to Follow-up|5|||
161535473|NCT03185832|583348153|FG001|Overall Study|Death|14|||
161535474|NCT03185832|583348154|FG002|Overall Study|Death|9|||
161535475|NCT03185832|583348155|FG003|Overall Study|Death|7|||
161535476|NCT03185832|583348152|FG000|Overall Study|Withdrawn - vital status available|0|||
161535477|NCT03185832|583348153|FG001|Overall Study|Withdrawn - vital status available|1|||
161535478|NCT03185832|583348154|FG002|Overall Study|Withdrawn - vital status available|1|||
161535479|NCT03185832|583348155|FG003|Overall Study|Withdrawn - vital status available|4|||
161591994|NCT00450658|583556674|FG000|Overall Study|UGI ulcer|33|||
161591995|NCT00450658|583556675|FG001|Overall Study|UGI ulcer|34|||
161535480|NCT01123382|583348158|FG000|Overall Study|Withdrawal by Subject|1|||
161535481|NCT01123382|583348159|FG001|Overall Study|Withdrawal by Subject|4|||
161535482|NCT01123382|583348158|FG000|Overall Study|Lost to Follow-up|1|||
161591996|NCT00450658|583556674|FG000|Overall Study|misc|21|||
161535483|NCT01123382|583348159|FG001|Overall Study|Lost to Follow-up|2|||
161535484|NCT01256411|583348160|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
161535485|NCT01256411|583348161|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
161591997|NCT00450658|583556675|FG001|Overall Study|misc|10|||
161829260|NCT03346070|584415736|FG004|Overall Study|Lost to Follow-up|0|||
161535486|NCT01256411|583348162|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
161535487|NCT01256411|583348163|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
161535488|NCT01256411|583348164|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
161535489|NCT01256411|583348165|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
161535490|NCT01256411|583348160|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
161535491|NCT01256411|583348161|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
161535492|NCT01256411|583348162|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
161535493|NCT01256411|583348163|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
161535494|NCT01256411|583348164|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
161535495|NCT01256411|583348165|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
161535496|NCT01256411|583348160|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
161535497|NCT01256411|583348161|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
161535498|NCT01256411|583348162|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
161535499|NCT01256411|583348163|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
161535500|NCT01256411|583348164|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
161535501|NCT01256411|583348165|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
161535502|NCT01256411|583348160|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
161535503|NCT01256411|583348161|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
161535504|NCT01256411|583348162|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
161535505|NCT01256411|583348163|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
161535506|NCT01256411|583348164|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
161535507|NCT01256411|583348165|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
161535508|NCT01256411|583348160|FG000|Extension by Maximum Treatment|Adverse Event|4|||
161535509|NCT01256411|583348161|FG001|Extension by Maximum Treatment|Adverse Event|2|||
161535510|NCT01256411|583348162|FG002|Extension by Maximum Treatment|Adverse Event|1|||
161535511|NCT01256411|583348163|FG003|Extension by Maximum Treatment|Adverse Event|0|||
161535512|NCT01256411|583348164|FG004|Extension by Maximum Treatment|Adverse Event|0|||
161535513|NCT01256411|583348165|FG005|Extension by Maximum Treatment|Adverse Event|0|||
161535514|NCT01256411|583348160|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
161535515|NCT01256411|583348161|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
161535516|NCT01256411|583348162|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
161535517|NCT01256411|583348163|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
161535518|NCT01256411|583348164|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
161535519|NCT01256411|583348165|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
161535520|NCT01256411|583348160|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
161535521|NCT01256411|583348161|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
161535522|NCT01256411|583348162|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
161535523|NCT01256411|583348163|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
161535524|NCT01256411|583348164|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
161535525|NCT01256411|583348165|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
161535526|NCT01256411|583348160|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
161535527|NCT01256411|583348161|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
161535528|NCT01256411|583348162|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
161535529|NCT01256411|583348163|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
161535530|NCT01256411|583348164|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
161535531|NCT01256411|583348165|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
161535532|NCT01256411|583348160|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
161535533|NCT01256411|583348161|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
161535534|NCT01256411|583348162|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
161535535|NCT01256411|583348163|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
161535536|NCT01256411|583348164|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
161535537|NCT01256411|583348165|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
161535538|NCT01256411|583348160|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
161535539|NCT01256411|583348161|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
161535540|NCT01256411|583348162|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
161535541|NCT01256411|583348163|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
161535542|NCT01256411|583348164|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
161535543|NCT01256411|583348165|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
161535544|NCT02274857|583348166|FG000|Overall Study|Adverse Event|1|||
161535545|NCT02274857|583348167|FG001|Overall Study|Adverse Event|0|||
161535546|NCT02274857|583348166|FG000|Overall Study|Death|1|||
161535547|NCT02274857|583348167|FG001|Overall Study|Death|2|||
161535548|NCT02274857|583348166|FG000|Overall Study|Lost to Follow-up|3|||
161535549|NCT02274857|583348167|FG001|Overall Study|Lost to Follow-up|0|||
161535550|NCT02274857|583348166|FG000|Overall Study|Physician Decision|2|||
161535551|NCT02274857|583348167|FG001|Overall Study|Physician Decision|0|||
161591998|NCT04727554|583556677|FG000|Overall Study|Lost to Follow-up|0|||
161591999|NCT04727554|583556678|FG001|Overall Study|Lost to Follow-up|1|||
161592000|NCT04727554|583556677|FG000|Overall Study|Death|2|||
161592001|NCT04727554|583556678|FG001|Overall Study|Death|6|||
161535552|NCT02274857|583348166|FG000|Overall Study|Trial screen failure|0|||
161535553|NCT02274857|583348167|FG001|Overall Study|Trial screen failure|2|||
161535554|NCT02274857|583348166|FG000|Overall Study|Withdrawal by Subject|11|||
161535555|NCT02274857|583348167|FG001|Overall Study|Withdrawal by Subject|2|||
161535556|NCT02274857|583348166|FG000|Overall Study|Other|2|||
161535557|NCT02274857|583348167|FG001|Overall Study|Other|0|||
161535558|NCT02403180|583348168|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
161535559|NCT02403180|583348169|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
161535560|NCT02403180|583348168|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
161535561|NCT02403180|583348169|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
161535562|NCT02230956|583348172|FG000|Overall Study|Adverse Event|1|||
161535563|NCT02230956|583348173|FG001|Overall Study|Adverse Event|1|||
161535564|NCT02230956|583348174|FG002|Overall Study|Adverse Event|0|||
161535565|NCT02230956|583348172|FG000|Overall Study|Lack of Efficacy|1|||
161535566|NCT02230956|583348173|FG001|Overall Study|Lack of Efficacy|1|||
161535567|NCT02230956|583348174|FG002|Overall Study|Lack of Efficacy|1|||
161535568|NCT02230956|583348172|FG000|Overall Study|Lost to Follow-up|1|||
161535569|NCT02230956|583348173|FG001|Overall Study|Lost to Follow-up|1|||
161535570|NCT02230956|583348174|FG002|Overall Study|Lost to Follow-up|2|||
161535571|NCT02230956|583348172|FG000|Overall Study|Personal Reasons|2|||
161535572|NCT02230956|583348173|FG001|Overall Study|Personal Reasons|1|||
161535573|NCT02230956|583348174|FG002|Overall Study|Personal Reasons|1|||
161535574|NCT02230956|583348172|FG000|Overall Study|Protocol Violation|0|||
161535575|NCT02230956|583348173|FG001|Overall Study|Protocol Violation|1|||
161535576|NCT02230956|583348174|FG002|Overall Study|Protocol Violation|1|||
161535577|NCT02230956|583348172|FG000|Overall Study|Other Miscellaneous Reason|0|||
161535578|NCT02230956|583348173|FG001|Overall Study|Other Miscellaneous Reason|1|||
161535579|NCT02230956|583348174|FG002|Overall Study|Other Miscellaneous Reason|2|||
161535580|NCT01445652|583348175|FG000|Overall Study|Not comfortable in lenses|5|||
161535581|NCT01445652|583348176|FG001|Overall Study|Not comfortable in lenses|0|||
161535582|NCT01445652|583348175|FG000|Overall Study|Failed to attend scheduled visit|2|||
161535583|NCT01445652|583348176|FG001|Overall Study|Failed to attend scheduled visit|3|||
161535584|NCT01445652|583348175|FG000|Overall Study|Failed teach session|2|||
161535585|NCT01445652|583348176|FG001|Overall Study|Failed teach session|0|||
161535586|NCT01445652|583348175|FG000|Overall Study|Adverse Event|1|||
161535587|NCT01445652|583348176|FG001|Overall Study|Adverse Event|0|||
161535588|NCT03002610|583348177|FG000|Overall Study|Withdrawal by Subject|6|||
161535589|NCT03002610|583348178|FG001|Overall Study|Withdrawal by Subject|25|||
161535590|NCT03002610|583348179|FG002|Overall Study|Withdrawal by Subject|13|||
161535591|NCT00929162|583348180|FG000|Overall Study|Adverse Event|8|||
161535592|NCT00929162|583348181|FG001|Overall Study|Adverse Event|5|||
161535593|NCT00929162|583348180|FG000|Overall Study|Withdrawal by Subject|3|||
161535594|NCT00929162|583348181|FG001|Overall Study|Withdrawal by Subject|1|||
161535595|NCT00929162|583348180|FG000|Overall Study|Protocol Violation|32|||
161535596|NCT00929162|583348181|FG001|Overall Study|Protocol Violation|30|||
161535597|NCT00929162|583348180|FG000|Overall Study|Other termination reason|5|||
161535598|NCT00929162|583348181|FG001|Overall Study|Other termination reason|6|||
161535599|NCT01822587|583348182|FG000|Overall Study|Lost to Follow-up|7|||
161535600|NCT01822587|583348183|FG001|Overall Study|Lost to Follow-up|9|||
161535601|NCT01822587|583348184|FG002|Overall Study|Lost to Follow-up|12|||
161535602|NCT01822587|583348182|FG000|Overall Study|Physician Decision|9|||
161535603|NCT01822587|583348183|FG001|Overall Study|Physician Decision|6|||
161535604|NCT01822587|583348184|FG002|Overall Study|Physician Decision|6|||
161535605|NCT00117676|583348186|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
161535606|NCT00117676|583348187|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
161535607|NCT00117676|583348186|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
161535608|NCT00117676|583348187|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
161535609|NCT00117676|583348186|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
161535610|NCT00117676|583348187|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
161535611|NCT00117676|583348186|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
161535612|NCT00117676|583348187|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
161535613|NCT00117676|583348186|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
161535614|NCT00117676|583348187|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
161535615|NCT00117676|583348186|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
161535616|NCT00117676|583348187|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
161535617|NCT00117676|583348186|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
161535618|NCT00117676|583348187|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
161829261|NCT03346070|584415732|FG000|Overall Study|Physician Decision|0|||
161829262|NCT03346070|584415733|FG001|Overall Study|Physician Decision|0|||
161829263|NCT03346070|584415734|FG002|Overall Study|Physician Decision|0|||
161829264|NCT03346070|584415735|FG003|Overall Study|Physician Decision|1|||
161535619|NCT00117676|583348186|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
161535620|NCT00117676|583348187|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
161535621|NCT00117676|583348186|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
161535622|NCT00117676|583348187|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
161535623|NCT00117676|583348186|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
161535624|NCT00117676|583348187|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
161535625|NCT00117676|583348186|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
161535626|NCT00117676|583348187|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
161535627|NCT00117676|583348186|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
161535628|NCT00117676|583348187|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
161535629|NCT00117676|583348186|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
161535630|NCT00117676|583348187|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
161535631|NCT00117676|583348186|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
161535632|NCT00117676|583348187|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
161535633|NCT00117676|583348186|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
161535634|NCT00117676|583348187|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
161535635|NCT00117676|583348186|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
161535636|NCT00117676|583348187|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
161535637|NCT00117676|583348186|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
161535638|NCT00117676|583348187|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
161535639|NCT00117676|583348186|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
161535640|NCT00117676|583348187|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
161535641|NCT00117676|583348186|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
161535642|NCT00117676|583348187|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
161535643|NCT00117676|583348186|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
161535644|NCT00117676|583348187|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
161535645|NCT00117676|583348186|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
161535646|NCT00117676|583348187|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
161535647|NCT00117676|583348186|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
161535648|NCT00117676|583348187|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
161535649|NCT00117676|583348186|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
161535650|NCT00117676|583348187|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
161535651|NCT00117676|583348186|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
161535652|NCT00117676|583348187|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
161535653|NCT00117676|583348186|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
161535654|NCT00117676|583348187|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
161535655|NCT00117676|583348186|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
161535656|NCT00117676|583348187|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
161535657|NCT00117676|583348186|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
161535658|NCT00117676|583348187|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
161535659|NCT00117676|583348186|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
161535660|NCT00117676|583348187|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
161829265|NCT03346070|584415736|FG004|Overall Study|Physician Decision|1|||
161829266|NCT03346070|584415732|FG000|Overall Study|Withdrawal by Subject|1|||
161829267|NCT03346070|584415733|FG001|Overall Study|Withdrawal by Subject|0|||
161829268|NCT03346070|584415734|FG002|Overall Study|Withdrawal by Subject|0|||
161829269|NCT03346070|584415735|FG003|Overall Study|Withdrawal by Subject|1|||
161829270|NCT03346070|584415736|FG004|Overall Study|Withdrawal by Subject|0|||
161829271|NCT03346070|584415732|FG000|Overall Study|Study medication not received as planned|2|||
161829272|NCT03346070|584415733|FG001|Overall Study|Study medication not received as planned|3|||
161829273|NCT03346070|584415734|FG002|Overall Study|Study medication not received as planned|2|||
161829274|NCT03346070|584415735|FG003|Overall Study|Study medication not received as planned|3|||
161829275|NCT03346070|584415736|FG004|Overall Study|Study medication not received as planned|2|||
161829276|NCT03346070|584415732|FG000|Overall Study|Screen Failure|0|||
161829277|NCT03346070|584415733|FG001|Overall Study|Screen Failure|0|||
161829278|NCT03346070|584415734|FG002|Overall Study|Screen Failure|0|||
161829279|NCT03346070|584415735|FG003|Overall Study|Screen Failure|1|||
161829280|NCT03346070|584415736|FG004|Overall Study|Screen Failure|1|||
161829281|NCT00977548|584415738|FG000|Overall Study|Ineligible|4|||
161829282|NCT00977548|584415738|FG000|Overall Study|Adverse Event|8|||
161829283|NCT00977548|584415738|FG000|Overall Study|Withdrawal by Subject|1|||
161829284|NCT00988208|584415739|FG000|Overall Study|Adverse Event|71|||
161829285|NCT00988208|584415740|FG001|Overall Study|Adverse Event|122|||
161829286|NCT00988208|584415739|FG000|Overall Study|Disease Progression|103|||
161829287|NCT00988208|584415740|FG001|Overall Study|Disease Progression|89|||
161829288|NCT00988208|584415739|FG000|Overall Study|Withdrawal by Subject|50|||
161829289|NCT00988208|584415740|FG001|Overall Study|Withdrawal by Subject|57|||
161829290|NCT00988208|584415739|FG000|Overall Study|Death|9|||
161829291|NCT00988208|584415740|FG001|Overall Study|Death|15|||
161829292|NCT00988208|584415739|FG000|Overall Study|Lost to Follow-up|2|||
161829293|NCT00988208|584415740|FG001|Overall Study|Lost to Follow-up|3|||
161829294|NCT00988208|584415739|FG000|Overall Study|Protocol Violation|9|||
161829295|NCT00988208|584415740|FG001|Overall Study|Protocol Violation|2|||
161829296|NCT00988208|584415739|FG000|Overall Study|Sponsor Decision|102|||
161829297|NCT00988208|584415740|FG001|Overall Study|Sponsor Decision|78|||
161829298|NCT00988208|584415739|FG000|Overall Study|Clinical Progression|17|||
161829299|NCT00988208|584415740|FG001|Overall Study|Clinical Progression|16|||
161829300|NCT00988208|584415739|FG000|Overall Study|Biochemical Progression|21|||
161829301|NCT00988208|584415740|FG001|Overall Study|Biochemical Progression|7|||
161829302|NCT00988208|584415739|FG000|Overall Study|Clinical Deterioration|7|||
161829303|NCT00988208|584415740|FG001|Overall Study|Clinical Deterioration|14|||
161829304|NCT00988208|584415739|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
161829305|NCT00988208|584415740|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
161829306|NCT00988208|584415739|FG000|Overall Study|Other|8|||
161829307|NCT00988208|584415740|FG001|Overall Study|Other|3|||
161535661|NCT00117676|583348186|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
161535662|NCT00117676|583348187|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
161535663|NCT00117676|583348186|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
161535664|NCT00117676|583348187|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
161535665|NCT00117676|583348186|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
161535666|NCT00117676|583348187|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
161535667|NCT00117676|583348186|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
161535668|NCT00117676|583348187|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
161535669|NCT00117676|583348186|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
161535670|NCT00117676|583348187|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
161535671|NCT00117676|583348186|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
161535672|NCT00117676|583348187|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
161535673|NCT00117676|583348186|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
161535674|NCT00117676|583348187|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
161535675|NCT00952822|583348188|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
161535676|NCT00952822|583348189|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
161535677|NCT00952822|583348190|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
161535678|NCT00952822|583348191|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
161535679|NCT00952822|583348188|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
161535680|NCT00952822|583348189|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
161535681|NCT00952822|583348190|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
161535682|NCT00952822|583348191|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
161535683|NCT00658567|583348192|FG000|Overall Study|Adverse Event|5|||
161592002|NCT04727554|583556677|FG000|Overall Study|Withdrawal by Subject|1|||
161592003|NCT04727554|583556678|FG001|Overall Study|Withdrawal by Subject|0|||
161592004|NCT05763823|583556679|FG000|Overall Study|Death|6|||
161592005|NCT05763823|583556679|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161592006|NCT05763823|583556679|FG000|Overall Study|Withdrawal by Subject|6|||
161592007|NCT00999804|583556682|FG000|Overall Study|Lack of Efficacy|9|||
161592008|NCT00999804|583556683|FG001|Overall Study|Lack of Efficacy|2|||
161592009|NCT00999804|583556682|FG000|Overall Study|Adverse Event|4|||
161592010|NCT00999804|583556683|FG001|Overall Study|Adverse Event|3|||
161592011|NCT00999804|583556682|FG000|Overall Study|Withdrawal by Subject|4|||
161592012|NCT00999804|583556683|FG001|Overall Study|Withdrawal by Subject|0|||
161592013|NCT00999804|583556682|FG000|Overall Study|Death|1|||
161592014|NCT00999804|583556683|FG001|Overall Study|Death|0|||
161592015|NCT00999804|583556682|FG000|Overall Study|Ineligible|3|||
161592016|NCT00999804|583556683|FG001|Overall Study|Ineligible|0|||
161592017|NCT05311384|583556694|FG000|Overall Study|Uncontrolled health conditions|2|||
161592018|NCT05311384|583556694|FG000|Overall Study|Withdrawal by Subject|1|||
161592019|NCT05076708|583556695|FG000|Overall Study|Withdrawal by Subject|4|||
161592020|NCT05076708|583556695|FG000|Overall Study|Lost to study during switch phase|8|||
161592021|NCT05590403|583556696|FG000|Overall Study|Lost to Follow-up|13|||
161592022|NCT05590403|583556697|FG001|Overall Study|Lost to Follow-up|1|||
161592023|NCT05590403|583556698|FG002|Overall Study|Lost to Follow-up|7|||
161592024|NCT05590403|583556699|FG003|Overall Study|Lost to Follow-up|3|||
161592025|NCT05590403|583556700|FG004|Overall Study|Lost to Follow-up|4|||
161592026|NCT05590403|583556696|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
161592027|NCT05590403|583556697|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
161592028|NCT05590403|583556698|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
161592029|NCT05590403|583556699|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
161592030|NCT05590403|583556700|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
161592031|NCT05590403|583556696|FG000|Overall Study|Other|2|||
161592032|NCT05590403|583556697|FG001|Overall Study|Other|0|||
161592033|NCT05590403|583556698|FG002|Overall Study|Other|2|||
161535684|NCT00658567|583348193|FG001|Overall Study|Adverse Event|2|||
161535685|NCT00658567|583348194|FG002|Overall Study|Adverse Event|3|||
161535686|NCT00658567|583348192|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
161535687|NCT00658567|583348193|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
161535688|NCT00658567|583348194|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
161535689|NCT00658567|583348192|FG000|Overall Study|Physician Decision|0|||
161535690|NCT00658567|583348193|FG001|Overall Study|Physician Decision|1|||
161535691|NCT00658567|583348194|FG002|Overall Study|Physician Decision|0|||
161535692|NCT00658567|583348192|FG000|Overall Study|At Discretion of Sponsor|1|||
161535693|NCT00658567|583348193|FG001|Overall Study|At Discretion of Sponsor|1|||
161535694|NCT00658567|583348194|FG002|Overall Study|At Discretion of Sponsor|1|||
161535695|NCT01755702|583348195|FG000|Wash Out Period I|Other Reason|3|||
161535696|NCT01755702|583348195|FG000|Washout Period II|Other Reason|5|||
161535697|NCT00691938|583348196|FG000|Overall Study|QTc prolongation|1|||
161535698|NCT00691938|583348197|FG001|Overall Study|QTc prolongation|0|||
161535699|NCT00691938|583348198|FG002|Overall Study|QTc prolongation|0|||
161535700|NCT00691938|583348199|FG003|Overall Study|QTc prolongation|0|||
161535701|NCT00691938|583348200|FG004|Overall Study|QTc prolongation|0|||
161535702|NCT00691938|583348201|FG005|Overall Study|QTc prolongation|0|||
161535703|NCT00691938|583348202|FG006|Overall Study|QTc prolongation|0|||
161535704|NCT04860518|583348204|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
161535705|NCT04860518|583348205|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
161535706|NCT00594854|583348209|FG000|Overall Study|Study terminated|7|||
161535707|NCT00594854|583348210|FG001|Overall Study|Study terminated|10|||
161535708|NCT04918147|583348221|FG000|Overall Study|Disease flare as defined in protocol|0|||
161535709|NCT04918147|583348222|FG001|Overall Study|Disease flare as defined in protocol|2|||
161535710|NCT03292146|583348223|FG000|Baseline to 12 months|Relocation|1|||
161535711|NCT03292146|583348224|FG001|Baseline to 12 months|Relocation|0|||
161535712|NCT03292146|583348223|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
161535713|NCT03292146|583348224|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
161535714|NCT03292146|583348223|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
161535715|NCT03292146|583348224|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
161535716|NCT03292146|583348223|FG000|12 months to 24 months|Planning pregnancy|2|||
161535717|NCT03292146|583348224|FG001|12 months to 24 months|Planning pregnancy|2|||
161535718|NCT03292146|583348223|FG000|12 months to 24 months|Personal reasons|1|||
161535719|NCT03292146|583348224|FG001|12 months to 24 months|Personal reasons|0|||
161535720|NCT03292146|583348223|FG000|12 months to 24 months|Lost to Follow-up|0|||
161535721|NCT03292146|583348224|FG001|12 months to 24 months|Lost to Follow-up|1|||
161535722|NCT02355743|583348225|FG000|Overall Study|Withdrawal by Subject|1|||
161535723|NCT02355743|583348225|FG000|Overall Study|Lost to Follow-up|1|||
161535724|NCT02712905|583348228|FG000|Monotherapy|Death|2|||
161535725|NCT02712905|583348229|FG001|Monotherapy|Death|5|||
161535726|NCT02712905|583348230|FG002|Monotherapy|Death|0|||
161535727|NCT02712905|583348231|FG003|Monotherapy|Death|3|||
161535728|NCT02712905|583348232|FG004|Monotherapy|Death|15|||
161535729|NCT02712905|583348233|FG005|Monotherapy|Death|1|||
161535730|NCT02712905|583348234|FG006|Monotherapy|Death|3|||
161535731|NCT02712905|583348235|FG007|Monotherapy|Death|3|||
161535732|NCT02712905|583348236|FG008|Monotherapy|Death|0|||
161535733|NCT02712905|583348237|FG009|Monotherapy|Death|27|||
161535734|NCT02712905|583348238|FG010|Monotherapy|Death|2|||
161535735|NCT02712905|583348239|FG011|Monotherapy|Death|5|||
161535736|NCT02712905|583348240|FG012|Monotherapy|Death|0|||
161535737|NCT02712905|583348241|FG013|Monotherapy|Death|0|||
161535738|NCT02712905|583348242|FG014|Monotherapy|Death|0|||
161535739|NCT02712905|583348243|FG015|Monotherapy|Death|0|||
161535740|NCT02712905|583348244|FG016|Monotherapy|Death|0|||
161535741|NCT02712905|583348245|FG017|Monotherapy|Death|0|||
161535742|NCT02712905|583348228|FG000|Monotherapy|Lost to Follow-up|0|||
161535743|NCT02712905|583348229|FG001|Monotherapy|Lost to Follow-up|1|||
161535744|NCT02712905|583348230|FG002|Monotherapy|Lost to Follow-up|0|||
161535745|NCT02712905|583348231|FG003|Monotherapy|Lost to Follow-up|1|||
161535746|NCT02712905|583348232|FG004|Monotherapy|Lost to Follow-up|0|||
161535747|NCT02712905|583348233|FG005|Monotherapy|Lost to Follow-up|0|||
161535748|NCT02712905|583348234|FG006|Monotherapy|Lost to Follow-up|0|||
161535749|NCT02712905|583348235|FG007|Monotherapy|Lost to Follow-up|0|||
161535750|NCT02712905|583348236|FG008|Monotherapy|Lost to Follow-up|0|||
161535751|NCT02712905|583348237|FG009|Monotherapy|Lost to Follow-up|2|||
161535752|NCT02712905|583348238|FG010|Monotherapy|Lost to Follow-up|0|||
161535753|NCT02712905|583348239|FG011|Monotherapy|Lost to Follow-up|0|||
161535754|NCT02712905|583348240|FG012|Monotherapy|Lost to Follow-up|0|||
161535755|NCT02712905|583348241|FG013|Monotherapy|Lost to Follow-up|0|||
161535756|NCT02712905|583348242|FG014|Monotherapy|Lost to Follow-up|0|||
161535757|NCT02712905|583348243|FG015|Monotherapy|Lost to Follow-up|0|||
161535758|NCT02712905|583348244|FG016|Monotherapy|Lost to Follow-up|0|||
161535759|NCT02712905|583348245|FG017|Monotherapy|Lost to Follow-up|0|||
161535760|NCT02712905|583348228|FG000|Monotherapy|Physician Decision|1|||
161535761|NCT02712905|583348229|FG001|Monotherapy|Physician Decision|0|||
161535762|NCT02712905|583348230|FG002|Monotherapy|Physician Decision|0|||
161535763|NCT02712905|583348231|FG003|Monotherapy|Physician Decision|1|||
161535764|NCT02712905|583348232|FG004|Monotherapy|Physician Decision|0|||
161535765|NCT02712905|583348233|FG005|Monotherapy|Physician Decision|0|||
161535766|NCT02712905|583348234|FG006|Monotherapy|Physician Decision|0|||
161535767|NCT02712905|583348235|FG007|Monotherapy|Physician Decision|0|||
161535768|NCT02712905|583348236|FG008|Monotherapy|Physician Decision|0|||
161535769|NCT02712905|583348237|FG009|Monotherapy|Physician Decision|1|||
161535770|NCT02712905|583348238|FG010|Monotherapy|Physician Decision|0|||
161535771|NCT02712905|583348239|FG011|Monotherapy|Physician Decision|0|||
161535772|NCT02712905|583348240|FG012|Monotherapy|Physician Decision|0|||
161535773|NCT02712905|583348241|FG013|Monotherapy|Physician Decision|0|||
161535774|NCT02712905|583348242|FG014|Monotherapy|Physician Decision|0|||
161535775|NCT02712905|583348243|FG015|Monotherapy|Physician Decision|0|||
161535776|NCT02712905|583348244|FG016|Monotherapy|Physician Decision|0|||
161535777|NCT02712905|583348245|FG017|Monotherapy|Physician Decision|0|||
161535778|NCT02712905|583348228|FG000|Monotherapy|Study Terminated by Sponsor|0|||
161535779|NCT02712905|583348229|FG001|Monotherapy|Study Terminated by Sponsor|0|||
161535780|NCT02712905|583348230|FG002|Monotherapy|Study Terminated by Sponsor|0|||
161535781|NCT02712905|583348231|FG003|Monotherapy|Study Terminated by Sponsor|0|||
161535782|NCT02712905|583348232|FG004|Monotherapy|Study Terminated by Sponsor|1|||
161535783|NCT02712905|583348233|FG005|Monotherapy|Study Terminated by Sponsor|0|||
161535784|NCT02712905|583348234|FG006|Monotherapy|Study Terminated by Sponsor|0|||
161535785|NCT02712905|583348235|FG007|Monotherapy|Study Terminated by Sponsor|0|||
161535786|NCT02712905|583348236|FG008|Monotherapy|Study Terminated by Sponsor|0|||
161535787|NCT02712905|583348237|FG009|Monotherapy|Study Terminated by Sponsor|2|||
161535788|NCT02712905|583348238|FG010|Monotherapy|Study Terminated by Sponsor|0|||
161535789|NCT02712905|583348239|FG011|Monotherapy|Study Terminated by Sponsor|0|||
161535790|NCT02712905|583348240|FG012|Monotherapy|Study Terminated by Sponsor|0|||
161535791|NCT02712905|583348241|FG013|Monotherapy|Study Terminated by Sponsor|0|||
161535792|NCT02712905|583348242|FG014|Monotherapy|Study Terminated by Sponsor|0|||
161535793|NCT02712905|583348243|FG015|Monotherapy|Study Terminated by Sponsor|0|||
161535794|NCT02712905|583348244|FG016|Monotherapy|Study Terminated by Sponsor|0|||
161535795|NCT02712905|583348245|FG017|Monotherapy|Study Terminated by Sponsor|0|||
161535796|NCT02712905|583348228|FG000|Monotherapy|Withdrawal by Subject|0|||
161535797|NCT02712905|583348229|FG001|Monotherapy|Withdrawal by Subject|0|||
161535798|NCT02712905|583348230|FG002|Monotherapy|Withdrawal by Subject|1|||
161535799|NCT02712905|583348231|FG003|Monotherapy|Withdrawal by Subject|0|||
161535800|NCT02712905|583348232|FG004|Monotherapy|Withdrawal by Subject|2|||
161535801|NCT02712905|583348233|FG005|Monotherapy|Withdrawal by Subject|0|||
161535802|NCT02712905|583348234|FG006|Monotherapy|Withdrawal by Subject|0|||
161535803|NCT02712905|583348235|FG007|Monotherapy|Withdrawal by Subject|0|||
161535804|NCT02712905|583348236|FG008|Monotherapy|Withdrawal by Subject|0|||
161535805|NCT02712905|583348237|FG009|Monotherapy|Withdrawal by Subject|4|||
161535806|NCT02712905|583348238|FG010|Monotherapy|Withdrawal by Subject|1|||
161592034|NCT05590403|583556699|FG003|Overall Study|Other|2|||
161592035|NCT05590403|583556700|FG004|Overall Study|Other|0|||
161592036|NCT05590403|583556696|FG000|Overall Study|Migrated / moved from the study area|1|||
161592037|NCT05590403|583556697|FG001|Overall Study|Migrated / moved from the study area|1|||
161592038|NCT05590403|583556698|FG002|Overall Study|Migrated / moved from the study area|0|||
161592039|NCT05590403|583556699|FG003|Overall Study|Migrated / moved from the study area|3|||
161592040|NCT05590403|583556700|FG004|Overall Study|Migrated / moved from the study area|1|||
161592041|NCT05590403|583556696|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
161592042|NCT05590403|583556697|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
161592043|NCT05590403|583556698|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
161592044|NCT05590403|583556699|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
161592045|NCT05590403|583556700|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
161592046|NCT04717492|583556701|FG000|Overall Study|Withdrawal by Subject|2|||
161592047|NCT04717492|583556702|FG001|Overall Study|Withdrawal by Subject|13|||
161592048|NCT04717492|583556701|FG000|Overall Study|Lost to Follow-up|2|||
161592049|NCT04717492|583556702|FG001|Overall Study|Lost to Follow-up|9|||
161592050|NCT03150810|583556703|FG000|Overall Study|Death|4|||
161592051|NCT03150810|583556704|FG001|Overall Study|Death|8|||
161592052|NCT03150810|583556705|FG002|Overall Study|Death|7|||
161592053|NCT03150810|583556706|FG003|Overall Study|Death|2|||
161592054|NCT03150810|583556707|FG004|Overall Study|Death|2|||
161592055|NCT03150810|583556708|FG005|Overall Study|Death|10|||
161592056|NCT03150810|583556709|FG006|Overall Study|Death|8|||
161592057|NCT03150810|583556710|FG007|Overall Study|Death|6|||
161592058|NCT03150810|583556711|FG008|Overall Study|Death|18|||
161592059|NCT03150810|583556712|FG009|Overall Study|Death|3|||
161592060|NCT03150810|583556713|FG010|Overall Study|Death|19|||
161592061|NCT03150810|583556714|FG011|Overall Study|Death|1|||
161592062|NCT03150810|583556715|FG012|Overall Study|Death|19|||
161592063|NCT03150810|583556703|FG000|Overall Study|Withdrawal by Subject|0|||
161592064|NCT03150810|583556704|FG001|Overall Study|Withdrawal by Subject|1|||
161592065|NCT03150810|583556705|FG002|Overall Study|Withdrawal by Subject|1|||
161592066|NCT03150810|583556706|FG003|Overall Study|Withdrawal by Subject|1|||
161592067|NCT03150810|583556707|FG004|Overall Study|Withdrawal by Subject|0|||
161592068|NCT03150810|583556708|FG005|Overall Study|Withdrawal by Subject|0|||
161592069|NCT03150810|583556709|FG006|Overall Study|Withdrawal by Subject|2|||
161592070|NCT03150810|583556710|FG007|Overall Study|Withdrawal by Subject|0|||
161592071|NCT03150810|583556711|FG008|Overall Study|Withdrawal by Subject|2|||
161592072|NCT03150810|583556712|FG009|Overall Study|Withdrawal by Subject|0|||
161592073|NCT03150810|583556713|FG010|Overall Study|Withdrawal by Subject|1|||
161535807|NCT02712905|583348239|FG011|Monotherapy|Withdrawal by Subject|2|||
161535808|NCT02712905|583348240|FG012|Monotherapy|Withdrawal by Subject|0|||
161829308|NCT02000531|584415745|FG000|Overall Study|Lost to Follow-up|1|||
161535809|NCT02712905|583348241|FG013|Monotherapy|Withdrawal by Subject|0|||
161592074|NCT03150810|583556714|FG011|Overall Study|Withdrawal by Subject|0|||
161592075|NCT03150810|583556715|FG012|Overall Study|Withdrawal by Subject|1|||
161592076|NCT03150810|583556703|FG000|Overall Study|Sponsor Decision|0|||
161829309|NCT02000531|584415746|FG001|Overall Study|Lost to Follow-up|0|||
161535810|NCT02712905|583348242|FG014|Monotherapy|Withdrawal by Subject|0|||
161535811|NCT02712905|583348243|FG015|Monotherapy|Withdrawal by Subject|0|||
161829310|NCT02000531|584415745|FG000|Overall Study|Discontinued due to data cut-off|3|||
161829311|NCT02000531|584415746|FG001|Overall Study|Discontinued due to data cut-off|8|||
161535812|NCT02712905|583348244|FG016|Monotherapy|Withdrawal by Subject|0|||
161592077|NCT03150810|583556704|FG001|Overall Study|Sponsor Decision|2|||
161592078|NCT03150810|583556705|FG002|Overall Study|Sponsor Decision|0|||
161535813|NCT02712905|583348245|FG017|Monotherapy|Withdrawal by Subject|0|||
161535814|NCT02712905|583348228|FG000|Monotherapy|Started New Cancer Drug|0|||
161535815|NCT02712905|583348229|FG001|Monotherapy|Started New Cancer Drug|0|||
161535816|NCT02712905|583348230|FG002|Monotherapy|Started New Cancer Drug|0|||
161535817|NCT02712905|583348231|FG003|Monotherapy|Started New Cancer Drug|0|||
161535818|NCT02712905|583348232|FG004|Monotherapy|Started New Cancer Drug|0|||
161535819|NCT02712905|583348233|FG005|Monotherapy|Started New Cancer Drug|1|||
161535820|NCT02712905|583348234|FG006|Monotherapy|Started New Cancer Drug|0|||
161535821|NCT02712905|583348235|FG007|Monotherapy|Started New Cancer Drug|0|||
161535822|NCT02712905|583348236|FG008|Monotherapy|Started New Cancer Drug|0|||
161535823|NCT02712905|583348237|FG009|Monotherapy|Started New Cancer Drug|0|||
161535824|NCT02712905|583348238|FG010|Monotherapy|Started New Cancer Drug|0|||
161535825|NCT02712905|583348239|FG011|Monotherapy|Started New Cancer Drug|0|||
161535826|NCT02712905|583348240|FG012|Monotherapy|Started New Cancer Drug|0|||
161535827|NCT02712905|583348241|FG013|Monotherapy|Started New Cancer Drug|0|||
161535828|NCT02712905|583348242|FG014|Monotherapy|Started New Cancer Drug|0|||
161535829|NCT02712905|583348243|FG015|Monotherapy|Started New Cancer Drug|0|||
161535830|NCT02712905|583348244|FG016|Monotherapy|Started New Cancer Drug|0|||
161535831|NCT02712905|583348245|FG017|Monotherapy|Started New Cancer Drug|0|||
161535832|NCT02712905|583348228|FG000|Monotherapy|Adverse Event|0|||
161535833|NCT02712905|583348229|FG001|Monotherapy|Adverse Event|0|||
161535834|NCT02712905|583348230|FG002|Monotherapy|Adverse Event|0|||
161535835|NCT02712905|583348231|FG003|Monotherapy|Adverse Event|0|||
161535836|NCT02712905|583348232|FG004|Monotherapy|Adverse Event|0|||
161535837|NCT02712905|583348233|FG005|Monotherapy|Adverse Event|0|||
161535838|NCT02712905|583348234|FG006|Monotherapy|Adverse Event|0|||
161535839|NCT02712905|583348235|FG007|Monotherapy|Adverse Event|0|||
161535840|NCT02712905|583348236|FG008|Monotherapy|Adverse Event|1|||
161535841|NCT02712905|583348237|FG009|Monotherapy|Adverse Event|0|||
161535842|NCT02712905|583348238|FG010|Monotherapy|Adverse Event|0|||
161535843|NCT02712905|583348239|FG011|Monotherapy|Adverse Event|0|||
161535844|NCT02712905|583348240|FG012|Monotherapy|Adverse Event|0|||
161535845|NCT02712905|583348241|FG013|Monotherapy|Adverse Event|0|||
161535846|NCT02712905|583348242|FG014|Monotherapy|Adverse Event|0|||
161535847|NCT02712905|583348243|FG015|Monotherapy|Adverse Event|0|||
161535848|NCT02712905|583348244|FG016|Monotherapy|Adverse Event|0|||
161535849|NCT02712905|583348245|FG017|Monotherapy|Adverse Event|0|||
161535850|NCT02712905|583348228|FG000|Combination Therapy|Death|0|||
161535851|NCT02712905|583348229|FG001|Combination Therapy|Death|0|||
161535852|NCT02712905|583348230|FG002|Combination Therapy|Death|0|||
161535853|NCT02712905|583348231|FG003|Combination Therapy|Death|0|||
161535854|NCT02712905|583348232|FG004|Combination Therapy|Death|0|||
161535855|NCT02712905|583348233|FG005|Combination Therapy|Death|0|||
161535856|NCT02712905|583348234|FG006|Combination Therapy|Death|0|||
161535857|NCT02712905|583348235|FG007|Combination Therapy|Death|0|||
161535858|NCT02712905|583348236|FG008|Combination Therapy|Death|0|||
161535859|NCT02712905|583348237|FG009|Combination Therapy|Death|0|||
161535860|NCT02712905|583348238|FG010|Combination Therapy|Death|0|||
161535861|NCT02712905|583348239|FG011|Combination Therapy|Death|0|||
161535862|NCT02712905|583348240|FG012|Combination Therapy|Death|5|||
161535863|NCT02712905|583348241|FG013|Combination Therapy|Death|6|||
161535864|NCT02712905|583348242|FG014|Combination Therapy|Death|1|||
161535865|NCT02712905|583348243|FG015|Combination Therapy|Death|3|||
161535866|NCT02712905|583348244|FG016|Combination Therapy|Death|1|||
161829312|NCT00794417|584415747|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
161535867|NCT02712905|583348245|FG017|Combination Therapy|Death|3|||
161535868|NCT02712905|583348228|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
161535869|NCT02712905|583348229|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
161535870|NCT02712905|583348230|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
161535871|NCT02712905|583348231|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
161535872|NCT02712905|583348232|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
161535873|NCT02712905|583348233|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
161829313|NCT00794417|584415748|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
161535874|NCT02712905|583348234|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
161535875|NCT02712905|583348235|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
161535876|NCT02712905|583348236|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
161829314|NCT00794417|584415749|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
161829315|NCT00794417|584415750|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
161535877|NCT02712905|583348237|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
161535878|NCT02712905|583348238|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
161535879|NCT02712905|583348239|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
161592079|NCT03150810|583556706|FG003|Overall Study|Sponsor Decision|0|||
161535880|NCT02712905|583348240|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
161535881|NCT02712905|583348241|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
161535882|NCT02712905|583348242|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
161535883|NCT02712905|583348243|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
161535884|NCT02712905|583348244|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
161535885|NCT02712905|583348245|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
161535886|NCT02712905|583348228|FG000|Combination Therapy|Withdrawal by Subject|0|||
161535887|NCT02712905|583348229|FG001|Combination Therapy|Withdrawal by Subject|0|||
161535888|NCT02712905|583348230|FG002|Combination Therapy|Withdrawal by Subject|0|||
161535889|NCT02712905|583348231|FG003|Combination Therapy|Withdrawal by Subject|0|||
161535890|NCT02712905|583348232|FG004|Combination Therapy|Withdrawal by Subject|0|||
161535891|NCT02712905|583348233|FG005|Combination Therapy|Withdrawal by Subject|0|||
161535892|NCT02712905|583348234|FG006|Combination Therapy|Withdrawal by Subject|0|||
161535893|NCT02712905|583348235|FG007|Combination Therapy|Withdrawal by Subject|0|||
161535894|NCT02712905|583348236|FG008|Combination Therapy|Withdrawal by Subject|0|||
161535895|NCT02712905|583348237|FG009|Combination Therapy|Withdrawal by Subject|0|||
161535896|NCT02712905|583348238|FG010|Combination Therapy|Withdrawal by Subject|0|||
161535897|NCT02712905|583348239|FG011|Combination Therapy|Withdrawal by Subject|0|||
161535898|NCT02712905|583348240|FG012|Combination Therapy|Withdrawal by Subject|0|||
161535899|NCT02712905|583348241|FG013|Combination Therapy|Withdrawal by Subject|0|||
161535900|NCT02712905|583348242|FG014|Combination Therapy|Withdrawal by Subject|0|||
161535901|NCT02712905|583348243|FG015|Combination Therapy|Withdrawal by Subject|1|||
161535902|NCT02712905|583348244|FG016|Combination Therapy|Withdrawal by Subject|0|||
161535903|NCT02712905|583348245|FG017|Combination Therapy|Withdrawal by Subject|2|||
161535904|NCT02712905|583348228|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535905|NCT02712905|583348229|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535906|NCT02712905|583348230|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535907|NCT02712905|583348231|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535908|NCT02712905|583348232|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535909|NCT02712905|583348233|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535910|NCT02712905|583348234|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535911|NCT02712905|583348235|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535912|NCT02712905|583348236|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535913|NCT02712905|583348237|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535914|NCT02712905|583348238|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535915|NCT02712905|583348239|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535916|NCT02712905|583348240|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535917|NCT02712905|583348241|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535918|NCT02712905|583348242|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535919|NCT02712905|583348243|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
161535920|NCT02712905|583348244|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535921|NCT02712905|583348245|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
161535922|NCT03624504|583348246|FG000|Overall Study|Unsuccessful Implant|1|||
161535923|NCT02975973|583348249|FG000|Overall Study|Adverse Event|1|||
161535924|NCT02975973|583348250|FG001|Overall Study|Adverse Event|1|||
161535925|NCT02975973|583348251|FG002|Overall Study|Adverse Event|1|||
161535926|NCT02975973|583348252|FG003|Overall Study|Adverse Event|0|||
161535927|NCT01812655|583348253|FG000|Overall Study|Protocol Violation|1|||
161535928|NCT01812655|583348254|FG001|Overall Study|Protocol Violation|1|||
161535929|NCT01812655|583348255|FG002|Overall Study|Protocol Violation|0|||
161535930|NCT01428076|583348256|FG000|Overall Study|Adverse Event|0|||
161535931|NCT01428076|583348257|FG001|Overall Study|Adverse Event|1|||
161535932|NCT04435665|583348258|FG000|Overall Study|Lost to Follow-up|0|||
161535933|NCT04435665|583348259|FG001|Overall Study|Lost to Follow-up|0|||
161535934|NCT04435665|583348260|FG002|Overall Study|Lost to Follow-up|0|||
161535935|NCT04435665|583348261|FG003|Overall Study|Lost to Follow-up|1|||
161535936|NCT00419263|583348262|FG000|Overall Study|Lost to Follow-up|2|||
161535937|NCT00419263|583348263|FG001|Overall Study|Lost to Follow-up|1|||
161535938|NCT00419263|583348264|FG002|Overall Study|Lost to Follow-up|1|||
161535939|NCT00419263|583348262|FG000|Overall Study|Randomized in Error, Not Treated|1|||
161535940|NCT00419263|583348263|FG001|Overall Study|Randomized in Error, Not Treated|1|||
161535941|NCT00419263|583348264|FG002|Overall Study|Randomized in Error, Not Treated|0|||
161535942|NCT00419263|583348262|FG000|Overall Study|Adverse Event|0|||
161535943|NCT00419263|583348263|FG001|Overall Study|Adverse Event|0|||
161535944|NCT00419263|583348264|FG002|Overall Study|Adverse Event|1|||
161535945|NCT00419263|583348262|FG000|Overall Study|Withdrawal by Subject|0|||
161535946|NCT00419263|583348263|FG001|Overall Study|Withdrawal by Subject|0|||
161535947|NCT00419263|583348264|FG002|Overall Study|Withdrawal by Subject|1|||
161535948|NCT00540124|583348265|FG000|Overall Study|Adverse Event|0|||
161535949|NCT00540124|583348266|FG001|Overall Study|Adverse Event|2|||
161535950|NCT00540124|583348267|FG002|Overall Study|Adverse Event|1|||
161535951|NCT00540124|583348265|FG000|Overall Study|Entry Criteria Not Met|2|||
161535952|NCT00540124|583348266|FG001|Overall Study|Entry Criteria Not Met|0|||
161535953|NCT00540124|583348267|FG002|Overall Study|Entry Criteria Not Met|0|||
161829316|NCT00794417|584415747|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
161829317|NCT00794417|584415748|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
161829318|NCT00794417|584415749|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
161829319|NCT00794417|584415750|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
161829320|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161829321|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161829322|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161829323|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
161829324|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161829325|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161829326|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161829327|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
161829328|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161829329|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161829330|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161829331|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
161592080|NCT03150810|583556707|FG004|Overall Study|Sponsor Decision|1|||
161592081|NCT03150810|583556708|FG005|Overall Study|Sponsor Decision|1|||
161592082|NCT03150810|583556709|FG006|Overall Study|Sponsor Decision|0|||
161592083|NCT03150810|583556710|FG007|Overall Study|Sponsor Decision|0|||
161592084|NCT03150810|583556711|FG008|Overall Study|Sponsor Decision|1|||
161592085|NCT03150810|583556712|FG009|Overall Study|Sponsor Decision|0|||
161592086|NCT03150810|583556713|FG010|Overall Study|Sponsor Decision|0|||
161592087|NCT03150810|583556714|FG011|Overall Study|Sponsor Decision|0|||
161592088|NCT03150810|583556715|FG012|Overall Study|Sponsor Decision|5|||
161592089|NCT03150810|583556703|FG000|Overall Study|Lost to Follow-up|0|||
161592090|NCT03150810|583556704|FG001|Overall Study|Lost to Follow-up|1|||
161592091|NCT03150810|583556705|FG002|Overall Study|Lost to Follow-up|1|||
161592092|NCT03150810|583556706|FG003|Overall Study|Lost to Follow-up|0|||
161592093|NCT03150810|583556707|FG004|Overall Study|Lost to Follow-up|0|||
161592094|NCT03150810|583556708|FG005|Overall Study|Lost to Follow-up|0|||
161592095|NCT03150810|583556709|FG006|Overall Study|Lost to Follow-up|1|||
161592096|NCT03150810|583556710|FG007|Overall Study|Lost to Follow-up|0|||
161592097|NCT03150810|583556711|FG008|Overall Study|Lost to Follow-up|0|||
161592098|NCT03150810|583556712|FG009|Overall Study|Lost to Follow-up|0|||
161592099|NCT03150810|583556713|FG010|Overall Study|Lost to Follow-up|1|||
161592100|NCT03150810|583556714|FG011|Overall Study|Lost to Follow-up|0|||
161592101|NCT03150810|583556715|FG012|Overall Study|Lost to Follow-up|0|||
161592102|NCT03150810|583556703|FG000|Overall Study|Physician Decision|0|||
161592103|NCT03150810|583556704|FG001|Overall Study|Physician Decision|0|||
161592104|NCT03150810|583556705|FG002|Overall Study|Physician Decision|0|||
161592105|NCT03150810|583556706|FG003|Overall Study|Physician Decision|0|||
161592106|NCT03150810|583556707|FG004|Overall Study|Physician Decision|0|||
161592107|NCT03150810|583556708|FG005|Overall Study|Physician Decision|1|||
161592108|NCT03150810|583556709|FG006|Overall Study|Physician Decision|1|||
161592109|NCT03150810|583556710|FG007|Overall Study|Physician Decision|0|||
161592110|NCT03150810|583556711|FG008|Overall Study|Physician Decision|0|||
161592111|NCT03150810|583556712|FG009|Overall Study|Physician Decision|0|||
161592112|NCT03150810|583556713|FG010|Overall Study|Physician Decision|0|||
161592113|NCT03150810|583556714|FG011|Overall Study|Physician Decision|0|||
161592114|NCT03150810|583556715|FG012|Overall Study|Physician Decision|0|||
161592115|NCT03150810|583556703|FG000|Overall Study|Site withdrawal from study|0|||
161592116|NCT03150810|583556704|FG001|Overall Study|Site withdrawal from study|1|||
161592117|NCT03150810|583556705|FG002|Overall Study|Site withdrawal from study|0|||
161592118|NCT03150810|583556706|FG003|Overall Study|Site withdrawal from study|0|||
161592119|NCT03150810|583556707|FG004|Overall Study|Site withdrawal from study|0|||
161592120|NCT03150810|583556708|FG005|Overall Study|Site withdrawal from study|0|||
161592121|NCT03150810|583556709|FG006|Overall Study|Site withdrawal from study|0|||
161592122|NCT03150810|583556710|FG007|Overall Study|Site withdrawal from study|0|||
161592123|NCT03150810|583556711|FG008|Overall Study|Site withdrawal from study|0|||
161592124|NCT03150810|583556712|FG009|Overall Study|Site withdrawal from study|1|||
161592125|NCT03150810|583556713|FG010|Overall Study|Site withdrawal from study|1|||
161592126|NCT03150810|583556714|FG011|Overall Study|Site withdrawal from study|0|||
161592127|NCT03150810|583556715|FG012|Overall Study|Site withdrawal from study|0|||
161592128|NCT03150810|583556703|FG000|Overall Study|Hospice|0|||
161592129|NCT03150810|583556704|FG001|Overall Study|Hospice|0|||
161592130|NCT03150810|583556705|FG002|Overall Study|Hospice|0|||
161592131|NCT03150810|583556706|FG003|Overall Study|Hospice|0|||
161592132|NCT03150810|583556707|FG004|Overall Study|Hospice|0|||
161592133|NCT03150810|583556708|FG005|Overall Study|Hospice|1|||
161592134|NCT03150810|583556709|FG006|Overall Study|Hospice|0|||
161592135|NCT03150810|583556710|FG007|Overall Study|Hospice|0|||
161592136|NCT03150810|583556711|FG008|Overall Study|Hospice|0|||
161592137|NCT03150810|583556712|FG009|Overall Study|Hospice|0|||
161535954|NCT00540124|583348265|FG000|Overall Study|Lack of Efficacy|1|||
161535955|NCT00540124|583348266|FG001|Overall Study|Lack of Efficacy|0|||
161535956|NCT00540124|583348267|FG002|Overall Study|Lack of Efficacy|0|||
161535957|NCT00540124|583348265|FG000|Overall Study|Withdrawal by Subject|1|||
161535958|NCT00540124|583348266|FG001|Overall Study|Withdrawal by Subject|1|||
161535959|NCT00540124|583348267|FG002|Overall Study|Withdrawal by Subject|0|||
161535960|NCT04839965|583348270|FG000|Overall Study|Death|6|||
161535961|NCT04839965|583348271|FG001|Overall Study|Death|6|||
161592138|NCT03150810|583556713|FG010|Overall Study|Hospice|0|||
161535962|NCT04839965|583348270|FG000|Overall Study|Lost to Follow-up|1|||
161535963|NCT04839965|583348271|FG001|Overall Study|Lost to Follow-up|0|||
161535964|NCT02291679|583348272|FG000|Overall Study|Adverse Event|2|||
161535965|NCT02291679|583348273|FG001|Overall Study|Adverse Event|12|||
161535966|NCT02291679|583348274|FG002|Overall Study|Adverse Event|19|||
161535967|NCT02291679|583348272|FG000|Overall Study|Protocol Violation|5|||
161535968|NCT02291679|583348273|FG001|Overall Study|Protocol Violation|1|||
161535969|NCT02291679|583348274|FG002|Overall Study|Protocol Violation|7|||
161535970|NCT02291679|583348272|FG000|Overall Study|Withdrew Consent|18|||
161535971|NCT02291679|583348273|FG001|Overall Study|Withdrew Consent|10|||
161535972|NCT02291679|583348274|FG002|Overall Study|Withdrew Consent|15|||
161535973|NCT02291679|583348272|FG000|Overall Study|Lost to Follow-up|12|||
161535974|NCT02291679|583348273|FG001|Overall Study|Lost to Follow-up|10|||
161535975|NCT02291679|583348274|FG002|Overall Study|Lost to Follow-up|9|||
161535976|NCT02291679|583348272|FG000|Overall Study|Insufficient Therapeutic Response|5|||
161535977|NCT02291679|583348273|FG001|Overall Study|Insufficient Therapeutic Response|5|||
161535978|NCT02291679|583348274|FG002|Overall Study|Insufficient Therapeutic Response|7|||
161535979|NCT02291679|583348272|FG000|Overall Study|Other|2|||
161535980|NCT02291679|583348273|FG001|Overall Study|Other|4|||
161535981|NCT02291679|583348274|FG002|Overall Study|Other|2|||
161535982|NCT02355028|583348275|FG000|Overall Study|Adverse Event|2|||
161535983|NCT02355028|583348276|FG001|Overall Study|Adverse Event|0|||
161535984|NCT02355028|583348275|FG000|Overall Study|Withdrawal by Subject|1|||
161535985|NCT02355028|583348276|FG001|Overall Study|Withdrawal by Subject|1|||
161535986|NCT02355028|583348275|FG000|Overall Study|Deemed ineligible after randomization|8|||
161535987|NCT02355028|583348276|FG001|Overall Study|Deemed ineligible after randomization|4|||
161535988|NCT02276222|583348277|FG000|Overall Study|Adverse Event|62|||
161535989|NCT02276222|583348278|FG001|Overall Study|Adverse Event|11|||
161535990|NCT02276222|583348277|FG000|Overall Study|Death|3|||
161535991|NCT02276222|583348278|FG001|Overall Study|Death|4|||
161535992|NCT02276222|583348277|FG000|Overall Study|Lack of Efficacy|13|||
161535993|NCT02276222|583348278|FG001|Overall Study|Lack of Efficacy|3|||
161535994|NCT02276222|583348277|FG000|Overall Study|Protocol Violation|3|||
161535995|NCT02276222|583348278|FG001|Overall Study|Protocol Violation|2|||
161535996|NCT02276222|583348277|FG000|Overall Study|Withdrawal by Subject|79|||
161678718|NCT03024970|583876061|FG000|Second Intervention|Lost to Follow-up|1|||
161678719|NCT03024970|583876062|FG001|Second Intervention|Lost to Follow-up|0|||
161678720|NCT00131469|583876063|FG000|Overall Study|Withdrawal by Subject|3|||
161678721|NCT00131469|583876064|FG001|Overall Study|Withdrawal by Subject|4|||
161678722|NCT00131469|583876063|FG000|Overall Study|Protocol Violation|3|||
161678723|NCT00131469|583876064|FG001|Overall Study|Protocol Violation|1|||
161535997|NCT02276222|583348278|FG001|Overall Study|Withdrawal by Subject|33|||
161535998|NCT02276222|583348277|FG000|Overall Study|non compliance with study medication|6|||
161535999|NCT02276222|583348278|FG001|Overall Study|non compliance with study medication|2|||
161592139|NCT03150810|583556714|FG011|Overall Study|Hospice|0|||
161592140|NCT03150810|583556715|FG012|Overall Study|Hospice|0|||
161592141|NCT03150810|583556703|FG000|Overall Study|Participant relocated abroad.|0|||
161592142|NCT03150810|583556704|FG001|Overall Study|Participant relocated abroad.|0|||
161592143|NCT03150810|583556705|FG002|Overall Study|Participant relocated abroad.|0|||
161592144|NCT03150810|583556706|FG003|Overall Study|Participant relocated abroad.|0|||
161592145|NCT03150810|583556707|FG004|Overall Study|Participant relocated abroad.|0|||
161592146|NCT03150810|583556708|FG005|Overall Study|Participant relocated abroad.|1|||
161592147|NCT03150810|583556709|FG006|Overall Study|Participant relocated abroad.|0|||
161678724|NCT00131469|583876063|FG000|Overall Study|Death|0|||
161536000|NCT02276222|583348277|FG000|Overall Study|sponsor decision|0|||
161536001|NCT02276222|583348278|FG001|Overall Study|sponsor decision|3|||
161536002|NCT02276222|583348277|FG000|Overall Study|Lost to Follow-up|15|||
161536003|NCT02276222|583348278|FG001|Overall Study|Lost to Follow-up|5|||
161592148|NCT03150810|583556710|FG007|Overall Study|Participant relocated abroad.|0|||
161536004|NCT02276222|583348277|FG000|Overall Study|Physician Decision|2|||
161536005|NCT02276222|583348278|FG001|Overall Study|Physician Decision|1|||
161536006|NCT02276222|583348277|FG000|Overall Study|sheduling conflict|1|||
161536007|NCT02276222|583348278|FG001|Overall Study|sheduling conflict|0|||
161536008|NCT02276222|583348277|FG000|Overall Study|subject withdrew after randomization|1|||
161536009|NCT02276222|583348278|FG001|Overall Study|subject withdrew after randomization|0|||
161592149|NCT03150810|583556711|FG008|Overall Study|Participant relocated abroad.|0|||
161678725|NCT00131469|583876064|FG001|Overall Study|Death|1|||
161678726|NCT00131469|583876063|FG000|Overall Study|Lost to Follow-up|0|||
161536010|NCT04102579|583348279|FG000|Overall Study|Withdrawal by Subject|3|||
161536011|NCT04102579|583348280|FG001|Overall Study|Withdrawal by Subject|4|||
161536012|NCT04102579|583348279|FG000|Overall Study|Lost to Follow-up|0|||
161536013|NCT04102579|583348280|FG001|Overall Study|Lost to Follow-up|1|||
161536014|NCT04102579|583348279|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
161536015|NCT04102579|583348280|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
161536016|NCT04102579|583348279|FG000|Overall Study|Other than Specified|1|||
161536017|NCT04102579|583348280|FG001|Overall Study|Other than Specified|0|||
161536018|NCT04102579|583348279|FG000|Overall Study|Not Dosed with Study Drug|0|||
161536019|NCT04102579|583348280|FG001|Overall Study|Not Dosed with Study Drug|1|||
161536020|NCT02170025|583348281|FG000|Overall Study|Adverse Event|2|||
161536021|NCT02170025|583348282|FG001|Overall Study|Adverse Event|0|||
161536022|NCT01525602|583348283|FG000|Overall Study|Adverse Event|1|||
161536023|NCT01525602|583348284|FG001|Overall Study|Adverse Event|0|||
161536024|NCT01525602|583348285|FG002|Overall Study|Adverse Event|1|||
161536025|NCT01525602|583348286|FG003|Overall Study|Adverse Event|1|||
161536026|NCT01525602|583348287|FG004|Overall Study|Adverse Event|3|||
161536027|NCT01525602|583348288|FG005|Overall Study|Adverse Event|3|||
161536028|NCT01525602|583348289|FG006|Overall Study|Adverse Event|0|||
161536029|NCT01525602|583348290|FG007|Overall Study|Adverse Event|1|||
161536030|NCT01525602|583348283|FG000|Overall Study|Disease progression|6|||
161536031|NCT01525602|583348284|FG001|Overall Study|Disease progression|3|||
161536032|NCT01525602|583348285|FG002|Overall Study|Disease progression|2|||
161536033|NCT01525602|583348286|FG003|Overall Study|Disease progression|5|||
161536034|NCT01525602|583348287|FG004|Overall Study|Disease progression|22|||
161536035|NCT01525602|583348288|FG005|Overall Study|Disease progression|2|||
161536036|NCT01525602|583348289|FG006|Overall Study|Disease progression|3|||
161536037|NCT01525602|583348290|FG007|Overall Study|Disease progression|3|||
161536038|NCT01525602|583348283|FG000|Overall Study|Clinical progression|2|||
161536039|NCT01525602|583348284|FG001|Overall Study|Clinical progression|0|||
161536040|NCT01525602|583348285|FG002|Overall Study|Clinical progression|0|||
161536041|NCT01525602|583348286|FG003|Overall Study|Clinical progression|0|||
161536042|NCT01525602|583348287|FG004|Overall Study|Clinical progression|0|||
161536043|NCT01525602|583348288|FG005|Overall Study|Clinical progression|0|||
161536044|NCT01525602|583348289|FG006|Overall Study|Clinical progression|1|||
161536045|NCT01525602|583348290|FG007|Overall Study|Clinical progression|1|||
161536046|NCT01525602|583348283|FG000|Overall Study|Non-compliance|0|||
161536047|NCT01525602|583348284|FG001|Overall Study|Non-compliance|0|||
161536048|NCT01525602|583348285|FG002|Overall Study|Non-compliance|0|||
161536049|NCT01525602|583348286|FG003|Overall Study|Non-compliance|0|||
161536050|NCT01525602|583348287|FG004|Overall Study|Non-compliance|1|||
161536051|NCT01525602|583348288|FG005|Overall Study|Non-compliance|0|||
161536052|NCT01525602|583348289|FG006|Overall Study|Non-compliance|0|||
161536053|NCT01525602|583348290|FG007|Overall Study|Non-compliance|0|||
161536054|NCT01525602|583348283|FG000|Overall Study|Withdrawal by Subject|0|||
161536055|NCT01525602|583348284|FG001|Overall Study|Withdrawal by Subject|0|||
161536056|NCT01525602|583348285|FG002|Overall Study|Withdrawal by Subject|0|||
161536057|NCT01525602|583348286|FG003|Overall Study|Withdrawal by Subject|0|||
161536058|NCT01525602|583348287|FG004|Overall Study|Withdrawal by Subject|3|||
161536059|NCT01525602|583348288|FG005|Overall Study|Withdrawal by Subject|1|||
161536060|NCT01525602|583348289|FG006|Overall Study|Withdrawal by Subject|0|||
161536061|NCT01525602|583348290|FG007|Overall Study|Withdrawal by Subject|1|||
161536062|NCT01525602|583348283|FG000|Overall Study|Physician Decision|0|||
161536063|NCT01525602|583348284|FG001|Overall Study|Physician Decision|0|||
161536064|NCT01525602|583348285|FG002|Overall Study|Physician Decision|0|||
161536065|NCT01525602|583348286|FG003|Overall Study|Physician Decision|0|||
161536066|NCT01525602|583348287|FG004|Overall Study|Physician Decision|3|||
161536067|NCT01525602|583348288|FG005|Overall Study|Physician Decision|0|||
161536068|NCT01525602|583348289|FG006|Overall Study|Physician Decision|1|||
161536069|NCT01525602|583348290|FG007|Overall Study|Physician Decision|0|||
161536070|NCT01525602|583348283|FG000|Overall Study|Death|0|||
161536071|NCT01525602|583348284|FG001|Overall Study|Death|0|||
161536072|NCT01525602|583348285|FG002|Overall Study|Death|0|||
161536073|NCT01525602|583348286|FG003|Overall Study|Death|0|||
161536074|NCT01525602|583348287|FG004|Overall Study|Death|1|||
161536075|NCT01525602|583348288|FG005|Overall Study|Death|1|||
161536076|NCT01525602|583348289|FG006|Overall Study|Death|0|||
161536077|NCT01525602|583348290|FG007|Overall Study|Death|0|||
161536078|NCT01525602|583348283|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
161536079|NCT01525602|583348284|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
161536080|NCT01525602|583348285|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
161536081|NCT01525602|583348286|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
161536082|NCT01525602|583348287|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
161536083|NCT01525602|583348288|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
161536084|NCT01525602|583348289|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
161536085|NCT01525602|583348290|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
161536086|NCT03703466|583348296|FG000|Overall Study|Death|2|||
161536087|NCT03703466|583348297|FG001|Overall Study|Death|1|||
161536088|NCT03703466|583348298|FG002|Overall Study|Death|0|||
161536089|NCT03703466|583348296|FG000|Overall Study|Withdrawal by Subject|0|||
161536090|NCT03703466|583348297|FG001|Overall Study|Withdrawal by Subject|3|||
161536091|NCT03703466|583348298|FG002|Overall Study|Withdrawal by Subject|0|||
161536092|NCT03703466|583348296|FG000|Overall Study|Completed < 3 Cycles|2|||
161536093|NCT03703466|583348297|FG001|Overall Study|Completed < 3 Cycles|2|||
161536094|NCT03703466|583348298|FG002|Overall Study|Completed < 3 Cycles|2|||
161536095|NCT02412137|583348299|FG000|Overall Study|Withdrawal by Subject|2|||
161536096|NCT02412137|583348300|FG001|Overall Study|Withdrawal by Subject|0|||
161536097|NCT02412137|583348299|FG000|Overall Study|Lost to Follow-up|21|||
161536098|NCT02412137|583348300|FG001|Overall Study|Lost to Follow-up|14|||
161536099|NCT02412137|583348299|FG000|Overall Study|Physician Decision|28|||
161536100|NCT02412137|583348300|FG001|Overall Study|Physician Decision|9|||
161536101|NCT00506493|583348301|FG000|Overall Study|Death|6|||
161536102|NCT00506493|583348301|FG000|Overall Study|Withdrawal by Subject|5|||
161536103|NCT02532179|583349956|FG000|Overall Study|Lost to Follow-up|1|||
161536104|NCT02532179|583349956|FG000|Overall Study|Pregnancy|1|||
161536105|NCT02532179|583349956|FG000|Overall Study|Subject received depot steroid injection|1|||
161536106|NCT02240108|583349957|FG000|Overall Study|Other than specified|8|||
161536107|NCT02240108|583349958|FG001|Overall Study|Other than specified|6|||
161536108|NCT02240108|583349957|FG000|Overall Study|Adverse Event|1|||
161536109|NCT02240108|583349958|FG001|Overall Study|Adverse Event|9|||
161536110|NCT02240108|583349957|FG000|Overall Study|Pregnancy|1|||
161536111|NCT02240108|583349958|FG001|Overall Study|Pregnancy|0|||
161536112|NCT02240108|583349957|FG000|Overall Study|Withdrawal by Subject|4|||
161536113|NCT02240108|583349958|FG001|Overall Study|Withdrawal by Subject|9|||
161536114|NCT02240108|583349957|FG000|Overall Study|StudyTerminated by Sponsor|0|||
161536115|NCT02240108|583349958|FG001|Overall Study|StudyTerminated by Sponsor|1|||
161536116|NCT00119405|583349959|FG000|Overall Study|Withdrawal by Subject|1|||
161536117|NCT00939484|583349961|FG000|Overall Study|Progression/Relapse|8|||
161536118|NCT00939484|583349962|FG001|Overall Study|Progression/Relapse|20|||
161536119|NCT00939484|583349963|FG002|Overall Study|Progression/Relapse|3|||
161536120|NCT04233372|583349964|FG000|Overall Study|Lost to Follow-up|104|||
161536121|NCT04233372|583349964|FG000|Overall Study|Adverse Event|8|||
161536122|NCT04233372|583349964|FG000|Overall Study|Withdrawal by Subject|2|||
161536123|NCT04958785|583349965|FG000|Overall Study|Study Terminated by Sponsor|4|||
161536124|NCT04958785|583349966|FG001|Overall Study|Study Terminated by Sponsor|10|||
161536125|NCT04958785|583349967|FG002|Overall Study|Study Terminated by Sponsor|7|||
161536126|NCT04958785|583349968|FG003|Overall Study|Study Terminated by Sponsor|6|||
161536127|NCT04958785|583349969|FG004|Overall Study|Study Terminated by Sponsor|34|||
161536128|NCT04958785|583349965|FG000|Overall Study|Death|2|||
161536129|NCT04958785|583349966|FG001|Overall Study|Death|3|||
161536130|NCT04958785|583349967|FG002|Overall Study|Death|4|||
161536131|NCT04958785|583349968|FG003|Overall Study|Death|5|||
161536132|NCT04958785|583349969|FG004|Overall Study|Death|5|||
161536133|NCT04958785|583349965|FG000|Overall Study|Withdrew consent|2|||
161536134|NCT04958785|583349966|FG001|Overall Study|Withdrew consent|0|||
161536135|NCT04958785|583349967|FG002|Overall Study|Withdrew consent|3|||
161536136|NCT04958785|583349968|FG003|Overall Study|Withdrew consent|1|||
161536137|NCT04958785|583349969|FG004|Overall Study|Withdrew consent|0|||
161536138|NCT04958785|583349965|FG000|Overall Study|Investigator's discretion|0|||
161592150|NCT03150810|583556712|FG009|Overall Study|Participant relocated abroad.|0|||
161592151|NCT03150810|583556713|FG010|Overall Study|Participant relocated abroad.|0|||
161592152|NCT03150810|583556714|FG011|Overall Study|Participant relocated abroad.|0|||
161592153|NCT03150810|583556715|FG012|Overall Study|Participant relocated abroad.|0|||
161592154|NCT03150810|583556703|FG000|Overall Study|Transferred care to oncologist|0|||
161592155|NCT03150810|583556704|FG001|Overall Study|Transferred care to oncologist|0|||
161592156|NCT03150810|583556705|FG002|Overall Study|Transferred care to oncologist|0|||
161592157|NCT03150810|583556706|FG003|Overall Study|Transferred care to oncologist|0|||
161592158|NCT03150810|583556707|FG004|Overall Study|Transferred care to oncologist|0|||
161536139|NCT04958785|583349966|FG001|Overall Study|Investigator's discretion|1|||
161536140|NCT04958785|583349967|FG002|Overall Study|Investigator's discretion|0|||
161536141|NCT04958785|583349968|FG003|Overall Study|Investigator's discretion|1|||
161536142|NCT04958785|583349969|FG004|Overall Study|Investigator's discretion|2|||
161536143|NCT04958785|583349965|FG000|Overall Study|Adverse Event|0|||
161536144|NCT04958785|583349966|FG001|Overall Study|Adverse Event|0|||
161536145|NCT04958785|583349967|FG002|Overall Study|Adverse Event|0|||
161536146|NCT04958785|583349968|FG003|Overall Study|Adverse Event|0|||
161536147|NCT04958785|583349969|FG004|Overall Study|Adverse Event|1|||
161536148|NCT04958785|583349965|FG000|Overall Study|Lost to Follow-up|0|||
161536149|NCT04958785|583349966|FG001|Overall Study|Lost to Follow-up|0|||
161592159|NCT03150810|583556708|FG005|Overall Study|Transferred care to oncologist|0|||
161536150|NCT04958785|583349967|FG002|Overall Study|Lost to Follow-up|0|||
161536151|NCT04958785|583349968|FG003|Overall Study|Lost to Follow-up|0|||
161536152|NCT04958785|583349969|FG004|Overall Study|Lost to Follow-up|1|||
161536153|NCT01090310|583349970|FG000|Core Study|Adverse Event|2|||
161536154|NCT01090310|583349971|FG001|Core Study|Adverse Event|2|||
161592160|NCT03150810|583556709|FG006|Overall Study|Transferred care to oncologist|2|||
161536155|NCT01090310|583349972|FG002|Core Study|Adverse Event|1|||
161536156|NCT01090310|583349973|FG003|Core Study|Adverse Event|1|||
161536157|NCT01090310|583349970|FG000|Core Study|Subject withdrew consent|0|||
161536158|NCT01090310|583349971|FG001|Core Study|Subject withdrew consent|3|||
161536159|NCT01090310|583349972|FG002|Core Study|Subject withdrew consent|1|||
161536160|NCT01090310|583349973|FG003|Core Study|Subject withdrew consent|1|||
161536161|NCT01090310|583349970|FG000|Core Study|Abnormal test procedure result|0|||
161536162|NCT01090310|583349971|FG001|Core Study|Abnormal test procedure result|0|||
161536163|NCT01090310|583349972|FG002|Core Study|Abnormal test procedure result|1|||
161536164|NCT01090310|583349973|FG003|Core Study|Abnormal test procedure result|0|||
161536165|NCT01090310|583349970|FG000|Core Study|Administrative reasons|5|||
161536166|NCT01090310|583349971|FG001|Core Study|Administrative reasons|6|||
161536167|NCT01090310|583349972|FG002|Core Study|Administrative reasons|4|||
161536168|NCT01090310|583349973|FG003|Core Study|Administrative reasons|4|||
161536169|NCT01090310|583349970|FG000|Core Study|Protocol deviation|1|||
161536170|NCT01090310|583349971|FG001|Core Study|Protocol deviation|0|||
161536171|NCT01090310|583349972|FG002|Core Study|Protocol deviation|0|||
161536172|NCT01090310|583349973|FG003|Core Study|Protocol deviation|1|||
161536173|NCT01090310|583349970|FG000|Extension Study|Aministrative problems|13|||
161536174|NCT01090310|583349971|FG001|Extension Study|Aministrative problems|15|||
161536175|NCT01090310|583349972|FG002|Extension Study|Aministrative problems|14|||
161536176|NCT01090310|583349973|FG003|Extension Study|Aministrative problems|18|||
161536177|NCT01090310|583349970|FG000|Extension Study|Adverse Event|0|||
161536178|NCT01090310|583349971|FG001|Extension Study|Adverse Event|0|||
161536179|NCT01090310|583349972|FG002|Extension Study|Adverse Event|0|||
161536180|NCT01090310|583349973|FG003|Extension Study|Adverse Event|1|||
161536181|NCT01090310|583349970|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
161536182|NCT01090310|583349971|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
161536183|NCT01090310|583349972|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
161536184|NCT01090310|583349973|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
161536185|NCT01090310|583349970|FG000|Extension Study|Subject withdrew consent|0|||
161536186|NCT01090310|583349971|FG001|Extension Study|Subject withdrew consent|1|||
161536187|NCT01090310|583349972|FG002|Extension Study|Subject withdrew consent|0|||
161536188|NCT01090310|583349973|FG003|Extension Study|Subject withdrew consent|0|||
161536189|NCT01224925|583349974|FG000|Overall Study|Lost to Follow-up|3|||
161536190|NCT01224925|583349975|FG001|Overall Study|Lost to Follow-up|2|||
161536191|NCT01083641|583349977|FG000|Overall Study|Withdrawal by Subject|2|||
161536192|NCT03439189|583349978|FG000|Overall Study|Protocol Violation|19|||
161536193|NCT03439189|583349978|FG000|Overall Study|Lack of Efficacy|63|||
161536194|NCT01777321|583349979|FG000|Overall Study|Withdrawal by Subject|0|||
161592161|NCT03150810|583556710|FG007|Overall Study|Transferred care to oncologist|0|||
161592162|NCT03150810|583556711|FG008|Overall Study|Transferred care to oncologist|0|||
161592163|NCT03150810|583556712|FG009|Overall Study|Transferred care to oncologist|0|||
161592164|NCT03150810|583556713|FG010|Overall Study|Transferred care to oncologist|0|||
161592165|NCT03150810|583556714|FG011|Overall Study|Transferred care to oncologist|0|||
161592166|NCT03150810|583556715|FG012|Overall Study|Transferred care to oncologist|0|||
161592167|NCT04526704|583556716|FG000|Overall Study|Adverse Event|1|||
161592168|NCT04526704|583556717|FG001|Overall Study|Adverse Event|0|||
161536195|NCT01777321|583349980|FG001|Overall Study|Withdrawal by Subject|1|||
161536196|NCT02173548|583349981|FG000|Overall Study|Lost to Follow-up|0|||
161536197|NCT02173548|583349982|FG001|Overall Study|Lost to Follow-up|2|||
161536198|NCT02173548|583349981|FG000|Overall Study|Withdrawal by Subject|1|||
161536199|NCT02173548|583349982|FG001|Overall Study|Withdrawal by Subject|0|||
161536200|NCT03597568|583349983|FG000|Overall Study|Withdrawal by Subject|1|||
161536201|NCT03597568|583349984|FG001|Overall Study|Withdrawal by Subject|1|||
161536202|NCT03597568|583349983|FG000|Overall Study|Unable to analyze vascular data|1|||
161536203|NCT03597568|583349984|FG001|Overall Study|Unable to analyze vascular data|1|||
161536204|NCT00999466|583349987|FG000|Main Part|Withdrawal by Subject|0|||
161536205|NCT00999466|583349988|FG001|Main Part|Withdrawal by Subject|0|||
161536206|NCT00999466|583349989|FG002|Main Part|Withdrawal by Subject|2|||
161536207|NCT00999466|583349987|FG000|Main Part|Adverse Event|0|||
161536208|NCT00999466|583349988|FG001|Main Part|Adverse Event|4|||
161592169|NCT04526704|583556716|FG000|Overall Study|Physician Decision|1|||
161536209|NCT00999466|583349989|FG002|Main Part|Adverse Event|2|||
161536210|NCT05131165|583349990|FG000|Overall Study|Death|1|||
161536211|NCT05131165|583349991|FG001|Overall Study|Death|1|||
161536212|NCT05131165|583349992|FG002|Overall Study|Death|0|||
161536213|NCT05131165|583349990|FG000|Overall Study|Lost to Follow-up|2|||
161536214|NCT05131165|583349991|FG001|Overall Study|Lost to Follow-up|2|||
161536215|NCT05131165|583349992|FG002|Overall Study|Lost to Follow-up|5|||
161536216|NCT05131165|583349990|FG000|Overall Study|Transferred out of clinic|1|||
161536217|NCT05131165|583349991|FG001|Overall Study|Transferred out of clinic|0|||
161536218|NCT05131165|583349992|FG002|Overall Study|Transferred out of clinic|3|||
161536219|NCT05131165|583349990|FG000|Overall Study|Dropped out|1|||
161536220|NCT05131165|583349991|FG001|Overall Study|Dropped out|2|||
161592170|NCT04526704|583556717|FG001|Overall Study|Physician Decision|0|||
161592171|NCT04526704|583556716|FG000|Overall Study|Withdrawal by Subject|2|||
161536221|NCT05131165|583349992|FG002|Overall Study|Dropped out|0|||
161536222|NCT00526630|583349993|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
161536223|NCT00526630|583349994|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
161536224|NCT00526630|583349993|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
161536225|NCT00526630|583349994|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
161536226|NCT00337272|583349995|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
161536227|NCT00337272|583349996|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
161536228|NCT00337272|583349995|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
161536229|NCT00337272|583349996|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
161536230|NCT00337272|583349995|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
161536231|NCT00337272|583349996|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
161536232|NCT00337272|583349995|FG000|Treatment Period|Non-compliance|1|||
161536233|NCT00337272|583349996|FG001|Treatment Period|Non-compliance|1|||
161536234|NCT00337272|583349995|FG000|Treatment Period|Withdrawal by Subject|0|||
161536235|NCT00337272|583349996|FG001|Treatment Period|Withdrawal by Subject|1|||
161536236|NCT00337272|583349995|FG000|Withdrawal Period|Non-compliance|0|||
161536237|NCT00337272|583349996|FG001|Withdrawal Period|Non-compliance|1|||
161536238|NCT03320018|583350002|FG000|Treatment Period|Withdrawal by Subject|1|||
161536239|NCT03320018|583350003|FG001|Treatment Period|Withdrawal by Subject|0|||
161536240|NCT03320018|583350002|FG000|Day 90 Follow up|Death|0|||
161536241|NCT03320018|583350003|FG001|Day 90 Follow up|Death|1|||
161536242|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
161536243|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
161536244|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
161536245|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
161536246|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
161536247|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
161536248|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
161536249|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
161536250|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
161536251|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
161536252|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
161536253|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
161536254|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
161536255|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
161536256|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
161536257|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
161536258|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
161536259|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
161536260|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
161536261|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
161536262|NCT00549757|583350004|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
161678727|NCT00131469|583876064|FG001|Overall Study|Lost to Follow-up|1|||
161678728|NCT00131469|583876063|FG000|Overall Study|scan not analyzable|3|||
161678729|NCT00131469|583876064|FG001|Overall Study|scan not analyzable|6|||
161678730|NCT00574288|583876065|FG000|Overall Study|Adverse Event|2|||
161678731|NCT00574288|583876066|FG001|Overall Study|Adverse Event|0|||
161678732|NCT00574288|583876067|FG002|Overall Study|Adverse Event|0|||
161678733|NCT00574288|583876068|FG003|Overall Study|Adverse Event|0|||
161536263|NCT00549757|583350005|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
161536264|NCT00549757|583350004|FG000|Extension Period (in Average 9 Months)|Death|143|||
161536265|NCT00549757|583350005|FG001|Extension Period (in Average 9 Months)|Death|136|||
161536266|NCT00549757|583350004|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
161536267|NCT00549757|583350005|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
161536268|NCT00549757|583350004|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
161536269|NCT00549757|583350005|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
161536270|NCT00549757|583350004|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
161536271|NCT00549757|583350005|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
161536272|NCT05453110|583350024|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
161536273|NCT05453110|583350025|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
161536274|NCT05453110|583350026|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
161536275|NCT05906368|583350027|FG000|Overall Study|Withdrawal by Subject|1|||
161678734|NCT00574288|583876069|FG004|Overall Study|Adverse Event|1|||
161678735|NCT00574288|583876070|FG005|Overall Study|Adverse Event|0|||
161678736|NCT00574288|583876071|FG006|Overall Study|Adverse Event|0|||
161678737|NCT00574288|583876065|FG000|Overall Study|Death|0|||
161678738|NCT00574288|583876066|FG001|Overall Study|Death|0|||
161678739|NCT00574288|583876067|FG002|Overall Study|Death|0|||
161678740|NCT00574288|583876068|FG003|Overall Study|Death|0|||
161678741|NCT00574288|583876069|FG004|Overall Study|Death|0|||
161592172|NCT04526704|583556717|FG001|Overall Study|Withdrawal by Subject|0|||
161592173|NCT06393088|583556718|FG000|Overall Study|Withdrawal by Subject|0|||
161592174|NCT06393088|583556719|FG001|Overall Study|Withdrawal by Subject|2|||
161592175|NCT04782973|583556720|FG000|Overall Study|Withdrawal by Subject|5|||
161592176|NCT04782973|583556720|FG000|Overall Study|Protocol Violation|6|||
161592177|NCT04782973|583556720|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
161592178|NCT04495894|583556731|FG000|Overall Study|Withdrawal by Subject|2|||
161592179|NCT04495894|583556732|FG001|Overall Study|Withdrawal by Subject|0|||
161592180|NCT04495894|583556733|FG002|Overall Study|Withdrawal by Subject|2|||
161592181|NCT04495894|583556734|FG003|Overall Study|Withdrawal by Subject|3|||
161592182|NCT04495894|583556731|FG000|Overall Study|Early termination|0|||
161592183|NCT04495894|583556732|FG001|Overall Study|Early termination|0|||
161592184|NCT04495894|583556733|FG002|Overall Study|Early termination|3|||
161592185|NCT04495894|583556734|FG003|Overall Study|Early termination|0|||
161592186|NCT01000961|583556735|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161592187|NCT01000961|583556736|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161536276|NCT05906368|583350028|FG001|Overall Study|Withdrawal by Subject|1|||
161536277|NCT05906368|583350027|FG000|Overall Study|Ineligibility criteria identified|2|||
161536278|NCT05906368|583350028|FG001|Overall Study|Ineligibility criteria identified|0|||
161536279|NCT01127646|583350029|FG000|Overall Study|Entry Criteria Not Met|1|||
161536280|NCT01127646|583350030|FG001|Overall Study|Entry Criteria Not Met|0|||
161536281|NCT01127646|583350029|FG000|Overall Study|Protocol Violation|0|||
161536282|NCT01127646|583350030|FG001|Overall Study|Protocol Violation|1|||
161536283|NCT00595504|583350034|FG000|Overall Study|Withdrawal by Subject|1|||
161536284|NCT00595504|583350035|FG001|Overall Study|Withdrawal by Subject|3|||
161536285|NCT00595504|583350034|FG000|Overall Study|Physician Decision|1|||
161536286|NCT00595504|583350035|FG001|Overall Study|Physician Decision|0|||
161536287|NCT01662063|583350036|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
161536288|NCT01662063|583350037|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
161536289|NCT01662063|583350038|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
161536290|NCT01662063|583350036|FG000|Overall Study|Lack of Efficacy|1|||
161536291|NCT01662063|583350037|FG001|Overall Study|Lack of Efficacy|6|||
161536292|NCT01662063|583350038|FG002|Overall Study|Lack of Efficacy|0|||
161536293|NCT01662063|583350036|FG000|Overall Study|Lost to Follow-up|0|||
161536294|NCT01662063|583350037|FG001|Overall Study|Lost to Follow-up|4|||
161536295|NCT01662063|583350038|FG002|Overall Study|Lost to Follow-up|0|||
161536296|NCT01662063|583350036|FG000|Overall Study|Protocol Violation|1|||
161536297|NCT01662063|583350037|FG001|Overall Study|Protocol Violation|0|||
161536298|NCT01662063|583350038|FG002|Overall Study|Protocol Violation|0|||
161536299|NCT01662063|583350036|FG000|Overall Study|Withdrawal by Subject|2|||
161536300|NCT01662063|583350037|FG001|Overall Study|Withdrawal by Subject|4|||
161536301|NCT01662063|583350038|FG002|Overall Study|Withdrawal by Subject|1|||
161536302|NCT01662063|583350036|FG000|Overall Study|Physician Decision|0|||
161536303|NCT01662063|583350037|FG001|Overall Study|Physician Decision|2|||
161536304|NCT01662063|583350038|FG002|Overall Study|Physician Decision|0|||
161536305|NCT01662063|583350036|FG000|Overall Study|Other|0|||
161536306|NCT01662063|583350037|FG001|Overall Study|Other|1|||
161536307|NCT01662063|583350038|FG002|Overall Study|Other|0|||
161536308|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
161536309|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
161536310|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
161536311|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
161536312|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
161536313|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
161536314|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
161536315|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
161536316|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
161536317|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
161536318|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
161536319|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
161536320|NCT00293267|583350042|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
161536321|NCT00293267|583350043|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
161536322|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
161536323|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
161536324|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
161536325|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
161536326|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
161536327|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
161536328|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
161592188|NCT01000961|583556735|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
161592189|NCT01000961|583556736|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
161592190|NCT05746455|583556739|FG000|Overall Study|Discharged from Clinical Service|1|||
161536329|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
161536330|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Death|3|||
161536331|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Death|0|||
161536332|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
161536333|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
161536334|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
161536335|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
161536336|NCT00293267|583350042|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
161536337|NCT00293267|583350043|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
161536338|NCT00293267|583350042|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
161536339|NCT00293267|583350043|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
161536340|NCT00293267|583350042|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
161536341|NCT00293267|583350043|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
161536342|NCT00293267|583350042|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
161536343|NCT00293267|583350043|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
161536344|NCT00293267|583350042|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
161536345|NCT00293267|583350043|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
161536346|NCT00293267|583350042|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
161536347|NCT00293267|583350043|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
161536348|NCT00293267|583350042|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
161536349|NCT00293267|583350043|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
161536350|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
161536351|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
161536352|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
161536353|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
161536354|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
161536355|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
161536356|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
161536357|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
161536358|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
161536359|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
161536360|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
161536361|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
161536362|NCT00293267|583350042|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
161536363|NCT00293267|583350043|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
161536364|NCT01477853|583350044|FG000|Phase A|Adverse Event|1|||
161536365|NCT01477853|583350045|FG001|Phase A|Adverse Event|2|||
161536366|NCT01477853|583350046|FG002|Phase A|Adverse Event|2|||
161536367|NCT01477853|583350044|FG000|Phase A|Lost to Follow-up|4|||
161536368|NCT01477853|583350045|FG001|Phase A|Lost to Follow-up|3|||
161536369|NCT01477853|583350046|FG002|Phase A|Lost to Follow-up|2|||
161536370|NCT01477853|583350044|FG000|Phase A|Physician Decision|1|||
161536371|NCT01477853|583350045|FG001|Phase A|Physician Decision|0|||
161536372|NCT01477853|583350046|FG002|Phase A|Physician Decision|1|||
161536373|NCT01477853|583350044|FG000|Phase A|Study terminated by sponsor|37|||
161536374|NCT01477853|583350045|FG001|Phase A|Study terminated by sponsor|40|||
161536375|NCT01477853|583350046|FG002|Phase A|Study terminated by sponsor|39|||
161536376|NCT01477853|583350044|FG000|Phase B|Lost to Follow-up|0|||
161536377|NCT01477853|583350045|FG001|Phase B|Lost to Follow-up|1|||
161536378|NCT01477853|583350046|FG002|Phase B|Lost to Follow-up|0|||
161536379|NCT01477853|583350044|FG000|Phase B|Study terminated by sponsor|12|||
161536380|NCT01477853|583350045|FG001|Phase B|Study terminated by sponsor|10|||
161536381|NCT01477853|583350046|FG002|Phase B|Study terminated by sponsor|11|||
161536382|NCT01050816|583350047|FG000|Overall Study|Lost to Follow-up|2|||
161536383|NCT01050816|583350047|FG000|Overall Study|patient's refusal|2|||
161536384|NCT01804816|583350048|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
161536385|NCT01804816|583350048|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
161536386|NCT01754467|583350049|FG000|Overall Study|Lost to Follow-up|1|||
161536387|NCT01970462|583350052|FG000|Overall Study|Lost to Follow-up|0|||
161536388|NCT01970462|583350053|FG001|Overall Study|Lost to Follow-up|2|||
161536389|NCT02740049|583350054|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
161536390|NCT03172702|583350058|FG000|Overall Study|Adverse Event|9|||
161536391|NCT03172702|583350058|FG000|Overall Study|Death|2|||
161592191|NCT05746455|583556739|FG000|Overall Study|Lost to Follow-up|1|||
161592192|NCT02023866|583556740|FG000|Overall Study|Non-compliance|2|||
161592193|NCT02023866|583556740|FG000|Overall Study|Adverse Event|3|||
161592194|NCT02023866|583556740|FG000|Overall Study|Withdrawal by Subject|1|||
161592195|NCT03307343|583556741|FG000|Overall Study|Withdrawal by Subject|1|||
161592196|NCT03307343|583556742|FG001|Overall Study|Withdrawal by Subject|2|||
161592197|NCT03307343|583556741|FG000|Overall Study|Pregnancy|0|||
161536392|NCT03172702|583350058|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
161536393|NCT03172702|583350058|FG000|Overall Study|Withdrawal by Subject|5|||
161592198|NCT03307343|583556742|FG001|Overall Study|Pregnancy|2|||
161592199|NCT03307343|583556741|FG000|Overall Study|Physician Decision|1|||
161536394|NCT03172702|583350058|FG000|Overall Study|Other|2|||
161536395|NCT00374322|583350059|FG000|Overall Study|Lost to Follow-up|92|||
161536396|NCT00374322|583350060|FG001|Overall Study|Lost to Follow-up|90|||
161536397|NCT00374322|583350059|FG000|Overall Study|Protocol Violation|8|||
161536398|NCT00374322|583350060|FG001|Overall Study|Protocol Violation|3|||
161536399|NCT00374322|583350059|FG000|Overall Study|Withdrawal by Subject|235|||
161536400|NCT00374322|583350060|FG001|Overall Study|Withdrawal by Subject|167|||
161536401|NCT00374322|583350059|FG000|Overall Study|Sponsor Terminated Study|866|||
161536402|NCT00374322|583350060|FG001|Overall Study|Sponsor Terminated Study|990|||
161536403|NCT00374322|583350059|FG000|Overall Study|Physician Decision|36|||
161536404|NCT00374322|583350060|FG001|Overall Study|Physician Decision|32|||
161536405|NCT00374322|583350059|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
161536406|NCT00374322|583350060|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
161536407|NCT00374322|583350059|FG000|Overall Study|Sponsor Decision|2|||
161536408|NCT00374322|583350060|FG001|Overall Study|Sponsor Decision|3|||
161536409|NCT00374322|583350059|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
161536410|NCT00374322|583350060|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
161536411|NCT00374322|583350059|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
161536412|NCT00374322|583350060|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
161536413|NCT00374322|583350059|FG000|Overall Study|Severe Toxicity|1|||
161536414|NCT00374322|583350060|FG001|Overall Study|Severe Toxicity|0|||
161536415|NCT00374322|583350059|FG000|Overall Study|Site Closed|2|||
161536416|NCT00374322|583350060|FG001|Overall Study|Site Closed|2|||
161536417|NCT00374322|583350059|FG000|Overall Study|Participant Changed Physician|1|||
161536418|NCT00374322|583350060|FG001|Overall Study|Participant Changed Physician|0|||
161536419|NCT00374322|583350059|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
161536420|NCT00374322|583350060|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
161536421|NCT00374322|583350059|FG000|Overall Study|Noncompliance with Study Requirements|0|||
161536422|NCT00374322|583350060|FG001|Overall Study|Noncompliance with Study Requirements|1|||
161536423|NCT00374322|583350059|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
161536424|NCT00374322|583350060|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
161536425|NCT00374322|583350059|FG000|Overall Study|Did Not Receive Study Medication|8|||
161536426|NCT00374322|583350060|FG001|Overall Study|Did Not Receive Study Medication|6|||
161536427|NCT00636610|583350064|FG000|Overall Study|Adverse Event|4|||
161536428|NCT00636610|583350065|FG001|Overall Study|Adverse Event|4|||
161536429|NCT00636610|583350064|FG000|Overall Study|Death|6|||
161536430|NCT00636610|583350065|FG001|Overall Study|Death|3|||
161536431|NCT00636610|583350064|FG000|Overall Study|Physician decision to withdraw patient|15|||
161536432|NCT00636610|583350065|FG001|Overall Study|Physician decision to withdraw patient|9|||
161536433|NCT00636610|583350064|FG000|Overall Study|Subject decision to withdraw|15|||
161536434|NCT00636610|583350065|FG001|Overall Study|Subject decision to withdraw|11|||
161536435|NCT00636610|583350064|FG000|Overall Study|Disease progression - radiographic|41|||
161536436|NCT00636610|583350065|FG001|Overall Study|Disease progression - radiographic|51|||
161536437|NCT00636610|583350064|FG000|Overall Study|Disease progression - clinical|8|||
161536438|NCT00636610|583350065|FG001|Overall Study|Disease progression - clinical|3|||
161536439|NCT00636610|583350064|FG000|Overall Study|Reason for discontinuation not available|3|||
161536440|NCT00636610|583350065|FG001|Overall Study|Reason for discontinuation not available|2|||
161536441|NCT02495025|583350066|FG000|Overall Study|Lost to Follow-up|21|||
161536442|NCT02495025|583350067|FG001|Overall Study|Lost to Follow-up|14|||
161592200|NCT03307343|583556742|FG001|Overall Study|Physician Decision|0|||
161592201|NCT03307343|583556741|FG000|Overall Study|Lost to Follow-up|0|||
161592202|NCT03307343|583556742|FG001|Overall Study|Lost to Follow-up|2|||
161592203|NCT04683744|583556744|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
161592204|NCT04683744|583556745|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
161592205|NCT04683744|583556746|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
161592206|NCT05184192|583556749|FG000|Overall Study|Lost to Follow-up|4|||
161592207|NCT05184192|583556750|FG001|Overall Study|Lost to Follow-up|7|||
161592208|NCT05184192|583556749|FG000|Overall Study|Adverse Event|1|||
161592209|NCT05184192|583556750|FG001|Overall Study|Adverse Event|4|||
161592210|NCT05184192|583556749|FG000|Overall Study|PI withdrawal|1|||
161592211|NCT05184192|583556750|FG001|Overall Study|PI withdrawal|2|||
161592212|NCT05184192|583556749|FG000|Overall Study|Withdrew due to adverse effect|1|||
161592213|NCT05184192|583556750|FG001|Overall Study|Withdrew due to adverse effect|0|||
161592214|NCT05184192|583556749|FG000|Overall Study|Medication schedule|1|||
161592215|NCT05184192|583556750|FG001|Overall Study|Medication schedule|0|||
161592216|NCT05184192|583556749|FG000|Overall Study|Concern for adverse effects|0|||
161592217|NCT05184192|583556750|FG001|Overall Study|Concern for adverse effects|4|||
161592218|NCT01824394|583556756|FG000|Overall Study|Early Termination|1|||
161592219|NCT01824394|583556757|FG001|Overall Study|Early Termination|1|||
161592220|NCT01824394|583556758|FG002|Overall Study|Early Termination|3|||
161592221|NCT01824394|583556756|FG000|Overall Study|Withdrawn due to Study Termination|91|||
161592222|NCT01824394|583556757|FG001|Overall Study|Withdrawn due to Study Termination|83|||
161592223|NCT01824394|583556758|FG002|Overall Study|Withdrawn due to Study Termination|41|||
161592224|NCT01824394|583556756|FG000|Overall Study|Lost to Follow-up|0|||
161592225|NCT01824394|583556757|FG001|Overall Study|Lost to Follow-up|9|||
161592226|NCT01824394|583556758|FG002|Overall Study|Lost to Follow-up|3|||
161592227|NCT01824394|583556756|FG000|Overall Study|Death|3|||
161592228|NCT01824394|583556757|FG001|Overall Study|Death|2|||
161592229|NCT01824394|583556758|FG002|Overall Study|Death|4|||
161592230|NCT01824394|583556756|FG000|Overall Study|Discontinued Subjects|1|||
161592231|NCT01824394|583556757|FG001|Overall Study|Discontinued Subjects|1|||
161592232|NCT01824394|583556758|FG002|Overall Study|Discontinued Subjects|2|||
161592233|NCT01824394|583556756|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
161592234|NCT01824394|583556757|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
161592235|NCT01824394|583556758|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
161592236|NCT04015167|583556760|FG000|Overall Study|Lost to Follow-up|40|||
161592237|NCT04015167|583556760|FG000|Overall Study|Adverse Event|5|||
161592238|NCT04015167|583556760|FG000|Overall Study|Withdrawal by Subject|2|||
161592239|NCT04015167|583556760|FG000|Overall Study|Subject went to jail|1|||
161592240|NCT04810650|583556762|FG000|Overall Study|Disenrolled in error|0|||
161592241|NCT04810650|583556763|FG001|Overall Study|Disenrolled in error|0|||
161592242|NCT04810650|583556764|FG002|Overall Study|Disenrolled in error|0|||
161592243|NCT04810650|583556765|FG003|Overall Study|Disenrolled in error|0|||
161592244|NCT04810650|583556766|FG004|Overall Study|Disenrolled in error|0|||
161592245|NCT04810650|583556767|FG005|Overall Study|Disenrolled in error|0|||
161592246|NCT04810650|583556768|FG006|Overall Study|Disenrolled in error|0|||
161592247|NCT04810650|583556769|FG007|Overall Study|Disenrolled in error|0|||
161592248|NCT04810650|583556770|FG008|Overall Study|Disenrolled in error|1|||
161592249|NCT04810650|583556771|FG009|Overall Study|Disenrolled in error|0|||
161536443|NCT02495025|583350066|FG000|Overall Study|Withdrawal by Subject|5|||
161592250|NCT04810650|583556772|FG010|Overall Study|Disenrolled in error|0|||
161592251|NCT04810650|583556773|FG011|Overall Study|Disenrolled in error|0|||
161592252|NCT04810650|583556774|FG012|Overall Study|Disenrolled in error|0|||
161592253|NCT04810650|583556775|FG013|Overall Study|Disenrolled in error|0|||
161592254|NCT04810650|583556762|FG000|Overall Study|Death|0|||
161592255|NCT04810650|583556763|FG001|Overall Study|Death|0|||
161592256|NCT04810650|583556764|FG002|Overall Study|Death|0|||
161592257|NCT04810650|583556765|FG003|Overall Study|Death|0|||
161592258|NCT04810650|583556766|FG004|Overall Study|Death|0|||
161592259|NCT04810650|583556767|FG005|Overall Study|Death|0|||
161536444|NCT02495025|583350067|FG001|Overall Study|Withdrawal by Subject|0|||
161536445|NCT02151266|583350072|FG000|Overall Study|Lost to Follow-up|1|||
161536446|NCT02151266|583350073|FG001|Overall Study|Lost to Follow-up|4|||
161536447|NCT02151266|583350074|FG002|Overall Study|Lost to Follow-up|1|||
161536448|NCT02151266|583350072|FG000|Overall Study|Did NOT receive intervention|3|||
161536449|NCT02151266|583350073|FG001|Overall Study|Did NOT receive intervention|6|||
161536450|NCT02151266|583350074|FG002|Overall Study|Did NOT receive intervention|2|||
161536451|NCT02151266|583350072|FG000|Overall Study|Not able to exercise|4|||
161536452|NCT02151266|583350073|FG001|Overall Study|Not able to exercise|5|||
161536453|NCT02151266|583350074|FG002|Overall Study|Not able to exercise|4|||
161536454|NCT01169675|583350075|FG000|Overall Study|Progressive disease|13|||
161536455|NCT01169675|583350076|FG001|Overall Study|Progressive disease|2|||
161536456|NCT01169675|583350077|FG002|Overall Study|Progressive disease|5|||
161536457|NCT01169675|583350078|FG003|Overall Study|Progressive disease|15|||
161536458|NCT01169675|583350079|FG004|Overall Study|Progressive disease|1|||
161536459|NCT01169675|583350075|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161536460|NCT01169675|583350076|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161536461|NCT01169675|583350077|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161536462|NCT01169675|583350078|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161536463|NCT01169675|583350079|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161536464|NCT01169675|583350075|FG000|Overall Study|Adverse Event|5|||
161536465|NCT01169675|583350076|FG001|Overall Study|Adverse Event|1|||
161536466|NCT01169675|583350077|FG002|Overall Study|Adverse Event|2|||
161536467|NCT01169675|583350078|FG003|Overall Study|Adverse Event|0|||
161536468|NCT01169675|583350079|FG004|Overall Study|Adverse Event|0|||
161536469|NCT01169675|583350075|FG000|Overall Study|Withdrawal by Subject|1|||
161536470|NCT01169675|583350076|FG001|Overall Study|Withdrawal by Subject|0|||
161536471|NCT01169675|583350077|FG002|Overall Study|Withdrawal by Subject|0|||
161536472|NCT01169675|583350078|FG003|Overall Study|Withdrawal by Subject|1|||
161536473|NCT01169675|583350079|FG004|Overall Study|Withdrawal by Subject|2|||
161536474|NCT01169675|583350075|FG000|Overall Study|Other Reason Not Defined Above|0|||
161536475|NCT01169675|583350076|FG001|Overall Study|Other Reason Not Defined Above|0|||
161536476|NCT01169675|583350077|FG002|Overall Study|Other Reason Not Defined Above|0|||
161536477|NCT01169675|583350078|FG003|Overall Study|Other Reason Not Defined Above|1|||
161536478|NCT01169675|583350079|FG004|Overall Study|Other Reason Not Defined Above|1|||
161536479|NCT05899686|583350082|FG000|Overall Study|Protocol Violation|1|||
161536480|NCT00572195|583350083|FG000|Overall Study|Withdrawal by Subject|50|||
161536481|NCT00572195|583350083|FG000|Overall Study|Death|9|||
161536482|NCT00572195|583350083|FG000|Overall Study|Adverse Event|4|||
161536483|NCT00572195|583350083|FG000|Overall Study|Lost to Follow-up|5|||
161536484|NCT03076970|583351917|FG000|Washout Period 2|Adverse Event|0|||
161536485|NCT03076970|583351918|FG001|Washout Period 2|Adverse Event|0|||
161536486|NCT03076970|583351919|FG002|Washout Period 2|Adverse Event|0|||
161536487|NCT03076970|583351920|FG003|Washout Period 2|Adverse Event|0|||
161536488|NCT03076970|583351921|FG004|Washout Period 2|Adverse Event|1|||
161536489|NCT03076970|583351922|FG005|Washout Period 2|Adverse Event|0|||
161536490|NCT03076970|583351917|FG000|Period 3|Withdrawal by Subject|0|||
161536491|NCT03076970|583351918|FG001|Period 3|Withdrawal by Subject|0|||
161536492|NCT03076970|583351919|FG002|Period 3|Withdrawal by Subject|0|||
161536493|NCT03076970|583351920|FG003|Period 3|Withdrawal by Subject|0|||
161536494|NCT03076970|583351921|FG004|Period 3|Withdrawal by Subject|0|||
161536495|NCT03076970|583351922|FG005|Period 3|Withdrawal by Subject|1|||
161536496|NCT03076970|583351917|FG000|Period 3|Failure to meet I/E criteria|0|||
161536497|NCT03076970|583351918|FG001|Period 3|Failure to meet I/E criteria|0|||
161536498|NCT03076970|583351919|FG002|Period 3|Failure to meet I/E criteria|0|||
161536499|NCT03076970|583351920|FG003|Period 3|Failure to meet I/E criteria|0|||
161536500|NCT03076970|583351921|FG004|Period 3|Failure to meet I/E criteria|1|||
161536501|NCT03076970|583351922|FG005|Period 3|Failure to meet I/E criteria|0|||
161536502|NCT01984697|583351923|FG000|Overall Study|Adverse Event|0|||
161536503|NCT01984697|583351924|FG001|Overall Study|Adverse Event|0|||
161536504|NCT01984697|583351925|FG002|Overall Study|Adverse Event|2|||
161536505|NCT01984697|583351926|FG003|Overall Study|Adverse Event|0|||
161536506|NCT01984697|583351927|FG004|Overall Study|Adverse Event|0|||
161536507|NCT01984697|583351923|FG000|Overall Study|Lost to Follow-up|14|||
161536508|NCT01984697|583351924|FG001|Overall Study|Lost to Follow-up|5|||
161536509|NCT01984697|583351925|FG002|Overall Study|Lost to Follow-up|10|||
161536510|NCT01984697|583351926|FG003|Overall Study|Lost to Follow-up|6|||
161536511|NCT01984697|583351927|FG004|Overall Study|Lost to Follow-up|21|||
161536512|NCT01984697|583351923|FG000|Overall Study|Physician Decision|3|||
161536513|NCT01984697|583351924|FG001|Overall Study|Physician Decision|0|||
161536514|NCT01984697|583351925|FG002|Overall Study|Physician Decision|0|||
161536515|NCT01984697|583351926|FG003|Overall Study|Physician Decision|1|||
161536516|NCT01984697|583351927|FG004|Overall Study|Physician Decision|0|||
161536517|NCT01984697|583351923|FG000|Overall Study|Protocol Violation|8|||
161536518|NCT01984697|583351924|FG001|Overall Study|Protocol Violation|5|||
161536519|NCT01984697|583351925|FG002|Overall Study|Protocol Violation|3|||
161536520|NCT01984697|583351926|FG003|Overall Study|Protocol Violation|2|||
161536521|NCT01984697|583351927|FG004|Overall Study|Protocol Violation|0|||
161536522|NCT01984697|583351923|FG000|Overall Study|Withdrawal by Subject|15|||
161536523|NCT01984697|583351924|FG001|Overall Study|Withdrawal by Subject|21|||
161536524|NCT01984697|583351925|FG002|Overall Study|Withdrawal by Subject|13|||
161536525|NCT01984697|583351926|FG003|Overall Study|Withdrawal by Subject|11|||
161536526|NCT01984697|583351927|FG004|Overall Study|Withdrawal by Subject|13|||
161536527|NCT01984697|583351923|FG000|Overall Study|Missed last follow-up visit|1|||
161536528|NCT01984697|583351924|FG001|Overall Study|Missed last follow-up visit|0|||
161536529|NCT01984697|583351925|FG002|Overall Study|Missed last follow-up visit|0|||
161536530|NCT01984697|583351926|FG003|Overall Study|Missed last follow-up visit|0|||
161536531|NCT01984697|583351927|FG004|Overall Study|Missed last follow-up visit|0|||
161536532|NCT01984697|583351923|FG000|Overall Study|Death|0|||
161536533|NCT01984697|583351924|FG001|Overall Study|Death|0|||
161536534|NCT01984697|583351925|FG002|Overall Study|Death|0|||
161536535|NCT01984697|583351926|FG003|Overall Study|Death|1|||
161536536|NCT01984697|583351927|FG004|Overall Study|Death|0|||
161536537|NCT01984697|583351923|FG000|Overall Study|Pregnancy|2|||
161536538|NCT01984697|583351924|FG001|Overall Study|Pregnancy|0|||
161536539|NCT01984697|583351925|FG002|Overall Study|Pregnancy|1|||
161536540|NCT01984697|583351926|FG003|Overall Study|Pregnancy|0|||
161536541|NCT01984697|583351927|FG004|Overall Study|Pregnancy|1|||
161536542|NCT01345630|583351928|FG000|Overall Study|Adverse Event|22|||
161536543|NCT01345630|583351929|FG001|Overall Study|Adverse Event|23|||
161536544|NCT01345630|583351928|FG000|Overall Study|Lost to Follow-up|17|||
161536545|NCT01345630|583351929|FG001|Overall Study|Lost to Follow-up|16|||
161536546|NCT01345630|583351928|FG000|Overall Study|Protocol Violation|4|||
161536547|NCT01345630|583351929|FG001|Overall Study|Protocol Violation|1|||
161536548|NCT01345630|583351928|FG000|Overall Study|Medication error without associated AE|0|||
161536549|NCT01345630|583351929|FG001|Overall Study|Medication error without associated AE|1|||
161536550|NCT01345630|583351928|FG000|Overall Study|Study terminated by sponsor|254|||
161536551|NCT01345630|583351929|FG001|Overall Study|Study terminated by sponsor|285|||
161536552|NCT01345630|583351928|FG000|Overall Study|Other reasons|6|||
161536553|NCT01345630|583351929|FG001|Overall Study|Other reasons|8|||
161536554|NCT01345630|583351928|FG000|Overall Study|Withdrawn due to pregnancy|1|||
161536555|NCT01345630|583351929|FG001|Overall Study|Withdrawn due to pregnancy|2|||
161536556|NCT01345630|583351928|FG000|Overall Study|No longer willing to participate|9|||
161536557|NCT01345630|583351929|FG001|Overall Study|No longer willing to participate|12|||
161536558|NCT01345630|583351928|FG000|Overall Study|Insufficient clinical response|48|||
161536559|NCT01345630|583351929|FG001|Overall Study|Insufficient clinical response|11|||
161536560|NCT01364922|583351937|FG000|Open-label (OL) Period|Adverse Event|7|||
161536561|NCT01364922|583351938|FG001|Open-label (OL) Period|Adverse Event|0|||
161536562|NCT01364922|583351939|FG002|Open-label (OL) Period|Adverse Event|0|||
161592260|NCT04810650|583556768|FG006|Overall Study|Death|2|||
161592261|NCT04810650|583556769|FG007|Overall Study|Death|2|||
161536563|NCT01364922|583351937|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
161536564|NCT01364922|583351938|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
161536565|NCT01364922|583351939|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
161536566|NCT01364922|583351937|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
161536567|NCT01364922|583351938|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
161592262|NCT04810650|583556770|FG008|Overall Study|Death|0|||
161536568|NCT01364922|583351939|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
161592263|NCT04810650|583556771|FG009|Overall Study|Death|1|||
161592264|NCT04810650|583556772|FG010|Overall Study|Death|0|||
161536569|NCT01364922|583351937|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
161536570|NCT01364922|583351938|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
161536571|NCT01364922|583351939|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
161536572|NCT01364922|583351937|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
161536573|NCT01364922|583351938|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
161536574|NCT01364922|583351939|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
161536575|NCT01364922|583351937|FG000|Open-label (OL) Period|Other, Unspecified|1|||
161536576|NCT01364922|583351938|FG001|Open-label (OL) Period|Other, Unspecified|0|||
161536577|NCT01364922|583351939|FG002|Open-label (OL) Period|Other, Unspecified|0|||
161536578|NCT01364922|583351937|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
161536579|NCT01364922|583351938|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
161829332|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161829333|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161536580|NCT01364922|583351939|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
161536581|NCT01364922|583351937|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
161536582|NCT01364922|583351938|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
161536583|NCT01364922|583351939|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
161536584|NCT01364922|583351937|FG000|Double-Blind (DB) Period|Adverse Event|0|||
161536585|NCT01364922|583351938|FG001|Double-Blind (DB) Period|Adverse Event|0|||
161536586|NCT01364922|583351939|FG002|Double-Blind (DB) Period|Adverse Event|1|||
161536587|NCT01364922|583351937|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
161536588|NCT01364922|583351938|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
161536589|NCT01364922|583351939|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
161536590|NCT05178121|583351940|FG000|Overall Study|Other|4|||
161536591|NCT05178121|583351940|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
161829334|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161536592|NCT00949884|583351941|FG000|Overall Study|Adverse Event|14|||
161536593|NCT00949884|583351942|FG001|Overall Study|Adverse Event|3|||
161829335|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
161829336|NCT00317642|584415753|FG000|Overall Study|Not Received Either Study Drug|1|||
161829337|NCT00317642|584415754|FG001|Overall Study|Not Received Either Study Drug|3|||
161829338|NCT00317642|584415753|FG000|Overall Study|Physician Decision|15|||
161829339|NCT00317642|584415754|FG001|Overall Study|Physician Decision|7|||
161829340|NCT00317642|584415753|FG000|Overall Study|Participant declined treatment|14|||
161829341|NCT00317642|584415754|FG001|Overall Study|Participant declined treatment|3|||
161829342|NCT00317642|584415753|FG000|Overall Study|Adverse Event|17|||
161829343|NCT00317642|584415754|FG001|Overall Study|Adverse Event|5|||
161829344|NCT00317642|584415753|FG000|Overall Study|Treatment Failure|56|||
161829345|NCT00317642|584415754|FG001|Overall Study|Treatment Failure|102|||
161829346|NCT00317642|584415753|FG000|Overall Study|Disease Recurrence|1|||
161829347|NCT00317642|584415754|FG001|Overall Study|Disease Recurrence|2|||
161829348|NCT00317642|584415753|FG000|Overall Study|Death|14|||
161829349|NCT00317642|584415754|FG001|Overall Study|Death|7|||
161829350|NCT00317642|584415753|FG000|Overall Study|Not Continue to Consolidation|2|||
161829351|NCT00317642|584415754|FG001|Overall Study|Not Continue to Consolidation|0|||
161829352|NCT00317642|584415753|FG000|Overall Study|Withdrawal by Subject|0|||
161829353|NCT00317642|584415754|FG001|Overall Study|Withdrawal by Subject|1|||
161829354|NCT00317642|584415753|FG000|Overall Study|Referred For Transplantation|1|||
161829355|NCT00317642|584415754|FG001|Overall Study|Referred For Transplantation|0|||
161829356|NCT00317642|584415753|FG000|Overall Study|AML Not Centrally Confirmed|1|||
161829357|NCT00317642|584415754|FG001|Overall Study|AML Not Centrally Confirmed|5|||
161829358|NCT00255151|584415756|FG000|Overall Study|Adverse Event|10|||
161829359|NCT00255151|584415757|FG001|Overall Study|Adverse Event|6|||
161829360|NCT00255151|584415758|FG002|Overall Study|Adverse Event|9|||
161829361|NCT00255151|584415756|FG000|Overall Study|Lost to Follow-up|4|||
161829362|NCT00255151|584415757|FG001|Overall Study|Lost to Follow-up|3|||
161829363|NCT00255151|584415758|FG002|Overall Study|Lost to Follow-up|4|||
161829364|NCT00255151|584415756|FG000|Overall Study|Withdrawal by Subject|18|||
161829365|NCT00255151|584415757|FG001|Overall Study|Withdrawal by Subject|17|||
161829366|NCT00255151|584415758|FG002|Overall Study|Withdrawal by Subject|8|||
161829367|NCT00255151|584415756|FG000|Overall Study|Noncompliance|0|||
161829368|NCT00255151|584415757|FG001|Overall Study|Noncompliance|1|||
161829369|NCT00255151|584415758|FG002|Overall Study|Noncompliance|2|||
161829370|NCT00255151|584415756|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
161829371|NCT00255151|584415757|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
161829372|NCT00255151|584415758|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
161829373|NCT00255151|584415756|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
161829374|NCT00255151|584415757|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
161829375|NCT00255151|584415758|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
161829376|NCT00255151|584415756|FG000|Overall Study|Possible Barrett's Esophagus|1|||
161829377|NCT00255151|584415757|FG001|Overall Study|Possible Barrett's Esophagus|3|||
161829378|NCT00255151|584415758|FG002|Overall Study|Possible Barrett's Esophagus|8|||
161536594|NCT00949884|583351943|FG002|Overall Study|Adverse Event|12|||
161536595|NCT00949884|583351941|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
161536596|NCT00949884|583351942|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
161536597|NCT00949884|583351943|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
161536598|NCT00949884|583351941|FG000|Overall Study|Lost to Follow-up|7|||
161536599|NCT00949884|583351942|FG001|Overall Study|Lost to Follow-up|5|||
161536600|NCT00949884|583351943|FG002|Overall Study|Lost to Follow-up|5|||
161536601|NCT00949884|583351941|FG000|Overall Study|Physician Decision|5|||
161536602|NCT00949884|583351942|FG001|Overall Study|Physician Decision|0|||
161536603|NCT00949884|583351943|FG002|Overall Study|Physician Decision|6|||
161536604|NCT00949884|583351941|FG000|Overall Study|Treatment non-compliance|5|||
161536605|NCT00949884|583351942|FG001|Overall Study|Treatment non-compliance|0|||
161536606|NCT00949884|583351943|FG002|Overall Study|Treatment non-compliance|8|||
161536607|NCT00949884|583351941|FG000|Overall Study|Withdrawal by Subject|13|||
161536608|NCT00949884|583351942|FG001|Overall Study|Withdrawal by Subject|4|||
161536609|NCT00949884|583351943|FG002|Overall Study|Withdrawal by Subject|16|||
161536610|NCT00949884|583351941|FG000|Overall Study|Lack of Efficacy|4|||
161536611|NCT00949884|583351942|FG001|Overall Study|Lack of Efficacy|2|||
161536612|NCT00949884|583351943|FG002|Overall Study|Lack of Efficacy|7|||
161536613|NCT00949884|583351941|FG000|Overall Study|Study terminated by sponsor|0|||
161536614|NCT00949884|583351942|FG001|Overall Study|Study terminated by sponsor|0|||
161536615|NCT00949884|583351943|FG002|Overall Study|Study terminated by sponsor|1|||
161536616|NCT01953003|583351944|FG000|Overall Study|Not treated|0|||
161536617|NCT01953003|583351945|FG001|Overall Study|Not treated|1|||
161536618|NCT01953003|583351944|FG000|Overall Study|Progressive disease|35|||
161536619|NCT01953003|583351945|FG001|Overall Study|Progressive disease|45|||
161536620|NCT01953003|583351944|FG000|Overall Study|Related Adverse events|7|||
161536621|NCT01953003|583351945|FG001|Overall Study|Related Adverse events|2|||
161536622|NCT01953003|583351944|FG000|Overall Study|Non-related adverse events|0|||
161536623|NCT01953003|583351945|FG001|Overall Study|Non-related adverse events|2|||
161536624|NCT01953003|583351944|FG000|Overall Study|Protocol Violation|0|||
161536625|NCT01953003|583351945|FG001|Overall Study|Protocol Violation|1|||
161536626|NCT01953003|583351944|FG000|Overall Study|Withdrawal by Subject|14|||
161536627|NCT01953003|583351945|FG001|Overall Study|Withdrawal by Subject|4|||
161536628|NCT01582789|583351954|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161536629|NCT01582789|583351955|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161536630|NCT03391765|583351956|FG000|Overall Study|Adverse Event|2|||
161536631|NCT03391765|583351957|FG001|Overall Study|Adverse Event|0|||
161536632|NCT03391765|583351958|FG002|Overall Study|Adverse Event|0|||
161536633|NCT03391765|583351959|FG003|Overall Study|Adverse Event|2|||
161536634|NCT03391765|583351956|FG000|Overall Study|Withdrew consent|5|||
161536635|NCT03391765|583351957|FG001|Overall Study|Withdrew consent|7|||
161536636|NCT03391765|583351958|FG002|Overall Study|Withdrew consent|2|||
161536637|NCT03391765|583351959|FG003|Overall Study|Withdrew consent|5|||
161536638|NCT03391765|583351956|FG000|Overall Study|Other, not specified|44|||
161536639|NCT03391765|583351957|FG001|Overall Study|Other, not specified|38|||
161536640|NCT03391765|583351958|FG002|Overall Study|Other, not specified|21|||
161536641|NCT03391765|583351959|FG003|Overall Study|Other, not specified|16|||
161536642|NCT00662857|583351964|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
161536643|NCT00662857|583351965|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
161536644|NCT00662857|583351964|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
161536645|NCT00662857|583351965|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
161536646|NCT00662857|583351964|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
161536647|NCT00662857|583351965|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
161536648|NCT03966053|583351966|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
161536649|NCT02832622|583351968|FG000|Overall Study|MPP not programmed|1259|||
161536650|NCT02832622|583351968|FG000|Overall Study|Withdrawal by Subject|123|||
161536651|NCT02832622|583351968|FG000|Overall Study|Death|119|||
161536652|NCT02832622|583351968|FG000|Overall Study|Unsuccessful CRT implant|93|||
161536653|NCT02832622|583351968|FG000|Overall Study|Lost to Follow-up|45|||
161536654|NCT02832622|583351968|FG000|Overall Study|Patient non-compliance|42|||
161536655|NCT02832622|583351968|FG000|Overall Study|Withdrawal by other reasons|25|||
161536656|NCT02832622|583351968|FG000|Overall Study|System explant|24|||
161536657|NCT02832622|583351968|FG000|Overall Study|Physician Decision|6|||
161536658|NCT04586569|583351969|FG000|Overall Study|Withdrawal by Subject|0|||
161536659|NCT04586569|583351970|FG001|Overall Study|Withdrawal by Subject|2|||
161536660|NCT04586569|583351969|FG000|Overall Study|No longer eligible|2|||
161536661|NCT04586569|583351970|FG001|Overall Study|No longer eligible|3|||
161536662|NCT04586569|583351969|FG000|Overall Study|Physician Decision|1|||
161536663|NCT04586569|583351970|FG001|Overall Study|Physician Decision|0|||
161536664|NCT00998400|583351971|FG000|Overall Study|Lack of interest/motivation|1|||
161592265|NCT04810650|583556773|FG011|Overall Study|Death|0|||
161536665|NCT00998400|583351972|FG001|Overall Study|Lack of interest/motivation|2|||
161536666|NCT00998400|583351971|FG000|Overall Study|Logistical problems|1|||
161536667|NCT00998400|583351972|FG001|Overall Study|Logistical problems|0|||
161536668|NCT00800202|583351974|FG000|Overall Study|Adverse Event|7|||
161536669|NCT00800202|583351975|FG001|Overall Study|Adverse Event|6|||
161536670|NCT00800202|583351974|FG000|Overall Study|Death|1|||
161536671|NCT00800202|583351975|FG001|Overall Study|Death|0|||
161536672|NCT00800202|583351974|FG000|Overall Study|Other|5|||
161536673|NCT00800202|583351975|FG001|Overall Study|Other|0|||
161536674|NCT00800202|583351974|FG000|Overall Study|Disease Progression|54|||
161536675|NCT00800202|583351975|FG001|Overall Study|Disease Progression|18|||
161536676|NCT05674890|583351978|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
161536677|NCT05674890|583351979|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
161536678|NCT05674890|583351978|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
161536679|NCT05674890|583351979|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
161536680|NCT05674890|583351978|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
161536681|NCT05674890|583351979|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
161536682|NCT02691182|583351980|FG000|Overall Study|Withdrawal by Subject|4|||
161536683|NCT02691182|583351981|FG001|Overall Study|Withdrawal by Subject|7|||
161536684|NCT02691182|583351982|FG002|Overall Study|Withdrawal by Subject|6|||
161536685|NCT02691182|583351983|FG003|Overall Study|Withdrawal by Subject|8|||
161536686|NCT02691182|583351980|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
161536687|NCT02691182|583351981|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
161536688|NCT02691182|583351982|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
161536689|NCT02691182|583351983|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
161536690|NCT02691182|583351980|FG000|Overall Study|Lost to Follow-up|8|||
161536691|NCT02691182|583351981|FG001|Overall Study|Lost to Follow-up|33|||
161536692|NCT02691182|583351982|FG002|Overall Study|Lost to Follow-up|19|||
161536693|NCT02691182|583351983|FG003|Overall Study|Lost to Follow-up|22|||
161536694|NCT02691182|583351980|FG000|Overall Study|Adverse Event|3|||
161536695|NCT02691182|583351981|FG001|Overall Study|Adverse Event|10|||
161536696|NCT02691182|583351982|FG002|Overall Study|Adverse Event|10|||
161536697|NCT02691182|583351983|FG003|Overall Study|Adverse Event|11|||
161536698|NCT02691182|583351980|FG000|Overall Study|Physician Decision|3|||
161536699|NCT02691182|583351981|FG001|Overall Study|Physician Decision|7|||
161536700|NCT02691182|583351982|FG002|Overall Study|Physician Decision|14|||
161536701|NCT02691182|583351983|FG003|Overall Study|Physician Decision|8|||
161536702|NCT02691182|583351980|FG000|Overall Study|Lack of Efficacy|0|||
161536703|NCT02691182|583351981|FG001|Overall Study|Lack of Efficacy|0|||
161536704|NCT02691182|583351982|FG002|Overall Study|Lack of Efficacy|0|||
161536705|NCT02691182|583351983|FG003|Overall Study|Lack of Efficacy|4|||
161536706|NCT02691182|583351980|FG000|Overall Study|Protocol Violation|2|||
161536707|NCT02691182|583351981|FG001|Overall Study|Protocol Violation|6|||
161536708|NCT02691182|583351982|FG002|Overall Study|Protocol Violation|6|||
161536709|NCT02691182|583351983|FG003|Overall Study|Protocol Violation|8|||
161536710|NCT02691182|583351980|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
161536711|NCT02691182|583351981|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
161536712|NCT02691182|583351982|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
161536713|NCT02691182|583351983|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
161536714|NCT02691182|583351980|FG000|Overall Study|Missing|0|||
161536715|NCT02691182|583351981|FG001|Overall Study|Missing|5|||
161536716|NCT02691182|583351982|FG002|Overall Study|Missing|1|||
161536717|NCT02691182|583351983|FG003|Overall Study|Missing|5|||
161536718|NCT00105235|583351984|FG000|Overall Study|Death|4|||
161536719|NCT00105235|583351984|FG000|Overall Study|Physician Decision|1|||
161536720|NCT00105235|583351984|FG000|Overall Study|Withdrawal by Subject|2|||
161536721|NCT02052310|583351985|FG000|Overall Study|Death|64|||
161536722|NCT02052310|583351986|FG001|Overall Study|Death|54|||
161536723|NCT02052310|583351985|FG000|Overall Study|Withdrawal by Subject|37|||
161536724|NCT02052310|583351986|FG001|Overall Study|Withdrawal by Subject|49|||
161536725|NCT02052310|583351985|FG000|Overall Study|Other than specified|32|||
161536726|NCT02052310|583351986|FG001|Overall Study|Other than specified|29|||
161536727|NCT02052310|583351985|FG000|Overall Study|Adverse Event|29|||
161536728|NCT02052310|583351986|FG001|Overall Study|Adverse Event|22|||
161536729|NCT02052310|583351985|FG000|Overall Study|Kidney Transplant|23|||
161536730|NCT02052310|583351986|FG001|Overall Study|Kidney Transplant|29|||
161536731|NCT02052310|583351985|FG000|Overall Study|Physician Decision|14|||
161536732|NCT02052310|583351986|FG001|Overall Study|Physician Decision|7|||
161536733|NCT02052310|583351985|FG000|Overall Study|Lack of Efficacy|6|||
161536734|NCT02052310|583351986|FG001|Overall Study|Lack of Efficacy|1|||
161536735|NCT02052310|583351985|FG000|Overall Study|Site Terminated by Sponsor|5|||
161536736|NCT02052310|583351986|FG001|Overall Study|Site Terminated by Sponsor|13|||
161536737|NCT02052310|583351985|FG000|Overall Study|Lost to Follow-up|4|||
161536738|NCT02052310|583351986|FG001|Overall Study|Lost to Follow-up|2|||
161536739|NCT02052310|583351985|FG000|Overall Study|Protocol Violation|1|||
161536740|NCT02052310|583351986|FG001|Overall Study|Protocol Violation|6|||
161536741|NCT01964326|583351987|FG000|Overall Study|Adverse Event|48|||
161536742|NCT01964326|583351987|FG000|Overall Study|Death|2|||
161536743|NCT01964326|583351987|FG000|Overall Study|Protocol Violation|4|||
161536744|NCT01964326|583351987|FG000|Overall Study|Lost to Follow-up|88|||
161536745|NCT01964326|583351987|FG000|Overall Study|Withdrawal by Subject|87|||
161536746|NCT01964326|583351987|FG000|Overall Study|Pregnancy|1|||
161536747|NCT01964326|583351987|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
161536748|NCT01964326|583351987|FG000|Overall Study|Physician Decision|55|||
161536749|NCT01964326|583351987|FG000|Overall Study|Investigator Discretion|1|||
161536750|NCT01964326|583351987|FG000|Overall Study|Other|9|||
161536751|NCT01964326|583351987|FG000|Overall Study|Did not meet eligibility criteria|1|||
161536752|NCT02563002|583351990|FG000|Overall Study|Death|72|||
161536753|NCT02563002|583351991|FG001|Overall Study|Death|87|||
161536754|NCT02563002|583351990|FG000|Overall Study|Lost to Follow-up|5|||
161536755|NCT02563002|583351991|FG001|Overall Study|Lost to Follow-up|0|||
161536756|NCT02563002|583351990|FG000|Overall Study|Physician Decision|0|||
161536757|NCT02563002|583351991|FG001|Overall Study|Physician Decision|2|||
161536758|NCT02563002|583351990|FG000|Overall Study|Withdrawal by Subject|2|||
161536759|NCT02563002|583351991|FG001|Overall Study|Withdrawal by Subject|10|||
161536760|NCT02563002|583351990|FG000|Overall Study|Sponsor decision|74|||
161536761|NCT02563002|583351991|FG001|Overall Study|Sponsor decision|55|||
161536762|NCT03518125|583351992|FG000|Overall Study|Lost to Follow-up|0|||
161536763|NCT03518125|583351993|FG001|Overall Study|Lost to Follow-up|2|||
161536764|NCT03518125|583351994|FG002|Overall Study|Lost to Follow-up|0|||
161536765|NCT03518125|583351995|FG003|Overall Study|Lost to Follow-up|0|||
161536766|NCT03518125|583351996|FG004|Overall Study|Lost to Follow-up|3|||
161536767|NCT03518125|583351997|FG005|Overall Study|Lost to Follow-up|5|||
161536768|NCT03518125|583351992|FG000|Overall Study|Physician Decision|0|||
161536769|NCT03518125|583351993|FG001|Overall Study|Physician Decision|1|||
161536770|NCT03518125|583351994|FG002|Overall Study|Physician Decision|0|||
161536771|NCT03518125|583351995|FG003|Overall Study|Physician Decision|0|||
161536772|NCT03518125|583351996|FG004|Overall Study|Physician Decision|0|||
161536773|NCT03518125|583351997|FG005|Overall Study|Physician Decision|0|||
161536774|NCT03518125|583351992|FG000|Overall Study|Withdrawal by Subject|1|||
161536775|NCT03518125|583351993|FG001|Overall Study|Withdrawal by Subject|1|||
161536776|NCT03518125|583351994|FG002|Overall Study|Withdrawal by Subject|0|||
161536777|NCT03518125|583351995|FG003|Overall Study|Withdrawal by Subject|1|||
161536778|NCT03518125|583351996|FG004|Overall Study|Withdrawal by Subject|1|||
161536779|NCT03518125|583351997|FG005|Overall Study|Withdrawal by Subject|3|||
161536780|NCT03518125|583351992|FG000|Overall Study|Missed Day 394 Visit|1|||
161536781|NCT03518125|583351993|FG001|Overall Study|Missed Day 394 Visit|0|||
161536782|NCT03518125|583351994|FG002|Overall Study|Missed Day 394 Visit|0|||
161536783|NCT03518125|583351995|FG003|Overall Study|Missed Day 394 Visit|0|||
161536784|NCT03518125|583351996|FG004|Overall Study|Missed Day 394 Visit|0|||
161536785|NCT03518125|583351997|FG005|Overall Study|Missed Day 394 Visit|0|||
161536786|NCT02093663|583351998|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
161536787|NCT02093663|583351999|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
161536788|NCT02093663|583352000|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
161536789|NCT02093663|583352001|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
161536790|NCT02093663|583352002|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
161536791|NCT02093663|583351998|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
161536792|NCT02093663|583351999|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536793|NCT02093663|583352000|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536794|NCT02093663|583352001|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536795|NCT02093663|583352002|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536796|NCT02093663|583351998|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
161536797|NCT02093663|583351999|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
161536798|NCT02093663|583352000|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
161536799|NCT02093663|583352001|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
161536800|NCT02093663|583352002|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
161536801|NCT02093663|583351998|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
161536802|NCT02093663|583351999|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
161536803|NCT02093663|583352000|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
161536804|NCT02093663|583352001|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
161536805|NCT02093663|583352002|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
161536806|NCT02093663|583351998|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536807|NCT02093663|583351999|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536808|NCT02093663|583352000|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
161536809|NCT02093663|583352001|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536810|NCT02093663|583352002|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
161536811|NCT02093663|583351998|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
161536812|NCT02093663|583351999|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
161536813|NCT02093663|583352000|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
161536814|NCT02093663|583352001|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
161536815|NCT02093663|583352002|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
161536816|NCT02093663|583351998|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
161536817|NCT02093663|583351999|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
161536818|NCT02093663|583352000|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
161536819|NCT02093663|583352001|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
161536820|NCT02093663|583352002|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
161536821|NCT02093663|583351998|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
161536822|NCT02093663|583351999|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
161536823|NCT02093663|583352000|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
161536824|NCT02093663|583352001|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
161536825|NCT02093663|583352002|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
161536826|NCT02093663|583351998|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
161536827|NCT02093663|583351999|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
161536828|NCT02093663|583352000|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
161536829|NCT02093663|583352001|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
161536830|NCT02093663|583352002|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
161536831|NCT00508404|583352003|FG000|Overall Study|Ongoing at Data Cut-off|12|||
161536832|NCT00508404|583352003|FG000|Overall Study|Adverse Event|2|||
161536833|NCT00508404|583352003|FG000|Overall Study|Death|16|||
161536834|NCT00508404|583352003|FG000|Overall Study|Physician Decision|2|||
161536835|NCT00508404|583352003|FG000|Overall Study|Withdrawal by Subject|3|||
161536836|NCT00508404|583352003|FG000|Overall Study|Protocol-specified Criteria|2|||
161536837|NCT00508404|583352003|FG000|Overall Study|Lost to Follow-up|2|||
161536838|NCT00508404|583352003|FG000|Overall Study|Other - Not Specified|3|||
161536839|NCT01505387|583352004|FG000|Overall Study|Protocol Violation|1|||
161536840|NCT01505387|583352005|FG001|Overall Study|Protocol Violation|0|||
161536841|NCT01505387|583352004|FG000|Overall Study|Withdrawal by Subject|1|||
161536842|NCT01505387|583352005|FG001|Overall Study|Withdrawal by Subject|1|||
161536843|NCT01197508|583352006|FG000|Overall Study|Withdrawal by Subject|8|||
161536844|NCT01197508|583352007|FG001|Overall Study|Withdrawal by Subject|7|||
161536845|NCT01197508|583352008|FG002|Overall Study|Withdrawal by Subject|15|||
161536846|NCT01197508|583352009|FG003|Overall Study|Withdrawal by Subject|4|||
161536847|NCT01197508|583352006|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
161536848|NCT01197508|583352007|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
161536849|NCT01197508|583352008|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
161536850|NCT01197508|583352009|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
161536851|NCT01197508|583352006|FG000|Overall Study|Adverse Event|10|||
161536852|NCT01197508|583352007|FG001|Overall Study|Adverse Event|13|||
161536853|NCT01197508|583352008|FG002|Overall Study|Adverse Event|23|||
161536854|NCT01197508|583352009|FG003|Overall Study|Adverse Event|3|||
161536855|NCT01197508|583352006|FG000|Overall Study|Severe non-compliance to protocol|0|||
161536856|NCT01197508|583352007|FG001|Overall Study|Severe non-compliance to protocol|3|||
161536857|NCT01197508|583352008|FG002|Overall Study|Severe non-compliance to protocol|1|||
161536858|NCT01197508|583352009|FG003|Overall Study|Severe non-compliance to protocol|3|||
161536859|NCT01197508|583352006|FG000|Overall Study|Condition under investigation worsened|1|||
161536860|NCT01197508|583352007|FG001|Overall Study|Condition under investigation worsened|1|||
161536861|NCT01197508|583352008|FG002|Overall Study|Condition under investigation worsened|1|||
161536862|NCT01197508|583352009|FG003|Overall Study|Condition under investigation worsened|1|||
161536863|NCT01197508|583352006|FG000|Overall Study|Lack of Efficacy|1|||
161536864|NCT01197508|583352007|FG001|Overall Study|Lack of Efficacy|2|||
161536865|NCT01197508|583352008|FG002|Overall Study|Lack of Efficacy|2|||
161536866|NCT01197508|583352009|FG003|Overall Study|Lack of Efficacy|1|||
161536867|NCT01197508|583352006|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161536868|NCT01197508|583352007|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161536869|NCT01197508|583352008|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161536870|NCT01197508|583352009|FG003|Overall Study|Study-specific withdrawal criteria|2|||
161536871|NCT01197508|583352006|FG000|Overall Study|Lost to Follow-up|1|||
161536872|NCT01197508|583352007|FG001|Overall Study|Lost to Follow-up|1|||
161536873|NCT01197508|583352008|FG002|Overall Study|Lost to Follow-up|2|||
161536874|NCT01197508|583352009|FG003|Overall Study|Lost to Follow-up|0|||
161536875|NCT01197508|583352006|FG000|Overall Study|Other|2|||
161536876|NCT01197508|583352007|FG001|Overall Study|Other|3|||
161536877|NCT01197508|583352008|FG002|Overall Study|Other|2|||
161536878|NCT01197508|583352009|FG003|Overall Study|Other|2|||
161536879|NCT00266825|583352010|FG000|Completed Follow-Up|Lost to Follow-up|14|||
161536880|NCT00266825|583352011|FG001|Completed Follow-Up|Lost to Follow-up|19|||
161536881|NCT00266825|583352010|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
161536882|NCT00266825|583352011|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
161536883|NCT02799784|583352014|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
161536884|NCT02799784|583352015|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
161536885|NCT02799784|583352014|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
161536886|NCT02799784|583352015|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
161536887|NCT02799784|583352014|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
161536888|NCT02799784|583352015|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
161536889|NCT02799784|583352014|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
161536890|NCT02799784|583352015|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
161536891|NCT02799784|583352014|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
161536892|NCT02799784|583352015|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
161536893|NCT02799784|583352014|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
161536894|NCT02799784|583352015|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
161536895|NCT01949870|583352016|FG000|Overall Study|Lack of Efficacy|2|||
161536896|NCT01949870|583352016|FG000|Overall Study|Adverse Event|1|||
161536897|NCT01949870|583352016|FG000|Overall Study|Study termination|1|||
161536898|NCT01949870|583352016|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
161536899|NCT03086330|583352017|FG000|Overall Study|Withdrawal by Subject|3|||
161536900|NCT03086330|583352018|FG001|Overall Study|Withdrawal by Subject|2|||
161536901|NCT03086330|583352017|FG000|Overall Study|Lost to Follow-up|1|||
161536902|NCT03086330|583352018|FG001|Overall Study|Lost to Follow-up|2|||
161536903|NCT01235546|583352019|FG000|Overall Study|Staff error, medication not administered|1|||
161536904|NCT01235546|583352020|FG001|Overall Study|Staff error, medication not administered|0|||
161536905|NCT01235546|583352019|FG000|Overall Study|Protocol Violation|1|||
161536906|NCT01235546|583352020|FG001|Overall Study|Protocol Violation|1|||
161536907|NCT00330174|583352022|FG000|Overall Study|Withdrawal by Subject|7|||
161536908|NCT00330174|583352023|FG001|Overall Study|Withdrawal by Subject|7|||
161536909|NCT00330174|583352022|FG000|Overall Study|Lost to Follow-up|4|||
161536910|NCT00330174|583352023|FG001|Overall Study|Lost to Follow-up|1|||
161536911|NCT00330174|583352022|FG000|Overall Study|Clinical deterioration|1|||
161536912|NCT00330174|583352023|FG001|Overall Study|Clinical deterioration|2|||
161536913|NCT00330174|583352022|FG000|Overall Study|Excessive missed visits|3|||
161536914|NCT00330174|583352023|FG001|Overall Study|Excessive missed visits|8|||
161536915|NCT00330174|583352022|FG000|Overall Study|Miscellaneous reasons|7|||
161536916|NCT00330174|583352023|FG001|Overall Study|Miscellaneous reasons|1|||
161536917|NCT02316769|583352026|FG000|Overall Study|Physician Decision|1|||
161536918|NCT02316769|583352027|FG001|Overall Study|Physician Decision|0|||
161536919|NCT02316769|583352026|FG000|Overall Study|Withdrawal by Subject|1|||
161592266|NCT04810650|583556774|FG012|Overall Study|Death|2|||
161592267|NCT04810650|583556775|FG013|Overall Study|Death|1|||
161592268|NCT04810650|583556762|FG000|Overall Study|Moved/transferred care|0|||
161592269|NCT04810650|583556763|FG001|Overall Study|Moved/transferred care|0|||
161592270|NCT04810650|583556764|FG002|Overall Study|Moved/transferred care|0|||
161592271|NCT04810650|583556765|FG003|Overall Study|Moved/transferred care|0|||
161536920|NCT02316769|583352027|FG001|Overall Study|Withdrawal by Subject|0|||
161536921|NCT04570436|583352028|FG000|Overall Study|Adverse Event|0|||
161536922|NCT04570436|583352029|FG001|Overall Study|Adverse Event|0|||
161536923|NCT04570436|583352030|FG002|Overall Study|Adverse Event|1|||
161536924|NCT04570436|583352031|FG003|Overall Study|Adverse Event|0|||
161536925|NCT04570436|583352032|FG004|Overall Study|Adverse Event|0|||
161536926|NCT04570436|583352033|FG005|Overall Study|Adverse Event|0|||
161536927|NCT04570436|583352034|FG006|Overall Study|Adverse Event|0|||
161536928|NCT04570436|583352035|FG007|Overall Study|Adverse Event|0|||
161536929|NCT04570436|583352036|FG008|Overall Study|Adverse Event|0|||
161536930|NCT04570436|583352037|FG009|Overall Study|Adverse Event|0|||
161536931|NCT04570436|583352028|FG000|Overall Study|Physician Decision|1|||
161536932|NCT04570436|583352029|FG001|Overall Study|Physician Decision|0|||
161536933|NCT04570436|583352030|FG002|Overall Study|Physician Decision|0|||
161536934|NCT04570436|583352031|FG003|Overall Study|Physician Decision|0|||
161536935|NCT04570436|583352032|FG004|Overall Study|Physician Decision|0|||
161536936|NCT04570436|583352033|FG005|Overall Study|Physician Decision|0|||
161536937|NCT04570436|583352034|FG006|Overall Study|Physician Decision|0|||
161536938|NCT04570436|583352035|FG007|Overall Study|Physician Decision|0|||
161536939|NCT04570436|583352036|FG008|Overall Study|Physician Decision|0|||
161536940|NCT04570436|583352037|FG009|Overall Study|Physician Decision|0|||
161536941|NCT00645164|583352038|FG000|Overall Study|Lost to Follow-up|2|||
161536942|NCT00645164|583352038|FG000|Overall Study|Withdrawal by Subject|4|||
161536943|NCT00645164|583352038|FG000|Overall Study|Protocol Violation|1|||
161536944|NCT02954354|583352039|FG000|Overall Study|Adverse Event|2|||
161592272|NCT04810650|583556766|FG004|Overall Study|Moved/transferred care|0|||
161592273|NCT04810650|583556767|FG005|Overall Study|Moved/transferred care|0|||
161592274|NCT04810650|583556768|FG006|Overall Study|Moved/transferred care|0|||
161536945|NCT02954354|583352040|FG001|Overall Study|Adverse Event|2|||
161592275|NCT04810650|583556769|FG007|Overall Study|Moved/transferred care|1|||
161592276|NCT04810650|583556770|FG008|Overall Study|Moved/transferred care|12|||
161592277|NCT04810650|583556771|FG009|Overall Study|Moved/transferred care|10|||
161592278|NCT04810650|583556772|FG010|Overall Study|Moved/transferred care|0|||
161592279|NCT04810650|583556773|FG011|Overall Study|Moved/transferred care|0|||
161592280|NCT04810650|583556774|FG012|Overall Study|Moved/transferred care|0|||
161592281|NCT04810650|583556775|FG013|Overall Study|Moved/transferred care|0|||
161592282|NCT04810650|583556762|FG000|Overall Study|Lost to Follow-up|15|||
161592283|NCT04810650|583556763|FG001|Overall Study|Lost to Follow-up|12|||
161592284|NCT04810650|583556764|FG002|Overall Study|Lost to Follow-up|7|||
161592285|NCT04810650|583556765|FG003|Overall Study|Lost to Follow-up|9|||
161592286|NCT04810650|583556766|FG004|Overall Study|Lost to Follow-up|10|||
161592287|NCT04810650|583556767|FG005|Overall Study|Lost to Follow-up|6|||
161592288|NCT04810650|583556768|FG006|Overall Study|Lost to Follow-up|0|||
161592289|NCT04810650|583556769|FG007|Overall Study|Lost to Follow-up|0|||
161592290|NCT04810650|583556770|FG008|Overall Study|Lost to Follow-up|0|||
161592291|NCT04810650|583556771|FG009|Overall Study|Lost to Follow-up|0|||
161592292|NCT04810650|583556772|FG010|Overall Study|Lost to Follow-up|1|||
161592293|NCT04810650|583556773|FG011|Overall Study|Lost to Follow-up|0|||
161592294|NCT04810650|583556774|FG012|Overall Study|Lost to Follow-up|3|||
161592295|NCT04810650|583556775|FG013|Overall Study|Lost to Follow-up|9|||
161592296|NCT04810650|583556762|FG000|Overall Study|Participant declined|0|||
161592297|NCT04810650|583556763|FG001|Overall Study|Participant declined|0|||
161678742|NCT00574288|583876070|FG005|Overall Study|Death|25|||
161536946|NCT02954354|583352041|FG002|Overall Study|Adverse Event|4|||
161536947|NCT02954354|583352039|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
161536948|NCT02954354|583352040|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
161536949|NCT02954354|583352041|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
161536950|NCT02954354|583352039|FG000|Overall Study|Lack of Efficacy|0|||
161536951|NCT02954354|583352040|FG001|Overall Study|Lack of Efficacy|2|||
161536952|NCT02954354|583352041|FG002|Overall Study|Lack of Efficacy|0|||
161536953|NCT02954354|583352039|FG000|Overall Study|Withdrawal by Subject|17|||
161536954|NCT02954354|583352040|FG001|Overall Study|Withdrawal by Subject|9|||
161536955|NCT02954354|583352041|FG002|Overall Study|Withdrawal by Subject|11|||
161536956|NCT02954354|583352039|FG000|Overall Study|Lost to Follow-up|12|||
161536957|NCT02954354|583352040|FG001|Overall Study|Lost to Follow-up|5|||
161536958|NCT02954354|583352041|FG002|Overall Study|Lost to Follow-up|0|||
161536959|NCT02954354|583352039|FG000|Overall Study|Miscellaneous|2|||
161536960|NCT02954354|583352040|FG001|Overall Study|Miscellaneous|2|||
161536961|NCT02954354|583352041|FG002|Overall Study|Miscellaneous|1|||
161536962|NCT02279043|583352052|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
161536963|NCT02279043|583352053|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
161536964|NCT02279043|583352054|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
161536965|NCT02279043|583352052|FG000|Overall Study|Lost to Follow-up|46|||
161536966|NCT02279043|583352053|FG001|Overall Study|Lost to Follow-up|88|||
161536967|NCT02279043|583352054|FG002|Overall Study|Lost to Follow-up|0|||
161536968|NCT00490282|583352055|FG000|Overall Study|Withdrawal by Subject|3|||
161536969|NCT01494584|583352062|FG000|Overall Study|Study Closed/Terminated|1|||
161536970|NCT01256567|583352069|FG000|Overall Study|Withdrawal by Subject|1|||
161536971|NCT00567190|583352075|FG000|Overall Study|Death|235|||
161536972|NCT00567190|583352076|FG001|Overall Study|Death|280|||
161536973|NCT00567190|583352075|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
161536974|NCT00567190|583352076|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
161536975|NCT04044456|583354136|FG000|Overall Study|Lost to Follow-up|4|||
161536976|NCT04044456|583354137|FG001|Overall Study|Lost to Follow-up|1|||
161536977|NCT04044456|583354136|FG000|Overall Study|Withdrawal by Subject|1|||
161536978|NCT04044456|583354137|FG001|Overall Study|Withdrawal by Subject|0|||
161536979|NCT04209725|583354144|FG000|Overall Study|Adverse Event|1|||
161536980|NCT01281644|583354147|FG000|Overall Study|Lost to Follow-up|3|||
161536981|NCT01281644|583354147|FG000|Overall Study|Withdrawal by Subject|2|||
161536982|NCT03039023|583354148|FG000|Overall Study|Withdrawal by Subject|1|||
161536983|NCT03039023|583354149|FG001|Overall Study|Withdrawal by Subject|0|||
161536984|NCT03039023|583354150|FG002|Overall Study|Withdrawal by Subject|1|||
161536985|NCT03039023|583354151|FG003|Overall Study|Withdrawal by Subject|1|||
161536986|NCT03039023|583354152|FG004|Overall Study|Withdrawal by Subject|0|||
161536987|NCT03039023|583354148|FG000|Overall Study|Physician Decision|0|||
161536988|NCT03039023|583354149|FG001|Overall Study|Physician Decision|0|||
161536989|NCT03039023|583354150|FG002|Overall Study|Physician Decision|0|||
161536990|NCT03039023|583354151|FG003|Overall Study|Physician Decision|1|||
161536991|NCT03039023|583354152|FG004|Overall Study|Physician Decision|0|||
161536992|NCT03338829|583354153|FG000|Overall Study|Lost to Follow-up|4|||
161536993|NCT03338829|583354154|FG001|Overall Study|Lost to Follow-up|2|||
161536994|NCT03338829|583354155|FG002|Overall Study|Lost to Follow-up|4|||
161536995|NCT03338829|583354153|FG000|Overall Study|Pregnancy loss|1|||
161536996|NCT03338829|583354154|FG001|Overall Study|Pregnancy loss|1|||
161536997|NCT03338829|583354155|FG002|Overall Study|Pregnancy loss|0|||
161536998|NCT03338829|583354153|FG000|Overall Study|Protocol Violation|0|||
161536999|NCT03338829|583354154|FG001|Overall Study|Protocol Violation|1|||
161537000|NCT03338829|583354155|FG002|Overall Study|Protocol Violation|0|||
161537001|NCT03701399|583354159|FG000|Overall Study|Adverse Event|3|||
161537002|NCT03701399|583354160|FG001|Overall Study|Adverse Event|5|||
161537003|NCT03701399|583354159|FG000|Overall Study|Withdrawal by Subject|6|||
161537004|NCT03701399|583354160|FG001|Overall Study|Withdrawal by Subject|3|||
161537005|NCT03701399|583354159|FG000|Overall Study|Investigators decision|1|||
161537006|NCT03701399|583354160|FG001|Overall Study|Investigators decision|2|||
161537007|NCT03701399|583354159|FG000|Overall Study|Lost to Follow-up|1|||
161537008|NCT03701399|583354160|FG001|Overall Study|Lost to Follow-up|2|||
161537009|NCT03701399|583354159|FG000|Overall Study|Death|1|||
161537010|NCT03701399|583354160|FG001|Overall Study|Death|1|||
161537011|NCT03701399|583354159|FG000|Overall Study|Randomized but not treated|1|||
161537012|NCT03701399|583354160|FG001|Overall Study|Randomized but not treated|0|||
161537013|NCT04179032|583354161|FG000|Part B (Up to Week 52)|Adverse Event|1|||
161537014|NCT04179032|583354161|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
161537015|NCT04179032|583354161|FG000|Access Extension Phase|Ongoing|11|||
161537016|NCT00448448|583354162|FG000|Overall Study|Withdrawal by Subject|13|||
161537017|NCT00448448|583354163|FG001|Overall Study|Withdrawal by Subject|2|||
161537018|NCT00448448|583354162|FG000|Overall Study|On protocol when study ended|83|||
161678743|NCT00574288|583876071|FG006|Overall Study|Death|21|||
161537019|NCT00448448|583354163|FG001|Overall Study|On protocol when study ended|36|||
161537020|NCT00448448|583354162|FG000|Overall Study|Lost to Follow-up|2|||
161537021|NCT00448448|583354163|FG001|Overall Study|Lost to Follow-up|1|||
161537022|NCT00448448|583354162|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
161537023|NCT00448448|583354163|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
161537024|NCT00448448|583354162|FG000|Overall Study|Signed consent lost|0|||
161537025|NCT00448448|583354163|FG001|Overall Study|Signed consent lost|1|||
161537026|NCT02340026|583354164|FG000|Treatment Phase|Withdrawal by Subject|2|||
161537027|NCT02340026|583354165|FG001|Treatment Phase|Withdrawal by Subject|2|||
161537028|NCT02340026|583354164|FG000|Follow-up Phase|Lost to Follow-up|1|||
161537029|NCT02340026|583354165|FG001|Follow-up Phase|Lost to Follow-up|0|||
161537030|NCT03945292|583354166|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
161537031|NCT03945292|583354167|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
161537032|NCT03945292|583354168|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
161537033|NCT03945292|583354169|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
161537034|NCT03945292|583354170|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
161537035|NCT03945292|583354171|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
161537036|NCT03945292|583354172|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
161537037|NCT03945292|583354173|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
161537038|NCT03945292|583354166|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537039|NCT03945292|583354167|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537040|NCT03945292|583354168|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
161537041|NCT03945292|583354169|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537042|NCT03945292|583354170|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537043|NCT03945292|583354171|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537044|NCT03945292|583354172|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537045|NCT03945292|583354173|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
161537046|NCT03945292|583354166|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537047|NCT03945292|583354167|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537048|NCT03945292|583354168|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537049|NCT03945292|583354169|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537050|NCT03945292|583354170|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537051|NCT03945292|583354171|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537052|NCT03945292|583354172|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
161537053|NCT03945292|583354173|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
161537054|NCT02684006|583354174|FG000|Overall Study|Other|18|||
161537055|NCT02684006|583354175|FG001|Overall Study|Other|6|||
161537056|NCT02684006|583354174|FG000|Overall Study|Protocol Violation|2|||
161537057|NCT02684006|583354175|FG001|Overall Study|Protocol Violation|1|||
161537058|NCT02684006|583354174|FG000|Overall Study|Non-compliance with study drug|1|||
161537059|NCT02684006|583354175|FG001|Overall Study|Non-compliance with study drug|1|||
161537060|NCT02684006|583354174|FG000|Overall Study|No longer met eligibility criteria|6|||
161537061|NCT02684006|583354175|FG001|Overall Study|No longer met eligibility criteria|2|||
161537062|NCT02684006|583354174|FG000|Overall Study|Lost to Follow-up|0|||
161537063|NCT02684006|583354175|FG001|Overall Study|Lost to Follow-up|1|||
161537064|NCT02684006|583354174|FG000|Overall Study|Death|25|||
161537065|NCT02684006|583354175|FG001|Overall Study|Death|22|||
161537066|NCT02684006|583354174|FG000|Overall Study|Global deterioration of health status|18|||
161537067|NCT02684006|583354175|FG001|Overall Study|Global deterioration of health status|20|||
161537068|NCT02684006|583354174|FG000|Overall Study|Physician Decision|15|||
161537069|NCT02684006|583354175|FG001|Overall Study|Physician Decision|8|||
161537070|NCT02684006|583354174|FG000|Overall Study|Adverse Event|86|||
161537071|NCT02684006|583354175|FG001|Overall Study|Adverse Event|65|||
161537072|NCT02684006|583354174|FG000|Overall Study|Withdrawal by Subject|29|||
161537073|NCT02684006|583354175|FG001|Overall Study|Withdrawal by Subject|43|||
161537074|NCT02684006|583354174|FG000|Overall Study|Progressive disease|236|||
161537075|NCT02684006|583354175|FG001|Overall Study|Progressive disease|266|||
161537076|NCT02684006|583354174|FG000|Overall Study|Participation terminated by sponsor|6|||
161537077|NCT02684006|583354175|FG001|Overall Study|Participation terminated by sponsor|9|||
161537078|NCT04642898|583354176|FG000|Overall Study|Withdrawal by Subject|2|||
161537079|NCT04642898|583354177|FG001|Overall Study|Withdrawal by Subject|4|||
161537080|NCT04642898|583354178|FG002|Overall Study|Withdrawal by Subject|4|||
161537081|NCT04642898|583354179|FG003|Overall Study|Withdrawal by Subject|6|||
161537082|NCT04642898|583354180|FG004|Overall Study|Withdrawal by Subject|2|||
161537083|NCT04642898|583354181|FG005|Overall Study|Withdrawal by Subject|6|||
161537084|NCT04642898|583354176|FG000|Overall Study|Lost to Follow-up|0|||
161537085|NCT04642898|583354177|FG001|Overall Study|Lost to Follow-up|0|||
161537086|NCT04642898|583354178|FG002|Overall Study|Lost to Follow-up|0|||
161537087|NCT04642898|583354179|FG003|Overall Study|Lost to Follow-up|2|||
161537088|NCT04642898|583354180|FG004|Overall Study|Lost to Follow-up|0|||
161537089|NCT04642898|583354181|FG005|Overall Study|Lost to Follow-up|1|||
161537090|NCT04642898|583354176|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
161537091|NCT04642898|583354177|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
161537092|NCT04642898|583354178|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
161537093|NCT04642898|583354179|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
161537094|NCT04642898|583354180|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
161537095|NCT04642898|583354181|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
161537096|NCT04642898|583354176|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
161537097|NCT04642898|583354177|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
161537098|NCT04642898|583354178|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
161537099|NCT04642898|583354179|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
161537100|NCT04642898|583354180|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
161537101|NCT04642898|583354181|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
161537102|NCT04495179|583354182|FG000|Overall Study|Lost to Follow-up|0|||
161537103|NCT04495179|583354183|FG001|Overall Study|Lost to Follow-up|1|||
161537104|NCT04495179|583354182|FG000|Overall Study|Withdrawal by Subject|2|||
161537105|NCT04495179|583354183|FG001|Overall Study|Withdrawal by Subject|4|||
161537106|NCT04495179|583354182|FG000|Overall Study|Study terminated by sponsor|0|||
161537107|NCT04495179|583354183|FG001|Overall Study|Study terminated by sponsor|18|||
161537108|NCT04495179|583354182|FG000|Overall Study|Death|0|||
161537109|NCT04495179|583354183|FG001|Overall Study|Death|4|||
161537110|NCT04495179|583354182|FG000|Overall Study|Adverse Event|0|||
161537111|NCT04495179|583354183|FG001|Overall Study|Adverse Event|1|||
161537112|NCT04280562|583354184|FG000|Study|Adverse Event|2|||
161537113|NCT04280562|583354185|FG001|Study|Adverse Event|0|||
161537114|NCT04280562|583354184|FG000|Study|Lost to Follow-up|3|||
161537115|NCT04280562|583354185|FG001|Study|Lost to Follow-up|3|||
161537116|NCT00946296|583354186|FG000|Overall Study|Physician Decision|3|||
161537117|NCT00946296|583354187|FG001|Overall Study|Physician Decision|0|||
161537118|NCT03434678|583354190|FG000|Overall Study|Withdrawal by Subject|13|||
161537119|NCT03434678|583354191|FG001|Overall Study|Withdrawal by Subject|13|||
161537120|NCT03434678|583354190|FG000|Overall Study|Found to be ineligible post randomization|2|||
161537121|NCT03434678|583354191|FG001|Overall Study|Found to be ineligible post randomization|1|||
161537122|NCT01368965|583354195|FG000|Overall Study|Lost to Follow-up|12|||
161537123|NCT06060457|583354196|FG000|Overall Study|Adverse Event|1|||
161537124|NCT06060457|583354197|FG001|Overall Study|Adverse Event|1|||
161537125|NCT06060457|583354196|FG000|Overall Study|Death|2|||
161537126|NCT06060457|583354197|FG001|Overall Study|Death|2|||
161537127|NCT06060457|583354196|FG000|Overall Study|Lost to Follow-up|17|||
161537128|NCT06060457|583354197|FG001|Overall Study|Lost to Follow-up|19|||
161537129|NCT06060457|583354196|FG000|Overall Study|Physician Decision|0|||
161537130|NCT06060457|583354197|FG001|Overall Study|Physician Decision|1|||
161537131|NCT06060457|583354196|FG000|Overall Study|Protocol Violation|1|||
161537132|NCT06060457|583354197|FG001|Overall Study|Protocol Violation|1|||
161678744|NCT00574288|583876065|FG000|Overall Study|Lost to Follow-up|0|||
161678745|NCT00574288|583876066|FG001|Overall Study|Lost to Follow-up|0|||
161537133|NCT06060457|583354196|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
161537134|NCT06060457|583354197|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
161537135|NCT06060457|583354196|FG000|Overall Study|Withdrawal by Subject|12|||
161678746|NCT00574288|583876067|FG002|Overall Study|Lost to Follow-up|0|||
161537136|NCT06060457|583354197|FG001|Overall Study|Withdrawal by Subject|15|||
161537137|NCT06060457|583354196|FG000|Overall Study|Other Than Specified|2|||
161537138|NCT06060457|583354197|FG001|Overall Study|Other Than Specified|1|||
161537139|NCT02061202|583354198|FG000|Overall Study|Lost to Follow-up|1|||
161537140|NCT02061202|583354199|FG001|Overall Study|Lost to Follow-up|1|||
161537141|NCT00162370|583354200|FG000|Efficacy Population|Lost to Follow-up|51|||
161537142|NCT00569582|583354214|FG000|Overall Study|Withdrawal by Subject|5|||
161537143|NCT00569582|583354214|FG000|Overall Study|Death|2|||
161537144|NCT00569582|583354214|FG000|Overall Study|Adverse Event|7|||
161537145|NCT00569582|583354214|FG000|Overall Study|Subject was too ill to travel.|1|||
161537146|NCT00569582|583354214|FG000|Overall Study|Subject was non-compliant.|1|||
161537147|NCT04559568|583354215|FG000|Overall Study|Physician Decision|0|||
161537148|NCT04559568|583354216|FG001|Overall Study|Physician Decision|0|||
161537149|NCT04559568|583354217|FG002|Overall Study|Physician Decision|0|||
161537150|NCT04559568|583354218|FG003|Overall Study|Physician Decision|0|||
161537151|NCT04559568|583354219|FG004|Overall Study|Physician Decision|0|||
161537152|NCT04559568|583354220|FG005|Overall Study|Physician Decision|0|||
161537153|NCT04559568|583354221|FG006|Overall Study|Physician Decision|0|||
161537154|NCT04559568|583354222|FG007|Overall Study|Physician Decision|0|||
161537155|NCT04559568|583354223|FG008|Overall Study|Physician Decision|0|||
161537156|NCT04559568|583354224|FG009|Overall Study|Physician Decision|1|||
161537157|NCT04559568|583354225|FG010|Overall Study|Physician Decision|0|||
161537158|NCT04559568|583354215|FG000|Overall Study|Withdrawal by Subject|0|||
161537159|NCT04559568|583354216|FG001|Overall Study|Withdrawal by Subject|0|||
161537160|NCT04559568|583354217|FG002|Overall Study|Withdrawal by Subject|0|||
161537161|NCT04559568|583354218|FG003|Overall Study|Withdrawal by Subject|0|||
161537162|NCT04559568|583354219|FG004|Overall Study|Withdrawal by Subject|0|||
161537163|NCT04559568|583354220|FG005|Overall Study|Withdrawal by Subject|0|||
161537164|NCT04559568|583354221|FG006|Overall Study|Withdrawal by Subject|0|||
161537165|NCT04559568|583354222|FG007|Overall Study|Withdrawal by Subject|0|||
161537166|NCT04559568|583354223|FG008|Overall Study|Withdrawal by Subject|0|||
161537167|NCT04559568|583354224|FG009|Overall Study|Withdrawal by Subject|0|||
161537168|NCT04559568|583354225|FG010|Overall Study|Withdrawal by Subject|1|||
161537169|NCT03721965|583354228|FG000|Overall Study|Death|1|||
161537170|NCT03721965|583354228|FG000|Overall Study|Study Terminated by Sponsor|1|||
161537171|NCT04085328|583354233|FG000|Overall Study|Witihdrew Consent|16|||
161537172|NCT04085328|583354234|FG001|Overall Study|Witihdrew Consent|16|||
161537173|NCT04085328|583354233|FG000|Overall Study|Adverse Event|8|||
161537174|NCT04085328|583354234|FG001|Overall Study|Adverse Event|7|||
161537175|NCT04085328|583354233|FG000|Overall Study|Lost to Follow-up|7|||
161537176|NCT04085328|583354234|FG001|Overall Study|Lost to Follow-up|2|||
161537177|NCT04085328|583354233|FG000|Overall Study|Physician Decision|0|||
161537178|NCT04085328|583354234|FG001|Overall Study|Physician Decision|1|||
161537179|NCT04085328|583354233|FG000|Overall Study|Pregnancy|0|||
161537180|NCT04085328|583354234|FG001|Overall Study|Pregnancy|1|||
161537181|NCT04085328|583354233|FG000|Overall Study|Reasons Related to COVID-19|5|||
161537182|NCT04085328|583354234|FG001|Overall Study|Reasons Related to COVID-19|8|||
161537183|NCT04085328|583354233|FG000|Overall Study|Did not meet inclusion criteria|1|||
161537184|NCT04085328|583354234|FG001|Overall Study|Did not meet inclusion criteria|1|||
161537185|NCT04085328|583354233|FG000|Overall Study|Early termination|1|||
161537186|NCT04085328|583354234|FG001|Overall Study|Early termination|0|||
161537187|NCT05608499|583354235|FG000|Overall Study|Lack of Efficacy|1|||
161537188|NCT05608499|583354236|FG001|Overall Study|Lack of Efficacy|0|||
161537189|NCT05608499|583354235|FG000|Overall Study|Lost to Follow-up|0|||
161537190|NCT05608499|583354236|FG001|Overall Study|Lost to Follow-up|1|||
161537191|NCT00514735|583354237|FG000|Overall Study|Withdrawal by Subject|13|||
161537192|NCT00514735|583354238|FG001|Overall Study|Withdrawal by Subject|5|||
161537193|NCT00514735|583354237|FG000|Overall Study|Death|1|||
161537194|NCT00514735|583354238|FG001|Overall Study|Death|0|||
161537195|NCT00514735|583354237|FG000|Overall Study|Lost to Follow-up|0|||
161537196|NCT00514735|583354238|FG001|Overall Study|Lost to Follow-up|1|||
161537197|NCT01422408|583354241|FG000|Overall Study|Adverse Event|1|||
161537198|NCT01422408|583354241|FG000|Overall Study|Withdrawal by Subject|3|||
161537199|NCT00724152|583354249|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
161537200|NCT00724152|583354250|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
161537201|NCT00724152|583354251|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
161537202|NCT00724152|583354249|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
161537203|NCT00724152|583354250|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
161537204|NCT00724152|583354251|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
161537205|NCT01328080|583354252|FG000|Overall Study|Lost to Follow-up|5|||
161537206|NCT00045305|583354253|FG000|Overall Study|Lack of Efficacy|6|||
161537207|NCT00045305|583354253|FG000|Overall Study|Adverse Event|3|||
161537208|NCT00045305|583354253|FG000|Overall Study|Death|3|||
161537209|NCT00045305|583354253|FG000|Overall Study|site error|2|||
161537210|NCT03266770|583354254|FG000|Overall Study|Physician Decision|3|||
161537211|NCT03266770|583354254|FG000|Overall Study|Insufficient study supplies|1|||
161537212|NCT03266770|583354254|FG000|Overall Study|Adverse Event|1|||
161537213|NCT04274894|583354255|FG000|Overall Study|Adverse Event|7|||
161537214|NCT04274894|583354255|FG000|Overall Study|Withdrew consent|5|||
161592298|NCT04810650|583556764|FG002|Overall Study|Participant declined|0|||
161592299|NCT04810650|583556765|FG003|Overall Study|Participant declined|0|||
161592300|NCT04810650|583556766|FG004|Overall Study|Participant declined|0|||
161592301|NCT04810650|583556767|FG005|Overall Study|Participant declined|0|||
161592302|NCT04810650|583556768|FG006|Overall Study|Participant declined|0|||
161537215|NCT04274894|583354255|FG000|Overall Study|Lost to Follow-up|9|||
161537216|NCT04274894|583354255|FG000|Overall Study|COVID-19 infection|1|||
161537217|NCT04274894|583354255|FG000|Overall Study|Other, not specified|20|||
161537218|NCT01936857|583354256|FG000|Overall Study|Sent to prison or 06 center|11|||
161537219|NCT01936857|583354257|FG001|Overall Study|Sent to prison or 06 center|12|||
161537220|NCT01936857|583354256|FG000|Overall Study|Lost to Follow-up|10|||
161592303|NCT04810650|583556769|FG007|Overall Study|Participant declined|0|||
161592304|NCT04810650|583556770|FG008|Overall Study|Participant declined|0|||
161537221|NCT01936857|583354257|FG001|Overall Study|Lost to Follow-up|7|||
161537222|NCT01936857|583354256|FG000|Overall Study|Death|7|||
161537223|NCT01936857|583354257|FG001|Overall Study|Death|3|||
161537224|NCT01936857|583354256|FG000|Overall Study|Moved|2|||
161537225|NCT01936857|583354257|FG001|Overall Study|Moved|1|||
161537226|NCT01936857|583354256|FG000|Overall Study|Withdrawal by Subject|1|||
161537227|NCT01936857|583354257|FG001|Overall Study|Withdrawal by Subject|0|||
161537228|NCT01936857|583354256|FG000|Overall Study|Side effect of medication|1|||
161592305|NCT04810650|583556771|FG009|Overall Study|Participant declined|0|||
161537229|NCT01936857|583354257|FG001|Overall Study|Side effect of medication|0|||
161537230|NCT01936857|583354256|FG000|Overall Study|Other|2|||
161537231|NCT01936857|583354257|FG001|Overall Study|Other|2|||
161537232|NCT03848403|583354258|FG000|Period 2 (Day 8)|Adverse Event|1|||
161537233|NCT03848403|583354259|FG001|Period 2 (Day 8)|Adverse Event|2|||
161678747|NCT00574288|583876068|FG003|Overall Study|Lost to Follow-up|0|||
161537234|NCT03848403|583354260|FG002|Period 2 (Day 8)|Adverse Event|2|||
161537235|NCT03848403|583354258|FG000|Period 2 (Day 8)|Physician Decision|0|||
161537236|NCT03848403|583354259|FG001|Period 2 (Day 8)|Physician Decision|1|||
161537237|NCT03848403|583354260|FG002|Period 2 (Day 8)|Physician Decision|0|||
161537238|NCT03848403|583354258|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
161537239|NCT03848403|583354259|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
161537240|NCT03848403|583354260|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
161537241|NCT00168038|583354261|FG000|Overall Study|Adverse Event|1|||
161537242|NCT00168038|583354261|FG000|Overall Study|Therapy failure|1|||
161537243|NCT04510675|583354263|FG000|Overall Study|Withdrawal by Subject|5|||
161537244|NCT01499082|583354266|FG000|Overall Study|Randomized but not Treated|0|||
161537245|NCT01499082|583354267|FG001|Overall Study|Randomized but not Treated|1|||
161537246|NCT01499082|583354266|FG000|Overall Study|Adverse Event|12|||
161537247|NCT01499082|583354267|FG001|Overall Study|Adverse Event|16|||
161537248|NCT01499082|583354266|FG000|Overall Study|Lack of Efficacy|1|||
161537249|NCT01499082|583354267|FG001|Overall Study|Lack of Efficacy|1|||
161537250|NCT01499082|583354266|FG000|Overall Study|Protocol Violation|6|||
161537251|NCT01499082|583354267|FG001|Overall Study|Protocol Violation|8|||
161537252|NCT01499082|583354266|FG000|Overall Study|Diverse Reasons|18|||
161537253|NCT01499082|583354267|FG001|Overall Study|Diverse Reasons|14|||
161537254|NCT01499082|583354266|FG000|Overall Study|Site Closure for Noncompliance|5|||
161537255|NCT01499082|583354267|FG001|Overall Study|Site Closure for Noncompliance|2|||
161537256|NCT01499082|583354266|FG000|Overall Study|Hypoglycemia|2|||
161537257|NCT01499082|583354267|FG001|Overall Study|Hypoglycemia|3|||
161537258|NCT01499082|583354266|FG000|Overall Study|Lost to Follow-up|1|||
161537259|NCT01499082|583354267|FG001|Overall Study|Lost to Follow-up|3|||
161537260|NCT01218126|583354272|FG000|Overall Study|Adverse Event|8|||
161537261|NCT01218126|583354273|FG001|Overall Study|Adverse Event|10|||
161537262|NCT01218126|583354274|FG002|Overall Study|Adverse Event|12|||
161537263|NCT01218126|583354275|FG003|Overall Study|Adverse Event|16|||
161537264|NCT01218126|583354272|FG000|Overall Study|Lack of Efficacy|7|||
161537265|NCT01218126|583354273|FG001|Overall Study|Lack of Efficacy|2|||
161537266|NCT01218126|583354274|FG002|Overall Study|Lack of Efficacy|2|||
161537267|NCT01218126|583354275|FG003|Overall Study|Lack of Efficacy|6|||
161537268|NCT01218126|583354272|FG000|Overall Study|Protocol Violation|5|||
161537269|NCT01218126|583354273|FG001|Overall Study|Protocol Violation|2|||
161537270|NCT01218126|583354274|FG002|Overall Study|Protocol Violation|2|||
161537271|NCT01218126|583354275|FG003|Overall Study|Protocol Violation|3|||
161537272|NCT01218126|583354272|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161537273|NCT01218126|583354273|FG001|Overall Study|Protocol-defined stopping criteria|1|||
161537274|NCT01218126|583354274|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161537275|NCT01218126|583354275|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161537276|NCT01218126|583354272|FG000|Overall Study|Lost to Follow-up|0|||
161537277|NCT01218126|583354273|FG001|Overall Study|Lost to Follow-up|0|||
161537278|NCT01218126|583354274|FG002|Overall Study|Lost to Follow-up|0|||
161537279|NCT01218126|583354275|FG003|Overall Study|Lost to Follow-up|2|||
161537280|NCT01218126|583354272|FG000|Overall Study|Physician Decision|1|||
161537281|NCT01218126|583354273|FG001|Overall Study|Physician Decision|2|||
161537282|NCT01218126|583354274|FG002|Overall Study|Physician Decision|4|||
161537283|NCT01218126|583354275|FG003|Overall Study|Physician Decision|2|||
161537284|NCT01218126|583354272|FG000|Overall Study|Withdrawal by Subject|2|||
161537285|NCT01218126|583354273|FG001|Overall Study|Withdrawal by Subject|5|||
161537286|NCT01218126|583354274|FG002|Overall Study|Withdrawal by Subject|4|||
161537287|NCT01218126|583354275|FG003|Overall Study|Withdrawal by Subject|6|||
161537288|NCT05380947|583354276|FG000|Washout Period 1|Not attend visit|1|||
161537289|NCT05380947|583354277|FG001|Washout Period 1|Not attend visit|0|||
161537290|NCT05380947|583354278|FG002|Washout Period 1|Not attend visit|0|||
161537291|NCT05380947|583354279|FG003|Washout Period 1|Not attend visit|0|||
161537292|NCT05380947|583354276|FG000|Washout Period 2|Adverse Event|1|||
161537293|NCT05380947|583354277|FG001|Washout Period 2|Adverse Event|0|||
161537294|NCT05380947|583354278|FG002|Washout Period 2|Adverse Event|0|||
161537295|NCT05380947|583354279|FG003|Washout Period 2|Adverse Event|0|||
161537296|NCT05380947|583354276|FG000|Washout Period 3|Adverse Event|0|||
161537297|NCT05380947|583354277|FG001|Washout Period 3|Adverse Event|1|||
161537298|NCT05380947|583354278|FG002|Washout Period 3|Adverse Event|0|||
161537299|NCT05380947|583354279|FG003|Washout Period 3|Adverse Event|0|||
161537300|NCT05380947|583354276|FG000|Washout Period 3|Not attend visit|0|||
161537301|NCT05380947|583354277|FG001|Washout Period 3|Not attend visit|1|||
161537302|NCT05380947|583354278|FG002|Washout Period 3|Not attend visit|0|||
161537303|NCT05380947|583354279|FG003|Washout Period 3|Not attend visit|1|||
161537304|NCT01563536|583354280|FG000|Overall Study|Withdrawal by Subject|0|||
161537305|NCT01563536|583354281|FG001|Overall Study|Withdrawal by Subject|2|||
161537306|NCT01563536|583354280|FG000|Overall Study|Lost to Follow-up|1|||
161537307|NCT01563536|583354281|FG001|Overall Study|Lost to Follow-up|0|||
161537308|NCT01860703|583354282|FG000|Overall Study|Adverse Event|1|||
161537309|NCT01860703|583354283|FG001|Overall Study|Adverse Event|4|||
161537310|NCT01860703|583354284|FG002|Overall Study|Adverse Event|0|||
161537311|NCT01860703|583354285|FG003|Overall Study|Adverse Event|2|||
161537312|NCT01860703|583354282|FG000|Overall Study|Withdrawal by Subject|0|||
161537313|NCT01860703|583354283|FG001|Overall Study|Withdrawal by Subject|1|||
161537314|NCT01860703|583354284|FG002|Overall Study|Withdrawal by Subject|0|||
161537315|NCT01860703|583354285|FG003|Overall Study|Withdrawal by Subject|0|||
161537316|NCT01860703|583354282|FG000|Overall Study|Personal reason|1|||
161537317|NCT01860703|583354283|FG001|Overall Study|Personal reason|0|||
161537318|NCT01860703|583354284|FG002|Overall Study|Personal reason|1|||
161537319|NCT01860703|583354285|FG003|Overall Study|Personal reason|0|||
161537320|NCT06213701|583354289|FG000|Overall Study|Withdrawal by Subject|2|||
161537321|NCT06213701|583354290|FG001|Overall Study|Withdrawal by Subject|1|||
161537322|NCT06213701|583354291|FG002|Overall Study|Withdrawal by Subject|0|||
161537323|NCT00538590|583354292|FG000|Overall Study|Death|1|||
161537324|NCT00538590|583354293|FG001|Overall Study|Death|0|||
161537325|NCT03184792|583354298|FG000|Overall Study|Pandemic|2|||
161537326|NCT03184792|583354299|FG001|Overall Study|Pandemic|2|||
161537327|NCT00313820|583354300|FG000|Assigned to Treatment|Other|1|||
161537328|NCT00313820|583354301|FG001|Assigned to Treatment|Other|0|||
161537329|NCT00313820|583354300|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
161537330|NCT00313820|583354301|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
161537331|NCT00313820|583354300|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
161537332|NCT00313820|583354301|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
161537333|NCT00313820|583354300|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
161537334|NCT00313820|583354301|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
161537335|NCT00313820|583354300|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
161537336|NCT00313820|583354301|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
161537337|NCT00313820|583354300|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
161537338|NCT00313820|583354301|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
161537339|NCT02453685|583354305|FG000|Overall Study|Adverse Event|0|||
161537340|NCT02453685|583354306|FG001|Overall Study|Adverse Event|1|||
161537341|NCT02453685|583354305|FG000|Overall Study|Protocol Violation|7|||
161537342|NCT02453685|583354306|FG001|Overall Study|Protocol Violation|4|||
161537343|NCT02453685|583354305|FG000|Overall Study|Lost to Follow-up|0|||
161537344|NCT02453685|583354306|FG001|Overall Study|Lost to Follow-up|1|||
161537345|NCT02453685|583354305|FG000|Overall Study|Withdrawal by Subject|8|||
161537346|NCT02453685|583354306|FG001|Overall Study|Withdrawal by Subject|4|||
161537347|NCT02453685|583354305|FG000|Overall Study|Unclassified|4|||
161537348|NCT02453685|583354306|FG001|Overall Study|Unclassified|2|||
161537349|NCT02778100|583354307|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
161537350|NCT02778100|583354308|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
161537351|NCT01515748|583354316|FG000|Overall Study|Withdrawal by Subject|32|||
161537352|NCT01515748|583354317|FG001|Overall Study|Withdrawal by Subject|41|||
161537353|NCT01515748|583354316|FG000|Overall Study|Lost to Follow-up|2|||
161537354|NCT01515748|583354317|FG001|Overall Study|Lost to Follow-up|4|||
161537355|NCT01515748|583354316|FG000|Overall Study|Other than specified above|5|||
161537356|NCT01515748|583354317|FG001|Overall Study|Other than specified above|10|||
161537357|NCT03221387|583354318|FG000|Overall Study|Lost to Follow-up|1|||
161537358|NCT03221387|583354318|FG000|Overall Study|Lung transplant|1|||
161537359|NCT00522626|583354319|FG000|Overall Study|Lost to Follow-up|7|||
161537360|NCT00803452|583354320|FG000|Overall Study|Adverse Event|0|||
161537361|NCT00803452|583354321|FG001|Overall Study|Adverse Event|2|||
161537362|NCT00803452|583354320|FG000|Overall Study|Lost to Follow-up|0|||
161537363|NCT00803452|583354321|FG001|Overall Study|Lost to Follow-up|3|||
161537364|NCT02365519|583354322|FG000|Randomized and Treated|Adverse Event|0|||
161537365|NCT02365519|583354323|FG001|Randomized and Treated|Adverse Event|1|||
161537366|NCT02365519|583354324|FG002|Randomized and Treated|Adverse Event|0|||
161537367|NCT02365519|583354322|FG000|Randomized and Treated|Withdrawal by Subject|0|||
161537368|NCT02365519|583354323|FG001|Randomized and Treated|Withdrawal by Subject|1|||
161537369|NCT02365519|583354324|FG002|Randomized and Treated|Withdrawal by Subject|1|||
161537370|NCT01971723|583354325|FG000|Overall Study|Withdrawal by Subject|1|||
161537371|NCT01971723|583354326|FG001|Overall Study|Withdrawal by Subject|1|||
161537372|NCT01971723|583354325|FG000|Overall Study|Protocol Violation|1|||
161537373|NCT01971723|583354326|FG001|Overall Study|Protocol Violation|2|||
161537374|NCT03017079|583354330|FG000|Overall Study|Physician Decision|1|||
161537375|NCT03017079|583354331|FG001|Overall Study|Physician Decision|1|||
161537376|NCT03017079|583354330|FG000|Overall Study|Death|3|||
161537377|NCT03017079|583354331|FG001|Overall Study|Death|2|||
161537378|NCT03017079|583354330|FG000|Overall Study|Lack of Efficacy|2|||
161537379|NCT03017079|583354331|FG001|Overall Study|Lack of Efficacy|2|||
161537380|NCT03017079|583354330|FG000|Overall Study|Protocol Violation|0|||
161537381|NCT03017079|583354331|FG001|Overall Study|Protocol Violation|1|||
161537382|NCT04120233|583354337|FG000|Overall Study|Adverse Event|0|||
161537383|NCT04120233|583354338|FG001|Overall Study|Adverse Event|0|||
161537384|NCT04120233|583354339|FG002|Overall Study|Adverse Event|0|||
161537385|NCT04120233|583354340|FG003|Overall Study|Adverse Event|0|||
161537386|NCT04120233|583354341|FG004|Overall Study|Adverse Event|1|||
161537387|NCT04120233|583354342|FG005|Overall Study|Adverse Event|0|||
161537388|NCT06223373|583354343|FG000|Overall Study|Lost to Follow-up|1|||
161537389|NCT06223373|583354344|FG001|Overall Study|Lost to Follow-up|2|||
161537390|NCT05809596|583354347|FG000|Overall Study|Death|16|||
161537391|NCT05809596|583354347|FG000|Overall Study|Withdrawal by Subject|4|||
161537392|NCT05809596|583354347|FG000|Overall Study|Physician Decision|1|||
161537393|NCT05809596|583354347|FG000|Overall Study|Missed Visit|2|||
161537394|NCT05809596|583354347|FG000|Overall Study|Other|3|||
161537395|NCT03770494|583354348|FG000|Overall Study|Lost to Follow-up|0|||
161537396|NCT03770494|583354349|FG001|Overall Study|Lost to Follow-up|0|||
161537397|NCT03770494|583354350|FG002|Overall Study|Lost to Follow-up|1|||
161537398|NCT03770494|583354351|FG003|Overall Study|Lost to Follow-up|1|||
161537399|NCT03770494|583354352|FG004|Overall Study|Lost to Follow-up|1|||
161537400|NCT03770494|583354353|FG005|Overall Study|Lost to Follow-up|0|||
161537401|NCT03770494|583354354|FG006|Overall Study|Lost to Follow-up|0|||
161537402|NCT03770494|583354355|FG007|Overall Study|Lost to Follow-up|0|||
161537403|NCT03770494|583354356|FG008|Overall Study|Lost to Follow-up|0|||
161537404|NCT03770494|583354357|FG009|Overall Study|Lost to Follow-up|0|||
161537405|NCT03770494|583354358|FG010|Overall Study|Lost to Follow-up|0|||
161537406|NCT03770494|583354359|FG011|Overall Study|Lost to Follow-up|0|||
161537407|NCT03770494|583354360|FG012|Overall Study|Lost to Follow-up|0|||
161537408|NCT03770494|583354361|FG013|Overall Study|Lost to Follow-up|0|||
161537409|NCT03770494|583354348|FG000|Overall Study|Study terminated by sponsor|1|||
161537410|NCT03770494|583354349|FG001|Overall Study|Study terminated by sponsor|2|||
161537411|NCT03770494|583354350|FG002|Overall Study|Study terminated by sponsor|1|||
161537412|NCT03770494|583354351|FG003|Overall Study|Study terminated by sponsor|1|||
161537413|NCT03770494|583354352|FG004|Overall Study|Study terminated by sponsor|1|||
161537414|NCT03770494|583354353|FG005|Overall Study|Study terminated by sponsor|2|||
161537415|NCT03770494|583354354|FG006|Overall Study|Study terminated by sponsor|1|||
161537416|NCT03770494|583354355|FG007|Overall Study|Study terminated by sponsor|2|||
161537417|NCT03770494|583354356|FG008|Overall Study|Study terminated by sponsor|1|||
161537418|NCT03770494|583354357|FG009|Overall Study|Study terminated by sponsor|2|||
161537419|NCT03770494|583354358|FG010|Overall Study|Study terminated by sponsor|1|||
161537420|NCT03770494|583354359|FG011|Overall Study|Study terminated by sponsor|2|||
161537421|NCT03770494|583354360|FG012|Overall Study|Study terminated by sponsor|0|||
161537422|NCT03770494|583354361|FG013|Overall Study|Study terminated by sponsor|0|||
161537423|NCT03770494|583354348|FG000|Overall Study|Withdrawal by Subject|1|||
161537424|NCT03770494|583354349|FG001|Overall Study|Withdrawal by Subject|1|||
161537425|NCT03770494|583354350|FG002|Overall Study|Withdrawal by Subject|0|||
161537426|NCT03770494|583354351|FG003|Overall Study|Withdrawal by Subject|0|||
161537427|NCT03770494|583354352|FG004|Overall Study|Withdrawal by Subject|2|||
161537428|NCT03770494|583354353|FG005|Overall Study|Withdrawal by Subject|2|||
161537429|NCT03770494|583354354|FG006|Overall Study|Withdrawal by Subject|2|||
161537430|NCT03770494|583354355|FG007|Overall Study|Withdrawal by Subject|0|||
161537431|NCT03770494|583354356|FG008|Overall Study|Withdrawal by Subject|2|||
161537432|NCT03770494|583354357|FG009|Overall Study|Withdrawal by Subject|3|||
161537433|NCT03770494|583354358|FG010|Overall Study|Withdrawal by Subject|1|||
161537434|NCT03770494|583354359|FG011|Overall Study|Withdrawal by Subject|0|||
161537435|NCT03770494|583354360|FG012|Overall Study|Withdrawal by Subject|0|||
161537436|NCT03770494|583354361|FG013|Overall Study|Withdrawal by Subject|0|||
161537437|NCT00553501|583356000|FG000|Overall Study|Adverse Event|2|||
161537438|NCT00553501|583356000|FG000|Overall Study|Death|1|||
161537439|NCT00553501|583356000|FG000|Overall Study|Progression|1|||
161537440|NCT00949715|583356003|FG000|Overall Study|Physician Decision|1|||
161537441|NCT00949715|583356004|FG001|Overall Study|Physician Decision|0|||
161537442|NCT00949715|583356003|FG000|Overall Study|Lost to Follow-up|1|||
161537443|NCT00949715|583356004|FG001|Overall Study|Lost to Follow-up|0|||
161537444|NCT00949715|583356003|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
161537445|NCT00949715|583356004|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
161537446|NCT05050578|583356008|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
161537447|NCT05050578|583356009|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
161537448|NCT05050578|583356008|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
161537449|NCT05050578|583356009|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
161537450|NCT05050578|583356008|FG000|Period 2, 30 Days|Protocol Violation|0|||
161537451|NCT05050578|583356009|FG001|Period 2, 30 Days|Protocol Violation|1|||
161537452|NCT02243280|583356010|FG000|Treated|Adverse Event|1|||
161537453|NCT02243280|583356011|FG001|Treated|Adverse Event|0|||
161537454|NCT02243280|583356012|FG002|Treated|Adverse Event|0|||
161537455|NCT02243280|583356013|FG003|Treated|Adverse Event|0|||
161537456|NCT02243280|583356014|FG004|Treated|Adverse Event|0|||
161537457|NCT02243280|583356015|FG005|Treated|Adverse Event|0|||
161537458|NCT02243280|583356016|FG006|Treated|Adverse Event|0|||
161537459|NCT02243280|583356017|FG007|Treated|Adverse Event|0|||
161537460|NCT02243280|583356018|FG008|Treated|Adverse Event|0|||
161537461|NCT02243280|583356019|FG009|Treated|Adverse Event|0|||
161537462|NCT02243280|583356020|FG010|Treated|Adverse Event|1|||
161537463|NCT02243280|583356010|FG000|Treated|Lost to Follow-up|0|||
161537464|NCT02243280|583356011|FG001|Treated|Lost to Follow-up|0|||
161537465|NCT02243280|583356012|FG002|Treated|Lost to Follow-up|0|||
161592306|NCT04810650|583556772|FG010|Overall Study|Participant declined|2|||
161592307|NCT04810650|583556773|FG011|Overall Study|Participant declined|0|||
161592308|NCT04810650|583556774|FG012|Overall Study|Participant declined|0|||
161592309|NCT04810650|583556775|FG013|Overall Study|Participant declined|0|||
161829379|NCT00255151|584415756|FG000|Overall Study|Esophageal Stricture|0|||
161829380|NCT00255151|584415757|FG001|Overall Study|Esophageal Stricture|0|||
161829381|NCT00255151|584415758|FG002|Overall Study|Esophageal Stricture|1|||
161537466|NCT02243280|583356013|FG003|Treated|Lost to Follow-up|0|||
161537467|NCT02243280|583356014|FG004|Treated|Lost to Follow-up|0|||
161537468|NCT02243280|583356015|FG005|Treated|Lost to Follow-up|0|||
161537469|NCT02243280|583356016|FG006|Treated|Lost to Follow-up|0|||
161537470|NCT02243280|583356017|FG007|Treated|Lost to Follow-up|0|||
161537471|NCT02243280|583356018|FG008|Treated|Lost to Follow-up|1|||
161537472|NCT02243280|583356019|FG009|Treated|Lost to Follow-up|0|||
161537473|NCT02243280|583356020|FG010|Treated|Lost to Follow-up|2|||
161537474|NCT03386032|583356029|FG000|Overall Study|Lack of Efficacy|6|||
161537475|NCT03386032|583356030|FG001|Overall Study|Lack of Efficacy|2|||
161537476|NCT03386032|583356031|FG002|Overall Study|Lack of Efficacy|0|||
161537477|NCT03386032|583356029|FG000|Overall Study|Adverse Event|2|||
161537478|NCT03386032|583356030|FG001|Overall Study|Adverse Event|2|||
161537479|NCT03386032|583356031|FG002|Overall Study|Adverse Event|0|||
161537480|NCT03386032|583356029|FG000|Overall Study|Withdrawal by Subject|1|||
161537481|NCT03386032|583356030|FG001|Overall Study|Withdrawal by Subject|0|||
161537482|NCT03386032|583356031|FG002|Overall Study|Withdrawal by Subject|0|||
161537483|NCT03386032|583356029|FG000|Overall Study|Lost to Follow-up|9|||
161537484|NCT03386032|583356030|FG001|Overall Study|Lost to Follow-up|3|||
161537485|NCT03386032|583356031|FG002|Overall Study|Lost to Follow-up|0|||
161537486|NCT04525547|583356040|FG000|Overall Study|Not treated with Ofev|2|||
161537487|NCT04525547|583356040|FG000|Overall Study|Off-label use|2|||
161537488|NCT04525547|583356040|FG000|Overall Study|Lost to Follow-up|1|||
161537489|NCT03122119|583356041|FG000|Overall Study|Did not meet eligibility critria|1|||
161537490|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
161537491|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
161537492|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
161537493|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
161537494|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
161537495|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
161537496|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
161537497|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
161537498|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
161537499|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
161537500|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
161537501|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
161537502|NCT01493687|583356048|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
161537503|NCT01493687|583356049|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
161537504|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
161537505|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
161537506|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
161537507|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
161537508|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
161537509|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
161537510|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
161537511|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
161537512|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
161537513|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
161537514|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
161537515|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
161537516|NCT01493687|583356048|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
161537517|NCT01493687|583356049|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
161537518|NCT01493687|583356048|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
161537519|NCT01493687|583356049|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
161537520|NCT02364180|583356050|FG000|Overall Study|Screen Fail|1|||
161537521|NCT01783418|583356051|FG000|Overall Study|Withdrawal by Subject|1|||
161537522|NCT01783418|583356052|FG001|Overall Study|Withdrawal by Subject|0|||
161537523|NCT00521144|583356053|FG000|Overall Study|Not Treated|0|||
161537524|NCT00521144|583356054|FG001|Overall Study|Not Treated|0|||
161537525|NCT00521144|583356055|FG002|Overall Study|Not Treated|0|||
161537526|NCT00521144|583356056|FG003|Overall Study|Not Treated|1|||
161537527|NCT00521144|583356057|FG004|Overall Study|Not Treated|0|||
161537528|NCT00521144|583356053|FG000|Overall Study|Adverse Event|0|||
161537529|NCT00521144|583356054|FG001|Overall Study|Adverse Event|1|||
161592310|NCT05794243|583556776|FG000|Overall Study|Withdrawal by Subject|1|||
161592311|NCT05794243|583556777|FG001|Overall Study|Withdrawal by Subject|0|||
161829382|NCT00255151|584415756|FG000|Overall Study|Therapeutic Failure|11|||
161537530|NCT00521144|583356055|FG002|Overall Study|Adverse Event|0|||
161537531|NCT00521144|583356056|FG003|Overall Study|Adverse Event|0|||
161537532|NCT00521144|583356057|FG004|Overall Study|Adverse Event|1|||
161537533|NCT00521144|583356053|FG000|Overall Study|Progressive Disease|4|||
161537534|NCT00521144|583356054|FG001|Overall Study|Progressive Disease|2|||
161537535|NCT00521144|583356055|FG002|Overall Study|Progressive Disease|2|||
161537536|NCT00521144|583356056|FG003|Overall Study|Progressive Disease|0|||
161537537|NCT00521144|583356057|FG004|Overall Study|Progressive Disease|6|||
161537538|NCT00508261|583356061|FG000|Overall Study|Other|0|||
161537539|NCT00508261|583356062|FG001|Overall Study|Other|1|||
161537540|NCT00508261|583356063|FG002|Overall Study|Other|1|||
161537541|NCT00508261|583356064|FG003|Overall Study|Other|0|||
161537542|NCT00508261|583356061|FG000|Overall Study|Serious Adverse Event|0|||
161537543|NCT00508261|583356062|FG001|Overall Study|Serious Adverse Event|1|||
161537544|NCT00508261|583356063|FG002|Overall Study|Serious Adverse Event|0|||
161537545|NCT00508261|583356064|FG003|Overall Study|Serious Adverse Event|0|||
161537546|NCT00508261|583356061|FG000|Overall Study|Withdrawal by Subject|3|||
161537547|NCT00508261|583356062|FG001|Overall Study|Withdrawal by Subject|4|||
161537548|NCT00508261|583356063|FG002|Overall Study|Withdrawal by Subject|4|||
161537549|NCT00508261|583356064|FG003|Overall Study|Withdrawal by Subject|0|||
161537550|NCT00508261|583356061|FG000|Overall Study|Migrated/ moved from study area|0|||
161537551|NCT00508261|583356062|FG001|Overall Study|Migrated/ moved from study area|1|||
161537552|NCT00508261|583356063|FG002|Overall Study|Migrated/ moved from study area|0|||
161537553|NCT00508261|583356064|FG003|Overall Study|Migrated/ moved from study area|0|||
161537554|NCT00508261|583356061|FG000|Overall Study|Lost to Follow-up|0|||
161537555|NCT00508261|583356062|FG001|Overall Study|Lost to Follow-up|1|||
161537556|NCT00508261|583356063|FG002|Overall Study|Lost to Follow-up|1|||
161537557|NCT00508261|583356064|FG003|Overall Study|Lost to Follow-up|1|||
161537558|NCT00180479|583356065|FG000|Overall Study|Death|4|||
161537559|NCT00180479|583356066|FG001|Overall Study|Death|2|||
161537560|NCT00180479|583356065|FG000|Overall Study|Lost to Follow-up|9|||
161537561|NCT00180479|583356066|FG001|Overall Study|Lost to Follow-up|7|||
161537562|NCT00180479|583356065|FG000|Overall Study|Withdrawal by Subject|3|||
161537563|NCT00180479|583356066|FG001|Overall Study|Withdrawal by Subject|3|||
161537564|NCT00180479|583356065|FG000|Overall Study|Informed consent not signed|0|||
161537565|NCT00180479|583356066|FG001|Overall Study|Informed consent not signed|1|||
161537566|NCT03315143|583356067|FG000|Overall Study|Death|240|||
161537567|NCT03315143|583356068|FG001|Overall Study|Death|246|||
161537568|NCT03315143|583356067|FG000|Overall Study|Withdrawal by Subject|57|||
161537569|NCT03315143|583356068|FG001|Overall Study|Withdrawal by Subject|68|||
161537570|NCT03315143|583356067|FG000|Overall Study|Site Terminated by Sponsor|256|||
161537571|NCT03315143|583356068|FG001|Overall Study|Site Terminated by Sponsor|282|||
161537572|NCT03315143|583356067|FG000|Overall Study|Study Terminated by Sponsor|4723|||
161537573|NCT03315143|583356068|FG001|Overall Study|Study Terminated by Sponsor|4664|||
161537574|NCT03315143|583356067|FG000|Overall Study|Reason not Specified|16|||
161537575|NCT03315143|583356068|FG001|Overall Study|Reason not Specified|32|||
161537576|NCT00840801|583356073|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
161537577|NCT00840801|583356074|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
161537578|NCT00840801|583356075|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
161537579|NCT00840801|583356073|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
161537580|NCT00840801|583356074|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
161537581|NCT00840801|583356075|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
161537582|NCT00840801|583356073|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
161537583|NCT00840801|583356074|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
161537584|NCT00840801|583356075|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
161537585|NCT00840801|583356073|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
161537586|NCT00840801|583356074|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
161537587|NCT00840801|583356075|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
161537588|NCT00335452|583356076|FG000|Overall Study|Death|156|||
161537589|NCT00335452|583356077|FG001|Overall Study|Death|144|||
161537590|NCT00335452|583356078|FG002|Overall Study|Death|158|||
161537591|NCT00335452|583356079|FG003|Overall Study|Death|129|||
161537592|NCT00335452|583356076|FG000|Overall Study|Lost to Follow-up|2|||
161537593|NCT00335452|583356077|FG001|Overall Study|Lost to Follow-up|3|||
161537594|NCT00335452|583356078|FG002|Overall Study|Lost to Follow-up|1|||
161537595|NCT00335452|583356079|FG003|Overall Study|Lost to Follow-up|2|||
161537596|NCT02736825|583356080|FG000|Overall Study|Lost to Follow-up|10|||
161829383|NCT00255151|584415757|FG001|Overall Study|Therapeutic Failure|2|||
161537597|NCT02736825|583356081|FG001|Overall Study|Lost to Follow-up|11|||
161537598|NCT02736825|583356080|FG000|Overall Study|Early Termination|0|||
161537599|NCT02736825|583356081|FG001|Overall Study|Early Termination|1|||
161537600|NCT00790452|583356082|FG000|Overall Study|Drug supply issue|1|||
161537601|NCT00790452|583356083|FG001|Overall Study|Drug supply issue|0|||
161537602|NCT02901626|583356084|FG000|Overall Study|Lost to Follow-up|1|||
161537603|NCT02901626|583356085|FG001|Overall Study|Lost to Follow-up|1|||
161537604|NCT04082884|583356086|FG000|Overall Study|Withdrawal by Subject|1|||
161537605|NCT02421666|583356089|FG000|6-month Follow-up|Lost to Follow-up|8|||
161537606|NCT02421666|583356090|FG001|6-month Follow-up|Lost to Follow-up|7|||
161537607|NCT02421666|583356089|FG000|6-month Follow-up|Withdrawal by Subject|5|||
161537608|NCT02421666|583356090|FG001|6-month Follow-up|Withdrawal by Subject|6|||
161537609|NCT02421666|583356089|FG000|12-month Follow-up|Lost to Follow-up|5|||
161537610|NCT02421666|583356090|FG001|12-month Follow-up|Lost to Follow-up|5|||
161537611|NCT02421666|583356089|FG000|12-month Follow-up|Withdrawal by Subject|6|||
161537612|NCT02421666|583356090|FG001|12-month Follow-up|Withdrawal by Subject|11|||
161537613|NCT01078155|583356092|FG000|Overall Study|Adverse Event|7|||
161537614|NCT01078155|583356092|FG000|Overall Study|Lack of Efficacy|16|||
161537615|NCT01078155|583356092|FG000|Overall Study|Participant's Decision|6|||
161537616|NCT01078155|583356092|FG000|Overall Study|Lost to Follow-up|15|||
161537617|NCT01621880|583356093|FG000|Overall Study|Adverse Event|5|||
161537618|NCT01621880|583356094|FG001|Overall Study|Adverse Event|1|||
161537619|NCT01621880|583356093|FG000|Overall Study|Withdrawal by Subject|5|||
161537620|NCT01621880|583356094|FG001|Overall Study|Withdrawal by Subject|4|||
161537621|NCT03033225|583356105|FG000|Overall Study|Withdrawal by Subject|5|||
161537622|NCT02618967|583356106|FG000|Overall Study|Lost to Follow-up|0|||
161537623|NCT02618967|583356107|FG001|Overall Study|Lost to Follow-up|0|||
161537624|NCT02618967|583356108|FG002|Overall Study|Lost to Follow-up|1|||
161537625|NCT02618967|583356109|FG003|Overall Study|Lost to Follow-up|0|||
161537626|NCT02618967|583356110|FG004|Overall Study|Lost to Follow-up|2|||
161537627|NCT02618967|583356111|FG005|Overall Study|Lost to Follow-up|0|||
161537628|NCT02618967|583356112|FG006|Overall Study|Lost to Follow-up|0|||
161537629|NCT02618967|583356113|FG007|Overall Study|Lost to Follow-up|0|||
161537630|NCT02618967|583356106|FG000|Overall Study|Withdrawal by Subject|1|||
161537631|NCT02618967|583356107|FG001|Overall Study|Withdrawal by Subject|0|||
161537632|NCT02618967|583356108|FG002|Overall Study|Withdrawal by Subject|0|||
161537633|NCT02618967|583356109|FG003|Overall Study|Withdrawal by Subject|0|||
161537634|NCT02618967|583356110|FG004|Overall Study|Withdrawal by Subject|0|||
161537635|NCT02618967|583356111|FG005|Overall Study|Withdrawal by Subject|0|||
161537636|NCT02618967|583356112|FG006|Overall Study|Withdrawal by Subject|0|||
161537637|NCT02618967|583356113|FG007|Overall Study|Withdrawal by Subject|0|||
161537638|NCT05103384|583356119|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
161537639|NCT02612311|583356120|FG000|Overall Study|Adverse Event|16|||
161537640|NCT02612311|583356121|FG001|Overall Study|Adverse Event|12|||
161537641|NCT02612311|583356122|FG002|Overall Study|Adverse Event|7|||
161537642|NCT02612311|583356123|FG003|Overall Study|Adverse Event|13|||
161537643|NCT02612311|583356120|FG000|Overall Study|Death|29|||
161537644|NCT02612311|583356121|FG001|Overall Study|Death|10|||
161537645|NCT02612311|583356122|FG002|Overall Study|Death|11|||
161537646|NCT02612311|583356123|FG003|Overall Study|Death|11|||
161537647|NCT02612311|583356120|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
161537648|NCT02612311|583356121|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
161537649|NCT02612311|583356122|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
161537650|NCT02612311|583356123|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
161537651|NCT02612311|583356120|FG000|Overall Study|Investigator's Decision|11|||
161537652|NCT02612311|583356121|FG001|Overall Study|Investigator's Decision|15|||
161537653|NCT02612311|583356122|FG002|Overall Study|Investigator's Decision|6|||
161537654|NCT02612311|583356123|FG003|Overall Study|Investigator's Decision|6|||
161592312|NCT05794243|583556778|FG002|Overall Study|Withdrawal by Subject|1|||
161592313|NCT05794243|583556776|FG000|Overall Study|Physician Decision|0|||
161592314|NCT05794243|583556777|FG001|Overall Study|Physician Decision|3|||
161592315|NCT05794243|583556778|FG002|Overall Study|Physician Decision|1|||
161592316|NCT05609760|583556784|FG000|Overall Study|Lost to Follow-up|0|||
161592317|NCT05609760|583556785|FG001|Overall Study|Lost to Follow-up|1|||
161592318|NCT05609760|583556784|FG000|Overall Study|Withdrawal by Subject|1|||
161592319|NCT05609760|583556785|FG001|Overall Study|Withdrawal by Subject|0|||
161592320|NCT05179395|583556786|FG000|Overall Study|Lack of Efficacy|1|||
161592321|NCT05093829|583556788|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161678748|NCT00574288|583876069|FG004|Overall Study|Lost to Follow-up|0|||
161829384|NCT00255151|584415758|FG002|Overall Study|Therapeutic Failure|3|||
161829385|NCT00792623|584415759|FG000|Overall Study|Adverse Event|2|||
161829386|NCT00792623|584415759|FG000|Overall Study|Withdrawal by Subject|5|||
161829387|NCT00880087|584415768|FG000|Overall Study|Lost to Follow-up|0|||
161829388|NCT00880087|584415769|FG001|Overall Study|Lost to Follow-up|2|||
161537655|NCT02612311|583356120|FG000|Overall Study|Lack of Efficacy|0|||
161537656|NCT02612311|583356121|FG001|Overall Study|Lack of Efficacy|0|||
161537657|NCT02612311|583356122|FG002|Overall Study|Lack of Efficacy|1|||
161537658|NCT02612311|583356123|FG003|Overall Study|Lack of Efficacy|1|||
161537659|NCT02612311|583356120|FG000|Overall Study|Lost to Follow-up|2|||
161537660|NCT02612311|583356121|FG001|Overall Study|Lost to Follow-up|2|||
161592322|NCT05093829|583556789|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161829389|NCT00743509|584415770|FG000|Overall Study|Withdrawal by Subject|2|||
161829390|NCT00892281|584415775|FG000|Overall Study|Adverse Event|65|||
161537661|NCT02612311|583356122|FG002|Overall Study|Lost to Follow-up|1|||
161537662|NCT02612311|583356123|FG003|Overall Study|Lost to Follow-up|2|||
161537663|NCT02612311|583356120|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
161537664|NCT02612311|583356121|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
161537665|NCT02612311|583356122|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
161537666|NCT02612311|583356123|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
161537667|NCT02612311|583356120|FG000|Overall Study|Site Terminated by Sponsor|29|||
161537668|NCT02612311|583356121|FG001|Overall Study|Site Terminated by Sponsor|12|||
161537669|NCT02612311|583356122|FG002|Overall Study|Site Terminated by Sponsor|13|||
161537670|NCT02612311|583356123|FG003|Overall Study|Site Terminated by Sponsor|5|||
161537671|NCT02612311|583356120|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
161537672|NCT02612311|583356121|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
161537673|NCT02612311|583356122|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
161537674|NCT02612311|583356123|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
161537675|NCT02612311|583356120|FG000|Overall Study|Reason Not Specified|3|||
161537676|NCT02612311|583356121|FG001|Overall Study|Reason Not Specified|7|||
161537677|NCT02612311|583356122|FG002|Overall Study|Reason Not Specified|4|||
161537678|NCT02612311|583356123|FG003|Overall Study|Reason Not Specified|5|||
161537679|NCT02612311|583356120|FG000|Overall Study|Unknown/Missing|10|||
161537680|NCT02612311|583356121|FG001|Overall Study|Unknown/Missing|13|||
161537681|NCT02612311|583356122|FG002|Overall Study|Unknown/Missing|4|||
161537682|NCT02612311|583356123|FG003|Overall Study|Unknown/Missing|0|||
161537683|NCT02612311|583356120|FG000|Overall Study|Non-Compliance with Study|1|||
161537684|NCT02612311|583356121|FG001|Overall Study|Non-Compliance with Study|0|||
161537685|NCT02612311|583356122|FG002|Overall Study|Non-Compliance with Study|0|||
161537686|NCT02612311|583356123|FG003|Overall Study|Non-Compliance with Study|0|||
161537687|NCT04751942|583356125|FG000|Overall Study|Lost to Follow-up|9|||
161537688|NCT04751942|583356126|FG001|Overall Study|Lost to Follow-up|6|||
161537689|NCT03355326|583356145|FG000|Overall Study|Protocol Violation|3|||
161537690|NCT03355326|583356146|FG001|Overall Study|Protocol Violation|3|||
161537691|NCT00608582|583356151|FG000|Overall Study|Lost to Follow-up|2|||
161537692|NCT00608582|583356152|FG001|Overall Study|Lost to Follow-up|0|||
161537693|NCT00608582|583356151|FG000|Overall Study|No Best Response in Phase 1 located|1|||
161537694|NCT00608582|583356152|FG001|Overall Study|No Best Response in Phase 1 located|1|||
161537695|NCT00608582|583356151|FG000|Overall Study|Illicit Drug Use|1|||
161537696|NCT00608582|583356152|FG001|Overall Study|Illicit Drug Use|0|||
161537697|NCT00608582|583356151|FG000|Overall Study|Early stage Design Change|0|||
161537698|NCT00608582|583356152|FG001|Overall Study|Early stage Design Change|3|||
161537699|NCT04922554|583356153|FG000|Overall Study|Adverse Event|4|||
161537700|NCT04922554|583356154|FG001|Overall Study|Adverse Event|0|||
161537701|NCT04922554|583356153|FG000|Overall Study|Withdrawal by Subject|1|||
161537702|NCT04922554|583356154|FG001|Overall Study|Withdrawal by Subject|0|||
161537703|NCT03092375|583357910|FG000|Overall Study|Lack of Efficacy|0|||
161537704|NCT03092375|583357911|FG001|Overall Study|Lack of Efficacy|1|||
161537705|NCT03092375|583357912|FG002|Overall Study|Lack of Efficacy|1|||
161537706|NCT03092375|583357913|FG003|Overall Study|Lack of Efficacy|0|||
161537707|NCT01679301|583357914|FG000|Screening Period|screen failure|3|||
161537708|NCT01679301|583357915|FG001|Screening Period|screen failure|0|||
161537709|NCT01679301|583357916|FG002|Screening Period|screen failure|0|||
161537710|NCT00861614|583357919|FG000|Overall Study|Disease Progression|182|||
161537711|NCT00861614|583357920|FG001|Overall Study|Disease Progression|263|||
161537712|NCT00861614|583357919|FG000|Overall Study|Study Drug Toxicity|79|||
161537713|NCT00861614|583357920|FG001|Overall Study|Study Drug Toxicity|6|||
161537714|NCT00861614|583357919|FG000|Overall Study|Death|32|||
161537715|NCT00861614|583357920|FG001|Overall Study|Death|19|||
161537716|NCT00861614|583357919|FG000|Overall Study|Adverse Event|27|||
161537717|NCT00861614|583357920|FG001|Overall Study|Adverse Event|23|||
161537718|NCT00861614|583357919|FG000|Overall Study|Withdrawal by Subject|34|||
161537719|NCT00861614|583357920|FG001|Overall Study|Withdrawal by Subject|35|||
161537720|NCT00861614|583357919|FG000|Overall Study|Other|17|||
161537721|NCT00861614|583357920|FG001|Overall Study|Other|22|||
161537722|NCT00944658|583357921|FG000|Treatment 12 Weeks|Adverse Event|0|||
161537723|NCT00944658|583357922|FG001|Treatment 12 Weeks|Adverse Event|2|||
161537724|NCT01255592|583357923|FG000|Overall Study|Adverse Event|5|||
161537725|NCT01255592|583357924|FG001|Overall Study|Adverse Event|0|||
161537726|NCT01255592|583357923|FG000|Overall Study|Withdrawal by Subject|1|||
161537727|NCT01255592|583357924|FG001|Overall Study|Withdrawal by Subject|0|||
161537728|NCT01255592|583357923|FG000|Overall Study|Other|0|||
161537729|NCT01255592|583357924|FG001|Overall Study|Other|1|||
161537730|NCT02259517|583357925|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
161537731|NCT02259517|583357926|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
161537732|NCT02259517|583357927|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
161537733|NCT02259517|583357925|FG000|Overall Study|Withdrawal by Subject|0|||
161537734|NCT02259517|583357926|FG001|Overall Study|Withdrawal by Subject|0|||
161537735|NCT02259517|583357927|FG002|Overall Study|Withdrawal by Subject|3|||
161537736|NCT01289418|583357931|FG000|Day 8 Survey|email address invalid|283|||
161537737|NCT01289418|583357931|FG000|Day 8 Survey|participants did not complete the survey|1935|||
161537738|NCT01289418|583357931|FG000|Day 29 Survey|email address invalid|283|||
161537739|NCT01289418|583357931|FG000|Day 29 Survey|participants did not complete the survey|2185|||
161537740|NCT01352585|583357933|FG000|Overall Study|Adverse Event|2|||
161537741|NCT01352585|583357934|FG001|Overall Study|Adverse Event|1|||
161537742|NCT01352585|583357933|FG000|Overall Study|Lost to Follow-up|1|||
161537743|NCT01352585|583357934|FG001|Overall Study|Lost to Follow-up|0|||
161537744|NCT01352585|583357933|FG000|Overall Study|Other|5|||
161537745|NCT01352585|583357934|FG001|Overall Study|Other|2|||
161537746|NCT00838682|583357937|FG000|Overall Study|Lost to Follow-up|21|||
161537747|NCT00838682|583357938|FG001|Overall Study|Lost to Follow-up|14|||
161537748|NCT00838682|583357937|FG000|Overall Study|detection of exclusion criteria|4|||
161537749|NCT00838682|583357938|FG001|Overall Study|detection of exclusion criteria|3|||
161537750|NCT00838682|583357937|FG000|Overall Study|Protocol Violation|0|||
161537751|NCT00838682|583357938|FG001|Overall Study|Protocol Violation|1|||
161537752|NCT00838682|583357937|FG000|Overall Study|Withdrawal by Subject|0|||
161537753|NCT00838682|583357938|FG001|Overall Study|Withdrawal by Subject|1|||
161537754|NCT02305381|583357939|FG000|Overall Study|Unclassified|5|||
161537755|NCT02305381|583357940|FG001|Overall Study|Unclassified|5|||
161537756|NCT02305381|583357941|FG002|Overall Study|Unclassified|7|||
161537757|NCT02276066|583357942|FG000|Overall Study|Lost to Follow-up|21|||
161537758|NCT02276066|583357943|FG001|Overall Study|Lost to Follow-up|11|||
161537759|NCT02882282|583357944|FG000|Overall Study|Adverse Event|1|||
161537760|NCT02882282|583357945|FG001|Overall Study|Adverse Event|0|||
161537761|NCT01807156|583357946|FG000|Overall Study|Physician Decision|1|||
161537762|NCT03928028|583357947|FG000|Overall Study|Physician Decision|9|||
161537763|NCT03928028|583357948|FG001|Overall Study|Physician Decision|6|||
161537764|NCT03928028|583357949|FG002|Overall Study|Physician Decision|3|||
161537765|NCT03928028|583357947|FG000|Overall Study|Withdrawal by Subject|12|||
161537766|NCT03928028|583357948|FG001|Overall Study|Withdrawal by Subject|3|||
161537767|NCT03928028|583357949|FG002|Overall Study|Withdrawal by Subject|3|||
161537768|NCT02710292|583357956|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
161537769|NCT02710292|583357957|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
161537770|NCT02710292|583357956|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
161537771|NCT02710292|583357957|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
161537772|NCT02323646|583357968|FG000|Treatment Course 1|Adverse Event|1|||
161537773|NCT02323646|583357969|FG001|Treatment Course 1|Adverse Event|0|||
161537774|NCT02323646|583357970|FG002|Treatment Course 1|Adverse Event|1|||
161537775|NCT02323646|583357968|FG000|Treatment Course 1|Heavy Bleeding|1|||
161537776|NCT02323646|583357969|FG001|Treatment Course 1|Heavy Bleeding|1|||
161537777|NCT02323646|583357970|FG002|Treatment Course 1|Heavy Bleeding|0|||
161537778|NCT02323646|583357968|FG000|Treatment Course 1|Lost to Follow-up|1|||
161537779|NCT02323646|583357969|FG001|Treatment Course 1|Lost to Follow-up|0|||
161537780|NCT02323646|583357970|FG002|Treatment Course 1|Lost to Follow-up|2|||
161537781|NCT02323646|583357968|FG000|Treatment Course 1|Withdrawal by Subject|0|||
161537782|NCT02323646|583357969|FG001|Treatment Course 1|Withdrawal by Subject|2|||
161537783|NCT02323646|583357970|FG002|Treatment Course 1|Withdrawal by Subject|0|||
161537784|NCT02323646|583357968|FG000|Treatment Course 2|Adverse Event|1|||
161537785|NCT02323646|583357969|FG001|Treatment Course 2|Adverse Event|0|||
161537786|NCT02323646|583357970|FG002|Treatment Course 2|Adverse Event|1|||
161537787|NCT02323646|583357968|FG000|Treatment Course 2|Lost to Follow-up|0|||
161537788|NCT02323646|583357969|FG001|Treatment Course 2|Lost to Follow-up|0|||
161537789|NCT02323646|583357970|FG002|Treatment Course 2|Lost to Follow-up|1|||
161537790|NCT02323646|583357968|FG000|Treatment Course 2|Non-compliance|0|||
161537791|NCT02323646|583357969|FG001|Treatment Course 2|Non-compliance|1|||
161537792|NCT02323646|583357970|FG002|Treatment Course 2|Non-compliance|1|||
161537793|NCT00089141|583357971|FG000|Overall Study|Termination of trial|18|||
161537794|NCT00089141|583357972|FG001|Overall Study|Termination of trial|24|||
161537795|NCT02459262|583357973|FG000|Overall Study|Withdrawal by Subject|0|||
161537796|NCT02459262|583357974|FG001|Overall Study|Withdrawal by Subject|0|||
161537797|NCT02459262|583357975|FG002|Overall Study|Withdrawal by Subject|0|||
161537798|NCT02459262|583357976|FG003|Overall Study|Withdrawal by Subject|0|||
161537799|NCT02459262|583357977|FG004|Overall Study|Withdrawal by Subject|0|||
161537800|NCT02459262|583357978|FG005|Overall Study|Withdrawal by Subject|0|||
161537801|NCT02459262|583357979|FG006|Overall Study|Withdrawal by Subject|0|||
161537802|NCT02459262|583357980|FG007|Overall Study|Withdrawal by Subject|0|||
161537803|NCT02459262|583357981|FG008|Overall Study|Withdrawal by Subject|0|||
161592323|NCT05093829|583556790|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
161592324|NCT05093829|583556791|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161592325|NCT05093829|583556792|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161592326|NCT01785719|583558654|FG000|4-week Baseline Evaluation|Physician Decision|1|||
161537804|NCT02459262|583357982|FG009|Overall Study|Withdrawal by Subject|1|||
161537805|NCT02459262|583357983|FG010|Overall Study|Withdrawal by Subject|0|||
161537806|NCT05168579|583357984|FG000|Overall Study|Lack of Consent|1|||
161537807|NCT05168579|583357985|FG001|Overall Study|Lack of Consent|0|||
161537808|NCT05168579|583357984|FG000|Overall Study|Conflicts with time|2|||
161537809|NCT05168579|583357985|FG001|Overall Study|Conflicts with time|0|||
161537810|NCT05168579|583357984|FG000|Overall Study|Time slots were full|3|||
161537811|NCT05168579|583357985|FG001|Overall Study|Time slots were full|0|||
161537812|NCT05168579|583357984|FG000|Overall Study|Lost to Follow-up|0|||
161537813|NCT05168579|583357985|FG001|Overall Study|Lost to Follow-up|15|||
161537814|NCT01242748|583357986|FG000|Overall Study|Adverse Event|10|||
161537815|NCT01242748|583357987|FG001|Overall Study|Adverse Event|5|||
161537816|NCT01242748|583357986|FG000|Overall Study|Lost to Follow-up|6|||
161537817|NCT01242748|583357987|FG001|Overall Study|Lost to Follow-up|2|||
161537818|NCT01242748|583357986|FG000|Overall Study|Physician Decision|3|||
161537819|NCT01242748|583357987|FG001|Overall Study|Physician Decision|2|||
161537820|NCT01242748|583357986|FG000|Overall Study|Protocol Violation|1|||
161537821|NCT01242748|583357987|FG001|Overall Study|Protocol Violation|0|||
161537822|NCT01242748|583357986|FG000|Overall Study|Withdrawal by Subject|10|||
161537823|NCT01242748|583357987|FG001|Overall Study|Withdrawal by Subject|2|||
161537824|NCT01242748|583357986|FG000|Overall Study|Miscellaneous reasons|8|||
161537825|NCT01242748|583357987|FG001|Overall Study|Miscellaneous reasons|3|||
161537826|NCT00387894|583357988|FG000|Overall Study|Withdrawal by Subject|1|||
161537827|NCT00659490|583357991|FG000|Overall Study|Lost to Follow-up|2|||
161537828|NCT00659490|583357992|FG001|Overall Study|Lost to Follow-up|0|||
161537829|NCT00659490|583357993|FG002|Overall Study|Lost to Follow-up|1|||
161537830|NCT00827541|583357994|FG000|Overall Study|Exitus|1|||
161537831|NCT00827541|583357995|FG001|Overall Study|Exitus|8|||
161537832|NCT00827541|583357994|FG000|Overall Study|Other|1|||
161537833|NCT00827541|583357995|FG001|Overall Study|Other|3|||
161537834|NCT00827541|583357994|FG000|Overall Study|Pathogen not susceptible|1|||
161537835|NCT00827541|583357995|FG001|Overall Study|Pathogen not susceptible|0|||
161537836|NCT00827541|583357994|FG000|Overall Study|Lack of effectiveness|1|||
161537837|NCT00827541|583357995|FG001|Overall Study|Lack of effectiveness|0|||
161537838|NCT01649232|583357996|FG000|Overall Study|Physician Decision|2|||
161537839|NCT01649232|583357997|FG001|Overall Study|Physician Decision|0|||
161537840|NCT01750879|583357998|FG000|Overall Study|Adverse Event|8|||
161537841|NCT01750879|583357999|FG001|Overall Study|Adverse Event|0|||
161537842|NCT01750879|583357998|FG000|Overall Study|Lack of Efficacy|1|||
161537843|NCT01750879|583357999|FG001|Overall Study|Lack of Efficacy|0|||
161537844|NCT01750879|583357998|FG000|Overall Study|Withdrawal by Subject|1|||
161537845|NCT01750879|583357999|FG001|Overall Study|Withdrawal by Subject|0|||
161537846|NCT01750879|583357998|FG000|Overall Study|Did not complete per protocol|0|||
161537847|NCT01750879|583357999|FG001|Overall Study|Did not complete per protocol|3|||
161537848|NCT02347657|583358000|FG000|Overall Study|Physician Decision|0|||
161537849|NCT02347657|583358001|FG001|Overall Study|Physician Decision|1|||
161537850|NCT02347657|583358000|FG000|Overall Study|Adverse Event|8|||
161537851|NCT02347657|583358001|FG001|Overall Study|Adverse Event|4|||
161592327|NCT01785719|583558655|FG001|4-week Baseline Evaluation|Physician Decision|0|||
161592328|NCT01785719|583558654|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
161592329|NCT01785719|583558655|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
161592330|NCT01785719|583558654|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
161592331|NCT01785719|583558655|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
161592332|NCT01785719|583558654|FG000|4-week Baseline Evaluation|Pregnancy|0|||
161592333|NCT01785719|583558655|FG001|4-week Baseline Evaluation|Pregnancy|2|||
161592334|NCT01785719|583558654|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
161592335|NCT01785719|583558655|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
161592336|NCT01785719|583558654|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
161592337|NCT01785719|583558655|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
161592338|NCT01785719|583558654|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
161592339|NCT01785719|583558655|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
161592340|NCT01785719|583558654|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
161592341|NCT01785719|583558655|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
161592342|NCT01785719|583558654|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
161592343|NCT01785719|583558655|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
161592344|NCT01785719|583558654|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
161592345|NCT01785719|583558655|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
161592346|NCT01785719|583558654|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
161592347|NCT01785719|583558655|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
161592348|NCT01785719|583558654|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
161537852|NCT02347657|583358000|FG000|Overall Study|Withdrawal by Subject|6|||
161537853|NCT02347657|583358001|FG001|Overall Study|Withdrawal by Subject|7|||
161537854|NCT02347657|583358000|FG000|Overall Study|Randomized but not treated|1|||
161537855|NCT02347657|583358001|FG001|Overall Study|Randomized but not treated|0|||
161537856|NCT02347657|583358000|FG000|Overall Study|Other|3|||
161537857|NCT02347657|583358001|FG001|Overall Study|Other|3|||
161537858|NCT00677352|583358004|FG000|Treatment Phase|Adverse Event|14|||
161537859|NCT00677352|583358005|FG001|Treatment Phase|Adverse Event|22|||
161537860|NCT00677352|583358004|FG000|Treatment Phase|Lack of Efficacy|2|||
161537861|NCT00677352|583358005|FG001|Treatment Phase|Lack of Efficacy|3|||
161537862|NCT00677352|583358004|FG000|Treatment Phase|Lost to Follow-up|0|||
161537863|NCT00677352|583358005|FG001|Treatment Phase|Lost to Follow-up|1|||
161537864|NCT00677352|583358004|FG000|Treatment Phase|Withdrawal by Subject|7|||
161537865|NCT00677352|583358005|FG001|Treatment Phase|Withdrawal by Subject|7|||
161537866|NCT00677352|583358004|FG000|Treatment Phase|Physician Decision|1|||
161537867|NCT00677352|583358005|FG001|Treatment Phase|Physician Decision|0|||
161537868|NCT00677352|583358004|FG000|Treatment Phase|Pregnancy|0|||
161537869|NCT00677352|583358005|FG001|Treatment Phase|Pregnancy|1|||
161537870|NCT00677352|583358004|FG000|Treatment Phase|Protocol Violation|1|||
161537871|NCT00677352|583358005|FG001|Treatment Phase|Protocol Violation|1|||
161537872|NCT00677352|583358004|FG000|Treatment Phase|Transference or work related matter|0|||
161537873|NCT00677352|583358005|FG001|Treatment Phase|Transference or work related matter|5|||
161537874|NCT00677352|583358004|FG000|Treatment Phase|Not treated|0|||
161537875|NCT00677352|583358005|FG001|Treatment Phase|Not treated|2|||
161537876|NCT00677352|583358004|FG000|Tapering Phase|Adverse Event|1|||
161537877|NCT00677352|583358005|FG001|Tapering Phase|Adverse Event|5|||
161537878|NCT00677352|583358004|FG000|Tapering Phase|Withdrawal by Subject|5|||
161537879|NCT00677352|583358005|FG001|Tapering Phase|Withdrawal by Subject|3|||
161537880|NCT00677352|583358004|FG000|Tapering Phase|Pregnancy|0|||
161537881|NCT00677352|583358005|FG001|Tapering Phase|Pregnancy|1|||
161537882|NCT00677352|583358004|FG000|Tapering Phase|Job transfer|0|||
161537883|NCT00677352|583358005|FG001|Tapering Phase|Job transfer|1|||
161537884|NCT02182973|583358006|FG000|Overall Study|Withdrawal by Subject|3|||
161537885|NCT02182973|583358007|FG001|Overall Study|Withdrawal by Subject|0|||
161537886|NCT05614089|583358008|FG000|Overall Study|Pregnancy|5|||
161537887|NCT05614089|583358009|FG001|Overall Study|Pregnancy|2|||
161537888|NCT05614089|583358008|FG000|Overall Study|Lost to Follow-up|5|||
161537889|NCT05614089|583358009|FG001|Overall Study|Lost to Follow-up|1|||
161537890|NCT05614089|583358008|FG000|Overall Study|Death|0|||
161537891|NCT05614089|583358009|FG001|Overall Study|Death|1|||
161537892|NCT05614089|583358008|FG000|Overall Study|Adverse Event|1|||
161537893|NCT05614089|583358009|FG001|Overall Study|Adverse Event|0|||
161537894|NCT03937219|583358010|FG000|Overall Study|Death|223|||
161537895|NCT03937219|583358011|FG001|Overall Study|Death|211|||
161537896|NCT03937219|583358010|FG000|Overall Study|Withdrawal by Subject|17|||
161537897|NCT03937219|583358011|FG001|Overall Study|Withdrawal by Subject|25|||
161537898|NCT03937219|583358010|FG000|Overall Study|Lost to Follow-up|3|||
161537899|NCT03937219|583358011|FG001|Overall Study|Lost to Follow-up|4|||
161537900|NCT04393441|583358017|FG000|Overall Study|Adverse Event|0|||
161537901|NCT04393441|583358018|FG001|Overall Study|Adverse Event|3|||
161537902|NCT04393441|583358017|FG000|Overall Study|Withdrawal by Subject|5|||
161537903|NCT04393441|583358018|FG001|Overall Study|Withdrawal by Subject|7|||
161537904|NCT04393441|583358017|FG000|Overall Study|Lost to Follow-up|0|||
161537905|NCT04393441|583358018|FG001|Overall Study|Lost to Follow-up|2|||
161537906|NCT04393441|583358017|FG000|Overall Study|Protocol Deviation|2|||
161537907|NCT04393441|583358018|FG001|Overall Study|Protocol Deviation|1|||
161537908|NCT04393441|583358017|FG000|Overall Study|Reason not Specified|1|||
161537909|NCT04393441|583358018|FG001|Overall Study|Reason not Specified|1|||
161537910|NCT02782169|583358019|FG000|Overall Study|Lost to Follow-up|1|||
161537911|NCT02782169|583358020|FG001|Overall Study|Lost to Follow-up|2|||
161537912|NCT04003610|583358021|FG000|Overall Study|Lost to Follow-up|0|||
161537913|NCT04003610|583358022|FG001|Overall Study|Lost to Follow-up|1|||
161537914|NCT04003610|583358023|FG002|Overall Study|Lost to Follow-up|0|||
161537915|NCT04003610|583358021|FG000|Overall Study|Death|0|||
161537916|NCT04003610|583358022|FG001|Overall Study|Death|0|||
161537917|NCT04003610|583358023|FG002|Overall Study|Death|3|||
161537918|NCT04003610|583358021|FG000|Overall Study|Study Terminated by Sponsor|0|||
161537919|NCT04003610|583358022|FG001|Overall Study|Study Terminated by Sponsor|0|||
161592349|NCT01785719|583558655|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
161592350|NCT01785719|583558654|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
161592351|NCT01785719|583558655|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
161537920|NCT04003610|583358023|FG002|Overall Study|Study Terminated by Sponsor|3|||
161537921|NCT00771810|583358024|FG000|Overall Study|Adverse Event|3|||
161537922|NCT00771810|583358025|FG001|Overall Study|Adverse Event|0|||
161537923|NCT00771810|583358026|FG002|Overall Study|Adverse Event|2|||
161592352|NCT01785719|583558654|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
161592353|NCT01785719|583558655|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
161592354|NCT01785719|583558654|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
161592355|NCT01785719|583558655|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
161592356|NCT03445988|583558656|FG000|Overall Study|Lost to Follow-up|14|||
161592357|NCT03445988|583558657|FG001|Overall Study|Lost to Follow-up|26|||
161592358|NCT03445988|583558658|FG002|Overall Study|Lost to Follow-up|27|||
161537924|NCT00771810|583358024|FG000|Overall Study|Lost to Follow-up|0|||
161537925|NCT00771810|583358025|FG001|Overall Study|Lost to Follow-up|0|||
161537926|NCT00771810|583358026|FG002|Overall Study|Lost to Follow-up|1|||
161537927|NCT00771810|583358024|FG000|Overall Study|Physician Decision|1|||
161537928|NCT00771810|583358025|FG001|Overall Study|Physician Decision|2|||
161537929|NCT00771810|583358026|FG002|Overall Study|Physician Decision|2|||
161537930|NCT00771810|583358024|FG000|Overall Study|Protocol Violation|0|||
161537931|NCT00771810|583358025|FG001|Overall Study|Protocol Violation|1|||
161537932|NCT00771810|583358026|FG002|Overall Study|Protocol Violation|1|||
161537933|NCT00771810|583358024|FG000|Overall Study|Withdrawal by Subject|1|||
161537934|NCT00771810|583358025|FG001|Overall Study|Withdrawal by Subject|2|||
161537935|NCT00771810|583358026|FG002|Overall Study|Withdrawal by Subject|0|||
161537936|NCT00771810|583358024|FG000|Overall Study|Other|0|||
161537937|NCT00771810|583358025|FG001|Overall Study|Other|0|||
161537938|NCT00771810|583358026|FG002|Overall Study|Other|1|||
161537939|NCT02660827|583358031|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
161537940|NCT02660827|583358031|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
161537941|NCT02660827|583358031|FG000|From Study to End of Continued Access|Adverse Event|3|||
161537942|NCT02660827|583358031|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
161537943|NCT02660827|583358031|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
161537944|NCT02660827|583358031|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
161537945|NCT02660827|583358031|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
161537946|NCT02660827|583358031|FG000|Period 2: Continued Access Period|Adverse Event|3|||
161592359|NCT03445988|583558659|FG003|Overall Study|Lost to Follow-up|66|||
161592360|NCT03445988|583558656|FG000|Overall Study|Withdrawal by Subject|7|||
161592361|NCT03445988|583558657|FG001|Overall Study|Withdrawal by Subject|4|||
161537947|NCT02953938|583358032|FG000|Overall Study|Adverse Event|0|||
161537948|NCT02953938|583358033|FG001|Overall Study|Adverse Event|1|||
161537949|NCT02953938|583358032|FG000|Overall Study|Withdrawal by Subject|1|||
161537950|NCT02953938|583358033|FG001|Overall Study|Withdrawal by Subject|1|||
161537951|NCT02657031|583358040|FG000|Overall Study|Adverse Event|1|||
161537952|NCT02657031|583358041|FG001|Overall Study|Adverse Event|2|||
161537953|NCT04198805|583358042|FG000|Overall Study|Death|0|||
161537954|NCT04198805|583358043|FG001|Overall Study|Death|0|||
161537955|NCT04198805|583358044|FG002|Overall Study|Death|0|||
161537956|NCT04198805|583358045|FG003|Overall Study|Death|1|||
161537957|NCT04198805|583358042|FG000|Overall Study|Early Termination|8|||
161537958|NCT04198805|583358043|FG001|Overall Study|Early Termination|4|||
161537959|NCT04198805|583358044|FG002|Overall Study|Early Termination|6|||
161537960|NCT04198805|583358045|FG003|Overall Study|Early Termination|9|||
161537961|NCT03078816|583358046|FG000|Overall Study|Withdrawal by Subject|1|||
161537962|NCT02114151|583358047|FG000|Overall Study|Death|1|||
161537963|NCT02114151|583358047|FG000|Overall Study|Lost to Follow-up|1|||
161537964|NCT02114151|583358047|FG000|Overall Study|Withdrawal by Subject|5|||
161537965|NCT03599349|583358048|FG000|Overall Study|Lost to Follow-up|1|||
161592362|NCT03445988|583558658|FG002|Overall Study|Withdrawal by Subject|3|||
161592363|NCT03445988|583558659|FG003|Overall Study|Withdrawal by Subject|5|||
161592364|NCT03445988|583558656|FG000|Overall Study|Death (unrelated to study)|5|||
161592365|NCT03445988|583558657|FG001|Overall Study|Death (unrelated to study)|1|||
161592366|NCT03445988|583558658|FG002|Overall Study|Death (unrelated to study)|2|||
161592367|NCT03445988|583558659|FG003|Overall Study|Death (unrelated to study)|4|||
161592368|NCT04977947|583558660|FG000|Overall Study|Lost to Follow-up|1|||
161592369|NCT04977947|583558661|FG001|Overall Study|Lost to Follow-up|1|||
161592370|NCT05875142|583558662|FG000|Overall Study|Lost to Follow-up|0|||
161592371|NCT05875142|583558663|FG001|Overall Study|Lost to Follow-up|1|||
161592372|NCT05875142|583558664|FG002|Overall Study|Lost to Follow-up|1|||
161592373|NCT03891667|583558665|FG000|Overall Study|Physician Decision|1|||
161592374|NCT03891667|583558666|FG001|Overall Study|Physician Decision|1|||
161592375|NCT03891667|583558665|FG000|Overall Study|COVID related pause|1|||
161592376|NCT03891667|583558666|FG001|Overall Study|COVID related pause|0|||
161592377|NCT03891667|583558665|FG000|Overall Study|Withdrawal by Subject|0|||
161592378|NCT03891667|583558666|FG001|Overall Study|Withdrawal by Subject|1|||
161592379|NCT03891667|583558665|FG000|Overall Study|Adverse Event|0|||
161592380|NCT03891667|583558666|FG001|Overall Study|Adverse Event|1|||
161592381|NCT05659537|583558667|FG000|Overall Study|Adverse Event|5|||
161592382|NCT05659537|583558667|FG000|Overall Study|Lost to Follow-up|4|||
161537966|NCT00810264|583358051|FG000|Overall Study|Lost to Follow-up|191|||
161537967|NCT00810264|583358051|FG000|Overall Study|Withdrawal by subject or physician|721|||
161537968|NCT00810264|583358051|FG000|Overall Study|Death|641|||
161537969|NCT00500903|583358052|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
161537970|NCT00500903|583358053|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
161592383|NCT05659537|583558667|FG000|Overall Study|Withdrawal by Subject|13|||
161592384|NCT05659537|583558667|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
161592385|NCT05659537|583558667|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
161537971|NCT00500903|583358054|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
161537972|NCT00500903|583358052|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
161537973|NCT00500903|583358053|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
161537974|NCT00500903|583358054|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161678749|NCT00574288|583876070|FG005|Overall Study|Lost to Follow-up|1|||
161537975|NCT00500903|583358052|FG000|Overall Study|Progressive Disease|41|||
161537976|NCT00500903|583358053|FG001|Overall Study|Progressive Disease|2|||
161537977|NCT00500903|583358054|FG002|Overall Study|Progressive Disease|15|||
161537978|NCT00500903|583358052|FG000|Overall Study|Patient Declined Further Treatment|0|||
161537979|NCT00500903|583358053|FG001|Overall Study|Patient Declined Further Treatment|0|||
161537980|NCT00500903|583358054|FG002|Overall Study|Patient Declined Further Treatment|3|||
161537981|NCT00500903|583358052|FG000|Overall Study|Symptomatic Deterioration|2|||
161537982|NCT00500903|583358053|FG001|Overall Study|Symptomatic Deterioration|0|||
161537983|NCT00500903|583358054|FG002|Overall Study|Symptomatic Deterioration|0|||
161537984|NCT00500903|583358052|FG000|Overall Study|Reason Not Specified|10|||
161537985|NCT00500903|583358053|FG001|Overall Study|Reason Not Specified|0|||
161537986|NCT00500903|583358054|FG002|Overall Study|Reason Not Specified|2|||
161537987|NCT01648348|583358057|FG000|Overall Study|Cancel|1|||
161537988|NCT01648348|583358058|FG001|Overall Study|Cancel|0|||
161537989|NCT01648348|583358059|FG002|Overall Study|Cancel|0|||
161537990|NCT01648348|583358060|FG003|Overall Study|Cancel|0|||
161537991|NCT01648348|583358061|FG004|Overall Study|Cancel|3|||
161537992|NCT01648348|583358062|FG005|Overall Study|Cancel|6|||
161537993|NCT01648348|583358057|FG000|Overall Study|Replaced for MTD analysis|1|||
161537994|NCT01648348|583358058|FG001|Overall Study|Replaced for MTD analysis|0|||
161537995|NCT01648348|583358059|FG002|Overall Study|Replaced for MTD analysis|1|||
161537996|NCT01648348|583358060|FG003|Overall Study|Replaced for MTD analysis|0|||
161537997|NCT01648348|583358061|FG004|Overall Study|Replaced for MTD analysis|0|||
161537998|NCT01648348|583358062|FG005|Overall Study|Replaced for MTD analysis|0|||
161537999|NCT00696410|583358063|FG000|Overall Study|Lost to Follow-up|2|||
161538000|NCT00696410|583358064|FG001|Overall Study|Lost to Follow-up|0|||
161538001|NCT00696410|583358063|FG000|Overall Study|Withdrawal by Subject|8|||
161538002|NCT00696410|583358064|FG001|Overall Study|Withdrawal by Subject|0|||
161538003|NCT00696410|583358063|FG000|Overall Study|Physician Decision|3|||
161538004|NCT00696410|583358064|FG001|Overall Study|Physician Decision|0|||
161538005|NCT00265889|583358068|FG000|Overall Study|Physician Decision|1|||
161538006|NCT00265889|583358068|FG000|Overall Study|Protocol Violation|1|||
161538007|NCT00265889|583358068|FG000|Overall Study|Insurance denied the request|3|||
161538008|NCT02134587|583358069|FG000|Overall Study|Did not completed all meetings|30|||
161538009|NCT00453986|583358073|FG000|Overall Study|Lost to Follow-up|6|||
161538010|NCT00453986|583358074|FG001|Overall Study|Lost to Follow-up|5|||
161538011|NCT00453986|583358075|FG002|Overall Study|Lost to Follow-up|6|||
161538012|NCT00453986|583358076|FG003|Overall Study|Lost to Follow-up|2|||
161538013|NCT00453986|583358077|FG004|Overall Study|Lost to Follow-up|0|||
161538014|NCT03419364|583358081|FG000|Overall Study|Delivery due to maternal condition|2|||
161538015|NCT03419364|583358082|FG001|Overall Study|Delivery due to maternal condition|0|||
161538016|NCT03419364|583358083|FG002|Overall Study|Delivery due to maternal condition|0|||
161538017|NCT03308825|583359792|FG000|Overall Study|Lost to Follow-up|2|||
161538018|NCT03308825|583359793|FG001|Overall Study|Lost to Follow-up|2|||
161538019|NCT03308825|583359794|FG002|Overall Study|Lost to Follow-up|1|||
161538020|NCT03308825|583359795|FG003|Overall Study|Lost to Follow-up|0|||
161538021|NCT03308825|583359792|FG000|Overall Study|Protocol Violation|0|||
161538022|NCT03308825|583359793|FG001|Overall Study|Protocol Violation|2|||
161538023|NCT03308825|583359794|FG002|Overall Study|Protocol Violation|0|||
161538024|NCT03308825|583359795|FG003|Overall Study|Protocol Violation|0|||
161538025|NCT03559218|583359796|FG000|Overall Study|Withdrawal by Subject|1|||
161538026|NCT03559218|583359797|FG001|Overall Study|Withdrawal by Subject|0|||
161538027|NCT04737109|583359807|FG000|Study Treatment|Disease Progression|5|||
161538028|NCT04737109|583359808|FG001|Study Treatment|Disease Progression|0|||
161538029|NCT04737109|583359809|FG002|Study Treatment|Disease Progression|0|||
161538030|NCT04737109|583359810|FG003|Study Treatment|Disease Progression|0|||
161538031|NCT04737109|583359807|FG000|Study Treatment|Death on study|1|||
161538032|NCT04737109|583359808|FG001|Study Treatment|Death on study|0|||
161538033|NCT04737109|583359809|FG002|Study Treatment|Death on study|0|||
161538034|NCT04737109|583359810|FG003|Study Treatment|Death on study|0|||
161538035|NCT03328143|583359811|FG000|Overall Study|Declined|3|||
161538036|NCT03328143|583359811|FG000|Overall Study|Required increased sedation|4|||
161538037|NCT03328143|583359811|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
161538038|NCT03328143|583359811|FG000|Overall Study|Surgery cancelled|1|||
161538039|NCT01370525|583359812|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
161538040|NCT01370525|583359813|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
161538041|NCT01370525|583359812|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161538042|NCT01370525|583359813|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161538043|NCT01370525|583359812|FG000|Overall Study|Adverse Event|0|||
161538044|NCT01370525|583359813|FG001|Overall Study|Adverse Event|1|||
161538045|NCT01370525|583359812|FG000|Overall Study|Protocol Violation|2|||
161538046|NCT01370525|583359813|FG001|Overall Study|Protocol Violation|1|||
161538047|NCT01370525|583359812|FG000|Overall Study|Lost to follow up|2|||
161538048|NCT01370525|583359813|FG001|Overall Study|Lost to follow up|6|||
161538049|NCT03642938|583359815|FG000|Overall Study|Withdrawal by Subject|0|||
161538050|NCT03642938|583359816|FG001|Overall Study|Withdrawal by Subject|0|||
161538051|NCT03642938|583359817|FG002|Overall Study|Withdrawal by Subject|0|||
161538052|NCT03642938|583359818|FG003|Overall Study|Withdrawal by Subject|1|||
161538053|NCT01424930|583359819|FG000|Overall Study|Adverse Event|0|||
161538054|NCT01424930|583359820|FG001|Overall Study|Adverse Event|1|||
161538055|NCT01424930|583359819|FG000|Overall Study|Death|1|||
161538056|NCT01424930|583359820|FG001|Overall Study|Death|0|||
161538057|NCT01424930|583359819|FG000|Overall Study|Progressive Disease|3|||
161538058|NCT01424930|583359820|FG001|Overall Study|Progressive Disease|6|||
161538059|NCT01424930|583359819|FG000|Overall Study|Screen Failure|0|||
161538060|NCT01424930|583359820|FG001|Overall Study|Screen Failure|1|||
161538061|NCT01424930|583359819|FG000|Overall Study|Reason not specified|0|||
161538062|NCT01424930|583359820|FG001|Overall Study|Reason not specified|6|||
161538063|NCT03286751|583359825|FG000|Washout Period 1|Withdrawal by Subject|0|||
161538064|NCT03286751|583359826|FG001|Washout Period 1|Withdrawal by Subject|0|||
161538065|NCT03286751|583359827|FG002|Washout Period 1|Withdrawal by Subject|0|||
161538066|NCT03286751|583359828|FG003|Washout Period 1|Withdrawal by Subject|0|||
161538067|NCT03286751|583359829|FG004|Washout Period 1|Withdrawal by Subject|1|||
161538068|NCT03286751|583359830|FG005|Washout Period 1|Withdrawal by Subject|0|||
161538069|NCT03286751|583359825|FG000|Washout Period 2|Personal Reasons|0|||
161538070|NCT03286751|583359826|FG001|Washout Period 2|Personal Reasons|1|||
161538071|NCT03286751|583359827|FG002|Washout Period 2|Personal Reasons|0|||
161538072|NCT03286751|583359828|FG003|Washout Period 2|Personal Reasons|0|||
161538073|NCT03286751|583359829|FG004|Washout Period 2|Personal Reasons|0|||
161538074|NCT03286751|583359830|FG005|Washout Period 2|Personal Reasons|0|||
161538075|NCT03286751|583359825|FG000|Washout Period 5|Adverse Event|0|||
161538076|NCT03286751|583359826|FG001|Washout Period 5|Adverse Event|0|||
161538077|NCT03286751|583359827|FG002|Washout Period 5|Adverse Event|0|||
161538078|NCT03286751|583359828|FG003|Washout Period 5|Adverse Event|0|||
161538079|NCT03286751|583359829|FG004|Washout Period 5|Adverse Event|1|||
161538080|NCT03286751|583359830|FG005|Washout Period 5|Adverse Event|0|||
161538081|NCT01119768|583359831|FG000|Treatment Period|Lack of Efficacy|18|||
161538082|NCT01119768|583359832|FG001|Treatment Period|Lack of Efficacy|25|||
161538083|NCT01301391|583359833|FG000|Overall Study|Death|13|||
161538084|NCT01301391|583359833|FG000|Overall Study|Lost to Follow-up|3|||
161538085|NCT01301391|583359833|FG000|Overall Study|Physician Decision|2|||
161538086|NCT01301391|583359833|FG000|Overall Study|Sponsor's decision|8|||
161538087|NCT01059643|583359834|FG000|Overall Study|Adverse Event|3|||
161538088|NCT01059643|583359834|FG000|Overall Study|Withdrawal by Subject|2|||
161538089|NCT01059643|583359834|FG000|Overall Study|Physician Decision|1|||
161538090|NCT00106184|583359835|FG000|Overall Study|Withdrawal by Subject|3|||
161538091|NCT00106184|583359836|FG001|Overall Study|Withdrawal by Subject|2|||
161538092|NCT05292534|583359842|FG000|Overall Study|Protocol Violation|3|||
161538093|NCT05292534|583359843|FG001|Overall Study|Protocol Violation|4|||
161538094|NCT05292534|583359842|FG000|Overall Study|Withdrawal by Subject|0|||
161538095|NCT05292534|583359843|FG001|Overall Study|Withdrawal by Subject|1|||
161538096|NCT00238433|583359849|FG000|Overall Study|Screen failure|1|||
161538097|NCT00238433|583359849|FG000|Overall Study|Lost to Follow-up|1|||
161538098|NCT00238433|583359849|FG000|Overall Study|Death|1|||
161538099|NCT01814748|583359850|FG000|Overall Study|Lost to Follow-up|1|||
161538100|NCT01814748|583359851|FG001|Overall Study|Lost to Follow-up|2|||
161538101|NCT01814748|583359850|FG000|Overall Study|Study site terminated by sponsor|1|||
161538102|NCT01814748|583359851|FG001|Overall Study|Study site terminated by sponsor|1|||
161538103|NCT01814748|583359850|FG000|Overall Study|Withdrawal by Subject|6|||
161592386|NCT05659537|583558667|FG000|Overall Study|Participant was suffering from anaemia|1|||
161592387|NCT04971395|583558668|FG000|Overall Study|Withdrawal by Subject|0|||
161592388|NCT04971395|583558669|FG001|Overall Study|Withdrawal by Subject|1|||
161592389|NCT04971395|583558670|FG002|Overall Study|Withdrawal by Subject|0|||
161592390|NCT02924272|583558671|FG000|Overall Study|Site Terminated by Sponsor|4|||
161592391|NCT02924272|583558672|FG001|Overall Study|Site Terminated by Sponsor|1|||
161538104|NCT01814748|583359851|FG001|Overall Study|Withdrawal by Subject|4|||
161538105|NCT00409682|583359857|FG000|Open-label Induction Period|Adverse Event|1|||
161538106|NCT00409682|583359858|FG001|Open-label Induction Period|Adverse Event|0|||
161538107|NCT00409682|583359859|FG002|Open-label Induction Period|Adverse Event|0|||
161538108|NCT00409682|583359857|FG000|Open-label Induction Period|Lack of Efficacy|1|||
161538109|NCT00409682|583359858|FG001|Open-label Induction Period|Lack of Efficacy|0|||
161538110|NCT00409682|583359859|FG002|Open-label Induction Period|Lack of Efficacy|0|||
161592392|NCT02924272|583558671|FG000|Overall Study|Withdrawal by Subject|2|||
161592393|NCT02924272|583558672|FG001|Overall Study|Withdrawal by Subject|0|||
161538111|NCT00409682|583359857|FG000|Open-label Induction Period|Protocol Violation|1|||
161538112|NCT00409682|583359858|FG001|Open-label Induction Period|Protocol Violation|0|||
161538113|NCT00409682|583359859|FG002|Open-label Induction Period|Protocol Violation|0|||
161538114|NCT00409682|583359857|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
161538115|NCT00409682|583359858|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
161538116|NCT00409682|583359859|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
161538117|NCT00409682|583359857|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
161538118|NCT00409682|583359858|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
161538119|NCT00409682|583359859|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
161538120|NCT00409682|583359857|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
161538121|NCT00409682|583359858|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
161538122|NCT00409682|583359859|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
161538123|NCT00409682|583359857|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
161538124|NCT00409682|583359858|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
161538125|NCT00409682|583359859|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
161538126|NCT00409682|583359857|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
161538127|NCT00409682|583359858|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
161538128|NCT00409682|583359859|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
161538129|NCT00409682|583359857|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
161538130|NCT00409682|583359858|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
161538131|NCT00409682|583359859|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
161538132|NCT00409682|583359857|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
161538133|NCT00409682|583359858|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
161538134|NCT00409682|583359859|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
161538135|NCT01896869|583359861|FG000|Overall Study|Withdrawal by Subject|0|||
161538136|NCT01896869|583359862|FG001|Overall Study|Withdrawal by Subject|6|||
161538137|NCT01896869|583359861|FG000|Overall Study|Lost to Follow-up|1|||
161538138|NCT01896869|583359862|FG001|Overall Study|Lost to Follow-up|0|||
161538139|NCT04710927|583359868|FG000|Overall Study|Lost to Follow-up|7|||
161538140|NCT04710927|583359869|FG001|Overall Study|Lost to Follow-up|6|||
161538141|NCT04710927|583359870|FG002|Overall Study|Lost to Follow-up|5|||
161538142|NCT00454571|583359874|FG000|Overall Study|Adverse Event|2|||
161538143|NCT00454571|583359875|FG001|Overall Study|Adverse Event|0|||
161538144|NCT00454571|583359874|FG000|Overall Study|Physician Decision|0|||
161538145|NCT00454571|583359875|FG001|Overall Study|Physician Decision|1|||
161538146|NCT00454571|583359874|FG000|Overall Study|Protocol Violation|1|||
161538147|NCT00454571|583359875|FG001|Overall Study|Protocol Violation|0|||
161538148|NCT00454571|583359874|FG000|Overall Study|Withdrawal by Subject|10|||
161538149|NCT00454571|583359875|FG001|Overall Study|Withdrawal by Subject|5|||
161538150|NCT01376323|583359876|FG000|Overall Study|Adverse Event|1|||
161538151|NCT01376323|583359877|FG001|Overall Study|Adverse Event|0|||
161538152|NCT01376323|583359878|FG002|Overall Study|Adverse Event|0|||
161538153|NCT01376323|583359879|FG003|Overall Study|Adverse Event|2|||
161538154|NCT01376323|583359880|FG004|Overall Study|Adverse Event|0|||
161538155|NCT01376323|583359876|FG000|Overall Study|Lost to Follow-up|0|||
161538156|NCT01376323|583359877|FG001|Overall Study|Lost to Follow-up|0|||
161538157|NCT01376323|583359878|FG002|Overall Study|Lost to Follow-up|0|||
161538158|NCT01376323|583359879|FG003|Overall Study|Lost to Follow-up|2|||
161538159|NCT01376323|583359880|FG004|Overall Study|Lost to Follow-up|0|||
161538160|NCT01376323|583359876|FG000|Overall Study|Physician Decision|1|||
161538161|NCT01376323|583359877|FG001|Overall Study|Physician Decision|0|||
161538162|NCT01376323|583359878|FG002|Overall Study|Physician Decision|2|||
161538163|NCT01376323|583359879|FG003|Overall Study|Physician Decision|1|||
161538164|NCT01376323|583359880|FG004|Overall Study|Physician Decision|1|||
161538165|NCT01376323|583359876|FG000|Overall Study|Withdrawal by Subject|0|||
161538166|NCT01376323|583359877|FG001|Overall Study|Withdrawal by Subject|1|||
161538167|NCT01376323|583359878|FG002|Overall Study|Withdrawal by Subject|1|||
161538168|NCT01376323|583359879|FG003|Overall Study|Withdrawal by Subject|0|||
161538169|NCT01376323|583359880|FG004|Overall Study|Withdrawal by Subject|0|||
161829391|NCT00892281|584415776|FG001|Overall Study|Adverse Event|8|||
161829392|NCT00892281|584415775|FG000|Overall Study|Lost to Follow-up|81|||
161829393|NCT00892281|584415776|FG001|Overall Study|Lost to Follow-up|8|||
161538170|NCT02436811|583359881|FG000|Overall Study|Lost to Follow-up|2|||
161538171|NCT02436811|583359882|FG001|Overall Study|Lost to Follow-up|9|||
161538172|NCT02436811|583359883|FG002|Overall Study|Lost to Follow-up|7|||
161538173|NCT00792103|583359884|FG000|Overall Study|Enrolled, not treated|15|||
161538174|NCT00792103|583359884|FG000|Overall Study|Lost to Follow-up|17|||
161538175|NCT00792103|583359884|FG000|Overall Study|Adverse Event|25|||
161538176|NCT00792103|583359884|FG000|Overall Study|Withdrawal by Subject|52|||
161538177|NCT00792103|583359884|FG000|Overall Study|Protocol Violation|10|||
161538178|NCT00792103|583359884|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
161538179|NCT03595332|583359885|FG000|Overall Study|Lost to Follow-up|16|||
161538180|NCT03595332|583359886|FG001|Overall Study|Lost to Follow-up|22|||
161538181|NCT03595332|583359885|FG000|Overall Study|Unable to retrieve ID from school|0|||
161538182|NCT03595332|583359886|FG001|Overall Study|Unable to retrieve ID from school|2|||
161538183|NCT02227875|583359887|FG000|Overall Study|Protocol Violation|10|||
161538184|NCT02227875|583359888|FG001|Overall Study|Protocol Violation|7|||
161829394|NCT00892281|584415775|FG000|Overall Study|Pregnancy|1|||
161829395|NCT00892281|584415776|FG001|Overall Study|Pregnancy|0|||
161538185|NCT02227875|583359887|FG000|Overall Study|Other|1|||
161538186|NCT02227875|583359888|FG001|Overall Study|Other|3|||
161538187|NCT02227875|583359887|FG000|Overall Study|Physician Decision|1|||
161538188|NCT02227875|583359888|FG001|Overall Study|Physician Decision|0|||
161538189|NCT02227875|583359887|FG000|Overall Study|Adverse Event|3|||
161538190|NCT02227875|583359888|FG001|Overall Study|Adverse Event|0|||
161538191|NCT02227875|583359887|FG000|Overall Study|Withdrawal by Subject|12|||
161538192|NCT02227875|583359888|FG001|Overall Study|Withdrawal by Subject|13|||
161538193|NCT02227875|583359887|FG000|Overall Study|Lost to Follow-up|10|||
161538194|NCT02227875|583359888|FG001|Overall Study|Lost to Follow-up|10|||
161538195|NCT01201811|583359889|FG000|Overall Study|Adverse Event|6|||
161538196|NCT01201811|583359889|FG000|Overall Study|Disease progression|3|||
161538197|NCT01201811|583359889|FG000|Overall Study|Withdrawal by Subject|3|||
161538198|NCT01201811|583359889|FG000|Overall Study|Death|4|||
161538199|NCT01201811|583359889|FG000|Overall Study|Treatment Failure|2|||
161538200|NCT01201811|583359889|FG000|Overall Study|Physician Decision|1|||
161538201|NCT02856113|583359890|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161538202|NCT02856113|583359891|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161538203|NCT02856113|583359890|FG000|Overall Study|Significant Protocol Deviation|1|||
161538204|NCT02856113|583359891|FG001|Overall Study|Significant Protocol Deviation|0|||
161538205|NCT02856113|583359890|FG000|Overall Study|Lost to Follow-up|3|||
161538206|NCT02856113|583359891|FG001|Overall Study|Lost to Follow-up|5|||
161538207|NCT02856113|583359890|FG000|Overall Study|Voluntary Withdrawal|3|||
161538208|NCT02856113|583359891|FG001|Overall Study|Voluntary Withdrawal|5|||
161538209|NCT02856113|583359890|FG000|Overall Study|Pregnancy|0|||
161538210|NCT02856113|583359891|FG001|Overall Study|Pregnancy|1|||
161538211|NCT02856113|583359890|FG000|Overall Study|Principal Investigator Discretion|2|||
161538212|NCT02856113|583359891|FG001|Overall Study|Principal Investigator Discretion|1|||
161538213|NCT02856113|583359890|FG000|Overall Study|Randomized but not Treated|1|||
161538214|NCT02856113|583359891|FG001|Overall Study|Randomized but not Treated|0|||
161538215|NCT02856113|583359890|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
161538216|NCT02856113|583359891|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
161538217|NCT03494166|583359892|FG000|Overall Study|Death|0|||
161538218|NCT03494166|583359893|FG001|Overall Study|Death|0|||
161538219|NCT03494166|583359894|FG002|Overall Study|Death|0|||
161538220|NCT03494166|583359895|FG003|Overall Study|Death|1|||
161538221|NCT03494166|583359896|FG004|Overall Study|Death|3|||
161538222|NCT03494166|583359897|FG005|Overall Study|Death|0|||
161538223|NCT03494166|583359892|FG000|Overall Study|Lost to Follow-up|2|||
161538224|NCT03494166|583359893|FG001|Overall Study|Lost to Follow-up|2|||
161538225|NCT03494166|583359894|FG002|Overall Study|Lost to Follow-up|2|||
161538226|NCT03494166|583359895|FG003|Overall Study|Lost to Follow-up|2|||
161538227|NCT03494166|583359896|FG004|Overall Study|Lost to Follow-up|14|||
161538228|NCT03494166|583359897|FG005|Overall Study|Lost to Follow-up|0|||
161538229|NCT03494166|583359892|FG000|Overall Study|Withdrawal by Subject|10|||
161538230|NCT03494166|583359893|FG001|Overall Study|Withdrawal by Subject|7|||
161538231|NCT03494166|583359894|FG002|Overall Study|Withdrawal by Subject|0|||
161538232|NCT03494166|583359895|FG003|Overall Study|Withdrawal by Subject|5|||
161538233|NCT03494166|583359896|FG004|Overall Study|Withdrawal by Subject|3|||
161538234|NCT03494166|583359897|FG005|Overall Study|Withdrawal by Subject|17|||
161538235|NCT03494166|583359892|FG000|Overall Study|Screen failure|1|||
161538236|NCT03494166|583359893|FG001|Overall Study|Screen failure|0|||
161538237|NCT03494166|583359894|FG002|Overall Study|Screen failure|0|||
161538238|NCT03494166|583359895|FG003|Overall Study|Screen failure|0|||
161538239|NCT03494166|583359896|FG004|Overall Study|Screen failure|1|||
161538240|NCT03494166|583359897|FG005|Overall Study|Screen failure|0|||
161592394|NCT02924272|583558671|FG000|Overall Study|Adverse Event|3|||
161592395|NCT02924272|583558672|FG001|Overall Study|Adverse Event|0|||
161592396|NCT02924272|583558671|FG000|Overall Study|Progressive Disease|11|||
161592397|NCT02924272|583558672|FG001|Overall Study|Progressive Disease|8|||
161592398|NCT02924272|583558671|FG000|Overall Study|Clinical Deterioration|1|||
161592399|NCT02924272|583558672|FG001|Overall Study|Clinical Deterioration|0|||
161592400|NCT02924272|583558671|FG000|Overall Study|Death|1|||
161592401|NCT02924272|583558672|FG001|Overall Study|Death|0|||
161592402|NCT02924272|583558671|FG000|Overall Study|Reason Not Specified|1|||
161592403|NCT02924272|583558672|FG001|Overall Study|Reason Not Specified|0|||
161538241|NCT02857426|583359898|FG000|Overall Study|Disease progression|34|||
161538242|NCT02857426|583359899|FG001|Overall Study|Disease progression|13|||
161538243|NCT02857426|583359898|FG000|Overall Study|Study drug toxicity|4|||
161538244|NCT02857426|583359899|FG001|Overall Study|Study drug toxicity|1|||
161538245|NCT02857426|583359898|FG000|Overall Study|Death|1|||
161538246|NCT02857426|583359899|FG001|Overall Study|Death|0|||
161538247|NCT02857426|583359898|FG000|Overall Study|Adverse event unrelated to study drug|6|||
161538248|NCT02857426|583359899|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161538249|NCT02857426|583359898|FG000|Overall Study|Participant withdrew consent|1|||
161592404|NCT03575897|583558676|FG000|Overall Study|Lost to Follow-up|12|||
161538250|NCT02857426|583359899|FG001|Overall Study|Participant withdrew consent|1|||
161538251|NCT02857426|583359898|FG000|Overall Study|Maximum clinical benefit|1|||
161592405|NCT03575897|583558677|FG001|Overall Study|Lost to Follow-up|13|||
161538252|NCT02857426|583359899|FG001|Overall Study|Maximum clinical benefit|0|||
161538253|NCT02857426|583359898|FG000|Overall Study|Completed treatment|0|||
161538254|NCT02857426|583359899|FG001|Overall Study|Completed treatment|2|||
161538255|NCT01960725|583359900|FG000|Overall Study|Lost to Follow-up|4|||
161538256|NCT01960725|583359901|FG001|Overall Study|Lost to Follow-up|3|||
161538257|NCT01960725|583359900|FG000|Overall Study|Withdrawal by Subject|1|||
161538258|NCT01960725|583359901|FG001|Overall Study|Withdrawal by Subject|0|||
161538259|NCT01960725|583359900|FG000|Overall Study|unable to obtain blood sample|1|||
161538260|NCT01960725|583359901|FG001|Overall Study|unable to obtain blood sample|2|||
161538261|NCT02831257|583359906|FG000|Overall Study|Lack of Efficacy|3|||
161538262|NCT02831257|583359906|FG000|Overall Study|Adverse Event|2|||
161538263|NCT02831257|583359906|FG000|Overall Study|Physician Decision|1|||
161538264|NCT02831257|583359906|FG000|Overall Study|Withdrawal by Subject|6|||
161538265|NCT01844284|583359907|FG000|Overall Study|Lost to Follow-up|12|||
161538266|NCT01844284|583359908|FG001|Overall Study|Lost to Follow-up|7|||
161538267|NCT00611858|583359909|FG000|Overall Study|Adverse Event|2|||
161538268|NCT00611858|583359909|FG000|Overall Study|Withdrawal by Subject|2|||
161538269|NCT01058304|583359911|FG000|Overall Study|Withdrawal by Subject|8|||
161538270|NCT01058304|583359912|FG001|Overall Study|Withdrawal by Subject|5|||
161538271|NCT01058304|583359911|FG000|Overall Study|Lost to Follow-up|13|||
161538272|NCT01058304|583359912|FG001|Overall Study|Lost to Follow-up|16|||
161538273|NCT01058304|583359911|FG000|Overall Study|Developed exclusion criterion|6|||
161538274|NCT01058304|583359912|FG001|Overall Study|Developed exclusion criterion|12|||
161538275|NCT01820559|583359913|FG000|Overall Study|Adverse Event|4|||
161538276|NCT01820559|583359914|FG001|Overall Study|Adverse Event|6|||
161538277|NCT01820559|583359915|FG002|Overall Study|Adverse Event|13|||
161538278|NCT01820559|583359913|FG000|Overall Study|Withdrawal by Subject|1|||
161538279|NCT01820559|583359914|FG001|Overall Study|Withdrawal by Subject|2|||
161538280|NCT01820559|583359915|FG002|Overall Study|Withdrawal by Subject|5|||
161538281|NCT01820559|583359913|FG000|Overall Study|Protocol Violation|2|||
161538282|NCT01820559|583359914|FG001|Overall Study|Protocol Violation|1|||
161538283|NCT01820559|583359915|FG002|Overall Study|Protocol Violation|3|||
161538284|NCT01820559|583359913|FG000|Overall Study|Subject's non-compliance|1|||
161538285|NCT01820559|583359914|FG001|Overall Study|Subject's non-compliance|0|||
161538286|NCT01820559|583359915|FG002|Overall Study|Subject's non-compliance|2|||
161538287|NCT01820559|583359913|FG000|Overall Study|Lost to Follow-up|3|||
161538288|NCT01820559|583359914|FG001|Overall Study|Lost to Follow-up|2|||
161538289|NCT01820559|583359915|FG002|Overall Study|Lost to Follow-up|2|||
161538290|NCT01820559|583359913|FG000|Overall Study|At sponsor request|0|||
161538291|NCT01820559|583359914|FG001|Overall Study|At sponsor request|0|||
161538292|NCT01820559|583359915|FG002|Overall Study|At sponsor request|1|||
161538293|NCT01820559|583359913|FG000|Overall Study|Lack of Efficacy|3|||
161538294|NCT01820559|583359914|FG001|Overall Study|Lack of Efficacy|2|||
161538295|NCT01820559|583359915|FG002|Overall Study|Lack of Efficacy|3|||
161538296|NCT02496767|583359917|FG000|Open-label Lead-in Phase|Adverse Event|176|||
161538297|NCT02496767|583359918|FG001|Open-label Lead-in Phase|Adverse Event|0|||
161538298|NCT02496767|583359919|FG002|Open-label Lead-in Phase|Adverse Event|0|||
161538299|NCT02496767|583359920|FG003|Open-label Lead-in Phase|Adverse Event|0|||
161538300|NCT02496767|583359921|FG004|Open-label Lead-in Phase|Adverse Event|0|||
161538301|NCT02496767|583359922|FG005|Open-label Lead-in Phase|Adverse Event|0|||
161538302|NCT02496767|583359923|FG006|Open-label Lead-in Phase|Adverse Event|0|||
161538303|NCT02496767|583359924|FG007|Open-label Lead-in Phase|Adverse Event|0|||
161538304|NCT02496767|583359917|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
161538305|NCT02496767|583359918|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
161538306|NCT02496767|583359919|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
161538307|NCT02496767|583359920|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
161538308|NCT02496767|583359921|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
161538309|NCT02496767|583359922|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
161538310|NCT02496767|583359923|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
161538311|NCT02496767|583359924|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
161538312|NCT02496767|583359917|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
161538313|NCT02496767|583359918|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
161538314|NCT02496767|583359919|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
161538315|NCT02496767|583359920|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
161592406|NCT00506519|583558684|FG000|Overall Study|Death|4|||
161538316|NCT02496767|583359921|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
161538317|NCT02496767|583359922|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
161538318|NCT02496767|583359923|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
161538319|NCT02496767|583359924|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
161538320|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161538321|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
161538322|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
161538323|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
161538324|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
161538325|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161538326|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161538327|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161538328|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
161538329|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
161538330|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
161538331|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
161538332|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
161538333|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
161538334|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
161538335|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
161538336|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
161538337|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
161538338|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
161538339|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
161538340|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
161538341|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
161538342|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
161538343|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
161538344|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
161538345|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
161538346|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
161538347|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
161538348|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
161538349|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
161538350|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
161538351|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
161538352|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161538353|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
161538354|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
161538355|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
161538356|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
161538357|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161538358|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161538359|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161538360|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161538361|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
161538362|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
161538363|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161538364|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161538365|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161538366|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161538367|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161538368|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161538369|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
161538370|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161538371|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
161538372|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
161538373|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161538374|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161538375|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161538376|NCT02496767|583359917|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538377|NCT02496767|583359918|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
161538378|NCT02496767|583359919|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538379|NCT02496767|583359920|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538380|NCT02496767|583359921|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538381|NCT02496767|583359922|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538382|NCT02496767|583359923|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538383|NCT02496767|583359924|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
161538384|NCT02496767|583359917|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
161538385|NCT02496767|583359918|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
161538386|NCT02496767|583359919|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
161538387|NCT02496767|583359920|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
161538388|NCT02496767|583359921|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
161538389|NCT02496767|583359922|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
161592407|NCT00506519|583558685|FG001|Overall Study|Death|6|||
161538390|NCT02496767|583359923|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
161538391|NCT02496767|583359924|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
161538392|NCT02496767|583359917|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
161538393|NCT02496767|583359918|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
161538394|NCT02496767|583359919|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
161538395|NCT02496767|583359920|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
161538396|NCT02496767|583359921|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
161538397|NCT02496767|583359922|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
161538398|NCT02496767|583359923|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
161538399|NCT02496767|583359924|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
161538400|NCT02496767|583359917|FG000|Double-blind, Withdrawal Phase|Death|0|||
161538401|NCT02496767|583359918|FG001|Double-blind, Withdrawal Phase|Death|0|||
161538402|NCT02496767|583359919|FG002|Double-blind, Withdrawal Phase|Death|0|||
161538403|NCT02496767|583359920|FG003|Double-blind, Withdrawal Phase|Death|0|||
161538404|NCT02496767|583359921|FG004|Double-blind, Withdrawal Phase|Death|0|||
161538405|NCT02496767|583359922|FG005|Double-blind, Withdrawal Phase|Death|0|||
161538406|NCT02496767|583359923|FG006|Double-blind, Withdrawal Phase|Death|1|||
161538407|NCT02496767|583359924|FG007|Double-blind, Withdrawal Phase|Death|2|||
161538408|NCT02496767|583359917|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
161538409|NCT02496767|583359918|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
161538410|NCT02496767|583359919|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
161538411|NCT02496767|583359920|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
161538412|NCT02496767|583359921|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
161538413|NCT02496767|583359922|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
161538414|NCT02496767|583359923|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
161538415|NCT02496767|583359924|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
161538416|NCT00166296|583359925|FG000|Overall Study|Withdrawal by Subject|1|||
161538417|NCT00166296|583359926|FG001|Overall Study|Withdrawal by Subject|3|||
161538418|NCT00166296|583359925|FG000|Overall Study|Adverse Event|2|||
161538419|NCT00166296|583359926|FG001|Overall Study|Adverse Event|4|||
161538420|NCT00166296|583359925|FG000|Overall Study|Lost to Follow-up|4|||
161538421|NCT00166296|583359926|FG001|Overall Study|Lost to Follow-up|2|||
161538422|NCT04035200|583359932|FG000|Overall Study|Lost to Follow-up|0|||
161538423|NCT04035200|583359933|FG001|Overall Study|Lost to Follow-up|1|||
161538424|NCT04035200|583359934|FG002|Overall Study|Lost to Follow-up|0|||
161538425|NCT04035200|583359932|FG000|Overall Study|Withdrawal by Subject|1|||
161538426|NCT04035200|583359933|FG001|Overall Study|Withdrawal by Subject|4|||
161538427|NCT04035200|583359934|FG002|Overall Study|Withdrawal by Subject|4|||
161538428|NCT04035200|583359932|FG000|Overall Study|COVID-19|1|||
161538429|NCT04035200|583359933|FG001|Overall Study|COVID-19|0|||
161538430|NCT04035200|583359934|FG002|Overall Study|COVID-19|0|||
161538431|NCT04035200|583359932|FG000|Overall Study|Early Termination|0|||
161538432|NCT04035200|583359933|FG001|Overall Study|Early Termination|1|||
161538433|NCT04035200|583359934|FG002|Overall Study|Early Termination|0|||
161538434|NCT04035200|583359932|FG000|Overall Study|Non-compliance|0|||
161538435|NCT04035200|583359933|FG001|Overall Study|Non-compliance|1|||
161538436|NCT04035200|583359934|FG002|Overall Study|Non-compliance|0|||
161538437|NCT02277990|583359935|FG000|Overall Study|Death|170|||
161538438|NCT02277990|583359936|FG001|Overall Study|Death|188|||
161538439|NCT02277990|583359935|FG000|Overall Study|Withdrawal by Subject|64|||
161538440|NCT02277990|583359936|FG001|Overall Study|Withdrawal by Subject|53|||
161538441|NCT02277990|583359935|FG000|Overall Study|Physician Decision|40|||
161538442|NCT02277990|583359936|FG001|Overall Study|Physician Decision|34|||
161538443|NCT02277990|583359935|FG000|Overall Study|Lost to Follow-up|66|||
161538444|NCT02277990|583359936|FG001|Overall Study|Lost to Follow-up|69|||
161538445|NCT02277990|583359935|FG000|Overall Study|Had other reason|26|||
161538446|NCT02277990|583359936|FG001|Overall Study|Had other reason|32|||
161538447|NCT03351738|583359937|FG000|Overall Study|Withdrawal by Subject|0|||
161538448|NCT03351738|583359938|FG001|Overall Study|Withdrawal by Subject|1|||
161538449|NCT03351738|583359939|FG002|Overall Study|Withdrawal by Subject|0|||
161538450|NCT03351738|583359940|FG003|Overall Study|Withdrawal by Subject|1|||
161538451|NCT03351738|583359941|FG004|Overall Study|Withdrawal by Subject|0|||
161538452|NCT03351738|583359942|FG005|Overall Study|Withdrawal by Subject|0|||
161538453|NCT03138733|583359947|FG000|Overall Study|Death|17|||
161538454|NCT03138733|583359948|FG001|Overall Study|Death|18|||
161538455|NCT03138733|583359947|FG000|Overall Study|Withdrawal by Subject|11|||
161538456|NCT03138733|583359948|FG001|Overall Study|Withdrawal by Subject|6|||
161538457|NCT03138733|583359947|FG000|Overall Study|Lost to Follow-up|3|||
161538458|NCT03138733|583359948|FG001|Overall Study|Lost to Follow-up|2|||
161538459|NCT03138733|583359947|FG000|Overall Study|Adverse Event|1|||
161538460|NCT03138733|583359948|FG001|Overall Study|Adverse Event|0|||
161538461|NCT03138733|583359947|FG000|Overall Study|Protocol Violation|1|||
161538462|NCT03138733|583359948|FG001|Overall Study|Protocol Violation|3|||
161538463|NCT03138733|583359947|FG000|Overall Study|Administrative or logistical reason|1|||
161538464|NCT03138733|583359948|FG001|Overall Study|Administrative or logistical reason|0|||
161538465|NCT03138733|583359947|FG000|Overall Study|The patient was transferred to another hospital|1|||
161538466|NCT03138733|583359948|FG001|Overall Study|The patient was transferred to another hospital|0|||
161538467|NCT03641313|583359952|FG000|Overall Study|Death|1|||
161538468|NCT03641313|583359952|FG000|Overall Study|Withdrawal by Subject|2|||
161538469|NCT03641313|583359952|FG000|Overall Study|Declining health|1|||
161538470|NCT03641313|583359952|FG000|Overall Study|Adverse Event|1|||
161538471|NCT01533493|583359955|FG000|Overall Study|Adverse Event|2|||
161538472|NCT01533493|583359956|FG001|Overall Study|Adverse Event|1|||
161538473|NCT01533493|583359955|FG000|Overall Study|Withdrawal by Subject|1|||
161538474|NCT01533493|583359956|FG001|Overall Study|Withdrawal by Subject|2|||
161538475|NCT01533493|583359955|FG000|Overall Study|Lost to Follow-up|2|||
161538476|NCT01533493|583359956|FG001|Overall Study|Lost to Follow-up|0|||
161538477|NCT02521285|583359960|FG000|Overall Study|Lost to Follow-up|1|||
161538478|NCT02521285|583359961|FG001|Overall Study|Lost to Follow-up|1|||
161538479|NCT02521285|583359960|FG000|Overall Study|Withdrawal by Subject|1|||
161538480|NCT02521285|583359961|FG001|Overall Study|Withdrawal by Subject|1|||
161538481|NCT02521285|583359960|FG000|Overall Study|Adverse Event|0|||
161538482|NCT02521285|583359961|FG001|Overall Study|Adverse Event|1|||
161538483|NCT05701995|583359963|FG000|Pre-Treatment|Randomization Error|1|||
161538484|NCT05701995|583359964|FG001|Pre-Treatment|Randomization Error|1|||
161538485|NCT05701995|583359963|FG000|Treatment|Withdrawal by Subject|8|||
161538486|NCT05701995|583359964|FG001|Treatment|Withdrawal by Subject|4|||
161538487|NCT05701995|583359963|FG000|Treatment|Lost to Follow-up|2|||
161538488|NCT05701995|583359964|FG001|Treatment|Lost to Follow-up|3|||
161538489|NCT05701995|583359963|FG000|Treatment|Adverse Event|3|||
161538490|NCT05701995|583359964|FG001|Treatment|Adverse Event|1|||
161538491|NCT05701995|583359963|FG000|Treatment|Other Reason|1|||
161538492|NCT05701995|583359964|FG001|Treatment|Other Reason|1|||
161538493|NCT05701995|583359963|FG000|Treatment|Death|1|||
161538494|NCT05701995|583359964|FG001|Treatment|Death|0|||
161538495|NCT05701995|583359963|FG000|Treatment|Physician Decision|0|||
161538496|NCT05701995|583359964|FG001|Treatment|Physician Decision|1|||
161538497|NCT00715429|583359965|FG000|Overall Study|Did not complete the study diary|0|||
161538498|NCT00715429|583359966|FG001|Overall Study|Did not complete the study diary|1|||
161538499|NCT04899245|583359971|FG000|Overall Study|Withdrawal by Subject|3|||
161538500|NCT04899245|583359972|FG001|Overall Study|Withdrawal by Subject|5|||
161538501|NCT04899245|583359973|FG002|Overall Study|Withdrawal by Subject|2|||
161538502|NCT04899245|583359971|FG000|Overall Study|No longer eligible - Left staff position|0|||
161538503|NCT04899245|583359972|FG001|Overall Study|No longer eligible - Left staff position|0|||
161538504|NCT04899245|583359973|FG002|Overall Study|No longer eligible - Left staff position|1|||
161538505|NCT04899245|583359971|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
161538506|NCT04899245|583359972|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
161538507|NCT04899245|583359973|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
161538508|NCT04899245|583359971|FG000|Overall Study|No longer eligible - Moved away from area|2|||
161538509|NCT04899245|583359972|FG001|Overall Study|No longer eligible - Moved away from area|2|||
161538510|NCT04899245|583359973|FG002|Overall Study|No longer eligible - Moved away from area|0|||
161538511|NCT02790073|583361739|FG000|Overall Study|Death|1|||
161538512|NCT02790073|583361739|FG000|Overall Study|Withdrawal from HD|1|||
161538513|NCT02790073|583361739|FG000|Overall Study|Withdrawal by Subject|1|||
161538514|NCT00514683|583361740|FG000|Overall Study|Not treated|2|||
161538515|NCT00514683|583361741|FG001|Overall Study|Not treated|1|||
161538516|NCT00514683|583361742|FG002|Overall Study|Not treated|0|||
161538517|NCT00514683|583361743|FG003|Overall Study|Not treated|0|||
161538518|NCT00514683|583361744|FG004|Overall Study|Not treated|1|||
161538519|NCT00514683|583361740|FG000|Overall Study|Adverse Event|21|||
161538520|NCT00514683|583361741|FG001|Overall Study|Adverse Event|20|||
161538521|NCT00514683|583361742|FG002|Overall Study|Adverse Event|15|||
161538522|NCT00514683|583361743|FG003|Overall Study|Adverse Event|13|||
161538523|NCT00514683|583361744|FG004|Overall Study|Adverse Event|27|||
161538524|NCT00514683|583361740|FG000|Overall Study|Protocol Violation|1|||
161538525|NCT00514683|583361741|FG001|Overall Study|Protocol Violation|1|||
161538526|NCT00514683|583361742|FG002|Overall Study|Protocol Violation|0|||
161538527|NCT00514683|583361743|FG003|Overall Study|Protocol Violation|1|||
161538528|NCT00514683|583361744|FG004|Overall Study|Protocol Violation|0|||
161538529|NCT00514683|583361740|FG000|Overall Study|Withdrawal by Subject|2|||
161538530|NCT00514683|583361741|FG001|Overall Study|Withdrawal by Subject|2|||
161538531|NCT00514683|583361742|FG002|Overall Study|Withdrawal by Subject|1|||
161538532|NCT00514683|583361743|FG003|Overall Study|Withdrawal by Subject|0|||
161538533|NCT00514683|583361744|FG004|Overall Study|Withdrawal by Subject|4|||
161538534|NCT00514683|583361740|FG000|Overall Study|Reason other than listed above|0|||
161538535|NCT00514683|583361741|FG001|Overall Study|Reason other than listed above|1|||
161538536|NCT00514683|583361742|FG002|Overall Study|Reason other than listed above|2|||
161538537|NCT00514683|583361743|FG003|Overall Study|Reason other than listed above|0|||
161538538|NCT00514683|583361744|FG004|Overall Study|Reason other than listed above|1|||
161538539|NCT00643123|583361747|FG000|Overall Study|Lost to Follow-up|4|||
161538540|NCT00643123|583361748|FG001|Overall Study|Lost to Follow-up|0|||
161538541|NCT00643123|583361747|FG000|Overall Study|Withdrawal by Subject|1|||
161538542|NCT00643123|583361748|FG001|Overall Study|Withdrawal by Subject|1|||
161538543|NCT01538472|583361749|FG000|Overall Study|Disease Progression|3|||
161538544|NCT01538472|583361749|FG000|Overall Study|Death|1|||
161538545|NCT00118716|583361754|FG000|Overall Study|Adverse Event|2|||
161538546|NCT00118716|583361755|FG001|Overall Study|Adverse Event|7|||
161538547|NCT00118716|583361754|FG000|Overall Study|Protocol Violation|5|||
161538548|NCT00118716|583361755|FG001|Overall Study|Protocol Violation|4|||
161538549|NCT00118716|583361754|FG000|Overall Study|Withdrawal by Subject|0|||
161538550|NCT00118716|583361755|FG001|Overall Study|Withdrawal by Subject|1|||
161538551|NCT00118716|583361754|FG000|Overall Study|Exacerbation|2|||
161592408|NCT00506519|583558686|FG002|Overall Study|Death|0|||
161592409|NCT00506519|583558684|FG000|Overall Study|Adverse Event|1|||
161538552|NCT00118716|583361755|FG001|Overall Study|Exacerbation|2|||
161538553|NCT00118716|583361754|FG000|Overall Study|Discontinued by sponsor|1|||
161538554|NCT00118716|583361755|FG001|Overall Study|Discontinued by sponsor|1|||
161538555|NCT00118716|583361754|FG000|Overall Study|Non-compliance|1|||
161538556|NCT00118716|583361755|FG001|Overall Study|Non-compliance|3|||
161538557|NCT00118716|583361754|FG000|Overall Study|misrandomized|1|||
161538558|NCT00118716|583361755|FG001|Overall Study|misrandomized|1|||
161538559|NCT00118716|583361754|FG000|Overall Study|Expired drug use|1|||
161538560|NCT00118716|583361755|FG001|Overall Study|Expired drug use|2|||
161538561|NCT00118716|583361754|FG000|Overall Study|Investigator discretion|0|||
161538562|NCT00118716|583361755|FG001|Overall Study|Investigator discretion|1|||
161538563|NCT00855062|583361756|FG000|Step1|Early Study Closure|5|||
161538564|NCT00855062|583361757|FG001|Step1|Early Study Closure|7|||
161538565|NCT00855062|583361756|FG000|Step1|Adverse Event|1|||
161538566|NCT00855062|583361757|FG001|Step1|Adverse Event|1|||
161538567|NCT00855062|583361756|FG000|Step1|Protocol Violation|1|||
161538568|NCT00855062|583361757|FG001|Step1|Protocol Violation|0|||
161538569|NCT00855062|583361756|FG000|Step1|Pregnancy|1|||
161538570|NCT00855062|583361757|FG001|Step1|Pregnancy|0|||
161538571|NCT00855062|583361756|FG000|Step1|Withdrawal by Subject|2|||
161538572|NCT00855062|583361757|FG001|Step1|Withdrawal by Subject|3|||
161538573|NCT00855062|583361756|FG000|Step2|Early Study Closure|6|||
161538574|NCT00855062|583361757|FG001|Step2|Early Study Closure|2|||
161538575|NCT00855062|583361756|FG000|Step2|Adverse Event|0|||
161538576|NCT00855062|583361757|FG001|Step2|Adverse Event|3|||
161538577|NCT00855062|583361756|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
161538578|NCT00855062|583361757|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
161538579|NCT04681729|583361758|FG000|Overall Study|Lack of Efficacy|2|||
161538580|NCT04681729|583361759|FG001|Overall Study|Lack of Efficacy|2|||
161538581|NCT04681729|583361758|FG000|Overall Study|Withdrawal by Subject|8|||
161538582|NCT04681729|583361759|FG001|Overall Study|Withdrawal by Subject|9|||
161538583|NCT02110901|583361760|FG000|Overall Study|Death|6|||
161538584|NCT02110901|583361761|FG001|Overall Study|Death|3|||
161538585|NCT02110901|583361760|FG000|Overall Study|Lost to Follow-up|12|||
161538586|NCT02110901|583361761|FG001|Overall Study|Lost to Follow-up|8|||
161538587|NCT02110901|583361760|FG000|Overall Study|Withdrawal by Subject|7|||
161592410|NCT00506519|583558685|FG001|Overall Study|Adverse Event|0|||
161592411|NCT00506519|583558686|FG002|Overall Study|Adverse Event|0|||
161592412|NCT02975882|583558687|FG000|Overall Study|Adverse Event|1|||
161592413|NCT02975882|583558688|FG001|Overall Study|Adverse Event|2|||
161592414|NCT02975882|583558689|FG002|Overall Study|Adverse Event|1|||
161592415|NCT02975882|583558690|FG003|Overall Study|Adverse Event|1|||
161592416|NCT02975882|583558687|FG000|Overall Study|Death|0|||
161592417|NCT02975882|583558688|FG001|Overall Study|Death|1|||
161592418|NCT02975882|583558689|FG002|Overall Study|Death|0|||
161592419|NCT02975882|583558690|FG003|Overall Study|Death|0|||
161592420|NCT02975882|583558687|FG000|Overall Study|Lack of Efficacy|3|||
161678750|NCT00574288|583876071|FG006|Overall Study|Lost to Follow-up|2|||
161538588|NCT02110901|583361761|FG001|Overall Study|Withdrawal by Subject|3|||
161538589|NCT02110901|583361760|FG000|Overall Study|received a kidney transplant|5|||
161538590|NCT02110901|583361761|FG001|Overall Study|received a kidney transplant|0|||
161538591|NCT00855595|583361763|FG000|Overall Study|Withdrawal by Subject|1|||
161538592|NCT00855595|583361764|FG001|Overall Study|Withdrawal by Subject|2|||
161538593|NCT00855595|583361763|FG000|Overall Study|Lost to Follow-up|3|||
161538594|NCT00855595|583361764|FG001|Overall Study|Lost to Follow-up|3|||
161538595|NCT00855595|583361763|FG000|Overall Study|Adverse Event|1|||
161538596|NCT00855595|583361764|FG001|Overall Study|Adverse Event|1|||
161538597|NCT00855595|583361763|FG000|Overall Study|patient moved out of state|1|||
161538598|NCT00855595|583361764|FG001|Overall Study|patient moved out of state|0|||
161538599|NCT00855595|583361763|FG000|Overall Study|patient left country|0|||
161592421|NCT02975882|583558688|FG001|Overall Study|Lack of Efficacy|7|||
161538600|NCT00855595|583361764|FG001|Overall Study|patient left country|1|||
161538601|NCT04581200|583361765|FG000|Overall Study|Lost to Follow-up|6|||
161538602|NCT04581200|583361766|FG001|Overall Study|Lost to Follow-up|5|||
161538603|NCT04711603|583361767|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
161538604|NCT04711603|583361768|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
161538605|NCT04711603|583361769|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
161538606|NCT04711603|583361770|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
161538607|NCT04711603|583361767|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
161538608|NCT04711603|583361768|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
161538609|NCT04711603|583361769|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
161538610|NCT04711603|583361770|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
161538611|NCT04711603|583361767|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
161538612|NCT04711603|583361768|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
161538613|NCT04711603|583361769|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
161538614|NCT04711603|583361770|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
161538615|NCT04711603|583361767|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
161538616|NCT04711603|583361768|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
161538617|NCT04711603|583361769|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
161538618|NCT04711603|583361770|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
161538619|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
161538620|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
161538621|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
161538622|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
161538623|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
161538624|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
161538625|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
161538626|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
161538627|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
161538628|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
161538629|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
161538630|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
161538631|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
161538632|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
161538633|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
161538634|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
161538635|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
161538636|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
161538637|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
161538638|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
161538639|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
161538640|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
161538641|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
161538642|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
161538643|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
161538644|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
161538645|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
161538646|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
161538647|NCT04711603|583361767|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
161538648|NCT04711603|583361768|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
161538649|NCT04711603|583361769|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
161538650|NCT04711603|583361770|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
161538651|NCT01089374|583361771|FG000|Overall Study|Lost to Follow-up|3|||
161538652|NCT01089374|583361772|FG001|Overall Study|Lost to Follow-up|0|||
161538653|NCT01089374|583361771|FG000|Overall Study|Withdrawal by Subject|1|||
161538654|NCT01089374|583361772|FG001|Overall Study|Withdrawal by Subject|0|||
161538655|NCT01089374|583361771|FG000|Overall Study|Study closed early - low accrual|6|||
161538656|NCT01089374|583361772|FG001|Overall Study|Study closed early - low accrual|0|||
161538657|NCT02597036|583361783|FG000|Overall Study|Progressive Disease|0|||
161538658|NCT02597036|583361784|FG001|Overall Study|Progressive Disease|0|||
161538659|NCT02597036|583361785|FG002|Overall Study|Progressive Disease|0|||
161538660|NCT02597036|583361786|FG003|Overall Study|Progressive Disease|0|||
161538661|NCT02597036|583361787|FG004|Overall Study|Progressive Disease|1|||
161538662|NCT02597036|583361788|FG005|Overall Study|Progressive Disease|1|||
161538663|NCT02597036|583361789|FG006|Overall Study|Progressive Disease|1|||
161538664|NCT02597036|583361790|FG007|Overall Study|Progressive Disease|0|||
161538665|NCT02597036|583361791|FG008|Overall Study|Progressive Disease|0|||
161538666|NCT02597036|583361792|FG009|Overall Study|Progressive Disease|0|||
161538667|NCT02597036|583361793|FG010|Overall Study|Progressive Disease|0|||
161538668|NCT02597036|583361794|FG011|Overall Study|Progressive Disease|0|||
161538669|NCT02597036|583361783|FG000|Overall Study|Adverse Event|0|||
161538670|NCT02597036|583361784|FG001|Overall Study|Adverse Event|0|||
161538671|NCT02597036|583361785|FG002|Overall Study|Adverse Event|0|||
161538672|NCT02597036|583361786|FG003|Overall Study|Adverse Event|0|||
161538673|NCT02597036|583361787|FG004|Overall Study|Adverse Event|0|||
161538674|NCT02597036|583361788|FG005|Overall Study|Adverse Event|0|||
161538675|NCT02597036|583361789|FG006|Overall Study|Adverse Event|0|||
161538676|NCT02597036|583361790|FG007|Overall Study|Adverse Event|1|||
161538677|NCT02597036|583361791|FG008|Overall Study|Adverse Event|0|||
161538678|NCT02597036|583361792|FG009|Overall Study|Adverse Event|0|||
161538679|NCT02597036|583361793|FG010|Overall Study|Adverse Event|0|||
161538680|NCT02597036|583361794|FG011|Overall Study|Adverse Event|1|||
161538681|NCT02597036|583361783|FG000|Overall Study|Death|0|||
161538682|NCT02597036|583361784|FG001|Overall Study|Death|0|||
161538683|NCT02597036|583361785|FG002|Overall Study|Death|0|||
161538684|NCT02597036|583361786|FG003|Overall Study|Death|0|||
161538685|NCT02597036|583361787|FG004|Overall Study|Death|0|||
161538686|NCT02597036|583361788|FG005|Overall Study|Death|0|||
161538687|NCT02597036|583361789|FG006|Overall Study|Death|0|||
161538688|NCT02597036|583361790|FG007|Overall Study|Death|0|||
161538689|NCT02597036|583361791|FG008|Overall Study|Death|0|||
161538690|NCT02597036|583361792|FG009|Overall Study|Death|1|||
161538691|NCT02597036|583361793|FG010|Overall Study|Death|1|||
161538692|NCT02597036|583361794|FG011|Overall Study|Death|0|||
161592422|NCT02975882|583558689|FG002|Overall Study|Lack of Efficacy|4|||
161592423|NCT02975882|583558690|FG003|Overall Study|Lack of Efficacy|3|||
161592424|NCT02975882|583558687|FG000|Overall Study|Physician Decision|0|||
161592425|NCT02975882|583558688|FG001|Overall Study|Physician Decision|2|||
161538693|NCT02597036|583361783|FG000|Overall Study|Lost to Follow-up|0|||
161538694|NCT02597036|583361784|FG001|Overall Study|Lost to Follow-up|0|||
161538695|NCT02597036|583361785|FG002|Overall Study|Lost to Follow-up|0|||
161538696|NCT02597036|583361786|FG003|Overall Study|Lost to Follow-up|0|||
161538697|NCT02597036|583361787|FG004|Overall Study|Lost to Follow-up|0|||
161538698|NCT02597036|583361788|FG005|Overall Study|Lost to Follow-up|0|||
161538699|NCT02597036|583361789|FG006|Overall Study|Lost to Follow-up|0|||
161538700|NCT02597036|583361790|FG007|Overall Study|Lost to Follow-up|0|||
161538701|NCT02597036|583361791|FG008|Overall Study|Lost to Follow-up|0|||
161538702|NCT02597036|583361792|FG009|Overall Study|Lost to Follow-up|0|||
161538703|NCT02597036|583361793|FG010|Overall Study|Lost to Follow-up|1|||
161538704|NCT02597036|583361794|FG011|Overall Study|Lost to Follow-up|0|||
161538705|NCT02597036|583361783|FG000|Overall Study|Withdrawal by Subject|0|||
161538706|NCT02597036|583361784|FG001|Overall Study|Withdrawal by Subject|0|||
161538707|NCT02597036|583361785|FG002|Overall Study|Withdrawal by Subject|0|||
161538708|NCT02597036|583361786|FG003|Overall Study|Withdrawal by Subject|0|||
161538709|NCT02597036|583361787|FG004|Overall Study|Withdrawal by Subject|0|||
161538710|NCT02597036|583361788|FG005|Overall Study|Withdrawal by Subject|0|||
161538711|NCT02597036|583361789|FG006|Overall Study|Withdrawal by Subject|0|||
161538712|NCT02597036|583361790|FG007|Overall Study|Withdrawal by Subject|0|||
161538713|NCT02597036|583361791|FG008|Overall Study|Withdrawal by Subject|0|||
161538714|NCT02597036|583361792|FG009|Overall Study|Withdrawal by Subject|0|||
161538715|NCT02597036|583361793|FG010|Overall Study|Withdrawal by Subject|0|||
161538716|NCT02597036|583361794|FG011|Overall Study|Withdrawal by Subject|1|||
161538717|NCT05163522|583361797|FG000|Overall Study|Withdrawal by Subject|0|||
161538718|NCT05163522|583361798|FG001|Overall Study|Withdrawal by Subject|0|||
161538719|NCT05163522|583361799|FG002|Overall Study|Withdrawal by Subject|1|||
161538720|NCT05163522|583361800|FG003|Overall Study|Withdrawal by Subject|0|||
161538721|NCT05163522|583361801|FG004|Overall Study|Withdrawal by Subject|0|||
161538722|NCT05163522|583361802|FG005|Overall Study|Withdrawal by Subject|0|||
161538723|NCT05163522|583361803|FG006|Overall Study|Withdrawal by Subject|0|||
161538724|NCT05163522|583361804|FG007|Overall Study|Withdrawal by Subject|0|||
161538725|NCT05163522|583361805|FG008|Overall Study|Withdrawal by Subject|0|||
161538726|NCT05163522|583361806|FG009|Overall Study|Withdrawal by Subject|0|||
161538727|NCT05163522|583361807|FG010|Overall Study|Withdrawal by Subject|0|||
161538728|NCT04672941|583361812|FG000|Overall Study|Investigator decision|1|||
161538729|NCT04672941|583361812|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
161538730|NCT04672941|583361812|FG000|Overall Study|COVID-19 related but no adverse event|1|||
161538731|NCT04672941|583361812|FG000|Overall Study|Adverse Event|2|||
161538732|NCT04672941|583361812|FG000|Overall Study|Lost to Follow-up|2|||
161538733|NCT00386022|583361818|FG000|Plus Estrogen|Lost to Follow-up|2|||
161538734|NCT00386022|583361819|FG001|Plus Estrogen|Lost to Follow-up|0|||
161538735|NCT00386022|583361818|FG000|Plus Estrogen|Adverse Event|0|||
161538736|NCT00386022|583361819|FG001|Plus Estrogen|Adverse Event|1|||
161538737|NCT00504426|583361822|FG000|Overall Study|Adverse Event|0|||
161538738|NCT00504426|583361823|FG001|Overall Study|Adverse Event|0|||
161538739|NCT00504426|583361824|FG002|Overall Study|Adverse Event|2|||
161538740|NCT00504426|583361825|FG003|Overall Study|Adverse Event|0|||
161538741|NCT00504426|583361822|FG000|Overall Study|Protocol Violation|1|||
161538742|NCT00504426|583361823|FG001|Overall Study|Protocol Violation|1|||
161538743|NCT00504426|583361824|FG002|Overall Study|Protocol Violation|2|||
161538744|NCT00504426|583361825|FG003|Overall Study|Protocol Violation|0|||
161538745|NCT00504426|583361822|FG000|Overall Study|Withdrawal by Subject|2|||
161538746|NCT00504426|583361823|FG001|Overall Study|Withdrawal by Subject|0|||
161538747|NCT00504426|583361824|FG002|Overall Study|Withdrawal by Subject|0|||
161538748|NCT00504426|583361825|FG003|Overall Study|Withdrawal by Subject|0|||
161538749|NCT03685591|583361829|FG000|Overall Study|Global Deterioration of Health Status|0|||
161538750|NCT03685591|583361830|FG001|Overall Study|Global Deterioration of Health Status|0|||
161538751|NCT03685591|583361831|FG002|Overall Study|Global Deterioration of Health Status|0|||
161538752|NCT03685591|583361832|FG003|Overall Study|Global Deterioration of Health Status|1|||
161538753|NCT03685591|583361833|FG004|Overall Study|Global Deterioration of Health Status|2|||
161538754|NCT03685591|583361834|FG005|Overall Study|Global Deterioration of Health Status|4|||
161538755|NCT03685591|583361835|FG006|Overall Study|Global Deterioration of Health Status|1|||
161538756|NCT03685591|583361836|FG007|Overall Study|Global Deterioration of Health Status|1|||
161538757|NCT03685591|583361837|FG008|Overall Study|Global Deterioration of Health Status|0|||
161538758|NCT03685591|583361829|FG000|Overall Study|Progressive Disease|1|||
161538759|NCT03685591|583361830|FG001|Overall Study|Progressive Disease|1|||
161538760|NCT03685591|583361831|FG002|Overall Study|Progressive Disease|0|||
161538761|NCT03685591|583361832|FG003|Overall Study|Progressive Disease|3|||
161538762|NCT03685591|583361833|FG004|Overall Study|Progressive Disease|5|||
161538763|NCT03685591|583361834|FG005|Overall Study|Progressive Disease|4|||
161538764|NCT03685591|583361835|FG006|Overall Study|Progressive Disease|3|||
161538765|NCT03685591|583361836|FG007|Overall Study|Progressive Disease|2|||
161538766|NCT03685591|583361837|FG008|Overall Study|Progressive Disease|1|||
161538767|NCT03685591|583361829|FG000|Overall Study|Other|0|||
161538768|NCT03685591|583361830|FG001|Overall Study|Other|0|||
161538769|NCT03685591|583361831|FG002|Overall Study|Other|1|||
161538770|NCT03685591|583361832|FG003|Overall Study|Other|0|||
161538771|NCT03685591|583361833|FG004|Overall Study|Other|2|||
161538772|NCT03685591|583361834|FG005|Overall Study|Other|3|||
161538773|NCT03685591|583361835|FG006|Overall Study|Other|0|||
161538774|NCT03685591|583361836|FG007|Overall Study|Other|0|||
161538775|NCT03685591|583361837|FG008|Overall Study|Other|0|||
161538776|NCT03685591|583361829|FG000|Overall Study|Withdrawal by Subject|0|||
161538777|NCT03685591|583361830|FG001|Overall Study|Withdrawal by Subject|0|||
161538778|NCT03685591|583361831|FG002|Overall Study|Withdrawal by Subject|0|||
161538779|NCT03685591|583361832|FG003|Overall Study|Withdrawal by Subject|0|||
161538780|NCT03685591|583361833|FG004|Overall Study|Withdrawal by Subject|3|||
161538781|NCT03685591|583361834|FG005|Overall Study|Withdrawal by Subject|2|||
161538782|NCT03685591|583361835|FG006|Overall Study|Withdrawal by Subject|0|||
161538783|NCT03685591|583361836|FG007|Overall Study|Withdrawal by Subject|0|||
161538784|NCT03685591|583361837|FG008|Overall Study|Withdrawal by Subject|1|||
161538785|NCT03685591|583361829|FG000|Overall Study|Adverse Event|0|||
161538786|NCT03685591|583361830|FG001|Overall Study|Adverse Event|0|||
161538787|NCT03685591|583361831|FG002|Overall Study|Adverse Event|0|||
161538788|NCT03685591|583361832|FG003|Overall Study|Adverse Event|1|||
161538789|NCT03685591|583361833|FG004|Overall Study|Adverse Event|1|||
161538790|NCT03685591|583361834|FG005|Overall Study|Adverse Event|4|||
161538791|NCT03685591|583361835|FG006|Overall Study|Adverse Event|0|||
161538792|NCT03685591|583361836|FG007|Overall Study|Adverse Event|1|||
161538793|NCT03685591|583361837|FG008|Overall Study|Adverse Event|1|||
161538794|NCT03988166|583361844|FG000|Overall Study|Lost to Follow-up|2|||
161538795|NCT03988166|583361844|FG000|Overall Study|Death|1|||
161538796|NCT03933826|583361846|FG000|Overall Study|Withdrawal by Subject|8|||
161538797|NCT03933826|583361847|FG001|Overall Study|Withdrawal by Subject|1|||
161538798|NCT03933826|583361846|FG000|Overall Study|Death|19|||
161538799|NCT03933826|583361847|FG001|Overall Study|Death|11|||
161538800|NCT03933826|583361846|FG000|Overall Study|Lost to Follow-up|41|||
161538801|NCT03933826|583361847|FG001|Overall Study|Lost to Follow-up|13|||
161538802|NCT02638948|583361848|FG000|Overall Study|Withdrawal by Subject|4|||
161538803|NCT02638948|583361849|FG001|Overall Study|Withdrawal by Subject|5|||
161538804|NCT02638948|583361850|FG002|Overall Study|Withdrawal by Subject|3|||
161538805|NCT02638948|583361851|FG003|Overall Study|Withdrawal by Subject|1|||
161538806|NCT02638948|583361848|FG000|Overall Study|Administrative Reason by Sponsor|0|||
161538807|NCT02638948|583361849|FG001|Overall Study|Administrative Reason by Sponsor|1|||
161538808|NCT02638948|583361850|FG002|Overall Study|Administrative Reason by Sponsor|0|||
161538809|NCT02638948|583361851|FG003|Overall Study|Administrative Reason by Sponsor|4|||
161538810|NCT02638948|583361848|FG000|Overall Study|Adverse Event|0|||
161538811|NCT02638948|583361849|FG001|Overall Study|Adverse Event|0|||
161538812|NCT02638948|583361850|FG002|Overall Study|Adverse Event|1|||
161538813|NCT02638948|583361851|FG003|Overall Study|Adverse Event|1|||
161538814|NCT02638948|583361848|FG000|Overall Study|Lack of Efficacy|1|||
161538815|NCT02638948|583361849|FG001|Overall Study|Lack of Efficacy|1|||
161538816|NCT02638948|583361850|FG002|Overall Study|Lack of Efficacy|0|||
161538817|NCT02638948|583361851|FG003|Overall Study|Lack of Efficacy|0|||
161538818|NCT02638948|583361848|FG000|Overall Study|Lost to Follow-up|0|||
161538819|NCT02638948|583361849|FG001|Overall Study|Lost to Follow-up|0|||
161538820|NCT02638948|583361850|FG002|Overall Study|Lost to Follow-up|1|||
161538821|NCT02638948|583361851|FG003|Overall Study|Lost to Follow-up|1|||
161538822|NCT02638948|583361848|FG000|Overall Study|Poor/Non-Compliance|0|||
161538823|NCT02638948|583361849|FG001|Overall Study|Poor/Non-Compliance|2|||
161538824|NCT02638948|583361850|FG002|Overall Study|Poor/Non-Compliance|1|||
161538825|NCT02638948|583361851|FG003|Overall Study|Poor/Non-Compliance|0|||
161538826|NCT02638948|583361848|FG000|Overall Study|Participant no longer met study criteria|0|||
161538827|NCT02638948|583361849|FG001|Overall Study|Participant no longer met study criteria|1|||
161538828|NCT02638948|583361850|FG002|Overall Study|Participant no longer met study criteria|0|||
161538829|NCT02638948|583361851|FG003|Overall Study|Participant no longer met study criteria|0|||
161538830|NCT02638948|583361848|FG000|Overall Study|Other than specified above|4|||
161538831|NCT02638948|583361849|FG001|Overall Study|Other than specified above|1|||
161538832|NCT02638948|583361850|FG002|Overall Study|Other than specified above|1|||
161538833|NCT02638948|583361851|FG003|Overall Study|Other than specified above|1|||
161592426|NCT02975882|583558689|FG002|Overall Study|Physician Decision|4|||
161592427|NCT02975882|583558690|FG003|Overall Study|Physician Decision|2|||
161592428|NCT02975882|583558687|FG000|Overall Study|Ineligible|0|||
161592429|NCT02975882|583558688|FG001|Overall Study|Ineligible|1|||
161592430|NCT02975882|583558689|FG002|Overall Study|Ineligible|0|||
161592431|NCT02975882|583558690|FG003|Overall Study|Ineligible|0|||
161592432|NCT05116787|583558691|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
161592433|NCT05116787|583558692|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
161538834|NCT04992546|583361852|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161592434|NCT05116787|583558691|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
161592435|NCT05116787|583558692|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
161592436|NCT05116787|583558691|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
161538835|NCT04992546|583361852|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
161538836|NCT04992546|583361852|FG000|Open-Label Treatment Period|Adverse Event|3|||
161538837|NCT04992546|583361852|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
161538838|NCT05007392|583361854|FG000|Overall Study|Randomized but not treated|1|||
161538839|NCT05007392|583361855|FG001|Overall Study|Randomized but not treated|2|||
161538840|NCT05007392|583361854|FG000|Overall Study|Other|5|||
161538841|NCT05007392|583361855|FG001|Overall Study|Other|4|||
161538842|NCT05007392|583361854|FG000|Overall Study|Lost to Follow-up|1|||
161538843|NCT05007392|583361855|FG001|Overall Study|Lost to Follow-up|2|||
161538844|NCT05007392|583361854|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
161538845|NCT05007392|583361855|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
161538846|NCT05007392|583361854|FG000|Overall Study|Use of prohibited concomitant drug|1|||
161538847|NCT05007392|583361855|FG001|Overall Study|Use of prohibited concomitant drug|1|||
161538848|NCT05007392|583361854|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
161538849|NCT05007392|583361855|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
161538850|NCT05007392|583361854|FG000|Overall Study|Adverse Event|10|||
161538851|NCT05007392|583361855|FG001|Overall Study|Adverse Event|6|||
161538852|NCT05007392|583361854|FG000|Overall Study|Participant choice|5|||
161538853|NCT05007392|583361855|FG001|Overall Study|Participant choice|10|||
161538854|NCT05007392|583361854|FG000|Overall Study|Withdrawal of consent|5|||
161538855|NCT05007392|583361855|FG001|Overall Study|Withdrawal of consent|4|||
161538856|NCT02703922|583361856|FG000|Overall Study|Death|5|||
161538857|NCT02703922|583361857|FG001|Overall Study|Death|8|||
161538858|NCT02703922|583361856|FG000|Overall Study|Lost to Follow-up|10|||
161538859|NCT02703922|583361857|FG001|Overall Study|Lost to Follow-up|10|||
161538860|NCT05805657|583361862|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
161538861|NCT05805657|583361863|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
161538862|NCT04058353|583361864|FG000|Overall Study|Adverse Event|2|||
161538863|NCT04058353|583361865|FG001|Overall Study|Adverse Event|1|||
161538864|NCT04058353|583361864|FG000|Overall Study|Physician Decision|1|||
161538865|NCT04058353|583361865|FG001|Overall Study|Physician Decision|0|||
161538866|NCT04058353|583361864|FG000|Overall Study|Other|1|||
161538867|NCT04058353|583361865|FG001|Overall Study|Other|0|||
161538868|NCT00316173|583361869|FG000|Run-in Phase|Adverse Event|1|||
161538869|NCT00316173|583361870|FG001|Run-in Phase|Adverse Event|0|||
161538870|NCT00316173|583361869|FG000|Run-in Phase|Protocol Violation|1|||
161538871|NCT00316173|583361870|FG001|Run-in Phase|Protocol Violation|0|||
161538872|NCT00316173|583361869|FG000|Run-in Phase|Study Follow-up Stopped|5|||
161538873|NCT00316173|583361870|FG001|Run-in Phase|Study Follow-up Stopped|0|||
161538874|NCT00316173|583361869|FG000|Treatment Phase|Adverse Event|0|||
161538875|NCT00316173|583361870|FG001|Treatment Phase|Adverse Event|1|||
161538876|NCT00316173|583361869|FG000|Treatment Phase|Lack of Efficacy|0|||
161538877|NCT00316173|583361870|FG001|Treatment Phase|Lack of Efficacy|3|||
161538878|NCT00316173|583361869|FG000|Treatment Phase|Lost to Follow-up|0|||
161538879|NCT00316173|583361870|FG001|Treatment Phase|Lost to Follow-up|3|||
161538880|NCT00316173|583361869|FG000|Treatment Phase|Withdrawal by Subject|0|||
161538881|NCT00316173|583361870|FG001|Treatment Phase|Withdrawal by Subject|1|||
161538882|NCT00316173|583361869|FG000|Treatment Phase|Study Follow-up Stopped|0|||
161538883|NCT00316173|583361870|FG001|Treatment Phase|Study Follow-up Stopped|34|||
161538884|NCT02390531|583361871|FG000|Overall Study|Death|0|||
161538885|NCT02390531|583361872|FG001|Overall Study|Death|2|||
161538886|NCT02390531|583361873|FG002|Overall Study|Death|0|||
161538887|NCT02390531|583361874|FG003|Overall Study|Death|1|||
161538888|NCT02390531|583361875|FG004|Overall Study|Death|0|||
161538889|NCT02390531|583361876|FG005|Overall Study|Death|0|||
161538890|NCT02390531|583361877|FG006|Overall Study|Death|0|||
161538891|NCT02390531|583361878|FG007|Overall Study|Death|1|||
161538892|NCT02390531|583361871|FG000|Overall Study|Protocol Violation|0|||
161538893|NCT02390531|583361872|FG001|Overall Study|Protocol Violation|0|||
161538894|NCT02390531|583361873|FG002|Overall Study|Protocol Violation|0|||
161538895|NCT02390531|583361874|FG003|Overall Study|Protocol Violation|0|||
161538896|NCT02390531|583361875|FG004|Overall Study|Protocol Violation|1|||
161538897|NCT02390531|583361876|FG005|Overall Study|Protocol Violation|0|||
161538898|NCT02390531|583361877|FG006|Overall Study|Protocol Violation|2|||
161538899|NCT02390531|583361878|FG007|Overall Study|Protocol Violation|0|||
161538900|NCT01951638|583361882|FG000|Treatment Period|Protocol Violation|0|||
161538901|NCT01951638|583361883|FG001|Treatment Period|Protocol Violation|0|||
161538902|NCT01951638|583361884|FG002|Treatment Period|Protocol Violation|0|||
161538903|NCT01951638|583361885|FG003|Treatment Period|Protocol Violation|2|||
161538904|NCT01951638|583361886|FG004|Treatment Period|Protocol Violation|0|||
161538905|NCT01951638|583361882|FG000|Treatment Period|Protocol-driven decision point|1|||
161538906|NCT01951638|583361883|FG001|Treatment Period|Protocol-driven decision point|3|||
161538907|NCT01951638|583361884|FG002|Treatment Period|Protocol-driven decision point|0|||
161592437|NCT05116787|583558692|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
161592438|NCT05116787|583558691|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
161538908|NCT01951638|583361885|FG003|Treatment Period|Protocol-driven decision point|0|||
161538909|NCT01951638|583361886|FG004|Treatment Period|Protocol-driven decision point|0|||
161538910|NCT01951638|583361882|FG000|Treatment Period|Logistical difficulties|0|||
161538911|NCT01951638|583361883|FG001|Treatment Period|Logistical difficulties|1|||
161538912|NCT01951638|583361884|FG002|Treatment Period|Logistical difficulties|1|||
161538913|NCT01951638|583361885|FG003|Treatment Period|Logistical difficulties|0|||
161538914|NCT01951638|583361886|FG004|Treatment Period|Logistical difficulties|0|||
161538915|NCT01951638|583361882|FG000|Treatment Period|Withdrawal by Subject|9|||
161538916|NCT01951638|583361883|FG001|Treatment Period|Withdrawal by Subject|6|||
161538917|NCT01951638|583361884|FG002|Treatment Period|Withdrawal by Subject|4|||
161538918|NCT01951638|583361885|FG003|Treatment Period|Withdrawal by Subject|5|||
161538919|NCT01951638|583361886|FG004|Treatment Period|Withdrawal by Subject|4|||
161538920|NCT01951638|583361882|FG000|Treatment Period|Death|0|||
161538921|NCT01951638|583361883|FG001|Treatment Period|Death|0|||
161538922|NCT01951638|583361884|FG002|Treatment Period|Death|0|||
161538923|NCT01951638|583361885|FG003|Treatment Period|Death|3|||
161538924|NCT01951638|583361886|FG004|Treatment Period|Death|1|||
161538925|NCT01951638|583361882|FG000|Treatment Period|Adverse Event|3|||
161538926|NCT01951638|583361883|FG001|Treatment Period|Adverse Event|4|||
161538927|NCT01951638|583361884|FG002|Treatment Period|Adverse Event|8|||
161538928|NCT01951638|583361885|FG003|Treatment Period|Adverse Event|6|||
161538929|NCT01951638|583361886|FG004|Treatment Period|Adverse Event|5|||
161538930|NCT01951638|583361882|FG000|Follow-up Period|Protocol Violation|0|||
161538931|NCT01951638|583361883|FG001|Follow-up Period|Protocol Violation|0|||
161538932|NCT01951638|583361884|FG002|Follow-up Period|Protocol Violation|0|||
161538933|NCT01951638|583361885|FG003|Follow-up Period|Protocol Violation|1|||
161538934|NCT01951638|583361886|FG004|Follow-up Period|Protocol Violation|0|||
161538935|NCT01951638|583361882|FG000|Follow-up Period|Logistical difficulties|0|||
161538936|NCT01951638|583361883|FG001|Follow-up Period|Logistical difficulties|2|||
161538937|NCT01951638|583361884|FG002|Follow-up Period|Logistical difficulties|0|||
161538938|NCT01951638|583361885|FG003|Follow-up Period|Logistical difficulties|0|||
161538939|NCT01951638|583361886|FG004|Follow-up Period|Logistical difficulties|1|||
161538940|NCT01951638|583361882|FG000|Follow-up Period|Withdrawal by Subject|1|||
161538941|NCT01951638|583361883|FG001|Follow-up Period|Withdrawal by Subject|5|||
161538942|NCT01951638|583361884|FG002|Follow-up Period|Withdrawal by Subject|2|||
161538943|NCT01951638|583361885|FG003|Follow-up Period|Withdrawal by Subject|1|||
161538944|NCT01951638|583361886|FG004|Follow-up Period|Withdrawal by Subject|2|||
161538945|NCT01951638|583361882|FG000|Follow-up Period|Lost to Follow-up|0|||
161538946|NCT01951638|583361883|FG001|Follow-up Period|Lost to Follow-up|1|||
161538947|NCT01951638|583361884|FG002|Follow-up Period|Lost to Follow-up|0|||
161538948|NCT01951638|583361885|FG003|Follow-up Period|Lost to Follow-up|1|||
161538949|NCT01951638|583361886|FG004|Follow-up Period|Lost to Follow-up|0|||
161538950|NCT01951638|583361882|FG000|Follow-up Period|Death|1|||
161538951|NCT01951638|583361883|FG001|Follow-up Period|Death|0|||
161538952|NCT01951638|583361884|FG002|Follow-up Period|Death|1|||
161538953|NCT01951638|583361885|FG003|Follow-up Period|Death|4|||
161538954|NCT01951638|583361886|FG004|Follow-up Period|Death|1|||
161538955|NCT01951638|583361882|FG000|Follow-up Period|Adverse Event|0|||
161538956|NCT01951638|583361883|FG001|Follow-up Period|Adverse Event|1|||
161538957|NCT01951638|583361884|FG002|Follow-up Period|Adverse Event|2|||
161538958|NCT01951638|583361885|FG003|Follow-up Period|Adverse Event|1|||
161538959|NCT01951638|583361886|FG004|Follow-up Period|Adverse Event|1|||
161538960|NCT03764072|583361887|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
161538961|NCT03764072|583361888|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
161538962|NCT03764072|583361889|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161538963|NCT03764072|583361890|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
161538964|NCT03764072|583361891|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
161538965|NCT03764072|583361892|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
161538966|NCT03764072|583361887|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
161538967|NCT03764072|583361888|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
161538968|NCT03764072|583361889|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
161538969|NCT03764072|583361890|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
161538970|NCT03764072|583361891|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
161538971|NCT03764072|583361892|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
161538972|NCT03764072|583361887|FG000|Overall Study|Lost to Follow-up|0|||
161538973|NCT03764072|583361888|FG001|Overall Study|Lost to Follow-up|0|||
161538974|NCT03764072|583361889|FG002|Overall Study|Lost to Follow-up|0|||
161538975|NCT03764072|583361890|FG003|Overall Study|Lost to Follow-up|0|||
161538976|NCT03764072|583361891|FG004|Overall Study|Lost to Follow-up|1|||
161538977|NCT03764072|583361892|FG005|Overall Study|Lost to Follow-up|0|||
161538978|NCT00552084|583361893|FG000|Overall Study|Adverse Event|2|||
161538979|NCT00552084|583361894|FG001|Overall Study|Adverse Event|3|||
161538980|NCT00552084|583361893|FG000|Overall Study|Withdrawal by Subject|4|||
161538981|NCT00552084|583361894|FG001|Overall Study|Withdrawal by Subject|5|||
161538982|NCT00552084|583361893|FG000|Overall Study|Protocol Violation|1|||
161538983|NCT00552084|583361894|FG001|Overall Study|Protocol Violation|0|||
161538984|NCT00552084|583361893|FG000|Overall Study|change in anti-arrythmic drug|1|||
161538985|NCT00552084|583361894|FG001|Overall Study|change in anti-arrythmic drug|1|||
161829396|NCT00892281|584415775|FG000|Overall Study|Protocol Violation|7|||
161538986|NCT01338025|583361895|FG000|Overall Study|Unexpected closure of study|10|||
161538987|NCT01338025|583361896|FG001|Overall Study|Unexpected closure of study|9|||
161538988|NCT01338025|583361895|FG000|Overall Study|Withdrawal by Subject|0|||
161538989|NCT01338025|583361896|FG001|Overall Study|Withdrawal by Subject|2|||
161538990|NCT01338025|583361895|FG000|Overall Study|Found ineligible after starting|1|||
161538991|NCT01338025|583361896|FG001|Overall Study|Found ineligible after starting|0|||
161538992|NCT03188055|583361897|FG000|Overall Study|Unavailable for training|0|||
161538993|NCT03188055|583361898|FG001|Overall Study|Unavailable for training|0|||
161538994|NCT03188055|583361899|FG002|Overall Study|Unavailable for training|19|||
161538995|NCT03188055|583361900|FG003|Overall Study|Unavailable for training|0|||
161538996|NCT03188055|583361901|FG004|Overall Study|Unavailable for training|0|||
161538997|NCT03188055|583361902|FG005|Overall Study|Unavailable for training|0|||
161538998|NCT03188055|583361897|FG000|Overall Study|Lost to Follow-up|0|||
161538999|NCT03188055|583361898|FG001|Overall Study|Lost to Follow-up|18|||
161539000|NCT03188055|583361899|FG002|Overall Study|Lost to Follow-up|0|||
161539001|NCT03188055|583361900|FG003|Overall Study|Lost to Follow-up|11|||
161539002|NCT03188055|583361901|FG004|Overall Study|Lost to Follow-up|0|||
161539003|NCT03188055|583361902|FG005|Overall Study|Lost to Follow-up|0|||
161539004|NCT03188055|583361897|FG000|Overall Study|Withdrawal by Subject|0|||
161539005|NCT03188055|583361898|FG001|Overall Study|Withdrawal by Subject|1|||
161539006|NCT03188055|583361899|FG002|Overall Study|Withdrawal by Subject|0|||
161539007|NCT03188055|583361900|FG003|Overall Study|Withdrawal by Subject|1|||
161539008|NCT03188055|583361901|FG004|Overall Study|Withdrawal by Subject|0|||
161539009|NCT03188055|583361902|FG005|Overall Study|Withdrawal by Subject|0|||
161539010|NCT03657277|583361903|FG000|Overall Study|Physician Decision|2|||
161539011|NCT03657277|583361903|FG000|Overall Study|Lost to Follow-up|1|||
161539012|NCT03657277|583361903|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
161539013|NCT01024608|583361906|FG000|Overall Study|Adverse Event|1|||
161539014|NCT01024608|583361907|FG001|Overall Study|Adverse Event|0|||
161539015|NCT01024608|583361906|FG000|Overall Study|Withdrawal by Subject|1|||
161539016|NCT01024608|583361907|FG001|Overall Study|Withdrawal by Subject|0|||
161539017|NCT01024608|583361906|FG000|Overall Study|Lost to Follow-up|0|||
161539018|NCT01024608|583361907|FG001|Overall Study|Lost to Follow-up|1|||
161539019|NCT01024608|583361906|FG000|Overall Study|Protocol Violation|0|||
161539020|NCT01024608|583361907|FG001|Overall Study|Protocol Violation|3|||
161539021|NCT01024608|583361906|FG000|Overall Study|Never received study treatment|2|||
161539022|NCT01024608|583361907|FG001|Overall Study|Never received study treatment|0|||
161539023|NCT04349280|583361908|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
161539024|NCT04349280|583361909|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
161539025|NCT04349280|583361908|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
161539026|NCT04349280|583361909|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
161539027|NCT04349280|583361908|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
161539028|NCT04349280|583361909|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
161539029|NCT02286089|583361910|FG000|Overall Study|Ongoing in Study|1|||
161539030|NCT02286089|583361911|FG001|Overall Study|Ongoing in Study|1|||
161539031|NCT02286089|583361912|FG002|Overall Study|Ongoing in Study|4|||
161539032|NCT02286089|583361913|FG003|Overall Study|Ongoing in Study|10|||
161539033|NCT02286089|583361910|FG000|Overall Study|Withdrawal by Subject|0|||
161539034|NCT02286089|583361911|FG001|Overall Study|Withdrawal by Subject|0|||
161539035|NCT02286089|583361912|FG002|Overall Study|Withdrawal by Subject|2|||
161539036|NCT02286089|583361913|FG003|Overall Study|Withdrawal by Subject|2|||
161539037|NCT00657618|583361916|FG000|Overall Study|Adverse Event|32|||
161539038|NCT00657618|583361916|FG000|Overall Study|Withdrawal by Subject|8|||
161539039|NCT00657618|583361916|FG000|Overall Study|negative for leishmaniasis|2|||
161539040|NCT00657618|583361916|FG000|Overall Study|didn't start due to schedule conflicts|1|||
161539041|NCT00045708|583363232|FG000|Phase 1|early progressive disease|0|||
161539042|NCT00045708|583363233|FG001|Phase 1|early progressive disease|1|||
161539043|NCT00045708|583363234|FG002|Phase 1|early progressive disease|0|||
161539044|NCT00685945|583363236|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
161539045|NCT00847405|583363238|FG000|First Intervention|Adverse Event|0|||
161539046|NCT00847405|583363239|FG001|First Intervention|Adverse Event|1|||
161539047|NCT00847405|583363238|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161539048|NCT00847405|583363239|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161539049|NCT01728792|583363240|FG000|Overall Study|Withdrawal of Consent|1|||
161539050|NCT01728792|583363241|FG001|Overall Study|Withdrawal of Consent|1|||
161539051|NCT01728792|583363242|FG002|Overall Study|Withdrawal of Consent|0|||
161539052|NCT01728792|583363243|FG003|Overall Study|Withdrawal of Consent|1|||
161539053|NCT01728792|583363244|FG004|Overall Study|Withdrawal of Consent|0|||
161539054|NCT01728792|583363240|FG000|Overall Study|Lost to Follow-up|2|||
161539055|NCT01728792|583363241|FG001|Overall Study|Lost to Follow-up|1|||
161539056|NCT01728792|583363242|FG002|Overall Study|Lost to Follow-up|4|||
161539057|NCT01728792|583363243|FG003|Overall Study|Lost to Follow-up|2|||
161539058|NCT01728792|583363244|FG004|Overall Study|Lost to Follow-up|0|||
161539059|NCT04277455|583363245|FG000|Overall Study|Lost to Follow-up|1|||
161539060|NCT04791761|583363247|FG000|Overall Study|Lost to Follow-up|8|||
161539061|NCT04791761|583363248|FG001|Overall Study|Lost to Follow-up|6|||
161539062|NCT04791761|583363249|FG002|Overall Study|Lost to Follow-up|10|||
161539063|NCT04791761|583363247|FG000|Overall Study|Withdrawal by Subject|0|||
161539064|NCT04791761|583363248|FG001|Overall Study|Withdrawal by Subject|1|||
161539065|NCT04791761|583363249|FG002|Overall Study|Withdrawal by Subject|1|||
161539066|NCT04791761|583363247|FG000|Overall Study|Protocol Violation|0|||
161539067|NCT04791761|583363248|FG001|Overall Study|Protocol Violation|1|||
161539068|NCT04791761|583363249|FG002|Overall Study|Protocol Violation|1|||
161539069|NCT04669600|583363250|FG000|Overall Study|Withdrawal by Subject|1|||
161539070|NCT04669600|583363250|FG000|Overall Study|Other|6|||
161539071|NCT02487498|583363253|FG000|Period: Period 1|Adverse Event|2|||
161539072|NCT02487498|583363254|FG001|Period: Period 1|Adverse Event|4|||
161539073|NCT02487498|583363253|FG000|Period: Period 1|Subject/guardian decision|2|||
161539074|NCT02487498|583363254|FG001|Period: Period 1|Subject/guardian decision|4|||
161539075|NCT02487498|583363253|FG000|Period: Period 1|Lost to Follow-up|0|||
161539076|NCT02487498|583363254|FG001|Period: Period 1|Lost to Follow-up|2|||
161539077|NCT02487498|583363253|FG000|Period: Period 1|Lack of Efficacy|1|||
161539078|NCT02487498|583363254|FG001|Period: Period 1|Lack of Efficacy|0|||
161539079|NCT02487498|583363253|FG000|Period: Period 1|Physician Decision|0|||
161539080|NCT02487498|583363254|FG001|Period: Period 1|Physician Decision|1|||
161539081|NCT02487498|583363253|FG000|Period: Period 1|Protocol deviation|1|||
161539082|NCT02487498|583363254|FG001|Period: Period 1|Protocol deviation|0|||
161539083|NCT02487498|583363253|FG000|Period: Washout|Subject/guardian decision|0|||
161539084|NCT02487498|583363254|FG001|Period: Washout|Subject/guardian decision|5|||
161539085|NCT02487498|583363253|FG000|Period: Washout|Lack of Efficacy|1|||
161539086|NCT02487498|583363254|FG001|Period: Washout|Lack of Efficacy|1|||
161539087|NCT02487498|583363253|FG000|Period: Washout|Physician Decision|1|||
161539088|NCT02487498|583363254|FG001|Period: Washout|Physician Decision|0|||
161539089|NCT02487498|583363253|FG000|Period: Washout|Non-compliance with study treatment|0|||
161539090|NCT02487498|583363254|FG001|Period: Washout|Non-compliance with study treatment|1|||
161539091|NCT02487498|583363253|FG000|Period: Period 2|Adverse Event|2|||
161539092|NCT02487498|583363254|FG001|Period: Period 2|Adverse Event|2|||
161539093|NCT02487498|583363253|FG000|Period: Period 2|Subject/guardian decision|2|||
161539094|NCT02487498|583363254|FG001|Period: Period 2|Subject/guardian decision|1|||
161539095|NCT02487498|583363253|FG000|Period: Period 2|Lost to Follow-up|1|||
161539096|NCT02487498|583363254|FG001|Period: Period 2|Lost to Follow-up|1|||
161539097|NCT02487498|583363253|FG000|Period: Period 2|Death|0|||
161539098|NCT02487498|583363254|FG001|Period: Period 2|Death|1|||
161539099|NCT02487498|583363253|FG000|Period: Period 2|Physician Decision|1|||
161539100|NCT02487498|583363254|FG001|Period: Period 2|Physician Decision|0|||
161539101|NCT00676130|583363261|FG000|Overall Study|Lost to Follow-up|0|||
161539102|NCT00676130|583363262|FG001|Overall Study|Lost to Follow-up|1|||
161539103|NCT00676130|583363261|FG000|Overall Study|Found ineligible|3|||
161539104|NCT00676130|583363262|FG001|Overall Study|Found ineligible|2|||
161539105|NCT00676130|583363261|FG000|Overall Study|Withdrawal by Subject|0|||
161539106|NCT00676130|583363262|FG001|Overall Study|Withdrawal by Subject|1|||
161539107|NCT01564368|583363263|FG000|Overall Study|Ineligible|18|||
161539108|NCT01564368|583363263|FG000|Overall Study|Not Randomized in Parent study|116|||
161829397|NCT00892281|584415776|FG001|Overall Study|Protocol Violation|2|||
161539109|NCT01564368|583363263|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
161539110|NCT01564368|583363263|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
161539111|NCT01802437|583363267|FG000|Overall Study|Lost to Follow-up|1|||
161539112|NCT01802437|583363268|FG001|Overall Study|Lost to Follow-up|0|||
161539113|NCT01802437|583363267|FG000|Overall Study|Withdrawal by Subject|3|||
161539114|NCT01802437|583363268|FG001|Overall Study|Withdrawal by Subject|4|||
161539115|NCT04857034|583363274|FG000|Placebo-Controlled Period|Request to discontinue|2|||
161539116|NCT04857034|583363275|FG001|Placebo-Controlled Period|Request to discontinue|2|||
161539117|NCT04857034|583363276|FG002|Placebo-Controlled Period|Request to discontinue|0|||
161539118|NCT04857034|583363277|FG003|Placebo-Controlled Period|Request to discontinue|0|||
161539119|NCT04857034|583363278|FG004|Placebo-Controlled Period|Request to discontinue|0|||
161539120|NCT04857034|583363274|FG000|Placebo-Controlled Period|withdrew consent|1|||
161539121|NCT04857034|583363275|FG001|Placebo-Controlled Period|withdrew consent|1|||
161539122|NCT04857034|583363276|FG002|Placebo-Controlled Period|withdrew consent|2|||
161539123|NCT04857034|583363277|FG003|Placebo-Controlled Period|withdrew consent|0|||
161539124|NCT04857034|583363278|FG004|Placebo-Controlled Period|withdrew consent|0|||
161539125|NCT04857034|583363274|FG000|Placebo-Controlled Period|Pregnancy|1|||
161539126|NCT04857034|583363275|FG001|Placebo-Controlled Period|Pregnancy|1|||
161539127|NCT04857034|583363276|FG002|Placebo-Controlled Period|Pregnancy|0|||
161539128|NCT04857034|583363277|FG003|Placebo-Controlled Period|Pregnancy|0|||
161539129|NCT04857034|583363278|FG004|Placebo-Controlled Period|Pregnancy|0|||
161539130|NCT04857034|583363274|FG000|Placebo-Controlled Period|Ongoing study period|0|||
161539131|NCT04857034|583363275|FG001|Placebo-Controlled Period|Ongoing study period|1|||
161539132|NCT04857034|583363276|FG002|Placebo-Controlled Period|Ongoing study period|0|||
161539133|NCT04857034|583363277|FG003|Placebo-Controlled Period|Ongoing study period|0|||
161539134|NCT04857034|583363278|FG004|Placebo-Controlled Period|Ongoing study period|0|||
161539135|NCT04857034|583363274|FG000|Active Treatment Period|Lack of Efficacy|1|||
161539136|NCT04857034|583363275|FG001|Active Treatment Period|Lack of Efficacy|0|||
161539137|NCT04857034|583363276|FG002|Active Treatment Period|Lack of Efficacy|0|||
161539138|NCT04857034|583363277|FG003|Active Treatment Period|Lack of Efficacy|0|||
161539139|NCT04857034|583363278|FG004|Active Treatment Period|Lack of Efficacy|0|||
161539140|NCT04857034|583363274|FG000|Active Treatment Period|request to discontinue|0|||
161539141|NCT04857034|583363275|FG001|Active Treatment Period|request to discontinue|1|||
161539142|NCT04857034|583363276|FG002|Active Treatment Period|request to discontinue|0|||
161539143|NCT04857034|583363277|FG003|Active Treatment Period|request to discontinue|1|||
161539144|NCT04857034|583363278|FG004|Active Treatment Period|request to discontinue|0|||
161539145|NCT04857034|583363274|FG000|Active Treatment Period|administrative reason by sponsor|1|||
161539146|NCT04857034|583363275|FG001|Active Treatment Period|administrative reason by sponsor|5|||
161539147|NCT04857034|583363276|FG002|Active Treatment Period|administrative reason by sponsor|0|||
161539148|NCT04857034|583363277|FG003|Active Treatment Period|administrative reason by sponsor|2|||
161539149|NCT04857034|583363278|FG004|Active Treatment Period|administrative reason by sponsor|2|||
161539150|NCT04857034|583363274|FG000|Active Treatment Period|other reasons|1|||
161539151|NCT04857034|583363275|FG001|Active Treatment Period|other reasons|1|||
161539152|NCT04857034|583363276|FG002|Active Treatment Period|other reasons|0|||
161539153|NCT04857034|583363277|FG003|Active Treatment Period|other reasons|0|||
161539154|NCT04857034|583363278|FG004|Active Treatment Period|other reasons|1|||
161539155|NCT04857034|583363274|FG000|Active Treatment Period|Ongoing Study Period|2|||
161539156|NCT04857034|583363275|FG001|Active Treatment Period|Ongoing Study Period|4|||
161539157|NCT04857034|583363276|FG002|Active Treatment Period|Ongoing Study Period|0|||
161539158|NCT04857034|583363277|FG003|Active Treatment Period|Ongoing Study Period|1|||
161539159|NCT04857034|583363278|FG004|Active Treatment Period|Ongoing Study Period|0|||
161539160|NCT02940574|583363279|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
161539161|NCT02940574|583363280|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
161539162|NCT02940574|583363279|FG000|1-year Follow-up|Lost to Follow-up|3|||
161539163|NCT02940574|583363280|FG001|1-year Follow-up|Lost to Follow-up|4|||
161539164|NCT00520975|583363281|FG000|Overall Study|Disease progression|31|||
161539165|NCT00520975|583363282|FG001|Overall Study|Disease progression|23|||
161539166|NCT00520975|583363281|FG000|Overall Study|Adverse Event|7|||
161539167|NCT00520975|583363282|FG001|Overall Study|Adverse Event|10|||
161539168|NCT00520975|583363281|FG000|Overall Study|Death|0|||
161539169|NCT00520975|583363282|FG001|Overall Study|Death|2|||
161539170|NCT00520975|583363281|FG000|Overall Study|Withdrawal by Subject|3|||
161539171|NCT00520975|583363282|FG001|Overall Study|Withdrawal by Subject|5|||
161539172|NCT00520975|583363281|FG000|Overall Study|Other therapy|2|||
161539173|NCT00520975|583363282|FG001|Overall Study|Other therapy|4|||
161539174|NCT00520975|583363281|FG000|Overall Study|Other reasons|4|||
161539175|NCT00520975|583363282|FG001|Overall Study|Other reasons|2|||
161539176|NCT00520975|583363281|FG000|Overall Study|Not start protocol therapy|1|||
161539177|NCT00520975|583363282|FG001|Overall Study|Not start protocol therapy|2|||
161539178|NCT04810221|583363283|FG000|Overall Study|Physician Decision|3|||
161539179|NCT01682213|583363286|FG000|Overall Study|Withdrawal by Subject|2|||
161539180|NCT01181726|583363287|FG000|First Intervention|Adverse Event|1|||
161539181|NCT01181726|583363288|FG001|First Intervention|Adverse Event|0|||
161539182|NCT01264380|583363289|FG000|Period C|Disease Progression|0|||
161539183|NCT01264380|583363290|FG001|Period C|Disease Progression|0|||
161539184|NCT01264380|583363291|FG002|Period C|Disease Progression|4|||
161539185|NCT01264380|583363289|FG000|Period C|Death|0|||
161539186|NCT01264380|583363290|FG001|Period C|Death|0|||
161539187|NCT01264380|583363291|FG002|Period C|Death|2|||
161539188|NCT01264380|583363289|FG000|Period C|Follow-up for survival status|0|||
161539189|NCT01264380|583363290|FG001|Period C|Follow-up for survival status|0|||
161539190|NCT01264380|583363291|FG002|Period C|Follow-up for survival status|6|||
161539191|NCT01264380|583363289|FG000|Period C|Withdrawal by Subject|0|||
161539192|NCT01264380|583363290|FG001|Period C|Withdrawal by Subject|0|||
161539193|NCT01264380|583363291|FG002|Period C|Withdrawal by Subject|1|||
161539194|NCT01264380|583363289|FG000|Period C|Adverse Event|0|||
161539195|NCT01264380|583363290|FG001|Period C|Adverse Event|0|||
161539196|NCT01264380|583363291|FG002|Period C|Adverse Event|1|||
161539197|NCT04382924|583363293|FG000|Overall Study|Death|2|||
161539198|NCT04382924|583363294|FG001|Overall Study|Death|5|||
161539199|NCT04382924|583363295|FG002|Overall Study|Death|4|||
161539200|NCT04382924|583363293|FG000|Overall Study|Protocol Violation|0|||
161539201|NCT04382924|583363294|FG001|Overall Study|Protocol Violation|1|||
161539202|NCT04382924|583363295|FG002|Overall Study|Protocol Violation|1|||
161539203|NCT04382924|583363293|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
161539204|NCT04382924|583363294|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
161539205|NCT04382924|583363295|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
161539206|NCT04382924|583363293|FG000|Overall Study|Withdrawal by Subject|6|||
161539207|NCT04382924|583363294|FG001|Overall Study|Withdrawal by Subject|3|||
161539208|NCT04382924|583363295|FG002|Overall Study|Withdrawal by Subject|6|||
161539209|NCT04998604|583363296|FG000|Overall Study|Adverse Event|3|||
161539210|NCT04998604|583363297|FG001|Overall Study|Adverse Event|2|||
161539211|NCT04998604|583363296|FG000|Overall Study|Withdrawal by Subject|2|||
161539212|NCT04998604|583363297|FG001|Overall Study|Withdrawal by Subject|4|||
161539213|NCT04998604|583363296|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
161539214|NCT04998604|583363297|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
161539215|NCT00642902|583363300|FG000|Overall Study|Adverse Event|0|||
161539216|NCT00642902|583363301|FG001|Overall Study|Adverse Event|1|||
161539217|NCT00642902|583363302|FG002|Overall Study|Adverse Event|3|||
161539218|NCT00642902|583363303|FG003|Overall Study|Adverse Event|1|||
161539219|NCT00642902|583363300|FG000|Overall Study|Lost to Follow-up|1|||
161539220|NCT00642902|583363301|FG001|Overall Study|Lost to Follow-up|1|||
161539221|NCT00642902|583363302|FG002|Overall Study|Lost to Follow-up|0|||
161539222|NCT00642902|583363303|FG003|Overall Study|Lost to Follow-up|0|||
161539223|NCT00642902|583363300|FG000|Overall Study|Lack of Efficacy|0|||
161539224|NCT00642902|583363301|FG001|Overall Study|Lack of Efficacy|3|||
161539225|NCT00642902|583363302|FG002|Overall Study|Lack of Efficacy|3|||
161539226|NCT00642902|583363303|FG003|Overall Study|Lack of Efficacy|0|||
161539227|NCT00642902|583363300|FG000|Overall Study|Death|1|||
161539228|NCT00642902|583363301|FG001|Overall Study|Death|0|||
161539229|NCT00642902|583363302|FG002|Overall Study|Death|0|||
161539230|NCT00642902|583363303|FG003|Overall Study|Death|0|||
161539231|NCT00642902|583363300|FG000|Overall Study|Premature termination of clinical trial|37|||
161539232|NCT00642902|583363301|FG001|Overall Study|Premature termination of clinical trial|32|||
161539233|NCT00642902|583363302|FG002|Overall Study|Premature termination of clinical trial|35|||
161592439|NCT05116787|583558692|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
161592440|NCT02737436|583558693|FG000|Washout Period|Lost to Follow-up|5|||
161592441|NCT02737436|583558694|FG001|Washout Period|Lost to Follow-up|11|||
161592442|NCT02737436|583558693|FG000|Data Analysis|Scanning data problems|5|||
161592443|NCT02737436|583558694|FG001|Data Analysis|Scanning data problems|8|||
161592444|NCT03936322|583558695|FG000|Overall Study|Lost to Follow-up|1|||
161592445|NCT03936322|583558695|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
161592446|NCT02919683|583558697|FG000|Post-Surgery Follow-Up|Death|2|||
161592447|NCT02919683|583558698|FG001|Post-Surgery Follow-Up|Death|2|||
161592448|NCT02919683|583558697|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
161592449|NCT02919683|583558698|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
161592450|NCT01160211|583558699|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
161592451|NCT01160211|583558700|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
161592452|NCT01160211|583558701|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
161539234|NCT00642902|583363303|FG003|Overall Study|Premature termination of clinical trial|35|||
161539235|NCT00642902|583363300|FG000|Overall Study|Randomized, but not treated|0|||
161539236|NCT00642902|583363301|FG001|Overall Study|Randomized, but not treated|0|||
161539237|NCT00642902|583363302|FG002|Overall Study|Randomized, but not treated|1|||
161539238|NCT00642902|583363303|FG003|Overall Study|Randomized, but not treated|0|||
161539239|NCT00642902|583363300|FG000|Overall Study|Other|1|||
161539240|NCT00642902|583363301|FG001|Overall Study|Other|5|||
161539241|NCT00642902|583363302|FG002|Overall Study|Other|1|||
161539242|NCT00642902|583363303|FG003|Overall Study|Other|4|||
161539243|NCT03953898|583363304|FG000|Overall Study|Lack of Efficacy|8|||
161539244|NCT03953898|583363304|FG000|Overall Study|Death|3|||
161539245|NCT03953898|583363304|FG000|Overall Study|Withdrawal by Subject|2|||
161539246|NCT03953898|583363304|FG000|Overall Study|Adverse Event|1|||
161539247|NCT01226511|583363307|FG000|Acute Treatment Period|Adverse Event|7|||
161539248|NCT01226511|583363308|FG001|Acute Treatment Period|Adverse Event|6|||
161539249|NCT01226511|583363307|FG000|Acute Treatment Period|Lack of Efficacy|2|||
161539250|NCT01226511|583363308|FG001|Acute Treatment Period|Lack of Efficacy|1|||
161539251|NCT01226511|583363307|FG000|Acute Treatment Period|Lost to Follow-up|3|||
161539252|NCT01226511|583363308|FG001|Acute Treatment Period|Lost to Follow-up|6|||
161539253|NCT01226511|583363307|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
161539254|NCT01226511|583363308|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
161539255|NCT01226511|583363307|FG000|Acute Treatment Period|Protocol Violation|5|||
161539256|NCT01226511|583363308|FG001|Acute Treatment Period|Protocol Violation|5|||
161539257|NCT01226511|583363307|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
161539258|NCT01226511|583363308|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
161539259|NCT01226511|583363307|FG000|Extension Treatment Period|Adverse Event|8|||
161539260|NCT01226511|583363308|FG001|Extension Treatment Period|Adverse Event|8|||
161539261|NCT01226511|583363307|FG000|Extension Treatment Period|Lack of Efficacy|3|||
161539262|NCT01226511|583363308|FG001|Extension Treatment Period|Lack of Efficacy|2|||
161539263|NCT01226511|583363307|FG000|Extension Treatment Period|Lost to Follow-up|4|||
161539264|NCT01226511|583363308|FG001|Extension Treatment Period|Lost to Follow-up|3|||
161539265|NCT01226511|583363307|FG000|Extension Treatment Period|Protocol Violation|2|||
161539266|NCT01226511|583363308|FG001|Extension Treatment Period|Protocol Violation|2|||
161539267|NCT01226511|583363307|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
161539268|NCT01226511|583363308|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
161539269|NCT01226511|583363307|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
161539270|NCT01226511|583363308|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
161539271|NCT01226511|583363307|FG000|Extension Treatment Period|Sponsor Decision|1|||
161539272|NCT01226511|583363308|FG001|Extension Treatment Period|Sponsor Decision|1|||
161539273|NCT01226511|583363307|FG000|Taper Period|Adverse Event|1|||
161539274|NCT01226511|583363308|FG001|Taper Period|Adverse Event|0|||
161539275|NCT01226511|583363307|FG000|Taper Period|Lost to Follow-up|2|||
161539276|NCT01226511|583363308|FG001|Taper Period|Lost to Follow-up|2|||
161539277|NCT01226511|583363307|FG000|Taper Period|Protocol Violation|1|||
161539278|NCT01226511|583363308|FG001|Taper Period|Protocol Violation|0|||
161539279|NCT01226511|583363307|FG000|Taper Period|Parent/Caregiver Decision|1|||
161539280|NCT01226511|583363308|FG001|Taper Period|Parent/Caregiver Decision|1|||
161539281|NCT05267600|583363313|FG000|Overall Study|Adverse Event|1|||
161539282|NCT05267600|583363314|FG001|Overall Study|Adverse Event|4|||
161539283|NCT05267600|583363313|FG000|Overall Study|Death|1|||
161539284|NCT05267600|583363314|FG001|Overall Study|Death|2|||
161539285|NCT05267600|583363313|FG000|Overall Study|Lack of Efficacy|1|||
161539286|NCT05267600|583363314|FG001|Overall Study|Lack of Efficacy|2|||
161539287|NCT05267600|583363313|FG000|Overall Study|Lost to Follow-up|3|||
161539288|NCT05267600|583363314|FG001|Overall Study|Lost to Follow-up|0|||
161539289|NCT05267600|583363313|FG000|Overall Study|Physician Decision|4|||
161539290|NCT05267600|583363314|FG001|Overall Study|Physician Decision|0|||
161539291|NCT05267600|583363313|FG000|Overall Study|Treatment Unblinded|0|||
161539292|NCT05267600|583363314|FG001|Overall Study|Treatment Unblinded|1|||
161539293|NCT05267600|583363313|FG000|Overall Study|Withdrawal by Subject|5|||
161539294|NCT05267600|583363314|FG001|Overall Study|Withdrawal by Subject|4|||
161539295|NCT01520402|583363317|FG000|Overall Study|Withdrawal by Subject|2|||
161539296|NCT01520402|583363317|FG000|Overall Study|Physician Decision|3|||
161539297|NCT01722162|583363323|FG000|Overall Study|Withdrawal by Subject|1|||
161539298|NCT01722162|583363324|FG001|Overall Study|Withdrawal by Subject|1|||
161539299|NCT01722162|583363323|FG000|Overall Study|Found ineligible|1|||
161539300|NCT01722162|583363324|FG001|Overall Study|Found ineligible|0|||
161539301|NCT01722162|583363323|FG000|Overall Study|Unrelated to study adverse event|2|||
161539302|NCT01722162|583363324|FG001|Overall Study|Unrelated to study adverse event|2|||
161539303|NCT01722162|583363323|FG000|Overall Study|Adverse Event|1|||
161539304|NCT01722162|583363324|FG001|Overall Study|Adverse Event|1|||
161539305|NCT01722162|583363323|FG000|Overall Study|Insurance denial post enrollment|0|||
161539306|NCT01722162|583363324|FG001|Overall Study|Insurance denial post enrollment|1|||
161539307|NCT01722162|583363323|FG000|Overall Study|Noncompliance|0|||
161539308|NCT01722162|583363324|FG001|Overall Study|Noncompliance|1|||
161539309|NCT02133872|583363325|FG000|Overall Study|Withdrawal by Subject|5|||
161539310|NCT02133872|583363326|FG001|Overall Study|Withdrawal by Subject|3|||
161539311|NCT02133872|583363327|FG002|Overall Study|Withdrawal by Subject|0|||
161539312|NCT02923739|583363328|FG000|Overall Study|Withdrawal by Subject|2|||
161539313|NCT02923739|583363329|FG001|Overall Study|Withdrawal by Subject|0|||
161539314|NCT02923739|583363330|FG002|Overall Study|Withdrawal by Subject|0|||
161539315|NCT02923739|583363331|FG003|Overall Study|Withdrawal by Subject|0|||
161539316|NCT02923739|583363328|FG000|Overall Study|Failed Screening|3|||
161539317|NCT02923739|583363329|FG001|Overall Study|Failed Screening|0|||
161539318|NCT02923739|583363330|FG002|Overall Study|Failed Screening|0|||
161539319|NCT02923739|583363331|FG003|Overall Study|Failed Screening|0|||
161539320|NCT00948974|583363334|FG000|Overall Study|Lost to Follow-up|23|||
161539321|NCT00948974|583363335|FG001|Overall Study|Lost to Follow-up|20|||
161539322|NCT02487810|583363336|FG000|Overall Study|Withdrawal by Subject|1|||
161539323|NCT02487810|583363337|FG001|Overall Study|Withdrawal by Subject|0|||
161539324|NCT01972529|583363338|FG000|Overall Study|Adverse Event|0|||
161539325|NCT01972529|583363339|FG001|Overall Study|Adverse Event|1|||
161539326|NCT01972529|583363340|FG002|Overall Study|Adverse Event|0|||
161539327|NCT01972529|583363341|FG003|Overall Study|Adverse Event|0|||
161539328|NCT01972529|583363338|FG000|Overall Study|Lost to Follow-up|1|||
161539329|NCT01972529|583363339|FG001|Overall Study|Lost to Follow-up|0|||
161539330|NCT01972529|583363340|FG002|Overall Study|Lost to Follow-up|0|||
161539331|NCT01972529|583363341|FG003|Overall Study|Lost to Follow-up|0|||
161539332|NCT01972529|583363338|FG000|Overall Study|Participant Choice|0|||
161539333|NCT01972529|583363339|FG001|Overall Study|Participant Choice|1|||
161539334|NCT01972529|583363340|FG002|Overall Study|Participant Choice|0|||
161539335|NCT01972529|583363341|FG003|Overall Study|Participant Choice|0|||
161539336|NCT01972529|583363338|FG000|Overall Study|Withdrawl of Consent|1|||
161539337|NCT01972529|583363339|FG001|Overall Study|Withdrawl of Consent|2|||
161539338|NCT01972529|583363340|FG002|Overall Study|Withdrawl of Consent|0|||
161539339|NCT01972529|583363341|FG003|Overall Study|Withdrawl of Consent|1|||
161539340|NCT01972529|583363338|FG000|Overall Study|Other|0|||
161539341|NCT01972529|583363339|FG001|Overall Study|Other|0|||
161539342|NCT01972529|583363340|FG002|Overall Study|Other|0|||
161539343|NCT01972529|583363341|FG003|Overall Study|Other|2|||
161539344|NCT01972529|583363338|FG000|Overall Study|Not treated|0|||
161539345|NCT01972529|583363339|FG001|Overall Study|Not treated|1|||
161539346|NCT01972529|583363340|FG002|Overall Study|Not treated|2|||
161539347|NCT01972529|583363341|FG003|Overall Study|Not treated|1|||
161539348|NCT01889186|583363342|FG000|Overall Study|Adverse event- not related to progression|18|||
161539349|NCT01889186|583363343|FG001|Overall Study|Adverse event- not related to progression|5|||
161539350|NCT01889186|583363342|FG000|Overall Study|Adverse event- related to progression|7|||
161539351|NCT01889186|583363343|FG001|Overall Study|Adverse event- related to progression|2|||
161539352|NCT01889186|583363342|FG000|Overall Study|COVID-19 logistical restrictions|1|||
161539353|NCT01889186|583363343|FG001|Overall Study|COVID-19 logistical restrictions|0|||
161539354|NCT01889186|583363342|FG000|Overall Study|Investigator request|1|||
161539355|NCT01889186|583363343|FG001|Overall Study|Investigator request|1|||
161539356|NCT01889186|583363342|FG000|Overall Study|Progressive disease- Richter's|12|||
161539357|NCT01889186|583363343|FG001|Overall Study|Progressive disease- Richter's|7|||
161539358|NCT01889186|583363342|FG000|Overall Study|Progressive disease per protocol|46|||
161539359|NCT01889186|583363343|FG001|Overall Study|Progressive disease per protocol|17|||
161539360|NCT01889186|583363342|FG000|Overall Study|Stem cell transplant|2|||
161539361|NCT01889186|583363343|FG001|Overall Study|Stem cell transplant|1|||
161539362|NCT01889186|583363342|FG000|Overall Study|Withdrew consent|2|||
161539363|NCT01889186|583363343|FG001|Overall Study|Withdrew consent|3|||
161539364|NCT01889186|583363342|FG000|Overall Study|Other, not specified|18|||
161539365|NCT01889186|583363343|FG001|Overall Study|Other, not specified|15|||
161539366|NCT00621543|583363346|FG000|Overall Study|Lost to Follow-up|23|||
161539367|NCT02755597|583363347|FG000|Overall Study|Withdrew consent|27|||
161539368|NCT02755597|583363348|FG001|Overall Study|Withdrew consent|11|||
161539369|NCT02755597|583363347|FG000|Overall Study|Lost to Follow-up|1|||
161539370|NCT02755597|583363348|FG001|Overall Study|Lost to Follow-up|0|||
161539371|NCT02755597|583363347|FG000|Overall Study|Death|78|||
161539372|NCT02755597|583363348|FG001|Overall Study|Death|36|||
161539373|NCT02755597|583363347|FG000|Overall Study|Study terminated by Sponsor|67|||
161539374|NCT02755597|583363348|FG001|Overall Study|Study terminated by Sponsor|47|||
161539375|NCT02755597|583363347|FG000|Overall Study|Other, not specified|20|||
161539376|NCT02755597|583363348|FG001|Overall Study|Other, not specified|3|||
161539377|NCT02755597|583363347|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
161539378|NCT02755597|583363348|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
161539379|NCT04252742|583363349|FG000|Overall Study|Decision by sponsor|0|||
161539380|NCT04252742|583363350|FG001|Overall Study|Decision by sponsor|2|||
161539381|NCT04252742|583363349|FG000|Overall Study|Withdrawal by Subject|15|||
161539382|NCT04252742|583363350|FG001|Overall Study|Withdrawal by Subject|9|||
161539383|NCT04252742|583363349|FG000|Overall Study|Lost to Follow-up|0|||
161539384|NCT04252742|583363350|FG001|Overall Study|Lost to Follow-up|1|||
161539385|NCT03759834|583363351|FG000|Overall Study|Withdrawal by Subject|1|||
161539386|NCT00031486|583363354|FG000|Overall Study|Adverse Event|1|||
161539387|NCT00031486|583363355|FG001|Overall Study|Adverse Event|0|||
161539388|NCT00031486|583363354|FG000|Overall Study|Lost to Follow-up|0|||
161539389|NCT00031486|583363355|FG001|Overall Study|Lost to Follow-up|1|||
161539390|NCT00031486|583363354|FG000|Overall Study|Withdrawal by Subject|3|||
161539391|NCT00031486|583363355|FG001|Overall Study|Withdrawal by Subject|2|||
161539392|NCT00031486|583363354|FG000|Overall Study|Death|0|||
161539393|NCT00031486|583363355|FG001|Overall Study|Death|3|||
161539394|NCT00031486|583363354|FG000|Overall Study|Non-compliant|0|||
161539395|NCT00031486|583363355|FG001|Overall Study|Non-compliant|4|||
161539396|NCT00031486|583363354|FG000|Overall Study|Did not meet eligibility requirement|2|||
161539397|NCT00031486|583363355|FG001|Overall Study|Did not meet eligibility requirement|1|||
161539398|NCT00031486|583363354|FG000|Overall Study|Other|1|||
161539399|NCT00031486|583363355|FG001|Overall Study|Other|1|||
161539400|NCT01685138|583363356|FG000|Overall Study|Lost to Follow-up|1|||
161539401|NCT01685138|583363356|FG000|Overall Study|Protocol Violation|1|||
161539402|NCT01685138|583363356|FG000|Overall Study|No longer requires treatment|1|||
161539403|NCT01685138|583363356|FG000|Overall Study|Subject/guardian decision|2|||
161539404|NCT01685138|583363356|FG000|Overall Study|Physician Decision|6|||
161539405|NCT01685138|583363356|FG000|Overall Study|Death|10|||
161539406|NCT01685138|583363356|FG000|Overall Study|Adverse Event|18|||
161539407|NCT01685138|583363356|FG000|Overall Study|Progressive disease|53|||
161539408|NCT00689026|583363359|FG000|Overall Study|Withdrawal by Subject|13|||
161539409|NCT00689026|583363360|FG001|Overall Study|Withdrawal by Subject|6|||
161539410|NCT03996291|583363365|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
161539411|NCT03996291|583363366|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
161539412|NCT03996291|583363367|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
161539413|NCT03996291|583363368|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
161539414|NCT03996291|583363369|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
161539415|NCT03996291|583363370|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
161539416|NCT03996291|583363371|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
161539417|NCT03996291|583363372|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
161539418|NCT03996291|583363365|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
161539419|NCT03996291|583363366|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
161539420|NCT03996291|583363367|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
161539421|NCT03996291|583363368|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
161539422|NCT03996291|583363369|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
161539423|NCT03996291|583363370|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
161539424|NCT03996291|583363371|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
161539425|NCT03996291|583363372|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
161539426|NCT03996291|583363365|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161539427|NCT03996291|583363366|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161539428|NCT03996291|583363367|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161539429|NCT03996291|583363368|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161539430|NCT03996291|583363369|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
161539431|NCT03996291|583363370|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161539432|NCT03996291|583363371|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
161539433|NCT03996291|583363372|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161539434|NCT03996291|583363365|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
161539435|NCT03996291|583363366|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
161539436|NCT03996291|583363367|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
161539437|NCT03996291|583363368|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
161539438|NCT03996291|583363369|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
161539439|NCT03996291|583363370|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
161539440|NCT03996291|583363371|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
161539441|NCT03996291|583363372|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
161539442|NCT03996291|583363365|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539443|NCT03996291|583363366|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539444|NCT03996291|583363367|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539445|NCT03996291|583363368|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539446|NCT03996291|583363369|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
161539447|NCT03996291|583363370|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539448|NCT03996291|583363371|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539449|NCT03996291|583363372|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
161539450|NCT01659151|583363375|FG000|Overall Study|Inadequate TIL growth|1|||
161539451|NCT05774197|583363376|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
161539452|NCT05073133|583363379|FG000|Overall Study|Death|2|||
161539453|NCT04981678|583363380|FG000|Overall Study|Lost to Follow-up|0|||
161539454|NCT04981678|583363381|FG001|Overall Study|Lost to Follow-up|1|||
161539455|NCT03779906|583363382|FG000|Overall Study|Lost to Follow-up|7|||
161539456|NCT03779906|583363382|FG000|Overall Study|COVID pandemic|1|||
161592453|NCT01160211|583558699|FG000|Overall Study|Lost to Follow-up|4|||
161829398|NCT00892281|584415775|FG000|Overall Study|Withdrawal by Subject|86|||
161829399|NCT00892281|584415776|FG001|Overall Study|Withdrawal by Subject|14|||
161539457|NCT02044848|583365174|FG000|Overall Study|Administrative Problems|2|||
161539458|NCT02044848|583365175|FG001|Overall Study|Administrative Problems|3|||
161539459|NCT03183388|583365176|FG000|Overall Study|Lost to Follow-up|3|||
161539460|NCT03183388|583365177|FG001|Overall Study|Lost to Follow-up|5|||
161539461|NCT03183388|583365176|FG000|Overall Study|Physician Decision|1|||
161539462|NCT03183388|583365177|FG001|Overall Study|Physician Decision|4|||
161539463|NCT03183388|583365176|FG000|Overall Study|Withdrawal by Subject|4|||
161539464|NCT03183388|583365177|FG001|Overall Study|Withdrawal by Subject|1|||
161539465|NCT03183388|583365176|FG000|Overall Study|Moved|1|||
161539466|NCT03183388|583365177|FG001|Overall Study|Moved|0|||
161539467|NCT03183388|583365176|FG000|Overall Study|Met Exclusion Criteria|2|||
161539468|NCT03183388|583365177|FG001|Overall Study|Met Exclusion Criteria|2|||
161539469|NCT03183388|583365176|FG000|Overall Study|COVID Pandemic Related|2|||
161539470|NCT03183388|583365177|FG001|Overall Study|COVID Pandemic Related|4|||
161539471|NCT00284141|583365182|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
161539472|NCT00284141|583365182|FG000|Overall Study|Adverse Event|19|||
161539473|NCT00284141|583365182|FG000|Overall Study|Participant's request|9|||
161539474|NCT00284141|583365182|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
161539475|NCT00284141|583365182|FG000|Overall Study|Clinical deterioration / death|2|||
161539476|NCT00284141|583365182|FG000|Overall Study|General decline|1|||
161539477|NCT00284141|583365182|FG000|Overall Study|Pneumonia|1|||
161539478|NCT00284141|583365182|FG000|Overall Study|Did not take study medication|2|||
161539479|NCT00284141|583365182|FG000|Overall Study|Ongoing treatment|2|||
161539480|NCT00803101|583365186|FG000|Overall Study|Death / Serious Adverse Event|4|||
161539481|NCT00803101|583365187|FG001|Overall Study|Death / Serious Adverse Event|6|||
161539482|NCT00803101|583365186|FG000|Overall Study|Withdrawal by Subject|6|||
161539483|NCT00803101|583365187|FG001|Overall Study|Withdrawal by Subject|4|||
161539484|NCT00803101|583365186|FG000|Overall Study|Lost to Follow-up|2|||
161539485|NCT00803101|583365187|FG001|Overall Study|Lost to Follow-up|2|||
161539486|NCT00803101|583365186|FG000|Overall Study|Protocol Violation|1|||
161539487|NCT00803101|583365187|FG001|Overall Study|Protocol Violation|7|||
161539488|NCT00803101|583365186|FG000|Overall Study|Surgery finished outside protocol window|1|||
161539489|NCT00803101|583365187|FG001|Overall Study|Surgery finished outside protocol window|1|||
161539490|NCT00803101|583365186|FG000|Overall Study|Patient died outside SAE report period|1|||
161539491|NCT00803101|583365187|FG001|Overall Study|Patient died outside SAE report period|0|||
161539492|NCT00803101|583365186|FG000|Overall Study|Patient did not attend scheduled visit|2|||
161539493|NCT00803101|583365187|FG001|Overall Study|Patient did not attend scheduled visit|1|||
161539494|NCT00803101|583365186|FG000|Overall Study|Patient did not have surgery|1|||
161539495|NCT00803101|583365187|FG001|Overall Study|Patient did not have surgery|1|||
161539496|NCT01782742|583365188|FG000|Double-blind Treatment Phase|Adverse Event|1|||
161539497|NCT01782742|583365189|FG001|Double-blind Treatment Phase|Adverse Event|0|||
161539498|NCT01529008|583365190|FG000|Bone Marrow Harvesting|Physician Decision|1|||
161539499|NCT01529008|583365191|FG001|Bone Marrow Harvesting|Physician Decision|1|||
161539500|NCT01529008|583365190|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
161539501|NCT01529008|583365191|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
161539502|NCT01529008|583365190|FG000|Treatment|Adverse Event|6|||
161539503|NCT01529008|583365191|FG001|Treatment|Adverse Event|0|||
161539504|NCT01529008|583365190|FG000|Treatment|Other|3|||
161539505|NCT01529008|583365191|FG001|Treatment|Other|1|||
161539506|NCT01529008|583365190|FG000|Efficacy Analysis|Protocol Violation|2|||
161539507|NCT01529008|583365191|FG001|Efficacy Analysis|Protocol Violation|0|||
161539508|NCT01529008|583365190|FG000|Efficacy Analysis|Physician Decision|0|||
161539509|NCT01529008|583365191|FG001|Efficacy Analysis|Physician Decision|1|||
161539510|NCT01529008|583365190|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
161539511|NCT01529008|583365191|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
161539512|NCT04170686|583365192|FG000|Screening|Physician Decision|12|||
161539513|NCT04170686|583365193|FG001|Screening|Physician Decision|13|||
161539514|NCT04170686|583365192|FG000|Randomization and Treatment|Lost to Follow-up|26|||
161539515|NCT04170686|583365193|FG001|Randomization and Treatment|Lost to Follow-up|15|||
161539516|NCT04425902|583365196|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
161539517|NCT01191840|583365197|FG000|Overall Study|withdrew consent|2|||
161539518|NCT01191840|583365198|FG001|Overall Study|withdrew consent|1|||
161539519|NCT01191840|583365197|FG000|Overall Study|Subject discontinued treatment|1|||
161539520|NCT01191840|583365198|FG001|Overall Study|Subject discontinued treatment|2|||
161539521|NCT01191840|583365197|FG000|Overall Study|Lost to Follow-up|4|||
161539522|NCT01191840|583365198|FG001|Overall Study|Lost to Follow-up|6|||
161539523|NCT01191840|583365197|FG000|Overall Study|Non Staph Infection|4|||
161539524|NCT01191840|583365198|FG001|Overall Study|Non Staph Infection|3|||
161539525|NCT01191840|583365197|FG000|Overall Study|ineligible at enrollment|1|||
161539526|NCT01191840|583365198|FG001|Overall Study|ineligible at enrollment|0|||
161539527|NCT01191840|583365197|FG000|Overall Study|IRB approval lapse|0|||
161539528|NCT01191840|583365198|FG001|Overall Study|IRB approval lapse|2|||
161539529|NCT01191840|583365197|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
161592454|NCT01160211|583558700|FG001|Overall Study|Lost to Follow-up|8|||
161539530|NCT01191840|583365198|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
161539531|NCT01191840|583365197|FG000|Overall Study|Withdrawal by Subject|2|||
161539532|NCT01191840|583365198|FG001|Overall Study|Withdrawal by Subject|0|||
161539533|NCT00261495|583365201|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
161539534|NCT00261495|583365202|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
161539535|NCT00261495|583365201|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
161539536|NCT00261495|583365202|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
161539537|NCT00261495|583365201|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
161539538|NCT00261495|583365202|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
161539539|NCT00261495|583365201|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
161539540|NCT00261495|583365202|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
161539541|NCT00261495|583365201|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
161539542|NCT00261495|583365202|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
161539543|NCT00261495|583365201|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
161539544|NCT00261495|583365202|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
161539545|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
161539546|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
161539547|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
161539548|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
161539549|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
161539550|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
161539551|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
161539552|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
161539553|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
161539554|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
161539555|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
161539556|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
161539557|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
161539558|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
161539559|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
161539560|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
161539561|NCT00261495|583365201|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
161539562|NCT00261495|583365202|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
161539563|NCT00261495|583365201|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
161539564|NCT00261495|583365202|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
161539565|NCT00261495|583365201|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
161539566|NCT00261495|583365202|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161539567|NCT00261495|583365201|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
161539568|NCT00261495|583365202|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
161539569|NCT00261495|583365201|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161539570|NCT00261495|583365202|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
161539571|NCT00261495|583365201|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
161592455|NCT01160211|583558701|FG002|Overall Study|Lost to Follow-up|4|||
161592456|NCT01160211|583558699|FG000|Overall Study|Physician Decision|1|||
161592457|NCT01160211|583558700|FG001|Overall Study|Physician Decision|0|||
161539572|NCT00261495|583365202|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
161539573|NCT00261495|583365201|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
161592458|NCT01160211|583558701|FG002|Overall Study|Physician Decision|0|||
161539574|NCT00261495|583365202|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161539575|NCT00429663|583365203|FG000|Overall Study|Lost to Follow-up|24|||
161539576|NCT00429663|583365204|FG001|Overall Study|Lost to Follow-up|31|||
161592459|NCT01160211|583558699|FG000|Overall Study|Withdrawal by Subject|4|||
161592460|NCT01160211|583558700|FG001|Overall Study|Withdrawal by Subject|2|||
161592461|NCT01160211|583558701|FG002|Overall Study|Withdrawal by Subject|2|||
161592462|NCT01160211|583558699|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
161592463|NCT01160211|583558700|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
161592464|NCT01160211|583558701|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
161592465|NCT02734290|583558702|FG000|Overall Study|Adverse Event|1|||
161592466|NCT02734290|583558703|FG001|Overall Study|Adverse Event|0|||
161592467|NCT02734290|583558702|FG000|Overall Study|Death|1|||
161592468|NCT02734290|583558703|FG001|Overall Study|Death|0|||
161592469|NCT03829410|583558705|FG000|Overall Study|Adverse Event|1|||
161592470|NCT03829410|583558706|FG001|Overall Study|Adverse Event|0|||
161592471|NCT03829410|583558707|FG002|Overall Study|Adverse Event|1|||
161592472|NCT03829410|583558708|FG003|Overall Study|Adverse Event|4|||
161592473|NCT03829410|583558705|FG000|Overall Study|Physician Decision|0|||
161592474|NCT03829410|583558706|FG001|Overall Study|Physician Decision|0|||
161592475|NCT03829410|583558707|FG002|Overall Study|Physician Decision|0|||
161592476|NCT03829410|583558708|FG003|Overall Study|Physician Decision|2|||
161592477|NCT03829410|583558705|FG000|Overall Study|Disease Progressing|3|||
161592478|NCT03829410|583558706|FG001|Overall Study|Disease Progressing|4|||
161678751|NCT00574288|583876065|FG000|Overall Study|Study Terminated By Sponsor|0|||
161539577|NCT00429663|583365203|FG000|Overall Study|Physician Decision|6|||
161539578|NCT00429663|583365204|FG001|Overall Study|Physician Decision|3|||
161539579|NCT00429663|583365203|FG000|Overall Study|Withdrawal by Subject|2|||
161539580|NCT00429663|583365204|FG001|Overall Study|Withdrawal by Subject|5|||
161539581|NCT00429663|583365203|FG000|Overall Study|Death|4|||
161539582|NCT00429663|583365204|FG001|Overall Study|Death|0|||
161539583|NCT04207840|583365205|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
161539584|NCT04207840|583365206|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
161539585|NCT04207840|583365207|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
161539586|NCT04207840|583365205|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
161539587|NCT04207840|583365206|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
161539588|NCT04207840|583365207|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
161539589|NCT03243422|583365210|FG000|Overall Study|Death|20|||
161539590|NCT03243422|583365211|FG001|Overall Study|Death|21|||
161539591|NCT03243422|583365210|FG000|Overall Study|Lost to Follow-up|9|||
161539592|NCT03243422|583365211|FG001|Overall Study|Lost to Follow-up|21|||
161539593|NCT03243422|583365210|FG000|Overall Study|Withdrawal by Subject|22|||
161539594|NCT03243422|583365211|FG001|Overall Study|Withdrawal by Subject|8|||
161539595|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
161539596|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
161539597|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
161539598|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
161539599|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
161539600|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
161539601|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
161539602|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
161539603|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
161539604|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
161539605|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
161539606|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
161539607|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161539608|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161539609|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161539610|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
161539611|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
161539612|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161539613|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161539614|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161539615|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Death|2|||
161539616|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Death|2|||
161539617|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Death|0|||
161539618|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Death|0|||
161539619|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Death|0|||
161539620|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
161539621|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
161539622|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
161539623|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
161539624|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
161539625|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
161539626|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
161539627|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
161539628|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
161539629|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
161539630|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
161539631|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
161539632|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
161539633|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
161539634|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
161539635|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
161539636|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
161539637|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
161539638|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
161539639|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
161539640|NCT03420781|583365214|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
161539641|NCT03420781|583365215|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161539642|NCT03420781|583365216|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161539643|NCT03420781|583365217|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161539644|NCT03420781|583365218|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161539645|NCT03420781|583365214|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
161678752|NCT00574288|583876066|FG001|Overall Study|Study Terminated By Sponsor|0|||
161678753|NCT00574288|583876067|FG002|Overall Study|Study Terminated By Sponsor|0|||
161539646|NCT03420781|583365215|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
161539647|NCT03420781|583365216|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
161539648|NCT03420781|583365217|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
161539649|NCT03420781|583365218|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
161539650|NCT03420781|583365214|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
161539651|NCT03420781|583365215|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
161539652|NCT03420781|583365216|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
161539653|NCT03420781|583365217|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
161539654|NCT03420781|583365218|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
161539655|NCT03420781|583365214|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
161539656|NCT03420781|583365215|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
161539657|NCT03420781|583365216|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
161539658|NCT03420781|583365217|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
161539659|NCT03420781|583365218|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
161539660|NCT01330316|583365219|FG000|Overall Study|Adverse Event|2|||
161539661|NCT01330316|583365220|FG001|Overall Study|Adverse Event|2|||
161539662|NCT01330316|583365219|FG000|Overall Study|Lack of Efficacy|0|||
161539663|NCT01330316|583365220|FG001|Overall Study|Lack of Efficacy|10|||
161539664|NCT01330316|583365219|FG000|Overall Study|Lost to Follow-up|0|||
161539665|NCT01330316|583365220|FG001|Overall Study|Lost to Follow-up|1|||
161539666|NCT01330316|583365219|FG000|Overall Study|Withdrawal by Subject|0|||
161539667|NCT01330316|583365220|FG001|Overall Study|Withdrawal by Subject|1|||
161539668|NCT01330316|583365219|FG000|Overall Study|other than above|0|||
161539669|NCT01330316|583365220|FG001|Overall Study|other than above|1|||
161539670|NCT00246337|583365223|FG000|Overall Study|Lost to Follow-up|3|||
161539671|NCT00246337|583365224|FG001|Overall Study|Lost to Follow-up|0|||
161539672|NCT00246337|583365225|FG002|Overall Study|Lost to Follow-up|0|||
161539673|NCT00246337|583365226|FG003|Overall Study|Lost to Follow-up|0|||
161539674|NCT00246337|583365227|FG004|Overall Study|Lost to Follow-up|2|||
161539675|NCT00246337|583365228|FG005|Overall Study|Lost to Follow-up|2|||
161539676|NCT00246337|583365229|FG006|Overall Study|Lost to Follow-up|1|||
161539677|NCT00246337|583365230|FG007|Overall Study|Lost to Follow-up|2|||
161539678|NCT00246337|583365231|FG008|Overall Study|Lost to Follow-up|0|||
161539679|NCT00246337|583365223|FG000|Overall Study|Protocol Violation|1|||
161539680|NCT00246337|583365224|FG001|Overall Study|Protocol Violation|0|||
161539681|NCT00246337|583365225|FG002|Overall Study|Protocol Violation|0|||
161539682|NCT00246337|583365226|FG003|Overall Study|Protocol Violation|0|||
161539683|NCT00246337|583365227|FG004|Overall Study|Protocol Violation|1|||
161539684|NCT00246337|583365228|FG005|Overall Study|Protocol Violation|0|||
161539685|NCT00246337|583365229|FG006|Overall Study|Protocol Violation|1|||
161539686|NCT00246337|583365230|FG007|Overall Study|Protocol Violation|1|||
161539687|NCT00246337|583365231|FG008|Overall Study|Protocol Violation|0|||
161539688|NCT00246337|583365223|FG000|Overall Study|Withdrawal by Subject|2|||
161539689|NCT00246337|583365224|FG001|Overall Study|Withdrawal by Subject|0|||
161539690|NCT00246337|583365225|FG002|Overall Study|Withdrawal by Subject|0|||
161539691|NCT00246337|583365226|FG003|Overall Study|Withdrawal by Subject|0|||
161539692|NCT00246337|583365227|FG004|Overall Study|Withdrawal by Subject|0|||
161539693|NCT00246337|583365228|FG005|Overall Study|Withdrawal by Subject|0|||
161539694|NCT00246337|583365229|FG006|Overall Study|Withdrawal by Subject|1|||
161539695|NCT00246337|583365230|FG007|Overall Study|Withdrawal by Subject|1|||
161539696|NCT00246337|583365231|FG008|Overall Study|Withdrawal by Subject|0|||
161539697|NCT00246337|583365223|FG000|Overall Study|Lack of Qualifying Event|8|||
161539698|NCT00246337|583365224|FG001|Overall Study|Lack of Qualifying Event|2|||
161539699|NCT00246337|583365225|FG002|Overall Study|Lack of Qualifying Event|1|||
161539700|NCT00246337|583365226|FG003|Overall Study|Lack of Qualifying Event|1|||
161539701|NCT00246337|583365227|FG004|Overall Study|Lack of Qualifying Event|1|||
161539702|NCT00246337|583365228|FG005|Overall Study|Lack of Qualifying Event|3|||
161539703|NCT00246337|583365229|FG006|Overall Study|Lack of Qualifying Event|3|||
161539704|NCT00246337|583365230|FG007|Overall Study|Lack of Qualifying Event|2|||
161539705|NCT00246337|583365231|FG008|Overall Study|Lack of Qualifying Event|5|||
161539706|NCT00246337|583365223|FG000|Overall Study|Site Terminated|10|||
161539707|NCT00246337|583365224|FG001|Overall Study|Site Terminated|0|||
161539708|NCT00246337|583365225|FG002|Overall Study|Site Terminated|0|||
161539709|NCT00246337|583365226|FG003|Overall Study|Site Terminated|0|||
161539710|NCT00246337|583365227|FG004|Overall Study|Site Terminated|0|||
161539711|NCT00246337|583365228|FG005|Overall Study|Site Terminated|7|||
161539712|NCT00246337|583365229|FG006|Overall Study|Site Terminated|1|||
161539713|NCT00246337|583365230|FG007|Overall Study|Site Terminated|6|||
161539714|NCT00246337|583365231|FG008|Overall Study|Site Terminated|2|||
161539715|NCT00246337|583365223|FG000|Overall Study|Abnormal baseline lab values|7|||
161539716|NCT00246337|583365224|FG001|Overall Study|Abnormal baseline lab values|0|||
161539717|NCT00246337|583365225|FG002|Overall Study|Abnormal baseline lab values|2|||
161539718|NCT00246337|583365226|FG003|Overall Study|Abnormal baseline lab values|0|||
161539719|NCT00246337|583365227|FG004|Overall Study|Abnormal baseline lab values|0|||
161539720|NCT00246337|583365228|FG005|Overall Study|Abnormal baseline lab values|2|||
161539721|NCT00246337|583365229|FG006|Overall Study|Abnormal baseline lab values|2|||
161539722|NCT00246337|583365230|FG007|Overall Study|Abnormal baseline lab values|0|||
161539723|NCT00246337|583365231|FG008|Overall Study|Abnormal baseline lab values|4|||
161539724|NCT00246337|583365223|FG000|Overall Study|Overwhelmed|0|||
161539725|NCT00246337|583365224|FG001|Overall Study|Overwhelmed|0|||
161539726|NCT00246337|583365225|FG002|Overall Study|Overwhelmed|0|||
161539727|NCT00246337|583365226|FG003|Overall Study|Overwhelmed|0|||
161539728|NCT00246337|583365227|FG004|Overall Study|Overwhelmed|0|||
161539729|NCT00246337|583365228|FG005|Overall Study|Overwhelmed|1|||
161539730|NCT00246337|583365229|FG006|Overall Study|Overwhelmed|0|||
161539731|NCT00246337|583365230|FG007|Overall Study|Overwhelmed|0|||
161539732|NCT00246337|583365231|FG008|Overall Study|Overwhelmed|0|||
161539733|NCT00246337|583365223|FG000|Overall Study|Protocol Violator|1|||
161539734|NCT00246337|583365224|FG001|Overall Study|Protocol Violator|0|||
161539735|NCT00246337|583365225|FG002|Overall Study|Protocol Violator|0|||
161539736|NCT00246337|583365226|FG003|Overall Study|Protocol Violator|0|||
161539737|NCT00246337|583365227|FG004|Overall Study|Protocol Violator|0|||
161539738|NCT00246337|583365228|FG005|Overall Study|Protocol Violator|0|||
161539739|NCT00246337|583365229|FG006|Overall Study|Protocol Violator|0|||
161539740|NCT00246337|583365230|FG007|Overall Study|Protocol Violator|0|||
161539741|NCT00246337|583365231|FG008|Overall Study|Protocol Violator|0|||
161539742|NCT00246337|583365223|FG000|Overall Study|Reported as completing trial in error|0|||
161539743|NCT00246337|583365224|FG001|Overall Study|Reported as completing trial in error|0|||
161539744|NCT00246337|583365225|FG002|Overall Study|Reported as completing trial in error|0|||
161539745|NCT00246337|583365226|FG003|Overall Study|Reported as completing trial in error|0|||
161539746|NCT00246337|583365227|FG004|Overall Study|Reported as completing trial in error|0|||
161539747|NCT00246337|583365228|FG005|Overall Study|Reported as completing trial in error|0|||
161539748|NCT00246337|583365229|FG006|Overall Study|Reported as completing trial in error|0|||
161539749|NCT00246337|583365230|FG007|Overall Study|Reported as completing trial in error|1|||
161539750|NCT00246337|583365231|FG008|Overall Study|Reported as completing trial in error|0|||
161539751|NCT02696564|583365234|FG000|Overall Study|Death|1|||
161539752|NCT02696564|583365235|FG001|Overall Study|Death|2|||
161539753|NCT02696564|583365234|FG000|Overall Study|Withdrawal by Subject|3|||
161539754|NCT02696564|583365235|FG001|Overall Study|Withdrawal by Subject|2|||
161539755|NCT02696564|583365234|FG000|Overall Study|Lost to Follow-up|3|||
161539756|NCT02696564|583365235|FG001|Overall Study|Lost to Follow-up|3|||
161539757|NCT02696564|583365234|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
161539758|NCT02696564|583365235|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
161539759|NCT02696564|583365234|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
161539760|NCT02696564|583365235|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
161539761|NCT02696564|583365234|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
161539762|NCT02696564|583365235|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
161539763|NCT02696564|583365234|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
161539764|NCT02696564|583365235|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
161539765|NCT02696564|583365234|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
161539766|NCT02696564|583365235|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
161539767|NCT04067401|583365236|FG000|Overall Study|Withdrawal by Subject|7|||
161539768|NCT04067401|583365237|FG001|Overall Study|Withdrawal by Subject|0|||
161539769|NCT04067401|583365236|FG000|Overall Study|no data provided|1|||
161539770|NCT04067401|583365237|FG001|Overall Study|no data provided|0|||
161539771|NCT03633929|583365238|FG000|Overall Study|Lost to Follow-up|1|||
161678754|NCT00574288|583876068|FG003|Overall Study|Study Terminated By Sponsor|0|||
161539772|NCT03633929|583365238|FG000|Overall Study|Did not login to software. Did not participate|3|||
161539773|NCT02287584|583365240|FG000|the Double-blind Phase|Adverse Event|17|||
161539774|NCT02287584|583365241|FG001|the Double-blind Phase|Adverse Event|17|||
161539775|NCT02287584|583365242|FG002|the Double-blind Phase|Adverse Event|12|||
161539776|NCT02287584|583365243|FG003|the Double-blind Phase|Adverse Event|0|||
161539777|NCT02287584|583365244|FG004|the Double-blind Phase|Adverse Event|0|||
161539778|NCT02287584|583365245|FG005|the Double-blind Phase|Adverse Event|0|||
161539779|NCT02287584|583365240|FG000|the Double-blind Phase|Lack of Efficacy|18|||
161539780|NCT02287584|583365241|FG001|the Double-blind Phase|Lack of Efficacy|8|||
161539781|NCT02287584|583365242|FG002|the Double-blind Phase|Lack of Efficacy|8|||
161539782|NCT02287584|583365243|FG003|the Double-blind Phase|Lack of Efficacy|0|||
161539783|NCT02287584|583365244|FG004|the Double-blind Phase|Lack of Efficacy|0|||
161539784|NCT02287584|583365245|FG005|the Double-blind Phase|Lack of Efficacy|0|||
161539785|NCT02287584|583365240|FG000|the Double-blind Phase|Lost to Follow-up|0|||
161539786|NCT02287584|583365241|FG001|the Double-blind Phase|Lost to Follow-up|1|||
161539787|NCT02287584|583365242|FG002|the Double-blind Phase|Lost to Follow-up|1|||
161539788|NCT02287584|583365243|FG003|the Double-blind Phase|Lost to Follow-up|0|||
161539789|NCT02287584|583365244|FG004|the Double-blind Phase|Lost to Follow-up|0|||
161539790|NCT02287584|583365245|FG005|the Double-blind Phase|Lost to Follow-up|0|||
161539791|NCT02287584|583365240|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
161539792|NCT02287584|583365241|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
161539793|NCT02287584|583365242|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
161539794|NCT02287584|583365243|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
161539795|NCT02287584|583365244|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
161539796|NCT02287584|583365245|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
161539797|NCT02287584|583365240|FG000|the Double-blind Phase|Pregnancy|0|||
161539798|NCT02287584|583365241|FG001|the Double-blind Phase|Pregnancy|1|||
161539799|NCT02287584|583365242|FG002|the Double-blind Phase|Pregnancy|0|||
161539800|NCT02287584|583365243|FG003|the Double-blind Phase|Pregnancy|0|||
161539801|NCT02287584|583365244|FG004|the Double-blind Phase|Pregnancy|0|||
161539802|NCT02287584|583365245|FG005|the Double-blind Phase|Pregnancy|0|||
161539803|NCT02287584|583365240|FG000|the Double-blind Phase|Protocol Violation|0|||
161539804|NCT02287584|583365241|FG001|the Double-blind Phase|Protocol Violation|3|||
161539805|NCT02287584|583365242|FG002|the Double-blind Phase|Protocol Violation|0|||
161539806|NCT02287584|583365243|FG003|the Double-blind Phase|Protocol Violation|0|||
161539807|NCT02287584|583365244|FG004|the Double-blind Phase|Protocol Violation|0|||
161539808|NCT02287584|583365245|FG005|the Double-blind Phase|Protocol Violation|0|||
161539809|NCT02287584|583365240|FG000|the Double-blind Phase|other reasons|0|||
161539810|NCT02287584|583365241|FG001|the Double-blind Phase|other reasons|0|||
161539811|NCT02287584|583365242|FG002|the Double-blind Phase|other reasons|1|||
161539812|NCT02287584|583365243|FG003|the Double-blind Phase|other reasons|0|||
161539813|NCT02287584|583365244|FG004|the Double-blind Phase|other reasons|0|||
161539814|NCT02287584|583365245|FG005|the Double-blind Phase|other reasons|0|||
161539815|NCT02287584|583365240|FG000|the Open-label Phase|Did not receive drug|0|||
161539816|NCT02287584|583365241|FG001|the Open-label Phase|Did not receive drug|0|||
161539817|NCT02287584|583365242|FG002|the Open-label Phase|Did not receive drug|0|||
161539818|NCT02287584|583365243|FG003|the Open-label Phase|Did not receive drug|7|||
161539819|NCT02287584|583365244|FG004|the Open-label Phase|Did not receive drug|6|||
161539820|NCT02287584|583365245|FG005|the Open-label Phase|Did not receive drug|4|||
161539821|NCT02287584|583365240|FG000|the Open-label Phase|Adverse Event|0|||
161539822|NCT02287584|583365241|FG001|the Open-label Phase|Adverse Event|0|||
161539823|NCT02287584|583365242|FG002|the Open-label Phase|Adverse Event|0|||
161539824|NCT02287584|583365243|FG003|the Open-label Phase|Adverse Event|15|||
161539825|NCT02287584|583365244|FG004|the Open-label Phase|Adverse Event|12|||
161539826|NCT02287584|583365245|FG005|the Open-label Phase|Adverse Event|16|||
161539827|NCT02287584|583365240|FG000|the Open-label Phase|Lack of Efficacy|0|||
161539828|NCT02287584|583365241|FG001|the Open-label Phase|Lack of Efficacy|0|||
161539829|NCT02287584|583365242|FG002|the Open-label Phase|Lack of Efficacy|0|||
161539830|NCT02287584|583365243|FG003|the Open-label Phase|Lack of Efficacy|8|||
161539831|NCT02287584|583365244|FG004|the Open-label Phase|Lack of Efficacy|3|||
161678755|NCT00574288|583876069|FG004|Overall Study|Study Terminated By Sponsor|0|||
161678756|NCT00574288|583876070|FG005|Overall Study|Study Terminated By Sponsor|0|||
161539832|NCT02287584|583365245|FG005|the Open-label Phase|Lack of Efficacy|7|||
161539833|NCT02287584|583365240|FG000|the Open-label Phase|Lost to Follow-up|0|||
161539834|NCT02287584|583365241|FG001|the Open-label Phase|Lost to Follow-up|0|||
161539835|NCT02287584|583365242|FG002|the Open-label Phase|Lost to Follow-up|0|||
161539836|NCT02287584|583365243|FG003|the Open-label Phase|Lost to Follow-up|4|||
161539837|NCT02287584|583365244|FG004|the Open-label Phase|Lost to Follow-up|1|||
161539838|NCT02287584|583365245|FG005|the Open-label Phase|Lost to Follow-up|2|||
161539839|NCT02287584|583365240|FG000|the Open-label Phase|Withdrawal by Subject|0|||
161539840|NCT02287584|583365241|FG001|the Open-label Phase|Withdrawal by Subject|0|||
161539841|NCT02287584|583365242|FG002|the Open-label Phase|Withdrawal by Subject|0|||
161539842|NCT02287584|583365243|FG003|the Open-label Phase|Withdrawal by Subject|18|||
161539843|NCT02287584|583365244|FG004|the Open-label Phase|Withdrawal by Subject|29|||
161539844|NCT02287584|583365245|FG005|the Open-label Phase|Withdrawal by Subject|21|||
161539845|NCT02287584|583365240|FG000|the Open-label Phase|non-compliance|0|||
161539846|NCT02287584|583365241|FG001|the Open-label Phase|non-compliance|0|||
161539847|NCT02287584|583365242|FG002|the Open-label Phase|non-compliance|0|||
161539848|NCT02287584|583365243|FG003|the Open-label Phase|non-compliance|2|||
161539849|NCT02287584|583365244|FG004|the Open-label Phase|non-compliance|5|||
161539850|NCT02287584|583365245|FG005|the Open-label Phase|non-compliance|1|||
161539851|NCT02287584|583365240|FG000|the Open-label Phase|other reasons|0|||
161539852|NCT02287584|583365241|FG001|the Open-label Phase|other reasons|0|||
161539853|NCT02287584|583365242|FG002|the Open-label Phase|other reasons|0|||
161539854|NCT02287584|583365243|FG003|the Open-label Phase|other reasons|3|||
161539855|NCT02287584|583365244|FG004|the Open-label Phase|other reasons|6|||
161539856|NCT02287584|583365245|FG005|the Open-label Phase|other reasons|6|||
161539857|NCT03124199|583365246|FG000|Overall Study|Lost to Follow-up|4|||
161539858|NCT03086018|583365248|FG000|Final Testing for End of Trial|Adverse Event|1|||
161539859|NCT03086018|583365248|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
161592479|NCT03829410|583558707|FG002|Overall Study|Disease Progressing|2|||
161592480|NCT03829410|583558708|FG003|Overall Study|Disease Progressing|31|||
161592481|NCT03829410|583558705|FG000|Overall Study|Miscellaneous|2|||
161592482|NCT03829410|583558706|FG001|Overall Study|Miscellaneous|4|||
161592483|NCT03829410|583558707|FG002|Overall Study|Miscellaneous|3|||
161592484|NCT03829410|583558708|FG003|Overall Study|Miscellaneous|10|||
161592485|NCT03158129|583558709|FG000|Overall Study|Adverse Event|0|||
161592486|NCT03158129|583558710|FG001|Overall Study|Adverse Event|1|||
161592487|NCT03158129|583558711|FG002|Overall Study|Adverse Event|0|||
161592488|NCT03158129|583558712|FG003|Overall Study|Adverse Event|0|||
161592489|NCT03158129|583558709|FG000|Overall Study|Death|0|||
161592490|NCT03158129|583558710|FG001|Overall Study|Death|0|||
161592491|NCT03158129|583558711|FG002|Overall Study|Death|0|||
161592492|NCT03158129|583558712|FG003|Overall Study|Death|1|||
161592493|NCT03158129|583558709|FG000|Overall Study|High surgical risk|1|||
161592494|NCT03158129|583558710|FG001|Overall Study|High surgical risk|1|||
161592495|NCT03158129|583558711|FG002|Overall Study|High surgical risk|0|||
161592496|NCT03158129|583558712|FG003|Overall Study|High surgical risk|0|||
161592497|NCT03158129|583558709|FG000|Overall Study|Progression|1|||
161592498|NCT03158129|583558710|FG001|Overall Study|Progression|1|||
161592499|NCT03158129|583558711|FG002|Overall Study|Progression|0|||
161592500|NCT03158129|583558712|FG003|Overall Study|Progression|0|||
161592501|NCT03158129|583558709|FG000|Overall Study|Lack of resectability|0|||
161592502|NCT03158129|583558710|FG001|Overall Study|Lack of resectability|1|||
161592503|NCT03158129|583558711|FG002|Overall Study|Lack of resectability|0|||
161592504|NCT03158129|583558712|FG003|Overall Study|Lack of resectability|0|||
161592505|NCT03158129|583558709|FG000|Overall Study|Declined surgery|0|||
161592506|NCT03158129|583558710|FG001|Overall Study|Declined surgery|1|||
161592507|NCT03158129|583558711|FG002|Overall Study|Declined surgery|0|||
161592508|NCT03158129|583558712|FG003|Overall Study|Declined surgery|0|||
161592509|NCT03158129|583558709|FG000|Overall Study|No longer surgical candidate|0|||
161592510|NCT03158129|583558710|FG001|Overall Study|No longer surgical candidate|0|||
161592511|NCT03158129|583558711|FG002|Overall Study|No longer surgical candidate|0|||
161592512|NCT03158129|583558712|FG003|Overall Study|No longer surgical candidate|1|||
161592513|NCT05051124|583558713|FG000|Overall Study|Lost to Follow-up|2|||
161592514|NCT05051124|583558713|FG000|Overall Study|Withdrawal by Subject|1|||
161592515|NCT05051124|583558713|FG000|Overall Study|Residential relocation|2|||
161592516|NCT05051124|583558713|FG000|Overall Study|Death|1|||
161592517|NCT02105766|583558718|FG000|Overall Study|Physician Decision|1|||
161592518|NCT02105766|583558719|FG001|Overall Study|Physician Decision|1|||
161592519|NCT02105766|583558720|FG002|Overall Study|Physician Decision|0|||
161592520|NCT02105766|583558718|FG000|Overall Study|Lost to Follow-up|2|||
161539860|NCT02309112|583365249|FG000|Overall Study|Withdrawal by Subject|1|||
161539861|NCT02309112|583365250|FG001|Overall Study|Withdrawal by Subject|0|||
161539862|NCT02309112|583365251|FG002|Overall Study|Withdrawal by Subject|1|||
161539863|NCT02309112|583365249|FG000|Overall Study|Lost to Follow-up|0|||
161592521|NCT02105766|583558719|FG001|Overall Study|Lost to Follow-up|0|||
161592522|NCT02105766|583558720|FG002|Overall Study|Lost to Follow-up|0|||
161592523|NCT02105766|583558718|FG000|Overall Study|Death|1|||
161592524|NCT02105766|583558719|FG001|Overall Study|Death|1|||
161592525|NCT02105766|583558720|FG002|Overall Study|Death|0|||
161539864|NCT02309112|583365250|FG001|Overall Study|Lost to Follow-up|1|||
161539865|NCT02309112|583365251|FG002|Overall Study|Lost to Follow-up|0|||
161539866|NCT01892345|583365252|FG000|Overall Study|Adverse Event|0|||
161539867|NCT01892345|583365253|FG001|Overall Study|Adverse Event|2|||
161539868|NCT01892345|583365252|FG000|Overall Study|Death|1|||
161539869|NCT01892345|583365253|FG001|Overall Study|Death|0|||
161539870|NCT01892345|583365252|FG000|Overall Study|Lost to Follow-up|3|||
161539871|NCT01892345|583365253|FG001|Overall Study|Lost to Follow-up|0|||
161539872|NCT01892345|583365252|FG000|Overall Study|Withdrawal by Subject|12|||
161539873|NCT01892345|583365253|FG001|Overall Study|Withdrawal by Subject|1|||
161539874|NCT00659984|583365257|FG000|Overall Study|Adverse Event|1|||
161539875|NCT03745222|583365258|FG000|Overall Study|Withdrawal by Subject|0|||
161539876|NCT03745222|583365259|FG001|Overall Study|Withdrawal by Subject|1|||
161539877|NCT03745222|583365260|FG002|Overall Study|Withdrawal by Subject|0|||
161539878|NCT02657317|583365261|FG000|Overall Study|Withdrawal by Subject|2|||
161539879|NCT02657317|583365262|FG001|Overall Study|Withdrawal by Subject|0|||
161539880|NCT02657317|583365261|FG000|Overall Study|Lost to Follow-up|3|||
161539881|NCT02657317|583365262|FG001|Overall Study|Lost to Follow-up|3|||
161539882|NCT01784068|583365266|FG000|NTCS Phase|Adverse Event|5|||
161539883|NCT01784068|583365267|FG001|NTCS Phase|Adverse Event|0|||
161539884|NCT01784068|583365266|FG000|NTCS Phase|Physician Decision|2|||
161829400|NCT00892281|584415775|FG000|Overall Study|Subject failed to return for final visit|2|||
161829401|NCT00892281|584415776|FG001|Overall Study|Subject failed to return for final visit|0|||
161829402|NCT00892281|584415775|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
161829403|NCT00892281|584415776|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
161829404|NCT00892281|584415775|FG000|Overall Study|Final visit completed 4 weeks late|0|||
161829405|NCT00892281|584415776|FG001|Overall Study|Final visit completed 4 weeks late|1|||
161829406|NCT00892281|584415775|FG000|Overall Study|Subject completed day after study closed|1|||
161829407|NCT00892281|584415776|FG001|Overall Study|Subject completed day after study closed|0|||
161829408|NCT00892281|584415775|FG000|Overall Study|Family emergency|1|||
161539885|NCT01784068|583365267|FG001|NTCS Phase|Physician Decision|0|||
161539886|NCT01784068|583365266|FG000|NTCS Phase|Patient/guardian decision|3|||
161539887|NCT01784068|583365267|FG001|NTCS Phase|Patient/guardian decision|0|||
161539888|NCT01784068|583365266|FG000|NTCS Phase|Death|2|||
161539889|NCT01784068|583365267|FG001|NTCS Phase|Death|0|||
161539890|NCT01784068|583365266|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
161539891|NCT01784068|583365267|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
161539892|NCT01784068|583365266|FG000|TFR Phase|Physician Decision|0|||
161539893|NCT01784068|583365267|FG001|TFR Phase|Physician Decision|1|||
161539894|NCT01784068|583365266|FG000|TFR Phase|Patient/guardian decision|0|||
161539895|NCT01784068|583365267|FG001|TFR Phase|Patient/guardian decision|3|||
161539896|NCT01784068|583365266|FG000|TFR Phase|Death|0|||
161539897|NCT01784068|583365267|FG001|TFR Phase|Death|1|||
161539898|NCT01784068|583365266|FG000|TFR Phase|Lack of Efficacy|0|||
161539899|NCT01784068|583365267|FG001|TFR Phase|Lack of Efficacy|88|||
161539900|NCT06351371|583365268|FG000|Overall Study|Mutation Status Not Confirmed|9|||
161539901|NCT06351371|583365268|FG000|Overall Study|Ineligible|1|||
161539902|NCT06351371|583365268|FG000|Overall Study|Adverse Event|4|||
161539903|NCT06351371|583365268|FG000|Overall Study|Death|1|||
161539904|NCT06351371|583365268|FG000|Overall Study|Disease progression|14|||
161539905|NCT06351371|583365268|FG000|Overall Study|Withdrawal by Subject|3|||
161539906|NCT06351371|583365268|FG000|Overall Study|Physician Decision|3|||
161539907|NCT04359784|583365269|FG000|Overall Study|Death|2|||
161539908|NCT02063828|583365270|FG000|Overall Study|Withdrawal by Subject|4|||
161539909|NCT02063828|583365271|FG001|Overall Study|Withdrawal by Subject|6|||
161539910|NCT02063828|583365272|FG002|Overall Study|Withdrawal by Subject|3|||
161539911|NCT02063828|583365270|FG000|Overall Study|Death|0|||
161592526|NCT06205407|583558721|FG000|Period 2|Withdrawal by Subject|0|||
161592527|NCT06205407|583558722|FG001|Period 2|Withdrawal by Subject|1|||
161592528|NCT06205407|583558721|FG000|Period 2|Adverse Event|2|||
161592529|NCT06205407|583558722|FG001|Period 2|Adverse Event|1|||
161829409|NCT00892281|584415776|FG001|Overall Study|Family emergency|0|||
161829410|NCT00892281|584415775|FG000|Overall Study|Last visit not done - death in family|1|||
161539912|NCT02063828|583365271|FG001|Overall Study|Death|0|||
161539913|NCT02063828|583365272|FG002|Overall Study|Death|1|||
161592530|NCT06491433|583558723|FG000|Overall Study|Protocol Violation|51|||
161829411|NCT00892281|584415776|FG001|Overall Study|Last visit not done - death in family|0|||
161592531|NCT06491433|583558723|FG000|Overall Study|consent withdrawal|2|||
161829412|NCT00892281|584415775|FG000|Overall Study|Did not meet incl/excl criteria|1|||
161539914|NCT02753595|583365273|FG000|Overall Study|Sponsor termination|2|||
161539915|NCT02753595|583365274|FG001|Overall Study|Sponsor termination|2|||
161539916|NCT02515279|583365278|FG000|Overall Study|Adverse Event|7|||
161539917|NCT02515279|583365278|FG000|Overall Study|Lack of Efficacy|31|||
161539918|NCT02515279|583365278|FG000|Overall Study|Lost to Follow-up|9|||
161539919|NCT02515279|583365278|FG000|Overall Study|Withdrawal by Subject|18|||
161539920|NCT02515279|583365278|FG000|Overall Study|End-of-treatment visit not attended|17|||
161539921|NCT02515279|583365278|FG000|Overall Study|Other|22|||
161539922|NCT01800968|583365279|FG000|Overall Study|Death|23|||
161539923|NCT01800968|583365280|FG001|Overall Study|Death|16|||
161539924|NCT01800968|583365279|FG000|Overall Study|Lost to Follow-up|5|||
161539925|NCT01800968|583365280|FG001|Overall Study|Lost to Follow-up|7|||
161539926|NCT01800968|583365279|FG000|Overall Study|Withdrawal by Subject|7|||
161539927|NCT01800968|583365280|FG001|Overall Study|Withdrawal by Subject|9|||
161539928|NCT01800968|583365279|FG000|Overall Study|Physician Decision|1|||
161539929|NCT01800968|583365280|FG001|Overall Study|Physician Decision|0|||
161539930|NCT04987762|583365282|FG000|Overall Study|Study was Terminated by Sponsor|103|||
161539931|NCT02068495|583365283|FG000|Overall Study|Case Report Forms Uncollected|60|||
161539932|NCT02068495|583365283|FG000|Overall Study|Protocol Deviation|49|||
161539933|NCT01666808|583365286|FG000|Overall Study|Lost to Follow-up|9|||
161539934|NCT01666808|583365287|FG001|Overall Study|Lost to Follow-up|15|||
161539935|NCT01666808|583365286|FG000|Overall Study|Withdrawal by Subject|3|||
161539936|NCT01666808|583365287|FG001|Overall Study|Withdrawal by Subject|1|||
161539937|NCT01666808|583365286|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
161539938|NCT01666808|583365287|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
161539939|NCT02220894|583365288|FG000|Overall Study|Adverse Event|127|||
161539940|NCT02220894|583365289|FG001|Overall Study|Adverse Event|74|||
161539941|NCT02220894|583365288|FG000|Overall Study|Death|418|||
161539942|NCT02220894|583365289|FG001|Overall Study|Death|508|||
161539943|NCT02220894|583365288|FG000|Overall Study|Lost to Follow-up|0|||
161539944|NCT02220894|583365289|FG001|Overall Study|Lost to Follow-up|4|||
161539945|NCT02220894|583365288|FG000|Overall Study|Site Terminated by Sponsor|2|||
161539946|NCT02220894|583365289|FG001|Overall Study|Site Terminated by Sponsor|0|||
161539947|NCT02220894|583365288|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
161539948|NCT02220894|583365289|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
161539949|NCT02220894|583365288|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161539950|NCT02220894|583365289|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161539951|NCT02220894|583365288|FG000|Overall Study|Withdrawal by Subject|10|||
161539952|NCT02220894|583365289|FG001|Overall Study|Withdrawal by Subject|9|||
161539953|NCT03217747|583365290|FG000|Overall Study|Adverse Event|0|||
161539954|NCT03217747|583365291|FG001|Overall Study|Adverse Event|1|||
161539955|NCT03217747|583365292|FG002|Overall Study|Adverse Event|0|||
161539956|NCT03217747|583365293|FG003|Overall Study|Adverse Event|0|||
161539957|NCT03217747|583365294|FG004|Overall Study|Adverse Event|0|||
161539958|NCT03217747|583365295|FG005|Overall Study|Adverse Event|0|||
161539959|NCT03217747|583365296|FG006|Overall Study|Adverse Event|0|||
161539960|NCT03217747|583365297|FG007|Overall Study|Adverse Event|0|||
161592532|NCT06491433|583558723|FG000|Overall Study|screen failure|1|||
161539961|NCT03217747|583365298|FG008|Overall Study|Adverse Event|0|||
161539962|NCT03217747|583365299|FG009|Overall Study|Adverse Event|0|||
161539963|NCT03217747|583365300|FG010|Overall Study|Adverse Event|0|||
161592533|NCT04676022|583558727|FG000|Overall Study|Screen Failure/|1|||
161592534|NCT04676022|583558728|FG001|Overall Study|Screen Failure/|1|||
161592535|NCT04676022|583558729|FG002|Overall Study|Screen Failure/|85|||
161592536|NCT04676022|583558727|FG000|Overall Study|Lost to Follow-up|1|||
161592537|NCT04676022|583558728|FG001|Overall Study|Lost to Follow-up|1|||
161592538|NCT04676022|583558729|FG002|Overall Study|Lost to Follow-up|0|||
161592539|NCT04676022|583558727|FG000|Overall Study|Adverse Event|2|||
161592540|NCT04676022|583558728|FG001|Overall Study|Adverse Event|0|||
161592541|NCT04676022|583558729|FG002|Overall Study|Adverse Event|1|||
161592542|NCT04676022|583558727|FG000|Overall Study|Physician Decision|2|||
161592543|NCT04676022|583558728|FG001|Overall Study|Physician Decision|0|||
161592544|NCT04676022|583558729|FG002|Overall Study|Physician Decision|1|||
161592545|NCT04676022|583558727|FG000|Overall Study|Withdrawal by Subject|3|||
161592546|NCT04676022|583558728|FG001|Overall Study|Withdrawal by Subject|1|||
161592547|NCT04676022|583558729|FG002|Overall Study|Withdrawal by Subject|6|||
161592548|NCT04676022|583558727|FG000|Overall Study|Will not move forward with permanent implant|6|||
161592549|NCT04676022|583558728|FG001|Overall Study|Will not move forward with permanent implant|0|||
161539964|NCT03217747|583365301|FG011|Overall Study|Adverse Event|0|||
161539965|NCT03217747|583365302|FG012|Overall Study|Adverse Event|1|||
161539966|NCT03217747|583365303|FG013|Overall Study|Adverse Event|1|||
161539967|NCT03217747|583365290|FG000|Overall Study|Death|0|||
161592550|NCT04676022|583558729|FG002|Overall Study|Will not move forward with permanent implant|0|||
161592551|NCT04676022|583558727|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
161592552|NCT04676022|583558728|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
161829413|NCT00892281|584415776|FG001|Overall Study|Did not meet incl/excl criteria|0|||
161829414|NCT00892281|584415775|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
161539968|NCT03217747|583365291|FG001|Overall Study|Death|0|||
161539969|NCT03217747|583365292|FG002|Overall Study|Death|0|||
161539970|NCT03217747|583365293|FG003|Overall Study|Death|0|||
161539971|NCT03217747|583365294|FG004|Overall Study|Death|0|||
161539972|NCT03217747|583365295|FG005|Overall Study|Death|0|||
161539973|NCT03217747|583365296|FG006|Overall Study|Death|0|||
161539974|NCT03217747|583365297|FG007|Overall Study|Death|0|||
161539975|NCT03217747|583365298|FG008|Overall Study|Death|1|||
161539976|NCT03217747|583365299|FG009|Overall Study|Death|0|||
161539977|NCT03217747|583365300|FG010|Overall Study|Death|0|||
161539978|NCT03217747|583365301|FG011|Overall Study|Death|0|||
161539979|NCT03217747|583365302|FG012|Overall Study|Death|0|||
161539980|NCT03217747|583365303|FG013|Overall Study|Death|0|||
161539981|NCT03217747|583365290|FG000|Overall Study|Lack of Efficacy|12|||
161539982|NCT03217747|583365291|FG001|Overall Study|Lack of Efficacy|6|||
161539983|NCT03217747|583365292|FG002|Overall Study|Lack of Efficacy|15|||
161539984|NCT03217747|583365293|FG003|Overall Study|Lack of Efficacy|11|||
161539985|NCT03217747|583365294|FG004|Overall Study|Lack of Efficacy|3|||
161539986|NCT03217747|583365295|FG005|Overall Study|Lack of Efficacy|14|||
161539987|NCT03217747|583365296|FG006|Overall Study|Lack of Efficacy|10|||
161539988|NCT03217747|583365297|FG007|Overall Study|Lack of Efficacy|4|||
161539989|NCT03217747|583365298|FG008|Overall Study|Lack of Efficacy|2|||
161539990|NCT03217747|583365299|FG009|Overall Study|Lack of Efficacy|7|||
161539991|NCT03217747|583365300|FG010|Overall Study|Lack of Efficacy|3|||
161539992|NCT03217747|583365301|FG011|Overall Study|Lack of Efficacy|1|||
161539993|NCT03217747|583365302|FG012|Overall Study|Lack of Efficacy|3|||
161539994|NCT03217747|583365303|FG013|Overall Study|Lack of Efficacy|1|||
161539995|NCT03217747|583365290|FG000|Overall Study|Withdrawal by Subject|2|||
161539996|NCT03217747|583365291|FG001|Overall Study|Withdrawal by Subject|1|||
161539997|NCT03217747|583365292|FG002|Overall Study|Withdrawal by Subject|1|||
161539998|NCT03217747|583365293|FG003|Overall Study|Withdrawal by Subject|1|||
161539999|NCT03217747|583365294|FG004|Overall Study|Withdrawal by Subject|1|||
161540000|NCT03217747|583365295|FG005|Overall Study|Withdrawal by Subject|2|||
161540001|NCT03217747|583365296|FG006|Overall Study|Withdrawal by Subject|1|||
161540002|NCT03217747|583365297|FG007|Overall Study|Withdrawal by Subject|0|||
161540003|NCT03217747|583365298|FG008|Overall Study|Withdrawal by Subject|0|||
161540004|NCT03217747|583365299|FG009|Overall Study|Withdrawal by Subject|0|||
161540005|NCT03217747|583365300|FG010|Overall Study|Withdrawal by Subject|0|||
161540006|NCT03217747|583365301|FG011|Overall Study|Withdrawal by Subject|1|||
161540007|NCT03217747|583365302|FG012|Overall Study|Withdrawal by Subject|0|||
161540008|NCT03217747|583365303|FG013|Overall Study|Withdrawal by Subject|1|||
161540009|NCT03217747|583365290|FG000|Overall Study|Toxicity and progression|1|||
161540010|NCT03217747|583365291|FG001|Overall Study|Toxicity and progression|0|||
161540011|NCT03217747|583365292|FG002|Overall Study|Toxicity and progression|0|||
161540012|NCT03217747|583365293|FG003|Overall Study|Toxicity and progression|0|||
161540013|NCT03217747|583365294|FG004|Overall Study|Toxicity and progression|0|||
161540014|NCT03217747|583365295|FG005|Overall Study|Toxicity and progression|0|||
161540015|NCT03217747|583365296|FG006|Overall Study|Toxicity and progression|0|||
161540016|NCT03217747|583365297|FG007|Overall Study|Toxicity and progression|0|||
161540017|NCT03217747|583365298|FG008|Overall Study|Toxicity and progression|0|||
161540018|NCT03217747|583365299|FG009|Overall Study|Toxicity and progression|0|||
161540019|NCT03217747|583365300|FG010|Overall Study|Toxicity and progression|0|||
161540020|NCT03217747|583365301|FG011|Overall Study|Toxicity and progression|0|||
161540021|NCT03217747|583365302|FG012|Overall Study|Toxicity and progression|0|||
161540022|NCT03217747|583365303|FG013|Overall Study|Toxicity and progression|0|||
161540023|NCT03217747|583365290|FG000|Overall Study|Removal of sole target lesion|1|||
161540024|NCT03217747|583365291|FG001|Overall Study|Removal of sole target lesion|0|||
161540025|NCT03217747|583365292|FG002|Overall Study|Removal of sole target lesion|0|||
161540026|NCT03217747|583365293|FG003|Overall Study|Removal of sole target lesion|0|||
161540027|NCT03217747|583365294|FG004|Overall Study|Removal of sole target lesion|0|||
161540028|NCT03217747|583365295|FG005|Overall Study|Removal of sole target lesion|0|||
161540029|NCT03217747|583365296|FG006|Overall Study|Removal of sole target lesion|0|||
161540030|NCT03217747|583365297|FG007|Overall Study|Removal of sole target lesion|0|||
161540031|NCT03217747|583365298|FG008|Overall Study|Removal of sole target lesion|0|||
161540032|NCT03217747|583365299|FG009|Overall Study|Removal of sole target lesion|0|||
161540033|NCT03217747|583365300|FG010|Overall Study|Removal of sole target lesion|0|||
161540034|NCT03217747|583365301|FG011|Overall Study|Removal of sole target lesion|0|||
161540035|NCT03217747|583365302|FG012|Overall Study|Removal of sole target lesion|0|||
161540036|NCT03217747|583365303|FG013|Overall Study|Removal of sole target lesion|0|||
161540037|NCT03217747|583365290|FG000|Overall Study|Stroke|0|||
161829415|NCT00892281|584415776|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
161540038|NCT03217747|583365291|FG001|Overall Study|Stroke|0|||
161540039|NCT03217747|583365292|FG002|Overall Study|Stroke|0|||
161540040|NCT03217747|583365293|FG003|Overall Study|Stroke|0|||
161540041|NCT03217747|583365294|FG004|Overall Study|Stroke|0|||
161540042|NCT03217747|583365295|FG005|Overall Study|Stroke|1|||
161540043|NCT03217747|583365296|FG006|Overall Study|Stroke|0|||
161540044|NCT03217747|583365297|FG007|Overall Study|Stroke|0|||
161540045|NCT03217747|583365298|FG008|Overall Study|Stroke|0|||
161540046|NCT03217747|583365299|FG009|Overall Study|Stroke|0|||
161592553|NCT04676022|583558729|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
161540047|NCT03217747|583365300|FG010|Overall Study|Stroke|0|||
161540048|NCT03217747|583365301|FG011|Overall Study|Stroke|1|||
161540049|NCT03217747|583365302|FG012|Overall Study|Stroke|0|||
161540050|NCT03217747|583365303|FG013|Overall Study|Stroke|0|||
161540051|NCT03248375|583365304|FG000|Overall Study|Lost to Follow-up|5|||
161540052|NCT00394355|583365305|FG000|Overall Study|Adverse Event|10|||
161540053|NCT00394355|583365306|FG001|Overall Study|Adverse Event|6|||
161540054|NCT00394355|583365307|FG002|Overall Study|Adverse Event|7|||
161540055|NCT00394355|583365308|FG003|Overall Study|Adverse Event|8|||
161540056|NCT00394355|583365305|FG000|Overall Study|Did not meet protocol eligibility|1|||
161540057|NCT00394355|583365306|FG001|Overall Study|Did not meet protocol eligibility|5|||
161540058|NCT00394355|583365307|FG002|Overall Study|Did not meet protocol eligibility|4|||
161540059|NCT00394355|583365308|FG003|Overall Study|Did not meet protocol eligibility|2|||
161829416|NCT00892281|584415775|FG000|Overall Study|Unable to redeem the drug voucher|1|||
161592554|NCT05409183|583558744|FG000|Complete Study|Adverse Event|1|||
161592555|NCT05409183|583558745|FG001|Complete Study|Adverse Event|2|||
161592556|NCT05409183|583558744|FG000|Complete Study|Withdrawal by Subject|3|||
161592557|NCT05409183|583558745|FG001|Complete Study|Withdrawal by Subject|0|||
161592558|NCT02274662|583558748|FG000|Overall Study|Death|1|||
161592559|NCT02274662|583558748|FG000|Overall Study|Lost to Follow-up|3|||
161592560|NCT04806451|583558749|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
161592561|NCT04806451|583558750|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
161592562|NCT04806451|583558749|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
161592563|NCT04806451|583558750|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
161592564|NCT04806451|583558749|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
161592565|NCT04806451|583558750|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
161592566|NCT02936752|583558751|FG000|Overall Study|Death|2|||
161592567|NCT02936752|583558752|FG001|Overall Study|Death|1|||
161592568|NCT02936752|583558751|FG000|Overall Study|Physician Decision|4|||
161592569|NCT02936752|583558752|FG001|Overall Study|Physician Decision|0|||
161592570|NCT02936752|583558751|FG000|Overall Study|Withdrawal by Subject|0|||
161592571|NCT02936752|583558752|FG001|Overall Study|Withdrawal by Subject|2|||
161592572|NCT05292365|583558755|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
161592573|NCT05292365|583558756|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
161592574|NCT05292365|583558757|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
161592575|NCT05292365|583558758|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
161592576|NCT05282173|583558759|FG000|Overall Study|Missed|3|||
161592577|NCT05282173|583558760|FG001|Overall Study|Missed|2|||
161592578|NCT05282173|583558761|FG002|Overall Study|Missed|4|||
161592579|NCT03134196|583558769|FG000|Overall Study|Death|2|||
161592580|NCT03134196|583558770|FG001|Overall Study|Death|1|||
161592581|NCT03134196|583558769|FG000|Overall Study|Lost to Follow-up|13|||
161592582|NCT03134196|583558770|FG001|Overall Study|Lost to Follow-up|15|||
161592583|NCT03134196|583558769|FG000|Overall Study|Physician Decision|0|||
161592584|NCT03134196|583558770|FG001|Overall Study|Physician Decision|1|||
161592585|NCT03134196|583558769|FG000|Overall Study|Withdrawal by Subject|19|||
161592586|NCT03134196|583558770|FG001|Overall Study|Withdrawal by Subject|12|||
161592587|NCT03134196|583558769|FG000|Overall Study|Site Unable to Contact Participant|2|||
161592588|NCT03134196|583558770|FG001|Overall Study|Site Unable to Contact Participant|0|||
161592589|NCT03134196|583558769|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
161592590|NCT03134196|583558770|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
161592591|NCT03134196|583558769|FG000|Overall Study|Scheduling Conflict|1|||
161829417|NCT00892281|584415776|FG001|Overall Study|Unable to redeem the drug voucher|0|||
161540060|NCT00394355|583365305|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
161829418|NCT00892281|584415775|FG000|Overall Study|Subject not good candidate for study|1|||
161540061|NCT00394355|583365306|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
161540062|NCT00394355|583365307|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
161540063|NCT00394355|583365308|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
161540064|NCT00394355|583365305|FG000|Overall Study|Subject withdrawal - related to drug|1|||
161540065|NCT00394355|583365306|FG001|Overall Study|Subject withdrawal - related to drug|0|||
161540066|NCT00394355|583365307|FG002|Overall Study|Subject withdrawal - related to drug|0|||
161540067|NCT00394355|583365308|FG003|Overall Study|Subject withdrawal - related to drug|0|||
161540068|NCT00394355|583365305|FG000|Overall Study|Lost to Follow-up|7|||
161540069|NCT00394355|583365306|FG001|Overall Study|Lost to Follow-up|5|||
161540070|NCT00394355|583365307|FG002|Overall Study|Lost to Follow-up|4|||
161540071|NCT00394355|583365308|FG003|Overall Study|Lost to Follow-up|3|||
161540072|NCT00394355|583365305|FG000|Overall Study|Noncompliance with protocol|4|||
161540073|NCT00394355|583365306|FG001|Overall Study|Noncompliance with protocol|3|||
161540074|NCT00394355|583365307|FG002|Overall Study|Noncompliance with protocol|10|||
161540075|NCT00394355|583365308|FG003|Overall Study|Noncompliance with protocol|8|||
161540076|NCT00394355|583365305|FG000|Overall Study|Administrative|0|||
161540077|NCT00394355|583365306|FG001|Overall Study|Administrative|1|||
161540078|NCT00394355|583365307|FG002|Overall Study|Administrative|1|||
161540079|NCT00394355|583365308|FG003|Overall Study|Administrative|1|||
161540080|NCT00394355|583365305|FG000|Overall Study|Lack of Efficacy|0|||
161540081|NCT00394355|583365306|FG001|Overall Study|Lack of Efficacy|0|||
161540082|NCT00394355|583365307|FG002|Overall Study|Lack of Efficacy|2|||
161540083|NCT00394355|583365308|FG003|Overall Study|Lack of Efficacy|3|||
161540084|NCT02618616|583365311|FG000|Overall Study|Lack of Efficacy|4|||
161540085|NCT02618616|583365312|FG001|Overall Study|Lack of Efficacy|0|||
161592592|NCT03134196|583558770|FG001|Overall Study|Scheduling Conflict|0|||
161592593|NCT01798498|583558783|FG000|Overall Study|Lost to Follow-up|1|||
161592594|NCT04592549|583558788|FG000|Overall Study|Withdrawal by Subject|0|||
161592595|NCT04592549|583558789|FG001|Overall Study|Withdrawal by Subject|1|||
161592596|NCT04592549|583558790|FG002|Overall Study|Withdrawal by Subject|0|||
161540086|NCT02618616|583365311|FG000|Overall Study|Pregnancy|0|||
161540087|NCT02618616|583365312|FG001|Overall Study|Pregnancy|1|||
161829419|NCT00892281|584415776|FG001|Overall Study|Subject not good candidate for study|0|||
161540088|NCT02618616|583365311|FG000|Overall Study|Adverse Event|8|||
161540089|NCT02618616|583365312|FG001|Overall Study|Adverse Event|0|||
161540090|NCT02618616|583365311|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
161540091|NCT02618616|583365312|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
161540092|NCT02618616|583365311|FG000|Overall Study|Consent withdrawn by subject|8|||
161540093|NCT02618616|583365312|FG001|Overall Study|Consent withdrawn by subject|5|||
161540094|NCT02618616|583365311|FG000|Overall Study|Lost to Follow-up|0|||
161540095|NCT02618616|583365312|FG001|Overall Study|Lost to Follow-up|1|||
161540096|NCT03904043|583365313|FG000|Overall Study|Adverse Event|1|||
161540097|NCT03904043|583365314|FG001|Overall Study|Adverse Event|1|||
161540098|NCT03904043|583365313|FG000|Overall Study|Withdrawal by Subject|1|||
161540099|NCT03904043|583365314|FG001|Overall Study|Withdrawal by Subject|0|||
161540100|NCT03904043|583365313|FG000|Overall Study|Non-compliance|1|||
161540101|NCT03904043|583365314|FG001|Overall Study|Non-compliance|0|||
161540102|NCT03904043|583365313|FG000|Overall Study|Did not start treatment|1|||
161540103|NCT03904043|583365314|FG001|Overall Study|Did not start treatment|0|||
161540104|NCT05002218|583365320|FG000|Overall Study|Lost to Follow-up|5|||
161540105|NCT05002218|583365321|FG001|Overall Study|Lost to Follow-up|6|||
161540106|NCT03421808|583365322|FG000|Overall Study|COVID related problems|2|||
161540107|NCT03421808|583365323|FG001|Overall Study|COVID related problems|0|||
161540108|NCT03421808|583365322|FG000|Overall Study|Withdrawal by Subject|1|||
161540109|NCT03421808|583365323|FG001|Overall Study|Withdrawal by Subject|0|||
161540110|NCT03421808|583365322|FG000|Overall Study|Protocol Violation|0|||
161540111|NCT03421808|583365323|FG001|Overall Study|Protocol Violation|1|||
161540112|NCT03764774|583365326|FG000|Overall Study|Withdrawal by Subject|0|||
161540113|NCT03764774|583365327|FG001|Overall Study|Withdrawal by Subject|0|||
161540114|NCT03764774|583365328|FG002|Overall Study|Withdrawal by Subject|0|||
161540115|NCT03764774|583365329|FG003|Overall Study|Withdrawal by Subject|0|||
161540116|NCT03764774|583365330|FG004|Overall Study|Withdrawal by Subject|0|||
161592597|NCT04592549|583558791|FG003|Overall Study|Withdrawal by Subject|1|||
161592598|NCT04592549|583558792|FG004|Overall Study|Withdrawal by Subject|1|||
161592599|NCT04592549|583558793|FG005|Overall Study|Withdrawal by Subject|0|||
161592600|NCT04592549|583558788|FG000|Overall Study|Lost to Follow-up|2|||
161592601|NCT04592549|583558789|FG001|Overall Study|Lost to Follow-up|0|||
161592602|NCT04592549|583558790|FG002|Overall Study|Lost to Follow-up|0|||
161592603|NCT04592549|583558791|FG003|Overall Study|Lost to Follow-up|1|||
161592604|NCT04592549|583558792|FG004|Overall Study|Lost to Follow-up|1|||
161592605|NCT04592549|583558793|FG005|Overall Study|Lost to Follow-up|1|||
161592606|NCT04295798|583558796|FG000|Overall Study|Lost to Follow-up|1|||
161592607|NCT04625283|583558799|FG000|Overall Study|post randomization exclusion|28|||
161592608|NCT04625283|583558800|FG001|Overall Study|post randomization exclusion|20|||
161592609|NCT05364671|583558801|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
161592610|NCT05364671|583558802|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
161592611|NCT05364671|583558801|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
161592612|NCT05364671|583558802|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
161592613|NCT05364671|583558801|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
161592614|NCT05364671|583558802|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
161540117|NCT03764774|583365331|FG005|Overall Study|Withdrawal by Subject|0|||
161540118|NCT03764774|583365332|FG006|Overall Study|Withdrawal by Subject|0|||
161540119|NCT03764774|583365333|FG007|Overall Study|Withdrawal by Subject|0|||
161540120|NCT03764774|583365334|FG008|Overall Study|Withdrawal by Subject|0|||
161592615|NCT05364671|583558801|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
161829420|NCT00892281|584415775|FG000|Overall Study|Subject did not return for any visits|1|||
161829421|NCT00892281|584415776|FG001|Overall Study|Subject did not return for any visits|0|||
161829422|NCT00892281|584415775|FG000|Overall Study|Subject missed several visits/lost meds|1|||
161829423|NCT00892281|584415776|FG001|Overall Study|Subject missed several visits/lost meds|0|||
161829424|NCT00892281|584415775|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
161829425|NCT00892281|584415776|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
161829426|NCT00892281|584415775|FG000|Overall Study|Scheduled for knee replacement|0|||
161829427|NCT00892281|584415776|FG001|Overall Study|Scheduled for knee replacement|1|||
161829428|NCT00892281|584415775|FG000|Overall Study|PI complained of inadequate compensation|3|||
161829429|NCT00892281|584415776|FG001|Overall Study|PI complained of inadequate compensation|0|||
161829430|NCT00892281|584415775|FG000|Overall Study|Subject lost interest in program|0|||
161829431|NCT00892281|584415776|FG001|Overall Study|Subject lost interest in program|1|||
161829432|NCT00892281|584415775|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
161829433|NCT00892281|584415776|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
161829434|NCT00892281|584415775|FG000|Overall Study|Death in family|1|||
161829435|NCT00892281|584415776|FG001|Overall Study|Death in family|0|||
161829436|NCT00892281|584415775|FG000|Overall Study|Lack of efficacy of study product|2|||
161829437|NCT00892281|584415776|FG001|Overall Study|Lack of efficacy of study product|0|||
161540121|NCT03764774|583365335|FG009|Overall Study|Withdrawal by Subject|0|||
161540122|NCT03764774|583365336|FG010|Overall Study|Withdrawal by Subject|1|||
161540123|NCT03764774|583365337|FG011|Overall Study|Withdrawal by Subject|0|||
161540124|NCT03764774|583365338|FG012|Overall Study|Withdrawal by Subject|0|||
161540125|NCT03764774|583365339|FG013|Overall Study|Withdrawal by Subject|0|||
161540126|NCT03764774|583365326|FG000|Overall Study|Adverse Event|0|||
161540127|NCT03764774|583365327|FG001|Overall Study|Adverse Event|0|||
161540128|NCT03764774|583365328|FG002|Overall Study|Adverse Event|0|||
161540129|NCT03764774|583365329|FG003|Overall Study|Adverse Event|0|||
161540130|NCT03764774|583365330|FG004|Overall Study|Adverse Event|0|||
161540131|NCT03764774|583365331|FG005|Overall Study|Adverse Event|0|||
161540132|NCT03764774|583365332|FG006|Overall Study|Adverse Event|0|||
161540133|NCT03764774|583365333|FG007|Overall Study|Adverse Event|0|||
161540134|NCT03764774|583365334|FG008|Overall Study|Adverse Event|0|||
161540135|NCT03764774|583365335|FG009|Overall Study|Adverse Event|0|||
161540136|NCT03764774|583365336|FG010|Overall Study|Adverse Event|0|||
161540137|NCT03764774|583365337|FG011|Overall Study|Adverse Event|0|||
161540138|NCT03764774|583365338|FG012|Overall Study|Adverse Event|2|||
161540139|NCT03764774|583365339|FG013|Overall Study|Adverse Event|0|||
161540140|NCT03764774|583365326|FG000|Overall Study|Lost to Follow-up|0|||
161540141|NCT03764774|583365327|FG001|Overall Study|Lost to Follow-up|0|||
161540142|NCT03764774|583365328|FG002|Overall Study|Lost to Follow-up|0|||
161540143|NCT03764774|583365329|FG003|Overall Study|Lost to Follow-up|0|||
161540144|NCT03764774|583365330|FG004|Overall Study|Lost to Follow-up|0|||
161540145|NCT03764774|583365331|FG005|Overall Study|Lost to Follow-up|0|||
161540146|NCT03764774|583365332|FG006|Overall Study|Lost to Follow-up|0|||
161540147|NCT03764774|583365333|FG007|Overall Study|Lost to Follow-up|0|||
161540148|NCT03764774|583365334|FG008|Overall Study|Lost to Follow-up|0|||
161540149|NCT03764774|583365335|FG009|Overall Study|Lost to Follow-up|0|||
161540150|NCT03764774|583365336|FG010|Overall Study|Lost to Follow-up|0|||
161540151|NCT03764774|583365337|FG011|Overall Study|Lost to Follow-up|0|||
161540152|NCT03764774|583365338|FG012|Overall Study|Lost to Follow-up|0|||
161540153|NCT03764774|583365339|FG013|Overall Study|Lost to Follow-up|1|||
161540154|NCT03764774|583365326|FG000|Overall Study|Physician Decision|0|||
161540155|NCT03764774|583365327|FG001|Overall Study|Physician Decision|0|||
161540156|NCT03764774|583365328|FG002|Overall Study|Physician Decision|0|||
161540157|NCT03764774|583365329|FG003|Overall Study|Physician Decision|0|||
161540158|NCT03764774|583365330|FG004|Overall Study|Physician Decision|0|||
161540159|NCT03764774|583365331|FG005|Overall Study|Physician Decision|0|||
161540160|NCT03764774|583365332|FG006|Overall Study|Physician Decision|0|||
161540161|NCT03764774|583365333|FG007|Overall Study|Physician Decision|0|||
161540162|NCT03764774|583365334|FG008|Overall Study|Physician Decision|0|||
161540163|NCT03764774|583365335|FG009|Overall Study|Physician Decision|4|||
161540164|NCT03764774|583365336|FG010|Overall Study|Physician Decision|1|||
161540165|NCT03764774|583365337|FG011|Overall Study|Physician Decision|4|||
161540166|NCT03764774|583365338|FG012|Overall Study|Physician Decision|9|||
161540167|NCT03764774|583365339|FG013|Overall Study|Physician Decision|0|||
161540168|NCT03764774|583365326|FG000|Overall Study|Study Termination|0|||
161540169|NCT03764774|583365327|FG001|Overall Study|Study Termination|0|||
161540170|NCT03764774|583365328|FG002|Overall Study|Study Termination|0|||
161540171|NCT03764774|583365329|FG003|Overall Study|Study Termination|0|||
161540172|NCT03764774|583365330|FG004|Overall Study|Study Termination|0|||
161540173|NCT03764774|583365331|FG005|Overall Study|Study Termination|0|||
161540174|NCT03764774|583365332|FG006|Overall Study|Study Termination|0|||
161540175|NCT03764774|583365333|FG007|Overall Study|Study Termination|0|||
161540176|NCT03764774|583365334|FG008|Overall Study|Study Termination|0|||
161540177|NCT03764774|583365335|FG009|Overall Study|Study Termination|1|||
161540178|NCT03764774|583365336|FG010|Overall Study|Study Termination|0|||
161540179|NCT03764774|583365337|FG011|Overall Study|Study Termination|0|||
161540180|NCT03764774|583365338|FG012|Overall Study|Study Termination|0|||
161540181|NCT03764774|583365339|FG013|Overall Study|Study Termination|2|||
161540182|NCT00766675|583366744|FG000|Overall Study|Adverse Event|16|||
161540183|NCT00766675|583366744|FG000|Overall Study|Lost to Follow-up|2|||
161540184|NCT00766675|583366744|FG000|Overall Study|Withdrawal by Subject|11|||
161540185|NCT00766675|583366744|FG000|Overall Study|Protocol Violation|8|||
161540186|NCT00766675|583366744|FG000|Overall Study|Participant took prohibited medication|1|||
161540187|NCT00766675|583366744|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
161540188|NCT00766675|583366744|FG000|Overall Study|Insufficient therapy|1|||
161540189|NCT01679236|583366745|FG000|Overall Study|Lost to Follow-up|15|||
161540190|NCT01679236|583366746|FG001|Overall Study|Lost to Follow-up|15|||
161540191|NCT03935217|583366749|FG000|Overall Study|Adverse Event|1|||
161540192|NCT03935217|583366750|FG001|Overall Study|Adverse Event|0|||
161540193|NCT03935217|583366749|FG000|Overall Study|Lost to Follow-up|0|||
161540194|NCT03935217|583366750|FG001|Overall Study|Lost to Follow-up|1|||
161540195|NCT03935217|583366749|FG000|Overall Study|Withdrawal by Subject|0|||
161540196|NCT03935217|583366750|FG001|Overall Study|Withdrawal by Subject|2|||
161540197|NCT02026232|583366759|FG000|Overall Study|incomplete visit/missing data|3|||
161540198|NCT02026232|583366760|FG001|Overall Study|incomplete visit/missing data|2|||
161540199|NCT00755222|583366761|FG000|Overall Study|Withdrawal by Subject|4|||
161540200|NCT00755222|583366762|FG001|Overall Study|Withdrawal by Subject|2|||
161540201|NCT00755222|583366761|FG000|Overall Study|Adverse Event|2|||
161540202|NCT00755222|583366762|FG001|Overall Study|Adverse Event|0|||
161540203|NCT00755222|583366761|FG000|Overall Study|Protocol Violation|2|||
161540204|NCT00755222|583366762|FG001|Overall Study|Protocol Violation|0|||
161540205|NCT00331344|583366763|FG000|Phase I|Adverse Event|0|||
161540206|NCT00331344|583366764|FG001|Phase I|Adverse Event|0|||
161540207|NCT00331344|583366765|FG002|Phase I|Adverse Event|0|||
161540208|NCT00331344|583366766|FG003|Phase I|Adverse Event|1|||
161540209|NCT00331344|583366767|FG004|Phase I|Adverse Event|2|||
161540210|NCT00331344|583366768|FG005|Phase I|Adverse Event|2|||
161540211|NCT00331344|583366769|FG006|Phase I|Adverse Event|0|||
161540212|NCT00331344|583366770|FG007|Phase I|Adverse Event|1|||
161540213|NCT00331344|583366771|FG008|Phase I|Adverse Event|0|||
161540214|NCT00331344|583366763|FG000|Phase II|Death|0|||
161540215|NCT00331344|583366764|FG001|Phase II|Death|0|||
161540216|NCT00331344|583366765|FG002|Phase II|Death|0|||
161540217|NCT00331344|583366766|FG003|Phase II|Death|0|||
161540218|NCT00331344|583366767|FG004|Phase II|Death|0|||
161540219|NCT00331344|583366768|FG005|Phase II|Death|0|||
161540220|NCT00331344|583366769|FG006|Phase II|Death|0|||
161540221|NCT00331344|583366770|FG007|Phase II|Death|0|||
161540222|NCT00331344|583366771|FG008|Phase II|Death|4|||
161540223|NCT04538144|583366777|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
161540224|NCT04538144|583366778|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
161540225|NCT04538144|583366779|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
161540226|NCT04538144|583366780|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
161540227|NCT02228967|583366781|FG000|Overall Study|Lost to Follow-up|146|||
161540228|NCT02228967|583366782|FG001|Overall Study|Lost to Follow-up|142|||
161540229|NCT02228967|583366781|FG000|Overall Study|Withdrawal by Subject|13|||
161540230|NCT02228967|583366782|FG001|Overall Study|Withdrawal by Subject|18|||
161540231|NCT01995539|583366785|FG000|Overall Study|Screening Failure|1|||
161540232|NCT01995539|583366785|FG000|Overall Study|Withdrawal by Investigator|15|||
161540233|NCT01995539|583366785|FG000|Overall Study|Withdrawal by Subject|11|||
161540234|NCT01995539|583366785|FG000|Overall Study|Lost to Follow-up|5|||
161540235|NCT01995539|583366785|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
161540236|NCT03261271|583366789|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
161540237|NCT03261271|583366790|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
161540238|NCT02173054|583366791|FG000|Overall Study|lack of compliance|1|||
161592616|NCT05364671|583558802|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
161592617|NCT05364671|583558801|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
161592618|NCT05364671|583558802|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
161592619|NCT02761057|583558803|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
161592620|NCT02761057|583558804|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
161592621|NCT02761057|583558805|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
161592622|NCT02761057|583558806|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
161592623|NCT02761057|583558803|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
161592624|NCT02761057|583558804|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
161592625|NCT02761057|583558805|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
161592626|NCT02761057|583558806|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
161592627|NCT02761057|583558803|FG000|Overall Study|Currently On Study Treatment|0|||
161592628|NCT02761057|583558804|FG001|Overall Study|Currently On Study Treatment|3|||
161592629|NCT02761057|583558805|FG002|Overall Study|Currently On Study Treatment|0|||
161592630|NCT02761057|583558806|FG003|Overall Study|Currently On Study Treatment|0|||
161592631|NCT02761057|583558803|FG000|Overall Study|Adverse Event|11|||
161592632|NCT02761057|583558804|FG001|Overall Study|Adverse Event|9|||
161592633|NCT02761057|583558805|FG002|Overall Study|Adverse Event|5|||
161592634|NCT02761057|583558806|FG003|Overall Study|Adverse Event|3|||
161592635|NCT02761057|583558803|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
161592636|NCT02761057|583558804|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
161592637|NCT02761057|583558805|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
161592638|NCT02761057|583558806|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
161592639|NCT02761057|583558803|FG000|Overall Study|Progression/Relapse|29|||
161592640|NCT02761057|583558804|FG001|Overall Study|Progression/Relapse|27|||
161592641|NCT02761057|583558805|FG002|Overall Study|Progression/Relapse|20|||
161540239|NCT02173054|583366792|FG001|Overall Study|lack of compliance|0|||
161540240|NCT02173054|583366793|FG002|Overall Study|lack of compliance|0|||
161540241|NCT02173054|583366791|FG000|Overall Study|Withdrawal by Subject|0|||
161540242|NCT02173054|583366792|FG001|Overall Study|Withdrawal by Subject|0|||
161540243|NCT02173054|583366793|FG002|Overall Study|Withdrawal by Subject|1|||
161540244|NCT01932697|583366794|FG000|Overall Study|Received a different amount of tx|1|||
161540245|NCT01932697|583366795|FG001|Overall Study|Received a different amount of tx|0|||
161540246|NCT01932697|583366794|FG000|Overall Study|Ineligible|1|||
161540247|NCT01932697|583366795|FG001|Overall Study|Ineligible|0|||
161540248|NCT00215540|583366800|FG000|Overall Study|Withdrew from study medication|1|||
161592642|NCT02761057|583558806|FG003|Overall Study|Progression/Relapse|23|||
161592643|NCT02761057|583558803|FG000|Overall Study|Death|2|||
161540249|NCT00215540|583366801|FG001|Overall Study|Withdrew from study medication|0|||
161540250|NCT00215540|583366802|FG002|Overall Study|Withdrew from study medication|0|||
161540251|NCT00674570|583366804|FG000|Overall Study|Withdrawal by Subject|0|||
161540252|NCT00674570|583366805|FG001|Overall Study|Withdrawal by Subject|2|||
161540253|NCT00674570|583366806|FG002|Overall Study|Withdrawal by Subject|0|||
161540254|NCT01337986|583366807|FG000|Overall Study|Adverse Event|2|||
161540255|NCT01337986|583366808|FG001|Overall Study|Adverse Event|2|||
161540256|NCT01337986|583366807|FG000|Overall Study|Lost to Follow-up|1|||
161540257|NCT01337986|583366808|FG001|Overall Study|Lost to Follow-up|0|||
161540258|NCT01337986|583366807|FG000|Overall Study|Protocol Violation|0|||
161540259|NCT01337986|583366808|FG001|Overall Study|Protocol Violation|3|||
161540260|NCT02313909|583366809|FG000|Overall Study|Consent withdrawn by participant|33|||
161540261|NCT02313909|583366810|FG001|Overall Study|Consent withdrawn by participant|33|||
161540262|NCT02313909|583366809|FG000|Overall Study|Lost to Follow-up|24|||
161540263|NCT02313909|583366810|FG001|Overall Study|Lost to Follow-up|17|||
161540264|NCT03430063|583366811|FG000|Overall Study|Adverse Event|0|||
161540265|NCT03430063|583366812|FG001|Overall Study|Adverse Event|1|||
161540266|NCT03430063|583366813|FG002|Overall Study|Adverse Event|0|||
161540267|NCT03430063|583366811|FG000|Overall Study|Death|3|||
161540268|NCT03430063|583366812|FG001|Overall Study|Death|2|||
161540269|NCT03430063|583366813|FG002|Overall Study|Death|3|||
161540270|NCT03430063|583366811|FG000|Overall Study|Lost to Follow-up|0|||
161540271|NCT03430063|583366812|FG001|Overall Study|Lost to Follow-up|1|||
161540272|NCT03430063|583366813|FG002|Overall Study|Lost to Follow-up|0|||
161540273|NCT03430063|583366811|FG000|Overall Study|Withdrawal by Subject|0|||
161540274|NCT03430063|583366812|FG001|Overall Study|Withdrawal by Subject|0|||
161540275|NCT03430063|583366813|FG002|Overall Study|Withdrawal by Subject|1|||
161540276|NCT03430063|583366811|FG000|Overall Study|Withdrawal of consent|3|||
161540277|NCT03430063|583366812|FG001|Overall Study|Withdrawal of consent|1|||
161540278|NCT03430063|583366813|FG002|Overall Study|Withdrawal of consent|2|||
161540279|NCT03430063|583366811|FG000|Overall Study|Progressive disease|1|||
161540280|NCT03430063|583366812|FG001|Overall Study|Progressive disease|2|||
161540281|NCT03430063|583366813|FG002|Overall Study|Progressive disease|1|||
161540282|NCT03430063|583366811|FG000|Overall Study|Other un-specified|1|||
161540283|NCT03430063|583366812|FG001|Overall Study|Other un-specified|1|||
161540284|NCT03430063|583366813|FG002|Overall Study|Other un-specified|0|||
161540285|NCT03430063|583366811|FG000|Overall Study|Randomized, but never treated|0|||
161540286|NCT03430063|583366812|FG001|Overall Study|Randomized, but never treated|0|||
161540287|NCT03430063|583366813|FG002|Overall Study|Randomized, but never treated|1|||
161540288|NCT02798211|583366814|FG000|Period 1|Adverse Event|1|||
161540289|NCT02798211|583366815|FG001|Period 1|Adverse Event|1|||
161540290|NCT02798211|583366816|FG002|Period 1|Adverse Event|0|||
161540291|NCT02798211|583366817|FG003|Period 1|Adverse Event|0|||
161540292|NCT02798211|583366818|FG004|Period 1|Adverse Event|0|||
161540293|NCT02798211|583366819|FG005|Period 1|Adverse Event|0|||
161540294|NCT02798211|583366814|FG000|Period 1|Lost to Follow-up|2|||
161540295|NCT02798211|583366815|FG001|Period 1|Lost to Follow-up|1|||
161540296|NCT02798211|583366816|FG002|Period 1|Lost to Follow-up|0|||
161540297|NCT02798211|583366817|FG003|Period 1|Lost to Follow-up|0|||
161540298|NCT02798211|583366818|FG004|Period 1|Lost to Follow-up|0|||
161540299|NCT02798211|583366819|FG005|Period 1|Lost to Follow-up|0|||
161540300|NCT02798211|583366814|FG000|Period 1|Protocol Violation|0|||
161540301|NCT02798211|583366815|FG001|Period 1|Protocol Violation|0|||
161540302|NCT02798211|583366816|FG002|Period 1|Protocol Violation|2|||
161540303|NCT02798211|583366817|FG003|Period 1|Protocol Violation|0|||
161540304|NCT02798211|583366818|FG004|Period 1|Protocol Violation|0|||
161540305|NCT02798211|583366819|FG005|Period 1|Protocol Violation|0|||
161540306|NCT02798211|583366814|FG000|Period 1|Withdrawal by Subject|1|||
161540307|NCT02798211|583366815|FG001|Period 1|Withdrawal by Subject|1|||
161540308|NCT02798211|583366816|FG002|Period 1|Withdrawal by Subject|0|||
161540309|NCT02798211|583366817|FG003|Period 1|Withdrawal by Subject|0|||
161540310|NCT02798211|583366818|FG004|Period 1|Withdrawal by Subject|0|||
161540311|NCT02798211|583366819|FG005|Period 1|Withdrawal by Subject|0|||
161540312|NCT02798211|583366814|FG000|Period 1|Death|0|||
161540313|NCT02798211|583366815|FG001|Period 1|Death|0|||
161540314|NCT02798211|583366816|FG002|Period 1|Death|1|||
161592644|NCT02761057|583558804|FG001|Overall Study|Death|2|||
161592645|NCT02761057|583558805|FG002|Overall Study|Death|1|||
161540315|NCT02798211|583366817|FG003|Period 1|Death|0|||
161540316|NCT02798211|583366818|FG004|Period 1|Death|0|||
161540317|NCT02798211|583366819|FG005|Period 1|Death|0|||
161540318|NCT02798211|583366814|FG000|Period 1|Withdrawal of Informed Consent|2|||
161540319|NCT02798211|583366815|FG001|Period 1|Withdrawal of Informed Consent|7|||
161540320|NCT02798211|583366816|FG002|Period 1|Withdrawal of Informed Consent|3|||
161540321|NCT02798211|583366817|FG003|Period 1|Withdrawal of Informed Consent|0|||
161540322|NCT02798211|583366818|FG004|Period 1|Withdrawal of Informed Consent|0|||
161540323|NCT02798211|583366819|FG005|Period 1|Withdrawal of Informed Consent|0|||
161592646|NCT02761057|583558806|FG003|Overall Study|Death|1|||
161540324|NCT02798211|583366814|FG000|Period 2|Withdrawal by Subject|2|||
161540325|NCT02798211|583366815|FG001|Period 2|Withdrawal by Subject|0|||
161540326|NCT02798211|583366816|FG002|Period 2|Withdrawal by Subject|0|||
161540327|NCT02798211|583366817|FG003|Period 2|Withdrawal by Subject|0|||
161540328|NCT02798211|583366818|FG004|Period 2|Withdrawal by Subject|2|||
161540329|NCT02798211|583366819|FG005|Period 2|Withdrawal by Subject|2|||
161540330|NCT02798211|583366814|FG000|Period 2|Adverse Event|5|||
161540331|NCT02798211|583366815|FG001|Period 2|Adverse Event|0|||
161540332|NCT02798211|583366816|FG002|Period 2|Adverse Event|0|||
161540333|NCT02798211|583366817|FG003|Period 2|Adverse Event|0|||
161540334|NCT02798211|583366818|FG004|Period 2|Adverse Event|1|||
161540335|NCT02798211|583366819|FG005|Period 2|Adverse Event|0|||
161540336|NCT02798211|583366814|FG000|Period 2|Lack of Efficacy|1|||
161540337|NCT02798211|583366815|FG001|Period 2|Lack of Efficacy|0|||
161540338|NCT02798211|583366816|FG002|Period 2|Lack of Efficacy|0|||
161540339|NCT02798211|583366817|FG003|Period 2|Lack of Efficacy|1|||
161540340|NCT02798211|583366818|FG004|Period 2|Lack of Efficacy|0|||
161540341|NCT02798211|583366819|FG005|Period 2|Lack of Efficacy|1|||
161540342|NCT02798211|583366814|FG000|Period 2|Lost to Follow-up|3|||
161540343|NCT02798211|583366815|FG001|Period 2|Lost to Follow-up|0|||
161540344|NCT02798211|583366816|FG002|Period 2|Lost to Follow-up|0|||
161540345|NCT02798211|583366817|FG003|Period 2|Lost to Follow-up|0|||
161540346|NCT02798211|583366818|FG004|Period 2|Lost to Follow-up|2|||
161540347|NCT02798211|583366819|FG005|Period 2|Lost to Follow-up|0|||
161540348|NCT02798211|583366814|FG000|Period 2|Physician Decision|1|||
161540349|NCT02798211|583366815|FG001|Period 2|Physician Decision|0|||
161540350|NCT02798211|583366816|FG002|Period 2|Physician Decision|0|||
161540351|NCT02798211|583366817|FG003|Period 2|Physician Decision|1|||
161540352|NCT02798211|583366818|FG004|Period 2|Physician Decision|1|||
161540353|NCT02798211|583366819|FG005|Period 2|Physician Decision|0|||
161540354|NCT02798211|583366814|FG000|Period 2|Pregnancy|0|||
161540355|NCT02798211|583366815|FG001|Period 2|Pregnancy|0|||
161540356|NCT02798211|583366816|FG002|Period 2|Pregnancy|0|||
161540357|NCT02798211|583366817|FG003|Period 2|Pregnancy|2|||
161540358|NCT02798211|583366818|FG004|Period 2|Pregnancy|0|||
161540359|NCT02798211|583366819|FG005|Period 2|Pregnancy|0|||
161540360|NCT02798211|583366814|FG000|Period 2|Technical problems|1|||
161540361|NCT02798211|583366815|FG001|Period 2|Technical problems|0|||
161540362|NCT02798211|583366816|FG002|Period 2|Technical problems|0|||
161540363|NCT02798211|583366817|FG003|Period 2|Technical problems|1|||
161540364|NCT02798211|583366818|FG004|Period 2|Technical problems|0|||
161540365|NCT02798211|583366819|FG005|Period 2|Technical problems|0|||
161540366|NCT02798211|583366814|FG000|Period 2|Withdrawal of Informed Consent|1|||
161540367|NCT02798211|583366815|FG001|Period 2|Withdrawal of Informed Consent|0|||
161540368|NCT02798211|583366816|FG002|Period 2|Withdrawal of Informed Consent|0|||
161540369|NCT02798211|583366817|FG003|Period 2|Withdrawal of Informed Consent|2|||
161540370|NCT02798211|583366818|FG004|Period 2|Withdrawal of Informed Consent|2|||
161540371|NCT02798211|583366819|FG005|Period 2|Withdrawal of Informed Consent|3|||
161540372|NCT01782872|583366820|FG000|Overall Study|Protocol Violation|0|||
161540373|NCT01782872|583366821|FG001|Overall Study|Protocol Violation|0|||
161540374|NCT01782872|583366822|FG002|Overall Study|Protocol Violation|0|||
161540375|NCT01782872|583366823|FG003|Overall Study|Protocol Violation|1|||
161540376|NCT01782872|583366820|FG000|Overall Study|Withdrawal by Subject|0|||
161540377|NCT01782872|583366821|FG001|Overall Study|Withdrawal by Subject|1|||
161540378|NCT01782872|583366822|FG002|Overall Study|Withdrawal by Subject|0|||
161540379|NCT01782872|583366823|FG003|Overall Study|Withdrawal by Subject|0|||
161540380|NCT03505476|583366824|FG000|Overall Study|Physician Decision|18|||
161540381|NCT03505476|583366824|FG000|Overall Study|Device Malfunctioned|101|||
161540382|NCT03505476|583366824|FG000|Overall Study|Data Corrupt|6|||
161540383|NCT03505476|583366824|FG000|Overall Study|Device application insufficiant|3|||
161540384|NCT01287611|583366826|FG000|Overall Study|Lost to Follow-up|29|||
161540385|NCT01287611|583366827|FG001|Overall Study|Lost to Follow-up|16|||
161540386|NCT01287611|583366826|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
161540387|NCT01287611|583366827|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
161540388|NCT02255357|583366830|FG000|Overall Study|Physician Decision|10|||
161540389|NCT02255357|583366831|FG001|Overall Study|Physician Decision|24|||
161540390|NCT02192970|583366834|FG000|Overall Study|Lost to Follow-up|6|||
161678757|NCT00574288|583876071|FG006|Overall Study|Study Terminated By Sponsor|5|||
161540391|NCT02192970|583366835|FG001|Overall Study|Lost to Follow-up|0|||
161540392|NCT04074590|583366838|FG000|Overall Study|Adverse Event|1|||
161540393|NCT04074590|583366839|FG001|Overall Study|Adverse Event|0|||
161540394|NCT04074590|583366838|FG000|Overall Study|Physician Decision|1|||
161540395|NCT04074590|583366839|FG001|Overall Study|Physician Decision|0|||
161540396|NCT04074590|583366838|FG000|Overall Study|Withdrawal by Subject|2|||
161540397|NCT04074590|583366839|FG001|Overall Study|Withdrawal by Subject|0|||
161540398|NCT00509236|583366840|FG000|Overall Study|Adverse Event|7|||
161540399|NCT00509236|583366841|FG001|Overall Study|Adverse Event|9|||
161540400|NCT00509236|583366840|FG000|Overall Study|Withdrawal by Subject|5|||
161829438|NCT00892281|584415775|FG000|Overall Study|Subject not seen by PI at final visit|1|||
161829439|NCT00892281|584415776|FG001|Overall Study|Subject not seen by PI at final visit|0|||
161829440|NCT00892281|584415775|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
161829441|NCT00892281|584415776|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
161829442|NCT00892281|584415775|FG000|Overall Study|Missed multiple visits|1|||
161829443|NCT00892281|584415776|FG001|Overall Study|Missed multiple visits|0|||
161829444|NCT00892281|584415775|FG000|Overall Study|Missed visits rescheduled out of window|1|||
161829445|NCT00892281|584415776|FG001|Overall Study|Missed visits rescheduled out of window|0|||
161829446|NCT00892281|584415775|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
161829447|NCT00892281|584415776|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
161540401|NCT00509236|583366841|FG001|Overall Study|Withdrawal by Subject|10|||
161540402|NCT00509236|583366840|FG000|Overall Study|Protocol Violation|3|||
161540403|NCT00509236|583366841|FG001|Overall Study|Protocol Violation|0|||
161540404|NCT00509236|583366840|FG000|Overall Study|Excluded Medication|1|||
161540405|NCT00509236|583366841|FG001|Overall Study|Excluded Medication|1|||
161540406|NCT00509236|583366840|FG000|Overall Study|Scheduled Kidney Transplant|1|||
161540407|NCT00509236|583366841|FG001|Overall Study|Scheduled Kidney Transplant|0|||
161540408|NCT02709005|583366855|FG000|Overall Study|Lost to Follow-up|1|||
161540409|NCT02709005|583366856|FG001|Overall Study|Lost to Follow-up|1|||
161540410|NCT02709005|583366855|FG000|Overall Study|Withdrawal by Subject|3|||
161540411|NCT02709005|583366856|FG001|Overall Study|Withdrawal by Subject|0|||
161540412|NCT01572389|583366857|FG000|Overall Study|Death|1|||
161540413|NCT01572389|583366858|FG001|Overall Study|Death|3|||
161540414|NCT01572389|583366857|FG000|Overall Study|Withdrawal by Subject|14|||
161540415|NCT01572389|583366858|FG001|Overall Study|Withdrawal by Subject|2|||
161540416|NCT01572389|583366857|FG000|Overall Study|Lost to Follow-up|25|||
161540417|NCT01572389|583366858|FG001|Overall Study|Lost to Follow-up|14|||
161592647|NCT02761057|583558803|FG000|Overall Study|Other - Not Protocol Specified|2|||
161592648|NCT02761057|583558804|FG001|Overall Study|Other - Not Protocol Specified|1|||
161592649|NCT02761057|583558805|FG002|Overall Study|Other - Not Protocol Specified|2|||
161592650|NCT02761057|583558806|FG003|Overall Study|Other - Not Protocol Specified|0|||
161592651|NCT04137289|583558813|FG000|Overall Study|Death|0|||
161592652|NCT04137289|583558814|FG001|Overall Study|Death|0|||
161592653|NCT04137289|583558815|FG002|Overall Study|Death|0|||
161592654|NCT04137289|583558816|FG003|Overall Study|Death|0|||
161592655|NCT04137289|583558817|FG004|Overall Study|Death|0|||
161592656|NCT04137289|583558818|FG005|Overall Study|Death|0|||
161592657|NCT04137289|583558819|FG006|Overall Study|Death|1|||
161592658|NCT04137289|583558820|FG007|Overall Study|Death|0|||
161592659|NCT04137289|583558821|FG008|Overall Study|Death|0|||
161592660|NCT04137289|583558813|FG000|Overall Study|Clinical disease progression|0|||
161592661|NCT04137289|583558814|FG001|Overall Study|Clinical disease progression|0|||
161592662|NCT04137289|583558815|FG002|Overall Study|Clinical disease progression|0|||
161592663|NCT04137289|583558816|FG003|Overall Study|Clinical disease progression|4|||
161592664|NCT04137289|583558817|FG004|Overall Study|Clinical disease progression|4|||
161592665|NCT04137289|583558818|FG005|Overall Study|Clinical disease progression|2|||
161592666|NCT04137289|583558819|FG006|Overall Study|Clinical disease progression|5|||
161592667|NCT04137289|583558820|FG007|Overall Study|Clinical disease progression|1|||
161592668|NCT04137289|583558821|FG008|Overall Study|Clinical disease progression|0|||
161592669|NCT04137289|583558813|FG000|Overall Study|Lost to Follow-up|0|||
161592670|NCT04137289|583558814|FG001|Overall Study|Lost to Follow-up|0|||
161592671|NCT04137289|583558815|FG002|Overall Study|Lost to Follow-up|0|||
161592672|NCT04137289|583558816|FG003|Overall Study|Lost to Follow-up|1|||
161592673|NCT04137289|583558817|FG004|Overall Study|Lost to Follow-up|0|||
161592674|NCT04137289|583558818|FG005|Overall Study|Lost to Follow-up|0|||
161592675|NCT04137289|583558819|FG006|Overall Study|Lost to Follow-up|0|||
161592676|NCT04137289|583558820|FG007|Overall Study|Lost to Follow-up|0|||
161592677|NCT04137289|583558821|FG008|Overall Study|Lost to Follow-up|0|||
161592678|NCT04137289|583558813|FG000|Overall Study|Adverse Event|0|||
161592679|NCT04137289|583558814|FG001|Overall Study|Adverse Event|0|||
161592680|NCT04137289|583558815|FG002|Overall Study|Adverse Event|1|||
161592681|NCT04137289|583558816|FG003|Overall Study|Adverse Event|0|||
161829448|NCT00892281|584415775|FG000|Overall Study|Subject had history of drug abuse|1|||
161829449|NCT00892281|584415776|FG001|Overall Study|Subject had history of drug abuse|0|||
161829450|NCT00892281|584415775|FG000|Overall Study|Rash on hand|1|||
161540418|NCT01572389|583366857|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
161592682|NCT04137289|583558817|FG004|Overall Study|Adverse Event|0|||
161592683|NCT04137289|583558818|FG005|Overall Study|Adverse Event|1|||
161592684|NCT04137289|583558819|FG006|Overall Study|Adverse Event|0|||
161592685|NCT04137289|583558820|FG007|Overall Study|Adverse Event|0|||
161592686|NCT04137289|583558821|FG008|Overall Study|Adverse Event|0|||
161592687|NCT04137289|583558813|FG000|Overall Study|Lack of clinical benefit|0|||
161592688|NCT04137289|583558814|FG001|Overall Study|Lack of clinical benefit|0|||
161592689|NCT04137289|583558815|FG002|Overall Study|Lack of clinical benefit|0|||
161592690|NCT04137289|583558816|FG003|Overall Study|Lack of clinical benefit|0|||
161592691|NCT04137289|583558817|FG004|Overall Study|Lack of clinical benefit|0|||
161540419|NCT01572389|583366858|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
161540420|NCT02634788|583366859|FG000|Overall Study|Adverse Event|0|||
161540421|NCT02634788|583366860|FG001|Overall Study|Adverse Event|8|||
161540422|NCT02634788|583366861|FG002|Overall Study|Adverse Event|3|||
161540423|NCT02634788|583366862|FG003|Overall Study|Adverse Event|1|||
161540424|NCT02634788|583366859|FG000|Overall Study|Lack of Efficacy|4|||
161540425|NCT02634788|583366860|FG001|Overall Study|Lack of Efficacy|0|||
161540426|NCT02634788|583366861|FG002|Overall Study|Lack of Efficacy|1|||
161540427|NCT02634788|583366862|FG003|Overall Study|Lack of Efficacy|4|||
161540428|NCT02634788|583366859|FG000|Overall Study|Lost to Follow-up|0|||
161540429|NCT02634788|583366860|FG001|Overall Study|Lost to Follow-up|1|||
161540430|NCT02634788|583366861|FG002|Overall Study|Lost to Follow-up|0|||
161540431|NCT02634788|583366862|FG003|Overall Study|Lost to Follow-up|0|||
161540432|NCT02634788|583366859|FG000|Overall Study|Withdrawal by Subject|0|||
161540433|NCT02634788|583366860|FG001|Overall Study|Withdrawal by Subject|1|||
161540434|NCT02634788|583366861|FG002|Overall Study|Withdrawal by Subject|1|||
161540435|NCT02634788|583366862|FG003|Overall Study|Withdrawal by Subject|0|||
161540436|NCT00758459|583366863|FG000|Overall Study|Adverse Event|3|||
161540437|NCT00758459|583366864|FG001|Overall Study|Adverse Event|2|||
161540438|NCT00758459|583366863|FG000|Overall Study|Protocol Violation|0|||
161540439|NCT00758459|583366864|FG001|Overall Study|Protocol Violation|1|||
161540440|NCT00758459|583366863|FG000|Overall Study|Withdrawal by Subject|0|||
161540441|NCT00758459|583366864|FG001|Overall Study|Withdrawal by Subject|1|||
161540442|NCT01780935|583366868|FG000|Overall Study|Admin problems due to early termination|321|||
161540443|NCT01780935|583366869|FG001|Overall Study|Admin problems due to early termination|309|||
161540444|NCT01780935|583366868|FG000|Overall Study|Adverse Event|2|||
161540445|NCT01780935|583366869|FG001|Overall Study|Adverse Event|4|||
161540446|NCT01780935|583366868|FG000|Overall Study|Death|1|||
161540447|NCT01780935|583366869|FG001|Overall Study|Death|6|||
161540448|NCT01780935|583366868|FG000|Overall Study|Lost to Follow-up|2|||
161540449|NCT01780935|583366869|FG001|Overall Study|Lost to Follow-up|6|||
161540450|NCT01780935|583366868|FG000|Overall Study|Physician Decision|1|||
161540451|NCT01780935|583366869|FG001|Overall Study|Physician Decision|1|||
161540452|NCT01780935|583366868|FG000|Overall Study|Protocol deviation|0|||
161540453|NCT01780935|583366869|FG001|Overall Study|Protocol deviation|1|||
161540454|NCT01780935|583366868|FG000|Overall Study|Patient withdrew consent|8|||
161540455|NCT01780935|583366869|FG001|Overall Study|Patient withdrew consent|9|||
161540456|NCT01281202|583366870|FG000|Overall Study|Adverse Event|2|||
161540457|NCT01281202|583366871|FG001|Overall Study|Adverse Event|0|||
161540458|NCT01281202|583366870|FG000|Overall Study|Withdrawal by Subject|2|||
161540459|NCT01281202|583366871|FG001|Overall Study|Withdrawal by Subject|2|||
161540460|NCT01281202|583366870|FG000|Overall Study|Protocol Violation|11|||
161540461|NCT01281202|583366871|FG001|Overall Study|Protocol Violation|10|||
161540462|NCT01281202|583366870|FG000|Overall Study|Administrative|2|||
161540463|NCT01281202|583366871|FG001|Overall Study|Administrative|8|||
161540464|NCT01281202|583366870|FG000|Overall Study|Lost to Follow-up|11|||
161540465|NCT01281202|583366871|FG001|Overall Study|Lost to Follow-up|13|||
161540466|NCT01281202|583366870|FG000|Overall Study|Incarceration|0|||
161540467|NCT01281202|583366871|FG001|Overall Study|Incarceration|3|||
161540468|NCT01215357|583366872|FG000|Overall Study|Withdrawal by Subject|3|||
161540469|NCT01215357|583366872|FG000|Overall Study|Protocol Violation|9|||
161540470|NCT05479604|583366873|FG000|Overall Study|Lost to Follow-up|1|||
161540471|NCT05479604|583366874|FG001|Overall Study|Lost to Follow-up|5|||
161540472|NCT01591382|583366875|FG000|Overall Study|Discharged Prior to Study Completion|2|||
161540473|NCT01591382|583366876|FG001|Overall Study|Discharged Prior to Study Completion|1|||
161540474|NCT01591382|583366875|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
161540475|NCT01591382|583366876|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
161540476|NCT03185481|583366879|FG000|Overall Study|Adverse Event|1|||
161540477|NCT03185481|583366879|FG000|Overall Study|Study Terminated by Sponsor|4|||
161540478|NCT00701038|583366883|FG000|Overall Study|study amended pilot group of patients|4|||
161540479|NCT00701038|583366884|FG001|Overall Study|study amended pilot group of patients|4|||
161540480|NCT03371940|583366887|FG000|Overall Study|Withdrawal by Subject|8|||
161540481|NCT03371940|583366888|FG001|Overall Study|Withdrawal by Subject|1|||
161540482|NCT03371940|583366889|FG002|Overall Study|Withdrawal by Subject|3|||
161540483|NCT03371940|583366890|FG003|Overall Study|Withdrawal by Subject|4|||
161540484|NCT05099926|583366891|FG000|Overall Study|Lost to Follow-up|1|||
161540485|NCT02686034|583366901|FG000|Run-In Period 1|Eligibility|12|||
161540486|NCT02686034|583366902|FG001|Run-In Period 1|Eligibility|10|||
161540487|NCT02686034|583366901|FG000|Run-In Period 1|Withdrawal by Subject|4|||
161540488|NCT02686034|583366902|FG001|Run-In Period 1|Withdrawal by Subject|3|||
161540489|NCT02686034|583366901|FG000|Run-In Period 1|Lost to Follow-up|4|||
161540490|NCT02686034|583366902|FG001|Run-In Period 1|Lost to Follow-up|4|||
161540491|NCT02686034|583366901|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
161540492|NCT02686034|583366902|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
161540493|NCT02686034|583366901|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
161540494|NCT02686034|583366902|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
161540495|NCT02686034|583366901|FG000|Randomized Controlled Period 2|Adverse Event|0|||
161540496|NCT02686034|583366902|FG001|Randomized Controlled Period 2|Adverse Event|2|||
161540497|NCT02686034|583366901|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
161540498|NCT02686034|583366902|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
161540499|NCT02686034|583366901|FG000|Open Label Period 3|Lost to Follow-up|0|||
161540500|NCT02686034|583366902|FG001|Open Label Period 3|Lost to Follow-up|1|||
161540501|NCT00459342|583366903|FG000|Overall Study|Not eligible|1|||
161540502|NCT01678131|583366904|FG000|Overall Study|Adverse Event|0|||
161540503|NCT01678131|583366905|FG001|Overall Study|Adverse Event|1|||
161540504|NCT01678131|583366906|FG002|Overall Study|Adverse Event|0|||
161540505|NCT01678131|583366904|FG000|Overall Study|Withdrawal by Subject|0|||
161540506|NCT01678131|583366905|FG001|Overall Study|Withdrawal by Subject|0|||
161540507|NCT01678131|583366906|FG002|Overall Study|Withdrawal by Subject|2|||
161540508|NCT00558064|583366907|FG000|Overall Study|Adverse Event|3|||
161540509|NCT00558064|583366908|FG001|Overall Study|Adverse Event|2|||
161540510|NCT00558064|583366907|FG000|Overall Study|Lack of Efficacy|0|||
161540511|NCT00558064|583366908|FG001|Overall Study|Lack of Efficacy|1|||
161540512|NCT00558064|583366907|FG000|Overall Study|Protocol Violation|1|||
161540513|NCT00558064|583366908|FG001|Overall Study|Protocol Violation|0|||
161540514|NCT00558064|583366907|FG000|Overall Study|Lost to Follow-up|0|||
161540515|NCT00558064|583366908|FG001|Overall Study|Lost to Follow-up|1|||
161540516|NCT00558064|583366907|FG000|Overall Study|Withdrawal by Subject|0|||
161540517|NCT00558064|583366908|FG001|Overall Study|Withdrawal by Subject|1|||
161540518|NCT00558064|583366907|FG000|Overall Study|No visit within allowance period|1|||
161540519|NCT00558064|583366908|FG001|Overall Study|No visit within allowance period|0|||
161540520|NCT02027402|583366910|FG000|Overall Study|Withdrawal by Subject|4|||
161540521|NCT02027402|583366911|FG001|Overall Study|Withdrawal by Subject|1|||
161540522|NCT00941798|583366912|FG000|Overall Study|Withdrawal by Subject|72|||
161540523|NCT00941798|583366913|FG001|Overall Study|Withdrawal by Subject|74|||
161540524|NCT00941798|583366912|FG000|Overall Study|Adverse Event|43|||
161540525|NCT00941798|583366913|FG001|Overall Study|Adverse Event|23|||
161540526|NCT00941798|583366912|FG000|Overall Study|Lost to Follow-up|29|||
161540527|NCT00941798|583366913|FG001|Overall Study|Lost to Follow-up|23|||
161540528|NCT00941798|583366912|FG000|Overall Study|Protocol Violation|17|||
161540529|NCT00941798|583366913|FG001|Overall Study|Protocol Violation|20|||
161540530|NCT00941798|583366912|FG000|Overall Study|Administrative problems|13|||
161540531|NCT00941798|583366913|FG001|Overall Study|Administrative problems|23|||
161540532|NCT00941798|583366912|FG000|Overall Study|Lack of Efficacy|10|||
161540533|NCT00941798|583366913|FG001|Overall Study|Lack of Efficacy|17|||
161540534|NCT00941798|583366912|FG000|Overall Study|Patient's inability to use device|6|||
161540535|NCT00941798|583366913|FG001|Overall Study|Patient's inability to use device|1|||
161540536|NCT00941798|583366912|FG000|Overall Study|Abnormal test procedure results|3|||
161540537|NCT00941798|583366913|FG001|Overall Study|Abnormal test procedure results|1|||
161540538|NCT00941798|583366912|FG000|Overall Study|Abnormal laboratory values|1|||
161540539|NCT00941798|583366913|FG001|Overall Study|Abnormal laboratory values|2|||
161540540|NCT00941798|583366912|FG000|Overall Study|Death|0|||
161592692|NCT04137289|583558818|FG005|Overall Study|Lack of clinical benefit|0|||
161592693|NCT04137289|583558819|FG006|Overall Study|Lack of clinical benefit|0|||
161592694|NCT04137289|583558820|FG007|Overall Study|Lack of clinical benefit|0|||
161592695|NCT04137289|583558821|FG008|Overall Study|Lack of clinical benefit|1|||
161592696|NCT04137289|583558813|FG000|Overall Study|Objective disease progression|1|||
161592697|NCT04137289|583558814|FG001|Overall Study|Objective disease progression|1|||
161829451|NCT00892281|584415776|FG001|Overall Study|Rash on hand|0|||
161829452|NCT00892281|584415775|FG000|Overall Study|Visit 4 date out of window|1|||
161540541|NCT00941798|583366913|FG001|Overall Study|Death|1|||
161540542|NCT05597722|583366916|FG000|Overall Study|Study was terminated|6|||
161540543|NCT05597722|583366917|FG001|Overall Study|Study was terminated|1|||
161540544|NCT00404495|583366918|FG000|Overall Study|Death|37|||
161540545|NCT00404495|583366919|FG001|Overall Study|Death|11|||
161829453|NCT00892281|584415776|FG001|Overall Study|Visit 4 date out of window|0|||
161829454|NCT01534078|584415777|FG000|Overall Study|Death|1|||
161540546|NCT00404495|583366918|FG000|Overall Study|Lost to Follow-up|5|||
161540547|NCT00404495|583366919|FG001|Overall Study|Lost to Follow-up|0|||
161540548|NCT00404495|583366918|FG000|Overall Study|Other|1|||
161540549|NCT00404495|583366919|FG001|Overall Study|Other|0|||
161540550|NCT00404495|583366918|FG000|Overall Study|Withdrawal by Subject|1|||
161540551|NCT00404495|583366919|FG001|Overall Study|Withdrawal by Subject|0|||
161540552|NCT04108000|583366920|FG000|Overall Study|Death of patient|1|||
161540553|NCT04108000|583366921|FG001|Overall Study|Death of patient|0|||
161540554|NCT04108000|583366922|FG002|Overall Study|Death of patient|1|||
161540555|NCT04108000|583366923|FG003|Overall Study|Death of patient|0|||
161540556|NCT04108000|583366920|FG000|Overall Study|Withdrawal by Subject|2|||
161592698|NCT04137289|583558815|FG002|Overall Study|Objective disease progression|6|||
161592699|NCT04137289|583558816|FG003|Overall Study|Objective disease progression|18|||
161592700|NCT04137289|583558817|FG004|Overall Study|Objective disease progression|12|||
161592701|NCT04137289|583558818|FG005|Overall Study|Objective disease progression|20|||
161592702|NCT04137289|583558819|FG006|Overall Study|Objective disease progression|18|||
161592703|NCT04137289|583558820|FG007|Overall Study|Objective disease progression|7|||
161592704|NCT04137289|583558821|FG008|Overall Study|Objective disease progression|6|||
161592705|NCT03396588|583558822|FG000|Overall Study|Physician Decision|2|||
161592706|NCT03396588|583558823|FG001|Overall Study|Physician Decision|3|||
161592707|NCT00812461|583558825|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
161592708|NCT00812461|583558826|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
161592709|NCT00812461|583558825|FG000|All Treated Patients|Adverse Event|8|||
161592710|NCT00812461|583558826|FG001|All Treated Patients|Adverse Event|15|||
161592711|NCT00812461|583558825|FG000|All Treated Patients|Lack of Efficacy|13|||
161592712|NCT00812461|583558826|FG001|All Treated Patients|Lack of Efficacy|7|||
161592713|NCT00812461|583558825|FG000|All Treated Patients|Non-compliance|6|||
161592714|NCT00812461|583558826|FG001|All Treated Patients|Non-compliance|9|||
161592715|NCT00812461|583558825|FG000|All Treated Patients|Protocol Violation|36|||
161592716|NCT00812461|583558826|FG001|All Treated Patients|Protocol Violation|27|||
161592717|NCT00812461|583558825|FG000|All Treated Patients|Withdrawal by Subject|45|||
161592718|NCT00812461|583558826|FG001|All Treated Patients|Withdrawal by Subject|54|||
161540557|NCT04108000|583366921|FG001|Overall Study|Withdrawal by Subject|2|||
161540558|NCT04108000|583366922|FG002|Overall Study|Withdrawal by Subject|0|||
161540559|NCT04108000|583366923|FG003|Overall Study|Withdrawal by Subject|0|||
161540560|NCT04108000|583366920|FG000|Overall Study|Death of surrogate partner|0|||
161540561|NCT04108000|583366921|FG001|Overall Study|Death of surrogate partner|1|||
161540562|NCT04108000|583366922|FG002|Overall Study|Death of surrogate partner|0|||
161540563|NCT04108000|583366923|FG003|Overall Study|Death of surrogate partner|1|||
161540564|NCT03750006|583366926|FG000|Overall Study|Withdrawal by Subject|8|||
161540565|NCT03750006|583366926|FG000|Overall Study|COVID PANDEMIC|11|||
161540566|NCT01160484|583368640|FG000|Overall Study|Lack of Efficacy|9|||
161540567|NCT01160484|583368640|FG000|Overall Study|Adverse Event|6|||
161540568|NCT01160484|583368640|FG000|Overall Study|Withdrawal by Subject|2|||
161540569|NCT01160484|583368640|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
161540570|NCT01382602|583368641|FG000|Overall Study|Protocol Violation|0|||
161540571|NCT01382602|583368642|FG001|Overall Study|Protocol Violation|3|||
161540572|NCT01382602|583368641|FG000|Overall Study|Withdrawal by Subject|0|||
161540573|NCT01382602|583368642|FG001|Overall Study|Withdrawal by Subject|1|||
161540574|NCT01392300|583368650|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
161540575|NCT01392300|583368651|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
161540576|NCT01392300|583368652|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
161540577|NCT01392300|583368650|FG000|Main Period (MP)|Withdrawal by Subject|5|||
161540578|NCT01392300|583368651|FG001|Main Period (MP)|Withdrawal by Subject|1|||
161540579|NCT01392300|583368652|FG002|Main Period (MP)|Withdrawal by Subject|0|||
161540580|NCT01392300|583368650|FG000|Main Period (MP)|Lost to Follow-up|3|||
161540581|NCT01392300|583368651|FG001|Main Period (MP)|Lost to Follow-up|3|||
161540582|NCT01392300|583368652|FG002|Main Period (MP)|Lost to Follow-up|0|||
161540583|NCT01392300|583368650|FG000|Main Period (MP)|Non-compliance|1|||
161540584|NCT01392300|583368651|FG001|Main Period (MP)|Non-compliance|0|||
161540585|NCT01392300|583368652|FG002|Main Period (MP)|Non-compliance|0|||
161540586|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
161540587|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
161592719|NCT00812461|583558825|FG000|All Treated Patients|Lost to Follow-up|11|||
161592720|NCT00812461|583558826|FG001|All Treated Patients|Lost to Follow-up|14|||
161592721|NCT00812461|583558825|FG000|All Treated Patients|Other Reason|13|||
161592722|NCT00812461|583558826|FG001|All Treated Patients|Other Reason|21|||
161540588|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
161540589|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
161540590|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
161540591|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
161540592|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
161540593|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
161592723|NCT04029688|583560284|FG000|Overall Study|Death|8|||
161592724|NCT04029688|583560285|FG001|Overall Study|Death|3|||
161592725|NCT04029688|583560286|FG002|Overall Study|Death|6|||
161592726|NCT04029688|583560287|FG003|Overall Study|Death|2|||
161592727|NCT04029688|583560288|FG004|Overall Study|Death|5|||
161540594|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
161540595|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Death|0|||
161540596|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Death|0|||
161540597|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Death|4|||
161540598|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
161540599|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
161540600|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
161540601|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
161540602|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
161540603|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
161540604|NCT01392300|583368650|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
161540605|NCT01392300|583368651|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
161540606|NCT01392300|583368652|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
161540607|NCT01147822|583368657|FG000|Overall Study|Lost to Follow-up|14|||
161540608|NCT01147822|583368658|FG001|Overall Study|Lost to Follow-up|6|||
161540609|NCT01147822|583368657|FG000|Overall Study|Withdrawal by Subject|10|||
161540610|NCT01147822|583368658|FG001|Overall Study|Withdrawal by Subject|16|||
161540611|NCT01147822|583368657|FG000|Overall Study|Physician Decision|9|||
161540612|NCT01147822|583368658|FG001|Overall Study|Physician Decision|8|||
161540613|NCT01147822|583368657|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
161540614|NCT01147822|583368658|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
161540615|NCT01147822|583368657|FG000|Overall Study|Protocol Violation|1|||
161540616|NCT01147822|583368658|FG001|Overall Study|Protocol Violation|1|||
161540617|NCT03010462|583368662|FG000|Overall Study|Withdrawal by Subject|3|||
161540618|NCT03010462|583368663|FG001|Overall Study|Withdrawal by Subject|1|||
161540619|NCT01966003|583368664|FG000|Overall Study|Death|43|||
161540620|NCT01966003|583368665|FG001|Overall Study|Death|36|||
161540621|NCT01966003|583368664|FG000|Overall Study|Protocol Violation|6|||
161540622|NCT01966003|583368665|FG001|Overall Study|Protocol Violation|4|||
161540623|NCT01966003|583368664|FG000|Overall Study|Lost to Follow-up|4|||
161540624|NCT01966003|583368665|FG001|Overall Study|Lost to Follow-up|3|||
161540625|NCT01966003|583368664|FG000|Overall Study|Physician Decision|12|||
161540626|NCT01966003|583368665|FG001|Overall Study|Physician Decision|13|||
161540627|NCT01966003|583368664|FG000|Overall Study|Withdrawal by Subject|29|||
161540628|NCT01966003|583368665|FG001|Overall Study|Withdrawal by Subject|19|||
161540629|NCT01966003|583368664|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
161540630|NCT01966003|583368665|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
161540631|NCT01966003|583368664|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
161540632|NCT01966003|583368665|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
161540633|NCT01966003|583368664|FG000|Overall Study|Other|1|||
161540634|NCT01966003|583368665|FG001|Overall Study|Other|1|||
161540635|NCT02748694|583368670|FG000|Overall Study|Voluntary Withdrawal|0|||
161540636|NCT02748694|583368671|FG001|Overall Study|Voluntary Withdrawal|0|||
161540637|NCT02748694|583368672|FG002|Overall Study|Voluntary Withdrawal|0|||
161540638|NCT02748694|583368673|FG003|Overall Study|Voluntary Withdrawal|0|||
161540639|NCT02748694|583368674|FG004|Overall Study|Voluntary Withdrawal|0|||
161540640|NCT02748694|583368675|FG005|Overall Study|Voluntary Withdrawal|0|||
161540641|NCT02748694|583368676|FG006|Overall Study|Voluntary Withdrawal|0|||
161540642|NCT02748694|583368677|FG007|Overall Study|Voluntary Withdrawal|0|||
161540643|NCT02748694|583368678|FG008|Overall Study|Voluntary Withdrawal|0|||
161540644|NCT02748694|583368679|FG009|Overall Study|Voluntary Withdrawal|0|||
161540645|NCT02748694|583368680|FG010|Overall Study|Voluntary Withdrawal|0|||
161540646|NCT02748694|583368681|FG011|Overall Study|Voluntary Withdrawal|0|||
161540647|NCT02748694|583368682|FG012|Overall Study|Voluntary Withdrawal|0|||
161540648|NCT02748694|583368683|FG013|Overall Study|Voluntary Withdrawal|0|||
161540649|NCT02748694|583368684|FG014|Overall Study|Voluntary Withdrawal|2|||
161540650|NCT04026165|583368685|FG000|Run-in Placebo Period|Enrollment Error|13|||
161540651|NCT04026165|583368686|FG001|Run-in Placebo Period|Enrollment Error|0|||
161540652|NCT04026165|583368687|FG002|Run-in Placebo Period|Enrollment Error|0|||
161540653|NCT04026165|583368688|FG003|Run-in Placebo Period|Enrollment Error|0|||
161540654|NCT04026165|583368685|FG000|Run-in Placebo Period|Run-in Failure|4|||
161540655|NCT04026165|583368686|FG001|Run-in Placebo Period|Run-in Failure|0|||
161540656|NCT04026165|583368687|FG002|Run-in Placebo Period|Run-in Failure|0|||
161540657|NCT04026165|583368688|FG003|Run-in Placebo Period|Run-in Failure|0|||
161540658|NCT04026165|583368685|FG000|Run-in Placebo Period|Protocol Violation|2|||
161540659|NCT04026165|583368686|FG001|Run-in Placebo Period|Protocol Violation|0|||
161540660|NCT04026165|583368687|FG002|Run-in Placebo Period|Protocol Violation|0|||
161540661|NCT04026165|583368688|FG003|Run-in Placebo Period|Protocol Violation|0|||
161540662|NCT04026165|583368685|FG000|Run-in Placebo Period|Withdrew Consent|2|||
161540663|NCT04026165|583368686|FG001|Run-in Placebo Period|Withdrew Consent|0|||
161540664|NCT04026165|583368687|FG002|Run-in Placebo Period|Withdrew Consent|0|||
161540665|NCT04026165|583368688|FG003|Run-in Placebo Period|Withdrew Consent|0|||
161540666|NCT04026165|583368685|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
161829455|NCT01534078|584415777|FG000|Overall Study|Withdrawal by Subject|1|||
161540667|NCT04026165|583368686|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
161540668|NCT04026165|583368687|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
161540669|NCT04026165|583368688|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
161540670|NCT04026165|583368685|FG000|Run-in SEL Period|Run-in Failure|0|||
161540671|NCT04026165|583368686|FG001|Run-in SEL Period|Run-in Failure|26|||
161540672|NCT04026165|583368687|FG002|Run-in SEL Period|Run-in Failure|0|||
161829456|NCT01280617|584415781|FG000|Overall Study|Adverse Event|0|||
161829457|NCT01280617|584415782|FG001|Overall Study|Adverse Event|1|||
161829458|NCT00986570|584415783|FG000|Overall Study|Lost to Follow-up|6|||
161829459|NCT00986570|584415783|FG000|Overall Study|Potential bias for objective assessment|1|||
161829460|NCT02225665|584415784|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
161829461|NCT02225665|584415785|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
161829462|NCT02225665|584415784|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
161829463|NCT02225665|584415785|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
161829464|NCT01311557|584415786|FG000|Overall Study|Serious adverse event|0|||
161829465|NCT01311557|584415787|FG001|Overall Study|Serious adverse event|1|||
161829466|NCT01311557|584415786|FG000|Overall Study|Protocol Violation|4|||
161829467|NCT01311557|584415787|FG001|Overall Study|Protocol Violation|2|||
161829468|NCT01311557|584415786|FG000|Overall Study|Lost to Follow-up|0|||
161829469|NCT01311557|584415787|FG001|Overall Study|Lost to Follow-up|1|||
161829470|NCT01311557|584415786|FG000|Overall Study|Withdrawal by Subject|1|||
161829471|NCT01311557|584415787|FG001|Overall Study|Withdrawal by Subject|2|||
161829472|NCT00608517|584415788|FG000|Overall Study|Death|1|||
161829473|NCT00608517|584415789|FG001|Overall Study|Death|0|||
161540673|NCT04026165|583368688|FG003|Run-in SEL Period|Run-in Failure|0|||
161540674|NCT04026165|583368685|FG000|Run-in SEL Period|Withdrew Consent|0|||
161540675|NCT04026165|583368686|FG001|Run-in SEL Period|Withdrew Consent|10|||
161540676|NCT04026165|583368687|FG002|Run-in SEL Period|Withdrew Consent|0|||
161540677|NCT04026165|583368688|FG003|Run-in SEL Period|Withdrew Consent|0|||
161540678|NCT04026165|583368685|FG000|Run-in SEL Period|Enrollment Error|0|||
161540679|NCT04026165|583368686|FG001|Run-in SEL Period|Enrollment Error|4|||
161540680|NCT04026165|583368687|FG002|Run-in SEL Period|Enrollment Error|0|||
161540681|NCT04026165|583368688|FG003|Run-in SEL Period|Enrollment Error|0|||
161540682|NCT04026165|583368685|FG000|Run-in SEL Period|Protocol Violation|0|||
161540683|NCT04026165|583368686|FG001|Run-in SEL Period|Protocol Violation|3|||
161540684|NCT04026165|583368687|FG002|Run-in SEL Period|Protocol Violation|0|||
161540685|NCT04026165|583368688|FG003|Run-in SEL Period|Protocol Violation|0|||
161540686|NCT04026165|583368685|FG000|Run-in SEL Period|Investigator's Discretion|0|||
161540687|NCT04026165|583368686|FG001|Run-in SEL Period|Investigator's Discretion|2|||
161540688|NCT04026165|583368687|FG002|Run-in SEL Period|Investigator's Discretion|0|||
161540689|NCT04026165|583368688|FG003|Run-in SEL Period|Investigator's Discretion|0|||
161540690|NCT04026165|583368685|FG000|Run-in SEL Period|Death|0|||
161540691|NCT04026165|583368686|FG001|Run-in SEL Period|Death|1|||
161592728|NCT04029688|583560289|FG005|Overall Study|Death|0|||
161592729|NCT04029688|583560290|FG006|Overall Study|Death|2|||
161592730|NCT04029688|583560291|FG007|Overall Study|Death|3|||
161592731|NCT04029688|583560284|FG000|Overall Study|Study Terminated by Sponsor|0|||
161592732|NCT04029688|583560285|FG001|Overall Study|Study Terminated by Sponsor|0|||
161592733|NCT04029688|583560286|FG002|Overall Study|Study Terminated by Sponsor|0|||
161592734|NCT04029688|583560287|FG003|Overall Study|Study Terminated by Sponsor|0|||
161592735|NCT04029688|583560288|FG004|Overall Study|Study Terminated by Sponsor|1|||
161592736|NCT04029688|583560289|FG005|Overall Study|Study Terminated by Sponsor|3|||
161592737|NCT04029688|583560290|FG006|Overall Study|Study Terminated by Sponsor|1|||
161592738|NCT04029688|583560291|FG007|Overall Study|Study Terminated by Sponsor|3|||
161592739|NCT04029688|583560284|FG000|Overall Study|Withdrawal by Subject|0|||
161592740|NCT04029688|583560285|FG001|Overall Study|Withdrawal by Subject|0|||
161592741|NCT04029688|583560286|FG002|Overall Study|Withdrawal by Subject|0|||
161592742|NCT04029688|583560287|FG003|Overall Study|Withdrawal by Subject|1|||
161592743|NCT04029688|583560288|FG004|Overall Study|Withdrawal by Subject|0|||
161592744|NCT04029688|583560289|FG005|Overall Study|Withdrawal by Subject|0|||
161592745|NCT04029688|583560290|FG006|Overall Study|Withdrawal by Subject|0|||
161592746|NCT04029688|583560291|FG007|Overall Study|Withdrawal by Subject|0|||
161592747|NCT03436290|583560292|FG000|Overall Study|Post-randomization Exclusion|1|||
161592748|NCT03436290|583560293|FG001|Overall Study|Post-randomization Exclusion|0|||
161592749|NCT03436290|583560292|FG000|Overall Study|Death|6|||
161829474|NCT00608517|584415790|FG002|Overall Study|Death|0|||
161540692|NCT04026165|583368687|FG002|Run-in SEL Period|Death|0|||
161540693|NCT04026165|583368688|FG003|Run-in SEL Period|Death|0|||
161540694|NCT04026165|583368685|FG000|Randomized Period|Withdrew Consent|0|||
161592750|NCT03436290|583560293|FG001|Overall Study|Death|0|||
161829475|NCT00572039|584415791|FG000|Overall Study|Withdrawal by Subject|9|||
161592751|NCT03436290|583560292|FG000|Overall Study|Withdrawal by Subject|4|||
161592752|NCT03436290|583560293|FG001|Overall Study|Withdrawal by Subject|0|||
161540695|NCT04026165|583368686|FG001|Randomized Period|Withdrew Consent|0|||
161540696|NCT04026165|583368687|FG002|Randomized Period|Withdrew Consent|5|||
161540697|NCT04026165|583368688|FG003|Randomized Period|Withdrew Consent|8|||
161540698|NCT04026165|583368685|FG000|Randomized Period|Death|0|||
161540699|NCT04026165|583368686|FG001|Randomized Period|Death|0|||
161540700|NCT04026165|583368687|FG002|Randomized Period|Death|5|||
161540701|NCT04026165|583368688|FG003|Randomized Period|Death|7|||
161540702|NCT04026165|583368685|FG000|Randomized Period|Investigator's Discretion|0|||
161540703|NCT04026165|583368686|FG001|Randomized Period|Investigator's Discretion|0|||
161540704|NCT04026165|583368687|FG002|Randomized Period|Investigator's Discretion|2|||
161540705|NCT04026165|583368688|FG003|Randomized Period|Investigator's Discretion|2|||
161540706|NCT04026165|583368685|FG000|Randomized Period|Lost to Follow-up|0|||
161540707|NCT04026165|583368686|FG001|Randomized Period|Lost to Follow-up|0|||
161540708|NCT04026165|583368687|FG002|Randomized Period|Lost to Follow-up|2|||
161540709|NCT04026165|583368688|FG003|Randomized Period|Lost to Follow-up|2|||
161540710|NCT01059630|583368691|FG000|Overall Study|Death|100|||
161540711|NCT01059630|583368692|FG001|Overall Study|Death|84|||
161540712|NCT01059630|583368691|FG000|Overall Study|Lost to Follow-up|4|||
161540713|NCT01059630|583368692|FG001|Overall Study|Lost to Follow-up|1|||
161540714|NCT01059630|583368691|FG000|Overall Study|Physician Decision|2|||
161540715|NCT01059630|583368692|FG001|Overall Study|Physician Decision|4|||
161540716|NCT01059630|583368691|FG000|Overall Study|Withdrawal by Subject|21|||
161540717|NCT01059630|583368692|FG001|Overall Study|Withdrawal by Subject|14|||
161540718|NCT02569437|583368693|FG000|Overall Study|Lost to Follow-up|12|||
161540719|NCT02569437|583368694|FG001|Overall Study|Lost to Follow-up|14|||
161540720|NCT00441701|583368695|FG000|Overall Study|Adverse Event|3|||
161540721|NCT00441701|583368696|FG001|Overall Study|Adverse Event|2|||
161540722|NCT00441701|583368697|FG002|Overall Study|Adverse Event|1|||
161540723|NCT00441701|583368698|FG003|Overall Study|Adverse Event|0|||
161540724|NCT00441701|583368699|FG004|Overall Study|Adverse Event|2|||
161540725|NCT00441701|583368700|FG005|Overall Study|Adverse Event|2|||
161540726|NCT00441701|583368701|FG006|Overall Study|Adverse Event|0|||
161540727|NCT00441701|583368702|FG007|Overall Study|Adverse Event|0|||
161540728|NCT00441701|583368703|FG008|Overall Study|Adverse Event|0|||
161540729|NCT00441701|583368704|FG009|Overall Study|Adverse Event|0|||
161540730|NCT00441701|583368695|FG000|Overall Study|Lack of Efficacy|2|||
161540731|NCT00441701|583368696|FG001|Overall Study|Lack of Efficacy|0|||
161540732|NCT00441701|583368697|FG002|Overall Study|Lack of Efficacy|2|||
161540733|NCT00441701|583368698|FG003|Overall Study|Lack of Efficacy|2|||
161540734|NCT00441701|583368699|FG004|Overall Study|Lack of Efficacy|0|||
161540735|NCT00441701|583368700|FG005|Overall Study|Lack of Efficacy|1|||
161540736|NCT00441701|583368701|FG006|Overall Study|Lack of Efficacy|0|||
161540737|NCT00441701|583368702|FG007|Overall Study|Lack of Efficacy|0|||
161540738|NCT00441701|583368703|FG008|Overall Study|Lack of Efficacy|0|||
161540739|NCT00441701|583368704|FG009|Overall Study|Lack of Efficacy|0|||
161540740|NCT00441701|583368695|FG000|Overall Study|Withdrawal by Subject|0|||
161540741|NCT00441701|583368696|FG001|Overall Study|Withdrawal by Subject|2|||
161540742|NCT00441701|583368697|FG002|Overall Study|Withdrawal by Subject|1|||
161540743|NCT00441701|583368698|FG003|Overall Study|Withdrawal by Subject|1|||
161540744|NCT00441701|583368699|FG004|Overall Study|Withdrawal by Subject|0|||
161540745|NCT00441701|583368700|FG005|Overall Study|Withdrawal by Subject|0|||
161540746|NCT00441701|583368701|FG006|Overall Study|Withdrawal by Subject|0|||
161540747|NCT00441701|583368702|FG007|Overall Study|Withdrawal by Subject|0|||
161540748|NCT00441701|583368703|FG008|Overall Study|Withdrawal by Subject|0|||
161540749|NCT00441701|583368704|FG009|Overall Study|Withdrawal by Subject|0|||
161540750|NCT00985985|583368708|FG000|Overall Study|Adverse Event|4|||
161540751|NCT00985985|583368709|FG001|Overall Study|Adverse Event|2|||
161540752|NCT00985985|583368710|FG002|Overall Study|Adverse Event|2|||
161540753|NCT00985985|583368711|FG003|Overall Study|Adverse Event|2|||
161540754|NCT00985985|583368708|FG000|Overall Study|Lost to Follow-up|4|||
161540755|NCT00985985|583368709|FG001|Overall Study|Lost to Follow-up|11|||
161540756|NCT00985985|583368710|FG002|Overall Study|Lost to Follow-up|2|||
161540757|NCT00985985|583368711|FG003|Overall Study|Lost to Follow-up|3|||
161540758|NCT00985985|583368708|FG000|Overall Study|Protocol Violation|1|||
161829476|NCT00572039|584415792|FG001|Overall Study|Withdrawal by Subject|6|||
161540759|NCT00985985|583368709|FG001|Overall Study|Protocol Violation|2|||
161540760|NCT00985985|583368710|FG002|Overall Study|Protocol Violation|0|||
161540761|NCT00985985|583368711|FG003|Overall Study|Protocol Violation|1|||
161540762|NCT00985985|583368708|FG000|Overall Study|Lack of Efficacy|5|||
161540763|NCT00985985|583368709|FG001|Overall Study|Lack of Efficacy|6|||
161540764|NCT00985985|583368710|FG002|Overall Study|Lack of Efficacy|1|||
161540765|NCT00985985|583368711|FG003|Overall Study|Lack of Efficacy|3|||
161540766|NCT00985985|583368708|FG000|Overall Study|Withdrawal by Subject|4|||
161540767|NCT00985985|583368709|FG001|Overall Study|Withdrawal by Subject|2|||
161540768|NCT00985985|583368710|FG002|Overall Study|Withdrawal by Subject|2|||
161540769|NCT00985985|583368711|FG003|Overall Study|Withdrawal by Subject|2|||
161540770|NCT00985985|583368708|FG000|Overall Study|Other Reason|6|||
161540771|NCT00985985|583368709|FG001|Overall Study|Other Reason|1|||
161540772|NCT00985985|583368710|FG002|Overall Study|Other Reason|4|||
161540773|NCT00985985|583368711|FG003|Overall Study|Other Reason|2|||
161540774|NCT00499863|583368719|FG000|Overall Study|Lack of Efficacy|21|||
161540775|NCT00499863|583368720|FG001|Overall Study|Lack of Efficacy|27|||
161540776|NCT00499863|583368719|FG000|Overall Study|Protocol Violation|12|||
161540777|NCT00499863|583368720|FG001|Overall Study|Protocol Violation|7|||
161540778|NCT00499863|583368719|FG000|Overall Study|Withdrawal by Subject|6|||
161540779|NCT00499863|583368720|FG001|Overall Study|Withdrawal by Subject|4|||
161540780|NCT00499863|583368719|FG000|Overall Study|Adverse Event|8|||
161540781|NCT00499863|583368720|FG001|Overall Study|Adverse Event|2|||
161540782|NCT00499863|583368719|FG000|Overall Study|Sponsor decision|2|||
161540783|NCT00499863|583368720|FG001|Overall Study|Sponsor decision|2|||
161540784|NCT00499863|583368719|FG000|Overall Study|Lost to Follow-up|1|||
161540785|NCT00499863|583368720|FG001|Overall Study|Lost to Follow-up|1|||
161540786|NCT02535364|583368721|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
161540787|NCT02535364|583368721|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
161540788|NCT02535364|583368721|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
161540789|NCT02535364|583368721|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
161540790|NCT02535364|583368721|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
161540791|NCT02535364|583368721|FG000|Part B Screening|Death|2|||
161540792|NCT02535364|583368721|FG000|Part B Screening|Physician Decision|1|||
161540793|NCT02535364|583368721|FG000|Part B Screening|Withdrawal by Subject|1|||
161540794|NCT02535364|583368721|FG000|Part B Screening|Adverse Event|1|||
161540795|NCT02535364|583368721|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
161540796|NCT02535364|583368721|FG000|Study Treatment|Death|1|||
161540797|NCT02535364|583368721|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
161540798|NCT02535364|583368721|FG000|12-Month Follow-up Period|Disease progression|22|||
161540799|NCT02535364|583368721|FG000|12-Month Follow-up Period|Death|5|||
161540800|NCT02535364|583368721|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
161540801|NCT02535364|583368721|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
161540802|NCT02535364|583368721|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
161540803|NCT00571701|583368722|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
161540804|NCT00571701|583368723|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
161540805|NCT00571701|583368722|FG000|First Intervention 12 Months|Death|1|||
161540806|NCT00571701|583368723|FG001|First Intervention 12 Months|Death|0|||
161540807|NCT00571701|583368722|FG000|Second Intervention 12 Months|Adverse Event|0|||
161540808|NCT00571701|583368723|FG001|Second Intervention 12 Months|Adverse Event|1|||
161540809|NCT00571701|583368722|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
161540810|NCT00571701|583368723|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
161540811|NCT00691132|583368724|FG000|Overall Study|Adverse Event|2|||
161540812|NCT00691132|583368725|FG001|Overall Study|Adverse Event|3|||
161540813|NCT00691132|583368724|FG000|Overall Study|Withdrawal by Subject|10|||
161540814|NCT00691132|583368725|FG001|Overall Study|Withdrawal by Subject|10|||
161540815|NCT01959347|583368736|FG000|Overall Study|Protocol Violation|9|||
161540816|NCT01959347|583368737|FG001|Overall Study|Protocol Violation|7|||
161540817|NCT01282801|583368738|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
161540818|NCT01282801|583368739|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
161540819|NCT02889133|583368743|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
161540820|NCT02889133|583368744|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
161540821|NCT02889133|583368743|FG000|Completed Primary Outcome|Manufacturing error|3|||
161540822|NCT02889133|583368744|FG001|Completed Primary Outcome|Manufacturing error|8|||
161540823|NCT02889133|583368743|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
161540824|NCT02889133|583368744|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
161540825|NCT02889133|583368743|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
161540826|NCT02889133|583368744|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
161540827|NCT02889133|583368743|FG000|Completed Primary Outcome|Protocol Violation|1|||
161540828|NCT02889133|583368744|FG001|Completed Primary Outcome|Protocol Violation|0|||
161540829|NCT02889133|583368743|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
161540830|NCT02889133|583368744|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
161540831|NCT02889133|583368743|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
161540832|NCT02889133|583368744|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
161540833|NCT02889133|583368743|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
161540834|NCT02889133|583368744|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
161540835|NCT02889133|583368743|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
161540836|NCT02889133|583368744|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
161540837|NCT02889133|583368743|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
161540838|NCT02889133|583368744|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
161540839|NCT01781390|583368746|FG000|Overall Study|Withdrawal of Consent|0|||
161540840|NCT01781390|583368747|FG001|Overall Study|Withdrawal of Consent|3|||
161540841|NCT01781390|583368748|FG002|Overall Study|Withdrawal of Consent|1|||
161540842|NCT01781390|583368746|FG000|Overall Study|Lost to Follow-up|1|||
161540843|NCT01781390|583368747|FG001|Overall Study|Lost to Follow-up|1|||
161540844|NCT01781390|583368748|FG002|Overall Study|Lost to Follow-up|1|||
161540845|NCT01781390|583368746|FG000|Overall Study|Adverse Event|1|||
161540846|NCT01781390|583368747|FG001|Overall Study|Adverse Event|2|||
161540847|NCT01781390|583368748|FG002|Overall Study|Adverse Event|1|||
161540848|NCT01781390|583368746|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
161540849|NCT01781390|583368747|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
161540850|NCT01781390|583368748|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
161540851|NCT01862796|583368749|FG000|Overall Study|Prohibited medications|0|||
161540852|NCT01862796|583368750|FG001|Overall Study|Prohibited medications|0|||
161540853|NCT01862796|583368751|FG002|Overall Study|Prohibited medications|1|||
161540854|NCT01375205|583368756|FG000|Overall Study|Lost to Follow-up|15|||
161540855|NCT01375205|583368757|FG001|Overall Study|Lost to Follow-up|12|||
161540856|NCT01375205|583368756|FG000|Overall Study|Withdrawal by Subject|6|||
161540857|NCT01375205|583368757|FG001|Overall Study|Withdrawal by Subject|1|||
161540858|NCT01859793|583368758|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
161540859|NCT01859793|583368759|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
161540860|NCT01859793|583368758|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
161540861|NCT01859793|583368759|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
161540862|NCT01859793|583368758|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161540863|NCT01859793|583368759|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161540864|NCT01859793|583368758|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
161540865|NCT01859793|583368759|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
161540866|NCT01064297|583368768|FG000|Overall Study|Lost to Follow-up|791|||
161540867|NCT01064297|583368769|FG001|Overall Study|Lost to Follow-up|48|||
161540868|NCT01064297|583368770|FG002|Overall Study|Lost to Follow-up|133|||
161540869|NCT00511875|583368780|FG000|Overall Study|Lost to Follow-up|4|||
161540870|NCT00511875|583368781|FG001|Overall Study|Lost to Follow-up|0|||
161540871|NCT00511875|583368780|FG000|Overall Study|Missing variables|1|||
161540872|NCT00511875|583368781|FG001|Overall Study|Missing variables|0|||
161540873|NCT00542880|583368783|FG000|Period 1|Eligibility criteria not fulfilled|2|||
161540874|NCT00542880|583368784|FG001|Period 1|Eligibility criteria not fulfilled|6|||
161540875|NCT00542880|583368783|FG000|Period 1|Adverse Event|2|||
161540876|NCT00542880|583368784|FG001|Period 1|Adverse Event|2|||
161540877|NCT00542880|583368783|FG000|Period 1|Development of study-specific criteria|1|||
161540878|NCT00542880|583368784|FG001|Period 1|Development of study-specific criteria|2|||
161540879|NCT00542880|583368783|FG000|Period 1|Withdrawal by Subject|1|||
161540880|NCT00542880|583368784|FG001|Period 1|Withdrawal by Subject|1|||
161540881|NCT00542880|583368783|FG000|Period 1|Protocol Violation|0|||
161540882|NCT00542880|583368784|FG001|Period 1|Protocol Violation|1|||
161540883|NCT00542880|583368783|FG000|Period 2|Adverse Event|5|||
161540884|NCT00542880|583368784|FG001|Period 2|Adverse Event|7|||
161540885|NCT00542880|583368783|FG000|Period 2|Eligibility not fulfilled|0|||
161540886|NCT00542880|583368784|FG001|Period 2|Eligibility not fulfilled|1|||
161540887|NCT00542880|583368783|FG000|Period 2|Discontinuation criteria|2|||
161540888|NCT00542880|583368784|FG001|Period 2|Discontinuation criteria|0|||
161540889|NCT00542880|583368783|FG000|Period 2|Severe non-compliance|0|||
161540890|NCT00542880|583368784|FG001|Period 2|Severe non-compliance|1|||
161540891|NCT00542880|583368783|FG000|Period 2|Other|0|||
161540892|NCT00542880|583368784|FG001|Period 2|Other|1|||
161540893|NCT00542880|583368783|FG000|Period 3|Adverse Event|0|||
161540894|NCT00542880|583368784|FG001|Period 3|Adverse Event|2|||
161540895|NCT00982930|583368789|FG000|Overall Study|Adverse Event|1|||
161540896|NCT00982930|583368789|FG000|Overall Study|Withdrawal by Subject|1|||
161540897|NCT00982930|583368789|FG000|Overall Study|Administrative Problems|2|||
161592753|NCT03436290|583560292|FG000|Overall Study|Protocol Violation|30|||
161540898|NCT04179721|583368790|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
161540899|NCT04179721|583368791|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
161540900|NCT04179721|583368790|FG000|Overall Study|Lost to Follow-up|0|||
161540901|NCT04179721|583368791|FG001|Overall Study|Lost to Follow-up|1|||
161540902|NCT03538951|583368794|FG000|Overall Study|Withdrawal by Subject|1|||
161540903|NCT03538951|583368795|FG001|Overall Study|Withdrawal by Subject|2|||
161540904|NCT06027619|583368796|FG000|Overall Study|Adverse Event|0|||
161540905|NCT06027619|583368797|FG001|Overall Study|Adverse Event|0|||
161540906|NCT06027619|583368798|FG002|Overall Study|Adverse Event|1|||
161540907|NCT01493960|583369991|FG000|Overall Study|Adverse Event|0|||
161540908|NCT01493960|583369992|FG001|Overall Study|Adverse Event|1|||
161540909|NCT01493960|583369991|FG000|Overall Study|Lack of Efficacy|15|||
161540910|NCT01493960|583369992|FG001|Overall Study|Lack of Efficacy|9|||
161540911|NCT01493960|583369991|FG000|Overall Study|Protocol Violation|3|||
161540912|NCT01493960|583369992|FG001|Overall Study|Protocol Violation|0|||
161540913|NCT01493960|583369991|FG000|Overall Study|Withdrawal by Subject|10|||
161540914|NCT01493960|583369992|FG001|Overall Study|Withdrawal by Subject|4|||
161540915|NCT01493960|583369991|FG000|Overall Study|Non-specified|4|||
161540916|NCT01493960|583369992|FG001|Overall Study|Non-specified|4|||
161540917|NCT00871403|583369995|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
161540918|NCT00871403|583369996|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
161540919|NCT00871403|583369997|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
161540920|NCT00871403|583369995|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
161540921|NCT00871403|583369996|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
161540922|NCT00871403|583369997|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
161540923|NCT00871403|583369995|FG000|Combination Treatment Phase|Adverse Event|0|||
161540924|NCT00871403|583369996|FG001|Combination Treatment Phase|Adverse Event|17|||
161540925|NCT00871403|583369997|FG002|Combination Treatment Phase|Adverse Event|2|||
161540926|NCT00871403|583369995|FG000|Combination Treatment Phase|Disease Progression|0|||
161540927|NCT00871403|583369996|FG001|Combination Treatment Phase|Disease Progression|8|||
161678758|NCT00574288|583876065|FG000|Overall Study|Progressive Disease|17|||
161678759|NCT00574288|583876066|FG001|Overall Study|Progressive Disease|2|||
161678760|NCT00574288|583876067|FG002|Overall Study|Progressive Disease|3|||
161678761|NCT00574288|583876068|FG003|Overall Study|Progressive Disease|2|||
161678762|NCT00574288|583876069|FG004|Overall Study|Progressive Disease|1|||
161678763|NCT00574288|583876070|FG005|Overall Study|Progressive Disease|0|||
161678764|NCT00574288|583876071|FG006|Overall Study|Progressive Disease|0|||
161678765|NCT00574288|583876065|FG000|Overall Study|Other|1|||
161678766|NCT00574288|583876066|FG001|Overall Study|Other|1|||
161678767|NCT00574288|583876067|FG002|Overall Study|Other|0|||
161678768|NCT00574288|583876068|FG003|Overall Study|Other|0|||
161678769|NCT00574288|583876069|FG004|Overall Study|Other|0|||
161678770|NCT00574288|583876070|FG005|Overall Study|Other|0|||
161678771|NCT00574288|583876071|FG006|Overall Study|Other|0|||
161678772|NCT01106027|583876072|FG000|Overall Study|Lost graft early, discontinued|1|||
161678773|NCT00356889|583876073|FG000|Overall Study|Protocol Violation|2|||
161678774|NCT00356889|583876073|FG000|Overall Study|Adverse Event|1|||
161678775|NCT02361944|583876074|FG000|Overall Study|surgery cancellation|0|||
161678776|NCT02361944|583876075|FG001|Overall Study|surgery cancellation|1|||
161678777|NCT03123250|583876076|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
161678778|NCT00773136|583876103|FG000|Overall Study|Physician Decision|2|||
161678779|NCT02463071|583876110|FG000|Overall Study|Adverse Event|3|||
161678780|NCT02463071|583876111|FG001|Overall Study|Adverse Event|5|||
161678781|NCT02463071|583876112|FG002|Overall Study|Adverse Event|1|||
161678782|NCT02463071|583876110|FG000|Overall Study|Death|1|||
161678783|NCT02463071|583876111|FG001|Overall Study|Death|0|||
161678784|NCT02463071|583876112|FG002|Overall Study|Death|0|||
161678785|NCT02463071|583876110|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161678786|NCT02463071|583876111|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161678787|NCT02463071|583876112|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161678788|NCT02463071|583876110|FG000|Overall Study|Reason not specified|7|||
161678789|NCT02463071|583876111|FG001|Overall Study|Reason not specified|9|||
161678790|NCT02463071|583876112|FG002|Overall Study|Reason not specified|4|||
161678791|NCT02463071|583876110|FG000|Overall Study|Protocol Violation|0|||
161678792|NCT02463071|583876111|FG001|Overall Study|Protocol Violation|2|||
161678793|NCT02463071|583876112|FG002|Overall Study|Protocol Violation|0|||
161678794|NCT02463071|583876110|FG000|Overall Study|Lost to Follow-up|0|||
161678795|NCT02463071|583876111|FG001|Overall Study|Lost to Follow-up|0|||
161678796|NCT02463071|583876112|FG002|Overall Study|Lost to Follow-up|1|||
161678797|NCT00175877|583876128|FG000|Overall Study|Adverse Event|136|||
161678798|NCT00175877|583876128|FG000|Overall Study|Withdrawal by Subject|141|||
161678799|NCT00175877|583876128|FG000|Overall Study|Lost to Follow-up|9|||
161678800|NCT00175877|583876128|FG000|Overall Study|Lack of Efficacy|26|||
161678801|NCT00175877|583876128|FG000|Overall Study|Protocol Violation|15|||
161678802|NCT00175877|583876128|FG000|Overall Study|Other Reason|20|||
161678803|NCT00175877|583876128|FG000|Overall Study|AE & Other|1|||
161678804|NCT00175877|583876128|FG000|Overall Study|Withdrawal by subject & Other|1|||
161678805|NCT02054325|583876132|FG000|Overall Study|Lost to Follow-up|8|||
161540928|NCT00871403|583369997|FG002|Combination Treatment Phase|Disease Progression|5|||
161540929|NCT00871403|583369995|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
161540930|NCT00871403|583369996|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
161540931|NCT00871403|583369997|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
161540932|NCT00871403|583369995|FG000|Combination Treatment Phase|Physician Decision|0|||
161540933|NCT00871403|583369996|FG001|Combination Treatment Phase|Physician Decision|1|||
161540934|NCT00871403|583369997|FG002|Combination Treatment Phase|Physician Decision|3|||
161540935|NCT00871403|583369995|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
161540936|NCT00871403|583369996|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
161540937|NCT00871403|583369997|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
161540938|NCT00871403|583369995|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
161540939|NCT00871403|583369996|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
161540940|NCT00871403|583369997|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
161540941|NCT03170375|583370000|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
161540942|NCT03170375|583370001|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
161540943|NCT03170375|583370002|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
161540944|NCT03170375|583370000|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
161540945|NCT03170375|583370001|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
161540946|NCT03170375|583370002|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
161540947|NCT00077064|583370003|FG000|Overall Study|Adverse Event|0|||
161540948|NCT00077064|583370004|FG001|Overall Study|Adverse Event|4|||
161540949|NCT00077064|583370003|FG000|Overall Study|Patient refusal|0|||
161540950|NCT00077064|583370004|FG001|Overall Study|Patient refusal|2|||
161540951|NCT02007434|583370005|FG000|Overall Study|Lost to Follow-up|0|||
161540952|NCT02007434|583370006|FG001|Overall Study|Lost to Follow-up|1|||
161540953|NCT02007434|583370007|FG002|Overall Study|Lost to Follow-up|0|||
161540954|NCT02007434|583370008|FG003|Overall Study|Lost to Follow-up|0|||
161540955|NCT02007434|583370009|FG004|Overall Study|Lost to Follow-up|0|||
161540956|NCT02007434|583370010|FG005|Overall Study|Lost to Follow-up|0|||
161540957|NCT02007434|583370011|FG006|Overall Study|Lost to Follow-up|0|||
161540958|NCT02007434|583370012|FG007|Overall Study|Lost to Follow-up|0|||
161540959|NCT02007434|583370005|FG000|Overall Study|Non-compliance|1|||
161540960|NCT02007434|583370006|FG001|Overall Study|Non-compliance|0|||
161540961|NCT02007434|583370007|FG002|Overall Study|Non-compliance|1|||
161540962|NCT02007434|583370008|FG003|Overall Study|Non-compliance|0|||
161540963|NCT02007434|583370009|FG004|Overall Study|Non-compliance|0|||
161540964|NCT02007434|583370010|FG005|Overall Study|Non-compliance|0|||
161540965|NCT02007434|583370011|FG006|Overall Study|Non-compliance|0|||
161540966|NCT02007434|583370012|FG007|Overall Study|Non-compliance|0|||
161540967|NCT00763958|583370013|FG000|Overall Study|did not meet final criteria|4|||
161540968|NCT00763958|583370014|FG001|Overall Study|did not meet final criteria|4|||
161540969|NCT00763958|583370013|FG000|Overall Study|Lost to Follow-up|10|||
161540970|NCT00763958|583370014|FG001|Overall Study|Lost to Follow-up|2|||
161540971|NCT00763958|583370013|FG000|Overall Study|Believed they were receiving placebo|0|||
161540972|NCT00763958|583370014|FG001|Overall Study|Believed they were receiving placebo|5|||
161540973|NCT00927355|583370015|FG000|Overall Study|Adverse Event|1|||
161540974|NCT00927355|583370016|FG001|Overall Study|Adverse Event|1|||
161540975|NCT03299686|583370017|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
161540976|NCT03299686|583370018|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
161540977|NCT03299686|583370017|FG000|Treatment Epoch|Physician Decision|1|||
161540978|NCT03299686|583370018|FG001|Treatment Epoch|Physician Decision|0|||
161540979|NCT03299686|583370017|FG000|Treatment Epoch|Adverse Event|8|||
161540980|NCT03299686|583370018|FG001|Treatment Epoch|Adverse Event|4|||
161540981|NCT03299686|583370017|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
161540982|NCT03299686|583370018|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
161540983|NCT01060553|583370020|FG000|Overall Study|Lost to Follow-up|3|||
161540984|NCT01060553|583370021|FG001|Overall Study|Lost to Follow-up|5|||
161540985|NCT01060553|583370020|FG000|Overall Study|Withdrawal by Subject|5|||
161540986|NCT01060553|583370021|FG001|Overall Study|Withdrawal by Subject|5|||
161540987|NCT01060553|583370020|FG000|Overall Study|Lack of Efficacy|1|||
161540988|NCT01060553|583370021|FG001|Overall Study|Lack of Efficacy|0|||
161540989|NCT01446796|583370022|FG000|Overall Study|Withdrawal by Subject|1|||
161540990|NCT01446796|583370023|FG001|Overall Study|Withdrawal by Subject|0|||
161540991|NCT00954733|583370027|FG000|Overall Study|blood gas machine did not work|1|||
161540992|NCT03131960|583370028|FG000|Overall Study|Adverse Event|0|||
161592754|NCT03436290|583560293|FG001|Overall Study|Protocol Violation|0|||
161592755|NCT02677298|583560306|FG000|Double Blind Phase|Adverse Event|2|||
161592756|NCT02677298|583560307|FG001|Double Blind Phase|Adverse Event|1|||
161592757|NCT02677298|583560308|FG002|Double Blind Phase|Adverse Event|0|||
161592758|NCT02677298|583560306|FG000|Double Blind Phase|Physician Decision|5|||
161592759|NCT02677298|583560307|FG001|Double Blind Phase|Physician Decision|0|||
161592760|NCT02677298|583560308|FG002|Double Blind Phase|Physician Decision|0|||
161592761|NCT02677298|583560306|FG000|Double Blind Phase|Lost to Follow-up|11|||
161540993|NCT03131960|583370029|FG001|Overall Study|Adverse Event|1|||
161540994|NCT04707196|583370030|FG000|Overall Study|Withdrawal by Subject|9|||
161540995|NCT04707196|583370031|FG001|Overall Study|Withdrawal by Subject|6|||
161592762|NCT02677298|583560307|FG001|Double Blind Phase|Lost to Follow-up|7|||
161678806|NCT02054325|583876133|FG001|Overall Study|Lost to Follow-up|5|||
161678807|NCT02003014|583876134|FG000|Overall Study|Case report forms uncollected|9|||
161678808|NCT02003014|583876134|FG000|Overall Study|Treatment started after contract period|1|||
161678809|NCT02003014|583876134|FG000|Overall Study|Patient did not visit the study site|5|||
161678810|NCT02003014|583876134|FG000|Overall Study|Investigator's transfer|4|||
161678811|NCT03007979|583876137|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
161678812|NCT03734016|583876138|FG000|Overall Study|Sponsor Ended Study|225|||
161678813|NCT03734016|583876139|FG001|Overall Study|Sponsor Ended Study|200|||
161678814|NCT03734016|583876138|FG000|Overall Study|Death|69|||
161678815|NCT03734016|583876139|FG001|Overall Study|Death|83|||
161678816|NCT03734016|583876138|FG000|Overall Study|Withdrawal by Subject|21|||
161678817|NCT03734016|583876139|FG001|Overall Study|Withdrawal by Subject|27|||
161678818|NCT03734016|583876138|FG000|Overall Study|Physician Decision|1|||
161678819|NCT03734016|583876139|FG001|Overall Study|Physician Decision|12|||
161678820|NCT03734016|583876138|FG000|Overall Study|Lost to Follow-up|6|||
161678821|NCT03734016|583876139|FG001|Overall Study|Lost to Follow-up|2|||
161678822|NCT03734016|583876138|FG000|Overall Study|Miscellaneous|5|||
161678823|NCT03734016|583876139|FG001|Overall Study|Miscellaneous|1|||
161678824|NCT01624259|583876142|FG000|Overall Study|Adverse Event|18|||
161678825|NCT01624259|583876143|FG001|Overall Study|Adverse Event|18|||
161678826|NCT01624259|583876142|FG000|Overall Study|Protocol Violation|1|||
161678827|NCT01624259|583876143|FG001|Overall Study|Protocol Violation|2|||
161678828|NCT01624259|583876142|FG000|Overall Study|Withdrawal by Subject|5|||
161678829|NCT01624259|583876143|FG001|Overall Study|Withdrawal by Subject|7|||
161678830|NCT01624259|583876142|FG000|Overall Study|Physician Decision|1|||
161678831|NCT01624259|583876143|FG001|Overall Study|Physician Decision|1|||
161678832|NCT01624259|583876142|FG000|Overall Study|Lost to Follow-up|2|||
161678833|NCT01624259|583876143|FG001|Overall Study|Lost to Follow-up|3|||
161678834|NCT01624259|583876142|FG000|Overall Study|Abnormal laboratory measure|3|||
161678835|NCT01624259|583876143|FG001|Overall Study|Abnormal laboratory measure|0|||
161678836|NCT01298518|583876144|FG000|Overall Study|Withdrawal by Subject|0|||
161678837|NCT01298518|583876145|FG001|Overall Study|Withdrawal by Subject|0|||
161678838|NCT01298518|583876146|FG002|Overall Study|Withdrawal by Subject|1|||
161678839|NCT02273726|583876147|FG000|Overall Study|Death|70|||
161678840|NCT02273726|583876148|FG001|Overall Study|Death|62|||
161678841|NCT02273726|583876147|FG000|Overall Study|Withdrawal by Subject|41|||
161678842|NCT02273726|583876148|FG001|Overall Study|Withdrawal by Subject|29|||
161678843|NCT02273726|583876147|FG000|Overall Study|Kidney transplant|31|||
161678844|NCT02273726|583876148|FG001|Overall Study|Kidney transplant|39|||
161678845|NCT02273726|583876147|FG000|Overall Study|Physician Decision|30|||
161678846|NCT02273726|583876148|FG001|Overall Study|Physician Decision|15|||
161678847|NCT02273726|583876147|FG000|Overall Study|Adverse Event|27|||
161678848|NCT02273726|583876148|FG001|Overall Study|Adverse Event|9|||
161678849|NCT02273726|583876147|FG000|Overall Study|Lost to Follow-up|6|||
161678850|NCT02273726|583876148|FG001|Overall Study|Lost to Follow-up|3|||
161678851|NCT02273726|583876147|FG000|Overall Study|Lack of Efficacy|6|||
161540996|NCT04707196|583370030|FG000|Overall Study|Lost to Follow-up|1|||
161540997|NCT04707196|583370031|FG001|Overall Study|Lost to Follow-up|0|||
161540998|NCT04707196|583370030|FG000|Overall Study|Protocol Violation|4|||
161540999|NCT04707196|583370031|FG001|Overall Study|Protocol Violation|1|||
161541000|NCT04707196|583370030|FG000|Overall Study|Adverse Event|2|||
161541001|NCT04707196|583370031|FG001|Overall Study|Adverse Event|2|||
161541002|NCT04707196|583370030|FG000|Overall Study|Death|3|||
161541003|NCT04707196|583370031|FG001|Overall Study|Death|1|||
161541004|NCT04707196|583370030|FG000|Overall Study|Non-compliance with study drug|1|||
161541005|NCT04707196|583370031|FG001|Overall Study|Non-compliance with study drug|0|||
161678852|NCT02273726|583876148|FG001|Overall Study|Lack of Efficacy|1|||
161678853|NCT02273726|583876147|FG000|Overall Study|Protocol Violation|4|||
161678854|NCT02273726|583876148|FG001|Overall Study|Protocol Violation|0|||
161678855|NCT02273726|583876147|FG000|Overall Study|Other than specified|28|||
161678856|NCT02273726|583876148|FG001|Overall Study|Other than specified|30|||
161678857|NCT01979835|583876149|FG000|Primary Outcome SA Measurment|failed insertion|18|||
161678858|NCT01979835|583876149|FG000|Follow-up|Lost to Follow-up|32|||
161678859|NCT03697720|583877722|FG000|Overall Study|Lost to Follow-up|7|||
161678860|NCT00382720|583877727|FG000|Overall Study|Adverse Event|21|||
161678861|NCT00382720|583877728|FG001|Overall Study|Adverse Event|23|||
161678862|NCT00382720|583877729|FG002|Overall Study|Adverse Event|15|||
161678863|NCT00382720|583877727|FG000|Overall Study|Protocol Violation|2|||
161678864|NCT00382720|583877728|FG001|Overall Study|Protocol Violation|5|||
161678865|NCT00382720|583877729|FG002|Overall Study|Protocol Violation|1|||
161678866|NCT00382720|583877727|FG000|Overall Study|Death|0|||
161678867|NCT00382720|583877728|FG001|Overall Study|Death|1|||
161678868|NCT00382720|583877729|FG002|Overall Study|Death|2|||
161678869|NCT00382720|583877727|FG000|Overall Study|Progressive disease|37|||
161678870|NCT00382720|583877728|FG001|Overall Study|Progressive disease|28|||
161678871|NCT00382720|583877729|FG002|Overall Study|Progressive disease|38|||
161678872|NCT00382720|583877727|FG000|Overall Study|Withdrew consent|1|||
161678873|NCT00382720|583877728|FG001|Overall Study|Withdrew consent|1|||
161678874|NCT00382720|583877729|FG002|Overall Study|Withdrew consent|2|||
161541006|NCT04707196|583370030|FG000|Overall Study|Progressive disease|9|||
161541007|NCT04707196|583370031|FG001|Overall Study|Progressive disease|10|||
161541008|NCT01462162|583370035|FG000|Overall Study|Adverse Event|5|||
161541009|NCT01462162|583370035|FG000|Overall Study|Lack of Efficacy|4|||
161541010|NCT01462162|583370035|FG000|Overall Study|Abnormal laboratory parameters|1|||
161541011|NCT01462162|583370035|FG000|Overall Study|Other|2|||
161541012|NCT03485911|583370036|FG000|Part 1|Perceived lack of efficacy|1|||
161541013|NCT03485911|583370037|FG001|Part 1|Perceived lack of efficacy|1|||
161541014|NCT03485911|583370038|FG002|Part 1|Perceived lack of efficacy|2|||
161541015|NCT03485911|583370039|FG003|Part 1|Perceived lack of efficacy|0|||
161541016|NCT03485911|583370036|FG000|Part 1|Subject withdrew consent|0|||
161541017|NCT03485911|583370037|FG001|Part 1|Subject withdrew consent|1|||
161592763|NCT02677298|583560308|FG002|Double Blind Phase|Lost to Follow-up|0|||
161592764|NCT02677298|583560306|FG000|Double Blind Phase|Withdrawal by Subject|11|||
161592765|NCT02677298|583560307|FG001|Double Blind Phase|Withdrawal by Subject|8|||
161592766|NCT02677298|583560308|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161592767|NCT02677298|583560306|FG000|Double Blind Phase|No study drug available at site|0|||
161592768|NCT02677298|583560307|FG001|Double Blind Phase|No study drug available at site|1|||
161592769|NCT02677298|583560308|FG002|Double Blind Phase|No study drug available at site|0|||
161592770|NCT02677298|583560306|FG000|Open Label Phase|Adverse Event|0|||
161592771|NCT02677298|583560307|FG001|Open Label Phase|Adverse Event|0|||
161592772|NCT02677298|583560308|FG002|Open Label Phase|Adverse Event|4|||
161592773|NCT02677298|583560306|FG000|Open Label Phase|Physician Decision|0|||
161592774|NCT02677298|583560307|FG001|Open Label Phase|Physician Decision|0|||
161592775|NCT02677298|583560308|FG002|Open Label Phase|Physician Decision|1|||
161592776|NCT02677298|583560306|FG000|Open Label Phase|Lost to Follow-up|0|||
161592777|NCT02677298|583560307|FG001|Open Label Phase|Lost to Follow-up|0|||
161592778|NCT02677298|583560308|FG002|Open Label Phase|Lost to Follow-up|17|||
161592779|NCT02677298|583560306|FG000|Open Label Phase|Withdrawal by Subject|0|||
161592780|NCT02677298|583560307|FG001|Open Label Phase|Withdrawal by Subject|0|||
161592781|NCT02677298|583560308|FG002|Open Label Phase|Withdrawal by Subject|38|||
161592782|NCT03611621|583560309|FG000|Overall Study|Graft loss|3|||
161592783|NCT03611621|583560309|FG000|Overall Study|Death|3|||
161592784|NCT03611621|583560309|FG000|Overall Study|Lost to Follow-up|1|||
161592785|NCT03812679|583560331|FG000|Overall Study|Adverse Event|2|||
161592786|NCT03812679|583560331|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
161592787|NCT03812679|583560331|FG000|Overall Study|Renal transplant|1|||
161592788|NCT03812679|583560331|FG000|Overall Study|Withdrawal by Subject|1|||
161592789|NCT03812679|583560331|FG000|Overall Study|Termination of study|2|||
161592790|NCT03812679|583560331|FG000|Overall Study|Water device replacement|1|||
161592791|NCT05653427|583560332|FG000|Overall Study|Study Terminated by Sponsor|13|||
161592792|NCT04456517|583560338|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
161592793|NCT04456517|583560339|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
161592794|NCT02100813|583560340|FG000|Overall Study|Adverse Event|0|||
161592795|NCT02100813|583560341|FG001|Overall Study|Adverse Event|0|||
161592796|NCT02100813|583560342|FG002|Overall Study|Adverse Event|0|||
161592797|NCT02100813|583560343|FG003|Overall Study|Adverse Event|0|||
161592798|NCT02100813|583560344|FG004|Overall Study|Adverse Event|0|||
161592799|NCT02100813|583560345|FG005|Overall Study|Adverse Event|0|||
161592800|NCT02100813|583560346|FG006|Overall Study|Adverse Event|0|||
161592801|NCT02100813|583560347|FG007|Overall Study|Adverse Event|1|||
161592802|NCT01186367|583560348|FG000|Overall Study|Lost to Follow-up|7|||
161592803|NCT01186367|583560349|FG001|Overall Study|Lost to Follow-up|4|||
161592804|NCT01186367|583560350|FG002|Overall Study|Lost to Follow-up|7|||
161592805|NCT01186367|583560348|FG000|Overall Study|Did not receive study treatment|0|||
161592806|NCT01186367|583560349|FG001|Overall Study|Did not receive study treatment|1|||
161592807|NCT01186367|583560350|FG002|Overall Study|Did not receive study treatment|0|||
161592808|NCT03867500|583560351|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
161592809|NCT04749615|583560352|FG000|Overall Study|Lost to Follow-up|6|||
161592810|NCT04749615|583560353|FG001|Overall Study|Lost to Follow-up|10|||
161592811|NCT03611491|583560354|FG000|Overall Study|Lost to Follow-up|1|||
161592812|NCT05894577|583560355|FG000|Overall Study|No receipt of study drug|14|||
161592813|NCT05894577|583560356|FG001|Overall Study|No receipt of study drug|13|||
161541018|NCT03485911|583370038|FG002|Part 1|Subject withdrew consent|0|||
161541019|NCT03485911|583370039|FG003|Part 1|Subject withdrew consent|1|||
161541020|NCT03485911|583370036|FG000|Part 1|Lab abnormalities/AEs|3|||
161541021|NCT03485911|583370037|FG001|Part 1|Lab abnormalities/AEs|1|||
161541022|NCT03485911|583370038|FG002|Part 1|Lab abnormalities/AEs|1|||
161592814|NCT05894577|583560355|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
161592815|NCT05894577|583560356|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
161592816|NCT05894577|583560355|FG000|Overall Study|Screen Fail|2|||
161592817|NCT05894577|583560356|FG001|Overall Study|Screen Fail|0|||
161592818|NCT05894577|583560355|FG000|Overall Study|Study drug recall|86|||
161592819|NCT05894577|583560356|FG001|Overall Study|Study drug recall|63|||
161592820|NCT04064164|583560361|FG000|Overall Study|Withdrawal by Subject|8|||
161592821|NCT04064164|583560362|FG001|Overall Study|Withdrawal by Subject|8|||
161592822|NCT04650269|583560370|FG000|Overall Study|Death|3|||
161678875|NCT00382720|583877727|FG000|Overall Study|Withdrawal by Subject|11|||
161678876|NCT00382720|583877728|FG001|Overall Study|Withdrawal by Subject|20|||
161678877|NCT00382720|583877729|FG002|Overall Study|Withdrawal by Subject|12|||
161678878|NCT00382720|583877727|FG000|Overall Study|Surgery|1|||
161678879|NCT00382720|583877728|FG001|Overall Study|Surgery|1|||
161678880|NCT00382720|583877729|FG002|Overall Study|Surgery|4|||
161678881|NCT00382720|583877727|FG000|Overall Study|Patient did not receive study medication|1|||
161678882|NCT00382720|583877728|FG001|Overall Study|Patient did not receive study medication|1|||
161678883|NCT00382720|583877729|FG002|Overall Study|Patient did not receive study medication|4|||
161678884|NCT00382720|583877727|FG000|Overall Study|Clinically progressive disease|0|||
161678885|NCT00382720|583877728|FG001|Overall Study|Clinically progressive disease|1|||
161678886|NCT00382720|583877729|FG002|Overall Study|Clinically progressive disease|0|||
161678887|NCT00382720|583877727|FG000|Overall Study|Good prognosis|0|||
161678888|NCT00382720|583877728|FG001|Overall Study|Good prognosis|1|||
161678889|NCT00382720|583877729|FG002|Overall Study|Good prognosis|0|||
161678890|NCT00382720|583877727|FG000|Overall Study|Investigator/Clinical decision|5|||
161678891|NCT00382720|583877728|FG001|Overall Study|Investigator/Clinical decision|6|||
161678892|NCT00382720|583877729|FG002|Overall Study|Investigator/Clinical decision|6|||
161678893|NCT00382720|583877727|FG000|Overall Study|Discontinued at end of study|0|||
161678894|NCT00382720|583877728|FG001|Overall Study|Discontinued at end of study|1|||
161678895|NCT00382720|583877729|FG002|Overall Study|Discontinued at end of study|2|||
161678896|NCT01183143|583877732|FG000|Overall Study|Protocol Violation|115|||
161678897|NCT01183143|583877732|FG000|Overall Study|Withdrawal by Subject|19|||
161678898|NCT01183143|583877732|FG000|Overall Study|Subject Questionnaires not returned|5|||
161678899|NCT01183143|583877732|FG000|Overall Study|Subjects enrolled, but not treated|11|||
161678900|NCT01704287|583877733|FG000|Initial Treatment Period|Death|139|||
161678901|NCT01704287|583877734|FG001|Initial Treatment Period|Death|129|||
161678902|NCT01704287|583877735|FG002|Initial Treatment Period|Death|71|||
161678903|NCT01704287|583877736|FG003|Initial Treatment Period|Death|0|||
161678904|NCT01704287|583877737|FG004|Initial Treatment Period|Death|0|||
161678905|NCT01704287|583877733|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
161678906|NCT01704287|583877734|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
161678907|NCT01704287|583877735|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
161678908|NCT01704287|583877736|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
161678909|NCT01704287|583877737|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
161678910|NCT01704287|583877733|FG000|Initial Treatment Period|Lost to Follow-up|5|||
161678911|NCT01704287|583877734|FG001|Initial Treatment Period|Lost to Follow-up|3|||
161678912|NCT01704287|583877735|FG002|Initial Treatment Period|Lost to Follow-up|0|||
161678913|NCT01704287|583877736|FG003|Initial Treatment Period|Lost to Follow-up|0|||
161678914|NCT01704287|583877737|FG004|Initial Treatment Period|Lost to Follow-up|0|||
161678915|NCT01704287|583877733|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678916|NCT01704287|583877734|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678917|NCT01704287|583877735|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
161678918|NCT01704287|583877736|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678919|NCT01704287|583877737|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678920|NCT01704287|583877733|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161678921|NCT01704287|583877734|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161678922|NCT01704287|583877735|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161678923|NCT01704287|583877736|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
161678924|NCT01704287|583877737|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
161678925|NCT01704287|583877733|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
161678926|NCT01704287|583877734|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
161678927|NCT01704287|583877735|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
161678928|NCT01704287|583877736|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
161678929|NCT01704287|583877737|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
161678930|NCT01704287|583877733|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678931|NCT01704287|583877734|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678932|NCT01704287|583877735|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678933|NCT01704287|583877736|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
161678934|NCT01704287|583877737|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678935|NCT04042740|583877738|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
161678936|NCT04042740|583877738|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
161678937|NCT01717287|583877739|FG000|Overall Study|Lost to Follow-up|0|||
161678938|NCT01717287|583877740|FG001|Overall Study|Lost to Follow-up|2|||
161678939|NCT01717287|583877739|FG000|Overall Study|Protocol Violation|0|||
161678940|NCT01717287|583877740|FG001|Overall Study|Protocol Violation|1|||
161829477|NCT00572039|584415791|FG000|Overall Study|Death|2|||
161829478|NCT00572039|584415792|FG001|Overall Study|Death|3|||
161678941|NCT04024228|583877741|FG000|Overall Study|Adverse Event|1|||
161678942|NCT04024228|583877742|FG001|Overall Study|Adverse Event|0|||
161829479|NCT00572039|584415791|FG000|Overall Study|Ill|5|||
161829480|NCT00572039|584415792|FG001|Overall Study|Ill|1|||
161592823|NCT04650269|583560370|FG000|Overall Study|Lost to Follow-up|6|||
161592824|NCT04091750|583560371|FG000|Overall Study|Adverse Event|4|||
161592825|NCT04091750|583560371|FG000|Overall Study|Withdrawal by Subject|1|||
161592826|NCT02619838|583560373|FG000|Overall Study|Lost to Follow-up|9|||
161592827|NCT02619838|583560373|FG000|Overall Study|Withdrawal by Subject|15|||
161592828|NCT05020249|583560374|FG000|Overall Study|Protocol Violation|1|||
161541023|NCT03485911|583370039|FG003|Part 1|Lab abnormalities/AEs|0|||
161541024|NCT03485911|583370036|FG000|Part 1|Withdrew Consent prior to dosing|0|||
161541025|NCT03485911|583370037|FG001|Part 1|Withdrew Consent prior to dosing|0|||
161541026|NCT03485911|583370038|FG002|Part 1|Withdrew Consent prior to dosing|0|||
161541027|NCT03485911|583370039|FG003|Part 1|Withdrew Consent prior to dosing|1|||
161541028|NCT03485911|583370036|FG000|Part 1|Other NOS|0|||
161541029|NCT03485911|583370037|FG001|Part 1|Other NOS|0|||
161541030|NCT03485911|583370038|FG002|Part 1|Other NOS|0|||
161541031|NCT03485911|583370039|FG003|Part 1|Other NOS|1|||
161541032|NCT03485911|583370036|FG000|Part 2|Perceived lack of efficacy|5|||
161541033|NCT03485911|583370037|FG001|Part 2|Perceived lack of efficacy|3|||
161541034|NCT03485911|583370038|FG002|Part 2|Perceived lack of efficacy|0|||
161541035|NCT03485911|583370039|FG003|Part 2|Perceived lack of efficacy|2|||
161541036|NCT03485911|583370036|FG000|Part 2|Subject withdrew consent|1|||
161541037|NCT03485911|583370037|FG001|Part 2|Subject withdrew consent|0|||
161541038|NCT03485911|583370038|FG002|Part 2|Subject withdrew consent|2|||
161541039|NCT03485911|583370039|FG003|Part 2|Subject withdrew consent|1|||
161541040|NCT03485911|583370036|FG000|Part 2|Lab abnormalities/AEs|1|||
161541041|NCT03485911|583370037|FG001|Part 2|Lab abnormalities/AEs|2|||
161541042|NCT03485911|583370038|FG002|Part 2|Lab abnormalities/AEs|0|||
161541043|NCT03485911|583370039|FG003|Part 2|Lab abnormalities/AEs|0|||
161541044|NCT03485911|583370036|FG000|Part 2|Other NOS|0|||
161541045|NCT03485911|583370037|FG001|Part 2|Other NOS|1|||
161541046|NCT03485911|583370038|FG002|Part 2|Other NOS|0|||
161541047|NCT03485911|583370039|FG003|Part 2|Other NOS|0|||
161541048|NCT03485911|583370036|FG000|Part 2|Intercurrent illness/new medical condition|1|||
161541049|NCT03485911|583370037|FG001|Part 2|Intercurrent illness/new medical condition|0|||
161541050|NCT03485911|583370038|FG002|Part 2|Intercurrent illness/new medical condition|0|||
161541051|NCT03485911|583370039|FG003|Part 2|Intercurrent illness/new medical condition|0|||
161541052|NCT03485911|583370036|FG000|Part 2|Investigator judgement|1|||
161541053|NCT03485911|583370037|FG001|Part 2|Investigator judgement|0|||
161541054|NCT03485911|583370038|FG002|Part 2|Investigator judgement|0|||
161541055|NCT03485911|583370039|FG003|Part 2|Investigator judgement|0|||
161541056|NCT03485911|583370036|FG000|Part 3|Perceived lack of efficacy|2|||
161541057|NCT03485911|583370037|FG001|Part 3|Perceived lack of efficacy|2|||
161541058|NCT03485911|583370038|FG002|Part 3|Perceived lack of efficacy|2|||
161541059|NCT03485911|583370039|FG003|Part 3|Perceived lack of efficacy|0|||
161541060|NCT03485911|583370036|FG000|Part 3|Subject withdrew consent|1|||
161541061|NCT03485911|583370037|FG001|Part 3|Subject withdrew consent|4|||
161541062|NCT03485911|583370038|FG002|Part 3|Subject withdrew consent|0|||
161541063|NCT03485911|583370039|FG003|Part 3|Subject withdrew consent|1|||
161541064|NCT03485911|583370036|FG000|Part 3|Lab abnormalities/AEs|1|||
161541065|NCT03485911|583370037|FG001|Part 3|Lab abnormalities/AEs|1|||
161541066|NCT03485911|583370038|FG002|Part 3|Lab abnormalities/AEs|0|||
161541067|NCT03485911|583370039|FG003|Part 3|Lab abnormalities/AEs|2|||
161541068|NCT03485911|583370036|FG000|Part 3|Other NOS|1|||
161541069|NCT03485911|583370037|FG001|Part 3|Other NOS|1|||
161541070|NCT03485911|583370038|FG002|Part 3|Other NOS|0|||
161541071|NCT03485911|583370039|FG003|Part 3|Other NOS|0|||
161541072|NCT03485911|583370036|FG000|Part 3|Intercurrent illness/new medical condition|0|||
161541073|NCT03485911|583370037|FG001|Part 3|Intercurrent illness/new medical condition|1|||
161541074|NCT03485911|583370038|FG002|Part 3|Intercurrent illness/new medical condition|1|||
161541075|NCT03485911|583370039|FG003|Part 3|Intercurrent illness/new medical condition|0|||
161541076|NCT03485911|583370036|FG000|Part 3|Sponsor discontinuation|1|||
161541077|NCT03485911|583370037|FG001|Part 3|Sponsor discontinuation|0|||
161541078|NCT03485911|583370038|FG002|Part 3|Sponsor discontinuation|0|||
161541079|NCT03485911|583370039|FG003|Part 3|Sponsor discontinuation|0|||
161541080|NCT03485911|583370036|FG000|Part 3|Berotralstat provided by alternative means|13|||
161541081|NCT03485911|583370037|FG001|Part 3|Berotralstat provided by alternative means|13|||
161541082|NCT03485911|583370038|FG002|Part 3|Berotralstat provided by alternative means|7|||
161541083|NCT03485911|583370039|FG003|Part 3|Berotralstat provided by alternative means|7|||
161541084|NCT03333928|583370040|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
161592829|NCT05020249|583560375|FG001|Overall Study|Protocol Violation|0|||
161541085|NCT03333928|583370041|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
161541086|NCT03333928|583370042|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
161541087|NCT03333928|583370040|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
161541088|NCT03333928|583370041|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
161541089|NCT03333928|583370042|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
161541090|NCT03333928|583370040|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
161592830|NCT04971681|583560386|FG000|Followup|Lost to Follow-up|1|||
161592831|NCT04971681|583560387|FG001|Followup|Lost to Follow-up|0|||
161541091|NCT03333928|583370041|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
161541092|NCT03333928|583370042|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
161541093|NCT03333928|583370040|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
161541094|NCT03333928|583370041|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
161541095|NCT03333928|583370042|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
161541096|NCT03333928|583370040|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
161541097|NCT03333928|583370041|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
161541098|NCT03333928|583370042|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
161541099|NCT03333928|583370040|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
161541100|NCT03333928|583370041|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
161541101|NCT03333928|583370042|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
161541102|NCT03333928|583370040|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
161541103|NCT03333928|583370041|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
161541104|NCT03333928|583370042|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
161541105|NCT03333928|583370040|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
161541106|NCT03333928|583370041|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
161541107|NCT03333928|583370042|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
161541108|NCT00728962|583370043|FG000|Implant Placement Surgery|Adverse Event|8|||
161541109|NCT00728962|583370043|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
161541110|NCT00728962|583370043|FG000|Implant Placement Surgery|Protocol Violation|1|||
161541111|NCT00728962|583370043|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
161541112|NCT00728962|583370043|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
161541113|NCT04954586|583370044|FG000|Overall Study|Withdrawal by Subject|5|||
161541114|NCT01987817|583370056|FG000|Overall Study|Adverse Event|4|||
161541115|NCT01987817|583370057|FG001|Overall Study|Adverse Event|0|||
161541116|NCT01987817|583370056|FG000|Overall Study|Withdrawal by Subject|1|||
161541117|NCT01987817|583370057|FG001|Overall Study|Withdrawal by Subject|1|||
161829481|NCT01098110|584415798|FG000|Overall Study|Withdrawal by Subject|14|||
161541118|NCT01987817|583370056|FG000|Overall Study|Physician Decision|1|||
161541119|NCT01987817|583370057|FG001|Overall Study|Physician Decision|0|||
161541120|NCT02612064|583370065|FG000|Overall Study|Withdrawal by Subject|1|||
161541121|NCT02612064|583370066|FG001|Overall Study|Withdrawal by Subject|1|||
161541122|NCT02612064|583370065|FG000|Overall Study|Other|0|||
161541123|NCT02612064|583370066|FG001|Overall Study|Other|2|||
161541124|NCT05918978|583370069|FG000|Overall Study|Study Terminated by Sponsor|17|||
161541125|NCT05918978|583370070|FG001|Overall Study|Study Terminated by Sponsor|11|||
161541126|NCT05918978|583370069|FG000|Overall Study|Withdrawal by Subject|1|||
161541127|NCT05918978|583370070|FG001|Overall Study|Withdrawal by Subject|1|||
161541128|NCT05918978|583370069|FG000|Overall Study|Adverse Event|1|||
161541129|NCT05918978|583370070|FG001|Overall Study|Adverse Event|0|||
161541130|NCT05918978|583370069|FG000|Overall Study|Other|0|||
161541131|NCT05918978|583370070|FG001|Overall Study|Other|1|||
161541132|NCT00622180|583370071|FG000|Overall Study|Lost to Follow-up|1|||
161541133|NCT00622180|583370072|FG001|Overall Study|Lost to Follow-up|2|||
161541134|NCT00279201|583370075|FG000|Initiation|Death|1|||
161541135|NCT00279201|583370076|FG001|Initiation|Death|5|||
161541136|NCT00279201|583370077|FG002|Initiation|Death|0|||
161541137|NCT00279201|583370078|FG003|Initiation|Death|0|||
161541138|NCT00279201|583370079|FG004|Initiation|Death|0|||
161541139|NCT00279201|583370080|FG005|Initiation|Death|0|||
161541140|NCT00279201|583370075|FG000|Initiation|Adverse Event|6|||
161541141|NCT00279201|583370076|FG001|Initiation|Adverse Event|15|||
161541142|NCT00279201|583370077|FG002|Initiation|Adverse Event|0|||
161541143|NCT00279201|583370078|FG003|Initiation|Adverse Event|0|||
161541144|NCT00279201|583370079|FG004|Initiation|Adverse Event|0|||
161541145|NCT00279201|583370080|FG005|Initiation|Adverse Event|0|||
161541146|NCT00279201|583370075|FG000|Initiation|Lost to Follow-up|42|||
161541147|NCT00279201|583370076|FG001|Initiation|Lost to Follow-up|41|||
161541148|NCT00279201|583370077|FG002|Initiation|Lost to Follow-up|0|||
161541149|NCT00279201|583370078|FG003|Initiation|Lost to Follow-up|0|||
161541150|NCT00279201|583370079|FG004|Initiation|Lost to Follow-up|0|||
161541151|NCT00279201|583370080|FG005|Initiation|Lost to Follow-up|0|||
161541152|NCT00279201|583370075|FG000|Initiation|Entry Criteria Exclusion|7|||
161541153|NCT00279201|583370076|FG001|Initiation|Entry Criteria Exclusion|9|||
161541154|NCT00279201|583370077|FG002|Initiation|Entry Criteria Exclusion|0|||
161541155|NCT00279201|583370078|FG003|Initiation|Entry Criteria Exclusion|0|||
161541156|NCT00279201|583370079|FG004|Initiation|Entry Criteria Exclusion|0|||
161541157|NCT00279201|583370080|FG005|Initiation|Entry Criteria Exclusion|0|||
161541158|NCT00279201|583370075|FG000|Initiation|Protocol Violation|9|||
161541159|NCT00279201|583370076|FG001|Initiation|Protocol Violation|10|||
161541160|NCT00279201|583370077|FG002|Initiation|Protocol Violation|0|||
161541161|NCT00279201|583370078|FG003|Initiation|Protocol Violation|0|||
161541162|NCT00279201|583370079|FG004|Initiation|Protocol Violation|0|||
161541163|NCT00279201|583370080|FG005|Initiation|Protocol Violation|0|||
161678943|NCT04024228|583877741|FG000|Overall Study|Protocol Deviation|0|||
161678944|NCT04024228|583877742|FG001|Overall Study|Protocol Deviation|2|||
161678945|NCT04024228|583877741|FG000|Overall Study|Withdrawal by Subject|3|||
161678946|NCT04024228|583877742|FG001|Overall Study|Withdrawal by Subject|4|||
161678947|NCT04490395|583877746|FG000|Overall Study|Lost to Follow-up|0|||
161678948|NCT04490395|583877747|FG001|Overall Study|Lost to Follow-up|1|||
161678949|NCT00938717|583877748|FG000|Overall Study|Adverse Event|10|||
161678950|NCT00938717|583877749|FG001|Overall Study|Adverse Event|41|||
161678951|NCT00938717|583877748|FG000|Overall Study|Protocol Violation|11|||
161678952|NCT00938717|583877749|FG001|Overall Study|Protocol Violation|8|||
161678953|NCT00938717|583877748|FG000|Overall Study|Withdrawal by Subject|26|||
161678954|NCT00938717|583877749|FG001|Overall Study|Withdrawal by Subject|24|||
161678955|NCT00938717|583877748|FG000|Overall Study|Lost to Follow-up|13|||
161678956|NCT00938717|583877749|FG001|Overall Study|Lost to Follow-up|18|||
161678957|NCT00938717|583877748|FG000|Overall Study|Lack of Efficacy|33|||
161678958|NCT00938717|583877749|FG001|Overall Study|Lack of Efficacy|15|||
161678959|NCT00938717|583877748|FG000|Overall Study|Other reason|5|||
161678960|NCT00938717|583877749|FG001|Overall Study|Other reason|2|||
161678961|NCT01942148|583877754|FG000|Overall Study|Adverse Event|4|||
161678962|NCT01942148|583877754|FG000|Overall Study|Lack of Efficacy|2|||
161541164|NCT00279201|583370075|FG000|Initiation|Withdrawal by Subject|35|||
161541165|NCT00279201|583370076|FG001|Initiation|Withdrawal by Subject|41|||
161541166|NCT00279201|583370077|FG002|Initiation|Withdrawal by Subject|0|||
161541167|NCT00279201|583370078|FG003|Initiation|Withdrawal by Subject|0|||
161541168|NCT00279201|583370079|FG004|Initiation|Withdrawal by Subject|0|||
161541169|NCT00279201|583370080|FG005|Initiation|Withdrawal by Subject|0|||
161541170|NCT00279201|583370075|FG000|Initiation|Physician Decision|15|||
161541171|NCT00279201|583370076|FG001|Initiation|Physician Decision|18|||
161541172|NCT00279201|583370077|FG002|Initiation|Physician Decision|0|||
161541173|NCT00279201|583370078|FG003|Initiation|Physician Decision|0|||
161541174|NCT00279201|583370079|FG004|Initiation|Physician Decision|0|||
161541175|NCT00279201|583370080|FG005|Initiation|Physician Decision|0|||
161541176|NCT00279201|583370075|FG000|Initiation|Sponsor Decision|13|||
161541177|NCT00279201|583370076|FG001|Initiation|Sponsor Decision|5|||
161541178|NCT00279201|583370077|FG002|Initiation|Sponsor Decision|0|||
161541179|NCT00279201|583370078|FG003|Initiation|Sponsor Decision|0|||
161541180|NCT00279201|583370079|FG004|Initiation|Sponsor Decision|0|||
161592832|NCT00686335|583560388|FG000|Run-in Period|Adverse Event|1|||
161592833|NCT00686335|583560388|FG000|Run-in Period|asthma exacerbation|1|||
161592834|NCT00686335|583560388|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
161592835|NCT04376502|583560389|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
161592836|NCT05603143|583560390|FG000|Overall Study|Withdrew consent|6|||
161592837|NCT05603143|583560391|FG001|Overall Study|Withdrew consent|2|||
161592838|NCT05603143|583560390|FG000|Overall Study|Randomized but never treated|0|||
161592839|NCT05603143|583560391|FG001|Overall Study|Randomized but never treated|3|||
161592840|NCT05603143|583560390|FG000|Overall Study|Adverse Event|2|||
161592841|NCT05603143|583560391|FG001|Overall Study|Adverse Event|0|||
161592842|NCT05603143|583560390|FG000|Overall Study|Death|0|||
161592843|NCT05603143|583560391|FG001|Overall Study|Death|1|||
161592844|NCT05603143|583560390|FG000|Overall Study|Investigator's discretion|1|||
161592845|NCT05603143|583560391|FG001|Overall Study|Investigator's discretion|0|||
161592846|NCT05603143|583560390|FG000|Overall Study|Lost to Follow-up|0|||
161592847|NCT05603143|583560391|FG001|Overall Study|Lost to Follow-up|1|||
161592848|NCT05603143|583560390|FG000|Overall Study|Protocol Violation|0|||
161592849|NCT05603143|583560391|FG001|Overall Study|Protocol Violation|1|||
161592850|NCT04171999|583560392|FG000|Overall Study|deemed ineligible after randomization|2|||
161592851|NCT04171999|583560393|FG001|Overall Study|deemed ineligible after randomization|1|||
161592852|NCT04505904|583560394|FG000|Overall Study|Withdrawal by Subject|1|||
161592853|NCT04505904|583560395|FG001|Overall Study|Withdrawal by Subject|2|||
161592854|NCT04505904|583560396|FG002|Overall Study|Withdrawal by Subject|0|||
161592855|NCT04505904|583560397|FG003|Overall Study|Withdrawal by Subject|0|||
161592856|NCT04505904|583560394|FG000|Overall Study|Physician Decision|1|||
161592857|NCT04505904|583560395|FG001|Overall Study|Physician Decision|0|||
161592858|NCT04505904|583560396|FG002|Overall Study|Physician Decision|0|||
161541181|NCT00279201|583370080|FG005|Initiation|Sponsor Decision|0|||
161541182|NCT00279201|583370075|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
161541183|NCT00279201|583370076|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
161541184|NCT00279201|583370077|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
161541185|NCT00279201|583370078|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
161592859|NCT04505904|583560397|FG003|Overall Study|Physician Decision|0|||
161592860|NCT04505904|583560394|FG000|Overall Study|Adverse Event|0|||
161592861|NCT04505904|583560395|FG001|Overall Study|Adverse Event|1|||
161592862|NCT04505904|583560396|FG002|Overall Study|Adverse Event|0|||
161592863|NCT04505904|583560397|FG003|Overall Study|Adverse Event|0|||
161592864|NCT04277442|583560400|FG000|Overall Study|Death|1|||
161592865|NCT03092518|583560401|FG000|Overall Study|Ineligible|2|||
161678963|NCT01942148|583877754|FG000|Overall Study|Physician Decision|11|||
161592866|NCT01824537|583560402|FG000|Overall Study|Lost to Follow-up|78|||
161592867|NCT01824537|583560403|FG001|Overall Study|Lost to Follow-up|87|||
161592868|NCT02547987|583560404|FG000|Overall Study|Withdrawal by Subject|1|||
161592869|NCT02547987|583560404|FG000|Overall Study|Adverse Event|2|||
161592870|NCT04938492|583560416|FG000|Overall Study|Lost to Follow-up|17|||
161592871|NCT04938492|583560417|FG001|Overall Study|Lost to Follow-up|18|||
161592872|NCT03865498|583560418|FG000|Overall Study|Lack of Efficacy|12|||
161592873|NCT03865498|583560419|FG001|Overall Study|Lack of Efficacy|11|||
161592874|NCT03865498|583560418|FG000|Overall Study|Lost to Follow-up|125|||
161592875|NCT03865498|583560419|FG001|Overall Study|Lost to Follow-up|133|||
161592876|NCT03865498|583560418|FG000|Overall Study|Withdrawal by Subject|2|||
161592877|NCT03865498|583560419|FG001|Overall Study|Withdrawal by Subject|4|||
161592878|NCT01648023|583560420|FG000|Overall Study|Screen Fail Post Randomization|1|||
161592879|NCT01648023|583560421|FG001|Overall Study|Screen Fail Post Randomization|2|||
161592880|NCT05084508|583560422|FG000|Overall Study|Lost to Follow-up|6|||
161592881|NCT05084508|583560423|FG001|Overall Study|Lost to Follow-up|3|||
161592882|NCT05084508|583560424|FG002|Overall Study|Lost to Follow-up|7|||
161592883|NCT05084508|583560425|FG003|Overall Study|Lost to Follow-up|3|||
161592884|NCT05084508|583560422|FG000|Overall Study|Withdrawal by Subject|0|||
161592885|NCT05084508|583560423|FG001|Overall Study|Withdrawal by Subject|2|||
161592886|NCT05084508|583560424|FG002|Overall Study|Withdrawal by Subject|3|||
161592887|NCT05084508|583560425|FG003|Overall Study|Withdrawal by Subject|1|||
161592888|NCT05084508|583560422|FG000|Overall Study|Other|0|||
161592889|NCT05084508|583560423|FG001|Overall Study|Other|0|||
161592890|NCT05084508|583560424|FG002|Overall Study|Other|0|||
161592891|NCT05084508|583560425|FG003|Overall Study|Other|1|||
161592892|NCT05296525|583560426|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161592893|NCT05296525|583560427|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161592894|NCT05296525|583560428|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161592895|NCT05296525|583560429|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
161592896|NCT02547363|583560436|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161592897|NCT02547363|583560437|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161592898|NCT02547363|583560436|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
161592899|NCT02547363|583560437|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
161592900|NCT02547363|583560436|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161592901|NCT02547363|583560437|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161592902|NCT02547363|583560436|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
161592903|NCT02547363|583560437|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
161592904|NCT02547363|583560436|FG000|12-month Follow-up|Withdrawal by Subject|4|||
161592905|NCT02547363|583560437|FG001|12-month Follow-up|Withdrawal by Subject|3|||
161592906|NCT02547363|583560436|FG000|12-month Follow-up|Lost to Follow-up|4|||
161592907|NCT02547363|583560437|FG001|12-month Follow-up|Lost to Follow-up|1|||
161592908|NCT02547363|583560436|FG000|12-month Follow-up|Lack of Efficacy|1|||
161592909|NCT02547363|583560437|FG001|12-month Follow-up|Lack of Efficacy|1|||
161592910|NCT02547363|583560436|FG000|12-month Follow-up|Other|1|||
161592911|NCT02547363|583560437|FG001|12-month Follow-up|Other|0|||
161592912|NCT03931174|583560438|FG000|Providers|Staff left organization|26|||
161592913|NCT03931174|583560439|FG001|Providers|Staff left organization|25|||
161592914|NCT03931174|583560438|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
161592915|NCT03931174|583560439|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
161592916|NCT03931174|583560438|FG000|Providers|Lost to Follow-up|4|||
161592917|NCT03931174|583560439|FG001|Providers|Lost to Follow-up|4|||
161592918|NCT03931174|583560438|FG000|Patients|Post-consent screening failure|1|||
161592919|NCT03931174|583560439|FG001|Patients|Post-consent screening failure|1|||
161592920|NCT03931174|583560438|FG000|Patients|Death|1|||
161592921|NCT03931174|583560439|FG001|Patients|Death|1|||
161592922|NCT03931174|583560438|FG000|Patients|Lost to Follow-up|60|||
161592923|NCT03931174|583560439|FG001|Patients|Lost to Follow-up|89|||
161592924|NCT05386030|583560440|FG000|Overall Study|Death|1|||
161592925|NCT05386030|583560441|FG001|Overall Study|Death|0|||
161592926|NCT05386030|583560440|FG000|Overall Study|Physician Decision|2|||
161592927|NCT05386030|583560441|FG001|Overall Study|Physician Decision|1|||
161592928|NCT05386030|583560440|FG000|Overall Study|Lost to Follow-up|19|||
161592929|NCT05386030|583560441|FG001|Overall Study|Lost to Follow-up|7|||
161592930|NCT05386030|583560440|FG000|Overall Study|Withdrawal by Subject|20|||
161592931|NCT05386030|583560441|FG001|Overall Study|Withdrawal by Subject|10|||
161592932|NCT05386030|583560440|FG000|Overall Study|Eligibility criteria violation|1|||
161592933|NCT05386030|583560441|FG001|Overall Study|Eligibility criteria violation|1|||
161592934|NCT05386030|583560440|FG000|Overall Study|Personal Reasons|1|||
161592935|NCT05386030|583560441|FG001|Overall Study|Personal Reasons|0|||
161592936|NCT03213691|583560442|FG000|Overall Study|Adverse Event|2|||
161592937|NCT03213691|583560442|FG000|Overall Study|Death|3|||
161592938|NCT03213691|583560442|FG000|Overall Study|Physician Decision|1|||
161678964|NCT01942148|583877754|FG000|Overall Study|Protocol Violation|1|||
161678965|NCT01942148|583877754|FG000|Overall Study|Withdrawal by Subject|8|||
161678966|NCT01942148|583877754|FG000|Overall Study|Use of the prohibition medicine|1|||
161678967|NCT01838616|583877755|FG000|Titration Period|Adverse Event|18|||
161678968|NCT01838616|583877756|FG001|Titration Period|Adverse Event|48|||
161678969|NCT01838616|583877755|FG000|Titration Period|Lack of Efficacy|5|||
161541186|NCT00279201|583370079|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
161541187|NCT00279201|583370080|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
161541188|NCT00279201|583370075|FG000|Maintenance|Lack of Efficacy|32|||
161541189|NCT00279201|583370076|FG001|Maintenance|Lack of Efficacy|30|||
161541190|NCT00279201|583370077|FG002|Maintenance|Lack of Efficacy|0|||
161541191|NCT00279201|583370078|FG003|Maintenance|Lack of Efficacy|0|||
161541192|NCT00279201|583370079|FG004|Maintenance|Lack of Efficacy|0|||
161541193|NCT00279201|583370080|FG005|Maintenance|Lack of Efficacy|0|||
161541194|NCT00279201|583370075|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
161541195|NCT00279201|583370076|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
161541196|NCT00279201|583370077|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
161541197|NCT00279201|583370078|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
161541198|NCT00279201|583370079|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
161541199|NCT00279201|583370080|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
161541200|NCT00279201|583370075|FG000|Maintenance|Adverse Event|4|||
161541201|NCT00279201|583370076|FG001|Maintenance|Adverse Event|4|||
161541202|NCT00279201|583370077|FG002|Maintenance|Adverse Event|0|||
161541203|NCT00279201|583370078|FG003|Maintenance|Adverse Event|0|||
161541204|NCT00279201|583370079|FG004|Maintenance|Adverse Event|0|||
161541205|NCT00279201|583370080|FG005|Maintenance|Adverse Event|0|||
161541206|NCT00279201|583370075|FG000|Maintenance|Death|4|||
161541207|NCT00279201|583370076|FG001|Maintenance|Death|4|||
161541208|NCT00279201|583370077|FG002|Maintenance|Death|0|||
161541209|NCT00279201|583370078|FG003|Maintenance|Death|0|||
161541210|NCT00279201|583370079|FG004|Maintenance|Death|0|||
161541211|NCT00279201|583370080|FG005|Maintenance|Death|0|||
161541212|NCT00279201|583370075|FG000|Maintenance|Lost to Follow-up|17|||
161541213|NCT00279201|583370076|FG001|Maintenance|Lost to Follow-up|13|||
161541214|NCT00279201|583370077|FG002|Maintenance|Lost to Follow-up|0|||
161541215|NCT00279201|583370078|FG003|Maintenance|Lost to Follow-up|0|||
161541216|NCT00279201|583370079|FG004|Maintenance|Lost to Follow-up|0|||
161541217|NCT00279201|583370080|FG005|Maintenance|Lost to Follow-up|0|||
161541218|NCT00279201|583370075|FG000|Maintenance|Entry Criteria Exclusion|1|||
161541219|NCT00279201|583370076|FG001|Maintenance|Entry Criteria Exclusion|4|||
161541220|NCT00279201|583370077|FG002|Maintenance|Entry Criteria Exclusion|0|||
161541221|NCT00279201|583370078|FG003|Maintenance|Entry Criteria Exclusion|0|||
161541222|NCT00279201|583370079|FG004|Maintenance|Entry Criteria Exclusion|0|||
161541223|NCT00279201|583370080|FG005|Maintenance|Entry Criteria Exclusion|0|||
161541224|NCT00279201|583370075|FG000|Maintenance|Protocol Violation|16|||
161541225|NCT00279201|583370076|FG001|Maintenance|Protocol Violation|24|||
161541226|NCT00279201|583370077|FG002|Maintenance|Protocol Violation|0|||
161541227|NCT00279201|583370078|FG003|Maintenance|Protocol Violation|0|||
161541228|NCT00279201|583370079|FG004|Maintenance|Protocol Violation|0|||
161541229|NCT00279201|583370080|FG005|Maintenance|Protocol Violation|0|||
161541230|NCT00279201|583370075|FG000|Maintenance|Withdrawal by Subject|18|||
161541231|NCT00279201|583370076|FG001|Maintenance|Withdrawal by Subject|18|||
161541232|NCT00279201|583370077|FG002|Maintenance|Withdrawal by Subject|0|||
161541233|NCT00279201|583370078|FG003|Maintenance|Withdrawal by Subject|0|||
161541234|NCT00279201|583370079|FG004|Maintenance|Withdrawal by Subject|0|||
161541235|NCT00279201|583370080|FG005|Maintenance|Withdrawal by Subject|0|||
161541236|NCT00279201|583370075|FG000|Maintenance|Physician Decision|9|||
161541237|NCT00279201|583370076|FG001|Maintenance|Physician Decision|9|||
161541238|NCT00279201|583370077|FG002|Maintenance|Physician Decision|0|||
161541239|NCT00279201|583370078|FG003|Maintenance|Physician Decision|0|||
161541240|NCT00279201|583370079|FG004|Maintenance|Physician Decision|0|||
161678970|NCT01838616|583877756|FG001|Titration Period|Lack of Efficacy|12|||
161541241|NCT00279201|583370080|FG005|Maintenance|Physician Decision|0|||
161678971|NCT01838616|583877755|FG000|Titration Period|Withdrawal by Subject|5|||
161541242|NCT00279201|583370075|FG000|Maintenance|Sponsor Decision|4|||
161541243|NCT00279201|583370076|FG001|Maintenance|Sponsor Decision|0|||
161541244|NCT00279201|583370077|FG002|Maintenance|Sponsor Decision|0|||
161541245|NCT00279201|583370078|FG003|Maintenance|Sponsor Decision|0|||
161541246|NCT00279201|583370079|FG004|Maintenance|Sponsor Decision|0|||
161541247|NCT00279201|583370080|FG005|Maintenance|Sponsor Decision|0|||
161541248|NCT00279201|583370075|FG000|Maintenance|HbA1c>7.5%|123|||
161541249|NCT00279201|583370076|FG001|Maintenance|HbA1c>7.5%|126|||
161541250|NCT00279201|583370077|FG002|Maintenance|HbA1c>7.5%|0|||
161541251|NCT00279201|583370078|FG003|Maintenance|HbA1c>7.5%|0|||
161541252|NCT00279201|583370079|FG004|Maintenance|HbA1c>7.5%|0|||
161541253|NCT00279201|583370080|FG005|Maintenance|HbA1c>7.5%|0|||
161541254|NCT00279201|583370075|FG000|Intensification Addendum|Withdrawal by Subject|0|||
161541255|NCT00279201|583370076|FG001|Intensification Addendum|Withdrawal by Subject|0|||
161678972|NCT01838616|583877756|FG001|Titration Period|Withdrawal by Subject|5|||
161678973|NCT01838616|583877755|FG000|Titration Period|Technical problems|1|||
161541256|NCT00279201|583370077|FG002|Intensification Addendum|Withdrawal by Subject|12|||
161541257|NCT00279201|583370078|FG003|Intensification Addendum|Withdrawal by Subject|14|||
161541258|NCT00279201|583370079|FG004|Intensification Addendum|Withdrawal by Subject|9|||
161541259|NCT00279201|583370080|FG005|Intensification Addendum|Withdrawal by Subject|18|||
161541260|NCT00279201|583370075|FG000|Intensification Addendum|Lost to Follow-up|0|||
161541261|NCT00279201|583370076|FG001|Intensification Addendum|Lost to Follow-up|0|||
161541262|NCT00279201|583370077|FG002|Intensification Addendum|Lost to Follow-up|4|||
161541263|NCT00279201|583370078|FG003|Intensification Addendum|Lost to Follow-up|6|||
161541264|NCT00279201|583370079|FG004|Intensification Addendum|Lost to Follow-up|7|||
161541265|NCT00279201|583370080|FG005|Intensification Addendum|Lost to Follow-up|7|||
161541266|NCT00279201|583370075|FG000|Intensification Addendum|Protocol Violation|0|||
161592939|NCT03213691|583560442|FG000|Overall Study|Progressive Disease|14|||
161592940|NCT03213691|583560442|FG000|Overall Study|Ineligible|1|||
161592941|NCT03161028|583560443|FG000|Overall Study|Withdrawal by Subject|6|||
161592942|NCT03161028|583560444|FG001|Overall Study|Withdrawal by Subject|4|||
161592943|NCT03161028|583560443|FG000|Overall Study|Adverse Event|5|||
161592944|NCT03161028|583560444|FG001|Overall Study|Adverse Event|1|||
161592945|NCT03161028|583560443|FG000|Overall Study|Study drug side effects|2|||
161592946|NCT03161028|583560444|FG001|Overall Study|Study drug side effects|2|||
161592947|NCT03161028|583560443|FG000|Overall Study|Administrative PD/UP|4|||
161592948|NCT03161028|583560444|FG001|Overall Study|Administrative PD/UP|2|||
161592949|NCT03161028|583560443|FG000|Overall Study|Lost to Follow-up|2|||
161592950|NCT03161028|583560444|FG001|Overall Study|Lost to Follow-up|0|||
161592951|NCT03161028|583560443|FG000|Overall Study|Unable to comply with procedures|1|||
161592952|NCT03161028|583560444|FG001|Overall Study|Unable to comply with procedures|1|||
161592953|NCT00736723|583560447|FG000|Overall Study|Withdrawal by Subject|4|||
161592954|NCT00736723|583560448|FG001|Overall Study|Withdrawal by Subject|3|||
161592955|NCT03492216|583560449|FG000|Overall Study|Death|1|||
161592956|NCT03492216|583560450|FG001|Overall Study|Death|0|||
161592957|NCT03492216|583560451|FG002|Overall Study|Death|4|||
161592958|NCT03492216|583560452|FG003|Overall Study|Death|0|||
161592959|NCT03492216|583560449|FG000|Overall Study|Withdrawal by Subject|5|||
161592960|NCT03492216|583560450|FG001|Overall Study|Withdrawal by Subject|3|||
161592961|NCT03492216|583560451|FG002|Overall Study|Withdrawal by Subject|1|||
161592962|NCT03492216|583560452|FG003|Overall Study|Withdrawal by Subject|1|||
161592963|NCT03492216|583560449|FG000|Overall Study|Lost to Follow-up|9|||
161592964|NCT03492216|583560450|FG001|Overall Study|Lost to Follow-up|2|||
161592965|NCT03492216|583560451|FG002|Overall Study|Lost to Follow-up|7|||
161592966|NCT03492216|583560452|FG003|Overall Study|Lost to Follow-up|8|||
161592967|NCT03492216|583560449|FG000|Overall Study|Moved|5|||
161592968|NCT03492216|583560450|FG001|Overall Study|Moved|3|||
161592969|NCT03492216|583560451|FG002|Overall Study|Moved|3|||
161592970|NCT03492216|583560452|FG003|Overall Study|Moved|5|||
161592971|NCT03492216|583560449|FG000|Overall Study|Too ill|0|||
161592972|NCT03492216|583560450|FG001|Overall Study|Too ill|1|||
161592973|NCT03492216|583560451|FG002|Overall Study|Too ill|0|||
161592974|NCT03492216|583560452|FG003|Overall Study|Too ill|0|||
161592975|NCT03492216|583560449|FG000|Overall Study|Incarcerated|0|||
161592976|NCT03492216|583560450|FG001|Overall Study|Incarcerated|0|||
161592977|NCT03492216|583560451|FG002|Overall Study|Incarcerated|2|||
161592978|NCT03492216|583560452|FG003|Overall Study|Incarcerated|0|||
161592979|NCT05351554|583560453|FG000|Overall Study|Study terminated by sponsor|1|||
161592980|NCT05030233|583560454|FG000|Overall Study|withdrawn for transfer|1|||
161592981|NCT05030233|583560455|FG001|Overall Study|withdrawn for transfer|0|||
161592982|NCT02727699|583562572|FG000|Overall Study|Adverse Event|2|||
161592983|NCT02727699|583562573|FG001|Overall Study|Adverse Event|0|||
161592984|NCT02727699|583562572|FG000|Overall Study|Withdrawal by Subject|5|||
161592985|NCT02727699|583562573|FG001|Overall Study|Withdrawal by Subject|3|||
161592986|NCT02727699|583562572|FG000|Overall Study|Protocol Violation|0|||
161592987|NCT02727699|583562573|FG001|Overall Study|Protocol Violation|1|||
161592988|NCT02727699|583562572|FG000|Overall Study|Physician Decision|0|||
161592989|NCT02727699|583562573|FG001|Overall Study|Physician Decision|1|||
161592990|NCT02727699|583562572|FG000|Overall Study|Lost to Follow-up|1|||
161592991|NCT02727699|583562573|FG001|Overall Study|Lost to Follow-up|0|||
161592992|NCT02727699|583562572|FG000|Overall Study|Sponsor Decision|1|||
161592993|NCT02727699|583562573|FG001|Overall Study|Sponsor Decision|0|||
161592994|NCT04318548|583562582|FG000|Overall Study|Adverse Event|0|||
161592995|NCT04318548|583562583|FG001|Overall Study|Adverse Event|0|||
161592996|NCT04318548|583562584|FG002|Overall Study|Adverse Event|1|||
161541267|NCT00279201|583370076|FG001|Intensification Addendum|Protocol Violation|0|||
161541268|NCT00279201|583370077|FG002|Intensification Addendum|Protocol Violation|2|||
161592997|NCT04318548|583562582|FG000|Overall Study|Lost to Follow-up|6|||
161592998|NCT04318548|583562583|FG001|Overall Study|Lost to Follow-up|13|||
161592999|NCT04318548|583562584|FG002|Overall Study|Lost to Follow-up|9|||
161593000|NCT04318548|583562582|FG000|Overall Study|Protocol Violation|1|||
161593001|NCT04318548|583562583|FG001|Overall Study|Protocol Violation|0|||
161593002|NCT04318548|583562584|FG002|Overall Study|Protocol Violation|2|||
161593003|NCT04318548|583562582|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
161678974|NCT01838616|583877756|FG001|Titration Period|Technical problems|0|||
161678975|NCT01838616|583877755|FG000|Titration Period|Other|1|||
161678976|NCT01838616|583877756|FG001|Titration Period|Other|0|||
161829482|NCT01098110|584415799|FG001|Overall Study|Withdrawal by Subject|24|||
161829483|NCT01098110|584415800|FG002|Overall Study|Withdrawal by Subject|19|||
161541269|NCT00279201|583370078|FG003|Intensification Addendum|Protocol Violation|2|||
161541270|NCT00279201|583370079|FG004|Intensification Addendum|Protocol Violation|6|||
161541271|NCT00279201|583370080|FG005|Intensification Addendum|Protocol Violation|6|||
161541272|NCT00279201|583370075|FG000|Intensification Addendum|Adverse Event|0|||
161541273|NCT00279201|583370076|FG001|Intensification Addendum|Adverse Event|0|||
161541274|NCT00279201|583370077|FG002|Intensification Addendum|Adverse Event|0|||
161541275|NCT00279201|583370078|FG003|Intensification Addendum|Adverse Event|4|||
161541276|NCT00279201|583370079|FG004|Intensification Addendum|Adverse Event|1|||
161541277|NCT00279201|583370080|FG005|Intensification Addendum|Adverse Event|3|||
161541278|NCT00279201|583370075|FG000|Intensification Addendum|Physician Decision|0|||
161541279|NCT00279201|583370076|FG001|Intensification Addendum|Physician Decision|0|||
161541280|NCT00279201|583370077|FG002|Intensification Addendum|Physician Decision|4|||
161541281|NCT00279201|583370078|FG003|Intensification Addendum|Physician Decision|1|||
161541282|NCT00279201|583370079|FG004|Intensification Addendum|Physician Decision|3|||
161541283|NCT00279201|583370080|FG005|Intensification Addendum|Physician Decision|2|||
161541284|NCT00279201|583370075|FG000|Intensification Addendum|Sponsor Decision|0|||
161541285|NCT00279201|583370076|FG001|Intensification Addendum|Sponsor Decision|0|||
161541286|NCT00279201|583370077|FG002|Intensification Addendum|Sponsor Decision|0|||
161541287|NCT00279201|583370078|FG003|Intensification Addendum|Sponsor Decision|0|||
161541288|NCT00279201|583370079|FG004|Intensification Addendum|Sponsor Decision|1|||
161541289|NCT00279201|583370080|FG005|Intensification Addendum|Sponsor Decision|1|||
161541290|NCT00279201|583370075|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
161541291|NCT00279201|583370076|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
161541292|NCT00279201|583370077|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
161541293|NCT00279201|583370078|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
161541294|NCT00279201|583370079|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
161541295|NCT00279201|583370080|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
161541296|NCT00279201|583370075|FG000|Intensification Addendum|Lack of Efficacy|0|||
161541297|NCT00279201|583370076|FG001|Intensification Addendum|Lack of Efficacy|0|||
161541298|NCT00279201|583370077|FG002|Intensification Addendum|Lack of Efficacy|0|||
161541299|NCT00279201|583370078|FG003|Intensification Addendum|Lack of Efficacy|1|||
161541300|NCT00279201|583370079|FG004|Intensification Addendum|Lack of Efficacy|1|||
161541301|NCT00279201|583370080|FG005|Intensification Addendum|Lack of Efficacy|0|||
161541302|NCT00279201|583370075|FG000|Intensification Addendum|Death|0|||
161541303|NCT00279201|583370076|FG001|Intensification Addendum|Death|0|||
161541304|NCT00279201|583370077|FG002|Intensification Addendum|Death|0|||
161541305|NCT00279201|583370078|FG003|Intensification Addendum|Death|0|||
161541306|NCT00279201|583370079|FG004|Intensification Addendum|Death|1|||
161541307|NCT00279201|583370080|FG005|Intensification Addendum|Death|0|||
161541308|NCT00696384|583370091|FG000|Open Label Phase|Adverse Event|27|||
161541309|NCT00696384|583370092|FG001|Open Label Phase|Adverse Event|0|||
161541310|NCT00696384|583370093|FG002|Open Label Phase|Adverse Event|0|||
161541311|NCT00696384|583370091|FG000|Open Label Phase|Protocol Violation|18|||
161541312|NCT00696384|583370092|FG001|Open Label Phase|Protocol Violation|0|||
161541313|NCT00696384|583370093|FG002|Open Label Phase|Protocol Violation|0|||
161541314|NCT00696384|583370091|FG000|Open Label Phase|Lost to Follow-up|24|||
161541315|NCT00696384|583370092|FG001|Open Label Phase|Lost to Follow-up|0|||
161541316|NCT00696384|583370093|FG002|Open Label Phase|Lost to Follow-up|0|||
161541317|NCT00696384|583370091|FG000|Open Label Phase|Withdrawal by Subject|37|||
161541318|NCT00696384|583370092|FG001|Open Label Phase|Withdrawal by Subject|0|||
161541319|NCT00696384|583370093|FG002|Open Label Phase|Withdrawal by Subject|0|||
161541320|NCT00696384|583370091|FG000|Open Label Phase|Other|6|||
161541321|NCT00696384|583370092|FG001|Open Label Phase|Other|0|||
161541322|NCT00696384|583370093|FG002|Open Label Phase|Other|0|||
161541323|NCT00696384|583370091|FG000|Open Label Phase|Lack of Efficacy|3|||
161541324|NCT00696384|583370092|FG001|Open Label Phase|Lack of Efficacy|0|||
161541325|NCT00696384|583370093|FG002|Open Label Phase|Lack of Efficacy|0|||
161541326|NCT00696384|583370091|FG000|Open Label Phase|Physician Decision|4|||
161541327|NCT00696384|583370092|FG001|Open Label Phase|Physician Decision|0|||
161829484|NCT01098110|584415798|FG000|Overall Study|Adverse Event|30|||
161541328|NCT00696384|583370093|FG002|Open Label Phase|Physician Decision|0|||
161541329|NCT00696384|583370091|FG000|Double Blind Phase|Adverse Event|0|||
161541330|NCT00696384|583370092|FG001|Double Blind Phase|Adverse Event|2|||
161541331|NCT00696384|583370093|FG002|Double Blind Phase|Adverse Event|2|||
161541332|NCT00696384|583370091|FG000|Double Blind Phase|Lost to Follow-up|0|||
161541333|NCT00696384|583370092|FG001|Double Blind Phase|Lost to Follow-up|2|||
161541334|NCT00696384|583370093|FG002|Double Blind Phase|Lost to Follow-up|1|||
161541335|NCT00696384|583370091|FG000|Double Blind Phase|Withdrawal by Subject|0|||
161541336|NCT00696384|583370092|FG001|Double Blind Phase|Withdrawal by Subject|4|||
161541337|NCT00696384|583370093|FG002|Double Blind Phase|Withdrawal by Subject|3|||
161678977|NCT01838616|583877755|FG000|Titration Period|Protocol Violation|0|||
161829485|NCT01098110|584415799|FG001|Overall Study|Adverse Event|32|||
161541338|NCT00696384|583370091|FG000|Double Blind Phase|Lack of Efficacy|0|||
161541339|NCT00696384|583370092|FG001|Double Blind Phase|Lack of Efficacy|1|||
161541340|NCT00696384|583370093|FG002|Double Blind Phase|Lack of Efficacy|0|||
161541341|NCT00696384|583370091|FG000|Double Blind Phase|Physician Decision|0|||
161541342|NCT00696384|583370092|FG001|Double Blind Phase|Physician Decision|2|||
161541343|NCT00696384|583370093|FG002|Double Blind Phase|Physician Decision|0|||
161541344|NCT05559866|583370097|FG000|Overall Study|Withdrawal by Subject|1|||
161593004|NCT04318548|583562583|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
161593005|NCT04318548|583562584|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
161593006|NCT04318548|583562582|FG000|Overall Study|Migrated / moved from the study area|0|||
161593007|NCT04318548|583562583|FG001|Overall Study|Migrated / moved from the study area|0|||
161593008|NCT04318548|583562584|FG002|Overall Study|Migrated / moved from the study area|1|||
161593009|NCT04318548|583562582|FG000|Overall Study|Other|1|||
161593010|NCT04318548|583562583|FG001|Overall Study|Other|2|||
161593011|NCT04318548|583562584|FG002|Overall Study|Other|3|||
161593012|NCT03366649|583562585|FG000|Overall Study|Failed preoperative screening|4|||
161593013|NCT03366649|583562586|FG001|Overall Study|Failed preoperative screening|0|||
161593014|NCT03366649|583562587|FG002|Overall Study|Failed preoperative screening|0|||
161593015|NCT03366649|583562585|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
161593016|NCT03366649|583562586|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
161593017|NCT03366649|583562587|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
161593018|NCT02140554|583562598|FG000|Overall Study|Withdrawal of consent|1|||
161593019|NCT02140554|583562599|FG001|Overall Study|Withdrawal of consent|0|||
161593020|NCT02140554|583562600|FG002|Overall Study|Withdrawal of consent|4|||
161593021|NCT02140554|583562598|FG000|Overall Study|Physician Decision|1|||
161593022|NCT02140554|583562599|FG001|Overall Study|Physician Decision|0|||
161593023|NCT02140554|583562600|FG002|Overall Study|Physician Decision|2|||
161593024|NCT02140554|583562598|FG000|Overall Study|Death|0|||
161593025|NCT02140554|583562599|FG001|Overall Study|Death|0|||
161593026|NCT02140554|583562600|FG002|Overall Study|Death|1|||
161593027|NCT02140554|583562598|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
161593028|NCT02140554|583562599|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
161593029|NCT02140554|583562600|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
161593030|NCT03953508|583562602|FG000|Baseline|Lost to Follow-up|3|||
161593031|NCT03953508|583562603|FG001|Baseline|Lost to Follow-up|2|||
161593032|NCT03953508|583562602|FG000|6-month Follow-up|Lost to Follow-up|62|||
161593033|NCT03953508|583562603|FG001|6-month Follow-up|Lost to Follow-up|70|||
161593034|NCT03771417|583562604|FG000|Overall Study|Withdrawal by Subject|1|||
161593035|NCT03771417|583562605|FG001|Overall Study|Withdrawal by Subject|0|||
161593036|NCT03771417|583562606|FG002|Overall Study|Withdrawal by Subject|0|||
161593037|NCT03771417|583562604|FG000|Overall Study|Covid-19 Shutdown|0|||
161593038|NCT03771417|583562605|FG001|Overall Study|Covid-19 Shutdown|1|||
161593039|NCT03771417|583562606|FG002|Overall Study|Covid-19 Shutdown|0|||
161593040|NCT04185298|583562608|FG000|Overall Study|Lost to Follow-up|1|||
161593041|NCT04185298|583562609|FG001|Overall Study|Lost to Follow-up|3|||
161593042|NCT04185298|583562608|FG000|Overall Study|Withdrawal by Subject|0|||
161593043|NCT04185298|583562609|FG001|Overall Study|Withdrawal by Subject|3|||
161593044|NCT03524118|583562610|FG000|Overall Study|Lost to Follow-up|0|||
161593045|NCT03524118|583562611|FG001|Overall Study|Lost to Follow-up|0|||
161593046|NCT03524118|583562612|FG002|Overall Study|Lost to Follow-up|0|||
161593047|NCT03524118|583562613|FG003|Overall Study|Lost to Follow-up|0|||
161593048|NCT03524118|583562614|FG004|Overall Study|Lost to Follow-up|1|||
161593049|NCT03524118|583562615|FG005|Overall Study|Lost to Follow-up|0|||
161593050|NCT03524118|583562610|FG000|Overall Study|Other|0|||
161593051|NCT03524118|583562611|FG001|Overall Study|Other|1|||
161593052|NCT03524118|583562612|FG002|Overall Study|Other|0|||
161593053|NCT03524118|583562613|FG003|Overall Study|Other|0|||
161593054|NCT03524118|583562614|FG004|Overall Study|Other|1|||
161593055|NCT03524118|583562615|FG005|Overall Study|Other|1|||
161593056|NCT03524118|583562610|FG000|Overall Study|Physician Decision|0|||
161593057|NCT03524118|583562611|FG001|Overall Study|Physician Decision|0|||
161829486|NCT01098110|584415800|FG002|Overall Study|Adverse Event|43|||
161829487|NCT01098110|584415798|FG000|Overall Study|Lack of Efficacy|13|||
161829488|NCT01098110|584415799|FG001|Overall Study|Lack of Efficacy|9|||
161593058|NCT03524118|583562612|FG002|Overall Study|Physician Decision|0|||
161593059|NCT03524118|583562613|FG003|Overall Study|Physician Decision|0|||
161829489|NCT01098110|584415800|FG002|Overall Study|Lack of Efficacy|27|||
161593060|NCT03524118|583562614|FG004|Overall Study|Physician Decision|1|||
161593061|NCT03524118|583562615|FG005|Overall Study|Physician Decision|0|||
161593062|NCT03524118|583562610|FG000|Overall Study|Protocol Violation|0|||
161593063|NCT03524118|583562611|FG001|Overall Study|Protocol Violation|0|||
161593064|NCT03524118|583562612|FG002|Overall Study|Protocol Violation|1|||
161829490|NCT01098110|584415798|FG000|Overall Study|Other|4|||
161541345|NCT05559866|583370098|FG001|Overall Study|Withdrawal by Subject|0|||
161541346|NCT03444376|583370100|FG000|Part A|Disease relapse or Progression|1|||
161829491|NCT01098110|584415799|FG001|Overall Study|Other|7|||
161829492|NCT01098110|584415800|FG002|Overall Study|Other|5|||
161829493|NCT01098110|584415798|FG000|Overall Study|Untreated|1|||
161829494|NCT01098110|584415799|FG001|Overall Study|Untreated|1|||
161829495|NCT01098110|584415800|FG002|Overall Study|Untreated|0|||
161829496|NCT00089076|584415807|FG000|Overall Study|Alternate Therapy|1|||
161829497|NCT00089076|584415807|FG000|Overall Study|Withdrawal by Subject|2|||
161829498|NCT00089076|584415807|FG000|Overall Study|Progression|7|||
161829499|NCT00931463|584415808|FG000|Overall Study|Death|8|||
161678978|NCT01838616|583877756|FG001|Titration Period|Protocol Violation|1|||
161678979|NCT01838616|583877755|FG000|Continuation Period|Lack of Efficacy|3|||
161678980|NCT01838616|583877756|FG001|Continuation Period|Lack of Efficacy|5|||
161678981|NCT01838616|583877755|FG000|Continuation Period|Adverse Event|8|||
161829500|NCT00931463|584415809|FG001|Overall Study|Death|4|||
161829501|NCT00931463|584415808|FG000|Overall Study|Withdrawal by Subject|5|||
161829502|NCT00931463|584415809|FG001|Overall Study|Withdrawal by Subject|0|||
161829503|NCT00931463|584415808|FG000|Overall Study|Lost to Follow-up|4|||
161678982|NCT01838616|583877756|FG001|Continuation Period|Adverse Event|4|||
161678983|NCT01838616|583877755|FG000|Continuation Period|Protocol Violation|2|||
161678984|NCT01838616|583877756|FG001|Continuation Period|Protocol Violation|0|||
161678985|NCT01838616|583877755|FG000|Continuation Period|Lost to Follow-up|1|||
161678986|NCT01838616|583877756|FG001|Continuation Period|Lost to Follow-up|0|||
161678987|NCT01838616|583877755|FG000|Continuation Period|Withdrawal by Subject|0|||
161678988|NCT01838616|583877756|FG001|Continuation Period|Withdrawal by Subject|4|||
161678989|NCT01838616|583877755|FG000|Continuation Period|Technical problems|0|||
161678990|NCT01838616|583877756|FG001|Continuation Period|Technical problems|1|||
161678991|NCT01838616|583877755|FG000|Pick-up Arm|Lack of Efficacy|4|||
161678992|NCT01838616|583877756|FG001|Pick-up Arm|Lack of Efficacy|0|||
161678993|NCT01838616|583877755|FG000|Pick-up Arm|Adverse Event|9|||
161678994|NCT01838616|583877756|FG001|Pick-up Arm|Adverse Event|0|||
161678995|NCT01838616|583877755|FG000|Pick-up Arm|Withdrawal by Subject|1|||
161678996|NCT01838616|583877756|FG001|Pick-up Arm|Withdrawal by Subject|0|||
161678997|NCT01838616|583877755|FG000|Pick-up Arm|Technical problems|1|||
161678998|NCT01838616|583877756|FG001|Pick-up Arm|Technical problems|0|||
161678999|NCT00257725|583877757|FG000|Overall Study|Adverse Event|3|||
161679000|NCT02573870|583877758|FG000|Overall Study|Adverse Event|0|||
161679001|NCT02573870|583877759|FG001|Overall Study|Adverse Event|2|||
161679002|NCT02573870|583877758|FG000|Overall Study|Lack of Efficacy|0|||
161679003|NCT02573870|583877759|FG001|Overall Study|Lack of Efficacy|1|||
161679004|NCT02573870|583877758|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
161679005|NCT02573870|583877759|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
161679006|NCT02573870|583877758|FG000|Overall Study|Lost to Follow-up|0|||
161679007|NCT02573870|583877759|FG001|Overall Study|Lost to Follow-up|1|||
161679008|NCT02573870|583877758|FG000|Overall Study|Other: Fail to Meet Visit|0|||
161679009|NCT02573870|583877759|FG001|Overall Study|Other: Fail to Meet Visit|2|||
161679010|NCT00514514|583877760|FG000|Pre-phase|Death|10|||
161679011|NCT00514514|583877761|FG001|Pre-phase|Death|0|||
161679012|NCT00514514|583877762|FG002|Pre-phase|Death|0|||
161679013|NCT00514514|583877760|FG000|Pre-phase|administrative problems|2|||
161679014|NCT00514514|583877761|FG001|Pre-phase|administrative problems|0|||
161679015|NCT00514514|583877762|FG002|Pre-phase|administrative problems|0|||
161679016|NCT00514514|583877760|FG000|Pre-phase|Protocol Violation|6|||
161679017|NCT00514514|583877761|FG001|Pre-phase|Protocol Violation|0|||
161679018|NCT00514514|583877762|FG002|Pre-phase|Protocol Violation|0|||
161679019|NCT00514514|583877760|FG000|Pre-phase|condition no longer requires study drug|7|||
161679020|NCT00514514|583877761|FG001|Pre-phase|condition no longer requires study drug|0|||
161679021|NCT00514514|583877762|FG002|Pre-phase|condition no longer requires study drug|0|||
161829504|NCT00931463|584415809|FG001|Overall Study|Lost to Follow-up|1|||
161829505|NCT00808509|584415810|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
161541347|NCT03444376|583370100|FG000|Part A|Withdrawal by Subject|2|||
161541348|NCT03444376|583370100|FG000|Part A|Adverse Event|1|||
161541349|NCT03444376|583370100|FG000|Part B|Disease relapse or Progression|18|||
161541350|NCT03444376|583370100|FG000|Part B|Withdrawal by Subject|2|||
161541351|NCT03444376|583370100|FG000|Part B|Adverse Event|2|||
161541352|NCT03444376|583370100|FG000|Part B|Physician Decision|1|||
161541353|NCT03444376|583370100|FG000|Part C|Disease relapse or Progression|43|||
161541354|NCT03444376|583370100|FG000|Part C|Withdrawal by Subject|5|||
161541355|NCT03444376|583370100|FG000|Part C|Adverse Event|2|||
161541356|NCT03444376|583370100|FG000|Part C|Physician Decision|2|||
161541357|NCT03444376|583370100|FG000|Part C|Death|1|||
161541358|NCT00856167|583370102|FG000|Period 1|Withdrawal by Subject|1|||
161541359|NCT00856167|583370103|FG001|Period 1|Withdrawal by Subject|4|||
161541360|NCT00856167|583370104|FG002|Period 1|Withdrawal by Subject|0|||
161541361|NCT00856167|583370105|FG003|Period 1|Withdrawal by Subject|0|||
161541362|NCT00856167|583370102|FG000|Period 1|Lost to Follow-up|2|||
161541363|NCT00856167|583370103|FG001|Period 1|Lost to Follow-up|1|||
161541364|NCT00856167|583370104|FG002|Period 1|Lost to Follow-up|0|||
161679022|NCT00514514|583877760|FG000|Pre-phase|abnormal test procedure results|15|||
161679023|NCT00514514|583877761|FG001|Pre-phase|abnormal test procedure results|0|||
161679024|NCT00514514|583877762|FG002|Pre-phase|abnormal test procedure results|0|||
161679025|NCT00514514|583877760|FG000|Pre-phase|Lost to Follow-up|2|||
161679026|NCT00514514|583877761|FG001|Pre-phase|Lost to Follow-up|0|||
161679027|NCT00514514|583877762|FG002|Pre-phase|Lost to Follow-up|0|||
161679028|NCT00514514|583877760|FG000|Pre-phase|abnormal lab values|23|||
161679029|NCT00514514|583877761|FG001|Pre-phase|abnormal lab values|0|||
161679030|NCT00514514|583877762|FG002|Pre-phase|abnormal lab values|0|||
161679031|NCT00514514|583877760|FG000|Pre-phase|Lack of Efficacy|35|||
161679032|NCT00514514|583877761|FG001|Pre-phase|Lack of Efficacy|0|||
161679033|NCT00514514|583877762|FG002|Pre-phase|Lack of Efficacy|0|||
161679034|NCT00514514|583877760|FG000|Pre-phase|Adverse Event|137|||
161679035|NCT00514514|583877761|FG001|Pre-phase|Adverse Event|0|||
161679036|NCT00514514|583877762|FG002|Pre-phase|Adverse Event|0|||
161679037|NCT00514514|583877760|FG000|Pre-phase|Withdrawal by Subject|66|||
161679038|NCT00514514|583877761|FG001|Pre-phase|Withdrawal by Subject|0|||
161679039|NCT00514514|583877762|FG002|Pre-phase|Withdrawal by Subject|0|||
161679040|NCT00514514|583877760|FG000|Randomized - 9 Month|Death|3|||
161679041|NCT00514514|583877761|FG001|Randomized - 9 Month|Death|2|||
161679042|NCT00514514|583877762|FG002|Randomized - 9 Month|Death|2|||
161679043|NCT00514514|583877760|FG000|Randomized - 9 Month|Administrative problems|1|||
161679044|NCT00514514|583877761|FG001|Randomized - 9 Month|Administrative problems|1|||
161679045|NCT00514514|583877762|FG002|Randomized - 9 Month|Administrative problems|2|||
161679046|NCT00514514|583877760|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
161679047|NCT00514514|583877761|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
161679048|NCT00514514|583877762|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
161679049|NCT00514514|583877760|FG000|Randomized - 9 Month|Protocol Violation|1|||
161679050|NCT00514514|583877761|FG001|Randomized - 9 Month|Protocol Violation|1|||
161679051|NCT00514514|583877762|FG002|Randomized - 9 Month|Protocol Violation|0|||
161679052|NCT00514514|583877760|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
161679053|NCT00514514|583877761|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
161679054|NCT00514514|583877762|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
161679055|NCT00514514|583877760|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
161679056|NCT00514514|583877761|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
161679057|NCT00514514|583877762|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
161679058|NCT00514514|583877760|FG000|Randomized - 9 Month|Adverse Event|25|||
161679059|NCT00514514|583877761|FG001|Randomized - 9 Month|Adverse Event|44|||
161679060|NCT00514514|583877762|FG002|Randomized - 9 Month|Adverse Event|27|||
161679061|NCT00514514|583877760|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
161679062|NCT00514514|583877761|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
161679063|NCT00514514|583877762|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
161679064|NCT00514514|583877760|FG000|Extension - 4 Years|Lost to Follow-up|12|||
161679065|NCT00514514|583877761|FG001|Extension - 4 Years|Lost to Follow-up|10|||
161679066|NCT00514514|583877762|FG002|Extension - 4 Years|Lost to Follow-up|9|||
161679067|NCT00514514|583877760|FG000|Extension - 4 Years|Administrative problems|3|||
161679068|NCT00514514|583877761|FG001|Extension - 4 Years|Administrative problems|1|||
161679069|NCT00514514|583877762|FG002|Extension - 4 Years|Administrative problems|1|||
161679070|NCT00514514|583877760|FG000|Extension - 4 Years|Death|8|||
161679071|NCT00514514|583877761|FG001|Extension - 4 Years|Death|3|||
161679072|NCT00514514|583877762|FG002|Extension - 4 Years|Death|6|||
161679073|NCT00514514|583877760|FG000|Extension - 4 Years|Adverse Event|9|||
161679074|NCT00514514|583877761|FG001|Extension - 4 Years|Adverse Event|6|||
161679075|NCT00514514|583877762|FG002|Extension - 4 Years|Adverse Event|3|||
161679076|NCT01480284|583877764|FG000|Overall Study|Withdrawal by Subject|2|||
161679077|NCT01480284|583877765|FG001|Overall Study|Withdrawal by Subject|0|||
161679078|NCT01480284|583877764|FG000|Overall Study|Adverse Event|1|||
161679079|NCT01480284|583877765|FG001|Overall Study|Adverse Event|0|||
161679080|NCT01480284|583877764|FG000|Overall Study|Study closed/terminated|3|||
161679081|NCT01480284|583877765|FG001|Overall Study|Study closed/terminated|0|||
161679082|NCT01480284|583877764|FG000|Overall Study|Lost to Follow-up|1|||
161679083|NCT01480284|583877765|FG001|Overall Study|Lost to Follow-up|0|||
161679084|NCT01480284|583877764|FG000|Overall Study|Physician Decision|1|||
161679085|NCT01480284|583877765|FG001|Overall Study|Physician Decision|0|||
161679086|NCT03374995|583877769|FG000|Overall Study|Withdrawal by Subject|0|||
161679087|NCT03374995|583877770|FG001|Overall Study|Withdrawal by Subject|1|||
161679088|NCT01383096|583877773|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161679089|NCT01383096|583877774|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161679090|NCT01383096|583877775|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
161679091|NCT01383096|583877773|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161829506|NCT00808509|584415811|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
161679092|NCT01383096|583877774|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161541365|NCT00856167|583370105|FG003|Period 1|Lost to Follow-up|0|||
161679093|NCT01383096|583877775|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161679094|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Elevated AST|0|||
161679095|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Elevated AST|1|||
161679096|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Elevated AST|0|||
161679097|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
161679098|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
161679099|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161679100|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Adverse Event|1|||
161679101|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Adverse Event|0|||
161679102|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Adverse Event|0|||
161679103|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
161679104|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
161679105|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
161679106|NCT01383096|583877773|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
161679107|NCT01383096|583877774|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679108|NCT01383096|583877775|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679109|NCT01383096|583877773|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161679110|NCT01383096|583877774|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161679111|NCT01383096|583877775|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161679112|NCT01383096|583877773|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
161679113|NCT01383096|583877774|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679114|NCT01383096|583877775|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679115|NCT01383096|583877773|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
161679116|NCT01383096|583877774|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
161679117|NCT01383096|583877775|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
161679118|NCT01383096|583877773|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
161679119|NCT01383096|583877774|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
161679120|NCT01383096|583877775|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
161679121|NCT01211535|583877776|FG000|Overall Study|Adverse Event|0|||
161679122|NCT01211535|583877777|FG001|Overall Study|Adverse Event|1|||
161679123|NCT03593850|583877783|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
161679124|NCT03593850|583877784|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
161679125|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
161679126|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
161679127|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
161679128|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
161679129|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161679130|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
161679131|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161679132|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161679133|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
161679134|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
161679135|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
161679136|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
161679137|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
161679138|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
161679139|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
161679140|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
161679141|NCT02490475|583877785|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
161679142|NCT02490475|583877786|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
161679143|NCT02490475|583877787|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
161679144|NCT02490475|583877788|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
161679145|NCT02490475|583877785|FG000|Period 2: Extension Phase|Refused Treatment|0|||
161679146|NCT02490475|583877786|FG001|Period 2: Extension Phase|Refused Treatment|0|||
161679147|NCT02490475|583877787|FG002|Period 2: Extension Phase|Refused Treatment|0|||
161679148|NCT02490475|583877788|FG003|Period 2: Extension Phase|Refused Treatment|1|||
161679149|NCT02490475|583877785|FG000|Period 2: Extension Phase|Adverse Event|0|||
161679150|NCT02490475|583877786|FG001|Period 2: Extension Phase|Adverse Event|0|||
161829507|NCT00808509|584415810|FG000|Randomized Phase|Reduced methotrexate dose|1|||
161829508|NCT00808509|584415811|FG001|Randomized Phase|Reduced methotrexate dose|2|||
161829509|NCT00808509|584415810|FG000|Randomized Phase|Patient refused rescue therapy|0|||
161679151|NCT02490475|583877787|FG002|Period 2: Extension Phase|Adverse Event|1|||
161679152|NCT02490475|583877788|FG003|Period 2: Extension Phase|Adverse Event|0|||
161679153|NCT00616434|583877790|FG000|Overall Study|Adverse Event|5|||
161679154|NCT00616434|583877791|FG001|Overall Study|Adverse Event|2|||
161829510|NCT00808509|584415811|FG001|Randomized Phase|Patient refused rescue therapy|3|||
161829511|NCT00436917|584415812|FG000|Overall Study|Withdrawal by Subject|13|||
161829512|NCT00436917|584415812|FG000|Overall Study|Adverse Event|2|||
161541366|NCT00856167|583370102|FG000|Period 2|Lost to Follow-up|0|||
161541367|NCT00856167|583370103|FG001|Period 2|Lost to Follow-up|0|||
161541368|NCT00856167|583370104|FG002|Period 2|Lost to Follow-up|3|||
161541369|NCT00856167|583370105|FG003|Period 2|Lost to Follow-up|1|||
161541370|NCT00856167|583370102|FG000|Period 2|Withdrawal by Subject|0|||
161541371|NCT00856167|583370103|FG001|Period 2|Withdrawal by Subject|0|||
161541372|NCT00856167|583370104|FG002|Period 2|Withdrawal by Subject|2|||
161541373|NCT00856167|583370105|FG003|Period 2|Withdrawal by Subject|4|||
161541374|NCT01061333|583370108|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
161541375|NCT01061333|583370109|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
161541376|NCT01816763|583372044|FG000|Overall Study|The main reason for an incomplete survey|4|||
161541377|NCT01816763|583372045|FG001|Overall Study|The main reason for an incomplete survey|15|||
161541378|NCT01816763|583372046|FG002|Overall Study|The main reason for an incomplete survey|11|||
161541379|NCT01186328|583372051|FG000|Overall Study|Death|1|||
161541380|NCT01186328|583372052|FG001|Overall Study|Death|0|||
161541381|NCT01186328|583372053|FG002|Overall Study|Death|0|||
161541382|NCT01691521|583372054|FG000|Overall Study|Adverse Event|4|||
161541383|NCT01691521|583372055|FG001|Overall Study|Adverse Event|0|||
161541384|NCT01691521|583372056|FG002|Overall Study|Adverse Event|1|||
161541385|NCT01691521|583372054|FG000|Overall Study|Lack of Efficacy|1|||
161541386|NCT01691521|583372055|FG001|Overall Study|Lack of Efficacy|1|||
161541387|NCT01691521|583372056|FG002|Overall Study|Lack of Efficacy|2|||
161541388|NCT01691521|583372054|FG000|Overall Study|Protocol Violation|0|||
161541389|NCT01691521|583372055|FG001|Overall Study|Protocol Violation|3|||
161541390|NCT01691521|583372056|FG002|Overall Study|Protocol Violation|0|||
161541391|NCT01691521|583372054|FG000|Overall Study|Lost to Follow-up|0|||
161541392|NCT01691521|583372055|FG001|Overall Study|Lost to Follow-up|2|||
161541393|NCT01691521|583372056|FG002|Overall Study|Lost to Follow-up|2|||
161541394|NCT01691521|583372054|FG000|Overall Study|Physician Decision|2|||
161541395|NCT01691521|583372055|FG001|Overall Study|Physician Decision|1|||
161541396|NCT01691521|583372056|FG002|Overall Study|Physician Decision|0|||
161541397|NCT01691521|583372054|FG000|Overall Study|Withdrawal by Subject|5|||
161541398|NCT01691521|583372055|FG001|Overall Study|Withdrawal by Subject|9|||
161541399|NCT01691521|583372056|FG002|Overall Study|Withdrawal by Subject|4|||
161541400|NCT02343003|583372057|FG000|Overall Study|Withdrawal by Subject|9|||
161541401|NCT02343003|583372058|FG001|Overall Study|Withdrawal by Subject|4|||
161541402|NCT02343003|583372057|FG000|Overall Study|Lost to Follow-up|5|||
161541403|NCT02343003|583372058|FG001|Overall Study|Lost to Follow-up|1|||
161541404|NCT02343003|583372057|FG000|Overall Study|Protocol Violation|1|||
161541405|NCT02343003|583372058|FG001|Overall Study|Protocol Violation|0|||
161541406|NCT02343003|583372057|FG000|Overall Study|Death|0|||
161541407|NCT02343003|583372058|FG001|Overall Study|Death|1|||
161541408|NCT02343003|583372057|FG000|Overall Study|exclusion criteria met|1|||
161541409|NCT02343003|583372058|FG001|Overall Study|exclusion criteria met|1|||
161541410|NCT02343003|583372057|FG000|Overall Study|terminated by sponsor|2|||
161541411|NCT02343003|583372058|FG001|Overall Study|terminated by sponsor|0|||
161541412|NCT00622713|583372063|FG000|Overall Study|Adverse Event|35|||
161541413|NCT00622713|583372063|FG000|Overall Study|Administrative problems|4|||
161541414|NCT00622713|583372063|FG000|Overall Study|Withdrawal by Subject|11|||
161541415|NCT00622713|583372063|FG000|Overall Study|Lost to Follow-up|5|||
161541416|NCT00622713|583372063|FG000|Overall Study|Death|2|||
161541417|NCT00622713|583372063|FG000|Overall Study|Subject no longer required study drug|1|||
161541418|NCT00622713|583372063|FG000|Overall Study|Did not meet eligibility criteria|1|||
161541419|NCT04404478|583372064|FG000|Overall Study|Withdrawal by Subject|1|||
161541420|NCT04404478|583372065|FG001|Overall Study|Withdrawal by Subject|3|||
161541421|NCT01674621|583372078|FG000|Overall Study|Adverse Event|3|||
161541422|NCT01674621|583372079|FG001|Overall Study|Adverse Event|2|||
161541423|NCT01674621|583372080|FG002|Overall Study|Adverse Event|5|||
161541424|NCT01674621|583372081|FG003|Overall Study|Adverse Event|5|||
161541425|NCT01674621|583372082|FG004|Overall Study|Adverse Event|1|||
161541426|NCT01674621|583372078|FG000|Overall Study|Inability to Complete Study Procedures|0|||
161593065|NCT03524118|583562613|FG003|Overall Study|Protocol Violation|0|||
161593066|NCT03524118|583562614|FG004|Overall Study|Protocol Violation|1|||
161593067|NCT03524118|583562615|FG005|Overall Study|Protocol Violation|0|||
161541427|NCT01674621|583372079|FG001|Overall Study|Inability to Complete Study Procedures|0|||
161541428|NCT01674621|583372080|FG002|Overall Study|Inability to Complete Study Procedures|0|||
161541429|NCT01674621|583372081|FG003|Overall Study|Inability to Complete Study Procedures|0|||
161541430|NCT01674621|583372082|FG004|Overall Study|Inability to Complete Study Procedures|2|||
161541431|NCT01674621|583372078|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
161541432|NCT01674621|583372079|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
161541433|NCT01674621|583372080|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
161541434|NCT01674621|583372081|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
161541435|NCT01674621|583372082|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
161541436|NCT01674621|583372078|FG000|Overall Study|Withdrawal by Subject|2|||
161541437|NCT01674621|583372079|FG001|Overall Study|Withdrawal by Subject|5|||
161541438|NCT01674621|583372080|FG002|Overall Study|Withdrawal by Subject|2|||
161679155|NCT00616434|583877790|FG000|Overall Study|Physician Decision|0|||
161679156|NCT00616434|583877791|FG001|Overall Study|Physician Decision|4|||
161679157|NCT00616434|583877790|FG000|Overall Study|Withdrawal by Subject|1|||
161679158|NCT00616434|583877791|FG001|Overall Study|Withdrawal by Subject|1|||
161679159|NCT00616434|583877790|FG000|Overall Study|Protocol deviation|0|||
161679160|NCT00616434|583877791|FG001|Overall Study|Protocol deviation|1|||
161679161|NCT04784897|583877797|FG000|Overall Study|Death|4|||
161679162|NCT04784897|583877798|FG001|Overall Study|Death|2|||
161679163|NCT04784897|583877799|FG002|Overall Study|Death|1|||
161679164|NCT04784897|583877797|FG000|Overall Study|Withdrawal by Subject|0|||
161679165|NCT04784897|583877798|FG001|Overall Study|Withdrawal by Subject|0|||
161679166|NCT04784897|583877799|FG002|Overall Study|Withdrawal by Subject|1|||
161679167|NCT02319668|583877800|FG000|Overall Study|Other (Not specified)|0|||
161679168|NCT02319668|583877801|FG001|Overall Study|Other (Not specified)|2|||
161679169|NCT01161043|583877802|FG000|Overall Study|Withdrawal by Subject|3|||
161679170|NCT02164929|583877803|FG000|Overall Study|Converted to open procedure|1|||
161679171|NCT02164929|583877804|FG001|Overall Study|Converted to open procedure|0|||
161679172|NCT02164929|583877805|FG002|Overall Study|Converted to open procedure|0|||
161679173|NCT02164929|583877806|FG003|Overall Study|Converted to open procedure|2|||
161679174|NCT02164929|583877803|FG000|Overall Study|Failed regional block|0|||
161679175|NCT02164929|583877804|FG001|Overall Study|Failed regional block|0|||
161679176|NCT02164929|583877805|FG002|Overall Study|Failed regional block|1|||
161679177|NCT02164929|583877806|FG003|Overall Study|Failed regional block|0|||
161679178|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Adverse Event|84|||
161679179|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Adverse Event|0|||
161679180|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Non-compliance|3|||
161541439|NCT01674621|583372081|FG003|Overall Study|Withdrawal by Subject|0|||
161541440|NCT01674621|583372082|FG004|Overall Study|Withdrawal by Subject|1|||
161541441|NCT01674621|583372078|FG000|Overall Study|Other than specified|0|||
161541442|NCT01674621|583372079|FG001|Overall Study|Other than specified|1|||
161541443|NCT01674621|583372080|FG002|Overall Study|Other than specified|0|||
161541444|NCT01674621|583372081|FG003|Overall Study|Other than specified|0|||
161541445|NCT01674621|583372082|FG004|Overall Study|Other than specified|2|||
161541446|NCT01725386|583372083|FG000|Overall Study|Death|84|||
161541447|NCT01725386|583372084|FG001|Overall Study|Death|40|||
161541448|NCT01725386|583372083|FG000|Overall Study|Lost to Follow-up|81|||
161541449|NCT01725386|583372084|FG001|Overall Study|Lost to Follow-up|6|||
161541450|NCT01725386|583372083|FG000|Overall Study|Withdrawal by Subject|10|||
161541451|NCT01725386|583372084|FG001|Overall Study|Withdrawal by Subject|0|||
161541452|NCT00879996|583372092|FG000|Overall Study|Lost to Follow-up|7|||
161541453|NCT00879996|583372093|FG001|Overall Study|Lost to Follow-up|6|||
161541454|NCT00879996|583372092|FG000|Overall Study|non-compliance|6|||
161541455|NCT00879996|583372093|FG001|Overall Study|non-compliance|4|||
161541456|NCT00879996|583372092|FG000|Overall Study|Physician Decision|1|||
161541457|NCT00879996|583372093|FG001|Overall Study|Physician Decision|2|||
161679181|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Non-compliance|0|||
161679182|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
161679183|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
161679184|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Other|11|||
161679185|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Other|0|||
161679186|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Adverse Event|0|||
161679187|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Adverse Event|6|||
161541458|NCT00879996|583372092|FG000|Overall Study|psychiatric problem|0|||
161541459|NCT00879996|583372093|FG001|Overall Study|psychiatric problem|1|||
161679188|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Non-compliance|0|||
161679189|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Non-compliance|2|||
161679190|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
161679191|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
161679192|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Other|0|||
161679193|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Other|1|||
161541460|NCT00879996|583372092|FG000|Overall Study|put on parole|1|||
161541461|NCT00879996|583372093|FG001|Overall Study|put on parole|0|||
161679194|NCT00365456|583877810|FG000|Trial Period III (12 Months)|Adverse Event|13|||
161679195|NCT00365456|583877811|FG001|Trial Period III (12 Months)|Adverse Event|3|||
161541462|NCT01216163|583372094|FG000|Overall Study|Withdrawal by Subject|1|||
161541463|NCT01216163|583372095|FG001|Overall Study|Withdrawal by Subject|1|||
161541464|NCT01216163|583372096|FG002|Overall Study|Withdrawal by Subject|0|||
161541465|NCT02914314|583372097|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
161541466|NCT02914314|583372098|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
161541467|NCT02914314|583372099|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
161679196|NCT00365456|583877810|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
161679197|NCT00365456|583877811|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
161679198|NCT00365456|583877810|FG000|Trial Period III (12 Months)|Other|1|||
161679199|NCT00365456|583877811|FG001|Trial Period III (12 Months)|Other|1|||
161679200|NCT04754802|583877814|FG000|Overall Study|Lost to Follow-up|0|||
161541468|NCT02914314|583372100|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
161679201|NCT04754802|583877815|FG001|Overall Study|Lost to Follow-up|2|||
161679202|NCT04754802|583877814|FG000|Overall Study|Withdrawal by Subject|2|||
161679203|NCT04754802|583877815|FG001|Overall Study|Withdrawal by Subject|0|||
161679204|NCT00701090|583877816|FG000|Overall Study|Adverse Event|11|||
161679205|NCT00701090|583877817|FG001|Overall Study|Adverse Event|2|||
161679206|NCT00701090|583877816|FG000|Overall Study|Death|0|||
161679207|NCT00701090|583877817|FG001|Overall Study|Death|1|||
161679208|NCT00701090|583877816|FG000|Overall Study|Lack of Efficacy|5|||
161679209|NCT00701090|583877817|FG001|Overall Study|Lack of Efficacy|4|||
161679210|NCT00701090|583877816|FG000|Overall Study|Lost to Follow-up|9|||
161679211|NCT00701090|583877817|FG001|Overall Study|Lost to Follow-up|9|||
161679212|NCT00701090|583877816|FG000|Overall Study|Physician Decision|3|||
161679213|NCT00701090|583877817|FG001|Overall Study|Physician Decision|4|||
161679214|NCT00701090|583877816|FG000|Overall Study|Protocol Violation|2|||
161679215|NCT00701090|583877817|FG001|Overall Study|Protocol Violation|3|||
161679216|NCT00701090|583877816|FG000|Overall Study|Withdrawal by Subject|11|||
161679217|NCT00701090|583877817|FG001|Overall Study|Withdrawal by Subject|16|||
161679218|NCT00701090|583877816|FG000|Overall Study|Other|7|||
161679219|NCT00701090|583877817|FG001|Overall Study|Other|12|||
161679220|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
161679221|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
161679222|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
161679223|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
161679224|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
161679225|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
161679226|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
161541469|NCT02914314|583372097|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
161679227|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
161679228|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
161679229|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
161679230|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
161679231|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
161679232|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
161679233|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
161679234|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
161679235|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
161679236|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
161679237|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
161679238|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
161679239|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
161679240|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
161679241|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
161679242|NCT00617604|583877831|FG000|Overall Study|Death|2|||
161679243|NCT00617604|583877832|FG001|Overall Study|Death|1|||
161679244|NCT00617604|583877831|FG000|Overall Study|Lost to Follow-up|1|||
161679245|NCT00617604|583877832|FG001|Overall Study|Lost to Follow-up|0|||
161679246|NCT00617604|583877831|FG000|Overall Study|Miscellaneous Reasons|8|||
161679247|NCT00617604|583877832|FG001|Overall Study|Miscellaneous Reasons|10|||
161679248|NCT00617604|583877831|FG000|Overall Study|Withdrawal by Subject|4|||
161679249|NCT00617604|583877832|FG001|Overall Study|Withdrawal by Subject|6|||
161679250|NCT00617604|583877831|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
161679251|NCT00617604|583877832|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
161679252|NCT02303704|583877833|FG000|Overall Study|Protocol Violation|5|||
161679253|NCT02303704|583877834|FG001|Overall Study|Protocol Violation|9|||
161679254|NCT00805025|583877835|FG000|Overall Study|Screened but not enrolled/treated|42|||
161679255|NCT00805025|583877835|FG000|Overall Study|Adverse Event|4|||
161679256|NCT00805025|583877835|FG000|Overall Study|Withdrawal by Subject|2|||
161679257|NCT00805025|583877835|FG000|Overall Study|Physician Decision|1|||
161679258|NCT04029961|583877841|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
161679259|NCT04029961|583877842|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
161679260|NCT04029961|583877841|FG000|Overall Study|Change in Treatment Course|0|||
161679261|NCT04029961|583877842|FG001|Overall Study|Change in Treatment Course|1|||
161679262|NCT01721876|583877843|FG000|Overall Study|Not treated|1|||
161679263|NCT01721876|583877844|FG001|Overall Study|Not treated|4|||
161679264|NCT01721876|583877843|FG000|Overall Study|Disease progression / relapse|123|||
161541470|NCT02914314|583372098|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
161679265|NCT01721876|583877844|FG001|Overall Study|Disease progression / relapse|156|||
161829513|NCT00436917|584415812|FG000|Overall Study|Physician Decision|1|||
161541471|NCT02914314|583372099|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
161679266|NCT01721876|583877843|FG000|Overall Study|Death|6|||
161679267|NCT01721876|583877844|FG001|Overall Study|Death|13|||
161679268|NCT01721876|583877843|FG000|Overall Study|Adverse Event|41|||
161541472|NCT02914314|583372100|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
161541473|NCT02914314|583372097|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
161541474|NCT02914314|583372098|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
161541475|NCT02914314|583372099|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
161541476|NCT02914314|583372100|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
161541477|NCT02914314|583372097|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
161541478|NCT02914314|583372098|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
161541479|NCT02914314|583372099|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
161541480|NCT02914314|583372100|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
161541481|NCT02914314|583372097|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
161541482|NCT02914314|583372098|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
161541483|NCT02914314|583372099|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
161541484|NCT02914314|583372100|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
161541485|NCT01148862|583372105|FG000|Second Intervention|Withdrawal by Subject|0|||
161541486|NCT01148862|583372106|FG001|Second Intervention|Withdrawal by Subject|2|||
161541487|NCT03056534|583372107|FG000|Overall Study|Participant withdrew consent|8|||
161541488|NCT03056534|583372107|FG000|Overall Study|Participant not able to return|6|||
161541489|NCT03056534|583372107|FG000|Overall Study|Lost to Follow-up|37|||
161541490|NCT03056534|583372107|FG000|Overall Study|Investigator judgment|1|||
161541491|NCT03056534|583372107|FG000|Overall Study|Death|4|||
161541492|NCT03056534|583372107|FG000|Overall Study|Adverse Event|1|||
161541493|NCT03056534|583372107|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
161541494|NCT04543188|583372108|FG000|Phase 1a|Adverse Event|0|||
161541495|NCT04543188|583372109|FG001|Phase 1a|Adverse Event|0|||
161541496|NCT04543188|583372110|FG002|Phase 1a|Adverse Event|0|||
161541497|NCT04543188|583372111|FG003|Phase 1a|Adverse Event|1|||
161541498|NCT04543188|583372112|FG004|Phase 1a|Adverse Event|0|||
161541499|NCT04543188|583372113|FG005|Phase 1a|Adverse Event|0|||
161541500|NCT04543188|583372114|FG006|Phase 1a|Adverse Event|1|||
161541501|NCT04543188|583372115|FG007|Phase 1a|Adverse Event|0|||
161541502|NCT04543188|583372116|FG008|Phase 1a|Adverse Event|0|||
161541503|NCT04543188|583372117|FG009|Phase 1a|Adverse Event|0|||
161541504|NCT04543188|583372118|FG010|Phase 1a|Adverse Event|0|||
161541505|NCT04543188|583372119|FG011|Phase 1a|Adverse Event|0|||
161541506|NCT04543188|583372120|FG012|Phase 1a|Adverse Event|0|||
161541507|NCT04543188|583372121|FG013|Phase 1a|Adverse Event|0|||
161541508|NCT04543188|583372122|FG014|Phase 1a|Adverse Event|0|||
161541509|NCT04543188|583372108|FG000|Phase 1a|Other (Death)|0|||
161541510|NCT04543188|583372109|FG001|Phase 1a|Other (Death)|1|||
161541511|NCT04543188|583372110|FG002|Phase 1a|Other (Death)|0|||
161541512|NCT04543188|583372111|FG003|Phase 1a|Other (Death)|0|||
161541513|NCT04543188|583372112|FG004|Phase 1a|Other (Death)|1|||
161541514|NCT04543188|583372113|FG005|Phase 1a|Other (Death)|0|||
161541515|NCT04543188|583372114|FG006|Phase 1a|Other (Death)|0|||
161541516|NCT04543188|583372115|FG007|Phase 1a|Other (Death)|0|||
161541517|NCT04543188|583372116|FG008|Phase 1a|Other (Death)|0|||
161541518|NCT04543188|583372117|FG009|Phase 1a|Other (Death)|1|||
161541519|NCT04543188|583372118|FG010|Phase 1a|Other (Death)|0|||
161541520|NCT04543188|583372119|FG011|Phase 1a|Other (Death)|0|||
161541521|NCT04543188|583372120|FG012|Phase 1a|Other (Death)|0|||
161541522|NCT04543188|583372121|FG013|Phase 1a|Other (Death)|0|||
161541523|NCT04543188|583372122|FG014|Phase 1a|Other (Death)|0|||
161541524|NCT04543188|583372108|FG000|Phase 1a|Lost to Follow-up|0|||
161541525|NCT04543188|583372109|FG001|Phase 1a|Lost to Follow-up|0|||
161541526|NCT04543188|583372110|FG002|Phase 1a|Lost to Follow-up|0|||
161541527|NCT04543188|583372111|FG003|Phase 1a|Lost to Follow-up|0|||
161541528|NCT04543188|583372112|FG004|Phase 1a|Lost to Follow-up|0|||
161593068|NCT03524118|583562610|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161593069|NCT03524118|583562611|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161593070|NCT03524118|583562612|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161593071|NCT03524118|583562613|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
161593072|NCT03524118|583562614|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
161593073|NCT03524118|583562615|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161593074|NCT01437709|583562618|FG000|Overall Study|Adverse Event|0|||
161541529|NCT04543188|583372113|FG005|Phase 1a|Lost to Follow-up|0|||
161541530|NCT04543188|583372114|FG006|Phase 1a|Lost to Follow-up|0|||
161541531|NCT04543188|583372115|FG007|Phase 1a|Lost to Follow-up|0|||
161541532|NCT04543188|583372116|FG008|Phase 1a|Lost to Follow-up|0|||
161541533|NCT04543188|583372117|FG009|Phase 1a|Lost to Follow-up|0|||
161541534|NCT04543188|583372118|FG010|Phase 1a|Lost to Follow-up|1|||
161541535|NCT04543188|583372119|FG011|Phase 1a|Lost to Follow-up|0|||
161541536|NCT04543188|583372120|FG012|Phase 1a|Lost to Follow-up|0|||
161593075|NCT01437709|583562619|FG001|Overall Study|Adverse Event|1|||
161593076|NCT01437709|583562620|FG002|Overall Study|Adverse Event|0|||
161593077|NCT01437709|583562618|FG000|Overall Study|Pt trasnferred care|0|||
161541537|NCT04543188|583372121|FG013|Phase 1a|Lost to Follow-up|0|||
161541538|NCT04543188|583372122|FG014|Phase 1a|Lost to Follow-up|0|||
161541539|NCT04543188|583372108|FG000|Phase 1a|Progressive Disease|2|||
161541540|NCT04543188|583372109|FG001|Phase 1a|Progressive Disease|2|||
161679269|NCT01721876|583877844|FG001|Overall Study|Adverse Event|165|||
161679270|NCT01721876|583877843|FG000|Overall Study|Protocol Violation|2|||
161679271|NCT01721876|583877844|FG001|Overall Study|Protocol Violation|1|||
161679272|NCT01721876|583877843|FG000|Overall Study|Withdrawal by Subject|15|||
161679273|NCT01721876|583877844|FG001|Overall Study|Withdrawal by Subject|38|||
161679274|NCT01721876|583877843|FG000|Overall Study|Reason not listed|34|||
161679275|NCT01721876|583877844|FG001|Overall Study|Reason not listed|63|||
161679276|NCT01721876|583877843|FG000|Overall Study|Sponsor terminated trial|0|||
161679277|NCT01721876|583877844|FG001|Overall Study|Sponsor terminated trial|4|||
161679278|NCT01252810|583877847|FG000|Overall Study|Withdrawal by Subject|4|||
161541541|NCT04543188|583372110|FG002|Phase 1a|Progressive Disease|3|||
161541542|NCT04543188|583372111|FG003|Phase 1a|Progressive Disease|1|||
161541543|NCT04543188|583372112|FG004|Phase 1a|Progressive Disease|4|||
161541544|NCT04543188|583372113|FG005|Phase 1a|Progressive Disease|2|||
161541545|NCT04543188|583372114|FG006|Phase 1a|Progressive Disease|3|||
161679279|NCT01252810|583877848|FG001|Overall Study|Withdrawal by Subject|1|||
161679280|NCT01252810|583877847|FG000|Overall Study|Lost to Follow-up|0|||
161679281|NCT01252810|583877848|FG001|Overall Study|Lost to Follow-up|1|||
161541546|NCT04543188|583372115|FG007|Phase 1a|Progressive Disease|4|||
161541547|NCT04543188|583372116|FG008|Phase 1a|Progressive Disease|1|||
161541548|NCT04543188|583372117|FG009|Phase 1a|Progressive Disease|0|||
161541549|NCT04543188|583372118|FG010|Phase 1a|Progressive Disease|4|||
161541550|NCT04543188|583372119|FG011|Phase 1a|Progressive Disease|0|||
161541551|NCT04543188|583372120|FG012|Phase 1a|Progressive Disease|0|||
161541552|NCT04543188|583372121|FG013|Phase 1a|Progressive Disease|0|||
161541553|NCT04543188|583372122|FG014|Phase 1a|Progressive Disease|0|||
161541554|NCT04543188|583372108|FG000|Phase 1a|Study terminated by sponsor|0|||
161541555|NCT04543188|583372109|FG001|Phase 1a|Study terminated by sponsor|0|||
161541556|NCT04543188|583372110|FG002|Phase 1a|Study terminated by sponsor|0|||
161541557|NCT04543188|583372111|FG003|Phase 1a|Study terminated by sponsor|0|||
161541558|NCT04543188|583372112|FG004|Phase 1a|Study terminated by sponsor|1|||
161541559|NCT04543188|583372113|FG005|Phase 1a|Study terminated by sponsor|0|||
161593078|NCT01437709|583562619|FG001|Overall Study|Pt trasnferred care|1|||
161593079|NCT01437709|583562620|FG002|Overall Study|Pt trasnferred care|0|||
161593080|NCT01842542|583562621|FG000|Overall Study|Withdrawal by Subject|2|||
161593081|NCT01842542|583562621|FG000|Overall Study|Lack of Efficacy|1|||
161593082|NCT01842542|583562621|FG000|Overall Study|Protocol Non-compliance|2|||
161593083|NCT01842542|583562621|FG000|Overall Study|Lost to Follow-up|1|||
161679282|NCT01252810|583877847|FG000|Overall Study|Physician Decision|2|||
161679283|NCT01252810|583877848|FG001|Overall Study|Physician Decision|1|||
161679284|NCT01252810|583877847|FG000|Overall Study|Various reasons|8|||
161679285|NCT01252810|583877848|FG001|Overall Study|Various reasons|0|||
161679286|NCT02811549|583877850|FG000|Overall Study|Lost to Follow-up|1|||
161679287|NCT02811549|583877850|FG000|Overall Study|Withdrawal by Subject|3|||
161679288|NCT02811549|583877850|FG000|Overall Study|Subject screen failed|4|||
161679289|NCT02811549|583877850|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
161679290|NCT05293743|583877851|FG000|Overall Study|Withdrawal by Subject|1|||
161679291|NCT05293743|583877852|FG001|Overall Study|Withdrawal by Subject|0|||
161679292|NCT00688155|583877853|FG000|Overall Study|Withdrawal by Subject|2|||
161679293|NCT00688155|583877854|FG001|Overall Study|Withdrawal by Subject|2|||
161679294|NCT00688155|583877855|FG002|Overall Study|Withdrawal by Subject|1|||
161679295|NCT00688155|583877856|FG003|Overall Study|Withdrawal by Subject|1|||
161679296|NCT00445224|583877859|FG000|Specific Exercises|Withdrawal by Subject|3|||
161679297|NCT00445224|583877860|FG001|Specific Exercises|Withdrawal by Subject|3|||
161679298|NCT00445224|583877859|FG000|Specific Exercises|Withdrawal by Subject|1|||
161593084|NCT02919306|583562622|FG000|Overall Study|Withdrawal by Subject|1|||
161593085|NCT02919306|583562623|FG001|Overall Study|Withdrawal by Subject|0|||
161593086|NCT02919306|583562622|FG000|Overall Study|Protocol Violation|1|||
161593087|NCT02919306|583562623|FG001|Overall Study|Protocol Violation|0|||
161593088|NCT04293055|583562624|FG000|Overall Study|Lost to Follow-up|1|||
161679299|NCT00445224|583877860|FG001|Specific Exercises|Withdrawal by Subject|0|||
161679300|NCT03184077|583877863|FG000|Overall Study|Lost to Follow-up|21|||
161679301|NCT03184077|583877864|FG001|Overall Study|Lost to Follow-up|21|||
161679302|NCT04136184|583877865|FG000|Overall Study|Lost to Follow-up|0|||
161679303|NCT04136184|583877866|FG001|Overall Study|Lost to Follow-up|3|||
161679304|NCT04136184|583877865|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
161679305|NCT04136184|583877866|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
161679306|NCT03318978|583877870|FG000|Overall Study|Withdrawal by Subject|1|||
161593089|NCT04293055|583562625|FG001|Overall Study|Lost to Follow-up|1|||
161593090|NCT04293055|583562624|FG000|Overall Study|Did not trigger randomization|6|||
161593091|NCT04293055|583562625|FG001|Overall Study|Did not trigger randomization|5|||
161593092|NCT02262728|583562626|FG000|Follow-up Phase (3 Years)|Death|0|||
161679307|NCT01200238|583877873|FG000|Overall Study|Adverse Event|2|||
161679308|NCT01200238|583877874|FG001|Overall Study|Adverse Event|1|||
161679309|NCT01200238|583877873|FG000|Overall Study|Progressive Disease|5|||
161541560|NCT04543188|583372114|FG006|Phase 1a|Study terminated by sponsor|0|||
161541561|NCT04543188|583372115|FG007|Phase 1a|Study terminated by sponsor|0|||
161541562|NCT04543188|583372116|FG008|Phase 1a|Study terminated by sponsor|0|||
161541563|NCT04543188|583372117|FG009|Phase 1a|Study terminated by sponsor|0|||
161541564|NCT04543188|583372118|FG010|Phase 1a|Study terminated by sponsor|1|||
161541565|NCT04543188|583372119|FG011|Phase 1a|Study terminated by sponsor|0|||
161541566|NCT04543188|583372120|FG012|Phase 1a|Study terminated by sponsor|0|||
161541567|NCT04543188|583372121|FG013|Phase 1a|Study terminated by sponsor|0|||
161541568|NCT04543188|583372122|FG014|Phase 1a|Study terminated by sponsor|0|||
161541569|NCT04543188|583372108|FG000|Phase 1a|Withdrawal by Subject|0|||
161541570|NCT04543188|583372109|FG001|Phase 1a|Withdrawal by Subject|0|||
161541571|NCT04543188|583372110|FG002|Phase 1a|Withdrawal by Subject|0|||
161541572|NCT04543188|583372111|FG003|Phase 1a|Withdrawal by Subject|0|||
161541573|NCT04543188|583372112|FG004|Phase 1a|Withdrawal by Subject|3|||
161541574|NCT04543188|583372113|FG005|Phase 1a|Withdrawal by Subject|0|||
161541575|NCT04543188|583372114|FG006|Phase 1a|Withdrawal by Subject|0|||
161541576|NCT04543188|583372115|FG007|Phase 1a|Withdrawal by Subject|0|||
161541577|NCT04543188|583372116|FG008|Phase 1a|Withdrawal by Subject|1|||
161541578|NCT04543188|583372117|FG009|Phase 1a|Withdrawal by Subject|1|||
161541579|NCT04543188|583372118|FG010|Phase 1a|Withdrawal by Subject|2|||
161541580|NCT04543188|583372119|FG011|Phase 1a|Withdrawal by Subject|0|||
161541581|NCT04543188|583372120|FG012|Phase 1a|Withdrawal by Subject|0|||
161541582|NCT04543188|583372121|FG013|Phase 1a|Withdrawal by Subject|0|||
161541583|NCT04543188|583372122|FG014|Phase 1a|Withdrawal by Subject|0|||
161541584|NCT04543188|583372108|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
161541585|NCT04543188|583372109|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
161541586|NCT04543188|583372110|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
161541587|NCT04543188|583372111|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
161541588|NCT04543188|583372112|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
161541589|NCT04543188|583372113|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
161541590|NCT04543188|583372114|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
161541591|NCT04543188|583372115|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
161541592|NCT04543188|583372116|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
161541593|NCT04543188|583372117|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
161541594|NCT04543188|583372118|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
161541595|NCT04543188|583372119|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
161541596|NCT04543188|583372120|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
161541597|NCT04543188|583372121|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
161541598|NCT04543188|583372122|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
161541599|NCT04543188|583372108|FG000|Phase 1a|Other|0|||
161541600|NCT04543188|583372109|FG001|Phase 1a|Other|0|||
161541601|NCT04543188|583372110|FG002|Phase 1a|Other|0|||
161541602|NCT04543188|583372111|FG003|Phase 1a|Other|0|||
161541603|NCT04543188|583372112|FG004|Phase 1a|Other|0|||
161541604|NCT04543188|583372113|FG005|Phase 1a|Other|0|||
161541605|NCT04543188|583372114|FG006|Phase 1a|Other|0|||
161541606|NCT04543188|583372115|FG007|Phase 1a|Other|0|||
161541607|NCT04543188|583372116|FG008|Phase 1a|Other|0|||
161541608|NCT04543188|583372117|FG009|Phase 1a|Other|1|||
161541609|NCT04543188|583372118|FG010|Phase 1a|Other|0|||
161541610|NCT04543188|583372119|FG011|Phase 1a|Other|0|||
161541611|NCT04543188|583372120|FG012|Phase 1a|Other|0|||
161541612|NCT04543188|583372121|FG013|Phase 1a|Other|0|||
161541613|NCT04543188|583372122|FG014|Phase 1a|Other|0|||
161541614|NCT04543188|583372108|FG000|Phase 1b|Adverse Event|0|||
161541615|NCT04543188|583372109|FG001|Phase 1b|Adverse Event|0|||
161541616|NCT04543188|583372110|FG002|Phase 1b|Adverse Event|0|||
161541617|NCT04543188|583372111|FG003|Phase 1b|Adverse Event|0|||
161541618|NCT04543188|583372112|FG004|Phase 1b|Adverse Event|0|||
161541619|NCT04543188|583372113|FG005|Phase 1b|Adverse Event|0|||
161541620|NCT04543188|583372114|FG006|Phase 1b|Adverse Event|0|||
161541621|NCT04543188|583372115|FG007|Phase 1b|Adverse Event|0|||
161541622|NCT04543188|583372116|FG008|Phase 1b|Adverse Event|0|||
161541623|NCT04543188|583372117|FG009|Phase 1b|Adverse Event|0|||
161541624|NCT04543188|583372118|FG010|Phase 1b|Adverse Event|0|||
161541625|NCT04543188|583372119|FG011|Phase 1b|Adverse Event|0|||
161541626|NCT04543188|583372120|FG012|Phase 1b|Adverse Event|0|||
161593093|NCT02262728|583562627|FG001|Follow-up Phase (3 Years)|Death|1|||
161593094|NCT02262728|583562626|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
161593095|NCT02262728|583562627|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
161829514|NCT00436917|584415812|FG000|Overall Study|Death|1|||
161829515|NCT00436917|584415812|FG000|Overall Study|Lost to Follow-up|1|||
161541627|NCT04543188|583372121|FG013|Phase 1b|Adverse Event|0|||
161541628|NCT04543188|583372122|FG014|Phase 1b|Adverse Event|2|||
161541629|NCT04543188|583372108|FG000|Phase 1b|Other (Death)|0|||
161541630|NCT04543188|583372109|FG001|Phase 1b|Other (Death)|0|||
161541631|NCT04543188|583372110|FG002|Phase 1b|Other (Death)|0|||
161541632|NCT04543188|583372111|FG003|Phase 1b|Other (Death)|0|||
161541633|NCT04543188|583372112|FG004|Phase 1b|Other (Death)|0|||
161541634|NCT04543188|583372113|FG005|Phase 1b|Other (Death)|0|||
161541635|NCT04543188|583372114|FG006|Phase 1b|Other (Death)|0|||
161541636|NCT04543188|583372115|FG007|Phase 1b|Other (Death)|0|||
161541637|NCT04543188|583372116|FG008|Phase 1b|Other (Death)|0|||
161541638|NCT04543188|583372117|FG009|Phase 1b|Other (Death)|0|||
161541639|NCT04543188|583372118|FG010|Phase 1b|Other (Death)|0|||
161541640|NCT04543188|583372119|FG011|Phase 1b|Other (Death)|0|||
161541641|NCT04543188|583372120|FG012|Phase 1b|Other (Death)|1|||
161541642|NCT04543188|583372121|FG013|Phase 1b|Other (Death)|0|||
161541643|NCT04543188|583372122|FG014|Phase 1b|Other (Death)|1|||
161541644|NCT04543188|583372108|FG000|Phase 1b|Progressive Disease|0|||
161541645|NCT04543188|583372109|FG001|Phase 1b|Progressive Disease|0|||
161541646|NCT04543188|583372110|FG002|Phase 1b|Progressive Disease|0|||
161541647|NCT04543188|583372111|FG003|Phase 1b|Progressive Disease|0|||
161541648|NCT04543188|583372112|FG004|Phase 1b|Progressive Disease|0|||
161541649|NCT04543188|583372113|FG005|Phase 1b|Progressive Disease|0|||
161541650|NCT04543188|583372114|FG006|Phase 1b|Progressive Disease|0|||
161541651|NCT04543188|583372115|FG007|Phase 1b|Progressive Disease|0|||
161541652|NCT04543188|583372116|FG008|Phase 1b|Progressive Disease|0|||
161541653|NCT04543188|583372117|FG009|Phase 1b|Progressive Disease|0|||
161541654|NCT04543188|583372118|FG010|Phase 1b|Progressive Disease|0|||
161541655|NCT04543188|583372119|FG011|Phase 1b|Progressive Disease|0|||
161541656|NCT04543188|583372120|FG012|Phase 1b|Progressive Disease|2|||
161593096|NCT02262728|583562626|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
161593097|NCT02262728|583562627|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
161593098|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
161593099|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
161593100|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
161593101|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
161593102|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
161593103|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
161593104|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
161593105|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
161593106|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
161593107|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
161593108|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
161593109|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
161593110|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
161593111|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
161593112|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
161593113|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
161593114|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
161593115|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
161593116|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
161593117|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
161593118|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
161593119|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
161593120|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
161593121|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
161593122|NCT01715285|583562628|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
161593123|NCT01715285|583562629|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
161593124|NCT01715285|583562630|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
161593125|NCT01715285|583562628|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
161593126|NCT01715285|583562629|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
161593127|NCT01715285|583562630|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
161593128|NCT01715285|583562628|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
161593129|NCT01715285|583562629|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
161593130|NCT01715285|583562630|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
161593131|NCT01715285|583562628|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
161593132|NCT01715285|583562629|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
161593133|NCT01715285|583562630|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
161593134|NCT01715285|583562628|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
161593135|NCT01715285|583562629|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
161593136|NCT01715285|583562630|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
161541657|NCT04543188|583372121|FG013|Phase 1b|Progressive Disease|1|||
161541658|NCT04543188|583372122|FG014|Phase 1b|Progressive Disease|5|||
161541659|NCT04543188|583372108|FG000|Phase 1b|Study Terminated By Sponsor|0|||
161593137|NCT01715285|583562628|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
161593138|NCT01715285|583562629|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
161541660|NCT04543188|583372109|FG001|Phase 1b|Study Terminated By Sponsor|0|||
161541661|NCT04543188|583372110|FG002|Phase 1b|Study Terminated By Sponsor|0|||
161541662|NCT04543188|583372111|FG003|Phase 1b|Study Terminated By Sponsor|0|||
161541663|NCT04543188|583372112|FG004|Phase 1b|Study Terminated By Sponsor|0|||
161541664|NCT04543188|583372113|FG005|Phase 1b|Study Terminated By Sponsor|0|||
161541665|NCT04543188|583372114|FG006|Phase 1b|Study Terminated By Sponsor|0|||
161541666|NCT04543188|583372115|FG007|Phase 1b|Study Terminated By Sponsor|0|||
161541667|NCT04543188|583372116|FG008|Phase 1b|Study Terminated By Sponsor|0|||
161541668|NCT04543188|583372117|FG009|Phase 1b|Study Terminated By Sponsor|0|||
161541669|NCT04543188|583372118|FG010|Phase 1b|Study Terminated By Sponsor|0|||
161541670|NCT04543188|583372119|FG011|Phase 1b|Study Terminated By Sponsor|1|||
161541671|NCT04543188|583372120|FG012|Phase 1b|Study Terminated By Sponsor|1|||
161541672|NCT04543188|583372121|FG013|Phase 1b|Study Terminated By Sponsor|0|||
161541673|NCT04543188|583372122|FG014|Phase 1b|Study Terminated By Sponsor|1|||
161541674|NCT04543188|583372108|FG000|Phase 1b|Withdrawal by Subject|0|||
161541675|NCT04543188|583372109|FG001|Phase 1b|Withdrawal by Subject|0|||
161541676|NCT04543188|583372110|FG002|Phase 1b|Withdrawal by Subject|0|||
161541677|NCT04543188|583372111|FG003|Phase 1b|Withdrawal by Subject|0|||
161541678|NCT04543188|583372112|FG004|Phase 1b|Withdrawal by Subject|0|||
161541679|NCT04543188|583372113|FG005|Phase 1b|Withdrawal by Subject|0|||
161541680|NCT04543188|583372114|FG006|Phase 1b|Withdrawal by Subject|0|||
161541681|NCT04543188|583372115|FG007|Phase 1b|Withdrawal by Subject|0|||
161541682|NCT04543188|583372116|FG008|Phase 1b|Withdrawal by Subject|0|||
161541683|NCT04543188|583372117|FG009|Phase 1b|Withdrawal by Subject|0|||
161541684|NCT04543188|583372118|FG010|Phase 1b|Withdrawal by Subject|0|||
161593139|NCT01715285|583562630|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
161593140|NCT04149704|583562644|FG000|Three Month Follow-up|Death|2|||
161593141|NCT04149704|583562645|FG001|Three Month Follow-up|Death|0|||
161593142|NCT04149704|583562646|FG002|Three Month Follow-up|Death|0|||
161593143|NCT04149704|583562647|FG003|Three Month Follow-up|Death|0|||
161593144|NCT04149704|583562644|FG000|Three Month Follow-up|Lost to Follow-up|1|||
161593145|NCT04149704|583562645|FG001|Three Month Follow-up|Lost to Follow-up|4|||
161593146|NCT04149704|583562646|FG002|Three Month Follow-up|Lost to Follow-up|5|||
161593147|NCT04149704|583562647|FG003|Three Month Follow-up|Lost to Follow-up|5|||
161593148|NCT04149704|583562644|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
161593149|NCT04149704|583562645|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
161593150|NCT04149704|583562646|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
161593151|NCT04149704|583562647|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
161593152|NCT04149704|583562644|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
161593153|NCT04149704|583562645|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
161593154|NCT04149704|583562646|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
161593155|NCT04149704|583562647|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
161593156|NCT04332926|583562648|FG000|Overall Study|Withdrawal by Subject|6|||
161593157|NCT04332926|583562648|FG000|Overall Study|Physician Decision|6|||
161593158|NCT04632992|583562658|FG000|Overall Study|Adverse Event|0|||
161593159|NCT04632992|583562659|FG001|Overall Study|Adverse Event|0|||
161593160|NCT04632992|583562660|FG002|Overall Study|Adverse Event|0|||
161593161|NCT04632992|583562661|FG003|Overall Study|Adverse Event|0|||
161593162|NCT04632992|583562662|FG004|Overall Study|Adverse Event|0|||
161593163|NCT04632992|583562663|FG005|Overall Study|Adverse Event|0|||
161593164|NCT04632992|583562664|FG006|Overall Study|Adverse Event|0|||
161593165|NCT04632992|583562665|FG007|Overall Study|Adverse Event|0|||
161593166|NCT04632992|583562666|FG008|Overall Study|Adverse Event|0|||
161593167|NCT04632992|583562667|FG009|Overall Study|Adverse Event|0|||
161593168|NCT04632992|583562668|FG010|Overall Study|Adverse Event|0|||
161593169|NCT04632992|583562669|FG011|Overall Study|Adverse Event|0|||
161593170|NCT04632992|583562670|FG012|Overall Study|Adverse Event|1|||
161593171|NCT04632992|583562671|FG013|Overall Study|Adverse Event|0|||
161593172|NCT04632992|583562658|FG000|Overall Study|Death|17|||
161593173|NCT04632992|583562659|FG001|Overall Study|Death|1|||
161593174|NCT04632992|583562660|FG002|Overall Study|Death|14|||
161593175|NCT04632992|583562661|FG003|Overall Study|Death|14|||
161593176|NCT04632992|583562662|FG004|Overall Study|Death|13|||
161593177|NCT04632992|583562663|FG005|Overall Study|Death|6|||
161593178|NCT04632992|583562664|FG006|Overall Study|Death|7|||
161593179|NCT04632992|583562665|FG007|Overall Study|Death|12|||
161593180|NCT04632992|583562666|FG008|Overall Study|Death|15|||
161593181|NCT04632992|583562667|FG009|Overall Study|Death|20|||
161593182|NCT04632992|583562668|FG010|Overall Study|Death|8|||
161593183|NCT04632992|583562669|FG011|Overall Study|Death|2|||
161593184|NCT04632992|583562670|FG012|Overall Study|Death|10|||
161593185|NCT04632992|583562671|FG013|Overall Study|Death|1|||
161593186|NCT04632992|583562658|FG000|Overall Study|Lost to Follow-up|1|||
161593187|NCT04632992|583562659|FG001|Overall Study|Lost to Follow-up|0|||
161593188|NCT04632992|583562660|FG002|Overall Study|Lost to Follow-up|1|||
161593189|NCT04632992|583562661|FG003|Overall Study|Lost to Follow-up|0|||
161541685|NCT04543188|583372119|FG011|Phase 1b|Withdrawal by Subject|0|||
161593190|NCT04632992|583562662|FG004|Overall Study|Lost to Follow-up|2|||
161593191|NCT04632992|583562663|FG005|Overall Study|Lost to Follow-up|0|||
161679310|NCT01200238|583877874|FG001|Overall Study|Progressive Disease|8|||
161593192|NCT04632992|583562664|FG006|Overall Study|Lost to Follow-up|1|||
161593193|NCT04632992|583562665|FG007|Overall Study|Lost to Follow-up|1|||
161593194|NCT04632992|583562666|FG008|Overall Study|Lost to Follow-up|1|||
161679311|NCT01200238|583877873|FG000|Overall Study|Withdrawal by Subject|0|||
161679312|NCT01200238|583877874|FG001|Overall Study|Withdrawal by Subject|1|||
161679313|NCT02717754|583877875|FG000|Overall Study|Incorrect Infusion Duration|0|||
161679314|NCT02717754|583877876|FG001|Overall Study|Incorrect Infusion Duration|0|||
161679315|NCT02717754|583877877|FG002|Overall Study|Incorrect Infusion Duration|0|||
161679316|NCT02717754|583877878|FG003|Overall Study|Incorrect Infusion Duration|10|||
161679317|NCT02717754|583877879|FG004|Overall Study|Incorrect Infusion Duration|20|||
161679318|NCT02717754|583877880|FG005|Overall Study|Incorrect Infusion Duration|20|||
161679319|NCT00482703|583877881|FG000|Overall Study|Poor compliance|1|||
161679320|NCT00482703|583877882|FG001|Overall Study|Poor compliance|0|||
161679321|NCT00667823|583877884|FG000|Overall Study|Lost to Follow-up|5|||
161679322|NCT00667823|583877884|FG000|Overall Study|Adverse Event|7|||
161679323|NCT00667823|583877884|FG000|Overall Study|Death|182|||
161679324|NCT00667823|583877884|FG000|Overall Study|Withdrawal by Subject|12|||
161679325|NCT00667823|583877884|FG000|Overall Study|Other|8|||
161679326|NCT00667823|583877884|FG000|Overall Study|Missing (completion page missing)|2|||
161829516|NCT00436917|584415812|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
161829517|NCT00436917|584415812|FG000|Overall Study|Increased creatinine|1|||
161829518|NCT00436917|584415812|FG000|Overall Study|Personal conflicts of patient|1|||
161541686|NCT04543188|583372120|FG012|Phase 1b|Withdrawal by Subject|0|||
161541687|NCT04543188|583372121|FG013|Phase 1b|Withdrawal by Subject|0|||
161541688|NCT04543188|583372122|FG014|Phase 1b|Withdrawal by Subject|2|||
161541689|NCT03815019|583372125|FG000|Overall Study|Withdrawal by Subject|6|||
161541690|NCT03815019|583372126|FG001|Overall Study|Withdrawal by Subject|8|||
161541691|NCT05398796|583372127|FG000|Overall Study|Participant moved from the area|0|||
161541692|NCT05398796|583372128|FG001|Overall Study|Participant moved from the area|1|||
161541693|NCT05398796|583372129|FG002|Overall Study|Participant moved from the area|0|||
161541694|NCT05398796|583372130|FG003|Overall Study|Participant moved from the area|0|||
161541695|NCT04270747|583372132|FG000|Through Week 16|Adverse Event|1|||
161541696|NCT04270747|583372133|FG001|Through Week 16|Adverse Event|2|||
161541697|NCT04270747|583372134|FG002|Through Week 16|Adverse Event|0|||
161541698|NCT04270747|583372132|FG000|Through Week 16|Death|0|||
161541699|NCT04270747|583372133|FG001|Through Week 16|Death|2|||
161541700|NCT04270747|583372134|FG002|Through Week 16|Death|0|||
161541701|NCT04270747|583372132|FG000|Through Week 16|Consent Withdrawn|3|||
161541702|NCT04270747|583372133|FG001|Through Week 16|Consent Withdrawn|3|||
161541703|NCT04270747|583372134|FG002|Through Week 16|Consent Withdrawn|0|||
161541704|NCT04270747|583372132|FG000|Through Week 16|Physician Decision|1|||
161541705|NCT04270747|583372133|FG001|Through Week 16|Physician Decision|1|||
161541706|NCT04270747|583372134|FG002|Through Week 16|Physician Decision|0|||
161541707|NCT04270747|583372132|FG000|Through Week 16|Lost to Follow-up|2|||
161541708|NCT04270747|583372133|FG001|Through Week 16|Lost to Follow-up|0|||
161541709|NCT04270747|583372134|FG002|Through Week 16|Lost to Follow-up|0|||
161541710|NCT04270747|583372132|FG000|Through Week 16|Protocol Violation|1|||
161541711|NCT04270747|583372133|FG001|Through Week 16|Protocol Violation|2|||
161541712|NCT04270747|583372134|FG002|Through Week 16|Protocol Violation|0|||
161541713|NCT04270747|583372132|FG000|Through Week 16|Protocol Specified Criteria|6|||
161541714|NCT04270747|583372133|FG001|Through Week 16|Protocol Specified Criteria|7|||
161541715|NCT04270747|583372134|FG002|Through Week 16|Protocol Specified Criteria|0|||
161541716|NCT04270747|583372132|FG000|Through Week 16|Miscellaneous|1|||
161541717|NCT04270747|583372133|FG001|Through Week 16|Miscellaneous|1|||
161541718|NCT04270747|583372134|FG002|Through Week 16|Miscellaneous|0|||
161541719|NCT04270747|583372132|FG000|Post Week 16|Adverse Event|7|||
161541720|NCT04270747|583372133|FG001|Post Week 16|Adverse Event|5|||
161541721|NCT04270747|583372134|FG002|Post Week 16|Adverse Event|1|||
161541722|NCT04270747|583372132|FG000|Post Week 16|Death|2|||
161541723|NCT04270747|583372133|FG001|Post Week 16|Death|0|||
161541724|NCT04270747|583372134|FG002|Post Week 16|Death|2|||
161541725|NCT04270747|583372132|FG000|Post Week 16|Consent Withdrawn|4|||
161541726|NCT04270747|583372133|FG001|Post Week 16|Consent Withdrawn|3|||
161541727|NCT04270747|583372134|FG002|Post Week 16|Consent Withdrawn|6|||
161541728|NCT04270747|583372132|FG000|Post Week 16|Physician Decision|3|||
161541729|NCT04270747|583372133|FG001|Post Week 16|Physician Decision|1|||
161541730|NCT04270747|583372134|FG002|Post Week 16|Physician Decision|1|||
161541731|NCT04270747|583372132|FG000|Post Week 16|Lost to Follow-up|2|||
161541732|NCT04270747|583372133|FG001|Post Week 16|Lost to Follow-up|1|||
161541733|NCT04270747|583372134|FG002|Post Week 16|Lost to Follow-up|0|||
161541734|NCT04270747|583372132|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
161541735|NCT04270747|583372133|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
161679327|NCT03496012|583879068|FG000|Overall Study|Withdrawal by Subject|2|||
161679328|NCT03496012|583879069|FG001|Overall Study|Withdrawal by Subject|0|||
161679329|NCT03496012|583879070|FG002|Overall Study|Withdrawal by Subject|2|||
161679330|NCT03496012|583879068|FG000|Overall Study|Adverse Event|0|||
161679331|NCT03496012|583879069|FG001|Overall Study|Adverse Event|0|||
161679332|NCT03496012|583879070|FG002|Overall Study|Adverse Event|1|||
161679333|NCT03496012|583879068|FG000|Overall Study|Reason Not Specified|2|||
161829519|NCT02169791|584415815|FG000|Overall Study|Death|6|||
161541736|NCT04270747|583372134|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
161541737|NCT04270747|583372132|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
161541738|NCT04270747|583372133|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
161541739|NCT04270747|583372134|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
161829520|NCT02169791|584415815|FG000|Overall Study|patient withdrew consent|1|||
161541740|NCT04270747|583372132|FG000|Post Week 16|Miscellaneous|1|||
161541741|NCT04270747|583372133|FG001|Post Week 16|Miscellaneous|0|||
161541742|NCT04270747|583372134|FG002|Post Week 16|Miscellaneous|1|||
161541743|NCT05004688|583372135|FG000|Overall Study|Protocol Violation|7|||
161541744|NCT05004688|583372135|FG000|Overall Study|Physician Decision|2|||
161541745|NCT05004688|583372135|FG000|Overall Study|Withdrawal by Subject|2|||
161541746|NCT05960097|583372136|FG000|Overall Study|Lost to Follow-up|3|||
161541747|NCT05960097|583372137|FG001|Overall Study|Lost to Follow-up|1|||
161541748|NCT05960097|583372138|FG002|Overall Study|Lost to Follow-up|1|||
161541749|NCT05960097|583372139|FG003|Overall Study|Lost to Follow-up|2|||
161541750|NCT05960097|583372140|FG004|Overall Study|Lost to Follow-up|1|||
161829521|NCT03170869|584415816|FG000|Overall Study|Protocol Violation|5|||
161541751|NCT05960097|583372141|FG005|Overall Study|Lost to Follow-up|1|||
161541752|NCT05960097|583372142|FG006|Overall Study|Lost to Follow-up|2|||
161541753|NCT05960097|583372143|FG007|Overall Study|Lost to Follow-up|3|||
161541754|NCT05960097|583372136|FG000|Overall Study|Physician Decision|0|||
161541755|NCT05960097|583372137|FG001|Overall Study|Physician Decision|0|||
161541756|NCT05960097|583372138|FG002|Overall Study|Physician Decision|0|||
161541757|NCT05960097|583372139|FG003|Overall Study|Physician Decision|0|||
161541758|NCT05960097|583372140|FG004|Overall Study|Physician Decision|0|||
161541759|NCT05960097|583372141|FG005|Overall Study|Physician Decision|0|||
161541760|NCT05960097|583372142|FG006|Overall Study|Physician Decision|1|||
161541761|NCT05960097|583372143|FG007|Overall Study|Physician Decision|0|||
161541762|NCT05960097|583372136|FG000|Overall Study|Withdrawal by Subject|1|||
161541763|NCT05960097|583372137|FG001|Overall Study|Withdrawal by Subject|0|||
161541764|NCT05960097|583372138|FG002|Overall Study|Withdrawal by Subject|0|||
161541765|NCT05960097|583372139|FG003|Overall Study|Withdrawal by Subject|1|||
161541766|NCT05960097|583372140|FG004|Overall Study|Withdrawal by Subject|1|||
161541767|NCT05960097|583372141|FG005|Overall Study|Withdrawal by Subject|0|||
161541768|NCT05960097|583372142|FG006|Overall Study|Withdrawal by Subject|0|||
161541769|NCT05960097|583372143|FG007|Overall Study|Withdrawal by Subject|0|||
161541770|NCT05960097|583372136|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541771|NCT05960097|583372137|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541772|NCT05960097|583372138|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
161541773|NCT05960097|583372139|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541774|NCT05960097|583372140|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541775|NCT05960097|583372141|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541776|NCT05960097|583372142|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541777|NCT05960097|583372143|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
161541778|NCT02134925|583372144|FG000|Overall Study|Withdrawal by Subject|1|||
161541779|NCT02134925|583372145|FG001|Overall Study|Withdrawal by Subject|0|||
161541780|NCT02134925|583372144|FG000|Overall Study|Cancel|1|||
161541781|NCT02134925|583372145|FG001|Overall Study|Cancel|6|||
161541782|NCT02158884|583372146|FG000|Baseline Assessment|Missed performance assessment|3|||
161541783|NCT02158884|583372146|FG000|Baseline Assessment|Missed SMFA|1|||
161541784|NCT02158884|583372146|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
161541785|NCT02158884|583372146|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
161541786|NCT02158884|583372146|FG000|6 Month Assessment|Missed SMFA|20|||
161541787|NCT02158884|583372146|FG000|12 Month Assessment|Missed SMFA|17|||
161541788|NCT05158296|583372147|FG000|Overall Study|Sponsor Decision|2|||
161541789|NCT05158296|583372148|FG001|Overall Study|Sponsor Decision|3|||
161541790|NCT05158296|583372149|FG002|Overall Study|Sponsor Decision|2|||
161541791|NCT04098250|583372152|FG000|Overall Study|Withdrawal by Subject|1|||
161541792|NCT04098250|583372153|FG001|Overall Study|Withdrawal by Subject|0|||
161541793|NCT04098250|583372152|FG000|Overall Study|Lost to Follow-up|0|||
161541794|NCT04098250|583372153|FG001|Overall Study|Lost to Follow-up|1|||
161541795|NCT00633464|583372154|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
161541796|NCT00633464|583372155|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
161541797|NCT00633464|583372154|FG000|Overall Study|Never Treated (Randomized in error)|0|||
161541798|NCT00633464|583372155|FG001|Overall Study|Never Treated (Randomized in error)|1|||
161541799|NCT06387472|583372156|FG000|Overall Study|Withdrawal by Subject|1|||
161541800|NCT06387472|583372156|FG000|Overall Study|Lost to Follow-up|2|||
161593195|NCT04632992|583562667|FG009|Overall Study|Lost to Follow-up|1|||
161593196|NCT04632992|583562668|FG010|Overall Study|Lost to Follow-up|2|||
161593197|NCT04632992|583562669|FG011|Overall Study|Lost to Follow-up|0|||
161593198|NCT04632992|583562670|FG012|Overall Study|Lost to Follow-up|0|||
161593199|NCT04632992|583562671|FG013|Overall Study|Lost to Follow-up|0|||
161593200|NCT04632992|583562658|FG000|Overall Study|Reason not Specified|2|||
161541801|NCT06387472|583372156|FG000|Overall Study|Physician Decision|1|||
161541802|NCT04182880|583372157|FG000|Overall Study|Pregnancy|1|||
161541803|NCT04182880|583372158|FG001|Overall Study|Pregnancy|0|||
161541804|NCT02036645|583372159|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541805|NCT02036645|583372160|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541806|NCT02036645|583372161|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541807|NCT02036645|583372162|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541808|NCT02036645|583372163|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541809|NCT02036645|583372164|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541810|NCT02036645|583372165|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
161541811|NCT02036645|583372166|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541812|NCT02036645|583372167|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541813|NCT02036645|583372168|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541814|NCT02036645|583372169|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541815|NCT02036645|583372170|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
161541816|NCT02036645|583372159|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541817|NCT02036645|583372160|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541818|NCT02036645|583372161|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541819|NCT02036645|583372162|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
161541820|NCT02036645|583372163|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541821|NCT02036645|583372164|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541822|NCT02036645|583372165|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541823|NCT02036645|583372166|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541824|NCT02036645|583372167|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541825|NCT02036645|583372168|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541826|NCT02036645|583372169|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541827|NCT02036645|583372170|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
161541828|NCT00717860|583372175|FG000|Overall Study|Clinical adverse experience|5|||
161541829|NCT00717860|583372176|FG001|Overall Study|Clinical adverse experience|9|||
161541830|NCT00717860|583372175|FG000|Overall Study|Laboratory adverse experience|2|||
161541831|NCT00717860|583372176|FG001|Overall Study|Laboratory adverse experience|2|||
161541832|NCT00717860|583372175|FG000|Overall Study|Lack of Efficacy|7|||
161541833|NCT00717860|583372176|FG001|Overall Study|Lack of Efficacy|13|||
161541834|NCT00717860|583372175|FG000|Overall Study|Discontinued for other reason|6|||
161541835|NCT00717860|583372176|FG001|Overall Study|Discontinued for other reason|1|||
161541836|NCT00717860|583372175|FG000|Overall Study|Withdrew consent|7|||
161541837|NCT00717860|583372176|FG001|Overall Study|Withdrew consent|3|||
161541838|NCT00698646|583372177|FG000|Overall Study|Adverse Event|8|||
161541839|NCT00698646|583372178|FG001|Overall Study|Adverse Event|7|||
161541840|NCT00698646|583372179|FG002|Overall Study|Adverse Event|8|||
161541841|NCT00698646|583372177|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
161541842|NCT00698646|583372178|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
161541843|NCT00698646|583372179|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
161541844|NCT00698646|583372177|FG000|Overall Study|Protocol Deviation|6|||
161541845|NCT00698646|583372178|FG001|Overall Study|Protocol Deviation|2|||
161541846|NCT00698646|583372179|FG002|Overall Study|Protocol Deviation|3|||
161541847|NCT00698646|583372177|FG000|Overall Study|Withdrawal by Subject|10|||
161541848|NCT00698646|583372178|FG001|Overall Study|Withdrawal by Subject|11|||
161541849|NCT00698646|583372179|FG002|Overall Study|Withdrawal by Subject|8|||
161541850|NCT00698646|583372177|FG000|Overall Study|Lost to Follow-up|0|||
161541851|NCT00698646|583372178|FG001|Overall Study|Lost to Follow-up|0|||
161541852|NCT00698646|583372179|FG002|Overall Study|Lost to Follow-up|2|||
161541853|NCT00698646|583372177|FG000|Overall Study|Administrative problems|1|||
161541854|NCT00698646|583372178|FG001|Overall Study|Administrative problems|0|||
161541855|NCT00698646|583372179|FG002|Overall Study|Administrative problems|1|||
161541856|NCT03995784|583372182|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
161541857|NCT01489189|583372183|FG000|Overall Study|Withdrawal by Subject|20|||
161541858|NCT01489189|583372184|FG001|Overall Study|Withdrawal by Subject|23|||
161541859|NCT01489189|583372183|FG000|Overall Study|Death|10|||
161541860|NCT01489189|583372184|FG001|Overall Study|Death|8|||
161541861|NCT01489189|583372183|FG000|Overall Study|Missed Visit|1|||
161541862|NCT01489189|583372184|FG001|Overall Study|Missed Visit|4|||
161541863|NCT04225988|583372185|FG000|Overall Study|Withdrawal by Subject|2|||
161541864|NCT04225988|583372186|FG001|Overall Study|Withdrawal by Subject|0|||
161541865|NCT00112580|583372187|FG000|Overall Study|Adverse Event|1|||
161541866|NCT00112580|583372188|FG001|Overall Study|Adverse Event|2|||
161541867|NCT00112580|583372187|FG000|Overall Study|Disease progression|5|||
161541868|NCT00112580|583372188|FG001|Overall Study|Disease progression|16|||
161541869|NCT00112580|583372187|FG000|Overall Study|Participant withdrew consent|2|||
161541870|NCT00112580|583372188|FG001|Overall Study|Participant withdrew consent|1|||
161541871|NCT05619003|583372191|FG000|Overall Study|Adverse Event|1|||
161541872|NCT07018999|583372196|FG000|Overall Study|Protocol Violation|0|||
161541873|NCT07018999|583372197|FG001|Overall Study|Protocol Violation|1|||
161541874|NCT07018999|583372196|FG000|Overall Study|Incomplete data entry|4|||
161541875|NCT07018999|583372197|FG001|Overall Study|Incomplete data entry|7|||
161541876|NCT04739761|583372199|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
161541877|NCT04739761|583372200|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
161541878|NCT04739761|583372199|FG000|Overall Study|By complete response from the participant|1|||
161541879|NCT04739761|583372200|FG001|Overall Study|By complete response from the participant|0|||
161541880|NCT04739761|583372199|FG000|Overall Study|Lost to Follow-up|3|||
161541881|NCT04739761|583372200|FG001|Overall Study|Lost to Follow-up|3|||
161541882|NCT04739761|583372199|FG000|Overall Study|Death|13|||
161541883|NCT04739761|583372200|FG001|Overall Study|Death|13|||
161541884|NCT04739761|583372199|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
161541885|NCT04739761|583372200|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
161541886|NCT04739761|583372199|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
161541887|NCT04739761|583372200|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
161541888|NCT04739761|583372199|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
161541889|NCT04739761|583372200|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
161541890|NCT04739761|583372199|FG000|Overall Study|Adverse Event|0|||
161541891|NCT04739761|583372200|FG001|Overall Study|Adverse Event|3|||
161541892|NCT04739761|583372199|FG000|Overall Study|Participant decision|1|||
161541893|NCT04739761|583372200|FG001|Overall Study|Participant decision|0|||
161541894|NCT04739761|583372199|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
161541895|NCT04739761|583372200|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
161541896|NCT04739761|583372199|FG000|Overall Study|Participant immediately started next line of treatment|1|||
161541897|NCT04739761|583372200|FG001|Overall Study|Participant immediately started next line of treatment|0|||
161541898|NCT04739761|583372199|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
161541899|NCT04739761|583372200|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
161541900|NCT04739761|583372199|FG000|Overall Study|Lack of clinical benefit|1|||
161541901|NCT04739761|583372200|FG001|Overall Study|Lack of clinical benefit|0|||
161541902|NCT04739761|583372199|FG000|Overall Study|Disease progression|5|||
161541903|NCT04739761|583372200|FG001|Overall Study|Disease progression|5|||
161541904|NCT04739761|583372199|FG000|Overall Study|Withdrawal by Subject|14|||
161541905|NCT04739761|583372200|FG001|Overall Study|Withdrawal by Subject|13|||
161541906|NCT04739761|583372199|FG000|Overall Study|Protocol Violation|1|||
161541907|NCT04739761|583372200|FG001|Overall Study|Protocol Violation|0|||
161541908|NCT04739761|583372199|FG000|Overall Study|Physician Decision|2|||
161541909|NCT04739761|583372200|FG001|Overall Study|Physician Decision|0|||
161541910|NCT03881696|583372204|FG000|Overall Study|Adverse Event|2|||
161541911|NCT03881696|583372205|FG001|Overall Study|Adverse Event|0|||
161541912|NCT03881696|583372204|FG000|Overall Study|Withdrawal by Subject|2|||
161541913|NCT03881696|583372205|FG001|Overall Study|Withdrawal by Subject|0|||
161541914|NCT03881696|583372204|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
161541915|NCT03881696|583372205|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
161541916|NCT03881696|583372204|FG000|Overall Study|Failure to meet continuation criteria|1|||
161541917|NCT03881696|583372205|FG001|Overall Study|Failure to meet continuation criteria|0|||
161541918|NCT02202434|583373584|FG000|Overall Study|Death|70|||
161541919|NCT02202434|583373585|FG001|Overall Study|Death|39|||
161541920|NCT02202434|583373586|FG002|Overall Study|Death|13|||
161541921|NCT02202434|583373587|FG003|Overall Study|Death|27|||
161541922|NCT02202434|583373584|FG000|Overall Study|Lost to Follow-up|1|||
161541923|NCT02202434|583373585|FG001|Overall Study|Lost to Follow-up|1|||
161541924|NCT02202434|583373586|FG002|Overall Study|Lost to Follow-up|1|||
161541925|NCT02202434|583373587|FG003|Overall Study|Lost to Follow-up|0|||
161541926|NCT02202434|583373584|FG000|Overall Study|Physician Decision|2|||
161541927|NCT02202434|583373585|FG001|Overall Study|Physician Decision|3|||
161541928|NCT02202434|583373586|FG002|Overall Study|Physician Decision|0|||
161541929|NCT02202434|583373587|FG003|Overall Study|Physician Decision|0|||
161541930|NCT02202434|583373584|FG000|Overall Study|Withdrawal by Subject|13|||
161541931|NCT02202434|583373585|FG001|Overall Study|Withdrawal by Subject|14|||
161593201|NCT04632992|583562659|FG001|Overall Study|Reason not Specified|0|||
161593202|NCT04632992|583562660|FG002|Overall Study|Reason not Specified|1|||
161593203|NCT04632992|583562661|FG003|Overall Study|Reason not Specified|1|||
161593204|NCT04632992|583562662|FG004|Overall Study|Reason not Specified|0|||
161593205|NCT04632992|583562663|FG005|Overall Study|Reason not Specified|0|||
161593206|NCT04632992|583562664|FG006|Overall Study|Reason not Specified|0|||
161541932|NCT02202434|583373586|FG002|Overall Study|Withdrawal by Subject|1|||
161593207|NCT04632992|583562665|FG007|Overall Study|Reason not Specified|0|||
161679334|NCT03496012|583879069|FG001|Overall Study|Reason Not Specified|0|||
161541933|NCT02202434|583373587|FG003|Overall Study|Withdrawal by Subject|4|||
161541934|NCT02202434|583373584|FG000|Overall Study|Completed Study|1|||
161541935|NCT02202434|583373585|FG001|Overall Study|Completed Study|0|||
161541936|NCT02202434|583373586|FG002|Overall Study|Completed Study|0|||
161593208|NCT04632992|583562666|FG008|Overall Study|Reason not Specified|0|||
161679335|NCT03496012|583879070|FG002|Overall Study|Reason Not Specified|1|||
161679336|NCT02322125|583879071|FG000|Overall Study|Withdrawal by Subject|2|||
161679337|NCT04096274|583879074|FG000|Phase I|Lost to Follow-up|5|||
161679338|NCT04096274|583879075|FG001|Phase I|Lost to Follow-up|5|||
161679339|NCT04096274|583879074|FG000|Phase II|Lost to Follow-up|11|||
161679340|NCT04096274|583879075|FG001|Phase II|Lost to Follow-up|11|||
161679341|NCT05092919|583879076|FG000|Overall Study|Lost to Follow-up|7|||
161679342|NCT05092919|583879076|FG000|Overall Study|Withdrawal by Subject|2|||
161679343|NCT02248259|583879078|FG000|Treatment Period 1|Adverse Event|0|||
161679344|NCT02248259|583879079|FG001|Treatment Period 1|Adverse Event|0|||
161679345|NCT02248259|583879080|FG002|Treatment Period 1|Adverse Event|1|||
161679346|NCT02248259|583879081|FG003|Treatment Period 1|Adverse Event|0|||
161679347|NCT01543152|583879082|FG000|Overall Study|Withdrawal by Subject|0|||
161679348|NCT01543152|583879083|FG001|Overall Study|Withdrawal by Subject|2|||
161679349|NCT01543152|583879084|FG002|Overall Study|Withdrawal by Subject|0|||
161679350|NCT01543152|583879085|FG003|Overall Study|Withdrawal by Subject|0|||
161679351|NCT01543152|583879086|FG004|Overall Study|Withdrawal by Subject|0|||
161679352|NCT00096785|583879087|FG000|Overall Study|Lost to Follow-up|1|||
161679353|NCT00096785|583879088|FG001|Overall Study|Lost to Follow-up|0|||
161679354|NCT00096785|583879087|FG000|Overall Study|Withdrawal by Subject|0|||
161679355|NCT00096785|583879088|FG001|Overall Study|Withdrawal by Subject|1|||
161679356|NCT00096785|583879087|FG000|Overall Study|Relocated|1|||
161679357|NCT00096785|583879088|FG001|Overall Study|Relocated|0|||
161679358|NCT00762892|583879090|FG000|Overall Study|Lost to Follow-up|2|||
161679359|NCT00762892|583879091|FG001|Overall Study|Lost to Follow-up|5|||
161829522|NCT03170869|584415816|FG000|Overall Study|Early study termination|3|||
161829523|NCT00373425|584415820|FG000|Overall Study|Relapse of NSCLC|116|||
161829524|NCT00373425|584415821|FG001|Overall Study|Relapse of NSCLC|104|||
161829525|NCT00373425|584415822|FG002|Overall Study|Relapse of NSCLC|19|||
161829526|NCT00373425|584415823|FG003|Overall Study|Relapse of NSCLC|2|||
161829527|NCT00373425|584415824|FG004|Overall Study|Relapse of NSCLC|26|||
161829528|NCT00373425|584415820|FG000|Overall Study|Adverse Event|191|||
161829529|NCT00373425|584415821|FG001|Overall Study|Adverse Event|22|||
161829530|NCT00373425|584415822|FG002|Overall Study|Adverse Event|59|||
161829531|NCT00373425|584415823|FG003|Overall Study|Adverse Event|0|||
161829532|NCT00373425|584415824|FG004|Overall Study|Adverse Event|34|||
161829533|NCT00373425|584415820|FG000|Overall Study|Patient request|35|||
161829534|NCT00373425|584415821|FG001|Overall Study|Patient request|18|||
161829535|NCT00373425|584415822|FG002|Overall Study|Patient request|43|||
161829536|NCT00373425|584415823|FG003|Overall Study|Patient request|6|||
161829537|NCT00373425|584415824|FG004|Overall Study|Patient request|7|||
161829538|NCT00373425|584415820|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
161829539|NCT00373425|584415821|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
161829540|NCT00373425|584415822|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
161829541|NCT00373425|584415823|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
161829542|NCT00373425|584415824|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
161829543|NCT00373425|584415820|FG000|Overall Study|Death|7|||
161829544|NCT00373425|584415821|FG001|Overall Study|Death|0|||
161829545|NCT00373425|584415822|FG002|Overall Study|Death|3|||
161829546|NCT00373425|584415823|FG003|Overall Study|Death|1|||
161829547|NCT00373425|584415824|FG004|Overall Study|Death|0|||
161829548|NCT00551616|584415827|FG000|Overall Study|Lost to Follow-up|48|||
161829549|NCT00551616|584415828|FG001|Overall Study|Lost to Follow-up|40|||
161829550|NCT02808819|584415829|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
161829551|NCT02808819|584415830|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
161829552|NCT02808819|584415829|FG000|Overall Study|Withdrawal by Subject|10|||
161829553|NCT02808819|584415830|FG001|Overall Study|Withdrawal by Subject|13|||
161679360|NCT00762892|583879090|FG000|Overall Study|Withdrawal by Subject|0|||
161679361|NCT00762892|583879091|FG001|Overall Study|Withdrawal by Subject|1|||
161679362|NCT00762892|583879090|FG000|Overall Study|Death|1|||
161829554|NCT02808819|584415829|FG000|Overall Study|Site terminated by sponsor|2|||
161829555|NCT02808819|584415830|FG001|Overall Study|Site terminated by sponsor|0|||
161829556|NCT02808819|584415829|FG000|Overall Study|Pregnancy|1|||
161829557|NCT02808819|584415830|FG001|Overall Study|Pregnancy|0|||
161829558|NCT02808819|584415829|FG000|Overall Study|Lost to Follow-up|1|||
161829559|NCT02808819|584415830|FG001|Overall Study|Lost to Follow-up|6|||
161829560|NCT02808819|584415829|FG000|Overall Study|Protocol Violation|0|||
161829561|NCT02808819|584415830|FG001|Overall Study|Protocol Violation|1|||
161829562|NCT02808819|584415829|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
161679363|NCT00762892|583879091|FG001|Overall Study|Death|0|||
161679364|NCT00762892|583879090|FG000|Overall Study|Pregnancy|1|||
161679365|NCT00762892|583879091|FG001|Overall Study|Pregnancy|0|||
161679366|NCT00762892|583879090|FG000|Overall Study|Incarceration|1|||
161679367|NCT00762892|583879091|FG001|Overall Study|Incarceration|0|||
161679368|NCT02234479|583879092|FG000|Overall Study|Withdrawal by Subject|1|||
161679369|NCT02234479|583879093|FG001|Overall Study|Withdrawal by Subject|3|||
161679370|NCT00914927|583879094|FG000|Overall Study|Adverse Event|0|||
161829563|NCT02808819|584415830|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
161829564|NCT02808819|584415829|FG000|Overall Study|Death|1|||
161593209|NCT04632992|583562667|FG009|Overall Study|Reason not Specified|0|||
161593210|NCT04632992|583562668|FG010|Overall Study|Reason not Specified|1|||
161593211|NCT04632992|583562669|FG011|Overall Study|Reason not Specified|0|||
161593212|NCT04632992|583562670|FG012|Overall Study|Reason not Specified|0|||
161593213|NCT04632992|583562671|FG013|Overall Study|Reason not Specified|0|||
161593214|NCT04632992|583562658|FG000|Overall Study|Physician Decision|0|||
161593215|NCT04632992|583562659|FG001|Overall Study|Physician Decision|0|||
161593216|NCT04632992|583562660|FG002|Overall Study|Physician Decision|0|||
161593217|NCT04632992|583562661|FG003|Overall Study|Physician Decision|2|||
161593218|NCT04632992|583562662|FG004|Overall Study|Physician Decision|1|||
161593219|NCT04632992|583562663|FG005|Overall Study|Physician Decision|0|||
161593220|NCT04632992|583562664|FG006|Overall Study|Physician Decision|0|||
161593221|NCT04632992|583562665|FG007|Overall Study|Physician Decision|0|||
161593222|NCT04632992|583562666|FG008|Overall Study|Physician Decision|0|||
161593223|NCT04632992|583562667|FG009|Overall Study|Physician Decision|0|||
161593224|NCT04632992|583562668|FG010|Overall Study|Physician Decision|0|||
161593225|NCT04632992|583562669|FG011|Overall Study|Physician Decision|0|||
161593226|NCT04632992|583562670|FG012|Overall Study|Physician Decision|3|||
161593227|NCT04632992|583562671|FG013|Overall Study|Physician Decision|0|||
161593228|NCT04632992|583562658|FG000|Overall Study|Progressive Disease|0|||
161593229|NCT04632992|583562659|FG001|Overall Study|Progressive Disease|0|||
161593230|NCT04632992|583562660|FG002|Overall Study|Progressive Disease|0|||
161593231|NCT04632992|583562661|FG003|Overall Study|Progressive Disease|0|||
161593232|NCT04632992|583562662|FG004|Overall Study|Progressive Disease|1|||
161593233|NCT04632992|583562663|FG005|Overall Study|Progressive Disease|0|||
161593234|NCT04632992|583562664|FG006|Overall Study|Progressive Disease|0|||
161593235|NCT04632992|583562665|FG007|Overall Study|Progressive Disease|0|||
161593236|NCT04632992|583562666|FG008|Overall Study|Progressive Disease|0|||
161593237|NCT04632992|583562667|FG009|Overall Study|Progressive Disease|1|||
161593238|NCT04632992|583562668|FG010|Overall Study|Progressive Disease|1|||
161593239|NCT04632992|583562669|FG011|Overall Study|Progressive Disease|0|||
161593240|NCT04632992|583562670|FG012|Overall Study|Progressive Disease|2|||
161593241|NCT04632992|583562671|FG013|Overall Study|Progressive Disease|0|||
161593242|NCT04632992|583562658|FG000|Overall Study|Withdrawal by Subject|4|||
161593243|NCT04632992|583562659|FG001|Overall Study|Withdrawal by Subject|1|||
161593244|NCT04632992|583562660|FG002|Overall Study|Withdrawal by Subject|5|||
161593245|NCT04632992|583562661|FG003|Overall Study|Withdrawal by Subject|4|||
161593246|NCT04632992|583562662|FG004|Overall Study|Withdrawal by Subject|3|||
161593247|NCT04632992|583562663|FG005|Overall Study|Withdrawal by Subject|3|||
161593248|NCT04632992|583562664|FG006|Overall Study|Withdrawal by Subject|0|||
161593249|NCT04632992|583562665|FG007|Overall Study|Withdrawal by Subject|5|||
161593250|NCT04632992|583562666|FG008|Overall Study|Withdrawal by Subject|0|||
161593251|NCT04632992|583562667|FG009|Overall Study|Withdrawal by Subject|2|||
161593252|NCT04632992|583562668|FG010|Overall Study|Withdrawal by Subject|8|||
161593253|NCT04632992|583562669|FG011|Overall Study|Withdrawal by Subject|0|||
161593254|NCT04632992|583562670|FG012|Overall Study|Withdrawal by Subject|1|||
161593255|NCT04632992|583562671|FG013|Overall Study|Withdrawal by Subject|1|||
161593256|NCT02677805|583562672|FG000|Double Blind Phase|Lost to Follow-up|8|||
161593257|NCT02677805|583562673|FG001|Double Blind Phase|Lost to Follow-up|3|||
161593258|NCT02677805|583562674|FG002|Double Blind Phase|Lost to Follow-up|0|||
161593259|NCT02677805|583562672|FG000|Double Blind Phase|Withdrawal by Subject|5|||
161593260|NCT02677805|583562673|FG001|Double Blind Phase|Withdrawal by Subject|2|||
161593261|NCT02677805|583562674|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161593262|NCT02677805|583562672|FG000|Open Label Phase|Lost to Follow-up|0|||
161593263|NCT02677805|583562673|FG001|Open Label Phase|Lost to Follow-up|0|||
161593264|NCT02677805|583562674|FG002|Open Label Phase|Lost to Follow-up|10|||
161593265|NCT02677805|583562672|FG000|Open Label Phase|Withdrawal by Subject|0|||
161593266|NCT02677805|583562673|FG001|Open Label Phase|Withdrawal by Subject|0|||
161593267|NCT02677805|583562674|FG002|Open Label Phase|Withdrawal by Subject|6|||
161593268|NCT04350463|583562679|FG000|Overall Study|Other reason|0|||
161593269|NCT04350463|583562680|FG001|Overall Study|Other reason|0|||
161593270|NCT04350463|583562681|FG002|Overall Study|Other reason|0|||
161593271|NCT04350463|583562682|FG003|Overall Study|Other reason|1|||
161593272|NCT04350463|583562679|FG000|Overall Study|Lost to Follow-up|0|||
161593273|NCT04350463|583562680|FG001|Overall Study|Lost to Follow-up|0|||
161593274|NCT04350463|583562681|FG002|Overall Study|Lost to Follow-up|0|||
161593275|NCT04350463|583562682|FG003|Overall Study|Lost to Follow-up|2|||
161593276|NCT04350463|583562679|FG000|Overall Study|Withdrawal by Subject|4|||
161593277|NCT04350463|583562680|FG001|Overall Study|Withdrawal by Subject|0|||
161593278|NCT04350463|583562681|FG002|Overall Study|Withdrawal by Subject|1|||
161593279|NCT04350463|583562682|FG003|Overall Study|Withdrawal by Subject|4|||
161593280|NCT04350463|583562679|FG000|Overall Study|Adverse Event|0|||
161593281|NCT04350463|583562680|FG001|Overall Study|Adverse Event|0|||
161593282|NCT04350463|583562681|FG002|Overall Study|Adverse Event|0|||
161593283|NCT04350463|583562682|FG003|Overall Study|Adverse Event|2|||
161593284|NCT04350463|583562679|FG000|Overall Study|Death|27|||
161593285|NCT04350463|583562680|FG001|Overall Study|Death|2|||
161593286|NCT04350463|583562681|FG002|Overall Study|Death|13|||
161593287|NCT04350463|583562682|FG003|Overall Study|Death|26|||
161541937|NCT02202434|583373587|FG003|Overall Study|Completed Study|0|||
161541938|NCT02202434|583373584|FG000|Overall Study|Visit Missed|21|||
161541939|NCT02202434|583373585|FG001|Overall Study|Visit Missed|12|||
161541940|NCT02202434|583373586|FG002|Overall Study|Visit Missed|0|||
161541941|NCT02202434|583373587|FG003|Overall Study|Visit Missed|5|||
161541942|NCT02202434|583373584|FG000|Overall Study|Other|1|||
161541943|NCT02202434|583373585|FG001|Overall Study|Other|0|||
161541944|NCT02202434|583373586|FG002|Overall Study|Other|0|||
161541945|NCT02202434|583373587|FG003|Overall Study|Other|1|||
161541946|NCT03237858|583373588|FG000|Overall Study|Death|19|||
161541947|NCT03237858|583373588|FG000|Overall Study|Withdrawal by Subject|37|||
161541948|NCT00332332|583373589|FG000|Overall Study|Adverse Event|13|||
161541949|NCT00332332|583373589|FG000|Overall Study|Death|1|||
161541950|NCT00332332|583373589|FG000|Overall Study|Withdrawal by Subject|8|||
161541951|NCT00332332|583373589|FG000|Overall Study|Physician Decision|1|||
161541952|NCT00332332|583373589|FG000|Overall Study|Lost to Follow-up|3|||
161541953|NCT00332332|583373589|FG000|Overall Study|Protocol deviation|4|||
161541954|NCT00332332|583373589|FG000|Overall Study|Noncompliance|2|||
161541955|NCT00332332|583373589|FG000|Overall Study|Disease progression|2|||
161541956|NCT00332332|583373589|FG000|Overall Study|Other|18|||
161593288|NCT04111536|583562683|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161593289|NCT04111536|583562684|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161593290|NCT04111536|583562683|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
161593291|NCT04111536|583562684|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
161593292|NCT04111536|583562683|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
161593293|NCT04111536|583562684|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161593294|NCT04111536|583562683|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
161593295|NCT04111536|583562684|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
161593296|NCT04652700|583562685|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
161593297|NCT04652700|583562686|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
161593298|NCT04652700|583562685|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
161593299|NCT04652700|583562686|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
161593300|NCT04652700|583562685|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
161593301|NCT04652700|583562686|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
161593302|NCT04652700|583562685|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
161593303|NCT04652700|583562686|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
161593304|NCT04652700|583562685|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
161593305|NCT04652700|583562686|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
161593306|NCT04652700|583562685|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
161593307|NCT04652700|583562686|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
161593308|NCT04652700|583562685|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
161593309|NCT04652700|583562686|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
161593310|NCT04652700|583562685|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
161593311|NCT04652700|583562686|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
161593312|NCT04652700|583562685|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
161593313|NCT04652700|583562686|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
161593314|NCT04187833|583562687|FG000|Overall Study|Withdrawal by Subject|1|||
161593315|NCT06037369|583562691|FG000|Overall Study|Lost to Follow-up|0|||
161593316|NCT06037369|583562692|FG001|Overall Study|Lost to Follow-up|1|||
161593317|NCT04209465|583562693|FG000|Overall Study|Adverse Event|0|||
161593318|NCT04209465|583562694|FG001|Overall Study|Adverse Event|0|||
161593319|NCT04209465|583562695|FG002|Overall Study|Adverse Event|0|||
161593320|NCT04209465|583562696|FG003|Overall Study|Adverse Event|0|||
161593321|NCT04209465|583562697|FG004|Overall Study|Adverse Event|0|||
161593322|NCT04209465|583562698|FG005|Overall Study|Adverse Event|1|||
161593323|NCT04209465|583562699|FG006|Overall Study|Adverse Event|0|||
161593324|NCT04209465|583562700|FG007|Overall Study|Adverse Event|0|||
161593325|NCT04209465|583562701|FG008|Overall Study|Adverse Event|1|||
161593326|NCT04209465|583562702|FG009|Overall Study|Adverse Event|0|||
161593327|NCT04209465|583562703|FG010|Overall Study|Adverse Event|2|||
161593328|NCT04209465|583562704|FG011|Overall Study|Adverse Event|1|||
161593329|NCT04209465|583562705|FG012|Overall Study|Adverse Event|1|||
161593330|NCT04209465|583562693|FG000|Overall Study|Death|1|||
161593331|NCT04209465|583562694|FG001|Overall Study|Death|0|||
161593332|NCT04209465|583562695|FG002|Overall Study|Death|0|||
161593333|NCT04209465|583562696|FG003|Overall Study|Death|0|||
161593334|NCT04209465|583562697|FG004|Overall Study|Death|2|||
161593335|NCT04209465|583562698|FG005|Overall Study|Death|7|||
161593336|NCT04209465|583562699|FG006|Overall Study|Death|2|||
161541957|NCT00332332|583373589|FG000|Overall Study|Did not receive study treatment|16|||
161541958|NCT01108458|583373590|FG000|Overall Study|Withdrawal by Subject|1|||
161541959|NCT03075501|583373592|FG000|Overall Study|Scheduling difficulties|15|||
161593337|NCT04209465|583562700|FG007|Overall Study|Death|2|||
161593338|NCT04209465|583562701|FG008|Overall Study|Death|1|||
161541960|NCT03075501|583373593|FG001|Overall Study|Scheduling difficulties|9|||
161541961|NCT03610737|583373598|FG000|Overall Study|Withdrawal by Subject|1|||
161541962|NCT03610737|583373599|FG001|Overall Study|Withdrawal by Subject|5|||
161679371|NCT00914927|583879095|FG001|Overall Study|Adverse Event|0|||
161541963|NCT03610737|583373598|FG000|Overall Study|Death|1|||
161541964|NCT03610737|583373599|FG001|Overall Study|Death|0|||
161541965|NCT03610737|583373598|FG000|Overall Study|Not treated|5|||
161541966|NCT03610737|583373599|FG001|Overall Study|Not treated|2|||
161541967|NCT03610737|583373598|FG000|Overall Study|Missed Visit|1|||
161541968|NCT03610737|583373599|FG001|Overall Study|Missed Visit|2|||
161541969|NCT00710606|583373606|FG000|Overall Study|Adverse Event|0|||
161541970|NCT00710606|583373607|FG001|Overall Study|Adverse Event|2|||
161541971|NCT02670538|583373612|FG000|Overall Study|Withdrawal of Consent|8|||
161541972|NCT02670538|583373613|FG001|Overall Study|Withdrawal of Consent|6|||
161541973|NCT02670538|583373614|FG002|Overall Study|Withdrawal of Consent|5|||
161541974|NCT02670538|583373612|FG000|Overall Study|Lost to Follow-up|8|||
161541975|NCT02670538|583373613|FG001|Overall Study|Lost to Follow-up|12|||
161679372|NCT00914927|583879096|FG002|Overall Study|Adverse Event|0|||
161679373|NCT00914927|583879097|FG003|Overall Study|Adverse Event|0|||
161679374|NCT00914927|583879098|FG004|Overall Study|Adverse Event|1|||
161679375|NCT00914927|583879099|FG005|Overall Study|Adverse Event|0|||
161679376|NCT00914927|583879100|FG006|Overall Study|Adverse Event|0|||
161679377|NCT00914927|583879094|FG000|Overall Study|Withdrawal by Subject|0|||
161679378|NCT00914927|583879095|FG001|Overall Study|Withdrawal by Subject|1|||
161679379|NCT00914927|583879096|FG002|Overall Study|Withdrawal by Subject|0|||
161679380|NCT00914927|583879097|FG003|Overall Study|Withdrawal by Subject|1|||
161679381|NCT00914927|583879098|FG004|Overall Study|Withdrawal by Subject|0|||
161679382|NCT00914927|583879099|FG005|Overall Study|Withdrawal by Subject|0|||
161679383|NCT00914927|583879100|FG006|Overall Study|Withdrawal by Subject|0|||
161679384|NCT00914927|583879094|FG000|Overall Study|Lost to Follow-up|0|||
161679385|NCT00914927|583879095|FG001|Overall Study|Lost to Follow-up|0|||
161679386|NCT00914927|583879096|FG002|Overall Study|Lost to Follow-up|0|||
161679387|NCT00914927|583879097|FG003|Overall Study|Lost to Follow-up|1|||
161679388|NCT00914927|583879098|FG004|Overall Study|Lost to Follow-up|0|||
161679389|NCT00914927|583879099|FG005|Overall Study|Lost to Follow-up|0|||
161679390|NCT00914927|583879100|FG006|Overall Study|Lost to Follow-up|0|||
161679391|NCT00914927|583879094|FG000|Overall Study|Administrative/Other|2|||
161679392|NCT00914927|583879095|FG001|Overall Study|Administrative/Other|1|||
161679393|NCT00914927|583879096|FG002|Overall Study|Administrative/Other|0|||
161679394|NCT00914927|583879097|FG003|Overall Study|Administrative/Other|0|||
161679395|NCT00914927|583879098|FG004|Overall Study|Administrative/Other|1|||
161679396|NCT00914927|583879099|FG005|Overall Study|Administrative/Other|0|||
161679397|NCT00914927|583879100|FG006|Overall Study|Administrative/Other|0|||
161679398|NCT01490814|583879101|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
161679399|NCT01490814|583879102|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
161679400|NCT01490814|583879101|FG000|Overall Study|Physician Decision|1|||
161679401|NCT01490814|583879102|FG001|Overall Study|Physician Decision|0|||
161679402|NCT01490814|583879101|FG000|Overall Study|Withdrawal by Subject|0|||
161679403|NCT01490814|583879102|FG001|Overall Study|Withdrawal by Subject|5|||
161679404|NCT01537198|583879103|FG000|Overall Study|RSV infection|2|||
161679405|NCT01537198|583879103|FG000|Overall Study|Adverse Event|4|||
161679406|NCT01537198|583879103|FG000|Overall Study|No Further Visits to the Clinic|37|||
161679407|NCT01537198|583879103|FG000|Overall Study|Other|111|||
161679408|NCT00496730|583879105|FG000|Overall Study|Lost to Follow-up|4|||
161679409|NCT00496730|583879106|FG001|Overall Study|Lost to Follow-up|3|||
161679410|NCT00496730|583879105|FG000|Overall Study|Withdrawal by Subject|2|||
161679411|NCT00496730|583879106|FG001|Overall Study|Withdrawal by Subject|2|||
161679412|NCT03962738|583879113|FG000|Overall Study|Protocol Deviation|3|||
161541976|NCT02670538|583373614|FG002|Overall Study|Lost to Follow-up|7|||
161541977|NCT02670538|583373612|FG000|Overall Study|Adverse Event|5|||
161679413|NCT03962738|583879114|FG001|Overall Study|Protocol Deviation|0|||
161679414|NCT03962738|583879115|FG002|Overall Study|Protocol Deviation|1|||
161679415|NCT03962738|583879116|FG003|Overall Study|Protocol Deviation|1|||
161679416|NCT03962738|583879113|FG000|Overall Study|Withdrawal by Subject|4|||
161541978|NCT02670538|583373613|FG001|Overall Study|Adverse Event|5|||
161541979|NCT02670538|583373614|FG002|Overall Study|Adverse Event|11|||
161541980|NCT02670538|583373612|FG000|Overall Study|Lack of Efficacy|7|||
161679417|NCT03962738|583879114|FG001|Overall Study|Withdrawal by Subject|0|||
161679418|NCT03962738|583879115|FG002|Overall Study|Withdrawal by Subject|0|||
161679419|NCT03962738|583879116|FG003|Overall Study|Withdrawal by Subject|0|||
161679420|NCT03962738|583879113|FG000|Overall Study|Lost to Follow-up|0|||
161541981|NCT02670538|583373613|FG001|Overall Study|Lack of Efficacy|1|||
161679421|NCT03962738|583879114|FG001|Overall Study|Lost to Follow-up|0|||
161679422|NCT03962738|583879115|FG002|Overall Study|Lost to Follow-up|1|||
161679423|NCT03962738|583879116|FG003|Overall Study|Lost to Follow-up|0|||
161679424|NCT02170779|583879117|FG000|Overall Study|Withdrawal by Subject|1|||
161541982|NCT02670538|583373614|FG002|Overall Study|Lack of Efficacy|2|||
161541983|NCT02670538|583373612|FG000|Overall Study|Protocol Violation|3|||
161679425|NCT02170779|583879118|FG001|Overall Study|Withdrawal by Subject|0|||
161679426|NCT02170779|583879117|FG000|Overall Study|Lost to Follow-up|0|||
161679427|NCT02170779|583879118|FG001|Overall Study|Lost to Follow-up|1|||
161679428|NCT04556136|583879121|FG000|Overall Study|Lost to Follow-up|6|||
161679429|NCT04556136|583879122|FG001|Overall Study|Lost to Follow-up|6|||
161679430|NCT04556136|583879121|FG000|Overall Study|Physician Decision|2|||
161679431|NCT04556136|583879122|FG001|Overall Study|Physician Decision|1|||
161679432|NCT04556136|583879121|FG000|Overall Study|Withdrawal by Subject|2|||
161679433|NCT04556136|583879122|FG001|Overall Study|Withdrawal by Subject|1|||
161679434|NCT00935272|583879125|FG000|Overall Study|Lost to Follow-up|10|||
161679435|NCT00935272|583879126|FG001|Overall Study|Lost to Follow-up|3|||
161679436|NCT00935272|583879125|FG000|Overall Study|Withdrawal by Subject|8|||
161679437|NCT00935272|583879126|FG001|Overall Study|Withdrawal by Subject|2|||
161679438|NCT00935272|583879125|FG000|Overall Study|Physician Decision|1|||
161679439|NCT00935272|583879126|FG001|Overall Study|Physician Decision|0|||
161829565|NCT02808819|584415830|FG001|Overall Study|Death|0|||
161541984|NCT02670538|583373613|FG001|Overall Study|Protocol Violation|4|||
161541985|NCT02670538|583373614|FG002|Overall Study|Protocol Violation|1|||
161541986|NCT02670538|583373612|FG000|Overall Study|Noncompliance with Study Drug|1|||
161541987|NCT02670538|583373613|FG001|Overall Study|Noncompliance with Study Drug|3|||
161541988|NCT02670538|583373614|FG002|Overall Study|Noncompliance with Study Drug|2|||
161541989|NCT02670538|583373612|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161541990|NCT02670538|583373613|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161541991|NCT02670538|583373614|FG002|Overall Study|Other Miscellaneous Reasons|2|||
161541992|NCT02243202|583373615|FG000|Overall Study|Adverse Event|5|||
161541993|NCT02243202|583373616|FG001|Overall Study|Adverse Event|6|||
161541994|NCT02243202|583373617|FG002|Overall Study|Adverse Event|10|||
161541995|NCT02243202|583373618|FG003|Overall Study|Adverse Event|4|||
161541996|NCT02243202|583373615|FG000|Overall Study|Lost to Follow-up|9|||
161541997|NCT02243202|583373616|FG001|Overall Study|Lost to Follow-up|9|||
161541998|NCT02243202|583373617|FG002|Overall Study|Lost to Follow-up|14|||
161541999|NCT02243202|583373618|FG003|Overall Study|Lost to Follow-up|11|||
161542000|NCT02243202|583373615|FG000|Overall Study|Protocol Violation|3|||
161542001|NCT02243202|583373616|FG001|Overall Study|Protocol Violation|1|||
161542002|NCT02243202|583373617|FG002|Overall Study|Protocol Violation|2|||
161542003|NCT02243202|583373618|FG003|Overall Study|Protocol Violation|1|||
161542004|NCT02243202|583373615|FG000|Overall Study|Withdrawal by Subject|7|||
161542005|NCT02243202|583373616|FG001|Overall Study|Withdrawal by Subject|6|||
161542006|NCT02243202|583373617|FG002|Overall Study|Withdrawal by Subject|4|||
161542007|NCT02243202|583373618|FG003|Overall Study|Withdrawal by Subject|4|||
161542008|NCT02243202|583373615|FG000|Overall Study|Other|1|||
161542009|NCT02243202|583373616|FG001|Overall Study|Other|3|||
161542010|NCT02243202|583373617|FG002|Overall Study|Other|1|||
161542011|NCT02243202|583373618|FG003|Overall Study|Other|2|||
161542012|NCT02243202|583373615|FG000|Overall Study|Randomized but not received treatment|0|||
161542013|NCT02243202|583373616|FG001|Overall Study|Randomized but not received treatment|0|||
161542014|NCT02243202|583373617|FG002|Overall Study|Randomized but not received treatment|0|||
161542015|NCT02243202|583373618|FG003|Overall Study|Randomized but not received treatment|1|||
161542016|NCT02207725|583373622|FG000|Overall Study|Did Not Receive Treatment|0|||
161542017|NCT02207725|583373623|FG001|Overall Study|Did Not Receive Treatment|1|||
161542018|NCT02207725|583373624|FG002|Overall Study|Did Not Receive Treatment|1|||
161542019|NCT02207725|583373625|FG003|Overall Study|Did Not Receive Treatment|1|||
161542020|NCT02799472|583373628|FG000|Overall Study|Withdrawal by Subject|2|||
161542021|NCT02799472|583373629|FG001|Overall Study|Withdrawal by Subject|4|||
161542022|NCT02799472|583373628|FG000|Overall Study|Lack of Efficacy|2|||
161542023|NCT02799472|583373629|FG001|Overall Study|Lack of Efficacy|0|||
161542024|NCT02799472|583373628|FG000|Overall Study|Lost to Follow-up|0|||
161542025|NCT02799472|583373629|FG001|Overall Study|Lost to Follow-up|1|||
161542026|NCT02801669|583373630|FG000|Overall Study|Death|66|||
161542027|NCT02801669|583373631|FG001|Overall Study|Death|69|||
161542028|NCT02801669|583373630|FG000|Overall Study|Withdrawal by Subject|81|||
161542029|NCT02801669|583373631|FG001|Overall Study|Withdrawal by Subject|77|||
161542030|NCT02801669|583373630|FG000|Overall Study|Other|4|||
161542031|NCT02801669|583373631|FG001|Overall Study|Other|6|||
161542032|NCT04461795|583373632|FG000|Overall Study|Lost to Follow-up|2|||
161542033|NCT04461795|583373632|FG000|Overall Study|Withdrawal by Subject|2|||
161542034|NCT04461795|583373632|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
161679440|NCT00935272|583879125|FG000|Overall Study|Protocol Violation|0|||
161829566|NCT02808819|584415829|FG000|Overall Study|Adverse Event|3|||
161829567|NCT02808819|584415830|FG001|Overall Study|Adverse Event|4|||
161829568|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
161829569|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
161829570|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161829571|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161679441|NCT00935272|583879126|FG001|Overall Study|Protocol Violation|1|||
161679442|NCT03492554|583879127|FG000|Overall Study|Protocol Violation|0|||
161679443|NCT03492554|583879128|FG001|Overall Study|Protocol Violation|14|||
161679444|NCT01478360|583879129|FG000|Overall Study|Lost to Follow-up|1|||
161679445|NCT01478360|583879130|FG001|Overall Study|Lost to Follow-up|0|||
161679446|NCT01478360|583879129|FG000|Overall Study|Adverse Event|0|||
161679447|NCT01478360|583879130|FG001|Overall Study|Adverse Event|1|||
161679448|NCT01478360|583879129|FG000|Overall Study|Administrative problems|1|||
161679449|NCT01478360|583879130|FG001|Overall Study|Administrative problems|2|||
161679450|NCT04340557|583879134|FG000|Overall Study|Transferred to ICU and/or death|1|||
161679451|NCT04340557|583879135|FG001|Overall Study|Transferred to ICU and/or death|2|||
161679452|NCT01221727|583879136|FG000|Overall Study|Physician Decision|2|||
161679453|NCT01221727|583879137|FG001|Overall Study|Physician Decision|0|||
161679454|NCT01221727|583879136|FG000|Overall Study|Withdrawal by Subject|1|||
161679455|NCT01221727|583879137|FG001|Overall Study|Withdrawal by Subject|1|||
161679456|NCT02566577|583879138|FG000|Overall Study|Withdrawal by Subject|1|||
161679457|NCT02566577|583879139|FG001|Overall Study|Withdrawal by Subject|1|||
161679458|NCT02566577|583879138|FG000|Overall Study|Equipment failure|1|||
161679459|NCT02566577|583879139|FG001|Overall Study|Equipment failure|1|||
161679460|NCT02566577|583879138|FG000|Overall Study|Physical limitation|1|||
161679461|NCT02566577|583879139|FG001|Overall Study|Physical limitation|0|||
161679462|NCT00529451|583879140|FG000|Overall Study|Subject withdrew consent|16|||
161679463|NCT00529451|583879141|FG001|Overall Study|Subject withdrew consent|21|||
161679464|NCT00529451|583879142|FG002|Overall Study|Subject withdrew consent|13|||
161679465|NCT00529451|583879143|FG003|Overall Study|Subject withdrew consent|12|||
161679466|NCT00529451|583879140|FG000|Overall Study|Adverse Event|9|||
161679467|NCT00529451|583879141|FG001|Overall Study|Adverse Event|16|||
161679468|NCT00529451|583879142|FG002|Overall Study|Adverse Event|14|||
161679469|NCT00529451|583879143|FG003|Overall Study|Adverse Event|8|||
161679470|NCT00529451|583879140|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
161679471|NCT00529451|583879141|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
161679472|NCT00529451|583879142|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
161679473|NCT00529451|583879143|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
161679474|NCT00529451|583879140|FG000|Overall Study|Lost to Follow-up|4|||
161679475|NCT00529451|583879141|FG001|Overall Study|Lost to Follow-up|7|||
161679476|NCT00529451|583879142|FG002|Overall Study|Lost to Follow-up|4|||
161679477|NCT00529451|583879143|FG003|Overall Study|Lost to Follow-up|4|||
161679478|NCT00529451|583879140|FG000|Overall Study|Protocol deviation|1|||
161679479|NCT00529451|583879141|FG001|Overall Study|Protocol deviation|1|||
161679480|NCT00529451|583879142|FG002|Overall Study|Protocol deviation|4|||
161679481|NCT00529451|583879143|FG003|Overall Study|Protocol deviation|1|||
161679482|NCT00529451|583879140|FG000|Overall Study|Administrative problems|1|||
161679483|NCT00529451|583879141|FG001|Overall Study|Administrative problems|1|||
161679484|NCT00529451|583879142|FG002|Overall Study|Administrative problems|0|||
161679485|NCT00529451|583879143|FG003|Overall Study|Administrative problems|2|||
161679486|NCT01010633|583879144|FG000|Overall Study|Adverse Event|1|||
161679487|NCT01010633|583879145|FG001|Overall Study|Adverse Event|1|||
161679488|NCT01010633|583879144|FG000|Overall Study|Protocol Violation|1|||
161679489|NCT01010633|583879145|FG001|Overall Study|Protocol Violation|2|||
161679490|NCT01010633|583879144|FG000|Overall Study|Withdrawal by Subject|2|||
161679491|NCT01010633|583879145|FG001|Overall Study|Withdrawal by Subject|1|||
161679492|NCT01010633|583879144|FG000|Overall Study|Investigator decision|0|||
161679493|NCT01010633|583879145|FG001|Overall Study|Investigator decision|1|||
161679494|NCT02941926|583879146|FG000|Core Phase|Progressive disease|1109|||
161679495|NCT02941926|583879146|FG000|Core Phase|Adverse Event|504|||
161679496|NCT02941926|583879146|FG000|Core Phase|Subject/guardian decision|127|||
161542035|NCT00615264|583373634|FG000|Overall Study|Withdrawal by Subject|17|||
161542036|NCT00615264|583373635|FG001|Overall Study|Withdrawal by Subject|19|||
161542037|NCT00615264|583373634|FG000|Overall Study|Lost to Follow-up|6|||
161542038|NCT00615264|583373635|FG001|Overall Study|Lost to Follow-up|13|||
161679497|NCT02941926|583879146|FG000|Core Phase|Physician Decision|112|||
161679498|NCT02941926|583879146|FG000|Core Phase|Death|46|||
161679499|NCT02941926|583879146|FG000|Core Phase|Protocol deviation|34|||
161679500|NCT02941926|583879146|FG000|Core Phase|Lost to Follow-up|8|||
161679501|NCT02941926|583879146|FG000|Core Phase|Technical problems|5|||
161679502|NCT02941926|583879146|FG000|Extension Phase|Physician Decision|155|||
161679503|NCT02941926|583879146|FG000|Extension Phase|Progressive disease|115|||
161679504|NCT02941926|583879146|FG000|Extension Phase|Adverse Event|13|||
161679505|NCT02941926|583879146|FG000|Extension Phase|Subject/Guardian decision|12|||
161679506|NCT02941926|583879146|FG000|Extension Phase|Death|6|||
161679507|NCT00097773|583879147|FG000|Overall Study|Lost to Follow-up|2|||
161679508|NCT00097773|583879148|FG001|Overall Study|Lost to Follow-up|2|||
161679509|NCT00097773|583879149|FG002|Overall Study|Lost to Follow-up|0|||
161679510|NCT00097773|583879150|FG003|Overall Study|Lost to Follow-up|1|||
161679511|NCT00097773|583879147|FG000|Overall Study|Physician Decision|2|||
161679512|NCT00097773|583879148|FG001|Overall Study|Physician Decision|2|||
161679513|NCT00097773|583879149|FG002|Overall Study|Physician Decision|3|||
161542039|NCT00615264|583373634|FG000|Overall Study|Adverse Event|8|||
161542040|NCT00615264|583373635|FG001|Overall Study|Adverse Event|5|||
161542041|NCT00615264|583373634|FG000|Overall Study|Death|1|||
161542042|NCT00615264|583373635|FG001|Overall Study|Death|1|||
161542043|NCT00615264|583373634|FG000|Overall Study|Protocol Violation|11|||
161542044|NCT00615264|583373635|FG001|Overall Study|Protocol Violation|7|||
161542045|NCT00615264|583373634|FG000|Overall Study|Not defined|7|||
161542046|NCT00615264|583373635|FG001|Overall Study|Not defined|4|||
161542047|NCT00615264|583373634|FG000|Overall Study|Dermal Hypersensitivity|0|||
161542048|NCT00615264|583373635|FG001|Overall Study|Dermal Hypersensitivity|3|||
161542049|NCT00185640|583373636|FG000|Overall Study|Not Eligible|4|||
161542050|NCT00185640|583373636|FG000|Overall Study|Withdrawal by Subject|3|||
161542051|NCT00185640|583373636|FG000|Overall Study|Death|138|||
161542052|NCT00058422|583373637|FG000|Overall Study|Not treated|2|||
161542053|NCT00633932|583373638|FG000|Overall Study|Adverse Event|1|||
161542054|NCT00633932|583373639|FG001|Overall Study|Adverse Event|3|||
161542055|NCT00633932|583373640|FG002|Overall Study|Adverse Event|4|||
161542056|NCT00633932|583373638|FG000|Overall Study|Withdrawal by Subject|3|||
161542057|NCT00633932|583373639|FG001|Overall Study|Withdrawal by Subject|9|||
161542058|NCT00633932|583373640|FG002|Overall Study|Withdrawal by Subject|1|||
161542059|NCT00633932|583373638|FG000|Overall Study|Lost to Follow-up|1|||
161542060|NCT00633932|583373639|FG001|Overall Study|Lost to Follow-up|0|||
161542061|NCT00633932|583373640|FG002|Overall Study|Lost to Follow-up|2|||
161542062|NCT00633932|583373638|FG000|Overall Study|Protocol Violation|5|||
161542063|NCT00633932|583373639|FG001|Overall Study|Protocol Violation|2|||
161542064|NCT00633932|583373640|FG002|Overall Study|Protocol Violation|3|||
161542065|NCT00633932|583373638|FG000|Overall Study|Physician Decision|0|||
161542066|NCT00633932|583373639|FG001|Overall Study|Physician Decision|0|||
161542067|NCT00633932|583373640|FG002|Overall Study|Physician Decision|1|||
161542068|NCT00633932|583373638|FG000|Overall Study|Doctor's judgement|1|||
161542069|NCT00633932|583373639|FG001|Overall Study|Doctor's judgement|0|||
161542070|NCT00633932|583373640|FG002|Overall Study|Doctor's judgement|0|||
161542071|NCT00633932|583373638|FG000|Overall Study|Moved Away|1|||
161542072|NCT00633932|583373639|FG001|Overall Study|Moved Away|0|||
161542073|NCT00633932|583373640|FG002|Overall Study|Moved Away|0|||
161542074|NCT04836858|583373641|FG000|Overall Study|Adverse Event|0|||
161542075|NCT04836858|583373642|FG001|Overall Study|Adverse Event|0|||
161542076|NCT04836858|583373643|FG002|Overall Study|Adverse Event|0|||
161542077|NCT04836858|583373644|FG003|Overall Study|Adverse Event|1|||
161542078|NCT04836858|583373641|FG000|Overall Study|Lost to Follow-up|1|||
161542079|NCT04836858|583373642|FG001|Overall Study|Lost to Follow-up|0|||
161542080|NCT04836858|583373643|FG002|Overall Study|Lost to Follow-up|0|||
161542081|NCT04836858|583373644|FG003|Overall Study|Lost to Follow-up|0|||
161542082|NCT04836858|583373641|FG000|Overall Study|Subject/Guardian decision|3|||
161542083|NCT04836858|583373642|FG001|Overall Study|Subject/Guardian decision|0|||
161542084|NCT04836858|583373643|FG002|Overall Study|Subject/Guardian decision|0|||
161542085|NCT04836858|583373644|FG003|Overall Study|Subject/Guardian decision|1|||
161542086|NCT04836858|583373641|FG000|Overall Study|Randomized but not treated|4|||
161542087|NCT04836858|583373642|FG001|Overall Study|Randomized but not treated|0|||
161542088|NCT04836858|583373643|FG002|Overall Study|Randomized but not treated|0|||
161542089|NCT04836858|583373644|FG003|Overall Study|Randomized but not treated|0|||
161542090|NCT01982435|583373647|FG000|Overall Study|Adverse Event|1|||
161542091|NCT01982435|583373648|FG001|Overall Study|Adverse Event|0|||
161542092|NCT00708435|583373650|FG000|Overall Study|Death / Serious Adverse Event|10|||
161542093|NCT00708435|583373651|FG001|Overall Study|Death / Serious Adverse Event|5|||
161542094|NCT00708435|583373650|FG000|Overall Study|Lost to Follow-up|9|||
161542095|NCT00708435|583373651|FG001|Overall Study|Lost to Follow-up|4|||
161542096|NCT00708435|583373650|FG000|Overall Study|Withdrawal by Subject|3|||
161542097|NCT00708435|583373651|FG001|Overall Study|Withdrawal by Subject|7|||
161542098|NCT00708435|583373650|FG000|Overall Study|Adverse Event|1|||
161542099|NCT00708435|583373651|FG001|Overall Study|Adverse Event|0|||
161542100|NCT00708435|583373650|FG000|Overall Study|Protocol Violation|0|||
161542101|NCT00708435|583373651|FG001|Overall Study|Protocol Violation|1|||
161542102|NCT00708435|583373650|FG000|Overall Study|Intervention by primary care physician|1|||
161542103|NCT00708435|583373651|FG001|Overall Study|Intervention by primary care physician|0|||
161542104|NCT00708435|583373650|FG000|Overall Study|Refused hospitalization|1|||
161542105|NCT00708435|583373651|FG001|Overall Study|Refused hospitalization|0|||
161542106|NCT04766086|583373652|FG000|Overall Study|Lost to Follow-up|3|||
161542107|NCT04766086|583373653|FG001|Overall Study|Lost to Follow-up|5|||
161542108|NCT04766086|583373654|FG002|Overall Study|Lost to Follow-up|3|||
161542109|NCT04766086|583373652|FG000|Overall Study|Withdrawal by Subject|1|||
161542110|NCT04766086|583373653|FG001|Overall Study|Withdrawal by Subject|1|||
161829572|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161542111|NCT04766086|583373654|FG002|Overall Study|Withdrawal by Subject|2|||
161542112|NCT04766086|583373652|FG000|Overall Study|Other|0|||
161542113|NCT04766086|583373653|FG001|Overall Study|Other|0|||
161542114|NCT04766086|583373654|FG002|Overall Study|Other|1|||
161542115|NCT02635724|583373657|FG000|Overall Study|Withdrawal by Subject|0|||
161542116|NCT02635724|583373658|FG001|Overall Study|Withdrawal by Subject|1|||
161542117|NCT02635724|583373659|FG002|Overall Study|Withdrawal by Subject|0|||
161542118|NCT03579290|583373660|FG000|Overall Study|Lost to Follow-up|9|||
161542119|NCT00532155|583373661|FG000|Overall Study|Adverse Event|66|||
161542120|NCT00532155|583373662|FG001|Overall Study|Adverse Event|123|||
161542121|NCT00532155|583373661|FG000|Overall Study|Lack of Efficacy|332|||
161542122|NCT00532155|583373662|FG001|Overall Study|Lack of Efficacy|255|||
161542123|NCT00532155|583373661|FG000|Overall Study|Protocol Violation|1|||
161542124|NCT00532155|583373662|FG001|Overall Study|Protocol Violation|3|||
161542125|NCT00532155|583373661|FG000|Overall Study|Lost to Follow-up|2|||
161542126|NCT00532155|583373662|FG001|Overall Study|Lost to Follow-up|0|||
161542127|NCT00532155|583373661|FG000|Overall Study|Physician Decision|16|||
161542128|NCT00532155|583373662|FG001|Overall Study|Physician Decision|15|||
161542129|NCT00532155|583373661|FG000|Overall Study|Withdrawal by Subject|23|||
161542130|NCT00532155|583373662|FG001|Overall Study|Withdrawal by Subject|44|||
161542131|NCT00532155|583373661|FG000|Overall Study|Consent withdrawn|5|||
161542132|NCT00532155|583373662|FG001|Overall Study|Consent withdrawn|7|||
161542133|NCT00532155|583373661|FG000|Overall Study|Moved|1|||
161542134|NCT00532155|583373662|FG001|Overall Study|Moved|0|||
161542135|NCT00532155|583373661|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
161542136|NCT00532155|583373662|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
161542137|NCT00532155|583373661|FG000|Overall Study|Occurence of a second cancer|0|||
161542138|NCT00532155|583373662|FG001|Overall Study|Occurence of a second cancer|1|||
161542139|NCT00532155|583373661|FG000|Overall Study|Occurence of a secondary cancer|0|||
161542140|NCT00532155|583373662|FG001|Overall Study|Occurence of a secondary cancer|1|||
161542141|NCT00532155|583373661|FG000|Overall Study|Promotor ended study|1|||
161542142|NCT00532155|583373662|FG001|Overall Study|Promotor ended study|0|||
161542143|NCT00532155|583373661|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
161542144|NCT00532155|583373662|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
161542145|NCT00532155|583373661|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
161542146|NCT00532155|583373662|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
161542147|NCT00532155|583373661|FG000|Overall Study|Study stopped|1|||
161542148|NCT00532155|583373662|FG001|Overall Study|Study stopped|0|||
161542149|NCT00532155|583373661|FG000|Overall Study|Study terminated by sponsor|1|||
161542150|NCT00532155|583373662|FG001|Overall Study|Study terminated by sponsor|0|||
161542151|NCT00532155|583373661|FG000|Overall Study|Study termination stop further treatment|4|||
161542152|NCT00532155|583373662|FG001|Overall Study|Study termination stop further treatment|0|||
161542153|NCT00532155|583373661|FG000|Overall Study|Did not receive study medication|2|||
161542154|NCT00532155|583373662|FG001|Overall Study|Did not receive study medication|6|||
161542155|NCT03483038|583373663|FG000|Overall Study|Subjects still in follow-up|18|||
161542156|NCT00654901|583373664|FG000|Overall Study|Lost to Follow-up|1|||
161542157|NCT00654901|583373665|FG001|Overall Study|Lost to Follow-up|0|||
161542158|NCT00654901|583373666|FG002|Overall Study|Lost to Follow-up|1|||
161542159|NCT00654901|583373667|FG003|Overall Study|Lost to Follow-up|0|||
161542160|NCT00654901|583373664|FG000|Overall Study|Withdrawal by Subject|3|||
161542161|NCT00654901|583373665|FG001|Overall Study|Withdrawal by Subject|0|||
161542162|NCT00654901|583373666|FG002|Overall Study|Withdrawal by Subject|1|||
161542163|NCT00654901|583373667|FG003|Overall Study|Withdrawal by Subject|0|||
161542164|NCT04843930|583373669|FG000|Randomization|Withdrawal by Subject|6|||
161542165|NCT04843930|583373670|FG001|Randomization|Withdrawal by Subject|6|||
161542166|NCT04843930|583373671|FG002|Randomization|Withdrawal by Subject|0|||
161542167|NCT04843930|583373672|FG003|Randomization|Withdrawal by Subject|0|||
161542168|NCT04843930|583373669|FG000|Week 6 Assessment|Adverse Event|3|||
161542169|NCT04843930|583373670|FG001|Week 6 Assessment|Adverse Event|0|||
161542170|NCT04843930|583373671|FG002|Week 6 Assessment|Adverse Event|0|||
161542171|NCT04843930|583373672|FG003|Week 6 Assessment|Adverse Event|0|||
161542172|NCT04843930|583373669|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
161542173|NCT04843930|583373670|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
161542174|NCT04843930|583373671|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
161542175|NCT04843930|583373672|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
161542176|NCT04843930|583373669|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
161542177|NCT04843930|583373670|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
161542178|NCT04843930|583373671|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
161542179|NCT04843930|583373672|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
161542180|NCT02552238|583373673|FG000|Overall Study|Withdrawal by Subject|2|||
161542181|NCT02552238|583373673|FG000|Overall Study|Adverse Event|2|||
161542182|NCT01576718|583373674|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
161829573|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
161829574|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
161542183|NCT01576718|583373675|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161542184|NCT01576718|583373676|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161542185|NCT01576718|583373677|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161542186|NCT01576718|583373678|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161542187|NCT01576718|583373679|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161542188|NCT01576718|583373680|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
161542189|NCT01576718|583373674|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
161542190|NCT01576718|583373675|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161542191|NCT01576718|583373676|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161542192|NCT01576718|583373677|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161542193|NCT01576718|583373678|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161542194|NCT01576718|583373679|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161542195|NCT01576718|583373680|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
161542196|NCT01576718|583373674|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
161542197|NCT01576718|583373675|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161542198|NCT01576718|583373676|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161542199|NCT01576718|583373677|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161542200|NCT01576718|583373678|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161542201|NCT01576718|583373679|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161542202|NCT01576718|583373680|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
161542203|NCT01576718|583373674|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
161542204|NCT01576718|583373675|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161542205|NCT01576718|583373676|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161542206|NCT01576718|583373677|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161542207|NCT01576718|583373678|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161542208|NCT01576718|583373679|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161542209|NCT01576718|583373680|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
161542210|NCT01576718|583373674|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
161542211|NCT01576718|583373675|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161542212|NCT01576718|583373676|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161542213|NCT01576718|583373677|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161542214|NCT01576718|583373678|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161542215|NCT01576718|583373679|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161542216|NCT01576718|583373680|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161542217|NCT01576718|583373674|FG000|Treatment Period|Adverse Event|0|||
161542218|NCT01576718|583373675|FG001|Treatment Period|Adverse Event|1|||
161542219|NCT01576718|583373676|FG002|Treatment Period|Adverse Event|1|||
161542220|NCT01576718|583373677|FG003|Treatment Period|Adverse Event|1|||
161542221|NCT01576718|583373678|FG004|Treatment Period|Adverse Event|1|||
161542222|NCT01576718|583373679|FG005|Treatment Period|Adverse Event|1|||
161542223|NCT01576718|583373680|FG006|Treatment Period|Adverse Event|0|||
161542224|NCT01576718|583373674|FG000|Treatment Period|Withdrawal by Subject|0|||
161542225|NCT01576718|583373675|FG001|Treatment Period|Withdrawal by Subject|1|||
161542226|NCT01576718|583373676|FG002|Treatment Period|Withdrawal by Subject|1|||
161542227|NCT01576718|583373677|FG003|Treatment Period|Withdrawal by Subject|0|||
161542228|NCT01576718|583373678|FG004|Treatment Period|Withdrawal by Subject|2|||
161542229|NCT01576718|583373679|FG005|Treatment Period|Withdrawal by Subject|4|||
161542230|NCT01576718|583373680|FG006|Treatment Period|Withdrawal by Subject|2|||
161542231|NCT01576718|583373674|FG000|Treatment Period|Physician Decision|0|||
161542232|NCT01576718|583373675|FG001|Treatment Period|Physician Decision|1|||
161542233|NCT01576718|583373676|FG002|Treatment Period|Physician Decision|1|||
161542234|NCT01576718|583373677|FG003|Treatment Period|Physician Decision|1|||
161542235|NCT01576718|583373678|FG004|Treatment Period|Physician Decision|1|||
161593339|NCT04209465|583562702|FG009|Overall Study|Death|1|||
161593340|NCT04209465|583562703|FG010|Overall Study|Death|1|||
161593341|NCT04209465|583562704|FG011|Overall Study|Death|0|||
161593342|NCT04209465|583562705|FG012|Overall Study|Death|10|||
161593343|NCT04209465|583562693|FG000|Overall Study|Physician Decision|0|||
161829575|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161829576|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161829577|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161542236|NCT01576718|583373679|FG005|Treatment Period|Physician Decision|0|||
161542237|NCT01576718|583373680|FG006|Treatment Period|Physician Decision|0|||
161542238|NCT01576718|583373674|FG000|Treatment Period|Protocol Violation|0|||
161542239|NCT01576718|583373675|FG001|Treatment Period|Protocol Violation|5|||
161542240|NCT01576718|583373676|FG002|Treatment Period|Protocol Violation|4|||
161542241|NCT01576718|583373677|FG003|Treatment Period|Protocol Violation|10|||
161542242|NCT01576718|583373678|FG004|Treatment Period|Protocol Violation|6|||
161542243|NCT01576718|583373679|FG005|Treatment Period|Protocol Violation|8|||
161542244|NCT01576718|583373680|FG006|Treatment Period|Protocol Violation|12|||
161542245|NCT01576718|583373674|FG000|Treatment Period|Sponsor request|0|||
161542246|NCT01576718|583373675|FG001|Treatment Period|Sponsor request|1|||
161542247|NCT01576718|583373676|FG002|Treatment Period|Sponsor request|0|||
161542248|NCT01576718|583373677|FG003|Treatment Period|Sponsor request|0|||
161542249|NCT01576718|583373678|FG004|Treatment Period|Sponsor request|0|||
161542250|NCT01576718|583373679|FG005|Treatment Period|Sponsor request|1|||
161542251|NCT01576718|583373680|FG006|Treatment Period|Sponsor request|0|||
161542252|NCT01576718|583373674|FG000|Treatment Period|Met stopping criteria|0|||
161542253|NCT01576718|583373675|FG001|Treatment Period|Met stopping criteria|16|||
161542254|NCT01576718|583373676|FG002|Treatment Period|Met stopping criteria|13|||
161542255|NCT01576718|583373677|FG003|Treatment Period|Met stopping criteria|19|||
161542256|NCT01576718|583373678|FG004|Treatment Period|Met stopping criteria|16|||
161542257|NCT01576718|583373679|FG005|Treatment Period|Met stopping criteria|33|||
161542258|NCT01576718|583373680|FG006|Treatment Period|Met stopping criteria|15|||
161542259|NCT01576718|583373674|FG000|Treatment Period|Lost to Follow-up|0|||
161542260|NCT01576718|583373675|FG001|Treatment Period|Lost to Follow-up|0|||
161542261|NCT01576718|583373676|FG002|Treatment Period|Lost to Follow-up|0|||
161542262|NCT01576718|583373677|FG003|Treatment Period|Lost to Follow-up|0|||
161542263|NCT01576718|583373678|FG004|Treatment Period|Lost to Follow-up|1|||
161542264|NCT01576718|583373679|FG005|Treatment Period|Lost to Follow-up|0|||
161542265|NCT01576718|583373680|FG006|Treatment Period|Lost to Follow-up|0|||
161542266|NCT01576718|583373674|FG000|Treatment Period|Noncompliance to study medication|0|||
161542267|NCT01576718|583373675|FG001|Treatment Period|Noncompliance to study medication|0|||
161542268|NCT01576718|583373676|FG002|Treatment Period|Noncompliance to study medication|0|||
161542269|NCT01576718|583373677|FG003|Treatment Period|Noncompliance to study medication|0|||
161542270|NCT01576718|583373678|FG004|Treatment Period|Noncompliance to study medication|0|||
161542271|NCT01576718|583373679|FG005|Treatment Period|Noncompliance to study medication|1|||
161542272|NCT01576718|583373680|FG006|Treatment Period|Noncompliance to study medication|1|||
161542273|NCT04631705|583373681|FG000|Overall Study|Withdrawal by Subject|0|||
161542274|NCT04631705|583373682|FG001|Overall Study|Withdrawal by Subject|0|||
161542275|NCT04631705|583373683|FG002|Overall Study|Withdrawal by Subject|0|||
161542276|NCT04631705|583373684|FG003|Overall Study|Withdrawal by Subject|0|||
161542277|NCT04631705|583373685|FG004|Overall Study|Withdrawal by Subject|0|||
161542278|NCT04631705|583373686|FG005|Overall Study|Withdrawal by Subject|0|||
161542279|NCT04631705|583373687|FG006|Overall Study|Withdrawal by Subject|1|||
161542280|NCT04631705|583373688|FG007|Overall Study|Withdrawal by Subject|0|||
161542281|NCT04631705|583373689|FG008|Overall Study|Withdrawal by Subject|0|||
161542282|NCT02070484|583373695|FG000|Overall Study|Withdrawal by Subject|1|||
161542283|NCT02070484|583373696|FG001|Overall Study|Withdrawal by Subject|0|||
161542284|NCT01521884|583373697|FG000|Overall Study|Non Responders|10|||
161829578|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
161829579|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
161542285|NCT01521884|583373697|FG000|Overall Study|Adverse Event|5|||
161542286|NCT01521884|583373697|FG000|Overall Study|Pregnancy|1|||
161829580|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161829581|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161542287|NCT01521884|583373697|FG000|Overall Study|Withdrawal by Subject|1|||
161542288|NCT01521884|583373697|FG000|Overall Study|Physician Decision|2|||
161542289|NCT01521884|583373697|FG000|Overall Study|Protocol Violation|3|||
161829582|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161829583|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161829584|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161829585|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161829586|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161829587|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161829588|NCT03297294|584415831|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161829589|NCT03297294|584415832|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161829590|NCT03297294|584415833|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161829591|NCT03297294|584415834|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
161829592|NCT03297294|584415835|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161542290|NCT01521884|583373697|FG000|Overall Study|Participant non-eligible|1|||
161542291|NCT01521884|583373697|FG000|Overall Study|Lost to Follow-up|4|||
161542292|NCT02821819|583373698|FG000|Overall Study|Protocol Violation|1|||
161542293|NCT04241094|583373699|FG000|Overall Study|Dropped out of treatment|4|||
161542294|NCT04241094|583373699|FG000|Overall Study|Ineligible after clinical assessment|2|||
161542295|NCT04241094|583373699|FG000|Overall Study|Lost to Follow-up|2|||
161542296|NCT01669798|583373700|FG000|Overall Study|Physician Decision|5|||
161542297|NCT02332590|583373704|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
161542298|NCT02332590|583373705|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
161542299|NCT02332590|583373704|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
161542300|NCT02332590|583373705|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
161542301|NCT02332590|583373704|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
161542302|NCT02332590|583373705|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
161542303|NCT02332590|583373704|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
161542304|NCT02332590|583373705|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
161542305|NCT02332590|583373704|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
161542306|NCT02332590|583373705|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
161542307|NCT02332590|583373704|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
161542308|NCT02332590|583373705|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
161542309|NCT02332590|583373704|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
161542310|NCT02332590|583373705|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
161542311|NCT02332590|583373704|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
161542312|NCT02332590|583373705|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
161542313|NCT02332590|583373704|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
161542314|NCT02332590|583373705|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
161542315|NCT01806584|583373706|FG000|Overall Study|Adverse Event|2|||
161542316|NCT01806584|583373707|FG001|Overall Study|Adverse Event|1|||
161542317|NCT01806584|583373706|FG000|Overall Study|Death|1|||
161542318|NCT01806584|583373707|FG001|Overall Study|Death|0|||
161542319|NCT01806584|583373706|FG000|Overall Study|Lost to Follow-up|0|||
161542320|NCT01806584|583373707|FG001|Overall Study|Lost to Follow-up|2|||
161542321|NCT01806584|583373706|FG000|Overall Study|Study terminated by sponsor|9|||
161542322|NCT01806584|583373707|FG001|Overall Study|Study terminated by sponsor|14|||
161593344|NCT04209465|583562694|FG001|Overall Study|Physician Decision|1|||
161593345|NCT04209465|583562695|FG002|Overall Study|Physician Decision|0|||
161593346|NCT04209465|583562696|FG003|Overall Study|Physician Decision|0|||
161593347|NCT04209465|583562697|FG004|Overall Study|Physician Decision|0|||
161593348|NCT04209465|583562698|FG005|Overall Study|Physician Decision|0|||
161593349|NCT04209465|583562699|FG006|Overall Study|Physician Decision|0|||
161593350|NCT04209465|583562700|FG007|Overall Study|Physician Decision|0|||
161593351|NCT04209465|583562701|FG008|Overall Study|Physician Decision|0|||
161593352|NCT04209465|583562702|FG009|Overall Study|Physician Decision|0|||
161593353|NCT04209465|583562703|FG010|Overall Study|Physician Decision|0|||
161593354|NCT04209465|583562704|FG011|Overall Study|Physician Decision|0|||
161593355|NCT04209465|583562705|FG012|Overall Study|Physician Decision|0|||
161593356|NCT04209465|583562693|FG000|Overall Study|Progressive Disease|0|||
161593357|NCT04209465|583562694|FG001|Overall Study|Progressive Disease|0|||
161593358|NCT04209465|583562695|FG002|Overall Study|Progressive Disease|1|||
161593359|NCT04209465|583562696|FG003|Overall Study|Progressive Disease|2|||
161593360|NCT04209465|583562697|FG004|Overall Study|Progressive Disease|8|||
161593361|NCT04209465|583562698|FG005|Overall Study|Progressive Disease|5|||
161593362|NCT04209465|583562699|FG006|Overall Study|Progressive Disease|3|||
161593363|NCT04209465|583562700|FG007|Overall Study|Progressive Disease|4|||
161593364|NCT04209465|583562701|FG008|Overall Study|Progressive Disease|1|||
161593365|NCT04209465|583562702|FG009|Overall Study|Progressive Disease|3|||
161593366|NCT04209465|583562703|FG010|Overall Study|Progressive Disease|2|||
161593367|NCT04209465|583562704|FG011|Overall Study|Progressive Disease|1|||
161542323|NCT01806584|583373706|FG000|Overall Study|Withdrawal by Subject|1|||
161542324|NCT01806584|583373707|FG001|Overall Study|Withdrawal by Subject|1|||
161593368|NCT04209465|583562705|FG012|Overall Study|Progressive Disease|0|||
161542325|NCT01806584|583373706|FG000|Overall Study|Other unspecified|1|||
161542326|NCT01806584|583373707|FG001|Overall Study|Other unspecified|0|||
161593369|NCT04209465|583562693|FG000|Overall Study|Withdrawal by Subject|0|||
161593370|NCT04209465|583562694|FG001|Overall Study|Withdrawal by Subject|0|||
161593371|NCT04209465|583562695|FG002|Overall Study|Withdrawal by Subject|0|||
161593372|NCT04209465|583562696|FG003|Overall Study|Withdrawal by Subject|0|||
161593373|NCT04209465|583562697|FG004|Overall Study|Withdrawal by Subject|0|||
161542327|NCT02272725|583373710|FG000|Overall Study|equipment malfunction|2|||
161542328|NCT02272725|583373711|FG001|Overall Study|equipment malfunction|0|||
161542329|NCT02764775|583375798|FG000|Overall Study|Death|1|||
161542330|NCT02764775|583375798|FG000|Overall Study|Lost to Follow-up|2|||
161542331|NCT02764775|583375798|FG000|Overall Study|Withdrawal by Subject|3|||
161542332|NCT04022889|583375799|FG000|Stage 1: Period 1|Adverse Event|1|||
161542333|NCT04022889|583375800|FG001|Stage 1: Period 1|Adverse Event|0|||
161542334|NCT04022889|583375801|FG002|Stage 1: Period 1|Adverse Event|0|||
161542335|NCT04022889|583375799|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
161542336|NCT04022889|583375800|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
161542337|NCT04022889|583375801|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
161542338|NCT04022889|583375799|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
161542339|NCT04022889|583375800|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
161542340|NCT04022889|583375801|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
161542341|NCT04022889|583375799|FG000|Stage 2|Screen Failure|0|||
161542342|NCT04022889|583375800|FG001|Stage 2|Screen Failure|0|||
161542343|NCT04022889|583375801|FG002|Stage 2|Screen Failure|3|||
161542344|NCT04022889|583375799|FG000|Stage 2|Ineligible for apheresis donation|0|||
161542345|NCT04022889|583375800|FG001|Stage 2|Ineligible for apheresis donation|0|||
161542346|NCT04022889|583375801|FG002|Stage 2|Ineligible for apheresis donation|2|||
161542347|NCT04022889|583375799|FG000|Stage 2|Adverse Event|0|||
161542348|NCT04022889|583375800|FG001|Stage 2|Adverse Event|0|||
161542349|NCT04022889|583375801|FG002|Stage 2|Adverse Event|2|||
161542350|NCT04022889|583375799|FG000|Stage 2|Protocol Violation|0|||
161542351|NCT04022889|583375800|FG001|Stage 2|Protocol Violation|0|||
161542352|NCT04022889|583375801|FG002|Stage 2|Protocol Violation|1|||
161542353|NCT04022889|583375799|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
161542354|NCT04022889|583375800|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
161542355|NCT04022889|583375801|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
161542356|NCT03015116|583375802|FG000|Overall Study|Lost to Follow-up|3|||
161542357|NCT03015116|583375803|FG001|Overall Study|Lost to Follow-up|0|||
161542358|NCT03015116|583375804|FG002|Overall Study|Lost to Follow-up|2|||
161542359|NCT03015116|583375802|FG000|Overall Study|Withdrawal by Subject|3|||
161542360|NCT03015116|583375803|FG001|Overall Study|Withdrawal by Subject|1|||
161542361|NCT03015116|583375804|FG002|Overall Study|Withdrawal by Subject|0|||
161542362|NCT03015116|583375802|FG000|Overall Study|Subject has New Medical Status|1|||
161542363|NCT03015116|583375803|FG001|Overall Study|Subject has New Medical Status|0|||
161542364|NCT03015116|583375804|FG002|Overall Study|Subject has New Medical Status|0|||
161542365|NCT03015116|583375802|FG000|Overall Study|Physician Decision|0|||
161542366|NCT03015116|583375803|FG001|Overall Study|Physician Decision|1|||
161542367|NCT03015116|583375804|FG002|Overall Study|Physician Decision|0|||
161542368|NCT01862991|583375805|FG000|Overall Study|Lost to Follow-up|2|||
161542369|NCT01862991|583375806|FG001|Overall Study|Lost to Follow-up|1|||
161542370|NCT01862991|583375807|FG002|Overall Study|Lost to Follow-up|1|||
161542371|NCT01862991|583375805|FG000|Overall Study|Protocol Violation|1|||
161542372|NCT01862991|583375806|FG001|Overall Study|Protocol Violation|0|||
161542373|NCT01862991|583375807|FG002|Overall Study|Protocol Violation|0|||
161542374|NCT04858802|583375808|FG000|Overall Study|Lost to Follow-up|1|||
161542375|NCT04858802|583375809|FG001|Overall Study|Lost to Follow-up|1|||
161542376|NCT04858802|583375808|FG000|Overall Study|Withdrawal by Subject|1|||
161542377|NCT04858802|583375809|FG001|Overall Study|Withdrawal by Subject|1|||
161542378|NCT00857805|583375810|FG000|Overall Study|Withdrawal by Subject|1|||
161542379|NCT00857805|583375811|FG001|Overall Study|Withdrawal by Subject|1|||
161542380|NCT01289041|583375812|FG000|Overall Study|Adverse Event|24|||
161542381|NCT01289041|583375812|FG000|Overall Study|Physician Decision|1|||
161542382|NCT01289041|583375812|FG000|Overall Study|Progressive Disease|41|||
161542383|NCT01289041|583375812|FG000|Overall Study|Withdrawal by Subject|3|||
161542384|NCT01289041|583375812|FG000|Overall Study|Death|1|||
161542385|NCT02714868|583375817|FG000|Overall Study|Withdrawal by Subject|3|||
161542386|NCT02714868|583375818|FG001|Overall Study|Withdrawal by Subject|0|||
161542387|NCT02714868|583375817|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
161542388|NCT02714868|583375818|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
161542389|NCT02714868|583375817|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
161542390|NCT02714868|583375818|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
161542391|NCT05056870|583375823|FG000|Period 1|Site COVID-19 Related|3|||
161593374|NCT04209465|583562698|FG005|Overall Study|Withdrawal by Subject|1|||
161593375|NCT04209465|583562699|FG006|Overall Study|Withdrawal by Subject|2|||
161593376|NCT04209465|583562700|FG007|Overall Study|Withdrawal by Subject|0|||
161593377|NCT04209465|583562701|FG008|Overall Study|Withdrawal by Subject|1|||
161542392|NCT05056870|583375824|FG001|Period 1|Site COVID-19 Related|3|||
161542393|NCT05056870|583375823|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
161542394|NCT05056870|583375824|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
161542395|NCT05056870|583375823|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
161542396|NCT05056870|583375824|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161542397|NCT05056870|583375823|FG000|Period 2|COVID-19 Related|1|||
161542398|NCT05056870|583375824|FG001|Period 2|COVID-19 Related|0|||
161542399|NCT05056870|583375823|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
161542400|NCT05056870|583375824|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
161542401|NCT05044325|583375827|FG000|Part A:Treatment Period 1|Adverse Event|0|||
161542402|NCT05044325|583375828|FG001|Part A:Treatment Period 1|Adverse Event|0|||
161542403|NCT05044325|583375829|FG002|Part A:Treatment Period 1|Adverse Event|0|||
161542404|NCT05044325|583375830|FG003|Part A:Treatment Period 1|Adverse Event|0|||
161542405|NCT05044325|583375831|FG004|Part A:Treatment Period 1|Adverse Event|0|||
161542406|NCT05044325|583375832|FG005|Part A:Treatment Period 1|Adverse Event|1|||
161542407|NCT05044325|583375833|FG006|Part A:Treatment Period 1|Adverse Event|0|||
161542408|NCT05044325|583375834|FG007|Part A:Treatment Period 1|Adverse Event|1|||
161542409|NCT05044325|583375835|FG008|Part A:Treatment Period 1|Adverse Event|0|||
161542410|NCT05044325|583375836|FG009|Part A:Treatment Period 1|Adverse Event|0|||
161542411|NCT05044325|583375827|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161542412|NCT05044325|583375828|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161542413|NCT05044325|583375829|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161542414|NCT05044325|583375830|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
161542415|NCT05044325|583375831|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
161542416|NCT05044325|583375832|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
161542417|NCT05044325|583375833|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161542418|NCT05044325|583375834|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161542419|NCT05044325|583375835|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161542420|NCT05044325|583375836|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
161593378|NCT04209465|583562702|FG009|Overall Study|Withdrawal by Subject|0|||
161593379|NCT04209465|583562703|FG010|Overall Study|Withdrawal by Subject|0|||
161593380|NCT04209465|583562704|FG011|Overall Study|Withdrawal by Subject|2|||
161593381|NCT04209465|583562705|FG012|Overall Study|Withdrawal by Subject|2|||
161593382|NCT04209465|583562693|FG000|Overall Study|Lost to Follow-up|0|||
161593383|NCT04209465|583562694|FG001|Overall Study|Lost to Follow-up|0|||
161593384|NCT04209465|583562695|FG002|Overall Study|Lost to Follow-up|0|||
161593385|NCT04209465|583562696|FG003|Overall Study|Lost to Follow-up|0|||
161593386|NCT04209465|583562697|FG004|Overall Study|Lost to Follow-up|0|||
161593387|NCT04209465|583562698|FG005|Overall Study|Lost to Follow-up|1|||
161593388|NCT04209465|583562699|FG006|Overall Study|Lost to Follow-up|0|||
161593389|NCT04209465|583562700|FG007|Overall Study|Lost to Follow-up|0|||
161593390|NCT04209465|583562701|FG008|Overall Study|Lost to Follow-up|1|||
161593391|NCT04209465|583562702|FG009|Overall Study|Lost to Follow-up|0|||
161593392|NCT04209465|583562703|FG010|Overall Study|Lost to Follow-up|0|||
161593393|NCT04209465|583562704|FG011|Overall Study|Lost to Follow-up|1|||
161593394|NCT04209465|583562705|FG012|Overall Study|Lost to Follow-up|0|||
161593395|NCT04209465|583562693|FG000|Overall Study|Started new therapy|0|||
161593396|NCT04209465|583562694|FG001|Overall Study|Started new therapy|0|||
161593397|NCT04209465|583562695|FG002|Overall Study|Started new therapy|0|||
161593398|NCT04209465|583562696|FG003|Overall Study|Started new therapy|0|||
161593399|NCT04209465|583562697|FG004|Overall Study|Started new therapy|0|||
161593400|NCT04209465|583562698|FG005|Overall Study|Started new therapy|1|||
161593401|NCT04209465|583562699|FG006|Overall Study|Started new therapy|0|||
161593402|NCT04209465|583562700|FG007|Overall Study|Started new therapy|0|||
161593403|NCT04209465|583562701|FG008|Overall Study|Started new therapy|0|||
161593404|NCT04209465|583562702|FG009|Overall Study|Started new therapy|0|||
161593405|NCT04209465|583562703|FG010|Overall Study|Started new therapy|0|||
161593406|NCT04209465|583562704|FG011|Overall Study|Started new therapy|0|||
161593407|NCT04209465|583562705|FG012|Overall Study|Started new therapy|0|||
161593408|NCT04209465|583562693|FG000|Overall Study|Study terminated early by sponsor|0|||
161593409|NCT04209465|583562694|FG001|Overall Study|Study terminated early by sponsor|0|||
161593410|NCT04209465|583562695|FG002|Overall Study|Study terminated early by sponsor|0|||
161593411|NCT04209465|583562696|FG003|Overall Study|Study terminated early by sponsor|0|||
161593412|NCT04209465|583562697|FG004|Overall Study|Study terminated early by sponsor|0|||
161593413|NCT04209465|583562698|FG005|Overall Study|Study terminated early by sponsor|0|||
161593414|NCT04209465|583562699|FG006|Overall Study|Study terminated early by sponsor|3|||
161593415|NCT04209465|583562700|FG007|Overall Study|Study terminated early by sponsor|0|||
161593416|NCT04209465|583562701|FG008|Overall Study|Study terminated early by sponsor|0|||
161593417|NCT04209465|583562702|FG009|Overall Study|Study terminated early by sponsor|0|||
161593418|NCT04209465|583562703|FG010|Overall Study|Study terminated early by sponsor|0|||
161593419|NCT04209465|583562704|FG011|Overall Study|Study terminated early by sponsor|0|||
161593420|NCT04209465|583562705|FG012|Overall Study|Study terminated early by sponsor|3|||
161593421|NCT04209465|583562693|FG000|Overall Study|Other|0|||
161593422|NCT04209465|583562694|FG001|Overall Study|Other|0|||
161593423|NCT04209465|583562695|FG002|Overall Study|Other|0|||
161593424|NCT04209465|583562696|FG003|Overall Study|Other|0|||
161593425|NCT04209465|583562697|FG004|Overall Study|Other|0|||
161542421|NCT05044325|583375827|FG000|Part A:Treatment Period 1|Physician Decision|0|||
161542422|NCT05044325|583375828|FG001|Part A:Treatment Period 1|Physician Decision|0|||
161593426|NCT04209465|583562698|FG005|Overall Study|Other|0|||
161679514|NCT00097773|583879150|FG003|Overall Study|Physician Decision|1|||
161679515|NCT00097773|583879147|FG000|Overall Study|Withdrawal by Subject|3|||
161679516|NCT00097773|583879148|FG001|Overall Study|Withdrawal by Subject|3|||
161679517|NCT00097773|583879149|FG002|Overall Study|Withdrawal by Subject|3|||
161679518|NCT00097773|583879150|FG003|Overall Study|Withdrawal by Subject|1|||
161679519|NCT00097773|583879147|FG000|Overall Study|Adverse Event|0|||
161679520|NCT00097773|583879148|FG001|Overall Study|Adverse Event|1|||
161679521|NCT00097773|583879149|FG002|Overall Study|Adverse Event|0|||
161679522|NCT00097773|583879150|FG003|Overall Study|Adverse Event|0|||
161679523|NCT00097773|583879147|FG000|Overall Study|Other|1|||
161679524|NCT00097773|583879148|FG001|Overall Study|Other|0|||
161679525|NCT00097773|583879149|FG002|Overall Study|Other|2|||
161679526|NCT00097773|583879150|FG003|Overall Study|Other|0|||
161679527|NCT01494350|583879151|FG000|Overall Study|Worsening of lesion|1|||
161679528|NCT00474708|583879152|FG000|Overall Study|Lack of Efficacy|11|||
161679529|NCT00474708|583879153|FG001|Overall Study|Lack of Efficacy|5|||
161679530|NCT00474708|583879152|FG000|Overall Study|Suicide ideation/behavior|0|||
161679531|NCT00474708|583879153|FG001|Overall Study|Suicide ideation/behavior|1|||
161679532|NCT00474708|583879152|FG000|Overall Study|Withdrawal by Subject|7|||
161679533|NCT00474708|583879153|FG001|Overall Study|Withdrawal by Subject|0|||
161679534|NCT00474708|583879152|FG000|Overall Study|Lack of compliance|12|||
161679535|NCT00474708|583879153|FG001|Overall Study|Lack of compliance|4|||
161679536|NCT00474708|583879152|FG000|Overall Study|Lost to Follow-up|18|||
161679537|NCT00474708|583879153|FG001|Overall Study|Lost to Follow-up|9|||
161679538|NCT00474708|583879152|FG000|Overall Study|Physician Decision|9|||
161679539|NCT00474708|583879153|FG001|Overall Study|Physician Decision|6|||
161679540|NCT03700320|583879154|FG000|Overall Study|Adverse Event|5|||
161679541|NCT03700320|583879155|FG001|Overall Study|Adverse Event|31|||
161679542|NCT03700320|583879154|FG000|Overall Study|Lack of Efficacy|2|||
161679543|NCT03700320|583879155|FG001|Overall Study|Lack of Efficacy|5|||
161679544|NCT03700320|583879154|FG000|Overall Study|Withdrawal by Subject|29|||
161679545|NCT03700320|583879155|FG001|Overall Study|Withdrawal by Subject|75|||
161679546|NCT03700320|583879154|FG000|Overall Study|Lost to Follow-up|16|||
161679547|NCT03700320|583879155|FG001|Overall Study|Lost to Follow-up|23|||
161679548|NCT03700320|583879154|FG000|Overall Study|Pregnancy|2|||
161679549|NCT03700320|583879155|FG001|Overall Study|Pregnancy|4|||
161679550|NCT03700320|583879154|FG000|Overall Study|Protocol Deviation|7|||
161679551|NCT03700320|583879155|FG001|Overall Study|Protocol Deviation|31|||
161679552|NCT03700320|583879154|FG000|Overall Study|Non-compliance with Study Drug|1|||
161679553|NCT03700320|583879155|FG001|Overall Study|Non-compliance with Study Drug|3|||
161679554|NCT03700320|583879154|FG000|Overall Study|Reason not Specified|0|||
161679555|NCT03700320|583879155|FG001|Overall Study|Reason not Specified|1|||
161542423|NCT05044325|583375829|FG002|Part A:Treatment Period 1|Physician Decision|0|||
161542424|NCT05044325|583375830|FG003|Part A:Treatment Period 1|Physician Decision|0|||
161542425|NCT05044325|583375831|FG004|Part A:Treatment Period 1|Physician Decision|0|||
161542426|NCT05044325|583375832|FG005|Part A:Treatment Period 1|Physician Decision|0|||
161542427|NCT05044325|583375833|FG006|Part A:Treatment Period 1|Physician Decision|1|||
161542428|NCT05044325|583375834|FG007|Part A:Treatment Period 1|Physician Decision|0|||
161542429|NCT05044325|583375835|FG008|Part A:Treatment Period 1|Physician Decision|0|||
161542430|NCT05044325|583375836|FG009|Part A:Treatment Period 1|Physician Decision|0|||
161542431|NCT05044325|583375827|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542432|NCT05044325|583375828|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542433|NCT05044325|583375829|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
161542434|NCT05044325|583375830|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542435|NCT05044325|583375831|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542436|NCT05044325|583375832|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542437|NCT05044325|583375833|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161679556|NCT04305275|583879156|FG000|Overall Study|Adverse Event|4|||
161679557|NCT04305275|583879157|FG001|Overall Study|Adverse Event|0|||
161679558|NCT04305275|583879156|FG000|Overall Study|Lost to Follow-up|1|||
161679559|NCT04305275|583879157|FG001|Overall Study|Lost to Follow-up|1|||
161679560|NCT04305275|583879156|FG000|Overall Study|Withdrawal by Participant|8|||
161679561|NCT04305275|583879157|FG001|Overall Study|Withdrawal by Participant|1|||
161679562|NCT03061175|583879160|FG000|Baseline|Participant was deemed ineligible|1|||
161679563|NCT03061175|583879161|FG001|Baseline|Participant was deemed ineligible|0|||
161679564|NCT03061175|583879160|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
161679565|NCT03061175|583879161|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
161679566|NCT03061175|583879160|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
161829593|NCT02692482|584415836|FG000|Overall Study|Death|2|||
161829594|NCT02692482|584415837|FG001|Overall Study|Death|2|||
161829595|NCT02692482|584415836|FG000|Overall Study|Withdrawal by Subject|1|||
161829596|NCT02692482|584415837|FG001|Overall Study|Withdrawal by Subject|2|||
161829597|NCT00127166|584415840|FG000|Period I|Protocol Violation|0|||
161829598|NCT00127166|584415841|FG001|Period I|Protocol Violation|2|||
161829599|NCT00127166|584415840|FG000|Period I|Withdrawal by Subject|2|||
161829600|NCT00127166|584415841|FG001|Period I|Withdrawal by Subject|0|||
161542438|NCT05044325|583375834|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542439|NCT05044325|583375835|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542440|NCT05044325|583375836|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161542441|NCT05044325|583375827|FG000|Part A:Treatment Period 2|Adverse Event|0|||
161542442|NCT05044325|583375828|FG001|Part A:Treatment Period 2|Adverse Event|1|||
161542443|NCT05044325|583375829|FG002|Part A:Treatment Period 2|Adverse Event|0|||
161542444|NCT05044325|583375830|FG003|Part A:Treatment Period 2|Adverse Event|0|||
161542445|NCT05044325|583375831|FG004|Part A:Treatment Period 2|Adverse Event|1|||
161542446|NCT05044325|583375832|FG005|Part A:Treatment Period 2|Adverse Event|1|||
161542447|NCT05044325|583375833|FG006|Part A:Treatment Period 2|Adverse Event|0|||
161542448|NCT05044325|583375834|FG007|Part A:Treatment Period 2|Adverse Event|0|||
161542449|NCT05044325|583375835|FG008|Part A:Treatment Period 2|Adverse Event|0|||
161542450|NCT05044325|583375836|FG009|Part A:Treatment Period 2|Adverse Event|0|||
161542451|NCT05044325|583375827|FG000|Part A:Treatment Period 2|Physician Decision|0|||
161542452|NCT05044325|583375828|FG001|Part A:Treatment Period 2|Physician Decision|0|||
161542453|NCT05044325|583375829|FG002|Part A:Treatment Period 2|Physician Decision|0|||
161542454|NCT05044325|583375830|FG003|Part A:Treatment Period 2|Physician Decision|0|||
161542455|NCT05044325|583375831|FG004|Part A:Treatment Period 2|Physician Decision|0|||
161542456|NCT05044325|583375832|FG005|Part A:Treatment Period 2|Physician Decision|1|||
161542457|NCT05044325|583375833|FG006|Part A:Treatment Period 2|Physician Decision|0|||
161542458|NCT05044325|583375834|FG007|Part A:Treatment Period 2|Physician Decision|0|||
161542459|NCT05044325|583375835|FG008|Part A:Treatment Period 2|Physician Decision|0|||
161542460|NCT05044325|583375836|FG009|Part A:Treatment Period 2|Physician Decision|0|||
161542461|NCT05044325|583375827|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542462|NCT05044325|583375828|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542463|NCT05044325|583375829|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542464|NCT05044325|583375830|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
161542465|NCT05044325|583375831|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
161593427|NCT04209465|583562699|FG006|Overall Study|Other|0|||
161593428|NCT04209465|583562700|FG007|Overall Study|Other|0|||
161593429|NCT04209465|583562701|FG008|Overall Study|Other|1|||
161593430|NCT04209465|583562702|FG009|Overall Study|Other|0|||
161593431|NCT04209465|583562703|FG010|Overall Study|Other|0|||
161593432|NCT04209465|583562704|FG011|Overall Study|Other|0|||
161593433|NCT04209465|583562705|FG012|Overall Study|Other|0|||
161593434|NCT03097549|583562706|FG000|Overall Study|Withdrawal by Subject|1|||
161593435|NCT03097549|583562707|FG001|Overall Study|Withdrawal by Subject|0|||
161593436|NCT03097549|583562706|FG000|Overall Study|Lost to Follow-up|1|||
161593437|NCT03097549|583562707|FG001|Overall Study|Lost to Follow-up|0|||
161593438|NCT05783102|583562708|FG000|Overall Study|Lost to Follow-up|1|||
161593439|NCT05783102|583562708|FG000|Overall Study|Withdrawal by Subject|2|||
161593440|NCT05647304|583562709|FG000|Overall Study|Withdrawal by Subject|1|||
161593441|NCT05647304|583562710|FG001|Overall Study|Withdrawal by Subject|0|||
161593442|NCT04282148|583562713|FG000|Overall Study|Death|7|||
161593443|NCT04282148|583562713|FG000|Overall Study|Withdrawal by Subject|1|||
161593444|NCT04282148|583562713|FG000|Overall Study|Physician Decision|1|||
161593445|NCT02146378|583562714|FG000|Overall Study|No information of administration|2|||
161593446|NCT06215521|583562715|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
161593447|NCT06215521|583562716|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
161593448|NCT06215521|583562717|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
161593449|NCT06215521|583562718|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
161593450|NCT06215521|583562719|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
161593451|NCT06215521|583562720|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
161593452|NCT04096040|583562721|FG000|Overall Study|Protocol Violation|12|||
161593453|NCT04096040|583562721|FG000|Overall Study|Non-compliant site|4|||
161593454|NCT04973254|583562722|FG000|Overall Study|Not adherent|0|||
161542466|NCT05044325|583375832|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161593455|NCT04973254|583562723|FG001|Overall Study|Not adherent|1|||
161593456|NCT04973254|583562724|FG002|Overall Study|Not adherent|0|||
161593457|NCT04044768|583562725|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
161593458|NCT04044768|583562726|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
161593459|NCT05089019|583562727|FG000|Period 1|Withdrawal by Subject|0|||
161593460|NCT05089019|583562728|FG001|Period 1|Withdrawal by Subject|1|||
161593461|NCT05089019|583562727|FG000|Washout Period|Adverse Event|3|||
161593462|NCT05089019|583562728|FG001|Washout Period|Adverse Event|4|||
161593463|NCT05089019|583562727|FG000|Washout Period|Lost to Follow-up|1|||
161593464|NCT05089019|583562728|FG001|Washout Period|Lost to Follow-up|0|||
161593465|NCT05089019|583562727|FG000|Washout Period|Physician Decision|2|||
161593466|NCT05089019|583562728|FG001|Washout Period|Physician Decision|0|||
161593467|NCT05089019|583562727|FG000|Washout Period|Withdrawal by Subject|6|||
161542467|NCT05044325|583375833|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542468|NCT05044325|583375834|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542469|NCT05044325|583375835|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542470|NCT05044325|583375836|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
161542471|NCT01373931|583375839|FG000|Lead-in Period|Adverse Event|2|||
161542472|NCT01373931|583375840|FG001|Lead-in Period|Adverse Event|0|||
161542473|NCT01373931|583375839|FG000|Period 1|Adverse Event|2|||
161542474|NCT01373931|583375840|FG001|Period 1|Adverse Event|0|||
161542475|NCT01373931|583375839|FG000|Period 1|Withdrawal by Subject|0|||
161542476|NCT01373931|583375840|FG001|Period 1|Withdrawal by Subject|2|||
161542477|NCT00674323|583375841|FG000|Overall Study|Adverse Event|0|||
161542478|NCT00674323|583375842|FG001|Overall Study|Adverse Event|1|||
161542479|NCT00674323|583375843|FG002|Overall Study|Adverse Event|0|||
161542480|NCT00674323|583375841|FG000|Overall Study|Protocol Violation|1|||
161542481|NCT00674323|583375842|FG001|Overall Study|Protocol Violation|0|||
161542482|NCT00674323|583375843|FG002|Overall Study|Protocol Violation|0|||
161542483|NCT00742079|583375844|FG000|Overall Study|Lost to Follow-up|0|||
161542484|NCT00742079|583375845|FG001|Overall Study|Lost to Follow-up|1|||
161542485|NCT02013388|583375851|FG000|Overall Study|work emergency|1|||
161542486|NCT02013388|583375852|FG001|Overall Study|work emergency|0|||
161542487|NCT02013388|583375853|FG002|Overall Study|work emergency|0|||
161542488|NCT02013388|583375854|FG003|Overall Study|work emergency|0|||
161542489|NCT02013388|583375855|FG004|Overall Study|work emergency|1|||
161542490|NCT02013388|583375856|FG005|Overall Study|work emergency|0|||
161542491|NCT02013388|583375857|FG006|Overall Study|work emergency|0|||
161542492|NCT02013388|583375858|FG007|Overall Study|work emergency|0|||
161542493|NCT01114204|583375862|FG000|Overall Study|Adverse Event|3|||
161542494|NCT01114204|583375863|FG001|Overall Study|Adverse Event|2|||
161542495|NCT01114204|583375862|FG000|Overall Study|Lost to Follow-up|1|||
161542496|NCT01114204|583375863|FG001|Overall Study|Lost to Follow-up|0|||
161542497|NCT01114204|583375862|FG000|Overall Study|Withdrawal by Subject|10|||
161593468|NCT05089019|583562728|FG001|Washout Period|Withdrawal by Subject|3|||
161593469|NCT05089019|583562727|FG000|Period 2|Adverse Event|4|||
161593470|NCT05089019|583562728|FG001|Period 2|Adverse Event|2|||
161593471|NCT05089019|583562727|FG000|Period 2|Lost to Follow-up|1|||
161593472|NCT05089019|583562728|FG001|Period 2|Lost to Follow-up|0|||
161593473|NCT05089019|583562727|FG000|Period 2|Withdrawal by Subject|0|||
161593474|NCT05089019|583562728|FG001|Period 2|Withdrawal by Subject|1|||
161593475|NCT05170009|583562729|FG000|Overall Study|Physician Decision|0|||
161593476|NCT05170009|583562730|FG001|Overall Study|Physician Decision|1|||
161593477|NCT04925986|583562731|FG000|Overall Study|Death|0|||
161593478|NCT04925986|583562732|FG001|Overall Study|Death|0|||
161593479|NCT04925986|583562733|FG002|Overall Study|Death|2|||
161593480|NCT04925986|583562734|FG003|Overall Study|Death|0|||
161593481|NCT04925986|583562731|FG000|Overall Study|Lack of Efficacy|1|||
161593482|NCT04925986|583562732|FG001|Overall Study|Lack of Efficacy|2|||
161593483|NCT04925986|583562733|FG002|Overall Study|Lack of Efficacy|0|||
161593484|NCT04925986|583562734|FG003|Overall Study|Lack of Efficacy|1|||
161593485|NCT04925986|583562731|FG000|Overall Study|Withdrawal by Subject|0|||
161593486|NCT04925986|583562732|FG001|Overall Study|Withdrawal by Subject|0|||
161593487|NCT04925986|583562733|FG002|Overall Study|Withdrawal by Subject|1|||
161593488|NCT04925986|583562734|FG003|Overall Study|Withdrawal by Subject|2|||
161593489|NCT03858634|583562735|FG000|Overall Study|Withdrawal by Subject|1|||
161593490|NCT03858634|583562736|FG001|Overall Study|Withdrawal by Subject|0|||
161593491|NCT03858634|583562735|FG000|Overall Study|Adverse Event|1|||
161593492|NCT03858634|583562736|FG001|Overall Study|Adverse Event|0|||
161593493|NCT03858634|583562735|FG000|Overall Study|Lost to Follow-up|0|||
161593494|NCT03858634|583562736|FG001|Overall Study|Lost to Follow-up|1|||
161593495|NCT03858634|583562735|FG000|Overall Study|Other, Not Specified|1|||
161593496|NCT03858634|583562736|FG001|Overall Study|Other, Not Specified|1|||
161593497|NCT03808818|583562737|FG000|Overall Study|Death|6|||
161593498|NCT03808818|583562738|FG001|Overall Study|Death|6|||
161593499|NCT03808818|583562737|FG000|Overall Study|Withdrawal by Subject|7|||
161593500|NCT03808818|583562738|FG001|Overall Study|Withdrawal by Subject|18|||
161593501|NCT03808818|583562737|FG000|Overall Study|Lost to Follow-up|31|||
161593502|NCT03808818|583562738|FG001|Overall Study|Lost to Follow-up|33|||
161593503|NCT06181760|583562739|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
161593504|NCT06181760|583562740|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
161542498|NCT01114204|583375863|FG001|Overall Study|Withdrawal by Subject|6|||
161593505|NCT06181760|583562741|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
161593506|NCT06181760|583562742|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
161593507|NCT05415722|583562744|FG000|Overall Study|Lost to Follow-up|0|||
161593508|NCT05415722|583562745|FG001|Overall Study|Lost to Follow-up|2|||
161593509|NCT05415722|583562746|FG002|Overall Study|Lost to Follow-up|0|||
161593510|NCT05415722|583562747|FG003|Overall Study|Lost to Follow-up|1|||
161593511|NCT05415722|583562748|FG004|Overall Study|Lost to Follow-up|0|||
161593512|NCT05415722|583562749|FG005|Overall Study|Lost to Follow-up|0|||
161542499|NCT01114204|583375862|FG000|Overall Study|Death|1|||
161542500|NCT01114204|583375863|FG001|Overall Study|Death|0|||
161593513|NCT05415722|583562750|FG006|Overall Study|Lost to Follow-up|1|||
161542501|NCT01114204|583375862|FG000|Overall Study|Other-Personal reasons|2|||
161829601|NCT00127166|584415840|FG000|Period I|Patient did not meet inclusion criteria|1|||
161542502|NCT01114204|583375863|FG001|Overall Study|Other-Personal reasons|0|||
161542503|NCT01114204|583375862|FG000|Overall Study|Other-Medical monitor request|1|||
161542504|NCT01114204|583375863|FG001|Overall Study|Other-Medical monitor request|0|||
161542505|NCT01114204|583375862|FG000|Overall Study|Other-Participant request|2|||
161542506|NCT01114204|583375863|FG001|Overall Study|Other-Participant request|0|||
161542507|NCT01114204|583375862|FG000|Overall Study|Other-Protocol Violation|1|||
161542508|NCT01114204|583375863|FG001|Overall Study|Other-Protocol Violation|0|||
161542509|NCT00991341|583375868|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
161542510|NCT00991341|583375869|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
161542511|NCT00991341|583375868|FG000|Overall Study|Death|3|||
161542512|NCT00991341|583375869|FG001|Overall Study|Death|0|||
161542513|NCT00991341|583375868|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
161542514|NCT00991341|583375869|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
161542515|NCT00991341|583375868|FG000|Overall Study|Physician Decision|1|||
161542516|NCT00991341|583375869|FG001|Overall Study|Physician Decision|2|||
161542517|NCT00991341|583375868|FG000|Overall Study|Withdrawal by Subject|3|||
161542518|NCT00991341|583375869|FG001|Overall Study|Withdrawal by Subject|4|||
161542519|NCT03145766|583375880|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
161542520|NCT03145766|583375881|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
161542521|NCT03145766|583375882|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
161542522|NCT03145766|583375883|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
161542523|NCT03145766|583375884|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
161542524|NCT03145766|583375880|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
161542525|NCT03145766|583375881|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
161542526|NCT03145766|583375882|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
161542527|NCT03145766|583375883|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
161542528|NCT03145766|583375884|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
161542529|NCT03145766|583375880|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
161542530|NCT03145766|583375881|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
161542531|NCT03145766|583375882|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
161542532|NCT03145766|583375883|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
161542533|NCT03145766|583375884|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
161542534|NCT03145766|583375880|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
161542535|NCT03145766|583375881|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
161542536|NCT03145766|583375882|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
161542537|NCT03145766|583375883|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
161542538|NCT03145766|583375884|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
161542539|NCT03145766|583375880|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
161542540|NCT03145766|583375881|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
161542541|NCT03145766|583375882|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
161542542|NCT03145766|583375883|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
161542543|NCT03145766|583375884|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
161542544|NCT03145766|583375880|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
161542545|NCT03145766|583375881|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
161542546|NCT03145766|583375882|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
161542547|NCT03145766|583375883|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
161542548|NCT03145766|583375884|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
161593514|NCT05415722|583562744|FG000|Overall Study|Physician Decision|0|||
161593515|NCT05415722|583562745|FG001|Overall Study|Physician Decision|0|||
161593516|NCT05415722|583562746|FG002|Overall Study|Physician Decision|0|||
161593517|NCT05415722|583562747|FG003|Overall Study|Physician Decision|1|||
161593518|NCT05415722|583562748|FG004|Overall Study|Physician Decision|0|||
161593519|NCT05415722|583562749|FG005|Overall Study|Physician Decision|0|||
161593520|NCT05415722|583562750|FG006|Overall Study|Physician Decision|1|||
161593521|NCT05415722|583562744|FG000|Overall Study|Protocol Violation|0|||
161593522|NCT05415722|583562745|FG001|Overall Study|Protocol Violation|0|||
161593523|NCT05415722|583562746|FG002|Overall Study|Protocol Violation|0|||
161593524|NCT05415722|583562747|FG003|Overall Study|Protocol Violation|1|||
161593525|NCT05415722|583562748|FG004|Overall Study|Protocol Violation|0|||
161593526|NCT05415722|583562749|FG005|Overall Study|Protocol Violation|0|||
161679567|NCT03061175|583879161|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
161593527|NCT05415722|583562750|FG006|Overall Study|Protocol Violation|0|||
161593528|NCT05415722|583562744|FG000|Overall Study|Sponsor Discretion|0|||
161593529|NCT05415722|583562745|FG001|Overall Study|Sponsor Discretion|0|||
161593530|NCT05415722|583562746|FG002|Overall Study|Sponsor Discretion|0|||
161593531|NCT05415722|583562747|FG003|Overall Study|Sponsor Discretion|0|||
161829602|NCT00127166|584415841|FG001|Period I|Patient did not meet inclusion criteria|0|||
161829603|NCT00127166|584415840|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
161593532|NCT05415722|583562748|FG004|Overall Study|Sponsor Discretion|1|||
161593533|NCT05415722|583562749|FG005|Overall Study|Sponsor Discretion|1|||
161593534|NCT05415722|583562750|FG006|Overall Study|Sponsor Discretion|0|||
161593535|NCT05415722|583562744|FG000|Overall Study|Withdrawal by Subject|0|||
161593536|NCT05415722|583562745|FG001|Overall Study|Withdrawal by Subject|1|||
161593537|NCT05415722|583562746|FG002|Overall Study|Withdrawal by Subject|0|||
161593538|NCT05415722|583562747|FG003|Overall Study|Withdrawal by Subject|1|||
161593539|NCT05415722|583562748|FG004|Overall Study|Withdrawal by Subject|1|||
161593540|NCT05415722|583562749|FG005|Overall Study|Withdrawal by Subject|0|||
161593541|NCT05415722|583562750|FG006|Overall Study|Withdrawal by Subject|1|||
161593542|NCT04629716|583562751|FG000|Overall Study|Lost to Follow-up|7|||
161593543|NCT04629716|583562752|FG001|Overall Study|Lost to Follow-up|3|||
161593544|NCT03524612|583562753|FG000|Overall Study|Lack of Efficacy|10|||
161593545|NCT03524612|583562753|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
161593546|NCT03524612|583562753|FG000|Overall Study|Adverse Event|10|||
161593547|NCT03524612|583562753|FG000|Overall Study|Withdrawal by Subject|7|||
161593548|NCT03524612|583562753|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
161593549|NCT03524612|583562753|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
161593550|NCT03524612|583562753|FG000|Overall Study|New therapy for study indication|6|||
161593551|NCT03524612|583562753|FG000|Overall Study|Death|3|||
161593552|NCT03524612|583562753|FG000|Overall Study|Lost to Follow-up|2|||
161593553|NCT03524612|583562753|FG000|Overall Study|Protocol Violation|1|||
161593554|NCT04537715|583562755|FG000|Overall Study|Death|3|||
161593555|NCT04537715|583562756|FG001|Overall Study|Death|1|||
161593556|NCT04537715|583562755|FG000|Overall Study|Withdrawal by Subject|3|||
161593557|NCT04537715|583562756|FG001|Overall Study|Withdrawal by Subject|1|||
161593558|NCT04537715|583562755|FG000|Overall Study|Other|4|||
161593559|NCT04537715|583562756|FG001|Overall Study|Other|3|||
161593560|NCT04537715|583562755|FG000|Overall Study|Progressive disease|1|||
161593561|NCT04537715|583562756|FG001|Overall Study|Progressive disease|0|||
161593562|NCT05457647|583562758|FG000|Overall Study|Lost to Follow-up|3|||
161593563|NCT03448107|583562759|FG000|Overall Study|Lost to Follow-up|229|||
161593564|NCT03448107|583562760|FG001|Overall Study|Lost to Follow-up|258|||
161593565|NCT03115476|583562761|FG000|LP0084-1369|Death|1|||
161593566|NCT03115476|583562762|FG001|LP0084-1369|Death|0|||
161593567|NCT03115476|583562763|FG002|LP0084-1369|Death|2|||
161593568|NCT03115476|583562761|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
161593569|NCT03115476|583562762|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
161593570|NCT03115476|583562763|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
161593571|NCT05228457|583562767|FG000|Overall Study|Withdrawal by Subject|1|||
161593572|NCT05228457|583562768|FG001|Overall Study|Withdrawal by Subject|1|||
161593573|NCT05302596|583562782|FG000|Overall Study|Withdrawal by Subject|1|||
161593574|NCT05302596|583562783|FG001|Overall Study|Withdrawal by Subject|1|||
161593575|NCT05251909|583564957|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
161593576|NCT05251909|583564958|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
161593577|NCT03338933|583564959|FG000|Screening Visit|Lost to Follow-up|1|||
161593578|NCT03338933|583564960|FG001|Screening Visit|Lost to Follow-up|3|||
161593579|NCT03338933|583564961|FG002|Screening Visit|Lost to Follow-up|1|||
161593580|NCT03338933|583564962|FG003|Screening Visit|Lost to Follow-up|4|||
161593581|NCT03338933|583564959|FG000|Screening Visit|Screen fail after consent|2|||
161593582|NCT03338933|583564960|FG001|Screening Visit|Screen fail after consent|7|||
161593583|NCT03338933|583564961|FG002|Screening Visit|Screen fail after consent|1|||
161593584|NCT03338933|583564962|FG003|Screening Visit|Screen fail after consent|4|||
161593585|NCT03338933|583564959|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
161593586|NCT03338933|583564960|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
161593587|NCT03338933|583564961|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
161593588|NCT03338933|583564962|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
161593589|NCT03338933|583564959|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
161593590|NCT03338933|583564960|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
161593591|NCT03338933|583564961|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
161593592|NCT03338933|583564962|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
161593593|NCT03338933|583564959|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
161593594|NCT03338933|583564960|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
161593595|NCT03338933|583564961|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
161679568|NCT03061175|583879160|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
161829604|NCT00127166|584415841|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
161829605|NCT00127166|584415840|FG000|Period II|Withdrawal by Subject|2|||
161829606|NCT00127166|584415841|FG001|Period II|Withdrawal by Subject|0|||
161829607|NCT00127166|584415840|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
161542549|NCT03145766|583375880|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
161542550|NCT03145766|583375881|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
161542551|NCT03145766|583375882|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
161542552|NCT03145766|583375883|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
161542553|NCT03145766|583375884|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
161542554|NCT03954743|583375885|FG000|Overall Study|Adverse Event|1|||
161542555|NCT03954743|583375886|FG001|Overall Study|Adverse Event|0|||
161542556|NCT03954743|583375885|FG000|Overall Study|Lost to Follow-up|6|||
161542557|NCT03954743|583375886|FG001|Overall Study|Lost to Follow-up|4|||
161542558|NCT03954743|583375885|FG000|Overall Study|Protocol Violation|1|||
161542559|NCT03954743|583375886|FG001|Overall Study|Protocol Violation|0|||
161542560|NCT03954743|583375885|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
161542561|NCT03954743|583375886|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
161542562|NCT03954743|583375885|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
161542563|NCT03954743|583375886|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161542564|NCT03541044|583375897|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
161542565|NCT03541044|583375898|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
161542566|NCT03541044|583375897|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
161542567|NCT03541044|583375898|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
161542568|NCT01153269|583375899|FG000|Overall Study|Withdrawal by Subject|1|||
161542569|NCT01153269|583375899|FG000|Overall Study|Antiretroviral therapy break|1|||
161542570|NCT02281760|583375900|FG000|Overall Study|Withdrawal by Subject|1|||
161542571|NCT00860067|583375901|FG000|Overall Study|Lost to Follow-up|46|||
161542572|NCT00860067|583375902|FG001|Overall Study|Lost to Follow-up|9|||
161542573|NCT00860067|583375903|FG002|Overall Study|Lost to Follow-up|9|||
161542574|NCT00860067|583375901|FG000|Overall Study|Withdrawal by Subject|4|||
161542575|NCT00860067|583375902|FG001|Overall Study|Withdrawal by Subject|0|||
161542576|NCT00860067|583375903|FG002|Overall Study|Withdrawal by Subject|0|||
161542577|NCT00860067|583375901|FG000|Overall Study|Pregnancy|1|||
161542578|NCT00860067|583375902|FG001|Overall Study|Pregnancy|0|||
161542579|NCT00860067|583375903|FG002|Overall Study|Pregnancy|0|||
161542580|NCT00100932|583375910|FG000|Overall Study|Adverse Event|11|||
161542581|NCT00100932|583375911|FG001|Overall Study|Adverse Event|2|||
161542582|NCT00100932|583375910|FG000|Overall Study|Withdrawal by Subject|6|||
161542583|NCT00100932|583375911|FG001|Overall Study|Withdrawal by Subject|0|||
161542584|NCT00100932|583375910|FG000|Overall Study|Progressive Disease|44|||
161542585|NCT00100932|583375911|FG001|Overall Study|Progressive Disease|18|||
161542586|NCT00100932|583375910|FG000|Overall Study|Physician Decision|7|||
161542587|NCT00100932|583375911|FG001|Overall Study|Physician Decision|5|||
161542588|NCT00100932|583375910|FG000|Overall Study|Other|5|||
161542589|NCT00100932|583375911|FG001|Overall Study|Other|2|||
161542590|NCT02387996|583375912|FG000|Overall Study|Disease Progression|167|||
161542591|NCT02387996|583375912|FG000|Overall Study|Study Drug Toxicity|31|||
161542592|NCT02387996|583375912|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
161542593|NCT02387996|583375912|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
161542594|NCT02387996|583375912|FG000|Overall Study|Subject Withdrew Consent|5|||
161542595|NCT02387996|583375912|FG000|Overall Study|Lost to Follow-up|1|||
161542596|NCT02387996|583375912|FG000|Overall Study|Poor/Non-Compliance|1|||
161542597|NCT02387996|583375912|FG000|Overall Study|Other Reasons|5|||
161542598|NCT02387996|583375912|FG000|Overall Study|Death|1|||
161542599|NCT00312702|583375913|FG000|Immunization Phase|Lost to Follow-up|0|||
161542600|NCT00312702|583375914|FG001|Immunization Phase|Lost to Follow-up|1|||
161542601|NCT00312702|583375915|FG002|Immunization Phase|Lost to Follow-up|0|||
161542602|NCT00770432|583375916|FG000|Overall Study|Other|4|||
161542603|NCT00770432|583375917|FG001|Overall Study|Other|6|||
161542604|NCT00770432|583375916|FG000|Overall Study|Non-compliance|0|||
161542605|NCT00770432|583375917|FG001|Overall Study|Non-compliance|1|||
161542606|NCT00988221|583375918|FG000|Part I|Adverse Event|0|||
161542607|NCT00988221|583375919|FG001|Part I|Adverse Event|1|||
161542608|NCT00988221|583375920|FG002|Part I|Adverse Event|2|||
161542609|NCT00988221|583375921|FG003|Part I|Adverse Event|0|||
161542610|NCT00988221|583375918|FG000|Part I|Insufficient Therapeutic Response|4|||
161542611|NCT00988221|583375919|FG001|Part I|Insufficient Therapeutic Response|6|||
161542612|NCT00988221|583375920|FG002|Part I|Insufficient Therapeutic Response|5|||
161542613|NCT00988221|583375921|FG003|Part I|Insufficient Therapeutic Response|0|||
161542614|NCT00988221|583375918|FG000|Part I|Refused Treatment|0|||
161542615|NCT00988221|583375919|FG001|Part I|Refused Treatment|2|||
161542616|NCT00988221|583375920|FG002|Part I|Refused Treatment|1|||
161542617|NCT00988221|583375921|FG003|Part I|Refused Treatment|0|||
161542618|NCT00988221|583375918|FG000|Part I|Lost to Follow-up|0|||
161542619|NCT00988221|583375919|FG001|Part I|Lost to Follow-up|1|||
161542620|NCT00988221|583375920|FG002|Part I|Lost to Follow-up|0|||
161542621|NCT00988221|583375921|FG003|Part I|Lost to Follow-up|0|||
161542622|NCT00988221|583375918|FG000|Part II|Adverse Event|1|||
161542623|NCT00988221|583375919|FG001|Part II|Adverse Event|0|||
161542624|NCT00988221|583375920|FG002|Part II|Adverse Event|0|||
161542625|NCT00988221|583375921|FG003|Part II|Adverse Event|1|||
161542626|NCT00988221|583375918|FG000|Part II|Withdrawal by Subject|0|||
161542627|NCT00988221|583375919|FG001|Part II|Withdrawal by Subject|0|||
161542628|NCT00988221|583375920|FG002|Part II|Withdrawal by Subject|2|||
161542629|NCT00988221|583375921|FG003|Part II|Withdrawal by Subject|2|||
161542630|NCT00988221|583375918|FG000|Part II|Reason not Specified|0|||
161542631|NCT00988221|583375919|FG001|Part II|Reason not Specified|0|||
161542632|NCT00988221|583375920|FG002|Part II|Reason not Specified|1|||
161542633|NCT00988221|583375921|FG003|Part II|Reason not Specified|0|||
161542634|NCT00988221|583375918|FG000|Part III|Adverse Event|1|||
161542635|NCT00988221|583375919|FG001|Part III|Adverse Event|0|||
161542636|NCT00988221|583375920|FG002|Part III|Adverse Event|1|||
161542637|NCT00988221|583375921|FG003|Part III|Adverse Event|0|||
161542638|NCT00988221|583375918|FG000|Part III|Insufficient Therapeutic Response|0|||
161542639|NCT00988221|583375919|FG001|Part III|Insufficient Therapeutic Response|1|||
161542640|NCT00988221|583375920|FG002|Part III|Insufficient Therapeutic Response|1|||
161542641|NCT00988221|583375921|FG003|Part III|Insufficient Therapeutic Response|0|||
161542642|NCT00988221|583375918|FG000|Part III|Refused Treatment|0|||
161542643|NCT00988221|583375919|FG001|Part III|Refused Treatment|0|||
161542644|NCT00988221|583375920|FG002|Part III|Refused Treatment|1|||
161542645|NCT00988221|583375921|FG003|Part III|Refused Treatment|0|||
161542646|NCT01453348|583375922|FG000|Overall Study|Death|0|||
161542647|NCT01453348|583375923|FG001|Overall Study|Death|0|||
161542648|NCT01453348|583375924|FG002|Overall Study|Death|1|||
161542649|NCT01453348|583375922|FG000|Overall Study|Withdrawal by Subject|0|||
161542650|NCT01453348|583375923|FG001|Overall Study|Withdrawal by Subject|1|||
161542651|NCT01453348|583375924|FG002|Overall Study|Withdrawal by Subject|0|||
161542652|NCT01453348|583375922|FG000|Overall Study|Protocol Violation|1|||
161542653|NCT01453348|583375923|FG001|Overall Study|Protocol Violation|0|||
161542654|NCT01453348|583375924|FG002|Overall Study|Protocol Violation|0|||
161542655|NCT02756832|583375925|FG000|Overall Study|Lost for Observation after Baseline|6|||
161542656|NCT02756832|583375925|FG000|Overall Study|Lost for Observation|13|||
161542657|NCT02756832|583375925|FG000|Overall Study|Patient's Unwillingness|12|||
161542658|NCT02756832|583375925|FG000|Overall Study|Insufficient Efficacy|2|||
161542659|NCT02756832|583375925|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
161542660|NCT02756832|583375925|FG000|Overall Study|Reason not Specified|9|||
161542661|NCT02756832|583375925|FG000|Overall Study|Protocol Deviation|10|||
161542662|NCT01498822|583375927|FG000|Overall Study|Protocol Violation|8|||
161542663|NCT01498822|583375928|FG001|Overall Study|Protocol Violation|4|||
161542664|NCT01498822|583375927|FG000|Overall Study|Other Reason|5|||
161542665|NCT01498822|583375928|FG001|Overall Study|Other Reason|2|||
161542666|NCT01498822|583375927|FG000|Overall Study|Lack of Efficacy|7|||
161542667|NCT01498822|583375928|FG001|Overall Study|Lack of Efficacy|2|||
161542668|NCT01498822|583375927|FG000|Overall Study|AE, non-serious non-fatal|8|||
161542669|NCT01498822|583375928|FG001|Overall Study|AE, non-serious non-fatal|17|||
161542670|NCT01498822|583375927|FG000|Overall Study|SAE, non-fatal|2|||
161542671|NCT01498822|583375928|FG001|Overall Study|SAE, non-fatal|2|||
161542672|NCT01498822|583375927|FG000|Overall Study|Adverse Event, serious fatal|1|||
161542673|NCT01498822|583375928|FG001|Overall Study|Adverse Event, serious fatal|1|||
161542674|NCT01498822|583375927|FG000|Overall Study|Withdrawal by Subject|15|||
161542675|NCT01498822|583375928|FG001|Overall Study|Withdrawal by Subject|25|||
161542676|NCT01498822|583375927|FG000|Overall Study|Lost to Follow-up|8|||
161542677|NCT01498822|583375928|FG001|Overall Study|Lost to Follow-up|3|||
161542678|NCT03592277|583375929|FG000|Overall Study|Withdrawal by Subject|6|||
161542679|NCT03592277|583375930|FG001|Overall Study|Withdrawal by Subject|8|||
161542680|NCT02917265|583375933|FG000|Overall Study|Physician Decision|1|||
161542681|NCT02917265|583375934|FG001|Overall Study|Physician Decision|0|||
161542682|NCT02917265|583375933|FG000|Overall Study|Withdrawal by Subject|1|||
161542683|NCT02917265|583375934|FG001|Overall Study|Withdrawal by Subject|0|||
161542684|NCT00979602|583375947|FG000|Overall Study|Serious Adverse Event|5|||
161542685|NCT00979602|583375948|FG001|Overall Study|Serious Adverse Event|3|||
161542686|NCT00979602|583375947|FG000|Overall Study|Protocol Violation|3|||
161542687|NCT00979602|583375948|FG001|Overall Study|Protocol Violation|0|||
161542688|NCT00979602|583375947|FG000|Overall Study|Withdrawal by Subject|31|||
161542689|NCT00979602|583375948|FG001|Overall Study|Withdrawal by Subject|25|||
161542690|NCT00979602|583375947|FG000|Overall Study|Lost to Follow-up|100|||
161542691|NCT00979602|583375948|FG001|Overall Study|Lost to Follow-up|96|||
161542692|NCT00979602|583375947|FG000|Overall Study|Migrated/moved from study area|3|||
161542693|NCT00979602|583375948|FG001|Overall Study|Migrated/moved from study area|6|||
161542694|NCT00979602|583375947|FG000|Overall Study|Others|3|||
161542695|NCT00979602|583375948|FG001|Overall Study|Others|3|||
161542696|NCT02712398|583375952|FG000|Overall Study|Withdrawal by Subject|6|||
161542697|NCT02712398|583375952|FG000|Overall Study|Lost to Follow-up|6|||
161542698|NCT02712398|583375952|FG000|Overall Study|Sponsor Decision|1|||
161542699|NCT02712398|583375952|FG000|Overall Study|Physician Decision|1|||
161542700|NCT02712398|583375952|FG000|Overall Study|Death|2|||
161542701|NCT02712398|583375952|FG000|Overall Study|Re-operation|21|||
161542702|NCT01719237|583375953|FG000|Overall Study|Physician Decision|0|||
161542703|NCT01719237|583375954|FG001|Overall Study|Physician Decision|1|||
161542704|NCT02002182|583375961|FG000|Overall Study|Withdraw from study|3|||
161542705|NCT02002182|583375962|FG001|Overall Study|Withdraw from study|1|||
161542706|NCT02002182|583375961|FG000|Overall Study|Health Reasons|1|||
161542707|NCT02002182|583375962|FG001|Overall Study|Health Reasons|0|||
161542708|NCT02002182|583375961|FG000|Overall Study|Death|1|||
161542709|NCT02002182|583375962|FG001|Overall Study|Death|0|||
161542710|NCT03787680|583375973|FG000|Overall Study|Physician Decision|2|||
161542711|NCT03787680|583375974|FG001|Overall Study|Physician Decision|3|||
161542712|NCT03787680|583375973|FG000|Overall Study|Adverse Event|7|||
161542713|NCT03787680|583375974|FG001|Overall Study|Adverse Event|3|||
161542714|NCT03787680|583375973|FG000|Overall Study|Withdrawal by Subject|2|||
161542715|NCT03787680|583375974|FG001|Overall Study|Withdrawal by Subject|1|||
161542716|NCT05454410|583375977|FG000|Overall Study|Withdrawal by Subject|0|||
161542717|NCT05454410|583375978|FG001|Overall Study|Withdrawal by Subject|0|||
161542718|NCT05454410|583375979|FG002|Overall Study|Withdrawal by Subject|1|||
161542719|NCT05454410|583375980|FG003|Overall Study|Withdrawal by Subject|1|||
161542720|NCT00895622|583375981|FG000|Overall Study|Protocol Violation|5|||
161542721|NCT00895622|583375982|FG001|Overall Study|Protocol Violation|4|||
161542722|NCT00895622|583375983|FG002|Overall Study|Protocol Violation|4|||
161542723|NCT03635489|583375991|FG000|Overall Study|Death|19|||
161542724|NCT03635489|583375992|FG001|Overall Study|Death|13|||
161542725|NCT03635489|583375991|FG000|Overall Study|Lost to Follow-up|1|||
161542726|NCT03635489|583375992|FG001|Overall Study|Lost to Follow-up|2|||
161542727|NCT03635489|583375991|FG000|Overall Study|Withdrawal by Subject|1|||
161542728|NCT03635489|583375992|FG001|Overall Study|Withdrawal by Subject|2|||
161542729|NCT03635489|583375991|FG000|Overall Study|Study Ended by Sponsor|28|||
161542730|NCT03635489|583375992|FG001|Overall Study|Study Ended by Sponsor|34|||
161542731|NCT01368900|583375993|FG000|Overall Study|Lost to Follow-up|7|||
161542732|NCT04027348|583375998|FG000|Overall Study|Adverse Event|2|||
161542733|NCT02487472|583375999|FG000|Overall Study|Did not complete telephonic interviews|9|||
161542734|NCT02487472|583375999|FG000|Overall Study|Other|2|||
161542735|NCT01313286|583376000|FG000|Period 1|Withdrawal by Subject|2|||
161542736|NCT01313286|583376001|FG001|Period 1|Withdrawal by Subject|0|||
161542737|NCT00311155|583377757|FG000|Overall Study|Adverse Event|21|||
161542738|NCT00311155|583377757|FG000|Overall Study|Withdrawal by Subject|17|||
161542739|NCT00311155|583377757|FG000|Overall Study|Did not meet entry criteria|55|||
161542740|NCT00429494|583377759|FG000|Overall Study|Withdrawal by Subject|9|||
161542741|NCT00429494|583377759|FG000|Overall Study|Death|6|||
161542742|NCT00976703|583377762|FG000|Overall Study|Physician Decision|1|||
161542743|NCT00976703|583377763|FG001|Overall Study|Physician Decision|1|||
161542744|NCT00976703|583377762|FG000|Overall Study|ineligible for study|2|||
161542745|NCT00976703|583377763|FG001|Overall Study|ineligible for study|2|||
161542746|NCT00975221|583377766|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
161542747|NCT00975221|583377767|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
161542748|NCT00975221|583377766|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
161542749|NCT00975221|583377767|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
161542750|NCT00975221|583377766|FG000|Titration Phase (Weeks 1-12)|Other|0|||
161542751|NCT00975221|583377767|FG001|Titration Phase (Weeks 1-12)|Other|1|||
161542752|NCT00975221|583377766|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
161542753|NCT00975221|583377767|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
161542754|NCT00975221|583377766|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
161542755|NCT00975221|583377767|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
161542756|NCT00975221|583377766|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
161542757|NCT00975221|583377767|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
161542758|NCT02243631|583377769|FG000|Overall Study|no synovial fluid on second aspirate|0|||
161542759|NCT02243631|583377770|FG001|Overall Study|no synovial fluid on second aspirate|1|||
161542760|NCT01992549|583377773|FG000|Overall Study|Lost to Follow-up|2|||
161542761|NCT01992549|583377773|FG000|Overall Study|Serious Adverse Event|1|||
161542762|NCT01992549|583377773|FG000|Overall Study|Product Switch to Extend Half Life|1|||
161542763|NCT01590771|583377774|FG000|Overall Study|Other Protocol Specified Criteria|5|||
161542764|NCT01590771|583377775|FG001|Overall Study|Other Protocol Specified Criteria|14|||
161542765|NCT01590771|583377774|FG000|Overall Study|Withdrawal by Subject|8|||
161542766|NCT01590771|583377775|FG001|Overall Study|Withdrawal by Subject|15|||
161829608|NCT00127166|584415841|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
161829609|NCT00105157|584415842|FG000|Double-Blind (DB)|Never Treated|1|||
161542767|NCT01590771|583377774|FG000|Overall Study|Protocol Violation|1|||
161542768|NCT01590771|583377775|FG001|Overall Study|Protocol Violation|2|||
161542769|NCT01590771|583377774|FG000|Overall Study|Lost to Follow-up|1|||
161542770|NCT01590771|583377775|FG001|Overall Study|Lost to Follow-up|1|||
161542771|NCT01590771|583377774|FG000|Overall Study|Lack of Efficacy|1|||
161542772|NCT01590771|583377775|FG001|Overall Study|Lack of Efficacy|0|||
161542773|NCT01590771|583377774|FG000|Overall Study|Adverse Event|3|||
161542774|NCT01590771|583377775|FG001|Overall Study|Adverse Event|7|||
161542775|NCT01785628|583377776|FG000|Overall Study|Lost to Follow-up|2|||
161542776|NCT01785628|583377777|FG001|Overall Study|Lost to Follow-up|3|||
161542777|NCT01250119|583377786|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
161829610|NCT00105157|584415843|FG001|Double-Blind (DB)|Never Treated|0|||
161542778|NCT01250119|583377787|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
161542779|NCT01250119|583377786|FG000|Diagnostic Phase|Participants Not Tested|44|||
161542780|NCT01250119|583377787|FG001|Diagnostic Phase|Participants Not Tested|0|||
161542781|NCT01250119|583377786|FG000|Treatment Phase|Progressive Disease|0|||
161542782|NCT01250119|583377787|FG001|Treatment Phase|Progressive Disease|32|||
161542783|NCT01250119|583377786|FG000|Treatment Phase|Death|0|||
161542784|NCT01250119|583377787|FG001|Treatment Phase|Death|2|||
161542785|NCT01250119|583377786|FG000|Treatment Phase|Withdrawal by Subject|0|||
161542786|NCT01250119|583377787|FG001|Treatment Phase|Withdrawal by Subject|1|||
161542787|NCT01250119|583377786|FG000|Treatment Phase|Adverse Event|0|||
161542788|NCT01250119|583377787|FG001|Treatment Phase|Adverse Event|2|||
161542789|NCT01250119|583377786|FG000|Treatment Phase|Unknown reason|0|||
161542790|NCT01250119|583377787|FG001|Treatment Phase|Unknown reason|4|||
161542791|NCT02045433|583377793|FG000|Overall Study|Withdrawal by Subject|1|||
161542792|NCT01559454|583377794|FG000|Overall Study|Lost to Follow-up|3|||
161542793|NCT01559454|583377795|FG001|Overall Study|Lost to Follow-up|2|||
161542794|NCT01559454|583377794|FG000|Overall Study|Withdrawal by Subject|0|||
161542795|NCT01559454|583377795|FG001|Overall Study|Withdrawal by Subject|1|||
161542796|NCT01559454|583377794|FG000|Overall Study|Physician Decision|0|||
161542797|NCT01559454|583377795|FG001|Overall Study|Physician Decision|1|||
161542798|NCT01559454|583377794|FG000|Overall Study|Protocol Violation|0|||
161542799|NCT01559454|583377795|FG001|Overall Study|Protocol Violation|1|||
161542800|NCT01559454|583377794|FG000|Overall Study|Lack of Efficacy|0|||
161542801|NCT01559454|583377795|FG001|Overall Study|Lack of Efficacy|1|||
161542802|NCT00462670|583377801|FG000|Overall Study|Adverse Event|3|||
161542803|NCT00462670|583377802|FG001|Overall Study|Adverse Event|5|||
161542804|NCT00462670|583377801|FG000|Overall Study|Lack of Efficacy|1|||
161542805|NCT00462670|583377802|FG001|Overall Study|Lack of Efficacy|0|||
161542806|NCT00462670|583377801|FG000|Overall Study|Protocol Violation|1|||
161542807|NCT00462670|583377802|FG001|Overall Study|Protocol Violation|0|||
161542808|NCT00462670|583377801|FG000|Overall Study|Resolution of signs and symptoms|0|||
161542809|NCT00462670|583377802|FG001|Overall Study|Resolution of signs and symptoms|2|||
161542810|NCT00482274|583377807|FG000|Overall Study|Adverse Event|1|||
161542811|NCT02396537|583377808|FG000|Overall Study|Protocol Violation|0|||
161542812|NCT02396537|583377809|FG001|Overall Study|Protocol Violation|1|||
161542813|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
161542814|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
161542815|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Adverse Event|2|||
161542816|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Adverse Event|5|||
161542817|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
161542818|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
161542819|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
161542820|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
161542821|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Randomized by error|0|||
161542822|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Randomized by error|5|||
161542823|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
161542824|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
161542825|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
161542826|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
161542827|NCT02948959|583377813|FG000|52 Weeks Treatment Period|Change of residence location|0|||
161542828|NCT02948959|583377814|FG001|52 Weeks Treatment Period|Change of residence location|1|||
161542829|NCT02948959|583377813|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
161542830|NCT02948959|583377814|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
161542831|NCT02948959|583377813|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
161542832|NCT02948959|583377814|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
161542833|NCT02948959|583377813|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
161542834|NCT02948959|583377814|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
161829611|NCT00105157|584415844|FG002|Double-Blind (DB)|Never Treated|0|||
161829612|NCT00105157|584415845|FG003|Double-Blind (DB)|Never Treated|0|||
161829613|NCT00105157|584415842|FG000|Double-Blind (DB)|Adverse Event|2|||
161829614|NCT00105157|584415843|FG001|Double-Blind (DB)|Adverse Event|0|||
161829615|NCT00105157|584415844|FG002|Double-Blind (DB)|Adverse Event|1|||
161829616|NCT00105157|584415845|FG003|Double-Blind (DB)|Adverse Event|1|||
161829617|NCT00105157|584415842|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
161829618|NCT00105157|584415843|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
161829619|NCT00105157|584415844|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
161542835|NCT02948959|583377813|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
161542836|NCT02948959|583377814|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
161542837|NCT02948959|583377813|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
161542838|NCT02948959|583377814|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
161829620|NCT00105157|584415845|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
161829621|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Adverse Event|3|||
161542839|NCT02948959|583377813|FG000|12 Weeks Follow-up Period|Study site closure|1|||
161542840|NCT02948959|583377814|FG001|12 Weeks Follow-up Period|Study site closure|0|||
161542841|NCT00787319|583377815|FG000|Overall Study|Lost to Follow-up|2|||
161542842|NCT00787319|583377815|FG000|Overall Study|Withdrawal by Subject|15|||
161542843|NCT00787319|583377815|FG000|Overall Study|Adverse Event|3|||
161542844|NCT00787319|583377815|FG000|Overall Study|Objective progression or relapse|30|||
161542845|NCT00787319|583377815|FG000|Overall Study|Lack of Efficacy|1|||
161542846|NCT00787319|583377815|FG000|Overall Study|Budget exhausted/exceeded|1|||
161542847|NCT00787319|583377815|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
161542848|NCT00787319|583377815|FG000|Overall Study|No health insurance reimbursement|2|||
161542849|NCT00787319|583377815|FG000|Overall Study|Stabilized disease findings|3|||
161542850|NCT00787319|583377815|FG000|Overall Study|Inactive disease|5|||
161542851|NCT01932294|583377816|FG000|Overall Study|Death|43|||
161542852|NCT01932294|583377816|FG000|Overall Study|Lost to Follow-up|8|||
161542853|NCT01932294|583377816|FG000|Overall Study|VAD Implantation|20|||
161542854|NCT01932294|583377816|FG000|Overall Study|Heart Transplantation|16|||
161542855|NCT01932294|583377816|FG000|Overall Study|Transferred to other hospitals|12|||
161542856|NCT00409786|583377820|FG000|Overall Study|Withdrawal by Subject|3|||
161542857|NCT03075904|583377827|FG000|Overall Study|Physician Decision|3|||
161542858|NCT03075904|583377827|FG000|Overall Study|Need for Medication not Permitted|1|||
161542859|NCT00597714|583377828|FG000|Overall Study|Death|56|||
161542860|NCT00597714|583377829|FG001|Overall Study|Death|46|||
161542861|NCT00597714|583377830|FG002|Overall Study|Death|0|||
161542862|NCT00597714|583377828|FG000|Overall Study|Recipient death|0|||
161542863|NCT00597714|583377829|FG001|Overall Study|Recipient death|0|||
161542864|NCT00597714|583377830|FG002|Overall Study|Recipient death|10|||
161542865|NCT02228395|583377831|FG000|First Intervention Period|No longer willing to participate|1|||
161542866|NCT02228395|583377832|FG001|First Intervention Period|No longer willing to participate|0|||
161542867|NCT02228395|583377833|FG002|First Intervention Period|No longer willing to participate|0|||
161542868|NCT02228395|583377831|FG000|First Intervention Period|Unable to comply with study dates|0|||
161542869|NCT02228395|583377832|FG001|First Intervention Period|Unable to comply with study dates|1|||
161542870|NCT02228395|583377833|FG002|First Intervention Period|Unable to comply with study dates|1|||
161542871|NCT02424591|583377838|FG000|Overall Study|Protocol Violation|2|||
161542872|NCT02424591|583377839|FG001|Overall Study|Protocol Violation|3|||
161542873|NCT04772053|583377852|FG000|Overall Study|Physician Decision|2|||
161542874|NCT04772053|583377852|FG000|Overall Study|Withdrawal by Subject|3|||
161542875|NCT04772053|583377852|FG000|Overall Study|Study Terminated by Sponsor|1|||
161542876|NCT04146896|583377857|FG000|Overall Study|Adverse Event|5|||
161542877|NCT04146896|583377858|FG001|Overall Study|Adverse Event|8|||
161542878|NCT04146896|583377857|FG000|Overall Study|Lack of Efficacy|3|||
161542879|NCT04146896|583377858|FG001|Overall Study|Lack of Efficacy|2|||
161542880|NCT04146896|583377857|FG000|Overall Study|Lost to Follow-up|0|||
161542881|NCT04146896|583377858|FG001|Overall Study|Lost to Follow-up|1|||
161542882|NCT04146896|583377857|FG000|Overall Study|Non-compliance|5|||
161542883|NCT04146896|583377858|FG001|Overall Study|Non-compliance|4|||
161542884|NCT04146896|583377857|FG000|Overall Study|Withdrawal by Subject|3|||
161542885|NCT04146896|583377858|FG001|Overall Study|Withdrawal by Subject|5|||
161542886|NCT04146896|583377857|FG000|Overall Study|Randomized in error|1|||
161542887|NCT04146896|583377858|FG001|Overall Study|Randomized in error|2|||
161542888|NCT03107377|583377859|FG000|Overall Study|Adverse Event|3|||
161542889|NCT03107377|583377860|FG001|Overall Study|Adverse Event|3|||
161542890|NCT03107377|583377859|FG000|Overall Study|Protocol Violation|9|||
161542891|NCT03107377|583377860|FG001|Overall Study|Protocol Violation|12|||
161542892|NCT03107377|583377859|FG000|Overall Study|Physician Decision|3|||
161542893|NCT03107377|583377860|FG001|Overall Study|Physician Decision|6|||
161542894|NCT03107377|583377859|FG000|Overall Study|Pregnancy|7|||
161542895|NCT03107377|583377860|FG001|Overall Study|Pregnancy|7|||
161542896|NCT03107377|583377859|FG000|Overall Study|Withdrawal by Subject|16|||
161542897|NCT03107377|583377860|FG001|Overall Study|Withdrawal by Subject|22|||
161542898|NCT03107377|583377859|FG000|Overall Study|Lost to Follow-up|37|||
161542899|NCT03107377|583377860|FG001|Overall Study|Lost to Follow-up|34|||
161542900|NCT03107377|583377859|FG000|Overall Study|Other reason not specified|16|||
161542901|NCT03107377|583377860|FG001|Overall Study|Other reason not specified|15|||
161542902|NCT01597505|583377861|FG000|Overall Study|Physician Decision|5|||
161542903|NCT01597505|583377862|FG001|Overall Study|Physician Decision|0|||
161542904|NCT01597505|583377861|FG000|Overall Study|Adverse Event|19|||
161542905|NCT01597505|583377862|FG001|Overall Study|Adverse Event|7|||
161542906|NCT01597505|583377861|FG000|Overall Study|Lost to Follow-up|4|||
161542907|NCT01597505|583377862|FG001|Overall Study|Lost to Follow-up|2|||
161542908|NCT01597505|583377861|FG000|Overall Study|Withdrawal by Subject|10|||
161542909|NCT01597505|583377862|FG001|Overall Study|Withdrawal by Subject|18|||
161542910|NCT01597505|583377861|FG000|Overall Study|Other|5|||
161542911|NCT01597505|583377862|FG001|Overall Study|Other|6|||
161542912|NCT01597505|583377861|FG000|Overall Study|Missing|1|||
161542913|NCT01597505|583377862|FG001|Overall Study|Missing|0|||
161542914|NCT02675465|583377864|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
161542915|NCT02675465|583377865|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
161542916|NCT02675465|583377866|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
161542917|NCT02675465|583377867|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
161542918|NCT02675465|583377868|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
161542919|NCT02675465|583377869|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
161542920|NCT02675465|583377864|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
161542921|NCT02675465|583377865|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
161542922|NCT02675465|583377866|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
161542923|NCT02675465|583377867|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
161542924|NCT02675465|583377868|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
161542925|NCT02675465|583377869|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
161542926|NCT02675465|583377864|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
161542927|NCT02675465|583377865|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
161542928|NCT02675465|583377866|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
161542929|NCT02675465|583377867|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
161542930|NCT02675465|583377868|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
161542931|NCT02675465|583377869|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
161542932|NCT02675465|583377864|FG000|Stage 4: Long Term Extension|Death|0|||
161542933|NCT02675465|583377865|FG001|Stage 4: Long Term Extension|Death|0|||
161542934|NCT02675465|583377866|FG002|Stage 4: Long Term Extension|Death|0|||
161542935|NCT02675465|583377867|FG003|Stage 4: Long Term Extension|Death|1|||
161542936|NCT02675465|583377868|FG004|Stage 4: Long Term Extension|Death|0|||
161542937|NCT02675465|583377869|FG005|Stage 4: Long Term Extension|Death|0|||
161542938|NCT00453102|583377870|FG000|Overall Study|Withdrawal by Subject|2|||
161542939|NCT05031078|583377871|FG000|Overall Study|Withdrawal by Subject|0|||
161542940|NCT05031078|583377872|FG001|Overall Study|Withdrawal by Subject|1|||
161542941|NCT05031078|583377873|FG002|Overall Study|Withdrawal by Subject|0|||
161542942|NCT03728972|583377874|FG000|Overall Study|Death|1|||
161542943|NCT03728972|583377875|FG001|Overall Study|Death|0|||
161542944|NCT03728972|583377874|FG000|Overall Study|Lack of Efficacy|1|||
161542945|NCT03728972|583377875|FG001|Overall Study|Lack of Efficacy|0|||
161542946|NCT03728972|583377874|FG000|Overall Study|Physician Decision|3|||
161542947|NCT03728972|583377875|FG001|Overall Study|Physician Decision|0|||
161542948|NCT03728972|583377874|FG000|Overall Study|Disease progression|4|||
161542949|NCT03728972|583377875|FG001|Overall Study|Disease progression|3|||
161542950|NCT01490125|583377880|FG000|Period I|Adverse Event|4|||
161542951|NCT01490125|583377881|FG001|Period I|Adverse Event|1|||
161542952|NCT01490125|583377882|FG002|Period I|Adverse Event|1|||
161542953|NCT01490125|583377883|FG003|Period I|Adverse Event|3|||
161542954|NCT01490125|583377884|FG004|Period I|Adverse Event|2|||
161542955|NCT01490125|583377885|FG005|Period I|Adverse Event|4|||
161542956|NCT01490125|583377880|FG000|Period I|Protocol Violation|1|||
161542957|NCT01490125|583377881|FG001|Period I|Protocol Violation|1|||
161542958|NCT01490125|583377882|FG002|Period I|Protocol Violation|1|||
161542959|NCT01490125|583377883|FG003|Period I|Protocol Violation|1|||
161542960|NCT01490125|583377884|FG004|Period I|Protocol Violation|0|||
161542961|NCT01490125|583377885|FG005|Period I|Protocol Violation|0|||
161542962|NCT01490125|583377880|FG000|Period I|Withdrawal by Subject|1|||
161542963|NCT01490125|583377881|FG001|Period I|Withdrawal by Subject|3|||
161542964|NCT01490125|583377882|FG002|Period I|Withdrawal by Subject|2|||
161542965|NCT01490125|583377883|FG003|Period I|Withdrawal by Subject|1|||
161542966|NCT01490125|583377884|FG004|Period I|Withdrawal by Subject|2|||
161542967|NCT01490125|583377885|FG005|Period I|Withdrawal by Subject|1|||
161542968|NCT01490125|583377880|FG000|Period II|Adverse Event|2|||
161542969|NCT01490125|583377881|FG001|Period II|Adverse Event|3|||
161542970|NCT01490125|583377882|FG002|Period II|Adverse Event|2|||
161542971|NCT01490125|583377883|FG003|Period II|Adverse Event|2|||
161829622|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Adverse Event|1|||
161542972|NCT01490125|583377884|FG004|Period II|Adverse Event|4|||
161542973|NCT01490125|583377885|FG005|Period II|Adverse Event|2|||
161542974|NCT01490125|583377880|FG000|Period II|Protocol Violation|0|||
161542975|NCT01490125|583377881|FG001|Period II|Protocol Violation|0|||
161542976|NCT01490125|583377882|FG002|Period II|Protocol Violation|1|||
161542977|NCT01490125|583377883|FG003|Period II|Protocol Violation|1|||
161542978|NCT01490125|583377884|FG004|Period II|Protocol Violation|0|||
161542979|NCT01490125|583377885|FG005|Period II|Protocol Violation|0|||
161542980|NCT01490125|583377880|FG000|Period II|Lost to Follow-up|0|||
161542981|NCT01490125|583377881|FG001|Period II|Lost to Follow-up|1|||
161542982|NCT01490125|583377882|FG002|Period II|Lost to Follow-up|0|||
161542983|NCT01490125|583377883|FG003|Period II|Lost to Follow-up|0|||
161542984|NCT01490125|583377884|FG004|Period II|Lost to Follow-up|0|||
161542985|NCT01490125|583377885|FG005|Period II|Lost to Follow-up|0|||
161542986|NCT01490125|583377880|FG000|Period II|Withdrawal by Subject|1|||
161542987|NCT01490125|583377881|FG001|Period II|Withdrawal by Subject|0|||
161542988|NCT01490125|583377882|FG002|Period II|Withdrawal by Subject|0|||
161542989|NCT01490125|583377883|FG003|Period II|Withdrawal by Subject|0|||
161542990|NCT01490125|583377884|FG004|Period II|Withdrawal by Subject|0|||
161542991|NCT01490125|583377885|FG005|Period II|Withdrawal by Subject|0|||
161542992|NCT01490125|583377880|FG000|Period III|Adverse Event|3|||
161542993|NCT01490125|583377881|FG001|Period III|Adverse Event|1|||
161542994|NCT01490125|583377882|FG002|Period III|Adverse Event|0|||
161542995|NCT01490125|583377883|FG003|Period III|Adverse Event|1|||
161542996|NCT01490125|583377884|FG004|Period III|Adverse Event|0|||
161542997|NCT01490125|583377885|FG005|Period III|Adverse Event|0|||
161542998|NCT01490125|583377880|FG000|Period III|Death|0|||
161542999|NCT01490125|583377881|FG001|Period III|Death|0|||
161543000|NCT01490125|583377882|FG002|Period III|Death|0|||
161543001|NCT01490125|583377883|FG003|Period III|Death|1|||
161543002|NCT01490125|583377884|FG004|Period III|Death|0|||
161543003|NCT01490125|583377885|FG005|Period III|Death|0|||
161543004|NCT01490125|583377880|FG000|Period III|Lack of Efficacy|0|||
161543005|NCT01490125|583377881|FG001|Period III|Lack of Efficacy|0|||
161543006|NCT01490125|583377882|FG002|Period III|Lack of Efficacy|0|||
161543007|NCT01490125|583377883|FG003|Period III|Lack of Efficacy|0|||
161543008|NCT01490125|583377884|FG004|Period III|Lack of Efficacy|1|||
161543009|NCT01490125|583377885|FG005|Period III|Lack of Efficacy|0|||
161543010|NCT01320943|583377886|FG000|Overall Study|Lost to Follow-up|1|||
161543011|NCT01320943|583377887|FG001|Overall Study|Lost to Follow-up|0|||
161543012|NCT01320943|583377886|FG000|Overall Study|Physician Decision|0|||
161543013|NCT01320943|583377887|FG001|Overall Study|Physician Decision|1|||
161543014|NCT01320943|583377886|FG000|Overall Study|Randomized but not Treated|0|||
161543015|NCT01320943|583377887|FG001|Overall Study|Randomized but not Treated|1|||
161543016|NCT04522180|583377888|FG000|Overall Study|Investigator judgement|3|||
161543017|NCT04522180|583377889|FG001|Overall Study|Investigator judgement|4|||
161543018|NCT04522180|583377888|FG000|Overall Study|Voluntary withdrawal|1|||
161543019|NCT04522180|583377889|FG001|Overall Study|Voluntary withdrawal|0|||
161543020|NCT04522180|583377888|FG000|Overall Study|Pregnancy|0|||
161543021|NCT04522180|583377889|FG001|Overall Study|Pregnancy|1|||
161543022|NCT04522180|583377888|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
161543023|NCT04522180|583377889|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
161543024|NCT04522180|583377888|FG000|Overall Study|Reason not specified|8|||
161543025|NCT04522180|583377889|FG001|Overall Study|Reason not specified|5|||
161543026|NCT02010632|583377890|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
161543027|NCT02010632|583377891|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
161543028|NCT02404389|583377892|FG000|Overall Study|Adverse Event|1|||
161543029|NCT02404389|583377893|FG001|Overall Study|Adverse Event|0|||
161543030|NCT02404389|583377894|FG002|Overall Study|Adverse Event|1|||
161543031|NCT02404389|583377895|FG003|Overall Study|Adverse Event|0|||
161543032|NCT02404389|583377896|FG004|Overall Study|Adverse Event|2|||
161543033|NCT02404389|583377892|FG000|Overall Study|Subject/guardian decision|1|||
161543034|NCT02404389|583377893|FG001|Overall Study|Subject/guardian decision|0|||
161543035|NCT02404389|583377894|FG002|Overall Study|Subject/guardian decision|0|||
161543036|NCT02404389|583377895|FG003|Overall Study|Subject/guardian decision|1|||
161543037|NCT02404389|583377896|FG004|Overall Study|Subject/guardian decision|1|||
161829623|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Adverse Event|0|||
161593596|NCT03338933|583564962|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
161593597|NCT04764448|583564963|FG000|Overall Study|Study terminated by sponsor|2|||
161593598|NCT04764448|583564964|FG001|Overall Study|Study terminated by sponsor|2|||
161829624|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Adverse Event|0|||
161829625|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
161829626|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
161593599|NCT04764448|583564965|FG002|Overall Study|Study terminated by sponsor|5|||
161829627|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
161543038|NCT01919970|583377902|FG000|Overall Study|Withdrawal by Subject|3|||
161543039|NCT01919970|583377903|FG001|Overall Study|Withdrawal by Subject|0|||
161543040|NCT00990340|583377904|FG000|First 14-day Treatment|Not Compliant|2|||
161543041|NCT00990340|583377905|FG001|First 14-day Treatment|Not Compliant|1|||
161543042|NCT00990340|583377904|FG000|First 14-day Treatment|Lost to Follow-up|2|||
161543043|NCT00990340|583377905|FG001|First 14-day Treatment|Lost to Follow-up|1|||
161543044|NCT00990340|583377904|FG000|First 14-day Treatment|Protocol Violation|2|||
161543045|NCT00990340|583377905|FG001|First 14-day Treatment|Protocol Violation|2|||
161543046|NCT04615182|583377906|FG000|Overall Study|Re-transplanted|2|||
161543047|NCT04615182|583377906|FG000|Overall Study|Protocol Violation|6|||
161543048|NCT04615182|583377906|FG000|Overall Study|Death|6|||
161543049|NCT04615182|583377906|FG000|Overall Study|Death and protocol violation|1|||
161543050|NCT01126060|583377907|FG000|Overall Study|Protocol Violation|0|||
161543051|NCT01126060|583377908|FG001|Overall Study|Protocol Violation|2|||
161543052|NCT03565068|583377909|FG000|Overall Study|Protocol Violation|0|||
161543053|NCT03565068|583377910|FG001|Overall Study|Protocol Violation|0|||
161543054|NCT03565068|583377911|FG002|Overall Study|Protocol Violation|0|||
161543055|NCT03565068|583377912|FG003|Overall Study|Protocol Violation|0|||
161543056|NCT03565068|583377913|FG004|Overall Study|Protocol Violation|1|||
161543057|NCT03565068|583377914|FG005|Overall Study|Protocol Violation|0|||
161543058|NCT03565068|583377915|FG006|Overall Study|Protocol Violation|0|||
161543059|NCT03565068|583377916|FG007|Overall Study|Protocol Violation|1|||
161543060|NCT03565068|583377917|FG008|Overall Study|Protocol Violation|0|||
161543061|NCT03565068|583377909|FG000|Overall Study|Sponsor decision|0|||
161543062|NCT03565068|583377910|FG001|Overall Study|Sponsor decision|0|||
161543063|NCT03565068|583377911|FG002|Overall Study|Sponsor decision|0|||
161543064|NCT03565068|583377912|FG003|Overall Study|Sponsor decision|0|||
161543065|NCT03565068|583377913|FG004|Overall Study|Sponsor decision|1|||
161543066|NCT03565068|583377914|FG005|Overall Study|Sponsor decision|1|||
161543067|NCT03565068|583377915|FG006|Overall Study|Sponsor decision|0|||
161543068|NCT03565068|583377916|FG007|Overall Study|Sponsor decision|0|||
161543069|NCT03565068|583377917|FG008|Overall Study|Sponsor decision|0|||
161543070|NCT03565068|583377909|FG000|Overall Study|Withdrawal by Subject|0|||
161543071|NCT03565068|583377910|FG001|Overall Study|Withdrawal by Subject|0|||
161543072|NCT03565068|583377911|FG002|Overall Study|Withdrawal by Subject|1|||
161543073|NCT03565068|583377912|FG003|Overall Study|Withdrawal by Subject|0|||
161543074|NCT03565068|583377913|FG004|Overall Study|Withdrawal by Subject|2|||
161543075|NCT03565068|583377914|FG005|Overall Study|Withdrawal by Subject|0|||
161543076|NCT03565068|583377915|FG006|Overall Study|Withdrawal by Subject|1|||
161543077|NCT03565068|583377916|FG007|Overall Study|Withdrawal by Subject|5|||
161543078|NCT03565068|583377917|FG008|Overall Study|Withdrawal by Subject|1|||
161543079|NCT03565068|583377909|FG000|Overall Study|Physician Decision|0|||
161543080|NCT03565068|583377910|FG001|Overall Study|Physician Decision|0|||
161543081|NCT03565068|583377911|FG002|Overall Study|Physician Decision|0|||
161543082|NCT03565068|583377912|FG003|Overall Study|Physician Decision|0|||
161543083|NCT03565068|583377913|FG004|Overall Study|Physician Decision|0|||
161543084|NCT03565068|583377914|FG005|Overall Study|Physician Decision|0|||
161543085|NCT03565068|583377915|FG006|Overall Study|Physician Decision|0|||
161543086|NCT03565068|583377916|FG007|Overall Study|Physician Decision|1|||
161543087|NCT03565068|583377917|FG008|Overall Study|Physician Decision|0|||
161543088|NCT03565068|583377909|FG000|Overall Study|Lost to Follow-up|0|||
161543089|NCT03565068|583377910|FG001|Overall Study|Lost to Follow-up|0|||
161543090|NCT03565068|583377911|FG002|Overall Study|Lost to Follow-up|0|||
161543091|NCT03565068|583377912|FG003|Overall Study|Lost to Follow-up|0|||
161543092|NCT03565068|583377913|FG004|Overall Study|Lost to Follow-up|0|||
161543093|NCT03565068|583377914|FG005|Overall Study|Lost to Follow-up|0|||
161543094|NCT03565068|583377915|FG006|Overall Study|Lost to Follow-up|0|||
161543095|NCT03565068|583377916|FG007|Overall Study|Lost to Follow-up|1|||
161543096|NCT03565068|583377917|FG008|Overall Study|Lost to Follow-up|0|||
161543097|NCT03285295|583380302|FG000|Alinity s HBsAg|Protocol Violation|11|||
161543098|NCT03285295|583380303|FG001|Alinity s HBsAg|Protocol Violation|0|||
161543099|NCT03285295|583380304|FG002|Alinity s HBsAg|Protocol Violation|0|||
161543100|NCT03285295|583380305|FG003|Alinity s HBsAg|Protocol Violation|0|||
161543101|NCT03285295|583380306|FG004|Alinity s HBsAg|Protocol Violation|0|||
161543102|NCT03285295|583380302|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
161543103|NCT03285295|583380303|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
161543104|NCT03285295|583380304|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
161543105|NCT03285295|583380305|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
161543106|NCT03285295|583380306|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
161543107|NCT03285295|583380302|FG000|Alinity s HBsAg|No Results Generated|74|||
161543108|NCT03285295|583380303|FG001|Alinity s HBsAg|No Results Generated|6|||
161543109|NCT03285295|583380304|FG002|Alinity s HBsAg|No Results Generated|0|||
161543110|NCT03285295|583380305|FG003|Alinity s HBsAg|No Results Generated|0|||
161543111|NCT03285295|583380306|FG004|Alinity s HBsAg|No Results Generated|0|||
161543112|NCT03285295|583380302|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
161543113|NCT03285295|583380303|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
161543114|NCT03285295|583380304|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
161543115|NCT03285295|583380305|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
161543116|NCT03285295|583380306|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
161543117|NCT03285295|583380302|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
161543118|NCT03285295|583380303|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
161543119|NCT03285295|583380304|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
161543120|NCT03285295|583380305|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
161543121|NCT03285295|583380306|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
161543122|NCT03285295|583380302|FG000|Alinity s HTLV I/II|No Results Generated|70|||
161543123|NCT03285295|583380303|FG001|Alinity s HTLV I/II|No Results Generated|0|||
161543124|NCT03285295|583380304|FG002|Alinity s HTLV I/II|No Results Generated|0|||
161543125|NCT03285295|583380305|FG003|Alinity s HTLV I/II|No Results Generated|0|||
161543126|NCT03285295|583380306|FG004|Alinity s HTLV I/II|No Results Generated|0|||
161543127|NCT03285295|583380302|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
161543128|NCT03285295|583380303|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
161543129|NCT03285295|583380304|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
161543130|NCT03285295|583380305|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
161543131|NCT03285295|583380306|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
161543132|NCT03285295|583380302|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
161543133|NCT03285295|583380303|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
161543134|NCT03285295|583380304|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
161543135|NCT03285295|583380305|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
161543136|NCT03285295|583380306|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
161543137|NCT03285295|583380302|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
161543138|NCT03285295|583380303|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
161543139|NCT03285295|583380304|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
161543140|NCT03285295|583380305|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
161543141|NCT03285295|583380306|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
161543142|NCT03285295|583380302|FG000|Alinity s Anti-HCV|No Results Generated|71|||
161543143|NCT03285295|583380303|FG001|Alinity s Anti-HCV|No Results Generated|0|||
161543144|NCT03285295|583380304|FG002|Alinity s Anti-HCV|No Results Generated|0|||
161543145|NCT03285295|583380305|FG003|Alinity s Anti-HCV|No Results Generated|0|||
161543146|NCT03285295|583380306|FG004|Alinity s Anti-HCV|No Results Generated|0|||
161543147|NCT03285295|583380302|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
161543148|NCT03285295|583380303|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
161543149|NCT03285295|583380304|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
161543150|NCT03285295|583380305|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
161543151|NCT03285295|583380306|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
161593600|NCT04764448|583564963|FG000|Overall Study|Withdrawal by Subject|3|||
161593601|NCT04764448|583564964|FG001|Overall Study|Withdrawal by Subject|3|||
161593602|NCT04764448|583564965|FG002|Overall Study|Withdrawal by Subject|1|||
161593603|NCT01084876|583564966|FG000|Main Study Treatment Period|Adverse Event|12|||
161593604|NCT01084876|583564967|FG001|Main Study Treatment Period|Adverse Event|7|||
161593605|NCT01084876|583564966|FG000|Main Study Treatment Period|Disease Progression|41|||
161593606|NCT01084876|583564967|FG001|Main Study Treatment Period|Disease Progression|24|||
161593607|NCT01084876|583564966|FG000|Main Study Treatment Period|Physician Decision|2|||
161593608|NCT01084876|583564967|FG001|Main Study Treatment Period|Physician Decision|0|||
161593609|NCT01084876|583564966|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
161593610|NCT01084876|583564967|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
161593611|NCT01084876|583564966|FG000|Main Study Treatment Period|Other Reason|0|||
161593612|NCT01084876|583564967|FG001|Main Study Treatment Period|Other Reason|1|||
161593613|NCT01084876|583564966|FG000|Main Study Treatment Period|Other|0|||
161593614|NCT01084876|583564967|FG001|Main Study Treatment Period|Other|1|||
161593615|NCT01084876|583564966|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
161829628|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
161829629|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
161543152|NCT03285295|583380302|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
161829630|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
161543153|NCT03285295|583380303|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
161829631|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
161829632|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
161829633|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
161829634|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
161829635|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
161829636|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
161593616|NCT01084876|583564967|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
161593617|NCT01084876|583564966|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
161593618|NCT01084876|583564967|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
161593619|NCT01084876|583564966|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
161593620|NCT01084876|583564967|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
161593621|NCT01084876|583564966|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
161593622|NCT01084876|583564967|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
161593623|NCT01084876|583564966|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
161593624|NCT01084876|583564967|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
161593625|NCT01084876|583564966|FG000|Treatment Period Beyond Cycle 8|Other|6|||
161593626|NCT01084876|583564967|FG001|Treatment Period Beyond Cycle 8|Other|9|||
161593627|NCT04515576|583564968|FG000|Overall Study|Withdrawal by Subject|0|||
161593628|NCT04515576|583564969|FG001|Overall Study|Withdrawal by Subject|0|||
161593629|NCT04515576|583564970|FG002|Overall Study|Withdrawal by Subject|0|||
161593630|NCT04515576|583564971|FG003|Overall Study|Withdrawal by Subject|0|||
161593631|NCT04515576|583564972|FG004|Overall Study|Withdrawal by Subject|0|||
161593632|NCT04515576|583564973|FG005|Overall Study|Withdrawal by Subject|1|||
161593633|NCT04256941|583564974|FG000|Overall Study|Withdrawal by Subject|0|||
161593634|NCT04256941|583564975|FG001|Overall Study|Withdrawal by Subject|1|||
161593635|NCT04256941|583564974|FG000|Overall Study|Death|1|||
161593636|NCT04256941|583564975|FG001|Overall Study|Death|0|||
161593637|NCT04256941|583564974|FG000|Overall Study|Disease Progession|0|||
161593638|NCT04256941|583564975|FG001|Overall Study|Disease Progession|2|||
161593639|NCT02577835|583564980|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
161593640|NCT04342494|583564981|FG000|Overall Study|Questionnaire partially completed|1|||
161593641|NCT04342494|583564982|FG001|Overall Study|Questionnaire partially completed|0|||
161593642|NCT04342494|583564983|FG002|Overall Study|Questionnaire partially completed|2|||
161593643|NCT04342494|583564984|FG003|Overall Study|Questionnaire partially completed|0|||
161593644|NCT04342494|583564985|FG004|Overall Study|Questionnaire partially completed|1|||
161593645|NCT04342494|583564981|FG000|Overall Study|Lost to Follow-up|49|||
161593646|NCT04342494|583564982|FG001|Overall Study|Lost to Follow-up|38|||
161593647|NCT04342494|583564983|FG002|Overall Study|Lost to Follow-up|34|||
161593648|NCT04342494|583564984|FG003|Overall Study|Lost to Follow-up|34|||
161593649|NCT04342494|583564985|FG004|Overall Study|Lost to Follow-up|35|||
161593650|NCT05119023|583564987|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
161593651|NCT05119023|583564987|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
161593652|NCT05119023|583564987|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
161593653|NCT03194217|583564988|FG000|Overall Study|Adverse Event|0|||
161593654|NCT03194217|583564989|FG001|Overall Study|Adverse Event|2|||
161593655|NCT03194217|583564990|FG002|Overall Study|Adverse Event|3|||
161593656|NCT03194217|583564991|FG003|Overall Study|Adverse Event|3|||
161593657|NCT03194217|583564988|FG000|Overall Study|Failure to meet randomisation criteria|0|||
161679569|NCT03061175|583879161|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
161679570|NCT00199836|583879162|FG000|Overall Study|Progressive Disease|5|||
161679571|NCT00199836|583879162|FG000|Overall Study|Death|1|||
161543154|NCT03285295|583380304|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
161543155|NCT03285295|583380305|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
161543156|NCT03285295|583380306|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
161543157|NCT03285295|583380302|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
161543158|NCT03285295|583380303|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
161543159|NCT03285295|583380304|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
161543160|NCT03285295|583380305|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
161543161|NCT03285295|583380306|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
161543162|NCT03285295|583380302|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
161543163|NCT03285295|583380303|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
161543164|NCT03285295|583380304|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
161543165|NCT03285295|583380305|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
161543166|NCT03285295|583380306|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
161543167|NCT03285295|583380302|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
161543168|NCT03285295|583380303|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
161543169|NCT03285295|583380304|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
161543170|NCT03285295|583380305|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
161593658|NCT03194217|583564989|FG001|Overall Study|Failure to meet randomisation criteria|0|||
161593659|NCT03194217|583564990|FG002|Overall Study|Failure to meet randomisation criteria|0|||
161543171|NCT03285295|583380306|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
161543172|NCT03285295|583380302|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
161543173|NCT03285295|583380303|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
161543174|NCT03285295|583380304|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
161543175|NCT03285295|583380305|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
161543176|NCT03285295|583380306|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
161543177|NCT03285295|583380302|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
161543178|NCT03285295|583380303|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
161543179|NCT03285295|583380304|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
161543180|NCT03285295|583380305|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
161543181|NCT03285295|583380306|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
161543182|NCT03285295|583380302|FG000|Alinity s Anti-HBc|No Results Generated|70|||
161543183|NCT03285295|583380303|FG001|Alinity s Anti-HBc|No Results Generated|0|||
161543184|NCT03285295|583380304|FG002|Alinity s Anti-HBc|No Results Generated|0|||
161543185|NCT03285295|583380305|FG003|Alinity s Anti-HBc|No Results Generated|0|||
161543186|NCT03285295|583380306|FG004|Alinity s Anti-HBc|No Results Generated|0|||
161543187|NCT03285295|583380302|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
161543188|NCT03285295|583380303|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
161543189|NCT03285295|583380304|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
161543190|NCT03285295|583380305|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
161679572|NCT00760669|583879163|FG000|Overall Study|Not assessed for overall improvement|18|||
161679573|NCT00760669|583879163|FG000|Overall Study|Participants missing efficacy assessment|6|||
161543191|NCT03285295|583380306|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
161543192|NCT03285295|583380302|FG000|Alinity s Chagas|Protocol Violation|76|||
161543193|NCT03285295|583380303|FG001|Alinity s Chagas|Protocol Violation|0|||
161543194|NCT03285295|583380304|FG002|Alinity s Chagas|Protocol Violation|0|||
161543195|NCT03285295|583380305|FG003|Alinity s Chagas|Protocol Violation|0|||
161543196|NCT03285295|583380306|FG004|Alinity s Chagas|Protocol Violation|0|||
161543197|NCT03285295|583380302|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
161543198|NCT03285295|583380303|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
161543199|NCT03285295|583380304|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
161543200|NCT03285295|583380305|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
161543201|NCT03285295|583380306|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
161543202|NCT03285295|583380302|FG000|Alinity s Chagas|No Results Generated|105|||
161543203|NCT03285295|583380303|FG001|Alinity s Chagas|No Results Generated|0|||
161543204|NCT03285295|583380304|FG002|Alinity s Chagas|No Results Generated|0|||
161543205|NCT03285295|583380305|FG003|Alinity s Chagas|No Results Generated|0|||
161543206|NCT03285295|583380306|FG004|Alinity s Chagas|No Results Generated|0|||
161543207|NCT03285295|583380302|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
161543208|NCT03285295|583380303|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
161543209|NCT03285295|583380304|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
161543210|NCT03285295|583380305|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
161543211|NCT03285295|583380306|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
161543212|NCT02200939|583380310|FG000|Overall Study|Participant withdrew consent|0|||
161543213|NCT02200939|583380311|FG001|Overall Study|Participant withdrew consent|1|||
161543214|NCT02200939|583380310|FG000|Overall Study|Lost to Follow-up|2|||
161543215|NCT02200939|583380311|FG001|Overall Study|Lost to Follow-up|9|||
161543216|NCT02200939|583380310|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
161543217|NCT02200939|583380311|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
161543218|NCT04567693|583380312|FG000|Overall Study|Death|0|||
161543219|NCT04567693|583380313|FG001|Overall Study|Death|0|||
161543220|NCT04567693|583380314|FG002|Overall Study|Death|2|||
161543221|NCT04567693|583380312|FG000|Overall Study|Lost to Follow-up|1|||
161543222|NCT04567693|583380313|FG001|Overall Study|Lost to Follow-up|0|||
161543223|NCT04567693|583380314|FG002|Overall Study|Lost to Follow-up|2|||
161543224|NCT04567693|583380312|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
161543225|NCT04567693|583380313|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
161543226|NCT04567693|583380314|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
161543227|NCT03722264|583380320|FG000|Overall Study|Physician Decision|3|||
161679574|NCT00760669|583879163|FG000|Overall Study|Participants with overlapping cases|1|||
161679575|NCT00760669|583879163|FG000|Overall Study|Took drug before entering in contract|5|||
161679576|NCT02456662|583879172|FG000|Overall Study|Lost to Follow-up|2|||
161679577|NCT02456662|583879173|FG001|Overall Study|Lost to Follow-up|1|||
161679578|NCT00504153|583879178|FG000|Overall Study|Withdrawal by Subject|1|||
161543228|NCT00957931|583380322|FG000|Overall Study|Death|4|||
161543229|NCT04867785|583380323|FG000|Overall Study|Adverse Event|1|||
161543230|NCT04867785|583380324|FG001|Overall Study|Adverse Event|0|||
161543231|NCT04867785|583380325|FG002|Overall Study|Adverse Event|1|||
161543232|NCT04867785|583380326|FG003|Overall Study|Adverse Event|0|||
161543233|NCT04867785|583380327|FG004|Overall Study|Adverse Event|0|||
161543234|NCT04867785|583380328|FG005|Overall Study|Adverse Event|0|||
161543235|NCT04867785|583380329|FG006|Overall Study|Adverse Event|0|||
161543236|NCT04867785|583380330|FG007|Overall Study|Adverse Event|2|||
161543237|NCT04867785|583380323|FG000|Overall Study|Lost to Follow-up|4|||
161543238|NCT04867785|583380324|FG001|Overall Study|Lost to Follow-up|4|||
161679579|NCT00504153|583879178|FG000|Overall Study|Adverse Event|4|||
161543239|NCT04867785|583380325|FG002|Overall Study|Lost to Follow-up|3|||
161543240|NCT04867785|583380326|FG003|Overall Study|Lost to Follow-up|2|||
161543241|NCT04867785|583380327|FG004|Overall Study|Lost to Follow-up|0|||
161543242|NCT04867785|583380328|FG005|Overall Study|Lost to Follow-up|1|||
161543243|NCT04867785|583380329|FG006|Overall Study|Lost to Follow-up|0|||
161543244|NCT04867785|583380330|FG007|Overall Study|Lost to Follow-up|1|||
161543245|NCT04867785|583380323|FG000|Overall Study|Withdrawal by Subject|6|||
161543246|NCT04867785|583380324|FG001|Overall Study|Withdrawal by Subject|2|||
161543247|NCT04867785|583380325|FG002|Overall Study|Withdrawal by Subject|2|||
161543248|NCT04867785|583380326|FG003|Overall Study|Withdrawal by Subject|1|||
161543249|NCT04867785|583380327|FG004|Overall Study|Withdrawal by Subject|2|||
161543250|NCT04867785|583380328|FG005|Overall Study|Withdrawal by Subject|0|||
161543251|NCT04867785|583380329|FG006|Overall Study|Withdrawal by Subject|2|||
161543252|NCT04867785|583380330|FG007|Overall Study|Withdrawal by Subject|5|||
161543253|NCT04867785|583380323|FG000|Overall Study|Physician Decision|0|||
161543254|NCT04867785|583380324|FG001|Overall Study|Physician Decision|0|||
161543255|NCT04867785|583380325|FG002|Overall Study|Physician Decision|0|||
161543256|NCT04867785|583380326|FG003|Overall Study|Physician Decision|0|||
161543257|NCT04867785|583380327|FG004|Overall Study|Physician Decision|0|||
161543258|NCT04867785|583380328|FG005|Overall Study|Physician Decision|0|||
161543259|NCT04867785|583380329|FG006|Overall Study|Physician Decision|0|||
161543260|NCT04867785|583380330|FG007|Overall Study|Physician Decision|1|||
161543261|NCT04867785|583380323|FG000|Overall Study|Inadvertent Enrollment|0|||
161543262|NCT04867785|583380324|FG001|Overall Study|Inadvertent Enrollment|0|||
161543263|NCT04867785|583380325|FG002|Overall Study|Inadvertent Enrollment|0|||
161543264|NCT04867785|583380326|FG003|Overall Study|Inadvertent Enrollment|1|||
161543265|NCT04867785|583380327|FG004|Overall Study|Inadvertent Enrollment|1|||
161543266|NCT04867785|583380328|FG005|Overall Study|Inadvertent Enrollment|0|||
161543267|NCT04867785|583380329|FG006|Overall Study|Inadvertent Enrollment|0|||
161543268|NCT04867785|583380330|FG007|Overall Study|Inadvertent Enrollment|1|||
161543269|NCT04867785|583380323|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161543270|NCT04867785|583380324|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161543271|NCT04867785|583380325|FG002|Overall Study|Eligibility Criteria Not Met|0|||
161543272|NCT04867785|583380326|FG003|Overall Study|Eligibility Criteria Not Met|0|||
161543273|NCT04867785|583380327|FG004|Overall Study|Eligibility Criteria Not Met|0|||
161543274|NCT04867785|583380328|FG005|Overall Study|Eligibility Criteria Not Met|0|||
161543275|NCT04867785|583380329|FG006|Overall Study|Eligibility Criteria Not Met|0|||
161543276|NCT04867785|583380330|FG007|Overall Study|Eligibility Criteria Not Met|1|||
161543277|NCT01486758|583380331|FG000|Overall Study|Lost to Follow-up|0|||
161543278|NCT01486758|583380332|FG001|Overall Study|Lost to Follow-up|1|||
161543279|NCT01062763|583380333|FG000|Overall Study|Adverse Event|3|||
161543280|NCT01062763|583380334|FG001|Overall Study|Adverse Event|4|||
161543281|NCT02494921|583380336|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
161543282|NCT02494921|583380337|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
161543283|NCT02494921|583380338|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
161543284|NCT02494921|583380339|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
161543285|NCT02494921|583380340|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
161543286|NCT02494921|583380336|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
161543287|NCT02494921|583380337|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
161543288|NCT02494921|583380338|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
161679580|NCT00504153|583879178|FG000|Overall Study|Death|1|||
161679581|NCT01034540|583879179|FG000|Overall Study|Adverse Event|0|||
161679582|NCT01034540|583879180|FG001|Overall Study|Adverse Event|1|||
161679583|NCT00932425|583879183|FG000|Overall Study|Lost to Follow-up|0|||
161543289|NCT02494921|583380339|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
161543290|NCT02494921|583380340|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
161543291|NCT02494921|583380336|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
161543292|NCT02494921|583380337|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
161543293|NCT02494921|583380338|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
161679584|NCT00932425|583879184|FG001|Overall Study|Lost to Follow-up|1|||
161679585|NCT00932425|583879183|FG000|Overall Study|Withdrawal by Subject|0|||
161543294|NCT02494921|583380339|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
161543295|NCT02494921|583380340|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
161543296|NCT02392611|583380346|FG000|Overall Study|Adverse Event|0|||
161543297|NCT02392611|583380347|FG001|Overall Study|Adverse Event|0|||
161543298|NCT02392611|583380348|FG002|Overall Study|Adverse Event|0|||
161543299|NCT02392611|583380349|FG003|Overall Study|Adverse Event|1|||
161543300|NCT02392611|583380350|FG004|Overall Study|Adverse Event|0|||
161543301|NCT02392611|583380351|FG005|Overall Study|Adverse Event|0|||
161543302|NCT02392611|583380352|FG006|Overall Study|Adverse Event|0|||
161543303|NCT02392611|583380353|FG007|Overall Study|Adverse Event|0|||
161679586|NCT00932425|583879184|FG001|Overall Study|Withdrawal by Subject|1|||
161679587|NCT03805750|583879185|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
161679588|NCT03805750|583879186|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
161543304|NCT02392611|583380354|FG008|Overall Study|Adverse Event|0|||
161543305|NCT02392611|583380346|FG000|Overall Study|Progressive disease|0|||
161543306|NCT02392611|583380347|FG001|Overall Study|Progressive disease|0|||
161543307|NCT02392611|583380348|FG002|Overall Study|Progressive disease|0|||
161543308|NCT02392611|583380349|FG003|Overall Study|Progressive disease|2|||
161543309|NCT02392611|583380350|FG004|Overall Study|Progressive disease|1|||
161543310|NCT02392611|583380351|FG005|Overall Study|Progressive disease|0|||
161543311|NCT02392611|583380352|FG006|Overall Study|Progressive disease|0|||
161543312|NCT02392611|583380353|FG007|Overall Study|Progressive disease|0|||
161543313|NCT02392611|583380354|FG008|Overall Study|Progressive disease|0|||
161543314|NCT02392611|583380346|FG000|Overall Study|Death|1|||
161543315|NCT02392611|583380347|FG001|Overall Study|Death|0|||
161543316|NCT02392611|583380348|FG002|Overall Study|Death|0|||
161543317|NCT02392611|583380349|FG003|Overall Study|Death|0|||
161543318|NCT02392611|583380350|FG004|Overall Study|Death|0|||
161543319|NCT02392611|583380351|FG005|Overall Study|Death|1|||
161543320|NCT02392611|583380352|FG006|Overall Study|Death|0|||
161543321|NCT02392611|583380353|FG007|Overall Study|Death|0|||
161543322|NCT02392611|583380354|FG008|Overall Study|Death|0|||
161543323|NCT02392611|583380346|FG000|Overall Study|Withdrawal by Subject|0|||
161543324|NCT02392611|583380347|FG001|Overall Study|Withdrawal by Subject|0|||
161543325|NCT02392611|583380348|FG002|Overall Study|Withdrawal by Subject|0|||
161543326|NCT02392611|583380349|FG003|Overall Study|Withdrawal by Subject|1|||
161543327|NCT02392611|583380350|FG004|Overall Study|Withdrawal by Subject|0|||
161543328|NCT02392611|583380351|FG005|Overall Study|Withdrawal by Subject|0|||
161543329|NCT02392611|583380352|FG006|Overall Study|Withdrawal by Subject|0|||
161543330|NCT02392611|583380353|FG007|Overall Study|Withdrawal by Subject|0|||
161543331|NCT02392611|583380354|FG008|Overall Study|Withdrawal by Subject|0|||
161543332|NCT02392611|583380346|FG000|Overall Study|Lost to Follow-up|0|||
161543333|NCT02392611|583380347|FG001|Overall Study|Lost to Follow-up|0|||
161543334|NCT02392611|583380348|FG002|Overall Study|Lost to Follow-up|0|||
161543335|NCT02392611|583380349|FG003|Overall Study|Lost to Follow-up|0|||
161543336|NCT02392611|583380350|FG004|Overall Study|Lost to Follow-up|0|||
161543337|NCT02392611|583380351|FG005|Overall Study|Lost to Follow-up|0|||
161543338|NCT02392611|583380352|FG006|Overall Study|Lost to Follow-up|1|||
161543339|NCT02392611|583380353|FG007|Overall Study|Lost to Follow-up|0|||
161543340|NCT02392611|583380354|FG008|Overall Study|Lost to Follow-up|0|||
161543341|NCT02392611|583380346|FG000|Overall Study|Enrolled, not treated|0|||
161543342|NCT02392611|583380347|FG001|Overall Study|Enrolled, not treated|0|||
161543343|NCT02392611|583380348|FG002|Overall Study|Enrolled, not treated|0|||
161543344|NCT02392611|583380349|FG003|Overall Study|Enrolled, not treated|2|||
161543345|NCT02392611|583380350|FG004|Overall Study|Enrolled, not treated|0|||
161543346|NCT02392611|583380351|FG005|Overall Study|Enrolled, not treated|0|||
161543347|NCT02392611|583380352|FG006|Overall Study|Enrolled, not treated|0|||
161543348|NCT02392611|583380353|FG007|Overall Study|Enrolled, not treated|0|||
161543349|NCT02392611|583380354|FG008|Overall Study|Enrolled, not treated|0|||
161543350|NCT00553202|583380361|FG000|Overall Study|Death|16|||
161543351|NCT00553202|583380361|FG000|Overall Study|Lost to Follow-up|1|||
161543352|NCT00553202|583380361|FG000|Overall Study|Physician Decision|28|||
161543353|NCT00553202|583380361|FG000|Overall Study|Withdrawal by Subject|1|||
161543354|NCT00553202|583380361|FG000|Overall Study|No donor identified|16|||
161543355|NCT00553202|583380361|FG000|Overall Study|Fails to meet organ function|6|||
161543356|NCT00369681|583380362|FG000|Overall Study|Death|1|||
161543357|NCT03239873|583380365|FG000|Overall Study|Lost to Follow-up|15|||
161543358|NCT03239873|583380366|FG001|Overall Study|Lost to Follow-up|16|||
161543359|NCT03239873|583380365|FG000|Overall Study|Physician Decision|1|||
161543360|NCT03239873|583380366|FG001|Overall Study|Physician Decision|0|||
161543361|NCT03239873|583380365|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
161543362|NCT03239873|583380366|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
161543363|NCT03239873|583380365|FG000|Overall Study|Withdrawal by Subject|2|||
161543364|NCT03239873|583380366|FG001|Overall Study|Withdrawal by Subject|0|||
161593660|NCT03194217|583564991|FG003|Overall Study|Failure to meet randomisation criteria|1|||
161593661|NCT03194217|583564988|FG000|Overall Study|Other|0|||
161593662|NCT03194217|583564989|FG001|Overall Study|Other|1|||
161543365|NCT03239873|583380365|FG000|Overall Study|Contraindication to study medication|1|||
161543366|NCT03239873|583380366|FG001|Overall Study|Contraindication to study medication|0|||
161543367|NCT03239873|583380365|FG000|Overall Study|Protocol Violation|1|||
161543368|NCT03239873|583380366|FG001|Overall Study|Protocol Violation|0|||
161543369|NCT01800201|583380367|FG000|Overall Study|Withdrawal by Subject|2|||
161543370|NCT01800201|583380368|FG001|Overall Study|Withdrawal by Subject|0|||
161543371|NCT01800201|583380367|FG000|Overall Study|patient privacy concerns|1|||
161543372|NCT01800201|583380368|FG001|Overall Study|patient privacy concerns|1|||
161543373|NCT01800201|583380367|FG000|Overall Study|did not want to use device|0|||
161543374|NCT01800201|583380368|FG001|Overall Study|did not want to use device|1|||
161543375|NCT01800201|583380367|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
161543376|NCT01800201|583380368|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
161543377|NCT01480596|583380369|FG000|Overall Study|Adverse Event|3|||
161543378|NCT01480596|583380370|FG001|Overall Study|Adverse Event|0|||
161543379|NCT01480596|583380369|FG000|Overall Study|MG exacerbation or change in medication|2|||
161543380|NCT01480596|583380370|FG001|Overall Study|MG exacerbation or change in medication|2|||
161543381|NCT02904902|583380371|FG000|Overall Study|Withdrawal by Subject|1|||
161543382|NCT05400746|583380376|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
161543383|NCT05400746|583380377|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
161543384|NCT05400746|583380378|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
161543385|NCT05375955|583380379|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
161543386|NCT05375955|583380380|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
161543387|NCT05375955|583380381|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
161543388|NCT05375955|583380382|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
161543389|NCT05375955|583380383|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
161543390|NCT05375955|583380384|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
161543391|NCT05375955|583380385|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
161543392|NCT05375955|583380379|FG000|Treatment (12 Weeks)|Physician Decision|4|||
161543393|NCT05375955|583380380|FG001|Treatment (12 Weeks)|Physician Decision|1|||
161543394|NCT05375955|583380381|FG002|Treatment (12 Weeks)|Physician Decision|3|||
161543395|NCT05375955|583380382|FG003|Treatment (12 Weeks)|Physician Decision|0|||
161543396|NCT05375955|583380383|FG004|Treatment (12 Weeks)|Physician Decision|0|||
161543397|NCT05375955|583380384|FG005|Treatment (12 Weeks)|Physician Decision|1|||
161543398|NCT05375955|583380385|FG006|Treatment (12 Weeks)|Physician Decision|0|||
161543399|NCT05375955|583380379|FG000|Treatment (12 Weeks)|Other|0|||
161543400|NCT05375955|583380380|FG001|Treatment (12 Weeks)|Other|1|||
161543401|NCT05375955|583380381|FG002|Treatment (12 Weeks)|Other|0|||
161543402|NCT05375955|583380382|FG003|Treatment (12 Weeks)|Other|0|||
161543403|NCT05375955|583380383|FG004|Treatment (12 Weeks)|Other|0|||
161543404|NCT05375955|583380384|FG005|Treatment (12 Weeks)|Other|0|||
161543405|NCT05375955|583380385|FG006|Treatment (12 Weeks)|Other|0|||
161543406|NCT05375955|583380379|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
161543407|NCT05375955|583380380|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
161543408|NCT05375955|583380381|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
161543409|NCT05375955|583380382|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
161543410|NCT05375955|583380383|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
161543411|NCT05375955|583380384|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
161543412|NCT05375955|583380385|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
161543413|NCT05375955|583380379|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
161543414|NCT05375955|583380380|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
161543415|NCT05375955|583380381|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
161543416|NCT05375955|583380382|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
161543417|NCT05375955|583380383|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
161543418|NCT05375955|583380384|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
161543419|NCT05375955|583380385|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
161543420|NCT05375955|583380379|FG000|Treatment (12 Weeks)|Pregnancy|0|||
161543421|NCT05375955|583380380|FG001|Treatment (12 Weeks)|Pregnancy|0|||
161543422|NCT05375955|583380381|FG002|Treatment (12 Weeks)|Pregnancy|1|||
161543423|NCT05375955|583380382|FG003|Treatment (12 Weeks)|Pregnancy|0|||
161543424|NCT05375955|583380383|FG004|Treatment (12 Weeks)|Pregnancy|0|||
161543425|NCT05375955|583380384|FG005|Treatment (12 Weeks)|Pregnancy|0|||
161831579|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
161831580|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
161831581|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
161831582|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
161831583|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
161831584|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
161831585|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
161831586|NCT00384293|584424836|FG000|Post-randomization Period|Adverse Event|0|||
161831587|NCT00384293|584424837|FG001|Post-randomization Period|Adverse Event|23|||
161831588|NCT00384293|584424838|FG002|Post-randomization Period|Adverse Event|7|||
161831589|NCT00384293|584424836|FG000|Post-randomization Period|Lost to Follow-up|0|||
161831590|NCT00384293|584424837|FG001|Post-randomization Period|Lost to Follow-up|2|||
161831591|NCT00384293|584424838|FG002|Post-randomization Period|Lost to Follow-up|1|||
161543426|NCT05375955|583380385|FG006|Treatment (12 Weeks)|Pregnancy|0|||
161543427|NCT05375955|583380379|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
161543428|NCT05375955|583380380|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
161543429|NCT05375955|583380381|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
161543430|NCT05375955|583380382|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
161543431|NCT05375955|583380383|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
161543432|NCT05375955|583380384|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
161543433|NCT05375955|583380385|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
161543434|NCT05375955|583380379|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
161543435|NCT05375955|583380380|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
161543436|NCT05375955|583380381|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
161543437|NCT05375955|583380382|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
161543438|NCT05375955|583380383|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
161543439|NCT05375955|583380384|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
161543440|NCT05375955|583380385|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
161543441|NCT05375955|583380379|FG000|Follow-up (up to 5 Weeks)|Other|0|||
161543442|NCT05375955|583380380|FG001|Follow-up (up to 5 Weeks)|Other|1|||
161543443|NCT05375955|583380381|FG002|Follow-up (up to 5 Weeks)|Other|0|||
161543444|NCT05375955|583380382|FG003|Follow-up (up to 5 Weeks)|Other|0|||
161543445|NCT05375955|583380383|FG004|Follow-up (up to 5 Weeks)|Other|0|||
161543446|NCT05375955|583380384|FG005|Follow-up (up to 5 Weeks)|Other|0|||
161543447|NCT05375955|583380385|FG006|Follow-up (up to 5 Weeks)|Other|0|||
161543448|NCT05375955|583380379|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
161543449|NCT05375955|583380380|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
161543450|NCT05375955|583380381|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
161543451|NCT05375955|583380382|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
161543452|NCT05375955|583380383|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
161543453|NCT05375955|583380384|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
161543454|NCT05375955|583380385|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
161543455|NCT05375955|583380379|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161543456|NCT05375955|583380380|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
161543457|NCT05375955|583380381|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161543458|NCT05375955|583380382|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
161543459|NCT05375955|583380383|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161543460|NCT05375955|583380384|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161543461|NCT05375955|583380385|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
161543462|NCT03879408|583380395|FG000|Overall Study|Lost to Follow-up|0|||
161543463|NCT03879408|583380396|FG001|Overall Study|Lost to Follow-up|3|||
161543464|NCT03879408|583380397|FG002|Overall Study|Lost to Follow-up|2|||
161543465|NCT03879408|583380398|FG003|Overall Study|Lost to Follow-up|1|||
161543466|NCT03879408|583380399|FG004|Overall Study|Lost to Follow-up|0|||
161543467|NCT03879408|583380395|FG000|Overall Study|Withdrawal by Subject|2|||
161543468|NCT03879408|583380396|FG001|Overall Study|Withdrawal by Subject|1|||
161543469|NCT03879408|583380397|FG002|Overall Study|Withdrawal by Subject|1|||
161543470|NCT03879408|583380398|FG003|Overall Study|Withdrawal by Subject|0|||
161543471|NCT03879408|583380399|FG004|Overall Study|Withdrawal by Subject|1|||
161543472|NCT05458024|583380400|FG000|Overall Study|Withdrawal by Subject|1|||
161543473|NCT05458024|583380401|FG001|Overall Study|Withdrawal by Subject|1|||
161543474|NCT05807919|583380402|FG000|Overall Study|Received antibiotics - excluded|0|||
161543475|NCT05807919|583380403|FG001|Overall Study|Received antibiotics - excluded|1|||
161543476|NCT05807919|583380402|FG000|Overall Study|Withdrawal by Subject|0|||
161543477|NCT05807919|583380403|FG001|Overall Study|Withdrawal by Subject|3|||
161593663|NCT03194217|583564990|FG002|Overall Study|Other|1|||
161593664|NCT03194217|583564991|FG003|Overall Study|Other|0|||
161593665|NCT02962895|583564992|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
161593666|NCT02962895|583564993|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
161543478|NCT05807919|583380402|FG000|Overall Study|Adverse Event|1|||
161593667|NCT02962895|583564994|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
161593668|NCT02962895|583564995|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161593669|NCT02962895|583564996|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161593670|NCT02962895|583564997|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161593671|NCT02962895|583564998|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161593672|NCT02962895|583564992|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161593673|NCT02962895|583564993|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
161593674|NCT02962895|583564994|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161831592|NCT00384293|584424836|FG000|Post-randomization Period|Protocol Violation|0|||
161543479|NCT05807919|583380403|FG001|Overall Study|Adverse Event|1|||
161543480|NCT00747123|583380404|FG000|Overall Study|Investigator's request|0|||
161543481|NCT00747123|583380405|FG001|Overall Study|Investigator's request|0|||
161543482|NCT00747123|583380406|FG002|Overall Study|Investigator's request|1|||
161543483|NCT00747123|583380407|FG003|Overall Study|Investigator's request|0|||
161543484|NCT00747123|583380404|FG000|Overall Study|Withdrew consent|0|||
161543485|NCT00747123|583380405|FG001|Overall Study|Withdrew consent|1|||
161543486|NCT00747123|583380406|FG002|Overall Study|Withdrew consent|0|||
161543487|NCT00747123|583380407|FG003|Overall Study|Withdrew consent|0|||
161543488|NCT00747123|583380404|FG000|Overall Study|Adverse Event|0|||
161543489|NCT00747123|583380405|FG001|Overall Study|Adverse Event|1|||
161543490|NCT00747123|583380406|FG002|Overall Study|Adverse Event|0|||
161543491|NCT00747123|583380407|FG003|Overall Study|Adverse Event|1|||
161543492|NCT02277743|583380416|FG000|Overall Study|Protocol Violation|1|||
161543493|NCT02277743|583380417|FG001|Overall Study|Protocol Violation|1|||
161543494|NCT02277743|583380418|FG002|Overall Study|Protocol Violation|1|||
161543495|NCT02277743|583380416|FG000|Overall Study|Adverse Event|10|||
161543496|NCT02277743|583380417|FG001|Overall Study|Adverse Event|6|||
161543497|NCT02277743|583380418|FG002|Overall Study|Adverse Event|6|||
161543498|NCT02277743|583380416|FG000|Overall Study|Lack of Efficacy|11|||
161543499|NCT02277743|583380417|FG001|Overall Study|Lack of Efficacy|4|||
161543500|NCT02277743|583380418|FG002|Overall Study|Lack of Efficacy|3|||
161543501|NCT02277743|583380416|FG000|Overall Study|Other than specified above|18|||
161543502|NCT02277743|583380417|FG001|Overall Study|Other than specified above|5|||
161543503|NCT02277743|583380418|FG002|Overall Study|Other than specified above|16|||
161543504|NCT01224158|583380422|FG000|Overall Study|Withdrawal by Subject|1|||
161543505|NCT01224158|583380423|FG001|Overall Study|Withdrawal by Subject|0|||
161543506|NCT03976466|583380426|FG000|Overall Study|Lost to Follow-up|1|||
161543507|NCT03976466|583380427|FG001|Overall Study|Lost to Follow-up|3|||
161543508|NCT02055157|583380428|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
161543509|NCT02055157|583380429|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
161543510|NCT02055157|583380430|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
161543511|NCT02055157|583380431|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
161543512|NCT02055157|583380428|FG000|Initial 6 Months|Adverse Event|0|||
161543513|NCT02055157|583380429|FG001|Initial 6 Months|Adverse Event|0|||
161543514|NCT02055157|583380430|FG002|Initial 6 Months|Adverse Event|0|||
161543515|NCT02055157|583380431|FG003|Initial 6 Months|Adverse Event|1|||
161543516|NCT02055157|583380428|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
161543517|NCT02055157|583380429|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
161543518|NCT02055157|583380430|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
161543519|NCT02055157|583380431|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
161543520|NCT02055157|583380428|FG000|18-month Extension|Investigator decision|0|||
161543521|NCT02055157|583380429|FG001|18-month Extension|Investigator decision|1|||
161543522|NCT02055157|583380430|FG002|18-month Extension|Investigator decision|0|||
161543523|NCT02055157|583380431|FG003|18-month Extension|Investigator decision|0|||
161543524|NCT02055157|583380428|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
161543525|NCT02055157|583380429|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
161543526|NCT02055157|583380430|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
161543527|NCT02055157|583380431|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
161543528|NCT02034708|583380432|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
161543529|NCT02034708|583380433|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
161543530|NCT02034708|583380432|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
161543531|NCT02034708|583380433|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
161543532|NCT02034708|583380432|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
161543533|NCT02034708|583380433|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
161543534|NCT02034708|583380432|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
161543535|NCT02034708|583380433|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
161543536|NCT00943306|583380436|FG000|Overall Study|Physician Decision|1|||
161543537|NCT00943306|583380436|FG000|Overall Study|Death|1|||
161543538|NCT00943306|583380436|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
161543539|NCT00733499|583380437|FG000|Pre-operative|Protocol Violation|0|||
161543540|NCT00733499|583380438|FG001|Pre-operative|Protocol Violation|1|||
161543541|NCT00733499|583380437|FG000|3 Months Follow-up|Death|1|||
161543542|NCT00733499|583380438|FG001|3 Months Follow-up|Death|2|||
161543543|NCT00733499|583380437|FG000|6 Months Follow-up|Death|0|||
161543544|NCT00733499|583380438|FG001|6 Months Follow-up|Death|2|||
161543545|NCT00733499|583380437|FG000|6 Months Follow-up|Adverse Event|0|||
161543546|NCT00733499|583380438|FG001|6 Months Follow-up|Adverse Event|1|||
161543547|NCT00733499|583380437|FG000|12 Months Follow-up|Death|2|||
161543548|NCT00733499|583380438|FG001|12 Months Follow-up|Death|1|||
161543549|NCT00733499|583380437|FG000|24 Months Follow-up|Death|0|||
161543550|NCT00733499|583380438|FG001|24 Months Follow-up|Death|1|||
161543551|NCT00733499|583380437|FG000|5 Year Followup|Adverse Event|2|||
161543552|NCT00733499|583380438|FG001|5 Year Followup|Adverse Event|2|||
161543553|NCT00733499|583380437|FG000|5 Year Followup|Non device related AE|0|||
161543554|NCT00733499|583380438|FG001|5 Year Followup|Non device related AE|1|||
161543555|NCT00733499|583380437|FG000|5 Year Followup|Revision of Study Implant|0|||
161543556|NCT00733499|583380438|FG001|5 Year Followup|Revision of Study Implant|1|||
161543557|NCT00733499|583380437|FG000|5 Year Followup|Lost to Follow-up|2|||
161543558|NCT00733499|583380438|FG001|5 Year Followup|Lost to Follow-up|0|||
161543559|NCT00733499|583380437|FG000|5 Year Followup|Death|13|||
161593675|NCT02962895|583564995|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161593676|NCT02962895|583564996|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161593677|NCT02962895|583564997|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161593678|NCT02962895|583564998|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161593679|NCT02962895|583564992|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161593680|NCT02962895|583564993|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
161593681|NCT02962895|583564994|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
161593682|NCT02962895|583564995|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161543560|NCT00733499|583380438|FG001|5 Year Followup|Death|19|||
161543561|NCT00733499|583380437|FG000|5 Year Followup|missing, unable to locate|0|||
161543562|NCT00733499|583380438|FG001|5 Year Followup|missing, unable to locate|1|||
161543563|NCT00733499|583380437|FG000|5 Year Followup|Withdrawal by Subject|4|||
161543564|NCT00733499|583380438|FG001|5 Year Followup|Withdrawal by Subject|1|||
161543565|NCT00733499|583380437|FG000|10 Year Followup|Death|9|||
161543566|NCT00733499|583380438|FG001|10 Year Followup|Death|7|||
161543567|NCT00733499|583380437|FG000|10 Year Followup|Adverse Event|3|||
161543568|NCT00733499|583380438|FG001|10 Year Followup|Adverse Event|3|||
161543569|NCT00733499|583380437|FG000|10 Year Followup|Lost to Follow-up|3|||
161543570|NCT00733499|583380438|FG001|10 Year Followup|Lost to Follow-up|2|||
161593683|NCT02962895|583564996|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161543571|NCT00733499|583380437|FG000|10 Year Followup|Withdrawal by Subject|5|||
161543572|NCT00733499|583380438|FG001|10 Year Followup|Withdrawal by Subject|5|||
161543573|NCT00733499|583380437|FG000|10 Year Followup|missing, unable to locate|0|||
161543574|NCT00733499|583380438|FG001|10 Year Followup|missing, unable to locate|2|||
161543575|NCT00733980|583380439|FG000|Overall Study|Adverse Event|5|||
161543576|NCT00733980|583380440|FG001|Overall Study|Adverse Event|2|||
161543577|NCT00733980|583380439|FG000|Overall Study|Lack of Efficacy|0|||
161543578|NCT00733980|583380440|FG001|Overall Study|Lack of Efficacy|1|||
161543579|NCT00733980|583380439|FG000|Overall Study|Protocol Violation|2|||
161543580|NCT00733980|583380440|FG001|Overall Study|Protocol Violation|1|||
161543581|NCT00733980|583380439|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
161543582|NCT00733980|583380440|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
161543583|NCT00733980|583380439|FG000|Overall Study|Lost to Follow-up|6|||
161593684|NCT02962895|583564997|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161593685|NCT02962895|583564998|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161593686|NCT02962895|583564992|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
161593687|NCT02962895|583564993|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161593688|NCT02962895|583564994|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161593689|NCT02962895|583564995|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161593690|NCT02962895|583564996|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161593691|NCT02962895|583564997|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161679589|NCT00493220|583879187|FG000|Third Intervention|Withdrawal by Subject|1|||
161829637|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
161829638|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161829639|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161679590|NCT00493220|583879188|FG001|Third Intervention|Withdrawal by Subject|0|||
161679591|NCT00493220|583879189|FG002|Third Intervention|Withdrawal by Subject|0|||
161543584|NCT00733980|583380440|FG001|Overall Study|Lost to Follow-up|11|||
161543585|NCT00733980|583380439|FG000|Overall Study|Physician Decision|2|||
161543586|NCT00733980|583380440|FG001|Overall Study|Physician Decision|3|||
161543587|NCT00733980|583380439|FG000|Overall Study|Withdrawal by Subject|6|||
161543588|NCT00733980|583380440|FG001|Overall Study|Withdrawal by Subject|2|||
161543589|NCT02739347|583380441|FG000|Overall Study|Adverse Event|3|||
161543590|NCT02739347|583380442|FG001|Overall Study|Adverse Event|0|||
161543591|NCT02739347|583380441|FG000|Overall Study|Protocol Violation|0|||
161543592|NCT02739347|583380442|FG001|Overall Study|Protocol Violation|1|||
161543593|NCT02739347|583380441|FG000|Overall Study|Lost to Follow-up|0|||
161543594|NCT02739347|583380442|FG001|Overall Study|Lost to Follow-up|2|||
161679592|NCT00493220|583879190|FG003|Third Intervention|Withdrawal by Subject|0|||
161679593|NCT00493220|583879191|FG004|Third Intervention|Withdrawal by Subject|0|||
161679594|NCT00493220|583879192|FG005|Third Intervention|Withdrawal by Subject|0|||
161679595|NCT00310804|583879193|FG000|Overall Study|Lost to Follow-up|2|||
161543595|NCT01552954|583380443|FG000|Overall Study|Adverse Event|1|||
161543596|NCT01552954|583380444|FG001|Overall Study|Adverse Event|2|||
161543597|NCT01552954|583380443|FG000|Overall Study|Lost to Follow-up|1|||
161543598|NCT01552954|583380444|FG001|Overall Study|Lost to Follow-up|1|||
161543599|NCT01552954|583380443|FG000|Overall Study|Withdrawal by Subject|1|||
161543600|NCT01552954|583380444|FG001|Overall Study|Withdrawal by Subject|1|||
161543601|NCT01552954|583380443|FG000|Overall Study|Protocol Violation|1|||
161543602|NCT01552954|583380444|FG001|Overall Study|Protocol Violation|2|||
161543603|NCT01552954|583380443|FG000|Overall Study|diagnosed DM|1|||
161543604|NCT01552954|583380444|FG001|Overall Study|diagnosed DM|0|||
161543605|NCT01931735|583380445|FG000|Randomized Phase|Lost to Follow-up|2|||
161543606|NCT01931735|583380446|FG001|Randomized Phase|Lost to Follow-up|2|||
161543607|NCT01931735|583380447|FG002|Randomized Phase|Lost to Follow-up|5|||
161543608|NCT01931735|583380448|FG003|Randomized Phase|Lost to Follow-up|0|||
161543609|NCT01931735|583380445|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
161543610|NCT01931735|583380446|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
161543611|NCT01931735|583380447|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
161543612|NCT01931735|583380448|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
161543613|NCT01931735|583380445|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
161543614|NCT01931735|583380446|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
161543615|NCT01931735|583380447|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
161543616|NCT01931735|583380448|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
161543617|NCT02719990|583380452|FG000|Overall Study|Physician Decision|2|||
161543618|NCT02719990|583380452|FG000|Overall Study|Withdrawal by Subject|2|||
161543619|NCT02719990|583380452|FG000|Overall Study|Study Terminated By Sponsor|32|||
161543620|NCT03324880|583380453|FG000|Overall Study|Adverse Event|0|||
161543621|NCT03324880|583380454|FG001|Overall Study|Adverse Event|2|||
161543622|NCT03324880|583380453|FG000|Overall Study|Withdrawal by Subject|2|||
161543623|NCT03324880|583380454|FG001|Overall Study|Withdrawal by Subject|2|||
161543624|NCT03324880|583380453|FG000|Overall Study|Lost to Follow-up|0|||
161543625|NCT03324880|583380454|FG001|Overall Study|Lost to Follow-up|1|||
161543626|NCT03324880|583380453|FG000|Overall Study|Product Recall|0|||
161543627|NCT03324880|583380454|FG001|Overall Study|Product Recall|1|||
161543628|NCT00652938|583380458|FG000|Overall Study|Adverse Event|1|||
161543629|NCT00652938|583380459|FG001|Overall Study|Adverse Event|0|||
161543630|NCT00652938|583380460|FG002|Overall Study|Adverse Event|2|||
161543631|NCT00652938|583380458|FG000|Overall Study|Withdrawal by Subject|0|||
161543632|NCT00652938|583380459|FG001|Overall Study|Withdrawal by Subject|6|||
161543633|NCT00652938|583380460|FG002|Overall Study|Withdrawal by Subject|1|||
161543634|NCT00652938|583380458|FG000|Overall Study|Lost to Follow-up|0|||
161543635|NCT00652938|583380459|FG001|Overall Study|Lost to Follow-up|0|||
161543636|NCT00652938|583380460|FG002|Overall Study|Lost to Follow-up|2|||
161543637|NCT00652938|583380458|FG000|Overall Study|fear of blood sampling|0|||
161543638|NCT00652938|583380459|FG001|Overall Study|fear of blood sampling|1|||
161543639|NCT00652938|583380460|FG002|Overall Study|fear of blood sampling|0|||
161543640|NCT01412801|583380461|FG000|Overall Study|Death|0|||
161543641|NCT01412801|583380462|FG001|Overall Study|Death|1|||
161543642|NCT01412801|583380463|FG002|Overall Study|Death|0|||
161829640|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161543643|NCT01412801|583380464|FG003|Overall Study|Death|4|||
161593692|NCT02962895|583564998|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161829641|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
161829642|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
161829643|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
161829644|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
161829645|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161829646|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161829647|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161829648|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
161829649|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
161829650|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
161543644|NCT01412801|583380465|FG004|Overall Study|Death|2|||
161543645|NCT01412801|583380466|FG005|Overall Study|Death|2|||
161543646|NCT01412801|583380461|FG000|Overall Study|Lost to Follow-up|1|||
161543647|NCT01412801|583380462|FG001|Overall Study|Lost to Follow-up|2|||
161543648|NCT01412801|583380463|FG002|Overall Study|Lost to Follow-up|4|||
161543649|NCT01412801|583380464|FG003|Overall Study|Lost to Follow-up|0|||
161543650|NCT01412801|583380465|FG004|Overall Study|Lost to Follow-up|1|||
161543651|NCT01412801|583380466|FG005|Overall Study|Lost to Follow-up|1|||
161543652|NCT01412801|583380461|FG000|Overall Study|Withdrawal by Subject|3|||
161543653|NCT01412801|583380462|FG001|Overall Study|Withdrawal by Subject|2|||
161543654|NCT01412801|583380463|FG002|Overall Study|Withdrawal by Subject|1|||
161543655|NCT01412801|583380464|FG003|Overall Study|Withdrawal by Subject|0|||
161543656|NCT01412801|583380465|FG004|Overall Study|Withdrawal by Subject|0|||
161543657|NCT01412801|583380466|FG005|Overall Study|Withdrawal by Subject|0|||
161543658|NCT01412801|583380461|FG000|Overall Study|Relocated to another area|0|||
161543659|NCT01412801|583380462|FG001|Overall Study|Relocated to another area|0|||
161543660|NCT01412801|583380463|FG002|Overall Study|Relocated to another area|2|||
161543661|NCT01412801|583380464|FG003|Overall Study|Relocated to another area|0|||
161543662|NCT01412801|583380465|FG004|Overall Study|Relocated to another area|0|||
161543663|NCT01412801|583380466|FG005|Overall Study|Relocated to another area|0|||
161543664|NCT01235403|583380467|FG000|Overall Study|Adverse Event|14|||
161543665|NCT01235403|583380467|FG000|Overall Study|Lost to Follow-up|2|||
161543666|NCT01235403|583380467|FG000|Overall Study|Withdrawal by Subject|4|||
161543667|NCT01235403|583380467|FG000|Overall Study|Lack of Efficacy|2|||
161543668|NCT01235403|583380467|FG000|Overall Study|Other reasons for premature termination|4|||
161543669|NCT01547299|583380468|FG000|Overall Study|Withdrawal by Subject|2|||
161543670|NCT01547299|583380469|FG001|Overall Study|Withdrawal by Subject|2|||
161543671|NCT05076149|583380470|FG000|Overall Study|Adverse Event|3|||
161543672|NCT05076149|583380471|FG001|Overall Study|Adverse Event|9|||
161543673|NCT05076149|583380470|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161543674|NCT05076149|583380471|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
161543675|NCT05076149|583380470|FG000|Overall Study|Lost to Follow-up|0|||
161543676|NCT05076149|583380471|FG001|Overall Study|Lost to Follow-up|1|||
161543677|NCT05076149|583380470|FG000|Overall Study|Commercial drug is available for participant|0|||
161543678|NCT05076149|583380471|FG001|Overall Study|Commercial drug is available for participant|1|||
161543679|NCT05076149|583380470|FG000|Overall Study|Other non compliance|1|||
161593693|NCT02962895|583564992|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161593694|NCT02962895|583564993|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
161593695|NCT02962895|583564994|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161593696|NCT02962895|583564995|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161593697|NCT02962895|583564996|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161593698|NCT02962895|583564997|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161593699|NCT02962895|583564998|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161829651|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
161829652|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
161829653|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
161543680|NCT05076149|583380471|FG001|Overall Study|Other non compliance|1|||
161543681|NCT05076149|583380470|FG000|Overall Study|Physician Decision|0|||
161543682|NCT05076149|583380471|FG001|Overall Study|Physician Decision|1|||
161829654|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
161829655|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
161829656|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
161829657|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161829658|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161829659|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161829660|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
161829661|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161829662|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
161829663|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161829664|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161829665|NCT01396421|584415848|FG000|Overall Study|Lost to Follow-up|0|||
161829666|NCT01396421|584415849|FG001|Overall Study|Lost to Follow-up|0|||
161829667|NCT01396421|584415850|FG002|Overall Study|Lost to Follow-up|0|||
161829668|NCT01396421|584415851|FG003|Overall Study|Lost to Follow-up|1|||
161829669|NCT01396421|584415848|FG000|Overall Study|Adverse Event|17|||
161829670|NCT01396421|584415849|FG001|Overall Study|Adverse Event|15|||
161829671|NCT01396421|584415850|FG002|Overall Study|Adverse Event|12|||
161829672|NCT01396421|584415851|FG003|Overall Study|Adverse Event|32|||
161829673|NCT01396421|584415848|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161829674|NCT01396421|584415849|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
161829675|NCT01396421|584415850|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
161829676|NCT01396421|584415851|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
161829677|NCT01396421|584415848|FG000|Overall Study|Physician Decision|1|||
161829678|NCT01396421|584415849|FG001|Overall Study|Physician Decision|1|||
161543683|NCT05076149|583380470|FG000|Overall Study|Other|5|||
161543684|NCT05076149|583380471|FG001|Overall Study|Other|4|||
161543685|NCT00782496|583380472|FG000|Overall Study|Lost to Follow-up|14|||
161543686|NCT00782496|583380473|FG001|Overall Study|Lost to Follow-up|15|||
161543687|NCT02087501|583380474|FG000|Overall Study|Death|7|||
161543688|NCT02087501|583380474|FG000|Overall Study|Open repair of aneurysm|1|||
161543689|NCT02087501|583380474|FG000|Overall Study|Lost to Follow-up|2|||
161829679|NCT01396421|584415850|FG002|Overall Study|Physician Decision|0|||
161829680|NCT01396421|584415851|FG003|Overall Study|Physician Decision|3|||
161829681|NCT01396421|584415848|FG000|Overall Study|Withdrawal by Subject|31|||
161829682|NCT01396421|584415849|FG001|Overall Study|Withdrawal by Subject|24|||
161829683|NCT01396421|584415850|FG002|Overall Study|Withdrawal by Subject|13|||
161829684|NCT01396421|584415851|FG003|Overall Study|Withdrawal by Subject|21|||
161829685|NCT01396421|584415848|FG000|Overall Study|Protocol Deviation|2|||
161829686|NCT01396421|584415849|FG001|Overall Study|Protocol Deviation|1|||
161829687|NCT01396421|584415850|FG002|Overall Study|Protocol Deviation|1|||
161829688|NCT01396421|584415851|FG003|Overall Study|Protocol Deviation|0|||
161829689|NCT01396421|584415848|FG000|Overall Study|Lack of Efficacy|7|||
161829690|NCT01396421|584415849|FG001|Overall Study|Lack of Efficacy|17|||
161829691|NCT01396421|584415850|FG002|Overall Study|Lack of Efficacy|7|||
161829692|NCT01396421|584415851|FG003|Overall Study|Lack of Efficacy|18|||
161829693|NCT01610063|584415860|FG000|Overall Study|Lost to Follow-up|42|||
161829694|NCT01610063|584415861|FG001|Overall Study|Lost to Follow-up|20|||
161829695|NCT03314662|584415862|FG000|Overall Study|Withdrawal by Subject|1|||
161829696|NCT03314662|584415863|FG001|Overall Study|Withdrawal by Subject|1|||
161829697|NCT03314662|584415864|FG002|Overall Study|Withdrawal by Subject|1|||
161543690|NCT03682705|583380477|FG000|Overall Study|Adverse Event|1|||
161543691|NCT03682705|583380478|FG001|Overall Study|Adverse Event|1|||
161543692|NCT03682705|583380479|FG002|Overall Study|Adverse Event|1|||
161543693|NCT03682705|583380480|FG003|Overall Study|Adverse Event|0|||
161543694|NCT03682705|583380481|FG004|Overall Study|Adverse Event|1|||
161543695|NCT03682705|583380482|FG005|Overall Study|Adverse Event|1|||
161543696|NCT03682705|583380477|FG000|Overall Study|Withdrawal by Subject|1|||
161543697|NCT03682705|583380478|FG001|Overall Study|Withdrawal by Subject|3|||
161593700|NCT02962895|583564992|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161593701|NCT02962895|583564993|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161593702|NCT02962895|583564994|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161593703|NCT02962895|583564995|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
161593704|NCT02962895|583564996|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161593705|NCT02962895|583564997|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161593706|NCT02962895|583564998|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161593707|NCT02962895|583564992|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161593708|NCT02962895|583564993|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161593709|NCT02962895|583564994|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161593710|NCT02962895|583564995|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161593711|NCT02962895|583564996|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161593712|NCT02962895|583564997|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161593713|NCT02962895|583564998|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
161593714|NCT02962895|583564992|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161593715|NCT02962895|583564993|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161593716|NCT02962895|583564994|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161593717|NCT02962895|583564995|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161593718|NCT02962895|583564996|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
161593719|NCT02962895|583564997|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161593720|NCT02962895|583564998|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
161829698|NCT03314662|584415862|FG000|Overall Study|Lost to Follow-up|5|||
161829699|NCT03314662|584415863|FG001|Overall Study|Lost to Follow-up|4|||
161829700|NCT03314662|584415864|FG002|Overall Study|Lost to Follow-up|4|||
161829701|NCT03314662|584415862|FG000|Overall Study|Death|2|||
161829702|NCT03314662|584415863|FG001|Overall Study|Death|0|||
161543698|NCT03682705|583380479|FG002|Overall Study|Withdrawal by Subject|2|||
161543699|NCT03682705|583380480|FG003|Overall Study|Withdrawal by Subject|4|||
161543700|NCT03682705|583380481|FG004|Overall Study|Withdrawal by Subject|0|||
161543701|NCT03682705|583380482|FG005|Overall Study|Withdrawal by Subject|1|||
161543702|NCT03682705|583380477|FG000|Overall Study|Other, not specified|0|||
161543703|NCT03682705|583380478|FG001|Overall Study|Other, not specified|0|||
161543704|NCT03682705|583380479|FG002|Overall Study|Other, not specified|0|||
161543705|NCT03682705|583380480|FG003|Overall Study|Other, not specified|1|||
161543706|NCT03682705|583380481|FG004|Overall Study|Other, not specified|2|||
161543707|NCT03682705|583380482|FG005|Overall Study|Other, not specified|0|||
161543708|NCT03682705|583380477|FG000|Overall Study|Lost to Follow-up|0|||
161543709|NCT03682705|583380478|FG001|Overall Study|Lost to Follow-up|0|||
161543710|NCT03682705|583380479|FG002|Overall Study|Lost to Follow-up|0|||
161543711|NCT03682705|583380480|FG003|Overall Study|Lost to Follow-up|0|||
161543712|NCT03682705|583380481|FG004|Overall Study|Lost to Follow-up|3|||
161543713|NCT03682705|583380482|FG005|Overall Study|Lost to Follow-up|0|||
161543714|NCT00094328|583380483|FG000|Overall Study|Lost to Follow-up|1|||
161543715|NCT00117156|583380484|FG000|Overall Study|Adverse Event|9|||
161543716|NCT00117156|583380484|FG000|Overall Study|Physician Decision|1|||
161543717|NCT00117156|583380484|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
161543718|NCT02213328|583380485|FG000|Overall Study|Withdrawal by Subject|10|||
161543719|NCT02213328|583380485|FG000|Overall Study|Physician Decision|2|||
161543720|NCT02213328|583380485|FG000|Overall Study|Lost to Follow-up|16|||
161543721|NCT04043962|583380486|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
161543722|NCT04043962|583380486|FG000|Post-Treatment|Withdrawal by Subject|5|||
161543723|NCT04043962|583380486|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
161543724|NCT01874145|583380487|FG000|Core Period|Non-compliance|1|||
161543725|NCT01874145|583380488|FG001|Core Period|Non-compliance|0|||
161543726|NCT01874145|583380487|FG000|Core Period|Protocol Violation|1|||
161543727|NCT01874145|583380488|FG001|Core Period|Protocol Violation|1|||
161543728|NCT01874145|583380487|FG000|Core Period|Physician Decision|1|||
161543729|NCT01874145|583380488|FG001|Core Period|Physician Decision|1|||
161543730|NCT01874145|583380487|FG000|Core Period|Adverse Event|0|||
161543731|NCT01874145|583380488|FG001|Core Period|Adverse Event|1|||
161543732|NCT01874145|583380487|FG000|Core Period|Withdrawal by Subject|0|||
161543733|NCT01874145|583380488|FG001|Core Period|Withdrawal by Subject|4|||
161543734|NCT01874145|583380487|FG000|Extension Period|Adverse Event|3|||
161543735|NCT01874145|583380488|FG001|Extension Period|Adverse Event|2|||
161543736|NCT01874145|583380487|FG000|Extension Period|Withdrawal by Subject|2|||
161543737|NCT01874145|583380488|FG001|Extension Period|Withdrawal by Subject|1|||
161543738|NCT01874145|583380487|FG000|Extension Period|Lost to Follow-up|1|||
161543739|NCT01874145|583380488|FG001|Extension Period|Lost to Follow-up|1|||
161543740|NCT00402337|583380489|FG000|Overall Study|Adverse Event|0|||
161543741|NCT00402337|583380490|FG001|Overall Study|Adverse Event|2|||
161543742|NCT00402337|583380491|FG002|Overall Study|Adverse Event|2|||
161543743|NCT00402337|583380492|FG003|Overall Study|Adverse Event|3|||
161543744|NCT00402337|583380493|FG004|Overall Study|Adverse Event|2|||
161543745|NCT00402337|583380489|FG000|Overall Study|Noncompliance|0|||
161543746|NCT00402337|583380490|FG001|Overall Study|Noncompliance|0|||
161543747|NCT00402337|583380491|FG002|Overall Study|Noncompliance|0|||
161543748|NCT00402337|583380492|FG003|Overall Study|Noncompliance|0|||
161543749|NCT00402337|583380493|FG004|Overall Study|Noncompliance|2|||
161543750|NCT00402337|583380489|FG000|Overall Study|Withdrawal by Subject|5|||
161543751|NCT00402337|583380490|FG001|Overall Study|Withdrawal by Subject|3|||
161543752|NCT00402337|583380491|FG002|Overall Study|Withdrawal by Subject|1|||
161543753|NCT00402337|583380492|FG003|Overall Study|Withdrawal by Subject|6|||
161543754|NCT00402337|583380493|FG004|Overall Study|Withdrawal by Subject|4|||
161543755|NCT00402337|583380489|FG000|Overall Study|Lost to Follow-up|0|||
161543756|NCT00402337|583380490|FG001|Overall Study|Lost to Follow-up|0|||
161543757|NCT00402337|583380491|FG002|Overall Study|Lost to Follow-up|1|||
161543758|NCT00402337|583380492|FG003|Overall Study|Lost to Follow-up|2|||
161543759|NCT00402337|583380493|FG004|Overall Study|Lost to Follow-up|0|||
161543760|NCT00402337|583380489|FG000|Overall Study|Physician Decision|0|||
161543761|NCT00402337|583380490|FG001|Overall Study|Physician Decision|0|||
161543762|NCT00402337|583380491|FG002|Overall Study|Physician Decision|0|||
161543763|NCT00402337|583380492|FG003|Overall Study|Physician Decision|1|||
161543764|NCT00402337|583380493|FG004|Overall Study|Physician Decision|0|||
161543765|NCT00402337|583380489|FG000|Overall Study|Other Reason|0|||
161829703|NCT03314662|584415864|FG002|Overall Study|Death|0|||
161829704|NCT01117766|584415869|FG000|First Intervention|Adverse Event|0|||
161829705|NCT01117766|584415870|FG001|First Intervention|Adverse Event|1|||
161829706|NCT01117766|584415869|FG000|First Intervention|Protocol Violation|1|||
161829707|NCT01117766|584415870|FG001|First Intervention|Protocol Violation|0|||
161543766|NCT00402337|583380490|FG001|Overall Study|Other Reason|1|||
161543767|NCT00402337|583380491|FG002|Overall Study|Other Reason|0|||
161543768|NCT00402337|583380492|FG003|Overall Study|Other Reason|0|||
161543769|NCT00402337|583380493|FG004|Overall Study|Other Reason|0|||
161543770|NCT01654601|583380494|FG000|1st Administration|Withdrawal by Subject|2|||
161543771|NCT01654601|583380495|FG001|1st Administration|Withdrawal by Subject|0|||
161543772|NCT01654601|583380494|FG000|1st Administration|Protocol Violation|0|||
161543773|NCT01654601|583380495|FG001|1st Administration|Protocol Violation|2|||
161543774|NCT01654601|583380494|FG000|2nd Administration|Adverse Event|1|||
161543775|NCT01654601|583380495|FG001|2nd Administration|Adverse Event|0|||
161543776|NCT01654601|583380494|FG000|2nd Administration|Protocol Violation|0|||
161543777|NCT01654601|583380495|FG001|2nd Administration|Protocol Violation|1|||
161543778|NCT02636270|583380496|FG000|Overall Study|Adverse Event|1|||
161543779|NCT02636270|583380497|FG001|Overall Study|Adverse Event|0|||
161543780|NCT02636270|583380498|FG002|Overall Study|Adverse Event|0|||
161543781|NCT02636270|583380496|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
161543782|NCT02636270|583380497|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
161543783|NCT02636270|583380498|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
161543784|NCT00767104|583382484|FG000|Overall Study|Lost to Follow-up|1|||
161679596|NCT00310804|583879194|FG001|Overall Study|Lost to Follow-up|0|||
161679597|NCT00310804|583879193|FG000|Overall Study|Withdrawal by Subject|3|||
161679598|NCT00310804|583879194|FG001|Overall Study|Withdrawal by Subject|0|||
161679599|NCT01889238|583879197|FG000|Overall Study|Death|1|||
161829708|NCT01117766|584415869|FG000|Washout Period|Protocol Violation|0|||
161829709|NCT01117766|584415870|FG001|Washout Period|Protocol Violation|2|||
161829710|NCT01117766|584415869|FG000|Second Intervention|Lost to Follow-up|1|||
161829711|NCT01117766|584415870|FG001|Second Intervention|Lost to Follow-up|0|||
161829712|NCT01117766|584415869|FG000|Second Intervention|Other|1|||
161829713|NCT01117766|584415870|FG001|Second Intervention|Other|2|||
161829714|NCT01117766|584415869|FG000|Second Intervention|Adverse Event|0|||
161829715|NCT01117766|584415870|FG001|Second Intervention|Adverse Event|2|||
161829716|NCT01117766|584415869|FG000|Second Intervention|Withdrawal by Subject|0|||
161829717|NCT01117766|584415870|FG001|Second Intervention|Withdrawal by Subject|1|||
161829718|NCT04405739|584415871|FG000|Overall Study|Adverse Event|0|||
161829719|NCT04405739|584415872|FG001|Overall Study|Adverse Event|1|||
161829720|NCT04405739|584415873|FG002|Overall Study|Adverse Event|0|||
161829721|NCT04405739|584415874|FG003|Overall Study|Adverse Event|0|||
161829722|NCT04405739|584415871|FG000|Overall Study|Lost to Follow-up|0|||
161829723|NCT04405739|584415872|FG001|Overall Study|Lost to Follow-up|2|||
161829724|NCT04405739|584415873|FG002|Overall Study|Lost to Follow-up|1|||
161829725|NCT04405739|584415874|FG003|Overall Study|Lost to Follow-up|3|||
161829726|NCT04405739|584415871|FG000|Overall Study|Withdrawal by Subject|0|||
161543785|NCT00767104|583382485|FG001|Overall Study|Lost to Follow-up|2|||
161543786|NCT00840996|583382486|FG000|Overall Study|Withdrawal by Subject|1|||
161543787|NCT00840996|583382487|FG001|Overall Study|Withdrawal by Subject|0|||
161543788|NCT02762981|583382488|FG000|Overall Study|Adverse Event|2|||
161543789|NCT02762981|583382489|FG001|Overall Study|Adverse Event|3|||
161543790|NCT02762981|583382490|FG002|Overall Study|Adverse Event|1|||
161543791|NCT02762981|583382491|FG003|Overall Study|Adverse Event|1|||
161543792|NCT02762981|583382492|FG004|Overall Study|Adverse Event|3|||
161543793|NCT02762981|583382488|FG000|Overall Study|Physician Decision|0|||
161543794|NCT02762981|583382489|FG001|Overall Study|Physician Decision|1|||
161543795|NCT02762981|583382490|FG002|Overall Study|Physician Decision|0|||
161543796|NCT02762981|583382491|FG003|Overall Study|Physician Decision|0|||
161543797|NCT02762981|583382492|FG004|Overall Study|Physician Decision|1|||
161543798|NCT02762981|583382488|FG000|Overall Study|Disease progression|11|||
161543799|NCT02762981|583382489|FG001|Overall Study|Disease progression|23|||
161543800|NCT02762981|583382490|FG002|Overall Study|Disease progression|4|||
161543801|NCT02762981|583382491|FG003|Overall Study|Disease progression|10|||
161543802|NCT02762981|583382492|FG004|Overall Study|Disease progression|1|||
161543803|NCT02762981|583382488|FG000|Overall Study|Enrolled not treated|1|||
161543804|NCT02762981|583382489|FG001|Overall Study|Enrolled not treated|5|||
161543805|NCT02762981|583382490|FG002|Overall Study|Enrolled not treated|0|||
161543806|NCT02762981|583382491|FG003|Overall Study|Enrolled not treated|2|||
161543807|NCT02762981|583382492|FG004|Overall Study|Enrolled not treated|0|||
161543808|NCT02762981|583382488|FG000|Overall Study|Other|2|||
161543809|NCT02762981|583382489|FG001|Overall Study|Other|3|||
161543810|NCT02762981|583382490|FG002|Overall Study|Other|1|||
161543811|NCT02762981|583382491|FG003|Overall Study|Other|0|||
161543812|NCT02762981|583382492|FG004|Overall Study|Other|0|||
161543813|NCT02762981|583382488|FG000|Overall Study|Missing|1|||
161543814|NCT02762981|583382489|FG001|Overall Study|Missing|0|||
161543815|NCT02762981|583382490|FG002|Overall Study|Missing|0|||
161543816|NCT02762981|583382491|FG003|Overall Study|Missing|0|||
161543817|NCT02762981|583382492|FG004|Overall Study|Missing|0|||
161543818|NCT02762981|583382488|FG000|Overall Study|Withdrawal by Subject|0|||
161543819|NCT02762981|583382489|FG001|Overall Study|Withdrawal by Subject|5|||
161543820|NCT02762981|583382490|FG002|Overall Study|Withdrawal by Subject|1|||
161543821|NCT02762981|583382491|FG003|Overall Study|Withdrawal by Subject|3|||
161543822|NCT02762981|583382492|FG004|Overall Study|Withdrawal by Subject|0|||
161543823|NCT02991482|583382493|FG000|Overall Study|Disease progression|56|||
161543824|NCT02991482|583382494|FG001|Overall Study|Disease progression|47|||
161543825|NCT02991482|583382493|FG000|Overall Study|Death|4|||
161543826|NCT02991482|583382494|FG001|Overall Study|Death|4|||
161543827|NCT02991482|583382493|FG000|Overall Study|Adverse Event|1|||
161543828|NCT02991482|583382494|FG001|Overall Study|Adverse Event|6|||
161543829|NCT02991482|583382493|FG000|Overall Study|Patient decision|1|||
161543830|NCT02991482|583382494|FG001|Overall Study|Patient decision|1|||
161543831|NCT02991482|583382493|FG000|Overall Study|Physician Decision|0|||
161543832|NCT02991482|583382494|FG001|Overall Study|Physician Decision|6|||
161543833|NCT02991482|583382493|FG000|Overall Study|Clinical deterioration|1|||
161593721|NCT02962895|583564992|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161543834|NCT02991482|583382494|FG001|Overall Study|Clinical deterioration|0|||
161543835|NCT02991482|583382493|FG000|Overall Study|Patient feeling too unwell|1|||
161543836|NCT02991482|583382494|FG001|Overall Study|Patient feeling too unwell|0|||
161679600|NCT01889238|583879197|FG000|Overall Study|Withdrawal by Subject|1|||
161679601|NCT01889238|583879197|FG000|Overall Study|Adverse Event|6|||
161679602|NCT01889238|583879197|FG000|Overall Study|Disease Progression|104|||
161679603|NCT01889238|583879197|FG000|Overall Study|Other|6|||
161679604|NCT02844816|583879198|FG000|Overall Study|No protocol treatment received|5|||
161679605|NCT02844816|583879199|FG001|Overall Study|No protocol treatment received|1|||
161679606|NCT02844816|583879198|FG000|Overall Study|Ineligible|22|||
161679607|NCT02844816|583879199|FG001|Overall Study|Ineligible|15|||
161679608|NCT02844816|583879198|FG000|Overall Study|Participant refusal|5|||
161679609|NCT02844816|583879199|FG001|Overall Study|Participant refusal|5|||
161679610|NCT02844816|583879198|FG000|Overall Study|Adverse Event|5|||
161679611|NCT02844816|583879199|FG001|Overall Study|Adverse Event|4|||
161679612|NCT02844816|583879198|FG000|Overall Study|Death|0|||
161679613|NCT02844816|583879199|FG001|Overall Study|Death|1|||
161679614|NCT02844816|583879198|FG000|Overall Study|Disease progression/recurrence|50|||
161679615|NCT02844816|583879199|FG001|Overall Study|Disease progression/recurrence|24|||
161679616|NCT02844816|583879198|FG000|Overall Study|Physician Decision|1|||
161679617|NCT02844816|583879199|FG001|Overall Study|Physician Decision|1|||
161679618|NCT06156215|583879200|FG000|Overall Study|Withdrawal by Subject|2|||
161679619|NCT06156215|583879201|FG001|Overall Study|Withdrawal by Subject|4|||
161679620|NCT06156215|583879202|FG002|Overall Study|Withdrawal by Subject|4|||
161679621|NCT06156215|583879203|FG003|Overall Study|Withdrawal by Subject|0|||
161679622|NCT06156215|583879204|FG004|Overall Study|Withdrawal by Subject|2|||
161679623|NCT06156215|583879205|FG005|Overall Study|Withdrawal by Subject|2|||
161679624|NCT06156215|583879200|FG000|Overall Study|Left ED without completing study|9|||
161679625|NCT06156215|583879201|FG001|Overall Study|Left ED without completing study|3|||
161679626|NCT06156215|583879202|FG002|Overall Study|Left ED without completing study|9|||
161679627|NCT06156215|583879203|FG003|Overall Study|Left ED without completing study|0|||
161679628|NCT06156215|583879204|FG004|Overall Study|Left ED without completing study|8|||
161679629|NCT06156215|583879205|FG005|Overall Study|Left ED without completing study|16|||
161679630|NCT06156215|583879200|FG000|Overall Study|Physician Decision|1|||
161679631|NCT06156215|583879201|FG001|Overall Study|Physician Decision|0|||
161679632|NCT06156215|583879202|FG002|Overall Study|Physician Decision|0|||
161679633|NCT06156215|583879203|FG003|Overall Study|Physician Decision|0|||
161679634|NCT06156215|583879204|FG004|Overall Study|Physician Decision|0|||
161679635|NCT06156215|583879205|FG005|Overall Study|Physician Decision|0|||
161679636|NCT06156215|583879200|FG000|Overall Study|Became or found ineligible|2|||
161679637|NCT06156215|583879201|FG001|Overall Study|Became or found ineligible|0|||
161679638|NCT06156215|583879202|FG002|Overall Study|Became or found ineligible|2|||
161679639|NCT06156215|583879203|FG003|Overall Study|Became or found ineligible|0|||
161679640|NCT06156215|583879204|FG004|Overall Study|Became or found ineligible|1|||
161679641|NCT06156215|583879205|FG005|Overall Study|Became or found ineligible|2|||
161679642|NCT04360551|583881346|FG000|Overall Study|Withdrawal by Subject|1|||
161679643|NCT04360551|583881347|FG001|Overall Study|Withdrawal by Subject|0|||
161679644|NCT01524198|583881354|FG000|Overall Study|Protocol Violation|8|||
161679645|NCT01524198|583881355|FG001|Overall Study|Protocol Violation|6|||
161679646|NCT01524198|583881354|FG000|Overall Study|Withdrawal by Subject|15|||
161679647|NCT01524198|583881355|FG001|Overall Study|Withdrawal by Subject|10|||
161679648|NCT02232802|583881356|FG000|Period 1|Sponsor request|1|||
161679649|NCT02232802|583881357|FG001|Period 1|Sponsor request|0|||
161679650|NCT02232802|583881356|FG000|Period 1|Adverse Event|1|||
161679651|NCT02232802|583881357|FG001|Period 1|Adverse Event|1|||
161679652|NCT00885703|583881363|FG000|Overall Study|Death|9|||
161679653|NCT00885703|583881364|FG001|Overall Study|Death|7|||
161679654|NCT00885703|583881365|FG002|Overall Study|Death|8|||
161679655|NCT00885703|583881366|FG003|Overall Study|Death|7|||
161679656|NCT00885703|583881367|FG004|Overall Study|Death|7|||
161679657|NCT00885703|583881368|FG005|Overall Study|Death|8|||
161679658|NCT00885703|583881369|FG006|Overall Study|Death|4|||
161679659|NCT00885703|583881363|FG000|Overall Study|Lost to Follow-up|0|||
161679660|NCT00885703|583881364|FG001|Overall Study|Lost to Follow-up|0|||
161679661|NCT00885703|583881365|FG002|Overall Study|Lost to Follow-up|1|||
161679662|NCT00885703|583881366|FG003|Overall Study|Lost to Follow-up|0|||
161679663|NCT00885703|583881367|FG004|Overall Study|Lost to Follow-up|0|||
161679664|NCT00885703|583881368|FG005|Overall Study|Lost to Follow-up|1|||
161679665|NCT00885703|583881369|FG006|Overall Study|Lost to Follow-up|0|||
161829727|NCT04405739|584415872|FG001|Overall Study|Withdrawal by Subject|2|||
161679666|NCT00885703|583881363|FG000|Overall Study|Withdrawal by Subject|0|||
161679667|NCT00885703|583881364|FG001|Overall Study|Withdrawal by Subject|0|||
161679668|NCT00885703|583881365|FG002|Overall Study|Withdrawal by Subject|0|||
161679669|NCT00885703|583881366|FG003|Overall Study|Withdrawal by Subject|1|||
161679670|NCT00885703|583881367|FG004|Overall Study|Withdrawal by Subject|3|||
161829728|NCT04405739|584415873|FG002|Overall Study|Withdrawal by Subject|1|||
161679671|NCT00885703|583881368|FG005|Overall Study|Withdrawal by Subject|1|||
161679672|NCT00885703|583881369|FG006|Overall Study|Withdrawal by Subject|1|||
161679673|NCT00885703|583881363|FG000|Overall Study|Ineligible (no CM)|1|||
161679674|NCT00885703|583881364|FG001|Overall Study|Ineligible (no CM)|3|||
161679675|NCT00885703|583881365|FG002|Overall Study|Ineligible (no CM)|2|||
161829729|NCT04405739|584415874|FG003|Overall Study|Withdrawal by Subject|1|||
161543837|NCT02991482|583382493|FG000|Overall Study|Worsening of performance status|0|||
161543838|NCT02991482|583382494|FG001|Overall Study|Worsening of performance status|1|||
161543839|NCT02991482|583382493|FG000|Overall Study|Death prior to study drug initiation|1|||
161543840|NCT02991482|583382494|FG001|Overall Study|Death prior to study drug initiation|0|||
161543841|NCT02991482|583382493|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
161543842|NCT02991482|583382494|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
161543843|NCT02887989|583382500|FG000|Overall Study|Withdrawal by Subject|8|||
161543844|NCT02887989|583382501|FG001|Overall Study|Withdrawal by Subject|11|||
161543845|NCT02887989|583382500|FG000|Overall Study|Death|1|||
161679676|NCT00885703|583881366|FG003|Overall Study|Ineligible (no CM)|1|||
161679677|NCT00885703|583881367|FG004|Overall Study|Ineligible (no CM)|2|||
161679678|NCT00885703|583881368|FG005|Overall Study|Ineligible (no CM)|3|||
161679679|NCT00885703|583881369|FG006|Overall Study|Ineligible (no CM)|1|||
161679680|NCT01490450|583881372|FG000|Period 1|Lack of Efficacy|2|||
161679681|NCT01490450|583881373|FG001|Period 1|Lack of Efficacy|0|||
161679682|NCT01490450|583881374|FG002|Period 1|Lack of Efficacy|3|||
161679683|NCT01490450|583881375|FG003|Period 1|Lack of Efficacy|0|||
161679684|NCT01490450|583881372|FG000|Period 1|Adverse Event|0|||
161679685|NCT01490450|583881373|FG001|Period 1|Adverse Event|0|||
161679686|NCT01490450|583881374|FG002|Period 1|Adverse Event|0|||
161679687|NCT01490450|583881375|FG003|Period 1|Adverse Event|5|||
161679688|NCT01490450|583881372|FG000|Period 1|Request to discontinue treatment|1|||
161679689|NCT01490450|583881373|FG001|Period 1|Request to discontinue treatment|0|||
161679690|NCT01490450|583881374|FG002|Period 1|Request to discontinue treatment|0|||
161679691|NCT01490450|583881375|FG003|Period 1|Request to discontinue treatment|0|||
161679692|NCT01490450|583881372|FG000|Period 1|Withdrawal by Subject|0|||
161679693|NCT01490450|583881373|FG001|Period 1|Withdrawal by Subject|0|||
161679694|NCT01490450|583881374|FG002|Period 1|Withdrawal by Subject|0|||
161679695|NCT01490450|583881375|FG003|Period 1|Withdrawal by Subject|3|||
161679696|NCT01490450|583881372|FG000|Period 1|No longer met study criteria|0|||
161679697|NCT01490450|583881373|FG001|Period 1|No longer met study criteria|1|||
161679698|NCT01490450|583881374|FG002|Period 1|No longer met study criteria|1|||
161679699|NCT01490450|583881375|FG003|Period 1|No longer met study criteria|0|||
161679700|NCT01490450|583881372|FG000|Period 2|Lack of Efficacy|0|||
161679701|NCT01490450|583881373|FG001|Period 2|Lack of Efficacy|0|||
161679702|NCT01490450|583881374|FG002|Period 2|Lack of Efficacy|0|||
161679703|NCT01490450|583881375|FG003|Period 2|Lack of Efficacy|1|||
161679704|NCT01490450|583881372|FG000|Period 2|Adverse Event|1|||
161679705|NCT01490450|583881373|FG001|Period 2|Adverse Event|1|||
161679706|NCT01490450|583881374|FG002|Period 2|Adverse Event|0|||
161679707|NCT01490450|583881375|FG003|Period 2|Adverse Event|1|||
161679708|NCT01490450|583881372|FG000|Period 2|Withdrawal by Subject|1|||
161679709|NCT01490450|583881373|FG001|Period 2|Withdrawal by Subject|0|||
161679710|NCT01490450|583881374|FG002|Period 2|Withdrawal by Subject|0|||
161679711|NCT01490450|583881375|FG003|Period 2|Withdrawal by Subject|0|||
161679712|NCT01490450|583881372|FG000|Period 2|Lost to Follow-up|0|||
161679713|NCT01490450|583881373|FG001|Period 2|Lost to Follow-up|0|||
161679714|NCT01490450|583881374|FG002|Period 2|Lost to Follow-up|0|||
161679715|NCT01490450|583881375|FG003|Period 2|Lost to Follow-up|2|||
161679716|NCT00404820|583881376|FG000|Overall Study|Adverse Event|4|||
161679717|NCT00404820|583881377|FG001|Overall Study|Adverse Event|16|||
161679718|NCT00404820|583881376|FG000|Overall Study|Withdrawal by Subject|5|||
161679719|NCT00404820|583881377|FG001|Overall Study|Withdrawal by Subject|3|||
161679720|NCT00404820|583881376|FG000|Overall Study|Lost to Follow-up|7|||
161679721|NCT00404820|583881377|FG001|Overall Study|Lost to Follow-up|3|||
161679722|NCT00404820|583881376|FG000|Overall Study|Administrative problems|2|||
161679723|NCT00404820|583881377|FG001|Overall Study|Administrative problems|0|||
161679724|NCT00404820|583881376|FG000|Overall Study|Death|1|||
161543846|NCT02887989|583382501|FG001|Overall Study|Death|0|||
161543847|NCT05648357|583382505|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
161679725|NCT00404820|583881377|FG001|Overall Study|Death|0|||
161679726|NCT00404820|583881376|FG000|Overall Study|Other|0|||
161679727|NCT00404820|583881377|FG001|Overall Study|Other|2|||
161679728|NCT01462435|583881378|FG000|Overall Study|Lack of Efficacy|1|||
161679729|NCT01462435|583881379|FG001|Overall Study|Lack of Efficacy|0|||
161679730|NCT01462435|583881380|FG002|Overall Study|Lack of Efficacy|0|||
161679731|NCT01462435|583881381|FG003|Overall Study|Lack of Efficacy|3|||
161679732|NCT01462435|583881378|FG000|Overall Study|Physician Decision|0|||
161679733|NCT01462435|583881379|FG001|Overall Study|Physician Decision|0|||
161679734|NCT01462435|583881380|FG002|Overall Study|Physician Decision|1|||
161679735|NCT01462435|583881381|FG003|Overall Study|Physician Decision|0|||
161679736|NCT01462435|583881378|FG000|Overall Study|Withdrawal by Subject|0|||
161679737|NCT01462435|583881379|FG001|Overall Study|Withdrawal by Subject|0|||
161679738|NCT01462435|583881380|FG002|Overall Study|Withdrawal by Subject|0|||
161679739|NCT01462435|583881381|FG003|Overall Study|Withdrawal by Subject|1|||
161679740|NCT01462435|583881378|FG000|Overall Study|Lost to Follow-up|0|||
161679741|NCT01462435|583881379|FG001|Overall Study|Lost to Follow-up|0|||
161679742|NCT01462435|583881380|FG002|Overall Study|Lost to Follow-up|0|||
161679743|NCT01462435|583881381|FG003|Overall Study|Lost to Follow-up|1|||
161679744|NCT02053168|583881386|FG000|Overall Study|Withdrawal by Subject|1|||
161679745|NCT02053168|583881386|FG000|Overall Study|Physician Decision|1|||
161679746|NCT02053168|583881386|FG000|Overall Study|Lost to Follow-up|1|||
161679747|NCT02687542|583881389|FG000|Overall Study|Medication error without associated AEs|0|||
161679748|NCT02687542|583881390|FG001|Overall Study|Medication error without associated AEs|0|||
161679749|NCT02687542|583881391|FG002|Overall Study|Medication error without associated AEs|0|||
161679750|NCT02687542|583881392|FG003|Overall Study|Medication error without associated AEs|0|||
161679751|NCT02687542|583881393|FG004|Overall Study|Medication error without associated AEs|1|||
161679752|NCT02687542|583881389|FG000|Overall Study|Lost to Follow-up|0|||
161679753|NCT02687542|583881390|FG001|Overall Study|Lost to Follow-up|0|||
161679754|NCT02687542|583881391|FG002|Overall Study|Lost to Follow-up|0|||
161679755|NCT02687542|583881392|FG003|Overall Study|Lost to Follow-up|0|||
161679756|NCT02687542|583881393|FG004|Overall Study|Lost to Follow-up|1|||
161679757|NCT02687542|583881389|FG000|Overall Study|Protocol Violation|0|||
161679758|NCT02687542|583881390|FG001|Overall Study|Protocol Violation|1|||
161679759|NCT02687542|583881391|FG002|Overall Study|Protocol Violation|0|||
161679760|NCT02687542|583881392|FG003|Overall Study|Protocol Violation|0|||
161679761|NCT02687542|583881393|FG004|Overall Study|Protocol Violation|0|||
161679762|NCT02687542|583881389|FG000|Overall Study|Other|5|||
161679763|NCT02687542|583881390|FG001|Overall Study|Other|9|||
161679764|NCT02687542|583881391|FG002|Overall Study|Other|10|||
161679765|NCT02687542|583881392|FG003|Overall Study|Other|6|||
161679766|NCT02687542|583881393|FG004|Overall Study|Other|5|||
161679767|NCT02687542|583881389|FG000|Overall Study|Adverse Event|3|||
161679768|NCT02687542|583881390|FG001|Overall Study|Adverse Event|1|||
161679769|NCT02687542|583881391|FG002|Overall Study|Adverse Event|3|||
161679770|NCT02687542|583881392|FG003|Overall Study|Adverse Event|2|||
161679771|NCT02687542|583881393|FG004|Overall Study|Adverse Event|9|||
161679772|NCT02687542|583881389|FG000|Overall Study|Withdrawal by Subject|0|||
161679773|NCT02687542|583881390|FG001|Overall Study|Withdrawal by Subject|1|||
161679774|NCT02687542|583881391|FG002|Overall Study|Withdrawal by Subject|1|||
161679775|NCT02687542|583881392|FG003|Overall Study|Withdrawal by Subject|2|||
161679776|NCT02687542|583881393|FG004|Overall Study|Withdrawal by Subject|4|||
161679777|NCT00636675|583881395|FG000|Overall Study|Lost to Follow-up|121|||
161679778|NCT00636675|583881396|FG001|Overall Study|Lost to Follow-up|31|||
161679779|NCT00636675|583881395|FG000|Overall Study|Withdrawal by Subject|19|||
161679780|NCT00636675|583881396|FG001|Overall Study|Withdrawal by Subject|10|||
161679781|NCT03785925|583881398|FG000|Overall Study|Withdrawal by Subject|15|||
161679782|NCT03785925|583881398|FG000|Overall Study|Lost to Follow-up|1|||
161679783|NCT00176605|583881399|FG000|Overall Study|Withdrawal by Subject|2|||
161679784|NCT01227187|583881400|FG000|Overall Study|Physician Decision|0|||
161679785|NCT01227187|583881401|FG001|Overall Study|Physician Decision|0|||
161679786|NCT01227187|583881402|FG002|Overall Study|Physician Decision|0|||
161679787|NCT01227187|583881403|FG003|Overall Study|Physician Decision|1|||
161679788|NCT01566773|583881405|FG000|Overall Study|Protocol specified criteria|4|||
161679789|NCT01566773|583881405|FG000|Overall Study|Protocol Violation|4|||
161679790|NCT01566773|583881405|FG000|Overall Study|Withdrawal by Subject|9|||
161679791|NCT01566773|583881405|FG000|Overall Study|Administrative reason|1|||
161679792|NCT01566773|583881405|FG000|Overall Study|Adverse Event|10|||
161679793|NCT01566773|583881405|FG000|Overall Study|Physician Decision|2|||
161679794|NCT00833053|583881406|FG000|Overall Study|Adverse Event|4|||
161679795|NCT00833053|583881407|FG001|Overall Study|Adverse Event|0|||
161679796|NCT00833053|583881406|FG000|Overall Study|Treatment Failure|3|||
161679797|NCT00833053|583881407|FG001|Overall Study|Treatment Failure|1|||
161679798|NCT00833053|583881406|FG000|Overall Study|Withdrawal by Subject|0|||
161679799|NCT00833053|583881407|FG001|Overall Study|Withdrawal by Subject|1|||
161679800|NCT00833053|583881406|FG000|Overall Study|Protocol Violation|2|||
161679801|NCT00833053|583881407|FG001|Overall Study|Protocol Violation|1|||
161679802|NCT02187471|583881408|FG000|Overall Study|Protocol Violation|4|||
161679803|NCT02187471|583881409|FG001|Overall Study|Protocol Violation|5|||
161679804|NCT02187471|583881410|FG002|Overall Study|Protocol Violation|4|||
161679805|NCT02187471|583881411|FG003|Overall Study|Protocol Violation|4|||
161679806|NCT02187471|583881408|FG000|Overall Study|Missing|0|||
161679807|NCT02187471|583881409|FG001|Overall Study|Missing|0|||
161679808|NCT02187471|583881410|FG002|Overall Study|Missing|0|||
161679809|NCT02187471|583881411|FG003|Overall Study|Missing|1|||
161679810|NCT02187471|583881408|FG000|Overall Study|Lack of Efficacy|18|||
161679811|NCT02187471|583881409|FG001|Overall Study|Lack of Efficacy|9|||
161679812|NCT02187471|583881410|FG002|Overall Study|Lack of Efficacy|13|||
161679813|NCT02187471|583881411|FG003|Overall Study|Lack of Efficacy|11|||
161679814|NCT02187471|583881408|FG000|Overall Study|Adverse Event|24|||
161679815|NCT02187471|583881409|FG001|Overall Study|Adverse Event|34|||
161543848|NCT00768430|583382506|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
161543849|NCT00768430|583382507|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
161543850|NCT03585296|583382510|FG000|Overall Study|Adverse Event|1|||
161543851|NCT03585296|583382510|FG000|Overall Study|Lost to Follow-up|2|||
161543852|NCT03585296|583382510|FG000|Overall Study|Withdrawal by Subject|2|||
161543853|NCT00041756|583382511|FG000|Overall Study|Adverse Event|4|||
161679816|NCT02187471|583881410|FG002|Overall Study|Adverse Event|44|||
161543854|NCT00041756|583382512|FG001|Overall Study|Adverse Event|10|||
161679817|NCT02187471|583881411|FG003|Overall Study|Adverse Event|36|||
161679818|NCT02187471|583881408|FG000|Overall Study|Withdrawal by Subject|23|||
161679819|NCT02187471|583881409|FG001|Overall Study|Withdrawal by Subject|29|||
161679820|NCT02187471|583881410|FG002|Overall Study|Withdrawal by Subject|22|||
161679821|NCT02187471|583881411|FG003|Overall Study|Withdrawal by Subject|24|||
161679822|NCT02187471|583881408|FG000|Overall Study|Other|7|||
161679823|NCT02187471|583881409|FG001|Overall Study|Other|5|||
161679824|NCT02187471|583881410|FG002|Overall Study|Other|3|||
161679825|NCT02187471|583881411|FG003|Overall Study|Other|4|||
161679826|NCT00957528|583881414|FG000|Overall Study|Protocol Violation|0|||
161679827|NCT00957528|583881415|FG001|Overall Study|Protocol Violation|1|||
161679828|NCT00957528|583881416|FG002|Overall Study|Protocol Violation|0|||
161679829|NCT00957528|583881414|FG000|Overall Study|Withdrawal by Subject|0|||
161679830|NCT00957528|583881415|FG001|Overall Study|Withdrawal by Subject|0|||
161679831|NCT00957528|583881416|FG002|Overall Study|Withdrawal by Subject|1|||
161679832|NCT02318667|583881417|FG000|Overall Study|Adverse Event|1|||
161679833|NCT02318667|583881417|FG000|Overall Study|Lack of Efficacy|6|||
161679834|NCT02318667|583881417|FG000|Overall Study|Protocol Violation|2|||
161679835|NCT01101438|583881419|FG000|Overall Study|Withdrawal by Subject|8|||
161679836|NCT01101438|583881420|FG001|Overall Study|Withdrawal by Subject|9|||
161679837|NCT02289742|583881429|FG000|First Wear Period|Adverse event prior to treatment|0|||
161679838|NCT02289742|583881430|FG001|First Wear Period|Adverse event prior to treatment|1|||
161679839|NCT02289742|583881431|FG002|First Wear Period|Adverse event prior to treatment|0|||
161679840|NCT02289742|583881432|FG003|First Wear Period|Adverse event prior to treatment|0|||
161679841|NCT02289742|583881429|FG000|First Wear Period|Adverse Event|0|||
161679842|NCT02289742|583881430|FG001|First Wear Period|Adverse Event|0|||
161679843|NCT02289742|583881431|FG002|First Wear Period|Adverse Event|1|||
161679844|NCT02289742|583881432|FG003|First Wear Period|Adverse Event|0|||
161679845|NCT02289742|583881429|FG000|First Wear Period|Other prior to treatment|0|||
161679846|NCT02289742|583881430|FG001|First Wear Period|Other prior to treatment|0|||
161679847|NCT02289742|583881431|FG002|First Wear Period|Other prior to treatment|0|||
161679848|NCT02289742|583881432|FG003|First Wear Period|Other prior to treatment|1|||
161679849|NCT02289742|583881429|FG000|Third Wear Period|Adverse Event|0|||
161679850|NCT02289742|583881430|FG001|Third Wear Period|Adverse Event|1|||
161679851|NCT02289742|583881431|FG002|Third Wear Period|Adverse Event|0|||
161679852|NCT02289742|583881432|FG003|Third Wear Period|Adverse Event|0|||
161679853|NCT02289742|583881429|FG000|Third Wear Period|Reason not given|0|||
161679854|NCT02289742|583881430|FG001|Third Wear Period|Reason not given|0|||
161679855|NCT02289742|583881431|FG002|Third Wear Period|Reason not given|0|||
161679856|NCT02289742|583881432|FG003|Third Wear Period|Reason not given|1|||
161679857|NCT00709111|583881433|FG000|Overall Study|Withdrawal by Subject|1|||
161679858|NCT00709111|583881433|FG000|Overall Study|Unable to attend clinic visits|1|||
161679859|NCT02865018|583881434|FG000|Overall Study|Withdrawal by Subject|1|||
161679860|NCT01735279|583881437|FG000|Overall Study|Lost to Follow-up|11|||
161679861|NCT01735279|583881438|FG001|Overall Study|Lost to Follow-up|8|||
161679862|NCT00806195|583881439|FG000|Overall Study|Death|6|||
161679863|NCT00806195|583881440|FG001|Overall Study|Death|0|||
161679864|NCT00806195|583881441|FG002|Overall Study|Death|1|||
161679865|NCT00806195|583881442|FG003|Overall Study|Death|0|||
161679866|NCT00806195|583881439|FG000|Overall Study|Adverse Event|25|||
161679867|NCT00806195|583881440|FG001|Overall Study|Adverse Event|5|||
161543855|NCT00041756|583382513|FG002|Overall Study|Adverse Event|6|||
161543856|NCT00041756|583382514|FG003|Overall Study|Adverse Event|11|||
161543857|NCT00041756|583382515|FG004|Overall Study|Adverse Event|34|||
161543858|NCT00041756|583382511|FG000|Overall Study|Protocol Violation|1|||
161543859|NCT00041756|583382512|FG001|Overall Study|Protocol Violation|1|||
161543860|NCT00041756|583382513|FG002|Overall Study|Protocol Violation|2|||
161543861|NCT00041756|583382514|FG003|Overall Study|Protocol Violation|2|||
161543862|NCT00041756|583382515|FG004|Overall Study|Protocol Violation|1|||
161543863|NCT00041756|583382511|FG000|Overall Study|Withdrawal by Subject|3|||
161543864|NCT00041756|583382512|FG001|Overall Study|Withdrawal by Subject|3|||
161543865|NCT00041756|583382513|FG002|Overall Study|Withdrawal by Subject|4|||
161593722|NCT02962895|583564993|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161593723|NCT02962895|583564994|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161593724|NCT02962895|583564995|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161593725|NCT02962895|583564996|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161593726|NCT02962895|583564997|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161593727|NCT02962895|583564998|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
161593728|NCT02962895|583564992|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161593729|NCT02962895|583564993|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
161593730|NCT02962895|583564994|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161593731|NCT02962895|583564995|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161593732|NCT02962895|583564996|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161593733|NCT02962895|583564997|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161593734|NCT02962895|583564998|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161593735|NCT02962895|583564992|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161593736|NCT02962895|583564993|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161593737|NCT02962895|583564994|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161593738|NCT02962895|583564995|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161593739|NCT02962895|583564996|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
161593740|NCT02962895|583564997|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161593741|NCT02962895|583564998|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161593742|NCT02962895|583564992|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161593743|NCT02962895|583564993|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161593744|NCT02962895|583564994|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161593745|NCT02962895|583564995|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161593746|NCT02962895|583564996|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
161593747|NCT02962895|583564997|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161593748|NCT02962895|583564998|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161593749|NCT02962895|583564992|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161593750|NCT02962895|583564993|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
161593751|NCT02962895|583564994|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
161679868|NCT00806195|583881441|FG002|Overall Study|Adverse Event|11|||
161679869|NCT00806195|583881442|FG003|Overall Study|Adverse Event|2|||
161679870|NCT00806195|583881439|FG000|Overall Study|Withdrawal by Subject|119|||
161679871|NCT00806195|583881440|FG001|Overall Study|Withdrawal by Subject|31|||
161679872|NCT00806195|583881441|FG002|Overall Study|Withdrawal by Subject|76|||
161543866|NCT00041756|583382514|FG003|Overall Study|Withdrawal by Subject|2|||
161543867|NCT00041756|583382515|FG004|Overall Study|Withdrawal by Subject|3|||
161679873|NCT00806195|583881442|FG003|Overall Study|Withdrawal by Subject|35|||
161679874|NCT00806195|583881439|FG000|Overall Study|Lost to Follow-up|217|||
161829730|NCT04405739|584415871|FG000|Overall Study|Death|0|||
161829731|NCT04405739|584415872|FG001|Overall Study|Death|0|||
161829732|NCT04405739|584415873|FG002|Overall Study|Death|1|||
161829733|NCT04405739|584415874|FG003|Overall Study|Death|0|||
161829734|NCT04405739|584415871|FG000|Overall Study|Transferred to rehab|0|||
161829735|NCT04405739|584415872|FG001|Overall Study|Transferred to rehab|0|||
161829736|NCT04405739|584415873|FG002|Overall Study|Transferred to rehab|0|||
161829737|NCT04405739|584415874|FG003|Overall Study|Transferred to rehab|1|||
161829738|NCT04405739|584415871|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
161829739|NCT04405739|584415872|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
161829740|NCT04405739|584415873|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
161829741|NCT04405739|584415874|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
161829742|NCT00438659|584415875|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
161829743|NCT00438659|584415876|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
161829744|NCT00438659|584415875|FG000|Overall Study|Cancel|5|||
161829745|NCT00438659|584415876|FG001|Overall Study|Cancel|2|||
161829746|NCT05766787|584415877|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
161829747|NCT05766787|584415878|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
161829748|NCT05766787|584415877|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
161679875|NCT00806195|583881440|FG001|Overall Study|Lost to Follow-up|66|||
161679876|NCT00806195|583881441|FG002|Overall Study|Lost to Follow-up|90|||
161679877|NCT00806195|583881442|FG003|Overall Study|Lost to Follow-up|34|||
161679878|NCT00806195|583881439|FG000|Overall Study|Inappropriate Enrollment|0|||
161679879|NCT00806195|583881440|FG001|Overall Study|Inappropriate Enrollment|1|||
161679880|NCT00806195|583881441|FG002|Overall Study|Inappropriate Enrollment|0|||
161679881|NCT00806195|583881442|FG003|Overall Study|Inappropriate Enrollment|0|||
161679882|NCT00806195|583881439|FG000|Overall Study|Administrative Reason|113|||
161679883|NCT00806195|583881440|FG001|Overall Study|Administrative Reason|35|||
161679884|NCT00806195|583881441|FG002|Overall Study|Administrative Reason|66|||
161679885|NCT00806195|583881442|FG003|Overall Study|Administrative Reason|26|||
161679886|NCT00806195|583881439|FG000|Overall Study|Protocol Violation|34|||
161679887|NCT00806195|583881440|FG001|Overall Study|Protocol Violation|24|||
161679888|NCT00806195|583881441|FG002|Overall Study|Protocol Violation|26|||
161679889|NCT00806195|583881442|FG003|Overall Study|Protocol Violation|9|||
161679890|NCT01519934|583881448|FG000|Overall Study|Lost to Follow-up|3|||
161679891|NCT00922480|583881449|FG000|Main Study|Protocol Violation|3|||
161679892|NCT00922480|583881450|FG001|Main Study|Protocol Violation|6|||
161679893|NCT00922480|583881449|FG000|Main Study|Adverse Event|6|||
161679894|NCT00922480|583881450|FG001|Main Study|Adverse Event|7|||
161679895|NCT00922480|583881449|FG000|Main Study|Lack of Efficacy|3|||
161679896|NCT00922480|583881450|FG001|Main Study|Lack of Efficacy|0|||
161679897|NCT00922480|583881449|FG000|Main Study|Withdrawal by Subject|20|||
161679898|NCT00922480|583881450|FG001|Main Study|Withdrawal by Subject|15|||
161679899|NCT00922480|583881449|FG000|Main Study|Lost to Follow-up|5|||
161679900|NCT00922480|583881450|FG001|Main Study|Lost to Follow-up|0|||
161679901|NCT00922480|583881449|FG000|Main Study|Physician Decision|0|||
161679902|NCT00922480|583881450|FG001|Main Study|Physician Decision|1|||
161679903|NCT00922480|583881449|FG000|Extension Study|Protocol Violation|3|||
161679904|NCT00922480|583881450|FG001|Extension Study|Protocol Violation|0|||
161679905|NCT00922480|583881449|FG000|Extension Study|Adverse Event|1|||
161679906|NCT00922480|583881450|FG001|Extension Study|Adverse Event|1|||
161679907|NCT00922480|583881449|FG000|Extension Study|Withdrawal by Subject|1|||
161679908|NCT00922480|583881450|FG001|Extension Study|Withdrawal by Subject|1|||
161679909|NCT00922480|583881449|FG000|Extension Study|Others|0|||
161679910|NCT00922480|583881450|FG001|Extension Study|Others|1|||
161679911|NCT00326209|583881457|FG000|Overall Study|Adverse Event|28|||
161679912|NCT00326209|583881457|FG000|Overall Study|Withdrawal by Subject|22|||
161679913|NCT00326209|583881457|FG000|Overall Study|Lack of Efficacy|31|||
161679914|NCT00326209|583881457|FG000|Overall Study|Lost to Follow-up|18|||
161679915|NCT00326209|583881457|FG000|Overall Study|Participant non-compliant|6|||
161679916|NCT00326209|583881457|FG000|Overall Study|Sponsor closed study|173|||
161679917|NCT00326209|583881457|FG000|Overall Study|Prohibited medication use|1|||
161679918|NCT00326209|583881457|FG000|Overall Study|Violation of entry criteria|1|||
161679919|NCT00326209|583881457|FG000|Overall Study|Withdrawn in error|1|||
161679920|NCT00326209|583881457|FG000|Overall Study|Pregnancy|1|||
161679921|NCT02138617|583881458|FG000|Overall Study|Death|1|||
161679922|NCT02138617|583881459|FG001|Overall Study|Death|2|||
161679923|NCT02138617|583881460|FG002|Overall Study|Death|2|||
161679924|NCT02138617|583881458|FG000|Overall Study|Adverse Event|8|||
161829749|NCT05766787|584415878|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
161679925|NCT02138617|583881459|FG001|Overall Study|Adverse Event|5|||
161679926|NCT02138617|583881460|FG002|Overall Study|Adverse Event|2|||
161679927|NCT02138617|583881458|FG000|Overall Study|Disease Progression|20|||
161679928|NCT02138617|583881459|FG001|Overall Study|Disease Progression|13|||
161679929|NCT02138617|583881460|FG002|Overall Study|Disease Progression|4|||
161679930|NCT02138617|583881458|FG000|Overall Study|Withdrawal by Subject|7|||
161679931|NCT02138617|583881459|FG001|Overall Study|Withdrawal by Subject|10|||
161679932|NCT02138617|583881460|FG002|Overall Study|Withdrawal by Subject|2|||
161679933|NCT02138617|583881458|FG000|Overall Study|other complicating disease|0|||
161829750|NCT05766787|584415877|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
161829751|NCT05766787|584415878|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
161829752|NCT01867606|584415879|FG000|Overall Study|Withdrawal by Subject|10|||
161829753|NCT01867606|584415880|FG001|Overall Study|Withdrawal by Subject|14|||
161829754|NCT01867606|584415879|FG000|Overall Study|Protocol Violation|0|||
161829755|NCT01867606|584415880|FG001|Overall Study|Protocol Violation|1|||
161829756|NCT00206102|584415881|FG000|Overall Study|Adverse Event|119|||
161829757|NCT00206102|584415882|FG001|Overall Study|Adverse Event|82|||
161829758|NCT00206102|584415881|FG000|Overall Study|Protocol Violation|0|||
161829759|NCT00206102|584415882|FG001|Overall Study|Protocol Violation|2|||
161829760|NCT00206102|584415881|FG000|Overall Study|Lack of therapeutic response|16|||
161829761|NCT00206102|584415882|FG001|Overall Study|Lack of therapeutic response|11|||
161829762|NCT00206102|584415881|FG000|Overall Study|Lost to Follow-up|95|||
161829763|NCT00206102|584415882|FG001|Overall Study|Lost to Follow-up|66|||
161829764|NCT00206102|584415881|FG000|Overall Study|Withdrawal by Subject|118|||
161829765|NCT00206102|584415882|FG001|Overall Study|Withdrawal by Subject|101|||
161829766|NCT00206102|584415881|FG000|Overall Study|Study-specific discontinuation criteria|18|||
161679934|NCT02138617|583881459|FG001|Overall Study|other complicating disease|2|||
161679935|NCT02138617|583881460|FG002|Overall Study|other complicating disease|0|||
161679936|NCT02138617|583881458|FG000|Overall Study|Protocol Violation|1|||
161679937|NCT02138617|583881459|FG001|Overall Study|Protocol Violation|0|||
161679938|NCT02138617|583881460|FG002|Overall Study|Protocol Violation|0|||
161679939|NCT02138617|583881458|FG000|Overall Study|Physician Decision|7|||
161679940|NCT02138617|583881459|FG001|Overall Study|Physician Decision|6|||
161679941|NCT02138617|583881460|FG002|Overall Study|Physician Decision|0|||
161679942|NCT02138617|583881458|FG000|Overall Study|financial reason|0|||
161679943|NCT02138617|583881459|FG001|Overall Study|financial reason|1|||
161679944|NCT02138617|583881460|FG002|Overall Study|financial reason|0|||
161679945|NCT02138617|583881458|FG000|Overall Study|other therapy|3|||
161679946|NCT02138617|583881459|FG001|Overall Study|other therapy|4|||
161679947|NCT02138617|583881460|FG002|Overall Study|other therapy|0|||
161679948|NCT01671111|583881462|FG000|Overall Study|Adverse Event|2|||
161679949|NCT01671111|583881462|FG000|Overall Study|Lack of Efficacy|1|||
161679950|NCT01671111|583881462|FG000|Overall Study|Withdrawal by Subject|2|||
161679951|NCT01671111|583881462|FG000|Overall Study|Physician Decision|1|||
161679952|NCT01671111|583881462|FG000|Overall Study|Other|24|||
161679953|NCT00113074|583881472|FG000|Overall Study|Lost to Follow-up|10|||
161679954|NCT00113074|583881473|FG001|Overall Study|Lost to Follow-up|10|||
161679955|NCT00113074|583881474|FG002|Overall Study|Lost to Follow-up|14|||
161679956|NCT03680911|583881475|FG000|At Home Treatment|Study Termination|3|||
161679957|NCT03680911|583881476|FG001|At Home Treatment|Study Termination|0|||
161679958|NCT03680911|583881475|FG000|At Home Treatment|Lost to Follow-up|0|||
161679959|NCT03680911|583881476|FG001|At Home Treatment|Lost to Follow-up|1|||
161679960|NCT03680911|583881475|FG000|At Home Treatment|Withdrawal by Subject|0|||
161679961|NCT03680911|583881476|FG001|At Home Treatment|Withdrawal by Subject|2|||
161679962|NCT03680911|583881475|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
161679963|NCT03680911|583881476|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
161679964|NCT03716050|583881480|FG000|Overall Study|Lost to Follow-up|0|||
161679965|NCT03716050|583881481|FG001|Overall Study|Lost to Follow-up|0|||
161679966|NCT03716050|583881482|FG002|Overall Study|Lost to Follow-up|1|||
161679967|NCT03716050|583881483|FG003|Overall Study|Lost to Follow-up|0|||
161679968|NCT03716050|583881484|FG004|Overall Study|Lost to Follow-up|0|||
161679969|NCT03716050|583881485|FG005|Overall Study|Lost to Follow-up|0|||
161679970|NCT03716050|583881486|FG006|Overall Study|Lost to Follow-up|0|||
161679971|NCT03716050|583881487|FG007|Overall Study|Lost to Follow-up|0|||
161679972|NCT03716050|583881480|FG000|Overall Study|Physician Decision|0|||
161679973|NCT03716050|583881481|FG001|Overall Study|Physician Decision|0|||
161679974|NCT03716050|583881482|FG002|Overall Study|Physician Decision|0|||
161679975|NCT03716050|583881483|FG003|Overall Study|Physician Decision|1|||
161679976|NCT03716050|583881484|FG004|Overall Study|Physician Decision|0|||
161543868|NCT00041756|583382511|FG000|Overall Study|Lost to Follow-up|0|||
161543869|NCT00041756|583382512|FG001|Overall Study|Lost to Follow-up|1|||
161543870|NCT00041756|583382513|FG002|Overall Study|Lost to Follow-up|0|||
161543871|NCT00041756|583382514|FG003|Overall Study|Lost to Follow-up|1|||
161543872|NCT00041756|583382515|FG004|Overall Study|Lost to Follow-up|0|||
161543873|NCT00041756|583382511|FG000|Overall Study|Unable to meet protocol criteria|0|||
161543874|NCT00041756|583382512|FG001|Overall Study|Unable to meet protocol criteria|0|||
161543875|NCT00041756|583382513|FG002|Overall Study|Unable to meet protocol criteria|1|||
161679977|NCT03716050|583881485|FG005|Overall Study|Physician Decision|0|||
161679978|NCT03716050|583881486|FG006|Overall Study|Physician Decision|0|||
161679979|NCT03716050|583881487|FG007|Overall Study|Physician Decision|0|||
161679980|NCT03716050|583881480|FG000|Overall Study|Protocol Violation|0|||
161679981|NCT03716050|583881481|FG001|Overall Study|Protocol Violation|0|||
161679982|NCT03716050|583881482|FG002|Overall Study|Protocol Violation|0|||
161679983|NCT03716050|583881483|FG003|Overall Study|Protocol Violation|1|||
161679984|NCT03716050|583881484|FG004|Overall Study|Protocol Violation|0|||
161679985|NCT03716050|583881485|FG005|Overall Study|Protocol Violation|0|||
161679986|NCT03716050|583881486|FG006|Overall Study|Protocol Violation|0|||
161679987|NCT03716050|583881487|FG007|Overall Study|Protocol Violation|2|||
161679988|NCT01289821|583881488|FG000|Treatment Period|Withdrawal by Subject|1|||
161543876|NCT00041756|583382514|FG003|Overall Study|Unable to meet protocol criteria|0|||
161543877|NCT00041756|583382515|FG004|Overall Study|Unable to meet protocol criteria|1|||
161543878|NCT00041756|583382511|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
161543879|NCT00041756|583382512|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
161543880|NCT00041756|583382513|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
161543881|NCT00041756|583382514|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
161543882|NCT00041756|583382515|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
161543883|NCT02110732|583382516|FG000|Overall Study|Physician Decision|5|||
161543884|NCT02110732|583382517|FG001|Overall Study|Physician Decision|2|||
161543885|NCT02110732|583382516|FG000|Overall Study|Lost to Follow-up|1|||
161543886|NCT02110732|583382517|FG001|Overall Study|Lost to Follow-up|1|||
161543887|NCT04887948|583382521|FG000|Overall Study|Death|1|||
161543888|NCT04887948|583382522|FG001|Overall Study|Death|0|||
161543889|NCT04887948|583382523|FG002|Overall Study|Death|0|||
161543890|NCT04887948|583382521|FG000|Overall Study|Lost to Follow-up|1|||
161543891|NCT04887948|583382522|FG001|Overall Study|Lost to Follow-up|0|||
161543892|NCT04887948|583382523|FG002|Overall Study|Lost to Follow-up|3|||
161543893|NCT04887948|583382521|FG000|Overall Study|Physician Decision|0|||
161593752|NCT02962895|583564995|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
161543894|NCT04887948|583382522|FG001|Overall Study|Physician Decision|4|||
161543895|NCT04887948|583382523|FG002|Overall Study|Physician Decision|1|||
161543896|NCT04887948|583382521|FG000|Overall Study|Protocol Violation|1|||
161543897|NCT04887948|583382522|FG001|Overall Study|Protocol Violation|1|||
161543898|NCT04887948|583382523|FG002|Overall Study|Protocol Violation|0|||
161543899|NCT04887948|583382521|FG000|Overall Study|Withdrawal by Subject|0|||
161543900|NCT04887948|583382522|FG001|Overall Study|Withdrawal by Subject|6|||
161543901|NCT04887948|583382523|FG002|Overall Study|Withdrawal by Subject|1|||
161543902|NCT04887948|583382521|FG000|Overall Study|No longer met eligibility criteria|1|||
161543903|NCT04887948|583382522|FG001|Overall Study|No longer met eligibility criteria|2|||
161593753|NCT02962895|583564996|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161593754|NCT02962895|583564997|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161593755|NCT02962895|583564998|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161593756|NCT02962895|583564992|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
161593757|NCT02962895|583564993|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161593758|NCT02962895|583564994|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
161593759|NCT02962895|583564995|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
161593760|NCT02962895|583564996|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161593761|NCT02962895|583564997|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161593762|NCT02962895|583564998|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
161593763|NCT04509674|583565001|FG000|Overall Study|Not treated|33|||
161593764|NCT04509674|583565002|FG001|Overall Study|Not treated|26|||
161593765|NCT04509674|583565001|FG000|Overall Study|Protocol Violation|9|||
161593766|NCT04509674|583565002|FG001|Overall Study|Protocol Violation|10|||
161593767|NCT04509674|583565001|FG000|Overall Study|Lost to Follow-up|31|||
161593768|NCT04509674|583565002|FG001|Overall Study|Lost to Follow-up|39|||
161593769|NCT04509674|583565001|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
161593770|NCT04509674|583565002|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
161593771|NCT04509674|583565001|FG000|Overall Study|Adverse event, serious fatal event|11|||
161593772|NCT04509674|583565002|FG001|Overall Study|Adverse event, serious fatal event|4|||
161593773|NCT04509674|583565001|FG000|Overall Study|Adverse event, non-fatal event|107|||
161593774|NCT04509674|583565002|FG001|Overall Study|Adverse event, non-fatal event|118|||
161593775|NCT04509674|583565001|FG000|Overall Study|Other reason than listed|106|||
161593776|NCT04509674|583565002|FG001|Overall Study|Other reason than listed|95|||
161593777|NCT06190691|583565012|FG000|Overall Study|Adverse Event|2|||
161593778|NCT06190691|583565013|FG001|Overall Study|Adverse Event|0|||
161593779|NCT06190691|583565014|FG002|Overall Study|Adverse Event|0|||
161593780|NCT06190691|583565015|FG003|Overall Study|Adverse Event|0|||
161593781|NCT03016754|583565017|FG000|Overall Study|Death|5|||
161593782|NCT03016754|583565018|FG001|Overall Study|Death|4|||
161593783|NCT03016754|583565019|FG002|Overall Study|Death|5|||
161593784|NCT03016754|583565020|FG003|Overall Study|Death|1|||
161593785|NCT03016754|583565017|FG000|Overall Study|Lost to Follow-up|23|||
161593786|NCT03016754|583565018|FG001|Overall Study|Lost to Follow-up|17|||
161593787|NCT03016754|583565019|FG002|Overall Study|Lost to Follow-up|4|||
161593788|NCT03016754|583565020|FG003|Overall Study|Lost to Follow-up|2|||
161593789|NCT03016754|583565017|FG000|Overall Study|Withdrawal by Subject|6|||
161593790|NCT03016754|583565018|FG001|Overall Study|Withdrawal by Subject|6|||
161593791|NCT03016754|583565019|FG002|Overall Study|Withdrawal by Subject|2|||
161593792|NCT03016754|583565020|FG003|Overall Study|Withdrawal by Subject|2|||
161593793|NCT03016754|583565017|FG000|Overall Study|Other/Unknown|2|||
161593794|NCT03016754|583565018|FG001|Overall Study|Other/Unknown|4|||
161593795|NCT03016754|583565019|FG002|Overall Study|Other/Unknown|2|||
161593796|NCT03016754|583565020|FG003|Overall Study|Other/Unknown|1|||
161593797|NCT03016754|583565017|FG000|Overall Study|Protocol Violation|0|||
161593798|NCT03016754|583565018|FG001|Overall Study|Protocol Violation|0|||
161593799|NCT03016754|583565019|FG002|Overall Study|Protocol Violation|0|||
161593800|NCT03016754|583565020|FG003|Overall Study|Protocol Violation|4|||
161593801|NCT04019873|583565021|FG000|Overall Study|Discontinued from the treatment|1|||
161593802|NCT04019873|583565022|FG001|Overall Study|Discontinued from the treatment|39|||
161593803|NCT04019873|583565023|FG002|Overall Study|Discontinued from the treatment|2|||
161593804|NCT03896789|583565031|FG000|Baseline|Lost to Follow-up|1|||
161593805|NCT03896789|583565032|FG001|Baseline|Lost to Follow-up|2|||
161593806|NCT03896789|583565031|FG000|Baseline|Death|3|||
161593807|NCT03896789|583565032|FG001|Baseline|Death|6|||
161593808|NCT03896789|583565031|FG000|Post-Randomization|Lost to Follow-up|12|||
161593809|NCT03896789|583565032|FG001|Post-Randomization|Lost to Follow-up|11|||
161593810|NCT03896789|583565031|FG000|Post-Randomization|Death|12|||
161593811|NCT03896789|583565032|FG001|Post-Randomization|Death|13|||
161593812|NCT01606215|583565033|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
161593813|NCT01606215|583565034|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
161593814|NCT04316871|583565040|FG000|Overall Study|Protocol Violation|2|||
161593815|NCT04316871|583565041|FG001|Overall Study|Protocol Violation|2|||
161593816|NCT04316871|583565042|FG002|Overall Study|Protocol Violation|2|||
161593817|NCT04316871|583565043|FG003|Overall Study|Protocol Violation|2|||
161593818|NCT05087992|583565044|FG000|Overall Study|Adverse Event|0|||
161593819|NCT05087992|583565045|FG001|Overall Study|Adverse Event|1|||
161593820|NCT05087992|583565046|FG002|Overall Study|Adverse Event|0|||
161593821|NCT05087992|583565044|FG000|Overall Study|Withdrawal by Subject|2|||
161593822|NCT05087992|583565045|FG001|Overall Study|Withdrawal by Subject|0|||
161679989|NCT01289821|583881488|FG000|Treatment Period|Physician Decision|3|||
161679990|NCT01289821|583881488|FG000|Treatment Period|Adverse Event|4|||
161679991|NCT01289821|583881488|FG000|Treatment Period|Radiological Progression|43|||
161679992|NCT01289821|583881488|FG000|Treatment Period|Clinical Progression|2|||
161679993|NCT01289821|583881488|FG000|Treatment Period|Therapeutic procedure required|1|||
161679994|NCT01289821|583881488|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
161679995|NCT01289821|583881488|FG000|Safety Follow-up Period|Protocol Violation|3|||
161679996|NCT01289821|583881488|FG000|Safety Follow-up Period|Unspecified reason|1|||
161593823|NCT05087992|583565046|FG002|Overall Study|Withdrawal by Subject|0|||
161593824|NCT05087992|583565044|FG000|Overall Study|clinical disease progression|3|||
161593825|NCT05087992|583565045|FG001|Overall Study|clinical disease progression|1|||
161679997|NCT01289821|583881488|FG000|Survival Follow-up Period|Protocol Violation|1|||
161679998|NCT01289821|583881488|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
161679999|NCT01289821|583881488|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
161680000|NCT01009034|583881489|FG000|Overall Study|Lost to Follow-up|2|||
161680001|NCT01009034|583881489|FG000|Overall Study|Withdrawal by Subject|2|||
161680002|NCT02243865|583881492|FG000|Overall Study|Protocol Violation|1|||
161680003|NCT02243865|583881493|FG001|Overall Study|Protocol Violation|3|||
161680004|NCT02243865|583881492|FG000|Overall Study|Lost to Follow-up|1|||
161680005|NCT02243865|583881493|FG001|Overall Study|Lost to Follow-up|1|||
161680006|NCT02243865|583881492|FG000|Overall Study|Withdrawal by Subject|1|||
161680007|NCT02243865|583881493|FG001|Overall Study|Withdrawal by Subject|0|||
161680008|NCT02243865|583881492|FG000|Overall Study|Adverse Event|1|||
161680009|NCT02243865|583881493|FG001|Overall Study|Adverse Event|1|||
161680010|NCT05093322|583881494|FG000|Overall Study|Death|6|||
161680011|NCT05093322|583881495|FG001|Overall Study|Death|2|||
161680012|NCT05093322|583881494|FG000|Overall Study|Other|4|||
161680013|NCT05093322|583881495|FG001|Overall Study|Other|1|||
161680014|NCT00898443|583881496|FG000|Overall Study|Withdrawal by Subject|1|||
161680015|NCT00898443|583881497|FG001|Overall Study|Withdrawal by Subject|0|||
161680016|NCT00074581|583881499|FG000|Overall Study|Death|15|||
161680017|NCT00074581|583881500|FG001|Overall Study|Death|16|||
161680018|NCT00074581|583881499|FG000|Overall Study|Withdrawal by Subject|50|||
161680019|NCT00074581|583881500|FG001|Overall Study|Withdrawal by Subject|49|||
161680020|NCT00074581|583881499|FG000|Overall Study|Unable to adhere to visit schedule|13|||
161680021|NCT00074581|583881500|FG001|Overall Study|Unable to adhere to visit schedule|14|||
161680022|NCT00074581|583881499|FG000|Overall Study|Relocated|14|||
161680023|NCT00074581|583881500|FG001|Overall Study|Relocated|9|||
161680024|NCT00074581|583881499|FG000|Overall Study|Were withdrawn by investigator|5|||
161680025|NCT00074581|583881500|FG001|Overall Study|Were withdrawn by investigator|2|||
161680026|NCT00074581|583881499|FG000|Overall Study|Lost to Follow-up|16|||
161680027|NCT00074581|583881500|FG001|Overall Study|Lost to Follow-up|11|||
161680028|NCT00074581|583881499|FG000|Overall Study|Ended relationship w. index participant|117|||
161680029|NCT00074581|583881500|FG001|Overall Study|Ended relationship w. index participant|106|||
161680030|NCT00074581|583881499|FG000|Overall Study|Other|14|||
161680031|NCT00074581|583881500|FG001|Overall Study|Other|19|||
161680032|NCT01770912|583881501|FG000|Overall Study|Lost to Follow-up|2|||
161680033|NCT01770912|583881502|FG001|Overall Study|Lost to Follow-up|0|||
161680034|NCT03250832|583881503|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
161680035|NCT03250832|583881504|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
161680036|NCT03250832|583881505|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
161680037|NCT03250832|583881506|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
161680038|NCT03250832|583881507|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
161680039|NCT03250832|583881508|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
161680040|NCT03250832|583881509|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
161680041|NCT03250832|583881510|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680042|NCT03250832|583881511|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680043|NCT03250832|583881512|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680044|NCT03250832|583881513|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680045|NCT03250832|583881514|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680046|NCT03250832|583881503|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
161680047|NCT03250832|583881504|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
161680048|NCT03250832|583881505|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
161680049|NCT03250832|583881506|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
161680050|NCT03250832|583881507|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
161680051|NCT03250832|583881508|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
161680052|NCT03250832|583881509|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
161680053|NCT03250832|583881510|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680054|NCT03250832|583881511|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680055|NCT03250832|583881512|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680056|NCT03250832|583881513|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680057|NCT03250832|583881514|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680058|NCT03250832|583881503|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680059|NCT03250832|583881504|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680060|NCT03250832|583881505|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
161680061|NCT03250832|583881506|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680062|NCT03250832|583881507|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680063|NCT03250832|583881508|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680064|NCT03250832|583881509|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680065|NCT03250832|583881510|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680066|NCT03250832|583881511|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680067|NCT03250832|583881512|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161543904|NCT04887948|583382523|FG002|Overall Study|No longer met eligibility criteria|1|||
161543905|NCT04887948|583382521|FG000|Overall Study|Other|2|||
161543906|NCT04887948|583382522|FG001|Overall Study|Other|1|||
161543907|NCT04887948|583382523|FG002|Overall Study|Other|1|||
161543908|NCT02312856|583382524|FG000|Overall Study|Death|1|||
161593826|NCT05087992|583565046|FG002|Overall Study|clinical disease progression|0|||
161593827|NCT05087992|583565044|FG000|Overall Study|objective disease progression|4|||
161593828|NCT05087992|583565045|FG001|Overall Study|objective disease progression|1|||
161593829|NCT05087992|583565046|FG002|Overall Study|objective disease progression|0|||
161593830|NCT04473222|583565047|FG000|Overall Study|Lost to Follow-up|13|||
161593831|NCT04473222|583565048|FG001|Overall Study|Lost to Follow-up|13|||
161593832|NCT04473222|583565047|FG000|Overall Study|Withdrawal by Subject|0|||
161593833|NCT04473222|583565048|FG001|Overall Study|Withdrawal by Subject|1|||
161593834|NCT04473222|583565047|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
161593835|NCT04473222|583565048|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
161593836|NCT01098812|583565057|FG000|Overall Study|Death|2|||
161593837|NCT01098812|583565058|FG001|Overall Study|Death|0|||
161593838|NCT01098812|583565059|FG002|Overall Study|Death|1|||
161593839|NCT01098812|583565057|FG000|Overall Study|Lost to Follow-up|0|||
161593840|NCT01098812|583565058|FG001|Overall Study|Lost to Follow-up|1|||
161593841|NCT01098812|583565059|FG002|Overall Study|Lost to Follow-up|0|||
161593842|NCT02319759|583565060|FG000|Week 0 - 16|Lack of Efficacy|1|||
161593843|NCT02319759|583565061|FG001|Week 0 - 16|Lack of Efficacy|0|||
161593844|NCT02319759|583565062|FG002|Week 0 - 16|Lack of Efficacy|0|||
161593845|NCT02319759|583565063|FG003|Week 0 - 16|Lack of Efficacy|0|||
161593846|NCT02319759|583565064|FG004|Week 0 - 16|Lack of Efficacy|0|||
161593847|NCT02319759|583565060|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
161593848|NCT02319759|583565061|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
161593849|NCT02319759|583565062|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
161593850|NCT02319759|583565063|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
161593851|NCT02319759|583565064|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
161593852|NCT02319759|583565060|FG000|Week 16 - 24|Lack of Efficacy|1|||
161593853|NCT02319759|583565061|FG001|Week 16 - 24|Lack of Efficacy|0|||
161593854|NCT02319759|583565062|FG002|Week 16 - 24|Lack of Efficacy|1|||
161593855|NCT02319759|583565063|FG003|Week 16 - 24|Lack of Efficacy|0|||
161593856|NCT02319759|583565064|FG004|Week 16 - 24|Lack of Efficacy|0|||
161593857|NCT02319759|583565060|FG000|Week 16 - 24|Lost to Follow-up|1|||
161593858|NCT02319759|583565061|FG001|Week 16 - 24|Lost to Follow-up|0|||
161593859|NCT02319759|583565062|FG002|Week 16 - 24|Lost to Follow-up|0|||
161593860|NCT02319759|583565063|FG003|Week 16 - 24|Lost to Follow-up|0|||
161593861|NCT02319759|583565064|FG004|Week 16 - 24|Lost to Follow-up|0|||
161593862|NCT02319759|583565060|FG000|Week 16 - 24|Withdrawal by Subject|0|||
161593863|NCT02319759|583565061|FG001|Week 16 - 24|Withdrawal by Subject|0|||
161593864|NCT02319759|583565062|FG002|Week 16 - 24|Withdrawal by Subject|2|||
161593865|NCT02319759|583565063|FG003|Week 16 - 24|Withdrawal by Subject|0|||
161593866|NCT02319759|583565064|FG004|Week 16 - 24|Withdrawal by Subject|0|||
161593867|NCT02319759|583565060|FG000|Week 24 - 56|Adverse Event|0|||
161593868|NCT02319759|583565061|FG001|Week 24 - 56|Adverse Event|0|||
161593869|NCT02319759|583565062|FG002|Week 24 - 56|Adverse Event|2|||
161593870|NCT02319759|583565063|FG003|Week 24 - 56|Adverse Event|0|||
161593871|NCT02319759|583565064|FG004|Week 24 - 56|Adverse Event|0|||
161593872|NCT02319759|583565060|FG000|Week 24 - 56|Lack of Efficacy|0|||
161593873|NCT02319759|583565061|FG001|Week 24 - 56|Lack of Efficacy|0|||
161593874|NCT02319759|583565062|FG002|Week 24 - 56|Lack of Efficacy|0|||
161593875|NCT02319759|583565063|FG003|Week 24 - 56|Lack of Efficacy|2|||
161593876|NCT02319759|583565064|FG004|Week 24 - 56|Lack of Efficacy|1|||
161593877|NCT02319759|583565060|FG000|Week 24 - 56|Withdrawal by Subject|0|||
161593878|NCT02319759|583565061|FG001|Week 24 - 56|Withdrawal by Subject|1|||
161593879|NCT02319759|583565062|FG002|Week 24 - 56|Withdrawal by Subject|0|||
161593880|NCT02319759|583565063|FG003|Week 24 - 56|Withdrawal by Subject|0|||
161593881|NCT02319759|583565064|FG004|Week 24 - 56|Withdrawal by Subject|0|||
161593882|NCT02319759|583565060|FG000|Week 24 - 56|Lost to Follow-up|0|||
161593883|NCT02319759|583565061|FG001|Week 24 - 56|Lost to Follow-up|0|||
161593884|NCT02319759|583565062|FG002|Week 24 - 56|Lost to Follow-up|0|||
161593885|NCT02319759|583565063|FG003|Week 24 - 56|Lost to Follow-up|0|||
161593886|NCT02319759|583565064|FG004|Week 24 - 56|Lost to Follow-up|1|||
161593887|NCT03452579|583565067|FG000|Overall Study|Death|0|||
161593888|NCT03452579|583565068|FG001|Overall Study|Death|1|||
161593889|NCT03452579|583565067|FG000|Overall Study|Withdrawal by Subject|2|||
161593890|NCT03452579|583565068|FG001|Overall Study|Withdrawal by Subject|0|||
161593891|NCT03452579|583565067|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
161593892|NCT03452579|583565068|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
161593893|NCT03452579|583565067|FG000|Overall Study|Physician Decision|1|||
161593894|NCT03452579|583565068|FG001|Overall Study|Physician Decision|1|||
161593895|NCT03452579|583565067|FG000|Overall Study|Adverse Event|1|||
161593896|NCT03452579|583565068|FG001|Overall Study|Adverse Event|4|||
161593897|NCT04858321|583565069|FG000|Overall Study|Withdrawal by Subject|3|||
161680068|NCT03250832|583881513|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161593898|NCT05006872|583565072|FG000|Overall Study|Lost to Follow-up|37|||
161593899|NCT05006872|583565073|FG001|Overall Study|Lost to Follow-up|31|||
161593900|NCT02573493|583565074|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
161680069|NCT03250832|583881514|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680070|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680071|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680072|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680073|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680074|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680075|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680076|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680077|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
161680078|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680079|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680080|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680081|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680082|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680083|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680084|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680085|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680086|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680087|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680088|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680089|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
161680090|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680091|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680092|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680093|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680094|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680095|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680096|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680097|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680098|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680099|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680100|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680101|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
161829767|NCT00206102|584415882|FG001|Overall Study|Study-specific discontinuation criteria|17|||
161829768|NCT00206102|584415881|FG000|Overall Study|None of those categories|42|||
161829769|NCT00206102|584415882|FG001|Overall Study|None of those categories|36|||
161829770|NCT01917968|584415883|FG000|Overall Study|Death|3|||
161829771|NCT01917968|584415884|FG001|Overall Study|Death|2|||
161543909|NCT02312856|583382524|FG000|Overall Study|Lost to Follow-up|3|||
161680102|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680103|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161829772|NCT01917968|584415883|FG000|Overall Study|Lost to Follow-up|21|||
161829773|NCT01917968|584415884|FG001|Overall Study|Lost to Follow-up|39|||
161829774|NCT01917968|584415883|FG000|Overall Study|Physician Decision|1|||
161829775|NCT01917968|584415884|FG001|Overall Study|Physician Decision|2|||
161829776|NCT01917968|584415883|FG000|Overall Study|Withdrawal by Subject|20|||
161829777|NCT01917968|584415884|FG001|Overall Study|Withdrawal by Subject|35|||
161829778|NCT01917968|584415883|FG000|Overall Study|Subject Relocation|5|||
161829779|NCT01917968|584415884|FG001|Overall Study|Subject Relocation|1|||
161829780|NCT01917968|584415883|FG000|Overall Study|36M Missed Visit|3|||
161829781|NCT01917968|584415884|FG001|Overall Study|36M Missed Visit|2|||
161829782|NCT01917968|584415883|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
161829783|NCT01917968|584415884|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
161829784|NCT01917968|584415883|FG000|Overall Study|Change in Family Circumstances|0|||
161829785|NCT01917968|584415884|FG001|Overall Study|Change in Family Circumstances|1|||
161829786|NCT01917968|584415883|FG000|Overall Study|No Data Available|0|||
161829787|NCT01917968|584415884|FG001|Overall Study|No Data Available|2|||
161829788|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
161829789|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
161829790|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
161829791|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
161829792|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
161829793|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
161829794|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
161829795|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
161829796|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
161829797|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
161829798|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
161829799|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
161829800|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
161829801|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
161829802|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
161829803|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
161829804|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
161829805|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
161829806|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
161829807|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
161829808|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
161829809|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
161829810|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
161829811|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
161829812|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
161829813|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
161829814|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
161829815|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
161829816|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
161829817|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
161829818|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
161829819|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
161829820|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
161829821|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
161829822|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
161829823|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
161829824|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
161829825|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
161829826|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
161829827|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
161829828|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
161829829|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
161829830|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
161829831|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
161829832|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
161829833|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
161829834|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
161829835|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
161543910|NCT04415151|583382525|FG000|Overall Study|Death|1|||
161543911|NCT04415151|583382526|FG001|Overall Study|Death|1|||
161543912|NCT04415151|583382525|FG000|Overall Study|Withdrawal by Subject|1|||
161543913|NCT04415151|583382526|FG001|Overall Study|Withdrawal by Subject|0|||
161543914|NCT00638235|583382527|FG000|Overall Study|Lost to Follow-up|31|||
161543915|NCT00638235|583382528|FG001|Overall Study|Lost to Follow-up|3|||
161543916|NCT00638235|583382529|FG002|Overall Study|Lost to Follow-up|18|||
161680104|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680105|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680106|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680107|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680108|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680109|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680110|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680111|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680112|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680113|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
161680114|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680115|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680116|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680117|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680118|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680119|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680120|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680121|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680122|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680123|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680124|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680125|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
161680126|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680127|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680128|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680129|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680130|NCT03250832|583881503|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680131|NCT03250832|583881504|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680132|NCT03250832|583881505|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680133|NCT03250832|583881506|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680134|NCT03250832|583881507|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680135|NCT03250832|583881508|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680136|NCT03250832|583881509|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680137|NCT03250832|583881510|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680138|NCT03250832|583881511|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
161680139|NCT03250832|583881512|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
161680140|NCT03250832|583881513|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680141|NCT03250832|583881514|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680142|NCT03250832|583881503|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680143|NCT03250832|583881504|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680144|NCT03250832|583881505|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680145|NCT03250832|583881506|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161543917|NCT00638235|583382530|FG003|Overall Study|Lost to Follow-up|10|||
161543918|NCT00638235|583382531|FG004|Overall Study|Lost to Follow-up|13|||
161829836|NCT00576303|584415892|FG000|Dose Titration Period|Early withdrawal|17|||
161829837|NCT00576303|584415892|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
161829838|NCT00576303|584415892|FG000|Long Term Safety Period|Early withdrawal|16|||
161829839|NCT02843659|584415896|FG000|Overall Study|Subject Withdrew Consent|0|||
161829840|NCT02843659|584415897|FG001|Overall Study|Subject Withdrew Consent|0|||
161829841|NCT02843659|584415898|FG002|Overall Study|Subject Withdrew Consent|1|||
161829842|NCT02843659|584415896|FG000|Overall Study|Administrative Reason by Sponsor|4|||
161829843|NCT02843659|584415897|FG001|Overall Study|Administrative Reason by Sponsor|5|||
161829844|NCT02843659|584415898|FG002|Overall Study|Administrative Reason by Sponsor|4|||
161829845|NCT02843659|584415896|FG000|Overall Study|Adverse Event|0|||
161829846|NCT02843659|584415897|FG001|Overall Study|Adverse Event|1|||
161829847|NCT02843659|584415898|FG002|Overall Study|Adverse Event|0|||
161829848|NCT03203642|584415899|FG000|Overall Study|Adverse Event|3|||
161829849|NCT03203642|584415900|FG001|Overall Study|Adverse Event|1|||
161829850|NCT03203642|584415899|FG000|Overall Study|Withdrawal by Subject|6|||
161829851|NCT03203642|584415900|FG001|Overall Study|Withdrawal by Subject|6|||
161829852|NCT03203642|584415899|FG000|Overall Study|Lost to Follow-up|2|||
161829853|NCT03203642|584415900|FG001|Overall Study|Lost to Follow-up|1|||
161829854|NCT03203642|584415899|FG000|Overall Study|Termination of the study by sponsor|1|||
161829855|NCT03203642|584415900|FG001|Overall Study|Termination of the study by sponsor|1|||
161829856|NCT03203642|584415899|FG000|Overall Study|Participant moved|0|||
161829857|NCT03203642|584415900|FG001|Overall Study|Participant moved|1|||
161829858|NCT03203642|584415899|FG000|Overall Study|Investigator's decision|3|||
161829859|NCT03203642|584415900|FG001|Overall Study|Investigator's decision|0|||
161829860|NCT03203642|584415899|FG000|Overall Study|Other than above specified|0|||
161829861|NCT03203642|584415900|FG001|Overall Study|Other than above specified|1|||
161680146|NCT03250832|583881507|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161543919|NCT00638235|583382532|FG005|Overall Study|Lost to Follow-up|26|||
161680147|NCT03250832|583881508|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161829862|NCT01546142|584418015|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
161829863|NCT01546142|584418016|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
161543920|NCT00638235|583382533|FG006|Overall Study|Lost to Follow-up|0|||
161543921|NCT00638235|583382534|FG007|Overall Study|Lost to Follow-up|1|||
161543922|NCT00638235|583382535|FG008|Overall Study|Lost to Follow-up|18|||
161543923|NCT01588990|583382536|FG000|Phase A|Withdrawal by Subject|5|||
161543924|NCT01588990|583382536|FG000|Phase A|Physician Decision|11|||
161543925|NCT01588990|583382536|FG000|Phase A|Other|14|||
161593901|NCT02573493|583565075|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
161593902|NCT02573493|583565076|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
161593903|NCT02573493|583565077|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
161593904|NCT04025554|583565078|FG000|Overall Study|Adverse Event|3|||
161593905|NCT03848065|583565079|FG000|Overall Study|Death|0|||
161593906|NCT03848065|583565080|FG001|Overall Study|Death|1|||
161593907|NCT03848065|583565081|FG002|Overall Study|Death|0|||
161593908|NCT03848065|583565079|FG000|Overall Study|Lost to Follow-up|0|||
161593909|NCT03848065|583565080|FG001|Overall Study|Lost to Follow-up|0|||
161593910|NCT03848065|583565081|FG002|Overall Study|Lost to Follow-up|1|||
161593911|NCT03848065|583565079|FG000|Overall Study|Physician Decision|0|||
161593912|NCT03848065|583565080|FG001|Overall Study|Physician Decision|0|||
161593913|NCT03848065|583565081|FG002|Overall Study|Physician Decision|1|||
161593914|NCT00764751|583565082|FG000|Overall Study|Adverse Event|1|||
161593915|NCT00764751|583565083|FG001|Overall Study|Adverse Event|1|||
161593916|NCT00764751|583565082|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
161593917|NCT00764751|583565083|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
161593918|NCT05270408|583565092|FG000|Started Treatment|Withdrawal by Subject|0|||
161593919|NCT05270408|583565093|FG001|Started Treatment|Withdrawal by Subject|0|||
161593920|NCT05270408|583565094|FG002|Started Treatment|Withdrawal by Subject|3|||
161593921|NCT05270408|583565092|FG000|Started Treatment|Adverse Event|0|||
161593922|NCT05270408|583565093|FG001|Started Treatment|Adverse Event|0|||
161593923|NCT05270408|583565094|FG002|Started Treatment|Adverse Event|1|||
161593924|NCT05270408|583565092|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
161593925|NCT05270408|583565093|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
161593926|NCT05270408|583565094|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
161593927|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
161593928|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
161593929|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
161593930|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
161593931|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
161593932|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
161593933|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
161593934|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
161593935|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
161593936|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
161593937|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
161593938|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
161593939|NCT04338061|583565095|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
161593940|NCT04338061|583565096|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
161593941|NCT04338061|583565095|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
161593942|NCT04338061|583565096|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
161593943|NCT04338061|583565095|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
161593944|NCT04338061|583565096|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
161593945|NCT04338061|583565095|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161593946|NCT04338061|583565096|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161593947|NCT04338061|583565095|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
161593948|NCT04338061|583565096|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
161593949|NCT04338061|583565095|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
161593950|NCT04338061|583565096|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
161593951|NCT04074759|583565097|FG000|Overall Study|Withdrawal by Subject|0|||
161829864|NCT01546142|584418015|FG000|Overall Study|Subject Noncompliance|1|||
161543926|NCT01588990|583382536|FG000|Phase A|Lost to Follow-up|1|||
161543927|NCT01588990|583382536|FG000|Phase A|Death|5|||
161543928|NCT01588990|583382536|FG000|Phase A|Adverse Event|28|||
161543929|NCT01588990|583382536|FG000|Phase A|Still on therapy at end of study|6|||
161543930|NCT01588990|583382536|FG000|Phase B|Adverse Event|2|||
161543931|NCT01588990|583382536|FG000|Phase B|Still on therapy at end of study|5|||
161543932|NCT01588990|583382536|FG000|Phase B|Withdrawal by Subject|3|||
161543933|NCT01588990|583382536|FG000|Phase B|Physician Decision|4|||
161543934|NCT01588990|583382536|FG000|Phase B|Other|2|||
161543935|NCT02367716|583382539|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
161543936|NCT01473381|583382540|FG000|Overall Study|Adverse Event|8|||
161543937|NCT01473381|583382541|FG001|Overall Study|Adverse Event|20|||
161543938|NCT01473381|583382542|FG002|Overall Study|Adverse Event|25|||
161543939|NCT01473381|583382543|FG003|Overall Study|Adverse Event|17|||
161543940|NCT01473381|583382540|FG000|Overall Study|Insufficient Therapeutic Response|10|||
161543941|NCT01473381|583382541|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161543942|NCT01473381|583382542|FG002|Overall Study|Insufficient Therapeutic Response|2|||
161593952|NCT04074759|583565098|FG001|Overall Study|Withdrawal by Subject|0|||
161593953|NCT04074759|583565099|FG002|Overall Study|Withdrawal by Subject|0|||
161593954|NCT04074759|583565100|FG003|Overall Study|Withdrawal by Subject|0|||
161593955|NCT04074759|583565101|FG004|Overall Study|Withdrawal by Subject|0|||
161593956|NCT04074759|583565102|FG005|Overall Study|Withdrawal by Subject|2|||
161593957|NCT04074759|583565103|FG006|Overall Study|Withdrawal by Subject|0|||
161593958|NCT04074759|583565104|FG007|Overall Study|Withdrawal by Subject|2|||
161593959|NCT04074759|583565105|FG008|Overall Study|Withdrawal by Subject|1|||
161593960|NCT04074759|583565106|FG009|Overall Study|Withdrawal by Subject|2|||
161593961|NCT04074759|583565107|FG010|Overall Study|Withdrawal by Subject|9|||
161593962|NCT04074759|583565108|FG011|Overall Study|Withdrawal by Subject|2|||
161593963|NCT04074759|583565109|FG012|Overall Study|Withdrawal by Subject|1|||
161593964|NCT04074759|583565110|FG013|Overall Study|Withdrawal by Subject|3|||
161593965|NCT04074759|583565111|FG014|Overall Study|Withdrawal by Subject|2|||
161593966|NCT04074759|583565112|FG015|Overall Study|Withdrawal by Subject|0|||
161593967|NCT04074759|583565113|FG016|Overall Study|Withdrawal by Subject|0|||
161593968|NCT04074759|583565114|FG017|Overall Study|Withdrawal by Subject|3|||
161593969|NCT04074759|583565115|FG018|Overall Study|Withdrawal by Subject|1|||
161593970|NCT04074759|583565097|FG000|Overall Study|Death|1|||
161593971|NCT04074759|583565098|FG001|Overall Study|Death|0|||
161593972|NCT04074759|583565099|FG002|Overall Study|Death|1|||
161593973|NCT04074759|583565100|FG003|Overall Study|Death|1|||
161593974|NCT04074759|583565101|FG004|Overall Study|Death|2|||
161593975|NCT04074759|583565102|FG005|Overall Study|Death|0|||
161593976|NCT04074759|583565103|FG006|Overall Study|Death|1|||
161593977|NCT04074759|583565104|FG007|Overall Study|Death|0|||
161593978|NCT04074759|583565105|FG008|Overall Study|Death|3|||
161593979|NCT04074759|583565106|FG009|Overall Study|Death|2|||
161593980|NCT04074759|583565107|FG010|Overall Study|Death|4|||
161593981|NCT04074759|583565108|FG011|Overall Study|Death|1|||
161593982|NCT04074759|583565109|FG012|Overall Study|Death|0|||
161593983|NCT04074759|583565110|FG013|Overall Study|Death|2|||
161593984|NCT04074759|583565111|FG014|Overall Study|Death|1|||
161593985|NCT04074759|583565112|FG015|Overall Study|Death|0|||
161593986|NCT04074759|583565113|FG016|Overall Study|Death|1|||
161593987|NCT04074759|583565114|FG017|Overall Study|Death|0|||
161593988|NCT04074759|583565115|FG018|Overall Study|Death|1|||
161593989|NCT04074759|583565097|FG000|Overall Study|Lost to Follow-up|0|||
161593990|NCT04074759|583565098|FG001|Overall Study|Lost to Follow-up|0|||
161593991|NCT04074759|583565099|FG002|Overall Study|Lost to Follow-up|0|||
161593992|NCT04074759|583565100|FG003|Overall Study|Lost to Follow-up|0|||
161593993|NCT04074759|583565101|FG004|Overall Study|Lost to Follow-up|0|||
161543943|NCT01473381|583382543|FG003|Overall Study|Insufficient Therapeutic Response|3|||
161543944|NCT01473381|583382540|FG000|Overall Study|Protocol Violation|17|||
161543945|NCT01473381|583382541|FG001|Overall Study|Protocol Violation|23|||
161543946|NCT01473381|583382542|FG002|Overall Study|Protocol Violation|19|||
161543947|NCT01473381|583382543|FG003|Overall Study|Protocol Violation|17|||
161543948|NCT01473381|583382540|FG000|Overall Study|Withdrawal of Consent|20|||
161543949|NCT01473381|583382541|FG001|Overall Study|Withdrawal of Consent|21|||
161543950|NCT01473381|583382542|FG002|Overall Study|Withdrawal of Consent|20|||
161543951|NCT01473381|583382543|FG003|Overall Study|Withdrawal of Consent|26|||
161543952|NCT01473381|583382540|FG000|Overall Study|Lost to Follow-up|25|||
161543953|NCT01473381|583382541|FG001|Overall Study|Lost to Follow-up|28|||
161543954|NCT01473381|583382542|FG002|Overall Study|Lost to Follow-up|35|||
161543955|NCT01473381|583382543|FG003|Overall Study|Lost to Follow-up|23|||
161543956|NCT01473381|583382540|FG000|Overall Study|Other Reasons|0|||
161543957|NCT01473381|583382541|FG001|Overall Study|Other Reasons|0|||
161543958|NCT01473381|583382542|FG002|Overall Study|Other Reasons|1|||
161543959|NCT01473381|583382543|FG003|Overall Study|Other Reasons|3|||
161593994|NCT04074759|583565102|FG005|Overall Study|Lost to Follow-up|0|||
161593995|NCT04074759|583565103|FG006|Overall Study|Lost to Follow-up|0|||
161593996|NCT04074759|583565104|FG007|Overall Study|Lost to Follow-up|0|||
161593997|NCT04074759|583565105|FG008|Overall Study|Lost to Follow-up|0|||
161593998|NCT04074759|583565106|FG009|Overall Study|Lost to Follow-up|0|||
161593999|NCT04074759|583565107|FG010|Overall Study|Lost to Follow-up|1|||
161594000|NCT04074759|583565108|FG011|Overall Study|Lost to Follow-up|0|||
161594001|NCT04074759|583565109|FG012|Overall Study|Lost to Follow-up|0|||
161594002|NCT04074759|583565110|FG013|Overall Study|Lost to Follow-up|0|||
161594003|NCT04074759|583565111|FG014|Overall Study|Lost to Follow-up|0|||
161594004|NCT04074759|583565112|FG015|Overall Study|Lost to Follow-up|0|||
161594005|NCT04074759|583565113|FG016|Overall Study|Lost to Follow-up|1|||
161543960|NCT00539643|583382544|FG000|Overall Study|Adverse Event|1|||
161543961|NCT00539643|583382545|FG001|Overall Study|Adverse Event|0|||
161543962|NCT00539643|583382544|FG000|Overall Study|Death|2|||
161594006|NCT04074759|583565114|FG017|Overall Study|Lost to Follow-up|0|||
161594007|NCT04074759|583565115|FG018|Overall Study|Lost to Follow-up|1|||
161594008|NCT04074759|583565097|FG000|Overall Study|Other|0|||
161594009|NCT04074759|583565098|FG001|Overall Study|Other|1|||
161594010|NCT04074759|583565099|FG002|Overall Study|Other|1|||
161594011|NCT04074759|583565100|FG003|Overall Study|Other|0|||
161594012|NCT04074759|583565101|FG004|Overall Study|Other|2|||
161543963|NCT00539643|583382545|FG001|Overall Study|Death|1|||
161543964|NCT00539643|583382544|FG000|Overall Study|Physician Decision|3|||
161543965|NCT00539643|583382545|FG001|Overall Study|Physician Decision|1|||
161543966|NCT00539643|583382544|FG000|Overall Study|Withdrawal by Subject|0|||
161543967|NCT00539643|583382545|FG001|Overall Study|Withdrawal by Subject|1|||
161543968|NCT01641926|583382548|FG000|Overall Study|Adverse Event|5|||
161543969|NCT01641926|583382549|FG001|Overall Study|Adverse Event|2|||
161543970|NCT01641926|583382550|FG002|Overall Study|Adverse Event|3|||
161543971|NCT01641926|583382551|FG003|Overall Study|Adverse Event|1|||
161543972|NCT01641926|583382548|FG000|Overall Study|Lost to Follow-up|2|||
161543973|NCT01641926|583382549|FG001|Overall Study|Lost to Follow-up|2|||
161543974|NCT01641926|583382550|FG002|Overall Study|Lost to Follow-up|1|||
161543975|NCT01641926|583382551|FG003|Overall Study|Lost to Follow-up|0|||
161543976|NCT01641926|583382548|FG000|Overall Study|Physician Decision|6|||
161543977|NCT01641926|583382549|FG001|Overall Study|Physician Decision|5|||
161543978|NCT01641926|583382550|FG002|Overall Study|Physician Decision|0|||
161594013|NCT04074759|583565102|FG005|Overall Study|Other|1|||
161594014|NCT04074759|583565103|FG006|Overall Study|Other|2|||
161594015|NCT04074759|583565104|FG007|Overall Study|Other|1|||
161594016|NCT04074759|583565105|FG008|Overall Study|Other|1|||
161594017|NCT04074759|583565106|FG009|Overall Study|Other|4|||
161594018|NCT04074759|583565107|FG010|Overall Study|Other|4|||
161594019|NCT04074759|583565108|FG011|Overall Study|Other|2|||
161594020|NCT04074759|583565109|FG012|Overall Study|Other|0|||
161594021|NCT04074759|583565110|FG013|Overall Study|Other|0|||
161594022|NCT04074759|583565111|FG014|Overall Study|Other|0|||
161594023|NCT04074759|583565112|FG015|Overall Study|Other|1|||
161594024|NCT04074759|583565113|FG016|Overall Study|Other|0|||
161594025|NCT04074759|583565114|FG017|Overall Study|Other|0|||
161594026|NCT04074759|583565115|FG018|Overall Study|Other|0|||
161543979|NCT01641926|583382551|FG003|Overall Study|Physician Decision|1|||
161543980|NCT01641926|583382548|FG000|Overall Study|Protocol Violation|1|||
161543981|NCT01641926|583382549|FG001|Overall Study|Protocol Violation|0|||
161543982|NCT01641926|583382550|FG002|Overall Study|Protocol Violation|0|||
161543983|NCT01641926|583382551|FG003|Overall Study|Protocol Violation|1|||
161543984|NCT01641926|583382548|FG000|Overall Study|Withdrawal by Subject|13|||
161543985|NCT01641926|583382549|FG001|Overall Study|Withdrawal by Subject|5|||
161543986|NCT01641926|583382550|FG002|Overall Study|Withdrawal by Subject|6|||
161543987|NCT01641926|583382551|FG003|Overall Study|Withdrawal by Subject|1|||
161543988|NCT01641926|583382548|FG000|Overall Study|Not Treated|1|||
161543989|NCT01641926|583382549|FG001|Overall Study|Not Treated|1|||
161543990|NCT01641926|583382550|FG002|Overall Study|Not Treated|1|||
161543991|NCT01641926|583382551|FG003|Overall Study|Not Treated|0|||
161543992|NCT03812536|583382552|FG000|Overall Study|Protocol Violation|2|||
161543993|NCT03812536|583382553|FG001|Overall Study|Protocol Violation|0|||
161543994|NCT03812536|583382552|FG000|Overall Study|Withdrawal by Subject|1|||
161543995|NCT03812536|583382553|FG001|Overall Study|Withdrawal by Subject|1|||
161543996|NCT00152009|583382554|FG000|Overall Study|Adverse Event|9|||
161543997|NCT00152009|583382555|FG001|Overall Study|Adverse Event|13|||
161543998|NCT00152009|583382556|FG002|Overall Study|Adverse Event|20|||
161543999|NCT00152009|583382557|FG003|Overall Study|Adverse Event|1|||
161544000|NCT00152009|583382554|FG000|Overall Study|Protocol Violation|3|||
161544001|NCT00152009|583382555|FG001|Overall Study|Protocol Violation|0|||
161544002|NCT00152009|583382556|FG002|Overall Study|Protocol Violation|0|||
161544003|NCT00152009|583382557|FG003|Overall Study|Protocol Violation|1|||
161544004|NCT00152009|583382554|FG000|Overall Study|Withdrawal by Subject|2|||
161544005|NCT00152009|583382555|FG001|Overall Study|Withdrawal by Subject|3|||
161544006|NCT00152009|583382556|FG002|Overall Study|Withdrawal by Subject|4|||
161594027|NCT04074759|583565097|FG000|Overall Study|Missing end of study status|0|||
161594028|NCT04074759|583565098|FG001|Overall Study|Missing end of study status|0|||
161594029|NCT04074759|583565099|FG002|Overall Study|Missing end of study status|0|||
161594030|NCT04074759|583565100|FG003|Overall Study|Missing end of study status|0|||
161544007|NCT00152009|583382557|FG003|Overall Study|Withdrawal by Subject|9|||
161544008|NCT00152009|583382554|FG000|Overall Study|Lost to Follow-up|2|||
161544009|NCT00152009|583382555|FG001|Overall Study|Lost to Follow-up|4|||
161594031|NCT04074759|583565101|FG004|Overall Study|Missing end of study status|0|||
161594032|NCT04074759|583565102|FG005|Overall Study|Missing end of study status|0|||
161594033|NCT04074759|583565103|FG006|Overall Study|Missing end of study status|0|||
161594034|NCT04074759|583565104|FG007|Overall Study|Missing end of study status|0|||
161544010|NCT00152009|583382556|FG002|Overall Study|Lost to Follow-up|3|||
161544011|NCT00152009|583382557|FG003|Overall Study|Lost to Follow-up|3|||
161544012|NCT00152009|583382554|FG000|Overall Study|Lack of Efficacy|8|||
161544013|NCT00152009|583382555|FG001|Overall Study|Lack of Efficacy|6|||
161544014|NCT00152009|583382556|FG002|Overall Study|Lack of Efficacy|7|||
161594035|NCT04074759|583565105|FG008|Overall Study|Missing end of study status|0|||
161544015|NCT00152009|583382557|FG003|Overall Study|Lack of Efficacy|15|||
161544016|NCT00152009|583382554|FG000|Overall Study|ECG abnormalities|2|||
161544017|NCT00152009|583382555|FG001|Overall Study|ECG abnormalities|2|||
161544018|NCT00152009|583382556|FG002|Overall Study|ECG abnormalities|2|||
161544019|NCT00152009|583382557|FG003|Overall Study|ECG abnormalities|1|||
161544020|NCT00152009|583382554|FG000|Overall Study|Sponsor's decision|3|||
161544021|NCT00152009|583382555|FG001|Overall Study|Sponsor's decision|3|||
161544022|NCT00152009|583382556|FG002|Overall Study|Sponsor's decision|1|||
161544023|NCT00152009|583382557|FG003|Overall Study|Sponsor's decision|3|||
161544024|NCT01306201|583382558|FG000|Overall Study|Arrhythmia|4|||
161544025|NCT01306201|583382558|FG000|Overall Study|Files could not be processed|3|||
161544026|NCT01306201|583382558|FG000|Overall Study|Files unreadable|3|||
161544027|NCT00393523|583382561|FG000|Overall Study|Lost to Follow-up|0|||
161544028|NCT00393523|583382562|FG001|Overall Study|Lost to Follow-up|0|||
161544029|NCT00393523|583382563|FG002|Overall Study|Lost to Follow-up|0|||
161544030|NCT00393523|583382564|FG003|Overall Study|Lost to Follow-up|2|||
161544031|NCT00393523|583382565|FG004|Overall Study|Lost to Follow-up|1|||
161544032|NCT00393523|583382561|FG000|Overall Study|Protocol Violation|6|||
161544033|NCT00393523|583382562|FG001|Overall Study|Protocol Violation|2|||
161544034|NCT00393523|583382563|FG002|Overall Study|Protocol Violation|0|||
161544035|NCT00393523|583382564|FG003|Overall Study|Protocol Violation|1|||
161544036|NCT00393523|583382565|FG004|Overall Study|Protocol Violation|0|||
161544037|NCT00393523|583382561|FG000|Overall Study|Withdrawal by Subject|6|||
161544038|NCT00393523|583382562|FG001|Overall Study|Withdrawal by Subject|7|||
161544039|NCT00393523|583382563|FG002|Overall Study|Withdrawal by Subject|2|||
161544040|NCT00393523|583382564|FG003|Overall Study|Withdrawal by Subject|3|||
161544041|NCT00393523|583382565|FG004|Overall Study|Withdrawal by Subject|0|||
161544042|NCT00393523|583382561|FG000|Overall Study|Difficulties in specimen collection|0|||
161544043|NCT00393523|583382562|FG001|Overall Study|Difficulties in specimen collection|0|||
161544044|NCT00393523|583382563|FG002|Overall Study|Difficulties in specimen collection|1|||
161544045|NCT00393523|583382564|FG003|Overall Study|Difficulties in specimen collection|0|||
161544046|NCT00393523|583382565|FG004|Overall Study|Difficulties in specimen collection|0|||
161544047|NCT00393523|583382561|FG000|Overall Study|Vaccine supply issue|0|||
161544048|NCT00393523|583382562|FG001|Overall Study|Vaccine supply issue|0|||
161544049|NCT00393523|583382563|FG002|Overall Study|Vaccine supply issue|1|||
161544050|NCT00393523|583382564|FG003|Overall Study|Vaccine supply issue|0|||
161544051|NCT00393523|583382565|FG004|Overall Study|Vaccine supply issue|0|||
161544052|NCT01735396|583382569|FG000|Overall Study|not evaluable|1|||
161544053|NCT00980005|583382572|FG000|Overall Study|Withdrawal by Subject|6|||
161544054|NCT00980005|583382573|FG001|Overall Study|Withdrawal by Subject|17|||
161544055|NCT00980005|583382572|FG000|Overall Study|Lost to Follow-up|37|||
161544056|NCT00980005|583382573|FG001|Overall Study|Lost to Follow-up|43|||
161544057|NCT00980005|583382572|FG000|Overall Study|Other|4|||
161544058|NCT00980005|583382573|FG001|Overall Study|Other|3|||
161544059|NCT00572624|583382574|FG000|Overall Study|Lost to Follow-up|10|||
161544060|NCT00572624|583382575|FG001|Overall Study|Lost to Follow-up|4|||
161544061|NCT00572624|583382574|FG000|Overall Study|Wanted to do a different diet program|1|||
161544062|NCT00572624|583382575|FG001|Overall Study|Wanted to do a different diet program|0|||
161544063|NCT00572624|583382574|FG000|Overall Study|Medication change|1|||
161544064|NCT00572624|583382575|FG001|Overall Study|Medication change|0|||
161544065|NCT00572624|583382574|FG000|Overall Study|Started a new job-- no time for study|1|||
161544066|NCT00572624|583382575|FG001|Overall Study|Started a new job-- no time for study|0|||
161544067|NCT00572624|583382574|FG000|Overall Study|Admitted to being a smoker|1|||
161544068|NCT00572624|583382575|FG001|Overall Study|Admitted to being a smoker|0|||
161544069|NCT00572624|583382574|FG000|Overall Study|Refused to do the stress test|1|||
161544070|NCT00572624|583382575|FG001|Overall Study|Refused to do the stress test|0|||
161544071|NCT00572624|583382574|FG000|Overall Study|Problem with vascular access|1|||
161544072|NCT00572624|583382575|FG001|Overall Study|Problem with vascular access|0|||
161544073|NCT00572624|583382574|FG000|Overall Study|Health issues unrelated to the study|1|||
161544074|NCT00572624|583382575|FG001|Overall Study|Health issues unrelated to the study|0|||
161544075|NCT00098254|583382580|FG000|Overall Study|Adverse Event|2|||
161544076|NCT00098254|583382580|FG000|Overall Study|Death|1|||
161544077|NCT02118337|583382581|FG000|Overall Study|Other|1|||
161544078|NCT02118337|583382582|FG001|Overall Study|Other|0|||
161544079|NCT02118337|583382583|FG002|Overall Study|Other|0|||
161544080|NCT02118337|583382584|FG003|Overall Study|Other|0|||
161544081|NCT02118337|583382585|FG004|Overall Study|Other|2|||
161544082|NCT02118337|583382586|FG005|Overall Study|Other|3|||
161544083|NCT02118337|583382587|FG006|Overall Study|Other|1|||
161544084|NCT02118337|583382588|FG007|Overall Study|Other|28|||
161544085|NCT02118337|583382589|FG008|Overall Study|Other|15|||
161544086|NCT02118337|583382581|FG000|Overall Study|Lost to Follow-up|0|||
161544087|NCT02118337|583382582|FG001|Overall Study|Lost to Follow-up|0|||
161544088|NCT02118337|583382583|FG002|Overall Study|Lost to Follow-up|0|||
161544089|NCT02118337|583382584|FG003|Overall Study|Lost to Follow-up|0|||
161544090|NCT02118337|583382585|FG004|Overall Study|Lost to Follow-up|0|||
161544091|NCT02118337|583382586|FG005|Overall Study|Lost to Follow-up|0|||
161544092|NCT02118337|583382587|FG006|Overall Study|Lost to Follow-up|0|||
161544093|NCT02118337|583382588|FG007|Overall Study|Lost to Follow-up|1|||
161544094|NCT02118337|583382589|FG008|Overall Study|Lost to Follow-up|0|||
161544095|NCT02118337|583382581|FG000|Overall Study|Withdrawal by Subject|1|||
161544096|NCT02118337|583382582|FG001|Overall Study|Withdrawal by Subject|3|||
161544097|NCT02118337|583382583|FG002|Overall Study|Withdrawal by Subject|2|||
161544098|NCT02118337|583382584|FG003|Overall Study|Withdrawal by Subject|1|||
161544099|NCT02118337|583382585|FG004|Overall Study|Withdrawal by Subject|2|||
161544100|NCT02118337|583382586|FG005|Overall Study|Withdrawal by Subject|2|||
161544101|NCT02118337|583382587|FG006|Overall Study|Withdrawal by Subject|1|||
161544102|NCT02118337|583382588|FG007|Overall Study|Withdrawal by Subject|4|||
161544103|NCT02118337|583382589|FG008|Overall Study|Withdrawal by Subject|2|||
161544104|NCT02118337|583382581|FG000|Overall Study|Death|2|||
161544105|NCT02118337|583382582|FG001|Overall Study|Death|2|||
161544106|NCT02118337|583382583|FG002|Overall Study|Death|1|||
161544107|NCT02118337|583382584|FG003|Overall Study|Death|2|||
161544108|NCT02118337|583382585|FG004|Overall Study|Death|5|||
161544109|NCT02118337|583382586|FG005|Overall Study|Death|1|||
161544110|NCT02118337|583382587|FG006|Overall Study|Death|2|||
161544111|NCT02118337|583382588|FG007|Overall Study|Death|9|||
161544112|NCT02118337|583382589|FG008|Overall Study|Death|4|||
161544113|NCT00130793|583382591|FG000|Overall Study|Lost to Follow-up|1|||
161544114|NCT00130793|583382592|FG001|Overall Study|Lost to Follow-up|4|||
161544115|NCT00130793|583382591|FG000|Overall Study|Withdrew consent|2|||
161544116|NCT00130793|583382592|FG001|Overall Study|Withdrew consent|0|||
161544117|NCT00211237|583382593|FG000|Baseline|Withdrew|1|||
161544118|NCT00211237|583382594|FG001|Baseline|Withdrew|3|||
161544119|NCT00211237|583382595|FG002|Baseline|Withdrew|0|||
161544120|NCT00211237|583382593|FG000|Baseline|Refused random assignment|1|||
161544121|NCT00211237|583382594|FG001|Baseline|Refused random assignment|0|||
161544122|NCT00211237|583382595|FG002|Baseline|Refused random assignment|0|||
161544123|NCT00211237|583382593|FG000|1 Month|Death|2|||
161544124|NCT00211237|583382594|FG001|1 Month|Death|1|||
161544125|NCT00211237|583382595|FG002|1 Month|Death|0|||
161544126|NCT00211237|583382593|FG000|1 Month|Lost to Follow-up|0|||
161544127|NCT00211237|583382594|FG001|1 Month|Lost to Follow-up|2|||
161544128|NCT00211237|583382595|FG002|1 Month|Lost to Follow-up|0|||
161544129|NCT00211237|583382593|FG000|1 Month|Withdrew|0|||
161544130|NCT00211237|583382594|FG001|1 Month|Withdrew|4|||
161544131|NCT00211237|583382595|FG002|1 Month|Withdrew|0|||
161544132|NCT00211237|583382593|FG000|1 Month|Additional surgery needed|1|||
161544133|NCT00211237|583382594|FG001|1 Month|Additional surgery needed|0|||
161544134|NCT00211237|583382595|FG002|1 Month|Additional surgery needed|0|||
161544135|NCT00211237|583382593|FG000|1 Month|Non-medical problem|0|||
161544136|NCT00211237|583382594|FG001|1 Month|Non-medical problem|2|||
161544137|NCT00211237|583382595|FG002|1 Month|Non-medical problem|0|||
161544138|NCT00211237|583382593|FG000|3 Months|Death|7|||
161544139|NCT00211237|583382594|FG001|3 Months|Death|3|||
161544140|NCT00211237|583382595|FG002|3 Months|Death|0|||
161544141|NCT00211237|583382593|FG000|3 Months|Could not comply with protocol|1|||
161544142|NCT00211237|583382594|FG001|3 Months|Could not comply with protocol|0|||
161544143|NCT00211237|583382595|FG002|3 Months|Could not comply with protocol|0|||
161544144|NCT00211237|583382593|FG000|3 Months|Withdrew|0|||
161544145|NCT00211237|583382594|FG001|3 Months|Withdrew|1|||
161544146|NCT00211237|583382595|FG002|3 Months|Withdrew|0|||
161544147|NCT00211237|583382593|FG000|3 Months|Non-medical problem|0|||
161544148|NCT00211237|583382594|FG001|3 Months|Non-medical problem|0|||
161544149|NCT00211237|583382595|FG002|3 Months|Non-medical problem|1|||
161544150|NCT00211237|583382593|FG000|6 Months|Death|6|||
161544151|NCT00211237|583382594|FG001|6 Months|Death|0|||
161544152|NCT00211237|583382595|FG002|6 Months|Death|3|||
161544153|NCT00211237|583382593|FG000|6 Months|Lost to Follow-up|2|||
161544154|NCT00211237|583382594|FG001|6 Months|Lost to Follow-up|0|||
161544155|NCT00211237|583382595|FG002|6 Months|Lost to Follow-up|0|||
161544156|NCT00211237|583382593|FG000|6 Months|Could not comply with protocol|0|||
161544157|NCT00211237|583382594|FG001|6 Months|Could not comply with protocol|2|||
161544158|NCT00211237|583382595|FG002|6 Months|Could not comply with protocol|0|||
161544159|NCT00211237|583382593|FG000|12 Months|Death|8|||
161544160|NCT00211237|583382594|FG001|12 Months|Death|2|||
161544161|NCT00211237|583382595|FG002|12 Months|Death|3|||
161544162|NCT00211237|583382593|FG000|12 Months|Lost to Follow-up|1|||
161544163|NCT00211237|583382594|FG001|12 Months|Lost to Follow-up|0|||
161544164|NCT00211237|583382595|FG002|12 Months|Lost to Follow-up|1|||
161544165|NCT00211237|583382593|FG000|12 Months|Withdrew|0|||
161544166|NCT00211237|583382594|FG001|12 Months|Withdrew|0|||
161544167|NCT00211237|583382595|FG002|12 Months|Withdrew|1|||
161544168|NCT00211237|583382593|FG000|12 Months|unrelated medical problem|0|||
161544169|NCT00211237|583382594|FG001|12 Months|unrelated medical problem|0|||
161544170|NCT00211237|583382595|FG002|12 Months|unrelated medical problem|1|||
161544171|NCT01003639|583382598|FG000|Overall Study|Lost to Follow-up|6|||
161544172|NCT01003639|583382599|FG001|Overall Study|Lost to Follow-up|9|||
161544173|NCT01003639|583382598|FG000|Overall Study|Withdrawal by Subject|9|||
161544174|NCT01003639|583382599|FG001|Overall Study|Withdrawal by Subject|5|||
161544175|NCT01003639|583382598|FG000|Overall Study|Lack of Efficacy|1|||
161544176|NCT01003639|583382599|FG001|Overall Study|Lack of Efficacy|6|||
161544177|NCT01003639|583382598|FG000|Overall Study|Adverse Event|0|||
161544178|NCT01003639|583382599|FG001|Overall Study|Adverse Event|1|||
161544179|NCT01003639|583382598|FG000|Overall Study|Protocol Violation|0|||
161544180|NCT01003639|583382599|FG001|Overall Study|Protocol Violation|1|||
161544181|NCT01003639|583382598|FG000|Overall Study|Physician Decision|1|||
161544182|NCT01003639|583382599|FG001|Overall Study|Physician Decision|0|||
161544183|NCT04000594|583382600|FG000|Overall Study|Withdrawal by Subject|1|||
161544184|NCT04000594|583382601|FG001|Overall Study|Withdrawal by Subject|0|||
161544185|NCT04000594|583382602|FG002|Overall Study|Withdrawal by Subject|0|||
161544186|NCT03489057|583382603|FG000|Overall Study|Lost to Follow-up|16|||
161544187|NCT03489057|583382604|FG001|Overall Study|Lost to Follow-up|16|||
161544188|NCT03489057|583382605|FG002|Overall Study|Lost to Follow-up|14|||
161544189|NCT03489057|583382606|FG003|Overall Study|Lost to Follow-up|14|||
161544190|NCT03489057|583382603|FG000|Overall Study|Withdrawal by Subject|12|||
161544191|NCT03489057|583382604|FG001|Overall Study|Withdrawal by Subject|12|||
161544192|NCT03489057|583382605|FG002|Overall Study|Withdrawal by Subject|8|||
161680148|NCT03250832|583881509|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680149|NCT03250832|583881510|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680150|NCT03250832|583881511|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
161680151|NCT03250832|583881512|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
161680152|NCT03250832|583881513|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680153|NCT03250832|583881514|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680154|NCT03250832|583881503|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680155|NCT03250832|583881504|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680156|NCT03250832|583881505|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680157|NCT03250832|583881506|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680158|NCT03250832|583881507|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680159|NCT03250832|583881508|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680160|NCT03250832|583881509|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680161|NCT03250832|583881510|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680162|NCT03250832|583881511|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
161680163|NCT03250832|583881512|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
161680164|NCT03250832|583881513|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680165|NCT03250832|583881514|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680166|NCT03250832|583881503|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680167|NCT03250832|583881504|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680168|NCT03250832|583881505|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680169|NCT03250832|583881506|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680170|NCT03250832|583881507|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680171|NCT03250832|583881508|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680172|NCT03250832|583881509|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680173|NCT03250832|583881510|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680174|NCT03250832|583881511|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680175|NCT03250832|583881512|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680176|NCT03250832|583881513|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680177|NCT03250832|583881514|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
161680178|NCT01708291|583881515|FG000|Overall Study|fighting|2|||
161680179|NCT01708291|583881516|FG001|Overall Study|fighting|1|||
161680180|NCT04411628|583881518|FG000|Overall Study|Withdrawal by Subject|1|||
161680181|NCT04411628|583881519|FG001|Overall Study|Withdrawal by Subject|1|||
161680182|NCT04411628|583881520|FG002|Overall Study|Withdrawal by Subject|2|||
161680183|NCT04411628|583881521|FG003|Overall Study|Withdrawal by Subject|0|||
161680184|NCT04411628|583881518|FG000|Overall Study|Lost to Follow-up|0|||
161680185|NCT04411628|583881519|FG001|Overall Study|Lost to Follow-up|1|||
161680186|NCT04411628|583881520|FG002|Overall Study|Lost to Follow-up|0|||
161680187|NCT04411628|583881521|FG003|Overall Study|Lost to Follow-up|0|||
161680188|NCT01428661|583881522|FG000|Double-Masked Phase|Protocol Violation|9|||
161680189|NCT01428661|583881523|FG001|Double-Masked Phase|Protocol Violation|4|||
161680190|NCT01428661|583881524|FG002|Double-Masked Phase|Protocol Violation|0|||
161680191|NCT01428661|583881522|FG000|Double-Masked Phase|Adverse Event|13|||
161680192|NCT01428661|583881523|FG001|Double-Masked Phase|Adverse Event|4|||
161680193|NCT01428661|583881524|FG002|Double-Masked Phase|Adverse Event|0|||
161680194|NCT01428661|583881522|FG000|Double-Masked Phase|Lost to Follow-up|14|||
161680195|NCT01428661|583881523|FG001|Double-Masked Phase|Lost to Follow-up|14|||
161680196|NCT01428661|583881524|FG002|Double-Masked Phase|Lost to Follow-up|0|||
161680197|NCT01428661|583881522|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
161680198|NCT01428661|583881523|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
161680199|NCT01428661|583881524|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
161680200|NCT01428661|583881522|FG000|Double-Masked Phase|Lack of Efficacy|2|||
161680201|NCT01428661|583881523|FG001|Double-Masked Phase|Lack of Efficacy|1|||
161680202|NCT01428661|583881524|FG002|Double-Masked Phase|Lack of Efficacy|0|||
161680203|NCT01428661|583881522|FG000|Double-Masked Phase|*Various|1|||
161680204|NCT01428661|583881523|FG001|Double-Masked Phase|*Various|6|||
161680205|NCT01428661|583881524|FG002|Double-Masked Phase|*Various|0|||
161680206|NCT01428661|583881522|FG000|Open Label Extension|Protocol Violation|0|||
161680207|NCT01428661|583881523|FG001|Open Label Extension|Protocol Violation|0|||
161680208|NCT01428661|583881524|FG002|Open Label Extension|Protocol Violation|9|||
161680209|NCT01428661|583881522|FG000|Open Label Extension|Adverse Event|0|||
161680210|NCT01428661|583881523|FG001|Open Label Extension|Adverse Event|0|||
161680211|NCT01428661|583881524|FG002|Open Label Extension|Adverse Event|15|||
161680212|NCT01428661|583881522|FG000|Open Label Extension|Lost to Follow-up|0|||
161680213|NCT01428661|583881523|FG001|Open Label Extension|Lost to Follow-up|0|||
161680214|NCT01428661|583881524|FG002|Open Label Extension|Lost to Follow-up|38|||
161680215|NCT01428661|583881522|FG000|Open Label Extension|Withdrawal by Subject|0|||
161680216|NCT01428661|583881523|FG001|Open Label Extension|Withdrawal by Subject|0|||
161680217|NCT01428661|583881524|FG002|Open Label Extension|Withdrawal by Subject|49|||
161680218|NCT01428661|583881522|FG000|Open Label Extension|Lack of Efficacy|0|||
161680219|NCT01428661|583881523|FG001|Open Label Extension|Lack of Efficacy|0|||
161680220|NCT01428661|583881524|FG002|Open Label Extension|Lack of Efficacy|24|||
161544193|NCT03489057|583382606|FG003|Overall Study|Withdrawal by Subject|8|||
161544194|NCT03489057|583382603|FG000|Overall Study|Protocol Violation|7|||
161544195|NCT03489057|583382604|FG001|Overall Study|Protocol Violation|7|||
161544196|NCT03489057|583382605|FG002|Overall Study|Protocol Violation|2|||
161544197|NCT03489057|583382606|FG003|Overall Study|Protocol Violation|2|||
161544198|NCT00779779|583382609|FG000|Overall Study|Adverse Event|1|||
161544199|NCT00779779|583382609|FG000|Overall Study|Protocol Violation|14|||
161544200|NCT00779779|583382609|FG000|Overall Study|Withdrawal by Subject|4|||
161544201|NCT00779779|583382609|FG000|Overall Study|Lost to Follow-up|5|||
161544202|NCT01395823|583382610|FG000|Overall Study|Death|4|||
161544203|NCT01395823|583382611|FG001|Overall Study|Death|4|||
161544204|NCT01395823|583382610|FG000|Overall Study|Physician Decision|3|||
161544205|NCT01395823|583382611|FG001|Overall Study|Physician Decision|1|||
161544206|NCT01395823|583382610|FG000|Overall Study|Lost to Follow-up|1|||
161544207|NCT01395823|583382611|FG001|Overall Study|Lost to Follow-up|0|||
161544208|NCT01395823|583382610|FG000|Overall Study|Transplant|1|||
161544209|NCT01395823|583382611|FG001|Overall Study|Transplant|0|||
161544210|NCT01395823|583382610|FG000|Overall Study|GI symptoms|1|||
161544211|NCT01395823|583382611|FG001|Overall Study|GI symptoms|0|||
161594036|NCT04074759|583565106|FG009|Overall Study|Missing end of study status|0|||
161594037|NCT04074759|583565107|FG010|Overall Study|Missing end of study status|2|||
161594038|NCT04074759|583565108|FG011|Overall Study|Missing end of study status|0|||
161594039|NCT04074759|583565109|FG012|Overall Study|Missing end of study status|0|||
161594040|NCT04074759|583565110|FG013|Overall Study|Missing end of study status|0|||
161594041|NCT04074759|583565111|FG014|Overall Study|Missing end of study status|0|||
161594042|NCT04074759|583565112|FG015|Overall Study|Missing end of study status|0|||
161594043|NCT04074759|583565113|FG016|Overall Study|Missing end of study status|1|||
161594044|NCT04074759|583565114|FG017|Overall Study|Missing end of study status|0|||
161594045|NCT04074759|583565115|FG018|Overall Study|Missing end of study status|0|||
161594046|NCT03631784|583565116|FG000|Overall Study|Participants Ongoing|1|||
161594047|NCT03631784|583565117|FG001|Overall Study|Participants Ongoing|0|||
161594048|NCT03631784|583565116|FG000|Overall Study|Withdrawal by Subject|3|||
161594049|NCT03631784|583565117|FG001|Overall Study|Withdrawal by Subject|3|||
161594050|NCT03631784|583565116|FG000|Overall Study|Sponsor's Decision|36|||
161594051|NCT03631784|583565117|FG001|Overall Study|Sponsor's Decision|52|||
161594052|NCT03631784|583565116|FG000|Overall Study|Lost to Follow-up|1|||
161594053|NCT03631784|583565117|FG001|Overall Study|Lost to Follow-up|0|||
161594054|NCT03631784|583565116|FG000|Overall Study|Death|71|||
161594055|NCT03631784|583565117|FG001|Overall Study|Death|49|||
161594056|NCT02465268|583565119|FG000|Overall Study|Withdrawal by Subject|4|||
161594057|NCT02465268|583565120|FG001|Overall Study|Withdrawal by Subject|3|||
161680221|NCT01428661|583881522|FG000|Open Label Extension|**Various|0|||
161680222|NCT01428661|583881523|FG001|Open Label Extension|**Various|0|||
161544212|NCT01395823|583382610|FG000|Overall Study|Withdrawal by Subject|5|||
161544213|NCT01395823|583382611|FG001|Overall Study|Withdrawal by Subject|4|||
161544214|NCT03300570|583382612|FG000|Overall Study|Adverse Event|0|||
161544215|NCT03300570|583382613|FG001|Overall Study|Adverse Event|1|||
161594058|NCT02465268|583565121|FG002|Overall Study|Withdrawal by Subject|1|||
161594059|NCT02465268|583565119|FG000|Overall Study|Not evaluable per protocol criteria|3|||
161594060|NCT02465268|583565120|FG001|Overall Study|Not evaluable per protocol criteria|2|||
161594061|NCT02465268|583565121|FG002|Overall Study|Not evaluable per protocol criteria|1|||
161594062|NCT02465268|583565119|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
161544216|NCT03300570|583382612|FG000|Overall Study|Withdrawal by Subject|1|||
161594063|NCT02465268|583565120|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
161594064|NCT02465268|583565121|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
161594065|NCT02465268|583565119|FG000|Overall Study|Study drug did not pass QA/QC|1|||
161594066|NCT02465268|583565120|FG001|Overall Study|Study drug did not pass QA/QC|0|||
161594067|NCT02465268|583565121|FG002|Overall Study|Study drug did not pass QA/QC|0|||
161594068|NCT02465268|583565119|FG000|Overall Study|Adverse Event|0|||
161594069|NCT02465268|583565120|FG001|Overall Study|Adverse Event|1|||
161594070|NCT02465268|583565121|FG002|Overall Study|Adverse Event|0|||
161594071|NCT02465268|583565119|FG000|Overall Study|Physician Decision|0|||
161594072|NCT02465268|583565120|FG001|Overall Study|Physician Decision|1|||
161594073|NCT02465268|583565121|FG002|Overall Study|Physician Decision|0|||
161594074|NCT03322267|583565123|FG000|Overall Study|Lack of Efficacy|11|||
161594075|NCT03322267|583565123|FG000|Overall Study|Adverse Event|1|||
161594076|NCT03322267|583565123|FG000|Overall Study|Withdrawal by Subject|2|||
161594077|NCT04719832|583565127|FG000|Overall Study|Adverse Event|2|||
161594078|NCT04719832|583565128|FG001|Overall Study|Adverse Event|0|||
161594079|NCT04719832|583565127|FG000|Overall Study|Lack of Efficacy|2|||
161594080|NCT04719832|583565128|FG001|Overall Study|Lack of Efficacy|4|||
161594081|NCT04719832|583565127|FG000|Overall Study|Lost to Follow-up|0|||
161594082|NCT04719832|583565128|FG001|Overall Study|Lost to Follow-up|2|||
161594083|NCT04719832|583565127|FG000|Overall Study|Physician Decision|0|||
161594084|NCT04719832|583565128|FG001|Overall Study|Physician Decision|1|||
161594085|NCT04719832|583565127|FG000|Overall Study|Pregnancy|1|||
161594086|NCT04719832|583565128|FG001|Overall Study|Pregnancy|1|||
161594087|NCT04719832|583565127|FG000|Overall Study|Withdrawal by Subject|5|||
161594088|NCT04719832|583565128|FG001|Overall Study|Withdrawal by Subject|5|||
161594089|NCT04719832|583565127|FG000|Overall Study|Randomized, not treated|0|||
161594090|NCT04719832|583565128|FG001|Overall Study|Randomized, not treated|2|||
161594091|NCT04719832|583565127|FG000|Overall Study|GCP violations|4|||
161594092|NCT04719832|583565128|FG001|Overall Study|GCP violations|7|||
161594093|NCT01799265|583565133|FG000|Overall Study|Lost to Follow-up|1|||
161594094|NCT01799265|583565134|FG001|Overall Study|Lost to Follow-up|0|||
161594095|NCT01799265|583565133|FG000|Overall Study|Protocol Violation|2|||
161594096|NCT01799265|583565134|FG001|Overall Study|Protocol Violation|1|||
161594097|NCT01799265|583565133|FG000|Overall Study|inadequate sleep study|0|||
161594098|NCT01799265|583565134|FG001|Overall Study|inadequate sleep study|2|||
161594099|NCT03084536|583565138|FG000|Overall Study|Determined to be ineligible|0|||
161594100|NCT03084536|583565139|FG001|Overall Study|Determined to be ineligible|0|||
161594101|NCT03084536|583565140|FG002|Overall Study|Determined to be ineligible|16|||
161594102|NCT03084536|583565138|FG000|Overall Study|Withdrawal by Subject|0|||
161594103|NCT03084536|583565139|FG001|Overall Study|Withdrawal by Subject|0|||
161594104|NCT03084536|583565140|FG002|Overall Study|Withdrawal by Subject|4|||
161594105|NCT03084536|583565138|FG000|Overall Study|Physician Decision|0|||
161594106|NCT03084536|583565139|FG001|Overall Study|Physician Decision|0|||
161594107|NCT03084536|583565140|FG002|Overall Study|Physician Decision|3|||
161594108|NCT03084536|583565138|FG000|Overall Study|Death|0|||
161594109|NCT03084536|583565139|FG001|Overall Study|Death|0|||
161594110|NCT03084536|583565140|FG002|Overall Study|Death|1|||
161594111|NCT03084536|583565138|FG000|Overall Study|Lost to Follow-up|0|||
161594112|NCT03084536|583565139|FG001|Overall Study|Lost to Follow-up|0|||
161594113|NCT03084536|583565140|FG002|Overall Study|Lost to Follow-up|1|||
161594114|NCT03084536|583565138|FG000|Overall Study|Protocol Violation|0|||
161594115|NCT03084536|583565139|FG001|Overall Study|Protocol Violation|0|||
161594116|NCT03084536|583565140|FG002|Overall Study|Protocol Violation|1|||
161594117|NCT03084536|583565138|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
161594118|NCT03084536|583565139|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
161594119|NCT03084536|583565140|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
161594120|NCT05704543|583565141|FG000|Overall Study|Withdrawal by Subject|1|||
161594121|NCT05704543|583565142|FG001|Overall Study|Withdrawal by Subject|1|||
161594122|NCT05704543|583565143|FG002|Overall Study|Withdrawal by Subject|0|||
161594123|NCT05704543|583565144|FG003|Overall Study|Withdrawal by Subject|2|||
161594124|NCT05704543|583565141|FG000|Overall Study|Lost to Follow-up|1|||
161594125|NCT05704543|583565142|FG001|Overall Study|Lost to Follow-up|2|||
161594126|NCT05704543|583565143|FG002|Overall Study|Lost to Follow-up|0|||
161829865|NCT01546142|584418016|FG001|Overall Study|Subject Noncompliance|1|||
161594127|NCT05704543|583565144|FG003|Overall Study|Lost to Follow-up|0|||
161594128|NCT04830800|583565148|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
161594129|NCT04830800|583565149|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
161594130|NCT04830800|583565150|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
161594131|NCT04830800|583565151|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
161594132|NCT04830800|583565152|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
161594133|NCT05192109|583565157|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161594134|NCT05192109|583565158|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161594135|NCT05192109|583565159|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161544217|NCT03300570|583382613|FG001|Overall Study|Withdrawal by Subject|0|||
161544218|NCT03300570|583382612|FG000|Overall Study|Inadequate bowel prep|1|||
161544219|NCT03300570|583382613|FG001|Overall Study|Inadequate bowel prep|0|||
161544220|NCT00116272|583382614|FG000|Overall Study|Lost to Follow-up|11|||
161544221|NCT00116272|583382615|FG001|Overall Study|Lost to Follow-up|6|||
161544222|NCT03188120|583382616|FG000|Overall Study|Adverse Event|4|||
161544223|NCT03188120|583382616|FG000|Overall Study|Insufficient Effectiveness|8|||
161544224|NCT03188120|583382616|FG000|Overall Study|Improved|12|||
161544225|NCT03188120|583382616|FG000|Overall Study|Lost to Follow-up|7|||
161544226|NCT03188120|583382616|FG000|Overall Study|Other than specified|3|||
161544227|NCT03188120|583382616|FG000|Overall Study|No visit after the first visit|13|||
161544228|NCT00717314|583382619|FG000|Overall Study|Adverse Event|3|||
161544229|NCT00717314|583382620|FG001|Overall Study|Adverse Event|2|||
161544230|NCT00717314|583382619|FG000|Overall Study|Protocol Violation|1|||
161544231|NCT00717314|583382620|FG001|Overall Study|Protocol Violation|0|||
161544232|NCT00717314|583382619|FG000|Overall Study|Lost to Follow-up|1|||
161544233|NCT00717314|583382620|FG001|Overall Study|Lost to Follow-up|5|||
161544234|NCT00717314|583382619|FG000|Overall Study|Withdrawal by Subject|1|||
161544235|NCT00717314|583382620|FG001|Overall Study|Withdrawal by Subject|3|||
161544236|NCT05096208|583382621|FG000|Overall Study|Lost to Follow-up|3|||
161544237|NCT05096208|583382622|FG001|Overall Study|Lost to Follow-up|5|||
161544238|NCT05096208|583382623|FG002|Overall Study|Lost to Follow-up|5|||
161544239|NCT05096208|583382624|FG003|Overall Study|Lost to Follow-up|2|||
161544240|NCT05096208|583382621|FG000|Overall Study|Withdrawal by Subject|0|||
161544241|NCT05096208|583382622|FG001|Overall Study|Withdrawal by Subject|1|||
161544242|NCT05096208|583382623|FG002|Overall Study|Withdrawal by Subject|2|||
161544243|NCT05096208|583382624|FG003|Overall Study|Withdrawal by Subject|3|||
161544244|NCT05096208|583382621|FG000|Overall Study|No longer met eligibility criteria|1|||
161544245|NCT05096208|583382622|FG001|Overall Study|No longer met eligibility criteria|0|||
161544246|NCT05096208|583382623|FG002|Overall Study|No longer met eligibility criteria|0|||
161544247|NCT05096208|583382624|FG003|Overall Study|No longer met eligibility criteria|0|||
161544248|NCT05096208|583382621|FG000|Overall Study|Other|0|||
161544249|NCT05096208|583382622|FG001|Overall Study|Other|0|||
161544250|NCT05096208|583382623|FG002|Overall Study|Other|1|||
161544251|NCT05096208|583382624|FG003|Overall Study|Other|0|||
161544252|NCT01483937|583382626|FG000|Overall Study|Withdrawal by Subject|4|||
161544253|NCT01483937|583382627|FG001|Overall Study|Withdrawal by Subject|3|||
161544254|NCT01833143|583382628|FG000|Overall Study|Not Treated|1|||
161544255|NCT00386308|583384212|FG000|Overall Study|Adverse Event|3|||
161544256|NCT00386308|583384213|FG001|Overall Study|Adverse Event|3|||
161544257|NCT00386308|583384212|FG000|Overall Study|Protocol Violation|2|||
161544258|NCT00386308|583384213|FG001|Overall Study|Protocol Violation|5|||
161544259|NCT00386308|583384212|FG000|Overall Study|Lack of Efficacy|0|||
161544260|NCT00386308|583384213|FG001|Overall Study|Lack of Efficacy|2|||
161544261|NCT00386308|583384212|FG000|Overall Study|Lost to Follow-up|10|||
161544262|NCT00386308|583384213|FG001|Overall Study|Lost to Follow-up|6|||
161544263|NCT00386308|583384212|FG000|Overall Study|Withdrawal by Subject|6|||
161544264|NCT00386308|583384213|FG001|Overall Study|Withdrawal by Subject|2|||
161544265|NCT00386308|583384212|FG000|Overall Study|Other Event|8|||
161544266|NCT00386308|583384213|FG001|Overall Study|Other Event|1|||
161544267|NCT03518658|583384214|FG000|Overall Study|Other|51|||
161544268|NCT03518658|583384215|FG001|Overall Study|Other|0|||
161544269|NCT00649389|583384216|FG000|Overall Study|Adverse Event|22|||
161544270|NCT00649389|583384217|FG001|Overall Study|Adverse Event|46|||
161544271|NCT00649389|583384218|FG002|Overall Study|Adverse Event|38|||
161544272|NCT00649389|583384219|FG003|Overall Study|Adverse Event|48|||
161544273|NCT00649389|583384216|FG000|Overall Study|Lost to Follow-up|15|||
161594136|NCT05192109|583565160|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161594137|NCT05192109|583565157|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161594138|NCT05192109|583565158|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161594139|NCT05192109|583565159|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161594140|NCT05192109|583565160|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161594141|NCT03287817|583567668|FG000|Overall Study|Progressive disease|4|||
161594142|NCT03287817|583567669|FG001|Overall Study|Progressive disease|2|||
161594143|NCT03287817|583567670|FG002|Overall Study|Progressive disease|3|||
161594144|NCT03287817|583567671|FG003|Overall Study|Progressive disease|10|||
161594145|NCT03287817|583567672|FG004|Overall Study|Progressive disease|8|||
161544274|NCT00649389|583384217|FG001|Overall Study|Lost to Follow-up|17|||
161544275|NCT00649389|583384218|FG002|Overall Study|Lost to Follow-up|21|||
161594146|NCT03287817|583567668|FG000|Overall Study|Death|0|||
161594147|NCT03287817|583567669|FG001|Overall Study|Death|0|||
161544276|NCT00649389|583384219|FG003|Overall Study|Lost to Follow-up|26|||
161544277|NCT00649389|583384216|FG000|Overall Study|Protocol Violation|11|||
161544278|NCT00649389|583384217|FG001|Overall Study|Protocol Violation|13|||
161544279|NCT00649389|583384218|FG002|Overall Study|Protocol Violation|9|||
161544280|NCT00649389|583384219|FG003|Overall Study|Protocol Violation|8|||
161544281|NCT00649389|583384216|FG000|Overall Study|Withdrawal by Subject|20|||
161544282|NCT00649389|583384217|FG001|Overall Study|Withdrawal by Subject|21|||
161594148|NCT03287817|583567670|FG002|Overall Study|Death|2|||
161594149|NCT03287817|583567671|FG003|Overall Study|Death|3|||
161829866|NCT01546142|584418015|FG000|Overall Study|Adverse Event|6|||
161829867|NCT01546142|584418016|FG001|Overall Study|Adverse Event|3|||
161829868|NCT01546142|584418015|FG000|Overall Study|Lost to Follow-up|20|||
161544283|NCT00649389|583384218|FG002|Overall Study|Withdrawal by Subject|19|||
161544284|NCT00649389|583384219|FG003|Overall Study|Withdrawal by Subject|23|||
161544285|NCT00649389|583384216|FG000|Overall Study|Other|3|||
161544286|NCT00649389|583384217|FG001|Overall Study|Other|9|||
161544287|NCT00649389|583384218|FG002|Overall Study|Other|1|||
161544288|NCT00649389|583384219|FG003|Overall Study|Other|6|||
161544289|NCT02746575|583384222|FG000|Overall Study|Surgery cancelled or time chaned|13|||
161544290|NCT02746575|583384222|FG000|Overall Study|Received epidural|10|||
161544291|NCT02746575|583384222|FG000|Overall Study|Withdrawal by Subject|3|||
161544292|NCT02746575|583384222|FG000|Overall Study|Bradycardia/hypotension|9|||
161544293|NCT02746575|583384222|FG000|Overall Study|Study paused|8|||
161829869|NCT01546142|584418016|FG001|Overall Study|Lost to Follow-up|15|||
161829870|NCT01546142|584418015|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
161829871|NCT01546142|584418016|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
161829872|NCT01546142|584418015|FG000|Overall Study|Subject Randomized but Not Treated|1|||
161829873|NCT01546142|584418016|FG001|Overall Study|Subject Randomized but Not Treated|0|||
161829874|NCT01213836|584418017|FG000|Period 1, First Intervention|Adverse Event|2|||
161829875|NCT01213836|584418018|FG001|Period 1, First Intervention|Adverse Event|1|||
161829876|NCT01213836|584418017|FG000|Period 1, First Intervention|Protocol Violation|0|||
161829877|NCT01213836|584418018|FG001|Period 1, First Intervention|Protocol Violation|1|||
161829878|NCT01213836|584418017|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
161829879|NCT01213836|584418018|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
161829880|NCT01470417|584418019|FG000|Overall Study|Disease progression|0|||
161829881|NCT01470417|584418020|FG001|Overall Study|Disease progression|2|||
161829882|NCT02973321|584418021|FG000|Overall Study|Other than specified|0|||
161829883|NCT02973321|584418022|FG001|Overall Study|Other than specified|5|||
161829884|NCT02973321|584418023|FG002|Overall Study|Other than specified|3|||
161829885|NCT02973321|584418024|FG003|Overall Study|Other than specified|3|||
161829886|NCT02973321|584418025|FG004|Overall Study|Other than specified|1|||
161829887|NCT02973321|584418021|FG000|Overall Study|Lack of Efficacy|0|||
161829888|NCT02973321|584418022|FG001|Overall Study|Lack of Efficacy|0|||
161829889|NCT02973321|584418023|FG002|Overall Study|Lack of Efficacy|0|||
161829890|NCT02973321|584418024|FG003|Overall Study|Lack of Efficacy|0|||
161829891|NCT02973321|584418025|FG004|Overall Study|Lack of Efficacy|1|||
161829892|NCT02973321|584418021|FG000|Overall Study|Adverse Event|1|||
161829893|NCT02973321|584418022|FG001|Overall Study|Adverse Event|10|||
161829894|NCT02973321|584418023|FG002|Overall Study|Adverse Event|11|||
161829895|NCT02973321|584418024|FG003|Overall Study|Adverse Event|13|||
161829896|NCT02973321|584418025|FG004|Overall Study|Adverse Event|3|||
161829897|NCT01355302|584418029|FG000|Phase 1b|Death|4|||
161829898|NCT01355302|584418030|FG001|Phase 1b|Death|0|||
161829899|NCT01355302|584418031|FG002|Phase 1b|Death|0|||
161544294|NCT02746575|583384222|FG000|Overall Study|put on beta-blocker|3|||
161594150|NCT03287817|583567672|FG004|Overall Study|Death|4|||
161594151|NCT03287817|583567668|FG000|Overall Study|Physician Decision|0|||
161594152|NCT03287817|583567669|FG001|Overall Study|Physician Decision|0|||
161829900|NCT01355302|584418029|FG000|Phase 1b|Study terminated by sponsor|2|||
161594153|NCT03287817|583567670|FG002|Overall Study|Physician Decision|0|||
161594154|NCT03287817|583567671|FG003|Overall Study|Physician Decision|1|||
161594155|NCT03287817|583567672|FG004|Overall Study|Physician Decision|0|||
161594156|NCT03287817|583567668|FG000|Overall Study|Withdrawal by Subject|0|||
161594157|NCT03287817|583567669|FG001|Overall Study|Withdrawal by Subject|0|||
161594158|NCT03287817|583567670|FG002|Overall Study|Withdrawal by Subject|0|||
161594159|NCT03287817|583567671|FG003|Overall Study|Withdrawal by Subject|0|||
161594160|NCT03287817|583567672|FG004|Overall Study|Withdrawal by Subject|4|||
161594161|NCT04130438|583567677|FG000|Overall Study|Lost to Follow-up|0|||
161594162|NCT04130438|583567678|FG001|Overall Study|Lost to Follow-up|0|||
161544295|NCT02746575|583384222|FG000|Overall Study|type of surgery|1|||
161544296|NCT02746575|583384222|FG000|Overall Study|typ of surgery|1|||
161594163|NCT04130438|583567679|FG002|Overall Study|Lost to Follow-up|1|||
161594164|NCT04728347|583567684|FG000|Overall Study|Sponsor decision|0|||
161594165|NCT04728347|583567685|FG001|Overall Study|Sponsor decision|0|||
161594166|NCT04728347|583567686|FG002|Overall Study|Sponsor decision|1|||
161829901|NCT01355302|584418030|FG001|Phase 1b|Study terminated by sponsor|0|||
161829902|NCT01355302|584418031|FG002|Phase 1b|Study terminated by sponsor|0|||
161829903|NCT00263887|584418032|FG000|Overall Study|Withdrawal by Subject|1|||
161829904|NCT00263887|584418033|FG001|Overall Study|Withdrawal by Subject|1|||
161829905|NCT00263887|584418032|FG000|Overall Study|Lung transplantation|1|||
161829906|NCT00263887|584418033|FG001|Overall Study|Lung transplantation|2|||
161829907|NCT00263887|584418032|FG000|Overall Study|Too ill to attend visit|1|||
161829908|NCT00263887|584418033|FG001|Overall Study|Too ill to attend visit|0|||
161544297|NCT02746575|583384222|FG000|Overall Study|PI unavailable|1|||
161544298|NCT02746575|583384222|FG000|Overall Study|Unknown history of CVA|1|||
161544299|NCT00976482|583384223|FG000|Overall Study|Death|208|||
161544300|NCT00976482|583384223|FG000|Overall Study|Withdrawal by Subject|45|||
161544301|NCT00976482|583384223|FG000|Overall Study|Center terminated|1|||
161544302|NCT00976482|583384223|FG000|Overall Study|Protocol Violation|5|||
161544303|NCT02959671|583384224|FG000|Overall Study|Adverse Event|2|||
161544304|NCT02959671|583384224|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
161544305|NCT00605319|583384230|FG000|Overall Study|Adverse Event|6|||
161544306|NCT00432835|583384233|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
161544307|NCT00432835|583384234|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
161544308|NCT02002884|583384236|FG000|Main Period (MP)|Other|0|||
161544309|NCT02002884|583384237|FG001|Main Period (MP)|Other|3|||
161544310|NCT02002884|583384238|FG002|Main Period (MP)|Other|3|||
161544311|NCT02002884|583384239|FG003|Main Period (MP)|Other|0|||
161544312|NCT02002884|583384236|FG000|Main Period (MP)|Adverse Event|0|||
161544313|NCT02002884|583384237|FG001|Main Period (MP)|Adverse Event|1|||
161544314|NCT02002884|583384238|FG002|Main Period (MP)|Adverse Event|1|||
161544315|NCT02002884|583384239|FG003|Main Period (MP)|Adverse Event|0|||
161544316|NCT02002884|583384236|FG000|Main Period (MP)|Withdrawal by Subject|6|||
161544317|NCT02002884|583384237|FG001|Main Period (MP)|Withdrawal by Subject|2|||
161544318|NCT02002884|583384238|FG002|Main Period (MP)|Withdrawal by Subject|2|||
161594167|NCT04728347|583567687|FG003|Overall Study|Sponsor decision|0|||
161544319|NCT02002884|583384239|FG003|Main Period (MP)|Withdrawal by Subject|0|||
161544320|NCT02002884|583384236|FG000|Main Period (MP)|Lost to Follow-up|0|||
161544321|NCT02002884|583384237|FG001|Main Period (MP)|Lost to Follow-up|0|||
161544322|NCT02002884|583384238|FG002|Main Period (MP)|Lost to Follow-up|2|||
161544323|NCT02002884|583384239|FG003|Main Period (MP)|Lost to Follow-up|0|||
161544324|NCT02002884|583384236|FG000|Open-Label Extension Period (OLEX)|Other|0|||
161544325|NCT02002884|583384237|FG001|Open-Label Extension Period (OLEX)|Other|0|||
161544326|NCT02002884|583384238|FG002|Open-Label Extension Period (OLEX)|Other|0|||
161544327|NCT02002884|583384239|FG003|Open-Label Extension Period (OLEX)|Other|24|||
161544328|NCT02002884|583384236|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
161544329|NCT02002884|583384237|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
161544330|NCT02002884|583384238|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
161544331|NCT02002884|583384239|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
161544332|NCT02002884|583384236|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
161544333|NCT02002884|583384237|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
161544334|NCT02002884|583384238|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
161544335|NCT02002884|583384239|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
161544336|NCT02002884|583384236|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
161544337|NCT02002884|583384237|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
161544338|NCT02002884|583384238|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
161544339|NCT02002884|583384239|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
161544340|NCT02002884|583384236|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
161544341|NCT02002884|583384237|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
161544342|NCT02002884|583384238|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
161544343|NCT02002884|583384239|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
161544344|NCT02145078|583384240|FG000|Overall Study|Death|1|||
161544345|NCT02145078|583384240|FG000|Overall Study|Reason not given|3|||
161544346|NCT01350141|583384241|FG000|Overall Study|Lost to Follow-up|1|||
161544347|NCT01350141|583384242|FG001|Overall Study|Lost to Follow-up|0|||
161544348|NCT01350141|583384243|FG002|Overall Study|Lost to Follow-up|1|||
161544349|NCT01350141|583384241|FG000|Overall Study|Withdrawal by Subject|1|||
161544350|NCT01350141|583384242|FG001|Overall Study|Withdrawal by Subject|0|||
161544351|NCT01350141|583384243|FG002|Overall Study|Withdrawal by Subject|0|||
161544352|NCT01350141|583384241|FG000|Overall Study|Randomized but not treated|1|||
161544353|NCT01350141|583384242|FG001|Overall Study|Randomized but not treated|0|||
161594168|NCT03869866|583567690|FG000|Overall Study|Protocol Violation|1|||
161544354|NCT01350141|583384243|FG002|Overall Study|Randomized but not treated|0|||
161544355|NCT00810082|583384244|FG000|Overall Study|Lost to Follow-up|0|||
161544356|NCT00810082|583384245|FG001|Overall Study|Lost to Follow-up|4|||
161544357|NCT02508532|583384250|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161829909|NCT00263887|584418032|FG000|Overall Study|Adverse Event|0|||
161829910|NCT00263887|584418033|FG001|Overall Study|Adverse Event|2|||
161680223|NCT01428661|583881524|FG002|Open Label Extension|**Various|185|||
161829911|NCT00263887|584418032|FG000|Overall Study|Disease progression|0|||
161829912|NCT00263887|584418033|FG001|Overall Study|Disease progression|1|||
161829913|NCT00263887|584418032|FG000|Overall Study|Lack of Efficacy|0|||
161829914|NCT00263887|584418033|FG001|Overall Study|Lack of Efficacy|1|||
161829915|NCT02274948|584418036|FG000|Overall Study|Lost to Follow-up|28|||
161829916|NCT02274948|584418037|FG001|Overall Study|Lost to Follow-up|25|||
161829917|NCT02274948|584418036|FG000|Overall Study|Withdrawal by Subject|64|||
161829918|NCT02274948|584418037|FG001|Overall Study|Withdrawal by Subject|58|||
161829919|NCT02274948|584418036|FG000|Overall Study|Stopped on family Practitioner advice|2|||
161829920|NCT02274948|584418037|FG001|Overall Study|Stopped on family Practitioner advice|5|||
161829921|NCT02274948|584418036|FG000|Overall Study|Left the area|4|||
161829922|NCT02274948|584418037|FG001|Overall Study|Left the area|3|||
161829923|NCT00707434|584418038|FG000|Overall Study|Adverse Event|1|||
161829924|NCT05212883|584418039|FG000|Overall Study|Invalid test result|125|||
161829925|NCT02502734|584418040|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
161829926|NCT02502734|584418041|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
161829927|NCT02502734|584418040|FG000|Washout Period|Adverse Event|1|||
161829928|NCT02502734|584418041|FG001|Washout Period|Adverse Event|0|||
161829929|NCT00614822|584418042|FG000|Overall Study|Adverse Event|3|||
161829930|NCT00865514|584418051|FG000|Overall Study|Infusion cost exceeded funding|2|||
161829931|NCT03649412|584418052|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
161829932|NCT03649412|584418053|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
161829933|NCT03649412|584418052|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
161829934|NCT03649412|584418053|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
161829935|NCT03649412|584418052|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
161829936|NCT03649412|584418053|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161829937|NCT03649412|584418052|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
161829938|NCT03649412|584418053|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
161829939|NCT03649412|584418052|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
161829940|NCT03649412|584418053|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
161829941|NCT03649412|584418052|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
161829942|NCT03649412|584418053|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
161829943|NCT03095118|584418054|FG000|Overall Study|Adverse Event|1|||
161829944|NCT03095118|584418054|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
161829945|NCT02865395|584418055|FG000|Overall Study|Physician Decision|6|||
161829946|NCT02865395|584418056|FG001|Overall Study|Physician Decision|10|||
161829947|NCT02865395|584418057|FG002|Overall Study|Physician Decision|7|||
161829948|NCT00530348|584418058|FG000|Overall Study|Adverse Event|5|||
161829949|NCT00530348|584418059|FG001|Overall Study|Adverse Event|1|||
161829950|NCT00530348|584418058|FG000|Overall Study|Death|0|||
161829951|NCT00530348|584418059|FG001|Overall Study|Death|1|||
161829952|NCT00530348|584418058|FG000|Overall Study|Lack of Efficacy|2|||
161829953|NCT00530348|584418059|FG001|Overall Study|Lack of Efficacy|0|||
161829954|NCT00530348|584418058|FG000|Overall Study|Lost to Follow-up|0|||
161829955|NCT00530348|584418059|FG001|Overall Study|Lost to Follow-up|2|||
161829956|NCT00530348|584418058|FG000|Overall Study|Physician Decision|1|||
161829957|NCT00530348|584418059|FG001|Overall Study|Physician Decision|2|||
161829958|NCT00530348|584418058|FG000|Overall Study|Pregnancy|1|||
161829959|NCT00530348|584418059|FG001|Overall Study|Pregnancy|0|||
161829960|NCT00530348|584418058|FG000|Overall Study|Withdrawal by Subject|12|||
161829961|NCT00530348|584418059|FG001|Overall Study|Withdrawal by Subject|12|||
161829962|NCT00530348|584418058|FG000|Overall Study|Randomised in error|1|||
161829963|NCT00530348|584418059|FG001|Overall Study|Randomised in error|0|||
161829964|NCT00530348|584418058|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
161829965|NCT00530348|584418059|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
161829966|NCT04364763|584418060|FG000|Overall Study|Death|1|||
161829967|NCT04364763|584418061|FG001|Overall Study|Death|2|||
161829968|NCT04364763|584418060|FG000|Overall Study|Lost to Follow-up|1|||
161829969|NCT04364763|584418061|FG001|Overall Study|Lost to Follow-up|0|||
161829970|NCT01256060|584418063|FG000|Overall Study|Lost to Follow-up|0|||
161829971|NCT01256060|584418064|FG001|Overall Study|Lost to Follow-up|1|||
161829972|NCT01256060|584418065|FG002|Overall Study|Lost to Follow-up|0|||
161829973|NCT01256060|584418066|FG003|Overall Study|Lost to Follow-up|0|||
161829974|NCT00985231|584418069|FG000|Overall Study|ineligible|1|||
161829975|NCT00985231|584418070|FG001|Overall Study|ineligible|0|||
161829976|NCT00985231|584418069|FG000|Overall Study|Protocol Violation|1|||
161829977|NCT00985231|584418070|FG001|Overall Study|Protocol Violation|0|||
161829978|NCT00985231|584418069|FG000|Overall Study|Withdrawal by Subject|1|||
161544358|NCT02508532|583384251|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544359|NCT02508532|583384252|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544360|NCT02508532|583384253|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544361|NCT02508532|583384254|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544362|NCT02508532|583384255|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544363|NCT02508532|583384256|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
161544364|NCT02508532|583384257|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544365|NCT02508532|583384258|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161544366|NCT02508532|583384250|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544367|NCT02508532|583384251|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544368|NCT02508532|583384252|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544369|NCT02508532|583384253|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544370|NCT02508532|583384254|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544371|NCT02508532|583384255|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544372|NCT02508532|583384256|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544373|NCT02508532|583384257|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
161544374|NCT02508532|583384258|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
161544375|NCT02508532|583384250|FG000|Part 2 - Treatment|Disease Progression|0|||
161544376|NCT02508532|583384251|FG001|Part 2 - Treatment|Disease Progression|0|||
161544377|NCT02508532|583384252|FG002|Part 2 - Treatment|Disease Progression|0|||
161544378|NCT02508532|583384253|FG003|Part 2 - Treatment|Disease Progression|0|||
161544379|NCT02508532|583384254|FG004|Part 2 - Treatment|Disease Progression|0|||
161544380|NCT02508532|583384255|FG005|Part 2 - Treatment|Disease Progression|0|||
161544381|NCT02508532|583384256|FG006|Part 2 - Treatment|Disease Progression|0|||
161544382|NCT02508532|583384257|FG007|Part 2 - Treatment|Disease Progression|0|||
161544383|NCT02508532|583384258|FG008|Part 2 - Treatment|Disease Progression|118|||
161544384|NCT02508532|583384250|FG000|Part 2 - Treatment|Adverse Event|0|||
161544385|NCT02508532|583384251|FG001|Part 2 - Treatment|Adverse Event|0|||
161544386|NCT02508532|583384252|FG002|Part 2 - Treatment|Adverse Event|0|||
161680224|NCT03828292|583881525|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680225|NCT03828292|583881526|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
161680226|NCT03828292|583881527|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680227|NCT03828292|583881528|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680228|NCT03828292|583881529|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680229|NCT03828292|583881530|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680230|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680231|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680232|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
161680233|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680234|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680235|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680236|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161544387|NCT02508532|583384253|FG003|Part 2 - Treatment|Adverse Event|0|||
161544388|NCT02508532|583384254|FG004|Part 2 - Treatment|Adverse Event|0|||
161544389|NCT02508532|583384255|FG005|Part 2 - Treatment|Adverse Event|0|||
161544390|NCT02508532|583384256|FG006|Part 2 - Treatment|Adverse Event|0|||
161544391|NCT02508532|583384257|FG007|Part 2 - Treatment|Adverse Event|0|||
161544392|NCT02508532|583384258|FG008|Part 2 - Treatment|Adverse Event|49|||
161544393|NCT02508532|583384250|FG000|Part 2 - Treatment|Physician Decision|0|||
161544394|NCT02508532|583384251|FG001|Part 2 - Treatment|Physician Decision|0|||
161680237|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680238|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680239|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
161680240|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680241|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680242|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680243|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680244|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680245|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
161680246|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680247|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680248|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680249|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680250|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
161680251|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
161680252|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680253|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680254|NCT04376827|583881531|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
161680255|NCT04376827|583881532|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
161680256|NCT04376827|583881531|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
161680257|NCT04376827|583881532|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
161680258|NCT04376827|583881531|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
161680259|NCT04376827|583881532|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
161680260|NCT04376827|583881531|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
161680261|NCT04376827|583881532|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
161680262|NCT04376827|583881531|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
161680263|NCT04376827|583881532|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
161680264|NCT00346073|583882868|FG000|Overall Study|Serious Adverse Event|2|||
161680265|NCT00346073|583882869|FG001|Overall Study|Serious Adverse Event|0|||
161680266|NCT00346073|583882868|FG000|Overall Study|Lost to Follow-up|39|||
161680267|NCT00346073|583882869|FG001|Overall Study|Lost to Follow-up|24|||
161680268|NCT00980200|583882871|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680269|NCT00980200|583882872|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
161680270|NCT00980200|583882873|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680271|NCT00980200|583882874|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680272|NCT00980200|583882875|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680273|NCT00980200|583882871|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
161680274|NCT00980200|583882872|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
161680275|NCT00980200|583882873|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
161680276|NCT00980200|583882874|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
161680277|NCT00980200|583882875|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
161680278|NCT01617460|583882876|FG000|Overall Study|Adverse Event|10|||
161680279|NCT01617460|583882876|FG000|Overall Study|Physician Decision|16|||
161680280|NCT01617460|583882876|FG000|Overall Study|Protocol Violation|5|||
161680281|NCT01617460|583882876|FG000|Overall Study|Withdrawal by Subject|9|||
161680282|NCT00915772|583882878|FG000|Overall Study|Adverse Event|12|||
161680283|NCT00915772|583882879|FG001|Overall Study|Adverse Event|13|||
161680284|NCT00915772|583882880|FG002|Overall Study|Adverse Event|11|||
161680285|NCT00915772|583882878|FG000|Overall Study|Protocol Violation|4|||
161680286|NCT00915772|583882879|FG001|Overall Study|Protocol Violation|1|||
161680287|NCT00915772|583882880|FG002|Overall Study|Protocol Violation|2|||
161680288|NCT00915772|583882878|FG000|Overall Study|Lost to Follow-up|1|||
161680289|NCT00915772|583882879|FG001|Overall Study|Lost to Follow-up|2|||
161680290|NCT00915772|583882880|FG002|Overall Study|Lost to Follow-up|2|||
161680291|NCT00915772|583882878|FG000|Overall Study|Lack of Efficacy|9|||
161680292|NCT00915772|583882879|FG001|Overall Study|Lack of Efficacy|15|||
161544395|NCT02508532|583384252|FG002|Part 2 - Treatment|Physician Decision|0|||
161680293|NCT00915772|583882880|FG002|Overall Study|Lack of Efficacy|3|||
161680294|NCT00915772|583882878|FG000|Overall Study|Refused to continue trial medication|6|||
161680295|NCT00915772|583882879|FG001|Overall Study|Refused to continue trial medication|8|||
161680296|NCT00915772|583882880|FG002|Overall Study|Refused to continue trial medication|4|||
161544396|NCT02508532|583384253|FG003|Part 2 - Treatment|Physician Decision|0|||
161544397|NCT02508532|583384254|FG004|Part 2 - Treatment|Physician Decision|0|||
161544398|NCT02508532|583384255|FG005|Part 2 - Treatment|Physician Decision|0|||
161544399|NCT02508532|583384256|FG006|Part 2 - Treatment|Physician Decision|0|||
161544400|NCT02508532|583384257|FG007|Part 2 - Treatment|Physician Decision|0|||
161544401|NCT02508532|583384258|FG008|Part 2 - Treatment|Physician Decision|12|||
161544402|NCT02508532|583384250|FG000|Part 2 - Treatment|Administrative|0|||
161544403|NCT02508532|583384251|FG001|Part 2 - Treatment|Administrative|0|||
161544404|NCT02508532|583384252|FG002|Part 2 - Treatment|Administrative|0|||
161544405|NCT02508532|583384253|FG003|Part 2 - Treatment|Administrative|0|||
161544406|NCT02508532|583384254|FG004|Part 2 - Treatment|Administrative|0|||
161544407|NCT02508532|583384255|FG005|Part 2 - Treatment|Administrative|0|||
161544408|NCT02508532|583384256|FG006|Part 2 - Treatment|Administrative|0|||
161544409|NCT02508532|583384257|FG007|Part 2 - Treatment|Administrative|0|||
161544410|NCT02508532|583384258|FG008|Part 2 - Treatment|Administrative|3|||
161544411|NCT02508532|583384250|FG000|Part 2 - Treatment|Sponsor Decision|0|||
161544412|NCT02508532|583384251|FG001|Part 2 - Treatment|Sponsor Decision|0|||
161544413|NCT02508532|583384252|FG002|Part 2 - Treatment|Sponsor Decision|0|||
161544414|NCT02508532|583384253|FG003|Part 2 - Treatment|Sponsor Decision|0|||
161544415|NCT02508532|583384254|FG004|Part 2 - Treatment|Sponsor Decision|0|||
161544416|NCT02508532|583384255|FG005|Part 2 - Treatment|Sponsor Decision|0|||
161544417|NCT02508532|583384256|FG006|Part 2 - Treatment|Sponsor Decision|0|||
161544418|NCT02508532|583384257|FG007|Part 2 - Treatment|Sponsor Decision|0|||
161544419|NCT02508532|583384258|FG008|Part 2 - Treatment|Sponsor Decision|28|||
161544420|NCT02508532|583384250|FG000|Part 2 - Treatment|Death|0|||
161544421|NCT02508532|583384251|FG001|Part 2 - Treatment|Death|0|||
161544422|NCT02508532|583384252|FG002|Part 2 - Treatment|Death|0|||
161544423|NCT02508532|583384253|FG003|Part 2 - Treatment|Death|0|||
161544424|NCT02508532|583384254|FG004|Part 2 - Treatment|Death|0|||
161544425|NCT02508532|583384255|FG005|Part 2 - Treatment|Death|0|||
161544426|NCT02508532|583384256|FG006|Part 2 - Treatment|Death|0|||
161544427|NCT02508532|583384257|FG007|Part 2 - Treatment|Death|0|||
161544428|NCT02508532|583384258|FG008|Part 2 - Treatment|Death|1|||
161544429|NCT02508532|583384250|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
161544430|NCT02508532|583384251|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
161544431|NCT02508532|583384252|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
161544432|NCT02508532|583384253|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
161544433|NCT02508532|583384254|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
161544434|NCT02508532|583384255|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
161544435|NCT02508532|583384256|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
161544436|NCT02508532|583384257|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
161544437|NCT02508532|583384258|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
161544438|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
161544439|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
161544440|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
161544441|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
161544442|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
161544443|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
161544444|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
161544445|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
161544446|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
161544447|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
161544448|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
161544449|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
161544450|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
161544451|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
161544452|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
161544453|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
161544454|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
161544455|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
161544456|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Death|0|||
161544457|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Death|4|||
161544458|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Death|2|||
161544459|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Death|4|||
161544460|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Death|3|||
161544461|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Death|0|||
161544462|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Death|0|||
161544463|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Death|1|||
161544464|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Death|111|||
161544465|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
161544466|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
161544467|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
161544468|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
161544469|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
161544470|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
161544471|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
161544472|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
161680297|NCT00915772|583882878|FG000|Overall Study|Any other reason|4|||
161829979|NCT00985231|584418070|FG001|Overall Study|Withdrawal by Subject|0|||
161829980|NCT00985231|584418069|FG000|Overall Study|Lost to Follow-up|0|||
161829981|NCT00985231|584418070|FG001|Overall Study|Lost to Follow-up|1|||
161829982|NCT00985231|584418069|FG000|Overall Study|Study related symptoms & complaints|0|||
161829983|NCT00985231|584418070|FG001|Overall Study|Study related symptoms & complaints|2|||
161544473|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
161594169|NCT03869866|583567690|FG000|Overall Study|Withdrawal by Subject|3|||
161680298|NCT00915772|583882879|FG001|Overall Study|Any other reason|7|||
161680299|NCT00915772|583882880|FG002|Overall Study|Any other reason|7|||
161680300|NCT00294060|583882885|FG000|Overall Study|Death|225|||
161680301|NCT00294060|583882885|FG000|Overall Study|Other|59|||
161680302|NCT00294060|583882885|FG000|Overall Study|Lost to Follow-up|55|||
161680303|NCT00294060|583882885|FG000|Overall Study|Withdrawal by Subject|11|||
161680304|NCT00294060|583882885|FG000|Overall Study|Physician Decision|797|||
161680305|NCT00294060|583882885|FG000|Overall Study|Medical condition|3|||
161680306|NCT00294060|583882885|FG000|Overall Study|Device explanted/not replaced|23|||
161680307|NCT00139776|583882886|FG000|Period I|Did not enter Period II|575|||
161680308|NCT00139776|583882887|FG001|Period I|Did not enter Period II|0|||
161680309|NCT00139776|583882888|FG002|Period I|Did not enter Period II|0|||
161680310|NCT00139776|583882889|FG003|Period I|Did not enter Period II|0|||
161680311|NCT00139776|583882886|FG000|Period II|Not Randomized into Period III|0|||
161829984|NCT01009515|584418072|FG000|Overall Study|Withdrawal by Subject|3|||
161829985|NCT01501110|584418074|FG000|Overall Study|Death|0|||
161544474|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544475|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544476|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544477|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544478|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544479|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544480|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544481|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
161544482|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
161544483|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
161544484|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
161544485|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
161544486|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
161544487|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
161544488|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
161544489|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
161544490|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
161544491|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
161544492|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161544493|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161544494|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161594170|NCT06181227|583567691|FG000|Overall Study|Study terminated by sponsor|7|||
161594171|NCT06181227|583567692|FG001|Overall Study|Study terminated by sponsor|9|||
161594172|NCT05543915|583567693|FG000|Overall Study|Lost to Follow-up|0|||
161594173|NCT05543915|583567694|FG001|Overall Study|Lost to Follow-up|1|||
161594174|NCT06516705|583567698|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
161594175|NCT06516705|583567699|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
161594176|NCT06516705|583567698|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
161594177|NCT06516705|583567699|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
161594178|NCT06516705|583567698|FG000|T3 ( 3 Month After Education)|covid-19|1|||
161594179|NCT06516705|583567699|FG001|T3 ( 3 Month After Education)|covid-19|2|||
161594180|NCT06516705|583567698|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
161594181|NCT06516705|583567699|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
161594182|NCT06516705|583567698|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
161594183|NCT06516705|583567699|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
161594184|NCT06516705|583567698|FG000|T4 ( 6 Month After Education)|covid-19|3|||
161594185|NCT06516705|583567699|FG001|T4 ( 6 Month After Education)|covid-19|2|||
161594186|NCT06516705|583567698|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
161594187|NCT06516705|583567699|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
161594188|NCT04719390|583567701|FG000|Overall Study|Withdrawal by Subject|1|||
161594189|NCT04292223|583567702|FG000|Overall Study|Adverse Event|1|||
161594190|NCT04292223|583567702|FG000|Overall Study|Lost to Follow-up|1|||
161594191|NCT04292223|583567702|FG000|Overall Study|Noncompliance with study drug|2|||
161680312|NCT00139776|583882887|FG001|Period II|Not Randomized into Period III|322|||
161680313|NCT00139776|583882888|FG002|Period II|Not Randomized into Period III|0|||
161680314|NCT00139776|583882889|FG003|Period II|Not Randomized into Period III|0|||
161544495|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161544496|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161829986|NCT01501110|584418075|FG001|Overall Study|Death|1|||
161544497|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161544498|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161544499|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
161544500|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
161544501|NCT02508532|583384250|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
161544502|NCT02508532|583384251|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
161544503|NCT02508532|583384252|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
161544504|NCT02508532|583384253|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
161544505|NCT02508532|583384254|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
161544506|NCT02508532|583384255|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
161544507|NCT02508532|583384256|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
161544508|NCT02508532|583384257|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
161544509|NCT02508532|583384258|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
161544510|NCT01111838|583384259|FG000|Overall Study|Patient Ineligible|2|||
161544511|NCT01111838|583384259|FG000|Overall Study|Not Treated|3|||
161544512|NCT01111838|583384259|FG000|Overall Study|Clinical deterioration|1|||
161544513|NCT01111838|583384259|FG000|Overall Study|Other Complicating Disease|1|||
161544514|NCT01616771|583384261|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
161544515|NCT04399356|583384266|FG000|Overall Study|Lost to Follow-up|1|||
161544516|NCT04399356|583384267|FG001|Overall Study|Lost to Follow-up|1|||
161544517|NCT04399356|583384266|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
161544518|NCT04399356|583384267|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
161544519|NCT04399356|583384266|FG000|Overall Study|Withdrawal by Subject|1|||
161544520|NCT04399356|583384267|FG001|Overall Study|Withdrawal by Subject|0|||
161544521|NCT04359771|583384268|FG000|Overall Study|Lack of Efficacy|2|||
161544522|NCT04359771|583384269|FG001|Overall Study|Lack of Efficacy|2|||
161544523|NCT04041440|583384271|FG000|Overall Study|Withdrawal by Subject|0|||
161544524|NCT04041440|583384272|FG001|Overall Study|Withdrawal by Subject|1|||
161544525|NCT04041440|583384271|FG000|Overall Study|Lost to Follow-up|0|||
161544526|NCT04041440|583384272|FG001|Overall Study|Lost to Follow-up|1|||
161544527|NCT02306265|583384273|FG000|Overall Study|Withdrawal by Subject|1|||
161544528|NCT02247804|583384278|FG000|Treatment Period 1|Adverse Event|9|||
161544529|NCT02247804|583384279|FG001|Treatment Period 1|Adverse Event|2|||
161594192|NCT04292223|583567702|FG000|Overall Study|Patient moved out of the state|1|||
161594193|NCT04633122|583567703|FG000|Overall Study|Remained on treatment|19|||
161594194|NCT04633122|583567704|FG001|Overall Study|Remained on treatment|14|||
161594195|NCT04633122|583567703|FG000|Overall Study|Survival follow-up stopped|22|||
161544530|NCT02247804|583384280|FG002|Treatment Period 1|Adverse Event|0|||
161544531|NCT02247804|583384278|FG000|Treatment Period 1|Lack of Efficacy|0|||
161544532|NCT02247804|583384279|FG001|Treatment Period 1|Lack of Efficacy|0|||
161594196|NCT04633122|583567704|FG001|Overall Study|Survival follow-up stopped|25|||
161594197|NCT02561247|583567705|FG000|Overall Study|Protocol Violation|1|||
161594198|NCT02561247|583567705|FG000|Overall Study|Withdrawal by Subject|1|||
161680315|NCT00139776|583882886|FG000|Period III|Adverse Event|0|||
161544533|NCT02247804|583384280|FG002|Treatment Period 1|Lack of Efficacy|2|||
161544534|NCT02247804|583384278|FG000|Treatment Period 1|Lost to Follow-up|1|||
161544535|NCT02247804|583384279|FG001|Treatment Period 1|Lost to Follow-up|0|||
161594199|NCT02561247|583567705|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
161594200|NCT04963270|583567706|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
161594201|NCT04963270|583567707|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
161594202|NCT04963270|583567708|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
161594203|NCT04963270|583567709|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
161594204|NCT04963270|583567706|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161594205|NCT04963270|583567707|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
161594206|NCT04963270|583567708|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161594207|NCT04963270|583567709|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161594208|NCT04963270|583567706|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
161594209|NCT04963270|583567707|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161594210|NCT04963270|583567708|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161594211|NCT04963270|583567709|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161594212|NCT04963270|583567706|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
161594213|NCT04963270|583567707|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161594214|NCT04963270|583567708|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161594215|NCT04963270|583567709|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161594216|NCT04963270|583567706|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161594217|NCT04963270|583567707|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
161594218|NCT04963270|583567708|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161594219|NCT04963270|583567709|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161594220|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161594221|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161594222|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161594223|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
161594224|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161594225|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161594226|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
161594227|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161594228|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
161594229|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
161594230|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
161594231|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
161594232|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
161594233|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
161594234|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
161594235|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
161594236|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161594237|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161594238|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
161594239|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161594240|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
161594241|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
161594242|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
161594243|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
161594244|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161594245|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161594246|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161594247|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
161594248|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161594249|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161594250|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161594251|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
161544536|NCT02247804|583384280|FG002|Treatment Period 1|Lost to Follow-up|2|||
161544537|NCT02247804|583384278|FG000|Treatment Period 1|Personal Reasons|7|||
161544538|NCT02247804|583384279|FG001|Treatment Period 1|Personal Reasons|1|||
161544539|NCT02247804|583384280|FG002|Treatment Period 1|Personal Reasons|2|||
161544540|NCT02247804|583384278|FG000|Treatment Period 1|Protocol Deviation|0|||
161544541|NCT02247804|583384279|FG001|Treatment Period 1|Protocol Deviation|0|||
161544542|NCT02247804|583384280|FG002|Treatment Period 1|Protocol Deviation|1|||
161544543|NCT02247804|583384278|FG000|Treatment Period 1|Randomized but not Treated|5|||
161544544|NCT02247804|583384279|FG001|Treatment Period 1|Randomized but not Treated|1|||
161544545|NCT02247804|583384280|FG002|Treatment Period 1|Randomized but not Treated|1|||
161544546|NCT02247804|583384278|FG000|Treatment Period 2|Adverse Event|6|||
161544547|NCT02247804|583384279|FG001|Treatment Period 2|Adverse Event|3|||
161544548|NCT02247804|583384280|FG002|Treatment Period 2|Adverse Event|3|||
161544549|NCT02247804|583384278|FG000|Treatment Period 2|Lack of Efficacy|0|||
161544550|NCT02247804|583384279|FG001|Treatment Period 2|Lack of Efficacy|0|||
161544551|NCT02247804|583384280|FG002|Treatment Period 2|Lack of Efficacy|1|||
161544552|NCT02247804|583384278|FG000|Treatment Period 2|Lost to Follow-up|0|||
161544553|NCT02247804|583384279|FG001|Treatment Period 2|Lost to Follow-up|1|||
161594252|NCT04963270|583567706|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161594253|NCT04963270|583567707|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161594254|NCT04963270|583567708|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161594255|NCT04963270|583567709|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
161594256|NCT03560609|583567710|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
161594257|NCT03560609|583567711|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
161594258|NCT04908722|583567714|FG000|Overall Study|Protocol deviation|1|||
161594259|NCT04908722|583567715|FG001|Overall Study|Protocol deviation|0|||
161594260|NCT04908722|583567716|FG002|Overall Study|Protocol deviation|0|||
161594261|NCT04908722|583567717|FG003|Overall Study|Protocol deviation|0|||
161594262|NCT04908722|583567718|FG004|Overall Study|Protocol deviation|0|||
161594263|NCT04908722|583567719|FG005|Overall Study|Protocol deviation|1|||
161594264|NCT04908722|583567714|FG000|Overall Study|Lost to Follow-up|33|||
161594265|NCT04908722|583567715|FG001|Overall Study|Lost to Follow-up|33|||
161594266|NCT04908722|583567716|FG002|Overall Study|Lost to Follow-up|36|||
161594267|NCT04908722|583567717|FG003|Overall Study|Lost to Follow-up|30|||
161594268|NCT04908722|583567718|FG004|Overall Study|Lost to Follow-up|32|||
161594269|NCT04908722|583567719|FG005|Overall Study|Lost to Follow-up|34|||
161594270|NCT04908722|583567714|FG000|Overall Study|Physician Decision|1|||
161594271|NCT04908722|583567715|FG001|Overall Study|Physician Decision|1|||
161594272|NCT04908722|583567716|FG002|Overall Study|Physician Decision|1|||
161594273|NCT04908722|583567717|FG003|Overall Study|Physician Decision|2|||
161594274|NCT04908722|583567718|FG004|Overall Study|Physician Decision|0|||
161594275|NCT04908722|583567719|FG005|Overall Study|Physician Decision|0|||
161594276|NCT04908722|583567714|FG000|Overall Study|Death|1|||
161594277|NCT04908722|583567715|FG001|Overall Study|Death|0|||
161594278|NCT04908722|583567716|FG002|Overall Study|Death|0|||
161594279|NCT04908722|583567717|FG003|Overall Study|Death|0|||
161594280|NCT04908722|583567718|FG004|Overall Study|Death|0|||
161594281|NCT04908722|583567719|FG005|Overall Study|Death|1|||
161594282|NCT04908722|583567714|FG000|Overall Study|Withdrawal by Subject|12|||
161594283|NCT04908722|583567715|FG001|Overall Study|Withdrawal by Subject|8|||
161594284|NCT04908722|583567716|FG002|Overall Study|Withdrawal by Subject|7|||
161594285|NCT04908722|583567717|FG003|Overall Study|Withdrawal by Subject|6|||
161594286|NCT04908722|583567718|FG004|Overall Study|Withdrawal by Subject|12|||
161594287|NCT04908722|583567719|FG005|Overall Study|Withdrawal by Subject|14|||
161594288|NCT04908722|583567714|FG000|Overall Study|Other|3|||
161680316|NCT00139776|583882887|FG001|Period III|Adverse Event|0|||
161680317|NCT00139776|583882888|FG002|Period III|Adverse Event|22|||
161680318|NCT00139776|583882889|FG003|Period III|Adverse Event|23|||
161680319|NCT00139776|583882886|FG000|Period III|Other|0|||
161680320|NCT00139776|583882887|FG001|Period III|Other|0|||
161680321|NCT00139776|583882888|FG002|Period III|Other|23|||
161680322|NCT00139776|583882889|FG003|Period III|Other|34|||
161680323|NCT00139776|583882886|FG000|Period III|Lack of Efficacy|0|||
161680324|NCT00139776|583882887|FG001|Period III|Lack of Efficacy|0|||
161680325|NCT00139776|583882888|FG002|Period III|Lack of Efficacy|10|||
161680326|NCT00139776|583882889|FG003|Period III|Lack of Efficacy|24|||
161680327|NCT00139776|583882886|FG000|Period III|Lost to Follow-up|0|||
161680328|NCT00139776|583882887|FG001|Period III|Lost to Follow-up|0|||
161680329|NCT00139776|583882888|FG002|Period III|Lost to Follow-up|5|||
161680330|NCT00139776|583882889|FG003|Period III|Lost to Follow-up|4|||
161680331|NCT00139776|583882886|FG000|Period III|Withdrawal by Subject|0|||
161680332|NCT00139776|583882887|FG001|Period III|Withdrawal by Subject|0|||
161680333|NCT00139776|583882888|FG002|Period III|Withdrawal by Subject|16|||
161680334|NCT00139776|583882889|FG003|Period III|Withdrawal by Subject|21|||
161680335|NCT00187096|583882890|FG000|Overall Study|unacceptable toxicity|0|||
161680336|NCT00187096|583882891|FG001|Overall Study|unacceptable toxicity|0|||
161680337|NCT00187096|583882892|FG002|Overall Study|unacceptable toxicity|1|||
161680338|NCT00971178|583882907|FG000|Overall Study|Lost to Follow-up|2|||
161680339|NCT00971178|583882908|FG001|Overall Study|Lost to Follow-up|2|||
161680340|NCT00971178|583882909|FG002|Overall Study|Lost to Follow-up|2|||
161680341|NCT02161575|583882910|FG000|Overall Study|Protocol Violation|8|||
161680342|NCT02161575|583882910|FG000|Overall Study|Lack of Efficacy|1|||
161680343|NCT02161575|583882910|FG000|Overall Study|Adverse Event|2|||
161680344|NCT00714285|583882911|FG000|Overall Study|Lost to Follow-up|0|||
161680345|NCT00714285|583882912|FG001|Overall Study|Lost to Follow-up|2|||
161680346|NCT00714285|583882913|FG002|Overall Study|Lost to Follow-up|0|||
161680347|NCT00714285|583882914|FG003|Overall Study|Lost to Follow-up|1|||
161680348|NCT00714285|583882911|FG000|Overall Study|Migrated/moved from study area|0|||
161680349|NCT00714285|583882912|FG001|Overall Study|Migrated/moved from study area|1|||
161680350|NCT00714285|583882913|FG002|Overall Study|Migrated/moved from study area|0|||
161680351|NCT00714285|583882914|FG003|Overall Study|Migrated/moved from study area|0|||
161680352|NCT01816061|583882916|FG000|Overall Study|Lost to Follow-up|13|||
161680353|NCT01816061|583882917|FG001|Overall Study|Lost to Follow-up|24|||
161680354|NCT01970488|583882918|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
161680355|NCT01970488|583882919|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
161680356|NCT01970488|583882920|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161680357|NCT01970488|583882921|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161680358|NCT01970488|583882922|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161680359|NCT01970488|583882918|FG000|Part 1: Through Week 16|Protocol Violation|1|||
161680360|NCT01970488|583882919|FG001|Part 1: Through Week 16|Protocol Violation|2|||
161680361|NCT01970488|583882920|FG002|Part 1: Through Week 16|Protocol Violation|0|||
161680362|NCT01970488|583882921|FG003|Part 1: Through Week 16|Protocol Violation|0|||
161680363|NCT01970488|583882922|FG004|Part 1: Through Week 16|Protocol Violation|0|||
161680364|NCT01970488|583882918|FG000|Part 1: Through Week 16|Adverse Event|6|||
161680365|NCT01970488|583882919|FG001|Part 1: Through Week 16|Adverse Event|5|||
161680366|NCT01970488|583882920|FG002|Part 1: Through Week 16|Adverse Event|0|||
161680367|NCT01970488|583882921|FG003|Part 1: Through Week 16|Adverse Event|0|||
161680368|NCT01970488|583882922|FG004|Part 1: Through Week 16|Adverse Event|0|||
161680369|NCT01970488|583882918|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
161680370|NCT01970488|583882919|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
161680371|NCT01970488|583882920|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
161680372|NCT01970488|583882921|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
161680373|NCT01970488|583882922|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
161680374|NCT01970488|583882918|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
161680375|NCT01970488|583882919|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
161680376|NCT01970488|583882920|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
161680377|NCT01970488|583882921|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
161680378|NCT01970488|583882922|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
161680379|NCT01970488|583882918|FG000|Part 2: Post Week 16|Physician Decision|0|||
161680380|NCT01970488|583882919|FG001|Part 2: Post Week 16|Physician Decision|0|||
161680381|NCT01970488|583882920|FG002|Part 2: Post Week 16|Physician Decision|0|||
161680382|NCT01970488|583882921|FG003|Part 2: Post Week 16|Physician Decision|0|||
161544554|NCT02247804|583384280|FG002|Treatment Period 2|Lost to Follow-up|1|||
161544555|NCT02247804|583384278|FG000|Treatment Period 2|Personal Reasons|2|||
161680383|NCT01970488|583882922|FG004|Part 2: Post Week 16|Physician Decision|1|||
161680384|NCT01970488|583882918|FG000|Part 2: Post Week 16|Non-compliance|0|||
161680385|NCT01970488|583882919|FG001|Part 2: Post Week 16|Non-compliance|0|||
161680386|NCT01970488|583882920|FG002|Part 2: Post Week 16|Non-compliance|1|||
161680387|NCT01970488|583882921|FG003|Part 2: Post Week 16|Non-compliance|0|||
161680388|NCT01970488|583882922|FG004|Part 2: Post Week 16|Non-compliance|0|||
161680389|NCT01970488|583882918|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
161829987|NCT02075606|584418079|FG000|Overall Study|Adverse Event|5|||
161594289|NCT04908722|583567715|FG001|Overall Study|Other|1|||
161594290|NCT04908722|583567716|FG002|Overall Study|Other|3|||
161594291|NCT04908722|583567717|FG003|Overall Study|Other|2|||
161594292|NCT04908722|583567718|FG004|Overall Study|Other|4|||
161594293|NCT04908722|583567719|FG005|Overall Study|Other|1|||
161594294|NCT04908722|583567714|FG000|Overall Study|Initiated prohibited medication|0|||
161594295|NCT04908722|583567715|FG001|Overall Study|Initiated prohibited medication|0|||
161594296|NCT04908722|583567716|FG002|Overall Study|Initiated prohibited medication|0|||
161594297|NCT04908722|583567717|FG003|Overall Study|Initiated prohibited medication|1|||
161594298|NCT04908722|583567718|FG004|Overall Study|Initiated prohibited medication|0|||
161594299|NCT04908722|583567719|FG005|Overall Study|Initiated prohibited medication|1|||
161594300|NCT04908722|583567714|FG000|Overall Study|Randomized but not vaccinated|3|||
161594301|NCT04908722|583567715|FG001|Overall Study|Randomized but not vaccinated|1|||
161594302|NCT04908722|583567716|FG002|Overall Study|Randomized but not vaccinated|2|||
161594303|NCT04908722|583567717|FG003|Overall Study|Randomized but not vaccinated|2|||
161594304|NCT04908722|583567718|FG004|Overall Study|Randomized but not vaccinated|3|||
161594305|NCT04908722|583567719|FG005|Overall Study|Randomized but not vaccinated|4|||
161594306|NCT01959425|583567723|FG000|Overall Study|Withdrawal by Subject|5|||
161594307|NCT01959425|583567724|FG001|Overall Study|Withdrawal by Subject|4|||
161594308|NCT01959425|583567723|FG000|Overall Study|Lost to Follow-up|1|||
161594309|NCT01959425|583567724|FG001|Overall Study|Lost to Follow-up|0|||
161594310|NCT01959425|583567723|FG000|Overall Study|Discontinued Subjects|6|||
161594311|NCT01959425|583567724|FG001|Overall Study|Discontinued Subjects|4|||
161594312|NCT00227344|583567725|FG000|Overall Study|study terminated early|12|||
161594313|NCT00227344|583567726|FG001|Overall Study|study terminated early|5|||
161594314|NCT01987895|583567727|FG000|Overall Study|Withdrawal by Subject|12|||
161594315|NCT01987895|583567728|FG001|Overall Study|Withdrawal by Subject|7|||
161594316|NCT01987895|583567727|FG000|Overall Study|Physician Decision|8|||
161594317|NCT01987895|583567728|FG001|Overall Study|Physician Decision|10|||
161594318|NCT01987895|583567727|FG000|Overall Study|Death|7|||
161594319|NCT01987895|583567728|FG001|Overall Study|Death|7|||
161594320|NCT01987895|583567727|FG000|Overall Study|Lost to Follow-up|3|||
161594321|NCT01987895|583567728|FG001|Overall Study|Lost to Follow-up|5|||
161829988|NCT02075606|584418079|FG000|Overall Study|Withdrawal by Subject|1|||
161829989|NCT02075606|584418079|FG000|Overall Study|Death|1|||
161594322|NCT01987895|583567727|FG000|Overall Study|randomized before giving IC|0|||
161594323|NCT01987895|583567728|FG001|Overall Study|randomized before giving IC|1|||
161829990|NCT02075606|584418079|FG000|Overall Study|Investigator's decision|1|||
161829991|NCT02075606|584418079|FG000|Overall Study|Symptom management|1|||
161594324|NCT02979327|583567729|FG000|First Intervention|Protocol Violation|1|||
161594325|NCT02979327|583567730|FG001|First Intervention|Protocol Violation|0|||
161829992|NCT02075606|584418079|FG000|Overall Study|Increasing Symptoms|1|||
161594326|NCT01073566|583567736|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
161594327|NCT01073566|583567737|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
161594328|NCT05780437|583567738|FG000|Overall Study|Withdrawal by Subject|22|||
161594329|NCT05780437|583567739|FG001|Overall Study|Withdrawal by Subject|16|||
161594330|NCT03474679|583567748|FG000|Overall Study|Death|7|||
161594331|NCT03474679|583567748|FG000|Overall Study|Withdrawal by Subject|1|||
161594332|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
161594333|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161594334|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161594335|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
161594336|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
161594337|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
161594338|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Death|6|||
161594339|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Death|0|||
161594340|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Death|0|||
161594341|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
161594342|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
161594343|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
161594344|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
161594345|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
161594346|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
161594347|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
161594348|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
161594349|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
161594350|NCT01539083|583567752|FG000|Before Randomization (VCD Induction)|Other|5|||
161594351|NCT01539083|583567753|FG001|Before Randomization (VCD Induction)|Other|0|||
161594352|NCT01539083|583567754|FG002|Before Randomization (VCD Induction)|Other|0|||
161594353|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
161594354|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
161594355|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
161594356|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Other|0|||
161594357|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Other|1|||
161594358|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Other|1|||
161594359|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
161594360|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
161594361|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
161594362|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
161594363|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
161594364|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
161594365|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
161594366|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
161594367|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
161594368|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
161594369|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
161594370|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
161594371|NCT01539083|583567752|FG000|After Randomization (TP and VTP)|Death|0|||
161594372|NCT01539083|583567753|FG001|After Randomization (TP and VTP)|Death|6|||
161594373|NCT01539083|583567754|FG002|After Randomization (TP and VTP)|Death|11|||
161594374|NCT05499377|583567759|FG000|Overall Study|Withdrawal by Subject|2|||
161594375|NCT05499377|583567760|FG001|Overall Study|Withdrawal by Subject|0|||
161594376|NCT05499377|583567759|FG000|Overall Study|Physician Decision|1|||
161594377|NCT05499377|583567760|FG001|Overall Study|Physician Decision|0|||
161680390|NCT01970488|583882919|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
161680391|NCT01970488|583882920|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
161680392|NCT01970488|583882921|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
161680393|NCT01970488|583882922|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
161680394|NCT01970488|583882918|FG000|Part 2: Post Week 16|Adverse Event|0|||
161680395|NCT01970488|583882919|FG001|Part 2: Post Week 16|Adverse Event|0|||
161680396|NCT01970488|583882920|FG002|Part 2: Post Week 16|Adverse Event|5|||
161680397|NCT01970488|583882921|FG003|Part 2: Post Week 16|Adverse Event|1|||
161680398|NCT01970488|583882922|FG004|Part 2: Post Week 16|Adverse Event|1|||
161680399|NCT01970488|583882918|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
161680400|NCT01970488|583882919|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
161680401|NCT01970488|583882920|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
161680402|NCT01970488|583882921|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
161680403|NCT01970488|583882922|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
161680404|NCT01970488|583882918|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
161680405|NCT01970488|583882919|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
161680406|NCT01970488|583882920|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
161680407|NCT01970488|583882921|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
161680408|NCT01970488|583882922|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
161680409|NCT05525689|583882924|FG000|Overall Study|Lost to Follow-up|1|||
161680410|NCT05525689|583882925|FG001|Overall Study|Lost to Follow-up|0|||
161680411|NCT01231659|583882926|FG000|Overall Study|Adverse Event|9|||
161680412|NCT01231659|583882926|FG000|Overall Study|Disease Progression|48|||
161680413|NCT01231659|583882926|FG000|Overall Study|Death|2|||
161680414|NCT01231659|583882926|FG000|Overall Study|Patient refused to complete study visit|1|||
161680415|NCT01231659|583882926|FG000|Overall Study|Other protocol defined criteria|12|||
161680416|NCT01075412|583882927|FG000|Overall Study|Withdrawal by Subject|0|||
161680417|NCT01075412|583882928|FG001|Overall Study|Withdrawal by Subject|1|||
161680418|NCT00509067|583882929|FG000|Overall Study|Lost to Follow-up|1|||
161680419|NCT00509067|583882930|FG001|Overall Study|Lost to Follow-up|1|||
161680420|NCT00509067|583882929|FG000|Overall Study|Adverse Event|3|||
161680421|NCT00509067|583882930|FG001|Overall Study|Adverse Event|1|||
161680422|NCT00509067|583882929|FG000|Overall Study|Protocol Violation|0|||
161680423|NCT00509067|583882930|FG001|Overall Study|Protocol Violation|3|||
161680424|NCT00702325|583882942|FG000|Overall Study|Adverse Event|1|||
161680425|NCT00702325|583882943|FG001|Overall Study|Adverse Event|0|||
161680426|NCT00702325|583882942|FG000|Overall Study|Withdrawal by Subject|7|||
161680427|NCT00702325|583882943|FG001|Overall Study|Withdrawal by Subject|7|||
161680428|NCT00702325|583882942|FG000|Overall Study|Lost to Follow-up|3|||
161680429|NCT00702325|583882943|FG001|Overall Study|Lost to Follow-up|4|||
161680430|NCT00702325|583882942|FG000|Overall Study|Incorrect enrollment|5|||
161680431|NCT00702325|583882943|FG001|Overall Study|Incorrect enrollment|7|||
161680432|NCT00702325|583882942|FG000|Overall Study|Developed study discontinuation criteria|18|||
161680433|NCT00702325|583882943|FG001|Overall Study|Developed study discontinuation criteria|28|||
161680434|NCT00702325|583882942|FG000|Overall Study|Severe noncompliance to protocol|3|||
161680435|NCT00702325|583882943|FG001|Overall Study|Severe noncompliance to protocol|3|||
161544556|NCT02247804|583384279|FG001|Treatment Period 2|Personal Reasons|1|||
161544557|NCT02247804|583384280|FG002|Treatment Period 2|Personal Reasons|1|||
161544558|NCT02247804|583384278|FG000|Treatment Period 2|Reason not Specified|0|||
161544559|NCT02247804|583384279|FG001|Treatment Period 2|Reason not Specified|0|||
161544560|NCT02247804|583384280|FG002|Treatment Period 2|Reason not Specified|2|||
161544561|NCT02247804|583384278|FG000|Treatment Period 3|Adverse Event|4|||
161544562|NCT02247804|583384279|FG001|Treatment Period 3|Adverse Event|3|||
161544563|NCT02247804|583384280|FG002|Treatment Period 3|Adverse Event|3|||
161544564|NCT02247804|583384278|FG000|Treatment Period 3|Lack of Efficacy|0|||
161544565|NCT02247804|583384279|FG001|Treatment Period 3|Lack of Efficacy|1|||
161544566|NCT02247804|583384280|FG002|Treatment Period 3|Lack of Efficacy|0|||
161544567|NCT02247804|583384278|FG000|Treatment Period 3|Lost to Follow-up|1|||
161544568|NCT02247804|583384279|FG001|Treatment Period 3|Lost to Follow-up|2|||
161544569|NCT02247804|583384280|FG002|Treatment Period 3|Lost to Follow-up|2|||
161544570|NCT02247804|583384278|FG000|Treatment Period 3|Personal Reasons|4|||
161544571|NCT02247804|583384279|FG001|Treatment Period 3|Personal Reasons|3|||
161544572|NCT02247804|583384280|FG002|Treatment Period 3|Personal Reasons|2|||
161544573|NCT02247804|583384278|FG000|Treatment Period 3|Reason not Specified|2|||
161544574|NCT02247804|583384279|FG001|Treatment Period 3|Reason not Specified|1|||
161544575|NCT02247804|583384280|FG002|Treatment Period 3|Reason not Specified|3|||
161544576|NCT01346514|583384283|FG000|Overall Study|Lost to Follow-up|19|||
161544577|NCT01346514|583384284|FG001|Overall Study|Lost to Follow-up|30|||
161544578|NCT01346514|583384283|FG000|Overall Study|Withdrawal by Subject|7|||
161544579|NCT01346514|583384284|FG001|Overall Study|Withdrawal by Subject|3|||
161544580|NCT01346514|583384283|FG000|Overall Study|Death|3|||
161544581|NCT01346514|583384284|FG001|Overall Study|Death|4|||
161544582|NCT00909480|583384285|FG000|Overall Study|Adverse Event|5|||
161544583|NCT00909480|583384286|FG001|Overall Study|Adverse Event|3|||
161544584|NCT00909480|583384285|FG000|Overall Study|Protocol Violation|6|||
161544585|NCT00909480|583384286|FG001|Overall Study|Protocol Violation|8|||
161544586|NCT00909480|583384285|FG000|Overall Study|Withdrawal criteria|9|||
161594378|NCT03544281|583567763|FG000|Main Study Phase|Death|3|||
161594379|NCT03544281|583567764|FG001|Main Study Phase|Death|2|||
161594380|NCT03544281|583567765|FG002|Main Study Phase|Death|6|||
161594381|NCT03544281|583567766|FG003|Main Study Phase|Death|8|||
161594382|NCT03544281|583567767|FG004|Main Study Phase|Death|4|||
161594383|NCT03544281|583567768|FG005|Main Study Phase|Death|2|||
161594384|NCT03544281|583567769|FG006|Main Study Phase|Death|4|||
161594385|NCT03544281|583567770|FG007|Main Study Phase|Death|5|||
161594386|NCT03544281|583567771|FG008|Main Study Phase|Death|5|||
161594387|NCT03544281|583567772|FG009|Main Study Phase|Death|8|||
161594388|NCT03544281|583567773|FG010|Main Study Phase|Death|6|||
161594389|NCT03544281|583567774|FG011|Main Study Phase|Death|4|||
161594390|NCT03544281|583567775|FG012|Main Study Phase|Death|0|||
161594391|NCT03544281|583567776|FG013|Main Study Phase|Death|0|||
161594392|NCT03544281|583567777|FG014|Main Study Phase|Death|0|||
161594393|NCT03544281|583567778|FG015|Main Study Phase|Death|0|||
161594394|NCT03544281|583567779|FG016|Main Study Phase|Death|0|||
161680436|NCT00702325|583882942|FG000|Overall Study|Termination due to lab results|1|||
161544587|NCT00909480|583384286|FG001|Overall Study|Withdrawal criteria|11|||
161544588|NCT00909480|583384285|FG000|Overall Study|Unclassified|18|||
161544589|NCT00909480|583384286|FG001|Overall Study|Unclassified|19|||
161544590|NCT03002038|583384290|FG000|Overall Study|Adverse Event|3|||
161544591|NCT03002038|583384291|FG001|Overall Study|Adverse Event|1|||
161544592|NCT03002038|583384290|FG000|Overall Study|Withdrawal by Subject|8|||
161544593|NCT03002038|583384291|FG001|Overall Study|Withdrawal by Subject|4|||
161544594|NCT03002038|583384290|FG000|Overall Study|Immigration to another region|0|||
161544595|NCT03002038|583384291|FG001|Overall Study|Immigration to another region|2|||
161544596|NCT01054573|583384292|FG000|Overall Study|Adverse Event|1|||
161544597|NCT01054573|583384293|FG001|Overall Study|Adverse Event|0|||
161544598|NCT01054573|583384294|FG002|Overall Study|Adverse Event|1|||
161544599|NCT01054573|583384295|FG003|Overall Study|Adverse Event|1|||
161544600|NCT01054573|583384292|FG000|Overall Study|Lost to Follow-up|0|||
161544601|NCT01054573|583384293|FG001|Overall Study|Lost to Follow-up|2|||
161544602|NCT01054573|583384294|FG002|Overall Study|Lost to Follow-up|0|||
161544603|NCT01054573|583384295|FG003|Overall Study|Lost to Follow-up|0|||
161544604|NCT01054573|583384292|FG000|Overall Study|Withdrawal by Subject|0|||
161544605|NCT01054573|583384293|FG001|Overall Study|Withdrawal by Subject|2|||
161544606|NCT01054573|583384294|FG002|Overall Study|Withdrawal by Subject|2|||
161594395|NCT03544281|583567780|FG017|Main Study Phase|Death|0|||
161594396|NCT03544281|583567781|FG018|Main Study Phase|Death|0|||
161594397|NCT03544281|583567782|FG019|Main Study Phase|Death|0|||
161594398|NCT03544281|583567783|FG020|Main Study Phase|Death|0|||
161594399|NCT03544281|583567784|FG021|Main Study Phase|Death|0|||
161680437|NCT00702325|583882943|FG001|Overall Study|Termination due to lab results|0|||
161544607|NCT01054573|583384295|FG003|Overall Study|Withdrawal by Subject|1|||
161544608|NCT03724396|583384296|FG000|Overall Study|Lost to Follow-up|1|||
161544609|NCT03724396|583384297|FG001|Overall Study|Lost to Follow-up|1|||
161544610|NCT03724396|583384296|FG000|Overall Study|Withdrawal by Subject|1|||
161544611|NCT03724396|583384297|FG001|Overall Study|Withdrawal by Subject|0|||
161544612|NCT02237508|583384299|FG000|Overall Study|Withdrawal by Subject|0|||
161544613|NCT02237508|583384300|FG001|Overall Study|Withdrawal by Subject|2|||
161544614|NCT02237508|583384301|FG002|Overall Study|Withdrawal by Subject|0|||
161544615|NCT02237508|583384302|FG003|Overall Study|Withdrawal by Subject|1|||
161544616|NCT02237508|583384303|FG004|Overall Study|Withdrawal by Subject|0|||
161544617|NCT02237508|583384304|FG005|Overall Study|Withdrawal by Subject|1|||
161544618|NCT02237508|583384305|FG006|Overall Study|Withdrawal by Subject|1|||
161544619|NCT02237508|583384306|FG007|Overall Study|Withdrawal by Subject|0|||
161544620|NCT02237508|583384307|FG008|Overall Study|Withdrawal by Subject|1|||
161544621|NCT02237508|583384308|FG009|Overall Study|Withdrawal by Subject|0|||
161544622|NCT02237508|583384299|FG000|Overall Study|Physician Decision|0|||
161544623|NCT02237508|583384300|FG001|Overall Study|Physician Decision|1|||
161544624|NCT02237508|583384301|FG002|Overall Study|Physician Decision|0|||
161544625|NCT02237508|583384302|FG003|Overall Study|Physician Decision|0|||
161544626|NCT02237508|583384303|FG004|Overall Study|Physician Decision|0|||
161544627|NCT02237508|583384304|FG005|Overall Study|Physician Decision|0|||
161544628|NCT02237508|583384305|FG006|Overall Study|Physician Decision|0|||
161544629|NCT02237508|583384306|FG007|Overall Study|Physician Decision|0|||
161544630|NCT02237508|583384307|FG008|Overall Study|Physician Decision|0|||
161544631|NCT02237508|583384308|FG009|Overall Study|Physician Decision|0|||
161544632|NCT02237508|583384299|FG000|Overall Study|Protocol Violation|0|||
161544633|NCT02237508|583384300|FG001|Overall Study|Protocol Violation|0|||
161544634|NCT02237508|583384301|FG002|Overall Study|Protocol Violation|1|||
161544635|NCT02237508|583384302|FG003|Overall Study|Protocol Violation|0|||
161544636|NCT02237508|583384303|FG004|Overall Study|Protocol Violation|0|||
161544637|NCT02237508|583384304|FG005|Overall Study|Protocol Violation|0|||
161544638|NCT02237508|583384305|FG006|Overall Study|Protocol Violation|0|||
161544639|NCT02237508|583384306|FG007|Overall Study|Protocol Violation|0|||
161544640|NCT02237508|583384307|FG008|Overall Study|Protocol Violation|0|||
161544641|NCT02237508|583384308|FG009|Overall Study|Protocol Violation|0|||
161680438|NCT00702325|583882942|FG000|Overall Study|Didn't follow study medication dosage|0|||
161680439|NCT00702325|583882943|FG001|Overall Study|Didn't follow study medication dosage|2|||
161680440|NCT00702325|583882942|FG000|Overall Study|Withdrew consent|0|||
161680441|NCT00702325|583882943|FG001|Overall Study|Withdrew consent|1|||
161829993|NCT00983476|584418080|FG000|Overall Study|Did not receive intervention|17|||
161829994|NCT00983476|584418081|FG001|Overall Study|Did not receive intervention|22|||
161680442|NCT00702325|583882942|FG000|Overall Study|Incorrectly Discontinued|0|||
161829995|NCT00983476|584418082|FG002|Overall Study|Did not receive intervention|0|||
161829996|NCT01439724|584418084|FG000|Overall Study|missing consultation|9|||
161829997|NCT01439724|584418085|FG001|Overall Study|missing consultation|8|||
161829998|NCT00575380|584418090|FG000|Overall Study|Withdrawal by Subject|1|||
161829999|NCT00575380|584418091|FG001|Overall Study|Withdrawal by Subject|0|||
161830000|NCT00575380|584418090|FG000|Overall Study|Adverse Event|0|||
161830001|NCT00575380|584418091|FG001|Overall Study|Adverse Event|1|||
161830002|NCT00575380|584418090|FG000|Overall Study|Various|0|||
161830003|NCT00575380|584418091|FG001|Overall Study|Various|2|||
161830004|NCT04019054|584418092|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
161830005|NCT04019054|584418093|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
161830006|NCT04019054|584418092|FG000|Overall Study|Withdrawal by Subject|3|||
161830007|NCT04019054|584418093|FG001|Overall Study|Withdrawal by Subject|1|||
161830008|NCT01040793|584418094|FG000|Overall Study|Adverse Event|5|||
161830009|NCT01040793|584418095|FG001|Overall Study|Adverse Event|3|||
161830010|NCT01040793|584418096|FG002|Overall Study|Adverse Event|0|||
161830011|NCT01040793|584418097|FG003|Overall Study|Adverse Event|2|||
161830012|NCT01040793|584418098|FG004|Overall Study|Adverse Event|2|||
161830013|NCT01040793|584418099|FG005|Overall Study|Adverse Event|1|||
161830014|NCT01040793|584418094|FG000|Overall Study|Protocol Violation|1|||
161830015|NCT01040793|584418095|FG001|Overall Study|Protocol Violation|1|||
161830016|NCT01040793|584418096|FG002|Overall Study|Protocol Violation|1|||
161830017|NCT01040793|584418097|FG003|Overall Study|Protocol Violation|0|||
161830018|NCT01040793|584418098|FG004|Overall Study|Protocol Violation|1|||
161830019|NCT01040793|584418099|FG005|Overall Study|Protocol Violation|0|||
161830020|NCT01040793|584418094|FG000|Overall Study|Lost to Follow-up|0|||
161830021|NCT01040793|584418095|FG001|Overall Study|Lost to Follow-up|1|||
161830022|NCT01040793|584418096|FG002|Overall Study|Lost to Follow-up|1|||
161830023|NCT01040793|584418097|FG003|Overall Study|Lost to Follow-up|0|||
161830024|NCT01040793|584418098|FG004|Overall Study|Lost to Follow-up|0|||
161830025|NCT01040793|584418099|FG005|Overall Study|Lost to Follow-up|0|||
161830026|NCT01040793|584418094|FG000|Overall Study|Withdrawal by Subject|0|||
161830027|NCT01040793|584418095|FG001|Overall Study|Withdrawal by Subject|0|||
161830028|NCT01040793|584418096|FG002|Overall Study|Withdrawal by Subject|0|||
161544642|NCT01650519|583384309|FG000|Overall Study|Withdrawal by Subject|1|||
161544643|NCT01650519|583384310|FG001|Overall Study|Withdrawal by Subject|0|||
161544644|NCT01778556|583384312|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
161544645|NCT01778556|583384313|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
161544646|NCT01778556|583384312|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
161544647|NCT01778556|583384313|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
161544648|NCT01778556|583384312|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
161544649|NCT01778556|583384313|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
161544650|NCT01778556|583384312|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
161544651|NCT01778556|583384313|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
161544652|NCT00576732|583384315|FG000|DOUBLE BLIND|Adverse Event|0|||
161544653|NCT00576732|583384316|FG001|DOUBLE BLIND|Adverse Event|0|||
161544654|NCT00576732|583384317|FG002|DOUBLE BLIND|Adverse Event|1|||
161544655|NCT00576732|583384318|FG003|DOUBLE BLIND|Adverse Event|0|||
161544656|NCT00576732|583384319|FG004|DOUBLE BLIND|Adverse Event|0|||
161544657|NCT00576732|583384320|FG005|DOUBLE BLIND|Adverse Event|0|||
161544658|NCT00576732|583384315|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
161544659|NCT00576732|583384316|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
161544660|NCT00576732|583384317|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
161544661|NCT00576732|583384318|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
161544662|NCT00576732|583384319|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
161544663|NCT00576732|583384320|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
161544664|NCT00576732|583384315|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
161544665|NCT00576732|583384316|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
161544666|NCT00576732|583384317|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
161544667|NCT00576732|583384318|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
161544668|NCT00576732|583384319|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
161544669|NCT00576732|583384320|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
161544670|NCT00576732|583384315|FG000|DOUBLE BLIND|OTHER|0|||
161544671|NCT00576732|583384316|FG001|DOUBLE BLIND|OTHER|2|||
161544672|NCT00576732|583384317|FG002|DOUBLE BLIND|OTHER|1|||
161544673|NCT00576732|583384318|FG003|DOUBLE BLIND|OTHER|0|||
161544674|NCT00576732|583384319|FG004|DOUBLE BLIND|OTHER|0|||
161544675|NCT00576732|583384320|FG005|DOUBLE BLIND|OTHER|0|||
161544676|NCT00576732|583384315|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
161544677|NCT00576732|583384316|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
161544678|NCT00576732|583384317|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
161544679|NCT00576732|583384318|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
161544680|NCT00576732|583384319|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
161544681|NCT00576732|583384320|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
161544682|NCT00576732|583384315|FG000|DOUBLE BLIND|Protocol Violation|1|||
161544683|NCT00576732|583384316|FG001|DOUBLE BLIND|Protocol Violation|0|||
161544684|NCT00576732|583384317|FG002|DOUBLE BLIND|Protocol Violation|0|||
161544685|NCT00576732|583384318|FG003|DOUBLE BLIND|Protocol Violation|0|||
161544686|NCT00576732|583384319|FG004|DOUBLE BLIND|Protocol Violation|0|||
161544687|NCT00576732|583384320|FG005|DOUBLE BLIND|Protocol Violation|0|||
161544688|NCT00576732|583384315|FG000|OPEN LABEL|Adverse Event|0|||
161544689|NCT00576732|583384316|FG001|OPEN LABEL|Adverse Event|0|||
161544690|NCT00576732|583384317|FG002|OPEN LABEL|Adverse Event|0|||
161544691|NCT00576732|583384318|FG003|OPEN LABEL|Adverse Event|4|||
161544692|NCT00576732|583384319|FG004|OPEN LABEL|Adverse Event|0|||
161544693|NCT00576732|583384320|FG005|OPEN LABEL|Adverse Event|1|||
161544694|NCT00576732|583384315|FG000|OPEN LABEL|Lost to Follow-up|0|||
161544695|NCT00576732|583384316|FG001|OPEN LABEL|Lost to Follow-up|0|||
161544696|NCT00576732|583384317|FG002|OPEN LABEL|Lost to Follow-up|0|||
161544697|NCT00576732|583384318|FG003|OPEN LABEL|Lost to Follow-up|2|||
161544698|NCT00576732|583384319|FG004|OPEN LABEL|Lost to Follow-up|1|||
161544699|NCT00576732|583384320|FG005|OPEN LABEL|Lost to Follow-up|1|||
161544700|NCT00576732|583384315|FG000|OPEN LABEL|Withdrawal by Subject|0|||
161544701|NCT00576732|583384316|FG001|OPEN LABEL|Withdrawal by Subject|0|||
161544702|NCT00576732|583384317|FG002|OPEN LABEL|Withdrawal by Subject|0|||
161544703|NCT00576732|583384318|FG003|OPEN LABEL|Withdrawal by Subject|1|||
161544704|NCT00576732|583384319|FG004|OPEN LABEL|Withdrawal by Subject|0|||
161544705|NCT00576732|583384320|FG005|OPEN LABEL|Withdrawal by Subject|1|||
161544706|NCT00576732|583384315|FG000|OPEN LABEL|OTHER|0|||
161544707|NCT00576732|583384316|FG001|OPEN LABEL|OTHER|0|||
161544708|NCT00576732|583384317|FG002|OPEN LABEL|OTHER|0|||
161544709|NCT00576732|583384318|FG003|OPEN LABEL|OTHER|0|||
161544710|NCT00576732|583384319|FG004|OPEN LABEL|OTHER|0|||
161544711|NCT00576732|583384320|FG005|OPEN LABEL|OTHER|2|||
161544712|NCT00576732|583384315|FG000|OPEN LABEL|Lack of Efficacy|0|||
161544713|NCT00576732|583384316|FG001|OPEN LABEL|Lack of Efficacy|0|||
161544714|NCT00576732|583384317|FG002|OPEN LABEL|Lack of Efficacy|0|||
161544715|NCT00576732|583384318|FG003|OPEN LABEL|Lack of Efficacy|2|||
161544716|NCT00576732|583384319|FG004|OPEN LABEL|Lack of Efficacy|2|||
161544717|NCT00576732|583384320|FG005|OPEN LABEL|Lack of Efficacy|3|||
161544718|NCT00576732|583384315|FG000|OPEN LABEL|Protocol Violation|0|||
161544719|NCT00576732|583384316|FG001|OPEN LABEL|Protocol Violation|0|||
161544720|NCT00576732|583384317|FG002|OPEN LABEL|Protocol Violation|0|||
161544721|NCT00576732|583384318|FG003|OPEN LABEL|Protocol Violation|2|||
161544722|NCT00576732|583384319|FG004|OPEN LABEL|Protocol Violation|1|||
161544723|NCT00576732|583384320|FG005|OPEN LABEL|Protocol Violation|0|||
161544724|NCT02296190|583384321|FG000|Overall Study|Lost to Follow-up|0|||
161544725|NCT02296190|583384322|FG001|Overall Study|Lost to Follow-up|0|||
161544726|NCT02296190|583384323|FG002|Overall Study|Lost to Follow-up|0|||
161544727|NCT02296190|583384324|FG003|Overall Study|Lost to Follow-up|0|||
161544728|NCT02296190|583384325|FG004|Overall Study|Lost to Follow-up|1|||
161544729|NCT02296190|583384326|FG005|Overall Study|Lost to Follow-up|0|||
161544730|NCT02296190|583384321|FG000|Overall Study|Failure to induce PSVT|6|||
161544731|NCT02296190|583384322|FG001|Overall Study|Failure to induce PSVT|10|||
161544732|NCT02296190|583384323|FG002|Overall Study|Failure to induce PSVT|5|||
161544733|NCT02296190|583384324|FG003|Overall Study|Failure to induce PSVT|13|||
161544734|NCT02296190|583384325|FG004|Overall Study|Failure to induce PSVT|8|||
161544735|NCT02296190|583384326|FG005|Overall Study|Failure to induce PSVT|0|||
161544736|NCT02296190|583384321|FG000|Overall Study|Physician Decision|1|||
161544737|NCT02296190|583384322|FG001|Overall Study|Physician Decision|1|||
161544738|NCT02296190|583384323|FG002|Overall Study|Physician Decision|0|||
161544739|NCT02296190|583384324|FG003|Overall Study|Physician Decision|1|||
161544740|NCT02296190|583384325|FG004|Overall Study|Physician Decision|2|||
161544741|NCT02296190|583384326|FG005|Overall Study|Physician Decision|0|||
161544742|NCT02296190|583384321|FG000|Overall Study|Withdrawal by Subject|0|||
161544743|NCT02296190|583384322|FG001|Overall Study|Withdrawal by Subject|1|||
161544744|NCT02296190|583384323|FG002|Overall Study|Withdrawal by Subject|0|||
161544745|NCT02296190|583384324|FG003|Overall Study|Withdrawal by Subject|0|||
161544746|NCT02296190|583384325|FG004|Overall Study|Withdrawal by Subject|0|||
161544747|NCT02296190|583384326|FG005|Overall Study|Withdrawal by Subject|0|||
161544748|NCT02296190|583384321|FG000|Overall Study|PSVT < 5 minutes|5|||
161544749|NCT02296190|583384322|FG001|Overall Study|PSVT < 5 minutes|6|||
161544750|NCT02296190|583384323|FG002|Overall Study|PSVT < 5 minutes|6|||
161544751|NCT02296190|583384324|FG003|Overall Study|PSVT < 5 minutes|6|||
161544752|NCT02296190|583384325|FG004|Overall Study|PSVT < 5 minutes|5|||
161544753|NCT02296190|583384326|FG005|Overall Study|PSVT < 5 minutes|0|||
161544754|NCT02296190|583384321|FG000|Overall Study|Patient was given Propofol|0|||
161544755|NCT02296190|583384322|FG001|Overall Study|Patient was given Propofol|1|||
161544756|NCT02296190|583384323|FG002|Overall Study|Patient was given Propofol|0|||
161544757|NCT02296190|583384324|FG003|Overall Study|Patient was given Propofol|1|||
161544758|NCT02296190|583384325|FG004|Overall Study|Patient was given Propofol|0|||
161544759|NCT02296190|583384326|FG005|Overall Study|Patient was given Propofol|0|||
161544760|NCT02296190|583384321|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
161544761|NCT02296190|583384322|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
161544762|NCT02296190|583384323|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
161544763|NCT02296190|583384324|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
161544764|NCT02296190|583384325|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
161544765|NCT02296190|583384326|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
161544766|NCT02296190|583384321|FG000|Overall Study|Blood pressure <100 after sedation|0|||
161544767|NCT02296190|583384322|FG001|Overall Study|Blood pressure <100 after sedation|0|||
161544768|NCT02296190|583384323|FG002|Overall Study|Blood pressure <100 after sedation|0|||
161544769|NCT02296190|583384324|FG003|Overall Study|Blood pressure <100 after sedation|1|||
161544770|NCT02296190|583384325|FG004|Overall Study|Blood pressure <100 after sedation|0|||
161544771|NCT02296190|583384326|FG005|Overall Study|Blood pressure <100 after sedation|0|||
161544772|NCT02296190|583384321|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
161544773|NCT02296190|583384322|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
161544774|NCT02296190|583384323|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
161544775|NCT02296190|583384324|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
161544776|NCT02296190|583384325|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
161544777|NCT02296190|583384326|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
161544778|NCT02296190|583384321|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
161544779|NCT02296190|583384322|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
161544780|NCT02296190|583384323|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
161544781|NCT02296190|583384324|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
161544782|NCT02296190|583384325|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
161544783|NCT02296190|583384326|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
161544784|NCT02296190|583384321|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
161544785|NCT02296190|583384322|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
161544786|NCT02296190|583384323|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
161544787|NCT02296190|583384324|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
161544788|NCT02296190|583384325|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
161544789|NCT02296190|583384326|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
161544790|NCT02296190|583384321|FG000|Overall Study|Lab result not available in time|1|||
161544791|NCT02296190|583384322|FG001|Overall Study|Lab result not available in time|0|||
161544792|NCT02296190|583384323|FG002|Overall Study|Lab result not available in time|0|||
161544793|NCT02296190|583384324|FG003|Overall Study|Lab result not available in time|0|||
161544794|NCT02296190|583384325|FG004|Overall Study|Lab result not available in time|0|||
161544795|NCT02296190|583384326|FG005|Overall Study|Lab result not available in time|0|||
161544796|NCT00265330|583384327|FG000|Overall Study|Adverse Event|41|||
161544797|NCT00265330|583384327|FG000|Overall Study|Lost to Follow-up|8|||
161544798|NCT00265330|583384327|FG000|Overall Study|Withdrawal by Subject|34|||
161544799|NCT00265330|583384327|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
161544800|NCT00265330|583384327|FG000|Overall Study|Lack of Efficacy|4|||
161544801|NCT00265330|583384327|FG000|Overall Study|Family Scheduling Conflicts|1|||
161544802|NCT00265330|583384327|FG000|Overall Study|Began Taking Formulary Geodon|1|||
161544803|NCT00265330|583384327|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
161544804|NCT00265330|583384327|FG000|Overall Study|Site Closed by Sponsor|1|||
161544805|NCT00265330|583384327|FG000|Overall Study|Principal Investigators Request|1|||
161544806|NCT00265330|583384327|FG000|Overall Study|Withdrew Consent|1|||
161544807|NCT00265330|583384327|FG000|Overall Study|Protocol Violation|1|||
161544808|NCT02178566|583384336|FG000|Overall Study|patient did not complete due to noncompliance|0|||
161544809|NCT02178566|583384337|FG001|Overall Study|patient did not complete due to noncompliance|1|||
161544810|NCT02658630|583384338|FG000|Overall Study|Withdrawal by Subject|4|||
161544811|NCT00682643|583384339|FG000|Overall Study|Adverse Event|12|||
161544812|NCT00682643|583384340|FG001|Overall Study|Adverse Event|23|||
161544813|NCT00682643|583384339|FG000|Overall Study|Lack of Efficacy|2|||
161544814|NCT00682643|583384340|FG001|Overall Study|Lack of Efficacy|0|||
161544815|NCT00682643|583384339|FG000|Overall Study|Protocol Violation|38|||
161544816|NCT00682643|583384340|FG001|Overall Study|Protocol Violation|76|||
161544817|NCT00682643|583384339|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
161544818|NCT00682643|583384340|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
161544819|NCT00682643|583384339|FG000|Overall Study|Lost to Follow-up|1|||
161544820|NCT00682643|583384340|FG001|Overall Study|Lost to Follow-up|6|||
161544821|NCT00682643|583384339|FG000|Overall Study|Physician Decision|2|||
161680443|NCT00702325|583882943|FG001|Overall Study|Incorrectly Discontinued|1|||
161544822|NCT00682643|583384340|FG001|Overall Study|Physician Decision|6|||
161544823|NCT00682643|583384339|FG000|Overall Study|Withdrawal by Subject|19|||
161544824|NCT00682643|583384340|FG001|Overall Study|Withdrawal by Subject|53|||
161544825|NCT00682643|583384339|FG000|Overall Study|Did Not Receive Study Drug|1|||
161544826|NCT00682643|583384340|FG001|Overall Study|Did Not Receive Study Drug|1|||
161544827|NCT01875185|583384341|FG000|Overall Study|study was terminated|52|||
161544828|NCT01875185|583384342|FG001|Overall Study|study was terminated|48|||
161544829|NCT00085202|583384343|FG000|Overall Study|Still on therapy|2|||
161544830|NCT00085202|583384344|FG001|Overall Study|Still on therapy|0|||
161544831|NCT00085202|583384343|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
161544832|NCT00085202|583384344|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
161544833|NCT00085202|583384343|FG000|Overall Study|Excessive toxicity|6|||
161544834|NCT00085202|583384344|FG001|Overall Study|Excessive toxicity|5|||
161544835|NCT00085202|583384343|FG000|Overall Study|Non-specified|3|||
161544836|NCT00085202|583384344|FG001|Overall Study|Non-specified|5|||
161544837|NCT00085202|583384343|FG000|Overall Study|Withdrawal by Subject|2|||
161544838|NCT00085202|583384344|FG001|Overall Study|Withdrawal by Subject|1|||
161544839|NCT00085202|583384343|FG000|Overall Study|Physician Decision|4|||
161544840|NCT00085202|583384344|FG001|Overall Study|Physician Decision|1|||
161544841|NCT00085202|583384343|FG000|Overall Study|Progressive disease|1|||
161544842|NCT00085202|583384344|FG001|Overall Study|Progressive disease|11|||
161544843|NCT03238300|583384345|FG000|Baseline (Before Intervention)|Physician Decision|0|||
161544844|NCT03238300|583384346|FG001|Baseline (Before Intervention)|Physician Decision|1|||
161544845|NCT03238300|583384345|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
161544846|NCT03238300|583384346|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
161544847|NCT03238300|583384345|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
161544848|NCT03238300|583384346|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
161544849|NCT03238300|583384345|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
161544850|NCT03238300|583384346|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
161544851|NCT00399763|583384354|FG000|Overall Study|Lost to Follow-up|2|||
161544852|NCT00399763|583384355|FG001|Overall Study|Lost to Follow-up|3|||
161544853|NCT03389477|583384358|FG000|Step 1|Withdrawal by Subject|1|||
161544854|NCT03389477|583384359|FG001|Step 1|Withdrawal by Subject|0|||
161544855|NCT03389477|583384358|FG000|Step 2|Withdrawal by Subject|1|||
161544856|NCT03389477|583384359|FG001|Step 2|Withdrawal by Subject|2|||
161544857|NCT03389477|583384358|FG000|Step 2|Disease progression|1|||
161544858|NCT03389477|583384359|FG001|Step 2|Disease progression|0|||
161544859|NCT03389477|583384358|FG000|Step 2|Death|0|||
161544860|NCT03389477|583384359|FG001|Step 2|Death|1|||
161544861|NCT03389477|583384358|FG000|Step 2|Poor performance status and nutrition|0|||
161544862|NCT03389477|583384359|FG001|Step 2|Poor performance status and nutrition|1|||
161544863|NCT03389477|583384358|FG000|Step 3|Withdrawal after 3 cycles|0|||
161544864|NCT03389477|583384359|FG001|Step 3|Withdrawal after 3 cycles|1|||
161544865|NCT03389477|583384358|FG000|Step 3|Still receiving active treatment|4|||
161544866|NCT03389477|583384359|FG001|Step 3|Still receiving active treatment|0|||
161544867|NCT03389477|583384358|FG000|Step 3|Progressive disease after 2 cycles|1|||
161544868|NCT03389477|583384359|FG001|Step 3|Progressive disease after 2 cycles|0|||
161544869|NCT04512066|583384362|FG000|Double-blind Treatment Period|Adverse Event|6|||
161544870|NCT04512066|583384363|FG001|Double-blind Treatment Period|Adverse Event|4|||
161544871|NCT04512066|583384364|FG002|Double-blind Treatment Period|Adverse Event|5|||
161544872|NCT04512066|583384365|FG003|Double-blind Treatment Period|Adverse Event|1|||
161544873|NCT04512066|583384366|FG004|Double-blind Treatment Period|Adverse Event|0|||
161544874|NCT04512066|583384367|FG005|Double-blind Treatment Period|Adverse Event|0|||
161544875|NCT04512066|583384362|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
161544876|NCT04512066|583384363|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
161544877|NCT04512066|583384364|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
161544878|NCT04512066|583384365|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
161544879|NCT04512066|583384366|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
161544880|NCT04512066|583384367|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
161544881|NCT04512066|583384362|FG000|Double-blind Treatment Period|Physician Decision|1|||
161544882|NCT04512066|583384363|FG001|Double-blind Treatment Period|Physician Decision|0|||
161544883|NCT04512066|583384364|FG002|Double-blind Treatment Period|Physician Decision|1|||
161544884|NCT04512066|583384365|FG003|Double-blind Treatment Period|Physician Decision|0|||
161544885|NCT04512066|583384366|FG004|Double-blind Treatment Period|Physician Decision|0|||
161544886|NCT04512066|583384367|FG005|Double-blind Treatment Period|Physician Decision|0|||
161544887|NCT04512066|583384362|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
161544888|NCT04512066|583384363|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
161544889|NCT04512066|583384364|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
161544890|NCT04512066|583384365|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
161544891|NCT04512066|583384366|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
161544892|NCT04512066|583384367|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
161544893|NCT04512066|583384362|FG000|Extension Period|Adverse Event|0|||
161544894|NCT04512066|583384363|FG001|Extension Period|Adverse Event|1|||
161544895|NCT04512066|583384364|FG002|Extension Period|Adverse Event|4|||
161544896|NCT04512066|583384365|FG003|Extension Period|Adverse Event|3|||
161544897|NCT04512066|583384366|FG004|Extension Period|Adverse Event|1|||
161544898|NCT04512066|583384367|FG005|Extension Period|Adverse Event|3|||
161544899|NCT04512066|583384362|FG000|Extension Period|Death|0|||
161544900|NCT04512066|583384363|FG001|Extension Period|Death|0|||
161544901|NCT04512066|583384364|FG002|Extension Period|Death|0|||
161544902|NCT04512066|583384365|FG003|Extension Period|Death|0|||
161544903|NCT04512066|583384366|FG004|Extension Period|Death|0|||
161544904|NCT04512066|583384367|FG005|Extension Period|Death|1|||
161544905|NCT04512066|583384362|FG000|Extension Period|Lack of Efficacy|0|||
161544906|NCT04512066|583384363|FG001|Extension Period|Lack of Efficacy|4|||
161544907|NCT04512066|583384364|FG002|Extension Period|Lack of Efficacy|4|||
161544908|NCT04512066|583384365|FG003|Extension Period|Lack of Efficacy|1|||
161544909|NCT04512066|583384366|FG004|Extension Period|Lack of Efficacy|3|||
161544910|NCT04512066|583384367|FG005|Extension Period|Lack of Efficacy|3|||
161544911|NCT04512066|583384362|FG000|Extension Period|Lost to Follow-up|0|||
161544912|NCT04512066|583384363|FG001|Extension Period|Lost to Follow-up|1|||
161544913|NCT04512066|583384364|FG002|Extension Period|Lost to Follow-up|5|||
161544914|NCT04512066|583384365|FG003|Extension Period|Lost to Follow-up|2|||
161544915|NCT04512066|583384366|FG004|Extension Period|Lost to Follow-up|3|||
161680444|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
161830029|NCT01040793|584418097|FG003|Overall Study|Withdrawal by Subject|2|||
161830030|NCT01040793|584418098|FG004|Overall Study|Withdrawal by Subject|0|||
161544916|NCT04512066|583384367|FG005|Extension Period|Lost to Follow-up|2|||
161544917|NCT04512066|583384362|FG000|Extension Period|Non-compliance with study drug|0|||
161544918|NCT04512066|583384363|FG001|Extension Period|Non-compliance with study drug|1|||
161544919|NCT04512066|583384364|FG002|Extension Period|Non-compliance with study drug|0|||
161544920|NCT04512066|583384365|FG003|Extension Period|Non-compliance with study drug|0|||
161544921|NCT04512066|583384366|FG004|Extension Period|Non-compliance with study drug|0|||
161544922|NCT04512066|583384367|FG005|Extension Period|Non-compliance with study drug|1|||
161544923|NCT04512066|583384362|FG000|Extension Period|Other|0|||
161544924|NCT04512066|583384363|FG001|Extension Period|Other|2|||
161544925|NCT04512066|583384364|FG002|Extension Period|Other|0|||
161544926|NCT04512066|583384365|FG003|Extension Period|Other|0|||
161544927|NCT04512066|583384366|FG004|Extension Period|Other|0|||
161544928|NCT04512066|583384367|FG005|Extension Period|Other|0|||
161544929|NCT04512066|583384362|FG000|Extension Period|Physician Decision|0|||
161680445|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
161830031|NCT01040793|584418099|FG005|Overall Study|Withdrawal by Subject|0|||
161544930|NCT04512066|583384363|FG001|Extension Period|Physician Decision|2|||
161544931|NCT04512066|583384364|FG002|Extension Period|Physician Decision|0|||
161544932|NCT04512066|583384365|FG003|Extension Period|Physician Decision|1|||
161544933|NCT04512066|583384366|FG004|Extension Period|Physician Decision|1|||
161544934|NCT04512066|583384367|FG005|Extension Period|Physician Decision|0|||
161544935|NCT04512066|583384362|FG000|Extension Period|Withdrawal by Subject|0|||
161544936|NCT04512066|583384363|FG001|Extension Period|Withdrawal by Subject|3|||
161544937|NCT04512066|583384364|FG002|Extension Period|Withdrawal by Subject|7|||
161544938|NCT04512066|583384365|FG003|Extension Period|Withdrawal by Subject|11|||
161544939|NCT04512066|583384366|FG004|Extension Period|Withdrawal by Subject|8|||
161544940|NCT04512066|583384367|FG005|Extension Period|Withdrawal by Subject|4|||
161544941|NCT03403426|583384369|FG000|Overall Study|Death|1|||
161544942|NCT03403426|583384369|FG000|Overall Study|Lost to Follow-up|2|||
161544943|NCT01657266|583384373|FG000|Overall Study|Lost to Follow-up|2|||
161544944|NCT01657266|583384374|FG001|Overall Study|Lost to Follow-up|2|||
161544945|NCT01657266|583384373|FG000|Overall Study|Adverse Event|2|||
161544946|NCT01657266|583384374|FG001|Overall Study|Adverse Event|3|||
161544947|NCT03520400|583384375|FG000|Overall Study|Physician Decision|15|||
161544948|NCT03520400|583384376|FG001|Overall Study|Physician Decision|7|||
161544949|NCT00445679|583384377|FG000|Overall Study|Adverse Event|22|||
161544950|NCT00445679|583384378|FG001|Overall Study|Adverse Event|12|||
161544951|NCT00445679|583384379|FG002|Overall Study|Adverse Event|30|||
161544952|NCT00445679|583384380|FG003|Overall Study|Adverse Event|19|||
161544953|NCT00445679|583384377|FG000|Overall Study|Failed to return|1|||
161544954|NCT00445679|583384378|FG001|Overall Study|Failed to return|3|||
161544955|NCT00445679|583384379|FG002|Overall Study|Failed to return|2|||
161544956|NCT00445679|583384380|FG003|Overall Study|Failed to return|2|||
161544957|NCT00445679|583384377|FG000|Overall Study|Physician Decision|0|||
161544958|NCT00445679|583384378|FG001|Overall Study|Physician Decision|0|||
161544959|NCT00445679|583384379|FG002|Overall Study|Physician Decision|1|||
161544960|NCT00445679|583384380|FG003|Overall Study|Physician Decision|0|||
161544961|NCT00445679|583384377|FG000|Overall Study|Lost to Follow-up|10|||
161544962|NCT00445679|583384378|FG001|Overall Study|Lost to Follow-up|6|||
161544963|NCT00445679|583384379|FG002|Overall Study|Lost to Follow-up|6|||
161544964|NCT00445679|583384380|FG003|Overall Study|Lost to Follow-up|5|||
161544965|NCT00445679|583384377|FG000|Overall Study|Compliance|3|||
161544966|NCT00445679|583384378|FG001|Overall Study|Compliance|2|||
161544967|NCT00445679|583384379|FG002|Overall Study|Compliance|1|||
161544968|NCT00445679|583384380|FG003|Overall Study|Compliance|2|||
161544969|NCT00445679|583384377|FG000|Overall Study|Withdrawal of Informed Consent|0|||
161544970|NCT00445679|583384378|FG001|Overall Study|Withdrawal of Informed Consent|0|||
161544971|NCT00445679|583384379|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161544972|NCT00445679|583384380|FG003|Overall Study|Withdrawal of Informed Consent|0|||
161544973|NCT00445679|583384377|FG000|Overall Study|Protocol Violation|2|||
161544974|NCT00445679|583384378|FG001|Overall Study|Protocol Violation|3|||
161544975|NCT00445679|583384379|FG002|Overall Study|Protocol Violation|3|||
161544976|NCT00445679|583384380|FG003|Overall Study|Protocol Violation|1|||
161544977|NCT00445679|583384377|FG000|Overall Study|Withdrawal by Subject|8|||
161544978|NCT00445679|583384378|FG001|Overall Study|Withdrawal by Subject|14|||
161544979|NCT00445679|583384379|FG002|Overall Study|Withdrawal by Subject|20|||
161594400|NCT03544281|583567763|FG000|Main Study Phase|Lost to Follow-up|0|||
161594401|NCT03544281|583567764|FG001|Main Study Phase|Lost to Follow-up|0|||
161594402|NCT03544281|583567765|FG002|Main Study Phase|Lost to Follow-up|0|||
161544980|NCT00445679|583384380|FG003|Overall Study|Withdrawal by Subject|18|||
161544981|NCT00445679|583384377|FG000|Overall Study|Lack of Efficacy|2|||
161544982|NCT00445679|583384378|FG001|Overall Study|Lack of Efficacy|6|||
161544983|NCT00445679|583384379|FG002|Overall Study|Lack of Efficacy|2|||
161544984|NCT00445679|583384380|FG003|Overall Study|Lack of Efficacy|0|||
161544985|NCT00909428|583384386|FG000|Overall Study|Lost to Follow-up|13|||
161594403|NCT03544281|583567766|FG003|Main Study Phase|Lost to Follow-up|0|||
161594404|NCT03544281|583567767|FG004|Main Study Phase|Lost to Follow-up|0|||
161544986|NCT00909428|583384387|FG001|Overall Study|Lost to Follow-up|10|||
161544987|NCT00909428|583384388|FG002|Overall Study|Lost to Follow-up|9|||
161544988|NCT03021668|583384389|FG000|Overall Study|Physician Decision|0|||
161544989|NCT03021668|583384390|FG001|Overall Study|Physician Decision|1|||
161544990|NCT00116844|583384393|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
161544991|NCT00116844|583384394|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
161544992|NCT00116844|583384393|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
161544993|NCT00116844|583384394|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
161544994|NCT00116844|583384393|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
161544995|NCT00116844|583384394|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
161544996|NCT00116844|583384393|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
161544997|NCT00116844|583384394|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
161544998|NCT00116844|583384393|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
161544999|NCT00116844|583384394|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
161594405|NCT03544281|583567768|FG005|Main Study Phase|Lost to Follow-up|0|||
161594406|NCT03544281|583567769|FG006|Main Study Phase|Lost to Follow-up|0|||
161594407|NCT03544281|583567770|FG007|Main Study Phase|Lost to Follow-up|0|||
161594408|NCT03544281|583567771|FG008|Main Study Phase|Lost to Follow-up|0|||
161594409|NCT03544281|583567772|FG009|Main Study Phase|Lost to Follow-up|0|||
161545000|NCT00116844|583384393|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
161594410|NCT03544281|583567773|FG010|Main Study Phase|Lost to Follow-up|1|||
161594411|NCT03544281|583567774|FG011|Main Study Phase|Lost to Follow-up|0|||
161545001|NCT00116844|583384394|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
161545002|NCT00116844|583384393|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
161545003|NCT00116844|583384394|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
161545004|NCT00116844|583384393|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
161545005|NCT00116844|583384394|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
161545006|NCT00116844|583384393|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
161545007|NCT00116844|583384394|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
161545008|NCT01933880|583384395|FG000|Overall Study|Withdrawal by Subject|5|||
161545009|NCT01933880|583384396|FG001|Overall Study|Withdrawal by Subject|0|||
161545010|NCT01933880|583384395|FG000|Overall Study|Lack of Efficacy|1|||
161545011|NCT01933880|583384396|FG001|Overall Study|Lack of Efficacy|0|||
161545012|NCT01933880|583384395|FG000|Overall Study|Concomitant medication Interference|0|||
161545013|NCT01933880|583384396|FG001|Overall Study|Concomitant medication Interference|1|||
161545014|NCT01933880|583384395|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
161545015|NCT01933880|583384396|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
161545016|NCT01933880|583384395|FG000|Overall Study|Other|4|||
161545017|NCT01933880|583384396|FG001|Overall Study|Other|0|||
161545018|NCT01933880|583384395|FG000|Overall Study|Protocol Violation|1|||
161545019|NCT01933880|583384396|FG001|Overall Study|Protocol Violation|0|||
161545020|NCT01125722|583384397|FG000|Overall Study|Withdrawal by Subject|2|||
161545021|NCT01125722|583384398|FG001|Overall Study|Withdrawal by Subject|1|||
161545022|NCT01125722|583384397|FG000|Overall Study|Lost to Follow-up|1|||
161545023|NCT01125722|583384398|FG001|Overall Study|Lost to Follow-up|0|||
161545024|NCT03474549|583384399|FG000|Overall Study|Death|31|||
161545025|NCT03474549|583384399|FG000|Overall Study|Lost to Follow-up|4|||
161545026|NCT03474549|583384399|FG000|Overall Study|Withdrawal by Subject|2|||
161545027|NCT00069784|583384400|FG000|Overall Study|Adverse Event|105|||
161545028|NCT00069784|583384401|FG001|Overall Study|Adverse Event|0|||
161545029|NCT00069784|583384400|FG000|Overall Study|Withdrawal by Subject|1090|||
161545030|NCT00069784|583384401|FG001|Overall Study|Withdrawal by Subject|0|||
161545031|NCT00069784|583384400|FG000|Overall Study|Other|17|||
161545032|NCT00069784|583384401|FG001|Overall Study|Other|0|||
161545033|NCT00926003|583384404|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
161545034|NCT00926003|583384405|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
161545035|NCT00926003|583384406|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
161545036|NCT00926003|583384404|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
161545037|NCT00926003|583384405|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
161545038|NCT00926003|583384406|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
161545039|NCT00709059|583384408|FG000|Overall Study|Lost to Follow-up|34|||
161545040|NCT00709059|583384408|FG000|Overall Study|Withdrawal by Subject|19|||
161545041|NCT00709059|583384408|FG000|Overall Study|Physician Decision|7|||
161545042|NCT00709059|583384408|FG000|Overall Study|Disease complication|3|||
161545043|NCT00709059|583384408|FG000|Overall Study|Side effects|20|||
161545044|NCT00709059|583384408|FG000|Overall Study|Serious side effects|11|||
161545045|NCT01786330|583384409|FG000|Overall Study|Withdrawal by Subject|0|||
161594412|NCT03544281|583567775|FG012|Main Study Phase|Lost to Follow-up|0|||
161594413|NCT03544281|583567776|FG013|Main Study Phase|Lost to Follow-up|0|||
161594414|NCT03544281|583567777|FG014|Main Study Phase|Lost to Follow-up|0|||
161594415|NCT03544281|583567778|FG015|Main Study Phase|Lost to Follow-up|0|||
161594416|NCT03544281|583567779|FG016|Main Study Phase|Lost to Follow-up|0|||
161545046|NCT01786330|583384410|FG001|Overall Study|Withdrawal by Subject|1|||
161545047|NCT01786330|583384409|FG000|Overall Study|Lost to Follow-up|0|||
161545048|NCT01786330|583384410|FG001|Overall Study|Lost to Follow-up|1|||
161545049|NCT01786330|583384409|FG000|Overall Study|Excluded intraoperatively|0|||
161545050|NCT01786330|583384410|FG001|Overall Study|Excluded intraoperatively|1|||
161545051|NCT01786330|583384409|FG000|Overall Study|Protocol Violation|1|||
161545052|NCT01786330|583384410|FG001|Overall Study|Protocol Violation|0|||
161545053|NCT01167179|583386343|FG000|Overall Study|disease recurrence|4|||
161545054|NCT01167179|583386344|FG001|Overall Study|disease recurrence|4|||
161545055|NCT01167179|583386343|FG000|Overall Study|Death|4|||
161545056|NCT01167179|583386344|FG001|Overall Study|Death|10|||
161545057|NCT01167179|583386343|FG000|Overall Study|Withdrawal by Subject|1|||
161545058|NCT01167179|583386344|FG001|Overall Study|Withdrawal by Subject|2|||
161545059|NCT01167179|583386343|FG000|Overall Study|diverse|6|||
161545060|NCT01167179|583386344|FG001|Overall Study|diverse|5|||
161594417|NCT03544281|583567780|FG017|Main Study Phase|Lost to Follow-up|0|||
161545061|NCT03017235|583386345|FG000|Overall Study|Withdrawal by Subject|4|||
161545062|NCT03017235|583386346|FG001|Overall Study|Withdrawal by Subject|3|||
161594418|NCT03544281|583567781|FG018|Main Study Phase|Lost to Follow-up|0|||
161545063|NCT03017235|583386345|FG000|Overall Study|Lost to Follow-up|2|||
161545064|NCT03017235|583386346|FG001|Overall Study|Lost to Follow-up|7|||
161545065|NCT03017235|583386345|FG000|Overall Study|Adverse Event|0|||
161545066|NCT03017235|583386346|FG001|Overall Study|Adverse Event|1|||
161545067|NCT03017235|583386345|FG000|Overall Study|Protocol Violation|2|||
161545068|NCT03017235|583386346|FG001|Overall Study|Protocol Violation|1|||
161545069|NCT03017235|583386345|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
161545070|NCT03017235|583386346|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
161545071|NCT02254408|583386351|FG000|Overall Study|Randomized But Not Treated|1|||
161545072|NCT02254408|583386352|FG001|Overall Study|Randomized But Not Treated|3|||
161545073|NCT02254408|583386351|FG000|Overall Study|Adverse Event|1|||
161545074|NCT02254408|583386352|FG001|Overall Study|Adverse Event|0|||
161545075|NCT02254408|583386351|FG000|Overall Study|Death|2|||
161545076|NCT02254408|583386352|FG001|Overall Study|Death|3|||
161545077|NCT02254408|583386351|FG000|Overall Study|Investigator's Discretion|0|||
161545078|NCT02254408|583386352|FG001|Overall Study|Investigator's Discretion|1|||
161545079|NCT02254408|583386351|FG000|Overall Study|Withdrawal by Subject|3|||
161545080|NCT02254408|583386352|FG001|Overall Study|Withdrawal by Subject|3|||
161545081|NCT02254408|583386351|FG000|Overall Study|Lost to Follow-up|1|||
161545082|NCT02254408|583386352|FG001|Overall Study|Lost to Follow-up|0|||
161545083|NCT00917267|583386353|FG000|Overall Study|Adverse Event|15|||
161545084|NCT00917267|583386354|FG001|Overall Study|Adverse Event|36|||
161545085|NCT00917267|583386353|FG000|Overall Study|Physician Decision|2|||
161545086|NCT00917267|583386354|FG001|Overall Study|Physician Decision|4|||
161545087|NCT00917267|583386353|FG000|Overall Study|Protocol Violation|9|||
161545088|NCT00917267|583386354|FG001|Overall Study|Protocol Violation|18|||
161545089|NCT00917267|583386353|FG000|Overall Study|Withdrawal by Subject|5|||
161545090|NCT00917267|583386354|FG001|Overall Study|Withdrawal by Subject|12|||
161545091|NCT00917267|583386353|FG000|Overall Study|Lost to follow up|0|||
161545092|NCT00917267|583386354|FG001|Overall Study|Lost to follow up|2|||
161545093|NCT00917267|583386353|FG000|Overall Study|Entry Criteria Not Met|1|||
161545094|NCT00917267|583386354|FG001|Overall Study|Entry Criteria Not Met|0|||
161545095|NCT00917267|583386353|FG000|Overall Study|Sponsor Decision|5|||
161545096|NCT00917267|583386354|FG001|Overall Study|Sponsor Decision|5|||
161545097|NCT00917267|583386353|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
161545098|NCT00917267|583386354|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
161545099|NCT01478113|583386357|FG000|Overall Study|Withdrawal by Subject|0|||
161545100|NCT01478113|583386358|FG001|Overall Study|Withdrawal by Subject|1|||
161545101|NCT01478113|583386357|FG000|Overall Study|Physician Decision|1|||
161545102|NCT01478113|583386358|FG001|Overall Study|Physician Decision|0|||
161545103|NCT00289770|583386359|FG000|Year 15|Withdrawal by Subject|1|||
161545104|NCT00423293|583386360|FG000|Overall Study|Ineligible / No protocol treatment|11|||
161545105|NCT02966002|583386367|FG000|Overall Study|Withdrawal by Subject|2|||
161545106|NCT02966002|583386367|FG000|Overall Study|Adverse Event|1|||
161545107|NCT02966002|583386367|FG000|Overall Study|Lost to Follow-up|1|||
161545108|NCT00067990|583386369|FG000|Overall Study|Death|5|||
161545109|NCT00067990|583386370|FG001|Overall Study|Death|7|||
161545110|NCT00067990|583386369|FG000|Overall Study|ESRD, Non IF/TA|1|||
161545111|NCT00067990|583386370|FG001|Overall Study|ESRD, Non IF/TA|3|||
161545112|NCT00067990|583386369|FG000|Overall Study|Withdrawal by Subject|4|||
161545113|NCT00067990|583386370|FG001|Overall Study|Withdrawal by Subject|12|||
161545114|NCT02291432|583386371|FG000|Overall Study|Withdrawal by Subject|2|||
161545115|NCT00519896|583386375|FG000|Overall Study|Protocol Violation|1|||
161545116|NCT00519896|583386375|FG000|Overall Study|Adverse Event|1|||
161545117|NCT03327402|583386376|FG000|Overall Study|Withdrawal by Subject|1|||
161545118|NCT03327402|583386376|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
161545119|NCT01454830|583386379|FG000|Overall Study|Withdrawal by Subject|4|||
161545120|NCT01454830|583386380|FG001|Overall Study|Withdrawal by Subject|4|||
161545121|NCT01454830|583386379|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
161545122|NCT01454830|583386380|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
161545123|NCT01454830|583386379|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
161545124|NCT01454830|583386380|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
161545125|NCT01454830|583386379|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
161545126|NCT01454830|583386380|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
161545127|NCT01454830|583386379|FG000|Overall Study|Withdrawal - no polysomnography|3|||
161545128|NCT01454830|583386380|FG001|Overall Study|Withdrawal - no polysomnography|2|||
161545129|NCT03810313|583386381|FG000|Overall Study|Study terminated by sponsor|164|||
161545130|NCT03810313|583386382|FG001|Overall Study|Study terminated by sponsor|159|||
161545131|NCT03810313|583386381|FG000|Overall Study|Subject decision|10|||
161545132|NCT03810313|583386382|FG001|Overall Study|Subject decision|11|||
161545133|NCT03810313|583386381|FG000|Overall Study|Lost to Follow-up|3|||
161545134|NCT03810313|583386382|FG001|Overall Study|Lost to Follow-up|3|||
161545135|NCT03810313|583386381|FG000|Overall Study|Adverse Event|2|||
161545136|NCT03810313|583386382|FG001|Overall Study|Adverse Event|1|||
161545137|NCT03810313|583386381|FG000|Overall Study|Death|2|||
161545138|NCT03810313|583386382|FG001|Overall Study|Death|1|||
161594419|NCT03544281|583567782|FG019|Main Study Phase|Lost to Follow-up|0|||
161545139|NCT03810313|583386381|FG000|Overall Study|Physician Decision|0|||
161545140|NCT03810313|583386382|FG001|Overall Study|Physician Decision|1|||
161545141|NCT00584805|583386385|FG000|Overall Study|No longer at risk of exposure|39|||
161545142|NCT00584805|583386385|FG000|Overall Study|Relocation|36|||
161545143|NCT00584805|583386385|FG000|Overall Study|Withdrawal by Subject|18|||
161545144|NCT00584805|583386385|FG000|Overall Study|Non-compliance|1|||
161545145|NCT00584805|583386385|FG000|Overall Study|Lost to follow up|3|||
161545146|NCT00584805|583386385|FG000|Overall Study|Screen failures|2|||
161545147|NCT02341456|583386389|FG000|Overall Study|Disease progression|2|||
161545148|NCT02341456|583386390|FG001|Overall Study|Disease progression|3|||
161545149|NCT02341456|583386391|FG002|Overall Study|Disease progression|1|||
161545150|NCT02341456|583386389|FG000|Overall Study|Death|1|||
161545151|NCT02341456|583386390|FG001|Overall Study|Death|1|||
161545152|NCT02341456|583386391|FG002|Overall Study|Death|1|||
161545153|NCT02341456|583386389|FG000|Overall Study|Withdrawal by Subject|0|||
161545154|NCT02341456|583386390|FG001|Overall Study|Withdrawal by Subject|1|||
161545155|NCT02341456|583386391|FG002|Overall Study|Withdrawal by Subject|1|||
161545156|NCT02341456|583386389|FG000|Overall Study|Moved to local access programme.|0|||
161545157|NCT02341456|583386390|FG001|Overall Study|Moved to local access programme.|1|||
161545158|NCT02341456|583386391|FG002|Overall Study|Moved to local access programme.|1|||
161545159|NCT02341456|583386389|FG000|Overall Study|Physician Decision|1|||
161545160|NCT02341456|583386390|FG001|Overall Study|Physician Decision|0|||
161545161|NCT02341456|583386391|FG002|Overall Study|Physician Decision|0|||
161545162|NCT01077362|583386392|FG000|Overall Study|Lack of Efficacy|13|||
161545163|NCT01077362|583386393|FG001|Overall Study|Lack of Efficacy|8|||
161545164|NCT01077362|583386394|FG002|Overall Study|Lack of Efficacy|10|||
161545165|NCT01077362|583386392|FG000|Overall Study|Lost to Follow-up|1|||
161545166|NCT01077362|583386393|FG001|Overall Study|Lost to Follow-up|0|||
161545167|NCT01077362|583386394|FG002|Overall Study|Lost to Follow-up|3|||
161545168|NCT01077362|583386392|FG000|Overall Study|Adverse Event|12|||
161545169|NCT01077362|583386393|FG001|Overall Study|Adverse Event|7|||
161545170|NCT01077362|583386394|FG002|Overall Study|Adverse Event|4|||
161545171|NCT01077362|583386392|FG000|Overall Study|Withdrawal by Subject|5|||
161594420|NCT03544281|583567783|FG020|Main Study Phase|Lost to Follow-up|0|||
161594421|NCT03544281|583567784|FG021|Main Study Phase|Lost to Follow-up|0|||
161594422|NCT03544281|583567763|FG000|Main Study Phase|Physician Decision|0|||
161594423|NCT03544281|583567764|FG001|Main Study Phase|Physician Decision|0|||
161594424|NCT03544281|583567765|FG002|Main Study Phase|Physician Decision|0|||
161594425|NCT03544281|583567766|FG003|Main Study Phase|Physician Decision|0|||
161594426|NCT03544281|583567767|FG004|Main Study Phase|Physician Decision|0|||
161594427|NCT03544281|583567768|FG005|Main Study Phase|Physician Decision|0|||
161594428|NCT03544281|583567769|FG006|Main Study Phase|Physician Decision|0|||
161594429|NCT03544281|583567770|FG007|Main Study Phase|Physician Decision|1|||
161594430|NCT03544281|583567771|FG008|Main Study Phase|Physician Decision|0|||
161594431|NCT03544281|583567772|FG009|Main Study Phase|Physician Decision|0|||
161594432|NCT03544281|583567773|FG010|Main Study Phase|Physician Decision|0|||
161594433|NCT03544281|583567774|FG011|Main Study Phase|Physician Decision|0|||
161594434|NCT03544281|583567775|FG012|Main Study Phase|Physician Decision|0|||
161594435|NCT03544281|583567776|FG013|Main Study Phase|Physician Decision|0|||
161545172|NCT01077362|583386393|FG001|Overall Study|Withdrawal by Subject|3|||
161545173|NCT01077362|583386394|FG002|Overall Study|Withdrawal by Subject|5|||
161545174|NCT01077362|583386392|FG000|Overall Study|Other|0|||
161594436|NCT03544281|583567777|FG014|Main Study Phase|Physician Decision|0|||
161594437|NCT03544281|583567778|FG015|Main Study Phase|Physician Decision|0|||
161594438|NCT03544281|583567779|FG016|Main Study Phase|Physician Decision|0|||
161594439|NCT03544281|583567780|FG017|Main Study Phase|Physician Decision|0|||
161594440|NCT03544281|583567781|FG018|Main Study Phase|Physician Decision|0|||
161594441|NCT03544281|583567782|FG019|Main Study Phase|Physician Decision|0|||
161594442|NCT03544281|583567783|FG020|Main Study Phase|Physician Decision|0|||
161594443|NCT03544281|583567784|FG021|Main Study Phase|Physician Decision|0|||
161594444|NCT03544281|583567763|FG000|Main Study Phase|Withdrawal by Subject|2|||
161594445|NCT03544281|583567764|FG001|Main Study Phase|Withdrawal by Subject|0|||
161594446|NCT03544281|583567765|FG002|Main Study Phase|Withdrawal by Subject|1|||
161680446|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
161680447|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
161680448|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
161680449|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
161680450|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
161680451|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
161545175|NCT01077362|583386393|FG001|Overall Study|Other|1|||
161594447|NCT03544281|583567766|FG003|Main Study Phase|Withdrawal by Subject|2|||
161594448|NCT03544281|583567767|FG004|Main Study Phase|Withdrawal by Subject|0|||
161594449|NCT03544281|583567768|FG005|Main Study Phase|Withdrawal by Subject|0|||
161594450|NCT03544281|583567769|FG006|Main Study Phase|Withdrawal by Subject|0|||
161594451|NCT03544281|583567770|FG007|Main Study Phase|Withdrawal by Subject|0|||
161545176|NCT01077362|583386394|FG002|Overall Study|Other|2|||
161545177|NCT00301080|583386401|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
161545178|NCT00301080|583386402|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
161545179|NCT00301080|583386403|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
161545180|NCT00301080|583386404|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
161545181|NCT00301080|583386405|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
161545182|NCT01287520|583386408|FG000|Overall Study|Adverse Event|2|||
161545183|NCT01287520|583386409|FG001|Overall Study|Adverse Event|2|||
161545184|NCT01287520|583386410|FG002|Overall Study|Adverse Event|2|||
161545185|NCT01287520|583386411|FG003|Overall Study|Adverse Event|1|||
161545186|NCT01287520|583386412|FG004|Overall Study|Adverse Event|1|||
161545187|NCT01287520|583386413|FG005|Overall Study|Adverse Event|2|||
161545188|NCT01287520|583386414|FG006|Overall Study|Adverse Event|0|||
161545189|NCT01287520|583386415|FG007|Overall Study|Adverse Event|2|||
161545190|NCT01287520|583386416|FG008|Overall Study|Adverse Event|0|||
161545191|NCT01287520|583386408|FG000|Overall Study|Physician Decision|1|||
161594452|NCT03544281|583567771|FG008|Main Study Phase|Withdrawal by Subject|2|||
161594453|NCT03544281|583567772|FG009|Main Study Phase|Withdrawal by Subject|3|||
161830032|NCT01040793|584418094|FG000|Overall Study|Other reasons not listed above|0|||
161545192|NCT01287520|583386409|FG001|Overall Study|Physician Decision|1|||
161594454|NCT03544281|583567773|FG010|Main Study Phase|Withdrawal by Subject|0|||
161594455|NCT03544281|583567774|FG011|Main Study Phase|Withdrawal by Subject|4|||
161594456|NCT03544281|583567775|FG012|Main Study Phase|Withdrawal by Subject|0|||
161594457|NCT03544281|583567776|FG013|Main Study Phase|Withdrawal by Subject|0|||
161594458|NCT03544281|583567777|FG014|Main Study Phase|Withdrawal by Subject|0|||
161594459|NCT03544281|583567778|FG015|Main Study Phase|Withdrawal by Subject|0|||
161594460|NCT03544281|583567779|FG016|Main Study Phase|Withdrawal by Subject|0|||
161594461|NCT03544281|583567780|FG017|Main Study Phase|Withdrawal by Subject|0|||
161594462|NCT03544281|583567781|FG018|Main Study Phase|Withdrawal by Subject|0|||
161594463|NCT03544281|583567782|FG019|Main Study Phase|Withdrawal by Subject|0|||
161594464|NCT03544281|583567783|FG020|Main Study Phase|Withdrawal by Subject|0|||
161594465|NCT03544281|583567784|FG021|Main Study Phase|Withdrawal by Subject|0|||
161594466|NCT03544281|583567763|FG000|Main Study Phase|Ongoing|3|||
161594467|NCT03544281|583567764|FG001|Main Study Phase|Ongoing|1|||
161594468|NCT03544281|583567765|FG002|Main Study Phase|Ongoing|2|||
161594469|NCT03544281|583567766|FG003|Main Study Phase|Ongoing|4|||
161594470|NCT03544281|583567767|FG004|Main Study Phase|Ongoing|2|||
161594471|NCT03544281|583567768|FG005|Main Study Phase|Ongoing|4|||
161594472|NCT03544281|583567769|FG006|Main Study Phase|Ongoing|4|||
161594473|NCT03544281|583567770|FG007|Main Study Phase|Ongoing|0|||
161594474|NCT03544281|583567771|FG008|Main Study Phase|Ongoing|2|||
161594475|NCT03544281|583567772|FG009|Main Study Phase|Ongoing|2|||
161594476|NCT03544281|583567773|FG010|Main Study Phase|Ongoing|1|||
161594477|NCT03544281|583567774|FG011|Main Study Phase|Ongoing|0|||
161594478|NCT03544281|583567775|FG012|Main Study Phase|Ongoing|0|||
161594479|NCT03544281|583567776|FG013|Main Study Phase|Ongoing|0|||
161594480|NCT03544281|583567777|FG014|Main Study Phase|Ongoing|0|||
161594481|NCT03544281|583567778|FG015|Main Study Phase|Ongoing|0|||
161594482|NCT03544281|583567779|FG016|Main Study Phase|Ongoing|0|||
161594483|NCT03544281|583567780|FG017|Main Study Phase|Ongoing|0|||
161594484|NCT03544281|583567781|FG018|Main Study Phase|Ongoing|0|||
161594485|NCT03544281|583567782|FG019|Main Study Phase|Ongoing|0|||
161594486|NCT03544281|583567783|FG020|Main Study Phase|Ongoing|0|||
161594487|NCT03544281|583567784|FG021|Main Study Phase|Ongoing|0|||
161594488|NCT03544281|583567763|FG000|Main Study Phase|Investigator Site Closed|0|||
161594489|NCT03544281|583567764|FG001|Main Study Phase|Investigator Site Closed|0|||
161594490|NCT03544281|583567765|FG002|Main Study Phase|Investigator Site Closed|0|||
161594491|NCT03544281|583567766|FG003|Main Study Phase|Investigator Site Closed|0|||
161594492|NCT03544281|583567767|FG004|Main Study Phase|Investigator Site Closed|0|||
161594493|NCT03544281|583567768|FG005|Main Study Phase|Investigator Site Closed|0|||
161594494|NCT03544281|583567769|FG006|Main Study Phase|Investigator Site Closed|0|||
161594495|NCT03544281|583567770|FG007|Main Study Phase|Investigator Site Closed|0|||
161594496|NCT03544281|583567771|FG008|Main Study Phase|Investigator Site Closed|0|||
161594497|NCT03544281|583567772|FG009|Main Study Phase|Investigator Site Closed|1|||
161594498|NCT03544281|583567773|FG010|Main Study Phase|Investigator Site Closed|0|||
161594499|NCT03544281|583567774|FG011|Main Study Phase|Investigator Site Closed|0|||
161594500|NCT03544281|583567775|FG012|Main Study Phase|Investigator Site Closed|0|||
161594501|NCT03544281|583567776|FG013|Main Study Phase|Investigator Site Closed|0|||
161830033|NCT01040793|584418095|FG001|Overall Study|Other reasons not listed above|0|||
161830034|NCT01040793|584418096|FG002|Overall Study|Other reasons not listed above|1|||
161545193|NCT01287520|583386410|FG002|Overall Study|Physician Decision|2|||
161594502|NCT03544281|583567777|FG014|Main Study Phase|Investigator Site Closed|0|||
161594503|NCT03544281|583567778|FG015|Main Study Phase|Investigator Site Closed|0|||
161594504|NCT03544281|583567779|FG016|Main Study Phase|Investigator Site Closed|0|||
161594505|NCT03544281|583567780|FG017|Main Study Phase|Investigator Site Closed|0|||
161594506|NCT03544281|583567781|FG018|Main Study Phase|Investigator Site Closed|0|||
161545194|NCT01287520|583386411|FG003|Overall Study|Physician Decision|0|||
161545195|NCT01287520|583386412|FG004|Overall Study|Physician Decision|1|||
161594507|NCT03544281|583567782|FG019|Main Study Phase|Investigator Site Closed|0|||
161594508|NCT03544281|583567783|FG020|Main Study Phase|Investigator Site Closed|0|||
161594509|NCT03544281|583567784|FG021|Main Study Phase|Investigator Site Closed|0|||
161545196|NCT01287520|583386413|FG005|Overall Study|Physician Decision|1|||
161545197|NCT01287520|583386414|FG006|Overall Study|Physician Decision|0|||
161545198|NCT01287520|583386415|FG007|Overall Study|Physician Decision|1|||
161545199|NCT01287520|583386416|FG008|Overall Study|Physician Decision|0|||
161545200|NCT01287520|583386408|FG000|Overall Study|Progressive disease|0|||
161545201|NCT01287520|583386409|FG001|Overall Study|Progressive disease|4|||
161545202|NCT01287520|583386410|FG002|Overall Study|Progressive disease|1|||
161545203|NCT01287520|583386411|FG003|Overall Study|Progressive disease|6|||
161545204|NCT01287520|583386412|FG004|Overall Study|Progressive disease|1|||
161545205|NCT01287520|583386413|FG005|Overall Study|Progressive disease|0|||
161545206|NCT01287520|583386414|FG006|Overall Study|Progressive disease|2|||
161545207|NCT01287520|583386415|FG007|Overall Study|Progressive disease|2|||
161545208|NCT01287520|583386416|FG008|Overall Study|Progressive disease|4|||
161545209|NCT01287520|583386408|FG000|Overall Study|Withdrawal by Subject|0|||
161545210|NCT01287520|583386409|FG001|Overall Study|Withdrawal by Subject|0|||
161545211|NCT01287520|583386410|FG002|Overall Study|Withdrawal by Subject|0|||
161545212|NCT01287520|583386411|FG003|Overall Study|Withdrawal by Subject|0|||
161545213|NCT01287520|583386412|FG004|Overall Study|Withdrawal by Subject|0|||
161545214|NCT01287520|583386413|FG005|Overall Study|Withdrawal by Subject|1|||
161545215|NCT01287520|583386414|FG006|Overall Study|Withdrawal by Subject|0|||
161545216|NCT01287520|583386415|FG007|Overall Study|Withdrawal by Subject|0|||
161545217|NCT01287520|583386416|FG008|Overall Study|Withdrawal by Subject|1|||
161545218|NCT03587142|583386417|FG000|Overall Study|Lost to Follow-up|5|||
161545219|NCT03587142|583386418|FG001|Overall Study|Lost to Follow-up|3|||
161545220|NCT03587142|583386417|FG000|Overall Study|Did not complete the f4 visit|3|||
161545221|NCT03587142|583386418|FG001|Overall Study|Did not complete the f4 visit|7|||
161545222|NCT02768662|583386419|FG000|Overall Study|Adverse Event|1|||
161545223|NCT02768662|583386419|FG000|Overall Study|Lost to Follow-up|4|||
161545224|NCT02768662|583386419|FG000|Overall Study|Withdrawal by Subject|3|||
161545225|NCT02768662|583386419|FG000|Overall Study|Study terminated by Sponsor|78|||
161545226|NCT03673462|583386420|FG000|Overall Study|Adverse Event|11|||
161545227|NCT03673462|583386421|FG001|Overall Study|Adverse Event|1|||
161545228|NCT03673462|583386420|FG000|Overall Study|Protocol Violation|25|||
161545229|NCT03673462|583386421|FG001|Overall Study|Protocol Violation|11|||
161545230|NCT03673462|583386420|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
161545231|NCT03673462|583386421|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
161545232|NCT03673462|583386420|FG000|Overall Study|Lost to Follow-up|102|||
161545233|NCT03673462|583386421|FG001|Overall Study|Lost to Follow-up|19|||
161545234|NCT02567825|583386426|FG000|Overall Study|No follow-up post-randomization|5|||
161545235|NCT02567825|583386427|FG001|Overall Study|No follow-up post-randomization|1|||
161545236|NCT02567825|583386426|FG000|Overall Study|Follow-up less than 23 months|16|||
161545237|NCT02567825|583386427|FG001|Overall Study|Follow-up less than 23 months|20|||
161545238|NCT03097861|583386435|FG000|Overall Study|Adverse Event|3|||
161545239|NCT03097861|583386436|FG001|Overall Study|Adverse Event|8|||
161545240|NCT03097861|583386437|FG002|Overall Study|Adverse Event|4|||
161545241|NCT03097861|583386435|FG000|Overall Study|Investigator Decision|0|||
161545242|NCT03097861|583386436|FG001|Overall Study|Investigator Decision|1|||
161545243|NCT03097861|583386437|FG002|Overall Study|Investigator Decision|0|||
161545244|NCT03097861|583386435|FG000|Overall Study|Lost to Follow-up|0|||
161545245|NCT03097861|583386436|FG001|Overall Study|Lost to Follow-up|7|||
161545246|NCT03097861|583386437|FG002|Overall Study|Lost to Follow-up|1|||
161594510|NCT03544281|583567763|FG000|Main Study Phase|Did not receive study treatment|0|||
161594511|NCT03544281|583567764|FG001|Main Study Phase|Did not receive study treatment|0|||
161594512|NCT03544281|583567765|FG002|Main Study Phase|Did not receive study treatment|0|||
161594513|NCT03544281|583567766|FG003|Main Study Phase|Did not receive study treatment|0|||
161594514|NCT03544281|583567767|FG004|Main Study Phase|Did not receive study treatment|0|||
161594515|NCT03544281|583567768|FG005|Main Study Phase|Did not receive study treatment|0|||
161594516|NCT03544281|583567769|FG006|Main Study Phase|Did not receive study treatment|1|||
161680452|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
161545247|NCT03097861|583386435|FG000|Overall Study|Withdrawal by Subject|1|||
161545248|NCT03097861|583386436|FG001|Overall Study|Withdrawal by Subject|5|||
161545249|NCT03097861|583386437|FG002|Overall Study|Withdrawal by Subject|3|||
161545250|NCT03097861|583386435|FG000|Overall Study|Reason not provided|3|||
161545251|NCT03097861|583386436|FG001|Overall Study|Reason not provided|1|||
161545252|NCT03097861|583386437|FG002|Overall Study|Reason not provided|1|||
161545253|NCT05061537|583386440|FG000|Treatment Phase|Progressive disease|0|||
161594517|NCT03544281|583567770|FG007|Main Study Phase|Did not receive study treatment|0|||
161545254|NCT05061537|583386441|FG001|Treatment Phase|Progressive disease|1|||
161545255|NCT05061537|583386442|FG002|Treatment Phase|Progressive disease|2|||
161545256|NCT05061537|583386443|FG003|Treatment Phase|Progressive disease|0|||
161545257|NCT05061537|583386444|FG004|Treatment Phase|Progressive disease|0|||
161545258|NCT05061537|583386440|FG000|Treatment Phase|Adverse Event|0|||
161545259|NCT05061537|583386441|FG001|Treatment Phase|Adverse Event|0|||
161545260|NCT05061537|583386442|FG002|Treatment Phase|Adverse Event|2|||
161545261|NCT05061537|583386443|FG003|Treatment Phase|Adverse Event|0|||
161545262|NCT05061537|583386444|FG004|Treatment Phase|Adverse Event|0|||
161545263|NCT05061537|583386440|FG000|Treatment Phase|Global deterioration of health status|0|||
161545264|NCT05061537|583386441|FG001|Treatment Phase|Global deterioration of health status|1|||
161545265|NCT05061537|583386442|FG002|Treatment Phase|Global deterioration of health status|0|||
161545266|NCT05061537|583386443|FG003|Treatment Phase|Global deterioration of health status|0|||
161545267|NCT05061537|583386444|FG004|Treatment Phase|Global deterioration of health status|0|||
161545268|NCT05061537|583386440|FG000|Follow up|Other|2|||
161545269|NCT05061537|583386441|FG001|Follow up|Other|0|||
161545270|NCT05061537|583386442|FG002|Follow up|Other|2|||
161545271|NCT05061537|583386443|FG003|Follow up|Other|0|||
161545272|NCT05061537|583386444|FG004|Follow up|Other|0|||
161545273|NCT05061537|583386440|FG000|Follow up|Study terminated by sponsor|0|||
161545274|NCT05061537|583386441|FG001|Follow up|Study terminated by sponsor|0|||
161545275|NCT05061537|583386442|FG002|Follow up|Study terminated by sponsor|2|||
161545276|NCT05061537|583386443|FG003|Follow up|Study terminated by sponsor|0|||
161545277|NCT05061537|583386444|FG004|Follow up|Study terminated by sponsor|0|||
161545278|NCT05061537|583386440|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
161545279|NCT05061537|583386441|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
161545280|NCT05061537|583386442|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
161545281|NCT05061537|583386443|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
161545282|NCT05061537|583386444|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
161545283|NCT05061537|583386440|FG000|Long-term Follow-up|Death|0|||
161545284|NCT05061537|583386441|FG001|Long-term Follow-up|Death|1|||
161545285|NCT05061537|583386442|FG002|Long-term Follow-up|Death|0|||
161545286|NCT05061537|583386443|FG003|Long-term Follow-up|Death|0|||
161545287|NCT05061537|583386444|FG004|Long-term Follow-up|Death|0|||
161545288|NCT03502616|583386446|FG000|Up to Week 16|Withdrawal by Subject|1|||
161545289|NCT03502616|583386447|FG001|Up to Week 16|Withdrawal by Subject|2|||
161545290|NCT03502616|583386446|FG000|Up to Week 16|Lost to Follow-up|0|||
161545291|NCT03502616|583386447|FG001|Up to Week 16|Lost to Follow-up|1|||
161545292|NCT03502616|583386446|FG000|Up to Week 16|Randomized, but not treated|1|||
161545293|NCT03502616|583386447|FG001|Up to Week 16|Randomized, but not treated|0|||
161545294|NCT03502616|583386446|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
161545295|NCT03502616|583386447|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
161545296|NCT03502616|583386446|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
161545297|NCT03502616|583386447|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
161545298|NCT04503096|583386448|FG000|Overall Study|Withdrawal by Subject|3|||
161545299|NCT01785563|583386449|FG000|Overall Study|Physician Decision|10|||
161545300|NCT01785563|583386449|FG000|Overall Study|Withdrawal by Subject|1|||
161545301|NCT01785563|583386449|FG000|Overall Study|Protocol Violation|2|||
161545302|NCT01872910|583386451|FG000|Overall Study|Lost to Follow-up|2|||
161545303|NCT01872910|583386452|FG001|Overall Study|Lost to Follow-up|0|||
161545304|NCT01872910|583386453|FG002|Overall Study|Lost to Follow-up|2|||
161545305|NCT01872910|583386454|FG003|Overall Study|Lost to Follow-up|0|||
161545306|NCT01872910|583386455|FG004|Overall Study|Lost to Follow-up|0|||
161545307|NCT01872910|583386456|FG005|Overall Study|Lost to Follow-up|0|||
161545308|NCT00744328|583386459|FG000|Overall Study|Lost to Follow-up|2|||
161545309|NCT00744328|583386460|FG001|Overall Study|Lost to Follow-up|5|||
161545310|NCT00744328|583386461|FG002|Overall Study|Lost to Follow-up|3|||
161545311|NCT00744328|583386459|FG000|Overall Study|Withdrawal by Subject|5|||
161545312|NCT00744328|583386460|FG001|Overall Study|Withdrawal by Subject|3|||
161545313|NCT00744328|583386461|FG002|Overall Study|Withdrawal by Subject|4|||
161830035|NCT01040793|584418097|FG003|Overall Study|Other reasons not listed above|0|||
161830036|NCT01040793|584418098|FG004|Overall Study|Other reasons not listed above|1|||
161830037|NCT01040793|584418099|FG005|Overall Study|Other reasons not listed above|0|||
161830038|NCT02412722|584418104|FG000|Overall Study|Adverse Event|0|||
161830039|NCT02412722|584418105|FG001|Overall Study|Adverse Event|2|||
161830040|NCT02412722|584418106|FG002|Overall Study|Adverse Event|0|||
161545314|NCT00744328|583386459|FG000|Overall Study|Found ineligible after randomization|0|||
161830041|NCT02412722|584418107|FG003|Overall Study|Adverse Event|3|||
161545315|NCT00744328|583386460|FG001|Overall Study|Found ineligible after randomization|0|||
161545316|NCT00744328|583386461|FG002|Overall Study|Found ineligible after randomization|1|||
161545317|NCT01576367|583386462|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161545318|NCT01576367|583386462|FG000|Overall Study|Moved to commercial use after 6 months|1|||
161545319|NCT02387216|583386466|FG000|Overall Study|Progressive disease|2|||
161545320|NCT02387216|583386467|FG001|Overall Study|Progressive disease|0|||
161545321|NCT02387216|583386466|FG000|Overall Study|Withdrawal by Subject|3|||
161545322|NCT02387216|583386467|FG001|Overall Study|Withdrawal by Subject|5|||
161545323|NCT02387216|583386466|FG000|Overall Study|Physician Decision|2|||
161545324|NCT02387216|583386467|FG001|Overall Study|Physician Decision|0|||
161545325|NCT02387216|583386466|FG000|Overall Study|Sponsor Decision|28|||
161545326|NCT02387216|583386467|FG001|Overall Study|Sponsor Decision|12|||
161545327|NCT02387216|583386466|FG000|Overall Study|Death|60|||
161545328|NCT02387216|583386467|FG001|Overall Study|Death|23|||
161545329|NCT02387216|583386466|FG000|Overall Study|Other|5|||
161545330|NCT02387216|583386467|FG001|Overall Study|Other|4|||
161545331|NCT02387216|583386466|FG000|Overall Study|Lost to Follow-up|0|||
161545332|NCT02387216|583386467|FG001|Overall Study|Lost to Follow-up|3|||
161545333|NCT02091739|583386468|FG000|MP: 16 Weeks|Adverse Event|1|||
161545334|NCT02091739|583386469|FG001|MP: 16 Weeks|Adverse Event|1|||
161545335|NCT02091739|583386470|FG002|MP: 16 Weeks|Adverse Event|1|||
161545336|NCT02091739|583386471|FG003|MP: 16 Weeks|Adverse Event|0|||
161545337|NCT02091739|583386472|FG004|MP: 16 Weeks|Adverse Event|0|||
161545338|NCT02091739|583386468|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
161545339|NCT02091739|583386469|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
161545340|NCT02091739|583386470|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
161545341|NCT02091739|583386471|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
161545342|NCT02091739|583386472|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
161545343|NCT02091739|583386468|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
161545344|NCT02091739|583386469|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
161545345|NCT02091739|583386470|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
161545346|NCT02091739|583386471|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
161545347|NCT02091739|583386472|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
161545348|NCT02091739|583386468|FG000|EP: 48 Weeks|Other|0|||
161545349|NCT02091739|583386469|FG001|EP: 48 Weeks|Other|0|||
161545350|NCT02091739|583386470|FG002|EP: 48 Weeks|Other|0|||
161545351|NCT02091739|583386471|FG003|EP: 48 Weeks|Other|1|||
161545352|NCT02091739|583386472|FG004|EP: 48 Weeks|Other|0|||
161545353|NCT02091739|583386468|FG000|EP: 48 Weeks|Death|0|||
161545354|NCT02091739|583386469|FG001|EP: 48 Weeks|Death|0|||
161545355|NCT02091739|583386470|FG002|EP: 48 Weeks|Death|0|||
161545356|NCT02091739|583386471|FG003|EP: 48 Weeks|Death|3|||
161545357|NCT02091739|583386472|FG004|EP: 48 Weeks|Death|2|||
161545358|NCT02091739|583386468|FG000|EP: 48 Weeks|Adverse Event|0|||
161545359|NCT02091739|583386469|FG001|EP: 48 Weeks|Adverse Event|0|||
161545360|NCT02091739|583386470|FG002|EP: 48 Weeks|Adverse Event|0|||
161545361|NCT02091739|583386471|FG003|EP: 48 Weeks|Adverse Event|2|||
161545362|NCT02091739|583386472|FG004|EP: 48 Weeks|Adverse Event|6|||
161545363|NCT02091739|583386468|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
161545364|NCT02091739|583386469|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
161545365|NCT02091739|583386470|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
161545366|NCT02091739|583386471|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
161545367|NCT02091739|583386472|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
161545368|NCT03528174|583386473|FG000|Overall Study|Adverse Event|1|||
161545369|NCT03528174|583386473|FG000|Overall Study|sensors dislodged|1|||
161545370|NCT04251065|583386474|FG000|Overall Study|Death|2|||
161545371|NCT04251065|583386474|FG000|Overall Study|Lack of Efficacy|3|||
161545372|NCT04251065|583386474|FG000|Overall Study|Death|1|||
161545373|NCT01436201|583386475|FG000|Overall Study|Adverse Event|2|||
161545374|NCT01436201|583386475|FG000|Overall Study|Withdrawal by Subject|1|||
161545375|NCT01436201|583386475|FG000|Overall Study|Protocol Violation|1|||
161545376|NCT00110890|583386476|FG000|Overall Study|Adverse Event|30|||
161545377|NCT00110890|583386477|FG001|Overall Study|Adverse Event|7|||
161545378|NCT00110890|583386476|FG000|Overall Study|Death|16|||
161545379|NCT00110890|583386477|FG001|Overall Study|Death|9|||
161545380|NCT00110890|583386476|FG000|Overall Study|Lost to Follow-up|3|||
161545381|NCT00110890|583386477|FG001|Overall Study|Lost to Follow-up|1|||
161545382|NCT00110890|583386476|FG000|Overall Study|Physician Decision|4|||
161594518|NCT03544281|583567771|FG008|Main Study Phase|Did not receive study treatment|0|||
161545383|NCT00110890|583386477|FG001|Overall Study|Physician Decision|5|||
161545384|NCT00110890|583386476|FG000|Overall Study|Withdrawal by Subject|17|||
161545385|NCT00110890|583386477|FG001|Overall Study|Withdrawal by Subject|5|||
161545386|NCT00110890|583386476|FG000|Overall Study|Protocol Deviation|1|||
161545387|NCT00110890|583386477|FG001|Overall Study|Protocol Deviation|0|||
161545388|NCT00110890|583386476|FG000|Overall Study|Noncompliance|10|||
161545389|NCT00110890|583386477|FG001|Overall Study|Noncompliance|0|||
161545390|NCT00110890|583386476|FG000|Overall Study|Kidney Transplant|16|||
161545391|NCT00110890|583386477|FG001|Overall Study|Kidney Transplant|12|||
161545392|NCT00110890|583386476|FG000|Overall Study|Invest. Product Commercially Available|217|||
161545393|NCT00110890|583386477|FG001|Overall Study|Invest. Product Commercially Available|110|||
161545394|NCT00110890|583386476|FG000|Overall Study|Other|34|||
161545395|NCT00110890|583386477|FG001|Overall Study|Other|23|||
161545396|NCT00110890|583386476|FG000|Overall Study|Ineligibility determined|3|||
161680453|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
161680454|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
161545397|NCT00110890|583386477|FG001|Overall Study|Ineligibility determined|0|||
161545398|NCT00110890|583386476|FG000|Overall Study|Requirement for alternative therapy|0|||
161545399|NCT00110890|583386477|FG001|Overall Study|Requirement for alternative therapy|1|||
161545400|NCT00110890|583386476|FG000|Overall Study|Disease progression|0|||
161545401|NCT00110890|583386477|FG001|Overall Study|Disease progression|1|||
161545402|NCT00110890|583386476|FG000|Overall Study|Parathyroidectomy|0|||
161545403|NCT00110890|583386477|FG001|Overall Study|Parathyroidectomy|1|||
161545404|NCT00110890|583386476|FG000|Overall Study|Did not enter follow-up phase|10|||
161545405|NCT00110890|583386477|FG001|Overall Study|Did not enter follow-up phase|4|||
161545406|NCT01686581|583386478|FG000|Overall Study|Side-effects or Health Problems|15|||
161545407|NCT01686581|583386478|FG000|Overall Study|Lack of Efficacy|90|||
161545408|NCT01686581|583386478|FG000|Overall Study|Participant Concerned about Risks|6|||
161545409|NCT01686581|583386478|FG000|Overall Study|Thinks Injections Too Painful|8|||
161545410|NCT01686581|583386478|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
161545411|NCT01686581|583386478|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
161545412|NCT01686581|583386478|FG000|Overall Study|Thinks it is Inconvenient|17|||
161545413|NCT01686581|583386478|FG000|Overall Study|Other Miscellaneous Reasons|36|||
161545414|NCT01686581|583386478|FG000|Overall Study|Reason Missing|1|||
161545415|NCT01975220|583386479|FG000|Test Period 1|Not treated|0|||
161545416|NCT01975220|583386480|FG001|Test Period 1|Not treated|1|||
161545417|NCT01975220|583386481|FG002|Test Period 1|Not treated|0|||
161545418|NCT01975220|583386482|FG003|Test Period 1|Not treated|0|||
161545419|NCT01975220|583386483|FG004|Test Period 1|Not treated|0|||
161545420|NCT01975220|583386484|FG005|Test Period 1|Not treated|0|||
161545421|NCT00263328|583386488|FG000|Overall Study|Death|0|||
161545422|NCT00263328|583386489|FG001|Overall Study|Death|0|||
161545423|NCT00263328|583386490|FG002|Overall Study|Death|1|||
161545424|NCT00263328|583386488|FG000|Overall Study|Lost to Follow-up|1|||
161545425|NCT00263328|583386489|FG001|Overall Study|Lost to Follow-up|1|||
161545426|NCT00263328|583386490|FG002|Overall Study|Lost to Follow-up|0|||
161545427|NCT00263328|583386488|FG000|Overall Study|Withdrawal by Subject|3|||
161545428|NCT00263328|583386489|FG001|Overall Study|Withdrawal by Subject|0|||
161545429|NCT00263328|583386490|FG002|Overall Study|Withdrawal by Subject|1|||
161545430|NCT00263328|583386488|FG000|Overall Study|Other|3|||
161545431|NCT00263328|583386489|FG001|Overall Study|Other|0|||
161594519|NCT03544281|583567772|FG009|Main Study Phase|Did not receive study treatment|0|||
161594520|NCT03544281|583567773|FG010|Main Study Phase|Did not receive study treatment|0|||
161594521|NCT03544281|583567774|FG011|Main Study Phase|Did not receive study treatment|0|||
161594522|NCT03544281|583567775|FG012|Main Study Phase|Did not receive study treatment|0|||
161594523|NCT03544281|583567776|FG013|Main Study Phase|Did not receive study treatment|0|||
161594524|NCT03544281|583567777|FG014|Main Study Phase|Did not receive study treatment|0|||
161594525|NCT03544281|583567778|FG015|Main Study Phase|Did not receive study treatment|0|||
161594526|NCT03544281|583567779|FG016|Main Study Phase|Did not receive study treatment|0|||
161594527|NCT03544281|583567780|FG017|Main Study Phase|Did not receive study treatment|0|||
161594528|NCT03544281|583567781|FG018|Main Study Phase|Did not receive study treatment|0|||
161594529|NCT03544281|583567782|FG019|Main Study Phase|Did not receive study treatment|0|||
161594530|NCT03544281|583567783|FG020|Main Study Phase|Did not receive study treatment|0|||
161594531|NCT03544281|583567784|FG021|Main Study Phase|Did not receive study treatment|0|||
161594532|NCT03544281|583567763|FG000|PACT Phase|Adverse Event|0|||
161594533|NCT03544281|583567764|FG001|PACT Phase|Adverse Event|0|||
161594534|NCT03544281|583567765|FG002|PACT Phase|Adverse Event|0|||
161594535|NCT03544281|583567766|FG003|PACT Phase|Adverse Event|0|||
161830042|NCT02412722|584418108|FG004|Overall Study|Adverse Event|0|||
161545432|NCT00263328|583386490|FG002|Overall Study|Other|1|||
161545433|NCT00263328|583386488|FG000|Overall Study|Adverse Event|1|||
161594536|NCT03544281|583567767|FG004|PACT Phase|Adverse Event|0|||
161594537|NCT03544281|583567768|FG005|PACT Phase|Adverse Event|0|||
161830043|NCT02412722|584418109|FG005|Overall Study|Adverse Event|3|||
161830044|NCT02412722|584418104|FG000|Overall Study|Progressive Disease|6|||
161545434|NCT00263328|583386489|FG001|Overall Study|Adverse Event|1|||
161545435|NCT00263328|583386490|FG002|Overall Study|Adverse Event|4|||
161545436|NCT01008475|583386494|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
161545437|NCT01008475|583386495|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
161545438|NCT01008475|583386496|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
161545439|NCT01008475|583386497|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
161594538|NCT03544281|583567769|FG006|PACT Phase|Adverse Event|0|||
161594539|NCT03544281|583567770|FG007|PACT Phase|Adverse Event|0|||
161594540|NCT03544281|583567771|FG008|PACT Phase|Adverse Event|0|||
161545440|NCT01008475|583386498|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
161545441|NCT01008475|583386499|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
161545442|NCT01008475|583386500|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
161545443|NCT01301274|583386501|FG000|Overall Study|Physician Decision|2|||
161545444|NCT01301274|583386502|FG001|Overall Study|Physician Decision|1|||
161545445|NCT00661661|583386503|FG000|Overall Study|Adverse Event|99|||
161545446|NCT00661661|583386504|FG001|Overall Study|Adverse Event|24|||
161545447|NCT00661661|583386503|FG000|Overall Study|Lack of Efficacy|3|||
161594541|NCT03544281|583567772|FG009|PACT Phase|Adverse Event|0|||
161594542|NCT03544281|583567773|FG010|PACT Phase|Adverse Event|0|||
161594543|NCT03544281|583567774|FG011|PACT Phase|Adverse Event|0|||
161594544|NCT03544281|583567775|FG012|PACT Phase|Adverse Event|1|||
161594545|NCT03544281|583567776|FG013|PACT Phase|Adverse Event|0|||
161594546|NCT03544281|583567777|FG014|PACT Phase|Adverse Event|0|||
161594547|NCT03544281|583567778|FG015|PACT Phase|Adverse Event|0|||
161594548|NCT03544281|583567779|FG016|PACT Phase|Adverse Event|0|||
161545448|NCT00661661|583386504|FG001|Overall Study|Lack of Efficacy|2|||
161545449|NCT00661661|583386503|FG000|Overall Study|Lost to Follow-up|0|||
161545450|NCT00661661|583386504|FG001|Overall Study|Lost to Follow-up|1|||
161545451|NCT00661661|583386503|FG000|Overall Study|Withdrawal by Subject|15|||
161545452|NCT00661661|583386504|FG001|Overall Study|Withdrawal by Subject|5|||
161545453|NCT00661661|583386503|FG000|Overall Study|Other|22|||
161545454|NCT00661661|583386504|FG001|Overall Study|Other|7|||
161594549|NCT03544281|583567780|FG017|PACT Phase|Adverse Event|1|||
161594550|NCT03544281|583567781|FG018|PACT Phase|Adverse Event|1|||
161680455|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
161680456|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Death|1|||
161545455|NCT00661661|583386503|FG000|Overall Study|Not assigned treatment|1|||
161545456|NCT00661661|583386504|FG001|Overall Study|Not assigned treatment|0|||
161545457|NCT02917941|583386505|FG000|Treatment Period|Adverse Event|11|||
161545458|NCT02917941|583386505|FG000|Treatment Period|Progressive Disease|11|||
161545459|NCT02917941|583386505|FG000|Treatment Period|Reason not Specified|2|||
161545460|NCT02917941|583386505|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
161545461|NCT02917941|583386505|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
161545462|NCT01893827|583386506|FG000|Overall Study|Lost to Follow-up|19|||
161545463|NCT01893827|583386507|FG001|Overall Study|Lost to Follow-up|26|||
161545464|NCT02769065|583388137|FG000|Overall Study|Voluntary Withdrawal|1|||
161545465|NCT02769065|583388138|FG001|Overall Study|Voluntary Withdrawal|0|||
161545466|NCT02769065|583388139|FG002|Overall Study|Voluntary Withdrawal|0|||
161545467|NCT02769065|583388140|FG003|Overall Study|Voluntary Withdrawal|0|||
161545468|NCT02769065|583388141|FG004|Overall Study|Voluntary Withdrawal|0|||
161545469|NCT02769065|583388142|FG005|Overall Study|Voluntary Withdrawal|0|||
161545470|NCT02769065|583388143|FG006|Overall Study|Voluntary Withdrawal|0|||
161545471|NCT02769065|583388144|FG007|Overall Study|Voluntary Withdrawal|0|||
161545472|NCT02769065|583388145|FG008|Overall Study|Voluntary Withdrawal|0|||
161545473|NCT02769065|583388146|FG009|Overall Study|Voluntary Withdrawal|0|||
161545474|NCT02769065|583388147|FG010|Overall Study|Voluntary Withdrawal|0|||
161545475|NCT02769065|583388148|FG011|Overall Study|Voluntary Withdrawal|0|||
161545476|NCT02769065|583388149|FG012|Overall Study|Voluntary Withdrawal|0|||
161545477|NCT02769065|583388150|FG013|Overall Study|Voluntary Withdrawal|0|||
161545478|NCT02769065|583388151|FG014|Overall Study|Voluntary Withdrawal|0|||
161545479|NCT02769065|583388152|FG015|Overall Study|Voluntary Withdrawal|0|||
161545480|NCT02769065|583388153|FG016|Overall Study|Voluntary Withdrawal|0|||
161545481|NCT02769065|583388154|FG017|Overall Study|Voluntary Withdrawal|0|||
161545482|NCT02769065|583388155|FG018|Overall Study|Voluntary Withdrawal|0|||
161545483|NCT02769065|583388156|FG019|Overall Study|Voluntary Withdrawal|0|||
161545484|NCT02769065|583388157|FG020|Overall Study|Voluntary Withdrawal|0|||
161545485|NCT02769065|583388158|FG021|Overall Study|Voluntary Withdrawal|0|||
161545486|NCT02769065|583388159|FG022|Overall Study|Voluntary Withdrawal|0|||
161545487|NCT02769065|583388160|FG023|Overall Study|Voluntary Withdrawal|0|||
161545488|NCT02769065|583388161|FG024|Overall Study|Voluntary Withdrawal|0|||
161545489|NCT02769065|583388162|FG025|Overall Study|Voluntary Withdrawal|0|||
161545490|NCT02769065|583388163|FG026|Overall Study|Voluntary Withdrawal|0|||
161545491|NCT02769065|583388164|FG027|Overall Study|Voluntary Withdrawal|0|||
161545492|NCT02769065|583388165|FG028|Overall Study|Voluntary Withdrawal|0|||
161545493|NCT02769065|583388166|FG029|Overall Study|Voluntary Withdrawal|0|||
161545494|NCT02769065|583388137|FG000|Overall Study|Reason Not Specified|0|||
161545495|NCT02769065|583388138|FG001|Overall Study|Reason Not Specified|0|||
161545496|NCT02769065|583388139|FG002|Overall Study|Reason Not Specified|0|||
161545497|NCT02769065|583388140|FG003|Overall Study|Reason Not Specified|0|||
161545498|NCT02769065|583388141|FG004|Overall Study|Reason Not Specified|0|||
161545499|NCT02769065|583388142|FG005|Overall Study|Reason Not Specified|0|||
161545500|NCT02769065|583388143|FG006|Overall Study|Reason Not Specified|1|||
161545501|NCT02769065|583388144|FG007|Overall Study|Reason Not Specified|0|||
161545502|NCT02769065|583388145|FG008|Overall Study|Reason Not Specified|0|||
161545503|NCT02769065|583388146|FG009|Overall Study|Reason Not Specified|0|||
161545504|NCT02769065|583388147|FG010|Overall Study|Reason Not Specified|0|||
161545505|NCT02769065|583388148|FG011|Overall Study|Reason Not Specified|0|||
161545506|NCT02769065|583388149|FG012|Overall Study|Reason Not Specified|0|||
161545507|NCT02769065|583388150|FG013|Overall Study|Reason Not Specified|0|||
161545508|NCT02769065|583388151|FG014|Overall Study|Reason Not Specified|0|||
161545509|NCT02769065|583388152|FG015|Overall Study|Reason Not Specified|0|||
161545510|NCT02769065|583388153|FG016|Overall Study|Reason Not Specified|0|||
161545511|NCT02769065|583388154|FG017|Overall Study|Reason Not Specified|0|||
161545512|NCT02769065|583388155|FG018|Overall Study|Reason Not Specified|0|||
161545513|NCT02769065|583388156|FG019|Overall Study|Reason Not Specified|0|||
161545514|NCT02769065|583388157|FG020|Overall Study|Reason Not Specified|0|||
161545515|NCT02769065|583388158|FG021|Overall Study|Reason Not Specified|0|||
161545516|NCT02769065|583388159|FG022|Overall Study|Reason Not Specified|0|||
161545517|NCT02769065|583388160|FG023|Overall Study|Reason Not Specified|0|||
161545518|NCT02769065|583388161|FG024|Overall Study|Reason Not Specified|0|||
161545519|NCT02769065|583388162|FG025|Overall Study|Reason Not Specified|0|||
161545520|NCT02769065|583388163|FG026|Overall Study|Reason Not Specified|0|||
161545521|NCT02769065|583388164|FG027|Overall Study|Reason Not Specified|0|||
161545522|NCT02769065|583388165|FG028|Overall Study|Reason Not Specified|0|||
161680457|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Death|0|||
161545523|NCT02769065|583388166|FG029|Overall Study|Reason Not Specified|0|||
161545524|NCT02769065|583388137|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545525|NCT02769065|583388138|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545526|NCT02769065|583388139|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545527|NCT02769065|583388140|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545528|NCT02769065|583388141|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545529|NCT02769065|583388142|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545530|NCT02769065|583388143|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545531|NCT02769065|583388144|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545532|NCT02769065|583388145|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545533|NCT02769065|583388146|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545534|NCT02769065|583388147|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
161545535|NCT02769065|583388148|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545536|NCT02769065|583388149|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545537|NCT02769065|583388150|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545538|NCT02769065|583388151|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545539|NCT02769065|583388152|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545540|NCT02769065|583388153|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545541|NCT02769065|583388154|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545542|NCT02769065|583388155|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
161594551|NCT03544281|583567782|FG019|PACT Phase|Adverse Event|0|||
161594552|NCT03544281|583567783|FG020|PACT Phase|Adverse Event|0|||
161594553|NCT03544281|583567784|FG021|PACT Phase|Adverse Event|0|||
161594554|NCT06019559|583567785|FG000|Overall Study|Withdrawal by Subject|7|||
161594555|NCT06019559|583567786|FG001|Overall Study|Withdrawal by Subject|6|||
161594556|NCT06019559|583567787|FG002|Overall Study|Withdrawal by Subject|5|||
161594557|NCT06019559|583567785|FG000|Overall Study|Lost to Follow-up|2|||
161594558|NCT06019559|583567786|FG001|Overall Study|Lost to Follow-up|0|||
161594559|NCT06019559|583567787|FG002|Overall Study|Lost to Follow-up|3|||
161594560|NCT04623671|583567793|FG000|Overall Study|Adverse Event|0|||
161594561|NCT04623671|583567794|FG001|Overall Study|Adverse Event|1|||
161594562|NCT04623671|583567793|FG000|Overall Study|Lost to Follow-up|2|||
161594563|NCT04623671|583567794|FG001|Overall Study|Lost to Follow-up|1|||
161594564|NCT04623671|583567793|FG000|Overall Study|Death|5|||
161594565|NCT04623671|583567794|FG001|Overall Study|Death|5|||
161594566|NCT01802788|583567798|FG000|Overall Study|Withdrawal by Subject|102|||
161594567|NCT01802788|583567799|FG001|Overall Study|Withdrawal by Subject|5|||
161594568|NCT01802788|583567798|FG000|Overall Study|Death|382|||
161594569|NCT01802788|583567799|FG001|Overall Study|Death|18|||
161594570|NCT01802788|583567798|FG000|Overall Study|Lost to Follow-up|31|||
161594571|NCT01802788|583567799|FG001|Overall Study|Lost to Follow-up|2|||
161594572|NCT01802788|583567798|FG000|Overall Study|Physician Decision|3|||
161594573|NCT01802788|583567799|FG001|Overall Study|Physician Decision|0|||
161594574|NCT01802788|583567798|FG000|Overall Study|Patient Non-Compliance|1|||
161594575|NCT01802788|583567799|FG001|Overall Study|Patient Non-Compliance|0|||
161594576|NCT01802788|583567798|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
161594577|NCT01802788|583567799|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
161594578|NCT01802788|583567798|FG000|Overall Study|Other Reasons|19|||
161594579|NCT01802788|583567799|FG001|Overall Study|Other Reasons|0|||
161594580|NCT05257486|583567800|FG000|Overall Study|Protocol Violation|3|||
161594581|NCT04542317|583567801|FG000|Overall Study|Care recipients passed away|18|||
161594582|NCT04542317|583567802|FG001|Overall Study|Care recipients passed away|13|||
161594583|NCT04542317|583567801|FG000|Overall Study|No longer a primary caregiver|5|||
161594584|NCT04542317|583567802|FG001|Overall Study|No longer a primary caregiver|1|||
161594585|NCT04542317|583567801|FG000|Overall Study|Withdrawal by Subject|4|||
161594586|NCT04542317|583567802|FG001|Overall Study|Withdrawal by Subject|2|||
161594587|NCT04542317|583567801|FG000|Overall Study|Caregivers passed away|0|||
161594588|NCT04542317|583567802|FG001|Overall Study|Caregivers passed away|2|||
161594589|NCT04700163|583567805|FG000|Overall Study|Lost to Follow-up|0|||
161594590|NCT04700163|583567806|FG001|Overall Study|Lost to Follow-up|0|||
161594591|NCT04700163|583567807|FG002|Overall Study|Lost to Follow-up|0|||
161594592|NCT04700163|583567808|FG003|Overall Study|Lost to Follow-up|0|||
161594593|NCT04700163|583567809|FG004|Overall Study|Lost to Follow-up|0|||
161594594|NCT04700163|583567810|FG005|Overall Study|Lost to Follow-up|1|||
161594595|NCT05543629|583567817|FG000|Overall Study|Death|1|||
161594596|NCT05543629|583567818|FG001|Overall Study|Death|0|||
161594597|NCT05543629|583567819|FG002|Overall Study|Death|1|||
161594598|NCT05543629|583567820|FG003|Overall Study|Death|0|||
161594599|NCT05543629|583567821|FG004|Overall Study|Death|0|||
161680458|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Death|0|||
161594600|NCT05543629|583567822|FG005|Overall Study|Death|1|||
161594601|NCT05543629|583567823|FG006|Overall Study|Death|2|||
161594602|NCT05543629|583567824|FG007|Overall Study|Death|2|||
161594603|NCT05543629|583567817|FG000|Overall Study|Other Reasons|0|||
161594604|NCT05543629|583567818|FG001|Overall Study|Other Reasons|0|||
161594605|NCT05543629|583567819|FG002|Overall Study|Other Reasons|0|||
161594606|NCT05543629|583567820|FG003|Overall Study|Other Reasons|0|||
161680459|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Death|0|||
161545543|NCT02769065|583388156|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545544|NCT02769065|583388157|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545545|NCT02769065|583388158|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545546|NCT02769065|583388159|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545547|NCT02769065|583388160|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545548|NCT02769065|583388161|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545549|NCT02769065|583388162|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545550|NCT02769065|583388163|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545551|NCT02769065|583388164|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545552|NCT02769065|583388165|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545553|NCT02769065|583388166|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
161545554|NCT01382940|583388169|FG000|Overall Study|Adverse Event|19|||
161545555|NCT01382940|583388169|FG000|Overall Study|Lost to Follow-up|4|||
161545556|NCT01382940|583388169|FG000|Overall Study|Physician Decision|7|||
161545557|NCT01382940|583388169|FG000|Overall Study|Withdrawal by Subject|23|||
161545558|NCT01382940|583388169|FG000|Overall Study|Protocol Violation|20|||
161545559|NCT02105636|583388170|FG000|Pre-Treatment|Disease Progression|1|||
161545560|NCT02105636|583388171|FG001|Pre-Treatment|Disease Progression|0|||
161545561|NCT02105636|583388170|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
161545562|NCT02105636|583388171|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
161545563|NCT02105636|583388170|FG000|Pre-Treatment|Participant withdrew consent|0|||
161545564|NCT02105636|583388171|FG001|Pre-Treatment|Participant withdrew consent|6|||
161545565|NCT02105636|583388170|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
161545566|NCT02105636|583388171|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
161545567|NCT02105636|583388170|FG000|Treatment|Study Drug Toxicity|14|||
161545568|NCT02105636|583388171|FG001|Treatment|Study Drug Toxicity|10|||
161545569|NCT02105636|583388170|FG000|Treatment|Adverse event unrelated to study drug|19|||
161545570|NCT02105636|583388171|FG001|Treatment|Adverse event unrelated to study drug|3|||
161545571|NCT02105636|583388170|FG000|Treatment|Participant request to discontinue study treatment|8|||
161545572|NCT02105636|583388171|FG001|Treatment|Participant request to discontinue study treatment|6|||
161545573|NCT02105636|583388170|FG000|Treatment|Participant withdrew consent|5|||
161545574|NCT02105636|583388171|FG001|Treatment|Participant withdrew consent|1|||
161545575|NCT02105636|583388170|FG000|Treatment|Lost to Follow-up|1|||
161545576|NCT02105636|583388171|FG001|Treatment|Lost to Follow-up|0|||
161545577|NCT02105636|583388170|FG000|Treatment|Maximum Clinical Benefit|1|||
161545578|NCT02105636|583388171|FG001|Treatment|Maximum Clinical Benefit|3|||
161545579|NCT02105636|583388170|FG000|Treatment|Poor/Non-compliance|0|||
161545580|NCT02105636|583388171|FG001|Treatment|Poor/Non-compliance|1|||
161545581|NCT02105636|583388170|FG000|Treatment|Participant no longer meets study criteria|1|||
161545582|NCT02105636|583388171|FG001|Treatment|Participant no longer meets study criteria|0|||
161545583|NCT02105636|583388170|FG000|Treatment|Other reasons|1|||
161545584|NCT02105636|583388171|FG001|Treatment|Other reasons|0|||
161545585|NCT02105636|583388170|FG000|Treatment|Disease Progression|185|||
161545586|NCT02105636|583388171|FG001|Treatment|Disease Progression|87|||
161545587|NCT00720902|583388172|FG000|Overall Study|Withdrawal by Subject|1|||
161545588|NCT00720902|583388173|FG001|Overall Study|Withdrawal by Subject|0|||
161545589|NCT00720902|583388172|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
161545590|NCT00720902|583388173|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
161545591|NCT01993017|583388175|FG000|Overall Study|Death|23|||
161545592|NCT01993017|583388176|FG001|Overall Study|Death|26|||
161545593|NCT01993017|583388177|FG002|Overall Study|Death|18|||
161545594|NCT01993017|583388175|FG000|Overall Study|Could not be contacted|43|||
161545595|NCT01993017|583388176|FG001|Overall Study|Could not be contacted|42|||
161545596|NCT01993017|583388177|FG002|Overall Study|Could not be contacted|38|||
161545597|NCT01993017|583388175|FG000|Overall Study|Dropped out|19|||
161545598|NCT01993017|583388176|FG001|Overall Study|Dropped out|6|||
161545599|NCT01993017|583388177|FG002|Overall Study|Dropped out|11|||
161594607|NCT05543629|583567821|FG004|Overall Study|Other Reasons|1|||
161594608|NCT05543629|583567822|FG005|Overall Study|Other Reasons|0|||
161594609|NCT05543629|583567823|FG006|Overall Study|Other Reasons|0|||
161594610|NCT05543629|583567824|FG007|Overall Study|Other Reasons|0|||
161545600|NCT01993017|583388175|FG000|Overall Study|Other reasons|17|||
161545601|NCT01993017|583388176|FG001|Overall Study|Other reasons|11|||
161545602|NCT01993017|583388177|FG002|Overall Study|Other reasons|7|||
161545603|NCT01993017|583388175|FG000|Overall Study|Ineligible after randomization|4|||
161545604|NCT01993017|583388176|FG001|Overall Study|Ineligible after randomization|5|||
161545605|NCT01993017|583388177|FG002|Overall Study|Ineligible after randomization|5|||
161545606|NCT00003511|583388178|FG000|Overall Study|Not evaluable|4|||
161545607|NCT03638635|583388179|FG000|Initial Hospitalization|Study terminated prematurely|0|||
161545608|NCT03638635|583388180|FG001|Initial Hospitalization|Study terminated prematurely|1|||
161545609|NCT03638635|583388179|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
161545610|NCT03638635|583388180|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
161594611|NCT05543629|583567817|FG000|Overall Study|Physician Decision|0|||
161830045|NCT02412722|584418105|FG001|Overall Study|Progressive Disease|4|||
161830046|NCT02412722|584418106|FG002|Overall Study|Progressive Disease|4|||
161830047|NCT02412722|584418107|FG003|Overall Study|Progressive Disease|9|||
161545611|NCT03638635|583388179|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
161545612|NCT03638635|583388180|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
161545613|NCT01540565|583388182|FG000|Overall Study|Ineligible|2|||
161545614|NCT03469349|583388183|FG000|Overall Study|Withdrawal by Subject|1|||
161545615|NCT03469349|583388184|FG001|Overall Study|Withdrawal by Subject|3|||
161545616|NCT03469349|583388183|FG000|Overall Study|Progressive Disease|0|||
161545617|NCT03469349|583388184|FG001|Overall Study|Progressive Disease|1|||
161545618|NCT03469349|583388183|FG000|Overall Study|Lost to Follow-up|2|||
161545619|NCT03469349|583388184|FG001|Overall Study|Lost to Follow-up|2|||
161545620|NCT03469349|583388183|FG000|Overall Study|Adverse Event|2|||
161545621|NCT03469349|583388184|FG001|Overall Study|Adverse Event|4|||
161545622|NCT01827254|583388185|FG000|Overall Study|Death|10|||
161545623|NCT01827254|583388185|FG000|Overall Study|Case report form not completed|4|||
161545624|NCT01827254|583388185|FG000|Overall Study|Invalidated centre|3|||
161545625|NCT01827254|583388185|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
161545626|NCT01827254|583388185|FG000|Overall Study|Did not complete re-challenge|1|||
161545627|NCT01827254|583388185|FG000|Overall Study|Disease progression|36|||
161545628|NCT01827254|583388185|FG000|Overall Study|Intolerance to treatment|4|||
161545629|NCT04145037|583388193|FG000|Overall Study|Study terminated|2|||
161545630|NCT04145037|583388194|FG001|Overall Study|Study terminated|0|||
161545631|NCT04145037|583388193|FG000|Overall Study|Withdrawal by Subject|1|||
161545632|NCT04145037|583388194|FG001|Overall Study|Withdrawal by Subject|0|||
161545633|NCT04145037|583388193|FG000|Overall Study|Lost to Follow-up|1|||
161545634|NCT04145037|583388194|FG001|Overall Study|Lost to Follow-up|0|||
161545635|NCT02307513|583388197|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
161545636|NCT02307513|583388198|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
161545637|NCT02307513|583388197|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
161545638|NCT02307513|583388198|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
161545639|NCT02307513|583388197|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
161545640|NCT02307513|583388198|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
161545641|NCT02307513|583388197|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
161545642|NCT02307513|583388198|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
161545643|NCT02307513|583388197|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
161545644|NCT02307513|583388198|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
161545645|NCT02307513|583388197|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
161545646|NCT02307513|583388198|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
161545647|NCT02307513|583388197|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
161545648|NCT02307513|583388198|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
161545649|NCT02307513|583388197|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
161545650|NCT02307513|583388198|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
161545651|NCT02307513|583388197|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
161545652|NCT02307513|583388198|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
161545653|NCT02307513|583388197|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
161545654|NCT02307513|583388198|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
161545655|NCT02307513|583388197|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
161545656|NCT02307513|583388198|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
161545657|NCT02307513|583388197|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
161545658|NCT02307513|583388198|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
161545659|NCT02307513|583388197|FG000|Long-term Extension|Physician Decision|1|||
161545660|NCT02307513|583388198|FG001|Long-term Extension|Physician Decision|0|||
161545661|NCT00525265|583388206|FG000|Overall Study|Protocol Violation|1|||
161545662|NCT00525265|583388207|FG001|Overall Study|Protocol Violation|0|||
161545663|NCT01107743|583388208|FG000|Overall Study|Protocol Violation|46|||
161545664|NCT00308737|583388209|FG000|Overall Study|Adverse Event|104|||
161545665|NCT00308737|583388210|FG001|Overall Study|Adverse Event|9|||
161545666|NCT00308737|583388211|FG002|Overall Study|Adverse Event|0|||
161545667|NCT00308737|583388209|FG000|Overall Study|Death|4|||
161545668|NCT00308737|583388210|FG001|Overall Study|Death|3|||
161545669|NCT00308737|583388211|FG002|Overall Study|Death|0|||
161545670|NCT00308737|583388209|FG000|Overall Study|Lost to Follow-up|56|||
161545671|NCT00308737|583388210|FG001|Overall Study|Lost to Follow-up|80|||
161545672|NCT00308737|583388211|FG002|Overall Study|Lost to Follow-up|5|||
161545673|NCT00308737|583388209|FG000|Overall Study|Physician Decision|15|||
161545674|NCT00308737|583388210|FG001|Overall Study|Physician Decision|2|||
161594612|NCT05543629|583567818|FG001|Overall Study|Physician Decision|0|||
161545675|NCT00308737|583388211|FG002|Overall Study|Physician Decision|1|||
161545676|NCT00308737|583388209|FG000|Overall Study|Protocol Violation|34|||
161545677|NCT00308737|583388210|FG001|Overall Study|Protocol Violation|9|||
161545678|NCT00308737|583388211|FG002|Overall Study|Protocol Violation|5|||
161830048|NCT02412722|584418108|FG004|Overall Study|Progressive Disease|3|||
161830049|NCT02412722|584418109|FG005|Overall Study|Progressive Disease|3|||
161545679|NCT00308737|583388209|FG000|Overall Study|Withdrawal by Subject|218|||
161545680|NCT00308737|583388210|FG001|Overall Study|Withdrawal by Subject|166|||
161545681|NCT00308737|583388211|FG002|Overall Study|Withdrawal by Subject|18|||
161545682|NCT00308737|583388209|FG000|Overall Study|Various|32|||
161545683|NCT00308737|583388210|FG001|Overall Study|Various|20|||
161545684|NCT00308737|583388211|FG002|Overall Study|Various|8|||
161545685|NCT00744263|583388214|FG000|Overall Study|Death|3006|||
161545686|NCT00744263|583388215|FG001|Overall Study|Death|3005|||
161545687|NCT00744263|583388214|FG000|Overall Study|Lost to Follow-up|2038|||
161545688|NCT00744263|583388215|FG001|Overall Study|Lost to Follow-up|2135|||
161545689|NCT00744263|583388214|FG000|Overall Study|Withdrawal by Subject|166|||
161545690|NCT00744263|583388215|FG001|Overall Study|Withdrawal by Subject|150|||
161545691|NCT00744263|583388214|FG000|Overall Study|Physician Decision|20|||
161545692|NCT00744263|583388215|FG001|Overall Study|Physician Decision|23|||
161545693|NCT00744263|583388214|FG000|Overall Study|Protocol Violation|3|||
161545694|NCT00744263|583388215|FG001|Overall Study|Protocol Violation|5|||
161545695|NCT00744263|583388214|FG000|Overall Study|Adverse Event|1|||
161545696|NCT00744263|583388215|FG001|Overall Study|Adverse Event|0|||
161545697|NCT00744263|583388214|FG000|Overall Study|Other|2|||
161545698|NCT00744263|583388215|FG001|Overall Study|Other|2|||
161545699|NCT01913639|583388216|FG000|Overall Study|Not Eligible|3|||
161545700|NCT01225822|583388226|FG000|Overall Study|Adverse Event|13|||
161545701|NCT01225822|583388227|FG001|Overall Study|Adverse Event|31|||
161545702|NCT01225822|583388228|FG002|Overall Study|Adverse Event|18|||
161545703|NCT01225822|583388229|FG003|Overall Study|Adverse Event|23|||
161545704|NCT01225822|583388230|FG004|Overall Study|Adverse Event|14|||
161545705|NCT01225822|583388226|FG000|Overall Study|Protocol Violation|6|||
161545706|NCT01225822|583388227|FG001|Overall Study|Protocol Violation|8|||
161545707|NCT01225822|583388228|FG002|Overall Study|Protocol Violation|6|||
161545708|NCT01225822|583388229|FG003|Overall Study|Protocol Violation|7|||
161545709|NCT01225822|583388230|FG004|Overall Study|Protocol Violation|4|||
161545710|NCT01225822|583388226|FG000|Overall Study|Lost to Follow-up|0|||
161545711|NCT01225822|583388227|FG001|Overall Study|Lost to Follow-up|0|||
161545712|NCT01225822|583388228|FG002|Overall Study|Lost to Follow-up|0|||
161545713|NCT01225822|583388229|FG003|Overall Study|Lost to Follow-up|1|||
161545714|NCT01225822|583388230|FG004|Overall Study|Lost to Follow-up|0|||
161545715|NCT01225822|583388226|FG000|Overall Study|Withdrawal by Subject|6|||
161545716|NCT01225822|583388227|FG001|Overall Study|Withdrawal by Subject|7|||
161545717|NCT01225822|583388228|FG002|Overall Study|Withdrawal by Subject|7|||
161545718|NCT01225822|583388229|FG003|Overall Study|Withdrawal by Subject|11|||
161545719|NCT01225822|583388230|FG004|Overall Study|Withdrawal by Subject|6|||
161545720|NCT01225822|583388226|FG000|Overall Study|Other|13|||
161545721|NCT01225822|583388227|FG001|Overall Study|Other|10|||
161545722|NCT01225822|583388228|FG002|Overall Study|Other|7|||
161545723|NCT01225822|583388229|FG003|Overall Study|Other|10|||
161545724|NCT01225822|583388230|FG004|Overall Study|Other|7|||
161545725|NCT01290822|583388233|FG000|Overall Study|Withdrawal by Subject|1|||
161545726|NCT01290822|583388233|FG000|Overall Study|Physician Decision|10|||
161545727|NCT04078035|583388234|FG000|Session 2|Lost to Follow-up|3|||
161545728|NCT04078035|583388235|FG001|Session 2|Lost to Follow-up|1|||
161545729|NCT04078035|583388234|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
161545730|NCT04078035|583388235|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
161545731|NCT04296890|583388238|FG000|Overall Study|Withdrawal by Subject|1|||
161545732|NCT04296890|583388238|FG000|Overall Study|Death|62|||
161545733|NCT04296890|583388238|FG000|Overall Study|Lost to Follow-up|3|||
161545734|NCT04296890|583388238|FG000|Overall Study|Other than specified|2|||
161545735|NCT02100722|583388239|FG000|Overall Study|Withdrawal pre-procedure|4|||
161545736|NCT02100722|583388240|FG001|Overall Study|Withdrawal pre-procedure|9|||
161545737|NCT02100722|583388239|FG000|Overall Study|Withdrawal post-procedure|0|||
161594613|NCT05543629|583567819|FG002|Overall Study|Physician Decision|3|||
161594614|NCT05543629|583567820|FG003|Overall Study|Physician Decision|0|||
161545738|NCT02100722|583388240|FG001|Overall Study|Withdrawal post-procedure|3|||
161545739|NCT02100722|583388239|FG000|Overall Study|Lost to Follow-up|2|||
161594615|NCT05543629|583567821|FG004|Overall Study|Physician Decision|0|||
161594616|NCT05543629|583567822|FG005|Overall Study|Physician Decision|0|||
161594617|NCT05543629|583567823|FG006|Overall Study|Physician Decision|1|||
161594618|NCT05543629|583567824|FG007|Overall Study|Physician Decision|0|||
161594619|NCT05543629|583567817|FG000|Overall Study|Study terminated by Sponsor|1|||
161545740|NCT02100722|583388240|FG001|Overall Study|Lost to Follow-up|2|||
161545741|NCT02100722|583388239|FG000|Overall Study|Continuing on study|751|||
161545742|NCT02100722|583388240|FG001|Overall Study|Continuing on study|729|||
161545743|NCT04986982|583388242|FG000|Overall Study|Withdrawal by Subject|3|||
161545744|NCT04986982|583388243|FG001|Overall Study|Withdrawal by Subject|1|||
161594620|NCT05543629|583567818|FG001|Overall Study|Study terminated by Sponsor|0|||
161594621|NCT05543629|583567819|FG002|Overall Study|Study terminated by Sponsor|0|||
161545745|NCT04986982|583388242|FG000|Overall Study|Lack of Efficacy|0|||
161594622|NCT05543629|583567820|FG003|Overall Study|Study terminated by Sponsor|1|||
161594623|NCT05543629|583567821|FG004|Overall Study|Study terminated by Sponsor|0|||
161594624|NCT05543629|583567822|FG005|Overall Study|Study terminated by Sponsor|4|||
161594625|NCT05543629|583567823|FG006|Overall Study|Study terminated by Sponsor|1|||
161594626|NCT05543629|583567824|FG007|Overall Study|Study terminated by Sponsor|0|||
161594627|NCT05543629|583567817|FG000|Overall Study|Withdrawal by Subject|1|||
161594628|NCT05543629|583567818|FG001|Overall Study|Withdrawal by Subject|1|||
161594629|NCT05543629|583567819|FG002|Overall Study|Withdrawal by Subject|0|||
161594630|NCT05543629|583567820|FG003|Overall Study|Withdrawal by Subject|2|||
161594631|NCT05543629|583567821|FG004|Overall Study|Withdrawal by Subject|1|||
161594632|NCT05543629|583567822|FG005|Overall Study|Withdrawal by Subject|1|||
161594633|NCT05543629|583567823|FG006|Overall Study|Withdrawal by Subject|1|||
161594634|NCT05543629|583567824|FG007|Overall Study|Withdrawal by Subject|1|||
161594635|NCT05543629|583567817|FG000|Overall Study|Not Reported|2|||
161594636|NCT05543629|583567818|FG001|Overall Study|Not Reported|2|||
161594637|NCT05543629|583567819|FG002|Overall Study|Not Reported|0|||
161594638|NCT05543629|583567820|FG003|Overall Study|Not Reported|0|||
161594639|NCT05543629|583567821|FG004|Overall Study|Not Reported|1|||
161594640|NCT05543629|583567822|FG005|Overall Study|Not Reported|1|||
161594641|NCT05543629|583567823|FG006|Overall Study|Not Reported|3|||
161594642|NCT05543629|583567824|FG007|Overall Study|Not Reported|0|||
161594643|NCT04568603|583567825|FG000|Overall Study|Physician Decision|1|||
161594644|NCT04564742|583567826|FG000|Overall Study|Lost to Follow-up|1|||
161594645|NCT04564742|583567827|FG001|Overall Study|Lost to Follow-up|0|||
161594646|NCT04564742|583567826|FG000|Overall Study|Consent Withdrawal|4|||
161594647|NCT04564742|583567827|FG001|Overall Study|Consent Withdrawal|4|||
161594648|NCT03313076|583567831|FG000|Overall Study|Withdrawal by Subject|2|||
161594649|NCT03313076|583567832|FG001|Overall Study|Withdrawal by Subject|0|||
161594650|NCT03313076|583567833|FG002|Overall Study|Withdrawal by Subject|0|||
161594651|NCT03313076|583567834|FG003|Overall Study|Withdrawal by Subject|0|||
161594652|NCT03313076|583567831|FG000|Overall Study|Lost to Follow-up|0|||
161680460|NCT03086057|583882946|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
161680461|NCT03086057|583882947|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
161680462|NCT03086057|583882948|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
161680463|NCT03086057|583882949|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
161680464|NCT03086057|583882946|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161680465|NCT03086057|583882947|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161680466|NCT03086057|583882948|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
161680467|NCT03086057|583882949|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161680468|NCT03086057|583882946|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
161680469|NCT03086057|583882947|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
161680470|NCT03086057|583882948|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
161680471|NCT03086057|583882949|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
161680472|NCT03654976|583882952|FG000|Overall Study|Withdrawal by Subject|12|||
161680473|NCT03654976|583882953|FG001|Overall Study|Withdrawal by Subject|11|||
161680474|NCT03654976|583882952|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
161680475|NCT03654976|583882953|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
161680476|NCT03654976|583882952|FG000|Overall Study|Adverse Event|5|||
161680477|NCT03654976|583882953|FG001|Overall Study|Adverse Event|0|||
161680478|NCT03654976|583882952|FG000|Overall Study|Lost to Follow-up|2|||
161680479|NCT03654976|583882953|FG001|Overall Study|Lost to Follow-up|0|||
161680480|NCT03654976|583882952|FG000|Overall Study|Lack of Efficacy|0|||
161680481|NCT03654976|583882953|FG001|Overall Study|Lack of Efficacy|1|||
161680482|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Death|40|||
161680483|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Death|41|||
161680484|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Death|37|||
161680485|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Death|0|||
161680486|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Death|0|||
161680487|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161680488|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
161680489|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
161680490|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161680491|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161680492|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
161680493|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
161680494|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
161680495|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
161680496|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
161680497|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Other|15|||
161680498|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Other|9|||
161680499|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Other|9|||
161680500|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Other|0|||
161680501|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Other|0|||
161680502|NCT00117598|583882954|FG000|After Treament Cross Over|Death|0|||
161680503|NCT00117598|583882955|FG001|After Treament Cross Over|Death|0|||
161680504|NCT00117598|583882956|FG002|After Treament Cross Over|Death|0|||
161680505|NCT00117598|583882957|FG003|After Treament Cross Over|Death|1|||
161680506|NCT00117598|583882958|FG004|After Treament Cross Over|Death|2|||
161680507|NCT00117598|583882954|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
161680508|NCT00117598|583882955|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
161680509|NCT00117598|583882956|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
161680510|NCT00117598|583882957|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
161680511|NCT00117598|583882958|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
161545746|NCT04986982|583388243|FG001|Overall Study|Lack of Efficacy|2|||
161545747|NCT04986982|583388242|FG000|Overall Study|Ineligibility|3|||
161545748|NCT04986982|583388243|FG001|Overall Study|Ineligibility|0|||
161545749|NCT04986982|583388242|FG000|Overall Study|Adverse Event|4|||
161545750|NCT04986982|583388243|FG001|Overall Study|Adverse Event|4|||
161680512|NCT00117598|583882954|FG000|After Treament Cross Over|Other|0|||
161680513|NCT00117598|583882955|FG001|After Treament Cross Over|Other|0|||
161545751|NCT04986982|583388242|FG000|Overall Study|Lost to Follow-up|0|||
161545752|NCT04986982|583388243|FG001|Overall Study|Lost to Follow-up|1|||
161545753|NCT04986982|583388242|FG000|Overall Study|Sponsor's discretion|1|||
161680514|NCT00117598|583882956|FG002|After Treament Cross Over|Other|0|||
161680515|NCT00117598|583882957|FG003|After Treament Cross Over|Other|1|||
161680516|NCT00117598|583882958|FG004|After Treament Cross Over|Other|2|||
161680517|NCT01235793|583882959|FG000|Overall Study|Death|6|||
161680518|NCT03098836|583882960|FG000|Overall Study|Adverse Event|1|||
161680519|NCT03098836|583882961|FG001|Overall Study|Adverse Event|3|||
161680520|NCT03098836|583882960|FG000|Overall Study|Lack of Efficacy|30|||
161680521|NCT03098836|583882961|FG001|Overall Study|Lack of Efficacy|15|||
161680522|NCT03098836|583882960|FG000|Overall Study|Physician Decision|2|||
161680523|NCT03098836|583882961|FG001|Overall Study|Physician Decision|1|||
161680524|NCT03098836|583882960|FG000|Overall Study|Withdrawal by Subject|3|||
161680525|NCT03098836|583882961|FG001|Overall Study|Withdrawal by Subject|2|||
161680526|NCT03986866|583882962|FG000|Overall Study|Withdrawal by Subject|0|||
161545754|NCT04986982|583388243|FG001|Overall Study|Sponsor's discretion|0|||
161545755|NCT03500640|583388244|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
161545756|NCT03500640|583388245|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
161830050|NCT02412722|584418104|FG000|Overall Study|Withdrawal by Subject|2|||
161830051|NCT02412722|584418105|FG001|Overall Study|Withdrawal by Subject|0|||
161545757|NCT03500640|583388246|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
161830052|NCT02412722|584418106|FG002|Overall Study|Withdrawal by Subject|1|||
161830053|NCT02412722|584418107|FG003|Overall Study|Withdrawal by Subject|2|||
161545758|NCT03500640|583388244|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
161545759|NCT03500640|583388245|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
161545760|NCT03500640|583388246|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
161545761|NCT03500640|583388244|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
161545762|NCT03500640|583388245|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
161545763|NCT03500640|583388246|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
161545764|NCT03500640|583388244|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
161545765|NCT03500640|583388245|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
161545766|NCT03500640|583388246|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
161545767|NCT03500640|583388244|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
161545768|NCT03500640|583388245|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
161545769|NCT03500640|583388246|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
161545770|NCT03500640|583388244|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
161545771|NCT03500640|583388245|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
161545772|NCT03500640|583388246|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
161545773|NCT03500640|583388244|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
161545774|NCT03500640|583388245|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
161545775|NCT03500640|583388246|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
161545776|NCT03500640|583388244|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
161545777|NCT03500640|583388245|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
161545778|NCT03500640|583388246|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
161545779|NCT03500640|583388244|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
161545780|NCT03500640|583388245|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
161545781|NCT03500640|583388246|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
161545782|NCT03500640|583388244|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
161545783|NCT03500640|583388245|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
161545784|NCT03500640|583388246|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
161545785|NCT02978443|583388247|FG000|Overall Study|Withdrawal by Subject|1|||
161545786|NCT02978443|583388247|FG000|Overall Study|Adverse Event|3|||
161545787|NCT02978443|583388247|FG000|Overall Study|Disease Progression on study|6|||
161545788|NCT02978443|583388247|FG000|Overall Study|Death|1|||
161545789|NCT02978443|583388247|FG000|Overall Study|Physician Decision|1|||
161545790|NCT02978443|583388247|FG000|Overall Study|Switch to alternative therapy|1|||
161545791|NCT02978443|583388247|FG000|Overall Study|Refused further treatment|1|||
161545792|NCT01852058|583388249|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
161545793|NCT01852058|583388250|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545794|NCT01852058|583388251|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545795|NCT01852058|583388252|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161594653|NCT03313076|583567832|FG001|Overall Study|Lost to Follow-up|2|||
161594654|NCT03313076|583567833|FG002|Overall Study|Lost to Follow-up|2|||
161594655|NCT03313076|583567834|FG003|Overall Study|Lost to Follow-up|2|||
161594656|NCT05869383|583567835|FG000|Overall Study|Withdrawal by Subject|2|||
161594657|NCT05869383|583567836|FG001|Overall Study|Withdrawal by Subject|0|||
161594658|NCT04137367|583567845|FG000|Overall Study|Lost to Follow-up|8|||
161594659|NCT04137367|583567846|FG001|Overall Study|Lost to Follow-up|6|||
161594660|NCT04137367|583567847|FG002|Overall Study|Lost to Follow-up|4|||
161594661|NCT05144009|583567848|FG000|Overall Study|Lost to Follow-up|0|||
161594662|NCT05144009|583567849|FG001|Overall Study|Lost to Follow-up|1|||
161594663|NCT05144009|583567848|FG000|Overall Study|Study Termination by the Sponsor|11|||
161594664|NCT05144009|583567849|FG001|Overall Study|Study Termination by the Sponsor|11|||
161594665|NCT05144009|583567848|FG000|Overall Study|Disease Progression|1|||
161594666|NCT05144009|583567849|FG001|Overall Study|Disease Progression|0|||
161594667|NCT05144009|583567848|FG000|Overall Study|Participant Decision|0|||
161594668|NCT05144009|583567849|FG001|Overall Study|Participant Decision|2|||
161594669|NCT05144009|583567848|FG000|Overall Study|Death|5|||
161594670|NCT05144009|583567849|FG001|Overall Study|Death|10|||
161594671|NCT03270501|583567850|FG000|Overall Study|Screen failure|6|||
161594672|NCT03270501|583567850|FG000|Overall Study|Lost to Follow-up|2|||
161594673|NCT03270501|583567850|FG000|Overall Study|Adverse Event|1|||
161594674|NCT02815566|583567858|FG000|Overall Study|Adverse Event|1|||
161594675|NCT02815566|583567859|FG001|Overall Study|Adverse Event|1|||
161594676|NCT02815566|583567858|FG000|Overall Study|Withdrawal by Subject|1|||
161594677|NCT02815566|583567859|FG001|Overall Study|Withdrawal by Subject|0|||
161594678|NCT02815566|583567858|FG000|Overall Study|Lost to Follow-up|0|||
161594679|NCT02815566|583567859|FG001|Overall Study|Lost to Follow-up|1|||
161594680|NCT04492722|583567861|FG000|Overall Study|Adverse Event|7|||
161594681|NCT04492722|583567862|FG001|Overall Study|Adverse Event|2|||
161594682|NCT04492722|583567863|FG002|Overall Study|Adverse Event|3|||
161594683|NCT04492722|583567864|FG003|Overall Study|Adverse Event|0|||
161594684|NCT04492722|583567861|FG000|Overall Study|Death|0|||
161594685|NCT04492722|583567862|FG001|Overall Study|Death|0|||
161594686|NCT04492722|583567863|FG002|Overall Study|Death|0|||
161594687|NCT04492722|583567864|FG003|Overall Study|Death|1|||
161594688|NCT04492722|583567861|FG000|Overall Study|Lost to Follow-up|0|||
161594689|NCT04492722|583567862|FG001|Overall Study|Lost to Follow-up|1|||
161594690|NCT04492722|583567863|FG002|Overall Study|Lost to Follow-up|0|||
161594691|NCT04492722|583567864|FG003|Overall Study|Lost to Follow-up|1|||
161594692|NCT04492722|583567861|FG000|Overall Study|Physician Decision|0|||
161594693|NCT04492722|583567862|FG001|Overall Study|Physician Decision|3|||
161594694|NCT04492722|583567863|FG002|Overall Study|Physician Decision|1|||
161594695|NCT04492722|583567864|FG003|Overall Study|Physician Decision|1|||
161594696|NCT04492722|583567861|FG000|Overall Study|Withdrawal by Subject|6|||
161594697|NCT04492722|583567862|FG001|Overall Study|Withdrawal by Subject|6|||
161594698|NCT04492722|583567863|FG002|Overall Study|Withdrawal by Subject|0|||
161594699|NCT04492722|583567864|FG003|Overall Study|Withdrawal by Subject|3|||
161594700|NCT04492722|583567861|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
161594701|NCT04492722|583567862|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
161594702|NCT04492722|583567863|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
161594703|NCT04492722|583567864|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
161594704|NCT04492722|583567861|FG000|Overall Study|Due to Covid-19 pandemic|7|||
161594705|NCT04492722|583567862|FG001|Overall Study|Due to Covid-19 pandemic|3|||
161594706|NCT04492722|583567863|FG002|Overall Study|Due to Covid-19 pandemic|7|||
161594707|NCT04492722|583567864|FG003|Overall Study|Due to Covid-19 pandemic|6|||
161594708|NCT04492722|583567861|FG000|Overall Study|Failure to meet randomisation criteria|2|||
161594709|NCT04492722|583567862|FG001|Overall Study|Failure to meet randomisation criteria|3|||
161594710|NCT04492722|583567863|FG002|Overall Study|Failure to meet randomisation criteria|4|||
161594711|NCT04492722|583567864|FG003|Overall Study|Failure to meet randomisation criteria|2|||
161594712|NCT04492722|583567861|FG000|Overall Study|Early termination from the study|54|||
161594713|NCT04492722|583567862|FG001|Overall Study|Early termination from the study|51|||
161594714|NCT04492722|583567863|FG002|Overall Study|Early termination from the study|50|||
161594715|NCT04492722|583567864|FG003|Overall Study|Early termination from the study|50|||
161594716|NCT04492722|583567861|FG000|Overall Study|Missing|3|||
161594717|NCT04492722|583567862|FG001|Overall Study|Missing|0|||
161594718|NCT04492722|583567863|FG002|Overall Study|Missing|0|||
161594719|NCT04492722|583567864|FG003|Overall Study|Missing|5|||
161594720|NCT04492722|583567861|FG000|Overall Study|Participants who did not receive treatment|0|||
161594721|NCT04492722|583567862|FG001|Overall Study|Participants who did not receive treatment|1|||
161594722|NCT04492722|583567863|FG002|Overall Study|Participants who did not receive treatment|4|||
161594723|NCT04492722|583567864|FG003|Overall Study|Participants who did not receive treatment|0|||
161594724|NCT05329220|583567868|FG000|Active Trial Period|Adverse Event|0|||
161594725|NCT05329220|583567869|FG001|Active Trial Period|Adverse Event|0|||
161594726|NCT05329220|583567870|FG002|Active Trial Period|Adverse Event|0|||
161594727|NCT05329220|583567871|FG003|Active Trial Period|Adverse Event|0|||
161594728|NCT05329220|583567872|FG004|Active Trial Period|Adverse Event|1|||
161594729|NCT05329220|583567873|FG005|Active Trial Period|Adverse Event|0|||
161594730|NCT05329220|583567868|FG000|Active Trial Period|Lost to Follow-up|0|||
161594731|NCT05329220|583567869|FG001|Active Trial Period|Lost to Follow-up|0|||
161594732|NCT05329220|583567870|FG002|Active Trial Period|Lost to Follow-up|0|||
161594733|NCT05329220|583567871|FG003|Active Trial Period|Lost to Follow-up|0|||
161594734|NCT05329220|583567872|FG004|Active Trial Period|Lost to Follow-up|32|||
161594735|NCT05329220|583567873|FG005|Active Trial Period|Lost to Follow-up|28|||
161594736|NCT05329220|583567868|FG000|Active Trial Period|Physician Decision|0|||
161594737|NCT05329220|583567869|FG001|Active Trial Period|Physician Decision|0|||
161594738|NCT05329220|583567870|FG002|Active Trial Period|Physician Decision|0|||
161594739|NCT05329220|583567871|FG003|Active Trial Period|Physician Decision|0|||
161594740|NCT05329220|583567872|FG004|Active Trial Period|Physician Decision|2|||
161594741|NCT05329220|583567873|FG005|Active Trial Period|Physician Decision|0|||
161594742|NCT05329220|583567868|FG000|Active Trial Period|Protocol Violation|0|||
161594743|NCT05329220|583567869|FG001|Active Trial Period|Protocol Violation|0|||
161594744|NCT05329220|583567870|FG002|Active Trial Period|Protocol Violation|0|||
161594745|NCT05329220|583567871|FG003|Active Trial Period|Protocol Violation|0|||
161594746|NCT05329220|583567872|FG004|Active Trial Period|Protocol Violation|1|||
161594747|NCT05329220|583567873|FG005|Active Trial Period|Protocol Violation|3|||
161594748|NCT05329220|583567868|FG000|Active Trial Period|Withdrawal by Subject|0|||
161594749|NCT05329220|583567869|FG001|Active Trial Period|Withdrawal by Subject|0|||
161594750|NCT05329220|583567870|FG002|Active Trial Period|Withdrawal by Subject|0|||
161680527|NCT03986866|583882963|FG001|Overall Study|Withdrawal by Subject|3|||
161680528|NCT03986866|583882962|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
161680529|NCT03986866|583882963|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
161680530|NCT00545064|583882966|FG000|Overall Study|Lost to Follow-up|3|||
161680531|NCT00545064|583882966|FG000|Overall Study|Withdrawal by Subject|2|||
161680532|NCT00545064|583882966|FG000|Overall Study|did not complete course of treatment|1|||
161594751|NCT05329220|583567871|FG003|Active Trial Period|Withdrawal by Subject|1|||
161680533|NCT00545064|583882966|FG000|Overall Study|cancel all appointments, no rebooking|1|||
161680534|NCT00545064|583882966|FG000|Overall Study|inclement weather|1|||
161680535|NCT01660451|583882967|FG000|Overall Study|Protocol Violation|0|||
161680536|NCT01660451|583882968|FG001|Overall Study|Protocol Violation|1|||
161680537|NCT01660451|583882969|FG002|Overall Study|Protocol Violation|1|||
161680538|NCT01660451|583882967|FG000|Overall Study|AE not associated with clinical disease progression|13|||
161680539|NCT01660451|583882968|FG001|Overall Study|AE not associated with clinical disease progression|10|||
161680540|NCT01660451|583882969|FG002|Overall Study|AE not associated with clinical disease progression|40|||
161680541|NCT01660451|583882967|FG000|Overall Study|AE associated with clinical disease progression|1|||
161680542|NCT01660451|583882968|FG001|Overall Study|AE associated with clinical disease progression|3|||
161680543|NCT01660451|583882969|FG002|Overall Study|AE associated with clinical disease progression|11|||
161680544|NCT01660451|583882967|FG000|Overall Study|Sponsor Decision|0|||
161680545|NCT01660451|583882968|FG001|Overall Study|Sponsor Decision|0|||
161680546|NCT01660451|583882969|FG002|Overall Study|Sponsor Decision|1|||
161680547|NCT01660451|583882967|FG000|Overall Study|Protocol Deviation|0|||
161680548|NCT01660451|583882968|FG001|Overall Study|Protocol Deviation|0|||
161680549|NCT01660451|583882969|FG002|Overall Study|Protocol Deviation|1|||
161680550|NCT01660451|583882967|FG000|Overall Study|Physician Decision|1|||
161680551|NCT01660451|583882968|FG001|Overall Study|Physician Decision|2|||
161594752|NCT05329220|583567872|FG004|Active Trial Period|Withdrawal by Subject|12|||
161594753|NCT05329220|583567873|FG005|Active Trial Period|Withdrawal by Subject|13|||
161594754|NCT05329220|583567868|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161594755|NCT05329220|583567869|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161594756|NCT05329220|583567870|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161594757|NCT05329220|583567871|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161594758|NCT05329220|583567872|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161594759|NCT05329220|583567873|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
161594760|NCT05329220|583567868|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161594761|NCT05329220|583567869|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161594762|NCT05329220|583567870|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161594763|NCT05329220|583567871|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161594764|NCT05329220|583567872|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161594765|NCT05329220|583567873|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
161594766|NCT05329220|583567868|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
161594767|NCT05329220|583567869|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
161594768|NCT05329220|583567870|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
161594769|NCT05329220|583567871|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
161594770|NCT05329220|583567872|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
161594771|NCT05329220|583567873|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
161594772|NCT05329220|583567868|FG000|Follow-up Period|Adverse Event|0|||
161594773|NCT05329220|583567869|FG001|Follow-up Period|Adverse Event|0|||
161594774|NCT05329220|583567870|FG002|Follow-up Period|Adverse Event|0|||
161594775|NCT05329220|583567871|FG003|Follow-up Period|Adverse Event|0|||
161594776|NCT05329220|583567872|FG004|Follow-up Period|Adverse Event|2|||
161594777|NCT05329220|583567873|FG005|Follow-up Period|Adverse Event|1|||
161594778|NCT05329220|583567868|FG000|Follow-up Period|Death|0|||
161594779|NCT05329220|583567869|FG001|Follow-up Period|Death|0|||
161594780|NCT05329220|583567870|FG002|Follow-up Period|Death|1|||
161594781|NCT05329220|583567871|FG003|Follow-up Period|Death|1|||
161594782|NCT05329220|583567872|FG004|Follow-up Period|Death|0|||
161594783|NCT05329220|583567873|FG005|Follow-up Period|Death|1|||
161594784|NCT05329220|583567868|FG000|Follow-up Period|Lost to Follow-up|0|||
161680552|NCT01660451|583882969|FG002|Overall Study|Physician Decision|5|||
161680553|NCT01660451|583882967|FG000|Overall Study|Withdrawal by Subject|1|||
161680554|NCT01660451|583882968|FG001|Overall Study|Withdrawal by Subject|1|||
161680555|NCT01660451|583882969|FG002|Overall Study|Withdrawal by Subject|20|||
161680556|NCT01660451|583882967|FG000|Overall Study|Trial closure.|0|||
161680557|NCT01660451|583882968|FG001|Overall Study|Trial closure.|0|||
161680558|NCT01660451|583882969|FG002|Overall Study|Trial closure.|1|||
161545796|NCT01852058|583388253|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161680559|NCT01660451|583882967|FG000|Overall Study|Switching to other therapy|0|||
161680560|NCT01660451|583882968|FG001|Overall Study|Switching to other therapy|1|||
161680561|NCT01660451|583882969|FG002|Overall Study|Switching to other therapy|1|||
161680562|NCT01660451|583882967|FG000|Overall Study|Progressive disease - clinical progression|4|||
161680563|NCT01660451|583882968|FG001|Overall Study|Progressive disease - clinical progression|10|||
161680564|NCT01660451|583882969|FG002|Overall Study|Progressive disease - clinical progression|9|||
161680565|NCT01660451|583882967|FG000|Overall Study|Progressive disease - radiological progression|12|||
161680566|NCT01660451|583882968|FG001|Overall Study|Progressive disease - radiological progression|23|||
161680567|NCT01660451|583882969|FG002|Overall Study|Progressive disease - radiological progression|50|||
161680568|NCT01660451|583882967|FG000|Overall Study|Death|1|||
161680569|NCT01660451|583882968|FG001|Overall Study|Death|0|||
161680570|NCT01660451|583882969|FG002|Overall Study|Death|1|||
161680571|NCT01660451|583882967|FG000|Overall Study|Other|0|||
161680572|NCT01660451|583882968|FG001|Overall Study|Other|0|||
161680573|NCT01660451|583882969|FG002|Overall Study|Other|1|||
161680574|NCT04688775|583882970|FG000|Placebo-controlled Period|Randomized, not treated|1|||
161680575|NCT04688775|583882971|FG001|Placebo-controlled Period|Randomized, not treated|1|||
161680576|NCT04688775|583882972|FG002|Placebo-controlled Period|Randomized, not treated|0|||
161680577|NCT04688775|583882973|FG003|Placebo-controlled Period|Randomized, not treated|0|||
161680578|NCT04688775|583882970|FG000|Placebo-controlled Period|Adverse Event|2|||
161680579|NCT04688775|583882971|FG001|Placebo-controlled Period|Adverse Event|0|||
161680580|NCT04688775|583882972|FG002|Placebo-controlled Period|Adverse Event|0|||
161680581|NCT04688775|583882973|FG003|Placebo-controlled Period|Adverse Event|0|||
161680582|NCT04688775|583882970|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
161680583|NCT04688775|583882971|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
161680584|NCT04688775|583882972|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
161680585|NCT04688775|583882973|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
161680586|NCT04688775|583882970|FG000|Placebo-controlled Period|Protocol Violation|0|||
161680587|NCT04688775|583882971|FG001|Placebo-controlled Period|Protocol Violation|1|||
161680588|NCT04688775|583882972|FG002|Placebo-controlled Period|Protocol Violation|0|||
161680589|NCT04688775|583882973|FG003|Placebo-controlled Period|Protocol Violation|0|||
161680590|NCT04688775|583882970|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161680591|NCT04688775|583882971|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
161680592|NCT04688775|583882972|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
161680593|NCT04688775|583882973|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
161680594|NCT04688775|583882970|FG000|Placebo-controlled Period|Other reasons|0|||
161680595|NCT04688775|583882971|FG001|Placebo-controlled Period|Other reasons|1|||
161680596|NCT04688775|583882972|FG002|Placebo-controlled Period|Other reasons|0|||
161680597|NCT04688775|583882973|FG003|Placebo-controlled Period|Other reasons|0|||
161680598|NCT04688775|583882970|FG000|Delayed Start Period|Adverse Event|0|||
161680599|NCT04688775|583882971|FG001|Delayed Start Period|Adverse Event|0|||
161680600|NCT04688775|583882972|FG002|Delayed Start Period|Adverse Event|1|||
161680601|NCT04688775|583882973|FG003|Delayed Start Period|Adverse Event|0|||
161680602|NCT04688775|583882970|FG000|Delayed Start Period|Lack of Efficacy|0|||
161680603|NCT04688775|583882971|FG001|Delayed Start Period|Lack of Efficacy|0|||
161680604|NCT04688775|583882972|FG002|Delayed Start Period|Lack of Efficacy|0|||
161680605|NCT04688775|583882973|FG003|Delayed Start Period|Lack of Efficacy|3|||
161680606|NCT04688775|583882970|FG000|Delayed Start Period|Withdrawal by Subject|0|||
161680607|NCT04688775|583882971|FG001|Delayed Start Period|Withdrawal by Subject|0|||
161680608|NCT04688775|583882972|FG002|Delayed Start Period|Withdrawal by Subject|2|||
161680609|NCT04688775|583882973|FG003|Delayed Start Period|Withdrawal by Subject|4|||
161680610|NCT04688775|583882970|FG000|Delayed Start Period|Lost to Follow-up|0|||
161680611|NCT04688775|583882971|FG001|Delayed Start Period|Lost to Follow-up|0|||
161680612|NCT04688775|583882972|FG002|Delayed Start Period|Lost to Follow-up|2|||
161680613|NCT04688775|583882973|FG003|Delayed Start Period|Lost to Follow-up|1|||
161545797|NCT01852058|583388254|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161680614|NCT04688775|583882970|FG000|Delayed Start Period|other reasons|0|||
161680615|NCT04688775|583882971|FG001|Delayed Start Period|other reasons|0|||
161680616|NCT04688775|583882972|FG002|Delayed Start Period|other reasons|1|||
161680617|NCT04688775|583882973|FG003|Delayed Start Period|other reasons|0|||
161680618|NCT01536951|583882980|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680619|NCT01536951|583882981|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680620|NCT01536951|583882982|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
161680621|NCT01536951|583882983|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680622|NCT01536951|583882984|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680623|NCT01536951|583882985|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680624|NCT01536951|583882986|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680625|NCT01536951|583882987|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161545798|NCT01852058|583388255|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545799|NCT01852058|583388256|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545800|NCT01852058|583388257|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545801|NCT01852058|583388258|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545802|NCT01852058|583388259|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545803|NCT01852058|583388260|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
161545804|NCT01852058|583388249|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545805|NCT01852058|583388250|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545806|NCT01852058|583388251|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545807|NCT01852058|583388252|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545808|NCT01852058|583388253|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
161545809|NCT01852058|583388254|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545810|NCT01852058|583388255|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545811|NCT01852058|583388256|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545812|NCT01852058|583388257|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545813|NCT01852058|583388258|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545814|NCT01852058|583388259|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545815|NCT01852058|583388260|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
161545816|NCT01852058|583388249|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545817|NCT01852058|583388250|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545818|NCT01852058|583388251|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545819|NCT01852058|583388252|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545820|NCT01852058|583388253|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
161545821|NCT01852058|583388254|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
161545822|NCT01852058|583388255|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545823|NCT01852058|583388256|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545824|NCT01852058|583388257|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545825|NCT01852058|583388258|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545826|NCT01852058|583388259|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545827|NCT01852058|583388260|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
161545828|NCT01852058|583388249|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545829|NCT01852058|583388250|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545830|NCT01852058|583388251|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545831|NCT01852058|583388252|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545832|NCT01852058|583388253|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
161545833|NCT01852058|583388254|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545834|NCT01852058|583388255|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545835|NCT01852058|583388256|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545836|NCT01852058|583388257|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545837|NCT01852058|583388258|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545838|NCT01852058|583388259|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545839|NCT01852058|583388260|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161545840|NCT01852058|583388249|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545841|NCT01852058|583388250|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545842|NCT01852058|583388251|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545843|NCT01852058|583388252|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545844|NCT01852058|583388253|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
161545845|NCT01852058|583388254|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
161545846|NCT01852058|583388255|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545847|NCT01852058|583388256|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545848|NCT01852058|583388257|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545849|NCT01852058|583388258|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545850|NCT01852058|583388259|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545851|NCT01852058|583388260|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
161545852|NCT01852058|583388249|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545853|NCT01852058|583388250|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161680626|NCT01536951|583882988|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680627|NCT01536951|583882980|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
161680628|NCT01536951|583882981|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
161680629|NCT01536951|583882982|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
161680630|NCT01536951|583882983|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
161680631|NCT01536951|583882984|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
161680632|NCT01536951|583882985|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
161680633|NCT01536951|583882986|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
161680634|NCT01536951|583882987|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
161680635|NCT01536951|583882988|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
161680636|NCT01843972|583882991|FG000|Overall Study|Withdrawal by Subject|0|||
161680637|NCT01843972|583882992|FG001|Overall Study|Withdrawal by Subject|0|||
161680638|NCT01843972|583882993|FG002|Overall Study|Withdrawal by Subject|0|||
161680639|NCT01843972|583882994|FG003|Overall Study|Withdrawal by Subject|0|||
161680640|NCT01843972|583882995|FG004|Overall Study|Withdrawal by Subject|1|||
161545854|NCT01852058|583388251|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545855|NCT01852058|583388252|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
161545856|NCT01852058|583388253|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545857|NCT01852058|583388254|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545858|NCT01852058|583388255|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545859|NCT01852058|583388256|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545860|NCT01852058|583388257|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545861|NCT01852058|583388258|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545862|NCT01852058|583388259|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545863|NCT01852058|583388260|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161545864|NCT01852058|583388249|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545865|NCT01852058|583388250|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545866|NCT01852058|583388251|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545867|NCT01852058|583388252|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545868|NCT01852058|583388253|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
161545869|NCT01852058|583388254|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
161545870|NCT01852058|583388255|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545871|NCT01852058|583388256|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545872|NCT01852058|583388257|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545873|NCT01852058|583388258|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545874|NCT01852058|583388259|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545875|NCT01852058|583388260|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
161545876|NCT01852058|583388249|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545877|NCT01852058|583388250|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545878|NCT01852058|583388251|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161594785|NCT05329220|583567869|FG001|Follow-up Period|Lost to Follow-up|1|||
161594786|NCT05329220|583567870|FG002|Follow-up Period|Lost to Follow-up|2|||
161594787|NCT05329220|583567871|FG003|Follow-up Period|Lost to Follow-up|2|||
161594788|NCT05329220|583567872|FG004|Follow-up Period|Lost to Follow-up|113|||
161594789|NCT05329220|583567873|FG005|Follow-up Period|Lost to Follow-up|89|||
161594790|NCT05329220|583567868|FG000|Follow-up Period|Physician Decision|0|||
161594791|NCT05329220|583567869|FG001|Follow-up Period|Physician Decision|0|||
161594792|NCT05329220|583567870|FG002|Follow-up Period|Physician Decision|0|||
161594793|NCT05329220|583567871|FG003|Follow-up Period|Physician Decision|0|||
161594794|NCT05329220|583567872|FG004|Follow-up Period|Physician Decision|2|||
161594795|NCT05329220|583567873|FG005|Follow-up Period|Physician Decision|2|||
161594796|NCT05329220|583567868|FG000|Follow-up Period|Protocol Violation|0|||
161594797|NCT05329220|583567869|FG001|Follow-up Period|Protocol Violation|0|||
161594798|NCT05329220|583567870|FG002|Follow-up Period|Protocol Violation|0|||
161594799|NCT05329220|583567871|FG003|Follow-up Period|Protocol Violation|0|||
161594800|NCT05329220|583567872|FG004|Follow-up Period|Protocol Violation|0|||
161594801|NCT05329220|583567873|FG005|Follow-up Period|Protocol Violation|1|||
161594802|NCT05329220|583567868|FG000|Follow-up Period|Withdrawal by Subject|0|||
161594803|NCT05329220|583567869|FG001|Follow-up Period|Withdrawal by Subject|0|||
161594804|NCT05329220|583567870|FG002|Follow-up Period|Withdrawal by Subject|1|||
161594805|NCT05329220|583567871|FG003|Follow-up Period|Withdrawal by Subject|1|||
161594806|NCT05329220|583567872|FG004|Follow-up Period|Withdrawal by Subject|34|||
161680641|NCT01843972|583882996|FG005|Overall Study|Withdrawal by Subject|0|||
161545879|NCT01852058|583388252|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545880|NCT01852058|583388253|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545881|NCT01852058|583388254|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545882|NCT01852058|583388255|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545883|NCT01852058|583388256|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
161545884|NCT01852058|583388257|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545885|NCT01852058|583388258|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545886|NCT01852058|583388259|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545887|NCT01852058|583388260|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
161545888|NCT01852058|583388249|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545889|NCT01852058|583388250|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545890|NCT01852058|583388251|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545891|NCT01852058|583388252|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545892|NCT01852058|583388253|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545893|NCT01852058|583388254|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545894|NCT01852058|583388255|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545895|NCT01852058|583388256|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545896|NCT01852058|583388257|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
161545897|NCT01852058|583388258|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545898|NCT01852058|583388259|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545899|NCT01852058|583388260|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
161545900|NCT01279343|583388261|FG000|Overall Study|Did not receive treatment|2|||
161545901|NCT01279343|583388262|FG001|Overall Study|Did not receive treatment|6|||
161545902|NCT03287414|583388263|FG000|Treatment Epoch|Adverse Event|0|||
161545903|NCT03287414|583388264|FG001|Treatment Epoch|Adverse Event|1|||
161545904|NCT03287414|583388263|FG000|Treatment Epoch|Study terminated by sponsor|2|||
161545905|NCT03287414|583388264|FG001|Treatment Epoch|Study terminated by sponsor|2|||
161545906|NCT03287414|583388263|FG000|Treatment Epoch|Subject/Guardian decision|4|||
161545907|NCT03287414|583388264|FG001|Treatment Epoch|Subject/Guardian decision|0|||
161545908|NCT03287414|583388263|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
161545909|NCT03287414|583388264|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
161545910|NCT03287414|583388263|FG000|Treatment Epoch|Withdrawal by Subject|1|||
161545911|NCT03287414|583388264|FG001|Treatment Epoch|Withdrawal by Subject|0|||
161545912|NCT03287414|583388263|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
161545913|NCT03287414|583388264|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
161545914|NCT03287414|583388263|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
161545915|NCT03287414|583388264|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
161545916|NCT02613221|583388267|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
161545917|NCT02613221|583388267|FG000|Overall Study|Adverse Event|2|||
161545918|NCT02613221|583388267|FG000|Overall Study|Voluntary Discontinuation|1|||
161545919|NCT02613221|583388267|FG000|Overall Study|Delayed Treatment|1|||
161545920|NCT02613221|583388267|FG000|Overall Study|Enrolled but Not Treated|1|||
161545921|NCT01353222|583388272|FG000|Overall Study|Death|30|||
161545922|NCT01353222|583388273|FG001|Overall Study|Death|30|||
161545923|NCT01353222|583388272|FG000|Overall Study|Withdrawal by Subject|8|||
161545924|NCT01353222|583388273|FG001|Overall Study|Withdrawal by Subject|5|||
161545925|NCT01353222|583388272|FG000|Overall Study|Study Terminated|31|||
161545926|NCT01353222|583388273|FG001|Overall Study|Study Terminated|37|||
161545927|NCT01353222|583388272|FG000|Overall Study|Site closed research department|1|||
161545928|NCT01353222|583388273|FG001|Overall Study|Site closed research department|0|||
161545929|NCT01119898|583388274|FG000|Overall Study|Adverse Event|4|||
161545930|NCT01119898|583388275|FG001|Overall Study|Adverse Event|5|||
161545931|NCT01119898|583388274|FG000|Overall Study|Withdrawal by Subject|1|||
161545932|NCT01119898|583388275|FG001|Overall Study|Withdrawal by Subject|4|||
161545933|NCT01119898|583388274|FG000|Overall Study|Lack of Efficacy|0|||
161545934|NCT01119898|583388275|FG001|Overall Study|Lack of Efficacy|2|||
161545935|NCT01119898|583388274|FG000|Overall Study|Protocol Violation|1|||
161545936|NCT01119898|583388275|FG001|Overall Study|Protocol Violation|1|||
161545937|NCT01119898|583388274|FG000|Overall Study|Medical procedure|1|||
161545938|NCT01119898|583388275|FG001|Overall Study|Medical procedure|0|||
161680642|NCT01843972|583882997|FG006|Overall Study|Withdrawal by Subject|0|||
161680643|NCT01843972|583882998|FG007|Overall Study|Withdrawal by Subject|0|||
161680644|NCT01843972|583882999|FG008|Overall Study|Withdrawal by Subject|0|||
161680645|NCT01843972|583883000|FG009|Overall Study|Withdrawal by Subject|0|||
161545939|NCT01119898|583388274|FG000|Overall Study|Randomized in error did not participate|1|||
161830054|NCT02412722|584418108|FG004|Overall Study|Withdrawal by Subject|1|||
161545940|NCT01119898|583388275|FG001|Overall Study|Randomized in error did not participate|0|||
161545941|NCT01807650|583388278|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
161545942|NCT01807650|583388278|FG000|Overall Study|Adverse Event|5|||
161680646|NCT01817751|583883006|FG000|Overall Study|Physician Decision|1|||
161545943|NCT01807650|583388278|FG000|Overall Study|Other|2|||
161545944|NCT02217280|583388279|FG000|Overall Study|Withdrawal by Subject|2|||
161545945|NCT02217280|583388279|FG000|Overall Study|Post-consent sceen fail|2|||
161545946|NCT03573908|583388285|FG000|Treatment Period|Adverse Event|4|||
161545947|NCT03573908|583388286|FG001|Treatment Period|Adverse Event|9|||
161545948|NCT03573908|583388287|FG002|Treatment Period|Adverse Event|0|||
161545949|NCT03573908|583388288|FG003|Treatment Period|Adverse Event|0|||
161545950|NCT03573908|583388289|FG004|Treatment Period|Adverse Event|0|||
161545951|NCT03573908|583388285|FG000|Treatment Period|Protocol Violation|1|||
161545952|NCT03573908|583388286|FG001|Treatment Period|Protocol Violation|0|||
161545953|NCT03573908|583388287|FG002|Treatment Period|Protocol Violation|0|||
161545954|NCT03573908|583388288|FG003|Treatment Period|Protocol Violation|0|||
161545955|NCT03573908|583388289|FG004|Treatment Period|Protocol Violation|0|||
161545956|NCT03573908|583388285|FG000|Treatment Period|Withdrawal by Subject|7|||
161545957|NCT03573908|583388286|FG001|Treatment Period|Withdrawal by Subject|5|||
161545958|NCT03573908|583388287|FG002|Treatment Period|Withdrawal by Subject|0|||
161545959|NCT03573908|583388288|FG003|Treatment Period|Withdrawal by Subject|0|||
161545960|NCT03573908|583388289|FG004|Treatment Period|Withdrawal by Subject|0|||
161545961|NCT03573908|583388285|FG000|Treatment Period|Lost to Follow-up|7|||
161545962|NCT03573908|583388286|FG001|Treatment Period|Lost to Follow-up|6|||
161545963|NCT03573908|583388287|FG002|Treatment Period|Lost to Follow-up|0|||
161545964|NCT03573908|583388288|FG003|Treatment Period|Lost to Follow-up|0|||
161545965|NCT03573908|583388289|FG004|Treatment Period|Lost to Follow-up|0|||
161545966|NCT03573908|583388285|FG000|Treatment Period|Pregnancy|1|||
161545967|NCT03573908|583388286|FG001|Treatment Period|Pregnancy|0|||
161545968|NCT03573908|583388287|FG002|Treatment Period|Pregnancy|0|||
161545969|NCT03573908|583388288|FG003|Treatment Period|Pregnancy|0|||
161594807|NCT05329220|583567873|FG005|Follow-up Period|Withdrawal by Subject|35|||
161594808|NCT05329220|583567868|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161594809|NCT05329220|583567869|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161594810|NCT05329220|583567870|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
161594811|NCT05329220|583567871|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161594812|NCT05329220|583567872|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161594813|NCT05329220|583567873|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161594814|NCT05329220|583567868|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161594815|NCT05329220|583567869|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161594816|NCT05329220|583567870|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161594817|NCT05329220|583567871|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161594818|NCT05329220|583567872|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
161594819|NCT05329220|583567873|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161594820|NCT05329220|583567868|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161594821|NCT05329220|583567869|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161594822|NCT05329220|583567870|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161594823|NCT05329220|583567871|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161594824|NCT05329220|583567872|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
161594825|NCT05329220|583567873|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161594826|NCT05329220|583567868|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161594827|NCT05329220|583567869|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161594828|NCT05329220|583567870|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161594829|NCT05329220|583567871|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161594830|NCT05329220|583567872|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161594831|NCT05329220|583567873|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
161594832|NCT05329220|583567868|FG000|Follow-up Period|EARLY TERMINATION|0|||
161594833|NCT05329220|583567869|FG001|Follow-up Period|EARLY TERMINATION|0|||
161594834|NCT05329220|583567870|FG002|Follow-up Period|EARLY TERMINATION|0|||
161594835|NCT05329220|583567871|FG003|Follow-up Period|EARLY TERMINATION|0|||
161594836|NCT05329220|583567872|FG004|Follow-up Period|EARLY TERMINATION|0|||
161594837|NCT05329220|583567873|FG005|Follow-up Period|EARLY TERMINATION|1|||
161594838|NCT05329220|583567868|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161594839|NCT05329220|583567869|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161594840|NCT05329220|583567870|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161594841|NCT05329220|583567871|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161545970|NCT03573908|583388289|FG004|Treatment Period|Pregnancy|0|||
161545971|NCT03573908|583388285|FG000|Treatment Period|Other, Not Specified|4|||
161545972|NCT03573908|583388286|FG001|Treatment Period|Other, Not Specified|6|||
161545973|NCT03573908|583388287|FG002|Treatment Period|Other, Not Specified|0|||
161545974|NCT03573908|583388288|FG003|Treatment Period|Other, Not Specified|0|||
161545975|NCT03573908|583388289|FG004|Treatment Period|Other, Not Specified|0|||
161545976|NCT03573908|583388285|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161545977|NCT03573908|583388286|FG001|Randomized Withdrawal Period|Adverse Event|0|||
161545978|NCT03573908|583388287|FG002|Randomized Withdrawal Period|Adverse Event|3|||
161545979|NCT03573908|583388288|FG003|Randomized Withdrawal Period|Adverse Event|0|||
161545980|NCT03573908|583388289|FG004|Randomized Withdrawal Period|Adverse Event|0|||
161545981|NCT03573908|583388285|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161545982|NCT03573908|583388286|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161545983|NCT03573908|583388287|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161545984|NCT03573908|583388288|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161545985|NCT03573908|583388289|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
161545986|NCT03573908|583388285|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
161545987|NCT03573908|583388286|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
161545988|NCT03573908|583388287|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
161545989|NCT03573908|583388288|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
161545990|NCT03573908|583388289|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
161545991|NCT03573908|583388285|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
161545992|NCT03573908|583388286|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
161545993|NCT03573908|583388287|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
161545994|NCT03573908|583388288|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
161545995|NCT03573908|583388289|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
161545996|NCT04006925|583388290|FG000|Overall Study|Side effects|2|||
161545997|NCT04006925|583388291|FG001|Overall Study|Side effects|0|||
161545998|NCT02906683|583389796|FG000|Overall Study|Adverse Event|0|||
161545999|NCT02906683|583389797|FG001|Overall Study|Adverse Event|1|||
161546000|NCT02906683|583389798|FG002|Overall Study|Adverse Event|0|||
161546001|NCT02906683|583389796|FG000|Overall Study|Physician Decision|0|||
161546002|NCT02906683|583389797|FG001|Overall Study|Physician Decision|1|||
161546003|NCT02906683|583389798|FG002|Overall Study|Physician Decision|1|||
161546004|NCT02906683|583389796|FG000|Overall Study|Withdrawal by Subject|0|||
161546005|NCT02906683|583389797|FG001|Overall Study|Withdrawal by Subject|2|||
161546006|NCT02906683|583389798|FG002|Overall Study|Withdrawal by Subject|1|||
161546007|NCT02906683|583389796|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
161546008|NCT02906683|583389797|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
161546009|NCT02906683|583389798|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
161546010|NCT02906683|583389796|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
161546011|NCT02906683|583389797|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
161546012|NCT02906683|583389798|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
161546013|NCT01158378|583389799|FG000|Overall Study|Death|4|||
161546014|NCT01158378|583389800|FG001|Overall Study|Death|5|||
161546015|NCT01158378|583389799|FG000|Overall Study|Lost to Follow-up|2|||
161546016|NCT01158378|583389800|FG001|Overall Study|Lost to Follow-up|4|||
161546017|NCT01158378|583389799|FG000|Overall Study|Withdrawal by Subject|4|||
161546018|NCT01158378|583389800|FG001|Overall Study|Withdrawal by Subject|0|||
161546019|NCT02531295|583389805|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
161546020|NCT02531295|583389806|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
161546021|NCT02531295|583389807|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
161546022|NCT02531295|583389808|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
161546023|NCT02531295|583389809|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
161546024|NCT02531295|583389810|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
161546025|NCT00453310|583389811|FG000|Overall Study|Progression of Disease|10|||
161546026|NCT01806740|583389812|FG000|Overall Study|Withdrawal by Subject|4|||
161546027|NCT01806740|583389812|FG000|Overall Study|Physician Decision|1|||
161546028|NCT01806740|583389812|FG000|Overall Study|Patient's refusal of treatment|1|||
161546029|NCT04666922|583389813|FG000|Overall Study|Withdrawal by Subject|1|||
161546030|NCT04666922|583389814|FG001|Overall Study|Withdrawal by Subject|0|||
161546031|NCT04666922|583389815|FG002|Overall Study|Withdrawal by Subject|0|||
161546032|NCT04666922|583389816|FG003|Overall Study|Withdrawal by Subject|0|||
161546033|NCT04666922|583389817|FG004|Overall Study|Withdrawal by Subject|0|||
161546034|NCT04666922|583389818|FG005|Overall Study|Withdrawal by Subject|0|||
161546035|NCT04666922|583389819|FG006|Overall Study|Withdrawal by Subject|0|||
161546036|NCT03980184|583389822|FG000|Overall Study|Dropped out before treatment|2|||
161546037|NCT03980184|583389823|FG001|Overall Study|Dropped out before treatment|2|||
161546038|NCT03980184|583389822|FG000|Overall Study|Lost to Follow-up|11|||
161546039|NCT03980184|583389823|FG001|Overall Study|Lost to Follow-up|13|||
161546040|NCT02176421|583389826|FG000|Overall Study|Lost to Follow-up|4|||
161546041|NCT02176421|583389826|FG000|Overall Study|Adverse Event|1|||
161546042|NCT01129336|583389830|FG000|Overall Study|Protocol Violation|1|||
161546043|NCT01129336|583389831|FG001|Overall Study|Protocol Violation|0|||
161546044|NCT01129336|583389830|FG000|Overall Study|Disease Progression|1|||
161546045|NCT01129336|583389831|FG001|Overall Study|Disease Progression|4|||
161680647|NCT00545402|583883007|FG000|Overall Study|Discontinuation of treatment|17|||
161546046|NCT01129336|583389830|FG000|Overall Study|Lost to Follow-up|1|||
161546047|NCT01129336|583389831|FG001|Overall Study|Lost to Follow-up|0|||
161546048|NCT01129336|583389830|FG000|Overall Study|Withdrawal by Subject|7|||
161546049|NCT01129336|583389831|FG001|Overall Study|Withdrawal by Subject|4|||
161546050|NCT01129336|583389830|FG000|Overall Study|Adverse Event|0|||
161546051|NCT01129336|583389831|FG001|Overall Study|Adverse Event|1|||
161546052|NCT01129336|583389830|FG000|Overall Study|Missing Study Completion Status|2|||
161546053|NCT01129336|583389831|FG001|Overall Study|Missing Study Completion Status|3|||
161546054|NCT01129336|583389830|FG000|Overall Study|Death|0|||
161546055|NCT01129336|583389831|FG001|Overall Study|Death|4|||
161546056|NCT00467142|583389834|FG000|Overall Study|Withdrawal by Subject|1|||
161546057|NCT00467142|583389834|FG000|Overall Study|Adverse Event|1|||
161546058|NCT00467142|583389834|FG000|Overall Study|Protocol Violation|1|||
161546059|NCT00154310|583389835|FG000|Overall Study|Adverse Event|19|||
161546060|NCT00154310|583389836|FG001|Overall Study|Adverse Event|9|||
161546061|NCT00154310|583389835|FG000|Overall Study|Lack of Efficacy|5|||
161546062|NCT00154310|583389836|FG001|Overall Study|Lack of Efficacy|4|||
161546063|NCT00154310|583389835|FG000|Overall Study|Protocol Violation|4|||
161546064|NCT00154310|583389836|FG001|Overall Study|Protocol Violation|2|||
161546065|NCT00154310|583389835|FG000|Overall Study|Withdrawal by Subject|9|||
161546066|NCT00154310|583389836|FG001|Overall Study|Withdrawal by Subject|3|||
161546067|NCT00154310|583389835|FG000|Overall Study|Lost to Follow-up|0|||
161546068|NCT00154310|583389836|FG001|Overall Study|Lost to Follow-up|8|||
161546069|NCT00154310|583389835|FG000|Overall Study|Administrative problems|0|||
161546070|NCT00154310|583389836|FG001|Overall Study|Administrative problems|1|||
161546071|NCT00154310|583389835|FG000|Overall Study|Death|0|||
161546072|NCT00154310|583389836|FG001|Overall Study|Death|1|||
161546073|NCT03447730|583389838|FG000|Overall Study|Adverse Event|0|||
161546074|NCT03447730|583389839|FG001|Overall Study|Adverse Event|2|||
161546075|NCT03447730|583389840|FG002|Overall Study|Adverse Event|0|||
161546076|NCT02086162|583389841|FG000|Overall Study|Withdrawal by Subject|4|||
161546077|NCT02086162|583389842|FG001|Overall Study|Withdrawal by Subject|4|||
161546078|NCT02086162|583389841|FG000|Overall Study|moved|1|||
161546079|NCT02086162|583389842|FG001|Overall Study|moved|1|||
161546080|NCT02086162|583389841|FG000|Overall Study|Lost to Follow-up|4|||
161546081|NCT02086162|583389842|FG001|Overall Study|Lost to Follow-up|2|||
161546082|NCT02086162|583389841|FG000|Overall Study|Death|1|||
161546083|NCT02086162|583389842|FG001|Overall Study|Death|0|||
161546084|NCT01248962|583389846|FG000|Overall Study|Withdrawal by Subject|1|||
161546085|NCT01248962|583389847|FG001|Overall Study|Withdrawal by Subject|1|||
161546086|NCT01248962|583389846|FG000|Overall Study|Adverse Event|2|||
161546087|NCT01248962|583389847|FG001|Overall Study|Adverse Event|1|||
161546088|NCT01248962|583389846|FG000|Overall Study|Complete Response after 4 Cycles|1|||
161546089|NCT01248962|583389847|FG001|Overall Study|Complete Response after 4 Cycles|0|||
161546090|NCT01248962|583389846|FG000|Overall Study|Complete Response after 3 Cycles|0|||
161546091|NCT01248962|583389847|FG001|Overall Study|Complete Response after 3 Cycles|1|||
161546092|NCT01248962|583389846|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
161546093|NCT01248962|583389847|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
161546094|NCT04848662|583389849|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
161546095|NCT04848662|583389850|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
161546096|NCT01350505|583389851|FG000|Overall Study|Lost to Follow-up|4|||
161546097|NCT01834222|583389852|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
161546098|NCT04702568|583389853|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
161546099|NCT04702568|583389854|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
161546100|NCT04702568|583389853|FG000|Overall Study|Pregnancy|1|||
161546101|NCT04702568|583389854|FG001|Overall Study|Pregnancy|0|||
161546102|NCT04702568|583389853|FG000|Overall Study|Bone marrow transplant|1|||
161546103|NCT04702568|583389854|FG001|Overall Study|Bone marrow transplant|0|||
161546104|NCT04702568|583389853|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
161546105|NCT04702568|583389854|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
161546106|NCT04702568|583389853|FG000|Overall Study|Withdrawal by Subject|0|||
161546107|NCT04702568|583389854|FG001|Overall Study|Withdrawal by Subject|2|||
161546108|NCT00423852|583389857|FG000|Overall Study|Removed pior to the high-dose portion|3|||
161546109|NCT00089895|583389858|FG000|Overall Study|Consent Withdrawn|11|||
161546110|NCT00089895|583389859|FG001|Overall Study|Consent Withdrawn|14|||
161546111|NCT00089895|583389858|FG000|Overall Study|Technical reason|7|||
161546112|NCT00089895|583389859|FG001|Overall Study|Technical reason|2|||
161546113|NCT00089895|583389858|FG000|Overall Study|Surgery|0|||
161546114|NCT00089895|583389859|FG001|Overall Study|Surgery|1|||
161546115|NCT00089895|583389858|FG000|Overall Study|Bleeding|0|||
161546116|NCT00089895|583389859|FG001|Overall Study|Bleeding|2|||
161546117|NCT00089895|583389858|FG000|Overall Study|Physician Decision|3|||
161546118|NCT00089895|583389859|FG001|Overall Study|Physician Decision|7|||
161830055|NCT02412722|584418109|FG005|Overall Study|Withdrawal by Subject|1|||
161546119|NCT00089895|583389858|FG000|Overall Study|Exclusion criteria met|6|||
161546120|NCT00089895|583389859|FG001|Overall Study|Exclusion criteria met|6|||
161546121|NCT00089895|583389858|FG000|Overall Study|Not otherwise specified|4|||
161546122|NCT00089895|583389859|FG001|Overall Study|Not otherwise specified|8|||
161546123|NCT00089895|583389858|FG000|Overall Study|Missing|4|||
161546124|NCT00089895|583389859|FG001|Overall Study|Missing|2|||
161546125|NCT05644353|583389860|FG000|Overall Study|Physician Decision|1|||
161546126|NCT05644353|583389861|FG001|Overall Study|Physician Decision|0|||
161546127|NCT05644353|583389862|FG002|Overall Study|Physician Decision|0|||
161546128|NCT05644353|583389863|FG003|Overall Study|Physician Decision|0|||
161546129|NCT05644353|583389864|FG004|Overall Study|Physician Decision|0|||
161546130|NCT05644353|583389865|FG005|Overall Study|Physician Decision|0|||
161546131|NCT05644353|583389860|FG000|Overall Study|Protocol Violation|1|||
161546132|NCT05644353|583389861|FG001|Overall Study|Protocol Violation|0|||
161546133|NCT05644353|583389862|FG002|Overall Study|Protocol Violation|0|||
161546134|NCT05644353|583389863|FG003|Overall Study|Protocol Violation|0|||
161546135|NCT05644353|583389864|FG004|Overall Study|Protocol Violation|0|||
161546136|NCT05644353|583389865|FG005|Overall Study|Protocol Violation|0|||
161546137|NCT05644353|583389860|FG000|Overall Study|Withdrawal by Subject|0|||
161546138|NCT05644353|583389861|FG001|Overall Study|Withdrawal by Subject|2|||
161546139|NCT05644353|583389862|FG002|Overall Study|Withdrawal by Subject|0|||
161546140|NCT05644353|583389863|FG003|Overall Study|Withdrawal by Subject|0|||
161546141|NCT05644353|583389864|FG004|Overall Study|Withdrawal by Subject|1|||
161546142|NCT05644353|583389865|FG005|Overall Study|Withdrawal by Subject|0|||
161546143|NCT05644353|583389860|FG000|Overall Study|Lost to Follow-up|0|||
161546144|NCT05644353|583389861|FG001|Overall Study|Lost to Follow-up|0|||
161546145|NCT05644353|583389862|FG002|Overall Study|Lost to Follow-up|1|||
161546146|NCT05644353|583389863|FG003|Overall Study|Lost to Follow-up|0|||
161546147|NCT05644353|583389864|FG004|Overall Study|Lost to Follow-up|0|||
161546148|NCT05644353|583389865|FG005|Overall Study|Lost to Follow-up|0|||
161546149|NCT01535274|583389866|FG000|Overall Study|Determined to be ineligible|0|||
161546150|NCT01535274|583389867|FG001|Overall Study|Determined to be ineligible|1|||
161546151|NCT01535274|583389866|FG000|Overall Study|Misallocated to propofol intervention|0|||
161546152|NCT01535274|583389867|FG001|Overall Study|Misallocated to propofol intervention|1|||
161546153|NCT02954458|583389870|FG000|Overall Study|Adverse Event|0|||
161546154|NCT02954458|583389871|FG001|Overall Study|Adverse Event|0|||
161546155|NCT02954458|583389872|FG002|Overall Study|Adverse Event|0|||
161546156|NCT02954458|583389873|FG003|Overall Study|Adverse Event|1|||
161546157|NCT02954458|583389870|FG000|Overall Study|Withdrawal by Subject|0|||
161546158|NCT02954458|583389871|FG001|Overall Study|Withdrawal by Subject|0|||
161546159|NCT02954458|583389872|FG002|Overall Study|Withdrawal by Subject|0|||
161546160|NCT02954458|583389873|FG003|Overall Study|Withdrawal by Subject|1|||
161546161|NCT02954458|583389870|FG000|Overall Study|Physician Decision|0|||
161546162|NCT02954458|583389871|FG001|Overall Study|Physician Decision|0|||
161546163|NCT02954458|583389872|FG002|Overall Study|Physician Decision|1|||
161546164|NCT02954458|583389873|FG003|Overall Study|Physician Decision|1|||
161546165|NCT02954458|583389870|FG000|Overall Study|Lost to Follow-up|1|||
161546166|NCT02954458|583389871|FG001|Overall Study|Lost to Follow-up|0|||
161546167|NCT02954458|583389872|FG002|Overall Study|Lost to Follow-up|0|||
161546168|NCT02954458|583389873|FG003|Overall Study|Lost to Follow-up|1|||
161546169|NCT02954458|583389870|FG000|Overall Study|Death|0|||
161546170|NCT02954458|583389871|FG001|Overall Study|Death|0|||
161546171|NCT02954458|583389872|FG002|Overall Study|Death|0|||
161546172|NCT02954458|583389873|FG003|Overall Study|Death|1|||
161546173|NCT02954458|583389870|FG000|Overall Study|Other|0|||
161546174|NCT02954458|583389871|FG001|Overall Study|Other|0|||
161546175|NCT02954458|583389872|FG002|Overall Study|Other|0|||
161546176|NCT02954458|583389873|FG003|Overall Study|Other|7|||
161546177|NCT02690077|583389876|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
161546178|NCT02690077|583389877|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
161546179|NCT02690077|583389876|FG000|Overall Study|Withdrawal by Subject|0|||
161546180|NCT02690077|583389877|FG001|Overall Study|Withdrawal by Subject|5|||
161546181|NCT02690077|583389876|FG000|Overall Study|Excluded by IRB|0|||
161546182|NCT02690077|583389877|FG001|Overall Study|Excluded by IRB|2|||
161546183|NCT01845974|583389878|FG000|Overall Study|screen failure|1|||
161546184|NCT01845974|583389879|FG001|Overall Study|screen failure|0|||
161546185|NCT02667886|583389880|FG000|Dose Escalation (Part A)|Adverse Event|1|||
161546186|NCT02667886|583389881|FG001|Dose Escalation (Part A)|Adverse Event|3|||
161546187|NCT02667886|583389882|FG002|Dose Escalation (Part A)|Adverse Event|1|||
161546188|NCT02667886|583389883|FG003|Dose Escalation (Part A)|Adverse Event|0|||
161546189|NCT02667886|583389884|FG004|Dose Escalation (Part A)|Adverse Event|0|||
161546190|NCT02667886|583389880|FG000|Dose Escalation (Part A)|Disease Progression|1|||
161546191|NCT02667886|583389881|FG001|Dose Escalation (Part A)|Disease Progression|4|||
161546192|NCT02667886|583389882|FG002|Dose Escalation (Part A)|Disease Progression|3|||
161546193|NCT02667886|583389883|FG003|Dose Escalation (Part A)|Disease Progression|0|||
161546194|NCT02667886|583389884|FG004|Dose Escalation (Part A)|Disease Progression|0|||
161546195|NCT02667886|583389880|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
161546196|NCT02667886|583389881|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
161546197|NCT02667886|583389882|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
161546198|NCT02667886|583389883|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
161546199|NCT02667886|583389884|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
161546200|NCT02667886|583389880|FG000|Dose Expansion (Part B)|Adverse Event|0|||
161546201|NCT02667886|583389881|FG001|Dose Expansion (Part B)|Adverse Event|0|||
161546202|NCT02667886|583389882|FG002|Dose Expansion (Part B)|Adverse Event|0|||
161546203|NCT02667886|583389883|FG003|Dose Expansion (Part B)|Adverse Event|9|||
161546204|NCT02667886|583389884|FG004|Dose Expansion (Part B)|Adverse Event|0|||
161546205|NCT02667886|583389880|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
161546206|NCT02667886|583389881|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
161546207|NCT02667886|583389882|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
161546208|NCT02667886|583389883|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
161546209|NCT02667886|583389884|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
161546210|NCT02667886|583389880|FG000|Dose Expansion (Part B)|Disease Progression|0|||
161546211|NCT02667886|583389881|FG001|Dose Expansion (Part B)|Disease Progression|0|||
161546212|NCT02667886|583389882|FG002|Dose Expansion (Part B)|Disease Progression|0|||
161546213|NCT02667886|583389883|FG003|Dose Expansion (Part B)|Disease Progression|38|||
161546214|NCT02667886|583389884|FG004|Dose Expansion (Part B)|Disease Progression|0|||
161546215|NCT02667886|583389880|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
161546216|NCT02667886|583389881|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
161546217|NCT02667886|583389882|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
161546218|NCT02667886|583389883|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
161546219|NCT02667886|583389884|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
161546220|NCT02667886|583389880|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
161546221|NCT02667886|583389881|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
161546222|NCT02667886|583389882|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
161546223|NCT02667886|583389883|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
161546224|NCT02667886|583389884|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
161546225|NCT02667886|583389880|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
161546226|NCT02667886|583389881|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
161546227|NCT02667886|583389882|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
161546228|NCT02667886|583389883|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
161546229|NCT02667886|583389884|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
161546230|NCT01905046|583389885|FG000|Months 13-24|Withdrawal by Subject|10|||
161546231|NCT01905046|583389886|FG001|Months 13-24|Withdrawal by Subject|10|||
161546232|NCT01905046|583389885|FG000|Months 13-24|Adverse Event|3|||
161546233|NCT01905046|583389886|FG001|Months 13-24|Adverse Event|2|||
161546234|NCT01905046|583389885|FG000|Months 13-24|Protocol Violation|3|||
161546235|NCT01905046|583389886|FG001|Months 13-24|Protocol Violation|3|||
161546236|NCT01905046|583389885|FG000|Months 13-24|Physician Decision|1|||
161546237|NCT01905046|583389886|FG001|Months 13-24|Physician Decision|0|||
161546238|NCT05672680|583389887|FG000|Overall Study|Patient Did Not Complete the Form|5|||
161546239|NCT05672680|583389888|FG001|Overall Study|Patient Did Not Complete the Form|4|||
161546240|NCT05672680|583389887|FG000|Overall Study|Procedure Aborted|1|||
161546241|NCT05672680|583389888|FG001|Overall Study|Procedure Aborted|0|||
161546242|NCT03929562|583389889|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
161546243|NCT03929562|583389890|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
161546244|NCT03929562|583389889|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
161546245|NCT03929562|583389890|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
161546246|NCT03929562|583389889|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
161546247|NCT03929562|583389890|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
161546248|NCT02778399|583389899|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
161546249|NCT02778399|583389900|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
161546250|NCT02778399|583389901|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
161546251|NCT02778399|583389902|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
161546252|NCT02778399|583389903|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
161546253|NCT02778399|583389904|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
161546254|NCT02778399|583389899|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
161546255|NCT02778399|583389900|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
161546256|NCT02778399|583389901|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
161546257|NCT02778399|583389902|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
161546258|NCT02778399|583389903|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
161546259|NCT02778399|583389904|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
161546260|NCT02778399|583389899|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
161546261|NCT02778399|583389900|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
161546262|NCT02778399|583389901|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
161546263|NCT02778399|583389902|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
161546264|NCT02778399|583389903|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
161546265|NCT02778399|583389904|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
161546266|NCT02778399|583389899|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
161546267|NCT02778399|583389900|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
161546268|NCT02778399|583389901|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
161546269|NCT02778399|583389902|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
161546270|NCT02778399|583389903|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
161546271|NCT02778399|583389904|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
161546272|NCT02778399|583389899|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
161546273|NCT02778399|583389900|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
161546274|NCT02778399|583389901|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
161546275|NCT02778399|583389902|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
161546276|NCT02778399|583389903|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
161546277|NCT02778399|583389904|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
161546278|NCT02778399|583389899|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
161546279|NCT02778399|583389900|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
161546280|NCT02778399|583389901|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
161546281|NCT02778399|583389902|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
161546282|NCT02778399|583389903|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
161546283|NCT02778399|583389904|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
161546284|NCT02778399|583389899|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
161546285|NCT02778399|583389900|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
161546286|NCT02778399|583389901|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
161546287|NCT02778399|583389902|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
161546288|NCT02778399|583389903|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
161546289|NCT02778399|583389904|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
161546290|NCT02778399|583389899|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
161546291|NCT02778399|583389900|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
161546292|NCT02778399|583389901|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
161546293|NCT02778399|583389902|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
161546294|NCT02778399|583389903|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
161546295|NCT02778399|583389904|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
161546296|NCT02778399|583389899|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
161546297|NCT02778399|583389900|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
161546298|NCT02778399|583389901|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
161546299|NCT02778399|583389902|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
161546300|NCT02778399|583389903|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
161546301|NCT02778399|583389904|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
161546302|NCT02778399|583389899|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
161546303|NCT02778399|583389900|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
161546304|NCT02778399|583389901|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
161546305|NCT02778399|583389902|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
161546306|NCT02778399|583389903|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
161546307|NCT02778399|583389904|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
161546308|NCT02778399|583389899|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
161546309|NCT02778399|583389900|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
161546310|NCT02778399|583389901|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
161546311|NCT02778399|583389902|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
161546312|NCT02778399|583389903|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
161546313|NCT02778399|583389904|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
161546314|NCT00405639|583389906|FG000|Overall Study|Withdrawal by Subject|1|||
161546315|NCT00405639|583389907|FG001|Overall Study|Withdrawal by Subject|0|||
161546316|NCT00405639|583389906|FG000|Overall Study|Adverse Event|1|||
161546317|NCT00405639|583389907|FG001|Overall Study|Adverse Event|0|||
161594842|NCT05329220|583567872|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161594843|NCT05329220|583567873|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
161594844|NCT05329220|583567868|FG000|Follow-up Period|DROPPED|0|||
161594845|NCT05329220|583567869|FG001|Follow-up Period|DROPPED|0|||
161594846|NCT05329220|583567870|FG002|Follow-up Period|DROPPED|0|||
161594847|NCT05329220|583567871|FG003|Follow-up Period|DROPPED|0|||
161594848|NCT05329220|583567872|FG004|Follow-up Period|DROPPED|0|||
161546318|NCT00405639|583389906|FG000|Overall Study|Seizure prior to receiving BNP|1|||
161546319|NCT00405639|583389907|FG001|Overall Study|Seizure prior to receiving BNP|0|||
161546320|NCT00612534|583389910|FG000|Overall Study|Adverse Event|0|||
161546321|NCT00612534|583389911|FG001|Overall Study|Adverse Event|4|||
161546322|NCT00612534|583389912|FG002|Overall Study|Adverse Event|2|||
161546323|NCT00612534|583389913|FG003|Overall Study|Adverse Event|1|||
161546324|NCT00612534|583389910|FG000|Overall Study|Lack of Efficacy|13|||
161546325|NCT00612534|583389911|FG001|Overall Study|Lack of Efficacy|12|||
161546326|NCT00612534|583389912|FG002|Overall Study|Lack of Efficacy|5|||
161546327|NCT00612534|583389913|FG003|Overall Study|Lack of Efficacy|16|||
161546328|NCT00612534|583389910|FG000|Overall Study|Other Reason|0|||
161546329|NCT00612534|583389911|FG001|Overall Study|Other Reason|1|||
161546330|NCT00612534|583389912|FG002|Overall Study|Other Reason|0|||
161546331|NCT00612534|583389913|FG003|Overall Study|Other Reason|0|||
161546332|NCT02130284|583389920|FG000|Overall Study|Withdrawal by Subject|3|||
161546333|NCT02130284|583389920|FG000|Overall Study|Subject Withdrew Consent|1|||
161546334|NCT02130284|583389920|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
161546335|NCT02130284|583389920|FG000|Overall Study|Subject was screened as backup for study|3|||
161546336|NCT02130284|583389920|FG000|Overall Study|Screen Failure|1|||
161546337|NCT01435655|583389922|FG000|Overall Study|Death|2|||
161546338|NCT01435655|583389922|FG000|Overall Study|Other|1|||
161546339|NCT02839343|583389925|FG000|Overall Study|Withdrawal by Subject|3|||
161546340|NCT02839343|583389926|FG001|Overall Study|Withdrawal by Subject|1|||
161546341|NCT02839343|583389925|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
161546342|NCT02839343|583389926|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
161546343|NCT02839343|583389925|FG000|Overall Study|Adverse Event|1|||
161546344|NCT02839343|583389926|FG001|Overall Study|Adverse Event|0|||
161546345|NCT02223754|583389927|FG000|Period 1|Adverse Event|1|||
161546346|NCT02223754|583389928|FG001|Period 1|Adverse Event|0|||
161546347|NCT02223754|583389927|FG000|Period 1|Lost to Follow-up|0|||
161546348|NCT02223754|583389928|FG001|Period 1|Lost to Follow-up|1|||
161546349|NCT02223754|583389927|FG000|Period 1|Protocol Violation|2|||
161546350|NCT02223754|583389928|FG001|Period 1|Protocol Violation|4|||
161546351|NCT02223754|583389927|FG000|Period 1|Withdrawal by Subject|0|||
161546352|NCT02223754|583389928|FG001|Period 1|Withdrawal by Subject|4|||
161546353|NCT02223754|583389927|FG000|Period 1|Test Article No Longer Available|1|||
161546354|NCT02223754|583389928|FG001|Period 1|Test Article No Longer Available|5|||
161546355|NCT02223754|583389927|FG000|Period 1|Unsatisfactory Visual Response|0|||
161546356|NCT02223754|583389928|FG001|Period 1|Unsatisfactory Visual Response|1|||
161546357|NCT02223754|583389927|FG000|Period 2|Adverse Event|0|||
161546358|NCT02223754|583389928|FG001|Period 2|Adverse Event|1|||
161546359|NCT02223754|583389927|FG000|Period 2|Protocol Violation|1|||
161546360|NCT02223754|583389928|FG001|Period 2|Protocol Violation|0|||
161546361|NCT02223754|583389927|FG000|Period 2|Lens Discomfort|1|||
161546362|NCT02223754|583389928|FG001|Period 2|Lens Discomfort|1|||
161546363|NCT02223754|583389927|FG000|Period 2|Lost to Follow-up|1|||
161546364|NCT02223754|583389928|FG001|Period 2|Lost to Follow-up|0|||
161546365|NCT02223754|583389927|FG000|Period 2|Test Article No Longer Available|0|||
161594849|NCT05329220|583567873|FG005|Follow-up Period|DROPPED|1|||
161594850|NCT05329220|583567868|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161594851|NCT05329220|583567869|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161594852|NCT05329220|583567870|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161594853|NCT05329220|583567871|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161546366|NCT02223754|583389928|FG001|Period 2|Test Article No Longer Available|1|||
161546367|NCT04395183|583389929|FG000|Overall Study|Withdrawal by Subject|1|||
161546368|NCT04395183|583389930|FG001|Overall Study|Withdrawal by Subject|0|||
161546369|NCT04395183|583389931|FG002|Overall Study|Withdrawal by Subject|2|||
161546370|NCT04395183|583389932|FG003|Overall Study|Withdrawal by Subject|2|||
161546371|NCT02234063|583389933|FG000|Overall Study|Lost to Follow-up|235|||
161546372|NCT02234063|583389934|FG001|Overall Study|Lost to Follow-up|42|||
161546373|NCT02234063|583389933|FG000|Overall Study|Withdrawal by Subject|20|||
161546374|NCT02234063|583389934|FG001|Overall Study|Withdrawal by Subject|1|||
161546375|NCT00510458|583389935|FG000|Overall Study|5 year not evaluable/missed|21|||
161546376|NCT00510458|583389935|FG000|Overall Study|Death|1|||
161546377|NCT00510458|583389935|FG000|Overall Study|Terminated|14|||
161830056|NCT02412722|584418104|FG000|Overall Study|Lost to Follow-up|0|||
161830057|NCT02412722|584418105|FG001|Overall Study|Lost to Follow-up|0|||
161830058|NCT02412722|584418106|FG002|Overall Study|Lost to Follow-up|0|||
161830059|NCT02412722|584418107|FG003|Overall Study|Lost to Follow-up|0|||
161830060|NCT02412722|584418108|FG004|Overall Study|Lost to Follow-up|1|||
161830061|NCT02412722|584418109|FG005|Overall Study|Lost to Follow-up|0|||
161830062|NCT02412722|584418104|FG000|Overall Study|Received drug in run-in and discontinued|0|||
161830063|NCT02412722|584418105|FG001|Overall Study|Received drug in run-in and discontinued|2|||
161830064|NCT02412722|584418106|FG002|Overall Study|Received drug in run-in and discontinued|0|||
161830065|NCT02412722|584418107|FG003|Overall Study|Received drug in run-in and discontinued|0|||
161830066|NCT02412722|584418108|FG004|Overall Study|Received drug in run-in and discontinued|0|||
161830067|NCT02412722|584418109|FG005|Overall Study|Received drug in run-in and discontinued|0|||
161830068|NCT02412722|584418104|FG000|Overall Study|Reason not Specified|3|||
161546378|NCT00510458|583389935|FG000|Overall Study|Lost to Follow-up|6|||
161546379|NCT00510458|583389935|FG000|Overall Study|Withdrawal by Subject|3|||
161546380|NCT00510458|583389935|FG000|Overall Study|Revision|2|||
161546381|NCT02569710|583389936|FG000|Overall Study|Adverse Event|1|||
161546382|NCT02569710|583389937|FG001|Overall Study|Adverse Event|0|||
161546383|NCT02569710|583389938|FG002|Overall Study|Adverse Event|0|||
161546384|NCT02569710|583389939|FG003|Overall Study|Adverse Event|0|||
161546385|NCT02569710|583389940|FG004|Overall Study|Adverse Event|0|||
161546386|NCT02569710|583389941|FG005|Overall Study|Adverse Event|0|||
161546387|NCT02569710|583389942|FG006|Overall Study|Adverse Event|0|||
161546388|NCT02569710|583389943|FG007|Overall Study|Adverse Event|0|||
161546389|NCT02569710|583389944|FG008|Overall Study|Adverse Event|0|||
161546390|NCT02569710|583389945|FG009|Overall Study|Adverse Event|0|||
161546391|NCT02569710|583389936|FG000|Overall Study|Lost to Follow-up|0|||
161546392|NCT02569710|583389937|FG001|Overall Study|Lost to Follow-up|0|||
161546393|NCT02569710|583389938|FG002|Overall Study|Lost to Follow-up|0|||
161546394|NCT02569710|583389939|FG003|Overall Study|Lost to Follow-up|0|||
161546395|NCT02569710|583389940|FG004|Overall Study|Lost to Follow-up|0|||
161546396|NCT02569710|583389941|FG005|Overall Study|Lost to Follow-up|0|||
161546397|NCT02569710|583389942|FG006|Overall Study|Lost to Follow-up|1|||
161546398|NCT02569710|583389943|FG007|Overall Study|Lost to Follow-up|0|||
161546399|NCT02569710|583389944|FG008|Overall Study|Lost to Follow-up|1|||
161546400|NCT02569710|583389945|FG009|Overall Study|Lost to Follow-up|0|||
161546401|NCT02569710|583389936|FG000|Overall Study|Virologic failure|0|||
161546402|NCT02569710|583389937|FG001|Overall Study|Virologic failure|0|||
161546403|NCT02569710|583389938|FG002|Overall Study|Virologic failure|0|||
161546404|NCT02569710|583389939|FG003|Overall Study|Virologic failure|0|||
161546405|NCT02569710|583389940|FG004|Overall Study|Virologic failure|1|||
161546406|NCT02569710|583389941|FG005|Overall Study|Virologic failure|0|||
161546407|NCT02569710|583389942|FG006|Overall Study|Virologic failure|1|||
161546408|NCT02569710|583389943|FG007|Overall Study|Virologic failure|0|||
161546409|NCT02569710|583389944|FG008|Overall Study|Virologic failure|0|||
161546410|NCT02569710|583389945|FG009|Overall Study|Virologic failure|0|||
161546411|NCT02569710|583389936|FG000|Overall Study|Withdrawal by Subject|0|||
161546412|NCT02569710|583389937|FG001|Overall Study|Withdrawal by Subject|0|||
161546413|NCT02569710|583389938|FG002|Overall Study|Withdrawal by Subject|0|||
161546414|NCT02569710|583389939|FG003|Overall Study|Withdrawal by Subject|0|||
161546415|NCT02569710|583389940|FG004|Overall Study|Withdrawal by Subject|0|||
161546416|NCT02569710|583389941|FG005|Overall Study|Withdrawal by Subject|1|||
161546417|NCT02569710|583389942|FG006|Overall Study|Withdrawal by Subject|0|||
161546418|NCT02569710|583389943|FG007|Overall Study|Withdrawal by Subject|0|||
161546419|NCT02569710|583389944|FG008|Overall Study|Withdrawal by Subject|0|||
161546420|NCT02569710|583389945|FG009|Overall Study|Withdrawal by Subject|0|||
161546421|NCT02946918|583389946|FG000|Overall Study|Patient unblinded himself|1|||
161546422|NCT02946918|583389947|FG001|Overall Study|Patient unblinded himself|0|||
161546423|NCT02946918|583389946|FG000|Overall Study|Physician Decision|0|||
161546424|NCT02946918|583389947|FG001|Overall Study|Physician Decision|2|||
161546425|NCT02946918|583389946|FG000|Overall Study|Ran out of study medication|0|||
161546426|NCT02946918|583389947|FG001|Overall Study|Ran out of study medication|1|||
161546427|NCT02669095|583389949|FG000|Overall Study|Adverse Event|1|||
161546428|NCT02669095|583389950|FG001|Overall Study|Adverse Event|0|||
161546429|NCT02669095|583389949|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
161546430|NCT02669095|583389950|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
161546431|NCT02669095|583389949|FG000|Overall Study|Torn Lens|0|||
161546432|NCT02669095|583389950|FG001|Overall Study|Torn Lens|1|||
161546433|NCT02669095|583389949|FG000|Overall Study|Visit 5 assessments not completed|0|||
161546434|NCT02669095|583389950|FG001|Overall Study|Visit 5 assessments not completed|1|||
161546435|NCT00738101|583389951|FG000|Overall Study|Physician Decision|5|||
161546436|NCT00738101|583389951|FG000|Overall Study|Death|1|||
161546437|NCT00738101|583389951|FG000|Overall Study|Repeat enrollment|1|||
161546438|NCT01396317|583389952|FG000|Overall Study|Adverse Event|1|||
161546439|NCT01396317|583389953|FG001|Overall Study|Adverse Event|0|||
161546440|NCT00663117|583392036|FG000|Overall Study|Lack of Efficacy|1|||
161546441|NCT00663117|583392037|FG001|Overall Study|Lack of Efficacy|0|||
161546442|NCT02781506|583392038|FG000|Overall Study|Adverse Event|5|||
161546443|NCT02593539|583392039|FG000|Overall Study|Adverse Event|1|||
161546444|NCT00437125|583392040|FG000|Overall Study|Adverse Event|12|||
161546445|NCT00437125|583392040|FG000|Overall Study|Death|1|||
161546446|NCT00437125|583392040|FG000|Overall Study|Clinical Relapse|1|||
161546447|NCT00437125|583392040|FG000|Overall Study|Lack of Efficacy|1|||
161546448|NCT00437125|583392040|FG000|Overall Study|Lost to Follow-up|1|||
161594854|NCT05329220|583567872|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161594855|NCT05329220|583567873|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
161594856|NCT05835336|583569932|FG000|Overall Study|Withdrawal by Subject|5|||
161594857|NCT05835336|583569932|FG000|Overall Study|Did not complete the personalization process|3|||
161594858|NCT04489771|583569933|FG000|Overall Study|Death|27|||
161546449|NCT00437125|583392040|FG000|Overall Study|Withdrawal by Subject|13|||
161546450|NCT00437125|583392040|FG000|Overall Study|Withdrawal by Caregiver|2|||
161546451|NCT00437125|583392040|FG000|Overall Study|Physician Decision|1|||
161546452|NCT02248961|583392043|FG000|Overall Study|Adverse Event|1|||
161546453|NCT02248961|583392044|FG001|Overall Study|Adverse Event|0|||
161546454|NCT02248961|583392043|FG000|Overall Study|Withdrawal by Subject|1|||
161546455|NCT02248961|583392044|FG001|Overall Study|Withdrawal by Subject|2|||
161546456|NCT02248961|583392043|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
161546457|NCT02248961|583392044|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
161546458|NCT00244374|583392051|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
161546459|NCT00244374|583392052|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
161546460|NCT00244374|583392053|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
161546461|NCT00244374|583392054|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
161546462|NCT00244374|583392055|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
161546463|NCT00244374|583392051|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
161546464|NCT00244374|583392052|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
161546465|NCT00244374|583392053|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
161546466|NCT00244374|583392054|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
161546467|NCT00244374|583392055|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
161546468|NCT00244374|583392051|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
161546469|NCT00244374|583392052|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
161546470|NCT00244374|583392053|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
161546471|NCT00244374|583392054|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
161546472|NCT00244374|583392055|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
161546473|NCT00244374|583392051|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
161546474|NCT00244374|583392052|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
161546475|NCT00244374|583392053|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
161546476|NCT00244374|583392054|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
161546477|NCT00244374|583392055|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
161546478|NCT00244374|583392051|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
161546479|NCT00244374|583392052|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
161546480|NCT00244374|583392053|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
161546481|NCT00244374|583392054|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
161546482|NCT00244374|583392055|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
161546483|NCT00244374|583392051|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
161546484|NCT00244374|583392052|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
161546485|NCT00244374|583392053|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
161546486|NCT00244374|583392054|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
161546487|NCT00244374|583392055|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
161546488|NCT00244374|583392051|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
161546489|NCT00244374|583392052|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
161546490|NCT00244374|583392053|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
161546491|NCT00244374|583392054|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
161546492|NCT00244374|583392055|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
161546493|NCT00244374|583392051|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
161546494|NCT00244374|583392052|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
161546495|NCT00244374|583392053|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
161546496|NCT00244374|583392054|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
161546497|NCT00244374|583392055|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
161546498|NCT00244374|583392051|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
161546499|NCT00244374|583392052|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
161546500|NCT00244374|583392053|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
161546501|NCT00244374|583392054|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
161594859|NCT04489771|583569934|FG001|Overall Study|Death|25|||
161546502|NCT00244374|583392055|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
161546503|NCT03462706|583392057|FG000|Overall Study|Polyp was pedunculated|1|||
161546504|NCT03462706|583392058|FG001|Overall Study|Polyp was pedunculated|0|||
161546505|NCT03462706|583392059|FG002|Overall Study|Polyp was pedunculated|1|||
161546506|NCT03462706|583392060|FG003|Overall Study|Polyp was pedunculated|0|||
161546507|NCT03462706|583392057|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
161546508|NCT03462706|583392058|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
161546509|NCT03462706|583392059|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
161546510|NCT03462706|583392060|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
161546511|NCT04105972|583392070|FG000|Overall Study|Adverse Event|2|||
161546512|NCT04105972|583392071|FG001|Overall Study|Adverse Event|1|||
161546513|NCT02802319|583392072|FG000|Overall Study|Physician Decision|2|||
161546514|NCT02802319|583392073|FG001|Overall Study|Physician Decision|1|||
161546515|NCT02802319|583392072|FG000|Overall Study|Lost to Follow-up|0|||
161546516|NCT02802319|583392073|FG001|Overall Study|Lost to Follow-up|4|||
161546517|NCT04651114|583392074|FG000|Overall Study|Withdrawal by Subject|8|||
161546518|NCT01923896|583392079|FG000|Overall Study|Adverse Event|1|||
161546519|NCT01923896|583392080|FG001|Overall Study|Adverse Event|0|||
161546520|NCT03545113|583392083|FG000|Overall Study|Surgery Cancelled|1|||
161546521|NCT03545113|583392084|FG001|Overall Study|Surgery Cancelled|0|||
161546522|NCT03545113|583392083|FG000|Overall Study|Death|1|||
161546523|NCT03545113|583392084|FG001|Overall Study|Death|0|||
161546524|NCT03545113|583392083|FG000|Overall Study|Adverse Event|2|||
161546525|NCT03545113|583392084|FG001|Overall Study|Adverse Event|0|||
161546526|NCT03545113|583392083|FG000|Overall Study|Received different surgery|1|||
161546527|NCT03545113|583392084|FG001|Overall Study|Received different surgery|0|||
161546528|NCT00235443|583392085|FG000|Overall Study|Adverse Event|4|||
161546529|NCT00235443|583392086|FG001|Overall Study|Adverse Event|12|||
161546530|NCT00235443|583392087|FG002|Overall Study|Adverse Event|17|||
161546531|NCT00235443|583392088|FG003|Overall Study|Adverse Event|44|||
161546532|NCT00235443|583392089|FG004|Overall Study|Adverse Event|10|||
161546533|NCT00235443|583392090|FG005|Overall Study|Adverse Event|15|||
161546534|NCT00235443|583392085|FG000|Overall Study|Lack of Efficacy|0|||
161546535|NCT00235443|583392086|FG001|Overall Study|Lack of Efficacy|1|||
161546536|NCT00235443|583392087|FG002|Overall Study|Lack of Efficacy|5|||
161546537|NCT00235443|583392088|FG003|Overall Study|Lack of Efficacy|12|||
161546538|NCT00235443|583392089|FG004|Overall Study|Lack of Efficacy|2|||
161546539|NCT00235443|583392090|FG005|Overall Study|Lack of Efficacy|9|||
161546540|NCT00235443|583392085|FG000|Overall Study|Withdrawal by Subject|3|||
161546541|NCT00235443|583392086|FG001|Overall Study|Withdrawal by Subject|9|||
161546542|NCT00235443|583392087|FG002|Overall Study|Withdrawal by Subject|25|||
161546543|NCT00235443|583392088|FG003|Overall Study|Withdrawal by Subject|24|||
161546544|NCT00235443|583392089|FG004|Overall Study|Withdrawal by Subject|10|||
161546545|NCT00235443|583392090|FG005|Overall Study|Withdrawal by Subject|12|||
161546546|NCT00235443|583392085|FG000|Overall Study|Lost to Follow-up|0|||
161546547|NCT00235443|583392086|FG001|Overall Study|Lost to Follow-up|8|||
161546548|NCT00235443|583392087|FG002|Overall Study|Lost to Follow-up|6|||
161546549|NCT00235443|583392088|FG003|Overall Study|Lost to Follow-up|6|||
161546550|NCT00235443|583392089|FG004|Overall Study|Lost to Follow-up|4|||
161546551|NCT00235443|583392090|FG005|Overall Study|Lost to Follow-up|3|||
161546552|NCT00235443|583392085|FG000|Overall Study|Unsatisfactory compliance|0|||
161546553|NCT00235443|583392086|FG001|Overall Study|Unsatisfactory compliance|2|||
161546554|NCT00235443|583392087|FG002|Overall Study|Unsatisfactory compliance|3|||
161546555|NCT00235443|583392088|FG003|Overall Study|Unsatisfactory compliance|4|||
161546556|NCT00235443|583392089|FG004|Overall Study|Unsatisfactory compliance|1|||
161546557|NCT00235443|583392090|FG005|Overall Study|Unsatisfactory compliance|0|||
161546558|NCT00235443|583392085|FG000|Overall Study|Other reasons for premature termination|1|||
161546559|NCT00235443|583392086|FG001|Overall Study|Other reasons for premature termination|6|||
161546560|NCT00235443|583392087|FG002|Overall Study|Other reasons for premature termination|6|||
161594860|NCT04489771|583569933|FG000|Overall Study|Withdrawal by Subject|1|||
161594861|NCT04489771|583569934|FG001|Overall Study|Withdrawal by Subject|0|||
161594862|NCT04489771|583569933|FG000|Overall Study|Participants Ongoing in Study|50|||
161594863|NCT04489771|583569934|FG001|Overall Study|Participants Ongoing in Study|51|||
161594864|NCT04059484|583569940|FG000|Overall Study|Adverse Event|2|||
161546561|NCT00235443|583392088|FG003|Overall Study|Other reasons for premature termination|7|||
161546562|NCT00235443|583392089|FG004|Overall Study|Other reasons for premature termination|3|||
161546563|NCT00235443|583392090|FG005|Overall Study|Other reasons for premature termination|6|||
161546564|NCT03661996|583392094|FG000|Overall Study|Adverse Event|0|||
161546565|NCT03661996|583392095|FG001|Overall Study|Adverse Event|0|||
161546566|NCT03661996|583392096|FG002|Overall Study|Adverse Event|1|||
161546567|NCT03661996|583392097|FG003|Overall Study|Adverse Event|1|||
161594865|NCT04059484|583569941|FG001|Overall Study|Adverse Event|5|||
161830069|NCT02412722|584418105|FG001|Overall Study|Reason not Specified|0|||
161830070|NCT02412722|584418106|FG002|Overall Study|Reason not Specified|2|||
161546568|NCT03661996|583392098|FG004|Overall Study|Adverse Event|0|||
161546569|NCT03661996|583392094|FG000|Overall Study|Lost to Follow-up|5|||
161546570|NCT03661996|583392095|FG001|Overall Study|Lost to Follow-up|1|||
161546571|NCT03661996|583392096|FG002|Overall Study|Lost to Follow-up|2|||
161546572|NCT03661996|583392097|FG003|Overall Study|Lost to Follow-up|2|||
161546573|NCT03661996|583392098|FG004|Overall Study|Lost to Follow-up|6|||
161546574|NCT03661996|583392094|FG000|Overall Study|Physician Decision|1|||
161546575|NCT03661996|583392095|FG001|Overall Study|Physician Decision|1|||
161546576|NCT03661996|583392096|FG002|Overall Study|Physician Decision|1|||
161546577|NCT03661996|583392097|FG003|Overall Study|Physician Decision|2|||
161546578|NCT03661996|583392098|FG004|Overall Study|Physician Decision|0|||
161546579|NCT03661996|583392094|FG000|Overall Study|Protocol Violation|0|||
161546580|NCT03661996|583392095|FG001|Overall Study|Protocol Violation|0|||
161546581|NCT03661996|583392096|FG002|Overall Study|Protocol Violation|0|||
161546582|NCT03661996|583392097|FG003|Overall Study|Protocol Violation|0|||
161546583|NCT03661996|583392098|FG004|Overall Study|Protocol Violation|1|||
161546584|NCT03661996|583392094|FG000|Overall Study|Withdrawal by Subject|3|||
161546585|NCT03661996|583392095|FG001|Overall Study|Withdrawal by Subject|5|||
161546586|NCT03661996|583392096|FG002|Overall Study|Withdrawal by Subject|1|||
161546587|NCT03661996|583392097|FG003|Overall Study|Withdrawal by Subject|7|||
161546588|NCT03661996|583392098|FG004|Overall Study|Withdrawal by Subject|7|||
161546589|NCT03661996|583392094|FG000|Overall Study|Sponsors Decision|2|||
161546590|NCT03661996|583392095|FG001|Overall Study|Sponsors Decision|0|||
161546591|NCT03661996|583392096|FG002|Overall Study|Sponsors Decision|0|||
161546592|NCT03661996|583392097|FG003|Overall Study|Sponsors Decision|0|||
161546593|NCT03661996|583392098|FG004|Overall Study|Sponsors Decision|0|||
161546594|NCT03661996|583392094|FG000|Overall Study|Other|1|||
161546595|NCT03661996|583392095|FG001|Overall Study|Other|1|||
161546596|NCT03661996|583392096|FG002|Overall Study|Other|1|||
161546597|NCT03661996|583392097|FG003|Overall Study|Other|1|||
161546598|NCT03661996|583392098|FG004|Overall Study|Other|0|||
161546599|NCT03321513|583392099|FG000|Overall Study|Death|11|||
161546600|NCT03321513|583392100|FG001|Overall Study|Death|5|||
161546601|NCT03321513|583392099|FG000|Overall Study|Withdrawal by Subject|5|||
161546602|NCT03321513|583392100|FG001|Overall Study|Withdrawal by Subject|10|||
161546603|NCT03321513|583392099|FG000|Overall Study|Lost to Follow-up|10|||
161546604|NCT03321513|583392100|FG001|Overall Study|Lost to Follow-up|11|||
161546605|NCT01161472|583392101|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
161546606|NCT01161472|583392102|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
161546607|NCT01161472|583392103|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
161546608|NCT01161472|583392104|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
161546609|NCT02912468|583392122|FG000|Overall Study|Adverse Event|3|||
161546610|NCT02912468|583392123|FG001|Overall Study|Adverse Event|2|||
161546611|NCT02912468|583392122|FG000|Overall Study|Withdrawal by Subject|6|||
161546612|NCT02912468|583392123|FG001|Overall Study|Withdrawal by Subject|2|||
161546613|NCT02912468|583392122|FG000|Overall Study|Randomized and not treated|0|||
161546614|NCT02912468|583392123|FG001|Overall Study|Randomized and not treated|1|||
161546615|NCT01515189|583392124|FG000|Induction|Disease Progression|109|||
161546616|NCT01515189|583392125|FG001|Induction|Disease Progression|155|||
161546617|NCT01515189|583392124|FG000|Induction|Study drug toxicity|86|||
161546618|NCT01515189|583392125|FG001|Induction|Study drug toxicity|36|||
161546619|NCT01515189|583392124|FG000|Induction|Death|24|||
161546620|NCT01515189|583392125|FG001|Induction|Death|17|||
161546621|NCT01515189|583392124|FG000|Induction|Adverse Event|14|||
161546622|NCT01515189|583392125|FG001|Induction|Adverse Event|9|||
161546623|NCT01515189|583392124|FG000|Induction|Withdrawal by Subject|3|||
161546624|NCT01515189|583392125|FG001|Induction|Withdrawal by Subject|9|||
161546625|NCT01515189|583392124|FG000|Induction|No longer meets study criteria|0|||
161546626|NCT01515189|583392125|FG001|Induction|No longer meets study criteria|2|||
161546627|NCT01515189|583392124|FG000|Induction|Lost to Follow-up|1|||
161546628|NCT01515189|583392125|FG001|Induction|Lost to Follow-up|0|||
161594866|NCT04059484|583569940|FG000|Overall Study|Withdrawal by Subject|5|||
161594867|NCT04059484|583569941|FG001|Overall Study|Withdrawal by Subject|3|||
161830071|NCT02412722|584418107|FG003|Overall Study|Reason not Specified|1|||
161830072|NCT02412722|584418108|FG004|Overall Study|Reason not Specified|2|||
161830073|NCT02412722|584418109|FG005|Overall Study|Reason not Specified|6|||
161830074|NCT02400476|584418110|FG000|Overall Study|Adverse Event|57|||
161546629|NCT01515189|583392124|FG000|Induction|Other|0|||
161546630|NCT01515189|583392125|FG001|Induction|Other|4|||
161546631|NCT01515189|583392124|FG000|First Re-Induction Phase|Disease progression|6|||
161546632|NCT01515189|583392125|FG001|First Re-Induction Phase|Disease progression|14|||
161546633|NCT01515189|583392124|FG000|First Re-Induction Phase|Study drug toxicity|5|||
161546634|NCT01515189|583392125|FG001|First Re-Induction Phase|Study drug toxicity|0|||
161546635|NCT01515189|583392124|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
161546636|NCT01515189|583392125|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
161546637|NCT01515189|583392124|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
161594868|NCT04059484|583569940|FG000|Overall Study|Progressive disease|112|||
161594869|NCT04059484|583569941|FG001|Overall Study|Progressive disease|112|||
161594870|NCT04059484|583569940|FG000|Overall Study|Other|8|||
161594871|NCT04059484|583569941|FG001|Overall Study|Other|3|||
161594872|NCT04059484|583569940|FG000|Overall Study|Ongoing|20|||
161594873|NCT04059484|583569941|FG001|Overall Study|Ongoing|20|||
161594874|NCT00753545|583569942|FG000|Overall Study|Death|98|||
161594875|NCT00753545|583569943|FG001|Overall Study|Death|112|||
161594876|NCT00753545|583569942|FG000|Overall Study|Lost to Follow-up|2|||
161594877|NCT00753545|583569943|FG001|Overall Study|Lost to Follow-up|3|||
161594878|NCT00753545|583569942|FG000|Overall Study|Protocol Violation|1|||
161594879|NCT00753545|583569943|FG001|Overall Study|Protocol Violation|0|||
161594880|NCT00753545|583569942|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
161594881|NCT00753545|583569943|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
161594882|NCT05453773|583569944|FG000|Overall Study|Withdrawal by Subject|3|||
161594883|NCT05453773|583569944|FG000|Overall Study|Lost to Follow-up|3|||
161594884|NCT05453773|583569944|FG000|Overall Study|Difficult Blood Draw|3|||
161594885|NCT02485938|583569947|FG000|Overall Study|Withdrawal of consent|2|||
161594886|NCT02485938|583569948|FG001|Overall Study|Withdrawal of consent|0|||
161594887|NCT03839940|583569949|FG000|Overall Study|Withdrawal by Subject|3|||
161594888|NCT03839940|583569950|FG001|Overall Study|Withdrawal by Subject|0|||
161680648|NCT00545402|583883008|FG001|Overall Study|Discontinuation of treatment|9|||
161680649|NCT00545402|583883007|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
161680650|NCT00545402|583883008|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
161680651|NCT00545402|583883007|FG000|Overall Study|Death|5|||
161680652|NCT00545402|583883008|FG001|Overall Study|Death|7|||
161680653|NCT00545402|583883007|FG000|Overall Study|Graft loss|2|||
161680654|NCT00545402|583883008|FG001|Overall Study|Graft loss|4|||
161680655|NCT00545402|583883007|FG000|Overall Study|Withdrawal by Subject|0|||
161680656|NCT00545402|583883008|FG001|Overall Study|Withdrawal by Subject|1|||
161680657|NCT00545402|583883007|FG000|Overall Study|Protocol Violation|1|||
161680658|NCT00545402|583883008|FG001|Overall Study|Protocol Violation|0|||
161680659|NCT00545402|583883007|FG000|Overall Study|Reason not specified|1|||
161680660|NCT00545402|583883008|FG001|Overall Study|Reason not specified|1|||
161680661|NCT00382018|583883009|FG000|Overall Study|Progression|0|||
161680662|NCT00382018|583883010|FG001|Overall Study|Progression|136|||
161680663|NCT00382018|583883011|FG002|Overall Study|Progression|51|||
161680664|NCT00382018|583883012|FG003|Overall Study|Progression|43|||
161680665|NCT00382018|583883009|FG000|Overall Study|Death|0|||
161680666|NCT00382018|583883010|FG001|Overall Study|Death|9|||
161680667|NCT00382018|583883011|FG002|Overall Study|Death|7|||
161680668|NCT00382018|583883012|FG003|Overall Study|Death|11|||
161680669|NCT00382018|583883009|FG000|Overall Study|Withdrawal by Subject|0|||
161680670|NCT00382018|583883010|FG001|Overall Study|Withdrawal by Subject|4|||
161680671|NCT00382018|583883011|FG002|Overall Study|Withdrawal by Subject|3|||
161680672|NCT00382018|583883012|FG003|Overall Study|Withdrawal by Subject|4|||
161680673|NCT00382018|583883009|FG000|Overall Study|Other, not protocol specified|0|||
161680674|NCT00382018|583883010|FG001|Overall Study|Other, not protocol specified|16|||
161680675|NCT00382018|583883011|FG002|Overall Study|Other, not protocol specified|3|||
161680676|NCT00382018|583883012|FG003|Overall Study|Other, not protocol specified|1|||
161680677|NCT01984164|583883013|FG000|Overall Study|Withdrawal by Subject|4|||
161680678|NCT01984164|583883014|FG001|Overall Study|Withdrawal by Subject|3|||
161680679|NCT01984164|583883013|FG000|Overall Study|Adverse Event|5|||
161680680|NCT01984164|583883014|FG001|Overall Study|Adverse Event|19|||
161680681|NCT01984164|583883013|FG000|Overall Study|Lost to Follow-up|1|||
161680682|NCT01984164|583883014|FG001|Overall Study|Lost to Follow-up|3|||
161680683|NCT00427349|583883018|FG000|Overall Study|Lack of Efficacy|23|||
161680684|NCT00427349|583883018|FG000|Overall Study|Adverse Event|14|||
161594889|NCT03839940|583569949|FG000|Overall Study|Protocol Violation|0|||
161594890|NCT03839940|583569950|FG001|Overall Study|Protocol Violation|1|||
161594891|NCT03839940|583569949|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
161594892|NCT03839940|583569950|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
161594893|NCT03241745|583569951|FG000|Overall Study|Adverse Event|7|||
161594894|NCT03241745|583569951|FG000|Overall Study|Death|1|||
161594895|NCT03241745|583569951|FG000|Overall Study|Withdrawal by Subject|5|||
161594896|NCT03241745|583569951|FG000|Overall Study|Treatment delay >28 days|2|||
161594897|NCT03241745|583569951|FG000|Overall Study|Lack of Efficacy|14|||
161594898|NCT00470704|583569952|FG000|Overall Study|Withdrawal by Subject|4|||
161594899|NCT00470704|583569953|FG001|Overall Study|Withdrawal by Subject|3|||
161680685|NCT00427349|583883018|FG000|Overall Study|Death|1|||
161680686|NCT00427349|583883018|FG000|Overall Study|Withdrawal by Subject|3|||
161680687|NCT00427349|583883018|FG000|Overall Study|Alternative therapy|1|||
161680688|NCT00427349|583883018|FG000|Overall Study|Other|2|||
161680689|NCT00427349|583883018|FG000|Overall Study|Ineligible|1|||
161680690|NCT00427349|583883018|FG000|Overall Study|Never started therapy|1|||
161680691|NCT00916279|583883021|FG000|Overall Study|Death|2|||
161680692|NCT00916279|583883021|FG000|Overall Study|Lost to Follow-up|2|||
161680693|NCT02592018|583883026|FG000|Overall Study|Adverse Event|1|||
161546638|NCT01515189|583392125|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
161546639|NCT01515189|583392124|FG000|First Re-Induction Phase|Other|1|||
161546640|NCT01515189|583392125|FG001|First Re-Induction Phase|Other|0|||
161830075|NCT02400476|584418111|FG001|Overall Study|Adverse Event|10|||
161830076|NCT02400476|584418112|FG002|Overall Study|Adverse Event|22|||
161830077|NCT02400476|584418113|FG003|Overall Study|Adverse Event|19|||
161830078|NCT02400476|584418114|FG004|Overall Study|Adverse Event|5|||
161830079|NCT02400476|584418115|FG005|Overall Study|Adverse Event|8|||
161830080|NCT02400476|584418110|FG000|Overall Study|Withdrawal by Subject|4|||
161680694|NCT02592018|583883026|FG000|Overall Study|Lost to Follow-up|1|||
161680695|NCT00574145|583884291|FG000|Overall Study|Withdrawal by Subject|2|||
161680696|NCT00574145|583884292|FG001|Overall Study|Withdrawal by Subject|1|||
161680697|NCT03227471|583884293|FG000|Overall Study|Withdrawal by Subject|0|||
161546641|NCT00284089|583392126|FG000|Multiple Dose Phase|Adverse Event|1|||
161546642|NCT00284089|583392127|FG001|Multiple Dose Phase|Adverse Event|0|||
161546643|NCT00284089|583392128|FG002|Multiple Dose Phase|Adverse Event|1|||
161546644|NCT00284089|583392129|FG003|Multiple Dose Phase|Adverse Event|1|||
161546645|NCT00284089|583392126|FG000|Multiple Dose Phase|Protocol Violation|0|||
161546646|NCT00284089|583392127|FG001|Multiple Dose Phase|Protocol Violation|0|||
161546647|NCT00284089|583392128|FG002|Multiple Dose Phase|Protocol Violation|1|||
161546648|NCT00284089|583392129|FG003|Multiple Dose Phase|Protocol Violation|0|||
161546649|NCT00284089|583392126|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
161546650|NCT00284089|583392127|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
161546651|NCT00284089|583392128|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
161546652|NCT00284089|583392129|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
161546653|NCT00284089|583392126|FG000|Multiple Dose Phase|Death|0|||
161546654|NCT00284089|583392127|FG001|Multiple Dose Phase|Death|0|||
161546655|NCT00284089|583392128|FG002|Multiple Dose Phase|Death|1|||
161546656|NCT00284089|583392129|FG003|Multiple Dose Phase|Death|1|||
161680698|NCT03227471|583884294|FG001|Overall Study|Withdrawal by Subject|0|||
161680699|NCT03227471|583884295|FG002|Overall Study|Withdrawal by Subject|0|||
161680700|NCT03227471|583884296|FG003|Overall Study|Withdrawal by Subject|0|||
161680701|NCT03227471|583884297|FG004|Overall Study|Withdrawal by Subject|1|||
161680702|NCT03227471|583884298|FG005|Overall Study|Withdrawal by Subject|0|||
161680703|NCT03227471|583884299|FG006|Overall Study|Withdrawal by Subject|0|||
161680704|NCT03227471|583884300|FG007|Overall Study|Withdrawal by Subject|0|||
161680705|NCT03227471|583884301|FG008|Overall Study|Withdrawal by Subject|0|||
161680706|NCT03227471|583884302|FG009|Overall Study|Withdrawal by Subject|0|||
161680707|NCT03227471|583884303|FG010|Overall Study|Withdrawal by Subject|0|||
161680708|NCT03227471|583884304|FG011|Overall Study|Withdrawal by Subject|0|||
161680709|NCT03227471|583884305|FG012|Overall Study|Withdrawal by Subject|1|||
161680710|NCT03227471|583884306|FG013|Overall Study|Withdrawal by Subject|0|||
161680711|NCT03227471|583884307|FG014|Overall Study|Withdrawal by Subject|0|||
161680712|NCT03227471|583884293|FG000|Overall Study|Randomized, Never Dosed|0|||
161680713|NCT03227471|583884294|FG001|Overall Study|Randomized, Never Dosed|0|||
161680714|NCT03227471|583884295|FG002|Overall Study|Randomized, Never Dosed|0|||
161680715|NCT03227471|583884296|FG003|Overall Study|Randomized, Never Dosed|0|||
161680716|NCT03227471|583884297|FG004|Overall Study|Randomized, Never Dosed|0|||
161546657|NCT00284089|583392126|FG000|Extension Phase|Adverse Event|0|||
161546658|NCT00284089|583392127|FG001|Extension Phase|Adverse Event|0|||
161680717|NCT03227471|583884298|FG005|Overall Study|Randomized, Never Dosed|0|||
161830081|NCT02400476|584418111|FG001|Overall Study|Withdrawal by Subject|1|||
161830082|NCT02400476|584418112|FG002|Overall Study|Withdrawal by Subject|12|||
161546659|NCT00284089|583392128|FG002|Extension Phase|Adverse Event|2|||
161546660|NCT00284089|583392129|FG003|Extension Phase|Adverse Event|2|||
161546661|NCT00284089|583392126|FG000|Extension Phase|condition no longer requires study drug|2|||
161546662|NCT00284089|583392127|FG001|Extension Phase|condition no longer requires study drug|0|||
161546663|NCT00284089|583392128|FG002|Extension Phase|condition no longer requires study drug|2|||
161546664|NCT00284089|583392129|FG003|Extension Phase|condition no longer requires study drug|7|||
161546665|NCT00284089|583392126|FG000|Extension Phase|Protocol Violation|0|||
161546666|NCT00284089|583392127|FG001|Extension Phase|Protocol Violation|0|||
161546667|NCT00284089|583392128|FG002|Extension Phase|Protocol Violation|1|||
161546668|NCT00284089|583392129|FG003|Extension Phase|Protocol Violation|0|||
161546669|NCT00284089|583392126|FG000|Extension Phase|Withdrawal by Subject|0|||
161546670|NCT00284089|583392127|FG001|Extension Phase|Withdrawal by Subject|0|||
161830083|NCT02400476|584418113|FG003|Overall Study|Withdrawal by Subject|7|||
161830084|NCT02400476|584418114|FG004|Overall Study|Withdrawal by Subject|5|||
161546671|NCT00284089|583392128|FG002|Extension Phase|Withdrawal by Subject|1|||
161546672|NCT00284089|583392129|FG003|Extension Phase|Withdrawal by Subject|3|||
161830085|NCT02400476|584418115|FG005|Overall Study|Withdrawal by Subject|5|||
161830086|NCT02400476|584418110|FG000|Overall Study|Lost to Follow-up|0|||
161546673|NCT02541383|583392130|FG000|Overall Study|Death|50|||
161546674|NCT02541383|583392131|FG001|Overall Study|Death|37|||
161680718|NCT03227471|583884299|FG006|Overall Study|Randomized, Never Dosed|0|||
161680719|NCT03227471|583884300|FG007|Overall Study|Randomized, Never Dosed|0|||
161680720|NCT03227471|583884301|FG008|Overall Study|Randomized, Never Dosed|0|||
161830087|NCT02400476|584418111|FG001|Overall Study|Lost to Follow-up|0|||
161546675|NCT02541383|583392132|FG002|Overall Study|Death|48|||
161546676|NCT02541383|583392133|FG003|Overall Study|Death|41|||
161546677|NCT02541383|583392134|FG004|Overall Study|Death|21|||
161546678|NCT02541383|583392135|FG005|Overall Study|Death|25|||
161546679|NCT02541383|583392130|FG000|Overall Study|Lost to Follow-up|5|||
161546680|NCT02541383|583392131|FG001|Overall Study|Lost to Follow-up|3|||
161546681|NCT02541383|583392132|FG002|Overall Study|Lost to Follow-up|1|||
161546682|NCT02541383|583392133|FG003|Overall Study|Lost to Follow-up|1|||
161546683|NCT02541383|583392134|FG004|Overall Study|Lost to Follow-up|3|||
161546684|NCT02541383|583392135|FG005|Overall Study|Lost to Follow-up|0|||
161546685|NCT02541383|583392130|FG000|Overall Study|Consent withdrawn|5|||
161546686|NCT02541383|583392131|FG001|Overall Study|Consent withdrawn|6|||
161546687|NCT02541383|583392132|FG002|Overall Study|Consent withdrawn|1|||
161546688|NCT02541383|583392133|FG003|Overall Study|Consent withdrawn|1|||
161546689|NCT02541383|583392134|FG004|Overall Study|Consent withdrawn|0|||
161546690|NCT02541383|583392135|FG005|Overall Study|Consent withdrawn|0|||
161546691|NCT02541383|583392130|FG000|Overall Study|Sponsor's decision|1|||
161546692|NCT02541383|583392131|FG001|Overall Study|Sponsor's decision|1|||
161546693|NCT02541383|583392132|FG002|Overall Study|Sponsor's decision|0|||
161546694|NCT02541383|583392133|FG003|Overall Study|Sponsor's decision|0|||
161546695|NCT02541383|583392134|FG004|Overall Study|Sponsor's decision|0|||
161546696|NCT02541383|583392135|FG005|Overall Study|Sponsor's decision|0|||
161546697|NCT05796518|583392136|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
161546698|NCT00594217|583392137|FG000|Overall Study|Withdrawal by Subject|1|||
161546699|NCT00594217|583392138|FG001|Overall Study|Withdrawal by Subject|3|||
161546700|NCT05778526|583392141|FG000|Overall Study|Lost to Follow-up|0|||
161546701|NCT05778526|583392142|FG001|Overall Study|Lost to Follow-up|1|||
161546702|NCT05778526|583392143|FG002|Overall Study|Lost to Follow-up|3|||
161546703|NCT05778526|583392141|FG000|Overall Study|Protocol Violation|0|||
161546704|NCT05778526|583392142|FG001|Overall Study|Protocol Violation|0|||
161546705|NCT05778526|583392143|FG002|Overall Study|Protocol Violation|8|||
161546706|NCT03108157|583392146|FG000|Overall Study|Protocol Violation|15|||
161546707|NCT03108157|583392147|FG001|Overall Study|Protocol Violation|4|||
161546708|NCT02668016|583392149|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
161546709|NCT02668016|583392149|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
161546710|NCT02668016|583392149|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
161546711|NCT02668016|583392149|FG000|Month 4|Withdrawal due to severe symptoms|1|||
161546712|NCT02668016|583392149|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
161546713|NCT02668016|583392149|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
161546714|NCT02668016|583392149|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
161546715|NCT02668016|583392149|FG000|Month 6|Withdrawal due to severe symptoms|2|||
161594900|NCT00470704|583569952|FG000|Overall Study|Relapse/Progression|37|||
161594901|NCT00470704|583569953|FG001|Overall Study|Relapse/Progression|42|||
161594902|NCT00470704|583569952|FG000|Overall Study|toxicity|0|||
161594903|NCT00470704|583569953|FG001|Overall Study|toxicity|1|||
161594904|NCT04802967|583569955|FG000|Part B|Withdrawal by Subject|0|||
161594905|NCT04802967|583569956|FG001|Part B|Withdrawal by Subject|0|||
161594906|NCT04802967|583569957|FG002|Part B|Withdrawal by Subject|0|||
161594907|NCT04802967|583569958|FG003|Part B|Withdrawal by Subject|0|||
161546716|NCT02668016|583392149|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
161546717|NCT02668016|583392149|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
161546718|NCT02668016|583392149|FG000|Month 8|Withdrawal due to severe symptoms|1|||
161546719|NCT02668016|583392149|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
161546720|NCT02668016|583392149|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
161546721|NCT02668016|583392149|FG000|Month 10|Withdrawal due to severe symptoms|1|||
161546722|NCT02668016|583392149|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
161546723|NCT01122381|583392154|FG000|Overall Study|study terminated early|0|||
161546724|NCT01122381|583392155|FG001|Overall Study|study terminated early|1|||
161546725|NCT00736489|583392156|FG000|Period 1|Lost to Follow-up|1|||
161546726|NCT00736489|583392157|FG001|Period 1|Lost to Follow-up|0|||
161546727|NCT00736489|583392158|FG002|Period 1|Lost to Follow-up|0|||
161546728|NCT00736489|583392159|FG003|Period 1|Lost to Follow-up|0|||
161546729|NCT00736489|583392160|FG004|Period 1|Lost to Follow-up|0|||
161546730|NCT00736489|583392161|FG005|Period 1|Lost to Follow-up|0|||
161546731|NCT00736489|583392156|FG000|Period 1|Withdrawal by Subject|0|||
161546732|NCT00736489|583392157|FG001|Period 1|Withdrawal by Subject|0|||
161546733|NCT00736489|583392158|FG002|Period 1|Withdrawal by Subject|0|||
161546734|NCT00736489|583392159|FG003|Period 1|Withdrawal by Subject|0|||
161546735|NCT00736489|583392160|FG004|Period 1|Withdrawal by Subject|0|||
161594908|NCT04802967|583569959|FG004|Part B|Withdrawal by Subject|0|||
161594909|NCT04802967|583569960|FG005|Part B|Withdrawal by Subject|1|||
161594910|NCT04802967|583569961|FG006|Part B|Withdrawal by Subject|0|||
161594911|NCT04802967|583569962|FG007|Part B|Withdrawal by Subject|0|||
161594912|NCT04802967|583569963|FG008|Part B|Withdrawal by Subject|0|||
161594913|NCT04802967|583569964|FG009|Part B|Withdrawal by Subject|0|||
161594914|NCT01369355|583569967|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
161594915|NCT01369355|583569968|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
161594916|NCT01369355|583569969|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
161594917|NCT01369355|583569970|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
161594918|NCT01369355|583569971|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
161594919|NCT01369355|583569972|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
161594920|NCT01369355|583569973|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161594921|NCT01369355|583569974|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161594922|NCT01369355|583569975|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161594923|NCT01369355|583569967|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161594924|NCT01369355|583569968|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
161594925|NCT01369355|583569969|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161594926|NCT01369355|583569970|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161594927|NCT01369355|583569971|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
161594928|NCT01369355|583569972|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
161594929|NCT01369355|583569973|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161594930|NCT01369355|583569974|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161594931|NCT01369355|583569975|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161594932|NCT01369355|583569967|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161594933|NCT01369355|583569968|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
161594934|NCT01369355|583569969|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
161594935|NCT01369355|583569970|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161594936|NCT01369355|583569971|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161594937|NCT01369355|583569972|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
161594938|NCT01369355|583569973|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161594939|NCT01369355|583569974|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161594940|NCT01369355|583569975|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161594941|NCT01369355|583569967|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
161594942|NCT01369355|583569968|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161594943|NCT01369355|583569969|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
161594944|NCT01369355|583569970|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
161594945|NCT01369355|583569971|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
161594946|NCT01369355|583569972|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
161594947|NCT01369355|583569973|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161594948|NCT01369355|583569974|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161594949|NCT01369355|583569975|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161594950|NCT01369355|583569967|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
161594951|NCT01369355|583569968|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
161546736|NCT00736489|583392161|FG005|Period 1|Withdrawal by Subject|1|||
161546737|NCT02395133|583392162|FG000|Overall Study|Adverse Event|4|||
161594952|NCT01369355|583569969|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
161594953|NCT01369355|583569970|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
161594954|NCT01369355|583569971|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
161594955|NCT01369355|583569972|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
161594956|NCT01369355|583569973|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161546738|NCT02395133|583392163|FG001|Overall Study|Adverse Event|1|||
161546739|NCT02395133|583392164|FG002|Overall Study|Adverse Event|3|||
161546740|NCT02395133|583392165|FG003|Overall Study|Adverse Event|0|||
161546741|NCT02395133|583392162|FG000|Overall Study|Lack of Efficacy|1|||
161546742|NCT02395133|583392163|FG001|Overall Study|Lack of Efficacy|0|||
161546743|NCT02395133|583392164|FG002|Overall Study|Lack of Efficacy|1|||
161546744|NCT02395133|583392165|FG003|Overall Study|Lack of Efficacy|1|||
161546745|NCT02395133|583392162|FG000|Overall Study|Protocol Violation|1|||
161546746|NCT02395133|583392163|FG001|Overall Study|Protocol Violation|1|||
161546747|NCT02395133|583392164|FG002|Overall Study|Protocol Violation|0|||
161546748|NCT02395133|583392165|FG003|Overall Study|Protocol Violation|3|||
161546749|NCT02395133|583392162|FG000|Overall Study|Lost to Follow-up|0|||
161546750|NCT02395133|583392163|FG001|Overall Study|Lost to Follow-up|1|||
161546751|NCT02395133|583392164|FG002|Overall Study|Lost to Follow-up|1|||
161546752|NCT02395133|583392165|FG003|Overall Study|Lost to Follow-up|0|||
161546753|NCT02395133|583392162|FG000|Overall Study|Pregnancy|0|||
161546754|NCT02395133|583392163|FG001|Overall Study|Pregnancy|0|||
161546755|NCT02395133|583392164|FG002|Overall Study|Pregnancy|3|||
161546756|NCT02395133|583392165|FG003|Overall Study|Pregnancy|0|||
161546757|NCT02395133|583392162|FG000|Overall Study|Consent withdrawn with no reason given|1|||
161546758|NCT02395133|583392163|FG001|Overall Study|Consent withdrawn with no reason given|3|||
161546759|NCT02395133|583392164|FG002|Overall Study|Consent withdrawn with no reason given|0|||
161546760|NCT02395133|583392165|FG003|Overall Study|Consent withdrawn with no reason given|2|||
161546761|NCT02395133|583392162|FG000|Overall Study|Consent withdrawn with personal reason|0|||
161546762|NCT02395133|583392163|FG001|Overall Study|Consent withdrawn with personal reason|1|||
161546763|NCT02395133|583392164|FG002|Overall Study|Consent withdrawn with personal reason|0|||
161546764|NCT02395133|583392165|FG003|Overall Study|Consent withdrawn with personal reason|3|||
161546765|NCT02395133|583392162|FG000|Overall Study|Sponsor decision|2|||
161546766|NCT02395133|583392163|FG001|Overall Study|Sponsor decision|0|||
161546767|NCT02395133|583392164|FG002|Overall Study|Sponsor decision|0|||
161546768|NCT02395133|583392165|FG003|Overall Study|Sponsor decision|1|||
161546769|NCT02395133|583392162|FG000|Overall Study|Other than specified above|5|||
161546770|NCT02395133|583392163|FG001|Overall Study|Other than specified above|2|||
161546771|NCT02395133|583392164|FG002|Overall Study|Other than specified above|2|||
161546772|NCT02395133|583392165|FG003|Overall Study|Other than specified above|4|||
161546773|NCT01555164|583392182|FG000|Overall Study|Adverse Event|5|||
161546774|NCT01555164|583392183|FG001|Overall Study|Adverse Event|7|||
161546775|NCT01555164|583392182|FG000|Overall Study|Hyperglycemia|0|||
161546776|NCT01555164|583392183|FG001|Overall Study|Hyperglycemia|1|||
161546777|NCT01555164|583392182|FG000|Overall Study|Investigator's Discretion|2|||
161546778|NCT01555164|583392183|FG001|Overall Study|Investigator's Discretion|2|||
161546779|NCT01555164|583392182|FG000|Overall Study|Lost to Follow-up|4|||
161546780|NCT01555164|583392183|FG001|Overall Study|Lost to Follow-up|3|||
161546781|NCT01555164|583392182|FG000|Overall Study|Protocol Violation|9|||
161546782|NCT01555164|583392183|FG001|Overall Study|Protocol Violation|5|||
161546783|NCT01555164|583392182|FG000|Overall Study|Subject Non-compliance|14|||
161546784|NCT01555164|583392183|FG001|Overall Study|Subject Non-compliance|6|||
161546785|NCT01555164|583392182|FG000|Overall Study|Subject Withdrew Consent|6|||
161546786|NCT01555164|583392183|FG001|Overall Study|Subject Withdrew Consent|11|||
161546787|NCT00886639|583392186|FG000|Overall Study|acute exacerbation|14|||
161546788|NCT00886639|583392186|FG000|Overall Study|non-compliance|2|||
161546789|NCT01871558|583392187|FG000|Overall Study|Other reason|0|||
161546790|NCT01871558|583392188|FG001|Overall Study|Other reason|1|||
161546791|NCT01871558|583392187|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
161546792|NCT01871558|583392188|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
161546793|NCT01871558|583392187|FG000|Overall Study|Withdrawal by Subject|2|||
161546794|NCT01871558|583392188|FG001|Overall Study|Withdrawal by Subject|0|||
161546795|NCT03203694|583392189|FG000|Overall Study|Withdrawal by Subject|2|||
161546796|NCT03203694|583392190|FG001|Overall Study|Withdrawal by Subject|0|||
161546797|NCT03203694|583392191|FG002|Overall Study|Withdrawal by Subject|0|||
161546798|NCT03203694|583392192|FG003|Overall Study|Withdrawal by Subject|0|||
161546799|NCT03203694|583392193|FG004|Overall Study|Withdrawal by Subject|0|||
161546800|NCT03203694|583392194|FG005|Overall Study|Withdrawal by Subject|0|||
161546801|NCT02969525|583392201|FG000|Double-Blind Period|Adverse Event|0|||
161546802|NCT02969525|583392202|FG001|Double-Blind Period|Adverse Event|0|||
161830088|NCT02400476|584418112|FG002|Overall Study|Lost to Follow-up|0|||
161546803|NCT02969525|583392203|FG002|Double-Blind Period|Adverse Event|1|||
161830089|NCT02400476|584418113|FG003|Overall Study|Lost to Follow-up|1|||
161546804|NCT02969525|583392204|FG003|Double-Blind Period|Adverse Event|1|||
161546805|NCT02969525|583392205|FG004|Double-Blind Period|Adverse Event|0|||
161546806|NCT02969525|583392206|FG005|Double-Blind Period|Adverse Event|0|||
161546807|NCT02969525|583392207|FG006|Double-Blind Period|Adverse Event|0|||
161546808|NCT02969525|583392208|FG007|Double-Blind Period|Adverse Event|0|||
161546809|NCT02969525|583392209|FG008|Double-Blind Period|Adverse Event|0|||
161546810|NCT02969525|583392210|FG009|Double-Blind Period|Adverse Event|0|||
161546811|NCT02969525|583392211|FG010|Double-Blind Period|Adverse Event|0|||
161546812|NCT02969525|583392212|FG011|Double-Blind Period|Adverse Event|0|||
161830090|NCT02400476|584418114|FG004|Overall Study|Lost to Follow-up|3|||
161546813|NCT02969525|583392201|FG000|Double-Blind Period|LOW EGFR|0|||
161546814|NCT02969525|583392202|FG001|Double-Blind Period|LOW EGFR|0|||
161546815|NCT02969525|583392203|FG002|Double-Blind Period|LOW EGFR|0|||
161546816|NCT02969525|583392204|FG003|Double-Blind Period|LOW EGFR|1|||
161546817|NCT02969525|583392205|FG004|Double-Blind Period|LOW EGFR|0|||
161546818|NCT02969525|583392206|FG005|Double-Blind Period|LOW EGFR|0|||
161546819|NCT02969525|583392207|FG006|Double-Blind Period|LOW EGFR|0|||
161546820|NCT02969525|583392208|FG007|Double-Blind Period|LOW EGFR|0|||
161546821|NCT02969525|583392209|FG008|Double-Blind Period|LOW EGFR|0|||
161546822|NCT02969525|583392210|FG009|Double-Blind Period|LOW EGFR|0|||
161546823|NCT02969525|583392211|FG010|Double-Blind Period|LOW EGFR|0|||
161546824|NCT02969525|583392212|FG011|Double-Blind Period|LOW EGFR|0|||
161546825|NCT02969525|583392201|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
161546826|NCT02969525|583392202|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546827|NCT02969525|583392203|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546828|NCT02969525|583392204|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
161546829|NCT02969525|583392205|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546830|NCT02969525|583392206|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546831|NCT02969525|583392207|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546832|NCT02969525|583392208|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546833|NCT02969525|583392209|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546834|NCT02969525|583392210|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546835|NCT02969525|583392211|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546836|NCT02969525|583392212|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
161546837|NCT02969525|583392201|FG000|Dose-Blind Period|Adverse Event|0|||
161546838|NCT02969525|583392202|FG001|Dose-Blind Period|Adverse Event|0|||
161546839|NCT02969525|583392203|FG002|Dose-Blind Period|Adverse Event|0|||
161546840|NCT02969525|583392204|FG003|Dose-Blind Period|Adverse Event|0|||
161546841|NCT02969525|583392205|FG004|Dose-Blind Period|Adverse Event|0|||
161546842|NCT02969525|583392206|FG005|Dose-Blind Period|Adverse Event|0|||
161546843|NCT02969525|583392207|FG006|Dose-Blind Period|Adverse Event|0|||
161546844|NCT02969525|583392208|FG007|Dose-Blind Period|Adverse Event|0|||
161546845|NCT02969525|583392209|FG008|Dose-Blind Period|Adverse Event|0|||
161546846|NCT02969525|583392210|FG009|Dose-Blind Period|Adverse Event|1|||
161546847|NCT02969525|583392211|FG010|Dose-Blind Period|Adverse Event|1|||
161546848|NCT02969525|583392212|FG011|Dose-Blind Period|Adverse Event|1|||
161546849|NCT02969525|583392201|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
161546850|NCT02969525|583392202|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
161546851|NCT02969525|583392203|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
161546852|NCT02969525|583392204|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
161546853|NCT02969525|583392205|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
161546854|NCT02969525|583392206|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
161546855|NCT02969525|583392207|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
161546856|NCT02969525|583392208|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
161546857|NCT02969525|583392209|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
161546858|NCT02969525|583392210|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
161546859|NCT02969525|583392211|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
161546860|NCT02969525|583392212|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
161546861|NCT02969525|583392201|FG000|Dose-Blind Period|Non-cooperating patient|0|||
161546862|NCT02969525|583392202|FG001|Dose-Blind Period|Non-cooperating patient|0|||
161546863|NCT02969525|583392203|FG002|Dose-Blind Period|Non-cooperating patient|0|||
161546864|NCT02969525|583392204|FG003|Dose-Blind Period|Non-cooperating patient|0|||
161546865|NCT02969525|583392205|FG004|Dose-Blind Period|Non-cooperating patient|0|||
161594957|NCT01369355|583569974|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161594958|NCT01369355|583569975|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161594959|NCT01369355|583569967|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
161594960|NCT01369355|583569968|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
161594961|NCT01369355|583569969|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
161546866|NCT02969525|583392206|FG005|Dose-Blind Period|Non-cooperating patient|0|||
161546867|NCT02969525|583392207|FG006|Dose-Blind Period|Non-cooperating patient|0|||
161546868|NCT02969525|583392208|FG007|Dose-Blind Period|Non-cooperating patient|0|||
161546869|NCT02969525|583392209|FG008|Dose-Blind Period|Non-cooperating patient|0|||
161546870|NCT02969525|583392210|FG009|Dose-Blind Period|Non-cooperating patient|0|||
161546871|NCT02969525|583392211|FG010|Dose-Blind Period|Non-cooperating patient|0|||
161546872|NCT02969525|583392212|FG011|Dose-Blind Period|Non-cooperating patient|1|||
161546873|NCT02969525|583392201|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546874|NCT02969525|583392202|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546875|NCT02969525|583392203|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546876|NCT02969525|583392204|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546877|NCT02969525|583392205|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546878|NCT02969525|583392206|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546879|NCT02969525|583392207|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546880|NCT02969525|583392208|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546881|NCT02969525|583392209|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546882|NCT02969525|583392210|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546883|NCT02969525|583392211|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
161546884|NCT02969525|583392212|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161546885|NCT03445065|583392213|FG000|Overall Study|Withdrawal by Subject|3|||
161546886|NCT03445065|583392214|FG001|Overall Study|Withdrawal by Subject|6|||
161546887|NCT03445065|583392215|FG002|Overall Study|Withdrawal by Subject|2|||
161546888|NCT03445065|583392216|FG003|Overall Study|Withdrawal by Subject|2|||
161546889|NCT03445065|583392213|FG000|Overall Study|Other|4|||
161546890|NCT03445065|583392214|FG001|Overall Study|Other|3|||
161546891|NCT03445065|583392215|FG002|Overall Study|Other|3|||
161546892|NCT03445065|583392216|FG003|Overall Study|Other|1|||
161546893|NCT02172625|583392217|FG000|Overall Study|Adverse Event|0|||
161546894|NCT02172625|583392218|FG001|Overall Study|Adverse Event|1|||
161546895|NCT02172625|583392217|FG000|Overall Study|Pregnancy|0|||
161546896|NCT02172625|583392218|FG001|Overall Study|Pregnancy|1|||
161546897|NCT02172625|583392217|FG000|Overall Study|car accident|0|||
161546898|NCT02172625|583392218|FG001|Overall Study|car accident|1|||
161546899|NCT03315130|583392219|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
161594962|NCT01369355|583569970|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
161594963|NCT01369355|583569971|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
161594964|NCT01369355|583569972|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
161594965|NCT01369355|583569973|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
161594966|NCT01369355|583569974|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
161594967|NCT01369355|583569975|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
161594968|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
161594969|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
161594970|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
161680721|NCT03227471|583884302|FG009|Overall Study|Randomized, Never Dosed|0|||
161680722|NCT03227471|583884303|FG010|Overall Study|Randomized, Never Dosed|0|||
161680723|NCT03227471|583884304|FG011|Overall Study|Randomized, Never Dosed|0|||
161680724|NCT03227471|583884305|FG012|Overall Study|Randomized, Never Dosed|0|||
161680725|NCT03227471|583884306|FG013|Overall Study|Randomized, Never Dosed|0|||
161546900|NCT03315130|583392220|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
161546901|NCT03315130|583392221|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
161546902|NCT03315130|583392222|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
161546903|NCT03315130|583392219|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
161546904|NCT03315130|583392220|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
161680726|NCT03227471|583884307|FG014|Overall Study|Randomized, Never Dosed|1|||
161680727|NCT00736255|583884315|FG000|Overall Study|Adverse Event|1|||
161680728|NCT00736255|583884316|FG001|Overall Study|Adverse Event|0|||
161680729|NCT00736255|583884315|FG000|Overall Study|Physician Decision|1|||
161680730|NCT00736255|583884316|FG001|Overall Study|Physician Decision|0|||
161680731|NCT00736255|583884315|FG000|Overall Study|Non-compliance|1|||
161680732|NCT00736255|583884316|FG001|Overall Study|Non-compliance|1|||
161680733|NCT00457015|583884317|FG000|Overall Study|Left study site against medical advice|0|||
161680734|NCT00457015|583884318|FG001|Overall Study|Left study site against medical advice|1|||
161680735|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
161680736|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161680737|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161680738|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161680739|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
161680740|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161680741|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161680742|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161680743|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
161680744|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161680745|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161680746|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161680747|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
161680748|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161680749|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161680750|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161680751|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
161680752|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161680753|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161680754|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161680755|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161680756|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
161680757|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161680758|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161680759|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161680760|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
161680761|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161680762|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161680763|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161680764|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
161680765|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161680766|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161680767|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161546905|NCT03315130|583392221|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
161546906|NCT03315130|583392222|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
161546907|NCT03315130|583392219|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
161546908|NCT03315130|583392220|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
161546909|NCT03315130|583392221|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
161680768|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
161680769|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161680770|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161546910|NCT03315130|583392222|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
161546911|NCT03315130|583392219|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
161680771|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161680772|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
161680773|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161680774|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161680775|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161680776|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
161546912|NCT03315130|583392220|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
161546913|NCT03315130|583392221|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
161546914|NCT03315130|583392222|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
161546915|NCT03315130|583392219|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
161546916|NCT03315130|583392220|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
161546917|NCT03315130|583392221|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
161546918|NCT03315130|583392222|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
161546919|NCT03315130|583392219|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
161546920|NCT03315130|583392220|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
161546921|NCT03315130|583392221|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
161546922|NCT03315130|583392222|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
161546923|NCT00524030|583392223|FG000|Overall Study|Lack of Efficacy|10|||
161546924|NCT00524030|583392224|FG001|Overall Study|Lack of Efficacy|24|||
161546925|NCT00524030|583392223|FG000|Overall Study|Lost to Follow-up|0|||
161546926|NCT00524030|583392224|FG001|Overall Study|Lost to Follow-up|2|||
161546927|NCT00524030|583392223|FG000|Overall Study|Withdrawal by Subject|3|||
161546928|NCT00524030|583392224|FG001|Overall Study|Withdrawal by Subject|8|||
161546929|NCT00524030|583392223|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
161546930|NCT00524030|583392224|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
161546931|NCT00524030|583392223|FG000|Overall Study|Protocol Violation|0|||
161546932|NCT00524030|583392224|FG001|Overall Study|Protocol Violation|1|||
161546933|NCT00524030|583392223|FG000|Overall Study|Pregnancy|1|||
161546934|NCT00524030|583392224|FG001|Overall Study|Pregnancy|0|||
161546935|NCT00524030|583392223|FG000|Overall Study|Adverse Event|3|||
161546936|NCT00524030|583392224|FG001|Overall Study|Adverse Event|21|||
161546937|NCT00524030|583392223|FG000|Overall Study|Death|0|||
161546938|NCT00524030|583392224|FG001|Overall Study|Death|1|||
161546939|NCT02944656|583392225|FG000|Overall Study|No longer eligible|3|||
161546940|NCT02944656|583392226|FG001|Overall Study|No longer eligible|0|||
161546941|NCT02944656|583392225|FG000|Overall Study|Lost to Follow-up|7|||
161546942|NCT02944656|583392226|FG001|Overall Study|Lost to Follow-up|10|||
161546943|NCT04398537|583392227|FG000|Overall Study|Physician Decision|10|||
161546944|NCT04398537|583392228|FG001|Overall Study|Physician Decision|15|||
161546945|NCT03535337|583392229|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
161546946|NCT03535337|583392230|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
161546947|NCT03535337|583392231|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
161546948|NCT03535337|583392232|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
161546949|NCT03535337|583392233|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
161546950|NCT03535337|583392234|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
161546951|NCT03535337|583392235|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
161546952|NCT03535337|583392236|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
161546953|NCT03535337|583392237|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
161546954|NCT03535337|583392238|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
161546955|NCT05879198|583392239|FG000|Overall Study|Lost to Follow-up|1|||
161546956|NCT01598298|583392240|FG000|Overall Study|Not eligible|5|||
161546957|NCT01598298|583392241|FG001|Overall Study|Not eligible|5|||
161546958|NCT01598298|583392240|FG000|Overall Study|Adverse Event|21|||
161546959|NCT01598298|583392241|FG001|Overall Study|Adverse Event|19|||
161546960|NCT01598298|583392240|FG000|Overall Study|Progression/relapse|0|||
161546961|NCT01598298|583392241|FG001|Overall Study|Progression/relapse|2|||
161546962|NCT01598298|583392240|FG000|Overall Study|Withdrawal by Subject|10|||
161546963|NCT01598298|583392241|FG001|Overall Study|Withdrawal by Subject|15|||
161546964|NCT01598298|583392240|FG000|Overall Study|Other reason (not protocol specified)|4|||
161546965|NCT01598298|583392241|FG001|Overall Study|Other reason (not protocol specified)|0|||
161546966|NCT00474929|583394089|FG000|Overall Study|Withdrawal by Subject|0|||
161546967|NCT00474929|583394090|FG001|Overall Study|Withdrawal by Subject|1|||
161546968|NCT00474929|583394091|FG002|Overall Study|Withdrawal by Subject|0|||
161546969|NCT00474929|583394092|FG003|Overall Study|Withdrawal by Subject|0|||
161546970|NCT00474929|583394093|FG004|Overall Study|Withdrawal by Subject|0|||
161546971|NCT00474929|583394089|FG000|Overall Study|Unrelated medical condition|0|||
161546972|NCT00474929|583394090|FG001|Overall Study|Unrelated medical condition|0|||
161546973|NCT00474929|583394091|FG002|Overall Study|Unrelated medical condition|1|||
161594971|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
161546974|NCT00474929|583394092|FG003|Overall Study|Unrelated medical condition|0|||
161546975|NCT00474929|583394093|FG004|Overall Study|Unrelated medical condition|0|||
161546976|NCT00474929|583394089|FG000|Overall Study|Physician Decision|0|||
161546977|NCT00474929|583394090|FG001|Overall Study|Physician Decision|0|||
161546978|NCT00474929|583394091|FG002|Overall Study|Physician Decision|1|||
161546979|NCT00474929|583394092|FG003|Overall Study|Physician Decision|2|||
161546980|NCT00474929|583394093|FG004|Overall Study|Physician Decision|0|||
161546981|NCT03029247|583394096|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
161546982|NCT03029247|583394097|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
161546983|NCT03029247|583394096|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
161546984|NCT03029247|583394097|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
161830091|NCT02400476|584418115|FG005|Overall Study|Lost to Follow-up|1|||
161546985|NCT03029247|583394096|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
161546986|NCT03029247|583394097|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
161546987|NCT03029247|583394096|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
161546988|NCT03029247|583394097|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
161546989|NCT02593305|583394098|FG000|Post 1|Comparison only group. No intervention.|0|||
161546990|NCT02593305|583394099|FG001|Post 1|Comparison only group. No intervention.|0|||
161546991|NCT02593305|583394100|FG002|Post 1|Comparison only group. No intervention.|10|||
161546992|NCT02757521|583394101|FG000|Overall Study|Adverse Event|1|||
161546993|NCT02757521|583394102|FG001|Overall Study|Adverse Event|0|||
161546994|NCT00999661|583394107|FG000|Overall Study|Lost to Follow-up|59|||
161546995|NCT00999661|583394107|FG000|Overall Study|Adverse Event|1|||
161546996|NCT00999661|583394107|FG000|Overall Study|Withdrawal by Subject|1|||
161546997|NCT00999661|583394107|FG000|Overall Study|Not meeting eligibility criteria|9|||
161546998|NCT00312858|583394108|FG000|Overall Study|Adverse Event|0|||
161546999|NCT00312858|583394109|FG001|Overall Study|Adverse Event|1|||
161547000|NCT00312858|583394108|FG000|Overall Study|Lost to Follow-up|25|||
161547001|NCT00312858|583394109|FG001|Overall Study|Lost to Follow-up|42|||
161547002|NCT00312858|583394108|FG000|Overall Study|Protocol Violation|3|||
161547003|NCT00312858|583394109|FG001|Overall Study|Protocol Violation|8|||
161547004|NCT00312858|583394108|FG000|Overall Study|Withdraw by Participant|20|||
161547005|NCT00312858|583394109|FG001|Overall Study|Withdraw by Participant|20|||
161547006|NCT00312858|583394108|FG000|Overall Study|Participant Moved|11|||
161547007|NCT00312858|583394109|FG001|Overall Study|Participant Moved|10|||
161547008|NCT00312858|583394108|FG000|Overall Study|Other|9|||
161547009|NCT00312858|583394109|FG001|Overall Study|Other|12|||
161547010|NCT00854295|583394115|FG000|Overall Study|Death|7|||
161547011|NCT00854295|583394116|FG001|Overall Study|Death|0|||
161547012|NCT00854295|583394117|FG002|Overall Study|Death|1|||
161547013|NCT00854295|583394118|FG003|Overall Study|Death|1|||
161547014|NCT00854295|583394115|FG000|Overall Study|Adverse Event|6|||
161547015|NCT00854295|583394116|FG001|Overall Study|Adverse Event|1|||
161547016|NCT00854295|583394117|FG002|Overall Study|Adverse Event|1|||
161547017|NCT00854295|583394118|FG003|Overall Study|Adverse Event|3|||
161547018|NCT00854295|583394115|FG000|Overall Study|Lost to Follow-up|18|||
161547019|NCT00854295|583394116|FG001|Overall Study|Lost to Follow-up|5|||
161547020|NCT00854295|583394117|FG002|Overall Study|Lost to Follow-up|21|||
161547021|NCT00854295|583394118|FG003|Overall Study|Lost to Follow-up|21|||
161547022|NCT00854295|583394115|FG000|Overall Study|Physician Decision|10|||
161547023|NCT00854295|583394116|FG001|Overall Study|Physician Decision|0|||
161547024|NCT00854295|583394117|FG002|Overall Study|Physician Decision|0|||
161547025|NCT00854295|583394118|FG003|Overall Study|Physician Decision|0|||
161547026|NCT02440594|583394120|FG000|Overall Study|Lost to Follow-up|34|||
161547027|NCT02440594|583394121|FG001|Overall Study|Lost to Follow-up|33|||
161547028|NCT02440594|583394122|FG002|Overall Study|Lost to Follow-up|54|||
161547029|NCT02440594|583394123|FG003|Overall Study|Lost to Follow-up|47|||
161547030|NCT02440594|583394124|FG004|Overall Study|Lost to Follow-up|5|||
161547031|NCT02440594|583394125|FG005|Overall Study|Lost to Follow-up|4|||
161547032|NCT02440594|583394126|FG006|Overall Study|Lost to Follow-up|28|||
161547033|NCT02440594|583394127|FG007|Overall Study|Lost to Follow-up|48|||
161547034|NCT02440594|583394120|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
161547035|NCT02440594|583394121|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
161547036|NCT02440594|583394122|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
161547037|NCT02440594|583394123|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
161547038|NCT02440594|583394124|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
161547039|NCT02440594|583394125|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
161547040|NCT02440594|583394126|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
161547041|NCT02440594|583394127|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
161547042|NCT02440594|583394120|FG000|Overall Study|Withdrawal by Subject|81|||
161547043|NCT02440594|583394121|FG001|Overall Study|Withdrawal by Subject|67|||
161547044|NCT02440594|583394122|FG002|Overall Study|Withdrawal by Subject|59|||
161547045|NCT02440594|583394123|FG003|Overall Study|Withdrawal by Subject|38|||
161547046|NCT02440594|583394124|FG004|Overall Study|Withdrawal by Subject|2|||
161547047|NCT02440594|583394125|FG005|Overall Study|Withdrawal by Subject|2|||
161547048|NCT02440594|583394126|FG006|Overall Study|Withdrawal by Subject|7|||
161547049|NCT02440594|583394127|FG007|Overall Study|Withdrawal by Subject|7|||
161547050|NCT02440594|583394120|FG000|Overall Study|Administratively w/drawn|3|||
161547051|NCT02440594|583394121|FG001|Overall Study|Administratively w/drawn|2|||
161547052|NCT02440594|583394122|FG002|Overall Study|Administratively w/drawn|0|||
161547053|NCT02440594|583394123|FG003|Overall Study|Administratively w/drawn|0|||
161547054|NCT02440594|583394124|FG004|Overall Study|Administratively w/drawn|0|||
161547055|NCT02440594|583394125|FG005|Overall Study|Administratively w/drawn|0|||
161547056|NCT02440594|583394126|FG006|Overall Study|Administratively w/drawn|2|||
161547057|NCT02440594|583394127|FG007|Overall Study|Administratively w/drawn|1|||
161547058|NCT00152763|583394128|FG000|Overall Study|Death|4|||
161547059|NCT00152763|583394129|FG001|Overall Study|Death|1|||
161547060|NCT00152763|583394130|FG002|Overall Study|Death|2|||
161547061|NCT00152763|583394131|FG003|Overall Study|Death|1|||
161680777|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161680778|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161547062|NCT00152763|583394128|FG000|Overall Study|Lost to Follow-up|6|||
161547063|NCT00152763|583394129|FG001|Overall Study|Lost to Follow-up|4|||
161547064|NCT00152763|583394130|FG002|Overall Study|Lost to Follow-up|2|||
161547065|NCT00152763|583394131|FG003|Overall Study|Lost to Follow-up|13|||
161547066|NCT04668989|583394134|FG000|First Intervention|Covid-19 related self-isolation|0|||
161547067|NCT04668989|583394135|FG001|First Intervention|Covid-19 related self-isolation|1|||
161547068|NCT04668989|583394134|FG000|Second Intervention|Adverse Event|0|||
161547069|NCT04668989|583394135|FG001|Second Intervention|Adverse Event|1|||
161547070|NCT01622348|583394141|FG000|Overall Study|Withdrawal by Subject|1|||
161547071|NCT01622348|583394142|FG001|Overall Study|Withdrawal by Subject|0|||
161547072|NCT01622348|583394143|FG002|Overall Study|Withdrawal by Subject|1|||
161547073|NCT00791921|583394146|FG000|Overall Study|Protocol planed|24|||
161547074|NCT00791921|583394147|FG001|Overall Study|Protocol planed|88|||
161547075|NCT00791921|583394146|FG000|Overall Study|Withdrawal by Subject|1|||
161547076|NCT00791921|583394147|FG001|Overall Study|Withdrawal by Subject|2|||
161547077|NCT00791921|583394146|FG000|Overall Study|Adverse Event|8|||
161547078|NCT00791921|583394147|FG001|Overall Study|Adverse Event|2|||
161547079|NCT00791921|583394146|FG000|Overall Study|Lack of Efficacy|0|||
161547080|NCT00791921|583394147|FG001|Overall Study|Lack of Efficacy|2|||
161547081|NCT00791921|583394146|FG000|Overall Study|Lack of study drug administration|1|||
161547082|NCT00791921|583394147|FG001|Overall Study|Lack of study drug administration|1|||
161547083|NCT00791921|583394146|FG000|Overall Study|Reason other than those above|0|||
161547084|NCT00791921|583394147|FG001|Overall Study|Reason other than those above|1|||
161547085|NCT00422799|583394148|FG000|Overall Study|Withdrawal by Subject|6|||
161547086|NCT00422799|583394148|FG000|Overall Study|Adverse Event|7|||
161547087|NCT01965158|583394149|FG000|Overall Study|Adverse Event|14|||
161547088|NCT01965158|583394150|FG001|Overall Study|Adverse Event|5|||
161547089|NCT01965158|583394149|FG000|Overall Study|Withdrawal by Subject|16|||
161547090|NCT01965158|583394150|FG001|Overall Study|Withdrawal by Subject|24|||
161547091|NCT01965158|583394149|FG000|Overall Study|Lost to Follow-up|7|||
161547092|NCT01965158|583394150|FG001|Overall Study|Lost to Follow-up|5|||
161547093|NCT01965158|583394149|FG000|Overall Study|Protocol Violation|1|||
161547094|NCT01965158|583394150|FG001|Overall Study|Protocol Violation|1|||
161547095|NCT01965158|583394149|FG000|Overall Study|Other - Miscellaneous|3|||
161547096|NCT01965158|583394150|FG001|Overall Study|Other - Miscellaneous|0|||
161547097|NCT00474175|583394151|FG000|Overall Study|Lack of Efficacy|0|||
161547098|NCT00474175|583394152|FG001|Overall Study|Lack of Efficacy|0|||
161547099|NCT00474175|583394153|FG002|Overall Study|Lack of Efficacy|1|||
161547100|NCT00474175|583394151|FG000|Overall Study|Withdrawal by Subject|0|||
161547101|NCT00474175|583394152|FG001|Overall Study|Withdrawal by Subject|1|||
161547102|NCT00474175|583394153|FG002|Overall Study|Withdrawal by Subject|1|||
161680779|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161680780|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
161680781|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161680782|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161680783|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
161680784|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
161680785|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
161680786|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
161547103|NCT00474175|583394151|FG000|Overall Study|Ineligible|1|||
161547104|NCT00474175|583394152|FG001|Overall Study|Ineligible|3|||
161547105|NCT00474175|583394153|FG002|Overall Study|Ineligible|1|||
161547106|NCT00474175|583394151|FG000|Overall Study|Protocol Violation|0|||
161547107|NCT00474175|583394152|FG001|Overall Study|Protocol Violation|2|||
161547108|NCT00474175|583394153|FG002|Overall Study|Protocol Violation|1|||
161547109|NCT00474175|583394151|FG000|Overall Study|Administrative|0|||
161547110|NCT00474175|583394152|FG001|Overall Study|Administrative|1|||
161547111|NCT00474175|583394153|FG002|Overall Study|Administrative|0|||
161547112|NCT01619787|583394154|FG000|Overall Study|Lost to Follow-up|5|||
161547113|NCT04537897|583394155|FG000|Overall Study|Other than listed|0|||
161547114|NCT04537897|583394156|FG001|Overall Study|Other than listed|0|||
161547115|NCT04537897|583394157|FG002|Overall Study|Other than listed|0|||
161547116|NCT04537897|583394158|FG003|Overall Study|Other than listed|0|||
161547117|NCT04537897|583394159|FG004|Overall Study|Other than listed|0|||
161680787|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
161547118|NCT04537897|583394160|FG005|Overall Study|Other than listed|0|||
161547119|NCT04537897|583394161|FG006|Overall Study|Other than listed|1|||
161547120|NCT04537897|583394162|FG007|Overall Study|Other than listed|0|||
161547121|NCT04537897|583394163|FG008|Overall Study|Other than listed|0|||
161547122|NCT04537897|583394155|FG000|Overall Study|Adverse Event|0|||
161547123|NCT04537897|583394156|FG001|Overall Study|Adverse Event|0|||
161547124|NCT04537897|583394157|FG002|Overall Study|Adverse Event|0|||
161547125|NCT04537897|583394158|FG003|Overall Study|Adverse Event|1|||
161547126|NCT04537897|583394159|FG004|Overall Study|Adverse Event|0|||
161547127|NCT04537897|583394160|FG005|Overall Study|Adverse Event|0|||
161547128|NCT04537897|583394161|FG006|Overall Study|Adverse Event|0|||
161547129|NCT04537897|583394162|FG007|Overall Study|Adverse Event|0|||
161547130|NCT04537897|583394163|FG008|Overall Study|Adverse Event|0|||
161547131|NCT04537897|583394155|FG000|Overall Study|Withdrawal by Subject|0|||
161547132|NCT04537897|583394156|FG001|Overall Study|Withdrawal by Subject|1|||
161547133|NCT04537897|583394157|FG002|Overall Study|Withdrawal by Subject|0|||
161547134|NCT04537897|583394158|FG003|Overall Study|Withdrawal by Subject|0|||
161547135|NCT04537897|583394159|FG004|Overall Study|Withdrawal by Subject|0|||
161547136|NCT04537897|583394160|FG005|Overall Study|Withdrawal by Subject|0|||
161547137|NCT04537897|583394161|FG006|Overall Study|Withdrawal by Subject|0|||
161547138|NCT04537897|583394162|FG007|Overall Study|Withdrawal by Subject|0|||
161547139|NCT04537897|583394163|FG008|Overall Study|Withdrawal by Subject|0|||
161547140|NCT00197028|583394167|FG000|Overall Study|Adverse Event|2|||
161547141|NCT00197028|583394168|FG001|Overall Study|Adverse Event|2|||
161547142|NCT00197028|583394167|FG000|Overall Study|Protocol Violation|2|||
161547143|NCT00197028|583394168|FG001|Overall Study|Protocol Violation|1|||
161547144|NCT00197028|583394167|FG000|Overall Study|Withdrawal by Subject|8|||
161547145|NCT00197028|583394168|FG001|Overall Study|Withdrawal by Subject|12|||
161547146|NCT00197028|583394167|FG000|Overall Study|Lost to Follow-up|1|||
161547147|NCT00197028|583394168|FG001|Overall Study|Lost to Follow-up|0|||
161547148|NCT00197028|583394167|FG000|Overall Study|Other|3|||
161547149|NCT00197028|583394168|FG001|Overall Study|Other|6|||
161547150|NCT03893825|583394169|FG000|Overall Study|Death|2|||
161547151|NCT03893825|583394170|FG001|Overall Study|Death|1|||
161547152|NCT03893825|583394169|FG000|Overall Study|Adverse Event|0|||
161547153|NCT03893825|583394170|FG001|Overall Study|Adverse Event|2|||
161547154|NCT03893825|583394169|FG000|Overall Study|Withdrawal by Subject|19|||
161547155|NCT03893825|583394170|FG001|Overall Study|Withdrawal by Subject|21|||
161547156|NCT03893825|583394169|FG000|Overall Study|Protocol deviation|1|||
161547157|NCT03893825|583394170|FG001|Overall Study|Protocol deviation|0|||
161547158|NCT03893825|583394169|FG000|Overall Study|Lost to Follow-up|10|||
161547159|NCT03893825|583394170|FG001|Overall Study|Lost to Follow-up|10|||
161547160|NCT03893825|583394169|FG000|Overall Study|Other than specified|7|||
161547161|NCT03893825|583394170|FG001|Overall Study|Other than specified|6|||
161547162|NCT04488003|583394176|FG000|Assessed for Eligibility|Screen Failure|24|||
161547163|NCT04488003|583394177|FG001|Assessed for Eligibility|Screen Failure|0|||
161547164|NCT04488003|583394178|FG002|Assessed for Eligibility|Screen Failure|0|||
161547165|NCT04488003|583394176|FG000|Assessed for Eligibility|Adverse Event|1|||
161547166|NCT04488003|583394177|FG001|Assessed for Eligibility|Adverse Event|0|||
161547167|NCT04488003|583394178|FG002|Assessed for Eligibility|Adverse Event|0|||
161547168|NCT04488003|583394176|FG000|Assessed for Eligibility|Death|1|||
161547169|NCT04488003|583394177|FG001|Assessed for Eligibility|Death|0|||
161547170|NCT04488003|583394178|FG002|Assessed for Eligibility|Death|0|||
161547171|NCT04488003|583394176|FG000|Assessed for Eligibility|Physician Decision|1|||
161547172|NCT04488003|583394177|FG001|Assessed for Eligibility|Physician Decision|0|||
161547173|NCT04488003|583394178|FG002|Assessed for Eligibility|Physician Decision|0|||
161547174|NCT04488003|583394176|FG000|Allocated to Treatment|Progressive Disease|51|||
161547175|NCT04488003|583394177|FG001|Allocated to Treatment|Progressive Disease|0|||
161594972|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
161594973|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
161594974|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
161594975|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
161594976|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
161594977|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Death|0|||
161594978|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Death|0|||
161594979|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Death|0|||
161594980|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Death|0|||
161594981|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Death|0|||
161547176|NCT04488003|583394178|FG002|Allocated to Treatment|Progressive Disease|0|||
161547177|NCT04488003|583394176|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
161547178|NCT04488003|583394177|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
161547179|NCT04488003|583394178|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
161547180|NCT04488003|583394176|FG000|Allocated to Treatment|Adverse Event|6|||
161547181|NCT04488003|583394177|FG001|Allocated to Treatment|Adverse Event|0|||
161547182|NCT04488003|583394178|FG002|Allocated to Treatment|Adverse Event|0|||
161547183|NCT04488003|583394176|FG000|Allocated to Treatment|Other|5|||
161547184|NCT04488003|583394177|FG001|Allocated to Treatment|Other|0|||
161547185|NCT04488003|583394178|FG002|Allocated to Treatment|Other|0|||
161830092|NCT02400476|584418110|FG000|Overall Study|Physician Decision|0|||
161830093|NCT02400476|584418111|FG001|Overall Study|Physician Decision|0|||
161547186|NCT04488003|583394176|FG000|Allocated to Treatment|Physician Decision|4|||
161547187|NCT04488003|583394177|FG001|Allocated to Treatment|Physician Decision|0|||
161547188|NCT04488003|583394178|FG002|Allocated to Treatment|Physician Decision|0|||
161547189|NCT04488003|583394176|FG000|Allocated to Treatment|Death|4|||
161547190|NCT04488003|583394177|FG001|Allocated to Treatment|Death|0|||
161547191|NCT04488003|583394178|FG002|Allocated to Treatment|Death|0|||
161547192|NCT01737996|583394179|FG000|Overall Study|Adverse Event|0|||
161547193|NCT01737996|583394180|FG001|Overall Study|Adverse Event|1|||
161547194|NCT01737996|583394181|FG002|Overall Study|Adverse Event|1|||
161547195|NCT01737996|583394179|FG000|Overall Study|Withdrawal by Subject|0|||
161547196|NCT01737996|583394180|FG001|Overall Study|Withdrawal by Subject|0|||
161547197|NCT01737996|583394181|FG002|Overall Study|Withdrawal by Subject|1|||
161547198|NCT01468922|583394184|FG000|Overall Study|Screening failure|0|||
161547199|NCT01468922|583394185|FG001|Overall Study|Screening failure|0|||
161547200|NCT01468922|583394186|FG002|Overall Study|Screening failure|0|||
161547201|NCT01468922|583394187|FG003|Overall Study|Screening failure|0|||
161547202|NCT01468922|583394188|FG004|Overall Study|Screening failure|0|||
161547203|NCT01468922|583394189|FG005|Overall Study|Screening failure|0|||
161547204|NCT01468922|583394190|FG006|Overall Study|Screening failure|0|||
161547205|NCT01468922|583394191|FG007|Overall Study|Screening failure|0|||
161547206|NCT01468922|583394192|FG008|Overall Study|Screening failure|1|||
161547207|NCT01468922|583394184|FG000|Overall Study|Per patient choice|1|||
161547208|NCT01468922|583394185|FG001|Overall Study|Per patient choice|0|||
161547209|NCT01468922|583394186|FG002|Overall Study|Per patient choice|0|||
161547210|NCT01468922|583394187|FG003|Overall Study|Per patient choice|0|||
161547211|NCT01468922|583394188|FG004|Overall Study|Per patient choice|0|||
161547212|NCT01468922|583394189|FG005|Overall Study|Per patient choice|0|||
161547213|NCT01468922|583394190|FG006|Overall Study|Per patient choice|0|||
161547214|NCT01468922|583394191|FG007|Overall Study|Per patient choice|0|||
161547215|NCT01468922|583394192|FG008|Overall Study|Per patient choice|0|||
161547216|NCT01468922|583394184|FG000|Overall Study|Switched to alternative treatment|1|||
161547217|NCT01468922|583394185|FG001|Overall Study|Switched to alternative treatment|0|||
161547218|NCT01468922|583394186|FG002|Overall Study|Switched to alternative treatment|0|||
161547219|NCT01468922|583394187|FG003|Overall Study|Switched to alternative treatment|0|||
161547220|NCT01468922|583394188|FG004|Overall Study|Switched to alternative treatment|1|||
161547221|NCT01468922|583394189|FG005|Overall Study|Switched to alternative treatment|0|||
161547222|NCT01468922|583394190|FG006|Overall Study|Switched to alternative treatment|0|||
161547223|NCT01468922|583394191|FG007|Overall Study|Switched to alternative treatment|0|||
161547224|NCT01468922|583394192|FG008|Overall Study|Switched to alternative treatment|0|||
161547225|NCT01468922|583394184|FG000|Overall Study|Enrolled on new protocol|0|||
161547226|NCT01468922|583394185|FG001|Overall Study|Enrolled on new protocol|0|||
161547227|NCT01468922|583394186|FG002|Overall Study|Enrolled on new protocol|0|||
161547228|NCT01468922|583394187|FG003|Overall Study|Enrolled on new protocol|0|||
161547229|NCT01468922|583394188|FG004|Overall Study|Enrolled on new protocol|1|||
161547230|NCT01468922|583394189|FG005|Overall Study|Enrolled on new protocol|0|||
161547231|NCT01468922|583394190|FG006|Overall Study|Enrolled on new protocol|0|||
161547232|NCT01468922|583394191|FG007|Overall Study|Enrolled on new protocol|0|||
161547233|NCT01468922|583394192|FG008|Overall Study|Enrolled on new protocol|0|||
161547234|NCT01468922|583394184|FG000|Overall Study|Adverse Event|0|||
161547235|NCT01468922|583394185|FG001|Overall Study|Adverse Event|0|||
161547236|NCT01468922|583394186|FG002|Overall Study|Adverse Event|0|||
161547237|NCT01468922|583394187|FG003|Overall Study|Adverse Event|0|||
161547238|NCT01468922|583394188|FG004|Overall Study|Adverse Event|0|||
161547239|NCT01468922|583394189|FG005|Overall Study|Adverse Event|0|||
161547240|NCT01468922|583394190|FG006|Overall Study|Adverse Event|0|||
161830094|NCT02400476|584418112|FG002|Overall Study|Physician Decision|1|||
161830095|NCT02400476|584418113|FG003|Overall Study|Physician Decision|1|||
161830096|NCT02400476|584418114|FG004|Overall Study|Physician Decision|0|||
161547241|NCT01468922|583394191|FG007|Overall Study|Adverse Event|1|||
161547242|NCT01468922|583394192|FG008|Overall Study|Adverse Event|0|||
161547243|NCT01468922|583394184|FG000|Overall Study|Infection of blood|0|||
161547244|NCT01468922|583394185|FG001|Overall Study|Infection of blood|0|||
161547245|NCT01468922|583394186|FG002|Overall Study|Infection of blood|0|||
161547246|NCT01468922|583394187|FG003|Overall Study|Infection of blood|0|||
161547247|NCT01468922|583394188|FG004|Overall Study|Infection of blood|0|||
161547248|NCT01468922|583394189|FG005|Overall Study|Infection of blood|0|||
161547249|NCT01468922|583394190|FG006|Overall Study|Infection of blood|0|||
161547250|NCT01468922|583394191|FG007|Overall Study|Infection of blood|1|||
161547251|NCT01468922|583394192|FG008|Overall Study|Infection of blood|0|||
161830097|NCT02400476|584418115|FG005|Overall Study|Physician Decision|1|||
161547252|NCT01468922|583394184|FG000|Overall Study|Patient choice - surgery|0|||
161547253|NCT01468922|583394185|FG001|Overall Study|Patient choice - surgery|0|||
161547254|NCT01468922|583394186|FG002|Overall Study|Patient choice - surgery|0|||
161547255|NCT01468922|583394187|FG003|Overall Study|Patient choice - surgery|0|||
161547256|NCT01468922|583394188|FG004|Overall Study|Patient choice - surgery|0|||
161830098|NCT02400476|584418110|FG000|Overall Study|Other, Disease Progression|0|||
161680788|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
161680789|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
161594982|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Death|0|||
161594983|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Death|0|||
161594984|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Death|1|||
161594985|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Death|3|||
161547257|NCT01468922|583394189|FG005|Overall Study|Patient choice - surgery|0|||
161547258|NCT01468922|583394190|FG006|Overall Study|Patient choice - surgery|0|||
161547259|NCT01468922|583394191|FG007|Overall Study|Patient choice - surgery|1|||
161547260|NCT01468922|583394192|FG008|Overall Study|Patient choice - surgery|0|||
161547261|NCT01468922|583394184|FG000|Overall Study|Refused further treatment|0|||
161547262|NCT01468922|583394185|FG001|Overall Study|Refused further treatment|0|||
161547263|NCT01468922|583394186|FG002|Overall Study|Refused further treatment|0|||
161547264|NCT01468922|583394187|FG003|Overall Study|Refused further treatment|0|||
161547265|NCT01468922|583394188|FG004|Overall Study|Refused further treatment|0|||
161547266|NCT01468922|583394189|FG005|Overall Study|Refused further treatment|0|||
161547267|NCT01468922|583394190|FG006|Overall Study|Refused further treatment|0|||
161547268|NCT01468922|583394191|FG007|Overall Study|Refused further treatment|1|||
161547269|NCT01468922|583394192|FG008|Overall Study|Refused further treatment|0|||
161547270|NCT01923389|583394193|FG000|Overall Study|Protocol Violation|1|||
161547271|NCT01923389|583394194|FG001|Overall Study|Protocol Violation|0|||
161547272|NCT00007475|583394197|FG000|Overall Study|Withdrawal by Subject|1|||
161547273|NCT00007475|583394198|FG001|Overall Study|Withdrawal by Subject|0|||
161547274|NCT00007475|583394199|FG002|Overall Study|Withdrawal by Subject|0|||
161547275|NCT00007475|583394200|FG003|Overall Study|Withdrawal by Subject|0|||
161547276|NCT00007475|583394197|FG000|Overall Study|Adverse Event|3|||
161547277|NCT00007475|583394198|FG001|Overall Study|Adverse Event|0|||
161547278|NCT00007475|583394199|FG002|Overall Study|Adverse Event|0|||
161547279|NCT00007475|583394200|FG003|Overall Study|Adverse Event|0|||
161547280|NCT01719224|583394201|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
161547281|NCT01719224|583394202|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
161547282|NCT00258440|583394203|FG000|Overall Study|Withdrawal by Subject|0|||
161547283|NCT00258440|583394204|FG001|Overall Study|Withdrawal by Subject|0|||
161547284|NCT00258440|583394205|FG002|Overall Study|Withdrawal by Subject|1|||
161547285|NCT00737061|583394206|FG000|Waiting Period|Lost to Follow-up|6|||
161594986|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161594987|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161594988|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161594989|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161594990|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161594991|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161594992|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
161594993|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
161594994|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
161594995|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161594996|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161594997|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161594998|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161594999|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161595000|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161595001|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161595002|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
161595003|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
161595004|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
161595005|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
161595006|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
161595007|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
161595008|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
161595009|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
161595010|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
161595011|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
161595012|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
161547286|NCT00737061|583394206|FG000|Waiting Period|Withdrawal by Subject|1|||
161547287|NCT00737061|583394206|FG000|Waiting Period|Bilateral placement failure|34|||
161547288|NCT00737061|583394206|FG000|Waiting Period|Deemed patent following HSG|26|||
161547289|NCT00737061|583394206|FG000|Waiting Period|Alternative contraception failure|3|||
161547290|NCT00737061|583394206|FG000|Waiting Period|Elected surgical tubal ligation|5|||
161547291|NCT00737061|583394206|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
161547292|NCT00737061|583394206|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
161547293|NCT00737061|583394206|FG000|1 Year Wearing Period|Discontinued reilance|3|||
161547294|NCT00737061|583394206|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
161547295|NCT03000673|583394207|FG000|Overall Study|Withdrawal by Subject|1|||
161547296|NCT03000673|583394208|FG001|Overall Study|Withdrawal by Subject|0|||
161547297|NCT03000673|583394209|FG002|Overall Study|Withdrawal by Subject|0|||
161547298|NCT03000673|583394210|FG003|Overall Study|Withdrawal by Subject|0|||
161547299|NCT00692406|583394211|FG000|Overall Study|PI dropped, bad data|57|||
161595013|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161595014|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161595015|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161547300|NCT02597933|583394212|FG000|Overall Study|Withdrawal by Subject|7|||
161547301|NCT02597933|583394213|FG001|Overall Study|Withdrawal by Subject|5|||
161547302|NCT02597933|583394212|FG000|Overall Study|Protocol Violation|2|||
161547303|NCT02597933|583394213|FG001|Overall Study|Protocol Violation|2|||
161547304|NCT02597933|583394212|FG000|Overall Study|Adverse Event|20|||
161547305|NCT02597933|583394213|FG001|Overall Study|Adverse Event|28|||
161547306|NCT02597933|583394212|FG000|Overall Study|Not treated|2|||
161547307|NCT02597933|583394213|FG001|Overall Study|Not treated|2|||
161547308|NCT02597933|583394212|FG000|Overall Study|Other than stated above|7|||
161547309|NCT02597933|583394213|FG001|Overall Study|Other than stated above|14|||
161547310|NCT01617005|583394214|FG000|Overall Study|Pregnancy|1|||
161547311|NCT01617005|583394214|FG000|Overall Study|Lack of motivation for treatment|1|||
161547312|NCT04186403|583394222|FG000|Overall Study|Adverse Event|1|||
161547313|NCT04186403|583394223|FG001|Overall Study|Adverse Event|8|||
161547314|NCT04186403|583394222|FG000|Overall Study|Lost to Follow-up|7|||
161547315|NCT04186403|583394223|FG001|Overall Study|Lost to Follow-up|3|||
161547316|NCT04186403|583394222|FG000|Overall Study|Physician Decision|1|||
161547317|NCT04186403|583394223|FG001|Overall Study|Physician Decision|0|||
161547318|NCT04186403|583394222|FG000|Overall Study|Withdrawal by Subject|7|||
161547319|NCT04186403|583394223|FG001|Overall Study|Withdrawal by Subject|8|||
161547320|NCT04186403|583394222|FG000|Overall Study|Other: Not Related to Covid-19|3|||
161547321|NCT04186403|583394223|FG001|Overall Study|Other: Not Related to Covid-19|0|||
161547322|NCT01407354|583394228|FG000|First Intervention|Withdrawal by Subject|0|||
161547323|NCT01407354|583394229|FG001|First Intervention|Withdrawal by Subject|2|||
161547324|NCT01407354|583394228|FG000|First Intervention|Adverse Event|1|||
161547325|NCT01407354|583394229|FG001|First Intervention|Adverse Event|0|||
161547326|NCT01407354|583394228|FG000|First Intervention|Physician Decision|1|||
161547327|NCT01407354|583394229|FG001|First Intervention|Physician Decision|0|||
161547328|NCT01036022|583394230|FG000|Overall Study|Adverse Event|1|||
161547329|NCT01036022|583394231|FG001|Overall Study|Adverse Event|3|||
161547330|NCT01036022|583394232|FG002|Overall Study|Adverse Event|2|||
161547331|NCT01036022|583394233|FG003|Overall Study|Adverse Event|1|||
161547332|NCT01036022|583394234|FG004|Overall Study|Adverse Event|0|||
161547333|NCT01036022|583394235|FG005|Overall Study|Adverse Event|2|||
161547334|NCT01036022|583394230|FG000|Overall Study|Lack of Efficacy|1|||
161547335|NCT01036022|583394231|FG001|Overall Study|Lack of Efficacy|1|||
161547336|NCT01036022|583394232|FG002|Overall Study|Lack of Efficacy|1|||
161547337|NCT01036022|583394233|FG003|Overall Study|Lack of Efficacy|0|||
161547338|NCT01036022|583394234|FG004|Overall Study|Lack of Efficacy|1|||
161547339|NCT01036022|583394235|FG005|Overall Study|Lack of Efficacy|1|||
161547340|NCT01036022|583394230|FG000|Overall Study|Physician Decision|0|||
161547341|NCT01036022|583394231|FG001|Overall Study|Physician Decision|0|||
161547342|NCT01036022|583394232|FG002|Overall Study|Physician Decision|1|||
161595016|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161595017|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161595018|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161547343|NCT01036022|583394233|FG003|Overall Study|Physician Decision|0|||
161547344|NCT01036022|583394234|FG004|Overall Study|Physician Decision|0|||
161547345|NCT01036022|583394235|FG005|Overall Study|Physician Decision|0|||
161547346|NCT01036022|583394230|FG000|Overall Study|Withdrawal by Subject|0|||
161547347|NCT01036022|583394231|FG001|Overall Study|Withdrawal by Subject|0|||
161547348|NCT01036022|583394232|FG002|Overall Study|Withdrawal by Subject|0|||
161547349|NCT01036022|583394233|FG003|Overall Study|Withdrawal by Subject|1|||
161547350|NCT01036022|583394234|FG004|Overall Study|Withdrawal by Subject|2|||
161547351|NCT01036022|583394235|FG005|Overall Study|Withdrawal by Subject|0|||
161547352|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
161595019|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
161680790|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
161680791|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
161680792|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
161680793|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
161680794|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
161680795|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161680796|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161680797|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
161680798|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161680799|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
161680800|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
161680801|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
161680802|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
161680803|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161680804|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161680805|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
161680806|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161680807|NCT00937937|583884323|FG000|Overall Study|Adverse Event|6|||
161680808|NCT00937937|583884323|FG000|Overall Study|Withdrawal by Subject|2|||
161680809|NCT00937937|583884323|FG000|Overall Study|Progression/relapse|61|||
161680810|NCT00937937|583884323|FG000|Overall Study|Death|1|||
161680811|NCT00937937|583884323|FG000|Overall Study|Other|2|||
161680812|NCT00362414|583884326|FG000|Overall Study|Death|2|||
161680813|NCT00362414|583884326|FG000|Overall Study|Adverse Event|1|||
161680814|NCT01365039|583884331|FG000|Overall Study|Study related symptoms and complaints|1|||
161680815|NCT01365039|583884332|FG001|Overall Study|Study related symptoms and complaints|0|||
161680816|NCT00549939|583884339|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
161680817|NCT00549939|583884340|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
161680818|NCT00549939|583884341|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
161680819|NCT00549939|583884339|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
161680820|NCT00549939|583884340|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
161680821|NCT00549939|583884341|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
161680822|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
161680823|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
161680824|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
161680825|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
161680826|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
161680827|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
161680828|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
161680829|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
161680830|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
161680831|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Other|0|||
161680832|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Other|1|||
161680833|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Other|4|||
161680834|NCT03677596|583884342|FG000|Overall Study|Adverse Event|0|||
161680835|NCT03677596|583884343|FG001|Overall Study|Adverse Event|1|||
161680836|NCT03677596|583884342|FG000|Overall Study|Death|10|||
161680837|NCT03677596|583884343|FG001|Overall Study|Death|6|||
161680838|NCT03677596|583884342|FG000|Overall Study|Lost to Follow-up|0|||
161680839|NCT03677596|583884343|FG001|Overall Study|Lost to Follow-up|1|||
161680840|NCT03677596|583884342|FG000|Overall Study|Progressive Disease|8|||
161680841|NCT03677596|583884343|FG001|Overall Study|Progressive Disease|8|||
161680842|NCT03677596|583884342|FG000|Overall Study|Withdrawal by Subject|3|||
161680843|NCT03677596|583884343|FG001|Overall Study|Withdrawal by Subject|0|||
161680844|NCT03677596|583884342|FG000|Overall Study|Disease Relapse|2|||
161680845|NCT03677596|583884343|FG001|Overall Study|Disease Relapse|2|||
161680846|NCT03677596|583884342|FG000|Overall Study|Other|0|||
161680847|NCT03677596|583884343|FG001|Overall Study|Other|1|||
161680848|NCT01911442|583884344|FG000|Overall Study|Adverse Event|2|||
161680849|NCT01911442|583884345|FG001|Overall Study|Adverse Event|2|||
161680850|NCT01911442|583884346|FG002|Overall Study|Adverse Event|4|||
161830099|NCT02400476|584418111|FG001|Overall Study|Other, Disease Progression|1|||
161680851|NCT01911442|583884344|FG000|Overall Study|Lack of Efficacy|1|||
161680852|NCT01911442|583884345|FG001|Overall Study|Lack of Efficacy|1|||
161830100|NCT02400476|584418112|FG002|Overall Study|Other, Disease Progression|2|||
161830101|NCT02400476|584418113|FG003|Overall Study|Other, Disease Progression|1|||
161680853|NCT01911442|583884346|FG002|Overall Study|Lack of Efficacy|1|||
161680854|NCT01911442|583884344|FG000|Overall Study|Lost to Follow-up|2|||
161680855|NCT01911442|583884345|FG001|Overall Study|Lost to Follow-up|0|||
161680856|NCT01911442|583884346|FG002|Overall Study|Lost to Follow-up|1|||
161680857|NCT01911442|583884344|FG000|Overall Study|Withdrawal by Subject|1|||
161830102|NCT02400476|584418114|FG004|Overall Study|Other, Disease Progression|2|||
161680858|NCT01911442|583884345|FG001|Overall Study|Withdrawal by Subject|0|||
161680859|NCT01911442|583884346|FG002|Overall Study|Withdrawal by Subject|6|||
161680860|NCT01911442|583884344|FG000|Overall Study|Mother's Work Schedule|0|||
161680861|NCT01911442|583884345|FG001|Overall Study|Mother's Work Schedule|1|||
161680862|NCT01911442|583884346|FG002|Overall Study|Mother's Work Schedule|0|||
161680863|NCT00424749|583884350|FG000|Overall Study|Withdrawal by Subject|1|||
161680864|NCT01022502|583884355|FG000|Overall Study|Adverse Event|1|||
161680865|NCT01022502|583884355|FG000|Overall Study|employment related reasons|1|||
161680866|NCT01022502|583884355|FG000|Overall Study|Withdrawal by Subject|1|||
161680867|NCT00073528|583884365|FG000|Overall Study|Death|488|||
161680868|NCT00073528|583884366|FG001|Overall Study|Death|473|||
161680869|NCT00073528|583884365|FG000|Overall Study|Lost to Follow-up|52|||
161680870|NCT00073528|583884366|FG001|Overall Study|Lost to Follow-up|45|||
161680871|NCT00073528|583884365|FG000|Overall Study|Withdrawal by Subject|50|||
161680872|NCT00073528|583884366|FG001|Overall Study|Withdrawal by Subject|45|||
161680873|NCT00073528|583884365|FG000|Overall Study|Study terminated by Sponsor|10|||
161680874|NCT00073528|583884366|FG001|Overall Study|Study terminated by Sponsor|29|||
161680875|NCT00073528|583884365|FG000|Overall Study|Other|18|||
161680876|NCT00073528|583884366|FG001|Overall Study|Other|19|||
161680877|NCT00073528|583884365|FG000|Overall Study|Other|9|||
161680878|NCT00073528|583884366|FG001|Overall Study|Other|12|||
161680879|NCT00073528|583884365|FG000|Overall Study|Protocol Violation|3|||
161680880|NCT00073528|583884366|FG001|Overall Study|Protocol Violation|5|||
161680881|NCT03199040|583884369|FG000|Overall Study|Lack of Efficacy|2|||
161680882|NCT03199040|583884370|FG001|Overall Study|Lack of Efficacy|0|||
161680883|NCT03199040|583884369|FG000|Overall Study|Withdrawal by Subject|2|||
161680884|NCT03199040|583884370|FG001|Overall Study|Withdrawal by Subject|0|||
161680885|NCT03199040|583884369|FG000|Overall Study|Adverse Event|0|||
161680886|NCT03199040|583884370|FG001|Overall Study|Adverse Event|1|||
161680887|NCT03199040|583884369|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
161680888|NCT03199040|583884370|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
161680889|NCT01786603|583884371|FG000|Overall Study|Death|5|||
161680890|NCT01786603|583884372|FG001|Overall Study|Death|1|||
161680891|NCT01786603|583884371|FG000|Overall Study|Adverse Event|6|||
161680892|NCT01786603|583884372|FG001|Overall Study|Adverse Event|2|||
161680893|NCT01786603|583884371|FG000|Overall Study|Physician decision to withdraw|6|||
161680894|NCT01786603|583884372|FG001|Overall Study|Physician decision to withdraw|7|||
161680895|NCT01786603|583884371|FG000|Overall Study|Lost to Follow-up|1|||
161680896|NCT01786603|583884372|FG001|Overall Study|Lost to Follow-up|2|||
161680897|NCT01226459|583884373|FG000|Overall Study|Adverse Event|2|||
161680898|NCT01226459|583884374|FG001|Overall Study|Adverse Event|8|||
161680899|NCT01226459|583884373|FG000|Overall Study|Protocol Violation|4|||
161680900|NCT01226459|583884374|FG001|Overall Study|Protocol Violation|3|||
161680901|NCT01226459|583884373|FG000|Overall Study|Withdrawal by Subject|10|||
161680902|NCT01226459|583884374|FG001|Overall Study|Withdrawal by Subject|13|||
161680903|NCT01226459|583884373|FG000|Overall Study|Lost to Follow-up|4|||
161680904|NCT01226459|583884374|FG001|Overall Study|Lost to Follow-up|8|||
161680905|NCT01226459|583884373|FG000|Overall Study|Pregnancy|1|||
161680906|NCT01226459|583884374|FG001|Overall Study|Pregnancy|0|||
161680907|NCT01092143|583884382|FG000|Overall Study|Adverse Event|10|||
161680908|NCT01092143|583884383|FG001|Overall Study|Adverse Event|5|||
161680909|NCT01092143|583884384|FG002|Overall Study|Adverse Event|1|||
161680910|NCT01092143|583884385|FG003|Overall Study|Adverse Event|4|||
161680911|NCT01092143|583884386|FG004|Overall Study|Adverse Event|3|||
161680912|NCT01092143|583884382|FG000|Overall Study|Lost to Follow-up|1|||
161680913|NCT01092143|583884383|FG001|Overall Study|Lost to Follow-up|0|||
161680914|NCT01092143|583884384|FG002|Overall Study|Lost to Follow-up|1|||
161680915|NCT01092143|583884385|FG003|Overall Study|Lost to Follow-up|0|||
161680916|NCT01092143|583884386|FG004|Overall Study|Lost to Follow-up|0|||
161680917|NCT01092143|583884382|FG000|Overall Study|Consent withdrawn|2|||
161680918|NCT01092143|583884383|FG001|Overall Study|Consent withdrawn|1|||
161680919|NCT01092143|583884384|FG002|Overall Study|Consent withdrawn|0|||
161680920|NCT01092143|583884385|FG003|Overall Study|Consent withdrawn|1|||
161680921|NCT01092143|583884386|FG004|Overall Study|Consent withdrawn|3|||
161680922|NCT01092143|583884382|FG000|Overall Study|Not treated|0|||
161830103|NCT02400476|584418115|FG005|Overall Study|Other, Disease Progression|1|||
161680923|NCT01092143|583884383|FG001|Overall Study|Not treated|0|||
161680924|NCT01092143|583884384|FG002|Overall Study|Not treated|1|||
161680925|NCT01092143|583884385|FG003|Overall Study|Not treated|0|||
161680926|NCT01092143|583884386|FG004|Overall Study|Not treated|0|||
161680927|NCT01092143|583884382|FG000|Overall Study|did not reversibility criteria|0|||
161830104|NCT02400476|584418110|FG000|Overall Study|Other, Decreased Quality of Life|0|||
161830105|NCT02400476|584418111|FG001|Overall Study|Other, Decreased Quality of Life|0|||
161680928|NCT01092143|583884383|FG001|Overall Study|did not reversibility criteria|0|||
161680929|NCT01092143|583884384|FG002|Overall Study|did not reversibility criteria|1|||
161680930|NCT01092143|583884385|FG003|Overall Study|did not reversibility criteria|0|||
161680931|NCT01092143|583884386|FG004|Overall Study|did not reversibility criteria|0|||
161680932|NCT01092143|583884382|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
161680933|NCT01092143|583884383|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
161680934|NCT01092143|583884384|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
161680935|NCT01092143|583884385|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
161680936|NCT01092143|583884386|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
161680937|NCT01092143|583884382|FG000|Overall Study|Ineligible patient|1|||
161680938|NCT01092143|583884383|FG001|Overall Study|Ineligible patient|0|||
161680939|NCT01092143|583884384|FG002|Overall Study|Ineligible patient|0|||
161680940|NCT01092143|583884385|FG003|Overall Study|Ineligible patient|0|||
161680941|NCT01092143|583884386|FG004|Overall Study|Ineligible patient|0|||
161680942|NCT01092143|583884382|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
161680943|NCT01092143|583884383|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
161680944|NCT01092143|583884384|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
161680945|NCT01092143|583884385|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
161680946|NCT01092143|583884386|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
161680947|NCT01092143|583884382|FG000|Overall Study|Patient travel|0|||
161680948|NCT01092143|583884383|FG001|Overall Study|Patient travel|0|||
161680949|NCT01092143|583884384|FG002|Overall Study|Patient travel|0|||
161547353|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
161547354|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
161547355|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
161547356|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
161680950|NCT01092143|583884385|FG003|Overall Study|Patient travel|0|||
161680951|NCT01092143|583884386|FG004|Overall Study|Patient travel|1|||
161547357|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
161547358|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
161680952|NCT01092143|583884382|FG000|Overall Study|Non compliance with study medication|0|||
161680953|NCT01092143|583884383|FG001|Overall Study|Non compliance with study medication|0|||
161680954|NCT01092143|583884384|FG002|Overall Study|Non compliance with study medication|0|||
161680955|NCT01092143|583884385|FG003|Overall Study|Non compliance with study medication|0|||
161680956|NCT01092143|583884386|FG004|Overall Study|Non compliance with study medication|1|||
161680957|NCT01092143|583884382|FG000|Overall Study|Randomized by mistake|0|||
161680958|NCT01092143|583884383|FG001|Overall Study|Randomized by mistake|0|||
161680959|NCT01092143|583884384|FG002|Overall Study|Randomized by mistake|0|||
161680960|NCT01092143|583884385|FG003|Overall Study|Randomized by mistake|1|||
161680961|NCT01092143|583884386|FG004|Overall Study|Randomized by mistake|0|||
161680962|NCT01092143|583884382|FG000|Overall Study|Pregnancy|0|||
161680963|NCT01092143|583884383|FG001|Overall Study|Pregnancy|0|||
161680964|NCT01092143|583884384|FG002|Overall Study|Pregnancy|0|||
161680965|NCT01092143|583884385|FG003|Overall Study|Pregnancy|1|||
161680966|NCT01092143|583884386|FG004|Overall Study|Pregnancy|0|||
161680967|NCT01854645|583884390|FG000|Overall Study|Protocol-Specified Criteria|13|||
161680968|NCT01854645|583884391|FG001|Overall Study|Protocol-Specified Criteria|10|||
161680969|NCT01854645|583884392|FG002|Overall Study|Protocol-Specified Criteria|8|||
161680970|NCT01854645|583884393|FG003|Overall Study|Protocol-Specified Criteria|5|||
161680971|NCT01854645|583884394|FG004|Overall Study|Protocol-Specified Criteria|7|||
161680972|NCT01854645|583884390|FG000|Overall Study|Administrative Reasons / Missing|0|||
161680973|NCT01854645|583884391|FG001|Overall Study|Administrative Reasons / Missing|0|||
161680974|NCT01854645|583884392|FG002|Overall Study|Administrative Reasons / Missing|0|||
161680975|NCT01854645|583884393|FG003|Overall Study|Administrative Reasons / Missing|1|||
161680976|NCT01854645|583884394|FG004|Overall Study|Administrative Reasons / Missing|1|||
161680977|NCT01854645|583884390|FG000|Overall Study|Protocol Violation|3|||
161680978|NCT01854645|583884391|FG001|Overall Study|Protocol Violation|0|||
161680979|NCT01854645|583884392|FG002|Overall Study|Protocol Violation|5|||
161680980|NCT01854645|583884393|FG003|Overall Study|Protocol Violation|4|||
161680981|NCT01854645|583884394|FG004|Overall Study|Protocol Violation|1|||
161680982|NCT01854645|583884390|FG000|Overall Study|Lost to Follow-up|10|||
161680983|NCT01854645|583884391|FG001|Overall Study|Lost to Follow-up|7|||
161680984|NCT01854645|583884392|FG002|Overall Study|Lost to Follow-up|8|||
161680985|NCT01854645|583884393|FG003|Overall Study|Lost to Follow-up|5|||
161680986|NCT01854645|583884394|FG004|Overall Study|Lost to Follow-up|0|||
161680987|NCT01854645|583884390|FG000|Overall Study|Physician Decision|1|||
161680988|NCT01854645|583884391|FG001|Overall Study|Physician Decision|5|||
161680989|NCT01854645|583884392|FG002|Overall Study|Physician Decision|3|||
161680990|NCT01854645|583884393|FG003|Overall Study|Physician Decision|3|||
161680991|NCT01854645|583884394|FG004|Overall Study|Physician Decision|7|||
161680992|NCT01854645|583884390|FG000|Overall Study|Withdrawal by Subject|31|||
161680993|NCT01854645|583884391|FG001|Overall Study|Withdrawal by Subject|41|||
161680994|NCT01854645|583884392|FG002|Overall Study|Withdrawal by Subject|30|||
161680995|NCT01854645|583884393|FG003|Overall Study|Withdrawal by Subject|21|||
161680996|NCT01854645|583884394|FG004|Overall Study|Withdrawal by Subject|24|||
161680997|NCT01854645|583884390|FG000|Overall Study|Lack of Efficacy|7|||
161680998|NCT01854645|583884391|FG001|Overall Study|Lack of Efficacy|12|||
161680999|NCT01854645|583884392|FG002|Overall Study|Lack of Efficacy|9|||
161681000|NCT01854645|583884393|FG003|Overall Study|Lack of Efficacy|3|||
161681001|NCT01854645|583884394|FG004|Overall Study|Lack of Efficacy|9|||
161681002|NCT01854645|583884390|FG000|Overall Study|Adverse Event|33|||
161681003|NCT01854645|583884391|FG001|Overall Study|Adverse Event|31|||
161547359|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
161547360|NCT01336621|583394237|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
161547361|NCT01336621|583394237|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
161547362|NCT01336621|583394237|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
161547363|NCT01336621|583394237|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
161547364|NCT01336621|583394237|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
161547365|NCT01336621|583394237|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
161547366|NCT02487095|583394238|FG000|Dose Expansion|Unable to scan/restage participant|0|||
161547367|NCT02487095|583394239|FG001|Dose Expansion|Unable to scan/restage participant|0|||
161547368|NCT02487095|583394240|FG002|Dose Expansion|Unable to scan/restage participant|0|||
161547369|NCT02487095|583394241|FG003|Dose Expansion|Unable to scan/restage participant|0|||
161547370|NCT02487095|583394242|FG004|Dose Expansion|Unable to scan/restage participant|1|||
161547371|NCT04534114|583394243|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
161547372|NCT04534114|583394244|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
161547373|NCT04534114|583394245|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
161547374|NCT04534114|583394246|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
161547375|NCT04534114|583394243|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
161547376|NCT04534114|583394244|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
161547377|NCT04534114|583394245|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
161547378|NCT04534114|583394246|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
161547379|NCT04534114|583394243|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
161547380|NCT04534114|583394244|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
161547381|NCT04534114|583394245|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
161547382|NCT04534114|583394246|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
161547383|NCT04534114|583394243|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
161547384|NCT04534114|583394244|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
161547385|NCT04534114|583394245|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
161547386|NCT04534114|583394246|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
161547387|NCT04534114|583394243|FG000|Main Treatment Period|Physician Decision|0|||
161547388|NCT04534114|583394244|FG001|Main Treatment Period|Physician Decision|0|||
161547389|NCT04534114|583394245|FG002|Main Treatment Period|Physician Decision|0|||
161547390|NCT04534114|583394246|FG003|Main Treatment Period|Physician Decision|1|||
161547391|NCT04534114|583394243|FG000|Main Treatment Period|Death|1|||
161547392|NCT04534114|583394244|FG001|Main Treatment Period|Death|0|||
161547393|NCT04534114|583394245|FG002|Main Treatment Period|Death|0|||
161547394|NCT04534114|583394246|FG003|Main Treatment Period|Death|1|||
161547395|NCT04534114|583394243|FG000|Main Treatment Period|Other reason|1|||
161547396|NCT04534114|583394244|FG001|Main Treatment Period|Other reason|1|||
161547397|NCT04534114|583394245|FG002|Main Treatment Period|Other reason|0|||
161547398|NCT04534114|583394246|FG003|Main Treatment Period|Other reason|0|||
161547399|NCT04534114|583394243|FG000|Main Treatment Period|Participant decision|1|||
161547400|NCT04534114|583394244|FG001|Main Treatment Period|Participant decision|3|||
161547401|NCT04534114|583394245|FG002|Main Treatment Period|Participant decision|3|||
161547402|NCT04534114|583394246|FG003|Main Treatment Period|Participant decision|1|||
161547403|NCT04534114|583394243|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
161547404|NCT04534114|583394244|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
161547405|NCT04534114|583394245|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
161547406|NCT04534114|583394246|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
161547407|NCT04534114|583394243|FG000|Main Treatment Period|Adverse Event|4|||
161547408|NCT04534114|583394244|FG001|Main Treatment Period|Adverse Event|2|||
161547409|NCT04534114|583394245|FG002|Main Treatment Period|Adverse Event|1|||
161547410|NCT04534114|583394246|FG003|Main Treatment Period|Adverse Event|2|||
161547411|NCT04534114|583394243|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
161547412|NCT04534114|583394244|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
161547413|NCT04534114|583394245|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
161547414|NCT04534114|583394246|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
161547415|NCT04534114|583394243|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
161547416|NCT04534114|583394244|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
161547417|NCT04534114|583394245|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
161547418|NCT04534114|583394246|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
161547419|NCT04534114|583394243|FG000|Extension Treatment Period|Other reason|0|||
161547420|NCT04534114|583394244|FG001|Extension Treatment Period|Other reason|1|||
161547421|NCT04534114|583394245|FG002|Extension Treatment Period|Other reason|0|||
161830106|NCT02400476|584418112|FG002|Overall Study|Other, Decreased Quality of Life|2|||
161830107|NCT02400476|584418113|FG003|Overall Study|Other, Decreased Quality of Life|0|||
161547422|NCT04534114|583394246|FG003|Extension Treatment Period|Other reason|0|||
161547423|NCT04534114|583394243|FG000|Extension Treatment Period|Death|0|||
161547424|NCT04534114|583394244|FG001|Extension Treatment Period|Death|0|||
161547425|NCT04534114|583394245|FG002|Extension Treatment Period|Death|1|||
161547426|NCT04534114|583394246|FG003|Extension Treatment Period|Death|2|||
161547427|NCT04534114|583394243|FG000|Extension Treatment Period|Adverse Event|0|||
161547428|NCT04534114|583394244|FG001|Extension Treatment Period|Adverse Event|1|||
161547429|NCT04534114|583394245|FG002|Extension Treatment Period|Adverse Event|0|||
161547430|NCT04534114|583394246|FG003|Extension Treatment Period|Adverse Event|1|||
161547431|NCT04534114|583394243|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
161547432|NCT04534114|583394244|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
161547433|NCT04534114|583394245|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
161547434|NCT04534114|583394246|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
161547435|NCT02759185|583394247|FG000|Stage 1|Adverse Event|0|||
161547436|NCT02759185|583394248|FG001|Stage 1|Adverse Event|1|||
161547437|NCT02759185|583394249|FG002|Stage 1|Adverse Event|3|||
161547438|NCT02759185|583394250|FG003|Stage 1|Adverse Event|0|||
161547439|NCT02759185|583394251|FG004|Stage 1|Adverse Event|0|||
161547440|NCT02759185|583394252|FG005|Stage 1|Adverse Event|0|||
161547441|NCT02759185|583394253|FG006|Stage 1|Adverse Event|0|||
161547442|NCT02759185|583394247|FG000|Stage 1|Withdrawal by Subject|1|||
161547443|NCT02759185|583394248|FG001|Stage 1|Withdrawal by Subject|0|||
161547444|NCT02759185|583394249|FG002|Stage 1|Withdrawal by Subject|0|||
161547445|NCT02759185|583394250|FG003|Stage 1|Withdrawal by Subject|0|||
161547446|NCT02759185|583394251|FG004|Stage 1|Withdrawal by Subject|0|||
161547447|NCT02759185|583394252|FG005|Stage 1|Withdrawal by Subject|0|||
161547448|NCT02759185|583394253|FG006|Stage 1|Withdrawal by Subject|0|||
161547449|NCT02759185|583394247|FG000|Stage 2|Adverse Event|0|||
161547450|NCT02759185|583394248|FG001|Stage 2|Adverse Event|0|||
161547451|NCT02759185|583394249|FG002|Stage 2|Adverse Event|0|||
161547452|NCT02759185|583394250|FG003|Stage 2|Adverse Event|0|||
161547453|NCT02759185|583394251|FG004|Stage 2|Adverse Event|1|||
161547454|NCT02759185|583394252|FG005|Stage 2|Adverse Event|2|||
161547455|NCT02759185|583394253|FG006|Stage 2|Adverse Event|0|||
161547456|NCT02759185|583394247|FG000|Stage 2|Withdrawal by Subject|0|||
161547457|NCT02759185|583394248|FG001|Stage 2|Withdrawal by Subject|0|||
161547458|NCT02759185|583394249|FG002|Stage 2|Withdrawal by Subject|0|||
161547459|NCT02759185|583394250|FG003|Stage 2|Withdrawal by Subject|0|||
161547460|NCT02759185|583394251|FG004|Stage 2|Withdrawal by Subject|1|||
161547461|NCT02759185|583394252|FG005|Stage 2|Withdrawal by Subject|1|||
161547462|NCT02759185|583394253|FG006|Stage 2|Withdrawal by Subject|1|||
161547463|NCT00962247|583394260|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
161547464|NCT00962247|583394260|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
161547465|NCT01709305|583394263|FG000|Phase 1|Clinical Adverse Event|80|||
161547466|NCT01709305|583394264|FG001|Phase 1|Clinical Adverse Event|0|||
161547467|NCT01709305|583394265|FG002|Phase 1|Clinical Adverse Event|0|||
161547468|NCT01709305|583394266|FG003|Phase 1|Clinical Adverse Event|0|||
161547469|NCT01709305|583394267|FG004|Phase 1|Clinical Adverse Event|0|||
161547470|NCT01709305|583394263|FG000|Phase 1|Death|2|||
161547471|NCT01709305|583394264|FG001|Phase 1|Death|0|||
161547472|NCT01709305|583394265|FG002|Phase 1|Death|0|||
161547473|NCT01709305|583394266|FG003|Phase 1|Death|0|||
161547474|NCT01709305|583394267|FG004|Phase 1|Death|0|||
161547475|NCT01709305|583394263|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
161547476|NCT01709305|583394264|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
161547477|NCT01709305|583394265|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
161547478|NCT01709305|583394266|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
161547479|NCT01709305|583394267|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
161547480|NCT01709305|583394263|FG000|Phase 1|Laboratory Adverse Event|16|||
161547481|NCT01709305|583394264|FG001|Phase 1|Laboratory Adverse Event|0|||
161547482|NCT01709305|583394265|FG002|Phase 1|Laboratory Adverse Event|0|||
161547483|NCT01709305|583394266|FG003|Phase 1|Laboratory Adverse Event|0|||
161547484|NCT01709305|583394267|FG004|Phase 1|Laboratory Adverse Event|0|||
161547485|NCT01709305|583394263|FG000|Phase 1|Lost to Follow-up|147|||
161547486|NCT01709305|583394264|FG001|Phase 1|Lost to Follow-up|0|||
161547487|NCT01709305|583394265|FG002|Phase 1|Lost to Follow-up|0|||
161547488|NCT01709305|583394266|FG003|Phase 1|Lost to Follow-up|0|||
161547489|NCT01709305|583394267|FG004|Phase 1|Lost to Follow-up|0|||
161547490|NCT01709305|583394263|FG000|Phase 1|Travel, moving, etc.|30|||
161547491|NCT01709305|583394264|FG001|Phase 1|Travel, moving, etc.|0|||
161547492|NCT01709305|583394265|FG002|Phase 1|Travel, moving, etc.|0|||
161547493|NCT01709305|583394266|FG003|Phase 1|Travel, moving, etc.|0|||
161547494|NCT01709305|583394267|FG004|Phase 1|Travel, moving, etc.|0|||
161547495|NCT01709305|583394263|FG000|Phase 1|Physician Decision|13|||
161547496|NCT01709305|583394264|FG001|Phase 1|Physician Decision|0|||
161547497|NCT01709305|583394265|FG002|Phase 1|Physician Decision|0|||
161547498|NCT01709305|583394266|FG003|Phase 1|Physician Decision|0|||
161547499|NCT01709305|583394267|FG004|Phase 1|Physician Decision|0|||
161547500|NCT01709305|583394263|FG000|Phase 1|Protocol Violation|118|||
161547501|NCT01709305|583394264|FG001|Phase 1|Protocol Violation|0|||
161547502|NCT01709305|583394265|FG002|Phase 1|Protocol Violation|0|||
161547503|NCT01709305|583394266|FG003|Phase 1|Protocol Violation|0|||
161547504|NCT01709305|583394267|FG004|Phase 1|Protocol Violation|0|||
161547505|NCT01709305|583394263|FG000|Phase 1|Withdrawal by Subject|218|||
161547506|NCT01709305|583394264|FG001|Phase 1|Withdrawal by Subject|0|||
161547507|NCT01709305|583394265|FG002|Phase 1|Withdrawal by Subject|0|||
161547508|NCT01709305|583394266|FG003|Phase 1|Withdrawal by Subject|0|||
161547509|NCT01709305|583394267|FG004|Phase 1|Withdrawal by Subject|0|||
161547510|NCT01709305|583394263|FG000|Phase 2|Clinical Adverse Event|0|||
161547511|NCT01709305|583394264|FG001|Phase 2|Clinical Adverse Event|10|||
161547512|NCT01709305|583394265|FG002|Phase 2|Clinical Adverse Event|10|||
161547513|NCT01709305|583394266|FG003|Phase 2|Clinical Adverse Event|6|||
161547514|NCT01709305|583394267|FG004|Phase 2|Clinical Adverse Event|11|||
161547515|NCT01709305|583394263|FG000|Phase 2|Death|0|||
161547516|NCT01709305|583394264|FG001|Phase 2|Death|0|||
161547517|NCT01709305|583394265|FG002|Phase 2|Death|1|||
161547518|NCT01709305|583394266|FG003|Phase 2|Death|0|||
161547519|NCT01709305|583394267|FG004|Phase 2|Death|0|||
161547520|NCT01709305|583394263|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
161547521|NCT01709305|583394264|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
161547522|NCT01709305|583394265|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
161681004|NCT01854645|583884392|FG002|Overall Study|Adverse Event|19|||
161681005|NCT01854645|583884393|FG003|Overall Study|Adverse Event|20|||
161681006|NCT01854645|583884394|FG004|Overall Study|Adverse Event|11|||
161681007|NCT00555477|583884395|FG000|Overall Study|Adverse Event|0|||
161681008|NCT00555477|583884396|FG001|Overall Study|Adverse Event|9|||
161547523|NCT01709305|583394266|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
161547524|NCT01709305|583394267|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
161547525|NCT01709305|583394263|FG000|Phase 2|Laboratory Adverse Event|0|||
161547526|NCT01709305|583394264|FG001|Phase 2|Laboratory Adverse Event|1|||
161547527|NCT01709305|583394265|FG002|Phase 2|Laboratory Adverse Event|0|||
161681009|NCT00555477|583884395|FG000|Overall Study|Withdrawal by Subject|1|||
161681010|NCT00555477|583884396|FG001|Overall Study|Withdrawal by Subject|2|||
161681011|NCT00555477|583884395|FG000|Overall Study|Physician Decision|1|||
161681012|NCT00555477|583884396|FG001|Overall Study|Physician Decision|2|||
161681013|NCT04702737|583884397|FG000|Overall Study|Decision by Sponsor|1|||
161681014|NCT04702737|583884397|FG000|Overall Study|Withdrawal of Consent from Study|3|||
161681015|NCT04702737|583884397|FG000|Overall Study|Lost to Follow-up|1|||
161681016|NCT04702737|583884397|FG000|Overall Study|Death|35|||
161681017|NCT01977820|583884400|FG000|Overall Study|Sponsor terminated the study|1|||
161681018|NCT01977820|583884401|FG001|Overall Study|Sponsor terminated the study|1|||
161681019|NCT00475722|583884402|FG000|Overall Study|Withdrawal by Subject|12|||
161681020|NCT00475722|583884403|FG001|Overall Study|Withdrawal by Subject|12|||
161681021|NCT00475722|583884402|FG000|Overall Study|Protocol Violation|3|||
161681022|NCT00475722|583884403|FG001|Overall Study|Protocol Violation|0|||
161681023|NCT00698997|583884404|FG000|Overall Study|Lost to Follow-up|3|||
161547528|NCT01709305|583394266|FG003|Phase 2|Laboratory Adverse Event|1|||
161547529|NCT01709305|583394267|FG004|Phase 2|Laboratory Adverse Event|1|||
161547530|NCT01709305|583394263|FG000|Phase 2|Lost to Follow-up|0|||
161547531|NCT01709305|583394264|FG001|Phase 2|Lost to Follow-up|10|||
161547532|NCT01709305|583394265|FG002|Phase 2|Lost to Follow-up|6|||
161547533|NCT01709305|583394266|FG003|Phase 2|Lost to Follow-up|9|||
161547534|NCT01709305|583394267|FG004|Phase 2|Lost to Follow-up|5|||
161547535|NCT01709305|583394263|FG000|Phase 2|Travel, moving, etc.|0|||
161547536|NCT01709305|583394264|FG001|Phase 2|Travel, moving, etc.|2|||
161547537|NCT01709305|583394265|FG002|Phase 2|Travel, moving, etc.|3|||
161547538|NCT01709305|583394266|FG003|Phase 2|Travel, moving, etc.|3|||
161547539|NCT01709305|583394267|FG004|Phase 2|Travel, moving, etc.|5|||
161547540|NCT01709305|583394263|FG000|Phase 2|Physician Decision|0|||
161547541|NCT01709305|583394264|FG001|Phase 2|Physician Decision|2|||
161547542|NCT01709305|583394265|FG002|Phase 2|Physician Decision|0|||
161547543|NCT01709305|583394266|FG003|Phase 2|Physician Decision|1|||
161547544|NCT01709305|583394267|FG004|Phase 2|Physician Decision|2|||
161681024|NCT00698997|583884405|FG001|Overall Study|Lost to Follow-up|0|||
161681025|NCT00698997|583884404|FG000|Overall Study|Withdrawal by Subject|7|||
161681026|NCT00698997|583884405|FG001|Overall Study|Withdrawal by Subject|27|||
161681027|NCT05082376|583884408|FG000|Overall Study|Lost to Follow-up|2|||
161681028|NCT02568475|583884409|FG000|Overall Study|Lost to Follow-up|40|||
161547545|NCT01709305|583394263|FG000|Phase 2|Protocol Violation|0|||
161681029|NCT02568475|583884410|FG001|Overall Study|Lost to Follow-up|39|||
161681030|NCT02568475|583884409|FG000|Overall Study|Withdrawal by Subject|2|||
161681031|NCT02568475|583884410|FG001|Overall Study|Withdrawal by Subject|0|||
161681032|NCT02568475|583884409|FG000|Overall Study|Discharged home|4|||
161547546|NCT01709305|583394264|FG001|Phase 2|Protocol Violation|19|||
161547547|NCT01709305|583394265|FG002|Phase 2|Protocol Violation|19|||
161547548|NCT01709305|583394266|FG003|Phase 2|Protocol Violation|13|||
161547549|NCT01709305|583394267|FG004|Phase 2|Protocol Violation|9|||
161547550|NCT01709305|583394263|FG000|Phase 2|Withdrawal by Subject|0|||
161547551|NCT01709305|583394264|FG001|Phase 2|Withdrawal by Subject|8|||
161681033|NCT02568475|583884410|FG001|Overall Study|Discharged home|4|||
161547552|NCT01709305|583394265|FG002|Phase 2|Withdrawal by Subject|6|||
161547553|NCT01709305|583394266|FG003|Phase 2|Withdrawal by Subject|15|||
161547554|NCT01709305|583394267|FG004|Phase 2|Withdrawal by Subject|12|||
161547555|NCT03443713|583394268|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
161547556|NCT03443713|583394269|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
161547557|NCT03443713|583394270|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
161547558|NCT01672853|583394271|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
161547559|NCT01672853|583394272|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
161547560|NCT01672853|583394273|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
161547561|NCT01672853|583394271|FG000|Overall Study|Pregnancy|0|||
161547562|NCT01672853|583394272|FG001|Overall Study|Pregnancy|1|||
161547563|NCT01672853|583394273|FG002|Overall Study|Pregnancy|0|||
161547564|NCT01672853|583394271|FG000|Overall Study|Investigator's Discretion|1|||
161547565|NCT01672853|583394272|FG001|Overall Study|Investigator's Discretion|0|||
161547566|NCT01672853|583394273|FG002|Overall Study|Investigator's Discretion|0|||
161547567|NCT01672853|583394271|FG000|Overall Study|Withdrew Consent|5|||
161547568|NCT01672853|583394272|FG001|Overall Study|Withdrew Consent|5|||
161547569|NCT01672853|583394273|FG002|Overall Study|Withdrew Consent|5|||
161547570|NCT01672853|583394271|FG000|Overall Study|Adverse Event|4|||
161547571|NCT01672853|583394272|FG001|Overall Study|Adverse Event|6|||
161547572|NCT01672853|583394273|FG002|Overall Study|Adverse Event|8|||
161547573|NCT01672853|583394271|FG000|Overall Study|Lost to Follow-up|0|||
161547574|NCT01672853|583394272|FG001|Overall Study|Lost to Follow-up|1|||
161547575|NCT01672853|583394273|FG002|Overall Study|Lost to Follow-up|0|||
161547576|NCT01672853|583394271|FG000|Overall Study|Randomized but Never Treated|0|||
161547577|NCT01672853|583394272|FG001|Overall Study|Randomized but Never Treated|0|||
161547578|NCT01672853|583394273|FG002|Overall Study|Randomized but Never Treated|1|||
161547579|NCT00118898|583394274|FG000|Overall Study|Death|6|||
161547580|NCT00118898|583394275|FG001|Overall Study|Death|11|||
161547581|NCT00118898|583394276|FG002|Overall Study|Death|6|||
161547582|NCT00118898|583394277|FG003|Overall Study|Death|8|||
161547583|NCT00118898|583394274|FG000|Overall Study|Lost to Follow-up|26|||
161547584|NCT00118898|583394275|FG001|Overall Study|Lost to Follow-up|34|||
161547585|NCT00118898|583394276|FG002|Overall Study|Lost to Follow-up|33|||
161547586|NCT00118898|583394277|FG003|Overall Study|Lost to Follow-up|33|||
161547587|NCT00118898|583394274|FG000|Overall Study|Withdrawal by Subject|10|||
161547588|NCT00118898|583394275|FG001|Overall Study|Withdrawal by Subject|5|||
161547589|NCT00118898|583394276|FG002|Overall Study|Withdrawal by Subject|8|||
161547590|NCT00118898|583394277|FG003|Overall Study|Withdrawal by Subject|8|||
161547591|NCT00118898|583394274|FG000|Overall Study|Site Closure|33|||
161547592|NCT00118898|583394275|FG001|Overall Study|Site Closure|31|||
161547593|NCT00118898|583394276|FG002|Overall Study|Site Closure|28|||
161547594|NCT00118898|583394277|FG003|Overall Study|Site Closure|37|||
161547595|NCT00118898|583394274|FG000|Overall Study|Severe debilitation|1|||
161547596|NCT00118898|583394275|FG001|Overall Study|Severe debilitation|4|||
161547597|NCT00118898|583394276|FG002|Overall Study|Severe debilitation|6|||
161547598|NCT00118898|583394277|FG003|Overall Study|Severe debilitation|4|||
161547599|NCT00118898|583394274|FG000|Overall Study|Not compliant with requirements|11|||
161547600|NCT00118898|583394275|FG001|Overall Study|Not compliant with requirements|13|||
161547601|NCT00118898|583394276|FG002|Overall Study|Not compliant with requirements|11|||
161547602|NCT00118898|583394277|FG003|Overall Study|Not compliant with requirements|11|||
161547603|NCT00118898|583394274|FG000|Overall Study|Not able to get to clinic|34|||
161547604|NCT00118898|583394275|FG001|Overall Study|Not able to get to clinic|43|||
161547605|NCT00118898|583394276|FG002|Overall Study|Not able to get to clinic|31|||
161547606|NCT00118898|583394277|FG003|Overall Study|Not able to get to clinic|40|||
161547607|NCT02714205|583394280|FG000|Overall Study|Cannot tolerate medication|1|||
161547608|NCT02714205|583394281|FG001|Overall Study|Cannot tolerate medication|0|||
161547609|NCT02714205|583394280|FG000|Overall Study|Adverse Event|2|||
161547610|NCT02714205|583394281|FG001|Overall Study|Adverse Event|0|||
161547611|NCT02714205|583394280|FG000|Overall Study|Too busy|1|||
161547612|NCT02714205|583394281|FG001|Overall Study|Too busy|0|||
161547613|NCT02714205|583394280|FG000|Overall Study|Incomplete outcome data|0|||
161595020|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
161595021|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
161595022|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161595023|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161547614|NCT02714205|583394281|FG001|Overall Study|Incomplete outcome data|1|||
161547615|NCT02073097|583394282|FG000|Overall Study|Adverse Event|0|||
161547616|NCT02073097|583394283|FG001|Overall Study|Adverse Event|0|||
161547617|NCT02073097|583394284|FG002|Overall Study|Adverse Event|0|||
161547618|NCT02073097|583394285|FG003|Overall Study|Adverse Event|0|||
161595024|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161547619|NCT02073097|583394286|FG004|Overall Study|Adverse Event|0|||
161547620|NCT02073097|583394287|FG005|Overall Study|Adverse Event|0|||
161547621|NCT02073097|583394288|FG006|Overall Study|Adverse Event|0|||
161595025|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161547622|NCT02073097|583394289|FG007|Overall Study|Adverse Event|2|||
161595026|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161595027|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161595028|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
161595029|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
161595030|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
161595031|NCT01369355|583569967|FG000|Long-term Extension (Week 44-272)|Other|0|||
161595032|NCT01369355|583569968|FG001|Long-term Extension (Week 44-272)|Other|0|||
161595033|NCT01369355|583569969|FG002|Long-term Extension (Week 44-272)|Other|0|||
161595034|NCT01369355|583569970|FG003|Long-term Extension (Week 44-272)|Other|0|||
161595035|NCT01369355|583569971|FG004|Long-term Extension (Week 44-272)|Other|0|||
161595036|NCT01369355|583569972|FG005|Long-term Extension (Week 44-272)|Other|0|||
161595037|NCT01369355|583569973|FG006|Long-term Extension (Week 44-272)|Other|110|||
161595038|NCT01369355|583569974|FG007|Long-term Extension (Week 44-272)|Other|9|||
161595039|NCT01369355|583569975|FG008|Long-term Extension (Week 44-272)|Other|17|||
161595040|NCT06424236|583569980|FG000|Overall Study|Adverse Event|0|||
161595041|NCT06424236|583569981|FG001|Overall Study|Adverse Event|1|||
161595042|NCT06424236|583569982|FG002|Overall Study|Adverse Event|0|||
161595043|NCT06424236|583569980|FG000|Overall Study|Withdrawal by Subject|3|||
161595044|NCT06424236|583569981|FG001|Overall Study|Withdrawal by Subject|1|||
161595045|NCT06424236|583569982|FG002|Overall Study|Withdrawal by Subject|2|||
161595046|NCT06424236|583569980|FG000|Overall Study|Physician Decision|0|||
161595047|NCT06424236|583569981|FG001|Overall Study|Physician Decision|1|||
161595048|NCT06424236|583569982|FG002|Overall Study|Physician Decision|0|||
161595049|NCT06424236|583569980|FG000|Overall Study|Study Terminated by Sponsor|11|||
161595050|NCT06424236|583569981|FG001|Overall Study|Study Terminated by Sponsor|20|||
161595051|NCT06424236|583569982|FG002|Overall Study|Study Terminated by Sponsor|16|||
161595052|NCT06424236|583569980|FG000|Overall Study|Lost to Follow-up|0|||
161595053|NCT06424236|583569981|FG001|Overall Study|Lost to Follow-up|1|||
161595054|NCT06424236|583569982|FG002|Overall Study|Lost to Follow-up|0|||
161595055|NCT06424236|583569980|FG000|Overall Study|Disease Progression|0|||
161595056|NCT06424236|583569981|FG001|Overall Study|Disease Progression|1|||
161595057|NCT06424236|583569982|FG002|Overall Study|Disease Progression|2|||
161595058|NCT06424236|583569980|FG000|Overall Study|Other|0|||
161595059|NCT06424236|583569981|FG001|Overall Study|Other|0|||
161595060|NCT06424236|583569982|FG002|Overall Study|Other|1|||
161595061|NCT02547233|583569989|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161595062|NCT02547233|583569990|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161595063|NCT02547233|583569989|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
161595064|NCT02547233|583569990|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
161595065|NCT02547233|583569989|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
161595066|NCT02547233|583569990|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
161595067|NCT02547233|583569989|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161595068|NCT02547233|583569990|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161595069|NCT02547233|583569989|FG000|12-month Follow-up|Withdrawal by Subject|10|||
161595070|NCT02547233|583569990|FG001|12-month Follow-up|Withdrawal by Subject|10|||
161595071|NCT02547233|583569989|FG000|12-month Follow-up|Lost to Follow-up|3|||
161595072|NCT02547233|583569990|FG001|12-month Follow-up|Lost to Follow-up|3|||
161595073|NCT02547233|583569989|FG000|12-month Follow-up|Lack of Efficacy|1|||
161595074|NCT02547233|583569990|FG001|12-month Follow-up|Lack of Efficacy|2|||
161595075|NCT02547233|583569989|FG000|12-month Follow-up|Protocol Violation|0|||
161595076|NCT02547233|583569990|FG001|12-month Follow-up|Protocol Violation|1|||
161595077|NCT02547233|583569989|FG000|12-month Follow-up|Other|0|||
161595078|NCT02547233|583569990|FG001|12-month Follow-up|Other|1|||
161595079|NCT05362487|583569992|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
161595080|NCT03603600|583569994|FG000|Overall Study|Withdrawal by Subject|5|||
161595081|NCT03603600|583569995|FG001|Overall Study|Withdrawal by Subject|7|||
161595082|NCT03603600|583569994|FG000|Overall Study|Lost to Follow-up|2|||
161595083|NCT03603600|583569995|FG001|Overall Study|Lost to Follow-up|3|||
161595084|NCT03603600|583569994|FG000|Overall Study|Death|3|||
161595085|NCT03603600|583569995|FG001|Overall Study|Death|1|||
161595086|NCT03603600|583569994|FG000|Overall Study|Physician Decision|2|||
161595087|NCT03603600|583569995|FG001|Overall Study|Physician Decision|1|||
161595088|NCT03603600|583569994|FG000|Overall Study|Other reason|1|||
161595089|NCT03603600|583569995|FG001|Overall Study|Other reason|0|||
161595090|NCT03461276|583569996|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
161595091|NCT03461276|583569997|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
161595092|NCT03461276|583569996|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
161595093|NCT03461276|583569997|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
161595094|NCT03461276|583569996|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
161595095|NCT03461276|583569997|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
161595096|NCT03461276|583569996|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
161595097|NCT03461276|583569997|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
161595098|NCT03461276|583569996|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
161681034|NCT02568475|583884409|FG000|Overall Study|Short-term: Discharge location unknown|4|||
161681035|NCT02568475|583884410|FG001|Overall Study|Short-term: Discharge location unknown|0|||
161681036|NCT02568475|583884409|FG000|Overall Study|Transferred to another facility|1|||
161681037|NCT02568475|583884410|FG001|Overall Study|Transferred to another facility|0|||
161681038|NCT02625233|583884411|FG000|Overall Study|Adverse Event|2|||
161681039|NCT02625233|583884412|FG001|Overall Study|Adverse Event|0|||
161681040|NCT00290186|583884413|FG000|Overall Study|Adverse Event|1|||
161681041|NCT00290186|583884414|FG001|Overall Study|Adverse Event|1|||
161681042|NCT00290186|583884413|FG000|Overall Study|Lost to Follow-up|3|||
161681043|NCT00290186|583884414|FG001|Overall Study|Lost to Follow-up|2|||
161681044|NCT00290186|583884413|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
161681045|NCT00290186|583884414|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
161681046|NCT00290186|583884413|FG000|Overall Study|Withdrawal by Subject|0|||
161681047|NCT00290186|583884414|FG001|Overall Study|Withdrawal by Subject|1|||
161681048|NCT02710136|583884415|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
161681049|NCT02710136|583884416|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
161681050|NCT02269787|583884417|FG000|Overall Study|Lost to Follow-up|20|||
161681051|NCT02269787|583884418|FG001|Overall Study|Lost to Follow-up|6|||
161681052|NCT02269787|583884417|FG000|Overall Study|Death|2|||
161681053|NCT02269787|583884418|FG001|Overall Study|Death|3|||
161681054|NCT02269787|583884417|FG000|Overall Study|Incapacitated|0|||
161681055|NCT02269787|583884418|FG001|Overall Study|Incapacitated|1|||
161681056|NCT00798135|583884419|FG000|Overall Study|Disease progression, relapse|11|||
161681057|NCT00798135|583884419|FG000|Overall Study|Disease progression, refractory|1|||
161681058|NCT00798135|583884419|FG000|Overall Study|Physician Decision|1|||
161681059|NCT02228720|583884420|FG000|Open Label - Day 30|Lost to Follow-up|1|||
161681060|NCT00282295|583884421|FG000|Overall Study|Adverse Event|0|||
161681061|NCT00282295|583884422|FG001|Overall Study|Adverse Event|1|||
161681062|NCT00282295|583884423|FG002|Overall Study|Adverse Event|0|||
161681063|NCT00282295|583884421|FG000|Overall Study|Serious Adverse Events|0|||
161681064|NCT00282295|583884422|FG001|Overall Study|Serious Adverse Events|0|||
161681065|NCT00282295|583884423|FG002|Overall Study|Serious Adverse Events|1|||
161681066|NCT00282295|583884421|FG000|Overall Study|Protocol Violation|0|||
161681067|NCT00282295|583884422|FG001|Overall Study|Protocol Violation|2|||
161681068|NCT00282295|583884423|FG002|Overall Study|Protocol Violation|1|||
161681069|NCT00282295|583884421|FG000|Overall Study|Withdrawal by Subject|2|||
161681070|NCT00282295|583884422|FG001|Overall Study|Withdrawal by Subject|6|||
161681071|NCT00282295|583884423|FG002|Overall Study|Withdrawal by Subject|4|||
161681072|NCT00282295|583884421|FG000|Overall Study|Lost to Follow-up|1|||
161681073|NCT00282295|583884422|FG001|Overall Study|Lost to Follow-up|7|||
161681074|NCT00282295|583884423|FG002|Overall Study|Lost to Follow-up|2|||
161681075|NCT00282295|583884421|FG000|Overall Study|Other|0|||
161681076|NCT00282295|583884422|FG001|Overall Study|Other|1|||
161681077|NCT00282295|583884423|FG002|Overall Study|Other|0|||
161681078|NCT03337542|583884426|FG000|Overall Study|Withdrew Consent|17|||
161681079|NCT03337542|583884426|FG000|Overall Study|Allergic Adverse Event|1|||
161681080|NCT03337542|583884426|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
161681081|NCT03337542|583884426|FG000|Overall Study|Lost to Follow-up|1|||
161681082|NCT03337542|583884426|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
161681083|NCT01401842|583884427|FG000|Overall Study|Withdrawal by Subject|3|||
161681084|NCT01401842|583884428|FG001|Overall Study|Withdrawal by Subject|2|||
161681085|NCT01401842|583884427|FG000|Overall Study|academic reason|4|||
161681086|NCT01401842|583884428|FG001|Overall Study|academic reason|1|||
161681087|NCT01401842|583884427|FG000|Overall Study|changed companies|20|||
161681088|NCT01401842|583884428|FG001|Overall Study|changed companies|34|||
161681089|NCT01401842|583884427|FG000|Overall Study|discharged from US Army|3|||
161681090|NCT01401842|583884428|FG001|Overall Study|discharged from US Army|4|||
161681091|NCT01401842|583884427|FG000|Overall Study|invalid follow-up strength data|1|||
161681092|NCT01401842|583884428|FG001|Overall Study|invalid follow-up strength data|4|||
161681093|NCT01401842|583884427|FG000|Overall Study|on profile|9|||
161681094|NCT01401842|583884428|FG001|Overall Study|on profile|5|||
161681095|NCT01401842|583884427|FG000|Overall Study|other/unknown|28|||
161681096|NCT01401842|583884428|FG001|Overall Study|other/unknown|17|||
161681097|NCT04183790|583886112|FG000|Overall Study|Participants did not rollover to Part B|12|||
161681098|NCT04183790|583886113|FG001|Overall Study|Participants did not rollover to Part B|0|||
161681099|NCT04183790|583886112|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
161681100|NCT04183790|583886113|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161681101|NCT04183790|583886112|FG000|Overall Study|Commercial drug is available for participant|6|||
161681102|NCT04183790|583886113|FG001|Overall Study|Commercial drug is available for participant|0|||
161681103|NCT04183790|583886112|FG000|Overall Study|Adverse Event|1|||
161681104|NCT04183790|583886113|FG001|Overall Study|Adverse Event|0|||
161681105|NCT04183790|583886112|FG000|Overall Study|Not enrolled in 107 study|0|||
161681106|NCT04183790|583886113|FG001|Overall Study|Not enrolled in 107 study|2|||
161681107|NCT01251653|583886114|FG000|Overall Study|Progressive Disease|1|||
161681108|NCT01251653|583886115|FG001|Overall Study|Progressive Disease|7|||
161681109|NCT01251653|583886116|FG002|Overall Study|Progressive Disease|16|||
161681110|NCT01251653|583886117|FG003|Overall Study|Progressive Disease|4|||
161681111|NCT01251653|583886118|FG004|Overall Study|Progressive Disease|0|||
161681112|NCT01251653|583886119|FG005|Overall Study|Progressive Disease|17|||
161681113|NCT01251653|583886120|FG006|Overall Study|Progressive Disease|14|||
161681114|NCT01251653|583886121|FG007|Overall Study|Progressive Disease|7|||
161681115|NCT01251653|583886122|FG008|Overall Study|Progressive Disease|5|||
161681116|NCT01251653|583886114|FG000|Overall Study|Dose-limiting toxicity|0|||
161681117|NCT01251653|583886115|FG001|Overall Study|Dose-limiting toxicity|1|||
161681118|NCT01251653|583886116|FG002|Overall Study|Dose-limiting toxicity|1|||
161681119|NCT01251653|583886117|FG003|Overall Study|Dose-limiting toxicity|1|||
161681120|NCT01251653|583886118|FG004|Overall Study|Dose-limiting toxicity|0|||
161681121|NCT01251653|583886119|FG005|Overall Study|Dose-limiting toxicity|0|||
161681122|NCT01251653|583886120|FG006|Overall Study|Dose-limiting toxicity|2|||
161681123|NCT01251653|583886121|FG007|Overall Study|Dose-limiting toxicity|0|||
161681124|NCT01251653|583886122|FG008|Overall Study|Dose-limiting toxicity|0|||
161681125|NCT01251653|583886114|FG000|Overall Study|Adverse Event|1|||
161681126|NCT01251653|583886115|FG001|Overall Study|Adverse Event|0|||
161681127|NCT01251653|583886116|FG002|Overall Study|Adverse Event|2|||
161681128|NCT01251653|583886117|FG003|Overall Study|Adverse Event|1|||
161681129|NCT01251653|583886118|FG004|Overall Study|Adverse Event|1|||
161830108|NCT02400476|584418114|FG004|Overall Study|Other, Decreased Quality of Life|0|||
161830109|NCT02400476|584418115|FG005|Overall Study|Other, Decreased Quality of Life|0|||
161830110|NCT02400476|584418110|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161830111|NCT02400476|584418111|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161547623|NCT02073097|583394282|FG000|Overall Study|Withdrawal by Subject|0|||
161547624|NCT02073097|583394283|FG001|Overall Study|Withdrawal by Subject|0|||
161547625|NCT02073097|583394284|FG002|Overall Study|Withdrawal by Subject|0|||
161547626|NCT02073097|583394285|FG003|Overall Study|Withdrawal by Subject|0|||
161547627|NCT02073097|583394286|FG004|Overall Study|Withdrawal by Subject|0|||
161547628|NCT02073097|583394287|FG005|Overall Study|Withdrawal by Subject|0|||
161547629|NCT02073097|583394288|FG006|Overall Study|Withdrawal by Subject|0|||
161547630|NCT02073097|583394289|FG007|Overall Study|Withdrawal by Subject|2|||
161547631|NCT02073097|583394282|FG000|Overall Study|Death|0|||
161547632|NCT02073097|583394283|FG001|Overall Study|Death|0|||
161547633|NCT02073097|583394284|FG002|Overall Study|Death|0|||
161547634|NCT02073097|583394285|FG003|Overall Study|Death|0|||
161547635|NCT02073097|583394286|FG004|Overall Study|Death|0|||
161547636|NCT02073097|583394287|FG005|Overall Study|Death|0|||
161547637|NCT02073097|583394288|FG006|Overall Study|Death|0|||
161547638|NCT02073097|583394289|FG007|Overall Study|Death|1|||
161547639|NCT02073097|583394282|FG000|Overall Study|Physician Decision|0|||
161547640|NCT02073097|583394283|FG001|Overall Study|Physician Decision|0|||
161547641|NCT02073097|583394284|FG002|Overall Study|Physician Decision|0|||
161547642|NCT02073097|583394285|FG003|Overall Study|Physician Decision|0|||
161547643|NCT02073097|583394286|FG004|Overall Study|Physician Decision|0|||
161547644|NCT02073097|583394287|FG005|Overall Study|Physician Decision|0|||
161547645|NCT02073097|583394288|FG006|Overall Study|Physician Decision|0|||
161547646|NCT02073097|583394289|FG007|Overall Study|Physician Decision|1|||
161547647|NCT03813147|583394292|FG000|Overall Study|Lack of Efficacy|4|||
161547648|NCT03813147|583394293|FG001|Overall Study|Lack of Efficacy|4|||
161547649|NCT03813147|583394292|FG000|Overall Study|Physician Decision|2|||
161547650|NCT03813147|583394293|FG001|Overall Study|Physician Decision|1|||
161547651|NCT01693692|583394294|FG000|Overall Study|Withdrawal by Subject|12|||
161547652|NCT01693692|583394295|FG001|Overall Study|Withdrawal by Subject|10|||
161547653|NCT01693692|583394296|FG002|Overall Study|Withdrawal by Subject|11|||
161547654|NCT01693692|583394294|FG000|Overall Study|Adverse Event|7|||
161681130|NCT01251653|583886119|FG005|Overall Study|Adverse Event|0|||
161830112|NCT02400476|584418112|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
161547655|NCT01693692|583394295|FG001|Overall Study|Adverse Event|14|||
161547656|NCT01693692|583394296|FG002|Overall Study|Adverse Event|9|||
161547657|NCT01693692|583394294|FG000|Overall Study|Physician Decision|0|||
161547658|NCT01693692|583394295|FG001|Overall Study|Physician Decision|0|||
161547659|NCT01693692|583394296|FG002|Overall Study|Physician Decision|1|||
161681131|NCT01251653|583886120|FG006|Overall Study|Adverse Event|2|||
161681132|NCT01251653|583886121|FG007|Overall Study|Adverse Event|2|||
161681133|NCT01251653|583886122|FG008|Overall Study|Adverse Event|1|||
161547660|NCT01693692|583394294|FG000|Overall Study|Protocol Violation|5|||
161547661|NCT01693692|583394295|FG001|Overall Study|Protocol Violation|4|||
161681134|NCT01251653|583886114|FG000|Overall Study|Withdrawal by Subject|1|||
161547662|NCT01693692|583394296|FG002|Overall Study|Protocol Violation|6|||
161547663|NCT01693692|583394294|FG000|Overall Study|Lost to Follow-up|2|||
161547664|NCT01693692|583394295|FG001|Overall Study|Lost to Follow-up|2|||
161547665|NCT01693692|583394296|FG002|Overall Study|Lost to Follow-up|3|||
161547666|NCT01693692|583394294|FG000|Overall Study|Other|4|||
161547667|NCT01693692|583394295|FG001|Overall Study|Other|4|||
161547668|NCT01693692|583394296|FG002|Overall Study|Other|6|||
161547669|NCT04424290|583396087|FG000|Overall Study|Not treated|0|||
161681135|NCT01251653|583886115|FG001|Overall Study|Withdrawal by Subject|0|||
161681136|NCT01251653|583886116|FG002|Overall Study|Withdrawal by Subject|1|||
161681137|NCT01251653|583886117|FG003|Overall Study|Withdrawal by Subject|0|||
161681138|NCT01251653|583886118|FG004|Overall Study|Withdrawal by Subject|1|||
161681139|NCT01251653|583886119|FG005|Overall Study|Withdrawal by Subject|1|||
161681140|NCT01251653|583886120|FG006|Overall Study|Withdrawal by Subject|0|||
161681141|NCT01251653|583886121|FG007|Overall Study|Withdrawal by Subject|1|||
161681142|NCT01251653|583886122|FG008|Overall Study|Withdrawal by Subject|0|||
161681143|NCT01251653|583886114|FG000|Overall Study|Other reason not mentioned above|0|||
161681144|NCT01251653|583886115|FG001|Overall Study|Other reason not mentioned above|0|||
161681145|NCT01251653|583886116|FG002|Overall Study|Other reason not mentioned above|0|||
161681146|NCT01251653|583886117|FG003|Overall Study|Other reason not mentioned above|0|||
161681147|NCT01251653|583886118|FG004|Overall Study|Other reason not mentioned above|0|||
161681148|NCT01251653|583886119|FG005|Overall Study|Other reason not mentioned above|0|||
161681149|NCT01251653|583886120|FG006|Overall Study|Other reason not mentioned above|0|||
161681150|NCT01251653|583886121|FG007|Overall Study|Other reason not mentioned above|2|||
161681151|NCT01251653|583886122|FG008|Overall Study|Other reason not mentioned above|0|||
161681152|NCT00847145|583886123|FG000|Overall Study|AE or Death|0|||
161547670|NCT04424290|583396088|FG001|Overall Study|Not treated|0|||
161547671|NCT04424290|583396089|FG002|Overall Study|Not treated|1|||
161547672|NCT04424290|583396090|FG003|Overall Study|Not treated|0|||
161547673|NCT04424290|583396091|FG004|Overall Study|Not treated|1|||
161547674|NCT04424290|583396087|FG000|Overall Study|Adverse Event|0|||
161547675|NCT04424290|583396088|FG001|Overall Study|Adverse Event|0|||
161547676|NCT04424290|583396089|FG002|Overall Study|Adverse Event|0|||
161547677|NCT04424290|583396090|FG003|Overall Study|Adverse Event|2|||
161547678|NCT04424290|583396091|FG004|Overall Study|Adverse Event|0|||
161547679|NCT04424290|583396087|FG000|Overall Study|Withdrawal by Subject|0|||
161547680|NCT04424290|583396088|FG001|Overall Study|Withdrawal by Subject|0|||
161547681|NCT04424290|583396089|FG002|Overall Study|Withdrawal by Subject|0|||
161547682|NCT04424290|583396090|FG003|Overall Study|Withdrawal by Subject|0|||
161547683|NCT04424290|583396091|FG004|Overall Study|Withdrawal by Subject|1|||
161547684|NCT04424290|583396087|FG000|Overall Study|Other than listed|0|||
161547685|NCT04424290|583396088|FG001|Overall Study|Other than listed|0|||
161547686|NCT04424290|583396089|FG002|Overall Study|Other than listed|0|||
161547687|NCT04424290|583396090|FG003|Overall Study|Other than listed|1|||
161547688|NCT04424290|583396091|FG004|Overall Study|Other than listed|0|||
161547689|NCT02914184|583396095|FG000|Overall Study|Lost to Follow-up|7|||
161547690|NCT02914184|583396096|FG001|Overall Study|Lost to Follow-up|10|||
161547691|NCT02914184|583396097|FG002|Overall Study|Lost to Follow-up|8|||
161547692|NCT02914184|583396098|FG003|Overall Study|Lost to Follow-up|7|||
161547693|NCT02914184|583396095|FG000|Overall Study|Withdrawal by Subject|4|||
161547694|NCT02914184|583396096|FG001|Overall Study|Withdrawal by Subject|2|||
161547695|NCT02914184|583396097|FG002|Overall Study|Withdrawal by Subject|7|||
161547696|NCT02914184|583396098|FG003|Overall Study|Withdrawal by Subject|3|||
161547697|NCT02914184|583396095|FG000|Overall Study|Other|1|||
161547698|NCT02914184|583396096|FG001|Overall Study|Other|0|||
161547699|NCT02914184|583396097|FG002|Overall Study|Other|0|||
161547700|NCT02914184|583396098|FG003|Overall Study|Other|0|||
161547701|NCT02914184|583396095|FG000|Overall Study|Migrated/moved from the study area|2|||
161547702|NCT02914184|583396096|FG001|Overall Study|Migrated/moved from the study area|1|||
161547703|NCT02914184|583396097|FG002|Overall Study|Migrated/moved from the study area|2|||
161547704|NCT02914184|583396098|FG003|Overall Study|Migrated/moved from the study area|1|||
161547705|NCT00798174|583396099|FG000|Overall Study|inability to implant azygos coil|3|||
161547706|NCT00798174|583396100|FG001|Overall Study|inability to implant azygos coil|3|||
161547707|NCT00798174|583396099|FG000|Overall Study|Inability to sedate for DFT testing|1|||
161547708|NCT00798174|583396100|FG001|Overall Study|Inability to sedate for DFT testing|0|||
161547709|NCT01683994|583396102|FG000|Overall Study|Withdrawal by Subject|1|||
161547710|NCT01683994|583396103|FG001|Overall Study|Withdrawal by Subject|0|||
161547711|NCT01683994|583396104|FG002|Overall Study|Withdrawal by Subject|0|||
161547712|NCT01683994|583396105|FG003|Overall Study|Withdrawal by Subject|1|||
161547713|NCT01683994|583396106|FG004|Overall Study|Withdrawal by Subject|0|||
161547714|NCT01683994|583396102|FG000|Overall Study|Intercurrent illness|0|||
161547715|NCT01683994|583396103|FG001|Overall Study|Intercurrent illness|0|||
161681153|NCT00847145|583886124|FG001|Overall Study|AE or Death|1|||
161681154|NCT00847145|583886125|FG002|Overall Study|AE or Death|1|||
161547716|NCT01683994|583396104|FG002|Overall Study|Intercurrent illness|0|||
161547717|NCT01683994|583396105|FG003|Overall Study|Intercurrent illness|2|||
161547718|NCT01683994|583396106|FG004|Overall Study|Intercurrent illness|1|||
161547719|NCT02318719|583396112|FG000|Double-blind Phase|Adverse Event|7|||
161547720|NCT02318719|583396113|FG001|Double-blind Phase|Adverse Event|6|||
161547721|NCT02318719|583396114|FG002|Double-blind Phase|Adverse Event|12|||
161547722|NCT02318719|583396115|FG003|Double-blind Phase|Adverse Event|4|||
161547723|NCT02318719|583396116|FG004|Double-blind Phase|Adverse Event|0|||
161547724|NCT02318719|583396112|FG000|Double-blind Phase|Lack of Efficacy|5|||
161547725|NCT02318719|583396113|FG001|Double-blind Phase|Lack of Efficacy|0|||
161681155|NCT00847145|583886126|FG003|Overall Study|AE or Death|0|||
161547726|NCT02318719|583396114|FG002|Double-blind Phase|Lack of Efficacy|1|||
161547727|NCT02318719|583396115|FG003|Double-blind Phase|Lack of Efficacy|1|||
161547728|NCT02318719|583396116|FG004|Double-blind Phase|Lack of Efficacy|0|||
161547729|NCT02318719|583396112|FG000|Double-blind Phase|Protocol Violation|0|||
161547730|NCT02318719|583396113|FG001|Double-blind Phase|Protocol Violation|1|||
161547731|NCT02318719|583396114|FG002|Double-blind Phase|Protocol Violation|3|||
161547732|NCT02318719|583396115|FG003|Double-blind Phase|Protocol Violation|0|||
161547733|NCT02318719|583396116|FG004|Double-blind Phase|Protocol Violation|0|||
161547734|NCT02318719|583396112|FG000|Double-blind Phase|Withdrawal by Subject|25|||
161547735|NCT02318719|583396113|FG001|Double-blind Phase|Withdrawal by Subject|7|||
161547736|NCT02318719|583396114|FG002|Double-blind Phase|Withdrawal by Subject|9|||
161547737|NCT02318719|583396115|FG003|Double-blind Phase|Withdrawal by Subject|10|||
161547738|NCT02318719|583396116|FG004|Double-blind Phase|Withdrawal by Subject|0|||
161547739|NCT02318719|583396112|FG000|Double-blind Phase|Other|1|||
161547740|NCT02318719|583396113|FG001|Double-blind Phase|Other|2|||
161547741|NCT02318719|583396114|FG002|Double-blind Phase|Other|0|||
161547742|NCT02318719|583396115|FG003|Double-blind Phase|Other|0|||
161547743|NCT02318719|583396116|FG004|Double-blind Phase|Other|0|||
161547744|NCT02318719|583396112|FG000|Open-label Extension Phase|Adverse Event|0|||
161547745|NCT02318719|583396113|FG001|Open-label Extension Phase|Adverse Event|0|||
161547746|NCT02318719|583396114|FG002|Open-label Extension Phase|Adverse Event|0|||
161547747|NCT02318719|583396115|FG003|Open-label Extension Phase|Adverse Event|0|||
161547748|NCT02318719|583396116|FG004|Open-label Extension Phase|Adverse Event|15|||
161547749|NCT02318719|583396112|FG000|Open-label Extension Phase|Death|0|||
161547750|NCT02318719|583396113|FG001|Open-label Extension Phase|Death|0|||
161547751|NCT02318719|583396114|FG002|Open-label Extension Phase|Death|0|||
161547752|NCT02318719|583396115|FG003|Open-label Extension Phase|Death|0|||
161547753|NCT02318719|583396116|FG004|Open-label Extension Phase|Death|1|||
161547754|NCT02318719|583396112|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
161547755|NCT02318719|583396113|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
161547756|NCT02318719|583396114|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
161547757|NCT02318719|583396115|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
161547758|NCT02318719|583396116|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
161547759|NCT02318719|583396112|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
161595099|NCT03461276|583569997|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
161595100|NCT03461276|583569996|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
161595101|NCT03461276|583569997|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
161595102|NCT03461276|583569996|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
161595103|NCT03461276|583569997|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
161595104|NCT03461276|583569996|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
161595105|NCT03461276|583569997|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
161595106|NCT03461276|583569996|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
161595107|NCT03461276|583569997|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
161595108|NCT03461276|583569996|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
161595109|NCT03461276|583569997|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
161595110|NCT02310646|583569999|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
161595111|NCT02310646|583570000|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
161595112|NCT02310646|583569999|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
161595113|NCT02310646|583570000|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
161595114|NCT00613106|583570007|FG000|Overall Study|Adverse Event|3|||
161595115|NCT00613106|583570008|FG001|Overall Study|Adverse Event|1|||
161595116|NCT00613106|583570007|FG000|Overall Study|Withdrawal by Subject|6|||
161595117|NCT00613106|583570008|FG001|Overall Study|Withdrawal by Subject|3|||
161595118|NCT00613106|583570007|FG000|Overall Study|Lost to Follow-up|7|||
161595119|NCT00613106|583570008|FG001|Overall Study|Lost to Follow-up|2|||
161595120|NCT00613106|583570007|FG000|Overall Study|misc|4|||
161595121|NCT00613106|583570008|FG001|Overall Study|misc|3|||
161595122|NCT03496168|583570009|FG000|Overall Study|Other Reasons|1|||
161595123|NCT03496168|583570009|FG000|Overall Study|Adverse Event|1|||
161595124|NCT02043678|583570014|FG000|Overall Study|Never treated|11|||
161595125|NCT02043678|583570015|FG001|Overall Study|Never treated|9|||
161547760|NCT02318719|583396113|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
161547761|NCT02318719|583396114|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
161547762|NCT02318719|583396115|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
161595126|NCT02043678|583570014|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
161595127|NCT02043678|583570015|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
161595128|NCT02043678|583570014|FG000|Overall Study|AE without clinical PD|54|||
161595129|NCT02043678|583570015|FG001|Overall Study|AE without clinical PD|36|||
161595130|NCT02043678|583570014|FG000|Overall Study|Lost to Follow-up|1|||
161595131|NCT02043678|583570015|FG001|Overall Study|Lost to Follow-up|1|||
161595132|NCT02043678|583570014|FG000|Overall Study|Other|10|||
161595133|NCT02043678|583570015|FG001|Overall Study|Other|14|||
161595134|NCT02043678|583570014|FG000|Overall Study|Clinical PD|114|||
161595135|NCT02043678|583570015|FG001|Overall Study|Clinical PD|148|||
161681156|NCT00847145|583886127|FG004|Overall Study|AE or Death|0|||
161547763|NCT02318719|583396116|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
161547764|NCT02318719|583396112|FG000|Open-label Extension Phase|Other|0|||
161547765|NCT02318719|583396113|FG001|Open-label Extension Phase|Other|0|||
161547766|NCT02318719|583396114|FG002|Open-label Extension Phase|Other|0|||
161547767|NCT02318719|583396115|FG003|Open-label Extension Phase|Other|0|||
161547768|NCT02318719|583396116|FG004|Open-label Extension Phase|Other|7|||
161547769|NCT00802659|583396117|FG000|Overall Study|Physician Decision|0|||
161547770|NCT00802659|583396118|FG001|Overall Study|Physician Decision|1|||
161547771|NCT00802659|583396119|FG002|Overall Study|Physician Decision|0|||
161547772|NCT00802659|583396120|FG003|Overall Study|Physician Decision|0|||
161547773|NCT00806624|583396121|FG000|Overall Study|Adverse Event|2|||
161547774|NCT00806624|583396122|FG001|Overall Study|Adverse Event|8|||
161547775|NCT00806624|583396123|FG002|Overall Study|Adverse Event|0|||
161547776|NCT00806624|583396121|FG000|Overall Study|Death|0|||
161547777|NCT00806624|583396122|FG001|Overall Study|Death|1|||
161547778|NCT00806624|583396123|FG002|Overall Study|Death|1|||
161547779|NCT00806624|583396121|FG000|Overall Study|Lost to Follow-up|1|||
161547780|NCT00806624|583396122|FG001|Overall Study|Lost to Follow-up|0|||
161547781|NCT00806624|583396123|FG002|Overall Study|Lost to Follow-up|1|||
161547782|NCT00806624|583396121|FG000|Overall Study|Withdrawal by Subject|6|||
161547783|NCT00806624|583396122|FG001|Overall Study|Withdrawal by Subject|3|||
161547784|NCT00806624|583396123|FG002|Overall Study|Withdrawal by Subject|3|||
161547785|NCT00806624|583396121|FG000|Overall Study|discontinued before start of treatment|0|||
161681157|NCT00847145|583886128|FG005|Overall Study|AE or Death|0|||
161681158|NCT00847145|583886129|FG006|Overall Study|AE or Death|0|||
161681159|NCT00847145|583886130|FG007|Overall Study|AE or Death|0|||
161681160|NCT00847145|583886123|FG000|Overall Study|Withdrawal by Subject|3|||
161681161|NCT00847145|583886124|FG001|Overall Study|Withdrawal by Subject|4|||
161681162|NCT00847145|583886125|FG002|Overall Study|Withdrawal by Subject|6|||
161681163|NCT00847145|583886126|FG003|Overall Study|Withdrawal by Subject|1|||
161681164|NCT00847145|583886127|FG004|Overall Study|Withdrawal by Subject|0|||
161681165|NCT00847145|583886128|FG005|Overall Study|Withdrawal by Subject|0|||
161681166|NCT00847145|583886129|FG006|Overall Study|Withdrawal by Subject|1|||
161681167|NCT00847145|583886130|FG007|Overall Study|Withdrawal by Subject|1|||
161681168|NCT00847145|583886123|FG000|Overall Study|Lost to Follow-up|3|||
161681169|NCT00847145|583886124|FG001|Overall Study|Lost to Follow-up|1|||
161547786|NCT00806624|583396122|FG001|Overall Study|discontinued before start of treatment|0|||
161547787|NCT00806624|583396123|FG002|Overall Study|discontinued before start of treatment|1|||
161547788|NCT03093428|583396124|FG000|Overall Study|Not eligible for treatment|2|||
161547789|NCT03093428|583396125|FG001|Overall Study|Not eligible for treatment|1|||
161547790|NCT03093428|583396124|FG000|Overall Study|Progression|14|||
161547791|NCT03093428|583396125|FG001|Overall Study|Progression|4|||
161547792|NCT03093428|583396124|FG000|Overall Study|Death|1|||
161547793|NCT03093428|583396125|FG001|Overall Study|Death|0|||
161547794|NCT03093428|583396124|FG000|Overall Study|Adverse Event|1|||
161547795|NCT03093428|583396125|FG001|Overall Study|Adverse Event|0|||
161547796|NCT03093428|583396124|FG000|Overall Study|Withdrawal by Subject|1|||
161547797|NCT03093428|583396125|FG001|Overall Study|Withdrawal by Subject|1|||
161547798|NCT01336634|583396129|FG000|Overall Study|Study closed/terminated|5|||
161547799|NCT01336634|583396130|FG001|Overall Study|Study closed/terminated|6|||
161595136|NCT02043678|583570014|FG000|Overall Study|Radiological PD|100|||
161595137|NCT02043678|583570015|FG001|Overall Study|Radiological PD|90|||
161595138|NCT02043678|583570014|FG000|Overall Study|Protocol-driven decision point|59|||
161595139|NCT02043678|583570015|FG001|Overall Study|Protocol-driven decision point|58|||
161595140|NCT02043678|583570014|FG000|Overall Study|Withdrawal by Subject|16|||
161595141|NCT02043678|583570015|FG001|Overall Study|Withdrawal by Subject|20|||
161595142|NCT02043678|583570014|FG000|Overall Study|Protocol Violation|1|||
161595143|NCT02043678|583570015|FG001|Overall Study|Protocol Violation|0|||
161595144|NCT02043678|583570014|FG000|Overall Study|Deterioration of general conditions|1|||
161595145|NCT02043678|583570015|FG001|Overall Study|Deterioration of general conditions|1|||
161595146|NCT02043678|583570014|FG000|Overall Study|Logistical difficulties|2|||
161595147|NCT02043678|583570015|FG001|Overall Study|Logistical difficulties|0|||
161595148|NCT02043678|583570014|FG000|Overall Study|Non-compliance with study drug|3|||
161595149|NCT02043678|583570015|FG001|Overall Study|Non-compliance with study drug|1|||
161595150|NCT02043678|583570014|FG000|Overall Study|Physician Decision|4|||
161595151|NCT02043678|583570015|FG001|Overall Study|Physician Decision|3|||
161595152|NCT02043678|583570014|FG000|Overall Study|Subject decision|0|||
161595153|NCT02043678|583570015|FG001|Overall Study|Subject decision|1|||
161595154|NCT02043678|583570014|FG000|Overall Study|Switching to other therapy|3|||
161595155|NCT02043678|583570015|FG001|Overall Study|Switching to other therapy|2|||
161595156|NCT02043678|583570014|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
161595157|NCT02043678|583570015|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
161595158|NCT02043678|583570014|FG000|Overall Study|Missing|1|||
161595159|NCT02043678|583570015|FG001|Overall Study|Missing|0|||
161595160|NCT02043678|583570014|FG000|Overall Study|Adverse Event|0|||
161595161|NCT02043678|583570015|FG001|Overall Study|Adverse Event|1|||
161681170|NCT00847145|583886125|FG002|Overall Study|Lost to Follow-up|1|||
161681171|NCT00847145|583886126|FG003|Overall Study|Lost to Follow-up|0|||
161681172|NCT00847145|583886127|FG004|Overall Study|Lost to Follow-up|4|||
161681173|NCT00847145|583886128|FG005|Overall Study|Lost to Follow-up|4|||
161681174|NCT00847145|583886129|FG006|Overall Study|Lost to Follow-up|8|||
161547800|NCT01336634|583396131|FG002|Overall Study|Study closed/terminated|6|||
161681175|NCT00847145|583886130|FG007|Overall Study|Lost to Follow-up|2|||
161547801|NCT01336634|583396129|FG000|Overall Study|Lost to Follow-up|2|||
161547802|NCT01336634|583396130|FG001|Overall Study|Lost to Follow-up|1|||
161547803|NCT01336634|583396131|FG002|Overall Study|Lost to Follow-up|1|||
161595162|NCT04307355|583570022|FG000|Overall Study|Non-Compliance|3|||
161595163|NCT04307355|583570023|FG001|Overall Study|Non-Compliance|3|||
161595164|NCT04307355|583570024|FG002|Overall Study|Non-Compliance|0|||
161595165|NCT04065841|583570025|FG000|Overall Study|Adverse Event|4|||
161681176|NCT00847145|583886123|FG000|Overall Study|Inappropriate enrollment|0|||
161681177|NCT00847145|583886124|FG001|Overall Study|Inappropriate enrollment|0|||
161681178|NCT00847145|583886125|FG002|Overall Study|Inappropriate enrollment|0|||
161681179|NCT00847145|583886126|FG003|Overall Study|Inappropriate enrollment|0|||
161681180|NCT00847145|583886127|FG004|Overall Study|Inappropriate enrollment|1|||
161681181|NCT00847145|583886128|FG005|Overall Study|Inappropriate enrollment|0|||
161681182|NCT00847145|583886129|FG006|Overall Study|Inappropriate enrollment|0|||
161681183|NCT00847145|583886130|FG007|Overall Study|Inappropriate enrollment|0|||
161547804|NCT01336634|583396129|FG000|Overall Study|Physician Decision|1|||
161547805|NCT01336634|583396130|FG001|Overall Study|Physician Decision|1|||
161547806|NCT01336634|583396131|FG002|Overall Study|Physician Decision|0|||
161547807|NCT01336634|583396129|FG000|Overall Study|Withdrawal by Subject|6|||
161547808|NCT01336634|583396130|FG001|Overall Study|Withdrawal by Subject|0|||
161547809|NCT01336634|583396131|FG002|Overall Study|Withdrawal by Subject|2|||
161547810|NCT01973491|583396132|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
161547811|NCT01973491|583396132|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
161547812|NCT01973491|583396132|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
161547813|NCT01863043|583396136|FG000|Overall Study|Death|6|||
161547814|NCT01863043|583396137|FG001|Overall Study|Death|1|||
161547815|NCT01863043|583396136|FG000|Overall Study|Withdrawal by Subject|0|||
161547816|NCT01863043|583396137|FG001|Overall Study|Withdrawal by Subject|2|||
161547817|NCT01863043|583396136|FG000|Overall Study|Adverse Event|7|||
161547818|NCT01863043|583396137|FG001|Overall Study|Adverse Event|8|||
161547819|NCT01863043|583396136|FG000|Overall Study|exclusion criteria found after enrollment|0|||
161547820|NCT01863043|583396137|FG001|Overall Study|exclusion criteria found after enrollment|1|||
161547821|NCT00313911|583396138|FG000|Overall Study|Serious adverse event|6|||
161547822|NCT00313911|583396139|FG001|Overall Study|Serious adverse event|1|||
161547823|NCT00313911|583396138|FG000|Overall Study|Adverse Event|2|||
161547824|NCT00313911|583396139|FG001|Overall Study|Adverse Event|3|||
161547825|NCT00313911|583396138|FG000|Overall Study|Protocol Violation|19|||
161547826|NCT00313911|583396139|FG001|Overall Study|Protocol Violation|10|||
161547827|NCT00313911|583396138|FG000|Overall Study|Lost to Follow-up|27|||
161595166|NCT04065841|583570026|FG001|Overall Study|Adverse Event|2|||
161595167|NCT04065841|583570027|FG002|Overall Study|Adverse Event|10|||
161595168|NCT04065841|583570028|FG003|Overall Study|Adverse Event|1|||
161595169|NCT04065841|583570025|FG000|Overall Study|Lost to Follow-up|1|||
161595170|NCT04065841|583570026|FG001|Overall Study|Lost to Follow-up|2|||
161595171|NCT04065841|583570027|FG002|Overall Study|Lost to Follow-up|2|||
161595172|NCT04065841|583570028|FG003|Overall Study|Lost to Follow-up|2|||
161595173|NCT04065841|583570025|FG000|Overall Study|Physician Decision|1|||
161595174|NCT04065841|583570026|FG001|Overall Study|Physician Decision|0|||
161595175|NCT04065841|583570027|FG002|Overall Study|Physician Decision|0|||
161595176|NCT04065841|583570028|FG003|Overall Study|Physician Decision|0|||
161595177|NCT04065841|583570025|FG000|Overall Study|Protocol Violation|0|||
161595178|NCT04065841|583570026|FG001|Overall Study|Protocol Violation|1|||
161595179|NCT04065841|583570027|FG002|Overall Study|Protocol Violation|0|||
161595180|NCT04065841|583570028|FG003|Overall Study|Protocol Violation|0|||
161595181|NCT04065841|583570025|FG000|Overall Study|Study terminated by Sponsor|22|||
161595182|NCT04065841|583570026|FG001|Overall Study|Study terminated by Sponsor|16|||
161595183|NCT04065841|583570027|FG002|Overall Study|Study terminated by Sponsor|28|||
161595184|NCT04065841|583570028|FG003|Overall Study|Study terminated by Sponsor|17|||
161681184|NCT00847145|583886123|FG000|Overall Study|Protocol Violation|0|||
161681185|NCT00847145|583886124|FG001|Overall Study|Protocol Violation|0|||
161681186|NCT00847145|583886125|FG002|Overall Study|Protocol Violation|3|||
161681187|NCT00847145|583886126|FG003|Overall Study|Protocol Violation|0|||
161681188|NCT00847145|583886127|FG004|Overall Study|Protocol Violation|1|||
161681189|NCT00847145|583886128|FG005|Overall Study|Protocol Violation|0|||
161681190|NCT00847145|583886129|FG006|Overall Study|Protocol Violation|0|||
161681191|NCT00847145|583886130|FG007|Overall Study|Protocol Violation|1|||
161681192|NCT02833974|583886131|FG000|Overall Study|Lost to Follow-up|1|||
161681193|NCT02833974|583886132|FG001|Overall Study|Lost to Follow-up|0|||
161681194|NCT02833974|583886131|FG000|Overall Study|Adverse Event|0|||
161681195|NCT02833974|583886132|FG001|Overall Study|Adverse Event|3|||
161681196|NCT04419610|583886133|FG000|Overall Study|Withdrawal by Subject|3|||
161681197|NCT04419610|583886134|FG001|Overall Study|Withdrawal by Subject|1|||
161681198|NCT04419610|583886133|FG000|Overall Study|Adverse Event|1|||
161681199|NCT04419610|583886134|FG001|Overall Study|Adverse Event|0|||
161681200|NCT04419610|583886133|FG000|Overall Study|discharged early|1|||
161547828|NCT00313911|583396139|FG001|Overall Study|Lost to Follow-up|14|||
161547829|NCT00313911|583396138|FG000|Overall Study|Withdrawal by Subject|39|||
161547830|NCT00313911|583396139|FG001|Overall Study|Withdrawal by Subject|12|||
161595185|NCT04065841|583570025|FG000|Overall Study|Withdrawal by Subject|1|||
161595186|NCT04065841|583570026|FG001|Overall Study|Withdrawal by Subject|1|||
161595187|NCT04065841|583570027|FG002|Overall Study|Withdrawal by Subject|2|||
161595188|NCT04065841|583570028|FG003|Overall Study|Withdrawal by Subject|0|||
161595189|NCT01420237|583570032|FG000|Overall Study|Death|13|||
161681201|NCT04419610|583886134|FG001|Overall Study|discharged early|1|||
161681202|NCT01439282|583886135|FG000|Overall Study|Adverse Event|5|||
161681203|NCT01439282|583886136|FG001|Overall Study|Adverse Event|0|||
161681204|NCT01439282|583886135|FG000|Overall Study|Withdrawal by Subject|2|||
161830113|NCT02400476|584418113|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
161830114|NCT02400476|584418114|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161830115|NCT02400476|584418115|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161681205|NCT01439282|583886136|FG001|Overall Study|Withdrawal by Subject|0|||
161681206|NCT01439282|583886135|FG000|Overall Study|Other|1|||
161681207|NCT01439282|583886136|FG001|Overall Study|Other|1|||
161547831|NCT00313911|583396138|FG000|Overall Study|Did not meet age criteria|1|||
161547832|NCT00313911|583396139|FG001|Overall Study|Did not meet age criteria|1|||
161547833|NCT01987596|583396140|FG000|Overall Study|Physician Decision|1|||
161547834|NCT01987596|583396141|FG001|Overall Study|Physician Decision|0|||
161547835|NCT01987596|583396140|FG000|Overall Study|Progressive Disease; missing all period|0|||
161547836|NCT01987596|583396141|FG001|Overall Study|Progressive Disease; missing all period|1|||
161547837|NCT02632786|583396142|FG000|Overall Study|Adverse Event|2|||
161547838|NCT02632786|583396143|FG001|Overall Study|Adverse Event|1|||
161547839|NCT02632786|583396142|FG000|Overall Study|Death|3|||
161547840|NCT02632786|583396143|FG001|Overall Study|Death|2|||
161547841|NCT02632786|583396142|FG000|Overall Study|Physician Decision|5|||
161547842|NCT02632786|583396143|FG001|Overall Study|Physician Decision|4|||
161547843|NCT02632786|583396142|FG000|Overall Study|Withdrawal by Subject|1|||
161547844|NCT02632786|583396143|FG001|Overall Study|Withdrawal by Subject|0|||
161547845|NCT00709592|583396144|FG000|Overall Study|Unable to proceed to transplant|0|||
161547846|NCT00709592|583396145|FG001|Overall Study|Unable to proceed to transplant|1|||
161547847|NCT00451217|583396146|FG000|Overall Study|Lost to Follow-up|0|||
161547848|NCT00451217|583396147|FG001|Overall Study|Lost to Follow-up|1|||
161547849|NCT00451217|583396148|FG002|Overall Study|Lost to Follow-up|1|||
161547850|NCT00451217|583396149|FG003|Overall Study|Lost to Follow-up|1|||
161547851|NCT00451217|583396146|FG000|Overall Study|Withdrawal by Subject|1|||
161547852|NCT00451217|583396147|FG001|Overall Study|Withdrawal by Subject|0|||
161547853|NCT00451217|583396148|FG002|Overall Study|Withdrawal by Subject|0|||
161547854|NCT00451217|583396149|FG003|Overall Study|Withdrawal by Subject|0|||
161547855|NCT00451217|583396146|FG000|Overall Study|Not Treated|1|||
161547856|NCT00451217|583396147|FG001|Overall Study|Not Treated|1|||
161547857|NCT00451217|583396148|FG002|Overall Study|Not Treated|3|||
161547858|NCT00451217|583396149|FG003|Overall Study|Not Treated|4|||
161547859|NCT03154359|583396152|FG000|Overall Study|Adverse Event|1|||
161547860|NCT03154359|583396152|FG000|Overall Study|Lack of Efficacy|2|||
161547861|NCT03154359|583396152|FG000|Overall Study|Lost to Follow-up|3|||
161547862|NCT03154359|583396152|FG000|Overall Study|Physician Decision|3|||
161547863|NCT03154359|583396152|FG000|Overall Study|Protocol Violation|4|||
161547864|NCT03154359|583396152|FG000|Overall Study|Withdrawal by Subject|5|||
161547865|NCT03154359|583396152|FG000|Overall Study|Disruption of study due to COVID-19|4|||
161547866|NCT04250337|583396153|FG000|Overall Study|Adverse Event|0|||
161547867|NCT04250337|583396154|FG001|Overall Study|Adverse Event|3|||
161547868|NCT04250337|583396153|FG000|Overall Study|Lack of Efficacy|1|||
161547869|NCT04250337|583396154|FG001|Overall Study|Lack of Efficacy|3|||
161547870|NCT04250337|583396153|FG000|Overall Study|Physician Decision|1|||
161547871|NCT04250337|583396154|FG001|Overall Study|Physician Decision|0|||
161547872|NCT04250337|583396153|FG000|Overall Study|Protocol Deviation|2|||
161547873|NCT04250337|583396154|FG001|Overall Study|Protocol Deviation|2|||
161547874|NCT04250337|583396153|FG000|Overall Study|Withdrawal by Subject|4|||
161547875|NCT04250337|583396154|FG001|Overall Study|Withdrawal by Subject|3|||
161547876|NCT00569803|583396155|FG000|Overall Study|Lost to Follow-up|1|||
161547877|NCT00569803|583396156|FG001|Overall Study|Lost to Follow-up|0|||
161681208|NCT04179734|583886140|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
161681209|NCT04179734|583886141|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
161681210|NCT04179734|583886140|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
161681211|NCT04179734|583886141|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
161547878|NCT00569803|583396157|FG002|Overall Study|Lost to Follow-up|0|||
161681212|NCT03197493|583886143|FG000|Overall Study|Withdrawal by Subject|5|||
161681213|NCT00054704|583886144|FG000|Overall Study|Lack of Efficacy|2|||
161681214|NCT00054704|583886145|FG001|Overall Study|Lack of Efficacy|3|||
161681215|NCT00054704|583886144|FG000|Overall Study|Adverse Event|3|||
161681216|NCT00054704|583886145|FG001|Overall Study|Adverse Event|1|||
161681217|NCT00054704|583886144|FG000|Overall Study|Lost to Follow-up|0|||
161681218|NCT00054704|583886145|FG001|Overall Study|Lost to Follow-up|1|||
161547879|NCT00569803|583396158|FG003|Overall Study|Lost to Follow-up|0|||
161547880|NCT00569803|583396159|FG004|Overall Study|Lost to Follow-up|0|||
161547881|NCT00569803|583396160|FG005|Overall Study|Lost to Follow-up|0|||
161547882|NCT00569803|583396161|FG006|Overall Study|Lost to Follow-up|0|||
161547883|NCT00569803|583396162|FG007|Overall Study|Lost to Follow-up|0|||
161547884|NCT00569803|583396155|FG000|Overall Study|injection syringe leaked during dosing|0|||
161681219|NCT01469182|583886148|FG000|Overall Study|Adverse Event|21|||
161830116|NCT00124462|584418116|FG000|Overall Study|Lost to Follow-up|3|||
161830117|NCT00124462|584418117|FG001|Overall Study|Lost to Follow-up|3|||
161547885|NCT00569803|583396156|FG001|Overall Study|injection syringe leaked during dosing|0|||
161681220|NCT01469182|583886149|FG001|Overall Study|Adverse Event|3|||
161681221|NCT01469182|583886148|FG000|Overall Study|Lost to Follow-up|3|||
161547886|NCT00569803|583396157|FG002|Overall Study|injection syringe leaked during dosing|0|||
161547887|NCT00569803|583396158|FG003|Overall Study|injection syringe leaked during dosing|1|||
161547888|NCT00569803|583396159|FG004|Overall Study|injection syringe leaked during dosing|0|||
161547889|NCT00569803|583396160|FG005|Overall Study|injection syringe leaked during dosing|0|||
161547890|NCT00569803|583396161|FG006|Overall Study|injection syringe leaked during dosing|0|||
161547891|NCT00569803|583396162|FG007|Overall Study|injection syringe leaked during dosing|0|||
161547892|NCT00569803|583396155|FG000|Overall Study|Withdrawal by Subject|0|||
161547893|NCT00569803|583396156|FG001|Overall Study|Withdrawal by Subject|0|||
161547894|NCT00569803|583396157|FG002|Overall Study|Withdrawal by Subject|0|||
161547895|NCT00569803|583396158|FG003|Overall Study|Withdrawal by Subject|0|||
161547896|NCT00569803|583396159|FG004|Overall Study|Withdrawal by Subject|0|||
161547897|NCT00569803|583396160|FG005|Overall Study|Withdrawal by Subject|0|||
161547898|NCT00569803|583396161|FG006|Overall Study|Withdrawal by Subject|0|||
161547899|NCT00569803|583396162|FG007|Overall Study|Withdrawal by Subject|1|||
161547900|NCT01993823|583396163|FG000|Overall Study|Requested by the patient|6|||
161547901|NCT01993823|583396164|FG001|Overall Study|Requested by the patient|11|||
161547902|NCT01993823|583396163|FG000|Overall Study|Protocol Violation|0|||
161830118|NCT00124462|584418116|FG000|Overall Study|Physician Decision|3|||
161830119|NCT00124462|584418117|FG001|Overall Study|Physician Decision|4|||
161830120|NCT00124462|584418116|FG000|Overall Study|Withdrawal by Subject|4|||
161830121|NCT00124462|584418117|FG001|Overall Study|Withdrawal by Subject|5|||
161830122|NCT00124462|584418116|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
161830123|NCT00124462|584418117|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
161830124|NCT00003531|584418118|FG000|Overall Study|Not evaluable|10|||
161830125|NCT00588731|584418119|FG000|Overall Study|Withdrawal by Subject|3|||
161830126|NCT00588731|584418120|FG001|Overall Study|Withdrawal by Subject|2|||
161830127|NCT00346164|584418121|FG000|Overall Study|Adverse Event|0|||
161830128|NCT00346164|584418122|FG001|Overall Study|Adverse Event|0|||
161830129|NCT00346164|584418123|FG002|Overall Study|Adverse Event|0|||
161830130|NCT00346164|584418124|FG003|Overall Study|Adverse Event|1|||
161830131|NCT00346164|584418121|FG000|Overall Study|Lack of Efficacy|0|||
161830132|NCT00346164|584418122|FG001|Overall Study|Lack of Efficacy|1|||
161547903|NCT01993823|583396164|FG001|Overall Study|Protocol Violation|1|||
161830133|NCT00346164|584418123|FG002|Overall Study|Lack of Efficacy|7|||
161830134|NCT00346164|584418124|FG003|Overall Study|Lack of Efficacy|25|||
161830135|NCT00346164|584418121|FG000|Overall Study|Physician Decision|0|||
161830136|NCT00346164|584418122|FG001|Overall Study|Physician Decision|1|||
161830137|NCT00346164|584418123|FG002|Overall Study|Physician Decision|2|||
161830138|NCT00346164|584418124|FG003|Overall Study|Physician Decision|27|||
161547904|NCT01993823|583396163|FG000|Overall Study|Lost to Follow-up|1|||
161547905|NCT01993823|583396164|FG001|Overall Study|Lost to Follow-up|4|||
161547906|NCT01592695|583396168|FG000|Overall Study|Lost to Follow-up|8|||
161547907|NCT01592695|583396169|FG001|Overall Study|Lost to Follow-up|4|||
161547908|NCT03029780|583396173|FG000|Overall Study|Disease Progression|20|||
161547909|NCT03029780|583396174|FG001|Overall Study|Disease Progression|22|||
161547910|NCT03029780|583396173|FG000|Overall Study|Study Drug Toxicity|15|||
161547911|NCT03029780|583396174|FG001|Overall Study|Study Drug Toxicity|11|||
161547912|NCT03029780|583396173|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
161547913|NCT03029780|583396174|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161547914|NCT03029780|583396173|FG000|Overall Study|Participant request to discontinue study treatment|4|||
161547915|NCT03029780|583396174|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161547916|NCT03029780|583396173|FG000|Overall Study|Maximum clinical benefit|1|||
161547917|NCT03029780|583396174|FG001|Overall Study|Maximum clinical benefit|0|||
161547918|NCT03029780|583396173|FG000|Overall Study|Participant no longer meets study criteria|0|||
161547919|NCT03029780|583396174|FG001|Overall Study|Participant no longer meets study criteria|1|||
161547920|NCT03029780|583396173|FG000|Overall Study|Other reasons|6|||
161547921|NCT03029780|583396174|FG001|Overall Study|Other reasons|6|||
161547922|NCT03029780|583396173|FG000|Overall Study|Not reported|1|||
161547923|NCT03029780|583396174|FG001|Overall Study|Not reported|1|||
161547924|NCT03029780|583396173|FG000|Overall Study|Death|2|||
161547925|NCT03029780|583396174|FG001|Overall Study|Death|6|||
161547926|NCT00178256|583396175|FG000|Overall Study|Adverse Event|2|||
161547927|NCT00178256|583396176|FG001|Overall Study|Adverse Event|0|||
161547928|NCT00178256|583396177|FG002|Overall Study|Adverse Event|0|||
161547929|NCT00178256|583396178|FG003|Overall Study|Adverse Event|0|||
161830139|NCT00346164|584418121|FG000|Overall Study|Protocol Violation|6|||
161830140|NCT00346164|584418122|FG001|Overall Study|Protocol Violation|2|||
161830141|NCT00346164|584418123|FG002|Overall Study|Protocol Violation|10|||
161830142|NCT00346164|584418124|FG003|Overall Study|Protocol Violation|4|||
161830143|NCT00346164|584418121|FG000|Overall Study|Withdrawal by Subject|0|||
161830144|NCT00346164|584418122|FG001|Overall Study|Withdrawal by Subject|0|||
161830145|NCT00346164|584418123|FG002|Overall Study|Withdrawal by Subject|2|||
161547930|NCT00178256|583396175|FG000|Overall Study|Death|0|||
161547931|NCT00178256|583396176|FG001|Overall Study|Death|1|||
161681222|NCT01469182|583886149|FG001|Overall Study|Lost to Follow-up|0|||
161681223|NCT01469182|583886148|FG000|Overall Study|Withdrawal by Subject|4|||
161547932|NCT00178256|583396177|FG002|Overall Study|Death|0|||
161547933|NCT00178256|583396178|FG003|Overall Study|Death|1|||
161547934|NCT00178256|583396175|FG000|Overall Study|Cancer progression|2|||
161547935|NCT00178256|583396176|FG001|Overall Study|Cancer progression|0|||
161547936|NCT00178256|583396177|FG002|Overall Study|Cancer progression|0|||
161547937|NCT00178256|583396178|FG003|Overall Study|Cancer progression|1|||
161547938|NCT03066622|583396179|FG000|Overall Study|Lost to Follow-up|24|||
161547939|NCT03066622|583396180|FG001|Overall Study|Lost to Follow-up|25|||
161547940|NCT03066622|583396179|FG000|Overall Study|Withdrawal by Subject|2|||
161547941|NCT03066622|583396180|FG001|Overall Study|Withdrawal by Subject|1|||
161547942|NCT01763788|583396181|FG000|Overall Study|Lost to Follow-up|0|||
161547943|NCT01763788|583396182|FG001|Overall Study|Lost to Follow-up|0|||
161547944|NCT01763788|583396183|FG002|Overall Study|Lost to Follow-up|1|||
161547945|NCT01763788|583396184|FG003|Overall Study|Lost to Follow-up|0|||
161547946|NCT00641719|583396185|FG000|Overall Study|Lack of Efficacy|1|||
161547947|NCT00641719|583396186|FG001|Overall Study|Lack of Efficacy|2|||
161547948|NCT00641719|583396185|FG000|Overall Study|Adverse Event|24|||
161547949|NCT00641719|583396186|FG001|Overall Study|Adverse Event|29|||
161681224|NCT01469182|583886149|FG001|Overall Study|Withdrawal by Subject|1|||
161681225|NCT01469182|583886148|FG000|Overall Study|Protocol Violation|4|||
161681226|NCT01469182|583886149|FG001|Overall Study|Protocol Violation|2|||
161681227|NCT01469182|583886148|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
161681228|NCT01469182|583886149|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
161681229|NCT02236520|583886151|FG000|Overall Study|Physician Decision|0|||
161681230|NCT02236520|583886152|FG001|Overall Study|Physician Decision|5|||
161681231|NCT02236520|583886153|FG002|Overall Study|Physician Decision|0|||
161681232|NCT02236520|583886154|FG003|Overall Study|Physician Decision|0|||
161547950|NCT00641719|583396185|FG000|Overall Study|Withdrawal by Subject|4|||
161595190|NCT01420237|583570032|FG000|Overall Study|Withdrawal by Subject|41|||
161681233|NCT02236520|583886151|FG000|Overall Study|Withdrawal by Subject|1|||
161681234|NCT02236520|583886152|FG001|Overall Study|Withdrawal by Subject|0|||
161681235|NCT02236520|583886153|FG002|Overall Study|Withdrawal by Subject|0|||
161681236|NCT02236520|583886154|FG003|Overall Study|Withdrawal by Subject|1|||
161681237|NCT02236520|583886151|FG000|Overall Study|Pregnancy|1|||
161681238|NCT02236520|583886152|FG001|Overall Study|Pregnancy|0|||
161681239|NCT02236520|583886153|FG002|Overall Study|Pregnancy|0|||
161681240|NCT02236520|583886154|FG003|Overall Study|Pregnancy|0|||
161681241|NCT01785160|583886155|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
161681242|NCT01785160|583886155|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
161681243|NCT01033734|583886156|FG000|Overall Study|Withdrawal by Subject|1|||
161595191|NCT01420237|583570032|FG000|Overall Study|Lost to Follow-up|32|||
161681244|NCT01360554|583886159|FG000|Overall Study|Death|359|||
161681245|NCT01360554|583886160|FG001|Overall Study|Death|371|||
161681246|NCT01360554|583886159|FG000|Overall Study|Lost to Follow-up|4|||
161681247|NCT01360554|583886160|FG001|Overall Study|Lost to Follow-up|4|||
161681248|NCT01360554|583886159|FG000|Overall Study|Withdrawal by Subject|23|||
161681249|NCT01360554|583886160|FG001|Overall Study|Withdrawal by Subject|24|||
161681250|NCT01360554|583886159|FG000|Overall Study|Study terminated by sponsor|49|||
161681251|NCT01360554|583886160|FG001|Overall Study|Study terminated by sponsor|37|||
161681252|NCT01360554|583886159|FG000|Overall Study|Other, not specified|1|||
161547951|NCT00641719|583396186|FG001|Overall Study|Withdrawal by Subject|4|||
161547952|NCT00641719|583396185|FG000|Overall Study|Reason Not Specified|1|||
161547953|NCT00641719|583396186|FG001|Overall Study|Reason Not Specified|2|||
161547954|NCT03321006|583396187|FG000|Overall Study|Death|1|||
161547955|NCT03321006|583396188|FG001|Overall Study|Death|0|||
161547956|NCT03321006|583396187|FG000|Overall Study|Lack of Efficacy|1|||
161595192|NCT01420237|583570032|FG000|Overall Study|Adverse Event|10|||
161595193|NCT01420237|583570032|FG000|Overall Study|Investigative Site Termination|43|||
161595194|NCT01420237|583570032|FG000|Overall Study|Censored because study device not implanted|21|||
161595195|NCT01420237|583570032|FG000|Overall Study|Censored because surgery not performed|2|||
161595196|NCT01420237|583570032|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
161595197|NCT01420237|583570032|FG000|Overall Study|Sponsor terminated study early|127|||
161595198|NCT05269667|583570033|FG000|Overall Study|Study Terminated by Sponsor|4|||
161595199|NCT04313972|583570036|FG000|Overall Study|Withdrawal by Subject|0|||
161595200|NCT04313972|583570037|FG001|Overall Study|Withdrawal by Subject|1|||
161595201|NCT05201079|583570051|FG000|Overall Study|Adverse Event|7|||
161595202|NCT05201079|583570052|FG001|Overall Study|Adverse Event|11|||
161681253|NCT01360554|583886160|FG001|Overall Study|Other, not specified|0|||
161547957|NCT03321006|583396188|FG001|Overall Study|Lack of Efficacy|0|||
161547958|NCT03303469|583396189|FG000|Overall Study|Lost to Follow-up|2|||
161547959|NCT00885352|583396192|FG000|Overall Study|Adverse Event|2|||
161681254|NCT01360554|583886159|FG000|Overall Study|Randomized but not treated.|3|||
161681255|NCT01360554|583886160|FG001|Overall Study|Randomized but not treated.|3|||
161681256|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
161681257|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
161681258|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161547960|NCT00885352|583396193|FG001|Overall Study|Adverse Event|3|||
161547961|NCT00885352|583396192|FG000|Overall Study|Lost to Follow-up|2|||
161547962|NCT00885352|583396193|FG001|Overall Study|Lost to Follow-up|2|||
161547963|NCT00885352|583396192|FG000|Overall Study|Physician Decision|0|||
161547964|NCT00885352|583396193|FG001|Overall Study|Physician Decision|3|||
161547965|NCT00885352|583396192|FG000|Overall Study|Protocol Violation|0|||
161547966|NCT00885352|583396193|FG001|Overall Study|Protocol Violation|2|||
161547967|NCT00885352|583396192|FG000|Overall Study|Withdrawal by Subject|1|||
161547968|NCT00885352|583396193|FG001|Overall Study|Withdrawal by Subject|5|||
161547969|NCT00885352|583396192|FG000|Overall Study|Contradiction to study medication|0|||
161547970|NCT00885352|583396193|FG001|Overall Study|Contradiction to study medication|2|||
161547971|NCT00885352|583396192|FG000|Overall Study|Excluded medication|2|||
161547972|NCT00885352|583396193|FG001|Overall Study|Excluded medication|2|||
161547973|NCT00885352|583396192|FG000|Overall Study|Lab abnormalities|1|||
161547974|NCT00885352|583396193|FG001|Overall Study|Lab abnormalities|1|||
161547975|NCT03560258|583396194|FG000|Overall Study|Lost to Follow-up|3|||
161547976|NCT03560258|583396195|FG001|Overall Study|Lost to Follow-up|0|||
161547977|NCT03560258|583396196|FG002|Overall Study|Lost to Follow-up|0|||
161547978|NCT03560258|583396194|FG000|Overall Study|Protocol Violation|0|||
161547979|NCT03560258|583396195|FG001|Overall Study|Protocol Violation|1|||
161547980|NCT03560258|583396196|FG002|Overall Study|Protocol Violation|0|||
161547981|NCT03560258|583396194|FG000|Overall Study|Withdrawal by Subject|0|||
161547982|NCT03560258|583396195|FG001|Overall Study|Withdrawal by Subject|0|||
161547983|NCT03560258|583396196|FG002|Overall Study|Withdrawal by Subject|1|||
161547984|NCT01460160|583396197|FG000|Treatment Phase|Lack of Efficacy|3|||
161547985|NCT01460160|583396197|FG000|Treatment Phase|Study Drug Toxicity|2|||
161547986|NCT01460160|583396197|FG000|Treatment Phase|Adverse Event|8|||
161547987|NCT01460160|583396197|FG000|Treatment Phase|Withdrawal by Subject|4|||
161547988|NCT01460160|583396197|FG000|Treatment Phase|Death|2|||
161547989|NCT01460160|583396197|FG000|Treatment Phase|Other reasons|9|||
161547990|NCT01460160|583396197|FG000|Follow-up Phase|Withdrawal by Subject|4|||
161547991|NCT01460160|583396197|FG000|Follow-up Phase|Death|14|||
161547992|NCT01460160|583396197|FG000|Follow-up Phase|Lost to Follow-up|7|||
161547993|NCT01460160|583396197|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
161547994|NCT01460160|583396197|FG000|Follow-up Phase|Other and not reported reasons|5|||
161547995|NCT02006121|583396198|FG000|Double Blind Phase|Adverse Event|6|||
161547996|NCT02006121|583396199|FG001|Double Blind Phase|Adverse Event|0|||
161547997|NCT02006121|583396198|FG000|Double Blind Phase|Lack of Efficacy|1|||
161547998|NCT02006121|583396199|FG001|Double Blind Phase|Lack of Efficacy|16|||
161547999|NCT02006121|583396198|FG000|Double Blind Phase|Withdrawal by Subject|3|||
161548000|NCT02006121|583396199|FG001|Double Blind Phase|Withdrawal by Subject|4|||
161548001|NCT02006121|583396198|FG000|Double Blind Phase|Non-compliance with study drug|1|||
161548002|NCT02006121|583396199|FG001|Double Blind Phase|Non-compliance with study drug|3|||
161548003|NCT02006121|583396198|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
161548004|NCT02006121|583396199|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
161548005|NCT02006121|583396198|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
161548006|NCT02006121|583396199|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
161548007|NCT02006121|583396198|FG000|Open Label Phase|Adverse Event|15|||
161548008|NCT02006121|583396199|FG001|Open Label Phase|Adverse Event|0|||
161548009|NCT02006121|583396198|FG000|Open Label Phase|Lack of Efficacy|2|||
161548010|NCT02006121|583396199|FG001|Open Label Phase|Lack of Efficacy|0|||
161548011|NCT02006121|583396198|FG000|Open Label Phase|Protocol Violation|2|||
161548012|NCT02006121|583396199|FG001|Open Label Phase|Protocol Violation|0|||
161548013|NCT02006121|583396198|FG000|Open Label Phase|Withdrawal by Subject|3|||
161548014|NCT02006121|583396199|FG001|Open Label Phase|Withdrawal by Subject|0|||
161548015|NCT02006121|583396198|FG000|Open Label Phase|Non-compliance with study drug|3|||
161548016|NCT02006121|583396199|FG001|Open Label Phase|Non-compliance with study drug|0|||
161548017|NCT04498247|583396203|FG000|Overall Study|Lost to Follow-up|0|||
161548018|NCT04498247|583396204|FG001|Overall Study|Lost to Follow-up|0|||
161548019|NCT04498247|583396205|FG002|Overall Study|Lost to Follow-up|0|||
161548020|NCT04498247|583396206|FG003|Overall Study|Lost to Follow-up|1|||
161548021|NCT04498247|583396207|FG004|Overall Study|Lost to Follow-up|0|||
161548022|NCT04498247|583396208|FG005|Overall Study|Lost to Follow-up|0|||
161548023|NCT04498247|583396209|FG006|Overall Study|Lost to Follow-up|0|||
161548024|NCT04498247|583396210|FG007|Overall Study|Lost to Follow-up|0|||
161548025|NCT04498247|583396203|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
161548026|NCT04498247|583396204|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548027|NCT04498247|583396205|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548028|NCT04498247|583396206|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548029|NCT04498247|583396207|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548030|NCT04498247|583396208|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548031|NCT04498247|583396209|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548032|NCT04498247|583396210|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
161548033|NCT04498247|583396203|FG000|Overall Study|Withdrawal by Subject|0|||
161548034|NCT04498247|583396204|FG001|Overall Study|Withdrawal by Subject|8|||
161548035|NCT04498247|583396205|FG002|Overall Study|Withdrawal by Subject|0|||
161681259|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161681260|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
161548036|NCT04498247|583396206|FG003|Overall Study|Withdrawal by Subject|7|||
161548037|NCT04498247|583396207|FG004|Overall Study|Withdrawal by Subject|0|||
161548038|NCT04498247|583396208|FG005|Overall Study|Withdrawal by Subject|0|||
161548039|NCT04498247|583396209|FG006|Overall Study|Withdrawal by Subject|1|||
161548040|NCT04498247|583396210|FG007|Overall Study|Withdrawal by Subject|0|||
161548041|NCT04498247|583396203|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
161548042|NCT04498247|583396204|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
161548043|NCT04498247|583396205|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
161548044|NCT04498247|583396206|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
161548045|NCT04498247|583396207|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
161548046|NCT04498247|583396208|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
161548047|NCT04498247|583396209|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
161548048|NCT04498247|583396210|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
161548049|NCT01003184|583396211|FG000|Overall Study|Adverse Event|12|||
161548050|NCT01003184|583396212|FG001|Overall Study|Adverse Event|5|||
161548051|NCT01003184|583396211|FG000|Overall Study|Lost to Follow-up|1|||
161681261|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161681262|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
161681263|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161681264|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
161681265|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161681266|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161681267|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
161548052|NCT01003184|583396212|FG001|Overall Study|Lost to Follow-up|0|||
161548053|NCT01003184|583396211|FG000|Overall Study|Loss of glucose control|1|||
161548054|NCT01003184|583396212|FG001|Overall Study|Loss of glucose control|1|||
161548055|NCT01003184|583396211|FG000|Overall Study|Protocol Violation|3|||
161548056|NCT01003184|583396212|FG001|Overall Study|Protocol Violation|0|||
161548057|NCT01003184|583396211|FG000|Overall Study|Withdrawal by Subject|1|||
161548058|NCT01003184|583396212|FG001|Overall Study|Withdrawal by Subject|6|||
161548059|NCT01003184|583396211|FG000|Overall Study|Physician Decision|1|||
161548060|NCT01003184|583396212|FG001|Overall Study|Physician Decision|0|||
161548061|NCT00557622|583396213|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
161548062|NCT00557622|583396214|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
161548063|NCT00557622|583396213|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
161548064|NCT00557622|583396214|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
161548065|NCT00557622|583396213|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
161548066|NCT00557622|583396214|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
161548067|NCT02765490|583396215|FG000|Overall Study|Lost to Follow-up|1|||
161548068|NCT02765490|583396216|FG001|Overall Study|Lost to Follow-up|1|||
161548069|NCT02765490|583396215|FG000|Overall Study|Other|0|||
161548070|NCT02765490|583396216|FG001|Overall Study|Other|1|||
161548071|NCT02765490|583396215|FG000|Overall Study|Death|0|||
161548072|NCT02765490|583396216|FG001|Overall Study|Death|1|||
161548073|NCT03237013|583396217|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
161548074|NCT03237013|583396218|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
161548075|NCT03237013|583396219|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
161548076|NCT05266963|583396220|FG000|Drug Period A|Withdrawal by Subject|0|||
161548077|NCT05266963|583396221|FG001|Drug Period A|Withdrawal by Subject|1|||
161548078|NCT00152971|583396222|FG000|Overall Study|Adverse Event|12|||
161548079|NCT00152971|583396223|FG001|Overall Study|Adverse Event|10|||
161548080|NCT00152971|583396224|FG002|Overall Study|Adverse Event|9|||
161548081|NCT00152971|583396222|FG000|Overall Study|Protocol Violation|10|||
161548082|NCT00152971|583396223|FG001|Overall Study|Protocol Violation|11|||
161548083|NCT00152971|583396224|FG002|Overall Study|Protocol Violation|8|||
161548084|NCT00152971|583396222|FG000|Overall Study|Lost to Follow-up|17|||
161548085|NCT00152971|583396223|FG001|Overall Study|Lost to Follow-up|14|||
161548086|NCT00152971|583396224|FG002|Overall Study|Lost to Follow-up|13|||
161548087|NCT00152971|583396222|FG000|Overall Study|Withdrawal by Subject|9|||
161548088|NCT00152971|583396223|FG001|Overall Study|Withdrawal by Subject|8|||
161548089|NCT00152971|583396224|FG002|Overall Study|Withdrawal by Subject|14|||
161548090|NCT00152971|583396222|FG000|Overall Study|Other|3|||
161548091|NCT00152971|583396223|FG001|Overall Study|Other|5|||
161548092|NCT00152971|583396224|FG002|Overall Study|Other|5|||
161548093|NCT00152971|583396222|FG000|Treatment|Adverse Event|49|||
161548094|NCT00152971|583396223|FG001|Treatment|Adverse Event|40|||
161548095|NCT00152971|583396224|FG002|Treatment|Adverse Event|54|||
161548096|NCT00152971|583396222|FG000|Treatment|Protocol Violation|8|||
161548097|NCT00152971|583396223|FG001|Treatment|Protocol Violation|6|||
161548098|NCT00152971|583396224|FG002|Treatment|Protocol Violation|10|||
161548099|NCT00152971|583396222|FG000|Treatment|Lost to Follow-up|1|||
161548100|NCT00152971|583396223|FG001|Treatment|Lost to Follow-up|2|||
161548101|NCT00152971|583396224|FG002|Treatment|Lost to Follow-up|1|||
161548102|NCT00152971|583396222|FG000|Treatment|Withdrawal by Subject|4|||
161548103|NCT00152971|583396223|FG001|Treatment|Withdrawal by Subject|4|||
161548104|NCT00152971|583396224|FG002|Treatment|Withdrawal by Subject|5|||
161548105|NCT00152971|583396222|FG000|Treatment|Other|9|||
161548106|NCT00152971|583396223|FG001|Treatment|Other|11|||
161548107|NCT00152971|583396224|FG002|Treatment|Other|10|||
161548108|NCT04091360|583396225|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548109|NCT04091360|583396226|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548110|NCT04091360|583396227|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548111|NCT04091360|583396228|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548112|NCT04091360|583396229|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548113|NCT04091360|583396230|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548114|NCT04091360|583396231|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548115|NCT04091360|583396232|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161548116|NCT04091360|583396233|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
161548117|NCT04091360|583396234|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
161548118|NCT04091360|583396225|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548119|NCT04091360|583396226|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548120|NCT04091360|583396227|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548121|NCT04091360|583396228|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548122|NCT04091360|583396229|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161830146|NCT00346164|584418124|FG003|Overall Study|Withdrawal by Subject|0|||
161830147|NCT00346164|584418121|FG000|Overall Study|Ineligible|11|||
161830148|NCT00346164|584418122|FG001|Overall Study|Ineligible|2|||
161830149|NCT00346164|584418123|FG002|Overall Study|Ineligible|2|||
161830150|NCT00346164|584418124|FG003|Overall Study|Ineligible|23|||
161830151|NCT00346164|584418121|FG000|Overall Study|Refusal of further protocol therapy|0|||
161830152|NCT00346164|584418122|FG001|Overall Study|Refusal of further protocol therapy|1|||
161830153|NCT00346164|584418123|FG002|Overall Study|Refusal of further protocol therapy|3|||
161830154|NCT00346164|584418124|FG003|Overall Study|Refusal of further protocol therapy|15|||
161830155|NCT00346164|584418121|FG000|Overall Study|Inability to start week 16 tx on time|0|||
161830156|NCT00346164|584418122|FG001|Overall Study|Inability to start week 16 tx on time|0|||
161830157|NCT00346164|584418123|FG002|Overall Study|Inability to start week 16 tx on time|0|||
161830158|NCT00346164|584418124|FG003|Overall Study|Inability to start week 16 tx on time|11|||
161830159|NCT01684878|584418125|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
161830160|NCT01684878|584418126|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
161830161|NCT01684878|584418127|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
161830162|NCT01684878|584418128|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
161830163|NCT01684878|584418125|FG000|Part 1: Safety Run in Phase|Death|15|||
161830164|NCT01684878|584418126|FG001|Part 1: Safety Run in Phase|Death|20|||
161830165|NCT01684878|584418127|FG002|Part 1: Safety Run in Phase|Death|0|||
161830166|NCT01684878|584418128|FG003|Part 1: Safety Run in Phase|Death|0|||
161830167|NCT01684878|584418125|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161830168|NCT01684878|584418126|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
161830169|NCT01684878|584418127|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161595203|NCT05201079|583570051|FG000|Overall Study|Death|1|||
161595204|NCT05201079|583570052|FG001|Overall Study|Death|1|||
161595205|NCT05201079|583570051|FG000|Overall Study|Lack of Efficacy|0|||
161595206|NCT05201079|583570052|FG001|Overall Study|Lack of Efficacy|2|||
161595207|NCT05201079|583570051|FG000|Overall Study|Lost to Follow-up|0|||
161595208|NCT05201079|583570052|FG001|Overall Study|Lost to Follow-up|1|||
161595209|NCT05201079|583570051|FG000|Overall Study|Physician Decision|1|||
161595210|NCT05201079|583570052|FG001|Overall Study|Physician Decision|1|||
161595211|NCT05201079|583570051|FG000|Overall Study|Protocol Violation|1|||
161595212|NCT05201079|583570052|FG001|Overall Study|Protocol Violation|0|||
161595213|NCT05201079|583570051|FG000|Overall Study|Withdrawal by Subject|1|||
161595214|NCT05201079|583570052|FG001|Overall Study|Withdrawal by Subject|0|||
161595215|NCT05201079|583570051|FG000|Overall Study|Forbidden medication|9|||
161595216|NCT05201079|583570052|FG001|Overall Study|Forbidden medication|5|||
161595217|NCT05201079|583570051|FG000|Overall Study|Transfer to another hospital|0|||
161595218|NCT05201079|583570052|FG001|Overall Study|Transfer to another hospital|1|||
161595219|NCT05201079|583570051|FG000|Overall Study|Clinical condition|1|||
161595220|NCT05201079|583570052|FG001|Overall Study|Clinical condition|0|||
161595221|NCT05201079|583570051|FG000|Overall Study|SAE and sepsis|1|||
161595222|NCT05201079|583570052|FG001|Overall Study|SAE and sepsis|0|||
161595223|NCT05281562|583570059|FG000|Overall Study|Ineligible patient|1|||
161595224|NCT05281562|583570060|FG001|Overall Study|Ineligible patient|0|||
161595225|NCT05792085|583570061|FG000|Overall Study|Death|0|||
161595226|NCT05792085|583570062|FG001|Overall Study|Death|0|||
161595227|NCT05792085|583570063|FG002|Overall Study|Death|0|||
161595228|NCT05792085|583570064|FG003|Overall Study|Death|0|||
161595229|NCT05792085|583570065|FG004|Overall Study|Death|1|||
161595230|NCT05977530|583570072|FG000|Overall Study|Withdrawal by Subject|1|||
161595231|NCT05977530|583570072|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
161595232|NCT04524442|583570073|FG000|Overall Study|Subject Decision|1|||
161595233|NCT04898673|583570076|FG000|Overall Study|Screenfail|1|||
161595234|NCT04898673|583570077|FG001|Overall Study|Screenfail|0|||
161595235|NCT04797897|583570078|FG000|Overall Study|Study Termination by Sponsor|1|||
161595236|NCT04797897|583570079|FG001|Overall Study|Study Termination by Sponsor|1|||
161595237|NCT05526430|583570084|FG000|Overall Study|Withdrawal by Subject|0|||
161595238|NCT05526430|583570085|FG001|Overall Study|Withdrawal by Subject|2|||
161595239|NCT05526430|583570086|FG002|Overall Study|Withdrawal by Subject|0|||
161595240|NCT05526430|583570087|FG003|Overall Study|Withdrawal by Subject|0|||
161595241|NCT02601313|583570088|FG000|Overall Study|Death|2|||
161595242|NCT02601313|583570089|FG001|Overall Study|Death|41|||
161595243|NCT02601313|583570090|FG002|Overall Study|Death|6|||
161595244|NCT02601313|583570088|FG000|Overall Study|Enrolled but never treated|0|||
161595245|NCT02601313|583570089|FG001|Overall Study|Enrolled but never treated|6|||
161595246|NCT02601313|583570090|FG002|Overall Study|Enrolled but never treated|3|||
161595247|NCT02601313|583570088|FG000|Overall Study|Enrolled, did not initiate AC|4|||
161595248|NCT02601313|583570089|FG001|Overall Study|Enrolled, did not initiate AC|0|||
161595249|NCT02601313|583570090|FG002|Overall Study|Enrolled, did not initiate AC|0|||
161595250|NCT02601313|583570088|FG000|Overall Study|Full consent withdrawal|0|||
161595251|NCT02601313|583570089|FG001|Overall Study|Full consent withdrawal|3|||
161595252|NCT02601313|583570090|FG002|Overall Study|Full consent withdrawal|2|||
161595253|NCT02601313|583570088|FG000|Overall Study|Lost to Follow-up|0|||
161595254|NCT02601313|583570089|FG001|Overall Study|Lost to Follow-up|1|||
161548123|NCT04091360|583396230|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548124|NCT04091360|583396231|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
161548125|NCT04091360|583396232|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
161548126|NCT04091360|583396233|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548127|NCT04091360|583396234|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
161548128|NCT04091360|583396225|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548129|NCT04091360|583396226|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548130|NCT04091360|583396227|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548131|NCT04091360|583396228|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548132|NCT04091360|583396229|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548133|NCT04091360|583396230|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548134|NCT04091360|583396231|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
161548135|NCT04091360|583396232|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548136|NCT04091360|583396233|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
161548137|NCT04091360|583396234|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
161548138|NCT01320735|583396235|FG000|Overall Study|Adverse Event|3|||
161548139|NCT01320735|583396235|FG000|Overall Study|Withdrawal by Subject|3|||
161548140|NCT01320735|583396235|FG000|Overall Study|Lost to Follow-up|13|||
161548141|NCT01320735|583396235|FG000|Overall Study|Administrative Reason|6|||
161548142|NCT01320735|583396235|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
161548143|NCT01320735|583396235|FG000|Overall Study|Protocol Violation|1|||
161548144|NCT01320735|583396235|FG000|Overall Study|Other|1|||
161548145|NCT01320735|583396235|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
161548146|NCT01320735|583396235|FG000|Overall Study|Investigator Unable to be Contacted|17|||
161548147|NCT04599101|583396236|FG000|Overall Study|Lost to Follow-up|5|||
161548148|NCT04599101|583396237|FG001|Overall Study|Lost to Follow-up|5|||
161548149|NCT05952297|583396238|FG000|Overall Study|Withdrawal by Subject|1|||
161548150|NCT05952297|583396239|FG001|Overall Study|Withdrawal by Subject|0|||
161548151|NCT02875834|583396251|FG000|Open-label Phase|Withdrawal by Subject|3|||
161548152|NCT02875834|583396252|FG001|Open-label Phase|Withdrawal by Subject|0|||
161548153|NCT02875834|583396253|FG002|Open-label Phase|Withdrawal by Subject|0|||
161548154|NCT02875834|583396254|FG003|Open-label Phase|Withdrawal by Subject|0|||
161548155|NCT02875834|583396251|FG000|Open-label Phase|(Not collected)|4|||
161548156|NCT02875834|583396252|FG001|Open-label Phase|(Not collected)|0|||
161548157|NCT02875834|583396253|FG002|Open-label Phase|(Not collected)|0|||
161548158|NCT02875834|583396254|FG003|Open-label Phase|(Not collected)|0|||
161548159|NCT02875834|583396251|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
161548160|NCT02875834|583396252|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
161548161|NCT02875834|583396253|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
161548162|NCT02875834|583396254|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
161548163|NCT02875834|583396251|FG000|Randomized Treatment Phase|Protocol Violation|0|||
161548164|NCT02875834|583396252|FG001|Randomized Treatment Phase|Protocol Violation|2|||
161548165|NCT02875834|583396253|FG002|Randomized Treatment Phase|Protocol Violation|0|||
161548166|NCT02875834|583396254|FG003|Randomized Treatment Phase|Protocol Violation|0|||
161548167|NCT02875834|583396251|FG000|Randomized Treatment Phase|(Not collected)|0|||
161548168|NCT02875834|583396252|FG001|Randomized Treatment Phase|(Not collected)|9|||
161548169|NCT02875834|583396253|FG002|Randomized Treatment Phase|(Not collected)|10|||
161548170|NCT02875834|583396254|FG003|Randomized Treatment Phase|(Not collected)|9|||
161548171|NCT01302938|583396255|FG000|Overall Study|Withdrawal by Subject|1|||
161548172|NCT01302938|583396256|FG001|Overall Study|Withdrawal by Subject|0|||
161548173|NCT01302938|583396255|FG000|Overall Study|Adverse Event|1|||
161548174|NCT01302938|583396256|FG001|Overall Study|Adverse Event|0|||
161548175|NCT00539279|583396258|FG000|Treatment|Withdrawal by Subject|10|||
161548176|NCT00539279|583396259|FG001|Treatment|Withdrawal by Subject|8|||
161548177|NCT00539279|583396258|FG000|Treatment|Death|1|||
161548178|NCT00539279|583396259|FG001|Treatment|Death|0|||
161548179|NCT00539279|583396258|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
161548180|NCT00539279|583396259|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
161548181|NCT00539279|583396258|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
161548182|NCT00539279|583396259|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
161548183|NCT01811563|583397796|FG000|Overall Study|Lost to Follow-up|5|||
161595255|NCT02601313|583570090|FG002|Overall Study|Lost to Follow-up|1|||
161595256|NCT03701763|583570095|FG000|Placebo-controlled Phase|Adverse Event|1|||
161548184|NCT01811563|583397797|FG001|Overall Study|Lost to Follow-up|2|||
161548185|NCT01811563|583397796|FG000|Overall Study|Incorrect Randomization procedure|0|||
161548186|NCT01811563|583397797|FG001|Overall Study|Incorrect Randomization procedure|1|||
161548187|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
161548188|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
161548189|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
161548190|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
161595257|NCT03701763|583570096|FG001|Placebo-controlled Phase|Adverse Event|5|||
161595258|NCT03701763|583570097|FG002|Placebo-controlled Phase|Adverse Event|0|||
161548191|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
161548192|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
161548193|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Death|0|||
161548194|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Death|1|||
161548195|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Adverse Event|11|||
161548196|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Adverse Event|11|||
161548197|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
161548198|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
161548199|NCT02936037|583397798|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161548200|NCT02936037|583397799|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161548201|NCT02936037|583397798|FG000|Open Label Extension|Adverse Event|0|||
161548202|NCT02936037|583397799|FG001|Open Label Extension|Adverse Event|3|||
161548203|NCT02936037|583397798|FG000|Open Label Extension|Other|0|||
161548204|NCT02936037|583397799|FG001|Open Label Extension|Other|3|||
161548205|NCT02936037|583397798|FG000|Open Label Extension|Withdrawal by Subject|0|||
161548206|NCT02936037|583397799|FG001|Open Label Extension|Withdrawal by Subject|4|||
161548207|NCT01267825|583397800|FG000|Overall Study|study terminated. no data collected.|1|||
161548208|NCT01267825|583397801|FG001|Overall Study|study terminated. no data collected.|0|||
161548209|NCT04249336|583397802|FG000|Overall Study|Lost to Follow-up|3|||
161548210|NCT04249336|583397803|FG001|Overall Study|Lost to Follow-up|3|||
161548211|NCT04249336|583397804|FG002|Overall Study|Lost to Follow-up|3|||
161548212|NCT04249336|583397805|FG003|Overall Study|Lost to Follow-up|3|||
161548213|NCT01189890|583397809|FG000|Overall Study|Adverse Event|3|||
161548214|NCT01189890|583397810|FG001|Overall Study|Adverse Event|4|||
161548215|NCT01189890|583397809|FG000|Overall Study|Lack of Efficacy|7|||
161548216|NCT01189890|583397810|FG001|Overall Study|Lack of Efficacy|2|||
161548217|NCT01189890|583397809|FG000|Overall Study|Lost to Follow-up|1|||
161548218|NCT01189890|583397810|FG001|Overall Study|Lost to Follow-up|7|||
161548219|NCT01189890|583397809|FG000|Overall Study|Protocol Violation|1|||
161548220|NCT01189890|583397810|FG001|Overall Study|Protocol Violation|5|||
161548221|NCT01189890|583397809|FG000|Overall Study|Withdrawal by Subject|15|||
161548222|NCT01189890|583397810|FG001|Overall Study|Withdrawal by Subject|11|||
161548223|NCT01189890|583397809|FG000|Overall Study|Non Compliance|0|||
161548224|NCT01189890|583397810|FG001|Overall Study|Non Compliance|1|||
161548225|NCT01189890|583397809|FG000|Overall Study|Physician Decision|5|||
161548226|NCT01189890|583397810|FG001|Overall Study|Physician Decision|4|||
161548227|NCT01189890|583397809|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
161548228|NCT01189890|583397810|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
161548229|NCT00077636|583397811|FG000|Overall Study|Refused Treatment|9|||
161548230|NCT00077636|583397812|FG001|Overall Study|Refused Treatment|31|||
161548231|NCT00077636|583397811|FG000|Overall Study|Admin|3|||
161548232|NCT00077636|583397812|FG001|Overall Study|Admin|3|||
161548233|NCT00077636|583397811|FG000|Overall Study|Withdrawal by Subject|2|||
161548234|NCT00077636|583397812|FG001|Overall Study|Withdrawal by Subject|2|||
161548235|NCT00077636|583397811|FG000|Overall Study|Adverse Event|17|||
161548236|NCT00077636|583397812|FG001|Overall Study|Adverse Event|34|||
161548237|NCT00077636|583397811|FG000|Overall Study|Protocol Violation|0|||
161548238|NCT00077636|583397812|FG001|Overall Study|Protocol Violation|2|||
161548239|NCT00077636|583397811|FG000|Overall Study|Lost to Follow-up|10|||
161548240|NCT00077636|583397812|FG001|Overall Study|Lost to Follow-up|18|||
161548241|NCT00077636|583397811|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
161548242|NCT00077636|583397812|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
161548243|NCT00068380|583397813|FG000|Overall Study|Withdrawal by Subject|3|||
161548244|NCT00068380|583397813|FG000|Overall Study|Adverse Event|2|||
161548245|NCT01976364|583397814|FG000|Main Study (36 Months)|Adverse Event|63|||
161548246|NCT01976364|583397815|FG001|Main Study (36 Months)|Adverse Event|0|||
161548247|NCT01976364|583397816|FG002|Main Study (36 Months)|Adverse Event|0|||
161595259|NCT03701763|583570098|FG003|Placebo-controlled Phase|Adverse Event|0|||
161595260|NCT03701763|583570095|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
161548248|NCT01976364|583397814|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
161595261|NCT03701763|583570096|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
161548249|NCT01976364|583397815|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
161548250|NCT01976364|583397816|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
161548251|NCT01976364|583397814|FG000|Main Study (36 Months)|Other|13|||
161548252|NCT01976364|583397815|FG001|Main Study (36 Months)|Other|0|||
161548253|NCT01976364|583397816|FG002|Main Study (36 Months)|Other|0|||
161595262|NCT03701763|583570097|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161681268|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
161681269|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
161681270|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
161681271|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
161681272|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
161681273|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
161681274|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
161681275|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
161681276|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
161681277|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
161830170|NCT01684878|584418128|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161681278|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
161681279|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
161681280|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
161681281|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161681282|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161681283|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
161681284|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161681285|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161830171|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
161830172|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
161830173|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
161830174|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
161830175|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
161681286|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681287|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681288|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681289|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681290|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681291|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681292|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161681293|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161681294|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161681295|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161683068|NCT01148537|583891235|FG002|Overall Study|Withdrawal by Subject|2|||
161830176|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
161548254|NCT01976364|583397814|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
161548255|NCT01976364|583397815|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
161548256|NCT01976364|583397816|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
161830177|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
161830178|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
161548257|NCT01976364|583397814|FG000|Main Study (36 Months)|Medication error|1|||
161681296|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161681297|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161681298|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
161681299|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
161681300|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681301|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681302|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681303|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681304|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
161681305|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681306|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161548258|NCT01976364|583397815|FG001|Main Study (36 Months)|Medication error|0|||
161548259|NCT01976364|583397816|FG002|Main Study (36 Months)|Medication error|0|||
161548260|NCT01976364|583397814|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
161548261|NCT01976364|583397815|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
161548262|NCT01976364|583397816|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
161548263|NCT01976364|583397814|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
161548264|NCT01976364|583397815|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
161548265|NCT01976364|583397816|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
161548266|NCT01976364|583397814|FG000|Main Study (36 Months)|Protocol Violation|13|||
161548267|NCT01976364|583397815|FG001|Main Study (36 Months)|Protocol Violation|0|||
161548268|NCT01976364|583397816|FG002|Main Study (36 Months)|Protocol Violation|0|||
161548269|NCT01976364|583397814|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
161548270|NCT01976364|583397815|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
161548271|NCT01976364|583397816|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
161548272|NCT01976364|583397814|FG000|Main Study (36 Months)|Death|5|||
161548273|NCT01976364|583397815|FG001|Main Study (36 Months)|Death|0|||
161548274|NCT01976364|583397816|FG002|Main Study (36 Months)|Death|0|||
161548275|NCT01976364|583397814|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
161548276|NCT01976364|583397815|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
161548277|NCT01976364|583397816|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
161548278|NCT01976364|583397814|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
161548279|NCT01976364|583397815|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
161548280|NCT01976364|583397816|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
161548281|NCT01976364|583397814|FG000|Sub-study (12 Months)|Protocol Violation|0|||
161548282|NCT01976364|583397815|FG001|Sub-study (12 Months)|Protocol Violation|1|||
161548283|NCT01976364|583397816|FG002|Sub-study (12 Months)|Protocol Violation|1|||
161548284|NCT01976364|583397814|FG000|Sub-study (12 Months)|Adverse Event|0|||
161548285|NCT01976364|583397815|FG001|Sub-study (12 Months)|Adverse Event|4|||
161548286|NCT01976364|583397816|FG002|Sub-study (12 Months)|Adverse Event|3|||
161548287|NCT01190215|583397817|FG000|Up to Month 6|Lost to Follow-up|2|||
161548288|NCT01190215|583397818|FG001|Up to Month 6|Lost to Follow-up|0|||
161548289|NCT02960763|583397819|FG000|Step 1|Withdrawal by Subject|10|||
161548290|NCT02960763|583397820|FG001|Step 1|Withdrawal by Subject|8|||
161548291|NCT02960763|583397821|FG002|Step 1|Withdrawal by Subject|13|||
161548292|NCT02960763|583397822|FG003|Step 1|Withdrawal by Subject|0|||
161548293|NCT02960763|583397823|FG004|Step 1|Withdrawal by Subject|0|||
161548294|NCT02960763|583397819|FG000|Step 1|Lost to Follow-up|7|||
161548295|NCT02960763|583397820|FG001|Step 1|Lost to Follow-up|9|||
161548296|NCT02960763|583397821|FG002|Step 1|Lost to Follow-up|12|||
161548297|NCT02960763|583397822|FG003|Step 1|Lost to Follow-up|0|||
161548298|NCT02960763|583397823|FG004|Step 1|Lost to Follow-up|0|||
161548299|NCT02960763|583397819|FG000|Step 1|Death|1|||
161548300|NCT02960763|583397820|FG001|Step 1|Death|1|||
161548301|NCT02960763|583397821|FG002|Step 1|Death|1|||
161548302|NCT02960763|583397822|FG003|Step 1|Death|0|||
161548303|NCT02960763|583397823|FG004|Step 1|Death|0|||
161548304|NCT02960763|583397819|FG000|Step 1|Investigator discretion|1|||
161548305|NCT02960763|583397820|FG001|Step 1|Investigator discretion|0|||
161548306|NCT02960763|583397821|FG002|Step 1|Investigator discretion|1|||
161548307|NCT02960763|583397822|FG003|Step 1|Investigator discretion|0|||
161548308|NCT02960763|583397823|FG004|Step 1|Investigator discretion|0|||
161548309|NCT02960763|583397819|FG000|Step 1|Other|0|||
161548310|NCT02960763|583397820|FG001|Step 1|Other|0|||
161548311|NCT02960763|583397821|FG002|Step 1|Other|1|||
161548312|NCT02960763|583397822|FG003|Step 1|Other|0|||
161548313|NCT02960763|583397823|FG004|Step 1|Other|0|||
161548314|NCT02960763|583397819|FG000|Step 2|Withdrawal by Subject|0|||
161548315|NCT02960763|583397820|FG001|Step 2|Withdrawal by Subject|0|||
161548316|NCT02960763|583397821|FG002|Step 2|Withdrawal by Subject|0|||
161548317|NCT02960763|583397822|FG003|Step 2|Withdrawal by Subject|7|||
161548318|NCT02960763|583397823|FG004|Step 2|Withdrawal by Subject|3|||
161548319|NCT02960763|583397819|FG000|Step 2|Lost to Follow-up|0|||
161548320|NCT02960763|583397820|FG001|Step 2|Lost to Follow-up|0|||
161548321|NCT02960763|583397821|FG002|Step 2|Lost to Follow-up|0|||
161548322|NCT02960763|583397822|FG003|Step 2|Lost to Follow-up|4|||
161548323|NCT02960763|583397823|FG004|Step 2|Lost to Follow-up|1|||
161548324|NCT02960763|583397819|FG000|Step 2|Investigator discretion|0|||
161548325|NCT02960763|583397820|FG001|Step 2|Investigator discretion|0|||
161548326|NCT02960763|583397821|FG002|Step 2|Investigator discretion|0|||
161548327|NCT02960763|583397822|FG003|Step 2|Investigator discretion|0|||
161548328|NCT02960763|583397823|FG004|Step 2|Investigator discretion|1|||
161548329|NCT05340751|583397824|FG000|Overall Study|Physician Decision|3|||
161548330|NCT01014975|583397837|FG000|Overall Study|Withdrawal by Subject|1|||
161548331|NCT01014975|583397838|FG001|Overall Study|Withdrawal by Subject|0|||
161548332|NCT01014975|583397839|FG002|Overall Study|Withdrawal by Subject|1|||
161595263|NCT03701763|583570098|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
161595264|NCT03701763|583570095|FG000|Placebo-controlled Phase|Miscellaneous|2|||
161595265|NCT03701763|583570096|FG001|Placebo-controlled Phase|Miscellaneous|0|||
161595266|NCT03701763|583570097|FG002|Placebo-controlled Phase|Miscellaneous|0|||
161595267|NCT03701763|583570098|FG003|Placebo-controlled Phase|Miscellaneous|0|||
161595268|NCT03701763|583570095|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
161595269|NCT03701763|583570096|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
161595270|NCT03701763|583570097|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
161595271|NCT03701763|583570098|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
161595272|NCT03701763|583570095|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
161595273|NCT03701763|583570096|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
161595274|NCT03701763|583570097|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161595275|NCT03701763|583570098|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
161595276|NCT03701763|583570095|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
161595277|NCT03701763|583570096|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
161595278|NCT03701763|583570097|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161595279|NCT03701763|583570098|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
161595280|NCT03701763|583570095|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161595281|NCT03701763|583570096|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161548333|NCT01014975|583397837|FG000|Overall Study|Death|3|||
161548334|NCT01014975|583397838|FG001|Overall Study|Death|3|||
161548335|NCT01014975|583397839|FG002|Overall Study|Death|4|||
161548336|NCT01014975|583397837|FG000|Overall Study|Lost to Follow-up|0|||
161548337|NCT01014975|583397838|FG001|Overall Study|Lost to Follow-up|0|||
161548338|NCT01014975|583397839|FG002|Overall Study|Lost to Follow-up|1|||
161548339|NCT02961881|583397840|FG000|Overall Study|Adverse Event|1|||
161548340|NCT02961881|583397841|FG001|Overall Study|Adverse Event|2|||
161548341|NCT02961881|583397842|FG002|Overall Study|Adverse Event|2|||
161548342|NCT02961881|583397843|FG003|Overall Study|Adverse Event|0|||
161548343|NCT02961881|583397844|FG004|Overall Study|Adverse Event|1|||
161548344|NCT02961881|583397840|FG000|Overall Study|Participant request|0|||
161548345|NCT02961881|583397841|FG001|Overall Study|Participant request|2|||
161548346|NCT02961881|583397842|FG002|Overall Study|Participant request|0|||
161683069|NCT01148537|583891233|FG000|Overall Study|Adverse Event|2|||
161548347|NCT02961881|583397843|FG003|Overall Study|Participant request|0|||
161548348|NCT02961881|583397844|FG004|Overall Study|Participant request|0|||
161548349|NCT02961881|583397840|FG000|Overall Study|Disease progression|1|||
161548350|NCT02961881|583397841|FG001|Overall Study|Disease progression|0|||
161548351|NCT02961881|583397842|FG002|Overall Study|Disease progression|1|||
161548352|NCT02961881|583397843|FG003|Overall Study|Disease progression|0|||
161548353|NCT02961881|583397844|FG004|Overall Study|Disease progression|0|||
161548354|NCT00636792|583397845|FG000|Overall Study|Adverse Event|16|||
161548355|NCT00636792|583397845|FG000|Overall Study|Physician Decision|7|||
161548356|NCT00636792|583397845|FG000|Overall Study|Progressive Disease|4|||
161548357|NCT00636792|583397845|FG000|Overall Study|Withdrawal by Subject|3|||
161548358|NCT00636792|583397845|FG000|Overall Study|Other|3|||
161548359|NCT01928225|583397846|FG000|Overall Study|Pregnancy|1|||
161548360|NCT01928225|583397847|FG001|Overall Study|Pregnancy|0|||
161548361|NCT01928225|583397846|FG000|Overall Study|basaloid cervical cancer|1|||
161548362|NCT01928225|583397847|FG001|Overall Study|basaloid cervical cancer|0|||
161548363|NCT01928225|583397846|FG000|Overall Study|Lost to Follow-up|1|||
161548364|NCT01928225|583397847|FG001|Overall Study|Lost to Follow-up|3|||
161548365|NCT03101241|583397849|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
161548366|NCT03101241|583397850|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
161548367|NCT03101241|583397849|FG000|Overall Study|Participant withdrew consent|3|||
161548368|NCT03101241|583397850|FG001|Overall Study|Participant withdrew consent|1|||
161548369|NCT03101241|583397849|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
161548370|NCT03101241|583397850|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
161548371|NCT03101241|583397849|FG000|Overall Study|Lost to Follow-up|2|||
161548372|NCT03101241|583397850|FG001|Overall Study|Lost to Follow-up|0|||
161548373|NCT03101241|583397849|FG000|Overall Study|Lack of Efficacy|0|||
161548374|NCT03101241|583397850|FG001|Overall Study|Lack of Efficacy|1|||
161548375|NCT03101241|583397849|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
161548376|NCT03101241|583397850|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
161548377|NCT00669903|583397851|FG000|Overall Study|Adverse Event|0|||
161548378|NCT00669903|583397852|FG001|Overall Study|Adverse Event|1|||
161548379|NCT00669903|583397853|FG002|Overall Study|Adverse Event|3|||
161548380|NCT00669903|583397854|FG003|Overall Study|Adverse Event|1|||
161548381|NCT00669903|583397851|FG000|Overall Study|Withdrawal by Subject|0|||
161548382|NCT00669903|583397852|FG001|Overall Study|Withdrawal by Subject|2|||
161548383|NCT00669903|583397853|FG002|Overall Study|Withdrawal by Subject|2|||
161548384|NCT00669903|583397854|FG003|Overall Study|Withdrawal by Subject|2|||
161548385|NCT00669903|583397851|FG000|Overall Study|Lost to Follow-up|1|||
161548386|NCT00669903|583397852|FG001|Overall Study|Lost to Follow-up|1|||
161548387|NCT00669903|583397853|FG002|Overall Study|Lost to Follow-up|0|||
161548388|NCT00669903|583397854|FG003|Overall Study|Lost to Follow-up|1|||
161548389|NCT00669903|583397851|FG000|Overall Study|Protocol Violation|0|||
161548390|NCT00669903|583397852|FG001|Overall Study|Protocol Violation|1|||
161548391|NCT00669903|583397853|FG002|Overall Study|Protocol Violation|0|||
161548392|NCT00669903|583397854|FG003|Overall Study|Protocol Violation|0|||
161548393|NCT00251927|583397855|FG000|Overall Study|Adverse Event|3|||
161548394|NCT00251927|583397856|FG001|Overall Study|Adverse Event|15|||
161548395|NCT00251927|583397855|FG000|Overall Study|Lack of Efficacy|22|||
161548396|NCT00251927|583397856|FG001|Overall Study|Lack of Efficacy|16|||
161548397|NCT00251927|583397855|FG000|Overall Study|Lost to Follow-up|22|||
161548398|NCT00251927|583397856|FG001|Overall Study|Lost to Follow-up|8|||
161548399|NCT00251927|583397855|FG000|Overall Study|Protocol Violation|1|||
161548400|NCT00251927|583397856|FG001|Overall Study|Protocol Violation|2|||
161548401|NCT00251927|583397855|FG000|Overall Study|Pregnancy|2|||
161548402|NCT00251927|583397856|FG001|Overall Study|Pregnancy|0|||
161548403|NCT00251927|583397855|FG000|Overall Study|Withdrawal by Subject|40|||
161595282|NCT03701763|583570097|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
161595283|NCT03701763|583570098|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
161595284|NCT03701763|583570095|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161595285|NCT03701763|583570096|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161595286|NCT03701763|583570097|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
161595287|NCT03701763|583570098|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
161595288|NCT03701763|583570095|FG000|Apremilast Extension Phase|Adverse Event|0|||
161595289|NCT03701763|583570096|FG001|Apremilast Extension Phase|Adverse Event|0|||
161595290|NCT03701763|583570097|FG002|Apremilast Extension Phase|Adverse Event|3|||
161548404|NCT00251927|583397856|FG001|Overall Study|Withdrawal by Subject|25|||
161548405|NCT00251927|583397855|FG000|Overall Study|Study-specific discont. achieved|13|||
161595291|NCT03701763|583570098|FG003|Apremilast Extension Phase|Adverse Event|1|||
161595292|NCT03701763|583570095|FG000|Apremilast Extension Phase|Miscellaneous|0|||
161548406|NCT00251927|583397856|FG001|Overall Study|Study-specific discont. achieved|2|||
161548407|NCT00251927|583397855|FG000|Overall Study|Study procedure non-compliance|5|||
161548408|NCT00251927|583397856|FG001|Overall Study|Study procedure non-compliance|6|||
161548409|NCT01678820|583397857|FG000|Overall Study|Study Terminated by Sponsor|45|||
161595293|NCT03701763|583570096|FG001|Apremilast Extension Phase|Miscellaneous|0|||
161595294|NCT03701763|583570097|FG002|Apremilast Extension Phase|Miscellaneous|2|||
161595295|NCT03701763|583570098|FG003|Apremilast Extension Phase|Miscellaneous|1|||
161595296|NCT03701763|583570095|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
161595297|NCT03701763|583570096|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
161595298|NCT03701763|583570097|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
161595299|NCT03701763|583570098|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
161595300|NCT03701763|583570095|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161595301|NCT03701763|583570096|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161595302|NCT03701763|583570097|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
161595303|NCT03701763|583570098|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
161595304|NCT03701763|583570095|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
161595305|NCT03701763|583570096|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
161595306|NCT03701763|583570097|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
161595307|NCT03701763|583570098|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
161595308|NCT03701763|583570095|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161595309|NCT03701763|583570096|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161595310|NCT03701763|583570097|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
161595311|NCT03701763|583570098|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161595312|NCT03701763|583570095|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
161595313|NCT03701763|583570096|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
161595314|NCT03701763|583570097|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
161595315|NCT03701763|583570098|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
161595316|NCT03701763|583570095|FG000|14-Week Observational Follow-up Phase|Other|0|||
161595317|NCT03701763|583570096|FG001|14-Week Observational Follow-up Phase|Other|0|||
161595318|NCT03701763|583570097|FG002|14-Week Observational Follow-up Phase|Other|1|||
161595319|NCT03701763|583570098|FG003|14-Week Observational Follow-up Phase|Other|0|||
161595320|NCT03701763|583570095|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161595321|NCT03701763|583570096|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161595322|NCT03701763|583570097|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161595323|NCT03701763|583570098|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
161595324|NCT03701763|583570095|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161595325|NCT03701763|583570096|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161595326|NCT03701763|583570097|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161595327|NCT03701763|583570098|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
161595328|NCT04437615|583570105|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
161595329|NCT04828005|583570106|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
161595330|NCT04828005|583570107|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161595331|NCT04828005|583570108|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161595332|NCT04828005|583570109|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161595333|NCT04828005|583570106|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
161595334|NCT04828005|583570107|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
161595335|NCT04828005|583570108|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
161595336|NCT04828005|583570109|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
161595337|NCT04828005|583570106|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161595338|NCT04828005|583570107|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161595339|NCT04828005|583570108|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
161595340|NCT04828005|583570109|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161595341|NCT04828005|583570106|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161595342|NCT04828005|583570107|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161595343|NCT04828005|583570108|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
161595344|NCT04828005|583570109|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
161595345|NCT04828005|583570106|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161595346|NCT04828005|583570107|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161595347|NCT04828005|583570108|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161595348|NCT04828005|583570109|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
161595349|NCT04828005|583570106|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161595350|NCT04828005|583570107|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161595351|NCT04828005|583570108|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
161595352|NCT04828005|583570109|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161595353|NCT04828005|583570106|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
161595354|NCT04828005|583570107|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
161595355|NCT04828005|583570108|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
161595356|NCT04828005|583570109|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
161595357|NCT04828005|583570106|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161595358|NCT04828005|583570107|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161595359|NCT04828005|583570108|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161595360|NCT04828005|583570109|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
161681307|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681308|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681309|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681310|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681311|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
161681312|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681313|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681314|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681315|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681316|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681317|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
161681318|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681319|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681320|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681321|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681322|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681323|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
161681324|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681325|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681326|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681327|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681328|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681329|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
161681330|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681331|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681332|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681333|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681334|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681335|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681336|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681337|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
161681338|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681339|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681340|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681341|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681342|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681343|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
161681344|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681345|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681346|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681347|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681348|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681349|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681350|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
161681351|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681352|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681353|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681354|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681355|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681356|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
161830179|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Death|0|||
161830180|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Death|0|||
161830181|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Death|62|||
161830182|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Death|68|||
161830183|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
161830184|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
161830185|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
161830186|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
161830187|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
161830188|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
161830189|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
161830190|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
161830191|NCT02087176|584418132|FG000|Overall Study|Withdrawal by Subject|1|||
161830192|NCT02087176|584418132|FG000|Overall Study|Death|10|||
161830193|NCT02087176|584418132|FG000|Overall Study|Censored|19|||
161830194|NCT02087176|584418132|FG000|Overall Study|Study Terminated by Sponsor|2|||
161830195|NCT02927834|584418133|FG000|Overall Study|Lost to Follow-up|1|||
161830196|NCT02927834|584418134|FG001|Overall Study|Lost to Follow-up|2|||
161830197|NCT02927834|584418135|FG002|Overall Study|Lost to Follow-up|2|||
161830198|NCT03812991|584418137|FG000|Overall Study|Lost to Follow-up|3|||
161830199|NCT03812991|584418138|FG001|Overall Study|Lost to Follow-up|1|||
161830200|NCT03942211|584418139|FG000|Overall Study|Death|1|||
161830201|NCT03942211|584418140|FG001|Overall Study|Death|0|||
161830202|NCT03942211|584418139|FG000|Overall Study|Study terminated by sponsor|5|||
161830203|NCT03942211|584418140|FG001|Overall Study|Study terminated by sponsor|3|||
161595361|NCT04828005|583570106|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161595362|NCT04828005|583570107|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161595363|NCT04828005|583570108|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161595364|NCT04828005|583570109|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
161595365|NCT05579899|583571641|FG000|Overall Study|Lost to Follow-up|3|||
161595366|NCT05579899|583571642|FG001|Overall Study|Lost to Follow-up|1|||
161595367|NCT05579899|583571641|FG000|Overall Study|Adverse Event|0|||
161595368|NCT05579899|583571642|FG001|Overall Study|Adverse Event|3|||
161595369|NCT05579899|583571641|FG000|Overall Study|Pregnancy|0|||
161595370|NCT05579899|583571642|FG001|Overall Study|Pregnancy|1|||
161681357|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161830204|NCT03942211|584418139|FG000|Overall Study|Adverse Event|0|||
161830205|NCT03942211|584418140|FG001|Overall Study|Adverse Event|1|||
161830206|NCT01148225|584418141|FG000|Overall Study|Other|185|||
161595371|NCT05579899|583571641|FG000|Overall Study|Withdrawal by Subject|0|||
161595372|NCT05579899|583571642|FG001|Overall Study|Withdrawal by Subject|3|||
161595373|NCT03339713|583571646|FG000|Overall Study|Lost to Follow-up|2|||
161595374|NCT03339713|583571647|FG001|Overall Study|Lost to Follow-up|1|||
161595375|NCT03339713|583571646|FG000|Overall Study|Protocol Violation|1|||
161595376|NCT03339713|583571647|FG001|Overall Study|Protocol Violation|0|||
161830207|NCT01955044|584418142|FG000|Overall Study|Death|1|||
161830208|NCT01955044|584418143|FG001|Overall Study|Death|1|||
161830209|NCT01955044|584418144|FG002|Overall Study|Death|0|||
161830210|NCT00925301|584418148|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161830211|NCT00925301|584418149|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
161830212|NCT00925301|584418150|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161830213|NCT00925301|584418151|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161830214|NCT00925301|584418148|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161830215|NCT00925301|584418149|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
161830216|NCT00925301|584418150|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161830217|NCT00925301|584418151|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161830218|NCT00925301|584418148|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161830219|NCT00925301|584418149|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161830220|NCT00925301|584418150|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
161595377|NCT03339713|583571646|FG000|Overall Study|Withdrawal by Subject|1|||
161595378|NCT03339713|583571647|FG001|Overall Study|Withdrawal by Subject|1|||
161595379|NCT05540665|583571648|FG000|Overall Study|Study terminated by sponsor|6|||
161595380|NCT05540665|583571649|FG001|Overall Study|Study terminated by sponsor|6|||
161595381|NCT05540665|583571650|FG002|Overall Study|Study terminated by sponsor|7|||
161595382|NCT03462030|583571651|FG000|Overall Study|Withdrawal by Subject|1|||
161595383|NCT03462030|583571652|FG001|Overall Study|Withdrawal by Subject|1|||
161595384|NCT03381196|583571653|FG000|Overall Study|Withdrawal by Subject|7|||
161595385|NCT03381196|583571654|FG001|Overall Study|Withdrawal by Subject|7|||
161595386|NCT03381196|583571653|FG000|Overall Study|Other|0|||
161595387|NCT03381196|583571654|FG001|Overall Study|Other|1|||
161595388|NCT03381196|583571653|FG000|Overall Study|Lost to Follow-up|5|||
161595389|NCT03381196|583571654|FG001|Overall Study|Lost to Follow-up|4|||
161595390|NCT03381196|583571653|FG000|Overall Study|Death|0|||
161595391|NCT03381196|583571654|FG001|Overall Study|Death|1|||
161595392|NCT03381196|583571653|FG000|Overall Study|Adverse Event|1|||
161595393|NCT03381196|583571654|FG001|Overall Study|Adverse Event|0|||
161595394|NCT03381196|583571653|FG000|Overall Study|Randomized, not treated|3|||
161595395|NCT03381196|583571654|FG001|Overall Study|Randomized, not treated|6|||
161595396|NCT02675751|583571655|FG000|Overall Study|Lost to Follow-up|16|||
161595397|NCT03371381|583571656|FG000|Overall Study|Death|5|||
161595398|NCT03371381|583571656|FG000|Overall Study|Study terminated by sponsor|3|||
161595399|NCT03371381|583571656|FG000|Overall Study|Other|4|||
161595400|NCT03628924|583571658|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
161595401|NCT03628924|583571659|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161595402|NCT03628924|583571660|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161595403|NCT03628924|583571661|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161595404|NCT03628924|583571662|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161595405|NCT03628924|583571663|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161595406|NCT03628924|583571664|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161595407|NCT03628924|583571658|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161595408|NCT03628924|583571659|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161595409|NCT03628924|583571660|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
161595410|NCT03628924|583571661|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161595411|NCT03628924|583571662|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161595412|NCT03628924|583571663|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161595413|NCT03628924|583571664|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161595414|NCT03628924|583571658|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
161595415|NCT03628924|583571659|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
161595416|NCT03628924|583571660|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
161595417|NCT03628924|583571661|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161595418|NCT03628924|583571662|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161595419|NCT03628924|583571663|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161595420|NCT03628924|583571664|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161595421|NCT03628924|583571658|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161595422|NCT03628924|583571659|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
161595423|NCT03628924|583571660|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161830221|NCT00925301|584418151|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161595424|NCT03628924|583571661|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161595425|NCT03628924|583571662|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161595426|NCT03628924|583571663|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161595427|NCT03628924|583571664|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161595428|NCT03628924|583571658|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
161595429|NCT03628924|583571659|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161595430|NCT03628924|583571660|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
161595431|NCT03628924|583571661|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161595432|NCT03628924|583571662|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161595433|NCT03628924|583571663|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161595434|NCT03628924|583571664|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161595435|NCT03628924|583571658|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161595436|NCT03628924|583571659|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161595437|NCT03628924|583571660|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161595438|NCT03628924|583571661|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161595439|NCT03628924|583571662|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161595440|NCT03628924|583571663|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
161595441|NCT03628924|583571664|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161595442|NCT03628924|583571658|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161595443|NCT03628924|583571659|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161595444|NCT03628924|583571660|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161595445|NCT03628924|583571661|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
161595446|NCT03628924|583571662|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161595447|NCT03628924|583571663|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
161595448|NCT03628924|583571664|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
161595449|NCT03628924|583571658|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161595450|NCT03628924|583571659|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161595451|NCT03628924|583571660|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161595452|NCT03628924|583571661|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161595453|NCT03628924|583571662|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161595454|NCT03628924|583571663|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161595455|NCT03628924|583571664|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161595456|NCT03628924|583571658|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161595457|NCT03628924|583571659|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161595458|NCT03628924|583571660|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161595459|NCT03628924|583571661|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
161595460|NCT03628924|583571662|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
161595461|NCT03628924|583571663|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
161595462|NCT03628924|583571664|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
161595463|NCT03628924|583571658|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161595464|NCT03628924|583571659|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161595465|NCT03628924|583571660|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161595466|NCT03628924|583571661|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161595467|NCT03628924|583571662|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
161595468|NCT03628924|583571663|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
161595469|NCT03628924|583571664|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
161595470|NCT02268253|583571665|FG000|Stage 1|Withdrawal by Subject|1|||
161595471|NCT02268253|583571666|FG001|Stage 1|Withdrawal by Subject|0|||
161595472|NCT02268253|583571667|FG002|Stage 1|Withdrawal by Subject|0|||
161595473|NCT02268253|583571668|FG003|Stage 1|Withdrawal by Subject|0|||
161595474|NCT02268253|583571669|FG004|Stage 1|Withdrawal by Subject|0|||
161595475|NCT02268253|583571670|FG005|Stage 1|Withdrawal by Subject|0|||
161595476|NCT02268253|583571671|FG006|Stage 1|Withdrawal by Subject|0|||
161595477|NCT02268253|583571665|FG000|Stage 1|Death|0|||
161595478|NCT02268253|583571666|FG001|Stage 1|Death|2|||
161595479|NCT02268253|583571667|FG002|Stage 1|Death|2|||
161595480|NCT02268253|583571668|FG003|Stage 1|Death|2|||
161595481|NCT02268253|583571669|FG004|Stage 1|Death|1|||
161595482|NCT02268253|583571670|FG005|Stage 1|Death|1|||
161595483|NCT02268253|583571671|FG006|Stage 1|Death|0|||
161830222|NCT00925301|584418148|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
161830223|NCT00925301|584418149|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
161830224|NCT00925301|584418150|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
161830225|NCT00925301|584418151|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
161830226|NCT00925301|584418148|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161830227|NCT00925301|584418149|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161830228|NCT00925301|584418150|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161595484|NCT02268253|583571665|FG000|Stage 2|Disease Recurrence/ Progression|0|||
161595485|NCT02268253|583571666|FG001|Stage 2|Disease Recurrence/ Progression|0|||
161595486|NCT02268253|583571667|FG002|Stage 2|Disease Recurrence/ Progression|1|||
161595487|NCT02268253|583571668|FG003|Stage 2|Disease Recurrence/ Progression|0|||
161595488|NCT02268253|583571669|FG004|Stage 2|Disease Recurrence/ Progression|0|||
161595489|NCT02268253|583571670|FG005|Stage 2|Disease Recurrence/ Progression|0|||
161595490|NCT02268253|583571671|FG006|Stage 2|Disease Recurrence/ Progression|0|||
161595491|NCT02268253|583571665|FG000|Stage 2|Withdrawal by Subject|0|||
161595492|NCT02268253|583571666|FG001|Stage 2|Withdrawal by Subject|0|||
161595493|NCT02268253|583571667|FG002|Stage 2|Withdrawal by Subject|2|||
161595494|NCT02268253|583571668|FG003|Stage 2|Withdrawal by Subject|0|||
161595495|NCT02268253|583571669|FG004|Stage 2|Withdrawal by Subject|0|||
161595496|NCT02268253|583571670|FG005|Stage 2|Withdrawal by Subject|2|||
161595497|NCT02268253|583571671|FG006|Stage 2|Withdrawal by Subject|0|||
161595498|NCT02268253|583571665|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161595499|NCT02268253|583571666|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161595500|NCT02268253|583571667|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
161595501|NCT02268253|583571668|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161595502|NCT02268253|583571669|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161595503|NCT02268253|583571670|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
161595504|NCT02268253|583571671|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161595505|NCT02268253|583571665|FG000|Stage 2|Death|0|||
161595506|NCT02268253|583571666|FG001|Stage 2|Death|0|||
161595507|NCT02268253|583571667|FG002|Stage 2|Death|19|||
161595508|NCT02268253|583571668|FG003|Stage 2|Death|0|||
161595509|NCT02268253|583571669|FG004|Stage 2|Death|0|||
161595510|NCT02268253|583571670|FG005|Stage 2|Death|20|||
161595511|NCT02268253|583571671|FG006|Stage 2|Death|1|||
161595512|NCT02268253|583571665|FG000|Stage 2|Lost to Follow-up|0|||
161595513|NCT02268253|583571666|FG001|Stage 2|Lost to Follow-up|0|||
161595514|NCT02268253|583571667|FG002|Stage 2|Lost to Follow-up|0|||
161595515|NCT02268253|583571668|FG003|Stage 2|Lost to Follow-up|0|||
161595516|NCT02268253|583571669|FG004|Stage 2|Lost to Follow-up|0|||
161595517|NCT02268253|583571670|FG005|Stage 2|Lost to Follow-up|4|||
161595518|NCT02268253|583571671|FG006|Stage 2|Lost to Follow-up|0|||
161595519|NCT02268253|583571665|FG000|Stage 2|Transferred to Hospice|0|||
161595520|NCT02268253|583571666|FG001|Stage 2|Transferred to Hospice|0|||
161595521|NCT02268253|583571667|FG002|Stage 2|Transferred to Hospice|0|||
161595522|NCT02268253|583571668|FG003|Stage 2|Transferred to Hospice|0|||
161595523|NCT02268253|583571669|FG004|Stage 2|Transferred to Hospice|0|||
161595524|NCT02268253|583571670|FG005|Stage 2|Transferred to Hospice|2|||
161595525|NCT02268253|583571671|FG006|Stage 2|Transferred to Hospice|0|||
161595526|NCT02268253|583571665|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
161595527|NCT02268253|583571666|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
161595528|NCT02268253|583571667|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
161595529|NCT02268253|583571668|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
161595530|NCT02268253|583571669|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
161595531|NCT02268253|583571670|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
161595532|NCT02268253|583571671|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
161595533|NCT02268253|583571665|FG000|Stage 3A|Withdrawal by Subject|0|||
161830229|NCT00925301|584418151|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
161595534|NCT02268253|583571666|FG001|Stage 3A|Withdrawal by Subject|0|||
161595535|NCT02268253|583571667|FG002|Stage 3A|Withdrawal by Subject|2|||
161595536|NCT02268253|583571668|FG003|Stage 3A|Withdrawal by Subject|0|||
161595537|NCT02268253|583571669|FG004|Stage 3A|Withdrawal by Subject|0|||
161595538|NCT02268253|583571670|FG005|Stage 3A|Withdrawal by Subject|0|||
161595539|NCT02268253|583571671|FG006|Stage 3A|Withdrawal by Subject|0|||
161595540|NCT02268253|583571665|FG000|Stage 3A|Physician Decision|0|||
161595541|NCT02268253|583571666|FG001|Stage 3A|Physician Decision|0|||
161595542|NCT02268253|583571667|FG002|Stage 3A|Physician Decision|2|||
161595543|NCT02268253|583571668|FG003|Stage 3A|Physician Decision|0|||
161595544|NCT02268253|583571669|FG004|Stage 3A|Physician Decision|0|||
161595545|NCT02268253|583571670|FG005|Stage 3A|Physician Decision|0|||
161595546|NCT02268253|583571671|FG006|Stage 3A|Physician Decision|0|||
161595547|NCT02268253|583571665|FG000|Stage 3A|Study Terminated by Sponsor|0|||
161595548|NCT02268253|583571666|FG001|Stage 3A|Study Terminated by Sponsor|0|||
161595549|NCT02268253|583571667|FG002|Stage 3A|Study Terminated by Sponsor|2|||
161595550|NCT02268253|583571668|FG003|Stage 3A|Study Terminated by Sponsor|0|||
161595551|NCT02268253|583571669|FG004|Stage 3A|Study Terminated by Sponsor|0|||
161595552|NCT02268253|583571670|FG005|Stage 3A|Study Terminated by Sponsor|0|||
161595553|NCT02268253|583571671|FG006|Stage 3A|Study Terminated by Sponsor|0|||
161595554|NCT02268253|583571665|FG000|Stage 3A|Lost to Follow-up|0|||
161595555|NCT02268253|583571666|FG001|Stage 3A|Lost to Follow-up|0|||
161595556|NCT02268253|583571667|FG002|Stage 3A|Lost to Follow-up|1|||
161595557|NCT02268253|583571668|FG003|Stage 3A|Lost to Follow-up|0|||
161595558|NCT02268253|583571669|FG004|Stage 3A|Lost to Follow-up|0|||
161595559|NCT02268253|583571670|FG005|Stage 3A|Lost to Follow-up|0|||
161595560|NCT02268253|583571671|FG006|Stage 3A|Lost to Follow-up|0|||
161595561|NCT02268253|583571665|FG000|Stage 3A|Death|0|||
161595562|NCT02268253|583571666|FG001|Stage 3A|Death|0|||
161595563|NCT02268253|583571667|FG002|Stage 3A|Death|5|||
161595564|NCT02268253|583571668|FG003|Stage 3A|Death|0|||
161595565|NCT02268253|583571669|FG004|Stage 3A|Death|0|||
161595566|NCT02268253|583571670|FG005|Stage 3A|Death|0|||
161595567|NCT02268253|583571671|FG006|Stage 3A|Death|0|||
161595568|NCT05714761|583571672|FG000|Overall Study|Lost to Follow-up|3|||
161595569|NCT05714761|583571672|FG000|Overall Study|Withdrawal by Subject|3|||
161595570|NCT05714761|583571672|FG000|Overall Study|unblinding of sensor data|1|||
161595571|NCT05714761|583571672|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
161595572|NCT05714761|583571672|FG000|Overall Study|did not return second CGM sensor|4|||
161595573|NCT05672069|583571673|FG000|Overall Study|Implant removal|1|||
161595574|NCT05672069|583571673|FG000|Overall Study|Lost to Follow-up|2|||
161595575|NCT05949788|583571674|FG000|Overall Study|severe birth deformity|2|||
161595576|NCT05949788|583571675|FG001|Overall Study|severe birth deformity|7|||
161595577|NCT05949788|583571674|FG000|Overall Study|twin-twin transfusion syndrome|2|||
161595578|NCT05949788|583571675|FG001|Overall Study|twin-twin transfusion syndrome|7|||
161595579|NCT05949788|583571674|FG000|Overall Study|neonatal hemolytic disease|3|||
161595580|NCT05949788|583571675|FG001|Overall Study|neonatal hemolytic disease|8|||
161595581|NCT05949788|583571674|FG000|Overall Study|death within 14 days after birth|2|||
161681358|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681359|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681360|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681361|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681362|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681363|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
161681364|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161681365|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
161681366|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
161681367|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
161681368|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161830230|NCT00925301|584418148|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161830231|NCT00925301|584418149|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161830232|NCT00925301|584418150|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161830233|NCT00925301|584418151|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
161830234|NCT00925301|584418148|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161830235|NCT00925301|584418149|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161595582|NCT05949788|583571675|FG001|Overall Study|death within 14 days after birth|6|||
161830236|NCT00925301|584418150|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161830237|NCT00925301|584418151|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
161595583|NCT05949788|583571674|FG000|Overall Study|transfer to another hospital|2|||
161595584|NCT05949788|583571675|FG001|Overall Study|transfer to another hospital|6|||
161595585|NCT05213390|583571676|FG000|Overall Study|Withdrawal by Subject|2|||
161595586|NCT05213390|583571676|FG000|Overall Study|Lost to Follow-up|12|||
161595587|NCT05213390|583571676|FG000|Overall Study|Protocol Violation|9|||
161595588|NCT02191618|583571684|FG000|Overall Study|Withdrawal by Subject|3|||
161595589|NCT02191618|583571684|FG000|Overall Study|Missed Visit|4|||
161595590|NCT03031470|583571686|FG000|Overall Study|Adverse Event|3|||
161595591|NCT03031470|583571687|FG001|Overall Study|Adverse Event|0|||
161595592|NCT03031470|583571686|FG000|Overall Study|Death|3|||
161595593|NCT03031470|583571687|FG001|Overall Study|Death|1|||
161595594|NCT03031470|583571686|FG000|Overall Study|Lost to Follow-up|1|||
161595595|NCT03031470|583571687|FG001|Overall Study|Lost to Follow-up|1|||
161595596|NCT03031470|583571686|FG000|Overall Study|Withdrawal by Subject|1|||
161595597|NCT03031470|583571687|FG001|Overall Study|Withdrawal by Subject|0|||
161595598|NCT03031470|583571686|FG000|Overall Study|Protocol entry criteria not met|0|||
161595599|NCT03031470|583571687|FG001|Overall Study|Protocol entry criteria not met|1|||
161595600|NCT03031470|583571686|FG000|Overall Study|Cancel the operation|0|||
161595601|NCT03031470|583571687|FG001|Overall Study|Cancel the operation|1|||
161595602|NCT01593917|583571688|FG000|Overall Study|Death|67|||
161595603|NCT01593917|583571688|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
161595604|NCT01593917|583571688|FG000|Overall Study|Withdrawal by Subject|23|||
161595605|NCT01593917|583571688|FG000|Overall Study|Lost to Follow-up|12|||
161595606|NCT01593917|583571688|FG000|Overall Study|Protocol Violation|5|||
161595607|NCT01593917|583571688|FG000|Overall Study|Physician Decision|3|||
161595608|NCT01943409|583571692|FG000|Overall Study|resumed oral/entral|24|||
161595609|NCT01943409|583571693|FG001|Overall Study|resumed oral/entral|20|||
161595610|NCT01943409|583571692|FG000|Overall Study|Protocol Violation|14|||
161595611|NCT01943409|583571693|FG001|Overall Study|Protocol Violation|24|||
161595612|NCT01943409|583571692|FG000|Overall Study|Death|3|||
161595613|NCT01943409|583571693|FG001|Overall Study|Death|1|||
161595614|NCT01943409|583571692|FG000|Overall Study|Withdrawal by Subject|4|||
161595615|NCT01943409|583571693|FG001|Overall Study|Withdrawal by Subject|3|||
161595616|NCT03021096|583571694|FG000|Overall Study|Lost to Follow-up|4|||
161595617|NCT03021096|583571694|FG000|Overall Study|Protocol Violation|2|||
161595618|NCT03216057|583571695|FG000|Overall Study|Lost to Follow-up|2|||
161595619|NCT03216057|583571696|FG001|Overall Study|Lost to Follow-up|2|||
161595620|NCT05126433|583571697|FG000|Overall Study|Withdrawal by Subject|3|||
161595621|NCT05126433|583571698|FG001|Overall Study|Withdrawal by Subject|0|||
161595622|NCT05126433|583571699|FG002|Overall Study|Withdrawal by Subject|4|||
161595623|NCT05126433|583571697|FG000|Overall Study|Death|9|||
161595624|NCT05126433|583571698|FG001|Overall Study|Death|3|||
161595625|NCT05126433|583571699|FG002|Overall Study|Death|5|||
161595626|NCT05126433|583571697|FG000|Overall Study|Study Terminated by sponsor|0|||
161595627|NCT05126433|583571698|FG001|Overall Study|Study Terminated by sponsor|1|||
161595628|NCT05126433|583571699|FG002|Overall Study|Study Terminated by sponsor|2|||
161595629|NCT05126433|583571697|FG000|Overall Study|Progressive Disease|1|||
161595630|NCT05126433|583571698|FG001|Overall Study|Progressive Disease|4|||
161595631|NCT05126433|583571699|FG002|Overall Study|Progressive Disease|3|||
161595632|NCT05126433|583571697|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
161595633|NCT05126433|583571698|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
161595634|NCT05126433|583571699|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
161595635|NCT03907878|583571700|FG000|Treatment Period|Withdrawal by Subject|5|||
161595636|NCT03907878|583571700|FG000|Treatment Period|Adverse Event|4|||
161595637|NCT03907878|583571700|FG000|Treatment Period|Lack of Efficacy|1|||
161595638|NCT03907878|583571700|FG000|Treatment Period|Protocol Violation|1|||
161595639|NCT03907878|583571700|FG000|Follow-up Period|Adverse Event|3|||
161595640|NCT03907878|583571700|FG000|Follow-up Period|Withdrawal by Subject|3|||
161595641|NCT03768505|583571703|FG000|Overall Study|sponsor decision|76|||
161595642|NCT03768505|583571703|FG000|Overall Study|Death|35|||
161595643|NCT03768505|583571703|FG000|Overall Study|Other -Various|30|||
161595644|NCT03768505|583571703|FG000|Overall Study|Withdrawal by Subject|22|||
161595645|NCT03768505|583571703|FG000|Overall Study|Lost to Follow-up|6|||
161595646|NCT02861300|583571707|FG000|Overall Study|Death|0|||
161595647|NCT02861300|583571708|FG001|Overall Study|Death|0|||
161595648|NCT02861300|583571709|FG002|Overall Study|Death|0|||
161595649|NCT02861300|583571710|FG003|Overall Study|Death|0|||
161595650|NCT02861300|583571711|FG004|Overall Study|Death|0|||
161595651|NCT02861300|583571712|FG005|Overall Study|Death|0|||
161595652|NCT02861300|583571713|FG006|Overall Study|Death|24|||
161595653|NCT02861300|583571707|FG000|Overall Study|Delay in treatment|0|||
161595654|NCT02861300|583571708|FG001|Overall Study|Delay in treatment|0|||
161595655|NCT02861300|583571709|FG002|Overall Study|Delay in treatment|0|||
161595656|NCT02861300|583571710|FG003|Overall Study|Delay in treatment|0|||
161595657|NCT02861300|583571711|FG004|Overall Study|Delay in treatment|0|||
161595658|NCT02861300|583571712|FG005|Overall Study|Delay in treatment|1|||
161595659|NCT02861300|583571713|FG006|Overall Study|Delay in treatment|0|||
161595660|NCT02861300|583571707|FG000|Overall Study|Disease Progression|0|||
161595661|NCT02861300|583571708|FG001|Overall Study|Disease Progression|1|||
161595662|NCT02861300|583571709|FG002|Overall Study|Disease Progression|0|||
161595663|NCT02861300|583571710|FG003|Overall Study|Disease Progression|0|||
161595664|NCT02861300|583571711|FG004|Overall Study|Disease Progression|0|||
161595665|NCT02861300|583571712|FG005|Overall Study|Disease Progression|0|||
161595666|NCT02861300|583571713|FG006|Overall Study|Disease Progression|2|||
161595667|NCT02861300|583571707|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
161595668|NCT02861300|583571708|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
161595669|NCT02861300|583571709|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
161595670|NCT02861300|583571710|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
161595671|NCT02861300|583571711|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
161595672|NCT02861300|583571712|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
161595673|NCT02861300|583571713|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
161595674|NCT02861300|583571707|FG000|Overall Study|Clinical Complications|0|||
161595675|NCT02861300|583571708|FG001|Overall Study|Clinical Complications|0|||
161595676|NCT02861300|583571709|FG002|Overall Study|Clinical Complications|0|||
161595677|NCT02861300|583571710|FG003|Overall Study|Clinical Complications|0|||
161595678|NCT02861300|583571711|FG004|Overall Study|Clinical Complications|0|||
161595679|NCT02861300|583571712|FG005|Overall Study|Clinical Complications|0|||
161595680|NCT02861300|583571713|FG006|Overall Study|Clinical Complications|1|||
161595681|NCT03133546|583571720|FG000|Overall Study|Death|46|||
161595682|NCT03133546|583571721|FG001|Overall Study|Death|43|||
161595683|NCT03133546|583571720|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
161595684|NCT03133546|583571721|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
161595685|NCT05034328|583571723|FG000|Overall Study|Protocol Violation|1|||
161595686|NCT05034328|583571724|FG001|Overall Study|Protocol Violation|0|||
161595687|NCT05034328|583571723|FG000|Overall Study|Lost to Follow-up|0|||
161595688|NCT05034328|583571724|FG001|Overall Study|Lost to Follow-up|10|||
161595689|NCT02993159|583571725|FG000|Overall Study|Withdrawal by Subject|1|||
161595690|NCT02993159|583571726|FG001|Overall Study|Withdrawal by Subject|3|||
161595691|NCT02993159|583571725|FG000|Overall Study|Protocol Violation|1|||
161595692|NCT02993159|583571726|FG001|Overall Study|Protocol Violation|0|||
161595693|NCT02993159|583571725|FG000|Overall Study|Opted out of surgery|2|||
161595694|NCT02993159|583571726|FG001|Overall Study|Opted out of surgery|0|||
161595695|NCT02993159|583571725|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161595696|NCT02993159|583571726|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161595697|NCT02993159|583571725|FG000|Overall Study|Physician Decision|0|||
161595698|NCT02993159|583571726|FG001|Overall Study|Physician Decision|1|||
161595699|NCT05399459|583571729|FG000|Overall Study|Randomized but not treated|29|||
161595700|NCT05399459|583571730|FG001|Overall Study|Randomized but not treated|30|||
161595701|NCT05399459|583571731|FG002|Overall Study|Randomized but not treated|38|||
161595702|NCT05399459|583571729|FG000|Overall Study|Lost to Follow-up|1|||
161595703|NCT05399459|583571730|FG001|Overall Study|Lost to Follow-up|0|||
161595704|NCT05399459|583571731|FG002|Overall Study|Lost to Follow-up|0|||
161595705|NCT04992520|583571732|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
161595706|NCT04992520|583571733|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
161595707|NCT04992520|583571734|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
161595708|NCT04992520|583571735|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
161595709|NCT04992520|583571736|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
161595710|NCT04992520|583571737|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
161595711|NCT04992520|583571732|FG000|Part A: First Challenge|Non-compliance|0|||
161595712|NCT04992520|583571733|FG001|Part A: First Challenge|Non-compliance|0|||
161681369|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161681370|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681371|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
161681372|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
161681373|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681374|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681375|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681376|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161681377|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
161595713|NCT04992520|583571734|FG002|Part A: First Challenge|Non-compliance|0|||
161595714|NCT04992520|583571735|FG003|Part A: First Challenge|Non-compliance|1|||
161595715|NCT04992520|583571736|FG004|Part A: First Challenge|Non-compliance|0|||
161595716|NCT04992520|583571737|FG005|Part A: First Challenge|Non-compliance|0|||
161595717|NCT04992520|583571732|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161595718|NCT04992520|583571733|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161595719|NCT04992520|583571734|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
161595720|NCT04992520|583571735|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161595721|NCT04992520|583571736|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161595722|NCT04992520|583571737|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
161595723|NCT04992520|583571732|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161595724|NCT04992520|583571733|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161595725|NCT04992520|583571734|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
161595726|NCT04992520|583571735|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161595727|NCT04992520|583571736|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161595728|NCT04992520|583571737|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161595729|NCT02231164|583571739|FG000|Overall Study|Adverse Event|1|||
161595730|NCT02231164|583571740|FG001|Overall Study|Adverse Event|1|||
161595731|NCT02231164|583571739|FG000|Overall Study|Lack of Efficacy|4|||
161595732|NCT02231164|583571740|FG001|Overall Study|Lack of Efficacy|3|||
161595733|NCT02231164|583571739|FG000|Overall Study|Withdrawal by Subject|1|||
161595734|NCT02231164|583571740|FG001|Overall Study|Withdrawal by Subject|2|||
161595735|NCT03625167|583571741|FG000|Overall Study|Protocol Violation|5|||
161595736|NCT06103188|583571742|FG000|Overall Study|Lost to Follow-up|1|||
161595737|NCT06103188|583571743|FG001|Overall Study|Lost to Follow-up|6|||
161595738|NCT06103188|583571744|FG002|Overall Study|Lost to Follow-up|4|||
161595739|NCT02969707|583571745|FG000|Overall Study|Withdrawal by Subject|6|||
161595740|NCT02969707|583571746|FG001|Overall Study|Withdrawal by Subject|5|||
161595741|NCT02969707|583571745|FG000|Overall Study|Severe anxiety|0|||
161595742|NCT02969707|583571746|FG001|Overall Study|Severe anxiety|1|||
161595743|NCT02969707|583571745|FG000|Overall Study|Positive toxicology screen|0|||
161595744|NCT02969707|583571746|FG001|Overall Study|Positive toxicology screen|2|||
161595745|NCT02969707|583571745|FG000|Overall Study|Claustrophobia|2|||
161595746|NCT02969707|583571746|FG001|Overall Study|Claustrophobia|2|||
161595747|NCT02969707|583571745|FG000|Overall Study|Non-compliance|1|||
161595748|NCT02969707|583571746|FG001|Overall Study|Non-compliance|2|||
161595749|NCT01175356|583571747|FG000|Overall Study|Death|1|||
161595750|NCT01175356|583571747|FG000|Overall Study|Lack of Efficacy|12|||
161595751|NCT01175356|583571747|FG000|Overall Study|Lost to Follow-up|1|||
161595752|NCT01175356|583571747|FG000|Overall Study|Physician Decision|23|||
161595753|NCT01175356|583571747|FG000|Overall Study|Ineligible|1|||
161595754|NCT01175356|583571747|FG000|Overall Study|Treatment Slot Not Available|18|||
161595755|NCT01175356|583571747|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
161595756|NCT01175356|583571747|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
161595757|NCT01175356|583571747|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
161595758|NCT01175356|583571747|FG000|Overall Study|Inadequate stem cell for transplant|1|||
161595759|NCT01175356|583571747|FG000|Overall Study|Initiation other tx prior to completion|9|||
161595760|NCT04103580|583571752|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
161595761|NCT04103580|583571753|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
161595762|NCT04103580|583571752|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
161595763|NCT04103580|583571753|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
161595764|NCT04103580|583571752|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
161595765|NCT04103580|583571753|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
161595766|NCT04103580|583571752|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
161595767|NCT04103580|583571753|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
161595768|NCT04103580|583571752|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
161595769|NCT04103580|583571753|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
161595770|NCT04103580|583571752|FG000|Phase 1 Active Caregiving|Other|3|||
161830238|NCT03043560|584418152|FG000|Overall Study|Discontinued Intervention|1|||
161830239|NCT03043560|584418153|FG001|Overall Study|Discontinued Intervention|2|||
161595771|NCT04103580|583571753|FG001|Phase 1 Active Caregiving|Other|3|||
161595772|NCT04103580|583571752|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
161595773|NCT04103580|583571753|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
161830240|NCT03043560|584418152|FG000|Overall Study|Lost to Follow-up|0|||
161830241|NCT03043560|584418153|FG001|Overall Study|Lost to Follow-up|1|||
161830242|NCT00442546|584418154|FG000|Overall Study|Adverse Event|11|||
161830243|NCT00442546|584418155|FG001|Overall Study|Adverse Event|17|||
161830244|NCT00442546|584418156|FG002|Overall Study|Adverse Event|13|||
161830245|NCT00442546|584418154|FG000|Overall Study|Lost to Follow-up|1|||
161830246|NCT00442546|584418155|FG001|Overall Study|Lost to Follow-up|2|||
161830247|NCT00442546|584418156|FG002|Overall Study|Lost to Follow-up|1|||
161830248|NCT00442546|584418154|FG000|Overall Study|Other|4|||
161830249|NCT00442546|584418155|FG001|Overall Study|Other|9|||
161830250|NCT00442546|584418156|FG002|Overall Study|Other|6|||
161830251|NCT00442546|584418154|FG000|Overall Study|Withdrawal by Subject|5|||
161830252|NCT00442546|584418155|FG001|Overall Study|Withdrawal by Subject|5|||
161830253|NCT00442546|584418156|FG002|Overall Study|Withdrawal by Subject|7|||
161830254|NCT00442546|584418154|FG000|Overall Study|Randomized But Not Treated|5|||
161830255|NCT00442546|584418155|FG001|Overall Study|Randomized But Not Treated|4|||
161681378|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
161681379|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161681380|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
161681381|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161681382|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681383|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
161681384|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681385|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161595774|NCT04103580|583571752|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
161595775|NCT04103580|583571753|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
161595776|NCT04103580|583571752|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
161595777|NCT04103580|583571753|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
161595778|NCT04103580|583571752|FG000|Phase 2 Bereavement|Other|8|||
161595779|NCT04103580|583571753|FG001|Phase 2 Bereavement|Other|6|||
161595780|NCT04568486|583571754|FG000|Overall Study|Withdrawal by Subject|26|||
161595781|NCT04568486|583571754|FG000|Overall Study|Lost to Follow-up|7|||
161595782|NCT04042233|583571755|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
161595783|NCT04042233|583571756|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
161595784|NCT04042233|583571755|FG000|Overall Study|Protocol Violation|0|||
161681386|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
161681387|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681388|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681389|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161830256|NCT00442546|584418156|FG002|Overall Study|Randomized But Not Treated|6|||
161595785|NCT04042233|583571756|FG001|Overall Study|Protocol Violation|2|||
161595786|NCT01210807|583571766|FG000|Overall Study|Lost to Follow-up|1|||
161595787|NCT01210807|583571767|FG001|Overall Study|Lost to Follow-up|2|||
161595788|NCT01210807|583571766|FG000|Overall Study|Not implanted bilaterally|2|||
161595789|NCT01210807|583571767|FG001|Overall Study|Not implanted bilaterally|1|||
161595790|NCT00324805|583571773|FG000|Overall Study|Adverse Event|62|||
161595791|NCT00324805|583571774|FG001|Overall Study|Adverse Event|203|||
161595792|NCT00324805|583571773|FG000|Overall Study|Progression|7|||
161595793|NCT00324805|583571774|FG001|Overall Study|Progression|35|||
161595794|NCT00324805|583571773|FG000|Overall Study|Withdrawal by Subject|51|||
161595795|NCT00324805|583571774|FG001|Overall Study|Withdrawal by Subject|174|||
161595796|NCT00324805|583571773|FG000|Overall Study|Death|6|||
161595797|NCT00324805|583571774|FG001|Overall Study|Death|9|||
161595798|NCT00324805|583571773|FG000|Overall Study|Alternative therapy|4|||
161595799|NCT00324805|583571774|FG001|Overall Study|Alternative therapy|8|||
161595800|NCT00324805|583571773|FG000|Overall Study|Other complicating disease|1|||
161595801|NCT00324805|583571774|FG001|Overall Study|Other complicating disease|9|||
161595802|NCT00324805|583571773|FG000|Overall Study|Other reasons|7|||
161595803|NCT00324805|583571774|FG001|Overall Study|Other reasons|26|||
161595804|NCT00324805|583571773|FG000|Overall Study|Other|0|||
161595805|NCT00324805|583571774|FG001|Overall Study|Other|2|||
161595806|NCT00324805|583571773|FG000|Overall Study|Did not start therapy|12|||
161595807|NCT00324805|583571774|FG001|Overall Study|Did not start therapy|17|||
161548410|NCT01678820|583397858|FG001|Overall Study|Study Terminated by Sponsor|43|||
161548411|NCT01678820|583397859|FG002|Overall Study|Study Terminated by Sponsor|43|||
161548412|NCT01678820|583397857|FG000|Overall Study|Withdrawal by Subject|2|||
161548413|NCT01678820|583397858|FG001|Overall Study|Withdrawal by Subject|5|||
161595808|NCT05496231|583571776|FG000|Overall Study|Adverse Event|1|||
161595809|NCT05496231|583571777|FG001|Overall Study|Adverse Event|1|||
161595810|NCT05496231|583571778|FG002|Overall Study|Adverse Event|0|||
161595811|NCT05496231|583571779|FG003|Overall Study|Adverse Event|4|||
161595812|NCT05496231|583571776|FG000|Overall Study|Withdrawal by Subject|5|||
161830257|NCT01557582|584418158|FG000|Overall Study|Protocol Violation|4|||
161548414|NCT01678820|583397859|FG002|Overall Study|Withdrawal by Subject|2|||
161548415|NCT01678820|583397857|FG000|Overall Study|Protocol Specified Criteria|2|||
161548416|NCT01678820|583397858|FG001|Overall Study|Protocol Specified Criteria|3|||
161548417|NCT01678820|583397859|FG002|Overall Study|Protocol Specified Criteria|1|||
161548418|NCT01678820|583397857|FG000|Overall Study|Adverse Event|2|||
161548419|NCT01678820|583397858|FG001|Overall Study|Adverse Event|2|||
161548420|NCT01678820|583397859|FG002|Overall Study|Adverse Event|2|||
161548421|NCT01678820|583397857|FG000|Overall Study|Lost to Follow-up|7|||
161548422|NCT01678820|583397858|FG001|Overall Study|Lost to Follow-up|2|||
161548423|NCT01678820|583397859|FG002|Overall Study|Lost to Follow-up|2|||
161548424|NCT01678820|583397857|FG000|Overall Study|Non-compliance with study drug|0|||
161548425|NCT01678820|583397858|FG001|Overall Study|Non-compliance with study drug|1|||
161548426|NCT01678820|583397859|FG002|Overall Study|Non-compliance with study drug|0|||
161548427|NCT01678820|583397857|FG000|Overall Study|Physician Decision|0|||
161548428|NCT01678820|583397858|FG001|Overall Study|Physician Decision|0|||
161548429|NCT01678820|583397859|FG002|Overall Study|Physician Decision|1|||
161548430|NCT01678820|583397857|FG000|Overall Study|Protocol Violation|4|||
161595813|NCT05496231|583571777|FG001|Overall Study|Withdrawal by Subject|5|||
161595814|NCT05496231|583571778|FG002|Overall Study|Withdrawal by Subject|4|||
161595815|NCT05496231|583571779|FG003|Overall Study|Withdrawal by Subject|11|||
161595816|NCT05496231|583571776|FG000|Overall Study|Migrated/moved from the study area|3|||
161595817|NCT05496231|583571777|FG001|Overall Study|Migrated/moved from the study area|5|||
161595818|NCT05496231|583571778|FG002|Overall Study|Migrated/moved from the study area|3|||
161595819|NCT05496231|583571779|FG003|Overall Study|Migrated/moved from the study area|3|||
161595820|NCT05496231|583571776|FG000|Overall Study|Lost to Follow-up|13|||
161595821|NCT05496231|583571777|FG001|Overall Study|Lost to Follow-up|6|||
161595822|NCT05496231|583571778|FG002|Overall Study|Lost to Follow-up|11|||
161595823|NCT05496231|583571779|FG003|Overall Study|Lost to Follow-up|6|||
161595824|NCT05496231|583571776|FG000|Overall Study|Other|9|||
161595825|NCT05496231|583571777|FG001|Overall Study|Other|7|||
161595826|NCT05496231|583571778|FG002|Overall Study|Other|7|||
161595827|NCT05496231|583571779|FG003|Overall Study|Other|8|||
161595828|NCT03085810|583571796|FG000|Main Study|Withdrawal by Subject|77|||
161595829|NCT03085810|583571797|FG001|Main Study|Withdrawal by Subject|0|||
161595830|NCT03085810|583571798|FG002|Main Study|Withdrawal by Subject|0|||
161595831|NCT03085810|583571796|FG000|Main Study|Terminated By Sponsor|14|||
161595832|NCT03085810|583571797|FG001|Main Study|Terminated By Sponsor|0|||
161595833|NCT03085810|583571798|FG002|Main Study|Terminated By Sponsor|0|||
161595834|NCT03085810|583571796|FG000|Main Study|Protocol Violation|15|||
161595835|NCT03085810|583571797|FG001|Main Study|Protocol Violation|0|||
161595836|NCT03085810|583571798|FG002|Main Study|Protocol Violation|0|||
161595837|NCT03085810|583571796|FG000|Main Study|Physician Decision|13|||
161595838|NCT03085810|583571797|FG001|Main Study|Physician Decision|0|||
161595839|NCT03085810|583571798|FG002|Main Study|Physician Decision|0|||
161595840|NCT03085810|583571796|FG000|Main Study|Lost to Follow-up|17|||
161595841|NCT03085810|583571797|FG001|Main Study|Lost to Follow-up|0|||
161595842|NCT03085810|583571798|FG002|Main Study|Lost to Follow-up|0|||
161595843|NCT03085810|583571796|FG000|Main Study|Adverse Event|25|||
161595844|NCT03085810|583571797|FG001|Main Study|Adverse Event|0|||
161595845|NCT03085810|583571798|FG002|Main Study|Adverse Event|0|||
161595846|NCT03085810|583571796|FG000|Main Study|Pregnancy|7|||
161595847|NCT03085810|583571797|FG001|Main Study|Pregnancy|0|||
161595848|NCT03085810|583571798|FG002|Main Study|Pregnancy|0|||
161595849|NCT03085810|583571796|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
161595850|NCT03085810|583571797|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
161595851|NCT03085810|583571798|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
161595852|NCT03085810|583571796|FG000|Main Study|Lack of Efficacy|10|||
161595853|NCT03085810|583571797|FG001|Main Study|Lack of Efficacy|0|||
161595854|NCT03085810|583571798|FG002|Main Study|Lack of Efficacy|0|||
161595855|NCT03085810|583571796|FG000|Main Study|Death|12|||
161595856|NCT03085810|583571797|FG001|Main Study|Death|0|||
161595857|NCT03085810|583571798|FG002|Main Study|Death|0|||
161595858|NCT03085810|583571796|FG000|Main Study|Disease progression|1|||
161595859|NCT03085810|583571797|FG001|Main Study|Disease progression|0|||
161595860|NCT03085810|583571798|FG002|Main Study|Disease progression|0|||
161595861|NCT03085810|583571796|FG000|Main Study|Site Closure|3|||
161595862|NCT03085810|583571797|FG001|Main Study|Site Closure|0|||
161595863|NCT03085810|583571798|FG002|Main Study|Site Closure|0|||
161595864|NCT03085810|583571796|FG000|Main Study|Planned pregnancy|17|||
161595865|NCT03085810|583571797|FG001|Main Study|Planned pregnancy|0|||
161595866|NCT03085810|583571798|FG002|Main Study|Planned pregnancy|0|||
161595867|NCT03085810|583571796|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
161595868|NCT03085810|583571797|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
161595869|NCT03085810|583571798|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
161595870|NCT03085810|583571796|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
161595871|NCT03085810|583571797|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
161595872|NCT03085810|583571798|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
161595873|NCT03085810|583571796|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
161595874|NCT03085810|583571797|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
161595875|NCT03085810|583571798|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
161595876|NCT03085810|583571796|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
161595877|NCT03085810|583571797|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
161595878|NCT03085810|583571798|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
161595879|NCT05239455|583571799|FG000|Overall Study|Adverse Event|1|||
161595880|NCT05239455|583571799|FG000|Overall Study|Sponsor Decision|5|||
161595881|NCT05239455|583571799|FG000|Overall Study|Incomplete Blood Collection|1|||
161595882|NCT03365882|583571801|FG000|Randomization|Still Receiving Protocol Treatment|2|||
161595883|NCT03365882|583571802|FG001|Randomization|Still Receiving Protocol Treatment|0|||
161595884|NCT03365882|583571801|FG000|Randomization|Adverse Event|1|||
161595885|NCT03365882|583571802|FG001|Randomization|Adverse Event|2|||
161595886|NCT03365882|583571801|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
161595887|NCT03365882|583571802|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
161595888|NCT03365882|583571801|FG000|Randomization|Progression/Relapse|21|||
161595889|NCT03365882|583571802|FG001|Randomization|Progression/Relapse|3|||
161595890|NCT03365882|583571801|FG000|Randomization|Death|1|||
161595891|NCT03365882|583571802|FG001|Randomization|Death|0|||
161595892|NCT03365882|583571801|FG000|Randomization|Other - Not Protocol Specified|1|||
161595893|NCT03365882|583571802|FG001|Randomization|Other - Not Protocol Specified|1|||
161595894|NCT03365882|583571801|FG000|Randomization|Major Protocol Deviation|0|||
161595895|NCT03365882|583571802|FG001|Randomization|Major Protocol Deviation|1|||
161595896|NCT03365882|583571801|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
161595897|NCT03365882|583571802|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
161595898|NCT03365882|583571801|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
161595899|NCT03365882|583571802|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
161595900|NCT03365882|583571801|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
161595901|NCT03365882|583571802|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
161595902|NCT03365882|583571801|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
161595903|NCT03365882|583571802|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
161595904|NCT03023410|583574420|FG000|Overall Study|study termination|0|||
161595905|NCT03023410|583574421|FG001|Overall Study|study termination|1|||
161595906|NCT04799899|583574422|FG000|Overall Study|Lost to Follow-up|2|||
161595907|NCT04799899|583574423|FG001|Overall Study|Lost to Follow-up|4|||
161595908|NCT04987320|583574428|FG000|Overall Study|Withdrawal by Subject|0|||
161595909|NCT04987320|583574429|FG001|Overall Study|Withdrawal by Subject|1|||
161595910|NCT00085735|583574430|FG000|Overall Study|Adverse Event|1|||
161595911|NCT00085735|583574431|FG001|Overall Study|Adverse Event|0|||
161595912|NCT00085735|583574432|FG002|Overall Study|Adverse Event|0|||
161595913|NCT00085735|583574433|FG003|Overall Study|Adverse Event|0|||
161595914|NCT00085735|583574434|FG004|Overall Study|Adverse Event|0|||
161595915|NCT00085735|583574435|FG005|Overall Study|Adverse Event|0|||
161595916|NCT00085735|583574430|FG000|Overall Study|Lack of Efficacy|2|||
161595917|NCT00085735|583574431|FG001|Overall Study|Lack of Efficacy|4|||
161595918|NCT00085735|583574432|FG002|Overall Study|Lack of Efficacy|6|||
161595919|NCT00085735|583574433|FG003|Overall Study|Lack of Efficacy|3|||
161595920|NCT00085735|583574434|FG004|Overall Study|Lack of Efficacy|4|||
161595921|NCT00085735|583574435|FG005|Overall Study|Lack of Efficacy|3|||
161595922|NCT00085735|583574430|FG000|Overall Study|Lost to Follow-up|0|||
161595923|NCT00085735|583574431|FG001|Overall Study|Lost to Follow-up|1|||
161595924|NCT00085735|583574432|FG002|Overall Study|Lost to Follow-up|0|||
161595925|NCT00085735|583574433|FG003|Overall Study|Lost to Follow-up|0|||
161595926|NCT00085735|583574434|FG004|Overall Study|Lost to Follow-up|1|||
161595927|NCT00085735|583574435|FG005|Overall Study|Lost to Follow-up|0|||
161595928|NCT00085735|583574430|FG000|Overall Study|Physician Decision|2|||
161595929|NCT00085735|583574431|FG001|Overall Study|Physician Decision|3|||
161595930|NCT00085735|583574432|FG002|Overall Study|Physician Decision|2|||
161595931|NCT00085735|583574433|FG003|Overall Study|Physician Decision|3|||
161595932|NCT00085735|583574434|FG004|Overall Study|Physician Decision|11|||
161595933|NCT00085735|583574435|FG005|Overall Study|Physician Decision|8|||
161595934|NCT00085735|583574430|FG000|Overall Study|Protocol Violation|1|||
161595935|NCT00085735|583574431|FG001|Overall Study|Protocol Violation|0|||
161595936|NCT00085735|583574432|FG002|Overall Study|Protocol Violation|0|||
161595937|NCT00085735|583574433|FG003|Overall Study|Protocol Violation|0|||
161595938|NCT00085735|583574434|FG004|Overall Study|Protocol Violation|0|||
161595939|NCT00085735|583574435|FG005|Overall Study|Protocol Violation|0|||
161595940|NCT00085735|583574430|FG000|Overall Study|Withdrawal by Subject|1|||
161595941|NCT00085735|583574431|FG001|Overall Study|Withdrawal by Subject|0|||
161595942|NCT00085735|583574432|FG002|Overall Study|Withdrawal by Subject|4|||
161595943|NCT00085735|583574433|FG003|Overall Study|Withdrawal by Subject|5|||
161595944|NCT00085735|583574434|FG004|Overall Study|Withdrawal by Subject|7|||
161595945|NCT00085735|583574435|FG005|Overall Study|Withdrawal by Subject|8|||
161595946|NCT00085735|583574430|FG000|Overall Study|Patient ineligible|1|||
161595947|NCT00085735|583574431|FG001|Overall Study|Patient ineligible|0|||
161595948|NCT00085735|583574432|FG002|Overall Study|Patient ineligible|3|||
161595949|NCT00085735|583574433|FG003|Overall Study|Patient ineligible|7|||
161595950|NCT00085735|583574434|FG004|Overall Study|Patient ineligible|17|||
161595951|NCT00085735|583574435|FG005|Overall Study|Patient ineligible|8|||
161595952|NCT00085735|583574430|FG000|Overall Study|Excess residual disease|2|||
161595953|NCT00085735|583574431|FG001|Overall Study|Excess residual disease|2|||
161595954|NCT00085735|583574432|FG002|Overall Study|Excess residual disease|1|||
161595955|NCT00085735|583574433|FG003|Overall Study|Excess residual disease|1|||
161595956|NCT00085735|583574434|FG004|Overall Study|Excess residual disease|1|||
161595957|NCT00085735|583574435|FG005|Overall Study|Excess residual disease|4|||
161595958|NCT00085735|583574430|FG000|Overall Study|Reason not documented|1|||
161595959|NCT00085735|583574431|FG001|Overall Study|Reason not documented|0|||
161595960|NCT00085735|583574432|FG002|Overall Study|Reason not documented|1|||
161595961|NCT00085735|583574433|FG003|Overall Study|Reason not documented|0|||
161595962|NCT00085735|583574434|FG004|Overall Study|Reason not documented|1|||
161595963|NCT00085735|583574435|FG005|Overall Study|Reason not documented|0|||
161595964|NCT00085735|583574430|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
161683070|NCT01148537|583891234|FG001|Overall Study|Adverse Event|0|||
161830258|NCT01557582|584418158|FG000|Overall Study|Operator error|2|||
161548431|NCT01678820|583397858|FG001|Overall Study|Protocol Violation|5|||
161548432|NCT01678820|583397859|FG002|Overall Study|Protocol Violation|4|||
161595965|NCT00085735|583574431|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
161595966|NCT00085735|583574432|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
161595967|NCT00085735|583574433|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
161595968|NCT00085735|583574434|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
161595969|NCT00085735|583574435|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
161595970|NCT01824875|583574436|FG000|Overall Study|Disease progression|22|||
161595971|NCT01824875|583574437|FG001|Overall Study|Disease progression|15|||
161595972|NCT01824875|583574436|FG000|Overall Study|Withdrawal by Subject|5|||
161595973|NCT01824875|583574437|FG001|Overall Study|Withdrawal by Subject|4|||
161595974|NCT01824875|583574436|FG000|Overall Study|Adverse Event|4|||
161595975|NCT01824875|583574437|FG001|Overall Study|Adverse Event|10|||
161595976|NCT01824875|583574436|FG000|Overall Study|Alternative therapy|3|||
161595977|NCT01824875|583574437|FG001|Overall Study|Alternative therapy|0|||
161595978|NCT01824875|583574436|FG000|Overall Study|Complicating disease|1|||
161595979|NCT01824875|583574437|FG001|Overall Study|Complicating disease|0|||
161595980|NCT01824875|583574436|FG000|Overall Study|Physician Decision|0|||
161595981|NCT01824875|583574437|FG001|Overall Study|Physician Decision|1|||
161595982|NCT01824875|583574436|FG000|Overall Study|Non-compliance|1|||
161595983|NCT01824875|583574437|FG001|Overall Study|Non-compliance|1|||
161595984|NCT01824875|583574436|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
161595985|NCT01824875|583574437|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
161595986|NCT01824875|583574436|FG000|Overall Study|Administrative issues|0|||
161595987|NCT01824875|583574437|FG001|Overall Study|Administrative issues|2|||
161595988|NCT01824875|583574436|FG000|Overall Study|Ineligible or never started treatment|9|||
161595989|NCT01824875|583574437|FG001|Overall Study|Ineligible or never started treatment|5|||
161595990|NCT01824875|583574436|FG000|Overall Study|Other|0|||
161595991|NCT01824875|583574437|FG001|Overall Study|Other|2|||
161595992|NCT04195698|583574440|FG000|Overall Study|Adverse Event|4|||
161595993|NCT04195698|583574441|FG001|Overall Study|Adverse Event|11|||
161595994|NCT04195698|583574440|FG000|Overall Study|Withdrawal by Subject|9|||
161595995|NCT04195698|583574441|FG001|Overall Study|Withdrawal by Subject|10|||
161595996|NCT04195698|583574440|FG000|Overall Study|Lost to Follow-up|5|||
161595997|NCT04195698|583574441|FG001|Overall Study|Lost to Follow-up|4|||
161548433|NCT01678820|583397857|FG000|Overall Study|Not treated with double-blind study drug|0|||
161548434|NCT01678820|583397858|FG001|Overall Study|Not treated with double-blind study drug|2|||
161548435|NCT01678820|583397859|FG002|Overall Study|Not treated with double-blind study drug|2|||
161548436|NCT03283696|583397860|FG000|Overall Study|Physician Decision|5|||
161548437|NCT03283696|583397861|FG001|Overall Study|Physician Decision|6|||
161548438|NCT03283696|583397860|FG000|Overall Study|Withdrawal by Subject|2|||
161548439|NCT03283696|583397861|FG001|Overall Study|Withdrawal by Subject|0|||
161548440|NCT00245856|583397862|FG000|Period Two|Withdrawal by Subject|0|||
161548441|NCT00245856|583397863|FG001|Period Two|Withdrawal by Subject|1|||
161548442|NCT03662997|583397868|FG000|Overall Study|Adverse Event|0|||
161548443|NCT03662997|583397869|FG001|Overall Study|Adverse Event|2|||
161548444|NCT03662997|583397870|FG002|Overall Study|Adverse Event|0|||
161548445|NCT03662997|583397871|FG003|Overall Study|Adverse Event|0|||
161548446|NCT01512745|583397875|FG000|Overall Study|Adverse Event|22|||
161548447|NCT01512745|583397876|FG001|Overall Study|Adverse Event|3|||
161548448|NCT01512745|583397875|FG000|Overall Study|Death|9|||
161548449|NCT01512745|583397876|FG001|Overall Study|Death|13|||
161548450|NCT01512745|583397875|FG000|Overall Study|Withdrawal by Subject|2|||
161548451|NCT01512745|583397876|FG001|Overall Study|Withdrawal by Subject|2|||
161548452|NCT01512745|583397875|FG000|Overall Study|Lost to Follow-up|4|||
161548453|NCT01512745|583397876|FG001|Overall Study|Lost to Follow-up|0|||
161548454|NCT01512745|583397875|FG000|Overall Study|Lack of Efficacy|2|||
161548455|NCT01512745|583397876|FG001|Overall Study|Lack of Efficacy|2|||
161548456|NCT01512745|583397875|FG000|Overall Study|Protocol Violation|1|||
161548457|NCT01512745|583397876|FG001|Overall Study|Protocol Violation|0|||
161548458|NCT02357810|583397877|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
161548459|NCT02357810|583397877|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
161548460|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Adverse Event|5|||
161548461|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
161548462|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
161548463|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
161548464|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Death|1|||
161548465|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Physician Decision|1|||
161548466|NCT02357810|583397877|FG000|Reached 12 Weeks Response|Other|1|||
161548467|NCT02357810|583397877|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
161548468|NCT02357810|583397877|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
161548469|NCT02357810|583397877|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
161548470|NCT02357810|583397877|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
161548471|NCT02357810|583397877|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
161830259|NCT00546910|584420031|FG000|Overall Study|Adverse Event|2|||
161830260|NCT00546910|584420032|FG001|Overall Study|Adverse Event|3|||
161830261|NCT00546910|584420031|FG000|Overall Study|Lack of Efficacy|5|||
161830262|NCT00546910|584420032|FG001|Overall Study|Lack of Efficacy|7|||
161830263|NCT00546910|584420031|FG000|Overall Study|Physician Decision|0|||
161830264|NCT00546910|584420032|FG001|Overall Study|Physician Decision|1|||
161830265|NCT00546910|584420031|FG000|Overall Study|Withdrawal by Subject|2|||
161830266|NCT00546910|584420032|FG001|Overall Study|Withdrawal by Subject|0|||
161830267|NCT01301482|584420033|FG000|Overall Study|Withdrawal by Subject|1|||
161830268|NCT04086641|584420041|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
161830269|NCT04086641|584420042|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
161830270|NCT00706095|584420043|FG000|Overall Study|Progressive Disease|4|||
161830271|NCT00706095|584420044|FG001|Overall Study|Progressive Disease|5|||
161830272|NCT00706095|584420045|FG002|Overall Study|Progressive Disease|3|||
161830273|NCT00706095|584420043|FG000|Overall Study|Clinical Progression|1|||
161830274|NCT00706095|584420044|FG001|Overall Study|Clinical Progression|2|||
161830275|NCT00706095|584420045|FG002|Overall Study|Clinical Progression|2|||
161830276|NCT00706095|584420043|FG000|Overall Study|Withdrawal by Subject|1|||
161830277|NCT00706095|584420044|FG001|Overall Study|Withdrawal by Subject|0|||
161830278|NCT00706095|584420045|FG002|Overall Study|Withdrawal by Subject|0|||
161830279|NCT01011556|584420051|FG000|Overall Study|Adverse Event|1|||
161830280|NCT01011556|584420052|FG001|Overall Study|Adverse Event|3|||
161830281|NCT01011556|584420053|FG002|Overall Study|Adverse Event|2|||
161830282|NCT01011556|584420054|FG003|Overall Study|Adverse Event|1|||
161830283|NCT01011556|584420051|FG000|Overall Study|Lost to Follow-up|1|||
161830284|NCT01011556|584420052|FG001|Overall Study|Lost to Follow-up|0|||
161830285|NCT01011556|584420053|FG002|Overall Study|Lost to Follow-up|0|||
161681390|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681391|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681392|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681393|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681394|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681395|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
161681396|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681397|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681398|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681399|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161830286|NCT01011556|584420054|FG003|Overall Study|Lost to Follow-up|0|||
161830287|NCT01011556|584420051|FG000|Overall Study|Physician Decision|1|||
161830288|NCT01011556|584420052|FG001|Overall Study|Physician Decision|0|||
161830289|NCT01011556|584420053|FG002|Overall Study|Physician Decision|0|||
161830290|NCT01011556|584420054|FG003|Overall Study|Physician Decision|1|||
161830291|NCT01011556|584420051|FG000|Overall Study|Protocol Violation|0|||
161830292|NCT01011556|584420052|FG001|Overall Study|Protocol Violation|1|||
161830293|NCT01011556|584420053|FG002|Overall Study|Protocol Violation|0|||
161830294|NCT01011556|584420054|FG003|Overall Study|Protocol Violation|0|||
161830295|NCT01011556|584420051|FG000|Overall Study|Withdrawal by Subject|1|||
161830296|NCT01011556|584420052|FG001|Overall Study|Withdrawal by Subject|2|||
161830297|NCT01011556|584420053|FG002|Overall Study|Withdrawal by Subject|4|||
161830298|NCT01011556|584420054|FG003|Overall Study|Withdrawal by Subject|4|||
161595998|NCT04195698|583574440|FG000|Overall Study|Lack of Efficacy|2|||
161595999|NCT04195698|583574441|FG001|Overall Study|Lack of Efficacy|10|||
161596000|NCT04195698|583574440|FG000|Overall Study|Other|5|||
161596001|NCT04195698|583574441|FG001|Overall Study|Other|4|||
161596002|NCT00433329|583574442|FG000|Overall Study|Adverse Event|9|||
161596003|NCT00433329|583574442|FG000|Overall Study|Death|4|||
161596004|NCT00433329|583574442|FG000|Overall Study|Withdrew consent|3|||
161596005|NCT00433329|583574442|FG000|Overall Study|Discontinued sildenafil|2|||
161596006|NCT00433329|583574442|FG000|Overall Study|Moved out of state|1|||
161681400|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161596007|NCT00433329|583574442|FG000|Overall Study|Lost to Follow-up|1|||
161683071|NCT01148537|583891235|FG002|Overall Study|Adverse Event|1|||
161830299|NCT01011556|584420051|FG000|Overall Study|Sponsor decision|0|||
161830300|NCT01011556|584420052|FG001|Overall Study|Sponsor decision|1|||
161830301|NCT01011556|584420053|FG002|Overall Study|Sponsor decision|1|||
161830302|NCT01011556|584420054|FG003|Overall Study|Sponsor decision|2|||
161830303|NCT01011556|584420051|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
161596008|NCT00433329|583574442|FG000|Overall Study|Physician Decision|1|||
161830304|NCT01011556|584420052|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161830305|NCT01011556|584420053|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
161830306|NCT01011556|584420054|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
161830307|NCT03920280|584420055|FG000|Overall Study|Adverse Event|2|||
161830308|NCT03920280|584420056|FG001|Overall Study|Adverse Event|3|||
161830309|NCT03920280|584420055|FG000|Overall Study|Lost to Follow-up|0|||
161830310|NCT03920280|584420056|FG001|Overall Study|Lost to Follow-up|1|||
161596009|NCT05459688|583574443|FG000|Overall Study|Lost to Follow-up|6|||
161596010|NCT05459688|583574443|FG000|Overall Study|Physician Decision|1|||
161596011|NCT05459688|583574443|FG000|Overall Study|Withdrawal by Subject|19|||
161596012|NCT05459688|583574443|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
161596013|NCT01129102|583574444|FG000|Overall Study|No study drug treatment|2|||
161596014|NCT01129102|583574445|FG001|Overall Study|No study drug treatment|3|||
161596015|NCT01129102|583574446|FG002|Overall Study|No study drug treatment|1|||
161596016|NCT01129102|583574444|FG000|Overall Study|Withdrawal by Subject|2|||
161596017|NCT01129102|583574445|FG001|Overall Study|Withdrawal by Subject|0|||
161596018|NCT01129102|583574446|FG002|Overall Study|Withdrawal by Subject|3|||
161596019|NCT01129102|583574444|FG000|Overall Study|Protocol Violation|0|||
161596020|NCT01129102|583574445|FG001|Overall Study|Protocol Violation|1|||
161596021|NCT01129102|583574446|FG002|Overall Study|Protocol Violation|1|||
161596022|NCT01129102|583574444|FG000|Overall Study|Pregnancy|0|||
161596023|NCT01129102|583574445|FG001|Overall Study|Pregnancy|0|||
161596024|NCT01129102|583574446|FG002|Overall Study|Pregnancy|1|||
161596025|NCT01129102|583574444|FG000|Overall Study|Adverse Event|2|||
161596026|NCT01129102|583574445|FG001|Overall Study|Adverse Event|2|||
161596027|NCT01129102|583574446|FG002|Overall Study|Adverse Event|1|||
161596028|NCT01129102|583574444|FG000|Overall Study|Lost to Follow-up|2|||
161596029|NCT01129102|583574445|FG001|Overall Study|Lost to Follow-up|0|||
161596030|NCT01129102|583574446|FG002|Overall Study|Lost to Follow-up|0|||
161596031|NCT03379675|583574449|FG000|Overall Study|Lost to Follow-up|0|||
161596032|NCT03379675|583574450|FG001|Overall Study|Lost to Follow-up|1|||
161596033|NCT03379675|583574451|FG002|Overall Study|Lost to Follow-up|0|||
161596034|NCT03379675|583574449|FG000|Overall Study|Adverse Event|2|||
161596035|NCT03379675|583574450|FG001|Overall Study|Adverse Event|0|||
161596036|NCT03379675|583574451|FG002|Overall Study|Adverse Event|0|||
161596037|NCT03379675|583574449|FG000|Overall Study|Withdrawal by Subject|2|||
161596038|NCT03379675|583574450|FG001|Overall Study|Withdrawal by Subject|1|||
161596039|NCT03379675|583574451|FG002|Overall Study|Withdrawal by Subject|2|||
161596040|NCT02817776|583574452|FG000|Overall Study|Excluded|33|||
161596041|NCT02817776|583574452|FG000|Overall Study|Lost to Follow-up|20|||
161596042|NCT02817776|583574452|FG000|Overall Study|Withdrawal by Subject|33|||
161596043|NCT02817776|583574452|FG000|Overall Study|Death|2|||
161596044|NCT02359890|583574453|FG000|Overall Study|Not meeting eligibility|4|||
161596045|NCT02359890|583574453|FG000|Overall Study|Never treated with study catheter|6|||
161596046|NCT02683447|583574457|FG000|Overall Study|Lost to Follow-up|2|||
161596047|NCT04663737|583574458|FG000|Overall Study|Withdrawal by Subject|2|||
161596048|NCT04663737|583574459|FG001|Overall Study|Withdrawal by Subject|0|||
161596049|NCT04016662|583574460|FG000|Run-In Phase|Death|1|||
161596050|NCT04016662|583574460|FG000|Run-In Phase|Withdrawal by Subject|11|||
161596051|NCT04016662|583574460|FG000|Run-In Phase|Not meeting screening eligibility|9|||
161596052|NCT04016662|583574460|FG000|Run-In Phase|Physician Decision|3|||
161596053|NCT04016662|583574460|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
161596054|NCT04016662|583574460|FG000|PLGS (12 Weeks)|Death|1|||
161596055|NCT04016662|583574460|FG000|SAP (12 Weeks)|Death|1|||
161596056|NCT02489903|583574464|FG000|Screening|Screen Failure|24|||
161596057|NCT02489903|583574465|FG001|Screening|Screen Failure|0|||
161596058|NCT02489903|583574466|FG002|Screening|Screen Failure|0|||
161596059|NCT02489903|583574467|FG003|Screening|Screen Failure|8|||
161596060|NCT02489903|583574464|FG000|Randomized and Received Treatment|Protocol Violation|0|||
161596061|NCT02489903|583574465|FG001|Randomized and Received Treatment|Protocol Violation|1|||
161596062|NCT02489903|583574466|FG002|Randomized and Received Treatment|Protocol Violation|0|||
161596063|NCT02489903|583574467|FG003|Randomized and Received Treatment|Protocol Violation|0|||
161596064|NCT02489903|583574464|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
161596065|NCT02489903|583574465|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
161596066|NCT02489903|583574466|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
161596067|NCT02489903|583574467|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
161596068|NCT02489903|583574464|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
161596069|NCT02489903|583574465|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
161596070|NCT02489903|583574466|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
161596071|NCT02489903|583574467|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
161596072|NCT02489903|583574464|FG000|Randomized and Received Treatment|Death|10|||
161596073|NCT02489903|583574465|FG001|Randomized and Received Treatment|Death|1|||
161596074|NCT02489903|583574466|FG002|Randomized and Received Treatment|Death|0|||
161596075|NCT02489903|583574467|FG003|Randomized and Received Treatment|Death|0|||
161681401|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161596076|NCT03904147|583574472|FG000|Overall Study|Death|15|||
161596077|NCT03904147|583574473|FG001|Overall Study|Death|13|||
161596078|NCT03904147|583574474|FG002|Overall Study|Death|15|||
161596079|NCT03904147|583574472|FG000|Overall Study|Withdrawal by Subject|7|||
161596080|NCT03904147|583574473|FG001|Overall Study|Withdrawal by Subject|12|||
161596081|NCT03904147|583574474|FG002|Overall Study|Withdrawal by Subject|1|||
161596082|NCT03904147|583574472|FG000|Overall Study|1Y visit completed after 365 days|1|||
161830311|NCT03920280|584420055|FG000|Overall Study|Withdrawal by Subject|1|||
161830312|NCT03920280|584420056|FG001|Overall Study|Withdrawal by Subject|1|||
161830313|NCT03920280|584420055|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
161548472|NCT02357810|583397877|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
161548473|NCT00562978|583397878|FG000|Overall Study|Patient had imaging dose only|1|||
161548474|NCT00562978|583397879|FG001|Overall Study|Patient had imaging dose only|11|||
161548475|NCT00675506|583397881|FG000|Overall Study|Lost to Follow-up|1|||
161548476|NCT00675506|583397882|FG001|Overall Study|Lost to Follow-up|5|||
161548477|NCT00675506|583397881|FG000|Overall Study|Lost interest|3|||
161548478|NCT00675506|583397882|FG001|Overall Study|Lost interest|5|||
161548479|NCT00675506|583397881|FG000|Overall Study|Elevated fasting glucose|2|||
161548480|NCT00675506|583397882|FG001|Overall Study|Elevated fasting glucose|1|||
161548481|NCT00675506|583397881|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
161548482|NCT00675506|583397882|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
161548483|NCT00675506|583397881|FG000|Overall Study|Elevated IGF-1|2|||
161548484|NCT00675506|583397882|FG001|Overall Study|Elevated IGF-1|0|||
161548485|NCT00675506|583397881|FG000|Overall Study|Hypersensitivity Reaction|1|||
161548486|NCT00675506|583397882|FG001|Overall Study|Hypersensitivity Reaction|0|||
161548487|NCT00675506|583397881|FG000|Overall Study|Disclosed history of cancer|1|||
161548488|NCT00675506|583397882|FG001|Overall Study|Disclosed history of cancer|0|||
161548489|NCT00675506|583397881|FG000|Overall Study|Declined participation|1|||
161548490|NCT00675506|583397882|FG001|Overall Study|Declined participation|0|||
161548491|NCT00675506|583397881|FG000|Overall Study|Schedule conflict|0|||
161548492|NCT00675506|583397882|FG001|Overall Study|Schedule conflict|1|||
161548493|NCT06173570|583397883|FG000|Overall Study|Adverse Event|1|||
161548494|NCT06173570|583397884|FG001|Overall Study|Adverse Event|0|||
161548495|NCT06173570|583397885|FG002|Overall Study|Adverse Event|0|||
161548496|NCT06173570|583397886|FG003|Overall Study|Adverse Event|2|||
161548497|NCT06173570|583397887|FG004|Overall Study|Adverse Event|0|||
161548498|NCT06173570|583397883|FG000|Overall Study|Lost to Follow-up|1|||
161548499|NCT06173570|583397884|FG001|Overall Study|Lost to Follow-up|0|||
161548500|NCT06173570|583397885|FG002|Overall Study|Lost to Follow-up|0|||
161548501|NCT06173570|583397886|FG003|Overall Study|Lost to Follow-up|0|||
161548502|NCT06173570|583397887|FG004|Overall Study|Lost to Follow-up|2|||
161548503|NCT06173570|583397883|FG000|Overall Study|Protocol Violation|0|||
161548504|NCT06173570|583397884|FG001|Overall Study|Protocol Violation|2|||
161548505|NCT06173570|583397885|FG002|Overall Study|Protocol Violation|0|||
161548506|NCT06173570|583397886|FG003|Overall Study|Protocol Violation|0|||
161548507|NCT06173570|583397887|FG004|Overall Study|Protocol Violation|1|||
161548508|NCT06173570|583397883|FG000|Overall Study|Withdrawal by Subject|0|||
161548509|NCT06173570|583397884|FG001|Overall Study|Withdrawal by Subject|1|||
161548510|NCT06173570|583397885|FG002|Overall Study|Withdrawal by Subject|1|||
161548511|NCT06173570|583397886|FG003|Overall Study|Withdrawal by Subject|1|||
161548512|NCT06173570|583397887|FG004|Overall Study|Withdrawal by Subject|1|||
161548513|NCT06173570|583397883|FG000|Overall Study|Non-compliance with Study Drug|1|||
161548514|NCT06173570|583397884|FG001|Overall Study|Non-compliance with Study Drug|0|||
161548515|NCT06173570|583397885|FG002|Overall Study|Non-compliance with Study Drug|0|||
161548516|NCT06173570|583397886|FG003|Overall Study|Non-compliance with Study Drug|0|||
161548517|NCT06173570|583397887|FG004|Overall Study|Non-compliance with Study Drug|0|||
161548518|NCT06173570|583397883|FG000|Overall Study|Screen Failure|0|||
161548519|NCT06173570|583397884|FG001|Overall Study|Screen Failure|0|||
161548520|NCT06173570|583397885|FG002|Overall Study|Screen Failure|0|||
161548521|NCT06173570|583397886|FG003|Overall Study|Screen Failure|0|||
161548522|NCT06173570|583397887|FG004|Overall Study|Screen Failure|1|||
161548523|NCT06173570|583397883|FG000|Overall Study|Other|2|||
161548524|NCT06173570|583397884|FG001|Overall Study|Other|1|||
161548525|NCT06173570|583397885|FG002|Overall Study|Other|0|||
161548526|NCT06173570|583397886|FG003|Overall Study|Other|2|||
161548527|NCT06173570|583397887|FG004|Overall Study|Other|0|||
161548528|NCT03820323|583397888|FG000|Overall Study|Lost to Follow-up|2|||
161548529|NCT03820323|583397889|FG001|Overall Study|Lost to Follow-up|1|||
161548530|NCT03820323|583397888|FG000|Overall Study|Missed 12-month visit|22|||
161548531|NCT03820323|583397889|FG001|Overall Study|Missed 12-month visit|14|||
161548532|NCT03820323|583397888|FG000|Overall Study|Death|2|||
161548533|NCT03820323|583397889|FG001|Overall Study|Death|1|||
161548534|NCT03820323|583397888|FG000|Overall Study|Transferred out|13|||
161548535|NCT03820323|583397889|FG001|Overall Study|Transferred out|11|||
161548536|NCT03820323|583397888|FG000|Overall Study|Terminated|0|||
161548537|NCT03820323|583397889|FG001|Overall Study|Terminated|3|||
161548538|NCT03820323|583397888|FG000|Overall Study|Withdrawal by Subject|1|||
161548539|NCT03820323|583397889|FG001|Overall Study|Withdrawal by Subject|6|||
161548540|NCT03151395|583397890|FG000|Overall Study|Adverse Event|2|||
161548541|NCT03151395|583397890|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
161548542|NCT03151395|583397890|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
161548543|NCT03151395|583397890|FG000|Overall Study|Unspecified reason|4|||
161548544|NCT00366301|583397891|FG000|Overall Study|Lost to Follow-up|4|||
161548545|NCT00366301|583397892|FG001|Overall Study|Lost to Follow-up|4|||
161830314|NCT03920280|584420056|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
161830315|NCT00271024|584420067|FG000|Overall Study|Lost Interest|3|||
161830316|NCT00271024|584420068|FG001|Overall Study|Lost Interest|4|||
161830317|NCT00271024|584420069|FG002|Overall Study|Lost Interest|2|||
161830318|NCT00271024|584420070|FG003|Overall Study|Lost Interest|3|||
161830319|NCT00271024|584420067|FG000|Overall Study|Unknown/Unspecified|11|||
161830320|NCT00271024|584420068|FG001|Overall Study|Unknown/Unspecified|11|||
161830321|NCT00271024|584420069|FG002|Overall Study|Unknown/Unspecified|8|||
161830322|NCT00271024|584420070|FG003|Overall Study|Unknown/Unspecified|4|||
161830323|NCT00271024|584420067|FG000|Overall Study|Protocol Violation|1|||
161830324|NCT00271024|584420068|FG001|Overall Study|Protocol Violation|6|||
161830325|NCT00271024|584420069|FG002|Overall Study|Protocol Violation|5|||
161830326|NCT00271024|584420070|FG003|Overall Study|Protocol Violation|11|||
161830327|NCT00271024|584420067|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
161830328|NCT00271024|584420068|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
161830329|NCT00271024|584420069|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
161830330|NCT00271024|584420070|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
161830331|NCT00271024|584420067|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
161830332|NCT00271024|584420068|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
161830333|NCT00271024|584420069|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
161830334|NCT00271024|584420070|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
161830335|NCT04449341|584420071|FG000|Overall Study|Protocol Violation|1|||
161830336|NCT04449341|584420072|FG001|Overall Study|Protocol Violation|0|||
161830337|NCT04499482|584420073|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
161830338|NCT01020526|584420075|FG000|Overall Study|Withdrawal by Subject|5|||
161830339|NCT01020526|584420075|FG000|Overall Study|Other reasons|3|||
161830340|NCT01020526|584420075|FG000|Overall Study|Insufficient clinical response|3|||
161830341|NCT01020526|584420075|FG000|Overall Study|Lost to Follow-up|1|||
161830342|NCT01020526|584420075|FG000|Overall Study|Adverse Event|2|||
161830343|NCT03573817|584420076|FG000|Overall Study|Adverse Event|0|||
161830344|NCT03573817|584420077|FG001|Overall Study|Adverse Event|2|||
161830345|NCT03573817|584420076|FG000|Overall Study|Protocol Violation|0|||
161830346|NCT03573817|584420077|FG001|Overall Study|Protocol Violation|1|||
161830347|NCT03573817|584420076|FG000|Overall Study|Withdrawal by Subject|1|||
161830348|NCT03573817|584420077|FG001|Overall Study|Withdrawal by Subject|1|||
161830349|NCT01083680|584420086|FG000|Overall Study|Lost to Follow-up|2758|||
161830350|NCT01083680|584420086|FG000|Overall Study|Withdrawal by Subject|1086|||
161830351|NCT00508027|584420087|FG000|Dose Level 1|Lost to Follow-up|4|||
161830352|NCT00508027|584420087|FG000|Dose Level 1|Withdrawal by Subject|2|||
161830353|NCT00508027|584420087|FG000|Dose Level 1|Physician Decision|2|||
161830354|NCT00508027|584420087|FG000|Dose Level 2|Lost to Follow-up|2|||
161830355|NCT00508027|584420087|FG000|Dose Level 2|Withdrawal by Subject|2|||
161830356|NCT01719562|584420088|FG000|Overall Study|Lost to Follow-up|1|||
161830357|NCT01719562|584420089|FG001|Overall Study|Lost to Follow-up|0|||
161830358|NCT01719562|584420088|FG000|Overall Study|Death|1|||
161830359|NCT01719562|584420089|FG001|Overall Study|Death|0|||
161830360|NCT01719562|584420088|FG000|Overall Study|New cancer diagnosis|1|||
161830361|NCT01719562|584420089|FG001|Overall Study|New cancer diagnosis|0|||
161830362|NCT03877926|584420090|FG000|Overall Study|Adverse Event|1|||
161830363|NCT03877926|584420091|FG001|Overall Study|Adverse Event|0|||
161830364|NCT03877926|584420092|FG002|Overall Study|Adverse Event|0|||
161830365|NCT03877926|584420093|FG003|Overall Study|Adverse Event|0|||
161830366|NCT03877926|584420090|FG000|Overall Study|Death|2|||
161830367|NCT03877926|584420091|FG001|Overall Study|Death|2|||
161830368|NCT03877926|584420092|FG002|Overall Study|Death|2|||
161830369|NCT03877926|584420093|FG003|Overall Study|Death|0|||
161830370|NCT03877926|584420090|FG000|Overall Study|Lost to Follow-up|41|||
161548546|NCT00366301|583397893|FG002|Overall Study|Lost to Follow-up|3|||
161681402|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
161681403|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161681404|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161681405|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161681406|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681407|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681408|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
161681409|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161830371|NCT03877926|584420091|FG001|Overall Study|Lost to Follow-up|52|||
161830372|NCT03877926|584420092|FG002|Overall Study|Lost to Follow-up|45|||
161830373|NCT03877926|584420093|FG003|Overall Study|Lost to Follow-up|17|||
161830374|NCT03877926|584420090|FG000|Overall Study|Physician Decision|2|||
161830375|NCT03877926|584420091|FG001|Overall Study|Physician Decision|0|||
161830376|NCT03877926|584420092|FG002|Overall Study|Physician Decision|2|||
161830377|NCT03877926|584420093|FG003|Overall Study|Physician Decision|0|||
161830378|NCT03877926|584420090|FG000|Overall Study|Withdrawal by Subject|18|||
161830379|NCT03877926|584420091|FG001|Overall Study|Withdrawal by Subject|21|||
161596083|NCT03904147|583574473|FG001|Overall Study|1Y visit completed after 365 days|1|||
161596084|NCT03904147|583574474|FG002|Overall Study|1Y visit completed after 365 days|0|||
161596085|NCT04413708|583574475|FG000|Overall Study|Lost to Follow-up|1|||
161596086|NCT04413708|583574476|FG001|Overall Study|Lost to Follow-up|2|||
161596087|NCT04948697|583574477|FG000|Overall Study|Progressive disease|27|||
161596088|NCT04948697|583574478|FG001|Overall Study|Progressive disease|18|||
161596089|NCT04948697|583574477|FG000|Overall Study|Adverse Event|14|||
161596090|NCT04948697|583574478|FG001|Overall Study|Adverse Event|4|||
161596091|NCT04948697|583574477|FG000|Overall Study|Participant moved to long term extension study|7|||
161596092|NCT04948697|583574478|FG001|Overall Study|Participant moved to long term extension study|4|||
161596093|NCT04948697|583574477|FG000|Overall Study|Withdrawal by Subject|10|||
161596094|NCT04948697|583574478|FG001|Overall Study|Withdrawal by Subject|0|||
161596095|NCT04948697|583574477|FG000|Overall Study|Closed by Sponsor|3|||
161596096|NCT04948697|583574478|FG001|Overall Study|Closed by Sponsor|2|||
161596097|NCT04948697|583574477|FG000|Overall Study|Physician Decision|0|||
161548547|NCT00366301|583397894|FG003|Overall Study|Lost to Follow-up|7|||
161548548|NCT00366301|583397891|FG000|Overall Study|Withdrawal by Subject|4|||
161548549|NCT00366301|583397892|FG001|Overall Study|Withdrawal by Subject|2|||
161548550|NCT00366301|583397893|FG002|Overall Study|Withdrawal by Subject|1|||
161548551|NCT00366301|583397894|FG003|Overall Study|Withdrawal by Subject|1|||
161548552|NCT01348776|583397895|FG000|Overall Study|Lost to Follow-up|3|||
161548553|NCT01372605|583397896|FG000|Overall Study|Death|1|||
161548554|NCT01372605|583397897|FG001|Overall Study|Death|2|||
161548555|NCT01372605|583397896|FG000|Overall Study|Lost to Follow-up|2|||
161548556|NCT01372605|583397897|FG001|Overall Study|Lost to Follow-up|1|||
161548557|NCT01372605|583397896|FG000|Overall Study|Withdrawal by Subject|4|||
161548558|NCT01372605|583397897|FG001|Overall Study|Withdrawal by Subject|7|||
161548559|NCT01372605|583397896|FG000|Overall Study|Moved|3|||
161548560|NCT01372605|583397897|FG001|Overall Study|Moved|0|||
161548561|NCT01372605|583397896|FG000|Overall Study|Changed medical home|2|||
161548562|NCT01372605|583397897|FG001|Overall Study|Changed medical home|0|||
161548563|NCT01830881|583397898|FG000|Overall Study|Changed decision to have an abortion|0|||
161548564|NCT01830881|583397899|FG001|Overall Study|Changed decision to have an abortion|1|||
161548565|NCT03856996|583397900|FG000|Overall Study|Withdrawal by Subject|1|||
161548566|NCT03856996|583397901|FG001|Overall Study|Withdrawal by Subject|0|||
161548567|NCT03856996|583397900|FG000|Overall Study|Lost to Follow-up|0|||
161548568|NCT03856996|583397901|FG001|Overall Study|Lost to Follow-up|1|||
161548569|NCT03856996|583397900|FG000|Overall Study|Adverse Event|1|||
161548570|NCT03856996|583397901|FG001|Overall Study|Adverse Event|1|||
161548571|NCT03856996|583397900|FG000|Overall Study|Other|1|||
161548572|NCT03856996|583397901|FG001|Overall Study|Other|0|||
161548573|NCT04362137|583397904|FG000|Overall Study|Death|9|||
161548574|NCT04362137|583397905|FG001|Overall Study|Death|3|||
161548575|NCT04362137|583397904|FG000|Overall Study|Patient decision|6|||
161548576|NCT04362137|583397905|FG001|Overall Study|Patient decision|3|||
161548577|NCT04362137|583397904|FG000|Overall Study|Adverse Event|1|||
161548578|NCT04362137|583397905|FG001|Overall Study|Adverse Event|0|||
161548579|NCT04362137|583397904|FG000|Overall Study|Lost to Follow-up|1|||
161548580|NCT04362137|583397905|FG001|Overall Study|Lost to Follow-up|0|||
161548581|NCT04362137|583397904|FG000|Overall Study|Protocol deviation|1|||
161548582|NCT04362137|583397905|FG001|Overall Study|Protocol deviation|0|||
161548583|NCT03679767|583397909|FG000|Overall Study|Death|16|||
161548584|NCT03679767|583397910|FG001|Overall Study|Death|11|||
161548585|NCT03679767|583397911|FG002|Overall Study|Death|17|||
161548586|NCT03679767|583397912|FG003|Overall Study|Death|10|||
161548587|NCT03679767|583397909|FG000|Overall Study|Lost to Follow-up|1|||
161548588|NCT03679767|583397910|FG001|Overall Study|Lost to Follow-up|1|||
161548589|NCT03679767|583397911|FG002|Overall Study|Lost to Follow-up|1|||
161548590|NCT03679767|583397912|FG003|Overall Study|Lost to Follow-up|1|||
161548591|NCT03679767|583397909|FG000|Overall Study|Withdrawal by Subject|0|||
161548592|NCT03679767|583397910|FG001|Overall Study|Withdrawal by Subject|0|||
161548593|NCT03679767|583397911|FG002|Overall Study|Withdrawal by Subject|0|||
161548594|NCT03679767|583397912|FG003|Overall Study|Withdrawal by Subject|1|||
161548595|NCT03679767|583397909|FG000|Overall Study|Follow-up Completed|18|||
161548596|NCT03679767|583397910|FG001|Overall Study|Follow-up Completed|11|||
161548597|NCT03679767|583397911|FG002|Overall Study|Follow-up Completed|11|||
161548598|NCT03679767|583397912|FG003|Overall Study|Follow-up Completed|20|||
161548599|NCT03679767|583397909|FG000|Overall Study|Entered Hospice Care|0|||
161548600|NCT03679767|583397910|FG001|Overall Study|Entered Hospice Care|0|||
161548601|NCT03679767|583397911|FG002|Overall Study|Entered Hospice Care|0|||
161548602|NCT03679767|583397912|FG003|Overall Study|Entered Hospice Care|1|||
161548603|NCT03679767|583397909|FG000|Overall Study|Progressive Disease|0|||
161548604|NCT03679767|583397910|FG001|Overall Study|Progressive Disease|0|||
161548605|NCT03679767|583397911|FG002|Overall Study|Progressive Disease|0|||
161548606|NCT03679767|583397912|FG003|Overall Study|Progressive Disease|1|||
161548607|NCT03556358|583397913|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
161548608|NCT03556358|583397914|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
161548609|NCT03556358|583397913|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
161596098|NCT04948697|583574478|FG001|Overall Study|Physician Decision|2|||
161596099|NCT04948697|583574477|FG000|Overall Study|Lost to Follow-up|0|||
161596100|NCT04948697|583574478|FG001|Overall Study|Lost to Follow-up|1|||
161596101|NCT04948697|583574477|FG000|Overall Study|Other-Miscellaneous|1|||
161596102|NCT04948697|583574478|FG001|Overall Study|Other-Miscellaneous|0|||
161596103|NCT04948697|583574477|FG000|Overall Study|Randomized but not treated|0|||
161596104|NCT04948697|583574478|FG001|Overall Study|Randomized but not treated|1|||
161596105|NCT04599062|583574479|FG000|Overall Study|Physician Decision|1|||
161596106|NCT04599062|583574480|FG001|Overall Study|Physician Decision|0|||
161596107|NCT04032704|583574481|FG000|Part A|Withdrawal by Subject|0|||
161596108|NCT04032704|583574482|FG001|Part A|Withdrawal by Subject|0|||
161596109|NCT04032704|583574483|FG002|Part A|Withdrawal by Subject|3|||
161596110|NCT04032704|583574484|FG003|Part A|Withdrawal by Subject|0|||
161596111|NCT04032704|583574485|FG004|Part A|Withdrawal by Subject|1|||
161596112|NCT04032704|583574486|FG005|Part A|Withdrawal by Subject|7|||
161596113|NCT04032704|583574487|FG006|Part A|Withdrawal by Subject|0|||
161596114|NCT04032704|583574488|FG007|Part A|Withdrawal by Subject|0|||
161596115|NCT04032704|583574489|FG008|Part A|Withdrawal by Subject|0|||
161596116|NCT04032704|583574490|FG009|Part A|Withdrawal by Subject|0|||
161596117|NCT04032704|583574491|FG010|Part A|Withdrawal by Subject|0|||
161596118|NCT04032704|583574492|FG011|Part A|Withdrawal by Subject|0|||
161596119|NCT04032704|583574493|FG012|Part A|Withdrawal by Subject|0|||
161596120|NCT04032704|583574494|FG013|Part A|Withdrawal by Subject|0|||
161596121|NCT04032704|583574495|FG014|Part A|Withdrawal by Subject|0|||
161596122|NCT04032704|583574496|FG015|Part A|Withdrawal by Subject|0|||
161596123|NCT04032704|583574497|FG016|Part A|Withdrawal by Subject|0|||
161596124|NCT04032704|583574498|FG017|Part A|Withdrawal by Subject|0|||
161596125|NCT04032704|583574481|FG000|Part A|Lost to Follow-up|1|||
161596126|NCT04032704|583574482|FG001|Part A|Lost to Follow-up|0|||
161596127|NCT04032704|583574483|FG002|Part A|Lost to Follow-up|0|||
161596128|NCT04032704|583574484|FG003|Part A|Lost to Follow-up|0|||
161596129|NCT04032704|583574485|FG004|Part A|Lost to Follow-up|0|||
161596130|NCT04032704|583574486|FG005|Part A|Lost to Follow-up|0|||
161596131|NCT04032704|583574487|FG006|Part A|Lost to Follow-up|0|||
161596132|NCT04032704|583574488|FG007|Part A|Lost to Follow-up|0|||
161596133|NCT04032704|583574489|FG008|Part A|Lost to Follow-up|0|||
161596134|NCT04032704|583574490|FG009|Part A|Lost to Follow-up|0|||
161596135|NCT04032704|583574491|FG010|Part A|Lost to Follow-up|0|||
161596136|NCT04032704|583574492|FG011|Part A|Lost to Follow-up|0|||
161596137|NCT04032704|583574493|FG012|Part A|Lost to Follow-up|0|||
161596138|NCT04032704|583574494|FG013|Part A|Lost to Follow-up|0|||
161596139|NCT04032704|583574495|FG014|Part A|Lost to Follow-up|0|||
161596140|NCT04032704|583574496|FG015|Part A|Lost to Follow-up|0|||
161596141|NCT04032704|583574497|FG016|Part A|Lost to Follow-up|0|||
161596142|NCT04032704|583574498|FG017|Part A|Lost to Follow-up|0|||
161596143|NCT04032704|583574481|FG000|Part A|Death|9|||
161596144|NCT04032704|583574482|FG001|Part A|Death|2|||
161596145|NCT04032704|583574483|FG002|Part A|Death|10|||
161596146|NCT04032704|583574484|FG003|Part A|Death|7|||
161596147|NCT04032704|583574485|FG004|Part A|Death|4|||
161596148|NCT04032704|583574486|FG005|Part A|Death|5|||
161596149|NCT04032704|583574487|FG006|Part A|Death|0|||
161596150|NCT04032704|583574488|FG007|Part A|Death|0|||
161596151|NCT04032704|583574489|FG008|Part A|Death|0|||
161596152|NCT04032704|583574490|FG009|Part A|Death|0|||
161596153|NCT04032704|583574491|FG010|Part A|Death|0|||
161596154|NCT04032704|583574492|FG011|Part A|Death|0|||
161596155|NCT04032704|583574493|FG012|Part A|Death|0|||
161596156|NCT04032704|583574494|FG013|Part A|Death|0|||
161596157|NCT04032704|583574495|FG014|Part A|Death|0|||
161596158|NCT04032704|583574496|FG015|Part A|Death|0|||
161596159|NCT04032704|583574497|FG016|Part A|Death|0|||
161596160|NCT04032704|583574498|FG017|Part A|Death|0|||
161596161|NCT04032704|583574481|FG000|Part B|Other|0|||
161596162|NCT04032704|583574482|FG001|Part B|Other|0|||
161596163|NCT04032704|583574483|FG002|Part B|Other|0|||
161596164|NCT04032704|583574484|FG003|Part B|Other|0|||
161596165|NCT04032704|583574485|FG004|Part B|Other|0|||
161596166|NCT04032704|583574486|FG005|Part B|Other|0|||
161596167|NCT04032704|583574487|FG006|Part B|Other|0|||
161596168|NCT04032704|583574488|FG007|Part B|Other|1|||
161596169|NCT04032704|583574489|FG008|Part B|Other|2|||
161596170|NCT04032704|583574490|FG009|Part B|Other|1|||
161596171|NCT04032704|583574491|FG010|Part B|Other|1|||
161596172|NCT04032704|583574492|FG011|Part B|Other|1|||
161596173|NCT04032704|583574493|FG012|Part B|Other|5|||
161596174|NCT04032704|583574494|FG013|Part B|Other|13|||
161596175|NCT04032704|583574495|FG014|Part B|Other|0|||
161596176|NCT04032704|583574496|FG015|Part B|Other|0|||
161596177|NCT04032704|583574497|FG016|Part B|Other|0|||
161596178|NCT04032704|583574498|FG017|Part B|Other|0|||
161596179|NCT04032704|583574481|FG000|Part B|Study termination by Sponsor|0|||
161596180|NCT04032704|583574482|FG001|Part B|Study termination by Sponsor|0|||
161596181|NCT04032704|583574483|FG002|Part B|Study termination by Sponsor|0|||
161596182|NCT04032704|583574484|FG003|Part B|Study termination by Sponsor|0|||
161596183|NCT04032704|583574485|FG004|Part B|Study termination by Sponsor|0|||
161596184|NCT04032704|583574486|FG005|Part B|Study termination by Sponsor|0|||
161596185|NCT04032704|583574487|FG006|Part B|Study termination by Sponsor|0|||
161596186|NCT04032704|583574488|FG007|Part B|Study termination by Sponsor|0|||
161596187|NCT04032704|583574489|FG008|Part B|Study termination by Sponsor|1|||
161596188|NCT04032704|583574490|FG009|Part B|Study termination by Sponsor|0|||
161596189|NCT04032704|583574491|FG010|Part B|Study termination by Sponsor|0|||
161596190|NCT04032704|583574492|FG011|Part B|Study termination by Sponsor|0|||
161596191|NCT04032704|583574493|FG012|Part B|Study termination by Sponsor|0|||
161596192|NCT04032704|583574494|FG013|Part B|Study termination by Sponsor|0|||
161596193|NCT04032704|583574495|FG014|Part B|Study termination by Sponsor|0|||
161596194|NCT04032704|583574496|FG015|Part B|Study termination by Sponsor|0|||
161596195|NCT04032704|583574497|FG016|Part B|Study termination by Sponsor|0|||
161596196|NCT04032704|583574498|FG017|Part B|Study termination by Sponsor|0|||
161596197|NCT04032704|583574481|FG000|Part B|Withdrawal by Subject|0|||
161596198|NCT04032704|583574482|FG001|Part B|Withdrawal by Subject|0|||
161596199|NCT04032704|583574483|FG002|Part B|Withdrawal by Subject|0|||
161596200|NCT04032704|583574484|FG003|Part B|Withdrawal by Subject|0|||
161596201|NCT04032704|583574485|FG004|Part B|Withdrawal by Subject|0|||
161596202|NCT04032704|583574486|FG005|Part B|Withdrawal by Subject|0|||
161596203|NCT04032704|583574487|FG006|Part B|Withdrawal by Subject|3|||
161596204|NCT04032704|583574488|FG007|Part B|Withdrawal by Subject|2|||
161596205|NCT04032704|583574489|FG008|Part B|Withdrawal by Subject|2|||
161596206|NCT04032704|583574490|FG009|Part B|Withdrawal by Subject|1|||
161596207|NCT04032704|583574491|FG010|Part B|Withdrawal by Subject|4|||
161596208|NCT04032704|583574492|FG011|Part B|Withdrawal by Subject|6|||
161596209|NCT04032704|583574493|FG012|Part B|Withdrawal by Subject|2|||
161596210|NCT04032704|583574494|FG013|Part B|Withdrawal by Subject|1|||
161596211|NCT04032704|583574495|FG014|Part B|Withdrawal by Subject|0|||
161596212|NCT04032704|583574496|FG015|Part B|Withdrawal by Subject|1|||
161596213|NCT04032704|583574497|FG016|Part B|Withdrawal by Subject|0|||
161596214|NCT04032704|583574498|FG017|Part B|Withdrawal by Subject|0|||
161596215|NCT04032704|583574481|FG000|Part B|Lost to Follow-up|0|||
161596216|NCT04032704|583574482|FG001|Part B|Lost to Follow-up|0|||
161596217|NCT04032704|583574483|FG002|Part B|Lost to Follow-up|0|||
161596218|NCT04032704|583574484|FG003|Part B|Lost to Follow-up|0|||
161596219|NCT04032704|583574485|FG004|Part B|Lost to Follow-up|0|||
161596220|NCT04032704|583574486|FG005|Part B|Lost to Follow-up|0|||
161596221|NCT04032704|583574487|FG006|Part B|Lost to Follow-up|0|||
161596222|NCT04032704|583574488|FG007|Part B|Lost to Follow-up|0|||
161596223|NCT04032704|583574489|FG008|Part B|Lost to Follow-up|0|||
161596224|NCT04032704|583574490|FG009|Part B|Lost to Follow-up|0|||
161596225|NCT04032704|583574491|FG010|Part B|Lost to Follow-up|0|||
161596226|NCT04032704|583574492|FG011|Part B|Lost to Follow-up|1|||
161596227|NCT04032704|583574493|FG012|Part B|Lost to Follow-up|0|||
161596228|NCT04032704|583574494|FG013|Part B|Lost to Follow-up|0|||
161596229|NCT04032704|583574495|FG014|Part B|Lost to Follow-up|0|||
161596230|NCT04032704|583574496|FG015|Part B|Lost to Follow-up|0|||
161596231|NCT04032704|583574497|FG016|Part B|Lost to Follow-up|0|||
161596232|NCT04032704|583574498|FG017|Part B|Lost to Follow-up|0|||
161596233|NCT04032704|583574481|FG000|Part B|Death|0|||
161596234|NCT04032704|583574482|FG001|Part B|Death|0|||
161596235|NCT04032704|583574483|FG002|Part B|Death|0|||
161596236|NCT04032704|583574484|FG003|Part B|Death|0|||
161596237|NCT04032704|583574485|FG004|Part B|Death|0|||
161596238|NCT04032704|583574486|FG005|Part B|Death|0|||
161596239|NCT04032704|583574487|FG006|Part B|Death|13|||
161596240|NCT04032704|583574488|FG007|Part B|Death|13|||
161596241|NCT04032704|583574489|FG008|Part B|Death|14|||
161596242|NCT04032704|583574490|FG009|Part B|Death|12|||
161596243|NCT04032704|583574491|FG010|Part B|Death|12|||
161681410|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681411|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681412|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
161681413|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
161681414|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
161681415|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
161681416|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
161681417|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
161596244|NCT04032704|583574492|FG011|Part B|Death|13|||
161596245|NCT04032704|583574493|FG012|Part B|Death|7|||
161596246|NCT04032704|583574494|FG013|Part B|Death|17|||
161596247|NCT04032704|583574495|FG014|Part B|Death|2|||
161596248|NCT04032704|583574496|FG015|Part B|Death|1|||
161596249|NCT04032704|583574497|FG016|Part B|Death|2|||
161596250|NCT04032704|583574498|FG017|Part B|Death|2|||
161596251|NCT03020199|583574505|FG000|Treatment Period|Adverse Event|0|||
161596252|NCT03020199|583574506|FG001|Treatment Period|Adverse Event|2|||
161596253|NCT03020199|583574505|FG000|Treatment Period|Lack of Efficacy|1|||
161596254|NCT03020199|583574506|FG001|Treatment Period|Lack of Efficacy|6|||
161596255|NCT03020199|583574505|FG000|Treatment Period|Lost to Follow-up|1|||
161596256|NCT03020199|583574506|FG001|Treatment Period|Lost to Follow-up|6|||
161596257|NCT03020199|583574505|FG000|Treatment Period|Physician Decision|0|||
161596258|NCT03020199|583574506|FG001|Treatment Period|Physician Decision|1|||
161596259|NCT03020199|583574505|FG000|Treatment Period|Subject/guardian decision|8|||
161830380|NCT03877926|584420092|FG002|Overall Study|Withdrawal by Subject|12|||
161830381|NCT03877926|584420093|FG003|Overall Study|Withdrawal by Subject|4|||
161830382|NCT03877926|584420090|FG000|Overall Study|Other - Various|4|||
161830383|NCT03877926|584420091|FG001|Overall Study|Other - Various|1|||
161830384|NCT03877926|584420092|FG002|Overall Study|Other - Various|1|||
161830385|NCT03877926|584420093|FG003|Overall Study|Other - Various|0|||
161830386|NCT03877926|584420090|FG000|Overall Study|Not Treated|3|||
161830387|NCT03877926|584420091|FG001|Overall Study|Not Treated|1|||
161830388|NCT03877926|584420092|FG002|Overall Study|Not Treated|1|||
161830389|NCT03877926|584420093|FG003|Overall Study|Not Treated|0|||
161830390|NCT03546647|584420094|FG000|Overall Study|Adverse Event|1|||
161548610|NCT03556358|583397914|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
161548611|NCT03556358|583397913|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
161596260|NCT03020199|583574506|FG001|Treatment Period|Subject/guardian decision|15|||
161596261|NCT03020199|583574505|FG000|Treatment Period|Subjects not treated|3|||
161596262|NCT03020199|583574506|FG001|Treatment Period|Subjects not treated|4|||
161596263|NCT03020199|583574505|FG000|Follow-up Period|Disease relapse|32|||
161596264|NCT03020199|583574506|FG001|Follow-up Period|Disease relapse|7|||
161596265|NCT03020199|583574505|FG000|Follow-up Period|Lack of Efficacy|1|||
161596266|NCT03020199|583574506|FG001|Follow-up Period|Lack of Efficacy|2|||
161596267|NCT03020199|583574505|FG000|Follow-up Period|Lost to Follow-up|4|||
161596268|NCT03020199|583574506|FG001|Follow-up Period|Lost to Follow-up|6|||
161596269|NCT03020199|583574505|FG000|Follow-up Period|Physician Decision|2|||
161596270|NCT03020199|583574506|FG001|Follow-up Period|Physician Decision|2|||
161596271|NCT03020199|583574505|FG000|Follow-up Period|Protocol Violation|1|||
161596272|NCT03020199|583574506|FG001|Follow-up Period|Protocol Violation|2|||
161596273|NCT03020199|583574505|FG000|Follow-up Period|Study terminated by Sponsor|6|||
161596274|NCT03020199|583574506|FG001|Follow-up Period|Study terminated by Sponsor|3|||
161596275|NCT03020199|583574505|FG000|Follow-up Period|Subject/guardian decision|14|||
161596276|NCT03020199|583574506|FG001|Follow-up Period|Subject/guardian decision|9|||
161596277|NCT05583578|583574507|FG000|Overall Study|Withdrawal by Subject|2|||
161596278|NCT05583578|583574508|FG001|Overall Study|Withdrawal by Subject|0|||
161596279|NCT05877976|583574509|FG000|Overall Study|Lost to Follow-up|31|||
161681418|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
161681419|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
161681420|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
161681421|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
161681422|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
161681423|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
161681424|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
161681425|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
161830391|NCT03546647|584420095|FG001|Overall Study|Adverse Event|0|||
161830392|NCT02487082|584420096|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
161596290|NCT00248287|583574512|FG000|Overall Study|Adverse Event|11|||
161596291|NCT00248287|583574513|FG001|Overall Study|Adverse Event|10|||
161596292|NCT00248287|583574512|FG000|Overall Study|Death|1|||
161596293|NCT00248287|583574513|FG001|Overall Study|Death|0|||
161596294|NCT00248287|583574512|FG000|Overall Study|Lost to Follow-up|0|||
161596295|NCT00248287|583574513|FG001|Overall Study|Lost to Follow-up|1|||
161596296|NCT00248287|583574512|FG000|Overall Study|Investigator Request|4|||
161596297|NCT00248287|583574513|FG001|Overall Study|Investigator Request|3|||
161596298|NCT00248287|583574512|FG000|Overall Study|Patient Request|5|||
161596299|NCT00248287|583574513|FG001|Overall Study|Patient Request|3|||
161596300|NCT00248287|583574512|FG000|Overall Study|Other|3|||
161596301|NCT00248287|583574513|FG001|Overall Study|Other|2|||
161596302|NCT02714257|583574514|FG000|Overall Study|Withdrawal by Subject|6|||
161596303|NCT02714257|583574515|FG001|Overall Study|Withdrawal by Subject|11|||
161596304|NCT02714257|583574514|FG000|Overall Study|Death|3|||
161596305|NCT02714257|583574515|FG001|Overall Study|Death|4|||
161596306|NCT02714257|583574514|FG000|Overall Study|Lost to Follow-up|1|||
161596307|NCT02714257|583574515|FG001|Overall Study|Lost to Follow-up|6|||
161548612|NCT03556358|583397914|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
161596308|NCT04145440|583574516|FG000|Overall Study|Physician Decision|3|||
161596309|NCT04145440|583574517|FG001|Overall Study|Physician Decision|0|||
161596310|NCT04145440|583574516|FG000|Overall Study|Use of prohibited therapy|2|||
161830393|NCT02487082|584420097|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
161830394|NCT02487082|584420096|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
161830395|NCT02487082|584420097|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
161548613|NCT03556358|583397913|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
161596311|NCT04145440|583574517|FG001|Overall Study|Use of prohibited therapy|3|||
161548614|NCT03556358|583397914|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
161548615|NCT03556358|583397913|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
161548616|NCT03556358|583397914|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
161596312|NCT05808257|583574522|FG000|Overall Study|Lost to Follow-up|8|||
161596313|NCT05808257|583574523|FG001|Overall Study|Lost to Follow-up|8|||
161596314|NCT04907851|583574526|FG000|Overall Study|Consent withdrawn|1|||
161596315|NCT04907851|583574527|FG001|Overall Study|Consent withdrawn|2|||
161596316|NCT04907851|583574528|FG002|Overall Study|Consent withdrawn|0|||
161596317|NCT04907851|583574526|FG000|Overall Study|Death|5|||
161596318|NCT04907851|583574527|FG001|Overall Study|Death|15|||
161596319|NCT04907851|583574528|FG002|Overall Study|Death|10|||
161596320|NCT04248725|583574531|FG000|Post-Treatment|Lost to Follow-up|6|||
161596321|NCT04248725|583574532|FG001|Post-Treatment|Lost to Follow-up|5|||
161596322|NCT04248725|583574531|FG000|6-Month Follow Up|Lost to Follow-up|9|||
161596323|NCT04248725|583574532|FG001|6-Month Follow Up|Lost to Follow-up|8|||
161596324|NCT04436276|583574541|FG000|Overall Study|Adverse Event|0|||
161596325|NCT04436276|583574542|FG001|Overall Study|Adverse Event|0|||
161596326|NCT04436276|583574543|FG002|Overall Study|Adverse Event|0|||
161596327|NCT04436276|583574544|FG003|Overall Study|Adverse Event|0|||
161596328|NCT04436276|583574545|FG004|Overall Study|Adverse Event|0|||
161596329|NCT04436276|583574546|FG005|Overall Study|Adverse Event|0|||
161596330|NCT04436276|583574547|FG006|Overall Study|Adverse Event|0|||
161596331|NCT04436276|583574548|FG007|Overall Study|Adverse Event|0|||
161596332|NCT04436276|583574549|FG008|Overall Study|Adverse Event|0|||
161596333|NCT04436276|583574550|FG009|Overall Study|Adverse Event|0|||
161596334|NCT04436276|583574551|FG010|Overall Study|Adverse Event|0|||
161596335|NCT04436276|583574552|FG011|Overall Study|Adverse Event|0|||
161596336|NCT04436276|583574553|FG012|Overall Study|Adverse Event|0|||
161596337|NCT04436276|583574554|FG013|Overall Study|Adverse Event|0|||
161596338|NCT04436276|583574555|FG014|Overall Study|Adverse Event|0|||
161596339|NCT04436276|583574556|FG015|Overall Study|Adverse Event|0|||
161596340|NCT04436276|583574557|FG016|Overall Study|Adverse Event|1|||
161596341|NCT04436276|583574558|FG017|Overall Study|Adverse Event|0|||
161596342|NCT04436276|583574559|FG018|Overall Study|Adverse Event|0|||
161596343|NCT04436276|583574560|FG019|Overall Study|Adverse Event|0|||
161596344|NCT04436276|583574561|FG020|Overall Study|Adverse Event|0|||
161596345|NCT04436276|583574562|FG021|Overall Study|Adverse Event|0|||
161596346|NCT04436276|583574563|FG022|Overall Study|Adverse Event|0|||
161596347|NCT04436276|583574541|FG000|Overall Study|Death|0|||
161596348|NCT04436276|583574542|FG001|Overall Study|Death|0|||
161596349|NCT04436276|583574543|FG002|Overall Study|Death|0|||
161596350|NCT04436276|583574544|FG003|Overall Study|Death|0|||
161596351|NCT04436276|583574545|FG004|Overall Study|Death|0|||
161596352|NCT04436276|583574546|FG005|Overall Study|Death|0|||
161596353|NCT04436276|583574547|FG006|Overall Study|Death|0|||
161596354|NCT04436276|583574548|FG007|Overall Study|Death|0|||
161596355|NCT04436276|583574549|FG008|Overall Study|Death|0|||
161596356|NCT04436276|583574550|FG009|Overall Study|Death|0|||
161596357|NCT04436276|583574551|FG010|Overall Study|Death|0|||
161596358|NCT04436276|583574552|FG011|Overall Study|Death|0|||
161596359|NCT04436276|583574553|FG012|Overall Study|Death|1|||
161596360|NCT04436276|583574554|FG013|Overall Study|Death|0|||
161596361|NCT04436276|583574555|FG014|Overall Study|Death|1|||
161596362|NCT04436276|583574556|FG015|Overall Study|Death|0|||
161596363|NCT04436276|583574557|FG016|Overall Study|Death|0|||
161596364|NCT04436276|583574558|FG017|Overall Study|Death|0|||
161596365|NCT04436276|583574559|FG018|Overall Study|Death|0|||
161596366|NCT04436276|583574560|FG019|Overall Study|Death|2|||
161596367|NCT04436276|583574561|FG020|Overall Study|Death|0|||
161596368|NCT04436276|583574562|FG021|Overall Study|Death|1|||
161596369|NCT04436276|583574563|FG022|Overall Study|Death|0|||
161596370|NCT04436276|583574541|FG000|Overall Study|Lost to Follow-up|0|||
161681426|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
161681427|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
161681428|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
161596371|NCT04436276|583574542|FG001|Overall Study|Lost to Follow-up|2|||
161596372|NCT04436276|583574543|FG002|Overall Study|Lost to Follow-up|2|||
161596373|NCT04436276|583574544|FG003|Overall Study|Lost to Follow-up|1|||
161596374|NCT04436276|583574545|FG004|Overall Study|Lost to Follow-up|4|||
161596375|NCT04436276|583574546|FG005|Overall Study|Lost to Follow-up|1|||
161681429|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
161596376|NCT04436276|583574547|FG006|Overall Study|Lost to Follow-up|0|||
161596377|NCT04436276|583574548|FG007|Overall Study|Lost to Follow-up|0|||
161596378|NCT04436276|583574549|FG008|Overall Study|Lost to Follow-up|1|||
161596379|NCT04436276|583574550|FG009|Overall Study|Lost to Follow-up|0|||
161596380|NCT04436276|583574551|FG010|Overall Study|Lost to Follow-up|5|||
161596381|NCT04436276|583574552|FG011|Overall Study|Lost to Follow-up|5|||
161596382|NCT04436276|583574553|FG012|Overall Study|Lost to Follow-up|4|||
161596383|NCT04436276|583574554|FG013|Overall Study|Lost to Follow-up|1|||
161596384|NCT04436276|583574555|FG014|Overall Study|Lost to Follow-up|7|||
161596385|NCT04436276|583574556|FG015|Overall Study|Lost to Follow-up|7|||
161596386|NCT04436276|583574557|FG016|Overall Study|Lost to Follow-up|1|||
161596387|NCT04436276|583574558|FG017|Overall Study|Lost to Follow-up|0|||
161596388|NCT04436276|583574559|FG018|Overall Study|Lost to Follow-up|1|||
161596389|NCT04436276|583574560|FG019|Overall Study|Lost to Follow-up|1|||
161596390|NCT04436276|583574561|FG020|Overall Study|Lost to Follow-up|2|||
161596391|NCT04436276|583574562|FG021|Overall Study|Lost to Follow-up|1|||
161681430|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
161596392|NCT04436276|583574563|FG022|Overall Study|Lost to Follow-up|1|||
161596393|NCT04436276|583574541|FG000|Overall Study|Physician Decision|1|||
161596394|NCT04436276|583574542|FG001|Overall Study|Physician Decision|0|||
161596395|NCT04436276|583574543|FG002|Overall Study|Physician Decision|2|||
161596396|NCT04436276|583574544|FG003|Overall Study|Physician Decision|1|||
161596397|NCT04436276|583574545|FG004|Overall Study|Physician Decision|0|||
161596398|NCT04436276|583574546|FG005|Overall Study|Physician Decision|0|||
161596399|NCT04436276|583574547|FG006|Overall Study|Physician Decision|0|||
161596400|NCT04436276|583574548|FG007|Overall Study|Physician Decision|0|||
161596401|NCT04436276|583574549|FG008|Overall Study|Physician Decision|0|||
161596402|NCT04436276|583574550|FG009|Overall Study|Physician Decision|0|||
161596403|NCT04436276|583574551|FG010|Overall Study|Physician Decision|0|||
161681431|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
161681432|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
161681433|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
161681434|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
161681435|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
161681436|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
161681437|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
161681438|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
161681439|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
161681440|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
161681441|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
161681442|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
161681443|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
161681444|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
161681445|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
161681446|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
161681447|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
161681448|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
161681449|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161681450|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161681451|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161681452|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
161681453|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161681454|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161681455|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161681456|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
161681457|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161681458|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161681459|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161681460|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
161681461|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161681462|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161681463|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161596404|NCT04436276|583574552|FG011|Overall Study|Physician Decision|1|||
161596405|NCT04436276|583574553|FG012|Overall Study|Physician Decision|2|||
161596406|NCT04436276|583574554|FG013|Overall Study|Physician Decision|0|||
161596407|NCT04436276|583574555|FG014|Overall Study|Physician Decision|0|||
161681464|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
161681465|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
161681466|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
161681467|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
161681468|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
161681469|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161681470|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161681471|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161681472|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
161681473|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
161681474|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
161681475|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
161681476|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
161681477|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
161681478|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
161681479|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
161681480|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
161596408|NCT04436276|583574556|FG015|Overall Study|Physician Decision|0|||
161596409|NCT04436276|583574557|FG016|Overall Study|Physician Decision|0|||
161596410|NCT04436276|583574558|FG017|Overall Study|Physician Decision|0|||
161596411|NCT04436276|583574559|FG018|Overall Study|Physician Decision|0|||
161681481|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
161830396|NCT00612677|584420099|FG000|Overall Study|study closed before treatment started|1|||
161830397|NCT00268892|584420103|FG000|Overall Study|Adverse Event|14|||
161830398|NCT00268892|584420104|FG001|Overall Study|Adverse Event|17|||
161830399|NCT00268892|584420105|FG002|Overall Study|Adverse Event|20|||
161830400|NCT00268892|584420103|FG000|Overall Study|Lack of Efficacy|1|||
161830401|NCT00268892|584420104|FG001|Overall Study|Lack of Efficacy|3|||
161830402|NCT00268892|584420105|FG002|Overall Study|Lack of Efficacy|0|||
161830403|NCT00268892|584420103|FG000|Overall Study|Withdrawal by Subject|14|||
161830404|NCT00268892|584420104|FG001|Overall Study|Withdrawal by Subject|15|||
161830405|NCT00268892|584420105|FG002|Overall Study|Withdrawal by Subject|13|||
161830406|NCT00268892|584420103|FG000|Overall Study|Physician Decision|0|||
161830407|NCT00268892|584420104|FG001|Overall Study|Physician Decision|1|||
161830408|NCT00268892|584420105|FG002|Overall Study|Physician Decision|0|||
161830409|NCT00268892|584420103|FG000|Overall Study|Lost to Follow-up|5|||
161830410|NCT00268892|584420104|FG001|Overall Study|Lost to Follow-up|2|||
161830411|NCT00268892|584420105|FG002|Overall Study|Lost to Follow-up|4|||
161830412|NCT00268892|584420103|FG000|Overall Study|Protocol Violation|0|||
161830413|NCT00268892|584420104|FG001|Overall Study|Protocol Violation|1|||
161830414|NCT00268892|584420105|FG002|Overall Study|Protocol Violation|0|||
161830415|NCT00268892|584420103|FG000|Overall Study|Disease Progression|1|||
161830416|NCT00268892|584420104|FG001|Overall Study|Disease Progression|1|||
161830417|NCT00268892|584420105|FG002|Overall Study|Disease Progression|0|||
161830418|NCT00268892|584420103|FG000|Overall Study|Trial Site Closed|4|||
161830419|NCT00268892|584420104|FG001|Overall Study|Trial Site Closed|2|||
161830420|NCT00268892|584420105|FG002|Overall Study|Trial Site Closed|2|||
161830421|NCT04569786|584420109|FG000|Overall Study|Lost to Follow-up|1|||
161830422|NCT04569786|584420110|FG001|Overall Study|Lost to Follow-up|0|||
161830423|NCT04569786|584420111|FG002|Overall Study|Lost to Follow-up|4|||
161830424|NCT04569786|584420112|FG003|Overall Study|Lost to Follow-up|1|||
161548617|NCT03556358|583397913|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
161830425|NCT04569786|584420113|FG004|Overall Study|Lost to Follow-up|0|||
161830426|NCT04569786|584420109|FG000|Overall Study|Withdrawal by Subject|0|||
161830427|NCT04569786|584420110|FG001|Overall Study|Withdrawal by Subject|0|||
161830428|NCT04569786|584420111|FG002|Overall Study|Withdrawal by Subject|0|||
161830429|NCT04569786|584420112|FG003|Overall Study|Withdrawal by Subject|5|||
161830430|NCT04569786|584420113|FG004|Overall Study|Withdrawal by Subject|1|||
161830431|NCT04569786|584420109|FG000|Overall Study|Physician Decision|0|||
161830432|NCT04569786|584420110|FG001|Overall Study|Physician Decision|0|||
161830433|NCT04569786|584420111|FG002|Overall Study|Physician Decision|0|||
161830434|NCT04569786|584420112|FG003|Overall Study|Physician Decision|1|||
161830435|NCT04569786|584420113|FG004|Overall Study|Physician Decision|0|||
161830436|NCT01640184|584420122|FG000|Overall Study|Death|1|||
161830437|NCT01640184|584420123|FG001|Overall Study|Death|0|||
161830438|NCT01640184|584420124|FG002|Overall Study|Death|0|||
161830439|NCT01640184|584420122|FG000|Overall Study|Lost to Follow-up|4|||
161548618|NCT03556358|583397914|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
161548619|NCT03556358|583397913|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
161548620|NCT03556358|583397914|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
161548621|NCT05067933|583397921|FG000|Overall Study|Withdrawal by Subject|2|||
161548622|NCT05067933|583397922|FG001|Overall Study|Withdrawal by Subject|0|||
161548623|NCT05067933|583397923|FG002|Overall Study|Withdrawal by Subject|0|||
161548624|NCT05067933|583397924|FG003|Overall Study|Withdrawal by Subject|0|||
161548625|NCT05067933|583397925|FG004|Overall Study|Withdrawal by Subject|0|||
161548626|NCT05067933|583397926|FG005|Overall Study|Withdrawal by Subject|0|||
161548627|NCT05067933|583397921|FG000|Overall Study|Lost to Follow-up|1|||
161548628|NCT05067933|583397922|FG001|Overall Study|Lost to Follow-up|1|||
161548629|NCT05067933|583397923|FG002|Overall Study|Lost to Follow-up|1|||
161548630|NCT05067933|583397924|FG003|Overall Study|Lost to Follow-up|2|||
161548631|NCT05067933|583397925|FG004|Overall Study|Lost to Follow-up|1|||
161548632|NCT05067933|583397926|FG005|Overall Study|Lost to Follow-up|0|||
161548633|NCT05067933|583397921|FG000|Overall Study|Miscellaneous|1|||
161548634|NCT05067933|583397922|FG001|Overall Study|Miscellaneous|0|||
161548635|NCT05067933|583397923|FG002|Overall Study|Miscellaneous|0|||
161548636|NCT05067933|583397924|FG003|Overall Study|Miscellaneous|0|||
161548637|NCT05067933|583397925|FG004|Overall Study|Miscellaneous|0|||
161548638|NCT05067933|583397926|FG005|Overall Study|Miscellaneous|0|||
161548639|NCT05067933|583397921|FG000|Overall Study|Death|0|||
161548640|NCT05067933|583397922|FG001|Overall Study|Death|0|||
161548641|NCT05067933|583397923|FG002|Overall Study|Death|0|||
161548642|NCT05067933|583397924|FG003|Overall Study|Death|1|||
161548643|NCT05067933|583397925|FG004|Overall Study|Death|0|||
161548644|NCT05067933|583397926|FG005|Overall Study|Death|0|||
161548645|NCT01065350|583397927|FG000|Overall Study|Received incorrect drug allocation|0|||
161548646|NCT01065350|583397928|FG001|Overall Study|Received incorrect drug allocation|1|||
161548647|NCT02716038|583397929|FG000|Overall Study|Not evaluable|1|||
161548648|NCT02716038|583397929|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
161548649|NCT02716038|583397929|FG000|Overall Study|Unresectable|3|||
161548650|NCT00550550|583397930|FG000|Overall Study|Adverse Event|13|||
161548651|NCT00550550|583397931|FG001|Overall Study|Adverse Event|5|||
161548652|NCT00550550|583397930|FG000|Overall Study|Treatment Failure|0|||
161548653|NCT00550550|583397931|FG001|Overall Study|Treatment Failure|1|||
161596412|NCT04436276|583574560|FG019|Overall Study|Physician Decision|0|||
161596413|NCT04436276|583574561|FG020|Overall Study|Physician Decision|1|||
161596414|NCT04436276|583574562|FG021|Overall Study|Physician Decision|2|||
161596415|NCT04436276|583574563|FG022|Overall Study|Physician Decision|0|||
161596416|NCT04436276|583574541|FG000|Overall Study|Protocol Violation|0|||
161596417|NCT04436276|583574542|FG001|Overall Study|Protocol Violation|0|||
161596418|NCT04436276|583574543|FG002|Overall Study|Protocol Violation|0|||
161596419|NCT04436276|583574544|FG003|Overall Study|Protocol Violation|0|||
161596420|NCT04436276|583574545|FG004|Overall Study|Protocol Violation|0|||
161596421|NCT04436276|583574546|FG005|Overall Study|Protocol Violation|0|||
161596422|NCT04436276|583574547|FG006|Overall Study|Protocol Violation|0|||
161596423|NCT04436276|583574548|FG007|Overall Study|Protocol Violation|0|||
161596424|NCT04436276|583574549|FG008|Overall Study|Protocol Violation|0|||
161596425|NCT04436276|583574550|FG009|Overall Study|Protocol Violation|0|||
161596426|NCT04436276|583574551|FG010|Overall Study|Protocol Violation|0|||
161596427|NCT04436276|583574552|FG011|Overall Study|Protocol Violation|0|||
161596428|NCT04436276|583574553|FG012|Overall Study|Protocol Violation|0|||
161596429|NCT04436276|583574554|FG013|Overall Study|Protocol Violation|1|||
161596430|NCT04436276|583574555|FG014|Overall Study|Protocol Violation|0|||
161596431|NCT04436276|583574556|FG015|Overall Study|Protocol Violation|1|||
161596432|NCT04436276|583574557|FG016|Overall Study|Protocol Violation|0|||
161596433|NCT04436276|583574558|FG017|Overall Study|Protocol Violation|0|||
161596434|NCT04436276|583574559|FG018|Overall Study|Protocol Violation|0|||
161596435|NCT04436276|583574560|FG019|Overall Study|Protocol Violation|0|||
161596436|NCT04436276|583574561|FG020|Overall Study|Protocol Violation|0|||
161596437|NCT04436276|583574562|FG021|Overall Study|Protocol Violation|0|||
161596438|NCT04436276|583574563|FG022|Overall Study|Protocol Violation|0|||
161596439|NCT04436276|583574541|FG000|Overall Study|Withdrawal by Subject|25|||
161548654|NCT00550550|583397930|FG000|Overall Study|Lost to Follow-up|4|||
161548655|NCT00550550|583397931|FG001|Overall Study|Lost to Follow-up|0|||
161548656|NCT00550550|583397930|FG000|Overall Study|Withdrawal by Subject|10|||
161548657|NCT00550550|583397931|FG001|Overall Study|Withdrawal by Subject|8|||
161548658|NCT00550550|583397930|FG000|Overall Study|Protocol Violation|5|||
161548659|NCT00550550|583397931|FG001|Overall Study|Protocol Violation|14|||
161548660|NCT00550550|583397930|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
161548661|NCT00550550|583397931|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161548662|NCT00550550|583397930|FG000|Overall Study|Randomized But Not Treated|1|||
161548663|NCT00550550|583397931|FG001|Overall Study|Randomized But Not Treated|0|||
161548664|NCT00118092|583397936|FG000|Overall Study|Withdrawal by Subject|1|||
161548665|NCT00118092|583397936|FG000|Overall Study|Protocol Violation|1|||
161548666|NCT02459093|583397937|FG000|Overall Study|Protocol Violation|6|||
161548667|NCT02459093|583397938|FG001|Overall Study|Protocol Violation|11|||
161548668|NCT02459093|583397937|FG000|Overall Study|Lost to Follow-up|6|||
161548669|NCT02459093|583397938|FG001|Overall Study|Lost to Follow-up|7|||
161548670|NCT00591864|583397939|FG000|Overall Study|Incomplete Imaging|5|||
161548671|NCT01103960|583397942|FG000|Overall Study|Adverse Event|2|||
161548672|NCT01103960|583397943|FG001|Overall Study|Adverse Event|1|||
161548673|NCT01103960|583397942|FG000|Overall Study|Withdrawal by Subject|2|||
161548674|NCT01103960|583397943|FG001|Overall Study|Withdrawal by Subject|1|||
161548675|NCT01103960|583397942|FG000|Overall Study|Other|1|||
161548676|NCT01103960|583397943|FG001|Overall Study|Other|0|||
161548677|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
161548678|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
161548679|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
161548680|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
161548681|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
161548682|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
161548683|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
161548684|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
161548685|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161681482|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
161681483|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
161681484|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
161681485|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
161681486|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
161681487|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
161681488|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
161681489|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
161681490|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
161681491|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
161681492|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Death|0|||
161681493|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Death|25|||
161681494|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Death|13|||
161681495|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Death|4|||
161681496|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
161681497|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
161681498|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
161681499|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
161681500|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
161681501|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
161681502|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
161681503|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
161681504|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
161681505|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
161681506|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
161681507|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
161681508|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
161681509|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
161681510|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
161681511|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
161681512|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161681513|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
161681514|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161681515|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161681516|NCT03668600|583886177|FG000|Overall Study|Study Terminated by the Sponsor|157|||
161681517|NCT03668600|583886177|FG000|Overall Study|Protocol Violation|1|||
161681518|NCT03668600|583886177|FG000|Overall Study|Pregnancy|1|||
161681519|NCT03668600|583886177|FG000|Overall Study|Lost to Follow-up|7|||
161681520|NCT03668600|583886177|FG000|Overall Study|Withdrawal by Subject|56|||
161681521|NCT03668600|583886177|FG000|Overall Study|Lack of Efficacy|7|||
161681522|NCT03668600|583886177|FG000|Overall Study|Adverse Event|1|||
161681523|NCT01263483|583886179|FG000|Overall Study|Adverse Event|4|||
161681524|NCT01263483|583886180|FG001|Overall Study|Adverse Event|0|||
161681525|NCT01263483|583886181|FG002|Overall Study|Adverse Event|3|||
161681526|NCT01263483|583886179|FG000|Overall Study|Withdrawal by Subject|1|||
161681527|NCT01263483|583886180|FG001|Overall Study|Withdrawal by Subject|0|||
161681528|NCT01263483|583886181|FG002|Overall Study|Withdrawal by Subject|0|||
161681529|NCT01263483|583886179|FG000|Overall Study|Lack of Efficacy|2|||
161681530|NCT01263483|583886180|FG001|Overall Study|Lack of Efficacy|0|||
161681531|NCT01263483|583886181|FG002|Overall Study|Lack of Efficacy|0|||
161681532|NCT01263483|583886179|FG000|Overall Study|Protocol Violation|0|||
161681533|NCT01263483|583886180|FG001|Overall Study|Protocol Violation|1|||
161681534|NCT01263483|583886181|FG002|Overall Study|Protocol Violation|1|||
161681535|NCT01263483|583886179|FG000|Overall Study|Participant Unavailability|0|||
161681536|NCT01263483|583886180|FG001|Overall Study|Participant Unavailability|1|||
161681537|NCT01263483|583886181|FG002|Overall Study|Participant Unavailability|1|||
161681538|NCT01131676|583886186|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
161681539|NCT01131676|583886187|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
161681540|NCT01131676|583886188|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
161681541|NCT01131676|583886186|FG000|Discontinuation From Treatment|Not treated|4|||
161681542|NCT01131676|583886187|FG001|Discontinuation From Treatment|Not treated|2|||
161681543|NCT01131676|583886188|FG002|Discontinuation From Treatment|Not treated|2|||
161681544|NCT01131676|583886186|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
161681545|NCT01131676|583886187|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
161681546|NCT01131676|583886188|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
161681547|NCT01131676|583886186|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
161681548|NCT01131676|583886187|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
161681549|NCT01131676|583886188|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
161681550|NCT01131676|583886186|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
161681551|NCT01131676|583886187|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
161681552|NCT01131676|583886188|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
161681553|NCT01131676|583886186|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
161681554|NCT01131676|583886187|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
161681555|NCT01131676|583886188|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
161681556|NCT01131676|583886186|FG000|Discontinuation From Treatment|Other than those specified|162|||
161681557|NCT01131676|583886187|FG001|Discontinuation From Treatment|Other than those specified|142|||
161681558|NCT01131676|583886188|FG002|Discontinuation From Treatment|Other than those specified|125|||
161681559|NCT01131676|583886186|FG000|Discontinuation From Treatment|Adverse Event|303|||
161681560|NCT01131676|583886187|FG001|Discontinuation From Treatment|Adverse Event|267|||
161681561|NCT01131676|583886188|FG002|Discontinuation From Treatment|Adverse Event|273|||
161681562|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
161596440|NCT04436276|583574542|FG001|Overall Study|Withdrawal by Subject|22|||
161596441|NCT04436276|583574543|FG002|Overall Study|Withdrawal by Subject|24|||
161596442|NCT04436276|583574544|FG003|Overall Study|Withdrawal by Subject|23|||
161596443|NCT04436276|583574545|FG004|Overall Study|Withdrawal by Subject|14|||
161596444|NCT04436276|583574546|FG005|Overall Study|Withdrawal by Subject|0|||
161596445|NCT04436276|583574547|FG006|Overall Study|Withdrawal by Subject|0|||
161596446|NCT04436276|583574548|FG007|Overall Study|Withdrawal by Subject|1|||
161596447|NCT04436276|583574549|FG008|Overall Study|Withdrawal by Subject|0|||
161596448|NCT04436276|583574550|FG009|Overall Study|Withdrawal by Subject|1|||
161596449|NCT04436276|583574551|FG010|Overall Study|Withdrawal by Subject|17|||
161596450|NCT04436276|583574552|FG011|Overall Study|Withdrawal by Subject|7|||
161596451|NCT04436276|583574553|FG012|Overall Study|Withdrawal by Subject|10|||
161596452|NCT04436276|583574554|FG013|Overall Study|Withdrawal by Subject|6|||
161681563|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
161681564|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
161681565|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
161681566|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
161681567|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
161681568|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
161683072|NCT01843842|583891239|FG000|Overall Study|Do not meet inclusion criteria|1|||
161596453|NCT04436276|583574555|FG014|Overall Study|Withdrawal by Subject|20|||
161596454|NCT04436276|583574556|FG015|Overall Study|Withdrawal by Subject|6|||
161596455|NCT04436276|583574557|FG016|Overall Study|Withdrawal by Subject|11|||
161681569|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
161596456|NCT04436276|583574558|FG017|Overall Study|Withdrawal by Subject|4|||
161596457|NCT04436276|583574559|FG018|Overall Study|Withdrawal by Subject|14|||
161596458|NCT04436276|583574560|FG019|Overall Study|Withdrawal by Subject|24|||
161596459|NCT04436276|583574561|FG020|Overall Study|Withdrawal by Subject|24|||
161596460|NCT04436276|583574562|FG021|Overall Study|Withdrawal by Subject|16|||
161596461|NCT04436276|583574563|FG022|Overall Study|Withdrawal by Subject|14|||
161596462|NCT04436276|583574541|FG000|Overall Study|Other|3|||
161596463|NCT04436276|583574542|FG001|Overall Study|Other|2|||
161596464|NCT04436276|583574543|FG002|Overall Study|Other|5|||
161596465|NCT04436276|583574544|FG003|Overall Study|Other|9|||
161596466|NCT04436276|583574545|FG004|Overall Study|Other|23|||
161596467|NCT04436276|583574546|FG005|Overall Study|Other|1|||
161596468|NCT04436276|583574547|FG006|Overall Study|Other|0|||
161596469|NCT04436276|583574548|FG007|Overall Study|Other|0|||
161596470|NCT04436276|583574549|FG008|Overall Study|Other|0|||
161596471|NCT04436276|583574550|FG009|Overall Study|Other|0|||
161596472|NCT04436276|583574551|FG010|Overall Study|Other|3|||
161596473|NCT04436276|583574552|FG011|Overall Study|Other|1|||
161596474|NCT04436276|583574553|FG012|Overall Study|Other|1|||
161596475|NCT04436276|583574554|FG013|Overall Study|Other|2|||
161596476|NCT04436276|583574555|FG014|Overall Study|Other|3|||
161596477|NCT04436276|583574556|FG015|Overall Study|Other|0|||
161596478|NCT04436276|583574557|FG016|Overall Study|Other|0|||
161596479|NCT04436276|583574558|FG017|Overall Study|Other|6|||
161596480|NCT04436276|583574559|FG018|Overall Study|Other|1|||
161596481|NCT04436276|583574560|FG019|Overall Study|Other|0|||
161596482|NCT04436276|583574561|FG020|Overall Study|Other|2|||
161596483|NCT04436276|583574562|FG021|Overall Study|Other|2|||
161596484|NCT04436276|583574563|FG022|Overall Study|Other|60|||
161596485|NCT03656510|583574566|FG000|Overall Study|Lost to Follow-up|1|||
161596486|NCT03656510|583574567|FG001|Overall Study|Lost to Follow-up|0|||
161596487|NCT03656510|583574568|FG002|Overall Study|Lost to Follow-up|0|||
161596488|NCT03656510|583574569|FG003|Overall Study|Lost to Follow-up|0|||
161596489|NCT03656510|583574570|FG004|Overall Study|Lost to Follow-up|0|||
161596490|NCT03656510|583574571|FG005|Overall Study|Lost to Follow-up|0|||
161596491|NCT03656510|583574566|FG000|Overall Study|Withdrawal by Subject|1|||
161596492|NCT03656510|583574567|FG001|Overall Study|Withdrawal by Subject|1|||
161596493|NCT03656510|583574568|FG002|Overall Study|Withdrawal by Subject|0|||
161596494|NCT03656510|583574569|FG003|Overall Study|Withdrawal by Subject|1|||
161596495|NCT03656510|583574570|FG004|Overall Study|Withdrawal by Subject|0|||
161596496|NCT03656510|583574571|FG005|Overall Study|Withdrawal by Subject|0|||
161596497|NCT06457802|583574577|FG000|Overall Study|Early termination of study prior to participant completion|2|||
161596498|NCT06457802|583574578|FG001|Overall Study|Early termination of study prior to participant completion|2|||
161596499|NCT03819153|583574581|FG000|Overall Study|Withdrawal by Subject|20|||
161596500|NCT03819153|583574582|FG001|Overall Study|Withdrawal by Subject|28|||
161596501|NCT03819153|583574581|FG000|Overall Study|Lost to Follow-up|23|||
161596502|NCT03819153|583574582|FG001|Overall Study|Lost to Follow-up|30|||
161596503|NCT03974178|583574583|FG000|Overall Study|Death|0|||
161596504|NCT03974178|583574584|FG001|Overall Study|Death|1|||
161596505|NCT03899259|583574585|FG000|Overall Study|Adverse Event|5|||
161596506|NCT03899259|583574586|FG001|Overall Study|Adverse Event|4|||
161596507|NCT03899259|583574587|FG002|Overall Study|Adverse Event|6|||
161596508|NCT03899259|583574585|FG000|Overall Study|Lack of Efficacy|5|||
161596509|NCT03899259|583574586|FG001|Overall Study|Lack of Efficacy|0|||
161596510|NCT03899259|583574587|FG002|Overall Study|Lack of Efficacy|2|||
161596511|NCT03899259|583574585|FG000|Overall Study|Pregnancy|3|||
161596512|NCT03899259|583574586|FG001|Overall Study|Pregnancy|0|||
161596513|NCT03899259|583574587|FG002|Overall Study|Pregnancy|1|||
161596514|NCT03899259|583574585|FG000|Overall Study|Physician Decision|0|||
161596515|NCT03899259|583574586|FG001|Overall Study|Physician Decision|1|||
161596516|NCT03899259|583574587|FG002|Overall Study|Physician Decision|0|||
161596517|NCT03899259|583574585|FG000|Overall Study|Protocol Deviation|1|||
161596518|NCT03899259|583574586|FG001|Overall Study|Protocol Deviation|1|||
161596519|NCT03899259|583574587|FG002|Overall Study|Protocol Deviation|1|||
161596520|NCT03899259|583574585|FG000|Overall Study|Withdrawal by Subject|8|||
161596521|NCT03899259|583574586|FG001|Overall Study|Withdrawal by Subject|10|||
161596522|NCT03899259|583574587|FG002|Overall Study|Withdrawal by Subject|12|||
161596523|NCT03899259|583574585|FG000|Overall Study|Lost to Follow-up|5|||
161681570|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
161681571|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
161596524|NCT03899259|583574586|FG001|Overall Study|Lost to Follow-up|6|||
161596525|NCT03899259|583574587|FG002|Overall Study|Lost to Follow-up|2|||
161596526|NCT03899259|583574585|FG000|Overall Study|Lack of Adherence|1|||
161596527|NCT03899259|583574586|FG001|Overall Study|Lack of Adherence|0|||
161596528|NCT03899259|583574587|FG002|Overall Study|Lack of Adherence|0|||
161596529|NCT03899259|583574585|FG000|Overall Study|Screen Failure|1|||
161830440|NCT01640184|584420123|FG001|Overall Study|Lost to Follow-up|1|||
161830441|NCT01640184|584420124|FG002|Overall Study|Lost to Follow-up|0|||
161830442|NCT01640184|584420122|FG000|Overall Study|Physician Decision|3|||
161830443|NCT01640184|584420123|FG001|Overall Study|Physician Decision|0|||
161830444|NCT01640184|584420124|FG002|Overall Study|Physician Decision|0|||
161830445|NCT01640184|584420122|FG000|Overall Study|Withdrawal by Subject|0|||
161830446|NCT01640184|584420123|FG001|Overall Study|Withdrawal by Subject|1|||
161830447|NCT01640184|584420124|FG002|Overall Study|Withdrawal by Subject|1|||
161830448|NCT01640184|584420122|FG000|Overall Study|Protocol Violation|0|||
161830449|NCT01640184|584420123|FG001|Overall Study|Protocol Violation|0|||
161830450|NCT01640184|584420124|FG002|Overall Study|Protocol Violation|1|||
161830451|NCT01876368|584420127|FG000|Overall Study|Adverse Event|2|||
161830452|NCT01876368|584420128|FG001|Overall Study|Adverse Event|5|||
161830453|NCT01876368|584420127|FG000|Overall Study|Lack of Efficacy|1|||
161830454|NCT01876368|584420128|FG001|Overall Study|Lack of Efficacy|0|||
161830455|NCT01876368|584420127|FG000|Overall Study|Lost to Follow-up|0|||
161830456|NCT01876368|584420128|FG001|Overall Study|Lost to Follow-up|1|||
161830457|NCT01876368|584420127|FG000|Overall Study|Non-compliance with study treatment|0|||
161830458|NCT01876368|584420128|FG001|Overall Study|Non-compliance with study treatment|1|||
161830459|NCT01876368|584420127|FG000|Overall Study|Physician Decision|0|||
161830460|NCT01876368|584420128|FG001|Overall Study|Physician Decision|2|||
161596530|NCT03899259|583574586|FG001|Overall Study|Screen Failure|0|||
161596531|NCT03899259|583574587|FG002|Overall Study|Screen Failure|0|||
161596532|NCT03899259|583574585|FG000|Overall Study|Ongoing Study Participation|127|||
161596533|NCT03899259|583574586|FG001|Overall Study|Ongoing Study Participation|134|||
161596534|NCT03899259|583574587|FG002|Overall Study|Ongoing Study Participation|210|||
161596535|NCT01152450|583574588|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
161596536|NCT01152450|583574589|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
161596537|NCT01152450|583574590|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
161596538|NCT01152450|583574591|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
161596539|NCT01152450|583574592|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
161596540|NCT01152450|583574593|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
161596541|NCT01152450|583574588|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
161596542|NCT01152450|583574589|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
161596543|NCT01152450|583574590|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
161596544|NCT01152450|583574591|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
161596545|NCT01152450|583574592|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
161596546|NCT01152450|583574593|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
161596547|NCT01152450|583574588|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161596548|NCT01152450|583574589|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161596549|NCT01152450|583574590|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161596550|NCT01152450|583574591|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161596551|NCT01152450|583574592|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161596552|NCT01152450|583574593|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161596553|NCT01544114|583574596|FG000|Overall Study|Withdrawal by Subject|0|||
161596554|NCT01544114|583574597|FG001|Overall Study|Withdrawal by Subject|0|||
161596555|NCT01544114|583574598|FG002|Overall Study|Withdrawal by Subject|3|||
161596556|NCT01544114|583574596|FG000|Overall Study|Lost to Follow-up|0|||
161596557|NCT01544114|583574597|FG001|Overall Study|Lost to Follow-up|2|||
161596558|NCT01544114|583574598|FG002|Overall Study|Lost to Follow-up|0|||
161596559|NCT01544114|583574596|FG000|Overall Study|Adverse Event|1|||
161596560|NCT01544114|583574597|FG001|Overall Study|Adverse Event|1|||
161596561|NCT01544114|583574598|FG002|Overall Study|Adverse Event|2|||
161596562|NCT01544114|583574596|FG000|Overall Study|Protocol Violation|0|||
161596563|NCT01544114|583574597|FG001|Overall Study|Protocol Violation|1|||
161596564|NCT01544114|583574598|FG002|Overall Study|Protocol Violation|0|||
161596565|NCT04508309|583574603|FG000|Overall Study|Death|0|||
161596566|NCT04508309|583574604|FG001|Overall Study|Death|0|||
161596567|NCT04508309|583574605|FG002|Overall Study|Death|0|||
161596568|NCT04508309|583574606|FG003|Overall Study|Death|0|||
161596569|NCT04508309|583574607|FG004|Overall Study|Death|1|||
161596570|NCT04508309|583574603|FG000|Overall Study|Lost to Follow-up|0|||
161596571|NCT04508309|583574604|FG001|Overall Study|Lost to Follow-up|0|||
161596572|NCT04508309|583574605|FG002|Overall Study|Lost to Follow-up|1|||
161830461|NCT01876368|584420127|FG000|Overall Study|Protocol deviation|3|||
161830462|NCT01876368|584420128|FG001|Overall Study|Protocol deviation|3|||
161830463|NCT01876368|584420127|FG000|Overall Study|Subject/guardian decision|3|||
161830464|NCT01876368|584420128|FG001|Overall Study|Subject/guardian decision|1|||
161830465|NCT02260258|584420129|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
161831593|NCT00384293|584424837|FG001|Post-randomization Period|Protocol Violation|1|||
161596573|NCT04508309|583574606|FG003|Overall Study|Lost to Follow-up|1|||
161596574|NCT04508309|583574607|FG004|Overall Study|Lost to Follow-up|0|||
161596575|NCT04508309|583574603|FG000|Overall Study|Withdrawal by Subject|0|||
161596576|NCT04508309|583574604|FG001|Overall Study|Withdrawal by Subject|0|||
161596577|NCT04508309|583574605|FG002|Overall Study|Withdrawal by Subject|0|||
161596578|NCT04508309|583574606|FG003|Overall Study|Withdrawal by Subject|0|||
161596579|NCT04508309|583574607|FG004|Overall Study|Withdrawal by Subject|1|||
161596580|NCT03058289|583574608|FG000|Overall Study|Radiographic Deterioration|0|||
161681572|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
161681573|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
161596581|NCT03058289|583574609|FG001|Overall Study|Radiographic Deterioration|3|||
161596582|NCT03058289|583574610|FG002|Overall Study|Radiographic Deterioration|1|||
161596583|NCT03058289|583574611|FG003|Overall Study|Radiographic Deterioration|2|||
161596584|NCT03058289|583574612|FG004|Overall Study|Radiographic Deterioration|6|||
161596585|NCT03058289|583574613|FG005|Overall Study|Radiographic Deterioration|3|||
161596586|NCT03058289|583574614|FG006|Overall Study|Radiographic Deterioration|0|||
161596587|NCT03058289|583574615|FG007|Overall Study|Radiographic Deterioration|4|||
161596588|NCT03058289|583574616|FG008|Overall Study|Radiographic Deterioration|2|||
161596589|NCT03058289|583574608|FG000|Overall Study|Adverse Event|2|||
161596590|NCT03058289|583574609|FG001|Overall Study|Adverse Event|0|||
161596591|NCT03058289|583574610|FG002|Overall Study|Adverse Event|1|||
161596592|NCT03058289|583574611|FG003|Overall Study|Adverse Event|3|||
161596593|NCT03058289|583574612|FG004|Overall Study|Adverse Event|1|||
161596594|NCT03058289|583574613|FG005|Overall Study|Adverse Event|0|||
161596595|NCT03058289|583574614|FG006|Overall Study|Adverse Event|1|||
161596596|NCT03058289|583574615|FG007|Overall Study|Adverse Event|3|||
161596597|NCT03058289|583574616|FG008|Overall Study|Adverse Event|0|||
161596598|NCT03058289|583574608|FG000|Overall Study|Withdrawal by Subject|0|||
161596599|NCT03058289|583574609|FG001|Overall Study|Withdrawal by Subject|0|||
161596600|NCT03058289|583574610|FG002|Overall Study|Withdrawal by Subject|0|||
161596601|NCT03058289|583574611|FG003|Overall Study|Withdrawal by Subject|2|||
161596602|NCT03058289|583574612|FG004|Overall Study|Withdrawal by Subject|0|||
161596603|NCT03058289|583574613|FG005|Overall Study|Withdrawal by Subject|2|||
161596604|NCT03058289|583574614|FG006|Overall Study|Withdrawal by Subject|0|||
161596605|NCT03058289|583574615|FG007|Overall Study|Withdrawal by Subject|4|||
161596606|NCT03058289|583574616|FG008|Overall Study|Withdrawal by Subject|1|||
161596607|NCT03058289|583574608|FG000|Overall Study|Physician Decision|1|||
161596608|NCT03058289|583574609|FG001|Overall Study|Physician Decision|0|||
161596609|NCT03058289|583574610|FG002|Overall Study|Physician Decision|0|||
161596610|NCT03058289|583574611|FG003|Overall Study|Physician Decision|2|||
161596611|NCT03058289|583574612|FG004|Overall Study|Physician Decision|1|||
161596612|NCT03058289|583574613|FG005|Overall Study|Physician Decision|0|||
161596613|NCT03058289|583574614|FG006|Overall Study|Physician Decision|2|||
161596614|NCT03058289|583574615|FG007|Overall Study|Physician Decision|3|||
161596615|NCT03058289|583574616|FG008|Overall Study|Physician Decision|0|||
161596616|NCT03058289|583574608|FG000|Overall Study|Clinical Deterioration|2|||
161596617|NCT03058289|583574609|FG001|Overall Study|Clinical Deterioration|0|||
161596618|NCT03058289|583574610|FG002|Overall Study|Clinical Deterioration|0|||
161596619|NCT03058289|583574611|FG003|Overall Study|Clinical Deterioration|2|||
161596620|NCT03058289|583574612|FG004|Overall Study|Clinical Deterioration|1|||
161596621|NCT03058289|583574613|FG005|Overall Study|Clinical Deterioration|1|||
161596622|NCT03058289|583574614|FG006|Overall Study|Clinical Deterioration|0|||
161596623|NCT03058289|583574615|FG007|Overall Study|Clinical Deterioration|3|||
161596624|NCT03058289|583574616|FG008|Overall Study|Clinical Deterioration|2|||
161596625|NCT03058289|583574608|FG000|Overall Study|Lost to Follow-up|0|||
161596626|NCT03058289|583574609|FG001|Overall Study|Lost to Follow-up|0|||
161596627|NCT03058289|583574610|FG002|Overall Study|Lost to Follow-up|0|||
161596628|NCT03058289|583574611|FG003|Overall Study|Lost to Follow-up|0|||
161596629|NCT03058289|583574612|FG004|Overall Study|Lost to Follow-up|1|||
161596630|NCT03058289|583574613|FG005|Overall Study|Lost to Follow-up|0|||
161596631|NCT03058289|583574614|FG006|Overall Study|Lost to Follow-up|0|||
161596632|NCT03058289|583574615|FG007|Overall Study|Lost to Follow-up|0|||
161596633|NCT03058289|583574616|FG008|Overall Study|Lost to Follow-up|0|||
161596634|NCT03058289|583574608|FG000|Overall Study|Refused Further Treatment|0|||
161596635|NCT03058289|583574609|FG001|Overall Study|Refused Further Treatment|0|||
161596636|NCT03058289|583574610|FG002|Overall Study|Refused Further Treatment|1|||
161596637|NCT03058289|583574611|FG003|Overall Study|Refused Further Treatment|0|||
161596638|NCT03058289|583574612|FG004|Overall Study|Refused Further Treatment|1|||
161596639|NCT03058289|583574613|FG005|Overall Study|Refused Further Treatment|0|||
161596640|NCT03058289|583574614|FG006|Overall Study|Refused Further Treatment|0|||
161681574|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
161681575|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
161830466|NCT02260258|584420130|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
161830467|NCT01644149|584420131|FG000|Overall Study|Withdrawal by Subject|1|||
161596641|NCT03058289|583574615|FG007|Overall Study|Refused Further Treatment|0|||
161596642|NCT03058289|583574616|FG008|Overall Study|Refused Further Treatment|0|||
161830468|NCT01644149|584420132|FG001|Overall Study|Withdrawal by Subject|0|||
161596643|NCT03058289|583574608|FG000|Overall Study|Rapid Progression of Disease|0|||
161596644|NCT03058289|583574609|FG001|Overall Study|Rapid Progression of Disease|0|||
161596645|NCT03058289|583574610|FG002|Overall Study|Rapid Progression of Disease|0|||
161830469|NCT01644149|584420131|FG000|Overall Study|Lost to Follow-up|3|||
161596646|NCT03058289|583574611|FG003|Overall Study|Rapid Progression of Disease|1|||
161596647|NCT03058289|583574612|FG004|Overall Study|Rapid Progression of Disease|0|||
161596648|NCT03058289|583574613|FG005|Overall Study|Rapid Progression of Disease|0|||
161596649|NCT03058289|583574614|FG006|Overall Study|Rapid Progression of Disease|0|||
161596650|NCT03058289|583574615|FG007|Overall Study|Rapid Progression of Disease|0|||
161596651|NCT03058289|583574616|FG008|Overall Study|Rapid Progression of Disease|0|||
161596652|NCT05940194|583574617|FG000|Overall Study|Adverse Event|0|||
161596653|NCT05940194|583574618|FG001|Overall Study|Adverse Event|1|||
161596654|NCT05940194|583574619|FG002|Overall Study|Adverse Event|0|||
161596655|NCT05940194|583574617|FG000|Overall Study|Migrated/Moved from the study area|2|||
161596656|NCT05940194|583574618|FG001|Overall Study|Migrated/Moved from the study area|2|||
161596657|NCT05940194|583574619|FG002|Overall Study|Migrated/Moved from the study area|4|||
161596658|NCT03800654|583574621|FG000|Overall Study|Time constraints|3|||
161596659|NCT03800654|583574622|FG001|Overall Study|Time constraints|3|||
161596660|NCT03800654|583574623|FG002|Overall Study|Time constraints|3|||
161596661|NCT03800654|583574621|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
161596662|NCT03800654|583574622|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
161596663|NCT03800654|583574623|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
161596664|NCT03800654|583574621|FG000|Overall Study|Lost to Follow-up|2|||
161596665|NCT03800654|583574622|FG001|Overall Study|Lost to Follow-up|1|||
161596666|NCT03800654|583574623|FG002|Overall Study|Lost to Follow-up|6|||
161596667|NCT03800654|583574621|FG000|Overall Study|Medical Health Issue|0|||
161596668|NCT03800654|583574622|FG001|Overall Study|Medical Health Issue|0|||
161596669|NCT03800654|583574623|FG002|Overall Study|Medical Health Issue|1|||
161596670|NCT03800654|583574621|FG000|Overall Study|Personal Issues|0|||
161596671|NCT03800654|583574622|FG001|Overall Study|Personal Issues|2|||
161596672|NCT03800654|583574623|FG002|Overall Study|Personal Issues|0|||
161596673|NCT03800654|583574621|FG000|Overall Study|Protocol Violation|0|||
161596674|NCT03800654|583574622|FG001|Overall Study|Protocol Violation|1|||
161596675|NCT03800654|583574623|FG002|Overall Study|Protocol Violation|0|||
161596676|NCT03459729|583574624|FG000|Overall Study|Physician Decision|2|||
161596677|NCT06182033|583574625|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
161596678|NCT06182033|583574626|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
161596679|NCT06182033|583574625|FG000|Overall Study|Target child relocation|1|||
161596680|NCT06182033|583574626|FG001|Overall Study|Target child relocation|1|||
161596681|NCT06182033|583574625|FG000|Overall Study|Withdrawal by Subject|1|||
161596682|NCT06182033|583574626|FG001|Overall Study|Withdrawal by Subject|0|||
161596683|NCT02626533|583574628|FG000|Overall Study|Protocol Violation|14|||
161596684|NCT02626533|583574628|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
161596685|NCT02626533|583574628|FG000|Overall Study|Withdrawal by Subject|1|||
161596686|NCT05576155|583574631|FG000|Overall Study|Withdrawal by Subject|1|||
161596687|NCT05576155|583574632|FG001|Overall Study|Withdrawal by Subject|1|||
161596688|NCT04515849|583574633|FG000|Overall Study|Adverse Event|0|||
161596689|NCT04515849|583574634|FG001|Overall Study|Adverse Event|0|||
161596690|NCT04515849|583574635|FG002|Overall Study|Adverse Event|0|||
161596691|NCT04515849|583574636|FG003|Overall Study|Adverse Event|1|||
161596692|NCT04515849|583574637|FG004|Overall Study|Adverse Event|2|||
161596693|NCT04515849|583574633|FG000|Overall Study|Death|2|||
161596694|NCT04515849|583574634|FG001|Overall Study|Death|0|||
161596695|NCT04515849|583574635|FG002|Overall Study|Death|0|||
161596696|NCT04515849|583574636|FG003|Overall Study|Death|0|||
161596697|NCT04515849|583574637|FG004|Overall Study|Death|0|||
161596698|NCT04515849|583574633|FG000|Overall Study|Other:family emergency|0|||
161596699|NCT04515849|583574634|FG001|Overall Study|Other:family emergency|0|||
161596700|NCT04515849|583574635|FG002|Overall Study|Other:family emergency|0|||
161596701|NCT04515849|583574636|FG003|Overall Study|Other:family emergency|1|||
161596702|NCT04515849|583574637|FG004|Overall Study|Other:family emergency|0|||
161596703|NCT04515849|583574633|FG000|Overall Study|Other:randomised by error|0|||
161596704|NCT04515849|583574634|FG001|Overall Study|Other:randomised by error|1|||
161596705|NCT04515849|583574635|FG002|Overall Study|Other:randomised by error|0|||
161596706|NCT04515849|583574636|FG003|Overall Study|Other:randomised by error|0|||
161596707|NCT04515849|583574637|FG004|Overall Study|Other:randomised by error|0|||
161596708|NCT04515849|583574633|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161596709|NCT04515849|583574634|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161596710|NCT04515849|583574635|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161596711|NCT04515849|583574636|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
161596712|NCT04515849|583574637|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161596713|NCT04515849|583574633|FG000|Overall Study|Physician Decision|0|||
161596714|NCT04515849|583574634|FG001|Overall Study|Physician Decision|1|||
161596715|NCT04515849|583574635|FG002|Overall Study|Physician Decision|0|||
161596716|NCT04515849|583574636|FG003|Overall Study|Physician Decision|0|||
161596717|NCT04515849|583574637|FG004|Overall Study|Physician Decision|0|||
161596718|NCT04515849|583574633|FG000|Overall Study|Withdrawal by Subject|1|||
161596719|NCT04515849|583574634|FG001|Overall Study|Withdrawal by Subject|2|||
161596720|NCT04515849|583574635|FG002|Overall Study|Withdrawal by Subject|1|||
161596721|NCT04515849|583574636|FG003|Overall Study|Withdrawal by Subject|0|||
161596722|NCT04515849|583574637|FG004|Overall Study|Withdrawal by Subject|0|||
161596723|NCT04049643|583574639|FG000|Overall Study|Lack of Efficacy|1|||
161596724|NCT04049643|583574640|FG001|Overall Study|Lack of Efficacy|1|||
161596725|NCT04049643|583574641|FG002|Overall Study|Lack of Efficacy|0|||
161596726|NCT04049643|583574639|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161596727|NCT04049643|583574640|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161596728|NCT04049643|583574641|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
161681576|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
161596729|NCT04081103|583574642|FG000|Overall Study|Adverse Event|1|||
161596730|NCT04081103|583574643|FG001|Overall Study|Adverse Event|1|||
161596731|NCT04081103|583574644|FG002|Overall Study|Adverse Event|1|||
161596732|NCT04081103|583574642|FG000|Overall Study|Physician Decision|0|||
161596733|NCT04081103|583574643|FG001|Overall Study|Physician Decision|0|||
161596734|NCT04081103|583574644|FG002|Overall Study|Physician Decision|1|||
161596735|NCT05623228|583574645|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
161596736|NCT05623228|583574646|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596737|NCT05623228|583574647|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596738|NCT05623228|583574648|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596739|NCT05623228|583574649|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596740|NCT05623228|583574650|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596741|NCT05623228|583574651|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596742|NCT05623228|583574652|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161596743|NCT05623228|583574645|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
161596744|NCT05623228|583574646|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161596745|NCT05623228|583574647|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
161596746|NCT05623228|583574648|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
161596747|NCT05623228|583574649|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161596748|NCT05623228|583574650|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161596749|NCT05623228|583574651|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161596750|NCT05623228|583574652|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161596751|NCT05256017|583576573|FG000|Treatment Period|Withdrawal by Subject|1|||
161596752|NCT05256017|583576574|FG001|Treatment Period|Withdrawal by Subject|1|||
161596753|NCT05256017|583576573|FG000|Follow-up|Lost to Follow-up|7|||
161596754|NCT05256017|583576574|FG001|Follow-up|Lost to Follow-up|1|||
161596755|NCT05256017|583576573|FG000|Follow-up|Withdrawal by Subject|1|||
161596756|NCT05256017|583576574|FG001|Follow-up|Withdrawal by Subject|0|||
161596757|NCT05256017|583576573|FG000|Follow-up|Death|0|||
161596758|NCT05256017|583576574|FG001|Follow-up|Death|1|||
161596759|NCT03854227|583576576|FG000|Overall Study|Adverse Event|0|||
161596760|NCT03854227|583576577|FG001|Overall Study|Adverse Event|0|||
161596761|NCT03854227|583576578|FG002|Overall Study|Adverse Event|0|||
161596762|NCT03854227|583576579|FG003|Overall Study|Adverse Event|1|||
161596763|NCT03854227|583576580|FG004|Overall Study|Adverse Event|0|||
161596764|NCT03854227|583576581|FG005|Overall Study|Adverse Event|0|||
161596765|NCT03854227|583576582|FG006|Overall Study|Adverse Event|1|||
161596766|NCT03854227|583576583|FG007|Overall Study|Adverse Event|0|||
161596767|NCT03854227|583576584|FG008|Overall Study|Adverse Event|0|||
161596768|NCT03854227|583576585|FG009|Overall Study|Adverse Event|3|||
161596769|NCT03854227|583576586|FG010|Overall Study|Adverse Event|0|||
161596770|NCT03854227|583576587|FG011|Overall Study|Adverse Event|1|||
161596771|NCT03854227|583576576|FG000|Overall Study|Death|0|||
161596772|NCT03854227|583576577|FG001|Overall Study|Death|0|||
161596773|NCT03854227|583576578|FG002|Overall Study|Death|0|||
161681577|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
161681578|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
161681579|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
161681580|NCT04109222|583886189|FG000|Overall Study|Adverse Event|1|||
161681581|NCT04109222|583886190|FG001|Overall Study|Adverse Event|0|||
161681582|NCT04109222|583886191|FG002|Overall Study|Adverse Event|0|||
161681583|NCT02577406|583886192|FG000|Randomized Period|Death|1|||
161681584|NCT02577406|583886193|FG001|Randomized Period|Death|0|||
161681585|NCT02577406|583886192|FG000|Randomized Period|Other reasons|0|||
161596774|NCT03854227|583576579|FG003|Overall Study|Death|0|||
161596775|NCT03854227|583576580|FG004|Overall Study|Death|0|||
161596776|NCT03854227|583576581|FG005|Overall Study|Death|1|||
161596777|NCT03854227|583576582|FG006|Overall Study|Death|0|||
161596778|NCT03854227|583576583|FG007|Overall Study|Death|0|||
161596779|NCT03854227|583576584|FG008|Overall Study|Death|0|||
161596780|NCT03854227|583576585|FG009|Overall Study|Death|1|||
161596781|NCT03854227|583576586|FG010|Overall Study|Death|0|||
161596782|NCT03854227|583576587|FG011|Overall Study|Death|1|||
161596783|NCT03854227|583576576|FG000|Overall Study|Physician Decision|0|||
161681586|NCT02577406|583886193|FG001|Randomized Period|Other reasons|20|||
161681587|NCT02577406|583886192|FG000|Treatment Period|Death|38|||
161681588|NCT02577406|583886193|FG001|Treatment Period|Death|23|||
161596784|NCT03854227|583576577|FG001|Overall Study|Physician Decision|0|||
161596785|NCT03854227|583576578|FG002|Overall Study|Physician Decision|0|||
161596786|NCT03854227|583576579|FG003|Overall Study|Physician Decision|0|||
161596787|NCT03854227|583576580|FG004|Overall Study|Physician Decision|0|||
161596788|NCT03854227|583576581|FG005|Overall Study|Physician Decision|1|||
161596789|NCT03854227|583576582|FG006|Overall Study|Physician Decision|0|||
161596790|NCT03854227|583576583|FG007|Overall Study|Physician Decision|0|||
161596791|NCT03854227|583576584|FG008|Overall Study|Physician Decision|1|||
161596792|NCT03854227|583576585|FG009|Overall Study|Physician Decision|1|||
161596793|NCT03854227|583576586|FG010|Overall Study|Physician Decision|0|||
161596794|NCT03854227|583576587|FG011|Overall Study|Physician Decision|1|||
161596795|NCT03854227|583576576|FG000|Overall Study|Progressive disease|1|||
161596796|NCT03854227|583576577|FG001|Overall Study|Progressive disease|1|||
161596797|NCT03854227|583576578|FG002|Overall Study|Progressive disease|1|||
161596798|NCT03854227|583576579|FG003|Overall Study|Progressive disease|2|||
161596799|NCT03854227|583576580|FG004|Overall Study|Progressive disease|3|||
161596800|NCT03854227|583576581|FG005|Overall Study|Progressive disease|1|||
161596801|NCT03854227|583576582|FG006|Overall Study|Progressive disease|2|||
161596802|NCT03854227|583576583|FG007|Overall Study|Progressive disease|5|||
161596803|NCT03854227|583576584|FG008|Overall Study|Progressive disease|2|||
161596804|NCT03854227|583576585|FG009|Overall Study|Progressive disease|5|||
161596805|NCT03854227|583576586|FG010|Overall Study|Progressive disease|1|||
161596806|NCT03854227|583576587|FG011|Overall Study|Progressive disease|6|||
161596807|NCT03854227|583576576|FG000|Overall Study|Study terminated by sponsor|0|||
161596808|NCT03854227|583576577|FG001|Overall Study|Study terminated by sponsor|0|||
161596809|NCT03854227|583576578|FG002|Overall Study|Study terminated by sponsor|0|||
161596810|NCT03854227|583576579|FG003|Overall Study|Study terminated by sponsor|0|||
161596811|NCT03854227|583576580|FG004|Overall Study|Study terminated by sponsor|0|||
161596812|NCT03854227|583576581|FG005|Overall Study|Study terminated by sponsor|0|||
161596813|NCT03854227|583576582|FG006|Overall Study|Study terminated by sponsor|0|||
161596814|NCT03854227|583576583|FG007|Overall Study|Study terminated by sponsor|0|||
161596815|NCT03854227|583576584|FG008|Overall Study|Study terminated by sponsor|0|||
161596816|NCT03854227|583576585|FG009|Overall Study|Study terminated by sponsor|1|||
161596817|NCT03854227|583576586|FG010|Overall Study|Study terminated by sponsor|0|||
161596818|NCT03854227|583576587|FG011|Overall Study|Study terminated by sponsor|0|||
161596819|NCT03854227|583576576|FG000|Overall Study|Withdrawal by Subject|0|||
161596820|NCT03854227|583576577|FG001|Overall Study|Withdrawal by Subject|0|||
161596821|NCT03854227|583576578|FG002|Overall Study|Withdrawal by Subject|1|||
161596822|NCT03854227|583576579|FG003|Overall Study|Withdrawal by Subject|0|||
161596823|NCT03854227|583576580|FG004|Overall Study|Withdrawal by Subject|0|||
161596824|NCT03854227|583576581|FG005|Overall Study|Withdrawal by Subject|0|||
161596825|NCT03854227|583576582|FG006|Overall Study|Withdrawal by Subject|0|||
161596826|NCT03854227|583576583|FG007|Overall Study|Withdrawal by Subject|0|||
161596827|NCT03854227|583576584|FG008|Overall Study|Withdrawal by Subject|0|||
161596828|NCT03854227|583576585|FG009|Overall Study|Withdrawal by Subject|1|||
161596829|NCT03854227|583576586|FG010|Overall Study|Withdrawal by Subject|1|||
161596830|NCT03854227|583576587|FG011|Overall Study|Withdrawal by Subject|0|||
161596831|NCT03854227|583576576|FG000|Overall Study|Disease relapse|0|||
161596832|NCT03854227|583576577|FG001|Overall Study|Disease relapse|0|||
161596833|NCT03854227|583576578|FG002|Overall Study|Disease relapse|0|||
161596834|NCT03854227|583576579|FG003|Overall Study|Disease relapse|0|||
161596835|NCT03854227|583576580|FG004|Overall Study|Disease relapse|0|||
161596836|NCT03854227|583576581|FG005|Overall Study|Disease relapse|0|||
161596837|NCT03854227|583576582|FG006|Overall Study|Disease relapse|0|||
161596838|NCT03854227|583576583|FG007|Overall Study|Disease relapse|0|||
161596839|NCT03854227|583576584|FG008|Overall Study|Disease relapse|1|||
161596840|NCT03854227|583576585|FG009|Overall Study|Disease relapse|0|||
161596841|NCT03854227|583576586|FG010|Overall Study|Disease relapse|0|||
161596842|NCT03854227|583576587|FG011|Overall Study|Disease relapse|0|||
161596843|NCT03854227|583576576|FG000|Overall Study|Global deterioration of health status|0|||
161596844|NCT03854227|583576577|FG001|Overall Study|Global deterioration of health status|0|||
161596845|NCT03854227|583576578|FG002|Overall Study|Global deterioration of health status|0|||
161596846|NCT03854227|583576579|FG003|Overall Study|Global deterioration of health status|0|||
161596847|NCT03854227|583576580|FG004|Overall Study|Global deterioration of health status|0|||
161596848|NCT03854227|583576581|FG005|Overall Study|Global deterioration of health status|1|||
161596849|NCT03854227|583576582|FG006|Overall Study|Global deterioration of health status|0|||
161596850|NCT03854227|583576583|FG007|Overall Study|Global deterioration of health status|1|||
161596851|NCT03854227|583576584|FG008|Overall Study|Global deterioration of health status|0|||
161596852|NCT03854227|583576585|FG009|Overall Study|Global deterioration of health status|0|||
161596853|NCT03854227|583576586|FG010|Overall Study|Global deterioration of health status|0|||
161596854|NCT03854227|583576587|FG011|Overall Study|Global deterioration of health status|0|||
161596855|NCT03854227|583576576|FG000|Overall Study|Refused further treatment|0|||
161596856|NCT03854227|583576577|FG001|Overall Study|Refused further treatment|0|||
161596857|NCT03854227|583576578|FG002|Overall Study|Refused further treatment|0|||
161596858|NCT03854227|583576579|FG003|Overall Study|Refused further treatment|0|||
161596859|NCT03854227|583576580|FG004|Overall Study|Refused further treatment|0|||
161596860|NCT03854227|583576581|FG005|Overall Study|Refused further treatment|0|||
161596861|NCT03854227|583576582|FG006|Overall Study|Refused further treatment|0|||
161596862|NCT03854227|583576583|FG007|Overall Study|Refused further treatment|0|||
161596863|NCT03854227|583576584|FG008|Overall Study|Refused further treatment|0|||
161596864|NCT03854227|583576585|FG009|Overall Study|Refused further treatment|1|||
161596865|NCT03854227|583576586|FG010|Overall Study|Refused further treatment|0|||
161596866|NCT03854227|583576587|FG011|Overall Study|Refused further treatment|1|||
161596867|NCT03854227|583576576|FG000|Overall Study|Other|0|||
161596868|NCT03854227|583576577|FG001|Overall Study|Other|0|||
161596869|NCT03854227|583576578|FG002|Overall Study|Other|0|||
161596870|NCT03854227|583576579|FG003|Overall Study|Other|0|||
161596871|NCT03854227|583576580|FG004|Overall Study|Other|0|||
161596872|NCT03854227|583576581|FG005|Overall Study|Other|0|||
161596873|NCT03854227|583576582|FG006|Overall Study|Other|0|||
161596874|NCT03854227|583576583|FG007|Overall Study|Other|0|||
161596875|NCT03854227|583576584|FG008|Overall Study|Other|1|||
161596876|NCT03854227|583576585|FG009|Overall Study|Other|1|||
161596877|NCT03854227|583576586|FG010|Overall Study|Other|0|||
161596878|NCT03854227|583576587|FG011|Overall Study|Other|0|||
161596879|NCT01574274|583576588|FG000|Overall Study|Ineligible|0|||
161596880|NCT01574274|583576589|FG001|Overall Study|Ineligible|1|||
161596881|NCT01574274|583576588|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
161596882|NCT01574274|583576589|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
161596883|NCT01574274|583576588|FG000|Overall Study|Ph+ B-ALL|3|||
161596884|NCT01574274|583576589|FG001|Overall Study|Ph+ B-ALL|4|||
161596885|NCT01574274|583576588|FG000|Overall Study|Induction Death|2|||
161596886|NCT01574274|583576589|FG001|Overall Study|Induction Death|0|||
161596887|NCT01574274|583576588|FG000|Overall Study|Induction Failure|4|||
161596888|NCT01574274|583576589|FG001|Overall Study|Induction Failure|1|||
161596889|NCT01574274|583576588|FG000|Overall Study|Adverse Event|16|||
161596890|NCT01574274|583576589|FG001|Overall Study|Adverse Event|13|||
161596891|NCT01574274|583576588|FG000|Overall Study|Remission Death|1|||
161596892|NCT01574274|583576589|FG001|Overall Study|Remission Death|0|||
161596893|NCT01574274|583576588|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
161596894|NCT01574274|583576589|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
161596895|NCT01574274|583576588|FG000|Overall Study|Other, unknown|3|||
161596896|NCT01574274|583576589|FG001|Overall Study|Other, unknown|2|||
161596897|NCT04314713|583576596|FG000|Overall Study|Lost to Follow-up|0|||
161596898|NCT04314713|583576597|FG001|Overall Study|Lost to Follow-up|0|||
161596899|NCT04314713|583576598|FG002|Overall Study|Lost to Follow-up|0|||
161596900|NCT04314713|583576599|FG003|Overall Study|Lost to Follow-up|1|||
161596901|NCT04314713|583576600|FG004|Overall Study|Lost to Follow-up|0|||
161596902|NCT04314713|583576601|FG005|Overall Study|Lost to Follow-up|0|||
161596903|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
161596904|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
161596905|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
161596906|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
161596907|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
161596908|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161596909|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
161596910|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
161596911|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161596912|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161596913|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
161596914|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
161596915|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
161596916|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
161596917|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
161596918|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
161596919|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161596920|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
161596921|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161596922|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161596923|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161596924|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
161596925|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161681589|NCT02577406|583886192|FG000|Treatment Period|Adverse Event|17|||
161681590|NCT02577406|583886193|FG001|Treatment Period|Adverse Event|12|||
161681591|NCT02577406|583886192|FG000|Treatment Period|Progressive Disease|53|||
161681592|NCT02577406|583886193|FG001|Treatment Period|Progressive Disease|37|||
161681593|NCT02577406|583886192|FG000|Treatment Period|Withdrawal by Subject|10|||
161681594|NCT02577406|583886193|FG001|Treatment Period|Withdrawal by Subject|24|||
161681595|NCT02577406|583886192|FG000|Treatment Period|Lost to Follow-up|0|||
161681596|NCT02577406|583886193|FG001|Treatment Period|Lost to Follow-up|1|||
161681597|NCT02577406|583886192|FG000|Treatment Period|Transition to commercially available treatment|1|||
161681598|NCT02577406|583886193|FG001|Treatment Period|Transition to commercially available treatment|1|||
161681599|NCT02577406|583886192|FG000|Treatment Period|Physician Decision|1|||
161681600|NCT02577406|583886193|FG001|Treatment Period|Physician Decision|0|||
161681601|NCT02577406|583886192|FG000|Treatment Period|Disease Relapse|28|||
161681602|NCT02577406|583886193|FG001|Treatment Period|Disease Relapse|1|||
161681603|NCT02577406|583886192|FG000|Treatment Period|Protocol Violation|0|||
161681604|NCT02577406|583886193|FG001|Treatment Period|Protocol Violation|1|||
161681605|NCT02577406|583886192|FG000|Treatment Period|Other Reasons|3|||
161681606|NCT02577406|583886193|FG001|Treatment Period|Other Reasons|39|||
161681607|NCT02577406|583886192|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
161681608|NCT02577406|583886193|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
161681609|NCT01111851|583886199|FG000|Overall Study|All planned PET scans were not obtained.|2|||
161681610|NCT01111851|583886200|FG001|Overall Study|All planned PET scans were not obtained.|0|||
161681611|NCT05500274|583886201|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
161681612|NCT05500274|583886202|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
161681613|NCT05500274|583886201|FG000|Overall Study|Lost to Follow-up|76|||
161681614|NCT05500274|583886202|FG001|Overall Study|Lost to Follow-up|51|||
161681615|NCT01555151|583886203|FG000|Overall Study|Withdrawal by Subject|6|||
161681616|NCT01555151|583886204|FG001|Overall Study|Withdrawal by Subject|2|||
161681617|NCT01555151|583886205|FG002|Overall Study|Withdrawal by Subject|0|||
161681618|NCT01555151|583886206|FG003|Overall Study|Withdrawal by Subject|2|||
161681619|NCT01555151|583886203|FG000|Overall Study|Administrative|3|||
161681620|NCT01555151|583886204|FG001|Overall Study|Administrative|1|||
161681621|NCT01555151|583886205|FG002|Overall Study|Administrative|2|||
161681622|NCT01555151|583886206|FG003|Overall Study|Administrative|0|||
161681623|NCT01555151|583886203|FG000|Overall Study|Protocol Violation|3|||
161681624|NCT01555151|583886204|FG001|Overall Study|Protocol Violation|3|||
161681625|NCT01555151|583886205|FG002|Overall Study|Protocol Violation|3|||
161681626|NCT01555151|583886206|FG003|Overall Study|Protocol Violation|5|||
161681627|NCT01555151|583886203|FG000|Overall Study|Adverse Event|1|||
161681628|NCT01555151|583886204|FG001|Overall Study|Adverse Event|2|||
161681629|NCT01555151|583886205|FG002|Overall Study|Adverse Event|1|||
161681630|NCT01555151|583886206|FG003|Overall Study|Adverse Event|2|||
161681631|NCT01555151|583886203|FG000|Overall Study|Lost to Follow-up|0|||
161681632|NCT01555151|583886204|FG001|Overall Study|Lost to Follow-up|0|||
161681633|NCT01555151|583886205|FG002|Overall Study|Lost to Follow-up|0|||
161681634|NCT01555151|583886206|FG003|Overall Study|Lost to Follow-up|1|||
161681635|NCT01961349|583886207|FG000|Overall Study|Withdrawal by Subject|1|||
161681636|NCT01961349|583886208|FG001|Overall Study|Withdrawal by Subject|4|||
161681637|NCT01961349|583886209|FG002|Overall Study|Withdrawal by Subject|0|||
161681638|NCT01961349|583886207|FG000|Overall Study|Adverse Event|0|||
161681639|NCT01961349|583886208|FG001|Overall Study|Adverse Event|0|||
161681640|NCT01961349|583886209|FG002|Overall Study|Adverse Event|1|||
161681641|NCT01961349|583886207|FG000|Overall Study|registration error, personal reason etc|2|||
161681642|NCT01961349|583886208|FG001|Overall Study|registration error, personal reason etc|2|||
161681643|NCT01961349|583886209|FG002|Overall Study|registration error, personal reason etc|1|||
161681644|NCT02343159|583886211|FG000|Overall Study|Early Study Termination|16|||
161681645|NCT02343159|583886212|FG001|Overall Study|Early Study Termination|19|||
161681646|NCT02343159|583886213|FG002|Overall Study|Early Study Termination|23|||
161681647|NCT02343159|583886211|FG000|Overall Study|Physician Decision|2|||
161681648|NCT02343159|583886212|FG001|Overall Study|Physician Decision|0|||
161681649|NCT02343159|583886213|FG002|Overall Study|Physician Decision|1|||
161681650|NCT02343159|583886211|FG000|Overall Study|Withdrawal by Subject|3|||
161830470|NCT01644149|584420132|FG001|Overall Study|Lost to Follow-up|1|||
161681651|NCT02343159|583886212|FG001|Overall Study|Withdrawal by Subject|0|||
161681652|NCT02343159|583886213|FG002|Overall Study|Withdrawal by Subject|2|||
161681653|NCT02343159|583886211|FG000|Overall Study|Lost to Follow-up|0|||
161681654|NCT02343159|583886212|FG001|Overall Study|Lost to Follow-up|2|||
161681655|NCT02343159|583886213|FG002|Overall Study|Lost to Follow-up|2|||
161681656|NCT02343159|583886211|FG000|Overall Study|Adverse Event|4|||
161681657|NCT02343159|583886212|FG001|Overall Study|Adverse Event|4|||
161681658|NCT02343159|583886213|FG002|Overall Study|Adverse Event|2|||
161681659|NCT02343159|583886211|FG000|Overall Study|Sponsor Decision|0|||
161681660|NCT02343159|583886212|FG001|Overall Study|Sponsor Decision|1|||
161681661|NCT02343159|583886213|FG002|Overall Study|Sponsor Decision|0|||
161681662|NCT02343159|583886211|FG000|Overall Study|Enrollment Error|1|||
161681663|NCT02343159|583886212|FG001|Overall Study|Enrollment Error|0|||
161681664|NCT02343159|583886213|FG002|Overall Study|Enrollment Error|0|||
161596926|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161596927|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161596928|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
161596929|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
161596930|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
161596931|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
161596932|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
161596933|NCT03852472|583576606|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
161596934|NCT03852472|583576607|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
161596935|NCT03852472|583576608|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
161596936|NCT03852472|583576609|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
161596937|NCT03852472|583576610|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
161596938|NCT03852472|583576606|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
161596939|NCT03852472|583576607|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
161596940|NCT03852472|583576608|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
161596941|NCT03852472|583576609|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
161596942|NCT03852472|583576610|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
161596943|NCT03852472|583576606|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
161596944|NCT03852472|583576607|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
161596945|NCT03852472|583576608|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
161596946|NCT03852472|583576609|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
161596947|NCT03852472|583576610|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
161596948|NCT03852472|583576606|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
161596949|NCT03852472|583576607|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
161596950|NCT03852472|583576608|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
161596951|NCT03852472|583576609|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
161596952|NCT03852472|583576610|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
161596953|NCT03852472|583576606|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
161596954|NCT03852472|583576607|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
161596955|NCT03852472|583576608|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
161596956|NCT03852472|583576609|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
161596957|NCT03852472|583576610|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
161596958|NCT03852472|583576606|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
161596959|NCT03852472|583576607|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
161596960|NCT03852472|583576608|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
161596961|NCT03852472|583576609|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
161596962|NCT03852472|583576610|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
161596963|NCT03852472|583576606|FG000|Period 2 - Week 44|Adverse Event|0|||
161596964|NCT03852472|583576607|FG001|Period 2 - Week 44|Adverse Event|3|||
161596965|NCT03852472|583576608|FG002|Period 2 - Week 44|Adverse Event|1|||
161596966|NCT03852472|583576609|FG003|Period 2 - Week 44|Adverse Event|2|||
161596967|NCT03852472|583576610|FG004|Period 2 - Week 44|Adverse Event|2|||
161596968|NCT03852472|583576606|FG000|Period 2 - Week 44|COVID-19 Related|0|||
161596969|NCT03852472|583576607|FG001|Period 2 - Week 44|COVID-19 Related|0|||
161596970|NCT03852472|583576608|FG002|Period 2 - Week 44|COVID-19 Related|0|||
161596971|NCT03852472|583576609|FG003|Period 2 - Week 44|COVID-19 Related|1|||
161596972|NCT03852472|583576610|FG004|Period 2 - Week 44|COVID-19 Related|0|||
161596973|NCT03852472|583576606|FG000|Period 2 - Week 44|Reason not stated|0|||
161596974|NCT03852472|583576607|FG001|Period 2 - Week 44|Reason not stated|0|||
161596975|NCT03852472|583576608|FG002|Period 2 - Week 44|Reason not stated|0|||
161596976|NCT03852472|583576609|FG003|Period 2 - Week 44|Reason not stated|0|||
161596977|NCT03852472|583576610|FG004|Period 2 - Week 44|Reason not stated|1|||
161596978|NCT04880863|583576613|FG000|Overall Study|Adverse Event|1|||
161596979|NCT04880863|583576613|FG000|Overall Study|Patient decision|2|||
161596980|NCT04880863|583576613|FG000|Overall Study|Confirmed Disease Progression|15|||
161596981|NCT04880863|583576613|FG000|Overall Study|Death|3|||
161596982|NCT04880863|583576613|FG000|Overall Study|Physician Decision|4|||
161596983|NCT04880863|583576613|FG000|Overall Study|Unconfirmed Disease Progression|4|||
161596984|NCT04880863|583576613|FG000|Overall Study|Withdrawal by Subject|2|||
161596985|NCT04880863|583576613|FG000|Overall Study|Study discontinuation by the sponsor|4|||
161596986|NCT04880863|583576613|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
161596987|NCT04880863|583576613|FG000|Overall Study|Not received study drug NAP|2|||
161596988|NCT05670587|583576614|FG000|Overall Study|Withdrawal by Subject|3|||
161596989|NCT02305888|583576624|FG000|Overall Study|Lost to Follow-up|0|||
161596990|NCT02305888|583576625|FG001|Overall Study|Lost to Follow-up|0|||
161596991|NCT02305888|583576626|FG002|Overall Study|Lost to Follow-up|1|||
161596992|NCT02305888|583576624|FG000|Overall Study|Adverse Event|0|||
161596993|NCT02305888|583576625|FG001|Overall Study|Adverse Event|1|||
161596994|NCT02305888|583576626|FG002|Overall Study|Adverse Event|0|||
161596995|NCT05139810|583576627|FG000|Overall Study|Voluntary Withdrawal|2|||
161596996|NCT05139810|583576628|FG001|Overall Study|Voluntary Withdrawal|1|||
161596997|NCT05139810|583576629|FG002|Overall Study|Voluntary Withdrawal|0|||
161596998|NCT05139810|583576627|FG000|Overall Study|Pregnancy|1|||
161596999|NCT05139810|583576628|FG001|Overall Study|Pregnancy|0|||
161597000|NCT05139810|583576629|FG002|Overall Study|Pregnancy|0|||
161597001|NCT05139810|583576627|FG000|Overall Study|Roll Over to CS7|19|||
161597002|NCT05139810|583576628|FG001|Overall Study|Roll Over to CS7|44|||
161597003|NCT05139810|583576629|FG002|Overall Study|Roll Over to CS7|20|||
161597004|NCT03240016|583576636|FG000|Overall Study|Adverse Event|9|||
161597005|NCT03240016|583576636|FG000|Overall Study|Withdrawal by Subject|7|||
161597006|NCT03240016|583576636|FG000|Overall Study|Death|1|||
161597007|NCT03240016|583576636|FG000|Overall Study|Physician Decision|2|||
161597008|NCT05200403|583576637|FG000|Overall Study|Withdrawal by Subject|4|||
161597009|NCT05200403|583576638|FG001|Overall Study|Withdrawal by Subject|2|||
161597010|NCT05200403|583576639|FG002|Overall Study|Withdrawal by Subject|6|||
161597011|NCT05546411|583576640|FG000|Overall Study|Progressive Disease|1|||
161597012|NCT05546411|583576641|FG001|Overall Study|Progressive Disease|0|||
161597013|NCT05546411|583576640|FG000|Overall Study|Adverse Event|0|||
161597014|NCT05546411|583576641|FG001|Overall Study|Adverse Event|1|||
161597015|NCT05546411|583576640|FG000|Overall Study|Metastatic disease|1|||
161597016|NCT05546411|583576641|FG001|Overall Study|Metastatic disease|0|||
161597017|NCT04068181|583576649|FG000|Overall Study|Death|17|||
161597018|NCT04068181|583576650|FG001|Overall Study|Death|12|||
161597019|NCT04068181|583576651|FG002|Overall Study|Death|4|||
161597020|NCT04068181|583576652|FG003|Overall Study|Death|7|||
161597021|NCT04068181|583576649|FG000|Overall Study|Lost to Follow-up|1|||
161597022|NCT04068181|583576650|FG001|Overall Study|Lost to Follow-up|0|||
161597023|NCT04068181|583576651|FG002|Overall Study|Lost to Follow-up|0|||
161597024|NCT04068181|583576652|FG003|Overall Study|Lost to Follow-up|0|||
161597025|NCT04068181|583576649|FG000|Overall Study|Withdrawal of consent from study|3|||
161597026|NCT04068181|583576650|FG001|Overall Study|Withdrawal of consent from study|0|||
161597027|NCT04068181|583576651|FG002|Overall Study|Withdrawal of consent from study|0|||
161597028|NCT04068181|583576652|FG003|Overall Study|Withdrawal of consent from study|0|||
161597029|NCT03785964|583576655|FG000|Overall Study|Adverse Event|14|||
161597030|NCT03785964|583576656|FG001|Overall Study|Adverse Event|1|||
161597031|NCT03785964|583576655|FG000|Overall Study|Unqualified Clinical Progression|1|||
161597032|NCT03785964|583576656|FG001|Overall Study|Unqualified Clinical Progression|1|||
161597033|NCT03785964|583576655|FG000|Overall Study|Participant non-compliance|1|||
161597034|NCT03785964|583576656|FG001|Overall Study|Participant non-compliance|1|||
161597035|NCT03785964|583576655|FG000|Overall Study|Not treated|1|||
161597036|NCT03785964|583576656|FG001|Overall Study|Not treated|0|||
161597037|NCT03785964|583576655|FG000|Overall Study|Other reason|5|||
161597038|NCT03785964|583576656|FG001|Overall Study|Other reason|11|||
161597039|NCT03785964|583576655|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
161597040|NCT03785964|583576656|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
161597041|NCT02723591|583576657|FG000|Overall Study|Adverse Event|48|||
161597042|NCT02723591|583576658|FG001|Overall Study|Adverse Event|40|||
161597043|NCT02723591|583576657|FG000|Overall Study|Death|2|||
161597044|NCT02723591|583576658|FG001|Overall Study|Death|2|||
161597045|NCT02723591|583576657|FG000|Overall Study|Lack of Efficacy|4|||
161597046|NCT02723591|583576658|FG001|Overall Study|Lack of Efficacy|3|||
161597047|NCT02723591|583576657|FG000|Overall Study|Lost to Follow-up|1|||
161597048|NCT02723591|583576658|FG001|Overall Study|Lost to Follow-up|7|||
161597049|NCT02723591|583576657|FG000|Overall Study|Protocol Violation|20|||
161597050|NCT02723591|583576658|FG001|Overall Study|Protocol Violation|23|||
161597051|NCT02723591|583576657|FG000|Overall Study|Withdrawal by Subject|4|||
161597052|NCT02723591|583576658|FG001|Overall Study|Withdrawal by Subject|8|||
161597053|NCT02723591|583576657|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
161597054|NCT02723591|583576658|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
161597055|NCT02723591|583576657|FG000|Overall Study|Miscellaneous|5|||
161597056|NCT02723591|583576658|FG001|Overall Study|Miscellaneous|6|||
161597057|NCT05070728|583576659|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
161597058|NCT05070728|583576660|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
161597059|NCT02151981|583576661|FG000|Overall Study|Death|184|||
161597060|NCT02151981|583576662|FG001|Overall Study|Death|88|||
161597061|NCT02151981|583576661|FG000|Overall Study|Lost to Follow-up|7|||
161597062|NCT02151981|583576662|FG001|Overall Study|Lost to Follow-up|1|||
161597063|NCT02151981|583576661|FG000|Overall Study|Withdrawal by Subject|27|||
161597064|NCT02151981|583576662|FG001|Overall Study|Withdrawal by Subject|21|||
161597065|NCT02151981|583576661|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161597066|NCT02151981|583576662|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161597067|NCT02151981|583576661|FG000|Overall Study|Other reasons|1|||
161597068|NCT02151981|583576662|FG001|Overall Study|Other reasons|2|||
161597069|NCT05645757|583576682|FG000|Overall Study|Enrolled but treatment not administered|0|||
161597070|NCT05645757|583576683|FG001|Overall Study|Enrolled but treatment not administered|0|||
161597071|NCT05645757|583576684|FG002|Overall Study|Enrolled but treatment not administered|0|||
161597072|NCT05645757|583576685|FG003|Overall Study|Enrolled but treatment not administered|0|||
161597073|NCT05645757|583576686|FG004|Overall Study|Enrolled but treatment not administered|1|||
161597074|NCT05645757|583576687|FG005|Overall Study|Enrolled but treatment not administered|1|||
161597075|NCT05645757|583576688|FG006|Overall Study|Enrolled but treatment not administered|0|||
161597076|NCT05645757|583576689|FG007|Overall Study|Enrolled but treatment not administered|0|||
161597077|NCT04568434|583576694|FG000|Overall Study|Voluntary Withdrawal|0|||
161597078|NCT04568434|583576695|FG001|Overall Study|Voluntary Withdrawal|1|||
161597079|NCT04568434|583576696|FG002|Overall Study|Voluntary Withdrawal|1|||
161597080|NCT04568434|583576694|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
161597081|NCT04568434|583576695|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
161597082|NCT04568434|583576696|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
161597083|NCT04568434|583576694|FG000|Overall Study|Investigator Judgement|1|||
161597084|NCT04568434|583576695|FG001|Overall Study|Investigator Judgement|0|||
161597085|NCT04568434|583576696|FG002|Overall Study|Investigator Judgement|0|||
161597086|NCT03463044|583576697|FG000|Overall Study|Lost to Follow-up|0|||
161597087|NCT03463044|583576698|FG001|Overall Study|Lost to Follow-up|0|||
161597088|NCT03463044|583576699|FG002|Overall Study|Lost to Follow-up|0|||
161597089|NCT03463044|583576700|FG003|Overall Study|Lost to Follow-up|0|||
161597090|NCT03463044|583576701|FG004|Overall Study|Lost to Follow-up|0|||
161597091|NCT03463044|583576702|FG005|Overall Study|Lost to Follow-up|0|||
161597092|NCT03463044|583576703|FG006|Overall Study|Lost to Follow-up|0|||
161597093|NCT03463044|583576704|FG007|Overall Study|Lost to Follow-up|1|||
161597094|NCT03463044|583576705|FG008|Overall Study|Lost to Follow-up|0|||
161597095|NCT03334630|583576706|FG000|Overall Study|Withdrawal by Subject|7|||
161597096|NCT03334630|583576707|FG001|Overall Study|Withdrawal by Subject|7|||
161597097|NCT03334630|583576706|FG000|Overall Study|Lost to Follow-up|3|||
161597098|NCT03334630|583576707|FG001|Overall Study|Lost to Follow-up|1|||
161597099|NCT03334630|583576706|FG000|Overall Study|Adverse Event|0|||
161597100|NCT03334630|583576707|FG001|Overall Study|Adverse Event|1|||
161597101|NCT03334630|583576706|FG000|Overall Study|Physician Decision|1|||
161597102|NCT03334630|583576707|FG001|Overall Study|Physician Decision|1|||
161597103|NCT03334630|583576706|FG000|Overall Study|Enrollment closed|2|||
161597104|NCT03334630|583576707|FG001|Overall Study|Enrollment closed|1|||
161597105|NCT03334630|583576706|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
161597106|NCT03334630|583576707|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
161597107|NCT03334630|583576706|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
161597108|NCT03334630|583576707|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
161597109|NCT05693935|583577737|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
161597110|NCT05693935|583577738|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
161597111|NCT05693935|583577739|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
161597112|NCT05693935|583577740|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
161597113|NCT05693935|583577741|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
161597114|NCT05693935|583577742|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
161597115|NCT05693935|583577743|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
161597116|NCT05693935|583577737|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
161597117|NCT05693935|583577738|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
161597118|NCT05693935|583577739|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
161597119|NCT05693935|583577740|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
161597120|NCT05693935|583577741|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161597121|NCT05693935|583577742|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161597122|NCT05693935|583577743|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161597123|NCT05693935|583577737|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
161597124|NCT05693935|583577738|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
161597125|NCT05693935|583577739|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
161597126|NCT05693935|583577740|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
161597127|NCT05693935|583577741|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161597128|NCT05693935|583577742|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161597129|NCT05693935|583577743|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161597130|NCT05693935|583577737|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
161597131|NCT05693935|583577738|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
161597132|NCT05693935|583577739|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161597133|NCT05693935|583577740|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161597134|NCT05693935|583577741|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161597135|NCT05693935|583577742|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161597136|NCT05693935|583577743|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161681665|NCT02114268|583886216|FG000|Overall Study|Lost to Follow-up|4|||
161681666|NCT02114268|583886217|FG001|Overall Study|Lost to Follow-up|1|||
161597137|NCT05693935|583577737|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161597138|NCT05693935|583577738|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
161597139|NCT05693935|583577739|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161597140|NCT05693935|583577740|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161681667|NCT02114268|583886218|FG002|Overall Study|Lost to Follow-up|1|||
161597141|NCT05693935|583577741|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161597142|NCT05693935|583577742|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161597143|NCT05693935|583577743|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161597144|NCT05693935|583577737|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
161597145|NCT05693935|583577738|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
161597146|NCT05693935|583577739|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
161597147|NCT05693935|583577740|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
161597148|NCT05693935|583577741|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161597149|NCT05693935|583577742|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161597150|NCT05693935|583577743|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161597151|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
161597152|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
161597153|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
161597154|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
161597155|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
161597156|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
161597157|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
161597158|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
161597159|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
161597160|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
161597161|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
161597162|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
161597163|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
161597164|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
161597165|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
161597166|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
161597167|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
161597168|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
161597169|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
161597170|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
161597171|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
161597172|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
161597173|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
161597174|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
161597175|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
161597176|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
161597177|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
161597178|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
161597179|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
161597180|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161597181|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
161597182|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161597183|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
161597184|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161597185|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
161597186|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161597187|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161597188|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
161597189|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161597190|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161597191|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161597192|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161597193|NCT05693935|583577737|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
161597194|NCT05693935|583577738|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
161597195|NCT05693935|583577739|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
161597196|NCT05693935|583577740|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
161597197|NCT05693935|583577741|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
161597198|NCT05693935|583577742|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
161597199|NCT05693935|583577743|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
161597200|NCT04304820|583577745|FG000|Overall Study|Death|1|||
161597201|NCT04304820|583577745|FG000|Overall Study|Lost to Follow-up|1|||
161597202|NCT04304820|583577745|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
161597203|NCT04304820|583577745|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
161597204|NCT04304820|583577745|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
161597205|NCT03873818|583577746|FG000|Overall Study|Death|9|||
161597206|NCT03873818|583577747|FG001|Overall Study|Death|3|||
161597207|NCT03873818|583577746|FG000|Overall Study|Lost to Follow-up|1|||
161597208|NCT03873818|583577747|FG001|Overall Study|Lost to Follow-up|0|||
161597209|NCT03474107|583577748|FG000|Overall Study|Adverse Event|42|||
161830471|NCT00690482|584420133|FG000|Overall Study|Adverse Event|2|||
161830472|NCT00690482|584420134|FG001|Overall Study|Adverse Event|1|||
161830473|NCT00690482|584420133|FG000|Overall Study|Incorrect enrolment|0|||
161830474|NCT00690482|584420134|FG001|Overall Study|Incorrect enrolment|1|||
161830475|NCT00690482|584420133|FG000|Overall Study|Study-specific discontinuation criteria|1|||
161830476|NCT00690482|584420134|FG001|Overall Study|Study-specific discontinuation criteria|0|||
161830477|NCT00690482|584420133|FG000|Overall Study|Intake of prohibited medicine|1|||
161830478|NCT00690482|584420134|FG001|Overall Study|Intake of prohibited medicine|0|||
161597210|NCT03474107|583577749|FG001|Overall Study|Adverse Event|46|||
161681668|NCT02114268|583886219|FG003|Overall Study|Lost to Follow-up|0|||
161681669|NCT02114268|583886220|FG004|Overall Study|Lost to Follow-up|0|||
161681670|NCT02114268|583886221|FG005|Overall Study|Lost to Follow-up|2|||
161681671|NCT02114268|583886216|FG000|Overall Study|Withdrawal by Subject|1|||
161681672|NCT02114268|583886217|FG001|Overall Study|Withdrawal by Subject|0|||
161681673|NCT02114268|583886218|FG002|Overall Study|Withdrawal by Subject|0|||
161681674|NCT02114268|583886219|FG003|Overall Study|Withdrawal by Subject|0|||
161681675|NCT02114268|583886220|FG004|Overall Study|Withdrawal by Subject|0|||
161681676|NCT02114268|583886221|FG005|Overall Study|Withdrawal by Subject|1|||
161681677|NCT02114268|583886216|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
161681678|NCT02114268|583886217|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
161681679|NCT02114268|583886218|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
161597211|NCT03474107|583577748|FG000|Overall Study|Death|2|||
161597212|NCT03474107|583577749|FG001|Overall Study|Death|2|||
161597213|NCT03474107|583577748|FG000|Overall Study|Lost to Follow-up|0|||
161597214|NCT03474107|583577749|FG001|Overall Study|Lost to Follow-up|1|||
161597215|NCT03474107|583577748|FG000|Overall Study|Progressive Disease|177|||
161597216|NCT03474107|583577749|FG001|Overall Study|Progressive Disease|180|||
161597217|NCT03474107|583577748|FG000|Overall Study|Protocol Violation|1|||
161597218|NCT03474107|583577749|FG001|Overall Study|Protocol Violation|1|||
161597219|NCT03474107|583577748|FG000|Overall Study|Withdrawal by Subject|15|||
161597220|NCT03474107|583577749|FG001|Overall Study|Withdrawal by Subject|27|||
161597221|NCT03474107|583577748|FG000|Overall Study|Physician Decision|7|||
161597222|NCT03474107|583577749|FG001|Overall Study|Physician Decision|22|||
161597223|NCT03474107|583577748|FG000|Overall Study|Miscellaneous|1|||
161597224|NCT03474107|583577749|FG001|Overall Study|Miscellaneous|6|||
161597225|NCT05171855|583577750|FG000|Overall Study|Death|1|||
161597226|NCT05171855|583577751|FG001|Overall Study|Death|0|||
161597227|NCT05171855|583577752|FG002|Overall Study|Death|0|||
161597228|NCT05171855|583577750|FG000|Overall Study|Withdrawal by Subject|2|||
161597229|NCT05171855|583577751|FG001|Overall Study|Withdrawal by Subject|0|||
161597230|NCT05171855|583577752|FG002|Overall Study|Withdrawal by Subject|5|||
161597231|NCT05171855|583577750|FG000|Overall Study|Physician Decision|1|||
161597232|NCT05171855|583577751|FG001|Overall Study|Physician Decision|0|||
161681680|NCT02114268|583886219|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
161681681|NCT02114268|583886220|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
161681682|NCT02114268|583886221|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
161681683|NCT02790138|583886222|FG000|Overall Study|Adverse Event|5|||
161681684|NCT02790138|583886223|FG001|Overall Study|Adverse Event|2|||
161681685|NCT02790138|583886222|FG000|Overall Study|Significant Protocol Deviation|0|||
161681686|NCT02790138|583886223|FG001|Overall Study|Significant Protocol Deviation|1|||
161681687|NCT02790138|583886222|FG000|Overall Study|Lost to Follow-up|1|||
161597233|NCT05171855|583577752|FG002|Overall Study|Physician Decision|0|||
161597234|NCT05171855|583577750|FG000|Overall Study|Adverse Event|2|||
161597235|NCT05171855|583577751|FG001|Overall Study|Adverse Event|4|||
161597236|NCT05171855|583577752|FG002|Overall Study|Adverse Event|2|||
161597237|NCT05171855|583577750|FG000|Overall Study|Other|0|||
161597238|NCT05171855|583577751|FG001|Overall Study|Other|0|||
161597239|NCT05171855|583577752|FG002|Overall Study|Other|1|||
161597240|NCT05041257|583577753|FG000|Overall Study|Death|37|||
161597241|NCT05041257|583577753|FG000|Overall Study|Lost to Follow-up|3|||
161597242|NCT05041257|583577753|FG000|Overall Study|Sponsor decision|39|||
161597243|NCT03067480|583577755|FG000|Overall Study|Lost to Follow-up|2|||
161597244|NCT03067480|583577756|FG001|Overall Study|Lost to Follow-up|4|||
161597245|NCT03067480|583577755|FG000|Overall Study|started insulin|1|||
161597246|NCT03067480|583577756|FG001|Overall Study|started insulin|1|||
161681688|NCT02790138|583886223|FG001|Overall Study|Lost to Follow-up|0|||
161681689|NCT02790138|583886222|FG000|Overall Study|Voluntary Withdrawal|8|||
161830479|NCT00690482|584420133|FG000|Overall Study|withdrew consent at rand.day|0|||
161681690|NCT02790138|583886223|FG001|Overall Study|Voluntary Withdrawal|9|||
161681691|NCT02790138|583886222|FG000|Overall Study|Lack of Efficacy|6|||
161681692|NCT02790138|583886223|FG001|Overall Study|Lack of Efficacy|7|||
161597247|NCT05782816|583577761|FG000|Overall Study|Withdrawal by Subject|1|||
161597248|NCT05782816|583577762|FG001|Overall Study|Withdrawal by Subject|0|||
161597249|NCT04221490|583577763|FG000|At 30 Days Follow-up|Death|7|||
161597250|NCT04221490|583577763|FG000|At 30 Days Follow-up|Physician Decision|1|||
161597251|NCT04221490|583577763|FG000|At 30 Days Follow-up|Missed Visit|4|||
161597252|NCT04221490|583577763|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
161681693|NCT02790138|583886222|FG000|Overall Study|Reason not Specified|1|||
161597253|NCT04221490|583577763|FG000|At 6 Months Follow-up|Death|9|||
161597254|NCT04221490|583577763|FG000|At 6 Months Follow-up|Missed Visit|8|||
161597255|NCT04221490|583577763|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
161597256|NCT04221490|583577763|FG000|At 1 Year Follow-up|Death|7|||
161597257|NCT04221490|583577763|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
161597258|NCT04221490|583577763|FG000|At 1 Year Follow-up|Missed Visit|9|||
161597259|NCT04221490|583577763|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
161597260|NCT05082025|583577764|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
161597261|NCT02442349|583577765|FG000|Overall Study|Death|95|||
161597262|NCT02442349|583577765|FG000|Overall Study|Withdrawal by Subject|27|||
161597263|NCT02442349|583577765|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
161597264|NCT02442349|583577765|FG000|Overall Study|Lost to Follow-up|1|||
161597265|NCT06504862|583577766|FG000|Transition period|Adverse Event|1|||
161597266|NCT06504862|583577767|FG001|Transition period|Adverse Event|0|||
161597267|NCT02296125|583577768|FG000|Overall Study|Withdrawal by Subject|18|||
161597268|NCT02296125|583577769|FG001|Overall Study|Withdrawal by Subject|8|||
161597269|NCT02296125|583577770|FG002|Overall Study|Withdrawal by Subject|6|||
161597270|NCT02296125|583577771|FG003|Overall Study|Withdrawal by Subject|2|||
161597271|NCT02296125|583577768|FG000|Overall Study|Adverse Event|41|||
161597272|NCT02296125|583577769|FG001|Overall Study|Adverse Event|52|||
161597273|NCT02296125|583577770|FG002|Overall Study|Adverse Event|9|||
161597274|NCT02296125|583577771|FG003|Overall Study|Adverse Event|4|||
161597275|NCT02296125|583577768|FG000|Overall Study|Severe non-compliance to protocol|0|||
161597276|NCT02296125|583577769|FG001|Overall Study|Severe non-compliance to protocol|1|||
161597277|NCT02296125|583577770|FG002|Overall Study|Severe non-compliance to protocol|0|||
161597278|NCT02296125|583577771|FG003|Overall Study|Severe non-compliance to protocol|0|||
161597279|NCT02296125|583577768|FG000|Overall Study|Condition under investigation worsened|153|||
161597280|NCT02296125|583577769|FG001|Overall Study|Condition under investigation worsened|199|||
161597281|NCT02296125|583577770|FG002|Overall Study|Condition under investigation worsened|39|||
161597282|NCT02296125|583577771|FG003|Overall Study|Condition under investigation worsened|56|||
161597283|NCT02296125|583577768|FG000|Overall Study|Any reason not specifically recorded|6|||
161597284|NCT02296125|583577769|FG001|Overall Study|Any reason not specifically recorded|4|||
161597285|NCT02296125|583577770|FG002|Overall Study|Any reason not specifically recorded|2|||
161597286|NCT02296125|583577771|FG003|Overall Study|Any reason not specifically recorded|0|||
161597287|NCT04192266|583577776|FG000|Overall Study|Withdrawal by Subject|3|||
161597288|NCT04192266|583577777|FG001|Overall Study|Withdrawal by Subject|2|||
161597289|NCT04870515|583577778|FG000|Overall Study|Lost to Follow-up|0|||
161597290|NCT04870515|583577779|FG001|Overall Study|Lost to Follow-up|2|||
161597291|NCT04870515|583577778|FG000|Overall Study|Withdrawal by Subject|0|||
161597292|NCT04870515|583577779|FG001|Overall Study|Withdrawal by Subject|1|||
161597293|NCT04870515|583577778|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
161597294|NCT04870515|583577779|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
161597295|NCT02838420|583577783|FG000|Overall Study|Ongoing in Study|113|||
161597296|NCT02838420|583577784|FG001|Overall Study|Ongoing in Study|45|||
161597297|NCT02838420|583577783|FG000|Overall Study|Lost to Follow-up|1|||
161597298|NCT02838420|583577784|FG001|Overall Study|Lost to Follow-up|0|||
161597299|NCT02838420|583577783|FG000|Overall Study|Withdrawal by Subject|3|||
161597300|NCT02838420|583577784|FG001|Overall Study|Withdrawal by Subject|4|||
161597301|NCT02838420|583577783|FG000|Overall Study|Death|8|||
161597302|NCT02838420|583577784|FG001|Overall Study|Death|13|||
161597303|NCT04811040|583577785|FG000|Overall Study|Lost to Follow-up|2|||
161597304|NCT04811040|583577786|FG001|Overall Study|Lost to Follow-up|0|||
161597305|NCT04811040|583577787|FG002|Overall Study|Lost to Follow-up|0|||
161597306|NCT04811040|583577788|FG003|Overall Study|Lost to Follow-up|0|||
161597307|NCT04811040|583577785|FG000|Overall Study|Withdrew consent|1|||
161597308|NCT04811040|583577786|FG001|Overall Study|Withdrew consent|1|||
161597309|NCT04811040|583577787|FG002|Overall Study|Withdrew consent|0|||
161597310|NCT04811040|583577788|FG003|Overall Study|Withdrew consent|0|||
161597311|NCT05934942|583577791|FG000|Run-in Period|Not treated|1|||
161597312|NCT05934942|583577791|FG000|Run-in Period|Withdrawal by Subject|1|||
161597313|NCT05469464|583577792|FG000|Overall Study|Withdrawal by Subject|8|||
161597314|NCT05469464|583577793|FG001|Overall Study|Withdrawal by Subject|7|||
161597315|NCT05469464|583577794|FG002|Overall Study|Withdrawal by Subject|4|||
161597316|NCT05469464|583577795|FG003|Overall Study|Withdrawal by Subject|5|||
161597317|NCT05469464|583577792|FG000|Overall Study|Adverse Event|8|||
161597318|NCT05469464|583577793|FG001|Overall Study|Adverse Event|14|||
161597319|NCT05469464|583577794|FG002|Overall Study|Adverse Event|13|||
161597320|NCT05469464|583577795|FG003|Overall Study|Adverse Event|2|||
161597321|NCT05469464|583577792|FG000|Overall Study|Lost to Follow-up|2|||
161597322|NCT05469464|583577793|FG001|Overall Study|Lost to Follow-up|5|||
161597323|NCT05469464|583577794|FG002|Overall Study|Lost to Follow-up|3|||
161597324|NCT05469464|583577795|FG003|Overall Study|Lost to Follow-up|3|||
161597325|NCT05469464|583577792|FG000|Overall Study|Lack of Efficacy|4|||
161597326|NCT05469464|583577793|FG001|Overall Study|Lack of Efficacy|1|||
161597327|NCT05469464|583577794|FG002|Overall Study|Lack of Efficacy|2|||
161597328|NCT05469464|583577795|FG003|Overall Study|Lack of Efficacy|2|||
161597329|NCT05469464|583577792|FG000|Overall Study|Physician Decision|0|||
161597330|NCT05469464|583577793|FG001|Overall Study|Physician Decision|0|||
161597331|NCT05469464|583577794|FG002|Overall Study|Physician Decision|0|||
161597332|NCT05469464|583577795|FG003|Overall Study|Physician Decision|1|||
161597333|NCT03905798|583577796|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
161597334|NCT05374798|583577799|FG000|Overall Study|Lost to Follow-up|2|||
161597335|NCT05374798|583577799|FG000|Overall Study|Withdrawal by Subject|2|||
161597336|NCT05374798|583577799|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
161597337|NCT01854775|583577800|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
161597338|NCT01854775|583577801|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
161597339|NCT01854775|583577802|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
161597340|NCT01854775|583577800|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
161597341|NCT01854775|583577801|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
161597342|NCT01854775|583577802|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
161597343|NCT01854775|583577800|FG000|Extension Phase|Pregnancy|1|||
161597344|NCT01854775|583577801|FG001|Extension Phase|Pregnancy|0|||
161597345|NCT01854775|583577802|FG002|Extension Phase|Pregnancy|0|||
161597346|NCT01854775|583577800|FG000|Extension Phase|Investigator's Discretion|1|||
161597347|NCT01854775|583577801|FG001|Extension Phase|Investigator's Discretion|0|||
161597348|NCT01854775|583577802|FG002|Extension Phase|Investigator's Discretion|0|||
161597349|NCT01854775|583577800|FG000|Extension Phase|Non-Compliance with study drug|1|||
161597350|NCT01854775|583577801|FG001|Extension Phase|Non-Compliance with study drug|0|||
161597351|NCT01854775|583577802|FG002|Extension Phase|Non-Compliance with study drug|0|||
161597352|NCT01854775|583577800|FG000|Extension Phase|Lost to Follow-up|1|||
161597353|NCT01854775|583577801|FG001|Extension Phase|Lost to Follow-up|0|||
161597354|NCT01854775|583577802|FG002|Extension Phase|Lost to Follow-up|0|||
161597355|NCT01854775|583577800|FG000|Extension Phase|Withdrew consent|0|||
161597356|NCT01854775|583577801|FG001|Extension Phase|Withdrew consent|1|||
161597357|NCT01854775|583577802|FG002|Extension Phase|Withdrew consent|0|||
161597358|NCT04068311|583577803|FG000|Overall Study|Death|3|||
161597359|NCT04068311|583577804|FG001|Overall Study|Death|3|||
161597360|NCT04068311|583577803|FG000|Overall Study|Lost to Follow-up|24|||
161597361|NCT04068311|583577804|FG001|Overall Study|Lost to Follow-up|68|||
161597362|NCT04068311|583577803|FG000|Overall Study|Withdrawal by Subject|5|||
161597363|NCT04068311|583577804|FG001|Overall Study|Withdrawal by Subject|0|||
161597364|NCT03100149|583577805|FG000|Overall Study|Adverse Event|0|||
161597365|NCT03100149|583577806|FG001|Overall Study|Adverse Event|1|||
161597366|NCT03100149|583577807|FG002|Overall Study|Adverse Event|0|||
161597367|NCT03100149|583577805|FG000|Overall Study|Participant Moved out of Country|0|||
161597368|NCT03100149|583577806|FG001|Overall Study|Participant Moved out of Country|0|||
161597369|NCT03100149|583577807|FG002|Overall Study|Participant Moved out of Country|1|||
161597370|NCT03100149|583577805|FG000|Overall Study|Withdrawal by Subject|0|||
161597371|NCT03100149|583577806|FG001|Overall Study|Withdrawal by Subject|3|||
161597372|NCT03100149|583577807|FG002|Overall Study|Withdrawal by Subject|1|||
161597373|NCT03697876|583577808|FG000|Overall Study|Lost to Follow-up|0|||
161597374|NCT03697876|583577809|FG001|Overall Study|Lost to Follow-up|1|||
161597375|NCT03697876|583577808|FG000|Overall Study|Adverse Event|1|||
161597376|NCT03697876|583577809|FG001|Overall Study|Adverse Event|0|||
161597377|NCT04721977|583577810|FG000|Overall Study|Death|15|||
161597378|NCT04721977|583577810|FG000|Overall Study|Ongoing|51|||
161597379|NCT02670525|583577811|FG000|Overall Study|Death|94|||
161597380|NCT02670525|583577812|FG001|Overall Study|Death|14|||
161597381|NCT02670525|583577811|FG000|Overall Study|Lost to Follow-up|4|||
161597382|NCT02670525|583577812|FG001|Overall Study|Lost to Follow-up|1|||
161681694|NCT02790138|583886223|FG001|Overall Study|Reason not Specified|0|||
161681695|NCT04037748|583886224|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161681696|NCT04037748|583886225|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161681697|NCT04037748|583886224|FG000|Treatment Period 1|Adverse Event|1|||
161681698|NCT04037748|583886225|FG001|Treatment Period 1|Adverse Event|1|||
161681699|NCT04037748|583886224|FG000|Treatment Period 1|Protocol Violation|4|||
161830480|NCT00690482|584420134|FG001|Overall Study|withdrew consent at rand.day|1|||
161597383|NCT02670525|583577811|FG000|Overall Study|Subject withdrew consent|1|||
161597384|NCT02670525|583577812|FG001|Overall Study|Subject withdrew consent|0|||
161597385|NCT02670525|583577811|FG000|Overall Study|Unknown, data entry delayed|123|||
161597386|NCT02670525|583577812|FG001|Overall Study|Unknown, data entry delayed|78|||
161597387|NCT02998268|583578362|FG000|Overall Study|Adverse Event|0|||
161597388|NCT02998268|583578363|FG001|Overall Study|Adverse Event|2|||
161597389|NCT02998268|583578362|FG000|Overall Study|Withdrawal by Subject|0|||
161597390|NCT02998268|583578363|FG001|Overall Study|Withdrawal by Subject|1|||
161597391|NCT04225273|583578364|FG000|Overall Study|Lost to Follow-up|3|||
161597392|NCT01501955|583578365|FG000|Overall Study|Withdrawal by Subject|1|||
161597393|NCT01501955|583578366|FG001|Overall Study|Withdrawal by Subject|0|||
161597394|NCT01501955|583578365|FG000|Overall Study|Adverse Event|1|||
161681700|NCT04037748|583886225|FG001|Treatment Period 1|Protocol Violation|5|||
161681701|NCT04037748|583886224|FG000|Treatment Period 2|Adverse Event|0|||
161597395|NCT01501955|583578366|FG001|Overall Study|Adverse Event|3|||
161597396|NCT01733316|583578367|FG000|RP103 Phase|Non-compliance|1|||
161597397|NCT01733316|583578367|FG000|Long Term Extension Phase|Adverse Event|1|||
161597398|NCT01733316|583578367|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
161597399|NCT01733316|583578367|FG000|Long Term Extension Phase|Sponsor Decision|2|||
161597400|NCT03235544|583578368|FG000|Overall Study|Death|11|||
161597401|NCT03235544|583578369|FG001|Overall Study|Death|31|||
161597402|NCT03235544|583578370|FG002|Overall Study|Death|19|||
161597403|NCT03235544|583578371|FG003|Overall Study|Death|34|||
161597404|NCT03235544|583578368|FG000|Overall Study|Lost to Follow-up|0|||
161597405|NCT03235544|583578369|FG001|Overall Study|Lost to Follow-up|1|||
161597406|NCT03235544|583578370|FG002|Overall Study|Lost to Follow-up|1|||
161597407|NCT03235544|583578371|FG003|Overall Study|Lost to Follow-up|1|||
161597408|NCT03235544|583578368|FG000|Overall Study|Withdrawal by Subject|0|||
161597409|NCT03235544|583578369|FG001|Overall Study|Withdrawal by Subject|3|||
161597410|NCT03235544|583578370|FG002|Overall Study|Withdrawal by Subject|1|||
161597411|NCT03235544|583578371|FG003|Overall Study|Withdrawal by Subject|5|||
161597412|NCT03235544|583578368|FG000|Overall Study|Disease Progression|0|||
161597413|NCT03235544|583578369|FG001|Overall Study|Disease Progression|1|||
161597414|NCT03235544|583578370|FG002|Overall Study|Disease Progression|0|||
161597415|NCT03235544|583578371|FG003|Overall Study|Disease Progression|2|||
161597416|NCT03235544|583578368|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
161597417|NCT03235544|583578369|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
161597418|NCT03235544|583578370|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
161597419|NCT03235544|583578371|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
161597420|NCT03235544|583578368|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
161597421|NCT03235544|583578369|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
161597422|NCT03235544|583578370|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
161597423|NCT03235544|583578371|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
161597424|NCT04498390|583578374|FG000|Overall Study|Adverse Event|0|||
161597425|NCT04498390|583578375|FG001|Overall Study|Adverse Event|0|||
161597426|NCT04498390|583578376|FG002|Overall Study|Adverse Event|1|||
161597427|NCT04498390|583578377|FG003|Overall Study|Adverse Event|0|||
161597428|NCT04498390|583578378|FG004|Overall Study|Adverse Event|0|||
161597429|NCT04498390|583578374|FG000|Overall Study|Withdrawal by Subject|0|||
161597430|NCT04498390|583578375|FG001|Overall Study|Withdrawal by Subject|0|||
161597431|NCT04498390|583578376|FG002|Overall Study|Withdrawal by Subject|0|||
161597432|NCT04498390|583578377|FG003|Overall Study|Withdrawal by Subject|1|||
161597433|NCT04498390|583578378|FG004|Overall Study|Withdrawal by Subject|0|||
161597434|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
161597435|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
161597436|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
161597437|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
161597438|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
161597439|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
161597440|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
161597441|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Death|0|||
161597442|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Death|2|||
161597443|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Death|0|||
161597444|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Death|0|||
161597445|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Death|0|||
161597446|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Death|0|||
161597447|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Death|0|||
161597448|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
161597449|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161597450|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161597451|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161681702|NCT04037748|583886225|FG001|Treatment Period 2|Adverse Event|1|||
161681703|NCT04037748|583886224|FG000|Treatment Period 2|Protocol Violation|2|||
161681704|NCT04037748|583886225|FG001|Treatment Period 2|Protocol Violation|0|||
161681705|NCT02064920|583886228|FG000|Overall Study|Adverse Event|0|||
161597452|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161597453|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161597454|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161597455|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161597456|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
161597457|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161597458|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161597459|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161597460|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161681706|NCT02064920|583886229|FG001|Overall Study|Adverse Event|4|||
161681707|NCT02064920|583886228|FG000|Overall Study|Physician Decision|0|||
161597461|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161597462|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
161597463|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
161597464|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
161597465|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
161597466|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
161597467|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
161597468|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
161597469|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
161597470|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
161597471|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161597472|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161597473|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161597474|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161597475|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161597476|NCT04585815|583578379|FG000|Sub-study A- Treatment Phase|Other|1|||
161597477|NCT04585815|583578380|FG001|Sub-study A- Treatment Phase|Other|0|||
161597478|NCT04585815|583578381|FG002|Sub-study A- Treatment Phase|Other|0|||
161597479|NCT04585815|583578382|FG003|Sub-study A- Treatment Phase|Other|0|||
161597480|NCT04585815|583578383|FG004|Sub-study A- Treatment Phase|Other|0|||
161597481|NCT04585815|583578384|FG005|Sub-study A- Treatment Phase|Other|0|||
161597482|NCT04585815|583578385|FG006|Sub-study A- Treatment Phase|Other|0|||
161597483|NCT04585815|583578379|FG000|Sub-study A- Follow-up Phase|Death|0|||
161597484|NCT04585815|583578380|FG001|Sub-study A- Follow-up Phase|Death|1|||
161597485|NCT04585815|583578381|FG002|Sub-study A- Follow-up Phase|Death|0|||
161597486|NCT04585815|583578382|FG003|Sub-study A- Follow-up Phase|Death|0|||
161597487|NCT04585815|583578383|FG004|Sub-study A- Follow-up Phase|Death|0|||
161597488|NCT04585815|583578384|FG005|Sub-study A- Follow-up Phase|Death|0|||
161597489|NCT04585815|583578385|FG006|Sub-study A- Follow-up Phase|Death|0|||
161597490|NCT04585815|583578379|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
161597491|NCT04585815|583578380|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
161597492|NCT04585815|583578381|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161597493|NCT04585815|583578382|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161597494|NCT04585815|583578383|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161597495|NCT04585815|583578384|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161597496|NCT04585815|583578385|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161597497|NCT04585815|583578379|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
161597498|NCT04585815|583578380|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
161597499|NCT04585815|583578381|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
161597500|NCT04585815|583578382|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
161597501|NCT04585815|583578383|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
161597502|NCT04585815|583578384|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
161597503|NCT04585815|583578385|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
161597504|NCT04585815|583578379|FG000|Sub-study B- Treatment Phase|Death|0|||
161597505|NCT04585815|583578380|FG001|Sub-study B- Treatment Phase|Death|0|||
161597506|NCT04585815|583578381|FG002|Sub-study B- Treatment Phase|Death|0|||
161597507|NCT04585815|583578382|FG003|Sub-study B- Treatment Phase|Death|1|||
161597508|NCT04585815|583578383|FG004|Sub-study B- Treatment Phase|Death|0|||
161597509|NCT04585815|583578384|FG005|Sub-study B- Treatment Phase|Death|0|||
161597510|NCT04585815|583578385|FG006|Sub-study B- Treatment Phase|Death|0|||
161597511|NCT04585815|583578379|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
161597512|NCT04585815|583578380|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
161597513|NCT04585815|583578381|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
161597514|NCT04585815|583578382|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
161597515|NCT04585815|583578383|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
161597516|NCT04585815|583578384|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
161597517|NCT04585815|583578385|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
161597518|NCT04585815|583578379|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161597519|NCT04585815|583578380|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161597520|NCT04585815|583578381|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161597521|NCT04585815|583578382|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
161597522|NCT04585815|583578383|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161597523|NCT04585815|583578384|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
161597524|NCT04585815|583578385|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161597525|NCT04585815|583578379|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161597526|NCT04585815|583578380|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161597527|NCT04585815|583578381|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161597528|NCT04585815|583578382|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
161597529|NCT04585815|583578383|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161597530|NCT04585815|583578384|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161597531|NCT04585815|583578385|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161597532|NCT04585815|583578379|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
161597533|NCT04585815|583578380|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
161597534|NCT04585815|583578381|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
161597535|NCT04585815|583578382|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
161597536|NCT04585815|583578383|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
161597537|NCT04585815|583578384|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
161597538|NCT04585815|583578385|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
161597539|NCT04585815|583578379|FG000|Sub-study B- Follow-up Phase|Death|0|||
161597540|NCT04585815|583578380|FG001|Sub-study B- Follow-up Phase|Death|0|||
161597541|NCT04585815|583578381|FG002|Sub-study B- Follow-up Phase|Death|1|||
161597542|NCT04585815|583578382|FG003|Sub-study B- Follow-up Phase|Death|3|||
161597543|NCT04585815|583578383|FG004|Sub-study B- Follow-up Phase|Death|1|||
161597544|NCT04585815|583578384|FG005|Sub-study B- Follow-up Phase|Death|0|||
161597545|NCT04585815|583578385|FG006|Sub-study B- Follow-up Phase|Death|3|||
161597546|NCT04585815|583578379|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161597547|NCT04585815|583578380|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161597548|NCT04585815|583578381|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161597549|NCT04585815|583578382|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161597550|NCT04585815|583578383|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161597551|NCT04585815|583578384|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
161597552|NCT04585815|583578385|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161597553|NCT02068885|583578386|FG000|Overall Study|Withdrew|3|||
161597554|NCT02068885|583578387|FG001|Overall Study|Withdrew|5|||
161597555|NCT02068885|583578388|FG002|Overall Study|Withdrew|8|||
161597556|NCT04622046|583578391|FG000|Intervention Period|Adverse Event|1|||
161597557|NCT04622046|583578391|FG000|Intervention Period|Withdrawal by Subject|2|||
161597558|NCT04622046|583578391|FG000|Extension Period|Ongoing in the Extension Period|21|||
161597559|NCT05321082|583578392|FG000|Overall Study|Other than listed|40|||
161597560|NCT05321082|583578393|FG001|Overall Study|Other than listed|26|||
161597561|NCT05321082|583578394|FG002|Overall Study|Other than listed|27|||
161597562|NCT05321082|583578392|FG000|Overall Study|Lost to Follow-up|0|||
161597563|NCT05321082|583578393|FG001|Overall Study|Lost to Follow-up|1|||
161597564|NCT05321082|583578394|FG002|Overall Study|Lost to Follow-up|0|||
161597565|NCT05321082|583578392|FG000|Overall Study|Withdrawal by Subject|30|||
161597566|NCT05321082|583578393|FG001|Overall Study|Withdrawal by Subject|34|||
161597567|NCT05321082|583578394|FG002|Overall Study|Withdrawal by Subject|42|||
161597568|NCT05321082|583578392|FG000|Overall Study|Protocol Violation|0|||
161597569|NCT05321082|583578393|FG001|Overall Study|Protocol Violation|0|||
161597570|NCT05321082|583578394|FG002|Overall Study|Protocol Violation|1|||
161597571|NCT05321082|583578392|FG000|Overall Study|Adverse Event|49|||
161597572|NCT05321082|583578393|FG001|Overall Study|Adverse Event|49|||
161597573|NCT05321082|583578394|FG002|Overall Study|Adverse Event|48|||
161597574|NCT05321082|583578392|FG000|Overall Study|Lack of Efficacy|2|||
161597575|NCT05321082|583578393|FG001|Overall Study|Lack of Efficacy|0|||
161597576|NCT05321082|583578394|FG002|Overall Study|Lack of Efficacy|1|||
161597577|NCT05321082|583578392|FG000|Overall Study|Not treated|1|||
161597578|NCT05321082|583578393|FG001|Overall Study|Not treated|0|||
161597579|NCT05321082|583578394|FG002|Overall Study|Not treated|1|||
161597580|NCT07147257|583578395|FG000|Overall Study|Pregnancy|1|||
161597581|NCT07147257|583578396|FG001|Overall Study|Pregnancy|0|||
161597582|NCT07147257|583578395|FG000|Overall Study|Physician Decision|0|||
161597583|NCT07147257|583578396|FG001|Overall Study|Physician Decision|1|||
161597584|NCT07147257|583578395|FG000|Overall Study|Withdrawal by Subject|0|||
161597585|NCT07147257|583578396|FG001|Overall Study|Withdrawal by Subject|1|||
161597586|NCT07147257|583578395|FG000|Overall Study|Drug administration failure|0|||
161597587|NCT07147257|583578396|FG001|Overall Study|Drug administration failure|1|||
161597588|NCT03748953|583580687|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
161597589|NCT03748953|583580688|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
161597590|NCT03748953|583580687|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
161597591|NCT03748953|583580688|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
161597592|NCT03748953|583580687|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
161597593|NCT03748953|583580688|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
161597594|NCT03748953|583580687|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
161597595|NCT03748953|583580688|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
161597596|NCT03748953|583580687|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
161597597|NCT03748953|583580688|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
161597598|NCT04676763|583580689|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
161597599|NCT04676763|583580690|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
161597600|NCT04676763|583580691|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
161597601|NCT04676763|583580689|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
161597602|NCT04676763|583580690|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
161597603|NCT04676763|583580691|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
161597604|NCT04676763|583580689|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
161597605|NCT04676763|583580690|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
161597606|NCT04676763|583580691|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
161597607|NCT04858451|583580692|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
161597608|NCT04858451|583580693|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597609|NCT04858451|583580694|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597610|NCT04858451|583580695|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597611|NCT04858451|583580696|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597612|NCT04858451|583580697|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597613|NCT04858451|583580698|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597614|NCT04858451|583580699|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597615|NCT04858451|583580700|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161597616|NCT04858451|583580692|FG000|Part 2|Discontinued|0|||
161597617|NCT04858451|583580693|FG001|Part 2|Discontinued|0|||
161597618|NCT04858451|583580694|FG002|Part 2|Discontinued|0|||
161597619|NCT04858451|583580695|FG003|Part 2|Discontinued|0|||
161597620|NCT04858451|583580696|FG004|Part 2|Discontinued|0|||
161597621|NCT04858451|583580697|FG005|Part 2|Discontinued|0|||
161597622|NCT04858451|583580698|FG006|Part 2|Discontinued|0|||
161597623|NCT04858451|583580699|FG007|Part 2|Discontinued|0|||
161597624|NCT04858451|583580700|FG008|Part 2|Discontinued|63|||
161597625|NCT04119843|583580701|FG000|Overall Study|Adverse Event|3|||
161597626|NCT04119843|583580701|FG000|Overall Study|Death|1|||
161597627|NCT03652389|583580703|FG000|Overall Study|Lost to Follow-up|1|||
161597628|NCT03652389|583580704|FG001|Overall Study|Lost to Follow-up|5|||
161597629|NCT03652389|583580703|FG000|Overall Study|Withdrawal by Subject|5|||
161597630|NCT03652389|583580704|FG001|Overall Study|Withdrawal by Subject|1|||
161597631|NCT03652389|583580703|FG000|Overall Study|New diagnosis|2|||
161597632|NCT03652389|583580704|FG001|Overall Study|New diagnosis|0|||
161597633|NCT04231149|583580705|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161597634|NCT04231149|583580706|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
161597635|NCT04231149|583580707|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161597636|NCT04231149|583580708|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161597637|NCT04231149|583580709|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161597638|NCT03252847|583580710|FG000|Overall Study|Withdrawal by Subject|0|||
161597639|NCT03252847|583580711|FG001|Overall Study|Withdrawal by Subject|0|||
161597640|NCT03252847|583580712|FG002|Overall Study|Withdrawal by Subject|1|||
161597641|NCT03252847|583580713|FG003|Overall Study|Withdrawal by Subject|0|||
161597642|NCT03252847|583580714|FG004|Overall Study|Withdrawal by Subject|0|||
161597643|NCT03252847|583580715|FG005|Overall Study|Withdrawal by Subject|0|||
161597644|NCT03252847|583580716|FG006|Overall Study|Withdrawal by Subject|0|||
161597645|NCT03252847|583580710|FG000|Overall Study|Other: Patient decision|0|||
161597646|NCT03252847|583580711|FG001|Overall Study|Other: Patient decision|0|||
161597647|NCT03252847|583580712|FG002|Overall Study|Other: Patient decision|0|||
161597648|NCT03252847|583580713|FG003|Overall Study|Other: Patient decision|0|||
161597649|NCT03252847|583580714|FG004|Overall Study|Other: Patient decision|1|||
161597650|NCT03252847|583580715|FG005|Overall Study|Other: Patient decision|0|||
161597651|NCT03252847|583580716|FG006|Overall Study|Other: Patient decision|0|||
161597652|NCT04298983|583580721|FG000|Overall Study|Adverse Event|4|||
161597653|NCT04298983|583580721|FG000|Overall Study|Lack of Efficacy|3|||
161597654|NCT02927236|583580722|FG000|Characterization Phase|Physician Decision|0|||
161597655|NCT02927236|583580723|FG001|Characterization Phase|Physician Decision|3|||
161597656|NCT02927236|583580724|FG002|Characterization Phase|Physician Decision|0|||
161597657|NCT02927236|583580725|FG003|Characterization Phase|Physician Decision|2|||
161597658|NCT02927236|583580722|FG000|Characterization Phase|Lost to Follow-up|0|||
161597659|NCT02927236|583580723|FG001|Characterization Phase|Lost to Follow-up|0|||
161597660|NCT02927236|583580724|FG002|Characterization Phase|Lost to Follow-up|0|||
161597661|NCT02927236|583580725|FG003|Characterization Phase|Lost to Follow-up|3|||
161597662|NCT02927236|583580722|FG000|Characterization Phase|Withdrawal by Subject|1|||
161597663|NCT02927236|583580723|FG001|Characterization Phase|Withdrawal by Subject|0|||
161597664|NCT02927236|583580724|FG002|Characterization Phase|Withdrawal by Subject|0|||
161597665|NCT02927236|583580725|FG003|Characterization Phase|Withdrawal by Subject|1|||
161597666|NCT02927236|583580722|FG000|Treatment Phase|Adverse Event|1|||
161597667|NCT02927236|583580723|FG001|Treatment Phase|Adverse Event|0|||
161597668|NCT02927236|583580724|FG002|Treatment Phase|Adverse Event|1|||
161597669|NCT02927236|583580725|FG003|Treatment Phase|Adverse Event|1|||
161597670|NCT02927236|583580722|FG000|Treatment Phase|Protocol Violation|3|||
161597671|NCT02927236|583580723|FG001|Treatment Phase|Protocol Violation|0|||
161597672|NCT02927236|583580724|FG002|Treatment Phase|Protocol Violation|0|||
161597673|NCT02927236|583580725|FG003|Treatment Phase|Protocol Violation|1|||
161597674|NCT02927236|583580722|FG000|Treatment Phase|Lost to Follow-up|1|||
161597675|NCT02927236|583580723|FG001|Treatment Phase|Lost to Follow-up|0|||
161597676|NCT02927236|583580724|FG002|Treatment Phase|Lost to Follow-up|0|||
161597677|NCT02927236|583580725|FG003|Treatment Phase|Lost to Follow-up|0|||
161597678|NCT02927236|583580722|FG000|Follow-up Phase|Lost to Follow-up|1|||
161597679|NCT02927236|583580723|FG001|Follow-up Phase|Lost to Follow-up|0|||
161597680|NCT02927236|583580724|FG002|Follow-up Phase|Lost to Follow-up|1|||
161597681|NCT02927236|583580725|FG003|Follow-up Phase|Lost to Follow-up|0|||
161597682|NCT05477186|583580726|FG000|Overall Study|Vaccine not administered|0|||
161597683|NCT05477186|583580727|FG001|Overall Study|Vaccine not administered|2|||
161597684|NCT05477186|583580728|FG002|Overall Study|Vaccine not administered|1|||
161597685|NCT05477186|583580729|FG003|Overall Study|Vaccine not administered|0|||
161597686|NCT05477186|583580730|FG004|Overall Study|Vaccine not administered|1|||
161597687|NCT05477186|583580731|FG005|Overall Study|Vaccine not administered|0|||
161597688|NCT05477186|583580732|FG006|Overall Study|Vaccine not administered|0|||
161597689|NCT05477186|583580726|FG000|Overall Study|Withdrawal by Subject|1|||
161597690|NCT05477186|583580727|FG001|Overall Study|Withdrawal by Subject|0|||
161597691|NCT05477186|583580728|FG002|Overall Study|Withdrawal by Subject|0|||
161597692|NCT05477186|583580729|FG003|Overall Study|Withdrawal by Subject|0|||
161597693|NCT05477186|583580730|FG004|Overall Study|Withdrawal by Subject|0|||
161597694|NCT05477186|583580731|FG005|Overall Study|Withdrawal by Subject|1|||
161597695|NCT05477186|583580732|FG006|Overall Study|Withdrawal by Subject|0|||
161597696|NCT05477186|583580726|FG000|Overall Study|Lost to Follow-up|1|||
161597697|NCT05477186|583580727|FG001|Overall Study|Lost to Follow-up|0|||
161597698|NCT05477186|583580728|FG002|Overall Study|Lost to Follow-up|2|||
161597699|NCT05477186|583580729|FG003|Overall Study|Lost to Follow-up|1|||
161597700|NCT05477186|583580730|FG004|Overall Study|Lost to Follow-up|1|||
161597701|NCT05477186|583580731|FG005|Overall Study|Lost to Follow-up|0|||
161597702|NCT05477186|583580732|FG006|Overall Study|Lost to Follow-up|2|||
161597703|NCT01919554|583580734|FG000|Overall Study|Withdrawal by Subject|0|||
161597704|NCT01919554|583580735|FG001|Overall Study|Withdrawal by Subject|0|||
161597705|NCT01919554|583580736|FG002|Overall Study|Withdrawal by Subject|1|||
161597706|NCT01919554|583580737|FG003|Overall Study|Withdrawal by Subject|1|||
161597707|NCT05297565|583580738|FG000|Overall Study|Other Reasons|0|||
161597708|NCT05297565|583580739|FG001|Overall Study|Other Reasons|1|||
161597709|NCT05297565|583580738|FG000|Overall Study|Physician Decision|0|||
161597710|NCT05297565|583580739|FG001|Overall Study|Physician Decision|1|||
161597711|NCT05297565|583580738|FG000|Overall Study|Disease recurrence|1|||
161597712|NCT05297565|583580739|FG001|Overall Study|Disease recurrence|0|||
161597713|NCT04914676|583580740|FG000|Overall Study|Study termination|3|||
161597714|NCT04914676|583580741|FG001|Overall Study|Study termination|0|||
161597715|NCT03024437|583580742|FG000|Overall Study|Adverse Event|0|||
161597716|NCT03024437|583580743|FG001|Overall Study|Adverse Event|1|||
161597717|NCT03024437|583580744|FG002|Overall Study|Adverse Event|3|||
161597718|NCT03024437|583580745|FG003|Overall Study|Adverse Event|5|||
161597719|NCT03024437|583580746|FG004|Overall Study|Adverse Event|0|||
161597720|NCT03024437|583580742|FG000|Overall Study|Physician Decision|1|||
161597721|NCT03024437|583580743|FG001|Overall Study|Physician Decision|0|||
161597722|NCT03024437|583580744|FG002|Overall Study|Physician Decision|0|||
161597723|NCT03024437|583580745|FG003|Overall Study|Physician Decision|1|||
161597724|NCT03024437|583580746|FG004|Overall Study|Physician Decision|0|||
161597725|NCT03024437|583580742|FG000|Overall Study|Disease progression, relapse|1|||
161597726|NCT03024437|583580743|FG001|Overall Study|Disease progression, relapse|0|||
161597727|NCT03024437|583580744|FG002|Overall Study|Disease progression, relapse|0|||
161597728|NCT03024437|583580745|FG003|Overall Study|Disease progression, relapse|3|||
161597729|NCT03024437|583580746|FG004|Overall Study|Disease progression, relapse|0|||
161597730|NCT03024437|583580742|FG000|Overall Study|Disease progression, refractory disease|4|||
161597731|NCT03024437|583580743|FG001|Overall Study|Disease progression, refractory disease|4|||
161597732|NCT03024437|583580744|FG002|Overall Study|Disease progression, refractory disease|2|||
161597733|NCT03024437|583580745|FG003|Overall Study|Disease progression, refractory disease|2|||
161597734|NCT03024437|583580746|FG004|Overall Study|Disease progression, refractory disease|1|||
161597735|NCT03024437|583580742|FG000|Overall Study|Newly diagnosed cancer|0|||
161597736|NCT03024437|583580743|FG001|Overall Study|Newly diagnosed cancer|0|||
161597737|NCT03024437|583580744|FG002|Overall Study|Newly diagnosed cancer|0|||
161597738|NCT03024437|583580745|FG003|Overall Study|Newly diagnosed cancer|1|||
161597739|NCT03024437|583580746|FG004|Overall Study|Newly diagnosed cancer|0|||
161597740|NCT03024437|583580742|FG000|Overall Study|Moved out of state|0|||
161597741|NCT03024437|583580743|FG001|Overall Study|Moved out of state|1|||
161597742|NCT03024437|583580744|FG002|Overall Study|Moved out of state|0|||
161597743|NCT03024437|583580745|FG003|Overall Study|Moved out of state|0|||
161597744|NCT03024437|583580746|FG004|Overall Study|Moved out of state|0|||
161597745|NCT03024437|583580742|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161830481|NCT04798482|584420135|FG000|Overall Study|Physician Decision|1|||
161597746|NCT03024437|583580743|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161597747|NCT03024437|583580744|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
161597748|NCT03024437|583580745|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161681708|NCT02064920|583886229|FG001|Overall Study|Physician Decision|1|||
161830482|NCT04798482|584420135|FG000|Overall Study|Lost eligibility|1|||
161597749|NCT03024437|583580746|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161597750|NCT02606422|583580747|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
161597751|NCT02606422|583580748|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
161597752|NCT02606422|583580747|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
161597753|NCT02606422|583580748|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
161597754|NCT02606422|583580747|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
161597755|NCT02606422|583580748|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
161597756|NCT02606422|583580747|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
161597757|NCT02606422|583580748|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
161597758|NCT04625465|583580749|FG000|Overall Study|Lost to Follow-up|2|||
161597759|NCT04625465|583580750|FG001|Overall Study|Lost to Follow-up|2|||
161597760|NCT04625465|583580751|FG002|Overall Study|Lost to Follow-up|1|||
161597761|NCT04625465|583580752|FG003|Overall Study|Lost to Follow-up|0|||
161597762|NCT04625465|583580753|FG004|Overall Study|Lost to Follow-up|0|||
161597763|NCT04625465|583580754|FG005|Overall Study|Lost to Follow-up|2|||
161597764|NCT04625465|583580755|FG006|Overall Study|Lost to Follow-up|0|||
161597765|NCT04625465|583580756|FG007|Overall Study|Lost to Follow-up|0|||
161597766|NCT04625465|583580749|FG000|Overall Study|Death|1|||
161597767|NCT04625465|583580750|FG001|Overall Study|Death|0|||
161597768|NCT04625465|583580751|FG002|Overall Study|Death|0|||
161597769|NCT04625465|583580752|FG003|Overall Study|Death|0|||
161597770|NCT04625465|583580753|FG004|Overall Study|Death|0|||
161597771|NCT04625465|583580754|FG005|Overall Study|Death|0|||
161597772|NCT04625465|583580755|FG006|Overall Study|Death|0|||
161597773|NCT04625465|583580756|FG007|Overall Study|Death|0|||
161597774|NCT04625465|583580749|FG000|Overall Study|Withdrawal by Subject|1|||
161597775|NCT04625465|583580750|FG001|Overall Study|Withdrawal by Subject|0|||
161597776|NCT04625465|583580751|FG002|Overall Study|Withdrawal by Subject|4|||
161597777|NCT04625465|583580752|FG003|Overall Study|Withdrawal by Subject|4|||
161597778|NCT04625465|583580753|FG004|Overall Study|Withdrawal by Subject|4|||
161597779|NCT04625465|583580754|FG005|Overall Study|Withdrawal by Subject|0|||
161597780|NCT04625465|583580755|FG006|Overall Study|Withdrawal by Subject|0|||
161597781|NCT04625465|583580756|FG007|Overall Study|Withdrawal by Subject|0|||
161597782|NCT05566639|583580760|FG000|Overall Study|Adverse Event|1|||
161597783|NCT05566639|583580761|FG001|Overall Study|Adverse Event|1|||
161597784|NCT05566639|583580760|FG000|Overall Study|Serious Adverse Event|1|||
161597785|NCT05566639|583580761|FG001|Overall Study|Serious Adverse Event|3|||
161597786|NCT05566639|583580760|FG000|Overall Study|Death|44|||
161597787|NCT05566639|583580761|FG001|Overall Study|Death|45|||
161597788|NCT05566639|583580760|FG000|Overall Study|Lost to Follow-up|467|||
161597789|NCT05566639|583580761|FG001|Overall Study|Lost to Follow-up|461|||
161597790|NCT05566639|583580760|FG000|Overall Study|Physician Decision|45|||
161597791|NCT05566639|583580761|FG001|Overall Study|Physician Decision|44|||
161597792|NCT05566639|583580760|FG000|Overall Study|Protocol Deviation|4|||
161597793|NCT05566639|583580761|FG001|Overall Study|Protocol Deviation|4|||
161597794|NCT05566639|583580760|FG000|Overall Study|Withdrawal by Subject|277|||
161597795|NCT05566639|583580761|FG001|Overall Study|Withdrawal by Subject|271|||
161597796|NCT05566639|583580760|FG000|Overall Study|Other Than Specified|52|||
161597797|NCT05566639|583580761|FG001|Overall Study|Other Than Specified|64|||
161597798|NCT04054193|583580769|FG000|Cycle 1|Physician Decision|1|||
161597799|NCT04054193|583580769|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
161597800|NCT04054193|583580769|FG000|Cycle 1|Allocated but not treated|3|||
161597801|NCT04054193|583580769|FG000|Cycles 2-3|Physician Decision|2|||
161597802|NCT04054193|583580769|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
161597803|NCT04054193|583580769|FG000|Cycles 2-3|Various reasons|17|||
161681709|NCT02064920|583886228|FG000|Overall Study|Technical Problems|0|||
161597804|NCT02966873|583580770|FG000|Overall Study|Lost to Follow-up|16|||
161681710|NCT02064920|583886229|FG001|Overall Study|Technical Problems|1|||
161597805|NCT02966873|583580771|FG001|Overall Study|Lost to Follow-up|15|||
161597806|NCT00950742|583580773|FG000|Overall Study|Other Adverse Event|1|||
161597807|NCT00950742|583580774|FG001|Overall Study|Other Adverse Event|0|||
161597808|NCT00950742|583580773|FG000|Overall Study|Withdrawal by Subject|3|||
161597809|NCT00950742|583580774|FG001|Overall Study|Withdrawal by Subject|0|||
161597810|NCT00950742|583580773|FG000|Overall Study|Progressive Disease|6|||
161597811|NCT00950742|583580774|FG001|Overall Study|Progressive Disease|2|||
161597812|NCT00950742|583580773|FG000|Overall Study|Dose limiting toxicity|6|||
161597813|NCT00950742|583580774|FG001|Overall Study|Dose limiting toxicity|0|||
161597814|NCT05436262|583580776|FG000|Pre-Randomization|Withdrawal by Subject|1|||
161597815|NCT05436262|583580777|FG001|Pre-Randomization|Withdrawal by Subject|0|||
161597816|NCT05436262|583580778|FG002|Pre-Randomization|Withdrawal by Subject|0|||
161597817|NCT05436262|583580776|FG000|Randomization|Withdrawal by Subject|0|||
161597818|NCT05436262|583580777|FG001|Randomization|Withdrawal by Subject|1|||
161681711|NCT02064920|583886228|FG000|Overall Study|Withdrawal by Subject|1|||
161597819|NCT05436262|583580778|FG002|Randomization|Withdrawal by Subject|0|||
161597820|NCT05299073|583580779|FG000|Overall Study|Withdrawal by Subject|0|||
161597821|NCT05299073|583580780|FG001|Overall Study|Withdrawal by Subject|0|||
161597822|NCT05299073|583580781|FG002|Overall Study|Withdrawal by Subject|1|||
161597823|NCT05299073|583580779|FG000|Overall Study|Adverse Event|0|||
161597824|NCT05299073|583580780|FG001|Overall Study|Adverse Event|1|||
161597825|NCT05299073|583580781|FG002|Overall Study|Adverse Event|0|||
161597826|NCT05299073|583580779|FG000|Overall Study|Lost to Follow-up|0|||
161597827|NCT05299073|583580780|FG001|Overall Study|Lost to Follow-up|1|||
161597828|NCT05299073|583580781|FG002|Overall Study|Lost to Follow-up|0|||
161597829|NCT03952338|583580782|FG000|Overall Study|Lost to Follow-up|11|||
161597830|NCT03952338|583580783|FG001|Overall Study|Lost to Follow-up|17|||
161597831|NCT03952338|583580782|FG000|Overall Study|Withdrawal by Subject|1|||
161597832|NCT03952338|583580783|FG001|Overall Study|Withdrawal by Subject|1|||
161597833|NCT03952338|583580782|FG000|Overall Study|Protocol Violation|1|||
161597834|NCT03952338|583580783|FG001|Overall Study|Protocol Violation|0|||
161597835|NCT01456949|583580784|FG000|Enrollment|PI death- incomplete data|6|||
161597836|NCT01456949|583580784|FG000|Enrollment|Death|1|||
161597837|NCT01456949|583580784|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
161597838|NCT01456949|583580784|FG000|Enrollment|Physician Decision|10|||
161597839|NCT01456949|583580784|FG000|Enrollment|Withdrawal by Subject|7|||
161597840|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
161597841|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
161597842|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
161597843|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
161597844|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
161597845|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
161597846|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
161597847|NCT01456949|583580784|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
161597848|NCT04753697|583580785|FG000|Induction Phase|Withdrawal by Subject|12|||
161597849|NCT04753697|583580786|FG001|Induction Phase|Withdrawal by Subject|5|||
161597850|NCT04753697|583580787|FG002|Induction Phase|Withdrawal by Subject|6|||
161597851|NCT04753697|583580785|FG000|Induction Phase|Physician Decision|1|||
161597852|NCT04753697|583580786|FG001|Induction Phase|Physician Decision|0|||
161597853|NCT04753697|583580787|FG002|Induction Phase|Physician Decision|0|||
161597854|NCT04753697|583580785|FG000|Induction Phase|Lost to Follow-up|2|||
161597855|NCT04753697|583580786|FG001|Induction Phase|Lost to Follow-up|2|||
161597856|NCT04753697|583580787|FG002|Induction Phase|Lost to Follow-up|1|||
161597857|NCT04753697|583580785|FG000|Induction Phase|Lack of Efficacy|1|||
161597858|NCT04753697|583580786|FG001|Induction Phase|Lack of Efficacy|0|||
161597859|NCT04753697|583580787|FG002|Induction Phase|Lack of Efficacy|0|||
161597860|NCT04753697|583580785|FG000|Maintenance Phase|Physician Decision|0|||
161597861|NCT04753697|583580786|FG001|Maintenance Phase|Physician Decision|0|||
161597862|NCT04753697|583580787|FG002|Maintenance Phase|Physician Decision|1|||
161597863|NCT04753697|583580785|FG000|Maintenance Phase|Withdrawal by Subject|3|||
161597864|NCT04753697|583580786|FG001|Maintenance Phase|Withdrawal by Subject|4|||
161597865|NCT04753697|583580787|FG002|Maintenance Phase|Withdrawal by Subject|6|||
161597866|NCT04753697|583580785|FG000|Maintenance Phase|Lost to Follow-up|2|||
161597867|NCT04753697|583580786|FG001|Maintenance Phase|Lost to Follow-up|2|||
161597868|NCT04753697|583580787|FG002|Maintenance Phase|Lost to Follow-up|0|||
161597869|NCT04753697|583580785|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
161597870|NCT04753697|583580786|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
161597871|NCT04753697|583580787|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
161597872|NCT04753697|583580785|FG000|Maintenance Phase|Adverse Event|0|||
161597873|NCT04753697|583580786|FG001|Maintenance Phase|Adverse Event|1|||
161597874|NCT04753697|583580787|FG002|Maintenance Phase|Adverse Event|1|||
161597875|NCT04753697|583580785|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
161597876|NCT04753697|583580786|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
161597877|NCT04753697|583580787|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
161597878|NCT04200456|583580790|FG000|Overall Study|Physician Decision|0|||
161597879|NCT04200456|583580791|FG001|Overall Study|Physician Decision|1|||
161597880|NCT04200456|583580790|FG000|Overall Study|Withdrawal by Subject|2|||
161597881|NCT04200456|583580791|FG001|Overall Study|Withdrawal by Subject|2|||
161597882|NCT04200456|583580790|FG000|Overall Study|Lack of Efficacy|1|||
161597883|NCT04200456|583580791|FG001|Overall Study|Lack of Efficacy|1|||
161597884|NCT04200456|583580790|FG000|Overall Study|Adverse event, non-fatal|0|||
161597885|NCT04200456|583580791|FG001|Overall Study|Adverse event, non-fatal|1|||
161597886|NCT04200456|583580790|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
161597887|NCT04200456|583580791|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
161597888|NCT00592852|583580792|FG000|Overall Study|Non-compliance|1|||
161597889|NCT00592852|583580792|FG000|Overall Study|Adverse Event|3|||
161597890|NCT00592852|583580792|FG000|Overall Study|Found ineligible|1|||
161597891|NCT00592852|583580792|FG000|Overall Study|Withdrawal by Subject|1|||
161597892|NCT05002088|583580793|FG000|Overall Study|Withdrawal by Subject|9|||
161597893|NCT05002088|583580794|FG001|Overall Study|Withdrawal by Subject|0|||
161597894|NCT05002088|583580793|FG000|Overall Study|Lost to Follow-up|0|||
161597895|NCT05002088|583580794|FG001|Overall Study|Lost to Follow-up|1|||
161597896|NCT05002088|583580793|FG000|Overall Study|Death|16|||
161830483|NCT00605917|584420140|FG000|Overall Study|Protocol Violation|79|||
161597897|NCT05002088|583580794|FG001|Overall Study|Death|2|||
161597898|NCT05002088|583580793|FG000|Overall Study|Protocol Violation|25|||
161597899|NCT05002088|583580794|FG001|Overall Study|Protocol Violation|7|||
161597900|NCT04770402|583580796|FG000|Overall Study|Lost to Follow-up|1|||
161597901|NCT04770402|583580797|FG001|Overall Study|Lost to Follow-up|2|||
161597902|NCT04770402|583580796|FG000|Overall Study|Non-compliance|1|||
161597903|NCT04770402|583580797|FG001|Overall Study|Non-compliance|0|||
161597904|NCT04770402|583580796|FG000|Overall Study|Withdrawal by Subject|0|||
161597905|NCT04770402|583580797|FG001|Overall Study|Withdrawal by Subject|1|||
161597906|NCT03599661|583580798|FG000|Overall Study|Lost to Follow-up|9|||
161597907|NCT05446168|583580799|FG000|Overall Study|Physician Decision|0|||
161597908|NCT05446168|583580800|FG001|Overall Study|Physician Decision|1|||
161597909|NCT01828099|583580801|FG000|Treatment Period|Adverse Event|24|||
161597910|NCT01828099|583580802|FG001|Treatment Period|Adverse Event|23|||
161597911|NCT01828099|583580801|FG000|Treatment Period|Death|10|||
161597912|NCT01828099|583580802|FG001|Treatment Period|Death|12|||
161597913|NCT01828099|583580801|FG000|Treatment Period|Lost to Follow-up|2|||
161597914|NCT01828099|583580802|FG001|Treatment Period|Lost to Follow-up|1|||
161597915|NCT01828099|583580801|FG000|Treatment Period|Non-compliance with study treatment|1|||
161597916|NCT01828099|583580802|FG001|Treatment Period|Non-compliance with study treatment|0|||
161597917|NCT01828099|583580801|FG000|Treatment Period|Physician Decision|17|||
161597918|NCT01828099|583580802|FG001|Treatment Period|Physician Decision|16|||
161597919|NCT01828099|583580801|FG000|Treatment Period|Progressive disease|99|||
161597920|NCT01828099|583580802|FG001|Treatment Period|Progressive disease|107|||
161597921|NCT01828099|583580801|FG000|Treatment Period|Subject/guardian decision|22|||
161597922|NCT01828099|583580802|FG001|Treatment Period|Subject/guardian decision|26|||
161597923|NCT01828099|583580801|FG000|Treatment Period|Study terminated by Sponsor|13|||
161597924|NCT01828099|583580802|FG001|Treatment Period|Study terminated by Sponsor|1|||
161597925|NCT01828099|583580801|FG000|Treatment Period|Protocol deviation|1|||
161597926|NCT01828099|583580802|FG001|Treatment Period|Protocol deviation|0|||
161597927|NCT01828099|583580801|FG000|Treatment Period|No longer requires treatment|0|||
161597928|NCT01828099|583580802|FG001|Treatment Period|No longer requires treatment|1|||
161597929|NCT01828099|583580801|FG000|Extension-treatment Phase|Adverse Event|0|||
161597930|NCT01828099|583580802|FG001|Extension-treatment Phase|Adverse Event|17|||
161597931|NCT01828099|583580801|FG000|Extension-treatment Phase|Death|0|||
161597932|NCT01828099|583580802|FG001|Extension-treatment Phase|Death|11|||
161597933|NCT01828099|583580801|FG000|Extension-treatment Phase|Physician Decision|0|||
161597934|NCT01828099|583580802|FG001|Extension-treatment Phase|Physician Decision|5|||
161597935|NCT01828099|583580801|FG000|Extension-treatment Phase|Progressive disease|0|||
161597936|NCT01828099|583580802|FG001|Extension-treatment Phase|Progressive disease|54|||
161597937|NCT01828099|583580801|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
161597938|NCT01828099|583580802|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
161597939|NCT01828099|583580801|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
161597940|NCT01828099|583580802|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
161597941|NCT03924635|583580805|FG000|Overall Study|Withdrawal by Subject|2|||
161597942|NCT03924635|583580806|FG001|Overall Study|Withdrawal by Subject|4|||
161597943|NCT06473662|583580807|FG000|Overall Study|Withdrawal by Subject|1|||
161597944|NCT06473662|583580808|FG001|Overall Study|Withdrawal by Subject|6|||
161597945|NCT06473662|583580809|FG002|Overall Study|Withdrawal by Subject|5|||
161597946|NCT06473662|583580807|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
161597947|NCT06473662|583580808|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
161597948|NCT06473662|583580809|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
161597949|NCT06473662|583580807|FG000|Overall Study|Starting HbA1c below 7%|0|||
161597950|NCT06473662|583580808|FG001|Overall Study|Starting HbA1c below 7%|1|||
161597951|NCT06473662|583580809|FG002|Overall Study|Starting HbA1c below 7%|1|||
161597952|NCT06473662|583580807|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
161597953|NCT06473662|583580808|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
161597954|NCT06473662|583580809|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
161597955|NCT06473662|583580807|FG000|Overall Study|Did not take medication|2|||
161597956|NCT06473662|583580808|FG001|Overall Study|Did not take medication|3|||
161597957|NCT06473662|583580809|FG002|Overall Study|Did not take medication|2|||
161597958|NCT04471246|583580812|FG000|Overall Study|Lost to Follow-up|2|||
161597959|NCT04471246|583580813|FG001|Overall Study|Lost to Follow-up|2|||
161597960|NCT04826471|583580814|FG000|Overall Study|Lost to Follow-up|2|||
161597961|NCT04826471|583580814|FG000|Overall Study|Protocol Violation|3|||
161597962|NCT04826471|583580814|FG000|Overall Study|Withdrawal by Subject|1|||
161597963|NCT05764525|583580815|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
161597964|NCT05764525|583580816|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
161597965|NCT05764525|583580815|FG000|Overall Study|Withdrawal by Subject|4|||
161597966|NCT05764525|583580816|FG001|Overall Study|Withdrawal by Subject|8|||
161597967|NCT05764525|583580815|FG000|Overall Study|Physician Decision|1|||
161597968|NCT05764525|583580816|FG001|Overall Study|Physician Decision|0|||
161597969|NCT04079218|583580817|FG000|Overall Study|Death|1|||
161597970|NCT04079218|583580818|FG001|Overall Study|Death|0|||
161597971|NCT04079218|583580817|FG000|Overall Study|Withdrawal by Subject|3|||
161597972|NCT04079218|583580818|FG001|Overall Study|Withdrawal by Subject|0|||
161597973|NCT04079218|583580817|FG000|Overall Study|Physician Decision|4|||
161597974|NCT04079218|583580818|FG001|Overall Study|Physician Decision|0|||
161597975|NCT04079218|583580817|FG000|Overall Study|Lost to Follow-up|0|||
161597976|NCT04079218|583580818|FG001|Overall Study|Lost to Follow-up|1|||
161597977|NCT05907174|583580824|FG000|3-Month Assessment|Withdrawal by Subject|0|||
161597978|NCT05907174|583580825|FG001|3-Month Assessment|Withdrawal by Subject|0|||
161597979|NCT05907174|583580826|FG002|3-Month Assessment|Withdrawal by Subject|0|||
161597980|NCT05907174|583580827|FG003|3-Month Assessment|Withdrawal by Subject|1|||
161597981|NCT05907174|583580824|FG000|3-Month Assessment|Lost to Follow-up|1|||
161597982|NCT05907174|583580825|FG001|3-Month Assessment|Lost to Follow-up|1|||
161597983|NCT05907174|583580826|FG002|3-Month Assessment|Lost to Follow-up|1|||
161597984|NCT05907174|583580827|FG003|3-Month Assessment|Lost to Follow-up|1|||
161597985|NCT05907174|583580824|FG000|6-Month Assessment|Death|0|||
161597986|NCT05907174|583580825|FG001|6-Month Assessment|Death|0|||
161597987|NCT05907174|583580826|FG002|6-Month Assessment|Death|3|||
161597988|NCT05907174|583580827|FG003|6-Month Assessment|Death|0|||
161597989|NCT05907174|583580824|FG000|6-Month Assessment|Withdrawal by Subject|0|||
161597990|NCT05907174|583580825|FG001|6-Month Assessment|Withdrawal by Subject|0|||
161830484|NCT01506908|584420141|FG000|Overall Study|Adverse Event|1|||
161830485|NCT01506908|584420142|FG001|Overall Study|Adverse Event|0|||
161597991|NCT05907174|583580826|FG002|6-Month Assessment|Withdrawal by Subject|1|||
161597992|NCT05907174|583580827|FG003|6-Month Assessment|Withdrawal by Subject|1|||
161597993|NCT05907174|583580824|FG000|6-Month Assessment|Lost to Follow-up|0|||
161597994|NCT05907174|583580825|FG001|6-Month Assessment|Lost to Follow-up|1|||
161597995|NCT05907174|583580826|FG002|6-Month Assessment|Lost to Follow-up|1|||
161597996|NCT05907174|583580827|FG003|6-Month Assessment|Lost to Follow-up|1|||
161597997|NCT05093842|583580830|FG000|Overall Study|Pregnancy loss|1|||
161597998|NCT05093842|583580831|FG001|Overall Study|Pregnancy loss|1|||
161597999|NCT05093842|583580830|FG000|Overall Study|Lost to Follow-up|6|||
161598000|NCT05093842|583580831|FG001|Overall Study|Lost to Follow-up|0|||
161598001|NCT05093842|583580830|FG000|Overall Study|Physician Decision|0|||
161598002|NCT05093842|583580831|FG001|Overall Study|Physician Decision|1|||
161598003|NCT03910478|583580837|FG000|Overall Study|Death|13|||
161598004|NCT03910478|583580838|FG001|Overall Study|Death|6|||
161598005|NCT03910478|583580837|FG000|Overall Study|Withdrawal by Subject|23|||
161598006|NCT03910478|583580838|FG001|Overall Study|Withdrawal by Subject|2|||
161598007|NCT03910478|583580837|FG000|Overall Study|Physician Decision|5|||
161598008|NCT03910478|583580838|FG001|Overall Study|Physician Decision|0|||
161598009|NCT03910478|583580837|FG000|Overall Study|Protocol Violation|1|||
161598010|NCT03910478|583580838|FG001|Overall Study|Protocol Violation|0|||
161598011|NCT03910478|583580837|FG000|Overall Study|Failure to meet continuation criteria|2|||
161598012|NCT03910478|583580838|FG001|Overall Study|Failure to meet continuation criteria|0|||
161598013|NCT03910478|583580837|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
161598014|NCT03910478|583580838|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
161598015|NCT01275677|583580842|FG000|Overall Study|Not at risk for recurrence.|1|||
161598016|NCT01275677|583580843|FG001|Overall Study|Not at risk for recurrence.|1|||
161598017|NCT01275677|583580842|FG000|Overall Study|No follow-up|26|||
161598018|NCT01275677|583580843|FG001|Overall Study|No follow-up|37|||
161598019|NCT01275677|583580842|FG000|Overall Study|No clinical follow up.|1|||
161598020|NCT01275677|583580843|FG001|Overall Study|No clinical follow up.|4|||
161598021|NCT03478956|583580844|FG000|Randomized Treatment Period|Adverse Event|1|||
161598022|NCT03478956|583580845|FG001|Randomized Treatment Period|Adverse Event|0|||
161598023|NCT03478956|583580846|FG002|Randomized Treatment Period|Adverse Event|0|||
161598024|NCT03478956|583580847|FG003|Randomized Treatment Period|Adverse Event|0|||
161830486|NCT00292227|584420145|FG000|Patch Period|Adverse Event|1|||
161598025|NCT03478956|583580844|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
161598026|NCT03478956|583580845|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
161598027|NCT03478956|583580846|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
161598028|NCT03478956|583580847|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
161598029|NCT03478956|583580844|FG000|Open Label Extension Period|Adverse Event|0|||
161598030|NCT03478956|583580845|FG001|Open Label Extension Period|Adverse Event|0|||
161598031|NCT03478956|583580846|FG002|Open Label Extension Period|Adverse Event|4|||
161598032|NCT03478956|583580847|FG003|Open Label Extension Period|Adverse Event|0|||
161598033|NCT03478956|583580844|FG000|Open Label Extension Period|Lack of Efficacy|0|||
161598034|NCT03478956|583580845|FG001|Open Label Extension Period|Lack of Efficacy|0|||
161598035|NCT03478956|583580846|FG002|Open Label Extension Period|Lack of Efficacy|8|||
161598036|NCT03478956|583580847|FG003|Open Label Extension Period|Lack of Efficacy|0|||
161598037|NCT03478956|583580844|FG000|Open Label Extension Period|Reason Not Provided|0|||
161598038|NCT03478956|583580845|FG001|Open Label Extension Period|Reason Not Provided|0|||
161598039|NCT03478956|583580846|FG002|Open Label Extension Period|Reason Not Provided|1|||
161598040|NCT03478956|583580847|FG003|Open Label Extension Period|Reason Not Provided|0|||
161830487|NCT00292227|584420146|FG001|Patch Period|Adverse Event|0|||
161598041|NCT03478956|583580844|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
161598042|NCT03478956|583580845|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
161598043|NCT03478956|583580846|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
161598044|NCT03478956|583580847|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
161598045|NCT03478956|583580844|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
161598046|NCT03478956|583580845|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
161598047|NCT03478956|583580846|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
161598048|NCT03478956|583580847|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
161598049|NCT03478956|583580844|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161598050|NCT03478956|583580845|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161598051|NCT03478956|583580846|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161598052|NCT03478956|583580847|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
161598053|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
161598054|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
161598055|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
161598056|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
161598057|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
161598058|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
161598059|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
161598060|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
161598061|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
161598062|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
161598063|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
161598064|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
161598065|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
161598066|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
161598067|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
161598068|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
161598069|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
161598070|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
161598071|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
161598072|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
161598073|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
161598074|NCT04800211|583580848|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
161598075|NCT04800211|583580849|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
161598076|NCT04800211|583580850|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
161598077|NCT04800211|583580848|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
161598078|NCT04800211|583580849|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
161598079|NCT04800211|583580850|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
161598080|NCT04800211|583580848|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
161598081|NCT04800211|583580849|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
161598082|NCT04800211|583580850|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
161598083|NCT04800211|583580848|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
161598084|NCT04800211|583580849|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
161598085|NCT04800211|583580850|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
161598086|NCT05170841|583580851|FG000|Single Dose Phase|Adverse Event|1|||
161598087|NCT05170841|583580852|FG001|Single Dose Phase|Adverse Event|2|||
161598088|NCT05170841|583580853|FG002|Single Dose Phase|Adverse Event|0|||
161598089|NCT05170841|583580854|FG003|Single Dose Phase|Adverse Event|2|||
161598090|NCT05170841|583580851|FG000|Multiple Dose Phase|Adverse Event|1|||
161598091|NCT05170841|583580852|FG001|Multiple Dose Phase|Adverse Event|2|||
161598092|NCT05170841|583580853|FG002|Multiple Dose Phase|Adverse Event|1|||
161598093|NCT05170841|583580854|FG003|Multiple Dose Phase|Adverse Event|4|||
161830488|NCT00292227|584420147|FG002|Patch Period|Adverse Event|2|||
161830489|NCT00292227|584420145|FG000|Patch Period|Withdrawal by Subject|0|||
161830490|NCT00292227|584420146|FG001|Patch Period|Withdrawal by Subject|0|||
161830491|NCT00292227|584420147|FG002|Patch Period|Withdrawal by Subject|1|||
161830492|NCT04232540|584420151|FG000|Overall Study|Lost to Follow-up|1|||
161830493|NCT04232540|584420152|FG001|Overall Study|Lost to Follow-up|0|||
161830494|NCT00537017|584420153|FG000|Treatment Phase|Adverse Event|19|||
161830495|NCT00537017|584420153|FG000|Treatment Phase|Withdrawal by Subject|13|||
161830496|NCT00537017|584420153|FG000|Treatment Phase|Protocol Violation|2|||
161830497|NCT00537017|584420153|FG000|Follow-up Phase|Withdrawal by Subject|9|||
161830498|NCT03234608|584420155|FG000|Overall Study|Lost to Follow-up|23|||
161830499|NCT03234608|584420156|FG001|Overall Study|Lost to Follow-up|21|||
161830500|NCT02105701|584420157|FG000|Overall Study|Lost to Follow-up|1|||
161830501|NCT02105701|584420158|FG001|Overall Study|Lost to Follow-up|0|||
161830502|NCT02105701|584420159|FG002|Overall Study|Lost to Follow-up|2|||
161830503|NCT02105701|584420160|FG003|Overall Study|Lost to Follow-up|1|||
161830504|NCT02105701|584420157|FG000|Overall Study|Protocol Violation|0|||
161830505|NCT02105701|584420158|FG001|Overall Study|Protocol Violation|0|||
161598094|NCT05170841|583580851|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
161598095|NCT05170841|583580852|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
161598096|NCT05170841|583580853|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
161598097|NCT05170841|583580854|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
161598098|NCT03734679|583580864|FG000|Overall Study|Missed Visit|1|||
161598099|NCT03088878|583580880|FG000|Overall Study|Adverse Event|0|||
161598100|NCT03088878|583580881|FG001|Overall Study|Adverse Event|0|||
161598101|NCT03088878|583580882|FG002|Overall Study|Adverse Event|0|||
161598102|NCT03088878|583580883|FG003|Overall Study|Adverse Event|0|||
161598103|NCT03088878|583580884|FG004|Overall Study|Adverse Event|4|||
161598104|NCT03088878|583580885|FG005|Overall Study|Adverse Event|2|||
161598105|NCT03088878|583580886|FG006|Overall Study|Adverse Event|1|||
161598106|NCT03088878|583580887|FG007|Overall Study|Adverse Event|0|||
161598107|NCT03088878|583580888|FG008|Overall Study|Adverse Event|0|||
161598108|NCT03088878|583580889|FG009|Overall Study|Adverse Event|0|||
161598109|NCT03088878|583580890|FG010|Overall Study|Adverse Event|0|||
161598110|NCT03088878|583580891|FG011|Overall Study|Adverse Event|0|||
161598111|NCT03088878|583580892|FG012|Overall Study|Adverse Event|5|||
161598112|NCT03088878|583580893|FG013|Overall Study|Adverse Event|3|||
161598113|NCT03088878|583580880|FG000|Overall Study|Clinical Progression|0|||
161598114|NCT03088878|583580881|FG001|Overall Study|Clinical Progression|0|||
161598115|NCT03088878|583580882|FG002|Overall Study|Clinical Progression|0|||
161598116|NCT03088878|583580883|FG003|Overall Study|Clinical Progression|0|||
161598117|NCT03088878|583580884|FG004|Overall Study|Clinical Progression|2|||
161598118|NCT03088878|583580885|FG005|Overall Study|Clinical Progression|0|||
161598119|NCT03088878|583580886|FG006|Overall Study|Clinical Progression|0|||
161598120|NCT03088878|583580887|FG007|Overall Study|Clinical Progression|0|||
161598121|NCT03088878|583580888|FG008|Overall Study|Clinical Progression|0|||
161598122|NCT03088878|583580889|FG009|Overall Study|Clinical Progression|0|||
161598123|NCT03088878|583580890|FG010|Overall Study|Clinical Progression|0|||
161598124|NCT03088878|583580891|FG011|Overall Study|Clinical Progression|0|||
161598125|NCT03088878|583580892|FG012|Overall Study|Clinical Progression|0|||
161598126|NCT03088878|583580893|FG013|Overall Study|Clinical Progression|0|||
161598127|NCT03088878|583580880|FG000|Overall Study|Death|0|||
161598128|NCT03088878|583580881|FG001|Overall Study|Death|0|||
161598129|NCT03088878|583580882|FG002|Overall Study|Death|0|||
161598130|NCT03088878|583580883|FG003|Overall Study|Death|0|||
161598131|NCT03088878|583580884|FG004|Overall Study|Death|2|||
161598132|NCT03088878|583580885|FG005|Overall Study|Death|0|||
161598133|NCT03088878|583580886|FG006|Overall Study|Death|0|||
161598134|NCT03088878|583580887|FG007|Overall Study|Death|0|||
161598135|NCT03088878|583580888|FG008|Overall Study|Death|0|||
161598136|NCT03088878|583580889|FG009|Overall Study|Death|0|||
161598137|NCT03088878|583580890|FG010|Overall Study|Death|0|||
161598138|NCT03088878|583580891|FG011|Overall Study|Death|1|||
161598139|NCT03088878|583580892|FG012|Overall Study|Death|0|||
161598140|NCT03088878|583580893|FG013|Overall Study|Death|0|||
161598141|NCT03088878|583580880|FG000|Overall Study|Disease Progression|1|||
161598142|NCT03088878|583580881|FG001|Overall Study|Disease Progression|2|||
161598143|NCT03088878|583580882|FG002|Overall Study|Disease Progression|3|||
161598144|NCT03088878|583580883|FG003|Overall Study|Disease Progression|0|||
161598145|NCT03088878|583580884|FG004|Overall Study|Disease Progression|3|||
161598146|NCT03088878|583580885|FG005|Overall Study|Disease Progression|0|||
161598147|NCT03088878|583580886|FG006|Overall Study|Disease Progression|0|||
161598148|NCT03088878|583580887|FG007|Overall Study|Disease Progression|0|||
161598149|NCT03088878|583580888|FG008|Overall Study|Disease Progression|0|||
161598150|NCT03088878|583580889|FG009|Overall Study|Disease Progression|0|||
161598151|NCT03088878|583580890|FG010|Overall Study|Disease Progression|0|||
161598152|NCT03088878|583580891|FG011|Overall Study|Disease Progression|0|||
161598153|NCT03088878|583580892|FG012|Overall Study|Disease Progression|1|||
161598154|NCT03088878|583580893|FG013|Overall Study|Disease Progression|1|||
161598155|NCT03088878|583580880|FG000|Overall Study|Initiation of Alternative Treatment|0|||
161598156|NCT03088878|583580881|FG001|Overall Study|Initiation of Alternative Treatment|0|||
161598157|NCT03088878|583580882|FG002|Overall Study|Initiation of Alternative Treatment|0|||
161598158|NCT03088878|583580883|FG003|Overall Study|Initiation of Alternative Treatment|1|||
161598159|NCT03088878|583580884|FG004|Overall Study|Initiation of Alternative Treatment|0|||
161598160|NCT03088878|583580885|FG005|Overall Study|Initiation of Alternative Treatment|0|||
161598161|NCT03088878|583580886|FG006|Overall Study|Initiation of Alternative Treatment|0|||
161598162|NCT03088878|583580887|FG007|Overall Study|Initiation of Alternative Treatment|1|||
161598163|NCT03088878|583580888|FG008|Overall Study|Initiation of Alternative Treatment|1|||
161598164|NCT03088878|583580889|FG009|Overall Study|Initiation of Alternative Treatment|0|||
161598165|NCT03088878|583580890|FG010|Overall Study|Initiation of Alternative Treatment|0|||
161598166|NCT03088878|583580891|FG011|Overall Study|Initiation of Alternative Treatment|0|||
161598167|NCT03088878|583580892|FG012|Overall Study|Initiation of Alternative Treatment|0|||
161598168|NCT03088878|583580893|FG013|Overall Study|Initiation of Alternative Treatment|0|||
161598169|NCT03088878|583580880|FG000|Overall Study|Withdrawal by Subject|0|||
161598170|NCT03088878|583580881|FG001|Overall Study|Withdrawal by Subject|0|||
161830506|NCT02105701|584420159|FG002|Overall Study|Protocol Violation|1|||
161598171|NCT03088878|583580882|FG002|Overall Study|Withdrawal by Subject|0|||
161598172|NCT03088878|583580883|FG003|Overall Study|Withdrawal by Subject|1|||
161598173|NCT03088878|583580884|FG004|Overall Study|Withdrawal by Subject|4|||
161598174|NCT03088878|583580885|FG005|Overall Study|Withdrawal by Subject|1|||
161598175|NCT03088878|583580886|FG006|Overall Study|Withdrawal by Subject|1|||
161598176|NCT03088878|583580887|FG007|Overall Study|Withdrawal by Subject|0|||
161598177|NCT03088878|583580888|FG008|Overall Study|Withdrawal by Subject|1|||
161598178|NCT03088878|583580889|FG009|Overall Study|Withdrawal by Subject|2|||
161598179|NCT03088878|583580890|FG010|Overall Study|Withdrawal by Subject|0|||
161598180|NCT03088878|583580891|FG011|Overall Study|Withdrawal by Subject|2|||
161598181|NCT03088878|583580892|FG012|Overall Study|Withdrawal by Subject|1|||
161598182|NCT03088878|583580893|FG013|Overall Study|Withdrawal by Subject|0|||
161598183|NCT03088878|583580880|FG000|Overall Study|Terminated by Sponsor|2|||
161598184|NCT03088878|583580881|FG001|Overall Study|Terminated by Sponsor|1|||
161598185|NCT03088878|583580882|FG002|Overall Study|Terminated by Sponsor|0|||
161598186|NCT03088878|583580883|FG003|Overall Study|Terminated by Sponsor|1|||
161598187|NCT03088878|583580884|FG004|Overall Study|Terminated by Sponsor|6|||
161598188|NCT03088878|583580885|FG005|Overall Study|Terminated by Sponsor|0|||
161598189|NCT03088878|583580886|FG006|Overall Study|Terminated by Sponsor|0|||
161598190|NCT03088878|583580887|FG007|Overall Study|Terminated by Sponsor|0|||
161598191|NCT03088878|583580888|FG008|Overall Study|Terminated by Sponsor|0|||
161598192|NCT03088878|583580889|FG009|Overall Study|Terminated by Sponsor|0|||
161598193|NCT03088878|583580890|FG010|Overall Study|Terminated by Sponsor|3|||
161598194|NCT03088878|583580891|FG011|Overall Study|Terminated by Sponsor|13|||
161598195|NCT03088878|583580892|FG012|Overall Study|Terminated by Sponsor|2|||
161598196|NCT03088878|583580893|FG013|Overall Study|Terminated by Sponsor|1|||
161598197|NCT03088878|583580880|FG000|Overall Study|Completed 2 years of Treatment|0|||
161598198|NCT03088878|583580881|FG001|Overall Study|Completed 2 years of Treatment|0|||
161598199|NCT03088878|583580882|FG002|Overall Study|Completed 2 years of Treatment|0|||
161598200|NCT03088878|583580883|FG003|Overall Study|Completed 2 years of Treatment|0|||
161598201|NCT03088878|583580884|FG004|Overall Study|Completed 2 years of Treatment|0|||
161598202|NCT03088878|583580885|FG005|Overall Study|Completed 2 years of Treatment|0|||
161598203|NCT03088878|583580886|FG006|Overall Study|Completed 2 years of Treatment|1|||
161598204|NCT03088878|583580887|FG007|Overall Study|Completed 2 years of Treatment|0|||
161598205|NCT03088878|583580888|FG008|Overall Study|Completed 2 years of Treatment|0|||
161598206|NCT03088878|583580889|FG009|Overall Study|Completed 2 years of Treatment|1|||
161598207|NCT03088878|583580890|FG010|Overall Study|Completed 2 years of Treatment|0|||
161598208|NCT03088878|583580891|FG011|Overall Study|Completed 2 years of Treatment|0|||
161598209|NCT03088878|583580892|FG012|Overall Study|Completed 2 years of Treatment|8|||
161598210|NCT03088878|583580893|FG013|Overall Study|Completed 2 years of Treatment|3|||
161598211|NCT03088878|583580880|FG000|Overall Study|Physician Decision|0|||
161598212|NCT03088878|583580881|FG001|Overall Study|Physician Decision|0|||
161598213|NCT03088878|583580882|FG002|Overall Study|Physician Decision|0|||
161598214|NCT03088878|583580883|FG003|Overall Study|Physician Decision|0|||
161598215|NCT03088878|583580884|FG004|Overall Study|Physician Decision|0|||
161598216|NCT03088878|583580885|FG005|Overall Study|Physician Decision|0|||
161598217|NCT03088878|583580886|FG006|Overall Study|Physician Decision|0|||
161598218|NCT03088878|583580887|FG007|Overall Study|Physician Decision|2|||
161598219|NCT03088878|583580888|FG008|Overall Study|Physician Decision|1|||
161598220|NCT03088878|583580889|FG009|Overall Study|Physician Decision|0|||
161598221|NCT03088878|583580890|FG010|Overall Study|Physician Decision|0|||
161598222|NCT03088878|583580891|FG011|Overall Study|Physician Decision|0|||
161830507|NCT02105701|584420160|FG003|Overall Study|Protocol Violation|0|||
161598223|NCT03088878|583580892|FG012|Overall Study|Physician Decision|0|||
161598224|NCT03088878|583580893|FG013|Overall Study|Physician Decision|1|||
161598225|NCT03088878|583580880|FG000|Overall Study|COVID Related noncompliance|0|||
161598226|NCT03088878|583580881|FG001|Overall Study|COVID Related noncompliance|0|||
161598227|NCT03088878|583580882|FG002|Overall Study|COVID Related noncompliance|0|||
161598228|NCT03088878|583580883|FG003|Overall Study|COVID Related noncompliance|0|||
161598229|NCT03088878|583580884|FG004|Overall Study|COVID Related noncompliance|0|||
161598230|NCT03088878|583580885|FG005|Overall Study|COVID Related noncompliance|0|||
161598231|NCT03088878|583580886|FG006|Overall Study|COVID Related noncompliance|0|||
161598232|NCT03088878|583580887|FG007|Overall Study|COVID Related noncompliance|0|||
161598233|NCT03088878|583580888|FG008|Overall Study|COVID Related noncompliance|0|||
161598234|NCT03088878|583580889|FG009|Overall Study|COVID Related noncompliance|0|||
161598235|NCT03088878|583580890|FG010|Overall Study|COVID Related noncompliance|0|||
161598236|NCT03088878|583580891|FG011|Overall Study|COVID Related noncompliance|0|||
161598237|NCT03088878|583580892|FG012|Overall Study|COVID Related noncompliance|0|||
161598238|NCT03088878|583580893|FG013|Overall Study|COVID Related noncompliance|1|||
161598239|NCT03088878|583580880|FG000|Overall Study|Drug or Study Noncompliance|0|||
161598240|NCT03088878|583580881|FG001|Overall Study|Drug or Study Noncompliance|0|||
161598241|NCT03088878|583580882|FG002|Overall Study|Drug or Study Noncompliance|0|||
161598242|NCT03088878|583580883|FG003|Overall Study|Drug or Study Noncompliance|0|||
161830508|NCT02105701|584420157|FG000|Overall Study|Withdrawal by Subject|2|||
161830509|NCT02105701|584420158|FG001|Overall Study|Withdrawal by Subject|1|||
161830510|NCT02105701|584420159|FG002|Overall Study|Withdrawal by Subject|0|||
161830511|NCT02105701|584420160|FG003|Overall Study|Withdrawal by Subject|1|||
161830512|NCT02105701|584420157|FG000|Overall Study|Death|1|||
161830513|NCT02105701|584420158|FG001|Overall Study|Death|0|||
161830514|NCT02105701|584420159|FG002|Overall Study|Death|0|||
161830515|NCT02105701|584420160|FG003|Overall Study|Death|0|||
161830516|NCT02329431|584420161|FG000|Overall Study|Lost to Follow-up|20|||
161830517|NCT02329431|584420162|FG001|Overall Study|Lost to Follow-up|13|||
161830518|NCT03693950|584420163|FG000|Overall Study|Withdrawal by Subject|1|||
161830519|NCT03693950|584420164|FG001|Overall Study|Withdrawal by Subject|0|||
161830520|NCT01362296|584420165|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
161830521|NCT01362296|584420166|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
161830522|NCT01362296|584420167|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
161830523|NCT01362296|584420168|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
161830524|NCT01362296|584420165|FG000|Randomized Phase (RP)|Physician Decision|1|||
161830525|NCT01362296|584420166|FG001|Randomized Phase (RP)|Physician Decision|9|||
161830526|NCT01362296|584420167|FG002|Randomized Phase (RP)|Physician Decision|0|||
161830527|NCT01362296|584420168|FG003|Randomized Phase (RP)|Physician Decision|0|||
161830528|NCT01362296|584420165|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
161830529|NCT01362296|584420166|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
161830530|NCT01362296|584420167|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
161830531|NCT01362296|584420168|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
161830532|NCT01362296|584420165|FG000|Randomized Phase (RP)|Adverse Event|20|||
161830533|NCT01362296|584420166|FG001|Randomized Phase (RP)|Adverse Event|4|||
161830534|NCT01362296|584420167|FG002|Randomized Phase (RP)|Adverse Event|0|||
161830535|NCT01362296|584420168|FG003|Randomized Phase (RP)|Adverse Event|0|||
161830536|NCT01362296|584420165|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
161830537|NCT01362296|584420166|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
161830538|NCT01362296|584420167|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
161830539|NCT01362296|584420168|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
161830540|NCT01362296|584420165|FG000|Crossover Phase|PD including Death due to PD|0|||
161830541|NCT01362296|584420166|FG001|Crossover Phase|PD including Death due to PD|0|||
161830542|NCT01362296|584420167|FG002|Crossover Phase|PD including Death due to PD|16|||
161830543|NCT01362296|584420168|FG003|Crossover Phase|PD including Death due to PD|1|||
161830544|NCT01362296|584420165|FG000|Crossover Phase|Withdrawal by Subject|0|||
161830545|NCT01362296|584420166|FG001|Crossover Phase|Withdrawal by Subject|0|||
161830546|NCT01362296|584420167|FG002|Crossover Phase|Withdrawal by Subject|2|||
161830547|NCT01362296|584420168|FG003|Crossover Phase|Withdrawal by Subject|1|||
161830548|NCT01362296|584420165|FG000|Crossover Phase|Adverse Event|0|||
161830549|NCT01362296|584420166|FG001|Crossover Phase|Adverse Event|0|||
161830550|NCT01362296|584420167|FG002|Crossover Phase|Adverse Event|4|||
161830551|NCT01362296|584420168|FG003|Crossover Phase|Adverse Event|0|||
161830552|NCT01362296|584420165|FG000|Crossover Phase|Study Closed/Terminated|0|||
161830553|NCT01362296|584420166|FG001|Crossover Phase|Study Closed/Terminated|0|||
161830554|NCT01362296|584420167|FG002|Crossover Phase|Study Closed/Terminated|1|||
161830555|NCT01362296|584420168|FG003|Crossover Phase|Study Closed/Terminated|0|||
161830556|NCT04230876|584420169|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
161830557|NCT04230876|584420170|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
161830558|NCT01662362|584420172|FG000|Overall Study|Lost to Follow-up|38|||
161598243|NCT03088878|583580884|FG004|Overall Study|Drug or Study Noncompliance|0|||
161598244|NCT03088878|583580885|FG005|Overall Study|Drug or Study Noncompliance|0|||
161598245|NCT03088878|583580886|FG006|Overall Study|Drug or Study Noncompliance|0|||
161598246|NCT03088878|583580887|FG007|Overall Study|Drug or Study Noncompliance|0|||
161598247|NCT03088878|583580888|FG008|Overall Study|Drug or Study Noncompliance|0|||
161598248|NCT03088878|583580889|FG009|Overall Study|Drug or Study Noncompliance|0|||
161598249|NCT03088878|583580890|FG010|Overall Study|Drug or Study Noncompliance|0|||
161598250|NCT03088878|583580891|FG011|Overall Study|Drug or Study Noncompliance|0|||
161598251|NCT03088878|583580892|FG012|Overall Study|Drug or Study Noncompliance|1|||
161598252|NCT03088878|583580893|FG013|Overall Study|Drug or Study Noncompliance|0|||
161598253|NCT05104463|583580899|FG000|Overall Study|Adverse Event|1|||
161598254|NCT05104463|583580900|FG001|Overall Study|Adverse Event|1|||
161598255|NCT05104463|583580899|FG000|Overall Study|Lost to Follow-up|1|||
161598256|NCT05104463|583580900|FG001|Overall Study|Lost to Follow-up|1|||
161830559|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161830560|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
161830561|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161830562|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161830563|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161598257|NCT05104463|583580899|FG000|Overall Study|Physician Decision|1|||
161598258|NCT05104463|583580900|FG001|Overall Study|Physician Decision|0|||
161598259|NCT05104463|583580899|FG000|Overall Study|Protocol Violation|0|||
161598260|NCT05104463|583580900|FG001|Overall Study|Protocol Violation|2|||
161598261|NCT05104463|583580899|FG000|Overall Study|Withdrawal by Subject|1|||
161598262|NCT05104463|583580900|FG001|Overall Study|Withdrawal by Subject|1|||
161598263|NCT02823145|583580901|FG000|Enrollment|Other|1|||
161598264|NCT02823145|583580902|FG001|Enrollment|Other|0|||
161598265|NCT02823145|583580901|FG000|Treatment|Adverse Event|0|||
161598266|NCT02823145|583580902|FG001|Treatment|Adverse Event|11|||
161598267|NCT02823145|583580901|FG000|Treatment|Death|0|||
161598268|NCT02823145|583580902|FG001|Treatment|Death|3|||
161598269|NCT02823145|583580901|FG000|Treatment|Family Decision|0|||
161598270|NCT02823145|583580902|FG001|Treatment|Family Decision|1|||
161598271|NCT02823145|583580901|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
161598272|NCT02823145|583580902|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
161598273|NCT02823145|583580901|FG000|Treatment|Lack of Efficacy|0|||
161598274|NCT02823145|583580902|FG001|Treatment|Lack of Efficacy|48|||
161598275|NCT02823145|583580901|FG000|Treatment|Non-Compliance With E-Diary|0|||
161598276|NCT02823145|583580902|FG001|Treatment|Non-Compliance With E-Diary|1|||
161598277|NCT02823145|583580901|FG000|Treatment|Physician Decision|0|||
161598278|NCT02823145|583580902|FG001|Treatment|Physician Decision|2|||
161598279|NCT02823145|583580901|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
161598280|NCT02823145|583580902|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
161598281|NCT02823145|583580901|FG000|Treatment|Subject needed to take prohibited medication|0|||
161598282|NCT02823145|583580902|FG001|Treatment|Subject needed to take prohibited medication|1|||
161598283|NCT02823145|583580901|FG000|Treatment|Subject transferred to direct access programme|0|||
161598284|NCT02823145|583580902|FG001|Treatment|Subject transferred to direct access programme|1|||
161598285|NCT02823145|583580901|FG000|Treatment|Switching to commercially available drug|0|||
161598286|NCT02823145|583580902|FG001|Treatment|Switching to commercially available drug|11|||
161598287|NCT02823145|583580901|FG000|Treatment|Transitioned to commercial supply of medication|0|||
161598288|NCT02823145|583580902|FG001|Treatment|Transitioned to commercial supply of medication|1|||
161598289|NCT02823145|583580901|FG000|Treatment|Withdrawal By Caregiver|0|||
161598290|NCT02823145|583580902|FG001|Treatment|Withdrawal By Caregiver|1|||
161598291|NCT02823145|583580901|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
161598292|NCT02823145|583580902|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
161598293|NCT02823145|583580901|FG000|Treatment|Withdrawal by Subject|0|||
161598294|NCT02823145|583580902|FG001|Treatment|Withdrawal by Subject|16|||
161598295|NCT02823145|583580901|FG000|Treatment|Reason unknown|0|||
161598296|NCT02823145|583580902|FG001|Treatment|Reason unknown|1|||
161598297|NCT04233216|583582696|FG000|Overall Study|Lost to Follow-up|1|||
161598298|NCT04233216|583582697|FG001|Overall Study|Lost to Follow-up|0|||
161598299|NCT04233216|583582698|FG002|Overall Study|Lost to Follow-up|2|||
161598300|NCT04233216|583582699|FG003|Overall Study|Lost to Follow-up|0|||
161598301|NCT04233216|583582696|FG000|Overall Study|Physician Decision|0|||
161598302|NCT04233216|583582697|FG001|Overall Study|Physician Decision|3|||
161598303|NCT04233216|583582698|FG002|Overall Study|Physician Decision|0|||
161598304|NCT04233216|583582699|FG003|Overall Study|Physician Decision|2|||
161598305|NCT04233216|583582696|FG000|Overall Study|Withdrawal by Subject|0|||
161598306|NCT04233216|583582697|FG001|Overall Study|Withdrawal by Subject|2|||
161598307|NCT04233216|583582698|FG002|Overall Study|Withdrawal by Subject|1|||
161598308|NCT04233216|583582699|FG003|Overall Study|Withdrawal by Subject|0|||
161598309|NCT02116530|583582700|FG000|Overall Study|Withdrawal by Subject|1|||
161598310|NCT02116530|583582701|FG001|Overall Study|Withdrawal by Subject|2|||
161598311|NCT02116530|583582700|FG000|Overall Study|Adverse Event|4|||
161598312|NCT02116530|583582701|FG001|Overall Study|Adverse Event|0|||
161598313|NCT02116530|583582700|FG000|Overall Study|Physician Decision|1|||
161598314|NCT02116530|583582701|FG001|Overall Study|Physician Decision|0|||
161598315|NCT02116530|583582700|FG000|Overall Study|Lost to Follow-up|1|||
161598316|NCT02116530|583582701|FG001|Overall Study|Lost to Follow-up|0|||
161598317|NCT02116530|583582700|FG000|Overall Study|Other Medical Problems|2|||
161598318|NCT02116530|583582701|FG001|Overall Study|Other Medical Problems|2|||
161598319|NCT05671653|583582704|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
161598320|NCT05671653|583582705|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
161598321|NCT05671653|583582706|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
161598322|NCT05671653|583582707|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
161598323|NCT05671653|583582708|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
161598324|NCT05671653|583582709|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
161598325|NCT05671653|583582710|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
161598326|NCT05671653|583582711|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
161598327|NCT05671653|583582712|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
161598328|NCT05671653|583582713|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
161598329|NCT05671653|583582714|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
161598330|NCT05671653|583582715|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
161598331|NCT05671653|583582716|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
161598332|NCT05671653|583582704|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598333|NCT05671653|583582705|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161681712|NCT02064920|583886229|FG001|Overall Study|Withdrawal by Subject|3|||
161681713|NCT02109562|583886230|FG000|Overall Study|Insufficient clinical response|2|||
161681714|NCT02109562|583886231|FG001|Overall Study|Insufficient clinical response|0|||
161681715|NCT02109562|583886232|FG002|Overall Study|Insufficient clinical response|4|||
161681716|NCT02109562|583886230|FG000|Overall Study|Adverse Event|0|||
161681717|NCT02109562|583886231|FG001|Overall Study|Adverse Event|2|||
161681718|NCT02109562|583886232|FG002|Overall Study|Adverse Event|3|||
161598334|NCT05671653|583582706|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598335|NCT05671653|583582707|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598336|NCT05671653|583582708|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598337|NCT05671653|583582709|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
161598338|NCT05671653|583582710|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598339|NCT05671653|583582711|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598340|NCT05671653|583582712|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598341|NCT05671653|583582713|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598342|NCT05671653|583582714|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598343|NCT05671653|583582715|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161598344|NCT05671653|583582716|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161681719|NCT02109562|583886230|FG000|Overall Study|Lost to Follow-up|1|||
161681720|NCT02109562|583886231|FG001|Overall Study|Lost to Follow-up|0|||
161681721|NCT02109562|583886232|FG002|Overall Study|Lost to Follow-up|1|||
161681722|NCT02109562|583886230|FG000|Overall Study|Protocol Violation|0|||
161598345|NCT05671653|583582704|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598346|NCT05671653|583582705|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598347|NCT05671653|583582706|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598348|NCT05671653|583582707|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598349|NCT05671653|583582708|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598350|NCT05671653|583582709|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
161598351|NCT05671653|583582710|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598352|NCT05671653|583582711|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598353|NCT05671653|583582712|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598354|NCT05671653|583582713|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598355|NCT05671653|583582714|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598356|NCT05671653|583582715|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598357|NCT05671653|583582716|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161598358|NCT05671653|583582704|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161681723|NCT02109562|583886231|FG001|Overall Study|Protocol Violation|3|||
161681724|NCT02109562|583886232|FG002|Overall Study|Protocol Violation|1|||
161681725|NCT02109562|583886230|FG000|Overall Study|Withdrawal by Subject|20|||
161681726|NCT02109562|583886231|FG001|Overall Study|Withdrawal by Subject|25|||
161681727|NCT02109562|583886232|FG002|Overall Study|Withdrawal by Subject|21|||
161681728|NCT02109562|583886230|FG000|Overall Study|Physician Decision|3|||
161681729|NCT02109562|583886231|FG001|Overall Study|Physician Decision|4|||
161681730|NCT02109562|583886232|FG002|Overall Study|Physician Decision|5|||
161681731|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
161681732|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
161681733|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
161681734|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
161681735|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
161681736|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
161681737|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
161681738|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
161681739|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
161681740|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
161681741|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
161681742|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
161681743|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
161681744|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
161681745|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
161681746|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
161598359|NCT05671653|583582705|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598360|NCT05671653|583582706|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598361|NCT05671653|583582707|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598362|NCT05671653|583582708|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598363|NCT05671653|583582709|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161681747|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Death|1|||
161598364|NCT05671653|583582710|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598365|NCT05671653|583582711|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598366|NCT05671653|583582712|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
161598367|NCT05671653|583582713|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598368|NCT05671653|583582714|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598369|NCT05671653|583582715|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598370|NCT05671653|583582716|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161598371|NCT05671653|583582704|FG000|Cohort 2 Period 2|Adverse Event|0|||
161598372|NCT05671653|583582705|FG001|Cohort 2 Period 2|Adverse Event|0|||
161598373|NCT05671653|583582706|FG002|Cohort 2 Period 2|Adverse Event|0|||
161598374|NCT05671653|583582707|FG003|Cohort 2 Period 2|Adverse Event|0|||
161598375|NCT05671653|583582708|FG004|Cohort 2 Period 2|Adverse Event|0|||
161598376|NCT05671653|583582709|FG005|Cohort 2 Period 2|Adverse Event|0|||
161598377|NCT05671653|583582710|FG006|Cohort 2 Period 2|Adverse Event|0|||
161598378|NCT05671653|583582711|FG007|Cohort 2 Period 2|Adverse Event|0|||
161598379|NCT05671653|583582712|FG008|Cohort 2 Period 2|Adverse Event|0|||
161598380|NCT05671653|583582713|FG009|Cohort 2 Period 2|Adverse Event|0|||
161598381|NCT05671653|583582714|FG010|Cohort 2 Period 2|Adverse Event|1|||
161598382|NCT05671653|583582715|FG011|Cohort 2 Period 2|Adverse Event|0|||
161598383|NCT05671653|583582716|FG012|Cohort 2 Period 2|Adverse Event|0|||
161598384|NCT05671653|583582704|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
161681748|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Death|0|||
161681749|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Death|0|||
161681750|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Death|0|||
161598385|NCT05671653|583582705|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
161598386|NCT05671653|583582706|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
161598387|NCT05671653|583582707|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
161598388|NCT05671653|583582708|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
161598389|NCT05671653|583582709|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
161598390|NCT05671653|583582710|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
161598391|NCT05671653|583582711|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
161598392|NCT05671653|583582712|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
161598393|NCT05671653|583582713|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
161598394|NCT05671653|583582714|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
161598395|NCT05671653|583582715|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
161598396|NCT05671653|583582716|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
161598397|NCT05671653|583582704|FG000|Cohort 2 Period 2|Pregnancy|0|||
161598398|NCT05671653|583582705|FG001|Cohort 2 Period 2|Pregnancy|0|||
161598399|NCT05671653|583582706|FG002|Cohort 2 Period 2|Pregnancy|0|||
161598400|NCT05671653|583582707|FG003|Cohort 2 Period 2|Pregnancy|0|||
161598401|NCT05671653|583582708|FG004|Cohort 2 Period 2|Pregnancy|0|||
161598402|NCT05671653|583582709|FG005|Cohort 2 Period 2|Pregnancy|0|||
161598403|NCT05671653|583582710|FG006|Cohort 2 Period 2|Pregnancy|0|||
161598404|NCT05671653|583582711|FG007|Cohort 2 Period 2|Pregnancy|0|||
161598405|NCT05671653|583582712|FG008|Cohort 2 Period 2|Pregnancy|0|||
161598406|NCT05671653|583582713|FG009|Cohort 2 Period 2|Pregnancy|0|||
161598407|NCT05671653|583582714|FG010|Cohort 2 Period 2|Pregnancy|1|||
161598408|NCT05671653|583582715|FG011|Cohort 2 Period 2|Pregnancy|0|||
161598409|NCT05671653|583582716|FG012|Cohort 2 Period 2|Pregnancy|0|||
161598410|NCT05671653|583582704|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598411|NCT05671653|583582705|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598412|NCT05671653|583582706|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598413|NCT05671653|583582707|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598414|NCT05671653|583582708|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598415|NCT05671653|583582709|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598416|NCT05671653|583582710|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598417|NCT05671653|583582711|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598418|NCT05671653|583582712|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598419|NCT05671653|583582713|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598420|NCT05671653|583582714|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
161598421|NCT05671653|583582715|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
161681751|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
161681752|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
161681753|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
161681754|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
161681755|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
161681756|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
161598422|NCT05671653|583582716|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
161598423|NCT05671653|583582704|FG000|Cohort 2 Period 2|Other|0|||
161598424|NCT05671653|583582705|FG001|Cohort 2 Period 2|Other|0|||
161598425|NCT05671653|583582706|FG002|Cohort 2 Period 2|Other|0|||
161598426|NCT05671653|583582707|FG003|Cohort 2 Period 2|Other|0|||
161598427|NCT05671653|583582708|FG004|Cohort 2 Period 2|Other|0|||
161598428|NCT05671653|583582709|FG005|Cohort 2 Period 2|Other|0|||
161598429|NCT05671653|583582710|FG006|Cohort 2 Period 2|Other|0|||
161598430|NCT05671653|583582711|FG007|Cohort 2 Period 2|Other|0|||
161598431|NCT05671653|583582712|FG008|Cohort 2 Period 2|Other|0|||
161598432|NCT05671653|583582713|FG009|Cohort 2 Period 2|Other|0|||
161598433|NCT05671653|583582714|FG010|Cohort 2 Period 2|Other|1|||
161598434|NCT05671653|583582715|FG011|Cohort 2 Period 2|Other|0|||
161598435|NCT05671653|583582716|FG012|Cohort 2 Period 2|Other|0|||
161598436|NCT05671653|583582704|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598437|NCT05671653|583582705|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598438|NCT05671653|583582706|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598439|NCT05671653|583582707|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598440|NCT05671653|583582708|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598441|NCT05671653|583582709|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598442|NCT05671653|583582710|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598443|NCT05671653|583582711|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598444|NCT05671653|583582712|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598445|NCT05671653|583582713|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598446|NCT05671653|583582714|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598447|NCT05671653|583582715|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
161598448|NCT05671653|583582716|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161598449|NCT01959607|583582717|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161598450|NCT01959607|583582718|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
161598451|NCT01959607|583582719|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161598452|NCT01959607|583582720|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161598453|NCT03913442|583582721|FG000|Overall Study|Adverse Event|0|||
161598454|NCT03913442|583582722|FG001|Overall Study|Adverse Event|3|||
161598455|NCT03913442|583582721|FG000|Overall Study|Withdrawal by Subject|5|||
161598456|NCT03913442|583582722|FG001|Overall Study|Withdrawal by Subject|5|||
161598457|NCT03913442|583582721|FG000|Overall Study|Terminations|2|||
161598458|NCT03913442|583582722|FG001|Overall Study|Terminations|1|||
161598459|NCT03913442|583582721|FG000|Overall Study|Lost to Follow-up|2|||
161598460|NCT03913442|583582722|FG001|Overall Study|Lost to Follow-up|2|||
161598461|NCT02433379|583582726|FG000|Overall Study|Screen Failures|55|||
161598462|NCT02433379|583582726|FG000|Overall Study|Death|57|||
161598463|NCT02433379|583582726|FG000|Overall Study|Total Withdrawals|209|||
161598464|NCT03710603|583582727|FG000|Overall Study|Adverse Event|1|||
161598465|NCT03710603|583582728|FG001|Overall Study|Adverse Event|0|||
161598466|NCT03710603|583582727|FG000|Overall Study|Death|44|||
161598467|NCT03710603|583582728|FG001|Overall Study|Death|34|||
161598468|NCT03710603|583582727|FG000|Overall Study|Lost to Follow-up|3|||
161598469|NCT03710603|583582728|FG001|Overall Study|Lost to Follow-up|5|||
161598470|NCT03710603|583582727|FG000|Overall Study|Withdrawal by Subject|11|||
161598471|NCT03710603|583582728|FG001|Overall Study|Withdrawal by Subject|10|||
161598472|NCT02589795|583582732|FG000|Overall Study|Lost to Follow-up|1|||
161598473|NCT02589795|583582733|FG001|Overall Study|Lost to Follow-up|0|||
161598474|NCT02589795|583582734|FG002|Overall Study|Lost to Follow-up|0|||
161598475|NCT02589795|583582732|FG000|Overall Study|Withdrawal by Subject|0|||
161598476|NCT02589795|583582733|FG001|Overall Study|Withdrawal by Subject|0|||
161598477|NCT02589795|583582734|FG002|Overall Study|Withdrawal by Subject|2|||
161598478|NCT02589795|583582732|FG000|Overall Study|Protocol Violation|0|||
161598479|NCT02589795|583582733|FG001|Overall Study|Protocol Violation|0|||
161598480|NCT02589795|583582734|FG002|Overall Study|Protocol Violation|1|||
161598481|NCT02505984|583582736|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
161598482|NCT02505984|583582737|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
161598483|NCT02505984|583582736|FG000|Overall Study|Unreliable self-report data|1|||
161598484|NCT02505984|583582737|FG001|Overall Study|Unreliable self-report data|0|||
161598485|NCT02505984|583582736|FG000|Overall Study|Study blind opened during assessment|0|||
161598486|NCT02505984|583582737|FG001|Overall Study|Study blind opened during assessment|1|||
161598487|NCT02505984|583582736|FG000|Overall Study|Noncompliance with study protocol|0|||
161598488|NCT02505984|583582737|FG001|Overall Study|Noncompliance with study protocol|1|||
161598489|NCT03691935|583582742|FG000|Overall Study|Physician Decision|2|||
161598490|NCT03691935|583582743|FG001|Overall Study|Physician Decision|1|||
161598491|NCT03691935|583582742|FG000|Overall Study|Adverse Event|3|||
161598492|NCT03691935|583582743|FG001|Overall Study|Adverse Event|0|||
161598493|NCT03511664|583582755|FG000|Overall Study|Death|457|||
161598494|NCT03511664|583582756|FG001|Overall Study|Death|201|||
161598495|NCT03511664|583582757|FG002|Overall Study|Death|21|||
161598496|NCT03511664|583582755|FG000|Overall Study|Withdrew consent|40|||
161830564|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161830565|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
161830566|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161830567|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
161830568|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161830569|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161830570|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161830571|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Death|0|||
161830572|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Death|1|||
161830573|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Death|0|||
161830574|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Death|0|||
161830575|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
161830576|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
161830577|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
161830578|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
161830579|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
161830580|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161830581|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161548686|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161548687|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161548688|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161548689|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161548690|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161548691|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
161548692|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
161598497|NCT03511664|583582756|FG001|Overall Study|Withdrew consent|63|||
161598498|NCT03511664|583582757|FG002|Overall Study|Withdrew consent|3|||
161598499|NCT03511664|583582755|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
161598500|NCT03511664|583582756|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
161598501|NCT03511664|583582757|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
161598502|NCT03511664|583582755|FG000|Overall Study|Lost to Follow-up|8|||
161598503|NCT03511664|583582756|FG001|Overall Study|Lost to Follow-up|5|||
161598504|NCT03511664|583582757|FG002|Overall Study|Lost to Follow-up|0|||
161598505|NCT03511664|583582755|FG000|Overall Study|Physician Decision|2|||
161598506|NCT03511664|583582756|FG001|Overall Study|Physician Decision|1|||
161598507|NCT03511664|583582757|FG002|Overall Study|Physician Decision|0|||
161598508|NCT03511664|583582755|FG000|Overall Study|Patient non-compliance|1|||
161598509|NCT03511664|583582756|FG001|Overall Study|Patient non-compliance|0|||
161598510|NCT03511664|583582757|FG002|Overall Study|Patient non-compliance|0|||
161598511|NCT01946789|583582758|FG000|Overall Study|Death|0|||
161598512|NCT01946789|583582759|FG001|Overall Study|Death|2|||
161598513|NCT01946789|583582760|FG002|Overall Study|Death|1|||
161598514|NCT01946789|583582761|FG003|Overall Study|Death|1|||
161598515|NCT01946789|583582762|FG004|Overall Study|Death|1|||
161598516|NCT01946789|583582763|FG005|Overall Study|Death|1|||
161598517|NCT01946789|583582764|FG006|Overall Study|Death|3|||
161598518|NCT01946789|583582765|FG007|Overall Study|Death|1|||
161598519|NCT01946789|583582766|FG008|Overall Study|Death|2|||
161598520|NCT01946789|583582758|FG000|Overall Study|Progressive Disease|0|||
161598521|NCT01946789|583582759|FG001|Overall Study|Progressive Disease|0|||
161598522|NCT01946789|583582760|FG002|Overall Study|Progressive Disease|1|||
161598523|NCT01946789|583582761|FG003|Overall Study|Progressive Disease|0|||
161598524|NCT01946789|583582762|FG004|Overall Study|Progressive Disease|0|||
161598525|NCT01946789|583582763|FG005|Overall Study|Progressive Disease|2|||
161598526|NCT01946789|583582764|FG006|Overall Study|Progressive Disease|0|||
161598527|NCT01946789|583582765|FG007|Overall Study|Progressive Disease|0|||
161598528|NCT01946789|583582766|FG008|Overall Study|Progressive Disease|0|||
161598529|NCT01946789|583582758|FG000|Overall Study|Withdrawal by Subject|0|||
161598530|NCT01946789|583582759|FG001|Overall Study|Withdrawal by Subject|0|||
161598531|NCT01946789|583582760|FG002|Overall Study|Withdrawal by Subject|0|||
161598532|NCT01946789|583582761|FG003|Overall Study|Withdrawal by Subject|2|||
161598533|NCT01946789|583582762|FG004|Overall Study|Withdrawal by Subject|1|||
161598534|NCT01946789|583582763|FG005|Overall Study|Withdrawal by Subject|0|||
161598535|NCT01946789|583582764|FG006|Overall Study|Withdrawal by Subject|1|||
161548693|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
161548694|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161548695|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161598536|NCT01946789|583582765|FG007|Overall Study|Withdrawal by Subject|0|||
161598537|NCT01946789|583582766|FG008|Overall Study|Withdrawal by Subject|0|||
161598538|NCT04076618|583582767|FG000|Overall Study|Lost to Follow-up|2|||
161598539|NCT04076618|583582768|FG001|Overall Study|Lost to Follow-up|1|||
161598540|NCT04076618|583582769|FG002|Overall Study|Lost to Follow-up|3|||
161598541|NCT04076618|583582767|FG000|Overall Study|Withdrawal by Subject|3|||
161598542|NCT04076618|583582768|FG001|Overall Study|Withdrawal by Subject|1|||
161598543|NCT04076618|583582769|FG002|Overall Study|Withdrawal by Subject|2|||
161681757|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
161681758|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
161681759|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
161681760|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
161681761|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
161681762|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
161681763|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
161681764|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
161681765|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
161681766|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
161681767|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Death|2|||
161681768|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Death|0|||
161681769|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Death|1|||
161681770|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Death|0|||
161681771|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
161681772|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
161681773|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
161681774|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
161681775|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
161681776|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
161681777|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
161681778|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
161681779|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
161681780|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
161681781|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
161681782|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
161598544|NCT04076618|583582767|FG000|Overall Study|Relocated out of state|0|||
161598545|NCT04076618|583582768|FG001|Overall Study|Relocated out of state|2|||
161598546|NCT04076618|583582769|FG002|Overall Study|Relocated out of state|0|||
161598547|NCT04076618|583582767|FG000|Overall Study|COVID concerns|0|||
161598548|NCT04076618|583582768|FG001|Overall Study|COVID concerns|1|||
161598549|NCT04076618|583582769|FG002|Overall Study|COVID concerns|0|||
161598550|NCT04076618|583582767|FG000|Overall Study|Adverse Event|0|||
161598551|NCT04076618|583582768|FG001|Overall Study|Adverse Event|0|||
161598552|NCT04076618|583582769|FG002|Overall Study|Adverse Event|2|||
161598553|NCT04299464|583582770|FG000|Overall Study|Adverse Event|1|||
161598554|NCT04299464|583582771|FG001|Overall Study|Adverse Event|0|||
161598555|NCT04299464|583582772|FG002|Overall Study|Adverse Event|2|||
161598556|NCT04299464|583582770|FG000|Overall Study|Non-compliance with Study Drug|1|||
161598557|NCT04299464|583582771|FG001|Overall Study|Non-compliance with Study Drug|0|||
161598558|NCT04299464|583582772|FG002|Overall Study|Non-compliance with Study Drug|0|||
161598559|NCT04299464|583582770|FG000|Overall Study|Reason not Specified|0|||
161598560|NCT04299464|583582771|FG001|Overall Study|Reason not Specified|1|||
161598561|NCT04299464|583582772|FG002|Overall Study|Reason not Specified|3|||
161598562|NCT04299464|583582770|FG000|Overall Study|Physician Decision|0|||
161598563|NCT04299464|583582771|FG001|Overall Study|Physician Decision|1|||
161598564|NCT04299464|583582772|FG002|Overall Study|Physician Decision|1|||
161598565|NCT04299464|583582770|FG000|Overall Study|Withdrawal by Subject|0|||
161598566|NCT04299464|583582771|FG001|Overall Study|Withdrawal by Subject|2|||
161598567|NCT04299464|583582772|FG002|Overall Study|Withdrawal by Subject|1|||
161598568|NCT05293171|583582779|FG000|Washout 5 to 7 Days|Adverse Event|1|||
161598569|NCT05293171|583582780|FG001|Washout 5 to 7 Days|Adverse Event|1|||
161598570|NCT05293171|583582781|FG002|Washout 5 to 7 Days|Adverse Event|0|||
161598571|NCT05293171|583582782|FG003|Washout 5 to 7 Days|Adverse Event|0|||
161598572|NCT05293171|583582783|FG004|Washout 5 to 7 Days|Adverse Event|0|||
161598573|NCT05293171|583582784|FG005|Washout 5 to 7 Days|Adverse Event|0|||
161598574|NCT05293171|583582785|FG006|Washout 5 to 7 Days|Adverse Event|0|||
161598575|NCT05293171|583582786|FG007|Washout 5 to 7 Days|Adverse Event|0|||
161598576|NCT05293171|583582787|FG008|Washout 5 to 7 Days|Adverse Event|0|||
161598577|NCT05293171|583582788|FG009|Washout 5 to 7 Days|Adverse Event|0|||
161598578|NCT05293171|583582789|FG010|Washout 5 to 7 Days|Adverse Event|0|||
161598579|NCT05293171|583582790|FG011|Washout 5 to 7 Days|Adverse Event|0|||
161598580|NCT05293171|583582779|FG000|Washout 5 to 7 Days|Adverse Event|0|||
161681783|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
161681784|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
161681785|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
161598581|NCT05293171|583582780|FG001|Washout 5 to 7 Days|Adverse Event|0|||
161598582|NCT05293171|583582781|FG002|Washout 5 to 7 Days|Adverse Event|0|||
161598583|NCT05293171|583582782|FG003|Washout 5 to 7 Days|Adverse Event|0|||
161598584|NCT05293171|583582783|FG004|Washout 5 to 7 Days|Adverse Event|0|||
161598585|NCT05293171|583582784|FG005|Washout 5 to 7 Days|Adverse Event|1|||
161598586|NCT05293171|583582785|FG006|Washout 5 to 7 Days|Adverse Event|0|||
161598587|NCT05293171|583582786|FG007|Washout 5 to 7 Days|Adverse Event|0|||
161598588|NCT05293171|583582787|FG008|Washout 5 to 7 Days|Adverse Event|0|||
161598589|NCT05293171|583582788|FG009|Washout 5 to 7 Days|Adverse Event|0|||
161598590|NCT05293171|583582789|FG010|Washout 5 to 7 Days|Adverse Event|0|||
161598591|NCT05293171|583582790|FG011|Washout 5 to 7 Days|Adverse Event|0|||
161598592|NCT04066205|583582791|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
161598593|NCT04066205|583582792|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
161598594|NCT04066205|583582791|FG000|T2 Immediate Post-Intervention|did not respond|5|||
161598595|NCT04066205|583582792|FG001|T2 Immediate Post-Intervention|did not respond|3|||
161598596|NCT02052882|583582793|FG000|Overall Study|Not treated|11|||
161598597|NCT02052882|583582793|FG000|Overall Study|Protocol Violation|1|||
161598598|NCT02052882|583582793|FG000|Overall Study|Inadequate testing|1|||
161598599|NCT05123586|583582801|FG000|Overall Study|Physician Decision|1|||
161598600|NCT05123586|583582802|FG001|Overall Study|Physician Decision|1|||
161598601|NCT05123586|583582801|FG000|Overall Study|Withdrawal by Subject|0|||
161598602|NCT05123586|583582802|FG001|Overall Study|Withdrawal by Subject|3|||
161598603|NCT02733159|583582814|FG000|Overall Study|Adverse Event|1|||
161598604|NCT02733159|583582814|FG000|Overall Study|Lack of disease progression|1|||
161598605|NCT06122194|583582817|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
161598606|NCT06122194|583582818|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
161598607|NCT06122194|583582819|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
161598608|NCT06122194|583582820|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
161598609|NCT05218096|583582821|FG000|Primary Evaluation|Withdrawal by Subject|0|||
161598610|NCT05218096|583582822|FG001|Primary Evaluation|Withdrawal by Subject|0|||
161598611|NCT05218096|583582823|FG002|Primary Evaluation|Withdrawal by Subject|2|||
161598612|NCT05218096|583582824|FG003|Primary Evaluation|Withdrawal by Subject|0|||
161598613|NCT05218096|583582825|FG004|Primary Evaluation|Withdrawal by Subject|0|||
161598614|NCT05218096|583582821|FG000|Primary Evaluation|Physician Decision|1|||
161598615|NCT05218096|583582822|FG001|Primary Evaluation|Physician Decision|0|||
161598616|NCT05218096|583582823|FG002|Primary Evaluation|Physician Decision|0|||
161598617|NCT05218096|583582824|FG003|Primary Evaluation|Physician Decision|0|||
161598618|NCT05218096|583582825|FG004|Primary Evaluation|Physician Decision|0|||
161598619|NCT05218096|583582821|FG000|Extended Treatment|Clinical Deterioration|1|||
161598620|NCT05218096|583582822|FG001|Extended Treatment|Clinical Deterioration|1|||
161598621|NCT05218096|583582823|FG002|Extended Treatment|Clinical Deterioration|0|||
161598622|NCT05218096|583582824|FG003|Extended Treatment|Clinical Deterioration|0|||
161598623|NCT05218096|583582825|FG004|Extended Treatment|Clinical Deterioration|0|||
161598624|NCT05218096|583582821|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
161598625|NCT05218096|583582822|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
161598626|NCT05218096|583582823|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
161598627|NCT05218096|583582824|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
161598628|NCT05218096|583582825|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
161598629|NCT05218096|583582821|FG000|Extended Treatment|Withdrawal by Subject|1|||
161598630|NCT05218096|583582822|FG001|Extended Treatment|Withdrawal by Subject|3|||
161598631|NCT05218096|583582823|FG002|Extended Treatment|Withdrawal by Subject|0|||
161598632|NCT05218096|583582824|FG003|Extended Treatment|Withdrawal by Subject|2|||
161598633|NCT05218096|583582825|FG004|Extended Treatment|Withdrawal by Subject|2|||
161598634|NCT05218096|583582821|FG000|Extended Treatment|Lack of Efficacy|3|||
161598635|NCT05218096|583582822|FG001|Extended Treatment|Lack of Efficacy|0|||
161598636|NCT05218096|583582823|FG002|Extended Treatment|Lack of Efficacy|0|||
161598637|NCT05218096|583582824|FG003|Extended Treatment|Lack of Efficacy|0|||
161598638|NCT05218096|583582825|FG004|Extended Treatment|Lack of Efficacy|0|||
161598639|NCT05218096|583582821|FG000|Extended Treatment|Physician Decision|0|||
161598640|NCT05218096|583582822|FG001|Extended Treatment|Physician Decision|1|||
161598641|NCT05218096|583582823|FG002|Extended Treatment|Physician Decision|0|||
161598642|NCT05218096|583582824|FG003|Extended Treatment|Physician Decision|0|||
161598643|NCT05218096|583582825|FG004|Extended Treatment|Physician Decision|0|||
161598644|NCT05218096|583582821|FG000|Open-label Extension|Adverse Event|1|||
161598645|NCT05218096|583582822|FG001|Open-label Extension|Adverse Event|0|||
161598646|NCT05218096|583582823|FG002|Open-label Extension|Adverse Event|0|||
161598647|NCT05218096|583582824|FG003|Open-label Extension|Adverse Event|0|||
161598648|NCT05218096|583582825|FG004|Open-label Extension|Adverse Event|1|||
161598649|NCT05218096|583582821|FG000|Open-label Extension|Pregnancy|0|||
161598650|NCT05218096|583582822|FG001|Open-label Extension|Pregnancy|0|||
161598651|NCT05218096|583582823|FG002|Open-label Extension|Pregnancy|0|||
161598652|NCT05218096|583582824|FG003|Open-label Extension|Pregnancy|0|||
161598653|NCT05218096|583582825|FG004|Open-label Extension|Pregnancy|1|||
161598654|NCT05218096|583582821|FG000|Open-label Extension|Lack of Efficacy|1|||
161598655|NCT05218096|583582822|FG001|Open-label Extension|Lack of Efficacy|2|||
161598656|NCT05218096|583582823|FG002|Open-label Extension|Lack of Efficacy|0|||
161598657|NCT05218096|583582824|FG003|Open-label Extension|Lack of Efficacy|0|||
161598658|NCT05218096|583582825|FG004|Open-label Extension|Lack of Efficacy|0|||
161598659|NCT05218096|583582821|FG000|Open-label Extension|Lost to Follow-up|1|||
161598660|NCT05218096|583582822|FG001|Open-label Extension|Lost to Follow-up|0|||
161598661|NCT05218096|583582823|FG002|Open-label Extension|Lost to Follow-up|0|||
161598662|NCT05218096|583582824|FG003|Open-label Extension|Lost to Follow-up|0|||
161598663|NCT05218096|583582825|FG004|Open-label Extension|Lost to Follow-up|0|||
161598664|NCT05218096|583582821|FG000|Open-label Extension|Death|0|||
161598665|NCT05218096|583582822|FG001|Open-label Extension|Death|0|||
161598666|NCT05218096|583582823|FG002|Open-label Extension|Death|0|||
161598667|NCT05218096|583582824|FG003|Open-label Extension|Death|1|||
161598668|NCT05218096|583582825|FG004|Open-label Extension|Death|0|||
161598669|NCT05218096|583582821|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
161598670|NCT05218096|583582822|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
161598671|NCT05218096|583582823|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
161598672|NCT05218096|583582824|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
161598673|NCT05218096|583582825|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
161598674|NCT04690582|583582831|FG000|Overall Study|Withdrawal by Subject|6|||
161598675|NCT04690582|583582832|FG001|Overall Study|Withdrawal by Subject|4|||
161598676|NCT04737330|583582841|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
161598677|NCT04737330|583582842|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
161598678|NCT04737330|583582841|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
161598679|NCT04737330|583582842|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
161598680|NCT04737330|583582841|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
161598681|NCT04737330|583582842|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
161598682|NCT04737330|583582841|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
161598683|NCT04737330|583582842|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
161598684|NCT04737330|583582841|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
161598685|NCT04737330|583582842|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
161598686|NCT04737330|583582841|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
161598687|NCT04737330|583582842|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
161598688|NCT04032847|583582845|FG000|Overall Study|Study termination by sponsor|8|||
161598689|NCT04032847|583582846|FG001|Overall Study|Study termination by sponsor|0|||
161598690|NCT04032847|583582847|FG002|Overall Study|Study termination by sponsor|4|||
161598691|NCT04032847|583582845|FG000|Overall Study|Death|12|||
161598692|NCT04032847|583582846|FG001|Overall Study|Death|0|||
161598693|NCT04032847|583582847|FG002|Overall Study|Death|0|||
161598694|NCT04032847|583582845|FG000|Overall Study|Progressive disease|2|||
161548696|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161548697|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161548698|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
161598695|NCT04032847|583582846|FG001|Overall Study|Progressive disease|0|||
161598696|NCT04032847|583582847|FG002|Overall Study|Progressive disease|1|||
161598697|NCT03056573|583582848|FG000|Overall Study|Death|2|||
161598698|NCT03056573|583582849|FG001|Overall Study|Death|4|||
161598699|NCT03056573|583582848|FG000|Overall Study|Withdrawal by Subject|2|||
161598700|NCT03056573|583582849|FG001|Overall Study|Withdrawal by Subject|0|||
161681786|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
161830582|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161830583|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
161548699|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
161548700|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
161548701|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
161548702|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
161548703|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
161548704|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
161548705|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161548706|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161548707|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
161548708|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161548709|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161548710|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161548711|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161548712|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
161548713|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
161548714|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
161548715|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161548716|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161548717|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161548718|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161548719|NCT04921969|583397944|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
161548720|NCT04921969|583397945|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
161548721|NCT04921969|583397946|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
161598701|NCT03056573|583582848|FG000|Overall Study|Lost to Follow-up|1|||
161598702|NCT03056573|583582849|FG001|Overall Study|Lost to Follow-up|1|||
161598703|NCT05267470|583582850|FG000|Overall Study|Decision by sponsor|0|||
161598704|NCT05267470|583582851|FG001|Overall Study|Decision by sponsor|3|||
161830584|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
161598705|NCT05267470|583582852|FG002|Overall Study|Decision by sponsor|19|||
161598706|NCT05267470|583582853|FG003|Overall Study|Decision by sponsor|7|||
161598707|NCT05267470|583582854|FG004|Overall Study|Decision by sponsor|3|||
161598708|NCT05267470|583582850|FG000|Overall Study|Withdrawal by Subject|1|||
161598709|NCT05267470|583582851|FG001|Overall Study|Withdrawal by Subject|1|||
161598710|NCT05267470|583582852|FG002|Overall Study|Withdrawal by Subject|2|||
161598711|NCT05267470|583582853|FG003|Overall Study|Withdrawal by Subject|2|||
161598712|NCT05267470|583582854|FG004|Overall Study|Withdrawal by Subject|0|||
161598713|NCT05267470|583582850|FG000|Overall Study|Death|3|||
161598714|NCT05267470|583582851|FG001|Overall Study|Death|5|||
161598715|NCT05267470|583582852|FG002|Overall Study|Death|8|||
161598716|NCT05267470|583582853|FG003|Overall Study|Death|18|||
161598717|NCT05267470|583582854|FG004|Overall Study|Death|1|||
161598718|NCT05267470|583582850|FG000|Overall Study|Lost to Follow-up|0|||
161598719|NCT05267470|583582851|FG001|Overall Study|Lost to Follow-up|0|||
161598720|NCT05267470|583582852|FG002|Overall Study|Lost to Follow-up|0|||
161598721|NCT05267470|583582853|FG003|Overall Study|Lost to Follow-up|1|||
161598722|NCT05267470|583582854|FG004|Overall Study|Lost to Follow-up|0|||
161598723|NCT04428203|583582855|FG000|Overall Study|Adverse Event|1|||
161598724|NCT04428203|583582856|FG001|Overall Study|Adverse Event|0|||
161598725|NCT04428203|583582857|FG002|Overall Study|Adverse Event|0|||
161598726|NCT04428203|583582855|FG000|Overall Study|Withdrawal by Subject|1|||
161598727|NCT04428203|583582856|FG001|Overall Study|Withdrawal by Subject|0|||
161598728|NCT04428203|583582857|FG002|Overall Study|Withdrawal by Subject|1|||
161598729|NCT04741776|583582858|FG000|Overall Study|Withdrawal by Subject|7|||
161598730|NCT04741776|583582859|FG001|Overall Study|Withdrawal by Subject|10|||
161598731|NCT04741776|583582860|FG002|Overall Study|Withdrawal by Subject|10|||
161598732|NCT04741776|583582861|FG003|Overall Study|Withdrawal by Subject|17|||
161598733|NCT04741776|583582858|FG000|Overall Study|Death|0|||
161598734|NCT04741776|583582859|FG001|Overall Study|Death|0|||
161598735|NCT04741776|583582860|FG002|Overall Study|Death|1|||
161598736|NCT04741776|583582861|FG003|Overall Study|Death|0|||
161598737|NCT02852655|583582877|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
161598738|NCT02852655|583582878|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
161598739|NCT02852655|583582879|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
161598740|NCT02852655|583582877|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
161598741|NCT02852655|583582878|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
161598742|NCT02852655|583582879|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
161598743|NCT02852655|583582877|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
161598744|NCT02852655|583582878|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
161598745|NCT02852655|583582879|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
161598746|NCT02852655|583582877|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
161598747|NCT02852655|583582878|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
161598748|NCT02852655|583582879|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
161598749|NCT02852655|583582877|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
161598750|NCT02852655|583582878|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
161598751|NCT02852655|583582879|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
161598752|NCT02852655|583582877|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
161598753|NCT02852655|583582878|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
161598754|NCT02852655|583582879|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
161598755|NCT02852655|583582877|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
161598756|NCT02852655|583582878|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
161598757|NCT02852655|583582879|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
161598758|NCT02852655|583582877|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
161598759|NCT02852655|583582878|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
161598760|NCT02852655|583582879|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
161598761|NCT02852655|583582877|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
161598762|NCT02852655|583582878|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
161598763|NCT02852655|583582879|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
161598764|NCT03257410|583584885|FG000|Overall Study|Adverse Event|2|||
161598765|NCT03257410|583584886|FG001|Overall Study|Adverse Event|3|||
161598766|NCT03257410|583584885|FG000|Overall Study|Protocol Violation|1|||
161598767|NCT03257410|583584886|FG001|Overall Study|Protocol Violation|2|||
161598768|NCT03257410|583584885|FG000|Overall Study|Lost to Follow-up|1|||
161598769|NCT03257410|583584886|FG001|Overall Study|Lost to Follow-up|0|||
161598770|NCT03257410|583584885|FG000|Overall Study|Withdrawal by Subject|1|||
161598771|NCT03257410|583584886|FG001|Overall Study|Withdrawal by Subject|2|||
161598772|NCT03257410|583584885|FG000|Overall Study|Physician Decision|1|||
161598773|NCT03257410|583584886|FG001|Overall Study|Physician Decision|1|||
161598774|NCT03257410|583584885|FG000|Overall Study|Renal transplantation|2|||
161598775|NCT03257410|583584886|FG001|Overall Study|Renal transplantation|0|||
161598776|NCT03257410|583584885|FG000|Overall Study|Switch to peritoneal dialysis|1|||
161598777|NCT03257410|583584886|FG001|Overall Study|Switch to peritoneal dialysis|0|||
161598778|NCT03257410|583584885|FG000|Overall Study|Death|3|||
161598779|NCT03257410|583584886|FG001|Overall Study|Death|2|||
161598780|NCT03257410|583584885|FG000|Overall Study|Change to another dialysis center|2|||
161598781|NCT03257410|583584886|FG001|Overall Study|Change to another dialysis center|2|||
161598782|NCT03257410|583584885|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
161598783|NCT03257410|583584886|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
161598784|NCT03257410|583584885|FG000|Overall Study|Miscellaneous|2|||
161598785|NCT03257410|583584886|FG001|Overall Study|Miscellaneous|2|||
161598786|NCT03257410|583584885|FG000|Overall Study|Other|0|||
161598787|NCT03257410|583584886|FG001|Overall Study|Other|1|||
161598788|NCT02598388|583584887|FG000|Overall Study|Lost to Follow-up|1|||
161598789|NCT02598388|583584888|FG001|Overall Study|Lost to Follow-up|0|||
161598790|NCT02598388|583584889|FG002|Overall Study|Lost to Follow-up|1|||
161598791|NCT02598388|583584890|FG003|Overall Study|Lost to Follow-up|0|||
161598792|NCT02598388|583584891|FG004|Overall Study|Lost to Follow-up|5|||
161598793|NCT02598388|583584892|FG005|Overall Study|Lost to Follow-up|1|||
161598794|NCT02598388|583584893|FG006|Overall Study|Lost to Follow-up|2|||
161598795|NCT02598388|583584894|FG007|Overall Study|Lost to Follow-up|1|||
161598796|NCT02598388|583584895|FG008|Overall Study|Lost to Follow-up|0|||
161598797|NCT02598388|583584896|FG009|Overall Study|Lost to Follow-up|0|||
161598798|NCT02598388|583584897|FG010|Overall Study|Lost to Follow-up|1|||
161598799|NCT02598388|583584898|FG011|Overall Study|Lost to Follow-up|0|||
161598800|NCT02598388|583584887|FG000|Overall Study|Withdrawal by Subject|0|||
161598801|NCT02598388|583584888|FG001|Overall Study|Withdrawal by Subject|0|||
161598802|NCT02598388|583584889|FG002|Overall Study|Withdrawal by Subject|0|||
161598803|NCT02598388|583584890|FG003|Overall Study|Withdrawal by Subject|0|||
161598804|NCT02598388|583584891|FG004|Overall Study|Withdrawal by Subject|2|||
161598805|NCT02598388|583584892|FG005|Overall Study|Withdrawal by Subject|0|||
161598806|NCT02598388|583584893|FG006|Overall Study|Withdrawal by Subject|2|||
161598807|NCT02598388|583584894|FG007|Overall Study|Withdrawal by Subject|0|||
161598808|NCT02598388|583584895|FG008|Overall Study|Withdrawal by Subject|0|||
161598809|NCT02598388|583584896|FG009|Overall Study|Withdrawal by Subject|1|||
161598810|NCT02598388|583584897|FG010|Overall Study|Withdrawal by Subject|0|||
161598811|NCT02598388|583584898|FG011|Overall Study|Withdrawal by Subject|0|||
161598812|NCT02598388|583584887|FG000|Overall Study|Other|0|||
161598813|NCT02598388|583584888|FG001|Overall Study|Other|0|||
161598814|NCT02598388|583584889|FG002|Overall Study|Other|1|||
161598815|NCT02598388|583584890|FG003|Overall Study|Other|0|||
161598816|NCT02598388|583584891|FG004|Overall Study|Other|3|||
161598817|NCT02598388|583584892|FG005|Overall Study|Other|0|||
161598818|NCT02598388|583584893|FG006|Overall Study|Other|1|||
161598819|NCT02598388|583584894|FG007|Overall Study|Other|0|||
161598820|NCT02598388|583584895|FG008|Overall Study|Other|0|||
161598821|NCT02598388|583584896|FG009|Overall Study|Other|0|||
161598822|NCT02598388|583584897|FG010|Overall Study|Other|0|||
161598823|NCT02598388|583584898|FG011|Overall Study|Other|0|||
161598824|NCT03668236|583584901|FG000|90-day Follow-up|Withdrawal by Subject|3|||
161598825|NCT03668236|583584902|FG001|90-day Follow-up|Withdrawal by Subject|2|||
161598826|NCT03668236|583584901|FG000|90-day Follow-up|Lost to Follow-up|3|||
161598827|NCT03668236|583584902|FG001|90-day Follow-up|Lost to Follow-up|1|||
161598828|NCT03668236|583584901|FG000|Baseline Characteristics|Lost to Follow-up|9|||
161598829|NCT03668236|583584902|FG001|Baseline Characteristics|Lost to Follow-up|5|||
161598830|NCT03668236|583584901|FG000|1-year Follow-up|Withdrawal by Subject|17|||
161598831|NCT03668236|583584902|FG001|1-year Follow-up|Withdrawal by Subject|15|||
161598832|NCT06132282|583584903|FG000|Overall Study|Lost to Follow-up|31|||
161598833|NCT04171141|583584904|FG000|Overall Study|Adverse Event|0|||
161598834|NCT04171141|583584905|FG001|Overall Study|Adverse Event|0|||
161598835|NCT04171141|583584906|FG002|Overall Study|Adverse Event|2|||
161598836|NCT04171141|583584907|FG003|Overall Study|Adverse Event|0|||
161598837|NCT04171141|583584908|FG004|Overall Study|Adverse Event|0|||
161598838|NCT04171141|583584909|FG005|Overall Study|Adverse Event|0|||
161598839|NCT04171141|583584910|FG006|Overall Study|Adverse Event|0|||
161598840|NCT04171141|583584911|FG007|Overall Study|Adverse Event|0|||
161598841|NCT04171141|583584912|FG008|Overall Study|Adverse Event|0|||
161598842|NCT04171141|583584913|FG009|Overall Study|Adverse Event|0|||
161598843|NCT04171141|583584914|FG010|Overall Study|Adverse Event|0|||
161598844|NCT04171141|583584915|FG011|Overall Study|Adverse Event|0|||
161598845|NCT04171141|583584916|FG012|Overall Study|Adverse Event|0|||
161598846|NCT04171141|583584917|FG013|Overall Study|Adverse Event|2|||
161598847|NCT04171141|583584918|FG014|Overall Study|Adverse Event|0|||
161598848|NCT04171141|583584919|FG015|Overall Study|Adverse Event|0|||
161598849|NCT04171141|583584904|FG000|Overall Study|Physician Decision|0|||
161681787|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
161598850|NCT04171141|583584905|FG001|Overall Study|Physician Decision|0|||
161598851|NCT04171141|583584906|FG002|Overall Study|Physician Decision|0|||
161598852|NCT04171141|583584907|FG003|Overall Study|Physician Decision|0|||
161598853|NCT04171141|583584908|FG004|Overall Study|Physician Decision|1|||
161598854|NCT04171141|583584909|FG005|Overall Study|Physician Decision|0|||
161598855|NCT04171141|583584910|FG006|Overall Study|Physician Decision|0|||
161598856|NCT04171141|583584911|FG007|Overall Study|Physician Decision|0|||
161598857|NCT04171141|583584912|FG008|Overall Study|Physician Decision|0|||
161598858|NCT04171141|583584913|FG009|Overall Study|Physician Decision|0|||
161598859|NCT04171141|583584914|FG010|Overall Study|Physician Decision|0|||
161598860|NCT04171141|583584915|FG011|Overall Study|Physician Decision|0|||
161598861|NCT04171141|583584916|FG012|Overall Study|Physician Decision|0|||
161598862|NCT04171141|583584917|FG013|Overall Study|Physician Decision|0|||
161598863|NCT04171141|583584918|FG014|Overall Study|Physician Decision|0|||
161598864|NCT04171141|583584919|FG015|Overall Study|Physician Decision|1|||
161598865|NCT04171141|583584904|FG000|Overall Study|Progressive disease|2|||
161598866|NCT04171141|583584905|FG001|Overall Study|Progressive disease|3|||
161598867|NCT04171141|583584906|FG002|Overall Study|Progressive disease|4|||
161598868|NCT04171141|583584907|FG003|Overall Study|Progressive disease|7|||
161598869|NCT04171141|583584908|FG004|Overall Study|Progressive disease|1|||
161598870|NCT04171141|583584909|FG005|Overall Study|Progressive disease|8|||
161598871|NCT04171141|583584910|FG006|Overall Study|Progressive disease|4|||
161598872|NCT04171141|583584911|FG007|Overall Study|Progressive disease|6|||
161598873|NCT04171141|583584912|FG008|Overall Study|Progressive disease|7|||
161598874|NCT04171141|583584913|FG009|Overall Study|Progressive disease|3|||
161598875|NCT04171141|583584914|FG010|Overall Study|Progressive disease|4|||
161598876|NCT04171141|583584915|FG011|Overall Study|Progressive disease|3|||
161598877|NCT04171141|583584916|FG012|Overall Study|Progressive disease|4|||
161598878|NCT04171141|583584917|FG013|Overall Study|Progressive disease|2|||
161598879|NCT04171141|583584918|FG014|Overall Study|Progressive disease|4|||
161598880|NCT04171141|583584919|FG015|Overall Study|Progressive disease|1|||
161598881|NCT04171141|583584904|FG000|Overall Study|Withdrawal by Subject|0|||
161598882|NCT04171141|583584905|FG001|Overall Study|Withdrawal by Subject|0|||
161598883|NCT04171141|583584906|FG002|Overall Study|Withdrawal by Subject|0|||
161598884|NCT04171141|583584907|FG003|Overall Study|Withdrawal by Subject|1|||
161598885|NCT04171141|583584908|FG004|Overall Study|Withdrawal by Subject|0|||
161598886|NCT04171141|583584909|FG005|Overall Study|Withdrawal by Subject|0|||
161598887|NCT04171141|583584910|FG006|Overall Study|Withdrawal by Subject|1|||
161598888|NCT04171141|583584911|FG007|Overall Study|Withdrawal by Subject|0|||
161598889|NCT04171141|583584912|FG008|Overall Study|Withdrawal by Subject|0|||
161598890|NCT04171141|583584913|FG009|Overall Study|Withdrawal by Subject|1|||
161598891|NCT04171141|583584914|FG010|Overall Study|Withdrawal by Subject|0|||
161598892|NCT04171141|583584915|FG011|Overall Study|Withdrawal by Subject|0|||
161598893|NCT04171141|583584916|FG012|Overall Study|Withdrawal by Subject|0|||
161598894|NCT04171141|583584917|FG013|Overall Study|Withdrawal by Subject|0|||
161598895|NCT04171141|583584918|FG014|Overall Study|Withdrawal by Subject|0|||
161598896|NCT04171141|583584919|FG015|Overall Study|Withdrawal by Subject|0|||
161598897|NCT04171141|583584904|FG000|Overall Study|Global deterioration of health status|0|||
161598898|NCT04171141|583584905|FG001|Overall Study|Global deterioration of health status|0|||
161598899|NCT04171141|583584906|FG002|Overall Study|Global deterioration of health status|0|||
161598900|NCT04171141|583584907|FG003|Overall Study|Global deterioration of health status|1|||
161598901|NCT04171141|583584908|FG004|Overall Study|Global deterioration of health status|0|||
161598902|NCT04171141|583584909|FG005|Overall Study|Global deterioration of health status|2|||
161598903|NCT04171141|583584910|FG006|Overall Study|Global deterioration of health status|1|||
161598904|NCT04171141|583584911|FG007|Overall Study|Global deterioration of health status|0|||
161598905|NCT04171141|583584912|FG008|Overall Study|Global deterioration of health status|1|||
161598906|NCT04171141|583584913|FG009|Overall Study|Global deterioration of health status|0|||
161598907|NCT04171141|583584914|FG010|Overall Study|Global deterioration of health status|0|||
161598908|NCT04171141|583584915|FG011|Overall Study|Global deterioration of health status|0|||
161598909|NCT04171141|583584916|FG012|Overall Study|Global deterioration of health status|0|||
161598910|NCT04171141|583584917|FG013|Overall Study|Global deterioration of health status|0|||
161598911|NCT04171141|583584918|FG014|Overall Study|Global deterioration of health status|1|||
161598912|NCT04171141|583584919|FG015|Overall Study|Global deterioration of health status|1|||
161598913|NCT03314454|583584920|FG000|Overall Study|Protocol Violation|1|||
161598914|NCT02841579|583584921|FG000|Overall Study|Death|1|||
161598915|NCT02841579|583584921|FG000|Overall Study|Adverse Event|1|||
161598916|NCT02841579|583584921|FG000|Overall Study|Lack of Efficacy|9|||
161681788|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
161681789|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
161681790|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
161681791|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
161681792|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
161681793|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
161681794|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
161681795|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Death|2|||
161681796|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Death|0|||
161681797|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Death|2|||
161681798|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Death|0|||
161681799|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
161681800|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
161681801|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
161681802|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
161598929|NCT04979442|583584924|FG000|Overall Study|Death|43|||
161598930|NCT04979442|583584925|FG001|Overall Study|Death|30|||
161598931|NCT04979442|583584924|FG000|Overall Study|Withdrawal by Subject|8|||
161598932|NCT04979442|583584925|FG001|Overall Study|Withdrawal by Subject|13|||
161598933|NCT04979442|583584924|FG000|Overall Study|Physician Decision|1|||
161598934|NCT04979442|583584925|FG001|Overall Study|Physician Decision|1|||
161598935|NCT04979442|583584924|FG000|Overall Study|Lost to Follow-up|0|||
161598936|NCT04979442|583584925|FG001|Overall Study|Lost to Follow-up|2|||
161598937|NCT04979442|583584924|FG000|Overall Study|do not want to continue|0|||
161598938|NCT04979442|583584925|FG001|Overall Study|do not want to continue|1|||
161598939|NCT04005794|583584927|FG000|Overall Study|Lost to Follow-up|0|||
161598940|NCT04005794|583584928|FG001|Overall Study|Lost to Follow-up|4|||
161598941|NCT04005794|583584929|FG002|Overall Study|Lost to Follow-up|0|||
161598942|NCT00104676|583584933|FG000|Overall Study|Death|3|||
161598943|NCT00104676|583584934|FG001|Overall Study|Death|2|||
161598944|NCT00104676|583584933|FG000|Overall Study|Withdrawal by Subject|0|||
161598945|NCT00104676|583584934|FG001|Overall Study|Withdrawal by Subject|2|||
161598946|NCT00104676|583584933|FG000|Overall Study|treatment interruption|4|||
161598947|NCT00104676|583584934|FG001|Overall Study|treatment interruption|10|||
161598948|NCT05622812|583584935|FG000|Overall Study|Withdrawal by Subject|1|||
161598949|NCT05622812|583584936|FG001|Overall Study|Withdrawal by Subject|4|||
161598950|NCT05622812|583584935|FG000|Overall Study|Lost to Follow-up|2|||
161598951|NCT05622812|583584936|FG001|Overall Study|Lost to Follow-up|1|||
161598952|NCT03916185|583584937|FG000|Overall Study|Lost to Follow-up|0|||
161598953|NCT03916185|583584938|FG001|Overall Study|Lost to Follow-up|1|||
161598954|NCT03916185|583584939|FG002|Overall Study|Lost to Follow-up|0|||
161598955|NCT03916185|583584940|FG003|Overall Study|Lost to Follow-up|0|||
161598956|NCT03916185|583584937|FG000|Overall Study|Moved|1|||
161598957|NCT03916185|583584938|FG001|Overall Study|Moved|0|||
161598958|NCT03916185|583584939|FG002|Overall Study|Moved|0|||
161598959|NCT03916185|583584940|FG003|Overall Study|Moved|1|||
161598960|NCT03916185|583584937|FG000|Overall Study|Not Able to Get to Clinic|1|||
161598961|NCT03916185|583584938|FG001|Overall Study|Not Able to Get to Clinic|0|||
161598962|NCT03916185|583584939|FG002|Overall Study|Not Able to Get to Clinic|0|||
161598963|NCT03916185|583584940|FG003|Overall Study|Not Able to Get to Clinic|0|||
161598964|NCT03766685|583584941|FG000|Overall Study|Lost to Follow-up|1|||
161598965|NCT03766685|583584942|FG001|Overall Study|Lost to Follow-up|1|||
161598966|NCT03766685|583584943|FG002|Overall Study|Lost to Follow-up|0|||
161598967|NCT03766685|583584944|FG003|Overall Study|Lost to Follow-up|0|||
161598968|NCT03766685|583584941|FG000|Overall Study|Adverse Event, not fatal|0|||
161598969|NCT03766685|583584942|FG001|Overall Study|Adverse Event, not fatal|1|||
161598970|NCT03766685|583584943|FG002|Overall Study|Adverse Event, not fatal|0|||
161598971|NCT03766685|583584944|FG003|Overall Study|Adverse Event, not fatal|1|||
161598972|NCT03766685|583584941|FG000|Overall Study|Withdrawal by Subject|0|||
161598973|NCT03766685|583584942|FG001|Overall Study|Withdrawal by Subject|2|||
161598974|NCT03766685|583584943|FG002|Overall Study|Withdrawal by Subject|0|||
161598975|NCT03766685|583584944|FG003|Overall Study|Withdrawal by Subject|0|||
161598976|NCT03766685|583584941|FG000|Overall Study|Protocol Violation|0|||
161598977|NCT03766685|583584942|FG001|Overall Study|Protocol Violation|1|||
161598978|NCT03766685|583584943|FG002|Overall Study|Protocol Violation|0|||
161598979|NCT03766685|583584944|FG003|Overall Study|Protocol Violation|0|||
161598980|NCT03766685|583584941|FG000|Overall Study|Non-compliance|0|||
161598981|NCT03766685|583584942|FG001|Overall Study|Non-compliance|2|||
161598982|NCT03766685|583584943|FG002|Overall Study|Non-compliance|0|||
161598983|NCT03766685|583584944|FG003|Overall Study|Non-compliance|0|||
161598984|NCT02844465|583584947|FG000|Overall Study|Screen Failure|36|||
161598985|NCT02844465|583584947|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
161598986|NCT02844465|583584947|FG000|Overall Study|Withdrawal by Subject|5|||
161598987|NCT02844465|583584947|FG000|Overall Study|Lost to Follow-up|1|||
161598988|NCT02844465|583584947|FG000|Overall Study|Retreatment|1|||
161598989|NCT05029622|583584948|FG000|Overall Study|Lost to Follow-up|1|||
161598990|NCT01197378|583584952|FG000|Overall Study|Adverse Event|3|||
161681803|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
161681804|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
161598991|NCT01197378|583584952|FG000|Overall Study|Withdrawal by Subject|1|||
161598992|NCT01197378|583584952|FG000|Overall Study|Physician Decision|1|||
161598993|NCT01197378|583584952|FG000|Overall Study|Other|2|||
161598994|NCT06232590|583584953|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
161598995|NCT06232590|583584954|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
161598996|NCT05299723|583584955|FG000|Overall Study|Withdrawal by Subject|0|||
161598997|NCT05299723|583584956|FG001|Overall Study|Withdrawal by Subject|2|||
161598998|NCT05299723|583584957|FG002|Overall Study|Withdrawal by Subject|0|||
161598999|NCT02460458|583584958|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
161599000|NCT02460458|583584958|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
161599001|NCT02460458|583584958|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
161599002|NCT02460458|583584958|FG000|First Prospective Phase|Lost to Follow-up|84|||
161599003|NCT02460458|583584958|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
161599004|NCT04362254|583584964|FG000|Overall Study|Adverse Event|1|||
161599005|NCT04362254|583584964|FG000|Overall Study|Protocol Violation|1|||
161599006|NCT04362254|583584964|FG000|Overall Study|Due to early termination of the trial|10|||
161599007|NCT01928394|583584965|FG000|Treatment Period|Disease progression|17|||
161599008|NCT01928394|583584966|FG001|Treatment Period|Disease progression|2|||
161599009|NCT01928394|583584967|FG002|Treatment Period|Disease progression|12|||
161599010|NCT01928394|583584968|FG003|Treatment Period|Disease progression|48|||
161599011|NCT01928394|583584969|FG004|Treatment Period|Disease progression|3|||
161599012|NCT01928394|583584970|FG005|Treatment Period|Disease progression|25|||
161599013|NCT01928394|583584971|FG006|Treatment Period|Disease progression|38|||
161599014|NCT01928394|583584972|FG007|Treatment Period|Disease progression|16|||
161599015|NCT01928394|583584973|FG008|Treatment Period|Disease progression|3|||
161599016|NCT01928394|583584974|FG009|Treatment Period|Disease progression|11|||
161599017|NCT01928394|583584975|FG010|Treatment Period|Disease progression|22|||
161599018|NCT01928394|583584976|FG011|Treatment Period|Disease progression|73|||
161599019|NCT01928394|583584977|FG012|Treatment Period|Disease progression|38|||
161599020|NCT01928394|583584978|FG013|Treatment Period|Disease progression|118|||
161599021|NCT01928394|583584979|FG014|Treatment Period|Disease progression|59|||
161599022|NCT01928394|583584980|FG015|Treatment Period|Disease progression|1|||
161599023|NCT01928394|583584981|FG016|Treatment Period|Disease progression|43|||
161599024|NCT01928394|583584982|FG017|Treatment Period|Disease progression|56|||
161599025|NCT01928394|583584983|FG018|Treatment Period|Disease progression|50|||
161599026|NCT01928394|583584984|FG019|Treatment Period|Disease progression|71|||
161599027|NCT01928394|583584985|FG020|Treatment Period|Disease progression|30|||
161599028|NCT01928394|583584986|FG021|Treatment Period|Disease progression|31|||
161599029|NCT01928394|583584987|FG022|Treatment Period|Disease progression|31|||
161599030|NCT01928394|583584965|FG000|Treatment Period|Study drug toxicity|1|||
161599031|NCT01928394|583584966|FG001|Treatment Period|Study drug toxicity|1|||
161599032|NCT01928394|583584967|FG002|Treatment Period|Study drug toxicity|3|||
161599033|NCT01928394|583584968|FG003|Treatment Period|Study drug toxicity|3|||
161599034|NCT01928394|583584969|FG004|Treatment Period|Study drug toxicity|0|||
161599035|NCT01928394|583584970|FG005|Treatment Period|Study drug toxicity|9|||
161599036|NCT01928394|583584971|FG006|Treatment Period|Study drug toxicity|7|||
161599037|NCT01928394|583584972|FG007|Treatment Period|Study drug toxicity|1|||
161599038|NCT01928394|583584973|FG008|Treatment Period|Study drug toxicity|0|||
161599039|NCT01928394|583584974|FG009|Treatment Period|Study drug toxicity|5|||
161599040|NCT01928394|583584975|FG010|Treatment Period|Study drug toxicity|2|||
161599041|NCT01928394|583584976|FG011|Treatment Period|Study drug toxicity|3|||
161599042|NCT01928394|583584977|FG012|Treatment Period|Study drug toxicity|7|||
161599043|NCT01928394|583584978|FG013|Treatment Period|Study drug toxicity|5|||
161599044|NCT01928394|583584979|FG014|Treatment Period|Study drug toxicity|12|||
161599045|NCT01928394|583584980|FG015|Treatment Period|Study drug toxicity|0|||
161599046|NCT01928394|583584981|FG016|Treatment Period|Study drug toxicity|3|||
161599047|NCT01928394|583584982|FG017|Treatment Period|Study drug toxicity|3|||
161599048|NCT01928394|583584983|FG018|Treatment Period|Study drug toxicity|12|||
161599049|NCT01928394|583584984|FG019|Treatment Period|Study drug toxicity|15|||
161599050|NCT01928394|583584985|FG020|Treatment Period|Study drug toxicity|4|||
161599051|NCT01928394|583584986|FG021|Treatment Period|Study drug toxicity|7|||
161599052|NCT01928394|583584987|FG022|Treatment Period|Study drug toxicity|4|||
161599053|NCT01928394|583584965|FG000|Treatment Period|AE unrelated to study drug|0|||
161599054|NCT01928394|583584966|FG001|Treatment Period|AE unrelated to study drug|0|||
161830585|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
161830586|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
161830587|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Disease Progression|3|||
161599055|NCT01928394|583584967|FG002|Treatment Period|AE unrelated to study drug|2|||
161599056|NCT01928394|583584968|FG003|Treatment Period|AE unrelated to study drug|3|||
161599057|NCT01928394|583584969|FG004|Treatment Period|AE unrelated to study drug|0|||
161599058|NCT01928394|583584970|FG005|Treatment Period|AE unrelated to study drug|5|||
161599059|NCT01928394|583584971|FG006|Treatment Period|AE unrelated to study drug|1|||
161599060|NCT01928394|583584972|FG007|Treatment Period|AE unrelated to study drug|0|||
161599061|NCT01928394|583584973|FG008|Treatment Period|AE unrelated to study drug|0|||
161599062|NCT01928394|583584974|FG009|Treatment Period|AE unrelated to study drug|2|||
161599063|NCT01928394|583584975|FG010|Treatment Period|AE unrelated to study drug|0|||
161599064|NCT01928394|583584976|FG011|Treatment Period|AE unrelated to study drug|12|||
161599065|NCT01928394|583584977|FG012|Treatment Period|AE unrelated to study drug|6|||
161830588|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Disease Progression|3|||
161830589|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Disease Progression|0|||
161830590|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Disease Progression|7|||
161599066|NCT01928394|583584978|FG013|Treatment Period|AE unrelated to study drug|13|||
161599067|NCT01928394|583584979|FG014|Treatment Period|AE unrelated to study drug|6|||
161599068|NCT01928394|583584980|FG015|Treatment Period|AE unrelated to study drug|1|||
161599069|NCT01928394|583584981|FG016|Treatment Period|AE unrelated to study drug|1|||
161599070|NCT01928394|583584982|FG017|Treatment Period|AE unrelated to study drug|6|||
161599071|NCT01928394|583584983|FG018|Treatment Period|AE unrelated to study drug|3|||
161599072|NCT01928394|583584984|FG019|Treatment Period|AE unrelated to study drug|5|||
161599073|NCT01928394|583584985|FG020|Treatment Period|AE unrelated to study drug|1|||
161599074|NCT01928394|583584986|FG021|Treatment Period|AE unrelated to study drug|1|||
161599075|NCT01928394|583584987|FG022|Treatment Period|AE unrelated to study drug|0|||
161599076|NCT01928394|583584965|FG000|Treatment Period|Participant request to stop therapy|0|||
161599077|NCT01928394|583584966|FG001|Treatment Period|Participant request to stop therapy|0|||
161599078|NCT01928394|583584967|FG002|Treatment Period|Participant request to stop therapy|0|||
161599079|NCT01928394|583584968|FG003|Treatment Period|Participant request to stop therapy|0|||
161599080|NCT01928394|583584969|FG004|Treatment Period|Participant request to stop therapy|0|||
161599081|NCT01928394|583584970|FG005|Treatment Period|Participant request to stop therapy|3|||
161599082|NCT01928394|583584971|FG006|Treatment Period|Participant request to stop therapy|3|||
161599083|NCT01928394|583584972|FG007|Treatment Period|Participant request to stop therapy|0|||
161599084|NCT01928394|583584973|FG008|Treatment Period|Participant request to stop therapy|0|||
161599085|NCT01928394|583584974|FG009|Treatment Period|Participant request to stop therapy|0|||
161599086|NCT01928394|583584975|FG010|Treatment Period|Participant request to stop therapy|3|||
161599087|NCT01928394|583584976|FG011|Treatment Period|Participant request to stop therapy|2|||
161599088|NCT01928394|583584977|FG012|Treatment Period|Participant request to stop therapy|1|||
161599089|NCT01928394|583584978|FG013|Treatment Period|Participant request to stop therapy|2|||
161599090|NCT01928394|583584979|FG014|Treatment Period|Participant request to stop therapy|4|||
161599091|NCT01928394|583584980|FG015|Treatment Period|Participant request to stop therapy|0|||
161599092|NCT01928394|583584981|FG016|Treatment Period|Participant request to stop therapy|1|||
161599093|NCT01928394|583584982|FG017|Treatment Period|Participant request to stop therapy|3|||
161599094|NCT01928394|583584983|FG018|Treatment Period|Participant request to stop therapy|1|||
161599095|NCT01928394|583584984|FG019|Treatment Period|Participant request to stop therapy|1|||
161599096|NCT01928394|583584985|FG020|Treatment Period|Participant request to stop therapy|3|||
161599097|NCT01928394|583584986|FG021|Treatment Period|Participant request to stop therapy|1|||
161599098|NCT01928394|583584987|FG022|Treatment Period|Participant request to stop therapy|3|||
161599099|NCT01928394|583584965|FG000|Treatment Period|Participant withdrew consent|0|||
161599100|NCT01928394|583584966|FG001|Treatment Period|Participant withdrew consent|0|||
161599101|NCT01928394|583584967|FG002|Treatment Period|Participant withdrew consent|1|||
161599102|NCT01928394|583584968|FG003|Treatment Period|Participant withdrew consent|1|||
161599103|NCT01928394|583584969|FG004|Treatment Period|Participant withdrew consent|0|||
161599104|NCT01928394|583584970|FG005|Treatment Period|Participant withdrew consent|1|||
161599105|NCT01928394|583584971|FG006|Treatment Period|Participant withdrew consent|0|||
161599106|NCT01928394|583584972|FG007|Treatment Period|Participant withdrew consent|1|||
161599107|NCT01928394|583584973|FG008|Treatment Period|Participant withdrew consent|0|||
161599108|NCT01928394|583584974|FG009|Treatment Period|Participant withdrew consent|0|||
161599109|NCT01928394|583584975|FG010|Treatment Period|Participant withdrew consent|1|||
161599110|NCT01928394|583584976|FG011|Treatment Period|Participant withdrew consent|1|||
161599111|NCT01928394|583584977|FG012|Treatment Period|Participant withdrew consent|1|||
161599112|NCT01928394|583584978|FG013|Treatment Period|Participant withdrew consent|0|||
161599113|NCT01928394|583584979|FG014|Treatment Period|Participant withdrew consent|2|||
161599114|NCT01928394|583584980|FG015|Treatment Period|Participant withdrew consent|0|||
161599115|NCT01928394|583584981|FG016|Treatment Period|Participant withdrew consent|2|||
161599116|NCT01928394|583584982|FG017|Treatment Period|Participant withdrew consent|1|||
161599117|NCT01928394|583584983|FG018|Treatment Period|Participant withdrew consent|1|||
161599118|NCT01928394|583584984|FG019|Treatment Period|Participant withdrew consent|1|||
161599119|NCT01928394|583584985|FG020|Treatment Period|Participant withdrew consent|0|||
161599120|NCT01928394|583584986|FG021|Treatment Period|Participant withdrew consent|2|||
161599121|NCT01928394|583584987|FG022|Treatment Period|Participant withdrew consent|0|||
161599122|NCT01928394|583584965|FG000|Treatment Period|Poor/non-compliance|0|||
161599123|NCT01928394|583584966|FG001|Treatment Period|Poor/non-compliance|0|||
161599124|NCT01928394|583584967|FG002|Treatment Period|Poor/non-compliance|0|||
161599125|NCT01928394|583584968|FG003|Treatment Period|Poor/non-compliance|1|||
161599126|NCT01928394|583584969|FG004|Treatment Period|Poor/non-compliance|0|||
161599127|NCT01928394|583584970|FG005|Treatment Period|Poor/non-compliance|0|||
161599128|NCT01928394|583584971|FG006|Treatment Period|Poor/non-compliance|0|||
161599129|NCT01928394|583584972|FG007|Treatment Period|Poor/non-compliance|0|||
161599130|NCT01928394|583584973|FG008|Treatment Period|Poor/non-compliance|0|||
161599131|NCT01928394|583584974|FG009|Treatment Period|Poor/non-compliance|0|||
161599132|NCT01928394|583584975|FG010|Treatment Period|Poor/non-compliance|0|||
161599133|NCT01928394|583584976|FG011|Treatment Period|Poor/non-compliance|0|||
161599134|NCT01928394|583584977|FG012|Treatment Period|Poor/non-compliance|1|||
161599135|NCT01928394|583584978|FG013|Treatment Period|Poor/non-compliance|0|||
161599136|NCT01928394|583584979|FG014|Treatment Period|Poor/non-compliance|1|||
161599137|NCT01928394|583584980|FG015|Treatment Period|Poor/non-compliance|0|||
161599138|NCT01928394|583584981|FG016|Treatment Period|Poor/non-compliance|0|||
161599139|NCT01928394|583584982|FG017|Treatment Period|Poor/non-compliance|1|||
161599140|NCT01928394|583584983|FG018|Treatment Period|Poor/non-compliance|0|||
161599141|NCT01928394|583584984|FG019|Treatment Period|Poor/non-compliance|1|||
161599142|NCT01928394|583584985|FG020|Treatment Period|Poor/non-compliance|0|||
161599143|NCT01928394|583584986|FG021|Treatment Period|Poor/non-compliance|0|||
161599144|NCT01928394|583584987|FG022|Treatment Period|Poor/non-compliance|0|||
161599145|NCT01928394|583584965|FG000|Treatment Period|other reason|0|||
161599146|NCT01928394|583584966|FG001|Treatment Period|other reason|0|||
161599147|NCT01928394|583584967|FG002|Treatment Period|other reason|0|||
161599148|NCT01928394|583584968|FG003|Treatment Period|other reason|0|||
161599149|NCT01928394|583584969|FG004|Treatment Period|other reason|0|||
161599150|NCT01928394|583584970|FG005|Treatment Period|other reason|0|||
161599151|NCT01928394|583584971|FG006|Treatment Period|other reason|0|||
161599152|NCT01928394|583584972|FG007|Treatment Period|other reason|0|||
161599153|NCT01928394|583584973|FG008|Treatment Period|other reason|0|||
161599154|NCT01928394|583584974|FG009|Treatment Period|other reason|0|||
161599155|NCT01928394|583584975|FG010|Treatment Period|other reason|1|||
161599156|NCT01928394|583584976|FG011|Treatment Period|other reason|1|||
161599157|NCT01928394|583584977|FG012|Treatment Period|other reason|1|||
161599158|NCT01928394|583584978|FG013|Treatment Period|other reason|0|||
161599159|NCT01928394|583584979|FG014|Treatment Period|other reason|1|||
161599160|NCT01928394|583584980|FG015|Treatment Period|other reason|0|||
161599161|NCT01928394|583584981|FG016|Treatment Period|other reason|0|||
161599162|NCT01928394|583584982|FG017|Treatment Period|other reason|0|||
161599163|NCT01928394|583584983|FG018|Treatment Period|other reason|2|||
161599164|NCT01928394|583584984|FG019|Treatment Period|other reason|2|||
161599165|NCT01928394|583584985|FG020|Treatment Period|other reason|0|||
161599166|NCT01928394|583584986|FG021|Treatment Period|other reason|0|||
161599167|NCT01928394|583584987|FG022|Treatment Period|other reason|0|||
161599168|NCT01928394|583584965|FG000|Treatment Period|Maximum clinical benefit|0|||
161599169|NCT01928394|583584966|FG001|Treatment Period|Maximum clinical benefit|0|||
161599170|NCT01928394|583584967|FG002|Treatment Period|Maximum clinical benefit|0|||
161599171|NCT01928394|583584968|FG003|Treatment Period|Maximum clinical benefit|0|||
161599172|NCT01928394|583584969|FG004|Treatment Period|Maximum clinical benefit|0|||
161599173|NCT01928394|583584970|FG005|Treatment Period|Maximum clinical benefit|0|||
161599174|NCT01928394|583584971|FG006|Treatment Period|Maximum clinical benefit|0|||
161599175|NCT01928394|583584972|FG007|Treatment Period|Maximum clinical benefit|0|||
161599176|NCT01928394|583584973|FG008|Treatment Period|Maximum clinical benefit|0|||
161599177|NCT01928394|583584974|FG009|Treatment Period|Maximum clinical benefit|0|||
161599178|NCT01928394|583584975|FG010|Treatment Period|Maximum clinical benefit|1|||
161599179|NCT01928394|583584976|FG011|Treatment Period|Maximum clinical benefit|1|||
161599180|NCT01928394|583584977|FG012|Treatment Period|Maximum clinical benefit|0|||
161599181|NCT01928394|583584978|FG013|Treatment Period|Maximum clinical benefit|0|||
161599182|NCT01928394|583584979|FG014|Treatment Period|Maximum clinical benefit|1|||
161599183|NCT01928394|583584980|FG015|Treatment Period|Maximum clinical benefit|0|||
161599184|NCT01928394|583584981|FG016|Treatment Period|Maximum clinical benefit|0|||
161599185|NCT01928394|583584982|FG017|Treatment Period|Maximum clinical benefit|1|||
161599186|NCT01928394|583584983|FG018|Treatment Period|Maximum clinical benefit|1|||
161599187|NCT01928394|583584984|FG019|Treatment Period|Maximum clinical benefit|0|||
161599188|NCT01928394|583584985|FG020|Treatment Period|Maximum clinical benefit|2|||
161599189|NCT01928394|583584986|FG021|Treatment Period|Maximum clinical benefit|0|||
161599190|NCT01928394|583584987|FG022|Treatment Period|Maximum clinical benefit|0|||
161599191|NCT01928394|583584965|FG000|Treatment Period|Lost to Follow-up|0|||
161599192|NCT01928394|583584966|FG001|Treatment Period|Lost to Follow-up|0|||
161599193|NCT01928394|583584967|FG002|Treatment Period|Lost to Follow-up|0|||
161830591|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
161830592|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
161830593|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
161599194|NCT01928394|583584968|FG003|Treatment Period|Lost to Follow-up|0|||
161599195|NCT01928394|583584969|FG004|Treatment Period|Lost to Follow-up|0|||
161599196|NCT01928394|583584970|FG005|Treatment Period|Lost to Follow-up|0|||
161599197|NCT01928394|583584971|FG006|Treatment Period|Lost to Follow-up|0|||
161599198|NCT01928394|583584972|FG007|Treatment Period|Lost to Follow-up|0|||
161599199|NCT01928394|583584973|FG008|Treatment Period|Lost to Follow-up|0|||
161599200|NCT01928394|583584974|FG009|Treatment Period|Lost to Follow-up|0|||
161599201|NCT01928394|583584975|FG010|Treatment Period|Lost to Follow-up|0|||
161599202|NCT01928394|583584976|FG011|Treatment Period|Lost to Follow-up|0|||
161599203|NCT01928394|583584977|FG012|Treatment Period|Lost to Follow-up|0|||
161599204|NCT01928394|583584978|FG013|Treatment Period|Lost to Follow-up|0|||
161599205|NCT01928394|583584979|FG014|Treatment Period|Lost to Follow-up|0|||
161599206|NCT01928394|583584980|FG015|Treatment Period|Lost to Follow-up|0|||
161599207|NCT01928394|583584981|FG016|Treatment Period|Lost to Follow-up|0|||
161830594|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
161599208|NCT01928394|583584982|FG017|Treatment Period|Lost to Follow-up|0|||
161599209|NCT01928394|583584983|FG018|Treatment Period|Lost to Follow-up|0|||
161599210|NCT01928394|583584984|FG019|Treatment Period|Lost to Follow-up|0|||
161599211|NCT01928394|583584985|FG020|Treatment Period|Lost to Follow-up|0|||
161599212|NCT01928394|583584986|FG021|Treatment Period|Lost to Follow-up|0|||
161599213|NCT01928394|583584987|FG022|Treatment Period|Lost to Follow-up|1|||
161599214|NCT01928394|583584965|FG000|Treatment Period|Death|0|||
161599215|NCT01928394|583584966|FG001|Treatment Period|Death|0|||
161599216|NCT01928394|583584967|FG002|Treatment Period|Death|0|||
161599217|NCT01928394|583584968|FG003|Treatment Period|Death|0|||
161599218|NCT01928394|583584969|FG004|Treatment Period|Death|0|||
161599219|NCT01928394|583584970|FG005|Treatment Period|Death|0|||
161599220|NCT01928394|583584971|FG006|Treatment Period|Death|0|||
161599221|NCT01928394|583584972|FG007|Treatment Period|Death|0|||
161599222|NCT01928394|583584973|FG008|Treatment Period|Death|0|||
161599223|NCT01928394|583584974|FG009|Treatment Period|Death|0|||
161599224|NCT01928394|583584975|FG010|Treatment Period|Death|0|||
161599225|NCT01928394|583584976|FG011|Treatment Period|Death|0|||
161599226|NCT01928394|583584977|FG012|Treatment Period|Death|0|||
161599227|NCT01928394|583584978|FG013|Treatment Period|Death|1|||
161599228|NCT01928394|583584979|FG014|Treatment Period|Death|2|||
161599229|NCT01928394|583584980|FG015|Treatment Period|Death|0|||
161599230|NCT01928394|583584981|FG016|Treatment Period|Death|0|||
161599231|NCT01928394|583584982|FG017|Treatment Period|Death|0|||
161599232|NCT01928394|583584983|FG018|Treatment Period|Death|0|||
161599233|NCT01928394|583584984|FG019|Treatment Period|Death|0|||
161599234|NCT01928394|583584985|FG020|Treatment Period|Death|0|||
161599235|NCT01928394|583584986|FG021|Treatment Period|Death|0|||
161599236|NCT01928394|583584987|FG022|Treatment Period|Death|0|||
161599237|NCT01928394|583584965|FG000|Follow-up Period|Participant withdrew consent|3|||
161599238|NCT01928394|583584966|FG001|Follow-up Period|Participant withdrew consent|0|||
161599239|NCT01928394|583584967|FG002|Follow-up Period|Participant withdrew consent|1|||
161599240|NCT01928394|583584968|FG003|Follow-up Period|Participant withdrew consent|4|||
161599241|NCT01928394|583584969|FG004|Follow-up Period|Participant withdrew consent|0|||
161599242|NCT01928394|583584970|FG005|Follow-up Period|Participant withdrew consent|2|||
161599243|NCT01928394|583584971|FG006|Follow-up Period|Participant withdrew consent|5|||
161599244|NCT01928394|583584972|FG007|Follow-up Period|Participant withdrew consent|1|||
161599245|NCT01928394|583584973|FG008|Follow-up Period|Participant withdrew consent|0|||
161599246|NCT01928394|583584974|FG009|Follow-up Period|Participant withdrew consent|0|||
161599247|NCT01928394|583584975|FG010|Follow-up Period|Participant withdrew consent|5|||
161599248|NCT01928394|583584976|FG011|Follow-up Period|Participant withdrew consent|8|||
161599249|NCT01928394|583584977|FG012|Follow-up Period|Participant withdrew consent|2|||
161599250|NCT01928394|583584978|FG013|Follow-up Period|Participant withdrew consent|12|||
161599251|NCT01928394|583584979|FG014|Follow-up Period|Participant withdrew consent|7|||
161599252|NCT01928394|583584980|FG015|Follow-up Period|Participant withdrew consent|0|||
161599253|NCT01928394|583584981|FG016|Follow-up Period|Participant withdrew consent|5|||
161599254|NCT01928394|583584982|FG017|Follow-up Period|Participant withdrew consent|3|||
161599255|NCT01928394|583584983|FG018|Follow-up Period|Participant withdrew consent|2|||
161599256|NCT01928394|583584984|FG019|Follow-up Period|Participant withdrew consent|7|||
161599257|NCT01928394|583584985|FG020|Follow-up Period|Participant withdrew consent|4|||
161599258|NCT01928394|583584986|FG021|Follow-up Period|Participant withdrew consent|6|||
161599259|NCT01928394|583584987|FG022|Follow-up Period|Participant withdrew consent|2|||
161599260|NCT01928394|583584965|FG000|Follow-up Period|Death|0|||
161599261|NCT01928394|583584966|FG001|Follow-up Period|Death|0|||
161599262|NCT01928394|583584967|FG002|Follow-up Period|Death|2|||
161599263|NCT01928394|583584968|FG003|Follow-up Period|Death|6|||
161599264|NCT01928394|583584969|FG004|Follow-up Period|Death|0|||
161599265|NCT01928394|583584970|FG005|Follow-up Period|Death|6|||
161599266|NCT01928394|583584971|FG006|Follow-up Period|Death|6|||
161599267|NCT01928394|583584972|FG007|Follow-up Period|Death|2|||
161599268|NCT01928394|583584973|FG008|Follow-up Period|Death|1|||
161599269|NCT01928394|583584974|FG009|Follow-up Period|Death|2|||
161599270|NCT01928394|583584975|FG010|Follow-up Period|Death|4|||
161599271|NCT01928394|583584976|FG011|Follow-up Period|Death|12|||
161599272|NCT01928394|583584977|FG012|Follow-up Period|Death|11|||
161599273|NCT01928394|583584978|FG013|Follow-up Period|Death|25|||
161599274|NCT01928394|583584979|FG014|Follow-up Period|Death|18|||
161599275|NCT01928394|583584980|FG015|Follow-up Period|Death|0|||
161599276|NCT01928394|583584981|FG016|Follow-up Period|Death|6|||
161599277|NCT01928394|583584982|FG017|Follow-up Period|Death|5|||
161599278|NCT01928394|583584983|FG018|Follow-up Period|Death|13|||
161599279|NCT01928394|583584984|FG019|Follow-up Period|Death|13|||
161599280|NCT01928394|583584985|FG020|Follow-up Period|Death|5|||
161599281|NCT01928394|583584986|FG021|Follow-up Period|Death|3|||
161599282|NCT01928394|583584987|FG022|Follow-up Period|Death|2|||
161599283|NCT01928394|583584965|FG000|Follow-up Period|other reason|0|||
161599284|NCT01928394|583584966|FG001|Follow-up Period|other reason|0|||
161599285|NCT01928394|583584967|FG002|Follow-up Period|other reason|0|||
161599286|NCT01928394|583584968|FG003|Follow-up Period|other reason|0|||
161599287|NCT01928394|583584969|FG004|Follow-up Period|other reason|0|||
161599288|NCT01928394|583584970|FG005|Follow-up Period|other reason|0|||
161599289|NCT01928394|583584971|FG006|Follow-up Period|other reason|1|||
161599290|NCT01928394|583584972|FG007|Follow-up Period|other reason|3|||
161599291|NCT01928394|583584973|FG008|Follow-up Period|other reason|0|||
161599292|NCT01928394|583584974|FG009|Follow-up Period|other reason|0|||
161599293|NCT01928394|583584975|FG010|Follow-up Period|other reason|2|||
161599294|NCT01928394|583584976|FG011|Follow-up Period|other reason|1|||
161599295|NCT01928394|583584977|FG012|Follow-up Period|other reason|0|||
161599296|NCT01928394|583584978|FG013|Follow-up Period|other reason|1|||
161599297|NCT01928394|583584979|FG014|Follow-up Period|other reason|4|||
161599298|NCT01928394|583584980|FG015|Follow-up Period|other reason|0|||
161599299|NCT01928394|583584981|FG016|Follow-up Period|other reason|2|||
161599300|NCT01928394|583584982|FG017|Follow-up Period|other reason|0|||
161599301|NCT01928394|583584983|FG018|Follow-up Period|other reason|1|||
161599302|NCT01928394|583584984|FG019|Follow-up Period|other reason|1|||
161599303|NCT01928394|583584985|FG020|Follow-up Period|other reason|0|||
161599304|NCT01928394|583584986|FG021|Follow-up Period|other reason|0|||
161599305|NCT01928394|583584987|FG022|Follow-up Period|other reason|1|||
161599306|NCT01928394|583584965|FG000|Follow-up Period|Lost to Follow-up|0|||
161599307|NCT01928394|583584966|FG001|Follow-up Period|Lost to Follow-up|0|||
161599308|NCT01928394|583584967|FG002|Follow-up Period|Lost to Follow-up|0|||
161599309|NCT01928394|583584968|FG003|Follow-up Period|Lost to Follow-up|0|||
161599310|NCT01928394|583584969|FG004|Follow-up Period|Lost to Follow-up|0|||
161599311|NCT01928394|583584970|FG005|Follow-up Period|Lost to Follow-up|0|||
161599312|NCT01928394|583584971|FG006|Follow-up Period|Lost to Follow-up|0|||
161599313|NCT01928394|583584972|FG007|Follow-up Period|Lost to Follow-up|0|||
161599314|NCT01928394|583584973|FG008|Follow-up Period|Lost to Follow-up|0|||
161599315|NCT01928394|583584974|FG009|Follow-up Period|Lost to Follow-up|0|||
161599316|NCT01928394|583584975|FG010|Follow-up Period|Lost to Follow-up|0|||
161599317|NCT01928394|583584976|FG011|Follow-up Period|Lost to Follow-up|1|||
161599318|NCT01928394|583584977|FG012|Follow-up Period|Lost to Follow-up|1|||
161599319|NCT01928394|583584978|FG013|Follow-up Period|Lost to Follow-up|0|||
161599320|NCT01928394|583584979|FG014|Follow-up Period|Lost to Follow-up|1|||
161599321|NCT01928394|583584980|FG015|Follow-up Period|Lost to Follow-up|0|||
161599322|NCT01928394|583584981|FG016|Follow-up Period|Lost to Follow-up|1|||
161599323|NCT01928394|583584982|FG017|Follow-up Period|Lost to Follow-up|0|||
161599324|NCT01928394|583584983|FG018|Follow-up Period|Lost to Follow-up|0|||
161599325|NCT01928394|583584984|FG019|Follow-up Period|Lost to Follow-up|0|||
161599326|NCT01928394|583584985|FG020|Follow-up Period|Lost to Follow-up|0|||
161599327|NCT01928394|583584986|FG021|Follow-up Period|Lost to Follow-up|0|||
161599328|NCT01928394|583584987|FG022|Follow-up Period|Lost to Follow-up|1|||
161599329|NCT00321048|583584988|FG000|Overall Study|Withdrawal by Subject|6|||
161599330|NCT00321048|583584989|FG001|Overall Study|Withdrawal by Subject|8|||
161599331|NCT04707625|583584990|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
161599332|NCT02038777|583584991|FG000|Overall Study|Death|0|||
161599333|NCT02038777|583584992|FG001|Overall Study|Death|2|||
161599334|NCT02038777|583584993|FG002|Overall Study|Death|0|||
161599335|NCT02038777|583584994|FG003|Overall Study|Death|1|||
161599336|NCT02038777|583584995|FG004|Overall Study|Death|2|||
161599337|NCT02038777|583584996|FG005|Overall Study|Death|4|||
161599338|NCT02038777|583584997|FG006|Overall Study|Death|0|||
161599339|NCT02038777|583584998|FG007|Overall Study|Death|11|||
161599340|NCT02038777|583584991|FG000|Overall Study|Lost to Follow-up|0|||
161599341|NCT02038777|583584992|FG001|Overall Study|Lost to Follow-up|0|||
161599342|NCT02038777|583584993|FG002|Overall Study|Lost to Follow-up|0|||
161681805|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
161681806|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
161599343|NCT02038777|583584994|FG003|Overall Study|Lost to Follow-up|1|||
161599344|NCT02038777|583584995|FG004|Overall Study|Lost to Follow-up|0|||
161599345|NCT02038777|583584996|FG005|Overall Study|Lost to Follow-up|0|||
161599346|NCT02038777|583584997|FG006|Overall Study|Lost to Follow-up|0|||
161599347|NCT02038777|583584998|FG007|Overall Study|Lost to Follow-up|0|||
161599348|NCT02038777|583584991|FG000|Overall Study|Other|0|||
161599349|NCT02038777|583584992|FG001|Overall Study|Other|1|||
161599350|NCT02038777|583584993|FG002|Overall Study|Other|0|||
161599351|NCT02038777|583584994|FG003|Overall Study|Other|2|||
161599352|NCT02038777|583584995|FG004|Overall Study|Other|1|||
161599353|NCT02038777|583584996|FG005|Overall Study|Other|0|||
161681807|NCT05318937|583886252|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161599354|NCT02038777|583584997|FG006|Overall Study|Other|0|||
161599355|NCT02038777|583584998|FG007|Overall Study|Other|0|||
161599356|NCT02038777|583584991|FG000|Overall Study|Randomized but not treated|0|||
161599357|NCT02038777|583584992|FG001|Overall Study|Randomized but not treated|1|||
161599358|NCT02038777|583584993|FG002|Overall Study|Randomized but not treated|0|||
161599359|NCT02038777|583584994|FG003|Overall Study|Randomized but not treated|0|||
161599360|NCT02038777|583584995|FG004|Overall Study|Randomized but not treated|0|||
161599361|NCT02038777|583584996|FG005|Overall Study|Randomized but not treated|0|||
161599362|NCT02038777|583584997|FG006|Overall Study|Randomized but not treated|0|||
161599363|NCT02038777|583584998|FG007|Overall Study|Randomized but not treated|0|||
161599364|NCT02038777|583584991|FG000|Overall Study|Started Chemotherapy|1|||
161599365|NCT02038777|583584992|FG001|Overall Study|Started Chemotherapy|0|||
161599366|NCT02038777|583584993|FG002|Overall Study|Started Chemotherapy|3|||
161599367|NCT02038777|583584994|FG003|Overall Study|Started Chemotherapy|0|||
161599368|NCT02038777|583584995|FG004|Overall Study|Started Chemotherapy|0|||
161599369|NCT02038777|583584996|FG005|Overall Study|Started Chemotherapy|0|||
161599370|NCT02038777|583584997|FG006|Overall Study|Started Chemotherapy|0|||
161599371|NCT02038777|583584998|FG007|Overall Study|Started Chemotherapy|0|||
161599372|NCT02038777|583584991|FG000|Overall Study|participation terminated by sponsor|0|||
161599373|NCT02038777|583584992|FG001|Overall Study|participation terminated by sponsor|0|||
161599374|NCT02038777|583584993|FG002|Overall Study|participation terminated by sponsor|0|||
161599375|NCT02038777|583584994|FG003|Overall Study|participation terminated by sponsor|0|||
161599376|NCT02038777|583584995|FG004|Overall Study|participation terminated by sponsor|0|||
161599377|NCT02038777|583584996|FG005|Overall Study|participation terminated by sponsor|0|||
161599378|NCT02038777|583584997|FG006|Overall Study|participation terminated by sponsor|1|||
161599379|NCT02038777|583584998|FG007|Overall Study|participation terminated by sponsor|1|||
161599380|NCT03386578|583585001|FG000|PK Component|Lost to Follow-up|0|||
161599381|NCT03386578|583585002|FG001|PK Component|Lost to Follow-up|1|||
161599382|NCT03386578|583585003|FG002|PK Component|Lost to Follow-up|0|||
161599383|NCT03386578|583585004|FG003|PK Component|Lost to Follow-up|0|||
161599384|NCT03386578|583585005|FG004|PK Component|Lost to Follow-up|0|||
161599385|NCT03386578|583585006|FG005|PK Component|Lost to Follow-up|0|||
161599386|NCT03386578|583585007|FG006|PK Component|Lost to Follow-up|1|||
161599387|NCT03386578|583585008|FG007|PK Component|Lost to Follow-up|0|||
161599388|NCT03386578|583585009|FG008|PK Component|Lost to Follow-up|0|||
161599389|NCT03386578|583585010|FG009|PK Component|Lost to Follow-up|0|||
161599390|NCT03386578|583585001|FG000|PK Component|Stillbirth/Abortion|0|||
161599391|NCT03386578|583585002|FG001|PK Component|Stillbirth/Abortion|0|||
161599392|NCT03386578|583585003|FG002|PK Component|Stillbirth/Abortion|0|||
161599393|NCT03386578|583585004|FG003|PK Component|Stillbirth/Abortion|0|||
161599394|NCT03386578|583585005|FG004|PK Component|Stillbirth/Abortion|0|||
161599395|NCT03386578|583585006|FG005|PK Component|Stillbirth/Abortion|2|||
161599396|NCT03386578|583585007|FG006|PK Component|Stillbirth/Abortion|0|||
161599397|NCT03386578|583585008|FG007|PK Component|Stillbirth/Abortion|0|||
161599398|NCT03386578|583585009|FG008|PK Component|Stillbirth/Abortion|0|||
161599399|NCT03386578|583585010|FG009|PK Component|Stillbirth/Abortion|0|||
161599400|NCT03386578|583585001|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161599401|NCT03386578|583585002|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161599402|NCT03386578|583585003|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
161599403|NCT03386578|583585004|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
161599404|NCT03386578|583585005|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161599405|NCT03386578|583585006|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161599406|NCT03386578|583585007|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161599407|NCT03386578|583585008|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
161599408|NCT03386578|583585009|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
161599409|NCT03386578|583585010|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161599410|NCT03386578|583585001|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161599411|NCT03386578|583585002|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161599412|NCT03386578|583585003|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
161599413|NCT03386578|583585004|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
161599414|NCT03386578|583585005|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161599415|NCT03386578|583585006|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161599416|NCT03386578|583585007|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161599417|NCT03386578|583585008|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
161599418|NCT03386578|583585009|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
161599419|NCT03386578|583585010|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161599420|NCT03386578|583585001|FG000|PrEP Comparison Component Step 1|Death|0|||
161599421|NCT03386578|583585002|FG001|PrEP Comparison Component Step 1|Death|0|||
161599422|NCT03386578|583585003|FG002|PrEP Comparison Component Step 1|Death|1|||
161599423|NCT03386578|583585004|FG003|PrEP Comparison Component Step 1|Death|0|||
161599424|NCT03386578|583585005|FG004|PrEP Comparison Component Step 1|Death|0|||
161599425|NCT03386578|583585006|FG005|PrEP Comparison Component Step 1|Death|0|||
161599426|NCT03386578|583585007|FG006|PrEP Comparison Component Step 1|Death|0|||
161599427|NCT03386578|583585008|FG007|PrEP Comparison Component Step 1|Death|9|||
161599428|NCT03386578|583585009|FG008|PrEP Comparison Component Step 1|Death|5|||
161599429|NCT03386578|583585010|FG009|PrEP Comparison Component Step 1|Death|0|||
161599430|NCT03386578|583585001|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599431|NCT03386578|583585002|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599432|NCT03386578|583585003|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599433|NCT03386578|583585004|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
161599434|NCT03386578|583585005|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599435|NCT03386578|583585006|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599436|NCT03386578|583585007|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599437|NCT03386578|583585008|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599438|NCT03386578|583585009|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
161599439|NCT03386578|583585010|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161599440|NCT03386578|583585001|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599441|NCT03386578|583585002|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599442|NCT03386578|583585003|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599443|NCT03386578|583585004|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599444|NCT03386578|583585005|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599445|NCT03386578|583585006|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599446|NCT03386578|583585007|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599447|NCT03386578|583585008|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
161599448|NCT03386578|583585009|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
161599449|NCT03386578|583585010|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161599450|NCT03386578|583585001|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599451|NCT03386578|583585002|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599452|NCT03386578|583585003|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599453|NCT03386578|583585004|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599454|NCT03386578|583585005|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599455|NCT03386578|583585006|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599456|NCT03386578|583585007|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599457|NCT03386578|583585008|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
161599458|NCT03386578|583585009|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
161599459|NCT03386578|583585010|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161599460|NCT03209973|583585018|FG000|Overall Study|Withdrawal by Subject|7|||
161599461|NCT03209973|583585018|FG000|Overall Study|Lost to Follow-up|2|||
161599462|NCT03209973|583585018|FG000|Overall Study|Death|8|||
161599463|NCT03209973|583585018|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
161599464|NCT03209973|583585018|FG000|Overall Study|Sponsor Decision|18|||
161599465|NCT03209973|583585018|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
161599466|NCT03209973|583585018|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
161599467|NCT03987022|583585022|FG000|Overall Study|Lost to Follow-up|2|||
161599468|NCT03987022|583585023|FG001|Overall Study|Lost to Follow-up|2|||
161599469|NCT03987022|583585022|FG000|Overall Study|Withdrawal by Subject|1|||
161599470|NCT03987022|583585023|FG001|Overall Study|Withdrawal by Subject|0|||
161599471|NCT01627574|583585026|FG000|Overall Study|Withdrawal by Subject|8|||
161599472|NCT01627574|583585027|FG001|Overall Study|Withdrawal by Subject|5|||
161599473|NCT01627574|583585026|FG000|Overall Study|Lost to Follow-up|13|||
161599474|NCT01627574|583585027|FG001|Overall Study|Lost to Follow-up|13|||
161599475|NCT04730739|583585028|FG000|Overall Study|Death|1|||
161599476|NCT01346540|583585030|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
161599477|NCT01346540|583585031|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
161599478|NCT01346540|583585030|FG000|Overall Study|Adverse Event|0|||
161599479|NCT01346540|583585031|FG001|Overall Study|Adverse Event|4|||
161599480|NCT05863156|583585032|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
161599481|NCT05863156|583585033|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
161599482|NCT05863156|583585034|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
161599483|NCT03362476|583585035|FG000|Overall Study|Withdrawal by Subject|0|||
161599484|NCT03362476|583585036|FG001|Overall Study|Withdrawal by Subject|1|||
161599485|NCT05216406|583585039|FG000|Overall Study|Lost to Follow-up|8|||
161599486|NCT05216406|583585040|FG001|Overall Study|Lost to Follow-up|9|||
161599487|NCT04270942|583585041|FG000|Overall Study|Death|1|||
161599488|NCT04797195|583585047|FG000|Overall Study|Death|8|||
161599489|NCT04797195|583585048|FG001|Overall Study|Death|15|||
161599490|NCT04797195|583585047|FG000|Overall Study|Change from PD|15|||
161599491|NCT04797195|583585048|FG001|Overall Study|Change from PD|15|||
161599492|NCT04797195|583585047|FG000|Overall Study|Withdrawal by Subject|3|||
161830595|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
161830596|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
161830597|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
161830598|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
161599493|NCT04797195|583585048|FG001|Overall Study|Withdrawal by Subject|2|||
161599494|NCT01236781|583585049|FG000|Overall Study|Ineligible|2|||
161599495|NCT01236781|583585050|FG001|Overall Study|Ineligible|1|||
161681808|NCT05318937|583886253|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161681809|NCT05318937|583886252|FG000|Overall Study|Lost to Follow-up|0|||
161681810|NCT05318937|583886253|FG001|Overall Study|Lost to Follow-up|1|||
161681811|NCT05318937|583886252|FG000|Overall Study|Withdrawal by Subject|0|||
161830599|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Adverse Event|0|||
161599496|NCT01236781|583585049|FG000|Overall Study|Did not complete study imaging|5|||
161599497|NCT01236781|583585050|FG001|Overall Study|Did not complete study imaging|0|||
161599498|NCT04862416|583585053|FG000|Overall Study|Withdrawal by Subject|0|||
161599499|NCT04862416|583585054|FG001|Overall Study|Withdrawal by Subject|1|||
161599500|NCT04862416|583585055|FG002|Overall Study|Withdrawal by Subject|0|||
161599501|NCT04862416|583585056|FG003|Overall Study|Withdrawal by Subject|1|||
161599502|NCT04862416|583585057|FG004|Overall Study|Withdrawal by Subject|0|||
161599503|NCT04862416|583585058|FG005|Overall Study|Withdrawal by Subject|0|||
161599504|NCT04862416|583585059|FG006|Overall Study|Withdrawal by Subject|0|||
161599505|NCT04862416|583585060|FG007|Overall Study|Withdrawal by Subject|0|||
161599506|NCT04059185|583585063|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
161599507|NCT04059185|583585064|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
161599508|NCT04059185|583585065|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
161599509|NCT04059185|583585063|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
161599510|NCT04059185|583585064|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
161599511|NCT04059185|583585065|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
161599512|NCT04059185|583585063|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
161599513|NCT04059185|583585064|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
161599514|NCT04059185|583585065|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
161599515|NCT04059185|583585063|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
161599516|NCT04059185|583585064|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
161599517|NCT04059185|583585065|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
161599518|NCT04059185|583585063|FG000|Longitudinal Assessment-Adults Only|Death|4|||
161599519|NCT04059185|583585064|FG001|Longitudinal Assessment-Adults Only|Death|4|||
161599520|NCT04059185|583585065|FG002|Longitudinal Assessment-Adults Only|Death|3|||
161599521|NCT04587453|583585079|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
161599522|NCT04587453|583585080|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
161599523|NCT03571581|583585081|FG000|Overall Study|Death|2|||
161599524|NCT03571581|583585081|FG000|Overall Study|Withdrawal by Subject|2|||
161599525|NCT01309672|583585082|FG000|Overall Study|Lack of Efficacy|20|||
161599526|NCT01309672|583585082|FG000|Overall Study|Other|9|||
161599527|NCT01309672|583585082|FG000|Overall Study|Adverse Event|5|||
161599528|NCT01309672|583585082|FG000|Overall Study|Withdrawal by Subject|3|||
161599529|NCT04499924|583586647|FG000|Overall Study|Study termination by sponsor|4|||
161599530|NCT04499924|583586648|FG001|Overall Study|Study termination by sponsor|6|||
161599531|NCT04499924|583586647|FG000|Overall Study|Withdrawal by Subject|1|||
161599532|NCT04499924|583586648|FG001|Overall Study|Withdrawal by Subject|3|||
161599533|NCT03011333|583586649|FG000|Overall Study|Lost to Follow-up|0|||
161599534|NCT03011333|583586650|FG001|Overall Study|Lost to Follow-up|1|||
161599535|NCT03011333|583586651|FG002|Overall Study|Lost to Follow-up|0|||
161599536|NCT03011333|583586652|FG003|Overall Study|Lost to Follow-up|1|||
161599537|NCT03011333|583586653|FG004|Overall Study|Lost to Follow-up|4|||
161599538|NCT03011333|583586654|FG005|Overall Study|Lost to Follow-up|4|||
161599539|NCT03011333|583586655|FG006|Overall Study|Lost to Follow-up|5|||
161599540|NCT03663569|583586656|FG000|Overall Study|Discontinuation of study|11|||
161599541|NCT03663569|583586656|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
161599542|NCT03663569|583586656|FG000|Overall Study|Deceased patient|6|||
161599543|NCT03663569|583586656|FG000|Overall Study|Lost to Follow-up|18|||
161599544|NCT03663569|583586656|FG000|Overall Study|Withdrawal of consent|5|||
161599545|NCT03663569|583586656|FG000|Overall Study|Patient's request|11|||
161599546|NCT03663569|583586656|FG000|Overall Study|Adverse Event|4|||
161599547|NCT03663569|583586656|FG000|Overall Study|Not come to second visit|3|||
161599548|NCT03663569|583586656|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
161599549|NCT03663569|583586656|FG000|Overall Study|Serious adverse event|1|||
161599550|NCT04183283|583586657|FG000|Period 1|Withdrawal by Subject|0|||
161599551|NCT04183283|583586658|FG001|Period 1|Withdrawal by Subject|1|||
161599552|NCT04183283|583586659|FG002|Period 1|Withdrawal by Subject|0|||
161599553|NCT04183283|583586660|FG003|Period 1|Withdrawal by Subject|0|||
161599554|NCT04183283|583586657|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
161599555|NCT04183283|583586658|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
161599556|NCT04183283|583586659|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
161599557|NCT04183283|583586660|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
161599558|NCT00696111|583586674|FG000|Overall Study|Withdrawal by Subject|17|||
161599559|NCT04909801|583586683|FG000|Overall Study|Lack of Efficacy|2|||
161599560|NCT04909801|583586684|FG001|Overall Study|Lack of Efficacy|1|||
161599561|NCT04909801|583586683|FG000|Overall Study|Adverse Event|1|||
161599562|NCT04909801|583586684|FG001|Overall Study|Adverse Event|2|||
161599563|NCT04909801|583586683|FG000|Overall Study|Participant request to discontinue study treatment|1|||
161599564|NCT04909801|583586684|FG001|Overall Study|Participant request to discontinue study treatment|2|||
161599565|NCT04909801|583586683|FG000|Overall Study|Withdrawal by Subject|2|||
161599566|NCT04909801|583586684|FG001|Overall Study|Withdrawal by Subject|1|||
161599567|NCT04909801|583586683|FG000|Overall Study|other reasons|1|||
161599568|NCT04909801|583586684|FG001|Overall Study|other reasons|1|||
161599569|NCT05274074|583586685|FG000|Overall Study|Lost to Follow-up|2|||
161599570|NCT05274074|583586686|FG001|Overall Study|Lost to Follow-up|3|||
161599571|NCT05274074|583586685|FG000|Overall Study|Withdrawal by Subject|1|||
161599572|NCT05274074|583586686|FG001|Overall Study|Withdrawal by Subject|2|||
161599573|NCT04117347|583586687|FG000|Overall Study|Adverse Event|0|||
161599574|NCT04117347|583586688|FG001|Overall Study|Adverse Event|0|||
161599575|NCT04117347|583586689|FG002|Overall Study|Adverse Event|1|||
161599576|NCT04117347|583586687|FG000|Overall Study|No time for study|0|||
161599577|NCT04117347|583586688|FG001|Overall Study|No time for study|2|||
161599578|NCT04117347|583586689|FG002|Overall Study|No time for study|0|||
161599579|NCT04117347|583586687|FG000|Overall Study|Family emergency|1|||
161599580|NCT04117347|583586688|FG001|Overall Study|Family emergency|0|||
161599581|NCT04117347|583586689|FG002|Overall Study|Family emergency|0|||
161599582|NCT05194956|583586690|FG000|Washout Period|Withdrawal by Subject|0|||
161599583|NCT05194956|583586691|FG001|Washout Period|Withdrawal by Subject|2|||
161599584|NCT03687086|583586692|FG000|Overall Study|Withdrawal by Subject|3|||
161599585|NCT03687086|583586693|FG001|Overall Study|Withdrawal by Subject|4|||
161599586|NCT03687086|583586692|FG000|Overall Study|Lost to Follow-up|1|||
161599587|NCT03687086|583586693|FG001|Overall Study|Lost to Follow-up|1|||
161599588|NCT03687086|583586692|FG000|Overall Study|Death|1|||
161599589|NCT03687086|583586693|FG001|Overall Study|Death|0|||
161599590|NCT03687086|583586692|FG000|Overall Study|Incomplete assessment|0|||
161599591|NCT03687086|583586693|FG001|Overall Study|Incomplete assessment|2|||
161599592|NCT05485779|583586696|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599593|NCT05485779|583586697|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599594|NCT05485779|583586698|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599595|NCT05485779|583586699|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599596|NCT05485779|583586700|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599597|NCT05485779|583586701|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599598|NCT05485779|583586702|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599599|NCT05485779|583586703|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
161599600|NCT05485779|583586704|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
161599601|NCT05485779|583586705|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599602|NCT05485779|583586706|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
161599603|NCT05485779|583586696|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599604|NCT05485779|583586697|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599605|NCT05485779|583586698|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599606|NCT05485779|583586699|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599607|NCT05485779|583586700|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599608|NCT05485779|583586701|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599609|NCT05485779|583586702|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599610|NCT05485779|583586703|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599611|NCT05485779|583586704|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599612|NCT05485779|583586705|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
161599613|NCT05485779|583586706|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
161599614|NCT05485779|583586696|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599615|NCT05485779|583586697|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599616|NCT05485779|583586698|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599617|NCT05485779|583586699|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
161599618|NCT05485779|583586700|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599619|NCT05485779|583586701|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599620|NCT05485779|583586702|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599621|NCT05485779|583586703|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599622|NCT05485779|583586704|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599623|NCT05485779|583586705|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599624|NCT05485779|583586706|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161599625|NCT03676192|583586707|FG000|Induction Study Period|Adverse Event|21|||
161599626|NCT03676192|583586708|FG001|Induction Study Period|Adverse Event|20|||
161599627|NCT03676192|583586707|FG000|Induction Study Period|Death|23|||
161599628|NCT03676192|583586708|FG001|Induction Study Period|Death|20|||
161599629|NCT03676192|583586707|FG000|Induction Study Period|Lost to Follow-up|3|||
161599630|NCT03676192|583586708|FG001|Induction Study Period|Lost to Follow-up|3|||
161599631|NCT03676192|583586707|FG000|Induction Study Period|Physician Decision|6|||
161599632|NCT03676192|583586708|FG001|Induction Study Period|Physician Decision|3|||
161599633|NCT03676192|583586707|FG000|Induction Study Period|Progressive Disease|32|||
161599634|NCT03676192|583586708|FG001|Induction Study Period|Progressive Disease|21|||
161599635|NCT03676192|583586707|FG000|Induction Study Period|Protocol Violation|1|||
161599636|NCT03676192|583586708|FG001|Induction Study Period|Protocol Violation|2|||
161599637|NCT03676192|583586707|FG000|Induction Study Period|Withdrawal by Subject|20|||
161599638|NCT03676192|583586708|FG001|Induction Study Period|Withdrawal by Subject|15|||
161599639|NCT01868997|583586710|FG000|Overall Study|Adverse Event|2|||
161599640|NCT01868997|583586711|FG001|Overall Study|Adverse Event|5|||
161599641|NCT01868997|583586710|FG000|Overall Study|Lack of Efficacy|2|||
161599642|NCT01868997|583586711|FG001|Overall Study|Lack of Efficacy|0|||
161599643|NCT01868997|583586710|FG000|Overall Study|Other|3|||
161599644|NCT01868997|583586711|FG001|Overall Study|Other|1|||
161599645|NCT04971109|583586712|FG000|Overall Study|Adverse Event|4|||
161599646|NCT04971109|583586713|FG001|Overall Study|Adverse Event|3|||
161599647|NCT04971109|583586712|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
161599648|NCT04971109|583586713|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
161599649|NCT04971109|583586712|FG000|Overall Study|Lost to Follow-up|8|||
161599650|NCT04971109|583586713|FG001|Overall Study|Lost to Follow-up|2|||
161599651|NCT04971109|583586712|FG000|Overall Study|Physician Decision|5|||
161599652|NCT04971109|583586713|FG001|Overall Study|Physician Decision|0|||
161599653|NCT04971109|583586712|FG000|Overall Study|Protocol Violation|0|||
161599654|NCT04971109|583586713|FG001|Overall Study|Protocol Violation|1|||
161599655|NCT04971109|583586712|FG000|Overall Study|Withdrawal by Subject|18|||
161599656|NCT04971109|583586713|FG001|Overall Study|Withdrawal by Subject|3|||
161599657|NCT04971109|583586712|FG000|Overall Study|Subject was randomized in error|1|||
161599658|NCT04971109|583586713|FG001|Overall Study|Subject was randomized in error|0|||
161599659|NCT03308877|583586716|FG000|Overall Study|Lost to Follow-up|32|||
161599660|NCT03308877|583586717|FG001|Overall Study|Lost to Follow-up|28|||
161599661|NCT03249090|583586727|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
161599662|NCT03249090|583586728|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
161599663|NCT03249090|583586727|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
161599664|NCT03249090|583586728|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
161599665|NCT03249090|583586727|FG000|3 Month Time Point|Voluntary withdrawal|6|||
161599666|NCT03249090|583586728|FG001|3 Month Time Point|Voluntary withdrawal|3|||
161599667|NCT03249090|583586727|FG000|3 Month Time Point|Changed oncology practice|4|||
161599668|NCT03249090|583586728|FG001|3 Month Time Point|Changed oncology practice|2|||
161599669|NCT03249090|583586727|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
161599670|NCT03249090|583586728|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
161599671|NCT03249090|583586727|FG000|12 Month Time Point|Voluntary withdrawal|35|||
161599672|NCT03249090|583586728|FG001|12 Month Time Point|Voluntary withdrawal|4|||
161599673|NCT03249090|583586727|FG000|12 Month Time Point|Changed oncology practice|20|||
161599674|NCT03249090|583586728|FG001|12 Month Time Point|Changed oncology practice|9|||
161599675|NCT05646355|583586739|FG000|Overall Study|Lost to Follow-up|1|||
161599676|NCT05646355|583586740|FG001|Overall Study|Lost to Follow-up|0|||
161599677|NCT05646355|583586739|FG000|Overall Study|translated materials not available for pilot|2|||
161599678|NCT05646355|583586740|FG001|Overall Study|translated materials not available for pilot|0|||
161599679|NCT05646355|583586739|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
161599680|NCT05646355|583586740|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
161599681|NCT04577963|583586741|FG000|Part 2|Death|0|||
161599682|NCT04577963|583586742|FG001|Part 2|Death|1|||
161599683|NCT04577963|583586743|FG002|Part 2|Death|8|||
161599684|NCT04577963|583586744|FG003|Part 2|Death|0|||
161599685|NCT04577963|583586745|FG004|Part 2|Death|20|||
161599686|NCT04577963|583586741|FG000|Part 2|Lost to Follow-up|0|||
161599687|NCT04577963|583586742|FG001|Part 2|Lost to Follow-up|0|||
161599688|NCT04577963|583586743|FG002|Part 2|Lost to Follow-up|0|||
161599689|NCT04577963|583586744|FG003|Part 2|Lost to Follow-up|0|||
161599690|NCT04577963|583586745|FG004|Part 2|Lost to Follow-up|2|||
161599691|NCT04577963|583586741|FG000|Part 2|Withdrawal by Subject|0|||
161599692|NCT04577963|583586742|FG001|Part 2|Withdrawal by Subject|0|||
161599693|NCT04577963|583586743|FG002|Part 2|Withdrawal by Subject|0|||
161599694|NCT04577963|583586744|FG003|Part 2|Withdrawal by Subject|0|||
161599695|NCT04577963|583586745|FG004|Part 2|Withdrawal by Subject|10|||
161599696|NCT04577963|583586741|FG000|Part 2|Progressive disease|0|||
161599697|NCT04577963|583586742|FG001|Part 2|Progressive disease|0|||
161599698|NCT04577963|583586743|FG002|Part 2|Progressive disease|0|||
161599699|NCT04577963|583586744|FG003|Part 2|Progressive disease|0|||
161599700|NCT04577963|583586745|FG004|Part 2|Progressive disease|2|||
161599701|NCT04577963|583586741|FG000|Part 2|Investigator decision|0|||
161599702|NCT04577963|583586742|FG001|Part 2|Investigator decision|0|||
161599703|NCT04577963|583586743|FG002|Part 2|Investigator decision|0|||
161599704|NCT04577963|583586744|FG003|Part 2|Investigator decision|0|||
161599705|NCT04577963|583586745|FG004|Part 2|Investigator decision|1|||
161599706|NCT04577963|583586741|FG000|Part 2|Sponsor terminated study|0|||
161599707|NCT04577963|583586742|FG001|Part 2|Sponsor terminated study|0|||
161599708|NCT04577963|583586743|FG002|Part 2|Sponsor terminated study|3|||
161599709|NCT04577963|583586744|FG003|Part 2|Sponsor terminated study|1|||
161599710|NCT04577963|583586745|FG004|Part 2|Sponsor terminated study|4|||
161599711|NCT02709161|583586748|FG000|Overall Study|Withdrawal by Subject|1|||
161599712|NCT02709161|583586749|FG001|Overall Study|Withdrawal by Subject|0|||
161599713|NCT00746096|583586753|FG000|Overall Study|Adverse Event|1|||
161599714|NCT00746096|583586754|FG001|Overall Study|Adverse Event|0|||
161599715|NCT00746096|583586753|FG000|Overall Study|Withdrawal by Subject|5|||
161599716|NCT00746096|583586754|FG001|Overall Study|Withdrawal by Subject|1|||
161599717|NCT00746096|583586753|FG000|Overall Study|Lost to Follow-up|2|||
161599718|NCT00746096|583586754|FG001|Overall Study|Lost to Follow-up|1|||
161599719|NCT00746096|583586753|FG000|Overall Study|Protocol Violation|1|||
161599720|NCT00746096|583586754|FG001|Overall Study|Protocol Violation|0|||
161599721|NCT00746096|583586753|FG000|Overall Study|No study drug treatment|1|||
161599722|NCT00746096|583586754|FG001|Overall Study|No study drug treatment|1|||
161599723|NCT01009788|583586760|FG000|Overall Study|Withdrawal by Subject|1|||
161599724|NCT01009788|583586761|FG001|Overall Study|Withdrawal by Subject|0|||
161599725|NCT01254864|583586763|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
161599726|NCT01254864|583586764|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
161599727|NCT01254864|583586765|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
161599728|NCT01254864|583586763|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
161599729|NCT01254864|583586764|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
161599730|NCT01254864|583586765|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
161599731|NCT01254864|583586763|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
161599732|NCT01254864|583586764|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
161599733|NCT01254864|583586765|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
161599734|NCT01254864|583586763|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
161599735|NCT01254864|583586764|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
161599736|NCT01254864|583586765|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
161599737|NCT01254864|583586763|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
161599738|NCT01254864|583586764|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
161599739|NCT01254864|583586765|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
161599740|NCT01254864|583586763|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
161599741|NCT01254864|583586764|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
161599742|NCT01254864|583586765|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
161599743|NCT01254864|583586763|FG000|Randomization Phase|Adverse Event|0|||
161599744|NCT01254864|583586764|FG001|Randomization Phase|Adverse Event|5|||
161599745|NCT01254864|583586765|FG002|Randomization Phase|Adverse Event|17|||
161599746|NCT01254864|583586763|FG000|Randomization Phase|Death|0|||
161599747|NCT01254864|583586764|FG001|Randomization Phase|Death|1|||
161599748|NCT01254864|583586765|FG002|Randomization Phase|Death|0|||
161599749|NCT01254864|583586763|FG000|Randomization Phase|Lost to Follow-up|0|||
161599750|NCT01254864|583586764|FG001|Randomization Phase|Lost to Follow-up|0|||
161599751|NCT01254864|583586765|FG002|Randomization Phase|Lost to Follow-up|1|||
161599752|NCT01254864|583586763|FG000|Randomization Phase|Physician Decision|0|||
161599753|NCT01254864|583586764|FG001|Randomization Phase|Physician Decision|20|||
161599754|NCT01254864|583586765|FG002|Randomization Phase|Physician Decision|25|||
161599755|NCT01254864|583586763|FG000|Randomization Phase|Withdrawal by Subject|0|||
161599756|NCT01254864|583586764|FG001|Randomization Phase|Withdrawal by Subject|4|||
161599757|NCT01254864|583586765|FG002|Randomization Phase|Withdrawal by Subject|2|||
161599758|NCT01254864|583586763|FG000|Randomization Phase|Non-Compliance|0|||
161599759|NCT01254864|583586764|FG001|Randomization Phase|Non-Compliance|1|||
161599760|NCT01254864|583586765|FG002|Randomization Phase|Non-Compliance|0|||
161599761|NCT01254864|583586763|FG000|Randomization Phase|Comorbidities|0|||
161599762|NCT01254864|583586764|FG001|Randomization Phase|Comorbidities|2|||
161599763|NCT01254864|583586765|FG002|Randomization Phase|Comorbidities|1|||
161599764|NCT04141891|583586767|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
161599765|NCT04141891|583586768|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
161599766|NCT04141891|583586767|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
161599767|NCT04141891|583586768|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
161599768|NCT04141891|583586767|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
161599769|NCT04141891|583586768|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
161599770|NCT04141891|583586767|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
161599771|NCT04141891|583586768|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
161599772|NCT04141891|583586767|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
161599773|NCT04141891|583586768|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
161599774|NCT04141891|583586767|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
161599775|NCT04141891|583586768|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
161599776|NCT04141891|583586767|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
161599777|NCT04141891|583586768|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
161599778|NCT04141891|583586767|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
161599779|NCT04141891|583586768|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
161599780|NCT04141891|583586767|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
161599781|NCT04141891|583586768|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
161599782|NCT04141891|583586767|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
161599783|NCT04141891|583586768|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
161599784|NCT04141891|583586767|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
161599785|NCT04141891|583586768|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
161599786|NCT04141891|583586767|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
161599787|NCT04141891|583586768|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
161599788|NCT04141891|583586767|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
161599789|NCT04141891|583586768|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
161599790|NCT04141891|583586767|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
161599791|NCT04141891|583586768|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
161599792|NCT03295721|583586769|FG000|Overall Study|Adverse Event|1|||
161599793|NCT03295721|583586770|FG001|Overall Study|Adverse Event|0|||
161599794|NCT03295721|583586771|FG002|Overall Study|Adverse Event|0|||
161599795|NCT03295721|583586769|FG000|Overall Study|Lost to Follow-up|1|||
161599796|NCT03295721|583586770|FG001|Overall Study|Lost to Follow-up|1|||
161599797|NCT03295721|583586771|FG002|Overall Study|Lost to Follow-up|1|||
161599798|NCT03295721|583586769|FG000|Overall Study|Withdrawal by Subject|1|||
161599799|NCT03295721|583586770|FG001|Overall Study|Withdrawal by Subject|0|||
161599800|NCT03295721|583586771|FG002|Overall Study|Withdrawal by Subject|1|||
161599801|NCT03295721|583586769|FG000|Overall Study|Death|0|||
161599802|NCT03295721|583586770|FG001|Overall Study|Death|0|||
161599803|NCT03295721|583586771|FG002|Overall Study|Death|1|||
161599804|NCT01651403|583586777|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
161599805|NCT01651403|583586778|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
161599806|NCT01651403|583586777|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
161599807|NCT01651403|583586778|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
161599808|NCT01651403|583586777|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
161599809|NCT01651403|583586778|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
161599810|NCT01651403|583586777|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
161599811|NCT01651403|583586778|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
161599812|NCT01651403|583586777|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
161599813|NCT01651403|583586778|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
161599814|NCT01651403|583586777|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
161599815|NCT01651403|583586778|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
161599816|NCT05090683|583586779|FG000|Overall Study|Lost to Follow-up|10|||
161599817|NCT05090683|583586780|FG001|Overall Study|Lost to Follow-up|2|||
161599818|NCT05090683|583586779|FG000|Overall Study|Withdrawal by Subject|15|||
161599819|NCT05090683|583586780|FG001|Overall Study|Withdrawal by Subject|0|||
161599820|NCT03325985|583586781|FG000|Overall Study|Lost to Follow-up|122|||
161599821|NCT03325985|583586782|FG001|Overall Study|Lost to Follow-up|26|||
161599822|NCT03325985|583586783|FG002|Overall Study|Lost to Follow-up|141|||
161599823|NCT03325985|583586784|FG003|Overall Study|Lost to Follow-up|28|||
161599824|NCT03325985|583586781|FG000|Overall Study|Death|99|||
161599825|NCT03325985|583586782|FG001|Overall Study|Death|36|||
161599826|NCT03325985|583586783|FG002|Overall Study|Death|94|||
161599827|NCT03325985|583586784|FG003|Overall Study|Death|32|||
161599828|NCT03213665|583586785|FG000|Overall Study|Adverse Event|1|||
161599829|NCT03213665|583586785|FG000|Overall Study|Physician Decision|2|||
161599830|NCT03213665|583586785|FG000|Overall Study|Withdrawal by Subject|3|||
161599831|NCT03213665|583586785|FG000|Overall Study|Progressive Disease|13|||
161599832|NCT03034356|583586786|FG000|Baseline|Lost to Follow-up|2|||
161599833|NCT03034356|583586787|FG001|Baseline|Lost to Follow-up|4|||
161599834|NCT03034356|583586786|FG000|Baseline|Withdrawal by Subject|2|||
161599835|NCT03034356|583586787|FG001|Baseline|Withdrawal by Subject|0|||
161599836|NCT03034356|583586786|FG000|Baseline|Physician Decision|0|||
161599837|NCT03034356|583586787|FG001|Baseline|Physician Decision|1|||
161599838|NCT03034356|583586786|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
161599839|NCT03034356|583586787|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
161599840|NCT03034356|583586786|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
161599841|NCT03034356|583586787|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
161599842|NCT03034356|583586786|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
161599843|NCT03034356|583586787|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
161599844|NCT03034356|583586786|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
161599845|NCT03034356|583586787|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
161599846|NCT02684227|583586788|FG000|Overall Study|Adverse Event|1|||
161599847|NCT02684227|583586789|FG001|Overall Study|Adverse Event|7|||
161599848|NCT02684227|583586788|FG000|Overall Study|Death|0|||
161599849|NCT02684227|583586789|FG001|Overall Study|Death|2|||
161599850|NCT02684227|583586788|FG000|Overall Study|Withdrawal by Subject|0|||
161599851|NCT02684227|583586789|FG001|Overall Study|Withdrawal by Subject|1|||
161599852|NCT02684227|583586788|FG000|Overall Study|Progressive Disease|0|||
161599853|NCT02684227|583586789|FG001|Overall Study|Progressive Disease|2|||
161599854|NCT04571619|583586792|FG000|Phase 1|Death|22|||
161599855|NCT04571619|583586793|FG001|Phase 1|Death|18|||
161599856|NCT04571619|583586792|FG000|Phase 1|Withdrawal by Subject|7|||
161599857|NCT04571619|583586793|FG001|Phase 1|Withdrawal by Subject|2|||
161599858|NCT04571619|583586792|FG000|Phase 2|Death|13|||
161599859|NCT04571619|583586793|FG001|Phase 2|Death|16|||
161599860|NCT04571619|583586792|FG000|Phase 2|Withdrawal by Subject|6|||
161599861|NCT04571619|583586793|FG001|Phase 2|Withdrawal by Subject|4|||
161599862|NCT04479761|583586796|FG000|Overall Study|could not perform the balance tasks|1|||
161599863|NCT04479761|583586797|FG001|Overall Study|could not perform the balance tasks|0|||
161599864|NCT04479761|583586798|FG002|Overall Study|could not perform the balance tasks|0|||
161599865|NCT04479761|583586796|FG000|Overall Study|Adverse Event|1|||
161599866|NCT04479761|583586797|FG001|Overall Study|Adverse Event|0|||
161599867|NCT04479761|583586798|FG002|Overall Study|Adverse Event|0|||
161599868|NCT04479761|583586796|FG000|Overall Study|one control did not meet screening criteria|0|||
161599869|NCT04479761|583586797|FG001|Overall Study|one control did not meet screening criteria|0|||
161599870|NCT04479761|583586798|FG002|Overall Study|one control did not meet screening criteria|1|||
161599871|NCT04479761|583586796|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
161599872|NCT04479761|583586797|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
161599873|NCT04479761|583586798|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
161599874|NCT05309291|583586799|FG000|Overall Study|Adverse Event|0|||
161599875|NCT05309291|583586800|FG001|Overall Study|Adverse Event|1|||
161599876|NCT05809453|583588691|FG000|Overall Study|Withdrawal by Subject|1|||
161681812|NCT05318937|583886253|FG001|Overall Study|Withdrawal by Subject|2|||
161681813|NCT05318937|583886252|FG000|Overall Study|Protocol Violation|0|||
161681814|NCT05318937|583886253|FG001|Overall Study|Protocol Violation|1|||
161681815|NCT04722042|583886254|FG000|Overall Study|Withdrawal by Subject|2|||
161681816|NCT04722042|583886255|FG001|Overall Study|Withdrawal by Subject|1|||
161681817|NCT04722042|583886256|FG002|Overall Study|Withdrawal by Subject|0|||
161681818|NCT01877915|583886264|FG000|Overall Study|Lost to Follow-up|10|||
161681819|NCT01877915|583886265|FG001|Overall Study|Lost to Follow-up|9|||
161681820|NCT01877915|583886264|FG000|Overall Study|Withdrawal by Subject|42|||
161681821|NCT01877915|583886265|FG001|Overall Study|Withdrawal by Subject|55|||
161681822|NCT01877915|583886264|FG000|Overall Study|Other|2|||
161681823|NCT01877915|583886265|FG001|Overall Study|Other|4|||
161681824|NCT01045798|583886270|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
161681825|NCT01045798|583886271|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
161681826|NCT01045798|583886270|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
161681827|NCT01045798|583886271|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
161681828|NCT01045798|583886270|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
161681829|NCT01045798|583886271|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
161681830|NCT01045798|583886270|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
161599877|NCT05809453|583588692|FG001|Overall Study|Withdrawal by Subject|0|||
161599878|NCT05809453|583588693|FG002|Overall Study|Withdrawal by Subject|0|||
161599879|NCT05809453|583588694|FG003|Overall Study|Withdrawal by Subject|0|||
161681831|NCT01045798|583886271|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
161681832|NCT01449461|583886272|FG000|Overall Study|Adverse Event|0|||
161681833|NCT01449461|583886273|FG001|Overall Study|Adverse Event|3|||
161599880|NCT02424617|583588695|FG000|Overall Study|Adverse Event|0|||
161599881|NCT02424617|583588696|FG001|Overall Study|Adverse Event|1|||
161599882|NCT02424617|583588697|FG002|Overall Study|Adverse Event|0|||
161599883|NCT02424617|583588698|FG003|Overall Study|Adverse Event|0|||
161599884|NCT02424617|583588695|FG000|Overall Study|Investigator Decision|0|||
161599885|NCT02424617|583588696|FG001|Overall Study|Investigator Decision|0|||
161681834|NCT01449461|583886274|FG002|Overall Study|Adverse Event|2|||
161681835|NCT01449461|583886275|FG003|Overall Study|Adverse Event|3|||
161681836|NCT01449461|583886276|FG004|Overall Study|Adverse Event|4|||
161599886|NCT02424617|583588697|FG002|Overall Study|Investigator Decision|0|||
161599887|NCT02424617|583588698|FG003|Overall Study|Investigator Decision|1|||
161681837|NCT01449461|583886277|FG005|Overall Study|Adverse Event|4|||
161681838|NCT01449461|583886272|FG000|Overall Study|Death|0|||
161681839|NCT01449461|583886273|FG001|Overall Study|Death|2|||
161681840|NCT01449461|583886274|FG002|Overall Study|Death|0|||
161681841|NCT01449461|583886275|FG003|Overall Study|Death|0|||
161681842|NCT01449461|583886276|FG004|Overall Study|Death|7|||
161681843|NCT01449461|583886277|FG005|Overall Study|Death|1|||
161599888|NCT02424617|583588695|FG000|Overall Study|Withdrawal by Subject|1|||
161599889|NCT02424617|583588696|FG001|Overall Study|Withdrawal by Subject|1|||
161599890|NCT02424617|583588697|FG002|Overall Study|Withdrawal by Subject|0|||
161599891|NCT02424617|583588698|FG003|Overall Study|Withdrawal by Subject|1|||
161599892|NCT02424617|583588695|FG000|Overall Study|Progressive Disease|7|||
161599893|NCT02424617|583588696|FG001|Overall Study|Progressive Disease|6|||
161599894|NCT02424617|583588697|FG002|Overall Study|Progressive Disease|11|||
161599895|NCT02424617|583588698|FG003|Overall Study|Progressive Disease|10|||
161599896|NCT02424617|583588695|FG000|Overall Study|Other|0|||
161599897|NCT02424617|583588696|FG001|Overall Study|Other|0|||
161599898|NCT02424617|583588697|FG002|Overall Study|Other|0|||
161599899|NCT02424617|583588698|FG003|Overall Study|Other|1|||
161599900|NCT02694822|583588699|FG000|Phase 1|Death|2|||
161599901|NCT02694822|583588700|FG001|Phase 1|Death|1|||
161599902|NCT02694822|583588701|FG002|Phase 1|Death|6|||
161599903|NCT02694822|583588702|FG003|Phase 1|Death|6|||
161599904|NCT02694822|583588703|FG004|Phase 1|Death|3|||
161599905|NCT02694822|583588704|FG005|Phase 1|Death|0|||
161599906|NCT02694822|583588699|FG000|Phase 1|Withdrawal by Subject|2|||
161599907|NCT02694822|583588700|FG001|Phase 1|Withdrawal by Subject|2|||
161599908|NCT02694822|583588701|FG002|Phase 1|Withdrawal by Subject|4|||
161599909|NCT02694822|583588702|FG003|Phase 1|Withdrawal by Subject|8|||
161599910|NCT02694822|583588703|FG004|Phase 1|Withdrawal by Subject|1|||
161599911|NCT02694822|583588704|FG005|Phase 1|Withdrawal by Subject|0|||
161599912|NCT02694822|583588699|FG000|Phase 2|Death|0|||
161599913|NCT02694822|583588700|FG001|Phase 2|Death|0|||
161599914|NCT02694822|583588701|FG002|Phase 2|Death|0|||
161599915|NCT02694822|583588702|FG003|Phase 2|Death|0|||
161599916|NCT02694822|583588703|FG004|Phase 2|Death|0|||
161599917|NCT02694822|583588704|FG005|Phase 2|Death|26|||
161599918|NCT02694822|583588699|FG000|Phase 2|Withdrawal by Subject|0|||
161599919|NCT02694822|583588700|FG001|Phase 2|Withdrawal by Subject|0|||
161599920|NCT02694822|583588701|FG002|Phase 2|Withdrawal by Subject|0|||
161599921|NCT02694822|583588702|FG003|Phase 2|Withdrawal by Subject|0|||
161599922|NCT02694822|583588703|FG004|Phase 2|Withdrawal by Subject|0|||
161599923|NCT02694822|583588704|FG005|Phase 2|Withdrawal by Subject|13|||
161599924|NCT02694822|583588699|FG000|Phase 2|Administrative Study Closure|0|||
161599925|NCT02694822|583588700|FG001|Phase 2|Administrative Study Closure|0|||
161599926|NCT02694822|583588701|FG002|Phase 2|Administrative Study Closure|0|||
161599927|NCT02694822|583588702|FG003|Phase 2|Administrative Study Closure|0|||
161599928|NCT02694822|583588703|FG004|Phase 2|Administrative Study Closure|0|||
161599929|NCT02694822|583588704|FG005|Phase 2|Administrative Study Closure|2|||
161599930|NCT02694822|583588699|FG000|Phase 2|Lost to Follow-up|0|||
161599931|NCT02694822|583588700|FG001|Phase 2|Lost to Follow-up|0|||
161599932|NCT02694822|583588701|FG002|Phase 2|Lost to Follow-up|0|||
161599933|NCT02694822|583588702|FG003|Phase 2|Lost to Follow-up|0|||
161599934|NCT02694822|583588703|FG004|Phase 2|Lost to Follow-up|0|||
161599935|NCT02694822|583588704|FG005|Phase 2|Lost to Follow-up|1|||
161599936|NCT02694822|583588699|FG000|Phase 2|Participant Transferred to Another Site|0|||
161599937|NCT02694822|583588700|FG001|Phase 2|Participant Transferred to Another Site|0|||
161599938|NCT02694822|583588701|FG002|Phase 2|Participant Transferred to Another Site|0|||
161599939|NCT02694822|583588702|FG003|Phase 2|Participant Transferred to Another Site|0|||
161599940|NCT02694822|583588703|FG004|Phase 2|Participant Transferred to Another Site|0|||
161599941|NCT02694822|583588704|FG005|Phase 2|Participant Transferred to Another Site|1|||
161599942|NCT05370040|583588705|FG000|Overall Study|Lost to Follow-up|0|||
161599943|NCT05370040|583588706|FG001|Overall Study|Lost to Follow-up|0|||
161599944|NCT05370040|583588707|FG002|Overall Study|Lost to Follow-up|1|||
161599945|NCT05370040|583588708|FG003|Overall Study|Lost to Follow-up|0|||
161599946|NCT05370040|583588709|FG004|Overall Study|Lost to Follow-up|1|||
161599947|NCT05370040|583588710|FG005|Overall Study|Lost to Follow-up|0|||
161599948|NCT04778397|583588711|FG000|Overall Study|Death|59|||
161599949|NCT04778397|583588712|FG001|Overall Study|Death|54|||
161599950|NCT04778397|583588713|FG002|Overall Study|Death|11|||
161599951|NCT04778397|583588714|FG003|Overall Study|Death|9|||
161599952|NCT04778397|583588711|FG000|Overall Study|Study Terminated by Sponsor|34|||
161599953|NCT04778397|583588712|FG001|Overall Study|Study Terminated by Sponsor|42|||
161599954|NCT04778397|583588713|FG002|Overall Study|Study Terminated by Sponsor|15|||
161599955|NCT04778397|583588714|FG003|Overall Study|Study Terminated by Sponsor|12|||
161599956|NCT04778397|583588711|FG000|Overall Study|Withdrew Consent|5|||
161599957|NCT04778397|583588712|FG001|Overall Study|Withdrew Consent|4|||
161599958|NCT04778397|583588713|FG002|Overall Study|Withdrew Consent|1|||
161599959|NCT04778397|583588714|FG003|Overall Study|Withdrew Consent|1|||
161599960|NCT04778397|583588711|FG000|Overall Study|Reason Not Specified|1|||
161599961|NCT04778397|583588712|FG001|Overall Study|Reason Not Specified|3|||
161599962|NCT04778397|583588713|FG002|Overall Study|Reason Not Specified|0|||
161599963|NCT04778397|583588714|FG003|Overall Study|Reason Not Specified|2|||
161599964|NCT04778397|583588711|FG000|Overall Study|Lost to Follow-up|2|||
161599965|NCT04778397|583588712|FG001|Overall Study|Lost to Follow-up|1|||
161599966|NCT04778397|583588713|FG002|Overall Study|Lost to Follow-up|0|||
161599967|NCT04778397|583588714|FG003|Overall Study|Lost to Follow-up|1|||
161599968|NCT04294641|583588715|FG000|Overall Study|Screen failure|4|||
161681844|NCT01449461|583886272|FG000|Overall Study|Physician Decision|0|||
161681845|NCT01449461|583886273|FG001|Overall Study|Physician Decision|1|||
161681846|NCT01449461|583886274|FG002|Overall Study|Physician Decision|0|||
161681847|NCT01449461|583886275|FG003|Overall Study|Physician Decision|4|||
161681848|NCT01449461|583886276|FG004|Overall Study|Physician Decision|1|||
161681849|NCT01449461|583886277|FG005|Overall Study|Physician Decision|0|||
161681850|NCT01449461|583886272|FG000|Overall Study|Documented Progressive Disease|4|||
161681851|NCT01449461|583886273|FG001|Overall Study|Documented Progressive Disease|7|||
161681852|NCT01449461|583886274|FG002|Overall Study|Documented Progressive Disease|14|||
161681853|NCT01449461|583886275|FG003|Overall Study|Documented Progressive Disease|15|||
161681854|NCT01449461|583886276|FG004|Overall Study|Documented Progressive Disease|24|||
161681855|NCT01449461|583886277|FG005|Overall Study|Documented Progressive Disease|5|||
161681856|NCT01449461|583886272|FG000|Overall Study|Clinical Progressive Disease|2|||
161681857|NCT01449461|583886273|FG001|Overall Study|Clinical Progressive Disease|2|||
161681858|NCT01449461|583886274|FG002|Overall Study|Clinical Progressive Disease|0|||
161681859|NCT01449461|583886275|FG003|Overall Study|Clinical Progressive Disease|3|||
161681860|NCT01449461|583886276|FG004|Overall Study|Clinical Progressive Disease|4|||
161681861|NCT01449461|583886277|FG005|Overall Study|Clinical Progressive Disease|2|||
161681862|NCT01449461|583886272|FG000|Overall Study|Protocol Violation|0|||
161681863|NCT01449461|583886273|FG001|Overall Study|Protocol Violation|0|||
161681864|NCT01449461|583886274|FG002|Overall Study|Protocol Violation|0|||
161681865|NCT01449461|583886275|FG003|Overall Study|Protocol Violation|1|||
161681866|NCT01449461|583886276|FG004|Overall Study|Protocol Violation|0|||
161681867|NCT01449461|583886277|FG005|Overall Study|Protocol Violation|0|||
161681868|NCT01449461|583886272|FG000|Overall Study|Site Terminated by Sponsor|0|||
161681869|NCT01449461|583886273|FG001|Overall Study|Site Terminated by Sponsor|1|||
161681870|NCT01449461|583886274|FG002|Overall Study|Site Terminated by Sponsor|2|||
161681871|NCT01449461|583886275|FG003|Overall Study|Site Terminated by Sponsor|3|||
161681872|NCT01449461|583886276|FG004|Overall Study|Site Terminated by Sponsor|4|||
161681873|NCT01449461|583886277|FG005|Overall Study|Site Terminated by Sponsor|1|||
161681874|NCT01449461|583886272|FG000|Overall Study|Withdrawal by Subject|0|||
161681875|NCT01449461|583886273|FG001|Overall Study|Withdrawal by Subject|1|||
161681876|NCT01449461|583886274|FG002|Overall Study|Withdrawal by Subject|0|||
161681877|NCT01449461|583886275|FG003|Overall Study|Withdrawal by Subject|0|||
161681878|NCT01449461|583886276|FG004|Overall Study|Withdrawal by Subject|2|||
161681879|NCT01449461|583886277|FG005|Overall Study|Withdrawal by Subject|1|||
161681880|NCT01449461|583886272|FG000|Overall Study|Reason not Specified|0|||
161681881|NCT01449461|583886273|FG001|Overall Study|Reason not Specified|1|||
161681882|NCT01449461|583886274|FG002|Overall Study|Reason not Specified|0|||
161681883|NCT01449461|583886275|FG003|Overall Study|Reason not Specified|3|||
161681884|NCT01449461|583886276|FG004|Overall Study|Reason not Specified|2|||
161681885|NCT01449461|583886277|FG005|Overall Study|Reason not Specified|1|||
161681886|NCT05314517|583886278|FG000|Double-blind Period|Adverse Event|4|||
161681887|NCT05314517|583886279|FG001|Double-blind Period|Adverse Event|0|||
161681888|NCT05314517|583886280|FG002|Double-blind Period|Adverse Event|0|||
161681889|NCT05314517|583886281|FG003|Double-blind Period|Adverse Event|0|||
161681890|NCT05314517|583886278|FG000|Double-blind Period|Noncompliance|0|||
161681891|NCT05314517|583886279|FG001|Double-blind Period|Noncompliance|1|||
161681892|NCT05314517|583886280|FG002|Double-blind Period|Noncompliance|0|||
161681893|NCT05314517|583886281|FG003|Double-blind Period|Noncompliance|0|||
161681894|NCT05314517|583886278|FG000|Double-blind Period|Randomized, not treated|1|||
161681895|NCT05314517|583886279|FG001|Double-blind Period|Randomized, not treated|0|||
161681896|NCT05314517|583886280|FG002|Double-blind Period|Randomized, not treated|0|||
161681897|NCT05314517|583886281|FG003|Double-blind Period|Randomized, not treated|0|||
161681898|NCT05314517|583886278|FG000|Open-label Extension|Adverse Event|0|||
161681899|NCT05314517|583886279|FG001|Open-label Extension|Adverse Event|0|||
161681900|NCT05314517|583886280|FG002|Open-label Extension|Adverse Event|1|||
161681901|NCT05314517|583886281|FG003|Open-label Extension|Adverse Event|2|||
161681902|NCT05314517|583886278|FG000|Open-label Extension|Investigator decision|0|||
161681903|NCT05314517|583886279|FG001|Open-label Extension|Investigator decision|0|||
161681904|NCT05314517|583886280|FG002|Open-label Extension|Investigator decision|1|||
161681905|NCT05314517|583886281|FG003|Open-label Extension|Investigator decision|0|||
161681906|NCT05314517|583886278|FG000|Open-label Extension|Lost to Follow-up|0|||
161681907|NCT05314517|583886279|FG001|Open-label Extension|Lost to Follow-up|0|||
161681908|NCT05314517|583886280|FG002|Open-label Extension|Lost to Follow-up|0|||
161681909|NCT05314517|583886281|FG003|Open-label Extension|Lost to Follow-up|1|||
161681910|NCT05314517|583886278|FG000|Open-label Extension|Withdrawal by Subject|0|||
161681911|NCT05314517|583886279|FG001|Open-label Extension|Withdrawal by Subject|0|||
161681912|NCT05314517|583886280|FG002|Open-label Extension|Withdrawal by Subject|1|||
161681913|NCT05314517|583886281|FG003|Open-label Extension|Withdrawal by Subject|2|||
161681914|NCT05314517|583886278|FG000|Open-label Extension|Use of prohibited medication|0|||
161681915|NCT05314517|583886279|FG001|Open-label Extension|Use of prohibited medication|0|||
161599969|NCT05906784|583588717|FG000|Overall Study|Lost to Follow-up|2|||
161599970|NCT05906784|583588718|FG001|Overall Study|Lost to Follow-up|1|||
161599971|NCT05906784|583588719|FG002|Overall Study|Lost to Follow-up|1|||
161599972|NCT05906784|583588720|FG003|Overall Study|Lost to Follow-up|1|||
161599973|NCT04314778|583588724|FG000|Overall Study|Lost to Follow-up|5|||
161599974|NCT04314778|583588725|FG001|Overall Study|Lost to Follow-up|3|||
161599975|NCT03523572|583588726|FG000|Dose Escalation|Progressive disease|1|||
161599976|NCT03523572|583588727|FG001|Dose Escalation|Progressive disease|0|||
161599977|NCT03523572|583588728|FG002|Dose Escalation|Progressive disease|0|||
161599978|NCT03523572|583588729|FG003|Dose Escalation|Progressive disease|0|||
161599979|NCT03523572|583588730|FG004|Dose Escalation|Progressive disease|0|||
161599980|NCT03523572|583588731|FG005|Dose Escalation|Progressive disease|0|||
161599981|NCT03523572|583588726|FG000|Dose Escalation|Clinical Progression|0|||
161599982|NCT03523572|583588727|FG001|Dose Escalation|Clinical Progression|1|||
161599983|NCT03523572|583588728|FG002|Dose Escalation|Clinical Progression|0|||
161599984|NCT03523572|583588729|FG003|Dose Escalation|Clinical Progression|0|||
161599985|NCT03523572|583588730|FG004|Dose Escalation|Clinical Progression|0|||
161599986|NCT03523572|583588731|FG005|Dose Escalation|Clinical Progression|0|||
161599987|NCT03523572|583588726|FG000|Dose Escalation|Adverse Event|2|||
161599988|NCT03523572|583588727|FG001|Dose Escalation|Adverse Event|0|||
161599989|NCT03523572|583588728|FG002|Dose Escalation|Adverse Event|0|||
161599990|NCT03523572|583588729|FG003|Dose Escalation|Adverse Event|0|||
161599991|NCT03523572|583588730|FG004|Dose Escalation|Adverse Event|0|||
161599992|NCT03523572|583588731|FG005|Dose Escalation|Adverse Event|0|||
161599993|NCT03523572|583588726|FG000|Dose Escalation|Physician Decision|1|||
161599994|NCT03523572|583588727|FG001|Dose Escalation|Physician Decision|1|||
161599995|NCT03523572|583588728|FG002|Dose Escalation|Physician Decision|0|||
161599996|NCT03523572|583588729|FG003|Dose Escalation|Physician Decision|0|||
161599997|NCT03523572|583588730|FG004|Dose Escalation|Physician Decision|0|||
161599998|NCT03523572|583588731|FG005|Dose Escalation|Physician Decision|0|||
161599999|NCT03523572|583588726|FG000|Dose Expansion|Progressive Disease|0|||
161600000|NCT03523572|583588727|FG001|Dose Expansion|Progressive Disease|0|||
161600001|NCT03523572|583588728|FG002|Dose Expansion|Progressive Disease|9|||
161600002|NCT03523572|583588729|FG003|Dose Expansion|Progressive Disease|11|||
161600003|NCT03523572|583588730|FG004|Dose Expansion|Progressive Disease|15|||
161600004|NCT03523572|583588731|FG005|Dose Expansion|Progressive Disease|2|||
161600005|NCT03523572|583588726|FG000|Dose Expansion|Clinical Progression|0|||
161600006|NCT03523572|583588727|FG001|Dose Expansion|Clinical Progression|0|||
161600007|NCT03523572|583588728|FG002|Dose Expansion|Clinical Progression|2|||
161600008|NCT03523572|583588729|FG003|Dose Expansion|Clinical Progression|2|||
161600009|NCT03523572|583588730|FG004|Dose Expansion|Clinical Progression|2|||
161600010|NCT03523572|583588731|FG005|Dose Expansion|Clinical Progression|0|||
161600011|NCT03523572|583588726|FG000|Dose Expansion|Adverse Event|0|||
161600012|NCT03523572|583588727|FG001|Dose Expansion|Adverse Event|0|||
161600013|NCT03523572|583588728|FG002|Dose Expansion|Adverse Event|10|||
161600014|NCT03523572|583588729|FG003|Dose Expansion|Adverse Event|1|||
161600015|NCT03523572|583588730|FG004|Dose Expansion|Adverse Event|5|||
161600016|NCT03523572|583588731|FG005|Dose Expansion|Adverse Event|2|||
161600017|NCT03523572|583588726|FG000|Dose Expansion|Withdrawal by Subject|0|||
161600018|NCT03523572|583588727|FG001|Dose Expansion|Withdrawal by Subject|0|||
161600019|NCT03523572|583588728|FG002|Dose Expansion|Withdrawal by Subject|1|||
161600020|NCT03523572|583588729|FG003|Dose Expansion|Withdrawal by Subject|1|||
161600021|NCT03523572|583588730|FG004|Dose Expansion|Withdrawal by Subject|0|||
161600022|NCT03523572|583588731|FG005|Dose Expansion|Withdrawal by Subject|0|||
161600023|NCT03523572|583588726|FG000|Dose Expansion|Physician Decision|0|||
161600024|NCT03523572|583588727|FG001|Dose Expansion|Physician Decision|0|||
161600025|NCT03523572|583588728|FG002|Dose Expansion|Physician Decision|1|||
161600026|NCT03523572|583588729|FG003|Dose Expansion|Physician Decision|0|||
161600027|NCT03523572|583588730|FG004|Dose Expansion|Physician Decision|1|||
161600028|NCT03523572|583588731|FG005|Dose Expansion|Physician Decision|0|||
161600029|NCT03523572|583588726|FG000|Dose Expansion|Miscellaneous|0|||
161600030|NCT03523572|583588727|FG001|Dose Expansion|Miscellaneous|0|||
161600031|NCT03523572|583588728|FG002|Dose Expansion|Miscellaneous|0|||
161600032|NCT03523572|583588729|FG003|Dose Expansion|Miscellaneous|0|||
161600033|NCT03523572|583588730|FG004|Dose Expansion|Miscellaneous|3|||
161600034|NCT03523572|583588731|FG005|Dose Expansion|Miscellaneous|0|||
161600035|NCT04685135|583588737|FG000|Overall Study|Death|126|||
161600036|NCT04685135|583588738|FG001|Overall Study|Death|53|||
161600037|NCT04685135|583588737|FG000|Overall Study|Withdrawal by Subject|12|||
161600038|NCT04685135|583588738|FG001|Overall Study|Withdrawal by Subject|16|||
161600039|NCT02240238|583588739|FG000|Phase 1|Adverse Event|0|||
161600040|NCT02240238|583588740|FG001|Phase 1|Adverse Event|0|||
161600041|NCT02240238|583588741|FG002|Phase 1|Adverse Event|0|||
161600042|NCT02240238|583588742|FG003|Phase 1|Adverse Event|0|||
161600043|NCT02240238|583588743|FG004|Phase 1|Adverse Event|0|||
161600044|NCT02240238|583588744|FG005|Phase 1|Adverse Event|0|||
161600045|NCT02240238|583588745|FG006|Phase 1|Adverse Event|3|||
161600046|NCT02240238|583588746|FG007|Phase 1|Adverse Event|1|||
161600047|NCT02240238|583588747|FG008|Phase 1|Adverse Event|0|||
161600048|NCT02240238|583588748|FG009|Phase 1|Adverse Event|0|||
161600049|NCT02240238|583588749|FG010|Phase 1|Adverse Event|0|||
161600050|NCT02240238|583588750|FG011|Phase 1|Adverse Event|0|||
161600051|NCT02240238|583588739|FG000|Phase 1|Death|0|||
161600052|NCT02240238|583588740|FG001|Phase 1|Death|0|||
161600053|NCT02240238|583588741|FG002|Phase 1|Death|0|||
161600054|NCT02240238|583588742|FG003|Phase 1|Death|0|||
161600055|NCT02240238|583588743|FG004|Phase 1|Death|0|||
161600056|NCT02240238|583588744|FG005|Phase 1|Death|1|||
161600057|NCT02240238|583588745|FG006|Phase 1|Death|0|||
161600058|NCT02240238|583588746|FG007|Phase 1|Death|0|||
161600059|NCT02240238|583588747|FG008|Phase 1|Death|0|||
161600060|NCT02240238|583588748|FG009|Phase 1|Death|0|||
161600061|NCT02240238|583588749|FG010|Phase 1|Death|0|||
161600062|NCT02240238|583588750|FG011|Phase 1|Death|0|||
161600063|NCT02240238|583588739|FG000|Phase 1|Sponsor termination|0|||
161600064|NCT02240238|583588740|FG001|Phase 1|Sponsor termination|0|||
161600065|NCT02240238|583588741|FG002|Phase 1|Sponsor termination|0|||
161600066|NCT02240238|583588742|FG003|Phase 1|Sponsor termination|0|||
161600067|NCT02240238|583588743|FG004|Phase 1|Sponsor termination|0|||
161600068|NCT02240238|583588744|FG005|Phase 1|Sponsor termination|1|||
161600069|NCT02240238|583588745|FG006|Phase 1|Sponsor termination|0|||
161600070|NCT02240238|583588746|FG007|Phase 1|Sponsor termination|0|||
161600071|NCT02240238|583588747|FG008|Phase 1|Sponsor termination|0|||
161600072|NCT02240238|583588748|FG009|Phase 1|Sponsor termination|0|||
161600073|NCT02240238|583588749|FG010|Phase 1|Sponsor termination|0|||
161600074|NCT02240238|583588750|FG011|Phase 1|Sponsor termination|0|||
161600075|NCT02240238|583588739|FG000|Phase 1|Withdrawal by Subject|0|||
161600076|NCT02240238|583588740|FG001|Phase 1|Withdrawal by Subject|0|||
161600077|NCT02240238|583588741|FG002|Phase 1|Withdrawal by Subject|0|||
161600078|NCT02240238|583588742|FG003|Phase 1|Withdrawal by Subject|0|||
161600079|NCT02240238|583588743|FG004|Phase 1|Withdrawal by Subject|0|||
161600080|NCT02240238|583588744|FG005|Phase 1|Withdrawal by Subject|2|||
161600081|NCT02240238|583588745|FG006|Phase 1|Withdrawal by Subject|0|||
161600082|NCT02240238|583588746|FG007|Phase 1|Withdrawal by Subject|0|||
161600083|NCT02240238|583588747|FG008|Phase 1|Withdrawal by Subject|0|||
161600084|NCT02240238|583588748|FG009|Phase 1|Withdrawal by Subject|0|||
161600085|NCT02240238|583588749|FG010|Phase 1|Withdrawal by Subject|0|||
161600086|NCT02240238|583588750|FG011|Phase 1|Withdrawal by Subject|0|||
161600087|NCT02240238|583588739|FG000|Phase 1|Physician Decision|0|||
161600088|NCT02240238|583588740|FG001|Phase 1|Physician Decision|0|||
161600089|NCT02240238|583588741|FG002|Phase 1|Physician Decision|0|||
161600090|NCT02240238|583588742|FG003|Phase 1|Physician Decision|0|||
161600091|NCT02240238|583588743|FG004|Phase 1|Physician Decision|0|||
161600092|NCT02240238|583588744|FG005|Phase 1|Physician Decision|2|||
161600093|NCT02240238|583588745|FG006|Phase 1|Physician Decision|0|||
161600094|NCT02240238|583588746|FG007|Phase 1|Physician Decision|0|||
161600095|NCT02240238|583588747|FG008|Phase 1|Physician Decision|0|||
161600096|NCT02240238|583588748|FG009|Phase 1|Physician Decision|0|||
161600097|NCT02240238|583588749|FG010|Phase 1|Physician Decision|0|||
161600098|NCT02240238|583588750|FG011|Phase 1|Physician Decision|0|||
161600099|NCT02240238|583588739|FG000|Phase 2|Adverse Event|0|||
161600100|NCT02240238|583588740|FG001|Phase 2|Adverse Event|0|||
161600101|NCT02240238|583588741|FG002|Phase 2|Adverse Event|0|||
161600102|NCT02240238|583588742|FG003|Phase 2|Adverse Event|0|||
161600103|NCT02240238|583588743|FG004|Phase 2|Adverse Event|0|||
161600104|NCT02240238|583588744|FG005|Phase 2|Adverse Event|0|||
161600105|NCT02240238|583588745|FG006|Phase 2|Adverse Event|0|||
161600106|NCT02240238|583588746|FG007|Phase 2|Adverse Event|0|||
161600107|NCT02240238|583588747|FG008|Phase 2|Adverse Event|0|||
161600108|NCT02240238|583588748|FG009|Phase 2|Adverse Event|7|||
161600109|NCT02240238|583588749|FG010|Phase 2|Adverse Event|14|||
161600110|NCT02240238|583588750|FG011|Phase 2|Adverse Event|2|||
161600111|NCT02240238|583588739|FG000|Phase 2|Death|0|||
161600112|NCT02240238|583588740|FG001|Phase 2|Death|0|||
161600113|NCT02240238|583588741|FG002|Phase 2|Death|0|||
161600114|NCT02240238|583588742|FG003|Phase 2|Death|0|||
161600115|NCT02240238|583588743|FG004|Phase 2|Death|0|||
161600116|NCT02240238|583588744|FG005|Phase 2|Death|0|||
161600117|NCT02240238|583588745|FG006|Phase 2|Death|0|||
161600118|NCT02240238|583588746|FG007|Phase 2|Death|0|||
161600119|NCT02240238|583588747|FG008|Phase 2|Death|0|||
161600120|NCT02240238|583588748|FG009|Phase 2|Death|3|||
161600121|NCT02240238|583588749|FG010|Phase 2|Death|2|||
161600122|NCT02240238|583588750|FG011|Phase 2|Death|1|||
161600123|NCT02240238|583588739|FG000|Phase 2|Disease progression|0|||
161600124|NCT02240238|583588740|FG001|Phase 2|Disease progression|0|||
161600125|NCT02240238|583588741|FG002|Phase 2|Disease progression|0|||
161600126|NCT02240238|583588742|FG003|Phase 2|Disease progression|0|||
161600127|NCT02240238|583588743|FG004|Phase 2|Disease progression|0|||
161600128|NCT02240238|583588744|FG005|Phase 2|Disease progression|0|||
161600129|NCT02240238|583588745|FG006|Phase 2|Disease progression|0|||
161681916|NCT05314517|583886280|FG002|Open-label Extension|Use of prohibited medication|1|||
161681917|NCT05314517|583886281|FG003|Open-label Extension|Use of prohibited medication|0|||
161681918|NCT05314517|583886278|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
161681919|NCT05314517|583886279|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
161681920|NCT05314517|583886280|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
161681921|NCT05314517|583886281|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
161681922|NCT04198623|583887402|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
161681923|NCT05050318|583887408|FG000|Overall Study|Protocol Deviation|1|||
161681924|NCT05050318|583887409|FG001|Overall Study|Protocol Deviation|0|||
161681925|NCT05050318|583887410|FG002|Overall Study|Protocol Deviation|0|||
161681926|NCT04259411|583887411|FG000|Overall Study|Death|1|||
161681927|NCT04259411|583887411|FG000|Overall Study|Missed visit|2|||
161681928|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
161681929|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
161681930|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
161681931|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161681932|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161681933|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161681934|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Death|2|||
161681935|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Death|0|||
161681936|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
161681937|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
161681938|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
161681939|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161681940|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
161681941|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161681942|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
161681943|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
161681944|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
161681945|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
161681946|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
161681947|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
161681948|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
161681949|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
161681950|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
161681951|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
161681952|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
161681953|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
161681954|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
161681955|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
161681956|NCT00916357|583887420|FG000|Period 1|Withdrawal by Subject|1|||
161681957|NCT00916357|583887421|FG001|Period 1|Withdrawal by Subject|0|||
161681958|NCT00916357|583887422|FG002|Period 1|Withdrawal by Subject|0|||
161681959|NCT00916357|583887423|FG003|Period 1|Withdrawal by Subject|0|||
161681960|NCT00916357|583887424|FG004|Period 1|Withdrawal by Subject|0|||
161681961|NCT00916357|583887425|FG005|Period 1|Withdrawal by Subject|0|||
161681962|NCT00916357|583887420|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681963|NCT00916357|583887421|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681964|NCT00916357|583887422|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681965|NCT00916357|583887423|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
161681966|NCT00916357|583887424|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681967|NCT00916357|583887425|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681968|NCT03807349|583887428|FG000|Overall Study|Early Study Termination|9|||
161681969|NCT05807464|583887431|FG000|Overall Study|Adverse Event|1|||
161681970|NCT04451161|583887432|FG000|Overall Study|Lost to Follow-up|28|||
161681971|NCT04451161|583887433|FG001|Overall Study|Lost to Follow-up|37|||
161681972|NCT04451161|583887434|FG002|Overall Study|Lost to Follow-up|22|||
161681973|NCT04451161|583887435|FG003|Overall Study|Lost to Follow-up|13|||
161681974|NCT04451161|583887436|FG004|Overall Study|Lost to Follow-up|11|||
161681975|NCT04451161|583887437|FG005|Overall Study|Lost to Follow-up|14|||
161681976|NCT04451161|583887432|FG000|Overall Study|Withdrawal by Subject|3|||
161681977|NCT04451161|583887433|FG001|Overall Study|Withdrawal by Subject|0|||
161681978|NCT04451161|583887434|FG002|Overall Study|Withdrawal by Subject|0|||
161830600|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Adverse Event|3|||
161681979|NCT04451161|583887435|FG003|Overall Study|Withdrawal by Subject|0|||
161681980|NCT04451161|583887436|FG004|Overall Study|Withdrawal by Subject|2|||
161681981|NCT04451161|583887437|FG005|Overall Study|Withdrawal by Subject|4|||
161681982|NCT03596866|583887441|FG000|Overall Study|Site terminated by Sponsor|64|||
161681983|NCT03596866|583887442|FG001|Overall Study|Site terminated by Sponsor|65|||
161681984|NCT03596866|583887441|FG000|Overall Study|Death|37|||
161681985|NCT03596866|583887442|FG001|Overall Study|Death|24|||
161830601|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Adverse Event|2|||
161830602|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Adverse Event|2|||
161600130|NCT02240238|583588746|FG007|Phase 2|Disease progression|0|||
161600131|NCT02240238|583588747|FG008|Phase 2|Disease progression|0|||
161600132|NCT02240238|583588748|FG009|Phase 2|Disease progression|5|||
161600133|NCT02240238|583588749|FG010|Phase 2|Disease progression|11|||
161600134|NCT02240238|583588750|FG011|Phase 2|Disease progression|1|||
161600135|NCT02240238|583588739|FG000|Phase 2|Withdrawal by Subject|0|||
161600136|NCT02240238|583588740|FG001|Phase 2|Withdrawal by Subject|0|||
161600137|NCT02240238|583588741|FG002|Phase 2|Withdrawal by Subject|0|||
161600138|NCT02240238|583588742|FG003|Phase 2|Withdrawal by Subject|0|||
161600139|NCT02240238|583588743|FG004|Phase 2|Withdrawal by Subject|0|||
161600140|NCT02240238|583588744|FG005|Phase 2|Withdrawal by Subject|0|||
161600141|NCT02240238|583588745|FG006|Phase 2|Withdrawal by Subject|0|||
161600142|NCT02240238|583588746|FG007|Phase 2|Withdrawal by Subject|0|||
161600143|NCT02240238|583588747|FG008|Phase 2|Withdrawal by Subject|0|||
161600144|NCT02240238|583588748|FG009|Phase 2|Withdrawal by Subject|1|||
161600145|NCT02240238|583588749|FG010|Phase 2|Withdrawal by Subject|1|||
161600146|NCT02240238|583588750|FG011|Phase 2|Withdrawal by Subject|0|||
161600147|NCT02240238|583588739|FG000|Phase 2|Physician Decision|0|||
161600148|NCT02240238|583588740|FG001|Phase 2|Physician Decision|0|||
161600149|NCT02240238|583588741|FG002|Phase 2|Physician Decision|0|||
161600150|NCT02240238|583588742|FG003|Phase 2|Physician Decision|0|||
161600151|NCT02240238|583588743|FG004|Phase 2|Physician Decision|0|||
161600152|NCT02240238|583588744|FG005|Phase 2|Physician Decision|0|||
161600153|NCT02240238|583588745|FG006|Phase 2|Physician Decision|0|||
161600154|NCT02240238|583588746|FG007|Phase 2|Physician Decision|0|||
161600155|NCT02240238|583588747|FG008|Phase 2|Physician Decision|0|||
161600156|NCT02240238|583588748|FG009|Phase 2|Physician Decision|1|||
161600157|NCT02240238|583588749|FG010|Phase 2|Physician Decision|3|||
161600158|NCT02240238|583588750|FG011|Phase 2|Physician Decision|0|||
161600159|NCT02240238|583588739|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600160|NCT02240238|583588740|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600161|NCT02240238|583588741|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600162|NCT02240238|583588742|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600163|NCT02240238|583588743|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600164|NCT02240238|583588744|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600165|NCT02240238|583588745|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600166|NCT02240238|583588746|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600167|NCT02240238|583588747|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600168|NCT02240238|583588748|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
161600169|NCT02240238|583588749|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600170|NCT02240238|583588750|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161600171|NCT02240238|583588739|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600172|NCT02240238|583588740|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600173|NCT02240238|583588741|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600174|NCT02240238|583588742|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600175|NCT02240238|583588743|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600176|NCT02240238|583588744|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600177|NCT02240238|583588745|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600178|NCT02240238|583588746|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600179|NCT02240238|583588747|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600180|NCT02240238|583588748|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
161600181|NCT02240238|583588749|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600182|NCT02240238|583588750|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161600183|NCT02240238|583588739|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600184|NCT02240238|583588740|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600185|NCT02240238|583588741|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600186|NCT02240238|583588742|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600187|NCT02240238|583588743|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600188|NCT02240238|583588744|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600189|NCT02240238|583588745|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600190|NCT02240238|583588746|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600191|NCT02240238|583588747|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600192|NCT02240238|583588748|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600193|NCT02240238|583588749|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
161600194|NCT02240238|583588750|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161600195|NCT02240238|583588739|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600196|NCT02240238|583588740|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600197|NCT02240238|583588741|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600198|NCT02240238|583588742|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600199|NCT02240238|583588743|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600200|NCT02240238|583588744|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600201|NCT02240238|583588745|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600202|NCT02240238|583588746|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600203|NCT02240238|583588747|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600204|NCT02240238|583588748|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600205|NCT02240238|583588749|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
161600206|NCT02240238|583588750|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161600207|NCT02240238|583588739|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600208|NCT02240238|583588740|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600209|NCT02240238|583588741|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600210|NCT02240238|583588742|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600211|NCT02240238|583588743|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600212|NCT02240238|583588744|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600213|NCT02240238|583588745|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600214|NCT02240238|583588746|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600215|NCT02240238|583588747|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600216|NCT02240238|583588748|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600217|NCT02240238|583588749|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
161600218|NCT02240238|583588750|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161600219|NCT02240238|583588739|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600220|NCT02240238|583588740|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600221|NCT02240238|583588741|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600222|NCT02240238|583588742|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600223|NCT02240238|583588743|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600224|NCT02240238|583588744|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600225|NCT02240238|583588745|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600226|NCT02240238|583588746|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600227|NCT02240238|583588747|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600228|NCT02240238|583588748|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600229|NCT02240238|583588749|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
161600230|NCT02240238|583588750|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161600231|NCT02240238|583588739|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600232|NCT02240238|583588740|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600233|NCT02240238|583588741|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600234|NCT02240238|583588742|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600235|NCT02240238|583588743|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600236|NCT02240238|583588744|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600237|NCT02240238|583588745|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600238|NCT02240238|583588746|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600239|NCT02240238|583588747|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600240|NCT02240238|583588748|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600241|NCT02240238|583588749|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
161600242|NCT02240238|583588750|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161600243|NCT02240238|583588739|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600244|NCT02240238|583588740|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600245|NCT02240238|583588741|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600246|NCT02240238|583588742|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600247|NCT02240238|583588743|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600248|NCT02240238|583588744|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600249|NCT02240238|583588745|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600250|NCT02240238|583588746|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600251|NCT02240238|583588747|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600252|NCT02240238|583588748|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600253|NCT02240238|583588749|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161600254|NCT02240238|583588750|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
161830603|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
161600255|NCT02315703|583588751|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161600256|NCT02315703|583588752|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161600257|NCT02315703|583588753|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161600258|NCT02315703|583588754|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
161600259|NCT02315703|583588755|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
161600260|NCT02315703|583588756|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161600261|NCT02315703|583588757|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
161600262|NCT02315703|583588758|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161600263|NCT02315703|583588751|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
161600264|NCT02315703|583588752|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
161600265|NCT02315703|583588753|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
161600266|NCT02315703|583588754|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
161600267|NCT02315703|583588755|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
161600268|NCT02315703|583588756|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
161600269|NCT02315703|583588757|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
161600270|NCT02315703|583588758|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
161600271|NCT02315703|583588751|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161600272|NCT02315703|583588752|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161600273|NCT02315703|583588753|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161600274|NCT02315703|583588754|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161600275|NCT02315703|583588755|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161600276|NCT02315703|583588756|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
161600277|NCT02315703|583588757|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
161600278|NCT02315703|583588758|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161600279|NCT02315703|583588751|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600280|NCT02315703|583588752|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600281|NCT02315703|583588753|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600282|NCT02315703|583588754|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600283|NCT02315703|583588755|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600284|NCT02315703|583588756|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600285|NCT02315703|583588757|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161600286|NCT02315703|583588758|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
161600287|NCT02315703|583588751|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
161600288|NCT02315703|583588752|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
161600289|NCT02315703|583588753|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
161600290|NCT02315703|583588754|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
161600291|NCT02315703|583588755|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
161600292|NCT02315703|583588756|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
161600293|NCT02315703|583588757|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
161600294|NCT02315703|583588758|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
161600295|NCT02315703|583588751|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
161600296|NCT02315703|583588752|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
161600297|NCT02315703|583588753|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
161600298|NCT02315703|583588754|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
161600299|NCT02315703|583588755|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
161600300|NCT02315703|583588756|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
161600301|NCT02315703|583588757|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
161600302|NCT02315703|583588758|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
161600303|NCT02315703|583588751|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
161600304|NCT02315703|583588752|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
161600305|NCT02315703|583588753|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161600306|NCT02315703|583588754|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161600307|NCT02315703|583588755|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161600308|NCT02315703|583588756|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161600309|NCT02315703|583588757|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161600310|NCT02315703|583588758|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161600311|NCT02315703|583588751|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600312|NCT02315703|583588752|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
161600313|NCT02315703|583588753|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600314|NCT02315703|583588754|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600315|NCT02315703|583588755|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600316|NCT02315703|583588756|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600317|NCT02315703|583588757|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600318|NCT02315703|583588758|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161600319|NCT02315703|583588751|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
161681986|NCT03596866|583887441|FG000|Overall Study|Withdrawal by Subject|4|||
161681987|NCT03596866|583887442|FG001|Overall Study|Withdrawal by Subject|6|||
161681988|NCT03596866|583887441|FG000|Overall Study|Missing|0|||
161681989|NCT03596866|583887442|FG001|Overall Study|Missing|6|||
161681990|NCT03596866|583887441|FG000|Overall Study|Lost to Follow-up|2|||
161681991|NCT03596866|583887442|FG001|Overall Study|Lost to Follow-up|3|||
161600320|NCT02315703|583588752|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
161600321|NCT02315703|583588753|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
161600322|NCT02315703|583588754|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
161600323|NCT02315703|583588755|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
161600324|NCT02315703|583588756|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
161600325|NCT02315703|583588757|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
161600326|NCT02315703|583588758|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
161600327|NCT02724969|583588773|FG000|Overall Study|Lost to Follow-up|12|||
161600328|NCT02724969|583588774|FG001|Overall Study|Lost to Follow-up|6|||
161600329|NCT02724969|583588773|FG000|Overall Study|Withdrawal by Subject|3|||
161600330|NCT02724969|583588774|FG001|Overall Study|Withdrawal by Subject|3|||
161600331|NCT02724969|583588773|FG000|Overall Study|Infant demise|0|||
161600332|NCT02724969|583588774|FG001|Overall Study|Infant demise|2|||
161600333|NCT05147116|583588777|FG000|Overall Study|Withdrawal by Subject|0|||
161600334|NCT05147116|583588778|FG001|Overall Study|Withdrawal by Subject|1|||
161600335|NCT03625115|583588779|FG000|Overall Study|Withdrawal by Subject|4|||
161600336|NCT03625115|583588780|FG001|Overall Study|Withdrawal by Subject|7|||
161681992|NCT03596866|583887441|FG000|Overall Study|Protocol Violation|1|||
161681993|NCT03596866|583887442|FG001|Overall Study|Protocol Violation|0|||
161681994|NCT03596866|583887441|FG000|Overall Study|Reason Not Specified|14|||
161681995|NCT03596866|583887442|FG001|Overall Study|Reason Not Specified|13|||
161681996|NCT00596947|583887443|FG000|Overall Study|study halted due to low enrollment|5|||
161681997|NCT00596947|583887444|FG001|Overall Study|study halted due to low enrollment|3|||
161681998|NCT00596947|583887443|FG000|Overall Study|Lost to Follow-up|1|||
161681999|NCT00596947|583887444|FG001|Overall Study|Lost to Follow-up|0|||
161682000|NCT03000179|583887445|FG000|Overall Study|Lost to Follow-up|2|||
161682001|NCT01431274|583887451|FG000|Overall Study|Adverse Event|51|||
161682002|NCT01431274|583887452|FG001|Overall Study|Adverse Event|37|||
161682003|NCT01431274|583887453|FG002|Overall Study|Adverse Event|43|||
161682004|NCT01431274|583887454|FG003|Overall Study|Adverse Event|30|||
161682005|NCT01431274|583887455|FG004|Overall Study|Adverse Event|37|||
161682006|NCT01431274|583887451|FG000|Overall Study|Consent withdrawn not due to AE|29|||
161682007|NCT01431274|583887452|FG001|Overall Study|Consent withdrawn not due to AE|20|||
161682008|NCT01431274|583887453|FG002|Overall Study|Consent withdrawn not due to AE|17|||
161682009|NCT01431274|583887454|FG003|Overall Study|Consent withdrawn not due to AE|20|||
161682010|NCT01431274|583887455|FG004|Overall Study|Consent withdrawn not due to AE|11|||
161682011|NCT01431274|583887451|FG000|Overall Study|Non compliant with protocol|5|||
161682012|NCT01431274|583887452|FG001|Overall Study|Non compliant with protocol|8|||
161682013|NCT01431274|583887453|FG002|Overall Study|Non compliant with protocol|4|||
161682014|NCT01431274|583887454|FG003|Overall Study|Non compliant with protocol|4|||
161682015|NCT01431274|583887455|FG004|Overall Study|Non compliant with protocol|4|||
161682016|NCT01431274|583887451|FG000|Overall Study|Lost to Follow-up|6|||
161682017|NCT01431274|583887452|FG001|Overall Study|Lost to Follow-up|7|||
161682018|NCT01431274|583887453|FG002|Overall Study|Lost to Follow-up|1|||
161682019|NCT01431274|583887454|FG003|Overall Study|Lost to Follow-up|4|||
161682020|NCT01431274|583887455|FG004|Overall Study|Lost to Follow-up|0|||
161600337|NCT03625115|583588779|FG000|Overall Study|Lost to Follow-up|17|||
161682021|NCT01431274|583887451|FG000|Overall Study|Other reason not stated above|6|||
161682022|NCT01431274|583887452|FG001|Overall Study|Other reason not stated above|5|||
161682023|NCT01431274|583887453|FG002|Overall Study|Other reason not stated above|7|||
161682024|NCT01431274|583887454|FG003|Overall Study|Other reason not stated above|2|||
161682025|NCT01431274|583887455|FG004|Overall Study|Other reason not stated above|4|||
161682026|NCT00003702|583887456|FG000|Overall Study|Ineligible cell types|2|||
161682027|NCT00003702|583887457|FG001|Overall Study|Ineligible cell types|2|||
161682028|NCT00003702|583887456|FG000|Overall Study|Did not meet criteria for persistence|8|||
161682029|NCT00003702|583887457|FG001|Overall Study|Did not meet criteria for persistence|5|||
161682030|NCT00003702|583887456|FG000|Overall Study|WHO score > 6|2|||
161682031|NCT00003702|583887457|FG001|Overall Study|WHO score > 6|1|||
161682032|NCT00003702|583887456|FG000|Overall Study|Inadequate documentation of disease|1|||
161682033|NCT00003702|583887457|FG001|Overall Study|Inadequate documentation of disease|3|||
161682034|NCT04995055|583887458|FG000|Period 1|COVID-19 Related|1|||
161682035|NCT04995055|583887459|FG001|Period 1|COVID-19 Related|0|||
161600338|NCT03625115|583588780|FG001|Overall Study|Lost to Follow-up|24|||
161600339|NCT03672916|583588781|FG000|Overall Study|Death|6|||
161600340|NCT03672916|583588781|FG000|Overall Study|Lost to Follow-up|29|||
161600341|NCT03672916|583588781|FG000|Overall Study|Adverse Event|6|||
161682036|NCT04995055|583887458|FG000|Period 1|Withdrawal by Subject|0|||
161682037|NCT04995055|583887459|FG001|Period 1|Withdrawal by Subject|1|||
161682038|NCT04995055|583887458|FG000|Period 1|Subject discontinued due to timing|4|||
161682039|NCT04995055|583887459|FG001|Period 1|Subject discontinued due to timing|4|||
161682040|NCT01358760|583887464|FG000|Overall Study|Adverse Event|3|||
161682041|NCT01358760|583887465|FG001|Overall Study|Adverse Event|4|||
161682042|NCT01358760|583887466|FG002|Overall Study|Adverse Event|3|||
161600342|NCT03672916|583588781|FG000|Overall Study|Withdrawal by Subject|11|||
161600343|NCT04197336|583588782|FG000|Overall Study|Withdrawal by Subject|1|||
161600344|NCT05868382|583588784|FG000|Overall Study|Lost to Follow-up|5|||
161600345|NCT05868382|583588785|FG001|Overall Study|Lost to Follow-up|0|||
161682043|NCT01358760|583887464|FG000|Overall Study|Lost to Follow-up|1|||
161682044|NCT01358760|583887465|FG001|Overall Study|Lost to Follow-up|1|||
161682045|NCT01358760|583887466|FG002|Overall Study|Lost to Follow-up|3|||
161682046|NCT01358760|583887464|FG000|Overall Study|Withdrawal by Subject|5|||
161682047|NCT01358760|583887465|FG001|Overall Study|Withdrawal by Subject|3|||
161682048|NCT01358760|583887466|FG002|Overall Study|Withdrawal by Subject|2|||
161682049|NCT01358760|583887464|FG000|Overall Study|Physician Decision|1|||
161682050|NCT01358760|583887465|FG001|Overall Study|Physician Decision|0|||
161682051|NCT01358760|583887466|FG002|Overall Study|Physician Decision|1|||
161682052|NCT01358760|583887464|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
161682053|NCT01358760|583887465|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
161682054|NCT01358760|583887466|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
161682055|NCT01506960|583887469|FG000|Overall Study|Did not meet angiographic criteria|47|||
161682056|NCT00397033|583887470|FG000|Overall Study|Adverse Event|7|||
161682057|NCT00397033|583887471|FG001|Overall Study|Adverse Event|10|||
161682058|NCT00397033|583887472|FG002|Overall Study|Adverse Event|4|||
161682059|NCT00397033|583887470|FG000|Overall Study|Lack of Efficacy|22|||
161682060|NCT00397033|583887471|FG001|Overall Study|Lack of Efficacy|12|||
161682061|NCT00397033|583887472|FG002|Overall Study|Lack of Efficacy|9|||
161682062|NCT00397033|583887470|FG000|Overall Study|Lost to Follow-up|3|||
161682063|NCT00397033|583887471|FG001|Overall Study|Lost to Follow-up|3|||
161682064|NCT00397033|583887472|FG002|Overall Study|Lost to Follow-up|3|||
161682065|NCT00397033|583887470|FG000|Overall Study|Withdrawal by Subject|12|||
161600346|NCT05868382|583588786|FG002|Overall Study|Lost to Follow-up|6|||
161600347|NCT05868382|583588787|FG003|Overall Study|Lost to Follow-up|4|||
161600348|NCT05868382|583588788|FG004|Overall Study|Lost to Follow-up|2|||
161600349|NCT05868382|583588789|FG005|Overall Study|Lost to Follow-up|6|||
161600350|NCT05868382|583588784|FG000|Overall Study|Withdrawal by Subject|1|||
161600351|NCT05868382|583588785|FG001|Overall Study|Withdrawal by Subject|0|||
161600352|NCT05868382|583588786|FG002|Overall Study|Withdrawal by Subject|0|||
161600353|NCT05868382|583588787|FG003|Overall Study|Withdrawal by Subject|0|||
161600354|NCT05868382|583588788|FG004|Overall Study|Withdrawal by Subject|1|||
161600355|NCT05868382|583588789|FG005|Overall Study|Withdrawal by Subject|0|||
161600356|NCT03655028|583588792|FG000|12-weeks Follow up|Death|1|||
161600357|NCT03655028|583588793|FG001|12-weeks Follow up|Death|0|||
161600358|NCT03655028|583588792|FG000|12-weeks Follow up|Physician Decision|3|||
161600359|NCT03655028|583588793|FG001|12-weeks Follow up|Physician Decision|3|||
161600360|NCT03655028|583588792|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
161600361|NCT03655028|583588793|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
161600362|NCT03655028|583588792|FG000|12-weeks Follow up|Lost to Follow-up|4|||
161600363|NCT03655028|583588793|FG001|12-weeks Follow up|Lost to Follow-up|4|||
161600364|NCT03655028|583588792|FG000|24-weeks|Lost to Follow-up|1|||
161600365|NCT03655028|583588793|FG001|24-weeks|Lost to Follow-up|1|||
161600366|NCT03655028|583588792|FG000|24-weeks|Death|0|||
161600367|NCT03655028|583588793|FG001|24-weeks|Death|1|||
161600368|NCT03513302|583588794|FG000|First Intervention (14 Days)|Screen failure|15|||
161600369|NCT03513302|583588795|FG001|First Intervention (14 Days)|Screen failure|16|||
161600370|NCT05256654|583588796|FG000|Overall Study|Adverse Event|0|||
161600371|NCT05256654|583588797|FG001|Overall Study|Adverse Event|0|||
161682066|NCT00397033|583887471|FG001|Overall Study|Withdrawal by Subject|7|||
161600372|NCT05256654|583588798|FG002|Overall Study|Adverse Event|1|||
161600373|NCT05256654|583588799|FG003|Overall Study|Adverse Event|0|||
161600374|NCT05256654|583588796|FG000|Overall Study|Lost to Follow-up|0|||
161600375|NCT05256654|583588797|FG001|Overall Study|Lost to Follow-up|0|||
161600376|NCT05256654|583588798|FG002|Overall Study|Lost to Follow-up|0|||
161682067|NCT00397033|583887472|FG002|Overall Study|Withdrawal by Subject|5|||
161682068|NCT00397033|583887470|FG000|Overall Study|Other|0|||
161682069|NCT00397033|583887471|FG001|Overall Study|Other|5|||
161682070|NCT00397033|583887472|FG002|Overall Study|Other|2|||
161682071|NCT03519867|583887473|FG000|Overall Study|Adverse Event|1|||
161600377|NCT05256654|583588799|FG003|Overall Study|Lost to Follow-up|1|||
161600378|NCT05256654|583588796|FG000|Overall Study|Withdrawal by Subject|1|||
161600379|NCT05256654|583588797|FG001|Overall Study|Withdrawal by Subject|2|||
161682072|NCT03519867|583887474|FG001|Overall Study|Adverse Event|1|||
161682073|NCT03519867|583887475|FG002|Overall Study|Adverse Event|0|||
161600380|NCT05256654|583588798|FG002|Overall Study|Withdrawal by Subject|1|||
161600381|NCT05256654|583588799|FG003|Overall Study|Withdrawal by Subject|3|||
161600382|NCT05256654|583588796|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
161600383|NCT05256654|583588797|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
161682074|NCT03519867|583887476|FG003|Overall Study|Adverse Event|0|||
161682075|NCT03519867|583887477|FG004|Overall Study|Adverse Event|0|||
161682076|NCT03519867|583887478|FG005|Overall Study|Adverse Event|0|||
161600384|NCT05256654|583588798|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
161600385|NCT05256654|583588799|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
161600386|NCT05256654|583588796|FG000|Overall Study|Other|0|||
161600387|NCT05256654|583588797|FG001|Overall Study|Other|0|||
161600388|NCT05256654|583588798|FG002|Overall Study|Other|0|||
161600389|NCT05256654|583588799|FG003|Overall Study|Other|1|||
161600390|NCT05167864|583588808|FG000|Overall Study|Lost to Follow-up|7|||
161600391|NCT05167864|583588809|FG001|Overall Study|Lost to Follow-up|6|||
161600392|NCT05167864|583588810|FG002|Overall Study|Lost to Follow-up|7|||
161600393|NCT05167864|583588811|FG003|Overall Study|Lost to Follow-up|9|||
161600394|NCT05204654|583588812|FG000|Overall Study|Study terminated due to time restraint|2|||
161600395|NCT05204654|583588813|FG001|Overall Study|Study terminated due to time restraint|2|||
161600396|NCT01221948|583588814|FG000|Overall Study|Physician Decision|5|||
161600397|NCT01221948|583588814|FG000|Overall Study|Withdrawal by Subject|2|||
161600398|NCT01221948|583588814|FG000|Overall Study|not disclosed|2|||
161600399|NCT01221948|583588814|FG000|Overall Study|Death|1|||
161600400|NCT01221948|583588814|FG000|Overall Study|Protocol Violation|4|||
161600401|NCT03756662|583588815|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
161600402|NCT04295512|583588818|FG000|Overall Study|Lack of family response to schedule assessment|0|||
161600403|NCT04295512|583588819|FG001|Overall Study|Lack of family response to schedule assessment|0|||
161600404|NCT04295512|583588820|FG002|Overall Study|Lack of family response to schedule assessment|0|||
161600405|NCT04295512|583588821|FG003|Overall Study|Lack of family response to schedule assessment|2|||
161600406|NCT04295512|583588818|FG000|Overall Study|Therapist did not refer eligible family|7|||
161600407|NCT04295512|583588819|FG001|Overall Study|Therapist did not refer eligible family|7|||
161600408|NCT04295512|583588820|FG002|Overall Study|Therapist did not refer eligible family|0|||
161600409|NCT04295512|583588821|FG003|Overall Study|Therapist did not refer eligible family|0|||
161600410|NCT05207956|583588825|FG000|Overall Study|Lost to follow up|1|||
161600411|NCT05207956|583588826|FG001|Overall Study|Lost to follow up|2|||
161600412|NCT03626220|583588829|FG000|Overall Study|Withdrawal by Subject|2|||
161600413|NCT03626220|583588830|FG001|Overall Study|Withdrawal by Subject|0|||
161600414|NCT04625725|583588831|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
161600415|NCT04625725|583588832|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161600416|NCT04625725|583588833|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161600417|NCT04625725|583588834|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161600418|NCT04625725|583588835|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161600419|NCT04625725|583588836|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161600420|NCT04625725|583588831|FG000|Provent Main Study|Withdrawal by Subject|242|||
161600421|NCT04625725|583588832|FG001|Provent Main Study|Withdrawal by Subject|144|||
161600422|NCT04625725|583588833|FG002|Provent Main Study|Withdrawal by Subject|0|||
161600423|NCT04625725|583588834|FG003|Provent Main Study|Withdrawal by Subject|0|||
161600424|NCT04625725|583588835|FG004|Provent Main Study|Withdrawal by Subject|0|||
161600425|NCT04625725|583588836|FG005|Provent Main Study|Withdrawal by Subject|0|||
161600426|NCT04625725|583588831|FG000|Provent Main Study|Physician Decision|5|||
161600427|NCT04625725|583588832|FG001|Provent Main Study|Physician Decision|0|||
161600428|NCT04625725|583588833|FG002|Provent Main Study|Physician Decision|0|||
161600429|NCT04625725|583588834|FG003|Provent Main Study|Physician Decision|0|||
161600430|NCT04625725|583588835|FG004|Provent Main Study|Physician Decision|0|||
161600431|NCT04625725|583588836|FG005|Provent Main Study|Physician Decision|0|||
161600432|NCT04625725|583588831|FG000|Provent Main Study|Protocol Violation|1|||
161600433|NCT04625725|583588832|FG001|Provent Main Study|Protocol Violation|0|||
161600434|NCT04625725|583588833|FG002|Provent Main Study|Protocol Violation|0|||
161600435|NCT04625725|583588834|FG003|Provent Main Study|Protocol Violation|0|||
161600436|NCT04625725|583588835|FG004|Provent Main Study|Protocol Violation|0|||
161600437|NCT04625725|583588836|FG005|Provent Main Study|Protocol Violation|0|||
161600438|NCT04625725|583588831|FG000|Provent Main Study|Lost to Follow-up|357|||
161600439|NCT04625725|583588832|FG001|Provent Main Study|Lost to Follow-up|200|||
161600440|NCT04625725|583588833|FG002|Provent Main Study|Lost to Follow-up|0|||
161600441|NCT04625725|583588834|FG003|Provent Main Study|Lost to Follow-up|0|||
161600442|NCT04625725|583588835|FG004|Provent Main Study|Lost to Follow-up|0|||
161600443|NCT04625725|583588836|FG005|Provent Main Study|Lost to Follow-up|0|||
161600444|NCT04625725|583588831|FG000|Provent Main Study|Death|22|||
161600445|NCT04625725|583588832|FG001|Provent Main Study|Death|10|||
161600446|NCT04625725|583588833|FG002|Provent Main Study|Death|0|||
161600447|NCT04625725|583588834|FG003|Provent Main Study|Death|0|||
161600448|NCT04625725|583588835|FG004|Provent Main Study|Death|0|||
161600449|NCT04625725|583588836|FG005|Provent Main Study|Death|0|||
161600450|NCT04625725|583588831|FG000|Provent Main Study|Adverse Event|2|||
161600451|NCT04625725|583588832|FG001|Provent Main Study|Adverse Event|1|||
161600452|NCT04625725|583588833|FG002|Provent Main Study|Adverse Event|0|||
161600453|NCT04625725|583588834|FG003|Provent Main Study|Adverse Event|0|||
161600454|NCT04625725|583588835|FG004|Provent Main Study|Adverse Event|0|||
161600455|NCT04625725|583588836|FG005|Provent Main Study|Adverse Event|0|||
161600456|NCT04625725|583588831|FG000|Provent Main Study|Participants dosed in sub-study|310|||
161600457|NCT04625725|583588832|FG001|Provent Main Study|Participants dosed in sub-study|193|||
161600458|NCT04625725|583588833|FG002|Provent Main Study|Participants dosed in sub-study|0|||
161600459|NCT04625725|583588834|FG003|Provent Main Study|Participants dosed in sub-study|0|||
161600460|NCT04625725|583588835|FG004|Provent Main Study|Participants dosed in sub-study|0|||
161600461|NCT04625725|583588836|FG005|Provent Main Study|Participants dosed in sub-study|0|||
161600462|NCT04625725|583588831|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
161600463|NCT04625725|583588832|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
161600464|NCT04625725|583588833|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161600465|NCT04625725|583588834|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161600466|NCT04625725|583588835|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161600467|NCT04625725|583588836|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161600468|NCT04625725|583588831|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
161600469|NCT04625725|583588832|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
161600470|NCT04625725|583588833|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161600471|NCT04625725|583588834|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161600472|NCT04625725|583588835|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161600473|NCT04625725|583588836|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161600474|NCT04625725|583588831|FG000|Provent Main Study|INCARCERATION|3|||
161600475|NCT04625725|583588832|FG001|Provent Main Study|INCARCERATION|0|||
161600476|NCT04625725|583588833|FG002|Provent Main Study|INCARCERATION|0|||
161600477|NCT04625725|583588834|FG003|Provent Main Study|INCARCERATION|0|||
161600478|NCT04625725|583588835|FG004|Provent Main Study|INCARCERATION|0|||
161600479|NCT04625725|583588836|FG005|Provent Main Study|INCARCERATION|0|||
161600480|NCT04625725|583588831|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
161600481|NCT04625725|583588832|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
161600482|NCT04625725|583588833|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161600483|NCT04625725|583588834|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161600484|NCT04625725|583588835|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161600485|NCT04625725|583588836|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161600486|NCT04625725|583588831|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
161600487|NCT04625725|583588832|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
161600488|NCT04625725|583588833|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161600489|NCT04625725|583588834|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161600490|NCT04625725|583588835|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161600491|NCT04625725|583588836|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161600492|NCT04625725|583588831|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
161600493|NCT04625725|583588832|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
161600494|NCT04625725|583588833|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161600495|NCT04625725|583588834|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161600496|NCT04625725|583588835|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161600497|NCT04625725|583588836|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161600498|NCT04625725|583588831|FG000|Provent Main Study|MISSING REASON|0|||
161600499|NCT04625725|583588832|FG001|Provent Main Study|MISSING REASON|1|||
161600500|NCT04625725|583588833|FG002|Provent Main Study|MISSING REASON|0|||
161600501|NCT04625725|583588834|FG003|Provent Main Study|MISSING REASON|0|||
161600502|NCT04625725|583588835|FG004|Provent Main Study|MISSING REASON|0|||
161600503|NCT04625725|583588836|FG005|Provent Main Study|MISSING REASON|0|||
161600504|NCT04625725|583588831|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161600505|NCT04625725|583588832|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161600506|NCT04625725|583588833|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161600507|NCT04625725|583588834|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
161600508|NCT04625725|583588835|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161600509|NCT04625725|583588836|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161600510|NCT04625725|583588831|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161600511|NCT04625725|583588832|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161600512|NCT04625725|583588833|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
161600513|NCT04625725|583588834|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161600514|NCT04625725|583588835|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161600515|NCT04625725|583588836|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161600516|NCT04625725|583588831|FG000|Provent Sub Study|Lost to Follow-up|0|||
161600517|NCT04625725|583588832|FG001|Provent Sub Study|Lost to Follow-up|0|||
161600518|NCT04625725|583588833|FG002|Provent Sub Study|Lost to Follow-up|20|||
161600519|NCT04625725|583588834|FG003|Provent Sub Study|Lost to Follow-up|10|||
161600520|NCT04625725|583588835|FG004|Provent Sub Study|Lost to Follow-up|6|||
161600521|NCT04625725|583588836|FG005|Provent Sub Study|Lost to Follow-up|4|||
161600522|NCT04625725|583588831|FG000|Provent Sub Study|Death|0|||
161600523|NCT04625725|583588832|FG001|Provent Sub Study|Death|0|||
161600524|NCT04625725|583588833|FG002|Provent Sub Study|Death|8|||
161600525|NCT04625725|583588834|FG003|Provent Sub Study|Death|5|||
161600526|NCT04625725|583588835|FG004|Provent Sub Study|Death|0|||
161600527|NCT04625725|583588836|FG005|Provent Sub Study|Death|1|||
161600528|NCT04625725|583588831|FG000|Provent Sub Study|Adverse Event|0|||
161600529|NCT04625725|583588832|FG001|Provent Sub Study|Adverse Event|0|||
161600530|NCT04625725|583588833|FG002|Provent Sub Study|Adverse Event|0|||
161600531|NCT04625725|583588834|FG003|Provent Sub Study|Adverse Event|0|||
161600532|NCT04625725|583588835|FG004|Provent Sub Study|Adverse Event|0|||
161600533|NCT04625725|583588836|FG005|Provent Sub Study|Adverse Event|1|||
161600534|NCT04625725|583588831|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161600535|NCT04625725|583588832|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161600536|NCT04625725|583588833|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161600537|NCT04625725|583588834|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161600538|NCT04625725|583588835|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
161600539|NCT04625725|583588836|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161600540|NCT04625725|583588831|FG000|Provent Sub Study|Withdrawal by Subject|0|||
161600541|NCT04625725|583588832|FG001|Provent Sub Study|Withdrawal by Subject|0|||
161600542|NCT04625725|583588833|FG002|Provent Sub Study|Withdrawal by Subject|11|||
161600543|NCT04625725|583588834|FG003|Provent Sub Study|Withdrawal by Subject|13|||
161600544|NCT04625725|583588835|FG004|Provent Sub Study|Withdrawal by Subject|5|||
161600545|NCT04625725|583588836|FG005|Provent Sub Study|Withdrawal by Subject|6|||
161600546|NCT04625725|583588831|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161600547|NCT04625725|583588832|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161600548|NCT04625725|583588833|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161600549|NCT04625725|583588834|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161600550|NCT04625725|583588835|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161600551|NCT04625725|583588836|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
161600552|NCT04308681|583588847|FG000|Pre-Treatment|Not reported|1|||
161600553|NCT04308681|583588848|FG001|Pre-Treatment|Not reported|1|||
161600554|NCT04308681|583588849|FG002|Pre-Treatment|Not reported|0|||
161600555|NCT04308681|583588850|FG003|Pre-Treatment|Not reported|0|||
161600556|NCT04308681|583588851|FG004|Pre-Treatment|Not reported|0|||
161600557|NCT04308681|583588852|FG005|Pre-Treatment|Not reported|2|||
161600558|NCT04308681|583588853|FG006|Pre-Treatment|Not reported|0|||
161600559|NCT04308681|583588854|FG007|Pre-Treatment|Not reported|0|||
161600560|NCT04308681|583588847|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
161600561|NCT04308681|583588848|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
161600562|NCT04308681|583588849|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
161600563|NCT04308681|583588850|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
161600564|NCT04308681|583588851|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
161600565|NCT04308681|583588852|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
161600566|NCT04308681|583588853|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
161600567|NCT04308681|583588854|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
161600568|NCT04308681|583588847|FG000|Treatment up to Week 26|Other reasons|2|||
161600569|NCT04308681|583588848|FG001|Treatment up to Week 26|Other reasons|0|||
161600570|NCT04308681|583588849|FG002|Treatment up to Week 26|Other reasons|0|||
161600571|NCT04308681|583588850|FG003|Treatment up to Week 26|Other reasons|0|||
161600572|NCT04308681|583588851|FG004|Treatment up to Week 26|Other reasons|1|||
161600573|NCT04308681|583588852|FG005|Treatment up to Week 26|Other reasons|1|||
161600574|NCT04308681|583588853|FG006|Treatment up to Week 26|Other reasons|0|||
161600575|NCT04308681|583588854|FG007|Treatment up to Week 26|Other reasons|0|||
161600576|NCT04308681|583588847|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161600577|NCT04308681|583588848|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
161600578|NCT04308681|583588849|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
161600579|NCT04308681|583588850|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161600580|NCT04308681|583588851|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
161600581|NCT04308681|583588852|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161600582|NCT04308681|583588853|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
161600583|NCT04308681|583588854|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161600584|NCT04308681|583588847|FG000|Treatment up to Week 26|Adverse Event|6|||
161600585|NCT04308681|583588848|FG001|Treatment up to Week 26|Adverse Event|5|||
161600586|NCT04308681|583588849|FG002|Treatment up to Week 26|Adverse Event|5|||
161600587|NCT04308681|583588850|FG003|Treatment up to Week 26|Adverse Event|0|||
161600588|NCT04308681|583588851|FG004|Treatment up to Week 26|Adverse Event|6|||
161600589|NCT04308681|583588852|FG005|Treatment up to Week 26|Adverse Event|1|||
161600590|NCT04308681|583588853|FG006|Treatment up to Week 26|Adverse Event|0|||
161600591|NCT04308681|583588854|FG007|Treatment up to Week 26|Adverse Event|0|||
161600592|NCT04308681|583588847|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161600593|NCT04308681|583588848|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
161600594|NCT04308681|583588849|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
161600595|NCT04308681|583588850|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161600596|NCT04308681|583588851|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161600597|NCT04308681|583588852|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161600598|NCT04308681|583588853|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161600599|NCT04308681|583588854|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161600600|NCT04308681|583588847|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
161600601|NCT04308681|583588848|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
161600602|NCT04308681|583588849|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
161600603|NCT04308681|583588850|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
161600604|NCT04308681|583588851|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
161600605|NCT04308681|583588852|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
161600606|NCT04308681|583588853|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
161600607|NCT04308681|583588854|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
161600608|NCT04308681|583588847|FG000|OTE - 26 Weeks|Death|0|||
161600609|NCT04308681|583588848|FG001|OTE - 26 Weeks|Death|1|||
161600610|NCT04308681|583588849|FG002|OTE - 26 Weeks|Death|0|||
161600611|NCT04308681|583588850|FG003|OTE - 26 Weeks|Death|0|||
161600612|NCT04308681|583588851|FG004|OTE - 26 Weeks|Death|0|||
161600613|NCT04308681|583588852|FG005|OTE - 26 Weeks|Death|0|||
161600614|NCT04308681|583588853|FG006|OTE - 26 Weeks|Death|1|||
161600615|NCT04308681|583588854|FG007|OTE - 26 Weeks|Death|0|||
161600616|NCT04308681|583588847|FG000|OTE - 26 Weeks|Adverse Event|0|||
161600617|NCT04308681|583588848|FG001|OTE - 26 Weeks|Adverse Event|2|||
161600618|NCT04308681|583588849|FG002|OTE - 26 Weeks|Adverse Event|8|||
161600619|NCT04308681|583588850|FG003|OTE - 26 Weeks|Adverse Event|3|||
161600620|NCT04308681|583588851|FG004|OTE - 26 Weeks|Adverse Event|0|||
161600621|NCT04308681|583588852|FG005|OTE - 26 Weeks|Adverse Event|1|||
161600622|NCT04308681|583588853|FG006|OTE - 26 Weeks|Adverse Event|2|||
161600623|NCT04308681|583588854|FG007|OTE - 26 Weeks|Adverse Event|0|||
161600624|NCT04308681|583588847|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161600625|NCT04308681|583588848|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
161600626|NCT04308681|583588849|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
161600627|NCT04308681|583588850|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161600628|NCT04308681|583588851|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161600629|NCT04308681|583588852|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
161600630|NCT04308681|583588853|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161600631|NCT04308681|583588854|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161600632|NCT00429364|583588855|FG000|Overall Study|Withdrawal by Subject|11|||
161600633|NCT00429364|583588856|FG001|Overall Study|Withdrawal by Subject|5|||
161600634|NCT00429364|583588855|FG000|Overall Study|Physician Decision|4|||
161600635|NCT00429364|583588856|FG001|Overall Study|Physician Decision|2|||
161600636|NCT00429364|583588855|FG000|Overall Study|Lost to Follow-up|7|||
161600637|NCT00429364|583588856|FG001|Overall Study|Lost to Follow-up|6|||
161600638|NCT00429364|583588855|FG000|Overall Study|Death|0|||
161682077|NCT03519867|583887479|FG006|Overall Study|Adverse Event|0|||
161682078|NCT03519867|583887480|FG007|Overall Study|Adverse Event|0|||
161682079|NCT03519867|583887481|FG008|Overall Study|Adverse Event|0|||
161682080|NCT03519867|583887482|FG009|Overall Study|Adverse Event|0|||
161682081|NCT03519867|583887473|FG000|Overall Study|Protocol Violation|0|||
161682082|NCT03519867|583887474|FG001|Overall Study|Protocol Violation|0|||
161682083|NCT03519867|583887475|FG002|Overall Study|Protocol Violation|0|||
161682084|NCT03519867|583887476|FG003|Overall Study|Protocol Violation|0|||
161682085|NCT03519867|583887477|FG004|Overall Study|Protocol Violation|0|||
161682086|NCT03519867|583887478|FG005|Overall Study|Protocol Violation|1|||
161682087|NCT03519867|583887479|FG006|Overall Study|Protocol Violation|0|||
161682088|NCT03519867|583887480|FG007|Overall Study|Protocol Violation|0|||
161682089|NCT03519867|583887481|FG008|Overall Study|Protocol Violation|0|||
161682090|NCT03519867|583887482|FG009|Overall Study|Protocol Violation|0|||
161682091|NCT03519867|583887473|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682092|NCT03519867|583887474|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682093|NCT03519867|583887475|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682094|NCT03519867|583887476|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682095|NCT03519867|583887477|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161600639|NCT00429364|583588856|FG001|Overall Study|Death|1|||
161600640|NCT00429364|583588855|FG000|Overall Study|Underwent aortic root surgery|10|||
161600641|NCT00429364|583588856|FG001|Overall Study|Underwent aortic root surgery|18|||
161600642|NCT00429364|583588855|FG000|Overall Study|Pregnancy|0|||
161600643|NCT00429364|583588856|FG001|Overall Study|Pregnancy|1|||
161600644|NCT02631746|583588862|FG000|Overall Study|Lack of Efficacy|3|||
161600645|NCT02361216|583588863|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
161600646|NCT02361216|583588864|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
161682096|NCT03519867|583887478|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682097|NCT03519867|583887479|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
161830604|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
161600647|NCT02361216|583588863|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
161600648|NCT02361216|583588864|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
161600649|NCT02361216|583588863|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
161600650|NCT02361216|583588864|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
161600651|NCT02361216|583588863|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
161600652|NCT02361216|583588864|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
161600653|NCT02361216|583588863|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
161600654|NCT02361216|583588864|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
161600655|NCT02361216|583588863|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
161600656|NCT02361216|583588864|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
161600657|NCT04086121|583588867|FG000|Overall Study|Other than listed|8|||
161600658|NCT04086121|583588867|FG000|Overall Study|Withdrawal by Subject|3|||
161600659|NCT04086121|583588867|FG000|Overall Study|Lost to Follow-up|2|||
161600660|NCT04086121|583588867|FG000|Overall Study|Adverse Event|1|||
161600661|NCT04167553|583588874|FG000|Overall Study|Withdrawal by Subject|1|||
161600662|NCT04167553|583588875|FG001|Overall Study|Withdrawal by Subject|0|||
161600663|NCT04167553|583588876|FG002|Overall Study|Withdrawal by Subject|1|||
161600664|NCT04167553|583588877|FG003|Overall Study|Withdrawal by Subject|2|||
161600665|NCT04167553|583588878|FG004|Overall Study|Withdrawal by Subject|1|||
161600666|NCT04167553|583588879|FG005|Overall Study|Withdrawal by Subject|0|||
161600667|NCT04167553|583588880|FG006|Overall Study|Withdrawal by Subject|0|||
161600668|NCT04167553|583588874|FG000|Overall Study|Physician Decision|0|||
161600669|NCT04167553|583588875|FG001|Overall Study|Physician Decision|0|||
161600670|NCT04167553|583588876|FG002|Overall Study|Physician Decision|0|||
161600671|NCT04167553|583588877|FG003|Overall Study|Physician Decision|0|||
161600672|NCT04167553|583588878|FG004|Overall Study|Physician Decision|2|||
161600673|NCT04167553|583588879|FG005|Overall Study|Physician Decision|2|||
161600674|NCT04167553|583588880|FG006|Overall Study|Physician Decision|0|||
161600675|NCT04167553|583588874|FG000|Overall Study|Lost to Follow-up|0|||
161600676|NCT04167553|583588875|FG001|Overall Study|Lost to Follow-up|0|||
161600677|NCT04167553|583588876|FG002|Overall Study|Lost to Follow-up|2|||
161600678|NCT04167553|583588877|FG003|Overall Study|Lost to Follow-up|0|||
161600679|NCT04167553|583588878|FG004|Overall Study|Lost to Follow-up|0|||
161600680|NCT04167553|583588879|FG005|Overall Study|Lost to Follow-up|0|||
161600681|NCT04167553|583588880|FG006|Overall Study|Lost to Follow-up|0|||
161600682|NCT05285137|583588883|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161600683|NCT05285137|583588884|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161600684|NCT05285137|583588885|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
161600685|NCT05285137|583588886|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
161600686|NCT05285137|583588887|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
161600687|NCT05285137|583588888|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
161600688|NCT05285137|583588889|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
161600689|NCT05285137|583588890|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
161600690|NCT05285137|583588891|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
161600691|NCT05285137|583588883|FG000|Overall Study|Lost to Follow-up|0|||
161600692|NCT05285137|583588884|FG001|Overall Study|Lost to Follow-up|0|||
161600693|NCT05285137|583588885|FG002|Overall Study|Lost to Follow-up|1|||
161600694|NCT05285137|583588886|FG003|Overall Study|Lost to Follow-up|3|||
161600695|NCT05285137|583588887|FG004|Overall Study|Lost to Follow-up|0|||
161600696|NCT05285137|583588888|FG005|Overall Study|Lost to Follow-up|0|||
161600697|NCT05285137|583588889|FG006|Overall Study|Lost to Follow-up|1|||
161600698|NCT05285137|583588890|FG007|Overall Study|Lost to Follow-up|0|||
161600699|NCT05285137|583588891|FG008|Overall Study|Lost to Follow-up|0|||
161600700|NCT05285137|583588883|FG000|Overall Study|Physician Decision|0|||
161600701|NCT05285137|583588884|FG001|Overall Study|Physician Decision|1|||
161600702|NCT05285137|583588885|FG002|Overall Study|Physician Decision|0|||
161600703|NCT05285137|583588886|FG003|Overall Study|Physician Decision|0|||
161600704|NCT05285137|583588887|FG004|Overall Study|Physician Decision|0|||
161600705|NCT05285137|583588888|FG005|Overall Study|Physician Decision|0|||
161600706|NCT05285137|583588889|FG006|Overall Study|Physician Decision|0|||
161600707|NCT05285137|583588890|FG007|Overall Study|Physician Decision|0|||
161682098|NCT03519867|583887480|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682099|NCT03519867|583887481|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682100|NCT03519867|583887482|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682101|NCT03519867|583887473|FG000|Overall Study|Admin. of other reversal agent|1|||
161600708|NCT05285137|583588891|FG008|Overall Study|Physician Decision|0|||
161600709|NCT05285137|583588883|FG000|Overall Study|Pregnancy|0|||
161600710|NCT05285137|583588884|FG001|Overall Study|Pregnancy|0|||
161600711|NCT05285137|583588885|FG002|Overall Study|Pregnancy|0|||
161600712|NCT05285137|583588886|FG003|Overall Study|Pregnancy|0|||
161600713|NCT05285137|583588887|FG004|Overall Study|Pregnancy|0|||
161600714|NCT05285137|583588888|FG005|Overall Study|Pregnancy|0|||
161600715|NCT05285137|583588889|FG006|Overall Study|Pregnancy|1|||
161600716|NCT05285137|583588890|FG007|Overall Study|Pregnancy|0|||
161600717|NCT05285137|583588891|FG008|Overall Study|Pregnancy|0|||
161600718|NCT05285137|583588883|FG000|Overall Study|Withdrawal by Subject|0|||
161600719|NCT05285137|583588884|FG001|Overall Study|Withdrawal by Subject|1|||
161600720|NCT05285137|583588885|FG002|Overall Study|Withdrawal by Subject|2|||
161600721|NCT05285137|583588886|FG003|Overall Study|Withdrawal by Subject|1|||
161600722|NCT05285137|583588887|FG004|Overall Study|Withdrawal by Subject|0|||
161600723|NCT05285137|583588888|FG005|Overall Study|Withdrawal by Subject|0|||
161600724|NCT05285137|583588889|FG006|Overall Study|Withdrawal by Subject|0|||
161600725|NCT05285137|583588890|FG007|Overall Study|Withdrawal by Subject|0|||
161600726|NCT05285137|583588891|FG008|Overall Study|Withdrawal by Subject|1|||
161600727|NCT05209152|583588892|FG000|Overall Study|Sponsor decision|1|||
161600728|NCT05209152|583588893|FG001|Overall Study|Sponsor decision|2|||
161600729|NCT05209152|583588892|FG000|Overall Study|Death|3|||
161600730|NCT05209152|583588893|FG001|Overall Study|Death|1|||
161600731|NCT03221426|583588894|FG000|Overall Study|Ongoing in study|212|||
161600732|NCT03221426|583588895|FG001|Overall Study|Ongoing in study|193|||
161600733|NCT03221426|583588896|FG002|Overall Study|Ongoing in study|61|||
161600734|NCT03221426|583588897|FG003|Overall Study|Ongoing in study|55|||
161600735|NCT03221426|583588894|FG000|Overall Study|Withdrawal by Subject|12|||
161600736|NCT03221426|583588895|FG001|Overall Study|Withdrawal by Subject|4|||
161600737|NCT03221426|583588896|FG002|Overall Study|Withdrawal by Subject|2|||
161600738|NCT03221426|583588897|FG003|Overall Study|Withdrawal by Subject|3|||
161600739|NCT03221426|583588894|FG000|Overall Study|Lost to Follow-up|4|||
161600740|NCT03221426|583588895|FG001|Overall Study|Lost to Follow-up|1|||
161600741|NCT03221426|583588896|FG002|Overall Study|Lost to Follow-up|1|||
161600742|NCT03221426|583588897|FG003|Overall Study|Lost to Follow-up|0|||
161600743|NCT03221426|583588894|FG000|Overall Study|Death|174|||
161600744|NCT03221426|583588895|FG001|Overall Study|Death|204|||
161600745|NCT03221426|583588896|FG002|Overall Study|Death|36|||
161600746|NCT03221426|583588897|FG003|Overall Study|Death|45|||
161600747|NCT06262477|583590447|FG000|Overall Study|Withdrawal by Subject|1|||
161600748|NCT06262477|583590448|FG001|Overall Study|Withdrawal by Subject|0|||
161600749|NCT06262477|583590447|FG000|Overall Study|Adverse Event|0|||
161600750|NCT06262477|583590448|FG001|Overall Study|Adverse Event|1|||
161600751|NCT06262477|583590447|FG000|Overall Study|Lost to Follow-up|0|||
161600752|NCT06262477|583590448|FG001|Overall Study|Lost to Follow-up|1|||
161600753|NCT04850898|583590451|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
161600754|NCT04850898|583590452|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
161600755|NCT04550221|583590459|FG000|Overall Study|Lost to Follow-up|0|||
161600756|NCT04550221|583590460|FG001|Overall Study|Lost to Follow-up|4|||
161600757|NCT04550221|583590459|FG000|Overall Study|Withdrawn|3|||
161600758|NCT04550221|583590460|FG001|Overall Study|Withdrawn|0|||
161600759|NCT04550221|583590459|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
161600760|NCT04550221|583590460|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
161600761|NCT02593773|583590461|FG000|Overall Study|Voluntary Withdrawal|3|||
161600762|NCT02593773|583590461|FG000|Overall Study|Study Terminated by Sponsor|31|||
161600763|NCT02593773|583590461|FG000|Overall Study|Death|1|||
161600764|NCT05452460|583590462|FG000|Overall Study|Lost to Follow-up|3|||
161600765|NCT05452460|583590463|FG001|Overall Study|Lost to Follow-up|3|||
161600766|NCT05452460|583590462|FG000|Overall Study|Did not receive intervention|1|||
161600767|NCT05452460|583590463|FG001|Overall Study|Did not receive intervention|0|||
161600768|NCT04447040|583590465|FG000|Overall Study|Lost to Follow-up|2|||
161600769|NCT04447040|583590466|FG001|Overall Study|Lost to Follow-up|1|||
161600770|NCT04447040|583590467|FG002|Overall Study|Lost to Follow-up|3|||
161600771|NCT04447040|583590468|FG003|Overall Study|Lost to Follow-up|3|||
161600772|NCT04447040|583590469|FG004|Overall Study|Lost to Follow-up|1|||
161600773|NCT04447040|583590470|FG005|Overall Study|Lost to Follow-up|3|||
161600774|NCT04447040|583590465|FG000|Overall Study|Withdrawal by Subject|0|||
161600775|NCT04447040|583590466|FG001|Overall Study|Withdrawal by Subject|1|||
161600776|NCT04447040|583590467|FG002|Overall Study|Withdrawal by Subject|1|||
161600777|NCT04447040|583590468|FG003|Overall Study|Withdrawal by Subject|1|||
161600778|NCT04447040|583590469|FG004|Overall Study|Withdrawal by Subject|0|||
161600779|NCT04447040|583590470|FG005|Overall Study|Withdrawal by Subject|0|||
161600780|NCT01208662|583590471|FG000|Induction and Consolidation|Disease Progression|23|||
161600781|NCT01208662|583590472|FG001|Induction and Consolidation|Disease Progression|13|||
161600782|NCT01208662|583590473|FG002|Induction and Consolidation|Disease Progression|0|||
161600783|NCT01208662|583590471|FG000|Induction and Consolidation|Adverse Event|16|||
161600784|NCT01208662|583590472|FG001|Induction and Consolidation|Adverse Event|18|||
161600785|NCT01208662|583590473|FG002|Induction and Consolidation|Adverse Event|2|||
161600786|NCT01208662|583590471|FG000|Induction and Consolidation|MD or Participant Decision|16|||
161600787|NCT01208662|583590472|FG001|Induction and Consolidation|MD or Participant Decision|34|||
161600788|NCT01208662|583590473|FG002|Induction and Consolidation|MD or Participant Decision|4|||
161600789|NCT01208662|583590471|FG000|Induction and Consolidation|Death|1|||
161600790|NCT01208662|583590472|FG001|Induction and Consolidation|Death|3|||
161600791|NCT01208662|583590473|FG002|Induction and Consolidation|Death|1|||
161600792|NCT01208662|583590471|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
161600793|NCT01208662|583590472|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
161600794|NCT01208662|583590473|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
161600795|NCT01208662|583590471|FG000|Maintenance|Disease Progression|156|||
161600796|NCT01208662|583590472|FG001|Maintenance|Disease Progression|102|||
161600797|NCT01208662|583590473|FG002|Maintenance|Disease Progression|0|||
161600798|NCT01208662|583590471|FG000|Maintenance|Adverse Event|12|||
161600799|NCT01208662|583590472|FG001|Maintenance|Adverse Event|28|||
161600800|NCT01208662|583590473|FG002|Maintenance|Adverse Event|0|||
161600801|NCT01208662|583590471|FG000|Maintenance|MD or Participant Decision|24|||
161600802|NCT01208662|583590472|FG001|Maintenance|MD or Participant Decision|36|||
161600803|NCT01208662|583590473|FG002|Maintenance|MD or Participant Decision|0|||
161600804|NCT01208662|583590471|FG000|Maintenance|Death|0|||
161600805|NCT01208662|583590472|FG001|Maintenance|Death|3|||
161600806|NCT01208662|583590473|FG002|Maintenance|Death|0|||
161600807|NCT01208662|583590471|FG000|Maintenance|Discontinued for other reasons|21|||
161600808|NCT01208662|583590472|FG001|Maintenance|Discontinued for other reasons|31|||
161600809|NCT01208662|583590473|FG002|Maintenance|Discontinued for other reasons|0|||
161600810|NCT01208662|583590471|FG000|Maintenance|Still on Treatment|78|||
161600811|NCT01208662|583590472|FG001|Maintenance|Still on Treatment|89|||
161600812|NCT01208662|583590473|FG002|Maintenance|Still on Treatment|0|||
161600813|NCT04433208|583590474|FG000|Overall Study|Withdrawal by Subject|0|||
161600814|NCT04433208|583590475|FG001|Overall Study|Withdrawal by Subject|1|||
161600815|NCT04433208|583590476|FG002|Overall Study|Withdrawal by Subject|1|||
161600816|NCT04433208|583590477|FG003|Overall Study|Withdrawal by Subject|0|||
161600817|NCT04433208|583590478|FG004|Overall Study|Withdrawal by Subject|2|||
161600818|NCT04433208|583590479|FG005|Overall Study|Withdrawal by Subject|1|||
161600819|NCT04433208|583590474|FG000|Overall Study|Lost to Follow-up|0|||
161600820|NCT04433208|583590475|FG001|Overall Study|Lost to Follow-up|0|||
161600821|NCT04433208|583590476|FG002|Overall Study|Lost to Follow-up|0|||
161600822|NCT04433208|583590477|FG003|Overall Study|Lost to Follow-up|0|||
161600823|NCT04433208|583590478|FG004|Overall Study|Lost to Follow-up|0|||
161600824|NCT04433208|583590479|FG005|Overall Study|Lost to Follow-up|1|||
161600825|NCT05269966|583590487|FG000|Overall Study|Adverse Event|4|||
161600826|NCT05269966|583590487|FG000|Overall Study|Withdrawal by Subject|1|||
161600827|NCT05269966|583590487|FG000|Overall Study|Lost to Follow-up|4|||
161600828|NCT05269966|583590487|FG000|Overall Study|Physician Decision|1|||
161600829|NCT06262347|583590490|FG000|Overall Study|Lost to Follow-up|4|||
161600830|NCT06262347|583590491|FG001|Overall Study|Lost to Follow-up|3|||
161600831|NCT06262347|583590490|FG000|Overall Study|Withdrawal by Subject|0|||
161600832|NCT06262347|583590491|FG001|Overall Study|Withdrawal by Subject|1|||
161600833|NCT03476343|583590492|FG000|Overall Study|Clinical exam moved to another scanner|7|||
161600834|NCT03476343|583590492|FG000|Overall Study|Clinical order cancelled|4|||
161600835|NCT03476343|583590492|FG000|Overall Study|Neonate did not settle down for the scan|1|||
161600836|NCT05974501|583590493|FG000|Overall Study|Physician Decision|0|||
161600837|NCT05974501|583590494|FG001|Overall Study|Physician Decision|1|||
161600838|NCT04304144|583590495|FG000|DLT Observation Period|Physician Decision|0|||
161600839|NCT04304144|583590496|FG001|DLT Observation Period|Physician Decision|1|||
161600840|NCT04304144|583590497|FG002|DLT Observation Period|Physician Decision|0|||
161600841|NCT04304144|583590498|FG003|DLT Observation Period|Physician Decision|0|||
161600842|NCT04304144|583590495|FG000|Continued Treatment Period|Adverse Event|0|||
161600843|NCT04304144|583590496|FG001|Continued Treatment Period|Adverse Event|1|||
161600844|NCT04304144|583590497|FG002|Continued Treatment Period|Adverse Event|0|||
161600845|NCT04304144|583590498|FG003|Continued Treatment Period|Adverse Event|0|||
161600846|NCT04304144|583590495|FG000|Continued Treatment Period|Death|0|||
161600847|NCT04304144|583590496|FG001|Continued Treatment Period|Death|0|||
161600848|NCT04304144|583590497|FG002|Continued Treatment Period|Death|1|||
161600849|NCT04304144|583590498|FG003|Continued Treatment Period|Death|2|||
161600850|NCT04304144|583590495|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
161600851|NCT04304144|583590496|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
161600852|NCT04304144|583590497|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
161600853|NCT04304144|583590498|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
161600854|NCT04304144|583590495|FG000|Continued Treatment Period|Other than specified|2|||
161600855|NCT04304144|583590496|FG001|Continued Treatment Period|Other than specified|0|||
161600856|NCT04304144|583590497|FG002|Continued Treatment Period|Other than specified|1|||
161600857|NCT04304144|583590498|FG003|Continued Treatment Period|Other than specified|1|||
161600858|NCT04101357|583590499|FG000|Overall Study|Death|1|||
161600859|NCT04101357|583590500|FG001|Overall Study|Death|1|||
161600860|NCT04101357|583590501|FG002|Overall Study|Death|1|||
161600861|NCT04101357|583590502|FG003|Overall Study|Death|2|||
161830605|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
161830606|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
161830607|NCT00545688|584420174|FG000|Follow-Up Period|Death|4|||
161830608|NCT00545688|584420175|FG001|Follow-Up Period|Death|2|||
161830609|NCT00545688|584420176|FG002|Follow-Up Period|Death|2|||
161830610|NCT00545688|584420177|FG003|Follow-Up Period|Death|6|||
161830611|NCT00545688|584420174|FG000|Follow-Up Period|Disease Progression|6|||
161830612|NCT00545688|584420175|FG001|Follow-Up Period|Disease Progression|5|||
161830613|NCT00545688|584420176|FG002|Follow-Up Period|Disease Progression|9|||
161830614|NCT00545688|584420177|FG003|Follow-Up Period|Disease Progression|9|||
161830615|NCT00545688|584420174|FG000|Follow-Up Period|Refused Treatment|6|||
161830616|NCT00545688|584420175|FG001|Follow-Up Period|Refused Treatment|2|||
161830617|NCT00545688|584420176|FG002|Follow-Up Period|Refused Treatment|0|||
161830618|NCT00545688|584420177|FG003|Follow-Up Period|Refused Treatment|2|||
161830619|NCT00545688|584420174|FG000|Follow-Up Period|Lost to Follow-up|3|||
161830620|NCT00545688|584420175|FG001|Follow-Up Period|Lost to Follow-up|3|||
161830621|NCT00545688|584420176|FG002|Follow-Up Period|Lost to Follow-up|3|||
161830622|NCT00545688|584420177|FG003|Follow-Up Period|Lost to Follow-up|1|||
161830623|NCT00545688|584420174|FG000|Follow-Up Period|Unspecified Reason|2|||
161830624|NCT00545688|584420175|FG001|Follow-Up Period|Unspecified Reason|5|||
161830625|NCT00545688|584420176|FG002|Follow-Up Period|Unspecified Reason|6|||
161830626|NCT00545688|584420177|FG003|Follow-Up Period|Unspecified Reason|8|||
161830627|NCT00545688|584420174|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
161830628|NCT00545688|584420175|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
161830629|NCT00545688|584420176|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
161830630|NCT00545688|584420177|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
161830631|NCT02339090|584420178|FG000|Overall Study|Adverse Event|1|||
161830632|NCT02339090|584420179|FG001|Overall Study|Adverse Event|0|||
161830633|NCT02339090|584420178|FG000|Overall Study|Lost to Follow-up|0|||
161830634|NCT02339090|584420179|FG001|Overall Study|Lost to Follow-up|1|||
161830635|NCT02339090|584420178|FG000|Overall Study|Non-compliance With Study Drug|0|||
161830636|NCT02339090|584420179|FG001|Overall Study|Non-compliance With Study Drug|1|||
161830637|NCT02339090|584420178|FG000|Overall Study|Withdrawal by Subject|2|||
161830638|NCT02339090|584420179|FG001|Overall Study|Withdrawal by Subject|1|||
161830639|NCT02339090|584420178|FG000|Overall Study|Poor Growth|3|||
161830640|NCT02339090|584420179|FG001|Overall Study|Poor Growth|0|||
161600862|NCT04101357|583590503|FG004|Overall Study|Death|4|||
161600863|NCT04101357|583590504|FG005|Overall Study|Death|11|||
161600864|NCT04101357|583590505|FG006|Overall Study|Death|4|||
161600865|NCT04101357|583590506|FG007|Overall Study|Death|4|||
161600866|NCT04101357|583590507|FG008|Overall Study|Death|5|||
161600867|NCT04101357|583590508|FG009|Overall Study|Death|2|||
161600868|NCT04101357|583590509|FG010|Overall Study|Death|3|||
161600869|NCT04101357|583590499|FG000|Overall Study|Trial closure|0|||
161600870|NCT04101357|583590500|FG001|Overall Study|Trial closure|0|||
161600871|NCT04101357|583590501|FG002|Overall Study|Trial closure|0|||
161600872|NCT04101357|583590502|FG003|Overall Study|Trial closure|0|||
161600873|NCT04101357|583590503|FG004|Overall Study|Trial closure|0|||
161600874|NCT04101357|583590504|FG005|Overall Study|Trial closure|2|||
161600875|NCT04101357|583590505|FG006|Overall Study|Trial closure|2|||
161600876|NCT04101357|583590506|FG007|Overall Study|Trial closure|0|||
161600877|NCT04101357|583590507|FG008|Overall Study|Trial closure|0|||
161600878|NCT04101357|583590508|FG009|Overall Study|Trial closure|0|||
161600879|NCT04101357|583590509|FG010|Overall Study|Trial closure|1|||
161600880|NCT04101357|583590499|FG000|Overall Study|Lost to Follow-up|0|||
161600881|NCT04101357|583590500|FG001|Overall Study|Lost to Follow-up|0|||
161600882|NCT04101357|583590501|FG002|Overall Study|Lost to Follow-up|0|||
161600883|NCT04101357|583590502|FG003|Overall Study|Lost to Follow-up|1|||
161600884|NCT04101357|583590503|FG004|Overall Study|Lost to Follow-up|0|||
161600885|NCT04101357|583590504|FG005|Overall Study|Lost to Follow-up|0|||
161600886|NCT04101357|583590505|FG006|Overall Study|Lost to Follow-up|0|||
161600887|NCT04101357|583590506|FG007|Overall Study|Lost to Follow-up|1|||
161600888|NCT04101357|583590507|FG008|Overall Study|Lost to Follow-up|0|||
161600889|NCT04101357|583590508|FG009|Overall Study|Lost to Follow-up|0|||
161600890|NCT04101357|583590509|FG010|Overall Study|Lost to Follow-up|0|||
161682102|NCT03519867|583887474|FG001|Overall Study|Admin. of other reversal agent|1|||
161830641|NCT02339090|584420178|FG000|Overall Study|Randomized but not treated|0|||
161830642|NCT02339090|584420179|FG001|Overall Study|Randomized but not treated|2|||
161830643|NCT02792218|584420183|FG000|Overall Study|Patient/guardian decision|15|||
161830644|NCT02792218|584420184|FG001|Overall Study|Patient/guardian decision|42|||
161830645|NCT02792218|584420183|FG000|Overall Study|Adverse Event|15|||
161830646|NCT02792218|584420184|FG001|Overall Study|Adverse Event|14|||
161830647|NCT02792218|584420183|FG000|Overall Study|Lost to Follow-up|10|||
161600891|NCT04101357|583590499|FG000|Overall Study|Withdrawal by Subject|1|||
161600892|NCT04101357|583590500|FG001|Overall Study|Withdrawal by Subject|0|||
161830648|NCT02792218|584420184|FG001|Overall Study|Lost to Follow-up|5|||
161830649|NCT02792218|584420183|FG000|Overall Study|Lack of Efficacy|1|||
161830650|NCT02792218|584420184|FG001|Overall Study|Lack of Efficacy|12|||
161600893|NCT04101357|583590501|FG002|Overall Study|Withdrawal by Subject|0|||
161600894|NCT04101357|583590502|FG003|Overall Study|Withdrawal by Subject|0|||
161600895|NCT04101357|583590503|FG004|Overall Study|Withdrawal by Subject|0|||
161600896|NCT04101357|583590504|FG005|Overall Study|Withdrawal by Subject|0|||
161600897|NCT04101357|583590505|FG006|Overall Study|Withdrawal by Subject|0|||
161600898|NCT04101357|583590506|FG007|Overall Study|Withdrawal by Subject|0|||
161600899|NCT04101357|583590507|FG008|Overall Study|Withdrawal by Subject|1|||
161600900|NCT04101357|583590508|FG009|Overall Study|Withdrawal by Subject|1|||
161600901|NCT04101357|583590509|FG010|Overall Study|Withdrawal by Subject|0|||
161600902|NCT04101357|583590499|FG000|Overall Study|Other|0|||
161600903|NCT04101357|583590500|FG001|Overall Study|Other|0|||
161600904|NCT04101357|583590501|FG002|Overall Study|Other|0|||
161600905|NCT04101357|583590502|FG003|Overall Study|Other|0|||
161600906|NCT04101357|583590503|FG004|Overall Study|Other|0|||
161600907|NCT04101357|583590504|FG005|Overall Study|Other|1|||
161600908|NCT04101357|583590505|FG006|Overall Study|Other|2|||
161600909|NCT04101357|583590506|FG007|Overall Study|Other|1|||
161600910|NCT04101357|583590507|FG008|Overall Study|Other|0|||
161600911|NCT04101357|583590508|FG009|Overall Study|Other|0|||
161600912|NCT04101357|583590509|FG010|Overall Study|Other|0|||
161600913|NCT04101357|583590499|FG000|Overall Study|Enrolled but not treated|0|||
161600914|NCT04101357|583590500|FG001|Overall Study|Enrolled but not treated|0|||
161682103|NCT03519867|583887475|FG002|Overall Study|Admin. of other reversal agent|0|||
161682104|NCT03519867|583887476|FG003|Overall Study|Admin. of other reversal agent|0|||
161682105|NCT03519867|583887477|FG004|Overall Study|Admin. of other reversal agent|0|||
161682106|NCT03519867|583887478|FG005|Overall Study|Admin. of other reversal agent|1|||
161682107|NCT03519867|583887479|FG006|Overall Study|Admin. of other reversal agent|0|||
161682108|NCT03519867|583887480|FG007|Overall Study|Admin. of other reversal agent|0|||
161682109|NCT03519867|583887481|FG008|Overall Study|Admin. of other reversal agent|0|||
161682110|NCT03519867|583887482|FG009|Overall Study|Admin. of other reversal agent|0|||
161682111|NCT03519867|583887473|FG000|Overall Study|Reason not provided|1|||
161682112|NCT03519867|583887474|FG001|Overall Study|Reason not provided|1|||
161682113|NCT03519867|583887475|FG002|Overall Study|Reason not provided|1|||
161682114|NCT03519867|583887476|FG003|Overall Study|Reason not provided|1|||
161682115|NCT03519867|583887477|FG004|Overall Study|Reason not provided|0|||
161682116|NCT03519867|583887478|FG005|Overall Study|Reason not provided|1|||
161682117|NCT03519867|583887479|FG006|Overall Study|Reason not provided|0|||
161682118|NCT03519867|583887480|FG007|Overall Study|Reason not provided|1|||
161682119|NCT03519867|583887481|FG008|Overall Study|Reason not provided|1|||
161682120|NCT03519867|583887482|FG009|Overall Study|Reason not provided|0|||
161682121|NCT01846624|583887483|FG000|Overall Study|Died during induction, no midostaurin|1|||
161682122|NCT01202279|583887486|FG000|Overall Study|Adverse Event|8|||
161600915|NCT04101357|583590501|FG002|Overall Study|Enrolled but not treated|0|||
161600916|NCT04101357|583590502|FG003|Overall Study|Enrolled but not treated|0|||
161600917|NCT04101357|583590503|FG004|Overall Study|Enrolled but not treated|0|||
161600918|NCT04101357|583590504|FG005|Overall Study|Enrolled but not treated|1|||
161600919|NCT04101357|583590505|FG006|Overall Study|Enrolled but not treated|1|||
161600920|NCT04101357|583590506|FG007|Overall Study|Enrolled but not treated|0|||
161600921|NCT04101357|583590507|FG008|Overall Study|Enrolled but not treated|0|||
161600922|NCT04101357|583590508|FG009|Overall Study|Enrolled but not treated|0|||
161600923|NCT04101357|583590509|FG010|Overall Study|Enrolled but not treated|0|||
161600924|NCT02497950|583590512|FG000|Overall Study|Death|209|||
161600925|NCT02497950|583590512|FG000|Overall Study|Transplanted|85|||
161600926|NCT02497950|583590512|FG000|Overall Study|Explanted|8|||
161600927|NCT02497950|583590512|FG000|Overall Study|Device Permanently Deactivated|4|||
161600928|NCT02497950|583590512|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
161600929|NCT02497950|583590512|FG000|Overall Study|Lost to Follow-up|6|||
161600930|NCT02497950|583590512|FG000|Overall Study|Withdrawal by Subject|2|||
161600931|NCT02497950|583590512|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
161600932|NCT02497950|583590512|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
161682123|NCT01202279|583887487|FG001|Overall Study|Adverse Event|6|||
161600933|NCT04660539|583590513|FG000|Overall Study|Adverse Event|10|||
161600934|NCT04660539|583590513|FG000|Overall Study|Lack of Efficacy|4|||
161600935|NCT04660539|583590513|FG000|Overall Study|Lost to Follow-up|5|||
161600936|NCT04660539|583590513|FG000|Overall Study|Non-Compliance With Study Drug|3|||
161682124|NCT01202279|583887486|FG000|Overall Study|Withdrawal by Subject|13|||
161682125|NCT01202279|583887487|FG001|Overall Study|Withdrawal by Subject|10|||
161600937|NCT04660539|583590513|FG000|Overall Study|Reason not Specified|12|||
161600938|NCT04660539|583590513|FG000|Overall Study|Pregnancy|2|||
161600939|NCT04660539|583590513|FG000|Overall Study|Protocol Violation|2|||
161600940|NCT04660539|583590513|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
161600941|NCT04660539|583590513|FG000|Overall Study|Withdrawal by Subject|21|||
161600942|NCT03852550|583590516|FG000|Overall Study|Lost to Follow-up|4|||
161600943|NCT03852550|583590517|FG001|Overall Study|Lost to Follow-up|3|||
161600944|NCT03852550|583590516|FG000|Overall Study|Only parent outcomes completed|0|||
161600945|NCT03852550|583590517|FG001|Overall Study|Only parent outcomes completed|1|||
161600946|NCT03852550|583590516|FG000|Overall Study|Withdrawal by Subject|1|||
161682126|NCT01202279|583887486|FG000|Overall Study|Physician Decision|0|||
161682127|NCT01202279|583887487|FG001|Overall Study|Physician Decision|1|||
161600947|NCT03852550|583590517|FG001|Overall Study|Withdrawal by Subject|0|||
161600948|NCT05873556|583590528|FG000|Overall Study|Lost to Follow-up|4|||
161600949|NCT05873556|583590529|FG001|Overall Study|Lost to Follow-up|1|||
161600950|NCT03606408|583590531|FG000|Overall Study|Adverse Event|13|||
161600951|NCT03606408|583590531|FG000|Overall Study|Withdrawal by Subject|7|||
161600952|NCT03606408|583590531|FG000|Overall Study|Physician Decision|4|||
161600953|NCT03606408|583590531|FG000|Overall Study|Lack of Efficacy|2|||
161600954|NCT03606408|583590531|FG000|Overall Study|Death|1|||
161600955|NCT03606408|583590531|FG000|Overall Study|new therapy for study indication|1|||
161600956|NCT05425420|583590543|FG000|Overall Study|Physician Decision|1|||
161600957|NCT05425420|583590543|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
161600958|NCT03714815|583590544|FG000|Overall Study|Physician Decision|2|||
161600959|NCT03714815|583590544|FG000|Overall Study|Withdrawal by Subject|2|||
161600960|NCT03714815|583590544|FG000|Overall Study|Death|11|||
161600961|NCT03505008|583590548|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
161600962|NCT03505008|583590549|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
161600963|NCT03505008|583590550|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
161600964|NCT03505008|583590551|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
161600965|NCT03505008|583590548|FG000|Before Week 24 Randomization|Adverse Event|10|||
161600966|NCT03505008|583590549|FG001|Before Week 24 Randomization|Adverse Event|0|||
161682128|NCT01202279|583887486|FG000|Overall Study|Lost to Follow-up|10|||
161682129|NCT01202279|583887487|FG001|Overall Study|Lost to Follow-up|7|||
161682130|NCT01202279|583887486|FG000|Overall Study|Protocol Violation|1|||
161682131|NCT01202279|583887487|FG001|Overall Study|Protocol Violation|1|||
161682132|NCT01202279|583887486|FG000|Overall Study|study compliance|5|||
161682133|NCT01202279|583887487|FG001|Overall Study|study compliance|2|||
161682134|NCT03574753|583887488|FG000|Overall Study|Adverse Event|3|||
161682135|NCT03574753|583887488|FG000|Overall Study|Progression/relapse|19|||
161682136|NCT03574753|583887488|FG000|Overall Study|Death|1|||
161682137|NCT03472924|583887489|FG000|Overall Study|Adverse Event|1|||
161600967|NCT03505008|583590550|FG002|Before Week 24 Randomization|Adverse Event|0|||
161600968|NCT03505008|583590551|FG003|Before Week 24 Randomization|Adverse Event|0|||
161600969|NCT03505008|583590548|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
161600970|NCT03505008|583590549|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
161600971|NCT03505008|583590550|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
161600972|NCT03505008|583590551|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
161682138|NCT03472924|583887490|FG001|Overall Study|Adverse Event|0|||
161682139|NCT02546765|583887492|FG000|Overall Study|Withdrawal by Subject|0|||
161682140|NCT02546765|583887493|FG001|Overall Study|Withdrawal by Subject|1|||
161682141|NCT02546765|583887494|FG002|Overall Study|Withdrawal by Subject|0|||
161682142|NCT02546765|583887495|FG003|Overall Study|Withdrawal by Subject|0|||
161682143|NCT04425720|583887498|FG000|Overall Study|Withdrawal by Subject|0|||
161682144|NCT04425720|583887499|FG001|Overall Study|Withdrawal by Subject|20|||
161682145|NCT00807742|583887500|FG000|Overall Study|Death|9|||
161682146|NCT00807742|583887501|FG001|Overall Study|Death|2|||
161682147|NCT00807742|583887500|FG000|Overall Study|Withdrawal by Subject|2|||
161682148|NCT00807742|583887501|FG001|Overall Study|Withdrawal by Subject|1|||
161682149|NCT00807742|583887500|FG000|Overall Study|Lost to Follow-up|35|||
161682150|NCT00807742|583887501|FG001|Overall Study|Lost to Follow-up|51|||
161600973|NCT03505008|583590548|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
161600974|NCT03505008|583590549|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
161600975|NCT03505008|583590550|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
161600976|NCT03505008|583590551|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
161600977|NCT03505008|583590548|FG000|Before Week 24 Randomization|Physician Decision|2|||
161600978|NCT03505008|583590549|FG001|Before Week 24 Randomization|Physician Decision|0|||
161600979|NCT03505008|583590550|FG002|Before Week 24 Randomization|Physician Decision|0|||
161600980|NCT03505008|583590551|FG003|Before Week 24 Randomization|Physician Decision|0|||
161600981|NCT03505008|583590548|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
161600982|NCT03505008|583590549|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
161682151|NCT04814823|583887503|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
161682152|NCT02044133|583887507|FG000|Overall Study|Lost to Follow-up|1|||
161600983|NCT03505008|583590550|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
161600984|NCT03505008|583590551|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
161600985|NCT03505008|583590548|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
161600986|NCT03505008|583590549|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
161600987|NCT03505008|583590550|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
161682153|NCT02044133|583887508|FG001|Overall Study|Lost to Follow-up|1|||
161682154|NCT02044133|583887507|FG000|Overall Study|Death|1|||
161682155|NCT02044133|583887508|FG001|Overall Study|Death|0|||
161830651|NCT02792218|584420183|FG000|Overall Study|Physician Decision|4|||
161830652|NCT02792218|584420184|FG001|Overall Study|Physician Decision|4|||
161830653|NCT02792218|584420183|FG000|Overall Study|Protocol deviation|3|||
161830654|NCT02792218|584420184|FG001|Overall Study|Protocol deviation|2|||
161830655|NCT02792218|584420183|FG000|Overall Study|New therapy for study indication|0|||
161600988|NCT03505008|583590551|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
161600989|NCT03505008|583590548|FG000|Before Week 24 Randomization|Complication|1|||
161600990|NCT03505008|583590549|FG001|Before Week 24 Randomization|Complication|0|||
161600991|NCT03505008|583590550|FG002|Before Week 24 Randomization|Complication|0|||
161600992|NCT03505008|583590551|FG003|Before Week 24 Randomization|Complication|0|||
161600993|NCT03505008|583590548|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
161600994|NCT03505008|583590549|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
161600995|NCT03505008|583590550|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
161830656|NCT02792218|584420184|FG001|Overall Study|New therapy for study indication|1|||
161830657|NCT02792218|584420183|FG000|Overall Study|Non-compliance with study treatment|0|||
161830658|NCT02792218|584420184|FG001|Overall Study|Non-compliance with study treatment|1|||
161830659|NCT02792218|584420183|FG000|Overall Study|Pregnancy|1|||
161830660|NCT02792218|584420184|FG001|Overall Study|Pregnancy|0|||
161830661|NCT00248170|584420185|FG000|Overall Study|Withdrawal by Subject|71|||
161830662|NCT00248170|584420186|FG001|Overall Study|Withdrawal by Subject|79|||
161830663|NCT00248170|584420185|FG000|Overall Study|Protocol Violation|35|||
161830664|NCT00248170|584420186|FG001|Overall Study|Protocol Violation|30|||
161830665|NCT00248170|584420185|FG000|Overall Study|Lost to Follow-up|28|||
161830666|NCT00248170|584420186|FG001|Overall Study|Lost to Follow-up|35|||
161830667|NCT00248170|584420185|FG000|Overall Study|Disease progression|196|||
161830668|NCT00248170|584420186|FG001|Overall Study|Disease progression|216|||
161830669|NCT00248170|584420185|FG000|Overall Study|Death|28|||
161830670|NCT00248170|584420186|FG001|Overall Study|Death|47|||
161830671|NCT00248170|584420185|FG000|Overall Study|Adverse Event|311|||
161830672|NCT00248170|584420186|FG001|Overall Study|Adverse Event|296|||
161830673|NCT00248170|584420185|FG000|Overall Study|Administrative problems|22|||
161830674|NCT00248170|584420186|FG001|Overall Study|Administrative problems|25|||
161830675|NCT00248170|584420185|FG000|Overall Study|Abnormal test procedure(s) result|49|||
161600996|NCT03505008|583590551|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
161600997|NCT03505008|583590548|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
161830676|NCT00248170|584420186|FG001|Overall Study|Abnormal test procedure(s) result|61|||
161830677|NCT00248170|584420185|FG000|Overall Study|Abnormal laboratory values|4|||
161830678|NCT00248170|584420186|FG001|Overall Study|Abnormal laboratory values|0|||
161830679|NCT00248170|584420185|FG000|Overall Study|Protocol deviation|17|||
161830680|NCT00248170|584420186|FG001|Overall Study|Protocol deviation|19|||
161600998|NCT03505008|583590549|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
161600999|NCT03505008|583590550|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
161601000|NCT03505008|583590551|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
161601001|NCT03505008|583590548|FG000|After Week 24 Randomization|Adverse Event|0|||
161601002|NCT03505008|583590549|FG001|After Week 24 Randomization|Adverse Event|1|||
161601003|NCT03505008|583590550|FG002|After Week 24 Randomization|Adverse Event|2|||
161601004|NCT03505008|583590551|FG003|After Week 24 Randomization|Adverse Event|2|||
161601005|NCT03505008|583590548|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
161601006|NCT03505008|583590549|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
161601007|NCT03505008|583590550|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
161601008|NCT03505008|583590551|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
161601009|NCT03505008|583590548|FG000|After Week 24 Randomization|Protocol Violation|0|||
161601010|NCT03505008|583590549|FG001|After Week 24 Randomization|Protocol Violation|0|||
161601011|NCT03505008|583590550|FG002|After Week 24 Randomization|Protocol Violation|1|||
161601012|NCT03505008|583590551|FG003|After Week 24 Randomization|Protocol Violation|0|||
161601013|NCT02437136|583590552|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
161601014|NCT02437136|583590553|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161601015|NCT02437136|583590554|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161601016|NCT02437136|583590555|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161601017|NCT02437136|583590556|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161601018|NCT02437136|583590557|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161601019|NCT02437136|583590558|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161601020|NCT02437136|583590552|FG000|Expansion (Phase 2)|Death|0|||
161601021|NCT02437136|583590553|FG001|Expansion (Phase 2)|Death|0|||
161601022|NCT02437136|583590554|FG002|Expansion (Phase 2)|Death|0|||
161601023|NCT02437136|583590555|FG003|Expansion (Phase 2)|Death|6|||
161601024|NCT02437136|583590556|FG004|Expansion (Phase 2)|Death|37|||
161601025|NCT02437136|583590557|FG005|Expansion (Phase 2)|Death|29|||
161601026|NCT02437136|583590558|FG006|Expansion (Phase 2)|Death|24|||
161830681|NCT03123783|584420187|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830682|NCT03123783|584420188|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
161830683|NCT03123783|584420189|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830684|NCT03123783|584420190|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830685|NCT03123783|584420191|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830686|NCT03123783|584420192|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830687|NCT03123783|584420193|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830688|NCT03123783|584420187|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
161830689|NCT03123783|584420188|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
161830690|NCT03123783|584420189|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
161830691|NCT03123783|584420190|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
161830692|NCT03123783|584420191|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
161830693|NCT03123783|584420192|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
161830694|NCT03123783|584420193|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
161830695|NCT03123783|584420187|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
161830696|NCT03123783|584420188|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
161830697|NCT03123783|584420189|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
161830698|NCT03123783|584420190|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
161830699|NCT03123783|584420191|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
161830700|NCT03123783|584420192|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
161830701|NCT03123783|584420193|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
161830702|NCT03123783|584420187|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161601027|NCT02437136|583590552|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
161601028|NCT02437136|583590553|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
161601029|NCT02437136|583590554|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
161601030|NCT02437136|583590555|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
161601031|NCT02437136|583590556|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
161601032|NCT02437136|583590557|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
161601033|NCT02437136|583590558|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
161601034|NCT02437136|583590552|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
161601035|NCT02437136|583590553|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
161601036|NCT02437136|583590554|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
161601037|NCT02437136|583590555|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
161601038|NCT02437136|583590556|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
161601039|NCT02437136|583590557|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
161601040|NCT02437136|583590558|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
161601041|NCT02056834|583590559|FG000|Overall Study|Lost to Follow-up|7|||
161601042|NCT00323856|583590560|FG000|Overall Study|Withdrawal by Subject|1|||
161601043|NCT00323856|583590560|FG000|Overall Study|Was uncooperative and noncompliant|1|||
161601044|NCT00323856|583590560|FG000|Overall Study|Reason not specified|1|||
161601045|NCT00323856|583590560|FG000|Overall Study|Missing|2|||
161601046|NCT04580914|583590561|FG000|Overall Study|Withdrawal by Subject|6|||
161601047|NCT04580914|583590561|FG000|Overall Study|Lost to Follow-up|2|||
161601048|NCT02828358|583590563|FG000|Overall Study|Physician Decision|7|||
161601049|NCT02828358|583590564|FG001|Overall Study|Physician Decision|1|||
161601050|NCT02828358|583590563|FG000|Overall Study|Treatment Failure|6|||
161601051|NCT02828358|583590564|FG001|Overall Study|Treatment Failure|0|||
161601052|NCT02828358|583590563|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
161601053|NCT02828358|583590564|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
161601054|NCT02828358|583590563|FG000|Overall Study|Refusal of further protocol therapy|2|||
161601055|NCT02828358|583590564|FG001|Overall Study|Refusal of further protocol therapy|0|||
161601056|NCT02828358|583590563|FG000|Overall Study|Relapse|25|||
161601057|NCT02828358|583590564|FG001|Overall Study|Relapse|0|||
161601058|NCT02828358|583590563|FG000|Overall Study|Still on therapy|5|||
161601059|NCT02828358|583590564|FG001|Overall Study|Still on therapy|0|||
161601060|NCT03993392|583590578|FG000|Overall Study|Withdrawal by Subject|3|||
161601061|NCT03993392|583590578|FG000|Overall Study|Lost to Follow-up|2|||
161601062|NCT03993392|583590578|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
161601063|NCT05292391|583590581|FG000|Overall Study|Lost to Follow-up|0|||
161601064|NCT05292391|583590582|FG001|Overall Study|Lost to Follow-up|0|||
161601065|NCT05292391|583590583|FG002|Overall Study|Lost to Follow-up|0|||
161601066|NCT05292391|583590584|FG003|Overall Study|Lost to Follow-up|1|||
161601067|NCT05292391|583590585|FG004|Overall Study|Lost to Follow-up|0|||
161601068|NCT04857723|583590588|FG000|Overall Study|Withdrawal by Subject|2|||
161601069|NCT01064440|583592255|FG000|Overall Study|Lost to Follow-up|1|||
161601070|NCT01064440|583592256|FG001|Overall Study|Lost to Follow-up|1|||
161601071|NCT01064440|583592257|FG002|Overall Study|Lost to Follow-up|1|||
161601072|NCT01064440|583592255|FG000|Overall Study|Non-compliance|0|||
161601073|NCT01064440|583592256|FG001|Overall Study|Non-compliance|1|||
161601074|NCT01064440|583592257|FG002|Overall Study|Non-compliance|0|||
161601075|NCT01064440|583592255|FG000|Overall Study|Death|1|||
161601076|NCT01064440|583592256|FG001|Overall Study|Death|0|||
161601077|NCT01064440|583592257|FG002|Overall Study|Death|1|||
161601078|NCT01064440|583592255|FG000|Overall Study|Withdrawal by Subject|0|||
161831594|NCT00384293|584424838|FG002|Post-randomization Period|Protocol Violation|0|||
161601079|NCT01064440|583592256|FG001|Overall Study|Withdrawal by Subject|1|||
161601080|NCT01064440|583592257|FG002|Overall Study|Withdrawal by Subject|1|||
161601081|NCT01064440|583592255|FG000|Overall Study|Other: amputation|1|||
161601082|NCT01064440|583592256|FG001|Overall Study|Other: amputation|0|||
161601083|NCT01064440|583592257|FG002|Overall Study|Other: amputation|0|||
161601084|NCT03220035|583592260|FG000|Overall Study|Adverse Event|1|||
161601085|NCT03220035|583592260|FG000|Overall Study|Protocol Violation|1|||
161601086|NCT03220035|583592260|FG000|Overall Study|Progressive Disease|2|||
161601087|NCT04024020|583592261|FG000|Overall Study|Withdrawal by Subject|2|||
161601088|NCT04024020|583592262|FG001|Overall Study|Withdrawal by Subject|2|||
161601089|NCT05618587|583592275|FG000|Overall Study|Lost to Follow-up|2|||
161601090|NCT05618587|583592276|FG001|Overall Study|Lost to Follow-up|0|||
161601091|NCT01828112|583592277|FG000|Treatment Phase|Adverse Event|7|||
161601092|NCT01828112|583592278|FG001|Treatment Phase|Adverse Event|8|||
161601093|NCT01828112|583592279|FG002|Treatment Phase|Adverse Event|0|||
161601094|NCT01828112|583592277|FG000|Treatment Phase|Death|9|||
161601095|NCT01828112|583592278|FG001|Treatment Phase|Death|5|||
161601096|NCT01828112|583592279|FG002|Treatment Phase|Death|0|||
161601097|NCT01828112|583592277|FG000|Treatment Phase|No longer required treatment|0|||
161601098|NCT01828112|583592278|FG001|Treatment Phase|No longer required treatment|1|||
161601099|NCT01828112|583592279|FG002|Treatment Phase|No longer required treatment|0|||
161601100|NCT01828112|583592277|FG000|Treatment Phase|Physician Decision|6|||
161601101|NCT01828112|583592278|FG001|Treatment Phase|Physician Decision|7|||
161601102|NCT01828112|583592279|FG002|Treatment Phase|Physician Decision|0|||
161601103|NCT01828112|583592277|FG000|Treatment Phase|Pregnancy|1|||
161601104|NCT01828112|583592278|FG001|Treatment Phase|Pregnancy|0|||
161601105|NCT01828112|583592279|FG002|Treatment Phase|Pregnancy|0|||
161601106|NCT01828112|583592277|FG000|Treatment Phase|Progressive disease|79|||
161601107|NCT01828112|583592278|FG001|Treatment Phase|Progressive disease|87|||
161601108|NCT01828112|583592279|FG002|Treatment Phase|Progressive disease|0|||
161601109|NCT01828112|583592277|FG000|Treatment Phase|Study terminated by sponsor|1|||
161601110|NCT01828112|583592278|FG001|Treatment Phase|Study terminated by sponsor|0|||
161601111|NCT01828112|583592279|FG002|Treatment Phase|Study terminated by sponsor|0|||
161601112|NCT01828112|583592277|FG000|Treatment Phase|Subject/guardian decision|12|||
161601113|NCT01828112|583592278|FG001|Treatment Phase|Subject/guardian decision|8|||
161601114|NCT01828112|583592279|FG002|Treatment Phase|Subject/guardian decision|0|||
161601115|NCT01828112|583592277|FG000|Extension Treatment Phase|Adverse Event|0|||
161601116|NCT01828112|583592278|FG001|Extension Treatment Phase|Adverse Event|0|||
161601117|NCT01828112|583592279|FG002|Extension Treatment Phase|Adverse Event|6|||
161601118|NCT01828112|583592277|FG000|Extension Treatment Phase|Death|0|||
161601119|NCT01828112|583592278|FG001|Extension Treatment Phase|Death|0|||
161601120|NCT01828112|583592279|FG002|Extension Treatment Phase|Death|17|||
161601121|NCT01828112|583592277|FG000|Extension Treatment Phase|Physician Decision|0|||
161601122|NCT01828112|583592278|FG001|Extension Treatment Phase|Physician Decision|0|||
161601123|NCT01828112|583592279|FG002|Extension Treatment Phase|Physician Decision|5|||
161601124|NCT01828112|583592277|FG000|Extension Treatment Phase|Progressive disease|0|||
161601125|NCT01828112|583592278|FG001|Extension Treatment Phase|Progressive disease|0|||
161601126|NCT01828112|583592279|FG002|Extension Treatment Phase|Progressive disease|46|||
161601127|NCT01828112|583592277|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
161601128|NCT01828112|583592278|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
161601129|NCT01828112|583592279|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
161601130|NCT01828112|583592277|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
161601131|NCT01828112|583592278|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
161601132|NCT01828112|583592279|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
161601133|NCT05565820|583592280|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
161601134|NCT05565820|583592281|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
161601135|NCT05565820|583592280|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
161601136|NCT05565820|583592281|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
161601137|NCT04871529|583592285|FG000|Overall Study|Withdrawal by Subject|0|||
161601138|NCT04871529|583592286|FG001|Overall Study|Withdrawal by Subject|1|||
161601139|NCT04871529|583592285|FG000|Overall Study|Death|0|||
161601140|NCT04871529|583592286|FG001|Overall Study|Death|1|||
161601141|NCT04871529|583592285|FG000|Overall Study|Not protocol specified|0|||
161601142|NCT04871529|583592286|FG001|Overall Study|Not protocol specified|1|||
161601143|NCT05184452|583592287|FG000|Overall Study|Lost to Follow-up|0|||
161601144|NCT05184452|583592288|FG001|Overall Study|Lost to Follow-up|0|||
161601145|NCT05184452|583592289|FG002|Overall Study|Lost to Follow-up|0|||
161601146|NCT05184452|583592290|FG003|Overall Study|Lost to Follow-up|0|||
161601147|NCT05184452|583592291|FG004|Overall Study|Lost to Follow-up|0|||
161601148|NCT05184452|583592292|FG005|Overall Study|Lost to Follow-up|2|||
161601149|NCT05184452|583592293|FG006|Overall Study|Lost to Follow-up|0|||
161601150|NCT05184452|583592294|FG007|Overall Study|Lost to Follow-up|0|||
161601151|NCT05184452|583592295|FG008|Overall Study|Lost to Follow-up|0|||
161601152|NCT05184452|583592296|FG009|Overall Study|Lost to Follow-up|1|||
161601153|NCT05184452|583592287|FG000|Overall Study|Withdrawal by Subject|0|||
161601154|NCT05184452|583592288|FG001|Overall Study|Withdrawal by Subject|0|||
161830703|NCT03123783|584420188|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830704|NCT03123783|584420189|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830705|NCT03123783|584420190|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830706|NCT03123783|584420191|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
161830707|NCT03123783|584420192|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830708|NCT03123783|584420193|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830709|NCT01253317|584420199|FG000|Overall Study|Adverse Event|2|||
161830710|NCT00749411|584420202|FG000|Overall Study|Adverse Event|0|||
161830711|NCT00749411|584420203|FG001|Overall Study|Adverse Event|2|||
161830712|NCT00749411|584420202|FG000|Overall Study|Lack of Efficacy|0|||
161830713|NCT00749411|584420203|FG001|Overall Study|Lack of Efficacy|1|||
161830714|NCT00749411|584420202|FG000|Overall Study|Protocol Violation|1|||
161830715|NCT00749411|584420203|FG001|Overall Study|Protocol Violation|1|||
161830716|NCT00749411|584420202|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161601155|NCT05184452|583592289|FG002|Overall Study|Withdrawal by Subject|0|||
161601156|NCT05184452|583592290|FG003|Overall Study|Withdrawal by Subject|0|||
161601157|NCT05184452|583592291|FG004|Overall Study|Withdrawal by Subject|0|||
161601158|NCT05184452|583592292|FG005|Overall Study|Withdrawal by Subject|1|||
161830717|NCT00749411|584420203|FG001|Overall Study|Protocol-defined stopping criteria|1|||
161830718|NCT03183141|584420204|FG000|Overall Study|Withdrawal by Subject|2|||
161830719|NCT03183141|584420205|FG001|Overall Study|Withdrawal by Subject|4|||
161601159|NCT05184452|583592293|FG006|Overall Study|Withdrawal by Subject|0|||
161601160|NCT05184452|583592294|FG007|Overall Study|Withdrawal by Subject|0|||
161601161|NCT05184452|583592295|FG008|Overall Study|Withdrawal by Subject|0|||
161601162|NCT05184452|583592296|FG009|Overall Study|Withdrawal by Subject|1|||
161601163|NCT05586490|583592297|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161601164|NCT05586490|583592298|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161601165|NCT05586490|583592299|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
161601166|NCT05586490|583592300|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161830720|NCT03183141|584420204|FG000|Overall Study|Death|0|||
161601167|NCT05586490|583592301|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161601168|NCT05586490|583592297|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
161601169|NCT05586490|583592298|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161601170|NCT05586490|583592299|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161601171|NCT05586490|583592300|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161601172|NCT05586490|583592301|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161601173|NCT05586490|583592297|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
161601174|NCT05586490|583592298|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161601175|NCT05586490|583592299|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161601176|NCT05586490|583592300|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161601177|NCT05586490|583592301|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161601178|NCT04689256|583592302|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
161601179|NCT04689256|583592303|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
161601180|NCT04862234|583592304|FG000|Overall Study|Surgery cancellation|1|||
161601181|NCT04862234|583592305|FG001|Overall Study|Surgery cancellation|2|||
161601182|NCT04862234|583592304|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
161601183|NCT04862234|583592305|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
161601184|NCT04862234|583592304|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
161601185|NCT04862234|583592305|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
161601186|NCT05828017|583592306|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
161601187|NCT05012163|583592310|FG000|Overall Study|Protocol Violation|0|||
161601188|NCT05012163|583592311|FG001|Overall Study|Protocol Violation|0|||
161601189|NCT05012163|583592312|FG002|Overall Study|Protocol Violation|1|||
161601190|NCT05012163|583592313|FG003|Overall Study|Protocol Violation|1|||
161601191|NCT04132518|583592321|FG000|Overall Study|Prematurely withdrawn from the study|0|||
161601192|NCT04132518|583592322|FG001|Overall Study|Prematurely withdrawn from the study|9|||
161601193|NCT04132518|583592323|FG002|Overall Study|Prematurely withdrawn from the study|1|||
161601194|NCT03381586|583592324|FG000|Overall Study|Adverse Event|1|||
161601195|NCT03381586|583592325|FG001|Overall Study|Adverse Event|1|||
161601196|NCT03381586|583592324|FG000|Overall Study|Protocol Violation|1|||
161601197|NCT03381586|583592325|FG001|Overall Study|Protocol Violation|0|||
161601198|NCT03381586|583592324|FG000|Overall Study|Withdrawal by Subject|1|||
161601199|NCT03381586|583592325|FG001|Overall Study|Withdrawal by Subject|2|||
161830721|NCT03183141|584420205|FG001|Overall Study|Death|8|||
161830722|NCT01507090|584420209|FG000|Overall Study|incomplete dataset|18|||
161830723|NCT02953678|584420210|FG000|Overall Study|Adverse Event|20|||
161601200|NCT03673501|583592329|FG000|Overall Study|Participants ongoing.|36|||
161601201|NCT03673501|583592330|FG001|Overall Study|Participants ongoing.|24|||
161601202|NCT05838027|583592331|FG000|Overall Study|Lost to Follow-up|5|||
161601203|NCT05838027|583592332|FG001|Overall Study|Lost to Follow-up|1|||
161601204|NCT05838027|583592331|FG000|Overall Study|Withdrawal by Subject|1|||
161601205|NCT05838027|583592332|FG001|Overall Study|Withdrawal by Subject|0|||
161601206|NCT05237284|583592333|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
161601207|NCT05237284|583592334|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
161601208|NCT05237284|583592335|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
161601209|NCT05237284|583592336|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
161601210|NCT05237284|583592333|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
161601211|NCT05237284|583592334|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
161601212|NCT05237284|583592335|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
161601213|NCT05237284|583592336|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
161601214|NCT05237284|583592333|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
161601215|NCT05237284|583592334|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
161601216|NCT05237284|583592335|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
161601217|NCT05237284|583592336|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
161601218|NCT05237284|583592333|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
161601219|NCT05237284|583592334|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
161601220|NCT05237284|583592335|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
161601221|NCT05237284|583592336|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
161601222|NCT05237284|583592333|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
161601223|NCT05237284|583592334|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
161601224|NCT05237284|583592335|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
161601225|NCT05237284|583592336|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
161601226|NCT05237284|583592333|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
161601227|NCT05237284|583592334|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
161601228|NCT05237284|583592335|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
161601229|NCT05237284|583592336|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
161601230|NCT05237284|583592333|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
161601231|NCT05237284|583592334|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
161601232|NCT05237284|583592335|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
161601233|NCT05237284|583592336|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
161601234|NCT05237284|583592333|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
161601235|NCT05237284|583592334|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
161601236|NCT05237284|583592335|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
161601237|NCT05237284|583592336|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
161601238|NCT05237284|583592333|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
161601239|NCT05237284|583592334|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
161601240|NCT05237284|583592335|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
161601241|NCT05237284|583592336|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
161601242|NCT04599634|583592337|FG000|Overall Study|Dose limiting toxicity|0|||
161601243|NCT04599634|583592338|FG001|Overall Study|Dose limiting toxicity|0|||
161601244|NCT04599634|583592339|FG002|Overall Study|Dose limiting toxicity|2|||
161601245|NCT04599634|583592340|FG003|Overall Study|Dose limiting toxicity|0|||
161601246|NCT04999111|583592341|FG000|Overall Study|Lost to Follow-up|21|||
161601247|NCT04999111|583592342|FG001|Overall Study|Lost to Follow-up|16|||
161601248|NCT04999111|583592343|FG002|Overall Study|Lost to Follow-up|2|||
161601249|NCT04999111|583592344|FG003|Overall Study|Lost to Follow-up|26|||
161601250|NCT04999111|583592345|FG004|Overall Study|Lost to Follow-up|30|||
161601251|NCT04999111|583592346|FG005|Overall Study|Lost to Follow-up|6|||
161601252|NCT04999111|583592341|FG000|Overall Study|Physician Decision|1|||
161601253|NCT04999111|583592342|FG001|Overall Study|Physician Decision|3|||
161601254|NCT04999111|583592343|FG002|Overall Study|Physician Decision|0|||
161601255|NCT04999111|583592344|FG003|Overall Study|Physician Decision|1|||
161601256|NCT04999111|583592345|FG004|Overall Study|Physician Decision|2|||
161601257|NCT04999111|583592346|FG005|Overall Study|Physician Decision|0|||
161601258|NCT04999111|583592341|FG000|Overall Study|Withdrawal by Subject|23|||
161601259|NCT04999111|583592342|FG001|Overall Study|Withdrawal by Subject|29|||
161601260|NCT04999111|583592343|FG002|Overall Study|Withdrawal by Subject|15|||
161601261|NCT04999111|583592344|FG003|Overall Study|Withdrawal by Subject|30|||
161601262|NCT04999111|583592345|FG004|Overall Study|Withdrawal by Subject|35|||
161601263|NCT04999111|583592346|FG005|Overall Study|Withdrawal by Subject|10|||
161601264|NCT04999111|583592341|FG000|Overall Study|Other|6|||
161601265|NCT04999111|583592342|FG001|Overall Study|Other|6|||
161601266|NCT04999111|583592343|FG002|Overall Study|Other|3|||
161601267|NCT04999111|583592344|FG003|Overall Study|Other|8|||
161601268|NCT04999111|583592345|FG004|Overall Study|Other|8|||
161601269|NCT04999111|583592346|FG005|Overall Study|Other|5|||
161601270|NCT04999111|583592341|FG000|Overall Study|Non-compliance with study schedule|1|||
161682156|NCT02044133|583887507|FG000|Overall Study|Release|3|||
161682157|NCT02044133|583887508|FG001|Overall Study|Release|4|||
161682158|NCT02044133|583887507|FG000|Overall Study|Transfer|1|||
161682159|NCT02044133|583887508|FG001|Overall Study|Transfer|0|||
161682160|NCT02044133|583887507|FG000|Overall Study|refusal of blood sampling|0|||
161682161|NCT02044133|583887508|FG001|Overall Study|refusal of blood sampling|1|||
161682162|NCT04085523|583887509|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682163|NCT04085523|583887510|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682164|NCT04085523|583887511|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682165|NCT04085523|583887512|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682166|NCT04085523|583887513|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682167|NCT04085523|583887514|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
161682168|NCT00430482|583887516|FG000|Completed Treatment|Insufficient Treatment|7|||
161682169|NCT00430482|583887517|FG001|Completed Treatment|Insufficient Treatment|11|||
161682170|NCT00583024|583887518|FG000|Overall Study|Lost to Follow-up|4|||
161682171|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
161682172|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
161682173|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
161682174|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
161682175|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
161682176|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
161682177|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
161682178|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
161682179|NCT00449670|583888811|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
161682180|NCT00449670|583888812|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
161682181|NCT00449670|583888811|FG000|Booster Phase (Study no.109873)|Other|0|||
161682182|NCT00449670|583888812|FG001|Booster Phase (Study no.109873)|Other|2|||
161682183|NCT01502709|583888813|FG000|Overall Study|Lost to Follow-up|4|||
161682184|NCT01502709|583888814|FG001|Overall Study|Lost to Follow-up|0|||
161682185|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
161682186|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
161682187|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Death|0|||
161682188|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Death|1|||
161682189|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
161682190|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
161682191|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
161682192|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
161682193|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Death|22|||
161682194|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Death|25|||
161548722|NCT04921969|583397947|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
161548723|NCT04921969|583397948|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
161548724|NCT04921969|583397949|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
161548725|NCT04921969|583397950|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
161548726|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
161548727|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
161548728|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
161548729|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
161548730|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
161548731|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
161548732|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
161548733|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161548734|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161548735|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161548736|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
161548737|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161548738|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
161548739|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
161548740|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161548741|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161548742|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161548743|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
161548744|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
161548745|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
161548746|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
161548747|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
161548748|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
161548749|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
161548750|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
161548751|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
161682195|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
161682196|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
161601271|NCT04999111|583592342|FG001|Overall Study|Non-compliance with study schedule|0|||
161601272|NCT04999111|583592343|FG002|Overall Study|Non-compliance with study schedule|0|||
161601273|NCT04999111|583592344|FG003|Overall Study|Non-compliance with study schedule|1|||
161601274|NCT04999111|583592345|FG004|Overall Study|Non-compliance with study schedule|1|||
161601275|NCT04999111|583592346|FG005|Overall Study|Non-compliance with study schedule|1|||
161601276|NCT04999111|583592341|FG000|Overall Study|Randomized but not vaccinated|1|||
161601277|NCT04999111|583592342|FG001|Overall Study|Randomized but not vaccinated|2|||
161601278|NCT04999111|583592343|FG002|Overall Study|Randomized but not vaccinated|0|||
161682197|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
161682198|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
161682199|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
161682200|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
161682201|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Death|36|||
161682202|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Death|33|||
161682203|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
161682204|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
161682205|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
161682206|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
161682207|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
161682208|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
161682209|NCT02966509|583888820|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
161601279|NCT04999111|583592344|FG003|Overall Study|Randomized but not vaccinated|3|||
161601280|NCT04999111|583592345|FG004|Overall Study|Randomized but not vaccinated|3|||
161601281|NCT04999111|583592346|FG005|Overall Study|Randomized but not vaccinated|0|||
161601282|NCT04999111|583592341|FG000|Overall Study|Adverse Event|1|||
161682210|NCT02966509|583888821|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
161601283|NCT04999111|583592342|FG001|Overall Study|Adverse Event|1|||
161601284|NCT04999111|583592343|FG002|Overall Study|Adverse Event|0|||
161601285|NCT04999111|583592344|FG003|Overall Study|Adverse Event|0|||
161601286|NCT04999111|583592345|FG004|Overall Study|Adverse Event|0|||
161601287|NCT04999111|583592346|FG005|Overall Study|Adverse Event|0|||
161601288|NCT04999111|583592341|FG000|Overall Study|Initiated prohibited medication|0|||
161601289|NCT04999111|583592342|FG001|Overall Study|Initiated prohibited medication|0|||
161601290|NCT04999111|583592343|FG002|Overall Study|Initiated prohibited medication|0|||
161601291|NCT04999111|583592344|FG003|Overall Study|Initiated prohibited medication|0|||
161601292|NCT04999111|583592345|FG004|Overall Study|Initiated prohibited medication|1|||
161601293|NCT04999111|583592346|FG005|Overall Study|Initiated prohibited medication|0|||
161601294|NCT04056611|583592350|FG000|Overall Study|Physician Decision|1|||
161601295|NCT03733925|583592353|FG000|Overall Study|Lost to Follow-up|1|||
161601296|NCT03733925|583592353|FG000|Overall Study|Withdrawal by Subject|2|||
161601297|NCT03733925|583592353|FG000|Overall Study|Adverse Event|2|||
161601298|NCT03733925|583592353|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161601299|NCT03213873|583592354|FG000|Overall Study|Withdrawal by Subject|8|||
161601300|NCT03213873|583592355|FG001|Overall Study|Withdrawal by Subject|9|||
161601301|NCT03213873|583592354|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
161601302|NCT03213873|583592355|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
161601303|NCT03213873|583592354|FG000|Overall Study|Lost to Follow-up|0|||
161601304|NCT03213873|583592355|FG001|Overall Study|Lost to Follow-up|2|||
161601305|NCT04709419|583592357|FG000|Overall Study|Physician Decision|1|||
161601306|NCT04709419|583592358|FG001|Overall Study|Physician Decision|0|||
161601307|NCT05683340|583592359|FG000|Overall Study|Adverse Event|1|||
161601308|NCT05683340|583592360|FG001|Overall Study|Adverse Event|1|||
161601309|NCT05683340|583592359|FG000|Overall Study|Protocol Violation|1|||
161601310|NCT05683340|583592360|FG001|Overall Study|Protocol Violation|0|||
161601311|NCT05683340|583592359|FG000|Overall Study|Withdrawal by Subject|0|||
161601312|NCT05683340|583592360|FG001|Overall Study|Withdrawal by Subject|2|||
161601313|NCT02224144|583592364|FG000|Overall Study|Lost to Follow-up|3|||
161601314|NCT02224144|583592365|FG001|Overall Study|Lost to Follow-up|1|||
161601315|NCT02224144|583592364|FG000|Overall Study|Death|2|||
161601316|NCT02224144|583592365|FG001|Overall Study|Death|0|||
161601317|NCT02224144|583592364|FG000|Overall Study|Withdrawal by Subject|0|||
161601318|NCT02224144|583592365|FG001|Overall Study|Withdrawal by Subject|1|||
161601319|NCT02780700|583592368|FG000|Overall Study|Progressive disease|1|||
161682211|NCT02966509|583888820|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
161682212|NCT02966509|583888821|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
161830724|NCT02953678|584420210|FG000|Overall Study|Death|7|||
161601320|NCT03824366|583592383|FG000|Overall Study|Death|1|||
161682213|NCT02982954|583888822|FG000|Overall Study|Death|55|||
161830725|NCT02953678|584420210|FG000|Overall Study|Physician Decision|23|||
161601321|NCT03824366|583592383|FG000|Overall Study|Previously unidentified metal artifact|1|||
161601322|NCT03824366|583592383|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
161601323|NCT03824366|583592383|FG000|Overall Study|Withdrawal by Subject|1|||
161601324|NCT02834390|583592385|FG000|Induction Phase|Progressive disease|0|||
161601325|NCT02834390|583592386|FG001|Induction Phase|Progressive disease|1|||
161601326|NCT02834390|583592385|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
161830726|NCT02953678|584420210|FG000|Overall Study|Progressive Disease of GVHD|7|||
161830727|NCT02953678|584420210|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
161830728|NCT02953678|584420210|FG000|Overall Study|Withdrawal by participant|3|||
161830729|NCT02953678|584420210|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
161830730|NCT02953678|584420210|FG000|Overall Study|Participants were transferred to commercial product.|3|||
161830731|NCT02070757|584421765|FG000|Overall Study|Adverse Event|107|||
161830732|NCT02070757|584421766|FG001|Overall Study|Adverse Event|99|||
161830733|NCT02070757|584421765|FG000|Overall Study|Lost to Follow-up|7|||
161830734|NCT02070757|584421766|FG001|Overall Study|Lost to Follow-up|4|||
161830735|NCT02070757|584421765|FG000|Overall Study|Protocol Violation|0|||
161830736|NCT02070757|584421766|FG001|Overall Study|Protocol Violation|4|||
161830737|NCT02070757|584421765|FG000|Overall Study|Withdrawal by Subject|1|||
161830738|NCT02070757|584421766|FG001|Overall Study|Withdrawal by Subject|3|||
161830739|NCT02070757|584421765|FG000|Overall Study|Investigator Decision|0|||
161830740|NCT02070757|584421766|FG001|Overall Study|Investigator Decision|2|||
161830741|NCT02070757|584421765|FG000|Overall Study|Discharged from Study Hospital|2|||
161830742|NCT02070757|584421766|FG001|Overall Study|Discharged from Study Hospital|2|||
161830743|NCT00126126|584421772|FG000|Overall Study|Lost to Follow-up|0|||
161830744|NCT00126126|584421773|FG001|Overall Study|Lost to Follow-up|2|||
161830745|NCT01570283|584421777|FG000|Cohort 1: Dose Level 1|Death|0|||
161830746|NCT01570283|584421778|FG001|Cohort 1: Dose Level 1|Death|1|||
161830747|NCT01570283|584421779|FG002|Cohort 1: Dose Level 1|Death|0|||
161830748|NCT01570283|584421780|FG003|Cohort 1: Dose Level 1|Death|0|||
161830749|NCT01570283|584421781|FG004|Cohort 1: Dose Level 1|Death|0|||
161830750|NCT01570283|584421782|FG005|Cohort 1: Dose Level 1|Death|0|||
161830751|NCT01570283|584421777|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830752|NCT01570283|584421778|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
161830753|NCT01570283|584421779|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830754|NCT01570283|584421780|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830755|NCT01570283|584421781|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830756|NCT01570283|584421782|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830757|NCT01570283|584421777|FG000|Cohort 2: Dose Level 2|Death|0|||
161830758|NCT01570283|584421778|FG001|Cohort 2: Dose Level 2|Death|0|||
161830759|NCT01570283|584421779|FG002|Cohort 2: Dose Level 2|Death|1|||
161830760|NCT01570283|584421780|FG003|Cohort 2: Dose Level 2|Death|0|||
161830761|NCT01570283|584421781|FG004|Cohort 2: Dose Level 2|Death|0|||
161830762|NCT01570283|584421782|FG005|Cohort 2: Dose Level 2|Death|0|||
161830763|NCT01570283|584421777|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830764|NCT01570283|584421778|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830765|NCT01570283|584421779|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830766|NCT01570283|584421780|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
161601327|NCT02834390|583592386|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
161601328|NCT02834390|583592385|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
161601329|NCT02834390|583592386|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
161601330|NCT02834390|583592385|FG000|Consolidation Phase|Physician Decision|1|||
161601331|NCT02834390|583592386|FG001|Consolidation Phase|Physician Decision|1|||
161601332|NCT03118518|583592387|FG000|Overall Study|Early Exit after treatment|2|||
161601333|NCT03118518|583592388|FG001|Overall Study|Early Exit after treatment|8|||
161601334|NCT03118518|583592387|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
161601335|NCT03118518|583592388|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
161601336|NCT03485729|583592394|FG000|Overall Study|Withdrawal by Subject|0|||
161601337|NCT03485729|583592395|FG001|Overall Study|Withdrawal by Subject|0|||
161601338|NCT03485729|583592396|FG002|Overall Study|Withdrawal by Subject|1|||
161601339|NCT03485729|583592394|FG000|Overall Study|Disease progression|8|||
161601340|NCT03485729|583592395|FG001|Overall Study|Disease progression|13|||
161601341|NCT03485729|583592396|FG002|Overall Study|Disease progression|1|||
161601342|NCT03485729|583592394|FG000|Overall Study|Hospice care|1|||
161601343|NCT03485729|583592395|FG001|Overall Study|Hospice care|0|||
161682214|NCT02982954|583888823|FG001|Overall Study|Death|29|||
161830767|NCT01570283|584421781|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830768|NCT01570283|584421782|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830769|NCT01570283|584421777|FG000|Cohort 3: Dose Level 3|Death|0|||
161830770|NCT01570283|584421778|FG001|Cohort 3: Dose Level 3|Death|0|||
161601344|NCT03485729|583592396|FG002|Overall Study|Hospice care|0|||
161601345|NCT03485729|583592394|FG000|Overall Study|Poor performance status|1|||
161601346|NCT03485729|583592395|FG001|Overall Study|Poor performance status|0|||
161601347|NCT03485729|583592396|FG002|Overall Study|Poor performance status|0|||
161601348|NCT03485729|583592394|FG000|Overall Study|Illness|0|||
161601349|NCT03485729|583592395|FG001|Overall Study|Illness|1|||
161830771|NCT01570283|584421779|FG002|Cohort 3: Dose Level 3|Death|0|||
161830772|NCT01570283|584421780|FG003|Cohort 3: Dose Level 3|Death|0|||
161830773|NCT01570283|584421781|FG004|Cohort 3: Dose Level 3|Death|0|||
161830774|NCT01570283|584421782|FG005|Cohort 3: Dose Level 3|Death|1|||
161830775|NCT01570283|584421777|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830776|NCT01570283|584421778|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830777|NCT01570283|584421779|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830778|NCT01570283|584421780|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830779|NCT01570283|584421781|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830780|NCT01570283|584421782|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
161830781|NCT01833533|584421783|FG000|Overall Study|Adverse Event|0|||
161830782|NCT01833533|584421784|FG001|Overall Study|Adverse Event|1|||
161830783|NCT01833533|584421783|FG000|Overall Study|Lost to Follow-up|4|||
161830784|NCT01833533|584421784|FG001|Overall Study|Lost to Follow-up|9|||
161830785|NCT01833533|584421783|FG000|Overall Study|To Enter an Extension Study|0|||
161830786|NCT01833533|584421784|FG001|Overall Study|To Enter an Extension Study|4|||
161830787|NCT01833533|584421783|FG000|Overall Study|Other|2|||
161830788|NCT01833533|584421784|FG001|Overall Study|Other|7|||
161830789|NCT02017860|584421785|FG000|Overall Study|Adverse Event|1|||
161830790|NCT02017860|584421785|FG000|Overall Study|Withdrawal by Subject|1|||
161830791|NCT01048502|584421788|FG000|Overall Study|Lost to Follow-up|2|||
161830792|NCT01048502|584421789|FG001|Overall Study|Lost to Follow-up|0|||
161830793|NCT01048502|584421790|FG002|Overall Study|Lost to Follow-up|0|||
161830794|NCT01048502|584421791|FG003|Overall Study|Lost to Follow-up|0|||
161830795|NCT01048502|584421788|FG000|Overall Study|Adverse Event|1|||
161830796|NCT01048502|584421789|FG001|Overall Study|Adverse Event|0|||
161830797|NCT01048502|584421790|FG002|Overall Study|Adverse Event|0|||
161830798|NCT01048502|584421791|FG003|Overall Study|Adverse Event|0|||
161830799|NCT01048502|584421788|FG000|Overall Study|Withdrawal by Subject|1|||
161830800|NCT01048502|584421789|FG001|Overall Study|Withdrawal by Subject|4|||
161830801|NCT01048502|584421790|FG002|Overall Study|Withdrawal by Subject|5|||
161830802|NCT01048502|584421791|FG003|Overall Study|Withdrawal by Subject|3|||
161830803|NCT01048502|584421788|FG000|Overall Study|Physician Decision|0|||
161830804|NCT01048502|584421789|FG001|Overall Study|Physician Decision|3|||
161830805|NCT01048502|584421790|FG002|Overall Study|Physician Decision|0|||
161830806|NCT01048502|584421791|FG003|Overall Study|Physician Decision|1|||
161830807|NCT01333072|584421793|FG000|Overall Study|Lost to Follow-up|3|||
161830808|NCT01333072|584421794|FG001|Overall Study|Lost to Follow-up|0|||
161830809|NCT01333072|584421793|FG000|Overall Study|Adverse Event|2|||
161830810|NCT01333072|584421794|FG001|Overall Study|Adverse Event|4|||
161830811|NCT01333072|584421793|FG000|Overall Study|Physician Decision|1|||
161830812|NCT01333072|584421794|FG001|Overall Study|Physician Decision|0|||
161830813|NCT02457611|584421795|FG000|Overall Study|Lost to Follow-up|3|||
161830814|NCT00493454|584421796|FG000|Overall Study|Withdrawal by Subject|1|||
161830815|NCT04220775|584421797|FG000|Overall Study|Adverse Event|1|||
161830816|NCT04220775|584421798|FG001|Overall Study|Adverse Event|0|||
161830817|NCT04220775|584421797|FG000|Overall Study|Disease Progression|1|||
161830818|NCT04220775|584421798|FG001|Overall Study|Disease Progression|0|||
161830819|NCT01857206|584421800|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
161830820|NCT01857206|584421801|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
161830821|NCT01857206|584421800|FG000|Overall Study|Lost to Follow-up|9|||
161830822|NCT01857206|584421801|FG001|Overall Study|Lost to Follow-up|6|||
161830823|NCT01857206|584421800|FG000|Overall Study|Unclassified|3|||
161830824|NCT01857206|584421801|FG001|Overall Study|Unclassified|3|||
161830825|NCT01857206|584421800|FG000|Overall Study|Withdrawal by Subject|1|||
161830826|NCT01857206|584421801|FG001|Overall Study|Withdrawal by Subject|0|||
161830827|NCT01483625|584421804|FG000|Overall Study|Adverse Event|1|||
161830828|NCT01483625|584421805|FG001|Overall Study|Adverse Event|1|||
161830829|NCT01483625|584421804|FG000|Overall Study|Refused to continue medication|2|||
161830830|NCT01483625|584421805|FG001|Overall Study|Refused to continue medication|1|||
161830831|NCT01483625|584421804|FG000|Overall Study|Due to other reason|1|||
161830832|NCT01483625|584421805|FG001|Overall Study|Due to other reason|0|||
161830833|NCT00084799|584421806|FG000|Overall Study|Disease Progression|1|||
161830834|NCT00084799|584421807|FG001|Overall Study|Disease Progression|0|||
161830835|NCT01261624|584421808|FG000|Week 0 to Week 12|Disease Progression|1|||
161830836|NCT01261624|584421809|FG001|Week 0 to Week 12|Disease Progression|1|||
161830837|NCT01261624|584421808|FG000|Week 0 to Week 12|Insufficient Response|0|||
161830838|NCT01261624|584421809|FG001|Week 0 to Week 12|Insufficient Response|2|||
161830839|NCT01261624|584421808|FG000|Week 13 to Week 24|Insufficient Response|0|||
161830840|NCT01261624|584421809|FG001|Week 13 to Week 24|Insufficient Response|1|||
161830841|NCT02094261|584421813|FG000|Overall Study|Death|24|||
161830842|NCT02094261|584421813|FG000|Overall Study|Lost to Follow-up|1|||
161830843|NCT02094261|584421813|FG000|Overall Study|Withdrawal by Subject|4|||
161682215|NCT02982954|583888824|FG002|Overall Study|Death|15|||
161682216|NCT02982954|583888825|FG003|Overall Study|Death|20|||
161682217|NCT02982954|583888822|FG000|Overall Study|Lost to Follow-up|2|||
161682218|NCT02982954|583888823|FG001|Overall Study|Lost to Follow-up|1|||
161682219|NCT02982954|583888824|FG002|Overall Study|Lost to Follow-up|0|||
161682220|NCT02982954|583888825|FG003|Overall Study|Lost to Follow-up|0|||
161682221|NCT02982954|583888822|FG000|Overall Study|Participant withdrew consent|7|||
161682222|NCT02982954|583888823|FG001|Overall Study|Participant withdrew consent|5|||
161682223|NCT02982954|583888824|FG002|Overall Study|Participant withdrew consent|1|||
161682224|NCT02982954|583888825|FG003|Overall Study|Participant withdrew consent|1|||
161682225|NCT02982954|583888822|FG000|Overall Study|Other reasons|42|||
161682226|NCT02982954|583888823|FG001|Overall Study|Other reasons|17|||
161682227|NCT02982954|583888824|FG002|Overall Study|Other reasons|12|||
161682228|NCT02982954|583888825|FG003|Overall Study|Other reasons|3|||
161682229|NCT02982954|583888822|FG000|Overall Study|Premature site closure|0|||
161682230|NCT02982954|583888823|FG001|Overall Study|Premature site closure|0|||
161682231|NCT02982954|583888824|FG002|Overall Study|Premature site closure|0|||
161682232|NCT02982954|583888825|FG003|Overall Study|Premature site closure|1|||
161682233|NCT03577730|583888826|FG000|Overall Study|Physician Decision|3|||
161682234|NCT03577730|583888827|FG001|Overall Study|Physician Decision|1|||
161682235|NCT03577730|583888826|FG000|Overall Study|Did not receive allocated intervention|1|||
161682236|NCT03577730|583888827|FG001|Overall Study|Did not receive allocated intervention|0|||
161682237|NCT03810781|583888829|FG000|Overall Study|COVID shut down|2|||
161682238|NCT00253643|583888834|FG000|Overall Study|Withdrawal by Subject|0|||
161682239|NCT00253643|583888835|FG001|Overall Study|Withdrawal by Subject|0|||
161682240|NCT00253643|583888836|FG002|Overall Study|Withdrawal by Subject|1|||
161682241|NCT00253643|583888837|FG003|Overall Study|Withdrawal by Subject|1|||
161682242|NCT00253643|583888834|FG000|Overall Study|Non-Compliance|0|||
161682243|NCT00253643|583888835|FG001|Overall Study|Non-Compliance|0|||
161682244|NCT00253643|583888836|FG002|Overall Study|Non-Compliance|0|||
161682245|NCT00253643|583888837|FG003|Overall Study|Non-Compliance|2|||
161682246|NCT01368536|583888838|FG000|Overall Study|Adverse Event|5|||
161682247|NCT01368536|583888839|FG001|Overall Study|Adverse Event|6|||
161682248|NCT01368536|583888840|FG002|Overall Study|Adverse Event|8|||
161682249|NCT01368536|583888838|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161682250|NCT01368536|583888839|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161682251|NCT01368536|583888840|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161682252|NCT01368536|583888838|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161682253|NCT01368536|583888839|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161682254|NCT01368536|583888840|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161682255|NCT01368536|583888838|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
161682256|NCT01368536|583888839|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161682257|NCT01368536|583888840|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161682258|NCT01368536|583888838|FG000|Overall Study|No longer required study medication|0|||
161682259|NCT01368536|583888839|FG001|Overall Study|No longer required study medication|0|||
161682260|NCT01368536|583888840|FG002|Overall Study|No longer required study medication|1|||
161682261|NCT01368536|583888838|FG000|Overall Study|Withdrawal by Subject|2|||
161682262|NCT01368536|583888839|FG001|Overall Study|Withdrawal by Subject|5|||
161682263|NCT01368536|583888840|FG002|Overall Study|Withdrawal by Subject|4|||
161682264|NCT01368536|583888838|FG000|Overall Study|Lost to Follow-up|3|||
161682265|NCT01368536|583888839|FG001|Overall Study|Lost to Follow-up|3|||
161682266|NCT01368536|583888840|FG002|Overall Study|Lost to Follow-up|5|||
161682267|NCT01368536|583888838|FG000|Overall Study|Administrative problems|34|||
161682268|NCT01368536|583888839|FG001|Overall Study|Administrative problems|39|||
161682269|NCT01368536|583888840|FG002|Overall Study|Administrative problems|35|||
161682270|NCT01368536|583888838|FG000|Overall Study|Protocol deviation|0|||
161682271|NCT01368536|583888839|FG001|Overall Study|Protocol deviation|3|||
161682272|NCT01368536|583888840|FG002|Overall Study|Protocol deviation|1|||
161682273|NCT04770532|583888841|FG000|Overall Study|Withdrawal by Subject|0|||
161682274|NCT04770532|583888842|FG001|Overall Study|Withdrawal by Subject|3|||
161682275|NCT04770532|583888841|FG000|Overall Study|Physician Decision|1|||
161682276|NCT04770532|583888842|FG001|Overall Study|Physician Decision|0|||
161682277|NCT04770532|583888841|FG000|Overall Study|Death|2|||
161682278|NCT04770532|583888842|FG001|Overall Study|Death|2|||
161682279|NCT00454857|583888846|FG000|Overall Study|Withdrawal by Subject|15|||
161682280|NCT00454857|583888846|FG000|Overall Study|Lost to Follow-up|16|||
161682281|NCT00454857|583888846|FG000|Overall Study|Noncompliance|6|||
161682282|NCT00454857|583888846|FG000|Overall Study|Death|5|||
161682283|NCT00454857|583888846|FG000|Overall Study|Other|11|||
161682284|NCT00454857|583888846|FG000|Overall Study|Reason unknown|1|||
161682285|NCT04707157|583888847|FG000|Overall Study|Adverse Event|12|||
161682286|NCT04707157|583888848|FG001|Overall Study|Adverse Event|3|||
161682287|NCT04707157|583888847|FG000|Overall Study|Lost to Follow-up|2|||
161682288|NCT04707157|583888848|FG001|Overall Study|Lost to Follow-up|0|||
161682289|NCT04707157|583888847|FG000|Overall Study|Sponsor's decision|1|||
161682290|NCT04707157|583888848|FG001|Overall Study|Sponsor's decision|0|||
161682291|NCT04707157|583888847|FG000|Overall Study|Physician Decision|8|||
161601350|NCT03485729|583592396|FG002|Overall Study|Illness|0|||
161601351|NCT05533190|583592401|FG000|Overall Study|Lost to Follow-up|19|||
161601352|NCT05533190|583592402|FG001|Overall Study|Lost to Follow-up|7|||
161601353|NCT05533190|583592401|FG000|Overall Study|Failed to download app|1|||
161601354|NCT05533190|583592402|FG001|Overall Study|Failed to download app|0|||
161601355|NCT05533190|583592401|FG000|Overall Study|Thought app was a scam|1|||
161601356|NCT05533190|583592402|FG001|Overall Study|Thought app was a scam|0|||
161601357|NCT05533190|583592401|FG000|Overall Study|Withdrawal by Subject|2|||
161601358|NCT05533190|583592402|FG001|Overall Study|Withdrawal by Subject|0|||
161601359|NCT05552508|583592403|FG000|Overall Study|Adverse Event|3|||
161601360|NCT01199133|583592410|FG000|Year 1|Adverse Event|16|||
161601361|NCT01199133|583592411|FG001|Year 1|Adverse Event|4|||
161601362|NCT01199133|583592410|FG000|Year 1|Withdrawal by Subject|8|||
161601363|NCT01199133|583592411|FG001|Year 1|Withdrawal by Subject|4|||
161601364|NCT01199133|583592410|FG000|Year 1|Any other reason not above-mentioned|6|||
161601365|NCT01199133|583592411|FG001|Year 1|Any other reason not above-mentioned|7|||
161601366|NCT01199133|583592410|FG000|Year 2|Adverse Event|1|||
161601367|NCT01199133|583592411|FG001|Year 2|Adverse Event|0|||
161601368|NCT01199133|583592410|FG000|Year 2|Withdrawal by Subject|1|||
161601369|NCT01199133|583592411|FG001|Year 2|Withdrawal by Subject|1|||
161601370|NCT01199133|583592410|FG000|Year 2|Any other reason not above-mentioned|1|||
161601371|NCT01199133|583592411|FG001|Year 2|Any other reason not above-mentioned|2|||
161601372|NCT02575950|583592412|FG000|Overall Study|Withdrawal by Subject|0|||
161601373|NCT02575950|583592413|FG001|Overall Study|Withdrawal by Subject|0|||
161601374|NCT02575950|583592414|FG002|Overall Study|Withdrawal by Subject|0|||
161601375|NCT02575950|583592415|FG003|Overall Study|Withdrawal by Subject|2|||
161601376|NCT02575950|583592412|FG000|Overall Study|Lost to Follow-up|0|||
161601377|NCT02575950|583592413|FG001|Overall Study|Lost to Follow-up|1|||
161601378|NCT02575950|583592414|FG002|Overall Study|Lost to Follow-up|0|||
161601379|NCT02575950|583592415|FG003|Overall Study|Lost to Follow-up|3|||
161601380|NCT04797858|583593540|FG000|Overall Study|Withdrawal by Subject|0|||
161601381|NCT04797858|583593541|FG001|Overall Study|Withdrawal by Subject|1|||
161601382|NCT04797858|583593540|FG000|Overall Study|Excluded due to administrative error|7|||
161601383|NCT04797858|583593541|FG001|Overall Study|Excluded due to administrative error|8|||
161601384|NCT01880515|583593542|FG000|Overall Study|Lost to Follow-up|3|||
161601385|NCT01880515|583593543|FG001|Overall Study|Lost to Follow-up|2|||
161601386|NCT01880515|583593542|FG000|Overall Study|Disease Progression|5|||
161601387|NCT01880515|583593543|FG001|Overall Study|Disease Progression|7|||
161601388|NCT03505710|583593544|FG000|Overall Study|Progressive Disease|24|||
161601389|NCT03505710|583593545|FG001|Overall Study|Progressive Disease|17|||
161601390|NCT03505710|583593546|FG002|Overall Study|Progressive Disease|43|||
161601391|NCT03505710|583593544|FG000|Overall Study|Clinical Progression|6|||
161601392|NCT03505710|583593545|FG001|Overall Study|Clinical Progression|8|||
161601393|NCT03505710|583593546|FG002|Overall Study|Clinical Progression|3|||
161601394|NCT03505710|583593544|FG000|Overall Study|Adverse Event|12|||
161601395|NCT03505710|583593545|FG001|Overall Study|Adverse Event|6|||
161601396|NCT03505710|583593546|FG002|Overall Study|Adverse Event|28|||
161601397|NCT03505710|583593544|FG000|Overall Study|Withdrawal by Subject|1|||
161601398|NCT03505710|583593545|FG001|Overall Study|Withdrawal by Subject|3|||
161601399|NCT03505710|583593546|FG002|Overall Study|Withdrawal by Subject|7|||
161601400|NCT03505710|583593544|FG000|Overall Study|Physician Decision|1|||
161601401|NCT03505710|583593545|FG001|Overall Study|Physician Decision|1|||
161601402|NCT03505710|583593546|FG002|Overall Study|Physician Decision|2|||
161601403|NCT03505710|583593544|FG000|Overall Study|Death|4|||
161601404|NCT03505710|583593545|FG001|Overall Study|Death|5|||
161601405|NCT03505710|583593546|FG002|Overall Study|Death|6|||
161601406|NCT03505710|583593544|FG000|Overall Study|Other Reasons|1|||
161601407|NCT03505710|583593545|FG001|Overall Study|Other Reasons|1|||
161601408|NCT03505710|583593546|FG002|Overall Study|Other Reasons|1|||
161601409|NCT03505710|583593544|FG000|Overall Study|Study Terminated by Sponsor|0|||
161601410|NCT03505710|583593545|FG001|Overall Study|Study Terminated by Sponsor|0|||
161601411|NCT03505710|583593546|FG002|Overall Study|Study Terminated by Sponsor|1|||
161601412|NCT04414722|583593547|FG000|Overall Study|Lost to Follow-up|3|||
161601413|NCT04414722|583593548|FG001|Overall Study|Lost to Follow-up|4|||
161601414|NCT04414722|583593549|FG002|Overall Study|Lost to Follow-up|3|||
161601415|NCT04414722|583593550|FG003|Overall Study|Lost to Follow-up|2|||
161601416|NCT04414722|583593551|FG004|Overall Study|Lost to Follow-up|3|||
161601417|NCT04414722|583593547|FG000|Overall Study|Withdrawal by Subject|6|||
161601418|NCT04414722|583593548|FG001|Overall Study|Withdrawal by Subject|3|||
161601419|NCT04414722|583593549|FG002|Overall Study|Withdrawal by Subject|1|||
161601420|NCT04414722|583593550|FG003|Overall Study|Withdrawal by Subject|5|||
161682292|NCT04707157|583888848|FG001|Overall Study|Physician Decision|5|||
161682293|NCT04707157|583888847|FG000|Overall Study|Protocol Deviation|1|||
161682294|NCT04707157|583888848|FG001|Overall Study|Protocol Deviation|0|||
161682295|NCT04707157|583888847|FG000|Overall Study|Withdrawal by Subject|1|||
161682296|NCT04707157|583888848|FG001|Overall Study|Withdrawal by Subject|1|||
161682297|NCT00827606|583888849|FG000|Overall Study|Protocol Violation|4|||
161682298|NCT00827606|583888850|FG001|Overall Study|Protocol Violation|3|||
161682299|NCT00827606|583888849|FG000|Overall Study|Lost to Follow-up|3|||
161682300|NCT00827606|583888850|FG001|Overall Study|Lost to Follow-up|1|||
161682301|NCT00827606|583888849|FG000|Overall Study|Withdrawal by Subject|7|||
161682302|NCT00827606|583888850|FG001|Overall Study|Withdrawal by Subject|6|||
161682303|NCT00827606|583888849|FG000|Overall Study|Pregnancy|0|||
161682304|NCT00827606|583888850|FG001|Overall Study|Pregnancy|1|||
161682305|NCT00827606|583888849|FG000|Overall Study|Other|5|||
161682306|NCT00827606|583888850|FG001|Overall Study|Other|13|||
161682307|NCT00827606|583888849|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
161682308|NCT00827606|583888850|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
161601421|NCT04414722|583593551|FG004|Overall Study|Withdrawal by Subject|1|||
161601422|NCT04414722|583593547|FG000|Overall Study|Physician Decision|0|||
161601423|NCT04414722|583593548|FG001|Overall Study|Physician Decision|1|||
161601424|NCT04414722|583593549|FG002|Overall Study|Physician Decision|2|||
161682309|NCT00827606|583888849|FG000|Overall Study|Adverse Event|4|||
161601425|NCT04414722|583593550|FG003|Overall Study|Physician Decision|0|||
161601426|NCT04414722|583593551|FG004|Overall Study|Physician Decision|0|||
161601427|NCT04414722|583593547|FG000|Overall Study|Non-participatory|0|||
161601428|NCT04414722|583593548|FG001|Overall Study|Non-participatory|1|||
161601429|NCT04414722|583593549|FG002|Overall Study|Non-participatory|1|||
161601430|NCT04414722|583593550|FG003|Overall Study|Non-participatory|0|||
161601431|NCT04414722|583593551|FG004|Overall Study|Non-participatory|0|||
161601432|NCT02446236|583593552|FG000|Overall Study|Screen Failure|1|||
161601433|NCT02446236|583593553|FG001|Overall Study|Screen Failure|0|||
161601434|NCT02446236|583593554|FG002|Overall Study|Screen Failure|1|||
161601435|NCT02446236|583593552|FG000|Overall Study|Actively Receiving Therapy|0|||
161682310|NCT00827606|583888850|FG001|Overall Study|Adverse Event|2|||
161682311|NCT00243386|583888855|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
161682312|NCT00243386|583888856|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
161682313|NCT00243386|583888857|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
161682314|NCT00243386|583888855|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
161682315|NCT00243386|583888856|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
161682316|NCT00243386|583888857|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
161682317|NCT00243386|583888855|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
161682318|NCT00243386|583888856|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
161682319|NCT00243386|583888857|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
161682320|NCT00243386|583888855|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
161682321|NCT00243386|583888856|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
161682322|NCT00243386|583888857|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
161682323|NCT00243386|583888855|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
161682324|NCT00243386|583888856|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
161682325|NCT00243386|583888857|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
161682326|NCT00243386|583888855|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
161682327|NCT00243386|583888856|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
161682328|NCT00243386|583888857|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
161682329|NCT00243386|583888855|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
161682330|NCT00243386|583888856|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
161682331|NCT00243386|583888857|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
161682332|NCT00243386|583888855|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
161682333|NCT00243386|583888856|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
161682334|NCT00243386|583888857|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
161682335|NCT00133991|583888858|FG000|Overall Study|Death|4|||
161682336|NCT03418129|583888862|FG000|Overall Study|Lost to Follow-up|11|||
161682337|NCT03418129|583888863|FG001|Overall Study|Lost to Follow-up|20|||
161682338|NCT03418129|583888864|FG002|Overall Study|Lost to Follow-up|15|||
161682339|NCT03418129|583888862|FG000|Overall Study|Withdrawal by Subject|3|||
161682340|NCT03418129|583888863|FG001|Overall Study|Withdrawal by Subject|6|||
161682341|NCT03418129|583888864|FG002|Overall Study|Withdrawal by Subject|4|||
161601436|NCT02446236|583593553|FG001|Overall Study|Actively Receiving Therapy|0|||
161601437|NCT02446236|583593554|FG002|Overall Study|Actively Receiving Therapy|1|||
161601438|NCT04136912|583593557|FG000|Overall Study|Operational reasons|0|||
161601439|NCT04136912|583593558|FG001|Overall Study|Operational reasons|0|||
161601440|NCT04136912|583593559|FG002|Overall Study|Operational reasons|2|||
161601441|NCT03556293|583593560|FG000|Overall Study|Ineligible for analysis|1904|||
161601442|NCT03556293|583593561|FG001|Overall Study|Ineligible for analysis|1471|||
161601443|NCT03556293|583593562|FG002|Overall Study|Ineligible for analysis|1091|||
161601444|NCT03556293|583593563|FG003|Overall Study|Ineligible for analysis|1269|||
161601445|NCT03292484|583593569|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
161601446|NCT03292484|583593569|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
161601447|NCT03292484|583593569|FG000|Overall Study|Protocol Violation|2|||
161601448|NCT03292484|583593569|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
161601449|NCT03292484|583593569|FG000|Overall Study|Sponsor decision|349|||
161601450|NCT03292484|583593569|FG000|Overall Study|Lost to Follow-up|7|||
161601451|NCT03292484|583593569|FG000|Overall Study|Coronavirus Disease 2019|1|||
161601452|NCT03292484|583593569|FG000|Overall Study|Other|20|||
161601453|NCT05290493|583593570|FG000|Overall Study|Withdrawal by Subject|2|||
161601454|NCT05290493|583593571|FG001|Overall Study|Withdrawal by Subject|2|||
161601455|NCT05290493|583593570|FG000|Overall Study|Adverse Event|1|||
161601456|NCT05290493|583593571|FG001|Overall Study|Adverse Event|0|||
161601457|NCT05524402|583593574|FG000|Overall Study|Withdrawal by Subject|3|||
161601458|NCT05524402|583593575|FG001|Overall Study|Withdrawal by Subject|1|||
161601459|NCT05524402|583593574|FG000|Overall Study|Lost to Follow-up|2|||
161601460|NCT05524402|583593575|FG001|Overall Study|Lost to Follow-up|1|||
161601461|NCT05976334|583593576|FG000|Part B|Death|0|||
161601462|NCT05976334|583593577|FG001|Part B|Death|1|||
161601463|NCT05976334|583593576|FG000|Part B|Study Terminated by Sponsor|0|||
161601464|NCT05976334|583593577|FG001|Part B|Study Terminated by Sponsor|1|||
161601465|NCT05976334|583593576|FG000|Part B|Reason Not Specified|0|||
161601466|NCT05976334|583593577|FG001|Part B|Reason Not Specified|1|||
161601467|NCT05280574|583593583|FG000|Overall Study|Withdrawal by Subject|0|||
161601468|NCT05280574|583593584|FG001|Overall Study|Withdrawal by Subject|2|||
161601469|NCT05280574|583593585|FG002|Overall Study|Withdrawal by Subject|0|||
161601470|NCT05363163|583593586|FG000|Overall Study|Withdrawal by Subject|13|||
161601471|NCT04526886|583593590|FG000|Overall Study|Physician Decision|4|||
161601472|NCT03276676|583593593|FG000|Overall Study|Withdrawal by Subject|2|||
161601473|NCT03276676|583593594|FG001|Overall Study|Withdrawal by Subject|1|||
161601474|NCT02962076|583593596|FG000|Overall Study|MHED tracer not available|5|||
161601475|NCT02962076|583593596|FG000|Overall Study|Protocol Violation|1|||
161601476|NCT02962076|583593596|FG000|Overall Study|Physician Decision|1|||
161601477|NCT03583333|583593608|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
161601478|NCT03583333|583593609|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
161601479|NCT03583333|583593608|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
161601480|NCT03583333|583593609|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
161601481|NCT03583333|583593608|FG000|Overall Study|Withdrawal by Subject|9|||
161601482|NCT03583333|583593609|FG001|Overall Study|Withdrawal by Subject|5|||
161601483|NCT03583333|583593608|FG000|Overall Study|Physician Decision|3|||
161601484|NCT03583333|583593609|FG001|Overall Study|Physician Decision|2|||
161601485|NCT03583333|583593608|FG000|Overall Study|Death|12|||
161601486|NCT03583333|583593609|FG001|Overall Study|Death|7|||
161601487|NCT03926130|583593610|FG000|Overall Study|Adverse Event|9|||
161601488|NCT03926130|583593611|FG001|Overall Study|Adverse Event|11|||
161601489|NCT03926130|583593612|FG002|Overall Study|Adverse Event|2|||
161601490|NCT03926130|583593613|FG003|Overall Study|Adverse Event|0|||
161601491|NCT03926130|583593610|FG000|Overall Study|Death|2|||
161601492|NCT03926130|583593611|FG001|Overall Study|Death|0|||
161601493|NCT03926130|583593612|FG002|Overall Study|Death|1|||
161601494|NCT03926130|583593613|FG003|Overall Study|Death|0|||
161601495|NCT03926130|583593610|FG000|Overall Study|Lack of Efficacy|14|||
161601496|NCT03926130|583593611|FG001|Overall Study|Lack of Efficacy|11|||
161601497|NCT03926130|583593612|FG002|Overall Study|Lack of Efficacy|7|||
161601498|NCT03926130|583593613|FG003|Overall Study|Lack of Efficacy|1|||
161601499|NCT03926130|583593610|FG000|Overall Study|Lost to Follow-up|0|||
161601500|NCT03926130|583593611|FG001|Overall Study|Lost to Follow-up|7|||
161601501|NCT03926130|583593612|FG002|Overall Study|Lost to Follow-up|1|||
161601502|NCT03926130|583593613|FG003|Overall Study|Lost to Follow-up|0|||
161601503|NCT03926130|583593610|FG000|Overall Study|As Reported by Investigator|2|||
161601504|NCT03926130|583593611|FG001|Overall Study|As Reported by Investigator|6|||
161601505|NCT03926130|583593612|FG002|Overall Study|As Reported by Investigator|6|||
161682342|NCT01378858|583888867|FG000|Overall Study|Withdrawal by Subject|4|||
161601506|NCT03926130|583593613|FG003|Overall Study|As Reported by Investigator|0|||
161601507|NCT03926130|583593610|FG000|Overall Study|Physician Decision|3|||
161601508|NCT03926130|583593611|FG001|Overall Study|Physician Decision|2|||
161601509|NCT03926130|583593612|FG002|Overall Study|Physician Decision|1|||
161601510|NCT03926130|583593613|FG003|Overall Study|Physician Decision|0|||
161601511|NCT03926130|583593610|FG000|Overall Study|Pregnancy|2|||
161601512|NCT03926130|583593611|FG001|Overall Study|Pregnancy|2|||
161601513|NCT03926130|583593612|FG002|Overall Study|Pregnancy|1|||
161601514|NCT03926130|583593613|FG003|Overall Study|Pregnancy|0|||
161601515|NCT03926130|583593610|FG000|Overall Study|Withdrawal by Subject|20|||
161682343|NCT01378858|583888868|FG001|Overall Study|Withdrawal by Subject|4|||
161682344|NCT02664272|583888869|FG000|Overall Study|Fluoroscopic images not made available|2|||
161682345|NCT03073980|583888870|FG000|Overall Study|Lost to Follow-up|10|||
161682346|NCT03073980|583888871|FG001|Overall Study|Lost to Follow-up|2|||
161682347|NCT03073980|583888872|FG002|Overall Study|Lost to Follow-up|9|||
161682348|NCT03073980|583888870|FG000|Overall Study|No post-procedure data|0|||
161682349|NCT03073980|583888871|FG001|Overall Study|No post-procedure data|0|||
161682350|NCT03073980|583888872|FG002|Overall Study|No post-procedure data|2|||
161682351|NCT04810689|583888873|FG000|Overall Study|Withdrawal by Subject|0|||
161682352|NCT04810689|583888874|FG001|Overall Study|Withdrawal by Subject|1|||
161682353|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
161682354|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
161682355|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
161682356|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
161682357|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
161682358|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
161682359|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161682360|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161682361|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
161682362|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
161682363|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161682364|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161682365|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
161682366|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
161682367|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
161682368|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
161682369|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
161682370|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
161682371|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
161682372|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
161682373|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
161682374|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
161682375|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161682376|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
161682377|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Death|2|||
161682378|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Death|1|||
161682379|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Death|0|||
161830844|NCT02094261|584421813|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
161830845|NCT02363439|584421814|FG000|Overall Study|Lack of Efficacy|4|||
161830846|NCT02010255|584421819|FG000|Overall Study|Death|0|||
161682380|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Death|0|||
161682381|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161830847|NCT02010255|584421820|FG001|Overall Study|Death|1|||
161830848|NCT02010255|584421821|FG002|Overall Study|Death|4|||
161682382|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161682383|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161682384|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161682385|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
161682386|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
161682387|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
161682388|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
161682389|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161682390|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161682391|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161682392|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161682393|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
161682394|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161682395|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161682396|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161682397|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
161682398|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
161682399|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
161682400|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
161682401|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161682402|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161682403|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
161830849|NCT02010255|584421822|FG003|Overall Study|Death|4|||
161830850|NCT02010255|584421823|FG004|Overall Study|Death|2|||
161830851|NCT02010255|584421824|FG005|Overall Study|Death|0|||
161830852|NCT02010255|584421825|FG006|Overall Study|Death|1|||
161601516|NCT03926130|583593611|FG001|Overall Study|Withdrawal by Subject|28|||
161601517|NCT03926130|583593612|FG002|Overall Study|Withdrawal by Subject|18|||
161601518|NCT03926130|583593613|FG003|Overall Study|Withdrawal by Subject|1|||
161682404|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
161682405|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161682406|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161601519|NCT03926130|583593610|FG000|Overall Study|Non-Compliance|1|||
161601520|NCT03926130|583593611|FG001|Overall Study|Non-Compliance|1|||
161601521|NCT03926130|583593612|FG002|Overall Study|Non-Compliance|0|||
161601522|NCT03926130|583593613|FG003|Overall Study|Non-Compliance|0|||
161601523|NCT03926130|583593610|FG000|Overall Study|Disposition Not Captured|0|||
161601524|NCT03926130|583593611|FG001|Overall Study|Disposition Not Captured|2|||
161601525|NCT03926130|583593612|FG002|Overall Study|Disposition Not Captured|1|||
161601526|NCT03926130|583593613|FG003|Overall Study|Disposition Not Captured|0|||
161601527|NCT05069896|583593621|FG000|Overall Study|Adverse Event|0|||
161601528|NCT05069896|583593622|FG001|Overall Study|Adverse Event|1|||
161601529|NCT05069896|583593623|FG002|Overall Study|Adverse Event|1|||
161601530|NCT05069896|583593624|FG003|Overall Study|Adverse Event|0|||
161601531|NCT05069896|583593625|FG004|Overall Study|Adverse Event|0|||
161601532|NCT05069896|583593626|FG005|Overall Study|Adverse Event|0|||
161601533|NCT05069896|583593621|FG000|Overall Study|Lost to Follow-up|0|||
161601534|NCT05069896|583593622|FG001|Overall Study|Lost to Follow-up|0|||
161601535|NCT05069896|583593623|FG002|Overall Study|Lost to Follow-up|1|||
161601536|NCT05069896|583593624|FG003|Overall Study|Lost to Follow-up|0|||
161601537|NCT05069896|583593625|FG004|Overall Study|Lost to Follow-up|1|||
161601538|NCT05069896|583593626|FG005|Overall Study|Lost to Follow-up|2|||
161601539|NCT04068831|583593627|FG000|Overall Study|Disease Progression|10|||
161601540|NCT04068831|583593628|FG001|Overall Study|Disease Progression|8|||
161601541|NCT03580356|583593633|FG000|Treatment Period|Withdrawal by Subject|13|||
161601542|NCT03580356|583593634|FG001|Treatment Period|Withdrawal by Subject|0|||
161601543|NCT03580356|583593635|FG002|Treatment Period|Withdrawal by Subject|13|||
161601544|NCT03580356|583593636|FG003|Treatment Period|Withdrawal by Subject|1|||
161601545|NCT03580356|583593637|FG004|Treatment Period|Withdrawal by Subject|17|||
161601546|NCT03580356|583593638|FG005|Treatment Period|Withdrawal by Subject|0|||
161601547|NCT03580356|583593639|FG006|Treatment Period|Withdrawal by Subject|5|||
161682407|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
161682408|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
161682409|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161682410|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161830853|NCT02010255|584421826|FG007|Overall Study|Death|1|||
161830854|NCT02010255|584421827|FG008|Overall Study|Death|1|||
161830855|NCT02010255|584421828|FG009|Overall Study|Death|0|||
161830856|NCT02010255|584421829|FG010|Overall Study|Death|1|||
161601548|NCT03580356|583593640|FG007|Treatment Period|Withdrawal by Subject|0|||
161601549|NCT03580356|583593633|FG000|Treatment Period|Adverse Event|10|||
161601550|NCT03580356|583593634|FG001|Treatment Period|Adverse Event|0|||
161830857|NCT02010255|584421830|FG011|Overall Study|Death|1|||
161601551|NCT03580356|583593635|FG002|Treatment Period|Adverse Event|13|||
161601552|NCT03580356|583593636|FG003|Treatment Period|Adverse Event|0|||
161601553|NCT03580356|583593637|FG004|Treatment Period|Adverse Event|5|||
161601554|NCT03580356|583593638|FG005|Treatment Period|Adverse Event|0|||
161601555|NCT03580356|583593639|FG006|Treatment Period|Adverse Event|8|||
161830858|NCT02010255|584421831|FG012|Overall Study|Death|0|||
161830859|NCT02010255|584421832|FG013|Overall Study|Death|0|||
161830860|NCT02010255|584421819|FG000|Overall Study|Lack of Efficacy|4|||
161830861|NCT02010255|584421820|FG001|Overall Study|Lack of Efficacy|1|||
161830862|NCT02010255|584421821|FG002|Overall Study|Lack of Efficacy|2|||
161830863|NCT02010255|584421822|FG003|Overall Study|Lack of Efficacy|1|||
161830864|NCT02010255|584421823|FG004|Overall Study|Lack of Efficacy|1|||
161830865|NCT02010255|584421824|FG005|Overall Study|Lack of Efficacy|0|||
161830866|NCT02010255|584421825|FG006|Overall Study|Lack of Efficacy|0|||
161830867|NCT02010255|584421826|FG007|Overall Study|Lack of Efficacy|0|||
161830868|NCT02010255|584421827|FG008|Overall Study|Lack of Efficacy|0|||
161830869|NCT02010255|584421828|FG009|Overall Study|Lack of Efficacy|0|||
161830870|NCT02010255|584421829|FG010|Overall Study|Lack of Efficacy|1|||
161830871|NCT02010255|584421830|FG011|Overall Study|Lack of Efficacy|0|||
161830872|NCT02010255|584421831|FG012|Overall Study|Lack of Efficacy|0|||
161830873|NCT02010255|584421832|FG013|Overall Study|Lack of Efficacy|0|||
161830874|NCT02010255|584421819|FG000|Overall Study|Withdrew Consent|1|||
161830875|NCT02010255|584421820|FG001|Overall Study|Withdrew Consent|0|||
161830876|NCT02010255|584421821|FG002|Overall Study|Withdrew Consent|0|||
161830877|NCT02010255|584421822|FG003|Overall Study|Withdrew Consent|1|||
161830878|NCT02010255|584421823|FG004|Overall Study|Withdrew Consent|0|||
161830879|NCT02010255|584421824|FG005|Overall Study|Withdrew Consent|0|||
161830880|NCT02010255|584421825|FG006|Overall Study|Withdrew Consent|0|||
161830881|NCT02010255|584421826|FG007|Overall Study|Withdrew Consent|0|||
161601556|NCT03580356|583593640|FG007|Treatment Period|Adverse Event|0|||
161601557|NCT03580356|583593633|FG000|Treatment Period|Protocol Violation|5|||
161601558|NCT03580356|583593634|FG001|Treatment Period|Protocol Violation|0|||
161601559|NCT03580356|583593635|FG002|Treatment Period|Protocol Violation|6|||
161601560|NCT03580356|583593636|FG003|Treatment Period|Protocol Violation|1|||
161601561|NCT03580356|583593637|FG004|Treatment Period|Protocol Violation|9|||
161601562|NCT03580356|583593638|FG005|Treatment Period|Protocol Violation|1|||
161601563|NCT03580356|583593639|FG006|Treatment Period|Protocol Violation|1|||
161601564|NCT03580356|583593640|FG007|Treatment Period|Protocol Violation|0|||
161601565|NCT03580356|583593633|FG000|Treatment Period|Lack of Efficacy|6|||
161601566|NCT03580356|583593634|FG001|Treatment Period|Lack of Efficacy|0|||
161601567|NCT03580356|583593635|FG002|Treatment Period|Lack of Efficacy|2|||
161601568|NCT03580356|583593636|FG003|Treatment Period|Lack of Efficacy|0|||
161601569|NCT03580356|583593637|FG004|Treatment Period|Lack of Efficacy|3|||
161601570|NCT03580356|583593638|FG005|Treatment Period|Lack of Efficacy|0|||
161601571|NCT03580356|583593639|FG006|Treatment Period|Lack of Efficacy|3|||
161601572|NCT03580356|583593640|FG007|Treatment Period|Lack of Efficacy|0|||
161601573|NCT03580356|583593633|FG000|Treatment Period|Pregnancy|1|||
161601574|NCT03580356|583593634|FG001|Treatment Period|Pregnancy|0|||
161601575|NCT03580356|583593635|FG002|Treatment Period|Pregnancy|7|||
161601576|NCT03580356|583593636|FG003|Treatment Period|Pregnancy|0|||
161601577|NCT03580356|583593637|FG004|Treatment Period|Pregnancy|2|||
161601578|NCT03580356|583593638|FG005|Treatment Period|Pregnancy|0|||
161601579|NCT03580356|583593639|FG006|Treatment Period|Pregnancy|1|||
161601580|NCT03580356|583593640|FG007|Treatment Period|Pregnancy|0|||
161601581|NCT03580356|583593633|FG000|Treatment Period|Physician Decision|2|||
161601582|NCT03580356|583593634|FG001|Treatment Period|Physician Decision|0|||
161601583|NCT03580356|583593635|FG002|Treatment Period|Physician Decision|1|||
161601584|NCT03580356|583593636|FG003|Treatment Period|Physician Decision|0|||
161601585|NCT03580356|583593637|FG004|Treatment Period|Physician Decision|4|||
161601586|NCT03580356|583593638|FG005|Treatment Period|Physician Decision|0|||
161601587|NCT03580356|583593639|FG006|Treatment Period|Physician Decision|2|||
161601588|NCT03580356|583593640|FG007|Treatment Period|Physician Decision|0|||
161601589|NCT03580356|583593633|FG000|Treatment Period|Lost to Follow-up|1|||
161601590|NCT03580356|583593634|FG001|Treatment Period|Lost to Follow-up|1|||
161601591|NCT03580356|583593635|FG002|Treatment Period|Lost to Follow-up|1|||
161601592|NCT03580356|583593636|FG003|Treatment Period|Lost to Follow-up|0|||
161601593|NCT03580356|583593637|FG004|Treatment Period|Lost to Follow-up|3|||
161601594|NCT03580356|583593638|FG005|Treatment Period|Lost to Follow-up|0|||
161601595|NCT03580356|583593639|FG006|Treatment Period|Lost to Follow-up|1|||
161601596|NCT03580356|583593640|FG007|Treatment Period|Lost to Follow-up|0|||
161601597|NCT03580356|583593633|FG000|Treatment Period|Death|0|||
161601598|NCT03580356|583593634|FG001|Treatment Period|Death|0|||
161601599|NCT03580356|583593635|FG002|Treatment Period|Death|1|||
161601600|NCT03580356|583593636|FG003|Treatment Period|Death|0|||
161601601|NCT03580356|583593637|FG004|Treatment Period|Death|0|||
161601602|NCT03580356|583593638|FG005|Treatment Period|Death|0|||
161601603|NCT03580356|583593639|FG006|Treatment Period|Death|0|||
161682411|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
161682412|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
161682413|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
161601604|NCT03580356|583593640|FG007|Treatment Period|Death|0|||
161601605|NCT03580356|583593633|FG000|Treatment Period|Technical problems|0|||
161601606|NCT03580356|583593634|FG001|Treatment Period|Technical problems|0|||
161601607|NCT03580356|583593635|FG002|Treatment Period|Technical problems|0|||
161601608|NCT03580356|583593636|FG003|Treatment Period|Technical problems|0|||
161601609|NCT03580356|583593637|FG004|Treatment Period|Technical problems|1|||
161601610|NCT03580356|583593638|FG005|Treatment Period|Technical problems|0|||
161601611|NCT03580356|583593639|FG006|Treatment Period|Technical problems|0|||
161601612|NCT03580356|583593640|FG007|Treatment Period|Technical problems|0|||
161601613|NCT03580356|583593633|FG000|Treatment Period|Misrandomized, no treatment|0|||
161601614|NCT03580356|583593634|FG001|Treatment Period|Misrandomized, no treatment|0|||
161601615|NCT03580356|583593635|FG002|Treatment Period|Misrandomized, no treatment|1|||
161601616|NCT03580356|583593636|FG003|Treatment Period|Misrandomized, no treatment|0|||
161601617|NCT03580356|583593637|FG004|Treatment Period|Misrandomized, no treatment|2|||
161601618|NCT03580356|583593638|FG005|Treatment Period|Misrandomized, no treatment|0|||
161601619|NCT03580356|583593639|FG006|Treatment Period|Misrandomized, no treatment|0|||
161601620|NCT03580356|583593640|FG007|Treatment Period|Misrandomized, no treatment|0|||
161601621|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
161601622|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
161601623|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
161601624|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
161601625|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
161601626|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
161601627|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
161601628|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
161601629|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
161601630|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161601631|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
161601632|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161601633|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
161601634|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161601635|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161601636|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161601637|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
161601638|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
161601639|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
161601640|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
161601641|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
161601642|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
161601643|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
161601644|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
161601645|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161601646|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161601647|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
161601648|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161601649|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
161601650|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161682414|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
161682415|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
161682416|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
161682417|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161682418|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161682419|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
161682420|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
161682421|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161682422|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161682423|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
161682424|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
161682425|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161682426|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161682427|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
161682428|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161682429|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161682430|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161682431|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
161830882|NCT02010255|584421827|FG008|Overall Study|Withdrew Consent|0|||
161830883|NCT02010255|584421828|FG009|Overall Study|Withdrew Consent|0|||
161830884|NCT02010255|584421829|FG010|Overall Study|Withdrew Consent|0|||
161830885|NCT02010255|584421830|FG011|Overall Study|Withdrew Consent|0|||
161830886|NCT02010255|584421831|FG012|Overall Study|Withdrew Consent|0|||
161830887|NCT02010255|584421832|FG013|Overall Study|Withdrew Consent|0|||
161830888|NCT02010255|584421819|FG000|Overall Study|Adverse Event|1|||
161830889|NCT02010255|584421820|FG001|Overall Study|Adverse Event|0|||
161830890|NCT02010255|584421821|FG002|Overall Study|Adverse Event|0|||
161830891|NCT02010255|584421822|FG003|Overall Study|Adverse Event|0|||
161830892|NCT02010255|584421823|FG004|Overall Study|Adverse Event|0|||
161830893|NCT02010255|584421824|FG005|Overall Study|Adverse Event|0|||
161830894|NCT02010255|584421825|FG006|Overall Study|Adverse Event|0|||
161830895|NCT02010255|584421826|FG007|Overall Study|Adverse Event|0|||
161830896|NCT02010255|584421827|FG008|Overall Study|Adverse Event|0|||
161830897|NCT02010255|584421828|FG009|Overall Study|Adverse Event|0|||
161830898|NCT02010255|584421829|FG010|Overall Study|Adverse Event|0|||
161830899|NCT02010255|584421830|FG011|Overall Study|Adverse Event|0|||
161830900|NCT02010255|584421831|FG012|Overall Study|Adverse Event|0|||
161830901|NCT02010255|584421832|FG013|Overall Study|Adverse Event|0|||
161830902|NCT02010255|584421819|FG000|Overall Study|Lost to Follow-up|0|||
161830903|NCT02010255|584421820|FG001|Overall Study|Lost to Follow-up|0|||
161830904|NCT02010255|584421821|FG002|Overall Study|Lost to Follow-up|1|||
161830905|NCT02010255|584421822|FG003|Overall Study|Lost to Follow-up|0|||
161830906|NCT02010255|584421823|FG004|Overall Study|Lost to Follow-up|1|||
161830907|NCT02010255|584421824|FG005|Overall Study|Lost to Follow-up|0|||
161830908|NCT02010255|584421825|FG006|Overall Study|Lost to Follow-up|0|||
161830909|NCT02010255|584421826|FG007|Overall Study|Lost to Follow-up|0|||
161830910|NCT02010255|584421827|FG008|Overall Study|Lost to Follow-up|0|||
161830911|NCT02010255|584421828|FG009|Overall Study|Lost to Follow-up|0|||
161830912|NCT02010255|584421829|FG010|Overall Study|Lost to Follow-up|0|||
161830913|NCT02010255|584421830|FG011|Overall Study|Lost to Follow-up|0|||
161830914|NCT02010255|584421831|FG012|Overall Study|Lost to Follow-up|0|||
161830915|NCT02010255|584421832|FG013|Overall Study|Lost to Follow-up|0|||
161830916|NCT02010255|584421819|FG000|Overall Study|Randomized but Not Treated|0|||
161830917|NCT02010255|584421820|FG001|Overall Study|Randomized but Not Treated|0|||
161830918|NCT02010255|584421821|FG002|Overall Study|Randomized but Not Treated|0|||
161830919|NCT02010255|584421822|FG003|Overall Study|Randomized but Not Treated|0|||
161830920|NCT02010255|584421823|FG004|Overall Study|Randomized but Not Treated|0|||
161830921|NCT02010255|584421824|FG005|Overall Study|Randomized but Not Treated|0|||
161830922|NCT02010255|584421825|FG006|Overall Study|Randomized but Not Treated|0|||
161830923|NCT02010255|584421826|FG007|Overall Study|Randomized but Not Treated|0|||
161830924|NCT02010255|584421827|FG008|Overall Study|Randomized but Not Treated|0|||
161830925|NCT02010255|584421828|FG009|Overall Study|Randomized but Not Treated|0|||
161830926|NCT02010255|584421829|FG010|Overall Study|Randomized but Not Treated|0|||
161830927|NCT02010255|584421830|FG011|Overall Study|Randomized but Not Treated|0|||
161830928|NCT02010255|584421831|FG012|Overall Study|Randomized but Not Treated|0|||
161830929|NCT02010255|584421832|FG013|Overall Study|Randomized but Not Treated|1|||
161830930|NCT02013531|584421833|FG000|Overall Study|Lost to Follow-up|3|||
161830931|NCT02013531|584421833|FG000|Overall Study|Met Withdrawal Criteria|1|||
161830932|NCT02013531|584421833|FG000|Overall Study|Withdrawal by Subject|1|||
161830933|NCT03554317|584421839|FG000|Overall Study|Withdrawal by Subject|1|||
161830934|NCT03554317|584421839|FG000|Overall Study|PSA Progression|3|||
161830935|NCT03554317|584421839|FG000|Overall Study|Radiographic Progression|4|||
161601651|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161601652|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161601653|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
161601654|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
161830936|NCT00537199|584421840|FG000|Overall Study|Study Terminated|1|||
161601655|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
161830937|NCT03139240|584421841|FG000|Overall Study|Lost to Follow-up|0|||
161830938|NCT03139240|584421842|FG001|Overall Study|Lost to Follow-up|1|||
161830939|NCT03139240|584421843|FG002|Overall Study|Lost to Follow-up|1|||
161830940|NCT03139240|584421844|FG003|Overall Study|Lost to Follow-up|0|||
161830941|NCT00860743|584421846|FG000|Overall Study|Withdrawal by Subject|3|||
161830942|NCT00860743|584421847|FG001|Overall Study|Withdrawal by Subject|0|||
161830943|NCT00823199|584421851|FG000|Overall Study|Withdrawal by Subject|2|||
161830944|NCT02776553|584421852|FG000|Overall Study|Lost to Follow-up|1|||
161830945|NCT02776553|584421853|FG001|Overall Study|Lost to Follow-up|0|||
161830946|NCT02776553|584421852|FG000|Overall Study|got liver transplant|1|||
161830947|NCT02776553|584421853|FG001|Overall Study|got liver transplant|2|||
161830948|NCT02776553|584421852|FG000|Overall Study|had other surgery|1|||
161830949|NCT02776553|584421853|FG001|Overall Study|had other surgery|0|||
161830950|NCT02776553|584421852|FG000|Overall Study|Protocol Violation|0|||
161830951|NCT02776553|584421853|FG001|Overall Study|Protocol Violation|1|||
161830952|NCT00941720|584421854|FG000|Overall Study|Withdrawal by Subject|1|||
161830953|NCT00941720|584421854|FG000|Overall Study|Insurance denied participation|11|||
161830954|NCT00941720|584421854|FG000|Overall Study|ineligible|2|||
161830955|NCT00171340|584421855|FG000|Overall Study|Adverse Event|46|||
161830956|NCT00171340|584421856|FG001|Overall Study|Adverse Event|42|||
161830957|NCT00171340|584421855|FG000|Overall Study|Lack of Efficacy|29|||
161830958|NCT00171340|584421856|FG001|Overall Study|Lack of Efficacy|41|||
161830959|NCT00171340|584421855|FG000|Overall Study|Protocol Violation|7|||
161830960|NCT00171340|584421856|FG001|Overall Study|Protocol Violation|8|||
161601656|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
161601657|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
161601658|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
161601659|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
161601660|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
161601661|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
161601662|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
161601663|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
161601664|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
161601665|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
161601666|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
161601667|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
161601668|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
161601669|NCT03580356|583593633|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
161601670|NCT03580356|583593634|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
161601671|NCT03580356|583593635|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
161601672|NCT03580356|583593636|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
161601673|NCT03580356|583593637|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
161601674|NCT03580356|583593638|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
161601675|NCT03580356|583593639|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
161601676|NCT03580356|583593640|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
161601677|NCT05715528|583593641|FG000|Overall Study|Randomized but never treated|11|||
161601678|NCT05715528|583593642|FG001|Overall Study|Randomized but never treated|13|||
161601679|NCT05715528|583593641|FG000|Overall Study|Withdrew consent|7|||
161601680|NCT05715528|583593642|FG001|Overall Study|Withdrew consent|15|||
161548752|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
161548753|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
161548754|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161548755|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161548756|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161548757|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
161548758|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
161548759|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
161548760|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
161548761|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
161548762|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
161601681|NCT05715528|583593641|FG000|Overall Study|Lost to Follow-up|5|||
161601682|NCT05715528|583593642|FG001|Overall Study|Lost to Follow-up|13|||
161601683|NCT05715528|583593641|FG000|Overall Study|Investigator's discretion|3|||
161601684|NCT05715528|583593642|FG001|Overall Study|Investigator's discretion|1|||
161601685|NCT05715528|583593641|FG000|Overall Study|Protocol Violation|2|||
161601686|NCT05715528|583593642|FG001|Overall Study|Protocol Violation|0|||
161601687|NCT05715528|583593641|FG000|Overall Study|Non-compliance with study drug|0|||
161601688|NCT05715528|583593642|FG001|Overall Study|Non-compliance with study drug|1|||
161601689|NCT05035654|583593645|FG000|Overall Study|Physician Decision|0|||
161601690|NCT05035654|583593646|FG001|Overall Study|Physician Decision|1|||
161601691|NCT05035654|583593647|FG002|Overall Study|Physician Decision|0|||
161601692|NCT05035654|583593645|FG000|Overall Study|Adverse Event|0|||
161601693|NCT05035654|583593646|FG001|Overall Study|Adverse Event|1|||
161601694|NCT05035654|583593647|FG002|Overall Study|Adverse Event|0|||
161601695|NCT05035654|583593645|FG000|Overall Study|Withdrawal by Subject|0|||
161601696|NCT05035654|583593646|FG001|Overall Study|Withdrawal by Subject|0|||
161601697|NCT05035654|583593647|FG002|Overall Study|Withdrawal by Subject|4|||
161601698|NCT05035654|583593645|FG000|Overall Study|Bilateral Dislodgement|1|||
161601699|NCT05035654|583593646|FG001|Overall Study|Bilateral Dislodgement|0|||
161601700|NCT05035654|583593647|FG002|Overall Study|Bilateral Dislodgement|0|||
161601701|NCT04632225|583593648|FG000|Overall Study|Withdrawal by Subject|2|||
161601702|NCT04632225|583593649|FG001|Overall Study|Withdrawal by Subject|2|||
161601703|NCT05660434|583593650|FG000|Overall Study|Never obtained study materials|2|||
161601704|NCT05660434|583593651|FG001|Overall Study|Never obtained study materials|1|||
161601705|NCT03213678|583593655|FG000|Overall Study|Death|1|||
161601706|NCT03213678|583593655|FG000|Overall Study|Physician Decision|1|||
161601707|NCT03213678|583593655|FG000|Overall Study|Progressive disease|16|||
161601708|NCT02413489|583593656|FG000|Overall Study|Death|11|||
161601709|NCT02413489|583593657|FG001|Overall Study|Death|3|||
161601710|NCT02413489|583593658|FG002|Overall Study|Death|4|||
161601711|NCT02413489|583593656|FG000|Overall Study|Withdrawal by Subject|2|||
161601712|NCT02413489|583593657|FG001|Overall Study|Withdrawal by Subject|0|||
161601713|NCT02413489|583593658|FG002|Overall Study|Withdrawal by Subject|0|||
161601714|NCT02413489|583593656|FG000|Overall Study|Study Terminated By Sponsor|2|||
161601715|NCT02413489|583593657|FG001|Overall Study|Study Terminated By Sponsor|13|||
161601716|NCT02413489|583593658|FG002|Overall Study|Study Terminated By Sponsor|1|||
161601717|NCT03717935|583593659|FG000|Overall Study|Withdrawal by Subject|0|||
161601718|NCT03717935|583593660|FG001|Overall Study|Withdrawal by Subject|2|||
161601719|NCT04456296|583593661|FG000|Overall Study|Withdrawal by Subject|14|||
161601720|NCT04456296|583593662|FG001|Overall Study|Withdrawal by Subject|21|||
161601721|NCT04456296|583593663|FG002|Overall Study|Withdrawal by Subject|21|||
161601722|NCT04456296|583593661|FG000|Overall Study|Adverse Event|2|||
161601723|NCT04456296|583593662|FG001|Overall Study|Adverse Event|2|||
161601724|NCT04456296|583593663|FG002|Overall Study|Adverse Event|2|||
161601725|NCT04456296|583593661|FG000|Overall Study|Death|1|||
161601726|NCT04456296|583593662|FG001|Overall Study|Death|0|||
161601727|NCT04456296|583593663|FG002|Overall Study|Death|0|||
161601728|NCT04456296|583593661|FG000|Overall Study|Lost to Follow-up|3|||
161601729|NCT04456296|583593662|FG001|Overall Study|Lost to Follow-up|5|||
161601730|NCT04456296|583593663|FG002|Overall Study|Lost to Follow-up|6|||
161601731|NCT04456296|583593661|FG000|Overall Study|Other than specified|0|||
161601732|NCT04456296|583593662|FG001|Overall Study|Other than specified|1|||
161601733|NCT04456296|583593663|FG002|Overall Study|Other than specified|4|||
161601734|NCT04456296|583593661|FG000|Overall Study|Randomized, not treated|2|||
161601735|NCT04456296|583593662|FG001|Overall Study|Randomized, not treated|1|||
161601736|NCT04456296|583593663|FG002|Overall Study|Randomized, not treated|0|||
161601737|NCT05736458|583593664|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
161601738|NCT05736458|583593665|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
161601739|NCT05736458|583593666|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
161601740|NCT05736458|583593664|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
161601741|NCT05736458|583593665|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
161601742|NCT05736458|583593666|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
161601743|NCT05736458|583593664|FG000|TMS/fMRI #1|Physician Decision|0|||
161601744|NCT05736458|583593665|FG001|TMS/fMRI #1|Physician Decision|0|||
161601745|NCT05736458|583593666|FG002|TMS/fMRI #1|Physician Decision|2|||
161601746|NCT05736458|583593664|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
161601747|NCT05736458|583593665|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
161601748|NCT05736458|583593666|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
161601749|NCT05654662|583593676|FG000|Overall Study|Withdrawal by Subject|1|||
161601750|NCT05654662|583593677|FG001|Overall Study|Withdrawal by Subject|0|||
161601751|NCT05654662|583593676|FG000|Overall Study|A death in the family|1|||
161601752|NCT05654662|583593677|FG001|Overall Study|A death in the family|0|||
161601753|NCT04230681|583593678|FG000|Overall Study|Physician Decision|2|||
161601754|NCT04230681|583593679|FG001|Overall Study|Physician Decision|3|||
161601755|NCT04230681|583593678|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
161601756|NCT04230681|583593679|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
161601757|NCT04230681|583593678|FG000|Overall Study|IV inadvertently removed|0|||
161601758|NCT04230681|583593679|FG001|Overall Study|IV inadvertently removed|1|||
161601759|NCT03106740|583595260|FG000|Overall Study|Lost to Follow-up|2|||
161601760|NCT03106740|583595261|FG001|Overall Study|Lost to Follow-up|2|||
161601761|NCT03106740|583595260|FG000|Overall Study|Withdrawal by Subject|2|||
161601762|NCT03106740|583595261|FG001|Overall Study|Withdrawal by Subject|4|||
161830961|NCT00171340|584421855|FG000|Overall Study|Withdrawal by Subject|22|||
161830962|NCT00171340|584421856|FG001|Overall Study|Withdrawal by Subject|19|||
161830963|NCT00171340|584421855|FG000|Overall Study|Lost to Follow-up|0|||
161830964|NCT00171340|584421856|FG001|Overall Study|Lost to Follow-up|5|||
161830965|NCT00171340|584421855|FG000|Overall Study|Abnormal Laboratory Results|2|||
161830966|NCT00171340|584421856|FG001|Overall Study|Abnormal Laboratory Results|0|||
161830967|NCT00171340|584421855|FG000|Overall Study|Abnormal Test Procedure Results|6|||
161830968|NCT00171340|584421856|FG001|Overall Study|Abnormal Test Procedure Results|11|||
161830969|NCT00171340|584421855|FG000|Overall Study|No Longer Required Study Drug|1|||
161830970|NCT00171340|584421856|FG001|Overall Study|No Longer Required Study Drug|1|||
161830971|NCT00171340|584421855|FG000|Overall Study|Administrative Problems|5|||
161830972|NCT00171340|584421856|FG001|Overall Study|Administrative Problems|2|||
161830973|NCT00171340|584421855|FG000|Overall Study|Death|6|||
161830974|NCT00171340|584421856|FG001|Overall Study|Death|6|||
161830975|NCT03827018|584421857|FG000|Overall Study|Adverse Event|1|||
161830976|NCT03827018|584421858|FG001|Overall Study|Adverse Event|0|||
161830977|NCT03827018|584421857|FG000|Overall Study|Withdrawal by Subject|2|||
161830978|NCT03827018|584421858|FG001|Overall Study|Withdrawal by Subject|2|||
161830979|NCT03827018|584421857|FG000|Overall Study|Lack of Efficacy|0|||
161830980|NCT03827018|584421858|FG001|Overall Study|Lack of Efficacy|1|||
161830981|NCT01998243|584421861|FG000|Overall Study|Pregnancy|0|||
161830982|NCT01998243|584421862|FG001|Overall Study|Pregnancy|1|||
161830983|NCT01998243|584421861|FG000|Overall Study|Protocol Violation|5|||
161830984|NCT01998243|584421862|FG001|Overall Study|Protocol Violation|2|||
161830985|NCT01998243|584421861|FG000|Overall Study|Withdrawal by Subject|3|||
161830986|NCT01998243|584421862|FG001|Overall Study|Withdrawal by Subject|4|||
161830987|NCT00680186|584421863|FG000|Overall Study|Adverse Event|47|||
161830988|NCT00680186|584421864|FG001|Overall Study|Adverse Event|44|||
161830989|NCT00680186|584421863|FG000|Overall Study|Protocol Violation|31|||
161830990|NCT00680186|584421864|FG001|Overall Study|Protocol Violation|26|||
161601763|NCT03106740|583595260|FG000|Overall Study|Physician Decision|0|||
161830991|NCT00680186|584421863|FG000|Overall Study|Lost to Follow-up|11|||
161830992|NCT00680186|584421864|FG001|Overall Study|Lost to Follow-up|6|||
161830993|NCT00680186|584421863|FG000|Overall Study|Withdrawal by Subject|32|||
161830994|NCT00680186|584421864|FG001|Overall Study|Withdrawal by Subject|39|||
161830995|NCT00680186|584421863|FG000|Overall Study|Other|4|||
161830996|NCT00680186|584421864|FG001|Overall Study|Other|1|||
161830997|NCT01351350|584421867|FG000|Overall Study|Disease Progression|5|||
161830998|NCT01351350|584421868|FG001|Overall Study|Disease Progression|13|||
161830999|NCT01351350|584421869|FG002|Overall Study|Disease Progression|6|||
161831000|NCT01351350|584421870|FG003|Overall Study|Disease Progression|8|||
161831001|NCT01351350|584421871|FG004|Overall Study|Disease Progression|5|||
161831002|NCT01351350|584421867|FG000|Overall Study|Adverse Event|1|||
161831003|NCT01351350|584421868|FG001|Overall Study|Adverse Event|10|||
161831004|NCT01351350|584421869|FG002|Overall Study|Adverse Event|1|||
161831005|NCT01351350|584421870|FG003|Overall Study|Adverse Event|2|||
161831006|NCT01351350|584421871|FG004|Overall Study|Adverse Event|0|||
161831007|NCT01351350|584421867|FG000|Overall Study|Participant Decision|2|||
161831008|NCT01351350|584421868|FG001|Overall Study|Participant Decision|6|||
161831009|NCT01351350|584421869|FG002|Overall Study|Participant Decision|3|||
161548763|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
161548764|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
161548765|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
161548766|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
161548767|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
161548768|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
161548769|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
161548770|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
161548771|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
161548772|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
161548773|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
161548774|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
161548775|NCT04921969|583397944|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
161548776|NCT04921969|583397945|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
161548777|NCT04921969|583397946|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
161548778|NCT04921969|583397947|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
161548779|NCT04921969|583397948|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
161548780|NCT04921969|583397949|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
161548781|NCT04921969|583397950|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
161548782|NCT04287868|583397951|FG000|Overall Study|Screening fail|1|||
161548783|NCT04287868|583397952|FG001|Overall Study|Screening fail|0|||
161548784|NCT02791490|583399262|FG000|Overall Study|Lost to Follow-up|1|||
161548785|NCT02791490|583399263|FG001|Overall Study|Lost to Follow-up|2|||
161548786|NCT02791490|583399262|FG000|Overall Study|Withdrawal by Subject|2|||
161548787|NCT02791490|583399263|FG001|Overall Study|Withdrawal by Subject|6|||
161548788|NCT01235975|583399268|FG000|Overall Study|Serious Adverse Event|0|||
161548789|NCT01235975|583399269|FG001|Overall Study|Serious Adverse Event|1|||
161548790|NCT01235975|583399268|FG000|Overall Study|Withdrawal by Subject|8|||
161548791|NCT01235975|583399269|FG001|Overall Study|Withdrawal by Subject|2|||
161548792|NCT01235975|583399268|FG000|Overall Study|Migrated/moved from study area|2|||
161548793|NCT01235975|583399269|FG001|Overall Study|Migrated/moved from study area|1|||
161548794|NCT01235975|583399268|FG000|Overall Study|Lost to Follow-up|7|||
161548795|NCT01235975|583399269|FG001|Overall Study|Lost to Follow-up|3|||
161548796|NCT01381874|583399270|FG000|Overall Study|Lost to Follow-up|1|||
161548797|NCT01381874|583399271|FG001|Overall Study|Lost to Follow-up|1|||
161548798|NCT01381874|583399272|FG002|Overall Study|Lost to Follow-up|0|||
161548799|NCT01381874|583399270|FG000|Overall Study|Withdrawal by Subject|9|||
161548800|NCT01381874|583399271|FG001|Overall Study|Withdrawal by Subject|10|||
161548801|NCT01381874|583399272|FG002|Overall Study|Withdrawal by Subject|9|||
161548802|NCT01381874|583399270|FG000|Overall Study|Other|67|||
161548803|NCT01381874|583399271|FG001|Overall Study|Other|52|||
161548804|NCT01381874|583399272|FG002|Overall Study|Other|67|||
161548805|NCT03119610|583399276|FG000|Overall Study|Adverse Event|1|||
161548806|NCT03119610|583399277|FG001|Overall Study|Adverse Event|0|||
161548807|NCT03119610|583399276|FG000|Overall Study|Lost to Follow-up|0|||
161548808|NCT03119610|583399277|FG001|Overall Study|Lost to Follow-up|1|||
161548809|NCT00114634|583399278|FG000|Overall Study|failure to return forms|3|||
161548810|NCT00684762|583399281|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
161548811|NCT00684762|583399282|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
161548812|NCT02310126|583399288|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
161831010|NCT01351350|584421870|FG003|Overall Study|Participant Decision|3|||
161831011|NCT01351350|584421871|FG004|Overall Study|Participant Decision|2|||
161831012|NCT01351350|584421867|FG000|Overall Study|Enrolled but not Treated|0|||
161831013|NCT01351350|584421868|FG001|Overall Study|Enrolled but not Treated|0|||
161831014|NCT01351350|584421869|FG002|Overall Study|Enrolled but not Treated|1|||
161831015|NCT01351350|584421870|FG003|Overall Study|Enrolled but not Treated|0|||
161831016|NCT01351350|584421871|FG004|Overall Study|Enrolled but not Treated|0|||
161831017|NCT04647383|584421872|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
161831018|NCT04647383|584421873|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
161831019|NCT04647383|584421874|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
161831020|NCT04647383|584421875|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
161831021|NCT00479388|584421878|FG000|Overall Study|Adverse Event|90|||
161831022|NCT00479388|584421879|FG001|Overall Study|Adverse Event|45|||
161831023|NCT00479388|584421878|FG000|Overall Study|Lost to Follow-up|0|||
161831024|NCT00479388|584421879|FG001|Overall Study|Lost to Follow-up|2|||
161831025|NCT00479388|584421878|FG000|Overall Study|Protocol Violation|10|||
161831026|NCT00479388|584421879|FG001|Overall Study|Protocol Violation|9|||
161831027|NCT00479388|584421878|FG000|Overall Study|Withdrawal by Subject|32|||
161831028|NCT00479388|584421879|FG001|Overall Study|Withdrawal by Subject|17|||
161831029|NCT00895037|584421889|FG000|Overall Study|Death|0|||
161831030|NCT00895037|584421890|FG001|Overall Study|Death|2|||
161831031|NCT00895037|584421891|FG002|Overall Study|Death|1|||
161831032|NCT01930175|584421893|FG000|Core Study|Lost to Follow-up|0|||
161831033|NCT01930175|584421894|FG001|Core Study|Lost to Follow-up|1|||
161831034|NCT01930175|584421895|FG002|Core Study|Lost to Follow-up|0|||
161831035|NCT01930175|584421893|FG000|Core Study|Adverse Event|0|||
161831036|NCT01930175|584421894|FG001|Core Study|Adverse Event|0|||
161831037|NCT01930175|584421895|FG002|Core Study|Adverse Event|1|||
161831038|NCT02820740|584421896|FG000|Overall Study|Did not have procedure|2|||
161831039|NCT00890552|584421897|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
161831040|NCT00890552|584421897|FG000|On-treatment|Early prog disease/ death|10|||
161831041|NCT03903159|584421898|FG000|Overall Study|Discharged with Staff Approval|2|||
161831042|NCT03903159|584421898|FG000|Overall Study|Discharged at Staff Request|2|||
161831043|NCT03903159|584421898|FG000|Overall Study|Discharged Against Staff Advice|1|||
161831044|NCT01382251|584421901|FG000|Overall Study|Surgeries cancelled or delayed|16|||
161831045|NCT01382251|584421902|FG001|Overall Study|Surgeries cancelled or delayed|16|||
161831046|NCT01382251|584421901|FG000|Overall Study|Lost to Follow-up|4|||
161831047|NCT01382251|584421902|FG001|Overall Study|Lost to Follow-up|4|||
161831048|NCT01382251|584421901|FG000|Overall Study|Contacted after study closed|1|||
161831049|NCT01382251|584421902|FG001|Overall Study|Contacted after study closed|1|||
161831050|NCT00702208|584421903|FG000|Overall Study|Lost to Follow-up|28|||
161831051|NCT00702208|584421903|FG000|Overall Study|Did not self-lavage|1|||
161831052|NCT00702208|584421903|FG000|Overall Study|Unsatisfactory colposcopy|2|||
161831053|NCT00562120|584421904|FG000|First Intervention Period|Adverse Event|1|||
161831054|NCT00562120|584421905|FG001|First Intervention Period|Adverse Event|0|||
161601764|NCT03106740|583595261|FG001|Overall Study|Physician Decision|1|||
161601765|NCT03106740|583595260|FG000|Overall Study|Partial data|1|||
161601766|NCT03106740|583595261|FG001|Overall Study|Partial data|0|||
161601767|NCT04565990|583595262|FG000|Overall Study|Death|5|||
161601768|NCT04565990|583595262|FG000|Overall Study|Lost to Follow-up|1|||
161601769|NCT04565990|583595262|FG000|Overall Study|Withdrawal by Subject|1|||
161601770|NCT05507333|583595263|FG000|Overall Study|Protocol Violation|1|||
161601771|NCT04766892|583595269|FG000|Overall Study|Withdrawal by Subject|1|||
161601772|NCT04766892|583595269|FG000|Overall Study|Lost to Follow-up|1|||
161601773|NCT04766892|583595269|FG000|Overall Study|Adverse Event|3|||
161831055|NCT00562120|584421906|FG002|First Intervention Period|Adverse Event|0|||
161831056|NCT00562120|584421907|FG003|First Intervention Period|Adverse Event|0|||
161831057|NCT00562120|584421904|FG000|First Intervention Period|Randomized but not Treated|1|||
161831058|NCT00562120|584421905|FG001|First Intervention Period|Randomized but not Treated|0|||
161831059|NCT00562120|584421906|FG002|First Intervention Period|Randomized but not Treated|0|||
161601774|NCT04766892|583595269|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
161831060|NCT00562120|584421907|FG003|First Intervention Period|Randomized but not Treated|0|||
161831061|NCT02148445|584421908|FG000|Overall Study|Death|1|||
161831062|NCT02148445|584421909|FG001|Overall Study|Death|3|||
161831063|NCT03450629|584421910|FG000|Overall Study|Adverse Event|15|||
161601775|NCT04359654|583595270|FG000|Overall Study|Withdrawal by Subject|1|||
161831064|NCT03450629|584421911|FG001|Overall Study|Adverse Event|14|||
161831065|NCT03450629|584421910|FG000|Overall Study|Physician Decision|2|||
161831066|NCT03450629|584421911|FG001|Overall Study|Physician Decision|2|||
161601776|NCT04359654|583595271|FG001|Overall Study|Withdrawal by Subject|0|||
161601777|NCT04359654|583595270|FG000|Overall Study|Adverse Event|0|||
161601778|NCT04359654|583595271|FG001|Overall Study|Adverse Event|1|||
161601779|NCT03711474|583595274|FG000|Overall Study|Physician Decision|2|||
161601780|NCT03711474|583595275|FG001|Overall Study|Physician Decision|0|||
161601781|NCT03677141|583595278|FG000|Overall Study|Death|2|||
161601782|NCT03677141|583595279|FG001|Overall Study|Death|1|||
161831067|NCT03450629|584421910|FG000|Overall Study|Lack of Efficacy|2|||
161601783|NCT03677141|583595280|FG002|Overall Study|Death|6|||
161601784|NCT03677141|583595281|FG003|Overall Study|Death|9|||
161831068|NCT03450629|584421911|FG001|Overall Study|Lack of Efficacy|0|||
161831069|NCT03450629|584421910|FG000|Overall Study|Lost to Follow-up|4|||
161831070|NCT03450629|584421911|FG001|Overall Study|Lost to Follow-up|2|||
161831071|NCT03450629|584421910|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161831072|NCT03450629|584421911|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161831073|NCT03450629|584421910|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161831074|NCT03450629|584421911|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161831075|NCT03450629|584421910|FG000|Overall Study|Protocol Violation|11|||
161831076|NCT03450629|584421911|FG001|Overall Study|Protocol Violation|8|||
161831077|NCT03450629|584421910|FG000|Overall Study|Withdrawal by Subject|12|||
161831078|NCT03450629|584421911|FG001|Overall Study|Withdrawal by Subject|6|||
161831079|NCT03366194|584421912|FG000|Overall Study|Lost to Follow-up|2|||
161831080|NCT02093923|584421913|FG000|Overall Study|Lost to Follow-up|0|||
161831081|NCT02093923|584421914|FG001|Overall Study|Lost to Follow-up|0|||
161831082|NCT02093923|584421915|FG002|Overall Study|Lost to Follow-up|0|||
161831083|NCT02093923|584421916|FG003|Overall Study|Lost to Follow-up|1|||
161831084|NCT02093923|584421917|FG004|Overall Study|Lost to Follow-up|0|||
161831085|NCT02093923|584421913|FG000|Overall Study|Screen failure after randomization|0|||
161831086|NCT02093923|584421914|FG001|Overall Study|Screen failure after randomization|0|||
161831087|NCT02093923|584421915|FG002|Overall Study|Screen failure after randomization|0|||
161831088|NCT02093923|584421916|FG003|Overall Study|Screen failure after randomization|1|||
161831089|NCT02093923|584421917|FG004|Overall Study|Screen failure after randomization|0|||
161831090|NCT03438006|584421918|FG000|Overall Study|Adverse Event|1|||
161831091|NCT03438006|584421918|FG000|Overall Study|Lost to Follow-up|67|||
161831092|NCT03438006|584421918|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
161831093|NCT03438006|584421918|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
161831094|NCT02737592|584421919|FG000|Overall Study|Withdrawal by Subject|1|||
161831095|NCT04678817|584422909|FG000|Overall Study|Lost to Follow-up|28|||
161831096|NCT04678817|584422910|FG001|Overall Study|Lost to Follow-up|0|||
161831097|NCT04678817|584422911|FG002|Overall Study|Lost to Follow-up|0|||
161831098|NCT01961687|584422914|FG000|Overall Study|Lost to Follow-up|19|||
161831099|NCT01961687|584422914|FG000|Overall Study|Re-operation|17|||
161831100|NCT01961687|584422914|FG000|Overall Study|Death|7|||
161831101|NCT01961687|584422914|FG000|Overall Study|Withdrawal by Subject|6|||
161831102|NCT01961687|584422914|FG000|Overall Study|Adverse Event|6|||
161831103|NCT01961687|584422914|FG000|Overall Study|Moved to area without study site|2|||
161831104|NCT01961687|584422914|FG000|Overall Study|Sponsor decision|2|||
161831105|NCT01961687|584422914|FG000|Overall Study|Physician Decision|1|||
161831106|NCT01961687|584422914|FG000|Overall Study|Unable to meet follow-up requirements|1|||
161831107|NCT00614926|584422915|FG000|Overall Study|Burden of travel|1|||
161831108|NCT00614926|584422916|FG001|Overall Study|Burden of travel|0|||
161831109|NCT00614926|584422915|FG000|Overall Study|Adverse Event|3|||
161831110|NCT00614926|584422916|FG001|Overall Study|Adverse Event|0|||
161831111|NCT02999984|584422917|FG000|Overall Study|Treatment Failure|1|||
161831112|NCT02310789|584422920|FG000|Overall Study|Adverse Event|1|||
161831113|NCT01197417|584422921|FG000|Overall Study|Physician Decision|3|||
161831114|NCT01197417|584422922|FG001|Overall Study|Physician Decision|2|||
161831115|NCT01197417|584422921|FG000|Overall Study|Withdrawal by Subject|2|||
161831116|NCT01197417|584422922|FG001|Overall Study|Withdrawal by Subject|4|||
161831117|NCT01197417|584422921|FG000|Overall Study|Site miscommunication|0|||
161831118|NCT01197417|584422922|FG001|Overall Study|Site miscommunication|1|||
161831119|NCT01197417|584422921|FG000|Overall Study|Subject transferred to intensive care|0|||
161831120|NCT01197417|584422922|FG001|Overall Study|Subject transferred to intensive care|1|||
161831121|NCT01197417|584422921|FG000|Overall Study|Not consented in time to receive drug|0|||
161831122|NCT01197417|584422922|FG001|Overall Study|Not consented in time to receive drug|1|||
161831123|NCT01197417|584422921|FG000|Overall Study|Hypotension|1|||
161831124|NCT01197417|584422922|FG001|Overall Study|Hypotension|2|||
161831125|NCT01197417|584422921|FG000|Overall Study|Found to be ineligible|2|||
161831126|NCT01197417|584422922|FG001|Overall Study|Found to be ineligible|5|||
161831127|NCT01197417|584422921|FG000|Overall Study|No 25-hour magnesium level|0|||
161831128|NCT01197417|584422922|FG001|Overall Study|No 25-hour magnesium level|2|||
161831129|NCT02813421|584422923|FG000|Overall Study|Withdrawal by Subject|1|||
161831130|NCT02813421|584422924|FG001|Overall Study|Withdrawal by Subject|2|||
161831131|NCT02813421|584422923|FG000|Overall Study|Lost to Follow-up|1|||
161831132|NCT02813421|584422924|FG001|Overall Study|Lost to Follow-up|1|||
161831133|NCT02129647|584422931|FG000|Overall Study|Adverse Event|2|||
161831134|NCT02129647|584422931|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
161831135|NCT02772562|584422932|FG000|Overall Study|Withdrawal by Subject|1|||
161831136|NCT02772562|584422932|FG000|Overall Study|Protocol Violation|1|||
161831137|NCT03756883|584422933|FG000|Overall Study|Adverse Event|2|||
161601785|NCT03677141|583595282|FG004|Overall Study|Death|5|||
161601786|NCT03677141|583595283|FG005|Overall Study|Death|3|||
161601787|NCT03677141|583595278|FG000|Overall Study|Lost to Follow-up|0|||
161831138|NCT03756883|584422934|FG001|Overall Study|Adverse Event|2|||
161831139|NCT03756883|584422935|FG002|Overall Study|Adverse Event|2|||
161831140|NCT03756883|584422933|FG000|Overall Study|Lack of Efficacy|0|||
161831141|NCT03756883|584422934|FG001|Overall Study|Lack of Efficacy|1|||
161682432|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161682433|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161682434|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161682435|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
161682436|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161682437|NCT04695392|583888879|FG000|Overall Study|Withdrawn by parent/guardian|0|||
161682438|NCT04695392|583888880|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161682439|NCT04695392|583888879|FG000|Overall Study|Withdrawn by physician|0|||
161682440|NCT04695392|583888880|FG001|Overall Study|Withdrawn by physician|1|||
161682441|NCT00450723|583888881|FG000|Overall Study|Physician Decision|5|||
161682442|NCT01721057|583888884|FG000|Treatment Period|Withdrawal by Subject|11|||
161682443|NCT01721057|583888885|FG001|Treatment Period|Withdrawal by Subject|5|||
161682444|NCT01721057|583888886|FG002|Treatment Period|Withdrawal by Subject|8|||
161682445|NCT01721057|583888887|FG003|Treatment Period|Withdrawal by Subject|0|||
161682446|NCT01721057|583888888|FG004|Treatment Period|Withdrawal by Subject|0|||
161682447|NCT01721057|583888889|FG005|Treatment Period|Withdrawal by Subject|0|||
161682448|NCT01721057|583888890|FG006|Treatment Period|Withdrawal by Subject|0|||
161682449|NCT01721057|583888884|FG000|Treatment Period|Adverse Event|7|||
161682450|NCT01721057|583888885|FG001|Treatment Period|Adverse Event|10|||
161682451|NCT01721057|583888886|FG002|Treatment Period|Adverse Event|12|||
161682452|NCT01721057|583888887|FG003|Treatment Period|Adverse Event|0|||
161682453|NCT01721057|583888888|FG004|Treatment Period|Adverse Event|0|||
161682454|NCT01721057|583888889|FG005|Treatment Period|Adverse Event|0|||
161548813|NCT02310126|583399289|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
161682455|NCT01721057|583888890|FG006|Treatment Period|Adverse Event|0|||
161682456|NCT01721057|583888884|FG000|Treatment Period|Lack of Efficacy|7|||
161682457|NCT01721057|583888885|FG001|Treatment Period|Lack of Efficacy|3|||
161682458|NCT01721057|583888886|FG002|Treatment Period|Lack of Efficacy|0|||
161682459|NCT01721057|583888887|FG003|Treatment Period|Lack of Efficacy|0|||
161831142|NCT03756883|584422935|FG002|Overall Study|Lack of Efficacy|2|||
161831143|NCT03756883|584422933|FG000|Overall Study|Lost to Follow-up|3|||
161831144|NCT03756883|584422934|FG001|Overall Study|Lost to Follow-up|3|||
161831145|NCT03756883|584422935|FG002|Overall Study|Lost to Follow-up|0|||
161831146|NCT03756883|584422933|FG000|Overall Study|Protocol Violation|2|||
161831147|NCT03756883|584422934|FG001|Overall Study|Protocol Violation|0|||
161831148|NCT03756883|584422935|FG002|Overall Study|Protocol Violation|1|||
161831149|NCT03756883|584422933|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
161831150|NCT03756883|584422934|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
161831151|NCT03756883|584422935|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
161831152|NCT03756883|584422933|FG000|Overall Study|Withdrawal by Subject|4|||
161831153|NCT03756883|584422934|FG001|Overall Study|Withdrawal by Subject|1|||
161831154|NCT03756883|584422935|FG002|Overall Study|Withdrawal by Subject|0|||
161831155|NCT03756883|584422933|FG000|Overall Study|Other Reasons|2|||
161831156|NCT03756883|584422934|FG001|Overall Study|Other Reasons|4|||
161831157|NCT03756883|584422935|FG002|Overall Study|Other Reasons|0|||
161831158|NCT01463982|584422936|FG000|Overall Study|Withdrawal by Subject|0|||
161831159|NCT01463982|584422937|FG001|Overall Study|Withdrawal by Subject|1|||
161831160|NCT01463982|584422938|FG002|Overall Study|Withdrawal by Subject|1|||
161831161|NCT01463982|584422939|FG003|Overall Study|Withdrawal by Subject|0|||
161831162|NCT01463982|584422936|FG000|Overall Study|Treatment delay over 5 week|0|||
161831163|NCT01463982|584422937|FG001|Overall Study|Treatment delay over 5 week|0|||
161831164|NCT01463982|584422938|FG002|Overall Study|Treatment delay over 5 week|1|||
161831165|NCT01463982|584422939|FG003|Overall Study|Treatment delay over 5 week|0|||
161831166|NCT04668274|584422942|FG000|Part 1 Study Period 1|Adverse Event|3|||
161831167|NCT04668274|584422943|FG001|Part 1 Study Period 1|Adverse Event|0|||
161831168|NCT04668274|584422944|FG002|Part 1 Study Period 1|Adverse Event|0|||
161831169|NCT04668274|584422945|FG003|Part 1 Study Period 1|Adverse Event|0|||
161831170|NCT04668274|584422942|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
161831171|NCT04668274|584422943|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
161831172|NCT04668274|584422944|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
161831173|NCT04668274|584422945|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
161831174|NCT04668274|584422942|FG000|Part 1 Study Period 2|Other|0|||
161831175|NCT04668274|584422943|FG001|Part 1 Study Period 2|Other|1|||
161831176|NCT04668274|584422944|FG002|Part 1 Study Period 2|Other|0|||
161831177|NCT04668274|584422945|FG003|Part 1 Study Period 2|Other|0|||
161831178|NCT04668274|584422942|FG000|Part 1 Study Period 3|Adverse Event|0|||
161831179|NCT04668274|584422943|FG001|Part 1 Study Period 3|Adverse Event|0|||
161831180|NCT04668274|584422944|FG002|Part 1 Study Period 3|Adverse Event|1|||
161831181|NCT04668274|584422945|FG003|Part 1 Study Period 3|Adverse Event|0|||
161831182|NCT04668274|584422942|FG000|Part 1 Study Period 3|Other|0|||
161831183|NCT04668274|584422943|FG001|Part 1 Study Period 3|Other|0|||
161601788|NCT03677141|583595279|FG001|Overall Study|Lost to Follow-up|0|||
161601789|NCT03677141|583595280|FG002|Overall Study|Lost to Follow-up|0|||
161601790|NCT03677141|583595281|FG003|Overall Study|Lost to Follow-up|2|||
161601791|NCT03677141|583595282|FG004|Overall Study|Lost to Follow-up|0|||
161601792|NCT03677141|583595283|FG005|Overall Study|Lost to Follow-up|0|||
161601793|NCT03677141|583595278|FG000|Overall Study|Screen failure or enrolled in error|0|||
161601794|NCT03677141|583595279|FG001|Overall Study|Screen failure or enrolled in error|0|||
161601795|NCT03677141|583595280|FG002|Overall Study|Screen failure or enrolled in error|0|||
161601796|NCT03677141|583595281|FG003|Overall Study|Screen failure or enrolled in error|0|||
161601797|NCT03677141|583595282|FG004|Overall Study|Screen failure or enrolled in error|2|||
161601798|NCT03677141|583595283|FG005|Overall Study|Screen failure or enrolled in error|0|||
161601799|NCT03677141|583595278|FG000|Overall Study|Physician Decision|0|||
161601800|NCT03677141|583595279|FG001|Overall Study|Physician Decision|0|||
161601801|NCT03677141|583595280|FG002|Overall Study|Physician Decision|0|||
161601802|NCT03677141|583595281|FG003|Overall Study|Physician Decision|0|||
161601803|NCT03677141|583595282|FG004|Overall Study|Physician Decision|1|||
161601804|NCT03677141|583595283|FG005|Overall Study|Physician Decision|0|||
161601805|NCT03677141|583595278|FG000|Overall Study|Withdrawal by Subject|0|||
161601806|NCT03677141|583595279|FG001|Overall Study|Withdrawal by Subject|0|||
161601807|NCT03677141|583595280|FG002|Overall Study|Withdrawal by Subject|1|||
161601808|NCT03677141|583595281|FG003|Overall Study|Withdrawal by Subject|1|||
161601809|NCT03677141|583595282|FG004|Overall Study|Withdrawal by Subject|1|||
161601810|NCT03677141|583595283|FG005|Overall Study|Withdrawal by Subject|0|||
161601811|NCT04003246|583595287|FG000|Overall Study|Death|9|||
161601812|NCT05405985|583595300|FG000|Overall Study|Withdrawal by Subject|1|||
161601813|NCT05405985|583595301|FG001|Overall Study|Withdrawal by Subject|0|||
161601814|NCT04451772|583595317|FG000|Overall Study|Adverse Event|1|||
161601815|NCT04451772|583595318|FG001|Overall Study|Adverse Event|0|||
161601816|NCT04451772|583595319|FG002|Overall Study|Adverse Event|1|||
161601817|NCT04451772|583595320|FG003|Overall Study|Adverse Event|1|||
161601818|NCT04451772|583595321|FG004|Overall Study|Adverse Event|0|||
161601819|NCT04451772|583595322|FG005|Overall Study|Adverse Event|3|||
161601820|NCT04451772|583595317|FG000|Overall Study|Withdrawal by Subject|2|||
161601821|NCT04451772|583595318|FG001|Overall Study|Withdrawal by Subject|7|||
161601822|NCT04451772|583595319|FG002|Overall Study|Withdrawal by Subject|2|||
161601823|NCT04451772|583595320|FG003|Overall Study|Withdrawal by Subject|1|||
161601824|NCT04451772|583595321|FG004|Overall Study|Withdrawal by Subject|1|||
161601825|NCT04451772|583595322|FG005|Overall Study|Withdrawal by Subject|0|||
161601826|NCT04451772|583595317|FG000|Overall Study|Other, not specified|1|||
161601827|NCT04451772|583595318|FG001|Overall Study|Other, not specified|2|||
161601828|NCT04451772|583595319|FG002|Overall Study|Other, not specified|1|||
161601829|NCT04451772|583595320|FG003|Overall Study|Other, not specified|0|||
161601830|NCT04451772|583595321|FG004|Overall Study|Other, not specified|0|||
161601831|NCT04451772|583595322|FG005|Overall Study|Other, not specified|1|||
161601832|NCT04451772|583595317|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
161601833|NCT04451772|583595318|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
161601834|NCT04451772|583595319|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
161601835|NCT04451772|583595320|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
161601836|NCT04451772|583595321|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
161601837|NCT04451772|583595322|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
161601838|NCT04311632|583595323|FG000|Overall Study|Withdrawal by Subject|0|||
161601839|NCT04311632|583595324|FG001|Overall Study|Withdrawal by Subject|0|||
161601840|NCT04311632|583595325|FG002|Overall Study|Withdrawal by Subject|1|||
161601841|NCT05856435|583595326|FG000|Overall Study|Lost to Follow-up|6|||
161601842|NCT04934072|583595327|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
161601843|NCT04934072|583595328|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
161601844|NCT04934072|583595329|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
161601845|NCT04934072|583595330|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
161601846|NCT04934072|583595331|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
161601847|NCT04934072|583595327|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
161601848|NCT04934072|583595328|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
161601849|NCT04934072|583595329|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
161601850|NCT04934072|583595330|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
161601851|NCT04934072|583595331|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
161601852|NCT04934072|583595327|FG000|Day 0 to Week 52|Other|3|||
161601853|NCT04934072|583595328|FG001|Day 0 to Week 52|Other|1|||
161601854|NCT04934072|583595329|FG002|Day 0 to Week 52|Other|0|||
161601855|NCT04934072|583595330|FG003|Day 0 to Week 52|Other|0|||
161601856|NCT04934072|583595331|FG004|Day 0 to Week 52|Other|0|||
161601857|NCT04934072|583595327|FG000|Day 0 to Week 52|Adverse Event|1|||
161601858|NCT04934072|583595328|FG001|Day 0 to Week 52|Adverse Event|3|||
161601859|NCT04934072|583595329|FG002|Day 0 to Week 52|Adverse Event|0|||
161601860|NCT04934072|583595330|FG003|Day 0 to Week 52|Adverse Event|0|||
161601861|NCT04934072|583595331|FG004|Day 0 to Week 52|Adverse Event|0|||
161601862|NCT04934072|583595327|FG000|Week 52 to Week 78|Adverse Event|0|||
161601863|NCT04934072|583595328|FG001|Week 52 to Week 78|Adverse Event|0|||
161601864|NCT04934072|583595329|FG002|Week 52 to Week 78|Adverse Event|0|||
161601865|NCT04934072|583595330|FG003|Week 52 to Week 78|Adverse Event|1|||
161601866|NCT04934072|583595331|FG004|Week 52 to Week 78|Adverse Event|1|||
161601867|NCT04934072|583595327|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
161601868|NCT04934072|583595328|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
161601869|NCT04934072|583595329|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
161831184|NCT04668274|584422944|FG002|Part 1 Study Period 3|Other|2|||
161601870|NCT04934072|583595330|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
161601871|NCT04934072|583595331|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
161831185|NCT04668274|584422945|FG003|Part 1 Study Period 3|Other|0|||
161831186|NCT04668274|584422942|FG000|Part 2 Study Period 4|Other|0|||
161831187|NCT04668274|584422943|FG001|Part 2 Study Period 4|Other|0|||
161831188|NCT04668274|584422944|FG002|Part 2 Study Period 4|Other|0|||
161831189|NCT04668274|584422945|FG003|Part 2 Study Period 4|Other|1|||
161831190|NCT00939627|584422950|FG000|Overall Study|Disease Progression|16|||
161831191|NCT00939627|584422951|FG001|Overall Study|Disease Progression|12|||
161831192|NCT00939627|584422952|FG002|Overall Study|Disease Progression|0|||
161831193|NCT00939627|584422950|FG000|Overall Study|Adverse Event|6|||
161831194|NCT00939627|584422951|FG001|Overall Study|Adverse Event|7|||
161831195|NCT00939627|584422952|FG002|Overall Study|Adverse Event|0|||
161831196|NCT00939627|584422950|FG000|Overall Study|Death|0|||
161831197|NCT00939627|584422951|FG001|Overall Study|Death|2|||
161831198|NCT00939627|584422952|FG002|Overall Study|Death|0|||
161831199|NCT00939627|584422950|FG000|Overall Study|Withdrawal by Subject|2|||
161831200|NCT00939627|584422951|FG001|Overall Study|Withdrawal by Subject|4|||
161831201|NCT00939627|584422952|FG002|Overall Study|Withdrawal by Subject|0|||
161831202|NCT00939627|584422950|FG000|Overall Study|Other complicating disease|1|||
161831203|NCT00939627|584422951|FG001|Overall Study|Other complicating disease|1|||
161831204|NCT00939627|584422952|FG002|Overall Study|Other complicating disease|0|||
161831205|NCT00939627|584422950|FG000|Overall Study|Not compliant|2|||
161831206|NCT00939627|584422951|FG001|Overall Study|Not compliant|0|||
161831207|NCT00939627|584422952|FG002|Overall Study|Not compliant|0|||
161831208|NCT00939627|584422950|FG000|Overall Study|No off-tx reason given|0|||
161831209|NCT00939627|584422951|FG001|Overall Study|No off-tx reason given|2|||
161831210|NCT00939627|584422952|FG002|Overall Study|No off-tx reason given|0|||
161831211|NCT02039063|584422955|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
161831212|NCT02039063|584422956|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
161831213|NCT02039063|584422957|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
161831214|NCT02039063|584422958|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
161831215|NCT02039063|584422955|FG000|Treatment Phase|Progression of disease|0|||
161831216|NCT02039063|584422956|FG001|Treatment Phase|Progression of disease|0|||
161831217|NCT02039063|584422957|FG002|Treatment Phase|Progression of disease|1|||
161831218|NCT02039063|584422958|FG003|Treatment Phase|Progression of disease|1|||
161831219|NCT02039063|584422955|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161831220|NCT02039063|584422956|FG001|Extension Phase|Inadequate therapeutic effect|1|||
161831221|NCT02039063|584422957|FG002|Extension Phase|Inadequate therapeutic effect|2|||
161831222|NCT02039063|584422958|FG003|Extension Phase|Inadequate therapeutic effect|0|||
161831223|NCT02039063|584422955|FG000|Extension Phase|Progression of disease|0|||
161831224|NCT02039063|584422956|FG001|Extension Phase|Progression of disease|0|||
161831225|NCT02039063|584422957|FG002|Extension Phase|Progression of disease|0|||
161831226|NCT02039063|584422958|FG003|Extension Phase|Progression of disease|1|||
161831227|NCT02039063|584422955|FG000|Extension Phase|Adverse Event|0|||
161831228|NCT02039063|584422956|FG001|Extension Phase|Adverse Event|0|||
161831229|NCT02039063|584422957|FG002|Extension Phase|Adverse Event|1|||
161831230|NCT02039063|584422958|FG003|Extension Phase|Adverse Event|0|||
161831231|NCT00467831|584422961|FG000|Overall Study|Death|2|||
161831232|NCT00467831|584422961|FG000|Overall Study|Withdrawal by Subject|1|||
161831233|NCT01832402|584422964|FG000|Overall Study|Lost to Follow-up|2|||
161831234|NCT01832402|584422965|FG001|Overall Study|Lost to Follow-up|0|||
161831235|NCT01832402|584422964|FG000|Overall Study|Withdrawal by Subject|3|||
161831236|NCT01832402|584422965|FG001|Overall Study|Withdrawal by Subject|3|||
161831237|NCT01832402|584422964|FG000|Overall Study|Declining Performance status|2|||
161831238|NCT01832402|584422965|FG001|Overall Study|Declining Performance status|1|||
161831239|NCT01198873|584422966|FG000|Overall Study|Adverse Event|4|||
161831240|NCT01198873|584422967|FG001|Overall Study|Adverse Event|7|||
161831241|NCT01198873|584422966|FG000|Overall Study|Study closure|29|||
161831242|NCT01198873|584422967|FG001|Overall Study|Study closure|23|||
161831243|NCT01198873|584422966|FG000|Overall Study|Other than above|4|||
161831244|NCT01198873|584422967|FG001|Overall Study|Other than above|2|||
161831245|NCT00775528|584422973|FG000|Overall Study|Protocol Violation|1|||
161831246|NCT02492841|584422974|FG000|Overall Study|Lost to Follow-up|34|||
161831247|NCT02492841|584422975|FG001|Overall Study|Lost to Follow-up|31|||
161831248|NCT02492841|584422976|FG002|Overall Study|Lost to Follow-up|35|||
161831249|NCT00613730|584422979|FG000|Overall Study|Disease progression|2|||
161601872|NCT04934072|583595327|FG000|Week 52 to Week 78|Other|0|||
161601873|NCT04934072|583595328|FG001|Week 52 to Week 78|Other|0|||
161601874|NCT04934072|583595329|FG002|Week 52 to Week 78|Other|1|||
161601875|NCT04934072|583595330|FG003|Week 52 to Week 78|Other|0|||
161601876|NCT04934072|583595331|FG004|Week 52 to Week 78|Other|0|||
161601877|NCT05970861|583595333|FG000|Overall Study|Physician Decision|4|||
161601878|NCT05970861|583595334|FG001|Overall Study|Physician Decision|4|||
161682460|NCT01721057|583888888|FG004|Treatment Period|Lack of Efficacy|0|||
161682461|NCT01721057|583888889|FG005|Treatment Period|Lack of Efficacy|0|||
161601879|NCT05970861|583595333|FG000|Overall Study|Lost to Follow-up|4|||
161682462|NCT01721057|583888890|FG006|Treatment Period|Lack of Efficacy|0|||
161601880|NCT05970861|583595334|FG001|Overall Study|Lost to Follow-up|3|||
161601881|NCT02990338|583595335|FG000|Overall Study|Randomized and not treated|4|||
161682463|NCT01721057|583888884|FG000|Treatment Period|Lost to Follow-up|1|||
161601882|NCT02990338|583595336|FG001|Overall Study|Randomized and not treated|2|||
161548814|NCT02310126|583399288|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
161548815|NCT02310126|583399289|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
161601883|NCT02990338|583595335|FG000|Overall Study|Adverse Event|23|||
161601884|NCT02990338|583595336|FG001|Overall Study|Adverse Event|22|||
161601885|NCT02990338|583595335|FG000|Overall Study|Progressive disease|118|||
161831250|NCT00613730|584422979|FG000|Overall Study|Administrative decision|1|||
161831251|NCT04965389|584422988|FG000|Overall Study|Other reasons|1|||
161831252|NCT04965389|584422989|FG001|Overall Study|Other reasons|0|||
161548816|NCT02693834|583399293|FG000|Baseline Measurement|Withdrawal by Subject|1|||
161548817|NCT02693834|583399294|FG001|Baseline Measurement|Withdrawal by Subject|0|||
161548818|NCT02693834|583399293|FG000|Baseline Measurement|Adverse Event|1|||
161548819|NCT02693834|583399294|FG001|Baseline Measurement|Adverse Event|0|||
161548820|NCT02693834|583399293|FG000|Week 2 Practice|Adverse Event|0|||
161548821|NCT02693834|583399294|FG001|Week 2 Practice|Adverse Event|1|||
161548822|NCT02111213|583399297|FG000|Overall Study|Withdrawal by Subject|3|||
161548823|NCT02111213|583399298|FG001|Overall Study|Withdrawal by Subject|2|||
161548824|NCT02111213|583399297|FG000|Overall Study|Lost to Follow-up|3|||
161548825|NCT02111213|583399298|FG001|Overall Study|Lost to Follow-up|4|||
161548826|NCT00439179|583399299|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
161548827|NCT00439179|583399300|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
161548828|NCT00439179|583399301|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
161548829|NCT00439179|583399302|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
161548830|NCT02761629|583399303|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
161548831|NCT02761629|583399304|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
161548832|NCT02761629|583399303|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161548833|NCT02761629|583399304|FG001|Overall Study|Insufficient Therapeutic Response|7|||
161548834|NCT02761629|583399303|FG000|Overall Study|Failure to Return|2|||
161548835|NCT02761629|583399304|FG001|Overall Study|Failure to Return|4|||
161548836|NCT02761629|583399303|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
161548837|NCT02761629|583399304|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
161548838|NCT02761629|583399303|FG000|Overall Study|Protocol Violation|2|||
161548839|NCT02761629|583399304|FG001|Overall Study|Protocol Violation|2|||
161548840|NCT02761629|583399303|FG000|Overall Study|Withdrawal by Subject|0|||
161548841|NCT02761629|583399304|FG001|Overall Study|Withdrawal by Subject|3|||
161548842|NCT02761629|583399303|FG000|Overall Study|Other|0|||
161548843|NCT02761629|583399304|FG001|Overall Study|Other|2|||
161548844|NCT02761629|583399303|FG000|Overall Study|Lost to Follow-up|4|||
161548845|NCT02761629|583399304|FG001|Overall Study|Lost to Follow-up|1|||
161548846|NCT02761629|583399303|FG000|Overall Study|Randomized But Not Treated|8|||
161548847|NCT02761629|583399304|FG001|Overall Study|Randomized But Not Treated|4|||
161548848|NCT00936221|583399311|FG000|Overall Study|Withdrawal by Subject|1|||
161548849|NCT00936221|583399312|FG001|Overall Study|Withdrawal by Subject|1|||
161548850|NCT01844115|583399315|FG000|Overall Study|Adverse Event|4|||
161548851|NCT01844115|583399316|FG001|Overall Study|Adverse Event|22|||
161548852|NCT01844115|583399315|FG000|Overall Study|Lack of Efficacy|1|||
161548853|NCT01844115|583399316|FG001|Overall Study|Lack of Efficacy|4|||
161548854|NCT01844115|583399315|FG000|Overall Study|Protocol Violation|12|||
161548855|NCT01844115|583399316|FG001|Overall Study|Protocol Violation|10|||
161548856|NCT01844115|583399315|FG000|Overall Study|Withdrawal by Subject|11|||
161831253|NCT04965389|584422990|FG002|Overall Study|Other reasons|0|||
161831254|NCT04965389|584422991|FG003|Overall Study|Other reasons|0|||
161831255|NCT04965389|584422988|FG000|Overall Study|Participant withdrew consent|0|||
161831256|NCT04965389|584422989|FG001|Overall Study|Participant withdrew consent|1|||
161831257|NCT04965389|584422990|FG002|Overall Study|Participant withdrew consent|0|||
161831258|NCT04965389|584422991|FG003|Overall Study|Participant withdrew consent|0|||
161831259|NCT04965389|584422988|FG000|Overall Study|Poor/Non-compliance|0|||
161831260|NCT04965389|584422989|FG001|Overall Study|Poor/Non-compliance|1|||
161831261|NCT04965389|584422990|FG002|Overall Study|Poor/Non-compliance|0|||
161831262|NCT04965389|584422991|FG003|Overall Study|Poor/Non-compliance|0|||
161831263|NCT02083926|584422994|FG000|Overall Study|Withdrawal by Subject|1|||
161831264|NCT02083926|584422995|FG001|Overall Study|Withdrawal by Subject|0|||
161831265|NCT01436643|584422996|FG000|2-week Pre-treatment|Abnormal test result|0|||
161831266|NCT01436643|584422997|FG001|2-week Pre-treatment|Abnormal test result|0|||
161831267|NCT01436643|584422998|FG002|2-week Pre-treatment|Abnormal test result|0|||
161831268|NCT01436643|584422999|FG003|2-week Pre-treatment|Abnormal test result|1|||
161831269|NCT01436643|584422996|FG000|2-week Pre-treatment|Adverse Event|0|||
161831270|NCT01436643|584422997|FG001|2-week Pre-treatment|Adverse Event|0|||
161831271|NCT01436643|584422998|FG002|2-week Pre-treatment|Adverse Event|0|||
161831272|NCT01436643|584422999|FG003|2-week Pre-treatment|Adverse Event|5|||
161831273|NCT01436643|584422996|FG000|2-week Pre-treatment|Protocol Violation|0|||
161831274|NCT01436643|584422997|FG001|2-week Pre-treatment|Protocol Violation|0|||
161831275|NCT01436643|584422998|FG002|2-week Pre-treatment|Protocol Violation|0|||
161831276|NCT01436643|584422999|FG003|2-week Pre-treatment|Protocol Violation|4|||
161831277|NCT01436643|584422996|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
161831278|NCT01436643|584422997|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
161601886|NCT02990338|583595336|FG001|Overall Study|Progressive disease|107|||
161601887|NCT02990338|583595335|FG000|Overall Study|Poor compliance to protocol|0|||
161601888|NCT02990338|583595336|FG001|Overall Study|Poor compliance to protocol|1|||
161601889|NCT02990338|583595335|FG000|Overall Study|Withdrawal by Subject|6|||
161601890|NCT02990338|583595336|FG001|Overall Study|Withdrawal by Subject|8|||
161601891|NCT02990338|583595335|FG000|Overall Study|Physician's decision|2|||
161601892|NCT02990338|583595336|FG001|Overall Study|Physician's decision|6|||
161601893|NCT02990338|583595335|FG000|Overall Study|Treatment extension study|0|||
161601894|NCT02990338|583595336|FG001|Overall Study|Treatment extension study|6|||
161601895|NCT02990338|583595335|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
161601896|NCT02990338|583595336|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
161601897|NCT02990338|583595335|FG000|Overall Study|Continue with therapy available commercially|0|||
161601898|NCT02990338|583595336|FG001|Overall Study|Continue with therapy available commercially|1|||
161601899|NCT05100628|583595338|FG000|Overall Study|Progressive Disease|1|||
161601900|NCT05100628|583595339|FG001|Overall Study|Progressive Disease|0|||
161601901|NCT05100628|583595340|FG002|Overall Study|Progressive Disease|0|||
161601902|NCT05100628|583595341|FG003|Overall Study|Progressive Disease|0|||
161601903|NCT05100628|583595338|FG000|Overall Study|Study Terminated by Sponsor|0|||
161601904|NCT05100628|583595339|FG001|Overall Study|Study Terminated by Sponsor|0|||
161601905|NCT05100628|583595340|FG002|Overall Study|Study Terminated by Sponsor|3|||
161601906|NCT05100628|583595341|FG003|Overall Study|Study Terminated by Sponsor|0|||
161601907|NCT05100628|583595338|FG000|Overall Study|unkown|0|||
161601908|NCT05100628|583595339|FG001|Overall Study|unkown|1|||
161601909|NCT05100628|583595340|FG002|Overall Study|unkown|0|||
161601910|NCT05100628|583595341|FG003|Overall Study|unkown|0|||
161601911|NCT03914469|583595342|FG000|Overall Study|Lost to Follow-up|1|||
161601912|NCT03914469|583595343|FG001|Overall Study|Lost to Follow-up|4|||
161601913|NCT00677365|583595348|FG000|Overall Study|Adverse Event|2|||
161601914|NCT00677365|583595349|FG001|Overall Study|Adverse Event|1|||
161601915|NCT00677365|583595350|FG002|Overall Study|Adverse Event|1|||
161601916|NCT00677365|583595351|FG003|Overall Study|Adverse Event|2|||
161601917|NCT00677365|583595348|FG000|Overall Study|Withdrawal by Subject|0|||
161601918|NCT00677365|583595349|FG001|Overall Study|Withdrawal by Subject|0|||
161831279|NCT01436643|584422998|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
161831280|NCT01436643|584422999|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
161831281|NCT01436643|584422996|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
161831282|NCT01436643|584422997|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
161831283|NCT01436643|584422998|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
161831284|NCT01436643|584422999|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
161831285|NCT01436643|584422996|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
161831286|NCT01436643|584422997|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
161831287|NCT01436643|584422998|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
161831288|NCT01436643|584422999|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
161831289|NCT01117987|584423000|FG000|Overall Study|Protocol deviation|0|||
161831290|NCT01117987|584423001|FG001|Overall Study|Protocol deviation|1|||
161831291|NCT01117987|584423000|FG000|Overall Study|Subject no longer requires study drug|1|||
161831292|NCT01117987|584423001|FG001|Overall Study|Subject no longer requires study drug|0|||
161831293|NCT01117987|584423000|FG000|Overall Study|Lost to Follow-up|1|||
161831294|NCT01117987|584423001|FG001|Overall Study|Lost to Follow-up|1|||
161831295|NCT01117987|584423000|FG000|Overall Study|Abnormal test procedure result|2|||
161831296|NCT01117987|584423001|FG001|Overall Study|Abnormal test procedure result|0|||
161831297|NCT01117987|584423000|FG000|Overall Study|Lack of Efficacy|3|||
161831298|NCT01117987|584423001|FG001|Overall Study|Lack of Efficacy|4|||
161601919|NCT00677365|583595350|FG002|Overall Study|Withdrawal by Subject|1|||
161601920|NCT00677365|583595351|FG003|Overall Study|Withdrawal by Subject|0|||
161601921|NCT00677365|583595348|FG000|Overall Study|Other reason|0|||
161601922|NCT00677365|583595349|FG001|Overall Study|Other reason|0|||
161601923|NCT00677365|583595350|FG002|Overall Study|Other reason|0|||
161601924|NCT00677365|583595351|FG003|Overall Study|Other reason|1|||
161601925|NCT05900154|583595352|FG000|Follow-Up Period|Lost to Follow-up|1|||
161601926|NCT05900154|583595353|FG001|Follow-Up Period|Lost to Follow-up|2|||
161601927|NCT05900154|583595354|FG002|Follow-Up Period|Lost to Follow-up|1|||
161601928|NCT05900154|583595355|FG003|Follow-Up Period|Lost to Follow-up|0|||
161601929|NCT05900154|583595356|FG004|Follow-Up Period|Lost to Follow-up|1|||
161601930|NCT05900154|583595357|FG005|Follow-Up Period|Lost to Follow-up|1|||
161601931|NCT04102111|583595360|FG000|Overall Study|Withdrawal by Subject|2|||
161601932|NCT04102111|583595361|FG001|Overall Study|Withdrawal by Subject|3|||
161601933|NCT04102111|583595360|FG000|Overall Study|Adverse Event|1|||
161601934|NCT04102111|583595361|FG001|Overall Study|Adverse Event|1|||
161601935|NCT04102111|583595360|FG000|Overall Study|Study terminated by sponsor|1|||
161601936|NCT04102111|583595361|FG001|Overall Study|Study terminated by sponsor|3|||
161601937|NCT03334695|583595362|FG000|Overall Study|Lost to Follow-up|3|||
161601938|NCT03334695|583595363|FG001|Overall Study|Lost to Follow-up|3|||
161601939|NCT03334695|583595362|FG000|Overall Study|Physician Decision|1|||
161601940|NCT03334695|583595363|FG001|Overall Study|Physician Decision|2|||
161601941|NCT03334695|583595362|FG000|Overall Study|Protocol Violation|0|||
161682464|NCT01721057|583888885|FG001|Treatment Period|Lost to Follow-up|0|||
161831299|NCT01117987|584423000|FG000|Overall Study|Death|5|||
161831300|NCT01117987|584423001|FG001|Overall Study|Death|10|||
161831301|NCT01117987|584423000|FG000|Overall Study|Withdrawal by Subject|5|||
161831302|NCT01117987|584423001|FG001|Overall Study|Withdrawal by Subject|10|||
161831303|NCT01117987|584423000|FG000|Overall Study|Adverse Event|19|||
161831304|NCT01117987|584423001|FG001|Overall Study|Adverse Event|26|||
161601942|NCT03334695|583595363|FG001|Overall Study|Protocol Violation|1|||
161601943|NCT02641730|583595364|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
161601944|NCT02641730|583595365|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161601945|NCT02641730|583595366|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161601946|NCT02641730|583595367|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
161601947|NCT02641730|583595368|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
161601948|NCT02641730|583595364|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161601949|NCT02641730|583595365|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161601950|NCT02641730|583595366|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161601951|NCT02641730|583595367|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
161601952|NCT02641730|583595368|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
161601953|NCT02641730|583595364|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
161601954|NCT02641730|583595365|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
161601955|NCT02641730|583595366|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
161682465|NCT01721057|583888886|FG002|Treatment Period|Lost to Follow-up|0|||
161601956|NCT02641730|583595367|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
161601957|NCT02641730|583595368|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
161601958|NCT02641730|583595364|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161601959|NCT02641730|583595365|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161601960|NCT02641730|583595366|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161601961|NCT02641730|583595367|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161601962|NCT02641730|583595368|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161601963|NCT02641730|583595364|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
161601964|NCT02641730|583595365|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
161601965|NCT02641730|583595366|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
161601966|NCT02641730|583595367|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
161601967|NCT02641730|583595368|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
161601968|NCT02641730|583595364|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
161601969|NCT02641730|583595365|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
161601970|NCT02641730|583595366|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
161601971|NCT02641730|583595367|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
161601972|NCT02641730|583595368|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
161601973|NCT05460871|583595369|FG000|Overall Study|Withdrawal by Subject|1|||
161601974|NCT05460871|583595370|FG001|Overall Study|Withdrawal by Subject|2|||
161601975|NCT02938923|583595371|FG000|Overall Study|Death|1|||
161601976|NCT02938923|583595372|FG001|Overall Study|Death|0|||
161601977|NCT02938923|583595373|FG002|Overall Study|Death|0|||
161601978|NCT02938923|583595371|FG000|Overall Study|Physician Decision|0|||
161601979|NCT02938923|583595372|FG001|Overall Study|Physician Decision|2|||
161601980|NCT02938923|583595373|FG002|Overall Study|Physician Decision|0|||
161601981|NCT02938923|583595371|FG000|Overall Study|Withdrawal by Subject|0|||
161601982|NCT02938923|583595372|FG001|Overall Study|Withdrawal by Subject|1|||
161601983|NCT02938923|583595373|FG002|Overall Study|Withdrawal by Subject|1|||
161601984|NCT00721149|583595374|FG000|Overall Study|Physician Decision|1|||
161601985|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
161601986|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
161601987|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
161601988|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
161601989|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
161601990|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
161601991|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
161601992|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
161601993|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
161682466|NCT01721057|583888887|FG003|Treatment Period|Lost to Follow-up|0|||
161601994|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
161601995|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
161601996|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
161601997|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
161601998|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
161601999|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
161602000|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
161602001|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
161602002|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
161602003|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
161602004|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
161602005|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
161831305|NCT01117987|584423000|FG000|Overall Study|Administrative problems|25|||
161602006|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
161831306|NCT01117987|584423001|FG001|Overall Study|Administrative problems|22|||
161831307|NCT02244424|584423002|FG000|Overall Study|Lost to Follow-up|20|||
161831308|NCT02244424|584423003|FG001|Overall Study|Lost to Follow-up|10|||
161831309|NCT04117945|584423006|FG000|Overall Study|Death|1|||
161831310|NCT04117945|584423007|FG001|Overall Study|Death|0|||
161831311|NCT04117945|584423006|FG000|Overall Study|Withdrawal by Subject|3|||
161831312|NCT04117945|584423007|FG001|Overall Study|Withdrawal by Subject|1|||
161831313|NCT04117945|584423006|FG000|Overall Study|Disease Progression|0|||
161831314|NCT04117945|584423007|FG001|Overall Study|Disease Progression|2|||
161831315|NCT04117945|584423006|FG000|Overall Study|Ineligible|8|||
161831316|NCT04117945|584423007|FG001|Overall Study|Ineligible|7|||
161831317|NCT01181531|584423011|FG000|Overall Study|Other|17|||
161831318|NCT01181531|584423012|FG001|Overall Study|Other|12|||
161831319|NCT01181531|584423011|FG000|Overall Study|Partial consent by subject withdrawn|0|||
161831320|NCT01181531|584423012|FG001|Overall Study|Partial consent by subject withdrawn|1|||
161831321|NCT01181531|584423011|FG000|Overall Study|Physician Decision|3|||
161831322|NCT01181531|584423012|FG001|Overall Study|Physician Decision|1|||
161831323|NCT01181531|584423011|FG000|Overall Study|Noncompliance|2|||
161831324|NCT01181531|584423012|FG001|Overall Study|Noncompliance|2|||
161831325|NCT01181531|584423011|FG000|Overall Study|Ineligibility determined|1|||
161831326|NCT01181531|584423012|FG001|Overall Study|Ineligibility determined|2|||
161831327|NCT01181531|584423011|FG000|Overall Study|Protocol Specified Criteria|15|||
161831328|NCT01181531|584423012|FG001|Overall Study|Protocol Specified Criteria|8|||
161831329|NCT01181531|584423011|FG000|Overall Study|Pregnancy|0|||
161831330|NCT01181531|584423012|FG001|Overall Study|Pregnancy|1|||
161831331|NCT01181531|584423011|FG000|Overall Study|Withdrawal by Subject|8|||
161831332|NCT01181531|584423012|FG001|Overall Study|Withdrawal by Subject|7|||
161831333|NCT01181531|584423011|FG000|Overall Study|Protocol Violation|6|||
161831334|NCT01181531|584423012|FG001|Overall Study|Protocol Violation|6|||
161831335|NCT01181531|584423011|FG000|Overall Study|Death|9|||
161831336|NCT01181531|584423012|FG001|Overall Study|Death|12|||
161831337|NCT01181531|584423011|FG000|Overall Study|Adverse Event|0|||
161831338|NCT01181531|584423012|FG001|Overall Study|Adverse Event|1|||
161831339|NCT00955721|584423013|FG000|Overall Study|Physician Decision|1|||
161831340|NCT00955721|584423014|FG001|Overall Study|Physician Decision|0|||
161831341|NCT00955721|584423013|FG000|Overall Study|Death|1|||
161831342|NCT00955721|584423014|FG001|Overall Study|Death|0|||
161831343|NCT00955721|584423013|FG000|Overall Study|Withdrawal by Subject|1|||
161831344|NCT00955721|584423014|FG001|Overall Study|Withdrawal by Subject|0|||
161831345|NCT04034355|584423019|FG000|Overall Study|Study terminated by Sponsor|10|||
161831346|NCT04034355|584423020|FG001|Overall Study|Study terminated by Sponsor|17|||
161831347|NCT04034355|584423019|FG000|Overall Study|Withdrawal by Subject|12|||
161831348|NCT04034355|584423020|FG001|Overall Study|Withdrawal by Subject|11|||
161831349|NCT04034355|584423019|FG000|Overall Study|Site terminated by Sponsor|4|||
161831350|NCT04034355|584423020|FG001|Overall Study|Site terminated by Sponsor|5|||
161831351|NCT04034355|584423019|FG000|Overall Study|Adverse Event|2|||
161831352|NCT04034355|584423020|FG001|Overall Study|Adverse Event|0|||
161831353|NCT04034355|584423019|FG000|Overall Study|Death|1|||
161831354|NCT04034355|584423020|FG001|Overall Study|Death|1|||
161831355|NCT04034355|584423019|FG000|Overall Study|Not reported|2|||
161831356|NCT04034355|584423020|FG001|Overall Study|Not reported|0|||
161831357|NCT04034355|584423019|FG000|Overall Study|Lost to Follow-up|1|||
161831358|NCT04034355|584423020|FG001|Overall Study|Lost to Follow-up|0|||
161831359|NCT04034355|584423019|FG000|Overall Study|Physician Decision|1|||
161831360|NCT04034355|584423020|FG001|Overall Study|Physician Decision|0|||
161831361|NCT04034355|584423019|FG000|Overall Study|Protocol Violation|0|||
161831362|NCT04034355|584423020|FG001|Overall Study|Protocol Violation|1|||
161831363|NCT04034355|584423019|FG000|Overall Study|Progressive disease|1|||
161831364|NCT04034355|584423020|FG001|Overall Study|Progressive disease|0|||
161831365|NCT02723773|584424722|FG000|Overall Study|Adverse Event|934|||
161831366|NCT02723773|584424723|FG001|Overall Study|Adverse Event|3|||
161831367|NCT02723773|584424724|FG002|Overall Study|Adverse Event|1|||
161831368|NCT02723773|584424725|FG003|Overall Study|Adverse Event|9|||
161831369|NCT02723773|584424722|FG000|Overall Study|Protocol Violation|1|||
161831370|NCT02723773|584424723|FG001|Overall Study|Protocol Violation|0|||
161831371|NCT02723773|584424724|FG002|Overall Study|Protocol Violation|0|||
161831372|NCT02723773|584424725|FG003|Overall Study|Protocol Violation|0|||
161602007|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
161602008|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
161602009|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
161602010|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
161602011|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
161602012|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
161602013|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
161602014|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
161602015|NCT04614948|583595377|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
161602016|NCT04614948|583595378|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
161602017|NCT04614948|583595379|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
161602018|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
161602019|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
161602020|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
161602021|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
161602022|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
161602023|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
161602024|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
161602025|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
161602026|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
161602027|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
161682467|NCT01721057|583888888|FG004|Treatment Period|Lost to Follow-up|0|||
161682468|NCT01721057|583888889|FG005|Treatment Period|Lost to Follow-up|0|||
161682469|NCT01721057|583888890|FG006|Treatment Period|Lost to Follow-up|0|||
161602028|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
161602029|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
161602030|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
161602031|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
161602032|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
161602033|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
161602034|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
161602035|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
161602036|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
161602037|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
161602038|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
161602039|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
161602040|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
161602041|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
161602042|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
161602043|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
161602044|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
161602045|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
161602046|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
161602047|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
161602048|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
161602049|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
161602050|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
161602051|NCT04614948|583595377|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
161602052|NCT04614948|583595378|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
161602053|NCT04614948|583595379|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
161602054|NCT04271046|583595380|FG000|Overall Study|Death|0|||
161602055|NCT04271046|583595381|FG001|Overall Study|Death|2|||
161602056|NCT04271046|583595382|FG002|Overall Study|Death|0|||
161602057|NCT04271046|583595383|FG003|Overall Study|Death|2|||
161602058|NCT04271046|583595380|FG000|Overall Study|Lost to Follow-up|12|||
161602059|NCT04271046|583595381|FG001|Overall Study|Lost to Follow-up|12|||
161602060|NCT04271046|583595382|FG002|Overall Study|Lost to Follow-up|11|||
161602061|NCT04271046|583595383|FG003|Overall Study|Lost to Follow-up|11|||
161602062|NCT04271046|583595380|FG000|Overall Study|Patient with Dementia Died|2|||
161602063|NCT04271046|583595381|FG001|Overall Study|Patient with Dementia Died|0|||
161602064|NCT04271046|583595382|FG002|Overall Study|Patient with Dementia Died|2|||
161602065|NCT04271046|583595383|FG003|Overall Study|Patient with Dementia Died|0|||
161602066|NCT04271046|583595380|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
161602067|NCT04271046|583595381|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
161602068|NCT04271046|583595382|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
161602069|NCT04271046|583595383|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
161602070|NCT04129554|583595384|FG000|Overall Study|Withdrawal by Subject|4|||
161602071|NCT04129554|583595385|FG001|Overall Study|Withdrawal by Subject|3|||
161602072|NCT04129554|583595384|FG000|Overall Study|Other|0|||
161602073|NCT04129554|583595385|FG001|Overall Study|Other|2|||
161602074|NCT01570361|583595386|FG000|Overall Study|Subject discontinued|1|||
161602075|NCT01570361|583595387|FG001|Overall Study|Subject discontinued|2|||
161602076|NCT01570361|583595386|FG000|Overall Study|Sponsor closing the study|51|||
161602077|NCT01570361|583595387|FG001|Overall Study|Sponsor closing the study|50|||
161602078|NCT01570361|583595386|FG000|Overall Study|Subject excluded|5|||
161602079|NCT01570361|583595387|FG001|Overall Study|Subject excluded|3|||
161602080|NCT01570361|583595386|FG000|Overall Study|Subject withdrew consent|14|||
161602081|NCT01570361|583595387|FG001|Overall Study|Subject withdrew consent|9|||
161602082|NCT01570361|583595386|FG000|Overall Study|Adverse Event|2|||
161602083|NCT01570361|583595387|FG001|Overall Study|Adverse Event|1|||
161602084|NCT01570361|583595386|FG000|Overall Study|Lost to Follow-up|4|||
161602085|NCT01570361|583595387|FG001|Overall Study|Lost to Follow-up|4|||
161602086|NCT01570361|583595386|FG000|Overall Study|Death|5|||
161602087|NCT01570361|583595387|FG001|Overall Study|Death|4|||
161602088|NCT01570361|583595386|FG000|Overall Study|Other|0|||
161602089|NCT01570361|583595387|FG001|Overall Study|Other|2|||
161602090|NCT05158504|583595388|FG000|Overall Study|Lost to Follow-up|2|||
161602091|NCT05158504|583595389|FG001|Overall Study|Lost to Follow-up|3|||
161602092|NCT03606512|583595390|FG000|Overall Study|Lost to Follow-up|0|||
161602093|NCT03606512|583595391|FG001|Overall Study|Lost to Follow-up|1|||
161602094|NCT03606512|583595390|FG000|Overall Study|'moved from study area|0|||
161602095|NCT03606512|583595391|FG001|Overall Study|'moved from study area|1|||
161602096|NCT05513937|583595392|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
161602097|NCT05513937|583595393|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
161602098|NCT05513937|583595394|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
161602099|NCT05513937|583595395|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
161602100|NCT05513937|583595392|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
161602101|NCT05513937|583595393|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
161602102|NCT05513937|583595394|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
161602103|NCT05513937|583595395|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
161602104|NCT05513937|583595392|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
161602105|NCT05513937|583595393|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
161602106|NCT05513937|583595394|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
161602107|NCT05513937|583595395|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
161602108|NCT05513937|583595392|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
161602109|NCT05513937|583595393|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161602110|NCT05513937|583595394|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161602111|NCT05513937|583595395|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161602112|NCT05513937|583595392|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
161602113|NCT05513937|583595393|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
161602114|NCT05513937|583595394|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
161602115|NCT05513937|583595395|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
161602116|NCT05513937|583595392|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161602117|NCT05513937|583595393|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161602118|NCT05513937|583595394|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
161602119|NCT05513937|583595395|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161602120|NCT02846545|583595396|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
161602121|NCT02846545|583595397|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
161602122|NCT02846545|583595396|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
161602123|NCT02846545|583595397|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
161602124|NCT02846545|583595396|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
161602125|NCT02846545|583595397|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
161602126|NCT02846545|583595396|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
161602127|NCT02846545|583595397|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
161602128|NCT02846545|583595396|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
161602129|NCT02846545|583595397|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
161602130|NCT03663205|583595400|FG000|Overall Study|Death|144|||
161602131|NCT03663205|583595401|FG001|Overall Study|Death|69|||
161602132|NCT03663205|583595400|FG000|Overall Study|Sponsor decision|53|||
161602133|NCT03663205|583595401|FG001|Overall Study|Sponsor decision|19|||
161602134|NCT03663205|583595400|FG000|Overall Study|Withdrawal by Subject|8|||
161602135|NCT03663205|583595401|FG001|Overall Study|Withdrawal by Subject|11|||
161602136|NCT03663205|583595400|FG000|Overall Study|Lost to Follow-up|7|||
161602137|NCT03663205|583595401|FG001|Overall Study|Lost to Follow-up|9|||
161602138|NCT03663205|583595400|FG000|Overall Study|Transferred to long term extension study|11|||
161602139|NCT03663205|583595401|FG001|Overall Study|Transferred to long term extension study|3|||
161602140|NCT04633538|583595402|FG000|Overall Study|Death|1|||
161602141|NCT04633538|583595402|FG000|Overall Study|Lost to Follow-up|3|||
161602142|NCT04633538|583595402|FG000|Overall Study|Withdrawal by Subject|1|||
161602143|NCT03582033|583595403|FG000|Part A|Other|0|||
161602144|NCT03582033|583595404|FG001|Part A|Other|0|||
161602145|NCT03582033|583595405|FG002|Part A|Other|0|||
161602146|NCT03582033|583595406|FG003|Part A|Other|0|||
161602147|NCT03582033|583595407|FG004|Part A|Other|2|||
161602148|NCT03582033|583595408|FG005|Part A|Other|0|||
161602149|NCT03582033|583595409|FG006|Part A|Other|0|||
161602150|NCT03582033|583595410|FG007|Part A|Other|0|||
161602151|NCT03582033|583595411|FG008|Part A|Other|0|||
161602152|NCT03582033|583595412|FG009|Part A|Other|0|||
161602153|NCT03582033|583595403|FG000|Part A|Death|1|||
161602154|NCT03582033|583595404|FG001|Part A|Death|1|||
161602155|NCT03582033|583595405|FG002|Part A|Death|2|||
161682470|NCT01721057|583888884|FG000|Treatment Period|Physician Decision|0|||
161682471|NCT01721057|583888885|FG001|Treatment Period|Physician Decision|1|||
161682472|NCT01721057|583888886|FG002|Treatment Period|Physician Decision|3|||
161682473|NCT01721057|583888887|FG003|Treatment Period|Physician Decision|0|||
161682474|NCT01721057|583888888|FG004|Treatment Period|Physician Decision|0|||
161682475|NCT01721057|583888889|FG005|Treatment Period|Physician Decision|0|||
161682476|NCT01721057|583888890|FG006|Treatment Period|Physician Decision|0|||
161682477|NCT01721057|583888884|FG000|Treatment Period|Death|2|||
161682478|NCT01721057|583888885|FG001|Treatment Period|Death|0|||
161682479|NCT01721057|583888886|FG002|Treatment Period|Death|0|||
161682480|NCT01721057|583888887|FG003|Treatment Period|Death|0|||
161682481|NCT01721057|583888888|FG004|Treatment Period|Death|0|||
161682482|NCT01721057|583888889|FG005|Treatment Period|Death|0|||
161682483|NCT01721057|583888890|FG006|Treatment Period|Death|0|||
161682484|NCT01721057|583888884|FG000|Rescue Period|Adverse Event|0|||
161602156|NCT03582033|583595406|FG003|Part A|Death|4|||
161602157|NCT03582033|583595407|FG004|Part A|Death|11|||
161602158|NCT03582033|583595408|FG005|Part A|Death|0|||
161602159|NCT03582033|583595409|FG006|Part A|Death|0|||
161602160|NCT03582033|583595410|FG007|Part A|Death|0|||
161602161|NCT03582033|583595411|FG008|Part A|Death|0|||
161602162|NCT03582033|583595412|FG009|Part A|Death|0|||
161602163|NCT03582033|583595403|FG000|Part A|Lost to Follow-up|0|||
161602164|NCT03582033|583595404|FG001|Part A|Lost to Follow-up|0|||
161602165|NCT03582033|583595405|FG002|Part A|Lost to Follow-up|0|||
161602166|NCT03582033|583595406|FG003|Part A|Lost to Follow-up|0|||
161602167|NCT03582033|583595407|FG004|Part A|Lost to Follow-up|1|||
161602168|NCT03582033|583595408|FG005|Part A|Lost to Follow-up|0|||
161602169|NCT03582033|583595409|FG006|Part A|Lost to Follow-up|0|||
161602170|NCT03582033|583595410|FG007|Part A|Lost to Follow-up|0|||
161602171|NCT03582033|583595411|FG008|Part A|Lost to Follow-up|0|||
161602172|NCT03582033|583595412|FG009|Part A|Lost to Follow-up|0|||
161602173|NCT03582033|583595403|FG000|Part A|Study terminated by sponsor|0|||
161602174|NCT03582033|583595404|FG001|Part A|Study terminated by sponsor|0|||
161602175|NCT03582033|583595405|FG002|Part A|Study terminated by sponsor|0|||
161602176|NCT03582033|583595406|FG003|Part A|Study terminated by sponsor|2|||
161602177|NCT03582033|583595407|FG004|Part A|Study terminated by sponsor|1|||
161602178|NCT03582033|583595408|FG005|Part A|Study terminated by sponsor|0|||
161602179|NCT03582033|583595409|FG006|Part A|Study terminated by sponsor|0|||
161602180|NCT03582033|583595410|FG007|Part A|Study terminated by sponsor|0|||
161602181|NCT03582033|583595411|FG008|Part A|Study terminated by sponsor|0|||
161602182|NCT03582033|583595412|FG009|Part A|Study terminated by sponsor|0|||
161602183|NCT03582033|583595403|FG000|Part A|Withdrawal by Subject|1|||
161602184|NCT03582033|583595404|FG001|Part A|Withdrawal by Subject|1|||
161602185|NCT03582033|583595405|FG002|Part A|Withdrawal by Subject|0|||
161602186|NCT03582033|583595406|FG003|Part A|Withdrawal by Subject|1|||
161602187|NCT03582033|583595407|FG004|Part A|Withdrawal by Subject|7|||
161602188|NCT03582033|583595408|FG005|Part A|Withdrawal by Subject|0|||
161602189|NCT03582033|583595409|FG006|Part A|Withdrawal by Subject|0|||
161602190|NCT03582033|583595410|FG007|Part A|Withdrawal by Subject|0|||
161602191|NCT03582033|583595411|FG008|Part A|Withdrawal by Subject|0|||
161602192|NCT03582033|583595412|FG009|Part A|Withdrawal by Subject|0|||
161602193|NCT03582033|583595403|FG000|Part B|Death|0|||
161682485|NCT01721057|583888885|FG001|Rescue Period|Adverse Event|0|||
161682486|NCT01721057|583888886|FG002|Rescue Period|Adverse Event|0|||
161682487|NCT01721057|583888887|FG003|Rescue Period|Adverse Event|1|||
161682488|NCT01721057|583888888|FG004|Rescue Period|Adverse Event|0|||
161682489|NCT01721057|583888889|FG005|Rescue Period|Adverse Event|0|||
161682490|NCT01721057|583888890|FG006|Rescue Period|Adverse Event|0|||
161602194|NCT03582033|583595404|FG001|Part B|Death|0|||
161602195|NCT03582033|583595405|FG002|Part B|Death|0|||
161602196|NCT03582033|583595406|FG003|Part B|Death|0|||
161602197|NCT03582033|583595407|FG004|Part B|Death|0|||
161602198|NCT03582033|583595408|FG005|Part B|Death|2|||
161602199|NCT03582033|583595409|FG006|Part B|Death|0|||
161602200|NCT03582033|583595410|FG007|Part B|Death|0|||
161602201|NCT03582033|583595411|FG008|Part B|Death|0|||
161602202|NCT03582033|583595412|FG009|Part B|Death|0|||
161602203|NCT03582033|583595403|FG000|Part B|Study terminated by sponsor|0|||
161602204|NCT03582033|583595404|FG001|Part B|Study terminated by sponsor|0|||
161602205|NCT03582033|583595405|FG002|Part B|Study terminated by sponsor|0|||
161602206|NCT03582033|583595406|FG003|Part B|Study terminated by sponsor|0|||
161602207|NCT03582033|583595407|FG004|Part B|Study terminated by sponsor|0|||
161602208|NCT03582033|583595408|FG005|Part B|Study terminated by sponsor|12|||
161682491|NCT01721057|583888884|FG000|Rescue Period|Lack of Efficacy|0|||
161602209|NCT03582033|583595409|FG006|Part B|Study terminated by sponsor|0|||
161602210|NCT03582033|583595410|FG007|Part B|Study terminated by sponsor|0|||
161602211|NCT03582033|583595411|FG008|Part B|Study terminated by sponsor|0|||
161602212|NCT03582033|583595412|FG009|Part B|Study terminated by sponsor|0|||
161602213|NCT03582033|583595403|FG000|Part B|Withdrawal by Subject|0|||
161602214|NCT03582033|583595404|FG001|Part B|Withdrawal by Subject|0|||
161602215|NCT03582033|583595405|FG002|Part B|Withdrawal by Subject|0|||
161602216|NCT03582033|583595406|FG003|Part B|Withdrawal by Subject|0|||
161602217|NCT03582033|583595407|FG004|Part B|Withdrawal by Subject|0|||
161602218|NCT03582033|583595408|FG005|Part B|Withdrawal by Subject|6|||
161602219|NCT03582033|583595409|FG006|Part B|Withdrawal by Subject|0|||
161602220|NCT03582033|583595410|FG007|Part B|Withdrawal by Subject|0|||
161602221|NCT03582033|583595411|FG008|Part B|Withdrawal by Subject|0|||
161602222|NCT03582033|583595412|FG009|Part B|Withdrawal by Subject|0|||
161602223|NCT03582033|583595403|FG000|Part C|Other|0|||
161602224|NCT03582033|583595404|FG001|Part C|Other|0|||
161602225|NCT03582033|583595405|FG002|Part C|Other|0|||
161602226|NCT03582033|583595406|FG003|Part C|Other|0|||
161602227|NCT03582033|583595407|FG004|Part C|Other|0|||
161602228|NCT03582033|583595408|FG005|Part C|Other|0|||
161602229|NCT03582033|583595409|FG006|Part C|Other|2|||
161602230|NCT03582033|583595410|FG007|Part C|Other|0|||
161602231|NCT03582033|583595411|FG008|Part C|Other|0|||
161602232|NCT03582033|583595412|FG009|Part C|Other|0|||
161602233|NCT03582033|583595403|FG000|Part C|Death|0|||
161602234|NCT03582033|583595404|FG001|Part C|Death|0|||
161602235|NCT03582033|583595405|FG002|Part C|Death|0|||
161602236|NCT03582033|583595406|FG003|Part C|Death|0|||
161602237|NCT03582033|583595407|FG004|Part C|Death|0|||
161602238|NCT03582033|583595408|FG005|Part C|Death|0|||
161602239|NCT03582033|583595409|FG006|Part C|Death|6|||
161602240|NCT03582033|583595410|FG007|Part C|Death|1|||
161602241|NCT03582033|583595411|FG008|Part C|Death|2|||
161602242|NCT03582033|583595412|FG009|Part C|Death|0|||
161602243|NCT03582033|583595403|FG000|Part C|Study terminated by sponsor|0|||
161602244|NCT03582033|583595404|FG001|Part C|Study terminated by sponsor|0|||
161602245|NCT03582033|583595405|FG002|Part C|Study terminated by sponsor|0|||
161602246|NCT03582033|583595406|FG003|Part C|Study terminated by sponsor|0|||
161602247|NCT03582033|583595407|FG004|Part C|Study terminated by sponsor|0|||
161602248|NCT03582033|583595408|FG005|Part C|Study terminated by sponsor|0|||
161602249|NCT03582033|583595409|FG006|Part C|Study terminated by sponsor|3|||
161602250|NCT03582033|583595410|FG007|Part C|Study terminated by sponsor|3|||
161602251|NCT03582033|583595411|FG008|Part C|Study terminated by sponsor|2|||
161602252|NCT03582033|583595412|FG009|Part C|Study terminated by sponsor|0|||
161602253|NCT03582033|583595403|FG000|Part C|Withdrawal by Subject|0|||
161602254|NCT03582033|583595404|FG001|Part C|Withdrawal by Subject|0|||
161602255|NCT03582033|583595405|FG002|Part C|Withdrawal by Subject|0|||
161602256|NCT03582033|583595406|FG003|Part C|Withdrawal by Subject|0|||
161602257|NCT03582033|583595407|FG004|Part C|Withdrawal by Subject|0|||
161602258|NCT03582033|583595408|FG005|Part C|Withdrawal by Subject|0|||
161602259|NCT03582033|583595409|FG006|Part C|Withdrawal by Subject|1|||
161602260|NCT03582033|583595410|FG007|Part C|Withdrawal by Subject|2|||
161602261|NCT03582033|583595411|FG008|Part C|Withdrawal by Subject|1|||
161602262|NCT03582033|583595412|FG009|Part C|Withdrawal by Subject|0|||
161602263|NCT03582033|583595403|FG000|Part D|Death|0|||
161602264|NCT03582033|583595404|FG001|Part D|Death|0|||
161602265|NCT03582033|583595405|FG002|Part D|Death|0|||
161602266|NCT03582033|583595406|FG003|Part D|Death|0|||
161602267|NCT03582033|583595407|FG004|Part D|Death|0|||
161602268|NCT03582033|583595408|FG005|Part D|Death|0|||
161602269|NCT03582033|583595409|FG006|Part D|Death|0|||
161602270|NCT03582033|583595410|FG007|Part D|Death|0|||
161602271|NCT03582033|583595411|FG008|Part D|Death|0|||
161602272|NCT03582033|583595412|FG009|Part D|Death|1|||
161602273|NCT03582033|583595403|FG000|Part D|Study terminated by sponsor|0|||
161602274|NCT03582033|583595404|FG001|Part D|Study terminated by sponsor|0|||
161602275|NCT03582033|583595405|FG002|Part D|Study terminated by sponsor|0|||
161602276|NCT03582033|583595406|FG003|Part D|Study terminated by sponsor|0|||
161602277|NCT03582033|583595407|FG004|Part D|Study terminated by sponsor|0|||
161602278|NCT03582033|583595408|FG005|Part D|Study terminated by sponsor|0|||
161602279|NCT03582033|583595409|FG006|Part D|Study terminated by sponsor|0|||
161602280|NCT03582033|583595410|FG007|Part D|Study terminated by sponsor|0|||
161602281|NCT03582033|583595411|FG008|Part D|Study terminated by sponsor|0|||
161602282|NCT03582033|583595412|FG009|Part D|Study terminated by sponsor|4|||
161602283|NCT04505410|583595415|FG000|Overall Study|Adverse Event|2|||
161602284|NCT04505410|583595416|FG001|Overall Study|Adverse Event|0|||
161602285|NCT04505410|583595415|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
161602286|NCT04505410|583595416|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
161602287|NCT04505410|583595415|FG000|Overall Study|did not want to follow diet|1|||
161602288|NCT04505410|583595416|FG001|Overall Study|did not want to follow diet|0|||
161602289|NCT04505410|583595415|FG000|Overall Study|flare up of ulcerative colitis|0|||
161602290|NCT04505410|583595416|FG001|Overall Study|flare up of ulcerative colitis|1|||
161602291|NCT04505410|583595415|FG000|Overall Study|Lost to Follow-up|0|||
161602292|NCT04505410|583595416|FG001|Overall Study|Lost to Follow-up|2|||
161602293|NCT04505410|583595415|FG000|Overall Study|Lost to Follow-up|1|||
161602294|NCT04505410|583595416|FG001|Overall Study|Lost to Follow-up|0|||
161602295|NCT04505410|583595415|FG000|Overall Study|initiated another diet on their own|0|||
161602296|NCT04505410|583595416|FG001|Overall Study|initiated another diet on their own|2|||
161602297|NCT05962814|583595417|FG000|Overall Study|failed eligibility|1|||
161602298|NCT03057054|583595418|FG000|Overall Study|Death|4|||
161602299|NCT03057054|583595419|FG001|Overall Study|Death|4|||
161602300|NCT03057054|583595418|FG000|Overall Study|Withdrawal by Subject|6|||
161602301|NCT03057054|583595419|FG001|Overall Study|Withdrawal by Subject|3|||
161602302|NCT03057054|583595418|FG000|Overall Study|Ineligible|1|||
161602303|NCT03057054|583595419|FG001|Overall Study|Ineligible|1|||
161602304|NCT05311176|583596871|FG000|Overall Study|Death|6|||
161602305|NCT05311176|583596871|FG000|Overall Study|Sponsor discontinued the study|1|||
161602306|NCT05247034|583596872|FG000|Overall Study|Lost to Follow-up|3|||
161602307|NCT05247034|583596873|FG001|Overall Study|Lost to Follow-up|2|||
161602308|NCT05247034|583596872|FG000|Overall Study|Organizational problems when attending appointments|1|||
161602309|NCT05247034|583596873|FG001|Overall Study|Organizational problems when attending appointments|0|||
161602310|NCT01960452|583596876|FG000|Overall Study|Withdrawal by Subject|2|||
161602311|NCT01960452|583596877|FG001|Overall Study|Withdrawal by Subject|1|||
161602312|NCT01960452|583596876|FG000|Overall Study|Sleep apnea in Night 1|1|||
161602313|NCT01960452|583596877|FG001|Overall Study|Sleep apnea in Night 1|0|||
161602314|NCT01960452|583596876|FG000|Overall Study|Poor Sleep in Night 1|0|||
161602315|NCT01960452|583596877|FG001|Overall Study|Poor Sleep in Night 1|2|||
161602316|NCT01960452|583596876|FG000|Overall Study|No Sex/Age Match Night 1|1|||
161602317|NCT01960452|583596877|FG001|Overall Study|No Sex/Age Match Night 1|0|||
161602318|NCT01960452|583596876|FG000|Overall Study|No Sex/Age Match Night 2|0|||
161602319|NCT01960452|583596877|FG001|Overall Study|No Sex/Age Match Night 2|2|||
161602320|NCT01960452|583596876|FG000|Overall Study|Technical Difficulties Night 2|2|||
161602321|NCT01960452|583596877|FG001|Overall Study|Technical Difficulties Night 2|0|||
161602322|NCT02668692|583596878|FG000|Overall Study|Adverse Event|1|||
161602323|NCT02668692|583596879|FG001|Overall Study|Adverse Event|0|||
161602324|NCT03981926|583596880|FG000|Overall Study|Lost to Follow-up|5|||
161682492|NCT01721057|583888885|FG001|Rescue Period|Lack of Efficacy|0|||
161682493|NCT01721057|583888886|FG002|Rescue Period|Lack of Efficacy|0|||
161682494|NCT01721057|583888887|FG003|Rescue Period|Lack of Efficacy|2|||
161682495|NCT01721057|583888888|FG004|Rescue Period|Lack of Efficacy|0|||
161682496|NCT01721057|583888889|FG005|Rescue Period|Lack of Efficacy|0|||
161682497|NCT01721057|583888890|FG006|Rescue Period|Lack of Efficacy|0|||
161682498|NCT02047253|583888891|FG000|Overall Study|Lost to Follow-up|8|||
161682499|NCT01987960|583888893|FG000|Period 1|Adverse Event|24|||
161602325|NCT03981926|583596881|FG001|Overall Study|Lost to Follow-up|9|||
161602326|NCT04615273|583596888|FG000|Overall Study|Withdrawal by Subject|3|||
161602327|NCT04615273|583596889|FG001|Overall Study|Withdrawal by Subject|1|||
161602328|NCT04615273|583596890|FG002|Overall Study|Withdrawal by Subject|2|||
161602329|NCT04615273|583596888|FG000|Overall Study|Adverse Event|1|||
161602330|NCT04615273|583596889|FG001|Overall Study|Adverse Event|0|||
161602331|NCT04615273|583596890|FG002|Overall Study|Adverse Event|1|||
161602332|NCT04615273|583596888|FG000|Overall Study|Lost to Follow-up|0|||
161602333|NCT04615273|583596889|FG001|Overall Study|Lost to Follow-up|1|||
161602334|NCT04615273|583596890|FG002|Overall Study|Lost to Follow-up|0|||
161602335|NCT04615273|583596888|FG000|Overall Study|Physician Decision|0|||
161602336|NCT04615273|583596889|FG001|Overall Study|Physician Decision|0|||
161602337|NCT04615273|583596890|FG002|Overall Study|Physician Decision|1|||
161602338|NCT04615273|583596888|FG000|Overall Study|Other|0|||
161602339|NCT04615273|583596889|FG001|Overall Study|Other|1|||
161602340|NCT04615273|583596890|FG002|Overall Study|Other|0|||
161602341|NCT04615273|583596888|FG000|Overall Study|Randomized but not treated|1|||
161602342|NCT04615273|583596889|FG001|Overall Study|Randomized but not treated|3|||
161682500|NCT01987960|583888894|FG001|Period 1|Adverse Event|0|||
161682501|NCT01987960|583888895|FG002|Period 1|Adverse Event|0|||
161831373|NCT02723773|584424722|FG000|Overall Study|Withdrawal by Subject|360|||
161831374|NCT02723773|584424723|FG001|Overall Study|Withdrawal by Subject|5|||
161831375|NCT02723773|584424724|FG002|Overall Study|Withdrawal by Subject|6|||
161831376|NCT02723773|584424725|FG003|Overall Study|Withdrawal by Subject|10|||
161831377|NCT02723773|584424722|FG000|Overall Study|Migrated/moved from study area|37|||
161831378|NCT02723773|584424723|FG001|Overall Study|Migrated/moved from study area|0|||
161831379|NCT02723773|584424724|FG002|Overall Study|Migrated/moved from study area|0|||
161831380|NCT02723773|584424725|FG003|Overall Study|Migrated/moved from study area|1|||
161831381|NCT02723773|584424722|FG000|Overall Study|Lost to Follow-up|198|||
161831382|NCT02723773|584424723|FG001|Overall Study|Lost to Follow-up|0|||
161831383|NCT02723773|584424724|FG002|Overall Study|Lost to Follow-up|0|||
161831384|NCT02723773|584424725|FG003|Overall Study|Lost to Follow-up|0|||
161831385|NCT02723773|584424722|FG000|Overall Study|Other|189|||
161831386|NCT02723773|584424723|FG001|Overall Study|Other|1|||
161831387|NCT02723773|584424724|FG002|Overall Study|Other|2|||
161831388|NCT02723773|584424725|FG003|Overall Study|Other|2|||
161831389|NCT05168774|584424726|FG000|Overall Study|Lack of Efficacy|1|||
161831390|NCT05168774|584424727|FG001|Overall Study|Lack of Efficacy|2|||
161831391|NCT05168774|584424726|FG000|Overall Study|Withdrawal by Subject|1|||
161831392|NCT05168774|584424727|FG001|Overall Study|Withdrawal by Subject|2|||
161831393|NCT05168774|584424726|FG000|Overall Study|Adverse Event|2|||
161831394|NCT05168774|584424727|FG001|Overall Study|Adverse Event|0|||
161831395|NCT03064438|584424729|FG000|Overall Study|Lost to Follow-up|1|||
161831396|NCT03064438|584424730|FG001|Overall Study|Lost to Follow-up|0|||
161831397|NCT03064438|584424729|FG000|Overall Study|Withdrawal by Subject|0|||
161831398|NCT03064438|584424730|FG001|Overall Study|Withdrawal by Subject|1|||
161831399|NCT02124902|584424731|FG000|Overall Study|Adverse Event|7|||
161831400|NCT02124902|584424732|FG001|Overall Study|Adverse Event|2|||
161831401|NCT02124902|584424731|FG000|Overall Study|Went to alternative treatment|4|||
161831402|NCT02124902|584424732|FG001|Overall Study|Went to alternative treatment|0|||
161831403|NCT02124902|584424731|FG000|Overall Study|Withdrawal by Subject|2|||
161831404|NCT02124902|584424732|FG001|Overall Study|Withdrawal by Subject|1|||
161831405|NCT02124902|584424731|FG000|Overall Study|Physician Decision|2|||
161831406|NCT02124902|584424732|FG001|Overall Study|Physician Decision|0|||
161831407|NCT02124902|584424731|FG000|Overall Study|Not eligible|1|||
161831408|NCT02124902|584424732|FG001|Overall Study|Not eligible|0|||
161831409|NCT02124902|584424731|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
161831410|NCT02124902|584424732|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
161831411|NCT01937351|584424733|FG000|Overall Study|Withdrawal by Subject|4|||
161831412|NCT01937351|584424734|FG001|Overall Study|Withdrawal by Subject|2|||
161548857|NCT01844115|583399316|FG001|Overall Study|Withdrawal by Subject|11|||
161831413|NCT01937351|584424733|FG000|Overall Study|Death|1|||
161831414|NCT01937351|584424734|FG001|Overall Study|Death|0|||
161831415|NCT01937351|584424733|FG000|Overall Study|Not treated w device, per protocol fail|4|||
161831416|NCT01937351|584424734|FG001|Overall Study|Not treated w device, per protocol fail|0|||
161831417|NCT01314118|584424735|FG000|Overall Study|Adverse Event|10|||
161831418|NCT01314118|584424735|FG000|Overall Study|Progressive disease|3|||
161548858|NCT01844115|583399315|FG000|Overall Study|Lost to Follow-up|11|||
161548859|NCT01844115|583399316|FG001|Overall Study|Lost to Follow-up|10|||
161548860|NCT01844115|583399315|FG000|Overall Study|Pregnancy|0|||
161548861|NCT01844115|583399316|FG001|Overall Study|Pregnancy|1|||
161548862|NCT00545363|583399317|FG000|Overall Study|Adverse Event|6|||
161548863|NCT00545363|583399318|FG001|Overall Study|Adverse Event|7|||
161548864|NCT00545363|583399317|FG000|Overall Study|Withdrawal by Subject|6|||
161548865|NCT00545363|583399318|FG001|Overall Study|Withdrawal by Subject|5|||
161548866|NCT00545363|583399317|FG000|Overall Study|Non-compliance|3|||
161548867|NCT00545363|583399318|FG001|Overall Study|Non-compliance|1|||
161548868|NCT00545363|583399317|FG000|Overall Study|Did not meet entry criteria|1|||
161548869|NCT00545363|583399318|FG001|Overall Study|Did not meet entry criteria|1|||
161548870|NCT00545363|583399317|FG000|Overall Study|Lost to Follow-up|2|||
161548871|NCT00545363|583399318|FG001|Overall Study|Lost to Follow-up|0|||
161548872|NCT00545363|583399317|FG000|Overall Study|Other|1|||
161548873|NCT00545363|583399318|FG001|Overall Study|Other|1|||
161548874|NCT02153359|583399319|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
161548875|NCT02153359|583399320|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
161548876|NCT00210119|583399321|FG000|Overall Study|Protocol Violation|1|||
161548877|NCT00210119|583399321|FG000|Overall Study|Withdrawal by Subject|1|||
161548878|NCT00951509|583399322|FG000|Overall Study|Withdrawal by Subject|2|||
161548879|NCT03125941|583399327|FG000|Overall Study|did not receive intervention|1|||
161548880|NCT03125941|583399328|FG001|Overall Study|did not receive intervention|2|||
161548881|NCT00734214|583399329|FG000|Overall Study|Withdrawal by Subject|3|||
161548882|NCT00734214|583399330|FG001|Overall Study|Withdrawal by Subject|4|||
161831419|NCT01314118|584424735|FG000|Overall Study|Death|8|||
161831420|NCT01314118|584424735|FG000|Overall Study|Physician Decision|13|||
161602343|NCT04615273|583596890|FG002|Overall Study|Randomized but not treated|1|||
161602344|NCT01314105|583596895|FG000|Overall Study|Progressive Disease|6|||
161602345|NCT01314105|583596896|FG001|Overall Study|Progressive Disease|10|||
161602346|NCT01314105|583596895|FG000|Overall Study|Refused to continue taking medication|0|||
161602347|NCT01314105|583596896|FG001|Overall Study|Refused to continue taking medication|1|||
161602348|NCT01314105|583596895|FG000|Overall Study|Other Adverse Event|1|||
161602349|NCT01314105|583596896|FG001|Overall Study|Other Adverse Event|1|||
161602350|NCT04820322|583596897|FG000|Overall Study|Adverse Event|1|||
161602351|NCT04820322|583596898|FG001|Overall Study|Adverse Event|0|||
161602352|NCT03156465|583596899|FG000|Overall Study|Withdrawal by Subject|2|||
161602353|NCT03640286|583596900|FG000|Overall Study|Adverse Event|6|||
161602354|NCT03640286|583596901|FG001|Overall Study|Adverse Event|6|||
161602355|NCT03640286|583596900|FG000|Overall Study|Lost to Follow-up|3|||
161602356|NCT03640286|583596901|FG001|Overall Study|Lost to Follow-up|6|||
161602357|NCT03640286|583596900|FG000|Overall Study|Pregnancy|1|||
161602358|NCT03640286|583596901|FG001|Overall Study|Pregnancy|0|||
161602359|NCT03640286|583596900|FG000|Overall Study|Withdrawal by Subject|10|||
161602360|NCT03640286|583596901|FG001|Overall Study|Withdrawal by Subject|10|||
161602361|NCT03640286|583596900|FG000|Overall Study|Non-compliance|4|||
161602362|NCT03640286|583596901|FG001|Overall Study|Non-compliance|10|||
161602363|NCT03640286|583596900|FG000|Overall Study|Medication change|1|||
161602364|NCT03640286|583596901|FG001|Overall Study|Medication change|0|||
161602365|NCT03640286|583596900|FG000|Overall Study|Other|1|||
161602366|NCT03640286|583596901|FG001|Overall Study|Other|2|||
161602367|NCT03640286|583596900|FG000|Overall Study|Joined another lifestyle program|0|||
161602368|NCT03640286|583596901|FG001|Overall Study|Joined another lifestyle program|1|||
161602369|NCT03181516|583596902|FG000|Overall Study|Withdrawal by Subject|14|||
161602370|NCT03181516|583596903|FG001|Overall Study|Withdrawal by Subject|7|||
161602371|NCT03181516|583596902|FG000|Overall Study|Lost to Follow-up|2|||
161602372|NCT03181516|583596903|FG001|Overall Study|Lost to Follow-up|2|||
161602373|NCT04544007|583596907|FG000|Overall Study|Withdrawal by Subject|1|||
161602374|NCT04544007|583596907|FG000|Overall Study|Confirmed Progressive Disease|1|||
161602375|NCT02839265|583596910|FG000|Overall Study|Screen Failure|2|||
161602376|NCT02839265|583596910|FG000|Overall Study|Death|1|||
161602377|NCT02839265|583596910|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
161602378|NCT04605159|583596914|FG000|Overall Study|Adverse Event|6|||
161602379|NCT04605159|583596915|FG001|Overall Study|Adverse Event|3|||
161602380|NCT04605159|583596916|FG002|Overall Study|Adverse Event|21|||
161602381|NCT04605159|583596917|FG003|Overall Study|Adverse Event|4|||
161602382|NCT04605159|583596914|FG000|Overall Study|Lost to Follow-up|74|||
161602383|NCT04605159|583596915|FG001|Overall Study|Lost to Follow-up|45|||
161602384|NCT04605159|583596916|FG002|Overall Study|Lost to Follow-up|119|||
161602385|NCT04605159|583596917|FG003|Overall Study|Lost to Follow-up|80|||
161602386|NCT04605159|583596914|FG000|Overall Study|Protocol Violation|4|||
161602387|NCT04605159|583596915|FG001|Overall Study|Protocol Violation|5|||
161602388|NCT04605159|583596916|FG002|Overall Study|Protocol Violation|2|||
161602389|NCT04605159|583596917|FG003|Overall Study|Protocol Violation|0|||
161602390|NCT04605159|583596914|FG000|Overall Study|Withdrawal by Subject|66|||
161602391|NCT04605159|583596915|FG001|Overall Study|Withdrawal by Subject|37|||
161602392|NCT04605159|583596916|FG002|Overall Study|Withdrawal by Subject|68|||
161602393|NCT04605159|583596917|FG003|Overall Study|Withdrawal by Subject|50|||
161602394|NCT04605159|583596914|FG000|Overall Study|Migrated / moved from the study area|32|||
161602395|NCT04605159|583596915|FG001|Overall Study|Migrated / moved from the study area|22|||
161602396|NCT04605159|583596916|FG002|Overall Study|Migrated / moved from the study area|41|||
161602397|NCT04605159|583596917|FG003|Overall Study|Migrated / moved from the study area|21|||
161602398|NCT04605159|583596914|FG000|Overall Study|Other|1|||
161602399|NCT04605159|583596915|FG001|Overall Study|Other|2|||
161602400|NCT04605159|583596916|FG002|Overall Study|Other|7|||
161602401|NCT04605159|583596917|FG003|Overall Study|Other|3|||
161602402|NCT02323880|583596918|FG000|Overall Study|Adverse Event|2|||
161602403|NCT02323880|583596919|FG001|Overall Study|Adverse Event|0|||
161602404|NCT02323880|583596920|FG002|Overall Study|Adverse Event|1|||
161602405|NCT02323880|583596921|FG003|Overall Study|Adverse Event|1|||
161602406|NCT02323880|583596922|FG004|Overall Study|Adverse Event|1|||
161602407|NCT02323880|583596923|FG005|Overall Study|Adverse Event|0|||
161602408|NCT02323880|583596924|FG006|Overall Study|Adverse Event|1|||
161602409|NCT02323880|583596925|FG007|Overall Study|Adverse Event|0|||
161602410|NCT02323880|583596918|FG000|Overall Study|Death|0|||
161602411|NCT02323880|583596919|FG001|Overall Study|Death|0|||
161602412|NCT02323880|583596920|FG002|Overall Study|Death|0|||
161602413|NCT02323880|583596921|FG003|Overall Study|Death|0|||
161602414|NCT02323880|583596922|FG004|Overall Study|Death|0|||
161602415|NCT02323880|583596923|FG005|Overall Study|Death|1|||
161602416|NCT02323880|583596924|FG006|Overall Study|Death|0|||
161602417|NCT02323880|583596925|FG007|Overall Study|Death|0|||
161682502|NCT01987960|583888896|FG003|Period 1|Adverse Event|0|||
161602418|NCT02323880|583596918|FG000|Overall Study|Lack of Efficacy|4|||
161602419|NCT02323880|583596919|FG001|Overall Study|Lack of Efficacy|11|||
161602420|NCT02323880|583596920|FG002|Overall Study|Lack of Efficacy|5|||
161682503|NCT01987960|583888893|FG000|Period 1|Lack of Efficacy|4|||
161602421|NCT02323880|583596921|FG003|Overall Study|Lack of Efficacy|5|||
161602422|NCT02323880|583596922|FG004|Overall Study|Lack of Efficacy|4|||
161602423|NCT02323880|583596923|FG005|Overall Study|Lack of Efficacy|8|||
161602424|NCT02323880|583596924|FG006|Overall Study|Lack of Efficacy|4|||
161602425|NCT02323880|583596925|FG007|Overall Study|Lack of Efficacy|6|||
161602426|NCT02323880|583596918|FG000|Overall Study|Physician Decision|0|||
161602427|NCT02323880|583596919|FG001|Overall Study|Physician Decision|0|||
161602428|NCT02323880|583596920|FG002|Overall Study|Physician Decision|0|||
161602429|NCT02323880|583596921|FG003|Overall Study|Physician Decision|0|||
161602430|NCT02323880|583596922|FG004|Overall Study|Physician Decision|1|||
161602431|NCT02323880|583596923|FG005|Overall Study|Physician Decision|1|||
161602432|NCT02323880|583596924|FG006|Overall Study|Physician Decision|1|||
161602433|NCT02323880|583596925|FG007|Overall Study|Physician Decision|0|||
161602434|NCT02323880|583596918|FG000|Overall Study|Withdrawal by Subject|0|||
161602435|NCT02323880|583596919|FG001|Overall Study|Withdrawal by Subject|2|||
161602436|NCT02323880|583596920|FG002|Overall Study|Withdrawal by Subject|0|||
161602437|NCT02323880|583596921|FG003|Overall Study|Withdrawal by Subject|0|||
161602438|NCT02323880|583596922|FG004|Overall Study|Withdrawal by Subject|0|||
161602439|NCT02323880|583596923|FG005|Overall Study|Withdrawal by Subject|0|||
161602440|NCT02323880|583596924|FG006|Overall Study|Withdrawal by Subject|0|||
161602441|NCT02323880|583596925|FG007|Overall Study|Withdrawal by Subject|0|||
161602442|NCT05424380|583596931|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
161602443|NCT05424380|583596932|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161602444|NCT05424380|583596933|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161602445|NCT05424380|583596934|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161602446|NCT05424380|583596935|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161602447|NCT05424380|583596936|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161602448|NCT05424380|583596931|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
161602449|NCT05424380|583596932|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161602450|NCT05424380|583596933|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161602451|NCT05424380|583596934|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161602452|NCT05424380|583596935|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161602453|NCT05424380|583596936|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161602454|NCT05424380|583596931|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
161602455|NCT05424380|583596932|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161602456|NCT05424380|583596933|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161602457|NCT05424380|583596934|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161602458|NCT05424380|583596935|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161602459|NCT05424380|583596936|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161602460|NCT05424380|583596931|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161602461|NCT05424380|583596932|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
161602462|NCT05424380|583596933|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161602463|NCT05424380|583596934|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161602464|NCT05424380|583596935|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161602465|NCT05424380|583596936|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161602466|NCT05424380|583596931|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161602467|NCT05424380|583596932|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
161602468|NCT05424380|583596933|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161602469|NCT05424380|583596934|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161602470|NCT05424380|583596935|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161602471|NCT05424380|583596936|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161602472|NCT05424380|583596931|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161602473|NCT05424380|583596932|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161602474|NCT05424380|583596933|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
161602475|NCT05424380|583596934|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161602476|NCT05424380|583596935|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161602477|NCT05424380|583596936|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161602478|NCT05424380|583596931|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161602479|NCT05424380|583596932|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161602480|NCT05424380|583596933|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
161602481|NCT05424380|583596934|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161602482|NCT05424380|583596935|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161602483|NCT05424380|583596936|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161602484|NCT05424380|583596931|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161602485|NCT05424380|583596932|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161602486|NCT05424380|583596933|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
161602487|NCT05424380|583596934|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161602488|NCT05424380|583596935|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161602489|NCT05424380|583596936|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161602490|NCT05424380|583596931|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602491|NCT05424380|583596932|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602492|NCT05424380|583596933|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602493|NCT05424380|583596934|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
161602494|NCT05424380|583596935|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602495|NCT05424380|583596936|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602496|NCT05424380|583596931|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161602497|NCT05424380|583596932|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161602498|NCT05424380|583596933|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161602499|NCT05424380|583596934|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
161602500|NCT05424380|583596935|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161602501|NCT05424380|583596936|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161602502|NCT05424380|583596931|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161602503|NCT05424380|583596932|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161602504|NCT05424380|583596933|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161602505|NCT05424380|583596934|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
161602506|NCT05424380|583596935|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161602507|NCT05424380|583596936|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161682504|NCT01987960|583888894|FG001|Period 1|Lack of Efficacy|0|||
161831421|NCT01314118|584424735|FG000|Overall Study|Sponsor Decision|1|||
161602508|NCT05424380|583596931|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161602509|NCT05424380|583596932|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161602510|NCT05424380|583596933|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161602511|NCT05424380|583596934|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161602512|NCT05424380|583596935|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
161602513|NCT05424380|583596936|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161602514|NCT05424380|583596931|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602515|NCT05424380|583596932|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602516|NCT05424380|583596933|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602517|NCT05424380|583596934|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602518|NCT05424380|583596935|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
161602519|NCT05424380|583596936|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161602520|NCT05424380|583596931|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161602521|NCT05424380|583596932|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161602522|NCT05424380|583596933|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161602523|NCT05424380|583596934|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161602524|NCT05424380|583596935|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
161602525|NCT05424380|583596936|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161602526|NCT04218851|583596943|FG000|Overall Study|Death|1|||
161602527|NCT04218851|583596944|FG001|Overall Study|Death|3|||
161602528|NCT00844415|583596945|FG000|Overall Study|Withdrawal by Subject|1|||
161602529|NCT03174275|583596948|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
161602530|NCT03174275|583596948|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
161602531|NCT03174275|583596948|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
161602532|NCT03174275|583596948|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
161602533|NCT03174275|583596948|FG000|Adjuvant Chemotherapy|Progression|1|||
161602534|NCT03174275|583596948|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
161602535|NCT03174275|583596948|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
161602536|NCT03174275|583596948|FG000|Adjuvant Durvalumab|Progression|1|||
161602537|NCT03174275|583596948|FG000|Adjuvant Durvalumab|Adverse Event|3|||
161602538|NCT03174275|583596948|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
161602539|NCT03174275|583596948|FG000|Adjuvant Radiotherapy|Progression|1|||
161602540|NCT03174275|583596948|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
161602541|NCT01820611|583596953|FG000|Overall Study|Death|8|||
161602542|NCT01820611|583596953|FG000|Overall Study|Adverse Event|1|||
161602543|NCT01820611|583596953|FG000|Overall Study|Withdrawal by Subject|9|||
161602544|NCT03484819|583596954|FG000|Overall Study|Death|2|||
161602545|NCT03484819|583596954|FG000|Overall Study|Adverse Event|2|||
161602546|NCT03484819|583596954|FG000|Overall Study|Physician Decision|1|||
161602547|NCT03484819|583596954|FG000|Overall Study|Withdrawal by Subject|2|||
161602548|NCT03484819|583596954|FG000|Overall Study|Disease Progression|4|||
161602549|NCT03484819|583596954|FG000|Overall Study|Complicating Condition|1|||
161602550|NCT03015532|583596955|FG000|Overall Study|Adverse Event|0|||
161602551|NCT03015532|583596956|FG001|Overall Study|Adverse Event|0|||
161602552|NCT03015532|583596957|FG002|Overall Study|Adverse Event|0|||
161602553|NCT03015532|583596958|FG003|Overall Study|Adverse Event|0|||
161602554|NCT03015532|583596959|FG004|Overall Study|Adverse Event|0|||
161602555|NCT03015532|583596960|FG005|Overall Study|Adverse Event|2|||
161602556|NCT03015532|583596961|FG006|Overall Study|Adverse Event|1|||
161602557|NCT03015532|583596962|FG007|Overall Study|Adverse Event|0|||
161602558|NCT03015532|583596955|FG000|Overall Study|Withdrawal by Subject|0|||
161602559|NCT03015532|583596956|FG001|Overall Study|Withdrawal by Subject|0|||
161602560|NCT03015532|583596957|FG002|Overall Study|Withdrawal by Subject|0|||
161602561|NCT03015532|583596958|FG003|Overall Study|Withdrawal by Subject|0|||
161602562|NCT03015532|583596959|FG004|Overall Study|Withdrawal by Subject|0|||
161602563|NCT03015532|583596960|FG005|Overall Study|Withdrawal by Subject|0|||
161602564|NCT03015532|583596961|FG006|Overall Study|Withdrawal by Subject|1|||
161602565|NCT03015532|583596962|FG007|Overall Study|Withdrawal by Subject|0|||
161602566|NCT04186819|583596963|FG000|Overall Study|Adverse Event|1|||
161602567|NCT04186819|583596963|FG000|Overall Study|Lost to Follow-up|1|||
161602568|NCT04186819|583596963|FG000|Overall Study|Opted for EBRT|1|||
161602569|NCT04186819|583596963|FG000|Overall Study|Opted SBRT|1|||
161602570|NCT04186819|583596963|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
161602571|NCT04186819|583596963|FG000|Overall Study|Physician Decision|1|||
161602572|NCT04186819|583596963|FG000|Overall Study|RP Delayed|1|||
161602573|NCT04186819|583596963|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
161602574|NCT04186819|583596963|FG000|Overall Study|Subject declined for financial reasons|1|||
161602575|NCT04186819|583596963|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
161602576|NCT04186819|583596963|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
161602577|NCT04186819|583596963|FG000|Overall Study|The subject opted for other treatment option|2|||
161602578|NCT04186819|583596963|FG000|Overall Study|The subject opted for other treatment options|1|||
161602579|NCT04186819|583596963|FG000|Overall Study|Withdrawal by Subject|3|||
161682505|NCT01987960|583888895|FG002|Period 1|Lack of Efficacy|0|||
161602580|NCT04186819|583596963|FG000|Overall Study|Reason not specified|1|||
161602581|NCT05013385|583596967|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
161602582|NCT01447719|583596968|FG000|Overall Study|Image acquisition failure|2|||
161602583|NCT01447719|583596968|FG000|Overall Study|Invalid image or not imaged|3|||
161602584|NCT01447719|583596968|FG000|Overall Study|Subject still living at end of study|79|||
161602585|NCT01447719|583596968|FG000|Overall Study|Withdrawal by Subject|2|||
161602586|NCT01447719|583596968|FG000|Overall Study|Family withdrew autopsy consent|7|||
161602587|NCT03252288|583596969|FG000|Overall Study|Death|1|||
161602588|NCT03252288|583596970|FG001|Overall Study|Death|0|||
161602589|NCT03252288|583596971|FG002|Overall Study|Death|0|||
161602590|NCT03252288|583596969|FG000|Overall Study|Death|11|||
161602591|NCT03252288|583596970|FG001|Overall Study|Death|0|||
161602592|NCT03252288|583596971|FG002|Overall Study|Death|0|||
161602593|NCT03252288|583596969|FG000|Overall Study|Withdrawal by Subject|2|||
161602594|NCT03252288|583596970|FG001|Overall Study|Withdrawal by Subject|0|||
161602595|NCT03252288|583596971|FG002|Overall Study|Withdrawal by Subject|0|||
161602596|NCT03252288|583596969|FG000|Overall Study|Lost to Follow-up|79|||
161602597|NCT03252288|583596970|FG001|Overall Study|Lost to Follow-up|0|||
161602598|NCT03252288|583596971|FG002|Overall Study|Lost to Follow-up|0|||
161602599|NCT03252288|583596969|FG000|Overall Study|Loss of baseline data on tablets|6|||
161602600|NCT03252288|583596970|FG001|Overall Study|Loss of baseline data on tablets|0|||
161602601|NCT03252288|583596971|FG002|Overall Study|Loss of baseline data on tablets|0|||
161602602|NCT02944968|583596972|FG000|Overall Study|Subject excluded before study procedure|1|||
161602603|NCT02944968|583596972|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
161602604|NCT02542631|583596980|FG000|Overall Study|Adverse Event|1|||
161602605|NCT02542631|583596981|FG001|Overall Study|Adverse Event|1|||
161602606|NCT02542631|583596980|FG000|Overall Study|Sponsor Termination|1|||
161602607|NCT02542631|583596981|FG001|Overall Study|Sponsor Termination|0|||
161602608|NCT02542631|583596980|FG000|Overall Study|Withdrawal by Subject|11|||
161602609|NCT02542631|583596981|FG001|Overall Study|Withdrawal by Subject|16|||
161602610|NCT02542631|583596980|FG000|Overall Study|Protocol Violation|1|||
161602611|NCT02542631|583596981|FG001|Overall Study|Protocol Violation|1|||
161602612|NCT02542631|583596980|FG000|Overall Study|Physician Decision|6|||
161602613|NCT02542631|583596981|FG001|Overall Study|Physician Decision|4|||
161602614|NCT02542631|583596980|FG000|Overall Study|Lost to Follow-up|6|||
161602615|NCT02542631|583596981|FG001|Overall Study|Lost to Follow-up|5|||
161602616|NCT02542631|583596980|FG000|Overall Study|Death|1|||
161602617|NCT02542631|583596981|FG001|Overall Study|Death|2|||
161602618|NCT02542631|583596980|FG000|Overall Study|Other|2|||
161602619|NCT02542631|583596981|FG001|Overall Study|Other|1|||
161602620|NCT02542631|583596980|FG000|Overall Study|Used Prohibited Medication|2|||
161602621|NCT02542631|583596981|FG001|Overall Study|Used Prohibited Medication|1|||
161602622|NCT02326974|583596984|FG000|Overall Study|Withdrawal by Subject|2|||
161602623|NCT02326974|583596984|FG000|Overall Study|failed heterogenity evaluation|5|||
161602624|NCT04924400|583596988|FG000|Overall Study|Lost to Follow-up|3|||
161602625|NCT04924400|583596989|FG001|Overall Study|Lost to Follow-up|0|||
161602626|NCT06010836|583596990|FG000|Overall Study|Lost to Follow-up|2|||
161602627|NCT06010836|583596991|FG001|Overall Study|Lost to Follow-up|2|||
161602628|NCT06010836|583596990|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
161602629|NCT06010836|583596991|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
161602630|NCT06010836|583596990|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
161602631|NCT06010836|583596991|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
161602632|NCT06010836|583596990|FG000|Overall Study|Did not receive intervention discussion|0|||
161602633|NCT06010836|583596991|FG001|Overall Study|Did not receive intervention discussion|4|||
161602634|NCT02994927|583597004|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161602635|NCT02994927|583597005|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161602636|NCT02994927|583597004|FG000|Overall Study|Did not meet eligibility criteria|0|||
161602637|NCT02994927|583597005|FG001|Overall Study|Did not meet eligibility criteria|1|||
161602638|NCT02994927|583597004|FG000|Overall Study|Physician Decision|4|||
161602639|NCT02994927|583597005|FG001|Overall Study|Physician Decision|3|||
161602640|NCT02994927|583597004|FG000|Overall Study|Death|4|||
161602641|NCT02994927|583597005|FG001|Overall Study|Death|2|||
161602642|NCT02994927|583597004|FG000|Overall Study|Adverse Event|2|||
161602643|NCT02994927|583597005|FG001|Overall Study|Adverse Event|1|||
161602644|NCT02994927|583597004|FG000|Overall Study|Withdrawal by Subject|3|||
161602645|NCT02994927|583597005|FG001|Overall Study|Withdrawal by Subject|6|||
161602646|NCT02994927|583597004|FG000|Overall Study|Lost to Follow-up|2|||
161602647|NCT02994927|583597005|FG001|Overall Study|Lost to Follow-up|1|||
161602648|NCT03533257|583597013|FG000|Overall Study|Adverse Event|4|||
161602649|NCT03533257|583597014|FG001|Overall Study|Adverse Event|2|||
161602650|NCT03533257|583597013|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
161602651|NCT03533257|583597014|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
161602652|NCT04427007|583598118|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
161602653|NCT04427007|583598119|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
161602654|NCT03972150|583598120|FG000|Overall Study|Adverse Event|0|||
161602655|NCT03972150|583598121|FG001|Overall Study|Adverse Event|1|||
161602656|NCT03972150|583598122|FG002|Overall Study|Adverse Event|1|||
161602657|NCT03972150|583598123|FG003|Overall Study|Adverse Event|0|||
161602658|NCT03972150|583598124|FG004|Overall Study|Adverse Event|0|||
161602659|NCT03972150|583598120|FG000|Overall Study|Progressive disease|3|||
161602660|NCT03972150|583598121|FG001|Overall Study|Progressive disease|5|||
161602661|NCT03972150|583598122|FG002|Overall Study|Progressive disease|2|||
161602662|NCT03972150|583598123|FG003|Overall Study|Progressive disease|2|||
161602663|NCT03972150|583598124|FG004|Overall Study|Progressive disease|3|||
161602664|NCT05464069|583598127|FG000|Overall Study|Protocol Violation|3|||
161602665|NCT05464069|583598128|FG001|Overall Study|Protocol Violation|2|||
161602666|NCT03442309|583598129|FG000|Overall Study|Lost to Follow-up|1676|||
161602667|NCT03442309|583598130|FG001|Overall Study|Lost to Follow-up|1642|||
161602668|NCT06106022|583598133|FG000|Overall Study|Lost to Follow-up|1|||
161602669|NCT06106022|583598134|FG001|Overall Study|Lost to Follow-up|0|||
161602670|NCT06106022|583598133|FG000|Overall Study|Voluntary Withdrawal|0|||
161602671|NCT06106022|583598134|FG001|Overall Study|Voluntary Withdrawal|2|||
161602672|NCT05524116|583598148|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
161602673|NCT05524116|583598149|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
161602674|NCT05524116|583598148|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
161602675|NCT05524116|583598149|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
161602676|NCT05524116|583598148|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
161602677|NCT05524116|583598149|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
161602678|NCT05524116|583598148|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
161602679|NCT05524116|583598149|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
161602680|NCT05524116|583598148|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
161602681|NCT05524116|583598149|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
161602682|NCT04389957|583598150|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
161602683|NCT04389957|583598151|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
161602684|NCT04389957|583598152|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
161602685|NCT04389957|583598153|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
161602686|NCT04389957|583598154|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
161602687|NCT03988621|583598158|FG000|Overall Study|Lost to Follow-up|16|||
161602688|NCT03988621|583598159|FG001|Overall Study|Lost to Follow-up|17|||
161682506|NCT01987960|583888896|FG003|Period 1|Lack of Efficacy|0|||
161602689|NCT03988621|583598158|FG000|Overall Study|Withdrawal by Subject|14|||
161602690|NCT03988621|583598159|FG001|Overall Study|Withdrawal by Subject|7|||
161602691|NCT03988621|583598158|FG000|Overall Study|Patient Lost to Follow Up|15|||
161602692|NCT03988621|583598159|FG001|Overall Study|Patient Lost to Follow Up|15|||
161602693|NCT03988621|583598158|FG000|Overall Study|Patient death|1|||
161602694|NCT03988621|583598159|FG001|Overall Study|Patient death|5|||
161602695|NCT02905331|583598160|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
161602696|NCT02905331|583598161|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
161602697|NCT02905331|583598162|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
161602698|NCT02905331|583598160|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
161602699|NCT02905331|583598161|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
161602700|NCT02905331|583598162|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
161602701|NCT02905331|583598160|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
161602702|NCT02905331|583598161|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
161602703|NCT02905331|583598162|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
161602704|NCT02905331|583598160|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
161602705|NCT02905331|583598161|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
161602706|NCT02905331|583598162|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
161602707|NCT02905331|583598160|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
161602708|NCT02905331|583598161|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
161602709|NCT02905331|583598162|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
161602710|NCT04424316|583598165|FG000|Overall Study|Adverse Event|0|||
161602711|NCT04424316|583598166|FG001|Overall Study|Adverse Event|1|||
161602712|NCT04424316|583598167|FG002|Overall Study|Adverse Event|0|||
161602713|NCT04424316|583598168|FG003|Overall Study|Adverse Event|0|||
161602714|NCT04424316|583598165|FG000|Overall Study|Death|1|||
161602715|NCT04424316|583598166|FG001|Overall Study|Death|0|||
161602716|NCT04424316|583598167|FG002|Overall Study|Death|8|||
161602717|NCT04424316|583598168|FG003|Overall Study|Death|14|||
161602718|NCT04424316|583598165|FG000|Overall Study|Lost to Follow-up|93|||
161602719|NCT04424316|583598166|FG001|Overall Study|Lost to Follow-up|88|||
161602720|NCT04424316|583598167|FG002|Overall Study|Lost to Follow-up|224|||
161602721|NCT04424316|583598168|FG003|Overall Study|Lost to Follow-up|211|||
161602722|NCT04424316|583598165|FG000|Overall Study|No longer met eligibility criteria|1|||
161602723|NCT04424316|583598166|FG001|Overall Study|No longer met eligibility criteria|0|||
161602724|NCT04424316|583598167|FG002|Overall Study|No longer met eligibility criteria|0|||
161602725|NCT04424316|583598168|FG003|Overall Study|No longer met eligibility criteria|0|||
161602726|NCT04424316|583598165|FG000|Overall Study|Other|15|||
161602727|NCT04424316|583598166|FG001|Overall Study|Other|11|||
161602728|NCT04424316|583598167|FG002|Overall Study|Other|34|||
161602729|NCT04424316|583598168|FG003|Overall Study|Other|45|||
161602730|NCT04424316|583598165|FG000|Overall Study|Physician Decision|1|||
161602731|NCT04424316|583598166|FG001|Overall Study|Physician Decision|0|||
161602732|NCT04424316|583598167|FG002|Overall Study|Physician Decision|1|||
161602733|NCT04424316|583598168|FG003|Overall Study|Physician Decision|1|||
161602734|NCT04424316|583598165|FG000|Overall Study|Protocol Violation|0|||
161602735|NCT04424316|583598166|FG001|Overall Study|Protocol Violation|1|||
161602736|NCT04424316|583598167|FG002|Overall Study|Protocol Violation|0|||
161602737|NCT04424316|583598168|FG003|Overall Study|Protocol Violation|0|||
161602738|NCT04424316|583598165|FG000|Overall Study|Withdrawal by Subject|71|||
161602739|NCT04424316|583598166|FG001|Overall Study|Withdrawal by Subject|77|||
161602740|NCT04424316|583598167|FG002|Overall Study|Withdrawal by Subject|0|||
161602741|NCT04424316|583598168|FG003|Overall Study|Withdrawal by Subject|0|||
161602742|NCT04424316|583598165|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161602743|NCT04424316|583598166|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161602744|NCT04424316|583598167|FG002|Overall Study|Withdrawal by parent/guardian|74|||
161602745|NCT04424316|583598168|FG003|Overall Study|Withdrawal by parent/guardian|81|||
161602746|NCT04424316|583598165|FG000|Overall Study|Randomized but not vaccinated|13|||
161602747|NCT04424316|583598166|FG001|Overall Study|Randomized but not vaccinated|21|||
161602748|NCT04424316|583598167|FG002|Overall Study|Randomized but not vaccinated|0|||
161602749|NCT04424316|583598168|FG003|Overall Study|Randomized but not vaccinated|0|||
161602750|NCT04424316|583598165|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
161602751|NCT04424316|583598166|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
161602752|NCT04424316|583598167|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
161602753|NCT04424316|583598168|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
161602754|NCT03812614|583598170|FG000|Intervention|Withdrawal by Subject|7|||
161602755|NCT03812614|583598171|FG001|Intervention|Withdrawal by Subject|2|||
161602756|NCT03812614|583598172|FG002|Intervention|Withdrawal by Subject|7|||
161602757|NCT03812614|583598173|FG003|Intervention|Withdrawal by Subject|2|||
161682507|NCT01987960|583888893|FG000|Period 1|Non-compliance with IMP|6|||
161602758|NCT03812614|583598170|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
161602759|NCT03812614|583598171|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
161682508|NCT01987960|583888894|FG001|Period 1|Non-compliance with IMP|0|||
161602760|NCT03812614|583598172|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
161602761|NCT03812614|583598173|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
161602762|NCT03812614|583598170|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
161602763|NCT03812614|583598171|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
161602764|NCT03812614|583598172|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
161602765|NCT03812614|583598173|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
161602766|NCT03812614|583598170|FG000|6-month Follow-up|Lost to Follow-up|0|||
161602767|NCT03812614|583598171|FG001|6-month Follow-up|Lost to Follow-up|0|||
161602768|NCT03812614|583598172|FG002|6-month Follow-up|Lost to Follow-up|12|||
161602769|NCT03812614|583598173|FG003|6-month Follow-up|Lost to Follow-up|8|||
161602770|NCT03812614|583598170|FG000|12-month Follow-up|Lost to Follow-up|18|||
161602771|NCT03812614|583598171|FG001|12-month Follow-up|Lost to Follow-up|17|||
161602772|NCT03812614|583598172|FG002|12-month Follow-up|Lost to Follow-up|5|||
161602773|NCT03812614|583598173|FG003|12-month Follow-up|Lost to Follow-up|2|||
161602774|NCT05652010|583598174|FG000|First Intervention|Withdrawal by Subject|0|||
161602775|NCT05652010|583598175|FG001|First Intervention|Withdrawal by Subject|1|||
161602776|NCT05652010|583598174|FG000|Second Intervention|Withdrawal by Subject|1|||
161602777|NCT05652010|583598175|FG001|Second Intervention|Withdrawal by Subject|0|||
161602778|NCT05451693|583598176|FG000|Overall Study|Withdrawal by Subject|1|||
161602779|NCT05451693|583598177|FG001|Overall Study|Withdrawal by Subject|1|||
161602780|NCT03372057|583598182|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
161602781|NCT03372057|583598183|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
161602782|NCT03372057|583598184|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
161602783|NCT03372057|583598182|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
161602784|NCT03372057|583598183|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
161602785|NCT03372057|583598184|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
161602786|NCT03372057|583598182|FG000|Dose Optimization Phase|Death|16|||
161602787|NCT03372057|583598183|FG001|Dose Optimization Phase|Death|11|||
161602788|NCT03372057|583598184|FG002|Dose Optimization Phase|Death|0|||
161602789|NCT03372057|583598182|FG000|Expansion Phase|Withdrawal by Subject|0|||
161602790|NCT03372057|583598183|FG001|Expansion Phase|Withdrawal by Subject|0|||
161602791|NCT03372057|583598184|FG002|Expansion Phase|Withdrawal by Subject|4|||
161602792|NCT03372057|583598182|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
161602793|NCT03372057|583598183|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
161602794|NCT03372057|583598184|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
161602795|NCT03372057|583598182|FG000|Expansion Phase|Death|0|||
161602796|NCT03372057|583598183|FG001|Expansion Phase|Death|0|||
161602797|NCT03372057|583598184|FG002|Expansion Phase|Death|78|||
161602798|NCT03372057|583598182|FG000|Expansion Phase|Progressive Disease|0|||
161602799|NCT03372057|583598183|FG001|Expansion Phase|Progressive Disease|0|||
161602800|NCT03372057|583598184|FG002|Expansion Phase|Progressive Disease|1|||
161602801|NCT03372057|583598182|FG000|Expansion Phase|Adverse Event|0|||
161602802|NCT03372057|583598183|FG001|Expansion Phase|Adverse Event|0|||
161602803|NCT03372057|583598184|FG002|Expansion Phase|Adverse Event|1|||
161602804|NCT02518048|583598185|FG000|Overall Study|Withdrawal by Subject|1|||
161602805|NCT05890105|583598186|FG000|Overall Study|Adverse Event|1|||
161602806|NCT05890105|583598187|FG001|Overall Study|Adverse Event|0|||
161602807|NCT05890105|583598188|FG002|Overall Study|Adverse Event|0|||
161602808|NCT05890105|583598186|FG000|Overall Study|Other|1|||
161602809|NCT05890105|583598187|FG001|Overall Study|Other|2|||
161602810|NCT05890105|583598188|FG002|Overall Study|Other|0|||
161602811|NCT05123027|583598190|FG000|Overall Study|Lost to Follow-up|17|||
161602812|NCT05123027|583598191|FG001|Overall Study|Lost to Follow-up|22|||
161602813|NCT05123027|583598190|FG000|Overall Study|Incarceration|3|||
161602814|NCT05123027|583598191|FG001|Overall Study|Incarceration|4|||
161602815|NCT05123027|583598190|FG000|Overall Study|Death|2|||
161602816|NCT05123027|583598191|FG001|Overall Study|Death|2|||
161602817|NCT05123027|583598190|FG000|Overall Study|Other|2|||
161602818|NCT05123027|583598191|FG001|Overall Study|Other|0|||
161602819|NCT04330040|583598192|FG000|Overall Study|Other: Adverse event|5|||
161602820|NCT04330040|583598193|FG001|Overall Study|Other: Adverse event|0|||
161602821|NCT04330040|583598194|FG002|Overall Study|Other: Adverse event|0|||
161602822|NCT04330040|583598192|FG000|Overall Study|Disease progression|38|||
161602823|NCT04330040|583598193|FG001|Overall Study|Disease progression|10|||
161602824|NCT04330040|583598194|FG002|Overall Study|Disease progression|0|||
161602825|NCT04330040|583598192|FG000|Overall Study|Physician Decision|5|||
161602826|NCT04330040|583598193|FG001|Overall Study|Physician Decision|3|||
161602827|NCT04330040|583598194|FG002|Overall Study|Physician Decision|0|||
161602828|NCT04330040|583598192|FG000|Overall Study|Lost to Follow-up|1|||
161602829|NCT04330040|583598193|FG001|Overall Study|Lost to Follow-up|1|||
161602830|NCT04330040|583598194|FG002|Overall Study|Lost to Follow-up|0|||
161602831|NCT04330040|583598192|FG000|Overall Study|Death|2|||
161602832|NCT04330040|583598193|FG001|Overall Study|Death|1|||
161602833|NCT04330040|583598194|FG002|Overall Study|Death|0|||
161602834|NCT04330040|583598192|FG000|Overall Study|Withdrawal by Subject|3|||
161602835|NCT04330040|583598193|FG001|Overall Study|Withdrawal by Subject|3|||
161602836|NCT04330040|583598194|FG002|Overall Study|Withdrawal by Subject|0|||
161602837|NCT04330040|583598192|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
161602838|NCT04330040|583598193|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
161602839|NCT04330040|583598194|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
161602840|NCT04330040|583598192|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
161602841|NCT04330040|583598193|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
161602842|NCT04330040|583598194|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
161602843|NCT04330040|583598192|FG000|Overall Study|Other: Disease progression|1|||
161602844|NCT04330040|583598193|FG001|Overall Study|Other: Disease progression|0|||
161602845|NCT04330040|583598194|FG002|Overall Study|Other: Disease progression|0|||
161602846|NCT04330040|583598192|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
161602847|NCT04330040|583598193|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
161602848|NCT04330040|583598194|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
161602849|NCT04330040|583598192|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
161602850|NCT04330040|583598193|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
161602851|NCT04330040|583598194|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
161602852|NCT04330040|583598192|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
161602853|NCT04330040|583598193|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
161602854|NCT04330040|583598194|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
161602855|NCT04761198|583598197|FG000|Overall Study|Progressive Disease|1|||
161602856|NCT04761198|583598198|FG001|Overall Study|Progressive Disease|0|||
161602857|NCT04761198|583598199|FG002|Overall Study|Progressive Disease|0|||
161602858|NCT04761198|583598200|FG003|Overall Study|Progressive Disease|1|||
161602859|NCT04761198|583598201|FG004|Overall Study|Progressive Disease|4|||
161602860|NCT04761198|583598202|FG005|Overall Study|Progressive Disease|1|||
161602861|NCT04761198|583598203|FG006|Overall Study|Progressive Disease|2|||
161602862|NCT04761198|583598197|FG000|Overall Study|Protocol Violation|0|||
161602863|NCT04761198|583598198|FG001|Overall Study|Protocol Violation|0|||
161602864|NCT04761198|583598199|FG002|Overall Study|Protocol Violation|0|||
161602865|NCT04761198|583598200|FG003|Overall Study|Protocol Violation|0|||
161602866|NCT04761198|583598201|FG004|Overall Study|Protocol Violation|1|||
161602867|NCT04761198|583598202|FG005|Overall Study|Protocol Violation|0|||
161602868|NCT04761198|583598203|FG006|Overall Study|Protocol Violation|0|||
161602869|NCT04761198|583598197|FG000|Overall Study|Death|2|||
161682509|NCT01987960|583888895|FG002|Period 1|Non-compliance with IMP|0|||
161602870|NCT04761198|583598198|FG001|Overall Study|Death|1|||
161602871|NCT04761198|583598199|FG002|Overall Study|Death|2|||
161602872|NCT04761198|583598200|FG003|Overall Study|Death|5|||
161682510|NCT01987960|583888896|FG003|Period 1|Non-compliance with IMP|0|||
161602873|NCT04761198|583598201|FG004|Overall Study|Death|14|||
161602874|NCT04761198|583598202|FG005|Overall Study|Death|2|||
161602875|NCT04761198|583598203|FG006|Overall Study|Death|5|||
161602876|NCT04761198|583598197|FG000|Overall Study|Lost to Follow-up|0|||
161602877|NCT04761198|583598198|FG001|Overall Study|Lost to Follow-up|0|||
161602878|NCT04761198|583598199|FG002|Overall Study|Lost to Follow-up|0|||
161602879|NCT04761198|583598200|FG003|Overall Study|Lost to Follow-up|0|||
161602880|NCT04761198|583598201|FG004|Overall Study|Lost to Follow-up|1|||
161602881|NCT04761198|583598202|FG005|Overall Study|Lost to Follow-up|0|||
161602882|NCT04761198|583598203|FG006|Overall Study|Lost to Follow-up|0|||
161602883|NCT04761198|583598197|FG000|Overall Study|Withdrawal by Subject|2|||
161602884|NCT04761198|583598198|FG001|Overall Study|Withdrawal by Subject|0|||
161602885|NCT04761198|583598199|FG002|Overall Study|Withdrawal by Subject|1|||
161602886|NCT04761198|583598200|FG003|Overall Study|Withdrawal by Subject|0|||
161602887|NCT04761198|583598201|FG004|Overall Study|Withdrawal by Subject|2|||
161602888|NCT04761198|583598202|FG005|Overall Study|Withdrawal by Subject|0|||
161602889|NCT04761198|583598203|FG006|Overall Study|Withdrawal by Subject|1|||
161602890|NCT04761198|583598197|FG000|Overall Study|Study Terminated by Sponsor|6|||
161602891|NCT04761198|583598198|FG001|Overall Study|Study Terminated by Sponsor|0|||
161602892|NCT04761198|583598199|FG002|Overall Study|Study Terminated by Sponsor|5|||
161602893|NCT04761198|583598200|FG003|Overall Study|Study Terminated by Sponsor|3|||
161602894|NCT04761198|583598201|FG004|Overall Study|Study Terminated by Sponsor|10|||
161602895|NCT04761198|583598202|FG005|Overall Study|Study Terminated by Sponsor|1|||
161602896|NCT04761198|583598203|FG006|Overall Study|Study Terminated by Sponsor|2|||
161602897|NCT05525104|583598205|FG000|Overall Study|Failed caudal analgesia|1|||
161602898|NCT05525104|583598206|FG001|Overall Study|Failed caudal analgesia|3|||
161602899|NCT05525104|583598205|FG000|Overall Study|Premedication needed|0|||
161602900|NCT05525104|583598206|FG001|Overall Study|Premedication needed|1|||
161602901|NCT05525104|583598205|FG000|Overall Study|Protocol Violation|10|||
161602902|NCT05525104|583598206|FG001|Overall Study|Protocol Violation|0|||
161602903|NCT05525104|583598205|FG000|Overall Study|Cancelled operation|1|||
161602904|NCT05525104|583598206|FG001|Overall Study|Cancelled operation|0|||
161602905|NCT02039401|583598207|FG000|Overall Study|Adverse Event|0|||
161602906|NCT02039401|583598208|FG001|Overall Study|Adverse Event|1|||
161602907|NCT04247802|583599800|FG000|Overall Study|Withdrawal by Subject|1|||
161602908|NCT04247802|583599801|FG001|Overall Study|Withdrawal by Subject|3|||
161602909|NCT04247802|583599800|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
161602910|NCT04247802|583599801|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
161602911|NCT01385202|583599813|FG000|Overall Study|Lost to Follow-up|6|||
161602912|NCT01385202|583599813|FG000|Overall Study|Not Eligible|11|||
161602913|NCT01385202|583599813|FG000|Overall Study|Withdrawn|1|||
161602914|NCT02095691|583599814|FG000|Overall Study|Physician Decision|1|||
161602915|NCT02874742|583599817|FG000|Overall Study|Death|0|||
161602916|NCT02874742|583599818|FG001|Overall Study|Death|1|||
161602917|NCT02874742|583599819|FG002|Overall Study|Death|0|||
161602918|NCT02874742|583599817|FG000|Overall Study|Lost to Follow-up|5|||
161602919|NCT02874742|583599818|FG001|Overall Study|Lost to Follow-up|4|||
161602920|NCT02874742|583599819|FG002|Overall Study|Lost to Follow-up|1|||
161602921|NCT02874742|583599817|FG000|Overall Study|Withdrawal by Subject|17|||
161602922|NCT02874742|583599818|FG001|Overall Study|Withdrawal by Subject|8|||
161602923|NCT02874742|583599819|FG002|Overall Study|Withdrawal by Subject|0|||
161602924|NCT02874742|583599817|FG000|Overall Study|Other|4|||
161602925|NCT02874742|583599818|FG001|Overall Study|Other|1|||
161602926|NCT02874742|583599819|FG002|Overall Study|Other|0|||
161602927|NCT02874742|583599817|FG000|Overall Study|Progressive Disease|1|||
161602928|NCT02874742|583599818|FG001|Overall Study|Progressive Disease|0|||
161602929|NCT02874742|583599819|FG002|Overall Study|Progressive Disease|0|||
161602930|NCT02874742|583599817|FG000|Overall Study|Screen Failure|0|||
161602931|NCT02874742|583599818|FG001|Overall Study|Screen Failure|2|||
161602932|NCT02874742|583599819|FG002|Overall Study|Screen Failure|0|||
161602933|NCT03691298|583599826|FG000|Overall Study|Lost to Follow-up|8|||
161602934|NCT03691298|583599826|FG000|Overall Study|Sponsor terminated study|2|||
161602935|NCT02577354|583599827|FG000|Overall Study|Lack of Efficacy|4|||
161602936|NCT02577354|583599828|FG001|Overall Study|Lack of Efficacy|4|||
161602937|NCT02577354|583599827|FG000|Overall Study|Lost to Follow-up|3|||
161602938|NCT02577354|583599828|FG001|Overall Study|Lost to Follow-up|1|||
161602939|NCT02577354|583599827|FG000|Overall Study|Missed Visit|4|||
161602940|NCT02577354|583599828|FG001|Overall Study|Missed Visit|3|||
161602941|NCT02577354|583599827|FG000|Overall Study|Adverse Event|4|||
161602942|NCT02577354|583599828|FG001|Overall Study|Adverse Event|5|||
161602943|NCT05070741|583599833|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
161602944|NCT03245840|583599834|FG000|Overall Study|Adverse Event|6|||
161602945|NCT03245840|583599835|FG001|Overall Study|Adverse Event|0|||
161602946|NCT03245840|583599834|FG000|Overall Study|Death|2|||
161602947|NCT03245840|583599835|FG001|Overall Study|Death|0|||
161602948|NCT03245840|583599834|FG000|Overall Study|Withdrawal by Subject|31|||
161602949|NCT03245840|583599835|FG001|Overall Study|Withdrawal by Subject|1|||
161602950|NCT03245840|583599834|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161602951|NCT03245840|583599835|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161602952|NCT03245840|583599834|FG000|Overall Study|Physician Decision|4|||
161602953|NCT03245840|583599835|FG001|Overall Study|Physician Decision|1|||
161602954|NCT03245840|583599834|FG000|Overall Study|Study Terminated by Sponsor|56|||
161602955|NCT03245840|583599835|FG001|Overall Study|Study Terminated by Sponsor|6|||
161602956|NCT03245840|583599834|FG000|Overall Study|Site Terminated by Sponsor|4|||
161602957|NCT03245840|583599835|FG001|Overall Study|Site Terminated by Sponsor|0|||
161602958|NCT03245840|583599834|FG000|Overall Study|Lost to Follow-up|12|||
161602959|NCT03245840|583599835|FG001|Overall Study|Lost to Follow-up|2|||
161602960|NCT03245840|583599834|FG000|Overall Study|Pregnancy|2|||
161602961|NCT03245840|583599835|FG001|Overall Study|Pregnancy|0|||
161602962|NCT03245840|583599834|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161602963|NCT03245840|583599835|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161602964|NCT03245840|583599834|FG000|Overall Study|Not treated|1|||
161602965|NCT03245840|583599835|FG001|Overall Study|Not treated|1|||
161602966|NCT05741294|583599841|FG000|Overall Study|Lost to Follow-up|3|||
161602967|NCT05741294|583599841|FG000|Overall Study|Protocol deviation|3|||
161602968|NCT05741294|583599841|FG000|Overall Study|Withdrawal by Subject|1|||
161602969|NCT04707768|583599844|FG000|Overall Study|Adverse Event|9|||
161602970|NCT04707768|583599845|FG001|Overall Study|Adverse Event|18|||
161602971|NCT04707768|583599846|FG002|Overall Study|Adverse Event|3|||
161602972|NCT04707768|583599844|FG000|Overall Study|Investigator's Discretion|8|||
161602973|NCT04707768|583599845|FG001|Overall Study|Investigator's Discretion|4|||
161602974|NCT04707768|583599846|FG002|Overall Study|Investigator's Discretion|3|||
161602975|NCT04707768|583599844|FG000|Overall Study|Withdrawal by Subject|6|||
161602976|NCT04707768|583599845|FG001|Overall Study|Withdrawal by Subject|8|||
161602977|NCT04707768|583599846|FG002|Overall Study|Withdrawal by Subject|2|||
161602978|NCT04707768|583599844|FG000|Overall Study|Lack of Efficacy|1|||
161602979|NCT04707768|583599845|FG001|Overall Study|Lack of Efficacy|3|||
161602980|NCT04707768|583599846|FG002|Overall Study|Lack of Efficacy|0|||
161602981|NCT04707768|583599844|FG000|Overall Study|Lost to Follow-up|0|||
161602982|NCT04707768|583599845|FG001|Overall Study|Lost to Follow-up|0|||
161602983|NCT04707768|583599846|FG002|Overall Study|Lost to Follow-up|3|||
161602984|NCT04707768|583599844|FG000|Overall Study|Death|13|||
161602985|NCT04707768|583599845|FG001|Overall Study|Death|11|||
161602986|NCT04707768|583599846|FG002|Overall Study|Death|13|||
161602987|NCT04707768|583599844|FG000|Overall Study|Protocol Violation|2|||
161602988|NCT04707768|583599845|FG001|Overall Study|Protocol Violation|1|||
161602989|NCT04707768|583599846|FG002|Overall Study|Protocol Violation|0|||
161602990|NCT04707768|583599844|FG000|Overall Study|Non Compliance with Study Drug|1|||
161602991|NCT04707768|583599845|FG001|Overall Study|Non Compliance with Study Drug|0|||
161602992|NCT04707768|583599846|FG002|Overall Study|Non Compliance with Study Drug|0|||
161602993|NCT04707768|583599844|FG000|Overall Study|Transplant|4|||
161602994|NCT04707768|583599845|FG001|Overall Study|Transplant|4|||
161602995|NCT04707768|583599846|FG002|Overall Study|Transplant|8|||
161602996|NCT04707768|583599844|FG000|Overall Study|Other|9|||
161602997|NCT04707768|583599845|FG001|Overall Study|Other|5|||
161602998|NCT04707768|583599846|FG002|Overall Study|Other|2|||
161602999|NCT04490109|583599847|FG000|Overall Study|Lost to Follow-up|3|||
161603000|NCT04490109|583599848|FG001|Overall Study|Lost to Follow-up|10|||
161603001|NCT04490109|583599849|FG002|Overall Study|Lost to Follow-up|4|||
161603002|NCT04490109|583599847|FG000|Overall Study|Withdrawal by Subject|8|||
161603003|NCT04490109|583599848|FG001|Overall Study|Withdrawal by Subject|6|||
161603004|NCT04490109|583599849|FG002|Overall Study|Withdrawal by Subject|9|||
161603005|NCT04490109|583599847|FG000|Overall Study|Physician Decision|0|||
161603006|NCT04490109|583599848|FG001|Overall Study|Physician Decision|2|||
161603007|NCT04490109|583599849|FG002|Overall Study|Physician Decision|3|||
161603008|NCT04490109|583599847|FG000|Overall Study|Adverse Event|2|||
161603009|NCT04490109|583599848|FG001|Overall Study|Adverse Event|1|||
161603010|NCT04490109|583599849|FG002|Overall Study|Adverse Event|0|||
161603011|NCT04490109|583599847|FG000|Overall Study|Significant Non-Compliance|2|||
161603012|NCT04490109|583599848|FG001|Overall Study|Significant Non-Compliance|4|||
161603013|NCT04490109|583599849|FG002|Overall Study|Significant Non-Compliance|4|||
161603014|NCT04490109|583599847|FG000|Overall Study|Significant Clinical Event|0|||
161603015|NCT04490109|583599848|FG001|Overall Study|Significant Clinical Event|1|||
161603016|NCT04490109|583599849|FG002|Overall Study|Significant Clinical Event|0|||
161603017|NCT04490109|583599847|FG000|Overall Study|Other Reason|4|||
161603018|NCT04490109|583599848|FG001|Overall Study|Other Reason|1|||
161603019|NCT04490109|583599849|FG002|Overall Study|Other Reason|1|||
161603020|NCT04163991|583599850|FG000|Overall Study|Adverse Event|0|||
161603021|NCT04163991|583599851|FG001|Overall Study|Adverse Event|0|||
161603022|NCT04163991|583599852|FG002|Overall Study|Adverse Event|0|||
161603023|NCT04163991|583599853|FG003|Overall Study|Adverse Event|1|||
161603024|NCT04163991|583599854|FG004|Overall Study|Adverse Event|0|||
161603025|NCT04163991|583599850|FG000|Overall Study|Death|0|||
161603026|NCT04163991|583599851|FG001|Overall Study|Death|0|||
161603027|NCT04163991|583599852|FG002|Overall Study|Death|1|||
161603028|NCT04163991|583599853|FG003|Overall Study|Death|0|||
161603029|NCT04163991|583599854|FG004|Overall Study|Death|0|||
161603030|NCT04163991|583599850|FG000|Overall Study|Lost to Follow-up|0|||
161603031|NCT04163991|583599851|FG001|Overall Study|Lost to Follow-up|1|||
161603032|NCT04163991|583599852|FG002|Overall Study|Lost to Follow-up|0|||
161603033|NCT04163991|583599853|FG003|Overall Study|Lost to Follow-up|0|||
161603034|NCT04163991|583599854|FG004|Overall Study|Lost to Follow-up|0|||
161603035|NCT04163991|583599850|FG000|Overall Study|Withdrawal by Subject|1|||
161603036|NCT04163991|583599851|FG001|Overall Study|Withdrawal by Subject|1|||
161603037|NCT04163991|583599852|FG002|Overall Study|Withdrawal by Subject|3|||
161603038|NCT04163991|583599853|FG003|Overall Study|Withdrawal by Subject|1|||
161603039|NCT04163991|583599854|FG004|Overall Study|Withdrawal by Subject|1|||
161603040|NCT04163991|583599850|FG000|Overall Study|Other, Not Specified|0|||
161603041|NCT04163991|583599851|FG001|Overall Study|Other, Not Specified|1|||
161603042|NCT04163991|583599852|FG002|Overall Study|Other, Not Specified|1|||
161603043|NCT04163991|583599853|FG003|Overall Study|Other, Not Specified|1|||
161603044|NCT04163991|583599854|FG004|Overall Study|Other, Not Specified|0|||
161603045|NCT05953740|583599855|FG000|Period 1|Physician Decision|0|||
161603046|NCT05953740|583599856|FG001|Period 1|Physician Decision|1|||
161603047|NCT05953740|583599857|FG002|Period 1|Physician Decision|0|||
161603048|NCT05953740|583599858|FG003|Period 1|Physician Decision|0|||
161603049|NCT05953740|583599859|FG004|Period 1|Physician Decision|0|||
161603050|NCT05953740|583599860|FG005|Period 1|Physician Decision|0|||
161603051|NCT05953740|583599861|FG006|Period 1|Physician Decision|0|||
161603052|NCT05953740|583599862|FG007|Period 1|Physician Decision|0|||
161603053|NCT05953740|583599855|FG000|Period 2|Withdrawal by Subject|0|||
161603054|NCT05953740|583599856|FG001|Period 2|Withdrawal by Subject|1|||
161603055|NCT05953740|583599857|FG002|Period 2|Withdrawal by Subject|1|||
161603056|NCT05953740|583599858|FG003|Period 2|Withdrawal by Subject|0|||
161603057|NCT05953740|583599859|FG004|Period 2|Withdrawal by Subject|0|||
161603058|NCT05953740|583599860|FG005|Period 2|Withdrawal by Subject|0|||
161603059|NCT05953740|583599861|FG006|Period 2|Withdrawal by Subject|0|||
161603060|NCT05953740|583599862|FG007|Period 2|Withdrawal by Subject|0|||
161603061|NCT03744676|583599863|FG000|Pre-Treatment Phase|Disease related complications|2|||
161603062|NCT03744676|583599863|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
161603063|NCT03744676|583599863|FG000|Pre-Treatment Phase|Death|7|||
161603064|NCT03744676|583599863|FG000|Pre-Treatment Phase|Other Reasons|7|||
161603065|NCT03744676|583599863|FG000|Treatment Phase|Participant withdrew consent|8|||
161603066|NCT03744676|583599863|FG000|Treatment Phase|Death|33|||
161603067|NCT03744676|583599863|FG000|Treatment Phase|other reasons|6|||
161603068|NCT04206787|583599865|FG000|Overall Study|Other than listed|2|||
161603069|NCT04206787|583599865|FG000|Overall Study|Investigator decision|1|||
161603070|NCT04206787|583599865|FG000|Overall Study|Death|25|||
161603071|NCT04206787|583599865|FG000|Overall Study|Lost to Follow-up|9|||
161603072|NCT04206787|583599865|FG000|Overall Study|Withdrawal of consent|9|||
161603073|NCT05008055|583599866|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
161603074|NCT05008055|583599867|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
161603075|NCT05008055|583599868|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
161603076|NCT03011034|583599876|FG000|Overall Study|Adverse Event|1|||
161603077|NCT03011034|583599877|FG001|Overall Study|Adverse Event|0|||
161603078|NCT03735979|583599886|FG000|Overall Study|Lost to Follow-up|1|||
161603079|NCT03735979|583599887|FG001|Overall Study|Lost to Follow-up|12|||
161603080|NCT03735979|583599888|FG002|Overall Study|Lost to Follow-up|14|||
161603081|NCT03735979|583599886|FG000|Overall Study|Withdrawal by Subject|1|||
161603082|NCT03735979|583599887|FG001|Overall Study|Withdrawal by Subject|5|||
161603083|NCT03735979|583599888|FG002|Overall Study|Withdrawal by Subject|2|||
161603084|NCT03735979|583599886|FG000|Overall Study|Not due to the above reasons|1|||
161603085|NCT03735979|583599887|FG001|Overall Study|Not due to the above reasons|0|||
161603086|NCT03735979|583599888|FG002|Overall Study|Not due to the above reasons|0|||
161603087|NCT00319111|583599891|FG000|Overall Study|Adverse Event|20|||
161548883|NCT00734214|583399329|FG000|Overall Study|MD withdrawal|1|||
161831422|NCT01314118|584424735|FG000|Overall Study|Protocol Violation|2|||
161603088|NCT00319111|583599891|FG000|Overall Study|Withdrawal of consent|11|||
161603089|NCT00319111|583599891|FG000|Overall Study|Death|9|||
161603090|NCT00319111|583599891|FG000|Overall Study|Lack of clinical improvement|4|||
161603091|NCT00319111|583599891|FG000|Overall Study|Administrative|2|||
161603092|NCT00319111|583599891|FG000|Overall Study|Treatment failure|1|||
161603093|NCT01475786|583599892|FG000|Overall Study|Adverse Event|0|||
161603094|NCT01475786|583599893|FG001|Overall Study|Adverse Event|1|||
161603095|NCT01475786|583599894|FG002|Overall Study|Adverse Event|0|||
161603096|NCT01475786|583599892|FG000|Overall Study|Lost to Follow-up|1|||
161603097|NCT01475786|583599893|FG001|Overall Study|Lost to Follow-up|2|||
161603098|NCT01475786|583599894|FG002|Overall Study|Lost to Follow-up|1|||
161603099|NCT01475786|583599892|FG000|Overall Study|Withdrawal by Subject|0|||
161603100|NCT01475786|583599893|FG001|Overall Study|Withdrawal by Subject|1|||
161603101|NCT01475786|583599894|FG002|Overall Study|Withdrawal by Subject|1|||
161603102|NCT01475786|583599892|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
161603103|NCT01475786|583599893|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
161603104|NCT01475786|583599894|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
161831423|NCT01314118|584424735|FG000|Overall Study|Withdrawal by Subject|26|||
161831424|NCT01314118|584424735|FG000|Overall Study|Other|21|||
161603105|NCT03165955|583599896|FG000|Treatment|Withdrawal by Subject|3|||
161603106|NCT03165955|583599896|FG000|Treatment|Death|1|||
161603107|NCT03165955|583599896|FG000|Treatment|Adverse Event|1|||
161603108|NCT03165955|583599896|FG000|Treatment|Progressive disease|3|||
161603109|NCT02865538|583599899|FG000|Overall Study|Withdrawal by Subject|0|||
161603110|NCT02865538|583599900|FG001|Overall Study|Withdrawal by Subject|0|||
161603111|NCT02865538|583599901|FG002|Overall Study|Withdrawal by Subject|1|||
161603112|NCT02865538|583599902|FG003|Overall Study|Withdrawal by Subject|0|||
161603113|NCT02865538|583599903|FG004|Overall Study|Withdrawal by Subject|0|||
161603114|NCT02865538|583599899|FG000|Overall Study|Lost to Follow-up|1|||
161603115|NCT02865538|583599900|FG001|Overall Study|Lost to Follow-up|0|||
161603116|NCT02865538|583599901|FG002|Overall Study|Lost to Follow-up|0|||
161603117|NCT02865538|583599902|FG003|Overall Study|Lost to Follow-up|0|||
161603118|NCT02865538|583599903|FG004|Overall Study|Lost to Follow-up|0|||
161603119|NCT04108130|583601372|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
161603120|NCT04108130|583601373|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
161603121|NCT04108130|583601372|FG000|Overall Study|Consent Withdrawn|9|||
161603122|NCT04108130|583601373|FG001|Overall Study|Consent Withdrawn|6|||
161603123|NCT04108130|583601372|FG000|Overall Study|Surgery Cancelled|4|||
161548884|NCT00734214|583399330|FG001|Overall Study|MD withdrawal|0|||
161548885|NCT00406419|583399337|FG000|Overall Study|Death|3|||
161548886|NCT00406419|583399338|FG001|Overall Study|Death|1|||
161548887|NCT00406419|583399339|FG002|Overall Study|Death|4|||
161548888|NCT00406419|583399337|FG000|Overall Study|Protocol Violation|6|||
161548889|NCT00406419|583399338|FG001|Overall Study|Protocol Violation|2|||
161548890|NCT00406419|583399339|FG002|Overall Study|Protocol Violation|5|||
161548891|NCT00406419|583399337|FG000|Overall Study|Study Terminated by Sponsor|260|||
161548892|NCT00406419|583399338|FG001|Overall Study|Study Terminated by Sponsor|288|||
161548893|NCT00406419|583399339|FG002|Overall Study|Study Terminated by Sponsor|282|||
161548894|NCT00406419|583399337|FG000|Overall Study|Withdrawal by Subject|17|||
161548895|NCT00406419|583399338|FG001|Overall Study|Withdrawal by Subject|24|||
161548896|NCT00406419|583399339|FG002|Overall Study|Withdrawal by Subject|26|||
161548897|NCT00406419|583399337|FG000|Overall Study|Lack of Efficacy|12|||
161548898|NCT00406419|583399338|FG001|Overall Study|Lack of Efficacy|1|||
161548899|NCT00406419|583399339|FG002|Overall Study|Lack of Efficacy|6|||
161548900|NCT00406419|583399337|FG000|Overall Study|Non-Compliance with Study Drug|5|||
161548901|NCT00406419|583399338|FG001|Overall Study|Non-Compliance with Study Drug|6|||
161548902|NCT00406419|583399339|FG002|Overall Study|Non-Compliance with Study Drug|3|||
161548903|NCT00406419|583399337|FG000|Overall Study|Adverse Event|10|||
161548904|NCT00406419|583399338|FG001|Overall Study|Adverse Event|12|||
161548905|NCT00406419|583399339|FG002|Overall Study|Adverse Event|16|||
161548906|NCT00406419|583399337|FG000|Overall Study|Lost to Follow-up|11|||
161548907|NCT00406419|583399338|FG001|Overall Study|Lost to Follow-up|10|||
161548908|NCT00406419|583399339|FG002|Overall Study|Lost to Follow-up|5|||
161548909|NCT01115491|583399342|FG000|Overall Study|Death|22|||
161548910|NCT01115491|583399342|FG000|Overall Study|Adverse Event|3|||
161548911|NCT01115491|583399342|FG000|Overall Study|Lost to Follow-up|3|||
161548912|NCT01115491|583399342|FG000|Overall Study|Withdrawal by Subject|1|||
161548913|NCT01115491|583399342|FG000|Overall Study|Physician Decision|1|||
161548914|NCT01461993|583399343|FG000|Overall Study|Withdrawal by Subject|60|||
161548915|NCT01461993|583399344|FG001|Overall Study|Withdrawal by Subject|53|||
161548916|NCT01461993|583399345|FG002|Overall Study|Withdrawal by Subject|16|||
161548917|NCT01461993|583399343|FG000|Overall Study|Lost to Follow-up|44|||
161548918|NCT01461993|583399344|FG001|Overall Study|Lost to Follow-up|48|||
161548919|NCT01461993|583399345|FG002|Overall Study|Lost to Follow-up|22|||
161548920|NCT01461993|583399343|FG000|Overall Study|Protocol Violation|10|||
161548921|NCT01461993|583399344|FG001|Overall Study|Protocol Violation|9|||
161548922|NCT01461993|583399345|FG002|Overall Study|Protocol Violation|7|||
161548923|NCT01461993|583399343|FG000|Overall Study|Adverse Event|9|||
161682511|NCT01987960|583888893|FG000|Period 1|Protocol Violation|12|||
161682512|NCT01987960|583888894|FG001|Period 1|Protocol Violation|0|||
161682513|NCT01987960|583888895|FG002|Period 1|Protocol Violation|0|||
161682514|NCT01987960|583888896|FG003|Period 1|Protocol Violation|0|||
161682515|NCT01987960|583888893|FG000|Period 1|Withdrawal by Subject|21|||
161682516|NCT01987960|583888894|FG001|Period 1|Withdrawal by Subject|0|||
161682517|NCT01987960|583888895|FG002|Period 1|Withdrawal by Subject|0|||
161682518|NCT01987960|583888896|FG003|Period 1|Withdrawal by Subject|0|||
161682519|NCT01987960|583888893|FG000|Period 1|Lost to Follow-up|40|||
161682520|NCT01987960|583888894|FG001|Period 1|Lost to Follow-up|0|||
161682521|NCT01987960|583888895|FG002|Period 1|Lost to Follow-up|0|||
161682522|NCT01987960|583888896|FG003|Period 1|Lost to Follow-up|0|||
161682523|NCT01987960|583888893|FG000|Period 1|administrative or other reason|75|||
161682524|NCT01987960|583888894|FG001|Period 1|administrative or other reason|0|||
161682525|NCT01987960|583888895|FG002|Period 1|administrative or other reason|0|||
161682526|NCT01987960|583888896|FG003|Period 1|administrative or other reason|0|||
161682527|NCT01987960|583888893|FG000|Period 1|Withdrawal of consent before treatment|4|||
161603124|NCT04108130|583601373|FG001|Overall Study|Surgery Cancelled|4|||
161603125|NCT04108130|583601372|FG000|Overall Study|Found Ineligible for Study|4|||
161603126|NCT04108130|583601373|FG001|Overall Study|Found Ineligible for Study|3|||
161603127|NCT04108130|583601372|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
161603128|NCT04108130|583601373|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
161603129|NCT04108130|583601372|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
161603130|NCT04108130|583601373|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
161603131|NCT04244175|583601374|FG000|Overall Study|Adverse Event|3|||
161603132|NCT04244175|583601375|FG001|Overall Study|Adverse Event|2|||
161603133|NCT04244175|583601376|FG002|Overall Study|Adverse Event|5|||
161603134|NCT04244175|583601374|FG000|Overall Study|Lack of Efficacy|1|||
161603135|NCT04244175|583601375|FG001|Overall Study|Lack of Efficacy|0|||
161603136|NCT04244175|583601376|FG002|Overall Study|Lack of Efficacy|1|||
161603137|NCT04244175|583601374|FG000|Overall Study|Lost to Follow-up|1|||
161603138|NCT04244175|583601375|FG001|Overall Study|Lost to Follow-up|0|||
161603139|NCT04244175|583601376|FG002|Overall Study|Lost to Follow-up|0|||
161603140|NCT04244175|583601374|FG000|Overall Study|Non-compliance with study drug|1|||
161603141|NCT04244175|583601375|FG001|Overall Study|Non-compliance with study drug|0|||
161603142|NCT04244175|583601376|FG002|Overall Study|Non-compliance with study drug|1|||
161603143|NCT04244175|583601374|FG000|Overall Study|Protocol deviation|0|||
161603144|NCT04244175|583601375|FG001|Overall Study|Protocol deviation|1|||
161603145|NCT04244175|583601376|FG002|Overall Study|Protocol deviation|0|||
161603146|NCT04244175|583601374|FG000|Overall Study|Withdrawal by Subject|1|||
161603147|NCT04244175|583601375|FG001|Overall Study|Withdrawal by Subject|3|||
161603148|NCT04244175|583601376|FG002|Overall Study|Withdrawal by Subject|1|||
161603149|NCT04244175|583601374|FG000|Overall Study|Other, not specified|0|||
161603150|NCT04244175|583601375|FG001|Overall Study|Other, not specified|1|||
161603151|NCT04244175|583601376|FG002|Overall Study|Other, not specified|2|||
161603152|NCT03417284|583601377|FG000|Overall Study|Inadequate supply on study drug|1|||
161603153|NCT03417284|583601378|FG001|Overall Study|Inadequate supply on study drug|0|||
161603154|NCT03417284|583601379|FG002|Overall Study|Inadequate supply on study drug|0|||
161603155|NCT03417284|583601380|FG003|Overall Study|Inadequate supply on study drug|0|||
161603156|NCT03417284|583601377|FG000|Overall Study|Disease Progression|0|||
161603157|NCT03417284|583601378|FG001|Overall Study|Disease Progression|0|||
161603158|NCT03417284|583601379|FG002|Overall Study|Disease Progression|1|||
161603159|NCT03417284|583601380|FG003|Overall Study|Disease Progression|0|||
161603160|NCT04089865|583601387|FG000|Overall Study|Withdrawal by Subject|2|||
161603161|NCT04089865|583601388|FG001|Overall Study|Withdrawal by Subject|2|||
161603162|NCT04089865|583601389|FG002|Overall Study|Withdrawal by Subject|7|||
161603163|NCT04089865|583601390|FG003|Overall Study|Withdrawal by Subject|2|||
161603164|NCT04282980|583601393|FG000|Overall Study|Remained on treatment|6|||
161682528|NCT01987960|583888894|FG001|Period 1|Withdrawal of consent before treatment|0|||
161603165|NCT04282980|583601393|FG000|Overall Study|Survival follow-up|11|||
161603166|NCT04282980|583601393|FG000|Overall Study|Withdrawal of informed consent|1|||
161603167|NCT04282980|583601393|FG000|Overall Study|Lost to Follow-up|1|||
161603168|NCT01917084|583601395|FG000|Overall Study|Withdrawal by Subject|1|||
161603169|NCT03571386|583601396|FG000|Overall Study|scheduling conflict|4|||
161603170|NCT03571386|583601397|FG001|Overall Study|scheduling conflict|0|||
161603171|NCT03571386|583601396|FG000|Overall Study|Withdrawal by Subject|15|||
161603172|NCT03571386|583601397|FG001|Overall Study|Withdrawal by Subject|5|||
161682529|NCT01987960|583888895|FG002|Period 1|Withdrawal of consent before treatment|0|||
161603173|NCT02909686|583601405|FG000|Overall Study|Physician Decision|3|||
161603174|NCT02909686|583601405|FG000|Overall Study|Withdrawal by Subject|2|||
161682530|NCT01987960|583888896|FG003|Period 1|Withdrawal of consent before treatment|0|||
161682531|NCT01987960|583888893|FG000|Period 2|Adverse Event|0|||
161682532|NCT01987960|583888894|FG001|Period 2|Adverse Event|0|||
161682533|NCT01987960|583888895|FG002|Period 2|Adverse Event|1|||
161682534|NCT01987960|583888896|FG003|Period 2|Adverse Event|0|||
161603175|NCT03858517|583601406|FG000|Overall Study|Adverse Event|1|||
161603176|NCT03858517|583601406|FG000|Overall Study|Lost to Follow-up|1|||
161603177|NCT03858517|583601406|FG000|Overall Study|removed for being incarcerated|1|||
161603178|NCT03858517|583601406|FG000|Overall Study|Sponsor Closure|48|||
161603179|NCT06037668|583601407|FG000|Overall Study|Lost to Follow-up|1|||
161603180|NCT06037668|583601408|FG001|Overall Study|Lost to Follow-up|1|||
161603181|NCT06037668|583601407|FG000|Overall Study|Protocol Violation|1|||
161603182|NCT06037668|583601408|FG001|Overall Study|Protocol Violation|0|||
161603183|NCT06037668|583601407|FG000|Overall Study|Withdrawal by Subject|1|||
161603184|NCT06037668|583601408|FG001|Overall Study|Withdrawal by Subject|0|||
161603185|NCT06037668|583601407|FG000|Overall Study|Other Study Discontinuation Reason|1|||
161603186|NCT06037668|583601408|FG001|Overall Study|Other Study Discontinuation Reason|0|||
161603187|NCT04804540|583601409|FG000|Overall Study|Adverse Event|26|||
161603188|NCT04804540|583601410|FG001|Overall Study|Adverse Event|13|||
161603189|NCT05172232|583601411|FG000|Overall Study|Lost to Follow-up|3|||
161603190|NCT02473445|583601412|FG000|Overall Study|Withdrawal by Subject|2|||
161603191|NCT02473445|583601412|FG000|Overall Study|Sponsor Decision|20|||
161603192|NCT04881461|583601413|FG000|Overall Study|Adverse Event|2|||
161603193|NCT04881461|583601414|FG001|Overall Study|Adverse Event|4|||
161603194|NCT04881461|583601413|FG000|Overall Study|Withdrawal by Subject|19|||
161831425|NCT04079712|584424736|FG000|Overall Study|Disease progression before starting treatment|1|||
161603195|NCT04881461|583601414|FG001|Overall Study|Withdrawal by Subject|19|||
161603196|NCT04881461|583601413|FG000|Overall Study|Lost to Follow-up|4|||
161603197|NCT04881461|583601414|FG001|Overall Study|Lost to Follow-up|4|||
161603198|NCT04881461|583601413|FG000|Overall Study|Lack of Efficacy|1|||
161603199|NCT04881461|583601414|FG001|Overall Study|Lack of Efficacy|0|||
161603200|NCT04881461|583601413|FG000|Overall Study|"Reason stated as other in CRF"|1|||
161603201|NCT04881461|583601414|FG001|Overall Study|"Reason stated as other in CRF"|2|||
161603202|NCT04629339|583601418|FG000|Overall Study|Death|1|||
161603203|NCT04629339|583601419|FG001|Overall Study|Death|0|||
161603204|NCT04629339|583601420|FG002|Overall Study|Death|2|||
161603205|NCT04629339|583601421|FG003|Overall Study|Death|2|||
161603206|NCT04629339|583601422|FG004|Overall Study|Death|0|||
161603207|NCT04629339|583601418|FG000|Overall Study|Disease Progression|0|||
161603208|NCT04629339|583601419|FG001|Overall Study|Disease Progression|0|||
161603209|NCT04629339|583601420|FG002|Overall Study|Disease Progression|1|||
161603210|NCT04629339|583601421|FG003|Overall Study|Disease Progression|1|||
161603211|NCT04629339|583601422|FG004|Overall Study|Disease Progression|0|||
161603212|NCT04629339|583601418|FG000|Overall Study|Lost to Follow-up|0|||
161603213|NCT04629339|583601419|FG001|Overall Study|Lost to Follow-up|0|||
161603214|NCT04629339|583601420|FG002|Overall Study|Lost to Follow-up|0|||
161603215|NCT04629339|583601421|FG003|Overall Study|Lost to Follow-up|1|||
161603216|NCT04629339|583601422|FG004|Overall Study|Lost to Follow-up|0|||
161603217|NCT04629339|583601418|FG000|Overall Study|Physician Decision|0|||
161603218|NCT04629339|583601419|FG001|Overall Study|Physician Decision|1|||
161603219|NCT04629339|583601420|FG002|Overall Study|Physician Decision|0|||
161603220|NCT04629339|583601421|FG003|Overall Study|Physician Decision|0|||
161603221|NCT04629339|583601422|FG004|Overall Study|Physician Decision|0|||
161831426|NCT01467479|584424742|FG000|Overall Study|No Study Medication|1|||
161831427|NCT01467479|584424743|FG001|Overall Study|No Study Medication|0|||
161548924|NCT01461993|583399344|FG001|Overall Study|Adverse Event|11|||
161548925|NCT01461993|583399345|FG002|Overall Study|Adverse Event|3|||
161548926|NCT01461993|583399343|FG000|Overall Study|No longer met eligibility criteria|13|||
161548927|NCT01461993|583399344|FG001|Overall Study|No longer met eligibility criteria|18|||
161548928|NCT01461993|583399345|FG002|Overall Study|No longer met eligibility criteria|10|||
161548929|NCT01461993|583399343|FG000|Overall Study|Did not meet entrance criteria|2|||
161548930|NCT01461993|583399344|FG001|Overall Study|Did not meet entrance criteria|3|||
161548931|NCT01461993|583399345|FG002|Overall Study|Did not meet entrance criteria|0|||
161548932|NCT01461993|583399343|FG000|Overall Study|Other|13|||
161548933|NCT01461993|583399344|FG001|Overall Study|Other|15|||
161548934|NCT01461993|583399345|FG002|Overall Study|Other|6|||
161548935|NCT01821898|583399347|FG000|Overall Study|Withdrawal by Subject|2|||
161548936|NCT01821898|583399348|FG001|Overall Study|Withdrawal by Subject|1|||
161548937|NCT01121484|583399349|FG000|Overall Study|Adverse Event|12|||
161548938|NCT01121484|583399350|FG001|Overall Study|Adverse Event|5|||
161548939|NCT01121484|583399349|FG000|Overall Study|Lack of Efficacy|3|||
161548940|NCT01121484|583399350|FG001|Overall Study|Lack of Efficacy|11|||
161548941|NCT01121484|583399349|FG000|Overall Study|Lost to Follow-up|5|||
161548942|NCT01121484|583399350|FG001|Overall Study|Lost to Follow-up|9|||
161548943|NCT01121484|583399349|FG000|Overall Study|Physician Decision|0|||
161548944|NCT01121484|583399350|FG001|Overall Study|Physician Decision|3|||
161548945|NCT01121484|583399349|FG000|Overall Study|Protocol Violation|1|||
161548946|NCT01121484|583399350|FG001|Overall Study|Protocol Violation|0|||
161548947|NCT01121484|583399349|FG000|Overall Study|Withdrawal by Subject|8|||
161548948|NCT01121484|583399350|FG001|Overall Study|Withdrawal by Subject|7|||
161548949|NCT01121484|583399349|FG000|Overall Study|Discontinuation of study by sponsor|0|||
161548950|NCT01121484|583399350|FG001|Overall Study|Discontinuation of study by sponsor|1|||
161548951|NCT01121484|583399349|FG000|Overall Study|Other|3|||
161548952|NCT01121484|583399350|FG001|Overall Study|Other|3|||
161548953|NCT01121484|583399349|FG000|Overall Study|Randomized, not treated|1|||
161548954|NCT01121484|583399350|FG001|Overall Study|Randomized, not treated|4|||
161548955|NCT06390826|583399353|FG000|Overall Study|Never Start Protocol Therapy|1|||
161548956|NCT06390826|583399353|FG000|Overall Study|Adverse Event|1|||
161548957|NCT06390826|583399353|FG000|Overall Study|Disease Progression|8|||
161548958|NCT03915951|583399354|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
161548959|NCT03915951|583399355|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
161548960|NCT03915951|583399354|FG000|Overall Study|Adverse Event|12|||
161548961|NCT03915951|583399355|FG001|Overall Study|Adverse Event|6|||
161548962|NCT03915951|583399354|FG000|Overall Study|Disease progression (radiological)|17|||
161548963|NCT03915951|583399355|FG001|Overall Study|Disease progression (radiological)|15|||
161548964|NCT03915951|583399354|FG000|Overall Study|Disease progression (clinical)|4|||
161548965|NCT03915951|583399355|FG001|Overall Study|Disease progression (clinical)|1|||
161548966|NCT03915951|583399354|FG000|Overall Study|Patient decision|0|||
161548967|NCT03915951|583399355|FG001|Overall Study|Patient decision|4|||
161548968|NCT03915951|583399354|FG000|Overall Study|Investigator decision|0|||
161548969|NCT03915951|583399355|FG001|Overall Study|Investigator decision|1|||
161548970|NCT03915951|583399354|FG000|Overall Study|Consent withdrawn|1|||
161548971|NCT03915951|583399355|FG001|Overall Study|Consent withdrawn|1|||
161548972|NCT03915951|583399354|FG000|Overall Study|Death|0|||
161548973|NCT03915951|583399355|FG001|Overall Study|Death|3|||
161548974|NCT05408468|583399356|FG000|Overall Study|Lost to Follow-up|3|||
161548975|NCT05408468|583399357|FG001|Overall Study|Lost to Follow-up|1|||
161548976|NCT05408468|583399356|FG000|Overall Study|Physician Decision|1|||
161548977|NCT05408468|583399357|FG001|Overall Study|Physician Decision|0|||
161548978|NCT05408468|583399356|FG000|Overall Study|Overwhelmed by clinical situation|3|||
161548979|NCT05408468|583399357|FG001|Overall Study|Overwhelmed by clinical situation|0|||
161548980|NCT05408468|583399356|FG000|Overall Study|Personal illness precluding participation|1|||
161548981|NCT05408468|583399357|FG001|Overall Study|Personal illness precluding participation|0|||
161548982|NCT05408468|583399356|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
161548983|NCT05408468|583399357|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
161548984|NCT02204579|583399362|FG000|Overall Study|Screen failures|2|||
161548985|NCT01396395|583399363|FG000|Overall Study|Withdrawal by Subject|10|||
161548986|NCT01396395|583399364|FG001|Overall Study|Withdrawal by Subject|12|||
161548987|NCT01396395|583399363|FG000|Overall Study|Protocol Violation|3|||
161548988|NCT01396395|583399364|FG001|Overall Study|Protocol Violation|1|||
161548989|NCT01396395|583399363|FG000|Overall Study|Adverse Event|10|||
161548990|NCT01396395|583399364|FG001|Overall Study|Adverse Event|2|||
161548991|NCT01396395|583399363|FG000|Overall Study|Lost to Follow-up|17|||
161548992|NCT01396395|583399364|FG001|Overall Study|Lost to Follow-up|11|||
161548993|NCT01396395|583399363|FG000|Overall Study|Other|0|||
161548994|NCT01396395|583399364|FG001|Overall Study|Other|1|||
161548995|NCT02120664|583399365|FG000|Overall Study|Withdrawal by Subject|0|||
161548996|NCT02120664|583399366|FG001|Overall Study|Withdrawal by Subject|0|||
161682535|NCT01987960|583888893|FG000|Period 2|Withdrawal by Subject|0|||
161603222|NCT04629339|583601418|FG000|Overall Study|Study Terminated by Sponsor|0|||
161603223|NCT04629339|583601419|FG001|Overall Study|Study Terminated by Sponsor|0|||
161603224|NCT04629339|583601420|FG002|Overall Study|Study Terminated by Sponsor|0|||
161603225|NCT04629339|583601421|FG003|Overall Study|Study Terminated by Sponsor|1|||
161603226|NCT04629339|583601422|FG004|Overall Study|Study Terminated by Sponsor|0|||
161603227|NCT04629339|583601418|FG000|Overall Study|Withdrawal by Subject|0|||
161603228|NCT04629339|583601419|FG001|Overall Study|Withdrawal by Subject|0|||
161603229|NCT04629339|583601420|FG002|Overall Study|Withdrawal by Subject|2|||
161603230|NCT04629339|583601421|FG003|Overall Study|Withdrawal by Subject|2|||
161603231|NCT04629339|583601422|FG004|Overall Study|Withdrawal by Subject|0|||
161603232|NCT04158739|583601425|FG000|Overall Study|Adverse Event|1|||
161603233|NCT04158739|583601426|FG001|Overall Study|Adverse Event|0|||
161603234|NCT04158739|583601425|FG000|Overall Study|Death|0|||
161603235|NCT04158739|583601426|FG001|Overall Study|Death|1|||
161603236|NCT04158739|583601425|FG000|Overall Study|Lack of Efficacy|3|||
161603237|NCT04158739|583601426|FG001|Overall Study|Lack of Efficacy|7|||
161603238|NCT04158739|583601425|FG000|Overall Study|Physician Decision|0|||
161603239|NCT04158739|583601426|FG001|Overall Study|Physician Decision|1|||
161603240|NCT04158739|583601425|FG000|Overall Study|Withdrawal by Subject|3|||
161603241|NCT04158739|583601426|FG001|Overall Study|Withdrawal by Subject|0|||
161603242|NCT04778410|583601427|FG000|Safety Run-in Period|Death|5|||
161603243|NCT04778410|583601428|FG001|Safety Run-in Period|Death|6|||
161603244|NCT04778410|583601429|FG002|Safety Run-in Period|Death|0|||
161603245|NCT04778410|583601430|FG003|Safety Run-in Period|Death|0|||
161603246|NCT04778410|583601431|FG004|Safety Run-in Period|Death|0|||
161603247|NCT04778410|583601432|FG005|Safety Run-in Period|Death|0|||
161603248|NCT04778410|583601427|FG000|Phase 2 Period|Death|0|||
161603249|NCT04778410|583601428|FG001|Phase 2 Period|Death|0|||
161603250|NCT04778410|583601429|FG002|Phase 2 Period|Death|0|||
161603251|NCT04778410|583601430|FG003|Phase 2 Period|Death|5|||
161603252|NCT04778410|583601431|FG004|Phase 2 Period|Death|18|||
161603253|NCT04778410|583601432|FG005|Phase 2 Period|Death|0|||
161603254|NCT04778410|583601427|FG000|Phase 2 Period|Lost to Follow-up|0|||
161603255|NCT04778410|583601428|FG001|Phase 2 Period|Lost to Follow-up|0|||
161603256|NCT04778410|583601429|FG002|Phase 2 Period|Lost to Follow-up|0|||
161603257|NCT04778410|583601430|FG003|Phase 2 Period|Lost to Follow-up|1|||
161603258|NCT04778410|583601431|FG004|Phase 2 Period|Lost to Follow-up|1|||
161603259|NCT04778410|583601432|FG005|Phase 2 Period|Lost to Follow-up|0|||
161603260|NCT04778410|583601427|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
161603261|NCT04778410|583601428|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
161603262|NCT04778410|583601429|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
161603263|NCT04778410|583601430|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
161603264|NCT04778410|583601431|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
161603265|NCT04778410|583601432|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
161603266|NCT04778410|583601427|FG000|Phase 2 Period|Withdrew Consent|0|||
161603267|NCT04778410|583601428|FG001|Phase 2 Period|Withdrew Consent|0|||
161603268|NCT04778410|583601429|FG002|Phase 2 Period|Withdrew Consent|0|||
161603269|NCT04778410|583601430|FG003|Phase 2 Period|Withdrew Consent|0|||
161603270|NCT04778410|583601431|FG004|Phase 2 Period|Withdrew Consent|2|||
161603271|NCT04778410|583601432|FG005|Phase 2 Period|Withdrew Consent|0|||
161603272|NCT05422885|583601439|FG000|Overall Study|Lost to Follow-up|1|||
161603273|NCT05422885|583601439|FG000|Overall Study|Withdrawal by Subject|2|||
161603274|NCT04084574|583601440|FG000|Overall Study|Lost to Follow-up|1|||
161603275|NCT04084574|583601441|FG001|Overall Study|Lost to Follow-up|0|||
161603276|NCT04084574|583601440|FG000|Overall Study|Physician Decision|1|||
161603277|NCT04084574|583601441|FG001|Overall Study|Physician Decision|0|||
161603278|NCT04084574|583601440|FG000|Overall Study|Relocated out of state|1|||
161603279|NCT04084574|583601441|FG001|Overall Study|Relocated out of state|0|||
161603280|NCT00942877|583601442|FG000|Overall Study|Refused further treatment|1|||
161603281|NCT00942877|583601443|FG001|Overall Study|Refused further treatment|1|||
161603282|NCT00942877|583601442|FG000|Overall Study|Patient was not treated|1|||
161603283|NCT00942877|583601443|FG001|Overall Study|Patient was not treated|0|||
161603284|NCT00942877|583601442|FG000|Overall Study|Adverse Event|1|||
161603285|NCT00942877|583601443|FG001|Overall Study|Adverse Event|0|||
161603286|NCT00942877|583601442|FG000|Overall Study|Progressive disease|42|||
161603287|NCT00942877|583601443|FG001|Overall Study|Progressive disease|3|||
161603288|NCT03681262|583601446|FG000|Overall Study|Continuing on study|3|||
161603289|NCT03681262|583601447|FG001|Overall Study|Continuing on study|3|||
161603290|NCT03681262|583601446|FG000|Overall Study|Lost to Follow-up|1|||
161603291|NCT03681262|583601447|FG001|Overall Study|Lost to Follow-up|0|||
161603292|NCT00887198|583601448|FG000|Randomized Period|Ongoing|42|||
161603293|NCT00887198|583601449|FG001|Randomized Period|Ongoing|0|||
161603294|NCT00887198|583601450|FG002|Randomized Period|Ongoing|0|||
161603295|NCT00887198|583601448|FG000|Randomized Period|Adverse Event|50|||
161603296|NCT00887198|583601449|FG001|Randomized Period|Adverse Event|33|||
161603297|NCT00887198|583601450|FG002|Randomized Period|Adverse Event|0|||
161603298|NCT00887198|583601448|FG000|Randomized Period|Lost to Follow-up|1|||
161603299|NCT00887198|583601449|FG001|Randomized Period|Lost to Follow-up|0|||
161603300|NCT00887198|583601450|FG002|Randomized Period|Lost to Follow-up|0|||
161682536|NCT01987960|583888894|FG001|Period 2|Withdrawal by Subject|0|||
161682537|NCT01987960|583888895|FG002|Period 2|Withdrawal by Subject|1|||
161682538|NCT01987960|583888896|FG003|Period 2|Withdrawal by Subject|0|||
161682539|NCT01987960|583888893|FG000|Period 2|Administrative or other reason|0|||
161682540|NCT01987960|583888894|FG001|Period 2|Administrative or other reason|5|||
161682541|NCT01987960|583888895|FG002|Period 2|Administrative or other reason|7|||
161682542|NCT01987960|583888896|FG003|Period 2|Administrative or other reason|0|||
161682543|NCT01987960|583888893|FG000|Period 3|Adverse Event|0|||
161682544|NCT01987960|583888894|FG001|Period 3|Adverse Event|0|||
161682545|NCT01987960|583888895|FG002|Period 3|Adverse Event|0|||
161682546|NCT01987960|583888896|FG003|Period 3|Adverse Event|7|||
161682547|NCT01987960|583888893|FG000|Period 3|Non-compliance with IMP|0|||
161682548|NCT01987960|583888894|FG001|Period 3|Non-compliance with IMP|0|||
161682549|NCT01987960|583888895|FG002|Period 3|Non-compliance with IMP|0|||
161682550|NCT01987960|583888896|FG003|Period 3|Non-compliance with IMP|1|||
161682551|NCT01987960|583888893|FG000|Period 3|Protocol Violation|0|||
161682552|NCT01987960|583888894|FG001|Period 3|Protocol Violation|0|||
161682553|NCT01987960|583888895|FG002|Period 3|Protocol Violation|0|||
161682554|NCT01987960|583888896|FG003|Period 3|Protocol Violation|6|||
161682555|NCT01987960|583888893|FG000|Period 3|Withdrawal by Subject|0|||
161682556|NCT01987960|583888894|FG001|Period 3|Withdrawal by Subject|0|||
161682557|NCT01987960|583888895|FG002|Period 3|Withdrawal by Subject|0|||
161603301|NCT00887198|583601448|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
161603302|NCT00887198|583601449|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
161603303|NCT00887198|583601450|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
161603304|NCT00887198|583601448|FG000|Randomized Period|Withdrawal by Subject|41|||
161603305|NCT00887198|583601449|FG001|Randomized Period|Withdrawal by Subject|56|||
161603306|NCT00887198|583601450|FG002|Randomized Period|Withdrawal by Subject|0|||
161603307|NCT00887198|583601448|FG000|Randomized Period|Progressive disease|366|||
161603308|NCT00887198|583601449|FG001|Randomized Period|Progressive disease|370|||
161603309|NCT00887198|583601450|FG002|Randomized Period|Progressive disease|0|||
161603310|NCT00887198|583601448|FG000|Randomized Period|Other|42|||
161603311|NCT00887198|583601449|FG001|Randomized Period|Other|30|||
161603312|NCT00887198|583601450|FG002|Randomized Period|Other|0|||
161603313|NCT00887198|583601448|FG000|Randomized Period|Randomized, Not treated|4|||
161603314|NCT00887198|583601449|FG001|Randomized Period|Randomized, Not treated|2|||
161603315|NCT00887198|583601450|FG002|Randomized Period|Randomized, Not treated|0|||
161603316|NCT00887198|583601448|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
161682558|NCT01987960|583888896|FG003|Period 3|Withdrawal by Subject|9|||
161682559|NCT01987960|583888893|FG000|Period 3|Lost to Follow-up|0|||
161682560|NCT01987960|583888894|FG001|Period 3|Lost to Follow-up|0|||
161682561|NCT01987960|583888895|FG002|Period 3|Lost to Follow-up|0|||
161682562|NCT01987960|583888896|FG003|Period 3|Lost to Follow-up|5|||
161682563|NCT01987960|583888893|FG000|Period 3|Administrative or other reason|0|||
161682564|NCT01987960|583888894|FG001|Period 3|Administrative or other reason|0|||
161682565|NCT01987960|583888895|FG002|Period 3|Administrative or other reason|0|||
161682566|NCT01987960|583888896|FG003|Period 3|Administrative or other reason|43|||
161682567|NCT00789880|583888898|FG000|Overall Study|Adverse Event|0|||
161682568|NCT00789880|583888899|FG001|Overall Study|Adverse Event|0|||
161682569|NCT00789880|583888900|FG002|Overall Study|Adverse Event|0|||
161682570|NCT00789880|583888901|FG003|Overall Study|Adverse Event|0|||
161682571|NCT00789880|583888902|FG004|Overall Study|Adverse Event|1|||
161682572|NCT00789880|583888903|FG005|Overall Study|Adverse Event|0|||
161682573|NCT00789880|583888898|FG000|Overall Study|Protocol Violation|0|||
161682574|NCT00789880|583888899|FG001|Overall Study|Protocol Violation|1|||
161682575|NCT00789880|583888900|FG002|Overall Study|Protocol Violation|0|||
161682576|NCT00789880|583888901|FG003|Overall Study|Protocol Violation|1|||
161682577|NCT00789880|583888902|FG004|Overall Study|Protocol Violation|0|||
161682578|NCT00789880|583888903|FG005|Overall Study|Protocol Violation|0|||
161682579|NCT00789880|583888898|FG000|Overall Study|Withdrawal by Subject|1|||
161682580|NCT00789880|583888899|FG001|Overall Study|Withdrawal by Subject|0|||
161682581|NCT00789880|583888900|FG002|Overall Study|Withdrawal by Subject|0|||
161682582|NCT00789880|583888901|FG003|Overall Study|Withdrawal by Subject|0|||
161682583|NCT00789880|583888902|FG004|Overall Study|Withdrawal by Subject|2|||
161831428|NCT01467479|584424744|FG002|Overall Study|No Study Medication|2|||
161682584|NCT00789880|583888903|FG005|Overall Study|Withdrawal by Subject|0|||
161682585|NCT01177683|583888904|FG000|Study Treatment|Disease Progressions during treatment|2|||
161682586|NCT01177683|583888905|FG001|Study Treatment|Disease Progressions during treatment|0|||
161831429|NCT01467479|584424742|FG000|Overall Study|Adverse Event|1|||
161603317|NCT00887198|583601449|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
161682587|NCT01177683|583888906|FG002|Study Treatment|Disease Progressions during treatment|3|||
161682588|NCT01177683|583888904|FG000|Study Treatment|Adverse Event|0|||
161682589|NCT01177683|583888905|FG001|Study Treatment|Adverse Event|1|||
161682590|NCT01177683|583888906|FG002|Study Treatment|Adverse Event|12|||
161831430|NCT01467479|584424743|FG001|Overall Study|Adverse Event|2|||
161603318|NCT00887198|583601450|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
161603319|NCT00887198|583601448|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
161682591|NCT01177683|583888904|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161682592|NCT01177683|583888905|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
161682593|NCT01177683|583888906|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161682594|NCT01177683|583888904|FG000|Study Treatment|Alternative therapy|0|||
161682595|NCT01177683|583888905|FG001|Study Treatment|Alternative therapy|0|||
161682596|NCT01177683|583888906|FG002|Study Treatment|Alternative therapy|4|||
161682597|NCT01177683|583888904|FG000|Study Treatment|Physician Decision|1|||
161682598|NCT01177683|583888905|FG001|Study Treatment|Physician Decision|0|||
161682599|NCT01177683|583888906|FG002|Study Treatment|Physician Decision|1|||
161682600|NCT01177683|583888904|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
161682601|NCT01177683|583888905|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
161682602|NCT01177683|583888906|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
161682603|NCT01177683|583888904|FG000|Study Treatment|Symptomatic Deterioration|0|||
161682604|NCT01177683|583888905|FG001|Study Treatment|Symptomatic Deterioration|0|||
161682605|NCT01177683|583888906|FG002|Study Treatment|Symptomatic Deterioration|1|||
161682606|NCT01177683|583888904|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
161682607|NCT01177683|583888905|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
161682608|NCT01177683|583888906|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
161682609|NCT01177683|583888904|FG000|Follow up|Patient lost to follow up|0|||
161682610|NCT01177683|583888905|FG001|Follow up|Patient lost to follow up|0|||
161682611|NCT01177683|583888906|FG002|Follow up|Patient lost to follow up|2|||
161682612|NCT01177683|583888904|FG000|Follow up|Death|2|||
161682613|NCT01177683|583888905|FG001|Follow up|Death|1|||
161682614|NCT01177683|583888906|FG002|Follow up|Death|7|||
161682615|NCT01177683|583888904|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
161682616|NCT01177683|583888905|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
161682617|NCT01177683|583888906|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
161682618|NCT06347731|583888907|FG000|Overall Study|Death|1|||
161682619|NCT06347731|583888907|FG000|Overall Study|Protocol Violation|1|||
161682620|NCT06347731|583888907|FG000|Overall Study|Withdrawal by Subject|2|||
161682621|NCT00609986|583888911|FG000|Overall Study|Did not receive transplant or treatment|8|||
161682622|NCT00609986|583888912|FG001|Overall Study|Did not receive transplant or treatment|3|||
161682623|NCT03159091|583888913|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
161682624|NCT03159091|583888914|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
161682625|NCT03159091|583888913|FG000|Overall Study|Patient has taken no dose of study drug|0|||
161682626|NCT03159091|583888914|FG001|Overall Study|Patient has taken no dose of study drug|1|||
161682627|NCT05678257|583888915|FG000|Overall Study|Withdrawal by Subject|2|||
161682628|NCT05678257|583888916|FG001|Overall Study|Withdrawal by Subject|0|||
161682629|NCT05678257|583888917|FG002|Overall Study|Withdrawal by Subject|5|||
161682630|NCT05678257|583888915|FG000|Overall Study|Physician Decision|1|||
161682631|NCT05678257|583888916|FG001|Overall Study|Physician Decision|0|||
161682632|NCT05678257|583888917|FG002|Overall Study|Physician Decision|1|||
161682633|NCT05678257|583888915|FG000|Overall Study|Adverse Event|1|||
161682634|NCT05678257|583888916|FG001|Overall Study|Adverse Event|3|||
161682635|NCT05678257|583888917|FG002|Overall Study|Adverse Event|1|||
161682636|NCT05678257|583888915|FG000|Overall Study|Progressive disease|11|||
161682637|NCT05678257|583888916|FG001|Overall Study|Progressive disease|18|||
161682638|NCT05678257|583888917|FG002|Overall Study|Progressive disease|7|||
161682639|NCT05678257|583888915|FG000|Overall Study|No longer clinically benefitting|2|||
161682640|NCT05678257|583888916|FG001|Overall Study|No longer clinically benefitting|1|||
161682641|NCT05678257|583888917|FG002|Overall Study|No longer clinically benefitting|0|||
161682642|NCT05678257|583888915|FG000|Overall Study|Sponsor decision|5|||
161682643|NCT05678257|583888916|FG001|Overall Study|Sponsor decision|9|||
161682644|NCT05678257|583888917|FG002|Overall Study|Sponsor decision|8|||
161682645|NCT05678257|583888915|FG000|Overall Study|Protocol Violation|0|||
161603320|NCT00887198|583601449|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
161603321|NCT00887198|583601450|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
161603322|NCT00887198|583601448|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
161603323|NCT00887198|583601449|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
161603324|NCT00887198|583601450|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
161603325|NCT00887198|583601448|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
161603326|NCT00887198|583601449|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
161603327|NCT00887198|583601450|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
161603328|NCT00887198|583601448|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
161682646|NCT05678257|583888916|FG001|Overall Study|Protocol Violation|0|||
161682647|NCT05678257|583888917|FG002|Overall Study|Protocol Violation|1|||
161682648|NCT05678257|583888915|FG000|Overall Study|Patient non-compliance|0|||
161831431|NCT01467479|584424744|FG002|Overall Study|Adverse Event|0|||
161603329|NCT00887198|583601449|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
161682649|NCT05678257|583888916|FG001|Overall Study|Patient non-compliance|0|||
161682650|NCT05678257|583888917|FG002|Overall Study|Patient non-compliance|3|||
161682651|NCT02046096|583888918|FG000|Overall Study|Death|28|||
161682652|NCT02046096|583888919|FG001|Overall Study|Death|45|||
161682653|NCT02046096|583888918|FG000|Overall Study|Lost to Follow-up|9|||
161682654|NCT02046096|583888919|FG001|Overall Study|Lost to Follow-up|20|||
161682655|NCT02046096|583888918|FG000|Overall Study|Withdrawal by Subject|5|||
161682656|NCT02046096|583888919|FG001|Overall Study|Withdrawal by Subject|17|||
161682657|NCT02046096|583888918|FG000|Overall Study|Other endpoint|2|||
161682658|NCT02046096|583888919|FG001|Overall Study|Other endpoint|19|||
161682659|NCT03520959|583888920|FG000|Overall Study|Study terminated by Sponsor|0|||
161682660|NCT03520959|583888921|FG001|Overall Study|Study terminated by Sponsor|1|||
161682661|NCT04969276|583888923|FG000|Overall Study|Protocol Deviation|0|||
161682662|NCT04969276|583888924|FG001|Overall Study|Protocol Deviation|1|||
161682663|NCT04969276|583888925|FG002|Overall Study|Protocol Deviation|0|||
161682664|NCT04969276|583888923|FG000|Overall Study|Withdrawal by Subject|1|||
161682665|NCT04969276|583888924|FG001|Overall Study|Withdrawal by Subject|10|||
161682666|NCT04969276|583888925|FG002|Overall Study|Withdrawal by Subject|0|||
161682667|NCT04969276|583888923|FG000|Overall Study|Lost to Follow-up|0|||
161682668|NCT04969276|583888924|FG001|Overall Study|Lost to Follow-up|1|||
161682669|NCT04969276|583888925|FG002|Overall Study|Lost to Follow-up|0|||
161682670|NCT00943579|583888928|FG000|Overall Study|Adverse Event|4|||
161682671|NCT00943579|583888929|FG001|Overall Study|Adverse Event|3|||
161682672|NCT00943579|583888928|FG000|Overall Study|Lack of Efficacy|2|||
161682673|NCT00943579|583888929|FG001|Overall Study|Lack of Efficacy|2|||
161682674|NCT00418665|583888932|FG000|Treatment Period|Ineligibility determined|1|||
161682675|NCT00418665|583888933|FG001|Treatment Period|Ineligibility determined|1|||
161682676|NCT00418665|583888934|FG002|Treatment Period|Ineligibility determined|0|||
161682677|NCT00418665|583888932|FG000|Treatment Period|Adverse Event|2|||
161682678|NCT00418665|583888933|FG001|Treatment Period|Adverse Event|2|||
161682679|NCT00418665|583888934|FG002|Treatment Period|Adverse Event|0|||
161682680|NCT00418665|583888932|FG000|Treatment Period|Withdrawal by Subject|0|||
161682681|NCT00418665|583888933|FG001|Treatment Period|Withdrawal by Subject|3|||
161682682|NCT00418665|583888934|FG002|Treatment Period|Withdrawal by Subject|1|||
161682683|NCT00418665|583888932|FG000|Treatment Period|Requirement for alternative therapy|1|||
161603330|NCT00887198|583601450|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
161603331|NCT00887198|583601448|FG000|Cross Over (Placebo to AA)|Other|0|||
161603332|NCT00887198|583601449|FG001|Cross Over (Placebo to AA)|Other|0|||
161603333|NCT00887198|583601450|FG002|Cross Over (Placebo to AA)|Other|19|||
161603334|NCT02782676|583601451|FG000|Overall Study|Lost to Follow-up|0|||
161603335|NCT02782676|583601452|FG001|Overall Study|Lost to Follow-up|1|||
161603336|NCT05007080|583601453|FG000|Overall Study|Lost to Follow-up|0|||
161603337|NCT05007080|583601454|FG001|Overall Study|Lost to Follow-up|1|||
161603338|NCT05007080|583601455|FG002|Overall Study|Lost to Follow-up|0|||
161603339|NCT05007080|583601456|FG003|Overall Study|Lost to Follow-up|1|||
161603340|NCT05007080|583601457|FG004|Overall Study|Lost to Follow-up|1|||
161603341|NCT05007080|583601458|FG005|Overall Study|Lost to Follow-up|1|||
161603342|NCT05007080|583601453|FG000|Overall Study|Death|0|||
161603343|NCT05007080|583601454|FG001|Overall Study|Death|1|||
161603344|NCT05007080|583601455|FG002|Overall Study|Death|0|||
161603345|NCT05007080|583601456|FG003|Overall Study|Death|0|||
161603346|NCT05007080|583601457|FG004|Overall Study|Death|0|||
161603347|NCT05007080|583601458|FG005|Overall Study|Death|0|||
161603348|NCT05007080|583601453|FG000|Overall Study|Withdrawal by Subject|1|||
161603349|NCT05007080|583601454|FG001|Overall Study|Withdrawal by Subject|2|||
161603350|NCT05007080|583601455|FG002|Overall Study|Withdrawal by Subject|0|||
161603351|NCT05007080|583601456|FG003|Overall Study|Withdrawal by Subject|2|||
161603352|NCT05007080|583601457|FG004|Overall Study|Withdrawal by Subject|1|||
161603353|NCT05007080|583601458|FG005|Overall Study|Withdrawal by Subject|1|||
161603354|NCT05007080|583601453|FG000|Overall Study|Other|1|||
161603355|NCT05007080|583601454|FG001|Overall Study|Other|0|||
161682684|NCT00418665|583888933|FG001|Treatment Period|Requirement for alternative therapy|0|||
161603356|NCT05007080|583601455|FG002|Overall Study|Other|1|||
161682685|NCT00418665|583888934|FG002|Treatment Period|Requirement for alternative therapy|0|||
161603357|NCT05007080|583601456|FG003|Overall Study|Other|1|||
161603358|NCT05007080|583601457|FG004|Overall Study|Other|0|||
161603359|NCT05007080|583601458|FG005|Overall Study|Other|2|||
161603360|NCT05007080|583601453|FG000|Overall Study|Randomized not vaccinated|0|||
161603361|NCT05007080|583601454|FG001|Overall Study|Randomized not vaccinated|0|||
161682686|NCT00418665|583888932|FG000|Treatment Period|Physician Decision|1|||
161682687|NCT00418665|583888933|FG001|Treatment Period|Physician Decision|0|||
161682688|NCT00418665|583888934|FG002|Treatment Period|Physician Decision|3|||
161603362|NCT05007080|583601455|FG002|Overall Study|Randomized not vaccinated|0|||
161603363|NCT05007080|583601456|FG003|Overall Study|Randomized not vaccinated|0|||
161603364|NCT05007080|583601457|FG004|Overall Study|Randomized not vaccinated|0|||
161603365|NCT05007080|583601458|FG005|Overall Study|Randomized not vaccinated|1|||
161603366|NCT04583280|583601462|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
161603367|NCT04583280|583601463|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
161603368|NCT00964392|583601464|FG000|Overall Study|Withdrawal by Subject|4|||
161603369|NCT00964392|583601465|FG001|Overall Study|Withdrawal by Subject|6|||
161603370|NCT00964392|583601464|FG000|Overall Study|Lost to Follow-up|4|||
161603371|NCT00964392|583601465|FG001|Overall Study|Lost to Follow-up|10|||
161603372|NCT00964392|583601464|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
161603373|NCT00964392|583601465|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
161603374|NCT00964392|583601464|FG000|Overall Study|Not completed|44|||
161603375|NCT00964392|583601465|FG001|Overall Study|Not completed|168|||
161603376|NCT00631475|583601466|FG000|Overall Study|Death|18|||
161603377|NCT00631475|583601466|FG000|Overall Study|Adverse Event|14|||
161603378|NCT00631475|583601466|FG000|Overall Study|Withdrew consent|5|||
161603379|NCT00631475|583601466|FG000|Overall Study|Preparation for lung transplant|8|||
161603380|NCT04173247|583601470|FG000|Overall Study|Withdrawal by Subject|0|||
161603381|NCT04173247|583601471|FG001|Overall Study|Withdrawal by Subject|2|||
161603382|NCT04173247|583601470|FG000|Overall Study|Death|1|||
161603383|NCT04173247|583601471|FG001|Overall Study|Death|0|||
161603384|NCT04173247|583601470|FG000|Overall Study|Physician Decision|1|||
161603385|NCT04173247|583601471|FG001|Overall Study|Physician Decision|0|||
161603386|NCT04214834|583601479|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
161603387|NCT04214834|583601480|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
161603388|NCT04109066|583601485|FG000|Pre-treatment|Participant withdrew consent|2|||
161603389|NCT04109066|583601486|FG001|Pre-treatment|Participant withdrew consent|0|||
161603390|NCT04109066|583601485|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
161603391|NCT04109066|583601486|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
161603392|NCT04109066|583601485|FG000|Treatment|Lack of Efficacy|2|||
161603393|NCT04109066|583601486|FG001|Treatment|Lack of Efficacy|4|||
161603394|NCT04109066|583601485|FG000|Treatment|Adverse Event|23|||
161603395|NCT04109066|583601486|FG001|Treatment|Adverse Event|7|||
161603396|NCT04109066|583601485|FG000|Treatment|Participant request to discontinue Study treatment|15|||
161603397|NCT04109066|583601486|FG001|Treatment|Participant request to discontinue Study treatment|14|||
161603398|NCT04109066|583601485|FG000|Treatment|Withdrawal by Subject|8|||
161603399|NCT04109066|583601486|FG001|Treatment|Withdrawal by Subject|8|||
161603400|NCT04109066|583601485|FG000|Treatment|Death|3|||
161603401|NCT04109066|583601486|FG001|Treatment|Death|0|||
161603402|NCT04109066|583601485|FG000|Treatment|Participant no longer meets study criteria|2|||
161603403|NCT04109066|583601486|FG001|Treatment|Participant no longer meets study criteria|2|||
161603404|NCT04109066|583601485|FG000|Treatment|Administrative reasons by sponsor|2|||
161603405|NCT04109066|583601486|FG001|Treatment|Administrative reasons by sponsor|3|||
161603406|NCT04109066|583601485|FG000|Treatment|Other reasons|17|||
161603407|NCT04109066|583601486|FG001|Treatment|Other reasons|23|||
161603408|NCT04109066|583601485|FG000|Treatment|Disease Progression|4|||
161603409|NCT04109066|583601486|FG001|Treatment|Disease Progression|7|||
161603410|NCT04109066|583601485|FG000|Treatment|Study drug toxicity|12|||
161603411|NCT04109066|583601486|FG001|Treatment|Study drug toxicity|5|||
161603412|NCT04109066|583601485|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
161603413|NCT04109066|583601486|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
161603414|NCT04109066|583601485|FG000|Treatment|Disease Recurrence|0|||
161603415|NCT04109066|583601486|FG001|Treatment|Disease Recurrence|2|||
161603416|NCT04109066|583601485|FG000|Treatment|Not reported|4|||
161603417|NCT04109066|583601486|FG001|Treatment|Not reported|8|||
161603418|NCT05205161|583601487|FG000|Overall Study|Study terminated by sponsor|3|||
161603419|NCT05205161|583601488|FG001|Overall Study|Study terminated by sponsor|3|||
161603420|NCT05205161|583601489|FG002|Overall Study|Study terminated by sponsor|1|||
161603421|NCT04369911|583601491|FG000|Overall Study|Lost to Follow-up|3|||
161603422|NCT04369911|583601492|FG001|Overall Study|Lost to Follow-up|3|||
161603423|NCT04369911|583601491|FG000|Overall Study|Withdrawal by Subject|1|||
161603424|NCT04369911|583601492|FG001|Overall Study|Withdrawal by Subject|2|||
161682689|NCT00418665|583888932|FG000|Treatment Extension|Adverse Event|1|||
161682690|NCT00418665|583888933|FG001|Treatment Extension|Adverse Event|0|||
161682691|NCT00418665|583888934|FG002|Treatment Extension|Adverse Event|0|||
161682692|NCT00418665|583888932|FG000|Treatment Extension|Withdrawal by Subject|1|||
161831432|NCT01467479|584424742|FG000|Overall Study|Death|0|||
161603425|NCT03880955|583601495|FG000|Overall Study|Adverse Event|1|||
161603426|NCT03880955|583601495|FG000|Overall Study|Death|1|||
161603427|NCT03880955|583601495|FG000|Overall Study|Lost to Follow-up|12|||
161603428|NCT03880955|583601495|FG000|Overall Study|Withdrawal by Subject|4|||
161682693|NCT00418665|583888933|FG001|Treatment Extension|Withdrawal by Subject|0|||
161831433|NCT01467479|584424743|FG001|Overall Study|Death|0|||
161682694|NCT00418665|583888934|FG002|Treatment Extension|Withdrawal by Subject|0|||
161682695|NCT00418665|583888932|FG000|Treatment Extension|Requirement for alternative therapy|2|||
161682696|NCT00418665|583888933|FG001|Treatment Extension|Requirement for alternative therapy|2|||
161682697|NCT00418665|583888934|FG002|Treatment Extension|Requirement for alternative therapy|0|||
161682698|NCT00418665|583888932|FG000|Treatment Extension|Physician Decision|2|||
161682699|NCT00418665|583888933|FG001|Treatment Extension|Physician Decision|2|||
161682700|NCT00418665|583888934|FG002|Treatment Extension|Physician Decision|1|||
161682701|NCT00418665|583888932|FG000|Treatment Extension|Death|0|||
161682702|NCT00418665|583888933|FG001|Treatment Extension|Death|0|||
161682703|NCT00418665|583888934|FG002|Treatment Extension|Death|1|||
161682704|NCT00687440|583888935|FG000|Overall Study|Adverse Event|3|||
161682705|NCT00687440|583888935|FG000|Overall Study|Lost to Follow-up|3|||
161682706|NCT00687440|583888935|FG000|Overall Study|Lack of Efficacy|2|||
161682707|NCT00687440|583888935|FG000|Overall Study|Death|2|||
161682708|NCT00687440|583888935|FG000|Overall Study|Other|1|||
161682709|NCT00687440|583888935|FG000|Overall Study|Missing|1|||
161682710|NCT01538628|583888945|FG000|Overall Study|Withdrawal by Subject|1|||
161682711|NCT01538628|583888946|FG001|Overall Study|Withdrawal by Subject|1|||
161682712|NCT01538628|583888945|FG000|Overall Study|Lost to Follow-up|0|||
161682713|NCT01538628|583888946|FG001|Overall Study|Lost to Follow-up|1|||
161682714|NCT00766038|583890138|FG000|Overall Study|Lost to Follow-up|15|||
161682715|NCT00766038|583890139|FG001|Overall Study|Lost to Follow-up|14|||
161682716|NCT00307151|583890140|FG000|Overall Study|Death|4|||
161682717|NCT00307151|583890141|FG001|Overall Study|Death|3|||
161682718|NCT00307151|583890142|FG002|Overall Study|Death|10|||
161682719|NCT00307151|583890143|FG003|Overall Study|Death|3|||
161682720|NCT00307151|583890140|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161682721|NCT00307151|583890141|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161682722|NCT00307151|583890142|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161682723|NCT00307151|583890143|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161682724|NCT00307151|583890140|FG000|Overall Study|Subject unable to get to clinic|1|||
161682725|NCT00307151|583890141|FG001|Overall Study|Subject unable to get to clinic|0|||
161682726|NCT00307151|583890142|FG002|Overall Study|Subject unable to get to clinic|6|||
161682727|NCT00307151|583890143|FG003|Overall Study|Subject unable to get to clinic|2|||
161682728|NCT00307151|583890140|FG000|Overall Study|Withdrew consent|0|||
161682729|NCT00307151|583890141|FG001|Overall Study|Withdrew consent|1|||
161682730|NCT00307151|583890142|FG002|Overall Study|Withdrew consent|1|||
161682731|NCT00307151|583890143|FG003|Overall Study|Withdrew consent|3|||
161682732|NCT00307151|583890140|FG000|Overall Study|Not willing to adhere to study reqs|2|||
161682733|NCT00307151|583890141|FG001|Overall Study|Not willing to adhere to study reqs|0|||
161682734|NCT00307151|583890142|FG002|Overall Study|Not willing to adhere to study reqs|2|||
161682735|NCT00307151|583890143|FG003|Overall Study|Not willing to adhere to study reqs|2|||
161682736|NCT00307151|583890140|FG000|Overall Study|Clinic unable to contact subject|3|||
161682737|NCT00307151|583890141|FG001|Overall Study|Clinic unable to contact subject|3|||
161682738|NCT00307151|583890142|FG002|Overall Study|Clinic unable to contact subject|1|||
161682739|NCT00307151|583890143|FG003|Overall Study|Clinic unable to contact subject|1|||
161682740|NCT03703882|583890144|FG000|Overall Study|Adverse Event|1|||
161682741|NCT03703882|583890145|FG001|Overall Study|Adverse Event|0|||
161682742|NCT03703882|583890144|FG000|Overall Study|Lost to Follow-up|0|||
161682743|NCT03703882|583890145|FG001|Overall Study|Lost to Follow-up|2|||
161682744|NCT03703882|583890144|FG000|Overall Study|Non-compliance with study drug|0|||
161682745|NCT03703882|583890145|FG001|Overall Study|Non-compliance with study drug|1|||
161682746|NCT03703882|583890144|FG000|Overall Study|Physician Decision|0|||
161682747|NCT03703882|583890145|FG001|Overall Study|Physician Decision|1|||
161682748|NCT03703882|583890144|FG000|Overall Study|Progressive disease|1|||
161682749|NCT03703882|583890145|FG001|Overall Study|Progressive disease|0|||
161682750|NCT03703882|583890144|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161682751|NCT03703882|583890145|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161682752|NCT03703882|583890144|FG000|Overall Study|Starting another treatment|0|||
161682753|NCT03703882|583890145|FG001|Overall Study|Starting another treatment|1|||
161682754|NCT03703882|583890144|FG000|Overall Study|noncompliance with study procedures|0|||
161682755|NCT03703882|583890145|FG001|Overall Study|noncompliance with study procedures|1|||
161682756|NCT00516048|583890148|FG000|Overall Study|Death|0|||
161682757|NCT00516048|583890149|FG001|Overall Study|Death|0|||
161682758|NCT00516048|583890150|FG002|Overall Study|Death|1|||
161682759|NCT00516048|583890148|FG000|Overall Study|Subject Decision|0|||
161682760|NCT00516048|583890149|FG001|Overall Study|Subject Decision|2|||
161682761|NCT00516048|583890150|FG002|Overall Study|Subject Decision|0|||
161831434|NCT01467479|584424744|FG002|Overall Study|Death|1|||
161682762|NCT02263079|583890151|FG000|Overall Study|Physician Decision|1|||
161682763|NCT02263079|583890152|FG001|Overall Study|Physician Decision|0|||
161682764|NCT02263079|583890153|FG002|Overall Study|Physician Decision|0|||
161682765|NCT02263079|583890151|FG000|Overall Study|Withdrawal by Subject|2|||
161682766|NCT02263079|583890152|FG001|Overall Study|Withdrawal by Subject|8|||
161682767|NCT02263079|583890153|FG002|Overall Study|Withdrawal by Subject|0|||
161682768|NCT00402649|583890154|FG000|Overall Study|Lost to Follow-up|1|||
161682769|NCT00402649|583890154|FG000|Overall Study|Withdrawal by Subject|1|||
161682770|NCT01321710|583890160|FG000|Overall Study|Lost to Follow-up|4|||
161682771|NCT01321710|583890161|FG001|Overall Study|Lost to Follow-up|5|||
161682772|NCT01321710|583890162|FG002|Overall Study|Lost to Follow-up|0|||
161682773|NCT01761292|583890163|FG000|Part 1|Adverse Event|1|||
161682774|NCT01761292|583890163|FG000|Part 1|not receiving treatment in Part 1|1|||
161682775|NCT01761292|583890163|FG000|Extension 1|Withdrawal by Subject|1|||
161682776|NCT00840086|583890164|FG000|Overall Study|Adverse Event|1|||
161682777|NCT00840086|583890164|FG000|Overall Study|Protocol Violation|2|||
161831435|NCT01467479|584424742|FG000|Overall Study|Lost to Follow-up|2|||
161682778|NCT00840086|583890164|FG000|Overall Study|Lost to Follow-up|1|||
161682779|NCT03332498|583890165|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
161682780|NCT03332498|583890166|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
161682781|NCT03332498|583890167|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
161682782|NCT05611671|583890168|FG000|Overall Study|Adverse Event|1|||
161682783|NCT05611671|583890169|FG001|Overall Study|Adverse Event|1|||
161682784|NCT05611671|583890170|FG002|Overall Study|Adverse Event|0|||
161682785|NCT05611671|583890171|FG003|Overall Study|Adverse Event|1|||
161682786|NCT05611671|583890168|FG000|Overall Study|Lack of Efficacy|1|||
161682787|NCT05611671|583890169|FG001|Overall Study|Lack of Efficacy|0|||
161682788|NCT05611671|583890170|FG002|Overall Study|Lack of Efficacy|1|||
161682789|NCT05611671|583890171|FG003|Overall Study|Lack of Efficacy|2|||
161682790|NCT05611671|583890168|FG000|Overall Study|Lost to Follow-up|0|||
161682791|NCT05611671|583890169|FG001|Overall Study|Lost to Follow-up|0|||
161682792|NCT05611671|583890170|FG002|Overall Study|Lost to Follow-up|0|||
161682793|NCT05611671|583890171|FG003|Overall Study|Lost to Follow-up|1|||
161682794|NCT05611671|583890168|FG000|Overall Study|Protocol Violation|0|||
161682795|NCT05611671|583890169|FG001|Overall Study|Protocol Violation|1|||
161682796|NCT05611671|583890170|FG002|Overall Study|Protocol Violation|0|||
161682797|NCT05611671|583890171|FG003|Overall Study|Protocol Violation|0|||
161682798|NCT05611671|583890168|FG000|Overall Study|Withdrawal by Subject|2|||
161682799|NCT05611671|583890169|FG001|Overall Study|Withdrawal by Subject|1|||
161682800|NCT05611671|583890170|FG002|Overall Study|Withdrawal by Subject|2|||
161682801|NCT05611671|583890171|FG003|Overall Study|Withdrawal by Subject|1|||
161682802|NCT03179891|583890172|FG000|First Intervention|Withdrawal by Subject|1|||
161682803|NCT03179891|583890173|FG001|First Intervention|Withdrawal by Subject|1|||
161682804|NCT03179891|583890172|FG000|First Intervention|Unspecified reason|1|||
161682805|NCT03179891|583890173|FG001|First Intervention|Unspecified reason|0|||
161682806|NCT03179891|583890172|FG000|First Intervention|Protocol Violation|0|||
161682807|NCT03179891|583890173|FG001|First Intervention|Protocol Violation|1|||
161682808|NCT00383084|583890180|FG000|Overall Study|Withdrawal by Subject|12|||
161682809|NCT00383084|583890181|FG001|Overall Study|Withdrawal by Subject|10|||
161682810|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Adverse Event|1|||
161682811|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Adverse Event|0|||
161682812|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Adverse Event|0|||
161682813|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Adverse Event|0|||
161682814|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
161682815|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
161682816|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
161682817|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
161682818|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
161682819|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
161682820|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
161682821|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
161682822|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
161682823|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161682824|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161682825|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161682826|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Adverse Event|0|||
161682827|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Adverse Event|0|||
161682828|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Adverse Event|4|||
161682829|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Adverse Event|5|||
161682830|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
161682831|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
161682832|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
161682833|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
161682834|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Physician Decision|0|||
161682835|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Physician Decision|0|||
161682836|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Physician Decision|2|||
161682837|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Physician Decision|0|||
161682838|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
161682839|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
161682840|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
161682841|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
161682842|NCT01486927|583890186|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
161682843|NCT01486927|583890186|FG000|Overall Study|Physician Decision|1|||
161682844|NCT01486927|583890186|FG000|Overall Study|50 Exposure days not reached|2|||
161831436|NCT01467479|584424743|FG001|Overall Study|Lost to Follow-up|5|||
161682845|NCT01486927|583890186|FG000|Overall Study|Withdrawal by Subject|8|||
161682846|NCT01486927|583890186|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
161682847|NCT02159729|583890187|FG000|Overall Study|Adverse Event|0|||
161682848|NCT02159729|583890188|FG001|Overall Study|Adverse Event|1|||
161682849|NCT02159729|583890187|FG000|Overall Study|Subject's Request|13|||
161682850|NCT02159729|583890188|FG001|Overall Study|Subject's Request|10|||
161682851|NCT02159729|583890187|FG000|Overall Study|Lost to Follow-up|24|||
161682852|NCT02159729|583890188|FG001|Overall Study|Lost to Follow-up|9|||
161682853|NCT02159729|583890187|FG000|Overall Study|Non compliance|2|||
161682854|NCT02159729|583890188|FG001|Overall Study|Non compliance|0|||
161682855|NCT02159729|583890187|FG000|Overall Study|Other Unspecified|3|||
161682856|NCT02159729|583890188|FG001|Overall Study|Other Unspecified|1|||
161682857|NCT02636582|583890189|FG000|Overall Study|Surgical Pathology|1|||
161831437|NCT01467479|584424744|FG002|Overall Study|Lost to Follow-up|3|||
161682858|NCT02636582|583890190|FG001|Overall Study|Surgical Pathology|0|||
161682859|NCT00573430|583890191|FG000|Overall Study|Incorrect enrollment of randomization|0|||
161682860|NCT00573430|583890192|FG001|Overall Study|Incorrect enrollment of randomization|4|||
161682861|NCT00573430|583890193|FG002|Overall Study|Incorrect enrollment of randomization|3|||
161682862|NCT00573430|583890191|FG000|Overall Study|Adverse Event|0|||
161682863|NCT00573430|583890192|FG001|Overall Study|Adverse Event|0|||
161682864|NCT00573430|583890193|FG002|Overall Study|Adverse Event|2|||
161682865|NCT00573430|583890191|FG000|Overall Study|Withdrawal by Subject|1|||
161682866|NCT00573430|583890192|FG001|Overall Study|Withdrawal by Subject|0|||
161682867|NCT00573430|583890193|FG002|Overall Study|Withdrawal by Subject|1|||
161682868|NCT00573430|583890191|FG000|Overall Study|Protocol Violation|0|||
161682869|NCT00573430|583890192|FG001|Overall Study|Protocol Violation|1|||
161682870|NCT00573430|583890193|FG002|Overall Study|Protocol Violation|1|||
161682871|NCT00573430|583890191|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161682872|NCT00573430|583890192|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161682873|NCT00573430|583890193|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
161682874|NCT05895552|583890194|FG000|Overall Study|Adverse Event|2|||
161682875|NCT05895552|583890195|FG001|Overall Study|Adverse Event|2|||
161682876|NCT05895552|583890196|FG002|Overall Study|Adverse Event|1|||
161682877|NCT05895552|583890194|FG000|Overall Study|Lost to Follow-up|0|||
161682878|NCT05895552|583890195|FG001|Overall Study|Lost to Follow-up|1|||
161682879|NCT05895552|583890196|FG002|Overall Study|Lost to Follow-up|0|||
161682880|NCT05895552|583890194|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161682881|NCT05895552|583890195|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161682882|NCT05895552|583890196|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161682883|NCT05895552|583890194|FG000|Overall Study|Protocol Deviation|0|||
161682884|NCT05895552|583890195|FG001|Overall Study|Protocol Deviation|0|||
161682885|NCT05895552|583890196|FG002|Overall Study|Protocol Deviation|2|||
161682886|NCT05895552|583890194|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161682887|NCT05895552|583890195|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161682888|NCT05895552|583890196|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
161682889|NCT05895552|583890194|FG000|Overall Study|Withdrawal by Subject|2|||
161682890|NCT05895552|583890195|FG001|Overall Study|Withdrawal by Subject|2|||
161682891|NCT05895552|583890196|FG002|Overall Study|Withdrawal by Subject|4|||
161682892|NCT03810911|583890197|FG000|Overall Study|Death|1|||
161682893|NCT03810911|583890198|FG001|Overall Study|Death|1|||
161682894|NCT03810911|583890197|FG000|Overall Study|Withdrawal by Subject|1|||
161682895|NCT03810911|583890198|FG001|Overall Study|Withdrawal by Subject|1|||
161682896|NCT05374525|583890199|FG000|Overall Study|Adverse Event|5|||
161682897|NCT05374525|583890200|FG001|Overall Study|Adverse Event|6|||
161682898|NCT05374525|583890199|FG000|Overall Study|Lost to Follow-up|3|||
161682899|NCT05374525|583890200|FG001|Overall Study|Lost to Follow-up|3|||
161682900|NCT05374525|583890199|FG000|Overall Study|Physician Decision|2|||
161682901|NCT05374525|583890200|FG001|Overall Study|Physician Decision|2|||
161682902|NCT05374525|583890199|FG000|Overall Study|Withdrawal by Subject|26|||
161682903|NCT05374525|583890200|FG001|Overall Study|Withdrawal by Subject|8|||
161682904|NCT01349101|583890203|FG000|Overall Study|Disease Progression|1|||
161682905|NCT01349101|583890204|FG001|Overall Study|Disease Progression|1|||
161682906|NCT01349101|583890203|FG000|Overall Study|Death|3|||
161682907|NCT01349101|583890204|FG001|Overall Study|Death|8|||
161682908|NCT00829179|583890205|FG000|Overall Study|Withdrawal by Subject|1|||
161682909|NCT00271596|583890208|FG000|Overall Study|Protocol Violation|1|||
161682910|NCT00271596|583890209|FG001|Overall Study|Protocol Violation|0|||
161831438|NCT01467479|584424742|FG000|Overall Study|Withdrawal of Consent|3|||
161682911|NCT00271596|583890208|FG000|Overall Study|Withdrawal by Subject|0|||
161682912|NCT00271596|583890209|FG001|Overall Study|Withdrawal by Subject|1|||
161682913|NCT04232553|583890210|FG000|Overall Study|Adverse Event|3|||
161682914|NCT04232553|583890211|FG001|Overall Study|Adverse Event|2|||
161682915|NCT04232553|583890212|FG002|Overall Study|Adverse Event|1|||
161682916|NCT04232553|583890213|FG003|Overall Study|Adverse Event|2|||
161682917|NCT04232553|583890214|FG004|Overall Study|Adverse Event|1|||
161682918|NCT04232553|583890215|FG005|Overall Study|Adverse Event|1|||
161682919|NCT04232553|583890216|FG006|Overall Study|Adverse Event|0|||
161682920|NCT04232553|583890217|FG007|Overall Study|Adverse Event|0|||
161682921|NCT04232553|583890218|FG008|Overall Study|Adverse Event|0|||
161682922|NCT04232553|583890210|FG000|Overall Study|Death|0|||
161682923|NCT04232553|583890211|FG001|Overall Study|Death|1|||
161682924|NCT04232553|583890212|FG002|Overall Study|Death|0|||
161682925|NCT04232553|583890213|FG003|Overall Study|Death|1|||
161682926|NCT04232553|583890214|FG004|Overall Study|Death|0|||
161603429|NCT03880955|583601495|FG000|Overall Study|Missing- Study Site Closed|27|||
161603430|NCT03817983|583601496|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
161603431|NCT03817983|583601497|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
161603432|NCT03817983|583601498|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
161603433|NCT02510235|583601499|FG000|Overall Study|Withdrawal by Subject|1|||
161603434|NCT02510235|583601500|FG001|Overall Study|Withdrawal by Subject|0|||
161603435|NCT00450216|583601501|FG000|Overall Study|Adverse Event|38|||
161603436|NCT00450216|583601502|FG001|Overall Study|Adverse Event|23|||
161603437|NCT00450216|583601501|FG000|Overall Study|Withdrawal by Subject|48|||
161603438|NCT00450216|583601502|FG001|Overall Study|Withdrawal by Subject|26|||
161603439|NCT00450216|583601501|FG000|Overall Study|Lost to Follow-up|16|||
161603440|NCT00450216|583601502|FG001|Overall Study|Lost to Follow-up|9|||
161603441|NCT00450216|583601501|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
161603442|NCT00450216|583601502|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
161603443|NCT00450216|583601501|FG000|Overall Study|misc|21|||
161603444|NCT00450216|583601502|FG001|Overall Study|misc|20|||
161603445|NCT03636490|583602388|FG000|Overall Study|Dropped out or incomplete data|141|||
161603446|NCT01130883|583602389|FG000|Overall Study|Patient Noncompliance|6|||
161603447|NCT01130883|583602389|FG000|Overall Study|Reason Unknown|1|||
161603448|NCT01130883|583602389|FG000|Overall Study|Adverse Event|3|||
161603449|NCT02585323|583602390|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
161603450|NCT02585323|583602391|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
161603451|NCT02585323|583602390|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
161603452|NCT02585323|583602391|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
161603453|NCT02585323|583602390|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
161603454|NCT02585323|583602391|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
161603455|NCT02585323|583602390|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
161603456|NCT02585323|583602391|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
161603457|NCT04165213|583602401|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
161603458|NCT04165213|583602402|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
161603459|NCT04165213|583602401|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
161603460|NCT04165213|583602402|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
161603461|NCT04165213|583602401|FG000|Clinician Enrollment|Termination from site|0|||
161603462|NCT04165213|583602402|FG001|Clinician Enrollment|Termination from site|1|||
161603463|NCT04165213|583602401|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
161603464|NCT04165213|583602402|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
161603465|NCT04165213|583602401|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
161603466|NCT04165213|583602402|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
161603467|NCT04165213|583602401|FG000|Caregiver Enrollment|Physician Decision|1|||
161603468|NCT04165213|583602402|FG001|Caregiver Enrollment|Physician Decision|0|||
161603469|NCT04165213|583602401|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
161603470|NCT04165213|583602402|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
161603471|NCT04165213|583602401|FG000|Caregiver Enrollment|PLWD death|2|||
161603472|NCT04165213|583602402|FG001|Caregiver Enrollment|PLWD death|0|||
161603473|NCT04165213|583602401|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
161603474|NCT04165213|583602402|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
161603475|NCT04165213|583602401|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
161603476|NCT04165213|583602402|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
161603477|NCT04165213|583602401|FG000|PLWD Enrollment|Lost to Follow-up|1|||
161603478|NCT04165213|583602402|FG001|PLWD Enrollment|Lost to Follow-up|1|||
161603479|NCT04165213|583602401|FG000|PLWD Enrollment|Physician Decision|1|||
161603480|NCT04165213|583602402|FG001|PLWD Enrollment|Physician Decision|0|||
161603481|NCT04165213|583602401|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
161603482|NCT04165213|583602402|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
161603483|NCT04165213|583602401|FG000|PLWD Enrollment|Death|2|||
161603484|NCT04165213|583602402|FG001|PLWD Enrollment|Death|0|||
161603485|NCT04165213|583602401|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
161603486|NCT04165213|583602402|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
161603487|NCT02997202|583602403|FG000|Overall Study|Miscellaneous|2|||
161603488|NCT02997202|583602404|FG001|Overall Study|Miscellaneous|2|||
161603489|NCT02997202|583602403|FG000|Overall Study|Withdrawal by Subject|8|||
161603490|NCT02997202|583602404|FG001|Overall Study|Withdrawal by Subject|12|||
161603491|NCT02997202|583602403|FG000|Overall Study|Lost to Follow-up|5|||
161603492|NCT02997202|583602404|FG001|Overall Study|Lost to Follow-up|3|||
161603493|NCT02997202|583602403|FG000|Overall Study|Death|41|||
161603494|NCT02997202|583602404|FG001|Overall Study|Death|45|||
161603495|NCT01121588|583602405|FG000|Overall Study|Death|5|||
161603496|NCT01121588|583602406|FG001|Overall Study|Death|3|||
161603497|NCT01121588|583602407|FG002|Overall Study|Death|13|||
161603498|NCT01121588|583602405|FG000|Overall Study|Study Terminated by Sponsor|1|||
161603499|NCT01121588|583602406|FG001|Overall Study|Study Terminated by Sponsor|1|||
161682927|NCT04232553|583890215|FG005|Overall Study|Death|0|||
161682928|NCT04232553|583890216|FG006|Overall Study|Death|0|||
161682929|NCT04232553|583890217|FG007|Overall Study|Death|0|||
161682930|NCT04232553|583890218|FG008|Overall Study|Death|0|||
161682931|NCT04232553|583890210|FG000|Overall Study|Lack of Efficacy|0|||
161682932|NCT04232553|583890211|FG001|Overall Study|Lack of Efficacy|2|||
161682933|NCT04232553|583890212|FG002|Overall Study|Lack of Efficacy|0|||
161682934|NCT04232553|583890213|FG003|Overall Study|Lack of Efficacy|0|||
161682935|NCT04232553|583890214|FG004|Overall Study|Lack of Efficacy|0|||
161682936|NCT04232553|583890215|FG005|Overall Study|Lack of Efficacy|0|||
161682937|NCT04232553|583890216|FG006|Overall Study|Lack of Efficacy|0|||
161682938|NCT04232553|583890217|FG007|Overall Study|Lack of Efficacy|0|||
161682939|NCT04232553|583890218|FG008|Overall Study|Lack of Efficacy|1|||
161682940|NCT04232553|583890210|FG000|Overall Study|Lost to Follow-up|0|||
161682941|NCT04232553|583890211|FG001|Overall Study|Lost to Follow-up|1|||
161682942|NCT04232553|583890212|FG002|Overall Study|Lost to Follow-up|0|||
161682943|NCT04232553|583890213|FG003|Overall Study|Lost to Follow-up|0|||
161682944|NCT04232553|583890214|FG004|Overall Study|Lost to Follow-up|1|||
161682945|NCT04232553|583890215|FG005|Overall Study|Lost to Follow-up|0|||
161682946|NCT04232553|583890216|FG006|Overall Study|Lost to Follow-up|0|||
161682947|NCT04232553|583890217|FG007|Overall Study|Lost to Follow-up|0|||
161682948|NCT04232553|583890218|FG008|Overall Study|Lost to Follow-up|1|||
161682949|NCT04232553|583890210|FG000|Overall Study|Other - As reported by the investigator|0|||
161682950|NCT04232553|583890211|FG001|Overall Study|Other - As reported by the investigator|1|||
161682951|NCT04232553|583890212|FG002|Overall Study|Other - As reported by the investigator|0|||
161682952|NCT04232553|583890213|FG003|Overall Study|Other - As reported by the investigator|0|||
161682953|NCT04232553|583890214|FG004|Overall Study|Other - As reported by the investigator|0|||
161682954|NCT04232553|583890215|FG005|Overall Study|Other - As reported by the investigator|0|||
161682955|NCT04232553|583890216|FG006|Overall Study|Other - As reported by the investigator|0|||
161682956|NCT04232553|583890217|FG007|Overall Study|Other - As reported by the investigator|0|||
161682957|NCT04232553|583890218|FG008|Overall Study|Other - As reported by the investigator|0|||
161682958|NCT04232553|583890210|FG000|Overall Study|Physician Decision|1|||
161682959|NCT04232553|583890211|FG001|Overall Study|Physician Decision|1|||
161682960|NCT04232553|583890212|FG002|Overall Study|Physician Decision|0|||
161682961|NCT04232553|583890213|FG003|Overall Study|Physician Decision|0|||
161682962|NCT04232553|583890214|FG004|Overall Study|Physician Decision|1|||
161682963|NCT04232553|583890215|FG005|Overall Study|Physician Decision|0|||
161682964|NCT04232553|583890216|FG006|Overall Study|Physician Decision|0|||
161682965|NCT04232553|583890217|FG007|Overall Study|Physician Decision|0|||
161682966|NCT04232553|583890218|FG008|Overall Study|Physician Decision|0|||
161831439|NCT01467479|584424743|FG001|Overall Study|Withdrawal of Consent|7|||
161548997|NCT02120664|583399367|FG002|Overall Study|Withdrawal by Subject|0|||
161682967|NCT04232553|583890210|FG000|Overall Study|Pregnancy|1|||
161682968|NCT04232553|583890211|FG001|Overall Study|Pregnancy|0|||
161682969|NCT04232553|583890212|FG002|Overall Study|Pregnancy|0|||
161682970|NCT04232553|583890213|FG003|Overall Study|Pregnancy|0|||
161682971|NCT04232553|583890214|FG004|Overall Study|Pregnancy|0|||
161682972|NCT04232553|583890215|FG005|Overall Study|Pregnancy|0|||
161682973|NCT04232553|583890216|FG006|Overall Study|Pregnancy|0|||
161548998|NCT02120664|583399368|FG003|Overall Study|Withdrawal by Subject|1|||
161682974|NCT04232553|583890217|FG007|Overall Study|Pregnancy|0|||
161682975|NCT04232553|583890218|FG008|Overall Study|Pregnancy|0|||
161682976|NCT04232553|583890210|FG000|Overall Study|Withdrawal by Subject|7|||
161682977|NCT04232553|583890211|FG001|Overall Study|Withdrawal by Subject|5|||
161682978|NCT04232553|583890212|FG002|Overall Study|Withdrawal by Subject|0|||
161682979|NCT04232553|583890213|FG003|Overall Study|Withdrawal by Subject|0|||
161682980|NCT04232553|583890214|FG004|Overall Study|Withdrawal by Subject|2|||
161682981|NCT04232553|583890215|FG005|Overall Study|Withdrawal by Subject|2|||
161682982|NCT04232553|583890216|FG006|Overall Study|Withdrawal by Subject|0|||
161548999|NCT02120664|583399369|FG004|Overall Study|Withdrawal by Subject|0|||
161549000|NCT02460263|583399370|FG000|Transition Period|Withdrawal by Subject|1|||
161603500|NCT01121588|583602407|FG002|Overall Study|Study Terminated by Sponsor|0|||
161603501|NCT01121588|583602405|FG000|Overall Study|Participant Refused Further Followup|2|||
161603502|NCT01121588|583602406|FG001|Overall Study|Participant Refused Further Followup|0|||
161603503|NCT01121588|583602407|FG002|Overall Study|Participant Refused Further Followup|2|||
161603504|NCT01121588|583602405|FG000|Overall Study|Lost to Follow-up|0|||
161603505|NCT01121588|583602406|FG001|Overall Study|Lost to Follow-up|1|||
161603506|NCT01121588|583602407|FG002|Overall Study|Lost to Follow-up|1|||
161603507|NCT01121588|583602405|FG000|Overall Study|Non-Specified Reasons|9|||
161603508|NCT01121588|583602406|FG001|Overall Study|Non-Specified Reasons|4|||
161603509|NCT01121588|583602407|FG002|Overall Study|Non-Specified Reasons|2|||
161603510|NCT00303459|583602410|FG000|Overall Study|Death|33|||
161603511|NCT00303459|583602411|FG001|Overall Study|Death|44|||
161603512|NCT00303459|583602410|FG000|Overall Study|Withdrawal of consent|32|||
161603513|NCT00303459|583602411|FG001|Overall Study|Withdrawal of consent|26|||
161603514|NCT00303459|583602410|FG000|Overall Study|Lost to Follow-up|5|||
161603515|NCT00303459|583602411|FG001|Overall Study|Lost to Follow-up|4|||
161603516|NCT00303459|583602410|FG000|Overall Study|Administrative reason|7|||
161603517|NCT00303459|583602411|FG001|Overall Study|Administrative reason|7|||
161603518|NCT00303459|583602410|FG000|Overall Study|Decision by the investigator|5|||
161603519|NCT00303459|583602411|FG001|Overall Study|Decision by the investigator|7|||
161603520|NCT00303459|583602410|FG000|Overall Study|Lung transplantation|1|||
161603521|NCT00303459|583602411|FG001|Overall Study|Lung transplantation|1|||
161603522|NCT04055012|583602412|FG000|Overall Study|Withdrawal by Subject|1|||
161603523|NCT04055012|583602413|FG001|Overall Study|Withdrawal by Subject|3|||
161603524|NCT04055012|583602414|FG002|Overall Study|Withdrawal by Subject|1|||
161603525|NCT04055012|583602415|FG003|Overall Study|Withdrawal by Subject|0|||
161682983|NCT04232553|583890217|FG007|Overall Study|Withdrawal by Subject|2|||
161682984|NCT04232553|583890218|FG008|Overall Study|Withdrawal by Subject|0|||
161549001|NCT02460263|583399370|FG000|Transition Period|Death|1|||
161549002|NCT03916744|583399371|FG000|Overall Study|Withdrawal by Subject|0|||
161549003|NCT03916744|583399372|FG001|Overall Study|Withdrawal by Subject|1|||
161549004|NCT03916744|583399373|FG002|Overall Study|Withdrawal by Subject|2|||
161549005|NCT03176238|583399376|FG000|Overall Study|Unacceptable AEs|15|||
161549006|NCT03176238|583399377|FG001|Overall Study|Unacceptable AEs|8|||
161549007|NCT03176238|583399376|FG000|Overall Study|Abnormal lab value(s)|2|||
161549008|NCT03176238|583399377|FG001|Overall Study|Abnormal lab value(s)|0|||
161549009|NCT03176238|583399376|FG000|Overall Study|Inter-current illness|0|||
161549010|NCT03176238|583399377|FG001|Overall Study|Inter-current illness|1|||
161549011|NCT03176238|583399376|FG000|Overall Study|Consent withdrawal|14|||
161549012|NCT03176238|583399377|FG001|Overall Study|Consent withdrawal|2|||
161549013|NCT03176238|583399376|FG000|Overall Study|Lost to Follow-up|3|||
161549014|NCT03176238|583399377|FG001|Overall Study|Lost to Follow-up|0|||
161549015|NCT03176238|583399376|FG000|Overall Study|Administrative problems|1|||
161549016|NCT03176238|583399377|FG001|Overall Study|Administrative problems|0|||
161549017|NCT03176238|583399376|FG000|Overall Study|Death|3|||
161549018|NCT03176238|583399377|FG001|Overall Study|Death|0|||
161549019|NCT03176238|583399376|FG000|Overall Study|Disease Progression|133|||
161549020|NCT03176238|583399377|FG001|Overall Study|Disease Progression|22|||
161549021|NCT03176238|583399376|FG000|Overall Study|Tx duration completed per EAP|0|||
161549022|NCT03176238|583399377|FG001|Overall Study|Tx duration completed per EAP|1|||
161549023|NCT03176238|583399376|FG000|Overall Study|Patient is switched to commercial drug|16|||
161549024|NCT03176238|583399377|FG001|Overall Study|Patient is switched to commercial drug|1|||
161549025|NCT03176238|583399376|FG000|Overall Study|Protocol Violation|1|||
161549026|NCT03176238|583399377|FG001|Overall Study|Protocol Violation|0|||
161549027|NCT03176238|583399376|FG000|Overall Study|Changes in the patient's condition|2|||
161549028|NCT03176238|583399377|FG001|Overall Study|Changes in the patient's condition|1|||
161683073|NCT01843842|583891240|FG001|Overall Study|Do not meet inclusion criteria|1|||
161831595|NCT00384293|584424836|FG000|Post-randomization Period|Withdrawal by Subject|0|||
161831596|NCT00384293|584424837|FG001|Post-randomization Period|Withdrawal by Subject|8|||
161831597|NCT00384293|584424838|FG002|Post-randomization Period|Withdrawal by Subject|6|||
161831598|NCT00384293|584424836|FG000|Post-randomization Period|Trial Termination|0|||
161831599|NCT00384293|584424837|FG001|Post-randomization Period|Trial Termination|180|||
161831600|NCT00384293|584424838|FG002|Post-randomization Period|Trial Termination|204|||
161831601|NCT00384293|584424836|FG000|Post-randomization Period|Patient Randomized in Error|0|||
161831602|NCT00384293|584424837|FG001|Post-randomization Period|Patient Randomized in Error|0|||
161831603|NCT00384293|584424838|FG002|Post-randomization Period|Patient Randomized in Error|1|||
161831604|NCT03005067|584424839|FG000|Overall Study|Withdrawal by Subject|3|||
161831605|NCT03005067|584424840|FG001|Overall Study|Withdrawal by Subject|2|||
161683074|NCT02953340|583891241|FG000|Overall Study|Death|0|||
161603645|NCT05412004|583603302|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
161603646|NCT03781089|583603303|FG000|Overall Study|Constipation|1|||
161831606|NCT03005067|584424839|FG000|Overall Study|Adverse Event|4|||
161603647|NCT03781089|583603304|FG001|Overall Study|Constipation|0|||
161603648|NCT03781089|583603303|FG000|Overall Study|Positive pregnancy test|0|||
161603649|NCT03781089|583603304|FG001|Overall Study|Positive pregnancy test|1|||
161603650|NCT04644029|583603305|FG000|Overall Study|Death|1|||
161603651|NCT04644029|583603306|FG001|Overall Study|Death|0|||
161603652|NCT04644029|583603305|FG000|Overall Study|Physician Decision|1|||
161603653|NCT04644029|583603306|FG001|Overall Study|Physician Decision|2|||
161603654|NCT04644029|583603305|FG000|Overall Study|Withdrawal by Subject|21|||
161603655|NCT04644029|583603306|FG001|Overall Study|Withdrawal by Subject|19|||
161603656|NCT04644029|583603305|FG000|Overall Study|Lost to Follow-up|31|||
161603657|NCT04644029|583603306|FG001|Overall Study|Lost to Follow-up|34|||
161603658|NCT04644029|583603305|FG000|Overall Study|Study Terminated by Sponsor|308|||
161603659|NCT04644029|583603306|FG001|Overall Study|Study Terminated by Sponsor|309|||
161603660|NCT04644029|583603305|FG000|Overall Study|Randomized in Error|2|||
161683075|NCT02953340|583891242|FG001|Overall Study|Death|1|||
161683076|NCT02953340|583891241|FG000|Overall Study|Investigator Decision|3|||
161683077|NCT02953340|583891242|FG001|Overall Study|Investigator Decision|3|||
161683078|NCT02953340|583891241|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
161683079|NCT02953340|583891242|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
161683080|NCT02953340|583891241|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
161683081|NCT02953340|583891242|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
161683082|NCT02953340|583891241|FG000|Overall Study|Withdrawal by Subject|9|||
161683083|NCT02953340|583891242|FG001|Overall Study|Withdrawal by Subject|9|||
161683084|NCT02953340|583891241|FG000|Overall Study|Sponsor decision|0|||
161683085|NCT02953340|583891242|FG001|Overall Study|Sponsor decision|2|||
161683086|NCT02953340|583891241|FG000|Overall Study|Lost to Follow-up|3|||
161683087|NCT02953340|583891242|FG001|Overall Study|Lost to Follow-up|2|||
161683088|NCT02953340|583891241|FG000|Overall Study|Reason not specified|2|||
161683089|NCT02953340|583891242|FG001|Overall Study|Reason not specified|2|||
161683090|NCT01376778|583891243|FG000|Overall Study|Lost to Follow-up|3|||
161683091|NCT01376778|583891244|FG001|Overall Study|Lost to Follow-up|2|||
161683092|NCT00632099|583891245|FG000|Overall Study|Lost to Follow-up|3|||
161683093|NCT00632099|583891246|FG001|Overall Study|Lost to Follow-up|3|||
161683094|NCT03374189|583891252|FG000|Overall Study|Lost to Follow-up|1|||
161683095|NCT03374189|583891253|FG001|Overall Study|Lost to Follow-up|0|||
161683096|NCT01517893|583891254|FG000|Overall Study|Withdrawal by Subject|3|||
161683097|NCT01517893|583891255|FG001|Overall Study|Withdrawal by Subject|0|||
161683098|NCT02018822|583891256|FG000|Overall Study|filling replaced by crown|0|||
161683099|NCT02018822|583891257|FG001|Overall Study|filling replaced by crown|1|||
161683100|NCT02018822|583891258|FG002|Overall Study|filling replaced by crown|0|||
161683101|NCT02018822|583891256|FG000|Overall Study|Physician Decision|0|||
161683102|NCT02018822|583891257|FG001|Overall Study|Physician Decision|1|||
161683103|NCT02018822|583891258|FG002|Overall Study|Physician Decision|1|||
161683104|NCT02018822|583891256|FG000|Overall Study|Lost to Follow-up|6|||
161683105|NCT02018822|583891257|FG001|Overall Study|Lost to Follow-up|6|||
161683106|NCT02018822|583891258|FG002|Overall Study|Lost to Follow-up|5|||
161683107|NCT03201458|583891259|FG000|Overall Study|No longer eligible|2|||
161683108|NCT03201458|583891260|FG001|Overall Study|No longer eligible|5|||
161683109|NCT03201458|583891259|FG000|Overall Study|Health event before starting|1|||
161683110|NCT03201458|583891260|FG001|Overall Study|Health event before starting|0|||
161683111|NCT03201458|583891259|FG000|Overall Study|Physician Decision|1|||
161683112|NCT03201458|583891260|FG001|Overall Study|Physician Decision|0|||
161683113|NCT01069172|583891269|FG000|Overall Study|Withdrawal by Subject|1|||
161683114|NCT01069172|583891270|FG001|Overall Study|Withdrawal by Subject|0|||
161683115|NCT02184195|583891273|FG000|Overall Study|Patient decision|5|||
161683116|NCT02184195|583891274|FG001|Overall Study|Patient decision|2|||
161603661|NCT04644029|583603306|FG001|Overall Study|Randomized in Error|1|||
161603662|NCT04644029|583603305|FG000|Overall Study|Other|0|||
161603663|NCT04644029|583603306|FG001|Overall Study|Other|1|||
161683117|NCT02184195|583891273|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161603664|NCT05132400|583603307|FG000|Overall Study|Withdrawal by Subject|14|||
161603665|NCT05132400|583603308|FG001|Overall Study|Withdrawal by Subject|8|||
161603666|NCT05132400|583603307|FG000|Overall Study|Lost to Follow-up|132|||
161603667|NCT05132400|583603308|FG001|Overall Study|Lost to Follow-up|121|||
161603668|NCT03934931|583603309|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
161603669|NCT03934931|583603310|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
161603670|NCT03934931|583603311|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
161603671|NCT02246127|583603312|FG000|First Course Treatment|Adverse Event|9|||
161603672|NCT02246127|583603313|FG001|First Course Treatment|Adverse Event|7|||
161603673|NCT02246127|583603312|FG000|First Course Treatment|Withdrawal by Subject|6|||
161603674|NCT02246127|583603313|FG001|First Course Treatment|Withdrawal by Subject|7|||
161603675|NCT02246127|583603312|FG000|First Course Treatment|Physician Decision|9|||
161603676|NCT02246127|583603313|FG001|First Course Treatment|Physician Decision|9|||
161603677|NCT02246127|583603312|FG000|First Course Treatment|Death|3|||
161603678|NCT02246127|583603313|FG001|First Course Treatment|Death|3|||
161603679|NCT02246127|583603312|FG000|First Course Treatment|Not reported reasons|6|||
161603680|NCT02246127|583603313|FG001|First Course Treatment|Not reported reasons|7|||
161603681|NCT02246127|583603312|FG000|First Course Treatment|Not treated|3|||
161603682|NCT02246127|583603313|FG001|First Course Treatment|Not treated|3|||
161603683|NCT03635567|583603316|FG000|Overall Study|Lost to Follow-up|4|||
161603684|NCT03635567|583603317|FG001|Overall Study|Lost to Follow-up|1|||
161603685|NCT03635567|583603316|FG000|Overall Study|Withdrawal by Subject|11|||
161603686|NCT03635567|583603317|FG001|Overall Study|Withdrawal by Subject|16|||
161603687|NCT03635567|583603316|FG000|Overall Study|Sponsor Decision|99|||
161603688|NCT03635567|583603317|FG001|Overall Study|Sponsor Decision|57|||
161603689|NCT03635567|583603316|FG000|Overall Study|Death|194|||
161603690|NCT03635567|583603317|FG001|Overall Study|Death|235|||
161603691|NCT00739908|583603318|FG000|Overall Study|Adverse Event|5|||
161603692|NCT00739908|583603319|FG001|Overall Study|Adverse Event|6|||
161603693|NCT00739908|583603318|FG000|Overall Study|Withdrawal by Subject|4|||
161603694|NCT00739908|583603319|FG001|Overall Study|Withdrawal by Subject|2|||
161603695|NCT00739908|583603318|FG000|Overall Study|Lost to Follow-up|14|||
161603696|NCT00739908|583603319|FG001|Overall Study|Lost to Follow-up|9|||
161603697|NCT00739908|583603318|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
161603698|NCT00739908|583603319|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
161603699|NCT00739908|583603318|FG000|Overall Study|Non-Compliance With Study Medication|0|||
161603700|NCT00739908|583603319|FG001|Overall Study|Non-Compliance With Study Medication|3|||
161603701|NCT00739908|583603318|FG000|Overall Study|Lack of Efficacy|0|||
161603702|NCT00739908|583603319|FG001|Overall Study|Lack of Efficacy|1|||
161603703|NCT00739908|583603318|FG000|Overall Study|Relocation|0|||
161603704|NCT00739908|583603319|FG001|Overall Study|Relocation|1|||
161603705|NCT05157841|583603320|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
161603706|NCT05157841|583603321|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
161603707|NCT05157841|583603322|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
161603708|NCT05157841|583603320|FG000|Part A (14 Days)|Adverse Event|1|||
161603709|NCT05157841|583603321|FG001|Part A (14 Days)|Adverse Event|0|||
161603710|NCT05157841|583603322|FG002|Part A (14 Days)|Adverse Event|0|||
161603711|NCT05157841|583603320|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
161603712|NCT05157841|583603321|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
161603713|NCT05157841|583603322|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
161683118|NCT02184195|583891274|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161683119|NCT02184195|583891273|FG000|Overall Study|Death|67|||
161603714|NCT04464564|583603324|FG000|Period A (Placebo lead-in)|Other|5|||
161603715|NCT04464564|583603325|FG001|Period A (Placebo lead-in)|Other|0|||
161603716|NCT04464564|583603326|FG002|Period A (Placebo lead-in)|Other|0|||
161603717|NCT04464564|583603327|FG003|Period A (Placebo lead-in)|Other|0|||
161831607|NCT03005067|584424840|FG001|Overall Study|Adverse Event|3|||
161831608|NCT03005067|584424839|FG000|Overall Study|Other (reason not specified)|3|||
161831609|NCT03005067|584424840|FG001|Overall Study|Other (reason not specified)|1|||
161831610|NCT03005067|584424839|FG000|Overall Study|Protocol Violation|0|||
161831611|NCT03005067|584424840|FG001|Overall Study|Protocol Violation|1|||
161831612|NCT00103038|584424846|FG000|Overall Study|Withdrawal by Subject|8|||
161831613|NCT00103038|584424846|FG000|Overall Study|Screen failure|3|||
161831614|NCT00103038|584424846|FG000|Overall Study|Death|1|||
161831615|NCT00103038|584424846|FG000|Overall Study|Physician Decision|1|||
161831616|NCT00355472|584424849|FG000|Overall Study|Physician Decision|1|||
161831617|NCT05445843|584424850|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
161831618|NCT05445843|584424851|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
161831619|NCT05445843|584424850|FG000|Overall Study|Progressive disease|17|||
161831620|NCT05445843|584424851|FG001|Overall Study|Progressive disease|9|||
161683120|NCT02184195|583891274|FG001|Overall Study|Death|44|||
161683121|NCT02184195|583891273|FG000|Overall Study|Lost to Follow-up|1|||
161683122|NCT02184195|583891274|FG001|Overall Study|Lost to Follow-up|5|||
161683123|NCT02184195|583891273|FG000|Overall Study|Other|0|||
161683124|NCT02184195|583891274|FG001|Overall Study|Other|3|||
161683125|NCT00589420|583891275|FG000|Overall Study|screen failure|1|||
161683126|NCT00841568|583891276|FG000|Overall Study|Adverse Event|1|||
161831621|NCT05445843|584424850|FG000|Overall Study|Physician Decision|16|||
161831622|NCT05445843|584424851|FG001|Overall Study|Physician Decision|4|||
161831623|NCT05445843|584424850|FG000|Overall Study|Death|6|||
161831624|NCT05445843|584424851|FG001|Overall Study|Death|3|||
161831625|NCT05445843|584424850|FG000|Overall Study|Subject decision|6|||
161831626|NCT05445843|584424851|FG001|Overall Study|Subject decision|2|||
161831627|NCT05445843|584424850|FG000|Overall Study|Adverse Event|2|||
161831628|NCT05445843|584424851|FG001|Overall Study|Adverse Event|0|||
161831629|NCT05307679|584424856|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
161831630|NCT05307679|584424857|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
161831631|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161831632|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161831633|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161831634|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
161831635|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
161831636|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
161831637|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
161831638|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161831639|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161831640|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
161831641|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
161831642|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
161831643|NCT02310763|584424860|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161831644|NCT02310763|584424861|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161831645|NCT02310763|584424862|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161831646|NCT01731886|584424864|FG000|Overall Study|Death|1|||
161831647|NCT01731886|584424865|FG001|Overall Study|Death|0|||
161831648|NCT01731886|584424864|FG000|Overall Study|Never started treatment|0|||
161831649|NCT01731886|584424865|FG001|Overall Study|Never started treatment|1|||
161831650|NCT01731886|584424864|FG000|Overall Study|Non-compliant|1|||
161831651|NCT01731886|584424865|FG001|Overall Study|Non-compliant|0|||
161831652|NCT02280187|584424866|FG000|Overall Study|Lost to Follow-up|218|||
161831653|NCT03417830|584424869|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
161831654|NCT03417830|584424870|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
161831655|NCT02563769|584424871|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
161831656|NCT02563769|584424872|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
161831657|NCT02563769|584424873|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
161831658|NCT01192399|584424885|FG000|Overall Study|Lack of Efficacy|2|||
161831659|NCT00724373|584424887|FG000|Overall Study|Adverse Event|41|||
161831660|NCT00724373|584424887|FG000|Overall Study|Lack of Efficacy|82|||
161831661|NCT00724373|584424887|FG000|Overall Study|Lost to Follow-up|7|||
161831662|NCT00724373|584424887|FG000|Overall Study|Non-compliance|2|||
161831663|NCT00724373|584424887|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
161831664|NCT00724373|584424887|FG000|Overall Study|Participant moved away|1|||
161603718|NCT04464564|583603324|FG000|Period B (Randomization Period)|Adverse Event|0|||
161603719|NCT04464564|583603325|FG001|Period B (Randomization Period)|Adverse Event|1|||
161603720|NCT04464564|583603326|FG002|Period B (Randomization Period)|Adverse Event|2|||
161603721|NCT04464564|583603327|FG003|Period B (Randomization Period)|Adverse Event|8|||
161603722|NCT04464564|583603324|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
161603723|NCT04464564|583603325|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
161603724|NCT04464564|583603326|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
161603725|NCT04464564|583603327|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
161603726|NCT04464564|583603324|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
161603727|NCT04464564|583603325|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
161603728|NCT04464564|583603326|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
161603729|NCT04464564|583603327|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
161603730|NCT04464564|583603324|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
161603731|NCT04464564|583603325|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
161603732|NCT04464564|583603326|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
161603733|NCT04464564|583603327|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
161831665|NCT00724373|584424887|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
161831666|NCT00724373|584424887|FG000|Overall Study|Only to have 24 week regimen|1|||
161831667|NCT00724373|584424887|FG000|Overall Study|Viral Relapse|1|||
161831668|NCT00724373|584424887|FG000|Overall Study|Acute HCV infection|1|||
161831669|NCT00724373|584424887|FG000|Overall Study|Drug Relapse|1|||
161831670|NCT00724373|584424887|FG000|Overall Study|Tolerability|23|||
161831671|NCT02377063|584424888|FG000|Overall Study|Non-compliance|5|||
161831672|NCT01524913|584424889|FG000|Overall Study|Lost to Follow-up|4|||
161831673|NCT01524913|584424890|FG001|Overall Study|Lost to Follow-up|0|||
161831674|NCT01524913|584424891|FG002|Overall Study|Lost to Follow-up|0|||
161831675|NCT01221090|584426925|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
161831676|NCT01221090|584426926|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
161831677|NCT01221090|584426927|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
161831678|NCT01221090|584426928|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
161831679|NCT01221090|584426925|FG000|Overall Study|Withdrawal by Subject|0|||
161831680|NCT01221090|584426926|FG001|Overall Study|Withdrawal by Subject|22|||
161831681|NCT01221090|584426927|FG002|Overall Study|Withdrawal by Subject|27|||
161831682|NCT01221090|584426928|FG003|Overall Study|Withdrawal by Subject|2|||
161831683|NCT04507126|584426929|FG000|Overall Study|Withdrawal by Subject|3|||
161831684|NCT04507126|584426929|FG000|Overall Study|Protocol Violation|4|||
161831685|NCT04213209|584426930|FG000|Overall Study|Protocol Violation|1|||
161831686|NCT04213209|584426931|FG001|Overall Study|Protocol Violation|0|||
161831687|NCT04213209|584426932|FG002|Overall Study|Protocol Violation|0|||
161831688|NCT04213209|584426933|FG003|Overall Study|Protocol Violation|0|||
161831689|NCT04213209|584426934|FG004|Overall Study|Protocol Violation|0|||
161831690|NCT04213209|584426935|FG005|Overall Study|Protocol Violation|0|||
161831691|NCT00440466|584426937|FG000|Overall Study|Death|3|||
161831692|NCT00440466|584426938|FG001|Overall Study|Death|2|||
161831693|NCT00440466|584426939|FG002|Overall Study|Death|9|||
161831694|NCT00440466|584426937|FG000|Overall Study|Adverse Event|3|||
161831695|NCT00440466|584426938|FG001|Overall Study|Adverse Event|4|||
161831696|NCT00440466|584426939|FG002|Overall Study|Adverse Event|11|||
161831697|NCT00440466|584426937|FG000|Overall Study|Lost to Follow-up|1|||
161831698|NCT00440466|584426938|FG001|Overall Study|Lost to Follow-up|0|||
161831699|NCT00440466|584426939|FG002|Overall Study|Lost to Follow-up|2|||
161831700|NCT00440466|584426937|FG000|Overall Study|Physician Decision|2|||
161831701|NCT00440466|584426938|FG001|Overall Study|Physician Decision|0|||
161831702|NCT00440466|584426939|FG002|Overall Study|Physician Decision|1|||
161831703|NCT00440466|584426937|FG000|Overall Study|Protocol Violation|2|||
161831704|NCT00440466|584426938|FG001|Overall Study|Protocol Violation|0|||
161831705|NCT00440466|584426939|FG002|Overall Study|Protocol Violation|4|||
161831706|NCT00440466|584426937|FG000|Overall Study|Withdrawal by Subject|2|||
161831707|NCT00440466|584426938|FG001|Overall Study|Withdrawal by Subject|5|||
161831708|NCT00440466|584426939|FG002|Overall Study|Withdrawal by Subject|9|||
161831709|NCT00440466|584426937|FG000|Overall Study|Began Dialysis|0|||
161683127|NCT00841568|583891276|FG000|Overall Study|Death|1|||
161683128|NCT00841568|583891276|FG000|Overall Study|Withdrawal by Subject|2|||
161683129|NCT00841568|583891276|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
161683130|NCT03002155|583891277|FG000|Overall Study|Lost to Follow-up|1|||
161683131|NCT03002155|583891278|FG001|Overall Study|Lost to Follow-up|2|||
161683132|NCT03002155|583891277|FG000|Overall Study|Withdrawal by Subject|1|||
161683133|NCT03002155|583891278|FG001|Overall Study|Withdrawal by Subject|0|||
161683134|NCT03002155|583891277|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
161831710|NCT00440466|584426938|FG001|Overall Study|Began Dialysis|0|||
161831711|NCT00440466|584426939|FG002|Overall Study|Began Dialysis|1|||
161831712|NCT00440466|584426937|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
161831713|NCT00440466|584426938|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
161831714|NCT00440466|584426939|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
161831715|NCT02065713|584426940|FG000|Overall Study|Adverse Event|0|||
161831716|NCT02065713|584426941|FG001|Overall Study|Adverse Event|1|||
161831717|NCT02065713|584426940|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161831718|NCT02065713|584426941|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161831719|NCT01223235|584426944|FG000|Overall Study|Withdrawal by Subject|1|||
161831720|NCT01014624|584426947|FG000|Overall Study|Adverse Event|0|||
161831721|NCT01014624|584426948|FG001|Overall Study|Adverse Event|1|||
161831722|NCT01014624|584426947|FG000|Overall Study|Protocol Violation|1|||
161831723|NCT01014624|584426948|FG001|Overall Study|Protocol Violation|0|||
161831724|NCT01014624|584426947|FG000|Overall Study|Withdrawal by Subject|1|||
161831725|NCT01014624|584426948|FG001|Overall Study|Withdrawal by Subject|0|||
161831726|NCT00754442|584426951|FG000|Overall Study|Withdrawal by Subject|5|||
161831727|NCT00754442|584426952|FG001|Overall Study|Withdrawal by Subject|3|||
161831728|NCT05560763|584426957|FG000|Overall Study|Withdrawal by Subject|4|||
161831729|NCT00296491|584426960|FG000|Overall Study|Low Pollen Counts|18|||
161831730|NCT00296491|584426961|FG001|Overall Study|Low Pollen Counts|26|||
161831731|NCT00296491|584426962|FG002|Overall Study|Low Pollen Counts|25|||
161831732|NCT00296491|584426963|FG003|Overall Study|Low Pollen Counts|16|||
161831733|NCT00296491|584426960|FG000|Overall Study|Protocol Violation|4|||
161831734|NCT00296491|584426961|FG001|Overall Study|Protocol Violation|6|||
161831735|NCT00296491|584426962|FG002|Overall Study|Protocol Violation|2|||
161831736|NCT00296491|584426963|FG003|Overall Study|Protocol Violation|3|||
161831737|NCT00296491|584426960|FG000|Overall Study|Adverse Event|1|||
161831738|NCT00296491|584426961|FG001|Overall Study|Adverse Event|3|||
161831739|NCT00296491|584426962|FG002|Overall Study|Adverse Event|1|||
161831740|NCT00296491|584426963|FG003|Overall Study|Adverse Event|4|||
161831741|NCT00296491|584426960|FG000|Overall Study|Withdrawn due to Asthma|0|||
161831742|NCT00296491|584426961|FG001|Overall Study|Withdrawn due to Asthma|0|||
161831743|NCT00296491|584426962|FG002|Overall Study|Withdrawn due to Asthma|0|||
161831744|NCT00296491|584426963|FG003|Overall Study|Withdrawn due to Asthma|4|||
161831745|NCT00296491|584426960|FG000|Overall Study|Withdrawal by Subject|7|||
161831746|NCT00296491|584426961|FG001|Overall Study|Withdrawal by Subject|3|||
161831747|NCT00296491|584426962|FG002|Overall Study|Withdrawal by Subject|3|||
161831748|NCT00296491|584426963|FG003|Overall Study|Withdrawal by Subject|2|||
161831749|NCT00296491|584426960|FG000|Overall Study|Non-Compliance|12|||
161831750|NCT00296491|584426961|FG001|Overall Study|Non-Compliance|13|||
161831751|NCT00296491|584426962|FG002|Overall Study|Non-Compliance|10|||
161831752|NCT00296491|584426963|FG003|Overall Study|Non-Compliance|14|||
161831753|NCT00296491|584426960|FG000|Overall Study|Lost to Follow-up|0|||
161831754|NCT00296491|584426961|FG001|Overall Study|Lost to Follow-up|2|||
161831755|NCT00296491|584426962|FG002|Overall Study|Lost to Follow-up|2|||
161831756|NCT00296491|584426963|FG003|Overall Study|Lost to Follow-up|0|||
161831757|NCT01929395|584426965|FG000|Overall Study|Did not complete - non-related toxicity|1|||
161831758|NCT01929395|584426966|FG001|Overall Study|Did not complete - non-related toxicity|0|||
161831759|NCT01929395|584426967|FG002|Overall Study|Did not complete - non-related toxicity|0|||
161831760|NCT01929395|584426965|FG000|Overall Study|Withdrawal by Subject|0|||
161831761|NCT01929395|584426966|FG001|Overall Study|Withdrawal by Subject|1|||
161831762|NCT01929395|584426967|FG002|Overall Study|Withdrawal by Subject|0|||
161831763|NCT01929395|584426965|FG000|Overall Study|Screen Fail|0|||
161831764|NCT01929395|584426966|FG001|Overall Study|Screen Fail|0|||
161831765|NCT01929395|584426967|FG002|Overall Study|Screen Fail|1|||
161831766|NCT00484419|584426969|FG000|Overall Study|Adverse Event|3|||
161831767|NCT00484419|584426970|FG001|Overall Study|Adverse Event|0|||
161831768|NCT00484419|584426971|FG002|Overall Study|Adverse Event|0|||
161831769|NCT00484419|584426969|FG000|Overall Study|Lost to Follow-up|1|||
161831770|NCT00484419|584426970|FG001|Overall Study|Lost to Follow-up|0|||
161831771|NCT00484419|584426971|FG002|Overall Study|Lost to Follow-up|2|||
161831772|NCT00484419|584426969|FG000|Overall Study|Withdrawal by Subject|3|||
161831773|NCT00484419|584426970|FG001|Overall Study|Withdrawal by Subject|1|||
161831774|NCT00484419|584426971|FG002|Overall Study|Withdrawal by Subject|1|||
161831775|NCT00484419|584426969|FG000|Overall Study|subject met discontinuation criteria|2|||
161603734|NCT04464564|583603324|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
161603735|NCT04464564|583603325|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
161603736|NCT04464564|583603326|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
161603737|NCT04464564|583603327|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
161603738|NCT04464564|583603324|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
161603739|NCT04464564|583603325|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
161603740|NCT04464564|583603326|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
161603741|NCT04464564|583603327|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
161603742|NCT04464564|583603324|FG000|Period B (Randomization Period)|Reason not Specified|0|||
161603743|NCT04464564|583603325|FG001|Period B (Randomization Period)|Reason not Specified|3|||
161603744|NCT04464564|583603326|FG002|Period B (Randomization Period)|Reason not Specified|3|||
161603745|NCT04464564|583603327|FG003|Period B (Randomization Period)|Reason not Specified|3|||
161603746|NCT03786926|583603330|FG000|Overall Study|Adverse Event|0|||
161603747|NCT03786926|583603331|FG001|Overall Study|Adverse Event|0|||
161603748|NCT03786926|583603332|FG002|Overall Study|Adverse Event|0|||
161603749|NCT03786926|583603333|FG003|Overall Study|Adverse Event|0|||
161603750|NCT03786926|583603334|FG004|Overall Study|Adverse Event|0|||
161603751|NCT03786926|583603335|FG005|Overall Study|Adverse Event|0|||
161603752|NCT03786926|583603336|FG006|Overall Study|Adverse Event|0|||
161603753|NCT03786926|583603337|FG007|Overall Study|Adverse Event|1|||
161603754|NCT03786926|583603338|FG008|Overall Study|Adverse Event|1|||
161603755|NCT03786926|583603339|FG009|Overall Study|Adverse Event|0|||
161603756|NCT03786926|583603340|FG010|Overall Study|Adverse Event|1|||
161603757|NCT03786926|583603330|FG000|Overall Study|Progressive disease|3|||
161603758|NCT03786926|583603331|FG001|Overall Study|Progressive disease|0|||
161603759|NCT03786926|583603332|FG002|Overall Study|Progressive disease|3|||
161603760|NCT03786926|583603333|FG003|Overall Study|Progressive disease|1|||
161603761|NCT03786926|583603334|FG004|Overall Study|Progressive disease|2|||
161603762|NCT03786926|583603335|FG005|Overall Study|Progressive disease|2|||
161603763|NCT03786926|583603336|FG006|Overall Study|Progressive disease|1|||
161603764|NCT03786926|583603337|FG007|Overall Study|Progressive disease|6|||
161831776|NCT00484419|584426970|FG001|Overall Study|subject met discontinuation criteria|2|||
161603765|NCT03786926|583603338|FG008|Overall Study|Progressive disease|1|||
161603766|NCT03786926|583603339|FG009|Overall Study|Progressive disease|1|||
161831777|NCT00484419|584426971|FG002|Overall Study|subject met discontinuation criteria|4|||
161831778|NCT00484419|584426969|FG000|Overall Study|required restricted medication|1|||
161831779|NCT00484419|584426970|FG001|Overall Study|required restricted medication|0|||
161831780|NCT00484419|584426971|FG002|Overall Study|required restricted medication|1|||
161831781|NCT00484419|584426969|FG000|Overall Study|Physician Decision|1|||
161831782|NCT00484419|584426970|FG001|Overall Study|Physician Decision|1|||
161831783|NCT00484419|584426971|FG002|Overall Study|Physician Decision|1|||
161831784|NCT00484419|584426969|FG000|Overall Study|subject unable to receive medication|1|||
161831785|NCT00484419|584426970|FG001|Overall Study|subject unable to receive medication|0|||
161831786|NCT00484419|584426971|FG002|Overall Study|subject unable to receive medication|0|||
161831787|NCT00484419|584426969|FG000|Overall Study|subject relocated|0|||
161831788|NCT00484419|584426970|FG001|Overall Study|subject relocated|1|||
161831789|NCT00484419|584426971|FG002|Overall Study|subject relocated|0|||
161831790|NCT00484419|584426969|FG000|Overall Study|sponsor decision, randomized in error|0|||
161831791|NCT00484419|584426970|FG001|Overall Study|sponsor decision, randomized in error|0|||
161831792|NCT00484419|584426971|FG002|Overall Study|sponsor decision, randomized in error|2|||
161831793|NCT03604341|584426972|FG000|Overall Study|Withdrawal by Subject|1|||
161831794|NCT03604341|584426973|FG001|Overall Study|Withdrawal by Subject|1|||
161831795|NCT03604341|584426972|FG000|Overall Study|Adverse Event|1|||
161831796|NCT03604341|584426973|FG001|Overall Study|Adverse Event|0|||
161831797|NCT03604341|584426972|FG000|Overall Study|Protocol Violation|0|||
161831798|NCT03604341|584426973|FG001|Overall Study|Protocol Violation|1|||
161831799|NCT01829113|584426974|FG000|Overall Study|Disease Progression|37|||
161831800|NCT01829113|584426975|FG001|Overall Study|Disease Progression|48|||
161831801|NCT01829113|584426974|FG000|Overall Study|Adverse Event|14|||
161831802|NCT01829113|584426975|FG001|Overall Study|Adverse Event|10|||
161831803|NCT01829113|584426974|FG000|Overall Study|Withdrawal by Subject|17|||
161831804|NCT01829113|584426975|FG001|Overall Study|Withdrawal by Subject|10|||
161831805|NCT01829113|584426974|FG000|Overall Study|Death|4|||
161831806|NCT01829113|584426975|FG001|Overall Study|Death|6|||
161831807|NCT01829113|584426974|FG000|Overall Study|Sponsor Decision|1|||
161831808|NCT01829113|584426975|FG001|Overall Study|Sponsor Decision|1|||
161831809|NCT01829113|584426974|FG000|Overall Study|No Study Treatment Received|3|||
161831810|NCT01829113|584426975|FG001|Overall Study|No Study Treatment Received|2|||
161831811|NCT01829113|584426974|FG000|Overall Study|Physician Decision|1|||
161831812|NCT01829113|584426975|FG001|Overall Study|Physician Decision|1|||
161831813|NCT01740791|584426976|FG000|Overall Study|Randomized but never treated|5|||
161831814|NCT01740791|584426977|FG001|Overall Study|Randomized but never treated|3|||
161831815|NCT01740791|584426978|FG002|Overall Study|Randomized but never treated|2|||
161603767|NCT03786926|583603340|FG010|Overall Study|Progressive disease|1|||
161603768|NCT03786926|583603330|FG000|Overall Study|Death|0|||
161831816|NCT01740791|584426979|FG003|Overall Study|Randomized but never treated|2|||
161831817|NCT01740791|584426980|FG004|Overall Study|Randomized but never treated|1|||
161831818|NCT01740791|584426981|FG005|Overall Study|Randomized but never treated|3|||
161831819|NCT01740791|584426976|FG000|Overall Study|Lost to Follow-up|2|||
161831820|NCT01740791|584426977|FG001|Overall Study|Lost to Follow-up|0|||
161831821|NCT01740791|584426978|FG002|Overall Study|Lost to Follow-up|2|||
161831822|NCT01740791|584426979|FG003|Overall Study|Lost to Follow-up|3|||
161831823|NCT01740791|584426980|FG004|Overall Study|Lost to Follow-up|2|||
161831824|NCT01740791|584426981|FG005|Overall Study|Lost to Follow-up|3|||
161831825|NCT01740791|584426976|FG000|Overall Study|Withdrew Consent|4|||
161831826|NCT01740791|584426977|FG001|Overall Study|Withdrew Consent|0|||
161831827|NCT01740791|584426978|FG002|Overall Study|Withdrew Consent|1|||
161831828|NCT01740791|584426979|FG003|Overall Study|Withdrew Consent|2|||
161831829|NCT01740791|584426980|FG004|Overall Study|Withdrew Consent|0|||
161831830|NCT01740791|584426981|FG005|Overall Study|Withdrew Consent|3|||
161831831|NCT01740791|584426976|FG000|Overall Study|Investigator's discretion|1|||
161831832|NCT01740791|584426977|FG001|Overall Study|Investigator's discretion|0|||
161831833|NCT01740791|584426978|FG002|Overall Study|Investigator's discretion|1|||
161831834|NCT01740791|584426979|FG003|Overall Study|Investigator's discretion|0|||
161831835|NCT01740791|584426980|FG004|Overall Study|Investigator's discretion|0|||
161831836|NCT01740791|584426981|FG005|Overall Study|Investigator's discretion|1|||
161831837|NCT01740791|584426976|FG000|Overall Study|Adverse Event|0|||
161831838|NCT01740791|584426977|FG001|Overall Study|Adverse Event|0|||
161831839|NCT01740791|584426978|FG002|Overall Study|Adverse Event|0|||
161831840|NCT01740791|584426979|FG003|Overall Study|Adverse Event|0|||
161831841|NCT01740791|584426980|FG004|Overall Study|Adverse Event|0|||
161831842|NCT01740791|584426981|FG005|Overall Study|Adverse Event|1|||
161831843|NCT02674386|584426984|FG000|Overall Study|Lost to Follow-up|0|||
161831844|NCT02674386|584426985|FG001|Overall Study|Lost to Follow-up|1|||
161831845|NCT02674386|584426986|FG002|Overall Study|Lost to Follow-up|1|||
161831846|NCT02674386|584426984|FG000|Overall Study|Withdrawal by Subject|0|||
161831847|NCT02674386|584426985|FG001|Overall Study|Withdrawal by Subject|4|||
161831848|NCT02674386|584426986|FG002|Overall Study|Withdrawal by Subject|0|||
161831849|NCT02674386|584426984|FG000|Overall Study|Other|0|||
161831850|NCT02674386|584426985|FG001|Overall Study|Other|1|||
161831851|NCT02674386|584426986|FG002|Overall Study|Other|0|||
161831852|NCT02674386|584426984|FG000|Overall Study|Enrolled but not evaluated|0|||
161831853|NCT02674386|584426985|FG001|Overall Study|Enrolled but not evaluated|4|||
161831854|NCT02674386|584426986|FG002|Overall Study|Enrolled but not evaluated|0|||
161831855|NCT02462486|584426991|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161831856|NCT02462486|584426992|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161831857|NCT02462486|584426993|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
161831858|NCT02462486|584426991|FG000|Overall Study|Adverse Event|53|||
161831859|NCT02462486|584426992|FG001|Overall Study|Adverse Event|48|||
161831860|NCT02462486|584426993|FG002|Overall Study|Adverse Event|21|||
161831861|NCT02462486|584426991|FG000|Overall Study|Lack of Efficacy|6|||
161831862|NCT02462486|584426992|FG001|Overall Study|Lack of Efficacy|12|||
161831863|NCT02462486|584426993|FG002|Overall Study|Lack of Efficacy|3|||
161831864|NCT02462486|584426991|FG000|Overall Study|Lost to Follow-up|3|||
161831865|NCT02462486|584426992|FG001|Overall Study|Lost to Follow-up|4|||
161831866|NCT02462486|584426993|FG002|Overall Study|Lost to Follow-up|2|||
161831867|NCT02462486|584426991|FG000|Overall Study|Withdrawal by Subject|25|||
161831868|NCT02462486|584426992|FG001|Overall Study|Withdrawal by Subject|22|||
161831869|NCT02462486|584426993|FG002|Overall Study|Withdrawal by Subject|19|||
161831870|NCT02462486|584426991|FG000|Overall Study|Protocol Violation|3|||
161831871|NCT02462486|584426992|FG001|Overall Study|Protocol Violation|1|||
161831872|NCT02462486|584426993|FG002|Overall Study|Protocol Violation|1|||
161831873|NCT02462486|584426991|FG000|Overall Study|Reason not Specified|3|||
161831874|NCT02462486|584426992|FG001|Overall Study|Reason not Specified|4|||
161831875|NCT02462486|584426993|FG002|Overall Study|Reason not Specified|3|||
161831876|NCT04706507|584426994|FG000|Overall Study|Death|45|||
161831877|NCT04706507|584426995|FG001|Overall Study|Death|22|||
161831878|NCT04706507|584426994|FG000|Overall Study|Unable to adhere|0|||
161831879|NCT04706507|584426995|FG001|Overall Study|Unable to adhere|2|||
161831880|NCT04706507|584426994|FG000|Overall Study|Lost to Follow-up|13|||
161831881|NCT04706507|584426995|FG001|Overall Study|Lost to Follow-up|12|||
161831882|NCT04706507|584426994|FG000|Overall Study|Withdrawal of consent|1|||
161831883|NCT04706507|584426995|FG001|Overall Study|Withdrawal of consent|1|||
161831884|NCT04706507|584426994|FG000|Overall Study|Patient or LAR refuses further participation|0|||
161831885|NCT04706507|584426995|FG001|Overall Study|Patient or LAR refuses further participation|3|||
161831886|NCT04099641|584427000|FG000|Overall Study|Death|46|||
161831887|NCT04099641|584427001|FG001|Overall Study|Death|12|||
161831888|NCT04099641|584427000|FG000|Overall Study|Lost to Follow-up|1|||
161831889|NCT04099641|584427001|FG001|Overall Study|Lost to Follow-up|0|||
161831890|NCT04099641|584427000|FG000|Overall Study|Withdrawal by Subject|2|||
161831891|NCT04099641|584427001|FG001|Overall Study|Withdrawal by Subject|0|||
161831892|NCT02470091|584427003|FG000|Overall Study|Withdrawal by Subject|1|||
161831893|NCT02470091|584427004|FG001|Overall Study|Withdrawal by Subject|0|||
161831894|NCT02470091|584427003|FG000|Overall Study|Ineligible|0|||
161831895|NCT02470091|584427004|FG001|Overall Study|Ineligible|2|||
161831896|NCT00303667|584427006|FG000|Overall Study|Death|0|||
161831897|NCT00303667|584427007|FG001|Overall Study|Death|4|||
161831898|NCT01029392|584427008|FG000|Overall Study|Withdrawal by Subject|18|||
161831899|NCT01029392|584427009|FG001|Overall Study|Withdrawal by Subject|11|||
161831900|NCT01029392|584427008|FG000|Overall Study|Physician Decision|2|||
161831901|NCT01029392|584427009|FG001|Overall Study|Physician Decision|0|||
161831902|NCT01103479|584427010|FG000|Overall Study|Up to date with CRC screening|1|||
161831903|NCT01103479|584427011|FG001|Overall Study|Up to date with CRC screening|9|||
161831904|NCT01103479|584427012|FG002|Overall Study|Up to date with CRC screening|12|||
161831905|NCT01103479|584427010|FG000|Overall Study|Family history of CRC|1|||
161831906|NCT01103479|584427011|FG001|Overall Study|Family history of CRC|0|||
161831907|NCT01103479|584427012|FG002|Overall Study|Family history of CRC|2|||
161831908|NCT01103479|584427010|FG000|Overall Study|Active cancer|1|||
161831909|NCT01103479|584427011|FG001|Overall Study|Active cancer|0|||
161831910|NCT01103479|584427012|FG002|Overall Study|Active cancer|0|||
161831911|NCT01103479|584427010|FG000|Overall Study|Saw non-study physician|2|||
161831912|NCT01103479|584427011|FG001|Overall Study|Saw non-study physician|0|||
161831913|NCT01103479|584427012|FG002|Overall Study|Saw non-study physician|0|||
161831914|NCT01523587|584427013|FG000|Overall Study|Other than listed|5|||
161831915|NCT01523587|584427014|FG001|Overall Study|Other than listed|5|||
161831916|NCT01523587|584427013|FG000|Overall Study|Worsening of underlying cancer disease|19|||
161831917|NCT01523587|584427014|FG001|Overall Study|Worsening of underlying cancer disease|34|||
161831918|NCT01523587|584427013|FG000|Overall Study|Adverse Event|68|||
161603769|NCT03786926|583603331|FG001|Overall Study|Death|1|||
161603770|NCT03786926|583603332|FG002|Overall Study|Death|1|||
161603771|NCT03786926|583603333|FG003|Overall Study|Death|0|||
161603772|NCT03786926|583603334|FG004|Overall Study|Death|0|||
161603773|NCT03786926|583603335|FG005|Overall Study|Death|0|||
161603774|NCT03786926|583603336|FG006|Overall Study|Death|0|||
161603775|NCT03786926|583603337|FG007|Overall Study|Death|0|||
161603776|NCT03786926|583603338|FG008|Overall Study|Death|0|||
161603777|NCT03786926|583603339|FG009|Overall Study|Death|1|||
161603778|NCT03786926|583603340|FG010|Overall Study|Death|2|||
161603779|NCT03786926|583603330|FG000|Overall Study|Physician Decision|0|||
161603780|NCT03786926|583603331|FG001|Overall Study|Physician Decision|1|||
161831919|NCT01523587|584427014|FG001|Overall Study|Adverse Event|52|||
161831920|NCT01523587|584427013|FG000|Overall Study|Protocol Violation|5|||
161831921|NCT01523587|584427014|FG001|Overall Study|Protocol Violation|3|||
161831922|NCT01523587|584427013|FG000|Overall Study|Lost to Follow-up|2|||
161831923|NCT01523587|584427014|FG001|Overall Study|Lost to Follow-up|2|||
161831924|NCT01523587|584427013|FG000|Overall Study|Withdrawal by Subject|28|||
161831925|NCT01523587|584427014|FG001|Overall Study|Withdrawal by Subject|20|||
161831926|NCT01523587|584427013|FG000|Overall Study|Withdrew due to Progressive disease|265|||
161831927|NCT01523587|584427014|FG001|Overall Study|Withdrew due to Progressive disease|279|||
161831928|NCT01523587|584427013|FG000|Overall Study|Randomised but bot treated|6|||
161831929|NCT01523587|584427014|FG001|Overall Study|Randomised but bot treated|2|||
161831930|NCT01298778|584427015|FG000|Overall Study|Lost to Follow-up|2|||
161831931|NCT01298778|584427016|FG001|Overall Study|Lost to Follow-up|3|||
161831932|NCT01298778|584427015|FG000|Overall Study|Incorrect use of VAS|1|||
161831933|NCT01298778|584427016|FG001|Overall Study|Incorrect use of VAS|0|||
161831934|NCT01298778|584427015|FG000|Overall Study|Withdrawal by Subject|0|||
161831935|NCT01298778|584427016|FG001|Overall Study|Withdrawal by Subject|1|||
161831936|NCT01298778|584427015|FG000|Overall Study|Protocol Violation|0|||
161831937|NCT01298778|584427016|FG001|Overall Study|Protocol Violation|1|||
161831938|NCT01298778|584427015|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
161831939|NCT01298778|584427016|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
161831940|NCT02709486|584427017|FG000|Overall Study|Adverse Event|2|||
161831941|NCT02709486|584427018|FG001|Overall Study|Adverse Event|5|||
161831942|NCT02709486|584427019|FG002|Overall Study|Adverse Event|3|||
161831943|NCT02709486|584427017|FG000|Overall Study|Death|0|||
161831944|NCT02709486|584427018|FG001|Overall Study|Death|0|||
161831945|NCT02709486|584427019|FG002|Overall Study|Death|2|||
161831946|NCT02709486|584427017|FG000|Overall Study|Insufficient clinical response|7|||
161603781|NCT03786926|583603332|FG002|Overall Study|Physician Decision|0|||
161603782|NCT03786926|583603333|FG003|Overall Study|Physician Decision|1|||
161603783|NCT03786926|583603334|FG004|Overall Study|Physician Decision|2|||
161831947|NCT02709486|584427018|FG001|Overall Study|Insufficient clinical response|3|||
161831948|NCT02709486|584427019|FG002|Overall Study|Insufficient clinical response|3|||
161831949|NCT02709486|584427017|FG000|Overall Study|Lost to Follow-up|3|||
161831950|NCT02709486|584427018|FG001|Overall Study|Lost to Follow-up|2|||
161831951|NCT02709486|584427019|FG002|Overall Study|Lost to Follow-up|2|||
161831952|NCT02709486|584427017|FG000|Overall Study|Other|0|||
161831953|NCT02709486|584427018|FG001|Overall Study|Other|2|||
161831954|NCT02709486|584427019|FG002|Overall Study|Other|3|||
161831955|NCT02709486|584427017|FG000|Overall Study|Withdrawal by Subject|32|||
161831956|NCT02709486|584427018|FG001|Overall Study|Withdrawal by Subject|22|||
161831957|NCT02709486|584427019|FG002|Overall Study|Withdrawal by Subject|32|||
161831958|NCT00384176|584427026|FG000|Overall Study|Death|239|||
161831959|NCT00384176|584427027|FG001|Overall Study|Death|247|||
161831960|NCT00384176|584427028|FG002|Overall Study|Death|105|||
161831961|NCT00384176|584427026|FG000|Overall Study|Withdrawal by Subject|52|||
161831962|NCT00384176|584427027|FG001|Overall Study|Withdrawal by Subject|48|||
161831963|NCT00384176|584427028|FG002|Overall Study|Withdrawal by Subject|22|||
161831964|NCT00384176|584427026|FG000|Overall Study|Lost to Follow-up|16|||
161831965|NCT00384176|584427027|FG001|Overall Study|Lost to Follow-up|18|||
161831966|NCT00384176|584427028|FG002|Overall Study|Lost to Follow-up|4|||
161831967|NCT00384176|584427026|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
161831968|NCT00384176|584427027|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
161831969|NCT00384176|584427028|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
161831970|NCT00384176|584427026|FG000|Overall Study|Longer QTC as Visit 1|1|||
161831971|NCT00384176|584427027|FG001|Overall Study|Longer QTC as Visit 1|0|||
161831972|NCT00384176|584427028|FG002|Overall Study|Longer QTC as Visit 1|0|||
161831973|NCT00384176|584427026|FG000|Overall Study|Toxicity of treatment|1|||
161831974|NCT00384176|584427027|FG001|Overall Study|Toxicity of treatment|0|||
161831975|NCT00384176|584427028|FG002|Overall Study|Toxicity of treatment|0|||
161831976|NCT00384176|584427026|FG000|Overall Study|Did not receive study treatment|0|||
161831977|NCT00384176|584427027|FG001|Overall Study|Did not receive study treatment|1|||
161831978|NCT00384176|584427028|FG002|Overall Study|Did not receive study treatment|1|||
161831979|NCT00384176|584427026|FG000|Overall Study|Physician Decision|0|||
161831980|NCT00384176|584427027|FG001|Overall Study|Physician Decision|2|||
161831981|NCT00384176|584427028|FG002|Overall Study|Physician Decision|0|||
161831982|NCT00384176|584427026|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
161831983|NCT00384176|584427027|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
161831984|NCT00384176|584427028|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
161831985|NCT02691741|584427029|FG000|Overall Study|Adverse Event|0|||
161831986|NCT02691741|584427030|FG001|Overall Study|Adverse Event|2|||
161831987|NCT02691741|584427029|FG000|Overall Study|Lost to Follow-up|1|||
161831988|NCT02691741|584427030|FG001|Overall Study|Lost to Follow-up|0|||
161831989|NCT02691741|584427029|FG000|Overall Study|Physician Decision|0|||
161831990|NCT02691741|584427030|FG001|Overall Study|Physician Decision|1|||
161831991|NCT02691741|584427029|FG000|Overall Study|Withdrawal by Subject|0|||
161831992|NCT02691741|584427030|FG001|Overall Study|Withdrawal by Subject|4|||
161831993|NCT03465436|584427031|FG000|Period 1|Protocol Violation|0|||
161831994|NCT03465436|584427032|FG001|Period 1|Protocol Violation|0|||
161831995|NCT03465436|584427033|FG002|Period 1|Protocol Violation|1|||
161831996|NCT03465436|584427034|FG003|Period 1|Protocol Violation|0|||
161831997|NCT03465436|584427031|FG000|Period 2|Protocol Violation|0|||
161831998|NCT03465436|584427032|FG001|Period 2|Protocol Violation|1|||
161831999|NCT03465436|584427033|FG002|Period 2|Protocol Violation|0|||
161832000|NCT03465436|584427034|FG003|Period 2|Protocol Violation|0|||
161832001|NCT03465436|584427031|FG000|Period 3|Protocol Violation|1|||
161832002|NCT03465436|584427032|FG001|Period 3|Protocol Violation|1|||
161832003|NCT03465436|584427033|FG002|Period 3|Protocol Violation|0|||
161832004|NCT03465436|584427034|FG003|Period 3|Protocol Violation|0|||
161832005|NCT03465436|584427031|FG000|Period 4|Protocol Violation|0|||
161603784|NCT03786926|583603335|FG005|Overall Study|Physician Decision|0|||
161832006|NCT03465436|584427032|FG001|Period 4|Protocol Violation|0|||
161832007|NCT03465436|584427033|FG002|Period 4|Protocol Violation|1|||
161832008|NCT03465436|584427034|FG003|Period 4|Protocol Violation|0|||
161832009|NCT01425528|584427035|FG000|Overall Study|Withdrawal by Subject|1|||
161832010|NCT01425528|584427036|FG001|Overall Study|Withdrawal by Subject|1|||
161832011|NCT02697773|584427037|FG000|Overall Study|Adverse Event|2|||
161832012|NCT02697773|584427038|FG001|Overall Study|Adverse Event|1|||
161832013|NCT02697773|584427039|FG002|Overall Study|Adverse Event|2|||
161832014|NCT02697773|584427037|FG000|Overall Study|Death|0|||
161832015|NCT02697773|584427038|FG001|Overall Study|Death|0|||
161832016|NCT02697773|584427039|FG002|Overall Study|Death|2|||
161832017|NCT02697773|584427037|FG000|Overall Study|Lack of Efficacy|4|||
161832018|NCT02697773|584427038|FG001|Overall Study|Lack of Efficacy|6|||
161832019|NCT02697773|584427039|FG002|Overall Study|Lack of Efficacy|6|||
161832020|NCT02697773|584427037|FG000|Overall Study|Lost to Follow-up|5|||
161832021|NCT02697773|584427038|FG001|Overall Study|Lost to Follow-up|5|||
161832022|NCT02697773|584427039|FG002|Overall Study|Lost to Follow-up|7|||
161832023|NCT02697773|584427037|FG000|Overall Study|Other|15|||
161832024|NCT02697773|584427038|FG001|Overall Study|Other|11|||
161603785|NCT03786926|583603336|FG006|Overall Study|Physician Decision|0|||
161603786|NCT03786926|583603337|FG007|Overall Study|Physician Decision|2|||
161603787|NCT03786926|583603338|FG008|Overall Study|Physician Decision|1|||
161603788|NCT03786926|583603339|FG009|Overall Study|Physician Decision|1|||
161603789|NCT03786926|583603340|FG010|Overall Study|Physician Decision|0|||
161603790|NCT03786926|583603330|FG000|Overall Study|Withdrawal by Subject|0|||
161603791|NCT03786926|583603331|FG001|Overall Study|Withdrawal by Subject|1|||
161603792|NCT03786926|583603332|FG002|Overall Study|Withdrawal by Subject|1|||
161603793|NCT03786926|583603333|FG003|Overall Study|Withdrawal by Subject|0|||
161603794|NCT03786926|583603334|FG004|Overall Study|Withdrawal by Subject|0|||
161603795|NCT03786926|583603335|FG005|Overall Study|Withdrawal by Subject|0|||
161603796|NCT03786926|583603336|FG006|Overall Study|Withdrawal by Subject|1|||
161603797|NCT03786926|583603337|FG007|Overall Study|Withdrawal by Subject|0|||
161603798|NCT03786926|583603338|FG008|Overall Study|Withdrawal by Subject|1|||
161603799|NCT03786926|583603339|FG009|Overall Study|Withdrawal by Subject|0|||
161603800|NCT03786926|583603340|FG010|Overall Study|Withdrawal by Subject|1|||
161603801|NCT03786926|583603330|FG000|Overall Study|Study terminated by Sponsor|0|||
161603802|NCT03786926|583603331|FG001|Overall Study|Study terminated by Sponsor|0|||
161603803|NCT03786926|583603332|FG002|Overall Study|Study terminated by Sponsor|0|||
161603804|NCT03786926|583603333|FG003|Overall Study|Study terminated by Sponsor|0|||
161603805|NCT03786926|583603334|FG004|Overall Study|Study terminated by Sponsor|1|||
161603806|NCT03786926|583603335|FG005|Overall Study|Study terminated by Sponsor|0|||
161603807|NCT03786926|583603336|FG006|Overall Study|Study terminated by Sponsor|0|||
161603808|NCT03786926|583603337|FG007|Overall Study|Study terminated by Sponsor|4|||
161603809|NCT03786926|583603338|FG008|Overall Study|Study terminated by Sponsor|0|||
161603810|NCT03786926|583603339|FG009|Overall Study|Study terminated by Sponsor|0|||
161683135|NCT03002155|583891278|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
161683136|NCT00974675|583891281|FG000|Overall Study|Adverse Event|2|||
161683137|NCT00974675|583891282|FG001|Overall Study|Adverse Event|1|||
161683138|NCT00974675|583891283|FG002|Overall Study|Adverse Event|1|||
161683139|NCT00974675|583891284|FG003|Overall Study|Adverse Event|1|||
161683140|NCT00974675|583891281|FG000|Overall Study|Physician Decision|0|||
161683141|NCT00974675|583891282|FG001|Overall Study|Physician Decision|0|||
161683142|NCT00974675|583891283|FG002|Overall Study|Physician Decision|1|||
161683143|NCT00974675|583891284|FG003|Overall Study|Physician Decision|0|||
161683144|NCT00974675|583891281|FG000|Overall Study|Participant on holiday; unable to attend|0|||
161683145|NCT00974675|583891282|FG001|Overall Study|Participant on holiday; unable to attend|0|||
161832025|NCT02697773|584427039|FG002|Overall Study|Other|10|||
161832026|NCT02697773|584427037|FG000|Overall Study|Protocol Violation|1|||
161832027|NCT02697773|584427038|FG001|Overall Study|Protocol Violation|1|||
161832028|NCT02697773|584427039|FG002|Overall Study|Protocol Violation|0|||
161832029|NCT02697773|584427037|FG000|Overall Study|Withdrawal by Subject|10|||
161832030|NCT02697773|584427038|FG001|Overall Study|Withdrawal by Subject|13|||
161832031|NCT02697773|584427039|FG002|Overall Study|Withdrawal by Subject|13|||
161832032|NCT02697773|584427037|FG000|Overall Study|Randomized but not treated|1|||
161832033|NCT02697773|584427038|FG001|Overall Study|Randomized but not treated|1|||
161832034|NCT02697773|584427039|FG002|Overall Study|Randomized but not treated|0|||
161603811|NCT03786926|583603340|FG010|Overall Study|Study terminated by Sponsor|0|||
161603812|NCT03786926|583603330|FG000|Overall Study|Anti-neoplasm treatment|0|||
161603813|NCT03786926|583603331|FG001|Overall Study|Anti-neoplasm treatment|0|||
161603814|NCT03786926|583603332|FG002|Overall Study|Anti-neoplasm treatment|0|||
161603815|NCT03786926|583603333|FG003|Overall Study|Anti-neoplasm treatment|0|||
161683146|NCT00974675|583891283|FG002|Overall Study|Participant on holiday; unable to attend|0|||
161683147|NCT00974675|583891284|FG003|Overall Study|Participant on holiday; unable to attend|1|||
161683148|NCT03302975|583891288|FG000|Overall Study|Lost to Follow-up|4|||
161683149|NCT01436084|583891289|FG000|Overall Study|Disease Progression|2|||
161683150|NCT01436084|583891289|FG000|Overall Study|Withdrawal by Subject|1|||
161683151|NCT01436084|583891289|FG000|Overall Study|Early Closure of Study|1|||
161683152|NCT05998148|583891290|FG000|Allocation|Did not attend any appointments|1|||
161683153|NCT05998148|583891291|FG001|Allocation|Did not attend any appointments|4|||
161683154|NCT05998148|583891290|FG000|Follow-Up|Lost to Follow-up|1|||
161683155|NCT05998148|583891291|FG001|Follow-Up|Lost to Follow-up|2|||
161683156|NCT05998148|583891290|FG000|Follow-Up|Change in insurance|1|||
161683157|NCT05998148|583891291|FG001|Follow-Up|Change in insurance|1|||
161683158|NCT03834519|583891293|FG000|Overall Study|Lost to Follow-up|2|||
161683159|NCT03834519|583891294|FG001|Overall Study|Lost to Follow-up|1|||
161683160|NCT03834519|583891293|FG000|Overall Study|Withdrawal by Subject|5|||
161683161|NCT03834519|583891294|FG001|Overall Study|Withdrawal by Subject|8|||
161683162|NCT03834519|583891293|FG000|Overall Study|Death|368|||
161683163|NCT03834519|583891294|FG001|Overall Study|Death|174|||
161683164|NCT03834519|583891293|FG000|Overall Study|Physician Decision|5|||
161683165|NCT03834519|583891294|FG001|Overall Study|Physician Decision|1|||
161683166|NCT03834519|583891293|FG000|Overall Study|Sponsor decision|149|||
161683167|NCT03834519|583891294|FG001|Overall Study|Sponsor decision|80|||
161683168|NCT04506086|583891295|FG000|Overall Study|Withdrawal by Subject|2|||
161683169|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
161683170|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
161683171|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
161683172|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
161683173|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
161683174|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
161683175|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
161683176|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
161603816|NCT03786926|583603334|FG004|Overall Study|Anti-neoplasm treatment|1|||
161603817|NCT03786926|583603335|FG005|Overall Study|Anti-neoplasm treatment|0|||
161603818|NCT03786926|583603336|FG006|Overall Study|Anti-neoplasm treatment|1|||
161603819|NCT03786926|583603337|FG007|Overall Study|Anti-neoplasm treatment|0|||
161603820|NCT03786926|583603338|FG008|Overall Study|Anti-neoplasm treatment|0|||
161603821|NCT03786926|583603339|FG009|Overall Study|Anti-neoplasm treatment|0|||
161603822|NCT03786926|583603340|FG010|Overall Study|Anti-neoplasm treatment|0|||
161603823|NCT03786926|583603330|FG000|Overall Study|Other|0|||
161603824|NCT03786926|583603331|FG001|Overall Study|Other|0|||
161603825|NCT03786926|583603332|FG002|Overall Study|Other|0|||
161603826|NCT03786926|583603333|FG003|Overall Study|Other|1|||
161603827|NCT03786926|583603334|FG004|Overall Study|Other|0|||
161603828|NCT03786926|583603335|FG005|Overall Study|Other|1|||
161603829|NCT03786926|583603336|FG006|Overall Study|Other|0|||
161683177|NCT01380379|583891300|FG000|Overall Study|Pregnancy|1|||
161683178|NCT05937165|583891303|FG000|Overall Study|Withdrawal by Subject|0|||
161683179|NCT05937165|583891304|FG001|Overall Study|Withdrawal by Subject|1|||
161683180|NCT06608368|583891305|FG000|Overall Study|Family Emergency|0|||
161683181|NCT06608368|583891306|FG001|Overall Study|Family Emergency|1|||
161683182|NCT06608368|583891307|FG002|Overall Study|Family Emergency|0|||
161683183|NCT06608368|583891305|FG000|Overall Study|Scheduling Issues|0|||
161683184|NCT06608368|583891306|FG001|Overall Study|Scheduling Issues|1|||
161683185|NCT06608368|583891307|FG002|Overall Study|Scheduling Issues|0|||
161683186|NCT03977974|583891308|FG000|Period 2|Adverse Event|0|||
161683187|NCT03977974|583891309|FG001|Period 2|Adverse Event|0|||
161683188|NCT03977974|583891310|FG002|Period 2|Adverse Event|0|||
161683189|NCT03977974|583891311|FG003|Period 2|Adverse Event|0|||
161683190|NCT03977974|583891312|FG004|Period 2|Adverse Event|1|||
161683191|NCT03977974|583891313|FG005|Period 2|Adverse Event|0|||
161683192|NCT03977974|583891314|FG006|Period 2|Adverse Event|0|||
161832035|NCT00842530|584427040|FG000|Overall Study|Serious adverse event|0|||
161832036|NCT00842530|584427041|FG001|Overall Study|Serious adverse event|6|||
161832037|NCT00842530|584427040|FG000|Overall Study|Other adverse event|6|||
161832038|NCT00842530|584427041|FG001|Overall Study|Other adverse event|1|||
161832039|NCT00842530|584427040|FG000|Overall Study|Protocol Violation|32|||
161832040|NCT00842530|584427041|FG001|Overall Study|Protocol Violation|14|||
161832041|NCT00842530|584427040|FG000|Overall Study|Lost to Follow-up|6|||
161832042|NCT00842530|584427041|FG001|Overall Study|Lost to Follow-up|8|||
161832043|NCT00842530|584427040|FG000|Overall Study|Withdrawal by Subject|73|||
161832044|NCT00842530|584427041|FG001|Overall Study|Withdrawal by Subject|28|||
161832045|NCT02939950|584427042|FG000|Overall Study|Lost to Follow-up|13|||
161832046|NCT02939950|584427043|FG001|Overall Study|Lost to Follow-up|16|||
161832047|NCT02939950|584427042|FG000|Overall Study|Positive slit lamp findings|0|||
161832048|NCT02939950|584427043|FG001|Overall Study|Positive slit lamp findings|1|||
161832049|NCT02939950|584427042|FG000|Overall Study|Chalazion upper lid|0|||
161832050|NCT02939950|584427043|FG001|Overall Study|Chalazion upper lid|1|||
161832051|NCT02939950|584427042|FG000|Overall Study|Lack of motivation|0|||
161832052|NCT02939950|584427043|FG001|Overall Study|Lack of motivation|2|||
161832053|NCT02939950|584427042|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
161832054|NCT02939950|584427043|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
161832055|NCT02939950|584427042|FG000|Overall Study|Military orders|1|||
161832056|NCT02939950|584427043|FG001|Overall Study|Military orders|0|||
161832057|NCT02939950|584427042|FG000|Overall Study|Participant Relocated|5|||
161832058|NCT02939950|584427043|FG001|Overall Study|Participant Relocated|3|||
161832059|NCT02939950|584427042|FG000|Overall Study|Study related symptoms|8|||
161832060|NCT02939950|584427043|FG001|Overall Study|Study related symptoms|8|||
161832061|NCT02939950|584427042|FG000|Overall Study|Unacceptable lens movement|2|||
161832062|NCT02939950|584427043|FG001|Overall Study|Unacceptable lens movement|0|||
161832063|NCT02939950|584427042|FG000|Overall Study|Protocol Violation|6|||
161832064|NCT02939950|584427043|FG001|Overall Study|Protocol Violation|3|||
161832065|NCT02939950|584427042|FG000|Overall Study|Physician Decision|2|||
161832066|NCT02939950|584427043|FG001|Overall Study|Physician Decision|0|||
161832067|NCT02939950|584427042|FG000|Overall Study|Pregnancy|6|||
161832068|NCT02939950|584427043|FG001|Overall Study|Pregnancy|7|||
161832069|NCT02939950|584427042|FG000|Overall Study|Withdrawal by Subject|12|||
161832070|NCT02939950|584427043|FG001|Overall Study|Withdrawal by Subject|28|||
161603830|NCT03786926|583603337|FG007|Overall Study|Other|0|||
161603831|NCT03786926|583603338|FG008|Overall Study|Other|2|||
161603832|NCT03786926|583603339|FG009|Overall Study|Other|0|||
161683193|NCT03977974|583891315|FG007|Period 2|Adverse Event|0|||
161683194|NCT03977974|583891316|FG008|Period 2|Adverse Event|0|||
161683195|NCT03977974|583891317|FG009|Period 2|Adverse Event|0|||
161683196|NCT03977974|583891318|FG010|Period 2|Adverse Event|0|||
161683197|NCT03977974|583891319|FG011|Period 2|Adverse Event|0|||
161683198|NCT03977974|583891320|FG012|Period 2|Adverse Event|0|||
161683199|NCT03080883|583891321|FG000|Overall Study|Withdrawal by Subject|11|||
161832071|NCT02939950|584427042|FG000|Overall Study|Adverse Event|7|||
161832072|NCT02939950|584427043|FG001|Overall Study|Adverse Event|3|||
161832073|NCT02939950|584427042|FG000|Overall Study|Randomized, not dispensed|1|||
161832074|NCT02939950|584427043|FG001|Overall Study|Randomized, not dispensed|0|||
161832075|NCT02939950|584427042|FG000|Overall Study|Ineligible at Baseline|2|||
161603833|NCT03786926|583603340|FG010|Overall Study|Other|0|||
161603834|NCT02278211|583603346|FG000|Overall Study|Unable to analyse PET scan|2|||
161603835|NCT01828021|583603349|FG000|Overall Study|Adverse Event|5|||
161603836|NCT01828021|583603349|FG000|Overall Study|Lack of Efficacy|17|||
161603837|NCT01828021|583603349|FG000|Overall Study|Withdrawal by Subject|2|||
161603838|NCT01828021|583603349|FG000|Overall Study|Ileal obstruction, unrelated|1|||
161603839|NCT02163694|583603361|FG000|Overall Study|Adverse event- related to progression|4|||
161603840|NCT02163694|583603362|FG001|Overall Study|Adverse event- related to progression|10|||
161603841|NCT02163694|583603361|FG000|Overall Study|Adverse event- not related to progression|7|||
161603842|NCT02163694|583603362|FG001|Overall Study|Adverse event- not related to progression|22|||
161603843|NCT02163694|583603361|FG000|Overall Study|Withdrew consent|13|||
161603844|NCT02163694|583603362|FG001|Overall Study|Withdrew consent|28|||
161603845|NCT02163694|583603361|FG000|Overall Study|Lost to Follow-up|2|||
161603846|NCT02163694|583603362|FG001|Overall Study|Lost to Follow-up|2|||
161603847|NCT02163694|583603361|FG000|Overall Study|Sponsor discontinued study|3|||
161683200|NCT03080883|583891322|FG001|Overall Study|Withdrawal by Subject|15|||
161603848|NCT02163694|583603362|FG001|Overall Study|Sponsor discontinued study|29|||
161603849|NCT02163694|583603361|FG000|Overall Study|Progressive disease per protocol|125|||
161603850|NCT02163694|583603362|FG001|Overall Study|Progressive disease per protocol|224|||
161603851|NCT02163694|583603361|FG000|Overall Study|Other, not specified|17|||
161603852|NCT02163694|583603362|FG001|Overall Study|Other, not specified|22|||
161603853|NCT02163694|583603361|FG000|Overall Study|Randomized but Not Treated|1|||
161603854|NCT02163694|583603362|FG001|Overall Study|Randomized but Not Treated|0|||
161603855|NCT02163694|583603361|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
161603856|NCT02163694|583603362|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
161603857|NCT03884101|583603363|FG000|Overall Study|Participant Ongoing in Study|202|||
161603858|NCT03884101|583603364|FG001|Overall Study|Participant Ongoing in Study|186|||
161603859|NCT03884101|583603363|FG000|Overall Study|Death|212|||
161603860|NCT03884101|583603364|FG001|Overall Study|Death|224|||
161603861|NCT03884101|583603363|FG000|Overall Study|Lost to Follow-up|0|||
161603862|NCT03884101|583603364|FG001|Overall Study|Lost to Follow-up|1|||
161683201|NCT03080883|583891321|FG000|Overall Study|Adverse Event|22|||
161603863|NCT03884101|583603363|FG000|Overall Study|Withdrawal by Subject|6|||
161683202|NCT03080883|583891322|FG001|Overall Study|Adverse Event|22|||
161683203|NCT03080883|583891321|FG000|Overall Study|Alternative Therapy|0|||
161683204|NCT03080883|583891322|FG001|Overall Study|Alternative Therapy|3|||
161683205|NCT03080883|583891321|FG000|Overall Study|Other Complicating Disease|9|||
161683206|NCT03080883|583891322|FG001|Overall Study|Other Complicating Disease|5|||
161683207|NCT03080883|583891321|FG000|Overall Study|Death|21|||
161683208|NCT03080883|583891322|FG001|Overall Study|Death|16|||
161683209|NCT03080883|583891321|FG000|Overall Study|Physician Decision|2|||
161683210|NCT03080883|583891322|FG001|Overall Study|Physician Decision|2|||
161832076|NCT02939950|584427043|FG001|Overall Study|Ineligible at Baseline|8|||
161683211|NCT03080883|583891321|FG000|Overall Study|Disease Progression|2|||
161683212|NCT03080883|583891322|FG001|Overall Study|Disease Progression|8|||
161683213|NCT03080883|583891321|FG000|Overall Study|Lost to Follow-up|1|||
161832077|NCT02243293|584427044|FG000|Overall Study|Adverse Event|1|||
161832078|NCT02243293|584427045|FG001|Overall Study|Adverse Event|0|||
161832079|NCT02243293|584427046|FG002|Overall Study|Adverse Event|0|||
161832080|NCT02243293|584427047|FG003|Overall Study|Adverse Event|0|||
161832081|NCT02243293|584427048|FG004|Overall Study|Adverse Event|0|||
161832082|NCT02243293|584427049|FG005|Overall Study|Adverse Event|0|||
161832083|NCT02243293|584427050|FG006|Overall Study|Adverse Event|0|||
161832084|NCT02243293|584427051|FG007|Overall Study|Adverse Event|0|||
161832085|NCT02243293|584427052|FG008|Overall Study|Adverse Event|0|||
161832086|NCT02243293|584427053|FG009|Overall Study|Adverse Event|0|||
161832087|NCT02243293|584427054|FG010|Overall Study|Adverse Event|0|||
161832088|NCT02243293|584427055|FG011|Overall Study|Adverse Event|0|||
161832089|NCT02243293|584427056|FG012|Overall Study|Adverse Event|0|||
161832090|NCT02243293|584427057|FG013|Overall Study|Adverse Event|0|||
161603864|NCT03884101|583603364|FG001|Overall Study|Withdrawal by Subject|11|||
161603865|NCT05112900|583603365|FG000|Overall Study|Withdrawal by Subject|960|||
161603866|NCT05112900|583603366|FG001|Overall Study|Withdrawal by Subject|921|||
161603867|NCT05112900|583603367|FG002|Overall Study|Withdrawal by Subject|968|||
161603868|NCT01438853|583603370|FG000|Overall Study|Death|0|||
161603869|NCT01438853|583603371|FG001|Overall Study|Death|0|||
161603870|NCT01438853|583603372|FG002|Overall Study|Death|0|||
161603871|NCT01438853|583603373|FG003|Overall Study|Death|1|||
161603872|NCT01438853|583603370|FG000|Overall Study|Withdrawal by Subject|0|||
161603873|NCT01438853|583603371|FG001|Overall Study|Withdrawal by Subject|0|||
161603874|NCT01438853|583603372|FG002|Overall Study|Withdrawal by Subject|1|||
161603875|NCT01438853|583603373|FG003|Overall Study|Withdrawal by Subject|0|||
161603876|NCT03279978|583603375|FG000|Overall Study|Withdrawal by Subject|0|||
161603877|NCT03279978|583603376|FG001|Overall Study|Withdrawal by Subject|1|||
161603878|NCT03279978|583603377|FG002|Overall Study|Withdrawal by Subject|0|||
161603879|NCT03279978|583603378|FG003|Overall Study|Withdrawal by Subject|0|||
161603880|NCT03279978|583603379|FG004|Overall Study|Withdrawal by Subject|0|||
161603881|NCT03279978|583603380|FG005|Overall Study|Withdrawal by Subject|0|||
161603882|NCT03279978|583603381|FG006|Overall Study|Withdrawal by Subject|0|||
161603883|NCT03279978|583603382|FG007|Overall Study|Withdrawal by Subject|0|||
161603884|NCT03279978|583603383|FG008|Overall Study|Withdrawal by Subject|0|||
161603885|NCT03279978|583603384|FG009|Overall Study|Withdrawal by Subject|1|||
161603886|NCT03279978|583603375|FG000|Overall Study|Lost to Follow-up|1|||
161603887|NCT03279978|583603376|FG001|Overall Study|Lost to Follow-up|0|||
161603888|NCT03279978|583603377|FG002|Overall Study|Lost to Follow-up|1|||
161603889|NCT03279978|583603378|FG003|Overall Study|Lost to Follow-up|0|||
161603890|NCT03279978|583603379|FG004|Overall Study|Lost to Follow-up|0|||
161603891|NCT03279978|583603380|FG005|Overall Study|Lost to Follow-up|0|||
161603892|NCT03279978|583603381|FG006|Overall Study|Lost to Follow-up|0|||
161603893|NCT03279978|583603382|FG007|Overall Study|Lost to Follow-up|0|||
161683214|NCT03080883|583891322|FG001|Overall Study|Lost to Follow-up|1|||
161683215|NCT00388973|583892871|FG000|Overall Study|Adverse Event|16|||
161683216|NCT00388973|583892872|FG001|Overall Study|Adverse Event|6|||
161683217|NCT00388973|583892871|FG000|Overall Study|Lack of Efficacy|1|||
161683218|NCT00388973|583892872|FG001|Overall Study|Lack of Efficacy|12|||
161683219|NCT00388973|583892871|FG000|Overall Study|Protocol Violation|3|||
161832091|NCT02243293|584427058|FG014|Overall Study|Adverse Event|0|||
161832092|NCT02243293|584427059|FG015|Overall Study|Adverse Event|1|||
161832093|NCT02243293|584427060|FG016|Overall Study|Adverse Event|0|||
161832094|NCT02243293|584427061|FG017|Overall Study|Adverse Event|0|||
161832095|NCT02243293|584427062|FG018|Overall Study|Adverse Event|0|||
161832096|NCT02243293|584427063|FG019|Overall Study|Adverse Event|0|||
161832097|NCT02243293|584427064|FG020|Overall Study|Adverse Event|1|||
161832098|NCT02243293|584427065|FG021|Overall Study|Adverse Event|0|||
161832099|NCT02243293|584427044|FG000|Overall Study|Withdrawal by Subject|1|||
161832100|NCT02243293|584427045|FG001|Overall Study|Withdrawal by Subject|0|||
161832101|NCT02243293|584427046|FG002|Overall Study|Withdrawal by Subject|0|||
161832102|NCT02243293|584427047|FG003|Overall Study|Withdrawal by Subject|0|||
161832103|NCT02243293|584427048|FG004|Overall Study|Withdrawal by Subject|0|||
161832104|NCT02243293|584427049|FG005|Overall Study|Withdrawal by Subject|0|||
161832105|NCT02243293|584427050|FG006|Overall Study|Withdrawal by Subject|0|||
161832106|NCT02243293|584427051|FG007|Overall Study|Withdrawal by Subject|0|||
161832107|NCT02243293|584427052|FG008|Overall Study|Withdrawal by Subject|0|||
161832108|NCT02243293|584427053|FG009|Overall Study|Withdrawal by Subject|1|||
161832109|NCT02243293|584427054|FG010|Overall Study|Withdrawal by Subject|0|||
161832110|NCT02243293|584427055|FG011|Overall Study|Withdrawal by Subject|1|||
161832111|NCT02243293|584427056|FG012|Overall Study|Withdrawal by Subject|0|||
161832112|NCT02243293|584427057|FG013|Overall Study|Withdrawal by Subject|0|||
161832113|NCT02243293|584427058|FG014|Overall Study|Withdrawal by Subject|0|||
161832114|NCT02243293|584427059|FG015|Overall Study|Withdrawal by Subject|0|||
161832115|NCT02243293|584427060|FG016|Overall Study|Withdrawal by Subject|0|||
161832116|NCT02243293|584427061|FG017|Overall Study|Withdrawal by Subject|0|||
161832117|NCT02243293|584427062|FG018|Overall Study|Withdrawal by Subject|0|||
161832118|NCT02243293|584427063|FG019|Overall Study|Withdrawal by Subject|0|||
161832119|NCT02243293|584427064|FG020|Overall Study|Withdrawal by Subject|0|||
161832120|NCT02243293|584427065|FG021|Overall Study|Withdrawal by Subject|1|||
161832121|NCT02243293|584427044|FG000|Overall Study|Lost to Follow-up|0|||
161832122|NCT02243293|584427045|FG001|Overall Study|Lost to Follow-up|1|||
161832123|NCT02243293|584427046|FG002|Overall Study|Lost to Follow-up|1|||
161832124|NCT02243293|584427047|FG003|Overall Study|Lost to Follow-up|1|||
161832125|NCT02243293|584427048|FG004|Overall Study|Lost to Follow-up|0|||
161832126|NCT02243293|584427049|FG005|Overall Study|Lost to Follow-up|0|||
161832127|NCT02243293|584427050|FG006|Overall Study|Lost to Follow-up|3|||
161832128|NCT02243293|584427051|FG007|Overall Study|Lost to Follow-up|0|||
161832129|NCT02243293|584427052|FG008|Overall Study|Lost to Follow-up|0|||
161832130|NCT02243293|584427053|FG009|Overall Study|Lost to Follow-up|0|||
161832131|NCT02243293|584427054|FG010|Overall Study|Lost to Follow-up|0|||
161832132|NCT02243293|584427055|FG011|Overall Study|Lost to Follow-up|2|||
161832133|NCT02243293|584427056|FG012|Overall Study|Lost to Follow-up|0|||
161832134|NCT02243293|584427057|FG013|Overall Study|Lost to Follow-up|0|||
161832135|NCT02243293|584427058|FG014|Overall Study|Lost to Follow-up|0|||
161832136|NCT02243293|584427059|FG015|Overall Study|Lost to Follow-up|0|||
161832137|NCT02243293|584427060|FG016|Overall Study|Lost to Follow-up|3|||
161832138|NCT02243293|584427061|FG017|Overall Study|Lost to Follow-up|1|||
161832139|NCT02243293|584427062|FG018|Overall Study|Lost to Follow-up|0|||
161832140|NCT02243293|584427063|FG019|Overall Study|Lost to Follow-up|0|||
161832141|NCT02243293|584427064|FG020|Overall Study|Lost to Follow-up|1|||
161832142|NCT02243293|584427065|FG021|Overall Study|Lost to Follow-up|2|||
161832143|NCT02243293|584427044|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
161832144|NCT02243293|584427045|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
161832145|NCT02243293|584427046|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
161832146|NCT02243293|584427047|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
161832147|NCT02243293|584427048|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
161832148|NCT02243293|584427049|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
161832149|NCT02243293|584427050|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
161832150|NCT02243293|584427051|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
161832151|NCT02243293|584427052|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
161832152|NCT02243293|584427053|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
161832153|NCT02243293|584427054|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
161832154|NCT02243293|584427055|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
161832155|NCT02243293|584427056|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
161832156|NCT02243293|584427057|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
161832157|NCT02243293|584427058|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
161683220|NCT00388973|583892872|FG001|Overall Study|Protocol Violation|0|||
161832158|NCT02243293|584427059|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
161832159|NCT02243293|584427060|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
161683221|NCT00388973|583892871|FG000|Overall Study|Withdrawal by Subject|14|||
161683222|NCT00388973|583892872|FG001|Overall Study|Withdrawal by Subject|17|||
161683223|NCT00388973|583892871|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
161683224|NCT00388973|583892872|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
161683225|NCT00388973|583892871|FG000|Overall Study|Did not complete 61 days of treatment|5|||
161683226|NCT00388973|583892872|FG001|Overall Study|Did not complete 61 days of treatment|4|||
161683227|NCT00388973|583892871|FG000|Overall Study|Left region|0|||
161683228|NCT00388973|583892872|FG001|Overall Study|Left region|1|||
161683229|NCT00388973|583892871|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
161683230|NCT00388973|583892872|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
161683231|NCT01999465|583892873|FG000|Overall Study|Lost to Follow-up|0|||
161683232|NCT01999465|583892874|FG001|Overall Study|Lost to Follow-up|2|||
161683233|NCT01999465|583892873|FG000|Overall Study|Protocol Violation|0|||
161683234|NCT01999465|583892874|FG001|Overall Study|Protocol Violation|1|||
161683235|NCT00390546|583892875|FG000|Overall Study|Renal impairment|1|||
161683236|NCT00390546|583892876|FG001|Overall Study|Renal impairment|0|||
161683237|NCT00390546|583892875|FG000|Overall Study|Physician Decision|5|||
161683238|NCT00390546|583892876|FG001|Overall Study|Physician Decision|5|||
161683239|NCT01308008|583892877|FG000|4 Weeks|Illness, disinterest, time|9|||
161683240|NCT01308008|583892878|FG001|4 Weeks|Illness, disinterest, time|2|||
161683241|NCT02325219|583892879|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
161683242|NCT02325219|583892880|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
161683243|NCT02325219|583892881|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161683244|NCT02325219|583892882|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161683245|NCT02325219|583892883|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161683246|NCT02325219|583892879|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
161683247|NCT02325219|583892880|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
161683248|NCT02325219|583892881|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161683249|NCT02325219|583892882|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161683250|NCT02325219|583892883|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161683251|NCT02325219|583892879|FG000|Controlled Period (Week 0 - 16)|Other|0|||
161683252|NCT02325219|583892880|FG001|Controlled Period (Week 0 - 16)|Other|0|||
161683253|NCT02325219|583892881|FG002|Controlled Period (Week 0 - 16)|Other|1|||
161683254|NCT02325219|583892882|FG003|Controlled Period (Week 0 - 16)|Other|0|||
161683255|NCT02325219|583892883|FG004|Controlled Period (Week 0 - 16)|Other|0|||
161683256|NCT02325219|583892879|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683257|NCT02325219|583892880|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683258|NCT02325219|583892881|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683259|NCT02325219|583892882|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683260|NCT02325219|583892883|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161683261|NCT02325219|583892879|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683262|NCT02325219|583892880|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
161683263|NCT02325219|583892881|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683264|NCT02325219|583892882|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683265|NCT02325219|583892883|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683266|NCT02325219|583892879|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683267|NCT02325219|583892880|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161683268|NCT02325219|583892881|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683269|NCT02325219|583892882|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683270|NCT02325219|583892883|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683271|NCT02187172|583892884|FG000|Overall Study|Lost to Follow-up|1|||
161683272|NCT02187172|583892885|FG001|Overall Study|Lost to Follow-up|2|||
161683273|NCT02187172|583892884|FG000|Overall Study|Lack of Efficacy|1|||
161683274|NCT02187172|583892885|FG001|Overall Study|Lack of Efficacy|2|||
161683275|NCT02187172|583892884|FG000|Overall Study|Adverse Event|0|||
161683276|NCT02187172|583892885|FG001|Overall Study|Adverse Event|1|||
161683277|NCT02187172|583892884|FG000|Overall Study|Physician Decision|1|||
161683278|NCT02187172|583892885|FG001|Overall Study|Physician Decision|1|||
161683279|NCT00880399|583892886|FG000|Overall Study|Adverse Event|4|||
161683280|NCT00880399|583892887|FG001|Overall Study|Adverse Event|6|||
161683281|NCT00880399|583892888|FG002|Overall Study|Adverse Event|5|||
161683282|NCT00880399|583892886|FG000|Overall Study|Lack of Efficacy|1|||
161683283|NCT00880399|583892887|FG001|Overall Study|Lack of Efficacy|4|||
161683284|NCT00880399|583892888|FG002|Overall Study|Lack of Efficacy|2|||
161683285|NCT00880399|583892886|FG000|Overall Study|Protocol Violation|4|||
161683286|NCT00880399|583892887|FG001|Overall Study|Protocol Violation|4|||
161683287|NCT00880399|583892888|FG002|Overall Study|Protocol Violation|6|||
161683288|NCT00880399|583892886|FG000|Overall Study|Study closed/terminated|3|||
161683289|NCT00880399|583892887|FG001|Overall Study|Study closed/terminated|7|||
161683290|NCT00880399|583892888|FG002|Overall Study|Study closed/terminated|4|||
161683291|NCT00880399|583892886|FG000|Overall Study|Lost to Follow-up|8|||
161683292|NCT00880399|583892887|FG001|Overall Study|Lost to Follow-up|5|||
161683293|NCT00880399|583892888|FG002|Overall Study|Lost to Follow-up|3|||
161683294|NCT00880399|583892886|FG000|Overall Study|Physician Decision|5|||
161683295|NCT00880399|583892887|FG001|Overall Study|Physician Decision|0|||
161683296|NCT00880399|583892888|FG002|Overall Study|Physician Decision|3|||
161683297|NCT00880399|583892886|FG000|Overall Study|Withdrawal by Subject|6|||
161683298|NCT00880399|583892887|FG001|Overall Study|Withdrawal by Subject|3|||
161683299|NCT00880399|583892888|FG002|Overall Study|Withdrawal by Subject|3|||
161683300|NCT02181816|583892893|FG000|Overall Study|Case Report Forms Uncollected|38|||
161683301|NCT02181816|583892893|FG000|Overall Study|Protocol Deviation|21|||
161683302|NCT00909181|583892894|FG000|Overall Study|Lost to Follow-up|39|||
161683303|NCT00909181|583892895|FG001|Overall Study|Lost to Follow-up|18|||
161683304|NCT00909181|583892896|FG002|Overall Study|Lost to Follow-up|33|||
161683305|NCT02830880|583892897|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
161683306|NCT02830880|583892897|FG000|Overall Study|Death|1|||
161683307|NCT02830880|583892897|FG000|Overall Study|Physician Decision|1|||
161683308|NCT02349048|583892902|FG000|Overall Study|Withdrawal by Subject|4|||
161683309|NCT02349048|583892903|FG001|Overall Study|Withdrawal by Subject|0|||
161683310|NCT02349048|583892902|FG000|Overall Study|Lost to Follow-up|1|||
161683311|NCT02349048|583892903|FG001|Overall Study|Lost to Follow-up|0|||
161683312|NCT03709654|583892906|FG000|Overall Study|Lost to Follow-up|1|||
161683313|NCT03709654|583892907|FG001|Overall Study|Lost to Follow-up|1|||
161683314|NCT03709654|583892906|FG000|Overall Study|Withdrawal by Subject|1|||
161683315|NCT03709654|583892907|FG001|Overall Study|Withdrawal by Subject|1|||
161683316|NCT03709654|583892906|FG000|Overall Study|Adverse Event|1|||
161683317|NCT03709654|583892907|FG001|Overall Study|Adverse Event|0|||
161683318|NCT01040351|583892908|FG000|Overall Study|poor ovarian response|1|||
161683319|NCT01040351|583892909|FG001|Overall Study|poor ovarian response|2|||
161683320|NCT01648790|583892914|FG000|Treatment 3|Withdrawal by Subject|0|||
161683321|NCT01648790|583892915|FG001|Treatment 3|Withdrawal by Subject|0|||
161683322|NCT01648790|583892916|FG002|Treatment 3|Withdrawal by Subject|0|||
161683323|NCT01648790|583892917|FG003|Treatment 3|Withdrawal by Subject|1|||
161683324|NCT01648790|583892918|FG004|Treatment 3|Withdrawal by Subject|0|||
161683325|NCT02969187|583892919|FG000|Overall Study|Physician Decision|12|||
161683326|NCT02969187|583892920|FG001|Overall Study|Physician Decision|13|||
161683327|NCT03923426|583892924|FG000|Overall Study|Other|19|||
161683328|NCT03923426|583892924|FG000|Overall Study|Lost to Follow-up|16|||
161683329|NCT03923426|583892924|FG000|Overall Study|Death|107|||
161683330|NCT03923426|583892924|FG000|Overall Study|Incomplete response to question|13|||
161683331|NCT01278745|583892929|FG000|Overall Study|Death|2|||
161683332|NCT01278745|583892930|FG001|Overall Study|Death|5|||
161683333|NCT01278745|583892931|FG002|Overall Study|Death|7|||
161683334|NCT01278745|583892932|FG003|Overall Study|Death|0|||
161683335|NCT01278745|583892929|FG000|Overall Study|Physician Decision|1|||
161832160|NCT02243293|584427061|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
161832161|NCT02243293|584427062|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
161832162|NCT02243293|584427063|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
161832163|NCT02243293|584427064|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
161832164|NCT02243293|584427065|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
161832165|NCT02243293|584427044|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
161832166|NCT02243293|584427045|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
161832167|NCT02243293|584427046|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
161832168|NCT02243293|584427047|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
161832169|NCT02243293|584427048|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
161832170|NCT02243293|584427049|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
161832171|NCT02243293|584427050|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
161832172|NCT02243293|584427051|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
161832173|NCT02243293|584427052|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
161832174|NCT02243293|584427053|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
161832175|NCT02243293|584427054|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
161832176|NCT02243293|584427055|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
161832177|NCT02243293|584427056|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
161832178|NCT02243293|584427057|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
161832179|NCT02243293|584427058|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
161832180|NCT02243293|584427059|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
161832181|NCT02243293|584427060|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
161832182|NCT02243293|584427061|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
161832183|NCT02243293|584427062|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
161832184|NCT02243293|584427063|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
161832185|NCT02243293|584427064|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
161683336|NCT01278745|583892930|FG001|Overall Study|Physician Decision|0|||
161683337|NCT01278745|583892931|FG002|Overall Study|Physician Decision|0|||
161683338|NCT01278745|583892932|FG003|Overall Study|Physician Decision|9|||
161683339|NCT01278745|583892929|FG000|Overall Study|Withdrawal by Subject|1|||
161683340|NCT01278745|583892930|FG001|Overall Study|Withdrawal by Subject|1|||
161683341|NCT01278745|583892931|FG002|Overall Study|Withdrawal by Subject|5|||
161683342|NCT01278745|583892932|FG003|Overall Study|Withdrawal by Subject|1|||
161683343|NCT01278745|583892929|FG000|Overall Study|Sponsor Decision|1|||
161683344|NCT01278745|583892930|FG001|Overall Study|Sponsor Decision|0|||
161683345|NCT01278745|583892931|FG002|Overall Study|Sponsor Decision|62|||
161683346|NCT01278745|583892932|FG003|Overall Study|Sponsor Decision|6|||
161683347|NCT01278745|583892929|FG000|Overall Study|Ineligible|0|||
161683348|NCT01278745|583892930|FG001|Overall Study|Ineligible|0|||
161832186|NCT02243293|584427065|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
161832187|NCT00402025|584427069|FG000|Overall Study|Adverse Event|0|||
161832188|NCT00402025|584427070|FG001|Overall Study|Adverse Event|0|||
161832189|NCT00402025|584427071|FG002|Overall Study|Adverse Event|2|||
161832190|NCT00402025|584427069|FG000|Overall Study|Death|0|||
161683349|NCT01278745|583892931|FG002|Overall Study|Ineligible|42|||
161832191|NCT00402025|584427070|FG001|Overall Study|Death|1|||
161832192|NCT00402025|584427071|FG002|Overall Study|Death|5|||
161832193|NCT00402025|584427069|FG000|Overall Study|Disease Progression|1|||
161832194|NCT00402025|584427070|FG001|Overall Study|Disease Progression|1|||
161832195|NCT00402025|584427071|FG002|Overall Study|Disease Progression|2|||
161832196|NCT00402025|584427069|FG000|Overall Study|Physician Decision|1|||
161832197|NCT00402025|584427070|FG001|Overall Study|Physician Decision|1|||
161832198|NCT00402025|584427071|FG002|Overall Study|Physician Decision|0|||
161832199|NCT00402025|584427069|FG000|Overall Study|Participant Decision|0|||
161832200|NCT00402025|584427070|FG001|Overall Study|Participant Decision|0|||
161832201|NCT00402025|584427071|FG002|Overall Study|Participant Decision|1|||
161832202|NCT01172821|584427106|FG000|Overall Study|Adverse Event|5|||
161832203|NCT01172821|584427107|FG001|Overall Study|Adverse Event|2|||
161832204|NCT01172821|584427108|FG002|Overall Study|Adverse Event|2|||
161832205|NCT01172821|584427109|FG003|Overall Study|Adverse Event|7|||
161832206|NCT01172821|584427106|FG000|Overall Study|Protocol Violation|0|||
161832207|NCT01172821|584427107|FG001|Overall Study|Protocol Violation|2|||
161683350|NCT01278745|583892932|FG003|Overall Study|Ineligible|61|||
161683351|NCT01278745|583892929|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
161683352|NCT01278745|583892930|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
161683353|NCT01278745|583892931|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
161683354|NCT01278745|583892932|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
161683355|NCT01923285|583892934|FG000|Overall Study|Withdrawal by Subject|7|||
161683356|NCT01923285|583892935|FG001|Overall Study|Withdrawal by Subject|6|||
161683357|NCT03462576|583892936|FG000|Overall Study|Protocol Violation|5|||
161683358|NCT03462576|583892937|FG001|Overall Study|Protocol Violation|11|||
161683359|NCT03462576|583892938|FG002|Overall Study|Protocol Violation|7|||
161683360|NCT03462576|583892936|FG000|Overall Study|Device Malfunction|0|||
161683361|NCT03462576|583892937|FG001|Overall Study|Device Malfunction|0|||
161683362|NCT03462576|583892938|FG002|Overall Study|Device Malfunction|1|||
161683363|NCT00715026|583892939|FG000|Overall Study|Withdrawal by Subject|5|||
161683364|NCT00715026|583892939|FG000|Overall Study|Lost to Follow-up|3|||
161683365|NCT00715026|583892939|FG000|Overall Study|Protocol Violation|1|||
161683366|NCT00715026|583892939|FG000|Overall Study|Surgery done on non-study consented hip|1|||
161683367|NCT00750737|583892947|FG000|Overall Study|Withdrawal by Subject|3|||
161683368|NCT00750737|583892948|FG001|Overall Study|Withdrawal by Subject|3|||
161683369|NCT00865904|583892951|FG000|Overall Study|Randomized but not Treated|2|||
161683370|NCT00865904|583892952|FG001|Overall Study|Randomized but not Treated|0|||
161683371|NCT00865904|583892953|FG002|Overall Study|Randomized but not Treated|0|||
161683372|NCT00865904|583892954|FG003|Overall Study|Randomized but not Treated|1|||
161683373|NCT00865904|583892955|FG004|Overall Study|Randomized but not Treated|1|||
161683374|NCT01543828|583892956|FG000|Treatment 2|Lost to Follow-up|1|||
161683375|NCT01543828|583892957|FG001|Treatment 2|Lost to Follow-up|0|||
161683376|NCT00711425|583892960|FG000|Overall Study|Protocol Violation|1|||
161683377|NCT00711425|583892960|FG000|Overall Study|Death|2|||
161683378|NCT00711425|583892960|FG000|Overall Study|Lost to Follow-up|1|||
161683379|NCT05879107|583892961|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
161832208|NCT01172821|584427108|FG002|Overall Study|Protocol Violation|1|||
161832209|NCT01172821|584427109|FG003|Overall Study|Protocol Violation|2|||
161832210|NCT01172821|584427106|FG000|Overall Study|Lost to Follow-up|4|||
161832211|NCT01172821|584427107|FG001|Overall Study|Lost to Follow-up|1|||
161832212|NCT01172821|584427108|FG002|Overall Study|Lost to Follow-up|2|||
161832213|NCT01172821|584427109|FG003|Overall Study|Lost to Follow-up|2|||
161832214|NCT01172821|584427106|FG000|Overall Study|Withdrawal by Subject|2|||
161832215|NCT01172821|584427107|FG001|Overall Study|Withdrawal by Subject|3|||
161832216|NCT01172821|584427108|FG002|Overall Study|Withdrawal by Subject|3|||
161832217|NCT01172821|584427109|FG003|Overall Study|Withdrawal by Subject|3|||
161832218|NCT01172821|584427106|FG000|Overall Study|Other|3|||
161832219|NCT01172821|584427107|FG001|Overall Study|Other|4|||
161832220|NCT01172821|584427108|FG002|Overall Study|Other|5|||
161832221|NCT01172821|584427109|FG003|Overall Study|Other|3|||
161832222|NCT02985879|584427110|FG000|Overall Study|Adverse Event|7|||
161832223|NCT02985879|584427111|FG001|Overall Study|Adverse Event|9|||
161832224|NCT02985879|584427112|FG002|Overall Study|Adverse Event|7|||
161832225|NCT02985879|584427110|FG000|Overall Study|Withdrew consent|6|||
161832226|NCT02985879|584427111|FG001|Overall Study|Withdrew consent|8|||
161832227|NCT02985879|584427112|FG002|Overall Study|Withdrew consent|10|||
161832228|NCT02985879|584427110|FG000|Overall Study|Lost to Follow-up|1|||
161832229|NCT02985879|584427111|FG001|Overall Study|Lost to Follow-up|0|||
161832230|NCT02985879|584427112|FG002|Overall Study|Lost to Follow-up|2|||
161832231|NCT02985879|584427110|FG000|Overall Study|Other, not specified|62|||
161832232|NCT02985879|584427111|FG001|Overall Study|Other, not specified|58|||
161832233|NCT02985879|584427112|FG002|Overall Study|Other, not specified|58|||
161832234|NCT03940703|584428378|FG000|Overall Study|Still under treatment|31|||
161832235|NCT03940703|584428379|FG001|Overall Study|Still under treatment|0|||
161832236|NCT02658487|584428380|FG000|Overall Study|Death|2|||
161603894|NCT03279978|583603383|FG008|Overall Study|Lost to Follow-up|0|||
161603895|NCT03279978|583603384|FG009|Overall Study|Lost to Follow-up|0|||
161603896|NCT03279978|583603375|FG000|Overall Study|Other than stated above|0|||
161603897|NCT03279978|583603376|FG001|Overall Study|Other than stated above|0|||
161603898|NCT03279978|583603377|FG002|Overall Study|Other than stated above|0|||
161603899|NCT03279978|583603378|FG003|Overall Study|Other than stated above|0|||
161603900|NCT03279978|583603379|FG004|Overall Study|Other than stated above|0|||
161603901|NCT03279978|583603380|FG005|Overall Study|Other than stated above|0|||
161832237|NCT02658487|584428380|FG000|Overall Study|Disease progression|10|||
161832238|NCT02658487|584428380|FG000|Overall Study|Alternative therapy|1|||
161832239|NCT02658487|584428380|FG000|Overall Study|Adverse Event|1|||
161832240|NCT02658487|584428380|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
161832241|NCT02658487|584428380|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
161832242|NCT01885182|584428381|FG000|Overall Study|Adverse Event|11|||
161832243|NCT01885182|584428382|FG001|Overall Study|Adverse Event|13|||
161603902|NCT03279978|583603381|FG006|Overall Study|Other than stated above|1|||
161603903|NCT03279978|583603382|FG007|Overall Study|Other than stated above|0|||
161603904|NCT03279978|583603383|FG008|Overall Study|Other than stated above|0|||
161603905|NCT03279978|583603384|FG009|Overall Study|Other than stated above|0|||
161603906|NCT04159519|583603385|FG000|Overall Study|Adverse Event|1|||
161603907|NCT04159519|583603386|FG001|Overall Study|Adverse Event|1|||
161603908|NCT04159519|583603385|FG000|Overall Study|Lack of Efficacy|1|||
161603909|NCT04159519|583603386|FG001|Overall Study|Lack of Efficacy|0|||
161603910|NCT04159519|583603385|FG000|Overall Study|Discontinued from study|1|||
161603911|NCT04159519|583603386|FG001|Overall Study|Discontinued from study|0|||
161603912|NCT04159519|583603385|FG000|Overall Study|Protocol Violation|1|||
161603913|NCT04159519|583603386|FG001|Overall Study|Protocol Violation|1|||
161603914|NCT04159519|583603385|FG000|Overall Study|Withdrawal by Subject|4|||
161603915|NCT04159519|583603386|FG001|Overall Study|Withdrawal by Subject|4|||
161603916|NCT03493542|583603389|FG000|Base Study|Withdrawal by Subject|0|||
161603917|NCT03493542|583603390|FG001|Base Study|Withdrawal by Subject|4|||
161603918|NCT03493542|583603391|FG002|Base Study|Withdrawal by Subject|0|||
161603919|NCT03493542|583603389|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
161603920|NCT03493542|583603390|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
161603921|NCT03493542|583603391|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
161603922|NCT03493542|583603389|FG000|Extension Study|Withdrawal by Subject|0|||
161603923|NCT03493542|583603390|FG001|Extension Study|Withdrawal by Subject|0|||
161603924|NCT03493542|583603391|FG002|Extension Study|Withdrawal by Subject|25|||
161603925|NCT01651000|583603395|FG000|Overall Study|Adverse Event|2|||
161603926|NCT01651000|583603396|FG001|Overall Study|Adverse Event|8|||
161603927|NCT01651000|583603395|FG000|Overall Study|Lost to Follow-up|3|||
161603928|NCT01651000|583603396|FG001|Overall Study|Lost to Follow-up|2|||
161603929|NCT01651000|583603395|FG000|Overall Study|Protocol Violation|0|||
161603930|NCT01651000|583603396|FG001|Overall Study|Protocol Violation|3|||
161603931|NCT01651000|583603395|FG000|Overall Study|Withdrawal by Subject|2|||
161603932|NCT01651000|583603396|FG001|Overall Study|Withdrawal by Subject|10|||
161603933|NCT01651000|583603395|FG000|Overall Study|Subject noncompliance|0|||
161603934|NCT01651000|583603396|FG001|Overall Study|Subject noncompliance|3|||
161603935|NCT01651000|583603395|FG000|Overall Study|Lack of Efficacy|1|||
161603936|NCT01651000|583603396|FG001|Overall Study|Lack of Efficacy|1|||
161603937|NCT01651000|583603395|FG000|Overall Study|Physician Decision|1|||
161603938|NCT01651000|583603396|FG001|Overall Study|Physician Decision|0|||
161603939|NCT01651000|583603395|FG000|Overall Study|Administrative reason|1|||
161603940|NCT01651000|583603396|FG001|Overall Study|Administrative reason|0|||
161603941|NCT01651000|583603395|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
161603942|NCT01651000|583603396|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
161603943|NCT02611687|583603870|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
161603944|NCT02611687|583603871|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
161603945|NCT02076009|583603872|FG000|Overall Study|Death|172|||
161603946|NCT02076009|583603873|FG001|Overall Study|Death|153|||
161603947|NCT02076009|583603872|FG000|Overall Study|Withdrawal by Subject|16|||
161603948|NCT02076009|583603873|FG001|Overall Study|Withdrawal by Subject|12|||
161603949|NCT02076009|583603872|FG000|Overall Study|Lost to Follow-up|4|||
161603950|NCT02076009|583603873|FG001|Overall Study|Lost to Follow-up|2|||
161603951|NCT02076009|583603872|FG000|Overall Study|Progressive Disease|1|||
161603952|NCT02076009|583603873|FG001|Overall Study|Progressive Disease|0|||
161603953|NCT02076009|583603872|FG000|Overall Study|Physician Decision|0|||
161603954|NCT02076009|583603873|FG001|Overall Study|Physician Decision|1|||
161603955|NCT02076009|583603872|FG000|Overall Study|End of data collection|90|||
161603956|NCT02076009|583603873|FG001|Overall Study|End of data collection|118|||
161603957|NCT04757753|583603874|FG000|Overall Study|Lost to Follow-up|7|||
161603958|NCT04757753|583603875|FG001|Overall Study|Lost to Follow-up|7|||
161603959|NCT04757753|583603874|FG000|Overall Study|Withdrawal by Subject|0|||
161603960|NCT04757753|583603875|FG001|Overall Study|Withdrawal by Subject|3|||
161603961|NCT04757753|583603874|FG000|Overall Study|Endodontic treatment failure|1|||
161683380|NCT05879107|583892962|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
161832244|NCT01885182|584428381|FG000|Overall Study|Withdrawal by Subject|13|||
161603962|NCT04757753|583603875|FG001|Overall Study|Endodontic treatment failure|2|||
161603963|NCT04757753|583603874|FG000|Overall Study|Tooth fracture/extraction|3|||
161832245|NCT01885182|584428382|FG001|Overall Study|Withdrawal by Subject|6|||
161832246|NCT01885182|584428381|FG000|Overall Study|Lost to Follow-up|2|||
161832247|NCT01885182|584428382|FG001|Overall Study|Lost to Follow-up|2|||
161832248|NCT01885182|584428381|FG000|Overall Study|Lack of Efficacy|8|||
161832249|NCT01885182|584428382|FG001|Overall Study|Lack of Efficacy|1|||
161832250|NCT04146363|584428383|FG000|Induction Period|Adverse Event|1|||
161832251|NCT04146363|584428384|FG001|Induction Period|Adverse Event|2|||
161832252|NCT04146363|584428385|FG002|Induction Period|Adverse Event|0|||
161832253|NCT04146363|584428386|FG003|Induction Period|Adverse Event|0|||
161832254|NCT04146363|584428387|FG004|Induction Period|Adverse Event|0|||
161832255|NCT04146363|584428388|FG005|Induction Period|Adverse Event|0|||
161832256|NCT04146363|584428389|FG006|Induction Period|Adverse Event|0|||
161832257|NCT04146363|584428390|FG007|Induction Period|Adverse Event|0|||
161832258|NCT04146363|584428391|FG008|Induction Period|Adverse Event|0|||
161603964|NCT04757753|583603875|FG001|Overall Study|Tooth fracture/extraction|0|||
161603965|NCT05988398|583603880|FG000|Overall Study|Lack of time|21|||
161603966|NCT05988398|583603881|FG001|Overall Study|Lack of time|0|||
161603967|NCT05988398|583603880|FG000|Overall Study|Absent from school|0|||
161603968|NCT05988398|583603881|FG001|Overall Study|Absent from school|38|||
161603969|NCT05988398|583603880|FG000|Overall Study|Chose not to participate|0|||
161603970|NCT05988398|583603881|FG001|Overall Study|Chose not to participate|42|||
161603971|NCT05988398|583603880|FG000|Overall Study|Other commitments (e.g., sports)|0|||
161603972|NCT05988398|583603881|FG001|Overall Study|Other commitments (e.g., sports)|25|||
161603973|NCT00942734|583603883|FG000|Overall Study|Adverse Event|2|||
161603974|NCT00942734|583603883|FG000|Overall Study|Protocol Violation|3|||
161603975|NCT00942734|583603883|FG000|Overall Study|Disease Progression|2|||
161603976|NCT00942734|583603883|FG000|Overall Study|Physician Decision|1|||
161603977|NCT03733626|583603884|FG000|Overall Study|Physician Decision|4|||
161603978|NCT03733626|583603885|FG001|Overall Study|Physician Decision|4|||
161603979|NCT00319046|583603886|FG000|Overall Study|withdrawal of subject's consent|7|||
161603980|NCT00319046|583603886|FG000|Overall Study|administrative reason|1|||
161603981|NCT05147584|583603887|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
161603982|NCT03370913|583603893|FG000|Overall Study|Death|1|||
161603983|NCT03370913|583603893|FG000|Overall Study|Lost to Follow-up|1|||
161603984|NCT04560179|583603896|FG000|Overall Study|Physician Decision|1|||
161603985|NCT04560179|583603897|FG001|Overall Study|Physician Decision|0|||
161603986|NCT04560179|583603898|FG002|Overall Study|Physician Decision|0|||
161603987|NCT04560179|583603899|FG003|Overall Study|Physician Decision|0|||
161603988|NCT04560179|583603900|FG004|Overall Study|Physician Decision|0|||
161603989|NCT04560179|583603896|FG000|Overall Study|Adverse Event|0|||
161603990|NCT04560179|583603897|FG001|Overall Study|Adverse Event|0|||
161603991|NCT04560179|583603898|FG002|Overall Study|Adverse Event|0|||
161603992|NCT04560179|583603899|FG003|Overall Study|Adverse Event|1|||
161603993|NCT04560179|583603900|FG004|Overall Study|Adverse Event|0|||
161603994|NCT05454514|583603901|FG000|Overall Study|Withdrawal by Subject|4|||
161603995|NCT02624050|583603902|FG000|Overall Study|Physician Decision|4|||
161603996|NCT02624050|583603903|FG001|Overall Study|Physician Decision|0|||
161603997|NCT02624050|583603902|FG000|Overall Study|Protocol Violation|2|||
161603998|NCT02624050|583603903|FG001|Overall Study|Protocol Violation|0|||
161603999|NCT04795245|583603904|FG000|Overall Study|Unkown reason|7|||
161604000|NCT04795245|583603904|FG000|Overall Study|Death|17|||
161604001|NCT04795245|583603904|FG000|Overall Study|Other than listed|19|||
161604002|NCT04795245|583603904|FG000|Overall Study|Adverse Event|143|||
161604003|NCT04795245|583603904|FG000|Overall Study|Progressive disease|512|||
161604004|NCT04795245|583603904|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
161604005|NCT01756300|583603905|FG000|Overall Study|Death|1|||
161604006|NCT01756300|583603905|FG000|Overall Study|Withdrawal by Subject|1|||
161604007|NCT03734029|583603906|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
161604008|NCT03734029|583603907|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
161604009|NCT03734029|583603906|FG000|Overall Study|Adverse Event|60|||
161604010|NCT03734029|583603907|FG001|Overall Study|Adverse Event|14|||
161604011|NCT03734029|583603906|FG000|Overall Study|Withdrawal by Subject|12|||
161604012|NCT03734029|583603907|FG001|Overall Study|Withdrawal by Subject|11|||
161604013|NCT03734029|583603906|FG000|Overall Study|Clinical progression by investigator|10|||
161604014|NCT03734029|583603907|FG001|Overall Study|Clinical progression by investigator|8|||
161604015|NCT03734029|583603906|FG000|Overall Study|Death|5|||
161604016|NCT03734029|583603907|FG001|Overall Study|Death|2|||
161604017|NCT03734029|583603906|FG000|Overall Study|Physician Decision|4|||
161604018|NCT03734029|583603907|FG001|Overall Study|Physician Decision|3|||
161604019|NCT03734029|583603906|FG000|Overall Study|Other|2|||
161604020|NCT03734029|583603907|FG001|Overall Study|Other|0|||
161604021|NCT03734029|583603906|FG000|Overall Study|Lost to Follow-up|0|||
161604022|NCT03734029|583603907|FG001|Overall Study|Lost to Follow-up|1|||
161604023|NCT03734029|583603906|FG000|Overall Study|Randomized, but not treated|2|||
161604024|NCT03734029|583603907|FG001|Overall Study|Randomized, but not treated|12|||
161604025|NCT04595331|583604726|FG000|Overall Study|Withdrawal by Subject|0|||
161604026|NCT04595331|583604727|FG001|Overall Study|Withdrawal by Subject|1|||
161604027|NCT04595331|583604726|FG000|Overall Study|Lost to Follow-up|0|||
161604028|NCT04595331|583604727|FG001|Overall Study|Lost to Follow-up|5|||
161604029|NCT04595331|583604726|FG000|Overall Study|Medical reason|0|||
161604030|NCT04595331|583604727|FG001|Overall Study|Medical reason|1|||
161604031|NCT02075554|583604732|FG000|Overall Study|Lost to Follow-up|7|||
161604032|NCT02075554|583604732|FG000|Overall Study|Withdrawal by Subject|5|||
161604033|NCT02075554|583604732|FG000|Overall Study|Physician Decision|3|||
161604034|NCT04933474|583604738|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
161604035|NCT04933474|583604739|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
161604036|NCT04933474|583604738|FG000|Overall Study|Lost to Follow-up|19|||
161604037|NCT04933474|583604739|FG001|Overall Study|Lost to Follow-up|9|||
161604038|NCT04933474|583604738|FG000|Overall Study|Life Burden - unable to participate|6|||
161604039|NCT04933474|583604739|FG001|Overall Study|Life Burden - unable to participate|2|||
161604040|NCT04933474|583604738|FG000|Overall Study|Disease Burden - unable to participate|4|||
161604041|NCT04933474|583604739|FG001|Overall Study|Disease Burden - unable to participate|1|||
161604042|NCT04933474|583604738|FG000|Overall Study|Surgery/Hospitalization|1|||
161604043|NCT04933474|583604739|FG001|Overall Study|Surgery/Hospitalization|2|||
161604044|NCT04933474|583604738|FG000|Overall Study|Dissatisfied with Intervention|1|||
161604045|NCT04933474|583604739|FG001|Overall Study|Dissatisfied with Intervention|1|||
161604046|NCT04933474|583604738|FG000|Overall Study|Withdrew interest in participation|1|||
161604047|NCT04933474|583604739|FG001|Overall Study|Withdrew interest in participation|0|||
161604048|NCT04933474|583604738|FG000|Overall Study|Had previously enrolled in the study|0|||
161604049|NCT04933474|583604739|FG001|Overall Study|Had previously enrolled in the study|1|||
161604050|NCT06655818|583604746|FG000|Overall Study|Withdrawal by Subject|1|||
161604051|NCT03816397|583604753|FG000|Overall Study|Censored at interim analysis date.|13|||
161604052|NCT03816397|583604754|FG001|Overall Study|Censored at interim analysis date.|6|||
161604053|NCT03816397|583604753|FG000|Overall Study|Withdrawal by Subject|1|||
161604054|NCT03816397|583604754|FG001|Overall Study|Withdrawal by Subject|1|||
161604055|NCT04496752|583604755|FG000|Second Assessment|Lost to Follow-up|3|||
161604056|NCT04496752|583604756|FG001|Second Assessment|Lost to Follow-up|3|||
161604057|NCT04496752|583604755|FG000|Second Assessment|Adverse Event|2|||
161604058|NCT04496752|583604756|FG001|Second Assessment|Adverse Event|0|||
161604059|NCT04214418|583604759|FG000|Overall Study|Withdrawal by Subject|1|||
161604060|NCT04214418|583604760|FG001|Overall Study|Withdrawal by Subject|0|||
161604061|NCT04214418|583604761|FG002|Overall Study|Withdrawal by Subject|0|||
161604062|NCT04214418|583604762|FG003|Overall Study|Withdrawal by Subject|0|||
161604063|NCT04214418|583604763|FG004|Overall Study|Withdrawal by Subject|0|||
161604064|NCT04214418|583604764|FG005|Overall Study|Withdrawal by Subject|0|||
161604065|NCT04214418|583604759|FG000|Overall Study|Adverse Event|0|||
161604066|NCT04214418|583604760|FG001|Overall Study|Adverse Event|2|||
161604067|NCT04214418|583604761|FG002|Overall Study|Adverse Event|0|||
161604068|NCT04214418|583604762|FG003|Overall Study|Adverse Event|0|||
161604069|NCT04214418|583604763|FG004|Overall Study|Adverse Event|0|||
161604070|NCT04214418|583604764|FG005|Overall Study|Adverse Event|0|||
161683381|NCT05879107|583892961|FG000|Overall Study|Migrated / moved from the study area|1|||
161604071|NCT04214418|583604759|FG000|Overall Study|Death|1|||
161604072|NCT04214418|583604760|FG001|Overall Study|Death|0|||
161604073|NCT04214418|583604761|FG002|Overall Study|Death|0|||
161604074|NCT04214418|583604762|FG003|Overall Study|Death|0|||
161604075|NCT04214418|583604763|FG004|Overall Study|Death|0|||
161604076|NCT04214418|583604764|FG005|Overall Study|Death|0|||
161604077|NCT04078152|583604765|FG000|Overall Study|Other|83|||
161604078|NCT04078152|583604766|FG001|Overall Study|Other|22|||
161604079|NCT04078152|583604767|FG002|Overall Study|Other|25|||
161604080|NCT04078152|583604765|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
161604081|NCT04078152|583604766|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
161832259|NCT04146363|584428392|FG009|Induction Period|Adverse Event|0|||
161604082|NCT04078152|583604767|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
161604083|NCT04078152|583604765|FG000|Overall Study|Withdrawal by Subject|5|||
161604084|NCT04078152|583604766|FG001|Overall Study|Withdrawal by Subject|0|||
161604085|NCT04078152|583604767|FG002|Overall Study|Withdrawal by Subject|1|||
161604086|NCT04078152|583604765|FG000|Overall Study|Death|10|||
161604087|NCT04078152|583604766|FG001|Overall Study|Death|2|||
161604088|NCT04078152|583604767|FG002|Overall Study|Death|12|||
161604089|NCT04078152|583604765|FG000|Overall Study|Adverse Event|1|||
161604090|NCT04078152|583604766|FG001|Overall Study|Adverse Event|0|||
161604091|NCT04078152|583604767|FG002|Overall Study|Adverse Event|0|||
161604092|NCT04908930|583604773|FG000|Overall Study|Lost to Follow-up|1|||
161604093|NCT04908930|583604774|FG001|Overall Study|Lost to Follow-up|1|||
161604094|NCT04908930|583604775|FG002|Overall Study|Lost to Follow-up|0|||
161604095|NCT04908930|583604776|FG003|Overall Study|Lost to Follow-up|0|||
161604096|NCT04908930|583604777|FG004|Overall Study|Lost to Follow-up|0|||
161604097|NCT04908930|583604773|FG000|Overall Study|hardware in mouth|1|||
161604098|NCT04908930|583604774|FG001|Overall Study|hardware in mouth|1|||
161604099|NCT04908930|583604775|FG002|Overall Study|hardware in mouth|0|||
161604100|NCT04908930|583604776|FG003|Overall Study|hardware in mouth|0|||
161604101|NCT04908930|583604777|FG004|Overall Study|hardware in mouth|0|||
161604102|NCT04908930|583604773|FG000|Overall Study|wrong team|1|||
161604103|NCT04908930|583604774|FG001|Overall Study|wrong team|0|||
161604104|NCT04908930|583604775|FG002|Overall Study|wrong team|0|||
161604105|NCT04908930|583604776|FG003|Overall Study|wrong team|0|||
161604106|NCT04908930|583604777|FG004|Overall Study|wrong team|0|||
161604107|NCT04908930|583604773|FG000|Overall Study|quit team|2|||
161604108|NCT04908930|583604774|FG001|Overall Study|quit team|4|||
161604109|NCT04908930|583604775|FG002|Overall Study|quit team|0|||
161604110|NCT04908930|583604776|FG003|Overall Study|quit team|0|||
161604111|NCT04908930|583604777|FG004|Overall Study|quit team|0|||
161604112|NCT04908930|583604773|FG000|Overall Study|Withdrawal by Subject|1|||
161604113|NCT04908930|583604774|FG001|Overall Study|Withdrawal by Subject|2|||
161604114|NCT04908930|583604775|FG002|Overall Study|Withdrawal by Subject|0|||
161604115|NCT04908930|583604776|FG003|Overall Study|Withdrawal by Subject|0|||
161604116|NCT04908930|583604777|FG004|Overall Study|Withdrawal by Subject|0|||
161604117|NCT04908930|583604773|FG000|Overall Study|parent not liking program|0|||
161604118|NCT04908930|583604774|FG001|Overall Study|parent not liking program|1|||
161604119|NCT04908930|583604775|FG002|Overall Study|parent not liking program|0|||
161604120|NCT04908930|583604776|FG003|Overall Study|parent not liking program|0|||
161604121|NCT04908930|583604777|FG004|Overall Study|parent not liking program|0|||
161604122|NCT04679389|583604778|FG000|Overall Study|Adverse Event|1|||
161604123|NCT04679389|583604779|FG001|Overall Study|Adverse Event|0|||
161604124|NCT04679389|583604778|FG000|Overall Study|Protocol Violation|2|||
161604125|NCT04679389|583604779|FG001|Overall Study|Protocol Violation|0|||
161604126|NCT04679389|583604778|FG000|Overall Study|Physician Decision|3|||
161604127|NCT04679389|583604779|FG001|Overall Study|Physician Decision|5|||
161604128|NCT04679389|583604778|FG000|Overall Study|Withdrawal by Subject|5|||
161604129|NCT04679389|583604779|FG001|Overall Study|Withdrawal by Subject|7|||
161604130|NCT02777593|583604782|FG000|Overall Study|Still in study|1|||
161604131|NCT02777593|583604783|FG001|Overall Study|Still in study|32|||
161604132|NCT02777593|583604784|FG002|Overall Study|Still in study|3|||
161604133|NCT02777593|583604785|FG003|Overall Study|Still in study|6|||
161604134|NCT02777593|583604786|FG004|Overall Study|Still in study|5|||
161604135|NCT02777593|583604782|FG000|Overall Study|Death|21|||
161604136|NCT02777593|583604783|FG001|Overall Study|Death|28|||
161604137|NCT02777593|583604784|FG002|Overall Study|Death|0|||
161604138|NCT02777593|583604785|FG003|Overall Study|Death|5|||
161604139|NCT02777593|583604786|FG004|Overall Study|Death|0|||
161604140|NCT02777593|583604782|FG000|Overall Study|Withdrawal by Subject|8|||
161604141|NCT02777593|583604783|FG001|Overall Study|Withdrawal by Subject|4|||
161604142|NCT02777593|583604784|FG002|Overall Study|Withdrawal by Subject|1|||
161604143|NCT02777593|583604785|FG003|Overall Study|Withdrawal by Subject|1|||
161604144|NCT02777593|583604786|FG004|Overall Study|Withdrawal by Subject|0|||
161604145|NCT02777593|583604782|FG000|Overall Study|Lost to Follow-up|8|||
161604146|NCT02777593|583604783|FG001|Overall Study|Lost to Follow-up|16|||
161604147|NCT02777593|583604784|FG002|Overall Study|Lost to Follow-up|5|||
161604148|NCT02777593|583604785|FG003|Overall Study|Lost to Follow-up|0|||
161604149|NCT02777593|583604786|FG004|Overall Study|Lost to Follow-up|1|||
161604150|NCT02777593|583604782|FG000|Overall Study|Physician Decision|2|||
161604151|NCT02777593|583604783|FG001|Overall Study|Physician Decision|2|||
161604152|NCT02777593|583604784|FG002|Overall Study|Physician Decision|0|||
161604153|NCT02777593|583604785|FG003|Overall Study|Physician Decision|0|||
161604154|NCT02777593|583604786|FG004|Overall Study|Physician Decision|0|||
161683382|NCT05879107|583892962|FG001|Overall Study|Migrated / moved from the study area|1|||
161604155|NCT02777593|583604782|FG000|Overall Study|Discontinued due to Other|1|||
161604156|NCT02777593|583604783|FG001|Overall Study|Discontinued due to Other|0|||
161604157|NCT02777593|583604784|FG002|Overall Study|Discontinued due to Other|0|||
161604158|NCT02777593|583604785|FG003|Overall Study|Discontinued due to Other|0|||
161604159|NCT02777593|583604786|FG004|Overall Study|Discontinued due to Other|0|||
161604160|NCT03547271|583604795|FG000|Overall Study|Adverse Event|1|||
161604161|NCT03547271|583604796|FG001|Overall Study|Adverse Event|1|||
161604162|NCT03547271|583604797|FG002|Overall Study|Adverse Event|0|||
161604163|NCT03547271|583604798|FG003|Overall Study|Adverse Event|0|||
161604164|NCT03547271|583604795|FG000|Overall Study|Protocol deviation|5|||
161604165|NCT03547271|583604796|FG001|Overall Study|Protocol deviation|7|||
161604166|NCT03547271|583604797|FG002|Overall Study|Protocol deviation|3|||
161604167|NCT03547271|583604798|FG003|Overall Study|Protocol deviation|0|||
161604168|NCT03547271|583604795|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
161604169|NCT03547271|583604796|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
161604170|NCT03547271|583604797|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161604171|NCT03547271|583604798|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
161604172|NCT03547271|583604795|FG000|Overall Study|Lost to Follow-up|3|||
161604173|NCT03547271|583604796|FG001|Overall Study|Lost to Follow-up|3|||
161604174|NCT03547271|583604797|FG002|Overall Study|Lost to Follow-up|1|||
161604175|NCT03547271|583604798|FG003|Overall Study|Lost to Follow-up|0|||
161604176|NCT03904576|583604807|FG000|Washout Period|Protocol Violation|1|||
161604177|NCT03904576|583604808|FG001|Washout Period|Protocol Violation|1|||
161604178|NCT04780581|583604811|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
161604179|NCT04780581|583604812|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
161604180|NCT04780581|583604811|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
161604181|NCT04780581|583604812|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
161604182|NCT02765412|583604813|FG000|Overall Study|Death|482|||
161604183|NCT02765412|583604814|FG001|Overall Study|Death|855|||
161604184|NCT03990883|583604815|FG000|Blinded Treatment Phase|Adverse Event|1|||
161604185|NCT03990883|583604816|FG001|Blinded Treatment Phase|Adverse Event|1|||
161604186|NCT03990883|583604817|FG002|Blinded Treatment Phase|Adverse Event|0|||
161604187|NCT03990883|583604815|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
161604188|NCT03990883|583604816|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
161604189|NCT03990883|583604817|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
161604190|NCT03990883|583604815|FG000|Blinded Treatment Phase|Physician Decision|1|||
161604191|NCT03990883|583604816|FG001|Blinded Treatment Phase|Physician Decision|0|||
161604192|NCT03990883|583604817|FG002|Blinded Treatment Phase|Physician Decision|0|||
161604193|NCT03990883|583604815|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
161604194|NCT03990883|583604816|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
161604195|NCT03990883|583604817|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
161604196|NCT03990883|583604815|FG000|Blinded Treatment Phase|COVID-19|3|||
161604197|NCT03990883|583604816|FG001|Blinded Treatment Phase|COVID-19|2|||
161604198|NCT03990883|583604817|FG002|Blinded Treatment Phase|COVID-19|0|||
161604199|NCT03990883|583604815|FG000|Blinded Treatment Phase|Personal Reasons|6|||
161604200|NCT03990883|583604816|FG001|Blinded Treatment Phase|Personal Reasons|3|||
161604201|NCT03990883|583604817|FG002|Blinded Treatment Phase|Personal Reasons|0|||
161604202|NCT03990883|583604815|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
161604203|NCT03990883|583604816|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
161604204|NCT03990883|583604817|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
161604205|NCT03990883|583604815|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
161604206|NCT03990883|583604816|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
161604207|NCT03990883|583604817|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
161604208|NCT03990883|583604815|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
161604209|NCT03990883|583604816|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
161604210|NCT03990883|583604817|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
161604211|NCT04678856|583604818|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
161604212|NCT04678856|583604819|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
161604213|NCT04678856|583604818|FG000|Overall Study|Withdrawal by Subject|5|||
161604214|NCT04678856|583604819|FG001|Overall Study|Withdrawal by Subject|1|||
161604215|NCT05020353|583605479|FG000|Overall Study|Protocol Violation|7|||
161604216|NCT05020353|583605479|FG000|Overall Study|Withdrawal by Subject|33|||
161604217|NCT04664881|583605484|FG000|Overall Study|Withdrawal by Subject|1|||
161604218|NCT04664881|583605485|FG001|Overall Study|Withdrawal by Subject|8|||
161604219|NCT04664881|583605484|FG000|Overall Study|Physician Decision|0|||
161604220|NCT04664881|583605485|FG001|Overall Study|Physician Decision|5|||
161604221|NCT04664881|583605484|FG000|Overall Study|Lost to Follow-up|1|||
161604222|NCT04664881|583605485|FG001|Overall Study|Lost to Follow-up|0|||
161604223|NCT04408755|583605497|FG000|Period A (Placebo lead-in)|Other|11|||
161604224|NCT04408755|583605498|FG001|Period A (Placebo lead-in)|Other|0|||
161604225|NCT04408755|583605499|FG002|Period A (Placebo lead-in)|Other|0|||
161604226|NCT04408755|583605500|FG003|Period A (Placebo lead-in)|Other|0|||
161604227|NCT04408755|583605497|FG000|Period B (Randomization Period)|Adverse Event|0|||
161604228|NCT04408755|583605498|FG001|Period B (Randomization Period)|Adverse Event|3|||
161604229|NCT04408755|583605499|FG002|Period B (Randomization Period)|Adverse Event|0|||
161604230|NCT04408755|583605500|FG003|Period B (Randomization Period)|Adverse Event|1|||
161604231|NCT04408755|583605497|FG000|Period B (Randomization Period)|Death|0|||
161604232|NCT04408755|583605498|FG001|Period B (Randomization Period)|Death|0|||
161604233|NCT04408755|583605499|FG002|Period B (Randomization Period)|Death|1|||
161683383|NCT05879107|583892961|FG000|Overall Study|Lost to Follow-up|8|||
161604234|NCT04408755|583605500|FG003|Period B (Randomization Period)|Death|0|||
161604235|NCT04408755|583605497|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
161604236|NCT04408755|583605498|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
161604237|NCT04408755|583605499|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
161604238|NCT04408755|583605500|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
161604239|NCT04408755|583605497|FG000|Period B (Randomization Period)|Physician Decision|0|||
161604240|NCT04408755|583605498|FG001|Period B (Randomization Period)|Physician Decision|0|||
161604241|NCT04408755|583605499|FG002|Period B (Randomization Period)|Physician Decision|1|||
161604242|NCT04408755|583605500|FG003|Period B (Randomization Period)|Physician Decision|0|||
161604243|NCT04408755|583605497|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
161604244|NCT04408755|583605498|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
161604245|NCT04408755|583605499|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
161604246|NCT04408755|583605500|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
161604247|NCT04408755|583605497|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
161604248|NCT04408755|583605498|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
161604249|NCT04408755|583605499|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
161832260|NCT04146363|584428393|FG010|Induction Period|Adverse Event|0|||
161832261|NCT04146363|584428383|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
161832262|NCT04146363|584428384|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
161832263|NCT04146363|584428385|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
161832264|NCT04146363|584428386|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
161832265|NCT04146363|584428387|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
161832266|NCT04146363|584428388|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
161832267|NCT04146363|584428389|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
161832268|NCT04146363|584428390|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
161832269|NCT04146363|584428391|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
161832270|NCT04146363|584428392|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
161832271|NCT04146363|584428393|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
161832272|NCT04146363|584428383|FG000|Induction Period|Lack of Efficacy|7|||
161832273|NCT04146363|584428384|FG001|Induction Period|Lack of Efficacy|2|||
161832274|NCT04146363|584428385|FG002|Induction Period|Lack of Efficacy|0|||
161832275|NCT04146363|584428386|FG003|Induction Period|Lack of Efficacy|0|||
161832276|NCT04146363|584428387|FG004|Induction Period|Lack of Efficacy|0|||
161832277|NCT04146363|584428388|FG005|Induction Period|Lack of Efficacy|0|||
161832278|NCT04146363|584428389|FG006|Induction Period|Lack of Efficacy|0|||
161832279|NCT04146363|584428390|FG007|Induction Period|Lack of Efficacy|0|||
161832280|NCT04146363|584428391|FG008|Induction Period|Lack of Efficacy|0|||
161832281|NCT04146363|584428392|FG009|Induction Period|Lack of Efficacy|0|||
161832282|NCT04146363|584428393|FG010|Induction Period|Lack of Efficacy|0|||
161832283|NCT04146363|584428383|FG000|Induction Period|Lost to Follow-up|1|||
161832284|NCT04146363|584428384|FG001|Induction Period|Lost to Follow-up|4|||
161832285|NCT04146363|584428385|FG002|Induction Period|Lost to Follow-up|0|||
161832286|NCT04146363|584428386|FG003|Induction Period|Lost to Follow-up|0|||
161832287|NCT04146363|584428387|FG004|Induction Period|Lost to Follow-up|0|||
161832288|NCT04146363|584428388|FG005|Induction Period|Lost to Follow-up|0|||
161832289|NCT04146363|584428389|FG006|Induction Period|Lost to Follow-up|0|||
161832290|NCT04146363|584428390|FG007|Induction Period|Lost to Follow-up|0|||
161832291|NCT04146363|584428391|FG008|Induction Period|Lost to Follow-up|0|||
161604250|NCT04408755|583605500|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
161604251|NCT04408755|583605497|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
161604252|NCT04408755|583605498|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
161604253|NCT04408755|583605499|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
161604254|NCT04408755|583605500|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
161604255|NCT04408755|583605497|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
161604256|NCT04408755|583605498|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
161604257|NCT04408755|583605499|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
161604258|NCT04408755|583605500|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
161604259|NCT04408755|583605497|FG000|Period B (Randomization Period)|Reason not Specified|0|||
161604260|NCT04408755|583605498|FG001|Period B (Randomization Period)|Reason not Specified|1|||
161604261|NCT04408755|583605499|FG002|Period B (Randomization Period)|Reason not Specified|0|||
161604262|NCT04408755|583605500|FG003|Period B (Randomization Period)|Reason not Specified|2|||
161604263|NCT05836012|583605503|FG000|Overall Study|Lost to Follow-up|1|||
161604264|NCT05836012|583605504|FG001|Overall Study|Lost to Follow-up|0|||
161604265|NCT05836012|583605503|FG000|Overall Study|Withdrawal by Subject|1|||
161604266|NCT05836012|583605504|FG001|Overall Study|Withdrawal by Subject|3|||
161604267|NCT05836012|583605503|FG000|Overall Study|Reason not included in pre-specified categories|2|||
161604268|NCT05836012|583605504|FG001|Overall Study|Reason not included in pre-specified categories|1|||
161604269|NCT05785130|583605507|FG000|Overall Study|Withdrawal by Subject|1|||
161604270|NCT05785130|583605508|FG001|Overall Study|Withdrawal by Subject|0|||
161604271|NCT05785130|583605507|FG000|Overall Study|Lack of Efficacy|0|||
161604272|NCT05785130|583605508|FG001|Overall Study|Lack of Efficacy|1|||
161604273|NCT05718687|583605511|FG000|Overall Study|Withdrawal by Subject|3|||
161604274|NCT05215054|583605514|FG000|Overall Study|Lost to Follow-up|1|||
161604275|NCT05215054|583605515|FG001|Overall Study|Lost to Follow-up|1|||
161604276|NCT05215054|583605514|FG000|Overall Study|Protocol Violation|1|||
161604277|NCT05215054|583605515|FG001|Overall Study|Protocol Violation|1|||
161604278|NCT05215054|583605514|FG000|Overall Study|Withdrawal by Subject|4|||
161604279|NCT05215054|583605515|FG001|Overall Study|Withdrawal by Subject|4|||
161604280|NCT01897441|583605516|FG000|Overall Study|Lost to Follow-up|0|||
161604281|NCT01897441|583605517|FG001|Overall Study|Lost to Follow-up|0|||
161604282|NCT01897441|583605518|FG002|Overall Study|Lost to Follow-up|1|||
161604283|NCT01897441|583605519|FG003|Overall Study|Lost to Follow-up|0|||
161604284|NCT01897441|583605520|FG004|Overall Study|Lost to Follow-up|0|||
161604285|NCT01897441|583605521|FG005|Overall Study|Lost to Follow-up|0|||
161604286|NCT01897441|583605516|FG000|Overall Study|Withdrawal by Subject|0|||
161832292|NCT04146363|584428392|FG009|Induction Period|Lost to Follow-up|0|||
161832293|NCT04146363|584428393|FG010|Induction Period|Lost to Follow-up|0|||
161832294|NCT04146363|584428383|FG000|Induction Period|Positive quantiferon test|0|||
161832295|NCT04146363|584428384|FG001|Induction Period|Positive quantiferon test|1|||
161604287|NCT01897441|583605517|FG001|Overall Study|Withdrawal by Subject|0|||
161604288|NCT01897441|583605518|FG002|Overall Study|Withdrawal by Subject|0|||
161604289|NCT01897441|583605519|FG003|Overall Study|Withdrawal by Subject|0|||
161604290|NCT01897441|583605520|FG004|Overall Study|Withdrawal by Subject|1|||
161604291|NCT01897441|583605521|FG005|Overall Study|Withdrawal by Subject|0|||
161604292|NCT01897441|583605516|FG000|Overall Study|Withdrawn by Provider|0|||
161604293|NCT01897441|583605517|FG001|Overall Study|Withdrawn by Provider|2|||
161604294|NCT01897441|583605518|FG002|Overall Study|Withdrawn by Provider|0|||
161604295|NCT01897441|583605519|FG003|Overall Study|Withdrawn by Provider|0|||
161604296|NCT01897441|583605520|FG004|Overall Study|Withdrawn by Provider|0|||
161604297|NCT01897441|583605521|FG005|Overall Study|Withdrawn by Provider|0|||
161604298|NCT02933489|583605522|FG000|Overall Study|Ineligible|3|||
161604299|NCT02933489|583605523|FG001|Overall Study|Ineligible|3|||
161604300|NCT02933489|583605522|FG000|Overall Study|Withdrawal by Subject|27|||
161604301|NCT02933489|583605523|FG001|Overall Study|Withdrawal by Subject|18|||
161604302|NCT02933489|583605522|FG000|Overall Study|Unable to complete exams (other)|14|||
161604303|NCT02933489|583605523|FG001|Overall Study|Unable to complete exams (other)|7|||
161604304|NCT05485935|583605524|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
161604305|NCT05485935|583605525|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
161604306|NCT05485935|583605524|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
161604307|NCT05485935|583605525|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
161604308|NCT05485935|583605524|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
161604309|NCT05485935|583605525|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
161604310|NCT05485935|583605524|FG000|Period 2 (T2 and V3)|loss of contact|0|||
161604311|NCT05485935|583605525|FG001|Period 2 (T2 and V3)|loss of contact|1|||
161604312|NCT04093869|583605526|FG000|Overall Study|Death|0|||
161604313|NCT04093869|583605527|FG001|Overall Study|Death|1|||
161604314|NCT04093869|583605526|FG000|Overall Study|Withdrawal by Subject|1|||
161604315|NCT04093869|583605527|FG001|Overall Study|Withdrawal by Subject|0|||
161604316|NCT03250676|583605528|FG000|Overall Study|Adverse Event|0|||
161604317|NCT03250676|583605529|FG001|Overall Study|Adverse Event|0|||
161604318|NCT03250676|583605530|FG002|Overall Study|Adverse Event|0|||
161604319|NCT03250676|583605531|FG003|Overall Study|Adverse Event|1|||
161683384|NCT05879107|583892962|FG001|Overall Study|Lost to Follow-up|13|||
161604320|NCT03250676|583605532|FG004|Overall Study|Adverse Event|2|||
161604321|NCT03250676|583605533|FG005|Overall Study|Adverse Event|9|||
161604322|NCT03250676|583605528|FG000|Overall Study|Withdrawal by Subject|1|||
161604323|NCT03250676|583605529|FG001|Overall Study|Withdrawal by Subject|0|||
161604324|NCT03250676|583605530|FG002|Overall Study|Withdrawal by Subject|0|||
161604325|NCT03250676|583605531|FG003|Overall Study|Withdrawal by Subject|1|||
161604326|NCT03250676|583605532|FG004|Overall Study|Withdrawal by Subject|1|||
161604327|NCT03250676|583605533|FG005|Overall Study|Withdrawal by Subject|2|||
161604328|NCT03250676|583605528|FG000|Overall Study|Physician Decision|0|||
161604329|NCT03250676|583605529|FG001|Overall Study|Physician Decision|0|||
161604330|NCT03250676|583605530|FG002|Overall Study|Physician Decision|0|||
161604331|NCT03250676|583605531|FG003|Overall Study|Physician Decision|2|||
161604332|NCT03250676|583605532|FG004|Overall Study|Physician Decision|0|||
161604333|NCT03250676|583605533|FG005|Overall Study|Physician Decision|3|||
161604334|NCT03250676|583605528|FG000|Overall Study|Withdrawal of consent|0|||
161604335|NCT03250676|583605529|FG001|Overall Study|Withdrawal of consent|0|||
161604336|NCT03250676|583605530|FG002|Overall Study|Withdrawal of consent|2|||
161604337|NCT03250676|583605531|FG003|Overall Study|Withdrawal of consent|0|||
161604338|NCT03250676|583605532|FG004|Overall Study|Withdrawal of consent|0|||
161604339|NCT03250676|583605533|FG005|Overall Study|Withdrawal of consent|2|||
161604340|NCT03250676|583605528|FG000|Overall Study|Other|1|||
161604341|NCT03250676|583605529|FG001|Overall Study|Other|0|||
161604342|NCT03250676|583605530|FG002|Overall Study|Other|0|||
161604343|NCT03250676|583605531|FG003|Overall Study|Other|0|||
161604344|NCT03250676|583605532|FG004|Overall Study|Other|0|||
161604345|NCT03250676|583605533|FG005|Overall Study|Other|0|||
161604346|NCT03250676|583605528|FG000|Overall Study|Disease progression|4|||
161604347|NCT03250676|583605529|FG001|Overall Study|Disease progression|12|||
161604348|NCT03250676|583605530|FG002|Overall Study|Disease progression|9|||
161604349|NCT03250676|583605531|FG003|Overall Study|Disease progression|7|||
161604350|NCT03250676|583605532|FG004|Overall Study|Disease progression|4|||
161832296|NCT04146363|584428385|FG002|Induction Period|Positive quantiferon test|0|||
161832297|NCT04146363|584428386|FG003|Induction Period|Positive quantiferon test|0|||
161832298|NCT04146363|584428387|FG004|Induction Period|Positive quantiferon test|0|||
161832299|NCT04146363|584428388|FG005|Induction Period|Positive quantiferon test|0|||
161832300|NCT04146363|584428389|FG006|Induction Period|Positive quantiferon test|0|||
161832301|NCT04146363|584428390|FG007|Induction Period|Positive quantiferon test|0|||
161832302|NCT04146363|584428391|FG008|Induction Period|Positive quantiferon test|0|||
161832303|NCT04146363|584428392|FG009|Induction Period|Positive quantiferon test|0|||
161832304|NCT04146363|584428393|FG010|Induction Period|Positive quantiferon test|0|||
161832305|NCT04146363|584428383|FG000|Induction Period|Protocol Deviation|5|||
161832306|NCT04146363|584428384|FG001|Induction Period|Protocol Deviation|6|||
161832307|NCT04146363|584428385|FG002|Induction Period|Protocol Deviation|0|||
161832308|NCT04146363|584428386|FG003|Induction Period|Protocol Deviation|0|||
161832309|NCT04146363|584428387|FG004|Induction Period|Protocol Deviation|0|||
161832310|NCT04146363|584428388|FG005|Induction Period|Protocol Deviation|0|||
161832311|NCT04146363|584428389|FG006|Induction Period|Protocol Deviation|0|||
161683385|NCT05879107|583892961|FG000|Overall Study|Death|0|||
161683386|NCT05879107|583892962|FG001|Overall Study|Death|2|||
161683387|NCT05879107|583892961|FG000|Overall Study|Other|0|||
161683388|NCT05879107|583892962|FG001|Overall Study|Other|3|||
161683389|NCT03901079|583892963|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
161683390|NCT00916149|583892964|FG000|Overall Study|Lost to Follow-up|3|||
161683391|NCT00916149|583892965|FG001|Overall Study|Lost to Follow-up|2|||
161683392|NCT00916149|583892966|FG002|Overall Study|Lost to Follow-up|0|||
161683393|NCT00916149|583892964|FG000|Overall Study|Unable to place scalp EEG leads|1|||
161683394|NCT00916149|583892965|FG001|Overall Study|Unable to place scalp EEG leads|0|||
161683395|NCT00916149|583892966|FG002|Overall Study|Unable to place scalp EEG leads|0|||
161683396|NCT00545298|583892967|FG000|Overall Study|Issues with Standard of Care|2|||
161683397|NCT00545298|583892968|FG001|Overall Study|Issues with Standard of Care|0|||
161683398|NCT00545298|583892969|FG002|Overall Study|Issues with Standard of Care|1|||
161683399|NCT00978029|583892970|FG000|Overall Study|Adverse Event|1|||
161683400|NCT00978029|583892971|FG001|Overall Study|Adverse Event|2|||
161683401|NCT00978029|583892972|FG002|Overall Study|Adverse Event|5|||
161683402|NCT00978029|583892970|FG000|Overall Study|Withdrawal by Subject|0|||
161683403|NCT00978029|583892971|FG001|Overall Study|Withdrawal by Subject|0|||
161683404|NCT00978029|583892972|FG002|Overall Study|Withdrawal by Subject|1|||
161683405|NCT00978029|583892970|FG000|Overall Study|Protocol Violation|0|||
161683406|NCT00978029|583892971|FG001|Overall Study|Protocol Violation|1|||
161683407|NCT00978029|583892972|FG002|Overall Study|Protocol Violation|0|||
161683408|NCT01820364|583892973|FG000|Part I: LGX818|Death|1|||
161683409|NCT01820364|583892974|FG001|Part I: LGX818|Death|0|||
161683410|NCT01820364|583892973|FG000|Part I: LGX818|Administrative Problems|3|||
161832312|NCT04146363|584428390|FG007|Induction Period|Protocol Deviation|0|||
161604351|NCT03250676|583605533|FG005|Overall Study|Disease progression|88|||
161604352|NCT01499368|583605534|FG000|Overall Study|Did not meet I/E criteria|8|||
161604353|NCT01499368|583605535|FG001|Overall Study|Did not meet I/E criteria|4|||
161604354|NCT01499368|583605536|FG002|Overall Study|Did not meet I/E criteria|4|||
161604355|NCT01499368|583605534|FG000|Overall Study|Prohibited Concomitant medication|1|||
161604356|NCT01499368|583605535|FG001|Overall Study|Prohibited Concomitant medication|1|||
161604357|NCT01499368|583605536|FG002|Overall Study|Prohibited Concomitant medication|0|||
161604358|NCT01499368|583605534|FG000|Overall Study|Withdrawal by Subject|11|||
161604359|NCT01499368|583605535|FG001|Overall Study|Withdrawal by Subject|10|||
161604360|NCT01499368|583605536|FG002|Overall Study|Withdrawal by Subject|8|||
161604361|NCT01499368|583605534|FG000|Overall Study|Lost to Follow-up|3|||
161604362|NCT01499368|583605535|FG001|Overall Study|Lost to Follow-up|2|||
161604363|NCT01499368|583605536|FG002|Overall Study|Lost to Follow-up|5|||
161604364|NCT01499368|583605534|FG000|Overall Study|Adverse Event|4|||
161604365|NCT01499368|583605535|FG001|Overall Study|Adverse Event|0|||
161604366|NCT01499368|583605536|FG002|Overall Study|Adverse Event|2|||
161604367|NCT01499368|583605534|FG000|Overall Study|Physician Decision|0|||
161604368|NCT01499368|583605535|FG001|Overall Study|Physician Decision|1|||
161604369|NCT01499368|583605536|FG002|Overall Study|Physician Decision|0|||
161604370|NCT01499368|583605534|FG000|Overall Study|Deviation from visit window|0|||
161604371|NCT01499368|583605535|FG001|Overall Study|Deviation from visit window|0|||
161604372|NCT01499368|583605536|FG002|Overall Study|Deviation from visit window|1|||
161604373|NCT01499368|583605534|FG000|Overall Study|Error of Prescriptions|0|||
161604374|NCT01499368|583605535|FG001|Overall Study|Error of Prescriptions|0|||
161604375|NCT01499368|583605536|FG002|Overall Study|Error of Prescriptions|1|||
161604376|NCT03092674|583605537|FG000|Overall Study|Adverse Event or Side Effects|1|||
161604377|NCT03092674|583605538|FG001|Overall Study|Adverse Event or Side Effects|4|||
161604378|NCT03092674|583605539|FG002|Overall Study|Adverse Event or Side Effects|4|||
161604379|NCT03092674|583605537|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
161604380|NCT03092674|583605538|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
161604381|NCT03092674|583605539|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
161604382|NCT03092674|583605537|FG000|Overall Study|Progression/Relapse|5|||
161604383|NCT03092674|583605538|FG001|Overall Study|Progression/Relapse|4|||
161683411|NCT01820364|583892974|FG001|Part I: LGX818|Administrative Problems|0|||
161683412|NCT01820364|583892973|FG000|Part I: LGX818|Adverse Event|6|||
161604384|NCT03092674|583605539|FG002|Overall Study|Progression/Relapse|8|||
161683413|NCT01820364|583892974|FG001|Part I: LGX818|Adverse Event|0|||
161683414|NCT01820364|583892973|FG000|Part I: LGX818|Disease Progression|4|||
161604385|NCT03092674|583605537|FG000|Overall Study|Death|4|||
161604386|NCT03092674|583605538|FG001|Overall Study|Death|8|||
161683415|NCT01820364|583892974|FG001|Part I: LGX818|Disease Progression|0|||
161604387|NCT03092674|583605539|FG002|Overall Study|Death|2|||
161604388|NCT03092674|583605537|FG000|Overall Study|Other - Not Protocol Specified|11|||
161604389|NCT03092674|583605538|FG001|Overall Study|Other - Not Protocol Specified|8|||
161604390|NCT03092674|583605539|FG002|Overall Study|Other - Not Protocol Specified|8|||
161604391|NCT02325154|583605540|FG000|Overall Study|Physician Decision|1|||
161604392|NCT04633278|583606423|FG000|Overall Study|Adverse Event|1|||
161604393|NCT04633278|583606424|FG001|Overall Study|Adverse Event|0|||
161604394|NCT04633278|583606423|FG000|Overall Study|Withdrawal by Subject|1|||
161604395|NCT04633278|583606424|FG001|Overall Study|Withdrawal by Subject|0|||
161604396|NCT04633278|583606423|FG000|Overall Study|Death|11|||
161604397|NCT04633278|583606424|FG001|Overall Study|Death|7|||
161604398|NCT04633278|583606423|FG000|Overall Study|Sponsor Decision|3|||
161604399|NCT04633278|583606424|FG001|Overall Study|Sponsor Decision|0|||
161604400|NCT04633278|583606423|FG000|Overall Study|Not Listed|1|||
161604401|NCT04633278|583606424|FG001|Overall Study|Not Listed|0|||
161604402|NCT03705793|583606428|FG000|Overall Study|Lost to Follow-up|3|||
161604403|NCT03705793|583606429|FG001|Overall Study|Lost to Follow-up|4|||
161683416|NCT01820364|583892973|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
161683417|NCT01820364|583892974|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
161683418|NCT01087775|583892975|FG000|Overall Study|failed inclusion criteria|2|||
161683419|NCT02090413|583892980|FG000|Overall Study|Adverse Event|11|||
161683420|NCT02090413|583892981|FG001|Overall Study|Adverse Event|15|||
161683421|NCT02090413|583892982|FG002|Overall Study|Adverse Event|20|||
161683422|NCT02090413|583892980|FG000|Overall Study|Flushing event|2|||
161683423|NCT02090413|583892981|FG001|Overall Study|Flushing event|0|||
161683424|NCT02090413|583892982|FG002|Overall Study|Flushing event|1|||
161683425|NCT02090413|583892980|FG000|Overall Study|Withdrawal by Subject|2|||
161683426|NCT02090413|583892981|FG001|Overall Study|Withdrawal by Subject|2|||
161683427|NCT02090413|583892982|FG002|Overall Study|Withdrawal by Subject|2|||
161683428|NCT02090413|583892980|FG000|Overall Study|Investigator Decision|1|||
161683429|NCT02090413|583892981|FG001|Overall Study|Investigator Decision|1|||
161683430|NCT02090413|583892982|FG002|Overall Study|Investigator Decision|0|||
161683431|NCT02090413|583892980|FG000|Overall Study|Other|2|||
161683432|NCT02090413|583892981|FG001|Overall Study|Other|1|||
161683433|NCT02090413|583892982|FG002|Overall Study|Other|0|||
161683434|NCT02090413|583892980|FG000|Overall Study|Lost to Follow-up|1|||
161683435|NCT02090413|583892981|FG001|Overall Study|Lost to Follow-up|1|||
161683436|NCT02090413|583892982|FG002|Overall Study|Lost to Follow-up|0|||
161683437|NCT05248295|583892983|FG000|Overall Study|found ineligible|4|||
161683438|NCT05248295|583892984|FG001|Overall Study|found ineligible|1|||
161683439|NCT05248295|583892983|FG000|Overall Study|Withdrawal by Subject|0|||
161683440|NCT05248295|583892984|FG001|Overall Study|Withdrawal by Subject|1|||
161683441|NCT05248295|583892983|FG000|Overall Study|Data loss: audio recording error|1|||
161683442|NCT05248295|583892984|FG001|Overall Study|Data loss: audio recording error|1|||
161683443|NCT04490018|583892985|FG000|Overall Study|Protocol Violation|0|||
161683444|NCT04490018|583892986|FG001|Overall Study|Protocol Violation|2|||
161683445|NCT04490018|583892987|FG002|Overall Study|Protocol Violation|1|||
161683446|NCT04490018|583892985|FG000|Overall Study|Lost to Follow-up|2|||
161683447|NCT04490018|583892986|FG001|Overall Study|Lost to Follow-up|2|||
161683448|NCT04490018|583892987|FG002|Overall Study|Lost to Follow-up|0|||
161683449|NCT04490018|583892985|FG000|Overall Study|Withdrawal by Subject|2|||
161683450|NCT04490018|583892986|FG001|Overall Study|Withdrawal by Subject|1|||
161683451|NCT04490018|583892987|FG002|Overall Study|Withdrawal by Subject|0|||
161683452|NCT04490018|583892985|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161683453|NCT04490018|583892986|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161683454|NCT04490018|583892987|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161683455|NCT02321930|583892988|FG000|Overall Study|Lost to Follow-up|1|||
161683456|NCT01293968|583892989|FG000|Overall Study|non-cooperation|3|||
161683457|NCT01293968|583892990|FG001|Overall Study|non-cooperation|3|||
161683458|NCT01484977|583892991|FG000|Overall Study|Adverse Event|8|||
161683459|NCT01484977|583892991|FG000|Overall Study|Lack of Efficacy|4|||
161683460|NCT01484977|583892991|FG000|Overall Study|Protocol Violation|6|||
161683461|NCT01484977|583892991|FG000|Overall Study|Lost to Follow-up|1|||
161683462|NCT01484977|583892991|FG000|Overall Study|Withdrawal by Subject|4|||
161683463|NCT01484977|583892991|FG000|Overall Study|Subject Protocol Non-compliant|1|||
161604404|NCT03705793|583606428|FG000|Overall Study|Withdrawal by Subject|2|||
161604405|NCT03705793|583606429|FG001|Overall Study|Withdrawal by Subject|1|||
161604406|NCT00447980|583606430|FG000|Overall Study|Withdrawal by Subject|1|||
161683464|NCT01484977|583892991|FG000|Overall Study|Moving Overseas|1|||
161683465|NCT01484977|583892991|FG000|Overall Study|Low White Blood Cell Count|1|||
161604407|NCT00447980|583606431|FG001|Overall Study|Withdrawal by Subject|1|||
161604408|NCT00447980|583606432|FG002|Overall Study|Withdrawal by Subject|4|||
161604409|NCT00447980|583606433|FG003|Overall Study|Withdrawal by Subject|4|||
161683466|NCT01484977|583892991|FG000|Overall Study|Lack of Compliance|1|||
161683467|NCT01133379|583892992|FG000|Overall Study|Withdrawal by Subject|0|||
161683468|NCT01133379|583892993|FG001|Overall Study|Withdrawal by Subject|1|||
161604410|NCT00447980|583606430|FG000|Overall Study|Lost to Follow-up|1|||
161604411|NCT00447980|583606431|FG001|Overall Study|Lost to Follow-up|1|||
161604412|NCT00447980|583606432|FG002|Overall Study|Lost to Follow-up|0|||
161604413|NCT00447980|583606433|FG003|Overall Study|Lost to Follow-up|0|||
161604414|NCT00447980|583606430|FG000|Overall Study|Did not proceed with surgery|3|||
161604415|NCT00447980|583606431|FG001|Overall Study|Did not proceed with surgery|3|||
161604416|NCT00447980|583606432|FG002|Overall Study|Did not proceed with surgery|2|||
161604417|NCT00447980|583606433|FG003|Overall Study|Did not proceed with surgery|2|||
161604418|NCT02720068|583606434|FG000|Overall Study|Adverse Event|0|||
161604419|NCT02720068|583606435|FG001|Overall Study|Adverse Event|0|||
161604420|NCT02720068|583606436|FG002|Overall Study|Adverse Event|0|||
161604421|NCT02720068|583606437|FG003|Overall Study|Adverse Event|0|||
161604422|NCT02720068|583606438|FG004|Overall Study|Adverse Event|0|||
161604423|NCT02720068|583606439|FG005|Overall Study|Adverse Event|0|||
161604424|NCT02720068|583606440|FG006|Overall Study|Adverse Event|0|||
161604425|NCT02720068|583606441|FG007|Overall Study|Adverse Event|0|||
161604426|NCT02720068|583606442|FG008|Overall Study|Adverse Event|0|||
161604427|NCT02720068|583606443|FG009|Overall Study|Adverse Event|0|||
161604428|NCT02720068|583606444|FG010|Overall Study|Adverse Event|0|||
161604429|NCT02720068|583606445|FG011|Overall Study|Adverse Event|1|||
161604430|NCT02720068|583606446|FG012|Overall Study|Adverse Event|0|||
161604431|NCT02720068|583606447|FG013|Overall Study|Adverse Event|0|||
161604432|NCT02720068|583606448|FG014|Overall Study|Adverse Event|0|||
161604433|NCT02720068|583606449|FG015|Overall Study|Adverse Event|0|||
161604434|NCT02720068|583606450|FG016|Overall Study|Adverse Event|0|||
161604435|NCT02720068|583606451|FG017|Overall Study|Adverse Event|0|||
161604436|NCT02720068|583606434|FG000|Overall Study|Death|1|||
161604437|NCT02720068|583606435|FG001|Overall Study|Death|3|||
161604438|NCT02720068|583606436|FG002|Overall Study|Death|2|||
161604439|NCT02720068|583606437|FG003|Overall Study|Death|1|||
161604440|NCT02720068|583606438|FG004|Overall Study|Death|2|||
161604441|NCT02720068|583606439|FG005|Overall Study|Death|1|||
161604442|NCT02720068|583606440|FG006|Overall Study|Death|2|||
161604443|NCT02720068|583606441|FG007|Overall Study|Death|2|||
161604444|NCT02720068|583606442|FG008|Overall Study|Death|3|||
161604445|NCT02720068|583606443|FG009|Overall Study|Death|1|||
161604446|NCT02720068|583606444|FG010|Overall Study|Death|20|||
161604447|NCT02720068|583606445|FG011|Overall Study|Death|166|||
161604448|NCT02720068|583606446|FG012|Overall Study|Death|34|||
161604449|NCT02720068|583606447|FG013|Overall Study|Death|30|||
161604450|NCT02720068|583606448|FG014|Overall Study|Death|45|||
161604451|NCT02720068|583606449|FG015|Overall Study|Death|16|||
161604452|NCT02720068|583606450|FG016|Overall Study|Death|20|||
161604453|NCT02720068|583606451|FG017|Overall Study|Death|28|||
161604454|NCT02720068|583606434|FG000|Overall Study|Lost to Follow-up|0|||
161604455|NCT02720068|583606435|FG001|Overall Study|Lost to Follow-up|0|||
161604456|NCT02720068|583606436|FG002|Overall Study|Lost to Follow-up|0|||
161604457|NCT02720068|583606437|FG003|Overall Study|Lost to Follow-up|0|||
161604458|NCT02720068|583606438|FG004|Overall Study|Lost to Follow-up|0|||
161604459|NCT02720068|583606439|FG005|Overall Study|Lost to Follow-up|0|||
161604460|NCT02720068|583606440|FG006|Overall Study|Lost to Follow-up|0|||
161604461|NCT02720068|583606441|FG007|Overall Study|Lost to Follow-up|0|||
161604462|NCT02720068|583606442|FG008|Overall Study|Lost to Follow-up|0|||
161604463|NCT02720068|583606443|FG009|Overall Study|Lost to Follow-up|0|||
161604464|NCT02720068|583606444|FG010|Overall Study|Lost to Follow-up|0|||
161604465|NCT02720068|583606445|FG011|Overall Study|Lost to Follow-up|1|||
161604466|NCT02720068|583606446|FG012|Overall Study|Lost to Follow-up|0|||
161604467|NCT02720068|583606447|FG013|Overall Study|Lost to Follow-up|1|||
161604468|NCT02720068|583606448|FG014|Overall Study|Lost to Follow-up|2|||
161604469|NCT02720068|583606449|FG015|Overall Study|Lost to Follow-up|0|||
161604470|NCT02720068|583606450|FG016|Overall Study|Lost to Follow-up|0|||
161604471|NCT02720068|583606451|FG017|Overall Study|Lost to Follow-up|1|||
161604472|NCT02720068|583606434|FG000|Overall Study|Physician Decision|0|||
161604473|NCT02720068|583606435|FG001|Overall Study|Physician Decision|0|||
161604474|NCT02720068|583606436|FG002|Overall Study|Physician Decision|0|||
161604475|NCT02720068|583606437|FG003|Overall Study|Physician Decision|1|||
161604476|NCT02720068|583606438|FG004|Overall Study|Physician Decision|0|||
161604477|NCT02720068|583606439|FG005|Overall Study|Physician Decision|0|||
161604478|NCT02720068|583606440|FG006|Overall Study|Physician Decision|0|||
161604479|NCT02720068|583606441|FG007|Overall Study|Physician Decision|0|||
161604480|NCT02720068|583606442|FG008|Overall Study|Physician Decision|0|||
161604481|NCT02720068|583606443|FG009|Overall Study|Physician Decision|0|||
161604482|NCT02720068|583606444|FG010|Overall Study|Physician Decision|0|||
161604483|NCT02720068|583606445|FG011|Overall Study|Physician Decision|1|||
161604484|NCT02720068|583606446|FG012|Overall Study|Physician Decision|0|||
161604485|NCT02720068|583606447|FG013|Overall Study|Physician Decision|0|||
161604486|NCT02720068|583606448|FG014|Overall Study|Physician Decision|0|||
161604487|NCT02720068|583606449|FG015|Overall Study|Physician Decision|0|||
161604488|NCT02720068|583606450|FG016|Overall Study|Physician Decision|0|||
161604489|NCT02720068|583606451|FG017|Overall Study|Physician Decision|1|||
161604490|NCT02720068|583606434|FG000|Overall Study|Progressive Disease|2|||
161604491|NCT02720068|583606435|FG001|Overall Study|Progressive Disease|3|||
161604492|NCT02720068|583606436|FG002|Overall Study|Progressive Disease|1|||
161604493|NCT02720068|583606437|FG003|Overall Study|Progressive Disease|1|||
161604494|NCT02720068|583606438|FG004|Overall Study|Progressive Disease|1|||
161604495|NCT02720068|583606439|FG005|Overall Study|Progressive Disease|2|||
161604496|NCT02720068|583606440|FG006|Overall Study|Progressive Disease|1|||
161604497|NCT02720068|583606441|FG007|Overall Study|Progressive Disease|1|||
161604498|NCT02720068|583606442|FG008|Overall Study|Progressive Disease|0|||
161604499|NCT02720068|583606443|FG009|Overall Study|Progressive Disease|1|||
161604500|NCT02720068|583606444|FG010|Overall Study|Progressive Disease|0|||
161604501|NCT02720068|583606445|FG011|Overall Study|Progressive Disease|4|||
161604502|NCT02720068|583606446|FG012|Overall Study|Progressive Disease|1|||
161604503|NCT02720068|583606447|FG013|Overall Study|Progressive Disease|0|||
161604504|NCT02720068|583606448|FG014|Overall Study|Progressive Disease|0|||
161604505|NCT02720068|583606449|FG015|Overall Study|Progressive Disease|0|||
161604506|NCT02720068|583606450|FG016|Overall Study|Progressive Disease|0|||
161604507|NCT02720068|583606451|FG017|Overall Study|Progressive Disease|0|||
161604508|NCT02720068|583606434|FG000|Overall Study|Sponsor Decision|0|||
161604509|NCT02720068|583606435|FG001|Overall Study|Sponsor Decision|0|||
161604510|NCT02720068|583606436|FG002|Overall Study|Sponsor Decision|0|||
161604511|NCT02720068|583606437|FG003|Overall Study|Sponsor Decision|0|||
161604512|NCT02720068|583606438|FG004|Overall Study|Sponsor Decision|0|||
161604513|NCT02720068|583606439|FG005|Overall Study|Sponsor Decision|0|||
161604514|NCT02720068|583606440|FG006|Overall Study|Sponsor Decision|0|||
161604515|NCT02720068|583606441|FG007|Overall Study|Sponsor Decision|0|||
161604516|NCT02720068|583606442|FG008|Overall Study|Sponsor Decision|0|||
161604517|NCT02720068|583606443|FG009|Overall Study|Sponsor Decision|0|||
161604518|NCT02720068|583606444|FG010|Overall Study|Sponsor Decision|0|||
161604519|NCT02720068|583606445|FG011|Overall Study|Sponsor Decision|6|||
161604520|NCT02720068|583606446|FG012|Overall Study|Sponsor Decision|3|||
161604521|NCT02720068|583606447|FG013|Overall Study|Sponsor Decision|2|||
161604522|NCT02720068|583606448|FG014|Overall Study|Sponsor Decision|4|||
161604523|NCT02720068|583606449|FG015|Overall Study|Sponsor Decision|4|||
161604524|NCT02720068|583606450|FG016|Overall Study|Sponsor Decision|0|||
161604525|NCT02720068|583606451|FG017|Overall Study|Sponsor Decision|8|||
161832313|NCT04146363|584428391|FG008|Induction Period|Protocol Deviation|0|||
161832314|NCT04146363|584428392|FG009|Induction Period|Protocol Deviation|0|||
161832315|NCT04146363|584428393|FG010|Induction Period|Protocol Deviation|0|||
161832316|NCT04146363|584428383|FG000|Induction Period|Withdrawal by Subject|6|||
161604526|NCT02720068|583606434|FG000|Overall Study|Withdrawal by Subject|0|||
161604527|NCT02720068|583606435|FG001|Overall Study|Withdrawal by Subject|0|||
161604528|NCT02720068|583606436|FG002|Overall Study|Withdrawal by Subject|0|||
161604529|NCT02720068|583606437|FG003|Overall Study|Withdrawal by Subject|0|||
161604530|NCT02720068|583606438|FG004|Overall Study|Withdrawal by Subject|0|||
161604531|NCT02720068|583606439|FG005|Overall Study|Withdrawal by Subject|0|||
161604532|NCT02720068|583606440|FG006|Overall Study|Withdrawal by Subject|0|||
161604533|NCT02720068|583606441|FG007|Overall Study|Withdrawal by Subject|0|||
161604534|NCT02720068|583606442|FG008|Overall Study|Withdrawal by Subject|0|||
161604535|NCT02720068|583606443|FG009|Overall Study|Withdrawal by Subject|1|||
161604536|NCT02720068|583606444|FG010|Overall Study|Withdrawal by Subject|0|||
161604537|NCT02720068|583606445|FG011|Overall Study|Withdrawal by Subject|27|||
161604538|NCT02720068|583606446|FG012|Overall Study|Withdrawal by Subject|2|||
161604539|NCT02720068|583606447|FG013|Overall Study|Withdrawal by Subject|8|||
161604540|NCT02720068|583606448|FG014|Overall Study|Withdrawal by Subject|7|||
161604541|NCT02720068|583606449|FG015|Overall Study|Withdrawal by Subject|0|||
161604542|NCT02720068|583606450|FG016|Overall Study|Withdrawal by Subject|0|||
161604543|NCT02720068|583606451|FG017|Overall Study|Withdrawal by Subject|2|||
161604544|NCT02720068|583606434|FG000|Overall Study|Protocol Violation|0|||
161604545|NCT02720068|583606435|FG001|Overall Study|Protocol Violation|0|||
161604546|NCT02720068|583606436|FG002|Overall Study|Protocol Violation|0|||
161604547|NCT02720068|583606437|FG003|Overall Study|Protocol Violation|0|||
161604548|NCT02720068|583606438|FG004|Overall Study|Protocol Violation|0|||
161604549|NCT02720068|583606439|FG005|Overall Study|Protocol Violation|0|||
161604550|NCT02720068|583606440|FG006|Overall Study|Protocol Violation|0|||
161604551|NCT02720068|583606441|FG007|Overall Study|Protocol Violation|0|||
161604552|NCT02720068|583606442|FG008|Overall Study|Protocol Violation|0|||
161604553|NCT02720068|583606443|FG009|Overall Study|Protocol Violation|0|||
161604554|NCT02720068|583606444|FG010|Overall Study|Protocol Violation|1|||
161604555|NCT02720068|583606445|FG011|Overall Study|Protocol Violation|0|||
161604556|NCT02720068|583606446|FG012|Overall Study|Protocol Violation|0|||
161604557|NCT02720068|583606447|FG013|Overall Study|Protocol Violation|0|||
161604558|NCT02720068|583606448|FG014|Overall Study|Protocol Violation|1|||
161604559|NCT02720068|583606449|FG015|Overall Study|Protocol Violation|0|||
161604560|NCT02720068|583606450|FG016|Overall Study|Protocol Violation|1|||
161604561|NCT02720068|583606451|FG017|Overall Study|Protocol Violation|0|||
161604562|NCT01773993|583606453|FG000|Overall Study|No Visit After Treatment|35|||
161604563|NCT00308997|583606461|FG000|Overall Study|Subject feigned clinical data|0|||
161604564|NCT00308997|583606462|FG001|Overall Study|Subject feigned clinical data|1|||
161604565|NCT00308997|583606461|FG000|Overall Study|Unable to tolerate intervention|1|||
161604566|NCT00308997|583606462|FG001|Overall Study|Unable to tolerate intervention|0|||
161604567|NCT00412607|583606470|FG000|Overall Study|Withdrawal by Subject|9|||
161604568|NCT00412607|583606470|FG000|Overall Study|Lost to Follow-up|19|||
161604569|NCT00412607|583606470|FG000|Overall Study|Death|61|||
161604570|NCT00412607|583606470|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
161604571|NCT03662022|583606471|FG000|Year 1 2019|prevalent case|83|||
161604572|NCT03662022|583606472|FG001|Year 1 2019|prevalent case|116|||
161604573|NCT03662022|583606473|FG002|Year 1 2019|prevalent case|158|||
161604574|NCT03662022|583606474|FG003|Year 1 2019|prevalent case|99|||
161604575|NCT03662022|583606471|FG000|Year 2 2020|incident case|18|||
161604576|NCT03662022|583606472|FG001|Year 2 2020|incident case|18|||
161604577|NCT03662022|583606473|FG002|Year 2 2020|incident case|16|||
161604578|NCT03662022|583606474|FG003|Year 2 2020|incident case|26|||
161604579|NCT03662022|583606471|FG000|Year 2 2020|other case|18|||
161604580|NCT03662022|583606472|FG001|Year 2 2020|other case|16|||
161604581|NCT03662022|583606473|FG002|Year 2 2020|other case|16|||
161604582|NCT03662022|583606474|FG003|Year 2 2020|other case|24|||
161604583|NCT03662022|583606471|FG000|Year 2 2020|Lost to Follow-up|1633|||
161604584|NCT03662022|583606472|FG001|Year 2 2020|Lost to Follow-up|1183|||
161604585|NCT03662022|583606473|FG002|Year 2 2020|Lost to Follow-up|1381|||
161604586|NCT03662022|583606474|FG003|Year 2 2020|Lost to Follow-up|2858|||
161604587|NCT03662022|583606471|FG000|Year 3 2021|incident case|24|||
161604588|NCT03662022|583606472|FG001|Year 3 2021|incident case|27|||
161604589|NCT03662022|583606473|FG002|Year 3 2021|incident case|24|||
161604590|NCT03662022|583606474|FG003|Year 3 2021|incident case|11|||
161604591|NCT03662022|583606471|FG000|Year 3 2021|other case|4|||
161604592|NCT03662022|583606472|FG001|Year 3 2021|other case|15|||
161604593|NCT03662022|583606473|FG002|Year 3 2021|other case|10|||
161604594|NCT03662022|583606474|FG003|Year 3 2021|other case|14|||
161604595|NCT03662022|583606471|FG000|Year 3 2021|Lost to Follow-up|179|||
161604596|NCT03662022|583606472|FG001|Year 3 2021|Lost to Follow-up|244|||
161604597|NCT03662022|583606473|FG002|Year 3 2021|Lost to Follow-up|480|||
161604598|NCT03662022|583606474|FG003|Year 3 2021|Lost to Follow-up|477|||
161604599|NCT03662022|583606471|FG000|Year 4 2022|incident case|25|||
161604600|NCT03662022|583606472|FG001|Year 4 2022|incident case|41|||
161604601|NCT03662022|583606473|FG002|Year 4 2022|incident case|28|||
161604602|NCT03662022|583606474|FG003|Year 4 2022|incident case|7|||
161604603|NCT03662022|583606471|FG000|Year 4 2022|other case|8|||
161604604|NCT03662022|583606472|FG001|Year 4 2022|other case|19|||
161604605|NCT03662022|583606473|FG002|Year 4 2022|other case|13|||
161604606|NCT03662022|583606474|FG003|Year 4 2022|other case|7|||
161604607|NCT03662022|583606471|FG000|Year 4 2022|Lost to Follow-up|986|||
161604608|NCT03662022|583606472|FG001|Year 4 2022|Lost to Follow-up|1079|||
161604609|NCT03662022|583606473|FG002|Year 4 2022|Lost to Follow-up|1236|||
161604610|NCT03662022|583606474|FG003|Year 4 2022|Lost to Follow-up|1826|||
161604611|NCT03248479|583606475|FG000|Overall Study|Death|12|||
161604612|NCT03248479|583606476|FG001|Overall Study|Death|44|||
161604613|NCT03248479|583606477|FG002|Overall Study|Death|1|||
161604614|NCT03248479|583606478|FG003|Overall Study|Death|72|||
161604615|NCT03248479|583606479|FG004|Overall Study|Death|17|||
161604616|NCT03248479|583606480|FG005|Overall Study|Death|6|||
161604617|NCT03248479|583606481|FG006|Overall Study|Death|1|||
161604618|NCT03248479|583606482|FG007|Overall Study|Death|14|||
161604619|NCT03248479|583606483|FG008|Overall Study|Death|3|||
161604620|NCT03248479|583606484|FG009|Overall Study|Death|7|||
161604621|NCT03248479|583606485|FG010|Overall Study|Death|3|||
161604622|NCT03248479|583606486|FG011|Overall Study|Death|1|||
161604623|NCT03248479|583606487|FG012|Overall Study|Death|1|||
161604624|NCT03248479|583606475|FG000|Overall Study|Study terminated by sponsor|12|||
161604625|NCT03248479|583606476|FG001|Overall Study|Study terminated by sponsor|15|||
161604626|NCT03248479|583606477|FG002|Overall Study|Study terminated by sponsor|0|||
161604627|NCT03248479|583606478|FG003|Overall Study|Study terminated by sponsor|5|||
161604628|NCT03248479|583606479|FG004|Overall Study|Study terminated by sponsor|0|||
161604629|NCT03248479|583606480|FG005|Overall Study|Study terminated by sponsor|0|||
161604630|NCT03248479|583606481|FG006|Overall Study|Study terminated by sponsor|0|||
161604631|NCT03248479|583606482|FG007|Overall Study|Study terminated by sponsor|1|||
161604632|NCT03248479|583606483|FG008|Overall Study|Study terminated by sponsor|1|||
161604633|NCT03248479|583606484|FG009|Overall Study|Study terminated by sponsor|0|||
161604634|NCT03248479|583606485|FG010|Overall Study|Study terminated by sponsor|5|||
161604635|NCT03248479|583606486|FG011|Overall Study|Study terminated by sponsor|4|||
161604636|NCT03248479|583606487|FG012|Overall Study|Study terminated by sponsor|0|||
161604637|NCT03248479|583606475|FG000|Overall Study|Consent withdrawn|6|||
161604638|NCT03248479|583606476|FG001|Overall Study|Consent withdrawn|3|||
161683469|NCT01133379|583892994|FG002|Overall Study|Withdrawal by Subject|1|||
161683470|NCT01133379|583892992|FG000|Overall Study|Lost to Follow-up|1|||
161604639|NCT03248479|583606477|FG002|Overall Study|Consent withdrawn|0|||
161604640|NCT03248479|583606478|FG003|Overall Study|Consent withdrawn|9|||
161604641|NCT03248479|583606479|FG004|Overall Study|Consent withdrawn|1|||
161604642|NCT03248479|583606480|FG005|Overall Study|Consent withdrawn|0|||
161604643|NCT03248479|583606481|FG006|Overall Study|Consent withdrawn|0|||
161604644|NCT03248479|583606482|FG007|Overall Study|Consent withdrawn|1|||
161604645|NCT03248479|583606483|FG008|Overall Study|Consent withdrawn|0|||
161604646|NCT03248479|583606484|FG009|Overall Study|Consent withdrawn|3|||
161604647|NCT03248479|583606485|FG010|Overall Study|Consent withdrawn|1|||
161604648|NCT03248479|583606486|FG011|Overall Study|Consent withdrawn|0|||
161683471|NCT01133379|583892993|FG001|Overall Study|Lost to Follow-up|1|||
161604649|NCT03248479|583606487|FG012|Overall Study|Consent withdrawn|1|||
161604650|NCT03248479|583606475|FG000|Overall Study|Lost to Follow-up|2|||
161604651|NCT03248479|583606476|FG001|Overall Study|Lost to Follow-up|1|||
161604652|NCT03248479|583606477|FG002|Overall Study|Lost to Follow-up|0|||
161604653|NCT03248479|583606478|FG003|Overall Study|Lost to Follow-up|0|||
161604654|NCT03248479|583606479|FG004|Overall Study|Lost to Follow-up|0|||
161604655|NCT03248479|583606480|FG005|Overall Study|Lost to Follow-up|0|||
161604656|NCT03248479|583606481|FG006|Overall Study|Lost to Follow-up|0|||
161604657|NCT03248479|583606482|FG007|Overall Study|Lost to Follow-up|0|||
161604658|NCT03248479|583606483|FG008|Overall Study|Lost to Follow-up|0|||
161604659|NCT03248479|583606484|FG009|Overall Study|Lost to Follow-up|0|||
161604660|NCT03248479|583606485|FG010|Overall Study|Lost to Follow-up|0|||
161604661|NCT03248479|583606486|FG011|Overall Study|Lost to Follow-up|0|||
161604662|NCT03248479|583606487|FG012|Overall Study|Lost to Follow-up|1|||
161604663|NCT03248479|583606475|FG000|Overall Study|Not reported|0|||
161604664|NCT03248479|583606476|FG001|Overall Study|Not reported|0|||
161604665|NCT03248479|583606477|FG002|Overall Study|Not reported|0|||
161604666|NCT03248479|583606478|FG003|Overall Study|Not reported|1|||
161604667|NCT03248479|583606479|FG004|Overall Study|Not reported|1|||
161604668|NCT03248479|583606480|FG005|Overall Study|Not reported|0|||
161604669|NCT03248479|583606481|FG006|Overall Study|Not reported|0|||
161604670|NCT03248479|583606482|FG007|Overall Study|Not reported|1|||
161604671|NCT03248479|583606483|FG008|Overall Study|Not reported|1|||
161604672|NCT03248479|583606484|FG009|Overall Study|Not reported|0|||
161604673|NCT03248479|583606485|FG010|Overall Study|Not reported|0|||
161604674|NCT03248479|583606486|FG011|Overall Study|Not reported|0|||
161604675|NCT03248479|583606487|FG012|Overall Study|Not reported|0|||
161604676|NCT06065735|583606494|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
161604677|NCT06065735|583606495|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
161604678|NCT06065735|583606496|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
161604679|NCT06065735|583606494|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
161604680|NCT06065735|583606495|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
161604681|NCT06065735|583606496|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
161604682|NCT06065735|583606494|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
161683472|NCT01133379|583892994|FG002|Overall Study|Lost to Follow-up|1|||
161604683|NCT06065735|583606495|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
161604684|NCT06065735|583606496|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
161604685|NCT06065735|583606494|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
161604686|NCT06065735|583606495|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
161604687|NCT06065735|583606496|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
161604688|NCT06065735|583606494|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
161604689|NCT06065735|583606495|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
161604690|NCT06065735|583606496|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
161604691|NCT03522298|583606497|FG000|Overall Study|Adverse Event|1|||
161604692|NCT03522298|583606498|FG001|Overall Study|Adverse Event|0|||
161604693|NCT03522298|583606499|FG002|Overall Study|Adverse Event|0|||
161604694|NCT03522298|583606500|FG003|Overall Study|Adverse Event|1|||
161604695|NCT03522298|583606497|FG000|Overall Study|Death|2|||
161604696|NCT03522298|583606498|FG001|Overall Study|Death|4|||
161604697|NCT03522298|583606499|FG002|Overall Study|Death|8|||
161604698|NCT03522298|583606500|FG003|Overall Study|Death|8|||
161604699|NCT03522298|583606497|FG000|Overall Study|Patient decision|0|||
161604700|NCT03522298|583606498|FG001|Overall Study|Patient decision|2|||
161604701|NCT03522298|583606499|FG002|Overall Study|Patient decision|2|||
161604702|NCT03522298|583606500|FG003|Overall Study|Patient decision|2|||
161604703|NCT02806726|583606505|FG000|Overall Study|Lost to Follow-up|1|||
161604704|NCT01527188|583606506|FG000|Overall Study|Adverse Event|5|||
161604705|NCT01527188|583606507|FG001|Overall Study|Adverse Event|5|||
161604706|NCT01527188|583606508|FG002|Overall Study|Adverse Event|11|||
161604707|NCT01527188|583606509|FG003|Overall Study|Adverse Event|0|||
161604708|NCT01527188|583606506|FG000|Overall Study|Withdrawal by Subject|3|||
161604709|NCT01527188|583606507|FG001|Overall Study|Withdrawal by Subject|6|||
161604710|NCT01527188|583606508|FG002|Overall Study|Withdrawal by Subject|4|||
161604711|NCT01527188|583606509|FG003|Overall Study|Withdrawal by Subject|4|||
161604712|NCT01527188|583606506|FG000|Overall Study|Any other reason not above-mentioned|6|||
161604713|NCT01527188|583606507|FG001|Overall Study|Any other reason not above-mentioned|7|||
161683473|NCT03996876|583892999|FG000|Overall Study|Incomplete Data|2|||
161604714|NCT01527188|583606508|FG002|Overall Study|Any other reason not above-mentioned|8|||
161604715|NCT01527188|583606509|FG003|Overall Study|Any other reason not above-mentioned|8|||
161604716|NCT04626427|583606510|FG000|Overall Study|Death|1|||
161604717|NCT04626427|583606510|FG000|Overall Study|Withdrawal by Subject|1|||
161604718|NCT04626427|583606510|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
161604719|NCT04626427|583606510|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
161604720|NCT01553149|583606511|FG000|Overall Study|Adverse Event|0|||
161604721|NCT01553149|583606512|FG001|Overall Study|Adverse Event|9|||
161604722|NCT01553149|583606511|FG000|Overall Study|Physician Decision|5|||
161604723|NCT01553149|583606512|FG001|Overall Study|Physician Decision|10|||
161604724|NCT01553149|583606511|FG000|Overall Study|Ineligible|0|||
161604725|NCT01553149|583606512|FG001|Overall Study|Ineligible|1|||
161604726|NCT01265537|583606513|FG000|Overall Study|Adverse Event|2|||
161604727|NCT01265537|583606514|FG001|Overall Study|Adverse Event|1|||
161604728|NCT01265537|583606513|FG000|Overall Study|Physician Decision|0|||
161604729|NCT01265537|583606514|FG001|Overall Study|Physician Decision|1|||
161604730|NCT04518943|583607367|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
161604731|NCT04518943|583607368|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
161604732|NCT04518943|583607369|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
161604733|NCT04518943|583607370|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
161604734|NCT04518943|583607371|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
161604735|NCT04518943|583607372|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
161604736|NCT04518943|583607373|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
161604737|NCT04518943|583607374|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
161604738|NCT04518943|583607375|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
161604739|NCT04518943|583607376|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
161604740|NCT04518943|583607377|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
161604741|NCT04518943|583607378|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
161604742|NCT04518943|583607379|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
161604743|NCT04518943|583607380|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
161604744|NCT04518943|583607381|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
161604745|NCT04518943|583607382|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
161604746|NCT06408870|583607383|FG000|Washout period|Withdrawal by Subject|1|||
161604747|NCT06408870|583607384|FG001|Washout period|Withdrawal by Subject|0|||
161604748|NCT06408870|583607383|FG000|Washout period|Adverse Event|2|||
161604749|NCT06408870|583607384|FG001|Washout period|Adverse Event|0|||
161604750|NCT04174170|583607388|FG000|Placebo Run-in Period|Not Randomized|38|||
161604751|NCT04174170|583607389|FG001|Placebo Run-in Period|Not Randomized|0|||
161604752|NCT04174170|583607390|FG002|Placebo Run-in Period|Not Randomized|0|||
161604753|NCT04174170|583607391|FG003|Placebo Run-in Period|Not Randomized|0|||
161604754|NCT04174170|583607388|FG000|Double Blind Treatment Period|Adverse Event|0|||
161604755|NCT04174170|583607389|FG001|Double Blind Treatment Period|Adverse Event|9|||
161604756|NCT04174170|583607390|FG002|Double Blind Treatment Period|Adverse Event|9|||
161604757|NCT04174170|583607391|FG003|Double Blind Treatment Period|Adverse Event|8|||
161604758|NCT04174170|583607388|FG000|Double Blind Treatment Period|Death|0|||
161604759|NCT04174170|583607389|FG001|Double Blind Treatment Period|Death|1|||
161604760|NCT04174170|583607390|FG002|Double Blind Treatment Period|Death|0|||
161604761|NCT04174170|583607391|FG003|Double Blind Treatment Period|Death|0|||
161604762|NCT04174170|583607388|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161604763|NCT04174170|583607389|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
161604764|NCT04174170|583607390|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
161604765|NCT04174170|583607391|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
161604766|NCT04174170|583607388|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
161604767|NCT04174170|583607389|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
161604768|NCT04174170|583607390|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
161604769|NCT04174170|583607391|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
161604770|NCT04174170|583607388|FG000|Double Blind Treatment Period|Physician Decision|0|||
161604771|NCT04174170|583607389|FG001|Double Blind Treatment Period|Physician Decision|1|||
161604772|NCT04174170|583607390|FG002|Double Blind Treatment Period|Physician Decision|0|||
161604773|NCT04174170|583607391|FG003|Double Blind Treatment Period|Physician Decision|1|||
161604774|NCT04174170|583607388|FG000|Double Blind Treatment Period|Pregnancy|0|||
161604775|NCT04174170|583607389|FG001|Double Blind Treatment Period|Pregnancy|1|||
161604776|NCT04174170|583607390|FG002|Double Blind Treatment Period|Pregnancy|0|||
161604777|NCT04174170|583607391|FG003|Double Blind Treatment Period|Pregnancy|1|||
161604778|NCT04174170|583607388|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
161604779|NCT04174170|583607389|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
161604780|NCT04174170|583607390|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
161604781|NCT04174170|583607391|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
161604782|NCT04174170|583607388|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161604783|NCT04174170|583607389|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
161604784|NCT04174170|583607390|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
161604785|NCT04174170|583607391|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
161604786|NCT04174170|583607388|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
161604787|NCT04174170|583607389|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
161604788|NCT04174170|583607390|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
161683474|NCT03996876|583893000|FG001|Overall Study|Incomplete Data|4|||
161604789|NCT04174170|583607391|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
161604790|NCT04772534|583607399|FG000|Overall Study|Physician Decision|1|||
161604791|NCT04772534|583607400|FG001|Overall Study|Physician Decision|0|||
161604792|NCT04772534|583607401|FG002|Overall Study|Physician Decision|0|||
161604793|NCT04772534|583607399|FG000|Overall Study|Withdrawal by Subject|3|||
161604794|NCT04772534|583607400|FG001|Overall Study|Withdrawal by Subject|0|||
161604795|NCT04772534|583607401|FG002|Overall Study|Withdrawal by Subject|1|||
161604796|NCT04194450|583607402|FG000|Overall Study|not eligible|1|||
161604797|NCT04194450|583607403|FG001|Overall Study|not eligible|0|||
161604798|NCT05875701|583607412|FG000|Overall Study|Lost to Follow-up|2|||
161604799|NCT05875701|583607413|FG001|Overall Study|Lost to Follow-up|0|||
161604800|NCT05875701|583607412|FG000|Overall Study|Withdrawal by Subject|1|||
161604801|NCT05875701|583607413|FG001|Overall Study|Withdrawal by Subject|1|||
161604803|NCT04490356|583607419|FG000|Overall Study|Lost to Follow-up|1|||
161604804|NCT03201939|583607422|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
161604805|NCT03201939|583607423|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
161604806|NCT03884439|583607424|FG000|Overall Study|No informed consent for publication of study results|38|||
161604807|NCT03884439|583607424|FG000|Overall Study|Contract violation/deficiency|7|||
161604808|NCT05129501|583607431|FG000|Overall Study|Lost to Follow-up|54|||
161604809|NCT05129501|583607432|FG001|Overall Study|Lost to Follow-up|41|||
161604810|NCT03142009|583607435|FG000|Overall Study|Lost to Follow-up|45|||
161604811|NCT03142009|583607436|FG001|Overall Study|Lost to Follow-up|30|||
161604812|NCT03982186|583607437|FG000|Overall Study|Lost to Follow-up|0|||
161604813|NCT03982186|583607438|FG001|Overall Study|Lost to Follow-up|1|||
161604814|NCT03982186|583607439|FG002|Overall Study|Lost to Follow-up|2|||
161604815|NCT03982186|583607440|FG003|Overall Study|Lost to Follow-up|1|||
161604816|NCT03982186|583607441|FG004|Overall Study|Lost to Follow-up|1|||
161604817|NCT03982186|583607442|FG005|Overall Study|Lost to Follow-up|0|||
161604818|NCT03982186|583607437|FG000|Overall Study|Physician Decision|0|||
161604819|NCT03982186|583607438|FG001|Overall Study|Physician Decision|1|||
161604820|NCT03982186|583607439|FG002|Overall Study|Physician Decision|0|||
161604821|NCT03982186|583607440|FG003|Overall Study|Physician Decision|0|||
161604822|NCT03982186|583607441|FG004|Overall Study|Physician Decision|0|||
161604823|NCT03982186|583607442|FG005|Overall Study|Physician Decision|0|||
161604824|NCT03982186|583607437|FG000|Overall Study|Withdrawal by Subject|3|||
161604825|NCT03982186|583607438|FG001|Overall Study|Withdrawal by Subject|4|||
161604826|NCT03982186|583607439|FG002|Overall Study|Withdrawal by Subject|1|||
161604827|NCT03982186|583607440|FG003|Overall Study|Withdrawal by Subject|7|||
161604828|NCT03982186|583607441|FG004|Overall Study|Withdrawal by Subject|2|||
161604829|NCT03982186|583607442|FG005|Overall Study|Withdrawal by Subject|0|||
161604830|NCT03982186|583607437|FG000|Overall Study|Randomized and not treated|0|||
161604831|NCT03982186|583607438|FG001|Overall Study|Randomized and not treated|0|||
161604832|NCT03982186|583607439|FG002|Overall Study|Randomized and not treated|0|||
161604833|NCT03982186|583607440|FG003|Overall Study|Randomized and not treated|1|||
161604834|NCT03982186|583607441|FG004|Overall Study|Randomized and not treated|0|||
161604835|NCT03982186|583607442|FG005|Overall Study|Randomized and not treated|0|||
161604836|NCT05267639|583608048|FG000|Overall Study|Withdrawal by Subject|1|||
161604837|NCT05267639|583608049|FG001|Overall Study|Withdrawal by Subject|0|||
161604838|NCT03512301|583608051|FG000|Overall Study|Protocol Violation|2|||
161604839|NCT03512301|583608051|FG000|Overall Study|Did Not Qualify|3|||
161604840|NCT03512301|583608051|FG000|Overall Study|Age-ineligible|1|||
161604841|NCT03512301|583608051|FG000|Overall Study|Inadequate fluency with the English language|3|||
161683475|NCT00121108|583893001|FG000|Overall Study|Lost to Follow-up|10|||
161683476|NCT00121108|583893002|FG001|Overall Study|Lost to Follow-up|22|||
161683477|NCT00121108|583893001|FG000|Overall Study|Withdrawal by Subject|106|||
161683478|NCT00121108|583893002|FG001|Overall Study|Withdrawal by Subject|195|||
161683479|NCT00121108|583893001|FG000|Overall Study|Death|5|||
161683480|NCT00121108|583893002|FG001|Overall Study|Death|8|||
161683481|NCT00597753|583893009|FG000|Overall Study|Adverse Event|6|||
161683482|NCT00597753|583893010|FG001|Overall Study|Adverse Event|2|||
161604842|NCT00113360|583608052|FG000|Overall Study|Adverse Event|3|||
161683483|NCT00597753|583893009|FG000|Overall Study|Death|55|||
161604843|NCT00113360|583608052|FG000|Overall Study|Subject required surgery|1|||
161604844|NCT00113360|583608052|FG000|Overall Study|Did not meet eligibility criteria|3|||
161604845|NCT04993677|583608059|FG000|Overall Study|Lost to Follow-up|1|||
161604846|NCT04993677|583608060|FG001|Overall Study|Lost to Follow-up|0|||
161604847|NCT04993677|583608061|FG002|Overall Study|Lost to Follow-up|0|||
161604848|NCT04993677|583608062|FG003|Overall Study|Lost to Follow-up|0|||
161604849|NCT04993677|583608059|FG000|Overall Study|Death|11|||
161604850|NCT04993677|583608060|FG001|Overall Study|Death|8|||
161683484|NCT00597753|583893010|FG001|Overall Study|Death|29|||
161683485|NCT00597753|583893009|FG000|Overall Study|Lack of Efficacy|2|||
161604851|NCT04993677|583608061|FG002|Overall Study|Death|3|||
161604852|NCT04993677|583608062|FG003|Overall Study|Death|1|||
161604853|NCT04993677|583608059|FG000|Overall Study|Subject withdrawal of consent|4|||
161604854|NCT04993677|583608060|FG001|Overall Study|Subject withdrawal of consent|3|||
161604855|NCT04993677|583608061|FG002|Overall Study|Subject withdrawal of consent|0|||
161604856|NCT04993677|583608062|FG003|Overall Study|Subject withdrawal of consent|2|||
161604857|NCT04993677|583608059|FG000|Overall Study|Study termination by sponsor|3|||
161604858|NCT04993677|583608060|FG001|Overall Study|Study termination by sponsor|25|||
161604859|NCT04993677|583608061|FG002|Overall Study|Study termination by sponsor|3|||
161604860|NCT04993677|583608062|FG003|Overall Study|Study termination by sponsor|3|||
161604861|NCT04993677|583608059|FG000|Overall Study|Other|2|||
161604862|NCT04993677|583608060|FG001|Overall Study|Other|3|||
161604863|NCT04993677|583608061|FG002|Overall Study|Other|3|||
161604864|NCT04993677|583608062|FG003|Overall Study|Other|2|||
161604865|NCT02231749|583608064|FG000|Overall Study|Disease progression|229|||
161604866|NCT02231749|583608065|FG001|Overall Study|Disease progression|297|||
161604867|NCT02231749|583608064|FG000|Overall Study|Study Drug Toxicity|134|||
161604868|NCT02231749|583608065|FG001|Overall Study|Study Drug Toxicity|63|||
161604869|NCT02231749|583608064|FG000|Overall Study|Death|1|||
161604870|NCT02231749|583608065|FG001|Overall Study|Death|1|||
161604871|NCT02231749|583608064|FG000|Overall Study|AE unrelated to Study drug|32|||
161604872|NCT02231749|583608065|FG001|Overall Study|AE unrelated to Study drug|31|||
161604873|NCT02231749|583608064|FG000|Overall Study|Participant's request to discontinue|10|||
161604874|NCT02231749|583608065|FG001|Overall Study|Participant's request to discontinue|21|||
161604875|NCT02231749|583608064|FG000|Overall Study|Participant withdrew Consent|8|||
161604876|NCT02231749|583608065|FG001|Overall Study|Participant withdrew Consent|15|||
161604877|NCT02231749|583608064|FG000|Overall Study|Lost to Follow-up|1|||
161604878|NCT02231749|583608065|FG001|Overall Study|Lost to Follow-up|2|||
161604879|NCT02231749|583608064|FG000|Overall Study|Maximum Clinical Benefit|5|||
161604880|NCT02231749|583608065|FG001|Overall Study|Maximum Clinical Benefit|8|||
161604881|NCT02231749|583608064|FG000|Overall Study|Poor/Non-Compliance|0|||
161604882|NCT02231749|583608065|FG001|Overall Study|Poor/Non-Compliance|3|||
161604883|NCT02231749|583608064|FG000|Overall Study|Pregnancy|1|||
161604884|NCT02231749|583608065|FG001|Overall Study|Pregnancy|0|||
161604885|NCT02231749|583608064|FG000|Overall Study|other|0|||
161604886|NCT02231749|583608065|FG001|Overall Study|other|8|||
161604887|NCT02231749|583608064|FG000|Overall Study|No longer meets Study Criteria|1|||
161604888|NCT02231749|583608065|FG001|Overall Study|No longer meets Study Criteria|0|||
161604889|NCT04675034|583608074|FG000|Overall Study|Lost to Follow-up|1|||
161604890|NCT04675034|583608075|FG001|Overall Study|Lost to Follow-up|1|||
161604891|NCT04675034|583608076|FG002|Overall Study|Lost to Follow-up|0|||
161604892|NCT04675034|583608077|FG003|Overall Study|Lost to Follow-up|2|||
161604893|NCT04675034|583608078|FG004|Overall Study|Lost to Follow-up|0|||
161604894|NCT04675034|583608074|FG000|Overall Study|Protocol Violation|1|||
161604895|NCT04675034|583608075|FG001|Overall Study|Protocol Violation|0|||
161604896|NCT04675034|583608076|FG002|Overall Study|Protocol Violation|0|||
161604897|NCT04675034|583608077|FG003|Overall Study|Protocol Violation|1|||
161604898|NCT04675034|583608078|FG004|Overall Study|Protocol Violation|3|||
161604899|NCT04675034|583608074|FG000|Overall Study|Withdrawal by Subject|9|||
161604900|NCT04675034|583608075|FG001|Overall Study|Withdrawal by Subject|3|||
161604901|NCT04675034|583608076|FG002|Overall Study|Withdrawal by Subject|4|||
161604902|NCT04675034|583608077|FG003|Overall Study|Withdrawal by Subject|8|||
161604903|NCT04675034|583608078|FG004|Overall Study|Withdrawal by Subject|6|||
161832317|NCT04146363|584428384|FG001|Induction Period|Withdrawal by Subject|3|||
161832318|NCT04146363|584428385|FG002|Induction Period|Withdrawal by Subject|0|||
161832319|NCT04146363|584428386|FG003|Induction Period|Withdrawal by Subject|0|||
161832320|NCT04146363|584428387|FG004|Induction Period|Withdrawal by Subject|0|||
161832321|NCT04146363|584428388|FG005|Induction Period|Withdrawal by Subject|0|||
161832322|NCT04146363|584428389|FG006|Induction Period|Withdrawal by Subject|0|||
161832323|NCT04146363|584428390|FG007|Induction Period|Withdrawal by Subject|0|||
161832324|NCT04146363|584428391|FG008|Induction Period|Withdrawal by Subject|0|||
161832325|NCT04146363|584428392|FG009|Induction Period|Withdrawal by Subject|0|||
161832326|NCT04146363|584428393|FG010|Induction Period|Withdrawal by Subject|0|||
161832327|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832328|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832329|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832330|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832331|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
161683486|NCT00597753|583893010|FG001|Overall Study|Lack of Efficacy|0|||
161604904|NCT02532621|583608083|FG000|Overall Study|Death|3|||
161604905|NCT02532621|583608083|FG000|Overall Study|Lost to Follow-up|3|||
161604906|NCT02532621|583608083|FG000|Overall Study|Withdrawal by Subject|6|||
161604907|NCT02532621|583608083|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
161832332|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
161604908|NCT02532621|583608083|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
161604909|NCT04281498|583608084|FG000|Overall Study|Progression of disease|1|||
161604910|NCT04281498|583608084|FG000|Overall Study|Planned SCT|1|||
161604911|NCT04281498|583608084|FG000|Overall Study|Alternative Treatment|1|||
161604912|NCT06059443|583608085|FG000|Overall Study|Withdrawal by Subject|2|||
161604913|NCT06059443|583608086|FG001|Overall Study|Withdrawal by Subject|0|||
161604914|NCT06059443|583608085|FG000|Overall Study|Lost to Follow-up|2|||
161604915|NCT06059443|583608086|FG001|Overall Study|Lost to Follow-up|2|||
161604916|NCT03587805|583608088|FG000|Overall Study|Adverse Event|72|||
161604917|NCT03587805|583608088|FG000|Overall Study|Death|1|||
161604918|NCT03587805|583608088|FG000|Overall Study|Lost to Follow-up|78|||
161604919|NCT03587805|583608088|FG000|Overall Study|Withdrawal by Subject|105|||
161604920|NCT03587805|583608088|FG000|Overall Study|Lack of Efficacy|119|||
161604921|NCT03587805|583608088|FG000|Overall Study|Reason unknown|26|||
161604922|NCT03587805|583608088|FG000|Overall Study|COVID_19 pandemic|4|||
161604923|NCT03587805|583608088|FG000|Overall Study|Various reasons|121|||
161604924|NCT03587805|583608088|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161604925|NCT01220531|583608089|FG000|Overall Study|Death|7|||
161604926|NCT01220531|583608089|FG000|Overall Study|Lost to Follow-up|1|||
161604927|NCT03008382|583608091|FG000|Overall Study|Withdrawal by Subject|2|||
161604928|NCT03008382|583608092|FG001|Overall Study|Withdrawal by Subject|5|||
161604929|NCT03008382|583608093|FG002|Overall Study|Withdrawal by Subject|2|||
161604930|NCT03008382|583608094|FG003|Overall Study|Withdrawal by Subject|0|||
161604931|NCT03008382|583608091|FG000|Overall Study|Protocol Violation|1|||
161604932|NCT03008382|583608092|FG001|Overall Study|Protocol Violation|0|||
161604933|NCT03008382|583608093|FG002|Overall Study|Protocol Violation|0|||
161604934|NCT03008382|583608094|FG003|Overall Study|Protocol Violation|0|||
161604935|NCT03008382|583608091|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
161604936|NCT03008382|583608092|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
161604937|NCT03008382|583608093|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
161604938|NCT03008382|583608094|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
161604939|NCT03008382|583608091|FG000|Overall Study|Lost to Follow-up|0|||
161604940|NCT03008382|583608092|FG001|Overall Study|Lost to Follow-up|0|||
161604941|NCT03008382|583608093|FG002|Overall Study|Lost to Follow-up|1|||
161604942|NCT03008382|583608094|FG003|Overall Study|Lost to Follow-up|0|||
161604943|NCT03008382|583608091|FG000|Overall Study|Screenfail|0|||
161604944|NCT03008382|583608092|FG001|Overall Study|Screenfail|0|||
161604945|NCT03008382|583608093|FG002|Overall Study|Screenfail|2|||
161604946|NCT03008382|583608094|FG003|Overall Study|Screenfail|0|||
161604947|NCT04732871|583609156|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
161604948|NCT04732871|583609157|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
161604949|NCT04732871|583609158|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
161604950|NCT04732871|583609156|FG000|Overall Study|Lost to Follow-up|7|||
161604951|NCT04732871|583609157|FG001|Overall Study|Lost to Follow-up|4|||
161604952|NCT04732871|583609158|FG002|Overall Study|Lost to Follow-up|3|||
161604953|NCT04732871|583609156|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
161604954|NCT04732871|583609157|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
161604955|NCT04732871|583609158|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
161604956|NCT04732871|583609156|FG000|Overall Study|Migrated / moved from the study area|5|||
161604957|NCT04732871|583609157|FG001|Overall Study|Migrated / moved from the study area|0|||
161604958|NCT04732871|583609158|FG002|Overall Study|Migrated / moved from the study area|0|||
161683487|NCT00597753|583893009|FG000|Overall Study|Lost to Follow-up|10|||
161683488|NCT00597753|583893010|FG001|Overall Study|Lost to Follow-up|3|||
161683489|NCT00597753|583893009|FG000|Overall Study|Physician Decision|5|||
161683490|NCT00597753|583893010|FG001|Overall Study|Physician Decision|1|||
161683491|NCT00597753|583893009|FG000|Overall Study|Pregnancy|1|||
161683492|NCT00597753|583893010|FG001|Overall Study|Pregnancy|0|||
161683493|NCT00597753|583893009|FG000|Overall Study|Withdrawal by Subject|35|||
161683494|NCT00597753|583893010|FG001|Overall Study|Withdrawal by Subject|12|||
161683495|NCT00597753|583893009|FG000|Overall Study|Discontinued Dialysis|0|||
161683496|NCT00597753|583893010|FG001|Overall Study|Discontinued Dialysis|1|||
161683497|NCT00597753|583893009|FG000|Overall Study|Never dosed|2|||
161683498|NCT00597753|583893010|FG001|Overall Study|Never dosed|0|||
161683499|NCT00597753|583893009|FG000|Overall Study|Noncompliance|2|||
161683500|NCT00597753|583893010|FG001|Overall Study|Noncompliance|1|||
161683501|NCT00597753|583893009|FG000|Overall Study|Relocation|17|||
161683502|NCT00597753|583893010|FG001|Overall Study|Relocation|6|||
161683503|NCT00597753|583893009|FG000|Overall Study|Renal transplant|10|||
161683504|NCT00597753|583893010|FG001|Overall Study|Renal transplant|3|||
161604959|NCT04732871|583609156|FG000|Overall Study|Other|1|||
161604960|NCT04732871|583609157|FG001|Overall Study|Other|0|||
161604961|NCT04732871|583609158|FG002|Overall Study|Other|1|||
161604962|NCT04732871|583609156|FG000|Overall Study|Ongoing|6|||
161604963|NCT04732871|583609157|FG001|Overall Study|Ongoing|0|||
161604964|NCT04732871|583609158|FG002|Overall Study|Ongoing|1|||
161604965|NCT04732871|583609156|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
161604966|NCT04732871|583609157|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
161604967|NCT04732871|583609158|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
161604968|NCT05180539|583609170|FG000|Overall Study|Lost to Follow-up|27|||
161604969|NCT05180539|583609171|FG001|Overall Study|Lost to Follow-up|30|||
161604970|NCT00968149|583609174|FG000|Overall Study|Adverse Event|5|||
161604971|NCT00968149|583609175|FG001|Overall Study|Adverse Event|1|||
161604972|NCT00968149|583609174|FG000|Overall Study|Lack of Efficacy|0|||
161604973|NCT00968149|583609175|FG001|Overall Study|Lack of Efficacy|4|||
161604974|NCT00968149|583609174|FG000|Overall Study|Lost to Follow-up|0|||
161604975|NCT00968149|583609175|FG001|Overall Study|Lost to Follow-up|1|||
161604976|NCT00968149|583609174|FG000|Overall Study|Protocol Violation|4|||
161604977|NCT00968149|583609175|FG001|Overall Study|Protocol Violation|0|||
161604978|NCT00968149|583609174|FG000|Overall Study|Withdrawal by Subject|2|||
161604979|NCT00968149|583609175|FG001|Overall Study|Withdrawal by Subject|0|||
161604980|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|Other|0|||
161604981|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|Other|2|||
161683505|NCT00597753|583893009|FG000|Overall Study|Site closed by sponsor|19|||
161683506|NCT00597753|583893010|FG001|Overall Study|Site closed by sponsor|7|||
161683507|NCT00597753|583893009|FG000|Overall Study|Site elected to close|2|||
161683508|NCT00597753|583893010|FG001|Overall Study|Site elected to close|4|||
161683509|NCT01652885|583894585|FG000|Overall Study|Adverse Event|1|||
161683510|NCT03723707|583894586|FG000|Overall Study|Death|32|||
161683511|NCT03723707|583894587|FG001|Overall Study|Death|32|||
161683512|NCT03723707|583894586|FG000|Overall Study|Admitted to long term care|12|||
161683513|NCT03723707|583894587|FG001|Overall Study|Admitted to long term care|12|||
161683514|NCT03723707|583894586|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
161683515|NCT03723707|583894587|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
161683516|NCT03723707|583894586|FG000|Overall Study|Lost to Follow-up|40|||
161683517|NCT03723707|583894587|FG001|Overall Study|Lost to Follow-up|22|||
161683518|NCT03723707|583894586|FG000|Overall Study|Discontinued after study closure|24|||
161683519|NCT03723707|583894587|FG001|Overall Study|Discontinued after study closure|12|||
161683520|NCT00075023|583894588|FG000|Pilot Study|Physician Decision|1|||
161683521|NCT00075023|583894589|FG001|Pilot Study|Physician Decision|2|||
161683522|NCT00075023|583894588|FG000|Pilot Study|Withdrawal by Subject|1|||
161683523|NCT00075023|583894589|FG001|Pilot Study|Withdrawal by Subject|0|||
161683524|NCT04342871|583894590|FG000|Overall Study|Death|4|||
161683525|NCT04342871|583894590|FG000|Overall Study|Clinical deterioration/illness progression|2|||
161683526|NCT04342871|583894590|FG000|Overall Study|Did not complete baseline assessments|5|||
161683527|NCT04342871|583894590|FG000|Overall Study|Lost to Follow-up|13|||
161604982|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|Other|1|||
161683528|NCT01429584|583894592|FG000|Overall Study|Withdrawal by Subject|1|||
161683529|NCT01429584|583894593|FG001|Overall Study|Withdrawal by Subject|0|||
161604983|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|Other|2|||
161604984|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|Other|2|||
161604985|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|Other|0|||
161604986|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|Other|0|||
161604987|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|Other|0|||
161604988|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|Other|0|||
161604989|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|Other|0|||
161604990|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|Other|0|||
161683530|NCT01429584|583894592|FG000|Overall Study|Protocol Violation|0|||
161683531|NCT01429584|583894593|FG001|Overall Study|Protocol Violation|1|||
161683532|NCT00750698|583894597|FG000|Overall Study|Withdrawal by Subject|1|||
161604991|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|Other|0|||
161604992|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|Other|0|||
161604993|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|Other|0|||
161604994|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|Other|0|||
161604995|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|Other|0|||
161604996|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|Other|0|||
161604997|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
161604998|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
161604999|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
161605000|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
161605001|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
161605002|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
161605003|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605004|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605005|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605006|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605007|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605008|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605009|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605010|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605011|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605012|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605013|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161605014|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605015|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
161605016|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
161605017|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605018|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
161605019|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
161605020|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605021|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605022|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605023|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605024|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605025|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605026|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605027|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605028|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605029|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605030|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161605031|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|Death|2|||
161605032|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|Death|1|||
161605033|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|Death|1|||
161605034|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|Death|0|||
161605035|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|Death|0|||
161605036|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|Death|0|||
161605037|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|Death|0|||
161605038|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|Death|0|||
161605039|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|Death|0|||
161605040|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|Death|0|||
161605041|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|Death|0|||
161605042|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|Death|0|||
161605043|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|Death|0|||
161605044|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|Death|0|||
161605045|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|Death|0|||
161605046|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|Death|0|||
161605047|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|Death|0|||
161605048|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605049|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
161605050|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605051|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605052|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
161605053|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
161605054|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605055|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605056|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605057|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605058|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605059|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605060|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605061|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605062|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605063|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605064|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
161605065|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605066|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605067|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605068|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605069|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
161605070|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
161605071|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605072|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605073|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605074|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605075|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605076|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605077|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605078|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605079|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605080|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605081|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
161605082|NCT02719574|583609176|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605083|NCT02719574|583609177|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605084|NCT02719574|583609178|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
161605085|NCT02719574|583609179|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605086|NCT02719574|583609180|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605087|NCT02719574|583609181|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605088|NCT02719574|583609182|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605089|NCT02719574|583609183|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605090|NCT02719574|583609184|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605091|NCT02719574|583609185|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605092|NCT02719574|583609186|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605093|NCT02719574|583609187|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605094|NCT02719574|583609188|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605095|NCT02719574|583609189|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605096|NCT02719574|583609190|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605097|NCT02719574|583609191|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605098|NCT02719574|583609192|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161605099|NCT02719574|583609176|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605100|NCT02719574|583609177|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605101|NCT02719574|583609178|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605102|NCT02719574|583609179|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605103|NCT02719574|583609180|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605104|NCT02719574|583609181|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605105|NCT02719574|583609182|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
161605106|NCT02719574|583609183|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
161605107|NCT02719574|583609184|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
161605108|NCT02719574|583609185|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605109|NCT02719574|583609186|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605110|NCT02719574|583609187|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605111|NCT02719574|583609188|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605112|NCT02719574|583609189|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605113|NCT02719574|583609190|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605114|NCT02719574|583609191|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605115|NCT02719574|583609192|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161605116|NCT02719574|583609176|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605117|NCT02719574|583609177|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605118|NCT02719574|583609178|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605119|NCT02719574|583609179|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605120|NCT02719574|583609180|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605121|NCT02719574|583609181|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605122|NCT02719574|583609182|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
161605123|NCT02719574|583609183|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
161605124|NCT02719574|583609184|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605125|NCT02719574|583609185|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605126|NCT02719574|583609186|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605127|NCT02719574|583609187|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605128|NCT02719574|583609188|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605129|NCT02719574|583609189|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605130|NCT02719574|583609190|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605131|NCT02719574|583609191|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605132|NCT02719574|583609192|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161605133|NCT02719574|583609176|FG000|Phase 1 (Dose Expansion)|Death|0|||
161605134|NCT02719574|583609177|FG001|Phase 1 (Dose Expansion)|Death|0|||
161605135|NCT02719574|583609178|FG002|Phase 1 (Dose Expansion)|Death|0|||
161683533|NCT00750698|583894598|FG001|Overall Study|Withdrawal by Subject|0|||
161605136|NCT02719574|583609179|FG003|Phase 1 (Dose Expansion)|Death|0|||
161605137|NCT02719574|583609180|FG004|Phase 1 (Dose Expansion)|Death|0|||
161605138|NCT02719574|583609181|FG005|Phase 1 (Dose Expansion)|Death|0|||
161605139|NCT02719574|583609182|FG006|Phase 1 (Dose Expansion)|Death|1|||
161605140|NCT02719574|583609183|FG007|Phase 1 (Dose Expansion)|Death|6|||
161605141|NCT02719574|583609184|FG008|Phase 1 (Dose Expansion)|Death|0|||
161605142|NCT02719574|583609185|FG009|Phase 1 (Dose Expansion)|Death|0|||
161605143|NCT02719574|583609186|FG010|Phase 1 (Dose Expansion)|Death|0|||
161605144|NCT02719574|583609187|FG011|Phase 1 (Dose Expansion)|Death|0|||
161605145|NCT02719574|583609188|FG012|Phase 1 (Dose Expansion)|Death|0|||
161683534|NCT00750698|583894597|FG000|Overall Study|Progressive disease|5|||
161683535|NCT00750698|583894598|FG001|Overall Study|Progressive disease|2|||
161683536|NCT01417195|583894599|FG000|Overall Study|Stimulation failure|1|||
161683537|NCT01417195|583894600|FG001|Overall Study|Stimulation failure|0|||
161683538|NCT01417195|583894599|FG000|Overall Study|No embryos for transfer|0|||
161683539|NCT01417195|583894600|FG001|Overall Study|No embryos for transfer|1|||
161683540|NCT01417195|583894599|FG000|Overall Study|No transfer due to risk of OHSS|1|||
161683541|NCT01417195|583894600|FG001|Overall Study|No transfer due to risk of OHSS|0|||
161683542|NCT01417195|583894599|FG000|Overall Study|No transfer due to elevated progesterone|1|||
161683543|NCT01417195|583894600|FG001|Overall Study|No transfer due to elevated progesterone|0|||
161683544|NCT04766021|583894601|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
161683545|NCT04766021|583894601|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
161605146|NCT02719574|583609189|FG013|Phase 1 (Dose Expansion)|Death|0|||
161605147|NCT02719574|583609190|FG014|Phase 1 (Dose Expansion)|Death|0|||
161605148|NCT02719574|583609191|FG015|Phase 1 (Dose Expansion)|Death|0|||
161683546|NCT02257372|583894604|FG000|Overall Study|Adverse Event|3|||
161605149|NCT02719574|583609192|FG016|Phase 1 (Dose Expansion)|Death|0|||
161605150|NCT02719574|583609176|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605151|NCT02719574|583609177|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605152|NCT02719574|583609178|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605153|NCT02719574|583609179|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605154|NCT02719574|583609180|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605155|NCT02719574|583609181|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605156|NCT02719574|583609182|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
161605157|NCT02719574|583609183|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
161605158|NCT02719574|583609184|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605159|NCT02719574|583609185|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605160|NCT02719574|583609186|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605161|NCT02719574|583609187|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605162|NCT02719574|583609188|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605163|NCT02719574|583609189|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605164|NCT02719574|583609190|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605165|NCT02719574|583609191|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605166|NCT02719574|583609192|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
161605167|NCT02719574|583609176|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605168|NCT02719574|583609177|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605169|NCT02719574|583609178|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605170|NCT02719574|583609179|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605171|NCT02719574|583609180|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605172|NCT02719574|583609181|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605173|NCT02719574|583609182|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
161605174|NCT02719574|583609183|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
161605175|NCT02719574|583609184|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605176|NCT02719574|583609185|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605177|NCT02719574|583609186|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605178|NCT02719574|583609187|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605179|NCT02719574|583609188|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605180|NCT02719574|583609189|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605181|NCT02719574|583609190|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605182|NCT02719574|583609191|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605183|NCT02719574|583609192|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
161605184|NCT02719574|583609176|FG000|Phase 1 (Dose Expansion)|Other|0|||
161605185|NCT02719574|583609177|FG001|Phase 1 (Dose Expansion)|Other|0|||
161605186|NCT02719574|583609178|FG002|Phase 1 (Dose Expansion)|Other|0|||
161605187|NCT02719574|583609179|FG003|Phase 1 (Dose Expansion)|Other|0|||
161605188|NCT02719574|583609180|FG004|Phase 1 (Dose Expansion)|Other|0|||
161605189|NCT02719574|583609181|FG005|Phase 1 (Dose Expansion)|Other|0|||
161605190|NCT02719574|583609182|FG006|Phase 1 (Dose Expansion)|Other|1|||
161605191|NCT02719574|583609183|FG007|Phase 1 (Dose Expansion)|Other|7|||
161605192|NCT02719574|583609184|FG008|Phase 1 (Dose Expansion)|Other|0|||
161605193|NCT02719574|583609185|FG009|Phase 1 (Dose Expansion)|Other|0|||
161605194|NCT02719574|583609186|FG010|Phase 1 (Dose Expansion)|Other|0|||
161605195|NCT02719574|583609187|FG011|Phase 1 (Dose Expansion)|Other|0|||
161605196|NCT02719574|583609188|FG012|Phase 1 (Dose Expansion)|Other|0|||
161605197|NCT02719574|583609189|FG013|Phase 1 (Dose Expansion)|Other|0|||
161605198|NCT02719574|583609190|FG014|Phase 1 (Dose Expansion)|Other|0|||
161605199|NCT02719574|583609191|FG015|Phase 1 (Dose Expansion)|Other|0|||
161605200|NCT02719574|583609192|FG016|Phase 1 (Dose Expansion)|Other|0|||
161605201|NCT02719574|583609176|FG000|Phase 2|Protocol Defined Disease Progression|0|||
161605202|NCT02719574|583609177|FG001|Phase 2|Protocol Defined Disease Progression|0|||
161605203|NCT02719574|583609178|FG002|Phase 2|Protocol Defined Disease Progression|0|||
161605204|NCT02719574|583609179|FG003|Phase 2|Protocol Defined Disease Progression|0|||
161605205|NCT02719574|583609180|FG004|Phase 2|Protocol Defined Disease Progression|0|||
161605206|NCT02719574|583609181|FG005|Phase 2|Protocol Defined Disease Progression|0|||
161605207|NCT02719574|583609182|FG006|Phase 2|Protocol Defined Disease Progression|0|||
161605208|NCT02719574|583609183|FG007|Phase 2|Protocol Defined Disease Progression|0|||
161605209|NCT02719574|583609184|FG008|Phase 2|Protocol Defined Disease Progression|0|||
161605210|NCT02719574|583609185|FG009|Phase 2|Protocol Defined Disease Progression|65|||
161605211|NCT02719574|583609186|FG010|Phase 2|Protocol Defined Disease Progression|8|||
161605212|NCT02719574|583609187|FG011|Phase 2|Protocol Defined Disease Progression|2|||
161605213|NCT02719574|583609188|FG012|Phase 2|Protocol Defined Disease Progression|4|||
161605214|NCT02719574|583609189|FG013|Phase 2|Protocol Defined Disease Progression|9|||
161605215|NCT02719574|583609190|FG014|Phase 2|Protocol Defined Disease Progression|11|||
161683547|NCT02257372|583894605|FG001|Overall Study|Adverse Event|7|||
161605216|NCT02719574|583609191|FG015|Phase 2|Protocol Defined Disease Progression|3|||
161605217|NCT02719574|583609192|FG016|Phase 2|Protocol Defined Disease Progression|4|||
161605218|NCT02719574|583609176|FG000|Phase 2|Adverse Event|0|||
161605219|NCT02719574|583609177|FG001|Phase 2|Adverse Event|0|||
161605220|NCT02719574|583609178|FG002|Phase 2|Adverse Event|0|||
161605221|NCT02719574|583609179|FG003|Phase 2|Adverse Event|0|||
161605222|NCT02719574|583609180|FG004|Phase 2|Adverse Event|0|||
161605223|NCT02719574|583609181|FG005|Phase 2|Adverse Event|0|||
161605224|NCT02719574|583609182|FG006|Phase 2|Adverse Event|0|||
161605225|NCT02719574|583609183|FG007|Phase 2|Adverse Event|0|||
161605226|NCT02719574|583609184|FG008|Phase 2|Adverse Event|0|||
161605227|NCT02719574|583609185|FG009|Phase 2|Adverse Event|27|||
161605228|NCT02719574|583609186|FG010|Phase 2|Adverse Event|0|||
161605229|NCT02719574|583609187|FG011|Phase 2|Adverse Event|1|||
161605230|NCT02719574|583609188|FG012|Phase 2|Adverse Event|1|||
161605231|NCT02719574|583609189|FG013|Phase 2|Adverse Event|1|||
161605232|NCT02719574|583609190|FG014|Phase 2|Adverse Event|2|||
161605233|NCT02719574|583609191|FG015|Phase 2|Adverse Event|2|||
161605234|NCT02719574|583609192|FG016|Phase 2|Adverse Event|3|||
161605235|NCT02719574|583609176|FG000|Phase 2|Other|0|||
161605236|NCT02719574|583609177|FG001|Phase 2|Other|0|||
161605237|NCT02719574|583609178|FG002|Phase 2|Other|0|||
161605238|NCT02719574|583609179|FG003|Phase 2|Other|0|||
161605239|NCT02719574|583609180|FG004|Phase 2|Other|0|||
161605240|NCT02719574|583609181|FG005|Phase 2|Other|0|||
161605241|NCT02719574|583609182|FG006|Phase 2|Other|0|||
161605242|NCT02719574|583609183|FG007|Phase 2|Other|0|||
161605243|NCT02719574|583609184|FG008|Phase 2|Other|0|||
161605244|NCT02719574|583609185|FG009|Phase 2|Other|20|||
161605245|NCT02719574|583609186|FG010|Phase 2|Other|7|||
161605246|NCT02719574|583609187|FG011|Phase 2|Other|0|||
161605247|NCT02719574|583609188|FG012|Phase 2|Other|5|||
161605248|NCT02719574|583609189|FG013|Phase 2|Other|7|||
161605249|NCT02719574|583609190|FG014|Phase 2|Other|0|||
161605250|NCT02719574|583609191|FG015|Phase 2|Other|1|||
161605251|NCT02719574|583609192|FG016|Phase 2|Other|4|||
161605252|NCT02719574|583609176|FG000|Phase 2|Transplant|0|||
161605253|NCT02719574|583609177|FG001|Phase 2|Transplant|0|||
161605254|NCT02719574|583609178|FG002|Phase 2|Transplant|0|||
161605255|NCT02719574|583609179|FG003|Phase 2|Transplant|0|||
161605256|NCT02719574|583609180|FG004|Phase 2|Transplant|0|||
161605257|NCT02719574|583609181|FG005|Phase 2|Transplant|0|||
161605258|NCT02719574|583609182|FG006|Phase 2|Transplant|0|||
161605259|NCT02719574|583609183|FG007|Phase 2|Transplant|0|||
161605260|NCT02719574|583609184|FG008|Phase 2|Transplant|0|||
161605261|NCT02719574|583609185|FG009|Phase 2|Transplant|15|||
161605262|NCT02719574|583609186|FG010|Phase 2|Transplant|2|||
161605263|NCT02719574|583609187|FG011|Phase 2|Transplant|0|||
161605264|NCT02719574|583609188|FG012|Phase 2|Transplant|6|||
161605265|NCT02719574|583609189|FG013|Phase 2|Transplant|1|||
161605266|NCT02719574|583609190|FG014|Phase 2|Transplant|1|||
161605267|NCT02719574|583609191|FG015|Phase 2|Transplant|0|||
161605268|NCT02719574|583609192|FG016|Phase 2|Transplant|0|||
161605269|NCT02719574|583609176|FG000|Phase 2|Death|0|||
161605270|NCT02719574|583609177|FG001|Phase 2|Death|0|||
161605271|NCT02719574|583609178|FG002|Phase 2|Death|0|||
161605272|NCT02719574|583609179|FG003|Phase 2|Death|0|||
161605273|NCT02719574|583609180|FG004|Phase 2|Death|0|||
161605274|NCT02719574|583609181|FG005|Phase 2|Death|0|||
161605275|NCT02719574|583609182|FG006|Phase 2|Death|0|||
161605276|NCT02719574|583609183|FG007|Phase 2|Death|0|||
161605277|NCT02719574|583609184|FG008|Phase 2|Death|0|||
161605278|NCT02719574|583609185|FG009|Phase 2|Death|14|||
161605279|NCT02719574|583609186|FG010|Phase 2|Death|0|||
161605280|NCT02719574|583609187|FG011|Phase 2|Death|0|||
161605281|NCT02719574|583609188|FG012|Phase 2|Death|1|||
161605282|NCT02719574|583609189|FG013|Phase 2|Death|1|||
161605283|NCT02719574|583609190|FG014|Phase 2|Death|2|||
161605284|NCT02719574|583609191|FG015|Phase 2|Death|0|||
161605285|NCT02719574|583609192|FG016|Phase 2|Death|0|||
161605286|NCT02719574|583609176|FG000|Phase 2|Investigator Decision|0|||
161605287|NCT02719574|583609177|FG001|Phase 2|Investigator Decision|0|||
161605288|NCT02719574|583609178|FG002|Phase 2|Investigator Decision|0|||
161605289|NCT02719574|583609179|FG003|Phase 2|Investigator Decision|0|||
161605290|NCT02719574|583609180|FG004|Phase 2|Investigator Decision|0|||
161605291|NCT02719574|583609181|FG005|Phase 2|Investigator Decision|0|||
161605292|NCT02719574|583609182|FG006|Phase 2|Investigator Decision|0|||
161605293|NCT02719574|583609183|FG007|Phase 2|Investigator Decision|0|||
161605294|NCT02719574|583609184|FG008|Phase 2|Investigator Decision|0|||
161605295|NCT02719574|583609185|FG009|Phase 2|Investigator Decision|6|||
161605296|NCT02719574|583609186|FG010|Phase 2|Investigator Decision|1|||
161605297|NCT02719574|583609187|FG011|Phase 2|Investigator Decision|2|||
161605298|NCT02719574|583609188|FG012|Phase 2|Investigator Decision|3|||
161605299|NCT02719574|583609189|FG013|Phase 2|Investigator Decision|1|||
161605300|NCT02719574|583609190|FG014|Phase 2|Investigator Decision|3|||
161605301|NCT02719574|583609191|FG015|Phase 2|Investigator Decision|2|||
161605302|NCT02719574|583609192|FG016|Phase 2|Investigator Decision|0|||
161605303|NCT02719574|583609176|FG000|Phase 2|Withdrawal by Subject|0|||
161605304|NCT02719574|583609177|FG001|Phase 2|Withdrawal by Subject|0|||
161605305|NCT02719574|583609178|FG002|Phase 2|Withdrawal by Subject|0|||
161605306|NCT02719574|583609179|FG003|Phase 2|Withdrawal by Subject|0|||
161605307|NCT02719574|583609180|FG004|Phase 2|Withdrawal by Subject|0|||
161605308|NCT02719574|583609181|FG005|Phase 2|Withdrawal by Subject|0|||
161605309|NCT02719574|583609182|FG006|Phase 2|Withdrawal by Subject|0|||
161605310|NCT02719574|583609183|FG007|Phase 2|Withdrawal by Subject|0|||
161605311|NCT02719574|583609184|FG008|Phase 2|Withdrawal by Subject|0|||
161605312|NCT02719574|583609185|FG009|Phase 2|Withdrawal by Subject|5|||
161605313|NCT02719574|583609186|FG010|Phase 2|Withdrawal by Subject|0|||
161605314|NCT02719574|583609187|FG011|Phase 2|Withdrawal by Subject|0|||
161605315|NCT02719574|583609188|FG012|Phase 2|Withdrawal by Subject|0|||
161605316|NCT02719574|583609189|FG013|Phase 2|Withdrawal by Subject|1|||
161605317|NCT02719574|583609190|FG014|Phase 2|Withdrawal by Subject|1|||
161605318|NCT02719574|583609191|FG015|Phase 2|Withdrawal by Subject|2|||
161605319|NCT02719574|583609192|FG016|Phase 2|Withdrawal by Subject|0|||
161605320|NCT02719574|583609176|FG000|Phase 2|Protocol Violation|0|||
161605321|NCT02719574|583609177|FG001|Phase 2|Protocol Violation|0|||
161605322|NCT02719574|583609178|FG002|Phase 2|Protocol Violation|0|||
161605323|NCT02719574|583609179|FG003|Phase 2|Protocol Violation|0|||
161605324|NCT02719574|583609180|FG004|Phase 2|Protocol Violation|0|||
161605325|NCT02719574|583609181|FG005|Phase 2|Protocol Violation|0|||
161605326|NCT02719574|583609182|FG006|Phase 2|Protocol Violation|0|||
161605327|NCT02719574|583609183|FG007|Phase 2|Protocol Violation|0|||
161605328|NCT02719574|583609184|FG008|Phase 2|Protocol Violation|0|||
161605329|NCT02719574|583609185|FG009|Phase 2|Protocol Violation|1|||
161605330|NCT02719574|583609186|FG010|Phase 2|Protocol Violation|0|||
161605331|NCT02719574|583609187|FG011|Phase 2|Protocol Violation|0|||
161605332|NCT02719574|583609188|FG012|Phase 2|Protocol Violation|0|||
161605333|NCT02719574|583609189|FG013|Phase 2|Protocol Violation|0|||
161605334|NCT02719574|583609190|FG014|Phase 2|Protocol Violation|0|||
161605335|NCT02719574|583609191|FG015|Phase 2|Protocol Violation|0|||
161605336|NCT02719574|583609192|FG016|Phase 2|Protocol Violation|0|||
161605337|NCT01976936|583609203|FG000|Overall Study|Did not receive at least 9 doses|9|||
161605338|NCT01976936|583609204|FG001|Overall Study|Did not receive at least 9 doses|4|||
161605339|NCT02467270|583609205|FG000|Overall Study|Participants Never Treated|0|||
161605340|NCT02467270|583609206|FG001|Overall Study|Participants Never Treated|1|||
161605341|NCT02467270|583609207|FG002|Overall Study|Participants Never Treated|0|||
161605342|NCT02467270|583609205|FG000|Overall Study|Ongoing|50|||
161605343|NCT02467270|583609206|FG001|Overall Study|Ongoing|41|||
161605344|NCT02467270|583609207|FG002|Overall Study|Ongoing|43|||
161605345|NCT02467270|583609205|FG000|Overall Study|Adverse Event|16|||
161605346|NCT02467270|583609206|FG001|Overall Study|Adverse Event|15|||
161605347|NCT02467270|583609207|FG002|Overall Study|Adverse Event|14|||
161605348|NCT02467270|583609205|FG000|Overall Study|Progressive Disease|7|||
161605349|NCT02467270|583609206|FG001|Overall Study|Progressive Disease|7|||
161605350|NCT02467270|583609207|FG002|Overall Study|Progressive Disease|4|||
161605351|NCT02467270|583609205|FG000|Overall Study|Death|2|||
161605352|NCT02467270|583609206|FG001|Overall Study|Death|0|||
161605353|NCT02467270|583609207|FG002|Overall Study|Death|2|||
161605354|NCT02467270|583609205|FG000|Overall Study|Lack of Efficacy|12|||
161605355|NCT02467270|583609206|FG001|Overall Study|Lack of Efficacy|18|||
161605356|NCT02467270|583609207|FG002|Overall Study|Lack of Efficacy|23|||
161605357|NCT02467270|583609205|FG000|Overall Study|Non-compliance With Study Drug|0|||
161605358|NCT02467270|583609206|FG001|Overall Study|Non-compliance With Study Drug|2|||
161605359|NCT02467270|583609207|FG002|Overall Study|Non-compliance With Study Drug|1|||
161605360|NCT02467270|583609205|FG000|Overall Study|Lost to Follow-up|2|||
161605361|NCT02467270|583609206|FG001|Overall Study|Lost to Follow-up|1|||
161683548|NCT02257372|583894604|FG000|Overall Study|Lack of Efficacy|2|||
161683549|NCT02257372|583894605|FG001|Overall Study|Lack of Efficacy|1|||
161683550|NCT02257372|583894604|FG000|Overall Study|Protocol Violation|1|||
161683551|NCT02257372|583894605|FG001|Overall Study|Protocol Violation|1|||
161683552|NCT02257372|583894604|FG000|Overall Study|Lost to Follow-up|0|||
161683553|NCT02257372|583894605|FG001|Overall Study|Lost to Follow-up|1|||
161605362|NCT02467270|583609207|FG002|Overall Study|Lost to Follow-up|0|||
161605363|NCT02467270|583609205|FG000|Overall Study|Pregnancy|0|||
161605364|NCT02467270|583609206|FG001|Overall Study|Pregnancy|1|||
161683554|NCT02257372|583894604|FG000|Overall Study|Withdrew consent|1|||
161683555|NCT02257372|583894605|FG001|Overall Study|Withdrew consent|0|||
161683556|NCT02634151|583894606|FG000|Overall Study|Withdrawal by Subject|1|||
161605365|NCT02467270|583609207|FG002|Overall Study|Pregnancy|0|||
161605366|NCT02467270|583609205|FG000|Overall Study|Physician Decision|0|||
161605367|NCT02467270|583609206|FG001|Overall Study|Physician Decision|4|||
161605368|NCT02467270|583609207|FG002|Overall Study|Physician Decision|1|||
161605369|NCT02467270|583609205|FG000|Overall Study|Withdrawal by Subject|4|||
161605370|NCT02467270|583609206|FG001|Overall Study|Withdrawal by Subject|3|||
161605371|NCT02467270|583609207|FG002|Overall Study|Withdrawal by Subject|5|||
161683557|NCT02634151|583894607|FG001|Overall Study|Withdrawal by Subject|0|||
161605372|NCT02467270|583609205|FG000|Overall Study|Reason not Specified|1|||
161605373|NCT02467270|583609206|FG001|Overall Study|Reason not Specified|2|||
161605374|NCT02467270|583609207|FG002|Overall Study|Reason not Specified|1|||
161605375|NCT00495677|583609208|FG000|Stage 1 (25 Days)|Adverse Event|0|||
161605376|NCT00495677|583609209|FG001|Stage 1 (25 Days)|Adverse Event|0|||
161605377|NCT00495677|583609210|FG002|Stage 1 (25 Days)|Adverse Event|1|||
161605378|NCT00495677|583609211|FG003|Stage 1 (25 Days)|Adverse Event|0|||
161605379|NCT00495677|583609212|FG004|Stage 1 (25 Days)|Adverse Event|0|||
161605380|NCT00495677|583609213|FG005|Stage 1 (25 Days)|Adverse Event|0|||
161605381|NCT00495677|583609214|FG006|Stage 1 (25 Days)|Adverse Event|0|||
161605382|NCT02306161|583609216|FG000|Overall Study|Death|1|||
161605383|NCT02306161|583609217|FG001|Overall Study|Death|3|||
161605384|NCT02306161|583609216|FG000|Overall Study|Lack of Efficacy|20|||
161605385|NCT02306161|583609217|FG001|Overall Study|Lack of Efficacy|43|||
161605386|NCT02306161|583609216|FG000|Overall Study|Physician Decision|30|||
161605387|NCT02306161|583609217|FG001|Overall Study|Physician Decision|18|||
161605388|NCT02306161|583609216|FG000|Overall Study|Withdrawal by Subject|4|||
161605389|NCT02306161|583609217|FG001|Overall Study|Withdrawal by Subject|0|||
161605390|NCT02306161|583609216|FG000|Overall Study|Ineligible|9|||
161605391|NCT02306161|583609217|FG001|Overall Study|Ineligible|5|||
161605392|NCT05162586|583609218|FG000|Overall Study|Other|0|||
161605393|NCT05162586|583609219|FG001|Overall Study|Other|0|||
161605394|NCT05162586|583609220|FG002|Overall Study|Other|0|||
161605395|NCT05162586|583609221|FG003|Overall Study|Other|0|||
161605396|NCT05162586|583609222|FG004|Overall Study|Other|1|||
161605397|NCT05162586|583609223|FG005|Overall Study|Other|0|||
161605398|NCT05162586|583609224|FG006|Overall Study|Other|2|||
161605399|NCT05162586|583609225|FG007|Overall Study|Other|2|||
161605400|NCT05162586|583609218|FG000|Overall Study|Lack of Efficacy|0|||
161605401|NCT05162586|583609219|FG001|Overall Study|Lack of Efficacy|0|||
161605402|NCT05162586|583609220|FG002|Overall Study|Lack of Efficacy|0|||
161605403|NCT05162586|583609221|FG003|Overall Study|Lack of Efficacy|0|||
161605404|NCT05162586|583609222|FG004|Overall Study|Lack of Efficacy|1|||
161605405|NCT05162586|583609223|FG005|Overall Study|Lack of Efficacy|0|||
161605406|NCT05162586|583609224|FG006|Overall Study|Lack of Efficacy|0|||
161605407|NCT05162586|583609225|FG007|Overall Study|Lack of Efficacy|1|||
161605408|NCT05162586|583609218|FG000|Overall Study|Lost to Follow-up|0|||
161605409|NCT05162586|583609219|FG001|Overall Study|Lost to Follow-up|0|||
161605410|NCT05162586|583609220|FG002|Overall Study|Lost to Follow-up|0|||
161605411|NCT05162586|583609221|FG003|Overall Study|Lost to Follow-up|0|||
161605412|NCT05162586|583609222|FG004|Overall Study|Lost to Follow-up|2|||
161605413|NCT05162586|583609223|FG005|Overall Study|Lost to Follow-up|0|||
161605414|NCT05162586|583609224|FG006|Overall Study|Lost to Follow-up|0|||
161605415|NCT05162586|583609225|FG007|Overall Study|Lost to Follow-up|2|||
161605416|NCT05162586|583609218|FG000|Overall Study|Non-Compliance|0|||
161605417|NCT05162586|583609219|FG001|Overall Study|Non-Compliance|1|||
161605418|NCT05162586|583609220|FG002|Overall Study|Non-Compliance|0|||
161605419|NCT05162586|583609221|FG003|Overall Study|Non-Compliance|0|||
161605420|NCT05162586|583609222|FG004|Overall Study|Non-Compliance|1|||
161605421|NCT05162586|583609223|FG005|Overall Study|Non-Compliance|0|||
161605422|NCT05162586|583609224|FG006|Overall Study|Non-Compliance|0|||
161605423|NCT05162586|583609225|FG007|Overall Study|Non-Compliance|1|||
161605424|NCT05162586|583609218|FG000|Overall Study|Withdrawal by Subject|2|||
161605425|NCT05162586|583609219|FG001|Overall Study|Withdrawal by Subject|0|||
161605426|NCT05162586|583609220|FG002|Overall Study|Withdrawal by Subject|0|||
161605427|NCT05162586|583609221|FG003|Overall Study|Withdrawal by Subject|0|||
161605428|NCT05162586|583609222|FG004|Overall Study|Withdrawal by Subject|7|||
161605429|NCT05162586|583609223|FG005|Overall Study|Withdrawal by Subject|6|||
161605430|NCT05162586|583609224|FG006|Overall Study|Withdrawal by Subject|2|||
161605431|NCT05162586|583609225|FG007|Overall Study|Withdrawal by Subject|2|||
161605432|NCT05162586|583609218|FG000|Overall Study|Adverse Event|2|||
161605433|NCT05162586|583609219|FG001|Overall Study|Adverse Event|0|||
161605434|NCT05162586|583609220|FG002|Overall Study|Adverse Event|1|||
161605435|NCT05162586|583609221|FG003|Overall Study|Adverse Event|2|||
161605436|NCT05162586|583609222|FG004|Overall Study|Adverse Event|4|||
161605437|NCT05162586|583609223|FG005|Overall Study|Adverse Event|1|||
161605438|NCT05162586|583609224|FG006|Overall Study|Adverse Event|5|||
161605439|NCT05162586|583609225|FG007|Overall Study|Adverse Event|2|||
161605440|NCT00357682|583609228|FG000|Overall Study|Did not receive allocated Treatment|10|||
161605441|NCT00357682|583609229|FG001|Overall Study|Did not receive allocated Treatment|9|||
161605442|NCT00357682|583609230|FG002|Overall Study|Did not receive allocated Treatment|9|||
161605443|NCT00357682|583609231|FG003|Overall Study|Did not receive allocated Treatment|10|||
161605444|NCT00357682|583609228|FG000|Overall Study|Withdrew consent|6|||
161605445|NCT00357682|583609229|FG001|Overall Study|Withdrew consent|6|||
161605446|NCT00357682|583609230|FG002|Overall Study|Withdrew consent|5|||
161605447|NCT00357682|583609231|FG003|Overall Study|Withdrew consent|5|||
161605448|NCT00357682|583609228|FG000|Overall Study|Lost to Follow-up|39|||
161605449|NCT00357682|583609229|FG001|Overall Study|Lost to Follow-up|33|||
161605450|NCT00357682|583609230|FG002|Overall Study|Lost to Follow-up|26|||
161605451|NCT00357682|583609231|FG003|Overall Study|Lost to Follow-up|35|||
161605452|NCT00357682|583609228|FG000|Overall Study|Adverse Event|24|||
161605453|NCT00357682|583609229|FG001|Overall Study|Adverse Event|32|||
161605454|NCT00357682|583609230|FG002|Overall Study|Adverse Event|22|||
161605455|NCT00357682|583609231|FG003|Overall Study|Adverse Event|27|||
161605456|NCT00357682|583609228|FG000|Overall Study|Physician Decision|32|||
161605457|NCT00357682|583609229|FG001|Overall Study|Physician Decision|20|||
161605458|NCT00357682|583609230|FG002|Overall Study|Physician Decision|24|||
161605459|NCT00357682|583609231|FG003|Overall Study|Physician Decision|30|||
161605460|NCT00357682|583609228|FG000|Overall Study|Patient decision|73|||
161605461|NCT00357682|583609229|FG001|Overall Study|Patient decision|80|||
161605462|NCT00357682|583609230|FG002|Overall Study|Patient decision|51|||
161605463|NCT00357682|583609231|FG003|Overall Study|Patient decision|59|||
161605464|NCT00357682|583609228|FG000|Overall Study|Other reason|157|||
161605465|NCT00357682|583609229|FG001|Overall Study|Other reason|130|||
161605466|NCT00357682|583609230|FG002|Overall Study|Other reason|114|||
161605467|NCT00357682|583609231|FG003|Overall Study|Other reason|99|||
161605468|NCT05424718|583609236|FG000|Overall Study|Lost to Follow-up|5|||
161605469|NCT05424718|583609237|FG001|Overall Study|Lost to Follow-up|4|||
161605470|NCT04046549|583609238|FG000|Overall Study|Adverse Event|1|||
161605471|NCT04046549|583609238|FG000|Overall Study|Physician Decision|1|||
161605472|NCT04046549|583609238|FG000|Overall Study|Withdrawal by Subject|3|||
161605473|NCT04046549|583609238|FG000|Overall Study|Other, Not Specified|5|||
161605474|NCT05771467|583609240|FG000|Overall Study|Lost to Follow-up|6|||
161605475|NCT05771467|583609241|FG001|Overall Study|Lost to Follow-up|3|||
161605476|NCT05866926|583609248|FG000|Overall Study|Death|16|||
161605477|NCT05866926|583609249|FG001|Overall Study|Death|9|||
161605478|NCT05866926|583609248|FG000|Overall Study|Lost to Follow-up|0|||
161605479|NCT05866926|583609249|FG001|Overall Study|Lost to Follow-up|1|||
161605480|NCT05866926|583609248|FG000|Overall Study|Adverse Event|1|||
161605481|NCT05866926|583609249|FG001|Overall Study|Adverse Event|0|||
161605482|NCT05866926|583609248|FG000|Overall Study|Withdrawal by Subject|5|||
161605483|NCT05866926|583609249|FG001|Overall Study|Withdrawal by Subject|1|||
161605484|NCT05866926|583609248|FG000|Overall Study|Disease progression|1|||
161605485|NCT05866926|583609249|FG001|Overall Study|Disease progression|0|||
161605486|NCT05866926|583609248|FG000|Overall Study|other causes|2|||
161605487|NCT05866926|583609249|FG001|Overall Study|other causes|1|||
161605488|NCT00709956|583609250|FG000|Overall Study|Withdrawal by Subject|1|||
161605489|NCT00709956|583609251|FG001|Overall Study|Withdrawal by Subject|1|||
161605490|NCT00709956|583609250|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
161605491|NCT00709956|583609251|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
161605492|NCT01105091|583609252|FG000|Overall Study|Death|2|||
161605493|NCT01105091|583609253|FG001|Overall Study|Death|0|||
161605494|NCT04940624|583609256|FG000|Overall Study|Adverse Event|4|||
161605495|NCT04940624|583609257|FG001|Overall Study|Adverse Event|11|||
161605496|NCT04940624|583609256|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161605497|NCT04940624|583609257|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161605498|NCT04940624|583609256|FG000|Overall Study|Physician Decision|1|||
161605499|NCT04940624|583609257|FG001|Overall Study|Physician Decision|0|||
161605500|NCT04940624|583609256|FG000|Overall Study|Lost to Follow-up|1|||
161605501|NCT04940624|583609257|FG001|Overall Study|Lost to Follow-up|0|||
161605502|NCT04940624|583609256|FG000|Overall Study|Reason Not Specified|1|||
161605503|NCT04940624|583609257|FG001|Overall Study|Reason Not Specified|0|||
161605504|NCT04479787|583609258|FG000|Through 6 Months|Withdrawal by Subject|16|||
161683558|NCT02634151|583894606|FG000|Overall Study|Non-Compliance|0|||
161683559|NCT02634151|583894607|FG001|Overall Study|Non-Compliance|1|||
161605505|NCT04479787|583609259|FG001|Through 6 Months|Withdrawal by Subject|14|||
161605506|NCT04479787|583609258|FG000|Through 6 Months|Unsuccessful Trial|17|||
161605507|NCT04479787|583609259|FG001|Through 6 Months|Unsuccessful Trial|0|||
161605508|NCT04479787|583609258|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
161605509|NCT04479787|583609259|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
161605510|NCT04479787|583609258|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
161605511|NCT04479787|583609259|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
161605512|NCT04479787|583609258|FG000|Through 6 Months|Lost to Follow-up|3|||
161605513|NCT04479787|583609259|FG001|Through 6 Months|Lost to Follow-up|2|||
161605514|NCT04479787|583609258|FG000|Through 6 Months|Death|3|||
161683560|NCT02634151|583894606|FG000|Overall Study|Other|0|||
161605515|NCT04479787|583609259|FG001|Through 6 Months|Death|0|||
161605516|NCT04479787|583609258|FG000|Through 6 Months|Inclusion/Exclusion|2|||
161605517|NCT04479787|583609259|FG001|Through 6 Months|Inclusion/Exclusion|1|||
161605518|NCT04479787|583609258|FG000|Through 6 Months|Subject Became Pregnant|1|||
161605519|NCT04479787|583609259|FG001|Through 6 Months|Subject Became Pregnant|1|||
161605520|NCT04479787|583609258|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
161605521|NCT04479787|583609259|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
161605522|NCT04479787|583609258|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
161605523|NCT04479787|583609259|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
161605524|NCT04479787|583609258|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
161605525|NCT04479787|583609259|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
161605526|NCT04479787|583609258|FG000|After 6 Months|Withdrawal by Subject|3|||
161605527|NCT04479787|583609259|FG001|After 6 Months|Withdrawal by Subject|13|||
161605528|NCT04479787|583609258|FG000|After 6 Months|Unsuccessful Trial|0|||
161605529|NCT04479787|583609259|FG001|After 6 Months|Unsuccessful Trial|7|||
161605530|NCT04479787|583609258|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
161605531|NCT04479787|583609259|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
161605532|NCT04479787|583609258|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
161605533|NCT04479787|583609259|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
161605534|NCT04479787|583609258|FG000|After 6 Months|Death|2|||
161605535|NCT04479787|583609259|FG001|After 6 Months|Death|0|||
161605536|NCT04479787|583609258|FG000|After 6 Months|Lost to Follow-up|1|||
161605537|NCT04479787|583609259|FG001|After 6 Months|Lost to Follow-up|1|||
161605538|NCT04479787|583609258|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
161605539|NCT04479787|583609259|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
161605540|NCT04479787|583609258|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
161605541|NCT04479787|583609259|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
161605542|NCT04479787|583609258|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
161605543|NCT04479787|583609259|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
161605544|NCT04479787|583609258|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
161605545|NCT04479787|583609259|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
161605546|NCT04039113|583609262|FG000|Overall Study|Withdrawal by Subject|8|||
161605547|NCT04039113|583609263|FG001|Overall Study|Withdrawal by Subject|11|||
161605548|NCT04039113|583609262|FG000|Overall Study|Lost to Follow-up|1|||
161605549|NCT04039113|583609263|FG001|Overall Study|Lost to Follow-up|1|||
161605550|NCT04039113|583609262|FG000|Overall Study|Adverse Event|2|||
161605551|NCT04039113|583609263|FG001|Overall Study|Adverse Event|2|||
161605552|NCT04039113|583609262|FG000|Overall Study|Death|2|||
161605553|NCT04039113|583609263|FG001|Overall Study|Death|4|||
161605554|NCT04039113|583609262|FG000|Overall Study|Site Closure|6|||
161605555|NCT04039113|583609263|FG001|Overall Study|Site Closure|0|||
161605556|NCT04039113|583609262|FG000|Overall Study|Failure to meet randomisation criteria|4|||
161605557|NCT04039113|583609263|FG001|Overall Study|Failure to meet randomisation criteria|0|||
161605558|NCT00353496|583609264|FG000|Overall Study|Adverse Event|1|||
161605559|NCT00353496|583609265|FG001|Overall Study|Adverse Event|0|||
161605560|NCT00353496|583609264|FG000|Overall Study|Protocol Violation|2|||
161605561|NCT00353496|583609265|FG001|Overall Study|Protocol Violation|2|||
161605562|NCT00353496|583609264|FG000|Overall Study|Withdrawal by Subject|3|||
161605563|NCT00353496|583609265|FG001|Overall Study|Withdrawal by Subject|4|||
161605564|NCT00353496|583609264|FG000|Overall Study|Physician Decision|6|||
161605565|NCT00353496|583609265|FG001|Overall Study|Physician Decision|9|||
161605566|NCT00353496|583609264|FG000|Overall Study|Not otherwise specified|4|||
161605567|NCT00353496|583609265|FG001|Overall Study|Not otherwise specified|2|||
161605568|NCT02180867|583609266|FG000|Overall Study|Adverse Event|3|||
161605569|NCT02180867|583609267|FG001|Overall Study|Adverse Event|4|||
161605570|NCT02180867|583609268|FG002|Overall Study|Adverse Event|1|||
161605571|NCT02180867|583609269|FG003|Overall Study|Adverse Event|5|||
161605572|NCT02180867|583609270|FG004|Overall Study|Adverse Event|0|||
161605573|NCT02180867|583609271|FG005|Overall Study|Adverse Event|0|||
161605574|NCT02180867|583609272|FG006|Overall Study|Adverse Event|0|||
161605575|NCT02180867|583609266|FG000|Overall Study|Death|0|||
161605576|NCT02180867|583609267|FG001|Overall Study|Death|0|||
161605577|NCT02180867|583609268|FG002|Overall Study|Death|0|||
161683561|NCT02634151|583894607|FG001|Overall Study|Other|1|||
161683562|NCT00003535|583894609|FG000|Overall Study|Not evaluable|5|||
161683563|NCT02347098|583894610|FG000|Overall Study|Death|1|||
161605578|NCT02180867|583609269|FG003|Overall Study|Death|0|||
161605579|NCT02180867|583609270|FG004|Overall Study|Death|1|||
161605580|NCT02180867|583609271|FG005|Overall Study|Death|0|||
161605581|NCT02180867|583609272|FG006|Overall Study|Death|0|||
161605582|NCT02180867|583609266|FG000|Overall Study|Lack of Efficacy|0|||
161605583|NCT02180867|583609267|FG001|Overall Study|Lack of Efficacy|2|||
161605584|NCT02180867|583609268|FG002|Overall Study|Lack of Efficacy|0|||
161605585|NCT02180867|583609269|FG003|Overall Study|Lack of Efficacy|1|||
161605586|NCT02180867|583609270|FG004|Overall Study|Lack of Efficacy|6|||
161605587|NCT02180867|583609271|FG005|Overall Study|Lack of Efficacy|0|||
161605588|NCT02180867|583609272|FG006|Overall Study|Lack of Efficacy|1|||
161605589|NCT02180867|583609266|FG000|Overall Study|Physician Decision|1|||
161605590|NCT02180867|583609267|FG001|Overall Study|Physician Decision|3|||
161605591|NCT02180867|583609268|FG002|Overall Study|Physician Decision|1|||
161605592|NCT02180867|583609269|FG003|Overall Study|Physician Decision|10|||
161605593|NCT02180867|583609270|FG004|Overall Study|Physician Decision|9|||
161605594|NCT02180867|583609271|FG005|Overall Study|Physician Decision|3|||
161605595|NCT02180867|583609272|FG006|Overall Study|Physician Decision|4|||
161605596|NCT02180867|583609266|FG000|Overall Study|Withdrawal by Subject|0|||
161605597|NCT02180867|583609267|FG001|Overall Study|Withdrawal by Subject|0|||
161605598|NCT02180867|583609268|FG002|Overall Study|Withdrawal by Subject|0|||
161605599|NCT02180867|583609269|FG003|Overall Study|Withdrawal by Subject|1|||
161605600|NCT02180867|583609270|FG004|Overall Study|Withdrawal by Subject|1|||
161605601|NCT02180867|583609271|FG005|Overall Study|Withdrawal by Subject|0|||
161605602|NCT02180867|583609272|FG006|Overall Study|Withdrawal by Subject|0|||
161605603|NCT02180867|583609266|FG000|Overall Study|Ineligible|1|||
161605604|NCT02180867|583609267|FG001|Overall Study|Ineligible|2|||
161605605|NCT02180867|583609268|FG002|Overall Study|Ineligible|0|||
161605606|NCT02180867|583609269|FG003|Overall Study|Ineligible|3|||
161605607|NCT02180867|583609270|FG004|Overall Study|Ineligible|5|||
161605608|NCT02180867|583609271|FG005|Overall Study|Ineligible|0|||
161605609|NCT02180867|583609272|FG006|Overall Study|Ineligible|0|||
161605610|NCT02180867|583609266|FG000|Overall Study|Repeat Eligibility Studies|0|||
161605611|NCT02180867|583609267|FG001|Overall Study|Repeat Eligibility Studies|0|||
161605612|NCT02180867|583609268|FG002|Overall Study|Repeat Eligibility Studies|0|||
161605613|NCT02180867|583609269|FG003|Overall Study|Repeat Eligibility Studies|0|||
161605614|NCT02180867|583609270|FG004|Overall Study|Repeat Eligibility Studies|1|||
161605615|NCT02180867|583609271|FG005|Overall Study|Repeat Eligibility Studies|0|||
161605616|NCT02180867|583609272|FG006|Overall Study|Repeat Eligibility Studies|0|||
161605617|NCT02180867|583609266|FG000|Overall Study|Refusal of further protocol therapy|1|||
161605618|NCT02180867|583609267|FG001|Overall Study|Refusal of further protocol therapy|0|||
161605619|NCT02180867|583609268|FG002|Overall Study|Refusal of further protocol therapy|2|||
161605620|NCT02180867|583609269|FG003|Overall Study|Refusal of further protocol therapy|6|||
161605621|NCT02180867|583609270|FG004|Overall Study|Refusal of further protocol therapy|4|||
161605622|NCT02180867|583609271|FG005|Overall Study|Refusal of further protocol therapy|0|||
161605623|NCT02180867|583609272|FG006|Overall Study|Refusal of further protocol therapy|0|||
161605624|NCT00945724|583609273|FG000|Overall Study|Withdrawal by Subject|2|||
161605625|NCT00945724|583609273|FG000|Overall Study|Physician Decision|1|||
161605626|NCT00945724|583609273|FG000|Overall Study|Adverse Event|5|||
161605627|NCT00945724|583609273|FG000|Overall Study|Second malignancy|1|||
161605628|NCT02502266|583609928|FG000|Overall Study|Adverse Event|0|||
161605629|NCT02502266|583609929|FG001|Overall Study|Adverse Event|0|||
161605630|NCT02502266|583609930|FG002|Overall Study|Adverse Event|0|||
161605631|NCT02502266|583609931|FG003|Overall Study|Adverse Event|0|||
161605632|NCT02502266|583609932|FG004|Overall Study|Adverse Event|1|||
161605633|NCT02502266|583609933|FG005|Overall Study|Adverse Event|1|||
161683564|NCT02347098|583894611|FG001|Overall Study|Death|0|||
161683565|NCT02347098|583894610|FG000|Overall Study|Withdrawal by Subject|1|||
161683566|NCT02347098|583894611|FG001|Overall Study|Withdrawal by Subject|0|||
161683567|NCT02347098|583894610|FG000|Overall Study|Lost to Follow-up|2|||
161683568|NCT02347098|583894611|FG001|Overall Study|Lost to Follow-up|2|||
161683569|NCT02347098|583894610|FG000|Overall Study|Refuse Follow-up Visit|1|||
161683570|NCT02347098|583894611|FG001|Overall Study|Refuse Follow-up Visit|5|||
161683571|NCT02347098|583894610|FG000|Overall Study|no visit due to illness|2|||
161683572|NCT02347098|583894611|FG001|Overall Study|no visit due to illness|1|||
161683573|NCT00530894|583894612|FG000|Overall Study|Death|84|||
161832333|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
161832334|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
161605634|NCT02502266|583609934|FG006|Overall Study|Adverse Event|1|||
161605635|NCT02502266|583609928|FG000|Overall Study|Withdrawal by Subject|30|||
161683574|NCT00530894|583894613|FG001|Overall Study|Death|89|||
161683575|NCT00530894|583894614|FG002|Overall Study|Death|55|||
161832335|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
161605636|NCT02502266|583609929|FG001|Overall Study|Withdrawal by Subject|15|||
161605637|NCT02502266|583609930|FG002|Overall Study|Withdrawal by Subject|16|||
161605638|NCT02502266|583609931|FG003|Overall Study|Withdrawal by Subject|0|||
161683576|NCT00530894|583894615|FG003|Overall Study|Death|89|||
161683577|NCT00530894|583894612|FG000|Overall Study|Lost to Follow-up|1|||
161605639|NCT02502266|583609932|FG004|Overall Study|Withdrawal by Subject|0|||
161605640|NCT02502266|583609933|FG005|Overall Study|Withdrawal by Subject|0|||
161605641|NCT02502266|583609934|FG006|Overall Study|Withdrawal by Subject|0|||
161605642|NCT02502266|583609928|FG000|Overall Study|Still on Treatment|0|||
161605643|NCT02502266|583609929|FG001|Overall Study|Still on Treatment|0|||
161605644|NCT02502266|583609930|FG002|Overall Study|Still on Treatment|1|||
161605645|NCT02502266|583609931|FG003|Overall Study|Still on Treatment|0|||
161605646|NCT02502266|583609932|FG004|Overall Study|Still on Treatment|0|||
161605647|NCT02502266|583609933|FG005|Overall Study|Still on Treatment|0|||
161605648|NCT02502266|583609934|FG006|Overall Study|Still on Treatment|0|||
161605649|NCT02502266|583609928|FG000|Overall Study|Other Reasons|19|||
161605650|NCT02502266|583609929|FG001|Overall Study|Other Reasons|6|||
161605651|NCT02502266|583609930|FG002|Overall Study|Other Reasons|14|||
161605652|NCT02502266|583609931|FG003|Overall Study|Other Reasons|0|||
161605653|NCT02502266|583609932|FG004|Overall Study|Other Reasons|1|||
161605654|NCT02502266|583609933|FG005|Overall Study|Other Reasons|1|||
161605655|NCT02502266|583609934|FG006|Overall Study|Other Reasons|0|||
161605656|NCT02502266|583609928|FG000|Overall Study|Arm 4 Discontinued|0|||
161605657|NCT02502266|583609929|FG001|Overall Study|Arm 4 Discontinued|0|||
161605658|NCT02502266|583609930|FG002|Overall Study|Arm 4 Discontinued|0|||
161605659|NCT02502266|583609931|FG003|Overall Study|Arm 4 Discontinued|52|||
161605660|NCT02502266|583609932|FG004|Overall Study|Arm 4 Discontinued|0|||
161605661|NCT02502266|583609933|FG005|Overall Study|Arm 4 Discontinued|0|||
161605662|NCT02502266|583609934|FG006|Overall Study|Arm 4 Discontinued|0|||
161605663|NCT02502266|583609928|FG000|Overall Study|Never treated|0|||
161605664|NCT02502266|583609929|FG001|Overall Study|Never treated|0|||
161605665|NCT02502266|583609930|FG002|Overall Study|Never treated|0|||
161605666|NCT02502266|583609931|FG003|Overall Study|Never treated|0|||
161605667|NCT02502266|583609932|FG004|Overall Study|Never treated|0|||
161605668|NCT02502266|583609933|FG005|Overall Study|Never treated|1|||
161605669|NCT02502266|583609934|FG006|Overall Study|Never treated|0|||
161605670|NCT03983382|583609937|FG000|Overall Study|Death|1|||
161605671|NCT03983382|583609937|FG000|Overall Study|Lost to Follow-up|3|||
161605672|NCT03983382|583609937|FG000|Overall Study|Physician Decision|2|||
161605673|NCT03983382|583609937|FG000|Overall Study|Withdrawal by Subject|10|||
161605674|NCT03983382|583609937|FG000|Overall Study|Change in cancer treatment|2|||
161605675|NCT02567435|583609944|FG000|Overall Study|Death|1|||
161605676|NCT02567435|583609945|FG001|Overall Study|Death|1|||
161605677|NCT02567435|583609946|FG002|Overall Study|Death|0|||
161605678|NCT02567435|583609947|FG003|Overall Study|Death|0|||
161605679|NCT02567435|583609944|FG000|Overall Study|Ineligible|1|||
161605680|NCT02567435|583609945|FG001|Overall Study|Ineligible|3|||
161605681|NCT02567435|583609946|FG002|Overall Study|Ineligible|0|||
161605682|NCT02567435|583609947|FG003|Overall Study|Ineligible|0|||
161605683|NCT02567435|583609944|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
161605684|NCT02567435|583609945|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
161605685|NCT02567435|583609946|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
161605686|NCT02567435|583609947|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
161605687|NCT02166463|583609948|FG000|Overall Study|Lost to Follow-up|0|||
161605688|NCT02166463|583609949|FG001|Overall Study|Lost to Follow-up|1|||
161605689|NCT02166463|583609948|FG000|Overall Study|Physician Decision|10|||
161605690|NCT02166463|583609949|FG001|Overall Study|Physician Decision|10|||
161605691|NCT02166463|583609948|FG000|Overall Study|Ineligible|11|||
161605692|NCT02166463|583609949|FG001|Overall Study|Ineligible|2|||
161605693|NCT02166463|583609948|FG000|Overall Study|Progressive Disease|9|||
161605694|NCT02166463|583609949|FG001|Overall Study|Progressive Disease|6|||
161605695|NCT02166463|583609948|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
161605696|NCT02166463|583609949|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
161605697|NCT02166463|583609948|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
161605698|NCT02166463|583609949|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
161605699|NCT02166463|583609948|FG000|Overall Study|Refusal of further protocol therapy|5|||
161605700|NCT02166463|583609949|FG001|Overall Study|Refusal of further protocol therapy|6|||
161605701|NCT00982644|583609952|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
161605702|NCT00982644|583609953|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
161605703|NCT00982644|583609952|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
161605704|NCT00982644|583609953|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
161605705|NCT00982644|583609952|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
161605706|NCT00982644|583609953|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
161605707|NCT00982644|583609952|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
161605708|NCT00982644|583609953|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
161605709|NCT00982644|583609952|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
161605710|NCT00982644|583609953|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
161605711|NCT00982644|583609952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
161605712|NCT00982644|583609953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
161605713|NCT00982644|583609952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
161605714|NCT00982644|583609953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
161605715|NCT00982644|583609952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
161605716|NCT00982644|583609953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
161605717|NCT00982644|583609952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
161605718|NCT00982644|583609953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
161605719|NCT00982644|583609952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
161605720|NCT00982644|583609953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
161605721|NCT05030584|583609956|FG000|Overall Study|Adverse Event|17|||
161605722|NCT05030584|583609957|FG001|Overall Study|Adverse Event|2|||
161605723|NCT05030584|583609956|FG000|Overall Study|Lack of Efficacy|0|||
161605724|NCT05030584|583609957|FG001|Overall Study|Lack of Efficacy|6|||
161605725|NCT05030584|583609956|FG000|Overall Study|Lost to Follow-up|5|||
161605726|NCT05030584|583609957|FG001|Overall Study|Lost to Follow-up|2|||
161605727|NCT05030584|583609956|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161605728|NCT05030584|583609957|FG001|Overall Study|Non-Compliance with Study Drug|3|||
161605729|NCT05030584|583609956|FG000|Overall Study|Other reason|4|||
161605730|NCT05030584|583609957|FG001|Overall Study|Other reason|3|||
161605731|NCT05030584|583609956|FG000|Overall Study|Physician Decision|1|||
161605732|NCT05030584|583609957|FG001|Overall Study|Physician Decision|4|||
161605733|NCT05030584|583609956|FG000|Overall Study|Protocol Violation|0|||
161605734|NCT05030584|583609957|FG001|Overall Study|Protocol Violation|2|||
161605735|NCT05030584|583609956|FG000|Overall Study|Randomized by Mistake|0|||
161605736|NCT05030584|583609957|FG001|Overall Study|Randomized by Mistake|2|||
161605737|NCT05030584|583609956|FG000|Overall Study|Withdrawal by Subject|21|||
161605738|NCT05030584|583609957|FG001|Overall Study|Withdrawal by Subject|28|||
161605739|NCT05030584|583609956|FG000|Overall Study|Technical Problems|0|||
161605740|NCT05030584|583609957|FG001|Overall Study|Technical Problems|1|||
161605741|NCT05030584|583609956|FG000|Overall Study|Completed post-treatment/FU visits|41|||
161605742|NCT05030584|583609957|FG001|Overall Study|Completed post-treatment/FU visits|31|||
161605743|NCT03767335|583609962|FG000|Overall Study|Physician Decision|1|||
161605744|NCT03767335|583609963|FG001|Overall Study|Physician Decision|1|||
161605745|NCT03767335|583609964|FG002|Overall Study|Physician Decision|0|||
161605746|NCT03767335|583609962|FG000|Overall Study|Withdrawal by Subject|0|||
161605747|NCT03767335|583609963|FG001|Overall Study|Withdrawal by Subject|0|||
161605748|NCT03767335|583609964|FG002|Overall Study|Withdrawal by Subject|6|||
161605749|NCT03767335|583609962|FG000|Overall Study|Participant excluded from efficacy population|0|||
161605750|NCT03767335|583609963|FG001|Overall Study|Participant excluded from efficacy population|0|||
161605751|NCT03767335|583609964|FG002|Overall Study|Participant excluded from efficacy population|1|||
161605752|NCT03767335|583609962|FG000|Overall Study|Death|0|||
161605753|NCT03767335|583609963|FG001|Overall Study|Death|0|||
161605754|NCT03767335|583609964|FG002|Overall Study|Death|2|||
161605755|NCT03767335|583609962|FG000|Overall Study|Progressive Disease|2|||
161605756|NCT03767335|583609963|FG001|Overall Study|Progressive Disease|2|||
161605757|NCT03767335|583609964|FG002|Overall Study|Progressive Disease|2|||
161605758|NCT03767335|583609962|FG000|Overall Study|Disease progression needing additional medication|0|||
161605759|NCT03767335|583609963|FG001|Overall Study|Disease progression needing additional medication|0|||
161605760|NCT03767335|583609964|FG002|Overall Study|Disease progression needing additional medication|17|||
161605761|NCT03767335|583609962|FG000|Overall Study|Sponsor decision|0|||
161605762|NCT03767335|583609963|FG001|Overall Study|Sponsor decision|0|||
161605763|NCT03767335|583609964|FG002|Overall Study|Sponsor decision|2|||
161605764|NCT03767335|583609962|FG000|Overall Study|Other Medical Reasons|0|||
161605765|NCT03767335|583609963|FG001|Overall Study|Other Medical Reasons|0|||
161605766|NCT03767335|583609964|FG002|Overall Study|Other Medical Reasons|3|||
161605767|NCT03705390|583609965|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
161605768|NCT03705390|583609965|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
161605769|NCT03047213|583609966|FG000|Overall Study|Withdrawal by Subject|2|||
161605770|NCT03047213|583609967|FG001|Overall Study|Withdrawal by Subject|0|||
161605771|NCT03047213|583609966|FG000|Overall Study|Adverse Event|2|||
161683578|NCT00530894|583894613|FG001|Overall Study|Lost to Follow-up|3|||
161683579|NCT00530894|583894614|FG002|Overall Study|Lost to Follow-up|0|||
161605772|NCT03047213|583609967|FG001|Overall Study|Adverse Event|0|||
161605773|NCT02989662|583609973|FG000|Overall Study|Lost to Follow-up|0|||
161605774|NCT02989662|583609974|FG001|Overall Study|Lost to Follow-up|0|||
161605775|NCT02989662|583609975|FG002|Overall Study|Lost to Follow-up|0|||
161605776|NCT02989662|583609976|FG003|Overall Study|Lost to Follow-up|2|||
161683580|NCT00530894|583894615|FG003|Overall Study|Lost to Follow-up|0|||
161832336|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
161605777|NCT02989662|583609973|FG000|Overall Study|Physician Decision|3|||
161605778|NCT02989662|583609974|FG001|Overall Study|Physician Decision|0|||
161605779|NCT02989662|583609975|FG002|Overall Study|Physician Decision|0|||
161605780|NCT02989662|583609976|FG003|Overall Study|Physician Decision|0|||
161605781|NCT02989662|583609973|FG000|Overall Study|Withdrawal by Subject|1|||
161605782|NCT02989662|583609974|FG001|Overall Study|Withdrawal by Subject|0|||
161605783|NCT02989662|583609975|FG002|Overall Study|Withdrawal by Subject|0|||
161683581|NCT00530894|583894612|FG000|Overall Study|Withdrawal by Subject|1|||
161605784|NCT02989662|583609976|FG003|Overall Study|Withdrawal by Subject|0|||
161605785|NCT06393127|583609977|FG000|Washout period|Withdrawal by Subject|1|||
161605786|NCT06393127|583609978|FG001|Washout period|Withdrawal by Subject|0|||
161605787|NCT06393127|583609977|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
161605788|NCT06393127|583609978|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
161605789|NCT02446600|583609979|FG000|Overall Study|Never treated|20|||
161605790|NCT02446600|583609980|FG001|Overall Study|Never treated|2|||
161605791|NCT02446600|583609981|FG002|Overall Study|Never treated|6|||
161605792|NCT02446600|583609982|FG003|Overall Study|Never treated|0|||
161605793|NCT02446600|583609979|FG000|Overall Study|Withdrawal by Subject|19|||
161605794|NCT02446600|583609980|FG001|Overall Study|Withdrawal by Subject|5|||
161605795|NCT02446600|583609981|FG002|Overall Study|Withdrawal by Subject|17|||
161605796|NCT02446600|583609982|FG003|Overall Study|Withdrawal by Subject|0|||
161605797|NCT02446600|583609979|FG000|Overall Study|Ineligible|1|||
161605798|NCT02446600|583609980|FG001|Overall Study|Ineligible|4|||
161605799|NCT02446600|583609981|FG002|Overall Study|Ineligible|4|||
161605800|NCT02446600|583609982|FG003|Overall Study|Ineligible|1|||
161605801|NCT02446600|583609979|FG000|Overall Study|Duplicate Enrollment|0|||
161605802|NCT02446600|583609980|FG001|Overall Study|Duplicate Enrollment|1|||
161605803|NCT02446600|583609981|FG002|Overall Study|Duplicate Enrollment|0|||
161605804|NCT02446600|583609982|FG003|Overall Study|Duplicate Enrollment|0|||
161605805|NCT00328783|583609983|FG000|Overall Study|Could not tolerate ABC|21|||
161605806|NCT00328783|583609983|FG000|Overall Study|No heart in RT field|4|||
161605807|NCT00328783|583609983|FG000|Overall Study|Withdrawal by Subject|1|||
161605808|NCT03660930|583609984|FG000|Overall Study|Adverse Event|0|||
161605809|NCT03660930|583609985|FG001|Overall Study|Adverse Event|0|||
161605810|NCT03660930|583609986|FG002|Overall Study|Adverse Event|0|||
161605811|NCT03660930|583609987|FG003|Overall Study|Adverse Event|2|||
161605812|NCT03660930|583609988|FG004|Overall Study|Adverse Event|0|||
161605813|NCT03660930|583609989|FG005|Overall Study|Adverse Event|1|||
161605814|NCT03660930|583609990|FG006|Overall Study|Adverse Event|0|||
161605815|NCT03660930|583609991|FG007|Overall Study|Adverse Event|0|||
161605816|NCT03660930|583609984|FG000|Overall Study|Withdrawal by Subject|0|||
161605817|NCT03660930|583609985|FG001|Overall Study|Withdrawal by Subject|0|||
161605818|NCT03660930|583609986|FG002|Overall Study|Withdrawal by Subject|0|||
161605819|NCT03660930|583609987|FG003|Overall Study|Withdrawal by Subject|0|||
161605820|NCT03660930|583609988|FG004|Overall Study|Withdrawal by Subject|0|||
161605821|NCT03660930|583609989|FG005|Overall Study|Withdrawal by Subject|1|||
161605822|NCT03660930|583609990|FG006|Overall Study|Withdrawal by Subject|0|||
161605823|NCT03660930|583609991|FG007|Overall Study|Withdrawal by Subject|0|||
161605824|NCT03725332|583609992|FG000|Overall Study|Adverse Event|5|||
161605825|NCT03725332|583609993|FG001|Overall Study|Adverse Event|10|||
161605826|NCT03725332|583609992|FG000|Overall Study|Death|1|||
161605827|NCT03725332|583609993|FG001|Overall Study|Death|3|||
161605828|NCT03725332|583609992|FG000|Overall Study|Lost to Follow-up|43|||
161605829|NCT03725332|583609993|FG001|Overall Study|Lost to Follow-up|122|||
161605830|NCT03725332|583609992|FG000|Overall Study|Withdrawal by Subject|0|||
161605831|NCT03725332|583609993|FG001|Overall Study|Withdrawal by Subject|1|||
161605832|NCT03725332|583609992|FG000|Overall Study|Duplicate enrollment|0|||
161605833|NCT03725332|583609993|FG001|Overall Study|Duplicate enrollment|1|||
161605834|NCT03725332|583609992|FG000|Overall Study|Did not consent|0|||
161605835|NCT03725332|583609993|FG001|Overall Study|Did not consent|1|||
161605836|NCT03242915|583610000|FG000|Overall Study|Adverse Event|5|||
161605837|NCT03242915|583610001|FG001|Overall Study|Adverse Event|1|||
161605838|NCT03242915|583610000|FG000|Overall Study|Withdrawal by Subject|0|||
161605839|NCT03242915|583610001|FG001|Overall Study|Withdrawal by Subject|2|||
161605840|NCT03242915|583610000|FG000|Overall Study|Physician Decision|4|||
161605841|NCT03242915|583610001|FG001|Overall Study|Physician Decision|1|||
161605842|NCT02726386|583610002|FG000|Overall Study|Adverse Event|17|||
161605843|NCT02726386|583610003|FG001|Overall Study|Adverse Event|20|||
161605844|NCT02726386|583610002|FG000|Overall Study|Withdrawal by Subject|14|||
161605845|NCT02726386|583610003|FG001|Overall Study|Withdrawal by Subject|28|||
161605846|NCT02726386|583610002|FG000|Overall Study|Other reasons|7|||
161605847|NCT02726386|583610003|FG001|Overall Study|Other reasons|8|||
161605848|NCT03140670|583610537|FG000|Overall Study|Withdrawal by Subject|2|||
161605849|NCT03140670|583610537|FG000|Overall Study|Lost to Follow-up|1|||
161605850|NCT03140670|583610537|FG000|Overall Study|Physician Decision|1|||
161605851|NCT03699163|583610538|FG000|Overall Study|Physician Decision|12|||
161605852|NCT03699163|583610539|FG001|Overall Study|Physician Decision|0|||
161605853|NCT03699163|583610538|FG000|Overall Study|failed QC measures|205|||
161605854|NCT03699163|583610539|FG001|Overall Study|failed QC measures|206|||
161605855|NCT00557492|583610542|FG000|Overall Study|Change in health insurance|1|||
161605856|NCT01260896|583610554|FG000|First Intervention|Withdrawn Due to Emesis|2|||
161605857|NCT01260896|583610555|FG001|First Intervention|Withdrawn Due to Emesis|0|||
161605858|NCT02754596|583610561|FG000|Overall Study|Withdrawal by Subject|3|||
161605859|NCT02754596|583610562|FG001|Overall Study|Withdrawal by Subject|4|||
161605860|NCT02754596|583610563|FG002|Overall Study|Withdrawal by Subject|0|||
161605861|NCT02754596|583610561|FG000|Overall Study|Physician Decision|1|||
161605862|NCT02754596|583610562|FG001|Overall Study|Physician Decision|1|||
161605863|NCT02754596|583610563|FG002|Overall Study|Physician Decision|1|||
161605864|NCT02754596|583610561|FG000|Overall Study|Lost to Follow-up|1|||
161605865|NCT02754596|583610562|FG001|Overall Study|Lost to Follow-up|1|||
161605866|NCT02754596|583610563|FG002|Overall Study|Lost to Follow-up|2|||
161605867|NCT02754596|583610561|FG000|Overall Study|Death|0|||
161605868|NCT02754596|583610562|FG001|Overall Study|Death|2|||
161605869|NCT02754596|583610563|FG002|Overall Study|Death|0|||
161605870|NCT02754596|583610561|FG000|Overall Study|Adverse Event|1|||
161605871|NCT02754596|583610562|FG001|Overall Study|Adverse Event|0|||
161605872|NCT02754596|583610563|FG002|Overall Study|Adverse Event|1|||
161605873|NCT02754596|583610561|FG000|Overall Study|Other|1|||
161605874|NCT02754596|583610562|FG001|Overall Study|Other|0|||
161605875|NCT02754596|583610563|FG002|Overall Study|Other|0|||
161605876|NCT02101853|583610566|FG000|Block 1 Induction|Adverse Event|11|||
161605877|NCT02101853|583610567|FG001|Block 1 Induction|Adverse Event|0|||
161605878|NCT02101853|583610568|FG002|Block 1 Induction|Adverse Event|0|||
161605879|NCT02101853|583610569|FG003|Block 1 Induction|Adverse Event|0|||
161605880|NCT02101853|583610570|FG004|Block 1 Induction|Adverse Event|0|||
161605881|NCT02101853|583610571|FG005|Block 1 Induction|Adverse Event|0|||
161605882|NCT02101853|583610566|FG000|Block 1 Induction|Death|20|||
161605883|NCT02101853|583610567|FG001|Block 1 Induction|Death|0|||
161605884|NCT02101853|583610568|FG002|Block 1 Induction|Death|0|||
161605885|NCT02101853|583610569|FG003|Block 1 Induction|Death|0|||
161605886|NCT02101853|583610570|FG004|Block 1 Induction|Death|0|||
161605887|NCT02101853|583610571|FG005|Block 1 Induction|Death|0|||
161605888|NCT02101853|583610566|FG000|Block 1 Induction|Lack of Efficacy|6|||
161605889|NCT02101853|583610567|FG001|Block 1 Induction|Lack of Efficacy|0|||
161605890|NCT02101853|583610568|FG002|Block 1 Induction|Lack of Efficacy|0|||
161605891|NCT02101853|583610569|FG003|Block 1 Induction|Lack of Efficacy|0|||
161605892|NCT02101853|583610570|FG004|Block 1 Induction|Lack of Efficacy|0|||
161605893|NCT02101853|583610571|FG005|Block 1 Induction|Lack of Efficacy|0|||
161605894|NCT02101853|583610566|FG000|Block 1 Induction|Physician Decision|61|||
161605895|NCT02101853|583610567|FG001|Block 1 Induction|Physician Decision|0|||
161605896|NCT02101853|583610568|FG002|Block 1 Induction|Physician Decision|0|||
161605897|NCT02101853|583610569|FG003|Block 1 Induction|Physician Decision|0|||
161605898|NCT02101853|583610570|FG004|Block 1 Induction|Physician Decision|0|||
161605899|NCT02101853|583610571|FG005|Block 1 Induction|Physician Decision|0|||
161605900|NCT02101853|583610566|FG000|Block 1 Induction|Protocol Violation|2|||
161605901|NCT02101853|583610567|FG001|Block 1 Induction|Protocol Violation|0|||
161605902|NCT02101853|583610568|FG002|Block 1 Induction|Protocol Violation|0|||
161605903|NCT02101853|583610569|FG003|Block 1 Induction|Protocol Violation|0|||
161605904|NCT02101853|583610570|FG004|Block 1 Induction|Protocol Violation|0|||
161605905|NCT02101853|583610571|FG005|Block 1 Induction|Protocol Violation|0|||
161605906|NCT02101853|583610566|FG000|Block 1 Induction|Withdrawal by Subject|65|||
161605907|NCT02101853|583610567|FG001|Block 1 Induction|Withdrawal by Subject|0|||
161605908|NCT02101853|583610568|FG002|Block 1 Induction|Withdrawal by Subject|0|||
161605909|NCT02101853|583610569|FG003|Block 1 Induction|Withdrawal by Subject|0|||
161605910|NCT02101853|583610570|FG004|Block 1 Induction|Withdrawal by Subject|0|||
161605911|NCT02101853|583610571|FG005|Block 1 Induction|Withdrawal by Subject|0|||
161605912|NCT02101853|583610566|FG000|Block 1 Induction|Ineligible|8|||
161605913|NCT02101853|583610567|FG001|Block 1 Induction|Ineligible|0|||
161605914|NCT02101853|583610568|FG002|Block 1 Induction|Ineligible|0|||
161605915|NCT02101853|583610569|FG003|Block 1 Induction|Ineligible|0|||
161605916|NCT02101853|583610570|FG004|Block 1 Induction|Ineligible|0|||
161605917|NCT02101853|583610571|FG005|Block 1 Induction|Ineligible|0|||
161605918|NCT02101853|583610566|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
161605919|NCT02101853|583610567|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161605920|NCT02101853|583610568|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161605921|NCT02101853|583610569|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161605922|NCT02101853|583610570|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161605923|NCT02101853|583610571|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161605924|NCT02101853|583610566|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
161605925|NCT02101853|583610567|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605926|NCT02101853|583610568|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605927|NCT02101853|583610569|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605928|NCT02101853|583610570|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605929|NCT02101853|583610571|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605930|NCT02101853|583610566|FG000|Post Induction Randomization|Adverse Event|0|||
161605931|NCT02101853|583610567|FG001|Post Induction Randomization|Adverse Event|3|||
161605932|NCT02101853|583610568|FG002|Post Induction Randomization|Adverse Event|8|||
161605933|NCT02101853|583610569|FG003|Post Induction Randomization|Adverse Event|4|||
161605934|NCT02101853|583610570|FG004|Post Induction Randomization|Adverse Event|4|||
161605935|NCT02101853|583610571|FG005|Post Induction Randomization|Adverse Event|0|||
161605936|NCT02101853|583610566|FG000|Post Induction Randomization|Death|0|||
161605937|NCT02101853|583610567|FG001|Post Induction Randomization|Death|9|||
161605938|NCT02101853|583610568|FG002|Post Induction Randomization|Death|2|||
161605939|NCT02101853|583610569|FG003|Post Induction Randomization|Death|2|||
161605940|NCT02101853|583610570|FG004|Post Induction Randomization|Death|0|||
161605941|NCT02101853|583610571|FG005|Post Induction Randomization|Death|0|||
161605942|NCT02101853|583610566|FG000|Post Induction Randomization|Lack of Efficacy|0|||
161605943|NCT02101853|583610567|FG001|Post Induction Randomization|Lack of Efficacy|14|||
161605944|NCT02101853|583610568|FG002|Post Induction Randomization|Lack of Efficacy|23|||
161605945|NCT02101853|583610569|FG003|Post Induction Randomization|Lack of Efficacy|18|||
161605946|NCT02101853|583610570|FG004|Post Induction Randomization|Lack of Efficacy|21|||
161605947|NCT02101853|583610571|FG005|Post Induction Randomization|Lack of Efficacy|0|||
161605948|NCT02101853|583610566|FG000|Post Induction Randomization|Physician Decision|0|||
161605949|NCT02101853|583610567|FG001|Post Induction Randomization|Physician Decision|43|||
161605950|NCT02101853|583610568|FG002|Post Induction Randomization|Physician Decision|23|||
161605951|NCT02101853|583610569|FG003|Post Induction Randomization|Physician Decision|14|||
161605952|NCT02101853|583610570|FG004|Post Induction Randomization|Physician Decision|14|||
161605953|NCT02101853|583610571|FG005|Post Induction Randomization|Physician Decision|0|||
161605954|NCT02101853|583610566|FG000|Post Induction Randomization|Protocol Violation|0|||
161605955|NCT02101853|583610567|FG001|Post Induction Randomization|Protocol Violation|3|||
161605956|NCT02101853|583610568|FG002|Post Induction Randomization|Protocol Violation|0|||
161605957|NCT02101853|583610569|FG003|Post Induction Randomization|Protocol Violation|0|||
161605958|NCT02101853|583610570|FG004|Post Induction Randomization|Protocol Violation|0|||
161605959|NCT02101853|583610571|FG005|Post Induction Randomization|Protocol Violation|0|||
161605960|NCT02101853|583610566|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
161605961|NCT02101853|583610567|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
161605962|NCT02101853|583610568|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
161605963|NCT02101853|583610569|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
161605964|NCT02101853|583610570|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
161605965|NCT02101853|583610571|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
161605966|NCT02101853|583610566|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605967|NCT02101853|583610567|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605968|NCT02101853|583610568|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605969|NCT02101853|583610569|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
161605970|NCT02101853|583610570|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605971|NCT02101853|583610571|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161605972|NCT02101853|583610566|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161605973|NCT02101853|583610567|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
161605974|NCT02101853|583610568|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
161605975|NCT02101853|583610569|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161605976|NCT02101853|583610570|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161605977|NCT02101853|583610571|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161605978|NCT02101853|583610566|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161605979|NCT02101853|583610567|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
161605980|NCT02101853|583610568|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161605981|NCT02101853|583610569|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161605982|NCT02101853|583610570|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161605983|NCT02101853|583610571|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161605984|NCT02101853|583610566|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161605985|NCT02101853|583610567|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161605986|NCT02101853|583610568|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161605987|NCT02101853|583610569|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
161605988|NCT02101853|583610570|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
161605989|NCT02101853|583610571|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161605990|NCT02101853|583610566|FG000|Blinatumomab Salvage Therapy|Death|0|||
161605991|NCT02101853|583610567|FG001|Blinatumomab Salvage Therapy|Death|0|||
161605992|NCT02101853|583610568|FG002|Blinatumomab Salvage Therapy|Death|0|||
161605993|NCT02101853|583610569|FG003|Blinatumomab Salvage Therapy|Death|0|||
161605994|NCT02101853|583610570|FG004|Blinatumomab Salvage Therapy|Death|0|||
161605995|NCT02101853|583610571|FG005|Blinatumomab Salvage Therapy|Death|2|||
161605996|NCT02101853|583610566|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161605997|NCT02101853|583610567|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161605998|NCT02101853|583610568|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161605999|NCT02101853|583610569|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161606000|NCT02101853|583610570|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161606001|NCT02101853|583610571|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
161606002|NCT02101853|583610566|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
161606003|NCT02101853|583610567|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
161606004|NCT02101853|583610568|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
161606005|NCT02101853|583610569|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
161606006|NCT02101853|583610570|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
161606007|NCT02101853|583610571|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
161606008|NCT02101853|583610566|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161606009|NCT02101853|583610567|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161606010|NCT02101853|583610568|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161606011|NCT02101853|583610569|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161606012|NCT02101853|583610570|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161606013|NCT02101853|583610571|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
161606014|NCT02112916|583610575|FG000|Overall Study|Adverse Event|6|||
161606015|NCT02112916|583610576|FG001|Overall Study|Adverse Event|9|||
161606016|NCT02112916|583610577|FG002|Overall Study|Adverse Event|3|||
161606017|NCT02112916|583610578|FG003|Overall Study|Adverse Event|2|||
161606018|NCT02112916|583610575|FG000|Overall Study|Death|9|||
161606019|NCT02112916|583610576|FG001|Overall Study|Death|9|||
161606020|NCT02112916|583610577|FG002|Overall Study|Death|3|||
161606021|NCT02112916|583610578|FG003|Overall Study|Death|4|||
161606022|NCT02112916|583610575|FG000|Overall Study|Lost to Follow-up|1|||
161606023|NCT02112916|583610576|FG001|Overall Study|Lost to Follow-up|0|||
161606024|NCT02112916|583610577|FG002|Overall Study|Lost to Follow-up|0|||
161606025|NCT02112916|583610578|FG003|Overall Study|Lost to Follow-up|0|||
161606026|NCT02112916|583610575|FG000|Overall Study|Physician Decision|94|||
161606027|NCT02112916|583610576|FG001|Overall Study|Physician Decision|72|||
161606028|NCT02112916|583610577|FG002|Overall Study|Physician Decision|24|||
161606029|NCT02112916|583610578|FG003|Overall Study|Physician Decision|15|||
161606030|NCT02112916|583610575|FG000|Overall Study|Withdrawal by Subject|5|||
161606031|NCT02112916|583610576|FG001|Overall Study|Withdrawal by Subject|3|||
161606032|NCT02112916|583610577|FG002|Overall Study|Withdrawal by Subject|1|||
161606033|NCT02112916|583610578|FG003|Overall Study|Withdrawal by Subject|1|||
161606034|NCT02112916|583610575|FG000|Overall Study|Ineligible|4|||
161606035|NCT02112916|583610576|FG001|Overall Study|Ineligible|8|||
161606036|NCT02112916|583610577|FG002|Overall Study|Ineligible|3|||
161606037|NCT02112916|583610578|FG003|Overall Study|Ineligible|8|||
161606038|NCT02112916|583610575|FG000|Overall Study|Inevaluable|6|||
161606039|NCT02112916|583610576|FG001|Overall Study|Inevaluable|4|||
161606040|NCT02112916|583610577|FG002|Overall Study|Inevaluable|5|||
161606041|NCT02112916|583610578|FG003|Overall Study|Inevaluable|5|||
161606042|NCT02112916|583610575|FG000|Overall Study|Refusal of further protocol therapy|19|||
161606043|NCT02112916|583610576|FG001|Overall Study|Refusal of further protocol therapy|16|||
161606044|NCT02112916|583610577|FG002|Overall Study|Refusal of further protocol therapy|1|||
161606045|NCT02112916|583610578|FG003|Overall Study|Refusal of further protocol therapy|7|||
161606046|NCT02112916|583610575|FG000|Overall Study|Development of SMN|1|||
161606047|NCT02112916|583610576|FG001|Overall Study|Development of SMN|0|||
161606048|NCT02112916|583610577|FG002|Overall Study|Development of SMN|0|||
161606049|NCT02112916|583610578|FG003|Overall Study|Development of SMN|1|||
161606050|NCT02112916|583610575|FG000|Overall Study|Relapse/Progression|10|||
161606051|NCT02112916|583610576|FG001|Overall Study|Relapse/Progression|18|||
161606052|NCT02112916|583610577|FG002|Overall Study|Relapse/Progression|15|||
161606053|NCT02112916|583610578|FG003|Overall Study|Relapse/Progression|2|||
161606054|NCT02112916|583610575|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
161606055|NCT02112916|583610576|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
161606056|NCT02112916|583610577|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
161606057|NCT02112916|583610578|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
161606058|NCT02112916|583610575|FG000|Overall Study|Still on Therapy|44|||
161606059|NCT02112916|583610576|FG001|Overall Study|Still on Therapy|47|||
161606060|NCT02112916|583610577|FG002|Overall Study|Still on Therapy|3|||
161606061|NCT02112916|583610578|FG003|Overall Study|Still on Therapy|2|||
161606062|NCT02112916|583610575|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
161606063|NCT02112916|583610576|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
161606064|NCT02112916|583610577|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
161606065|NCT02112916|583610578|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
161606066|NCT02112916|583610575|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
161606067|NCT02112916|583610576|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
161606068|NCT02112916|583610577|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
161606069|NCT02112916|583610578|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
161606070|NCT03333915|583610580|FG000|Overall Study|Lost to Follow-up|0|||
161606071|NCT03333915|583610581|FG001|Overall Study|Lost to Follow-up|0|||
161606072|NCT03333915|583610582|FG002|Overall Study|Lost to Follow-up|1|||
161606073|NCT03333915|583610583|FG003|Overall Study|Lost to Follow-up|0|||
161606074|NCT03333915|583610584|FG004|Overall Study|Lost to Follow-up|0|||
161606075|NCT03333915|583610580|FG000|Overall Study|Disease Progression|0|||
161606076|NCT03333915|583610581|FG001|Overall Study|Disease Progression|1|||
161606077|NCT03333915|583610582|FG002|Overall Study|Disease Progression|0|||
161606078|NCT03333915|583610583|FG003|Overall Study|Disease Progression|0|||
161606079|NCT03333915|583610584|FG004|Overall Study|Disease Progression|0|||
161606080|NCT03333915|583610580|FG000|Overall Study|Death|0|||
161606081|NCT03333915|583610581|FG001|Overall Study|Death|0|||
161606082|NCT03333915|583610582|FG002|Overall Study|Death|0|||
161606083|NCT03333915|583610583|FG003|Overall Study|Death|37|||
161606084|NCT03333915|583610584|FG004|Overall Study|Death|18|||
161606085|NCT03333915|583610580|FG000|Overall Study|Sponsor's Decision|0|||
161606086|NCT03333915|583610581|FG001|Overall Study|Sponsor's Decision|0|||
161606087|NCT03333915|583610582|FG002|Overall Study|Sponsor's Decision|0|||
161606088|NCT03333915|583610583|FG003|Overall Study|Sponsor's Decision|48|||
161606089|NCT03333915|583610584|FG004|Overall Study|Sponsor's Decision|4|||
161606090|NCT03333915|583610580|FG000|Overall Study|Withdrawal by Subject|0|||
161606091|NCT03333915|583610581|FG001|Overall Study|Withdrawal by Subject|0|||
161606092|NCT03333915|583610582|FG002|Overall Study|Withdrawal by Subject|0|||
161606093|NCT03333915|583610583|FG003|Overall Study|Withdrawal by Subject|5|||
161606094|NCT03333915|583610584|FG004|Overall Study|Withdrawal by Subject|1|||
161606095|NCT02206828|583610598|FG000|Overall Study|Lost to Follow-up|7|||
161606096|NCT05039021|583611261|FG000|Overall Study|Death|1|||
161606097|NCT05039021|583611261|FG000|Overall Study|Lost to Follow-up|3|||
161606098|NCT00994643|583611262|FG000|Overall Study|Withdrawal by Subject|1|||
161606099|NCT02566889|583611263|FG000|Overall Study|Withdrawal by Subject|3|||
161606100|NCT02566889|583611264|FG001|Overall Study|Withdrawal by Subject|1|||
161606101|NCT02566889|583611263|FG000|Overall Study|Adverse Event|4|||
161606102|NCT02566889|583611264|FG001|Overall Study|Adverse Event|2|||
161606103|NCT02566889|583611263|FG000|Overall Study|Other|6|||
161606104|NCT02566889|583611264|FG001|Overall Study|Other|2|||
161606105|NCT03391466|583611266|FG000|Overall Study|Death|84|||
161606106|NCT03391466|583611267|FG001|Overall Study|Death|91|||
161606107|NCT03391466|583611266|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
161606108|NCT03391466|583611267|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
161606109|NCT03391466|583611266|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
161606110|NCT03391466|583611267|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
161606111|NCT03391466|583611266|FG000|Overall Study|Lost to Follow-up|9|||
161606112|NCT03391466|583611267|FG001|Overall Study|Lost to Follow-up|5|||
161606113|NCT03391466|583611266|FG000|Overall Study|Reason Not Specified|2|||
161606114|NCT03391466|583611267|FG001|Overall Study|Reason Not Specified|2|||
161606115|NCT03391466|583611266|FG000|Overall Study|Investigator Decision|0|||
161606116|NCT03391466|583611267|FG001|Overall Study|Investigator Decision|1|||
161606117|NCT00220805|583611268|FG000|Overall Study|Adverse Event|1|||
161606118|NCT00220805|583611269|FG001|Overall Study|Adverse Event|3|||
161606119|NCT00220805|583611268|FG000|Overall Study|Withdrawal by Subject|3|||
161606120|NCT00220805|583611269|FG001|Overall Study|Withdrawal by Subject|0|||
161606121|NCT00220805|583611268|FG000|Overall Study|Lack of Efficacy|1|||
161606122|NCT00220805|583611269|FG001|Overall Study|Lack of Efficacy|0|||
161606123|NCT00220805|583611268|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
161606124|NCT00220805|583611269|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
161606125|NCT02325466|583611270|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
161606126|NCT02325466|583611271|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
161606127|NCT02325466|583611272|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
161606128|NCT02325466|583611270|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
161606129|NCT02325466|583611271|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
161606130|NCT02325466|583611272|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
161606131|NCT02325466|583611270|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
161606132|NCT02325466|583611271|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
161606133|NCT02325466|583611272|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
161606134|NCT02325466|583611270|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
161606135|NCT02325466|583611271|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
161683582|NCT00530894|583894613|FG001|Overall Study|Withdrawal by Subject|23|||
161683583|NCT00530894|583894614|FG002|Overall Study|Withdrawal by Subject|0|||
161606136|NCT02325466|583611272|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
161606137|NCT02325466|583611270|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
161606138|NCT02325466|583611271|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
161606139|NCT02325466|583611272|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
161606140|NCT02325466|583611270|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
161606141|NCT02325466|583611271|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
161606142|NCT02325466|583611272|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
161606143|NCT02325466|583611270|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
161606144|NCT02325466|583611271|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
161606145|NCT02325466|583611272|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
161606146|NCT02325466|583611270|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
161606147|NCT02325466|583611271|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
161606148|NCT02325466|583611272|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
161606149|NCT02325466|583611270|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
161606150|NCT02325466|583611271|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
161606151|NCT02325466|583611272|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
161606152|NCT04121546|583611293|FG000|Overall Study|Lost to Follow-up|1|||
161606153|NCT04121546|583611294|FG001|Overall Study|Lost to Follow-up|3|||
161606154|NCT04129164|583611295|FG000|Overall Study|Non-compliance with procedures|0|||
161606155|NCT04129164|583611296|FG001|Overall Study|Non-compliance with procedures|0|||
161606156|NCT04129164|583611297|FG002|Overall Study|Non-compliance with procedures|2|||
161606157|NCT04129164|583611298|FG003|Overall Study|Non-compliance with procedures|0|||
161606158|NCT04129164|583611295|FG000|Overall Study|Adverse Event|0|||
161606159|NCT04129164|583611296|FG001|Overall Study|Adverse Event|0|||
161606160|NCT04129164|583611297|FG002|Overall Study|Adverse Event|2|||
161606161|NCT04129164|583611298|FG003|Overall Study|Adverse Event|0|||
161606162|NCT04129164|583611295|FG000|Overall Study|Pregnancy|0|||
161606163|NCT04129164|583611296|FG001|Overall Study|Pregnancy|0|||
161606164|NCT04129164|583611297|FG002|Overall Study|Pregnancy|0|||
161606165|NCT04129164|583611298|FG003|Overall Study|Pregnancy|1|||
161606166|NCT04129164|583611295|FG000|Overall Study|Withdrawal by Subject|3|||
161606167|NCT04129164|583611296|FG001|Overall Study|Withdrawal by Subject|2|||
161606168|NCT04129164|583611297|FG002|Overall Study|Withdrawal by Subject|4|||
161606169|NCT04129164|583611298|FG003|Overall Study|Withdrawal by Subject|6|||
161606170|NCT04129164|583611295|FG000|Overall Study|Death|0|||
161606171|NCT04129164|583611296|FG001|Overall Study|Death|1|||
161606172|NCT04129164|583611297|FG002|Overall Study|Death|0|||
161606173|NCT04129164|583611298|FG003|Overall Study|Death|0|||
161606174|NCT04129164|583611295|FG000|Overall Study|Lost to Follow-up|0|||
161606175|NCT04129164|583611296|FG001|Overall Study|Lost to Follow-up|1|||
161606176|NCT04129164|583611297|FG002|Overall Study|Lost to Follow-up|0|||
161606177|NCT04129164|583611298|FG003|Overall Study|Lost to Follow-up|0|||
161606178|NCT03653364|583611299|FG000|Overall Study|Withdrawal by Subject|1|||
161606179|NCT03653364|583611299|FG000|Overall Study|Enrolled in Error|1|||
161606180|NCT03653364|583611299|FG000|Overall Study|Death|1|||
161606181|NCT00943917|583611309|FG000|Stage I|Adverse Event|1|||
161606182|NCT00943917|583611310|FG001|Stage I|Adverse Event|2|||
161606183|NCT00943917|583611311|FG002|Stage I|Adverse Event|2|||
161606184|NCT00943917|583611312|FG003|Stage I|Adverse Event|0|||
161606185|NCT00943917|583611313|FG004|Stage I|Adverse Event|0|||
161606186|NCT00943917|583611314|FG005|Stage I|Adverse Event|0|||
161606187|NCT00943917|583611315|FG006|Stage I|Adverse Event|0|||
161606188|NCT00943917|583611316|FG007|Stage I|Adverse Event|0|||
161606189|NCT00943917|583611317|FG008|Stage I|Adverse Event|0|||
161606190|NCT00943917|583611318|FG009|Stage I|Adverse Event|0|||
161606191|NCT00943917|583611319|FG010|Stage I|Adverse Event|0|||
161606192|NCT00943917|583611320|FG011|Stage I|Adverse Event|0|||
161606193|NCT00943917|583611321|FG012|Stage I|Adverse Event|0|||
161606194|NCT00943917|583611322|FG013|Stage I|Adverse Event|0|||
161606195|NCT00943917|583611323|FG014|Stage I|Adverse Event|0|||
161606196|NCT00943917|583611309|FG000|Stage I|Lost to Follow-up|0|||
161606197|NCT00943917|583611310|FG001|Stage I|Lost to Follow-up|0|||
161606198|NCT00943917|583611311|FG002|Stage I|Lost to Follow-up|1|||
161606199|NCT00943917|583611312|FG003|Stage I|Lost to Follow-up|0|||
161606200|NCT00943917|583611313|FG004|Stage I|Lost to Follow-up|0|||
161606201|NCT00943917|583611314|FG005|Stage I|Lost to Follow-up|0|||
161606202|NCT00943917|583611315|FG006|Stage I|Lost to Follow-up|0|||
161606203|NCT00943917|583611316|FG007|Stage I|Lost to Follow-up|0|||
161606204|NCT00943917|583611317|FG008|Stage I|Lost to Follow-up|0|||
161606205|NCT00943917|583611318|FG009|Stage I|Lost to Follow-up|0|||
161606206|NCT00943917|583611319|FG010|Stage I|Lost to Follow-up|0|||
161606207|NCT00943917|583611320|FG011|Stage I|Lost to Follow-up|0|||
161606208|NCT00943917|583611321|FG012|Stage I|Lost to Follow-up|0|||
161606209|NCT00943917|583611322|FG013|Stage I|Lost to Follow-up|0|||
161606210|NCT00943917|583611323|FG014|Stage I|Lost to Follow-up|0|||
161606211|NCT00943917|583611309|FG000|Stage I|hyperglycemia|0|||
161606212|NCT00943917|583611310|FG001|Stage I|hyperglycemia|0|||
161606213|NCT00943917|583611311|FG002|Stage I|hyperglycemia|1|||
161606214|NCT00943917|583611312|FG003|Stage I|hyperglycemia|0|||
161606215|NCT00943917|583611313|FG004|Stage I|hyperglycemia|0|||
161606216|NCT00943917|583611314|FG005|Stage I|hyperglycemia|0|||
161606217|NCT00943917|583611315|FG006|Stage I|hyperglycemia|0|||
161606218|NCT00943917|583611316|FG007|Stage I|hyperglycemia|0|||
161606219|NCT00943917|583611317|FG008|Stage I|hyperglycemia|0|||
161606220|NCT00943917|583611318|FG009|Stage I|hyperglycemia|0|||
161606221|NCT00943917|583611319|FG010|Stage I|hyperglycemia|0|||
161606222|NCT00943917|583611320|FG011|Stage I|hyperglycemia|0|||
161606223|NCT00943917|583611321|FG012|Stage I|hyperglycemia|0|||
161606224|NCT00943917|583611322|FG013|Stage I|hyperglycemia|0|||
161606225|NCT00943917|583611323|FG014|Stage I|hyperglycemia|0|||
161606226|NCT00943917|583611309|FG000|Stage I|A1C elevation|1|||
161606227|NCT00943917|583611310|FG001|Stage I|A1C elevation|0|||
161606228|NCT00943917|583611311|FG002|Stage I|A1C elevation|0|||
161606229|NCT00943917|583611312|FG003|Stage I|A1C elevation|0|||
161606230|NCT00943917|583611313|FG004|Stage I|A1C elevation|0|||
161606231|NCT00943917|583611314|FG005|Stage I|A1C elevation|0|||
161606232|NCT00943917|583611315|FG006|Stage I|A1C elevation|0|||
161606233|NCT00943917|583611316|FG007|Stage I|A1C elevation|0|||
161606234|NCT00943917|583611317|FG008|Stage I|A1C elevation|0|||
161606235|NCT00943917|583611318|FG009|Stage I|A1C elevation|0|||
161606236|NCT00943917|583611319|FG010|Stage I|A1C elevation|0|||
161606237|NCT00943917|583611320|FG011|Stage I|A1C elevation|0|||
161606238|NCT00943917|583611321|FG012|Stage I|A1C elevation|0|||
161606239|NCT00943917|583611322|FG013|Stage I|A1C elevation|0|||
161606240|NCT00943917|583611323|FG014|Stage I|A1C elevation|0|||
161606241|NCT00943917|583611309|FG000|Stage I|Withdrawal by Subject|2|||
161606242|NCT00943917|583611310|FG001|Stage I|Withdrawal by Subject|1|||
161606243|NCT00943917|583611311|FG002|Stage I|Withdrawal by Subject|2|||
161606244|NCT00943917|583611312|FG003|Stage I|Withdrawal by Subject|0|||
161606245|NCT00943917|583611313|FG004|Stage I|Withdrawal by Subject|0|||
161606246|NCT00943917|583611314|FG005|Stage I|Withdrawal by Subject|0|||
161606247|NCT00943917|583611315|FG006|Stage I|Withdrawal by Subject|0|||
161606248|NCT00943917|583611316|FG007|Stage I|Withdrawal by Subject|0|||
161606249|NCT00943917|583611317|FG008|Stage I|Withdrawal by Subject|0|||
161606250|NCT00943917|583611318|FG009|Stage I|Withdrawal by Subject|0|||
161606251|NCT00943917|583611319|FG010|Stage I|Withdrawal by Subject|0|||
161606252|NCT00943917|583611320|FG011|Stage I|Withdrawal by Subject|0|||
161606253|NCT00943917|583611321|FG012|Stage I|Withdrawal by Subject|0|||
161606254|NCT00943917|583611322|FG013|Stage I|Withdrawal by Subject|0|||
161606255|NCT00943917|583611323|FG014|Stage I|Withdrawal by Subject|0|||
161606256|NCT00943917|583611309|FG000|Stage II|Adverse Event|0|||
161606257|NCT00943917|583611310|FG001|Stage II|Adverse Event|0|||
161606258|NCT00943917|583611311|FG002|Stage II|Adverse Event|0|||
161683584|NCT00530894|583894615|FG003|Overall Study|Withdrawal by Subject|5|||
161683585|NCT00530894|583894612|FG000|Overall Study|Alive and censored prior to 1 year|2|||
161683586|NCT00530894|583894613|FG001|Overall Study|Alive and censored prior to 1 year|0|||
161683587|NCT00530894|583894614|FG002|Overall Study|Alive and censored prior to 1 year|0|||
161683588|NCT00530894|583894615|FG003|Overall Study|Alive and censored prior to 1 year|0|||
161606259|NCT00943917|583611312|FG003|Stage II|Adverse Event|0|||
161606260|NCT00943917|583611313|FG004|Stage II|Adverse Event|0|||
161606261|NCT00943917|583611314|FG005|Stage II|Adverse Event|1|||
161606262|NCT00943917|583611315|FG006|Stage II|Adverse Event|3|||
161606263|NCT00943917|583611316|FG007|Stage II|Adverse Event|0|||
161606264|NCT00943917|583611317|FG008|Stage II|Adverse Event|1|||
161606265|NCT00943917|583611318|FG009|Stage II|Adverse Event|0|||
161606266|NCT00943917|583611319|FG010|Stage II|Adverse Event|0|||
161606267|NCT00943917|583611320|FG011|Stage II|Adverse Event|0|||
161606268|NCT00943917|583611321|FG012|Stage II|Adverse Event|0|||
161606269|NCT00943917|583611322|FG013|Stage II|Adverse Event|0|||
161606270|NCT00943917|583611323|FG014|Stage II|Adverse Event|0|||
161606271|NCT00943917|583611309|FG000|Stage II|Withdrawal by Subject|0|||
161606272|NCT00943917|583611310|FG001|Stage II|Withdrawal by Subject|0|||
161606273|NCT00943917|583611311|FG002|Stage II|Withdrawal by Subject|0|||
161606274|NCT00943917|583611312|FG003|Stage II|Withdrawal by Subject|0|||
161606275|NCT00943917|583611313|FG004|Stage II|Withdrawal by Subject|0|||
161606276|NCT00943917|583611314|FG005|Stage II|Withdrawal by Subject|1|||
161606277|NCT00943917|583611315|FG006|Stage II|Withdrawal by Subject|0|||
161606278|NCT00943917|583611316|FG007|Stage II|Withdrawal by Subject|0|||
161606279|NCT00943917|583611317|FG008|Stage II|Withdrawal by Subject|0|||
161606280|NCT00943917|583611318|FG009|Stage II|Withdrawal by Subject|0|||
161606281|NCT00943917|583611319|FG010|Stage II|Withdrawal by Subject|0|||
161606282|NCT00943917|583611320|FG011|Stage II|Withdrawal by Subject|0|||
161606283|NCT00943917|583611321|FG012|Stage II|Withdrawal by Subject|0|||
161606284|NCT00943917|583611322|FG013|Stage II|Withdrawal by Subject|0|||
161606285|NCT00943917|583611323|FG014|Stage II|Withdrawal by Subject|0|||
161606286|NCT00943917|583611309|FG000|Stage II|Pregnancy|0|||
161606287|NCT00943917|583611310|FG001|Stage II|Pregnancy|0|||
161606288|NCT00943917|583611311|FG002|Stage II|Pregnancy|0|||
161606289|NCT00943917|583611312|FG003|Stage II|Pregnancy|0|||
161606290|NCT00943917|583611313|FG004|Stage II|Pregnancy|0|||
161606291|NCT00943917|583611314|FG005|Stage II|Pregnancy|1|||
161606292|NCT00943917|583611315|FG006|Stage II|Pregnancy|0|||
161606293|NCT00943917|583611316|FG007|Stage II|Pregnancy|0|||
161606294|NCT00943917|583611317|FG008|Stage II|Pregnancy|0|||
161606295|NCT00943917|583611318|FG009|Stage II|Pregnancy|0|||
161606296|NCT00943917|583611319|FG010|Stage II|Pregnancy|0|||
161606297|NCT00943917|583611320|FG011|Stage II|Pregnancy|0|||
161606298|NCT00943917|583611321|FG012|Stage II|Pregnancy|0|||
161606299|NCT00943917|583611322|FG013|Stage II|Pregnancy|0|||
161606300|NCT00943917|583611323|FG014|Stage II|Pregnancy|0|||
161606301|NCT00943917|583611309|FG000|Stage II Continuation|Adverse Event|0|||
161606302|NCT00943917|583611310|FG001|Stage II Continuation|Adverse Event|0|||
161606303|NCT00943917|583611311|FG002|Stage II Continuation|Adverse Event|0|||
161606304|NCT00943917|583611312|FG003|Stage II Continuation|Adverse Event|0|||
161606305|NCT00943917|583611313|FG004|Stage II Continuation|Adverse Event|0|||
161606306|NCT00943917|583611314|FG005|Stage II Continuation|Adverse Event|0|||
161606307|NCT00943917|583611315|FG006|Stage II Continuation|Adverse Event|0|||
161606308|NCT00943917|583611316|FG007|Stage II Continuation|Adverse Event|0|||
161606309|NCT00943917|583611317|FG008|Stage II Continuation|Adverse Event|0|||
161606310|NCT00943917|583611318|FG009|Stage II Continuation|Adverse Event|0|||
161606311|NCT00943917|583611319|FG010|Stage II Continuation|Adverse Event|0|||
161606312|NCT00943917|583611320|FG011|Stage II Continuation|Adverse Event|1|||
161606313|NCT00943917|583611321|FG012|Stage II Continuation|Adverse Event|2|||
161606314|NCT00943917|583611322|FG013|Stage II Continuation|Adverse Event|1|||
161606315|NCT00943917|583611323|FG014|Stage II Continuation|Adverse Event|1|||
161606316|NCT00943917|583611309|FG000|Stage II Continuation|Withdrawal by Subject|0|||
161606317|NCT00943917|583611310|FG001|Stage II Continuation|Withdrawal by Subject|0|||
161606318|NCT00943917|583611311|FG002|Stage II Continuation|Withdrawal by Subject|0|||
161606319|NCT00943917|583611312|FG003|Stage II Continuation|Withdrawal by Subject|0|||
161606320|NCT00943917|583611313|FG004|Stage II Continuation|Withdrawal by Subject|0|||
161606321|NCT00943917|583611314|FG005|Stage II Continuation|Withdrawal by Subject|0|||
161606322|NCT00943917|583611315|FG006|Stage II Continuation|Withdrawal by Subject|0|||
161606323|NCT00943917|583611316|FG007|Stage II Continuation|Withdrawal by Subject|0|||
161606324|NCT00943917|583611317|FG008|Stage II Continuation|Withdrawal by Subject|0|||
161606325|NCT00943917|583611318|FG009|Stage II Continuation|Withdrawal by Subject|0|||
161606326|NCT00943917|583611319|FG010|Stage II Continuation|Withdrawal by Subject|0|||
161606327|NCT00943917|583611320|FG011|Stage II Continuation|Withdrawal by Subject|0|||
161606328|NCT00943917|583611321|FG012|Stage II Continuation|Withdrawal by Subject|0|||
161606329|NCT00943917|583611322|FG013|Stage II Continuation|Withdrawal by Subject|1|||
161606330|NCT00943917|583611323|FG014|Stage II Continuation|Withdrawal by Subject|3|||
161606331|NCT00943917|583611309|FG000|Stage II Continuation|Protocol Violation|0|||
161606332|NCT00943917|583611310|FG001|Stage II Continuation|Protocol Violation|0|||
161606333|NCT00943917|583611311|FG002|Stage II Continuation|Protocol Violation|0|||
161606334|NCT00943917|583611312|FG003|Stage II Continuation|Protocol Violation|0|||
161606335|NCT00943917|583611313|FG004|Stage II Continuation|Protocol Violation|0|||
161606336|NCT00943917|583611314|FG005|Stage II Continuation|Protocol Violation|0|||
161606337|NCT00943917|583611315|FG006|Stage II Continuation|Protocol Violation|0|||
161606338|NCT00943917|583611316|FG007|Stage II Continuation|Protocol Violation|0|||
161606339|NCT00943917|583611317|FG008|Stage II Continuation|Protocol Violation|0|||
161606340|NCT00943917|583611318|FG009|Stage II Continuation|Protocol Violation|1|||
161606341|NCT00943917|583611319|FG010|Stage II Continuation|Protocol Violation|0|||
161606342|NCT00943917|583611320|FG011|Stage II Continuation|Protocol Violation|1|||
161606343|NCT00943917|583611321|FG012|Stage II Continuation|Protocol Violation|0|||
161606344|NCT00943917|583611322|FG013|Stage II Continuation|Protocol Violation|0|||
161606345|NCT00943917|583611323|FG014|Stage II Continuation|Protocol Violation|0|||
161606346|NCT00943917|583611309|FG000|Stage II Continuation|hypoglycemia|0|||
161606347|NCT00943917|583611310|FG001|Stage II Continuation|hypoglycemia|0|||
161606348|NCT00943917|583611311|FG002|Stage II Continuation|hypoglycemia|0|||
161606349|NCT00943917|583611312|FG003|Stage II Continuation|hypoglycemia|0|||
161606350|NCT00943917|583611313|FG004|Stage II Continuation|hypoglycemia|0|||
161606351|NCT00943917|583611314|FG005|Stage II Continuation|hypoglycemia|0|||
161606352|NCT00943917|583611315|FG006|Stage II Continuation|hypoglycemia|0|||
161606353|NCT00943917|583611316|FG007|Stage II Continuation|hypoglycemia|0|||
161606354|NCT00943917|583611317|FG008|Stage II Continuation|hypoglycemia|0|||
161606355|NCT00943917|583611318|FG009|Stage II Continuation|hypoglycemia|0|||
161606356|NCT00943917|583611319|FG010|Stage II Continuation|hypoglycemia|0|||
161606357|NCT00943917|583611320|FG011|Stage II Continuation|hypoglycemia|0|||
161606358|NCT00943917|583611321|FG012|Stage II Continuation|hypoglycemia|1|||
161606359|NCT00943917|583611322|FG013|Stage II Continuation|hypoglycemia|0|||
161606360|NCT00943917|583611323|FG014|Stage II Continuation|hypoglycemia|0|||
161606361|NCT00943917|583611309|FG000|Stage II Continuation|A1C elevation|0|||
161606362|NCT00943917|583611310|FG001|Stage II Continuation|A1C elevation|0|||
161606363|NCT00943917|583611311|FG002|Stage II Continuation|A1C elevation|0|||
161606364|NCT00943917|583611312|FG003|Stage II Continuation|A1C elevation|0|||
161606365|NCT00943917|583611313|FG004|Stage II Continuation|A1C elevation|0|||
161832337|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832338|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832339|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832340|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832341|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832342|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832343|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832344|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832345|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
161832346|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832347|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832348|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832349|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832350|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832351|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832352|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832353|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161606366|NCT00943917|583611314|FG005|Stage II Continuation|A1C elevation|0|||
161606367|NCT00943917|583611315|FG006|Stage II Continuation|A1C elevation|0|||
161606368|NCT00943917|583611316|FG007|Stage II Continuation|A1C elevation|0|||
161606369|NCT00943917|583611317|FG008|Stage II Continuation|A1C elevation|0|||
161606370|NCT00943917|583611318|FG009|Stage II Continuation|A1C elevation|0|||
161606371|NCT00943917|583611319|FG010|Stage II Continuation|A1C elevation|0|||
161606372|NCT00943917|583611320|FG011|Stage II Continuation|A1C elevation|0|||
161606373|NCT00943917|583611321|FG012|Stage II Continuation|A1C elevation|0|||
161606374|NCT00943917|583611322|FG013|Stage II Continuation|A1C elevation|1|||
161606375|NCT00943917|583611323|FG014|Stage II Continuation|A1C elevation|0|||
161606376|NCT02466971|583611326|FG000|Overall Study|eligible and never treated|14|||
161832354|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161606377|NCT02466971|583611327|FG001|Overall Study|eligible and never treated|20|||
161606378|NCT02466971|583611326|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
161606379|NCT02466971|583611327|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
161683589|NCT02256540|583894616|FG000|Overall Study|Withdrawal by Subject|0|||
161683590|NCT02256540|583894617|FG001|Overall Study|Withdrawal by Subject|1|||
161683591|NCT02256540|583894618|FG002|Overall Study|Withdrawal by Subject|1|||
161683592|NCT02256540|583894616|FG000|Overall Study|Back pain preventing exercise|0|||
161683593|NCT02256540|583894617|FG001|Overall Study|Back pain preventing exercise|0|||
161683594|NCT02256540|583894618|FG002|Overall Study|Back pain preventing exercise|1|||
161683595|NCT01230242|583894619|FG000|Overall Study|Physician Decision|2|||
161683596|NCT01230242|583894619|FG000|Overall Study|Withdrawal by Subject|1|||
161683597|NCT02576444|583894628|FG000|Overall Study|Death|1|||
161683598|NCT02576444|583894629|FG001|Overall Study|Death|1|||
161683599|NCT02576444|583894630|FG002|Overall Study|Death|0|||
161683600|NCT02576444|583894631|FG003|Overall Study|Death|0|||
161683601|NCT02576444|583894628|FG000|Overall Study|Withdrawal by Subject|0|||
161683602|NCT02576444|583894629|FG001|Overall Study|Withdrawal by Subject|0|||
161683603|NCT02576444|583894630|FG002|Overall Study|Withdrawal by Subject|2|||
161683604|NCT02576444|583894631|FG003|Overall Study|Withdrawal by Subject|0|||
161683605|NCT02576444|583894628|FG000|Overall Study|Adverse Event|0|||
161683606|NCT02576444|583894629|FG001|Overall Study|Adverse Event|0|||
161683607|NCT02576444|583894630|FG002|Overall Study|Adverse Event|1|||
161683608|NCT02576444|583894631|FG003|Overall Study|Adverse Event|0|||
161683609|NCT02576444|583894628|FG000|Overall Study|Physician Decision|0|||
161683610|NCT02576444|583894629|FG001|Overall Study|Physician Decision|0|||
161683611|NCT02576444|583894630|FG002|Overall Study|Physician Decision|1|||
161683612|NCT02576444|583894631|FG003|Overall Study|Physician Decision|0|||
161683613|NCT00928889|583894639|FG000|Overall Study|Lost to Follow-up|3|||
161683614|NCT00928889|583894640|FG001|Overall Study|Lost to Follow-up|1|||
161683615|NCT00928889|583894639|FG000|Overall Study|Protocol Violation|0|||
161683616|NCT00928889|583894640|FG001|Overall Study|Protocol Violation|1|||
161683617|NCT00928889|583894639|FG000|Overall Study|Adverse Event|1|||
161683618|NCT00928889|583894640|FG001|Overall Study|Adverse Event|0|||
161683619|NCT00928889|583894639|FG000|Overall Study|Other|1|||
161683620|NCT00928889|583894640|FG001|Overall Study|Other|0|||
161683621|NCT02700412|583894641|FG000|Overall Study|Adverse Event|6|||
161683622|NCT02700412|583894641|FG000|Overall Study|Death|1|||
161683623|NCT02700412|583894641|FG000|Overall Study|Lack of Efficacy|19|||
161683624|NCT02700412|583894641|FG000|Overall Study|Protocol Violation|5|||
161683625|NCT02700412|583894641|FG000|Overall Study|Withdrawal by Subject|2|||
161683626|NCT04416555|583894643|FG000|Overall Study|Withdrawal by Subject|0|||
161683627|NCT04416555|583894644|FG001|Overall Study|Withdrawal by Subject|3|||
161683628|NCT00530270|583894647|FG000|Overall Study|Protocol Violation|1|||
161683629|NCT00530270|583894648|FG001|Overall Study|Protocol Violation|0|||
161683630|NCT01197521|583894657|FG000|Overall Study|Not reported|24|||
161683631|NCT01197521|583894658|FG001|Overall Study|Not reported|25|||
161683632|NCT01197521|583894659|FG002|Overall Study|Not reported|21|||
161683633|NCT01197521|583894657|FG000|Overall Study|Enrolment in long term extension|42|||
161683634|NCT01197521|583894658|FG001|Overall Study|Enrolment in long term extension|36|||
161683635|NCT01197521|583894659|FG002|Overall Study|Enrolment in long term extension|87|||
161683636|NCT01197521|583894657|FG000|Overall Study|Severe non-compliance to protocol|1|||
161683637|NCT01197521|583894658|FG001|Overall Study|Severe non-compliance to protocol|3|||
161683638|NCT01197521|583894659|FG002|Overall Study|Severe non-compliance to protocol|3|||
161683639|NCT01197521|583894657|FG000|Overall Study|Lack of therapeutic response|2|||
161683640|NCT01197521|583894658|FG001|Overall Study|Lack of therapeutic response|3|||
161683641|NCT01197521|583894659|FG002|Overall Study|Lack of therapeutic response|4|||
161683642|NCT01197521|583894657|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
161683643|NCT01197521|583894658|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
161683644|NCT01197521|583894659|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
161683645|NCT01197521|583894657|FG000|Overall Study|Lost to Follow-up|3|||
161683646|NCT01197521|583894658|FG001|Overall Study|Lost to Follow-up|2|||
161683647|NCT01197521|583894659|FG002|Overall Study|Lost to Follow-up|2|||
161683648|NCT01197521|583894657|FG000|Overall Study|Adverse Event|25|||
161683649|NCT01197521|583894658|FG001|Overall Study|Adverse Event|28|||
161683650|NCT01197521|583894659|FG002|Overall Study|Adverse Event|24|||
161683651|NCT01309659|583894660|FG000|Overall Study|Protocol Violation|0|||
161683652|NCT01309659|583894661|FG001|Overall Study|Protocol Violation|1|||
161683653|NCT04607148|583894662|FG000|Overall Study|Withdrawal by Subject|0|||
161683654|NCT04607148|583894663|FG001|Overall Study|Withdrawal by Subject|4|||
161683655|NCT04607148|583894664|FG002|Overall Study|Withdrawal by Subject|2|||
161683656|NCT04607148|583894665|FG003|Overall Study|Withdrawal by Subject|8|||
161683657|NCT04607148|583894662|FG000|Overall Study|Study Terminated by Sponsor|14|||
161683658|NCT04607148|583894663|FG001|Overall Study|Study Terminated by Sponsor|59|||
161683659|NCT04607148|583894664|FG002|Overall Study|Study Terminated by Sponsor|9|||
161683660|NCT04607148|583894665|FG003|Overall Study|Study Terminated by Sponsor|39|||
161683661|NCT04607148|583894662|FG000|Overall Study|Sponsor Decision|0|||
161683662|NCT04607148|583894663|FG001|Overall Study|Sponsor Decision|0|||
161683663|NCT04607148|583894664|FG002|Overall Study|Sponsor Decision|1|||
161683664|NCT04607148|583894665|FG003|Overall Study|Sponsor Decision|0|||
161683665|NCT04607148|583894662|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161606380|NCT02466971|583611326|FG000|Overall Study|ineligible and treated|1|||
161606381|NCT02466971|583611327|FG001|Overall Study|ineligible and treated|0|||
161832355|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161832356|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161606382|NCT02466971|583611326|FG000|Overall Study|ineligible and never treated|0|||
161606383|NCT02466971|583611327|FG001|Overall Study|ineligible and never treated|1|||
161606384|NCT05707351|583611328|FG000|Overall Study|Withdrawal by Subject|2|||
161606385|NCT05707351|583611328|FG000|Overall Study|Reason Not Specified|1|||
161606386|NCT04174560|583611332|FG000|Overall Study|Lost to Follow-up|1|||
161606387|NCT04174560|583611333|FG001|Overall Study|Lost to Follow-up|0|||
161606388|NCT04174560|583611334|FG002|Overall Study|Lost to Follow-up|0|||
161606389|NCT04174560|583611335|FG003|Overall Study|Lost to Follow-up|0|||
161606390|NCT04174560|583611332|FG000|Overall Study|Withdrawal by Subject|0|||
161606391|NCT04174560|583611333|FG001|Overall Study|Withdrawal by Subject|0|||
161606392|NCT04174560|583611334|FG002|Overall Study|Withdrawal by Subject|2|||
161606393|NCT04174560|583611335|FG003|Overall Study|Withdrawal by Subject|0|||
161606394|NCT03782116|583611342|FG000|Completed Intervetion|Lost to Follow-up|11|||
161606395|NCT03782116|583611343|FG001|Completed Intervetion|Lost to Follow-up|7|||
161606396|NCT03782116|583611342|FG000|Completed Intervetion|Withdrawal by Subject|6|||
161606397|NCT03782116|583611343|FG001|Completed Intervetion|Withdrawal by Subject|5|||
161606398|NCT03782116|583611342|FG000|Included in Analysis|Protocol Violation|5|||
161606399|NCT03782116|583611343|FG001|Included in Analysis|Protocol Violation|5|||
161606400|NCT04908514|583611344|FG000|Overall Study|Lost to Follow-up|2|||
161606401|NCT04908514|583611344|FG000|Overall Study|Withdrawal by Subject|1|||
161606402|NCT02890355|583611345|FG000|Overall Study|Adverse Event|5|||
161606403|NCT02890355|583611346|FG001|Overall Study|Adverse Event|5|||
161606404|NCT02890355|583611345|FG000|Overall Study|Refusal unrelated to adverse event|5|||
161606405|NCT02890355|583611346|FG001|Overall Study|Refusal unrelated to adverse event|10|||
161606406|NCT02890355|583611345|FG000|Overall Study|Progression/relapse|46|||
161606407|NCT02890355|583611346|FG001|Overall Study|Progression/relapse|39|||
161606408|NCT02890355|583611345|FG000|Overall Study|Not protocol specified|3|||
161606409|NCT02890355|583611346|FG001|Overall Study|Not protocol specified|4|||
161606410|NCT04129450|583611348|FG000|Overall Study|Lost to Follow-up|20|||
161606411|NCT04129450|583611349|FG001|Overall Study|Lost to Follow-up|10|||
161606412|NCT04129450|583611348|FG000|Overall Study|Withdrawal by Subject|9|||
161606413|NCT04129450|583611349|FG001|Overall Study|Withdrawal by Subject|5|||
161606414|NCT04129450|583611348|FG000|Overall Study|Work Family Obligations|2|||
161606415|NCT04129450|583611349|FG001|Overall Study|Work Family Obligations|0|||
161606416|NCT04129450|583611348|FG000|Overall Study|Other|3|||
161606417|NCT04129450|583611349|FG001|Overall Study|Other|0|||
161606418|NCT04974047|583612065|FG000|Overall Study|Sponsor Ended Study|20|||
161606419|NCT04974047|583612066|FG001|Overall Study|Sponsor Ended Study|22|||
161606420|NCT04974047|583612065|FG000|Overall Study|Death|8|||
161606421|NCT04974047|583612066|FG001|Overall Study|Death|17|||
161606422|NCT04974047|583612065|FG000|Overall Study|Lost to Follow-up|2|||
161606423|NCT04974047|583612066|FG001|Overall Study|Lost to Follow-up|0|||
161606424|NCT04974047|583612065|FG000|Overall Study|Withdrawal by Subject|0|||
161606425|NCT04974047|583612066|FG001|Overall Study|Withdrawal by Subject|1|||
161606426|NCT00655499|583612067|FG000|Overall Study|not eligible|4|||
161606427|NCT01596972|583612069|FG000|Overall Study|Physician Decision|1|||
161606428|NCT01596972|583612070|FG001|Overall Study|Physician Decision|9|||
161606429|NCT01596972|583612069|FG000|Overall Study|Lost to Follow-up|0|||
161606430|NCT01596972|583612070|FG001|Overall Study|Lost to Follow-up|4|||
161606431|NCT01596972|583612069|FG000|Overall Study|Withdrawal by Subject|0|||
161606432|NCT01596972|583612070|FG001|Overall Study|Withdrawal by Subject|1|||
161606433|NCT01639131|583612071|FG000|Overall Study|Disease Progression|6|||
161606434|NCT01964300|583612072|FG000|Overall Study|Ineligible after enrollment|0|||
161606435|NCT01964300|583612073|FG001|Overall Study|Ineligible after enrollment|1|||
161606436|NCT01964300|583612072|FG000|Overall Study|Adverse Event|1|||
161606437|NCT01964300|583612073|FG001|Overall Study|Adverse Event|1|||
161606438|NCT01964300|583612072|FG000|Overall Study|Lack of Efficacy|3|||
161606439|NCT01964300|583612073|FG001|Overall Study|Lack of Efficacy|5|||
161606440|NCT01964300|583612072|FG000|Overall Study|Withdrawal by Subject|0|||
161606441|NCT01964300|583612073|FG001|Overall Study|Withdrawal by Subject|1|||
161606442|NCT01964300|583612072|FG000|Overall Study|To receive alternative therapy|1|||
161606443|NCT01964300|583612073|FG001|Overall Study|To receive alternative therapy|2|||
161606444|NCT01964300|583612072|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
161606445|NCT01964300|583612073|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
161683666|NCT04607148|583894663|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161683667|NCT04607148|583894664|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161683668|NCT04607148|583894665|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161683669|NCT04607148|583894662|FG000|Overall Study|Lost to Follow-up|0|||
161683670|NCT04607148|583894663|FG001|Overall Study|Lost to Follow-up|2|||
161683671|NCT04607148|583894664|FG002|Overall Study|Lost to Follow-up|0|||
161683672|NCT04607148|583894665|FG003|Overall Study|Lost to Follow-up|0|||
161683673|NCT04607148|583894662|FG000|Overall Study|Death|0|||
161683674|NCT04607148|583894663|FG001|Overall Study|Death|3|||
161683675|NCT04607148|583894664|FG002|Overall Study|Death|0|||
161683676|NCT04607148|583894665|FG003|Overall Study|Death|1|||
161683677|NCT04607148|583894662|FG000|Overall Study|Adverse Event|0|||
161683678|NCT04607148|583894663|FG001|Overall Study|Adverse Event|1|||
161683679|NCT04607148|583894664|FG002|Overall Study|Adverse Event|0|||
161683680|NCT04607148|583894665|FG003|Overall Study|Adverse Event|0|||
161683681|NCT01793142|583894666|FG000|Overall Study|Randomized not treated|7|||
161683682|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
161683683|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
161683684|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
161683685|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
161606446|NCT01964300|583612072|FG000|Overall Study|Weight criteria not met|0|||
161606447|NCT01964300|583612073|FG001|Overall Study|Weight criteria not met|1|||
161606448|NCT01637402|583612074|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
161606449|NCT01637402|583612075|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
161606450|NCT01637402|583612074|FG000|Standard Dose Regimen|Adverse Event|1|||
161606451|NCT01637402|583612075|FG001|Standard Dose Regimen|Adverse Event|0|||
161606452|NCT01637402|583612074|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
161606453|NCT01637402|583612075|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
161606454|NCT01637402|583612074|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
161606455|NCT01637402|583612075|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
161606456|NCT01637402|583612074|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
161606457|NCT01637402|583612075|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
161606458|NCT01637402|583612074|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
161606459|NCT01637402|583612075|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
161606460|NCT02285270|583612078|FG000|Overall Study|Lost to Follow-up|1|||
161606461|NCT02285270|583612078|FG000|Overall Study|Physician Decision|3|||
161606462|NCT02285270|583612078|FG000|Overall Study|Determined to be ineligible|1|||
161606463|NCT02111096|583612079|FG000|Overall Study|Adverse Event|4|||
161683686|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
161683687|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
161683688|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
161683689|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
161683690|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
161683691|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
161683692|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
161683693|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
161832357|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832358|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832359|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832360|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
161606464|NCT02111096|583612080|FG001|Overall Study|Adverse Event|1|||
161606465|NCT02111096|583612081|FG002|Overall Study|Adverse Event|2|||
161606466|NCT02111096|583612079|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161606467|NCT02111096|583612080|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161606468|NCT02111096|583612081|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161606469|NCT02111096|583612079|FG000|Overall Study|Lost to Follow Up|1|||
161606470|NCT02111096|583612080|FG001|Overall Study|Lost to Follow Up|1|||
161606471|NCT02111096|583612081|FG002|Overall Study|Lost to Follow Up|1|||
161606472|NCT02111096|583612079|FG000|Overall Study|Physician Decision|0|||
161606473|NCT02111096|583612080|FG001|Overall Study|Physician Decision|1|||
161606474|NCT02111096|583612081|FG002|Overall Study|Physician Decision|0|||
161606475|NCT02111096|583612079|FG000|Overall Study|Protocol Violation|1|||
161606476|NCT02111096|583612080|FG001|Overall Study|Protocol Violation|0|||
161606477|NCT02111096|583612081|FG002|Overall Study|Protocol Violation|1|||
161606478|NCT02111096|583612079|FG000|Overall Study|Terminated by Sponsor|53|||
161606479|NCT02111096|583612080|FG001|Overall Study|Terminated by Sponsor|35|||
161606480|NCT02111096|583612081|FG002|Overall Study|Terminated by Sponsor|54|||
161606481|NCT02111096|583612079|FG000|Overall Study|Withdrawal by Subject|4|||
161606482|NCT02111096|583612080|FG001|Overall Study|Withdrawal by Subject|2|||
161606483|NCT02111096|583612081|FG002|Overall Study|Withdrawal by Subject|8|||
161606484|NCT00439270|583612084|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
161606485|NCT00439270|583612085|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
161606486|NCT00439270|583612086|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
161606487|NCT00439270|583612087|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
161606488|NCT00439270|583612088|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
161606489|NCT00439270|583612084|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161606490|NCT00439270|583612085|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
161606491|NCT00439270|583612086|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161606492|NCT00439270|583612087|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161606493|NCT00439270|583612088|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161606494|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
161606495|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
161606496|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
161606497|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
161606498|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
161606499|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161606500|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161606501|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161606502|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
161606503|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161683694|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
161683695|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
161683696|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
161683697|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
161683698|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
161683699|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
161683700|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
161683701|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
161683702|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
161683703|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161683704|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161683705|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
161683706|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
161683707|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
161683708|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
161683709|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161683710|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
161683711|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
161683712|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
161683713|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
161683714|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
161683715|NCT04744207|583894670|FG000|Treatment|Withdrawal by Subject|2|||
161683716|NCT04744207|583894671|FG001|Treatment|Withdrawal by Subject|0|||
161683717|NCT04744207|583894670|FG000|Treatment|Adverse Event|1|||
161683718|NCT04744207|583894671|FG001|Treatment|Adverse Event|2|||
161683719|NCT00825162|583894678|FG000|Overall Study|Withdrawal by Subject|11|||
161683720|NCT00825162|583894679|FG001|Overall Study|Withdrawal by Subject|13|||
161683721|NCT00825162|583894680|FG002|Overall Study|Withdrawal by Subject|3|||
161683722|NCT00825162|583894678|FG000|Overall Study|Lost to Follow-up|9|||
161683723|NCT00825162|583894679|FG001|Overall Study|Lost to Follow-up|6|||
161683724|NCT00825162|583894680|FG002|Overall Study|Lost to Follow-up|3|||
161683725|NCT00825162|583894678|FG000|Overall Study|Physician Decision|2|||
161683726|NCT00825162|583894679|FG001|Overall Study|Physician Decision|0|||
161683727|NCT00825162|583894680|FG002|Overall Study|Physician Decision|0|||
161683728|NCT00825162|583894678|FG000|Overall Study|Move away from the study area|1|||
161683729|NCT00825162|583894679|FG001|Overall Study|Move away from the study area|0|||
161683730|NCT00825162|583894680|FG002|Overall Study|Move away from the study area|0|||
161683731|NCT00825162|583894678|FG000|Overall Study|Unable to attend the study visit|5|||
161683732|NCT00825162|583894679|FG001|Overall Study|Unable to attend the study visit|2|||
161683733|NCT00825162|583894680|FG002|Overall Study|Unable to attend the study visit|0|||
161683734|NCT00258674|583894685|FG000|Overall Study|Death|32|||
161683735|NCT00258674|583894686|FG001|Overall Study|Death|53|||
161683736|NCT00258674|583894687|FG002|Overall Study|Death|34|||
161683737|NCT02973087|583894688|FG000|Overall Study|Withdrawal by Subject|2|||
161683738|NCT02973087|583894689|FG001|Overall Study|Withdrawal by Subject|1|||
161683739|NCT02973087|583894688|FG000|Overall Study|Adverse Event|1|||
161683740|NCT02973087|583894689|FG001|Overall Study|Adverse Event|0|||
161683741|NCT02973087|583894688|FG000|Overall Study|other|1|||
161683742|NCT02973087|583894689|FG001|Overall Study|other|1|||
161683743|NCT03710486|583894690|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
161683744|NCT03710486|583894691|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
161683745|NCT03710486|583894690|FG000|Overall Study|Missing|0|||
161683746|NCT03710486|583894691|FG001|Overall Study|Missing|2|||
161683747|NCT01279850|583894696|FG000|Overall Study|Protocol Violation|50|||
161683748|NCT01279850|583894696|FG000|Overall Study|No Drug Administration Information|7|||
161683749|NCT01279850|583894696|FG000|Overall Study|No Visit After Treatment|34|||
161606504|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161606505|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161606506|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161606507|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
161683750|NCT01147744|583894697|FG000|Overall Study|Protocol Violation|1|||
161683751|NCT01147744|583894698|FG001|Overall Study|Protocol Violation|0|||
161683752|NCT01147744|583894699|FG002|Overall Study|Protocol Violation|1|||
161683753|NCT01147744|583894700|FG003|Overall Study|Protocol Violation|0|||
161683754|NCT01147744|583894701|FG004|Overall Study|Protocol Violation|1|||
161683755|NCT01147744|583894702|FG005|Overall Study|Protocol Violation|3|||
161683756|NCT01147744|583894703|FG006|Overall Study|Protocol Violation|1|||
161683757|NCT01147744|583894697|FG000|Overall Study|Physician Decision|0|||
161683758|NCT01147744|583894698|FG001|Overall Study|Physician Decision|1|||
161683759|NCT01147744|583894699|FG002|Overall Study|Physician Decision|1|||
161683760|NCT01147744|583894700|FG003|Overall Study|Physician Decision|0|||
161683761|NCT01147744|583894701|FG004|Overall Study|Physician Decision|0|||
161683762|NCT01147744|583894702|FG005|Overall Study|Physician Decision|0|||
161683763|NCT01147744|583894703|FG006|Overall Study|Physician Decision|1|||
161683764|NCT01147744|583894697|FG000|Overall Study|Lack of Efficacy|11|||
161832361|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832362|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
161832363|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832364|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832365|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
161683765|NCT01147744|583894698|FG001|Overall Study|Lack of Efficacy|11|||
161683766|NCT01147744|583894699|FG002|Overall Study|Lack of Efficacy|9|||
161683767|NCT01147744|583894700|FG003|Overall Study|Lack of Efficacy|11|||
161683768|NCT01147744|583894701|FG004|Overall Study|Lack of Efficacy|13|||
161683769|NCT01147744|583894702|FG005|Overall Study|Lack of Efficacy|8|||
161683770|NCT01147744|583894703|FG006|Overall Study|Lack of Efficacy|7|||
161683771|NCT01147744|583894697|FG000|Overall Study|Adverse Event|1|||
161683772|NCT01147744|583894698|FG001|Overall Study|Adverse Event|2|||
161683773|NCT01147744|583894699|FG002|Overall Study|Adverse Event|3|||
161683774|NCT01147744|583894700|FG003|Overall Study|Adverse Event|0|||
161683775|NCT01147744|583894701|FG004|Overall Study|Adverse Event|2|||
161683776|NCT01147744|583894702|FG005|Overall Study|Adverse Event|1|||
161683777|NCT01147744|583894703|FG006|Overall Study|Adverse Event|2|||
161683778|NCT01147744|583894697|FG000|Overall Study|Withdrawal by Subject|8|||
161683779|NCT01147744|583894698|FG001|Overall Study|Withdrawal by Subject|4|||
161683780|NCT01147744|583894699|FG002|Overall Study|Withdrawal by Subject|2|||
161683781|NCT01147744|583894700|FG003|Overall Study|Withdrawal by Subject|2|||
161683782|NCT01147744|583894701|FG004|Overall Study|Withdrawal by Subject|2|||
161683783|NCT01147744|583894702|FG005|Overall Study|Withdrawal by Subject|5|||
161683784|NCT01147744|583894703|FG006|Overall Study|Withdrawal by Subject|2|||
161683785|NCT01147744|583894697|FG000|Overall Study|Lost to Follow-up|0|||
161683786|NCT01147744|583894698|FG001|Overall Study|Lost to Follow-up|1|||
161683787|NCT01147744|583894699|FG002|Overall Study|Lost to Follow-up|0|||
161683788|NCT01147744|583894700|FG003|Overall Study|Lost to Follow-up|0|||
161683789|NCT01147744|583894701|FG004|Overall Study|Lost to Follow-up|0|||
161683790|NCT01147744|583894702|FG005|Overall Study|Lost to Follow-up|0|||
161683791|NCT01147744|583894703|FG006|Overall Study|Lost to Follow-up|0|||
161683792|NCT01147744|583894697|FG000|Overall Study|Sponsor decision to amend protocol|7|||
161683793|NCT01147744|583894698|FG001|Overall Study|Sponsor decision to amend protocol|4|||
161683794|NCT01147744|583894699|FG002|Overall Study|Sponsor decision to amend protocol|2|||
161683795|NCT01147744|583894700|FG003|Overall Study|Sponsor decision to amend protocol|5|||
161683796|NCT01147744|583894701|FG004|Overall Study|Sponsor decision to amend protocol|7|||
161683797|NCT01147744|583894702|FG005|Overall Study|Sponsor decision to amend protocol|2|||
161683798|NCT01147744|583894703|FG006|Overall Study|Sponsor decision to amend protocol|6|||
161683799|NCT01147744|583894697|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161683800|NCT01147744|583894698|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683801|NCT01147744|583894699|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683802|NCT01147744|583894700|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683803|NCT01147744|583894701|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683804|NCT01147744|583894702|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161683805|NCT01147744|583894703|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683806|NCT01342484|583894712|FG000|Overall Study|Other Reasons|1|||
161683807|NCT01342484|583894713|FG001|Overall Study|Other Reasons|0|||
161683808|NCT01342484|583894714|FG002|Overall Study|Other Reasons|0|||
161683809|NCT01342484|583894712|FG000|Overall Study|Protocol Violation|0|||
161832366|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832367|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832368|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
161606508|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161606509|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161606510|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161606511|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161606512|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
161606513|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161606514|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161606515|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161606516|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161606517|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
161606518|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161606519|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161606520|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161606521|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161606522|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
161606523|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161683810|NCT01342484|583894713|FG001|Overall Study|Protocol Violation|0|||
161683811|NCT01342484|583894714|FG002|Overall Study|Protocol Violation|1|||
161683812|NCT01342484|583894712|FG000|Overall Study|Withdrawal by Subject|1|||
161683813|NCT01342484|583894713|FG001|Overall Study|Withdrawal by Subject|0|||
161683814|NCT01342484|583894714|FG002|Overall Study|Withdrawal by Subject|0|||
161606524|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161606525|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161606526|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161683815|NCT00432042|583894715|FG000|Overall Study|Protocol Violation|2|||
161683816|NCT00432042|583894716|FG001|Overall Study|Protocol Violation|0|||
161683817|NCT00432042|583894717|FG002|Overall Study|Protocol Violation|0|||
161832369|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832370|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
161683818|NCT00432042|583894715|FG000|Overall Study|Withdrawal by Subject|0|||
161606527|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
161606528|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161606529|NCT00439270|583612084|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161606530|NCT00439270|583612085|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161606531|NCT00439270|583612086|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161606532|NCT00439270|583612087|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
161606533|NCT00439270|583612088|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161606534|NCT01268306|583612089|FG000|Overall Study|Lost to Follow-up|1|||
161606535|NCT03286114|583612094|FG000|Overall Study|Adverse Event|6|||
161606536|NCT03286114|583612094|FG000|Overall Study|Death|3|||
161606537|NCT01171976|583612099|FG000|Overall Study|Protocol Violation|0|||
161606538|NCT01171976|583612100|FG001|Overall Study|Protocol Violation|0|||
161606539|NCT01171976|583612101|FG002|Overall Study|Protocol Violation|1|||
161606540|NCT01171976|583612099|FG000|Overall Study|Death|2|||
161606541|NCT01171976|583612100|FG001|Overall Study|Death|4|||
161606542|NCT01171976|583612101|FG002|Overall Study|Death|1|||
161606543|NCT01171976|583612099|FG000|Overall Study|Lost to Follow-up|4|||
161606544|NCT01171976|583612100|FG001|Overall Study|Lost to Follow-up|0|||
161606545|NCT01171976|583612101|FG002|Overall Study|Lost to Follow-up|2|||
161606546|NCT01171976|583612099|FG000|Overall Study|Withdrawal by Subject|1|||
161606547|NCT01171976|583612100|FG001|Overall Study|Withdrawal by Subject|5|||
161606548|NCT01171976|583612101|FG002|Overall Study|Withdrawal by Subject|6|||
161606549|NCT01171976|583612099|FG000|Overall Study|Abnormal test result|1|||
161606550|NCT01171976|583612100|FG001|Overall Study|Abnormal test result|0|||
161606551|NCT01171976|583612101|FG002|Overall Study|Abnormal test result|0|||
161606552|NCT01171976|583612099|FG000|Overall Study|Adverse Event|6|||
161606553|NCT01171976|583612100|FG001|Overall Study|Adverse Event|2|||
161606554|NCT01171976|583612101|FG002|Overall Study|Adverse Event|5|||
161606555|NCT00003222|583612104|FG000|Overall Study|Physician Decision|0|||
161606556|NCT00003222|583612105|FG001|Overall Study|Physician Decision|1|||
161683819|NCT00432042|583894716|FG001|Overall Study|Withdrawal by Subject|0|||
161683820|NCT00432042|583894717|FG002|Overall Study|Withdrawal by Subject|2|||
161606557|NCT01313559|583612112|FG000|Overall Study|Withdrawal by Subject|1|||
161606558|NCT01313559|583612113|FG001|Overall Study|Withdrawal by Subject|2|||
161606559|NCT01313559|583612112|FG000|Overall Study|Disease progression|1|||
161606560|NCT01313559|583612113|FG001|Overall Study|Disease progression|0|||
161606561|NCT01313559|583612112|FG000|Overall Study|Rising PSA|2|||
161606562|NCT01313559|583612113|FG001|Overall Study|Rising PSA|0|||
161606563|NCT03872466|583612114|FG000|Overall Study|Withdrawal by Subject|1|||
161832371|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832372|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161606564|NCT03872466|583612115|FG001|Overall Study|Withdrawal by Subject|0|||
161606565|NCT03872466|583612114|FG000|Overall Study|Physician Decision|2|||
161606566|NCT03872466|583612115|FG001|Overall Study|Physician Decision|0|||
161606567|NCT01778686|583612116|FG000|Overall Study|Adverse Event|0|||
161606568|NCT01778686|583612117|FG001|Overall Study|Adverse Event|0|||
161606569|NCT01778686|583612118|FG002|Overall Study|Adverse Event|1|||
161606570|NCT04012567|583612119|FG000|Overall Study|Lost to Follow-up|0|||
161606571|NCT04012567|583612120|FG001|Overall Study|Lost to Follow-up|1|||
161606572|NCT04012567|583612119|FG000|Overall Study|Withdrawal by Subject|1|||
161606573|NCT04012567|583612120|FG001|Overall Study|Withdrawal by Subject|0|||
161606574|NCT04018495|583612122|FG000|Overall Study|Physician Decision|1|||
161606575|NCT05934292|583612131|FG000|Overall Study|Lost to Follow-up|0|||
161606576|NCT05934292|583612132|FG001|Overall Study|Lost to Follow-up|0|||
161606577|NCT05934292|583612133|FG002|Overall Study|Lost to Follow-up|1|||
161606578|NCT05934292|583612134|FG003|Overall Study|Lost to Follow-up|0|||
161606579|NCT05714059|583612137|FG000|Overall Study|Withdrawal by Subject|2|||
161606580|NCT05714059|583612138|FG001|Overall Study|Withdrawal by Subject|2|||
161606581|NCT05714059|583612137|FG000|Overall Study|Adverse Event|0|||
161606582|NCT05714059|583612138|FG001|Overall Study|Adverse Event|1|||
161606583|NCT05714059|583612137|FG000|Overall Study|Lost to Follow-up|0|||
161606584|NCT05714059|583612138|FG001|Overall Study|Lost to Follow-up|1|||
161606585|NCT05714059|583612137|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
161606586|NCT05714059|583612138|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
161606587|NCT05714059|583612137|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
161606588|NCT05714059|583612138|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
161606589|NCT04899674|583612139|FG000|Test|Adverse Event|1|||
161606590|NCT01288443|583612993|FG000|Overall Study|Adverse Event|0|||
161606591|NCT01288443|583612994|FG001|Overall Study|Adverse Event|0|||
161683821|NCT00432042|583894715|FG000|Overall Study|Lost to Follow-up|5|||
161683822|NCT00432042|583894716|FG001|Overall Study|Lost to Follow-up|1|||
161683823|NCT00432042|583894717|FG002|Overall Study|Lost to Follow-up|0|||
161606592|NCT01288443|583612995|FG002|Overall Study|Adverse Event|1|||
161606593|NCT01288443|583612996|FG003|Overall Study|Adverse Event|1|||
161606594|NCT01288443|583612997|FG004|Overall Study|Adverse Event|3|||
161606595|NCT01288443|583612998|FG005|Overall Study|Adverse Event|1|||
161606596|NCT01288443|583612993|FG000|Overall Study|Poor compliance to protocol|0|||
161606597|NCT01288443|583612994|FG001|Overall Study|Poor compliance to protocol|0|||
161606598|NCT01288443|583612995|FG002|Overall Study|Poor compliance to protocol|0|||
161606599|NCT01288443|583612996|FG003|Overall Study|Poor compliance to protocol|0|||
161683824|NCT01744665|583894719|FG000|Monitoring Phase|Adverse Event|4|||
161683825|NCT01744665|583894719|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
161683826|NCT01744665|583894719|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
161683827|NCT01744665|583894719|FG000|Monitoring Phase|Withdrawal by Subject|5|||
161683828|NCT01744665|583894719|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
161683829|NCT01744665|583894719|FG000|Consolidation Phase|Adverse Event|2|||
161683830|NCT01744665|583894719|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
161832373|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832374|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832375|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
161832376|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
161832377|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
161832378|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
161832379|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832380|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832381|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832382|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161606600|NCT01288443|583612997|FG004|Overall Study|Poor compliance to protocol|0|||
161606601|NCT01288443|583612998|FG005|Overall Study|Poor compliance to protocol|1|||
161606602|NCT01288443|583612993|FG000|Overall Study|Participant Moved|0|||
161606603|NCT01288443|583612994|FG001|Overall Study|Participant Moved|0|||
161606604|NCT01288443|583612995|FG002|Overall Study|Participant Moved|0|||
161606605|NCT01288443|583612996|FG003|Overall Study|Participant Moved|1|||
161606606|NCT01288443|583612997|FG004|Overall Study|Participant Moved|2|||
161606607|NCT01288443|583612998|FG005|Overall Study|Participant Moved|1|||
161683831|NCT01744665|583894719|FG000|Consolidation Phase|Withdrawal by Subject|4|||
161832383|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832384|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161832385|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832386|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832387|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
161832388|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
161832389|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
161832390|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832391|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832392|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832393|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832394|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832395|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832396|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832397|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832398|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832399|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832400|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832401|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
161832402|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
161832403|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832404|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832405|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832406|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832407|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832408|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832409|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832410|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832411|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832412|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
161832413|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
161832414|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
161832415|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832416|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832417|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832418|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832419|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832420|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161683832|NCT01744665|583894719|FG000|Consolidation Phase|Administrative problems|9|||
161683833|NCT01744665|583894719|FG000|Re-initiation Phase|Administrative problems|10|||
161683834|NCT01744665|583894719|FG000|Re-initiation Phase|Adverse Event|1|||
161683835|NCT01744665|583894719|FG000|Re-initiation Phase|No longer required treatment|1|||
161683836|NCT01744665|583894719|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
161683837|NCT00492752|583894720|FG000|Double Blind Treatment|Death|13|||
161683838|NCT00492752|583894721|FG001|Double Blind Treatment|Death|0|||
161683839|NCT00492752|583894722|FG002|Double Blind Treatment|Death|2|||
161683840|NCT00492752|583894723|FG003|Double Blind Treatment|Death|0|||
161683841|NCT00492752|583894720|FG000|Double Blind Treatment|Adverse Event|1|||
161683842|NCT00492752|583894721|FG001|Double Blind Treatment|Adverse Event|0|||
161683843|NCT00492752|583894722|FG002|Double Blind Treatment|Adverse Event|0|||
161683844|NCT00492752|583894723|FG003|Double Blind Treatment|Adverse Event|0|||
161683845|NCT00492752|583894720|FG000|Double Blind Treatment|Protocol Violation|0|||
161683846|NCT00492752|583894721|FG001|Double Blind Treatment|Protocol Violation|0|||
161683847|NCT00492752|583894722|FG002|Double Blind Treatment|Protocol Violation|1|||
161683848|NCT00492752|583894723|FG003|Double Blind Treatment|Protocol Violation|0|||
161683849|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
161683850|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
161683851|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
161683852|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
161683853|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
161683854|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
161683855|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
161683856|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
161683857|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
161683858|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
161683859|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
161683860|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
161606608|NCT01288443|583612993|FG000|Overall Study|Consent withdrawn by Participant|0|||
161606609|NCT01288443|583612994|FG001|Overall Study|Consent withdrawn by Participant|0|||
161606610|NCT01288443|583612995|FG002|Overall Study|Consent withdrawn by Participant|0|||
161606611|NCT01288443|583612996|FG003|Overall Study|Consent withdrawn by Participant|0|||
161606612|NCT01288443|583612997|FG004|Overall Study|Consent withdrawn by Participant|0|||
161606613|NCT01288443|583612998|FG005|Overall Study|Consent withdrawn by Participant|1|||
161606614|NCT01288443|583612993|FG000|Overall Study|Lost to Follow-up|0|||
161606615|NCT01288443|583612994|FG001|Overall Study|Lost to Follow-up|1|||
161606616|NCT01288443|583612995|FG002|Overall Study|Lost to Follow-up|0|||
161606617|NCT01288443|583612996|FG003|Overall Study|Lost to Follow-up|0|||
161606618|NCT01288443|583612997|FG004|Overall Study|Lost to Follow-up|0|||
161606619|NCT01288443|583612998|FG005|Overall Study|Lost to Follow-up|0|||
161606620|NCT01288443|583612993|FG000|Overall Study|Study drug auto-injector administration|0|||
161606621|NCT01288443|583612994|FG001|Overall Study|Study drug auto-injector administration|0|||
161606622|NCT01288443|583612995|FG002|Overall Study|Study drug auto-injector administration|0|||
161606623|NCT01288443|583612996|FG003|Overall Study|Study drug auto-injector administration|0|||
161606624|NCT01288443|583612997|FG004|Overall Study|Study drug auto-injector administration|1|||
161606625|NCT01288443|583612998|FG005|Overall Study|Study drug auto-injector administration|1|||
161606626|NCT01288443|583612993|FG000|Overall Study|Other than above|0|||
161606627|NCT01288443|583612994|FG001|Overall Study|Other than above|0|||
161606628|NCT01288443|583612995|FG002|Overall Study|Other than above|0|||
161606629|NCT01288443|583612996|FG003|Overall Study|Other than above|2|||
161606630|NCT01288443|583612997|FG004|Overall Study|Other than above|1|||
161606631|NCT01288443|583612998|FG005|Overall Study|Other than above|0|||
161606632|NCT00945321|583613003|FG000|Period 1|Adverse Event|0|||
161606633|NCT00945321|583613004|FG001|Period 1|Adverse Event|0|||
161606634|NCT00945321|583613005|FG002|Period 1|Adverse Event|0|||
161606635|NCT00945321|583613006|FG003|Period 1|Adverse Event|0|||
161606636|NCT00945321|583613007|FG004|Period 1|Adverse Event|1|||
161606637|NCT00945321|583613008|FG005|Period 1|Adverse Event|0|||
161606638|NCT00945321|583613003|FG000|Period 4|Lost to Follow-up|0|||
161606639|NCT00945321|583613004|FG001|Period 4|Lost to Follow-up|0|||
161606640|NCT00945321|583613005|FG002|Period 4|Lost to Follow-up|0|||
161606641|NCT00945321|583613006|FG003|Period 4|Lost to Follow-up|0|||
161606642|NCT00945321|583613007|FG004|Period 4|Lost to Follow-up|0|||
161606643|NCT00945321|583613008|FG005|Period 4|Lost to Follow-up|1|||
161606644|NCT02438137|583613009|FG000|Overall Study|Lost to Follow-up|3|||
161606645|NCT02438137|583613010|FG001|Overall Study|Lost to Follow-up|2|||
161606646|NCT02438137|583613009|FG000|Overall Study|Adverse Event|1|||
161606647|NCT02438137|583613010|FG001|Overall Study|Adverse Event|0|||
161606648|NCT02438137|583613009|FG000|Overall Study|Withdrawal by Subject|4|||
161606649|NCT02438137|583613010|FG001|Overall Study|Withdrawal by Subject|3|||
161606650|NCT02438137|583613009|FG000|Overall Study|Physician Decision|0|||
161606651|NCT02438137|583613010|FG001|Overall Study|Physician Decision|1|||
161606652|NCT00692913|583613011|FG000|Overall Study|Adverse Event|8|||
161606653|NCT00692913|583613012|FG001|Overall Study|Adverse Event|4|||
161606654|NCT00692913|583613011|FG000|Overall Study|Lost to Follow-up|3|||
161606655|NCT00692913|583613012|FG001|Overall Study|Lost to Follow-up|5|||
161606656|NCT00692913|583613011|FG000|Overall Study|Physician Decision|2|||
161606657|NCT00692913|583613012|FG001|Overall Study|Physician Decision|0|||
161606658|NCT00692913|583613011|FG000|Overall Study|Protocol Violation|1|||
161606659|NCT00692913|583613012|FG001|Overall Study|Protocol Violation|1|||
161606660|NCT00692913|583613011|FG000|Overall Study|Withdrawal by Subject|15|||
161606661|NCT00692913|583613012|FG001|Overall Study|Withdrawal by Subject|20|||
161606662|NCT02291913|583613013|FG000|Overall Study|Progressive Disease|32|||
161832421|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832422|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161606663|NCT02291913|583613013|FG000|Overall Study|Adverse Event|11|||
161606664|NCT02291913|583613013|FG000|Overall Study|Death|2|||
161606665|NCT02291913|583613013|FG000|Overall Study|Physician Decision|1|||
161606666|NCT02291913|583613013|FG000|Overall Study|Withdrawal by Subject|1|||
161606667|NCT02291913|583613013|FG000|Overall Study|Protocol Violation|1|||
161606668|NCT03621735|583613014|FG000|Overall Study|Withdrawal by Subject|13|||
161606669|NCT03621735|583613015|FG001|Overall Study|Withdrawal by Subject|13|||
161606670|NCT04334317|583613016|FG000|Overall Study|Adverse Event|1|||
161606671|NCT04334317|583613017|FG001|Overall Study|Adverse Event|2|||
161606672|NCT04334317|583613018|FG002|Overall Study|Adverse Event|0|||
161606673|NCT04334317|583613019|FG003|Overall Study|Adverse Event|0|||
161606674|NCT04334317|583613016|FG000|Overall Study|Protocol Deviation|0|||
161606675|NCT04334317|583613017|FG001|Overall Study|Protocol Deviation|1|||
161606676|NCT04334317|583613018|FG002|Overall Study|Protocol Deviation|0|||
161606677|NCT04334317|583613019|FG003|Overall Study|Protocol Deviation|0|||
161606678|NCT04334317|583613016|FG000|Overall Study|Withdrawal by Subject|2|||
161606679|NCT04334317|583613017|FG001|Overall Study|Withdrawal by Subject|2|||
161606680|NCT04334317|583613018|FG002|Overall Study|Withdrawal by Subject|0|||
161606681|NCT04334317|583613019|FG003|Overall Study|Withdrawal by Subject|0|||
161606682|NCT00605306|583613022|FG000|Overall Study|Adverse Event|0|||
161606683|NCT00605306|583613023|FG001|Overall Study|Adverse Event|1|||
161606684|NCT03875313|583613026|FG000|Overall Study|Withdrawal by Subject|1|||
161606685|NCT03875313|583613027|FG001|Overall Study|Withdrawal by Subject|3|||
161606686|NCT03875313|583613028|FG002|Overall Study|Withdrawal by Subject|0|||
161606687|NCT03875313|583613029|FG003|Overall Study|Withdrawal by Subject|0|||
161606688|NCT03875313|583613030|FG004|Overall Study|Withdrawal by Subject|0|||
161606689|NCT03875313|583613026|FG000|Overall Study|Death|0|||
161606690|NCT03875313|583613027|FG001|Overall Study|Death|0|||
161606691|NCT03875313|583613028|FG002|Overall Study|Death|0|||
161606692|NCT03875313|583613029|FG003|Overall Study|Death|0|||
161606693|NCT03875313|583613030|FG004|Overall Study|Death|1|||
161606694|NCT03875313|583613026|FG000|Overall Study|Lost to Follow-up|0|||
161606695|NCT03875313|583613027|FG001|Overall Study|Lost to Follow-up|0|||
161606696|NCT03875313|583613028|FG002|Overall Study|Lost to Follow-up|0|||
161606697|NCT03875313|583613029|FG003|Overall Study|Lost to Follow-up|0|||
161606698|NCT03875313|583613030|FG004|Overall Study|Lost to Follow-up|1|||
161606699|NCT03875313|583613026|FG000|Overall Study|Study Termination by Sponsor|0|||
161606700|NCT03875313|583613027|FG001|Overall Study|Study Termination by Sponsor|1|||
161606701|NCT03875313|583613028|FG002|Overall Study|Study Termination by Sponsor|1|||
161606702|NCT03875313|583613029|FG003|Overall Study|Study Termination by Sponsor|0|||
161606703|NCT03875313|583613030|FG004|Overall Study|Study Termination by Sponsor|1|||
161606704|NCT03875313|583613026|FG000|Overall Study|New Anticancer Treatment|0|||
161606705|NCT03875313|583613027|FG001|Overall Study|New Anticancer Treatment|1|||
161606706|NCT03875313|583613028|FG002|Overall Study|New Anticancer Treatment|2|||
161606707|NCT03875313|583613029|FG003|Overall Study|New Anticancer Treatment|1|||
161606708|NCT03875313|583613030|FG004|Overall Study|New Anticancer Treatment|0|||
161606709|NCT03875313|583613026|FG000|Overall Study|Other, Not Specified|2|||
161606710|NCT03875313|583613027|FG001|Overall Study|Other, Not Specified|11|||
161606711|NCT03875313|583613028|FG002|Overall Study|Other, Not Specified|3|||
161606712|NCT03875313|583613029|FG003|Overall Study|Other, Not Specified|3|||
161606713|NCT03875313|583613030|FG004|Overall Study|Other, Not Specified|1|||
161606714|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
161606715|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
161606716|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
161606717|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
161606718|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
161606719|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
161606720|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
161606721|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
161606722|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
161606723|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161606724|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161606725|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161606726|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
161606727|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
161606728|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
161606729|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
161606730|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
161606731|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
161606732|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
161606733|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
161606734|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
161606735|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
161606736|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
161606737|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
161606738|NCT01074294|583613031|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
161606739|NCT01074294|583613032|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
161606740|NCT01074294|583613033|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
161606741|NCT01074294|583613034|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
161606742|NCT01074294|583613031|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
161606743|NCT01074294|583613032|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
161606744|NCT01074294|583613033|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
161606745|NCT01074294|583613034|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
161606746|NCT01074294|583613031|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
161606747|NCT01074294|583613032|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
161606748|NCT01074294|583613033|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
161606749|NCT01074294|583613034|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
161606750|NCT01074294|583613031|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
161606751|NCT01074294|583613032|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
161606752|NCT01074294|583613033|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
161606753|NCT01074294|583613034|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
161606754|NCT01074294|583613031|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
161606755|NCT01074294|583613032|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
161606756|NCT01074294|583613033|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
161606757|NCT01074294|583613034|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
161606758|NCT01074294|583613031|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
161606759|NCT01074294|583613032|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
161606760|NCT01074294|583613033|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
161606761|NCT01074294|583613034|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
161606762|NCT01074294|583613031|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
161606763|NCT01074294|583613032|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
161683861|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
161683862|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
161683863|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
161683864|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
161683865|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
161683866|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
161683867|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
161683868|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
161683869|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161683870|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161683871|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161683872|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
161683873|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161683874|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
161683875|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161683876|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161683877|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
161683878|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161683879|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161683880|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161683881|NCT04857996|583894724|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
161683882|NCT04857996|583894725|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
161683883|NCT04857996|583894724|FG000|Overall Study|Lost to Follow-up|1|||
161683884|NCT04857996|583894725|FG001|Overall Study|Lost to Follow-up|3|||
161683885|NCT04857996|583894724|FG000|Overall Study|Site Closure|1|||
161683886|NCT04857996|583894725|FG001|Overall Study|Site Closure|0|||
161683887|NCT04857996|583894724|FG000|Overall Study|Withdrawal by Subject|1|||
161683888|NCT04857996|583894725|FG001|Overall Study|Withdrawal by Subject|0|||
161683889|NCT02988661|583894726|FG000|Overall Study|Death|2|||
161683890|NCT02988661|583894727|FG001|Overall Study|Death|18|||
161683891|NCT02988661|583894726|FG000|Overall Study|Lost to Follow-up|0|||
161683892|NCT02988661|583894727|FG001|Overall Study|Lost to Follow-up|33|||
161683893|NCT02988661|583894726|FG000|Overall Study|Withdrawal by Subject|0|||
161683894|NCT02988661|583894727|FG001|Overall Study|Withdrawal by Subject|6|||
161683895|NCT02988661|583894726|FG000|Overall Study|Unable to complete the 18-month survey|1|||
161683896|NCT02988661|583894727|FG001|Overall Study|Unable to complete the 18-month survey|27|||
161683897|NCT04050982|583894728|FG000|Overall Study|Did not meet eligibility criteria|0|||
161683898|NCT04050982|583894729|FG001|Overall Study|Did not meet eligibility criteria|1|||
161683899|NCT04050982|583894730|FG002|Overall Study|Did not meet eligibility criteria|0|||
161683900|NCT04050982|583894728|FG000|Overall Study|Withdrawal by Subject|1|||
161683901|NCT04050982|583894729|FG001|Overall Study|Withdrawal by Subject|0|||
161683902|NCT04050982|583894730|FG002|Overall Study|Withdrawal by Subject|0|||
161683903|NCT04050982|583894728|FG000|Overall Study|Unable to enroll on platform|1|||
161683904|NCT04050982|583894729|FG001|Overall Study|Unable to enroll on platform|0|||
161683905|NCT04050982|583894730|FG002|Overall Study|Unable to enroll on platform|0|||
161683906|NCT04649255|583895877|FG000|Overall Study|Death|9|||
161683907|NCT04649255|583895877|FG000|Overall Study|Withdrawal by Subject|1|||
161683908|NCT02222207|583895881|FG000|Overall Study|Death|1|||
161683909|NCT02222207|583895881|FG000|Overall Study|Other reasons|2|||
161683910|NCT02222207|583895881|FG000|Overall Study|Adverse Event|1|||
161683911|NCT04682405|583895882|FG000|Overall Study|Adverse Event|0|||
161683912|NCT04682405|583895883|FG001|Overall Study|Adverse Event|1|||
161683913|NCT00747643|583895884|FG000|Overall Study|Withdrawal by Subject|36|||
161683914|NCT00747643|583895885|FG001|Overall Study|Withdrawal by Subject|27|||
161606764|NCT01074294|583613033|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
161606765|NCT01074294|583613034|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
161606766|NCT03248492|583613035|FG000|Overall Study|Progressive Disease|24|||
161606767|NCT03248492|583613036|FG001|Overall Study|Progressive Disease|23|||
161606768|NCT03248492|583613037|FG002|Overall Study|Progressive Disease|11|||
161606769|NCT03248492|583613038|FG003|Overall Study|Progressive Disease|66|||
161606770|NCT03248492|583613039|FG004|Overall Study|Progressive Disease|1|||
161606771|NCT03248492|583613035|FG000|Overall Study|Adverse Event|14|||
161606772|NCT03248492|583613036|FG001|Overall Study|Adverse Event|13|||
161606773|NCT03248492|583613037|FG002|Overall Study|Adverse Event|9|||
161606774|NCT03248492|583613038|FG003|Overall Study|Adverse Event|22|||
161606775|NCT03248492|583613039|FG004|Overall Study|Adverse Event|2|||
161606776|NCT03248492|583613035|FG000|Overall Study|Withdrawal by Subject|5|||
161606777|NCT03248492|583613036|FG001|Overall Study|Withdrawal by Subject|4|||
161606778|NCT03248492|583613037|FG002|Overall Study|Withdrawal by Subject|0|||
161606779|NCT03248492|583613038|FG003|Overall Study|Withdrawal by Subject|8|||
161606780|NCT03248492|583613039|FG004|Overall Study|Withdrawal by Subject|1|||
161606781|NCT03248492|583613035|FG000|Overall Study|Physician Decision|1|||
161606782|NCT03248492|583613036|FG001|Overall Study|Physician Decision|1|||
161606783|NCT03248492|583613037|FG002|Overall Study|Physician Decision|1|||
161606784|NCT03248492|583613038|FG003|Overall Study|Physician Decision|7|||
161606785|NCT03248492|583613039|FG004|Overall Study|Physician Decision|0|||
161606786|NCT03248492|583613035|FG000|Overall Study|Death|1|||
161606787|NCT03248492|583613036|FG001|Overall Study|Death|1|||
161606788|NCT03248492|583613037|FG002|Overall Study|Death|0|||
161606789|NCT03248492|583613038|FG003|Overall Study|Death|6|||
161606790|NCT03248492|583613039|FG004|Overall Study|Death|0|||
161606791|NCT03248492|583613035|FG000|Overall Study|Study Terminated by Sponsor|3|||
161606792|NCT03248492|583613036|FG001|Overall Study|Study Terminated by Sponsor|1|||
161606793|NCT03248492|583613037|FG002|Overall Study|Study Terminated by Sponsor|0|||
161606794|NCT03248492|583613038|FG003|Overall Study|Study Terminated by Sponsor|7|||
161606795|NCT03248492|583613039|FG004|Overall Study|Study Terminated by Sponsor|0|||
161606796|NCT03248492|583613035|FG000|Overall Study|Other|2|||
161606797|NCT03248492|583613036|FG001|Overall Study|Other|5|||
161606798|NCT03248492|583613037|FG002|Overall Study|Other|0|||
161606799|NCT03248492|583613038|FG003|Overall Study|Other|14|||
161606800|NCT03248492|583613039|FG004|Overall Study|Other|0|||
161606801|NCT04495621|583613040|FG000|Overall Study|Withdrawal by Subject|0|||
161606802|NCT04495621|583613041|FG001|Overall Study|Withdrawal by Subject|3|||
161606803|NCT04495621|583613040|FG000|Overall Study|Death|7|||
161606804|NCT04495621|583613041|FG001|Overall Study|Death|11|||
161606805|NCT04495621|583613040|FG000|Overall Study|Investigator Decision|0|||
161606806|NCT04495621|583613041|FG001|Overall Study|Investigator Decision|7|||
161606807|NCT04495621|583613040|FG000|Overall Study|Lost to Follow-up|0|||
161606808|NCT04495621|583613041|FG001|Overall Study|Lost to Follow-up|1|||
161606809|NCT03774472|583613045|FG000|Overall Study|Physician Decision|1|||
161606810|NCT03774472|583613046|FG001|Overall Study|Physician Decision|0|||
161606811|NCT03774472|583613047|FG002|Overall Study|Physician Decision|0|||
161606812|NCT03774472|583613045|FG000|Overall Study|Progression prior to 4 weeks|0|||
161606813|NCT03774472|583613046|FG001|Overall Study|Progression prior to 4 weeks|1|||
161606814|NCT03774472|583613047|FG002|Overall Study|Progression prior to 4 weeks|0|||
161606815|NCT03774472|583613045|FG000|Overall Study|Withdrawal by Subject|0|||
161606816|NCT03774472|583613046|FG001|Overall Study|Withdrawal by Subject|1|||
161606817|NCT03774472|583613047|FG002|Overall Study|Withdrawal by Subject|0|||
161606818|NCT04059406|583613048|FG000|Overall Study|Early Treatment Termination|5|||
161606819|NCT04059406|583613049|FG001|Overall Study|Early Treatment Termination|5|||
161606820|NCT04059406|583613050|FG002|Overall Study|Early Treatment Termination|15|||
161606821|NCT05155306|583613055|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
161606822|NCT05155306|583613056|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
161606823|NCT05155306|583613057|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
161606824|NCT05155306|583613058|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
161606825|NCT05155306|583613055|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
161606826|NCT05155306|583613056|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
161606827|NCT05155306|583613057|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
161606828|NCT05155306|583613058|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
161606829|NCT04158141|583613059|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
161606830|NCT04158141|583613060|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
161606831|NCT04158141|583613061|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
161606832|NCT04158141|583613059|FG000|Step 1: Registration|Adverse Event|1|||
161606833|NCT04158141|583613060|FG001|Step 1: Registration|Adverse Event|0|||
161606834|NCT04158141|583613061|FG002|Step 1: Registration|Adverse Event|0|||
161606835|NCT04158141|583613059|FG000|Step 1: Registration|Withdrawal by Subject|1|||
161606836|NCT04158141|583613060|FG001|Step 1: Registration|Withdrawal by Subject|0|||
161606837|NCT04158141|583613061|FG002|Step 1: Registration|Withdrawal by Subject|0|||
161606838|NCT04158141|583613059|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
161606839|NCT04158141|583613060|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
161606840|NCT04158141|583613061|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
161606841|NCT04121741|583613062|FG000|Overall Study|Protocol Violation|1|||
161606842|NCT04121741|583613063|FG001|Overall Study|Protocol Violation|0|||
161606843|NCT04121741|583613064|FG002|Overall Study|Protocol Violation|0|||
161606844|NCT04121741|583613065|FG003|Overall Study|Protocol Violation|0|||
161606845|NCT04121741|583613066|FG004|Overall Study|Protocol Violation|0|||
161606846|NCT04121741|583613067|FG005|Overall Study|Protocol Violation|0|||
161606847|NCT01084863|583613069|FG000|Main Study Treatment Period|Disease progression|11|||
161606848|NCT01084863|583613070|FG001|Main Study Treatment Period|Disease progression|7|||
161606849|NCT01084863|583613069|FG000|Main Study Treatment Period|Adverse Event|5|||
161606850|NCT01084863|583613070|FG001|Main Study Treatment Period|Adverse Event|3|||
161606851|NCT01084863|583613069|FG000|Main Study Treatment Period|Other Reason|0|||
161606852|NCT01084863|583613070|FG001|Main Study Treatment Period|Other Reason|1|||
161606853|NCT01084863|583613069|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
161606854|NCT01084863|583613070|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
161606855|NCT01084863|583613069|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
161606856|NCT01084863|583613070|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
161606857|NCT01084863|583613069|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
161606858|NCT01084863|583613070|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
161606859|NCT01084863|583613069|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
161606860|NCT01084863|583613070|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
161606861|NCT01084863|583613069|FG000|Treatment Period Beyond Cycle 8|Other|0|||
161606862|NCT01084863|583613070|FG001|Treatment Period Beyond Cycle 8|Other|1|||
161606863|NCT01084863|583613069|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
161606864|NCT01084863|583613070|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
161606865|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
161606866|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
161606867|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
161606868|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
161606869|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
161606870|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
161606871|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
161606872|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
161606873|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
161606874|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
161606875|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
161606876|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
161606877|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
161606878|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
161606879|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
161606880|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
161606881|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
161606882|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
161606883|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
161606884|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
161606885|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
161606886|NCT04505722|583613071|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
161606887|NCT04505722|583613072|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
161606888|NCT04505722|583613073|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
161606889|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
161606890|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
161606891|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
161606892|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
161606893|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
161606894|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
161606895|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
161606896|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
161606897|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
161606898|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
161606899|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
161606900|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
161606901|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
161606902|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
161606903|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
161606904|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
161606905|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
161606906|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
161606907|NCT04505722|583613071|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
161606908|NCT04505722|583613072|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
161606909|NCT04505722|583613073|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
161606910|NCT04755595|583613074|FG000|Overall Study|Lost to Follow-up|1|||
161606911|NCT00319696|583613075|FG000|Overall Study|Adverse Event|36|||
161606912|NCT00319696|583613075|FG000|Overall Study|withdrawal of consent|14|||
161606913|NCT00319696|583613075|FG000|Overall Study|administrative|7|||
161606914|NCT00319696|583613075|FG000|Overall Study|Lost to Follow-up|3|||
161606915|NCT04305327|583613078|FG000|Overall Study|Study early termination|2|||
161606916|NCT04305327|583613079|FG001|Overall Study|Study early termination|5|||
161606917|NCT04305327|583613080|FG002|Overall Study|Study early termination|2|||
161606918|NCT04305327|583613081|FG003|Overall Study|Study early termination|2|||
161606919|NCT04305327|583613078|FG000|Overall Study|Withdrawal by Subject|0|||
161606920|NCT04305327|583613079|FG001|Overall Study|Withdrawal by Subject|1|||
161606921|NCT04305327|583613080|FG002|Overall Study|Withdrawal by Subject|0|||
161606922|NCT04305327|583613081|FG003|Overall Study|Withdrawal by Subject|0|||
161606923|NCT05864209|583613852|FG000|Overall Study|Lost to Follow-up|2|||
161606924|NCT05864209|583613853|FG001|Overall Study|Lost to Follow-up|3|||
161606925|NCT04530487|583613854|FG000|Overall Study|Death|1|||
161606926|NCT04977583|583613855|FG000|Overall Study|Lost to Follow-up|8|||
161606927|NCT04977583|583613856|FG001|Overall Study|Lost to Follow-up|4|||
161606928|NCT04977583|583613857|FG002|Overall Study|Lost to Follow-up|13|||
161606929|NCT04977583|583613855|FG000|Overall Study|Withdrawal by Subject|3|||
161606930|NCT04977583|583613856|FG001|Overall Study|Withdrawal by Subject|2|||
161606931|NCT04977583|583613857|FG002|Overall Study|Withdrawal by Subject|1|||
161606932|NCT00146172|583613862|FG000|Overall Study|Adverse Event|0|||
161606933|NCT00146172|583613863|FG001|Overall Study|Adverse Event|0|||
161606934|NCT00146172|583613864|FG002|Overall Study|Adverse Event|1|||
161606935|NCT00146172|583613865|FG003|Overall Study|Adverse Event|1|||
161606936|NCT00146172|583613866|FG004|Overall Study|Adverse Event|0|||
161606937|NCT00146172|583613867|FG005|Overall Study|Adverse Event|2|||
161606938|NCT00146172|583613868|FG006|Overall Study|Adverse Event|3|||
161606939|NCT00146172|583613869|FG007|Overall Study|Adverse Event|10|||
161606940|NCT00146172|583613862|FG000|Overall Study|Lost to Follow-up|0|||
161606941|NCT00146172|583613863|FG001|Overall Study|Lost to Follow-up|0|||
161606942|NCT00146172|583613864|FG002|Overall Study|Lost to Follow-up|0|||
161606943|NCT00146172|583613865|FG003|Overall Study|Lost to Follow-up|0|||
161606944|NCT00146172|583613866|FG004|Overall Study|Lost to Follow-up|0|||
161606945|NCT00146172|583613867|FG005|Overall Study|Lost to Follow-up|0|||
161606946|NCT00146172|583613868|FG006|Overall Study|Lost to Follow-up|0|||
161606947|NCT00146172|583613869|FG007|Overall Study|Lost to Follow-up|1|||
161606948|NCT00146172|583613862|FG000|Overall Study|Disease Progression|2|||
161606949|NCT00146172|583613863|FG001|Overall Study|Disease Progression|4|||
161606950|NCT00146172|583613864|FG002|Overall Study|Disease Progression|2|||
161606951|NCT00146172|583613865|FG003|Overall Study|Disease Progression|5|||
161606952|NCT00146172|583613866|FG004|Overall Study|Disease Progression|2|||
161606953|NCT00146172|583613867|FG005|Overall Study|Disease Progression|2|||
161606954|NCT00146172|583613868|FG006|Overall Study|Disease Progression|1|||
161606955|NCT00146172|583613869|FG007|Overall Study|Disease Progression|22|||
161606956|NCT00146172|583613862|FG000|Overall Study|Death|0|||
161606957|NCT00146172|583613863|FG001|Overall Study|Death|0|||
161606958|NCT00146172|583613864|FG002|Overall Study|Death|0|||
161606959|NCT00146172|583613865|FG003|Overall Study|Death|0|||
161606960|NCT00146172|583613866|FG004|Overall Study|Death|0|||
161606961|NCT00146172|583613867|FG005|Overall Study|Death|0|||
161606962|NCT00146172|583613868|FG006|Overall Study|Death|1|||
161683915|NCT03557281|583895886|FG000|Overall Study|Investigator discretion|0|||
161683916|NCT03557281|583895887|FG001|Overall Study|Investigator discretion|0|||
161683917|NCT03557281|583895888|FG002|Overall Study|Investigator discretion|1|||
161683918|NCT03557281|583895889|FG003|Overall Study|Investigator discretion|0|||
161606963|NCT00146172|583613869|FG007|Overall Study|Death|0|||
161606964|NCT00146172|583613862|FG000|Overall Study|Physician Decision|0|||
161606965|NCT00146172|583613863|FG001|Overall Study|Physician Decision|0|||
161606966|NCT00146172|583613864|FG002|Overall Study|Physician Decision|0|||
161606967|NCT00146172|583613865|FG003|Overall Study|Physician Decision|0|||
161606968|NCT00146172|583613866|FG004|Overall Study|Physician Decision|0|||
161606969|NCT00146172|583613867|FG005|Overall Study|Physician Decision|0|||
161606970|NCT00146172|583613868|FG006|Overall Study|Physician Decision|0|||
161606971|NCT00146172|583613869|FG007|Overall Study|Physician Decision|1|||
161606972|NCT00146172|583613862|FG000|Overall Study|Withdrawal by Subject|0|||
161606973|NCT00146172|583613863|FG001|Overall Study|Withdrawal by Subject|0|||
161606974|NCT00146172|583613864|FG002|Overall Study|Withdrawal by Subject|0|||
161683919|NCT03557281|583895890|FG004|Overall Study|Investigator discretion|0|||
161606975|NCT00146172|583613865|FG003|Overall Study|Withdrawal by Subject|0|||
161606976|NCT00146172|583613866|FG004|Overall Study|Withdrawal by Subject|0|||
161606977|NCT00146172|583613867|FG005|Overall Study|Withdrawal by Subject|1|||
161606978|NCT00146172|583613868|FG006|Overall Study|Withdrawal by Subject|1|||
161606979|NCT00146172|583613869|FG007|Overall Study|Withdrawal by Subject|4|||
161683920|NCT03557281|583895886|FG000|Overall Study|Withdrawal by Subject|0|||
161683921|NCT03557281|583895887|FG001|Overall Study|Withdrawal by Subject|1|||
161606980|NCT00146172|583613862|FG000|Overall Study|Symptomatic Deterioration|1|||
161606981|NCT00146172|583613863|FG001|Overall Study|Symptomatic Deterioration|0|||
161683922|NCT03557281|583895888|FG002|Overall Study|Withdrawal by Subject|1|||
161683923|NCT03557281|583895889|FG003|Overall Study|Withdrawal by Subject|1|||
161683924|NCT03557281|583895890|FG004|Overall Study|Withdrawal by Subject|2|||
161683925|NCT03557281|583895886|FG000|Overall Study|Randomized, but did not receive treatment|0|||
161683926|NCT03557281|583895887|FG001|Overall Study|Randomized, but did not receive treatment|0|||
161683927|NCT03557281|583895888|FG002|Overall Study|Randomized, but did not receive treatment|0|||
161683928|NCT03557281|583895889|FG003|Overall Study|Randomized, but did not receive treatment|0|||
161683929|NCT03557281|583895890|FG004|Overall Study|Randomized, but did not receive treatment|1|||
161683930|NCT01199042|583895891|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
161683931|NCT01199042|583895891|FG000|At Home (3 Months)|Lost to Follow-up|1|||
161683932|NCT03357731|583895896|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
161683933|NCT03357731|583895897|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
161683934|NCT03357731|583895898|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
161683935|NCT03357731|583895899|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
161683936|NCT03357731|583895900|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
161683937|NCT03357731|583895901|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
161683938|NCT03357731|583895896|FG000|Overall Study|Acute bradycardia and hypotension|0|||
161683939|NCT03357731|583895897|FG001|Overall Study|Acute bradycardia and hypotension|0|||
161683940|NCT03357731|583895898|FG002|Overall Study|Acute bradycardia and hypotension|0|||
161683941|NCT03357731|583895899|FG003|Overall Study|Acute bradycardia and hypotension|1|||
161606982|NCT00146172|583613864|FG002|Overall Study|Symptomatic Deterioration|1|||
161606983|NCT00146172|583613865|FG003|Overall Study|Symptomatic Deterioration|0|||
161606984|NCT00146172|583613866|FG004|Overall Study|Symptomatic Deterioration|1|||
161606985|NCT00146172|583613867|FG005|Overall Study|Symptomatic Deterioration|2|||
161606986|NCT00146172|583613868|FG006|Overall Study|Symptomatic Deterioration|0|||
161606987|NCT00146172|583613869|FG007|Overall Study|Symptomatic Deterioration|2|||
161606988|NCT00210106|583613870|FG000|Overall Study|Death|1|||
161606989|NCT00210106|583613870|FG000|Overall Study|Protocol Violation|13|||
161606990|NCT00786864|583613871|FG000|Overall Study|Lost to Follow-up|0|||
161606991|NCT00786864|583613872|FG001|Overall Study|Lost to Follow-up|1|||
161606992|NCT00786864|583613871|FG000|Overall Study|Sustained serious back injury|1|||
161606993|NCT00786864|583613872|FG001|Overall Study|Sustained serious back injury|0|||
161606994|NCT02422615|583613873|FG000|Treatment Period|Progressive disease|314|||
161606995|NCT02422615|583613874|FG001|Treatment Period|Progressive disease|200|||
161606996|NCT02422615|583613873|FG000|Treatment Period|Adverse Event|51|||
161606997|NCT02422615|583613874|FG001|Treatment Period|Adverse Event|9|||
161606998|NCT02422615|583613873|FG000|Treatment Period|Physician Decision|32|||
161606999|NCT02422615|583613874|FG001|Treatment Period|Physician Decision|8|||
161607000|NCT02422615|583613873|FG000|Treatment Period|Subject/guardian decision|38|||
161607001|NCT02422615|583613874|FG001|Treatment Period|Subject/guardian decision|8|||
161607002|NCT02422615|583613873|FG000|Treatment Period|Death|2|||
161607003|NCT02422615|583613874|FG001|Treatment Period|Death|1|||
161607004|NCT02422615|583613873|FG000|Treatment Period|Technical problems|0|||
161607005|NCT02422615|583613874|FG001|Treatment Period|Technical problems|1|||
161607006|NCT02422615|583613873|FG000|Treatment Period|Protocol deviation|1|||
161607007|NCT02422615|583613874|FG001|Treatment Period|Protocol deviation|1|||
161607008|NCT02422615|583613873|FG000|Treatment Period|Study terminated as per protocol|46|||
161607009|NCT02422615|583613874|FG001|Treatment Period|Study terminated as per protocol|14|||
161607010|NCT02422615|583613873|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161607011|NCT02422615|583613874|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161607012|NCT02422615|583613873|FG000|Post-treatment Efficacy Follow-up|Death|2|||
161683942|NCT03357731|583895900|FG004|Overall Study|Acute bradycardia and hypotension|0|||
161683943|NCT03357731|583895901|FG005|Overall Study|Acute bradycardia and hypotension|0|||
161683944|NCT03357731|583895896|FG000|Overall Study|Adverse Event|0|||
161683945|NCT03357731|583895897|FG001|Overall Study|Adverse Event|0|||
161683946|NCT03357731|583895898|FG002|Overall Study|Adverse Event|0|||
161607013|NCT02422615|583613874|FG001|Post-treatment Efficacy Follow-up|Death|1|||
161607014|NCT02422615|583613873|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161607015|NCT02422615|583613874|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161607016|NCT02422615|583613873|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
161607017|NCT02422615|583613874|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
161607018|NCT02422615|583613873|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
161683947|NCT03357731|583895899|FG003|Overall Study|Adverse Event|0|||
161683948|NCT03357731|583895900|FG004|Overall Study|Adverse Event|0|||
161683949|NCT03357731|583895901|FG005|Overall Study|Adverse Event|1|||
161607019|NCT02422615|583613874|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
161607020|NCT02422615|583613873|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
161607021|NCT02422615|583613874|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
161607022|NCT04876417|583613875|FG000|Overall Study|Lost to Follow-up|5|||
161607023|NCT04876417|583613876|FG001|Overall Study|Lost to Follow-up|8|||
161607024|NCT04876417|583613877|FG002|Overall Study|Lost to Follow-up|0|||
161607025|NCT04876417|583613878|FG003|Overall Study|Lost to Follow-up|0|||
161607026|NCT01092416|583613879|FG000|Enrollment|Atherectomy device not inserted|3|||
161607027|NCT01092416|583613879|FG000|30-Day Follow-up|Death|2|||
161607028|NCT01092416|583613879|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
161607029|NCT01092416|583613879|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
161607030|NCT01092416|583613879|FG000|12-Month Follow-up|Death|16|||
161607031|NCT01092416|583613879|FG000|12-Month Follow-up|Lost to Follow-up|4|||
161607032|NCT01092416|583613879|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
161607033|NCT01092416|583613879|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
161607034|NCT01092416|583613879|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
161607035|NCT03709706|583613880|FG000|Overall Study|Adverse Event|0|||
161607036|NCT03709706|583613881|FG001|Overall Study|Adverse Event|1|||
161607037|NCT03709706|583613880|FG000|Overall Study|Physician Decision|14|||
161607038|NCT03709706|583613881|FG001|Overall Study|Physician Decision|8|||
161607039|NCT03709706|583613880|FG000|Overall Study|Withdrawal by Subject|2|||
161607040|NCT03709706|583613881|FG001|Overall Study|Withdrawal by Subject|1|||
161607041|NCT03709706|583613880|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
161607042|NCT03709706|583613881|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
161607043|NCT01105975|583613882|FG000|Overall Study|Adverse Event|2|||
161607044|NCT01105975|583613883|FG001|Overall Study|Adverse Event|1|||
161607045|NCT01105975|583613884|FG002|Overall Study|Adverse Event|5|||
161607046|NCT01105975|583613885|FG003|Overall Study|Adverse Event|1|||
161607047|NCT01105975|583613886|FG004|Overall Study|Adverse Event|0|||
161607048|NCT01105975|583613887|FG005|Overall Study|Adverse Event|1|||
161607049|NCT01105975|583613888|FG006|Overall Study|Adverse Event|2|||
161607050|NCT01105975|583613889|FG007|Overall Study|Adverse Event|4|||
161607051|NCT01105975|583613890|FG008|Overall Study|Adverse Event|1|||
161607052|NCT01105975|583613891|FG009|Overall Study|Adverse Event|4|||
161607053|NCT01105975|583613882|FG000|Overall Study|Withdrawal by Subject|2|||
161607054|NCT01105975|583613883|FG001|Overall Study|Withdrawal by Subject|2|||
161607055|NCT01105975|583613884|FG002|Overall Study|Withdrawal by Subject|2|||
161607056|NCT01105975|583613885|FG003|Overall Study|Withdrawal by Subject|0|||
161607057|NCT01105975|583613886|FG004|Overall Study|Withdrawal by Subject|4|||
161607058|NCT01105975|583613887|FG005|Overall Study|Withdrawal by Subject|1|||
161607059|NCT01105975|583613888|FG006|Overall Study|Withdrawal by Subject|2|||
161607060|NCT01105975|583613889|FG007|Overall Study|Withdrawal by Subject|1|||
161607061|NCT01105975|583613890|FG008|Overall Study|Withdrawal by Subject|0|||
161607062|NCT01105975|583613891|FG009|Overall Study|Withdrawal by Subject|3|||
161607063|NCT01105975|583613882|FG000|Overall Study|Lost to Follow-up|1|||
161607064|NCT01105975|583613883|FG001|Overall Study|Lost to Follow-up|0|||
161607065|NCT01105975|583613884|FG002|Overall Study|Lost to Follow-up|0|||
161607066|NCT01105975|583613885|FG003|Overall Study|Lost to Follow-up|1|||
161607067|NCT01105975|583613886|FG004|Overall Study|Lost to Follow-up|1|||
161607068|NCT01105975|583613887|FG005|Overall Study|Lost to Follow-up|0|||
161607069|NCT01105975|583613888|FG006|Overall Study|Lost to Follow-up|0|||
161607070|NCT01105975|583613889|FG007|Overall Study|Lost to Follow-up|0|||
161607071|NCT01105975|583613890|FG008|Overall Study|Lost to Follow-up|1|||
161607072|NCT01105975|583613891|FG009|Overall Study|Lost to Follow-up|0|||
161607073|NCT01105975|583613882|FG000|Overall Study|Physician Decision|0|||
161607074|NCT01105975|583613883|FG001|Overall Study|Physician Decision|0|||
161607075|NCT01105975|583613884|FG002|Overall Study|Physician Decision|0|||
161607076|NCT01105975|583613885|FG003|Overall Study|Physician Decision|0|||
161607077|NCT01105975|583613886|FG004|Overall Study|Physician Decision|0|||
161607078|NCT01105975|583613887|FG005|Overall Study|Physician Decision|0|||
161607079|NCT01105975|583613888|FG006|Overall Study|Physician Decision|2|||
161607080|NCT01105975|583613889|FG007|Overall Study|Physician Decision|0|||
161607081|NCT01105975|583613890|FG008|Overall Study|Physician Decision|0|||
161607082|NCT01105975|583613891|FG009|Overall Study|Physician Decision|0|||
161607083|NCT01105975|583613882|FG000|Overall Study|Protocol Violation|0|||
161607084|NCT01105975|583613883|FG001|Overall Study|Protocol Violation|2|||
161607085|NCT01105975|583613884|FG002|Overall Study|Protocol Violation|2|||
161607086|NCT01105975|583613885|FG003|Overall Study|Protocol Violation|0|||
161607087|NCT01105975|583613886|FG004|Overall Study|Protocol Violation|1|||
161607088|NCT01105975|583613887|FG005|Overall Study|Protocol Violation|1|||
161607089|NCT01105975|583613888|FG006|Overall Study|Protocol Violation|1|||
161607090|NCT01105975|583613889|FG007|Overall Study|Protocol Violation|1|||
161607091|NCT01105975|583613890|FG008|Overall Study|Protocol Violation|2|||
161607092|NCT01105975|583613891|FG009|Overall Study|Protocol Violation|2|||
161607093|NCT01105975|583613882|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161607094|NCT01105975|583613883|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161607095|NCT01105975|583613884|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161607096|NCT01105975|583613885|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161607097|NCT01105975|583613886|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161607098|NCT01105975|583613887|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
161607099|NCT01105975|583613888|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161607100|NCT01105975|583613889|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161607101|NCT01105975|583613890|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
161607102|NCT01105975|583613891|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161607103|NCT04868617|583613892|FG000|Overall Study|Death|1|||
161607104|NCT04868617|583613893|FG001|Overall Study|Death|0|||
161607105|NCT04868617|583613892|FG000|Overall Study|Adverse Event|1|||
161607106|NCT04868617|583613893|FG001|Overall Study|Adverse Event|0|||
161607107|NCT04868617|583613892|FG000|Overall Study|Withdrawal by Subject|1|||
161607108|NCT04868617|583613893|FG001|Overall Study|Withdrawal by Subject|0|||
161607109|NCT04868617|583613892|FG000|Overall Study|Device deficiency|1|||
161607110|NCT04868617|583613893|FG001|Overall Study|Device deficiency|0|||
161607111|NCT03183050|583613894|FG000|Overall Study|Lost to Follow-up|23|||
161607112|NCT00686595|583613898|FG000|Overall Study|Adverse Event|3|||
161607113|NCT00686595|583613898|FG000|Overall Study|Protocol Violation|1|||
161607114|NCT00686595|583613898|FG000|Overall Study|Lost to Follow-up|1|||
161607115|NCT00686595|583613898|FG000|Overall Study|Lack of Efficacy|1|||
161607116|NCT00686595|583613898|FG000|Overall Study|Poor Compliance|1|||
161607117|NCT02797132|583613899|FG000|Part A (15 Days)|Adverse Event|1|||
161607118|NCT02797132|583613899|FG000|Part B (24 Weeks)|Adverse Event|3|||
161607119|NCT02502526|583613900|FG000|Overall Study|Lost to Follow-up|2|||
161607120|NCT02502526|583613901|FG001|Overall Study|Lost to Follow-up|2|||
161607121|NCT02502526|583613902|FG002|Overall Study|Lost to Follow-up|3|||
161607122|NCT02502526|583613900|FG000|Overall Study|Withdrawal by Subject|0|||
161607123|NCT02502526|583613901|FG001|Overall Study|Withdrawal by Subject|1|||
161607124|NCT02502526|583613902|FG002|Overall Study|Withdrawal by Subject|1|||
161607125|NCT02502526|583613900|FG000|Overall Study|Disqualified due to cataract grading|0|||
161607126|NCT02502526|583613901|FG001|Overall Study|Disqualified due to cataract grading|0|||
161607127|NCT02502526|583613902|FG002|Overall Study|Disqualified due to cataract grading|1|||
161607128|NCT02502526|583613900|FG000|Overall Study|Enrollment suspension|4|||
161607129|NCT02502526|583613901|FG001|Overall Study|Enrollment suspension|1|||
161607130|NCT02502526|583613902|FG002|Overall Study|Enrollment suspension|1|||
161607131|NCT03473223|583613908|FG000|Overall Study|Lost to Follow-up|1|||
161607132|NCT03473223|583613909|FG001|Overall Study|Lost to Follow-up|1|||
161607133|NCT03473223|583613908|FG000|Overall Study|Withdrawal by Subject|47|||
161607134|NCT03473223|583613909|FG001|Overall Study|Withdrawal by Subject|42|||
161607135|NCT03473223|583613908|FG000|Overall Study|Indirect contact|32|||
161607136|NCT03473223|583613909|FG001|Overall Study|Indirect contact|29|||
161607137|NCT03473223|583613908|FG000|Overall Study|Other (Not specified)|32|||
161607138|NCT03473223|583613909|FG001|Overall Study|Other (Not specified)|20|||
161607139|NCT03777657|583613911|FG000|Overall Study|Death|397|||
161607140|NCT03777657|583613912|FG001|Overall Study|Death|431|||
161607141|NCT03777657|583613911|FG000|Overall Study|Study Closed by Sponsor|77|||
161607142|NCT03777657|583613912|FG001|Overall Study|Study Closed by Sponsor|38|||
161607143|NCT03777657|583613911|FG000|Overall Study|Withdrawal by Subject|20|||
161607144|NCT03777657|583613912|FG001|Overall Study|Withdrawal by Subject|17|||
161607145|NCT03777657|583613911|FG000|Overall Study|Lost to Follow-up|6|||
161607146|NCT03777657|583613912|FG001|Overall Study|Lost to Follow-up|10|||
161683950|NCT03357731|583895896|FG000|Overall Study|Hypotension|0|||
161683951|NCT03357731|583895897|FG001|Overall Study|Hypotension|0|||
161683952|NCT03357731|583895898|FG002|Overall Study|Hypotension|1|||
161832423|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
161832424|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
161607147|NCT02549352|583613915|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161607148|NCT02549352|583613916|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161607149|NCT02549352|583613915|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
161607150|NCT02549352|583613916|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
161607151|NCT02549352|583613915|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
161607152|NCT02549352|583613916|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
161607153|NCT02549352|583613915|FG000|12-month Follow-up|Withdrawal by Subject|4|||
161607154|NCT02549352|583613916|FG001|12-month Follow-up|Withdrawal by Subject|5|||
161683953|NCT03357731|583895899|FG003|Overall Study|Hypotension|1|||
161683954|NCT03357731|583895900|FG004|Overall Study|Hypotension|0|||
161683955|NCT03357731|583895901|FG005|Overall Study|Hypotension|0|||
161683956|NCT03357731|583895896|FG000|Overall Study|Lost to Follow-up|0|||
161683957|NCT03357731|583895897|FG001|Overall Study|Lost to Follow-up|0|||
161683958|NCT03357731|583895898|FG002|Overall Study|Lost to Follow-up|0|||
161683959|NCT03357731|583895899|FG003|Overall Study|Lost to Follow-up|1|||
161683960|NCT03357731|583895900|FG004|Overall Study|Lost to Follow-up|0|||
161683961|NCT03357731|583895901|FG005|Overall Study|Lost to Follow-up|0|||
161683962|NCT01773109|583895902|FG000|Overall Study|Symptomatic Progression|2|||
161683963|NCT01773109|583895902|FG000|Overall Study|Death|1|||
161683964|NCT01239342|583895903|FG000|Overall Study|Adverse Event|1|||
161683965|NCT01239342|583895904|FG001|Overall Study|Adverse Event|0|||
161683966|NCT01239342|583895903|FG000|Overall Study|Withdrawal by Subject|1|||
161683967|NCT01239342|583895904|FG001|Overall Study|Withdrawal by Subject|5|||
161683968|NCT01239342|583895903|FG000|Overall Study|Reason Unknown|1|||
161683969|NCT01239342|583895904|FG001|Overall Study|Reason Unknown|1|||
161683970|NCT01849874|583895907|FG000|Overall Study|Death|89|||
161683971|NCT01849874|583895908|FG001|Overall Study|Death|42|||
161683972|NCT01849874|583895907|FG000|Overall Study|Withdrawal by Subject|17|||
161683973|NCT01849874|583895908|FG001|Overall Study|Withdrawal by Subject|16|||
161683974|NCT01849874|583895907|FG000|Overall Study|Lost to Follow-up|3|||
161683975|NCT01849874|583895908|FG001|Overall Study|Lost to Follow-up|2|||
161683976|NCT01849874|583895907|FG000|Overall Study|Study Termination By Sponsor|93|||
161683977|NCT01849874|583895908|FG001|Overall Study|Study Termination By Sponsor|48|||
161683978|NCT01849874|583895907|FG000|Overall Study|Completed as per protocol amendment 6|3|||
161683979|NCT01849874|583895908|FG001|Overall Study|Completed as per protocol amendment 6|0|||
161683980|NCT01849874|583895907|FG000|Overall Study|Physician Decision|7|||
161683981|NCT01849874|583895908|FG001|Overall Study|Physician Decision|1|||
161683982|NCT01849874|583895907|FG000|Overall Study|Other|16|||
161683983|NCT01849874|583895908|FG001|Overall Study|Other|4|||
161683984|NCT04640272|583895910|FG000|Overall Study|Subject moved out of area|1|||
161683985|NCT02535715|583895914|FG000|Overall Study|Withdrawal by Subject|0|||
161683986|NCT02535715|583895915|FG001|Overall Study|Withdrawal by Subject|0|||
161683987|NCT02535715|583895916|FG002|Overall Study|Withdrawal by Subject|1|||
161607155|NCT02549352|583613915|FG000|12-month Follow-up|Lost to Follow-up|3|||
161607156|NCT02549352|583613916|FG001|12-month Follow-up|Lost to Follow-up|2|||
161607157|NCT02549352|583613915|FG000|12-month Follow-up|Death|0|||
161607158|NCT02549352|583613916|FG001|12-month Follow-up|Death|1|||
161607159|NCT02549352|583613915|FG000|12-month Follow-up|Protocol Violation|0|||
161607160|NCT02549352|583613916|FG001|12-month Follow-up|Protocol Violation|1|||
161607161|NCT02549352|583613915|FG000|12-month Follow-up|Other|1|||
161607162|NCT02549352|583613916|FG001|12-month Follow-up|Other|3|||
161607163|NCT04559698|583614449|FG000|Overall Study|Lost to Follow-up|14|||
161607164|NCT04559698|583614450|FG001|Overall Study|Lost to Follow-up|15|||
161607165|NCT04559698|583614449|FG000|Overall Study|Withdrawal by Subject|0|||
161607166|NCT04559698|583614450|FG001|Overall Study|Withdrawal by Subject|1|||
161607167|NCT01982682|583614451|FG000|Overall Study|Physician Decision|1|||
161607168|NCT02760654|583614452|FG000|Overall Study|Lost to Follow-up|3|||
161607169|NCT02760654|583614453|FG001|Overall Study|Lost to Follow-up|3|||
161607170|NCT02760654|583614452|FG000|Overall Study|Withdrawal by Subject|4|||
161607171|NCT02760654|583614453|FG001|Overall Study|Withdrawal by Subject|3|||
161607172|NCT01574716|583614454|FG000|Part 1|Death|3|||
161607173|NCT01574716|583614455|FG001|Part 1|Death|1|||
161607174|NCT01574716|583614456|FG002|Part 1|Death|8|||
161607175|NCT01574716|583614457|FG003|Part 1|Death|0|||
161607176|NCT01574716|583614458|FG004|Part 1|Death|0|||
161607177|NCT01574716|583614454|FG000|Part 1|Discontinuation of study by sponsor|0|||
161607178|NCT01574716|583614455|FG001|Part 1|Discontinuation of study by sponsor|0|||
161607179|NCT01574716|583614456|FG002|Part 1|Discontinuation of study by sponsor|1|||
161607180|NCT01574716|583614457|FG003|Part 1|Discontinuation of study by sponsor|0|||
161683988|NCT04353284|583895917|FG000|Overall Study|Adverse Event|1|||
161683989|NCT04353284|583895918|FG001|Overall Study|Adverse Event|1|||
161683990|NCT04353284|583895917|FG000|Overall Study|Lost to Follow-up|1|||
161683991|NCT04353284|583895918|FG001|Overall Study|Lost to Follow-up|0|||
161832425|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161683992|NCT01438489|583895922|FG000|Overall Study|Lost to Follow-up|4|||
161683993|NCT01438489|583895923|FG001|Overall Study|Lost to Follow-up|2|||
161683994|NCT01438489|583895924|FG002|Overall Study|Lost to Follow-up|2|||
161607181|NCT01574716|583614458|FG004|Part 1|Discontinuation of study by sponsor|0|||
161607182|NCT01574716|583614454|FG000|Part 1|Withdrawal by Subject|0|||
161607183|NCT01574716|583614455|FG001|Part 1|Withdrawal by Subject|2|||
161607184|NCT01574716|583614456|FG002|Part 1|Withdrawal by Subject|0|||
161683995|NCT01438489|583895922|FG000|Overall Study|Withdrawal by Subject|11|||
161607185|NCT01574716|583614457|FG003|Part 1|Withdrawal by Subject|0|||
161607186|NCT01574716|583614458|FG004|Part 1|Withdrawal by Subject|0|||
161607187|NCT01574716|583614454|FG000|Part 1|Lost to Follow-up|0|||
161683996|NCT01438489|583895923|FG001|Overall Study|Withdrawal by Subject|3|||
161607188|NCT01574716|583614455|FG001|Part 1|Lost to Follow-up|1|||
161607189|NCT01574716|583614456|FG002|Part 1|Lost to Follow-up|0|||
161607190|NCT01574716|583614457|FG003|Part 1|Lost to Follow-up|0|||
161607191|NCT01574716|583614458|FG004|Part 1|Lost to Follow-up|0|||
161607192|NCT01574716|583614454|FG000|Part 2|Progressive disease|0|||
161607193|NCT01574716|583614455|FG001|Part 2|Progressive disease|0|||
161607194|NCT01574716|583614456|FG002|Part 2|Progressive disease|0|||
161607195|NCT01574716|583614457|FG003|Part 2|Progressive disease|1|||
161607196|NCT01574716|583614458|FG004|Part 2|Progressive disease|0|||
161607197|NCT01574716|583614454|FG000|Part 2|Death|0|||
161607198|NCT01574716|583614455|FG001|Part 2|Death|0|||
161607199|NCT01574716|583614456|FG002|Part 2|Death|0|||
161607200|NCT01574716|583614457|FG003|Part 2|Death|76|||
161607201|NCT01574716|583614458|FG004|Part 2|Death|35|||
161607202|NCT01574716|583614454|FG000|Part 2|Discontinuation of study by sponsor|0|||
161607203|NCT01574716|583614455|FG001|Part 2|Discontinuation of study by sponsor|0|||
161683997|NCT01438489|583895924|FG002|Overall Study|Withdrawal by Subject|8|||
161683998|NCT01438489|583895922|FG000|Overall Study|Death|0|||
161683999|NCT01438489|583895923|FG001|Overall Study|Death|0|||
161684000|NCT01438489|583895924|FG002|Overall Study|Death|1|||
161832426|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832427|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832428|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832429|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832430|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832431|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
161684001|NCT01438489|583895922|FG000|Overall Study|Sponsor decision|4|||
161684002|NCT01438489|583895923|FG001|Overall Study|Sponsor decision|1|||
161684003|NCT01438489|583895924|FG002|Overall Study|Sponsor decision|4|||
161684004|NCT01438489|583895922|FG000|Overall Study|Subject choice/Subject moved|2|||
161684005|NCT01438489|583895923|FG001|Overall Study|Subject choice/Subject moved|1|||
161684006|NCT01438489|583895924|FG002|Overall Study|Subject choice/Subject moved|1|||
161684007|NCT01438489|583895922|FG000|Overall Study|Investigator decision|0|||
161684008|NCT01438489|583895923|FG001|Overall Study|Investigator decision|1|||
161684009|NCT01438489|583895924|FG002|Overall Study|Investigator decision|0|||
161684010|NCT01438489|583895922|FG000|Overall Study|AE/SAEs|2|||
161684011|NCT01438489|583895923|FG001|Overall Study|AE/SAEs|1|||
161684012|NCT01438489|583895924|FG002|Overall Study|AE/SAEs|1|||
161684013|NCT01438489|583895922|FG000|Overall Study|Received prohibited medication|1|||
161684014|NCT01438489|583895923|FG001|Overall Study|Received prohibited medication|0|||
161684015|NCT01438489|583895924|FG002|Overall Study|Received prohibited medication|0|||
161684016|NCT01438489|583895922|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
161832432|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
161684017|NCT01438489|583895923|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
161684018|NCT01438489|583895924|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
161684019|NCT01438489|583895922|FG000|Overall Study|Inadequate venous access|0|||
161684020|NCT01438489|583895923|FG001|Overall Study|Inadequate venous access|2|||
161684021|NCT01438489|583895924|FG002|Overall Study|Inadequate venous access|0|||
161684022|NCT00766532|583895925|FG000|Overall Study|Protocol Violation|2|||
161684023|NCT03719690|583895927|FG000|Overall Study|Withdrawal by Subject|5|||
161832433|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832434|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
161607204|NCT01574716|583614456|FG002|Part 2|Discontinuation of study by sponsor|0|||
161607205|NCT01574716|583614457|FG003|Part 2|Discontinuation of study by sponsor|51|||
161607206|NCT01574716|583614458|FG004|Part 2|Discontinuation of study by sponsor|31|||
161607207|NCT01574716|583614454|FG000|Part 2|Withdrawal by Subject|0|||
161607208|NCT01574716|583614455|FG001|Part 2|Withdrawal by Subject|0|||
161607209|NCT01574716|583614456|FG002|Part 2|Withdrawal by Subject|0|||
161607210|NCT01574716|583614457|FG003|Part 2|Withdrawal by Subject|5|||
161607211|NCT01574716|583614458|FG004|Part 2|Withdrawal by Subject|4|||
161607212|NCT01574716|583614454|FG000|Part 2|Brain metastases|0|||
161607213|NCT01574716|583614455|FG001|Part 2|Brain metastases|0|||
161607214|NCT01574716|583614456|FG002|Part 2|Brain metastases|0|||
161607215|NCT01574716|583614457|FG003|Part 2|Brain metastases|1|||
161607216|NCT01574716|583614458|FG004|Part 2|Brain metastases|0|||
161607217|NCT01574716|583614454|FG000|Part 2|Lost to Follow-up|0|||
161607218|NCT01574716|583614455|FG001|Part 2|Lost to Follow-up|0|||
161607219|NCT01574716|583614456|FG002|Part 2|Lost to Follow-up|0|||
161607220|NCT01574716|583614457|FG003|Part 2|Lost to Follow-up|3|||
161607221|NCT01574716|583614458|FG004|Part 2|Lost to Follow-up|0|||
161607222|NCT02964741|583614460|FG000|Overall Study|Protocol Violation|1|||
161607223|NCT02964741|583614461|FG001|Overall Study|Protocol Violation|0|||
161607224|NCT02964741|583614462|FG002|Overall Study|Protocol Violation|0|||
161607225|NCT02964741|583614460|FG000|Overall Study|Withdrawal by Subject|0|||
161607226|NCT02964741|583614461|FG001|Overall Study|Withdrawal by Subject|1|||
161607227|NCT02964741|583614462|FG002|Overall Study|Withdrawal by Subject|0|||
161607228|NCT02964741|583614460|FG000|Overall Study|claustrophobia|1|||
161607229|NCT02964741|583614461|FG001|Overall Study|claustrophobia|0|||
161607230|NCT02964741|583614462|FG002|Overall Study|claustrophobia|0|||
161607231|NCT00640159|583614466|FG000|Overall Study|Lost to Follow-up|2|||
161607232|NCT00112359|583614467|FG000|Overall Study|Unrelated adverse event|16|||
161607233|NCT00112359|583614468|FG001|Overall Study|Unrelated adverse event|8|||
161607234|NCT00112359|583614467|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
161607235|NCT00112359|583614468|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
161607236|NCT00112359|583614467|FG000|Overall Study|Related adverse event|5|||
161607237|NCT00112359|583614468|FG001|Overall Study|Related adverse event|3|||
161607238|NCT00112359|583614467|FG000|Overall Study|Lost to Follow-up|0|||
161607239|NCT00112359|583614468|FG001|Overall Study|Lost to Follow-up|1|||
161607240|NCT00112359|583614467|FG000|Overall Study|Personal/administrative|1|||
161607241|NCT00112359|583614468|FG001|Overall Study|Personal/administrative|1|||
161607242|NCT00112359|583614467|FG000|Overall Study|Other|3|||
161607243|NCT00112359|583614468|FG001|Overall Study|Other|0|||
161607244|NCT00312208|583614469|FG000|Overall Study|Adverse Event|97|||
161607245|NCT00312208|583614470|FG001|Overall Study|Adverse Event|61|||
161607246|NCT00312208|583614469|FG000|Overall Study|Protocol Violation|5|||
161607247|NCT00312208|583614470|FG001|Overall Study|Protocol Violation|3|||
161607248|NCT00312208|583614469|FG000|Overall Study|Death|2|||
161607249|NCT00312208|583614470|FG001|Overall Study|Death|1|||
161607250|NCT00312208|583614469|FG000|Overall Study|Lack of Efficacy|7|||
161607251|NCT00312208|583614470|FG001|Overall Study|Lack of Efficacy|4|||
161607252|NCT00312208|583614469|FG000|Overall Study|Lost to Follow-up|3|||
161607253|NCT00312208|583614470|FG001|Overall Study|Lost to Follow-up|5|||
161607254|NCT00312208|583614469|FG000|Overall Study|Withdrawal by Subject|53|||
161607255|NCT00312208|583614470|FG001|Overall Study|Withdrawal by Subject|42|||
161607256|NCT00312208|583614469|FG000|Overall Study|Other|5|||
161607257|NCT00312208|583614470|FG001|Overall Study|Other|7|||
161607258|NCT01324310|583614471|FG000|Overall Study|Adverse Event|1|||
161607259|NCT01324310|583614471|FG000|Overall Study|Disease Progression|1|||
161607260|NCT01315132|583614472|FG000|Overall Study|not treated due to disease progression|1|||
161607261|NCT03213457|583614478|FG000|Screening Period|Withdrawal by Subject|0|||
161607262|NCT03213457|583614479|FG001|Screening Period|Withdrawal by Subject|1|||
161607263|NCT03213457|583614480|FG002|Screening Period|Withdrawal by Subject|0|||
161607264|NCT03213457|583614478|FG000|Screening Period|Other|1|||
161607265|NCT03213457|583614479|FG001|Screening Period|Other|0|||
161607266|NCT03213457|583614480|FG002|Screening Period|Other|0|||
161607267|NCT03213457|583614478|FG000|Double-Blind Period|Adverse Event|3|||
161607268|NCT03213457|583614479|FG001|Double-Blind Period|Adverse Event|2|||
161607269|NCT03213457|583614480|FG002|Double-Blind Period|Adverse Event|7|||
161607270|NCT03213457|583614478|FG000|Double-Blind Period|Withdrawal by Subject|14|||
161607271|NCT03213457|583614479|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161607272|NCT03213457|583614480|FG002|Double-Blind Period|Withdrawal by Subject|14|||
161607273|NCT03213457|583614478|FG000|Double-Blind Period|Lost to Follow-up|2|||
161607274|NCT03213457|583614479|FG001|Double-Blind Period|Lost to Follow-up|3|||
161607275|NCT03213457|583614480|FG002|Double-Blind Period|Lost to Follow-up|9|||
161607276|NCT03213457|583614478|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
161607277|NCT03213457|583614479|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
161607278|NCT03213457|583614480|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
161607279|NCT03213457|583614478|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
161607280|NCT03213457|583614479|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
161607281|NCT03213457|583614480|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
161607282|NCT03213457|583614478|FG000|Double-Blind Period|Pregnancy|5|||
161607283|NCT03213457|583614479|FG001|Double-Blind Period|Pregnancy|0|||
161607284|NCT03213457|583614480|FG002|Double-Blind Period|Pregnancy|0|||
161607285|NCT03213457|583614478|FG000|Double-Blind Period|Other|10|||
161607286|NCT03213457|583614479|FG001|Double-Blind Period|Other|3|||
161607287|NCT03213457|583614480|FG002|Double-Blind Period|Other|17|||
161607288|NCT03213457|583614478|FG000|Open-Label Period|Adverse Event|1|||
161607289|NCT03213457|583614479|FG001|Open-Label Period|Adverse Event|2|||
161607290|NCT03213457|583614480|FG002|Open-Label Period|Adverse Event|2|||
161607291|NCT03213457|583614478|FG000|Open-Label Period|Withdrawal by Subject|12|||
161607292|NCT03213457|583614479|FG001|Open-Label Period|Withdrawal by Subject|5|||
161607293|NCT03213457|583614480|FG002|Open-Label Period|Withdrawal by Subject|24|||
161607294|NCT03213457|583614478|FG000|Open-Label Period|Lost to Follow-up|1|||
161607295|NCT03213457|583614479|FG001|Open-Label Period|Lost to Follow-up|2|||
161607296|NCT03213457|583614480|FG002|Open-Label Period|Lost to Follow-up|8|||
161607297|NCT03213457|583614478|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
161607298|NCT03213457|583614479|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
161607299|NCT03213457|583614480|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
161607300|NCT03213457|583614478|FG000|Open-Label Period|Non-compliance with study procedures|1|||
161607301|NCT03213457|583614479|FG001|Open-Label Period|Non-compliance with study procedures|1|||
161607302|NCT03213457|583614480|FG002|Open-Label Period|Non-compliance with study procedures|2|||
161607303|NCT03213457|583614478|FG000|Open-Label Period|Exclusionary medications|0|||
161607304|NCT03213457|583614479|FG001|Open-Label Period|Exclusionary medications|0|||
161607305|NCT03213457|583614480|FG002|Open-Label Period|Exclusionary medications|1|||
161607306|NCT03213457|583614478|FG000|Open-Label Period|Other|1|||
161607307|NCT03213457|583614479|FG001|Open-Label Period|Other|1|||
161607308|NCT03213457|583614480|FG002|Open-Label Period|Other|6|||
161607309|NCT03213457|583614478|FG000|Follow-Up Period|Adverse Event|16|||
161607310|NCT03213457|583614479|FG001|Follow-Up Period|Adverse Event|8|||
161607311|NCT03213457|583614480|FG002|Follow-Up Period|Adverse Event|37|||
161607312|NCT03213457|583614478|FG000|Follow-Up Period|Withdrawal by Subject|18|||
161607313|NCT03213457|583614479|FG001|Follow-Up Period|Withdrawal by Subject|11|||
161607314|NCT03213457|583614480|FG002|Follow-Up Period|Withdrawal by Subject|55|||
161607315|NCT03213457|583614478|FG000|Follow-Up Period|Lost to Follow-up|28|||
161607316|NCT03213457|583614479|FG001|Follow-Up Period|Lost to Follow-up|15|||
161607317|NCT03213457|583614480|FG002|Follow-Up Period|Lost to Follow-up|50|||
161607318|NCT03213457|583614478|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
161607319|NCT03213457|583614479|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
161607320|NCT03213457|583614480|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
161607321|NCT03213457|583614478|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
161607322|NCT03213457|583614479|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
161607323|NCT03213457|583614480|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
161607324|NCT03213457|583614478|FG000|Follow-Up Period|Pregnancy|7|||
161607325|NCT03213457|583614479|FG001|Follow-Up Period|Pregnancy|0|||
161607326|NCT03213457|583614480|FG002|Follow-Up Period|Pregnancy|18|||
161684024|NCT03719690|583895928|FG001|Overall Study|Withdrawal by Subject|10|||
161684025|NCT03719690|583895927|FG000|Overall Study|Death|40|||
161684026|NCT03719690|583895928|FG001|Overall Study|Death|149|||
161684027|NCT03719690|583895927|FG000|Overall Study|Miscellaneous|12|||
161684028|NCT03719690|583895928|FG001|Overall Study|Miscellaneous|56|||
161684029|NCT03719690|583895927|FG000|Overall Study|Lost to Follow-up|2|||
161607327|NCT03213457|583614478|FG000|Follow-Up Period|Exclusionary medications|1|||
161607328|NCT03213457|583614479|FG001|Follow-Up Period|Exclusionary medications|1|||
161607329|NCT03213457|583614480|FG002|Follow-Up Period|Exclusionary medications|5|||
161607330|NCT03213457|583614478|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
161607331|NCT03213457|583614479|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
161607332|NCT03213457|583614480|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
161607333|NCT03213457|583614478|FG000|Follow-Up Period|Other|14|||
161607334|NCT03213457|583614479|FG001|Follow-Up Period|Other|10|||
161607335|NCT03213457|583614480|FG002|Follow-Up Period|Other|31|||
161607336|NCT03150862|583614485|FG000|Overall Study|Death|2|||
161607337|NCT03150862|583614486|FG001|Overall Study|Death|7|||
161607338|NCT03150862|583614487|FG002|Overall Study|Death|8|||
161607339|NCT03150862|583614488|FG003|Overall Study|Death|27|||
161607340|NCT03150862|583614489|FG004|Overall Study|Death|4|||
161607341|NCT03150862|583614490|FG005|Overall Study|Death|8|||
161607342|NCT03150862|583614491|FG006|Overall Study|Death|6|||
161607343|NCT03150862|583614492|FG007|Overall Study|Death|21|||
161607344|NCT03150862|583614485|FG000|Overall Study|Withdrawal by Subject|1|||
161607345|NCT03150862|583614486|FG001|Overall Study|Withdrawal by Subject|1|||
161607346|NCT03150862|583614487|FG002|Overall Study|Withdrawal by Subject|0|||
161607347|NCT03150862|583614488|FG003|Overall Study|Withdrawal by Subject|3|||
161607348|NCT03150862|583614489|FG004|Overall Study|Withdrawal by Subject|1|||
161607349|NCT03150862|583614490|FG005|Overall Study|Withdrawal by Subject|1|||
161607350|NCT03150862|583614491|FG006|Overall Study|Withdrawal by Subject|1|||
161607351|NCT03150862|583614492|FG007|Overall Study|Withdrawal by Subject|3|||
161607352|NCT03150862|583614485|FG000|Overall Study|Lost to Follow-up|0|||
161607353|NCT03150862|583614486|FG001|Overall Study|Lost to Follow-up|0|||
161607354|NCT03150862|583614487|FG002|Overall Study|Lost to Follow-up|1|||
161607355|NCT03150862|583614488|FG003|Overall Study|Lost to Follow-up|0|||
161607356|NCT03150862|583614489|FG004|Overall Study|Lost to Follow-up|0|||
161607357|NCT03150862|583614490|FG005|Overall Study|Lost to Follow-up|0|||
161607358|NCT03150862|583614491|FG006|Overall Study|Lost to Follow-up|0|||
161607359|NCT03150862|583614492|FG007|Overall Study|Lost to Follow-up|2|||
161607360|NCT03150862|583614485|FG000|Overall Study|Sponsor's decision|0|||
161607361|NCT03150862|583614486|FG001|Overall Study|Sponsor's decision|0|||
161607362|NCT03150862|583614487|FG002|Overall Study|Sponsor's decision|0|||
161607363|NCT03150862|583614488|FG003|Overall Study|Sponsor's decision|10|||
161607364|NCT03150862|583614489|FG004|Overall Study|Sponsor's decision|3|||
161607365|NCT03150862|583614490|FG005|Overall Study|Sponsor's decision|0|||
161607366|NCT03150862|583614491|FG006|Overall Study|Sponsor's decision|1|||
161607367|NCT03150862|583614492|FG007|Overall Study|Sponsor's decision|1|||
161607368|NCT03150862|583614485|FG000|Overall Study|Change in Methylation status|0|||
161607369|NCT03150862|583614486|FG001|Overall Study|Change in Methylation status|0|||
161607370|NCT03150862|583614487|FG002|Overall Study|Change in Methylation status|0|||
161607371|NCT03150862|583614488|FG003|Overall Study|Change in Methylation status|0|||
161607372|NCT03150862|583614489|FG004|Overall Study|Change in Methylation status|1|||
161607373|NCT03150862|583614490|FG005|Overall Study|Change in Methylation status|0|||
161607374|NCT03150862|583614491|FG006|Overall Study|Change in Methylation status|0|||
161832435|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
161684030|NCT03719690|583895928|FG001|Overall Study|Lost to Follow-up|18|||
161684031|NCT03719690|583895927|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
161832436|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832437|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161684032|NCT03719690|583895928|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
161684033|NCT01372384|583895929|FG000|Overall Study|Progression of disease|3|||
161832438|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161607375|NCT03150862|583614492|FG007|Overall Study|Change in Methylation status|0|||
161607376|NCT03150862|583614485|FG000|Overall Study|Roll over in to Long Term Extension|0|||
161832439|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832440|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832441|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832442|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832443|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832444|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832445|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
161607377|NCT03150862|583614486|FG001|Overall Study|Roll over in to Long Term Extension|0|||
161607378|NCT03150862|583614487|FG002|Overall Study|Roll over in to Long Term Extension|0|||
161607379|NCT03150862|583614488|FG003|Overall Study|Roll over in to Long Term Extension|0|||
161607380|NCT03150862|583614489|FG004|Overall Study|Roll over in to Long Term Extension|0|||
161607381|NCT03150862|583614490|FG005|Overall Study|Roll over in to Long Term Extension|0|||
161607382|NCT03150862|583614491|FG006|Overall Study|Roll over in to Long Term Extension|0|||
161607383|NCT03150862|583614492|FG007|Overall Study|Roll over in to Long Term Extension|1|||
161607384|NCT03150862|583614485|FG000|Overall Study|Progressive Disease|0|||
161607385|NCT03150862|583614486|FG001|Overall Study|Progressive Disease|0|||
161607386|NCT03150862|583614487|FG002|Overall Study|Progressive Disease|0|||
161607387|NCT03150862|583614488|FG003|Overall Study|Progressive Disease|0|||
161607388|NCT03150862|583614489|FG004|Overall Study|Progressive Disease|0|||
161607389|NCT03150862|583614490|FG005|Overall Study|Progressive Disease|0|||
161607390|NCT03150862|583614491|FG006|Overall Study|Progressive Disease|0|||
161607391|NCT03150862|583614492|FG007|Overall Study|Progressive Disease|2|||
161607392|NCT05521516|583614495|FG000|Overall Study|Withdrawal by Subject|1|||
161607393|NCT05521516|583614496|FG001|Overall Study|Withdrawal by Subject|1|||
161607394|NCT00747565|583614497|FG000|Overall Study|Withdrawal by Subject|10|||
161607395|NCT00747565|583614498|FG001|Overall Study|Withdrawal by Subject|6|||
161607396|NCT00747565|583614497|FG000|Overall Study|Lost to Follow-up|4|||
161607397|NCT00747565|583614498|FG001|Overall Study|Lost to Follow-up|1|||
161607398|NCT01983683|583614504|FG000|Overall Study|Withdrawal by Subject|14|||
161607399|NCT01983683|583614505|FG001|Overall Study|Withdrawal by Subject|18|||
161607400|NCT01983683|583614504|FG000|Overall Study|Death|11|||
161607401|NCT01983683|583614505|FG001|Overall Study|Death|15|||
161607402|NCT01983683|583614504|FG000|Overall Study|Physician Decision|8|||
161607403|NCT01983683|583614505|FG001|Overall Study|Physician Decision|9|||
161607404|NCT01983683|583614504|FG000|Overall Study|Lost to Follow-up|4|||
161607405|NCT01983683|583614505|FG001|Overall Study|Lost to Follow-up|8|||
161607406|NCT01983683|583614504|FG000|Overall Study|Sponsor Decision|1|||
161607407|NCT01983683|583614505|FG001|Overall Study|Sponsor Decision|1|||
161607408|NCT00536120|583615438|FG000|Overall Study|Lost to Follow-up|1|||
161607409|NCT00536120|583615439|FG001|Overall Study|Lost to Follow-up|0|||
161607410|NCT00536120|583615438|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
161607411|NCT00536120|583615439|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
161607412|NCT00536120|583615438|FG000|Overall Study|Non-compliance|1|||
161607413|NCT00536120|583615439|FG001|Overall Study|Non-compliance|0|||
161607414|NCT00536120|583615438|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
161607415|NCT00536120|583615439|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
161607416|NCT00536120|583615438|FG000|Overall Study|Steroid Use|0|||
161607417|NCT00536120|583615439|FG001|Overall Study|Steroid Use|2|||
161607418|NCT00536120|583615438|FG000|Overall Study|Missed Study Visit|0|||
161607419|NCT00536120|583615439|FG001|Overall Study|Missed Study Visit|1|||
161607420|NCT03437733|583615440|FG000|Overall Study|Eligibility criteria not met|0|||
161607421|NCT03437733|583615441|FG001|Overall Study|Eligibility criteria not met|3|||
161607422|NCT03876457|583615449|FG000|Overall Study|Lost to Follow-up|1|||
161607423|NCT03876457|583615450|FG001|Overall Study|Lost to Follow-up|3|||
161607424|NCT01184326|583615451|FG000|Overall Study|Adverse Event|1|||
161607425|NCT01184326|583615452|FG001|Overall Study|Adverse Event|2|||
161607426|NCT01184326|583615453|FG002|Overall Study|Adverse Event|0|||
161607427|NCT01184326|583615451|FG000|Overall Study|Death|0|||
161607428|NCT01184326|583615452|FG001|Overall Study|Death|0|||
161607429|NCT01184326|583615453|FG002|Overall Study|Death|1|||
161607430|NCT01184326|583615451|FG000|Overall Study|Withdrawal by Subject|0|||
161607431|NCT01184326|583615452|FG001|Overall Study|Withdrawal by Subject|0|||
161607432|NCT01184326|583615453|FG002|Overall Study|Withdrawal by Subject|1|||
161607433|NCT01184326|583615451|FG000|Overall Study|Physician Decision|1|||
161607434|NCT01184326|583615452|FG001|Overall Study|Physician Decision|1|||
161607435|NCT01184326|583615453|FG002|Overall Study|Physician Decision|0|||
161607436|NCT01184326|583615451|FG000|Overall Study|Disease Progression|1|||
161607437|NCT01184326|583615452|FG001|Overall Study|Disease Progression|3|||
161607438|NCT01184326|583615453|FG002|Overall Study|Disease Progression|12|||
161607439|NCT01036724|583615454|FG000|Overall Study|Adverse Event|1|||
161607440|NCT01036724|583615455|FG001|Overall Study|Adverse Event|2|||
161607441|NCT01036724|583615454|FG000|Overall Study|Lack of Efficacy|1|||
161607442|NCT01036724|583615455|FG001|Overall Study|Lack of Efficacy|1|||
161607443|NCT01036724|583615454|FG000|Overall Study|Protocol Violation|4|||
161607444|NCT01036724|583615455|FG001|Overall Study|Protocol Violation|5|||
161607445|NCT04017611|583615457|FG000|Overall Study|Withdrawn prior to completion|1|||
161607446|NCT00246805|583615469|FG000|Phase 1|Lost to Follow-up|1|||
161607447|NCT00246805|583615470|FG001|Phase 1|Lost to Follow-up|0|||
161607448|NCT01342367|583615472|FG000|Overall Study|Death|1|||
161607449|NCT01342367|583615473|FG001|Overall Study|Death|0|||
161607450|NCT01342367|583615472|FG000|Overall Study|Withdrawal by Subject|1|||
161607451|NCT01342367|583615473|FG001|Overall Study|Withdrawal by Subject|2|||
161607452|NCT01500200|583615474|FG000|Stage 1|Adverse Event|1|||
161607453|NCT01500200|583615475|FG001|Stage 1|Adverse Event|4|||
161607454|NCT01500200|583615476|FG002|Stage 1|Adverse Event|5|||
161607455|NCT01500200|583615477|FG003|Stage 1|Adverse Event|0|||
161607456|NCT01500200|583615478|FG004|Stage 1|Adverse Event|0|||
161607457|NCT01500200|583615479|FG005|Stage 1|Adverse Event|0|||
161607458|NCT01500200|583615474|FG000|Stage 1|Lost to Follow-up|2|||
161607459|NCT01500200|583615475|FG001|Stage 1|Lost to Follow-up|2|||
161607460|NCT01500200|583615476|FG002|Stage 1|Lost to Follow-up|1|||
161607461|NCT01500200|583615477|FG003|Stage 1|Lost to Follow-up|0|||
161607462|NCT01500200|583615478|FG004|Stage 1|Lost to Follow-up|0|||
161607463|NCT01500200|583615479|FG005|Stage 1|Lost to Follow-up|0|||
161607464|NCT01500200|583615474|FG000|Stage 1|Withdrawal by Subject|3|||
161607465|NCT01500200|583615475|FG001|Stage 1|Withdrawal by Subject|0|||
161607466|NCT01500200|583615476|FG002|Stage 1|Withdrawal by Subject|0|||
161607467|NCT01500200|583615477|FG003|Stage 1|Withdrawal by Subject|0|||
161607468|NCT01500200|583615478|FG004|Stage 1|Withdrawal by Subject|0|||
161607469|NCT01500200|583615479|FG005|Stage 1|Withdrawal by Subject|0|||
161607470|NCT01500200|583615474|FG000|Stage 1|Noncompliance with Study Drug|1|||
161607471|NCT01500200|583615475|FG001|Stage 1|Noncompliance with Study Drug|0|||
161607472|NCT01500200|583615476|FG002|Stage 1|Noncompliance with Study Drug|0|||
161607473|NCT01500200|583615477|FG003|Stage 1|Noncompliance with Study Drug|0|||
161607474|NCT01500200|583615478|FG004|Stage 1|Noncompliance with Study Drug|0|||
161607475|NCT01500200|583615479|FG005|Stage 1|Noncompliance with Study Drug|0|||
161607476|NCT01500200|583615474|FG000|Stage 1|Physician Decision|1|||
161607477|NCT01500200|583615475|FG001|Stage 1|Physician Decision|0|||
161607478|NCT01500200|583615476|FG002|Stage 1|Physician Decision|0|||
161607479|NCT01500200|583615477|FG003|Stage 1|Physician Decision|0|||
161607480|NCT01500200|583615478|FG004|Stage 1|Physician Decision|0|||
161607481|NCT01500200|583615479|FG005|Stage 1|Physician Decision|0|||
161607482|NCT01500200|583615474|FG000|Stage 2|Adverse Event|0|||
161607483|NCT01500200|583615475|FG001|Stage 2|Adverse Event|0|||
161607484|NCT01500200|583615476|FG002|Stage 2|Adverse Event|0|||
161607485|NCT01500200|583615477|FG003|Stage 2|Adverse Event|0|||
161607486|NCT01500200|583615478|FG004|Stage 2|Adverse Event|5|||
161607487|NCT01500200|583615479|FG005|Stage 2|Adverse Event|4|||
161607488|NCT01218659|583615481|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
161607489|NCT01218659|583615482|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
161607490|NCT01218659|583615483|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
161607491|NCT01218659|583615481|FG000|18-Month Randomized Period|Did not receive study drug|0|||
161607492|NCT01218659|583615482|FG001|18-Month Randomized Period|Did not receive study drug|3|||
161684034|NCT03370120|583895930|FG000|Overall Study|Adverse event, non-fatal|24|||
161684035|NCT03370120|583895930|FG000|Overall Study|Withdrawal by Subject|6|||
161607493|NCT01218659|583615483|FG002|18-Month Randomized Period|Did not receive study drug|0|||
161607494|NCT01218659|583615481|FG000|12-Month OLE|Withdrawal by Subject|0|||
161607495|NCT01218659|583615482|FG001|12-Month OLE|Withdrawal by Subject|0|||
161607496|NCT01218659|583615483|FG002|12-Month OLE|Withdrawal by Subject|2|||
161607497|NCT01218659|583615481|FG000|12-Month OLE|Physician Decision|0|||
161684036|NCT03370120|583895930|FG000|Overall Study|Lost to Follow-up|1|||
161684037|NCT03370120|583895930|FG000|Overall Study|Lack of Efficacy|37|||
161684038|NCT03370120|583895930|FG000|Overall Study|Per sponsor's instructions|1|||
161607498|NCT01218659|583615482|FG001|12-Month OLE|Physician Decision|0|||
161607499|NCT01218659|583615483|FG002|12-Month OLE|Physician Decision|1|||
161607500|NCT01218659|583615481|FG000|12-Month OLE|Lost to Follow-up|0|||
161607501|NCT01218659|583615482|FG001|12-Month OLE|Lost to Follow-up|0|||
161684039|NCT03370120|583895930|FG000|Overall Study|Study was terminated by parent company UCB|2|||
161607502|NCT01218659|583615483|FG002|12-Month OLE|Lost to Follow-up|1|||
161607503|NCT01218659|583615481|FG000|12-Month OLE|Pregnancy|0|||
161607504|NCT01218659|583615482|FG001|12-Month OLE|Pregnancy|0|||
161607505|NCT01218659|583615483|FG002|12-Month OLE|Pregnancy|1|||
161607506|NCT01218659|583615481|FG000|12-Month OLE|Lack of Efficacy|0|||
161607507|NCT01218659|583615482|FG001|12-Month OLE|Lack of Efficacy|0|||
161607508|NCT01218659|583615483|FG002|12-Month OLE|Lack of Efficacy|1|||
161607509|NCT01218659|583615481|FG000|12-Month OLE|Declined to participate in the OLE|0|||
161607510|NCT01218659|583615482|FG001|12-Month OLE|Declined to participate in the OLE|0|||
161607511|NCT01218659|583615483|FG002|12-Month OLE|Declined to participate in the OLE|4|||
161607512|NCT03066609|583615486|FG000|INDUCTION|Pregnancy|0|||
161607513|NCT03066609|583615487|FG001|INDUCTION|Pregnancy|0|||
161607514|NCT03066609|583615488|FG002|INDUCTION|Pregnancy|1|||
161607515|NCT03066609|583615489|FG003|INDUCTION|Pregnancy|0|||
161607516|NCT03066609|583615486|FG000|INDUCTION|Lack of Efficacy|0|||
161607517|NCT03066609|583615487|FG001|INDUCTION|Lack of Efficacy|0|||
161607518|NCT03066609|583615488|FG002|INDUCTION|Lack of Efficacy|1|||
161607519|NCT03066609|583615489|FG003|INDUCTION|Lack of Efficacy|0|||
161607520|NCT03066609|583615486|FG000|INDUCTION|Adverse Event|2|||
161607521|NCT03066609|583615487|FG001|INDUCTION|Adverse Event|2|||
161607522|NCT03066609|583615488|FG002|INDUCTION|Adverse Event|0|||
161607523|NCT03066609|583615489|FG003|INDUCTION|Adverse Event|0|||
161607524|NCT03066609|583615486|FG000|MAINTENANCE|Adverse Event|0|||
161607525|NCT03066609|583615487|FG001|MAINTENANCE|Adverse Event|0|||
161607526|NCT03066609|583615488|FG002|MAINTENANCE|Adverse Event|0|||
161607527|NCT03066609|583615489|FG003|MAINTENANCE|Adverse Event|1|||
161607528|NCT03066609|583615486|FG000|MAINTENANCE|Withdrawal by Subject|4|||
161607529|NCT03066609|583615487|FG001|MAINTENANCE|Withdrawal by Subject|2|||
161607530|NCT03066609|583615488|FG002|MAINTENANCE|Withdrawal by Subject|1|||
161607531|NCT03066609|583615489|FG003|MAINTENANCE|Withdrawal by Subject|1|||
161607532|NCT03066609|583615486|FG000|MAINTENANCE|Lost to Follow-up|0|||
161607533|NCT03066609|583615487|FG001|MAINTENANCE|Lost to Follow-up|1|||
161607534|NCT03066609|583615488|FG002|MAINTENANCE|Lost to Follow-up|1|||
161607535|NCT03066609|583615489|FG003|MAINTENANCE|Lost to Follow-up|0|||
161607536|NCT03066609|583615486|FG000|MAINTENANCE|Pregnancy|1|||
161607537|NCT03066609|583615487|FG001|MAINTENANCE|Pregnancy|0|||
161607538|NCT03066609|583615488|FG002|MAINTENANCE|Pregnancy|0|||
161607539|NCT03066609|583615489|FG003|MAINTENANCE|Pregnancy|0|||
161607540|NCT03066609|583615486|FG000|MAINTENANCE|Lack of Efficacy|2|||
161607541|NCT03066609|583615487|FG001|MAINTENANCE|Lack of Efficacy|1|||
161607542|NCT03066609|583615488|FG002|MAINTENANCE|Lack of Efficacy|0|||
161607543|NCT03066609|583615489|FG003|MAINTENANCE|Lack of Efficacy|1|||
161607544|NCT03066609|583615486|FG000|OVERALL STUDY|Adverse Event|2|||
161607545|NCT03066609|583615487|FG001|OVERALL STUDY|Adverse Event|2|||
161607546|NCT03066609|583615488|FG002|OVERALL STUDY|Adverse Event|0|||
161607547|NCT03066609|583615489|FG003|OVERALL STUDY|Adverse Event|1|||
161607548|NCT03066609|583615486|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
161607549|NCT03066609|583615487|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
161607550|NCT03066609|583615488|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
161607551|NCT03066609|583615489|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
161607552|NCT03066609|583615486|FG000|OVERALL STUDY|Lost to Follow-up|1|||
161607553|NCT03066609|583615487|FG001|OVERALL STUDY|Lost to Follow-up|1|||
161607554|NCT03066609|583615488|FG002|OVERALL STUDY|Lost to Follow-up|1|||
161607555|NCT03066609|583615489|FG003|OVERALL STUDY|Lost to Follow-up|1|||
161607556|NCT03066609|583615486|FG000|OVERALL STUDY|Pregnancy|1|||
161607557|NCT03066609|583615487|FG001|OVERALL STUDY|Pregnancy|0|||
161607558|NCT03066609|583615488|FG002|OVERALL STUDY|Pregnancy|1|||
161607559|NCT03066609|583615489|FG003|OVERALL STUDY|Pregnancy|0|||
161607560|NCT03066609|583615486|FG000|OVERALL STUDY|Lack of Efficacy|2|||
161607561|NCT03066609|583615487|FG001|OVERALL STUDY|Lack of Efficacy|1|||
161607562|NCT03066609|583615488|FG002|OVERALL STUDY|Lack of Efficacy|1|||
161607563|NCT03066609|583615489|FG003|OVERALL STUDY|Lack of Efficacy|1|||
161832446|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
161607564|NCT03066609|583615486|FG000|OVERALL STUDY|discontinued follow up|0|||
161607565|NCT03066609|583615487|FG001|OVERALL STUDY|discontinued follow up|2|||
161607566|NCT03066609|583615488|FG002|OVERALL STUDY|discontinued follow up|0|||
161607567|NCT03066609|583615489|FG003|OVERALL STUDY|discontinued follow up|0|||
161607568|NCT02284113|583615490|FG000|Overall Study|Adverse Event|1|||
161607569|NCT02284113|583615491|FG001|Overall Study|Adverse Event|0|||
161607570|NCT02284113|583615490|FG000|Overall Study|non-compliance|0|||
161607571|NCT02284113|583615491|FG001|Overall Study|non-compliance|1|||
161607572|NCT02284113|583615490|FG000|Overall Study|Withdrawal by Subject|0|||
161607573|NCT02284113|583615491|FG001|Overall Study|Withdrawal by Subject|1|||
161607574|NCT02284113|583615490|FG000|Overall Study|not provided|0|||
161607575|NCT02284113|583615491|FG001|Overall Study|not provided|1|||
161607576|NCT02284113|583615490|FG000|Overall Study|surgery cancelled|2|||
161607577|NCT02284113|583615491|FG001|Overall Study|surgery cancelled|0|||
161607578|NCT04191824|583615492|FG000|Overall Study|Death|13|||
161607579|NCT04191824|583615493|FG001|Overall Study|Death|12|||
161607580|NCT04191824|583615492|FG000|Overall Study|Lost to Follow-up|456|||
161607581|NCT04191824|583615493|FG001|Overall Study|Lost to Follow-up|435|||
161607582|NCT04191824|583615492|FG000|Overall Study|Physician Decision|2|||
161607583|NCT04191824|583615493|FG001|Overall Study|Physician Decision|1|||
161607584|NCT04191824|583615492|FG000|Overall Study|Protocol Violation|0|||
161607585|NCT04191824|583615493|FG001|Overall Study|Protocol Violation|2|||
161607586|NCT04191824|583615492|FG000|Overall Study|Withdrawal by Subject|16|||
161607587|NCT04191824|583615493|FG001|Overall Study|Withdrawal by Subject|18|||
161607588|NCT04191824|583615492|FG000|Overall Study|Early site closure|24|||
161607589|NCT04191824|583615493|FG001|Overall Study|Early site closure|22|||
161607590|NCT03170882|583615496|FG000|Overall Study|Death|17|||
161607591|NCT03170882|583615497|FG001|Overall Study|Death|29|||
161607592|NCT03170882|583615496|FG000|Overall Study|Lost to Follow-up|0|||
161607593|NCT03170882|583615497|FG001|Overall Study|Lost to Follow-up|1|||
161607594|NCT03170882|583615496|FG000|Overall Study|Withdrawal by Subject|4|||
161607595|NCT03170882|583615497|FG001|Overall Study|Withdrawal by Subject|7|||
161607596|NCT03170882|583615496|FG000|Overall Study|Reason not Specified|28|||
161607597|NCT03170882|583615497|FG001|Overall Study|Reason not Specified|36|||
161607598|NCT01371994|583615501|FG000|Overall Study|Adverse Event|3|||
161607599|NCT01371994|583615502|FG001|Overall Study|Adverse Event|6|||
161607600|NCT01371994|583615501|FG000|Overall Study|Lack of Efficacy|3|||
161607601|NCT01371994|583615502|FG001|Overall Study|Lack of Efficacy|0|||
161607602|NCT01371994|583615501|FG000|Overall Study|Withdrawal by Subject|13|||
161607603|NCT01371994|583615502|FG001|Overall Study|Withdrawal by Subject|7|||
161607604|NCT01371994|583615501|FG000|Overall Study|Lost to Follow-up|1|||
161607605|NCT01371994|583615502|FG001|Overall Study|Lost to Follow-up|1|||
161607606|NCT01371994|583615501|FG000|Overall Study|Protocol Violation|24|||
161607607|NCT01371994|583615502|FG001|Overall Study|Protocol Violation|17|||
161607608|NCT01371994|583615501|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
161607609|NCT01371994|583615502|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
161607610|NCT01371994|583615501|FG000|Overall Study|Physician Decision|1|||
161607611|NCT01371994|583615502|FG001|Overall Study|Physician Decision|1|||
161607612|NCT01371994|583615501|FG000|Overall Study|Miscellaneous Reasons|6|||
161607613|NCT01371994|583615502|FG001|Overall Study|Miscellaneous Reasons|4|||
161607614|NCT00087685|583615503|FG000|Overall Study|Adverse Event|5|||
161607615|NCT00087685|583615503|FG000|Overall Study|Non-Compliance|1|||
161607616|NCT00087685|583615503|FG000|Overall Study|Progressive Disease|5|||
161607617|NCT00087685|583615503|FG000|Overall Study|Withdrawal by Subject|3|||
161607618|NCT01830595|583615504|FG000|First Period|Withdrawal by Subject|1|||
161607619|NCT01830595|583615505|FG001|First Period|Withdrawal by Subject|3|||
161607620|NCT01830595|583615504|FG000|Washout|Withdrawal by Subject|2|||
161607621|NCT01830595|583615505|FG001|Washout|Withdrawal by Subject|2|||
161607622|NCT05116774|583615506|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
161607623|NCT05116774|583615507|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
161607624|NCT05116774|583615506|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
161607625|NCT05116774|583615507|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
161607626|NCT05116774|583615506|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
161607627|NCT05116774|583615507|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
161607628|NCT05116774|583615506|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
161607629|NCT05116774|583615507|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
161607630|NCT03280030|583615509|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
161607631|NCT03280030|583615510|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
161607632|NCT03280030|583615511|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
161607633|NCT03280030|583615509|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
161607634|NCT03280030|583615510|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
161607635|NCT03280030|583615511|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
161607636|NCT03280030|583615509|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
161607637|NCT03280030|583615510|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
161607638|NCT03280030|583615511|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
161607639|NCT03280030|583615509|FG000|Part 2 - Efficacy|Adverse Event|0|||
161607640|NCT03280030|583615510|FG001|Part 2 - Efficacy|Adverse Event|4|||
161607641|NCT03280030|583615511|FG002|Part 2 - Efficacy|Adverse Event|6|||
161607642|NCT03280030|583615509|FG000|Part 2 - Efficacy|Death|0|||
161607643|NCT03280030|583615510|FG001|Part 2 - Efficacy|Death|3|||
161607644|NCT03280030|583615511|FG002|Part 2 - Efficacy|Death|0|||
161607645|NCT03280030|583615509|FG000|Part 2 - Efficacy|Physician Decision|0|||
161607646|NCT03280030|583615510|FG001|Part 2 - Efficacy|Physician Decision|10|||
161607647|NCT03280030|583615511|FG002|Part 2 - Efficacy|Physician Decision|16|||
161607648|NCT03280030|583615509|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
161607649|NCT03280030|583615510|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
161607650|NCT03280030|583615511|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
161607651|NCT03280030|583615509|FG000|Part 2 - Efficacy|Progressive disease|0|||
161607652|NCT03280030|583615510|FG001|Part 2 - Efficacy|Progressive disease|7|||
161607653|NCT03280030|583615511|FG002|Part 2 - Efficacy|Progressive disease|5|||
161607654|NCT05139992|583615512|FG000|Overall Study|Withdrawal by Subject|12|||
161607655|NCT05139992|583615512|FG000|Overall Study|Lost to Follow-up|6|||
161607656|NCT03275285|583615515|FG000|Overall Study|Ongoing|45|||
161607657|NCT03275285|583615516|FG001|Overall Study|Ongoing|69|||
161607658|NCT00115934|583615517|FG000|Overall Study|Lost to Follow-up|1|||
161607659|NCT00115934|583615518|FG001|Overall Study|Lost to Follow-up|0|||
161607660|NCT00115934|583615517|FG000|Overall Study|Did not receive intervention|3|||
161607661|NCT00115934|583615518|FG001|Overall Study|Did not receive intervention|2|||
161607662|NCT04882917|583615519|FG000|Overall Study|Adverse Event|0|||
161607663|NCT04882917|583615520|FG001|Overall Study|Adverse Event|1|||
161607664|NCT04882917|583615521|FG002|Overall Study|Adverse Event|2|||
161607665|NCT04882917|583615522|FG003|Overall Study|Adverse Event|2|||
161607666|NCT04882917|583615519|FG000|Overall Study|Withdrawal by Subject|1|||
161607667|NCT04882917|583615520|FG001|Overall Study|Withdrawal by Subject|0|||
161607668|NCT04882917|583615521|FG002|Overall Study|Withdrawal by Subject|2|||
161607669|NCT04882917|583615522|FG003|Overall Study|Withdrawal by Subject|1|||
161607670|NCT04882917|583615519|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
161607671|NCT04882917|583615520|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
161607672|NCT04882917|583615521|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
161607673|NCT04882917|583615522|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
161607674|NCT00319020|583615523|FG000|Overall Study|Death|2|||
161607675|NCT00319020|583615524|FG001|Overall Study|Death|2|||
161607676|NCT00319020|583615523|FG000|Overall Study|Withdrawal by Subject|4|||
161607677|NCT00319020|583615524|FG001|Overall Study|Withdrawal by Subject|1|||
161607678|NCT00319020|583615523|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
161607679|NCT00319020|583615524|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
161607680|NCT00319020|583615523|FG000|Overall Study|Administrative reason|0|||
161684040|NCT03370120|583895930|FG000|Overall Study|The study was ended by the promoter|3|||
161684041|NCT03370120|583895930|FG000|Overall Study|Discontinuation of drug development|3|||
161607681|NCT00319020|583615524|FG001|Overall Study|Administrative reason|5|||
161607682|NCT00319020|583615523|FG000|Overall Study|Disease progression|0|||
161607683|NCT00319020|583615524|FG001|Overall Study|Disease progression|2|||
161607684|NCT00319020|583615523|FG000|Overall Study|Transplant|0|||
161607685|NCT00319020|583615524|FG001|Overall Study|Transplant|1|||
161684042|NCT03370120|583895930|FG000|Overall Study|End of project|2|||
161607686|NCT00319020|583615523|FG000|Overall Study|Treatment failure|0|||
161607687|NCT00319020|583615524|FG001|Overall Study|Treatment failure|1|||
161607688|NCT00319020|583615523|FG000|Overall Study|Adverse Event|0|||
161607689|NCT00319020|583615524|FG001|Overall Study|Adverse Event|1|||
161607690|NCT04980300|583615527|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
161607691|NCT04980300|583615528|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
161607692|NCT04980300|583615527|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
161607693|NCT04980300|583615528|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
161607694|NCT04980300|583615527|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
161607695|NCT04980300|583615528|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
161607696|NCT04980300|583615527|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
161607697|NCT04980300|583615528|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
161607698|NCT00593840|583615531|FG000|Overall Study|Withdrawal by Subject|1|||
161684043|NCT03370120|583895930|FG000|Overall Study|Premature study closure|2|||
161684044|NCT03370120|583895930|FG000|Overall Study|Premature program termination|1|||
161684045|NCT03370120|583895930|FG000|Overall Study|Premature study termination|7|||
161684046|NCT03370120|583895930|FG000|Overall Study|Trial terminated by sponsor|2|||
161684047|NCT03370120|583895930|FG000|Overall Study|Trial discontinued by sponsor|2|||
161684048|NCT03370120|583895930|FG000|Overall Study|Study ended|15|||
161684049|NCT03370120|583895930|FG000|Overall Study|Clinical trial has been cancelled|1|||
161684050|NCT03370120|583895930|FG000|Overall Study|End of study per sponsor decision|2|||
161684051|NCT03370120|583895930|FG000|Overall Study|Promoter's decision|2|||
161684052|NCT03370120|583895930|FG000|Overall Study|The trial has been suspended|3|||
161684053|NCT03370120|583895930|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
161684054|NCT03370120|583895930|FG000|Overall Study|Early termination by order of sponsor|2|||
161684055|NCT03370120|583895930|FG000|Overall Study|Discontinuation of the study|5|||
161684056|NCT03370120|583895930|FG000|Overall Study|End of clinical trial discontinuation|1|||
161684057|NCT03370120|583895930|FG000|Overall Study|Because the clinical trial ended halfway|4|||
161684058|NCT03370120|583895930|FG000|Overall Study|Development discontinued|5|||
161684059|NCT03370120|583895930|FG000|Overall Study|Padsenovil program closed|3|||
161684060|NCT03370120|583895930|FG000|Overall Study|End of project|2|||
161684061|NCT03370120|583895930|FG000|Overall Study|Termination of project|1|||
161684062|NCT03370120|583895930|FG000|Overall Study|The study was interrupted by sponsor|4|||
161684063|NCT03370120|583895930|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
161684064|NCT03370120|583895930|FG000|Overall Study|End of sponsor decision|1|||
161684065|NCT03370120|583895930|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
161684066|NCT03370120|583895930|FG000|Overall Study|Early termination of studies|5|||
161684067|NCT03370120|583895930|FG000|Overall Study|This study is ended early|1|||
161684068|NCT03370120|583895930|FG000|Overall Study|End of padsevonil program|2|||
161684069|NCT03370120|583895930|FG000|Overall Study|Decision of sponsor|6|||
161684070|NCT03370120|583895930|FG000|Overall Study|Asked by the sponsor|3|||
161832447|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
161832448|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832449|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832450|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832451|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832452|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832453|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832454|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
161684071|NCT03370120|583895930|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
161684072|NCT03370120|583895930|FG000|Overall Study|PI decision poor compliance from participant|1|||
161684073|NCT03370120|583895930|FG000|Overall Study|Promoter ended the study|3|||
161684074|NCT03370120|583895930|FG000|Overall Study|Premature study close by sponsor's decision|4|||
161684075|NCT03370120|583895930|FG000|Overall Study|Study terminated by sponsor|33|||
161684076|NCT03370120|583895930|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
161684077|NCT03370120|583895930|FG000|Overall Study|Sponsor decision to terminate study|63|||
161684078|NCT03370120|583895930|FG000|Overall Study|Program closure|3|||
161684079|NCT03370120|583895930|FG000|Overall Study|Study ended prematurely|1|||
161684080|NCT03370120|583895930|FG000|Overall Study|Study stopped by sponsor|2|||
161684081|NCT03370120|583895930|FG000|Overall Study|Program termination|55|||
161684082|NCT03370120|583895930|FG000|Overall Study|Sponsor decision|62|||
161684083|NCT03370120|583895930|FG000|Overall Study|Sponsor study closure|10|||
161684084|NCT02375724|583895932|FG000|Overall Study|Lack of Efficacy|1|||
161684085|NCT02375724|583895933|FG001|Overall Study|Lack of Efficacy|1|||
161684086|NCT02375724|583895932|FG000|Overall Study|Withdrawal by Subject|1|||
161684087|NCT02375724|583895933|FG001|Overall Study|Withdrawal by Subject|1|||
161684088|NCT02375724|583895932|FG000|Overall Study|Lost to Follow-up|1|||
161832455|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
161684089|NCT02375724|583895933|FG001|Overall Study|Lost to Follow-up|0|||
161684090|NCT02375724|583895932|FG000|Overall Study|Protocol Violation|1|||
161684091|NCT02375724|583895933|FG001|Overall Study|Protocol Violation|0|||
161684092|NCT02375724|583895932|FG000|Overall Study|Adverse Event|2|||
161607699|NCT02722434|583616649|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
161607700|NCT02722434|583616650|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
161607701|NCT02722434|583616649|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
161607702|NCT02722434|583616650|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
161607703|NCT04989816|583616651|FG000|Overall Study|Death|77|||
161607704|NCT04989816|583616651|FG000|Overall Study|Lost to Follow-up|3|||
161607705|NCT01084694|583616653|FG000|Overall Study|Withdrawal by Subject|2|||
161607706|NCT01084694|583616654|FG001|Overall Study|Withdrawal by Subject|1|||
161607707|NCT01084694|583616653|FG000|Overall Study|Death|2|||
161607708|NCT01084694|583616654|FG001|Overall Study|Death|12|||
161607709|NCT01084694|583616653|FG000|Overall Study|eligibility not maintained|2|||
161607710|NCT01084694|583616654|FG001|Overall Study|eligibility not maintained|7|||
161607711|NCT01128595|583616660|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161607712|NCT01128595|583616661|FG001|Treatment Period 3|Withdrawal by Subject|1|||
161607713|NCT01128595|583616662|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161607714|NCT01128595|583616663|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161607715|NCT02185794|583616665|FG000|Overall Study|Enrolled but Never Dosed|1|||
161607716|NCT02185794|583616666|FG001|Overall Study|Enrolled but Never Dosed|6|||
161684093|NCT02375724|583895933|FG001|Overall Study|Adverse Event|4|||
161684094|NCT04712110|583895934|FG000|Overall Study|Lost to Follow-up|0|||
161684095|NCT04712110|583895935|FG001|Overall Study|Lost to Follow-up|1|||
161684096|NCT04712110|583895934|FG000|Overall Study|Withdrawal by Subject|0|||
161684097|NCT04712110|583895935|FG001|Overall Study|Withdrawal by Subject|4|||
161684098|NCT04712110|583895934|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
161684099|NCT04712110|583895935|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
161684100|NCT01356407|583895936|FG000|Overall Study|Lost to Follow-up|2|||
161684101|NCT01356407|583895937|FG001|Overall Study|Lost to Follow-up|0|||
161684102|NCT01356407|583895936|FG000|Overall Study|Patient Withdrew Consent|2|||
161684103|NCT01356407|583895937|FG001|Overall Study|Patient Withdrew Consent|1|||
161684104|NCT01356407|583895936|FG000|Overall Study|Could not afford IMP administration|0|||
161684105|NCT01356407|583895937|FG001|Overall Study|Could not afford IMP administration|1|||
161684106|NCT01356407|583895936|FG000|Overall Study|Not complete Endoscopy|2|||
161684107|NCT01356407|583895937|FG001|Overall Study|Not complete Endoscopy|2|||
161684108|NCT02285777|583895938|FG000|Overall Study|Withdrawal by Subject|1|||
161684109|NCT02285777|583895939|FG001|Overall Study|Withdrawal by Subject|1|||
161684110|NCT02285777|583895938|FG000|Overall Study|Lost to Follow-up|4|||
161684111|NCT02285777|583895939|FG001|Overall Study|Lost to Follow-up|2|||
161684112|NCT03962101|583895940|FG000|Overall Study|Adverse Event|1|||
161684113|NCT03962101|583895940|FG000|Overall Study|Physician Decision|2|||
161684114|NCT03962101|583895940|FG000|Overall Study|Not related to medical events|1|||
161684115|NCT01074190|583895941|FG000|Overall Study|Emergency Cesarean Delivery|1|||
161684116|NCT01074190|583895942|FG001|Overall Study|Emergency Cesarean Delivery|2|||
161684117|NCT01074190|583895943|FG002|Overall Study|Emergency Cesarean Delivery|1|||
161684118|NCT01074190|583895941|FG000|Overall Study|Protocol Violation|2|||
161684119|NCT01074190|583895942|FG001|Overall Study|Protocol Violation|1|||
161684120|NCT01074190|583895943|FG002|Overall Study|Protocol Violation|0|||
161684121|NCT01074190|583895941|FG000|Overall Study|Delivered in under 90 minutes|0|||
161684122|NCT01074190|583895942|FG001|Overall Study|Delivered in under 90 minutes|2|||
161684123|NCT01074190|583895943|FG002|Overall Study|Delivered in under 90 minutes|1|||
161684124|NCT01074190|583895941|FG000|Overall Study|Subject withdrew consent|1|||
161684125|NCT01074190|583895942|FG001|Overall Study|Subject withdrew consent|1|||
161607717|NCT02185794|583616667|FG002|Overall Study|Enrolled but Never Dosed|3|||
161607718|NCT02185794|583616668|FG003|Overall Study|Enrolled but Never Dosed|1|||
161607719|NCT02185794|583616669|FG004|Overall Study|Enrolled but Never Dosed|1|||
161607720|NCT02185794|583616670|FG005|Overall Study|Enrolled but Never Dosed|0|||
161607721|NCT02185794|583616665|FG000|Overall Study|Investigator's Discretion|1|||
161607722|NCT02185794|583616666|FG001|Overall Study|Investigator's Discretion|0|||
161607723|NCT02185794|583616667|FG002|Overall Study|Investigator's Discretion|1|||
161607724|NCT02185794|583616668|FG003|Overall Study|Investigator's Discretion|2|||
161607725|NCT02185794|583616669|FG004|Overall Study|Investigator's Discretion|2|||
161607726|NCT02185794|583616670|FG005|Overall Study|Investigator's Discretion|15|||
161607727|NCT02185794|583616665|FG000|Overall Study|Withdrew Consent|2|||
161607728|NCT02185794|583616666|FG001|Overall Study|Withdrew Consent|5|||
161607729|NCT02185794|583616667|FG002|Overall Study|Withdrew Consent|10|||
161607730|NCT02185794|583616668|FG003|Overall Study|Withdrew Consent|2|||
161607731|NCT02185794|583616669|FG004|Overall Study|Withdrew Consent|0|||
161607732|NCT02185794|583616670|FG005|Overall Study|Withdrew Consent|0|||
161607733|NCT02185794|583616665|FG000|Overall Study|Lost to Follow-up|1|||
161607734|NCT02185794|583616666|FG001|Overall Study|Lost to Follow-up|2|||
161607735|NCT02185794|583616667|FG002|Overall Study|Lost to Follow-up|2|||
161607736|NCT02185794|583616668|FG003|Overall Study|Lost to Follow-up|3|||
161607737|NCT02185794|583616669|FG004|Overall Study|Lost to Follow-up|0|||
161607738|NCT02185794|583616670|FG005|Overall Study|Lost to Follow-up|1|||
161607739|NCT00336505|583616671|FG000|Overall Study|Adverse Event|10|||
161607740|NCT00336505|583616672|FG001|Overall Study|Adverse Event|9|||
161607741|NCT00336505|583616671|FG000|Overall Study|Lack of Efficacy|8|||
161607742|NCT00336505|583616672|FG001|Overall Study|Lack of Efficacy|4|||
161607743|NCT00336505|583616671|FG000|Overall Study|Lost to Follow-up|7|||
161607744|NCT00336505|583616672|FG001|Overall Study|Lost to Follow-up|4|||
161607745|NCT00336505|583616671|FG000|Overall Study|Withdrawal by Subject|5|||
161607746|NCT00336505|583616672|FG001|Overall Study|Withdrawal by Subject|3|||
161684126|NCT01074190|583895943|FG002|Overall Study|Subject withdrew consent|1|||
161684127|NCT00290342|583895946|FG000|Overall Study|Other|0|||
161684128|NCT00290342|583895947|FG001|Overall Study|Other|1|||
161684129|NCT00290342|583895946|FG000|Overall Study|Withdrawal by Subject|6|||
161684130|NCT00290342|583895947|FG001|Overall Study|Withdrawal by Subject|4|||
161684131|NCT00290342|583895946|FG000|Overall Study|Lost to Follow-up|1|||
161684132|NCT00290342|583895947|FG001|Overall Study|Lost to Follow-up|0|||
161684133|NCT00912028|583895952|FG000|Overall Study|Lost to Follow-up|2|||
161684134|NCT00912028|583895953|FG001|Overall Study|Lost to Follow-up|3|||
161607747|NCT00336505|583616671|FG000|Overall Study|Other|7|||
161607748|NCT00336505|583616672|FG001|Overall Study|Other|7|||
161607749|NCT00366249|583616673|FG000|Overall Study|Adverse Event|53|||
161607750|NCT00366249|583616674|FG001|Overall Study|Adverse Event|28|||
161607751|NCT00366249|583616673|FG000|Overall Study|Death|0|||
161832456|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832457|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
161607752|NCT00366249|583616674|FG001|Overall Study|Death|1|||
161607753|NCT00366249|583616673|FG000|Overall Study|Physician Decision|5|||
161607754|NCT00366249|583616674|FG001|Overall Study|Physician Decision|2|||
161607755|NCT00366249|583616673|FG000|Overall Study|Lost to Follow-up|2|||
161607756|NCT00366249|583616674|FG001|Overall Study|Lost to Follow-up|0|||
161607757|NCT00366249|583616673|FG000|Overall Study|Protocol Violation|1|||
161607758|NCT00366249|583616674|FG001|Overall Study|Protocol Violation|2|||
161607759|NCT00366249|583616673|FG000|Overall Study|Withdrawal by Subject|18|||
161607760|NCT00366249|583616674|FG001|Overall Study|Withdrawal by Subject|4|||
161607761|NCT00366249|583616673|FG000|Overall Study|Lack of Efficacy|21|||
161607762|NCT00366249|583616674|FG001|Overall Study|Lack of Efficacy|21|||
161607763|NCT00366249|583616673|FG000|Overall Study|Most due to osteomylitis status|31|||
161607764|NCT00366249|583616674|FG001|Overall Study|Most due to osteomylitis status|20|||
161607765|NCT00609869|583616675|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
161607766|NCT00609869|583616675|FG000|Overall Study|Severe hematologic toxicity|1|||
161607767|NCT00609869|583616675|FG000|Overall Study|Withdrawal by Subject|1|||
161607768|NCT00609869|583616675|FG000|Overall Study|Seizures|1|||
161607769|NCT00609869|583616675|FG000|Overall Study|Severe tumor flare reaction|1|||
161607770|NCT00609869|583616675|FG000|Overall Study|Hepatitis B infection|1|||
161607771|NCT00609869|583616675|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
161607772|NCT00609869|583616675|FG000|Overall Study|Mantle cell: not evaluable|4|||
161607773|NCT03478969|583616676|FG000|Overall Study|Withdrawal by Subject|4|||
161607774|NCT03478969|583616677|FG001|Overall Study|Withdrawal by Subject|7|||
161607775|NCT03478969|583616678|FG002|Overall Study|Withdrawal by Subject|6|||
161607776|NCT03478969|583616676|FG000|Overall Study|Adverse Event|2|||
161607777|NCT03478969|583616677|FG001|Overall Study|Adverse Event|0|||
161607778|NCT03478969|583616678|FG002|Overall Study|Adverse Event|1|||
161607779|NCT03478969|583616676|FG000|Overall Study|Pregnancy|1|||
161607780|NCT03478969|583616677|FG001|Overall Study|Pregnancy|0|||
161607781|NCT03478969|583616678|FG002|Overall Study|Pregnancy|0|||
161607782|NCT03478969|583616676|FG000|Overall Study|Personal Reasons|1|||
161607783|NCT03478969|583616677|FG001|Overall Study|Personal Reasons|0|||
161607784|NCT03478969|583616678|FG002|Overall Study|Personal Reasons|1|||
161607785|NCT03478969|583616676|FG000|Overall Study|Covid-19|1|||
161607786|NCT03478969|583616677|FG001|Overall Study|Covid-19|4|||
161607787|NCT03478969|583616678|FG002|Overall Study|Covid-19|3|||
161607788|NCT03478969|583616676|FG000|Overall Study|Multiple Reasons|0|||
161607789|NCT03478969|583616677|FG001|Overall Study|Multiple Reasons|1|||
161607790|NCT03478969|583616678|FG002|Overall Study|Multiple Reasons|1|||
161607791|NCT03478969|583616676|FG000|Overall Study|Eligibility Criteria|0|||
161607792|NCT03478969|583616677|FG001|Overall Study|Eligibility Criteria|0|||
161607793|NCT03478969|583616678|FG002|Overall Study|Eligibility Criteria|5|||
161607794|NCT03478969|583616676|FG000|Overall Study|Lost to Follow-up|0|||
161607795|NCT03478969|583616677|FG001|Overall Study|Lost to Follow-up|0|||
161607796|NCT03478969|583616678|FG002|Overall Study|Lost to Follow-up|1|||
161607797|NCT01185600|583616679|FG000|Overall Study|Adverse Event|1|||
161607798|NCT01185600|583616680|FG001|Overall Study|Adverse Event|1|||
161607799|NCT01185600|583616679|FG000|Overall Study|Death|0|||
161607800|NCT01185600|583616680|FG001|Overall Study|Death|1|||
161607801|NCT01185600|583616679|FG000|Overall Study|Lost to Follow-up|0|||
161607802|NCT01185600|583616680|FG001|Overall Study|Lost to Follow-up|5|||
161607803|NCT01185600|583616679|FG000|Overall Study|Physician Decision|29|||
161607804|NCT01185600|583616680|FG001|Overall Study|Physician Decision|35|||
161607805|NCT01185600|583616679|FG000|Overall Study|Withdrawal by Subject|1|||
161607806|NCT01185600|583616680|FG001|Overall Study|Withdrawal by Subject|1|||
161607807|NCT01185600|583616679|FG000|Overall Study|Hold by DSMB|1|||
161607808|NCT01185600|583616680|FG001|Overall Study|Hold by DSMB|2|||
161607809|NCT05405244|583616681|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
161607810|NCT05405244|583616682|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
161607811|NCT05405244|583616681|FG000|Washout (2 Weeks)|Adverse Event|2|||
161607812|NCT05405244|583616682|FG001|Washout (2 Weeks)|Adverse Event|0|||
161607813|NCT05405244|583616681|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
161607814|NCT05405244|583616682|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
161607815|NCT00739934|583616683|FG000|Voriconazole IV|Adverse Event|6|||
161607816|NCT00739934|583616683|FG000|Voriconazole Oral|Other|3|||
161607817|NCT00754065|583616688|FG000|Overall Study|Never received treatment|12|||
161607818|NCT00754065|583616689|FG001|Overall Study|Never received treatment|2|||
161607819|NCT00754065|583616688|FG000|Overall Study|Adverse Event|19|||
161607820|NCT00754065|583616689|FG001|Overall Study|Adverse Event|25|||
161607821|NCT00754065|583616688|FG000|Overall Study|Lost to Follow-up|7|||
161607822|NCT00754065|583616689|FG001|Overall Study|Lost to Follow-up|11|||
161607823|NCT00754065|583616688|FG000|Overall Study|Protocol Violation|12|||
161607824|NCT00754065|583616689|FG001|Overall Study|Protocol Violation|10|||
161607825|NCT00754065|583616688|FG000|Overall Study|Withdrawal by Subject|4|||
161607826|NCT00754065|583616689|FG001|Overall Study|Withdrawal by Subject|5|||
161607827|NCT00754065|583616688|FG000|Overall Study|Pregnancy|6|||
161607828|NCT00754065|583616689|FG001|Overall Study|Pregnancy|0|||
161607829|NCT00754065|583616688|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
161607830|NCT00754065|583616689|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
161607831|NCT04353492|583616692|FG000|Overall Study|Subject decision|24|||
161607832|NCT04353492|583616692|FG000|Overall Study|Physician Decision|5|||
161607833|NCT04353492|583616692|FG000|Overall Study|Adverse Event|3|||
161607834|NCT04353492|583616692|FG000|Overall Study|Pregnancy|3|||
161607835|NCT04353492|583616692|FG000|Overall Study|Lost to Follow-up|2|||
161607836|NCT04353492|583616692|FG000|Overall Study|Protocol deviation|1|||
161607837|NCT04353492|583616692|FG000|Overall Study|Technical problems|1|||
161607838|NCT04250194|583616693|FG000|Overall Study|Declined to schedule biopsy|6|||
161607839|NCT04250194|583616694|FG001|Overall Study|Declined to schedule biopsy|10|||
161607840|NCT04250194|583616693|FG000|Overall Study|Medically Unfit for Biopsy|2|||
161607841|NCT04250194|583616694|FG001|Overall Study|Medically Unfit for Biopsy|1|||
161607842|NCT04250194|583616693|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
161607843|NCT04250194|583616694|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
161607844|NCT04250194|583616693|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
161607845|NCT04250194|583616694|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
161607846|NCT04250194|583616693|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
161607847|NCT04250194|583616694|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
161607848|NCT01961609|583616697|FG000|Initiation|Missing|3|||
161607849|NCT01961609|583616698|FG001|Initiation|Missing|2|||
161607850|NCT01961609|583616699|FG002|Initiation|Missing|0|||
161607851|NCT01961609|583616700|FG003|Initiation|Missing|0|||
161607852|NCT01961609|583616697|FG000|Initiation|Protocol deviation|1|||
161607853|NCT01961609|583616698|FG001|Initiation|Protocol deviation|0|||
161607854|NCT01961609|583616699|FG002|Initiation|Protocol deviation|0|||
161607855|NCT01961609|583616700|FG003|Initiation|Protocol deviation|0|||
161607856|NCT01961609|583616697|FG000|Initiation|Death|0|||
161607857|NCT01961609|583616698|FG001|Initiation|Death|1|||
161607858|NCT01961609|583616699|FG002|Initiation|Death|0|||
161607859|NCT01961609|583616700|FG003|Initiation|Death|0|||
161607860|NCT01961609|583616697|FG000|Initiation|Administrative problems|1|||
161607861|NCT01961609|583616698|FG001|Initiation|Administrative problems|0|||
161607862|NCT01961609|583616699|FG002|Initiation|Administrative problems|0|||
161607863|NCT01961609|583616700|FG003|Initiation|Administrative problems|0|||
161607864|NCT01961609|583616697|FG000|Initiation|Withdrawal by Subject|1|||
161607865|NCT01961609|583616698|FG001|Initiation|Withdrawal by Subject|2|||
161607866|NCT01961609|583616699|FG002|Initiation|Withdrawal by Subject|0|||
161607867|NCT01961609|583616700|FG003|Initiation|Withdrawal by Subject|0|||
161607868|NCT01961609|583616697|FG000|Initiation|Lack of Efficacy|2|||
161607869|NCT01961609|583616698|FG001|Initiation|Lack of Efficacy|1|||
161607870|NCT01961609|583616699|FG002|Initiation|Lack of Efficacy|0|||
161607871|NCT01961609|583616700|FG003|Initiation|Lack of Efficacy|0|||
161607872|NCT01961609|583616697|FG000|Initiation|Abnormal lab values|0|||
161607873|NCT01961609|583616698|FG001|Initiation|Abnormal lab values|1|||
161607874|NCT01961609|583616699|FG002|Initiation|Abnormal lab values|0|||
161607875|NCT01961609|583616700|FG003|Initiation|Abnormal lab values|0|||
161607876|NCT01961609|583616697|FG000|Initiation|Adverse Event|3|||
161607877|NCT01961609|583616698|FG001|Initiation|Adverse Event|5|||
161832458|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832459|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161607878|NCT01961609|583616699|FG002|Initiation|Adverse Event|0|||
161607879|NCT01961609|583616700|FG003|Initiation|Adverse Event|0|||
161607880|NCT01961609|583616697|FG000|Initiation|Randomized but not treated|1|||
161607881|NCT01961609|583616698|FG001|Initiation|Randomized but not treated|1|||
161684135|NCT00912028|583895954|FG002|Overall Study|Lost to Follow-up|0|||
161684136|NCT00912028|583895955|FG003|Overall Study|Lost to Follow-up|1|||
161607882|NCT01961609|583616699|FG002|Initiation|Randomized but not treated|0|||
161607883|NCT01961609|583616700|FG003|Initiation|Randomized but not treated|0|||
161607884|NCT01961609|583616697|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
161607885|NCT01961609|583616698|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
161607886|NCT01961609|583616699|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
161607887|NCT01961609|583616700|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
161607888|NCT01961609|583616697|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
161607889|NCT01961609|583616698|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
161607890|NCT01961609|583616699|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
161607891|NCT01961609|583616700|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
161684137|NCT00912028|583895956|FG004|Overall Study|Lost to Follow-up|3|||
161607892|NCT01961609|583616697|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
161607893|NCT01961609|583616698|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
161607894|NCT01961609|583616699|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
161607895|NCT01961609|583616700|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
161607896|NCT01961609|583616697|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
161607897|NCT01961609|583616698|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
161607898|NCT01961609|583616699|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
161607899|NCT01961609|583616700|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
161607900|NCT01961609|583616697|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
161607901|NCT01961609|583616698|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
161607902|NCT01961609|583616699|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
161607903|NCT01961609|583616700|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
161607904|NCT01961609|583616697|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
161607905|NCT01961609|583616698|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
161607906|NCT01961609|583616699|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
161607907|NCT01961609|583616700|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
161607908|NCT01961609|583616697|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
161607909|NCT01961609|583616698|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
161607910|NCT01961609|583616699|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
161607911|NCT01961609|583616700|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
161607912|NCT01961609|583616697|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
161607913|NCT01961609|583616698|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
161607914|NCT01961609|583616699|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
161607915|NCT01961609|583616700|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
161607916|NCT01961609|583616697|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
161607917|NCT01961609|583616698|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
161607918|NCT01961609|583616699|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
161607919|NCT01961609|583616700|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
161607920|NCT01961609|583616697|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
161607921|NCT01961609|583616698|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
161607922|NCT01961609|583616699|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
161607923|NCT01961609|583616700|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
161607924|NCT01961609|583616697|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
161607925|NCT01961609|583616698|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
161607926|NCT01961609|583616699|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
161607927|NCT01961609|583616700|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
161607928|NCT01961609|583616697|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
161607929|NCT01961609|583616698|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
161607930|NCT01961609|583616699|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
161607931|NCT01961609|583616700|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
161607932|NCT02167451|583616703|FG000|Overall Study|Withdrawal by Subject|1|||
161607933|NCT00571649|583616704|FG000|Treatment Period|Adverse Event|438|||
161607934|NCT00571649|583616705|FG001|Treatment Period|Adverse Event|385|||
161607935|NCT00571649|583616704|FG000|Treatment Period|Clinical endpoint reached|50|||
161607936|NCT00571649|583616705|FG001|Treatment Period|Clinical endpoint reached|56|||
161684138|NCT00912028|583895952|FG000|Overall Study|Withdrawal by Subject|3|||
161684139|NCT00912028|583895953|FG001|Overall Study|Withdrawal by Subject|0|||
161607937|NCT00571649|583616704|FG000|Treatment Period|Withdrawal by Subject|285|||
161607938|NCT00571649|583616705|FG001|Treatment Period|Withdrawal by Subject|255|||
161607939|NCT00571649|583616704|FG000|Treatment Period|Death|76|||
161607940|NCT00571649|583616705|FG001|Treatment Period|Death|59|||
161607941|NCT00571649|583616704|FG000|Treatment Period|Physician Decision|8|||
161607942|NCT00571649|583616705|FG001|Treatment Period|Physician Decision|9|||
161607943|NCT00571649|583616704|FG000|Treatment Period|Lost to Follow-up|43|||
161607944|NCT00571649|583616705|FG001|Treatment Period|Lost to Follow-up|41|||
161607945|NCT00571649|583616704|FG000|Treatment Period|Non-compliant with study medication|88|||
161607946|NCT00571649|583616705|FG001|Treatment Period|Non-compliant with study medication|89|||
161607947|NCT00571649|583616704|FG000|Treatment Period|Patient convenience|11|||
161607948|NCT00571649|583616705|FG001|Treatment Period|Patient convenience|13|||
161607949|NCT00571649|583616704|FG000|Treatment Period|Protocol Violation|90|||
161607950|NCT00571649|583616705|FG001|Treatment Period|Protocol Violation|92|||
161607951|NCT00571649|583616704|FG000|Treatment Period|Technical problems|3|||
161607952|NCT00571649|583616705|FG001|Treatment Period|Technical problems|5|||
161607953|NCT00571649|583616704|FG000|Follow-up Period|Adverse Event|46|||
161607954|NCT00571649|583616705|FG001|Follow-up Period|Adverse Event|40|||
161607955|NCT00571649|583616704|FG000|Follow-up Period|Clinical endpoint reached|5|||
161607956|NCT00571649|583616705|FG001|Follow-up Period|Clinical endpoint reached|2|||
161607957|NCT00571649|583616704|FG000|Follow-up Period|Withdrawal by Subject|119|||
161607958|NCT00571649|583616705|FG001|Follow-up Period|Withdrawal by Subject|115|||
161607959|NCT00571649|583616704|FG000|Follow-up Period|Death|132|||
161607960|NCT00571649|583616705|FG001|Follow-up Period|Death|133|||
161607961|NCT00571649|583616704|FG000|Follow-up Period|Physician Decision|7|||
161607962|NCT00571649|583616705|FG001|Follow-up Period|Physician Decision|13|||
161607963|NCT00571649|583616704|FG000|Follow-up Period|Lost to Follow-up|95|||
161607964|NCT00571649|583616705|FG001|Follow-up Period|Lost to Follow-up|92|||
161607965|NCT00571649|583616704|FG000|Follow-up Period|Patient convenience|136|||
161607966|NCT00571649|583616705|FG001|Follow-up Period|Patient convenience|121|||
161607967|NCT00571649|583616704|FG000|Follow-up Period|Protocol Violation|5|||
161607968|NCT00571649|583616705|FG001|Follow-up Period|Protocol Violation|12|||
161607969|NCT03355573|583616710|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
161607970|NCT03355573|583616710|FG000|Overall Study|Sponsor's decision|1|||
161607971|NCT03355573|583616710|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
161607972|NCT03355573|583616710|FG000|Overall Study|PI's decision|2|||
161607973|NCT03355573|583616710|FG000|Overall Study|Withdrawal by Subject|23|||
161607974|NCT03355573|583616710|FG000|Overall Study|Lost to Follow-up|4|||
161607975|NCT03355573|583616710|FG000|Overall Study|Lack of Efficacy|2|||
161607976|NCT03355573|583616710|FG000|Overall Study|Adverse Event, non-fatal|17|||
161607977|NCT03355573|583616710|FG000|Overall Study|Adverse Event, serious fatal|2|||
161607978|NCT01566890|583616711|FG000|Overall Study|Adverse Event|1|||
161607979|NCT01566890|583616712|FG001|Overall Study|Adverse Event|0|||
161607980|NCT01566890|583616713|FG002|Overall Study|Adverse Event|0|||
161607981|NCT01566890|583616714|FG003|Overall Study|Adverse Event|0|||
161607982|NCT01566890|583616715|FG004|Overall Study|Adverse Event|0|||
161607983|NCT01566890|583616711|FG000|Overall Study|Withdrawal by Subject|3|||
161607984|NCT01566890|583616712|FG001|Overall Study|Withdrawal by Subject|1|||
161607985|NCT01566890|583616713|FG002|Overall Study|Withdrawal by Subject|1|||
161607986|NCT01566890|583616714|FG003|Overall Study|Withdrawal by Subject|1|||
161607987|NCT01566890|583616715|FG004|Overall Study|Withdrawal by Subject|0|||
161607988|NCT01566890|583616711|FG000|Overall Study|Screen failure|6|||
161607989|NCT01566890|583616712|FG001|Overall Study|Screen failure|0|||
161607990|NCT01566890|583616713|FG002|Overall Study|Screen failure|1|||
161607991|NCT01566890|583616714|FG003|Overall Study|Screen failure|1|||
161607992|NCT01566890|583616715|FG004|Overall Study|Screen failure|0|||
161607993|NCT01566890|583616711|FG000|Overall Study|Incomplete CEU data|1|||
161607994|NCT01566890|583616712|FG001|Overall Study|Incomplete CEU data|3|||
161607995|NCT01566890|583616713|FG002|Overall Study|Incomplete CEU data|5|||
161607996|NCT01566890|583616714|FG003|Overall Study|Incomplete CEU data|8|||
161607997|NCT01566890|583616715|FG004|Overall Study|Incomplete CEU data|0|||
161607998|NCT01566890|583616711|FG000|Overall Study|Lost to Follow-up|0|||
161607999|NCT01566890|583616712|FG001|Overall Study|Lost to Follow-up|0|||
161608000|NCT01566890|583616713|FG002|Overall Study|Lost to Follow-up|4|||
161608001|NCT01566890|583616714|FG003|Overall Study|Lost to Follow-up|4|||
161608002|NCT01566890|583616715|FG004|Overall Study|Lost to Follow-up|0|||
161608003|NCT01566890|583616711|FG000|Overall Study|Other|0|||
161608004|NCT01566890|583616712|FG001|Overall Study|Other|0|||
161608005|NCT01566890|583616713|FG002|Overall Study|Other|0|||
161608006|NCT01566890|583616714|FG003|Overall Study|Other|0|||
161608007|NCT01566890|583616715|FG004|Overall Study|Other|7|||
161608008|NCT01218009|583616718|FG000|Overall Study|Protocol Violation|2|||
161608009|NCT01218009|583616719|FG001|Overall Study|Protocol Violation|1|||
161608010|NCT01218009|583616718|FG000|Overall Study|Withdrawal by Subject|3|||
161608011|NCT01218009|583616719|FG001|Overall Study|Withdrawal by Subject|1|||
161608012|NCT01218009|583616718|FG000|Overall Study|Sponsor terminated study|161|||
161608013|NCT01218009|583616719|FG001|Overall Study|Sponsor terminated study|163|||
161608014|NCT02397096|583616720|FG000|Day 1 to Week 24|Adverse Event|7|||
161608015|NCT02397096|583616721|FG001|Day 1 to Week 24|Adverse Event|1|||
161608016|NCT02397096|583616720|FG000|Day 1 to Week 24|Death|1|||
161608017|NCT02397096|583616721|FG001|Day 1 to Week 24|Death|0|||
161608018|NCT02397096|583616720|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
161608019|NCT02397096|583616721|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
161608020|NCT02397096|583616720|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
161608021|NCT02397096|583616721|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
161608022|NCT02397096|583616720|FG000|Day 1 to Week 24|Physician Decision|2|||
161608023|NCT02397096|583616721|FG001|Day 1 to Week 24|Physician Decision|3|||
161608024|NCT02397096|583616720|FG000|Day 1 to Week 24|Protocol Violation|1|||
161608025|NCT02397096|583616721|FG001|Day 1 to Week 24|Protocol Violation|4|||
161608026|NCT02397096|583616720|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
161608027|NCT02397096|583616721|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
161608028|NCT02397096|583616720|FG000|Day 1 to Week 24|Randomized, not treated|3|||
161608029|NCT02397096|583616721|FG001|Day 1 to Week 24|Randomized, not treated|0|||
161608030|NCT02397096|583616720|FG000|Week 24 to Week 48|Adverse Event|6|||
161608031|NCT02397096|583616721|FG001|Week 24 to Week 48|Adverse Event|2|||
161608032|NCT02397096|583616720|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
161608033|NCT02397096|583616721|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
161608034|NCT02397096|583616720|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
161608035|NCT02397096|583616721|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
161608036|NCT02397096|583616720|FG000|Week 24 to Week 48|Physician Decision|2|||
161608037|NCT02397096|583616721|FG001|Week 24 to Week 48|Physician Decision|1|||
161608038|NCT02397096|583616720|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
161608039|NCT02397096|583616721|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
161608040|NCT02397096|583616720|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
161608041|NCT02397096|583616721|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
161608042|NCT02397096|583616720|FG000|Study Extension 1|Adverse Event|7|||
161608043|NCT02397096|583616721|FG001|Study Extension 1|Adverse Event|5|||
161608044|NCT02397096|583616720|FG000|Study Extension 1|Death|1|||
161608045|NCT02397096|583616721|FG001|Study Extension 1|Death|0|||
161608046|NCT02397096|583616720|FG000|Study Extension 1|Lack of Efficacy|2|||
161608047|NCT02397096|583616721|FG001|Study Extension 1|Lack of Efficacy|5|||
161608048|NCT02397096|583616720|FG000|Study Extension 1|Lost to Follow-up|2|||
161608049|NCT02397096|583616721|FG001|Study Extension 1|Lost to Follow-up|3|||
161608050|NCT02397096|583616720|FG000|Study Extension 1|Non-compliance with study drug|3|||
161608051|NCT02397096|583616721|FG001|Study Extension 1|Non-compliance with study drug|0|||
161608052|NCT02397096|583616720|FG000|Study Extension 1|Physician Decision|4|||
161684140|NCT00912028|583895954|FG002|Overall Study|Withdrawal by Subject|0|||
161684141|NCT00912028|583895955|FG003|Overall Study|Withdrawal by Subject|0|||
161684142|NCT00912028|583895956|FG004|Overall Study|Withdrawal by Subject|0|||
161684143|NCT02285998|583895957|FG000|Overall Study|Adverse Event|9|||
161684144|NCT02285998|583895958|FG001|Overall Study|Adverse Event|8|||
161684145|NCT02285998|583895957|FG000|Overall Study|Physician Decision|1|||
161684146|NCT02285998|583895958|FG001|Overall Study|Physician Decision|2|||
161684147|NCT02285998|583895957|FG000|Overall Study|Lost to Follow-up|176|||
161684148|NCT02285998|583895958|FG001|Overall Study|Lost to Follow-up|172|||
161684149|NCT02285998|583895957|FG000|Overall Study|Withdrawal by Subject|53|||
161608053|NCT02397096|583616721|FG001|Study Extension 1|Physician Decision|2|||
161608054|NCT02397096|583616720|FG000|Study Extension 1|Pregnancy|1|||
161608055|NCT02397096|583616721|FG001|Study Extension 1|Pregnancy|0|||
161608056|NCT02397096|583616720|FG000|Study Extension 1|Protocol Violation|0|||
161608057|NCT02397096|583616721|FG001|Study Extension 1|Protocol Violation|1|||
161608058|NCT02397096|583616720|FG000|Study Extension 1|Withdrawal by Subject|21|||
161608059|NCT02397096|583616721|FG001|Study Extension 1|Withdrawal by Subject|7|||
161608060|NCT02397096|583616720|FG000|Study Extension 2|Adverse Event|3|||
161608061|NCT02397096|583616721|FG001|Study Extension 2|Adverse Event|3|||
161684150|NCT02285998|583895958|FG001|Overall Study|Withdrawal by Subject|61|||
161684151|NCT02285998|583895957|FG000|Overall Study|Other Reasons|7|||
161684152|NCT02285998|583895958|FG001|Overall Study|Other Reasons|10|||
161684153|NCT02829138|583895959|FG000|Overall Study|Withdrawal by Subject|1|||
161832460|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832461|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161608062|NCT02397096|583616720|FG000|Study Extension 2|Availability of study medication locally|152|||
161684154|NCT02829138|583895960|FG001|Overall Study|Withdrawal by Subject|0|||
161684155|NCT01394627|583895961|FG000|First Intervention (1 Day)|poor intravenous access|0|||
161832462|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161608063|NCT02397096|583616721|FG001|Study Extension 2|Availability of study medication locally|64|||
161608064|NCT02397096|583616720|FG000|Study Extension 2|Death|2|||
161608065|NCT02397096|583616721|FG001|Study Extension 2|Death|0|||
161608066|NCT02397096|583616720|FG000|Study Extension 2|Lack of Efficacy|1|||
161608067|NCT02397096|583616721|FG001|Study Extension 2|Lack of Efficacy|0|||
161608068|NCT02397096|583616720|FG000|Study Extension 2|Lost to Follow-up|2|||
161608069|NCT02397096|583616721|FG001|Study Extension 2|Lost to Follow-up|1|||
161608070|NCT02397096|583616720|FG000|Study Extension 2|Non-compliance with study drug|1|||
161608071|NCT02397096|583616721|FG001|Study Extension 2|Non-compliance with study drug|0|||
161608072|NCT02397096|583616720|FG000|Study Extension 2|Physician Decision|2|||
161608073|NCT02397096|583616721|FG001|Study Extension 2|Physician Decision|5|||
161608074|NCT02397096|583616720|FG000|Study Extension 2|Pregnancy|1|||
161608075|NCT02397096|583616721|FG001|Study Extension 2|Pregnancy|0|||
161608076|NCT02397096|583616720|FG000|Study Extension 2|Withdrawal by Subject|10|||
161608077|NCT02397096|583616721|FG001|Study Extension 2|Withdrawal by Subject|3|||
161608078|NCT02397096|583616720|FG000|Study Extension 3|Adverse Event|1|||
161608079|NCT02397096|583616721|FG001|Study Extension 3|Adverse Event|0|||
161608080|NCT02397096|583616720|FG000|Study Extension 3|Availability of study medication locally|11|||
161608081|NCT02397096|583616721|FG001|Study Extension 3|Availability of study medication locally|3|||
161608082|NCT02397096|583616720|FG000|Study Extension 3|Lost to Follow-up|1|||
161608083|NCT02397096|583616721|FG001|Study Extension 3|Lost to Follow-up|0|||
161608084|NCT02397096|583616720|FG000|Study Extension 3|Withdrawal by Subject|2|||
161608085|NCT02397096|583616721|FG001|Study Extension 3|Withdrawal by Subject|1|||
161608086|NCT05018143|583616722|FG000|Overall Study|Lost to Follow-up|5|||
161608087|NCT05018143|583616723|FG001|Overall Study|Lost to Follow-up|4|||
161608088|NCT05018143|583616722|FG000|Overall Study|Withdrawal by Subject|0|||
161608089|NCT05018143|583616723|FG001|Overall Study|Withdrawal by Subject|1|||
161608090|NCT06688357|583616724|FG000|Overall Study|Adverse Event|0|||
161608091|NCT06688357|583616725|FG001|Overall Study|Adverse Event|1|||
161608092|NCT03789110|583616726|FG000|Overall Study|Adverse Event|2|||
161608093|NCT03789110|583616726|FG000|Overall Study|Physician Decision|1|||
161608094|NCT03789110|583616726|FG000|Overall Study|Withdrawal by Subject|2|||
161608095|NCT03789110|583616726|FG000|Overall Study|Lack of Efficacy|22|||
161608096|NCT03789110|583616726|FG000|Overall Study|still on treatment|3|||
161608097|NCT00545545|583616727|FG000|Overall Study|Progressive Neoplastic Disease|1|||
161608098|NCT00545545|583616728|FG001|Overall Study|Progressive Neoplastic Disease|5|||
161608099|NCT00545545|583616729|FG002|Overall Study|Progressive Neoplastic Disease|0|||
161608100|NCT00545545|583616730|FG003|Overall Study|Progressive Neoplastic Disease|4|||
161608101|NCT00545545|583616731|FG004|Overall Study|Progressive Neoplastic Disease|8|||
161608102|NCT00545545|583616732|FG005|Overall Study|Progressive Neoplastic Disease|7|||
161608103|NCT00545545|583616727|FG000|Overall Study|Withdrawal by Subject|0|||
161608104|NCT00545545|583616728|FG001|Overall Study|Withdrawal by Subject|1|||
161608105|NCT00545545|583616729|FG002|Overall Study|Withdrawal by Subject|0|||
161608106|NCT00545545|583616730|FG003|Overall Study|Withdrawal by Subject|0|||
161608107|NCT00545545|583616731|FG004|Overall Study|Withdrawal by Subject|0|||
161608108|NCT00545545|583616732|FG005|Overall Study|Withdrawal by Subject|0|||
161608109|NCT00545545|583616727|FG000|Overall Study|Physician Decision|1|||
161608110|NCT00545545|583616728|FG001|Overall Study|Physician Decision|0|||
161608111|NCT00545545|583616729|FG002|Overall Study|Physician Decision|0|||
161608112|NCT00545545|583616730|FG003|Overall Study|Physician Decision|0|||
161608113|NCT00545545|583616731|FG004|Overall Study|Physician Decision|0|||
161608114|NCT00545545|583616732|FG005|Overall Study|Physician Decision|1|||
161608115|NCT00545545|583616727|FG000|Overall Study|Irinotecan intolerance|1|||
161608116|NCT00545545|583616728|FG001|Overall Study|Irinotecan intolerance|1|||
161608117|NCT00545545|583616729|FG002|Overall Study|Irinotecan intolerance|0|||
161608118|NCT00545545|583616730|FG003|Overall Study|Irinotecan intolerance|0|||
161608119|NCT00545545|583616731|FG004|Overall Study|Irinotecan intolerance|0|||
161608120|NCT00545545|583616732|FG005|Overall Study|Irinotecan intolerance|0|||
161608121|NCT00545545|583616727|FG000|Overall Study|No target lesions to track post surgery|0|||
161608122|NCT00545545|583616728|FG001|Overall Study|No target lesions to track post surgery|0|||
161608123|NCT00545545|583616729|FG002|Overall Study|No target lesions to track post surgery|0|||
161608124|NCT00545545|583616730|FG003|Overall Study|No target lesions to track post surgery|0|||
161608125|NCT00545545|583616731|FG004|Overall Study|No target lesions to track post surgery|1|||
161608126|NCT00545545|583616732|FG005|Overall Study|No target lesions to track post surgery|1|||
161608127|NCT03959423|583616741|FG000|Overall Study|Withdrawal by Subject|2|||
161684156|NCT01394627|583895962|FG001|First Intervention (1 Day)|poor intravenous access|1|||
161608128|NCT03959423|583616742|FG001|Overall Study|Withdrawal by Subject|3|||
161832463|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832464|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832465|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832466|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832467|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832468|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
161832469|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161608129|NCT03959423|583616741|FG000|Overall Study|Physician Decision|0|||
161608130|NCT03959423|583616742|FG001|Overall Study|Physician Decision|1|||
161608131|NCT03959423|583616741|FG000|Overall Study|Lost to Follow-up|1|||
161608132|NCT03959423|583616742|FG001|Overall Study|Lost to Follow-up|0|||
161608133|NCT03959423|583616741|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
161608134|NCT03959423|583616742|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161608135|NCT04926740|583616743|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
161608136|NCT04926740|583616744|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
161608137|NCT04926740|583616743|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
161608138|NCT04926740|583616744|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
161608139|NCT01470144|583616747|FG000|Overall Study|Adverse Event|2|||
161608140|NCT01470144|583616747|FG000|Overall Study|Death|1|||
161608141|NCT01470144|583616747|FG000|Overall Study|Lung transplant|6|||
161608142|NCT01470144|583616747|FG000|Overall Study|Patient's and investigator's decision|1|||
161608143|NCT06056310|583617670|FG000|Overall Study|Other Reasons|2|||
161608144|NCT06056310|583617670|FG000|Overall Study|Sponsor Request|16|||
161608145|NCT02866942|583617673|FG000|Overall Study|Invalid consent|1|||
161608146|NCT01750684|583617674|FG000|Overall Study|Death|1|||
161608147|NCT01750684|583617675|FG001|Overall Study|Death|0|||
161608148|NCT01750684|583617674|FG000|Overall Study|Non-compliance with Study Drug|0|||
161608149|NCT01750684|583617675|FG001|Overall Study|Non-compliance with Study Drug|1|||
161608150|NCT01750684|583617674|FG000|Overall Study|Withdrawn by Sponsor|0|||
161608151|NCT01750684|583617675|FG001|Overall Study|Withdrawn by Sponsor|1|||
161608152|NCT01750684|583617674|FG000|Overall Study|Protocol Violation|1|||
161608153|NCT01750684|583617675|FG001|Overall Study|Protocol Violation|0|||
161608154|NCT00372775|583617676|FG000|Overall Study|Adverse Event|8|||
161608155|NCT00372775|583617676|FG000|Overall Study|Death|15|||
161608156|NCT00372775|583617676|FG000|Overall Study|Objective progression or relapse|30|||
161608157|NCT00372775|583617676|FG000|Overall Study|Global deterioration of health status|6|||
161608158|NCT00372775|583617676|FG000|Overall Study|Withdrawal by Subject|1|||
161608159|NCT00372775|583617676|FG000|Overall Study|Other|1|||
161608160|NCT00372775|583617676|FG000|Overall Study|Not Treated|2|||
161608161|NCT01561300|583617677|FG000|Run in on Placebo|Adverse Event|1|||
161684157|NCT01394627|583895961|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
161608162|NCT01561300|583617678|FG001|Run in on Placebo|Adverse Event|0|||
161608163|NCT00777049|583617679|FG000|Overall Study|Withdrawal by Subject|1|||
161608164|NCT00777049|583617680|FG001|Overall Study|Withdrawal by Subject|0|||
161608165|NCT00777049|583617679|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
161608166|NCT00777049|583617680|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
161608167|NCT01436175|583617681|FG000|Overall Study|Adverse Event|111|||
161608168|NCT01436175|583617681|FG000|Overall Study|Protocol Violation|49|||
161608169|NCT01436175|583617681|FG000|Overall Study|Withdrawal by Subject|108|||
161608170|NCT01436175|583617681|FG000|Overall Study|Lost to Follow-up|89|||
161608171|NCT01436175|583617681|FG000|Overall Study|Lack of Efficacy|24|||
161608172|NCT01436175|583617681|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
161608173|NCT01436175|583617681|FG000|Overall Study|Other|826|||
161608174|NCT00623194|583617684|FG000|Overall Study|Lack of Efficacy|1|||
161608175|NCT00623194|583617684|FG000|Overall Study|Protocol Violation|3|||
161608176|NCT00623194|583617684|FG000|Overall Study|Unclassified|1|||
161608177|NCT01952366|583617685|FG000|Overall Study|Death|22|||
161608178|NCT01952366|583617685|FG000|Overall Study|Withdrawal by Subject|9|||
161608179|NCT00857766|583617686|FG000|Overall Study|Adverse Event|13|||
161608180|NCT00857766|583617687|FG001|Overall Study|Adverse Event|12|||
161608181|NCT00857766|583617686|FG000|Overall Study|Protocol Violation|11|||
161608182|NCT00857766|583617687|FG001|Overall Study|Protocol Violation|11|||
161608183|NCT00857766|583617686|FG000|Overall Study|Lost to Follow-up|1|||
161608184|NCT00857766|583617687|FG001|Overall Study|Lost to Follow-up|0|||
161608185|NCT00857766|583617686|FG000|Overall Study|Investigator Discretion|2|||
161608186|NCT00857766|583617687|FG001|Overall Study|Investigator Discretion|3|||
161608187|NCT00857766|583617686|FG000|Overall Study|Participant Withdrew Consent|4|||
161608188|NCT00857766|583617687|FG001|Overall Study|Participant Withdrew Consent|4|||
161608189|NCT01988402|583617688|FG000|Overall Study|Adverse Event|1|||
161608190|NCT01988402|583617689|FG001|Overall Study|Adverse Event|2|||
161608191|NCT01988402|583617688|FG000|Overall Study|Withdrawal by Subject|1|||
161608192|NCT01988402|583617689|FG001|Overall Study|Withdrawal by Subject|0|||
161608193|NCT01212744|583617690|FG000|Overall Study|Withdrawal by Subject|1|||
161608194|NCT00523419|583617694|FG000|Overall Study|Adverse Event|1|||
161608195|NCT00523419|583617694|FG000|Overall Study|Withdrawal by Subject|1|||
161608196|NCT00523419|583617694|FG000|Overall Study|Physician Decision|2|||
161608197|NCT00523419|583617694|FG000|Overall Study|Progressive Disease|22|||
161608198|NCT00523419|583617694|FG000|Overall Study|Death due to Study Disease|4|||
161608199|NCT00523419|583617694|FG000|Overall Study|Death due to Adverse Event|2|||
161608200|NCT00822120|583617695|FG000|Initial Registration|Adverse Event|1|||
161608201|NCT00822120|583617696|FG001|Initial Registration|Adverse Event|0|||
161608202|NCT00822120|583617697|FG002|Initial Registration|Adverse Event|0|||
161608203|NCT00822120|583617698|FG003|Initial Registration|Adverse Event|0|||
161608204|NCT00822120|583617699|FG004|Initial Registration|Adverse Event|0|||
161608205|NCT00822120|583617700|FG005|Initial Registration|Adverse Event|0|||
161608206|NCT00822120|583617695|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
161608207|NCT00822120|583617696|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161608208|NCT00822120|583617697|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161608209|NCT00822120|583617698|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161608210|NCT00822120|583617699|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161608211|NCT00822120|583617700|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161608212|NCT00822120|583617695|FG000|Initial Registration|Reasons not Protocol Specified|2|||
161608213|NCT00822120|583617696|FG001|Initial Registration|Reasons not Protocol Specified|0|||
161608214|NCT00822120|583617697|FG002|Initial Registration|Reasons not Protocol Specified|0|||
161608215|NCT00822120|583617698|FG003|Initial Registration|Reasons not Protocol Specified|0|||
161608216|NCT00822120|583617699|FG004|Initial Registration|Reasons not Protocol Specified|0|||
161608217|NCT00822120|583617700|FG005|Initial Registration|Reasons not Protocol Specified|0|||
161608218|NCT00822120|583617695|FG000|Initial Registration|Ineligible|22|||
161608219|NCT00822120|583617696|FG001|Initial Registration|Ineligible|1|||
161608220|NCT00822120|583617697|FG002|Initial Registration|Ineligible|0|||
161608221|NCT00822120|583617698|FG003|Initial Registration|Ineligible|0|||
161608222|NCT00822120|583617699|FG004|Initial Registration|Ineligible|0|||
161608223|NCT00822120|583617700|FG005|Initial Registration|Ineligible|0|||
161608224|NCT00822120|583617695|FG000|PET-directed Therapy|Adverse Event|0|||
161608225|NCT00822120|583617696|FG001|PET-directed Therapy|Adverse Event|0|||
161608226|NCT00822120|583617697|FG002|PET-directed Therapy|Adverse Event|0|||
161608227|NCT00822120|583617698|FG003|PET-directed Therapy|Adverse Event|1|||
161608228|NCT00822120|583617699|FG004|PET-directed Therapy|Adverse Event|0|||
161608229|NCT00822120|583617700|FG005|PET-directed Therapy|Adverse Event|0|||
161608230|NCT00822120|583617695|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161608231|NCT00822120|583617696|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161608232|NCT00822120|583617697|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161684158|NCT01394627|583895962|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
161608233|NCT00822120|583617698|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
161608234|NCT00822120|583617699|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161608235|NCT00822120|583617700|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161608236|NCT00822120|583617695|FG000|PET-directed Therapy|Death|0|||
161608237|NCT00822120|583617696|FG001|PET-directed Therapy|Death|0|||
161608238|NCT00822120|583617697|FG002|PET-directed Therapy|Death|0|||
161608239|NCT00822120|583617698|FG003|PET-directed Therapy|Death|2|||
161608240|NCT00822120|583617699|FG004|PET-directed Therapy|Death|0|||
161608241|NCT00822120|583617700|FG005|PET-directed Therapy|Death|0|||
161608242|NCT00822120|583617695|FG000|PET-directed Therapy|Protocol Violation|0|||
161608243|NCT00822120|583617696|FG001|PET-directed Therapy|Protocol Violation|0|||
161608244|NCT00822120|583617697|FG002|PET-directed Therapy|Protocol Violation|0|||
161608245|NCT00822120|583617698|FG003|PET-directed Therapy|Protocol Violation|6|||
161608246|NCT00822120|583617699|FG004|PET-directed Therapy|Protocol Violation|0|||
161608247|NCT00822120|583617700|FG005|PET-directed Therapy|Protocol Violation|0|||
161608248|NCT01759862|583617701|FG000|Overall Study|Physician Decision|3|||
161608249|NCT01759862|583617702|FG001|Overall Study|Physician Decision|1|||
161608250|NCT01759862|583617701|FG000|Overall Study|Adverse Event|0|||
161608251|NCT01759862|583617702|FG001|Overall Study|Adverse Event|1|||
161608252|NCT04060212|583617704|FG000|Overall Study|Withdrawal by Subject|7|||
161608253|NCT01499849|583617705|FG000|Overall Study|Adverse Event|28|||
161608254|NCT01499849|583617706|FG001|Overall Study|Adverse Event|32|||
161608255|NCT01499849|583617705|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
161608256|NCT01499849|583617706|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
161608257|NCT01499849|583617705|FG000|Overall Study|Withdrawal by Subject|43|||
161608258|NCT01499849|583617706|FG001|Overall Study|Withdrawal by Subject|43|||
161608259|NCT01499849|583617705|FG000|Overall Study|Death|5|||
161608260|NCT01499849|583617706|FG001|Overall Study|Death|7|||
161608261|NCT01499849|583617705|FG000|Overall Study|Disease Progression|11|||
161608262|NCT01499849|583617706|FG001|Overall Study|Disease Progression|10|||
161608263|NCT01499849|583617705|FG000|Overall Study|Protocol Violation|11|||
161608264|NCT01499849|583617706|FG001|Overall Study|Protocol Violation|11|||
161608265|NCT01499849|583617705|FG000|Overall Study|Physician Decision|20|||
161608266|NCT01499849|583617706|FG001|Overall Study|Physician Decision|19|||
161608267|NCT01499849|583617705|FG000|Overall Study|Lack of Efficacy|3|||
161608268|NCT01499849|583617706|FG001|Overall Study|Lack of Efficacy|4|||
161608269|NCT01499849|583617705|FG000|Overall Study|Lost to Follow-up|6|||
161608270|NCT01499849|583617706|FG001|Overall Study|Lost to Follow-up|3|||
161608271|NCT01499849|583617705|FG000|Overall Study|Other Reasons|27|||
161608272|NCT01499849|583617706|FG001|Overall Study|Other Reasons|30|||
161608273|NCT01437319|583617707|FG000|Phase I|Lost to Follow-up|2|||
161608274|NCT01437319|583617708|FG001|Phase I|Lost to Follow-up|0|||
161608275|NCT01437319|583617709|FG002|Phase I|Lost to Follow-up|0|||
161608276|NCT01437319|583617707|FG000|Phase I|Protocol Violation|1|||
161608277|NCT01437319|583617708|FG001|Phase I|Protocol Violation|0|||
161608278|NCT01437319|583617709|FG002|Phase I|Protocol Violation|0|||
161608279|NCT01437319|583617707|FG000|Phase I|Study related symptoms/complaints|27|||
161608280|NCT01437319|583617708|FG001|Phase I|Study related symptoms/complaints|0|||
161608281|NCT01437319|583617709|FG002|Phase I|Study related symptoms/complaints|0|||
161608282|NCT01437319|583617707|FG000|Phase I|Withdrawal by Subject|25|||
161608283|NCT01437319|583617708|FG001|Phase I|Withdrawal by Subject|0|||
161608284|NCT01437319|583617709|FG002|Phase I|Withdrawal by Subject|0|||
161608285|NCT01437319|583617707|FG000|Phase II|Withdrawal by Subject|0|||
161608286|NCT01437319|583617708|FG001|Phase II|Withdrawal by Subject|8|||
161608287|NCT01437319|583617709|FG002|Phase II|Withdrawal by Subject|16|||
161608288|NCT01437319|583617707|FG000|Phase II|Lost to Follow-up|0|||
161608289|NCT01437319|583617708|FG001|Phase II|Lost to Follow-up|7|||
161608290|NCT01437319|583617709|FG002|Phase II|Lost to Follow-up|2|||
161608291|NCT01437319|583617707|FG000|Phase II|Study related symptoms/complaints|0|||
161608292|NCT01437319|583617708|FG001|Phase II|Study related symptoms/complaints|28|||
161608293|NCT01437319|583617709|FG002|Phase II|Study related symptoms/complaints|19|||
161608294|NCT01437319|583617707|FG000|Phase II|Protocol Violation|0|||
161608295|NCT01437319|583617708|FG001|Phase II|Protocol Violation|1|||
161608296|NCT01437319|583617709|FG002|Phase II|Protocol Violation|0|||
161608297|NCT02646618|583617710|FG000|Overall Study|Lost to Follow-up|10|||
161608298|NCT02646618|583617711|FG001|Overall Study|Lost to Follow-up|14|||
161608299|NCT03885232|583617712|FG000|Overall Study|Lost to Follow-up|74|||
161684159|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
161608300|NCT03885232|583617713|FG001|Overall Study|Lost to Follow-up|32|||
161608301|NCT03885232|583617712|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
161608302|NCT03885232|583617713|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
161608303|NCT00274261|583617714|FG000|Overall Study|Adverse Event|19|||
161608304|NCT00274261|583617715|FG001|Overall Study|Adverse Event|11|||
161608305|NCT00274261|583617714|FG000|Overall Study|Pregnancy|114|||
161608306|NCT00274261|583617715|FG001|Overall Study|Pregnancy|83|||
161608307|NCT00274261|583617714|FG000|Overall Study|Withdrawal by Subject|179|||
161608308|NCT00274261|583617715|FG001|Overall Study|Withdrawal by Subject|126|||
161608309|NCT00274261|583617714|FG000|Overall Study|Protocol Violation|71|||
161684160|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
161684161|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
161684162|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
161684163|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
161684164|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
161684165|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
161684166|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
161684167|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
161684168|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
161684169|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Other than specified|1|||
161684170|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Other than specified|0|||
161684171|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
161684172|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
161684173|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
161684174|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
161684175|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
161684176|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
161684177|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Other than specified|6|||
161684178|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Other than specified|2|||
161684179|NCT02016820|583895972|FG000|Overall Study|Lost to Follow-up|2|||
161684180|NCT02016820|583895973|FG001|Overall Study|Lost to Follow-up|4|||
161608310|NCT00274261|583617715|FG001|Overall Study|Protocol Violation|42|||
161608311|NCT00274261|583617714|FG000|Overall Study|Lost to Follow-up|106|||
161608312|NCT00274261|583617715|FG001|Overall Study|Lost to Follow-up|75|||
161608313|NCT03500549|583617716|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
161608314|NCT03500549|583617717|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
161608315|NCT03500549|583617716|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
161608316|NCT03500549|583617717|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
161608317|NCT02016872|583617720|FG000|Overall Study|Withdrawal by Subject|10|||
161608318|NCT02016872|583617720|FG000|Overall Study|Death Progression|2|||
161608319|NCT02016872|583617720|FG000|Overall Study|No FMISO scan|1|||
161608320|NCT02016872|583617720|FG000|Overall Study|Ineligible|2|||
161608321|NCT05601882|583617721|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
161608322|NCT05601882|583617722|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
161608323|NCT05601882|583617723|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
161608324|NCT05601882|583617724|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
161608325|NCT05601882|583617721|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
161608326|NCT05601882|583617722|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
161608327|NCT05601882|583617723|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
161608328|NCT05601882|583617724|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
161608329|NCT05601882|583617721|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
161608330|NCT05601882|583617722|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
161608331|NCT05601882|583617723|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
161608332|NCT05601882|583617724|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
161608333|NCT05601882|583617721|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
161608334|NCT05601882|583617722|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
161608335|NCT05601882|583617723|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
161608336|NCT05601882|583617724|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
161608337|NCT05601882|583617721|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
161608338|NCT05601882|583617722|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
161608339|NCT05601882|583617723|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
161608340|NCT05601882|583617724|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
161608341|NCT05601882|583617721|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
161608342|NCT05601882|583617722|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
161608343|NCT05601882|583617723|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
161684181|NCT00884273|583895974|FG000|Overall Study|Adverse Event|0|||
161684182|NCT00884273|583895975|FG001|Overall Study|Adverse Event|2|||
161684183|NCT00884273|583895974|FG000|Overall Study|Protocol Violation|1|||
161684184|NCT00884273|583895975|FG001|Overall Study|Protocol Violation|3|||
161684185|NCT00884273|583895974|FG000|Overall Study|Practical reasons|1|||
161684186|NCT00884273|583895975|FG001|Overall Study|Practical reasons|0|||
161684187|NCT02437864|583895976|FG000|Overall Study|Protocol Violation|4|||
161684188|NCT02437864|583895977|FG001|Overall Study|Protocol Violation|0|||
161684189|NCT03803059|583895978|FG000|Overall Study|Protocol Violation|2|||
161684190|NCT03803059|583895978|FG000|Overall Study|Lost to Follow-up|1|||
161608344|NCT05601882|583617724|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
161608345|NCT03222609|583617727|FG000|Overall Study|Withdrew consent|2|||
161684191|NCT05419128|583895982|FG000|Overall Study|Withdrawal by Subject|1|||
161684192|NCT05419128|583895983|FG001|Overall Study|Withdrawal by Subject|1|||
161684193|NCT05419128|583895984|FG002|Overall Study|Withdrawal by Subject|0|||
161684194|NCT05419128|583895985|FG003|Overall Study|Withdrawal by Subject|1|||
161684195|NCT05419128|583895986|FG004|Overall Study|Withdrawal by Subject|1|||
161684196|NCT05419128|583895987|FG005|Overall Study|Withdrawal by Subject|0|||
161608346|NCT03222609|583617728|FG001|Overall Study|Withdrew consent|3|||
161608347|NCT03222609|583617729|FG002|Overall Study|Withdrew consent|4|||
161608348|NCT03222609|583617730|FG003|Overall Study|Withdrew consent|2|||
161608349|NCT03222609|583617727|FG000|Overall Study|Lost to Follow-up|1|||
161608350|NCT03222609|583617728|FG001|Overall Study|Lost to Follow-up|0|||
161608351|NCT03222609|583617729|FG002|Overall Study|Lost to Follow-up|0|||
161608352|NCT03222609|583617730|FG003|Overall Study|Lost to Follow-up|0|||
161608353|NCT03222609|583617727|FG000|Overall Study|Death|16|||
161608354|NCT03222609|583617728|FG001|Overall Study|Death|13|||
161608355|NCT03222609|583617729|FG002|Overall Study|Death|9|||
161608356|NCT03222609|583617730|FG003|Overall Study|Death|6|||
161608357|NCT03222609|583617727|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
161608358|NCT03222609|583617728|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
161608359|NCT03222609|583617729|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
161608360|NCT03222609|583617730|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
161608361|NCT01208974|583617731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
161608362|NCT01208974|583617732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
161608363|NCT01208974|583617733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
161608364|NCT01208974|583617734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
161608365|NCT01208974|583617731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
161608366|NCT01208974|583617732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
161608367|NCT01208974|583617733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
161608368|NCT01208974|583617734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
161608369|NCT01208974|583617731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
161608370|NCT01208974|583617732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
161608371|NCT01208974|583617733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
161608372|NCT01208974|583617734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
161608373|NCT02500576|583617735|FG000|Overall Study|Adverse Event|0|||
161608374|NCT02500576|583617736|FG001|Overall Study|Adverse Event|1|||
161608375|NCT02500576|583617735|FG000|Overall Study|Death|2|||
161608376|NCT02500576|583617736|FG001|Overall Study|Death|1|||
161608377|NCT02500576|583617735|FG000|Overall Study|Lack of Efficacy|5|||
161608378|NCT02500576|583617736|FG001|Overall Study|Lack of Efficacy|5|||
161608379|NCT02500576|583617735|FG000|Overall Study|Withdrawal by Subject|1|||
161608380|NCT02500576|583617736|FG001|Overall Study|Withdrawal by Subject|1|||
161608381|NCT03691493|583617740|FG000|Overall Study|Withdrawal by Subject|1|||
161608382|NCT00227266|583617741|FG000|Overall Study|Withdrawal by Subject|0|||
161608383|NCT00227266|583617742|FG001|Overall Study|Withdrawal by Subject|0|||
161608384|NCT00227266|583617743|FG002|Overall Study|Withdrawal by Subject|1|||
161608385|NCT00227266|583617741|FG000|Overall Study|Protocol Violation|1|||
161608386|NCT00227266|583617742|FG001|Overall Study|Protocol Violation|0|||
161608387|NCT00227266|583617743|FG002|Overall Study|Protocol Violation|1|||
161608388|NCT00227266|583617741|FG000|Overall Study|Excessive weight gain|0|||
161608389|NCT00227266|583617742|FG001|Overall Study|Excessive weight gain|0|||
161608390|NCT00227266|583617743|FG002|Overall Study|Excessive weight gain|2|||
161608391|NCT02761187|583617746|FG000|Overall Study|Too ill to Participate|13|||
161608392|NCT02761187|583617747|FG001|Overall Study|Too ill to Participate|8|||
161608393|NCT02761187|583617746|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
161608394|NCT02761187|583617747|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
161608395|NCT02761187|583617746|FG000|Overall Study|Patient withdrew consent|64|||
161608396|NCT02761187|583617747|FG001|Overall Study|Patient withdrew consent|58|||
161608397|NCT02761187|583617746|FG000|Overall Study|Physician discretion|4|||
161608398|NCT02761187|583617747|FG001|Overall Study|Physician discretion|8|||
161608399|NCT02761187|583617746|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
161608400|NCT02761187|583617747|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
161608401|NCT02761187|583617746|FG000|Overall Study|On Hospice|20|||
161608402|NCT02761187|583617747|FG001|Overall Study|On Hospice|26|||
161608403|NCT02761187|583617746|FG000|Overall Study|Deceased|474|||
161608404|NCT02761187|583617747|FG001|Overall Study|Deceased|642|||
161608405|NCT02761187|583617746|FG000|Overall Study|Lost to Follow-up|73|||
161608406|NCT02761187|583617747|FG001|Overall Study|Lost to Follow-up|63|||
161608407|NCT02761187|583617746|FG000|Overall Study|Due to study discontinued at site|100|||
161608408|NCT02761187|583617747|FG001|Overall Study|Due to study discontinued at site|85|||
161608409|NCT02761187|583617746|FG000|Overall Study|Reason not Specified|1484|||
161608410|NCT02761187|583617747|FG001|Overall Study|Reason not Specified|937|||
161684197|NCT05419128|583895982|FG000|Overall Study|Lost to Follow-up|0|||
161684198|NCT05419128|583895983|FG001|Overall Study|Lost to Follow-up|0|||
161608411|NCT05704725|583617749|FG000|Overall Study|Lost to Follow-up|0|||
161608412|NCT05704725|583617750|FG001|Overall Study|Lost to Follow-up|1|||
161608413|NCT05704725|583617749|FG000|Overall Study|Withdrawal by Subject|1|||
161608414|NCT05704725|583617750|FG001|Overall Study|Withdrawal by Subject|0|||
161608415|NCT02798471|583617753|FG000|Overall Study|Adverse Event|7|||
161608416|NCT02798471|583617754|FG001|Overall Study|Adverse Event|2|||
161684199|NCT05419128|583895984|FG002|Overall Study|Lost to Follow-up|1|||
161684200|NCT05419128|583895985|FG003|Overall Study|Lost to Follow-up|0|||
161608417|NCT02798471|583617753|FG000|Overall Study|Physician Decision|3|||
161608418|NCT02798471|583617754|FG001|Overall Study|Physician Decision|7|||
161608419|NCT02798471|583617753|FG000|Overall Study|Death|2|||
161608420|NCT02798471|583617754|FG001|Overall Study|Death|3|||
161608421|NCT02798471|583617753|FG000|Overall Study|Lost to Follow-up|0|||
161608422|NCT02798471|583617754|FG001|Overall Study|Lost to Follow-up|1|||
161608423|NCT02798471|583617753|FG000|Overall Study|Other|5|||
161608424|NCT02798471|583617754|FG001|Overall Study|Other|3|||
161608425|NCT02798471|583617753|FG000|Overall Study|Subject withdrew consent|0|||
161608426|NCT02798471|583617754|FG001|Overall Study|Subject withdrew consent|6|||
161608427|NCT02798471|583617753|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
161608428|NCT02798471|583617754|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
161608429|NCT02798471|583617753|FG000|Overall Study|Randomized, but not treated|0|||
161608430|NCT02798471|583617754|FG001|Overall Study|Randomized, but not treated|2|||
161608431|NCT05802173|583619401|FG000|Overall Study|Withdrawal by Subject|2|||
161608432|NCT05802173|583619402|FG001|Overall Study|Withdrawal by Subject|0|||
161608433|NCT05802173|583619403|FG002|Overall Study|Withdrawal by Subject|0|||
161608434|NCT05802173|583619401|FG000|Overall Study|Protocol Violation|1|||
161608435|NCT05802173|583619402|FG001|Overall Study|Protocol Violation|0|||
161608436|NCT05802173|583619403|FG002|Overall Study|Protocol Violation|0|||
161608437|NCT05802173|583619401|FG000|Overall Study|Lost to Follow-up|0|||
161608438|NCT05802173|583619402|FG001|Overall Study|Lost to Follow-up|6|||
161608439|NCT05802173|583619403|FG002|Overall Study|Lost to Follow-up|4|||
161608440|NCT05802173|583619401|FG000|Overall Study|non-compliance|0|||
161608441|NCT05802173|583619402|FG001|Overall Study|non-compliance|1|||
161608442|NCT05802173|583619403|FG002|Overall Study|non-compliance|0|||
161608443|NCT04503681|583619404|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
161608444|NCT04503681|583619405|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
161608445|NCT03352713|583619406|FG000|Overall Study|Lost to Follow-up|8|||
161608446|NCT03352713|583619406|FG000|Overall Study|Withdrawn by investigator|5|||
161608447|NCT03352713|583619406|FG000|Overall Study|Completed 0 EMAs|8|||
161608448|NCT03352713|583619406|FG000|Overall Study|Device incompatible/stolen|5|||
161608449|NCT01812759|583619407|FG000|Overall Study|Physician Decision|0|||
161608450|NCT01812759|583619408|FG001|Overall Study|Physician Decision|0|||
161608451|NCT01812759|583619409|FG002|Overall Study|Physician Decision|1|||
161608452|NCT00360269|583619410|FG000|Overall Study|Lost to Follow-up|7|||
161608453|NCT00360269|583619411|FG001|Overall Study|Lost to Follow-up|9|||
161608454|NCT00360269|583619410|FG000|Overall Study|Physician Decision|1|||
161608455|NCT00360269|583619411|FG001|Overall Study|Physician Decision|2|||
161608456|NCT00360269|583619410|FG000|Overall Study|Adverse Event|1|||
161608457|NCT00360269|583619411|FG001|Overall Study|Adverse Event|0|||
161608458|NCT00360269|583619410|FG000|Overall Study|Withdrawal by Subject|1|||
161608459|NCT00360269|583619411|FG001|Overall Study|Withdrawal by Subject|1|||
161608460|NCT03758638|583619414|FG000|Overall Study|Pregnancy|17|||
161608461|NCT03758638|583619415|FG001|Overall Study|Pregnancy|25|||
161608462|NCT03758638|583619414|FG000|Overall Study|Lost to Follow-up|60|||
161608463|NCT03758638|583619415|FG001|Overall Study|Lost to Follow-up|54|||
161608464|NCT03758638|583619414|FG000|Overall Study|Protocol Violation|2|||
161684201|NCT05419128|583895986|FG004|Overall Study|Lost to Follow-up|0|||
161684202|NCT05419128|583895987|FG005|Overall Study|Lost to Follow-up|1|||
161684203|NCT02581202|583895988|FG000|Overall Study|Lack of Efficacy|2|||
161684204|NCT02581202|583895988|FG000|Overall Study|Withdrawal by Subject|4|||
161608465|NCT03758638|583619415|FG001|Overall Study|Protocol Violation|0|||
161608466|NCT03758638|583619414|FG000|Overall Study|Withdrawal by Subject|8|||
161608467|NCT03758638|583619415|FG001|Overall Study|Withdrawal by Subject|2|||
161608468|NCT03758638|583619414|FG000|Overall Study|Providers not included in the primary outcome.|183|||
161608469|NCT03758638|583619415|FG001|Overall Study|Providers not included in the primary outcome.|128|||
161608470|NCT04213807|583619417|FG000|Overall Study|Physician Decision|0|||
161608471|NCT04213807|583619418|FG001|Overall Study|Physician Decision|0|||
161608472|NCT04213807|583619419|FG002|Overall Study|Physician Decision|1|||
161608473|NCT03442777|583619420|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
161608474|NCT03442777|583619421|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
161608475|NCT03442777|583619422|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
161684205|NCT02581202|583895988|FG000|Overall Study|Lost to Follow-up|5|||
161608476|NCT00790569|583619423|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
161608477|NCT00790569|583619424|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
161608478|NCT00790569|583619425|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
161608479|NCT00790569|583619423|FG000|End of Treatment (6 Month Interview)|Death|0|||
161608480|NCT00790569|583619424|FG001|End of Treatment (6 Month Interview)|Death|2|||
161608481|NCT00790569|583619425|FG002|End of Treatment (6 Month Interview)|Death|1|||
161608482|NCT00790569|583619423|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
161608483|NCT00790569|583619424|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
161608484|NCT00790569|583619425|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
161608485|NCT00790569|583619423|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
161608486|NCT00790569|583619424|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
161608487|NCT00790569|583619425|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
161608488|NCT00790569|583619423|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
161608489|NCT00790569|583619424|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
161608490|NCT00790569|583619425|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
161608491|NCT00790569|583619423|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
161608492|NCT00790569|583619424|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
161608493|NCT00790569|583619425|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
161608494|NCT01627561|583619426|FG000|Overall Study|Lost to Follow-up|1|||
161608495|NCT01627561|583619427|FG001|Overall Study|Lost to Follow-up|0|||
161608496|NCT01627561|583619426|FG000|Overall Study|Withdrawal by Subject|0|||
161608497|NCT01627561|583619427|FG001|Overall Study|Withdrawal by Subject|1|||
161608498|NCT01627561|583619426|FG000|Overall Study|Migrated/moved from study area|0|||
161608499|NCT01627561|583619427|FG001|Overall Study|Migrated/moved from study area|2|||
161608500|NCT00724126|583619428|FG000|Overall Study|Adverse Event|2|||
161608501|NCT00724126|583619429|FG001|Overall Study|Adverse Event|0|||
161608502|NCT00724126|583619428|FG000|Overall Study|Withdrawal by Subject|8|||
161608503|NCT00724126|583619429|FG001|Overall Study|Withdrawal by Subject|6|||
161608504|NCT00724126|583619428|FG000|Overall Study|Lost to Follow-up|6|||
161608505|NCT00724126|583619429|FG001|Overall Study|Lost to Follow-up|6|||
161608506|NCT00724126|583619428|FG000|Overall Study|Noncompliance|2|||
161608507|NCT00724126|583619429|FG001|Overall Study|Noncompliance|1|||
161608508|NCT00724126|583619428|FG000|Overall Study|Subject randomized although ineligible|1|||
161608509|NCT00724126|583619429|FG001|Overall Study|Subject randomized although ineligible|1|||
161608510|NCT00724126|583619428|FG000|Overall Study|Subject had to leave vicinity of site|0|||
161608511|NCT00724126|583619429|FG001|Overall Study|Subject had to leave vicinity of site|1|||
161608512|NCT03577106|583619433|FG000|Overall Study|Withdrawal by Subject|3|||
161608513|NCT03451422|583619434|FG000|Overall Study|Lost to Follow-up|0|||
161608514|NCT03451422|583619435|FG001|Overall Study|Lost to Follow-up|0|||
161608515|NCT03451422|583619436|FG002|Overall Study|Lost to Follow-up|0|||
161608516|NCT03451422|583619437|FG003|Overall Study|Lost to Follow-up|0|||
161608517|NCT03451422|583619438|FG004|Overall Study|Lost to Follow-up|0|||
161608518|NCT03451422|583619439|FG005|Overall Study|Lost to Follow-up|1|||
161608519|NCT03451422|583619434|FG000|Overall Study|Decision by sponsor|1|||
161608520|NCT03451422|583619435|FG001|Overall Study|Decision by sponsor|0|||
161608521|NCT03451422|583619436|FG002|Overall Study|Decision by sponsor|1|||
161608522|NCT03451422|583619437|FG003|Overall Study|Decision by sponsor|0|||
161608523|NCT03451422|583619438|FG004|Overall Study|Decision by sponsor|0|||
161608524|NCT03451422|583619439|FG005|Overall Study|Decision by sponsor|0|||
161608525|NCT03451422|583619434|FG000|Overall Study|Withdrawal by Subject|0|||
161608526|NCT03451422|583619435|FG001|Overall Study|Withdrawal by Subject|0|||
161608527|NCT03451422|583619436|FG002|Overall Study|Withdrawal by Subject|2|||
161608528|NCT03451422|583619437|FG003|Overall Study|Withdrawal by Subject|3|||
161608529|NCT03451422|583619438|FG004|Overall Study|Withdrawal by Subject|2|||
161608530|NCT03451422|583619439|FG005|Overall Study|Withdrawal by Subject|1|||
161608531|NCT01579318|583619440|FG000|Overall Study|Disease Progression|1|||
161608532|NCT03601715|583619443|FG000|Second Intervention|Lost to Follow-up|1|||
161608533|NCT03601715|583619444|FG001|Second Intervention|Lost to Follow-up|1|||
161608534|NCT03601715|583619445|FG002|Second Intervention|Lost to Follow-up|0|||
161608535|NCT02347332|583619446|FG000|Overall Study|Not treated|5|||
161608536|NCT02347332|583619447|FG001|Overall Study|Not treated|2|||
161608537|NCT02347332|583619446|FG000|Overall Study|Progressive disease|141|||
161608538|NCT02347332|583619447|FG001|Overall Study|Progressive disease|159|||
161608539|NCT02347332|583619446|FG000|Overall Study|Adverse Event|50|||
161608540|NCT02347332|583619447|FG001|Overall Study|Adverse Event|41|||
161608541|NCT02347332|583619446|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
161832470|NCT00380692|584428400|FG000|Study Period II - Double Blind|Adverse Event|1|||
161608542|NCT02347332|583619447|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
161608543|NCT02347332|583619446|FG000|Overall Study|Protocol Violation|1|||
161608544|NCT02347332|583619447|FG001|Overall Study|Protocol Violation|1|||
161608545|NCT02347332|583619446|FG000|Overall Study|Lost to Follow-up|2|||
161608546|NCT02347332|583619447|FG001|Overall Study|Lost to Follow-up|1|||
161608547|NCT02347332|583619446|FG000|Overall Study|Physician Decision|4|||
161832471|NCT00380692|584428401|FG001|Study Period II - Double Blind|Adverse Event|0|||
161608548|NCT02347332|583619447|FG001|Overall Study|Physician Decision|3|||
161608549|NCT02347332|583619446|FG000|Overall Study|Withdrawal by Subject|20|||
161608550|NCT02347332|583619447|FG001|Overall Study|Withdrawal by Subject|14|||
161608551|NCT02347332|583619446|FG000|Overall Study|Protocol requirement|1|||
161608552|NCT02347332|583619447|FG001|Overall Study|Protocol requirement|1|||
161608553|NCT02347332|583619446|FG000|Overall Study|Switch Post-Trial program|0|||
161608554|NCT02347332|583619447|FG001|Overall Study|Switch Post-Trial program|1|||
161608555|NCT01478594|583619449|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
161608556|NCT01478594|583619450|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
161608557|NCT01478594|583619449|FG000|Overall Study|Death|45|||
161608558|NCT01478594|583619450|FG001|Overall Study|Death|18|||
161608559|NCT01478594|583619449|FG000|Overall Study|Lost to Follow-up|3|||
161608560|NCT01478594|583619450|FG001|Overall Study|Lost to Follow-up|1|||
161608561|NCT01478594|583619449|FG000|Overall Study|Withdrawal by Subject|9|||
161608562|NCT01478594|583619450|FG001|Overall Study|Withdrawal by Subject|3|||
161608563|NCT01478594|583619449|FG000|Overall Study|Study Closed by Sponsor|8|||
161608564|NCT01478594|583619450|FG001|Overall Study|Study Closed by Sponsor|5|||
161608565|NCT01313884|583619451|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
161608566|NCT01970007|583619452|FG000|Overall Study|Death|5|||
161608567|NCT01970007|583619452|FG000|Overall Study|Withdrawal by Subject|23|||
161608568|NCT01970007|583619452|FG000|Overall Study|Lost to Follow-up|24|||
161608569|NCT01970007|583619452|FG000|Overall Study|"Other endpoint"|3|||
161608570|NCT04384172|583619454|FG000|Overall Study|Lost to Follow-up|0|||
161608571|NCT04384172|583619455|FG001|Overall Study|Lost to Follow-up|2|||
161608572|NCT04384172|583619454|FG000|Overall Study|Pregnancy|1|||
161608573|NCT04384172|583619455|FG001|Overall Study|Pregnancy|0|||
161608574|NCT04384172|583619454|FG000|Overall Study|Withdrawal by Subject|0|||
161608575|NCT04384172|583619455|FG001|Overall Study|Withdrawal by Subject|1|||
161608576|NCT04860505|583619457|FG000|Overall Study|Lost to Follow-up|2|||
161608577|NCT00811941|583619461|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
161608578|NCT00811941|583619462|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
161608579|NCT00811941|583619461|FG000|All Treated Patients|Adverse Event|2|||
161608580|NCT00811941|583619462|FG001|All Treated Patients|Adverse Event|43|||
161608581|NCT00811941|583619461|FG000|All Treated Patients|Lack of Efficacy|2|||
161608582|NCT00811941|583619462|FG001|All Treated Patients|Lack of Efficacy|3|||
161608583|NCT00811941|583619461|FG000|All Treated Patients|Non-compliance|1|||
161608584|NCT00811941|583619462|FG001|All Treated Patients|Non-compliance|8|||
161608585|NCT00811941|583619461|FG000|All Treated Patients|Protocol Violation|5|||
161608586|NCT00811941|583619462|FG001|All Treated Patients|Protocol Violation|17|||
161608587|NCT00811941|583619461|FG000|All Treated Patients|Withdrawal by Subject|35|||
161608588|NCT00811941|583619462|FG001|All Treated Patients|Withdrawal by Subject|94|||
161608589|NCT00811941|583619461|FG000|All Treated Patients|Lost to Follow-up|3|||
161608590|NCT00811941|583619462|FG001|All Treated Patients|Lost to Follow-up|12|||
161608591|NCT00811941|583619461|FG000|All Treated Patients|Other Reason|4|||
161608592|NCT00811941|583619462|FG001|All Treated Patients|Other Reason|14|||
161608593|NCT00942266|583619470|FG000|Overall Study|Withdrawal by Subject|1|||
161608594|NCT00942266|583619471|FG001|Overall Study|Withdrawal by Subject|0|||
161608595|NCT00942266|583619470|FG000|Overall Study|Adverse Event|2|||
161608596|NCT00942266|583619471|FG001|Overall Study|Adverse Event|1|||
161608597|NCT00942266|583619470|FG000|Overall Study|Disease Progression|38|||
161608598|NCT00942266|583619471|FG001|Overall Study|Disease Progression|11|||
161608599|NCT00942266|583619470|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
161608600|NCT00942266|583619471|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
161608601|NCT00942266|583619470|FG000|Overall Study|Intercurrent illness|0|||
161608602|NCT00942266|583619471|FG001|Overall Study|Intercurrent illness|1|||
161608603|NCT00942266|583619470|FG000|Overall Study|Physician Decision|2|||
161608604|NCT00942266|583619471|FG001|Overall Study|Physician Decision|0|||
161608605|NCT00942266|583619470|FG000|Overall Study|medical deterioration (pneumonia)|0|||
161608606|NCT00942266|583619471|FG001|Overall Study|medical deterioration (pneumonia)|1|||
161608607|NCT04035447|583619488|FG000|Treatment Period|Lost to Follow-up|6|||
161608608|NCT04035447|583619489|FG001|Treatment Period|Lost to Follow-up|5|||
161608609|NCT04035447|583619488|FG000|Treatment Period|Physician Decision|0|||
161608610|NCT04035447|583619489|FG001|Treatment Period|Physician Decision|2|||
161608611|NCT03304587|583619493|FG000|Overall Study|Headache after intervention|0|||
161608612|NCT03304587|583619494|FG001|Overall Study|Headache after intervention|1|||
161608613|NCT03304587|583619493|FG000|Overall Study|Withdrawal by Subject|1|||
161608614|NCT03304587|583619494|FG001|Overall Study|Withdrawal by Subject|0|||
161608615|NCT01458366|583619496|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
161608616|NCT01458366|583619497|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
161608617|NCT01458366|583619498|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
161608618|NCT01458366|583619499|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
161608619|NCT01458366|583619500|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
161608620|NCT01458366|583619496|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161608621|NCT01458366|583619497|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161608622|NCT01458366|583619498|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161608623|NCT01458366|583619499|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161608624|NCT01458366|583619500|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
161608625|NCT00174252|583619501|FG000|Overall Study|Protocol Violation|2|||
161608626|NCT05509816|583619502|FG000|Overall Study|Lost to Follow-up|1|||
161608627|NCT02107261|583619509|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
161608628|NCT02107261|583619510|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
161608629|NCT02107261|583619509|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
161608630|NCT02107261|583619510|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
161608631|NCT04337931|583619512|FG000|Overall Study|Death|4|||
161608632|NCT04337931|583619513|FG001|Overall Study|Death|1|||
161608633|NCT04337931|583619514|FG002|Overall Study|Death|7|||
161608634|NCT04337931|583619512|FG000|Overall Study|Withdrawal by Subject|0|||
161608635|NCT04337931|583619513|FG001|Overall Study|Withdrawal by Subject|1|||
161608636|NCT04337931|583619514|FG002|Overall Study|Withdrawal by Subject|0|||
161608637|NCT04337931|583619512|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
161608638|NCT04337931|583619513|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
161608639|NCT04337931|583619514|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
161608640|NCT04337931|583619512|FG000|Overall Study|Study terminated by sponsor|3|||
161608641|NCT04337931|583619513|FG001|Overall Study|Study terminated by sponsor|6|||
161608642|NCT04337931|583619514|FG002|Overall Study|Study terminated by sponsor|2|||
161608643|NCT04337931|583619512|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
161608644|NCT04337931|583619513|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
161608645|NCT04337931|583619514|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
161608646|NCT04337931|583619512|FG000|Overall Study|Colorectal cancer treatment|1|||
161608647|NCT04337931|583619513|FG001|Overall Study|Colorectal cancer treatment|0|||
161608648|NCT04337931|583619514|FG002|Overall Study|Colorectal cancer treatment|0|||
161608649|NCT04337931|583619512|FG000|Overall Study|Participant decision|0|||
161608650|NCT04337931|583619513|FG001|Overall Study|Participant decision|1|||
161608651|NCT04337931|583619514|FG002|Overall Study|Participant decision|0|||
161608652|NCT01738438|583619516|FG000|Overall Study|Disease Progression|32|||
161608653|NCT01738438|583619516|FG000|Overall Study|Adverse Event|3|||
161608654|NCT02130557|583619518|FG000|Overall Study|Withdrawal by Subject|12|||
161608655|NCT02130557|583619519|FG001|Overall Study|Withdrawal by Subject|12|||
161608656|NCT02130557|583619518|FG000|Overall Study|Investigator Request|0|||
161608657|NCT02130557|583619519|FG001|Overall Study|Investigator Request|2|||
161608658|NCT02130557|583619518|FG000|Overall Study|Deceased|14|||
161608659|NCT02130557|583619519|FG001|Overall Study|Deceased|14|||
161608660|NCT02130557|583619518|FG000|Overall Study|Lost to Follow-up|6|||
161608661|NCT02130557|583619519|FG001|Overall Study|Lost to Follow-up|7|||
161608662|NCT02130557|583619518|FG000|Overall Study|Other|2|||
161608663|NCT02130557|583619519|FG001|Overall Study|Other|1|||
161608664|NCT02130557|583619518|FG000|Overall Study|Missing|2|||
161608665|NCT02130557|583619519|FG001|Overall Study|Missing|1|||
161608666|NCT01532999|583619520|FG000|Overall Study|Lost to Follow-up|14|||
161608667|NCT01532999|583619521|FG001|Overall Study|Lost to Follow-up|8|||
161608668|NCT01532999|583619520|FG000|Overall Study|Physician Decision|1|||
161608669|NCT01532999|583619521|FG001|Overall Study|Physician Decision|2|||
161608670|NCT01532999|583619520|FG000|Overall Study|Withdrawal by Subject|5|||
161608671|NCT01532999|583619521|FG001|Overall Study|Withdrawal by Subject|0|||
161608672|NCT01532999|583619520|FG000|Overall Study|Relocated|2|||
161608673|NCT01532999|583619521|FG001|Overall Study|Relocated|0|||
161608674|NCT01532999|583619520|FG000|Overall Study|should not have been randomized|1|||
161608675|NCT01532999|583619521|FG001|Overall Study|should not have been randomized|0|||
161608676|NCT01532999|583619520|FG000|Overall Study|substantial noncompliance|2|||
161608677|NCT01532999|583619521|FG001|Overall Study|substantial noncompliance|0|||
161608678|NCT01532999|583619520|FG000|Overall Study|no show for week 9 assessments|6|||
161608679|NCT01532999|583619521|FG001|Overall Study|no show for week 9 assessments|4|||
161608680|NCT01532999|583619520|FG000|Overall Study|Adverse Event|0|||
161608681|NCT01532999|583619521|FG001|Overall Study|Adverse Event|1|||
161608682|NCT01532999|583619520|FG000|Overall Study|incarcerated|0|||
161608683|NCT01532999|583619521|FG001|Overall Study|incarcerated|1|||
161608684|NCT01532999|583619520|FG000|Overall Study|New job|0|||
161608685|NCT01532999|583619521|FG001|Overall Study|New job|2|||
161608686|NCT02928172|583619522|FG000|Overall Study|Device did not record data|1|||
161608687|NCT03333109|583619523|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
161608688|NCT03333109|583619524|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
161608689|NCT03333109|583619525|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
161608690|NCT03333109|583619523|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161608691|NCT03333109|583619524|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161608692|NCT03333109|583619525|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
161608693|NCT03333109|583619523|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
161608694|NCT03333109|583619524|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
161608695|NCT03333109|583619525|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
161608696|NCT03333109|583619523|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
161608697|NCT03333109|583619524|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
161608698|NCT03333109|583619525|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
161608699|NCT03333109|583619523|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
161608700|NCT03333109|583619524|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
161608701|NCT03333109|583619525|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
161608702|NCT03333109|583619523|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
161608703|NCT03333109|583619524|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
161608704|NCT03333109|583619525|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
161608705|NCT03333109|583619523|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
161608706|NCT03333109|583619524|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
161608707|NCT03333109|583619525|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
161608708|NCT03333109|583619523|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
161608709|NCT03333109|583619524|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
161608710|NCT03333109|583619525|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
161608711|NCT00918203|583619528|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
161608712|NCT00918203|583619529|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
161608713|NCT00918203|583619530|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
161608714|NCT00918203|583619528|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
161608715|NCT00918203|583619529|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
161608716|NCT00918203|583619530|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
161608717|NCT00918203|583619528|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
161608718|NCT00918203|583619529|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
161608719|NCT00918203|583619530|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
161608720|NCT00918203|583619528|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
161608721|NCT00918203|583619529|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
161608722|NCT00918203|583619530|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
161608723|NCT00701701|583619531|FG000|Overall Study|Withdrawal by Subject|0|||
161608724|NCT00701701|583619532|FG001|Overall Study|Withdrawal by Subject|1|||
161608725|NCT00701701|583619531|FG000|Overall Study|Adverse Event|0|||
161608726|NCT00701701|583619532|FG001|Overall Study|Adverse Event|1|||
161608727|NCT03357952|583619533|FG000|Overall Study|Withdrawal by Subject|0|||
161608728|NCT03357952|583619534|FG001|Overall Study|Withdrawal by Subject|1|||
161608729|NCT03357952|583619533|FG000|Overall Study|Sponsor Decision|9|||
161608730|NCT03357952|583619534|FG001|Overall Study|Sponsor Decision|0|||
161608731|NCT03834740|583619535|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
161608732|NCT03834740|583619536|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
161608733|NCT03834740|583619537|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
161684206|NCT02581202|583895988|FG000|Overall Study|Pregnancy|3|||
161684207|NCT04218201|583897861|FG000|Overall Study|Death|0|||
161684208|NCT04218201|583897862|FG001|Overall Study|Death|0|||
161684209|NCT04218201|583897863|FG002|Overall Study|Death|2|||
161684210|NCT04218201|583897864|FG003|Overall Study|Death|0|||
161684211|NCT04218201|583897861|FG000|Overall Study|Unable to contact participant|4|||
161684212|NCT04218201|583897862|FG001|Overall Study|Unable to contact participant|0|||
161684213|NCT04218201|583897863|FG002|Overall Study|Unable to contact participant|3|||
161684214|NCT04218201|583897864|FG003|Overall Study|Unable to contact participant|0|||
161832472|NCT00380692|584428400|FG000|Study Period II - Double Blind|Protocol Violation|2|||
161684215|NCT04218201|583897861|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
161684216|NCT04218201|583897862|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161684217|NCT04218201|583897863|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161684218|NCT04218201|583897864|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161684219|NCT04218201|583897861|FG000|Overall Study|Withdrawal by Subject|2|||
161684220|NCT04218201|583897862|FG001|Overall Study|Withdrawal by Subject|0|||
161684221|NCT04218201|583897863|FG002|Overall Study|Withdrawal by Subject|0|||
161684222|NCT04218201|583897864|FG003|Overall Study|Withdrawal by Subject|0|||
161684223|NCT04218201|583897861|FG000|Overall Study|PCP plans to leave practice|0|||
161608749|NCT03593226|583619543|FG000|Overall Study|Disease progression|6|||
161608750|NCT03593226|583619544|FG001|Overall Study|Disease progression|13|||
161608751|NCT03593226|583619545|FG002|Overall Study|Disease progression|5|||
161608752|NCT03593226|583619546|FG003|Overall Study|Disease progression|6|||
161608753|NCT03593226|583619543|FG000|Overall Study|Adverse Event|0|||
161608754|NCT03593226|583619544|FG001|Overall Study|Adverse Event|1|||
161608755|NCT03593226|583619545|FG002|Overall Study|Adverse Event|0|||
161608756|NCT03593226|583619546|FG003|Overall Study|Adverse Event|0|||
161608757|NCT03593226|583619543|FG000|Overall Study|Withdrawal by Subject|0|||
161608758|NCT03593226|583619544|FG001|Overall Study|Withdrawal by Subject|4|||
161608759|NCT03593226|583619545|FG002|Overall Study|Withdrawal by Subject|1|||
161608760|NCT03593226|583619546|FG003|Overall Study|Withdrawal by Subject|0|||
161608761|NCT03593226|583619543|FG000|Overall Study|Physician Decision|0|||
161608762|NCT03593226|583619544|FG001|Overall Study|Physician Decision|1|||
161608763|NCT03593226|583619545|FG002|Overall Study|Physician Decision|0|||
161608764|NCT03593226|583619546|FG003|Overall Study|Physician Decision|0|||
161608765|NCT03593226|583619543|FG000|Overall Study|Clinical disease progression|0|||
161608766|NCT03593226|583619544|FG001|Overall Study|Clinical disease progression|0|||
161608767|NCT03593226|583619545|FG002|Overall Study|Clinical disease progression|1|||
161608768|NCT03593226|583619546|FG003|Overall Study|Clinical disease progression|0|||
161608769|NCT02678689|583619557|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
161608770|NCT02678689|583619558|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
161608771|NCT05786612|583619563|FG000|Overall Study|Adverse Event|1|||
161608772|NCT05786612|583619564|FG001|Overall Study|Adverse Event|2|||
161608773|NCT05786612|583619563|FG000|Overall Study|one screening failure|0|||
161608774|NCT05786612|583619564|FG001|Overall Study|one screening failure|2|||
161608775|NCT03459196|583621341|FG000|Overall Study|Subject didn't receive study catheter|2|||
161608776|NCT03367156|583621342|FG000|Overall Study|Lack of interest|3|||
161608777|NCT03367156|583621343|FG001|Overall Study|Lack of interest|1|||
161608778|NCT03367156|583621342|FG000|Overall Study|Death|2|||
161608779|NCT03367156|583621343|FG001|Overall Study|Death|0|||
161608780|NCT03367156|583621342|FG000|Overall Study|Lost to Follow-up|2|||
161608781|NCT03367156|583621343|FG001|Overall Study|Lost to Follow-up|1|||
161608782|NCT03367156|583621342|FG000|Overall Study|Became ineligible|1|||
161608783|NCT03367156|583621343|FG001|Overall Study|Became ineligible|2|||
161608784|NCT03367156|583621342|FG000|Overall Study|Hospitalization|1|||
161608785|NCT03367156|583621343|FG001|Overall Study|Hospitalization|0|||
161608786|NCT03367156|583621342|FG000|Overall Study|Concerned about Treatment|11|||
161608787|NCT03367156|583621343|FG001|Overall Study|Concerned about Treatment|3|||
161608788|NCT03367156|583621342|FG000|Overall Study|Started new treatment|4|||
161608789|NCT03367156|583621343|FG001|Overall Study|Started new treatment|1|||
161608790|NCT03762850|583621344|FG000|Overall Study|Death|0|||
161608791|NCT03762850|583621345|FG001|Overall Study|Death|1|||
161608792|NCT03762850|583621344|FG000|Overall Study|Lost to Follow-up|0|||
161608793|NCT03762850|583621345|FG001|Overall Study|Lost to Follow-up|1|||
161608794|NCT03762850|583621344|FG000|Overall Study|Physician Decision|0|||
161608795|NCT03762850|583621345|FG001|Overall Study|Physician Decision|1|||
161608796|NCT03762850|583621344|FG000|Overall Study|Withdrawal by Subject|4|||
161608797|NCT03762850|583621345|FG001|Overall Study|Withdrawal by Subject|9|||
161608798|NCT00092534|583621348|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
161608799|NCT00092534|583621349|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
161608800|NCT00092534|583621350|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161608801|NCT00092534|583621351|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161608802|NCT00092534|583621352|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161608803|NCT00092534|583621348|FG000|Base Study Vaccination Period|Adverse Event|3|||
161608804|NCT00092534|583621349|FG001|Base Study Vaccination Period|Adverse Event|1|||
161608805|NCT00092534|583621350|FG002|Base Study Vaccination Period|Adverse Event|0|||
161608806|NCT00092534|583621351|FG003|Base Study Vaccination Period|Adverse Event|0|||
161608807|NCT00092534|583621352|FG004|Base Study Vaccination Period|Adverse Event|0|||
161608808|NCT00092534|583621348|FG000|Base Study Vaccination Period|Death|5|||
161608809|NCT00092534|583621349|FG001|Base Study Vaccination Period|Death|4|||
161608810|NCT00092534|583621350|FG002|Base Study Vaccination Period|Death|0|||
161608811|NCT00092534|583621351|FG003|Base Study Vaccination Period|Death|0|||
161608812|NCT00092534|583621352|FG004|Base Study Vaccination Period|Death|0|||
161608813|NCT00092534|583621348|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
161608814|NCT00092534|583621349|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
161608815|NCT00092534|583621350|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161608816|NCT00092534|583621351|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161608817|NCT00092534|583621352|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161608818|NCT00092534|583621348|FG000|Base Study Vaccination Period|Physician Decision|1|||
161608819|NCT00092534|583621349|FG001|Base Study Vaccination Period|Physician Decision|0|||
161608820|NCT00092534|583621350|FG002|Base Study Vaccination Period|Physician Decision|0|||
161608821|NCT00092534|583621351|FG003|Base Study Vaccination Period|Physician Decision|0|||
161608822|NCT00092534|583621352|FG004|Base Study Vaccination Period|Physician Decision|0|||
161608823|NCT00092534|583621348|FG000|Base Study Vaccination Period|Pregnancy|9|||
161608824|NCT00092534|583621349|FG001|Base Study Vaccination Period|Pregnancy|7|||
161608825|NCT00092534|583621350|FG002|Base Study Vaccination Period|Pregnancy|0|||
161608826|NCT00092534|583621351|FG003|Base Study Vaccination Period|Pregnancy|0|||
161608827|NCT00092534|583621352|FG004|Base Study Vaccination Period|Pregnancy|0|||
161608828|NCT00092534|583621348|FG000|Base Study Vaccination Period|Protocol Violation|2|||
161608829|NCT00092534|583621349|FG001|Base Study Vaccination Period|Protocol Violation|1|||
161608830|NCT00092534|583621350|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161608831|NCT00092534|583621351|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161608832|NCT00092534|583621352|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161608833|NCT00092534|583621348|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
161608834|NCT00092534|583621349|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
161608835|NCT00092534|583621350|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161608836|NCT00092534|583621351|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161608837|NCT00092534|583621352|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161608838|NCT00092534|583621348|FG000|Base Study Vaccination Period|Moved|14|||
161608839|NCT00092534|583621349|FG001|Base Study Vaccination Period|Moved|12|||
161608840|NCT00092534|583621350|FG002|Base Study Vaccination Period|Moved|0|||
161608841|NCT00092534|583621351|FG003|Base Study Vaccination Period|Moved|0|||
161608842|NCT00092534|583621352|FG004|Base Study Vaccination Period|Moved|0|||
161608843|NCT00092534|583621348|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
161608844|NCT00092534|583621349|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161608845|NCT00092534|583621350|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161608846|NCT00092534|583621351|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161608847|NCT00092534|583621352|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161608848|NCT00092534|583621348|FG000|Base Study Vaccination Period|Travel|1|||
161608849|NCT00092534|583621349|FG001|Base Study Vaccination Period|Travel|0|||
161608850|NCT00092534|583621350|FG002|Base Study Vaccination Period|Travel|0|||
161608851|NCT00092534|583621351|FG003|Base Study Vaccination Period|Travel|0|||
161608852|NCT00092534|583621352|FG004|Base Study Vaccination Period|Travel|0|||
161608853|NCT00092534|583621348|FG000|Base Study Vaccination Period|Site Closed|0|||
161608854|NCT00092534|583621349|FG001|Base Study Vaccination Period|Site Closed|1|||
161608855|NCT00092534|583621350|FG002|Base Study Vaccination Period|Site Closed|0|||
161608856|NCT00092534|583621351|FG003|Base Study Vaccination Period|Site Closed|0|||
161608857|NCT00092534|583621352|FG004|Base Study Vaccination Period|Site Closed|0|||
161608858|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Adverse Event|2|||
161608859|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Adverse Event|4|||
161608860|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Adverse Event|0|||
161608861|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Adverse Event|0|||
161608862|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Adverse Event|0|||
161608863|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Death|2|||
161608864|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Death|1|||
161608865|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Death|0|||
161608866|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Death|0|||
161608867|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Death|0|||
161608868|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
161608869|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
161608870|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
161608871|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
161608872|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
161608873|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Pregnancy|6|||
161608874|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Pregnancy|10|||
161608875|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Pregnancy|0|||
161608876|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Pregnancy|0|||
161608877|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Pregnancy|0|||
161608878|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
161608879|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
161608880|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
161608881|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
161608882|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
161608883|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
161608884|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
161608885|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
161684224|NCT04218201|583897862|FG001|Overall Study|PCP plans to leave practice|8|||
161684225|NCT04218201|583897863|FG002|Overall Study|PCP plans to leave practice|0|||
161684226|NCT04218201|583897864|FG003|Overall Study|PCP plans to leave practice|5|||
161684227|NCT04218201|583897861|FG000|Overall Study|Reduced panel|0|||
161684228|NCT04218201|583897862|FG001|Overall Study|Reduced panel|0|||
161684229|NCT04218201|583897863|FG002|Overall Study|Reduced panel|0|||
161684230|NCT04218201|583897864|FG003|Overall Study|Reduced panel|1|||
161684231|NCT04218201|583897861|FG000|Overall Study|No longer interested in participating|0|||
161684232|NCT04218201|583897862|FG001|Overall Study|No longer interested in participating|1|||
161684233|NCT04218201|583897863|FG002|Overall Study|No longer interested in participating|0|||
161684234|NCT04218201|583897864|FG003|Overall Study|No longer interested in participating|0|||
161684235|NCT04036708|583897873|FG000|Overall Study|Lost to Follow-up|14|||
161684236|NCT04036708|583897874|FG001|Overall Study|Lost to Follow-up|4|||
161684237|NCT04036708|583897875|FG002|Overall Study|Lost to Follow-up|14|||
161684238|NCT04036708|583897876|FG003|Overall Study|Lost to Follow-up|4|||
161684239|NCT02918864|583897877|FG000|Overall Study|Withdrawal by Subject|1|||
161684240|NCT02918864|583897878|FG001|Overall Study|Withdrawal by Subject|1|||
161684241|NCT02918864|583897877|FG000|Overall Study|Lost to Follow-up|3|||
161684242|NCT02918864|583897878|FG001|Overall Study|Lost to Follow-up|2|||
161684243|NCT02104583|583897881|FG000|Overall Study|New ICD or CRT-D implanted|2|||
161684244|NCT02104583|583897882|FG001|Overall Study|New ICD or CRT-D implanted|0|||
161684245|NCT02104583|583897883|FG002|Overall Study|New ICD or CRT-D implanted|1|||
161684246|NCT02104583|583897884|FG003|Overall Study|New ICD or CRT-D implanted|0|||
161684247|NCT02104583|583897885|FG004|Overall Study|New ICD or CRT-D implanted|0|||
161684248|NCT02104583|583897881|FG000|Overall Study|Death|2|||
161608886|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
161684249|NCT02104583|583897882|FG001|Overall Study|Death|1|||
161684250|NCT02104583|583897883|FG002|Overall Study|Death|3|||
161608887|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
161608888|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Moved|62|||
161684251|NCT02104583|583897884|FG003|Overall Study|Death|3|||
161684252|NCT02104583|583897885|FG004|Overall Study|Death|5|||
161684253|NCT02104583|583897881|FG000|Overall Study|Subject required cardiac ablation|6|||
161608889|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Moved|58|||
161608890|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Moved|0|||
161608891|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Moved|0|||
161608892|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Moved|0|||
161608893|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Travel|10|||
161608894|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Travel|7|||
161608895|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Travel|0|||
161608896|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Travel|0|||
161608897|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Travel|0|||
161608898|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Site Closed|0|||
161608899|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Site Closed|2|||
161608900|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Site Closed|0|||
161608901|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Site Closed|0|||
161608902|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Site Closed|0|||
161608903|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
161608904|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
161608905|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
161608906|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
161608907|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
161608908|NCT00092534|583621348|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
161608909|NCT00092534|583621349|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
161608910|NCT00092534|583621350|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
161608911|NCT00092534|583621351|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
161608912|NCT00092534|583621352|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
161608913|NCT00092534|583621348|FG000|Base Study EXT|Lost to Follow-up|0|||
161608914|NCT00092534|583621349|FG001|Base Study EXT|Lost to Follow-up|0|||
161608915|NCT00092534|583621350|FG002|Base Study EXT|Lost to Follow-up|41|||
161608916|NCT00092534|583621351|FG003|Base Study EXT|Lost to Follow-up|0|||
161608917|NCT00092534|583621352|FG004|Base Study EXT|Lost to Follow-up|0|||
161608918|NCT00092534|583621348|FG000|Base Study EXT|Physician Decision|0|||
161608919|NCT00092534|583621349|FG001|Base Study EXT|Physician Decision|0|||
161608920|NCT00092534|583621350|FG002|Base Study EXT|Physician Decision|1|||
161608921|NCT00092534|583621351|FG003|Base Study EXT|Physician Decision|0|||
161608922|NCT00092534|583621352|FG004|Base Study EXT|Physician Decision|0|||
161608923|NCT00092534|583621348|FG000|Base Study EXT|Pregnancy|0|||
161608924|NCT00092534|583621349|FG001|Base Study EXT|Pregnancy|0|||
161608925|NCT00092534|583621350|FG002|Base Study EXT|Pregnancy|12|||
161608926|NCT00092534|583621351|FG003|Base Study EXT|Pregnancy|0|||
161608927|NCT00092534|583621352|FG004|Base Study EXT|Pregnancy|0|||
161608928|NCT00092534|583621348|FG000|Base Study EXT|Withdrawal by Subject|0|||
161608929|NCT00092534|583621349|FG001|Base Study EXT|Withdrawal by Subject|0|||
161608930|NCT00092534|583621350|FG002|Base Study EXT|Withdrawal by Subject|18|||
161608931|NCT00092534|583621351|FG003|Base Study EXT|Withdrawal by Subject|0|||
161608932|NCT00092534|583621352|FG004|Base Study EXT|Withdrawal by Subject|0|||
161608933|NCT00092534|583621348|FG000|Base Study EXT|Participant moved|0|||
161608934|NCT00092534|583621349|FG001|Base Study EXT|Participant moved|0|||
161608935|NCT00092534|583621350|FG002|Base Study EXT|Participant moved|6|||
161608936|NCT00092534|583621351|FG003|Base Study EXT|Participant moved|0|||
161608937|NCT00092534|583621352|FG004|Base Study EXT|Participant moved|0|||
161608938|NCT00092534|583621348|FG000|Base Study EXT|Travel|0|||
161608939|NCT00092534|583621349|FG001|Base Study EXT|Travel|0|||
161608940|NCT00092534|583621350|FG002|Base Study EXT|Travel|2|||
161608941|NCT00092534|583621351|FG003|Base Study EXT|Travel|0|||
161608942|NCT00092534|583621352|FG004|Base Study EXT|Travel|0|||
161608943|NCT00092534|583621348|FG000|Base Study EXT|Site closed|0|||
161608944|NCT00092534|583621349|FG001|Base Study EXT|Site closed|0|||
161608945|NCT00092534|583621350|FG002|Base Study EXT|Site closed|21|||
161684254|NCT02104583|583897882|FG001|Overall Study|Subject required cardiac ablation|4|||
161684255|NCT02104583|583897883|FG002|Overall Study|Subject required cardiac ablation|4|||
161608946|NCT00092534|583621351|FG003|Base Study EXT|Site closed|0|||
161608947|NCT00092534|583621352|FG004|Base Study EXT|Site closed|0|||
161608948|NCT00092534|583621348|FG000|Base Study EXT|Study ended|0|||
161608949|NCT00092534|583621349|FG001|Base Study EXT|Study ended|0|||
161684256|NCT02104583|583897884|FG003|Overall Study|Subject required cardiac ablation|5|||
161684257|NCT02104583|583897885|FG004|Overall Study|Subject required cardiac ablation|4|||
161608950|NCT00092534|583621350|FG002|Base Study EXT|Study ended|29|||
161608951|NCT00092534|583621351|FG003|Base Study EXT|Study ended|0|||
161608952|NCT00092534|583621352|FG004|Base Study EXT|Study ended|0|||
161608953|NCT00092534|583621348|FG000|Base Study EXT|Protocol Violation|0|||
161608954|NCT00092534|583621349|FG001|Base Study EXT|Protocol Violation|0|||
161608955|NCT00092534|583621350|FG002|Base Study EXT|Protocol Violation|15|||
161608956|NCT00092534|583621351|FG003|Base Study EXT|Protocol Violation|0|||
161608957|NCT00092534|583621352|FG004|Base Study EXT|Protocol Violation|0|||
161608958|NCT00092534|583621348|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161608959|NCT00092534|583621349|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161608960|NCT00092534|583621350|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161608961|NCT00092534|583621351|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
161608962|NCT00092534|583621352|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161608963|NCT03083366|583621353|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
161608964|NCT03083366|583621354|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
161608965|NCT03083366|583621353|FG000|Enrollment Period|Lack of Efficacy|1|||
161608966|NCT03083366|583621354|FG001|Enrollment Period|Lack of Efficacy|0|||
161608967|NCT03752684|583621361|FG000|Overall Study|Lost to Follow-up|4|||
161608968|NCT00048932|583621364|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
161608969|NCT00048932|583621365|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
161608970|NCT00048932|583621366|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
161608971|NCT00048932|583621364|FG000|Double Blind Period (DB)|Adverse Event|51|||
161608972|NCT00048932|583621365|FG001|Double Blind Period (DB)|Adverse Event|19|||
161608973|NCT00048932|583621366|FG002|Double Blind Period (DB)|Adverse Event|0|||
161608974|NCT00048932|583621364|FG000|Double Blind Period (DB)|Death|5|||
161608975|NCT00048932|583621365|FG001|Double Blind Period (DB)|Death|3|||
161608976|NCT00048932|583621366|FG002|Double Blind Period (DB)|Death|0|||
161608977|NCT00048932|583621364|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
161608978|NCT00048932|583621365|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
161608979|NCT00048932|583621366|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
161608980|NCT00048932|583621364|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
161608981|NCT00048932|583621365|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
161608982|NCT00048932|583621366|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
161608983|NCT00048932|583621364|FG000|Double Blind Period (DB)|Relocation|1|||
161608984|NCT00048932|583621365|FG001|Double Blind Period (DB)|Relocation|0|||
161608985|NCT00048932|583621366|FG002|Double Blind Period (DB)|Relocation|0|||
161608986|NCT00048932|583621364|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
161608987|NCT00048932|583621365|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
161608988|NCT00048932|583621366|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
161608989|NCT00048932|583621364|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
161608990|NCT00048932|583621365|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
161608991|NCT00048932|583621366|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
161608992|NCT00048932|583621364|FG000|Double Blind Period (DB)|Pregnancy|1|||
161608993|NCT00048932|583621365|FG001|Double Blind Period (DB)|Pregnancy|0|||
161608994|NCT00048932|583621366|FG002|Double Blind Period (DB)|Pregnancy|0|||
161608995|NCT00048932|583621364|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
161608996|NCT00048932|583621365|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
161608997|NCT00048932|583621366|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
161608998|NCT00048932|583621364|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
161684258|NCT02104583|583897881|FG000|Overall Study|Subject required prohibited medication|0|||
161608999|NCT00048932|583621365|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
161609000|NCT00048932|583621366|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
161609001|NCT00048932|583621364|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
161609002|NCT00048932|583621365|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
161609003|NCT00048932|583621366|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
161609004|NCT00048932|583621364|FG000|Open Label Period (OL)|Death|0|||
161609005|NCT00048932|583621365|FG001|Open Label Period (OL)|Death|0|||
161609006|NCT00048932|583621366|FG002|Open Label Period (OL)|Death|25|||
161609007|NCT00048932|583621364|FG000|Open Label Period (OL)|Adverse Event|0|||
161609008|NCT00048932|583621365|FG001|Open Label Period (OL)|Adverse Event|0|||
161609009|NCT00048932|583621366|FG002|Open Label Period (OL)|Adverse Event|103|||
161609010|NCT00048932|583621364|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
161609011|NCT00048932|583621365|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
161609012|NCT00048932|583621366|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
161609013|NCT00048932|583621364|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
161609014|NCT00048932|583621365|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
161609015|NCT00048932|583621366|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
161609016|NCT00048932|583621364|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
161609017|NCT00048932|583621365|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
161609018|NCT00048932|583621366|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
161609019|NCT00048932|583621364|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
161609020|NCT00048932|583621365|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
161609021|NCT00048932|583621366|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
161609022|NCT00048932|583621364|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
161609023|NCT00048932|583621365|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
161609024|NCT00048932|583621366|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
161609025|NCT00048932|583621364|FG000|Open Label Period (OL)|Pregnancy|0|||
161609026|NCT00048932|583621365|FG001|Open Label Period (OL)|Pregnancy|0|||
161609027|NCT00048932|583621366|FG002|Open Label Period (OL)|Pregnancy|6|||
161609028|NCT00048932|583621364|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
161609029|NCT00048932|583621365|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
161609030|NCT00048932|583621366|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
161609031|NCT00048932|583621364|FG000|Open Label Period (OL)|Investigator Retiring|0|||
161609032|NCT00048932|583621365|FG001|Open Label Period (OL)|Investigator Retiring|0|||
161609033|NCT00048932|583621366|FG002|Open Label Period (OL)|Investigator Retiring|2|||
161609034|NCT00048932|583621364|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
161609035|NCT00048932|583621365|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
161609036|NCT00048932|583621366|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
161609037|NCT00048932|583621364|FG000|Open Label Period (OL)|Participant Relocated|0|||
161609038|NCT00048932|583621365|FG001|Open Label Period (OL)|Participant Relocated|0|||
161609039|NCT00048932|583621366|FG002|Open Label Period (OL)|Participant Relocated|6|||
161609040|NCT00048932|583621364|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
161609041|NCT00048932|583621365|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
161609042|NCT00048932|583621366|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
161609043|NCT00048932|583621364|FG000|Open Label Period (OL)|Site Closure|0|||
161609044|NCT00048932|583621365|FG001|Open Label Period (OL)|Site Closure|0|||
161609045|NCT00048932|583621366|FG002|Open Label Period (OL)|Site Closure|3|||
161609046|NCT00048932|583621364|FG000|Open Label Period (OL)|Trial Terminated|0|||
161609047|NCT00048932|583621365|FG001|Open Label Period (OL)|Trial Terminated|0|||
161609048|NCT00048932|583621366|FG002|Open Label Period (OL)|Trial Terminated|1|||
161609049|NCT00048932|583621364|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
161609050|NCT00048932|583621365|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
161609051|NCT00048932|583621366|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
161609052|NCT00048932|583621364|FG000|Open Label Period (OL)|Patient Decision|0|||
161609053|NCT00048932|583621365|FG001|Open Label Period (OL)|Patient Decision|0|||
161609054|NCT00048932|583621366|FG002|Open Label Period (OL)|Patient Decision|4|||
161609055|NCT00048932|583621364|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
161609056|NCT00048932|583621365|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
161609057|NCT00048932|583621366|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
161609058|NCT00048932|583621364|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
161609059|NCT00048932|583621365|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
161609060|NCT00048932|583621366|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
161609061|NCT00048932|583621364|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
161609062|NCT00048932|583621365|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
161609063|NCT00048932|583621366|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
161609064|NCT00048932|583621364|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
161609065|NCT00048932|583621365|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
161609066|NCT00048932|583621366|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
161609067|NCT00048932|583621364|FG000|Open Label Period (OL)|Investigator Decision|0|||
161609068|NCT00048932|583621365|FG001|Open Label Period (OL)|Investigator Decision|0|||
161609069|NCT00048932|583621366|FG002|Open Label Period (OL)|Investigator Decision|4|||
161609070|NCT00048932|583621364|FG000|Open Label Period (OL)|Site Staff Issues|0|||
161609071|NCT00048932|583621365|FG001|Open Label Period (OL)|Site Staff Issues|0|||
161609072|NCT00048932|583621366|FG002|Open Label Period (OL)|Site Staff Issues|2|||
161609073|NCT00048932|583621364|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
161609074|NCT00048932|583621365|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
161609075|NCT00048932|583621366|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
161609076|NCT00048932|583621364|FG000|Open Label Period (OL)|Participant Surgery|0|||
161609077|NCT00048932|583621365|FG001|Open Label Period (OL)|Participant Surgery|0|||
161609078|NCT00048932|583621366|FG002|Open Label Period (OL)|Participant Surgery|1|||
161609079|NCT05250115|583621369|FG000|Overall Study|Premature study end|40|||
161609080|NCT05250115|583621369|FG000|Overall Study|Adverse Event|8|||
161609081|NCT05250115|583621369|FG000|Overall Study|Lost to Follow-up|7|||
161609082|NCT05250115|583621369|FG000|Overall Study|Withdrawal by Subject|6|||
161609083|NCT05250115|583621369|FG000|Overall Study|Withdrawal of informed consent|1|||
161609084|NCT05250115|583621369|FG000|Overall Study|Other|7|||
161609085|NCT03244800|583621371|FG000|Overall Study|Adverse Event|0|||
161609086|NCT03244800|583621372|FG001|Overall Study|Adverse Event|1|||
161609087|NCT03244800|583621373|FG002|Overall Study|Adverse Event|0|||
161609088|NCT03244800|583621374|FG003|Overall Study|Adverse Event|1|||
161609089|NCT03244800|583621371|FG000|Overall Study|Withdrew treatment|0|||
161609090|NCT03244800|583621372|FG001|Overall Study|Withdrew treatment|0|||
161609091|NCT03244800|583621373|FG002|Overall Study|Withdrew treatment|0|||
161609092|NCT03244800|583621374|FG003|Overall Study|Withdrew treatment|1|||
161609093|NCT03418922|583621376|FG000|Overall Study|Withdrawal by Subject|0|||
161609094|NCT03418922|583621377|FG001|Overall Study|Withdrawal by Subject|2|||
161609095|NCT03418922|583621376|FG000|Overall Study|Adverse Event|2|||
161609096|NCT03418922|583621377|FG001|Overall Study|Adverse Event|2|||
161609097|NCT03418922|583621376|FG000|Overall Study|Death|0|||
161609098|NCT03418922|583621377|FG001|Overall Study|Death|1|||
161609099|NCT03418922|583621376|FG000|Overall Study|Physician Decision|0|||
161609100|NCT03418922|583621377|FG001|Overall Study|Physician Decision|1|||
161609101|NCT01640951|583621378|FG000|Overall Study|Adverse Event|8|||
161609102|NCT01640951|583621379|FG001|Overall Study|Adverse Event|3|||
161609103|NCT01640951|583621380|FG002|Overall Study|Adverse Event|10|||
161609104|NCT01640951|583621381|FG003|Overall Study|Adverse Event|6|||
161609105|NCT01640951|583621382|FG004|Overall Study|Adverse Event|1|||
161609106|NCT01640951|583621383|FG005|Overall Study|Adverse Event|11|||
161609107|NCT01640951|583621384|FG006|Overall Study|Adverse Event|1|||
161609108|NCT01640951|583621385|FG007|Overall Study|Adverse Event|3|||
161609109|NCT01640951|583621378|FG000|Overall Study|Lack of Efficacy|20|||
161609110|NCT01640951|583621379|FG001|Overall Study|Lack of Efficacy|1|||
161609111|NCT01640951|583621380|FG002|Overall Study|Lack of Efficacy|7|||
161609112|NCT01640951|583621381|FG003|Overall Study|Lack of Efficacy|14|||
161609113|NCT01640951|583621382|FG004|Overall Study|Lack of Efficacy|0|||
161609114|NCT01640951|583621383|FG005|Overall Study|Lack of Efficacy|6|||
161609115|NCT01640951|583621384|FG006|Overall Study|Lack of Efficacy|5|||
161609116|NCT01640951|583621385|FG007|Overall Study|Lack of Efficacy|6|||
161609117|NCT01640951|583621378|FG000|Overall Study|Lost to Follow-up|1|||
161609118|NCT01640951|583621379|FG001|Overall Study|Lost to Follow-up|0|||
161609119|NCT01640951|583621380|FG002|Overall Study|Lost to Follow-up|6|||
161609120|NCT01640951|583621381|FG003|Overall Study|Lost to Follow-up|2|||
161609121|NCT01640951|583621382|FG004|Overall Study|Lost to Follow-up|2|||
161609122|NCT01640951|583621383|FG005|Overall Study|Lost to Follow-up|3|||
161609123|NCT01640951|583621384|FG006|Overall Study|Lost to Follow-up|1|||
161609124|NCT01640951|583621385|FG007|Overall Study|Lost to Follow-up|1|||
161609125|NCT01640951|583621378|FG000|Overall Study|Non-compliance with study treatment|0|||
161609126|NCT01640951|583621379|FG001|Overall Study|Non-compliance with study treatment|0|||
161609127|NCT01640951|583621380|FG002|Overall Study|Non-compliance with study treatment|1|||
161609128|NCT01640951|583621381|FG003|Overall Study|Non-compliance with study treatment|1|||
161609129|NCT01640951|583621382|FG004|Overall Study|Non-compliance with study treatment|1|||
161609130|NCT01640951|583621383|FG005|Overall Study|Non-compliance with study treatment|4|||
161609131|NCT01640951|583621384|FG006|Overall Study|Non-compliance with study treatment|1|||
161609132|NCT01640951|583621385|FG007|Overall Study|Non-compliance with study treatment|0|||
161609133|NCT01640951|583621378|FG000|Overall Study|Physician Decision|2|||
161609134|NCT01640951|583621379|FG001|Overall Study|Physician Decision|5|||
161609135|NCT01640951|583621380|FG002|Overall Study|Physician Decision|2|||
161609136|NCT01640951|583621381|FG003|Overall Study|Physician Decision|2|||
161609137|NCT01640951|583621382|FG004|Overall Study|Physician Decision|2|||
161609138|NCT01640951|583621383|FG005|Overall Study|Physician Decision|3|||
161609139|NCT01640951|583621384|FG006|Overall Study|Physician Decision|3|||
161609140|NCT01640951|583621385|FG007|Overall Study|Physician Decision|0|||
161609141|NCT01640951|583621378|FG000|Overall Study|Pregnancy|3|||
161609142|NCT01640951|583621379|FG001|Overall Study|Pregnancy|0|||
161609143|NCT01640951|583621380|FG002|Overall Study|Pregnancy|0|||
161609144|NCT01640951|583621381|FG003|Overall Study|Pregnancy|4|||
161609145|NCT01640951|583621382|FG004|Overall Study|Pregnancy|0|||
161609146|NCT01640951|583621383|FG005|Overall Study|Pregnancy|0|||
161609147|NCT01640951|583621384|FG006|Overall Study|Pregnancy|2|||
161609148|NCT01640951|583621385|FG007|Overall Study|Pregnancy|0|||
161609149|NCT01640951|583621378|FG000|Overall Study|Protocol Deviation|0|||
161609150|NCT01640951|583621379|FG001|Overall Study|Protocol Deviation|1|||
161609151|NCT01640951|583621380|FG002|Overall Study|Protocol Deviation|2|||
161609152|NCT01640951|583621381|FG003|Overall Study|Protocol Deviation|1|||
161609153|NCT01640951|583621382|FG004|Overall Study|Protocol Deviation|0|||
161609154|NCT01640951|583621383|FG005|Overall Study|Protocol Deviation|1|||
161609155|NCT01640951|583621384|FG006|Overall Study|Protocol Deviation|0|||
161609156|NCT01640951|583621385|FG007|Overall Study|Protocol Deviation|0|||
161609157|NCT01640951|583621378|FG000|Overall Study|Subject/Guardian decision|12|||
161609158|NCT01640951|583621379|FG001|Overall Study|Subject/Guardian decision|4|||
161609159|NCT01640951|583621380|FG002|Overall Study|Subject/Guardian decision|13|||
161609160|NCT01640951|583621381|FG003|Overall Study|Subject/Guardian decision|15|||
161609161|NCT01640951|583621382|FG004|Overall Study|Subject/Guardian decision|7|||
161609162|NCT01640951|583621383|FG005|Overall Study|Subject/Guardian decision|19|||
161609163|NCT01640951|583621384|FG006|Overall Study|Subject/Guardian decision|5|||
161609164|NCT01640951|583621385|FG007|Overall Study|Subject/Guardian decision|4|||
161609165|NCT01640951|583621378|FG000|Overall Study|Death|0|||
161609166|NCT01640951|583621379|FG001|Overall Study|Death|1|||
161609167|NCT01640951|583621380|FG002|Overall Study|Death|1|||
161609168|NCT01640951|583621381|FG003|Overall Study|Death|0|||
161609169|NCT01640951|583621382|FG004|Overall Study|Death|0|||
161609170|NCT01640951|583621383|FG005|Overall Study|Death|0|||
161609171|NCT01640951|583621384|FG006|Overall Study|Death|0|||
161609172|NCT01640951|583621385|FG007|Overall Study|Death|2|||
161609173|NCT00582972|583621386|FG000|Overall Study|Protocol Violation|2|||
161609174|NCT00293397|583621387|FG000|Overall Study|Death|2|||
161609175|NCT03631407|583621388|FG000|Overall Study|Withdrawal by Subject|3|||
161609176|NCT03631407|583621389|FG001|Overall Study|Withdrawal by Subject|2|||
161609177|NCT03631407|583621388|FG000|Overall Study|Sponsor Decision|0|||
161609178|NCT03631407|583621389|FG001|Overall Study|Sponsor Decision|2|||
161609179|NCT03631407|583621388|FG000|Overall Study|Death|16|||
161609180|NCT03631407|583621389|FG001|Overall Study|Death|16|||
161609181|NCT03631407|583621388|FG000|Overall Study|Randomized by mistake without study treatment|1|||
161609182|NCT03631407|583621389|FG001|Overall Study|Randomized by mistake without study treatment|0|||
161609183|NCT03802994|583621391|FG000|Overall Study|Lost to Follow-up|0|||
161609184|NCT03802994|583621392|FG001|Overall Study|Lost to Follow-up|2|||
161609185|NCT03802994|583621393|FG002|Overall Study|Lost to Follow-up|3|||
161609186|NCT03802994|583621394|FG003|Overall Study|Lost to Follow-up|2|||
161609187|NCT03802994|583621395|FG004|Overall Study|Lost to Follow-up|2|||
161609188|NCT00983294|583621396|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
161609189|NCT00983294|583621396|FG000|Colchicine With Azithromycin|Adverse Event|1|||
161609190|NCT00622700|583621397|FG000|Core Treatment Period|Randomized but Not Treated|0|||
161609191|NCT00622700|583621398|FG001|Core Treatment Period|Randomized but Not Treated|2|||
161609192|NCT00622700|583621399|FG002|Core Treatment Period|Randomized but Not Treated|2|||
161609193|NCT00622700|583621400|FG003|Core Treatment Period|Randomized but Not Treated|0|||
161609194|NCT00622700|583621401|FG004|Core Treatment Period|Randomized but Not Treated|0|||
161609195|NCT00622700|583621402|FG005|Core Treatment Period|Randomized but Not Treated|0|||
161609196|NCT00622700|583621403|FG006|Core Treatment Period|Randomized but Not Treated|0|||
161609197|NCT00622700|583621397|FG000|Core Treatment Period|Adverse Event|18|||
161609198|NCT00622700|583621398|FG001|Core Treatment Period|Adverse Event|25|||
161609199|NCT00622700|583621399|FG002|Core Treatment Period|Adverse Event|18|||
161609200|NCT00622700|583621400|FG003|Core Treatment Period|Adverse Event|0|||
161609201|NCT00622700|583621401|FG004|Core Treatment Period|Adverse Event|0|||
161609202|NCT00622700|583621402|FG005|Core Treatment Period|Adverse Event|0|||
161609203|NCT00622700|583621403|FG006|Core Treatment Period|Adverse Event|0|||
161609204|NCT00622700|583621397|FG000|Core Treatment Period|Lack of Efficacy|19|||
161609205|NCT00622700|583621398|FG001|Core Treatment Period|Lack of Efficacy|6|||
161609206|NCT00622700|583621399|FG002|Core Treatment Period|Lack of Efficacy|12|||
161609207|NCT00622700|583621400|FG003|Core Treatment Period|Lack of Efficacy|0|||
161609208|NCT00622700|583621401|FG004|Core Treatment Period|Lack of Efficacy|0|||
161609209|NCT00622700|583621402|FG005|Core Treatment Period|Lack of Efficacy|0|||
161609210|NCT00622700|583621403|FG006|Core Treatment Period|Lack of Efficacy|0|||
161609211|NCT00622700|583621397|FG000|Core Treatment Period|Lost to Follow-up|1|||
161609212|NCT00622700|583621398|FG001|Core Treatment Period|Lost to Follow-up|1|||
161609213|NCT00622700|583621399|FG002|Core Treatment Period|Lost to Follow-up|1|||
161609214|NCT00622700|583621400|FG003|Core Treatment Period|Lost to Follow-up|0|||
161609215|NCT00622700|583621401|FG004|Core Treatment Period|Lost to Follow-up|0|||
161609216|NCT00622700|583621402|FG005|Core Treatment Period|Lost to Follow-up|0|||
161609217|NCT00622700|583621403|FG006|Core Treatment Period|Lost to Follow-up|0|||
161609218|NCT00622700|583621397|FG000|Core Treatment Period|Death|1|||
161609219|NCT00622700|583621398|FG001|Core Treatment Period|Death|0|||
161609220|NCT00622700|583621399|FG002|Core Treatment Period|Death|0|||
161609221|NCT00622700|583621400|FG003|Core Treatment Period|Death|0|||
161609222|NCT00622700|583621401|FG004|Core Treatment Period|Death|0|||
161609223|NCT00622700|583621402|FG005|Core Treatment Period|Death|0|||
161609224|NCT00622700|583621403|FG006|Core Treatment Period|Death|0|||
161609225|NCT00622700|583621397|FG000|Core Treatment Period|Progressive Disease|3|||
161609226|NCT00622700|583621398|FG001|Core Treatment Period|Progressive Disease|1|||
161609227|NCT00622700|583621399|FG002|Core Treatment Period|Progressive Disease|0|||
161609228|NCT00622700|583621400|FG003|Core Treatment Period|Progressive Disease|0|||
161609229|NCT00622700|583621401|FG004|Core Treatment Period|Progressive Disease|0|||
161832473|NCT00380692|584428401|FG001|Study Period II - Double Blind|Protocol Violation|2|||
161609230|NCT00622700|583621402|FG005|Core Treatment Period|Progressive Disease|0|||
161609231|NCT00622700|583621403|FG006|Core Treatment Period|Progressive Disease|0|||
161609232|NCT00622700|583621397|FG000|Core Treatment Period|Withdrawal by Subject|12|||
161609233|NCT00622700|583621398|FG001|Core Treatment Period|Withdrawal by Subject|18|||
161609234|NCT00622700|583621399|FG002|Core Treatment Period|Withdrawal by Subject|15|||
161609235|NCT00622700|583621400|FG003|Core Treatment Period|Withdrawal by Subject|0|||
161609236|NCT00622700|583621401|FG004|Core Treatment Period|Withdrawal by Subject|0|||
161609237|NCT00622700|583621402|FG005|Core Treatment Period|Withdrawal by Subject|0|||
161609238|NCT00622700|583621403|FG006|Core Treatment Period|Withdrawal by Subject|0|||
161609239|NCT00622700|583621397|FG000|Core Treatment Period|Other than specified above|2|||
161609240|NCT00622700|583621398|FG001|Core Treatment Period|Other than specified above|2|||
161609241|NCT00622700|583621399|FG002|Core Treatment Period|Other than specified above|5|||
161609242|NCT00622700|583621400|FG003|Core Treatment Period|Other than specified above|0|||
161609243|NCT00622700|583621401|FG004|Core Treatment Period|Other than specified above|0|||
161609244|NCT00622700|583621402|FG005|Core Treatment Period|Other than specified above|0|||
161609245|NCT00622700|583621403|FG006|Core Treatment Period|Other than specified above|0|||
161609246|NCT00622700|583621397|FG000|Extension Treatment Period|Adverse Event|0|||
161609247|NCT00622700|583621398|FG001|Extension Treatment Period|Adverse Event|0|||
161609248|NCT00622700|583621399|FG002|Extension Treatment Period|Adverse Event|0|||
161609249|NCT00622700|583621400|FG003|Extension Treatment Period|Adverse Event|5|||
161609250|NCT00622700|583621401|FG004|Extension Treatment Period|Adverse Event|9|||
161609251|NCT00622700|583621402|FG005|Extension Treatment Period|Adverse Event|6|||
161609252|NCT00622700|583621403|FG006|Extension Treatment Period|Adverse Event|8|||
161609253|NCT00622700|583621397|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161609254|NCT00622700|583621398|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161609255|NCT00622700|583621399|FG002|Extension Treatment Period|Lack of Efficacy|0|||
161609256|NCT00622700|583621400|FG003|Extension Treatment Period|Lack of Efficacy|2|||
161609257|NCT00622700|583621401|FG004|Extension Treatment Period|Lack of Efficacy|8|||
161609258|NCT00622700|583621402|FG005|Extension Treatment Period|Lack of Efficacy|1|||
161609259|NCT00622700|583621403|FG006|Extension Treatment Period|Lack of Efficacy|9|||
161609260|NCT00622700|583621397|FG000|Extension Treatment Period|Protocol Violation|0|||
161609261|NCT00622700|583621398|FG001|Extension Treatment Period|Protocol Violation|0|||
161609262|NCT00622700|583621399|FG002|Extension Treatment Period|Protocol Violation|0|||
161609263|NCT00622700|583621400|FG003|Extension Treatment Period|Protocol Violation|0|||
161609264|NCT00622700|583621401|FG004|Extension Treatment Period|Protocol Violation|0|||
161609265|NCT00622700|583621402|FG005|Extension Treatment Period|Protocol Violation|2|||
161609266|NCT00622700|583621403|FG006|Extension Treatment Period|Protocol Violation|0|||
161609267|NCT00622700|583621397|FG000|Extension Treatment Period|Lost to Follow-up|0|||
161609268|NCT00622700|583621398|FG001|Extension Treatment Period|Lost to Follow-up|0|||
161609269|NCT00622700|583621399|FG002|Extension Treatment Period|Lost to Follow-up|0|||
161609270|NCT00622700|583621400|FG003|Extension Treatment Period|Lost to Follow-up|0|||
161609271|NCT00622700|583621401|FG004|Extension Treatment Period|Lost to Follow-up|1|||
161609272|NCT00622700|583621402|FG005|Extension Treatment Period|Lost to Follow-up|0|||
161609273|NCT00622700|583621403|FG006|Extension Treatment Period|Lost to Follow-up|0|||
161609274|NCT00622700|583621397|FG000|Extension Treatment Period|Progressive Disease|0|||
161609275|NCT00622700|583621398|FG001|Extension Treatment Period|Progressive Disease|0|||
161609276|NCT00622700|583621399|FG002|Extension Treatment Period|Progressive Disease|0|||
161609277|NCT00622700|583621400|FG003|Extension Treatment Period|Progressive Disease|1|||
161609278|NCT00622700|583621401|FG004|Extension Treatment Period|Progressive Disease|2|||
161609279|NCT00622700|583621402|FG005|Extension Treatment Period|Progressive Disease|0|||
161609280|NCT00622700|583621403|FG006|Extension Treatment Period|Progressive Disease|2|||
161609281|NCT00622700|583621397|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
161609282|NCT00622700|583621398|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161609283|NCT00622700|583621399|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161609284|NCT00622700|583621400|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
161609285|NCT00622700|583621401|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
161609286|NCT00622700|583621402|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
161609287|NCT00622700|583621403|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
161609288|NCT00622700|583621397|FG000|Extension Treatment Period|Missing|0|||
161609289|NCT00622700|583621398|FG001|Extension Treatment Period|Missing|0|||
161609290|NCT00622700|583621399|FG002|Extension Treatment Period|Missing|0|||
161609291|NCT00622700|583621400|FG003|Extension Treatment Period|Missing|2|||
161609292|NCT00622700|583621401|FG004|Extension Treatment Period|Missing|3|||
161609293|NCT00622700|583621402|FG005|Extension Treatment Period|Missing|1|||
161609294|NCT00622700|583621403|FG006|Extension Treatment Period|Missing|0|||
161609295|NCT00622700|583621397|FG000|Extension Treatment Period|Other than specified above|0|||
161609296|NCT00622700|583621398|FG001|Extension Treatment Period|Other than specified above|0|||
161609297|NCT00622700|583621399|FG002|Extension Treatment Period|Other than specified above|0|||
161609298|NCT00622700|583621400|FG003|Extension Treatment Period|Other than specified above|0|||
161609299|NCT00622700|583621401|FG004|Extension Treatment Period|Other than specified above|0|||
161609300|NCT00622700|583621402|FG005|Extension Treatment Period|Other than specified above|1|||
161609301|NCT00622700|583621403|FG006|Extension Treatment Period|Other than specified above|1|||
161609302|NCT03611556|583621404|FG000|Overall Study|Death|7|||
161609303|NCT03611556|583621405|FG001|Overall Study|Death|7|||
161609304|NCT03611556|583621406|FG002|Overall Study|Death|3|||
161609305|NCT03611556|583621407|FG003|Overall Study|Death|8|||
161609306|NCT03611556|583621408|FG004|Overall Study|Death|47|||
161609307|NCT03611556|583621409|FG005|Overall Study|Death|32|||
161609308|NCT03611556|583621410|FG006|Overall Study|Death|53|||
161609309|NCT03611556|583621404|FG000|Overall Study|Withdrawal by Subject|0|||
161609310|NCT03611556|583621405|FG001|Overall Study|Withdrawal by Subject|0|||
161609311|NCT03611556|583621406|FG002|Overall Study|Withdrawal by Subject|0|||
161609312|NCT03611556|583621407|FG003|Overall Study|Withdrawal by Subject|0|||
161609313|NCT03611556|583621408|FG004|Overall Study|Withdrawal by Subject|4|||
161609314|NCT03611556|583621409|FG005|Overall Study|Withdrawal by Subject|2|||
161609315|NCT03611556|583621410|FG006|Overall Study|Withdrawal by Subject|4|||
161609316|NCT03611556|583621404|FG000|Overall Study|Sponsor decision|0|||
161609317|NCT03611556|583621405|FG001|Overall Study|Sponsor decision|0|||
161609318|NCT03611556|583621406|FG002|Overall Study|Sponsor decision|0|||
161609319|NCT03611556|583621407|FG003|Overall Study|Sponsor decision|0|||
161609320|NCT03611556|583621408|FG004|Overall Study|Sponsor decision|9|||
161609321|NCT03611556|583621409|FG005|Overall Study|Sponsor decision|4|||
161609322|NCT03611556|583621410|FG006|Overall Study|Sponsor decision|12|||
161609323|NCT03611556|583621404|FG000|Overall Study|Reasons|0|||
161609324|NCT03611556|583621405|FG001|Overall Study|Reasons|0|||
161609325|NCT03611556|583621406|FG002|Overall Study|Reasons|0|||
161609326|NCT03611556|583621407|FG003|Overall Study|Reasons|0|||
161609327|NCT03611556|583621408|FG004|Overall Study|Reasons|2|||
161609328|NCT03611556|583621409|FG005|Overall Study|Reasons|0|||
161609329|NCT03611556|583621410|FG006|Overall Study|Reasons|1|||
161609330|NCT02844439|583621416|FG000|Overall Study|Withdrawal by Subject|1|||
161609331|NCT02844439|583621416|FG000|Overall Study|Lost to Follow-up|2|||
161609332|NCT02844439|583621416|FG000|Overall Study|Termination by Sponsor|4|||
161609333|NCT02844439|583621416|FG000|Overall Study|Death|28|||
161609334|NCT02844439|583621416|FG000|Overall Study|Other|5|||
161609335|NCT00390884|583621419|FG000|Overall Study|Withdrawal by Subject|2|||
161609336|NCT00390884|583621420|FG001|Overall Study|Withdrawal by Subject|2|||
161609337|NCT00756574|583621421|FG000|Overall Study|Withdrawal by Subject|9|||
161609338|NCT00756574|583621422|FG001|Overall Study|Withdrawal by Subject|7|||
161609339|NCT00756574|583621421|FG000|Overall Study|Lost to Follow-up|4|||
161609340|NCT00756574|583621422|FG001|Overall Study|Lost to Follow-up|4|||
161609341|NCT04622332|583621423|FG000|Overall Study|Withdrawal by Subject|4|||
161609342|NCT04622332|583621424|FG001|Overall Study|Withdrawal by Subject|2|||
161609343|NCT04622332|583621423|FG000|Overall Study|Physician Decision|1|||
161609344|NCT04622332|583621424|FG001|Overall Study|Physician Decision|1|||
161609345|NCT04622332|583621423|FG000|Overall Study|Adverse Event|0|||
161609346|NCT04622332|583621424|FG001|Overall Study|Adverse Event|2|||
161609347|NCT04622332|583621423|FG000|Overall Study|Protocol Violation|0|||
161609348|NCT04622332|583621424|FG001|Overall Study|Protocol Violation|1|||
161609349|NCT05966155|583621425|FG000|Overall Study|Death|1|||
161684259|NCT02104583|583897882|FG001|Overall Study|Subject required prohibited medication|1|||
161609350|NCT05966155|583621426|FG001|Overall Study|Death|2|||
161609351|NCT05966155|583621425|FG000|Overall Study|Lost to Follow-up|63|||
161609352|NCT05966155|583621426|FG001|Overall Study|Lost to Follow-up|67|||
161609353|NCT05966155|583621425|FG000|Overall Study|Protocol Violation|1|||
161609354|NCT05966155|583621426|FG001|Overall Study|Protocol Violation|0|||
161609355|NCT05966155|583621425|FG000|Overall Study|Withdrawal by Subject|8|||
161609356|NCT05966155|583621426|FG001|Overall Study|Withdrawal by Subject|9|||
161609357|NCT05966155|583621425|FG000|Overall Study|Enrolled Erroneously|0|||
161609358|NCT05966155|583621426|FG001|Overall Study|Enrolled Erroneously|1|||
161609359|NCT05966155|583621425|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
161609360|NCT05966155|583621426|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
161609361|NCT05036278|583621431|FG000|Overall Study|Withdrawal by Subject|1|||
161609362|NCT05036278|583621431|FG000|Overall Study|Adverse Event|1|||
161609363|NCT04647487|583621434|FG000|Overall Study|Protocol Deviation|0|||
161609364|NCT04647487|583621435|FG001|Overall Study|Protocol Deviation|0|||
161609365|NCT04647487|583621436|FG002|Overall Study|Protocol Deviation|1|||
161609366|NCT04647487|583621434|FG000|Overall Study|Withdrawal by Subject|1|||
161609367|NCT04647487|583621435|FG001|Overall Study|Withdrawal by Subject|0|||
161609368|NCT04647487|583621436|FG002|Overall Study|Withdrawal by Subject|2|||
161609369|NCT02787005|583621437|FG000|Overall Study|Adverse Event|24|||
161609370|NCT02787005|583621438|FG001|Overall Study|Adverse Event|9|||
161609371|NCT02787005|583621439|FG002|Overall Study|Adverse Event|9|||
161609372|NCT02787005|583621440|FG003|Overall Study|Adverse Event|7|||
161609373|NCT02787005|583621441|FG004|Overall Study|Adverse Event|2|||
161609374|NCT02787005|583621437|FG000|Overall Study|Death|100|||
161609375|NCT02787005|583621438|FG001|Overall Study|Death|53|||
161609376|NCT02787005|583621439|FG002|Overall Study|Death|48|||
161609377|NCT02787005|583621440|FG003|Overall Study|Death|69|||
161609378|NCT02787005|583621441|FG004|Overall Study|Death|38|||
161609379|NCT02787005|583621437|FG000|Overall Study|Sponsor Decision|7|||
161609380|NCT02787005|583621438|FG001|Overall Study|Sponsor Decision|4|||
161609381|NCT02787005|583621439|FG002|Overall Study|Sponsor Decision|0|||
161609382|NCT02787005|583621440|FG003|Overall Study|Sponsor Decision|4|||
161609383|NCT02787005|583621441|FG004|Overall Study|Sponsor Decision|5|||
161609384|NCT02787005|583621437|FG000|Overall Study|Withdrawal by Subject|2|||
161609385|NCT02787005|583621438|FG001|Overall Study|Withdrawal by Subject|1|||
161609386|NCT02787005|583621439|FG002|Overall Study|Withdrawal by Subject|1|||
161609387|NCT02787005|583621440|FG003|Overall Study|Withdrawal by Subject|0|||
161609388|NCT02787005|583621441|FG004|Overall Study|Withdrawal by Subject|1|||
161609389|NCT02787005|583621437|FG000|Overall Study|Screen Failure|0|||
161609390|NCT02787005|583621438|FG001|Overall Study|Screen Failure|2|||
161609391|NCT02787005|583621439|FG002|Overall Study|Screen Failure|0|||
161609392|NCT02787005|583621440|FG003|Overall Study|Screen Failure|0|||
161609393|NCT02787005|583621441|FG004|Overall Study|Screen Failure|1|||
161609394|NCT02787005|583621437|FG000|Overall Study|Lost to Follow-up|0|||
161609395|NCT02787005|583621438|FG001|Overall Study|Lost to Follow-up|0|||
161609396|NCT02787005|583621439|FG002|Overall Study|Lost to Follow-up|0|||
161609397|NCT02787005|583621440|FG003|Overall Study|Lost to Follow-up|1|||
161609398|NCT02787005|583621441|FG004|Overall Study|Lost to Follow-up|0|||
161609399|NCT03890289|583621447|FG000|Overall Study|Adverse Event|1|||
161609400|NCT03890289|583621447|FG000|Overall Study|Physician Decision|1|||
161609401|NCT03890289|583621447|FG000|Overall Study|Lack of Efficacy|2|||
161609402|NCT02744066|583621454|FG000|Overall Study|Withdrawal by parent|0|||
161609403|NCT02744066|583621455|FG001|Overall Study|Withdrawal by parent|1|||
161609404|NCT02744066|583621454|FG000|Overall Study|Discharged from NICU prior to completion|0|||
161609405|NCT02744066|583621455|FG001|Overall Study|Discharged from NICU prior to completion|4|||
161609406|NCT02408887|583621456|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
161609407|NCT02408887|583621457|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
161609408|NCT02408887|583621456|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
161609409|NCT02408887|583621457|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
161609410|NCT04066075|583621459|FG000|Overall Study|Lost to Follow-up|3|||
161609411|NCT04066075|583621460|FG001|Overall Study|Lost to Follow-up|3|||
161609412|NCT04066075|583621459|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
161609413|NCT04066075|583621460|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
161609414|NCT04066075|583621459|FG000|Overall Study|Withdrawal by Subject|2|||
161609415|NCT04066075|583621460|FG001|Overall Study|Withdrawal by Subject|2|||
161609416|NCT00309166|583621461|FG000|Overall Study|Adverse event, non-fatal|1|||
161609417|NCT00309166|583621462|FG001|Overall Study|Adverse event, non-fatal|0|||
161609418|NCT00309166|583621461|FG000|Overall Study|Withdrawal by Subject|4|||
161609419|NCT00309166|583621462|FG001|Overall Study|Withdrawal by Subject|3|||
161609420|NCT00589875|583621465|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
161609421|NCT00589875|583621465|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
161609422|NCT01675492|583621472|FG000|Overall Study|study completed early - product approval|42|||
161609423|NCT04517435|583621489|FG000|Overall Study|Withdrawal by Subject|0|||
161609424|NCT04517435|583621490|FG001|Overall Study|Withdrawal by Subject|0|||
161609425|NCT04517435|583621491|FG002|Overall Study|Withdrawal by Subject|1|||
161609426|NCT04517435|583621489|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
161609427|NCT04517435|583621490|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
161609428|NCT04517435|583621491|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
161609429|NCT06191679|583621492|FG000|Baseline|Lost to Follow-up|1|||
161609430|NCT06191679|583621493|FG001|Baseline|Lost to Follow-up|0|||
161609431|NCT06191679|583621494|FG002|Baseline|Lost to Follow-up|1|||
161609432|NCT06191679|583621495|FG003|Baseline|Lost to Follow-up|0|||
161609433|NCT06191679|583621492|FG000|Allocation to Group|Withdrawal by Subject|0|||
161609434|NCT06191679|583621493|FG001|Allocation to Group|Withdrawal by Subject|1|||
161609435|NCT06191679|583621494|FG002|Allocation to Group|Withdrawal by Subject|2|||
161609436|NCT06191679|583621495|FG003|Allocation to Group|Withdrawal by Subject|0|||
161609437|NCT06191679|583621492|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
161609438|NCT06191679|583621493|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
161609439|NCT06191679|583621494|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
161609440|NCT06191679|583621495|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
161609441|NCT06191679|583621492|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
161609442|NCT06191679|583621493|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
161609443|NCT06191679|583621494|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
161609444|NCT06191679|583621495|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
161609445|NCT06191679|583621492|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
161609446|NCT06191679|583621493|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
161609447|NCT06191679|583621494|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
161609448|NCT06191679|583621495|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
161609449|NCT03656718|583621496|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
161609450|NCT03656718|583621497|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
161609451|NCT03656718|583621498|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
161609452|NCT03656718|583621499|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
161609453|NCT03656718|583621500|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
161609454|NCT03656718|583621501|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
161609455|NCT03656718|583621502|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
161609456|NCT03656718|583621496|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
161609457|NCT03656718|583621497|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
161609458|NCT03656718|583621498|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
161609459|NCT03656718|583621499|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
161609460|NCT03656718|583621500|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
161609461|NCT03656718|583621501|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
161609462|NCT03656718|583621502|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
161609463|NCT03656718|583621496|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
161609464|NCT03656718|583621497|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
161609465|NCT03656718|583621498|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
161609466|NCT03656718|583621499|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
161609467|NCT03656718|583621500|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
161609468|NCT03656718|583621501|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
161609469|NCT03656718|583621502|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
161609470|NCT03656718|583621496|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161609471|NCT03656718|583621497|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161609472|NCT03656718|583621498|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161609473|NCT03656718|583621499|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161609474|NCT03656718|583621500|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161609475|NCT03656718|583621501|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
161609476|NCT03656718|583621502|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
161609477|NCT03656718|583621496|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
161609478|NCT03656718|583621497|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161609479|NCT03656718|583621498|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161609480|NCT03656718|583621499|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161609481|NCT03656718|583621500|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161609482|NCT03656718|583621501|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161609483|NCT03656718|583621502|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
161609484|NCT03656718|583621496|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161609485|NCT03656718|583621497|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161609486|NCT03656718|583621498|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161609487|NCT03656718|583621499|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161609488|NCT03656718|583621500|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161609489|NCT03656718|583621501|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
161609490|NCT03656718|583621502|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
161609491|NCT03656718|583621496|FG000|Treatment Period Part C|Disease progression|0|||
161609492|NCT03656718|583621497|FG001|Treatment Period Part C|Disease progression|0|||
161609493|NCT03656718|583621498|FG002|Treatment Period Part C|Disease progression|0|||
161609494|NCT03656718|583621499|FG003|Treatment Period Part C|Disease progression|0|||
161609495|NCT03656718|583621500|FG004|Treatment Period Part C|Disease progression|12|||
161609496|NCT03656718|583621501|FG005|Treatment Period Part C|Disease progression|0|||
161609497|NCT03656718|583621502|FG006|Treatment Period Part C|Disease progression|0|||
161609498|NCT03656718|583621496|FG000|Treatment Period Part C|Death|0|||
161609499|NCT03656718|583621497|FG001|Treatment Period Part C|Death|0|||
161609500|NCT03656718|583621498|FG002|Treatment Period Part C|Death|0|||
161609501|NCT03656718|583621499|FG003|Treatment Period Part C|Death|0|||
161609502|NCT03656718|583621500|FG004|Treatment Period Part C|Death|1|||
161609503|NCT03656718|583621501|FG005|Treatment Period Part C|Death|0|||
161609504|NCT03656718|583621502|FG006|Treatment Period Part C|Death|0|||
161609505|NCT03656718|583621496|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161609506|NCT03656718|583621497|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161609507|NCT03656718|583621498|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161609508|NCT03656718|583621499|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161609509|NCT03656718|583621500|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
161609510|NCT03656718|583621501|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161609511|NCT03656718|583621502|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161609512|NCT03656718|583621496|FG000|Treatment Period Part C|Other reasons|0|||
161609513|NCT03656718|583621497|FG001|Treatment Period Part C|Other reasons|0|||
161609514|NCT03656718|583621498|FG002|Treatment Period Part C|Other reasons|0|||
161609515|NCT03656718|583621499|FG003|Treatment Period Part C|Other reasons|0|||
161609516|NCT03656718|583621500|FG004|Treatment Period Part C|Other reasons|1|||
161609517|NCT03656718|583621501|FG005|Treatment Period Part C|Other reasons|0|||
161609518|NCT03656718|583621502|FG006|Treatment Period Part C|Other reasons|0|||
161609519|NCT03656718|583621496|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
161609520|NCT03656718|583621497|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
161609521|NCT03656718|583621498|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
161609522|NCT03656718|583621499|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
161609523|NCT03656718|583621500|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
161609524|NCT03656718|583621501|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
161609525|NCT03656718|583621502|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
161609526|NCT05827068|583621503|FG000|Overall Study|Lost to Follow-up|1|||
161609527|NCT05827068|583621504|FG001|Overall Study|Lost to Follow-up|4|||
161609528|NCT05827068|583621505|FG002|Overall Study|Lost to Follow-up|1|||
161609529|NCT05827068|583621506|FG003|Overall Study|Lost to Follow-up|1|||
161609530|NCT05827068|583621507|FG004|Overall Study|Lost to Follow-up|2|||
161609531|NCT05827068|583621508|FG005|Overall Study|Lost to Follow-up|4|||
161609532|NCT05827068|583621509|FG006|Overall Study|Lost to Follow-up|1|||
161609533|NCT05827068|583621503|FG000|Overall Study|Withdrawal by Subject|4|||
161609534|NCT05827068|583621504|FG001|Overall Study|Withdrawal by Subject|0|||
161609535|NCT05827068|583621505|FG002|Overall Study|Withdrawal by Subject|1|||
161609536|NCT05827068|583621506|FG003|Overall Study|Withdrawal by Subject|2|||
161609537|NCT05827068|583621507|FG004|Overall Study|Withdrawal by Subject|3|||
161609538|NCT05827068|583621508|FG005|Overall Study|Withdrawal by Subject|0|||
161609539|NCT05827068|583621509|FG006|Overall Study|Withdrawal by Subject|1|||
161609540|NCT05827068|583621503|FG000|Overall Study|Physician Decision|0|||
161609541|NCT05827068|583621504|FG001|Overall Study|Physician Decision|0|||
161609542|NCT05827068|583621505|FG002|Overall Study|Physician Decision|0|||
161609543|NCT05827068|583621506|FG003|Overall Study|Physician Decision|0|||
161609544|NCT05827068|583621507|FG004|Overall Study|Physician Decision|1|||
161609545|NCT05827068|583621508|FG005|Overall Study|Physician Decision|0|||
161609546|NCT05827068|583621509|FG006|Overall Study|Physician Decision|1|||
161609547|NCT05827068|583621503|FG000|Overall Study|Other Than Specified|0|||
161609548|NCT05827068|583621504|FG001|Overall Study|Other Than Specified|1|||
161609549|NCT05827068|583621505|FG002|Overall Study|Other Than Specified|0|||
161609550|NCT05827068|583621506|FG003|Overall Study|Other Than Specified|0|||
161609551|NCT05827068|583621507|FG004|Overall Study|Other Than Specified|0|||
161609552|NCT05827068|583621508|FG005|Overall Study|Other Than Specified|0|||
161609553|NCT05827068|583621509|FG006|Overall Study|Other Than Specified|0|||
161609554|NCT05630833|583621510|FG000|Overall Study|Adverse Event|3|||
161609555|NCT05630833|583621511|FG001|Overall Study|Adverse Event|0|||
161609556|NCT05630833|583621510|FG000|Overall Study|Lack of Efficacy|0|||
161609557|NCT05630833|583621511|FG001|Overall Study|Lack of Efficacy|1|||
161609558|NCT05630833|583621510|FG000|Overall Study|Lost to Follow-up|1|||
161609559|NCT05630833|583621511|FG001|Overall Study|Lost to Follow-up|0|||
161609560|NCT05630833|583621510|FG000|Overall Study|Withdrawal by Subject|3|||
161609561|NCT05630833|583621511|FG001|Overall Study|Withdrawal by Subject|1|||
161609562|NCT05071430|583621512|FG000|Overall Study|Adverse Event|1|||
161609563|NCT05071430|583621513|FG001|Overall Study|Adverse Event|2|||
161609564|NCT05071430|583621512|FG000|Overall Study|Lost to Follow-up|4|||
161609565|NCT05071430|583621513|FG001|Overall Study|Lost to Follow-up|4|||
161609566|NCT05071430|583621512|FG000|Overall Study|Protocol Violation|1|||
161609567|NCT05071430|583621513|FG001|Overall Study|Protocol Violation|0|||
161609568|NCT05071430|583621512|FG000|Overall Study|Withdrawal by Subject|3|||
161609569|NCT05071430|583621513|FG001|Overall Study|Withdrawal by Subject|2|||
161609570|NCT05071430|583621512|FG000|Overall Study|Other|1|||
161609571|NCT05071430|583621513|FG001|Overall Study|Other|1|||
161609572|NCT01958021|583621514|FG000|Treatment|Progressive disease|206|||
161609573|NCT01958021|583621515|FG001|Treatment|Progressive disease|265|||
161609574|NCT01958021|583621514|FG000|Treatment|Adverse Event|38|||
161609575|NCT01958021|583621515|FG001|Treatment|Adverse Event|10|||
161609576|NCT01958021|583621514|FG000|Treatment|Subject/guardian decision|29|||
161609577|NCT01958021|583621515|FG001|Treatment|Subject/guardian decision|25|||
161609578|NCT01958021|583621514|FG000|Treatment|Physician Decision|28|||
161609579|NCT01958021|583621515|FG001|Treatment|Physician Decision|21|||
161609580|NCT01958021|583621514|FG000|Treatment|Death|6|||
161609581|NCT01958021|583621515|FG001|Treatment|Death|1|||
161609582|NCT01958021|583621514|FG000|Treatment|Protocol deviation|3|||
161609583|NCT01958021|583621515|FG001|Treatment|Protocol deviation|1|||
161609584|NCT01958021|583621514|FG000|Treatment|Sponsor decision|24|||
161609585|NCT01958021|583621515|FG001|Treatment|Sponsor decision|11|||
161609586|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161609587|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161609588|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Death|1|||
161609589|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161609590|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
161609591|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161609592|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161609593|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161609594|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
161609595|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161609596|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
161609597|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
161609598|NCT01958021|583621514|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
161609599|NCT01958021|583621515|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
161609600|NCT00490139|583621516|FG000|Overall Study|Lost to Follow-up|249|||
161609601|NCT00490139|583621517|FG001|Overall Study|Lost to Follow-up|216|||
161609602|NCT00490139|583621518|FG002|Overall Study|Lost to Follow-up|205|||
161609603|NCT00490139|583621519|FG003|Overall Study|Lost to Follow-up|229|||
161609604|NCT00490139|583621516|FG000|Overall Study|Withdrawal by Subject|333|||
161609605|NCT00490139|583621517|FG001|Overall Study|Withdrawal by Subject|322|||
161609606|NCT00490139|583621518|FG002|Overall Study|Withdrawal by Subject|396|||
161609607|NCT00490139|583621519|FG003|Overall Study|Withdrawal by Subject|295|||
161609608|NCT00490139|583621516|FG000|Overall Study|Patient did not sign ICF 12|169|||
161684260|NCT02104583|583897883|FG002|Overall Study|Subject required prohibited medication|1|||
161609609|NCT00490139|583621517|FG001|Overall Study|Patient did not sign ICF 12|176|||
161609610|NCT00490139|583621518|FG002|Overall Study|Patient did not sign ICF 12|139|||
161609611|NCT00490139|583621519|FG003|Overall Study|Patient did not sign ICF 12|167|||
161609612|NCT00490139|583621516|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
161609613|NCT00490139|583621517|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
161609614|NCT00490139|583621518|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
161609615|NCT00490139|583621519|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
161609616|NCT00490139|583621516|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
161609617|NCT00490139|583621517|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
161609618|NCT00490139|583621518|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
161609619|NCT00490139|583621519|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
161609620|NCT00490139|583621516|FG000|Overall Study|Other reasons as defined per protocol|98|||
161609621|NCT00490139|583621517|FG001|Overall Study|Other reasons as defined per protocol|84|||
161609622|NCT00490139|583621518|FG002|Overall Study|Other reasons as defined per protocol|82|||
161609623|NCT00490139|583621519|FG003|Overall Study|Other reasons as defined per protocol|105|||
161609624|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
161609625|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
161609626|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
161609627|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
161609628|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
161609629|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
161609630|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
161609631|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
161609632|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
161609633|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
161609634|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
161609635|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
161609636|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
161609637|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
161609638|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
161609639|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161609640|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
161609641|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161609642|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161609643|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161609644|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
161609645|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
161609646|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
161609647|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
161609648|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
161609649|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Other|1|||
161609650|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Other|0|||
161609651|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Other|0|||
161609652|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Other|0|||
161609653|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Other|0|||
161609654|NCT02386098|583622876|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
161609655|NCT02386098|583622877|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
161609656|NCT02386098|583622878|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
161609657|NCT02386098|583622879|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
161609658|NCT02386098|583622880|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
161609659|NCT00890591|583622890|FG000|Overall Study|Lack of Efficacy|20|||
161609660|NCT00776009|583622895|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
161609661|NCT00776009|583622896|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
161609662|NCT00776009|583622897|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
161609663|NCT00776009|583622898|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
161609664|NCT00776009|583622899|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
161609665|NCT00776009|583622900|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
161609666|NCT00776009|583622895|FG000|Period 1: First Intervention|Protocol Violation|0|||
161609667|NCT00776009|583622896|FG001|Period 1: First Intervention|Protocol Violation|1|||
161609668|NCT00776009|583622897|FG002|Period 1: First Intervention|Protocol Violation|0|||
161609669|NCT00776009|583622898|FG003|Period 1: First Intervention|Protocol Violation|0|||
161609670|NCT00776009|583622899|FG004|Period 1: First Intervention|Protocol Violation|1|||
161609671|NCT00776009|583622900|FG005|Period 1: First Intervention|Protocol Violation|0|||
161609672|NCT00776009|583622895|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
161609673|NCT00776009|583622896|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
161609674|NCT00776009|583622897|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
161609675|NCT00776009|583622898|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
161609676|NCT00776009|583622899|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
161609677|NCT00776009|583622900|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
161609678|NCT00776009|583622895|FG000|Period 2: Second Intervention|Protocol Violation|1|||
161609679|NCT00776009|583622896|FG001|Period 2: Second Intervention|Protocol Violation|0|||
161609680|NCT00776009|583622897|FG002|Period 2: Second Intervention|Protocol Violation|1|||
161609681|NCT00776009|583622898|FG003|Period 2: Second Intervention|Protocol Violation|0|||
161609682|NCT00776009|583622899|FG004|Period 2: Second Intervention|Protocol Violation|0|||
161684261|NCT02104583|583897884|FG003|Overall Study|Subject required prohibited medication|0|||
161684262|NCT02104583|583897885|FG004|Overall Study|Subject required prohibited medication|1|||
161609683|NCT00776009|583622900|FG005|Period 2: Second Intervention|Protocol Violation|0|||
161609684|NCT00776009|583622895|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
161609685|NCT00776009|583622896|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
161609686|NCT00776009|583622897|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
161609687|NCT00776009|583622898|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
161609688|NCT00776009|583622899|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
161609689|NCT00776009|583622900|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
161609690|NCT01536093|583622903|FG000|Overall Study|Death|1|||
161609691|NCT01536093|583622904|FG001|Overall Study|Death|2|||
161609692|NCT01536093|583622903|FG000|Overall Study|absence of maternal colostrum|2|||
161609693|NCT01536093|583622904|FG001|Overall Study|absence of maternal colostrum|0|||
161609694|NCT01536093|583622903|FG000|Overall Study|Withdrawal by Subject|0|||
161609695|NCT01536093|583622904|FG001|Overall Study|Withdrawal by Subject|1|||
161609696|NCT02275611|583622907|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
161609697|NCT02275611|583622908|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
161609698|NCT02275611|583622909|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
161609699|NCT02275611|583622910|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
161609700|NCT01211184|583622916|FG000|Overall Study|Withdrawal by Subject|0|||
161609701|NCT01211184|583622917|FG001|Overall Study|Withdrawal by Subject|2|||
161609702|NCT01211184|583622918|FG002|Overall Study|Withdrawal by Subject|1|||
161609703|NCT01421667|583622919|FG000|Overall Study|Withdrawal by Subject|0|||
161609704|NCT01421667|583622920|FG001|Overall Study|Withdrawal by Subject|1|||
161609705|NCT01421667|583622921|FG002|Overall Study|Withdrawal by Subject|2|||
161609706|NCT01421667|583622922|FG003|Overall Study|Withdrawal by Subject|1|||
161609707|NCT01421667|583622919|FG000|Overall Study|Lost to Follow-up|0|||
161609708|NCT01421667|583622920|FG001|Overall Study|Lost to Follow-up|1|||
161609709|NCT01421667|583622921|FG002|Overall Study|Lost to Follow-up|0|||
161609710|NCT01421667|583622922|FG003|Overall Study|Lost to Follow-up|0|||
161609711|NCT00503906|583622923|FG000|Overall Study|Withdrawal by Subject|1|||
161609712|NCT05580003|583622926|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609713|NCT05580003|583622927|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609714|NCT05580003|583622928|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609715|NCT05580003|583622929|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609716|NCT05580003|583622930|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609717|NCT05580003|583622931|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609718|NCT05580003|583622932|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161609719|NCT05580003|583622933|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609720|NCT05580003|583622934|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609721|NCT05580003|583622935|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609722|NCT05580003|583622936|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609723|NCT05580003|583622937|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609724|NCT05580003|583622938|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609725|NCT05580003|583622939|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609726|NCT05580003|583622940|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609727|NCT05580003|583622941|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609728|NCT05580003|583622942|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609729|NCT05580003|583622943|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609730|NCT05580003|583622944|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609731|NCT05580003|583622945|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609732|NCT05580003|583622946|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609733|NCT05580003|583622947|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609734|NCT05580003|583622948|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609735|NCT05580003|583622949|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609736|NCT05580003|583622950|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609737|NCT05580003|583622951|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609738|NCT05580003|583622952|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609739|NCT05580003|583622953|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161609740|NCT05580003|583622926|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609741|NCT05580003|583622927|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609742|NCT05580003|583622928|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161684263|NCT02104583|583897881|FG000|Overall Study|Withdrew Consent|3|||
161684264|NCT02104583|583897882|FG001|Overall Study|Withdrew Consent|2|||
161609743|NCT05580003|583622929|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609744|NCT05580003|583622930|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609745|NCT05580003|583622931|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
161609746|NCT05580003|583622932|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609747|NCT05580003|583622933|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609748|NCT05580003|583622934|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609749|NCT05580003|583622935|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609750|NCT05580003|583622936|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609751|NCT05580003|583622937|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609752|NCT05580003|583622938|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609753|NCT05580003|583622939|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609754|NCT05580003|583622940|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609755|NCT05580003|583622941|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609756|NCT05580003|583622942|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609757|NCT05580003|583622943|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609758|NCT05580003|583622944|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609759|NCT05580003|583622945|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609760|NCT05580003|583622946|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609761|NCT05580003|583622947|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609762|NCT05580003|583622948|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609763|NCT05580003|583622949|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609764|NCT05580003|583622950|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609765|NCT05580003|583622951|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609766|NCT05580003|583622952|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609767|NCT05580003|583622953|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161609768|NCT05580003|583622926|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609769|NCT05580003|583622927|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609770|NCT05580003|583622928|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609771|NCT05580003|583622929|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
161609772|NCT05580003|583622930|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609773|NCT05580003|583622931|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609774|NCT05580003|583622932|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609775|NCT05580003|583622933|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609776|NCT05580003|583622934|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609777|NCT05580003|583622935|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609778|NCT05580003|583622936|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609779|NCT05580003|583622937|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609780|NCT05580003|583622938|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609781|NCT05580003|583622939|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609782|NCT05580003|583622940|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609783|NCT05580003|583622941|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609784|NCT05580003|583622942|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609785|NCT05580003|583622943|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609786|NCT05580003|583622944|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609787|NCT05580003|583622945|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609788|NCT05580003|583622946|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609789|NCT05580003|583622947|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609790|NCT05580003|583622948|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609791|NCT05580003|583622949|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609792|NCT05580003|583622950|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609793|NCT05580003|583622951|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609794|NCT05580003|583622952|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609795|NCT05580003|583622953|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161609796|NCT05580003|583622926|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609797|NCT05580003|583622927|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
161609798|NCT05580003|583622928|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609799|NCT05580003|583622929|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609800|NCT05580003|583622930|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609801|NCT05580003|583622931|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609802|NCT05580003|583622932|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609803|NCT05580003|583622933|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609804|NCT05580003|583622934|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609805|NCT05580003|583622935|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609806|NCT05580003|583622936|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609807|NCT05580003|583622937|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609808|NCT05580003|583622938|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609809|NCT05580003|583622939|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609810|NCT05580003|583622940|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609811|NCT05580003|583622941|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609812|NCT05580003|583622942|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609813|NCT05580003|583622943|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609814|NCT05580003|583622944|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609815|NCT05580003|583622945|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609816|NCT05580003|583622946|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609817|NCT05580003|583622947|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609818|NCT05580003|583622948|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609819|NCT05580003|583622949|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609820|NCT05580003|583622950|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609821|NCT05580003|583622951|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609822|NCT05580003|583622952|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609823|NCT05580003|583622953|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161609824|NCT05580003|583622926|FG000|Part 2 (up to 10 Days)|Other|0|||
161609825|NCT05580003|583622927|FG001|Part 2 (up to 10 Days)|Other|0|||
161609826|NCT05580003|583622928|FG002|Part 2 (up to 10 Days)|Other|0|||
161609827|NCT05580003|583622929|FG003|Part 2 (up to 10 Days)|Other|0|||
161609828|NCT05580003|583622930|FG004|Part 2 (up to 10 Days)|Other|0|||
161609829|NCT05580003|583622931|FG005|Part 2 (up to 10 Days)|Other|0|||
161609830|NCT05580003|583622932|FG006|Part 2 (up to 10 Days)|Other|0|||
161609831|NCT05580003|583622933|FG007|Part 2 (up to 10 Days)|Other|0|||
161609832|NCT05580003|583622934|FG008|Part 2 (up to 10 Days)|Other|0|||
161609833|NCT05580003|583622935|FG009|Part 2 (up to 10 Days)|Other|1|||
161609834|NCT05580003|583622936|FG010|Part 2 (up to 10 Days)|Other|0|||
161609835|NCT05580003|583622937|FG011|Part 2 (up to 10 Days)|Other|0|||
161609836|NCT05580003|583622938|FG012|Part 2 (up to 10 Days)|Other|0|||
161609837|NCT05580003|583622939|FG013|Part 2 (up to 10 Days)|Other|0|||
161609838|NCT05580003|583622940|FG014|Part 2 (up to 10 Days)|Other|0|||
161609839|NCT05580003|583622941|FG015|Part 2 (up to 10 Days)|Other|0|||
161609840|NCT05580003|583622942|FG016|Part 2 (up to 10 Days)|Other|0|||
161609841|NCT05580003|583622943|FG017|Part 2 (up to 10 Days)|Other|0|||
161609842|NCT05580003|583622944|FG018|Part 2 (up to 10 Days)|Other|0|||
161609843|NCT05580003|583622945|FG019|Part 2 (up to 10 Days)|Other|0|||
161609844|NCT05580003|583622946|FG020|Part 2 (up to 10 Days)|Other|0|||
161609845|NCT05580003|583622947|FG021|Part 2 (up to 10 Days)|Other|0|||
161609846|NCT05580003|583622948|FG022|Part 2 (up to 10 Days)|Other|0|||
161609847|NCT05580003|583622949|FG023|Part 2 (up to 10 Days)|Other|0|||
161609848|NCT05580003|583622950|FG024|Part 2 (up to 10 Days)|Other|0|||
161609849|NCT05580003|583622951|FG025|Part 2 (up to 10 Days)|Other|0|||
161609850|NCT05580003|583622952|FG026|Part 2 (up to 10 Days)|Other|0|||
161609851|NCT05580003|583622953|FG027|Part 2 (up to 10 Days)|Other|0|||
161609852|NCT05580003|583622926|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609853|NCT05580003|583622927|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609854|NCT05580003|583622928|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609855|NCT05580003|583622929|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161832474|NCT00380692|584428400|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
161609856|NCT05580003|583622930|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609857|NCT05580003|583622931|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609858|NCT05580003|583622932|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609859|NCT05580003|583622933|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609860|NCT05580003|583622934|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609861|NCT05580003|583622935|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161832475|NCT00380692|584428401|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
161609862|NCT05580003|583622936|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609863|NCT05580003|583622937|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609864|NCT05580003|583622938|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609865|NCT05580003|583622939|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609866|NCT05580003|583622940|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609867|NCT05580003|583622941|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609868|NCT05580003|583622942|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609869|NCT05580003|583622943|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609870|NCT05580003|583622944|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609871|NCT05580003|583622945|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
161609872|NCT05580003|583622946|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609873|NCT05580003|583622947|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609874|NCT05580003|583622948|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609875|NCT05580003|583622949|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609876|NCT05580003|583622950|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609877|NCT05580003|583622951|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609878|NCT05580003|583622952|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609879|NCT05580003|583622953|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161609880|NCT05580003|583622926|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609881|NCT05580003|583622927|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609882|NCT05580003|583622928|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609883|NCT05580003|583622929|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609884|NCT05580003|583622930|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609885|NCT05580003|583622931|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609886|NCT05580003|583622932|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609887|NCT05580003|583622933|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609888|NCT05580003|583622934|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609889|NCT05580003|583622935|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609890|NCT05580003|583622936|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609891|NCT05580003|583622937|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609892|NCT05580003|583622938|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609893|NCT05580003|583622939|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609894|NCT05580003|583622940|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609895|NCT05580003|583622941|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609896|NCT05580003|583622942|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609897|NCT05580003|583622943|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609898|NCT05580003|583622944|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609899|NCT05580003|583622945|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609900|NCT05580003|583622946|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
161609901|NCT05580003|583622947|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609902|NCT05580003|583622948|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609903|NCT05580003|583622949|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609904|NCT05580003|583622950|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609905|NCT05580003|583622951|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609906|NCT05580003|583622952|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609907|NCT05580003|583622953|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161609908|NCT05580003|583622926|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609909|NCT05580003|583622927|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609910|NCT05580003|583622928|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609911|NCT05580003|583622929|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609912|NCT05580003|583622930|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609913|NCT05580003|583622931|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609914|NCT05580003|583622932|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609915|NCT05580003|583622933|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609916|NCT05580003|583622934|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609917|NCT05580003|583622935|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609918|NCT05580003|583622936|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609919|NCT05580003|583622937|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609920|NCT05580003|583622938|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609921|NCT05580003|583622939|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609922|NCT05580003|583622940|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609923|NCT05580003|583622941|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609924|NCT05580003|583622942|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609925|NCT05580003|583622943|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609926|NCT05580003|583622944|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609927|NCT05580003|583622945|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609928|NCT05580003|583622946|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609929|NCT05580003|583622947|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
161609930|NCT05580003|583622948|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609931|NCT05580003|583622949|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609932|NCT05580003|583622950|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609933|NCT05580003|583622951|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609934|NCT05580003|583622952|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609935|NCT05580003|583622953|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161609936|NCT05580003|583622926|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609937|NCT05580003|583622927|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609938|NCT05580003|583622928|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609939|NCT05580003|583622929|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609940|NCT05580003|583622930|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609941|NCT05580003|583622931|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609942|NCT05580003|583622932|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609943|NCT05580003|583622933|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609944|NCT05580003|583622934|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609945|NCT05580003|583622935|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609946|NCT05580003|583622936|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609947|NCT05580003|583622937|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609948|NCT05580003|583622938|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609949|NCT05580003|583622939|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609950|NCT05580003|583622940|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609951|NCT05580003|583622941|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609952|NCT05580003|583622942|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609953|NCT05580003|583622943|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609954|NCT05580003|583622944|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609955|NCT05580003|583622945|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161684265|NCT02104583|583897883|FG002|Overall Study|Withdrew Consent|0|||
161684266|NCT02104583|583897884|FG003|Overall Study|Withdrew Consent|2|||
161609956|NCT05580003|583622946|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609957|NCT05580003|583622947|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609958|NCT05580003|583622948|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609959|NCT05580003|583622949|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609960|NCT05580003|583622950|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609961|NCT05580003|583622951|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609962|NCT05580003|583622952|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161609963|NCT05580003|583622953|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
161609964|NCT05580003|583622926|FG000|Part 6 Period 2 (Day 1)|Other|0|||
161609965|NCT05580003|583622927|FG001|Part 6 Period 2 (Day 1)|Other|0|||
161609966|NCT05580003|583622928|FG002|Part 6 Period 2 (Day 1)|Other|0|||
161609967|NCT05580003|583622929|FG003|Part 6 Period 2 (Day 1)|Other|0|||
161609968|NCT05580003|583622930|FG004|Part 6 Period 2 (Day 1)|Other|0|||
161609969|NCT05580003|583622931|FG005|Part 6 Period 2 (Day 1)|Other|0|||
161609970|NCT05580003|583622932|FG006|Part 6 Period 2 (Day 1)|Other|0|||
161609971|NCT05580003|583622933|FG007|Part 6 Period 2 (Day 1)|Other|0|||
161609972|NCT05580003|583622934|FG008|Part 6 Period 2 (Day 1)|Other|0|||
161609973|NCT05580003|583622935|FG009|Part 6 Period 2 (Day 1)|Other|0|||
161609974|NCT05580003|583622936|FG010|Part 6 Period 2 (Day 1)|Other|0|||
161609975|NCT05580003|583622937|FG011|Part 6 Period 2 (Day 1)|Other|0|||
161609976|NCT05580003|583622938|FG012|Part 6 Period 2 (Day 1)|Other|0|||
161609977|NCT05580003|583622939|FG013|Part 6 Period 2 (Day 1)|Other|0|||
161609978|NCT05580003|583622940|FG014|Part 6 Period 2 (Day 1)|Other|0|||
161609979|NCT05580003|583622941|FG015|Part 6 Period 2 (Day 1)|Other|0|||
161609980|NCT05580003|583622942|FG016|Part 6 Period 2 (Day 1)|Other|0|||
161609981|NCT05580003|583622943|FG017|Part 6 Period 2 (Day 1)|Other|0|||
161609982|NCT05580003|583622944|FG018|Part 6 Period 2 (Day 1)|Other|0|||
161609983|NCT05580003|583622945|FG019|Part 6 Period 2 (Day 1)|Other|0|||
161609984|NCT05580003|583622946|FG020|Part 6 Period 2 (Day 1)|Other|0|||
161609985|NCT05580003|583622947|FG021|Part 6 Period 2 (Day 1)|Other|0|||
161609986|NCT05580003|583622948|FG022|Part 6 Period 2 (Day 1)|Other|0|||
161609987|NCT05580003|583622949|FG023|Part 6 Period 2 (Day 1)|Other|0|||
161609988|NCT05580003|583622950|FG024|Part 6 Period 2 (Day 1)|Other|1|||
161609989|NCT05580003|583622951|FG025|Part 6 Period 2 (Day 1)|Other|0|||
161609990|NCT05580003|583622952|FG026|Part 6 Period 2 (Day 1)|Other|0|||
161609991|NCT05580003|583622953|FG027|Part 6 Period 2 (Day 1)|Other|0|||
161609992|NCT03516812|583622954|FG000|Overall Study|Adverse Event|4|||
161609993|NCT03516812|583622954|FG000|Overall Study|Lack of Efficacy|2|||
161609994|NCT04795167|583622955|FG000|Overall Study|Death|1|||
161609995|NCT04795167|583622956|FG001|Overall Study|Death|18|||
161609996|NCT04795167|583622957|FG002|Overall Study|Death|1|||
161609997|NCT04795167|583622955|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
161609998|NCT04795167|583622956|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
161609999|NCT04795167|583622957|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
161610000|NCT01753999|583622958|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
161610001|NCT01753999|583622959|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
161610002|NCT01753999|583622958|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
161610003|NCT01753999|583622959|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
161610004|NCT01753999|583622958|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
161610005|NCT01753999|583622959|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
161610006|NCT01753999|583622958|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
161610007|NCT01753999|583622959|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
161610008|NCT01753999|583622958|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
161610009|NCT01753999|583622959|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
161610010|NCT01753999|583622958|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
161610011|NCT01753999|583622959|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
161610012|NCT03840902|583622960|FG000|Overall Study|Randomized but not treated|1|||
161610013|NCT03840902|583622961|FG001|Overall Study|Randomized but not treated|1|||
161610014|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161610015|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
161610016|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161610017|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
161610018|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161610019|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161610020|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161684267|NCT02104583|583897885|FG004|Overall Study|Withdrew Consent|1|||
161610021|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161610022|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161610023|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161610024|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
161610025|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161610026|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161610027|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161610028|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161610029|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161610030|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161610031|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
161610032|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
161610033|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161610034|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161610035|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
161610036|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161610037|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161610038|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161610039|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161610040|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161610041|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161610042|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161610043|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
161610044|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
161610045|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
161610046|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
161610047|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
161610048|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
161610049|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
161610050|NCT02392234|583622962|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161610051|NCT02392234|583622963|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161610052|NCT02392234|583622964|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
161610053|NCT02392234|583622965|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161610054|NCT02392234|583622966|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
161610055|NCT02392234|583622967|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161610056|NCT02392234|583622962|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
161610057|NCT02392234|583622963|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161610058|NCT02392234|583622964|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161610059|NCT02392234|583622965|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161610060|NCT02392234|583622966|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161610061|NCT02392234|583622967|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161610062|NCT02029235|583622973|FG000|Overall Study|Non-compliance with study meds or diary|4|||
161610063|NCT02029235|583622974|FG001|Overall Study|Non-compliance with study meds or diary|1|||
161610064|NCT02816398|583622975|FG000|Overall Study|Death|5|||
161610065|NCT02816398|583622975|FG000|Overall Study|Lack of Efficacy|8|||
161610066|NCT02816398|583622975|FG000|Overall Study|Lost to Follow-up|1|||
161610067|NCT03582475|583622976|FG000|Treatment Period|Withdrawal by Subject|0|||
161610068|NCT03582475|583622977|FG001|Treatment Period|Withdrawal by Subject|1|||
161610069|NCT03582475|583622976|FG000|Follow-up Period|Withdrawal by Subject|0|||
161610070|NCT03582475|583622977|FG001|Follow-up Period|Withdrawal by Subject|1|||
161610071|NCT01400958|583622981|FG000|Overall Study|Physician Decision|0|||
161610072|NCT01400958|583622982|FG001|Overall Study|Physician Decision|1|||
161610073|NCT01400958|583622981|FG000|Overall Study|Withdrawal by Subject|0|||
161610074|NCT01400958|583622982|FG001|Overall Study|Withdrawal by Subject|1|||
161610075|NCT01400958|583622981|FG000|Overall Study|Adverse Event|1|||
161610076|NCT01400958|583622982|FG001|Overall Study|Adverse Event|0|||
161610077|NCT04436289|583622983|FG000|Overall Study|Death prior to hospital discharge|8|||
161610078|NCT04436289|583622984|FG001|Overall Study|Death prior to hospital discharge|5|||
161610079|NCT04436289|583622985|FG002|Overall Study|Death prior to hospital discharge|0|||
161610080|NCT04436289|583622986|FG003|Overall Study|Death prior to hospital discharge|1|||
161610081|NCT04436289|583622983|FG000|Overall Study|Withdrawal by Subject|0|||
161610082|NCT04436289|583622984|FG001|Overall Study|Withdrawal by Subject|1|||
161610083|NCT04436289|583622985|FG002|Overall Study|Withdrawal by Subject|4|||
161610084|NCT04436289|583622986|FG003|Overall Study|Withdrawal by Subject|0|||
161610085|NCT04436289|583622983|FG000|Overall Study|Extended hospital stay|0|||
161610086|NCT04436289|583622984|FG001|Overall Study|Extended hospital stay|1|||
161610087|NCT04436289|583622985|FG002|Overall Study|Extended hospital stay|0|||
161610088|NCT04436289|583622986|FG003|Overall Study|Extended hospital stay|0|||
161610089|NCT04436289|583622983|FG000|Overall Study|Lost to Follow-up|0|||
161610090|NCT04436289|583622984|FG001|Overall Study|Lost to Follow-up|4|||
161610091|NCT04436289|583622985|FG002|Overall Study|Lost to Follow-up|1|||
161610092|NCT04436289|583622986|FG003|Overall Study|Lost to Follow-up|3|||
161610093|NCT03598907|583622987|FG000|Overall Study|Physician Decision|14|||
161610094|NCT03598907|583622988|FG001|Overall Study|Physician Decision|19|||
161610095|NCT03211247|583622991|FG000|Overall Study|Adverse Event|8|||
161610096|NCT03211247|583622992|FG001|Overall Study|Adverse Event|0|||
161610097|NCT03211247|583622993|FG002|Overall Study|Adverse Event|1|||
161610098|NCT03211247|583622994|FG003|Overall Study|Adverse Event|0|||
161610099|NCT03211247|583622995|FG004|Overall Study|Adverse Event|0|||
161610100|NCT03211247|583622991|FG000|Overall Study|Lost to Follow-up|2|||
161610101|NCT03211247|583622992|FG001|Overall Study|Lost to Follow-up|1|||
161610102|NCT03211247|583622993|FG002|Overall Study|Lost to Follow-up|0|||
161610103|NCT03211247|583622994|FG003|Overall Study|Lost to Follow-up|0|||
161610104|NCT03211247|583622995|FG004|Overall Study|Lost to Follow-up|0|||
161610105|NCT03211247|583622991|FG000|Overall Study|Physician Decision|1|||
161610106|NCT03211247|583622992|FG001|Overall Study|Physician Decision|2|||
161610107|NCT03211247|583622993|FG002|Overall Study|Physician Decision|0|||
161610108|NCT03211247|583622994|FG003|Overall Study|Physician Decision|0|||
161610109|NCT03211247|583622995|FG004|Overall Study|Physician Decision|0|||
161610110|NCT03211247|583622991|FG000|Overall Study|Non-compliance with study drug|2|||
161610111|NCT03211247|583622992|FG001|Overall Study|Non-compliance with study drug|0|||
161610112|NCT03211247|583622993|FG002|Overall Study|Non-compliance with study drug|0|||
161610113|NCT03211247|583622994|FG003|Overall Study|Non-compliance with study drug|0|||
161610114|NCT03211247|583622995|FG004|Overall Study|Non-compliance with study drug|0|||
161610115|NCT03211247|583622991|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
161610116|NCT03211247|583622992|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
161610117|NCT03211247|583622993|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
161610118|NCT03211247|583622994|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
161610119|NCT03211247|583622995|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
161610120|NCT03211247|583622991|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
161610121|NCT03211247|583622992|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
161610122|NCT03211247|583622993|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
161610123|NCT03211247|583622994|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
161610124|NCT03211247|583622995|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
161610125|NCT03211247|583622991|FG000|Overall Study|Protocol Violation|0|||
161610126|NCT03211247|583622992|FG001|Overall Study|Protocol Violation|1|||
161610127|NCT03211247|583622993|FG002|Overall Study|Protocol Violation|0|||
161610128|NCT03211247|583622994|FG003|Overall Study|Protocol Violation|0|||
161610129|NCT03211247|583622995|FG004|Overall Study|Protocol Violation|0|||
161610130|NCT02415127|583622996|FG000|Overall Study|Adverse Event|1|||
161610131|NCT02415127|583622997|FG001|Overall Study|Adverse Event|0|||
161610132|NCT05464732|583623000|FG000|Overall Study|Lost to Follow-up|0|||
161610133|NCT05464732|583623001|FG001|Overall Study|Lost to Follow-up|1|||
161610134|NCT05464732|583623000|FG000|Overall Study|Adverse Event|1|||
161610135|NCT05464732|583623001|FG001|Overall Study|Adverse Event|0|||
161610136|NCT03997474|583623002|FG000|Overall Study|Death|6|||
161610137|NCT03997474|583623003|FG001|Overall Study|Death|2|||
161610138|NCT03997474|583623004|FG002|Overall Study|Death|1|||
161610139|NCT03997474|583623002|FG000|Overall Study|Physician Decision|2|||
161610140|NCT03997474|583623003|FG001|Overall Study|Physician Decision|0|||
161610141|NCT03997474|583623004|FG002|Overall Study|Physician Decision|0|||
161610142|NCT03997474|583623002|FG000|Overall Study|study terminated by sponsor|1|||
161610143|NCT03997474|583623003|FG001|Overall Study|study terminated by sponsor|0|||
161610144|NCT03997474|583623004|FG002|Overall Study|study terminated by sponsor|1|||
161610145|NCT03277989|583623005|FG000|Overall Study|Lost to Follow-up|6|||
161610146|NCT03277989|583623005|FG000|Overall Study|Adverse Event|6|||
161610147|NCT03277989|583623005|FG000|Overall Study|Withdrawal by Subject|3|||
161610148|NCT03277989|583623005|FG000|Overall Study|Didn't Receive Study Device|7|||
161610149|NCT03277989|583623005|FG000|Overall Study|Site Closure|26|||
161610150|NCT03277989|583623005|FG000|Overall Study|Sponsor Closure|107|||
161610151|NCT05349838|583623006|FG000|Overall Study|Virological Failure|1|||
161610152|NCT05349838|583623007|FG001|Overall Study|Virological Failure|2|||
161610153|NCT05349838|583623006|FG000|Overall Study|Withdrawal by Subject|2|||
161610154|NCT05349838|583623007|FG001|Overall Study|Withdrawal by Subject|3|||
161610155|NCT05349838|583623006|FG000|Overall Study|Adverse Event|3|||
161610156|NCT05349838|583623007|FG001|Overall Study|Adverse Event|1|||
161610157|NCT05349838|583623006|FG000|Overall Study|Lost to Follow-up|1|||
161610158|NCT05349838|583623007|FG001|Overall Study|Lost to Follow-up|2|||
161610159|NCT05349838|583623006|FG000|Overall Study|Other reasons|5|||
161610160|NCT05349838|583623007|FG001|Overall Study|Other reasons|1|||
161610161|NCT05037513|583623011|FG000|Intervention Period|Lost to Follow-up|1|||
161610162|NCT05037513|583623012|FG001|Intervention Period|Lost to Follow-up|2|||
161610163|NCT05037513|583623011|FG000|Follow Up Period|Lost to Follow-up|16|||
161610164|NCT05037513|583623012|FG001|Follow Up Period|Lost to Follow-up|21|||
161610165|NCT05037513|583623011|FG000|Follow Up Period|Death|0|||
161610166|NCT05037513|583623012|FG001|Follow Up Period|Death|1|||
161610167|NCT05037513|583623011|FG000|Follow Up Period|Incarcerated|4|||
161610168|NCT05037513|583623012|FG001|Follow Up Period|Incarcerated|2|||
161610169|NCT03664804|583623014|FG000|Overall Study|Withdrawal by Subject|7|||
161610170|NCT05529992|583623015|FG000|Overall Study|Withdrawal by Subject|1|||
161610171|NCT06140290|583623016|FG000|Period 1|Adverse Event|1|||
161610172|NCT06140290|583623017|FG001|Period 1|Adverse Event|0|||
161610173|NCT06140290|583623016|FG000|Period 2|Assigned but not treated|0|||
161610174|NCT06140290|583623017|FG001|Period 2|Assigned but not treated|1|||
161684268|NCT02104583|583897881|FG000|Overall Study|Investigator's Discretion|1|||
161684269|NCT02104583|583897882|FG001|Overall Study|Investigator's Discretion|0|||
161610175|NCT06140290|583623016|FG000|Period 2|Withdrawal by Subject|0|||
161610176|NCT06140290|583623017|FG001|Period 2|Withdrawal by Subject|1|||
161610177|NCT02036970|583624450|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161610178|NCT02036970|583624451|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161610179|NCT02036970|583624452|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
161610180|NCT02036970|583624453|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
161610181|NCT02036970|583624454|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161610182|NCT02036970|583624455|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161610183|NCT02036970|583624456|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161610184|NCT02036970|583624457|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161610185|NCT02036970|583624458|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
161610186|NCT02036970|583624459|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161610187|NCT02036970|583624450|FG000|Part 1: Day 1 Through Week 16|Death|0|||
161610188|NCT02036970|583624451|FG001|Part 1: Day 1 Through Week 16|Death|0|||
161610189|NCT02036970|583624452|FG002|Part 1: Day 1 Through Week 16|Death|0|||
161610190|NCT02036970|583624453|FG003|Part 1: Day 1 Through Week 16|Death|0|||
161610191|NCT02036970|583624454|FG004|Part 1: Day 1 Through Week 16|Death|0|||
161610192|NCT02036970|583624455|FG005|Part 1: Day 1 Through Week 16|Death|0|||
161610193|NCT02036970|583624456|FG006|Part 1: Day 1 Through Week 16|Death|0|||
161610194|NCT02036970|583624457|FG007|Part 1: Day 1 Through Week 16|Death|0|||
161610195|NCT02036970|583624458|FG008|Part 1: Day 1 Through Week 16|Death|1|||
161610196|NCT02036970|583624459|FG009|Part 1: Day 1 Through Week 16|Death|0|||
161610197|NCT02036970|583624450|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
161610198|NCT02036970|583624451|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610199|NCT02036970|583624452|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
161610200|NCT02036970|583624453|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610201|NCT02036970|583624454|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610202|NCT02036970|583624455|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610203|NCT02036970|583624456|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610204|NCT02036970|583624457|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610205|NCT02036970|583624458|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
161610206|NCT02036970|583624459|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161610207|NCT02036970|583624450|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610208|NCT02036970|583624451|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610209|NCT02036970|583624452|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610210|NCT02036970|583624453|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610211|NCT02036970|583624454|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
161610212|NCT02036970|583624455|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610213|NCT02036970|583624456|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610214|NCT02036970|583624457|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161610215|NCT02036970|583624458|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
161610216|NCT02036970|583624459|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
161610217|NCT02036970|583624450|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610218|NCT02036970|583624451|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610219|NCT02036970|583624452|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610220|NCT02036970|583624453|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
161610221|NCT02036970|583624454|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610222|NCT02036970|583624455|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610223|NCT02036970|583624456|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610224|NCT02036970|583624457|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610225|NCT02036970|583624458|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610226|NCT02036970|583624459|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161610227|NCT02036970|583624450|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
161610228|NCT02036970|583624451|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
161610229|NCT02036970|583624452|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
161610230|NCT02036970|583624453|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
161610231|NCT02036970|583624454|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
161610232|NCT02036970|583624455|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
161610233|NCT02036970|583624456|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
161610234|NCT02036970|583624457|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
161610235|NCT02036970|583624458|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
161610236|NCT02036970|583624459|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
161610237|NCT02036970|583624450|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610238|NCT02036970|583624451|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610239|NCT02036970|583624452|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610240|NCT02036970|583624453|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610241|NCT02036970|583624454|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610242|NCT02036970|583624455|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610243|NCT02036970|583624456|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610244|NCT02036970|583624457|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
161610245|NCT02036970|583624458|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610246|NCT02036970|583624459|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
161610247|NCT02036970|583624450|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610248|NCT02036970|583624451|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
161610249|NCT02036970|583624452|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
161610250|NCT02036970|583624453|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610251|NCT02036970|583624454|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610252|NCT02036970|583624455|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610253|NCT02036970|583624456|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610254|NCT02036970|583624457|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610255|NCT02036970|583624458|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
161610256|NCT02036970|583624459|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161610257|NCT02036970|583624450|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
161610258|NCT02036970|583624451|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
161610259|NCT02036970|583624452|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
161610260|NCT02036970|583624453|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
161610261|NCT02036970|583624454|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
161610262|NCT02036970|583624455|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
161610263|NCT02036970|583624456|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
161610264|NCT02036970|583624457|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
161610265|NCT02036970|583624458|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
161610266|NCT02036970|583624459|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
161610267|NCT02702843|583624460|FG000|Overall Study|Insufficient data to analyze|15|||
161610268|NCT02702843|583624461|FG001|Overall Study|Insufficient data to analyze|23|||
161610269|NCT05029284|583624464|FG000|Overall Study|Lost to Follow-up|1|||
161610270|NCT03002194|583624466|FG000|Overall Study|Lost to Follow-up|6|||
161610271|NCT03002194|583624466|FG000|Overall Study|Adverse Event|1|||
161610272|NCT03002194|583624466|FG000|Overall Study|Lack of Efficacy|1|||
161610273|NCT03002194|583624466|FG000|Overall Study|Withdrawal by Subject|2|||
161610274|NCT02232737|583624467|FG000|Overall Study|Lost to Follow-up|18|||
161610275|NCT02232737|583624468|FG001|Overall Study|Lost to Follow-up|28|||
161610276|NCT02232737|583624469|FG002|Overall Study|Lost to Follow-up|33|||
161610277|NCT02232737|583624467|FG000|Overall Study|Personal reasons|7|||
161610278|NCT02232737|583624468|FG001|Overall Study|Personal reasons|8|||
161610279|NCT02232737|583624469|FG002|Overall Study|Personal reasons|14|||
161610280|NCT02232737|583624467|FG000|Overall Study|Adverse Event|6|||
161610281|NCT02232737|583624468|FG001|Overall Study|Adverse Event|3|||
161610282|NCT02232737|583624469|FG002|Overall Study|Adverse Event|8|||
161610283|NCT02232737|583624467|FG000|Overall Study|Incarcerated|2|||
161610284|NCT02232737|583624468|FG001|Overall Study|Incarcerated|1|||
161610285|NCT02232737|583624469|FG002|Overall Study|Incarcerated|2|||
161610286|NCT02232737|583624467|FG000|Overall Study|Withdrawal by Subject|0|||
161610287|NCT02232737|583624468|FG001|Overall Study|Withdrawal by Subject|1|||
161610288|NCT02232737|583624469|FG002|Overall Study|Withdrawal by Subject|2|||
161610289|NCT02232737|583624467|FG000|Overall Study|Death|0|||
161610290|NCT02232737|583624468|FG001|Overall Study|Death|1|||
161610291|NCT02232737|583624469|FG002|Overall Study|Death|1|||
161610292|NCT02232737|583624467|FG000|Overall Study|Physician Decision|1|||
161610293|NCT02232737|583624468|FG001|Overall Study|Physician Decision|3|||
161610294|NCT02232737|583624469|FG002|Overall Study|Physician Decision|1|||
161610295|NCT02232737|583624467|FG000|Overall Study|Protocol Violation|1|||
161610296|NCT02232737|583624468|FG001|Overall Study|Protocol Violation|0|||
161610297|NCT02232737|583624469|FG002|Overall Study|Protocol Violation|1|||
161610298|NCT02232737|583624467|FG000|Overall Study|Reason unknown|1|||
161610299|NCT02232737|583624468|FG001|Overall Study|Reason unknown|0|||
161610300|NCT02232737|583624469|FG002|Overall Study|Reason unknown|0|||
161610301|NCT02200705|583624472|FG000|Overall Study|Excluded|12|||
161610302|NCT02200705|583624472|FG000|Overall Study|Death|21|||
161610303|NCT02200705|583624472|FG000|Overall Study|Withdrawal by Subject|22|||
161610304|NCT02200705|583624472|FG000|Overall Study|Lost to Follow-up|13|||
161610305|NCT02200705|583624472|FG000|Overall Study|Physician Decision|5|||
161610306|NCT02200705|583624472|FG000|Overall Study|Adverse Event|2|||
161610307|NCT00065182|583624483|FG000|Overall Study|Adverse Event|24|||
161610308|NCT00065182|583624484|FG001|Overall Study|Adverse Event|17|||
161610309|NCT00065182|583624483|FG000|Overall Study|Lost to Follow-up|0|||
161610310|NCT00065182|583624484|FG001|Overall Study|Lost to Follow-up|4|||
161610311|NCT00065182|583624483|FG000|Overall Study|Protocol Violation|3|||
161610312|NCT00065182|583624484|FG001|Overall Study|Protocol Violation|4|||
161610313|NCT00065182|583624483|FG000|Overall Study|Serious adverse events (SAE)|1|||
161610314|NCT00065182|583624484|FG001|Overall Study|Serious adverse events (SAE)|0|||
161610315|NCT00065182|583624483|FG000|Overall Study|Sponsor Decision|11|||
161610316|NCT00065182|583624484|FG001|Overall Study|Sponsor Decision|7|||
161610317|NCT00065182|583624483|FG000|Overall Study|Withdrawal by Subject|8|||
161610318|NCT00065182|583624484|FG001|Overall Study|Withdrawal by Subject|3|||
161610319|NCT00065182|583624483|FG000|Overall Study|No clinical benefit|1|||
161610320|NCT00065182|583624484|FG001|Overall Study|No clinical benefit|0|||
161610321|NCT00065182|583624483|FG000|Overall Study|Death|0|||
161610322|NCT00065182|583624484|FG001|Overall Study|Death|1|||
161610323|NCT00065182|583624483|FG000|Overall Study|Decline in Status|0|||
161610324|NCT00065182|583624484|FG001|Overall Study|Decline in Status|1|||
161610325|NCT02633215|583624485|FG000|Overall Study|Lost to Follow-up|2|||
161610326|NCT02633215|583624486|FG001|Overall Study|Lost to Follow-up|3|||
161610327|NCT00754325|583624487|FG000|Initial Treatment|Continuing Active Treatment|4|||
161610328|NCT00754325|583624488|FG001|Initial Treatment|Continuing Active Treatment|5|||
161610329|NCT00754325|583624487|FG000|Initial Treatment|Adverse Event|7|||
161610330|NCT00754325|583624488|FG001|Initial Treatment|Adverse Event|6|||
161610331|NCT00754325|583624487|FG000|Initial Treatment|Withdrawal by Subject|2|||
161610332|NCT00754325|583624488|FG001|Initial Treatment|Withdrawal by Subject|2|||
161610333|NCT00754325|583624487|FG000|Initial Treatment|Physician Decision|2|||
161610334|NCT00754325|583624488|FG001|Initial Treatment|Physician Decision|0|||
161610335|NCT00754325|583624487|FG000|Initial Treatment|Sponsor Request|0|||
161610336|NCT00754325|583624488|FG001|Initial Treatment|Sponsor Request|1|||
161610337|NCT00754325|583624487|FG000|Initial Treatment|Disease Progression|35|||
161684270|NCT02104583|583897883|FG002|Overall Study|Investigator's Discretion|0|||
161684271|NCT02104583|583897884|FG003|Overall Study|Investigator's Discretion|0|||
161610338|NCT00754325|583624488|FG001|Initial Treatment|Disease Progression|35|||
161610339|NCT03738228|583624489|FG000|Overall Study|Never received study treatment|2|||
161610340|NCT03738228|583624490|FG001|Overall Study|Never received study treatment|2|||
161610341|NCT03801148|583624491|FG000|Period 1 (2 Days)|Adverse Event|1|||
161684272|NCT02104583|583897885|FG004|Overall Study|Investigator's Discretion|0|||
161684273|NCT02104583|583897881|FG000|Overall Study|Protocol Violation|0|||
161684274|NCT02104583|583897882|FG001|Overall Study|Protocol Violation|0|||
161610342|NCT03801148|583624492|FG001|Period 1 (2 Days)|Adverse Event|1|||
161610343|NCT03801148|583624493|FG002|Period 1 (2 Days)|Adverse Event|0|||
161684275|NCT02104583|583897883|FG002|Overall Study|Protocol Violation|1|||
161684276|NCT02104583|583897884|FG003|Overall Study|Protocol Violation|0|||
161684277|NCT02104583|583897885|FG004|Overall Study|Protocol Violation|0|||
161684278|NCT02104583|583897881|FG000|Overall Study|Adverse Event|3|||
161684279|NCT02104583|583897882|FG001|Overall Study|Adverse Event|3|||
161610344|NCT03801148|583624494|FG003|Period 1 (2 Days)|Adverse Event|0|||
161610345|NCT03801148|583624491|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161610346|NCT03801148|583624492|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161610347|NCT03801148|583624493|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161610348|NCT03801148|583624494|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
161610349|NCT03801148|583624491|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161610350|NCT03801148|583624492|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161610351|NCT03801148|583624493|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161610352|NCT03801148|583624494|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161610353|NCT03801148|583624491|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
161610354|NCT03801148|583624492|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
161610355|NCT03801148|583624493|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
161610356|NCT03801148|583624494|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
161610357|NCT06212752|583624495|FG000|Overall Study|Death|5|||
161610358|NCT06212752|583624496|FG001|Overall Study|Death|3|||
161610359|NCT06212752|583624495|FG000|Overall Study|Participants ongoing|23|||
161610360|NCT06212752|583624496|FG001|Overall Study|Participants ongoing|8|||
161610361|NCT04162210|583624497|FG000|Overall Study|Lost to Follow-up|4|||
161610362|NCT04162210|583624498|FG001|Overall Study|Lost to Follow-up|1|||
161610363|NCT04162210|583624497|FG000|Overall Study|Withdrawal by Subject|17|||
161610364|NCT04162210|583624498|FG001|Overall Study|Withdrawal by Subject|9|||
161610365|NCT04162210|583624497|FG000|Overall Study|Ongoing|113|||
161610366|NCT04162210|583624498|FG001|Overall Study|Ongoing|59|||
161610367|NCT02568215|583624499|FG000|Overall Study|Death|1|||
161610368|NCT02568215|583624500|FG001|Overall Study|Death|2|||
161610369|NCT02568215|583624501|FG002|Overall Study|Death|0|||
161610370|NCT02568215|583624499|FG000|Overall Study|Physician Decision|2|||
161610371|NCT02568215|583624500|FG001|Overall Study|Physician Decision|2|||
161684280|NCT02104583|583897883|FG002|Overall Study|Adverse Event|6|||
161684281|NCT02104583|583897884|FG003|Overall Study|Adverse Event|6|||
161684282|NCT02104583|583897885|FG004|Overall Study|Adverse Event|1|||
161684283|NCT02104583|583897881|FG000|Overall Study|Lost to Follow-up|1|||
161684284|NCT02104583|583897882|FG001|Overall Study|Lost to Follow-up|0|||
161684285|NCT02104583|583897883|FG002|Overall Study|Lost to Follow-up|0|||
161684286|NCT02104583|583897884|FG003|Overall Study|Lost to Follow-up|0|||
161684287|NCT02104583|583897885|FG004|Overall Study|Lost to Follow-up|0|||
161684288|NCT02104583|583897881|FG000|Overall Study|Randomized but Never Treated|0|||
161684289|NCT02104583|583897882|FG001|Overall Study|Randomized but Never Treated|0|||
161610372|NCT02568215|583624501|FG002|Overall Study|Physician Decision|2|||
161610373|NCT02568215|583624499|FG000|Overall Study|Lost to Follow-up|29|||
161610374|NCT02568215|583624500|FG001|Overall Study|Lost to Follow-up|32|||
161610375|NCT02568215|583624501|FG002|Overall Study|Lost to Follow-up|41|||
161610376|NCT02568215|583624499|FG000|Overall Study|Withdrawal by Subject|21|||
161684290|NCT02104583|583897883|FG002|Overall Study|Randomized but Never Treated|0|||
161684291|NCT02104583|583897884|FG003|Overall Study|Randomized but Never Treated|1|||
161684292|NCT02104583|583897885|FG004|Overall Study|Randomized but Never Treated|0|||
161610377|NCT02568215|583624500|FG001|Overall Study|Withdrawal by Subject|19|||
161610378|NCT02568215|583624501|FG002|Overall Study|Withdrawal by Subject|22|||
161610379|NCT02568215|583624499|FG000|Overall Study|Protocol Violation|1|||
161610380|NCT02568215|583624500|FG001|Overall Study|Protocol Violation|1|||
161610381|NCT02568215|583624501|FG002|Overall Study|Protocol Violation|0|||
161610382|NCT02568215|583624499|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
161610383|NCT02568215|583624500|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
161610384|NCT02568215|583624501|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
161610385|NCT02568215|583624499|FG000|Overall Study|Other|0|||
161610386|NCT02568215|583624500|FG001|Overall Study|Other|1|||
161610387|NCT02568215|583624501|FG002|Overall Study|Other|4|||
161610388|NCT01641900|583624502|FG000|Overall Study|Withdrawal by Subject|2|||
161610389|NCT01641900|583624503|FG001|Overall Study|Withdrawal by Subject|2|||
161610390|NCT02941549|583624504|FG000|Overall Study|Adverse Event|1|||
161610391|NCT02941549|583624505|FG001|Overall Study|Adverse Event|0|||
161610392|NCT02941549|583624506|FG002|Overall Study|Adverse Event|0|||
161610393|NCT02941549|583624504|FG000|Overall Study|Withdrawal by Subject|2|||
161610394|NCT02941549|583624505|FG001|Overall Study|Withdrawal by Subject|1|||
161610395|NCT02941549|583624506|FG002|Overall Study|Withdrawal by Subject|2|||
161610396|NCT00263757|583624507|FG000|Overall Study|Withdrawal by Subject|5|||
161610397|NCT00263757|583624508|FG001|Overall Study|Withdrawal by Subject|4|||
161610398|NCT00263757|583624507|FG000|Overall Study|Screen failure|0|||
161610399|NCT00263757|583624508|FG001|Overall Study|Screen failure|1|||
161610400|NCT00263757|583624507|FG000|Overall Study|Adverse Event|3|||
161610401|NCT00263757|583624508|FG001|Overall Study|Adverse Event|3|||
161610402|NCT00713596|583624509|FG000|Overall Study|Study was terminated|2|||
161610403|NCT00713596|583624510|FG001|Overall Study|Study was terminated|3|||
161610404|NCT00713596|583624511|FG002|Overall Study|Study was terminated|2|||
161610405|NCT04545619|583624512|FG000|Overall Study|due to equipment challenges|1|||
161610406|NCT03712371|583624513|FG000|Overall Study|Lack of Efficacy|0|||
161610407|NCT03712371|583624514|FG001|Overall Study|Lack of Efficacy|0|||
161610408|NCT03712371|583624515|FG002|Overall Study|Lack of Efficacy|0|||
161610409|NCT03712371|583624516|FG003|Overall Study|Lack of Efficacy|1|||
161610410|NCT04949542|583624526|FG000|Overall Study|Lost to Follow-up|4|||
161610411|NCT04949542|583624527|FG001|Overall Study|Lost to Follow-up|1|||
161610412|NCT03021993|583624529|FG000|Overall Study|Withdrawal by Subject|4|||
161610413|NCT03021993|583624529|FG000|Overall Study|Physician Decision|1|||
161610414|NCT03021993|583624529|FG000|Overall Study|enrolled but were not treated|1|||
161610415|NCT03021993|583624529|FG000|Overall Study|Death|3|||
161610416|NCT02101775|583624531|FG000|Overall Study|Adverse Event|4|||
161610417|NCT02101775|583624532|FG001|Overall Study|Adverse Event|0|||
161610418|NCT02101775|583624533|FG002|Overall Study|Adverse Event|0|||
161610419|NCT02101775|583624531|FG000|Overall Study|Admission to Hospital|0|||
161610420|NCT02101775|583624532|FG001|Overall Study|Admission to Hospital|1|||
161610421|NCT02101775|583624533|FG002|Overall Study|Admission to Hospital|0|||
161610422|NCT01387516|583624540|FG000|Overall Study|Lost to Follow-up|4|||
161610423|NCT01387516|583624541|FG001|Overall Study|Lost to Follow-up|4|||
161610424|NCT01387516|583624542|FG002|Overall Study|Lost to Follow-up|2|||
161610425|NCT01387516|583624543|FG003|Overall Study|Lost to Follow-up|3|||
161610426|NCT01387516|583624540|FG000|Overall Study|Withdrawal by Subject|1|||
161610427|NCT01387516|583624541|FG001|Overall Study|Withdrawal by Subject|1|||
161610428|NCT01387516|583624542|FG002|Overall Study|Withdrawal by Subject|2|||
161610429|NCT01387516|583624543|FG003|Overall Study|Withdrawal by Subject|0|||
161610430|NCT01387516|583624540|FG000|Overall Study|Death|0|||
161610431|NCT01387516|583624541|FG001|Overall Study|Death|0|||
161610432|NCT01387516|583624542|FG002|Overall Study|Death|0|||
161610433|NCT01387516|583624543|FG003|Overall Study|Death|1|||
161610434|NCT03509909|583624545|FG000|Overall Study|Withdrawal by Subject|16|||
161610435|NCT03509909|583624546|FG001|Overall Study|Withdrawal by Subject|9|||
161610436|NCT03509909|583624545|FG000|Overall Study|Lost to Follow-up|3|||
161610437|NCT03509909|583624546|FG001|Overall Study|Lost to Follow-up|4|||
161610438|NCT03509909|583624545|FG000|Overall Study|Adverse Event|2|||
161610439|NCT03509909|583624546|FG001|Overall Study|Adverse Event|0|||
161610440|NCT04801420|583624550|FG000|Overall Study|Other|1|||
161610441|NCT04801420|583624551|FG001|Overall Study|Other|2|||
161610442|NCT04801420|583624552|FG002|Overall Study|Other|1|||
161610443|NCT04801420|583624550|FG000|Overall Study|Lost to Follow-up|7|||
161610444|NCT04801420|583624551|FG001|Overall Study|Lost to Follow-up|9|||
161610445|NCT04801420|583624552|FG002|Overall Study|Lost to Follow-up|10|||
161610446|NCT04801420|583624550|FG000|Overall Study|Moved from study area|0|||
161610447|NCT04801420|583624551|FG001|Overall Study|Moved from study area|1|||
161610448|NCT04801420|583624552|FG002|Overall Study|Moved from study area|1|||
161610449|NCT04801420|583624550|FG000|Overall Study|Withdrawal by Subject|5|||
161610450|NCT04801420|583624551|FG001|Overall Study|Withdrawal by Subject|1|||
161610451|NCT04801420|583624552|FG002|Overall Study|Withdrawal by Subject|4|||
161610452|NCT04801420|583624550|FG000|Overall Study|Individual stopping criteria reached|0|||
161610453|NCT04801420|583624551|FG001|Overall Study|Individual stopping criteria reached|1|||
161610454|NCT04801420|583624552|FG002|Overall Study|Individual stopping criteria reached|0|||
161610455|NCT04801420|583624550|FG000|Overall Study|Ongoing in the study|195|||
161610456|NCT04801420|583624551|FG001|Overall Study|Ongoing in the study|195|||
161610457|NCT04801420|583624552|FG002|Overall Study|Ongoing in the study|192|||
161610458|NCT01855750|583624553|FG000|Overall Study|Death|78|||
161610459|NCT01855750|583624554|FG001|Overall Study|Death|78|||
161610460|NCT01855750|583624553|FG000|Overall Study|Lost to Follow-up|9|||
161610461|NCT01855750|583624554|FG001|Overall Study|Lost to Follow-up|23|||
161610462|NCT01855750|583624553|FG000|Overall Study|Withdrawal by Subject|35|||
161610463|NCT01855750|583624554|FG001|Overall Study|Withdrawal by Subject|28|||
161610464|NCT01855750|583624553|FG000|Overall Study|Sponsor ends the study|297|||
161610465|NCT01855750|583624554|FG001|Overall Study|Sponsor ends the study|290|||
161610466|NCT05379270|583624555|FG000|Overall Study|Withdrawal by Subject|1|||
161610467|NCT05379270|583624556|FG001|Overall Study|Withdrawal by Subject|1|||
161610468|NCT03160885|583624557|FG000|Initial Treatment Period|Not dosed|2|||
161610469|NCT03160885|583624558|FG001|Initial Treatment Period|Not dosed|0|||
161610470|NCT03160885|583624559|FG002|Initial Treatment Period|Not dosed|0|||
161610471|NCT03160885|583624560|FG003|Initial Treatment Period|Not dosed|0|||
161610472|NCT03160885|583624561|FG004|Initial Treatment Period|Not dosed|0|||
161610473|NCT03160885|583624562|FG005|Initial Treatment Period|Not dosed|0|||
161610474|NCT03160885|583624563|FG006|Initial Treatment Period|Not dosed|0|||
161610475|NCT03160885|583624557|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
161610476|NCT03160885|583624558|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
161610477|NCT03160885|583624559|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161610478|NCT03160885|583624560|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161610479|NCT03160885|583624561|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161610480|NCT03160885|583624562|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161610481|NCT03160885|583624563|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161610482|NCT03160885|583624557|FG000|Open-label Treatment|Not dosed|0|||
161610483|NCT03160885|583624558|FG001|Open-label Treatment|Not dosed|0|||
161610484|NCT03160885|583624559|FG002|Open-label Treatment|Not dosed|0|||
161610485|NCT03160885|583624560|FG003|Open-label Treatment|Not dosed|0|||
161610486|NCT03160885|583624561|FG004|Open-label Treatment|Not dosed|0|||
161610487|NCT03160885|583624562|FG005|Open-label Treatment|Not dosed|0|||
161610488|NCT03160885|583624563|FG006|Open-label Treatment|Not dosed|2|||
161610489|NCT03160885|583624557|FG000|Open-label Treatment|Discontinued IMP|0|||
161610490|NCT03160885|583624558|FG001|Open-label Treatment|Discontinued IMP|0|||
161610491|NCT03160885|583624559|FG002|Open-label Treatment|Discontinued IMP|0|||
161610492|NCT03160885|583624560|FG003|Open-label Treatment|Discontinued IMP|0|||
161610493|NCT03160885|583624561|FG004|Open-label Treatment|Discontinued IMP|0|||
161610494|NCT03160885|583624562|FG005|Open-label Treatment|Discontinued IMP|0|||
161610495|NCT03160885|583624563|FG006|Open-label Treatment|Discontinued IMP|131|||
161610496|NCT03160885|583624557|FG000|Open-label Treatment|Completed Week 50|0|||
161610497|NCT03160885|583624558|FG001|Open-label Treatment|Completed Week 50|0|||
161610498|NCT03160885|583624559|FG002|Open-label Treatment|Completed Week 50|0|||
161610499|NCT03160885|583624560|FG003|Open-label Treatment|Completed Week 50|0|||
161610500|NCT03160885|583624561|FG004|Open-label Treatment|Completed Week 50|0|||
161610501|NCT03160885|583624562|FG005|Open-label Treatment|Completed Week 50|0|||
161610502|NCT03160885|583624563|FG006|Open-label Treatment|Completed Week 50|4|||
161610503|NCT03160885|583624557|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161610504|NCT03160885|583624558|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161610505|NCT03160885|583624559|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161610506|NCT03160885|583624560|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
161684293|NCT00129766|583897886|FG000|Overall Study|Death|3|||
161610507|NCT03160885|583624561|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161610508|NCT03160885|583624562|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161610509|NCT03160885|583624563|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161610510|NCT03160885|583624557|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
161610511|NCT03160885|583624558|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
161610512|NCT03160885|583624559|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
161610513|NCT03160885|583624560|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
161610514|NCT03160885|583624561|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
161610515|NCT03160885|583624562|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
161610516|NCT03160885|583624563|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
161610517|NCT03160885|583624557|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161610518|NCT03160885|583624558|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161610519|NCT03160885|583624559|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
161610520|NCT03160885|583624560|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
161610521|NCT03160885|583624561|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
161610522|NCT03160885|583624562|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
161610523|NCT03160885|583624563|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161610524|NCT03160885|583624557|FG000|Maintenance Treatment Period|Completed Week 50|0|||
161610525|NCT03160885|583624558|FG001|Maintenance Treatment Period|Completed Week 50|0|||
161610526|NCT03160885|583624559|FG002|Maintenance Treatment Period|Completed Week 50|1|||
161610527|NCT03160885|583624560|FG003|Maintenance Treatment Period|Completed Week 50|0|||
161610528|NCT03160885|583624561|FG004|Maintenance Treatment Period|Completed Week 50|0|||
161610529|NCT03160885|583624562|FG005|Maintenance Treatment Period|Completed Week 50|0|||
161610530|NCT03160885|583624563|FG006|Maintenance Treatment Period|Completed Week 50|0|||
161610531|NCT03425682|583624564|FG000|Overall Study|Lost to Follow-up|2|||
161610532|NCT03425682|583624565|FG001|Overall Study|Lost to Follow-up|4|||
161610533|NCT03425682|583624564|FG000|Overall Study|Withdrawal by Subject|0|||
161610534|NCT03425682|583624565|FG001|Overall Study|Withdrawal by Subject|3|||
161610535|NCT03425682|583624564|FG000|Overall Study|Subject did not meet I/E|4|||
161610536|NCT03425682|583624565|FG001|Overall Study|Subject did not meet I/E|10|||
161610537|NCT04153890|583624566|FG000|Overall Study|Lost to Follow-up|9|||
161610538|NCT04153890|583624567|FG001|Overall Study|Lost to Follow-up|0|||
161610539|NCT04153890|583624568|FG002|Overall Study|Lost to Follow-up|9|||
161610540|NCT04153890|583624569|FG003|Overall Study|Lost to Follow-up|0|||
161610541|NCT04153890|583624566|FG000|Overall Study|Death|0|||
161610542|NCT04153890|583624567|FG001|Overall Study|Death|2|||
161610543|NCT04153890|583624568|FG002|Overall Study|Death|0|||
161610544|NCT04153890|583624569|FG003|Overall Study|Death|0|||
161610545|NCT04153890|583624566|FG000|Overall Study|Withdrawal by Subject|0|||
161610546|NCT04153890|583624567|FG001|Overall Study|Withdrawal by Subject|0|||
161610547|NCT04153890|583624568|FG002|Overall Study|Withdrawal by Subject|0|||
161610548|NCT04153890|583624569|FG003|Overall Study|Withdrawal by Subject|2|||
161610549|NCT03610581|583624570|FG000|Overall Study|Study terminated by sponsor|2|||
161610550|NCT03610581|583624571|FG001|Overall Study|Study terminated by sponsor|0|||
161610551|NCT03610581|583624570|FG000|Overall Study|Other|0|||
161610552|NCT03610581|583624571|FG001|Overall Study|Other|1|||
161610553|NCT03610581|583624570|FG000|Overall Study|Withdrawal by Subject|1|||
161610554|NCT03610581|583624571|FG001|Overall Study|Withdrawal by Subject|0|||
161610555|NCT02307682|583624576|FG000|Overall Study|Adverse Event|9|||
161610556|NCT02307682|583624577|FG001|Overall Study|Adverse Event|8|||
161610557|NCT02307682|583624578|FG002|Overall Study|Adverse Event|12|||
161610558|NCT02307682|583624576|FG000|Overall Study|Lack of Efficacy|1|||
161610559|NCT02307682|583624577|FG001|Overall Study|Lack of Efficacy|0|||
161610560|NCT02307682|583624578|FG002|Overall Study|Lack of Efficacy|1|||
161610561|NCT02307682|583624576|FG000|Overall Study|Physician Decision|2|||
161610562|NCT02307682|583624577|FG001|Overall Study|Physician Decision|2|||
161610563|NCT02307682|583624578|FG002|Overall Study|Physician Decision|8|||
161610564|NCT02307682|583624576|FG000|Overall Study|Progressive Disease|1|||
161610565|NCT02307682|583624577|FG001|Overall Study|Progressive Disease|0|||
161610566|NCT02307682|583624578|FG002|Overall Study|Progressive Disease|0|||
161610567|NCT02307682|583624576|FG000|Overall Study|Withdrawal by Subject|26|||
161610568|NCT02307682|583624577|FG001|Overall Study|Withdrawal by Subject|34|||
161610569|NCT02307682|583624578|FG002|Overall Study|Withdrawal by Subject|23|||
161610570|NCT02307682|583624576|FG000|Overall Study|Death|9|||
161610571|NCT02307682|583624577|FG001|Overall Study|Death|7|||
161610572|NCT02307682|583624578|FG002|Overall Study|Death|12|||
161610573|NCT02307682|583624576|FG000|Overall Study|Lost to Follow-up|1|||
161610574|NCT02307682|583624577|FG001|Overall Study|Lost to Follow-up|5|||
161610575|NCT02307682|583624578|FG002|Overall Study|Lost to Follow-up|6|||
161610576|NCT02307682|583624576|FG000|Overall Study|Protocol Deviation|0|||
161610577|NCT02307682|583624577|FG001|Overall Study|Protocol Deviation|0|||
161610578|NCT02307682|583624578|FG002|Overall Study|Protocol Deviation|2|||
161610579|NCT02307682|583624576|FG000|Overall Study|Other|1|||
161610580|NCT02307682|583624577|FG001|Overall Study|Other|1|||
161610581|NCT02307682|583624578|FG002|Overall Study|Other|0|||
161610582|NCT04306367|583624581|FG000|Overall Study|Progression of Disease|9|||
161610583|NCT04306367|583624581|FG000|Overall Study|Adverse Event|3|||
161610584|NCT04306367|583624581|FG000|Overall Study|Withdrawal by Subject|1|||
161684294|NCT00129766|583897887|FG001|Overall Study|Death|8|||
161684295|NCT00129766|583897886|FG000|Overall Study|Withdrawal of consent|31|||
161684296|NCT00129766|583897887|FG001|Overall Study|Withdrawal of consent|30|||
161684297|NCT00129766|583897886|FG000|Overall Study|Lost to Follow-up|26|||
161684298|NCT00129766|583897887|FG001|Overall Study|Lost to Follow-up|21|||
161684299|NCT01230307|583897889|FG000|Overall Study|LVAD Placement|0|||
161610585|NCT02751528|583624588|FG000|Overall Study|Withdrawal by Subject|1|||
161610586|NCT02751528|583624588|FG000|Overall Study|Adverse Event|1|||
161610587|NCT05485805|583624589|FG000|Overall Study|Withdrawal by Subject|1|||
161684300|NCT01230307|583897890|FG001|Overall Study|LVAD Placement|2|||
161610588|NCT05485805|583624590|FG001|Overall Study|Withdrawal by Subject|2|||
161610589|NCT05485805|583624591|FG002|Overall Study|Withdrawal by Subject|2|||
161610590|NCT05485805|583624592|FG003|Overall Study|Withdrawal by Subject|0|||
161610591|NCT05485805|583624593|FG004|Overall Study|Withdrawal by Subject|2|||
161610592|NCT05485805|583624589|FG000|Overall Study|Adverse Event|0|||
161610593|NCT05485805|583624590|FG001|Overall Study|Adverse Event|1|||
161610594|NCT05485805|583624591|FG002|Overall Study|Adverse Event|0|||
161610595|NCT05485805|583624592|FG003|Overall Study|Adverse Event|0|||
161610596|NCT05485805|583624593|FG004|Overall Study|Adverse Event|0|||
161610597|NCT05485805|583624589|FG000|Overall Study|Lost to Follow-up|1|||
161610598|NCT05485805|583624590|FG001|Overall Study|Lost to Follow-up|1|||
161610599|NCT05485805|583624591|FG002|Overall Study|Lost to Follow-up|3|||
161610600|NCT05485805|583624592|FG003|Overall Study|Lost to Follow-up|1|||
161610601|NCT05485805|583624593|FG004|Overall Study|Lost to Follow-up|0|||
161610602|NCT04218357|583624594|FG000|1st Allocation|Withdrawal by Subject|1|||
161610603|NCT04218357|583624595|FG001|1st Allocation|Withdrawal by Subject|0|||
161610604|NCT03116464|583626116|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
161610605|NCT00371345|583626119|FG000|Overall Study|Disease Progression|21|||
161610606|NCT00371345|583626120|FG001|Overall Study|Disease Progression|35|||
161610607|NCT00371345|583626119|FG000|Overall Study|Study Drug Toxicity|1|||
161610608|NCT00371345|583626120|FG001|Overall Study|Study Drug Toxicity|7|||
161610609|NCT00371345|583626119|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
161610610|NCT00371345|583626120|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
161610611|NCT00371345|583626119|FG000|Overall Study|Participant Request|1|||
161610612|NCT00371345|583626120|FG001|Overall Study|Participant Request|1|||
161610613|NCT00371345|583626119|FG000|Overall Study|Participant Withdrew Consent|0|||
161610614|NCT00371345|583626120|FG001|Overall Study|Participant Withdrew Consent|1|||
161610615|NCT00705406|583626121|FG000|Overall Study|Lost to Follow-up|3|||
161610616|NCT00705406|583626122|FG001|Overall Study|Lost to Follow-up|3|||
161610617|NCT00705406|583626121|FG000|Overall Study|Did not receive study drug|1|||
161610618|NCT00705406|583626122|FG001|Overall Study|Did not receive study drug|2|||
161610619|NCT01779700|583626123|FG000|Overall Study|Adverse Event|4|||
161610620|NCT01779700|583626124|FG001|Overall Study|Adverse Event|3|||
161610621|NCT01779700|583626123|FG000|Overall Study|Withdrawal by Subject|0|||
161610622|NCT01779700|583626124|FG001|Overall Study|Withdrawal by Subject|2|||
161610623|NCT00442104|583626125|FG000|Overall Study|Adverse Event|5|||
161610624|NCT00442104|583626125|FG000|Overall Study|Death|2|||
161610625|NCT00442104|583626125|FG000|Overall Study|Lost to Follow-up|3|||
161610626|NCT00442104|583626125|FG000|Overall Study|Withdrawal by Subject|5|||
161610627|NCT00442104|583626125|FG000|Overall Study|Insufficient Clinical Response|10|||
161610628|NCT00442104|583626125|FG000|Overall Study|Other|21|||
161610629|NCT00442104|583626125|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
161610630|NCT00918333|583626129|FG000|Overall Study|Drug not taken per protocol|1|||
161610631|NCT00918333|583626130|FG001|Overall Study|Drug not taken per protocol|0|||
161684301|NCT04773106|583897891|FG000|Overall Study|Withdrawal by Subject|3|||
161610632|NCT00918333|583626129|FG000|Overall Study|Inadequate amount of drugs provided|1|||
161610633|NCT00918333|583626130|FG001|Overall Study|Inadequate amount of drugs provided|4|||
161610634|NCT00918333|583626129|FG000|Overall Study|Ineligible|1|||
161610635|NCT00918333|583626130|FG001|Overall Study|Ineligible|0|||
161610636|NCT00918333|583626129|FG000|Overall Study|Withdrawal by Subject|0|||
161610637|NCT00918333|583626130|FG001|Overall Study|Withdrawal by Subject|1|||
161610638|NCT04497415|583626134|FG000|Overall Study|Lost to Follow-up|43|||
161610639|NCT04497415|583626135|FG001|Overall Study|Lost to Follow-up|27|||
161610640|NCT02463448|583626139|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
161610641|NCT02463448|583626139|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
161610642|NCT02463448|583626139|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
161610643|NCT02463448|583626139|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
161610644|NCT00975585|583626140|FG000|Overall Study|Adverse Event|0|||
161610645|NCT00975585|583626141|FG001|Overall Study|Adverse Event|4|||
161610646|NCT00975585|583626140|FG000|Overall Study|Lost to Follow-up|3|||
161610647|NCT00975585|583626141|FG001|Overall Study|Lost to Follow-up|5|||
161610648|NCT00975585|583626140|FG000|Overall Study|Withdrawal by Subject|2|||
161610649|NCT00975585|583626141|FG001|Overall Study|Withdrawal by Subject|1|||
161610650|NCT00975585|583626140|FG000|Overall Study|Lens issue|2|||
161610651|NCT00975585|583626141|FG001|Overall Study|Lens issue|2|||
161610652|NCT00683800|583626142|FG000|Overall Study|Adverse Event|195|||
161610653|NCT00683800|583626143|FG001|Overall Study|Adverse Event|102|||
161610654|NCT00683800|583626142|FG000|Overall Study|Death|0|||
161610655|NCT00683800|583626143|FG001|Overall Study|Death|1|||
161610656|NCT00683800|583626142|FG000|Overall Study|Lost to Follow-up|57|||
161610657|NCT00683800|583626143|FG001|Overall Study|Lost to Follow-up|44|||
161610658|NCT00683800|583626142|FG000|Overall Study|Other|5|||
161610659|NCT00683800|583626143|FG001|Overall Study|Other|2|||
161610660|NCT00683800|583626142|FG000|Overall Study|Protocol Violation|13|||
161610661|NCT00683800|583626143|FG001|Overall Study|Protocol Violation|16|||
161610662|NCT00683800|583626142|FG000|Overall Study|Withdrawal by Subject|66|||
161610663|NCT00683800|583626143|FG001|Overall Study|Withdrawal by Subject|64|||
161610664|NCT00683800|583626142|FG000|Overall Study|Lack of Efficacy|61|||
161610665|NCT00683800|583626143|FG001|Overall Study|Lack of Efficacy|104|||
161610666|NCT00683800|583626142|FG000|Overall Study|Randomized, not treated|35|||
161610667|NCT00683800|583626143|FG001|Overall Study|Randomized, not treated|33|||
161610668|NCT00205179|583626144|FG000|Overall Study|Death|0|||
161610669|NCT00205179|583626145|FG001|Overall Study|Death|2|||
161610670|NCT00205179|583626144|FG000|Overall Study|Physician Decision|1|||
161610671|NCT00205179|583626145|FG001|Overall Study|Physician Decision|1|||
161610672|NCT00205179|583626144|FG000|Overall Study|Adverse Event|1|||
161610673|NCT00205179|583626145|FG001|Overall Study|Adverse Event|1|||
161610674|NCT01619059|583626150|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
161610675|NCT01619059|583626151|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
161610676|NCT01619059|583626150|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
161610677|NCT01619059|583626151|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
161610678|NCT01619059|583626150|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
161610679|NCT01619059|583626151|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
161610680|NCT01619059|583626150|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
161610681|NCT01619059|583626151|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
161610682|NCT01619059|583626150|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
161610683|NCT01619059|583626151|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
161610684|NCT01619059|583626150|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
161610685|NCT01619059|583626151|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
161610686|NCT01619059|583626150|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
161610687|NCT01619059|583626151|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
161610688|NCT01619059|583626150|FG000|Long-Term (LT) Treatment Period|Death|1|||
161610689|NCT01619059|583626151|FG001|Long-Term (LT) Treatment Period|Death|0|||
161610690|NCT01619059|583626150|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
161610691|NCT01619059|583626151|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
161610692|NCT01619059|583626150|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
161610693|NCT01619059|583626151|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
161610694|NCT03170648|583626156|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
161610695|NCT03170648|583626156|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
161610696|NCT01588951|583626157|FG000|Overall Study|Ineligible in retrospect|0|||
161610697|NCT01588951|583626158|FG001|Overall Study|Ineligible in retrospect|0|||
161610698|NCT01588951|583626159|FG002|Overall Study|Ineligible in retrospect|1|||
161610699|NCT03683576|583626160|FG000|Overall Study|Withdrawal by Subject|2|||
161610700|NCT03683576|583626161|FG001|Overall Study|Withdrawal by Subject|0|||
161610701|NCT03683576|583626162|FG002|Overall Study|Withdrawal by Subject|8|||
161610702|NCT03683576|583626163|FG003|Overall Study|Withdrawal by Subject|3|||
161610703|NCT03683576|583626160|FG000|Overall Study|Adverse Event|3|||
161610704|NCT03683576|583626161|FG001|Overall Study|Adverse Event|0|||
161610705|NCT03683576|583626162|FG002|Overall Study|Adverse Event|0|||
161610706|NCT03683576|583626163|FG003|Overall Study|Adverse Event|4|||
161610707|NCT03683576|583626160|FG000|Overall Study|Lack of Efficacy|1|||
161610708|NCT03683576|583626161|FG001|Overall Study|Lack of Efficacy|0|||
161610709|NCT03683576|583626162|FG002|Overall Study|Lack of Efficacy|1|||
161610710|NCT03683576|583626163|FG003|Overall Study|Lack of Efficacy|1|||
161610711|NCT03683576|583626160|FG000|Overall Study|Lost to Follow-up|0|||
161610712|NCT03683576|583626161|FG001|Overall Study|Lost to Follow-up|1|||
161610713|NCT03683576|583626162|FG002|Overall Study|Lost to Follow-up|2|||
161610714|NCT03683576|583626163|FG003|Overall Study|Lost to Follow-up|0|||
161610715|NCT03683576|583626160|FG000|Overall Study|Other, Not Specified|0|||
161610716|NCT03683576|583626161|FG001|Overall Study|Other, Not Specified|2|||
161610717|NCT03683576|583626162|FG002|Overall Study|Other, Not Specified|0|||
161610718|NCT03683576|583626163|FG003|Overall Study|Other, Not Specified|0|||
161610719|NCT03683576|583626160|FG000|Overall Study|Protocol Violation|0|||
161610720|NCT03683576|583626161|FG001|Overall Study|Protocol Violation|1|||
161610721|NCT03683576|583626162|FG002|Overall Study|Protocol Violation|1|||
161610722|NCT03683576|583626163|FG003|Overall Study|Protocol Violation|0|||
161610723|NCT02454959|583626164|FG000|Overall Study|Protocol-Specified Criteria|3|||
161610724|NCT02454959|583626164|FG000|Overall Study|Physician Decision|1|||
161610725|NCT02454959|583626164|FG000|Overall Study|Withdrawal by Subject|3|||
161610726|NCT02454959|583626164|FG000|Overall Study|Adverse Event|2|||
161610727|NCT02350634|583626165|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
161610728|NCT02499328|583626175|FG000|Overall Study|Withdrawal by Subject|1|||
161610729|NCT02499328|583626176|FG001|Overall Study|Withdrawal by Subject|1|||
161610730|NCT02499328|583626177|FG002|Overall Study|Withdrawal by Subject|5|||
161610731|NCT02499328|583626178|FG003|Overall Study|Withdrawal by Subject|3|||
161684302|NCT04773106|583897891|FG000|Overall Study|Death|1|||
161610732|NCT02499328|583626179|FG004|Overall Study|Withdrawal by Subject|5|||
161610733|NCT02499328|583626180|FG005|Overall Study|Withdrawal by Subject|0|||
161610734|NCT02499328|583626181|FG006|Overall Study|Withdrawal by Subject|0|||
161610735|NCT02499328|583626182|FG007|Overall Study|Withdrawal by Subject|0|||
161610736|NCT02499328|583626183|FG008|Overall Study|Withdrawal by Subject|2|||
161610737|NCT02499328|583626184|FG009|Overall Study|Withdrawal by Subject|2|||
161610738|NCT02499328|583626185|FG010|Overall Study|Withdrawal by Subject|0|||
161610739|NCT02499328|583626186|FG011|Overall Study|Withdrawal by Subject|3|||
161610740|NCT02499328|583626187|FG012|Overall Study|Withdrawal by Subject|7|||
161610741|NCT02499328|583626188|FG013|Overall Study|Withdrawal by Subject|3|||
161610742|NCT02499328|583626189|FG014|Overall Study|Withdrawal by Subject|1|||
161610743|NCT02499328|583626190|FG015|Overall Study|Withdrawal by Subject|0|||
161610744|NCT02499328|583626191|FG016|Overall Study|Withdrawal by Subject|0|||
161610745|NCT02499328|583626192|FG017|Overall Study|Withdrawal by Subject|3|||
161610746|NCT02499328|583626193|FG018|Overall Study|Withdrawal by Subject|0|||
161610747|NCT02499328|583626175|FG000|Overall Study|Lost to Follow-up|0|||
161610748|NCT02499328|583626176|FG001|Overall Study|Lost to Follow-up|1|||
161610749|NCT02499328|583626177|FG002|Overall Study|Lost to Follow-up|1|||
161610750|NCT02499328|583626178|FG003|Overall Study|Lost to Follow-up|2|||
161610751|NCT02499328|583626179|FG004|Overall Study|Lost to Follow-up|0|||
161610752|NCT02499328|583626180|FG005|Overall Study|Lost to Follow-up|0|||
161610753|NCT02499328|583626181|FG006|Overall Study|Lost to Follow-up|0|||
161610754|NCT02499328|583626182|FG007|Overall Study|Lost to Follow-up|2|||
161610755|NCT02499328|583626183|FG008|Overall Study|Lost to Follow-up|3|||
161610756|NCT02499328|583626184|FG009|Overall Study|Lost to Follow-up|0|||
161610757|NCT02499328|583626185|FG010|Overall Study|Lost to Follow-up|0|||
161610758|NCT02499328|583626186|FG011|Overall Study|Lost to Follow-up|0|||
161610759|NCT02499328|583626187|FG012|Overall Study|Lost to Follow-up|0|||
161610760|NCT02499328|583626188|FG013|Overall Study|Lost to Follow-up|0|||
161610761|NCT02499328|583626189|FG014|Overall Study|Lost to Follow-up|0|||
161610762|NCT02499328|583626190|FG015|Overall Study|Lost to Follow-up|0|||
161610763|NCT02499328|583626191|FG016|Overall Study|Lost to Follow-up|0|||
161610764|NCT02499328|583626192|FG017|Overall Study|Lost to Follow-up|0|||
161610765|NCT02499328|583626193|FG018|Overall Study|Lost to Follow-up|1|||
161610766|NCT02499328|583626175|FG000|Overall Study|Death|0|||
161610767|NCT02499328|583626176|FG001|Overall Study|Death|3|||
161610768|NCT02499328|583626177|FG002|Overall Study|Death|3|||
161610769|NCT02499328|583626178|FG003|Overall Study|Death|2|||
161610770|NCT02499328|583626179|FG004|Overall Study|Death|4|||
161610771|NCT02499328|583626180|FG005|Overall Study|Death|7|||
161610772|NCT02499328|583626181|FG006|Overall Study|Death|3|||
161610773|NCT02499328|583626182|FG007|Overall Study|Death|0|||
161610774|NCT02499328|583626183|FG008|Overall Study|Death|2|||
161610775|NCT02499328|583626184|FG009|Overall Study|Death|6|||
161610776|NCT02499328|583626185|FG010|Overall Study|Death|6|||
161610777|NCT02499328|583626186|FG011|Overall Study|Death|20|||
161610778|NCT02499328|583626187|FG012|Overall Study|Death|9|||
161610779|NCT02499328|583626188|FG013|Overall Study|Death|7|||
161610780|NCT02499328|583626189|FG014|Overall Study|Death|3|||
161610781|NCT02499328|583626190|FG015|Overall Study|Death|1|||
161610782|NCT02499328|583626191|FG016|Overall Study|Death|1|||
161610783|NCT02499328|583626192|FG017|Overall Study|Death|16|||
161610784|NCT02499328|583626193|FG018|Overall Study|Death|5|||
161610785|NCT02499328|583626175|FG000|Overall Study|"Other"|2|||
161610786|NCT02499328|583626176|FG001|Overall Study|"Other"|2|||
161610787|NCT02499328|583626177|FG002|Overall Study|"Other"|1|||
161610788|NCT02499328|583626178|FG003|Overall Study|"Other"|3|||
161610789|NCT02499328|583626179|FG004|Overall Study|"Other"|6|||
161610790|NCT02499328|583626180|FG005|Overall Study|"Other"|2|||
161610791|NCT02499328|583626181|FG006|Overall Study|"Other"|3|||
161610792|NCT02499328|583626182|FG007|Overall Study|"Other"|4|||
161610793|NCT02499328|583626183|FG008|Overall Study|"Other"|6|||
161610794|NCT02499328|583626184|FG009|Overall Study|"Other"|16|||
161610795|NCT02499328|583626185|FG010|Overall Study|"Other"|13|||
161610796|NCT02499328|583626186|FG011|Overall Study|"Other"|31|||
161610797|NCT02499328|583626187|FG012|Overall Study|"Other"|8|||
161610798|NCT02499328|583626188|FG013|Overall Study|"Other"|7|||
161610799|NCT02499328|583626189|FG014|Overall Study|"Other"|6|||
161610800|NCT02499328|583626190|FG015|Overall Study|"Other"|0|||
161610801|NCT02499328|583626191|FG016|Overall Study|"Other"|0|||
161610802|NCT02499328|583626192|FG017|Overall Study|"Other"|34|||
161610803|NCT02499328|583626193|FG018|Overall Study|"Other"|43|||
161610804|NCT02499328|583626175|FG000|Overall Study|Disease Progression|0|||
161610805|NCT02499328|583626176|FG001|Overall Study|Disease Progression|0|||
161610806|NCT02499328|583626177|FG002|Overall Study|Disease Progression|0|||
161610807|NCT02499328|583626178|FG003|Overall Study|Disease Progression|0|||
161610808|NCT02499328|583626179|FG004|Overall Study|Disease Progression|0|||
161610809|NCT02499328|583626180|FG005|Overall Study|Disease Progression|0|||
161610810|NCT02499328|583626181|FG006|Overall Study|Disease Progression|1|||
161610811|NCT02499328|583626182|FG007|Overall Study|Disease Progression|0|||
161610812|NCT02499328|583626183|FG008|Overall Study|Disease Progression|1|||
161610813|NCT02499328|583626184|FG009|Overall Study|Disease Progression|0|||
161610814|NCT02499328|583626185|FG010|Overall Study|Disease Progression|1|||
161610815|NCT02499328|583626186|FG011|Overall Study|Disease Progression|0|||
161610816|NCT02499328|583626187|FG012|Overall Study|Disease Progression|0|||
161610817|NCT02499328|583626188|FG013|Overall Study|Disease Progression|0|||
161610818|NCT02499328|583626189|FG014|Overall Study|Disease Progression|0|||
161610819|NCT02499328|583626190|FG015|Overall Study|Disease Progression|0|||
161610820|NCT02499328|583626191|FG016|Overall Study|Disease Progression|0|||
161610821|NCT02499328|583626192|FG017|Overall Study|Disease Progression|2|||
161610822|NCT02499328|583626193|FG018|Overall Study|Disease Progression|0|||
161610823|NCT02499328|583626175|FG000|Overall Study|Adverse Event|1|||
161610824|NCT02499328|583626176|FG001|Overall Study|Adverse Event|0|||
161610825|NCT02499328|583626177|FG002|Overall Study|Adverse Event|0|||
161610826|NCT02499328|583626178|FG003|Overall Study|Adverse Event|1|||
161610827|NCT02499328|583626179|FG004|Overall Study|Adverse Event|0|||
161610828|NCT02499328|583626180|FG005|Overall Study|Adverse Event|0|||
161610829|NCT02499328|583626181|FG006|Overall Study|Adverse Event|0|||
161610830|NCT02499328|583626182|FG007|Overall Study|Adverse Event|0|||
161610831|NCT02499328|583626183|FG008|Overall Study|Adverse Event|0|||
161610832|NCT02499328|583626184|FG009|Overall Study|Adverse Event|0|||
161610833|NCT02499328|583626185|FG010|Overall Study|Adverse Event|0|||
161610834|NCT02499328|583626186|FG011|Overall Study|Adverse Event|0|||
161610835|NCT02499328|583626187|FG012|Overall Study|Adverse Event|1|||
161610836|NCT02499328|583626188|FG013|Overall Study|Adverse Event|0|||
161610837|NCT02499328|583626189|FG014|Overall Study|Adverse Event|0|||
161610838|NCT02499328|583626190|FG015|Overall Study|Adverse Event|0|||
161610839|NCT02499328|583626191|FG016|Overall Study|Adverse Event|0|||
161610840|NCT02499328|583626192|FG017|Overall Study|Adverse Event|0|||
161610841|NCT02499328|583626193|FG018|Overall Study|Adverse Event|0|||
161610842|NCT03611075|583626194|FG000|Overall Study|Physician Decision|0|||
161610843|NCT03611075|583626195|FG001|Overall Study|Physician Decision|1|||
161610844|NCT03611075|583626196|FG002|Overall Study|Physician Decision|1|||
161610845|NCT03611075|583626197|FG003|Overall Study|Physician Decision|0|||
161610846|NCT03611075|583626198|FG004|Overall Study|Physician Decision|0|||
161610847|NCT03611075|583626199|FG005|Overall Study|Physician Decision|0|||
161610848|NCT03611075|583626200|FG006|Overall Study|Physician Decision|0|||
161610849|NCT03611075|583626201|FG007|Overall Study|Physician Decision|0|||
161610850|NCT03611075|583626202|FG008|Overall Study|Physician Decision|0|||
161610851|NCT03611075|583626194|FG000|Overall Study|Lost to Follow-up|1|||
161610852|NCT03611075|583626195|FG001|Overall Study|Lost to Follow-up|0|||
161610853|NCT03611075|583626196|FG002|Overall Study|Lost to Follow-up|0|||
161610854|NCT03611075|583626197|FG003|Overall Study|Lost to Follow-up|2|||
161610855|NCT03611075|583626198|FG004|Overall Study|Lost to Follow-up|0|||
161610856|NCT03611075|583626199|FG005|Overall Study|Lost to Follow-up|0|||
161610857|NCT03611075|583626200|FG006|Overall Study|Lost to Follow-up|0|||
161610858|NCT03611075|583626201|FG007|Overall Study|Lost to Follow-up|0|||
161610859|NCT03611075|583626202|FG008|Overall Study|Lost to Follow-up|0|||
161610860|NCT03611075|583626194|FG000|Overall Study|Withdrawal by Subject|0|||
161610861|NCT03611075|583626195|FG001|Overall Study|Withdrawal by Subject|1|||
161610862|NCT03611075|583626196|FG002|Overall Study|Withdrawal by Subject|1|||
161610863|NCT03611075|583626197|FG003|Overall Study|Withdrawal by Subject|1|||
161610864|NCT03611075|583626198|FG004|Overall Study|Withdrawal by Subject|0|||
161610865|NCT03611075|583626199|FG005|Overall Study|Withdrawal by Subject|0|||
161610866|NCT03611075|583626200|FG006|Overall Study|Withdrawal by Subject|1|||
161610867|NCT03611075|583626201|FG007|Overall Study|Withdrawal by Subject|0|||
161610868|NCT03611075|583626202|FG008|Overall Study|Withdrawal by Subject|0|||
161610869|NCT03611075|583626194|FG000|Overall Study|Reason unknown|0|||
161610870|NCT03611075|583626195|FG001|Overall Study|Reason unknown|0|||
161610871|NCT03611075|583626196|FG002|Overall Study|Reason unknown|0|||
161610872|NCT03611075|583626197|FG003|Overall Study|Reason unknown|1|||
161610873|NCT03611075|583626198|FG004|Overall Study|Reason unknown|0|||
161610874|NCT03611075|583626199|FG005|Overall Study|Reason unknown|0|||
161610875|NCT03611075|583626200|FG006|Overall Study|Reason unknown|1|||
161610876|NCT03611075|583626201|FG007|Overall Study|Reason unknown|0|||
161610877|NCT03611075|583626202|FG008|Overall Study|Reason unknown|0|||
161610878|NCT03488719|583626203|FG000|Overall Study|Adverse Event|0|||
161610879|NCT03488719|583626204|FG001|Overall Study|Adverse Event|4|||
161610880|NCT03488719|583626205|FG002|Overall Study|Adverse Event|2|||
161610881|NCT03488719|583626203|FG000|Overall Study|Other|0|||
161610882|NCT03488719|583626204|FG001|Overall Study|Other|0|||
161610883|NCT03488719|583626205|FG002|Overall Study|Other|5|||
161610884|NCT03414684|583626213|FG000|First-course Treatment|Complete response|0|||
161610885|NCT03414684|583626214|FG001|First-course Treatment|Complete response|1|||
161610886|NCT03414684|583626213|FG000|First-course Treatment|Intercurrent illness|1|||
161610887|NCT03414684|583626214|FG001|First-course Treatment|Intercurrent illness|0|||
161610888|NCT03414684|583626213|FG000|First-course Treatment|Progressive Disease|31|||
161610889|NCT03414684|583626214|FG001|First-course Treatment|Progressive Disease|32|||
161610890|NCT03414684|583626213|FG000|First-course Treatment|Adverse Event|1|||
161610891|NCT03414684|583626214|FG001|First-course Treatment|Adverse Event|2|||
161610892|NCT03414684|583626213|FG000|First-course Treatment|Physician Decision|0|||
161610893|NCT03414684|583626214|FG001|First-course Treatment|Physician Decision|1|||
161610894|NCT03414684|583626213|FG000|First-course Treatment|Withdrawal by Subject|0|||
161610895|NCT03414684|583626214|FG001|First-course Treatment|Withdrawal by Subject|1|||
161610896|NCT03414684|583626213|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
161610897|NCT03414684|583626214|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
161610898|NCT03414684|583626213|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
161610899|NCT03414684|583626214|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
161610900|NCT03414684|583626213|FG000|First-course Treatment|Still on treatment|3|||
161610901|NCT03414684|583626214|FG001|First-course Treatment|Still on treatment|0|||
161610902|NCT03414684|583626213|FG000|First-course Treatment|Never started protocol therapy|2|||
161610903|NCT03414684|583626214|FG001|First-course Treatment|Never started protocol therapy|1|||
161610904|NCT03414684|583626213|FG000|Crossover Treatment|Progressive disease|0|||
161610905|NCT03414684|583626214|FG001|Crossover Treatment|Progressive disease|12|||
161610906|NCT03414684|583626213|FG000|Crossover Treatment|Adverse Event|0|||
161610907|NCT03414684|583626214|FG001|Crossover Treatment|Adverse Event|3|||
161610908|NCT03414684|583626213|FG000|Crossover Treatment|Physician Decision|0|||
161610909|NCT03414684|583626214|FG001|Crossover Treatment|Physician Decision|1|||
161610910|NCT03414684|583626213|FG000|Crossover Treatment|Still on treatment|0|||
161610911|NCT03414684|583626214|FG001|Crossover Treatment|Still on treatment|2|||
161610912|NCT04038580|583626215|FG000|Washout 1|Death|0|||
161610913|NCT04038580|583626216|FG001|Washout 1|Death|0|||
161610914|NCT04038580|583626217|FG002|Washout 1|Death|0|||
161610915|NCT04038580|583626218|FG003|Washout 1|Death|1|||
161610916|NCT04038580|583626219|FG004|Washout 1|Death|0|||
161610917|NCT04038580|583626220|FG005|Washout 1|Death|0|||
161610918|NCT04038580|583626215|FG000|Washout 1|Withdrawal by Subject|0|||
161610919|NCT04038580|583626216|FG001|Washout 1|Withdrawal by Subject|0|||
161610920|NCT04038580|583626217|FG002|Washout 1|Withdrawal by Subject|0|||
161610921|NCT04038580|583626218|FG003|Washout 1|Withdrawal by Subject|0|||
161610922|NCT04038580|583626219|FG004|Washout 1|Withdrawal by Subject|1|||
161610923|NCT04038580|583626220|FG005|Washout 1|Withdrawal by Subject|0|||
161610924|NCT04038580|583626215|FG000|Wash-out 2|Withdrawal by Subject|1|||
161610925|NCT04038580|583626216|FG001|Wash-out 2|Withdrawal by Subject|0|||
161610926|NCT04038580|583626217|FG002|Wash-out 2|Withdrawal by Subject|0|||
161610927|NCT04038580|583626218|FG003|Wash-out 2|Withdrawal by Subject|2|||
161610928|NCT04038580|583626219|FG004|Wash-out 2|Withdrawal by Subject|0|||
161610929|NCT04038580|583626220|FG005|Wash-out 2|Withdrawal by Subject|1|||
161610930|NCT04038580|583626215|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
161610931|NCT04038580|583626216|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
161610932|NCT04038580|583626217|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
161610933|NCT04038580|583626218|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
161610934|NCT04038580|583626219|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
161610935|NCT04038580|583626220|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
161610936|NCT04038580|583626215|FG000|Wash-out 3|Withdrawal by Subject|1|||
161610937|NCT04038580|583626216|FG001|Wash-out 3|Withdrawal by Subject|0|||
161610938|NCT04038580|583626217|FG002|Wash-out 3|Withdrawal by Subject|2|||
161610939|NCT04038580|583626218|FG003|Wash-out 3|Withdrawal by Subject|0|||
161610940|NCT04038580|583626219|FG004|Wash-out 3|Withdrawal by Subject|0|||
161610941|NCT04038580|583626220|FG005|Wash-out 3|Withdrawal by Subject|0|||
161610942|NCT03477175|583626221|FG000|Overall Study|Unable to travel due to COVID-19|0|||
161610943|NCT03477175|583626222|FG001|Overall Study|Unable to travel due to COVID-19|1|||
161610944|NCT03477175|583626221|FG000|Overall Study|Physician Decision|1|||
161610945|NCT03477175|583626222|FG001|Overall Study|Physician Decision|0|||
161610946|NCT03477175|583626221|FG000|Overall Study|Transitioned to commercial drug|6|||
161610947|NCT03477175|583626222|FG001|Overall Study|Transitioned to commercial drug|6|||
161610948|NCT03477175|583626221|FG000|Overall Study|Lost to Follow-up|1|||
161610949|NCT03477175|583626222|FG001|Overall Study|Lost to Follow-up|1|||
161610950|NCT03477175|583626221|FG000|Overall Study|Withdrawal by Subject|3|||
161610951|NCT03477175|583626222|FG001|Overall Study|Withdrawal by Subject|1|||
161610952|NCT03477175|583626221|FG000|Overall Study|Adverse Event|1|||
161610953|NCT03477175|583626222|FG001|Overall Study|Adverse Event|5|||
161610954|NCT03477175|583626221|FG000|Overall Study|Disease Progression|7|||
161610955|NCT03477175|583626222|FG001|Overall Study|Disease Progression|7|||
161610956|NCT02078648|583626223|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
161832476|NCT00380692|584428400|FG000|Study Period II - Double Blind|Physician Decision|0|||
161832477|NCT00380692|584428401|FG001|Study Period II - Double Blind|Physician Decision|1|||
161832478|NCT00380692|584428400|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
161832479|NCT00380692|584428401|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
161832480|NCT00380692|584428400|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
161832481|NCT00380692|584428401|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
161832482|NCT00380692|584428400|FG000|Study Period III - Open Label|Adverse Event|5|||
161832483|NCT00380692|584428401|FG001|Study Period III - Open Label|Adverse Event|3|||
161832484|NCT00380692|584428400|FG000|Study Period III - Open Label|Protocol Violation|0|||
161832485|NCT00380692|584428401|FG001|Study Period III - Open Label|Protocol Violation|0|||
161832486|NCT00380692|584428400|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
161832487|NCT00380692|584428401|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
161832488|NCT00380692|584428400|FG000|Study Period III - Open Label|Physician Decision|0|||
161610957|NCT02078648|583626224|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
161610958|NCT02078648|583626223|FG000|Overall Study|Adverse Event|0|||
161610959|NCT02078648|583626224|FG001|Overall Study|Adverse Event|1|||
161610960|NCT02078648|583626223|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
161610961|NCT02078648|583626224|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
161610962|NCT02078648|583626223|FG000|Overall Study|Withdrawal by Subject|3|||
161610963|NCT02078648|583626224|FG001|Overall Study|Withdrawal by Subject|1|||
161610964|NCT02078648|583626223|FG000|Overall Study|Investigator Decision|5|||
161610965|NCT02078648|583626224|FG001|Overall Study|Investigator Decision|7|||
161610966|NCT02078648|583626223|FG000|Overall Study|Death|1|||
161610967|NCT02078648|583626224|FG001|Overall Study|Death|1|||
161610968|NCT02078648|583626223|FG000|Overall Study|Undefined|0|||
161610969|NCT02078648|583626224|FG001|Overall Study|Undefined|1|||
161610970|NCT04088227|583626225|FG000|Overall Study|Withdrawal by Subject|1|||
161610971|NCT04088227|583626226|FG001|Overall Study|Withdrawal by Subject|0|||
161610972|NCT04088227|583626225|FG000|Overall Study|Surgery postponed >5weeks|1|||
161610973|NCT04088227|583626226|FG001|Overall Study|Surgery postponed >5weeks|0|||
161610974|NCT04021862|583626227|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161610975|NCT04021862|583626228|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
161610976|NCT04021862|583626229|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161610977|NCT04021862|583626230|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161610978|NCT04021862|583626231|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161610979|NCT04021862|583626232|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161610980|NCT04021862|583626227|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
161610981|NCT04021862|583626228|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161610982|NCT04021862|583626229|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161610983|NCT04021862|583626230|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161610984|NCT04021862|583626231|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161610985|NCT04021862|583626232|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161610986|NCT04021862|583626227|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161610987|NCT04021862|583626228|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161610988|NCT04021862|583626229|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
161610989|NCT04021862|583626230|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161610990|NCT04021862|583626231|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161610991|NCT04021862|583626232|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161610992|NCT04021862|583626227|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
161610993|NCT04021862|583626228|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
161610994|NCT04021862|583626229|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
161610995|NCT04021862|583626230|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
161610996|NCT04021862|583626231|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
161610997|NCT04021862|583626232|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
161610998|NCT04021862|583626227|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161610999|NCT04021862|583626228|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161684303|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
161832489|NCT00380692|584428401|FG001|Study Period III - Open Label|Physician Decision|3|||
161832490|NCT00380692|584428400|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
161611000|NCT04021862|583626229|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161611001|NCT04021862|583626230|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
161611002|NCT04021862|583626231|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161611003|NCT04021862|583626232|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161611004|NCT03227861|583626233|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
161611005|NCT03227861|583626233|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
161611006|NCT03227861|583626233|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
161611007|NCT03227861|583626233|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
161611008|NCT03227861|583626233|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
161611009|NCT03227861|583626233|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
161611010|NCT03227861|583626233|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
161611011|NCT03227861|583626233|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
161611012|NCT03227861|583626233|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
161611013|NCT03227861|583626233|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
161611014|NCT00345046|583627147|FG000|Overall Study|Protocol Violation|1|||
161611015|NCT00345046|583627148|FG001|Overall Study|Protocol Violation|1|||
161611016|NCT00345046|583627149|FG002|Overall Study|Protocol Violation|2|||
161611017|NCT01787032|583627159|FG000|Overall Study|Protocol Violation|0|||
161611018|NCT01787032|583627160|FG001|Overall Study|Protocol Violation|0|||
161611019|NCT01787032|583627161|FG002|Overall Study|Protocol Violation|0|||
161611020|NCT01787032|583627162|FG003|Overall Study|Protocol Violation|0|||
161611021|NCT01787032|583627163|FG004|Overall Study|Protocol Violation|1|||
161611022|NCT01787032|583627164|FG005|Overall Study|Protocol Violation|1|||
161611023|NCT02040870|583627165|FG000|Overall Study|Completed treatment phase|6|||
161611024|NCT02040870|583627165|FG000|Overall Study|Adverse Event|7|||
161611025|NCT02040870|583627165|FG000|Overall Study|Progressive disease|58|||
161611026|NCT02040870|583627165|FG000|Overall Study|Physician Decision|6|||
161611027|NCT02040870|583627165|FG000|Overall Study|Subject/guardian decision|10|||
161611028|NCT02040870|583627165|FG000|Overall Study|Lost to Follow-up|3|||
161611029|NCT02040870|583627165|FG000|Overall Study|Death|13|||
161611030|NCT00388726|583627166|FG000|Overall Study|Adverse Event|50|||
161611031|NCT00388726|583627167|FG001|Overall Study|Adverse Event|24|||
161611032|NCT00388726|583627166|FG000|Overall Study|Progressive Disease|336|||
161611033|NCT00388726|583627167|FG001|Overall Study|Progressive Disease|153|||
161611034|NCT00388726|583627166|FG000|Overall Study|Clinical Progression|61|||
161611035|NCT00388726|583627167|FG001|Overall Study|Clinical Progression|36|||
161611036|NCT00388726|583627166|FG000|Overall Study|Withdrawal by Subject|10|||
161611037|NCT00388726|583627167|FG001|Overall Study|Withdrawal by Subject|7|||
161611038|NCT00388726|583627166|FG000|Overall Study|Administrative|6|||
161611039|NCT00388726|583627167|FG001|Overall Study|Administrative|9|||
161611040|NCT00388726|583627166|FG000|Overall Study|Physician Decision|18|||
161611041|NCT00388726|583627167|FG001|Overall Study|Physician Decision|13|||
161611042|NCT00388726|583627166|FG000|Overall Study|Death|3|||
161611043|NCT00388726|583627167|FG001|Overall Study|Death|2|||
161611044|NCT02406092|583627173|FG000|Overall Study|Screen failure|10|||
161611045|NCT02406092|583627174|FG001|Overall Study|Screen failure|7|||
161611046|NCT02406092|583627173|FG000|Overall Study|Death|22|||
161611047|NCT02406092|583627174|FG001|Overall Study|Death|5|||
161611048|NCT02406092|583627173|FG000|Overall Study|Lost to Follow-up|4|||
161611049|NCT02406092|583627174|FG001|Overall Study|Lost to Follow-up|1|||
161611050|NCT02406092|583627173|FG000|Overall Study|Adverse Event|1|||
161611051|NCT02406092|583627174|FG001|Overall Study|Adverse Event|0|||
161611052|NCT02406092|583627173|FG000|Overall Study|Withdrawal by Subject|1|||
161611053|NCT02406092|583627174|FG001|Overall Study|Withdrawal by Subject|0|||
161611054|NCT03041233|583627175|FG000|Overall Study|Death|5|||
161611055|NCT03041233|583627175|FG000|Overall Study|Physician Decision|1|||
161611056|NCT03041233|583627175|FG000|Overall Study|Lost to Follow-up|16|||
161611057|NCT03041233|583627175|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
161611058|NCT03041233|583627175|FG000|Overall Study|Sponsor Request|1|||
161611059|NCT03041233|583627175|FG000|Overall Study|Duplicate subject|1|||
161611060|NCT03041233|583627175|FG000|Overall Study|Re-ablation|1|||
161611061|NCT00853593|583627179|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
161611062|NCT00853593|583627179|FG000|Overall Study|Model 4396 lead not attempted|29|||
161611063|NCT00853593|583627179|FG000|Overall Study|Implant not attempted|4|||
161611064|NCT03229408|583627182|FG000|Overall Study|Withdrawal by Subject|4|||
161611065|NCT03229408|583627183|FG001|Overall Study|Withdrawal by Subject|1|||
161611066|NCT03229408|583627182|FG000|Overall Study|Adverse Event|2|||
161611067|NCT03229408|583627183|FG001|Overall Study|Adverse Event|0|||
161611068|NCT03229408|583627182|FG000|Overall Study|Pregnancy|0|||
161611069|NCT03229408|583627183|FG001|Overall Study|Pregnancy|1|||
161611070|NCT03229408|583627182|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
161611071|NCT03229408|583627183|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
161611072|NCT03745313|583627188|FG000|At 30 Days Follow-up|Death|2|||
161611073|NCT03745313|583627188|FG000|At 6 Months Follow-up|Death|1|||
161611074|NCT03745313|583627188|FG000|At 6 Months Follow-up|Missed Visit|1|||
161611075|NCT03745313|583627188|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
161611076|NCT03745313|583627188|FG000|At 1 Year Follow-up|Death|2|||
161611077|NCT03745313|583627188|FG000|At 1 Year Follow-up|Missed Visit|2|||
161611078|NCT03745313|583627188|FG000|At 2 Year Follow-up|Missed Visit|1|||
161611079|NCT02052440|583627192|FG000|Overall Study|Withdrawal by Subject|0|||
161611080|NCT02052440|583627193|FG001|Overall Study|Withdrawal by Subject|1|||
161611081|NCT01367236|583627197|FG000|Overall Study|Withdrawal by Subject|3|||
161611082|NCT01367236|583627198|FG001|Overall Study|Withdrawal by Subject|1|||
161611083|NCT02628626|583627203|FG000|Overall Study|Withdrawal by Subject|2|||
161611084|NCT02628626|583627204|FG001|Overall Study|Withdrawal by Subject|2|||
161611085|NCT01593020|583627205|FG000|Overall Study|Adverse Event|1|||
161611086|NCT01593020|583627206|FG001|Overall Study|Adverse Event|1|||
161611087|NCT01593020|583627205|FG000|Overall Study|Death|0|||
161611088|NCT01593020|583627206|FG001|Overall Study|Death|1|||
161611089|NCT01593020|583627205|FG000|Overall Study|Ineligible|1|||
161832491|NCT00380692|584428401|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
161611090|NCT01593020|583627206|FG001|Overall Study|Ineligible|0|||
161611091|NCT02972359|583627210|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
161611092|NCT02972359|583627210|FG000|Overall Study|Lack of Efficacy|1|||
161611093|NCT02972359|583627210|FG000|Overall Study|Adverse Event|4|||
161611094|NCT02972359|583627210|FG000|Overall Study|Death|1|||
161611095|NCT02972359|583627210|FG000|Overall Study|Withdrawal by Subject|30|||
161611096|NCT02972359|583627210|FG000|Overall Study|Protocol Violation|1|||
161611097|NCT02972359|583627210|FG000|Overall Study|Lost to Follow-up|26|||
161611098|NCT02972359|583627210|FG000|Overall Study|Other reasons|5|||
161611099|NCT02972359|583627210|FG000|Overall Study|Missing|1|||
161611100|NCT05525572|583627214|FG000|Overall Study|Lost to Follow-up|2|||
161611101|NCT05025384|583627221|FG000|Overall Study|Physician Decision|5|||
161611102|NCT05025384|583627222|FG001|Overall Study|Physician Decision|6|||
161611103|NCT05251363|583627223|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
161611104|NCT05251363|583627223|FG000|Overall Study After Implant Period|Death|9|||
161611105|NCT05251363|583627223|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
161611106|NCT05251363|583627223|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
161611107|NCT05251363|583627223|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
161611108|NCT05251363|583627223|FG000|Overall Study After Implant Period|Physician Decision|1|||
161611109|NCT05251363|583627223|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
161611110|NCT00489307|583627224|FG000|Overall Study|Death|1|||
161611111|NCT00489307|583627225|FG001|Overall Study|Death|1|||
161611112|NCT00489307|583627224|FG000|Overall Study|Lost to Follow-up|2|||
161611113|NCT00489307|583627225|FG001|Overall Study|Lost to Follow-up|2|||
161832492|NCT00380692|584428400|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
161611114|NCT00489307|583627224|FG000|Overall Study|Physician Decision|1|||
161611115|NCT00489307|583627225|FG001|Overall Study|Physician Decision|0|||
161611116|NCT00489307|583627224|FG000|Overall Study|Withdrawal by Subject|2|||
161611117|NCT00489307|583627225|FG001|Overall Study|Withdrawal by Subject|4|||
161611118|NCT00489307|583627224|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
161611119|NCT00489307|583627225|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
161611120|NCT00489307|583627224|FG000|Overall Study|Surgery after assignment|1|||
161611121|NCT00489307|583627225|FG001|Overall Study|Surgery after assignment|0|||
161611122|NCT00489307|583627224|FG000|Overall Study|Did not fill up the forms|2|||
161832493|NCT00380692|584428401|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
161832494|NCT00107042|584428402|FG000|Overall Study|Lost to Follow-up|9|||
161832495|NCT00107042|584428403|FG001|Overall Study|Lost to Follow-up|7|||
161611123|NCT00489307|583627225|FG001|Overall Study|Did not fill up the forms|1|||
161611124|NCT00489307|583627224|FG000|Overall Study|Patient or family refusal|5|||
161611125|NCT00489307|583627225|FG001|Overall Study|Patient or family refusal|9|||
161611126|NCT03835754|583627226|FG000|Overall Study|Death|4|||
161832496|NCT00107042|584428402|FG000|Overall Study|Withdrawal by Subject|6|||
161832497|NCT00107042|584428403|FG001|Overall Study|Withdrawal by Subject|1|||
161832498|NCT00107042|584428402|FG000|Overall Study|Moved out of area|5|||
161611127|NCT02517268|583627229|FG000|Overall Study|Withdrawal by Subject|1|||
161611128|NCT02517268|583627230|FG001|Overall Study|Withdrawal by Subject|0|||
161611129|NCT05810285|583627236|FG000|Overall Study|Death|4|||
161611130|NCT05810285|583627237|FG001|Overall Study|Death|21|||
161611131|NCT05810285|583627236|FG000|Overall Study|Adverse Event|18|||
161611132|NCT05810285|583627237|FG001|Overall Study|Adverse Event|16|||
161611133|NCT04484623|583627238|FG000|Overall Study|Lost to Follow-up|0|||
161611134|NCT04484623|583627239|FG001|Overall Study|Lost to Follow-up|1|||
161611135|NCT04484623|583627238|FG000|Overall Study|Protocol Deviation|1|||
161611136|NCT04484623|583627239|FG001|Overall Study|Protocol Deviation|0|||
161611137|NCT04484623|583627238|FG000|Overall Study|Physician Decision|1|||
161611138|NCT04484623|583627239|FG001|Overall Study|Physician Decision|0|||
161611139|NCT04484623|583627238|FG000|Overall Study|Withdrawal by Subject|11|||
161611140|NCT04484623|583627239|FG001|Overall Study|Withdrawal by Subject|8|||
161611141|NCT04484623|583627238|FG000|Overall Study|Ongoing|94|||
161611142|NCT04484623|583627239|FG001|Overall Study|Ongoing|84|||
161611143|NCT05470114|583627240|FG000|Overall Study|Withdrawal by Subject|1|||
161611144|NCT05470114|583627241|FG001|Overall Study|Withdrawal by Subject|0|||
161611145|NCT05470114|583627240|FG000|Overall Study|Lost to Follow-up|1|||
161611146|NCT05470114|583627241|FG001|Overall Study|Lost to Follow-up|0|||
161611147|NCT04649047|583627246|FG000|Overall Study|Withdrawal by Subject|3|||
161611148|NCT05886777|583627247|FG000|Overall Study|Lost to Follow-up|1|||
161611149|NCT05886777|583627248|FG001|Overall Study|Lost to Follow-up|0|||
161611150|NCT05886777|583627249|FG002|Overall Study|Lost to Follow-up|2|||
161611151|NCT05886777|583627250|FG003|Overall Study|Lost to Follow-up|1|||
161611152|NCT05886777|583627251|FG004|Overall Study|Lost to Follow-up|0|||
161611153|NCT05886777|583627252|FG005|Overall Study|Lost to Follow-up|2|||
161611154|NCT05886777|583627253|FG006|Overall Study|Lost to Follow-up|0|||
161611155|NCT05886777|583627247|FG000|Overall Study|Other|0|||
161611156|NCT05886777|583627248|FG001|Overall Study|Other|2|||
161611157|NCT05886777|583627249|FG002|Overall Study|Other|1|||
161611158|NCT05886777|583627250|FG003|Overall Study|Other|0|||
161611159|NCT05886777|583627251|FG004|Overall Study|Other|0|||
161611160|NCT05886777|583627252|FG005|Overall Study|Other|0|||
161611161|NCT05886777|583627253|FG006|Overall Study|Other|0|||
161611162|NCT05886777|583627247|FG000|Overall Study|Withdrawal by Subject|1|||
161611163|NCT05886777|583627248|FG001|Overall Study|Withdrawal by Subject|0|||
161611164|NCT05886777|583627249|FG002|Overall Study|Withdrawal by Subject|1|||
161611165|NCT05886777|583627250|FG003|Overall Study|Withdrawal by Subject|4|||
161611166|NCT05886777|583627251|FG004|Overall Study|Withdrawal by Subject|3|||
161611167|NCT05886777|583627252|FG005|Overall Study|Withdrawal by Subject|1|||
161611168|NCT05886777|583627253|FG006|Overall Study|Withdrawal by Subject|1|||
161611169|NCT05886777|583627247|FG000|Overall Study|Protocol Violation|0|||
161611170|NCT05886777|583627248|FG001|Overall Study|Protocol Violation|0|||
161611171|NCT05886777|583627249|FG002|Overall Study|Protocol Violation|1|||
161611172|NCT05886777|583627250|FG003|Overall Study|Protocol Violation|0|||
161611173|NCT05886777|583627251|FG004|Overall Study|Protocol Violation|0|||
161611174|NCT05886777|583627252|FG005|Overall Study|Protocol Violation|0|||
161611175|NCT05886777|583627253|FG006|Overall Study|Protocol Violation|0|||
161611176|NCT05886777|583627247|FG000|Overall Study|No longer met eligibility criteria|0|||
161611177|NCT05886777|583627248|FG001|Overall Study|No longer met eligibility criteria|1|||
161611178|NCT05886777|583627249|FG002|Overall Study|No longer met eligibility criteria|0|||
161611179|NCT05886777|583627250|FG003|Overall Study|No longer met eligibility criteria|0|||
161611180|NCT05886777|583627251|FG004|Overall Study|No longer met eligibility criteria|0|||
161611181|NCT05886777|583627252|FG005|Overall Study|No longer met eligibility criteria|0|||
161611182|NCT05886777|583627253|FG006|Overall Study|No longer met eligibility criteria|0|||
161611183|NCT03773107|583627254|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
161611184|NCT03773107|583627255|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
161611185|NCT03773107|583627256|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
161832499|NCT00107042|584428403|FG001|Overall Study|Moved out of area|3|||
161832500|NCT00107042|584428402|FG000|Overall Study|Pregnancy|1|||
161832501|NCT00107042|584428403|FG001|Overall Study|Pregnancy|1|||
161832502|NCT00107042|584428402|FG000|Overall Study|Inadvertent enrollment|0|||
161832503|NCT00107042|584428403|FG001|Overall Study|Inadvertent enrollment|1|||
161832504|NCT00107042|584428402|FG000|Overall Study|vaccinated outside window|1|||
161832505|NCT00107042|584428403|FG001|Overall Study|vaccinated outside window|1|||
161832506|NCT00107042|584428402|FG000|Overall Study|Disallowed medications|0|||
161832507|NCT00107042|584428403|FG001|Overall Study|Disallowed medications|2|||
161832508|NCT00708708|584428404|FG000|Overall Study|Another therapy instead of Enbrel|141|||
161832509|NCT00708708|584428404|FG000|Overall Study|Lost to Follow-up|52|||
161832510|NCT00708708|584428404|FG000|Overall Study|Withdrawal by Subject|51|||
161832511|NCT00708708|584428404|FG000|Overall Study|Intolerance|42|||
161611186|NCT03773107|583627257|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
161611187|NCT07204444|583627259|FG000|Overall Study|Medical/Hospitalization|6|||
161611188|NCT07204444|583627260|FG001|Overall Study|Medical/Hospitalization|9|||
161611189|NCT07204444|583627261|FG002|Overall Study|Medical/Hospitalization|6|||
161611190|NCT07204444|583627259|FG000|Overall Study|Treatment Provider Issue|1|||
161611191|NCT07204444|583627260|FG001|Overall Study|Treatment Provider Issue|3|||
161611192|NCT07204444|583627261|FG002|Overall Study|Treatment Provider Issue|0|||
161611193|NCT07204444|583627259|FG000|Overall Study|Withdrawal by Subject|11|||
161611194|NCT07204444|583627260|FG001|Overall Study|Withdrawal by Subject|5|||
161611195|NCT07204444|583627261|FG002|Overall Study|Withdrawal by Subject|5|||
161611196|NCT07204444|583627259|FG000|Overall Study|Death|3|||
161611197|NCT07204444|583627260|FG001|Overall Study|Death|6|||
161611198|NCT07204444|583627261|FG002|Overall Study|Death|1|||
161611199|NCT07204444|583627259|FG000|Overall Study|Unable To Reach|29|||
161611200|NCT07204444|583627260|FG001|Overall Study|Unable To Reach|26|||
161611201|NCT07204444|583627261|FG002|Overall Study|Unable To Reach|17|||
161611202|NCT07204444|583627259|FG000|Overall Study|Protocol Deviation|3|||
161611203|NCT07204444|583627260|FG001|Overall Study|Protocol Deviation|2|||
161611204|NCT07204444|583627261|FG002|Overall Study|Protocol Deviation|0|||
161611205|NCT04172675|583628730|FG000|Overall Study|Withdrawal by Subject|7|||
161611206|NCT04172675|583628731|FG001|Overall Study|Withdrawal by Subject|5|||
161611207|NCT04172675|583628732|FG002|Overall Study|Withdrawal by Subject|1|||
161611208|NCT04172675|583628733|FG003|Overall Study|Withdrawal by Subject|4|||
161611209|NCT02972034|583628734|FG000|Overall Study|Death|11|||
161611210|NCT02972034|583628735|FG001|Overall Study|Death|1|||
161611211|NCT02972034|583628736|FG002|Overall Study|Death|3|||
161611212|NCT02972034|583628737|FG003|Overall Study|Death|3|||
161611213|NCT02972034|583628738|FG004|Overall Study|Death|2|||
161611214|NCT02972034|583628739|FG005|Overall Study|Death|2|||
161611215|NCT02972034|583628740|FG006|Overall Study|Death|3|||
161611216|NCT02972034|583628741|FG007|Overall Study|Death|4|||
161611217|NCT02972034|583628742|FG008|Overall Study|Death|8|||
161611218|NCT02972034|583628743|FG009|Overall Study|Death|11|||
161611219|NCT02972034|583628744|FG010|Overall Study|Death|3|||
161611220|NCT02972034|583628745|FG011|Overall Study|Death|2|||
161611221|NCT02972034|583628746|FG012|Overall Study|Death|11|||
161611222|NCT02972034|583628747|FG013|Overall Study|Death|10|||
161611223|NCT02972034|583628748|FG014|Overall Study|Death|9|||
161611224|NCT02972034|583628734|FG000|Overall Study|Lost to Follow-up|0|||
161611225|NCT02972034|583628735|FG001|Overall Study|Lost to Follow-up|0|||
161611226|NCT02972034|583628736|FG002|Overall Study|Lost to Follow-up|0|||
161611227|NCT02972034|583628737|FG003|Overall Study|Lost to Follow-up|0|||
161611228|NCT02972034|583628738|FG004|Overall Study|Lost to Follow-up|1|||
161611229|NCT02972034|583628739|FG005|Overall Study|Lost to Follow-up|0|||
161611230|NCT02972034|583628740|FG006|Overall Study|Lost to Follow-up|0|||
161611231|NCT02972034|583628741|FG007|Overall Study|Lost to Follow-up|1|||
161611232|NCT02972034|583628742|FG008|Overall Study|Lost to Follow-up|0|||
161611233|NCT02972034|583628743|FG009|Overall Study|Lost to Follow-up|0|||
161611234|NCT02972034|583628744|FG010|Overall Study|Lost to Follow-up|0|||
161611235|NCT02972034|583628745|FG011|Overall Study|Lost to Follow-up|0|||
161611236|NCT02972034|583628746|FG012|Overall Study|Lost to Follow-up|0|||
161611237|NCT02972034|583628747|FG013|Overall Study|Lost to Follow-up|0|||
161611238|NCT02972034|583628748|FG014|Overall Study|Lost to Follow-up|1|||
161611239|NCT02972034|583628734|FG000|Overall Study|Physician Decision|0|||
161611240|NCT02972034|583628735|FG001|Overall Study|Physician Decision|0|||
161611241|NCT02972034|583628736|FG002|Overall Study|Physician Decision|0|||
161611242|NCT02972034|583628737|FG003|Overall Study|Physician Decision|0|||
161611243|NCT02972034|583628738|FG004|Overall Study|Physician Decision|0|||
161611244|NCT02972034|583628739|FG005|Overall Study|Physician Decision|0|||
161611245|NCT02972034|583628740|FG006|Overall Study|Physician Decision|0|||
161611246|NCT02972034|583628741|FG007|Overall Study|Physician Decision|1|||
161611247|NCT02972034|583628742|FG008|Overall Study|Physician Decision|0|||
161611248|NCT02972034|583628743|FG009|Overall Study|Physician Decision|0|||
161611249|NCT02972034|583628744|FG010|Overall Study|Physician Decision|1|||
161611250|NCT02972034|583628745|FG011|Overall Study|Physician Decision|0|||
161611251|NCT02972034|583628746|FG012|Overall Study|Physician Decision|0|||
161611252|NCT02972034|583628747|FG013|Overall Study|Physician Decision|0|||
161611253|NCT02972034|583628748|FG014|Overall Study|Physician Decision|0|||
161611254|NCT02972034|583628734|FG000|Overall Study|Sponsor Decision|0|||
161611255|NCT02972034|583628735|FG001|Overall Study|Sponsor Decision|0|||
161611256|NCT02972034|583628736|FG002|Overall Study|Sponsor Decision|0|||
161611257|NCT02972034|583628737|FG003|Overall Study|Sponsor Decision|1|||
161611258|NCT02972034|583628738|FG004|Overall Study|Sponsor Decision|0|||
161611259|NCT02972034|583628739|FG005|Overall Study|Sponsor Decision|0|||
161611260|NCT02972034|583628740|FG006|Overall Study|Sponsor Decision|1|||
161611261|NCT02972034|583628741|FG007|Overall Study|Sponsor Decision|1|||
161611262|NCT02972034|583628742|FG008|Overall Study|Sponsor Decision|1|||
161611263|NCT02972034|583628743|FG009|Overall Study|Sponsor Decision|2|||
161611264|NCT02972034|583628744|FG010|Overall Study|Sponsor Decision|2|||
161611265|NCT02972034|583628745|FG011|Overall Study|Sponsor Decision|0|||
161611266|NCT02972034|583628746|FG012|Overall Study|Sponsor Decision|1|||
161611267|NCT02972034|583628747|FG013|Overall Study|Sponsor Decision|0|||
161611268|NCT02972034|583628748|FG014|Overall Study|Sponsor Decision|1|||
161611269|NCT02972034|583628734|FG000|Overall Study|Withdrawal by Subject|3|||
161611270|NCT02972034|583628735|FG001|Overall Study|Withdrawal by Subject|0|||
161611271|NCT02972034|583628736|FG002|Overall Study|Withdrawal by Subject|0|||
161611272|NCT02972034|583628737|FG003|Overall Study|Withdrawal by Subject|0|||
161611273|NCT02972034|583628738|FG004|Overall Study|Withdrawal by Subject|1|||
161611274|NCT02972034|583628739|FG005|Overall Study|Withdrawal by Subject|1|||
161611275|NCT02972034|583628740|FG006|Overall Study|Withdrawal by Subject|0|||
161611276|NCT02972034|583628741|FG007|Overall Study|Withdrawal by Subject|0|||
161611277|NCT02972034|583628742|FG008|Overall Study|Withdrawal by Subject|1|||
161611278|NCT02972034|583628743|FG009|Overall Study|Withdrawal by Subject|1|||
161611279|NCT02972034|583628744|FG010|Overall Study|Withdrawal by Subject|2|||
161611280|NCT02972034|583628745|FG011|Overall Study|Withdrawal by Subject|1|||
161611281|NCT02972034|583628746|FG012|Overall Study|Withdrawal by Subject|1|||
161684304|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
161684305|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
161684306|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
161684307|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
161684308|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
161684309|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
161684310|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684311|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684312|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684313|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684314|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684315|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684316|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684317|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684318|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684319|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
161684320|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
161684321|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
161684322|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684323|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684324|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684325|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684326|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684327|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684328|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684329|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684330|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684331|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684332|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
161684333|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
161684334|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684335|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684336|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684337|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684338|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684339|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684340|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684341|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684342|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684343|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684344|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684345|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
161684346|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684347|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684348|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161832512|NCT00708708|584428404|FG000|Overall Study|Another therapy along with Enbrel|15|||
161611282|NCT02972034|583628747|FG013|Overall Study|Withdrawal by Subject|1|||
161611283|NCT02972034|583628748|FG014|Overall Study|Withdrawal by Subject|0|||
161611284|NCT02972034|583628734|FG000|Overall Study|Screen Failure|0|||
161611285|NCT02972034|583628735|FG001|Overall Study|Screen Failure|0|||
161611286|NCT02972034|583628736|FG002|Overall Study|Screen Failure|0|||
161611287|NCT02972034|583628737|FG003|Overall Study|Screen Failure|0|||
161611288|NCT02972034|583628738|FG004|Overall Study|Screen Failure|0|||
161611289|NCT02972034|583628739|FG005|Overall Study|Screen Failure|0|||
161611290|NCT02972034|583628740|FG006|Overall Study|Screen Failure|0|||
161611291|NCT02972034|583628741|FG007|Overall Study|Screen Failure|0|||
161611292|NCT02972034|583628742|FG008|Overall Study|Screen Failure|0|||
161611293|NCT02972034|583628743|FG009|Overall Study|Screen Failure|0|||
161611294|NCT02972034|583628744|FG010|Overall Study|Screen Failure|0|||
161611295|NCT02972034|583628745|FG011|Overall Study|Screen Failure|0|||
161611296|NCT02972034|583628746|FG012|Overall Study|Screen Failure|1|||
161611297|NCT02972034|583628747|FG013|Overall Study|Screen Failure|0|||
161611298|NCT02972034|583628748|FG014|Overall Study|Screen Failure|0|||
161611299|NCT03861052|583628749|FG000|Overall Study|Adverse Event|1|||
161611300|NCT03861052|583628750|FG001|Overall Study|Adverse Event|1|||
161611301|NCT03861052|583628751|FG002|Overall Study|Adverse Event|2|||
161611302|NCT03861052|583628752|FG003|Overall Study|Adverse Event|4|||
161611303|NCT03861052|583628749|FG000|Overall Study|Lost to Follow-up|0|||
161611304|NCT03861052|583628750|FG001|Overall Study|Lost to Follow-up|0|||
161611305|NCT03861052|583628751|FG002|Overall Study|Lost to Follow-up|0|||
161611306|NCT03861052|583628752|FG003|Overall Study|Lost to Follow-up|1|||
161611307|NCT03861052|583628749|FG000|Overall Study|Physician Decision|0|||
161611308|NCT03861052|583628750|FG001|Overall Study|Physician Decision|1|||
161611309|NCT03861052|583628751|FG002|Overall Study|Physician Decision|0|||
161611310|NCT03861052|583628752|FG003|Overall Study|Physician Decision|0|||
161611311|NCT03861052|583628749|FG000|Overall Study|Withdrawal by Subject|2|||
161611312|NCT03861052|583628750|FG001|Overall Study|Withdrawal by Subject|5|||
161611313|NCT03861052|583628751|FG002|Overall Study|Withdrawal by Subject|3|||
161611314|NCT03861052|583628752|FG003|Overall Study|Withdrawal by Subject|0|||
161611315|NCT03861052|583628749|FG000|Overall Study|Relocation to other city|1|||
161611316|NCT03861052|583628750|FG001|Overall Study|Relocation to other city|0|||
161611317|NCT03861052|583628751|FG002|Overall Study|Relocation to other city|0|||
161611318|NCT03861052|583628752|FG003|Overall Study|Relocation to other city|0|||
161611319|NCT03009344|583628753|FG000|Overall Study|Lack of Efficacy|5|||
161611320|NCT03009344|583628753|FG000|Overall Study|Withdrawal by Subject|1|||
161611321|NCT03009344|583628753|FG000|Overall Study|Adverse Event|1|||
161611322|NCT03689946|583628755|FG000|Overall Study|Withdrawal by Subject|3|||
161611323|NCT03689946|583628755|FG000|Overall Study|Lost to Follow-up|3|||
161611324|NCT03689946|583628755|FG000|Overall Study|Data corruption|2|||
161611325|NCT01555138|583628756|FG000|Overall Study|Death|0|||
161611326|NCT01555138|583628757|FG001|Overall Study|Death|1|||
161611327|NCT01555138|583628756|FG000|Overall Study|Lost to Follow-up|1|||
161611328|NCT01555138|583628757|FG001|Overall Study|Lost to Follow-up|0|||
161611329|NCT01555138|583628756|FG000|Overall Study|Abnormal Lab reults|1|||
161611330|NCT01555138|583628757|FG001|Overall Study|Abnormal Lab reults|3|||
161611331|NCT01555138|583628756|FG000|Overall Study|Lack of Efficacy|2|||
161611332|NCT01555138|583628757|FG001|Overall Study|Lack of Efficacy|2|||
161611333|NCT01555138|583628756|FG000|Overall Study|Protocol Violation|5|||
161611334|NCT01555138|583628757|FG001|Overall Study|Protocol Violation|3|||
161611335|NCT01555138|583628756|FG000|Overall Study|Administrative problems|8|||
161611336|NCT01555138|583628757|FG001|Overall Study|Administrative problems|0|||
161611337|NCT01555138|583628756|FG000|Overall Study|Withdrawal by Subject|16|||
161611338|NCT01555138|583628757|FG001|Overall Study|Withdrawal by Subject|15|||
161611339|NCT01555138|583628756|FG000|Overall Study|Adverse Event|14|||
161611340|NCT01555138|583628757|FG001|Overall Study|Adverse Event|14|||
161611341|NCT00512252|583628761|FG000|Overall Study|Lost to Follow-up|0|||
161611342|NCT00512252|583628762|FG001|Overall Study|Lost to Follow-up|0|||
161611343|NCT00512252|583628763|FG002|Overall Study|Lost to Follow-up|1|||
161611344|NCT00512252|583628761|FG000|Overall Study|Protocol Violation|0|||
161611345|NCT00512252|583628762|FG001|Overall Study|Protocol Violation|0|||
161611346|NCT00512252|583628763|FG002|Overall Study|Protocol Violation|1|||
161611347|NCT00512252|583628761|FG000|Overall Study|Death|0|||
161611348|NCT00512252|583628762|FG001|Overall Study|Death|0|||
161611349|NCT00512252|583628763|FG002|Overall Study|Death|1|||
161611350|NCT02357966|583628764|FG000|Overall Study|Death|0|||
161611351|NCT02357966|583628765|FG001|Overall Study|Death|0|||
161611352|NCT02357966|583628766|FG002|Overall Study|Death|1|||
161611353|NCT02357966|583628767|FG003|Overall Study|Death|0|||
161611354|NCT02357966|583628768|FG004|Overall Study|Death|2|||
161611355|NCT02357966|583628769|FG005|Overall Study|Death|0|||
161611356|NCT02357966|583628764|FG000|Overall Study|Physician Decision|1|||
161611357|NCT02357966|583628765|FG001|Overall Study|Physician Decision|0|||
161611358|NCT02357966|583628766|FG002|Overall Study|Physician Decision|0|||
161611359|NCT02357966|583628767|FG003|Overall Study|Physician Decision|0|||
161611360|NCT02357966|583628768|FG004|Overall Study|Physician Decision|1|||
161611361|NCT02357966|583628769|FG005|Overall Study|Physician Decision|0|||
161611362|NCT04608409|583628773|FG000|Overall Study|Physician Decision|1|||
161611363|NCT04608409|583628774|FG001|Overall Study|Physician Decision|1|||
161611364|NCT04608409|583628775|FG002|Overall Study|Physician Decision|2|||
161611365|NCT00454194|583628776|FG000|Overall Study|Adverse Event|7|||
161611366|NCT00454194|583628777|FG001|Overall Study|Adverse Event|2|||
161611367|NCT00454194|583628776|FG000|Overall Study|Withdrawal by Subject|12|||
161611368|NCT00454194|583628777|FG001|Overall Study|Withdrawal by Subject|8|||
161611369|NCT00454194|583628776|FG000|Overall Study|Other Medical Problems|1|||
161611370|NCT00454194|583628777|FG001|Overall Study|Other Medical Problems|2|||
161611371|NCT00454194|583628776|FG000|Overall Study|Other Unspecified Reason|2|||
161611372|NCT00454194|583628777|FG001|Overall Study|Other Unspecified Reason|2|||
161611373|NCT00229658|583628791|FG000|Overall Study|Administrative|2|||
161611374|NCT00229658|583628792|FG001|Overall Study|Administrative|1|||
161611375|NCT00229658|583628791|FG000|Overall Study|Investigator decision|13|||
161611376|NCT00229658|583628792|FG001|Overall Study|Investigator decision|10|||
161611377|NCT00229658|583628791|FG000|Overall Study|Other|80|||
161611378|NCT00229658|583628792|FG001|Overall Study|Other|60|||
161611379|NCT00229658|583628791|FG000|Overall Study|Lost to Follow-up|82|||
161611380|NCT00229658|583628792|FG001|Overall Study|Lost to Follow-up|55|||
161611381|NCT00229658|583628791|FG000|Overall Study|Serious Adverse Event|2|||
161611382|NCT00229658|583628792|FG001|Overall Study|Serious Adverse Event|2|||
161611383|NCT00229658|583628791|FG000|Overall Study|Withdrawal of consent|46|||
161611384|NCT00229658|583628792|FG001|Overall Study|Withdrawal of consent|39|||
161611385|NCT02157116|583628793|FG000|Overall Study|Withdrawal by Subject|4|||
161611386|NCT02157116|583628793|FG000|Overall Study|Physician Decision|3|||
161611387|NCT02157116|583628793|FG000|Overall Study|Failed Screening|2|||
161611388|NCT01953224|583628794|FG000|Overall Study|Lost to Follow-up|1|||
161611389|NCT01953224|583628795|FG001|Overall Study|Lost to Follow-up|1|||
161611390|NCT01953224|583628794|FG000|Overall Study|Withdrawal by Subject|1|||
161611391|NCT01953224|583628795|FG001|Overall Study|Withdrawal by Subject|2|||
161611392|NCT00463229|583628796|FG000|Overall Study|Lost to Follow-up|5|||
161611393|NCT00463229|583628797|FG001|Overall Study|Lost to Follow-up|7|||
161611394|NCT00463229|583628796|FG000|Overall Study|Death|4|||
161611395|NCT00463229|583628797|FG001|Overall Study|Death|3|||
161611396|NCT01359150|583628798|FG000|Overall Study|Lack of Efficacy|1|||
161611397|NCT01359150|583628799|FG001|Overall Study|Lack of Efficacy|1|||
161832513|NCT00708708|584428404|FG000|Overall Study|Other unspecified|11|||
161832514|NCT00708708|584428404|FG000|Overall Study|Good effectiveness|9|||
161832515|NCT00708708|584428404|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
161832516|NCT00708708|584428404|FG000|Overall Study|Administrative reasons|7|||
161832517|NCT00708708|584428404|FG000|Overall Study|Lack of effectiveness|4|||
161832518|NCT00708708|584428404|FG000|Overall Study|Lack of compliance|3|||
161832519|NCT00708708|584428404|FG000|Overall Study|Pregnancy|3|||
161611398|NCT01359150|583628798|FG000|Overall Study|Withdrawal by Subject|1|||
161611399|NCT01359150|583628799|FG001|Overall Study|Withdrawal by Subject|1|||
161611400|NCT01359150|583628798|FG000|Overall Study|Adverse Event|4|||
161611401|NCT01359150|583628799|FG001|Overall Study|Adverse Event|3|||
161611402|NCT01359150|583628798|FG000|Overall Study|Other|1|||
161611403|NCT01359150|583628799|FG001|Overall Study|Other|0|||
161611404|NCT01700205|583628800|FG000|Overall Study|Withdrawal by Subject|13|||
161611405|NCT01700205|583628801|FG001|Overall Study|Withdrawal by Subject|13|||
161611406|NCT01700205|583628800|FG000|Overall Study|Protocol Violation|2|||
161611407|NCT01700205|583628801|FG001|Overall Study|Protocol Violation|2|||
161611408|NCT01728324|583628802|FG000|Termination of DBV|Adverse Event|14|||
161611409|NCT01728324|583628803|FG001|Termination of DBV|Adverse Event|13|||
161611410|NCT01728324|583628804|FG002|Termination of DBV|Adverse Event|4|||
161611411|NCT01728324|583628802|FG000|Termination of DBV|Lack of Efficacy|14|||
161611412|NCT01728324|583628803|FG001|Termination of DBV|Lack of Efficacy|12|||
161611413|NCT01728324|583628804|FG002|Termination of DBV|Lack of Efficacy|8|||
161611414|NCT01728324|583628802|FG000|Termination of DBV|Withdrawal by Subject|9|||
161611415|NCT01728324|583628803|FG001|Termination of DBV|Withdrawal by Subject|6|||
161611416|NCT01728324|583628804|FG002|Termination of DBV|Withdrawal by Subject|2|||
161611417|NCT01728324|583628802|FG000|Termination of DBV|Other than stated|1|||
161611418|NCT01728324|583628803|FG001|Termination of DBV|Other than stated|3|||
161611419|NCT01728324|583628804|FG002|Termination of DBV|Other than stated|0|||
161832520|NCT00708708|584428404|FG000|Overall Study|Adverse Event|3|||
161832521|NCT00708708|584428404|FG000|Overall Study|Missing values|392|||
161611420|NCT01728324|583628802|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
161611421|NCT01728324|583628803|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
161611422|NCT01728324|583628804|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
161611423|NCT01728324|583628802|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
161611424|NCT01728324|583628803|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
161684349|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684350|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684351|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
161684352|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
161611425|NCT01728324|583628804|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
161611426|NCT01728324|583628802|FG000|Termination of FDV|Adverse Event|14|||
161611427|NCT01728324|583628803|FG001|Termination of FDV|Adverse Event|13|||
161611428|NCT01728324|583628804|FG002|Termination of FDV|Adverse Event|4|||
161611429|NCT01728324|583628802|FG000|Termination of FDV|Lack of Efficacy|14|||
161611430|NCT01728324|583628803|FG001|Termination of FDV|Lack of Efficacy|12|||
161611431|NCT01728324|583628804|FG002|Termination of FDV|Lack of Efficacy|8|||
161611432|NCT01728324|583628802|FG000|Termination of FDV|Withdrawal by Subject|9|||
161611433|NCT01728324|583628803|FG001|Termination of FDV|Withdrawal by Subject|6|||
161611434|NCT01728324|583628804|FG002|Termination of FDV|Withdrawal by Subject|2|||
161611435|NCT01728324|583628802|FG000|Termination of FDV|Other than stated|1|||
161611436|NCT01728324|583628803|FG001|Termination of FDV|Other than stated|3|||
161611437|NCT01728324|583628804|FG002|Termination of FDV|Other than stated|0|||
161611438|NCT01728324|583628802|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
161611439|NCT01728324|583628803|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
161611440|NCT01728324|583628804|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
161611441|NCT01728324|583628802|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
161611442|NCT01728324|583628803|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
161611443|NCT01728324|583628804|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
161611444|NCT01728324|583628802|FG000|Termination of RBV|Adverse Event|15|||
161611445|NCT01728324|583628803|FG001|Termination of RBV|Adverse Event|16|||
161611446|NCT01728324|583628804|FG002|Termination of RBV|Adverse Event|5|||
161611447|NCT01728324|583628802|FG000|Termination of RBV|Lack of Efficacy|14|||
161611448|NCT01728324|583628803|FG001|Termination of RBV|Lack of Efficacy|11|||
161611449|NCT01728324|583628804|FG002|Termination of RBV|Lack of Efficacy|7|||
161611450|NCT01728324|583628802|FG000|Termination of RBV|Withdrawal by Subject|9|||
161611451|NCT01728324|583628803|FG001|Termination of RBV|Withdrawal by Subject|5|||
161611452|NCT01728324|583628804|FG002|Termination of RBV|Withdrawal by Subject|2|||
161611453|NCT01728324|583628802|FG000|Termination of RBV|Other than stated|1|||
161611454|NCT01728324|583628803|FG001|Termination of RBV|Other than stated|3|||
161611455|NCT01728324|583628804|FG002|Termination of RBV|Other than stated|1|||
161611456|NCT01728324|583628802|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
161611457|NCT01728324|583628803|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
161611458|NCT01728324|583628804|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
161611459|NCT01728324|583628802|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
161611460|NCT01728324|583628803|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
161611461|NCT01728324|583628804|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
161611462|NCT00641537|583628809|FG000|96-week Period|Adverse Event|0|||
161611463|NCT00641537|583628810|FG001|96-week Period|Adverse Event|1|||
161611464|NCT00641537|583628811|FG002|96-week Period|Adverse Event|3|||
161611465|NCT00641537|583628812|FG003|96-week Period|Adverse Event|0|||
161611466|NCT00641537|583628813|FG004|96-week Period|Adverse Event|2|||
161611467|NCT00641537|583628814|FG005|96-week Period|Adverse Event|0|||
161611468|NCT00641537|583628815|FG006|96-week Period|Adverse Event|0|||
161611469|NCT00641537|583628816|FG007|96-week Period|Adverse Event|0|||
161611470|NCT00641537|583628809|FG000|96-week Period|Lost to Follow-up|3|||
161611471|NCT00641537|583628810|FG001|96-week Period|Lost to Follow-up|1|||
161611472|NCT00641537|583628811|FG002|96-week Period|Lost to Follow-up|2|||
161611473|NCT00641537|583628812|FG003|96-week Period|Lost to Follow-up|2|||
161684353|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
161684354|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
161684355|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
161684356|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
161684357|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
161832522|NCT00140413|584428405|FG000|Overall Study|Lost to Follow-up|1|||
161684358|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684359|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684360|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161611474|NCT00641537|583628813|FG004|96-week Period|Lost to Follow-up|4|||
161611475|NCT00641537|583628814|FG005|96-week Period|Lost to Follow-up|0|||
161611476|NCT00641537|583628815|FG006|96-week Period|Lost to Follow-up|1|||
161611477|NCT00641537|583628816|FG007|96-week Period|Lost to Follow-up|0|||
161611478|NCT00641537|583628809|FG000|96-week Period|Protocol Violation|0|||
161611479|NCT00641537|583628810|FG001|96-week Period|Protocol Violation|1|||
161832523|NCT00140413|584428406|FG001|Overall Study|Lost to Follow-up|0|||
161611480|NCT00641537|583628811|FG002|96-week Period|Protocol Violation|0|||
161611481|NCT00641537|583628812|FG003|96-week Period|Protocol Violation|1|||
161611482|NCT00641537|583628813|FG004|96-week Period|Protocol Violation|0|||
161611483|NCT00641537|583628814|FG005|96-week Period|Protocol Violation|1|||
161611484|NCT00641537|583628815|FG006|96-week Period|Protocol Violation|0|||
161611485|NCT00641537|583628816|FG007|96-week Period|Protocol Violation|0|||
161611486|NCT00641537|583628809|FG000|96-week Period|Death|2|||
161611487|NCT00641537|583628810|FG001|96-week Period|Death|0|||
161611488|NCT00641537|583628811|FG002|96-week Period|Death|1|||
161611489|NCT00641537|583628812|FG003|96-week Period|Death|0|||
161611490|NCT00641537|583628813|FG004|96-week Period|Death|0|||
161611491|NCT00641537|583628814|FG005|96-week Period|Death|0|||
161611492|NCT00641537|583628815|FG006|96-week Period|Death|0|||
161611493|NCT00641537|583628816|FG007|96-week Period|Death|0|||
161611494|NCT00641537|583628809|FG000|96-week Period|Other|4|||
161611495|NCT00641537|583628810|FG001|96-week Period|Other|7|||
161611496|NCT00641537|583628811|FG002|96-week Period|Other|14|||
161611497|NCT00641537|583628812|FG003|96-week Period|Other|9|||
161611498|NCT00641537|583628813|FG004|96-week Period|Other|11|||
161611499|NCT00641537|583628814|FG005|96-week Period|Other|6|||
161611500|NCT00641537|583628815|FG006|96-week Period|Other|4|||
161611501|NCT00641537|583628816|FG007|96-week Period|Other|6|||
161611502|NCT00641537|583628809|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
161611503|NCT00641537|583628810|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
161611504|NCT00641537|583628811|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
161611505|NCT00641537|583628812|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
161611506|NCT00641537|583628813|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
161611507|NCT00641537|583628814|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
161611508|NCT00641537|583628815|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
161611509|NCT00641537|583628816|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
161611510|NCT00641537|583628809|FG000|24-Week Supplemental Follow-up Period|Other|0|||
161611511|NCT00641537|583628810|FG001|24-Week Supplemental Follow-up Period|Other|2|||
161611512|NCT00641537|583628811|FG002|24-Week Supplemental Follow-up Period|Other|2|||
161611513|NCT00641537|583628812|FG003|24-Week Supplemental Follow-up Period|Other|1|||
161611514|NCT00641537|583628813|FG004|24-Week Supplemental Follow-up Period|Other|3|||
161611515|NCT00641537|583628814|FG005|24-Week Supplemental Follow-up Period|Other|0|||
161611516|NCT00641537|583628815|FG006|24-Week Supplemental Follow-up Period|Other|1|||
161611517|NCT00641537|583628816|FG007|24-Week Supplemental Follow-up Period|Other|1|||
161611518|NCT01706159|583628817|FG000|Overall Study|Withdrawal Criteria|2|||
161611519|NCT01706159|583628818|FG001|Overall Study|Withdrawal Criteria|1|||
161611520|NCT01706159|583628817|FG000|Overall Study|Unclassified|6|||
161611521|NCT01706159|583628818|FG001|Overall Study|Unclassified|1|||
161611522|NCT02235298|583628819|FG000|Overall Study|Lost to Follow-up|6|||
161611523|NCT02235298|583628820|FG001|Overall Study|Lost to Follow-up|5|||
161611524|NCT02235298|583628819|FG000|Overall Study|Adverse Event|2|||
161611525|NCT02235298|583628820|FG001|Overall Study|Adverse Event|2|||
161611526|NCT02235298|583628819|FG000|Overall Study|Withdrawal by Subject|0|||
161611527|NCT02235298|583628820|FG001|Overall Study|Withdrawal by Subject|1|||
161611528|NCT03371017|583628822|FG000|Overall Study|Physician Decision|0|||
161611529|NCT03371017|583628823|FG001|Overall Study|Physician Decision|1|||
161611530|NCT03371017|583628822|FG000|Overall Study|Reason not Specified|0|||
161611531|NCT03371017|583628823|FG001|Overall Study|Reason not Specified|1|||
161611532|NCT03371017|583628822|FG000|Overall Study|Lost to Follow-up|13|||
161611533|NCT03371017|583628823|FG001|Overall Study|Lost to Follow-up|16|||
161611534|NCT03371017|583628822|FG000|Overall Study|Death|228|||
161611535|NCT03371017|583628823|FG001|Overall Study|Death|215|||
161611536|NCT03371017|583628822|FG000|Overall Study|Withdrawal by Subject|20|||
161611537|NCT03371017|583628823|FG001|Overall Study|Withdrawal by Subject|25|||
161611538|NCT03371017|583628822|FG000|Overall Study|Study Ended by Sponsor|37|||
161611539|NCT03371017|583628823|FG001|Overall Study|Study Ended by Sponsor|38|||
161611540|NCT03371017|583628822|FG000|Overall Study|Protocol Deviation|0|||
161611541|NCT03371017|583628823|FG001|Overall Study|Protocol Deviation|1|||
161611542|NCT04300023|583628824|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
161611543|NCT04300023|583628825|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
161611544|NCT04057131|583628826|FG000|Overall Study|Protocol Violation|24|||
161611545|NCT02830204|583628827|FG000|Overall Study|Death|9|||
161611546|NCT02830204|583628827|FG000|Overall Study|Withdrawal by Subject|1|||
161611547|NCT04686266|583628830|FG000|Overall Study|Withdrawal by Subject|0|||
161611548|NCT04686266|583628831|FG001|Overall Study|Withdrawal by Subject|1|||
161611549|NCT02401815|583628836|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611550|NCT02401815|583628837|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611551|NCT02401815|583628838|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611552|NCT02401815|583628839|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
161611553|NCT02401815|583628840|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611554|NCT02401815|583628841|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611555|NCT02401815|583628842|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611556|NCT02401815|583628843|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611557|NCT02401815|583628844|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611558|NCT02401815|583628845|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161611559|NCT02401815|583628836|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
161611560|NCT02401815|583628837|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611561|NCT02401815|583628838|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611562|NCT02401815|583628839|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
161611563|NCT02401815|583628840|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611564|NCT02401815|583628841|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611565|NCT02401815|583628842|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611566|NCT02401815|583628843|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611567|NCT02401815|583628844|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611568|NCT02401815|583628845|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161611569|NCT02401815|583628836|FG000|Dose Escalation (up to 670 Days)|Death|1|||
161611570|NCT02401815|583628837|FG001|Dose Escalation (up to 670 Days)|Death|2|||
161611571|NCT02401815|583628838|FG002|Dose Escalation (up to 670 Days)|Death|3|||
161611572|NCT02401815|583628839|FG003|Dose Escalation (up to 670 Days)|Death|5|||
161611573|NCT02401815|583628840|FG004|Dose Escalation (up to 670 Days)|Death|4|||
161611574|NCT02401815|583628841|FG005|Dose Escalation (up to 670 Days)|Death|0|||
161611575|NCT02401815|583628842|FG006|Dose Escalation (up to 670 Days)|Death|0|||
161611576|NCT02401815|583628843|FG007|Dose Escalation (up to 670 Days)|Death|0|||
161611577|NCT02401815|583628844|FG008|Dose Escalation (up to 670 Days)|Death|0|||
161611578|NCT02401815|583628845|FG009|Dose Escalation (up to 670 Days)|Death|0|||
161611579|NCT02401815|583628836|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611580|NCT02401815|583628837|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
161611581|NCT02401815|583628838|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611582|NCT02401815|583628839|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611583|NCT02401815|583628840|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
161611584|NCT02401815|583628841|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611585|NCT02401815|583628842|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611586|NCT02401815|583628843|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611587|NCT02401815|583628844|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611588|NCT02401815|583628845|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161611589|NCT02401815|583628836|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
161611590|NCT02401815|583628837|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611591|NCT02401815|583628838|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611592|NCT02401815|583628839|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611593|NCT02401815|583628840|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
161611594|NCT02401815|583628841|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611595|NCT02401815|583628842|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611596|NCT02401815|583628843|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611597|NCT02401815|583628844|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611598|NCT02401815|583628845|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161611599|NCT02401815|583628836|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611600|NCT02401815|583628837|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611601|NCT02401815|583628838|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611602|NCT02401815|583628839|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611603|NCT02401815|583628840|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611604|NCT02401815|583628841|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
161611605|NCT02401815|583628842|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611606|NCT02401815|583628843|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611607|NCT02401815|583628844|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611608|NCT02401815|583628845|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161611609|NCT02401815|583628836|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611610|NCT02401815|583628837|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611611|NCT02401815|583628838|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611612|NCT02401815|583628839|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611613|NCT02401815|583628840|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611614|NCT02401815|583628841|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611615|NCT02401815|583628842|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
161611616|NCT02401815|583628843|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611617|NCT02401815|583628844|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611618|NCT02401815|583628845|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611619|NCT02401815|583628836|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611620|NCT02401815|583628837|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611621|NCT02401815|583628838|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611622|NCT02401815|583628839|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611623|NCT02401815|583628840|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611624|NCT02401815|583628841|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
161611625|NCT02401815|583628842|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
161611626|NCT02401815|583628843|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611627|NCT02401815|583628844|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611628|NCT02401815|583628845|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161611629|NCT02401815|583628836|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611630|NCT02401815|583628837|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611631|NCT02401815|583628838|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611632|NCT02401815|583628839|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611633|NCT02401815|583628840|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611634|NCT02401815|583628841|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
161611635|NCT02401815|583628842|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611636|NCT02401815|583628843|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611637|NCT02401815|583628844|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611638|NCT02401815|583628845|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161611639|NCT02401815|583628836|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611640|NCT02401815|583628837|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611641|NCT02401815|583628838|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611642|NCT02401815|583628839|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611643|NCT02401815|583628840|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611644|NCT02401815|583628841|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611645|NCT02401815|583628842|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161611646|NCT02401815|583628843|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
161611647|NCT02401815|583628844|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
161611648|NCT02401815|583628845|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
161611649|NCT02401815|583628836|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611650|NCT02401815|583628837|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611651|NCT02401815|583628838|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611652|NCT02401815|583628839|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611653|NCT02401815|583628840|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611654|NCT02401815|583628841|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611655|NCT02401815|583628842|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611656|NCT02401815|583628843|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161611657|NCT02401815|583628844|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
161611658|NCT02401815|583628845|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
161611659|NCT02401815|583628836|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611660|NCT02401815|583628837|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611661|NCT02401815|583628838|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611662|NCT02401815|583628839|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611663|NCT02401815|583628840|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611664|NCT02401815|583628841|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611665|NCT02401815|583628842|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611666|NCT02401815|583628843|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611667|NCT02401815|583628844|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161611668|NCT02401815|583628845|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
161611669|NCT02401815|583628836|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611670|NCT02401815|583628837|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611671|NCT02401815|583628838|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611672|NCT02401815|583628839|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611673|NCT02401815|583628840|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611674|NCT02401815|583628841|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611675|NCT02401815|583628842|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611676|NCT02401815|583628843|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161611677|NCT02401815|583628844|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
161611678|NCT02401815|583628845|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161832524|NCT00140413|584428405|FG000|Overall Study|Withdrawal by Subject|2|||
161832525|NCT00140413|584428406|FG001|Overall Study|Withdrawal by Subject|0|||
161832526|NCT02459665|584428407|FG000|Overall Study|Withdrawal by Subject|0|||
161832527|NCT02459665|584428408|FG001|Overall Study|Withdrawal by Subject|1|||
161611679|NCT02401815|583628836|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611680|NCT02401815|583628837|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611681|NCT02401815|583628838|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611682|NCT02401815|583628839|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611683|NCT02401815|583628840|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611684|NCT02401815|583628841|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611685|NCT02401815|583628842|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611686|NCT02401815|583628843|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
161611687|NCT02401815|583628844|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161611688|NCT02401815|583628845|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
161611689|NCT05613907|583628846|FG000|Overall Study|Lost to Follow-up|5|||
161611690|NCT05613907|583628846|FG000|Overall Study|Death|3|||
161611691|NCT05613907|583628846|FG000|Overall Study|Withdrawal by Subject|2|||
161611692|NCT00748709|583628856|FG000|Overall Study|Progressive disease|15|||
161611693|NCT00748709|583628856|FG000|Overall Study|Drug reducing Toxity|2|||
161611694|NCT00748709|583628856|FG000|Overall Study|Other Adverse Event|1|||
161611695|NCT00748709|583628856|FG000|Overall Study|Withdrawal by Subject|1|||
161611696|NCT00748709|583628856|FG000|Overall Study|Other Reasons|1|||
161611697|NCT03789656|583628857|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
161611698|NCT03789656|583628858|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
161611699|NCT03789656|583628859|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
161611700|NCT03789656|583628860|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
161611701|NCT03789656|583628861|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
161611702|NCT03789656|583628857|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161611703|NCT03789656|583628858|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161611704|NCT03789656|583628859|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
161611705|NCT03789656|583628860|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161611706|NCT03789656|583628861|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161611707|NCT03789656|583628857|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
161611708|NCT03789656|583628858|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161611709|NCT03789656|583628859|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161611710|NCT03789656|583628860|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161611711|NCT03789656|583628861|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161611712|NCT03789656|583628857|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
161611713|NCT03789656|583628858|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161611714|NCT03789656|583628859|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161611715|NCT03789656|583628860|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161611716|NCT03789656|583628861|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161611717|NCT05325294|583628866|FG000|Overall Study|Adverse Event|3|||
161611718|NCT05325294|583628867|FG001|Overall Study|Adverse Event|3|||
161611719|NCT05325294|583628866|FG000|Overall Study|Physician Decision|0|||
161611720|NCT05325294|583628867|FG001|Overall Study|Physician Decision|1|||
161611721|NCT05325294|583628866|FG000|Overall Study|Withdrawal by Subject|0|||
161611722|NCT05325294|583628867|FG001|Overall Study|Withdrawal by Subject|3|||
161611723|NCT05325294|583628866|FG000|Overall Study|Lost to Follow-up|1|||
161611724|NCT05325294|583628867|FG001|Overall Study|Lost to Follow-up|0|||
161611725|NCT05325294|583628866|FG000|Overall Study|Sponsor Request|0|||
161611726|NCT05325294|583628867|FG001|Overall Study|Sponsor Request|2|||
161611727|NCT02488408|583628868|FG000|Part A|Adverse Event|2|||
161611728|NCT02488408|583628869|FG001|Part A|Adverse Event|0|||
161611729|NCT02488408|583628870|FG002|Part A|Adverse Event|0|||
161611730|NCT02488408|583628871|FG003|Part A|Adverse Event|0|||
161611731|NCT02488408|583628872|FG004|Part A|Adverse Event|0|||
161832528|NCT02459665|584428409|FG002|Overall Study|Withdrawal by Subject|1|||
161611732|NCT02488408|583628873|FG005|Part A|Adverse Event|0|||
161611733|NCT02488408|583628874|FG006|Part A|Adverse Event|0|||
161611734|NCT02488408|583628875|FG007|Part A|Adverse Event|0|||
161611735|NCT02488408|583628876|FG008|Part A|Adverse Event|0|||
161611736|NCT02488408|583628877|FG009|Part A|Adverse Event|0|||
161611737|NCT02488408|583628868|FG000|Part A|Death|1|||
161611738|NCT02488408|583628869|FG001|Part A|Death|5|||
161611739|NCT02488408|583628870|FG002|Part A|Death|0|||
161611740|NCT02488408|583628871|FG003|Part A|Death|0|||
161611741|NCT02488408|583628872|FG004|Part A|Death|3|||
161611742|NCT02488408|583628873|FG005|Part A|Death|0|||
161611743|NCT02488408|583628874|FG006|Part A|Death|0|||
161832529|NCT02459665|584428410|FG003|Overall Study|Withdrawal by Subject|2|||
161611744|NCT02488408|583628875|FG007|Part A|Death|0|||
161611745|NCT02488408|583628876|FG008|Part A|Death|0|||
161611746|NCT02488408|583628877|FG009|Part A|Death|0|||
161611747|NCT02488408|583628868|FG000|Part A|Disease Progression|2|||
161611748|NCT02488408|583628869|FG001|Part A|Disease Progression|8|||
161611749|NCT02488408|583628870|FG002|Part A|Disease Progression|2|||
161611750|NCT02488408|583628871|FG003|Part A|Disease Progression|3|||
161611751|NCT02488408|583628872|FG004|Part A|Disease Progression|4|||
161611752|NCT02488408|583628873|FG005|Part A|Disease Progression|0|||
161611753|NCT02488408|583628874|FG006|Part A|Disease Progression|0|||
161611754|NCT02488408|583628875|FG007|Part A|Disease Progression|0|||
161611755|NCT02488408|583628876|FG008|Part A|Disease Progression|0|||
161611756|NCT02488408|583628877|FG009|Part A|Disease Progression|0|||
161611757|NCT02488408|583628868|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
161611758|NCT02488408|583628869|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
161611759|NCT02488408|583628870|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
161611760|NCT02488408|583628871|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
161611761|NCT02488408|583628872|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
161611762|NCT02488408|583628873|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
161611763|NCT02488408|583628874|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
161611764|NCT02488408|583628875|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
161611765|NCT02488408|583628876|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
161611766|NCT02488408|583628877|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
161611767|NCT02488408|583628868|FG000|Part A|Investigator Decision|0|||
161611768|NCT02488408|583628869|FG001|Part A|Investigator Decision|1|||
161611769|NCT02488408|583628870|FG002|Part A|Investigator Decision|1|||
161611770|NCT02488408|583628871|FG003|Part A|Investigator Decision|0|||
161611771|NCT02488408|583628872|FG004|Part A|Investigator Decision|0|||
161611772|NCT02488408|583628873|FG005|Part A|Investigator Decision|0|||
161611773|NCT02488408|583628874|FG006|Part A|Investigator Decision|0|||
161611774|NCT02488408|583628875|FG007|Part A|Investigator Decision|0|||
161611775|NCT02488408|583628876|FG008|Part A|Investigator Decision|0|||
161611776|NCT02488408|583628877|FG009|Part A|Investigator Decision|0|||
161611777|NCT02488408|583628868|FG000|Part A|Withdrawal by Subject|0|||
161611778|NCT02488408|583628869|FG001|Part A|Withdrawal by Subject|0|||
161611779|NCT02488408|583628870|FG002|Part A|Withdrawal by Subject|2|||
161611780|NCT02488408|583628871|FG003|Part A|Withdrawal by Subject|0|||
161611781|NCT02488408|583628872|FG004|Part A|Withdrawal by Subject|0|||
161611782|NCT02488408|583628873|FG005|Part A|Withdrawal by Subject|0|||
161611783|NCT02488408|583628874|FG006|Part A|Withdrawal by Subject|0|||
161611784|NCT02488408|583628875|FG007|Part A|Withdrawal by Subject|0|||
161611785|NCT02488408|583628876|FG008|Part A|Withdrawal by Subject|0|||
161611786|NCT02488408|583628877|FG009|Part A|Withdrawal by Subject|0|||
161611787|NCT02488408|583628868|FG000|Part A|Other|1|||
161611788|NCT02488408|583628869|FG001|Part A|Other|0|||
161611789|NCT02488408|583628870|FG002|Part A|Other|0|||
161611790|NCT02488408|583628871|FG003|Part A|Other|0|||
161611791|NCT02488408|583628872|FG004|Part A|Other|0|||
161611792|NCT02488408|583628873|FG005|Part A|Other|0|||
161611793|NCT02488408|583628874|FG006|Part A|Other|0|||
161611794|NCT02488408|583628875|FG007|Part A|Other|0|||
161611795|NCT02488408|583628876|FG008|Part A|Other|0|||
161611796|NCT02488408|583628877|FG009|Part A|Other|0|||
161611797|NCT02488408|583628868|FG000|Part B|Adverse Event|0|||
161611798|NCT02488408|583628869|FG001|Part B|Adverse Event|0|||
161832530|NCT00865098|584428414|FG000|Overall Study|Progressive disease|1|||
161832531|NCT01117337|584428431|FG000|Overall Study|Lost to Follow-up|4|||
161832532|NCT01117337|584428432|FG001|Overall Study|Lost to Follow-up|0|||
161832533|NCT05444556|584428433|FG000|Overall Study|Withdrawal by Subject|0|||
161832534|NCT05444556|584428434|FG001|Overall Study|Withdrawal by Subject|0|||
161832535|NCT05444556|584428435|FG002|Overall Study|Withdrawal by Subject|2|||
161832536|NCT05444556|584428436|FG003|Overall Study|Withdrawal by Subject|1|||
161832537|NCT02791893|584428438|FG000|Blinded Phase|Lost to Follow-up|2|||
161611799|NCT02488408|583628870|FG002|Part B|Adverse Event|0|||
161611800|NCT02488408|583628871|FG003|Part B|Adverse Event|0|||
161611801|NCT02488408|583628872|FG004|Part B|Adverse Event|0|||
161611802|NCT02488408|583628873|FG005|Part B|Adverse Event|2|||
161611803|NCT02488408|583628874|FG006|Part B|Adverse Event|2|||
161611804|NCT02488408|583628875|FG007|Part B|Adverse Event|7|||
161832538|NCT02791893|584428439|FG001|Blinded Phase|Lost to Follow-up|2|||
161611805|NCT02488408|583628876|FG008|Part B|Adverse Event|2|||
161611806|NCT02488408|583628877|FG009|Part B|Adverse Event|2|||
161611807|NCT02488408|583628868|FG000|Part B|Death|0|||
161611808|NCT02488408|583628869|FG001|Part B|Death|0|||
161611809|NCT02488408|583628870|FG002|Part B|Death|0|||
161611810|NCT02488408|583628871|FG003|Part B|Death|0|||
161611811|NCT02488408|583628872|FG004|Part B|Death|0|||
161611812|NCT02488408|583628873|FG005|Part B|Death|3|||
161611813|NCT02488408|583628874|FG006|Part B|Death|1|||
161611814|NCT02488408|583628875|FG007|Part B|Death|2|||
161611815|NCT02488408|583628876|FG008|Part B|Death|2|||
161611816|NCT02488408|583628877|FG009|Part B|Death|2|||
161611817|NCT02488408|583628868|FG000|Part B|Death due to Disease Progression|0|||
161611818|NCT02488408|583628869|FG001|Part B|Death due to Disease Progression|0|||
161611819|NCT02488408|583628870|FG002|Part B|Death due to Disease Progression|0|||
161611820|NCT02488408|583628871|FG003|Part B|Death due to Disease Progression|0|||
161611821|NCT02488408|583628872|FG004|Part B|Death due to Disease Progression|0|||
161611822|NCT02488408|583628873|FG005|Part B|Death due to Disease Progression|2|||
161611823|NCT02488408|583628874|FG006|Part B|Death due to Disease Progression|2|||
161611824|NCT02488408|583628875|FG007|Part B|Death due to Disease Progression|1|||
161611825|NCT02488408|583628876|FG008|Part B|Death due to Disease Progression|1|||
161611826|NCT02488408|583628877|FG009|Part B|Death due to Disease Progression|1|||
161611827|NCT02488408|583628868|FG000|Part B|Disease Progression|0|||
161611828|NCT02488408|583628869|FG001|Part B|Disease Progression|0|||
161611829|NCT02488408|583628870|FG002|Part B|Disease Progression|0|||
161611830|NCT02488408|583628871|FG003|Part B|Disease Progression|0|||
161611831|NCT02488408|583628872|FG004|Part B|Disease Progression|0|||
161611832|NCT02488408|583628873|FG005|Part B|Disease Progression|6|||
161611833|NCT02488408|583628874|FG006|Part B|Disease Progression|9|||
161611834|NCT02488408|583628875|FG007|Part B|Disease Progression|7|||
161611835|NCT02488408|583628876|FG008|Part B|Disease Progression|9|||
161611836|NCT02488408|583628877|FG009|Part B|Disease Progression|11|||
161611837|NCT02488408|583628868|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
161611838|NCT02488408|583628869|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
161611839|NCT02488408|583628870|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
161611840|NCT02488408|583628871|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
161611841|NCT02488408|583628872|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
161611842|NCT02488408|583628873|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
161611843|NCT02488408|583628874|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
161611844|NCT02488408|583628875|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
161611845|NCT02488408|583628876|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
161611846|NCT02488408|583628877|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
161611847|NCT02488408|583628868|FG000|Part B|Investigator Decision|0|||
161611848|NCT02488408|583628869|FG001|Part B|Investigator Decision|0|||
161611849|NCT02488408|583628870|FG002|Part B|Investigator Decision|0|||
161611850|NCT02488408|583628871|FG003|Part B|Investigator Decision|0|||
161611851|NCT02488408|583628872|FG004|Part B|Investigator Decision|0|||
161611852|NCT02488408|583628873|FG005|Part B|Investigator Decision|0|||
161611853|NCT02488408|583628874|FG006|Part B|Investigator Decision|1|||
161611854|NCT02488408|583628875|FG007|Part B|Investigator Decision|0|||
161611855|NCT02488408|583628876|FG008|Part B|Investigator Decision|2|||
161611856|NCT02488408|583628877|FG009|Part B|Investigator Decision|1|||
161611857|NCT00719888|583628878|FG000|Overall Study|Death|24|||
161611858|NCT00719888|583628879|FG001|Overall Study|Death|9|||
161611859|NCT00719888|583628878|FG000|Overall Study|Relapse|8|||
161611860|NCT00719888|583628879|FG001|Overall Study|Relapse|3|||
161611861|NCT00719888|583628878|FG000|Overall Study|Physician Decision|1|||
161611862|NCT00719888|583628879|FG001|Overall Study|Physician Decision|0|||
161611863|NCT00719888|583628878|FG000|Overall Study|Withdrawal by Subject|1|||
161611864|NCT00719888|583628879|FG001|Overall Study|Withdrawal by Subject|0|||
161611865|NCT00491894|583628880|FG000|Overall Study|Adverse Event|14|||
161611866|NCT00491894|583628880|FG000|Overall Study|Withdrawal by Subject|5|||
161611867|NCT00491894|583628880|FG000|Overall Study|Death|3|||
161611868|NCT00491894|583628880|FG000|Overall Study|Lost to Follow-up|3|||
161611869|NCT00491894|583628880|FG000|Overall Study|Lack of Efficacy|2|||
161611870|NCT00491894|583628880|FG000|Overall Study|Other-Failed to meet any criteria|2|||
161684361|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684362|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684363|NCT02819635|583897892|FG000|Substudy 2, Part 2|Adverse Event|0|||
161832539|NCT02791893|584428438|FG000|Blinded Phase|Withdrawal by Subject|1|||
161611871|NCT00491894|583628880|FG000|Overall Study|Physician Decision|2|||
161611872|NCT00491894|583628880|FG000|Overall Study|Protocol Violation|2|||
161611873|NCT00491894|583628880|FG000|Overall Study|Other-Intake of prohibited medication|1|||
161611874|NCT00378898|583630031|FG000|Overall Study|Withdrawal by Subject|10|||
161611875|NCT00378898|583630032|FG001|Overall Study|Withdrawal by Subject|5|||
161611876|NCT00378898|583630031|FG000|Overall Study|Protocol Violation|1|||
161611877|NCT00378898|583630032|FG001|Overall Study|Protocol Violation|1|||
161611878|NCT00551421|583630033|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
161611879|NCT01278030|583630034|FG000|Overall Study|Withdrawal by Subject|8|||
161611880|NCT01278030|583630035|FG001|Overall Study|Withdrawal by Subject|4|||
161611881|NCT05815342|583630039|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
161611882|NCT05815342|583630039|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
161611883|NCT05815342|583630039|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
161611884|NCT05815342|583630039|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
161684364|NCT02819635|583897893|FG001|Substudy 2, Part 2|Adverse Event|0|||
161611885|NCT05815342|583630039|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
161611886|NCT00745875|583630044|FG000|Overall Study|Continuing study treatment|4|||
161611887|NCT00745875|583630045|FG001|Overall Study|Continuing study treatment|4|||
161611888|NCT03220724|583630050|FG000|Overall Study|Lost to Follow-up|2|||
161611889|NCT03220724|583630051|FG001|Overall Study|Lost to Follow-up|2|||
161611890|NCT03220724|583630052|FG002|Overall Study|Lost to Follow-up|0|||
161611891|NCT03220724|583630053|FG003|Overall Study|Lost to Follow-up|3|||
161611892|NCT03220724|583630054|FG004|Overall Study|Lost to Follow-up|1|||
161611893|NCT03220724|583630055|FG005|Overall Study|Lost to Follow-up|0|||
161611894|NCT03220724|583630056|FG006|Overall Study|Lost to Follow-up|2|||
161611895|NCT03220724|583630057|FG007|Overall Study|Lost to Follow-up|1|||
161611896|NCT03220724|583630058|FG008|Overall Study|Lost to Follow-up|0|||
161611897|NCT03220724|583630050|FG000|Overall Study|Withdrawal by Subject|1|||
161611898|NCT03220724|583630051|FG001|Overall Study|Withdrawal by Subject|0|||
161611899|NCT03220724|583630052|FG002|Overall Study|Withdrawal by Subject|1|||
161611900|NCT03220724|583630053|FG003|Overall Study|Withdrawal by Subject|0|||
161611901|NCT03220724|583630054|FG004|Overall Study|Withdrawal by Subject|0|||
161611902|NCT03220724|583630055|FG005|Overall Study|Withdrawal by Subject|0|||
161611903|NCT03220724|583630056|FG006|Overall Study|Withdrawal by Subject|0|||
161611904|NCT03220724|583630057|FG007|Overall Study|Withdrawal by Subject|0|||
161611905|NCT03220724|583630058|FG008|Overall Study|Withdrawal by Subject|0|||
161611906|NCT01613417|583630059|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
161611907|NCT01613417|583630060|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
161611908|NCT02000752|583630063|FG000|Overall Study|Dystocic delivery|19|||
161611909|NCT02000752|583630064|FG001|Overall Study|Dystocic delivery|8|||
161611910|NCT02000752|583630063|FG000|Overall Study|Shift Changes|12|||
161611911|NCT02000752|583630064|FG001|Overall Study|Shift Changes|5|||
161611912|NCT00019604|583630066|FG000|Overall Study|Death|1|||
161611913|NCT00019604|583630066|FG000|Overall Study|Progressive disease|23|||
161611914|NCT00019604|583630066|FG000|Overall Study|Refused treatment|1|||
161611915|NCT00019604|583630066|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
161611916|NCT00019604|583630066|FG000|Overall Study|Going to have liver transplant|1|||
161611917|NCT00019604|583630066|FG000|Overall Study|Move to a different study|1|||
161611918|NCT00019604|583630066|FG000|Overall Study|Non compliant on systemic CH|1|||
161611919|NCT00019604|583630066|FG000|Overall Study|Non compliant|1|||
161611920|NCT00019604|583630066|FG000|Overall Study|Resectable disease|1|||
161611921|NCT00019604|583630066|FG000|Overall Study|Started new chemo regimen|1|||
161611922|NCT00019604|583630066|FG000|Overall Study|Pt going to immunotherapy study|1|||
161611923|NCT00019604|583630066|FG000|Overall Study|Too much disease|1|||
161611924|NCT00019604|583630066|FG000|Overall Study|Unable to evaluate|1|||
161611925|NCT00019604|583630066|FG000|Overall Study|Details for other not available|4|||
161611926|NCT03392194|583630068|FG000|Overall Study|Withdrawal by Subject|1|||
161611927|NCT03392194|583630069|FG001|Overall Study|Withdrawal by Subject|2|||
161611928|NCT03392194|583630068|FG000|Overall Study|Conflicts with personal schedule|1|||
161611929|NCT03392194|583630069|FG001|Overall Study|Conflicts with personal schedule|0|||
161611930|NCT00620854|583630072|FG000|Washout 1|Withdrawal by Subject|0|||
161611931|NCT00620854|583630073|FG001|Washout 1|Withdrawal by Subject|0|||
161611932|NCT00620854|583630074|FG002|Washout 1|Withdrawal by Subject|1|||
161611933|NCT00620854|583630075|FG003|Washout 1|Withdrawal by Subject|1|||
161611934|NCT00620854|583630076|FG004|Washout 1|Withdrawal by Subject|0|||
161611935|NCT00620854|583630077|FG005|Washout 1|Withdrawal by Subject|0|||
161611936|NCT00093496|583630080|FG000|Overall Study|Protocol Violation|1|||
161611937|NCT00093496|583630081|FG001|Overall Study|Protocol Violation|3|||
161611938|NCT00586313|583630082|FG000|Overall Study|Lack of Efficacy|2|||
161611939|NCT03205566|583630087|FG000|Phase 1|Protocol Violation|1|||
161611940|NCT03205566|583630088|FG001|Phase 1|Protocol Violation|1|||
161611941|NCT01170208|583630091|FG000|Overall Study|Withdrawal by Subject|5|||
161611942|NCT01170208|583630092|FG001|Overall Study|Withdrawal by Subject|0|||
161611943|NCT01170208|583630093|FG002|Overall Study|Withdrawal by Subject|1|||
161611944|NCT01170208|583630091|FG000|Overall Study|Protocol Violation|1|||
161611945|NCT01170208|583630092|FG001|Overall Study|Protocol Violation|0|||
161611946|NCT01170208|583630093|FG002|Overall Study|Protocol Violation|1|||
161611947|NCT03113409|583630094|FG000|Overall Study|Withdrawal by Subject|5|||
161611948|NCT03113409|583630095|FG001|Overall Study|Withdrawal by Subject|0|||
161611949|NCT03113409|583630096|FG002|Overall Study|Withdrawal by Subject|0|||
161611950|NCT03335488|583630097|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
161611951|NCT03335488|583630098|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
161611952|NCT03335488|583630097|FG000|Safety Extension Period|Adverse Event|1|||
161611953|NCT03335488|583630098|FG001|Safety Extension Period|Adverse Event|0|||
161611954|NCT03335488|583630097|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
161611955|NCT03335488|583630098|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
161611956|NCT04971733|583630099|FG000|Overall Study|Adverse Event|1|||
161611957|NCT04971733|583630100|FG001|Overall Study|Adverse Event|1|||
161611958|NCT04971733|583630099|FG000|Overall Study|Subject choice|2|||
161611959|NCT04971733|583630100|FG001|Overall Study|Subject choice|0|||
161611960|NCT04971733|583630099|FG000|Overall Study|Withdrawal by Subject|1|||
161611961|NCT04971733|583630100|FG001|Overall Study|Withdrawal by Subject|0|||
161611962|NCT04971733|583630099|FG000|Overall Study|Other|1|||
161611963|NCT04971733|583630100|FG001|Overall Study|Other|0|||
161611964|NCT01160354|583630101|FG000|Overall Study|Death|0|||
161611965|NCT01160354|583630102|FG001|Overall Study|Death|1|||
161611966|NCT01160354|583630103|FG002|Overall Study|Death|1|||
161611967|NCT01801007|583630107|FG000|Overall Study|Adverse Event|2|||
161611968|NCT01801007|583630107|FG000|Overall Study|Lost to Follow-up|4|||
161611969|NCT01801007|583630107|FG000|Overall Study|Withdrawal by Subject|5|||
161611970|NCT00600353|583630108|FG000|Overall Study|history of malignancy within 5 years|1|||
161611971|NCT00600353|583630109|FG001|Overall Study|history of malignancy within 5 years|0|||
161611972|NCT00600353|583630108|FG000|Overall Study|History of prepartive regimen|0|||
161611973|NCT00600353|583630109|FG001|Overall Study|History of prepartive regimen|1|||
161611974|NCT04941482|583630110|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
161611975|NCT04941482|583630111|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
161611976|NCT02743819|583630112|FG000|Overall Study|Lack of Efficacy|5|||
161611977|NCT02743819|583630112|FG000|Overall Study|Death|2|||
161611978|NCT02743819|583630112|FG000|Overall Study|Adverse Event|1|||
161611979|NCT04200664|583630113|FG000|Overall Study|Withdrawal by Subject|1|||
161832540|NCT02791893|584428439|FG001|Blinded Phase|Withdrawal by Subject|2|||
161832541|NCT02791893|584428438|FG000|Open Label Phase|Lost to Follow-up|3|||
161832542|NCT02791893|584428439|FG001|Open Label Phase|Lost to Follow-up|0|||
161611980|NCT04200664|583630114|FG001|Overall Study|Withdrawal by Subject|0|||
161611981|NCT04200664|583630115|FG002|Overall Study|Withdrawal by Subject|0|||
161611982|NCT03362190|583630118|FG000|Overall Study|Adverse Event|0|||
161611983|NCT03362190|583630119|FG001|Overall Study|Adverse Event|0|||
161611984|NCT03362190|583630120|FG002|Overall Study|Adverse Event|0|||
161611985|NCT03362190|583630121|FG003|Overall Study|Adverse Event|1|||
161611986|NCT03362190|583630118|FG000|Overall Study|Withdrawal by Subject|0|||
161611987|NCT03362190|583630119|FG001|Overall Study|Withdrawal by Subject|0|||
161611988|NCT03362190|583630120|FG002|Overall Study|Withdrawal by Subject|0|||
161611989|NCT03362190|583630121|FG003|Overall Study|Withdrawal by Subject|1|||
161611990|NCT00687219|583630122|FG000|Overall Study|Adverse Event|8|||
161611991|NCT00687219|583630122|FG000|Overall Study|Discontinuance criteria met|7|||
161832543|NCT02791893|584428438|FG000|Open Label Phase|Withdrawal by Subject|0|||
161832544|NCT02791893|584428439|FG001|Open Label Phase|Withdrawal by Subject|2|||
161611992|NCT00687219|583630122|FG000|Overall Study|HCV-RNA positive conversion|34|||
161832545|NCT04319159|584428445|FG000|Overall Study|Screening failure|13|||
161832546|NCT04319159|584428445|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
161832547|NCT04319159|584428445|FG000|Overall Study|Withdrawal by Subject|1|||
161611993|NCT00687219|583630122|FG000|Overall Study|Withdrawal by Subject|1|||
161611994|NCT00687219|583630122|FG000|Overall Study|Lack of Efficacy|1|||
161611995|NCT02063659|583630135|FG000|Double-Blind Treatment Period|Adverse Event|1|||
161611996|NCT02063659|583630136|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161832548|NCT05575063|584428453|FG000|Overall Study|Withdrawal by Subject|1|||
161611997|NCT02063659|583630137|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161611998|NCT02063659|583630138|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161611999|NCT02063659|583630135|FG000|Double-Blind Treatment Period|Physician Decision|1|||
161612000|NCT02063659|583630136|FG001|Double-Blind Treatment Period|Physician Decision|0|||
161832549|NCT00949988|584428458|FG000|Overall Study|Withdrawal by Subject|3|||
161832550|NCT00396331|584428461|FG000|Overall Study|Failed to mobilize - no transplant|8|||
161832551|NCT00396331|584428461|FG000|Overall Study|Did not go on to transplant|5|||
161612001|NCT02063659|583630137|FG002|Double-Blind Treatment Period|Physician Decision|0|||
161612002|NCT02063659|583630138|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161612003|NCT02063659|583630135|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
161612004|NCT02063659|583630136|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
161612005|NCT02063659|583630137|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
161612006|NCT02063659|583630138|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
161612007|NCT02063659|583630135|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
161612008|NCT02063659|583630136|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
161612009|NCT02063659|583630137|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
161612010|NCT02063659|583630138|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
161612011|NCT02063659|583630135|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161612012|NCT02063659|583630136|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161612013|NCT02063659|583630137|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161612014|NCT02063659|583630138|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
161612015|NCT02063659|583630135|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161612016|NCT02063659|583630136|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161612017|NCT02063659|583630137|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161612018|NCT02063659|583630138|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
161612019|NCT02063659|583630135|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
161612020|NCT02063659|583630136|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
161612021|NCT02063659|583630137|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
161612022|NCT02063659|583630138|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
161612023|NCT02063659|583630135|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161612024|NCT02063659|583630136|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161612025|NCT02063659|583630137|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161612026|NCT02063659|583630138|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
161612027|NCT00989196|583630139|FG000|Treatment Period|Lost to Follow-up|1|||
161612028|NCT00989196|583630140|FG001|Treatment Period|Lost to Follow-up|0|||
161612029|NCT04762277|583630143|FG000|Overall Study|Withdrawal by Subject|0|||
161612030|NCT04762277|583630144|FG001|Overall Study|Withdrawal by Subject|2|||
161612031|NCT04762277|583630143|FG000|Overall Study|Protocol Violation|0|||
161612032|NCT04762277|583630144|FG001|Overall Study|Protocol Violation|1|||
161612033|NCT04762277|583630143|FG000|Overall Study|Adverse Event|1|||
161612034|NCT04762277|583630144|FG001|Overall Study|Adverse Event|0|||
161612035|NCT05422339|583631625|FG000|Overall Study|Withdrawal by Subject|17|||
161612036|NCT05422339|583631626|FG001|Overall Study|Withdrawal by Subject|15|||
161612037|NCT03070392|583631633|FG000|Overall Study|Not Treated|7|||
161612038|NCT03070392|583631634|FG001|Overall Study|Not Treated|0|||
161612039|NCT03070392|583631635|FG002|Overall Study|Not Treated|3|||
161612040|NCT03070392|583631636|FG003|Overall Study|Not Treated|12|||
161612041|NCT03070392|583631633|FG000|Overall Study|Death|3|||
161612042|NCT03070392|583631634|FG001|Overall Study|Death|0|||
161612043|NCT03070392|583631635|FG002|Overall Study|Death|0|||
161612044|NCT03070392|583631636|FG003|Overall Study|Death|1|||
161612045|NCT03070392|583631633|FG000|Overall Study|Withdrawal by Subject|7|||
161612046|NCT03070392|583631634|FG001|Overall Study|Withdrawal by Subject|0|||
161612047|NCT03070392|583631635|FG002|Overall Study|Withdrawal by Subject|0|||
161612048|NCT03070392|583631636|FG003|Overall Study|Withdrawal by Subject|3|||
161612049|NCT03070392|583631633|FG000|Overall Study|Physician Decision|1|||
161612050|NCT03070392|583631634|FG001|Overall Study|Physician Decision|0|||
161612051|NCT03070392|583631635|FG002|Overall Study|Physician Decision|0|||
161612052|NCT03070392|583631636|FG003|Overall Study|Physician Decision|2|||
161612053|NCT03070392|583631633|FG000|Overall Study|Progressive Disease|154|||
161612054|NCT03070392|583631634|FG001|Overall Study|Progressive Disease|6|||
161612055|NCT03070392|583631635|FG002|Overall Study|Progressive Disease|2|||
161612056|NCT03070392|583631636|FG003|Overall Study|Progressive Disease|70|||
161612057|NCT03070392|583631633|FG000|Overall Study|Adverse Event|6|||
161612058|NCT03070392|583631634|FG001|Overall Study|Adverse Event|1|||
161612059|NCT03070392|583631635|FG002|Overall Study|Adverse Event|1|||
161612060|NCT03070392|583631636|FG003|Overall Study|Adverse Event|3|||
161612061|NCT03070392|583631633|FG000|Overall Study|Alternate anticancer treatment|1|||
161612062|NCT03070392|583631634|FG001|Overall Study|Alternate anticancer treatment|0|||
161612063|NCT03070392|583631635|FG002|Overall Study|Alternate anticancer treatment|0|||
161612064|NCT03070392|583631636|FG003|Overall Study|Alternate anticancer treatment|1|||
161612065|NCT03070392|583631633|FG000|Overall Study|Ongoing|73|||
161612066|NCT03070392|583631634|FG001|Overall Study|Ongoing|0|||
161612067|NCT03070392|583631635|FG002|Overall Study|Ongoing|0|||
161612068|NCT03070392|583631636|FG003|Overall Study|Ongoing|11|||
161612069|NCT03678688|583631637|FG000|Overall Study|Reason not Specified|0|||
161612070|NCT03678688|583631638|FG001|Overall Study|Reason not Specified|0|||
161612071|NCT03678688|583631639|FG002|Overall Study|Reason not Specified|3|||
161612072|NCT03678688|583631640|FG003|Overall Study|Reason not Specified|0|||
161612073|NCT03678688|583631641|FG004|Overall Study|Reason not Specified|1|||
161612074|NCT03678688|583631642|FG005|Overall Study|Reason not Specified|0|||
161612075|NCT03678688|583631643|FG006|Overall Study|Reason not Specified|0|||
161612076|NCT03678688|583631644|FG007|Overall Study|Reason not Specified|0|||
161612077|NCT03678688|583631645|FG008|Overall Study|Reason not Specified|0|||
161612078|NCT03678688|583631637|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
161612079|NCT03678688|583631638|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
161612080|NCT03678688|583631639|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
161612081|NCT03678688|583631640|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
161612082|NCT03678688|583631641|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
161612083|NCT03678688|583631642|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
161612084|NCT03678688|583631643|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
161612085|NCT03678688|583631644|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
161612086|NCT03678688|583631645|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
161612087|NCT03678688|583631637|FG000|Overall Study|Covid Related Adverse Event|0|||
161612088|NCT03678688|583631638|FG001|Overall Study|Covid Related Adverse Event|0|||
161612089|NCT03678688|583631639|FG002|Overall Study|Covid Related Adverse Event|0|||
161612090|NCT03678688|583631640|FG003|Overall Study|Covid Related Adverse Event|0|||
161612091|NCT03678688|583631641|FG004|Overall Study|Covid Related Adverse Event|0|||
161612092|NCT03678688|583631642|FG005|Overall Study|Covid Related Adverse Event|3|||
161612093|NCT03678688|583631643|FG006|Overall Study|Covid Related Adverse Event|1|||
161612094|NCT03678688|583631644|FG007|Overall Study|Covid Related Adverse Event|1|||
161612095|NCT03678688|583631645|FG008|Overall Study|Covid Related Adverse Event|0|||
161612096|NCT03678688|583631637|FG000|Overall Study|Physician Decision|0|||
161612097|NCT03678688|583631638|FG001|Overall Study|Physician Decision|0|||
161612098|NCT03678688|583631639|FG002|Overall Study|Physician Decision|0|||
161612099|NCT03678688|583631640|FG003|Overall Study|Physician Decision|0|||
161612100|NCT03678688|583631641|FG004|Overall Study|Physician Decision|0|||
161612101|NCT03678688|583631642|FG005|Overall Study|Physician Decision|1|||
161612102|NCT03678688|583631643|FG006|Overall Study|Physician Decision|0|||
161612103|NCT03678688|583631644|FG007|Overall Study|Physician Decision|0|||
161612104|NCT03678688|583631645|FG008|Overall Study|Physician Decision|0|||
161612105|NCT03678688|583631637|FG000|Overall Study|Withdrawal by Subject|0|||
161612106|NCT03678688|583631638|FG001|Overall Study|Withdrawal by Subject|0|||
161612107|NCT03678688|583631639|FG002|Overall Study|Withdrawal by Subject|0|||
161612108|NCT03678688|583631640|FG003|Overall Study|Withdrawal by Subject|0|||
161612109|NCT03678688|583631641|FG004|Overall Study|Withdrawal by Subject|0|||
161612110|NCT03678688|583631642|FG005|Overall Study|Withdrawal by Subject|0|||
161612111|NCT03678688|583631643|FG006|Overall Study|Withdrawal by Subject|2|||
161612112|NCT03678688|583631644|FG007|Overall Study|Withdrawal by Subject|1|||
161612113|NCT03678688|583631645|FG008|Overall Study|Withdrawal by Subject|0|||
161612114|NCT02534233|583631648|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
161612115|NCT03136159|583631652|FG000|Overall Study|chorioamnionitis|2|||
161612116|NCT03136159|583631653|FG001|Overall Study|chorioamnionitis|0|||
161612117|NCT03136159|583631652|FG000|Overall Study|vertical skin incision|1|||
161612118|NCT03136159|583631653|FG001|Overall Study|vertical skin incision|0|||
161612119|NCT03136159|583631652|FG000|Overall Study|additional dressing|1|||
161612120|NCT03136159|583631653|FG001|Overall Study|additional dressing|0|||
161612121|NCT03136159|583631652|FG000|Overall Study|never got dressing placed|1|||
161612122|NCT03136159|583631653|FG001|Overall Study|never got dressing placed|0|||
161612123|NCT03823703|583631654|FG000|Overall Study|Sponsor request|0|||
161612124|NCT03823703|583631655|FG001|Overall Study|Sponsor request|3|||
161612125|NCT03823703|583631656|FG002|Overall Study|Sponsor request|4|||
161612126|NCT03823703|583631654|FG000|Overall Study|Adverse Event|3|||
161612127|NCT03823703|583631655|FG001|Overall Study|Adverse Event|1|||
161612128|NCT03823703|583631656|FG002|Overall Study|Adverse Event|0|||
161612129|NCT03823703|583631654|FG000|Overall Study|Withdrawal by Subject|0|||
161612130|NCT03823703|583631655|FG001|Overall Study|Withdrawal by Subject|1|||
161612131|NCT03823703|583631656|FG002|Overall Study|Withdrawal by Subject|0|||
161612132|NCT00925548|583631657|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
161612133|NCT00925548|583631658|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
161612134|NCT00458783|583631660|FG000|Overall Study|Protocol Violation|1228|||
161612135|NCT00458783|583631661|FG001|Overall Study|Protocol Violation|1220|||
161612136|NCT01737398|583631662|FG000|Overall Study|Adverse event or SAE|16|||
161612137|NCT01737398|583631663|FG001|Overall Study|Adverse event or SAE|1|||
161612138|NCT01737398|583631662|FG000|Overall Study|Stopping rule met|2|||
161612139|NCT01737398|583631663|FG001|Overall Study|Stopping rule met|1|||
161612140|NCT01737398|583631662|FG000|Overall Study|Voluntary withdrawal|2|||
161612141|NCT01737398|583631663|FG001|Overall Study|Voluntary withdrawal|3|||
161612142|NCT01737398|583631662|FG000|Overall Study|Ineligibility|1|||
161612143|NCT01737398|583631663|FG001|Overall Study|Ineligibility|0|||
161612144|NCT01737398|583631662|FG000|Overall Study|Liver transplant|1|||
161612145|NCT01737398|583631663|FG001|Overall Study|Liver transplant|0|||
161612146|NCT01737398|583631662|FG000|Overall Study|Disease progression|2|||
161612147|NCT01737398|583631663|FG001|Overall Study|Disease progression|3|||
161612148|NCT01737398|583631662|FG000|Overall Study|Sponsor's decision|2|||
161612149|NCT01737398|583631663|FG001|Overall Study|Sponsor's decision|0|||
161612150|NCT00089609|583631664|FG000|Overall Study|Withdrawal by Subject|3|||
161612151|NCT00089609|583631665|FG001|Overall Study|Withdrawal by Subject|1|||
161612152|NCT00357994|583631666|FG000|Overall Study|Adverse Event|1|||
161612153|NCT00357994|583631667|FG001|Overall Study|Adverse Event|2|||
161612154|NCT00357994|583631666|FG000|Overall Study|Lack of Efficacy|0|||
161612155|NCT00357994|583631667|FG001|Overall Study|Lack of Efficacy|1|||
161612156|NCT00357994|583631666|FG000|Overall Study|Protocol Violation|1|||
161612157|NCT00357994|583631667|FG001|Overall Study|Protocol Violation|0|||
161612158|NCT01833455|583631668|FG000|Overall Study|Withdrawal by Subject|1|||
161612159|NCT01833455|583631669|FG001|Overall Study|Withdrawal by Subject|0|||
161612160|NCT00047385|583631670|FG000|Overall Study|Death before any screening|2|||
161612161|NCT00047385|583631671|FG001|Overall Study|Death before any screening|5|||
161612162|NCT00047385|583631670|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
161612163|NCT00047385|583631671|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
161612164|NCT00047385|583631670|FG000|Overall Study|Eligible for screening but had no screen|260|||
161612165|NCT00047385|583631671|FG001|Overall Study|Eligible for screening but had no screen|492|||
161612166|NCT03865732|583631672|FG000|Overall Study|Adverse Event|0|||
161612167|NCT03865732|583631673|FG001|Overall Study|Adverse Event|1|||
161612168|NCT02095145|583631676|FG000|Overall Study|Withdrawal by Subject|1|||
161612169|NCT02095145|583631677|FG001|Overall Study|Withdrawal by Subject|0|||
161612170|NCT02085941|583631678|FG000|Overall Study|Lack of Efficacy|1|||
161612171|NCT02085941|583631679|FG001|Overall Study|Lack of Efficacy|0|||
161612172|NCT02085941|583631678|FG000|Overall Study|Death|6|||
161612173|NCT02085941|583631679|FG001|Overall Study|Death|1|||
161612174|NCT02085941|583631678|FG000|Overall Study|Lost to Follow-up|1|||
161612175|NCT02085941|583631679|FG001|Overall Study|Lost to Follow-up|0|||
161612176|NCT02085941|583631678|FG000|Overall Study|Physician Decision|0|||
161612177|NCT02085941|583631679|FG001|Overall Study|Physician Decision|2|||
161612178|NCT03184987|583631682|FG000|Overall Study|Withdrawal by Subject|0|||
161612179|NCT03184987|583631683|FG001|Overall Study|Withdrawal by Subject|1|||
161612180|NCT03184987|583631684|FG002|Overall Study|Withdrawal by Subject|2|||
161612181|NCT03184987|583631682|FG000|Overall Study|Physician Decision|0|||
161612182|NCT03184987|583631683|FG001|Overall Study|Physician Decision|0|||
161612183|NCT03184987|583631684|FG002|Overall Study|Physician Decision|1|||
161612184|NCT03184987|583631682|FG000|Overall Study|Adverse Event|1|||
161612185|NCT03184987|583631683|FG001|Overall Study|Adverse Event|0|||
161612186|NCT03184987|583631684|FG002|Overall Study|Adverse Event|1|||
161612187|NCT01767467|583631685|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
161612188|NCT01767467|583631686|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
161612189|NCT01767467|583631685|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
161612190|NCT01767467|583631686|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
161612191|NCT01767467|583631685|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
161612192|NCT01767467|583631686|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
161612193|NCT01767467|583631685|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
161612194|NCT01767467|583631686|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
161612195|NCT01767467|583631685|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
161612196|NCT01767467|583631686|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
161612197|NCT01767467|583631685|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
161612198|NCT01767467|583631686|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
161612199|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
161612200|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
161612201|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
161612202|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
161612203|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
161612204|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
161612205|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
161612206|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
161612207|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
161612208|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
161612209|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
161612210|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
161612211|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
161612212|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
161832552|NCT00396331|584428461|FG000|Overall Study|Lost to Follow-up|3|||
161612213|NCT01767467|583631685|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
161612214|NCT01767467|583631686|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
161612215|NCT00853580|583631687|FG000|Overall Study|Lost to Follow-up|3|||
161612216|NCT00853580|583631688|FG001|Overall Study|Lost to Follow-up|5|||
161612217|NCT00853580|583631687|FG000|Overall Study|Protocol Violation|2|||
161612218|NCT00853580|583631688|FG001|Overall Study|Protocol Violation|1|||
161612219|NCT00853580|583631687|FG000|Overall Study|Withdrawal by Subject|2|||
161612220|NCT00853580|583631688|FG001|Overall Study|Withdrawal by Subject|8|||
161612221|NCT00853580|583631687|FG000|Overall Study|Commenced contraindicated therapy|0|||
161612222|NCT00853580|583631688|FG001|Overall Study|Commenced contraindicated therapy|2|||
161612223|NCT02203799|583631693|FG000|Overall Study|Withdrawal by Subject|3|||
161612224|NCT01065779|583631700|FG000|Overall Study|Duplicate Investigation|1|||
161612225|NCT01065779|583631700|FG000|Overall Study|Investigation Before Contract Date|37|||
161612226|NCT01065779|583631700|FG000|Overall Study|Non-enrollment Period Administration|10|||
161612227|NCT01065779|583631700|FG000|Overall Study|Not Administered With Study Drug|17|||
161612228|NCT01065779|583631700|FG000|Overall Study|Failed to Follow-up|10|||
161612229|NCT01065779|583631700|FG000|Overall Study|Inclusion Criteria Violation|7|||
161612230|NCT01683409|583631701|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161612231|NCT01683409|583631702|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161612232|NCT01683409|583631703|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
161612233|NCT01683409|583631704|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161612234|NCT01683409|583631705|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161612235|NCT01683409|583631701|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
161612236|NCT01683409|583631702|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
161612237|NCT01683409|583631703|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
161612238|NCT01683409|583631704|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
161612239|NCT01683409|583631705|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
161612240|NCT01683409|583631701|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161612241|NCT01683409|583631702|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
161612242|NCT01683409|583631703|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161612243|NCT01683409|583631704|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161612244|NCT01683409|583631705|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161612245|NCT01683409|583631701|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
161612246|NCT01683409|583631702|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
161612247|NCT01683409|583631703|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
161612248|NCT01683409|583631704|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
161612249|NCT01683409|583631705|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
161612250|NCT01683409|583631701|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161612251|NCT01683409|583631702|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161612252|NCT01683409|583631703|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
161612253|NCT01683409|583631704|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161612254|NCT01683409|583631705|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161612255|NCT01683409|583631701|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
161612256|NCT01683409|583631702|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161612257|NCT01683409|583631703|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161612258|NCT01683409|583631704|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
161612259|NCT01683409|583631705|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161612260|NCT01683409|583631701|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
161612261|NCT01683409|583631702|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
161612262|NCT01683409|583631703|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
161612263|NCT01683409|583631704|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
161612264|NCT01683409|583631705|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
161612265|NCT01683409|583631701|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
161612266|NCT01683409|583631702|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161612267|NCT01683409|583631703|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161612268|NCT01683409|583631704|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161612269|NCT01683409|583631705|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161612270|NCT01683409|583631701|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
161612271|NCT01683409|583631702|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
161612272|NCT01683409|583631703|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
161612273|NCT01683409|583631704|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
161612274|NCT01683409|583631705|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
161612275|NCT01683409|583631701|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161612276|NCT01683409|583631702|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161684365|NCT02819635|583897894|FG002|Substudy 2, Part 2|Adverse Event|0|||
161684366|NCT02819635|583897895|FG003|Substudy 2, Part 2|Adverse Event|0|||
161684367|NCT02819635|583897896|FG004|Substudy 2, Part 2|Adverse Event|0|||
161684368|NCT02819635|583897897|FG005|Substudy 2, Part 2|Adverse Event|4|||
161684369|NCT02819635|583897898|FG006|Substudy 2, Part 2|Adverse Event|0|||
161684370|NCT02819635|583897899|FG007|Substudy 2, Part 2|Adverse Event|0|||
161832553|NCT00396331|584428461|FG000|Overall Study|Death|16|||
161612277|NCT01683409|583631703|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161612278|NCT01683409|583631704|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161612279|NCT01683409|583631705|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
161612280|NCT01683409|583631701|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161612281|NCT01683409|583631702|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161612282|NCT01683409|583631703|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
161612283|NCT01683409|583631704|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161612284|NCT01683409|583631705|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161684371|NCT02819635|583897900|FG008|Substudy 2, Part 2|Adverse Event|0|||
161832554|NCT00873119|584428468|FG000|Overall Study|Patient request|4|||
161832555|NCT00873119|584428469|FG001|Overall Study|Patient request|2|||
161832556|NCT00873119|584428468|FG000|Overall Study|Adverse Event|8|||
161832557|NCT00873119|584428469|FG001|Overall Study|Adverse Event|0|||
161832558|NCT00873119|584428468|FG000|Overall Study|Progressive disease|26|||
161684372|NCT02819635|583897901|FG009|Substudy 2, Part 2|Adverse Event|0|||
161684373|NCT02819635|583897902|FG010|Substudy 2, Part 2|Adverse Event|0|||
161832559|NCT00873119|584428469|FG001|Overall Study|Progressive disease|18|||
161832560|NCT00873119|584428468|FG000|Overall Study|Death|2|||
161832561|NCT00873119|584428469|FG001|Overall Study|Death|1|||
161832562|NCT00873119|584428468|FG000|Overall Study|Other|2|||
161832563|NCT00873119|584428469|FG001|Overall Study|Other|5|||
161832564|NCT00873119|584428468|FG000|Overall Study|Not treated|2|||
161832565|NCT00873119|584428469|FG001|Overall Study|Not treated|0|||
161832566|NCT03648879|584428470|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
161832567|NCT00285584|584428471|FG000|Month 3|Lost to Follow-up|3|||
161832568|NCT00285584|584428472|FG001|Month 3|Lost to Follow-up|3|||
161832569|NCT00285584|584428471|FG000|Month 3|Withdrawal by Subject|1|||
161832570|NCT00285584|584428472|FG001|Month 3|Withdrawal by Subject|0|||
161832571|NCT00285584|584428471|FG000|Month 6|Lost to Follow-up|0|||
161832572|NCT00285584|584428472|FG001|Month 6|Lost to Follow-up|1|||
161832573|NCT01884688|584428473|FG000|Overall Study|Screen Failure|2|||
161832574|NCT00536484|584428474|FG000|Overall Study|Adverse Event|21|||
161832575|NCT00536484|584428475|FG001|Overall Study|Adverse Event|34|||
161832576|NCT00536484|584428474|FG000|Overall Study|Withdrawal by Subject|11|||
161832577|NCT00536484|584428475|FG001|Overall Study|Withdrawal by Subject|11|||
161684374|NCT02819635|583897903|FG011|Substudy 2, Part 2|Adverse Event|0|||
161832578|NCT00536484|584428474|FG000|Overall Study|Lost to Follow-up|8|||
161832579|NCT00536484|584428475|FG001|Overall Study|Lost to Follow-up|6|||
161832580|NCT00536484|584428474|FG000|Overall Study|Lack of Efficacy|16|||
161832581|NCT00536484|584428475|FG001|Overall Study|Lack of Efficacy|5|||
161832582|NCT00536484|584428474|FG000|Overall Study|Other|4|||
161832583|NCT00536484|584428475|FG001|Overall Study|Other|0|||
161832584|NCT00706355|584428476|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
161832585|NCT00706355|584428477|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161832586|NCT00706355|584428478|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161832587|NCT00706355|584428479|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161832588|NCT00706355|584428476|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
161832589|NCT00706355|584428477|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161549286|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Adverse Event|0|||
161832590|NCT00706355|584428478|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161832591|NCT00706355|584428479|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161832592|NCT00706355|584428476|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161832593|NCT00706355|584428477|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
161832594|NCT00706355|584428478|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161832595|NCT00706355|584428479|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161832596|NCT00706355|584428476|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161612285|NCT00553332|583631706|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
161612286|NCT04745676|583631713|FG000|Overall Study|Death|1|||
161612287|NCT04745676|583631714|FG001|Overall Study|Death|0|||
161612288|NCT04745676|583631715|FG002|Overall Study|Death|0|||
161612289|NCT03102034|583631718|FG000|Overall Study|Withdrawal by Subject|1|||
161612290|NCT03102034|583631719|FG001|Overall Study|Withdrawal by Subject|0|||
161612291|NCT00145470|583631720|FG000|Overall Study|Adverse Event|19|||
161612292|NCT00145470|583631721|FG001|Overall Study|Adverse Event|25|||
161612293|NCT00145470|583631720|FG000|Overall Study|Lack of Efficacy|27|||
161612294|NCT00145470|583631721|FG001|Overall Study|Lack of Efficacy|13|||
161612295|NCT00145470|583631720|FG000|Overall Study|Withdrawal by Subject|36|||
161612296|NCT00145470|583631721|FG001|Overall Study|Withdrawal by Subject|34|||
161612297|NCT00145470|583631720|FG000|Overall Study|Lost to Follow-up|21|||
161612298|NCT00145470|583631721|FG001|Overall Study|Lost to Follow-up|17|||
161612299|NCT00145470|583631720|FG000|Overall Study|Reason Not Reported|9|||
161612300|NCT00145470|583631721|FG001|Overall Study|Reason Not Reported|9|||
161612301|NCT00676091|583631723|FG000|Infant Series|Parent or legal guardian request|10|||
161612302|NCT00676091|583631724|FG001|Infant Series|Parent or legal guardian request|8|||
161612303|NCT00676091|583631723|FG000|Infant Series|Protocol Violation|6|||
161684375|NCT02819635|583897892|FG000|Substudy 2, Part 2|Withdrew consent|0|||
161612304|NCT00676091|583631724|FG001|Infant Series|Protocol Violation|3|||
161612305|NCT00676091|583631723|FG000|Infant Series|Adverse Event|2|||
161612306|NCT00676091|583631724|FG001|Infant Series|Adverse Event|3|||
161612307|NCT00676091|583631723|FG000|Infant Series|Failed to return|1|||
161612308|NCT00676091|583631724|FG001|Infant Series|Failed to return|3|||
161612309|NCT00676091|583631723|FG000|Infant Series|Lost to Follow-up|1|||
161612310|NCT00676091|583631724|FG001|Infant Series|Lost to Follow-up|0|||
161612311|NCT00676091|583631723|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
161612312|NCT00676091|583631724|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
161612313|NCT00676091|583631723|FG000|After Infant Series|Adverse Event|0|||
161612314|NCT00676091|583631724|FG001|After Infant Series|Adverse Event|1|||
161612315|NCT00676091|583631723|FG000|After Infant Series|Protocol Violation|0|||
161612316|NCT00676091|583631724|FG001|After Infant Series|Protocol Violation|1|||
161612317|NCT00676091|583631723|FG000|After Infant Series|Failed to return|1|||
161612318|NCT00676091|583631724|FG001|After Infant Series|Failed to return|1|||
161612319|NCT00676091|583631723|FG000|Toddler Dose|Failed to return|2|||
161612320|NCT00676091|583631724|FG001|Toddler Dose|Failed to return|0|||
161612321|NCT00676091|583631723|FG000|Toddler Dose|Parent or legal guardian request|1|||
161612322|NCT00676091|583631724|FG001|Toddler Dose|Parent or legal guardian request|0|||
161612323|NCT00914966|583631725|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
161612324|NCT00914966|583631725|FG000|Step 1: 1500 Units|Physician Decision|1|||
161612325|NCT00914966|583631725|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
161612326|NCT01701401|583631726|FG000|Overall Study|Randomized But Not Treated|3|||
161612327|NCT01701401|583631727|FG001|Overall Study|Randomized But Not Treated|1|||
161612328|NCT01701401|583631728|FG002|Overall Study|Randomized But Not Treated|0|||
161612329|NCT01701401|583631729|FG003|Overall Study|Randomized But Not Treated|1|||
161612330|NCT01701401|583631726|FG000|Overall Study|Lost to Follow-up|5|||
161612331|NCT01701401|583631727|FG001|Overall Study|Lost to Follow-up|5|||
161612332|NCT01701401|583631728|FG002|Overall Study|Lost to Follow-up|1|||
161612333|NCT01701401|583631729|FG003|Overall Study|Lost to Follow-up|3|||
161612334|NCT01701401|583631726|FG000|Overall Study|Withdrew Consent|0|||
161612335|NCT01701401|583631727|FG001|Overall Study|Withdrew Consent|3|||
161612336|NCT01701401|583631728|FG002|Overall Study|Withdrew Consent|1|||
161612337|NCT01701401|583631729|FG003|Overall Study|Withdrew Consent|2|||
161612338|NCT01701401|583631726|FG000|Overall Study|Lack of Efficacy|1|||
161612339|NCT01701401|583631727|FG001|Overall Study|Lack of Efficacy|0|||
161612340|NCT01701401|583631728|FG002|Overall Study|Lack of Efficacy|2|||
161612341|NCT01701401|583631729|FG003|Overall Study|Lack of Efficacy|0|||
161612342|NCT01701401|583631726|FG000|Overall Study|Adverse Event|1|||
161612343|NCT01701401|583631727|FG001|Overall Study|Adverse Event|0|||
161612344|NCT01701401|583631728|FG002|Overall Study|Adverse Event|0|||
161612345|NCT01701401|583631729|FG003|Overall Study|Adverse Event|0|||
161612346|NCT01701401|583631726|FG000|Overall Study|Protocol Violation|0|||
161612347|NCT01701401|583631727|FG001|Overall Study|Protocol Violation|0|||
161612348|NCT01701401|583631728|FG002|Overall Study|Protocol Violation|1|||
161612349|NCT01701401|583631729|FG003|Overall Study|Protocol Violation|0|||
161612350|NCT04827732|583631730|FG000|Overall Study|Did not start treatment|0|||
161612351|NCT04827732|583631731|FG001|Overall Study|Did not start treatment|1|||
161612352|NCT04827732|583631732|FG002|Overall Study|Did not start treatment|0|||
161612353|NCT04827732|583631733|FG003|Overall Study|Did not start treatment|1|||
161612354|NCT04577651|583631740|FG000|Overall Study|Screen Failure|7|||
161612355|NCT04577651|583631740|FG000|Overall Study|Adverse Event|1|||
161612356|NCT04577651|583631740|FG000|Overall Study|Death|1|||
161612357|NCT04577651|583631740|FG000|Overall Study|Physician Decision|1|||
161612358|NCT04577651|583631740|FG000|Overall Study|Withdrawal by Subject|3|||
161612359|NCT05293717|583631742|FG000|Overall Study|Physician Decision|1|||
161612360|NCT03147287|583631743|FG000|Overall Study|Randomized Not Treated|2|||
161612361|NCT03147287|583631744|FG001|Overall Study|Randomized Not Treated|1|||
161612362|NCT03147287|583631745|FG002|Overall Study|Randomized Not Treated|1|||
161612363|NCT03147287|583631743|FG000|Overall Study|Progressive Disease RECIST|31|||
161612364|NCT03147287|583631744|FG001|Overall Study|Progressive Disease RECIST|72|||
161612365|NCT03147287|583631745|FG002|Overall Study|Progressive Disease RECIST|32|||
161612366|NCT03147287|583631743|FG000|Overall Study|Progressive Disease not RECIST|13|||
161612367|NCT03147287|583631744|FG001|Overall Study|Progressive Disease not RECIST|21|||
161612368|NCT03147287|583631745|FG002|Overall Study|Progressive Disease not RECIST|13|||
161612369|NCT03147287|583631743|FG000|Overall Study|Physician Decision|1|||
161612370|NCT03147287|583631744|FG001|Overall Study|Physician Decision|2|||
161612371|NCT03147287|583631745|FG002|Overall Study|Physician Decision|1|||
161612372|NCT03147287|583631743|FG000|Overall Study|Intercurrent illness|0|||
161612373|NCT03147287|583631744|FG001|Overall Study|Intercurrent illness|1|||
161612374|NCT03147287|583631745|FG002|Overall Study|Intercurrent illness|0|||
161612375|NCT03147287|583631743|FG000|Overall Study|Withdrawal by Subject|2|||
161612376|NCT03147287|583631744|FG001|Overall Study|Withdrawal by Subject|3|||
161612377|NCT03147287|583631745|FG002|Overall Study|Withdrawal by Subject|2|||
161612378|NCT03147287|583631743|FG000|Overall Study|Patient Non-Compliance|0|||
161612379|NCT03147287|583631744|FG001|Overall Study|Patient Non-Compliance|2|||
161612380|NCT03147287|583631745|FG002|Overall Study|Patient Non-Compliance|0|||
161612381|NCT03147287|583631743|FG000|Overall Study|Patient moved|0|||
161612382|NCT03147287|583631744|FG001|Overall Study|Patient moved|1|||
161612383|NCT03147287|583631745|FG002|Overall Study|Patient moved|0|||
161612384|NCT03147287|583631743|FG000|Overall Study|Arm A crossover without PD|1|||
161612385|NCT03147287|583631744|FG001|Overall Study|Arm A crossover without PD|0|||
161612386|NCT03147287|583631745|FG002|Overall Study|Arm A crossover without PD|0|||
161612387|NCT03147287|583631743|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
161612388|NCT03147287|583631744|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
161612389|NCT03147287|583631745|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
161612390|NCT02556918|583633715|FG000|Overall Study|Protocol Violation|5|||
161612391|NCT02556918|583633716|FG001|Overall Study|Protocol Violation|6|||
161612392|NCT02556918|583633715|FG000|Overall Study|Withdrawal by Subject|4|||
161612393|NCT02556918|583633716|FG001|Overall Study|Withdrawal by Subject|4|||
161612394|NCT04511702|583633726|FG000|Overall Study|Lost to Follow-up|3|||
161612395|NCT04511702|583633727|FG001|Overall Study|Lost to Follow-up|0|||
161612396|NCT04511702|583633728|FG002|Overall Study|Lost to Follow-up|4|||
161612397|NCT04511702|583633726|FG000|Overall Study|Withdrawal by Subject|17|||
161612398|NCT04511702|583633727|FG001|Overall Study|Withdrawal by Subject|1|||
161612399|NCT04511702|583633728|FG002|Overall Study|Withdrawal by Subject|8|||
161612400|NCT05349721|583633729|FG000|Part A (24 Weeks)|Adverse Event|9|||
161612401|NCT05349721|583633730|FG001|Part A (24 Weeks)|Adverse Event|2|||
161612402|NCT05349721|583633729|FG000|Part A (24 Weeks)|Death|8|||
161612403|NCT05349721|583633730|FG001|Part A (24 Weeks)|Death|3|||
161612404|NCT05349721|583633729|FG000|Part A (24 Weeks)|Disease Progression|1|||
161612405|NCT05349721|583633730|FG001|Part A (24 Weeks)|Disease Progression|1|||
161612406|NCT05349721|583633729|FG000|Part A (24 Weeks)|Screen Failure|2|||
161612407|NCT05349721|583633730|FG001|Part A (24 Weeks)|Screen Failure|0|||
161612408|NCT05349721|583633729|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
161612409|NCT05349721|583633730|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
161612410|NCT05349721|583633729|FG000|Part A (24 Weeks)|Other Than Specified|5|||
161612411|NCT05349721|583633730|FG001|Part A (24 Weeks)|Other Than Specified|1|||
161612412|NCT05349721|583633729|FG000|Part B (28 Weeks)|Adverse Event|3|||
161612413|NCT05349721|583633730|FG001|Part B (28 Weeks)|Adverse Event|0|||
161612414|NCT05349721|583633729|FG000|Part B (28 Weeks)|Death|21|||
161612415|NCT05349721|583633730|FG001|Part B (28 Weeks)|Death|11|||
161612416|NCT05349721|583633729|FG000|Part B (28 Weeks)|Disease Progression|2|||
161612417|NCT05349721|583633730|FG001|Part B (28 Weeks)|Disease Progression|1|||
161612418|NCT05349721|583633729|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
161612419|NCT05349721|583633730|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
161612420|NCT05349721|583633729|FG000|Part B (28 Weeks)|Physician Decision|1|||
161612421|NCT05349721|583633730|FG001|Part B (28 Weeks)|Physician Decision|0|||
161612422|NCT05349721|583633729|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
161612423|NCT05349721|583633730|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
161612424|NCT05349721|583633729|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
161612425|NCT05349721|583633730|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
161612426|NCT05349721|583633729|FG000|Part B (28 Weeks)|Other Than Specified|4|||
161612427|NCT05349721|583633730|FG001|Part B (28 Weeks)|Other Than Specified|2|||
161612428|NCT05349721|583633729|FG000|Part C (108 Weeks)|Death|0|||
161612429|NCT05349721|583633730|FG001|Part C (108 Weeks)|Death|1|||
161612430|NCT05349721|583633729|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
161612431|NCT05349721|583633730|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
161612432|NCT05349721|583633729|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
161612433|NCT05349721|583633730|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
161612434|NCT05349721|583633729|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
161612435|NCT05349721|583633730|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
161612436|NCT00799409|583633733|FG000|Overall Study|Withdrawal by Subject|1|||
161612437|NCT00799409|583633734|FG001|Overall Study|Withdrawal by Subject|0|||
161612438|NCT00799409|583633735|FG002|Overall Study|Withdrawal by Subject|0|||
161612439|NCT00799409|583633733|FG000|Overall Study|Lost to Follow-up|1|||
161612440|NCT00799409|583633734|FG001|Overall Study|Lost to Follow-up|0|||
161612441|NCT00799409|583633735|FG002|Overall Study|Lost to Follow-up|0|||
161612442|NCT00799409|583633733|FG000|Overall Study|Optimal Dose Not Achieved|2|||
161612443|NCT00799409|583633734|FG001|Overall Study|Optimal Dose Not Achieved|0|||
161612444|NCT00799409|583633735|FG002|Overall Study|Optimal Dose Not Achieved|0|||
161612445|NCT00799409|583633733|FG000|Overall Study|Failure to follow study protocol)|1|||
161612446|NCT00799409|583633734|FG001|Overall Study|Failure to follow study protocol)|0|||
161612447|NCT00799409|583633735|FG002|Overall Study|Failure to follow study protocol)|0|||
161612448|NCT00799409|583633733|FG000|Overall Study|Did not attend lab school day 1|1|||
161612449|NCT00799409|583633734|FG001|Overall Study|Did not attend lab school day 1|0|||
161612450|NCT00799409|583633735|FG002|Overall Study|Did not attend lab school day 1|0|||
161612451|NCT00799409|583633733|FG000|Overall Study|medication compliance|1|||
161612452|NCT00799409|583633734|FG001|Overall Study|medication compliance|0|||
161612453|NCT00799409|583633735|FG002|Overall Study|medication compliance|0|||
161612454|NCT04323800|583633736|FG000|Overall Study|Withdrawal by Subject|4|||
161612455|NCT04323800|583633737|FG001|Overall Study|Withdrawal by Subject|4|||
161612456|NCT04323800|583633736|FG000|Overall Study|Incomplete transfusion|1|||
161612457|NCT04323800|583633737|FG001|Overall Study|Incomplete transfusion|0|||
161612458|NCT04323800|583633736|FG000|Overall Study|Other|0|||
161612459|NCT04323800|583633737|FG001|Overall Study|Other|1|||
161612460|NCT04323800|583633736|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
161612461|NCT04323800|583633737|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
161612462|NCT00489554|583633738|FG000|Overall Study|Adverse Event|2|||
161612463|NCT00489554|583633738|FG000|Overall Study|Withdrawal by Subject|1|||
161612464|NCT00489554|583633738|FG000|Overall Study|Lost to Follow-up|1|||
161612465|NCT01732757|583633739|FG000|Overall Study|Lost to Follow-up|1|||
161612466|NCT01732757|583633740|FG001|Overall Study|Lost to Follow-up|0|||
161612467|NCT01732757|583633741|FG002|Overall Study|Lost to Follow-up|0|||
161612468|NCT00731692|583633742|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
161612469|NCT00731692|583633743|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
161612470|NCT00731692|583633744|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
161612471|NCT00731692|583633742|FG000|Core Study (36 Months)|Physician Decision|1|||
161612472|NCT00731692|583633743|FG001|Core Study (36 Months)|Physician Decision|0|||
161612473|NCT00731692|583633744|FG002|Core Study (36 Months)|Physician Decision|2|||
161612474|NCT00731692|583633742|FG000|Core Study (36 Months)|Death|2|||
161612475|NCT00731692|583633743|FG001|Core Study (36 Months)|Death|1|||
161612476|NCT00731692|583633744|FG002|Core Study (36 Months)|Death|2|||
161612477|NCT00731692|583633742|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
161612478|NCT00731692|583633743|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
161612479|NCT00731692|583633744|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
161612480|NCT00731692|583633742|FG000|Core Study (36 Months)|Administrative|2|||
161612481|NCT00731692|583633743|FG001|Core Study (36 Months)|Administrative|2|||
161684376|NCT02819635|583897893|FG001|Substudy 2, Part 2|Withdrew consent|0|||
161684377|NCT02819635|583897894|FG002|Substudy 2, Part 2|Withdrew consent|0|||
161684378|NCT02819635|583897895|FG003|Substudy 2, Part 2|Withdrew consent|0|||
161684379|NCT02819635|583897896|FG004|Substudy 2, Part 2|Withdrew consent|0|||
161684380|NCT02819635|583897897|FG005|Substudy 2, Part 2|Withdrew consent|3|||
161612482|NCT00731692|583633744|FG002|Core Study (36 Months)|Administrative|6|||
161612483|NCT00731692|583633742|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
161612484|NCT00731692|583633743|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
161612485|NCT00731692|583633744|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
161612486|NCT00731692|583633742|FG000|Core Study (36 Months)|Protocol Violation|4|||
161612487|NCT00731692|583633743|FG001|Core Study (36 Months)|Protocol Violation|5|||
161612488|NCT00731692|583633744|FG002|Core Study (36 Months)|Protocol Violation|8|||
161612489|NCT00731692|583633742|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
161612490|NCT00731692|583633743|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
161612491|NCT00731692|583633744|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
161684381|NCT02819635|583897898|FG006|Substudy 2, Part 2|Withdrew consent|1|||
161612492|NCT00731692|583633742|FG000|Core Study (36 Months)|Adverse Event|25|||
161612493|NCT00731692|583633743|FG001|Core Study (36 Months)|Adverse Event|28|||
161612494|NCT00731692|583633744|FG002|Core Study (36 Months)|Adverse Event|29|||
161612495|NCT00731692|583633742|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
161612496|NCT00731692|583633743|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
161612497|NCT00731692|583633744|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
161612498|NCT00731692|583633742|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
161612499|NCT00731692|583633743|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
161612500|NCT00731692|583633744|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
161612501|NCT00731692|583633742|FG000|Extension Phase|Abnormal test procedure|0|||
161612502|NCT00731692|583633743|FG001|Extension Phase|Abnormal test procedure|0|||
161612503|NCT00731692|583633744|FG002|Extension Phase|Abnormal test procedure|1|||
161612504|NCT00731692|583633742|FG000|Extension Phase|Abnormal lab values|0|||
161612505|NCT00731692|583633743|FG001|Extension Phase|Abnormal lab values|0|||
161684382|NCT02819635|583897899|FG007|Substudy 2, Part 2|Withdrew consent|0|||
161684383|NCT02819635|583897900|FG008|Substudy 2, Part 2|Withdrew consent|0|||
161684384|NCT02819635|583897901|FG009|Substudy 2, Part 2|Withdrew consent|0|||
161684385|NCT02819635|583897902|FG010|Substudy 2, Part 2|Withdrew consent|0|||
161684386|NCT02819635|583897903|FG011|Substudy 2, Part 2|Withdrew consent|0|||
161684387|NCT02819635|583897892|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
161684388|NCT02819635|583897893|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
161684389|NCT02819635|583897894|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
161684390|NCT02819635|583897895|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
161684391|NCT02819635|583897896|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
161684392|NCT02819635|583897897|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
161684393|NCT02819635|583897898|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
161612506|NCT00731692|583633744|FG002|Extension Phase|Abnormal lab values|1|||
161612507|NCT00731692|583633742|FG000|Extension Phase|Lost to Follow-up|0|||
161612508|NCT00731692|583633743|FG001|Extension Phase|Lost to Follow-up|1|||
161612509|NCT00731692|583633744|FG002|Extension Phase|Lost to Follow-up|4|||
161612510|NCT00731692|583633742|FG000|Extension Phase|Withdrawal by Subject|4|||
161612511|NCT00731692|583633743|FG001|Extension Phase|Withdrawal by Subject|5|||
161612512|NCT00731692|583633744|FG002|Extension Phase|Withdrawal by Subject|3|||
161612513|NCT00731692|583633742|FG000|Extension Phase|Adverse Event|1|||
161612514|NCT00731692|583633743|FG001|Extension Phase|Adverse Event|1|||
161612515|NCT00731692|583633744|FG002|Extension Phase|Adverse Event|15|||
161612516|NCT02372799|583633745|FG000|Treatment Period|Adverse Event|3|||
161612517|NCT02372799|583633746|FG001|Treatment Period|Adverse Event|10|||
161612518|NCT02372799|583633747|FG002|Treatment Period|Adverse Event|6|||
161612519|NCT02372799|583633745|FG000|Treatment Period|Insufficient therapeutic response|2|||
161612520|NCT02372799|583633746|FG001|Treatment Period|Insufficient therapeutic response|2|||
161612521|NCT02372799|583633747|FG002|Treatment Period|Insufficient therapeutic response|0|||
161612522|NCT02372799|583633745|FG000|Treatment Period|Withdrawal by Subject|10|||
161612523|NCT02372799|583633746|FG001|Treatment Period|Withdrawal by Subject|10|||
161612524|NCT02372799|583633747|FG002|Treatment Period|Withdrawal by Subject|2|||
161612525|NCT02372799|583633745|FG000|Treatment Period|Lost to Follow-up|11|||
161612526|NCT02372799|583633746|FG001|Treatment Period|Lost to Follow-up|5|||
161612527|NCT02372799|583633747|FG002|Treatment Period|Lost to Follow-up|3|||
161612528|NCT02372799|583633745|FG000|Treatment Period|Protocol Violation|3|||
161612529|NCT02372799|583633746|FG001|Treatment Period|Protocol Violation|0|||
161612530|NCT02372799|583633747|FG002|Treatment Period|Protocol Violation|0|||
161612531|NCT02372799|583633745|FG000|Treatment Period|Non-compliance with study drug|4|||
161612532|NCT02372799|583633746|FG001|Treatment Period|Non-compliance with study drug|4|||
161612533|NCT02372799|583633747|FG002|Treatment Period|Non-compliance with study drug|4|||
161612534|NCT02372799|583633745|FG000|Treatment Period|Miscellaneous Reasons|1|||
161612535|NCT02372799|583633746|FG001|Treatment Period|Miscellaneous Reasons|1|||
161612536|NCT02372799|583633747|FG002|Treatment Period|Miscellaneous Reasons|0|||
161612537|NCT02372799|583633745|FG000|Down-taper Period|Lost to Follow-up|1|||
161612538|NCT02372799|583633746|FG001|Down-taper Period|Lost to Follow-up|2|||
161612539|NCT02372799|583633747|FG002|Down-taper Period|Lost to Follow-up|2|||
161612540|NCT00747006|583633748|FG000|Overall Study|Adverse Event|1|||
161612541|NCT00747006|583633749|FG001|Overall Study|Adverse Event|0|||
161612542|NCT00747006|583633750|FG002|Overall Study|Adverse Event|0|||
161612543|NCT00747006|583633748|FG000|Overall Study|Lost to Follow-up|0|||
161612544|NCT00747006|583633749|FG001|Overall Study|Lost to Follow-up|1|||
161684394|NCT02819635|583897899|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
161684395|NCT02819635|583897900|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
161684396|NCT02819635|583897901|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
161612545|NCT00747006|583633750|FG002|Overall Study|Lost to Follow-up|0|||
161612546|NCT00747006|583633748|FG000|Overall Study|Physician Decision|2|||
161612547|NCT00747006|583633749|FG001|Overall Study|Physician Decision|0|||
161612548|NCT00747006|583633750|FG002|Overall Study|Physician Decision|1|||
161612549|NCT02132949|583633755|FG000|Overall Study|Death|7|||
161612550|NCT02132949|583633756|FG001|Overall Study|Death|13|||
161612551|NCT02132949|583633755|FG000|Overall Study|Lost to Follow-up|14|||
161612552|NCT02132949|583633756|FG001|Overall Study|Lost to Follow-up|4|||
161612553|NCT02132949|583633755|FG000|Overall Study|Withdrawal by Subject|6|||
161612554|NCT02132949|583633756|FG001|Overall Study|Withdrawal by Subject|5|||
161612555|NCT02132949|583633755|FG000|Overall Study|Noncompliance|5|||
161612556|NCT02132949|583633756|FG001|Overall Study|Noncompliance|1|||
161612557|NCT02132949|583633755|FG000|Overall Study|Physician Decision|3|||
161612558|NCT02132949|583633756|FG001|Overall Study|Physician Decision|1|||
161612559|NCT02132949|583633755|FG000|Overall Study|Disease Progression|3|||
161612560|NCT02132949|583633756|FG001|Overall Study|Disease Progression|0|||
161612561|NCT02132949|583633755|FG000|Overall Study|Adverse Event|2|||
161612562|NCT02132949|583633756|FG001|Overall Study|Adverse Event|1|||
161612563|NCT02132949|583633755|FG000|Overall Study|Withdrew Prior to Treatment|1|||
161612564|NCT02132949|583633756|FG001|Overall Study|Withdrew Prior to Treatment|2|||
161612565|NCT02132949|583633755|FG000|Overall Study|Reason Unspecified|0|||
161612566|NCT02132949|583633756|FG001|Overall Study|Reason Unspecified|1|||
161612567|NCT01583166|583633759|FG000|Overall Study|Withdrawal by Subject|4|||
161612568|NCT01583166|583633760|FG001|Overall Study|Withdrawal by Subject|6|||
161612569|NCT04652869|583633763|FG000|Overall Study|Withdrawal by Subject|0|||
161612570|NCT04652869|583633764|FG001|Overall Study|Withdrawal by Subject|2|||
161612571|NCT04652869|583633765|FG002|Overall Study|Withdrawal by Subject|0|||
161612572|NCT01372085|583633766|FG000|Washout Period 2|Physician Decision|0|||
161612573|NCT01372085|583633767|FG001|Washout Period 2|Physician Decision|0|||
161612574|NCT01372085|583633768|FG002|Washout Period 2|Physician Decision|0|||
161612575|NCT01372085|583633769|FG003|Washout Period 2|Physician Decision|0|||
161612576|NCT01372085|583633770|FG004|Washout Period 2|Physician Decision|1|||
161612577|NCT01372085|583633771|FG005|Washout Period 2|Physician Decision|0|||
161612578|NCT01372085|583633772|FG006|Washout Period 2|Physician Decision|0|||
161612579|NCT01372085|583633773|FG007|Washout Period 2|Physician Decision|0|||
161612580|NCT01372085|583633774|FG008|Washout Period 2|Physician Decision|0|||
161612581|NCT01372085|583633775|FG009|Washout Period 2|Physician Decision|0|||
161612582|NCT01372085|583633766|FG000|Washout Period 3|Withdrawal by Subject|0|||
161612583|NCT01372085|583633767|FG001|Washout Period 3|Withdrawal by Subject|0|||
161612584|NCT01372085|583633768|FG002|Washout Period 3|Withdrawal by Subject|0|||
161612585|NCT01372085|583633769|FG003|Washout Period 3|Withdrawal by Subject|0|||
161612586|NCT01372085|583633770|FG004|Washout Period 3|Withdrawal by Subject|0|||
161612587|NCT01372085|583633771|FG005|Washout Period 3|Withdrawal by Subject|2|||
161612588|NCT01372085|583633772|FG006|Washout Period 3|Withdrawal by Subject|0|||
161612589|NCT01372085|583633773|FG007|Washout Period 3|Withdrawal by Subject|0|||
161612590|NCT01372085|583633774|FG008|Washout Period 3|Withdrawal by Subject|0|||
161612591|NCT01372085|583633775|FG009|Washout Period 3|Withdrawal by Subject|0|||
161612592|NCT00562094|583633776|FG000|Overall Study|Lost to Follow-up|62|||
161612593|NCT03960645|583633777|FG000|Overall Study|Protocol Violation|1|||
161612594|NCT03960645|583633778|FG001|Overall Study|Protocol Violation|0|||
161612595|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
161612596|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
161612597|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
161612598|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
161612599|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
161612600|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
161612601|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
161612602|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
161612603|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161612604|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
161612605|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
161612606|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
161612607|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161612608|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161612609|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
161612610|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
161612611|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
161612612|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
161612613|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
161612614|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
161612615|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
161612616|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
161612617|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
161612618|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
161612619|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
161612620|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
161612621|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
161612622|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
161612623|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
161612624|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
161612625|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
161612626|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
161612627|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
161612628|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
161612629|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
161612630|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161612631|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161612632|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161612633|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161612634|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
161612635|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
161612636|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
161612637|NCT03732807|583633783|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161612638|NCT03732807|583633784|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161612639|NCT03732807|583633785|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161612640|NCT03732807|583633786|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161612641|NCT03732807|583633787|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161612642|NCT03732807|583633788|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
161612643|NCT03732807|583633789|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161612644|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
161612645|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
161612646|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
161612647|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
161612648|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
161612649|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
161612650|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
161612651|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
161612652|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
161612653|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
161612654|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
161612655|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
161612656|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
161612657|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
161612658|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
161612659|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
161612660|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
161612661|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
161612662|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
161612663|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
161612664|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
161612665|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161612666|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
161612667|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161684397|NCT02819635|583897902|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
161612668|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161612669|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161612670|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161612671|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161612672|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161612673|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
161612674|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161612675|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
161612676|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
161612677|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161612678|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161612679|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
161612680|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
161612681|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161612682|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161612683|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
161612684|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161612685|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161612686|NCT03732807|583633783|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
161612687|NCT03732807|583633784|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
161612688|NCT03732807|583633785|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
161612689|NCT03732807|583633786|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
161612690|NCT03732807|583633787|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
161612691|NCT03732807|583633788|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
161612692|NCT03732807|583633789|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
161612693|NCT03345979|583633791|FG000|Overall Study|Withdrawal by Subject|20|||
161612694|NCT03345979|583633792|FG001|Overall Study|Withdrawal by Subject|31|||
161612695|NCT03345979|583633791|FG000|Overall Study|Adverse Event|10|||
161612696|NCT03345979|583633792|FG001|Overall Study|Adverse Event|11|||
161612697|NCT03345979|583633791|FG000|Overall Study|Lost to Follow-up|8|||
161612698|NCT03345979|583633792|FG001|Overall Study|Lost to Follow-up|9|||
161612699|NCT03345979|583633791|FG000|Overall Study|Lack of Efficacy|4|||
161612700|NCT03345979|583633792|FG001|Overall Study|Lack of Efficacy|2|||
161612701|NCT03345979|583633791|FG000|Overall Study|Protocol Violation|1|||
161612702|NCT03345979|583633792|FG001|Overall Study|Protocol Violation|3|||
161612703|NCT03345979|583633791|FG000|Overall Study|Physician Decision|0|||
161612704|NCT03345979|583633792|FG001|Overall Study|Physician Decision|2|||
161612705|NCT00734578|583633793|FG000|Overall Study|Adverse Event|4|||
161612706|NCT00734578|583633794|FG001|Overall Study|Adverse Event|6|||
161612707|NCT00734578|583633795|FG002|Overall Study|Adverse Event|1|||
161612708|NCT00734578|583633793|FG000|Overall Study|Protocol Violation|8|||
161612709|NCT00734578|583633794|FG001|Overall Study|Protocol Violation|6|||
161612710|NCT00734578|583633795|FG002|Overall Study|Protocol Violation|3|||
161612711|NCT00734578|583633793|FG000|Overall Study|Withdrawal by Subject|7|||
161612712|NCT00734578|583633794|FG001|Overall Study|Withdrawal by Subject|8|||
161612713|NCT00734578|583633795|FG002|Overall Study|Withdrawal by Subject|11|||
161612714|NCT00734578|583633793|FG000|Overall Study|Lost to Follow-up|9|||
161612715|NCT00734578|583633794|FG001|Overall Study|Lost to Follow-up|3|||
161684398|NCT02819635|583897903|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
161684399|NCT02819635|583897892|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684400|NCT02819635|583897893|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161612716|NCT00734578|583633795|FG002|Overall Study|Lost to Follow-up|5|||
161612717|NCT00734578|583633793|FG000|Overall Study|Lack of Efficacy|3|||
161612718|NCT00734578|583633794|FG001|Overall Study|Lack of Efficacy|2|||
161612719|NCT00734578|583633795|FG002|Overall Study|Lack of Efficacy|5|||
161612720|NCT00734578|583633793|FG000|Overall Study|Randomized in error|1|||
161612721|NCT00734578|583633794|FG001|Overall Study|Randomized in error|0|||
161612722|NCT00734578|583633795|FG002|Overall Study|Randomized in error|0|||
161612723|NCT00734578|583633793|FG000|Overall Study|Exclusion criteria|1|||
161612724|NCT00734578|583633794|FG001|Overall Study|Exclusion criteria|0|||
161612725|NCT00734578|583633795|FG002|Overall Study|Exclusion criteria|0|||
161612726|NCT00999596|583633796|FG000|Overall Study|Statistical population not required|101|||
161612727|NCT01629589|583633803|FG000|Overall Study|Protocol Violation|4|||
161612728|NCT01629589|583633804|FG001|Overall Study|Protocol Violation|2|||
161612729|NCT01629589|583633803|FG000|Overall Study|Lost to Follow-up|2|||
161612730|NCT01629589|583633804|FG001|Overall Study|Lost to Follow-up|1|||
161612731|NCT01629589|583633803|FG000|Overall Study|Withdrawal by Subject|2|||
161612732|NCT01629589|583633804|FG001|Overall Study|Withdrawal by Subject|3|||
161612733|NCT01629589|583633803|FG000|Overall Study|Did not receive study vaccine|0|||
161612734|NCT01629589|583633804|FG001|Overall Study|Did not receive study vaccine|1|||
161612735|NCT02079649|583633805|FG000|Overall Study|Lost to Follow-up|0|||
161612736|NCT02079649|583633806|FG001|Overall Study|Lost to Follow-up|0|||
161612737|NCT02079649|583633807|FG002|Overall Study|Lost to Follow-up|0|||
161612738|NCT02079649|583633808|FG003|Overall Study|Lost to Follow-up|1|||
161612739|NCT02079649|583633805|FG000|Overall Study|Withdrawal by Subject|0|||
161612740|NCT02079649|583633806|FG001|Overall Study|Withdrawal by Subject|0|||
161612741|NCT02079649|583633807|FG002|Overall Study|Withdrawal by Subject|0|||
161612742|NCT02079649|583633808|FG003|Overall Study|Withdrawal by Subject|1|||
161612743|NCT02079649|583633805|FG000|Overall Study|Randomization error (prior to treatment)|1|||
161612744|NCT02079649|583633806|FG001|Overall Study|Randomization error (prior to treatment)|0|||
161612745|NCT02079649|583633807|FG002|Overall Study|Randomization error (prior to treatment)|1|||
161612746|NCT02079649|583633808|FG003|Overall Study|Randomization error (prior to treatment)|0|||
161612747|NCT01932970|583633830|FG000|Overall Study|Withdrawal by Subject|5|||
161612748|NCT01932970|583633830|FG000|Overall Study|Death|1|||
161612749|NCT01932970|583633830|FG000|Overall Study|Lost to Follow-up|2|||
161612750|NCT01932970|583633830|FG000|Overall Study|Protocol Specified Criteria|10|||
161612751|NCT03739866|583633834|FG000|Overall Study|Lost to Follow-up|0|||
161612752|NCT03739866|583633835|FG001|Overall Study|Lost to Follow-up|0|||
161612753|NCT03739866|583633836|FG002|Overall Study|Lost to Follow-up|0|||
161612754|NCT03739866|583633837|FG003|Overall Study|Lost to Follow-up|1|||
161612755|NCT03739866|583633838|FG004|Overall Study|Lost to Follow-up|0|||
161612756|NCT03739866|583633839|FG005|Overall Study|Lost to Follow-up|0|||
161612757|NCT03739866|583633840|FG006|Overall Study|Lost to Follow-up|0|||
161612758|NCT03739866|583633841|FG007|Overall Study|Lost to Follow-up|0|||
161612759|NCT03739866|583633834|FG000|Overall Study|Enrolled but not treated|0|||
161612760|NCT03739866|583633835|FG001|Overall Study|Enrolled but not treated|0|||
161612761|NCT03739866|583633836|FG002|Overall Study|Enrolled but not treated|1|||
161612762|NCT03739866|583633837|FG003|Overall Study|Enrolled but not treated|0|||
161612763|NCT03739866|583633838|FG004|Overall Study|Enrolled but not treated|1|||
161612764|NCT03739866|583633839|FG005|Overall Study|Enrolled but not treated|0|||
161612765|NCT03739866|583633840|FG006|Overall Study|Enrolled but not treated|0|||
161612766|NCT03739866|583633841|FG007|Overall Study|Enrolled but not treated|0|||
161612767|NCT01034306|583633842|FG000|Overall Study|Adverse Event|1|||
161612768|NCT01034306|583633843|FG001|Overall Study|Adverse Event|0|||
161612769|NCT01034306|583633842|FG000|Overall Study|Lost to Follow-up|0|||
161612770|NCT01034306|583633843|FG001|Overall Study|Lost to Follow-up|1|||
161612771|NCT01034306|583633842|FG000|Overall Study|Withdrawal by Subject|2|||
161612772|NCT01034306|583633843|FG001|Overall Study|Withdrawal by Subject|2|||
161612773|NCT01034306|583633842|FG000|Overall Study|hospitalized and decided to stop|1|||
161612774|NCT01034306|583633843|FG001|Overall Study|hospitalized and decided to stop|0|||
161612775|NCT01034306|583633842|FG000|Overall Study|Noncomplience|1|||
161612776|NCT01034306|583633843|FG001|Overall Study|Noncomplience|0|||
161612777|NCT00836498|583633844|FG000|Overall Study|Adverse Event|1|||
161612778|NCT00836498|583633845|FG001|Overall Study|Adverse Event|0|||
161612779|NCT00836498|583633844|FG000|Overall Study|Lost to Follow-up|1|||
161612780|NCT00836498|583633845|FG001|Overall Study|Lost to Follow-up|0|||
161612781|NCT00836498|583633844|FG000|Overall Study|Withdrawal by Subject|2|||
161612782|NCT00836498|583633845|FG001|Overall Study|Withdrawal by Subject|1|||
161612783|NCT03057600|583633846|FG000|Overall Study|Adverse Event|0|||
161612784|NCT03057600|583633847|FG001|Overall Study|Adverse Event|0|||
161612785|NCT03057600|583633848|FG002|Overall Study|Adverse Event|4|||
161612786|NCT03057600|583633849|FG003|Overall Study|Adverse Event|0|||
161612787|NCT03057600|583633846|FG000|Overall Study|Radiologic Disease Progression|8|||
161612788|NCT03057600|583633847|FG001|Overall Study|Radiologic Disease Progression|7|||
161612789|NCT03057600|583633848|FG002|Overall Study|Radiologic Disease Progression|13|||
161612790|NCT03057600|583633849|FG003|Overall Study|Radiologic Disease Progression|10|||
161612791|NCT03057600|583633846|FG000|Overall Study|Symptomatic Deterioration|0|||
161612792|NCT03057600|583633847|FG001|Overall Study|Symptomatic Deterioration|1|||
161612793|NCT03057600|583633848|FG002|Overall Study|Symptomatic Deterioration|1|||
161612794|NCT03057600|583633849|FG003|Overall Study|Symptomatic Deterioration|0|||
161612795|NCT03057600|583633846|FG000|Overall Study|Investigator Decision|0|||
161612796|NCT03057600|583633847|FG001|Overall Study|Investigator Decision|0|||
161612797|NCT03057600|583633848|FG002|Overall Study|Investigator Decision|1|||
161612798|NCT03057600|583633849|FG003|Overall Study|Investigator Decision|0|||
161612799|NCT03057600|583633846|FG000|Overall Study|Study Termination by Sponsor|0|||
161612800|NCT03057600|583633847|FG001|Overall Study|Study Termination by Sponsor|0|||
161612801|NCT03057600|583633848|FG002|Overall Study|Study Termination by Sponsor|0|||
161612802|NCT03057600|583633849|FG003|Overall Study|Study Termination by Sponsor|2|||
161612803|NCT03057600|583633846|FG000|Overall Study|Withdrawal by Subject|0|||
161612804|NCT03057600|583633847|FG001|Overall Study|Withdrawal by Subject|1|||
161612805|NCT03057600|583633848|FG002|Overall Study|Withdrawal by Subject|0|||
161612806|NCT03057600|583633849|FG003|Overall Study|Withdrawal by Subject|0|||
161612807|NCT03057600|583633846|FG000|Overall Study|Other, Not Specified|1|||
161612808|NCT03057600|583633847|FG001|Overall Study|Other, Not Specified|1|||
161612809|NCT03057600|583633848|FG002|Overall Study|Other, Not Specified|1|||
161612810|NCT03057600|583633849|FG003|Overall Study|Other, Not Specified|1|||
161612811|NCT02384382|583633850|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
161612812|NCT02384382|583633850|FG000|Overall Study|Death|1|||
161612813|NCT02384382|583633850|FG000|Overall Study|Adverse Event|1|||
161612814|NCT02384382|583633850|FG000|Overall Study|Disease progression|16|||
161612815|NCT01953692|583633851|FG000|Overall Study|Adverse Event|5|||
161612816|NCT01953692|583633852|FG001|Overall Study|Adverse Event|2|||
161612817|NCT01953692|583633853|FG002|Overall Study|Adverse Event|4|||
161612818|NCT01953692|583633854|FG003|Overall Study|Adverse Event|2|||
161612819|NCT01953692|583633855|FG004|Overall Study|Adverse Event|1|||
161612820|NCT01953692|583633856|FG005|Overall Study|Adverse Event|2|||
161612821|NCT01953692|583633857|FG006|Overall Study|Adverse Event|0|||
161612822|NCT01953692|583633858|FG007|Overall Study|Adverse Event|0|||
161612823|NCT01953692|583633859|FG008|Overall Study|Adverse Event|0|||
161612824|NCT01953692|583633851|FG000|Overall Study|Clinical Progression|0|||
161612825|NCT01953692|583633852|FG001|Overall Study|Clinical Progression|15|||
161612826|NCT01953692|583633853|FG002|Overall Study|Clinical Progression|7|||
161612827|NCT01953692|583633854|FG003|Overall Study|Clinical Progression|5|||
161612828|NCT01953692|583633855|FG004|Overall Study|Clinical Progression|0|||
161612829|NCT01953692|583633856|FG005|Overall Study|Clinical Progression|7|||
161612830|NCT01953692|583633857|FG006|Overall Study|Clinical Progression|20|||
161612831|NCT01953692|583633858|FG007|Overall Study|Clinical Progression|3|||
161612832|NCT01953692|583633859|FG008|Overall Study|Clinical Progression|3|||
161612833|NCT01953692|583633851|FG000|Overall Study|Death|5|||
161612834|NCT01953692|583633852|FG001|Overall Study|Death|0|||
161612835|NCT01953692|583633853|FG002|Overall Study|Death|2|||
161612836|NCT01953692|583633854|FG003|Overall Study|Death|2|||
161832597|NCT00706355|584428477|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
161612837|NCT01953692|583633855|FG004|Overall Study|Death|1|||
161612838|NCT01953692|583633856|FG005|Overall Study|Death|3|||
161612839|NCT01953692|583633857|FG006|Overall Study|Death|6|||
161612840|NCT01953692|583633858|FG007|Overall Study|Death|2|||
161612841|NCT01953692|583633859|FG008|Overall Study|Death|1|||
161612842|NCT01953692|583633851|FG000|Overall Study|Excluded Medication|1|||
161612843|NCT01953692|583633852|FG001|Overall Study|Excluded Medication|0|||
161612844|NCT01953692|583633853|FG002|Overall Study|Excluded Medication|0|||
161612845|NCT01953692|583633854|FG003|Overall Study|Excluded Medication|0|||
161612846|NCT01953692|583633855|FG004|Overall Study|Excluded Medication|0|||
161612847|NCT01953692|583633856|FG005|Overall Study|Excluded Medication|0|||
161612848|NCT01953692|583633857|FG006|Overall Study|Excluded Medication|0|||
161612849|NCT01953692|583633858|FG007|Overall Study|Excluded Medication|0|||
161612850|NCT01953692|583633859|FG008|Overall Study|Excluded Medication|0|||
161612851|NCT01953692|583633851|FG000|Overall Study|Lost to Follow-up|1|||
161612852|NCT01953692|583633852|FG001|Overall Study|Lost to Follow-up|0|||
161612853|NCT01953692|583633853|FG002|Overall Study|Lost to Follow-up|3|||
161612854|NCT01953692|583633854|FG003|Overall Study|Lost to Follow-up|1|||
161612855|NCT01953692|583633855|FG004|Overall Study|Lost to Follow-up|0|||
161612856|NCT01953692|583633856|FG005|Overall Study|Lost to Follow-up|1|||
161612857|NCT01953692|583633857|FG006|Overall Study|Lost to Follow-up|0|||
161612858|NCT01953692|583633858|FG007|Overall Study|Lost to Follow-up|0|||
161612859|NCT01953692|583633859|FG008|Overall Study|Lost to Follow-up|0|||
161612860|NCT01953692|583633851|FG000|Overall Study|Physician Decision|11|||
161612861|NCT01953692|583633852|FG001|Overall Study|Physician Decision|4|||
161612862|NCT01953692|583633853|FG002|Overall Study|Physician Decision|2|||
161612863|NCT01953692|583633854|FG003|Overall Study|Physician Decision|2|||
161612864|NCT01953692|583633855|FG004|Overall Study|Physician Decision|1|||
161612865|NCT01953692|583633856|FG005|Overall Study|Physician Decision|2|||
161612866|NCT01953692|583633857|FG006|Overall Study|Physician Decision|4|||
161612867|NCT01953692|583633858|FG007|Overall Study|Physician Decision|1|||
161612868|NCT01953692|583633859|FG008|Overall Study|Physician Decision|0|||
161612869|NCT01953692|583633851|FG000|Overall Study|Protocol Violation|0|||
161612870|NCT01953692|583633852|FG001|Overall Study|Protocol Violation|2|||
161612871|NCT01953692|583633853|FG002|Overall Study|Protocol Violation|1|||
161612872|NCT01953692|583633854|FG003|Overall Study|Protocol Violation|0|||
161612873|NCT01953692|583633855|FG004|Overall Study|Protocol Violation|0|||
161612874|NCT01953692|583633856|FG005|Overall Study|Protocol Violation|0|||
161612875|NCT01953692|583633857|FG006|Overall Study|Protocol Violation|0|||
161612876|NCT01953692|583633858|FG007|Overall Study|Protocol Violation|1|||
161612877|NCT01953692|583633859|FG008|Overall Study|Protocol Violation|0|||
161612878|NCT01953692|583633851|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612879|NCT01953692|583633852|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612880|NCT01953692|583633853|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612881|NCT01953692|583633854|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612882|NCT01953692|583633855|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612883|NCT01953692|583633856|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612884|NCT01953692|583633857|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612885|NCT01953692|583633858|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
161612886|NCT01953692|583633859|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161612887|NCT01953692|583633851|FG000|Overall Study|Withdrawal by Subject|4|||
161612888|NCT01953692|583633852|FG001|Overall Study|Withdrawal by Subject|2|||
161612889|NCT01953692|583633853|FG002|Overall Study|Withdrawal by Subject|1|||
161612890|NCT01953692|583633854|FG003|Overall Study|Withdrawal by Subject|2|||
161612891|NCT01953692|583633855|FG004|Overall Study|Withdrawal by Subject|0|||
161612892|NCT01953692|583633856|FG005|Overall Study|Withdrawal by Subject|3|||
161612893|NCT01953692|583633857|FG006|Overall Study|Withdrawal by Subject|2|||
161832598|NCT00706355|584428478|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161832599|NCT00706355|584428479|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161612894|NCT01953692|583633858|FG007|Overall Study|Withdrawal by Subject|1|||
161612895|NCT01953692|583633859|FG008|Overall Study|Withdrawal by Subject|1|||
161612896|NCT01822756|583633862|FG000|Overall Study|Adverse Event|0|||
161612897|NCT01822756|583633863|FG001|Overall Study|Adverse Event|0|||
161612898|NCT01822756|583633864|FG002|Overall Study|Adverse Event|0|||
161612899|NCT01822756|583633865|FG003|Overall Study|Adverse Event|2|||
161612900|NCT01822756|583633866|FG004|Overall Study|Adverse Event|0|||
161612901|NCT01822756|583633862|FG000|Overall Study|Disease progression|11|||
161612902|NCT01822756|583633863|FG001|Overall Study|Disease progression|1|||
161832600|NCT00706355|584428476|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161832601|NCT00706355|584428477|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
161832602|NCT00706355|584428478|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161612903|NCT01822756|583633864|FG002|Overall Study|Disease progression|7|||
161612904|NCT01822756|583633865|FG003|Overall Study|Disease progression|2|||
161612905|NCT01822756|583633866|FG004|Overall Study|Disease progression|6|||
161612906|NCT01822756|583633862|FG000|Overall Study|Death|2|||
161612907|NCT01822756|583633863|FG001|Overall Study|Death|2|||
161612908|NCT01822756|583633864|FG002|Overall Study|Death|1|||
161612909|NCT01822756|583633865|FG003|Overall Study|Death|0|||
161612910|NCT01822756|583633866|FG004|Overall Study|Death|0|||
161612911|NCT01822756|583633862|FG000|Overall Study|Lost to Follow-up|1|||
161612912|NCT01822756|583633863|FG001|Overall Study|Lost to Follow-up|0|||
161612913|NCT01822756|583633864|FG002|Overall Study|Lost to Follow-up|1|||
161612914|NCT01822756|583633865|FG003|Overall Study|Lost to Follow-up|0|||
161612915|NCT01822756|583633866|FG004|Overall Study|Lost to Follow-up|1|||
161612916|NCT01822756|583633862|FG000|Overall Study|Physician Decision|0|||
161612917|NCT01822756|583633863|FG001|Overall Study|Physician Decision|1|||
161612918|NCT01822756|583633864|FG002|Overall Study|Physician Decision|0|||
161612919|NCT01822756|583633865|FG003|Overall Study|Physician Decision|0|||
161612920|NCT01822756|583633866|FG004|Overall Study|Physician Decision|0|||
161612921|NCT01822756|583633862|FG000|Overall Study|disease progression & patient preference|2|||
161612922|NCT01822756|583633863|FG001|Overall Study|disease progression & patient preference|0|||
161612923|NCT01822756|583633864|FG002|Overall Study|disease progression & patient preference|1|||
161612924|NCT01822756|583633865|FG003|Overall Study|disease progression & patient preference|0|||
161612925|NCT01822756|583633866|FG004|Overall Study|disease progression & patient preference|0|||
161612926|NCT02157948|583633867|FG000|Overall Study|Withdrawal by Subject|4|||
161612927|NCT02157948|583633868|FG001|Overall Study|Withdrawal by Subject|5|||
161612928|NCT02157948|583633867|FG000|Overall Study|Lost to Follow-up|3|||
161612929|NCT02157948|583633868|FG001|Overall Study|Lost to Follow-up|2|||
161612930|NCT02157948|583633867|FG000|Overall Study|Protocol Specified Criteria|2|||
161612931|NCT02157948|583633868|FG001|Overall Study|Protocol Specified Criteria|1|||
161612932|NCT02157948|583633867|FG000|Overall Study|Decision by Sponsor|0|||
161612933|NCT02157948|583633868|FG001|Overall Study|Decision by Sponsor|1|||
161612934|NCT00467272|583633872|FG000|Overall Study|Pneumonia|2|||
161612935|NCT00467272|583633872|FG000|Overall Study|Thrombophlebitis|1|||
161612936|NCT01690624|583633876|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
161612937|NCT01690624|583633877|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
161612938|NCT01690624|583633878|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
161612939|NCT01690624|583633879|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
161612940|NCT01690624|583633876|FG000|Overall Study|Adverse event (other than DLT)|3|||
161612941|NCT01690624|583633877|FG001|Overall Study|Adverse event (other than DLT)|1|||
161612942|NCT01690624|583633878|FG002|Overall Study|Adverse event (other than DLT)|1|||
161832603|NCT00706355|584428479|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161832604|NCT00706355|584428476|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161832605|NCT00706355|584428477|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161612943|NCT01690624|583633879|FG003|Overall Study|Adverse event (other than DLT)|1|||
161612944|NCT01690624|583633876|FG000|Overall Study|Withdrawal by Subject|0|||
161612945|NCT01690624|583633877|FG001|Overall Study|Withdrawal by Subject|0|||
161612946|NCT01690624|583633878|FG002|Overall Study|Withdrawal by Subject|1|||
161612947|NCT01690624|583633879|FG003|Overall Study|Withdrawal by Subject|0|||
161612948|NCT01690624|583633876|FG000|Overall Study|Sponsor is ending trial|0|||
161612949|NCT01690624|583633877|FG001|Overall Study|Sponsor is ending trial|0|||
161612950|NCT01690624|583633878|FG002|Overall Study|Sponsor is ending trial|0|||
161612951|NCT01690624|583633879|FG003|Overall Study|Sponsor is ending trial|1|||
161612952|NCT01690624|583633876|FG000|Overall Study|Physician Decision|0|||
161612953|NCT01690624|583633877|FG001|Overall Study|Physician Decision|0|||
161612954|NCT01690624|583633878|FG002|Overall Study|Physician Decision|0|||
161612955|NCT01690624|583633879|FG003|Overall Study|Physician Decision|1|||
161612956|NCT01690624|583633876|FG000|Overall Study|Withdrawal by Subject|0|||
161612957|NCT01690624|583633877|FG001|Overall Study|Withdrawal by Subject|1|||
161612958|NCT01690624|583633878|FG002|Overall Study|Withdrawal by Subject|0|||
161612959|NCT01690624|583633879|FG003|Overall Study|Withdrawal by Subject|0|||
161612960|NCT01690624|583633876|FG000|Overall Study|Lack of Efficacy|1|||
161612961|NCT01690624|583633877|FG001|Overall Study|Lack of Efficacy|1|||
161612962|NCT01690624|583633878|FG002|Overall Study|Lack of Efficacy|3|||
161612963|NCT01690624|583633879|FG003|Overall Study|Lack of Efficacy|0|||
161612964|NCT04445831|583633880|FG000|Overall Study|Withdrawal by Subject|2|||
161612965|NCT04445831|583633881|FG001|Overall Study|Withdrawal by Subject|1|||
161612966|NCT04445831|583633882|FG002|Overall Study|Withdrawal by Subject|1|||
161832606|NCT00706355|584428478|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
161832607|NCT00706355|584428479|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161612967|NCT04445831|583633883|FG003|Overall Study|Withdrawal by Subject|0|||
161612968|NCT04445831|583633884|FG004|Overall Study|Withdrawal by Subject|0|||
161612969|NCT04445831|583633885|FG005|Overall Study|Withdrawal by Subject|0|||
161612970|NCT04445831|583633886|FG006|Overall Study|Withdrawal by Subject|0|||
161612971|NCT04445831|583633880|FG000|Overall Study|Subject withdrawal by caregiver|0|||
161612972|NCT04445831|583633881|FG001|Overall Study|Subject withdrawal by caregiver|1|||
161612973|NCT04445831|583633882|FG002|Overall Study|Subject withdrawal by caregiver|0|||
161612974|NCT04445831|583633883|FG003|Overall Study|Subject withdrawal by caregiver|0|||
161612975|NCT04445831|583633884|FG004|Overall Study|Subject withdrawal by caregiver|0|||
161612976|NCT04445831|583633885|FG005|Overall Study|Subject withdrawal by caregiver|0|||
161612977|NCT04445831|583633886|FG006|Overall Study|Subject withdrawal by caregiver|0|||
161612978|NCT04701203|583633887|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
161612979|NCT04701203|583633888|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
161612980|NCT04701203|583633889|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
161612981|NCT04701203|583633887|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
161612982|NCT04701203|583633888|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
161612983|NCT04701203|583633889|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
161612984|NCT04701203|583633887|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
161612985|NCT04701203|583633888|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
161612986|NCT04701203|583633889|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
161612987|NCT04701203|583633887|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
161612988|NCT04701203|583633888|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
161612989|NCT04701203|583633889|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
161612990|NCT02434328|583633890|FG000|Overall Study|Adverse Event|9|||
161612991|NCT02434328|583633891|FG001|Overall Study|Adverse Event|4|||
161612992|NCT02434328|583633890|FG000|Overall Study|Lack of Efficacy|0|||
161684401|NCT02819635|583897894|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161612993|NCT02434328|583633891|FG001|Overall Study|Lack of Efficacy|2|||
161612994|NCT02434328|583633890|FG000|Overall Study|Physician Decision|0|||
161612995|NCT02434328|583633891|FG001|Overall Study|Physician Decision|1|||
161612996|NCT02434328|583633890|FG000|Overall Study|Withdrawal by Subject|12|||
161612997|NCT02434328|583633891|FG001|Overall Study|Withdrawal by Subject|21|||
161612998|NCT02434328|583633890|FG000|Overall Study|Death|4|||
161612999|NCT02434328|583633891|FG001|Overall Study|Death|7|||
161613000|NCT02434328|583633890|FG000|Overall Study|Lost to Follow-up|1|||
161613001|NCT02434328|583633891|FG001|Overall Study|Lost to Follow-up|6|||
161613002|NCT02434328|583633890|FG000|Overall Study|Other|4|||
161613003|NCT02434328|583633891|FG001|Overall Study|Other|1|||
161613004|NCT01563185|583633892|FG000|Overall Study|Withdrawal by Subject|1|||
161613005|NCT01563185|583633892|FG000|Overall Study|Non-Compliance with study drug|1|||
161613006|NCT06571695|583635297|FG000|Overall Study|Lost to Follow-up|1|||
161613007|NCT06571695|583635298|FG001|Overall Study|Lost to Follow-up|6|||
161613008|NCT00108355|583635299|FG000|Overall Study|Peritonitis at index paracentesis|1|||
161613009|NCT00108355|583635300|FG001|Overall Study|Peritonitis at index paracentesis|1|||
161613010|NCT00108355|583635299|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
161613011|NCT00108355|583635300|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
161613012|NCT04921358|583635301|FG000|Overall Study|Withdrawal by Subject|6|||
161613013|NCT04921358|583635302|FG001|Overall Study|Withdrawal by Subject|13|||
161613014|NCT04921358|583635301|FG000|Overall Study|Lost to Follow-up|3|||
161613015|NCT04921358|583635302|FG001|Overall Study|Lost to Follow-up|6|||
161613016|NCT04921358|583635301|FG000|Overall Study|Study Terminated by Sponsor|86|||
161613017|NCT04921358|583635302|FG001|Overall Study|Study Terminated by Sponsor|89|||
161613018|NCT04921358|583635301|FG000|Overall Study|Death|92|||
161613019|NCT04921358|583635302|FG001|Overall Study|Death|82|||
161613020|NCT02278796|583635303|FG000|Overall Study|Death|2|||
161613021|NCT02278796|583635304|FG001|Overall Study|Death|3|||
161613022|NCT04926857|583635305|FG000|Overall Study|Withdrawal by Subject|40|||
161613023|NCT04926857|583635305|FG000|Overall Study|Death|9|||
161613024|NCT04926857|583635305|FG000|Overall Study|Study product no longer in use|44|||
161613025|NCT04926857|583635305|FG000|Overall Study|Inadequate data to address primary objective|16|||
161613026|NCT03737110|583635308|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
161613027|NCT03737110|583635309|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
161613028|NCT03737110|583635310|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
161684402|NCT02819635|583897895|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684403|NCT02819635|583897896|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684404|NCT02819635|583897897|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161613029|NCT03737110|583635311|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
161613030|NCT03737110|583635312|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
161613031|NCT03737110|583635313|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
161613032|NCT03737110|583635308|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
161613033|NCT03737110|583635309|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161613034|NCT03737110|583635310|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161613035|NCT03737110|583635311|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161613036|NCT03737110|583635312|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161613037|NCT03737110|583635313|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161613038|NCT03737110|583635308|FG000|Run-in (RI) Period|Adverse Event|4|||
161613039|NCT03737110|583635309|FG001|Run-in (RI) Period|Adverse Event|0|||
161613040|NCT03737110|583635310|FG002|Run-in (RI) Period|Adverse Event|0|||
161613041|NCT03737110|583635311|FG003|Run-in (RI) Period|Adverse Event|0|||
161613042|NCT03737110|583635312|FG004|Run-in (RI) Period|Adverse Event|0|||
161613043|NCT03737110|583635313|FG005|Run-in (RI) Period|Adverse Event|0|||
161613044|NCT03737110|583635308|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161613045|NCT03737110|583635309|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
161613046|NCT03737110|583635310|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161613047|NCT03737110|583635311|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161613048|NCT03737110|583635312|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161613049|NCT03737110|583635313|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161613050|NCT03737110|583635308|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161613051|NCT03737110|583635309|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161613052|NCT03737110|583635310|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
161613053|NCT03737110|583635311|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161613054|NCT03737110|583635312|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161613055|NCT03737110|583635313|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161613056|NCT03737110|583635308|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161613057|NCT03737110|583635309|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161613058|NCT03737110|583635310|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161613059|NCT03737110|583635311|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
161613060|NCT03737110|583635312|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161613061|NCT03737110|583635313|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161613062|NCT03737110|583635308|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161613063|NCT03737110|583635309|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161613064|NCT03737110|583635310|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161613065|NCT03737110|583635311|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
161613066|NCT03737110|583635312|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161613067|NCT03737110|583635313|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
161613068|NCT03737110|583635308|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161613069|NCT03737110|583635309|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161613070|NCT03737110|583635310|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161613071|NCT03737110|583635311|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161613072|NCT03737110|583635312|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
161613073|NCT03737110|583635313|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161613074|NCT00599196|583635318|FG000|Overall Study|Lack of Efficacy|22|||
161613075|NCT00599196|583635318|FG000|Overall Study|Adverse Event|93|||
161613076|NCT00599196|583635318|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
161613077|NCT00599196|583635318|FG000|Overall Study|Subject withdrew consent|43|||
161613078|NCT00599196|583635318|FG000|Overall Study|Study ended per sponsor|197|||
161613079|NCT00599196|583635318|FG000|Overall Study|Lost to Follow-up|17|||
161613080|NCT00599196|583635318|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
161613081|NCT00599196|583635318|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
161613082|NCT00599196|583635318|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
161613083|NCT00599196|583635318|FG000|Overall Study|Other: Pt Moved To Australia|1|||
161613084|NCT00599196|583635318|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
161613085|NCT00599196|583635318|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
161613086|NCT01009645|583635332|FG000|Overall Study|Lost to Follow-up|2|||
161613087|NCT01009645|583635333|FG001|Overall Study|Lost to Follow-up|8|||
161613088|NCT01009645|583635334|FG002|Overall Study|Lost to Follow-up|4|||
161613089|NCT01009645|583635335|FG003|Overall Study|Lost to Follow-up|5|||
161613090|NCT01124045|583635336|FG000|Overall Study|Lost to Follow-up|0|||
161613091|NCT01124045|583635337|FG001|Overall Study|Lost to Follow-up|1|||
161613092|NCT01124045|583635336|FG000|Overall Study|Physician Decision|0|||
161613093|NCT01124045|583635337|FG001|Overall Study|Physician Decision|2|||
161613094|NCT01079806|583635343|FG000|Day 1 to Week 96|Adverse Event|0|||
161832608|NCT00706355|584428476|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161832609|NCT00706355|584428477|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161613095|NCT01079806|583635344|FG001|Day 1 to Week 96|Adverse Event|3|||
161613096|NCT01079806|583635343|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
161613097|NCT01079806|583635344|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
161613098|NCT01079806|583635343|FG000|Day 1 to Week 96|Pregnancy|0|||
161613099|NCT01079806|583635344|FG001|Day 1 to Week 96|Pregnancy|1|||
161613100|NCT01079806|583635343|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
161832610|NCT00706355|584428478|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
161613101|NCT01079806|583635344|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
161613102|NCT01079806|583635343|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
161613103|NCT01079806|583635344|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
161613104|NCT01079806|583635343|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
161613105|NCT01079806|583635344|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
161613106|NCT01079806|583635343|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
161613107|NCT01079806|583635344|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
161613108|NCT01079806|583635343|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
161613109|NCT01079806|583635344|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
161613110|NCT01079806|583635343|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
161613111|NCT01079806|583635344|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
161613112|NCT01079806|583635343|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
161613113|NCT01079806|583635344|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
161613114|NCT01530334|583635349|FG000|Overall Study|Adverse Event|3|||
161613115|NCT01530334|583635349|FG000|Overall Study|unknown reason|1|||
161613116|NCT01530334|583635349|FG000|Overall Study|Progressive disease|47|||
161613117|NCT03489369|583635350|FG000|Overall Study|Documented Progressive Disease|3|||
161613118|NCT03489369|583635351|FG001|Overall Study|Documented Progressive Disease|2|||
161613119|NCT03489369|583635352|FG002|Overall Study|Documented Progressive Disease|3|||
161613120|NCT03489369|583635353|FG003|Overall Study|Documented Progressive Disease|6|||
161613121|NCT03489369|583635350|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
161613122|NCT03489369|583635351|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
161613123|NCT03489369|583635352|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
161613124|NCT03489369|583635353|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
161613125|NCT01604824|583635360|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161613126|NCT01604824|583635361|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161613127|NCT01604824|583635362|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161613128|NCT01604824|583635363|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161613129|NCT01604824|583635364|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
161613130|NCT01604824|583635365|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161613131|NCT01604824|583635360|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
161613132|NCT01604824|583635361|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
161613133|NCT01604824|583635362|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
161613134|NCT01604824|583635363|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
161613135|NCT01604824|583635364|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
161613136|NCT01604824|583635365|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
161613137|NCT02630966|583635366|FG000|Overall Study|Adverse Event|1|||
161613138|NCT02630966|583635367|FG001|Overall Study|Adverse Event|3|||
161613139|NCT02630966|583635366|FG000|Overall Study|Significant Protocol Deviation|0|||
161613140|NCT02630966|583635367|FG001|Overall Study|Significant Protocol Deviation|2|||
161613141|NCT02630966|583635366|FG000|Overall Study|Voluntary Withdrawal|1|||
161613142|NCT02630966|583635367|FG001|Overall Study|Voluntary Withdrawal|1|||
161613143|NCT02630966|583635366|FG000|Overall Study|Lack of Efficacy|0|||
161613144|NCT02630966|583635367|FG001|Overall Study|Lack of Efficacy|2|||
161613145|NCT00665392|583635368|FG000|Overall Study|not treated|1|||
161613146|NCT00243867|583635374|FG000|Overall Study|Adverse Event|24|||
161613147|NCT00243867|583635375|FG001|Overall Study|Adverse Event|34|||
161613148|NCT00243867|583635374|FG000|Overall Study|Lack of Efficacy|115|||
161613149|NCT00243867|583635375|FG001|Overall Study|Lack of Efficacy|78|||
161613150|NCT00243867|583635374|FG000|Overall Study|Withdrawal by Subject|11|||
161613151|NCT00243867|583635375|FG001|Overall Study|Withdrawal by Subject|23|||
161613152|NCT00243867|583635374|FG000|Overall Study|Lost to Follow-up|2|||
161613153|NCT00243867|583635375|FG001|Overall Study|Lost to Follow-up|1|||
161613154|NCT00243867|583635374|FG000|Overall Study|Physician Decision|2|||
161613155|NCT00243867|583635375|FG001|Overall Study|Physician Decision|7|||
161613156|NCT00243867|583635374|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
161613157|NCT00243867|583635375|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
161613158|NCT03389802|583635399|FG000|Overall Study|Lack of Efficacy|3|||
161613159|NCT03389802|583635400|FG001|Overall Study|Lack of Efficacy|3|||
161613160|NCT03389802|583635401|FG002|Overall Study|Lack of Efficacy|13|||
161613161|NCT03389802|583635402|FG003|Overall Study|Lack of Efficacy|6|||
161613162|NCT03389802|583635403|FG004|Overall Study|Lack of Efficacy|1|||
161613163|NCT03389802|583635399|FG000|Overall Study|Adverse Event|0|||
161613164|NCT03389802|583635400|FG001|Overall Study|Adverse Event|0|||
161613165|NCT03389802|583635401|FG002|Overall Study|Adverse Event|1|||
161613166|NCT03389802|583635402|FG003|Overall Study|Adverse Event|0|||
161613167|NCT03389802|583635403|FG004|Overall Study|Adverse Event|4|||
161613168|NCT03389802|583635399|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
161613169|NCT03389802|583635400|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
161613170|NCT03389802|583635401|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
161613171|NCT03389802|583635402|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
161613172|NCT03389802|583635403|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
161613173|NCT02426138|583635404|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161613174|NCT02426138|583635405|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161613175|NCT04677738|583635406|FG000|Overall Study|Withdrawal by Subject|4|||
161613176|NCT04677738|583635407|FG001|Overall Study|Withdrawal by Subject|2|||
161613177|NCT02409680|583635415|FG000|Overall Study|Lost to Follow-up|15|||
161613178|NCT02409680|583635416|FG001|Overall Study|Lost to Follow-up|30|||
161613179|NCT05366751|583635417|FG000|Overall Study|Adverse Event|25|||
161613180|NCT05366751|583635417|FG000|Overall Study|Physician Decision|3|||
161613181|NCT05366751|583635417|FG000|Overall Study|Lost to Follow-up|2|||
161613182|NCT05366751|583635417|FG000|Overall Study|Withdrawal by Subject|14|||
161613183|NCT05366751|583635417|FG000|Overall Study|Study Terminated by Sponsor|50|||
161613184|NCT05366751|583635417|FG000|Overall Study|Site Terminated by Sponsor|3|||
161613185|NCT04912856|583635426|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
161613186|NCT04912856|583635427|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
161613187|NCT04912856|583635426|FG000|Overall Study|Not reported in synoptic CSR.|0|||
161613188|NCT04912856|583635427|FG001|Overall Study|Not reported in synoptic CSR.|1|||
161613189|NCT00647387|583635432|FG000|Overall Study|Lost to Follow-up|6|||
161613190|NCT00647387|583635432|FG000|Overall Study|Unsuccessful implant|5|||
161613191|NCT00647387|583635432|FG000|Overall Study|Device explanted|3|||
161613192|NCT00647387|583635432|FG000|Overall Study|Other Reason|3|||
161613193|NCT00647387|583635432|FG000|Overall Study|Death|2|||
161613194|NCT00302211|583635433|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
161613195|NCT00302211|583635434|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
161613196|NCT00302211|583635435|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
161613197|NCT00302211|583635436|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
161613198|NCT00302211|583635437|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
161613199|NCT00302211|583635433|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
161613200|NCT00302211|583635434|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
161613201|NCT00302211|583635435|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
161613202|NCT00302211|583635436|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
161613203|NCT00302211|583635437|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
161613204|NCT00302211|583635433|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
161613205|NCT00302211|583635434|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
161613206|NCT00302211|583635435|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
161613207|NCT00302211|583635436|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
161613208|NCT00302211|583635437|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
161613209|NCT00302211|583635433|FG000|Double Blind Period (New Patients)|Disease progression|0|||
161613210|NCT00302211|583635434|FG001|Double Blind Period (New Patients)|Disease progression|1|||
161613211|NCT00302211|583635435|FG002|Double Blind Period (New Patients)|Disease progression|1|||
161613212|NCT00302211|583635436|FG003|Double Blind Period (New Patients)|Disease progression|0|||
161613213|NCT00302211|583635437|FG004|Double Blind Period (New Patients)|Disease progression|0|||
161832611|NCT00706355|584428479|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161832612|NCT00706355|584428476|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161832613|NCT00706355|584428477|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161832614|NCT00706355|584428478|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161832615|NCT00706355|584428479|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
161832616|NCT00706355|584428476|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161832617|NCT00706355|584428477|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161832618|NCT00706355|584428478|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161832619|NCT00706355|584428479|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
161832620|NCT02549573|584428482|FG000|Overall Study|Withdrawal by Subject|0|||
161832621|NCT02549573|584428483|FG001|Overall Study|Withdrawal by Subject|2|||
161832622|NCT02549573|584428482|FG000|Overall Study|Protocol Violation|0|||
161832623|NCT02549573|584428483|FG001|Overall Study|Protocol Violation|1|||
161832624|NCT02610816|584428486|FG000|Phase 1|Withdrawal by Subject|2|||
161832625|NCT02610816|584428487|FG001|Phase 1|Withdrawal by Subject|6|||
161832626|NCT02610816|584428488|FG002|Phase 1|Withdrawal by Subject|0|||
161832627|NCT02610816|584428489|FG003|Phase 1|Withdrawal by Subject|0|||
161832628|NCT02610816|584428486|FG000|Phase 1|Lost to Follow-up|2|||
161832629|NCT02610816|584428487|FG001|Phase 1|Lost to Follow-up|1|||
161832630|NCT02610816|584428488|FG002|Phase 1|Lost to Follow-up|0|||
161832631|NCT02610816|584428489|FG003|Phase 1|Lost to Follow-up|0|||
161832632|NCT02610816|584428486|FG000|Phase 1|Physician Decision|0|||
161832633|NCT02610816|584428487|FG001|Phase 1|Physician Decision|1|||
161832634|NCT02610816|584428488|FG002|Phase 1|Physician Decision|0|||
161832635|NCT02610816|584428489|FG003|Phase 1|Physician Decision|0|||
161832636|NCT02610816|584428486|FG000|Phase 2|Withdrawal by Subject|0|||
161832637|NCT02610816|584428487|FG001|Phase 2|Withdrawal by Subject|0|||
161832638|NCT02610816|584428488|FG002|Phase 2|Withdrawal by Subject|9|||
161832639|NCT02610816|584428489|FG003|Phase 2|Withdrawal by Subject|3|||
161832640|NCT02610816|584428486|FG000|Phase 2|Lost to Follow-up|0|||
161613214|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
161613215|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
161613216|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
161613217|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
161613218|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
161613219|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
161613220|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
161613221|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
161613222|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
161613223|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
161613224|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161613225|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161613226|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161613227|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
161613228|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161613229|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
161613230|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
161613231|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
161613232|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
161613233|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
161613234|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Death|0|||
161613235|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Death|0|||
161613236|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Death|0|||
161613237|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Death|1|||
161613238|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Death|1|||
161832641|NCT02610816|584428487|FG001|Phase 2|Lost to Follow-up|0|||
161832642|NCT02610816|584428488|FG002|Phase 2|Lost to Follow-up|2|||
161832643|NCT02610816|584428489|FG003|Phase 2|Lost to Follow-up|0|||
161832644|NCT02610816|584428486|FG000|Phase 2|Physician Decision|0|||
161832645|NCT02610816|584428487|FG001|Phase 2|Physician Decision|0|||
161832646|NCT02610816|584428488|FG002|Phase 2|Physician Decision|0|||
161832647|NCT02610816|584428489|FG003|Phase 2|Physician Decision|2|||
161832648|NCT02610816|584428486|FG000|Phase 2|Pregnancy|0|||
161832649|NCT02610816|584428487|FG001|Phase 2|Pregnancy|0|||
161832650|NCT02610816|584428488|FG002|Phase 2|Pregnancy|0|||
161613239|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161613240|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161832651|NCT02610816|584428489|FG003|Phase 2|Pregnancy|1|||
161832652|NCT02139124|584428490|FG000|Overall Study|Adverse Event|2|||
161832653|NCT02139124|584428491|FG001|Overall Study|Adverse Event|0|||
161832654|NCT02139124|584428492|FG002|Overall Study|Adverse Event|1|||
161832655|NCT02139124|584428493|FG003|Overall Study|Adverse Event|2|||
161832656|NCT02139124|584428494|FG004|Overall Study|Adverse Event|5|||
161832657|NCT02139124|584428490|FG000|Overall Study|Withdrawal by Subject|2|||
161832658|NCT02139124|584428491|FG001|Overall Study|Withdrawal by Subject|2|||
161832659|NCT02139124|584428492|FG002|Overall Study|Withdrawal by Subject|2|||
161832660|NCT02139124|584428493|FG003|Overall Study|Withdrawal by Subject|2|||
161832661|NCT02139124|584428494|FG004|Overall Study|Withdrawal by Subject|3|||
161613241|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161613242|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161613243|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
161613244|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161613245|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161613246|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161613247|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161613248|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
161613249|NCT00302211|583635433|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161613250|NCT00302211|583635434|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161613251|NCT00302211|583635435|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161613252|NCT00302211|583635436|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
161613253|NCT00302211|583635437|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161613254|NCT03137459|583637527|FG000|2-month Assessment|Withdrawal by Subject|13|||
161613255|NCT03137459|583637528|FG001|2-month Assessment|Withdrawal by Subject|3|||
161613256|NCT03137459|583637527|FG000|2-month Assessment|Unable to reach|42|||
161613257|NCT03137459|583637528|FG001|2-month Assessment|Unable to reach|32|||
161613258|NCT03137459|583637527|FG000|2-month Assessment|Refused assessment|7|||
161613259|NCT03137459|583637528|FG001|2-month Assessment|Refused assessment|5|||
161613260|NCT03137459|583637527|FG000|2-month Assessment|Acutely ill|6|||
161613261|NCT03137459|583637528|FG001|2-month Assessment|Acutely ill|2|||
161613262|NCT03137459|583637527|FG000|4-month Assessment|Death|4|||
161613263|NCT03137459|583637528|FG001|4-month Assessment|Death|2|||
161613264|NCT03137459|583637527|FG000|4-month Assessment|Withdrawal by Subject|4|||
161613265|NCT03137459|583637528|FG001|4-month Assessment|Withdrawal by Subject|2|||
161613266|NCT03137459|583637527|FG000|4-month Assessment|Unable to reach|44|||
161613267|NCT03137459|583637528|FG001|4-month Assessment|Unable to reach|29|||
161613268|NCT03137459|583637527|FG000|4-month Assessment|Refused assessment|24|||
161613269|NCT03137459|583637528|FG001|4-month Assessment|Refused assessment|10|||
161613270|NCT03137459|583637527|FG000|4-month Assessment|Acutely ill|2|||
161613271|NCT03137459|583637528|FG001|4-month Assessment|Acutely ill|3|||
161613272|NCT03137459|583637527|FG000|6-months|Lost to Follow-up|14|||
161613273|NCT03137459|583637528|FG001|6-months|Lost to Follow-up|11|||
161613274|NCT03137459|583637527|FG000|6-months|Death|0|||
161613275|NCT03137459|583637528|FG001|6-months|Death|2|||
161613276|NCT03137459|583637527|FG000|6-months|Refused assessment|6|||
161613277|NCT03137459|583637528|FG001|6-months|Refused assessment|3|||
161613278|NCT03137459|583637527|FG000|6-months|Acutely ill|1|||
161613279|NCT03137459|583637528|FG001|6-months|Acutely ill|1|||
161613280|NCT00985088|583637529|FG000|Overall Study|Serious Adverse Event|1|||
161613281|NCT00985088|583637530|FG001|Overall Study|Serious Adverse Event|1|||
161613282|NCT00985088|583637531|FG002|Overall Study|Serious Adverse Event|0|||
161613283|NCT00985088|583637532|FG003|Overall Study|Serious Adverse Event|0|||
161613284|NCT00985088|583637533|FG004|Overall Study|Serious Adverse Event|0|||
161613285|NCT00985088|583637534|FG005|Overall Study|Serious Adverse Event|0|||
161613286|NCT00985088|583637535|FG006|Overall Study|Serious Adverse Event|0|||
161613287|NCT00985088|583637536|FG007|Overall Study|Serious Adverse Event|1|||
161613288|NCT00985088|583637529|FG000|Overall Study|Adverse Event|0|||
161613289|NCT00985088|583637530|FG001|Overall Study|Adverse Event|0|||
161613290|NCT00985088|583637531|FG002|Overall Study|Adverse Event|1|||
161613291|NCT00985088|583637532|FG003|Overall Study|Adverse Event|0|||
161613292|NCT00985088|583637533|FG004|Overall Study|Adverse Event|0|||
161613293|NCT00985088|583637534|FG005|Overall Study|Adverse Event|0|||
161613294|NCT00985088|583637535|FG006|Overall Study|Adverse Event|0|||
161613295|NCT00985088|583637536|FG007|Overall Study|Adverse Event|0|||
161613296|NCT00985088|583637529|FG000|Overall Study|Withdrawal by Subject|4|||
161613297|NCT00985088|583637530|FG001|Overall Study|Withdrawal by Subject|0|||
161613298|NCT00985088|583637531|FG002|Overall Study|Withdrawal by Subject|0|||
161613299|NCT00985088|583637532|FG003|Overall Study|Withdrawal by Subject|1|||
161613300|NCT00985088|583637533|FG004|Overall Study|Withdrawal by Subject|3|||
161613301|NCT00985088|583637534|FG005|Overall Study|Withdrawal by Subject|2|||
161613302|NCT00985088|583637535|FG006|Overall Study|Withdrawal by Subject|1|||
161613303|NCT00985088|583637536|FG007|Overall Study|Withdrawal by Subject|2|||
161832662|NCT02139124|584428490|FG000|Overall Study|Protocol Violation|0|||
161613304|NCT00985088|583637529|FG000|Overall Study|Migrated/moved from study area|0|||
161613305|NCT00985088|583637530|FG001|Overall Study|Migrated/moved from study area|0|||
161613306|NCT00985088|583637531|FG002|Overall Study|Migrated/moved from study area|1|||
161613307|NCT00985088|583637532|FG003|Overall Study|Migrated/moved from study area|0|||
161613308|NCT00985088|583637533|FG004|Overall Study|Migrated/moved from study area|0|||
161613309|NCT00985088|583637534|FG005|Overall Study|Migrated/moved from study area|0|||
161613310|NCT00985088|583637535|FG006|Overall Study|Migrated/moved from study area|0|||
161613311|NCT00985088|583637536|FG007|Overall Study|Migrated/moved from study area|1|||
161613312|NCT00985088|583637529|FG000|Overall Study|Lost to Follow-up|6|||
161613313|NCT00985088|583637530|FG001|Overall Study|Lost to Follow-up|1|||
161613314|NCT00985088|583637531|FG002|Overall Study|Lost to Follow-up|2|||
161613315|NCT00985088|583637532|FG003|Overall Study|Lost to Follow-up|6|||
161613316|NCT00985088|583637533|FG004|Overall Study|Lost to Follow-up|6|||
161613317|NCT00985088|583637534|FG005|Overall Study|Lost to Follow-up|5|||
161613318|NCT00985088|583637535|FG006|Overall Study|Lost to Follow-up|3|||
161613319|NCT00985088|583637536|FG007|Overall Study|Lost to Follow-up|2|||
161613320|NCT01970878|583637537|FG000|Overall Study|Withdrawal by Subject|11|||
161613321|NCT01970878|583637538|FG001|Overall Study|Withdrawal by Subject|10|||
161613322|NCT01970878|583637539|FG002|Overall Study|Withdrawal by Subject|14|||
161613323|NCT01970878|583637540|FG003|Overall Study|Withdrawal by Subject|7|||
161613324|NCT01970878|583637537|FG000|Overall Study|Lost to Follow-up|1|||
161613325|NCT01970878|583637538|FG001|Overall Study|Lost to Follow-up|3|||
161613326|NCT01970878|583637539|FG002|Overall Study|Lost to Follow-up|2|||
161613327|NCT01970878|583637540|FG003|Overall Study|Lost to Follow-up|4|||
161613328|NCT01970878|583637537|FG000|Overall Study|Administrative Reasons|1|||
161613329|NCT01970878|583637538|FG001|Overall Study|Administrative Reasons|0|||
161613330|NCT01970878|583637539|FG002|Overall Study|Administrative Reasons|0|||
161613331|NCT01970878|583637540|FG003|Overall Study|Administrative Reasons|4|||
161613332|NCT01970878|583637537|FG000|Overall Study|Lack of Efficacy|2|||
161613333|NCT01970878|583637538|FG001|Overall Study|Lack of Efficacy|1|||
161613334|NCT01970878|583637539|FG002|Overall Study|Lack of Efficacy|2|||
161613335|NCT01970878|583637540|FG003|Overall Study|Lack of Efficacy|0|||
161613336|NCT01970878|583637537|FG000|Overall Study|Adverse Event|12|||
161613337|NCT01970878|583637538|FG001|Overall Study|Adverse Event|7|||
161613338|NCT01970878|583637539|FG002|Overall Study|Adverse Event|4|||
161613339|NCT01970878|583637540|FG003|Overall Study|Adverse Event|3|||
161613340|NCT01970878|583637537|FG000|Overall Study|Protocol Specified Criteria|10|||
161613341|NCT01970878|583637538|FG001|Overall Study|Protocol Specified Criteria|4|||
161613342|NCT01970878|583637539|FG002|Overall Study|Protocol Specified Criteria|3|||
161613343|NCT01970878|583637540|FG003|Overall Study|Protocol Specified Criteria|6|||
161613344|NCT01970878|583637537|FG000|Overall Study|Physician Decision|0|||
161613345|NCT01970878|583637538|FG001|Overall Study|Physician Decision|1|||
161613346|NCT01970878|583637539|FG002|Overall Study|Physician Decision|1|||
161613347|NCT01970878|583637540|FG003|Overall Study|Physician Decision|0|||
161613348|NCT01970878|583637537|FG000|Overall Study|No Completion Status|0|||
161613349|NCT01970878|583637538|FG001|Overall Study|No Completion Status|1|||
161613350|NCT01970878|583637539|FG002|Overall Study|No Completion Status|0|||
161613351|NCT01970878|583637540|FG003|Overall Study|No Completion Status|0|||
161613352|NCT03214081|583637542|FG000|Overall Study|Case Report Forms Uncollected|9|||
161613353|NCT03214081|583637542|FG000|Overall Study|Protocol Deviation|54|||
161613354|NCT00491400|583637543|FG000|Overall Study|Withdrawal by Subject|5|||
161684405|NCT02819635|583897898|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
161684406|NCT02819635|583897899|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684407|NCT02819635|583897900|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161613355|NCT00491400|583637544|FG001|Overall Study|Withdrawal by Subject|4|||
161613356|NCT00597376|583637545|FG000|Overall Study|Withdrawal by Subject|4|||
161613357|NCT00597376|583637546|FG001|Overall Study|Withdrawal by Subject|3|||
161613358|NCT00597376|583637545|FG000|Overall Study|Adverse Event|4|||
161613359|NCT00597376|583637546|FG001|Overall Study|Adverse Event|1|||
161613360|NCT02634307|583637547|FG000|Overall Study|Adverse Event|50|||
161613361|NCT02634307|583637548|FG001|Overall Study|Adverse Event|24|||
161613362|NCT02634307|583637549|FG002|Overall Study|Adverse Event|14|||
161613363|NCT02634307|583637547|FG000|Overall Study|Lost to Follow-up|21|||
161613364|NCT02634307|583637548|FG001|Overall Study|Lost to Follow-up|5|||
161613365|NCT02634307|583637549|FG002|Overall Study|Lost to Follow-up|6|||
161613366|NCT02634307|583637547|FG000|Overall Study|Pregnancy|5|||
161613367|NCT02634307|583637548|FG001|Overall Study|Pregnancy|1|||
161613368|NCT02634307|583637549|FG002|Overall Study|Pregnancy|3|||
161613369|NCT02634307|583637547|FG000|Overall Study|Withdrawal by Subject|38|||
161613370|NCT02634307|583637548|FG001|Overall Study|Withdrawal by Subject|24|||
161613371|NCT02634307|583637549|FG002|Overall Study|Withdrawal by Subject|18|||
161613372|NCT02634307|583637547|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161613373|NCT02634307|583637548|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161613374|NCT02634307|583637549|FG002|Overall Study|Non-Compliance with Study Drug|2|||
161613375|NCT02634307|583637547|FG000|Overall Study|Lack of Efficacy|1|||
161613376|NCT02634307|583637548|FG001|Overall Study|Lack of Efficacy|5|||
161613377|NCT02634307|583637549|FG002|Overall Study|Lack of Efficacy|3|||
161613378|NCT02634307|583637547|FG000|Overall Study|Physician Decision|7|||
161613379|NCT02634307|583637548|FG001|Overall Study|Physician Decision|5|||
161613380|NCT02634307|583637549|FG002|Overall Study|Physician Decision|5|||
161613381|NCT02634307|583637547|FG000|Overall Study|Reason not Specified|3|||
161613382|NCT02634307|583637548|FG001|Overall Study|Reason not Specified|5|||
161613383|NCT02634307|583637549|FG002|Overall Study|Reason not Specified|10|||
161613384|NCT02698475|583637550|FG000|Main Study Period|Lack of Efficacy|1|||
161613385|NCT02698475|583637550|FG000|Main Study Period|Protocol Violation|2|||
161613386|NCT02698475|583637550|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
161613387|NCT02698475|583637550|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
161613388|NCT02698475|583637550|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
161613389|NCT02698475|583637550|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
161613390|NCT02698475|583637550|FG000|Long-Term Extension Period|Other|1|||
161613391|NCT02310581|583637561|FG000|Overall Study|Adverse Event|1|||
161613392|NCT02310581|583637562|FG001|Overall Study|Adverse Event|1|||
161613393|NCT02310581|583637563|FG002|Overall Study|Adverse Event|1|||
161613394|NCT02310581|583637564|FG003|Overall Study|Adverse Event|0|||
161613395|NCT02310581|583637561|FG000|Overall Study|Withdrawal by Subject|2|||
161613396|NCT02310581|583637562|FG001|Overall Study|Withdrawal by Subject|1|||
161613397|NCT02310581|583637563|FG002|Overall Study|Withdrawal by Subject|0|||
161613398|NCT02310581|583637564|FG003|Overall Study|Withdrawal by Subject|1|||
161613399|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
161613400|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
161613401|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
161613402|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
161613403|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
161613404|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
161613405|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
161613406|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
161613407|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
161613408|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
161613409|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
161613410|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
161613411|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Other|1|||
161613412|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Other|0|||
161613413|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Other|0|||
161613414|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
161613415|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
161613416|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
161613417|NCT00887224|583637565|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
161613418|NCT00887224|583637566|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
161613419|NCT00887224|583637567|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
161613420|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
161613421|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
161613422|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
161613423|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
161613424|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
161613425|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
161832663|NCT02139124|584428491|FG001|Overall Study|Protocol Violation|0|||
161832664|NCT02139124|584428492|FG002|Overall Study|Protocol Violation|0|||
161613426|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
161613427|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
161613428|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
161613429|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
161613430|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
161613431|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
161613432|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Other|1|||
161613433|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Other|0|||
161613434|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Other|0|||
161613435|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
161613436|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
161832665|NCT02139124|584428493|FG003|Overall Study|Protocol Violation|1|||
161613437|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
161613438|NCT00887224|583637565|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
161613439|NCT00887224|583637566|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
161613440|NCT00887224|583637567|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
161613441|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
161613442|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
161613443|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
161613444|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
161613445|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
161613446|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
161613447|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
161613448|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
161613449|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
161613450|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
161613451|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
161613452|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
161613453|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Other|30|||
161613454|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Other|0|||
161613455|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Other|0|||
161613456|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
161613457|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
161613458|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
161613459|NCT00887224|583637565|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
161613460|NCT00887224|583637566|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
161613461|NCT00887224|583637567|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
161613462|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Adverse Event|0|||
161613463|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Adverse Event|7|||
161613464|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Adverse Event|2|||
161613465|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Failed to return|0|||
161613466|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Failed to return|2|||
161613467|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Failed to return|2|||
161613468|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
161613469|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
161613470|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
161613471|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
161613472|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
161613473|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
161613474|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Other|0|||
161613475|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Other|2|||
161613476|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Other|0|||
161613477|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
161613478|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
161613479|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
161613480|NCT00887224|583637565|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
161613481|NCT00887224|583637566|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
161613482|NCT00887224|583637567|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
161613483|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
161613484|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
161613485|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
161613486|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
161613487|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
161613488|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
161613489|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
161613490|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
161613491|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
161613492|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
161613493|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
161613494|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
161613495|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
161613496|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
161613497|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
161613498|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
161613499|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
161613500|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
161613501|NCT00887224|583637565|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
161613502|NCT00887224|583637566|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
161613503|NCT00887224|583637567|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
161613504|NCT03883828|583637568|FG000|Overall Study|Did not start radiotherapy|1|||
161613505|NCT03883828|583637569|FG001|Overall Study|Did not start radiotherapy|2|||
161832666|NCT02139124|584428494|FG004|Overall Study|Protocol Violation|1|||
161613506|NCT01256359|583637573|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
161613507|NCT01256359|583637574|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
161613508|NCT01256359|583637573|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
161613509|NCT01256359|583637574|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
161613510|NCT04693637|583637577|FG000|Overall Study|Death|4|||
161613511|NCT04693637|583637577|FG000|Overall Study|Withdrawal by Subject|3|||
161613512|NCT04693637|583637577|FG000|Overall Study|Physician Decision|2|||
161613513|NCT04693637|583637577|FG000|Overall Study|Lost to Follow-up|1|||
161613514|NCT04237792|583637578|FG000|Treatment (Day 1)|Adverse Event|1|||
161613515|NCT04237792|583637579|FG001|Treatment (Day 1)|Adverse Event|0|||
161613516|NCT04237792|583637580|FG002|Treatment (Day 1)|Adverse Event|0|||
161613517|NCT04237792|583637581|FG003|Treatment (Day 1)|Adverse Event|0|||
161613518|NCT04237792|583637582|FG004|Treatment (Day 1)|Adverse Event|1|||
161613519|NCT04237792|583637583|FG005|Treatment (Day 1)|Adverse Event|1|||
161613520|NCT04237792|583637578|FG000|Treatment (Day 1)|Other|0|||
161613521|NCT04237792|583637579|FG001|Treatment (Day 1)|Other|0|||
161613522|NCT04237792|583637580|FG002|Treatment (Day 1)|Other|1|||
161613523|NCT04237792|583637581|FG003|Treatment (Day 1)|Other|0|||
161613524|NCT04237792|583637582|FG004|Treatment (Day 1)|Other|0|||
161613525|NCT04237792|583637583|FG005|Treatment (Day 1)|Other|1|||
161613526|NCT04237792|583637578|FG000|Treatment (Day 1)|Not treated|1|||
161613527|NCT04237792|583637579|FG001|Treatment (Day 1)|Not treated|1|||
161613528|NCT04237792|583637580|FG002|Treatment (Day 1)|Not treated|2|||
161613529|NCT04237792|583637581|FG003|Treatment (Day 1)|Not treated|1|||
161613530|NCT04237792|583637582|FG004|Treatment (Day 1)|Not treated|0|||
161613531|NCT04237792|583637583|FG005|Treatment (Day 1)|Not treated|1|||
161613532|NCT03052517|583637584|FG000|Overall Study|Study Terminated By Sponsor|928|||
161613533|NCT03052517|583637585|FG001|Overall Study|Study Terminated By Sponsor|938|||
161613534|NCT03052517|583637586|FG002|Overall Study|Study Terminated By Sponsor|296|||
161613535|NCT03052517|583637584|FG000|Overall Study|Subject/Guardian Decision|50|||
161613536|NCT03052517|583637585|FG001|Overall Study|Subject/Guardian Decision|45|||
161613537|NCT03052517|583637586|FG002|Overall Study|Subject/Guardian Decision|22|||
161613538|NCT03052517|583637584|FG000|Overall Study|Lack of Efficacy|23|||
161613539|NCT03052517|583637585|FG001|Overall Study|Lack of Efficacy|14|||
161613540|NCT03052517|583637586|FG002|Overall Study|Lack of Efficacy|7|||
161613541|NCT03052517|583637584|FG000|Overall Study|Adverse Event|6|||
161613542|NCT03052517|583637585|FG001|Overall Study|Adverse Event|5|||
161613543|NCT03052517|583637586|FG002|Overall Study|Adverse Event|0|||
161613544|NCT03052517|583637584|FG000|Overall Study|Physician Decision|4|||
161613545|NCT03052517|583637585|FG001|Overall Study|Physician Decision|5|||
161613546|NCT03052517|583637586|FG002|Overall Study|Physician Decision|1|||
161613547|NCT03052517|583637584|FG000|Overall Study|Death|3|||
161613548|NCT03052517|583637585|FG001|Overall Study|Death|0|||
161613549|NCT03052517|583637586|FG002|Overall Study|Death|1|||
161613550|NCT03052517|583637584|FG000|Overall Study|Lost to Follow-up|2|||
161613551|NCT03052517|583637585|FG001|Overall Study|Lost to Follow-up|4|||
161613552|NCT03052517|583637586|FG002|Overall Study|Lost to Follow-up|0|||
161613553|NCT03052517|583637584|FG000|Overall Study|Pregnancy|1|||
161613554|NCT03052517|583637585|FG001|Overall Study|Pregnancy|0|||
161832667|NCT02139124|584428490|FG000|Overall Study|non-compliant|1|||
161832668|NCT02139124|584428491|FG001|Overall Study|non-compliant|0|||
161832669|NCT02139124|584428492|FG002|Overall Study|non-compliant|0|||
161832670|NCT02139124|584428493|FG003|Overall Study|non-compliant|2|||
161613555|NCT03052517|583637586|FG002|Overall Study|Pregnancy|1|||
161613556|NCT03052517|583637584|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
161613557|NCT03052517|583637585|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
161832671|NCT02139124|584428494|FG004|Overall Study|non-compliant|0|||
161832672|NCT02139124|584428490|FG000|Overall Study|incarceration|0|||
161832673|NCT02139124|584428491|FG001|Overall Study|incarceration|0|||
161832674|NCT02139124|584428492|FG002|Overall Study|incarceration|1|||
161832675|NCT02139124|584428493|FG003|Overall Study|incarceration|0|||
161832676|NCT02139124|584428494|FG004|Overall Study|incarceration|0|||
161613558|NCT03052517|583637586|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
161613559|NCT03052517|583637584|FG000|Overall Study|Technical Problems|0|||
161613560|NCT03052517|583637585|FG001|Overall Study|Technical Problems|1|||
161613561|NCT03052517|583637586|FG002|Overall Study|Technical Problems|0|||
161613562|NCT04885998|583637589|FG000|Overall Study|Withdrawal by Subject|0|||
161613563|NCT04885998|583637590|FG001|Overall Study|Withdrawal by Subject|2|||
161832677|NCT02139124|584428490|FG000|Overall Study|subject moved|1|||
161613564|NCT04885998|583637591|FG002|Overall Study|Withdrawal by Subject|0|||
161613565|NCT04885998|583637592|FG003|Overall Study|Withdrawal by Subject|3|||
161832678|NCT02139124|584428491|FG001|Overall Study|subject moved|0|||
161832679|NCT02139124|584428492|FG002|Overall Study|subject moved|0|||
161613566|NCT04885998|583637589|FG000|Overall Study|Lost to Follow-up|1|||
161613567|NCT04885998|583637590|FG001|Overall Study|Lost to Follow-up|1|||
161613568|NCT04885998|583637591|FG002|Overall Study|Lost to Follow-up|0|||
161613569|NCT04885998|583637592|FG003|Overall Study|Lost to Follow-up|0|||
161613570|NCT04885998|583637589|FG000|Overall Study|Death|2|||
161613571|NCT04885998|583637590|FG001|Overall Study|Death|1|||
161613572|NCT04885998|583637591|FG002|Overall Study|Death|2|||
161613573|NCT04885998|583637592|FG003|Overall Study|Death|2|||
161613574|NCT04885998|583637589|FG000|Overall Study|Decision by sponsor|1|||
161613575|NCT04885998|583637590|FG001|Overall Study|Decision by sponsor|1|||
161613576|NCT04885998|583637591|FG002|Overall Study|Decision by sponsor|0|||
161613577|NCT04885998|583637592|FG003|Overall Study|Decision by sponsor|0|||
161613578|NCT05260437|583637594|FG000|Overall Study|Lost to Follow-up|5|||
161613579|NCT05260437|583637595|FG001|Overall Study|Lost to Follow-up|2|||
161613580|NCT05260437|583637596|FG002|Overall Study|Lost to Follow-up|1|||
161613581|NCT05260437|583637597|FG003|Overall Study|Lost to Follow-up|2|||
161613582|NCT05260437|583637598|FG004|Overall Study|Lost to Follow-up|2|||
161613583|NCT05260437|583637594|FG000|Overall Study|Withdrawal by Subject|3|||
161613584|NCT05260437|583637595|FG001|Overall Study|Withdrawal by Subject|0|||
161613585|NCT05260437|583637596|FG002|Overall Study|Withdrawal by Subject|4|||
161613586|NCT05260437|583637597|FG003|Overall Study|Withdrawal by Subject|5|||
161613587|NCT05260437|583637598|FG004|Overall Study|Withdrawal by Subject|0|||
161613588|NCT05260437|583637594|FG000|Overall Study|Vaccine Not Administered|0|||
161613589|NCT05260437|583637595|FG001|Overall Study|Vaccine Not Administered|1|||
161613590|NCT05260437|583637596|FG002|Overall Study|Vaccine Not Administered|0|||
161613591|NCT05260437|583637597|FG003|Overall Study|Vaccine Not Administered|0|||
161613592|NCT05260437|583637598|FG004|Overall Study|Vaccine Not Administered|0|||
161613593|NCT00910962|583637599|FG000|Overall Study|Adverse Event|5|||
161613594|NCT00910962|583637600|FG001|Overall Study|Adverse Event|20|||
161613595|NCT00910962|583637601|FG002|Overall Study|Adverse Event|17|||
161613596|NCT00910962|583637599|FG000|Overall Study|Protocol Violation|1|||
161613597|NCT00910962|583637600|FG001|Overall Study|Protocol Violation|3|||
161613598|NCT00910962|583637601|FG002|Overall Study|Protocol Violation|3|||
161613599|NCT00910962|583637599|FG000|Overall Study|Lost to Follow-up|0|||
161613600|NCT00910962|583637600|FG001|Overall Study|Lost to Follow-up|3|||
161613601|NCT00910962|583637601|FG002|Overall Study|Lost to Follow-up|1|||
161613602|NCT00910962|583637599|FG000|Overall Study|Physician Decision|0|||
161613603|NCT00910962|583637600|FG001|Overall Study|Physician Decision|6|||
161613604|NCT00910962|583637601|FG002|Overall Study|Physician Decision|6|||
161613605|NCT00910962|583637599|FG000|Overall Study|Withdrawal by Subject|25|||
161613606|NCT00910962|583637600|FG001|Overall Study|Withdrawal by Subject|32|||
161613607|NCT00910962|583637601|FG002|Overall Study|Withdrawal by Subject|32|||
161613608|NCT00910962|583637599|FG000|Overall Study|Reached defined stopping criteria|12|||
161613609|NCT00910962|583637600|FG001|Overall Study|Reached defined stopping criteria|14|||
161613610|NCT00910962|583637601|FG002|Overall Study|Reached defined stopping criteria|17|||
161613611|NCT00195819|583637602|FG000|Double-Blind|Withdrawal by Subject|1|||
161613612|NCT00195819|583637603|FG001|Double-Blind|Withdrawal by Subject|0|||
161613613|NCT00195819|583637602|FG000|Double-Blind|Moved|1|||
161613614|NCT00195819|583637603|FG001|Double-Blind|Moved|0|||
161613615|NCT00195819|583637602|FG000|Open-label|Adverse Event|0|||
161613616|NCT00195819|583637603|FG001|Open-label|Adverse Event|9|||
161613617|NCT00195819|583637602|FG000|Open-label|Lack of Efficacy|0|||
161613618|NCT00195819|583637603|FG001|Open-label|Lack of Efficacy|2|||
161613619|NCT00195819|583637602|FG000|Open-label|Pregnancy|0|||
161684408|NCT02819635|583897901|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161613620|NCT00195819|583637603|FG001|Open-label|Pregnancy|1|||
161613621|NCT00195819|583637602|FG000|Open-label|Protocol Violation|0|||
161613622|NCT00195819|583637603|FG001|Open-label|Protocol Violation|2|||
161613623|NCT00195819|583637602|FG000|Open-label|Moved|0|||
161613624|NCT00195819|583637603|FG001|Open-label|Moved|1|||
161613625|NCT00195819|583637602|FG000|Open-label|Withdrawal by Subject|0|||
161613626|NCT00195819|583637603|FG001|Open-label|Withdrawal by Subject|5|||
161613627|NCT00787176|583637604|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
161613628|NCT00787176|583637605|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
161613629|NCT00787176|583637606|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
161613630|NCT00787176|583637607|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
161613631|NCT03298087|583637608|FG000|Overall Study|Withdrawal by Subject|4|||
161613632|NCT02788981|583637609|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
161613633|NCT02788981|583637610|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
161613634|NCT05553366|583637611|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
161613635|NCT05553366|583637612|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
161613636|NCT05553366|583637613|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
161613637|NCT05553366|583637611|FG000|Overall Study|Lost to Follow-up|3|||
161613638|NCT05553366|583637612|FG001|Overall Study|Lost to Follow-up|3|||
161613639|NCT05553366|583637613|FG002|Overall Study|Lost to Follow-up|3|||
161613640|NCT05553366|583637611|FG000|Overall Study|Other non-compliance|1|||
161613641|NCT05553366|583637612|FG001|Overall Study|Other non-compliance|1|||
161613642|NCT05553366|583637613|FG002|Overall Study|Other non-compliance|0|||
161613643|NCT05553366|583637611|FG000|Overall Study|Randomized but not dosed|0|||
161613644|NCT05553366|583637612|FG001|Overall Study|Randomized but not dosed|0|||
161613645|NCT05553366|583637613|FG002|Overall Study|Randomized but not dosed|2|||
161613646|NCT00249769|583637614|FG000|Overall Study|Withdrawal by Subject|1|||
161613647|NCT00249769|583637615|FG001|Overall Study|Withdrawal by Subject|10|||
161613648|NCT00249769|583637616|FG002|Overall Study|Withdrawal by Subject|6|||
161613649|NCT00249769|583637614|FG000|Overall Study|Migration from Study Area|1|||
161613650|NCT00249769|583637615|FG001|Overall Study|Migration from Study Area|3|||
161613651|NCT00249769|583637616|FG002|Overall Study|Migration from Study Area|14|||
161613652|NCT00249769|583637614|FG000|Overall Study|Miscellaneous|0|||
161613653|NCT00249769|583637615|FG001|Overall Study|Miscellaneous|2|||
161613654|NCT00249769|583637616|FG002|Overall Study|Miscellaneous|2|||
161613655|NCT00249769|583637614|FG000|Overall Study|Adverse Event|0|||
161613656|NCT00249769|583637615|FG001|Overall Study|Adverse Event|0|||
161613657|NCT00249769|583637616|FG002|Overall Study|Adverse Event|1|||
161613658|NCT00249769|583637614|FG000|Overall Study|Physician Decision|0|||
161613659|NCT00249769|583637615|FG001|Overall Study|Physician Decision|0|||
161613660|NCT00249769|583637616|FG002|Overall Study|Physician Decision|2|||
161613661|NCT00249769|583637614|FG000|Overall Study|Lost to Follow-up|0|||
161613662|NCT00249769|583637615|FG001|Overall Study|Lost to Follow-up|0|||
161613663|NCT00249769|583637616|FG002|Overall Study|Lost to Follow-up|3|||
161613664|NCT02022657|583637621|FG000|Overall Study|Withdrawal by Subject|2|||
161613665|NCT02022657|583637622|FG001|Overall Study|Withdrawal by Subject|0|||
161613666|NCT02022657|583637623|FG002|Overall Study|Withdrawal by Subject|1|||
161613667|NCT02022657|583637624|FG003|Overall Study|Withdrawal by Subject|0|||
161613668|NCT02022657|583637625|FG004|Overall Study|Withdrawal by Subject|0|||
161684409|NCT02819635|583897902|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161613669|NCT02022657|583637626|FG005|Overall Study|Withdrawal by Subject|0|||
161613670|NCT02022657|583637621|FG000|Overall Study|Physician Decision|0|||
161613671|NCT02022657|583637622|FG001|Overall Study|Physician Decision|0|||
161613672|NCT02022657|583637623|FG002|Overall Study|Physician Decision|0|||
161613673|NCT02022657|583637624|FG003|Overall Study|Physician Decision|0|||
161613674|NCT02022657|583637625|FG004|Overall Study|Physician Decision|0|||
161613675|NCT02022657|583637626|FG005|Overall Study|Physician Decision|1|||
161613676|NCT03274076|583637627|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
161613677|NCT03274076|583637628|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
161613678|NCT03274076|583637629|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
161613679|NCT03274076|583637630|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
161613680|NCT03274076|583637627|FG000|24 Weeks Open Label|Adverse Event|0|||
161613681|NCT03274076|583637628|FG001|24 Weeks Open Label|Adverse Event|0|||
161613682|NCT03274076|583637629|FG002|24 Weeks Open Label|Adverse Event|2|||
161613683|NCT03274076|583637630|FG003|24 Weeks Open Label|Adverse Event|0|||
161613684|NCT03274076|583637627|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
161613685|NCT03274076|583637628|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
161613686|NCT03274076|583637629|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
161613687|NCT03274076|583637630|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
161613688|NCT00795184|583637632|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
161613689|NCT00795184|583637633|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
161613690|NCT03781375|583637634|FG000|Double-blind Phase|Adverse Event|0|||
161613691|NCT03781375|583637635|FG001|Double-blind Phase|Adverse Event|1|||
161613692|NCT03781375|583637634|FG000|Double-blind Phase|Lack of Response|6|||
161613693|NCT03781375|583637635|FG001|Double-blind Phase|Lack of Response|2|||
161613694|NCT03781375|583637634|FG000|Double-blind Phase|Other|1|||
161613695|NCT03781375|583637635|FG001|Double-blind Phase|Other|3|||
161613696|NCT03781375|583637634|FG000|Open-label Phase|Protocol Issues|0|||
161613697|NCT03781375|583637635|FG001|Open-label Phase|Protocol Issues|1|||
161613698|NCT03781375|583637634|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
161613699|NCT03781375|583637635|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
161613700|NCT03781375|583637634|FG000|Open-label Phase|Other|2|||
161613701|NCT03781375|583637635|FG001|Open-label Phase|Other|2|||
161613702|NCT01303510|583637637|FG000|Overall Study|Lost to Follow-up|1|||
161613703|NCT01303510|583637638|FG001|Overall Study|Lost to Follow-up|0|||
161613704|NCT00822900|583637642|FG000|Overall Study|Withdrawal by Subject|14|||
161613705|NCT00822900|583637643|FG001|Overall Study|Withdrawal by Subject|14|||
161613706|NCT00822900|583637642|FG000|Overall Study|Lost to Follow-up|9|||
161613707|NCT00822900|583637643|FG001|Overall Study|Lost to Follow-up|9|||
161613708|NCT00822900|583637642|FG000|Overall Study|Death|83|||
161613709|NCT00822900|583637643|FG001|Overall Study|Death|69|||
161613710|NCT00822900|583637642|FG000|Overall Study|Became a ward of the state|2|||
161613711|NCT00822900|583637643|FG001|Overall Study|Became a ward of the state|1|||
161613712|NCT01968967|583637644|FG000|Treatment Period|Other|22|||
161613713|NCT01968967|583637645|FG001|Treatment Period|Other|22|||
161613714|NCT01968967|583637646|FG002|Treatment Period|Other|0|||
161613715|NCT01968967|583637647|FG003|Treatment Period|Other|0|||
161613716|NCT01968967|583637648|FG004|Treatment Period|Other|0|||
161613717|NCT01968967|583637644|FG000|Treatment Period|Withdrawal by Subject|71|||
161613718|NCT01968967|583637645|FG001|Treatment Period|Withdrawal by Subject|61|||
161613719|NCT01968967|583637646|FG002|Treatment Period|Withdrawal by Subject|0|||
161613720|NCT01968967|583637647|FG003|Treatment Period|Withdrawal by Subject|0|||
161613721|NCT01968967|583637648|FG004|Treatment Period|Withdrawal by Subject|0|||
161613722|NCT01968967|583637644|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
161613723|NCT01968967|583637645|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
161613724|NCT01968967|583637646|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
161613725|NCT01968967|583637647|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
161613726|NCT01968967|583637648|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
161613727|NCT01968967|583637644|FG000|Treatment Period|Lost to Follow-up|26|||
161613728|NCT01968967|583637645|FG001|Treatment Period|Lost to Follow-up|31|||
161613729|NCT01968967|583637646|FG002|Treatment Period|Lost to Follow-up|0|||
161613730|NCT01968967|583637647|FG003|Treatment Period|Lost to Follow-up|0|||
161613731|NCT01968967|583637648|FG004|Treatment Period|Lost to Follow-up|0|||
161613732|NCT01968967|583637644|FG000|Treatment Period|Protocol Violation|1|||
161613733|NCT01968967|583637645|FG001|Treatment Period|Protocol Violation|2|||
161613734|NCT01968967|583637646|FG002|Treatment Period|Protocol Violation|0|||
161613735|NCT01968967|583637647|FG003|Treatment Period|Protocol Violation|0|||
161613736|NCT01968967|583637648|FG004|Treatment Period|Protocol Violation|0|||
161613737|NCT01968967|583637644|FG000|Treatment Period|Adverse Event|9|||
161613738|NCT01968967|583637645|FG001|Treatment Period|Adverse Event|8|||
161613739|NCT01968967|583637646|FG002|Treatment Period|Adverse Event|0|||
161613740|NCT01968967|583637647|FG003|Treatment Period|Adverse Event|0|||
161613741|NCT01968967|583637648|FG004|Treatment Period|Adverse Event|0|||
161613742|NCT01968967|583637644|FG000|Treatment Period|Death|9|||
161613743|NCT01968967|583637645|FG001|Treatment Period|Death|2|||
161613744|NCT01968967|583637646|FG002|Treatment Period|Death|0|||
161613745|NCT01968967|583637647|FG003|Treatment Period|Death|0|||
161613746|NCT01968967|583637648|FG004|Treatment Period|Death|0|||
161613747|NCT01968967|583637644|FG000|Treatment Period|Randomized Not Treated|6|||
161613748|NCT01968967|583637645|FG001|Treatment Period|Randomized Not Treated|5|||
161613749|NCT01968967|583637646|FG002|Treatment Period|Randomized Not Treated|0|||
161613750|NCT01968967|583637647|FG003|Treatment Period|Randomized Not Treated|0|||
161613751|NCT01968967|583637648|FG004|Treatment Period|Randomized Not Treated|0|||
161613752|NCT01968967|583637644|FG000|Extension Period|Withdrew Consent|0|||
161613753|NCT01968967|583637645|FG001|Extension Period|Withdrew Consent|0|||
161613754|NCT01968967|583637646|FG002|Extension Period|Withdrew Consent|2|||
161613755|NCT01968967|583637647|FG003|Extension Period|Withdrew Consent|0|||
161613756|NCT01968967|583637648|FG004|Extension Period|Withdrew Consent|5|||
161613757|NCT00701415|583637655|FG000|Overall Study|Adverse Event|0|||
161613758|NCT00701415|583637656|FG001|Overall Study|Adverse Event|1|||
161613759|NCT00701415|583637655|FG000|Overall Study|Social/family issues and needle phobia|1|||
161613760|NCT00701415|583637656|FG001|Overall Study|Social/family issues and needle phobia|0|||
161613761|NCT02106884|583637657|FG000|Overall Study|Change of diagnosis/exclusion|0|||
161613762|NCT02106884|583637658|FG001|Overall Study|Change of diagnosis/exclusion|1|||
161613763|NCT02022670|583637661|FG000|Overall Study|Adverse Event|1|||
161613764|NCT02022670|583637662|FG001|Overall Study|Adverse Event|0|||
161613765|NCT02022670|583637663|FG002|Overall Study|Adverse Event|1|||
161613766|NCT02113449|583637664|FG000|Overall Study|Adverse Event|4|||
161613767|NCT00109031|583637665|FG000|Overall Study|Adverse Event|0|||
161613768|NCT00109031|583637666|FG001|Overall Study|Adverse Event|0|||
161613769|NCT00109031|583637667|FG002|Overall Study|Adverse Event|1|||
161613770|NCT00109031|583637668|FG003|Overall Study|Adverse Event|0|||
161613771|NCT00109031|583637665|FG000|Overall Study|Withdrawal by Subject|0|||
161613772|NCT00109031|583637666|FG001|Overall Study|Withdrawal by Subject|1|||
161613773|NCT00109031|583637667|FG002|Overall Study|Withdrawal by Subject|0|||
161613774|NCT00109031|583637668|FG003|Overall Study|Withdrawal by Subject|0|||
161613775|NCT00109031|583637665|FG000|Overall Study|Physician Decision|0|||
161613776|NCT00109031|583637666|FG001|Overall Study|Physician Decision|1|||
161613777|NCT00109031|583637667|FG002|Overall Study|Physician Decision|0|||
161613778|NCT00109031|583637668|FG003|Overall Study|Physician Decision|0|||
161613779|NCT00109031|583637665|FG000|Overall Study|Protocol Violation|0|||
161613780|NCT00109031|583637666|FG001|Overall Study|Protocol Violation|0|||
161613781|NCT00109031|583637667|FG002|Overall Study|Protocol Violation|1|||
161613782|NCT00109031|583637668|FG003|Overall Study|Protocol Violation|0|||
161613783|NCT02091752|583637671|FG000|Overall Study|Study terminated by Sponsor|2|||
161613784|NCT02091752|583637671|FG000|Overall Study|Adverse Event|1|||
161613785|NCT02060487|583637672|FG000|Overall Study|Other|1|||
161613786|NCT02060487|583637673|FG001|Overall Study|Other|2|||
161613787|NCT02060487|583637674|FG002|Overall Study|Other|1|||
161613788|NCT02060487|583637672|FG000|Overall Study|Lack of Efficacy|0|||
161613789|NCT02060487|583637673|FG001|Overall Study|Lack of Efficacy|1|||
161613790|NCT02060487|583637674|FG002|Overall Study|Lack of Efficacy|0|||
161613791|NCT02060487|583637672|FG000|Overall Study|Withdrawal by Subject|3|||
161613792|NCT02060487|583637673|FG001|Overall Study|Withdrawal by Subject|10|||
161613793|NCT02060487|583637674|FG002|Overall Study|Withdrawal by Subject|4|||
161613794|NCT02060487|583637672|FG000|Overall Study|Study Terminated By Sponsor|87|||
161613795|NCT02060487|583637673|FG001|Overall Study|Study Terminated By Sponsor|89|||
161613796|NCT02060487|583637674|FG002|Overall Study|Study Terminated By Sponsor|100|||
161613797|NCT02060487|583637672|FG000|Overall Study|Randomized in error|1|||
161613798|NCT02060487|583637673|FG001|Overall Study|Randomized in error|0|||
161613799|NCT02060487|583637674|FG002|Overall Study|Randomized in error|0|||
161613800|NCT02060487|583637672|FG000|Overall Study|Protocol Violation|0|||
161613801|NCT02060487|583637673|FG001|Overall Study|Protocol Violation|1|||
161613802|NCT02060487|583637674|FG002|Overall Study|Protocol Violation|1|||
161613803|NCT02060487|583637672|FG000|Overall Study|Lost to Follow-up|3|||
161613804|NCT02060487|583637673|FG001|Overall Study|Lost to Follow-up|0|||
161613805|NCT02060487|583637674|FG002|Overall Study|Lost to Follow-up|2|||
161613806|NCT02060487|583637672|FG000|Overall Study|Death|34|||
161613807|NCT02060487|583637673|FG001|Overall Study|Death|25|||
161613808|NCT02060487|583637674|FG002|Overall Study|Death|19|||
161613809|NCT02060487|583637672|FG000|Overall Study|Adverse Event|0|||
161613810|NCT02060487|583637673|FG001|Overall Study|Adverse Event|0|||
161613811|NCT02060487|583637674|FG002|Overall Study|Adverse Event|1|||
161613812|NCT03697603|583637679|FG000|Overall Study|Adverse Event|3|||
161613813|NCT03697603|583637680|FG001|Overall Study|Adverse Event|18|||
161613814|NCT03697603|583637681|FG002|Overall Study|Adverse Event|3|||
161613815|NCT03697603|583637679|FG000|Overall Study|Physician Decision|1|||
161613816|NCT03697603|583637680|FG001|Overall Study|Physician Decision|0|||
161613817|NCT03697603|583637681|FG002|Overall Study|Physician Decision|2|||
161613818|NCT03697603|583637679|FG000|Overall Study|Protocol Violation|3|||
161613819|NCT03697603|583637680|FG001|Overall Study|Protocol Violation|8|||
161613820|NCT03697603|583637681|FG002|Overall Study|Protocol Violation|5|||
161613821|NCT03697603|583637679|FG000|Overall Study|Withdrawal by Subject|5|||
161613822|NCT03697603|583637680|FG001|Overall Study|Withdrawal by Subject|1|||
161613823|NCT03697603|583637681|FG002|Overall Study|Withdrawal by Subject|1|||
161613824|NCT03697603|583637679|FG000|Overall Study|Protocol Violation|0|||
161613825|NCT03697603|583637680|FG001|Overall Study|Protocol Violation|0|||
161613826|NCT03697603|583637681|FG002|Overall Study|Protocol Violation|1|||
161613827|NCT04218864|583637682|FG000|Overall Study|Lost to Follow-up|8|||
161613828|NCT04218864|583637683|FG001|Overall Study|Lost to Follow-up|4|||
161613829|NCT04218864|583637682|FG000|Overall Study|Withdrawal by Subject|1|||
161613830|NCT04218864|583637683|FG001|Overall Study|Withdrawal by Subject|3|||
161613831|NCT03683030|583637684|FG000|Overall Study|Enrolled but screen failures|12|||
161613832|NCT03683030|583637685|FG001|Overall Study|Enrolled but screen failures|7|||
161613833|NCT03683030|583637684|FG000|Overall Study|Enrolled but no catheter inserted|11|||
161613834|NCT03683030|583637685|FG001|Overall Study|Enrolled but no catheter inserted|13|||
161613835|NCT03683030|583637684|FG000|Overall Study|Withdrawal by Subject|0|||
161613836|NCT03683030|583637685|FG001|Overall Study|Withdrawal by Subject|2|||
161613837|NCT03683030|583637684|FG000|Overall Study|Early termination by subject|1|||
161613838|NCT03683030|583637685|FG001|Overall Study|Early termination by subject|0|||
161613839|NCT03683030|583637684|FG000|Overall Study|Lost to Follow-up|0|||
161613840|NCT03683030|583637685|FG001|Overall Study|Lost to Follow-up|6|||
161613841|NCT03683030|583637684|FG000|Overall Study|Death|0|||
161613842|NCT03683030|583637685|FG001|Overall Study|Death|2|||
161613843|NCT03683030|583637684|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
161613844|NCT03683030|583637685|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
161613845|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
161613846|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
161613847|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
161613848|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
161684410|NCT02819635|583897903|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161613849|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
161613850|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
161613851|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
161613852|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
161613853|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
161613854|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
161613855|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
161613856|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
161613857|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
161613858|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
161613859|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
161613860|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
161613861|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
161613862|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
161613863|NCT02222493|583637686|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
161613864|NCT02222493|583637687|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
161613865|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
161613866|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
161613867|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
161613868|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
161613869|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
161613870|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
161613871|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
161613872|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
161613873|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
161613874|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
161613875|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
161613876|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
161613877|NCT02222493|583637686|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
161613878|NCT02222493|583637687|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
161613879|NCT02222493|583637686|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
161613880|NCT02222493|583637687|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
161613881|NCT02222493|583637686|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
161613882|NCT02222493|583637687|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
161613883|NCT02222493|583637686|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
161613884|NCT02222493|583637687|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
161613885|NCT02222493|583637686|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
161613886|NCT02222493|583637687|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
161613887|NCT02222493|583637686|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
161613888|NCT02222493|583637687|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
161613889|NCT00933270|583637690|FG000|Overall Study|Withdrawal by Subject|26|||
161613890|NCT00933270|583637690|FG000|Overall Study|Insufficient Follow-up|10|||
161613891|NCT00933270|583637690|FG000|Overall Study|Lost to Follow-up|14|||
161613892|NCT00933270|583637690|FG000|Overall Study|Adverse Event|1|||
161613893|NCT00933270|583637690|FG000|Overall Study|Missed Visit|2|||
161613894|NCT00933270|583637690|FG000|Overall Study|Death|24|||
161613895|NCT00933270|583637690|FG000|Overall Study|Moved or would not return|10|||
161613896|NCT02542943|583637691|FG000|Overall Study|Lost to Follow-up|1|||
161613897|NCT02542943|583637692|FG001|Overall Study|Lost to Follow-up|0|||
161613898|NCT02542943|583637693|FG002|Overall Study|Lost to Follow-up|0|||
161613899|NCT02542943|583637691|FG000|Overall Study|Withdrawal by Subject|0|||
161613900|NCT02542943|583637692|FG001|Overall Study|Withdrawal by Subject|1|||
161613901|NCT02542943|583637693|FG002|Overall Study|Withdrawal by Subject|0|||
161613902|NCT05824559|583637696|FG000|Overall Study|Adverse Event|2|||
161613903|NCT05824559|583637696|FG000|Overall Study|Physician Decision|2|||
161613904|NCT05824559|583637696|FG000|Overall Study|Progressive Disease|16|||
161613905|NCT05824559|583637696|FG000|Overall Study|Study Terminated by Sponsor|1|||
161613906|NCT05824559|583637696|FG000|Overall Study|Withdrawal by Subject|2|||
161613907|NCT04992273|583639227|FG000|Overall Study|Lost to Follow-up|0|||
161613908|NCT04992273|583639228|FG001|Overall Study|Lost to Follow-up|1|||
161613909|NCT01364597|583639229|FG000|Overall Study|Adverse Event|4|||
161613910|NCT01364597|583639230|FG001|Overall Study|Adverse Event|5|||
161613911|NCT01364597|583639231|FG002|Overall Study|Adverse Event|16|||
161613912|NCT01364597|583639232|FG003|Overall Study|Adverse Event|7|||
161613913|NCT01364597|583639229|FG000|Overall Study|Lack of Efficacy|4|||
161613914|NCT01364597|583639230|FG001|Overall Study|Lack of Efficacy|4|||
161613915|NCT01364597|583639231|FG002|Overall Study|Lack of Efficacy|23|||
161613916|NCT01364597|583639232|FG003|Overall Study|Lack of Efficacy|8|||
161613917|NCT01364597|583639229|FG000|Overall Study|Protocol Violation|0|||
161613918|NCT01364597|583639230|FG001|Overall Study|Protocol Violation|0|||
161613919|NCT01364597|583639231|FG002|Overall Study|Protocol Violation|2|||
161613920|NCT01364597|583639232|FG003|Overall Study|Protocol Violation|0|||
161613921|NCT01364597|583639229|FG000|Overall Study|Lost to Follow-up|0|||
161613922|NCT01364597|583639230|FG001|Overall Study|Lost to Follow-up|0|||
161613923|NCT01364597|583639231|FG002|Overall Study|Lost to Follow-up|5|||
161613924|NCT01364597|583639232|FG003|Overall Study|Lost to Follow-up|3|||
161613925|NCT01364597|583639229|FG000|Overall Study|Withdrawal by Subject|4|||
161613926|NCT01364597|583639230|FG001|Overall Study|Withdrawal by Subject|1|||
161613927|NCT01364597|583639231|FG002|Overall Study|Withdrawal by Subject|18|||
161613928|NCT01364597|583639232|FG003|Overall Study|Withdrawal by Subject|6|||
161613929|NCT01364597|583639229|FG000|Overall Study|Non compliance|1|||
161613930|NCT01364597|583639230|FG001|Overall Study|Non compliance|0|||
161613931|NCT01364597|583639231|FG002|Overall Study|Non compliance|1|||
161613932|NCT01364597|583639232|FG003|Overall Study|Non compliance|0|||
161613933|NCT01364597|583639229|FG000|Overall Study|Lack of compliance|1|||
161613934|NCT01364597|583639230|FG001|Overall Study|Lack of compliance|0|||
161613935|NCT01364597|583639231|FG002|Overall Study|Lack of compliance|0|||
161613936|NCT01364597|583639232|FG003|Overall Study|Lack of compliance|0|||
161613937|NCT01364597|583639229|FG000|Overall Study|End of treatment epilepsy|1|||
161613938|NCT01364597|583639230|FG001|Overall Study|End of treatment epilepsy|0|||
161613939|NCT01364597|583639231|FG002|Overall Study|End of treatment epilepsy|0|||
161613940|NCT01364597|583639232|FG003|Overall Study|End of treatment epilepsy|0|||
161613941|NCT01364597|583639229|FG000|Overall Study|No Seizures|1|||
161613942|NCT01364597|583639230|FG001|Overall Study|No Seizures|0|||
161613943|NCT01364597|583639231|FG002|Overall Study|No Seizures|0|||
161613944|NCT01364597|583639232|FG003|Overall Study|No Seizures|0|||
161613945|NCT01364597|583639229|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
161613946|NCT01364597|583639230|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
161613947|NCT01364597|583639231|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
161613948|NCT01364597|583639232|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
161613949|NCT01364597|583639229|FG000|Overall Study|Cure|1|||
161613950|NCT01364597|583639230|FG001|Overall Study|Cure|0|||
161613951|NCT01364597|583639231|FG002|Overall Study|Cure|0|||
161613952|NCT01364597|583639232|FG003|Overall Study|Cure|0|||
161613953|NCT01364597|583639229|FG000|Overall Study|Patient was moving|0|||
161613954|NCT01364597|583639230|FG001|Overall Study|Patient was moving|1|||
161613955|NCT01364597|583639231|FG002|Overall Study|Patient was moving|0|||
161613956|NCT01364597|583639232|FG003|Overall Study|Patient was moving|0|||
161613957|NCT01364597|583639229|FG000|Overall Study|Seizures resolved|0|||
161613958|NCT01364597|583639230|FG001|Overall Study|Seizures resolved|0|||
161613959|NCT01364597|583639231|FG002|Overall Study|Seizures resolved|1|||
161613960|NCT01364597|583639232|FG003|Overall Study|Seizures resolved|0|||
161613961|NCT01364597|583639229|FG000|Overall Study|Patient became seizure-free after surgery|0|||
161613962|NCT01364597|583639230|FG001|Overall Study|Patient became seizure-free after surgery|0|||
161613963|NCT01364597|583639231|FG002|Overall Study|Patient became seizure-free after surgery|1|||
161613964|NCT01364597|583639232|FG003|Overall Study|Patient became seizure-free after surgery|0|||
161613965|NCT01364597|583639229|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
161613966|NCT01364597|583639230|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
161613967|NCT01364597|583639231|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
161613968|NCT01364597|583639232|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
161613969|NCT01364597|583639229|FG000|Overall Study|Patient cured from Epilepsy|0|||
161613970|NCT01364597|583639230|FG001|Overall Study|Patient cured from Epilepsy|0|||
161613971|NCT01364597|583639231|FG002|Overall Study|Patient cured from Epilepsy|1|||
161613972|NCT01364597|583639232|FG003|Overall Study|Patient cured from Epilepsy|0|||
161613973|NCT01364597|583639229|FG000|Overall Study|Investigator decision|0|||
161613974|NCT01364597|583639230|FG001|Overall Study|Investigator decision|0|||
161613975|NCT01364597|583639231|FG002|Overall Study|Investigator decision|1|||
161613976|NCT01364597|583639232|FG003|Overall Study|Investigator decision|0|||
161613977|NCT01364597|583639229|FG000|Overall Study|Sponsor recommended discontinuation|0|||
161613978|NCT01364597|583639230|FG001|Overall Study|Sponsor recommended discontinuation|0|||
161613979|NCT01364597|583639231|FG002|Overall Study|Sponsor recommended discontinuation|0|||
161613980|NCT01364597|583639232|FG003|Overall Study|Sponsor recommended discontinuation|1|||
161613981|NCT01364597|583639229|FG000|Overall Study|Parents went abroad with the patient|0|||
161613982|NCT01364597|583639230|FG001|Overall Study|Parents went abroad with the patient|0|||
161613983|NCT01364597|583639231|FG002|Overall Study|Parents went abroad with the patient|1|||
161613984|NCT01364597|583639232|FG003|Overall Study|Parents went abroad with the patient|0|||
161613985|NCT01364597|583639229|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
161613986|NCT01364597|583639230|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
161613987|NCT01364597|583639231|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
161613988|NCT01364597|583639232|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
161613989|NCT01364597|583639229|FG000|Overall Study|BRV administration dropout|0|||
161613990|NCT01364597|583639230|FG001|Overall Study|BRV administration dropout|0|||
161613991|NCT01364597|583639231|FG002|Overall Study|BRV administration dropout|1|||
161613992|NCT01364597|583639232|FG003|Overall Study|BRV administration dropout|0|||
161613993|NCT01364597|583639229|FG000|Overall Study|Dropout|0|||
161613994|NCT01364597|583639230|FG001|Overall Study|Dropout|0|||
161613995|NCT01364597|583639231|FG002|Overall Study|Dropout|3|||
161613996|NCT01364597|583639232|FG003|Overall Study|Dropout|1|||
161613997|NCT01364597|583639229|FG000|Overall Study|Unreliable subject|0|||
161613998|NCT01364597|583639230|FG001|Overall Study|Unreliable subject|0|||
161613999|NCT01364597|583639231|FG002|Overall Study|Unreliable subject|0|||
161614000|NCT01364597|583639232|FG003|Overall Study|Unreliable subject|1|||
161614001|NCT01364597|583639229|FG000|Overall Study|Other|0|||
161614002|NCT01364597|583639230|FG001|Overall Study|Other|0|||
161614003|NCT01364597|583639231|FG002|Overall Study|Other|0|||
161614004|NCT01364597|583639232|FG003|Overall Study|Other|1|||
161614005|NCT02962284|583639233|FG000|Overall Study|Death|2|||
161614006|NCT02962284|583639234|FG001|Overall Study|Death|0|||
161614007|NCT02962284|583639233|FG000|Overall Study|Progressive disease|2|||
161614008|NCT02962284|583639234|FG001|Overall Study|Progressive disease|3|||
161614009|NCT02962284|583639233|FG000|Overall Study|Withdrawal by Subject|1|||
161614010|NCT02962284|583639234|FG001|Overall Study|Withdrawal by Subject|0|||
161614011|NCT03493282|583639238|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
161614012|NCT03493282|583639239|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
161614013|NCT03493282|583639240|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
161614014|NCT03493282|583639238|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
161614015|NCT03493282|583639239|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
161614016|NCT03493282|583639240|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
161684411|NCT02819635|583897892|FG000|Substudy 2, Part 2|Other, not specified|0|||
161684412|NCT02819635|583897893|FG001|Substudy 2, Part 2|Other, not specified|0|||
161684413|NCT02819635|583897894|FG002|Substudy 2, Part 2|Other, not specified|0|||
161684414|NCT02819635|583897895|FG003|Substudy 2, Part 2|Other, not specified|0|||
161684415|NCT02819635|583897896|FG004|Substudy 2, Part 2|Other, not specified|0|||
161684416|NCT02819635|583897897|FG005|Substudy 2, Part 2|Other, not specified|4|||
161684417|NCT02819635|583897898|FG006|Substudy 2, Part 2|Other, not specified|8|||
161684418|NCT02819635|583897899|FG007|Substudy 2, Part 2|Other, not specified|0|||
161684419|NCT02819635|583897900|FG008|Substudy 2, Part 2|Other, not specified|0|||
161614017|NCT02637063|583639241|FG000|Overall Study|Lost to Follow-up|3|||
161614018|NCT02637063|583639242|FG001|Overall Study|Lost to Follow-up|2|||
161614019|NCT02637063|583639243|FG002|Overall Study|Lost to Follow-up|3|||
161614020|NCT02637063|583639241|FG000|Overall Study|Withdrawal by Subject|2|||
161614021|NCT02637063|583639242|FG001|Overall Study|Withdrawal by Subject|2|||
161614022|NCT02637063|583639243|FG002|Overall Study|Withdrawal by Subject|3|||
161614023|NCT01380145|583639244|FG000|Overall Study|Progressive disease|4|||
161614024|NCT02038049|583639249|FG000|Overall Study|Lost to Follow-up|1|||
161832680|NCT02139124|584428493|FG003|Overall Study|subject moved|0|||
161684420|NCT02819635|583897901|FG009|Substudy 2, Part 2|Other, not specified|0|||
161684421|NCT02819635|583897902|FG010|Substudy 2, Part 2|Other, not specified|0|||
161684422|NCT02819635|583897903|FG011|Substudy 2, Part 2|Other, not specified|0|||
161684423|NCT02819635|583897892|FG000|Substudy 3|Adverse Event|0|||
161684424|NCT02819635|583897893|FG001|Substudy 3|Adverse Event|0|||
161684425|NCT02819635|583897894|FG002|Substudy 3|Adverse Event|0|||
161684426|NCT02819635|583897895|FG003|Substudy 3|Adverse Event|0|||
161614025|NCT02038049|583639250|FG001|Overall Study|Lost to Follow-up|0|||
161614026|NCT00413283|583639251|FG000|Overall Study|Withdrawal by Subject|1|||
161614027|NCT00413283|583639252|FG001|Overall Study|Withdrawal by Subject|0|||
161614028|NCT00413283|583639253|FG002|Overall Study|Withdrawal by Subject|0|||
161614029|NCT00413283|583639254|FG003|Overall Study|Withdrawal by Subject|1|||
161614030|NCT00413283|583639251|FG000|Overall Study|Death|0|||
161614031|NCT00413283|583639252|FG001|Overall Study|Death|0|||
161614032|NCT00413283|583639253|FG002|Overall Study|Death|1|||
161614033|NCT00413283|583639254|FG003|Overall Study|Death|1|||
161614034|NCT00413283|583639251|FG000|Overall Study|Adverse Event|0|||
161614035|NCT00413283|583639252|FG001|Overall Study|Adverse Event|0|||
161614036|NCT00413283|583639253|FG002|Overall Study|Adverse Event|0|||
161614037|NCT00413283|583639254|FG003|Overall Study|Adverse Event|1|||
161614038|NCT00413283|583639251|FG000|Overall Study|Ineligibility determined|0|||
161614039|NCT00413283|583639252|FG001|Overall Study|Ineligibility determined|0|||
161614040|NCT00413283|583639253|FG002|Overall Study|Ineligibility determined|0|||
161614041|NCT00413283|583639254|FG003|Overall Study|Ineligibility determined|1|||
161614042|NCT00413283|583639251|FG000|Overall Study|Protocol deviation|0|||
161614043|NCT00413283|583639252|FG001|Overall Study|Protocol deviation|1|||
161614044|NCT00413283|583639253|FG002|Overall Study|Protocol deviation|0|||
161614045|NCT00413283|583639254|FG003|Overall Study|Protocol deviation|0|||
161614046|NCT00413283|583639251|FG000|Overall Study|Requirement for alternative therapy|0|||
161614047|NCT00413283|583639252|FG001|Overall Study|Requirement for alternative therapy|2|||
161614048|NCT00413283|583639253|FG002|Overall Study|Requirement for alternative therapy|0|||
161614049|NCT00413283|583639254|FG003|Overall Study|Requirement for alternative therapy|0|||
161614050|NCT00413283|583639251|FG000|Overall Study|Other|0|||
161614051|NCT00413283|583639252|FG001|Overall Study|Other|0|||
161614052|NCT00413283|583639253|FG002|Overall Study|Other|1|||
161614053|NCT00413283|583639254|FG003|Overall Study|Other|0|||
161614054|NCT02660086|583639256|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
161614055|NCT02660086|583639257|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
161684427|NCT02819635|583897896|FG004|Substudy 3|Adverse Event|0|||
161684428|NCT02819635|583897897|FG005|Substudy 3|Adverse Event|0|||
161684429|NCT02819635|583897898|FG006|Substudy 3|Adverse Event|0|||
161614056|NCT02660086|583639256|FG000|Overall Study- 12-month|Left full-time employment|12|||
161614057|NCT02660086|583639257|FG001|Overall Study- 12-month|Left full-time employment|20|||
161614058|NCT02660086|583639256|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
161614059|NCT02660086|583639257|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
161614060|NCT02660086|583639256|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
161614061|NCT02660086|583639257|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
161614062|NCT02660086|583639256|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
161614063|NCT02660086|583639257|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
161614064|NCT02660086|583639256|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
161614065|NCT02660086|583639257|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
161614066|NCT01214200|583639260|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
161684430|NCT02819635|583897899|FG007|Substudy 3|Adverse Event|0|||
161684431|NCT02819635|583897900|FG008|Substudy 3|Adverse Event|32|||
161684432|NCT02819635|583897901|FG009|Substudy 3|Adverse Event|3|||
161684433|NCT02819635|583897902|FG010|Substudy 3|Adverse Event|12|||
161614067|NCT01214200|583639260|FG000|Overall Study|Withdrawal by Subject|2|||
161614068|NCT02575365|583639261|FG000|Overall Study|Lost to Follow-up|4|||
161614069|NCT00487240|583639265|FG000|Overall Study|Withdrawal by Subject|12|||
161614070|NCT00487240|583639266|FG001|Overall Study|Withdrawal by Subject|6|||
161614071|NCT00487240|583639265|FG000|Overall Study|Lost to Follow-up|7|||
161614072|NCT00487240|583639266|FG001|Overall Study|Lost to Follow-up|6|||
161614073|NCT00487240|583639265|FG000|Overall Study|Adverse Event|0|||
161614074|NCT00487240|583639266|FG001|Overall Study|Adverse Event|4|||
161614075|NCT00487240|583639265|FG000|Overall Study|Protocol Violation|5|||
161614076|NCT00487240|583639266|FG001|Overall Study|Protocol Violation|5|||
161614077|NCT00487240|583639265|FG000|Overall Study|Entry Criteria Not Met|3|||
161614078|NCT00487240|583639266|FG001|Overall Study|Entry Criteria Not Met|4|||
161614079|NCT00487240|583639265|FG000|Overall Study|Sponsor Decision|2|||
161614080|NCT00487240|583639266|FG001|Overall Study|Sponsor Decision|1|||
161614081|NCT00487240|583639265|FG000|Overall Study|Physician Decision|2|||
161614082|NCT00487240|583639266|FG001|Overall Study|Physician Decision|0|||
161614083|NCT02736188|583639267|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
161614084|NCT02736188|583639267|FG000|Overall Study|Adverse Event|1|||
161614085|NCT02736188|583639267|FG000|Overall Study|Withdrawal by Subject|1|||
161614086|NCT02736188|583639267|FG000|Overall Study|Other|6|||
161614087|NCT01698918|583639268|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
161614088|NCT01698918|583639268|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
161614089|NCT01698918|583639268|FG000|First Line Treatment (Core+Extension)|Death|2|||
161614090|NCT01698918|583639268|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
161614091|NCT01698918|583639268|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
161614092|NCT01698918|583639268|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
161614093|NCT01698918|583639268|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
161614094|NCT01698918|583639268|FG000|Second Line Treatment (Core+Extension)|Death|1|||
161614095|NCT01698918|583639268|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
161614096|NCT01698918|583639268|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
161614097|NCT01428583|583639270|FG000|Overall Study|Adverse Event|75|||
161614098|NCT01428583|583639270|FG000|Overall Study|Withdrawal by Subject|51|||
161614099|NCT01428583|583639270|FG000|Overall Study|Lack of Efficacy|37|||
161614100|NCT01428583|583639270|FG000|Overall Study|Lost to Follow-up|17|||
161614101|NCT01428583|583639270|FG000|Overall Study|Death|1|||
161614102|NCT01428583|583639270|FG000|Overall Study|Pregnancy|1|||
161614103|NCT01428583|583639270|FG000|Overall Study|Protocol Violation|1|||
161614104|NCT01428583|583639270|FG000|Overall Study|Physician Decision|12|||
161614105|NCT01428583|583639270|FG000|Overall Study|Non-compliant|25|||
161614106|NCT01428583|583639270|FG000|Overall Study|Confirmed positive urine drug test|8|||
161614107|NCT01428583|583639270|FG000|Overall Study|Sponsor's request|3|||
161614108|NCT01428583|583639270|FG000|Overall Study|Other|6|||
161614109|NCT00768755|583639273|FG000|Phase 1|Death|6|||
161614110|NCT00768755|583639274|FG001|Phase 1|Death|0|||
161614111|NCT00768755|583639275|FG002|Phase 1|Death|0|||
161614112|NCT00768755|583639276|FG003|Phase 1|Death|0|||
161614113|NCT00768755|583639273|FG000|Phase 1|Other|4|||
161614114|NCT00768755|583639274|FG001|Phase 1|Other|0|||
161614115|NCT00768755|583639275|FG002|Phase 1|Other|0|||
161614116|NCT00768755|583639276|FG003|Phase 1|Other|0|||
161614117|NCT00768755|583639273|FG000|Phase 2|Death|0|||
161614118|NCT00768755|583639274|FG001|Phase 2|Death|37|||
161614119|NCT00768755|583639275|FG002|Phase 2|Death|48|||
161614120|NCT00768755|583639276|FG003|Phase 2|Death|31|||
161614121|NCT00768755|583639273|FG000|Phase 2|Protocol Violation|0|||
161614122|NCT00768755|583639274|FG001|Phase 2|Protocol Violation|2|||
161614123|NCT00768755|583639275|FG002|Phase 2|Protocol Violation|0|||
161614124|NCT00768755|583639276|FG003|Phase 2|Protocol Violation|1|||
161614125|NCT00768755|583639273|FG000|Phase 2|Lost to Follow-up|0|||
161614126|NCT00768755|583639274|FG001|Phase 2|Lost to Follow-up|1|||
161684434|NCT02819635|583897903|FG011|Substudy 3|Adverse Event|18|||
161684435|NCT02819635|583897892|FG000|Substudy 3|Withdrew consent|0|||
161614127|NCT00768755|583639275|FG002|Phase 2|Lost to Follow-up|1|||
161614128|NCT00768755|583639276|FG003|Phase 2|Lost to Follow-up|4|||
161614129|NCT00768755|583639273|FG000|Phase 2|Withdrawal by Subject|0|||
161684436|NCT02819635|583897893|FG001|Substudy 3|Withdrew consent|0|||
161614130|NCT00768755|583639274|FG001|Phase 2|Withdrawal by Subject|1|||
161614131|NCT00768755|583639275|FG002|Phase 2|Withdrawal by Subject|0|||
161614132|NCT00768755|583639276|FG003|Phase 2|Withdrawal by Subject|1|||
161684437|NCT02819635|583897894|FG002|Substudy 3|Withdrew consent|0|||
161614133|NCT00768755|583639273|FG000|Phase 2|Other|0|||
161614134|NCT00768755|583639274|FG001|Phase 2|Other|1|||
161614135|NCT00768755|583639275|FG002|Phase 2|Other|2|||
161614136|NCT00768755|583639276|FG003|Phase 2|Other|4|||
161614137|NCT00768755|583639273|FG000|Phase 2|Study Terminated by Sponsor|0|||
161684438|NCT02819635|583897895|FG003|Substudy 3|Withdrew consent|0|||
161684439|NCT02819635|583897896|FG004|Substudy 3|Withdrew consent|0|||
161614138|NCT00768755|583639274|FG001|Phase 2|Study Terminated by Sponsor|13|||
161614139|NCT00768755|583639275|FG002|Phase 2|Study Terminated by Sponsor|7|||
161614140|NCT00768755|583639276|FG003|Phase 2|Study Terminated by Sponsor|14|||
161684440|NCT02819635|583897897|FG005|Substudy 3|Withdrew consent|0|||
161614141|NCT00768755|583639273|FG000|Phase 2|Randomized but not treated|0|||
161614142|NCT00768755|583639274|FG001|Phase 2|Randomized but not treated|0|||
161614143|NCT00768755|583639275|FG002|Phase 2|Randomized but not treated|0|||
161614144|NCT00768755|583639276|FG003|Phase 2|Randomized but not treated|2|||
161614145|NCT00670488|583639277|FG000|Overall Study|Adverse Event|0|||
161614146|NCT00670488|583639278|FG001|Overall Study|Adverse Event|7|||
161614147|NCT00670488|583639279|FG002|Overall Study|Adverse Event|0|||
161614148|NCT00670488|583639280|FG003|Overall Study|Adverse Event|3|||
161614149|NCT00670488|583639281|FG004|Overall Study|Adverse Event|1|||
161614150|NCT00670488|583639282|FG005|Overall Study|Adverse Event|1|||
161614151|NCT00670488|583639283|FG006|Overall Study|Adverse Event|5|||
161614152|NCT00670488|583639284|FG007|Overall Study|Adverse Event|1|||
161614153|NCT00670488|583639285|FG008|Overall Study|Adverse Event|0|||
161614154|NCT00670488|583639286|FG009|Overall Study|Adverse Event|1|||
161614155|NCT00670488|583639277|FG000|Overall Study|Physician Decision|1|||
161614156|NCT00670488|583639278|FG001|Overall Study|Physician Decision|9|||
161614157|NCT00670488|583639279|FG002|Overall Study|Physician Decision|0|||
161614158|NCT00670488|583639280|FG003|Overall Study|Physician Decision|1|||
161614159|NCT00670488|583639281|FG004|Overall Study|Physician Decision|0|||
161614160|NCT00670488|583639282|FG005|Overall Study|Physician Decision|0|||
161614161|NCT00670488|583639283|FG006|Overall Study|Physician Decision|0|||
161614162|NCT00670488|583639284|FG007|Overall Study|Physician Decision|0|||
161614163|NCT00670488|583639285|FG008|Overall Study|Physician Decision|0|||
161614164|NCT00670488|583639286|FG009|Overall Study|Physician Decision|0|||
161614165|NCT00670488|583639277|FG000|Overall Study|Progressive Disease|2|||
161614166|NCT00670488|583639278|FG001|Overall Study|Progressive Disease|41|||
161614167|NCT00670488|583639279|FG002|Overall Study|Progressive Disease|3|||
161614168|NCT00670488|583639280|FG003|Overall Study|Progressive Disease|2|||
161614169|NCT00670488|583639281|FG004|Overall Study|Progressive Disease|2|||
161614170|NCT00670488|583639282|FG005|Overall Study|Progressive Disease|4|||
161614171|NCT00670488|583639283|FG006|Overall Study|Progressive Disease|11|||
161614172|NCT00670488|583639284|FG007|Overall Study|Progressive Disease|2|||
161614173|NCT00670488|583639285|FG008|Overall Study|Progressive Disease|2|||
161614174|NCT00670488|583639286|FG009|Overall Study|Progressive Disease|1|||
161614175|NCT00670488|583639277|FG000|Overall Study|Withdrawal by Subject|0|||
161614176|NCT00670488|583639278|FG001|Overall Study|Withdrawal by Subject|1|||
161614177|NCT00670488|583639279|FG002|Overall Study|Withdrawal by Subject|0|||
161614178|NCT00670488|583639280|FG003|Overall Study|Withdrawal by Subject|1|||
161614179|NCT00670488|583639281|FG004|Overall Study|Withdrawal by Subject|0|||
161614180|NCT00670488|583639282|FG005|Overall Study|Withdrawal by Subject|0|||
161614181|NCT00670488|583639283|FG006|Overall Study|Withdrawal by Subject|1|||
161614182|NCT00670488|583639284|FG007|Overall Study|Withdrawal by Subject|0|||
161614183|NCT00670488|583639285|FG008|Overall Study|Withdrawal by Subject|1|||
161614184|NCT00670488|583639286|FG009|Overall Study|Withdrawal by Subject|0|||
161614185|NCT00878189|583639287|FG000|Overall Study|Death|0|||
161614186|NCT00878189|583639288|FG001|Overall Study|Death|1|||
161614187|NCT00878189|583639289|FG002|Overall Study|Death|0|||
161614188|NCT00878189|583639290|FG003|Overall Study|Death|1|||
161614189|NCT00878189|583639291|FG004|Overall Study|Death|0|||
161614190|NCT00878189|583639292|FG005|Overall Study|Death|0|||
161614191|NCT00878189|583639293|FG006|Overall Study|Death|0|||
161614192|NCT00878189|583639294|FG007|Overall Study|Death|0|||
161614193|NCT00878189|583639295|FG008|Overall Study|Death|1|||
161614194|NCT00878189|583639287|FG000|Overall Study|Participant Refused to Follow-up|0|||
161614195|NCT00878189|583639288|FG001|Overall Study|Participant Refused to Follow-up|0|||
161614196|NCT00878189|583639289|FG002|Overall Study|Participant Refused to Follow-up|0|||
161614197|NCT00878189|583639290|FG003|Overall Study|Participant Refused to Follow-up|0|||
161614198|NCT00878189|583639291|FG004|Overall Study|Participant Refused to Follow-up|0|||
161614199|NCT00878189|583639292|FG005|Overall Study|Participant Refused to Follow-up|4|||
161614200|NCT00878189|583639293|FG006|Overall Study|Participant Refused to Follow-up|0|||
161614201|NCT00878189|583639294|FG007|Overall Study|Participant Refused to Follow-up|0|||
161614202|NCT00878189|583639295|FG008|Overall Study|Participant Refused to Follow-up|0|||
161614203|NCT00878189|583639287|FG000|Overall Study|Other|3|||
161614204|NCT00878189|583639288|FG001|Overall Study|Other|2|||
161614205|NCT00878189|583639289|FG002|Overall Study|Other|4|||
161614206|NCT00878189|583639290|FG003|Overall Study|Other|7|||
161614207|NCT00878189|583639291|FG004|Overall Study|Other|4|||
161614208|NCT00878189|583639292|FG005|Overall Study|Other|18|||
161614209|NCT00878189|583639293|FG006|Overall Study|Other|15|||
161614210|NCT00878189|583639294|FG007|Overall Study|Other|3|||
161614211|NCT00878189|583639295|FG008|Overall Study|Other|4|||
161614212|NCT00878189|583639287|FG000|Overall Study|Lost to Follow-up|0|||
161614213|NCT00878189|583639288|FG001|Overall Study|Lost to Follow-up|0|||
161614214|NCT00878189|583639289|FG002|Overall Study|Lost to Follow-up|0|||
161614215|NCT00878189|583639290|FG003|Overall Study|Lost to Follow-up|0|||
161614216|NCT00878189|583639291|FG004|Overall Study|Lost to Follow-up|0|||
161614217|NCT00878189|583639292|FG005|Overall Study|Lost to Follow-up|1|||
161614218|NCT00878189|583639293|FG006|Overall Study|Lost to Follow-up|1|||
161614219|NCT00878189|583639294|FG007|Overall Study|Lost to Follow-up|0|||
161614220|NCT00878189|583639295|FG008|Overall Study|Lost to Follow-up|0|||
161614221|NCT00878189|583639287|FG000|Overall Study|Objection Progression or Relapse|0|||
161614222|NCT00878189|583639288|FG001|Overall Study|Objection Progression or Relapse|0|||
161614223|NCT00878189|583639289|FG002|Overall Study|Objection Progression or Relapse|0|||
161614224|NCT00878189|583639290|FG003|Overall Study|Objection Progression or Relapse|0|||
161614225|NCT00878189|583639291|FG004|Overall Study|Objection Progression or Relapse|0|||
161614226|NCT00878189|583639292|FG005|Overall Study|Objection Progression or Relapse|0|||
161614227|NCT00878189|583639293|FG006|Overall Study|Objection Progression or Relapse|0|||
161614228|NCT00878189|583639294|FG007|Overall Study|Objection Progression or Relapse|0|||
161614229|NCT00878189|583639295|FG008|Overall Study|Objection Progression or Relapse|3|||
161614230|NCT02708498|583639296|FG000|Overall Study|Death|20|||
161614231|NCT02708498|583639297|FG001|Overall Study|Death|19|||
161614232|NCT02708498|583639298|FG002|Overall Study|Death|0|||
161614233|NCT02708498|583639299|FG003|Overall Study|Death|0|||
161614234|NCT02708498|583639300|FG004|Overall Study|Death|1|||
161614235|NCT02708498|583639301|FG005|Overall Study|Death|0|||
161614236|NCT02708498|583639302|FG006|Overall Study|Death|0|||
161614237|NCT02708498|583639303|FG007|Overall Study|Death|0|||
161614238|NCT02708498|583639296|FG000|Overall Study|Unknown reason, missing data|0|||
161614239|NCT02708498|583639297|FG001|Overall Study|Unknown reason, missing data|0|||
161614240|NCT02708498|583639298|FG002|Overall Study|Unknown reason, missing data|62|||
161614241|NCT02708498|583639299|FG003|Overall Study|Unknown reason, missing data|51|||
161614242|NCT02708498|583639300|FG004|Overall Study|Unknown reason, missing data|195|||
161614243|NCT02708498|583639301|FG005|Overall Study|Unknown reason, missing data|132|||
161614244|NCT02708498|583639302|FG006|Overall Study|Unknown reason, missing data|0|||
161614245|NCT02708498|583639303|FG007|Overall Study|Unknown reason, missing data|0|||
161614246|NCT01858688|583639304|FG000|Overall Study|Withdrawal by Subject|8|||
161614247|NCT01858688|583639304|FG000|Overall Study|Participant began another therapy|3|||
161614248|NCT01858688|583639304|FG000|Overall Study|Physician Decision|2|||
161614249|NCT01858688|583639304|FG000|Overall Study|Progressive Disease|2|||
161614250|NCT01858688|583639304|FG000|Overall Study|Reason not reproted|5|||
161614251|NCT00659373|583639316|FG000|Overall Study|Withdrawal by Subject|3|||
161614252|NCT00659373|583639317|FG001|Overall Study|Withdrawal by Subject|5|||
161614253|NCT00659373|583639316|FG000|Overall Study|Assessment Missed|2|||
161614254|NCT00659373|583639317|FG001|Overall Study|Assessment Missed|2|||
161614255|NCT03042767|583639320|FG000|Overall Study|Lost to Follow-up|1|||
161614256|NCT03042767|583639321|FG001|Overall Study|Lost to Follow-up|2|||
161614257|NCT04638816|583639323|FG000|Overall Study|Withdrawal by Subject|0|||
161614258|NCT04638816|583639324|FG001|Overall Study|Withdrawal by Subject|1|||
161614259|NCT04638816|583639323|FG000|Overall Study|Lost to Follow-up|0|||
161614260|NCT04638816|583639324|FG001|Overall Study|Lost to Follow-up|1|||
161614261|NCT01328496|583639327|FG000|Overall Study|Significant Change in Health Status|1|||
161614262|NCT01328496|583639328|FG001|Overall Study|Significant Change in Health Status|0|||
161614263|NCT02208843|583639329|FG000|Overall Study|Clinical symptoms of progression|2|||
161614264|NCT02208843|583639329|FG000|Overall Study|Progression disease according to RECIST|24|||
161614265|NCT02208843|583639329|FG000|Overall Study|Adverse Event|12|||
161614266|NCT02208843|583639329|FG000|Overall Study|Protocol Violation|1|||
161614267|NCT02208843|583639329|FG000|Overall Study|Withdrawal by Subject|1|||
161614268|NCT02208843|583639329|FG000|Overall Study|Switched to commercial afatinib|20|||
161614269|NCT04399837|583639331|FG000|Overall Study|Other than listed|0|||
161614270|NCT04399837|583639332|FG001|Overall Study|Other than listed|2|||
161614271|NCT04399837|583639333|FG002|Overall Study|Other than listed|2|||
161614272|NCT04399837|583639334|FG003|Overall Study|Other than listed|3|||
161614273|NCT04399837|583639331|FG000|Overall Study|Withdrawal by Subject|1|||
161614274|NCT04399837|583639332|FG001|Overall Study|Withdrawal by Subject|2|||
161614275|NCT04399837|583639333|FG002|Overall Study|Withdrawal by Subject|1|||
161614276|NCT04399837|583639334|FG003|Overall Study|Withdrawal by Subject|1|||
161614277|NCT02686658|583639339|FG000|Overall Study|Adverse Event|0|||
161614278|NCT02686658|583639340|FG001|Overall Study|Adverse Event|0|||
161614279|NCT02686658|583639341|FG002|Overall Study|Adverse Event|1|||
161614280|NCT02686658|583639342|FG003|Overall Study|Adverse Event|1|||
161614281|NCT02686658|583639343|FG004|Overall Study|Adverse Event|2|||
161684441|NCT02819635|583897898|FG006|Substudy 3|Withdrew consent|0|||
161684442|NCT02819635|583897899|FG007|Substudy 3|Withdrew consent|0|||
161684443|NCT02819635|583897900|FG008|Substudy 3|Withdrew consent|11|||
161614282|NCT02686658|583639344|FG005|Overall Study|Adverse Event|1|||
161614283|NCT02686658|583639339|FG000|Overall Study|Investigator decision|0|||
161614284|NCT02686658|583639340|FG001|Overall Study|Investigator decision|0|||
161614285|NCT02686658|583639341|FG002|Overall Study|Investigator decision|0|||
161614286|NCT02686658|583639342|FG003|Overall Study|Investigator decision|1|||
161614287|NCT02686658|583639343|FG004|Overall Study|Investigator decision|2|||
161614288|NCT02686658|583639344|FG005|Overall Study|Investigator decision|1|||
161614289|NCT02686658|583639339|FG000|Overall Study|Sponsor decision|1|||
161684444|NCT02819635|583897901|FG009|Substudy 3|Withdrew consent|1|||
161684445|NCT02819635|583897902|FG010|Substudy 3|Withdrew consent|4|||
161614290|NCT02686658|583639340|FG001|Overall Study|Sponsor decision|2|||
161614291|NCT02686658|583639341|FG002|Overall Study|Sponsor decision|1|||
161614292|NCT02686658|583639342|FG003|Overall Study|Sponsor decision|5|||
161614293|NCT02686658|583639343|FG004|Overall Study|Sponsor decision|13|||
161614294|NCT02686658|583639344|FG005|Overall Study|Sponsor decision|2|||
161614295|NCT02686658|583639339|FG000|Overall Study|Lost to Follow-up|0|||
161614296|NCT02686658|583639340|FG001|Overall Study|Lost to Follow-up|0|||
161614297|NCT02686658|583639341|FG002|Overall Study|Lost to Follow-up|2|||
161614298|NCT02686658|583639342|FG003|Overall Study|Lost to Follow-up|0|||
161614299|NCT02686658|583639343|FG004|Overall Study|Lost to Follow-up|0|||
161614300|NCT02686658|583639344|FG005|Overall Study|Lost to Follow-up|1|||
161614301|NCT02686658|583639339|FG000|Overall Study|Death|1|||
161614302|NCT02686658|583639340|FG001|Overall Study|Death|0|||
161614303|NCT02686658|583639341|FG002|Overall Study|Death|0|||
161614304|NCT02686658|583639342|FG003|Overall Study|Death|1|||
161614305|NCT02686658|583639343|FG004|Overall Study|Death|1|||
161614306|NCT02686658|583639344|FG005|Overall Study|Death|1|||
161614307|NCT02686658|583639339|FG000|Overall Study|Withdrawal by Subject|2|||
161614308|NCT02686658|583639340|FG001|Overall Study|Withdrawal by Subject|5|||
161614309|NCT02686658|583639341|FG002|Overall Study|Withdrawal by Subject|4|||
161614310|NCT02686658|583639342|FG003|Overall Study|Withdrawal by Subject|4|||
161614311|NCT02686658|583639343|FG004|Overall Study|Withdrawal by Subject|17|||
161614312|NCT02686658|583639344|FG005|Overall Study|Withdrawal by Subject|8|||
161614313|NCT02686658|583639339|FG000|Overall Study|Placed in hospice care|0|||
161614314|NCT02686658|583639340|FG001|Overall Study|Placed in hospice care|0|||
161614315|NCT02686658|583639341|FG002|Overall Study|Placed in hospice care|1|||
161614316|NCT02686658|583639342|FG003|Overall Study|Placed in hospice care|0|||
161614317|NCT02686658|583639343|FG004|Overall Study|Placed in hospice care|0|||
161614318|NCT02686658|583639344|FG005|Overall Study|Placed in hospice care|0|||
161614319|NCT02686658|583639339|FG000|Overall Study|Participant non-compliance|0|||
161614320|NCT02686658|583639340|FG001|Overall Study|Participant non-compliance|0|||
161614321|NCT02686658|583639341|FG002|Overall Study|Participant non-compliance|0|||
161614322|NCT02686658|583639342|FG003|Overall Study|Participant non-compliance|0|||
161614323|NCT02686658|583639343|FG004|Overall Study|Participant non-compliance|0|||
161614324|NCT02686658|583639344|FG005|Overall Study|Participant non-compliance|1|||
161614325|NCT02686658|583639339|FG000|Overall Study|Concern over coronavirus disease care|0|||
161614326|NCT02686658|583639340|FG001|Overall Study|Concern over coronavirus disease care|0|||
161614327|NCT02686658|583639341|FG002|Overall Study|Concern over coronavirus disease care|0|||
161614328|NCT02686658|583639342|FG003|Overall Study|Concern over coronavirus disease care|0|||
161614329|NCT02686658|583639343|FG004|Overall Study|Concern over coronavirus disease care|2|||
161614330|NCT02686658|583639344|FG005|Overall Study|Concern over coronavirus disease care|1|||
161614331|NCT03476798|583639348|FG000|Overall Study|Death|1|||
161614332|NCT03476798|583639348|FG000|Overall Study|Withdrawal by Subject|2|||
161614333|NCT03476798|583639348|FG000|Overall Study|Protocol Violation|2|||
161614334|NCT06269003|583639349|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
161614335|NCT06269003|583639350|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
161614336|NCT06269003|583639351|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
161614337|NCT06269003|583639352|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
161614338|NCT03343704|583639356|FG000|Overall Study|Refused to complete follow up|0|||
161614339|NCT03343704|583639357|FG001|Overall Study|Refused to complete follow up|1|||
161614340|NCT03343704|583639356|FG000|Overall Study|Death|0|||
161614341|NCT03343704|583639357|FG001|Overall Study|Death|1|||
161614342|NCT03343704|583639356|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
161614343|NCT03343704|583639357|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
161614344|NCT04224272|583639358|FG000|Part 1 - Dose Finding|Death|4|||
161614345|NCT04224272|583639358|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
161614346|NCT04224272|583639358|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
161614347|NCT04224272|583639358|FG000|Part 2 - Dose Expansion|Death|10|||
161614348|NCT04224272|583639358|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
161614349|NCT02609048|583639359|FG000|Overall Study|Adverse Event|3|||
161614350|NCT02609048|583639360|FG001|Overall Study|Adverse Event|0|||
161614351|NCT02609048|583639361|FG002|Overall Study|Adverse Event|0|||
161614352|NCT02609048|583639359|FG000|Overall Study|Randomized but never treated|1|||
161614353|NCT02609048|583639360|FG001|Overall Study|Randomized but never treated|1|||
161614354|NCT02609048|583639361|FG002|Overall Study|Randomized but never treated|1|||
161614355|NCT02609048|583639359|FG000|Overall Study|Withdrawal of informed consent|1|||
161614356|NCT02609048|583639360|FG001|Overall Study|Withdrawal of informed consent|0|||
161614357|NCT02609048|583639361|FG002|Overall Study|Withdrawal of informed consent|0|||
161614358|NCT02609048|583639359|FG000|Overall Study|Reason not specified|6|||
161614359|NCT02609048|583639360|FG001|Overall Study|Reason not specified|9|||
161614360|NCT02609048|583639361|FG002|Overall Study|Reason not specified|9|||
161614361|NCT05432986|583639367|FG000|Overall Study|Withdrawal by Subject|2|||
161614362|NCT05432986|583639367|FG000|Overall Study|incomplete measurement|7|||
161614363|NCT01276509|583640575|FG000|Overall Study|Adverse Event|9|||
161614364|NCT01276509|583640576|FG001|Overall Study|Adverse Event|8|||
161614365|NCT01276509|583640577|FG002|Overall Study|Adverse Event|4|||
161614366|NCT01276509|583640578|FG003|Overall Study|Adverse Event|3|||
161614367|NCT01276509|583640575|FG000|Overall Study|Lack of Efficacy|2|||
161614368|NCT01276509|583640576|FG001|Overall Study|Lack of Efficacy|1|||
161614369|NCT01276509|583640577|FG002|Overall Study|Lack of Efficacy|1|||
161614370|NCT01276509|583640578|FG003|Overall Study|Lack of Efficacy|2|||
161614371|NCT01276509|583640575|FG000|Overall Study|Pregnancy|1|||
161614372|NCT01276509|583640576|FG001|Overall Study|Pregnancy|0|||
161614373|NCT01276509|583640577|FG002|Overall Study|Pregnancy|0|||
161614374|NCT01276509|583640578|FG003|Overall Study|Pregnancy|0|||
161614375|NCT01276509|583640575|FG000|Overall Study|Withdrawal by Subject|1|||
161614376|NCT01276509|583640576|FG001|Overall Study|Withdrawal by Subject|2|||
161614377|NCT01276509|583640577|FG002|Overall Study|Withdrawal by Subject|0|||
161614378|NCT01276509|583640578|FG003|Overall Study|Withdrawal by Subject|0|||
161614379|NCT01276509|583640575|FG000|Overall Study|Other|0|||
161614380|NCT01276509|583640576|FG001|Overall Study|Other|1|||
161614381|NCT01276509|583640577|FG002|Overall Study|Other|0|||
161614382|NCT01276509|583640578|FG003|Overall Study|Other|0|||
161614383|NCT00949117|583640580|FG000|Overall Study|Lack of Efficacy|2|||
161614384|NCT00949117|583640581|FG001|Overall Study|Lack of Efficacy|3|||
161614385|NCT00949117|583640580|FG000|Overall Study|Protocol Violation|1|||
161614386|NCT00949117|583640581|FG001|Overall Study|Protocol Violation|1|||
161614387|NCT00949117|583640580|FG000|Overall Study|Adverse Event|0|||
161614388|NCT00949117|583640581|FG001|Overall Study|Adverse Event|1|||
161614389|NCT03964974|583640582|FG000|Overall Study|Lost to Follow-up|3|||
161614390|NCT03964974|583640583|FG001|Overall Study|Lost to Follow-up|2|||
161614391|NCT03964974|583640582|FG000|Overall Study|Withdrawal by Subject|0|||
161614392|NCT03964974|583640583|FG001|Overall Study|Withdrawal by Subject|3|||
161614393|NCT02014402|583640587|FG000|Overall Study|Adverse Event|1|||
161614394|NCT02014402|583640588|FG001|Overall Study|Adverse Event|0|||
161614395|NCT02014402|583640589|FG002|Overall Study|Adverse Event|0|||
161614396|NCT02014402|583640590|FG003|Overall Study|Adverse Event|0|||
161614397|NCT02014402|583640587|FG000|Overall Study|Withdrawal by Subject|1|||
161614398|NCT02014402|583640588|FG001|Overall Study|Withdrawal by Subject|2|||
161614399|NCT02014402|583640589|FG002|Overall Study|Withdrawal by Subject|2|||
161614400|NCT02014402|583640590|FG003|Overall Study|Withdrawal by Subject|1|||
161614401|NCT02014402|583640587|FG000|Overall Study|Subject did not have transportation|0|||
161614402|NCT02014402|583640588|FG001|Overall Study|Subject did not have transportation|1|||
161614403|NCT02014402|583640589|FG002|Overall Study|Subject did not have transportation|0|||
161614404|NCT02014402|583640590|FG003|Overall Study|Subject did not have transportation|0|||
161614405|NCT02014402|583640587|FG000|Overall Study|Lost to Follow-up|0|||
161614406|NCT02014402|583640588|FG001|Overall Study|Lost to Follow-up|0|||
161614407|NCT02014402|583640589|FG002|Overall Study|Lost to Follow-up|1|||
161614408|NCT02014402|583640590|FG003|Overall Study|Lost to Follow-up|2|||
161614409|NCT00670449|583640591|FG000|Overall Study|Adverse Event|6|||
161614410|NCT00670449|583640592|FG001|Overall Study|Adverse Event|2|||
161614411|NCT00670449|583640593|FG002|Overall Study|Adverse Event|8|||
161614412|NCT00670449|583640594|FG003|Overall Study|Adverse Event|5|||
161614413|NCT00670449|583640591|FG000|Overall Study|Protocol Deviation|1|||
161614414|NCT00670449|583640592|FG001|Overall Study|Protocol Deviation|2|||
161614415|NCT00670449|583640593|FG002|Overall Study|Protocol Deviation|0|||
161614416|NCT00670449|583640594|FG003|Overall Study|Protocol Deviation|1|||
161614417|NCT00670449|583640591|FG000|Overall Study|Administrative Problems|0|||
161614418|NCT00670449|583640592|FG001|Overall Study|Administrative Problems|2|||
161614419|NCT00670449|583640593|FG002|Overall Study|Administrative Problems|0|||
161614420|NCT00670449|583640594|FG003|Overall Study|Administrative Problems|1|||
161614421|NCT00670449|583640591|FG000|Overall Study|Subject Withdrew Consent|0|||
161614422|NCT00670449|583640592|FG001|Overall Study|Subject Withdrew Consent|2|||
161614423|NCT00670449|583640593|FG002|Overall Study|Subject Withdrew Consent|0|||
161684446|NCT02819635|583897903|FG011|Substudy 3|Withdrew consent|9|||
161614424|NCT00670449|583640594|FG003|Overall Study|Subject Withdrew Consent|1|||
161614425|NCT00670449|583640591|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
161614426|NCT00670449|583640592|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161614427|NCT00670449|583640593|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161614428|NCT00670449|583640594|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161614429|NCT00670449|583640591|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
161614430|NCT00670449|583640592|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
161614431|NCT00670449|583640593|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161614432|NCT00670449|583640594|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
161614433|NCT01377844|583640595|FG000|Overall Study|Withdrawal by Subject|25|||
161684447|NCT02819635|583897892|FG000|Substudy 3|Lost to Follow-up|0|||
161614434|NCT01377844|583640596|FG001|Overall Study|Withdrawal by Subject|28|||
161614435|NCT01377844|583640595|FG000|Overall Study|Protocol Violation|2|||
161614436|NCT01377844|583640596|FG001|Overall Study|Protocol Violation|3|||
161614437|NCT01377844|583640595|FG000|Overall Study|Adverse Event|3|||
161614438|NCT01377844|583640596|FG001|Overall Study|Adverse Event|0|||
161614439|NCT01377844|583640595|FG000|Overall Study|Physician Decision|6|||
161614440|NCT01377844|583640596|FG001|Overall Study|Physician Decision|3|||
161614441|NCT01377844|583640595|FG000|Overall Study|Study terminated by Sponsor|0|||
161614442|NCT01377844|583640596|FG001|Overall Study|Study terminated by Sponsor|1|||
161614443|NCT00667017|583640598|FG000|Overall Study|Withdrawal by Subject|1|||
161614444|NCT01823224|583640599|FG000|Overall Study|Lost to Follow-up|5|||
161614445|NCT01823224|583640600|FG001|Overall Study|Lost to Follow-up|6|||
161614446|NCT01823224|583640599|FG000|Overall Study|didn't qualify|1|||
161614447|NCT01823224|583640600|FG001|Overall Study|didn't qualify|2|||
161614448|NCT01823224|583640599|FG000|Overall Study|pharmacy error|0|||
161614449|NCT01823224|583640600|FG001|Overall Study|pharmacy error|1|||
161614450|NCT01823224|583640599|FG000|Overall Study|missed med dose|0|||
161614451|NCT01823224|583640600|FG001|Overall Study|missed med dose|1|||
161614452|NCT01823224|583640599|FG000|Overall Study|Withdrawal by Subject|0|||
161614453|NCT01823224|583640600|FG001|Overall Study|Withdrawal by Subject|1|||
161614454|NCT00587171|583640601|FG000|Overall Study|Lost to Follow-up|1|||
161614455|NCT00587171|583640602|FG001|Overall Study|Lost to Follow-up|1|||
161614456|NCT01532648|583640603|FG000|Overall Study|Lost to Follow-up|3|||
161614457|NCT01532648|583640604|FG001|Overall Study|Lost to Follow-up|4|||
161614458|NCT01532648|583640603|FG000|Overall Study|Lack of Efficacy|4|||
161614459|NCT01532648|583640604|FG001|Overall Study|Lack of Efficacy|1|||
161614460|NCT01532648|583640603|FG000|Overall Study|Protocol Violation|1|||
161614461|NCT01532648|583640604|FG001|Overall Study|Protocol Violation|1|||
161614462|NCT01532648|583640603|FG000|Overall Study|Adverse Event|12|||
161614463|NCT01532648|583640604|FG001|Overall Study|Adverse Event|9|||
161614464|NCT01532648|583640603|FG000|Overall Study|Withdrawal by Subject|16|||
161614465|NCT01532648|583640604|FG001|Overall Study|Withdrawal by Subject|2|||
161614466|NCT02148705|583640605|FG000|Overall Study|Death|2|||
161614467|NCT02148705|583640606|FG001|Overall Study|Death|0|||
161614468|NCT02148705|583640607|FG002|Overall Study|Death|0|||
161614469|NCT02148705|583640605|FG000|Overall Study|Lost to Follow-up|13|||
161614470|NCT02148705|583640606|FG001|Overall Study|Lost to Follow-up|4|||
161614471|NCT02148705|583640607|FG002|Overall Study|Lost to Follow-up|10|||
161614472|NCT02148705|583640605|FG000|Overall Study|Withdrawal by Subject|3|||
161614473|NCT02148705|583640606|FG001|Overall Study|Withdrawal by Subject|0|||
161614474|NCT02148705|583640607|FG002|Overall Study|Withdrawal by Subject|2|||
161614475|NCT02148705|583640605|FG000|Overall Study|Not Treated|0|||
161614476|NCT02148705|583640606|FG001|Overall Study|Not Treated|1|||
161614477|NCT02148705|583640607|FG002|Overall Study|Not Treated|5|||
161614478|NCT01737021|583640608|FG000|Overall Study|Lost to Follow-up|5|||
161614479|NCT01737021|583640609|FG001|Overall Study|Lost to Follow-up|3|||
161614480|NCT01673594|583640610|FG000|Overall Study|Adverse Event|3|||
161614481|NCT01673594|583640611|FG001|Overall Study|Adverse Event|1|||
161614482|NCT01673594|583640610|FG000|Overall Study|Lost to Follow-up|1|||
161614483|NCT01673594|583640611|FG001|Overall Study|Lost to Follow-up|0|||
161614484|NCT01673594|583640610|FG000|Overall Study|Physician Decision|2|||
161614485|NCT01673594|583640611|FG001|Overall Study|Physician Decision|4|||
161614486|NCT01673594|583640610|FG000|Overall Study|Withdrawal by Subject|0|||
161614487|NCT01673594|583640611|FG001|Overall Study|Withdrawal by Subject|1|||
161614488|NCT02824198|583640615|FG000|Overall Study|Non-compliance with the protocol|5|||
161614489|NCT02824198|583640616|FG001|Overall Study|Non-compliance with the protocol|1|||
161614490|NCT02824198|583640615|FG000|Overall Study|Lost to Follow-up|5|||
161614491|NCT02824198|583640616|FG001|Overall Study|Lost to Follow-up|2|||
161614492|NCT02824198|583640615|FG000|Overall Study|Withdrawal by Subject|5|||
161614493|NCT02824198|583640616|FG001|Overall Study|Withdrawal by Subject|0|||
161614494|NCT02605174|583640617|FG000|Overall Study|Adverse Event|0|||
161614495|NCT02605174|583640618|FG001|Overall Study|Adverse Event|0|||
161614496|NCT02605174|583640619|FG002|Overall Study|Adverse Event|1|||
161614497|NCT02605174|583640620|FG003|Overall Study|Adverse Event|0|||
161614498|NCT02605174|583640621|FG004|Overall Study|Adverse Event|4|||
161614499|NCT02605174|583640622|FG005|Overall Study|Adverse Event|0|||
161614500|NCT02605174|583640623|FG006|Overall Study|Adverse Event|0|||
161614501|NCT02605174|583640617|FG000|Overall Study|Lost to Follow-up|20|||
161614502|NCT02605174|583640618|FG001|Overall Study|Lost to Follow-up|7|||
161614503|NCT02605174|583640619|FG002|Overall Study|Lost to Follow-up|27|||
161614504|NCT02605174|583640620|FG003|Overall Study|Lost to Follow-up|10|||
161614505|NCT02605174|583640621|FG004|Overall Study|Lost to Follow-up|20|||
161614506|NCT02605174|583640622|FG005|Overall Study|Lost to Follow-up|10|||
161614507|NCT02605174|583640623|FG006|Overall Study|Lost to Follow-up|29|||
161614508|NCT02605174|583640617|FG000|Overall Study|Protocol Violation|10|||
161614509|NCT02605174|583640618|FG001|Overall Study|Protocol Violation|4|||
161614510|NCT02605174|583640619|FG002|Overall Study|Protocol Violation|14|||
161614511|NCT02605174|583640620|FG003|Overall Study|Protocol Violation|6|||
161614512|NCT02605174|583640621|FG004|Overall Study|Protocol Violation|7|||
161614513|NCT02605174|583640622|FG005|Overall Study|Protocol Violation|7|||
161614514|NCT02605174|583640623|FG006|Overall Study|Protocol Violation|12|||
161614515|NCT02605174|583640617|FG000|Overall Study|Pregnancy|1|||
161614516|NCT02605174|583640618|FG001|Overall Study|Pregnancy|0|||
161614517|NCT02605174|583640619|FG002|Overall Study|Pregnancy|0|||
161614518|NCT02605174|583640620|FG003|Overall Study|Pregnancy|2|||
161614519|NCT02605174|583640621|FG004|Overall Study|Pregnancy|0|||
161614520|NCT02605174|583640622|FG005|Overall Study|Pregnancy|0|||
161614521|NCT02605174|583640623|FG006|Overall Study|Pregnancy|0|||
161614522|NCT02605174|583640617|FG000|Overall Study|Withdrawal by Subject|9|||
161614523|NCT02605174|583640618|FG001|Overall Study|Withdrawal by Subject|6|||
161614524|NCT02605174|583640619|FG002|Overall Study|Withdrawal by Subject|14|||
161614525|NCT02605174|583640620|FG003|Overall Study|Withdrawal by Subject|11|||
161614526|NCT02605174|583640621|FG004|Overall Study|Withdrawal by Subject|6|||
161614527|NCT02605174|583640622|FG005|Overall Study|Withdrawal by Subject|4|||
161614528|NCT02605174|583640623|FG006|Overall Study|Withdrawal by Subject|15|||
161614529|NCT02605174|583640617|FG000|Overall Study|Physician Decision|2|||
161614530|NCT02605174|583640618|FG001|Overall Study|Physician Decision|0|||
161614531|NCT02605174|583640619|FG002|Overall Study|Physician Decision|0|||
161614532|NCT02605174|583640620|FG003|Overall Study|Physician Decision|0|||
161614533|NCT02605174|583640621|FG004|Overall Study|Physician Decision|0|||
161614534|NCT02605174|583640622|FG005|Overall Study|Physician Decision|0|||
161614535|NCT02605174|583640623|FG006|Overall Study|Physician Decision|3|||
161614536|NCT02605174|583640617|FG000|Overall Study|Randomization Failure|22|||
161614537|NCT02605174|583640618|FG001|Overall Study|Randomization Failure|6|||
161614538|NCT02605174|583640619|FG002|Overall Study|Randomization Failure|20|||
161614539|NCT02605174|583640620|FG003|Overall Study|Randomization Failure|7|||
161614540|NCT02605174|583640621|FG004|Overall Study|Randomization Failure|16|||
161614541|NCT02605174|583640622|FG005|Overall Study|Randomization Failure|11|||
161614542|NCT02605174|583640623|FG006|Overall Study|Randomization Failure|30|||
161614543|NCT04250636|583640624|FG000|Overall Study|Lost to Follow-up|2|||
161614544|NCT01779050|583640625|FG000|Overall Study|Withdrawal by Subject|1|||
161614545|NCT01779050|583640626|FG001|Overall Study|Withdrawal by Subject|0|||
161614546|NCT01353274|583640627|FG000|Overall Study|No case report form (CRF) collected|28|||
161614547|NCT01128959|583640628|FG000|Lead in Period|Adverse Event|3|||
161614548|NCT01128959|583640628|FG000|Treatment Period|Adverse Event|3|||
161614549|NCT01128959|583640628|FG000|Treatment Period|Withdrawal by Subject|1|||
161614550|NCT01409837|583640629|FG000|Overall Study|Withdrawal by Subject|2|||
161614551|NCT01409837|583640630|FG001|Overall Study|Withdrawal by Subject|1|||
161614552|NCT01409837|583640629|FG000|Overall Study|Lost to Follow-up|1|||
161614553|NCT01409837|583640630|FG001|Overall Study|Lost to Follow-up|0|||
161614554|NCT01409837|583640629|FG000|Overall Study|Physician Decision|0|||
161614555|NCT01409837|583640630|FG001|Overall Study|Physician Decision|1|||
161614556|NCT04938453|583640633|FG000|Washout Period 1|Adverse Event|1|||
161614557|NCT04938453|583640634|FG001|Washout Period 1|Adverse Event|0|||
161614558|NCT04938453|583640633|FG000|Washout Period 1|Physician Decision|0|||
161614559|NCT04938453|583640634|FG001|Washout Period 1|Physician Decision|1|||
161614560|NCT03292406|583640636|FG000|Overall Study|Progressive Disease|6|||
161614561|NCT03292406|583640637|FG001|Overall Study|Progressive Disease|3|||
161614562|NCT03292406|583640638|FG002|Overall Study|Progressive Disease|4|||
161614563|NCT03292406|583640636|FG000|Overall Study|Adverse Event|7|||
161614564|NCT03292406|583640637|FG001|Overall Study|Adverse Event|1|||
161614565|NCT03292406|583640638|FG002|Overall Study|Adverse Event|4|||
161614566|NCT03292406|583640636|FG000|Overall Study|Withdrawal by Subject|0|||
161614567|NCT03292406|583640637|FG001|Overall Study|Withdrawal by Subject|7|||
161614568|NCT03292406|583640638|FG002|Overall Study|Withdrawal by Subject|2|||
161614569|NCT03292406|583640636|FG000|Overall Study|Protocol Violation|0|||
161614570|NCT03292406|583640637|FG001|Overall Study|Protocol Violation|1|||
161614571|NCT03292406|583640638|FG002|Overall Study|Protocol Violation|1|||
161614572|NCT03292406|583640636|FG000|Overall Study|Other|0|||
161614573|NCT03292406|583640637|FG001|Overall Study|Other|1|||
161614574|NCT03292406|583640638|FG002|Overall Study|Other|2|||
161614575|NCT00022672|583640640|FG000|Main Phase: 24 Months|Adverse Event|6|||
161614576|NCT00022672|583640641|FG001|Main Phase: 24 Months|Adverse Event|0|||
161614577|NCT00022672|583640640|FG000|Main Phase: 24 Months|Death|0|||
161614578|NCT00022672|583640641|FG001|Main Phase: 24 Months|Death|3|||
161614579|NCT00022672|583640640|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
161614580|NCT00022672|583640641|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
161614581|NCT00022672|583640640|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
161614582|NCT00022672|583640641|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
161614583|NCT00022672|583640640|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
161614584|NCT00022672|583640641|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
161614585|NCT00022672|583640640|FG000|Main Phase: 24 Months|Refused Treatment|3|||
161614586|NCT00022672|583640641|FG001|Main Phase: 24 Months|Refused Treatment|4|||
161614587|NCT00022672|583640640|FG000|Main Phase: 24 Months|Failure to Return|1|||
161614588|NCT00022672|583640641|FG001|Main Phase: 24 Months|Failure to Return|1|||
161614589|NCT00022672|583640640|FG000|Main Phase: 24 Months|Other|1|||
161614590|NCT00022672|583640641|FG001|Main Phase: 24 Months|Other|0|||
161614591|NCT00022672|583640640|FG000|Extension Phase|Adverse Event|1|||
161614592|NCT00022672|583640641|FG001|Extension Phase|Adverse Event|3|||
161614593|NCT00022672|583640640|FG000|Extension Phase|Death|0|||
161614594|NCT00022672|583640641|FG001|Extension Phase|Death|1|||
161614595|NCT00022672|583640640|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
161614596|NCT00022672|583640641|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
161614597|NCT00022672|583640640|FG000|Extension Phase|Refused Treatment|0|||
161614598|NCT00022672|583640641|FG001|Extension Phase|Refused Treatment|2|||
161614599|NCT00022672|583640640|FG000|Extension Phase|Other|1|||
161614600|NCT00022672|583640641|FG001|Extension Phase|Other|1|||
161614601|NCT00403494|583640642|FG000|Overall Study|Adverse Event|10|||
161614602|NCT00403494|583640643|FG001|Overall Study|Adverse Event|8|||
161614603|NCT00403494|583640642|FG000|Overall Study|Withdrew Consent|3|||
161614604|NCT00403494|583640643|FG001|Overall Study|Withdrew Consent|2|||
161614605|NCT00403494|583640642|FG000|Overall Study|Inappropriately enrolled|0|||
161614606|NCT00403494|583640643|FG001|Overall Study|Inappropriately enrolled|1|||
161614607|NCT00403494|583640642|FG000|Overall Study|Lost to Follow-up|0|||
161614608|NCT00403494|583640643|FG001|Overall Study|Lost to Follow-up|2|||
161614609|NCT00403494|583640642|FG000|Overall Study|Protocol noncompliance|0|||
161614610|NCT00403494|583640643|FG001|Overall Study|Protocol noncompliance|1|||
161614611|NCT00403494|583640642|FG000|Overall Study|Death|1|||
161614612|NCT00403494|583640643|FG001|Overall Study|Death|0|||
161614613|NCT00403494|583640642|FG000|Overall Study|Sponsor Request|1|||
161614614|NCT00403494|583640643|FG001|Overall Study|Sponsor Request|0|||
161614615|NCT05005247|583640644|FG000|Overall Study|Withdrawal by Subject|0|||
161614616|NCT05005247|583640645|FG001|Overall Study|Withdrawal by Subject|1|||
161614617|NCT05005247|583640646|FG002|Overall Study|Withdrawal by Subject|0|||
161614618|NCT03176407|583640651|FG000|Overall Study|Protocol Violation|1|||
161614619|NCT03176407|583640651|FG000|Overall Study|human failure|1|||
161614620|NCT03176407|583640651|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
161614621|NCT02128269|583640653|FG000|Treatment Period|Adverse Event|1|||
161614622|NCT02128269|583640653|FG000|Treatment Period|Physician Decision|1|||
161614623|NCT01829711|583640654|FG000|Overall Study|Lost to Follow-up|2|||
161614624|NCT01829711|583640654|FG000|Overall Study|Withdrawal by Subject|3|||
161614625|NCT01829711|583640654|FG000|Overall Study|Death|4|||
161614626|NCT01829711|583640654|FG000|Overall Study|Started new therapies|17|||
161614627|NCT01829711|583640654|FG000|Overall Study|Adverse Event|3|||
161614628|NCT01829711|583640654|FG000|Overall Study|Due to progression of disease|13|||
161614629|NCT01829711|583640654|FG000|Overall Study|Due to lack of response|1|||
161614630|NCT01480258|583640655|FG000|Infant Series|Protocol Violation|2|||
161614631|NCT01480258|583640656|FG001|Infant Series|Protocol Violation|0|||
161614632|NCT01480258|583640655|FG000|Infant Series|Physician Decision|0|||
161614633|NCT01480258|583640656|FG001|Infant Series|Physician Decision|1|||
161614634|NCT01480258|583640655|FG000|Infant Series|Not Vaccinated|3|||
161614635|NCT01480258|583640656|FG001|Infant Series|Not Vaccinated|0|||
161614636|NCT01480258|583640655|FG000|Infant Series|Adverse Event|1|||
161614637|NCT01480258|583640656|FG001|Infant Series|Adverse Event|1|||
161614638|NCT01480258|583640655|FG000|Infant Series|Withdrawal by Subject|1|||
161614639|NCT01480258|583640656|FG001|Infant Series|Withdrawal by Subject|6|||
161614640|NCT01480258|583640655|FG000|Interim Period|Lost to Follow-up|0|||
161614641|NCT01480258|583640656|FG001|Interim Period|Lost to Follow-up|2|||
161614642|NCT01480258|583640655|FG000|Interim Period|Physician Decision|1|||
161614643|NCT01480258|583640656|FG001|Interim Period|Physician Decision|0|||
161614644|NCT01480258|583640655|FG000|Interim Period|Protocol Violation|0|||
161614645|NCT01480258|583640656|FG001|Interim Period|Protocol Violation|1|||
161614646|NCT01480258|583640655|FG000|Interim Period|Withdrawal by Subject|9|||
161614647|NCT01480258|583640656|FG001|Interim Period|Withdrawal by Subject|6|||
161614648|NCT04248868|583640657|FG000|Overall Study|Death|1|||
161614649|NCT04248868|583640657|FG000|Overall Study|Lost to Follow-up|3|||
161614650|NCT04248868|583640657|FG000|Overall Study|Protocol Violation|2|||
161614651|NCT01543204|583640660|FG000|Overall Study|Non-compliance|1|||
161614652|NCT01543204|583640660|FG000|Overall Study|Adverse Event|1|||
161614653|NCT01543204|583640660|FG000|Overall Study|Withdrawal by Subject|4|||
161614654|NCT01543204|583640660|FG000|Overall Study|Requirement for Alternative Therapy|1|||
161684448|NCT02819635|583897893|FG001|Substudy 3|Lost to Follow-up|0|||
161614655|NCT01543204|583640660|FG000|Overall Study|Lost to Follow-up|1|||
161614656|NCT03822832|583640668|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
161614657|NCT03822832|583640669|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
161614658|NCT03822832|583640668|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
161614659|NCT03822832|583640669|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
161614660|NCT03822832|583640668|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
161614661|NCT03822832|583640669|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
161614662|NCT03822832|583640668|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
161614663|NCT03822832|583640669|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
161614664|NCT03822832|583640668|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
161614665|NCT03822832|583640669|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
161614666|NCT03822832|583640668|FG000|Re-allocation|Not re-allocated to open label period|2|||
161614667|NCT03822832|583640669|FG001|Re-allocation|Not re-allocated to open label period|6|||
161614668|NCT03822832|583640668|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
161614669|NCT03822832|583640669|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
161614670|NCT03822832|583640668|FG000|Period 2 - Open Label Period|Adverse Event|0|||
161614671|NCT03822832|583640669|FG001|Period 2 - Open Label Period|Adverse Event|3|||
161614672|NCT01668719|583640670|FG000|Phase I|On treatment|1|||
161614673|NCT01668719|583640671|FG001|Phase I|On treatment|0|||
161614674|NCT01668719|583640672|FG002|Phase I|On treatment|0|||
161614675|NCT01668719|583640670|FG000|Phase I|Adverse Event|2|||
161614676|NCT01668719|583640671|FG001|Phase I|Adverse Event|0|||
161614677|NCT01668719|583640672|FG002|Phase I|Adverse Event|0|||
161614678|NCT01668719|583640670|FG000|Phase I|Progression/relapse|1|||
161614679|NCT01668719|583640671|FG001|Phase I|Progression/relapse|0|||
161614680|NCT01668719|583640672|FG002|Phase I|Progression/relapse|0|||
161614681|NCT01668719|583640670|FG000|Phase I|not protocol specified|2|||
161614682|NCT01668719|583640671|FG001|Phase I|not protocol specified|0|||
161614683|NCT01668719|583640672|FG002|Phase I|not protocol specified|0|||
161614684|NCT01668719|583640670|FG000|Phase II|On treatment|0|||
161614685|NCT01668719|583640671|FG001|Phase II|On treatment|4|||
161614686|NCT01668719|583640672|FG002|Phase II|On treatment|3|||
161614687|NCT01668719|583640670|FG000|Phase II|Adverse Event|0|||
161614688|NCT01668719|583640671|FG001|Phase II|Adverse Event|18|||
161614689|NCT01668719|583640672|FG002|Phase II|Adverse Event|18|||
161614690|NCT01668719|583640670|FG000|Phase II|Refusal unrelated to adverse event|0|||
161614691|NCT01668719|583640671|FG001|Phase II|Refusal unrelated to adverse event|4|||
161614692|NCT01668719|583640672|FG002|Phase II|Refusal unrelated to adverse event|1|||
161614693|NCT01668719|583640670|FG000|Phase II|Progression/relapse|0|||
161614694|NCT01668719|583640671|FG001|Phase II|Progression/relapse|13|||
161614695|NCT01668719|583640672|FG002|Phase II|Progression/relapse|17|||
161614696|NCT01668719|583640670|FG000|Phase II|Death|0|||
161614697|NCT01668719|583640671|FG001|Phase II|Death|0|||
161614698|NCT01668719|583640672|FG002|Phase II|Death|2|||
161614699|NCT01668719|583640670|FG000|Phase II|not protocol specified|0|||
161614700|NCT01668719|583640671|FG001|Phase II|not protocol specified|13|||
161614701|NCT01668719|583640672|FG002|Phase II|not protocol specified|7|||
161614702|NCT01321073|583640673|FG000|Overall Study|Did not attempt implant|4|||
161614703|NCT01321073|583640673|FG000|Overall Study|Death|3|||
161614704|NCT04248803|583640674|FG000|Overall Study|Lost to Follow-up|7|||
161614705|NCT04248803|583640675|FG001|Overall Study|Lost to Follow-up|7|||
161614706|NCT04248803|583640676|FG002|Overall Study|Lost to Follow-up|7|||
161614707|NCT04248803|583640677|FG003|Overall Study|Lost to Follow-up|7|||
161614708|NCT04248803|583640678|FG004|Overall Study|Lost to Follow-up|7|||
161614709|NCT04248803|583640679|FG005|Overall Study|Lost to Follow-up|7|||
161614710|NCT05352230|583640680|FG000|First Intervention (3 Months)|study terminated|2|||
161614711|NCT05352230|583640681|FG001|First Intervention (3 Months)|study terminated|2|||
161614712|NCT02309294|583640685|FG000|Overall Study|Withdrawal by Subject|2|||
161614713|NCT01227421|583640686|FG000|Overall Study|Lost to Follow-up|6|||
161614714|NCT01227421|583640687|FG001|Overall Study|Lost to Follow-up|7|||
161614715|NCT01227421|583640688|FG002|Overall Study|Lost to Follow-up|5|||
161614716|NCT01227421|583640686|FG000|Overall Study|Adverse Event|2|||
161614717|NCT01227421|583640687|FG001|Overall Study|Adverse Event|7|||
161614718|NCT01227421|583640688|FG002|Overall Study|Adverse Event|2|||
161614719|NCT01227421|583640686|FG000|Overall Study|Withdrawal by Subject|1|||
161614720|NCT01227421|583640687|FG001|Overall Study|Withdrawal by Subject|2|||
161614721|NCT01227421|583640688|FG002|Overall Study|Withdrawal by Subject|1|||
161614722|NCT01227421|583640686|FG000|Overall Study|Protocol Violation|1|||
161614723|NCT01227421|583640687|FG001|Overall Study|Protocol Violation|1|||
161614724|NCT01227421|583640688|FG002|Overall Study|Protocol Violation|2|||
161614725|NCT01227421|583640686|FG000|Overall Study|Randomized in error|1|||
161614726|NCT01227421|583640687|FG001|Overall Study|Randomized in error|1|||
161614727|NCT01227421|583640688|FG002|Overall Study|Randomized in error|0|||
161614728|NCT02969356|583640696|FG000|Overall Study|Adverse Event|7|||
161614729|NCT02969356|583640696|FG000|Overall Study|Consent withdrawn|2|||
161614730|NCT02969356|583640696|FG000|Overall Study|Lost to Follow-up|3|||
161614731|NCT02969356|583640696|FG000|Overall Study|Did not need to be reinjected|6|||
161614732|NCT02969356|583640696|FG000|Overall Study|Personal reasons|5|||
161614733|NCT03332589|583642389|FG000|Overall Study|Lack of Efficacy|2|||
161614734|NCT03332589|583642390|FG001|Overall Study|Lack of Efficacy|0|||
161614735|NCT03332589|583642391|FG002|Overall Study|Lack of Efficacy|0|||
161614736|NCT03332589|583642389|FG000|Overall Study|Adverse Event|1|||
161614737|NCT03332589|583642390|FG001|Overall Study|Adverse Event|0|||
161614738|NCT03332589|583642391|FG002|Overall Study|Adverse Event|0|||
161614739|NCT03332589|583642389|FG000|Overall Study|Death|1|||
161614740|NCT03332589|583642390|FG001|Overall Study|Death|0|||
161614741|NCT03332589|583642391|FG002|Overall Study|Death|0|||
161614742|NCT02713594|583642392|FG000|Overall Study|Withdrawal by Subject|32|||
161614743|NCT02713594|583642393|FG001|Overall Study|Withdrawal by Subject|22|||
161614744|NCT02713594|583642392|FG000|Overall Study|Lost to Follow-up|358|||
161614745|NCT02713594|583642393|FG001|Overall Study|Lost to Follow-up|374|||
161614746|NCT02771366|583642394|FG000|Period 1|Withdrawal by Subject|0|||
161614747|NCT02771366|583642395|FG001|Period 1|Withdrawal by Subject|2|||
161614748|NCT02771366|583642394|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
161614749|NCT02771366|583642395|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
161614750|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
161614751|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161614752|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161614753|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161614754|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
161614755|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161614756|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161614757|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161614758|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
161614759|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161614760|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161614761|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161614762|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
161614763|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161614764|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161614765|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161614766|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
161614767|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161614768|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161614769|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161614770|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
161614771|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161614772|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161614773|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161614774|NCT01185340|583642398|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
161614775|NCT01185340|583642399|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161614776|NCT01185340|583642400|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161614777|NCT01185340|583642401|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161614778|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
161614779|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
161614780|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
161614781|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
161614782|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
161614783|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
161614784|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
161614785|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
161614786|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161614787|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
161614788|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
161614789|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
161614790|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161614791|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161614792|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161614793|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161614794|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
161614795|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161614796|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
161614797|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161614798|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
161614799|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
161614800|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
161614801|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
161614802|NCT01185340|583642398|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161614803|NCT01185340|583642399|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161614804|NCT01185340|583642400|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
161614805|NCT01185340|583642401|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
161614806|NCT00246129|583642404|FG000|Overall Study|Lost to Follow-up|1|||
161614807|NCT00246129|583642405|FG001|Overall Study|Lost to Follow-up|0|||
161614808|NCT00246129|583642404|FG000|Overall Study|Death|2|||
161614809|NCT00246129|583642405|FG001|Overall Study|Death|1|||
161614810|NCT00246129|583642404|FG000|Overall Study|suffered primary non-function|1|||
161614811|NCT00246129|583642405|FG001|Overall Study|suffered primary non-function|0|||
161614812|NCT00246129|583642404|FG000|Overall Study|grafts failed|3|||
161614813|NCT00246129|583642405|FG001|Overall Study|grafts failed|1|||
161614814|NCT03469258|583642406|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
161614815|NCT03403036|583642412|FG000|Overall Study|Lack of Efficacy|5|||
161614816|NCT03648541|583642414|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
161614817|NCT03648541|583642415|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
161614818|NCT03648541|583642414|FG000|Re-induction Period Only|Lack of Efficacy|7|||
161614819|NCT03648541|583642415|FG001|Re-induction Period Only|Lack of Efficacy|0|||
161614820|NCT03648541|583642414|FG000|Maintenance Period Only|Missing|0|||
161614821|NCT03648541|583642415|FG001|Maintenance Period Only|Missing|1|||
161614822|NCT03648541|583642414|FG000|Maintenance Period Only|Other not listed below|0|||
161614823|NCT03648541|583642415|FG001|Maintenance Period Only|Other not listed below|4|||
161614824|NCT03648541|583642414|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
161614825|NCT03648541|583642415|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
161614826|NCT03648541|583642414|FG000|Maintenance Period Only|Protocol Violation|0|||
161614827|NCT03648541|583642415|FG001|Maintenance Period Only|Protocol Violation|1|||
161614828|NCT03648541|583642414|FG000|Maintenance Period Only|Lack of Efficacy|0|||
161614829|NCT03648541|583642415|FG001|Maintenance Period Only|Lack of Efficacy|18|||
161614830|NCT03648541|583642414|FG000|Maintenance Period Only|Adverse Event|0|||
161614831|NCT03648541|583642415|FG001|Maintenance Period Only|Adverse Event|4|||
161614832|NCT03648541|583642414|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
161614833|NCT03648541|583642415|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
161614834|NCT03490032|583642418|FG000|Overall Study|family issue (child custody)|1|||
161614835|NCT03490032|583642419|FG001|Overall Study|family issue (child custody)|0|||
161614836|NCT03490032|583642420|FG002|Overall Study|family issue (child custody)|0|||
161614837|NCT00308308|583642421|FG000|Overall Study|Adverse Event|17|||
161614838|NCT00308308|583642422|FG001|Overall Study|Adverse Event|2|||
161614839|NCT00308308|583642421|FG000|Overall Study|Lost to Follow-up|5|||
161614840|NCT00308308|583642422|FG001|Overall Study|Lost to Follow-up|5|||
161614841|NCT00308308|583642421|FG000|Overall Study|Physician Decision|15|||
161614842|NCT00308308|583642422|FG001|Overall Study|Physician Decision|7|||
161614843|NCT00308308|583642421|FG000|Overall Study|Protocol Violation|3|||
161614844|NCT00308308|583642422|FG001|Overall Study|Protocol Violation|14|||
161614845|NCT00308308|583642421|FG000|Overall Study|Withdrawal by Subject|47|||
161614846|NCT00308308|583642422|FG001|Overall Study|Withdrawal by Subject|19|||
161614847|NCT00308308|583642421|FG000|Overall Study|Various|7|||
161614848|NCT00308308|583642422|FG001|Overall Study|Various|5|||
161614849|NCT00308308|583642421|FG000|Overall Study|Randomized but not dosed|8|||
161614850|NCT00308308|583642422|FG001|Overall Study|Randomized but not dosed|16|||
161614851|NCT00308308|583642421|FG000|Overall Study|Other|1|||
161614852|NCT00308308|583642422|FG001|Overall Study|Other|0|||
161614853|NCT01852045|583642425|FG000|Overall Study|Adverse Event|1|||
161614854|NCT01852045|583642426|FG001|Overall Study|Adverse Event|0|||
161614855|NCT01852045|583642427|FG002|Overall Study|Adverse Event|0|||
161614856|NCT01852045|583642425|FG000|Overall Study|Lack of Efficacy|3|||
161614857|NCT01852045|583642426|FG001|Overall Study|Lack of Efficacy|0|||
161614858|NCT01852045|583642427|FG002|Overall Study|Lack of Efficacy|0|||
161614859|NCT01852045|583642425|FG000|Overall Study|Lost to Follow-up|0|||
161614860|NCT01852045|583642426|FG001|Overall Study|Lost to Follow-up|1|||
161614861|NCT01852045|583642427|FG002|Overall Study|Lost to Follow-up|1|||
161614862|NCT01852045|583642425|FG000|Overall Study|Withdrawal by Subject|1|||
161614863|NCT01852045|583642426|FG001|Overall Study|Withdrawal by Subject|0|||
161614864|NCT01852045|583642427|FG002|Overall Study|Withdrawal by Subject|1|||
161614865|NCT01852045|583642425|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161614866|NCT01852045|583642426|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161614867|NCT01852045|583642427|FG002|Overall Study|Other Miscellaneous Reasons|2|||
161614868|NCT01951703|583642428|FG000|First Intervention|Withdrawal by Subject|1|||
161614869|NCT01951703|583642429|FG001|First Intervention|Withdrawal by Subject|0|||
161614870|NCT01951703|583642428|FG000|First Intervention|Subject was not compliant|1|||
161614871|NCT01951703|583642429|FG001|First Intervention|Subject was not compliant|1|||
161614872|NCT01951703|583642428|FG000|First Intervention|Physician Decision|1|||
161614873|NCT01951703|583642429|FG001|First Intervention|Physician Decision|0|||
161363808|NCT00392288|582720029|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
161614874|NCT01951703|583642428|FG000|Second Intervention|Protocol Violation|0|||
161614875|NCT01951703|583642429|FG001|Second Intervention|Protocol Violation|1|||
161614876|NCT01951703|583642428|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
161614877|NCT01951703|583642429|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
161614878|NCT02827201|583642430|FG000|Overall Study|Death|1|||
161614879|NCT02827201|583642431|FG001|Overall Study|Death|2|||
161614880|NCT02827201|583642430|FG000|Overall Study|Patients not treated|1|||
161614881|NCT02827201|583642431|FG001|Overall Study|Patients not treated|1|||
161614882|NCT01021748|583642432|FG000|Overall Study|Adverse Event|2|||
161614883|NCT01021748|583642433|FG001|Overall Study|Adverse Event|1|||
161614884|NCT01021748|583642434|FG002|Overall Study|Adverse Event|2|||
161614885|NCT01021748|583642435|FG003|Overall Study|Adverse Event|0|||
161614886|NCT01021748|583642436|FG004|Overall Study|Adverse Event|2|||
161614887|NCT01021748|583642437|FG005|Overall Study|Adverse Event|0|||
161614888|NCT01021748|583642438|FG006|Overall Study|Adverse Event|1|||
161614889|NCT01021748|583642439|FG007|Overall Study|Adverse Event|0|||
161614890|NCT01021748|583642440|FG008|Overall Study|Adverse Event|7|||
161614891|NCT01021748|583642432|FG000|Overall Study|Physician Decision|1|||
161614892|NCT01021748|583642433|FG001|Overall Study|Physician Decision|0|||
161614893|NCT01021748|583642434|FG002|Overall Study|Physician Decision|1|||
161614894|NCT01021748|583642435|FG003|Overall Study|Physician Decision|1|||
161614895|NCT01021748|583642436|FG004|Overall Study|Physician Decision|0|||
161614896|NCT01021748|583642437|FG005|Overall Study|Physician Decision|0|||
161614897|NCT01021748|583642438|FG006|Overall Study|Physician Decision|1|||
161614898|NCT01021748|583642439|FG007|Overall Study|Physician Decision|1|||
161614899|NCT01021748|583642440|FG008|Overall Study|Physician Decision|2|||
161614900|NCT01021748|583642432|FG000|Overall Study|Progressive Disease|3|||
161614901|NCT01021748|583642433|FG001|Overall Study|Progressive Disease|3|||
161614902|NCT01021748|583642434|FG002|Overall Study|Progressive Disease|4|||
161614903|NCT01021748|583642435|FG003|Overall Study|Progressive Disease|6|||
161614904|NCT01021748|583642436|FG004|Overall Study|Progressive Disease|7|||
161614905|NCT01021748|583642437|FG005|Overall Study|Progressive Disease|3|||
161614906|NCT01021748|583642438|FG006|Overall Study|Progressive Disease|0|||
161614907|NCT01021748|583642439|FG007|Overall Study|Progressive Disease|5|||
161614908|NCT01021748|583642440|FG008|Overall Study|Progressive Disease|6|||
161614909|NCT01021748|583642432|FG000|Overall Study|Withdrawal by Subject|0|||
161614910|NCT01021748|583642433|FG001|Overall Study|Withdrawal by Subject|0|||
161614911|NCT01021748|583642434|FG002|Overall Study|Withdrawal by Subject|0|||
161614912|NCT01021748|583642435|FG003|Overall Study|Withdrawal by Subject|0|||
161614913|NCT01021748|583642436|FG004|Overall Study|Withdrawal by Subject|0|||
161614914|NCT01021748|583642437|FG005|Overall Study|Withdrawal by Subject|0|||
161614915|NCT01021748|583642438|FG006|Overall Study|Withdrawal by Subject|1|||
161614916|NCT01021748|583642439|FG007|Overall Study|Withdrawal by Subject|0|||
161614917|NCT01021748|583642440|FG008|Overall Study|Withdrawal by Subject|1|||
161614918|NCT01021748|583642432|FG000|Overall Study|Not Treated|0|||
161614919|NCT01021748|583642433|FG001|Overall Study|Not Treated|1|||
161614920|NCT01021748|583642434|FG002|Overall Study|Not Treated|0|||
161614921|NCT01021748|583642435|FG003|Overall Study|Not Treated|0|||
161614922|NCT01021748|583642436|FG004|Overall Study|Not Treated|0|||
161614923|NCT01021748|583642437|FG005|Overall Study|Not Treated|0|||
161614924|NCT01021748|583642438|FG006|Overall Study|Not Treated|0|||
161614925|NCT01021748|583642439|FG007|Overall Study|Not Treated|0|||
161614926|NCT01021748|583642440|FG008|Overall Study|Not Treated|0|||
161614927|NCT01640288|583642443|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
161614928|NCT01640288|583642444|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
161614929|NCT01640288|583642443|FG000|Overall Study|Screen Failure|20|||
161614930|NCT01640288|583642444|FG001|Overall Study|Screen Failure|18|||
161614931|NCT01640288|583642443|FG000|Overall Study|Withdrawn by PI|5|||
161614932|NCT01640288|583642444|FG001|Overall Study|Withdrawn by PI|0|||
161614933|NCT01640288|583642443|FG000|Overall Study|Withdrawal by Subject|1|||
161614934|NCT01640288|583642444|FG001|Overall Study|Withdrawal by Subject|0|||
161614935|NCT01485887|583642445|FG000|Overall Study|Withdrawal by Subject|2|||
161614936|NCT01485887|583642445|FG000|Overall Study|Adverse Event|8|||
161614937|NCT01485887|583642445|FG000|Overall Study|Deterioration of primary disease|1|||
161614938|NCT01485887|583642445|FG000|Overall Study|Primary disease markedly improved|1|||
161614939|NCT02234141|583642446|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
161614940|NCT02234141|583642447|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
161614941|NCT02234141|583642448|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
161614942|NCT02234141|583642449|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
161614943|NCT02234141|583642450|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
161614944|NCT02234141|583642451|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
161684449|NCT02819635|583897894|FG002|Substudy 3|Lost to Follow-up|0|||
161684450|NCT02819635|583897895|FG003|Substudy 3|Lost to Follow-up|0|||
161614945|NCT02234141|583642452|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
161614946|NCT02234141|583642446|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161614947|NCT02234141|583642447|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
161614948|NCT02234141|583642448|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161614949|NCT02234141|583642449|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161614950|NCT02234141|583642450|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161614951|NCT02234141|583642451|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161614952|NCT02234141|583642452|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161614953|NCT02234141|583642446|FG000|Treatment Period (24 Weeks)|Death|1|||
161614954|NCT02234141|583642447|FG001|Treatment Period (24 Weeks)|Death|2|||
161614955|NCT02234141|583642448|FG002|Treatment Period (24 Weeks)|Death|0|||
161614956|NCT02234141|583642449|FG003|Treatment Period (24 Weeks)|Death|1|||
161614957|NCT02234141|583642450|FG004|Treatment Period (24 Weeks)|Death|0|||
161614958|NCT02234141|583642451|FG005|Treatment Period (24 Weeks)|Death|0|||
161614959|NCT02234141|583642452|FG006|Treatment Period (24 Weeks)|Death|0|||
161614960|NCT02234141|583642446|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
161614961|NCT02234141|583642447|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
161614962|NCT02234141|583642448|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
161614963|NCT02234141|583642449|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
161614964|NCT02234141|583642450|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
161614965|NCT02234141|583642451|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
161614966|NCT02234141|583642452|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
161614967|NCT02234141|583642446|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161614968|NCT02234141|583642447|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
161614969|NCT02234141|583642448|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161614970|NCT02234141|583642449|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161614971|NCT02234141|583642450|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161614972|NCT02234141|583642451|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161614973|NCT02234141|583642452|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161614974|NCT02234141|583642446|FG000|Long-Term Treatment Period|Death|0|||
161614975|NCT02234141|583642447|FG001|Long-Term Treatment Period|Death|0|||
161614976|NCT02234141|583642448|FG002|Long-Term Treatment Period|Death|0|||
161614977|NCT02234141|583642449|FG003|Long-Term Treatment Period|Death|0|||
161614978|NCT02234141|583642450|FG004|Long-Term Treatment Period|Death|0|||
161614979|NCT02234141|583642451|FG005|Long-Term Treatment Period|Death|1|||
161614980|NCT02234141|583642452|FG006|Long-Term Treatment Period|Death|0|||
161614981|NCT02234141|583642446|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
161614982|NCT02234141|583642447|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
161614983|NCT02234141|583642448|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
161614984|NCT02234141|583642449|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
161614985|NCT02234141|583642450|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
161614986|NCT02234141|583642451|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
161614987|NCT02234141|583642452|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
161614988|NCT02234141|583642446|FG000|Long-Term Treatment Period|Adverse Event|4|||
161614989|NCT02234141|583642447|FG001|Long-Term Treatment Period|Adverse Event|0|||
161614990|NCT02234141|583642448|FG002|Long-Term Treatment Period|Adverse Event|5|||
161614991|NCT02234141|583642449|FG003|Long-Term Treatment Period|Adverse Event|0|||
161614992|NCT02234141|583642450|FG004|Long-Term Treatment Period|Adverse Event|1|||
161614993|NCT02234141|583642451|FG005|Long-Term Treatment Period|Adverse Event|1|||
161614994|NCT02234141|583642452|FG006|Long-Term Treatment Period|Adverse Event|1|||
161614995|NCT02234141|583642446|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
161614996|NCT02234141|583642447|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
161614997|NCT02234141|583642448|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
161614998|NCT02234141|583642449|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
161614999|NCT02234141|583642450|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
161615000|NCT02234141|583642451|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
161615001|NCT02234141|583642452|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
161615002|NCT02234141|583642446|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
161615003|NCT02234141|583642447|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
161615004|NCT02234141|583642448|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
161615005|NCT02234141|583642449|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
161615006|NCT02234141|583642450|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
161615007|NCT02234141|583642451|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
161615008|NCT02234141|583642452|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
161615009|NCT00895245|583642453|FG000|Overall Study|Lack of Efficacy|6|||
161615010|NCT02095678|583642454|FG000|Overall Study|Withdrawal by Subject|0|||
161615011|NCT02095678|583642455|FG001|Overall Study|Withdrawal by Subject|1|||
161615012|NCT02095678|583642454|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
161615013|NCT02095678|583642455|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
161615014|NCT02095678|583642454|FG000|Overall Study|lesion impacted by previous treatment|1|||
161615015|NCT02095678|583642455|FG001|Overall Study|lesion impacted by previous treatment|1|||
161615016|NCT02095678|583642454|FG000|Overall Study|No Confirmed Diagnosis|0|||
161615017|NCT02095678|583642455|FG001|Overall Study|No Confirmed Diagnosis|3|||
161615018|NCT02095678|583642454|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
161615019|NCT02095678|583642455|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
161615020|NCT02095678|583642454|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
161615021|NCT02095678|583642455|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
161615022|NCT03418545|583642456|FG000|Overall Study|Withdrawal by Participant|2|||
161615023|NCT03418545|583642457|FG001|Overall Study|Withdrawal by Participant|4|||
161615024|NCT03418545|583642456|FG000|Overall Study|Lost to Follow-up|3|||
161615025|NCT03418545|583642457|FG001|Overall Study|Lost to Follow-up|5|||
161615026|NCT03418545|583642456|FG000|Overall Study|Reason Not Specified|0|||
161615027|NCT03418545|583642457|FG001|Overall Study|Reason Not Specified|1|||
161615028|NCT03418545|583642456|FG000|Overall Study|Missing Completion Status|0|||
161615029|NCT03418545|583642457|FG001|Overall Study|Missing Completion Status|1|||
161615030|NCT02706483|583642458|FG000|Overall Study|Adverse Event|97|||
161615031|NCT02706483|583642458|FG000|Overall Study|Death|1|||
161615032|NCT02706483|583642458|FG000|Overall Study|Lack of Efficacy|39|||
161615033|NCT02706483|583642458|FG000|Overall Study|Lost to Follow-up|101|||
161615034|NCT02706483|583642458|FG000|Overall Study|Non-compliance with study drug|15|||
161615035|NCT02706483|583642458|FG000|Overall Study|Physician Decision|6|||
161615036|NCT02706483|583642458|FG000|Overall Study|Pregnancy|6|||
161615037|NCT02706483|583642458|FG000|Overall Study|Protocol Violation|18|||
161615038|NCT02706483|583642458|FG000|Overall Study|Withdrawal by Subject|136|||
161615039|NCT02706483|583642458|FG000|Overall Study|Non-compliance with visits|6|||
161615040|NCT02706483|583642458|FG000|Overall Study|Site closure|4|||
161615041|NCT02706483|583642458|FG000|Overall Study|Subject moved|1|||
161615042|NCT04660799|583642459|FG000|Overall Study|Progressive Disease|1|||
161615043|NCT04660799|583642460|FG001|Overall Study|Progressive Disease|1|||
161615044|NCT04660799|583642459|FG000|Overall Study|Death|2|||
161615045|NCT04660799|583642460|FG001|Overall Study|Death|1|||
161615046|NCT04660799|583642459|FG000|Overall Study|Adverse Event|2|||
161615047|NCT04660799|583642460|FG001|Overall Study|Adverse Event|1|||
161615048|NCT04660799|583642459|FG000|Overall Study|Withdrawal by Subject|2|||
161615049|NCT04660799|583642460|FG001|Overall Study|Withdrawal by Subject|5|||
161615050|NCT03131713|583642461|FG000|Overall Study|Lost to Follow-up|5|||
161615051|NCT03131713|583642462|FG001|Overall Study|Lost to Follow-up|0|||
161615052|NCT01972776|583642465|FG000|Part 1|Withdrawal by Subject|0|||
161615053|NCT01972776|583642466|FG001|Part 1|Withdrawal by Subject|0|||
161615054|NCT01972776|583642467|FG002|Part 1|Withdrawal by Subject|1|||
161615055|NCT01972776|583642468|FG003|Part 1|Withdrawal by Subject|0|||
161615056|NCT01972776|583642469|FG004|Part 1|Withdrawal by Subject|0|||
161615057|NCT01972776|583642470|FG005|Part 1|Withdrawal by Subject|0|||
161615058|NCT01972776|583642465|FG000|Part 1|Adverse Event|0|||
161615059|NCT01972776|583642466|FG001|Part 1|Adverse Event|0|||
161615060|NCT01972776|583642467|FG002|Part 1|Adverse Event|1|||
161615061|NCT01972776|583642468|FG003|Part 1|Adverse Event|1|||
161615062|NCT01972776|583642469|FG004|Part 1|Adverse Event|0|||
161615063|NCT01972776|583642470|FG005|Part 1|Adverse Event|0|||
161615064|NCT01972776|583642465|FG000|Part 2|Adverse Event|0|||
161615065|NCT01972776|583642466|FG001|Part 2|Adverse Event|0|||
161615066|NCT01972776|583642467|FG002|Part 2|Adverse Event|0|||
161615067|NCT01972776|583642468|FG003|Part 2|Adverse Event|0|||
161615068|NCT01972776|583642469|FG004|Part 2|Adverse Event|3|||
161615069|NCT01972776|583642470|FG005|Part 2|Adverse Event|0|||
161615070|NCT01972776|583642465|FG000|Part 2|Administrative problems|0|||
161615071|NCT01972776|583642466|FG001|Part 2|Administrative problems|0|||
161615072|NCT01972776|583642467|FG002|Part 2|Administrative problems|0|||
161615073|NCT01972776|583642468|FG003|Part 2|Administrative problems|0|||
161615074|NCT01972776|583642469|FG004|Part 2|Administrative problems|10|||
161615075|NCT01972776|583642470|FG005|Part 2|Administrative problems|7|||
161615076|NCT01228734|583642474|FG000|Overall Study|Randomized, but not treated|0|||
161615077|NCT01228734|583642475|FG001|Overall Study|Randomized, but not treated|4|||
161615078|NCT02382640|583642479|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
161615079|NCT02382640|583642480|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
161615080|NCT02382640|583642481|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
161615081|NCT02382640|583642482|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
161615082|NCT01220999|583642483|FG000|Overall Study|Progressive disease|0|||
161615083|NCT01220999|583642484|FG001|Overall Study|Progressive disease|0|||
161615084|NCT01220999|583642485|FG002|Overall Study|Progressive disease|1|||
161615085|NCT01220999|583642486|FG003|Overall Study|Progressive disease|0|||
161615086|NCT01220999|583642487|FG004|Overall Study|Progressive disease|0|||
161615087|NCT01560429|583642490|FG000|Overall Study|Protocol Violation|3|||
161615088|NCT01560429|583642491|FG001|Overall Study|Protocol Violation|6|||
161615089|NCT02449902|583642492|FG000|Overall Study|Adverse Event|0|||
161615090|NCT02449902|583642493|FG001|Overall Study|Adverse Event|1|||
161684451|NCT02819635|583897896|FG004|Substudy 3|Lost to Follow-up|0|||
161684452|NCT02819635|583897897|FG005|Substudy 3|Lost to Follow-up|0|||
161615091|NCT02449902|583642492|FG000|Overall Study|Withdrawal by Subject|0|||
161615092|NCT02449902|583642493|FG001|Overall Study|Withdrawal by Subject|1|||
161615093|NCT01365546|583642494|FG000|Overall Study|Withdrawal by Subject|1|||
161615094|NCT01365546|583642494|FG000|Overall Study|Screen failure|9|||
161615095|NCT01365546|583642494|FG000|Overall Study|Study termination|1|||
161615096|NCT03326856|583642495|FG000|Overall Study|Lost to Follow-up|1|||
161615097|NCT03326856|583642496|FG001|Overall Study|Lost to Follow-up|1|||
161615098|NCT03326856|583642497|FG002|Overall Study|Lost to Follow-up|0|||
161615099|NCT03326856|583642498|FG003|Overall Study|Lost to Follow-up|0|||
161615100|NCT03326856|583642499|FG004|Overall Study|Lost to Follow-up|0|||
161615101|NCT03162614|583642500|FG000|Overall Study|Lost to Follow-up|2|||
161615102|NCT03162614|583642501|FG001|Overall Study|Lost to Follow-up|1|||
161615103|NCT03162614|583642502|FG002|Overall Study|Lost to Follow-up|1|||
161615104|NCT03162614|583642503|FG003|Overall Study|Lost to Follow-up|1|||
161615105|NCT03162614|583642504|FG004|Overall Study|Lost to Follow-up|2|||
161615106|NCT03162614|583642505|FG005|Overall Study|Lost to Follow-up|0|||
161615107|NCT03162614|583642500|FG000|Overall Study|Protocol Violation|0|||
161615108|NCT03162614|583642501|FG001|Overall Study|Protocol Violation|1|||
161615109|NCT03162614|583642502|FG002|Overall Study|Protocol Violation|0|||
161615110|NCT03162614|583642503|FG003|Overall Study|Protocol Violation|1|||
161615111|NCT03162614|583642504|FG004|Overall Study|Protocol Violation|0|||
161615112|NCT03162614|583642505|FG005|Overall Study|Protocol Violation|0|||
161615113|NCT03162614|583642500|FG000|Overall Study|Withdrawal by Subject|2|||
161615114|NCT03162614|583642501|FG001|Overall Study|Withdrawal by Subject|1|||
161615115|NCT03162614|583642502|FG002|Overall Study|Withdrawal by Subject|1|||
161615116|NCT03162614|583642503|FG003|Overall Study|Withdrawal by Subject|1|||
161615117|NCT03162614|583642504|FG004|Overall Study|Withdrawal by Subject|0|||
161615118|NCT03162614|583642505|FG005|Overall Study|Withdrawal by Subject|0|||
161615119|NCT03162614|583642500|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
161615120|NCT03162614|583642501|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
161615121|NCT03162614|583642502|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
161615122|NCT03162614|583642503|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
161615123|NCT03162614|583642504|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
161615124|NCT03162614|583642505|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
161615125|NCT03861234|583642506|FG000|Overall Study|Not treated|0|||
161615126|NCT03861234|583642507|FG001|Overall Study|Not treated|0|||
161615127|NCT03861234|583642508|FG002|Overall Study|Not treated|0|||
161615128|NCT03861234|583642509|FG003|Overall Study|Not treated|0|||
161615129|NCT03861234|583642510|FG004|Overall Study|Not treated|0|||
161615130|NCT03861234|583642511|FG005|Overall Study|Not treated|1|||
161615131|NCT03861234|583642512|FG006|Overall Study|Not treated|0|||
161615132|NCT03861234|583642513|FG007|Overall Study|Not treated|0|||
161615133|NCT03861234|583642506|FG000|Overall Study|Adverse Event|0|||
161615134|NCT03861234|583642507|FG001|Overall Study|Adverse Event|0|||
161615135|NCT03861234|583642508|FG002|Overall Study|Adverse Event|0|||
161615136|NCT03861234|583642509|FG003|Overall Study|Adverse Event|0|||
161615137|NCT03861234|583642510|FG004|Overall Study|Adverse Event|0|||
161615138|NCT03861234|583642511|FG005|Overall Study|Adverse Event|1|||
161615139|NCT03861234|583642512|FG006|Overall Study|Adverse Event|0|||
161615140|NCT03861234|583642513|FG007|Overall Study|Adverse Event|0|||
161615141|NCT03861234|583642506|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
161615142|NCT03861234|583642507|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
161615143|NCT03861234|583642508|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
161615144|NCT03861234|583642509|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
161615145|NCT03861234|583642510|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
161615146|NCT03861234|583642511|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
161615147|NCT03861234|583642512|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
161615148|NCT03861234|583642513|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
161615149|NCT03861234|583642506|FG000|Overall Study|As per sponsor decision|0|||
161615150|NCT03861234|583642507|FG001|Overall Study|As per sponsor decision|0|||
161615151|NCT03861234|583642508|FG002|Overall Study|As per sponsor decision|0|||
161615152|NCT03861234|583642509|FG003|Overall Study|As per sponsor decision|0|||
161615153|NCT03861234|583642510|FG004|Overall Study|As per sponsor decision|0|||
161615154|NCT03861234|583642511|FG005|Overall Study|As per sponsor decision|0|||
161615155|NCT03861234|583642512|FG006|Overall Study|As per sponsor decision|1|||
161615156|NCT03861234|583642513|FG007|Overall Study|As per sponsor decision|0|||
161615157|NCT03861234|583642506|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
161615158|NCT03861234|583642507|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
161615159|NCT03861234|583642508|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
161615160|NCT03861234|583642509|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
161615161|NCT03861234|583642510|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
161615162|NCT03861234|583642511|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
161615163|NCT03861234|583642512|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
161615164|NCT03861234|583642513|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
161615165|NCT00621842|583642514|FG000|Overall Study|Adverse Event|6|||
161615166|NCT00621842|583642514|FG000|Overall Study|Withdrawal by Subject|7|||
161615167|NCT00621842|583642514|FG000|Overall Study|Protocol Violation|4|||
161615168|NCT00621842|583642514|FG000|Overall Study|Lack of Efficacy|2|||
161615169|NCT01074242|583642517|FG000|Overall Study|Case report before date of contract|40|||
161615170|NCT01074242|583642517|FG000|Overall Study|Lost to Follow-up|1|||
161615171|NCT01074242|583642517|FG000|Overall Study|Case report unclear|6|||
161615172|NCT01074242|583642517|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
161615173|NCT01074242|583642517|FG000|Overall Study|Duplicate Case Report Form|5|||
161615174|NCT01957163|583642518|FG000|Overall Study|Adverse Event|5|||
161615175|NCT01957163|583642519|FG001|Overall Study|Adverse Event|2|||
161615176|NCT01957163|583642520|FG002|Overall Study|Adverse Event|4|||
161615177|NCT01957163|583642518|FG000|Overall Study|Lack of Efficacy|5|||
161615178|NCT01957163|583642519|FG001|Overall Study|Lack of Efficacy|4|||
161615179|NCT01957163|583642520|FG002|Overall Study|Lack of Efficacy|9|||
161615180|NCT01957163|583642518|FG000|Overall Study|Protocol Violation|1|||
161615181|NCT01957163|583642519|FG001|Overall Study|Protocol Violation|2|||
161615182|NCT01957163|583642520|FG002|Overall Study|Protocol Violation|0|||
161615183|NCT01957163|583642518|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
161615184|NCT01957163|583642519|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
161615185|NCT01957163|583642520|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
161615186|NCT01957163|583642518|FG000|Overall Study|Lost to Follow-up|0|||
161615187|NCT01957163|583642519|FG001|Overall Study|Lost to Follow-up|1|||
161615188|NCT01957163|583642520|FG002|Overall Study|Lost to Follow-up|0|||
161615189|NCT01957163|583642518|FG000|Overall Study|Withdrawal by Subject|4|||
161615190|NCT01957163|583642519|FG001|Overall Study|Withdrawal by Subject|2|||
161615191|NCT01957163|583642520|FG002|Overall Study|Withdrawal by Subject|4|||
161615192|NCT03539055|583642521|FG000|Overall Study|Death|4|||
161615193|NCT03539055|583642521|FG000|Overall Study|Lost to Follow-up|1|||
161615194|NCT03539055|583642521|FG000|Overall Study|Withdrawal by Subject|2|||
161615195|NCT03539055|583642521|FG000|Overall Study|Screen Fail|7|||
161615196|NCT03539055|583642521|FG000|Overall Study|Drug Intolerance|2|||
161615197|NCT01638000|583642523|FG000|Overall Study|Randomized but Never Received Drug|7|||
161615198|NCT01638000|583642524|FG001|Overall Study|Randomized but Never Received Drug|10|||
161615199|NCT01638000|583642523|FG000|Overall Study|Adverse Event|14|||
161615200|NCT01638000|583642524|FG001|Overall Study|Adverse Event|16|||
161615201|NCT01638000|583642523|FG000|Overall Study|Lack of Efficacy|5|||
161615202|NCT01638000|583642524|FG001|Overall Study|Lack of Efficacy|6|||
161615203|NCT01638000|583642523|FG000|Overall Study|Protocol Violation|11|||
161615204|NCT01638000|583642524|FG001|Overall Study|Protocol Violation|13|||
161615205|NCT01638000|583642523|FG000|Overall Study|Withdrawal by Subject|21|||
161615206|NCT01638000|583642524|FG001|Overall Study|Withdrawal by Subject|24|||
161615207|NCT01638000|583642523|FG000|Overall Study|Miscellaneous|2|||
161615208|NCT01638000|583642524|FG001|Overall Study|Miscellaneous|2|||
161615209|NCT00875706|583642525|FG000|Overall Study|Withdrawal by Subject|1|||
161615210|NCT00875706|583642526|FG001|Overall Study|Withdrawal by Subject|0|||
161615211|NCT00875706|583642527|FG002|Overall Study|Withdrawal by Subject|0|||
161615212|NCT03775213|583642528|FG000|Overall Study|Withdrawal by Subject|51|||
161615213|NCT03775213|583642529|FG001|Overall Study|Withdrawal by Subject|53|||
161615214|NCT03775213|583642528|FG000|Overall Study|Incomplete Survey|7|||
161615215|NCT03775213|583642529|FG001|Overall Study|Incomplete Survey|7|||
161615216|NCT00786188|583642530|FG000|Overall Study|Adverse Event|3|||
161615217|NCT00786188|583642531|FG001|Overall Study|Adverse Event|1|||
161615218|NCT00786188|583642530|FG000|Overall Study|Withdrawal by Subject|2|||
161615219|NCT00786188|583642531|FG001|Overall Study|Withdrawal by Subject|0|||
161615220|NCT00326183|583642532|FG000|Overall Study|Lost to Follow-up|104|||
161615221|NCT00326183|583642533|FG001|Overall Study|Lost to Follow-up|56|||
161615222|NCT00326183|583642532|FG000|Overall Study|Protocol Violation|6|||
161615223|NCT00326183|583642533|FG001|Overall Study|Protocol Violation|3|||
161615224|NCT00326183|583642532|FG000|Overall Study|Withdrawal by Subject|35|||
161615225|NCT00326183|583642533|FG001|Overall Study|Withdrawal by Subject|7|||
161615226|NCT00326183|583642532|FG000|Overall Study|Subject Moved|7|||
161615227|NCT00326183|583642533|FG001|Overall Study|Subject Moved|4|||
161615228|NCT00326183|583642532|FG000|Overall Study|Other|47|||
161615229|NCT00326183|583642533|FG001|Overall Study|Other|13|||
161615230|NCT00326183|583642532|FG000|Overall Study|Adverse Event|1|||
161615231|NCT00326183|583642533|FG001|Overall Study|Adverse Event|0|||
161615232|NCT01827839|583642537|FG000|Overall Study|Adverse Event|1|||
161615233|NCT01827839|583642537|FG000|Overall Study|Consent Withdrawal|2|||
161615234|NCT00570505|583642538|FG000|Overall Study|Adverse Event|7|||
161615235|NCT00570505|583642538|FG000|Overall Study|Withdrawal by Subject|7|||
161615236|NCT00570505|583642538|FG000|Overall Study|Lost to Follow-up|23|||
161615237|NCT00570505|583642538|FG000|Overall Study|Other loss to follow-up|4|||
161615238|NCT00614614|583642539|FG000|Primary Vaccination Phase|Adverse Event|6|||
161615239|NCT00614614|583642540|FG001|Primary Vaccination Phase|Adverse Event|0|||
161615240|NCT00614614|583642541|FG002|Primary Vaccination Phase|Adverse Event|0|||
161832681|NCT02139124|584428494|FG004|Overall Study|subject moved|0|||
161615241|NCT00614614|583642542|FG003|Primary Vaccination Phase|Adverse Event|0|||
161615242|NCT00614614|583642543|FG004|Primary Vaccination Phase|Adverse Event|0|||
161615243|NCT00614614|583642539|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
161615244|NCT00614614|583642540|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
161615245|NCT00614614|583642541|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
161615246|NCT00614614|583642542|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
161615247|NCT00614614|583642543|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
161615248|NCT00614614|583642539|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
161615249|NCT00614614|583642540|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
161684453|NCT02819635|583897898|FG006|Substudy 3|Lost to Follow-up|0|||
161615250|NCT00614614|583642541|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
161615251|NCT00614614|583642542|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
161615252|NCT00614614|583642543|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
161615253|NCT00614614|583642539|FG000|Primary Vaccination Phase|Protocol Violation|9|||
161684454|NCT02819635|583897899|FG007|Substudy 3|Lost to Follow-up|0|||
161615254|NCT00614614|583642540|FG001|Primary Vaccination Phase|Protocol Violation|3|||
161615255|NCT00614614|583642541|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161615256|NCT00614614|583642542|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161615257|NCT00614614|583642543|FG004|Primary Vaccination Phase|Protocol Violation|0|||
161615258|NCT00614614|583642539|FG000|Primary Vaccination Phase|Other|4|||
161615259|NCT00614614|583642540|FG001|Primary Vaccination Phase|Other|0|||
161615260|NCT00614614|583642541|FG002|Primary Vaccination Phase|Other|0|||
161615261|NCT00614614|583642542|FG003|Primary Vaccination Phase|Other|0|||
161615262|NCT00614614|583642543|FG004|Primary Vaccination Phase|Other|0|||
161615263|NCT00614614|583642539|FG000|Booster Vaccination Phase|Adverse Event|0|||
161615264|NCT00614614|583642540|FG001|Booster Vaccination Phase|Adverse Event|0|||
161615265|NCT00614614|583642541|FG002|Booster Vaccination Phase|Adverse Event|1|||
161615266|NCT00614614|583642542|FG003|Booster Vaccination Phase|Adverse Event|1|||
161615267|NCT00614614|583642543|FG004|Booster Vaccination Phase|Adverse Event|0|||
161615268|NCT00614614|583642539|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
161615269|NCT00614614|583642540|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161615270|NCT00614614|583642541|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
161615271|NCT00614614|583642542|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
161615272|NCT00614614|583642543|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
161615273|NCT00614614|583642539|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
161615274|NCT00614614|583642540|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
161615275|NCT00614614|583642541|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
161615276|NCT00614614|583642542|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
161615277|NCT00614614|583642543|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
161615278|NCT00614614|583642539|FG000|Booster Vaccination Phase|Protocol Violation|0|||
161615279|NCT00614614|583642540|FG001|Booster Vaccination Phase|Protocol Violation|0|||
161615280|NCT00614614|583642541|FG002|Booster Vaccination Phase|Protocol Violation|2|||
161615281|NCT00614614|583642542|FG003|Booster Vaccination Phase|Protocol Violation|3|||
161615282|NCT00614614|583642543|FG004|Booster Vaccination Phase|Protocol Violation|0|||
161615283|NCT00614614|583642539|FG000|Booster Vaccination Phase|Other|0|||
161615284|NCT00614614|583642540|FG001|Booster Vaccination Phase|Other|1|||
161615285|NCT00614614|583642541|FG002|Booster Vaccination Phase|Other|3|||
161615286|NCT00614614|583642542|FG003|Booster Vaccination Phase|Other|2|||
161615287|NCT00614614|583642543|FG004|Booster Vaccination Phase|Other|1|||
161615288|NCT05426109|583642544|FG000|Overall Study|Withdrawal by Subject|0|||
161615289|NCT05426109|583642545|FG001|Overall Study|Withdrawal by Subject|1|||
161615290|NCT05212285|583642546|FG000|Overall Study|Lack of Efficacy|12|||
161615291|NCT05212285|583642547|FG001|Overall Study|Lack of Efficacy|8|||
161615292|NCT05212285|583642546|FG000|Overall Study|Withdrawal by Subject|8|||
161615293|NCT05212285|583642547|FG001|Overall Study|Withdrawal by Subject|1|||
161615294|NCT05212285|583642546|FG000|Overall Study|Lost to Follow-up|13|||
161615295|NCT05212285|583642547|FG001|Overall Study|Lost to Follow-up|1|||
161615296|NCT05212285|583642546|FG000|Overall Study|miss data|21|||
161615297|NCT05212285|583642547|FG001|Overall Study|miss data|2|||
161615298|NCT01000805|583642548|FG000|Overall Study|Adverse Event|21|||
161615299|NCT01000805|583642549|FG001|Overall Study|Adverse Event|9|||
161615300|NCT01000805|583642548|FG000|Overall Study|Lack of Efficacy|5|||
161615301|NCT01000805|583642549|FG001|Overall Study|Lack of Efficacy|16|||
161615302|NCT01000805|583642548|FG000|Overall Study|Lost to Follow-up|16|||
161615303|NCT01000805|583642549|FG001|Overall Study|Lost to Follow-up|21|||
161615304|NCT01000805|583642548|FG000|Overall Study|Physician Decision|0|||
161615305|NCT01000805|583642549|FG001|Overall Study|Physician Decision|1|||
161615306|NCT01000805|583642548|FG000|Overall Study|Protocol Violation|12|||
161615307|NCT01000805|583642549|FG001|Overall Study|Protocol Violation|8|||
161615308|NCT01000805|583642548|FG000|Overall Study|Withdrawal by Subject|16|||
161615309|NCT01000805|583642549|FG001|Overall Study|Withdrawal by Subject|6|||
161615310|NCT01000805|583642548|FG000|Overall Study|Sponsor Decision|0|||
161615311|NCT01000805|583642549|FG001|Overall Study|Sponsor Decision|1|||
161615312|NCT04118894|583642550|FG000|Overall Study|Lost to Follow-up|21|||
161615313|NCT04118894|583642550|FG000|Overall Study|Withdrawal by Subject|10|||
161615314|NCT04118894|583642550|FG000|Overall Study|Adverse Event|4|||
161615315|NCT04369664|583643842|FG000|Overall Study|Physician Decision|1|||
161615316|NCT04369664|583643843|FG001|Overall Study|Physician Decision|0|||
161615317|NCT03840200|583643844|FG000|Overall Study|Death|6|||
161615318|NCT03840200|583643845|FG001|Overall Study|Death|3|||
161615319|NCT03840200|583643846|FG002|Overall Study|Death|6|||
161615320|NCT03840200|583643847|FG003|Overall Study|Death|10|||
161615321|NCT03840200|583643844|FG000|Overall Study|Reason Not Specified|2|||
161615322|NCT03840200|583643845|FG001|Overall Study|Reason Not Specified|2|||
161615323|NCT03840200|583643846|FG002|Overall Study|Reason Not Specified|1|||
161615324|NCT03840200|583643847|FG003|Overall Study|Reason Not Specified|15|||
161615325|NCT03840200|583643844|FG000|Overall Study|Physician Decision|0|||
161615326|NCT03840200|583643845|FG001|Overall Study|Physician Decision|0|||
161615327|NCT03840200|583643846|FG002|Overall Study|Physician Decision|0|||
161615328|NCT03840200|583643847|FG003|Overall Study|Physician Decision|2|||
161615329|NCT03840200|583643844|FG000|Overall Study|Progressive Disease|0|||
161615330|NCT03840200|583643845|FG001|Overall Study|Progressive Disease|0|||
161615331|NCT03840200|583643846|FG002|Overall Study|Progressive Disease|0|||
161615332|NCT03840200|583643847|FG003|Overall Study|Progressive Disease|1|||
161615333|NCT03840200|583643844|FG000|Overall Study|Withdrawal by Subject|0|||
161615334|NCT03840200|583643845|FG001|Overall Study|Withdrawal by Subject|1|||
161615335|NCT03840200|583643846|FG002|Overall Study|Withdrawal by Subject|0|||
161615336|NCT03840200|583643847|FG003|Overall Study|Withdrawal by Subject|2|||
161615337|NCT04493424|583643848|FG000|Overall Study|Termination of the trial by the sponsor|89|||
161615338|NCT04493424|583643848|FG000|Overall Study|Withdrawal by Subject|9|||
161615339|NCT04493424|583643848|FG000|Overall Study|Lost to Follow-up|2|||
161615340|NCT04493424|583643848|FG000|Overall Study|Lack of Efficacy|3|||
161615341|NCT04493424|583643848|FG000|Overall Study|Adverse Event|5|||
161615342|NCT03769090|583643850|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
161615343|NCT03769090|583643851|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
161615344|NCT03769090|583643852|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
161615345|NCT03769090|583643850|FG000|Overall Study|Withdrawal by Subject|52|||
161615346|NCT03769090|583643851|FG001|Overall Study|Withdrawal by Subject|62|||
161615347|NCT03769090|583643852|FG002|Overall Study|Withdrawal by Subject|74|||
161615348|NCT03769090|583643850|FG000|Overall Study|Death|4|||
161615349|NCT03769090|583643851|FG001|Overall Study|Death|2|||
161615350|NCT03769090|583643852|FG002|Overall Study|Death|2|||
161615351|NCT03769090|583643850|FG000|Overall Study|Adverse Event|7|||
161615352|NCT03769090|583643851|FG001|Overall Study|Adverse Event|7|||
161615353|NCT03769090|583643852|FG002|Overall Study|Adverse Event|8|||
161615354|NCT03769090|583643850|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
161615355|NCT03769090|583643851|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
161615356|NCT03769090|583643852|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
161615357|NCT03769090|583643850|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
161615358|NCT03769090|583643851|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
161615359|NCT03769090|583643852|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
161615360|NCT03769090|583643850|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
161615361|NCT03769090|583643851|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
161615362|NCT03769090|583643852|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
161615363|NCT03769090|583643850|FG000|Overall Study|Protocol Violation|5|||
161615364|NCT03769090|583643851|FG001|Overall Study|Protocol Violation|6|||
161615365|NCT03769090|583643852|FG002|Overall Study|Protocol Violation|8|||
161615366|NCT03769090|583643850|FG000|Overall Study|Pregnancy|1|||
161615367|NCT03769090|583643851|FG001|Overall Study|Pregnancy|0|||
161615368|NCT03769090|583643852|FG002|Overall Study|Pregnancy|3|||
161615369|NCT03769090|583643850|FG000|Overall Study|Lost to Follow-up|19|||
161615370|NCT03769090|583643851|FG001|Overall Study|Lost to Follow-up|25|||
161615371|NCT03769090|583643852|FG002|Overall Study|Lost to Follow-up|21|||
161615372|NCT03769090|583643850|FG000|Overall Study|Condition under investigation worsened|2|||
161615373|NCT03769090|583643851|FG001|Overall Study|Condition under investigation worsened|0|||
161615374|NCT03769090|583643852|FG002|Overall Study|Condition under investigation worsened|1|||
161615375|NCT03769090|583643850|FG000|Overall Study|Lack of Efficacy|1|||
161615376|NCT03769090|583643851|FG001|Overall Study|Lack of Efficacy|2|||
161615377|NCT03769090|583643852|FG002|Overall Study|Lack of Efficacy|2|||
161615378|NCT03769090|583643850|FG000|Overall Study|Other reasons|8|||
161615379|NCT03769090|583643851|FG001|Overall Study|Other reasons|12|||
161615380|NCT03769090|583643852|FG002|Overall Study|Other reasons|15|||
161615381|NCT02830893|583643858|FG000|Overall Study|Relocation to out of the country|1|||
161615382|NCT02830893|583643859|FG001|Overall Study|Relocation to out of the country|0|||
161615383|NCT02830893|583643858|FG000|Overall Study|Lost to Follow-up|0|||
161615384|NCT02830893|583643859|FG001|Overall Study|Lost to Follow-up|2|||
161615385|NCT02830893|583643858|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
161615386|NCT02830893|583643859|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
161615387|NCT01277302|583643860|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
161615388|NCT01277302|583643861|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
161615389|NCT01277302|583643862|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
161615390|NCT01277302|583643860|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
161615391|NCT01277302|583643861|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
161615392|NCT01277302|583643862|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
161615393|NCT01277302|583643860|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
161615394|NCT01277302|583643861|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
161615395|NCT01277302|583643862|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
161615396|NCT01277302|583643860|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
161615397|NCT01277302|583643861|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
161615398|NCT01277302|583643862|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
161615399|NCT01277302|583643860|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
161615400|NCT01277302|583643861|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
161615401|NCT01277302|583643862|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
161615402|NCT01277302|583643860|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
161615403|NCT01277302|583643861|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
161615404|NCT01277302|583643862|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
161615405|NCT01277302|583643860|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
161615406|NCT01277302|583643861|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
161615407|NCT01277302|583643862|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
161615408|NCT01277302|583643860|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
161615409|NCT01277302|583643861|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
161615410|NCT01277302|583643862|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
161615411|NCT01277302|583643860|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
161615412|NCT01277302|583643861|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
161615413|NCT01277302|583643862|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
161615414|NCT02710669|583643865|FG000|Overall Study|Physician Decision|2|||
161615415|NCT02710669|583643866|FG001|Overall Study|Physician Decision|1|||
161615416|NCT02710669|583643867|FG002|Overall Study|Physician Decision|0|||
161615417|NCT02710669|583643865|FG000|Overall Study|Institutional delays (including COVID)|2|||
161615418|NCT02710669|583643866|FG001|Overall Study|Institutional delays (including COVID)|2|||
161615419|NCT02710669|583643867|FG002|Overall Study|Institutional delays (including COVID)|0|||
161615420|NCT02710669|583643865|FG000|Overall Study|arrived in afib/aflutter|10|||
161615421|NCT02710669|583643866|FG001|Overall Study|arrived in afib/aflutter|8|||
161615422|NCT02710669|583643867|FG002|Overall Study|arrived in afib/aflutter|2|||
161615423|NCT01567852|583643868|FG000|Overall Study|Withdrawal by Subject|3|||
161615424|NCT01567852|583643869|FG001|Overall Study|Withdrawal by Subject|6|||
161615425|NCT01567852|583643868|FG000|Overall Study|ECT discontinued|1|||
161615426|NCT01567852|583643869|FG001|Overall Study|ECT discontinued|1|||
161615427|NCT01190124|583643871|FG000|Overall Study|Death|3|||
161615428|NCT01190124|583643872|FG001|Overall Study|Death|0|||
161615429|NCT01190124|583643873|FG002|Overall Study|Death|0|||
161615430|NCT01190124|583643871|FG000|Overall Study|Therapeutic Failure|12|||
161615431|NCT01190124|583643872|FG001|Overall Study|Therapeutic Failure|0|||
161615432|NCT01190124|583643873|FG002|Overall Study|Therapeutic Failure|1|||
161615433|NCT01190124|583643871|FG000|Overall Study|Lost to Follow-up|2|||
161615434|NCT01190124|583643872|FG001|Overall Study|Lost to Follow-up|0|||
161615435|NCT01190124|583643873|FG002|Overall Study|Lost to Follow-up|0|||
161615436|NCT03690219|583643874|FG000|Overall Study|no injuries|9|||
161615437|NCT03690219|583643875|FG001|Overall Study|no injuries|20|||
161615438|NCT03690219|583643874|FG000|Overall Study|missing information|7|||
161615439|NCT03690219|583643875|FG001|Overall Study|missing information|7|||
161615440|NCT01523392|583643876|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161615441|NCT01523392|583643877|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161615442|NCT01523392|583643876|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
161615443|NCT01523392|583643877|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
161615444|NCT01523392|583643876|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
161615445|NCT01523392|583643877|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
161615446|NCT02092285|583643879|FG000|Induction Phase|Adverse Event|7|||
161615447|NCT02092285|583643879|FG000|Induction Phase|Physician Decision|4|||
161615448|NCT02092285|583643879|FG000|Induction Phase|Pregnancy|1|||
161615449|NCT02092285|583643879|FG000|Induction Phase|Relapse/Recurrence|7|||
161615450|NCT02092285|583643879|FG000|Induction Phase|Withdrawal by Subject|2|||
161615451|NCT02092285|583643879|FG000|Induction Phase|Lack of Efficacy|14|||
161615452|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
161615453|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
161615454|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
161615455|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
161615456|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
161615457|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
161615458|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
161615459|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
161615460|NCT02092285|583643879|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
161615461|NCT01719172|583643880|FG000|Overall Study|Lost to Follow-up|1|||
161615462|NCT01719172|583643880|FG000|Overall Study|Death|1|||
161615463|NCT00087516|583643881|FG000|Overall Study|Adverse Event|10|||
161615464|NCT00087516|583643882|FG001|Overall Study|Adverse Event|10|||
161615465|NCT00087516|583643883|FG002|Overall Study|Adverse Event|3|||
161615466|NCT00087516|583643884|FG003|Overall Study|Adverse Event|6|||
161615467|NCT00087516|583643881|FG000|Overall Study|Lack of Efficacy|82|||
161615468|NCT00087516|583643882|FG001|Overall Study|Lack of Efficacy|80|||
161615469|NCT00087516|583643883|FG002|Overall Study|Lack of Efficacy|39|||
161615470|NCT00087516|583643884|FG003|Overall Study|Lack of Efficacy|29|||
161615471|NCT00087516|583643881|FG000|Overall Study|Lost to Follow-up|8|||
161615472|NCT00087516|583643882|FG001|Overall Study|Lost to Follow-up|6|||
161615473|NCT00087516|583643883|FG002|Overall Study|Lost to Follow-up|5|||
161615474|NCT00087516|583643884|FG003|Overall Study|Lost to Follow-up|5|||
161615475|NCT00087516|583643881|FG000|Overall Study|Protocol Violation|4|||
161615476|NCT00087516|583643882|FG001|Overall Study|Protocol Violation|8|||
161615477|NCT00087516|583643883|FG002|Overall Study|Protocol Violation|3|||
161615478|NCT00087516|583643884|FG003|Overall Study|Protocol Violation|6|||
161615479|NCT00087516|583643881|FG000|Overall Study|Withdrawal by Subject|16|||
161615480|NCT00087516|583643882|FG001|Overall Study|Withdrawal by Subject|27|||
161615481|NCT00087516|583643883|FG002|Overall Study|Withdrawal by Subject|11|||
161615482|NCT00087516|583643884|FG003|Overall Study|Withdrawal by Subject|12|||
161615483|NCT00087516|583643881|FG000|Overall Study|Site terminated|0|||
161615484|NCT00087516|583643882|FG001|Overall Study|Site terminated|2|||
161615485|NCT00087516|583643883|FG002|Overall Study|Site terminated|1|||
161615486|NCT00087516|583643884|FG003|Overall Study|Site terminated|0|||
161615487|NCT00087516|583643881|FG000|Overall Study|Protocol specified discontinuation|35|||
161615488|NCT00087516|583643882|FG001|Overall Study|Protocol specified discontinuation|33|||
161615489|NCT00087516|583643883|FG002|Overall Study|Protocol specified discontinuation|33|||
161615490|NCT00087516|583643884|FG003|Overall Study|Protocol specified discontinuation|26|||
161615491|NCT00087516|583643881|FG000|Overall Study|Patient moved|3|||
161615492|NCT00087516|583643882|FG001|Overall Study|Patient moved|2|||
161615493|NCT00087516|583643883|FG002|Overall Study|Patient moved|1|||
161615494|NCT00087516|583643884|FG003|Overall Study|Patient moved|0|||
161615495|NCT00087516|583643881|FG000|Overall Study|Patient was non-compliant|3|||
161615496|NCT00087516|583643882|FG001|Overall Study|Patient was non-compliant|1|||
161615497|NCT00087516|583643883|FG002|Overall Study|Patient was non-compliant|0|||
161615498|NCT00087516|583643884|FG003|Overall Study|Patient was non-compliant|0|||
161615499|NCT00087516|583643881|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
161615500|NCT00087516|583643882|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
161615501|NCT00087516|583643883|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
161615502|NCT00087516|583643884|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
161615503|NCT00087516|583643881|FG000|Overall Study|Other|0|||
161615504|NCT00087516|583643882|FG001|Overall Study|Other|0|||
161615505|NCT00087516|583643883|FG002|Overall Study|Other|1|||
161615506|NCT00087516|583643884|FG003|Overall Study|Other|0|||
161615507|NCT02392507|583643885|FG000|Induction Regimen|Death|3|||
161615508|NCT02392507|583643885|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
161615509|NCT02392507|583643885|FG000|Induction Regimen|Physician Decision|1|||
161615510|NCT02392507|583643885|FG000|Induction Regimen|Withdrawal by Subject|2|||
161615511|NCT02392507|583643885|FG000|Maintenance Regimen|Death|1|||
161615512|NCT02392507|583643885|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
161615513|NCT00273052|583643886|FG000|Overall Study|Withdrawal by Subject|16|||
161615514|NCT00273052|583643887|FG001|Overall Study|Withdrawal by Subject|19|||
161615515|NCT00273052|583643886|FG000|Overall Study|Adverse Event|21|||
161615516|NCT00273052|583643887|FG001|Overall Study|Adverse Event|19|||
161615517|NCT00273052|583643886|FG000|Overall Study|Protocol Violation|14|||
161615518|NCT00273052|583643887|FG001|Overall Study|Protocol Violation|18|||
161615519|NCT00273052|583643886|FG000|Overall Study|Lost to Follow-up|7|||
161615520|NCT00273052|583643887|FG001|Overall Study|Lost to Follow-up|25|||
161615521|NCT00273052|583643886|FG000|Overall Study|Lack of Efficacy|6|||
161615522|NCT00273052|583643887|FG001|Overall Study|Lack of Efficacy|4|||
161615523|NCT00273052|583643886|FG000|Overall Study|Non-Compliance|3|||
161615524|NCT00273052|583643887|FG001|Overall Study|Non-Compliance|1|||
161615525|NCT00273052|583643886|FG000|Overall Study|Other|2|||
161615526|NCT00273052|583643887|FG001|Overall Study|Other|0|||
161615527|NCT00273052|583643886|FG000|Overall Study|Worsening serum lipid levels|0|||
161615528|NCT00273052|583643887|FG001|Overall Study|Worsening serum lipid levels|2|||
161615529|NCT00240994|583643888|FG000|Overall Study|Lost to Follow-up|1|||
161615530|NCT00240994|583643888|FG000|Overall Study|Protocol Violation|1|||
161615531|NCT00240994|583643888|FG000|Overall Study|Graft failure|1|||
161615532|NCT02630186|583643890|FG000|Overall Study|Withdrawal by Subject|1|||
161615533|NCT00439218|583643891|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
161615534|NCT03142932|583643894|FG000|Overall Study|Lost to Follow-up|2|||
161615535|NCT03142932|583643895|FG001|Overall Study|Lost to Follow-up|11|||
161615536|NCT00624377|583643898|FG000|Overall Study|Lost to Follow-up|355|||
161615537|NCT00624377|583643898|FG000|Overall Study|Withdrawal by Subject|100|||
161615538|NCT00624377|583643898|FG000|Overall Study|Adverse Event|14|||
161615539|NCT00624377|583643898|FG000|Overall Study|Other|91|||
161615540|NCT00624377|583643898|FG000|Overall Study|Non-evaluable population|84|||
161615541|NCT02037568|583643902|FG000|Overall Study|Withdrawal by Subject|17|||
161615542|NCT02037568|583643903|FG001|Overall Study|Withdrawal by Subject|24|||
161615543|NCT02037568|583643902|FG000|Overall Study|Lost to Follow-up|16|||
161615544|NCT02037568|583643903|FG001|Overall Study|Lost to Follow-up|13|||
161615545|NCT02037568|583643902|FG000|Overall Study|Screen Failure|3|||
161615546|NCT02037568|583643903|FG001|Overall Study|Screen Failure|1|||
161615547|NCT02037568|583643902|FG000|Overall Study|Patient did not receive transplant|0|||
161615548|NCT02037568|583643903|FG001|Overall Study|Patient did not receive transplant|1|||
161615549|NCT00721734|583643904|FG000|Overall Study|Progressive Disease|3|||
161615550|NCT00721734|583643905|FG001|Overall Study|Progressive Disease|10|||
161615551|NCT00721734|583643906|FG002|Overall Study|Progressive Disease|4|||
161615552|NCT00721734|583643907|FG003|Overall Study|Progressive Disease|5|||
161615553|NCT00721734|583643908|FG004|Overall Study|Progressive Disease|2|||
161615554|NCT00721734|583643904|FG000|Overall Study|Adverse Event|3|||
161615555|NCT00721734|583643905|FG001|Overall Study|Adverse Event|1|||
161615556|NCT00721734|583643906|FG002|Overall Study|Adverse Event|4|||
161615557|NCT00721734|583643907|FG003|Overall Study|Adverse Event|0|||
161615558|NCT00721734|583643908|FG004|Overall Study|Adverse Event|3|||
161615559|NCT00721734|583643904|FG000|Overall Study|Withdrawal by Subject|2|||
161615560|NCT00721734|583643905|FG001|Overall Study|Withdrawal by Subject|1|||
161615561|NCT00721734|583643906|FG002|Overall Study|Withdrawal by Subject|0|||
161615562|NCT00721734|583643907|FG003|Overall Study|Withdrawal by Subject|0|||
161615563|NCT00721734|583643908|FG004|Overall Study|Withdrawal by Subject|1|||
161615564|NCT00721734|583643904|FG000|Overall Study|Other|0|||
161615565|NCT00721734|583643905|FG001|Overall Study|Other|0|||
161615566|NCT00721734|583643906|FG002|Overall Study|Other|0|||
161615567|NCT00721734|583643907|FG003|Overall Study|Other|1|||
161615568|NCT00721734|583643908|FG004|Overall Study|Other|0|||
161615569|NCT05169684|583643914|FG000|Overall Study|Adverse Event|1|||
161615570|NCT05169684|583643915|FG001|Overall Study|Adverse Event|3|||
161615571|NCT05169684|583643914|FG000|Overall Study|Physician Decision|0|||
161615572|NCT05169684|583643915|FG001|Overall Study|Physician Decision|1|||
161832682|NCT02139124|584428490|FG000|Overall Study|Lost to Follow-up|3|||
161832683|NCT02139124|584428491|FG001|Overall Study|Lost to Follow-up|2|||
161832684|NCT02139124|584428492|FG002|Overall Study|Lost to Follow-up|0|||
161832685|NCT02139124|584428493|FG003|Overall Study|Lost to Follow-up|5|||
161832686|NCT02139124|584428494|FG004|Overall Study|Lost to Follow-up|4|||
161832687|NCT00613834|584428495|FG000|Overall Study|Withdrawal by Subject|0|||
161832688|NCT00613834|584428496|FG001|Overall Study|Withdrawal by Subject|3|||
161832689|NCT02756637|584428499|FG000|Overall Study|Not eligible for initial SWOG study|10|||
161832690|NCT02756637|584428500|FG001|Overall Study|Not eligible for initial SWOG study|10|||
161832691|NCT02756637|584428499|FG000|Overall Study|No available NLR value|44|||
161832692|NCT02756637|584428500|FG001|Overall Study|No available NLR value|44|||
161832693|NCT02756637|584428499|FG000|Overall Study|Did not complete curative therapy|33|||
161832694|NCT02756637|584428500|FG001|Overall Study|Did not complete curative therapy|0|||
161832695|NCT03310957|584429589|FG000|Overall Study|Withdrawal by Subject|1|||
161832696|NCT03310957|584429590|FG001|Overall Study|Withdrawal by Subject|1|||
161832697|NCT03310957|584429591|FG002|Overall Study|Withdrawal by Subject|1|||
161832698|NCT03310957|584429592|FG003|Overall Study|Withdrawal by Subject|5|||
161832699|NCT03310957|584429593|FG004|Overall Study|Withdrawal by Subject|0|||
161832700|NCT03310957|584429594|FG005|Overall Study|Withdrawal by Subject|4|||
161832701|NCT03310957|584429595|FG006|Overall Study|Withdrawal by Subject|3|||
161832702|NCT03310957|584429589|FG000|Overall Study|Site Terminated|0|||
161832703|NCT03310957|584429590|FG001|Overall Study|Site Terminated|1|||
161832704|NCT03310957|584429591|FG002|Overall Study|Site Terminated|1|||
161832705|NCT03310957|584429592|FG003|Overall Study|Site Terminated|1|||
161832706|NCT03310957|584429593|FG004|Overall Study|Site Terminated|0|||
161832707|NCT03310957|584429594|FG005|Overall Study|Site Terminated|2|||
161832708|NCT03310957|584429595|FG006|Overall Study|Site Terminated|8|||
161615573|NCT05169684|583643914|FG000|Overall Study|Progressive Disease|1|||
161615574|NCT05169684|583643915|FG001|Overall Study|Progressive Disease|1|||
161615575|NCT05169684|583643914|FG000|Overall Study|Participant request to discontinue treatment|0|||
161615576|NCT05169684|583643915|FG001|Overall Study|Participant request to discontinue treatment|1|||
161615577|NCT05169684|583643914|FG000|Overall Study|Other Reason|0|||
161615578|NCT05169684|583643915|FG001|Overall Study|Other Reason|1|||
161615579|NCT05484661|583643921|FG000|Overall Study|Withdrawal by Subject|1|||
161615580|NCT05484661|583643922|FG001|Overall Study|Withdrawal by Subject|0|||
161615581|NCT03205488|583643928|FG000|Overall Study|Adverse Event|1|||
161615582|NCT03205488|583643929|FG001|Overall Study|Adverse Event|2|||
161832709|NCT03310957|584429589|FG000|Overall Study|Lost to Follow-up|1|||
161832710|NCT03310957|584429590|FG001|Overall Study|Lost to Follow-up|1|||
161832711|NCT03310957|584429591|FG002|Overall Study|Lost to Follow-up|1|||
161832712|NCT03310957|584429592|FG003|Overall Study|Lost to Follow-up|4|||
161832713|NCT03310957|584429593|FG004|Overall Study|Lost to Follow-up|0|||
161615583|NCT03205488|583643930|FG002|Overall Study|Adverse Event|4|||
161684455|NCT02819635|583897900|FG008|Substudy 3|Lost to Follow-up|1|||
161832714|NCT03310957|584429594|FG005|Overall Study|Lost to Follow-up|4|||
161832715|NCT03310957|584429595|FG006|Overall Study|Lost to Follow-up|2|||
161832716|NCT03310957|584429589|FG000|Overall Study|Death|5|||
161832717|NCT03310957|584429590|FG001|Overall Study|Death|8|||
161615584|NCT03205488|583643928|FG000|Overall Study|Protocol Violation|0|||
161615585|NCT03205488|583643929|FG001|Overall Study|Protocol Violation|0|||
161832718|NCT03310957|584429591|FG002|Overall Study|Death|18|||
161832719|NCT03310957|584429592|FG003|Overall Study|Death|31|||
161832720|NCT03310957|584429593|FG004|Overall Study|Death|1|||
161832721|NCT03310957|584429594|FG005|Overall Study|Death|29|||
161615586|NCT03205488|583643930|FG002|Overall Study|Protocol Violation|1|||
161615587|NCT03652610|583643931|FG000|Overall Study|Lost to Follow-up|1|||
161615588|NCT03652610|583643932|FG001|Overall Study|Lost to Follow-up|0|||
161615589|NCT03652610|583643931|FG000|Overall Study|Withdrawal by Subject|3|||
161615590|NCT03652610|583643932|FG001|Overall Study|Withdrawal by Subject|5|||
161615591|NCT04748341|583643935|FG000|Overall Study|Lost to Follow-up|1|||
161615592|NCT04748341|583643936|FG001|Overall Study|Lost to Follow-up|1|||
161615593|NCT02334215|583643939|FG000|Overall Study|Death|1|||
161615594|NCT02334215|583643940|FG001|Overall Study|Death|1|||
161615595|NCT02334215|583643941|FG002|Overall Study|Death|0|||
161615596|NCT02334215|583643939|FG000|Overall Study|Lost to Follow-up|1|||
161615597|NCT02334215|583643940|FG001|Overall Study|Lost to Follow-up|0|||
161615598|NCT02334215|583643941|FG002|Overall Study|Lost to Follow-up|4|||
161615599|NCT02334215|583643939|FG000|Overall Study|Withdrawal by Subject|2|||
161615600|NCT02334215|583643940|FG001|Overall Study|Withdrawal by Subject|2|||
161615601|NCT02334215|583643941|FG002|Overall Study|Withdrawal by Subject|1|||
161615602|NCT02334215|583643939|FG000|Overall Study|Not released from incarceration on time|3|||
161615603|NCT02334215|583643940|FG001|Overall Study|Not released from incarceration on time|3|||
161615604|NCT02334215|583643941|FG002|Overall Study|Not released from incarceration on time|3|||
161615605|NCT02334215|583643939|FG000|Overall Study|Incarcerated|0|||
161615606|NCT02334215|583643940|FG001|Overall Study|Incarcerated|0|||
161615607|NCT02334215|583643941|FG002|Overall Study|Incarcerated|7|||
161615608|NCT05615363|583643942|FG000|Overall Study|Adverse Event|0|||
161615609|NCT05615363|583643943|FG001|Overall Study|Adverse Event|4|||
161615610|NCT05615363|583643944|FG002|Overall Study|Adverse Event|4|||
161615611|NCT05615363|583643945|FG003|Overall Study|Adverse Event|3|||
161615612|NCT05615363|583643946|FG004|Overall Study|Adverse Event|1|||
161615613|NCT05615363|583643942|FG000|Overall Study|Physician Decision|2|||
161615614|NCT05615363|583643943|FG001|Overall Study|Physician Decision|0|||
161615615|NCT05615363|583643944|FG002|Overall Study|Physician Decision|4|||
161615616|NCT05615363|583643945|FG003|Overall Study|Physician Decision|1|||
161615617|NCT05615363|583643946|FG004|Overall Study|Physician Decision|3|||
161615618|NCT05615363|583643942|FG000|Overall Study|Protocol Violation|2|||
161615619|NCT05615363|583643943|FG001|Overall Study|Protocol Violation|0|||
161615620|NCT05615363|583643944|FG002|Overall Study|Protocol Violation|0|||
161615621|NCT05615363|583643945|FG003|Overall Study|Protocol Violation|0|||
161615622|NCT05615363|583643946|FG004|Overall Study|Protocol Violation|1|||
161615623|NCT05615363|583643942|FG000|Overall Study|Withdrawal by Subject|0|||
161615624|NCT05615363|583643943|FG001|Overall Study|Withdrawal by Subject|0|||
161615625|NCT05615363|583643944|FG002|Overall Study|Withdrawal by Subject|1|||
161615626|NCT05615363|583643945|FG003|Overall Study|Withdrawal by Subject|0|||
161615627|NCT05615363|583643946|FG004|Overall Study|Withdrawal by Subject|0|||
161615628|NCT05865392|583643949|FG000|Overall Study|Withdrawal by Subject|4|||
161615629|NCT05865392|583643950|FG001|Overall Study|Withdrawal by Subject|0|||
161615630|NCT05865392|583643949|FG000|Overall Study|Didn't meet inclusion criteria|4|||
161615631|NCT05865392|583643950|FG001|Overall Study|Didn't meet inclusion criteria|0|||
161615632|NCT02159989|583643951|FG000|Overall Study|Adverse Event|1|||
161615633|NCT02159989|583643952|FG001|Overall Study|Adverse Event|0|||
161615634|NCT02159989|583643953|FG002|Overall Study|Adverse Event|0|||
161615635|NCT02159989|583643954|FG003|Overall Study|Adverse Event|0|||
161615636|NCT02159989|583643955|FG004|Overall Study|Adverse Event|1|||
161615637|NCT02159989|583643956|FG005|Overall Study|Adverse Event|0|||
161615638|NCT02159989|583643957|FG006|Overall Study|Adverse Event|1|||
161615639|NCT02159989|583643958|FG007|Overall Study|Adverse Event|2|||
161615640|NCT02159989|583643959|FG008|Overall Study|Adverse Event|0|||
161615641|NCT02159989|583643960|FG009|Overall Study|Adverse Event|2|||
161615642|NCT02159989|583643961|FG010|Overall Study|Adverse Event|1|||
161615643|NCT02159989|583643951|FG000|Overall Study|Death|0|||
161615644|NCT02159989|583643952|FG001|Overall Study|Death|0|||
161615645|NCT02159989|583643953|FG002|Overall Study|Death|0|||
161615646|NCT02159989|583643954|FG003|Overall Study|Death|0|||
161615647|NCT02159989|583643955|FG004|Overall Study|Death|0|||
161615648|NCT02159989|583643956|FG005|Overall Study|Death|0|||
161615649|NCT02159989|583643957|FG006|Overall Study|Death|0|||
161615650|NCT02159989|583643958|FG007|Overall Study|Death|0|||
161615651|NCT02159989|583643959|FG008|Overall Study|Death|0|||
161615652|NCT02159989|583643960|FG009|Overall Study|Death|0|||
161615653|NCT02159989|583643961|FG010|Overall Study|Death|1|||
161615654|NCT02159989|583643951|FG000|Overall Study|Lack of Efficacy|2|||
161615655|NCT02159989|583643952|FG001|Overall Study|Lack of Efficacy|3|||
161615656|NCT02159989|583643953|FG002|Overall Study|Lack of Efficacy|3|||
161615657|NCT02159989|583643954|FG003|Overall Study|Lack of Efficacy|0|||
161615658|NCT02159989|583643955|FG004|Overall Study|Lack of Efficacy|2|||
161615659|NCT02159989|583643956|FG005|Overall Study|Lack of Efficacy|3|||
161615660|NCT02159989|583643957|FG006|Overall Study|Lack of Efficacy|3|||
161615661|NCT02159989|583643958|FG007|Overall Study|Lack of Efficacy|1|||
161615662|NCT02159989|583643959|FG008|Overall Study|Lack of Efficacy|3|||
161615663|NCT02159989|583643960|FG009|Overall Study|Lack of Efficacy|6|||
161615664|NCT02159989|583643961|FG010|Overall Study|Lack of Efficacy|7|||
161615665|NCT02159989|583643951|FG000|Overall Study|Lost to Follow-up|0|||
161615666|NCT02159989|583643952|FG001|Overall Study|Lost to Follow-up|0|||
161615667|NCT02159989|583643953|FG002|Overall Study|Lost to Follow-up|0|||
161615668|NCT02159989|583643954|FG003|Overall Study|Lost to Follow-up|1|||
161615669|NCT02159989|583643955|FG004|Overall Study|Lost to Follow-up|0|||
161615670|NCT02159989|583643956|FG005|Overall Study|Lost to Follow-up|0|||
161615671|NCT02159989|583643957|FG006|Overall Study|Lost to Follow-up|0|||
161615672|NCT02159989|583643958|FG007|Overall Study|Lost to Follow-up|0|||
161615673|NCT02159989|583643959|FG008|Overall Study|Lost to Follow-up|0|||
161615674|NCT02159989|583643960|FG009|Overall Study|Lost to Follow-up|0|||
161615675|NCT02159989|583643961|FG010|Overall Study|Lost to Follow-up|1|||
161615676|NCT02159989|583643951|FG000|Overall Study|Withdrawal by Subject|2|||
161615677|NCT02159989|583643952|FG001|Overall Study|Withdrawal by Subject|0|||
161615678|NCT02159989|583643953|FG002|Overall Study|Withdrawal by Subject|0|||
161615679|NCT02159989|583643954|FG003|Overall Study|Withdrawal by Subject|2|||
161615680|NCT02159989|583643955|FG004|Overall Study|Withdrawal by Subject|1|||
161615681|NCT02159989|583643956|FG005|Overall Study|Withdrawal by Subject|0|||
161615682|NCT02159989|583643957|FG006|Overall Study|Withdrawal by Subject|3|||
161615683|NCT02159989|583643958|FG007|Overall Study|Withdrawal by Subject|1|||
161615684|NCT02159989|583643959|FG008|Overall Study|Withdrawal by Subject|0|||
161615685|NCT02159989|583643960|FG009|Overall Study|Withdrawal by Subject|0|||
161615686|NCT02159989|583643961|FG010|Overall Study|Withdrawal by Subject|0|||
161615687|NCT02159989|583643951|FG000|Overall Study|New treatment|0|||
161615688|NCT02159989|583643952|FG001|Overall Study|New treatment|1|||
161615689|NCT02159989|583643953|FG002|Overall Study|New treatment|0|||
161615690|NCT02159989|583643954|FG003|Overall Study|New treatment|0|||
161615691|NCT02159989|583643955|FG004|Overall Study|New treatment|0|||
161615692|NCT02159989|583643956|FG005|Overall Study|New treatment|0|||
161615693|NCT02159989|583643957|FG006|Overall Study|New treatment|0|||
161615694|NCT02159989|583643958|FG007|Overall Study|New treatment|0|||
161615695|NCT02159989|583643959|FG008|Overall Study|New treatment|0|||
161615696|NCT02159989|583643960|FG009|Overall Study|New treatment|0|||
161615697|NCT02159989|583643961|FG010|Overall Study|New treatment|0|||
161615698|NCT02159989|583643951|FG000|Overall Study|Insurance Issues|0|||
161615699|NCT02159989|583643952|FG001|Overall Study|Insurance Issues|0|||
161615700|NCT02159989|583643953|FG002|Overall Study|Insurance Issues|0|||
161615701|NCT02159989|583643954|FG003|Overall Study|Insurance Issues|0|||
161615702|NCT02159989|583643955|FG004|Overall Study|Insurance Issues|0|||
161615703|NCT02159989|583643956|FG005|Overall Study|Insurance Issues|0|||
161615704|NCT02159989|583643957|FG006|Overall Study|Insurance Issues|0|||
161615705|NCT02159989|583643958|FG007|Overall Study|Insurance Issues|0|||
161615706|NCT02159989|583643959|FG008|Overall Study|Insurance Issues|0|||
161615707|NCT02159989|583643960|FG009|Overall Study|Insurance Issues|1|||
161615708|NCT02159989|583643961|FG010|Overall Study|Insurance Issues|0|||
161615709|NCT04447027|583643963|FG000|Dose Escalation|Withdrawal by Subject|1|||
161615710|NCT04447027|583643964|FG001|Dose Escalation|Withdrawal by Subject|4|||
161615711|NCT04447027|583643965|FG002|Dose Escalation|Withdrawal by Subject|3|||
161615712|NCT04447027|583643966|FG003|Dose Escalation|Withdrawal by Subject|3|||
161615713|NCT04447027|583643967|FG004|Dose Escalation|Withdrawal by Subject|1|||
161615714|NCT04447027|583643968|FG005|Dose Escalation|Withdrawal by Subject|0|||
161615715|NCT04447027|583643969|FG006|Dose Escalation|Withdrawal by Subject|0|||
161615716|NCT04447027|583643970|FG007|Dose Escalation|Withdrawal by Subject|0|||
161615717|NCT04447027|583643971|FG008|Dose Escalation|Withdrawal by Subject|0|||
161615718|NCT04447027|583643963|FG000|Dose Escalation|Refused further treatment|0|||
161615719|NCT04447027|583643964|FG001|Dose Escalation|Refused further treatment|1|||
161615720|NCT04447027|583643965|FG002|Dose Escalation|Refused further treatment|1|||
161615721|NCT04447027|583643966|FG003|Dose Escalation|Refused further treatment|0|||
161615722|NCT04447027|583643967|FG004|Dose Escalation|Refused further treatment|0|||
161615723|NCT04447027|583643968|FG005|Dose Escalation|Refused further treatment|0|||
161615724|NCT04447027|583643969|FG006|Dose Escalation|Refused further treatment|0|||
161615725|NCT04447027|583643970|FG007|Dose Escalation|Refused further treatment|0|||
161615726|NCT04447027|583643971|FG008|Dose Escalation|Refused further treatment|0|||
161615727|NCT04447027|583643963|FG000|Dose Expansion|Withdrawal by Subject|0|||
161615728|NCT04447027|583643964|FG001|Dose Expansion|Withdrawal by Subject|0|||
161615729|NCT04447027|583643965|FG002|Dose Expansion|Withdrawal by Subject|0|||
161615730|NCT04447027|583643966|FG003|Dose Expansion|Withdrawal by Subject|0|||
161615731|NCT04447027|583643967|FG004|Dose Expansion|Withdrawal by Subject|0|||
161615732|NCT04447027|583643968|FG005|Dose Expansion|Withdrawal by Subject|2|||
161615733|NCT04447027|583643969|FG006|Dose Expansion|Withdrawal by Subject|0|||
161615734|NCT04447027|583643970|FG007|Dose Expansion|Withdrawal by Subject|2|||
161615735|NCT04447027|583643971|FG008|Dose Expansion|Withdrawal by Subject|0|||
161615736|NCT02485925|583643974|FG000|Overall Study|Withdrawal by Subject|3|||
161615737|NCT02485925|583643974|FG000|Overall Study|Death|1|||
161615738|NCT02485925|583643974|FG000|Overall Study|Lost to Follow-up|11|||
161615739|NCT04937504|583643975|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
161615740|NCT04937504|583643976|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
161615741|NCT04937504|583643975|FG000|9 Months Assessment|Lost to Follow-up|3|||
161615742|NCT04937504|583643976|FG001|9 Months Assessment|Lost to Follow-up|2|||
161615743|NCT03662659|583643977|FG000|Pre-treatment|Participant no longer met study criteria|1|||
161615744|NCT03662659|583643978|FG001|Pre-treatment|Participant no longer met study criteria|1|||
161615745|NCT03662659|583643977|FG000|Pre-treatment|Other reasons|1|||
161615746|NCT03662659|583643978|FG001|Pre-treatment|Other reasons|0|||
161615747|NCT03662659|583643977|FG000|Treatment|Completed Treatment|0|||
161615748|NCT03662659|583643978|FG001|Treatment|Completed Treatment|2|||
161615749|NCT03662659|583643977|FG000|Treatment|Disease Progression|85|||
161615750|NCT03662659|583643978|FG001|Treatment|Disease Progression|97|||
161615751|NCT03662659|583643977|FG000|Treatment|Study Drug Toxicity|19|||
161615752|NCT03662659|583643978|FG001|Treatment|Study Drug Toxicity|9|||
161615753|NCT03662659|583643977|FG000|Treatment|Death|11|||
161615754|NCT03662659|583643978|FG001|Treatment|Death|9|||
161615755|NCT03662659|583643977|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
161615756|NCT03662659|583643978|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
161615757|NCT03662659|583643977|FG000|Treatment|Withdrawal by Subject|1|||
161615758|NCT03662659|583643978|FG001|Treatment|Withdrawal by Subject|1|||
161615759|NCT03662659|583643977|FG000|Treatment|Poor/Non-compliance|1|||
161615760|NCT03662659|583643978|FG001|Treatment|Poor/Non-compliance|0|||
161615761|NCT03662659|583643977|FG000|Treatment|Participant no longer meets study criteria|1|||
161615762|NCT03662659|583643978|FG001|Treatment|Participant no longer meets study criteria|0|||
161615763|NCT03662659|583643977|FG000|Treatment|Other reasons|10|||
161615764|NCT03662659|583643978|FG001|Treatment|Other reasons|8|||
161615765|NCT03662659|583643977|FG000|Treatment|Administrative reasons by sponsor|1|||
161615766|NCT03662659|583643978|FG001|Treatment|Administrative reasons by sponsor|0|||
161615767|NCT03662659|583643977|FG000|Treatment|maximum clinical benefit|0|||
161615768|NCT03662659|583643978|FG001|Treatment|maximum clinical benefit|2|||
161615769|NCT04809623|583645292|FG000|Overall Study|Study Terminated by Sponsor|1|||
161615770|NCT04809623|583645293|FG001|Overall Study|Study Terminated by Sponsor|0|||
161615771|NCT00671853|583645294|FG000|Overall Study|Lack of Efficacy|3|||
161615772|NCT00671853|583645295|FG001|Overall Study|Lack of Efficacy|7|||
161615773|NCT00671853|583645294|FG000|Overall Study|Adverse Event|7|||
161615774|NCT00671853|583645295|FG001|Overall Study|Adverse Event|1|||
161615775|NCT00671853|583645294|FG000|Overall Study|Withdrawal by Subject|1|||
161615776|NCT00671853|583645295|FG001|Overall Study|Withdrawal by Subject|5|||
161615777|NCT00671853|583645294|FG000|Overall Study|Lost to Follow-up|8|||
161615778|NCT00671853|583645295|FG001|Overall Study|Lost to Follow-up|8|||
161615779|NCT00671853|583645294|FG000|Overall Study|Physician Decision|0|||
161615780|NCT00671853|583645295|FG001|Overall Study|Physician Decision|2|||
161615781|NCT00671853|583645294|FG000|Overall Study|Non-adherence with study procedures|1|||
161615782|NCT00671853|583645295|FG001|Overall Study|Non-adherence with study procedures|4|||
161615783|NCT02354417|583645296|FG000|Overall Study|Physician Decision|1|||
161615784|NCT01848483|583645297|FG000|Overall Study|Death|2|||
161615785|NCT01848483|583645298|FG001|Overall Study|Death|1|||
161615786|NCT01848483|583645297|FG000|Overall Study|Lost to Follow-up|6|||
161615787|NCT01848483|583645298|FG001|Overall Study|Lost to Follow-up|8|||
161615788|NCT01848483|583645297|FG000|Overall Study|Withdrawal by Subject|1|||
161615789|NCT01848483|583645298|FG001|Overall Study|Withdrawal by Subject|0|||
161615790|NCT01848483|583645297|FG000|Overall Study|Incarceration|2|||
161615791|NCT01848483|583645298|FG001|Overall Study|Incarceration|2|||
161615792|NCT02236611|583645301|FG000|Overall Study|Adverse Event|10|||
161615793|NCT02236611|583645302|FG001|Overall Study|Adverse Event|16|||
161615794|NCT02236611|583645301|FG000|Overall Study|Lack of Efficacy|4|||
161615795|NCT02236611|583645302|FG001|Overall Study|Lack of Efficacy|7|||
161615796|NCT02236611|583645301|FG000|Overall Study|Lost to Follow-up|0|||
161615797|NCT02236611|583645302|FG001|Overall Study|Lost to Follow-up|2|||
161615798|NCT02236611|583645301|FG000|Overall Study|Protocol deviation|3|||
161615799|NCT02236611|583645302|FG001|Overall Study|Protocol deviation|5|||
161615800|NCT02236611|583645301|FG000|Overall Study|Withdrew consent|9|||
161615801|NCT02236611|583645302|FG001|Overall Study|Withdrew consent|4|||
161615802|NCT03041090|583645303|FG000|Overall Study|technical error|0|||
161615803|NCT03041090|583645304|FG001|Overall Study|technical error|3|||
161615804|NCT02202317|583645305|FG000|Overall Study|Lost to Follow-up|1|||
161615805|NCT02338999|583645306|FG000|First Intervention|Withdrawal by Subject|3|||
161615806|NCT02338999|583645307|FG001|First Intervention|Withdrawal by Subject|1|||
161615807|NCT02338999|583645306|FG000|Washout Period|Withdrawal by Subject|0|||
161615808|NCT02338999|583645307|FG001|Washout Period|Withdrawal by Subject|2|||
161615809|NCT02338999|583645306|FG000|Second Intervention|Withdrawal by Subject|0|||
161615810|NCT02338999|583645307|FG001|Second Intervention|Withdrawal by Subject|2|||
161615811|NCT02701296|583645308|FG000|Overall Study|Incomplete Data|0|||
161615812|NCT02701296|583645309|FG001|Overall Study|Incomplete Data|2|||
161615813|NCT01450007|583645311|FG000|Overall Study|Late exclusion before treatment|2|||
161615814|NCT01450007|583645312|FG001|Overall Study|Late exclusion before treatment|3|||
161615815|NCT01450007|583645313|FG002|Overall Study|Late exclusion before treatment|2|||
161615816|NCT01450007|583645311|FG000|Overall Study|Protocol Violation|0|||
161615817|NCT01450007|583645312|FG001|Overall Study|Protocol Violation|1|||
161615818|NCT01450007|583645313|FG002|Overall Study|Protocol Violation|1|||
161615819|NCT01450007|583645311|FG000|Overall Study|Adverse Event|0|||
161615820|NCT01450007|583645312|FG001|Overall Study|Adverse Event|1|||
161615821|NCT01450007|583645313|FG002|Overall Study|Adverse Event|0|||
161615822|NCT03851094|583645314|FG000|Overall Study|Withdrawal by Subject|0|||
161615823|NCT03851094|583645315|FG001|Overall Study|Withdrawal by Subject|1|||
161615824|NCT03851094|583645314|FG000|Overall Study|Participant lost device|0|||
161615825|NCT03851094|583645315|FG001|Overall Study|Participant lost device|1|||
161615826|NCT03851094|583645314|FG000|Overall Study|Participant returned device|0|||
161615827|NCT03851094|583645315|FG001|Overall Study|Participant returned device|2|||
161615828|NCT00484198|583645316|FG000|Overall Study|Participant Withdrew Consent|12|||
161615829|NCT00484198|583645317|FG001|Overall Study|Participant Withdrew Consent|21|||
161615830|NCT00484198|583645318|FG002|Overall Study|Participant Withdrew Consent|47|||
161615831|NCT00484198|583645319|FG003|Overall Study|Participant Withdrew Consent|59|||
161615832|NCT00484198|583645316|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
161615833|NCT00484198|583645317|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
161615834|NCT00484198|583645318|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
161615835|NCT00484198|583645319|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
161615836|NCT00484198|583645316|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
161615837|NCT00484198|583645317|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
161615838|NCT00484198|583645318|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
161615839|NCT00484198|583645319|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
161615840|NCT00484198|583645316|FG000|Overall Study|Adverse Event|3|||
161615841|NCT00484198|583645317|FG001|Overall Study|Adverse Event|11|||
161615842|NCT00484198|583645318|FG002|Overall Study|Adverse Event|32|||
161615843|NCT00484198|583645319|FG003|Overall Study|Adverse Event|31|||
161615844|NCT00484198|583645316|FG000|Overall Study|Protocol Violation|0|||
161615845|NCT00484198|583645317|FG001|Overall Study|Protocol Violation|5|||
161615846|NCT00484198|583645318|FG002|Overall Study|Protocol Violation|6|||
161615847|NCT00484198|583645319|FG003|Overall Study|Protocol Violation|8|||
161615848|NCT00484198|583645316|FG000|Overall Study|Other|7|||
161615849|NCT00484198|583645317|FG001|Overall Study|Other|10|||
161615850|NCT00484198|583645318|FG002|Overall Study|Other|31|||
161615851|NCT00484198|583645319|FG003|Overall Study|Other|28|||
161615852|NCT01536704|583645320|FG000|Washout Period 1|Withdrawal by Subject|1|||
161615853|NCT01536704|583645321|FG001|Washout Period 1|Withdrawal by Subject|2|||
161615854|NCT01536704|583645322|FG002|Washout Period 1|Withdrawal by Subject|0|||
161615855|NCT01536704|583645323|FG003|Washout Period 1|Withdrawal by Subject|0|||
161615856|NCT01536704|583645320|FG000|Washout Period 2|Adverse Event|1|||
161615857|NCT01536704|583645321|FG001|Washout Period 2|Adverse Event|0|||
161615858|NCT01536704|583645322|FG002|Washout Period 2|Adverse Event|0|||
161615859|NCT01536704|583645323|FG003|Washout Period 2|Adverse Event|0|||
161615860|NCT01536704|583645320|FG000|Washout Period 2|Withdrawal by Subject|0|||
161615861|NCT01536704|583645321|FG001|Washout Period 2|Withdrawal by Subject|0|||
161615862|NCT01536704|583645322|FG002|Washout Period 2|Withdrawal by Subject|0|||
161615863|NCT01536704|583645323|FG003|Washout Period 2|Withdrawal by Subject|1|||
161615864|NCT01536704|583645320|FG000|Period 3|Adverse Event|0|||
161615865|NCT01536704|583645321|FG001|Period 3|Adverse Event|0|||
161615866|NCT01536704|583645322|FG002|Period 3|Adverse Event|0|||
161615867|NCT01536704|583645323|FG003|Period 3|Adverse Event|1|||
161615868|NCT01536704|583645320|FG000|Washout Period 3|Adverse Event|0|||
161615869|NCT01536704|583645321|FG001|Washout Period 3|Adverse Event|0|||
161615870|NCT01536704|583645322|FG002|Washout Period 3|Adverse Event|1|||
161615871|NCT01536704|583645323|FG003|Washout Period 3|Adverse Event|0|||
161615872|NCT04658784|583645324|FG000|6-month Follow-up|Lost to Follow-up|2|||
161615873|NCT04658784|583645325|FG001|6-month Follow-up|Lost to Follow-up|5|||
161615874|NCT02958553|583645326|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
161615875|NCT02958553|583645326|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
161615876|NCT00704340|583645334|FG000|Overall Study|Lost to Follow-up|2|||
161615877|NCT00704340|583645335|FG001|Overall Study|Lost to Follow-up|1|||
161615878|NCT00704340|583645334|FG000|Overall Study|Death|0|||
161615879|NCT00704340|583645335|FG001|Overall Study|Death|1|||
161615880|NCT00703092|583645339|FG000|Overall Study|Withdrawal by Subject|2|||
161615881|NCT02007070|583645340|FG000|Overall Study|Adverse Event|4|||
161615882|NCT02007070|583645340|FG000|Overall Study|Clinical Progression|4|||
161615883|NCT02007070|583645340|FG000|Overall Study|Death|1|||
161615884|NCT02007070|583645340|FG000|Overall Study|Protocol Violation|2|||
161615885|NCT02007070|583645340|FG000|Overall Study|Physician Decision|1|||
161615886|NCT02007070|583645340|FG000|Overall Study|Progressive Disease|21|||
161615887|NCT00403845|583645344|FG000|Treatment Period 1|Subject withdrew consent|1|||
161615888|NCT00403845|583645345|FG001|Treatment Period 1|Subject withdrew consent|0|||
161615889|NCT00403845|583645346|FG002|Treatment Period 1|Subject withdrew consent|0|||
161615890|NCT00403845|583645347|FG003|Treatment Period 1|Subject withdrew consent|0|||
161615891|NCT00403845|583645344|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
161615892|NCT00403845|583645345|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
161615893|NCT00403845|583645346|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
161615894|NCT00403845|583645347|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
161615895|NCT00403845|583645344|FG000|Treatment Period 2|Subject withdrew consent|1|||
161615896|NCT00403845|583645345|FG001|Treatment Period 2|Subject withdrew consent|0|||
161615897|NCT00403845|583645346|FG002|Treatment Period 2|Subject withdrew consent|0|||
161615898|NCT00403845|583645347|FG003|Treatment Period 2|Subject withdrew consent|0|||
161615899|NCT00403845|583645344|FG000|Treatment Period 3|Subject withdrew consent|0|||
161615900|NCT00403845|583645345|FG001|Treatment Period 3|Subject withdrew consent|0|||
161615901|NCT00403845|583645346|FG002|Treatment Period 3|Subject withdrew consent|0|||
161615902|NCT00403845|583645347|FG003|Treatment Period 3|Subject withdrew consent|1|||
161615903|NCT00403845|583645344|FG000|Treatment Period 3|Adverse Event|0|||
161615904|NCT00403845|583645345|FG001|Treatment Period 3|Adverse Event|0|||
161615905|NCT00403845|583645346|FG002|Treatment Period 3|Adverse Event|0|||
161615906|NCT00403845|583645347|FG003|Treatment Period 3|Adverse Event|1|||
161615907|NCT03316170|583645348|FG000|Overall Study|Death|1|||
161615908|NCT03316170|583645349|FG001|Overall Study|Death|0|||
161615909|NCT03316170|583645348|FG000|Overall Study|Lost to Follow-up|6|||
161615910|NCT03316170|583645349|FG001|Overall Study|Lost to Follow-up|7|||
161615911|NCT01836523|583645350|FG000|Overall Study|Adverse Event|15|||
161615912|NCT01836523|583645351|FG001|Overall Study|Adverse Event|41|||
161615913|NCT01836523|583645352|FG002|Overall Study|Adverse Event|49|||
161615914|NCT01836523|583645353|FG003|Overall Study|Adverse Event|14|||
161615915|NCT01836523|583645350|FG000|Overall Study|Protocol Violation|6|||
161615916|NCT01836523|583645351|FG001|Overall Study|Protocol Violation|3|||
161615917|NCT01836523|583645352|FG002|Overall Study|Protocol Violation|2|||
161615918|NCT01836523|583645353|FG003|Overall Study|Protocol Violation|4|||
161615919|NCT01836523|583645350|FG000|Overall Study|Met Withdrawal Criteria|13|||
161615920|NCT01836523|583645351|FG001|Overall Study|Met Withdrawal Criteria|13|||
161615921|NCT01836523|583645352|FG002|Overall Study|Met Withdrawal Criteria|21|||
161615922|NCT01836523|583645353|FG003|Overall Study|Met Withdrawal Criteria|27|||
161615923|NCT01836523|583645350|FG000|Overall Study|Unclassified|17|||
161615924|NCT01836523|583645351|FG001|Overall Study|Unclassified|28|||
161615925|NCT01836523|583645352|FG002|Overall Study|Unclassified|19|||
161615926|NCT01836523|583645353|FG003|Overall Study|Unclassified|29|||
161615927|NCT02935673|583645354|FG000|Overall Study|Adverse Event|0|||
161615928|NCT02935673|583645355|FG001|Overall Study|Adverse Event|1|||
161615929|NCT02935673|583645356|FG002|Overall Study|Adverse Event|0|||
161615930|NCT02935673|583645354|FG000|Overall Study|Withdrawal by Subject|1|||
161615931|NCT02935673|583645355|FG001|Overall Study|Withdrawal by Subject|2|||
161615932|NCT02935673|583645356|FG002|Overall Study|Withdrawal by Subject|0|||
161615933|NCT00749944|583645357|FG000|Overall Study|Lost to Follow-up|2|||
161615934|NCT00749944|583645358|FG001|Overall Study|Lost to Follow-up|1|||
161615935|NCT00749944|583645357|FG000|Overall Study|Other|1|||
161615936|NCT00749944|583645358|FG001|Overall Study|Other|0|||
161615937|NCT00749944|583645357|FG000|Overall Study|Withdrawal by Subject|2|||
161615938|NCT00749944|583645358|FG001|Overall Study|Withdrawal by Subject|0|||
161615939|NCT00681109|583645359|FG000|Overall Study|Lost to Follow-up|2|||
161615940|NCT00681109|583645360|FG001|Overall Study|Lost to Follow-up|6|||
161615941|NCT00681109|583645361|FG002|Overall Study|Lost to Follow-up|0|||
161615942|NCT03128099|583645362|FG000|Overall Study|High dose task was too long|0|||
161615943|NCT03128099|583645363|FG001|Overall Study|High dose task was too long|4|||
161615944|NCT03128099|583645364|FG002|Overall Study|High dose task was too long|0|||
161615945|NCT03128099|583645362|FG000|Overall Study|Participant got a full time job.|1|||
161615946|NCT03128099|583645363|FG001|Overall Study|Participant got a full time job.|0|||
161615947|NCT03128099|583645364|FG002|Overall Study|Participant got a full time job.|0|||
161615948|NCT03128099|583645362|FG000|Overall Study|Became homeless and lost contact|1|||
161615949|NCT03128099|583645363|FG001|Overall Study|Became homeless and lost contact|0|||
161615950|NCT03128099|583645364|FG002|Overall Study|Became homeless and lost contact|0|||
161615951|NCT03128099|583645362|FG000|Overall Study|Did not complete all the assessments|0|||
161615952|NCT03128099|583645363|FG001|Overall Study|Did not complete all the assessments|0|||
161615953|NCT03128099|583645364|FG002|Overall Study|Did not complete all the assessments|1|||
161615954|NCT00148122|583645365|FG000|Overall Study|Withdrawal by Subject|2|||
161615955|NCT02362789|583645375|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
161615956|NCT02362789|583645376|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
161615957|NCT02362789|583645377|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
161615958|NCT02362789|583645375|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
161615959|NCT02362789|583645376|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
161615960|NCT02362789|583645377|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
161615961|NCT02362789|583645375|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
161615962|NCT02362789|583645376|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
161615963|NCT02362789|583645377|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
161615964|NCT02362789|583645375|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
161615965|NCT02362789|583645376|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
161615966|NCT02362789|583645377|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
161615967|NCT02362789|583645375|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
161615968|NCT02362789|583645376|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
161615969|NCT02362789|583645377|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
161615970|NCT03035942|583645382|FG000|Overall Study|Adverse Event|8|||
161615971|NCT03035942|583645383|FG001|Overall Study|Adverse Event|4|||
161615972|NCT03035942|583645384|FG002|Overall Study|Adverse Event|5|||
161615973|NCT05270460|583645385|FG000|Overall Study|Adverse Event|0|||
161615974|NCT05270460|583645386|FG001|Overall Study|Adverse Event|1|||
161615975|NCT05270460|583645387|FG002|Overall Study|Adverse Event|0|||
161615976|NCT05270460|583645385|FG000|Overall Study|Early Termination|0|||
161615977|NCT05270460|583645386|FG001|Overall Study|Early Termination|1|||
161615978|NCT05270460|583645387|FG002|Overall Study|Early Termination|0|||
161615979|NCT00380250|583645388|FG000|Overall Study|Withdrawal by Subject|39|||
161615980|NCT00380250|583645389|FG001|Overall Study|Withdrawal by Subject|28|||
161615981|NCT00380250|583645388|FG000|Overall Study|Adverse Event|20|||
161615982|NCT00380250|583645389|FG001|Overall Study|Adverse Event|9|||
161615983|NCT00380250|583645388|FG000|Overall Study|Lack of Efficacy|10|||
161615984|NCT00380250|583645389|FG001|Overall Study|Lack of Efficacy|8|||
161615985|NCT00380250|583645388|FG000|Overall Study|Protocol Violation|15|||
161615986|NCT00380250|583645389|FG001|Overall Study|Protocol Violation|5|||
161615987|NCT00380250|583645388|FG000|Overall Study|Lost to Follow-up|14|||
161615988|NCT00380250|583645389|FG001|Overall Study|Lost to Follow-up|5|||
161615989|NCT00380250|583645388|FG000|Overall Study|Physician Decision|1|||
161615990|NCT00380250|583645389|FG001|Overall Study|Physician Decision|0|||
161615991|NCT01989104|583645390|FG000|Overall Study|Withdrawal by Subject|3|||
161615992|NCT01989104|583645391|FG001|Overall Study|Withdrawal by Subject|0|||
161615993|NCT01989104|583645392|FG002|Overall Study|Withdrawal by Subject|0|||
161615994|NCT01989104|583645393|FG003|Overall Study|Withdrawal by Subject|0|||
161615995|NCT01989104|583645394|FG004|Overall Study|Withdrawal by Subject|0|||
161615996|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
161615997|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
161615998|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
161615999|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
161616000|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
161616001|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
161616002|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
161616003|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
161616004|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
161616005|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
161616006|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
161616007|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
161616008|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
161616009|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
161616010|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
161616011|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
161616012|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
161616013|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
161616014|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
161616015|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
161616016|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
161616017|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
161616018|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
161684456|NCT02819635|583897901|FG009|Substudy 3|Lost to Follow-up|0|||
161616019|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
161684457|NCT02819635|583897902|FG010|Substudy 3|Lost to Follow-up|1|||
161684458|NCT02819635|583897903|FG011|Substudy 3|Lost to Follow-up|1|||
161616020|NCT02203032|583645396|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
161616021|NCT02203032|583645397|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
161684459|NCT02819635|583897892|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
161616022|NCT02203032|583645398|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
161616023|NCT02203032|583645399|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
161616024|NCT02203032|583645396|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
161616025|NCT02203032|583645397|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
161616026|NCT02203032|583645398|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
161616027|NCT02203032|583645399|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
161616028|NCT02203032|583645396|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
161616029|NCT02203032|583645397|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
161616030|NCT02203032|583645398|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
161616031|NCT02203032|583645399|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
161616032|NCT02203032|583645396|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
161616033|NCT02203032|583645397|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
161616034|NCT02203032|583645398|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
161616035|NCT02203032|583645399|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
161616036|NCT02203032|583645396|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
161616037|NCT02203032|583645397|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
161616038|NCT02203032|583645398|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
161616039|NCT02203032|583645399|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
161616040|NCT02203032|583645396|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
161616041|NCT02203032|583645397|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
161616042|NCT02203032|583645398|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
161616043|NCT02203032|583645399|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
161616044|NCT02241785|583645400|FG000|Overall Study|Sponsor Termination|43|||
161616045|NCT02241785|583645400|FG000|Overall Study|Withdrawal by Subject|1|||
161616046|NCT02241785|583645400|FG000|Overall Study|Lost to Follow-up|2|||
161616047|NCT02241785|583645400|FG000|Overall Study|Adverse Event|1|||
161616048|NCT03905642|583645405|FG000|Overall Study|Withdrawal by Subject|3|||
161616049|NCT03905642|583645405|FG000|Overall Study|Pregnancy|1|||
161616050|NCT03905642|583645405|FG000|Overall Study|Adverse Event|1|||
161616051|NCT03905642|583645405|FG000|Overall Study|Lack of Efficacy|1|||
161616052|NCT03905642|583645405|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
161616053|NCT05995977|583645410|FG000|Overall Study|Withdrawal by Subject|1|||
161616054|NCT05995977|583645411|FG001|Overall Study|Withdrawal by Subject|4|||
161616055|NCT05995977|583645410|FG000|Overall Study|Lost to Follow-up|2|||
161616056|NCT05995977|583645411|FG001|Overall Study|Lost to Follow-up|0|||
161616057|NCT04181788|583645412|FG000|TREATMENT|Adverse Event|0|||
161616058|NCT04181788|583645413|FG001|TREATMENT|Adverse Event|2|||
161616059|NCT04181788|583645414|FG002|TREATMENT|Adverse Event|1|||
161616060|NCT04181788|583645415|FG003|TREATMENT|Adverse Event|0|||
161616061|NCT04181788|583645416|FG004|TREATMENT|Adverse Event|1|||
161616062|NCT04181788|583645417|FG005|TREATMENT|Adverse Event|3|||
161616063|NCT04181788|583645412|FG000|TREATMENT|Death|0|||
161616064|NCT04181788|583645413|FG001|TREATMENT|Death|0|||
161616065|NCT04181788|583645414|FG002|TREATMENT|Death|0|||
161616066|NCT04181788|583645415|FG003|TREATMENT|Death|0|||
161616067|NCT04181788|583645416|FG004|TREATMENT|Death|8|||
161616068|NCT04181788|583645417|FG005|TREATMENT|Death|8|||
161616069|NCT04181788|583645412|FG000|TREATMENT|Physician Decision|0|||
161616070|NCT04181788|583645413|FG001|TREATMENT|Physician Decision|0|||
161616071|NCT04181788|583645414|FG002|TREATMENT|Physician Decision|0|||
161616072|NCT04181788|583645415|FG003|TREATMENT|Physician Decision|0|||
161616073|NCT04181788|583645416|FG004|TREATMENT|Physician Decision|0|||
161616074|NCT04181788|583645417|FG005|TREATMENT|Physician Decision|1|||
161616075|NCT04181788|583645412|FG000|TREATMENT|Progressive disease|3|||
161616076|NCT04181788|583645413|FG001|TREATMENT|Progressive disease|3|||
161616077|NCT04181788|583645414|FG002|TREATMENT|Progressive disease|5|||
161616078|NCT04181788|583645415|FG003|TREATMENT|Progressive disease|7|||
161616079|NCT04181788|583645416|FG004|TREATMENT|Progressive disease|20|||
161616080|NCT04181788|583645417|FG005|TREATMENT|Progressive disease|38|||
161616081|NCT04181788|583645412|FG000|TREATMENT|Global deterioration of health status|0|||
161616082|NCT04181788|583645413|FG001|TREATMENT|Global deterioration of health status|2|||
161616083|NCT04181788|583645414|FG002|TREATMENT|Global deterioration of health status|0|||
161363809|NCT00392288|582720030|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
161616084|NCT04181788|583645415|FG003|TREATMENT|Global deterioration of health status|0|||
161616085|NCT04181788|583645416|FG004|TREATMENT|Global deterioration of health status|2|||
161616086|NCT04181788|583645417|FG005|TREATMENT|Global deterioration of health status|8|||
161616087|NCT04181788|583645412|FG000|TREATMENT|Withdrawal by Subject|1|||
161616088|NCT04181788|583645413|FG001|TREATMENT|Withdrawal by Subject|2|||
161616089|NCT04181788|583645414|FG002|TREATMENT|Withdrawal by Subject|0|||
161616090|NCT04181788|583645415|FG003|TREATMENT|Withdrawal by Subject|0|||
161616091|NCT04181788|583645416|FG004|TREATMENT|Withdrawal by Subject|3|||
161616092|NCT04181788|583645417|FG005|TREATMENT|Withdrawal by Subject|5|||
161616093|NCT04181788|583645412|FG000|TREATMENT|Other unspecified|0|||
161616094|NCT04181788|583645413|FG001|TREATMENT|Other unspecified|0|||
161616095|NCT04181788|583645414|FG002|TREATMENT|Other unspecified|0|||
161616096|NCT04181788|583645415|FG003|TREATMENT|Other unspecified|0|||
161616097|NCT04181788|583645416|FG004|TREATMENT|Other unspecified|0|||
161616098|NCT04181788|583645417|FG005|TREATMENT|Other unspecified|2|||
161616099|NCT04181788|583645412|FG000|TREATMENT|Ongoing|0|||
161616100|NCT04181788|583645413|FG001|TREATMENT|Ongoing|3|||
161616101|NCT04181788|583645414|FG002|TREATMENT|Ongoing|0|||
161616102|NCT04181788|583645415|FG003|TREATMENT|Ongoing|5|||
161616103|NCT04181788|583645416|FG004|TREATMENT|Ongoing|7|||
161616104|NCT04181788|583645417|FG005|TREATMENT|Ongoing|15|||
161616105|NCT04181788|583645412|FG000|FOLLOW-UP|Death|0|||
161616106|NCT04181788|583645413|FG001|FOLLOW-UP|Death|0|||
161616107|NCT04181788|583645414|FG002|FOLLOW-UP|Death|1|||
161616108|NCT04181788|583645415|FG003|FOLLOW-UP|Death|2|||
161616109|NCT04181788|583645416|FG004|FOLLOW-UP|Death|8|||
161616110|NCT04181788|583645417|FG005|FOLLOW-UP|Death|20|||
161616111|NCT04181788|583645412|FG000|FOLLOW-UP|Lost to Follow-up|0|||
161616112|NCT04181788|583645413|FG001|FOLLOW-UP|Lost to Follow-up|0|||
161616113|NCT04181788|583645414|FG002|FOLLOW-UP|Lost to Follow-up|0|||
161616114|NCT04181788|583645415|FG003|FOLLOW-UP|Lost to Follow-up|0|||
161616115|NCT04181788|583645416|FG004|FOLLOW-UP|Lost to Follow-up|0|||
161616116|NCT04181788|583645417|FG005|FOLLOW-UP|Lost to Follow-up|2|||
161616117|NCT04181788|583645412|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
161616118|NCT04181788|583645413|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
161616119|NCT04181788|583645414|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
161616120|NCT04181788|583645415|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
161616121|NCT04181788|583645416|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
161616122|NCT04181788|583645417|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
161616123|NCT04181788|583645412|FG000|FOLLOW-UP|Other unspecified|0|||
161616124|NCT04181788|583645413|FG001|FOLLOW-UP|Other unspecified|1|||
161616125|NCT04181788|583645414|FG002|FOLLOW-UP|Other unspecified|0|||
161616126|NCT04181788|583645415|FG003|FOLLOW-UP|Other unspecified|0|||
161616127|NCT04181788|583645416|FG004|FOLLOW-UP|Other unspecified|0|||
161616128|NCT04181788|583645417|FG005|FOLLOW-UP|Other unspecified|3|||
161616129|NCT04181788|583645412|FG000|FOLLOW-UP|Ongoing|0|||
161616130|NCT04181788|583645413|FG001|FOLLOW-UP|Ongoing|0|||
161616131|NCT04181788|583645414|FG002|FOLLOW-UP|Ongoing|1|||
161616132|NCT04181788|583645415|FG003|FOLLOW-UP|Ongoing|3|||
161616133|NCT04181788|583645416|FG004|FOLLOW-UP|Ongoing|2|||
161616134|NCT04181788|583645417|FG005|FOLLOW-UP|Ongoing|2|||
161616135|NCT04535414|583645418|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
161616136|NCT04535414|583645419|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
161616137|NCT04535414|583645418|FG000|Overall Study|Cancelled appointment|1|||
161616138|NCT04535414|583645419|FG001|Overall Study|Cancelled appointment|0|||
161616139|NCT04535414|583645418|FG000|Overall Study|cancelled - food in stomach|2|||
161616140|NCT04535414|583645419|FG001|Overall Study|cancelled - food in stomach|0|||
161616141|NCT04535414|583645418|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
161616142|NCT04535414|583645419|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
161616143|NCT04535414|583645418|FG000|Overall Study|Withdrawal by Subject|0|||
161616144|NCT04535414|583645419|FG001|Overall Study|Withdrawal by Subject|1|||
161616145|NCT01332266|583647909|FG000|Phase 1b|Death|3|||
161616146|NCT01332266|583647910|FG001|Phase 1b|Death|3|||
161616147|NCT01332266|583647911|FG002|Phase 1b|Death|2|||
161616148|NCT01332266|583647912|FG003|Phase 1b|Death|0|||
161616149|NCT01332266|583647913|FG004|Phase 1b|Death|0|||
161616150|NCT01332266|583647909|FG000|Phase 1b|Lost to Follow-up|0|||
161616151|NCT01332266|583647910|FG001|Phase 1b|Lost to Follow-up|1|||
161616152|NCT01332266|583647911|FG002|Phase 1b|Lost to Follow-up|0|||
161616153|NCT01332266|583647912|FG003|Phase 1b|Lost to Follow-up|0|||
161616154|NCT01332266|583647913|FG004|Phase 1b|Lost to Follow-up|0|||
161616155|NCT01332266|583647909|FG000|Phase 1b|Withdrawal by Subject|1|||
161616156|NCT01332266|583647910|FG001|Phase 1b|Withdrawal by Subject|1|||
161616157|NCT01332266|583647911|FG002|Phase 1b|Withdrawal by Subject|1|||
161616158|NCT01332266|583647912|FG003|Phase 1b|Withdrawal by Subject|0|||
161832722|NCT03310957|584429595|FG006|Overall Study|Death|7|||
161616159|NCT01332266|583647913|FG004|Phase 1b|Withdrawal by Subject|0|||
161616160|NCT01332266|583647909|FG000|Phase 2|Death|0|||
161616161|NCT01332266|583647910|FG001|Phase 2|Death|0|||
161832723|NCT03310957|584429589|FG000|Overall Study|Discontinuation per sponsor|0|||
161832724|NCT03310957|584429590|FG001|Overall Study|Discontinuation per sponsor|1|||
161616162|NCT01332266|583647911|FG002|Phase 2|Death|0|||
161616163|NCT01332266|583647912|FG003|Phase 2|Death|33|||
161616164|NCT01332266|583647913|FG004|Phase 2|Death|36|||
161616165|NCT01332266|583647909|FG000|Phase 2|Lost to Follow-up|0|||
161832725|NCT03310957|584429591|FG002|Overall Study|Discontinuation per sponsor|2|||
161616166|NCT01332266|583647910|FG001|Phase 2|Lost to Follow-up|0|||
161616167|NCT01332266|583647911|FG002|Phase 2|Lost to Follow-up|0|||
161616168|NCT01332266|583647912|FG003|Phase 2|Lost to Follow-up|2|||
161616169|NCT01332266|583647913|FG004|Phase 2|Lost to Follow-up|0|||
161616170|NCT01332266|583647909|FG000|Phase 2|Physician Decision|0|||
161616171|NCT01332266|583647910|FG001|Phase 2|Physician Decision|0|||
161616172|NCT01332266|583647911|FG002|Phase 2|Physician Decision|0|||
161616173|NCT01332266|583647912|FG003|Phase 2|Physician Decision|3|||
161616174|NCT01332266|583647913|FG004|Phase 2|Physician Decision|1|||
161616175|NCT01332266|583647909|FG000|Phase 2|Symptomatic deterioration|0|||
161616176|NCT01332266|583647910|FG001|Phase 2|Symptomatic deterioration|0|||
161616177|NCT01332266|583647911|FG002|Phase 2|Symptomatic deterioration|0|||
161616178|NCT01332266|583647912|FG003|Phase 2|Symptomatic deterioration|0|||
161616179|NCT01332266|583647913|FG004|Phase 2|Symptomatic deterioration|1|||
161616180|NCT01332266|583647909|FG000|Phase 2|Progression Disease|0|||
161616181|NCT01332266|583647910|FG001|Phase 2|Progression Disease|0|||
161616182|NCT01332266|583647911|FG002|Phase 2|Progression Disease|0|||
161616183|NCT01332266|583647912|FG003|Phase 2|Progression Disease|2|||
161616184|NCT01332266|583647913|FG004|Phase 2|Progression Disease|1|||
161616185|NCT01332266|583647909|FG000|Phase 2|Withdrawal by Subject|0|||
161616186|NCT01332266|583647910|FG001|Phase 2|Withdrawal by Subject|0|||
161616187|NCT01332266|583647911|FG002|Phase 2|Withdrawal by Subject|0|||
161616188|NCT01332266|583647912|FG003|Phase 2|Withdrawal by Subject|2|||
161616189|NCT01332266|583647913|FG004|Phase 2|Withdrawal by Subject|2|||
161616190|NCT01686152|583647916|FG000|Overall Study|Withdrawal by Subject|11|||
161616191|NCT01686152|583647917|FG001|Overall Study|Withdrawal by Subject|11|||
161616192|NCT01686152|583647918|FG002|Overall Study|Withdrawal by Subject|3|||
161616193|NCT01686152|583647916|FG000|Overall Study|Drug Code Unblinded|0|||
161616194|NCT01686152|583647917|FG001|Overall Study|Drug Code Unblinded|1|||
161616195|NCT01686152|583647918|FG002|Overall Study|Drug Code Unblinded|0|||
161616196|NCT01686152|583647916|FG000|Overall Study|Protocol Violation|6|||
161616197|NCT01686152|583647917|FG001|Overall Study|Protocol Violation|1|||
161616198|NCT01686152|583647918|FG002|Overall Study|Protocol Violation|0|||
161616199|NCT01686152|583647916|FG000|Overall Study|Adverse Event|12|||
161616200|NCT01686152|583647917|FG001|Overall Study|Adverse Event|11|||
161616201|NCT01686152|583647918|FG002|Overall Study|Adverse Event|0|||
161616202|NCT01686152|583647916|FG000|Overall Study|Lack of Efficacy|0|||
161616203|NCT01686152|583647917|FG001|Overall Study|Lack of Efficacy|0|||
161616204|NCT01686152|583647918|FG002|Overall Study|Lack of Efficacy|1|||
161616205|NCT01686152|583647916|FG000|Overall Study|IP Non-compliance|5|||
161616206|NCT01686152|583647917|FG001|Overall Study|IP Non-compliance|5|||
161616207|NCT01686152|583647918|FG002|Overall Study|IP Non-compliance|0|||
161616208|NCT01686152|583647916|FG000|Overall Study|Lost to Follow-up|7|||
161616209|NCT01686152|583647917|FG001|Overall Study|Lost to Follow-up|6|||
161616210|NCT01686152|583647918|FG002|Overall Study|Lost to Follow-up|5|||
161616211|NCT01802333|583647919|FG000|Overall Study|Ineligible|2|||
161616212|NCT01802333|583647920|FG001|Overall Study|Ineligible|6|||
161616213|NCT01802333|583647921|FG002|Overall Study|Ineligible|8|||
161616214|NCT01802333|583647919|FG000|Overall Study|Adverse Event|1|||
161616215|NCT01802333|583647920|FG001|Overall Study|Adverse Event|8|||
161616216|NCT01802333|583647921|FG002|Overall Study|Adverse Event|8|||
161616217|NCT01802333|583647919|FG000|Overall Study|Withdrawal by Subject|6|||
161616218|NCT01802333|583647920|FG001|Overall Study|Withdrawal by Subject|6|||
161616219|NCT01802333|583647921|FG002|Overall Study|Withdrawal by Subject|5|||
161616220|NCT01802333|583647919|FG000|Overall Study|Progression/relapse|1|||
161832726|NCT03310957|584429592|FG003|Overall Study|Discontinuation per sponsor|4|||
161616221|NCT01802333|583647920|FG001|Overall Study|Progression/relapse|3|||
161616222|NCT01802333|583647921|FG002|Overall Study|Progression/relapse|0|||
161616223|NCT01802333|583647919|FG000|Overall Study|Death|7|||
161832727|NCT03310957|584429593|FG004|Overall Study|Discontinuation per sponsor|1|||
161616224|NCT01802333|583647920|FG001|Overall Study|Death|14|||
161616225|NCT01802333|583647921|FG002|Overall Study|Death|13|||
161616226|NCT01802333|583647919|FG000|Overall Study|Other - not protocol specified|32|||
161616227|NCT01802333|583647920|FG001|Overall Study|Other - not protocol specified|22|||
161616228|NCT01802333|583647921|FG002|Overall Study|Other - not protocol specified|24|||
161616229|NCT01802333|583647919|FG000|Overall Study|Did not start treatment|0|||
161832728|NCT03310957|584429594|FG005|Overall Study|Discontinuation per sponsor|9|||
161616230|NCT01802333|583647920|FG001|Overall Study|Did not start treatment|2|||
161616231|NCT01802333|583647921|FG002|Overall Study|Did not start treatment|5|||
161616232|NCT01947491|583647925|FG000|Overall Study|Lost to Follow-up|5|||
161616233|NCT01947491|583647926|FG001|Overall Study|Lost to Follow-up|3|||
161616234|NCT01947491|583647927|FG002|Overall Study|Lost to Follow-up|1|||
161616235|NCT01947491|583647928|FG003|Overall Study|Lost to Follow-up|2|||
161616236|NCT01947491|583647925|FG000|Overall Study|Lack of Efficacy|1|||
161616237|NCT01947491|583647926|FG001|Overall Study|Lack of Efficacy|0|||
161616238|NCT01947491|583647927|FG002|Overall Study|Lack of Efficacy|0|||
161616239|NCT01947491|583647928|FG003|Overall Study|Lack of Efficacy|1|||
161616240|NCT01947491|583647925|FG000|Overall Study|Protocol Violation|1|||
161616241|NCT01947491|583647926|FG001|Overall Study|Protocol Violation|0|||
161616242|NCT01947491|583647927|FG002|Overall Study|Protocol Violation|0|||
161616243|NCT01947491|583647928|FG003|Overall Study|Protocol Violation|0|||
161616244|NCT01947491|583647925|FG000|Overall Study|Withdrawal by Subject|1|||
161616245|NCT01947491|583647926|FG001|Overall Study|Withdrawal by Subject|1|||
161616246|NCT01947491|583647927|FG002|Overall Study|Withdrawal by Subject|1|||
161616247|NCT01947491|583647928|FG003|Overall Study|Withdrawal by Subject|0|||
161616248|NCT01947491|583647925|FG000|Overall Study|Worsening of condition|0|||
161616249|NCT01947491|583647926|FG001|Overall Study|Worsening of condition|1|||
161616250|NCT01947491|583647927|FG002|Overall Study|Worsening of condition|0|||
161616251|NCT01947491|583647928|FG003|Overall Study|Worsening of condition|0|||
161616252|NCT01947491|583647925|FG000|Overall Study|Adverse Event|0|||
161616253|NCT01947491|583647926|FG001|Overall Study|Adverse Event|1|||
161616254|NCT01947491|583647927|FG002|Overall Study|Adverse Event|0|||
161616255|NCT01947491|583647928|FG003|Overall Study|Adverse Event|2|||
161616256|NCT02224755|583647929|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
161616257|NCT02224755|583647930|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
161616258|NCT02224755|583647929|FG000|Two Year Follow up Post-implant|Death|103|||
161616259|NCT02224755|583647930|FG001|Two Year Follow up Post-implant|Death|98|||
161616260|NCT02224755|583647929|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
161616261|NCT02224755|583647930|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
161616262|NCT02224755|583647929|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
161616263|NCT02224755|583647930|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
161616264|NCT02224755|583647929|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
161616265|NCT02224755|583647930|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
161616266|NCT02067663|583647931|FG000|Overall Study|Lost to Follow-up|13|||
161616267|NCT02067663|583647932|FG001|Overall Study|Lost to Follow-up|14|||
161616268|NCT04311983|583647933|FG000|Overall Study|Lost to Follow-up|421|||
161616269|NCT04311983|583647934|FG001|Overall Study|Lost to Follow-up|456|||
161616270|NCT04311983|583647933|FG000|Overall Study|Incomplete survey|7|||
161616271|NCT04311983|583647934|FG001|Overall Study|Incomplete survey|9|||
161616272|NCT04311983|583647933|FG000|Overall Study|Death|1|||
161616273|NCT04311983|583647934|FG001|Overall Study|Death|0|||
161616274|NCT01019135|583647938|FG000|Overall Study|Did not receive allocated intervention|12|||
161616275|NCT01019135|583647939|FG001|Overall Study|Did not receive allocated intervention|6|||
161616276|NCT01019135|583647940|FG002|Overall Study|Did not receive allocated intervention|25|||
161616277|NCT01019135|583647938|FG000|Overall Study|Did not attend CR|8|||
161616278|NCT01019135|583647939|FG001|Overall Study|Did not attend CR|13|||
161616279|NCT01019135|583647940|FG002|Overall Study|Did not attend CR|6|||
161616280|NCT01205126|583647941|FG000|Titration Phase|Adverse Event|5|||
161616281|NCT01205126|583647942|FG001|Titration Phase|Adverse Event|3|||
161616282|NCT01205126|583647941|FG000|Titration Phase|Withdrawal by Subject|5|||
161616283|NCT01205126|583647942|FG001|Titration Phase|Withdrawal by Subject|5|||
161616284|NCT01205126|583647941|FG000|Titration Phase|Lost to Follow-up|2|||
161616285|NCT01205126|583647942|FG001|Titration Phase|Lost to Follow-up|2|||
161616286|NCT01205126|583647941|FG000|Titration Phase|No stable titration dose|1|||
161616287|NCT01205126|583647942|FG001|Titration Phase|No stable titration dose|0|||
161616288|NCT01205126|583647941|FG000|Titration Phase|More than maximum dosage required|2|||
161616289|NCT01205126|583647942|FG001|Titration Phase|More than maximum dosage required|3|||
161616290|NCT01205126|583647941|FG000|Titration Phase|Other|8|||
161616291|NCT01205126|583647942|FG001|Titration Phase|Other|6|||
161832729|NCT03310957|584429595|FG006|Overall Study|Discontinuation per sponsor|12|||
161832730|NCT03310957|584429589|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
161832731|NCT03310957|584429590|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
161832732|NCT03310957|584429591|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
161616292|NCT01205126|583647941|FG000|Between Titration & Maintenance Phase|Other|0|||
161616293|NCT01205126|583647942|FG001|Between Titration & Maintenance Phase|Other|4|||
161616294|NCT01205126|583647941|FG000|Maintenance Phase|Adverse Event|3|||
161616295|NCT01205126|583647942|FG001|Maintenance Phase|Adverse Event|7|||
161616296|NCT01205126|583647941|FG000|Maintenance Phase|Death|4|||
161616297|NCT01205126|583647942|FG001|Maintenance Phase|Death|4|||
161616298|NCT01205126|583647941|FG000|Maintenance Phase|More than the maximum dosage required|5|||
161616299|NCT01205126|583647942|FG001|Maintenance Phase|More than the maximum dosage required|5|||
161616300|NCT01205126|583647941|FG000|Maintenance Phase|Prohibited drugs used|1|||
161616301|NCT01205126|583647942|FG001|Maintenance Phase|Prohibited drugs used|0|||
161616302|NCT01205126|583647941|FG000|Maintenance Phase|Other|11|||
161616303|NCT01205126|583647942|FG001|Maintenance Phase|Other|8|||
161616304|NCT01205126|583647941|FG000|Maintenance Phase|Lost to Follow-up|5|||
161616305|NCT01205126|583647942|FG001|Maintenance Phase|Lost to Follow-up|5|||
161616306|NCT01205126|583647941|FG000|Maintenance Phase|Withdrawal by Subject|8|||
161616307|NCT01205126|583647942|FG001|Maintenance Phase|Withdrawal by Subject|11|||
161616308|NCT00486954|583647943|FG000|Pilot Part|Adverse Event|4|||
161616309|NCT00486954|583647944|FG001|Pilot Part|Adverse Event|0|||
161616310|NCT00486954|583647945|FG002|Pilot Part|Adverse Event|5|||
161616311|NCT00486954|583647946|FG003|Pilot Part|Adverse Event|0|||
161616312|NCT00486954|583647947|FG004|Pilot Part|Adverse Event|0|||
161616313|NCT00486954|583647943|FG000|Pilot Part|Disease Progression|2|||
161616314|NCT00486954|583647944|FG001|Pilot Part|Disease Progression|0|||
161616315|NCT00486954|583647945|FG002|Pilot Part|Disease Progression|1|||
161616316|NCT00486954|583647946|FG003|Pilot Part|Disease Progression|0|||
161616317|NCT00486954|583647947|FG004|Pilot Part|Disease Progression|0|||
161616318|NCT00486954|583647943|FG000|Randomized Part|Lost to Follow-up|0|||
161616319|NCT00486954|583647944|FG001|Randomized Part|Lost to Follow-up|0|||
161616320|NCT00486954|583647945|FG002|Randomized Part|Lost to Follow-up|0|||
161616321|NCT00486954|583647946|FG003|Randomized Part|Lost to Follow-up|0|||
161616322|NCT00486954|583647947|FG004|Randomized Part|Lost to Follow-up|1|||
161616323|NCT00486954|583647943|FG000|Randomized Part|Withdrawal by Subject|0|||
161616324|NCT00486954|583647944|FG001|Randomized Part|Withdrawal by Subject|0|||
161616325|NCT00486954|583647945|FG002|Randomized Part|Withdrawal by Subject|0|||
161616326|NCT00486954|583647946|FG003|Randomized Part|Withdrawal by Subject|1|||
161616327|NCT00486954|583647947|FG004|Randomized Part|Withdrawal by Subject|0|||
161616328|NCT00486954|583647943|FG000|Randomized Part|Sponsor Terminated Study|0|||
161616329|NCT00486954|583647944|FG001|Randomized Part|Sponsor Terminated Study|0|||
161616330|NCT00486954|583647945|FG002|Randomized Part|Sponsor Terminated Study|0|||
161616331|NCT00486954|583647946|FG003|Randomized Part|Sponsor Terminated Study|19|||
161616332|NCT00486954|583647947|FG004|Randomized Part|Sponsor Terminated Study|13|||
161616333|NCT05124210|583647948|FG000|Overall Study|Lost to Follow-up|1|||
161616334|NCT05124210|583647949|FG001|Overall Study|Lost to Follow-up|0|||
161616335|NCT05124210|583647948|FG000|Overall Study|Withdrawal by Subject|1|||
161616336|NCT05124210|583647949|FG001|Overall Study|Withdrawal by Subject|0|||
161616337|NCT00638456|583647952|FG000|Overall Study|Withdrawal by Subject|6|||
161616338|NCT00638456|583647953|FG001|Overall Study|Withdrawal by Subject|2|||
161616339|NCT03236779|583647954|FG000|Overall Study|Lost to Follow-up|13|||
161616340|NCT03236779|583647955|FG001|Overall Study|Lost to Follow-up|21|||
161616341|NCT00929526|583647957|FG000|Overall Study|Withdrawal by Subject|1|||
161616342|NCT00929526|583647958|FG001|Overall Study|Withdrawal by Subject|11|||
161616343|NCT00929526|583647957|FG000|Overall Study|Lost to Follow-up|8|||
161616344|NCT00929526|583647958|FG001|Overall Study|Lost to Follow-up|12|||
161616345|NCT00929526|583647957|FG000|Overall Study|Other|8|||
161616346|NCT00929526|583647958|FG001|Overall Study|Other|6|||
161616347|NCT00578344|583647961|FG000|Overall Study|Insurance problems|1|||
161616348|NCT00578344|583647961|FG000|Overall Study|Graft failure|1|||
161616349|NCT02169414|583647962|FG000|Overall Study|Withdrawal by Subject|1|||
161616350|NCT02169414|583647963|FG001|Overall Study|Withdrawal by Subject|0|||
161616351|NCT02169414|583647964|FG002|Overall Study|Withdrawal by Subject|0|||
161616352|NCT02169414|583647965|FG003|Overall Study|Withdrawal by Subject|0|||
161616353|NCT02169414|583647962|FG000|Overall Study|Adverse Event|0|||
161616354|NCT02169414|583647963|FG001|Overall Study|Adverse Event|1|||
161616355|NCT02169414|583647964|FG002|Overall Study|Adverse Event|0|||
161616356|NCT02169414|583647965|FG003|Overall Study|Adverse Event|0|||
161616357|NCT02309515|583647969|FG000|Overall Study|Withdrawal by Subject|0|||
161616358|NCT02309515|583647970|FG001|Overall Study|Withdrawal by Subject|1|||
161616359|NCT04070105|583647971|FG000|Overall Study|Lost to Follow-up|0|||
161616360|NCT04070105|583647972|FG001|Overall Study|Lost to Follow-up|0|||
161616361|NCT04070105|583647973|FG002|Overall Study|Lost to Follow-up|0|||
161616362|NCT04070105|583647974|FG003|Overall Study|Lost to Follow-up|0|||
161616363|NCT04070105|583647975|FG004|Overall Study|Lost to Follow-up|0|||
161616364|NCT04070105|583647976|FG005|Overall Study|Lost to Follow-up|1|||
161616365|NCT02547974|583647979|FG000|Overall Study|Withdrawal by Subject|1|||
161616366|NCT02547974|583647980|FG001|Overall Study|Withdrawal by Subject|0|||
161616367|NCT02547974|583647981|FG002|Overall Study|Withdrawal by Subject|0|||
161616368|NCT02547974|583647982|FG003|Overall Study|Withdrawal by Subject|0|||
161832733|NCT03310957|584429592|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
161832734|NCT03310957|584429593|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
161616369|NCT00923078|583647983|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
161616370|NCT00923078|583647984|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
161616371|NCT00923078|583647985|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
161616372|NCT00923078|583647983|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
161616373|NCT00923078|583647984|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
161616374|NCT00923078|583647985|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
161616375|NCT01072149|583647989|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616376|NCT01072149|583647990|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616377|NCT01072149|583647991|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161616378|NCT01072149|583647992|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616379|NCT01072149|583647993|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616380|NCT01072149|583647994|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616381|NCT01072149|583647995|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616382|NCT01072149|583647996|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616383|NCT01072149|583647997|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616384|NCT01072149|583647998|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616385|NCT01072149|583647999|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616386|NCT01072149|583648000|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616387|NCT01072149|583648001|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616388|NCT01072149|583648002|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616389|NCT01072149|583648003|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616390|NCT01072149|583648004|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616391|NCT01072149|583648005|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616392|NCT01072149|583648006|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161616393|NCT01072149|583647989|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616394|NCT01072149|583647990|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616395|NCT01072149|583647991|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616396|NCT01072149|583647992|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616397|NCT01072149|583647993|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616398|NCT01072149|583647994|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616399|NCT01072149|583647995|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616400|NCT01072149|583647996|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616401|NCT01072149|583647997|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616402|NCT01072149|583647998|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616403|NCT01072149|583647999|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616404|NCT01072149|583648000|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616405|NCT01072149|583648001|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616406|NCT01072149|583648002|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616407|NCT01072149|583648003|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616408|NCT01072149|583648004|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616409|NCT01072149|583648005|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161616410|NCT01072149|583648006|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
161616411|NCT01072149|583647989|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616412|NCT01072149|583647990|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616413|NCT01072149|583647991|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616414|NCT01072149|583647992|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616415|NCT01072149|583647993|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616416|NCT01072149|583647994|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616417|NCT01072149|583647995|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616418|NCT01072149|583647996|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616419|NCT01072149|583647997|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616420|NCT01072149|583647998|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616421|NCT01072149|583647999|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
161616422|NCT01072149|583648000|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616423|NCT01072149|583648001|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616424|NCT01072149|583648002|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616425|NCT01072149|583648003|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616426|NCT01072149|583648004|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616427|NCT01072149|583648005|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616428|NCT01072149|583648006|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161616429|NCT01072149|583647989|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616430|NCT01072149|583647990|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
161616431|NCT01072149|583647991|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616432|NCT01072149|583647992|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616433|NCT01072149|583647993|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616434|NCT01072149|583647994|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616435|NCT01072149|583647995|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161684460|NCT02819635|583897893|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684461|NCT02819635|583897894|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
161616436|NCT01072149|583647996|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616437|NCT01072149|583647997|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616438|NCT01072149|583647998|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161684462|NCT02819635|583897895|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684463|NCT02819635|583897896|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
161616439|NCT01072149|583647999|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616440|NCT01072149|583648000|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616441|NCT01072149|583648001|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616442|NCT01072149|583648002|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616443|NCT01072149|583648003|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616444|NCT01072149|583648004|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616445|NCT01072149|583648005|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616446|NCT01072149|583648006|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161616447|NCT01072149|583647989|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616448|NCT01072149|583647990|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616449|NCT01072149|583647991|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161616450|NCT01072149|583647992|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616451|NCT01072149|583647993|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616452|NCT01072149|583647994|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616453|NCT01072149|583647995|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616454|NCT01072149|583647996|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616455|NCT01072149|583647997|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616456|NCT01072149|583647998|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616457|NCT01072149|583647999|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616458|NCT01072149|583648000|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616459|NCT01072149|583648001|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616460|NCT01072149|583648002|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616461|NCT01072149|583648003|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616462|NCT01072149|583648004|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616463|NCT01072149|583648005|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616464|NCT01072149|583648006|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161616465|NCT01072149|583647989|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616466|NCT01072149|583647990|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616467|NCT01072149|583647991|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616468|NCT01072149|583647992|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616469|NCT01072149|583647993|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616470|NCT01072149|583647994|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616471|NCT01072149|583647995|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616472|NCT01072149|583647996|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
161616473|NCT01072149|583647997|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616474|NCT01072149|583647998|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616475|NCT01072149|583647999|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616476|NCT01072149|583648000|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616477|NCT01072149|583648001|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616478|NCT01072149|583648002|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616479|NCT01072149|583648003|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616480|NCT01072149|583648004|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616481|NCT01072149|583648005|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616482|NCT01072149|583648006|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
161616483|NCT01072149|583647989|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
161616484|NCT01072149|583647990|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
161616485|NCT01072149|583647991|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
161616486|NCT01072149|583647992|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
161616487|NCT01072149|583647993|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
161616488|NCT01072149|583647994|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
161616489|NCT01072149|583647995|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
161616490|NCT01072149|583647996|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
161616491|NCT01072149|583647997|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
161616492|NCT01072149|583647998|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
161616493|NCT01072149|583647999|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
161616494|NCT01072149|583648000|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
161616495|NCT01072149|583648001|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
161616496|NCT01072149|583648002|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
161616497|NCT01072149|583648003|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
161616498|NCT01072149|583648004|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
161616499|NCT01072149|583648005|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
161616500|NCT01072149|583648006|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
161616501|NCT01072149|583647989|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616502|NCT01072149|583647990|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616503|NCT01072149|583647991|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616504|NCT01072149|583647992|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616505|NCT01072149|583647993|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616506|NCT01072149|583647994|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616507|NCT01072149|583647995|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616508|NCT01072149|583647996|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616509|NCT01072149|583647997|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616510|NCT01072149|583647998|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616511|NCT01072149|583647999|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616512|NCT01072149|583648000|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616513|NCT01072149|583648001|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616514|NCT01072149|583648002|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616515|NCT01072149|583648003|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616516|NCT01072149|583648004|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
161616517|NCT01072149|583648005|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616518|NCT01072149|583648006|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161616519|NCT01072149|583647989|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
161616520|NCT01072149|583647990|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
161616521|NCT01072149|583647991|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
161616522|NCT01072149|583647992|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
161616523|NCT01072149|583647993|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
161616524|NCT01072149|583647994|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
161616525|NCT01072149|583647995|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
161616526|NCT01072149|583647996|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
161616527|NCT01072149|583647997|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
161616528|NCT01072149|583647998|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
161616529|NCT01072149|583647999|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
161616530|NCT01072149|583648000|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
161616531|NCT01072149|583648001|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
161616532|NCT01072149|583648002|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
161616533|NCT01072149|583648003|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
161616534|NCT01072149|583648004|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
161616535|NCT01072149|583648005|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
161616536|NCT01072149|583648006|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
161616537|NCT01072149|583647989|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616538|NCT01072149|583647990|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616539|NCT01072149|583647991|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616540|NCT01072149|583647992|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616541|NCT01072149|583647993|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616542|NCT01072149|583647994|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616543|NCT01072149|583647995|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616544|NCT01072149|583647996|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616545|NCT01072149|583647997|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616546|NCT01072149|583647998|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616547|NCT01072149|583647999|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616548|NCT01072149|583648000|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616549|NCT01072149|583648001|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
161616550|NCT01072149|583648002|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616551|NCT01072149|583648003|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616552|NCT01072149|583648004|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161832735|NCT03310957|584429594|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
161832736|NCT03310957|584429595|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
161832737|NCT03310957|584429589|FG000|Overall Study|Treatment landscape|0|||
161832738|NCT03310957|584429590|FG001|Overall Study|Treatment landscape|0|||
161832739|NCT03310957|584429591|FG002|Overall Study|Treatment landscape|1|||
161832740|NCT03310957|584429592|FG003|Overall Study|Treatment landscape|1|||
161832741|NCT03310957|584429593|FG004|Overall Study|Treatment landscape|0|||
161832742|NCT03310957|584429594|FG005|Overall Study|Treatment landscape|1|||
161832743|NCT03310957|584429595|FG006|Overall Study|Treatment landscape|0|||
161832744|NCT03310957|584429589|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832745|NCT03310957|584429590|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832746|NCT03310957|584429591|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832747|NCT03310957|584429592|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832748|NCT03310957|584429593|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
161832749|NCT03310957|584429594|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832750|NCT03310957|584429595|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161616553|NCT01072149|583648005|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616554|NCT01072149|583648006|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161616555|NCT01072149|583647989|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616556|NCT01072149|583647990|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616557|NCT01072149|583647991|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
161832751|NCT03310957|584429589|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161832752|NCT03310957|584429590|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161616558|NCT01072149|583647992|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616559|NCT01072149|583647993|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616560|NCT01072149|583647994|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616561|NCT01072149|583647995|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616562|NCT01072149|583647996|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616563|NCT01072149|583647997|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616564|NCT01072149|583647998|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616565|NCT01072149|583647999|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616566|NCT01072149|583648000|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616567|NCT01072149|583648001|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616568|NCT01072149|583648002|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
161616569|NCT01072149|583648003|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616570|NCT01072149|583648004|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616571|NCT01072149|583648005|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616572|NCT01072149|583648006|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161616573|NCT01768572|583648007|FG000|Overall Study|Adverse Event|7|||
161616574|NCT01768572|583648008|FG001|Overall Study|Adverse Event|8|||
161616575|NCT01768572|583648009|FG002|Overall Study|Adverse Event|4|||
161616576|NCT01768572|583648007|FG000|Overall Study|Lack of Efficacy|1|||
161616577|NCT01768572|583648008|FG001|Overall Study|Lack of Efficacy|3|||
161616578|NCT01768572|583648009|FG002|Overall Study|Lack of Efficacy|1|||
161616579|NCT01768572|583648007|FG000|Overall Study|Other, Not due to an adverse event|1|||
161616580|NCT01768572|583648008|FG001|Overall Study|Other, Not due to an adverse event|1|||
161616581|NCT01768572|583648009|FG002|Overall Study|Other, Not due to an adverse event|1|||
161616582|NCT03265132|583648020|FG000|Overall Study|Adverse Event|0|||
161616583|NCT03265132|583648021|FG001|Overall Study|Adverse Event|1|||
161616584|NCT03265132|583648020|FG000|Overall Study|Lack of Efficacy|0|||
161616585|NCT03265132|583648021|FG001|Overall Study|Lack of Efficacy|2|||
161616586|NCT03265132|583648020|FG000|Overall Study|Progressive disease|0|||
161616587|NCT03265132|583648021|FG001|Overall Study|Progressive disease|2|||
161616588|NCT03265132|583648020|FG000|Overall Study|Withdrawal by Subject|0|||
161616589|NCT03265132|583648021|FG001|Overall Study|Withdrawal by Subject|1|||
161616590|NCT03259568|583648027|FG000|Overall Study|Participant performance was low|3|||
161616591|NCT00089791|583648028|FG000|Overall Study|Physician Decision|6|||
161616592|NCT00089791|583648029|FG001|Overall Study|Physician Decision|3|||
161616593|NCT00089791|583648028|FG000|Overall Study|Adverse Event|81|||
161616594|NCT00089791|583648029|FG001|Overall Study|Adverse Event|93|||
161616595|NCT00089791|583648028|FG000|Overall Study|Withdrawal by Subject|403|||
161616596|NCT00089791|583648029|FG001|Overall Study|Withdrawal by Subject|344|||
161616597|NCT00089791|583648028|FG000|Overall Study|Death|78|||
161616598|NCT00089791|583648029|FG001|Overall Study|Death|62|||
161616599|NCT00089791|583648028|FG000|Overall Study|Disease progression|7|||
161616600|NCT00089791|583648029|FG001|Overall Study|Disease progression|3|||
161616601|NCT00089791|583648028|FG000|Overall Study|Ineligibility determined|12|||
161616602|NCT00089791|583648029|FG001|Overall Study|Ineligibility determined|9|||
161616603|NCT00089791|583648028|FG000|Overall Study|Lost to Follow-up|57|||
161616604|NCT00089791|583648029|FG001|Overall Study|Lost to Follow-up|57|||
161616605|NCT00089791|583648028|FG000|Overall Study|Noncompliance|17|||
161616606|NCT00089791|583648029|FG001|Overall Study|Noncompliance|13|||
161616607|NCT00089791|583648028|FG000|Overall Study|Other|20|||
161616608|NCT00089791|583648029|FG001|Overall Study|Other|32|||
161684464|NCT02819635|583897897|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684465|NCT02819635|583897898|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684466|NCT02819635|583897899|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684467|NCT02819635|583897900|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
161832753|NCT03310957|584429591|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
161832754|NCT03310957|584429592|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161616609|NCT00089791|583648028|FG000|Overall Study|Protocol deviation|12|||
161616610|NCT00089791|583648029|FG001|Overall Study|Protocol deviation|10|||
161616611|NCT00089791|583648028|FG000|Overall Study|Requirement for alternative therapy|7|||
161616612|NCT00089791|583648029|FG001|Overall Study|Requirement for alternative therapy|4|||
161616613|NCT02161458|583648030|FG000|Overall Study|Withdrawal by Subject|0|||
161616614|NCT02161458|583648031|FG001|Overall Study|Withdrawal by Subject|4|||
161684468|NCT02819635|583897901|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
161616615|NCT02161458|583648032|FG002|Overall Study|Withdrawal by Subject|4|||
161616616|NCT02161458|583648033|FG003|Overall Study|Withdrawal by Subject|0|||
161616617|NCT02161458|583648030|FG000|Overall Study|Lost to Follow-up|0|||
161616618|NCT02161458|583648031|FG001|Overall Study|Lost to Follow-up|2|||
161616619|NCT02161458|583648032|FG002|Overall Study|Lost to Follow-up|1|||
161616620|NCT02161458|583648033|FG003|Overall Study|Lost to Follow-up|0|||
161616621|NCT05074433|583648034|FG000|Overall Study|Adverse Event|0|||
161616622|NCT05074433|583648035|FG001|Overall Study|Adverse Event|2|||
161616623|NCT05074433|583648036|FG002|Overall Study|Adverse Event|0|||
161616624|NCT05074433|583648037|FG003|Overall Study|Adverse Event|1|||
161616625|NCT05074433|583648034|FG000|Overall Study|Sponsor Request|0|||
161616626|NCT05074433|583648035|FG001|Overall Study|Sponsor Request|1|||
161616627|NCT05074433|583648036|FG002|Overall Study|Sponsor Request|1|||
161616628|NCT05074433|583648037|FG003|Overall Study|Sponsor Request|0|||
161616629|NCT05074433|583648034|FG000|Overall Study|Death|1|||
161616630|NCT05074433|583648035|FG001|Overall Study|Death|0|||
161616631|NCT05074433|583648036|FG002|Overall Study|Death|0|||
161616632|NCT05074433|583648037|FG003|Overall Study|Death|0|||
161616633|NCT05074433|583648034|FG000|Overall Study|Lost to Follow-up|0|||
161616634|NCT05074433|583648035|FG001|Overall Study|Lost to Follow-up|0|||
161616635|NCT05074433|583648036|FG002|Overall Study|Lost to Follow-up|2|||
161616636|NCT05074433|583648037|FG003|Overall Study|Lost to Follow-up|0|||
161616637|NCT05074433|583648034|FG000|Overall Study|Subject Decision|8|||
161616638|NCT05074433|583648035|FG001|Overall Study|Subject Decision|6|||
161616639|NCT05074433|583648036|FG002|Overall Study|Subject Decision|4|||
161616640|NCT05074433|583648037|FG003|Overall Study|Subject Decision|5|||
161616641|NCT04397263|583648038|FG000|Overall Study|Withdrawal by Subject|2|||
161616642|NCT02251652|583648039|FG000|Overall Study|Withdrawal by Subject|1|||
161616643|NCT01989689|583648040|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
161616644|NCT01989689|583648041|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
161616645|NCT01989689|583648040|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
161616646|NCT01989689|583648041|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
161616647|NCT04492475|583648042|FG000|Overall Study|Enrolled but not treated|8|||
161616648|NCT04492475|583648043|FG001|Overall Study|Enrolled but not treated|8|||
161616649|NCT04492475|583648042|FG000|Overall Study|Withdrawal by Subject|4|||
161616650|NCT04492475|583648043|FG001|Overall Study|Withdrawal by Subject|0|||
161616651|NCT04492475|583648042|FG000|Overall Study|Became ineligible after enrollment|2|||
161616652|NCT04492475|583648043|FG001|Overall Study|Became ineligible after enrollment|0|||
161616653|NCT02066636|583648044|FG000|Overall Study|Disease progression|51|||
161616654|NCT02066636|583648045|FG001|Overall Study|Disease progression|60|||
161616655|NCT02066636|583648046|FG002|Overall Study|Disease progression|700|||
161616656|NCT02066636|583648044|FG000|Overall Study|Study drug toxicity|13|||
161616657|NCT02066636|583648045|FG001|Overall Study|Study drug toxicity|2|||
161616658|NCT02066636|583648046|FG002|Overall Study|Study drug toxicity|58|||
161616659|NCT02066636|583648044|FG000|Overall Study|Death|4|||
161616660|NCT02066636|583648045|FG001|Overall Study|Death|2|||
161616661|NCT02066636|583648046|FG002|Overall Study|Death|158|||
161616662|NCT02066636|583648044|FG000|Overall Study|Adverse event unrelated to study drug|6|||
161616663|NCT02066636|583648045|FG001|Overall Study|Adverse event unrelated to study drug|4|||
161616664|NCT02066636|583648046|FG002|Overall Study|Adverse event unrelated to study drug|45|||
161616665|NCT02066636|583648044|FG000|Overall Study|Participant request to discontinue treatment|12|||
161616666|NCT02066636|583648045|FG001|Overall Study|Participant request to discontinue treatment|12|||
161616667|NCT02066636|583648046|FG002|Overall Study|Participant request to discontinue treatment|70|||
161616668|NCT02066636|583648044|FG000|Overall Study|Participant withdrew consent|10|||
161616669|NCT02066636|583648045|FG001|Overall Study|Participant withdrew consent|18|||
161832755|NCT03310957|584429593|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161832756|NCT03310957|584429594|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161616670|NCT02066636|583648046|FG002|Overall Study|Participant withdrew consent|61|||
161616671|NCT02066636|583648044|FG000|Overall Study|Lost to Follow-up|0|||
161616672|NCT02066636|583648045|FG001|Overall Study|Lost to Follow-up|2|||
161616673|NCT02066636|583648046|FG002|Overall Study|Lost to Follow-up|2|||
161616674|NCT02066636|583648044|FG000|Overall Study|Maximum clinical benefit|2|||
161616675|NCT02066636|583648045|FG001|Overall Study|Maximum clinical benefit|2|||
161616676|NCT02066636|583648046|FG002|Overall Study|Maximum clinical benefit|3|||
161616677|NCT02066636|583648044|FG000|Overall Study|Poor/non-compliance|2|||
161616678|NCT02066636|583648045|FG001|Overall Study|Poor/non-compliance|1|||
161616679|NCT02066636|583648046|FG002|Overall Study|Poor/non-compliance|1|||
161616680|NCT02066636|583648044|FG000|Overall Study|Participant no loner meets study criteria|3|||
161616681|NCT02066636|583648045|FG001|Overall Study|Participant no loner meets study criteria|2|||
161616682|NCT02066636|583648046|FG002|Overall Study|Participant no loner meets study criteria|28|||
161616683|NCT02066636|583648044|FG000|Overall Study|Administrative reasons by sponsor|8|||
161616684|NCT02066636|583648045|FG001|Overall Study|Administrative reasons by sponsor|5|||
161616685|NCT02066636|583648046|FG002|Overall Study|Administrative reasons by sponsor|0|||
161616686|NCT02066636|583648044|FG000|Overall Study|Other reasons|16|||
161616687|NCT02066636|583648045|FG001|Overall Study|Other reasons|15|||
161616688|NCT02066636|583648046|FG002|Overall Study|Other reasons|50|||
161616689|NCT00391170|583648055|FG000|Overall Study|Withdrawal by Subject|1|||
161616690|NCT00391170|583648056|FG001|Overall Study|Withdrawal by Subject|0|||
161616691|NCT00391170|583648055|FG000|Overall Study|Adverse Event|3|||
161616692|NCT00391170|583648056|FG001|Overall Study|Adverse Event|2|||
161616693|NCT00391170|583648055|FG000|Overall Study|Physician Decision|2|||
161616694|NCT00391170|583648056|FG001|Overall Study|Physician Decision|2|||
161616695|NCT03567616|583648059|FG000|Overall Study|Disease progression|4|||
161616696|NCT03567616|583648059|FG000|Overall Study|Withdrawal by Subject|1|||
161616697|NCT03567616|583648059|FG000|Overall Study|Physician Decision|1|||
161616698|NCT03567616|583648059|FG000|Overall Study|Death|1|||
161616699|NCT03567616|583648059|FG000|Overall Study|Adverse Event|1|||
161616700|NCT02833948|583648061|FG000|Overall Study|Death|2|||
161616701|NCT02833948|583648062|FG001|Overall Study|Death|3|||
161616702|NCT02833948|583648061|FG000|Overall Study|were not scanned|8|||
161616703|NCT02833948|583648062|FG001|Overall Study|were not scanned|13|||
161616704|NCT02833948|583648061|FG000|Overall Study|scans could not be evaluated|5|||
161616705|NCT02833948|583648062|FG001|Overall Study|scans could not be evaluated|2|||
161616706|NCT00680771|583648065|FG000|Overall Study|Withdrawal by Subject|1|||
161616707|NCT00680771|583648066|FG001|Overall Study|Withdrawal by Subject|0|||
161616708|NCT00680771|583648065|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
161616709|NCT00680771|583648066|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
161616710|NCT00680771|583648065|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
161616711|NCT00680771|583648066|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
161616712|NCT02691702|583648067|FG000|Overall Study|Adverse Event|1|||
161616713|NCT02691702|583648068|FG001|Overall Study|Adverse Event|0|||
161616714|NCT02691702|583648069|FG002|Overall Study|Adverse Event|0|||
161616715|NCT02691702|583648070|FG003|Overall Study|Adverse Event|0|||
161616716|NCT02691702|583648071|FG004|Overall Study|Adverse Event|0|||
161616717|NCT02691702|583648072|FG005|Overall Study|Adverse Event|0|||
161616718|NCT02691702|583648073|FG006|Overall Study|Adverse Event|0|||
161616719|NCT02691702|583648074|FG007|Overall Study|Adverse Event|0|||
161616720|NCT02691702|583648075|FG008|Overall Study|Adverse Event|1|||
161616721|NCT02691702|583648076|FG009|Overall Study|Adverse Event|0|||
161616722|NCT02691702|583648077|FG010|Overall Study|Adverse Event|1|||
161616723|NCT02691702|583648067|FG000|Overall Study|Lost to Follow-up|0|||
161616724|NCT02691702|583648068|FG001|Overall Study|Lost to Follow-up|0|||
161616725|NCT02691702|583648069|FG002|Overall Study|Lost to Follow-up|1|||
161616726|NCT02691702|583648070|FG003|Overall Study|Lost to Follow-up|0|||
161616727|NCT02691702|583648071|FG004|Overall Study|Lost to Follow-up|0|||
161616728|NCT02691702|583648072|FG005|Overall Study|Lost to Follow-up|2|||
161616729|NCT02691702|583648073|FG006|Overall Study|Lost to Follow-up|0|||
161616730|NCT02691702|583648074|FG007|Overall Study|Lost to Follow-up|0|||
161616731|NCT02691702|583648075|FG008|Overall Study|Lost to Follow-up|0|||
161684469|NCT02819635|583897902|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684470|NCT02819635|583897903|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
161684471|NCT02819635|583897892|FG000|Substudy 3|Other, not specified|0|||
161684472|NCT02819635|583897893|FG001|Substudy 3|Other, not specified|0|||
161684473|NCT02819635|583897894|FG002|Substudy 3|Other, not specified|0|||
161684474|NCT02819635|583897895|FG003|Substudy 3|Other, not specified|0|||
161684475|NCT02819635|583897896|FG004|Substudy 3|Other, not specified|0|||
161684476|NCT02819635|583897897|FG005|Substudy 3|Other, not specified|0|||
161684477|NCT02819635|583897898|FG006|Substudy 3|Other, not specified|0|||
161684478|NCT02819635|583897899|FG007|Substudy 3|Other, not specified|0|||
161684479|NCT02819635|583897900|FG008|Substudy 3|Other, not specified|202|||
161684480|NCT02819635|583897901|FG009|Substudy 3|Other, not specified|5|||
161832757|NCT03310957|584429595|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161684481|NCT02819635|583897902|FG010|Substudy 3|Other, not specified|89|||
161684482|NCT02819635|583897903|FG011|Substudy 3|Other, not specified|39|||
161616732|NCT02691702|583648076|FG009|Overall Study|Lost to Follow-up|0|||
161616733|NCT02691702|583648077|FG010|Overall Study|Lost to Follow-up|1|||
161616734|NCT02691702|583648067|FG000|Overall Study|Withdrawal by Subject|1|||
161616735|NCT02691702|583648068|FG001|Overall Study|Withdrawal by Subject|1|||
161616736|NCT02691702|583648069|FG002|Overall Study|Withdrawal by Subject|0|||
161616737|NCT02691702|583648070|FG003|Overall Study|Withdrawal by Subject|0|||
161616738|NCT02691702|583648071|FG004|Overall Study|Withdrawal by Subject|0|||
161616739|NCT02691702|583648072|FG005|Overall Study|Withdrawal by Subject|1|||
161616740|NCT02691702|583648073|FG006|Overall Study|Withdrawal by Subject|2|||
161616741|NCT02691702|583648074|FG007|Overall Study|Withdrawal by Subject|0|||
161616742|NCT02691702|583648075|FG008|Overall Study|Withdrawal by Subject|0|||
161616743|NCT02691702|583648076|FG009|Overall Study|Withdrawal by Subject|0|||
161616744|NCT02691702|583648077|FG010|Overall Study|Withdrawal by Subject|0|||
161684483|NCT01349465|583897905|FG000|Overall Study|Adverse Event|1|||
161616745|NCT02691702|583648067|FG000|Overall Study|Other|0|||
161616746|NCT02691702|583648068|FG001|Overall Study|Other|0|||
161616747|NCT02691702|583648069|FG002|Overall Study|Other|0|||
161616748|NCT02691702|583648070|FG003|Overall Study|Other|0|||
161616749|NCT02691702|583648071|FG004|Overall Study|Other|0|||
161616750|NCT02691702|583648072|FG005|Overall Study|Other|0|||
161616751|NCT02691702|583648073|FG006|Overall Study|Other|1|||
161616752|NCT02691702|583648074|FG007|Overall Study|Other|0|||
161616753|NCT02691702|583648075|FG008|Overall Study|Other|1|||
161616754|NCT02691702|583648076|FG009|Overall Study|Other|0|||
161616755|NCT02691702|583648077|FG010|Overall Study|Other|0|||
161616756|NCT02691702|583648067|FG000|Overall Study|Protocol Violation|0|||
161616757|NCT02691702|583648068|FG001|Overall Study|Protocol Violation|0|||
161616758|NCT02691702|583648069|FG002|Overall Study|Protocol Violation|0|||
161616759|NCT02691702|583648070|FG003|Overall Study|Protocol Violation|0|||
161616760|NCT02691702|583648071|FG004|Overall Study|Protocol Violation|0|||
161616761|NCT02691702|583648072|FG005|Overall Study|Protocol Violation|0|||
161616762|NCT02691702|583648073|FG006|Overall Study|Protocol Violation|0|||
161616763|NCT02691702|583648074|FG007|Overall Study|Protocol Violation|0|||
161616764|NCT02691702|583648075|FG008|Overall Study|Protocol Violation|0|||
161616765|NCT02691702|583648076|FG009|Overall Study|Protocol Violation|2|||
161616766|NCT02691702|583648077|FG010|Overall Study|Protocol Violation|0|||
161616767|NCT05613088|583648078|FG000|Treatment|Ongoing Study Treatment|9|||
161616768|NCT05613088|583648079|FG001|Treatment|Ongoing Study Treatment|2|||
161616769|NCT05613088|583648078|FG000|Treatment|Adverse Event|3|||
161616770|NCT05613088|583648079|FG001|Treatment|Adverse Event|1|||
161616771|NCT05613088|583648078|FG000|Treatment|Other Reasons|0|||
161616772|NCT05613088|583648079|FG001|Treatment|Other Reasons|1|||
161616773|NCT05613088|583648078|FG000|Treatment|Progressive Disease|58|||
161616774|NCT05613088|583648079|FG001|Treatment|Progressive Disease|26|||
161616775|NCT05613088|583648078|FG000|Treatment|Withdrawal by Subject|0|||
161616776|NCT05613088|583648079|FG001|Treatment|Withdrawal by Subject|4|||
161616777|NCT05163353|583648082|FG000|Overall Study|Adverse Event|1|||
161616778|NCT05163353|583648083|FG001|Overall Study|Adverse Event|0|||
161616779|NCT05163353|583648082|FG000|Overall Study|Withdrawal by Subject|21|||
161616780|NCT05163353|583648083|FG001|Overall Study|Withdrawal by Subject|6|||
161616781|NCT05163353|583648082|FG000|Overall Study|Protocol Violation|0|||
161616782|NCT05163353|583648083|FG001|Overall Study|Protocol Violation|1|||
161616783|NCT05163353|583648082|FG000|Overall Study|Lost to Follow-up|13|||
161616784|NCT05163353|583648083|FG001|Overall Study|Lost to Follow-up|2|||
161616785|NCT06086028|583648085|FG000|Overall Study|Withdrawal by Subject|1|||
161616786|NCT06086028|583648086|FG001|Overall Study|Withdrawal by Subject|1|||
161616787|NCT06086028|583648085|FG000|Overall Study|Lost to Follow-up|2|||
161616788|NCT06086028|583648086|FG001|Overall Study|Lost to Follow-up|3|||
161616789|NCT00824408|583648087|FG000|Run-in Phase|Progressive disease|4|||
161616790|NCT00824408|583648088|FG001|Run-in Phase|Progressive disease|4|||
161616791|NCT00824408|583648089|FG002|Run-in Phase|Progressive disease|0|||
161616792|NCT00824408|583648090|FG003|Run-in Phase|Progressive disease|0|||
161616793|NCT00824408|583648091|FG004|Run-in Phase|Progressive disease|0|||
161616794|NCT00824408|583648087|FG000|Run-in Phase|Adverse Event|1|||
161616795|NCT00824408|583648088|FG001|Run-in Phase|Adverse Event|1|||
161616796|NCT00824408|583648089|FG002|Run-in Phase|Adverse Event|0|||
161616797|NCT00824408|583648090|FG003|Run-in Phase|Adverse Event|0|||
161616798|NCT00824408|583648091|FG004|Run-in Phase|Adverse Event|0|||
161616799|NCT00824408|583648087|FG000|Run-in Phase|Refused to continue medication|1|||
161616800|NCT00824408|583648088|FG001|Run-in Phase|Refused to continue medication|0|||
161616801|NCT00824408|583648089|FG002|Run-in Phase|Refused to continue medication|0|||
161616802|NCT00824408|583648090|FG003|Run-in Phase|Refused to continue medication|0|||
161616803|NCT00824408|583648091|FG004|Run-in Phase|Refused to continue medication|0|||
161616804|NCT00824408|583648087|FG000|Run-in Phase|Other reason not defined above|0|||
161616805|NCT00824408|583648088|FG001|Run-in Phase|Other reason not defined above|1|||
161616806|NCT00824408|583648089|FG002|Run-in Phase|Other reason not defined above|0|||
161616807|NCT00824408|583648090|FG003|Run-in Phase|Other reason not defined above|0|||
161616808|NCT00824408|583648091|FG004|Run-in Phase|Other reason not defined above|0|||
161616809|NCT00824408|583648087|FG000|Randomized Phase|Not treated|0|||
161616810|NCT00824408|583648088|FG001|Randomized Phase|Not treated|0|||
161616811|NCT00824408|583648089|FG002|Randomized Phase|Not treated|1|||
161616812|NCT00824408|583648090|FG003|Randomized Phase|Not treated|1|||
161616813|NCT00824408|583648091|FG004|Randomized Phase|Not treated|1|||
161616814|NCT00824408|583648087|FG000|Randomized Phase|Progressive disease|0|||
161616815|NCT00824408|583648088|FG001|Randomized Phase|Progressive disease|0|||
161616816|NCT00824408|583648089|FG002|Randomized Phase|Progressive disease|25|||
161616817|NCT00824408|583648090|FG003|Randomized Phase|Progressive disease|36|||
161616818|NCT00824408|583648091|FG004|Randomized Phase|Progressive disease|34|||
161616819|NCT00824408|583648087|FG000|Randomized Phase|Adverse Event|0|||
161616820|NCT00824408|583648088|FG001|Randomized Phase|Adverse Event|0|||
161616821|NCT00824408|583648089|FG002|Randomized Phase|Adverse Event|4|||
161616822|NCT00824408|583648090|FG003|Randomized Phase|Adverse Event|5|||
161616823|NCT00824408|583648091|FG004|Randomized Phase|Adverse Event|5|||
161616824|NCT00824408|583648087|FG000|Randomized Phase|Refused to continue medication|0|||
161616825|NCT00824408|583648088|FG001|Randomized Phase|Refused to continue medication|0|||
161616826|NCT00824408|583648089|FG002|Randomized Phase|Refused to continue medication|2|||
161616827|NCT00824408|583648090|FG003|Randomized Phase|Refused to continue medication|2|||
161616828|NCT00824408|583648091|FG004|Randomized Phase|Refused to continue medication|2|||
161616829|NCT00824408|583648087|FG000|Randomized Phase|Other reason not defined above|0|||
161616830|NCT00824408|583648088|FG001|Randomized Phase|Other reason not defined above|0|||
161616831|NCT00824408|583648089|FG002|Randomized Phase|Other reason not defined above|4|||
161616832|NCT00824408|583648090|FG003|Randomized Phase|Other reason not defined above|2|||
161616833|NCT00824408|583648091|FG004|Randomized Phase|Other reason not defined above|4|||
161616834|NCT01263496|583648097|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
161616835|NCT01263496|583648098|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616836|NCT01263496|583648099|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616837|NCT01263496|583648100|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616838|NCT01263496|583648101|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616839|NCT01263496|583648102|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616840|NCT01263496|583648103|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616841|NCT01263496|583648104|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616842|NCT01263496|583648105|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161616843|NCT01263496|583648097|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616844|NCT01263496|583648098|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616845|NCT01263496|583648099|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616846|NCT01263496|583648100|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161616847|NCT01263496|583648101|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
161616848|NCT01263496|583648102|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616849|NCT01263496|583648103|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616850|NCT01263496|583648104|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616851|NCT01263496|583648105|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161616852|NCT01263496|583648097|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
161616853|NCT01263496|583648098|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
161616854|NCT01263496|583648099|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
161616855|NCT01263496|583648100|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
161616856|NCT01263496|583648101|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
161616857|NCT01263496|583648102|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
161616858|NCT01263496|583648103|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
161616859|NCT01263496|583648104|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
161616860|NCT01263496|583648105|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
161616861|NCT01263496|583648097|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616862|NCT01263496|583648098|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
161616863|NCT01263496|583648099|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616864|NCT01263496|583648100|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616865|NCT01263496|583648101|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616866|NCT01263496|583648102|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616867|NCT01263496|583648103|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616868|NCT01263496|583648104|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616869|NCT01263496|583648105|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161616870|NCT01263496|583648097|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161616871|NCT01263496|583648098|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161616872|NCT01263496|583648099|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161616873|NCT01263496|583648100|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161616874|NCT01263496|583648101|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
161616875|NCT01263496|583648102|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161616876|NCT01263496|583648103|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161616877|NCT01263496|583648104|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161616878|NCT01263496|583648105|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161616879|NCT01263496|583648097|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
161616880|NCT01263496|583648098|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
161684484|NCT01349465|583897906|FG001|Overall Study|Adverse Event|0|||
161684485|NCT01349465|583897905|FG000|Overall Study|Death|3|||
161684486|NCT01349465|583897906|FG001|Overall Study|Death|0|||
161616881|NCT01263496|583648099|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
161616882|NCT01263496|583648100|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161616883|NCT01263496|583648101|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
161616884|NCT01263496|583648102|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161616885|NCT01263496|583648103|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161616886|NCT01263496|583648104|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161616887|NCT01263496|583648105|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161616888|NCT01263496|583648097|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616889|NCT01263496|583648098|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616890|NCT01263496|583648099|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616891|NCT01263496|583648100|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616892|NCT01263496|583648101|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616893|NCT01263496|583648102|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616894|NCT01263496|583648103|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616895|NCT01263496|583648104|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
161616896|NCT01263496|583648105|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161616897|NCT01218594|583648106|FG000|Overall Study|Death|1|||
161616898|NCT01218594|583648106|FG000|Overall Study|Withdrawal by Subject|3|||
161616899|NCT01218594|583648106|FG000|Overall Study|Adverse Event|2|||
161616900|NCT01218594|583648106|FG000|Overall Study|Physician Decision|6|||
161616901|NCT04852978|583648107|FG000|Overall Study|Physician Decision|0|||
161616902|NCT04852978|583648108|FG001|Overall Study|Physician Decision|1|||
161616903|NCT04852978|583648109|FG002|Overall Study|Physician Decision|0|||
161616904|NCT04852978|583648110|FG003|Overall Study|Physician Decision|0|||
161616905|NCT04852978|583648111|FG004|Overall Study|Physician Decision|0|||
161616906|NCT04852978|583648112|FG005|Overall Study|Physician Decision|0|||
161616907|NCT04852978|583648113|FG006|Overall Study|Physician Decision|0|||
161616908|NCT04852978|583648114|FG007|Overall Study|Physician Decision|2|||
161616909|NCT04852978|583648115|FG008|Overall Study|Physician Decision|0|||
161616910|NCT04852978|583648107|FG000|Overall Study|Sponsor request|0|||
161616911|NCT04852978|583648108|FG001|Overall Study|Sponsor request|0|||
161616912|NCT04852978|583648109|FG002|Overall Study|Sponsor request|1|||
161616913|NCT04852978|583648110|FG003|Overall Study|Sponsor request|0|||
161616914|NCT04852978|583648111|FG004|Overall Study|Sponsor request|0|||
161616915|NCT04852978|583648112|FG005|Overall Study|Sponsor request|0|||
161616916|NCT04852978|583648113|FG006|Overall Study|Sponsor request|0|||
161616917|NCT04852978|583648114|FG007|Overall Study|Sponsor request|0|||
161616918|NCT04852978|583648115|FG008|Overall Study|Sponsor request|0|||
161616919|NCT04852978|583648107|FG000|Overall Study|Death|0|||
161616920|NCT04852978|583648108|FG001|Overall Study|Death|0|||
161616921|NCT04852978|583648109|FG002|Overall Study|Death|0|||
161616922|NCT04852978|583648110|FG003|Overall Study|Death|0|||
161616923|NCT04852978|583648111|FG004|Overall Study|Death|0|||
161616924|NCT04852978|583648112|FG005|Overall Study|Death|0|||
161616925|NCT04852978|583648113|FG006|Overall Study|Death|1|||
161616926|NCT04852978|583648114|FG007|Overall Study|Death|0|||
161616927|NCT04852978|583648115|FG008|Overall Study|Death|0|||
161616928|NCT04852978|583648107|FG000|Overall Study|Lost to Follow-up|3|||
161616929|NCT04852978|583648108|FG001|Overall Study|Lost to Follow-up|2|||
161616930|NCT04852978|583648109|FG002|Overall Study|Lost to Follow-up|2|||
161616931|NCT04852978|583648110|FG003|Overall Study|Lost to Follow-up|0|||
161616932|NCT04852978|583648111|FG004|Overall Study|Lost to Follow-up|2|||
161616933|NCT04852978|583648112|FG005|Overall Study|Lost to Follow-up|4|||
161616934|NCT04852978|583648113|FG006|Overall Study|Lost to Follow-up|1|||
161616935|NCT04852978|583648114|FG007|Overall Study|Lost to Follow-up|2|||
161616936|NCT04852978|583648115|FG008|Overall Study|Lost to Follow-up|2|||
161616937|NCT04852978|583648107|FG000|Overall Study|Withdrawal by Subject|4|||
161616938|NCT04852978|583648108|FG001|Overall Study|Withdrawal by Subject|2|||
161616939|NCT04852978|583648109|FG002|Overall Study|Withdrawal by Subject|2|||
161616940|NCT04852978|583648110|FG003|Overall Study|Withdrawal by Subject|1|||
161616941|NCT04852978|583648111|FG004|Overall Study|Withdrawal by Subject|5|||
161616942|NCT04852978|583648112|FG005|Overall Study|Withdrawal by Subject|3|||
161616943|NCT04852978|583648113|FG006|Overall Study|Withdrawal by Subject|2|||
161616944|NCT04852978|583648114|FG007|Overall Study|Withdrawal by Subject|2|||
161616945|NCT04852978|583648115|FG008|Overall Study|Withdrawal by Subject|1|||
161616946|NCT02196259|583650047|FG000|Overall Study|Researcher choice|0|||
161616947|NCT02196259|583650048|FG001|Overall Study|Researcher choice|0|||
161616948|NCT02196259|583650049|FG002|Overall Study|Researcher choice|1|||
161616949|NCT02196259|583650047|FG000|Overall Study|Partial data analysis|0|||
161616950|NCT02196259|583650048|FG001|Overall Study|Partial data analysis|3|||
161616951|NCT02196259|583650049|FG002|Overall Study|Partial data analysis|0|||
161616952|NCT01668355|583650051|FG000|Overall Study|Death|3|||
161616953|NCT01668355|583650052|FG001|Overall Study|Death|1|||
161616954|NCT01668355|583650051|FG000|Overall Study|Withdrawal by Subject|6|||
161616955|NCT01668355|583650052|FG001|Overall Study|Withdrawal by Subject|1|||
161616956|NCT00535626|583650053|FG000|Overall Study|Death|15|||
161616957|NCT00535626|583650053|FG000|Overall Study|Lost to Follow-up|29|||
161616958|NCT00535626|583650053|FG000|Overall Study|Withdrawal by Subject|20|||
161832758|NCT03310957|584429589|FG000|Overall Study|Hospice|0|||
161616959|NCT00535626|583650053|FG000|Overall Study|Removal/revision of study component|8|||
161616960|NCT00535626|583650053|FG000|Overall Study|Subject terminated|31|||
161616961|NCT00535626|583650053|FG000|Overall Study|Unable to return|2|||
161616962|NCT04633200|583650054|FG000|Overall Study|Lost to Follow-up|3|||
161616963|NCT04633200|583650055|FG001|Overall Study|Lost to Follow-up|5|||
161616964|NCT02002689|583650056|FG000|Overall Study|Disease Progression|7|||
161616965|NCT02002689|583650056|FG000|Overall Study|Adverse Event|3|||
161616966|NCT01808534|583650057|FG000|Overall Study|Disease progression|3|||
161616967|NCT01808534|583650057|FG000|Overall Study|Physician Decision|1|||
161616968|NCT01148017|583650060|FG000|Overall Study|Withdrawal by Subject|31|||
161616969|NCT01148017|583650061|FG001|Overall Study|Withdrawal by Subject|14|||
161616970|NCT01148017|583650062|FG002|Overall Study|Withdrawal by Subject|0|||
161616971|NCT01148017|583650063|FG003|Overall Study|Withdrawal by Subject|0|||
161616972|NCT01148017|583650060|FG000|Overall Study|Lost to Follow-up|23|||
161616973|NCT01148017|583650061|FG001|Overall Study|Lost to Follow-up|10|||
161616974|NCT01148017|583650062|FG002|Overall Study|Lost to Follow-up|0|||
161616975|NCT01148017|583650063|FG003|Overall Study|Lost to Follow-up|0|||
161616976|NCT01148017|583650060|FG000|Overall Study|Inappropriate enrollment|1|||
161616977|NCT01148017|583650061|FG001|Overall Study|Inappropriate enrollment|0|||
161616978|NCT01148017|583650062|FG002|Overall Study|Inappropriate enrollment|0|||
161616979|NCT01148017|583650063|FG003|Overall Study|Inappropriate enrollment|0|||
161616980|NCT01148017|583650060|FG000|Overall Study|Administrative reason|22|||
161616981|NCT01148017|583650061|FG001|Overall Study|Administrative reason|9|||
161616982|NCT01148017|583650062|FG002|Overall Study|Administrative reason|0|||
161616983|NCT01148017|583650063|FG003|Overall Study|Administrative reason|0|||
161616984|NCT01148017|583650060|FG000|Overall Study|Unable to classify|3|||
161616985|NCT01148017|583650061|FG001|Overall Study|Unable to classify|1|||
161616986|NCT01148017|583650062|FG002|Overall Study|Unable to classify|0|||
161616987|NCT01148017|583650063|FG003|Overall Study|Unable to classify|0|||
161616988|NCT01853384|583650064|FG000|Randomized|Adverse Event|5|||
161616989|NCT01853384|583650065|FG001|Randomized|Adverse Event|3|||
161616990|NCT01853384|583650064|FG000|Randomized|Death|1|||
161616991|NCT01853384|583650065|FG001|Randomized|Death|2|||
161616992|NCT01853384|583650064|FG000|Randomized|Lost to Follow-up|1|||
161616993|NCT01853384|583650065|FG001|Randomized|Lost to Follow-up|1|||
161616994|NCT01853384|583650064|FG000|Randomized|Withdrawal by Subject|5|||
161616995|NCT01853384|583650065|FG001|Randomized|Withdrawal by Subject|3|||
161616996|NCT01853384|583650064|FG000|Randomized|Sponsor Decision|47|||
161616997|NCT01853384|583650065|FG001|Randomized|Sponsor Decision|34|||
161616998|NCT01853384|583650064|FG000|Randomized|Other|3|||
161616999|NCT01853384|583650065|FG001|Randomized|Other|3|||
161617000|NCT01853384|583650064|FG000|Completed Follow up Visit 1|Early Termination|13|||
161617001|NCT01853384|583650065|FG001|Completed Follow up Visit 1|Early Termination|9|||
161617002|NCT01853384|583650064|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
161617003|NCT01853384|583650065|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
161617004|NCT01853384|583650064|FG000|Completed Follow up Visit 2|Adverse Event|1|||
161617005|NCT01853384|583650065|FG001|Completed Follow up Visit 2|Adverse Event|0|||
161617006|NCT01853384|583650064|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
161617007|NCT01853384|583650065|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
161617008|NCT01853384|583650064|FG000|Completed Follow up Visit 2|Death|1|||
161617009|NCT01853384|583650065|FG001|Completed Follow up Visit 2|Death|0|||
161617010|NCT01853384|583650064|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
161617011|NCT01853384|583650065|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
161617012|NCT03374254|583650066|FG000|Overall Study|Death|5|||
161617013|NCT03374254|583650067|FG001|Overall Study|Death|16|||
161617014|NCT03374254|583650068|FG002|Overall Study|Death|13|||
161617015|NCT03374254|583650069|FG003|Overall Study|Death|11|||
161617016|NCT03374254|583650070|FG004|Overall Study|Death|9|||
161617017|NCT03374254|583650071|FG005|Overall Study|Death|12|||
161617018|NCT03374254|583650072|FG006|Overall Study|Death|11|||
161617019|NCT03374254|583650073|FG007|Overall Study|Death|6|||
161617020|NCT03374254|583650074|FG008|Overall Study|Death|7|||
161617021|NCT03374254|583650066|FG000|Overall Study|Lost to Follow-up|0|||
161617022|NCT03374254|583650067|FG001|Overall Study|Lost to Follow-up|0|||
161617023|NCT03374254|583650068|FG002|Overall Study|Lost to Follow-up|0|||
161617024|NCT03374254|583650069|FG003|Overall Study|Lost to Follow-up|0|||
161617025|NCT03374254|583650070|FG004|Overall Study|Lost to Follow-up|0|||
161617026|NCT03374254|583650071|FG005|Overall Study|Lost to Follow-up|0|||
161617027|NCT03374254|583650072|FG006|Overall Study|Lost to Follow-up|2|||
161617028|NCT03374254|583650073|FG007|Overall Study|Lost to Follow-up|0|||
161617029|NCT03374254|583650074|FG008|Overall Study|Lost to Follow-up|0|||
161617030|NCT03374254|583650066|FG000|Overall Study|Sponsor Decision|1|||
161617031|NCT03374254|583650067|FG001|Overall Study|Sponsor Decision|0|||
161617032|NCT03374254|583650068|FG002|Overall Study|Sponsor Decision|2|||
161617033|NCT03374254|583650069|FG003|Overall Study|Sponsor Decision|3|||
161617034|NCT03374254|583650070|FG004|Overall Study|Sponsor Decision|2|||
161617035|NCT03374254|583650071|FG005|Overall Study|Sponsor Decision|3|||
161617036|NCT03374254|583650072|FG006|Overall Study|Sponsor Decision|3|||
161617037|NCT03374254|583650073|FG007|Overall Study|Sponsor Decision|3|||
161617038|NCT03374254|583650074|FG008|Overall Study|Sponsor Decision|4|||
161617039|NCT03374254|583650066|FG000|Overall Study|Withdrawal by Subject|0|||
161617040|NCT03374254|583650067|FG001|Overall Study|Withdrawal by Subject|0|||
161617041|NCT03374254|583650068|FG002|Overall Study|Withdrawal by Subject|0|||
161617042|NCT03374254|583650069|FG003|Overall Study|Withdrawal by Subject|2|||
161617043|NCT03374254|583650070|FG004|Overall Study|Withdrawal by Subject|0|||
161617044|NCT03374254|583650071|FG005|Overall Study|Withdrawal by Subject|1|||
161617045|NCT03374254|583650072|FG006|Overall Study|Withdrawal by Subject|0|||
161617046|NCT03374254|583650073|FG007|Overall Study|Withdrawal by Subject|0|||
161617047|NCT03374254|583650074|FG008|Overall Study|Withdrawal by Subject|0|||
161617048|NCT02245620|583650080|FG000|Overall Study|Physician Decision|1|||
161617049|NCT02245620|583650081|FG001|Overall Study|Physician Decision|1|||
161617050|NCT04766996|583650082|FG000|Overall Study|Withdrawal by Subject|1|||
161617051|NCT04766996|583650083|FG001|Overall Study|Withdrawal by Subject|0|||
161617052|NCT04766996|583650084|FG002|Overall Study|Withdrawal by Subject|13|||
161617053|NCT01322386|583650085|FG000|Overall Study|Protocol Violation|0|||
161617054|NCT01322386|583650086|FG001|Overall Study|Protocol Violation|1|||
161617055|NCT01322386|583650085|FG000|Overall Study|Physician Decision|0|||
161617056|NCT01322386|583650086|FG001|Overall Study|Physician Decision|1|||
161617057|NCT01102426|583650089|FG000|Overall Study|Randomized but not treated|4|||
161617058|NCT01102426|583650090|FG001|Overall Study|Randomized but not treated|1|||
161617059|NCT01102426|583650089|FG000|Overall Study|Adverse Events (treatment-related)|15|||
161617060|NCT01102426|583650090|FG001|Overall Study|Adverse Events (treatment-related)|8|||
161617061|NCT01102426|583650089|FG000|Overall Study|Physician Decision|9|||
161617062|NCT01102426|583650090|FG001|Overall Study|Physician Decision|6|||
161617063|NCT01102426|583650089|FG000|Overall Study|Progressive Disease|85|||
161617064|NCT01102426|583650090|FG001|Overall Study|Progressive Disease|44|||
161617065|NCT01102426|583650089|FG000|Overall Study|Adverse Events (unrelated to|9|||
161617066|NCT01102426|583650090|FG001|Overall Study|Adverse Events (unrelated to|1|||
161617067|NCT01102426|583650089|FG000|Overall Study|Patient Refusal|24|||
161617068|NCT01102426|583650090|FG001|Overall Study|Patient Refusal|12|||
161617069|NCT01102426|583650089|FG000|Overall Study|Death (due to adverse events|0|||
161617070|NCT01102426|583650090|FG001|Overall Study|Death (due to adverse events|1|||
161617071|NCT01102426|583650089|FG000|Overall Study|Death (non-related to the study|19|||
161617072|NCT01102426|583650090|FG001|Overall Study|Death (non-related to the study|8|||
161617073|NCT00871494|583650094|FG000|Overall Study|Protocol Violation|5|||
161617074|NCT00871494|583650094|FG000|Overall Study|Lack of Efficacy|4|||
161617075|NCT00871494|583650094|FG000|Overall Study|Adverse Event|4|||
161617076|NCT00871494|583650094|FG000|Overall Study|Lost to Follow-up|1|||
161617077|NCT02988713|583650101|FG000|Overall Study|Withdrawal by Subject|1|||
161617078|NCT02988713|583650101|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
161617079|NCT02404441|583650102|FG000|Phase 1 Part|Adverse Event|1|||
161617080|NCT02404441|583650103|FG001|Phase 1 Part|Adverse Event|0|||
161617081|NCT02404441|583650104|FG002|Phase 1 Part|Adverse Event|0|||
161617082|NCT02404441|583650105|FG003|Phase 1 Part|Adverse Event|0|||
161617083|NCT02404441|583650106|FG004|Phase 1 Part|Adverse Event|0|||
161617084|NCT02404441|583650107|FG005|Phase 1 Part|Adverse Event|0|||
161617085|NCT02404441|583650108|FG006|Phase 1 Part|Adverse Event|0|||
161617086|NCT02404441|583650109|FG007|Phase 1 Part|Adverse Event|0|||
161617087|NCT02404441|583650110|FG008|Phase 1 Part|Adverse Event|0|||
161617088|NCT02404441|583650111|FG009|Phase 1 Part|Adverse Event|0|||
161617089|NCT02404441|583650102|FG000|Phase 1 Part|Physician Decision|0|||
161617090|NCT02404441|583650103|FG001|Phase 1 Part|Physician Decision|1|||
161617091|NCT02404441|583650104|FG002|Phase 1 Part|Physician Decision|0|||
161617092|NCT02404441|583650105|FG003|Phase 1 Part|Physician Decision|0|||
161617093|NCT02404441|583650106|FG004|Phase 1 Part|Physician Decision|0|||
161617094|NCT02404441|583650107|FG005|Phase 1 Part|Physician Decision|0|||
161617095|NCT02404441|583650108|FG006|Phase 1 Part|Physician Decision|0|||
161617096|NCT02404441|583650109|FG007|Phase 1 Part|Physician Decision|0|||
161617097|NCT02404441|583650110|FG008|Phase 1 Part|Physician Decision|0|||
161617098|NCT02404441|583650111|FG009|Phase 1 Part|Physician Decision|0|||
161617099|NCT02404441|583650102|FG000|Phase 1 Part|Progressive Disease|14|||
161617100|NCT02404441|583650103|FG001|Phase 1 Part|Progressive Disease|11|||
161617101|NCT02404441|583650104|FG002|Phase 1 Part|Progressive Disease|7|||
161617102|NCT02404441|583650105|FG003|Phase 1 Part|Progressive Disease|6|||
161617103|NCT02404441|583650106|FG004|Phase 1 Part|Progressive Disease|9|||
161617104|NCT02404441|583650107|FG005|Phase 1 Part|Progressive Disease|0|||
161617105|NCT02404441|583650108|FG006|Phase 1 Part|Progressive Disease|0|||
161617106|NCT02404441|583650109|FG007|Phase 1 Part|Progressive Disease|0|||
161617107|NCT02404441|583650110|FG008|Phase 1 Part|Progressive Disease|0|||
161617108|NCT02404441|583650111|FG009|Phase 1 Part|Progressive Disease|0|||
161617109|NCT02404441|583650102|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
161617110|NCT02404441|583650103|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
161617111|NCT02404441|583650104|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
161617112|NCT02404441|583650105|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
161617113|NCT02404441|583650106|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
161617114|NCT02404441|583650107|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
161617115|NCT02404441|583650108|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
161617116|NCT02404441|583650109|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
161617117|NCT02404441|583650110|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
161617118|NCT02404441|583650111|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
161617119|NCT02404441|583650102|FG000|Phase 1 Part|Death|1|||
161617120|NCT02404441|583650103|FG001|Phase 1 Part|Death|1|||
161617121|NCT02404441|583650104|FG002|Phase 1 Part|Death|1|||
161617122|NCT02404441|583650105|FG003|Phase 1 Part|Death|0|||
161617123|NCT02404441|583650106|FG004|Phase 1 Part|Death|1|||
161617124|NCT02404441|583650107|FG005|Phase 1 Part|Death|0|||
161617125|NCT02404441|583650108|FG006|Phase 1 Part|Death|0|||
161617126|NCT02404441|583650109|FG007|Phase 1 Part|Death|0|||
161617127|NCT02404441|583650110|FG008|Phase 1 Part|Death|0|||
161617128|NCT02404441|583650111|FG009|Phase 1 Part|Death|0|||
161617129|NCT02404441|583650102|FG000|Phase 2 Part|Adverse Event|0|||
161617130|NCT02404441|583650103|FG001|Phase 2 Part|Adverse Event|0|||
161617131|NCT02404441|583650104|FG002|Phase 2 Part|Adverse Event|0|||
161617132|NCT02404441|583650105|FG003|Phase 2 Part|Adverse Event|0|||
161617133|NCT02404441|583650106|FG004|Phase 2 Part|Adverse Event|0|||
161617134|NCT02404441|583650107|FG005|Phase 2 Part|Adverse Event|2|||
161617135|NCT02404441|583650108|FG006|Phase 2 Part|Adverse Event|3|||
161617136|NCT02404441|583650109|FG007|Phase 2 Part|Adverse Event|3|||
161617137|NCT02404441|583650110|FG008|Phase 2 Part|Adverse Event|6|||
161617138|NCT02404441|583650111|FG009|Phase 2 Part|Adverse Event|1|||
161617139|NCT02404441|583650102|FG000|Phase 2 Part|Physician Decision|0|||
161617140|NCT02404441|583650103|FG001|Phase 2 Part|Physician Decision|0|||
161617141|NCT02404441|583650104|FG002|Phase 2 Part|Physician Decision|0|||
161617142|NCT02404441|583650105|FG003|Phase 2 Part|Physician Decision|0|||
161617143|NCT02404441|583650106|FG004|Phase 2 Part|Physician Decision|0|||
161617144|NCT02404441|583650107|FG005|Phase 2 Part|Physician Decision|7|||
161617145|NCT02404441|583650108|FG006|Phase 2 Part|Physician Decision|9|||
161617146|NCT02404441|583650109|FG007|Phase 2 Part|Physician Decision|2|||
161617147|NCT02404441|583650110|FG008|Phase 2 Part|Physician Decision|1|||
161617148|NCT02404441|583650111|FG009|Phase 2 Part|Physician Decision|3|||
161617149|NCT02404441|583650102|FG000|Phase 2 Part|Progressive disease|0|||
161617150|NCT02404441|583650103|FG001|Phase 2 Part|Progressive disease|0|||
161617151|NCT02404441|583650104|FG002|Phase 2 Part|Progressive disease|0|||
161617152|NCT02404441|583650105|FG003|Phase 2 Part|Progressive disease|0|||
161617153|NCT02404441|583650106|FG004|Phase 2 Part|Progressive disease|0|||
161617154|NCT02404441|583650107|FG005|Phase 2 Part|Progressive disease|43|||
161617155|NCT02404441|583650108|FG006|Phase 2 Part|Progressive disease|32|||
161617156|NCT02404441|583650109|FG007|Phase 2 Part|Progressive disease|31|||
161617157|NCT02404441|583650110|FG008|Phase 2 Part|Progressive disease|39|||
161617158|NCT02404441|583650111|FG009|Phase 2 Part|Progressive disease|27|||
161617159|NCT02404441|583650102|FG000|Phase 2 Part|Subject/guardian decision|0|||
161617160|NCT02404441|583650103|FG001|Phase 2 Part|Subject/guardian decision|0|||
161617161|NCT02404441|583650104|FG002|Phase 2 Part|Subject/guardian decision|0|||
161617162|NCT02404441|583650105|FG003|Phase 2 Part|Subject/guardian decision|0|||
161617163|NCT02404441|583650106|FG004|Phase 2 Part|Subject/guardian decision|0|||
161617164|NCT02404441|583650107|FG005|Phase 2 Part|Subject/guardian decision|3|||
161617165|NCT02404441|583650108|FG006|Phase 2 Part|Subject/guardian decision|9|||
161617166|NCT02404441|583650109|FG007|Phase 2 Part|Subject/guardian decision|0|||
161684487|NCT01349465|583897905|FG000|Overall Study|Lost to Follow-up|10|||
161617167|NCT02404441|583650110|FG008|Phase 2 Part|Subject/guardian decision|3|||
161617168|NCT02404441|583650111|FG009|Phase 2 Part|Subject/guardian decision|2|||
161617169|NCT02404441|583650102|FG000|Phase 2 Part|Death|0|||
161617170|NCT02404441|583650103|FG001|Phase 2 Part|Death|0|||
161617171|NCT02404441|583650104|FG002|Phase 2 Part|Death|0|||
161684488|NCT01349465|583897906|FG001|Overall Study|Lost to Follow-up|1|||
161684489|NCT01349465|583897905|FG000|Overall Study|Withdrawal by Subject|4|||
161684490|NCT01349465|583897906|FG001|Overall Study|Withdrawal by Subject|2|||
161684491|NCT01349465|583897905|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
161832759|NCT03310957|584429590|FG001|Overall Study|Hospice|0|||
161617172|NCT02404441|583650105|FG003|Phase 2 Part|Death|0|||
161617173|NCT02404441|583650106|FG004|Phase 2 Part|Death|0|||
161617174|NCT02404441|583650107|FG005|Phase 2 Part|Death|4|||
161617175|NCT02404441|583650108|FG006|Phase 2 Part|Death|8|||
161617176|NCT02404441|583650109|FG007|Phase 2 Part|Death|4|||
161617177|NCT02404441|583650110|FG008|Phase 2 Part|Death|10|||
161617178|NCT02404441|583650111|FG009|Phase 2 Part|Death|9|||
161617179|NCT00088166|583650112|FG000|Overall Study|Adverse Event|11|||
161617180|NCT00088166|583650113|FG001|Overall Study|Adverse Event|9|||
161617181|NCT00088166|583650112|FG000|Overall Study|Death|3|||
161617182|NCT00088166|583650113|FG001|Overall Study|Death|1|||
161617183|NCT00088166|583650112|FG000|Overall Study|Lost to Follow-up|0|||
161617184|NCT00088166|583650113|FG001|Overall Study|Lost to Follow-up|1|||
161617185|NCT00088166|583650112|FG000|Overall Study|Physician Decision|4|||
161617186|NCT00088166|583650113|FG001|Overall Study|Physician Decision|1|||
161617187|NCT00088166|583650112|FG000|Overall Study|Protocol Violation|1|||
161617188|NCT00088166|583650113|FG001|Overall Study|Protocol Violation|5|||
161617189|NCT00088166|583650112|FG000|Overall Study|Patient deterioration|29|||
161617190|NCT00088166|583650113|FG001|Overall Study|Patient deterioration|39|||
161617191|NCT00088166|583650112|FG000|Overall Study|Withdrawal by Subject|5|||
161617192|NCT00088166|583650113|FG001|Overall Study|Withdrawal by Subject|5|||
161617193|NCT02671266|583650114|FG000|Overall Study|Withdrawal by Subject|1|||
161684492|NCT01349465|583897906|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
161684493|NCT04329702|583897909|FG000|Overall Study|illness|3|||
161684494|NCT04329702|583897910|FG001|Overall Study|illness|4|||
161684495|NCT04329702|583897911|FG002|Overall Study|illness|0|||
161684496|NCT04329702|583897909|FG000|Overall Study|Lost to Follow-up|0|||
161684497|NCT04329702|583897910|FG001|Overall Study|Lost to Follow-up|0|||
161684498|NCT04329702|583897911|FG002|Overall Study|Lost to Follow-up|2|||
161684499|NCT04329702|583897909|FG000|Overall Study|Death|0|||
161684500|NCT04329702|583897910|FG001|Overall Study|Death|2|||
161684501|NCT04329702|583897911|FG002|Overall Study|Death|0|||
161684502|NCT01476475|583897912|FG000|Overall Study|Adverse Event|6|||
161684503|NCT01476475|583897913|FG001|Overall Study|Adverse Event|0|||
161684504|NCT01476475|583897912|FG000|Overall Study|Poor compliance to protocol|1|||
161684505|NCT01476475|583897913|FG001|Overall Study|Poor compliance to protocol|1|||
161684506|NCT01476475|583897912|FG000|Overall Study|Other reasons|4|||
161684507|NCT01476475|583897913|FG001|Overall Study|Other reasons|2|||
161684508|NCT00751400|583897915|FG000|Overall Study|Lost to Follow-up|10|||
161684509|NCT01918007|583897918|FG000|Overall Study|Baseline oximetry not acceptable|11|||
161684510|NCT01918007|583897919|FG001|Overall Study|Baseline oximetry not acceptable|7|||
161684511|NCT01918007|583897918|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
161684512|NCT01918007|583897919|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
161684513|NCT01918007|583897918|FG000|Overall Study|Lost to Follow-up|4|||
161684514|NCT01918007|583897919|FG001|Overall Study|Lost to Follow-up|7|||
161684515|NCT01471015|583897926|FG000|Overall Study|Death|0|||
161684516|NCT01471015|583897927|FG001|Overall Study|Death|1|||
161684517|NCT01471015|583897928|FG002|Overall Study|Death|1|||
161684518|NCT04206020|583897929|FG000|Overall Study|Adverse Event|1|||
161684519|NCT04206020|583897930|FG001|Overall Study|Adverse Event|4|||
161684520|NCT04206020|583897929|FG000|Overall Study|Protocol Violation|2|||
161684521|NCT04206020|583897930|FG001|Overall Study|Protocol Violation|0|||
161684522|NCT04206020|583897929|FG000|Overall Study|Withdrawal by Subject|2|||
161684523|NCT04206020|583897930|FG001|Overall Study|Withdrawal by Subject|0|||
161684524|NCT04206020|583897929|FG000|Overall Study|Lost to Follow-up|2|||
161684525|NCT04206020|583897930|FG001|Overall Study|Lost to Follow-up|0|||
161684526|NCT04206020|583897929|FG000|Overall Study|Pregnancy|0|||
161684527|NCT04206020|583897930|FG001|Overall Study|Pregnancy|1|||
161684528|NCT04206020|583897929|FG000|Overall Study|Unable to attend visits|1|||
161684529|NCT04206020|583897930|FG001|Overall Study|Unable to attend visits|2|||
161684530|NCT04962022|583897931|FG000|Period 1|Withdrawal by Subject|1|||
161684531|NCT04962022|583897932|FG001|Period 1|Withdrawal by Subject|0|||
161684532|NCT02055820|583897939|FG000|Phase I: Dose-Finding|Death|1|||
161684533|NCT02055820|583897940|FG001|Phase I: Dose-Finding|Death|0|||
161684534|NCT02055820|583897941|FG002|Phase I: Dose-Finding|Death|1|||
161684535|NCT02055820|583897942|FG003|Phase I: Dose-Finding|Death|2|||
161684536|NCT02055820|583897943|FG004|Phase I: Dose-Finding|Death|0|||
161684537|NCT02055820|583897944|FG005|Phase I: Dose-Finding|Death|1|||
161684538|NCT02055820|583897945|FG006|Phase I: Dose-Finding|Death|1|||
161684539|NCT02055820|583897946|FG007|Phase I: Dose-Finding|Death|0|||
161617194|NCT02671266|583650115|FG001|Overall Study|Withdrawal by Subject|1|||
161684540|NCT02055820|583897947|FG008|Phase I: Dose-Finding|Death|0|||
161684541|NCT02055820|583897948|FG009|Phase I: Dose-Finding|Death|0|||
161684542|NCT02055820|583897939|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684543|NCT02055820|583897940|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684544|NCT02055820|583897941|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684545|NCT02055820|583897942|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684546|NCT02055820|583897943|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161617195|NCT00666705|583650116|FG000|Overall Study|Withdrawal by Subject|1|||
161684547|NCT02055820|583897944|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
161684548|NCT02055820|583897945|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684549|NCT02055820|583897946|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684550|NCT02055820|583897947|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684551|NCT02055820|583897948|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161617196|NCT01976507|583650119|FG000|Overall Study|Adverse Event|6|||
161617197|NCT01976507|583650119|FG000|Overall Study|ablation not done, drug not given|1|||
161617198|NCT01029704|583650121|FG000|Overall Study|Adverse Event|0|||
161617199|NCT01029704|583650122|FG001|Overall Study|Adverse Event|0|||
161617200|NCT01029704|583650123|FG002|Overall Study|Adverse Event|0|||
161617201|NCT01029704|583650124|FG003|Overall Study|Adverse Event|0|||
161617202|NCT01029704|583650125|FG004|Overall Study|Adverse Event|0|||
161617203|NCT01029704|583650126|FG005|Overall Study|Adverse Event|0|||
161617204|NCT01029704|583650127|FG006|Overall Study|Adverse Event|1|||
161617205|NCT01029704|583650128|FG007|Overall Study|Adverse Event|1|||
161617206|NCT01029704|583650129|FG008|Overall Study|Adverse Event|0|||
161617207|NCT01029704|583650121|FG000|Overall Study|Withdrawal by Subject|0|||
161617208|NCT01029704|583650122|FG001|Overall Study|Withdrawal by Subject|0|||
161617209|NCT01029704|583650123|FG002|Overall Study|Withdrawal by Subject|0|||
161617210|NCT01029704|583650124|FG003|Overall Study|Withdrawal by Subject|0|||
161617211|NCT01029704|583650125|FG004|Overall Study|Withdrawal by Subject|2|||
161617212|NCT01029704|583650126|FG005|Overall Study|Withdrawal by Subject|1|||
161617213|NCT01029704|583650127|FG006|Overall Study|Withdrawal by Subject|1|||
161617214|NCT01029704|583650128|FG007|Overall Study|Withdrawal by Subject|1|||
161617215|NCT01029704|583650129|FG008|Overall Study|Withdrawal by Subject|0|||
161617216|NCT01029704|583650121|FG000|Overall Study|Lost to Follow-up|0|||
161617217|NCT01029704|583650122|FG001|Overall Study|Lost to Follow-up|0|||
161617218|NCT01029704|583650123|FG002|Overall Study|Lost to Follow-up|0|||
161617219|NCT01029704|583650124|FG003|Overall Study|Lost to Follow-up|0|||
161617220|NCT01029704|583650125|FG004|Overall Study|Lost to Follow-up|0|||
161617221|NCT01029704|583650126|FG005|Overall Study|Lost to Follow-up|0|||
161617222|NCT01029704|583650127|FG006|Overall Study|Lost to Follow-up|1|||
161617223|NCT01029704|583650128|FG007|Overall Study|Lost to Follow-up|1|||
161617224|NCT01029704|583650129|FG008|Overall Study|Lost to Follow-up|1|||
161617225|NCT01029704|583650121|FG000|Overall Study|Lack of Efficacy|0|||
161617226|NCT01029704|583650122|FG001|Overall Study|Lack of Efficacy|0|||
161617227|NCT01029704|583650123|FG002|Overall Study|Lack of Efficacy|0|||
161617228|NCT01029704|583650124|FG003|Overall Study|Lack of Efficacy|0|||
161617229|NCT01029704|583650125|FG004|Overall Study|Lack of Efficacy|2|||
161617230|NCT01029704|583650126|FG005|Overall Study|Lack of Efficacy|3|||
161617231|NCT01029704|583650127|FG006|Overall Study|Lack of Efficacy|1|||
161617232|NCT01029704|583650128|FG007|Overall Study|Lack of Efficacy|2|||
161617233|NCT01029704|583650129|FG008|Overall Study|Lack of Efficacy|0|||
161617234|NCT01029704|583650121|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
161617235|NCT01029704|583650122|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
161617236|NCT01029704|583650123|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
161617237|NCT01029704|583650124|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
161617238|NCT01029704|583650125|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
161617239|NCT01029704|583650126|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
161617240|NCT01029704|583650127|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
161617241|NCT01029704|583650128|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
161617242|NCT01029704|583650129|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
161617243|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
161617244|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
161617245|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
161617246|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
161617247|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Death|0|||
161617248|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Death|0|||
161617249|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Death|1|||
161617250|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Death|0|||
161617251|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
161617252|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
161617253|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
161617254|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
161684552|NCT02055820|583897939|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
161617255|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161617256|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
161617257|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161617258|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
161617259|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
161617260|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
161617261|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
161832760|NCT03310957|584429591|FG002|Overall Study|Hospice|0|||
161617262|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
161617263|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
161617264|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
161617265|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
161617266|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
161617267|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
161617268|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
161617269|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
161617270|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
161617271|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Other|2|||
161617272|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Other|0|||
161617273|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Other|0|||
161617274|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Other|0|||
161617275|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
161617276|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
161617277|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
161617278|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
161617279|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
161617280|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
161617281|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
161617282|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
161617283|NCT03845517|583650130|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
161617284|NCT03845517|583650131|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
161617285|NCT03845517|583650132|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
161617286|NCT03845517|583650133|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
161617287|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
161617288|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
161617289|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
161617290|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
161617291|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Death|0|||
161617292|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Death|0|||
161617293|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Death|1|||
161617294|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Death|1|||
161617295|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
161617296|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
161617297|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
161617298|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
161617299|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
161617300|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
161617301|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
161617302|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
161617303|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
161617304|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
161617305|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
161617306|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
161617307|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Other|1|||
161617308|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Other|0|||
161617309|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Other|1|||
161617310|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Other|0|||
161617311|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
161617312|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
161617313|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
161617314|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
161617315|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
161617316|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
161617317|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
161684553|NCT02055820|583897940|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684554|NCT02055820|583897941|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
161617318|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
161617319|NCT03845517|583650130|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
161617320|NCT03845517|583650131|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
161617321|NCT03845517|583650132|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
161617322|NCT03845517|583650133|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
161617323|NCT01109979|583650134|FG000|Overall Study|Physician Decision|2|||
161617324|NCT01109979|583650135|FG001|Overall Study|Physician Decision|0|||
161617325|NCT01109979|583650134|FG000|Overall Study|Withdrawal by Subject|0|||
161617326|NCT01109979|583650135|FG001|Overall Study|Withdrawal by Subject|1|||
161617327|NCT03136861|583650138|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
161617328|NCT03136861|583650139|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
161617329|NCT03136861|583650140|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161617330|NCT03136861|583650141|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161617331|NCT03136861|583650142|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161617332|NCT03136861|583650143|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161617333|NCT03136861|583650144|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161617334|NCT03136861|583650138|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
161684555|NCT02055820|583897942|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
161684556|NCT02055820|583897943|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684557|NCT02055820|583897944|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684558|NCT02055820|583897945|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
161684559|NCT02055820|583897946|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684560|NCT02055820|583897947|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684561|NCT02055820|583897948|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684562|NCT02055820|583897939|FG000|Phase II: Expansion|Death|0|||
161684563|NCT02055820|583897940|FG001|Phase II: Expansion|Death|0|||
161684564|NCT02055820|583897941|FG002|Phase II: Expansion|Death|0|||
161684565|NCT02055820|583897942|FG003|Phase II: Expansion|Death|0|||
161684566|NCT02055820|583897943|FG004|Phase II: Expansion|Death|33|||
161684567|NCT02055820|583897944|FG005|Phase II: Expansion|Death|0|||
161832761|NCT03310957|584429592|FG003|Overall Study|Hospice|0|||
161832762|NCT03310957|584429593|FG004|Overall Study|Hospice|0|||
161832763|NCT03310957|584429594|FG005|Overall Study|Hospice|1|||
161684568|NCT02055820|583897945|FG006|Phase II: Expansion|Death|0|||
161684569|NCT02055820|583897946|FG007|Phase II: Expansion|Death|0|||
161832764|NCT03310957|584429595|FG006|Overall Study|Hospice|0|||
161617335|NCT03136861|583650139|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
161684570|NCT02055820|583897947|FG008|Phase II: Expansion|Death|0|||
161684571|NCT02055820|583897948|FG009|Phase II: Expansion|Death|0|||
161684572|NCT02055820|583897939|FG000|Phase II: Expansion|Lost to Follow-up|0|||
161684573|NCT02055820|583897940|FG001|Phase II: Expansion|Lost to Follow-up|0|||
161684574|NCT02055820|583897941|FG002|Phase II: Expansion|Lost to Follow-up|0|||
161684575|NCT02055820|583897942|FG003|Phase II: Expansion|Lost to Follow-up|0|||
161684576|NCT02055820|583897943|FG004|Phase II: Expansion|Lost to Follow-up|4|||
161684577|NCT02055820|583897944|FG005|Phase II: Expansion|Lost to Follow-up|0|||
161684578|NCT02055820|583897945|FG006|Phase II: Expansion|Lost to Follow-up|0|||
161684579|NCT02055820|583897946|FG007|Phase II: Expansion|Lost to Follow-up|0|||
161684580|NCT02055820|583897947|FG008|Phase II: Expansion|Lost to Follow-up|0|||
161684581|NCT02055820|583897948|FG009|Phase II: Expansion|Lost to Follow-up|0|||
161684582|NCT02055820|583897939|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
161684583|NCT02055820|583897940|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
161684584|NCT02055820|583897941|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
161684585|NCT02055820|583897942|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
161617336|NCT03136861|583650140|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161617337|NCT03136861|583650141|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161617338|NCT03136861|583650142|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161617339|NCT03136861|583650143|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161617340|NCT03136861|583650144|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161617341|NCT03136861|583650138|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
161617342|NCT03136861|583650139|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
161617343|NCT03136861|583650140|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161617344|NCT03136861|583650141|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161617345|NCT03136861|583650142|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161617346|NCT03136861|583650143|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161617347|NCT03136861|583650144|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161617348|NCT03136861|583650138|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161617349|NCT03136861|583650139|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
161617350|NCT03136861|583650140|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161617351|NCT03136861|583650141|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161617352|NCT03136861|583650142|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161617353|NCT03136861|583650143|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161617354|NCT03136861|583650144|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161617355|NCT03136861|583650138|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
161617356|NCT03136861|583650139|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
161617357|NCT03136861|583650140|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161617358|NCT03136861|583650141|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161617359|NCT03136861|583650142|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161617360|NCT03136861|583650143|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161617361|NCT03136861|583650144|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161617362|NCT03136861|583650138|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161617363|NCT03136861|583650139|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161617364|NCT03136861|583650140|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161684586|NCT02055820|583897943|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
161684587|NCT02055820|583897944|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
161684588|NCT02055820|583897945|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
161684589|NCT02055820|583897946|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
161684590|NCT02055820|583897947|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
161684591|NCT02055820|583897948|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
161684592|NCT03548935|583897949|FG000|Overall Study|Withdrawal by Subject|26|||
161617365|NCT03136861|583650141|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
161617366|NCT03136861|583650142|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
161617367|NCT03136861|583650143|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161617368|NCT03136861|583650144|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
161617369|NCT03136861|583650138|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161617370|NCT03136861|583650139|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161617371|NCT03136861|583650140|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
161617372|NCT03136861|583650141|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161617373|NCT03136861|583650142|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161617374|NCT03136861|583650143|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161617375|NCT03136861|583650144|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161617376|NCT03136861|583650138|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161617377|NCT03136861|583650139|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161617378|NCT03136861|583650140|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
161617379|NCT03136861|583650141|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161617380|NCT03136861|583650142|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161617381|NCT03136861|583650143|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161617382|NCT03136861|583650144|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161617383|NCT03200574|583650146|FG000|Overall Study|Death|4|||
161617384|NCT03200574|583650146|FG000|Overall Study|Withdrawal by Subject|8|||
161617385|NCT03200574|583650146|FG000|Overall Study|Long-Term need for anticoagulation|1|||
161617386|NCT03200574|583650146|FG000|Overall Study|Relocation|2|||
161617387|NCT03200574|583650146|FG000|Overall Study|Lost to Follow-up|2|||
161617388|NCT00705159|583650150|FG000|Overall Study|Withdrawal by Subject|0|||
161617389|NCT00705159|583650151|FG001|Overall Study|Withdrawal by Subject|1|||
161617390|NCT00705159|583650152|FG002|Overall Study|Withdrawal by Subject|1|||
161617391|NCT00705159|583650153|FG003|Overall Study|Withdrawal by Subject|1|||
161617392|NCT00705159|583650150|FG000|Overall Study|Protocol Violation|0|||
161617393|NCT00705159|583650151|FG001|Overall Study|Protocol Violation|1|||
161617394|NCT00705159|583650152|FG002|Overall Study|Protocol Violation|0|||
161617395|NCT00705159|583650153|FG003|Overall Study|Protocol Violation|0|||
161617396|NCT00705159|583650150|FG000|Overall Study|Adverse Event|0|||
161617397|NCT00705159|583650151|FG001|Overall Study|Adverse Event|0|||
161617398|NCT00705159|583650152|FG002|Overall Study|Adverse Event|1|||
161617399|NCT00705159|583650153|FG003|Overall Study|Adverse Event|0|||
161617400|NCT00705159|583650150|FG000|Overall Study|Lost to Follow-up|0|||
161617401|NCT00705159|583650151|FG001|Overall Study|Lost to Follow-up|0|||
161617402|NCT00705159|583650152|FG002|Overall Study|Lost to Follow-up|3|||
161617403|NCT00705159|583650153|FG003|Overall Study|Lost to Follow-up|2|||
161617404|NCT00705159|583650150|FG000|Overall Study|Screen Failure|0|||
161684593|NCT03548935|583897950|FG001|Overall Study|Withdrawal by Subject|17|||
161684594|NCT03548935|583897949|FG000|Overall Study|Lost to Follow-up|39|||
161617405|NCT00705159|583650151|FG001|Overall Study|Screen Failure|0|||
161684595|NCT03548935|583897950|FG001|Overall Study|Lost to Follow-up|28|||
161684596|NCT03548935|583897949|FG000|Overall Study|Death|1|||
161684597|NCT03548935|583897950|FG001|Overall Study|Death|1|||
161684598|NCT02919436|583897951|FG000|Overall Study|Did not undergo surgery|16|||
161684599|NCT02919436|583897952|FG001|Overall Study|Did not undergo surgery|20|||
161684600|NCT02919436|583897951|FG000|Overall Study|Enrolled before trial registration|44|||
161684601|NCT02919436|583897952|FG001|Overall Study|Enrolled before trial registration|33|||
161684602|NCT00804570|583897953|FG000|Overall Study|Adverse Event|14|||
161684603|NCT00804570|583897954|FG001|Overall Study|Adverse Event|7|||
161684604|NCT00804570|583897953|FG000|Overall Study|Lack of Efficacy|0|||
161684605|NCT00804570|583897954|FG001|Overall Study|Lack of Efficacy|1|||
161684606|NCT00804570|583897953|FG000|Overall Study|Lost to Follow-up|18|||
161684607|NCT00804570|583897954|FG001|Overall Study|Lost to Follow-up|21|||
161617406|NCT00705159|583650152|FG002|Overall Study|Screen Failure|0|||
161617407|NCT00705159|583650153|FG003|Overall Study|Screen Failure|1|||
161617408|NCT03026166|583650154|FG000|Overall Study|Death|22|||
161617409|NCT03026166|583650155|FG001|Overall Study|Death|7|||
161684608|NCT00804570|583897953|FG000|Overall Study|Entry criteria not met|5|||
161684609|NCT00804570|583897954|FG001|Overall Study|Entry criteria not met|5|||
161617410|NCT03026166|583650154|FG000|Overall Study|Physician Decision|2|||
161617411|NCT03026166|583650155|FG001|Overall Study|Physician Decision|0|||
161617412|NCT03026166|583650154|FG000|Overall Study|Withdrawal by Subject|1|||
161617413|NCT03026166|583650155|FG001|Overall Study|Withdrawal by Subject|2|||
161617414|NCT03026166|583650154|FG000|Overall Study|Lost to Follow-up|1|||
161617415|NCT03026166|583650155|FG001|Overall Study|Lost to Follow-up|0|||
161617416|NCT03026166|583650154|FG000|Overall Study|Study Terminated by Sponsor|3|||
161617417|NCT03026166|583650155|FG001|Overall Study|Study Terminated by Sponsor|3|||
161617418|NCT03026166|583650154|FG000|Overall Study|Other|1|||
161617419|NCT03026166|583650155|FG001|Overall Study|Other|0|||
161617420|NCT01262456|583650156|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
161617421|NCT01262456|583650157|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
161617422|NCT01262456|583650158|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
161617423|NCT01262456|583650156|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
161617424|NCT01262456|583650157|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
161617425|NCT01262456|583650158|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
161617426|NCT01262456|583650156|FG000|3-Month Double-Blind Period|Adverse Event|6|||
161617427|NCT01262456|583650157|FG001|3-Month Double-Blind Period|Adverse Event|4|||
161617428|NCT01262456|583650158|FG002|3-Month Double-Blind Period|Adverse Event|8|||
161617429|NCT01262456|583650156|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
161617430|NCT01262456|583650157|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
161617431|NCT01262456|583650158|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
161617432|NCT01262456|583650156|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
161617433|NCT01262456|583650157|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
161617434|NCT01262456|583650158|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
161617435|NCT01262456|583650156|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
161617436|NCT01262456|583650157|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
161617437|NCT01262456|583650158|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
161617438|NCT01262456|583650156|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
161617439|NCT01262456|583650157|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
161617440|NCT01262456|583650158|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
161617441|NCT01262456|583650156|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
161617442|NCT01262456|583650157|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
161617443|NCT01262456|583650158|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
161617444|NCT01262456|583650156|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
161617445|NCT01262456|583650157|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
161617446|NCT01262456|583650158|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
161617447|NCT03938272|583650159|FG000|Overall Study|Withdrawal by Subject|1|||
161617448|NCT03938272|583650160|FG001|Overall Study|Withdrawal by Subject|0|||
161617449|NCT03938272|583650159|FG000|Overall Study|Physician Decision|0|||
161617450|NCT03938272|583650160|FG001|Overall Study|Physician Decision|2|||
161617451|NCT03938272|583650159|FG000|Overall Study|Study termination by sponsor|10|||
161617452|NCT03938272|583650160|FG001|Overall Study|Study termination by sponsor|8|||
161617453|NCT04821271|583650165|FG000|Period 1|Withdrawal by Subject|2|||
161617454|NCT04821271|583650166|FG001|Period 1|Withdrawal by Subject|0|||
161617455|NCT00266656|583650170|FG000|Overall Study|Death|1|||
161617456|NCT00266656|583650171|FG001|Overall Study|Death|0|||
161617457|NCT00266656|583650170|FG000|Overall Study|Lost to Follow-up|4|||
161617458|NCT00266656|583650171|FG001|Overall Study|Lost to Follow-up|1|||
161617459|NCT00266656|583650170|FG000|Overall Study|Withdrawal by Subject|4|||
161617460|NCT00266656|583650171|FG001|Overall Study|Withdrawal by Subject|2|||
161617461|NCT00266656|583650170|FG000|Overall Study|Did Not Reach Final Height|4|||
161617462|NCT00266656|583650171|FG001|Overall Study|Did Not Reach Final Height|8|||
161617463|NCT00266656|583650170|FG000|Overall Study|Parent/Caregiver Decision|1|||
161617464|NCT00266656|583650171|FG001|Overall Study|Parent/Caregiver Decision|2|||
161617465|NCT00667732|583650173|FG000|Run -In (8 Weeks)|Adverse Event|4|||
161617466|NCT00667732|583650174|FG001|Run -In (8 Weeks)|Adverse Event|0|||
161617467|NCT00667732|583650175|FG002|Run -In (8 Weeks)|Adverse Event|0|||
161617468|NCT00667732|583650173|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
161617469|NCT00667732|583650174|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
161617470|NCT00667732|583650175|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
161617471|NCT00667732|583650173|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
161617472|NCT00667732|583650174|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
161617473|NCT00667732|583650175|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
161617474|NCT02106325|583650178|FG000|Phase 1|Lost to Follow-up|2|||
161617475|NCT02106325|583650179|FG001|Phase 1|Lost to Follow-up|2|||
161617476|NCT02106325|583650178|FG000|Phase 2|Lost to Follow-up|2|||
161617477|NCT02106325|583650179|FG001|Phase 2|Lost to Follow-up|3|||
161617478|NCT02106325|583650178|FG000|Phase 3|Lost to Follow-up|2|||
161617479|NCT02106325|583650179|FG001|Phase 3|Lost to Follow-up|1|||
161617480|NCT00452114|583650181|FG000|Overall Study|Physician Decision|3|||
161684610|NCT00804570|583897953|FG000|Overall Study|Protocol Violation|12|||
161617481|NCT00452114|583650182|FG001|Overall Study|Physician Decision|3|||
161617482|NCT03242863|583650183|FG000|Study Week 1|Withdrawal by Subject|0|||
161617483|NCT03242863|583650184|FG001|Study Week 1|Withdrawal by Subject|1|||
161617484|NCT03242863|583650185|FG002|Study Week 1|Withdrawal by Subject|0|||
161617485|NCT03242863|583650186|FG003|Study Week 1|Withdrawal by Subject|0|||
161617486|NCT03242863|583650187|FG004|Study Week 1|Withdrawal by Subject|3|||
161617487|NCT03242863|583650188|FG005|Study Week 1|Withdrawal by Subject|0|||
161617488|NCT04602728|583650189|FG000|Overall Study|Lost to Follow-up|4|||
161617489|NCT04602728|583650190|FG001|Overall Study|Lost to Follow-up|4|||
161617490|NCT05289037|583650196|FG000|Overall Study|Withdrawal by Subject|7|||
161617491|NCT05289037|583650197|FG001|Overall Study|Withdrawal by Subject|0|||
161617492|NCT05289037|583650198|FG002|Overall Study|Withdrawal by Subject|3|||
161617493|NCT05289037|583650199|FG003|Overall Study|Withdrawal by Subject|3|||
161617494|NCT05289037|583650200|FG004|Overall Study|Withdrawal by Subject|1|||
161617495|NCT05289037|583650201|FG005|Overall Study|Withdrawal by Subject|5|||
161617496|NCT05289037|583650202|FG006|Overall Study|Withdrawal by Subject|2|||
161617497|NCT05289037|583650203|FG007|Overall Study|Withdrawal by Subject|1|||
161617498|NCT05289037|583650204|FG008|Overall Study|Withdrawal by Subject|2|||
161617499|NCT05289037|583650205|FG009|Overall Study|Withdrawal by Subject|2|||
161617500|NCT05289037|583650206|FG010|Overall Study|Withdrawal by Subject|1|||
161617501|NCT05289037|583650207|FG011|Overall Study|Withdrawal by Subject|0|||
161617502|NCT05289037|583650208|FG012|Overall Study|Withdrawal by Subject|1|||
161617503|NCT05289037|583650209|FG013|Overall Study|Withdrawal by Subject|2|||
161617504|NCT05289037|583650210|FG014|Overall Study|Withdrawal by Subject|0|||
161617505|NCT05289037|583650211|FG015|Overall Study|Withdrawal by Subject|3|||
161617506|NCT05289037|583650212|FG016|Overall Study|Withdrawal by Subject|3|||
161617507|NCT05289037|583650196|FG000|Overall Study|Lost to Follow-up|1|||
161617508|NCT05289037|583650197|FG001|Overall Study|Lost to Follow-up|4|||
161617509|NCT05289037|583650198|FG002|Overall Study|Lost to Follow-up|3|||
161617510|NCT05289037|583650199|FG003|Overall Study|Lost to Follow-up|3|||
161617511|NCT05289037|583650200|FG004|Overall Study|Lost to Follow-up|3|||
161617512|NCT05289037|583650201|FG005|Overall Study|Lost to Follow-up|2|||
161617513|NCT05289037|583650202|FG006|Overall Study|Lost to Follow-up|3|||
161617514|NCT05289037|583650203|FG007|Overall Study|Lost to Follow-up|2|||
161617515|NCT05289037|583650204|FG008|Overall Study|Lost to Follow-up|2|||
161617516|NCT05289037|583650205|FG009|Overall Study|Lost to Follow-up|1|||
161617517|NCT05289037|583650206|FG010|Overall Study|Lost to Follow-up|3|||
161617518|NCT05289037|583650207|FG011|Overall Study|Lost to Follow-up|4|||
161617519|NCT05289037|583650208|FG012|Overall Study|Lost to Follow-up|2|||
161617520|NCT05289037|583650209|FG013|Overall Study|Lost to Follow-up|7|||
161617521|NCT05289037|583650210|FG014|Overall Study|Lost to Follow-up|4|||
161617522|NCT05289037|583650211|FG015|Overall Study|Lost to Follow-up|6|||
161617523|NCT05289037|583650212|FG016|Overall Study|Lost to Follow-up|4|||
161617524|NCT05289037|583650196|FG000|Overall Study|Death|0|||
161617525|NCT05289037|583650197|FG001|Overall Study|Death|0|||
161617526|NCT05289037|583650198|FG002|Overall Study|Death|0|||
161617527|NCT05289037|583650199|FG003|Overall Study|Death|0|||
161617528|NCT05289037|583650200|FG004|Overall Study|Death|0|||
161617529|NCT05289037|583650201|FG005|Overall Study|Death|1|||
161617530|NCT05289037|583650202|FG006|Overall Study|Death|0|||
161617531|NCT05289037|583650203|FG007|Overall Study|Death|0|||
161617532|NCT05289037|583650204|FG008|Overall Study|Death|0|||
161617533|NCT05289037|583650205|FG009|Overall Study|Death|0|||
161617534|NCT05289037|583650206|FG010|Overall Study|Death|0|||
161617535|NCT05289037|583650207|FG011|Overall Study|Death|0|||
161617536|NCT05289037|583650208|FG012|Overall Study|Death|0|||
161617537|NCT05289037|583650209|FG013|Overall Study|Death|0|||
161617538|NCT05289037|583650210|FG014|Overall Study|Death|1|||
161617539|NCT05289037|583650211|FG015|Overall Study|Death|0|||
161617540|NCT05289037|583650212|FG016|Overall Study|Death|0|||
161617541|NCT05289037|583650196|FG000|Overall Study|Did not receive vaccine|0|||
161617542|NCT05289037|583650197|FG001|Overall Study|Did not receive vaccine|3|||
161617543|NCT05289037|583650198|FG002|Overall Study|Did not receive vaccine|0|||
161617544|NCT05289037|583650199|FG003|Overall Study|Did not receive vaccine|0|||
161617545|NCT05289037|583650200|FG004|Overall Study|Did not receive vaccine|1|||
161617546|NCT05289037|583650201|FG005|Overall Study|Did not receive vaccine|1|||
161617547|NCT05289037|583650202|FG006|Overall Study|Did not receive vaccine|1|||
161617548|NCT05289037|583650203|FG007|Overall Study|Did not receive vaccine|0|||
161617549|NCT05289037|583650204|FG008|Overall Study|Did not receive vaccine|0|||
161617550|NCT05289037|583650205|FG009|Overall Study|Did not receive vaccine|0|||
161617551|NCT05289037|583650206|FG010|Overall Study|Did not receive vaccine|0|||
161617552|NCT05289037|583650207|FG011|Overall Study|Did not receive vaccine|0|||
161617553|NCT05289037|583650208|FG012|Overall Study|Did not receive vaccine|0|||
161617554|NCT05289037|583650209|FG013|Overall Study|Did not receive vaccine|0|||
161617555|NCT05289037|583650210|FG014|Overall Study|Did not receive vaccine|1|||
161617556|NCT05289037|583650211|FG015|Overall Study|Did not receive vaccine|0|||
161617557|NCT05289037|583650212|FG016|Overall Study|Did not receive vaccine|0|||
161617558|NCT05289037|583650196|FG000|Overall Study|Unable to make last visit|0|||
161617559|NCT05289037|583650197|FG001|Overall Study|Unable to make last visit|0|||
161684611|NCT00804570|583897954|FG001|Overall Study|Protocol Violation|16|||
161684612|NCT00804570|583897953|FG000|Overall Study|Physician Decision|1|||
161684613|NCT00804570|583897954|FG001|Overall Study|Physician Decision|2|||
161684614|NCT00804570|583897953|FG000|Overall Study|Sponsor decision|1|||
161684615|NCT00804570|583897954|FG001|Overall Study|Sponsor decision|4|||
161684616|NCT00804570|583897953|FG000|Overall Study|Withdrawal by Subject|21|||
161684617|NCT00804570|583897954|FG001|Overall Study|Withdrawal by Subject|38|||
161684618|NCT01056510|583897955|FG000|Overall Study|Dropout Before Start of Treatment|1|||
161684619|NCT01056510|583897956|FG001|Overall Study|Dropout Before Start of Treatment|1|||
161617560|NCT05289037|583650198|FG002|Overall Study|Unable to make last visit|1|||
161617561|NCT05289037|583650199|FG003|Overall Study|Unable to make last visit|0|||
161617562|NCT05289037|583650200|FG004|Overall Study|Unable to make last visit|0|||
161617563|NCT05289037|583650201|FG005|Overall Study|Unable to make last visit|0|||
161617564|NCT05289037|583650202|FG006|Overall Study|Unable to make last visit|0|||
161617565|NCT05289037|583650203|FG007|Overall Study|Unable to make last visit|0|||
161617566|NCT05289037|583650204|FG008|Overall Study|Unable to make last visit|0|||
161617567|NCT05289037|583650205|FG009|Overall Study|Unable to make last visit|0|||
161617568|NCT05289037|583650206|FG010|Overall Study|Unable to make last visit|0|||
161617569|NCT05289037|583650207|FG011|Overall Study|Unable to make last visit|0|||
161617570|NCT05289037|583650208|FG012|Overall Study|Unable to make last visit|0|||
161617571|NCT05289037|583650209|FG013|Overall Study|Unable to make last visit|0|||
161617572|NCT05289037|583650210|FG014|Overall Study|Unable to make last visit|0|||
161617573|NCT05289037|583650211|FG015|Overall Study|Unable to make last visit|0|||
161617574|NCT05289037|583650212|FG016|Overall Study|Unable to make last visit|0|||
161617575|NCT05289037|583650196|FG000|Overall Study|Protocol deviation|0|||
161617576|NCT05289037|583650197|FG001|Overall Study|Protocol deviation|0|||
161617577|NCT05289037|583650198|FG002|Overall Study|Protocol deviation|0|||
161617578|NCT05289037|583650199|FG003|Overall Study|Protocol deviation|0|||
161617579|NCT05289037|583650200|FG004|Overall Study|Protocol deviation|0|||
161617580|NCT05289037|583650201|FG005|Overall Study|Protocol deviation|0|||
161617581|NCT05289037|583650202|FG006|Overall Study|Protocol deviation|0|||
161617582|NCT05289037|583650203|FG007|Overall Study|Protocol deviation|0|||
161617583|NCT05289037|583650204|FG008|Overall Study|Protocol deviation|0|||
161617584|NCT05289037|583650205|FG009|Overall Study|Protocol deviation|0|||
161617585|NCT05289037|583650206|FG010|Overall Study|Protocol deviation|0|||
161617586|NCT05289037|583650207|FG011|Overall Study|Protocol deviation|0|||
161617587|NCT05289037|583650208|FG012|Overall Study|Protocol deviation|0|||
161617588|NCT05289037|583650209|FG013|Overall Study|Protocol deviation|0|||
161617589|NCT05289037|583650210|FG014|Overall Study|Protocol deviation|0|||
161617590|NCT05289037|583650211|FG015|Overall Study|Protocol deviation|1|||
161617591|NCT05289037|583650212|FG016|Overall Study|Protocol deviation|0|||
161617592|NCT02831049|583650213|FG000|Overall Study|Lost to Follow-up|0|||
161617593|NCT02831049|583650214|FG001|Overall Study|Lost to Follow-up|0|||
161617594|NCT02831049|583650215|FG002|Overall Study|Lost to Follow-up|1|||
161617595|NCT02831049|583650213|FG000|Overall Study|Withdrawal by Subject|0|||
161617596|NCT02831049|583650214|FG001|Overall Study|Withdrawal by Subject|1|||
161617597|NCT02831049|583650215|FG002|Overall Study|Withdrawal by Subject|1|||
161617598|NCT02831049|583650213|FG000|Overall Study|Pandemic shutdown|1|||
161617599|NCT02831049|583650214|FG001|Overall Study|Pandemic shutdown|0|||
161617600|NCT02831049|583650215|FG002|Overall Study|Pandemic shutdown|0|||
161617601|NCT04186247|583650216|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
161617602|NCT04186247|583650217|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161617603|NCT04186247|583650218|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161617604|NCT04186247|583650219|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161617605|NCT04186247|583650220|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161617606|NCT05006703|583651369|FG000|Overall Study|Withdrawal by Subject|1|||
161617607|NCT05006703|583651370|FG001|Overall Study|Withdrawal by Subject|0|||
161617608|NCT05006703|583651369|FG000|Overall Study|Lost to Follow-up|13|||
161617609|NCT05006703|583651370|FG001|Overall Study|Lost to Follow-up|5|||
161684620|NCT01056510|583897955|FG000|Overall Study|Withdrawal by Subject|4|||
161617610|NCT00264576|583651375|FG000|Overall Study|Lost to Follow-up|1|||
161617611|NCT00264576|583651376|FG001|Overall Study|Lost to Follow-up|1|||
161617612|NCT02659059|583651377|FG000|Overall Study|Other reasons|6|||
161617613|NCT02659059|583651378|FG001|Overall Study|Other reasons|1|||
161617614|NCT02659059|583651377|FG000|Overall Study|Disease Progression|143|||
161617615|NCT02659059|583651378|FG001|Overall Study|Disease Progression|16|||
161617616|NCT02659059|583651377|FG000|Overall Study|Study Drug toxicity|56|||
161684621|NCT01056510|583897956|FG001|Overall Study|Withdrawal by Subject|2|||
161684622|NCT01056510|583897955|FG000|Overall Study|Death|29|||
161684623|NCT01056510|583897956|FG001|Overall Study|Death|34|||
161684624|NCT01056510|583897955|FG000|Overall Study|Noncompliance|1|||
161617617|NCT02659059|583651378|FG001|Overall Study|Study Drug toxicity|9|||
161617618|NCT02659059|583651377|FG000|Overall Study|Death|3|||
161684625|NCT01056510|583897956|FG001|Overall Study|Noncompliance|3|||
161684626|NCT01056510|583897955|FG000|Overall Study|Physician Decision|4|||
161617619|NCT02659059|583651378|FG001|Overall Study|Death|1|||
161617620|NCT02659059|583651377|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
161617621|NCT02659059|583651378|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
161617622|NCT02659059|583651377|FG000|Overall Study|Participant request to discontinue study treatment|5|||
161617623|NCT02659059|583651378|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161617624|NCT02659059|583651377|FG000|Overall Study|Participant withdrew consent|6|||
161617625|NCT02659059|583651378|FG001|Overall Study|Participant withdrew consent|1|||
161617626|NCT00278395|583651381|FG000|Overall Study|Adverse Event|2|||
161617627|NCT00278395|583651381|FG000|Overall Study|Nonevaluable|1|||
161617628|NCT00569166|583651384|FG000|Overall Study|Withdrawal by Subject|7|||
161617629|NCT00569166|583651385|FG001|Overall Study|Withdrawal by Subject|5|||
161617630|NCT00569166|583651386|FG002|Overall Study|Withdrawal by Subject|3|||
161617631|NCT00569166|583651384|FG000|Overall Study|Lost to Follow-up|2|||
161617632|NCT00569166|583651385|FG001|Overall Study|Lost to Follow-up|1|||
161617633|NCT00569166|583651386|FG002|Overall Study|Lost to Follow-up|1|||
161617634|NCT02784834|583651388|FG000|Overall Study|Lack of Efficacy|1|||
161617635|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
161617636|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
161617637|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
161617638|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
161617639|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Adverse Event|7|||
161617640|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Adverse Event|8|||
161617641|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Adverse Event|8|||
161617642|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Adverse Event|9|||
161617643|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
161617644|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
161617645|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
161617646|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
161617647|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
161617648|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
161617649|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
161617650|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
161617651|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Pregnancy|0|||
161617652|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Pregnancy|2|||
161617653|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Pregnancy|2|||
161617654|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Pregnancy|0|||
161617655|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Non-compliance|1|||
161617656|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Non-compliance|0|||
161617657|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Non-compliance|0|||
161617658|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Non-compliance|3|||
161617659|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Other|3|||
161617660|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Other|0|||
161617661|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Other|3|||
161617662|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Other|2|||
161617663|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
161617664|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
161617665|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
161617666|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
161617667|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
161617668|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
161617669|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
161617670|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
161684627|NCT01056510|583897956|FG001|Overall Study|Physician Decision|5|||
161684628|NCT01056510|583897955|FG000|Overall Study|Lost to Follow-up|5|||
161684629|NCT01056510|583897956|FG001|Overall Study|Lost to Follow-up|6|||
161684630|NCT01056510|583897955|FG000|Overall Study|Other|10|||
161684631|NCT01056510|583897956|FG001|Overall Study|Other|12|||
161684632|NCT01056510|583897955|FG000|Overall Study|Missing|0|||
161684633|NCT01056510|583897956|FG001|Overall Study|Missing|1|||
161684634|NCT03451084|583897959|FG000|Overall Study|Withdrawal by Subject|2|||
161684635|NCT03451084|583897960|FG001|Overall Study|Withdrawal by Subject|1|||
161684636|NCT03451084|583897961|FG002|Overall Study|Withdrawal by Subject|2|||
161617671|NCT02143713|583651389|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
161617672|NCT02143713|583651390|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
161617673|NCT02143713|583651391|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
161684637|NCT03451084|583897962|FG003|Overall Study|Withdrawal by Subject|1|||
161684638|NCT03451084|583897959|FG000|Overall Study|Disease recurrence|0|||
161684639|NCT03451084|583897960|FG001|Overall Study|Disease recurrence|2|||
161617674|NCT02143713|583651392|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
161617675|NCT02143713|583651389|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
161617676|NCT02143713|583651390|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
161617677|NCT02143713|583651391|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
161617678|NCT02143713|583651392|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
161617679|NCT02143713|583651389|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
161617680|NCT02143713|583651390|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
161617681|NCT02143713|583651391|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
161617682|NCT02143713|583651392|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
161617683|NCT02143713|583651389|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
161617684|NCT02143713|583651390|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
161617685|NCT02143713|583651391|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
161617686|NCT02143713|583651392|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
161617687|NCT02143713|583651389|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
161617688|NCT02143713|583651390|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
161617689|NCT02143713|583651391|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
161617690|NCT02143713|583651392|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
161617691|NCT02143713|583651389|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
161617692|NCT02143713|583651390|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
161617693|NCT02143713|583651391|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
161617694|NCT02143713|583651392|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
161617695|NCT02143713|583651389|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
161617696|NCT02143713|583651390|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
161617697|NCT02143713|583651391|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
161617698|NCT02143713|583651392|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
161617699|NCT01999335|583651393|FG000|Overall Study|Discontinued before receiving treatment|0|||
161617700|NCT01999335|583651394|FG001|Overall Study|Discontinued before receiving treatment|0|||
161617701|NCT01999335|583651395|FG002|Overall Study|Discontinued before receiving treatment|0|||
161617702|NCT01999335|583651396|FG003|Overall Study|Discontinued before receiving treatment|0|||
161617703|NCT01999335|583651397|FG004|Overall Study|Discontinued before receiving treatment|2|||
161617704|NCT01215253|583651398|FG000|Overall Study|Withdrawal by Subject|57|||
161617705|NCT01215253|583651399|FG001|Overall Study|Withdrawal by Subject|35|||
161617706|NCT01215253|583651398|FG000|Overall Study|Physician Decision|9|||
161617707|NCT01215253|583651399|FG001|Overall Study|Physician Decision|12|||
161617708|NCT01215253|583651398|FG000|Overall Study|Lost to Follow-up|6|||
161617709|NCT01215253|583651399|FG001|Overall Study|Lost to Follow-up|4|||
161617710|NCT01215253|583651398|FG000|Overall Study|Other|14|||
161617711|NCT01215253|583651399|FG001|Overall Study|Other|12|||
161617712|NCT00080119|583651400|FG000|Overall Study|Discontinued because of study closure|0|||
161617713|NCT00080119|583651401|FG001|Overall Study|Discontinued because of study closure|0|||
161617714|NCT00080119|583651402|FG002|Overall Study|Discontinued because of study closure|130|||
161617715|NCT00080119|583651403|FG003|Overall Study|Discontinued because of study closure|141|||
161617716|NCT00080119|583651400|FG000|Overall Study|Unable to get to clinic|24|||
161617717|NCT00080119|583651401|FG001|Overall Study|Unable to get to clinic|24|||
161617718|NCT00080119|583651402|FG002|Overall Study|Unable to get to clinic|7|||
161617719|NCT00080119|583651403|FG003|Overall Study|Unable to get to clinic|1|||
161617720|NCT00080119|583651400|FG000|Overall Study|Consent withdrawn|13|||
161617721|NCT00080119|583651401|FG001|Overall Study|Consent withdrawn|17|||
161617722|NCT00080119|583651402|FG002|Overall Study|Consent withdrawn|4|||
161617723|NCT00080119|583651403|FG003|Overall Study|Consent withdrawn|6|||
161617724|NCT00080119|583651400|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
161617725|NCT00080119|583651401|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
161617726|NCT00080119|583651402|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
161617727|NCT00080119|583651403|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
161617728|NCT00080119|583651400|FG000|Overall Study|Lost to Follow-up|16|||
161617729|NCT00080119|583651401|FG001|Overall Study|Lost to Follow-up|19|||
161617730|NCT00080119|583651402|FG002|Overall Study|Lost to Follow-up|19|||
161617731|NCT00080119|583651403|FG003|Overall Study|Lost to Follow-up|14|||
161617732|NCT01090739|583651408|FG000|Enrollment|Withdrawal by Subject|24|||
161617733|NCT01090739|583651408|FG000|Enrollment|Protocol Violation|14|||
161617734|NCT01090739|583651408|FG000|Enrollment|Lost to Follow-up|5|||
161617735|NCT01090739|583651408|FG000|Enrollment|Physician Decision|5|||
161617736|NCT01090739|583651408|FG000|Enrollment|Sponsor termination of site|4|||
161617737|NCT01090739|583651408|FG000|Enrollment|Study implant limit reached|2|||
161684640|NCT03451084|583897961|FG002|Overall Study|Disease recurrence|0|||
161684641|NCT03451084|583897962|FG003|Overall Study|Disease recurrence|0|||
161684642|NCT03451084|583897959|FG000|Overall Study|Lack of Efficacy|0|||
161617738|NCT01090739|583651408|FG000|Enrollment|Adverse Event|1|||
161617739|NCT01090739|583651408|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
161684643|NCT03451084|583897960|FG001|Overall Study|Lack of Efficacy|3|||
161617740|NCT01090739|583651408|FG000|12 Month Follow-up|Lost to Follow-up|1|||
161617741|NCT01090739|583651408|FG000|12 Month Follow-up|Physician Decision|1|||
161617742|NCT01090739|583651408|FG000|12 Month Follow-up|Death|1|||
161617743|NCT01090739|583651408|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
161617744|NCT01090739|583651408|FG000|24 Month Follow-up|Lost to Follow-up|1|||
161617745|NCT01090739|583651408|FG000|24 Month Follow-up|Death|1|||
161617746|NCT01090739|583651408|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
161617747|NCT01090739|583651408|FG000|36 Month Follow-up|Visit still pending|17|||
161617748|NCT00441168|583651409|FG000|Treatment Period|Death|3|||
161617749|NCT00441168|583651410|FG001|Treatment Period|Death|0|||
161617750|NCT00441168|583651409|FG000|Treatment Period|Adverse Event|1|||
161617751|NCT00441168|583651410|FG001|Treatment Period|Adverse Event|2|||
161617752|NCT00441168|583651409|FG000|Treatment Period|Progressive Disease|0|||
161617753|NCT00441168|583651410|FG001|Treatment Period|Progressive Disease|2|||
161617754|NCT00441168|583651409|FG000|Treatment Period|Protocol Violation|0|||
161617755|NCT00441168|583651410|FG001|Treatment Period|Protocol Violation|1|||
161617756|NCT00441168|583651409|FG000|Treatment Period|Lost to Follow-up|0|||
161617757|NCT00441168|583651410|FG001|Treatment Period|Lost to Follow-up|1|||
161617758|NCT00441168|583651409|FG000|Treatment Period|Withdrawal by Subject|3|||
161617759|NCT00441168|583651410|FG001|Treatment Period|Withdrawal by Subject|0|||
161617760|NCT00441168|583651409|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
161617761|NCT00441168|583651410|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
161617762|NCT00441168|583651409|FG000|Treatment Period|refractory disease|1|||
161617763|NCT00441168|583651410|FG001|Treatment Period|refractory disease|0|||
161617764|NCT00441168|583651409|FG000|Follow-up Period|Death|3|||
161617765|NCT00441168|583651410|FG001|Follow-up Period|Death|0|||
161617766|NCT00441168|583651409|FG000|Follow-up Period|Lost to Follow-up|5|||
161617767|NCT00441168|583651410|FG001|Follow-up Period|Lost to Follow-up|6|||
161617768|NCT00441168|583651409|FG000|Follow-up Period|Withdrawal by Subject|3|||
161617769|NCT00441168|583651410|FG001|Follow-up Period|Withdrawal by Subject|0|||
161617770|NCT00441168|583651409|FG000|Follow-up Period|Other|1|||
161617771|NCT00441168|583651410|FG001|Follow-up Period|Other|3|||
161617772|NCT04410445|583651412|FG000|Overall Study|Lost to Follow-up|3|||
161617773|NCT04410445|583651413|FG001|Overall Study|Lost to Follow-up|9|||
161617774|NCT04410445|583651412|FG000|Overall Study|Withdrawal by Subject|27|||
161617775|NCT04410445|583651413|FG001|Overall Study|Withdrawal by Subject|15|||
161617776|NCT01320683|583651414|FG000|Overall Study|Positive antibody response|1|||
161617777|NCT02291861|583651415|FG000|Overall Study|Adverse Event|2|||
161617778|NCT02291861|583651416|FG001|Overall Study|Adverse Event|4|||
161617779|NCT02291861|583651417|FG002|Overall Study|Adverse Event|1|||
161617780|NCT02291861|583651418|FG003|Overall Study|Adverse Event|2|||
161617781|NCT02291861|583651415|FG000|Overall Study|Death|0|||
161617782|NCT02291861|583651416|FG001|Overall Study|Death|0|||
161617783|NCT02291861|583651417|FG002|Overall Study|Death|1|||
161617784|NCT02291861|583651418|FG003|Overall Study|Death|1|||
161617785|NCT02291861|583651415|FG000|Overall Study|Protocol Violation|1|||
161617786|NCT02291861|583651416|FG001|Overall Study|Protocol Violation|0|||
161617787|NCT02291861|583651417|FG002|Overall Study|Protocol Violation|0|||
161617788|NCT02291861|583651418|FG003|Overall Study|Protocol Violation|1|||
161617789|NCT02291861|583651415|FG000|Overall Study|Withdrawal by Subject|1|||
161617790|NCT02291861|583651416|FG001|Overall Study|Withdrawal by Subject|2|||
161617791|NCT02291861|583651417|FG002|Overall Study|Withdrawal by Subject|1|||
161617792|NCT02291861|583651418|FG003|Overall Study|Withdrawal by Subject|4|||
161617793|NCT02291861|583651415|FG000|Overall Study|Noncompliance|1|||
161617794|NCT02291861|583651416|FG001|Overall Study|Noncompliance|1|||
161617795|NCT02291861|583651417|FG002|Overall Study|Noncompliance|2|||
161617796|NCT02291861|583651418|FG003|Overall Study|Noncompliance|1|||
161617797|NCT02291861|583651415|FG000|Overall Study|Lost to Follow-up|2|||
161617798|NCT02291861|583651416|FG001|Overall Study|Lost to Follow-up|1|||
161617799|NCT02291861|583651417|FG002|Overall Study|Lost to Follow-up|4|||
161617800|NCT02291861|583651418|FG003|Overall Study|Lost to Follow-up|0|||
161617801|NCT02291861|583651415|FG000|Overall Study|Other|0|||
161617802|NCT02291861|583651416|FG001|Overall Study|Other|0|||
161617803|NCT02291861|583651417|FG002|Overall Study|Other|0|||
161617804|NCT02291861|583651418|FG003|Overall Study|Other|1|||
161617805|NCT02005484|583651421|FG000|Overall Study|Death|1|||
161617806|NCT02005484|583651421|FG000|Overall Study|Disease progression|1|||
161617807|NCT02005484|583651421|FG000|Overall Study|Changed to a Different Study|1|||
161617808|NCT02005484|583651421|FG000|Overall Study|Sponsor decision|1|||
161617809|NCT03547154|583651426|FG000|Overall Study|Disease Progression/Recurrence|6|||
161617810|NCT03547154|583651427|FG001|Overall Study|Disease Progression/Recurrence|14|||
161617811|NCT03547154|583651426|FG000|Overall Study|Adverse Event|26|||
161617812|NCT03547154|583651427|FG001|Overall Study|Adverse Event|31|||
161617813|NCT03547154|583651426|FG000|Overall Study|Protocol Violation|6|||
161617814|NCT03547154|583651427|FG001|Overall Study|Protocol Violation|1|||
161617815|NCT03547154|583651426|FG000|Overall Study|Physician Decision|4|||
161617816|NCT03547154|583651427|FG001|Overall Study|Physician Decision|3|||
161617817|NCT03547154|583651426|FG000|Overall Study|Insufficient Therapeutic Response|13|||
161617818|NCT03547154|583651427|FG001|Overall Study|Insufficient Therapeutic Response|10|||
161617819|NCT03547154|583651426|FG000|Overall Study|Withdrawal by Subject|10|||
161617820|NCT03547154|583651427|FG001|Overall Study|Withdrawal by Subject|6|||
161617821|NCT03547154|583651426|FG000|Overall Study|Not Selected|0|||
161617822|NCT03547154|583651427|FG001|Overall Study|Not Selected|1|||
161617823|NCT03547154|583651426|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
161617824|NCT03547154|583651427|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
161617825|NCT03695185|583651429|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
161617826|NCT03695185|583651429|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
161617827|NCT03695185|583651429|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
161617828|NCT03695185|583651429|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
161617829|NCT03695185|583651429|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
161617830|NCT03695185|583651429|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
161617831|NCT03390166|583651432|FG000|Overall Study|Death|0|||
161617832|NCT03390166|583651433|FG001|Overall Study|Death|1|||
161617833|NCT03390166|583651432|FG000|Overall Study|Lost to Follow-up|6|||
161617834|NCT03390166|583651433|FG001|Overall Study|Lost to Follow-up|4|||
161617835|NCT03390166|583651432|FG000|Overall Study|Physician Decision|2|||
161617836|NCT03390166|583651433|FG001|Overall Study|Physician Decision|1|||
161617837|NCT03390166|583651432|FG000|Overall Study|Move from study area|3|||
161617838|NCT03390166|583651433|FG001|Overall Study|Move from study area|2|||
161617839|NCT03390166|583651432|FG000|Overall Study|To militarycamp for conscript|1|||
161617840|NCT03390166|583651433|FG001|Overall Study|To militarycamp for conscript|0|||
161617841|NCT03390166|583651432|FG000|Overall Study|To drug therapy course|0|||
161617842|NCT03390166|583651433|FG001|Overall Study|To drug therapy course|1|||
161617843|NCT03390166|583651432|FG000|Overall Study|Move to work oversea|0|||
161617844|NCT03390166|583651433|FG001|Overall Study|Move to work oversea|1|||
161617845|NCT01328756|583651437|FG000|Overall Study|Protocol Violation|4|||
161617846|NCT01328756|583651437|FG000|Overall Study|Adverse Event|39|||
161617847|NCT01328756|583651437|FG000|Overall Study|Lack of Efficacy|5|||
161617848|NCT01328756|583651437|FG000|Overall Study|Withdrawal by Subject|41|||
161617849|NCT01328756|583651437|FG000|Overall Study|Lost to Follow-up|5|||
161617850|NCT01328756|583651437|FG000|Overall Study|Other|29|||
161617851|NCT00526994|583651452|FG000|Overall Study|Lost to Follow-up|98|||
161617852|NCT00526994|583651453|FG001|Overall Study|Lost to Follow-up|108|||
161617853|NCT00526994|583651454|FG002|Overall Study|Lost to Follow-up|96|||
161617854|NCT00526994|583651452|FG000|Overall Study|Death|4|||
161617855|NCT00526994|583651453|FG001|Overall Study|Death|3|||
161617856|NCT00526994|583651454|FG002|Overall Study|Death|3|||
161617857|NCT00526994|583651452|FG000|Overall Study|Withdrawal by Subject|2|||
161617858|NCT00526994|583651453|FG001|Overall Study|Withdrawal by Subject|7|||
161617859|NCT00526994|583651454|FG002|Overall Study|Withdrawal by Subject|5|||
161617860|NCT00526994|583651452|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
161617861|NCT00526994|583651453|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
161617862|NCT00526994|583651454|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
161617863|NCT02521493|583651458|FG000|Overall Study|Death|3|||
161617864|NCT02521493|583651459|FG001|Overall Study|Death|4|||
161617865|NCT02521493|583651460|FG002|Overall Study|Death|1|||
161617866|NCT02521493|583651458|FG000|Overall Study|Physician Decision|19|||
161617867|NCT02521493|583651459|FG001|Overall Study|Physician Decision|1|||
161617868|NCT02521493|583651460|FG002|Overall Study|Physician Decision|2|||
161617869|NCT02521493|583651458|FG000|Overall Study|Withdrawal by Subject|3|||
161617870|NCT02521493|583651459|FG001|Overall Study|Withdrawal by Subject|0|||
161617871|NCT02521493|583651460|FG002|Overall Study|Withdrawal by Subject|0|||
161617872|NCT02521493|583651458|FG000|Overall Study|Ineligible|0|||
161617873|NCT02521493|583651459|FG001|Overall Study|Ineligible|1|||
161617874|NCT02521493|583651460|FG002|Overall Study|Ineligible|0|||
161617875|NCT02521493|583651458|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
161684644|NCT03451084|583897961|FG002|Overall Study|Lack of Efficacy|0|||
161684645|NCT03451084|583897962|FG003|Overall Study|Lack of Efficacy|1|||
161684646|NCT03451084|583897959|FG000|Overall Study|Death|1|||
161617876|NCT02521493|583651459|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
161617877|NCT02521493|583651460|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
161617878|NCT02521493|583651458|FG000|Overall Study|No MRD result|0|||
161617879|NCT02521493|583651459|FG001|Overall Study|No MRD result|0|||
161617880|NCT02521493|583651460|FG002|Overall Study|No MRD result|4|||
161617881|NCT01880736|583651461|FG000|Overall Study|Adverse Event|0|||
161617882|NCT01880736|583651462|FG001|Overall Study|Adverse Event|0|||
161617883|NCT01880736|583651463|FG002|Overall Study|Adverse Event|0|||
161617884|NCT01880736|583651464|FG003|Overall Study|Adverse Event|1|||
161617885|NCT01880736|583651461|FG000|Overall Study|Withdrawal Criteria|1|||
161617886|NCT01880736|583651462|FG001|Overall Study|Withdrawal Criteria|2|||
161617887|NCT01880736|583651463|FG002|Overall Study|Withdrawal Criteria|1|||
161684647|NCT03451084|583897960|FG001|Overall Study|Death|0|||
161617888|NCT01880736|583651464|FG003|Overall Study|Withdrawal Criteria|5|||
161617889|NCT00428714|583651467|FG000|Overall Study|Progressive Disease|28|||
161617890|NCT00428714|583651468|FG001|Overall Study|Progressive Disease|36|||
161617891|NCT00428714|583651467|FG000|Overall Study|Withdrawal by Subject|0|||
161617892|NCT00428714|583651468|FG001|Overall Study|Withdrawal by Subject|3|||
161617893|NCT00428714|583651467|FG000|Overall Study|Adverse Event|0|||
161617894|NCT00428714|583651468|FG001|Overall Study|Adverse Event|2|||
161617895|NCT00428714|583651467|FG000|Overall Study|Physician Decision|1|||
161617896|NCT00428714|583651468|FG001|Overall Study|Physician Decision|1|||
161617897|NCT00428714|583651467|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
161617898|NCT00428714|583651468|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
161617899|NCT00428714|583651467|FG000|Overall Study|Death due to other then PD|1|||
161617900|NCT00428714|583651468|FG001|Overall Study|Death due to other then PD|0|||
161617901|NCT02807857|583651471|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
161617902|NCT02807857|583651471|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
161617903|NCT02807857|583651471|FG000|Follow-Up Set|Withdrawal by Subject|8|||
161617904|NCT02807857|583651471|FG000|Follow-Up Set|Lost to Follow-up|7|||
161617905|NCT02807857|583651471|FG000|Follow-Up Set|Physician Decision|6|||
161617906|NCT02807857|583651471|FG000|Follow-Up Set|Adverse Event|3|||
161617907|NCT02807857|583651471|FG000|Follow-Up Set|Death|27|||
161617908|NCT02807857|583651471|FG000|Follow-Up Set|Relocation|2|||
161617909|NCT00513071|583651473|FG000|Overall Study|Adverse Event|1|||
161617910|NCT00513071|583651473|FG000|Overall Study|Withdrawal by Subject|1|||
161617911|NCT00513071|583651473|FG000|Overall Study|Physician Decision|3|||
161617912|NCT03786471|583651477|FG000|Overall Study|Death|254|||
161617913|NCT03786471|583651478|FG001|Overall Study|Death|223|||
161617914|NCT03786471|583651479|FG002|Overall Study|Death|37|||
161617915|NCT03786471|583651477|FG000|Overall Study|Lost to Follow-up|63|||
161617916|NCT03786471|583651478|FG001|Overall Study|Lost to Follow-up|50|||
161617917|NCT03786471|583651479|FG002|Overall Study|Lost to Follow-up|15|||
161617918|NCT03786471|583651477|FG000|Overall Study|Withdrawal by Subject|99|||
161617919|NCT03786471|583651478|FG001|Overall Study|Withdrawal by Subject|81|||
161617920|NCT03786471|583651479|FG002|Overall Study|Withdrawal by Subject|11|||
161617921|NCT00747149|583653007|FG000|Overall Study|Adverse Event|0|||
161617922|NCT00747149|583653008|FG001|Overall Study|Adverse Event|15|||
161684648|NCT03451084|583897961|FG002|Overall Study|Death|2|||
161684649|NCT03451084|583897962|FG003|Overall Study|Death|0|||
161684650|NCT03451084|583897959|FG000|Overall Study|Physician Decision|0|||
161684651|NCT03451084|583897960|FG001|Overall Study|Physician Decision|0|||
161684652|NCT03451084|583897961|FG002|Overall Study|Physician Decision|2|||
161684653|NCT03451084|583897962|FG003|Overall Study|Physician Decision|2|||
161684654|NCT03451084|583897959|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
161684655|NCT03451084|583897960|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
161684656|NCT03451084|583897961|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
161684657|NCT03451084|583897962|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
161684658|NCT02121262|583897965|FG000|Overall Study|Adverse Event|6|||
161684659|NCT02121262|583897966|FG001|Overall Study|Adverse Event|3|||
161684660|NCT02121262|583897965|FG000|Overall Study|Lack of Efficacy|3|||
161684661|NCT02121262|583897966|FG001|Overall Study|Lack of Efficacy|0|||
161684662|NCT02121262|583897965|FG000|Overall Study|Personal Reasons|19|||
161684663|NCT02121262|583897966|FG001|Overall Study|Personal Reasons|5|||
161617923|NCT00747149|583653007|FG000|Overall Study|Lost to Follow-up|0|||
161617924|NCT00747149|583653008|FG001|Overall Study|Lost to Follow-up|10|||
161617925|NCT00747149|583653007|FG000|Overall Study|Withdrawal by Subject|0|||
161617926|NCT00747149|583653008|FG001|Overall Study|Withdrawal by Subject|6|||
161617927|NCT00747149|583653007|FG000|Overall Study|Did not receive treatment|0|||
161617928|NCT00747149|583653008|FG001|Overall Study|Did not receive treatment|1|||
161617929|NCT00747149|583653007|FG000|Overall Study|Incorrect enrollment|0|||
161617930|NCT00747149|583653008|FG001|Overall Study|Incorrect enrollment|6|||
161617931|NCT00747149|583653007|FG000|Overall Study|Severe non-compliance to protocol|0|||
161684664|NCT02121262|583897965|FG000|Overall Study|Protocol Violation|1|||
161684665|NCT02121262|583897966|FG001|Overall Study|Protocol Violation|1|||
161684666|NCT02121262|583897965|FG000|Overall Study|Participant Dropped-out|0|||
161684667|NCT02121262|583897966|FG001|Overall Study|Participant Dropped-out|1|||
161617932|NCT00747149|583653008|FG001|Overall Study|Severe non-compliance to protocol|1|||
161684668|NCT02121262|583897965|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
161684669|NCT02121262|583897966|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
161684670|NCT02121262|583897965|FG000|Overall Study|Consent Withdrawn|1|||
161617933|NCT00747149|583653007|FG000|Overall Study|Not reported|1|||
161617934|NCT00747149|583653008|FG001|Overall Study|Not reported|4|||
161617935|NCT03141177|583653011|FG000|Overall Study|Death|62|||
161617936|NCT03141177|583653012|FG001|Overall Study|Death|13|||
161617937|NCT03141177|583653013|FG002|Overall Study|Death|84|||
161617938|NCT03141177|583653011|FG000|Overall Study|Participant withdrew consent|9|||
161617939|NCT03141177|583653012|FG001|Overall Study|Participant withdrew consent|2|||
161617940|NCT03141177|583653013|FG002|Overall Study|Participant withdrew consent|13|||
161617941|NCT03141177|583653011|FG000|Overall Study|Not reported|1|||
161617942|NCT03141177|583653012|FG001|Overall Study|Not reported|0|||
161617943|NCT03141177|583653013|FG002|Overall Study|Not reported|1|||
161617944|NCT03141177|583653011|FG000|Overall Study|Lost to Follow-up|2|||
161617945|NCT03141177|583653012|FG001|Overall Study|Lost to Follow-up|1|||
161617946|NCT03141177|583653013|FG002|Overall Study|Lost to Follow-up|1|||
161617947|NCT03141177|583653011|FG000|Overall Study|Other reasons|4|||
161617948|NCT03141177|583653012|FG001|Overall Study|Other reasons|0|||
161617949|NCT03141177|583653013|FG002|Overall Study|Other reasons|11|||
161617950|NCT03141177|583653011|FG000|Overall Study|Participants did not start treatment period|3|||
161617951|NCT03141177|583653012|FG001|Overall Study|Participants did not start treatment period|0|||
161617952|NCT03141177|583653013|FG002|Overall Study|Participants did not start treatment period|8|||
161617953|NCT00092456|583653014|FG000|Overall Study|Adverse Event|0|||
161617954|NCT00092456|583653015|FG001|Overall Study|Adverse Event|0|||
161617955|NCT00092456|583653016|FG002|Overall Study|Adverse Event|1|||
161617956|NCT00092456|583653017|FG003|Overall Study|Adverse Event|1|||
161617957|NCT00092456|583653014|FG000|Overall Study|Lost to Follow-up|2|||
161617958|NCT00092456|583653015|FG001|Overall Study|Lost to Follow-up|2|||
161617959|NCT00092456|583653016|FG002|Overall Study|Lost to Follow-up|1|||
161617960|NCT00092456|583653017|FG003|Overall Study|Lost to Follow-up|2|||
161617961|NCT00092456|583653014|FG000|Overall Study|Protocol Violation|5|||
161617962|NCT00092456|583653015|FG001|Overall Study|Protocol Violation|7|||
161617963|NCT00092456|583653016|FG002|Overall Study|Protocol Violation|8|||
161617964|NCT00092456|583653017|FG003|Overall Study|Protocol Violation|6|||
161617965|NCT00092456|583653014|FG000|Overall Study|Withdrawal by Subject|13|||
161617966|NCT00092456|583653015|FG001|Overall Study|Withdrawal by Subject|5|||
161617967|NCT00092456|583653016|FG002|Overall Study|Withdrawal by Subject|16|||
161617968|NCT00092456|583653017|FG003|Overall Study|Withdrawal by Subject|6|||
161617969|NCT00092456|583653014|FG000|Overall Study|Moved|1|||
161617970|NCT00092456|583653015|FG001|Overall Study|Moved|1|||
161617971|NCT00092456|583653016|FG002|Overall Study|Moved|0|||
161617972|NCT00092456|583653017|FG003|Overall Study|Moved|1|||
161617973|NCT00092456|583653014|FG000|Overall Study|Other|4|||
161617974|NCT00092456|583653015|FG001|Overall Study|Other|2|||
161617975|NCT00092456|583653016|FG002|Overall Study|Other|3|||
161617976|NCT00092456|583653017|FG003|Overall Study|Other|0|||
161617977|NCT00215943|583653018|FG000|Overall Study|Disease Progression|3|||
161617978|NCT00215943|583653019|FG001|Overall Study|Disease Progression|5|||
161617979|NCT00215943|583653018|FG000|Overall Study|Alternate therapy|0|||
161617980|NCT00215943|583653019|FG001|Overall Study|Alternate therapy|1|||
161617981|NCT00215943|583653018|FG000|Overall Study|Adverse Event|3|||
161617982|NCT00215943|583653019|FG001|Overall Study|Adverse Event|6|||
161617983|NCT00215943|583653018|FG000|Overall Study|Other disease|0|||
161617984|NCT00215943|583653019|FG001|Overall Study|Other disease|1|||
161617985|NCT00215943|583653018|FG000|Overall Study|Other complications|3|||
161617986|NCT00215943|583653019|FG001|Overall Study|Other complications|1|||
161617987|NCT00443820|583653020|FG000|Overall Study|Adverse Event|1|||
161617988|NCT00443820|583653021|FG001|Overall Study|Adverse Event|1|||
161617989|NCT00443820|583653022|FG002|Overall Study|Adverse Event|0|||
161617990|NCT00443820|583653023|FG003|Overall Study|Adverse Event|0|||
161617991|NCT00443820|583653020|FG000|Overall Study|Lack of Efficacy|3|||
161617992|NCT00443820|583653021|FG001|Overall Study|Lack of Efficacy|2|||
161617993|NCT00443820|583653022|FG002|Overall Study|Lack of Efficacy|1|||
161617994|NCT00443820|583653023|FG003|Overall Study|Lack of Efficacy|1|||
161617995|NCT00443820|583653020|FG000|Overall Study|Protocol Violation|2|||
161617996|NCT00443820|583653021|FG001|Overall Study|Protocol Violation|1|||
161617997|NCT00443820|583653022|FG002|Overall Study|Protocol Violation|2|||
161617998|NCT00443820|583653023|FG003|Overall Study|Protocol Violation|1|||
161617999|NCT00443820|583653020|FG000|Overall Study|Withdrawal by Subject|6|||
161618000|NCT00443820|583653021|FG001|Overall Study|Withdrawal by Subject|7|||
161618001|NCT00443820|583653022|FG002|Overall Study|Withdrawal by Subject|8|||
161618002|NCT00443820|583653023|FG003|Overall Study|Withdrawal by Subject|9|||
161618003|NCT00443820|583653020|FG000|Overall Study|Lost to Follow-up|9|||
161618004|NCT00443820|583653021|FG001|Overall Study|Lost to Follow-up|8|||
161618005|NCT00443820|583653022|FG002|Overall Study|Lost to Follow-up|6|||
161618006|NCT00443820|583653023|FG003|Overall Study|Lost to Follow-up|5|||
161618007|NCT00443820|583653020|FG000|Overall Study|Administrative problems|0|||
161618008|NCT00443820|583653021|FG001|Overall Study|Administrative problems|0|||
161618009|NCT00443820|583653022|FG002|Overall Study|Administrative problems|0|||
161618010|NCT00443820|583653023|FG003|Overall Study|Administrative problems|1|||
161618011|NCT00443820|583653020|FG000|Overall Study|Death|0|||
161618012|NCT00443820|583653021|FG001|Overall Study|Death|0|||
161618013|NCT00443820|583653022|FG002|Overall Study|Death|1|||
161618014|NCT00443820|583653023|FG003|Overall Study|Death|0|||
161618015|NCT02121808|583653024|FG000|Overall Study|Technical problem|3|||
161618016|NCT03924193|583653025|FG000|Overall Study|Adverse Event|10|||
161618017|NCT03924193|583653026|FG001|Overall Study|Adverse Event|0|||
161618018|NCT03924193|583653027|FG002|Overall Study|Adverse Event|10|||
161618019|NCT03924193|583653025|FG000|Overall Study|Withdrawal by Subject|5|||
161618020|NCT03924193|583653026|FG001|Overall Study|Withdrawal by Subject|10|||
161618021|NCT03924193|583653027|FG002|Overall Study|Withdrawal by Subject|2|||
161618022|NCT02489799|583653028|FG000|Overall Study|Lost to Follow-up|4|||
161618023|NCT02489799|583653029|FG001|Overall Study|Lost to Follow-up|1|||
161618024|NCT02489799|583653028|FG000|Overall Study|Failure to Maintain Eligibility|4|||
161618025|NCT02489799|583653029|FG001|Overall Study|Failure to Maintain Eligibility|6|||
161618026|NCT02489799|583653028|FG000|Overall Study|Withdrawal by Subject|1|||
161618027|NCT02489799|583653029|FG001|Overall Study|Withdrawal by Subject|1|||
161618028|NCT02489799|583653028|FG000|Overall Study|Death|0|||
161618029|NCT02489799|583653029|FG001|Overall Study|Death|1|||
161618030|NCT00515112|583653031|FG000|Overall Study|Death|0|||
161618031|NCT00515112|583653032|FG001|Overall Study|Death|1|||
161618032|NCT00515112|583653031|FG000|Overall Study|The study was terminated|3|||
161618033|NCT00515112|583653032|FG001|Overall Study|The study was terminated|2|||
161618034|NCT01241448|583653042|FG000|Overall Study|Adverse Event|1|||
161618035|NCT01241448|583653043|FG001|Overall Study|Adverse Event|0|||
161618036|NCT01241448|583653044|FG002|Overall Study|Adverse Event|2|||
161618037|NCT01241448|583653045|FG003|Overall Study|Adverse Event|2|||
161618038|NCT01241448|583653042|FG000|Overall Study|Lost to Follow-up|2|||
161618039|NCT01241448|583653043|FG001|Overall Study|Lost to Follow-up|1|||
161618040|NCT01241448|583653044|FG002|Overall Study|Lost to Follow-up|1|||
161618041|NCT01241448|583653045|FG003|Overall Study|Lost to Follow-up|1|||
161618042|NCT01241448|583653042|FG000|Overall Study|Physician Decision|0|||
161618043|NCT01241448|583653043|FG001|Overall Study|Physician Decision|2|||
161618044|NCT01241448|583653044|FG002|Overall Study|Physician Decision|0|||
161618045|NCT01241448|583653045|FG003|Overall Study|Physician Decision|0|||
161618046|NCT01241448|583653042|FG000|Overall Study|Protocol Violation|10|||
161618047|NCT01241448|583653043|FG001|Overall Study|Protocol Violation|5|||
161618048|NCT01241448|583653044|FG002|Overall Study|Protocol Violation|3|||
161618049|NCT01241448|583653045|FG003|Overall Study|Protocol Violation|6|||
161618050|NCT01241448|583653042|FG000|Overall Study|Sponsor Decision|17|||
161618051|NCT01241448|583653043|FG001|Overall Study|Sponsor Decision|14|||
161618052|NCT01241448|583653044|FG002|Overall Study|Sponsor Decision|12|||
161618053|NCT01241448|583653045|FG003|Overall Study|Sponsor Decision|6|||
161618054|NCT01241448|583653042|FG000|Overall Study|Withdrawal by Subject|4|||
161618055|NCT01241448|583653043|FG001|Overall Study|Withdrawal by Subject|5|||
161618056|NCT01241448|583653044|FG002|Overall Study|Withdrawal by Subject|3|||
161618057|NCT01241448|583653045|FG003|Overall Study|Withdrawal by Subject|6|||
161618058|NCT01241448|583653042|FG000|Overall Study|Excluded due to data integrity issues|3|||
161618059|NCT01241448|583653043|FG001|Overall Study|Excluded due to data integrity issues|2|||
161618060|NCT01241448|583653044|FG002|Overall Study|Excluded due to data integrity issues|2|||
161618061|NCT01241448|583653045|FG003|Overall Study|Excluded due to data integrity issues|2|||
161618062|NCT01304940|583653047|FG000|Overall Study|not meet symptom severity requirement|3|||
161618063|NCT01304940|583653048|FG001|Overall Study|not meet symptom severity requirement|0|||
161618064|NCT00304278|583653049|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
161618065|NCT00304278|583653049|FG000|Overall Study|PT had medical condition preventing TX|1|||
161618066|NCT02065895|583653052|FG000|Overall Study|Protocol Violation|1|||
161618067|NCT02065895|583653053|FG001|Overall Study|Protocol Violation|0|||
161618068|NCT02065895|583653054|FG002|Overall Study|Protocol Violation|0|||
161618069|NCT02065895|583653055|FG003|Overall Study|Protocol Violation|1|||
161618070|NCT02065895|583653056|FG004|Overall Study|Protocol Violation|0|||
161618071|NCT02065895|583653057|FG005|Overall Study|Protocol Violation|0|||
161618072|NCT02065895|583653052|FG000|Overall Study|Scheduling conflicts|0|||
161618073|NCT02065895|583653053|FG001|Overall Study|Scheduling conflicts|1|||
161618074|NCT02065895|583653054|FG002|Overall Study|Scheduling conflicts|0|||
161618075|NCT02065895|583653055|FG003|Overall Study|Scheduling conflicts|0|||
161618076|NCT02065895|583653056|FG004|Overall Study|Scheduling conflicts|0|||
161618077|NCT02065895|583653057|FG005|Overall Study|Scheduling conflicts|0|||
161618078|NCT03740737|583653058|FG000|Overall Study|Protocol deviation|13|||
161618079|NCT03740737|583653059|FG001|Overall Study|Protocol deviation|0|||
161618080|NCT03740737|583653058|FG000|Overall Study|Adverse Event|2|||
161618081|NCT03740737|583653059|FG001|Overall Study|Adverse Event|0|||
161618082|NCT03740737|583653058|FG000|Overall Study|Lost to Follow-up|1|||
161618083|NCT03740737|583653059|FG001|Overall Study|Lost to Follow-up|0|||
161618084|NCT03740737|583653058|FG000|Overall Study|Randomization failure|1|||
161618085|NCT03740737|583653059|FG001|Overall Study|Randomization failure|0|||
161618086|NCT03740737|583653058|FG000|Overall Study|Participant withdrew consent|1|||
161618087|NCT03740737|583653059|FG001|Overall Study|Participant withdrew consent|0|||
161618088|NCT03740737|583653058|FG000|Overall Study|Participant withdrew from trial|2|||
161618089|NCT03740737|583653059|FG001|Overall Study|Participant withdrew from trial|1|||
161618090|NCT03340961|583653065|FG000|Overall Study|Adverse Event|1|||
161832765|NCT03310957|584429589|FG000|Overall Study|Progressive|0|||
161832766|NCT03310957|584429590|FG001|Overall Study|Progressive|0|||
161832767|NCT03310957|584429591|FG002|Overall Study|Progressive|1|||
161832768|NCT03310957|584429592|FG003|Overall Study|Progressive|0|||
161618091|NCT03340961|583653066|FG001|Overall Study|Adverse Event|3|||
161618092|NCT03340961|583653067|FG002|Overall Study|Adverse Event|2|||
161618093|NCT03340961|583653068|FG003|Overall Study|Adverse Event|4|||
161618094|NCT03340961|583653065|FG000|Overall Study|Lost to Follow-up|0|||
161618095|NCT03340961|583653066|FG001|Overall Study|Lost to Follow-up|1|||
161618096|NCT03340961|583653067|FG002|Overall Study|Lost to Follow-up|0|||
161618097|NCT03340961|583653068|FG003|Overall Study|Lost to Follow-up|1|||
161618098|NCT03340961|583653065|FG000|Overall Study|Withdrawal by Subject|3|||
161618099|NCT03340961|583653066|FG001|Overall Study|Withdrawal by Subject|2|||
161618100|NCT03340961|583653067|FG002|Overall Study|Withdrawal by Subject|4|||
161618101|NCT03340961|583653068|FG003|Overall Study|Withdrawal by Subject|7|||
161618102|NCT03340961|583653065|FG000|Overall Study|Use of prohibited treatment|0|||
161618103|NCT03340961|583653066|FG001|Overall Study|Use of prohibited treatment|3|||
161618104|NCT03340961|583653067|FG002|Overall Study|Use of prohibited treatment|2|||
161618105|NCT03340961|583653068|FG003|Overall Study|Use of prohibited treatment|4|||
161618106|NCT03340961|583653065|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
161618107|NCT03340961|583653066|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
161618108|NCT03340961|583653067|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
161618109|NCT03340961|583653068|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
161618110|NCT03340961|583653065|FG000|Overall Study|Subject developed an exclusion criterion|0|||
161618111|NCT03340961|583653066|FG001|Overall Study|Subject developed an exclusion criterion|1|||
161618112|NCT03340961|583653067|FG002|Overall Study|Subject developed an exclusion criterion|0|||
161618113|NCT03340961|583653068|FG003|Overall Study|Subject developed an exclusion criterion|0|||
161618114|NCT03340961|583653065|FG000|Overall Study|Protocol Violation|1|||
161618115|NCT03340961|583653066|FG001|Overall Study|Protocol Violation|0|||
161618116|NCT03340961|583653067|FG002|Overall Study|Protocol Violation|1|||
161618117|NCT03340961|583653068|FG003|Overall Study|Protocol Violation|0|||
161618118|NCT03340961|583653065|FG000|Overall Study|Adverse Event|1|||
161618119|NCT03340961|583653066|FG001|Overall Study|Adverse Event|1|||
161618120|NCT03340961|583653067|FG002|Overall Study|Adverse Event|0|||
161618121|NCT03340961|583653068|FG003|Overall Study|Adverse Event|0|||
161618122|NCT03340961|583653065|FG000|Overall Study|Lack of Efficacy|0|||
161618123|NCT03340961|583653066|FG001|Overall Study|Lack of Efficacy|0|||
161618124|NCT03340961|583653067|FG002|Overall Study|Lack of Efficacy|0|||
161618125|NCT03340961|583653068|FG003|Overall Study|Lack of Efficacy|1|||
161618126|NCT03137784|583653071|FG000|Overall Study|Adverse Event|1|||
161618127|NCT03137784|583653072|FG001|Overall Study|Adverse Event|1|||
161618128|NCT03137784|583653073|FG002|Overall Study|Adverse Event|0|||
161832769|NCT03310957|584429593|FG004|Overall Study|Progressive|0|||
161618129|NCT03137784|583653074|FG003|Overall Study|Adverse Event|0|||
161618130|NCT03137784|583653075|FG004|Overall Study|Adverse Event|0|||
161618131|NCT03137784|583653076|FG005|Overall Study|Adverse Event|0|||
161618132|NCT03137784|583653071|FG000|Overall Study|Subject/guardian decision|1|||
161618133|NCT03137784|583653072|FG001|Overall Study|Subject/guardian decision|0|||
161618134|NCT03137784|583653073|FG002|Overall Study|Subject/guardian decision|0|||
161618135|NCT03137784|583653074|FG003|Overall Study|Subject/guardian decision|0|||
161618136|NCT03137784|583653075|FG004|Overall Study|Subject/guardian decision|0|||
161618137|NCT03137784|583653076|FG005|Overall Study|Subject/guardian decision|0|||
161618138|NCT03137784|583653071|FG000|Overall Study|Non-compliance with study treatment|0|||
161618139|NCT03137784|583653072|FG001|Overall Study|Non-compliance with study treatment|0|||
161618140|NCT03137784|583653073|FG002|Overall Study|Non-compliance with study treatment|0|||
161618141|NCT03137784|583653074|FG003|Overall Study|Non-compliance with study treatment|0|||
161618142|NCT03137784|583653075|FG004|Overall Study|Non-compliance with study treatment|1|||
161618143|NCT03137784|583653076|FG005|Overall Study|Non-compliance with study treatment|0|||
161618144|NCT02753075|583653084|FG000|Overall Study|Adverse Event|2|||
161618145|NCT02753075|583653085|FG001|Overall Study|Adverse Event|1|||
161618146|NCT02753075|583653086|FG002|Overall Study|Adverse Event|0|||
161618147|NCT02753075|583653084|FG000|Overall Study|Lost to Follow-up|2|||
161618148|NCT02753075|583653085|FG001|Overall Study|Lost to Follow-up|0|||
161618149|NCT02753075|583653086|FG002|Overall Study|Lost to Follow-up|0|||
161618150|NCT02753075|583653084|FG000|Overall Study|Withdrawal of Consent|1|||
161618151|NCT02753075|583653085|FG001|Overall Study|Withdrawal of Consent|1|||
161618152|NCT02753075|583653086|FG002|Overall Study|Withdrawal of Consent|3|||
161618153|NCT02753075|583653084|FG000|Overall Study|Physician Decision|3|||
161618154|NCT02753075|583653085|FG001|Overall Study|Physician Decision|1|||
161618155|NCT02753075|583653086|FG002|Overall Study|Physician Decision|0|||
161618156|NCT00889863|583653087|FG000|Part I: Open Label|Death|1|||
161618157|NCT00889863|583653088|FG001|Part I: Open Label|Death|0|||
161618158|NCT00889863|583653087|FG000|Part I: Open Label|Adverse Event|4|||
161832770|NCT03310957|584429594|FG005|Overall Study|Progressive|0|||
161832771|NCT03310957|584429595|FG006|Overall Study|Progressive|0|||
161832772|NCT01475253|584429600|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
161832773|NCT01475253|584429601|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
161832774|NCT01475253|584429602|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
161832775|NCT01475253|584429603|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
161832776|NCT01475253|584429600|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
161832777|NCT01475253|584429601|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
161832778|NCT01475253|584429602|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
161618159|NCT00889863|583653088|FG001|Part I: Open Label|Adverse Event|0|||
161618160|NCT00889863|583653087|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
161618161|NCT00889863|583653088|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
161618162|NCT00889863|583653087|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
161618163|NCT00889863|583653088|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
161618164|NCT00889863|583653087|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
161618165|NCT00889863|583653088|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
161618166|NCT00889863|583653087|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
161618167|NCT00889863|583653088|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
161618168|NCT00889863|583653087|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
161618169|NCT00889863|583653088|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
161618170|NCT03909100|583653089|FG000|Overall Study|Protocol Deviation|2|||
161618171|NCT03909100|583653089|FG000|Overall Study|Technical Problems|4|||
161618172|NCT03909100|583653089|FG000|Overall Study|Withdrawal by Subject|4|||
161618173|NCT03909100|583653089|FG000|Overall Study|Lost to Follow-up|1|||
161618174|NCT03909100|583653089|FG000|Overall Study|Reason not Specified|4|||
161618175|NCT01794299|583653091|FG000|Overall Study|ATIR manufacturing not possible|1|||
161618176|NCT01794299|583653091|FG000|Overall Study|Death|14|||
161618177|NCT01794299|583653091|FG000|Overall Study|Graft failure|1|||
161618178|NCT01794299|583653091|FG000|Overall Study|ATIR batch rejected|2|||
161618179|NCT01794299|583653091|FG000|Overall Study|Relapse|2|||
161618180|NCT01794299|583653091|FG000|Overall Study|Discontinued from active follow-up|1|||
161618181|NCT01794299|583653091|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
161618182|NCT03006393|583653092|FG000|Overall Study|Withdrawal by Subject|1|||
161618183|NCT03006393|583653093|FG001|Overall Study|Withdrawal by Subject|1|||
161618184|NCT03006393|583653092|FG000|Overall Study|Pregnancy|0|||
161618185|NCT03006393|583653093|FG001|Overall Study|Pregnancy|1|||
161618186|NCT03006393|583653092|FG000|Overall Study|Lost to Follow-up|0|||
161618187|NCT03006393|583653093|FG001|Overall Study|Lost to Follow-up|1|||
161618188|NCT00807599|583653096|FG000|Overall Study|Not treated on protocol study|0|||
161618189|NCT00807599|583653097|FG001|Overall Study|Not treated on protocol study|0|||
161618190|NCT00807599|583653098|FG002|Overall Study|Not treated on protocol study|2|||
161618191|NCT00807599|583653096|FG000|Overall Study|Adverse Event|0|||
161618192|NCT00807599|583653097|FG001|Overall Study|Adverse Event|0|||
161618193|NCT00807599|583653098|FG002|Overall Study|Adverse Event|5|||
161618194|NCT00807599|583653096|FG000|Overall Study|Inadequate response to induction|0|||
161618195|NCT00807599|583653097|FG001|Overall Study|Inadequate response to induction|0|||
161618196|NCT00807599|583653098|FG002|Overall Study|Inadequate response to induction|9|||
161618197|NCT00807599|583653096|FG000|Overall Study|Withdrawal by Subject|0|||
161618198|NCT00807599|583653097|FG001|Overall Study|Withdrawal by Subject|0|||
161618199|NCT00807599|583653098|FG002|Overall Study|Withdrawal by Subject|1|||
161618200|NCT00274287|583653099|FG000|Overall Study|Withdrawal by Subject|1|||
161618201|NCT00274287|583653099|FG000|Overall Study|subject non-compliance|1|||
161618202|NCT04183491|583653103|FG000|Overall Study|Withdrawal by Subject|0|||
161618203|NCT04183491|583653104|FG001|Overall Study|Withdrawal by Subject|0|||
161618204|NCT04183491|583653105|FG002|Overall Study|Withdrawal by Subject|1|||
161618205|NCT04183491|583653106|FG003|Overall Study|Withdrawal by Subject|0|||
161618206|NCT04183491|583653107|FG004|Overall Study|Withdrawal by Subject|0|||
161618207|NCT04183491|583653108|FG005|Overall Study|Withdrawal by Subject|1|||
161618208|NCT04183491|583653109|FG006|Overall Study|Withdrawal by Subject|0|||
161618209|NCT02538094|583653110|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
161618210|NCT02538094|583653111|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
161618211|NCT02538094|583653110|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
161618212|NCT02538094|583653111|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
161618213|NCT03288506|583653112|FG000|Overall Study|Withdrawal by Subject|52|||
161618214|NCT03692871|583653113|FG000|Overall Study|Death|1|||
161618215|NCT03692871|583653114|FG001|Overall Study|Death|1|||
161618216|NCT03692871|583653113|FG000|Overall Study|Lost to Follow-up|24|||
161618217|NCT03692871|583653114|FG001|Overall Study|Lost to Follow-up|9|||
161618218|NCT03692871|583653113|FG000|Overall Study|Physician Decision|22|||
161618219|NCT03692871|583653114|FG001|Overall Study|Physician Decision|7|||
161618220|NCT03692871|583653113|FG000|Overall Study|Protocol Deviation|1|||
161618221|NCT03692871|583653114|FG001|Overall Study|Protocol Deviation|0|||
161618222|NCT03692871|583653113|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
161618223|NCT03692871|583653114|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
161618224|NCT02852824|583653118|FG000|Overall Study|Withdrawal by Subject|1|||
161618225|NCT02852824|583653119|FG001|Overall Study|Withdrawal by Subject|0|||
161618226|NCT02852824|583653120|FG002|Overall Study|Withdrawal by Subject|0|||
161618227|NCT02852824|583653121|FG003|Overall Study|Withdrawal by Subject|0|||
161618228|NCT02852824|583653122|FG004|Overall Study|Withdrawal by Subject|0|||
161618229|NCT02852824|583653123|FG005|Overall Study|Withdrawal by Subject|0|||
161618230|NCT02852824|583653124|FG006|Overall Study|Withdrawal by Subject|0|||
161618231|NCT02852824|583653118|FG000|Overall Study|Adverse Event|0|||
161618232|NCT02852824|583653119|FG001|Overall Study|Adverse Event|0|||
161618233|NCT02852824|583653120|FG002|Overall Study|Adverse Event|0|||
161618234|NCT02852824|583653121|FG003|Overall Study|Adverse Event|0|||
161618235|NCT02852824|583653122|FG004|Overall Study|Adverse Event|2|||
161618236|NCT02852824|583653123|FG005|Overall Study|Adverse Event|0|||
161618237|NCT02852824|583653124|FG006|Overall Study|Adverse Event|0|||
161618238|NCT01316913|583653125|FG000|Overall Study|Adverse Event|17|||
161618239|NCT01316913|583653126|FG001|Overall Study|Adverse Event|20|||
161618240|NCT01316913|583653127|FG002|Overall Study|Adverse Event|15|||
161618241|NCT01316913|583653128|FG003|Overall Study|Adverse Event|11|||
161618242|NCT01316913|583653125|FG000|Overall Study|Lack of Efficacy|22|||
161618243|NCT01316913|583653126|FG001|Overall Study|Lack of Efficacy|12|||
161618244|NCT01316913|583653127|FG002|Overall Study|Lack of Efficacy|9|||
161684671|NCT02121262|583897966|FG001|Overall Study|Consent Withdrawn|0|||
161684672|NCT02716987|583897967|FG000|Overall Study|Ligand synthesis failure|0|||
161684673|NCT02716987|583897968|FG001|Overall Study|Ligand synthesis failure|0|||
161684674|NCT02716987|583897969|FG002|Overall Study|Ligand synthesis failure|1|||
161684675|NCT02716987|583897970|FG003|Overall Study|Ligand synthesis failure|0|||
161684676|NCT02716987|583897971|FG004|Overall Study|Ligand synthesis failure|0|||
161684677|NCT02716987|583897972|FG005|Overall Study|Ligand synthesis failure|0|||
161684678|NCT02716987|583897967|FG000|Overall Study|Withdrawal by Subject|0|||
161684679|NCT02716987|583897968|FG001|Overall Study|Withdrawal by Subject|0|||
161684680|NCT02716987|583897969|FG002|Overall Study|Withdrawal by Subject|0|||
161684681|NCT02716987|583897970|FG003|Overall Study|Withdrawal by Subject|0|||
161684682|NCT02716987|583897971|FG004|Overall Study|Withdrawal by Subject|1|||
161684683|NCT02716987|583897972|FG005|Overall Study|Withdrawal by Subject|1|||
161684684|NCT01553188|583897973|FG000|Overall Study|Patient choice|1|||
161684685|NCT01553188|583897974|FG001|Overall Study|Patient choice|0|||
161684686|NCT01553188|583897975|FG002|Overall Study|Patient choice|0|||
161684687|NCT01553188|583897976|FG003|Overall Study|Patient choice|0|||
161684688|NCT01553188|583897973|FG000|Overall Study|Intercurrent illness and adverse event|0|||
161684689|NCT01553188|583897974|FG001|Overall Study|Intercurrent illness and adverse event|1|||
161684690|NCT01553188|583897975|FG002|Overall Study|Intercurrent illness and adverse event|2|||
161684691|NCT01553188|583897976|FG003|Overall Study|Intercurrent illness and adverse event|0|||
161684692|NCT01617070|583897978|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
161684693|NCT04544475|583897979|FG000|Overall Study|Withdrawal by Subject|1|||
161684694|NCT04544475|583897980|FG001|Overall Study|Withdrawal by Subject|3|||
161684695|NCT03223428|583897981|FG000|Overall Study|No longer taking Xermelo|27|||
161684696|NCT03223428|583897981|FG000|Overall Study|Declined Consent|1|||
161684697|NCT03223428|583897981|FG000|Overall Study|Non-responders|56|||
161684698|NCT03223428|583897981|FG000|Overall Study|Withdrawal by Subject|14|||
161684699|NCT02230384|583897983|FG000|Phase 1|Lost to Follow-up|1|||
161618245|NCT01316913|583653128|FG003|Overall Study|Lack of Efficacy|13|||
161684700|NCT02230384|583897984|FG001|Phase 1|Lost to Follow-up|0|||
161684701|NCT02230384|583897983|FG000|Phase 1|Physician Decision|0|||
161684702|NCT02230384|583897984|FG001|Phase 1|Physician Decision|1|||
161684703|NCT02230384|583897983|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
161684704|NCT02230384|583897984|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
161684705|NCT02230384|583897983|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
161684706|NCT02230384|583897984|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
161618246|NCT01316913|583653125|FG000|Overall Study|Protocol Violation|1|||
161618247|NCT01316913|583653126|FG001|Overall Study|Protocol Violation|4|||
161618248|NCT01316913|583653127|FG002|Overall Study|Protocol Violation|4|||
161618249|NCT01316913|583653128|FG003|Overall Study|Protocol Violation|1|||
161618250|NCT01316913|583653125|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
161618251|NCT01316913|583653126|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
161618252|NCT01316913|583653127|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
161618253|NCT01316913|583653128|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
161618254|NCT01316913|583653125|FG000|Overall Study|Lost to Follow-up|0|||
161618255|NCT01316913|583653126|FG001|Overall Study|Lost to Follow-up|1|||
161618256|NCT01316913|583653127|FG002|Overall Study|Lost to Follow-up|0|||
161618257|NCT01316913|583653128|FG003|Overall Study|Lost to Follow-up|2|||
161618258|NCT01316913|583653125|FG000|Overall Study|Withdrawal by Subject|10|||
161618259|NCT01316913|583653126|FG001|Overall Study|Withdrawal by Subject|9|||
161618260|NCT01316913|583653127|FG002|Overall Study|Withdrawal by Subject|10|||
161618261|NCT01316913|583653128|FG003|Overall Study|Withdrawal by Subject|6|||
161618262|NCT01860079|583653129|FG000|Overall Study|Physician Decision|14|||
161618263|NCT01860079|583653130|FG001|Overall Study|Physician Decision|22|||
161618264|NCT02102724|583653131|FG000|Overall Study|Lost to Follow-up|1|||
161618265|NCT02102724|583653132|FG001|Overall Study|Lost to Follow-up|0|||
161618266|NCT02102724|583653131|FG000|Overall Study|surgery for brain aneurysm|1|||
161618267|NCT02102724|583653132|FG001|Overall Study|surgery for brain aneurysm|1|||
161618268|NCT02008916|583653133|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
161618269|NCT02008916|583653134|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
161618270|NCT02008916|583653135|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
161618271|NCT02008916|583653133|FG000|Week 16 - 156|Adverse Event|4|||
161618272|NCT02008916|583653134|FG001|Week 16 - 156|Adverse Event|2|||
161618273|NCT02008916|583653135|FG002|Week 16 - 156|Adverse Event|3|||
161618274|NCT02008916|583653133|FG000|Week 16 - 156|Withdrawal by Subject|7|||
161618275|NCT02008916|583653134|FG001|Week 16 - 156|Withdrawal by Subject|3|||
161618276|NCT02008916|583653135|FG002|Week 16 - 156|Withdrawal by Subject|5|||
161618277|NCT02008916|583653133|FG000|Week 16 - 156|No longer requires treatment|0|||
161618278|NCT02008916|583653134|FG001|Week 16 - 156|No longer requires treatment|1|||
161618279|NCT02008916|583653135|FG002|Week 16 - 156|No longer requires treatment|0|||
161618280|NCT02008916|583653133|FG000|Week 16 - 156|Lost to Follow-up|5|||
161618281|NCT02008916|583653134|FG001|Week 16 - 156|Lost to Follow-up|0|||
161618282|NCT02008916|583653135|FG002|Week 16 - 156|Lost to Follow-up|0|||
161618283|NCT02008916|583653133|FG000|Week 16 - 156|Lack of Efficacy|3|||
161618284|NCT02008916|583653134|FG001|Week 16 - 156|Lack of Efficacy|5|||
161618285|NCT02008916|583653135|FG002|Week 16 - 156|Lack of Efficacy|2|||
161618286|NCT02008916|583653133|FG000|Week 16 - 156|Pregnancy|0|||
161618287|NCT02008916|583653134|FG001|Week 16 - 156|Pregnancy|1|||
161618288|NCT02008916|583653135|FG002|Week 16 - 156|Pregnancy|0|||
161618289|NCT02008916|583653133|FG000|Week 16 - 156|Physician Decision|0|||
161618290|NCT02008916|583653134|FG001|Week 16 - 156|Physician Decision|1|||
161618291|NCT02008916|583653135|FG002|Week 16 - 156|Physician Decision|0|||
161618292|NCT03803475|583653136|FG000|Overall Study|Physician Decision|1|||
161618293|NCT02915783|583653143|FG000|Overall Study|Death|21|||
161618294|NCT02915783|583653143|FG000|Overall Study|Lost to Follow-up|1|||
161618295|NCT02915783|583653143|FG000|Overall Study|Withdrawal by Subject|2|||
161618296|NCT02950961|583653145|FG000|Overall Study|Study had to stop due to COVID.|7|||
161618297|NCT01915914|583653146|FG000|Acute Phase|Withdrawal by Subject|4|||
161618298|NCT01915914|583653147|FG001|Acute Phase|Withdrawal by Subject|0|||
161618299|NCT01915914|583653148|FG002|Acute Phase|Withdrawal by Subject|0|||
161618300|NCT01915914|583653149|FG003|Acute Phase|Withdrawal by Subject|0|||
161618301|NCT01915914|583653146|FG000|Acute Phase|Lost to Follow-up|4|||
161618302|NCT01915914|583653147|FG001|Acute Phase|Lost to Follow-up|0|||
161618303|NCT01915914|583653148|FG002|Acute Phase|Lost to Follow-up|0|||
161618304|NCT01915914|583653149|FG003|Acute Phase|Lost to Follow-up|0|||
161618305|NCT01915914|583653146|FG000|Acute Phase|Physician Decision|1|||
161618306|NCT01915914|583653147|FG001|Acute Phase|Physician Decision|0|||
161618307|NCT01915914|583653148|FG002|Acute Phase|Physician Decision|0|||
161618308|NCT01915914|583653149|FG003|Acute Phase|Physician Decision|0|||
161618309|NCT01915914|583653146|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
161618310|NCT01915914|583653147|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
161618311|NCT01915914|583653148|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
161618312|NCT01915914|583653149|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
161618313|NCT01915914|583653146|FG000|Acute Phase|"Not Achieved treatment success"|1|||
161618314|NCT01915914|583653147|FG001|Acute Phase|"Not Achieved treatment success"|0|||
161618315|NCT01915914|583653148|FG002|Acute Phase|"Not Achieved treatment success"|0|||
161618316|NCT01915914|583653149|FG003|Acute Phase|"Not Achieved treatment success"|0|||
161618317|NCT01915914|583653146|FG000|Acute Phase|Missing|1|||
161618318|NCT01915914|583653147|FG001|Acute Phase|Missing|0|||
161618319|NCT01915914|583653148|FG002|Acute Phase|Missing|0|||
161618320|NCT01915914|583653149|FG003|Acute Phase|Missing|0|||
161618321|NCT01915914|583653146|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161684707|NCT02230384|583897983|FG000|Phase 2 - Switch|Adverse Event|2|||
161618322|NCT01915914|583653147|FG001|Maintenance Phase|Withdrawal by Subject|1|||
161618323|NCT01915914|583653148|FG002|Maintenance Phase|Withdrawal by Subject|1|||
161618324|NCT01915914|583653149|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161618325|NCT01915914|583653146|FG000|Maintenance Phase|Lost to Follow-up|0|||
161618326|NCT01915914|583653147|FG001|Maintenance Phase|Lost to Follow-up|4|||
161618327|NCT01915914|583653148|FG002|Maintenance Phase|Lost to Follow-up|1|||
161618328|NCT01915914|583653149|FG003|Maintenance Phase|Lost to Follow-up|0|||
161618329|NCT01915914|583653146|FG000|Maintenance Phase|Missing|0|||
161618330|NCT01915914|583653147|FG001|Maintenance Phase|Missing|1|||
161618331|NCT01915914|583653148|FG002|Maintenance Phase|Missing|0|||
161618332|NCT01915914|583653149|FG003|Maintenance Phase|Missing|0|||
161618333|NCT01915914|583653146|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161618334|NCT01915914|583653147|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161618335|NCT01915914|583653148|FG002|Follow-up Phase|Withdrawal by Subject|0|||
161618336|NCT01915914|583653149|FG003|Follow-up Phase|Withdrawal by Subject|1|||
161618337|NCT01915914|583653146|FG000|Follow-up Phase|Physician Decision|0|||
161618338|NCT01915914|583653147|FG001|Follow-up Phase|Physician Decision|0|||
161618339|NCT01915914|583653148|FG002|Follow-up Phase|Physician Decision|0|||
161618340|NCT01915914|583653149|FG003|Follow-up Phase|Physician Decision|1|||
161618341|NCT02432274|583653151|FG000|Overall Study|Death|2|||
161618342|NCT02432274|583653152|FG001|Overall Study|Death|6|||
161618343|NCT02432274|583653153|FG002|Overall Study|Death|7|||
161618344|NCT02432274|583653154|FG003|Overall Study|Death|0|||
161618345|NCT02432274|583653155|FG004|Overall Study|Death|27|||
161618346|NCT02432274|583653156|FG005|Overall Study|Death|7|||
161618347|NCT02432274|583653157|FG006|Overall Study|Death|9|||
161618348|NCT02432274|583653158|FG007|Overall Study|Death|14|||
161618349|NCT02432274|583653151|FG000|Overall Study|Withdrawal of Consent|0|||
161618350|NCT02432274|583653152|FG001|Overall Study|Withdrawal of Consent|0|||
161618351|NCT02432274|583653153|FG002|Overall Study|Withdrawal of Consent|0|||
161618352|NCT02432274|583653154|FG003|Overall Study|Withdrawal of Consent|0|||
161618353|NCT02432274|583653155|FG004|Overall Study|Withdrawal of Consent|2|||
161618354|NCT02432274|583653156|FG005|Overall Study|Withdrawal of Consent|0|||
161618355|NCT02432274|583653157|FG006|Overall Study|Withdrawal of Consent|1|||
161618356|NCT02432274|583653158|FG007|Overall Study|Withdrawal of Consent|2|||
161618357|NCT02114515|583653159|FG000|Overall Study|Lost to Follow-up|52|||
161618358|NCT02114515|583653160|FG001|Overall Study|Lost to Follow-up|55|||
161618359|NCT02114515|583653159|FG000|Overall Study|Death|12|||
161618360|NCT02114515|583653160|FG001|Overall Study|Death|12|||
161618361|NCT02114515|583653159|FG000|Overall Study|Withdrawal by Subject|4|||
161618362|NCT02114515|583653160|FG001|Overall Study|Withdrawal by Subject|22|||
161618363|NCT02114515|583653159|FG000|Overall Study|Other|65|||
161618364|NCT02114515|583653160|FG001|Overall Study|Other|61|||
161618365|NCT04197713|583653161|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
161618366|NCT04197713|583653162|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
161618367|NCT05338476|583653172|FG000|Period 2|Adverse Event|0|||
161618368|NCT05338476|583653173|FG001|Period 2|Adverse Event|1|||
161618369|NCT05522777|583654761|FG000|Overall Study|Lack of Efficacy|1|||
161618370|NCT05522777|583654761|FG000|Overall Study|Withdrawal by Subject|1|||
161618371|NCT05487300|583654764|FG000|Overall Study|Withdrawal by Subject|1|||
161618372|NCT05487300|583654765|FG001|Overall Study|Withdrawal by Subject|0|||
161618373|NCT04914897|583654766|FG000|Overall Study|Withdrawal by Subject|3|||
161618374|NCT04914897|583654767|FG001|Overall Study|Withdrawal by Subject|1|||
161618375|NCT04914897|583654768|FG002|Overall Study|Withdrawal by Subject|1|||
161618376|NCT04914897|583654769|FG003|Overall Study|Withdrawal by Subject|1|||
161618377|NCT04914897|583654766|FG000|Overall Study|Poor compliance to protocol|0|||
161618378|NCT04914897|583654767|FG001|Overall Study|Poor compliance to protocol|0|||
161618379|NCT04914897|583654768|FG002|Overall Study|Poor compliance to protocol|1|||
161618380|NCT04914897|583654769|FG003|Overall Study|Poor compliance to protocol|0|||
161618381|NCT04914897|583654766|FG000|Overall Study|Progressive disease|5|||
161618382|NCT04914897|583654767|FG001|Overall Study|Progressive disease|14|||
161618383|NCT04914897|583654768|FG002|Overall Study|Progressive disease|30|||
161618384|NCT04914897|583654769|FG003|Overall Study|Progressive disease|21|||
161618385|NCT04914897|583654766|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161618386|NCT04914897|583654767|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
161618387|NCT04914897|583654768|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
161618388|NCT04914897|583654769|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
161618389|NCT04914897|583654766|FG000|Overall Study|Other|1|||
161618390|NCT04914897|583654767|FG001|Overall Study|Other|0|||
161618391|NCT04914897|583654768|FG002|Overall Study|Other|0|||
161618392|NCT04914897|583654769|FG003|Overall Study|Other|1|||
161618393|NCT04783389|583654779|FG000|Overall Study|Withdrawal by Subject|2|||
161618394|NCT04783389|583654780|FG001|Overall Study|Withdrawal by Subject|0|||
161618395|NCT04783389|583654781|FG002|Overall Study|Withdrawal by Subject|0|||
161618396|NCT04783389|583654779|FG000|Overall Study|Termination of Study by Sponsor|10|||
161618397|NCT04783389|583654780|FG001|Overall Study|Termination of Study by Sponsor|12|||
161618398|NCT04783389|583654781|FG002|Overall Study|Termination of Study by Sponsor|14|||
161618399|NCT02164578|583654783|FG000|Treatment Period|Withdrawal by Subject|3|||
161618400|NCT02164578|583654784|FG001|Treatment Period|Withdrawal by Subject|3|||
161618401|NCT02164578|583654783|FG000|Treatment Period|Adverse Event|13|||
161618402|NCT02164578|583654784|FG001|Treatment Period|Adverse Event|6|||
161618403|NCT02164578|583654783|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
161618404|NCT02164578|583654784|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
161618405|NCT02164578|583654783|FG000|Treatment Period|Protocol Violation|0|||
161618406|NCT02164578|583654784|FG001|Treatment Period|Protocol Violation|2|||
161618407|NCT02164578|583654783|FG000|Extension Period|Withdrawal by Subject|2|||
161618408|NCT02164578|583654784|FG001|Extension Period|Withdrawal by Subject|0|||
161618409|NCT02164578|583654783|FG000|Extension Period|Adverse Event|4|||
161618410|NCT02164578|583654784|FG001|Extension Period|Adverse Event|0|||
161618411|NCT02164578|583654783|FG000|Extension Period|Expiry of study medication|1|||
161618412|NCT02164578|583654784|FG001|Extension Period|Expiry of study medication|0|||
161618413|NCT02164578|583654783|FG000|Extension Period|Protocol Violation|0|||
161618414|NCT02164578|583654784|FG001|Extension Period|Protocol Violation|1|||
161618415|NCT02507297|583654790|FG000|Overall Study|Withdrawal by Subject|1|||
161618416|NCT02507297|583654791|FG001|Overall Study|Withdrawal by Subject|0|||
161618417|NCT02507297|583654790|FG000|Overall Study|Lost to Follow-up|0|||
161618418|NCT02507297|583654791|FG001|Overall Study|Lost to Follow-up|1|||
161618419|NCT01562275|583654792|FG000|Stage 1|Adverse Event|0|||
161618420|NCT01562275|583654793|FG001|Stage 1|Adverse Event|0|||
161618421|NCT01562275|583654794|FG002|Stage 1|Adverse Event|0|||
161618422|NCT01562275|583654795|FG003|Stage 1|Adverse Event|1|||
161618423|NCT01562275|583654796|FG004|Stage 1|Adverse Event|1|||
161618424|NCT01562275|583654797|FG005|Stage 1|Adverse Event|0|||
161618425|NCT01562275|583654798|FG006|Stage 1|Adverse Event|0|||
161618426|NCT01562275|583654799|FG007|Stage 1|Adverse Event|0|||
161618427|NCT01562275|583654800|FG008|Stage 1|Adverse Event|0|||
161618428|NCT01562275|583654801|FG009|Stage 1|Adverse Event|1|||
161618429|NCT01562275|583654802|FG010|Stage 1|Adverse Event|0|||
161618430|NCT01562275|583654803|FG011|Stage 1|Adverse Event|0|||
161618431|NCT01562275|583654804|FG012|Stage 1|Adverse Event|0|||
161618432|NCT01562275|583654792|FG000|Stage 1|Death|1|||
161618433|NCT01562275|583654793|FG001|Stage 1|Death|0|||
161618434|NCT01562275|583654794|FG002|Stage 1|Death|0|||
161618435|NCT01562275|583654795|FG003|Stage 1|Death|0|||
161618436|NCT01562275|583654796|FG004|Stage 1|Death|0|||
161618437|NCT01562275|583654797|FG005|Stage 1|Death|0|||
161618438|NCT01562275|583654798|FG006|Stage 1|Death|0|||
161618439|NCT01562275|583654799|FG007|Stage 1|Death|0|||
161618440|NCT01562275|583654800|FG008|Stage 1|Death|0|||
161618441|NCT01562275|583654801|FG009|Stage 1|Death|0|||
161618442|NCT01562275|583654802|FG010|Stage 1|Death|0|||
161618443|NCT01562275|583654803|FG011|Stage 1|Death|0|||
161618444|NCT01562275|583654804|FG012|Stage 1|Death|0|||
161618445|NCT01562275|583654792|FG000|Stage 1|Non Compliance|0|||
161618446|NCT01562275|583654793|FG001|Stage 1|Non Compliance|0|||
161618447|NCT01562275|583654794|FG002|Stage 1|Non Compliance|1|||
161618448|NCT01562275|583654795|FG003|Stage 1|Non Compliance|0|||
161618449|NCT01562275|583654796|FG004|Stage 1|Non Compliance|0|||
161618450|NCT01562275|583654797|FG005|Stage 1|Non Compliance|0|||
161618451|NCT01562275|583654798|FG006|Stage 1|Non Compliance|0|||
161618452|NCT01562275|583654799|FG007|Stage 1|Non Compliance|0|||
161618453|NCT01562275|583654800|FG008|Stage 1|Non Compliance|0|||
161618454|NCT01562275|583654801|FG009|Stage 1|Non Compliance|0|||
161618455|NCT01562275|583654802|FG010|Stage 1|Non Compliance|0|||
161618456|NCT01562275|583654803|FG011|Stage 1|Non Compliance|0|||
161618457|NCT01562275|583654804|FG012|Stage 1|Non Compliance|0|||
161618458|NCT01562275|583654792|FG000|Stage 1|Physician Decision|0|||
161618459|NCT01562275|583654793|FG001|Stage 1|Physician Decision|0|||
161618460|NCT01562275|583654794|FG002|Stage 1|Physician Decision|0|||
161618461|NCT01562275|583654795|FG003|Stage 1|Physician Decision|0|||
161618462|NCT01562275|583654796|FG004|Stage 1|Physician Decision|1|||
161618463|NCT01562275|583654797|FG005|Stage 1|Physician Decision|0|||
161618464|NCT01562275|583654798|FG006|Stage 1|Physician Decision|1|||
161618465|NCT01562275|583654799|FG007|Stage 1|Physician Decision|0|||
161618466|NCT01562275|583654800|FG008|Stage 1|Physician Decision|1|||
161618467|NCT01562275|583654801|FG009|Stage 1|Physician Decision|0|||
161618468|NCT01562275|583654802|FG010|Stage 1|Physician Decision|0|||
161618469|NCT01562275|583654803|FG011|Stage 1|Physician Decision|0|||
161618470|NCT01562275|583654804|FG012|Stage 1|Physician Decision|0|||
161618471|NCT01562275|583654792|FG000|Stage 1|Progression of Disease|2|||
161618472|NCT01562275|583654793|FG001|Stage 1|Progression of Disease|6|||
161618473|NCT01562275|583654794|FG002|Stage 1|Progression of Disease|2|||
161618474|NCT01562275|583654795|FG003|Stage 1|Progression of Disease|1|||
161618475|NCT01562275|583654796|FG004|Stage 1|Progression of Disease|2|||
161618476|NCT01562275|583654797|FG005|Stage 1|Progression of Disease|4|||
161618477|NCT01562275|583654798|FG006|Stage 1|Progression of Disease|1|||
161618478|NCT01562275|583654799|FG007|Stage 1|Progression of Disease|7|||
161618479|NCT01562275|583654800|FG008|Stage 1|Progression of Disease|2|||
161618480|NCT01562275|583654801|FG009|Stage 1|Progression of Disease|5|||
161618481|NCT01562275|583654802|FG010|Stage 1|Progression of Disease|3|||
161618482|NCT01562275|583654803|FG011|Stage 1|Progression of Disease|0|||
161618483|NCT01562275|583654804|FG012|Stage 1|Progression of Disease|0|||
161618484|NCT01562275|583654792|FG000|Stage 1|Withdrawal by Subject|0|||
161618485|NCT01562275|583654793|FG001|Stage 1|Withdrawal by Subject|1|||
161618486|NCT01562275|583654794|FG002|Stage 1|Withdrawal by Subject|0|||
161618487|NCT01562275|583654795|FG003|Stage 1|Withdrawal by Subject|2|||
161618488|NCT01562275|583654796|FG004|Stage 1|Withdrawal by Subject|0|||
161618489|NCT01562275|583654797|FG005|Stage 1|Withdrawal by Subject|0|||
161618490|NCT01562275|583654798|FG006|Stage 1|Withdrawal by Subject|1|||
161618491|NCT01562275|583654799|FG007|Stage 1|Withdrawal by Subject|0|||
161618492|NCT01562275|583654800|FG008|Stage 1|Withdrawal by Subject|0|||
161618493|NCT01562275|583654801|FG009|Stage 1|Withdrawal by Subject|1|||
161618494|NCT01562275|583654802|FG010|Stage 1|Withdrawal by Subject|0|||
161618495|NCT01562275|583654803|FG011|Stage 1|Withdrawal by Subject|0|||
161618496|NCT01562275|583654804|FG012|Stage 1|Withdrawal by Subject|0|||
161618497|NCT01562275|583654792|FG000|Stage 2|Death|0|||
161618498|NCT01562275|583654793|FG001|Stage 2|Death|0|||
161618499|NCT01562275|583654794|FG002|Stage 2|Death|0|||
161618500|NCT01562275|583654795|FG003|Stage 2|Death|0|||
161618501|NCT01562275|583654796|FG004|Stage 2|Death|0|||
161618502|NCT01562275|583654797|FG005|Stage 2|Death|0|||
161618503|NCT01562275|583654798|FG006|Stage 2|Death|0|||
161618504|NCT01562275|583654799|FG007|Stage 2|Death|0|||
161618505|NCT01562275|583654800|FG008|Stage 2|Death|0|||
161618506|NCT01562275|583654801|FG009|Stage 2|Death|0|||
161618507|NCT01562275|583654802|FG010|Stage 2|Death|0|||
161618508|NCT01562275|583654803|FG011|Stage 2|Death|2|||
161618509|NCT01562275|583654804|FG012|Stage 2|Death|1|||
161618510|NCT01562275|583654792|FG000|Stage 2|Progression of Disease|0|||
161618511|NCT01562275|583654793|FG001|Stage 2|Progression of Disease|0|||
161618512|NCT01562275|583654794|FG002|Stage 2|Progression of Disease|0|||
161618513|NCT01562275|583654795|FG003|Stage 2|Progression of Disease|0|||
161618514|NCT01562275|583654796|FG004|Stage 2|Progression of Disease|0|||
161618515|NCT01562275|583654797|FG005|Stage 2|Progression of Disease|0|||
161618516|NCT01562275|583654798|FG006|Stage 2|Progression of Disease|0|||
161618517|NCT01562275|583654799|FG007|Stage 2|Progression of Disease|0|||
161618518|NCT01562275|583654800|FG008|Stage 2|Progression of Disease|0|||
161618519|NCT01562275|583654801|FG009|Stage 2|Progression of Disease|0|||
161618520|NCT01562275|583654802|FG010|Stage 2|Progression of Disease|0|||
161618521|NCT01562275|583654803|FG011|Stage 2|Progression of Disease|12|||
161618522|NCT01562275|583654804|FG012|Stage 2|Progression of Disease|4|||
161618523|NCT01863368|583654805|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
161618524|NCT01863368|583654806|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
161618525|NCT01863368|583654805|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
161618526|NCT01863368|583654806|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
161618527|NCT01863368|583654805|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
161618528|NCT01863368|583654806|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
161618529|NCT01863368|583654805|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
161618530|NCT01863368|583654806|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
161618531|NCT01863368|583654805|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
161618532|NCT01863368|583654806|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
161618533|NCT01863368|583654805|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
161618534|NCT01863368|583654806|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
161618535|NCT00070707|583654807|FG000|Overall Study|Adverse Event|1|||
161618536|NCT00070707|583654808|FG001|Overall Study|Adverse Event|2|||
161618537|NCT00070707|583654807|FG000|Overall Study|Lack of Efficacy|4|||
161618538|NCT00070707|583654808|FG001|Overall Study|Lack of Efficacy|1|||
161618539|NCT00070707|583654807|FG000|Overall Study|Protocol Violation|8|||
161618540|NCT00070707|583654808|FG001|Overall Study|Protocol Violation|4|||
161618541|NCT00070707|583654807|FG000|Overall Study|Unrelated to Study Medication|1|||
161618542|NCT00070707|583654808|FG001|Overall Study|Unrelated to Study Medication|0|||
161618543|NCT00647699|583654809|FG000|Overall Study|Lost to Follow-up|5|||
161618544|NCT00647699|583654810|FG001|Overall Study|Lost to Follow-up|4|||
161618545|NCT00647699|583654809|FG000|Overall Study|Withdrawal by Subject|3|||
161618546|NCT00647699|583654810|FG001|Overall Study|Withdrawal by Subject|8|||
161618547|NCT04909593|583654811|FG000|Overall Study|Withdrawal by Subject|1|||
161618548|NCT01018992|583654812|FG000|Overall Study|Adverse Event|8|||
161618549|NCT01018992|583654813|FG001|Overall Study|Adverse Event|3|||
161618550|NCT01018992|583654812|FG000|Overall Study|Withdrawal by Subject|3|||
161618551|NCT01018992|583654813|FG001|Overall Study|Withdrawal by Subject|8|||
161618552|NCT01018992|583654812|FG000|Overall Study|Protocol Violation|0|||
161618553|NCT01018992|583654813|FG001|Overall Study|Protocol Violation|4|||
161618554|NCT01018992|583654812|FG000|Overall Study|Lost to Follow-up|5|||
161618555|NCT01018992|583654813|FG001|Overall Study|Lost to Follow-up|1|||
161618556|NCT00307489|583654814|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
161618557|NCT00307489|583654815|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
161618558|NCT00307489|583654814|FG000|Baseline Through Week 48|Physician Decision|1|||
161618559|NCT00307489|583654815|FG001|Baseline Through Week 48|Physician Decision|0|||
161618560|NCT00307489|583654814|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
161618561|NCT00307489|583654815|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
161618562|NCT00307489|583654814|FG000|Week 48 Through Week 168|Adverse Event|1|||
161618563|NCT00307489|583654815|FG001|Week 48 Through Week 168|Adverse Event|0|||
161618564|NCT00307489|583654814|FG000|Week 48 Through Week 168|Physician Decision|1|||
161618565|NCT00307489|583654815|FG001|Week 48 Through Week 168|Physician Decision|0|||
161618566|NCT00307489|583654814|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
161618567|NCT00307489|583654815|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
161618568|NCT00307489|583654814|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
161618569|NCT00307489|583654815|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
161618570|NCT00307489|583654814|FG000|Week 48 Through Week 168|Death|0|||
161618571|NCT00307489|583654815|FG001|Week 48 Through Week 168|Death|1|||
161618572|NCT00307489|583654814|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
161618573|NCT00307489|583654815|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
161618574|NCT00307489|583654814|FG000|Week 48 Through Week 168|Seroconversion|1|||
161618575|NCT00307489|583654815|FG001|Week 48 Through Week 168|Seroconversion|0|||
161618576|NCT00507429|583654817|FG000|Treatment Phase|Disease Progression|12|||
161618577|NCT00507429|583654818|FG001|Treatment Phase|Disease Progression|5|||
161618578|NCT00507429|583654817|FG000|Treatment Phase|Adverse Event|12|||
161618579|NCT00507429|583654818|FG001|Treatment Phase|Adverse Event|5|||
161618580|NCT00507429|583654817|FG000|Treatment Phase|Withdrawal by Subject|3|||
161618581|NCT00507429|583654818|FG001|Treatment Phase|Withdrawal by Subject|3|||
161618582|NCT00507429|583654817|FG000|Treatment Phase|Physician Decision|4|||
161618583|NCT00507429|583654818|FG001|Treatment Phase|Physician Decision|2|||
161618584|NCT00507429|583654817|FG000|Treatment Phase|Other|6|||
161618585|NCT00507429|583654818|FG001|Treatment Phase|Other|3|||
161618586|NCT00507429|583654817|FG000|Maintenance Phase|Progressive Disease|14|||
161618587|NCT00507429|583654818|FG001|Maintenance Phase|Progressive Disease|0|||
161618588|NCT04025762|583654819|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
161618589|NCT04025762|583654820|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
161618590|NCT04803734|583654826|FG000|Overall Study|Withdrawal by Subject|0|||
161618591|NCT04803734|583654827|FG001|Overall Study|Withdrawal by Subject|1|||
161618592|NCT04803734|583654826|FG000|Overall Study|Protocol Violation|0|||
161618593|NCT04803734|583654827|FG001|Overall Study|Protocol Violation|1|||
161618594|NCT02152384|583654835|FG000|Period 1|Withdrawal by Subject|0|||
161618595|NCT02152384|583654836|FG001|Period 1|Withdrawal by Subject|1|||
161618596|NCT02152384|583654835|FG000|Period 1|Adverse Event|1|||
161618597|NCT02152384|583654836|FG001|Period 1|Adverse Event|1|||
161618598|NCT01393600|583654838|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
161618599|NCT01393600|583654839|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
161618600|NCT01393600|583654840|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
161618601|NCT01393600|583654841|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
161618602|NCT01393600|583654838|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
161618603|NCT01393600|583654839|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
161618604|NCT01393600|583654840|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
161618605|NCT01393600|583654841|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
161618606|NCT01393600|583654838|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161618607|NCT01393600|583654839|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161618608|NCT01393600|583654840|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161618609|NCT01393600|583654841|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
161618610|NCT01393600|583654838|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
161618611|NCT01393600|583654839|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
161618612|NCT01393600|583654840|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
161618613|NCT01393600|583654841|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
161618614|NCT01393600|583654838|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
161618615|NCT01393600|583654839|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
161618616|NCT01393600|583654840|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
161618617|NCT01393600|583654841|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
161618618|NCT01393600|583654838|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
161832779|NCT01475253|584429603|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
161832780|NCT02676284|584429604|FG000|Overall Study|Withdrawal by Subject|1|||
161832781|NCT03919448|584429606|FG000|Overall Study|Withdrawal by Subject|1|||
161832782|NCT03919448|584429607|FG001|Overall Study|Withdrawal by Subject|0|||
161832783|NCT03919448|584429608|FG002|Overall Study|Withdrawal by Subject|0|||
161832784|NCT04776746|584429610|FG000|Overall Study|Study terminated by sponsor|61|||
161832785|NCT04776746|584429610|FG000|Overall Study|Adverse Event|5|||
161832786|NCT04776746|584429610|FG000|Overall Study|Death|4|||
161832787|NCT04776746|584429610|FG000|Overall Study|Lack of Efficacy|3|||
161832788|NCT04776746|584429610|FG000|Overall Study|Noncompliance with study drug|2|||
161832789|NCT04776746|584429610|FG000|Overall Study|Not related to COVID-19|2|||
161832790|NCT01567826|584429619|FG000|Overall Study|Lost to Follow-up|3|||
161832791|NCT01567826|584429620|FG001|Overall Study|Lost to Follow-up|2|||
161832792|NCT03265288|584429623|FG000|Overall Study|Adverse Event|0|||
161832793|NCT03265288|584429624|FG001|Overall Study|Adverse Event|1|||
161832794|NCT03265288|584429623|FG000|Overall Study|Withdrawal by Subject|13|||
161832795|NCT03265288|584429624|FG001|Overall Study|Withdrawal by Subject|5|||
161832796|NCT03265288|584429623|FG000|Overall Study|Drug Withdrawn|3|||
161832797|NCT03265288|584429624|FG001|Overall Study|Drug Withdrawn|3|||
161832798|NCT03265288|584429623|FG000|Overall Study|Any Other Reason|7|||
161832799|NCT03265288|584429624|FG001|Overall Study|Any Other Reason|3|||
161832800|NCT00171301|584429625|FG000|Overall Study|Death|1|||
161832801|NCT00171301|584429626|FG001|Overall Study|Death|2|||
161832802|NCT00171301|584429625|FG000|Overall Study|Adverse Event|1|||
161832803|NCT00171301|584429626|FG001|Overall Study|Adverse Event|2|||
161832804|NCT00171301|584429625|FG000|Overall Study|Lost to Follow-up|6|||
161832805|NCT00171301|584429626|FG001|Overall Study|Lost to Follow-up|2|||
161832806|NCT00171301|584429625|FG000|Overall Study|Protocol Violation|0|||
161618619|NCT01393600|583654839|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
161618620|NCT01393600|583654840|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
161618621|NCT01393600|583654841|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
161618622|NCT01393600|583654838|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
161618623|NCT01393600|583654839|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
161618624|NCT01393600|583654840|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
161618625|NCT01393600|583654841|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
161618626|NCT00603798|583654842|FG000|Overall Study|Adverse Event|4|||
161618627|NCT00603798|583654843|FG001|Overall Study|Adverse Event|2|||
161618628|NCT00603798|583654844|FG002|Overall Study|Adverse Event|1|||
161618629|NCT00603798|583654842|FG000|Overall Study|Withdrawal by Subject|4|||
161618630|NCT00603798|583654843|FG001|Overall Study|Withdrawal by Subject|3|||
161618631|NCT00603798|583654844|FG002|Overall Study|Withdrawal by Subject|4|||
161618632|NCT00603798|583654842|FG000|Overall Study|Lost to Follow-up|1|||
161618633|NCT00603798|583654843|FG001|Overall Study|Lost to Follow-up|0|||
161618634|NCT00603798|583654844|FG002|Overall Study|Lost to Follow-up|1|||
161618635|NCT00603798|583654842|FG000|Overall Study|Non-compliance with study procedures|0|||
161618636|NCT00603798|583654843|FG001|Overall Study|Non-compliance with study procedures|1|||
161618637|NCT00603798|583654844|FG002|Overall Study|Non-compliance with study procedures|0|||
161618638|NCT00603798|583654842|FG000|Overall Study|Not due to AE|1|||
161618639|NCT00603798|583654843|FG001|Overall Study|Not due to AE|1|||
161618640|NCT00603798|583654844|FG002|Overall Study|Not due to AE|4|||
161618641|NCT02964234|583654850|FG000|Overall Study|Lost to Follow-up|22|||
161618642|NCT02964234|583654851|FG001|Overall Study|Lost to Follow-up|13|||
161832807|NCT00171301|584429626|FG001|Overall Study|Protocol Violation|2|||
161832808|NCT00171301|584429625|FG000|Overall Study|Withdrawal by Subject|0|||
161832809|NCT00171301|584429626|FG001|Overall Study|Withdrawal by Subject|1|||
161832810|NCT02100319|584429631|FG000|Overall Study|Case Report Forms Uncollected|11|||
161832811|NCT02100319|584429631|FG000|Overall Study|Protocol Deviation|5|||
161618643|NCT01799993|583654852|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
161618644|NCT01799993|583654853|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
161618645|NCT01799993|583654852|FG000|Overall Study|Death|61|||
161618646|NCT01799993|583654853|FG001|Overall Study|Death|45|||
161618647|NCT01799993|583654852|FG000|Overall Study|Withdrawal by Subject|23|||
161832812|NCT04976621|584429632|FG000|Overall Study|Lost to Follow-up|2|||
161832813|NCT04976621|584429633|FG001|Overall Study|Lost to Follow-up|2|||
161832814|NCT04976621|584429632|FG000|Overall Study|Withdrawal by Subject|1|||
161832815|NCT04976621|584429633|FG001|Overall Study|Withdrawal by Subject|1|||
161832816|NCT02589522|584429634|FG000|Overall Study|Physician Decision|1|||
161832817|NCT02589522|584429635|FG001|Overall Study|Physician Decision|2|||
161832818|NCT02589522|584429636|FG002|Overall Study|Physician Decision|0|||
161618648|NCT01799993|583654853|FG001|Overall Study|Withdrawal by Subject|24|||
161618649|NCT01799993|583654852|FG000|Overall Study|Lost to Follow-up|5|||
161618650|NCT01799993|583654853|FG001|Overall Study|Lost to Follow-up|8|||
161618651|NCT01799993|583654852|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
161618652|NCT01799993|583654853|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
161618653|NCT01799993|583654852|FG000|Overall Study|Protocol driven decision point|0|||
161618654|NCT01799993|583654853|FG001|Overall Study|Protocol driven decision point|3|||
161618655|NCT01799993|583654852|FG000|Overall Study|Protocol Violation|1|||
161618656|NCT01799993|583654853|FG001|Overall Study|Protocol Violation|1|||
161618657|NCT01799993|583654852|FG000|Overall Study|Deterioration of general conditions|2|||
161618658|NCT01799993|583654853|FG001|Overall Study|Deterioration of general conditions|0|||
161618659|NCT01799993|583654852|FG000|Overall Study|Screen failure|0|||
161618660|NCT01799993|583654853|FG001|Overall Study|Screen failure|1|||
161618661|NCT01799993|583654852|FG000|Overall Study|Adverse Event|1|||
161618662|NCT01799993|583654853|FG001|Overall Study|Adverse Event|0|||
161618663|NCT01799993|583654852|FG000|Overall Study|Lack of Efficacy|1|||
161618664|NCT01799993|583654853|FG001|Overall Study|Lack of Efficacy|0|||
161618665|NCT01799993|583654852|FG000|Overall Study|Recovery|0|||
161618666|NCT01799993|583654853|FG001|Overall Study|Recovery|1|||
161618667|NCT01799993|583654852|FG000|Overall Study|Logistical difficulties|1|||
161618668|NCT01799993|583654853|FG001|Overall Study|Logistical difficulties|0|||
161618669|NCT01799993|583654852|FG000|Overall Study|Protocol deviation|1|||
161618670|NCT01799993|583654853|FG001|Overall Study|Protocol deviation|0|||
161618671|NCT01799993|583654852|FG000|Overall Study|Non-compliance with medical device|1|||
161618672|NCT01799993|583654853|FG001|Overall Study|Non-compliance with medical device|0|||
161618673|NCT01799993|583654852|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161618674|NCT01799993|583654853|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161618675|NCT01799993|583654852|FG000|Overall Study|Other|1|||
161618676|NCT01799993|583654853|FG001|Overall Study|Other|0|||
161618677|NCT01799993|583654852|FG000|Overall Study|Subject didn't return for follow-up|0|||
161618678|NCT01799993|583654853|FG001|Overall Study|Subject didn't return for follow-up|1|||
161618679|NCT04361617|583654854|FG000|Overall Study|Withdrawal by Subject|0|||
161618680|NCT04361617|583654855|FG001|Overall Study|Withdrawal by Subject|1|||
161618681|NCT01263223|583654856|FG000|Period 2|Withdrawal by Subject|0|||
161618682|NCT01263223|583654857|FG001|Period 2|Withdrawal by Subject|1|||
161618683|NCT01263223|583654856|FG000|7-day Follow-up|Withdrawal by Subject|0|||
161618684|NCT01263223|583654857|FG001|7-day Follow-up|Withdrawal by Subject|1|||
161618685|NCT01263223|583654856|FG000|7-day Follow-up|Lost to Follow-up|1|||
161618686|NCT01263223|583654857|FG001|7-day Follow-up|Lost to Follow-up|0|||
161618687|NCT02246647|583654858|FG000|Overall Study|Withdrawal by Subject|1|||
161618688|NCT02246647|583654859|FG001|Overall Study|Withdrawal by Subject|1|||
161618689|NCT01113541|583654861|FG000|Overall Study|Withdrawal by Subject|1|||
161618690|NCT01113541|583654861|FG000|Overall Study|Protocol Violation|1|||
161618691|NCT01113541|583654861|FG000|Overall Study|Study Terminated by Sponsor|7|||
161618692|NCT01113541|583654861|FG000|Overall Study|Adverse Event|4|||
161618693|NCT01918033|583654865|FG000|Overall Study|Adverse Event|1|||
161618694|NCT01918033|583654866|FG001|Overall Study|Adverse Event|0|||
161618695|NCT01918033|583654867|FG002|Overall Study|Adverse Event|2|||
161618696|NCT01918033|583654865|FG000|Overall Study|Lost to Follow-up|0|||
161618697|NCT01918033|583654866|FG001|Overall Study|Lost to Follow-up|1|||
161618698|NCT01918033|583654867|FG002|Overall Study|Lost to Follow-up|0|||
161618699|NCT01918033|583654865|FG000|Overall Study|Protocol Violation|2|||
161618700|NCT01918033|583654866|FG001|Overall Study|Protocol Violation|0|||
161618701|NCT01918033|583654867|FG002|Overall Study|Protocol Violation|1|||
161618702|NCT01918033|583654865|FG000|Overall Study|Withdrawal by Subject|2|||
161618703|NCT01918033|583654866|FG001|Overall Study|Withdrawal by Subject|1|||
161618704|NCT01918033|583654867|FG002|Overall Study|Withdrawal by Subject|0|||
161684708|NCT02230384|583897984|FG001|Phase 2 - Switch|Adverse Event|0|||
161684709|NCT00808236|583897985|FG000|Overall Study|Was not resuscitated|50|||
161832819|NCT02589522|584429634|FG000|Overall Study|Did not start treatment|1|||
161832820|NCT02589522|584429635|FG001|Overall Study|Did not start treatment|0|||
161832821|NCT02589522|584429636|FG002|Overall Study|Did not start treatment|0|||
161618705|NCT04679675|583654868|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
161618706|NCT04679675|583654869|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
161618707|NCT04679675|583654870|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
161618708|NCT04679675|583654871|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
161618709|NCT04679675|583654868|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
161618710|NCT04679675|583654869|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
161618711|NCT04679675|583654870|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
161684710|NCT00808236|583897986|FG001|Overall Study|Was not resuscitated|56|||
161684711|NCT00808236|583897985|FG000|Overall Study|Pre-defined exclusion|13|||
161832822|NCT01478828|584429637|FG000|Overall Study|Adverse Event|1|||
161618712|NCT04679675|583654871|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
161618713|NCT00687297|583654879|FG000|Randomization|Withdrawal by Subject|2|||
161618714|NCT00687297|583654880|FG001|Randomization|Withdrawal by Subject|0|||
161618715|NCT00687297|583654879|FG000|Randomization|Withdrew before treatment, ineligible|1|||
161618716|NCT00687297|583654880|FG001|Randomization|Withdrew before treatment, ineligible|1|||
161618717|NCT00687297|583654879|FG000|Induction|Withdrawal by Subject|4|||
161618718|NCT00687297|583654880|FG001|Induction|Withdrawal by Subject|4|||
161618719|NCT00687297|583654879|FG000|Induction|Adverse Event|16|||
161618720|NCT00687297|583654880|FG001|Induction|Adverse Event|15|||
161618721|NCT00687297|583654879|FG000|Induction|Death|7|||
161618722|NCT00687297|583654880|FG001|Induction|Death|11|||
161618723|NCT00687297|583654879|FG000|Induction|Lack of Efficacy|17|||
161618724|NCT00687297|583654880|FG001|Induction|Lack of Efficacy|21|||
161618725|NCT00687297|583654879|FG000|Induction|Ineligible|0|||
161618726|NCT00687297|583654880|FG001|Induction|Ineligible|1|||
161618727|NCT00687297|583654879|FG000|Induction|Patient Noncompliance|1|||
161618728|NCT00687297|583654880|FG001|Induction|Patient Noncompliance|0|||
161618729|NCT00687297|583654879|FG000|Induction|Physician Decision|0|||
161618730|NCT00687297|583654880|FG001|Induction|Physician Decision|2|||
161618731|NCT00687297|583654879|FG000|Induction|Other|0|||
161618732|NCT00687297|583654880|FG001|Induction|Other|1|||
161618733|NCT02525744|583654883|FG000|Period 1|Physician Decision|0|||
161618734|NCT02525744|583654884|FG001|Period 1|Physician Decision|0|||
161618735|NCT02525744|583654885|FG002|Period 1|Physician Decision|1|||
161618736|NCT02525744|583654886|FG003|Period 1|Physician Decision|0|||
161618737|NCT02525744|583654883|FG000|Period 3|Adverse Event|0|||
161618738|NCT02525744|583654884|FG001|Period 3|Adverse Event|1|||
161618739|NCT02525744|583654885|FG002|Period 3|Adverse Event|0|||
161618740|NCT02525744|583654886|FG003|Period 3|Adverse Event|0|||
161618741|NCT02525744|583654883|FG000|Period 4|Withdrawal by Subject|1|||
161618742|NCT02525744|583654884|FG001|Period 4|Withdrawal by Subject|0|||
161618743|NCT02525744|583654885|FG002|Period 4|Withdrawal by Subject|0|||
161618744|NCT02525744|583654886|FG003|Period 4|Withdrawal by Subject|0|||
161618745|NCT02525744|583654883|FG000|Period 5|Physician Decision|1|||
161618746|NCT02525744|583654884|FG001|Period 5|Physician Decision|0|||
161618747|NCT02525744|583654885|FG002|Period 5|Physician Decision|0|||
161618748|NCT02525744|583654886|FG003|Period 5|Physician Decision|0|||
161618749|NCT01182285|583654887|FG000|First Intervention Week 1-10|Disease progression|1|||
161618750|NCT01182285|583654888|FG001|First Intervention Week 1-10|Disease progression|0|||
161618751|NCT01182285|583654889|FG002|First Intervention Week 1-10|Disease progression|0|||
161618752|NCT01182285|583654887|FG000|First Intervention Week 1-10|Adverse Event|1|||
161618753|NCT01182285|583654888|FG001|First Intervention Week 1-10|Adverse Event|0|||
161618754|NCT01182285|583654889|FG002|First Intervention Week 1-10|Adverse Event|0|||
161618755|NCT01182285|583654887|FG000|First Intervention Week 1-10|Non-compliance|1|||
161618756|NCT01182285|583654888|FG001|First Intervention Week 1-10|Non-compliance|0|||
161618757|NCT01182285|583654889|FG002|First Intervention Week 1-10|Non-compliance|0|||
161618758|NCT01182285|583654887|FG000|Third Intervention Week 11-52|Disease Progression|0|||
161618759|NCT01182285|583654888|FG001|Third Intervention Week 11-52|Disease Progression|0|||
161618760|NCT01182285|583654889|FG002|Third Intervention Week 11-52|Disease Progression|6|||
161618761|NCT01182285|583654887|FG000|Third Intervention Week 11-52|Other|0|||
161618762|NCT01182285|583654888|FG001|Third Intervention Week 11-52|Other|0|||
161684712|NCT00808236|583897986|FG001|Overall Study|Pre-defined exclusion|3|||
161618763|NCT01182285|583654889|FG002|Third Intervention Week 11-52|Other|2|||
161618764|NCT00472082|583654890|FG000|Overall Study|Study prematurely terminated|5|||
161618765|NCT02069379|583654891|FG000|Baseline Measurements|Lost to Follow-up|1|||
161618766|NCT02069379|583654892|FG001|Baseline Measurements|Lost to Follow-up|0|||
161832823|NCT01557842|584429638|FG000|Overall Study|Lost to Follow-up|0|||
161618767|NCT02069379|583654893|FG002|Baseline Measurements|Lost to Follow-up|0|||
161618768|NCT02069379|583654894|FG003|Baseline Measurements|Lost to Follow-up|0|||
161618769|NCT02069379|583654891|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
161618770|NCT02069379|583654892|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
161618771|NCT02069379|583654893|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
161618772|NCT02069379|583654894|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
161618773|NCT02069379|583654891|FG000|First Treatment Arm|Lost to Follow-up|0|||
161618774|NCT02069379|583654892|FG001|First Treatment Arm|Lost to Follow-up|1|||
161618775|NCT02069379|583654893|FG002|First Treatment Arm|Lost to Follow-up|1|||
161618776|NCT02069379|583654894|FG003|First Treatment Arm|Lost to Follow-up|0|||
161618777|NCT02069379|583654891|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
161618778|NCT02069379|583654892|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
161618779|NCT02069379|583654893|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
161618780|NCT02069379|583654894|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
161618781|NCT02069379|583654891|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
161618782|NCT02069379|583654892|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
161618783|NCT02069379|583654893|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
161618784|NCT02069379|583654894|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
161618785|NCT02069379|583654891|FG000|Second Treatment Arm|Lost to Follow-up|0|||
161618786|NCT02069379|583654892|FG001|Second Treatment Arm|Lost to Follow-up|0|||
161618787|NCT02069379|583654893|FG002|Second Treatment Arm|Lost to Follow-up|1|||
161618788|NCT02069379|583654894|FG003|Second Treatment Arm|Lost to Follow-up|0|||
161618789|NCT04617847|583654897|FG000|Overall Study|Withdrawal by Subject|1|||
161618790|NCT04617847|583654898|FG001|Overall Study|Withdrawal by Subject|0|||
161618791|NCT04617847|583654897|FG000|Overall Study|Adverse Event|0|||
161618792|NCT04617847|583654898|FG001|Overall Study|Adverse Event|2|||
161618793|NCT04617847|583654897|FG000|Overall Study|Death|0|||
161618794|NCT04617847|583654898|FG001|Overall Study|Death|1|||
161618795|NCT04617847|583654897|FG000|Overall Study|Termination of Study by Sponsor|2|||
161618796|NCT04617847|583654898|FG001|Overall Study|Termination of Study by Sponsor|21|||
161618797|NCT01525875|583654899|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161618798|NCT01525875|583654900|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
161618799|NCT01525875|583654899|FG000|Open-label Period|Lost to Follow-up|0|||
161618800|NCT01525875|583654900|FG001|Open-label Period|Lost to Follow-up|2|||
161618801|NCT00700999|583654901|FG000|Overall Study|Lost to Follow-up|7|||
161618802|NCT00700999|583654902|FG001|Overall Study|Lost to Follow-up|7|||
161618803|NCT00700999|583654901|FG000|Overall Study|Excluded - did not meet study criteria|0|||
161618804|NCT00700999|583654902|FG001|Overall Study|Excluded - did not meet study criteria|1|||
161618805|NCT00700999|583654901|FG000|Overall Study|Withdrawal by Subject|8|||
161618806|NCT00700999|583654902|FG001|Overall Study|Withdrawal by Subject|1|||
161618807|NCT00244751|583654903|FG000|Overall Study|Adverse Event|7|||
161618808|NCT00244751|583654904|FG001|Overall Study|Adverse Event|7|||
161618809|NCT00244751|583654905|FG002|Overall Study|Adverse Event|5|||
161618810|NCT00244751|583654903|FG000|Overall Study|Lost to Follow-up|0|||
161618811|NCT00244751|583654904|FG001|Overall Study|Lost to Follow-up|1|||
161618812|NCT00244751|583654905|FG002|Overall Study|Lost to Follow-up|0|||
161618813|NCT00244751|583654903|FG000|Overall Study|Protocol Violation|1|||
161618814|NCT00244751|583654904|FG001|Overall Study|Protocol Violation|0|||
161618815|NCT00244751|583654905|FG002|Overall Study|Protocol Violation|1|||
161618816|NCT00244751|583654903|FG000|Overall Study|Withdrawal by Subject|7|||
161618817|NCT00244751|583654904|FG001|Overall Study|Withdrawal by Subject|5|||
161618818|NCT00244751|583654905|FG002|Overall Study|Withdrawal by Subject|3|||
161618819|NCT00244751|583654903|FG000|Overall Study|Elevated liver enzymes|1|||
161618820|NCT00244751|583654904|FG001|Overall Study|Elevated liver enzymes|0|||
161618821|NCT00244751|583654905|FG002|Overall Study|Elevated liver enzymes|0|||
161618822|NCT00244751|583654903|FG000|Overall Study|Lack of compliance with protocol|0|||
161618823|NCT00244751|583654904|FG001|Overall Study|Lack of compliance with protocol|1|||
161618824|NCT00244751|583654905|FG002|Overall Study|Lack of compliance with protocol|0|||
161618825|NCT00244751|583654903|FG000|Overall Study|Safety reasons|0|||
161618826|NCT00244751|583654904|FG001|Overall Study|Safety reasons|1|||
161618827|NCT00244751|583654905|FG002|Overall Study|Safety reasons|0|||
161618828|NCT00244751|583654903|FG000|Overall Study|Participant randomized by mistake|0|||
161618829|NCT00244751|583654904|FG001|Overall Study|Participant randomized by mistake|0|||
161618830|NCT00244751|583654905|FG002|Overall Study|Participant randomized by mistake|1|||
161618831|NCT03031782|583654908|FG000|Treatment Period 1|Lack of Efficacy|3|||
161618832|NCT03031782|583654909|FG001|Treatment Period 1|Lack of Efficacy|0|||
161618833|NCT03031782|583654910|FG002|Treatment Period 1|Lack of Efficacy|0|||
161618834|NCT03031782|583654911|FG003|Treatment Period 1|Lack of Efficacy|0|||
161618835|NCT03031782|583654912|FG004|Treatment Period 1|Lack of Efficacy|0|||
161618836|NCT03031782|583654908|FG000|Treatment Period 2|Physician Decision|0|||
161618837|NCT03031782|583654909|FG001|Treatment Period 2|Physician Decision|1|||
161618838|NCT03031782|583654910|FG002|Treatment Period 2|Physician Decision|0|||
161618839|NCT03031782|583654911|FG003|Treatment Period 2|Physician Decision|0|||
161618840|NCT03031782|583654912|FG004|Treatment Period 2|Physician Decision|3|||
161618841|NCT03031782|583654908|FG000|Treatment Period 2|Lack of Efficacy|0|||
161618842|NCT03031782|583654909|FG001|Treatment Period 2|Lack of Efficacy|1|||
161618843|NCT03031782|583654910|FG002|Treatment Period 2|Lack of Efficacy|0|||
161618844|NCT03031782|583654911|FG003|Treatment Period 2|Lack of Efficacy|0|||
161618845|NCT03031782|583654912|FG004|Treatment Period 2|Lack of Efficacy|1|||
161618846|NCT03031782|583654908|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161618847|NCT03031782|583654909|FG001|Treatment Period 2|Withdrawal by Subject|3|||
161618848|NCT03031782|583654910|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161618849|NCT03031782|583654911|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161618850|NCT03031782|583654912|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161618851|NCT03031782|583654908|FG000|Treatment Period 2|Adverse Event|0|||
161618852|NCT03031782|583654909|FG001|Treatment Period 2|Adverse Event|1|||
161618853|NCT03031782|583654910|FG002|Treatment Period 2|Adverse Event|2|||
161618854|NCT03031782|583654911|FG003|Treatment Period 2|Adverse Event|0|||
161618855|NCT03031782|583654912|FG004|Treatment Period 2|Adverse Event|0|||
161618856|NCT03031782|583654908|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161618857|NCT03031782|583654909|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161618858|NCT03031782|583654910|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161618859|NCT03031782|583654911|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161618860|NCT03031782|583654912|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161618861|NCT04867382|583654915|FG000|Overall Study|Did not complete the survey|2|||
161618862|NCT04867382|583654916|FG001|Overall Study|Did not complete the survey|1|||
161618863|NCT05445557|583654917|FG000|Double Blind Part|Lost to Follow-up|1|||
161618864|NCT01323790|583654918|FG000|Overall Study|Other|3|||
161618865|NCT01323790|583654919|FG001|Overall Study|Other|2|||
161618866|NCT01323790|583654920|FG002|Overall Study|Other|1|||
161618867|NCT01323790|583654918|FG000|Overall Study|Lost to Follow-up|11|||
161618868|NCT01323790|583654919|FG001|Overall Study|Lost to Follow-up|9|||
161618869|NCT01323790|583654920|FG002|Overall Study|Lost to Follow-up|9|||
161618870|NCT01323790|583654918|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
161618871|NCT01323790|583654919|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
161618872|NCT01323790|583654920|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
161618873|NCT01323790|583654918|FG000|Overall Study|Lack of Efficacy|3|||
161618874|NCT01323790|583654919|FG001|Overall Study|Lack of Efficacy|0|||
161618875|NCT01323790|583654920|FG002|Overall Study|Lack of Efficacy|3|||
161618876|NCT01323790|583654918|FG000|Overall Study|Adverse Event|11|||
161618877|NCT01323790|583654919|FG001|Overall Study|Adverse Event|24|||
161618878|NCT01323790|583654920|FG002|Overall Study|Adverse Event|12|||
161618879|NCT01323790|583654918|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161618880|NCT01323790|583654919|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161618881|NCT01323790|583654920|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
161618882|NCT01323790|583654918|FG000|Overall Study|Withdrawal by Subject|23|||
161618883|NCT01323790|583654919|FG001|Overall Study|Withdrawal by Subject|20|||
161618884|NCT01323790|583654920|FG002|Overall Study|Withdrawal by Subject|13|||
161618885|NCT01323790|583654918|FG000|Overall Study|Did Not Receive Treatment|2|||
161618886|NCT01323790|583654919|FG001|Overall Study|Did Not Receive Treatment|0|||
161618887|NCT01323790|583654920|FG002|Overall Study|Did Not Receive Treatment|1|||
161618888|NCT01323790|583654918|FG000|Overall Study|Severe non-compliance with protocol|2|||
161618889|NCT01323790|583654919|FG001|Overall Study|Severe non-compliance with protocol|2|||
161618890|NCT01323790|583654920|FG002|Overall Study|Severe non-compliance with protocol|2|||
161618891|NCT01736475|583654921|FG000|Overall Study|Adverse Event|4|||
161618892|NCT01736475|583654922|FG001|Overall Study|Adverse Event|0|||
161618893|NCT01736475|583654921|FG000|Overall Study|Withdrawal by Subject|2|||
161618894|NCT01736475|583654922|FG001|Overall Study|Withdrawal by Subject|0|||
161832824|NCT01557842|584429639|FG001|Overall Study|Lost to Follow-up|1|||
161832825|NCT01557842|584429638|FG000|Overall Study|Death|1|||
161832826|NCT01557842|584429639|FG001|Overall Study|Death|0|||
161832827|NCT01557842|584429638|FG000|Overall Study|Lack of Efficacy|0|||
161618895|NCT01736475|583654921|FG000|Overall Study|Protocol Violation|4|||
161618896|NCT01736475|583654922|FG001|Overall Study|Protocol Violation|0|||
161618897|NCT01736475|583654921|FG000|Overall Study|Other - Screen failure|1|||
161618898|NCT01736475|583654922|FG001|Overall Study|Other - Screen failure|0|||
161618899|NCT01736475|583654921|FG000|Overall Study|Other - Surgical procedure|1|||
161618900|NCT01736475|583654922|FG001|Overall Study|Other - Surgical procedure|0|||
161618901|NCT02144285|583654924|FG000|Overall Study|Withdrawal by Subject|0|||
161618902|NCT02144285|583654925|FG001|Overall Study|Withdrawal by Subject|0|||
161618903|NCT02144285|583654926|FG002|Overall Study|Withdrawal by Subject|0|||
161618904|NCT02144285|583654927|FG003|Overall Study|Withdrawal by Subject|0|||
161618905|NCT02144285|583654928|FG004|Overall Study|Withdrawal by Subject|1|||
161618906|NCT02144285|583654929|FG005|Overall Study|Withdrawal by Subject|0|||
161618907|NCT02144285|583654930|FG006|Overall Study|Withdrawal by Subject|0|||
161618908|NCT02144285|583654931|FG007|Overall Study|Withdrawal by Subject|0|||
161618909|NCT02144285|583654932|FG008|Overall Study|Withdrawal by Subject|0|||
161618910|NCT02144285|583654933|FG009|Overall Study|Withdrawal by Subject|0|||
161618911|NCT01529632|583654934|FG000|Overall Study|Administrative problem|2|||
161832828|NCT01557842|584429639|FG001|Overall Study|Lack of Efficacy|1|||
161618912|NCT01529632|583654935|FG001|Overall Study|Administrative problem|1|||
161618913|NCT01529632|583654934|FG000|Overall Study|Protocol Violation|0|||
161618914|NCT01529632|583654935|FG001|Overall Study|Protocol Violation|1|||
161618915|NCT01529632|583654934|FG000|Overall Study|Adverse Event|1|||
161618916|NCT01529632|583654935|FG001|Overall Study|Adverse Event|1|||
161618917|NCT05184062|583654937|FG000|Overall Study|Lost to Follow-up|5|||
161618918|NCT05184062|583654938|FG001|Overall Study|Lost to Follow-up|1|||
161618919|NCT05184062|583654937|FG000|Overall Study|Withdrawal by Subject|1|||
161618920|NCT05184062|583654938|FG001|Overall Study|Withdrawal by Subject|0|||
161618921|NCT00711555|583656767|FG000|Overall Study|Adverse Event|3|||
161618922|NCT03029585|583656772|FG000|Overall Study|Death|1|||
161618923|NCT03029585|583656773|FG001|Overall Study|Death|1|||
161618924|NCT03029585|583656772|FG000|Overall Study|Withdrawal by Subject|1|||
161618925|NCT03029585|583656773|FG001|Overall Study|Withdrawal by Subject|0|||
161618926|NCT02400749|583656774|FG000|Week 0 -16|Withdrawal by Subject|5|||
161618927|NCT02400749|583656775|FG001|Week 0 -16|Withdrawal by Subject|5|||
161618928|NCT02400749|583656774|FG000|Week 0 -16|Adverse Event|3|||
161618929|NCT02400749|583656775|FG001|Week 0 -16|Adverse Event|1|||
161618930|NCT02400749|583656774|FG000|Week 0 -16|Lost to Follow-up|2|||
161618931|NCT02400749|583656775|FG001|Week 0 -16|Lost to Follow-up|0|||
161618932|NCT02400749|583656774|FG000|Week 0 -16|Protocol Violation|1|||
161618933|NCT02400749|583656775|FG001|Week 0 -16|Protocol Violation|0|||
161618934|NCT02400749|583656774|FG000|Week 17 - 32|Withdrawal by Subject|3|||
161618935|NCT02400749|583656775|FG001|Week 17 - 32|Withdrawal by Subject|2|||
161618936|NCT02400749|583656774|FG000|Week 17 - 32|Adverse Event|2|||
161618937|NCT02400749|583656775|FG001|Week 17 - 32|Adverse Event|1|||
161618938|NCT04425252|583656776|FG000|Overall Study|Withdrawal by Subject|2|||
161618939|NCT04425252|583656777|FG001|Overall Study|Withdrawal by Subject|1|||
161618940|NCT04425252|583656776|FG000|Overall Study|Lost to Follow-up|1|||
161618941|NCT04425252|583656777|FG001|Overall Study|Lost to Follow-up|0|||
161618942|NCT04425252|583656776|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
161618943|NCT04425252|583656777|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
161618944|NCT01825785|583656778|FG000|Overall Study|Adverse Event|0|||
161618945|NCT01825785|583656779|FG001|Overall Study|Adverse Event|0|||
161618946|NCT01825785|583656780|FG002|Overall Study|Adverse Event|0|||
161618947|NCT01825785|583656781|FG003|Overall Study|Adverse Event|0|||
161618948|NCT01825785|583656782|FG004|Overall Study|Adverse Event|1|||
161618949|NCT01825785|583656783|FG005|Overall Study|Adverse Event|0|||
161618950|NCT01825785|583656784|FG006|Overall Study|Adverse Event|0|||
161618951|NCT01825785|583656778|FG000|Overall Study|Withdrawal by Subject|0|||
161618952|NCT01825785|583656779|FG001|Overall Study|Withdrawal by Subject|0|||
161618953|NCT01825785|583656780|FG002|Overall Study|Withdrawal by Subject|0|||
161618954|NCT01825785|583656781|FG003|Overall Study|Withdrawal by Subject|0|||
161618955|NCT01825785|583656782|FG004|Overall Study|Withdrawal by Subject|1|||
161618956|NCT01825785|583656783|FG005|Overall Study|Withdrawal by Subject|1|||
161618957|NCT01825785|583656784|FG006|Overall Study|Withdrawal by Subject|0|||
161618958|NCT01286311|583656785|FG000|Overall Study|Physician did not want outreach sent|14|||
161618959|NCT01286311|583656786|FG001|Overall Study|Physician did not want outreach sent|0|||
161618960|NCT01437540|583656787|FG000|Overall Study|Not listed below|7|||
161618961|NCT01437540|583656788|FG001|Overall Study|Not listed below|6|||
161618962|NCT01437540|583656787|FG000|Overall Study|COPD exacerbation|13|||
161618963|NCT01437540|583656788|FG001|Overall Study|COPD exacerbation|3|||
161618964|NCT01437540|583656787|FG000|Overall Study|Lost to Follow-up|3|||
161684713|NCT00808236|583897985|FG000|Overall Study|Lost to Follow-up|1|||
161618965|NCT01437540|583656788|FG001|Overall Study|Lost to Follow-up|5|||
161618966|NCT01437540|583656787|FG000|Overall Study|Lack of Efficacy|23|||
161618967|NCT01437540|583656788|FG001|Overall Study|Lack of Efficacy|11|||
161618968|NCT01437540|583656787|FG000|Overall Study|Protocol Violation|24|||
161618969|NCT01437540|583656788|FG001|Overall Study|Protocol Violation|12|||
161618970|NCT01437540|583656787|FG000|Overall Study|Adverse Event|26|||
161618971|NCT01437540|583656788|FG001|Overall Study|Adverse Event|13|||
161618972|NCT01437540|583656787|FG000|Overall Study|Withdrawal by Subject|31|||
161618973|NCT01437540|583656788|FG001|Overall Study|Withdrawal by Subject|15|||
161618974|NCT01381549|583656789|FG000|Overall Study|Ineligible: No organisms isolated|0|||
161618975|NCT01381549|583656790|FG001|Overall Study|Ineligible: No organisms isolated|0|||
161684714|NCT00808236|583897986|FG001|Overall Study|Lost to Follow-up|1|||
161684715|NCT00808236|583897985|FG000|Overall Study|Physician Decision|0|||
161618976|NCT01381549|583656791|FG002|Overall Study|Ineligible: No organisms isolated|1|||
161618977|NCT02981953|583656792|FG000|Overall Study|Death|9|||
161618978|NCT02981953|583656792|FG000|Overall Study|Withdrawal by Subject|1|||
161618979|NCT02981953|583656792|FG000|Overall Study|Withdrawal to non-compliance|1|||
161618980|NCT00805792|583656797|FG000|Overall Study|Death|3|||
161618981|NCT00805792|583656797|FG000|Overall Study|Lost to Follow-up|2|||
161618982|NCT02165202|583656802|FG000|Oral Phase|Refused further participation|5|||
161618983|NCT02165202|583656803|FG001|Oral Phase|Refused further participation|1|||
161618984|NCT02165202|583656802|FG000|Oral Phase|Study product Related Toxicity|1|||
161618985|NCT02165202|583656803|FG001|Oral Phase|Study product Related Toxicity|0|||
161618986|NCT02165202|583656802|FG000|Oral Phase|Unable to contact Participant|1|||
161618987|NCT02165202|583656803|FG001|Oral Phase|Unable to contact Participant|1|||
161618988|NCT02165202|583656802|FG000|Oral Phase|Clinical reasons|1|||
161618989|NCT02165202|583656803|FG001|Oral Phase|Clinical reasons|0|||
161618990|NCT02165202|583656802|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
161618991|NCT02165202|583656803|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
161618992|NCT02165202|583656802|FG000|Oral Phase|CMC advised termination|1|||
161618993|NCT02165202|583656803|FG001|Oral Phase|CMC advised termination|0|||
161618994|NCT02165202|583656802|FG000|Oral Phase|Relocated, no follow-up planned|1|||
161618995|NCT02165202|583656803|FG001|Oral Phase|Relocated, no follow-up planned|0|||
161618996|NCT02165202|583656802|FG000|Oral Phase|Abnormal EKG|0|||
161618997|NCT02165202|583656803|FG001|Oral Phase|Abnormal EKG|1|||
161618998|NCT02165202|583656802|FG000|Injection Phase|Abnormal Lab Value|5|||
161618999|NCT02165202|583656803|FG001|Injection Phase|Abnormal Lab Value|1|||
161619000|NCT02165202|583656802|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
161619001|NCT02165202|583656803|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
161619002|NCT02165202|583656802|FG000|Injection Phase|Unable to attend within Visit Window|1|||
161619003|NCT02165202|583656803|FG001|Injection Phase|Unable to attend within Visit Window|0|||
161619004|NCT02165202|583656802|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
161619005|NCT02165202|583656803|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
161619006|NCT02165202|583656802|FG000|Injection Phase|End of Study|2|||
161619007|NCT02165202|583656803|FG001|Injection Phase|End of Study|1|||
161619008|NCT02165202|583656802|FG000|Injection Phase|Study Product related Toxicity|1|||
161619009|NCT02165202|583656803|FG001|Injection Phase|Study Product related Toxicity|0|||
161619010|NCT02165202|583656802|FG000|Injection Phase|No longer interested|0|||
161619011|NCT02165202|583656803|FG001|Injection Phase|No longer interested|1|||
161619012|NCT02165202|583656802|FG000|Injection Phase|Participant unwilling to comply|1|||
161619013|NCT02165202|583656803|FG001|Injection Phase|Participant unwilling to comply|0|||
161619014|NCT04328467|583656813|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
161619015|NCT04328467|583656814|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
161619016|NCT04328467|583656815|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
161619017|NCT00990184|583656816|FG000|Overall Study|Physician Decision|1|||
161619018|NCT01975701|583656817|FG000|Overall Study|Lost to Follow-up|1|||
161619019|NCT01975701|583656817|FG000|Overall Study|Death|23|||
161619020|NCT01975701|583656817|FG000|Overall Study|Physician Decision|1|||
161619021|NCT00813709|583656818|FG000|Double Blind Period|Adverse Event|4|||
161619022|NCT00813709|583656819|FG001|Double Blind Period|Adverse Event|1|||
161619023|NCT00813709|583656820|FG002|Double Blind Period|Adverse Event|4|||
161619024|NCT00813709|583656821|FG003|Double Blind Period|Adverse Event|0|||
161619025|NCT00813709|583656822|FG004|Double Blind Period|Adverse Event|0|||
161619026|NCT00813709|583656823|FG005|Double Blind Period|Adverse Event|0|||
161619027|NCT00813709|583656818|FG000|Double Blind Period|Lost to Follow-up|3|||
161619028|NCT00813709|583656819|FG001|Double Blind Period|Lost to Follow-up|2|||
161619029|NCT00813709|583656820|FG002|Double Blind Period|Lost to Follow-up|2|||
161619030|NCT00813709|583656821|FG003|Double Blind Period|Lost to Follow-up|0|||
161619031|NCT00813709|583656822|FG004|Double Blind Period|Lost to Follow-up|0|||
161619032|NCT00813709|583656823|FG005|Double Blind Period|Lost to Follow-up|0|||
161619033|NCT00813709|583656818|FG000|Double Blind Period|Switched to open label phase|9|||
161619034|NCT00813709|583656819|FG001|Double Blind Period|Switched to open label phase|26|||
161619035|NCT00813709|583656820|FG002|Double Blind Period|Switched to open label phase|18|||
161619036|NCT00813709|583656821|FG003|Double Blind Period|Switched to open label phase|0|||
161619037|NCT00813709|583656822|FG004|Double Blind Period|Switched to open label phase|0|||
161619038|NCT00813709|583656823|FG005|Double Blind Period|Switched to open label phase|0|||
161619039|NCT00813709|583656818|FG000|Double Blind Period|Randomized but not treated|1|||
161684716|NCT00808236|583897986|FG001|Overall Study|Physician Decision|1|||
161619040|NCT00813709|583656819|FG001|Double Blind Period|Randomized but not treated|3|||
161619041|NCT00813709|583656820|FG002|Double Blind Period|Randomized but not treated|1|||
161619042|NCT00813709|583656821|FG003|Double Blind Period|Randomized but not treated|0|||
161619043|NCT00813709|583656822|FG004|Double Blind Period|Randomized but not treated|0|||
161619044|NCT00813709|583656823|FG005|Double Blind Period|Randomized but not treated|0|||
161619045|NCT00813709|583656818|FG000|Double Blind Period|Other|14|||
161619046|NCT00813709|583656819|FG001|Double Blind Period|Other|9|||
161619047|NCT00813709|583656820|FG002|Double Blind Period|Other|6|||
161684717|NCT00808236|583897985|FG000|Overall Study|Death|18|||
161619048|NCT00813709|583656821|FG003|Double Blind Period|Other|0|||
161619049|NCT00813709|583656822|FG004|Double Blind Period|Other|0|||
161619050|NCT00813709|583656823|FG005|Double Blind Period|Other|0|||
161619051|NCT00813709|583656818|FG000|Open Label Period|Adverse Event|0|||
161619052|NCT00813709|583656819|FG001|Open Label Period|Adverse Event|0|||
161619053|NCT00813709|583656820|FG002|Open Label Period|Adverse Event|0|||
161619054|NCT00813709|583656821|FG003|Open Label Period|Adverse Event|5|||
161619055|NCT00813709|583656822|FG004|Open Label Period|Adverse Event|4|||
161619056|NCT00813709|583656823|FG005|Open Label Period|Adverse Event|3|||
161619057|NCT00813709|583656818|FG000|Open Label Period|Lack of Efficacy|0|||
161619058|NCT00813709|583656819|FG001|Open Label Period|Lack of Efficacy|0|||
161619059|NCT00813709|583656820|FG002|Open Label Period|Lack of Efficacy|0|||
161619060|NCT00813709|583656821|FG003|Open Label Period|Lack of Efficacy|3|||
161619061|NCT00813709|583656822|FG004|Open Label Period|Lack of Efficacy|1|||
161619062|NCT00813709|583656823|FG005|Open Label Period|Lack of Efficacy|1|||
161619063|NCT00813709|583656818|FG000|Open Label Period|Randomized but not treated|0|||
161619064|NCT00813709|583656819|FG001|Open Label Period|Randomized but not treated|0|||
161619065|NCT00813709|583656820|FG002|Open Label Period|Randomized but not treated|0|||
161619066|NCT00813709|583656821|FG003|Open Label Period|Randomized but not treated|1|||
161619067|NCT00813709|583656822|FG004|Open Label Period|Randomized but not treated|0|||
161619068|NCT00813709|583656823|FG005|Open Label Period|Randomized but not treated|1|||
161619069|NCT00813709|583656818|FG000|Open Label Period|Other|0|||
161619070|NCT00813709|583656819|FG001|Open Label Period|Other|0|||
161619071|NCT00813709|583656820|FG002|Open Label Period|Other|0|||
161619072|NCT00813709|583656821|FG003|Open Label Period|Other|11|||
161619073|NCT00813709|583656822|FG004|Open Label Period|Other|5|||
161619074|NCT00813709|583656823|FG005|Open Label Period|Other|6|||
161619075|NCT01655498|583656824|FG000|Overall Study|Unrelated health issue|2|||
161619076|NCT01655498|583656824|FG000|Overall Study|Protocol Violation|2|||
161619077|NCT01655498|583656824|FG000|Overall Study|Withdrawal by Subject|1|||
161619078|NCT02446015|583656827|FG000|Overall Study|Adverse Event|0|||
161619079|NCT02446015|583656828|FG001|Overall Study|Adverse Event|1|||
161619080|NCT02446015|583656827|FG000|Overall Study|Withdrawal by Subject|1|||
161619081|NCT02446015|583656828|FG001|Overall Study|Withdrawal by Subject|0|||
161619082|NCT00988429|583656829|FG000|Overall Study|Adverse Event|9|||
161619083|NCT00988429|583656830|FG001|Overall Study|Adverse Event|21|||
161619084|NCT00988429|583656831|FG002|Overall Study|Adverse Event|45|||
161619085|NCT00988429|583656829|FG000|Overall Study|Lack of Efficacy|0|||
161619086|NCT00988429|583656830|FG001|Overall Study|Lack of Efficacy|0|||
161619087|NCT00988429|583656831|FG002|Overall Study|Lack of Efficacy|1|||
161619088|NCT00988429|583656829|FG000|Overall Study|Non-Compliance with Study Drug|5|||
161619089|NCT00988429|583656830|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161619090|NCT00988429|583656831|FG002|Overall Study|Non-Compliance with Study Drug|3|||
161619091|NCT00988429|583656829|FG000|Overall Study|Physician Decision|1|||
161619092|NCT00988429|583656830|FG001|Overall Study|Physician Decision|0|||
161619093|NCT00988429|583656831|FG002|Overall Study|Physician Decision|3|||
161619094|NCT00988429|583656829|FG000|Overall Study|Pregnancy|2|||
161619095|NCT00988429|583656830|FG001|Overall Study|Pregnancy|1|||
161619096|NCT00988429|583656831|FG002|Overall Study|Pregnancy|0|||
161619097|NCT00988429|583656829|FG000|Overall Study|Protocol Violation|4|||
161619098|NCT00988429|583656830|FG001|Overall Study|Protocol Violation|3|||
161619099|NCT00988429|583656831|FG002|Overall Study|Protocol Violation|3|||
161619100|NCT00988429|583656829|FG000|Overall Study|Withdrawal by Subject|7|||
161619101|NCT00988429|583656830|FG001|Overall Study|Withdrawal by Subject|7|||
161619102|NCT00988429|583656831|FG002|Overall Study|Withdrawal by Subject|12|||
161619103|NCT00988429|583656829|FG000|Overall Study|Administrative Reasons|1|||
161619104|NCT00988429|583656830|FG001|Overall Study|Administrative Reasons|2|||
161619105|NCT00988429|583656831|FG002|Overall Study|Administrative Reasons|1|||
161619106|NCT00988429|583656829|FG000|Overall Study|other reasons|8|||
161619107|NCT00988429|583656830|FG001|Overall Study|other reasons|8|||
161619108|NCT00988429|583656831|FG002|Overall Study|other reasons|1|||
161619109|NCT01714947|583656832|FG000|Part B|Progressive Disease|3|||
161619110|NCT01123356|583656833|FG000|Overall Study|Adverse Event|2|||
161619111|NCT01123356|583656833|FG000|Overall Study|Lack of Efficacy|4|||
161619112|NCT01123356|583656833|FG000|Overall Study|Withdrawal by Subject|1|||
161619113|NCT00376259|583656836|FG000|Overall Study|Sponsor request - study termination|21|||
161619114|NCT00376259|583656837|FG001|Overall Study|Sponsor request - study termination|21|||
161619115|NCT00376259|583656836|FG000|Overall Study|Patient request|1|||
161619116|NCT00376259|583656837|FG001|Overall Study|Patient request|0|||
161619117|NCT01877720|583656839|FG000|Overall Study|Adverse Event|1|||
161619118|NCT01877720|583656840|FG001|Overall Study|Adverse Event|0|||
161619119|NCT00267956|583656843|FG000|Controlled Period|Adverse Event|4|||
161619120|NCT00267956|583656844|FG001|Controlled Period|Adverse Event|1|||
161619121|NCT00267956|583656845|FG002|Controlled Period|Adverse Event|0|||
161619122|NCT00267956|583656846|FG003|Controlled Period|Adverse Event|0|||
161619123|NCT00267956|583656843|FG000|Controlled Period|Lack of Efficacy|4|||
161619124|NCT00267956|583656844|FG001|Controlled Period|Lack of Efficacy|2|||
161619125|NCT00267956|583656845|FG002|Controlled Period|Lack of Efficacy|0|||
161619126|NCT00267956|583656846|FG003|Controlled Period|Lack of Efficacy|0|||
161619127|NCT00267956|583656843|FG000|Controlled Period|Lost to Follow-up|2|||
161619128|NCT00267956|583656844|FG001|Controlled Period|Lost to Follow-up|0|||
161619129|NCT00267956|583656845|FG002|Controlled Period|Lost to Follow-up|0|||
161619130|NCT00267956|583656846|FG003|Controlled Period|Lost to Follow-up|0|||
161619131|NCT00267956|583656843|FG000|Controlled Period|Withdrew consent|3|||
161619132|NCT00267956|583656844|FG001|Controlled Period|Withdrew consent|1|||
161619133|NCT00267956|583656845|FG002|Controlled Period|Withdrew consent|0|||
161619134|NCT00267956|583656846|FG003|Controlled Period|Withdrew consent|0|||
161619135|NCT00267956|583656843|FG000|After Controlled Period|Adverse Event|0|||
161619136|NCT00267956|583656844|FG001|After Controlled Period|Adverse Event|0|||
161619137|NCT00267956|583656845|FG002|After Controlled Period|Adverse Event|2|||
161619138|NCT00267956|583656846|FG003|After Controlled Period|Adverse Event|1|||
161619139|NCT00267956|583656843|FG000|After Controlled Period|Lack of Efficacy|0|||
161619140|NCT00267956|583656844|FG001|After Controlled Period|Lack of Efficacy|0|||
161619141|NCT00267956|583656845|FG002|After Controlled Period|Lack of Efficacy|1|||
161619142|NCT00267956|583656846|FG003|After Controlled Period|Lack of Efficacy|1|||
161619143|NCT00267956|583656843|FG000|After Controlled Period|Lost to Follow-up|0|||
161619144|NCT00267956|583656844|FG001|After Controlled Period|Lost to Follow-up|0|||
161619145|NCT00267956|583656845|FG002|After Controlled Period|Lost to Follow-up|1|||
161619146|NCT00267956|583656846|FG003|After Controlled Period|Lost to Follow-up|0|||
161619147|NCT00267956|583656843|FG000|After Controlled Period|Withdrew consent|0|||
161619148|NCT00267956|583656844|FG001|After Controlled Period|Withdrew consent|0|||
161619149|NCT00267956|583656845|FG002|After Controlled Period|Withdrew consent|1|||
161619150|NCT00267956|583656846|FG003|After Controlled Period|Withdrew consent|0|||
161619151|NCT01393964|583656851|FG000|Overall Study|Disease Progression|4|||
161619152|NCT01393964|583656852|FG001|Overall Study|Disease Progression|3|||
161619153|NCT01393964|583656853|FG002|Overall Study|Disease Progression|5|||
161619154|NCT01393964|583656851|FG000|Overall Study|Study drug toxicity|1|||
161619155|NCT01393964|583656852|FG001|Overall Study|Study drug toxicity|0|||
161619156|NCT01393964|583656853|FG002|Overall Study|Study drug toxicity|0|||
161619157|NCT01393964|583656851|FG000|Overall Study|Withdrawal by Subject|0|||
161619158|NCT01393964|583656852|FG001|Overall Study|Withdrawal by Subject|0|||
161619159|NCT01393964|583656853|FG002|Overall Study|Withdrawal by Subject|1|||
161619160|NCT01393964|583656851|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161619161|NCT01393964|583656852|FG001|Overall Study|Adverse event unrelated to study drug|3|||
161619162|NCT01393964|583656853|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161619163|NCT01393964|583656851|FG000|Overall Study|Subject request stop study treatment|0|||
161619164|NCT01393964|583656852|FG001|Overall Study|Subject request stop study treatment|1|||
161619165|NCT01393964|583656853|FG002|Overall Study|Subject request stop study treatment|0|||
161619166|NCT01393964|583656851|FG000|Overall Study|Subject decided to move to transplant|1|||
161619167|NCT01393964|583656852|FG001|Overall Study|Subject decided to move to transplant|0|||
161619168|NCT01393964|583656853|FG002|Overall Study|Subject decided to move to transplant|0|||
161619169|NCT01393964|583656851|FG000|Overall Study|Subject switched to commercial supply|1|||
161619170|NCT01393964|583656852|FG001|Overall Study|Subject switched to commercial supply|0|||
161619171|NCT01393964|583656853|FG002|Overall Study|Subject switched to commercial supply|2|||
161619172|NCT01393964|583656851|FG000|Overall Study|Subject plateaued in terms of effect|1|||
161619173|NCT01393964|583656852|FG001|Overall Study|Subject plateaued in terms of effect|0|||
161619174|NCT01393964|583656853|FG002|Overall Study|Subject plateaued in terms of effect|0|||
161619175|NCT01393964|583656851|FG000|Overall Study|Investigator removed subject from study|0|||
161619176|NCT01393964|583656852|FG001|Overall Study|Investigator removed subject from study|1|||
161619177|NCT01393964|583656853|FG002|Overall Study|Investigator removed subject from study|0|||
161619178|NCT01393964|583656851|FG000|Overall Study|Subject converted to roll-over study|0|||
161619179|NCT01393964|583656852|FG001|Overall Study|Subject converted to roll-over study|1|||
161619180|NCT01393964|583656853|FG002|Overall Study|Subject converted to roll-over study|0|||
161619181|NCT01393964|583656851|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
161619182|NCT01393964|583656852|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
161619183|NCT01393964|583656853|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
161619184|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
161684718|NCT00808236|583897986|FG001|Overall Study|Death|30|||
161619185|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
161684719|NCT00961220|583897987|FG000|Overall Study|Adverse Event|3|||
161619186|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
161619187|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
161619188|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
161619189|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
161619190|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
161684720|NCT00961220|583897987|FG000|Overall Study|Lack of Efficacy|1|||
161684721|NCT00961220|583897987|FG000|Overall Study|No IV access for O6BG|1|||
161684722|NCT00961220|583897987|FG000|Overall Study|O6BG no longer supplied|1|||
161684723|NCT00961220|583897987|FG000|Overall Study|Complete Response prior to 12 courses|1|||
161684724|NCT05376215|583897988|FG000|Overall Study|Withdrawal by Subject|2|||
161684725|NCT05376215|583897989|FG001|Overall Study|Withdrawal by Subject|1|||
161684726|NCT05376215|583897988|FG000|Overall Study|Lost to Follow-up|0|||
161684727|NCT05376215|583897989|FG001|Overall Study|Lost to Follow-up|1|||
161684728|NCT01301950|583897990|FG000|Overall Study|Surgery was cancelled by patient|0|||
161684729|NCT01301950|583897991|FG001|Overall Study|Surgery was cancelled by patient|1|||
161684730|NCT00942175|583897992|FG000|Overall Study|Adverse Event|2|||
161684731|NCT00942175|583897993|FG001|Overall Study|Adverse Event|1|||
161684732|NCT00942175|583897994|FG002|Overall Study|Adverse Event|0|||
161684733|NCT00942175|583897995|FG003|Overall Study|Adverse Event|0|||
161684734|NCT00942175|583897992|FG000|Overall Study|Protocol Violation|0|||
161684735|NCT00942175|583897993|FG001|Overall Study|Protocol Violation|1|||
161684736|NCT00942175|583897994|FG002|Overall Study|Protocol Violation|2|||
161684737|NCT00942175|583897995|FG003|Overall Study|Protocol Violation|0|||
161363810|NCT00392288|582720028|FG000|Overall Study|Other|3|||
161619191|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
161619192|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
161619193|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
161619194|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
161619195|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
161619196|NCT01494467|583656858|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
161619197|NCT01494467|583656859|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
161619198|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
161619199|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
161619200|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
161619201|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
161619202|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
161619203|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
161619204|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
161619205|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
161619206|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
161619207|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
161619208|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
161619209|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
161619210|NCT01494467|583656858|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
161619211|NCT01494467|583656859|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
161619212|NCT02077374|583656862|FG000|Overall Study|Withdrawal by Subject|0|||
161619213|NCT02077374|583656863|FG001|Overall Study|Withdrawal by Subject|1|||
161619214|NCT02077374|583656862|FG000|Overall Study|Protocol Violation|0|||
161619215|NCT02077374|583656863|FG001|Overall Study|Protocol Violation|1|||
161619216|NCT01777932|583656864|FG000|Overall Study|Disease progression|136|||
161619217|NCT01777932|583656864|FG000|Overall Study|Death|3|||
161619218|NCT01777932|583656864|FG000|Overall Study|Adverse Event|34|||
161619219|NCT01777932|583656864|FG000|Overall Study|Lost to Follow-up|3|||
161619220|NCT01777932|583656864|FG000|Overall Study|Investigator decision|10|||
161619221|NCT01777932|583656864|FG000|Overall Study|Reimbursement limit|9|||
161619222|NCT01777932|583656864|FG000|Overall Study|Patient refused further treatment|10|||
161619223|NCT00068107|583656868|FG000|Overall Study|end-stage renal disease|6|||
161619224|NCT00068107|583656868|FG000|Overall Study|Death|2|||
161619225|NCT00068107|583656868|FG000|Overall Study|Withdrawal by Subject|1|||
161619226|NCT03989232|583656873|FG000|Overall Study|Lost to Follow-up|3|||
161619227|NCT03989232|583656874|FG001|Overall Study|Lost to Follow-up|10|||
161619228|NCT03989232|583656873|FG000|Overall Study|Withdrawal by Subject|6|||
161619229|NCT03989232|583656874|FG001|Overall Study|Withdrawal by Subject|6|||
161619230|NCT03989232|583656873|FG000|Overall Study|Death|1|||
161619231|NCT03989232|583656874|FG001|Overall Study|Death|2|||
161619232|NCT02644122|583656877|FG000|Overall Study|Withdrawal by Subject|1|||
161684738|NCT00942175|583897992|FG000|Overall Study|Pregnancy|0|||
161684739|NCT00942175|583897993|FG001|Overall Study|Pregnancy|0|||
161684740|NCT00942175|583897994|FG002|Overall Study|Pregnancy|0|||
161684741|NCT00942175|583897995|FG003|Overall Study|Pregnancy|1|||
161619233|NCT00424476|583656880|FG000|Overall Study|Withdrawal by Subject|7|||
161619234|NCT00424476|583656881|FG001|Overall Study|Withdrawal by Subject|6|||
161619235|NCT00424476|583656882|FG002|Overall Study|Withdrawal by Subject|3|||
161619236|NCT00424476|583656880|FG000|Overall Study|Adverse Event|19|||
161619237|NCT00424476|583656881|FG001|Overall Study|Adverse Event|16|||
161619238|NCT00424476|583656882|FG002|Overall Study|Adverse Event|15|||
161619239|NCT00424476|583656880|FG000|Overall Study|Lack of Efficacy|16|||
161684742|NCT00942175|583897992|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
161684743|NCT00942175|583897993|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
161619240|NCT00424476|583656881|FG001|Overall Study|Lack of Efficacy|12|||
161619241|NCT00424476|583656882|FG002|Overall Study|Lack of Efficacy|12|||
161619242|NCT00424476|583656880|FG000|Overall Study|Lack of Compliance|1|||
161619243|NCT00424476|583656881|FG001|Overall Study|Lack of Compliance|1|||
161619244|NCT00424476|583656882|FG002|Overall Study|Lack of Compliance|1|||
161619245|NCT00424476|583656880|FG000|Overall Study|Lost to Follow-up|4|||
161619246|NCT00424476|583656881|FG001|Overall Study|Lost to Follow-up|6|||
161619247|NCT00424476|583656882|FG002|Overall Study|Lost to Follow-up|3|||
161619248|NCT00424476|583656880|FG000|Overall Study|Protocol Violation|7|||
161619249|NCT00424476|583656881|FG001|Overall Study|Protocol Violation|2|||
161619250|NCT00424476|583656882|FG002|Overall Study|Protocol Violation|3|||
161619251|NCT00424476|583656880|FG000|Overall Study|Physician Decision|3|||
161619252|NCT00424476|583656881|FG001|Overall Study|Physician Decision|2|||
161619253|NCT00424476|583656882|FG002|Overall Study|Physician Decision|3|||
161619254|NCT00424476|583656880|FG000|Overall Study|Other|4|||
161619255|NCT00424476|583656881|FG001|Overall Study|Other|3|||
161619256|NCT00424476|583656882|FG002|Overall Study|Other|9|||
161619257|NCT01930188|583656883|FG000|Overall Study|unclassified|4|||
161619258|NCT01930188|583656884|FG001|Overall Study|unclassified|5|||
161619259|NCT01930188|583656885|FG002|Overall Study|unclassified|3|||
161619260|NCT01930188|583656883|FG000|Overall Study|Missing follow-up information|2|||
161619261|NCT01930188|583656884|FG001|Overall Study|Missing follow-up information|2|||
161619262|NCT01930188|583656885|FG002|Overall Study|Missing follow-up information|3|||
161619263|NCT01930188|583656883|FG000|Overall Study|Lost to Follow-up|5|||
161619264|NCT01930188|583656884|FG001|Overall Study|Lost to Follow-up|2|||
161619265|NCT01930188|583656885|FG002|Overall Study|Lost to Follow-up|2|||
161619266|NCT01930188|583656883|FG000|Overall Study|Death|2|||
161619267|NCT01930188|583656884|FG001|Overall Study|Death|1|||
161619268|NCT01930188|583656885|FG002|Overall Study|Death|3|||
161619269|NCT01930188|583656883|FG000|Overall Study|Withdrawal by Subject|9|||
161619270|NCT01930188|583656884|FG001|Overall Study|Withdrawal by Subject|11|||
161619271|NCT01930188|583656885|FG002|Overall Study|Withdrawal by Subject|8|||
161619272|NCT02514824|583656886|FG000|Overall Study|Withdrawal by Subject|1|||
161619273|NCT02514824|583656887|FG001|Overall Study|Withdrawal by Subject|0|||
161619274|NCT02514824|583656888|FG002|Overall Study|Withdrawal by Subject|0|||
161619275|NCT02514824|583656889|FG003|Overall Study|Withdrawal by Subject|0|||
161619276|NCT02514824|583656886|FG000|Overall Study|Dose-Limiting Toxicity|0|||
161619277|NCT02514824|583656887|FG001|Overall Study|Dose-Limiting Toxicity|1|||
161619278|NCT02514824|583656888|FG002|Overall Study|Dose-Limiting Toxicity|0|||
161619279|NCT02514824|583656889|FG003|Overall Study|Dose-Limiting Toxicity|0|||
161619280|NCT02399449|583656890|FG000|Overall Study|Withdrawal by Subject|3|||
161619281|NCT02399449|583656891|FG001|Overall Study|Withdrawal by Subject|9|||
161619282|NCT02399449|583656890|FG000|Overall Study|Physician Decision|0|||
161619283|NCT02399449|583656891|FG001|Overall Study|Physician Decision|1|||
161619284|NCT01020435|583656892|FG000|Overall Study|Lost to Follow-up|0|||
161619285|NCT01020435|583656893|FG001|Overall Study|Lost to Follow-up|1|||
161619286|NCT00346398|583656894|FG000|Overall Study|Lost to Follow-up|3|||
161619287|NCT00346398|583656895|FG001|Overall Study|Lost to Follow-up|0|||
161619288|NCT00346398|583656894|FG000|Overall Study|Withdrawal by Subject|0|||
161619289|NCT00346398|583656895|FG001|Overall Study|Withdrawal by Subject|2|||
161619290|NCT03979040|583656896|FG000|Overall Study|Withdrawal by Subject|24|||
161619291|NCT03979040|583656897|FG001|Overall Study|Withdrawal by Subject|32|||
161619292|NCT03979040|583656896|FG000|Overall Study|randomized but never started treatment|32|||
161619293|NCT03979040|583656897|FG001|Overall Study|randomized but never started treatment|39|||
161619294|NCT03979040|583656896|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
161619295|NCT03979040|583656897|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
161619296|NCT02607956|583656898|FG000|Double-Blinded Phase|Withdrew Consent|17|||
161619297|NCT02607956|583656899|FG001|Double-Blinded Phase|Withdrew Consent|19|||
161619298|NCT02607956|583656900|FG002|Double-Blinded Phase|Withdrew Consent|0|||
161619299|NCT02607956|583656901|FG003|Double-Blinded Phase|Withdrew Consent|0|||
161619300|NCT02607956|583656898|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
161619301|NCT02607956|583656899|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
161619302|NCT02607956|583656900|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
161619303|NCT02607956|583656901|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
161619304|NCT02607956|583656898|FG000|Double-Blinded Phase|Randomized but never treated|7|||
161619305|NCT02607956|583656899|FG001|Double-Blinded Phase|Randomized but never treated|5|||
161619306|NCT02607956|583656900|FG002|Double-Blinded Phase|Randomized but never treated|0|||
161619307|NCT02607956|583656901|FG003|Double-Blinded Phase|Randomized but never treated|0|||
161619308|NCT02607956|583656898|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
161619309|NCT02607956|583656899|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
161619310|NCT02607956|583656900|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
161619311|NCT02607956|583656901|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
161619312|NCT02607956|583656898|FG000|Double-Blinded Phase|Death|4|||
161619313|NCT02607956|583656899|FG001|Double-Blinded Phase|Death|4|||
161619314|NCT02607956|583656900|FG002|Double-Blinded Phase|Death|0|||
161619315|NCT02607956|583656901|FG003|Double-Blinded Phase|Death|0|||
161619316|NCT02607956|583656898|FG000|Double-Blinded Phase|Adverse Event|4|||
161619317|NCT02607956|583656899|FG001|Double-Blinded Phase|Adverse Event|3|||
161619318|NCT02607956|583656900|FG002|Double-Blinded Phase|Adverse Event|0|||
161619319|NCT02607956|583656901|FG003|Double-Blinded Phase|Adverse Event|0|||
161619320|NCT02607956|583656898|FG000|Double-Blinded Phase|Protocol Violation|3|||
161619321|NCT02607956|583656899|FG001|Double-Blinded Phase|Protocol Violation|1|||
161619322|NCT02607956|583656900|FG002|Double-Blinded Phase|Protocol Violation|0|||
161619323|NCT02607956|583656901|FG003|Double-Blinded Phase|Protocol Violation|0|||
161619324|NCT02607956|583656898|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
161619325|NCT02607956|583656899|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
161619326|NCT02607956|583656900|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
161619327|NCT02607956|583656901|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
161619328|NCT02607956|583656898|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
161619329|NCT02607956|583656899|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
161619330|NCT02607956|583656900|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
161619331|NCT02607956|583656901|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
161619332|NCT02607956|583656898|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161619333|NCT02607956|583656899|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161619334|NCT02607956|583656900|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
161619335|NCT02607956|583656901|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
161619336|NCT02607956|583656898|FG000|Open-Label Extension Phase|Death|0|||
161619337|NCT02607956|583656899|FG001|Open-Label Extension Phase|Death|0|||
161619338|NCT02607956|583656900|FG002|Open-Label Extension Phase|Death|1|||
161619339|NCT02607956|583656901|FG003|Open-Label Extension Phase|Death|3|||
161619340|NCT02607956|583656898|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
161619341|NCT02607956|583656899|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161619342|NCT02607956|583656900|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
161619343|NCT02607956|583656901|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
161619344|NCT02607956|583656898|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
161619345|NCT02607956|583656899|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
161619346|NCT02607956|583656900|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
161619347|NCT02607956|583656901|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
161619348|NCT02607956|583656898|FG000|Open-Label Extension Phase|Protocol Violation|0|||
161619349|NCT02607956|583656899|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161619350|NCT02607956|583656900|FG002|Open-Label Extension Phase|Protocol Violation|0|||
161619351|NCT02607956|583656901|FG003|Open-Label Extension Phase|Protocol Violation|2|||
161619352|NCT02607956|583656898|FG000|Open-Label Extension Phase|Pregnancy|0|||
161619353|NCT02607956|583656899|FG001|Open-Label Extension Phase|Pregnancy|0|||
161619354|NCT02607956|583656900|FG002|Open-Label Extension Phase|Pregnancy|0|||
161619355|NCT02607956|583656901|FG003|Open-Label Extension Phase|Pregnancy|1|||
161619356|NCT00090519|583656908|FG000|Overall Study|Adverse Event|5|||
161619357|NCT00090519|583656909|FG001|Overall Study|Adverse Event|4|||
161619358|NCT00090519|583656908|FG000|Overall Study|Death|9|||
161619359|NCT00090519|583656909|FG001|Overall Study|Death|9|||
161619360|NCT00090519|583656908|FG000|Overall Study|Lost to Follow-up|26|||
161619361|NCT00090519|583656909|FG001|Overall Study|Lost to Follow-up|29|||
161619362|NCT00090519|583656908|FG000|Overall Study|Withdrawal by Subject|28|||
161619363|NCT00090519|583656909|FG001|Overall Study|Withdrawal by Subject|29|||
161619364|NCT00090519|583656908|FG000|Overall Study|Physician Decision|2|||
161619365|NCT00090519|583656909|FG001|Overall Study|Physician Decision|3|||
161619366|NCT00090519|583656908|FG000|Overall Study|Sponsor Decision|3|||
161619367|NCT00090519|583656909|FG001|Overall Study|Sponsor Decision|1|||
161619368|NCT00960206|583656910|FG000|Overall Study|Death|7|||
161619369|NCT00960206|583656911|FG001|Overall Study|Death|4|||
161619370|NCT00960206|583656912|FG002|Overall Study|Death|1|||
161619371|NCT00960206|583656910|FG000|Overall Study|Unwilling/Unable to return|1|||
161619372|NCT00960206|583656911|FG001|Overall Study|Unwilling/Unable to return|2|||
161619373|NCT00960206|583656912|FG002|Overall Study|Unwilling/Unable to return|0|||
161619374|NCT00960206|583656910|FG000|Overall Study|Lost to Follow-up|8|||
161619375|NCT00960206|583656911|FG001|Overall Study|Lost to Follow-up|14|||
161619376|NCT00960206|583656912|FG002|Overall Study|Lost to Follow-up|8|||
161619377|NCT00960206|583656910|FG000|Overall Study|Withdrawal by Subject|2|||
161619378|NCT00960206|583656911|FG001|Overall Study|Withdrawal by Subject|4|||
161619379|NCT00960206|583656912|FG002|Overall Study|Withdrawal by Subject|0|||
161619380|NCT00960206|583656910|FG000|Overall Study|Revision of study component|2|||
161619381|NCT00960206|583656911|FG001|Overall Study|Revision of study component|2|||
161619382|NCT00960206|583656912|FG002|Overall Study|Revision of study component|2|||
161619383|NCT00960206|583656910|FG000|Overall Study|Missing 10 year data|20|||
161619384|NCT00960206|583656911|FG001|Overall Study|Missing 10 year data|1|||
161619385|NCT00960206|583656912|FG002|Overall Study|Missing 10 year data|1|||
161619386|NCT01240590|583656917|FG000|Phase I|Refused further treatment|0|||
161619387|NCT01240590|583656918|FG001|Phase I|Refused further treatment|0|||
161619388|NCT01240590|583656919|FG002|Phase I|Refused further treatment|3|||
161619389|NCT01240590|583656920|FG003|Phase I|Refused further treatment|0|||
161619390|NCT01240590|583656921|FG004|Phase I|Refused further treatment|0|||
161619391|NCT01240590|583656917|FG000|Phase II|Refused further treatment|0|||
161619392|NCT01240590|583656918|FG001|Phase II|Refused further treatment|0|||
161619393|NCT01240590|583656919|FG002|Phase II|Refused further treatment|0|||
161619394|NCT01240590|583656920|FG003|Phase II|Refused further treatment|2|||
161619395|NCT01240590|583656921|FG004|Phase II|Refused further treatment|1|||
161619396|NCT02659540|583656922|FG000|Overall Study|Adverse Event|3|||
161619397|NCT02659540|583656923|FG001|Overall Study|Adverse Event|2|||
161619398|NCT02659540|583656922|FG000|Overall Study|Death|1|||
161619399|NCT02659540|583656923|FG001|Overall Study|Death|0|||
161619400|NCT02659540|583656922|FG000|Overall Study|Progressive disease|2|||
161619401|NCT02659540|583656923|FG001|Overall Study|Progressive disease|6|||
161619402|NCT00824850|583656926|FG000|Overall Study|Withdrawal by Subject|0|||
161619403|NCT00824850|583656927|FG001|Overall Study|Withdrawal by Subject|1|||
161619404|NCT02548585|583656928|FG000|Overall Study|Withdrawal by Subject|0|||
161619405|NCT02548585|583656929|FG001|Overall Study|Withdrawal by Subject|0|||
161619406|NCT02548585|583656930|FG002|Overall Study|Withdrawal by Subject|0|||
161619407|NCT02548585|583656931|FG003|Overall Study|Withdrawal by Subject|0|||
161619408|NCT02548585|583656932|FG004|Overall Study|Withdrawal by Subject|0|||
161619409|NCT02548585|583656933|FG005|Overall Study|Withdrawal by Subject|1|||
161619410|NCT02548585|583656934|FG006|Overall Study|Withdrawal by Subject|0|||
161619411|NCT02548585|583656928|FG000|Overall Study|Lost to Follow-up|1|||
161619412|NCT02548585|583656929|FG001|Overall Study|Lost to Follow-up|0|||
161619413|NCT02548585|583656930|FG002|Overall Study|Lost to Follow-up|0|||
161619414|NCT02548585|583656931|FG003|Overall Study|Lost to Follow-up|0|||
161619415|NCT02548585|583656932|FG004|Overall Study|Lost to Follow-up|0|||
161619416|NCT02548585|583656933|FG005|Overall Study|Lost to Follow-up|0|||
161619417|NCT02548585|583656934|FG006|Overall Study|Lost to Follow-up|0|||
161619418|NCT02548585|583656928|FG000|Overall Study|Other|1|||
161619419|NCT02548585|583656929|FG001|Overall Study|Other|0|||
161619420|NCT02548585|583656930|FG002|Overall Study|Other|0|||
161619421|NCT02548585|583656931|FG003|Overall Study|Other|2|||
161619422|NCT02548585|583656932|FG004|Overall Study|Other|3|||
161619423|NCT02548585|583656933|FG005|Overall Study|Other|0|||
161619424|NCT02548585|583656934|FG006|Overall Study|Other|1|||
161619425|NCT02548585|583656928|FG000|Overall Study|Randomized but not treated|0|||
161619426|NCT02548585|583656929|FG001|Overall Study|Randomized but not treated|0|||
161619427|NCT02548585|583656930|FG002|Overall Study|Randomized but not treated|0|||
161619428|NCT02548585|583656931|FG003|Overall Study|Randomized but not treated|0|||
161619429|NCT02548585|583656932|FG004|Overall Study|Randomized but not treated|0|||
161619430|NCT02548585|583656933|FG005|Overall Study|Randomized but not treated|1|||
161619431|NCT02548585|583656934|FG006|Overall Study|Randomized but not treated|0|||
161619432|NCT01075152|583656935|FG000|Overall Study|Withdrawal by Subject|1|||
161619433|NCT01075152|583656936|FG001|Overall Study|Withdrawal by Subject|0|||
161619434|NCT01079949|583656939|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
161619435|NCT01079949|583656940|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
161619436|NCT01079949|583656939|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
161619437|NCT01079949|583656940|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
161619438|NCT01079949|583656939|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
161619439|NCT01079949|583656940|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
161619440|NCT01079949|583656939|FG000|Overall Study|Randomized but not treated|1|||
161619441|NCT01079949|583656940|FG001|Overall Study|Randomized but not treated|0|||
161619442|NCT03659136|583656945|FG000|Overall Study|Not treated|2|||
161832829|NCT01557842|584429638|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
161619443|NCT03659136|583656946|FG001|Overall Study|Not treated|0|||
161619444|NCT03659136|583656945|FG000|Overall Study|Covid-19 related|1|||
161619445|NCT03659136|583656946|FG001|Overall Study|Covid-19 related|1|||
161619446|NCT03659136|583656945|FG000|Overall Study|Withdrawal by Subject|1|||
161619447|NCT03659136|583656946|FG001|Overall Study|Withdrawal by Subject|6|||
161619448|NCT03659136|583656945|FG000|Overall Study|Adverse Event|4|||
161619449|NCT03659136|583656946|FG001|Overall Study|Adverse Event|6|||
161619450|NCT03659136|583656945|FG000|Overall Study|Progressive disease|37|||
161619451|NCT03659136|583656946|FG001|Overall Study|Progressive disease|31|||
161619452|NCT03659136|583656945|FG000|Overall Study|Study closure|2|||
161619453|NCT03659136|583656946|FG001|Overall Study|Study closure|2|||
161619454|NCT03659136|583656945|FG000|Overall Study|Sponsor decision/recommendation|3|||
161619455|NCT03659136|583656946|FG001|Overall Study|Sponsor decision/recommendation|2|||
161619456|NCT03659136|583656945|FG000|Overall Study|Switched to other drug/therapy|2|||
161619457|NCT03659136|583656946|FG001|Overall Study|Switched to other drug/therapy|2|||
161619458|NCT03659136|583656945|FG000|Overall Study|Lack of clinical benefit|0|||
161619459|NCT03659136|583656946|FG001|Overall Study|Lack of clinical benefit|1|||
161619460|NCT05066230|583658614|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
161619461|NCT05066230|583658615|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
161619462|NCT05066230|583658614|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
161619463|NCT05066230|583658615|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
161619464|NCT05066230|583658614|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
161619465|NCT05066230|583658615|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
161619466|NCT05066230|583658614|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
161619467|NCT05066230|583658615|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
161619468|NCT05066230|583658614|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
161619469|NCT05066230|583658615|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
161619470|NCT05066230|583658614|FG000|After Week 48|Adverse Event|1|||
161619471|NCT05066230|583658615|FG001|After Week 48|Adverse Event|0|||
161619472|NCT05066230|583658614|FG000|After Week 48|Non-compliance with study schedule|1|||
161619473|NCT05066230|583658615|FG001|After Week 48|Non-compliance with study schedule|0|||
161619474|NCT05066230|583658614|FG000|After Week 48|Withdrawal by Subject|0|||
161619475|NCT05066230|583658615|FG001|After Week 48|Withdrawal by Subject|1|||
161619476|NCT05066230|583658614|FG000|After Week 48|Lost to Follow-up|3|||
161619477|NCT05066230|583658615|FG001|After Week 48|Lost to Follow-up|3|||
161619478|NCT05066230|583658614|FG000|After Week 48|Sponsor Request|115|||
161619479|NCT05066230|583658615|FG001|After Week 48|Sponsor Request|111|||
161619480|NCT00759681|583658616|FG000|Overall Study|Death|2|||
161619481|NCT00759681|583658617|FG001|Overall Study|Death|5|||
161619482|NCT00759681|583658616|FG000|Overall Study|Lost to Follow-up|8|||
161619483|NCT00759681|583658617|FG001|Overall Study|Lost to Follow-up|5|||
161619484|NCT01012999|583658618|FG000|Overall Study|Protocol Violation|1|||
161619485|NCT02410278|583658619|FG000|Run-in Period|Adverse Event|5|||
161619486|NCT02410278|583658620|FG001|Run-in Period|Adverse Event|0|||
161619487|NCT02410278|583658621|FG002|Run-in Period|Adverse Event|0|||
161619488|NCT02410278|583658619|FG000|Run-in Period|GSRS Threshold Not Met|30|||
161619489|NCT02410278|583658620|FG001|Run-in Period|GSRS Threshold Not Met|0|||
161619490|NCT02410278|583658621|FG002|Run-in Period|GSRS Threshold Not Met|0|||
161619491|NCT02410278|583658619|FG000|Run-in Period|Lost to Follow-up|1|||
161619492|NCT02410278|583658620|FG001|Run-in Period|Lost to Follow-up|0|||
161619493|NCT02410278|583658621|FG002|Run-in Period|Lost to Follow-up|0|||
161619494|NCT02410278|583658619|FG000|Run-in Period|Withdrawal by Subject|1|||
161619495|NCT02410278|583658620|FG001|Run-in Period|Withdrawal by Subject|0|||
161619496|NCT02410278|583658621|FG002|Run-in Period|Withdrawal by Subject|0|||
161619497|NCT02410278|583658619|FG000|Run-in Period|Pregnancy|1|||
161619498|NCT02410278|583658620|FG001|Run-in Period|Pregnancy|0|||
161619499|NCT02410278|583658621|FG002|Run-in Period|Pregnancy|0|||
161619500|NCT02410278|583658619|FG000|Study Treatment Period|Adverse Event|0|||
161619501|NCT02410278|583658620|FG001|Study Treatment Period|Adverse Event|6|||
161619502|NCT02410278|583658621|FG002|Study Treatment Period|Adverse Event|3|||
161619503|NCT02410278|583658619|FG000|Study Treatment Period|Physician Decision|0|||
161619504|NCT02410278|583658620|FG001|Study Treatment Period|Physician Decision|0|||
161619505|NCT02410278|583658621|FG002|Study Treatment Period|Physician Decision|1|||
161619506|NCT02410278|583658619|FG000|Study Treatment Period|Withdrawal by Subject|0|||
161619507|NCT02410278|583658620|FG001|Study Treatment Period|Withdrawal by Subject|1|||
161619508|NCT02410278|583658621|FG002|Study Treatment Period|Withdrawal by Subject|0|||
161619509|NCT02410278|583658619|FG000|Study Treatment Period|Other|0|||
161619510|NCT02410278|583658620|FG001|Study Treatment Period|Other|3|||
161619511|NCT02410278|583658621|FG002|Study Treatment Period|Other|0|||
161619512|NCT02410278|583658619|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
161619513|NCT02410278|583658620|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
161619514|NCT02410278|583658621|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
161619515|NCT02584257|583658622|FG000|Period 1|Withdrawal by Subject|0|||
161619516|NCT02584257|583658623|FG001|Period 1|Withdrawal by Subject|0|||
161619517|NCT02584257|583658624|FG002|Period 1|Withdrawal by Subject|0|||
161619518|NCT02584257|583658625|FG003|Period 1|Withdrawal by Subject|0|||
161619519|NCT02584257|583658626|FG004|Period 1|Withdrawal by Subject|0|||
161619520|NCT02584257|583658627|FG005|Period 1|Withdrawal by Subject|0|||
161619521|NCT02584257|583658628|FG006|Period 1|Withdrawal by Subject|1|||
161619522|NCT02584257|583658629|FG007|Period 1|Withdrawal by Subject|0|||
161619523|NCT02584257|583658630|FG008|Period 1|Withdrawal by Subject|0|||
161619524|NCT02584257|583658622|FG000|Period 2|Physician Decision|1|||
161619525|NCT02584257|583658623|FG001|Period 2|Physician Decision|0|||
161619526|NCT02584257|583658624|FG002|Period 2|Physician Decision|0|||
161619527|NCT02584257|583658625|FG003|Period 2|Physician Decision|0|||
161619528|NCT02584257|583658626|FG004|Period 2|Physician Decision|0|||
161619529|NCT02584257|583658627|FG005|Period 2|Physician Decision|0|||
161619530|NCT02584257|583658628|FG006|Period 2|Physician Decision|0|||
161619531|NCT02584257|583658629|FG007|Period 2|Physician Decision|0|||
161619532|NCT02584257|583658630|FG008|Period 2|Physician Decision|0|||
161619533|NCT02584257|583658622|FG000|Period 2|Adverse Event|0|||
161619534|NCT02584257|583658623|FG001|Period 2|Adverse Event|1|||
161619535|NCT02584257|583658624|FG002|Period 2|Adverse Event|0|||
161619536|NCT02584257|583658625|FG003|Period 2|Adverse Event|0|||
161619537|NCT02584257|583658626|FG004|Period 2|Adverse Event|0|||
161619538|NCT02584257|583658627|FG005|Period 2|Adverse Event|0|||
161619539|NCT02584257|583658628|FG006|Period 2|Adverse Event|0|||
161619540|NCT02584257|583658629|FG007|Period 2|Adverse Event|0|||
161619541|NCT02584257|583658630|FG008|Period 2|Adverse Event|0|||
161619542|NCT01670877|583658631|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161619543|NCT01670877|583658632|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
161619544|NCT01670877|583658633|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161619545|NCT01670877|583658634|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161619546|NCT01670877|583658635|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161619547|NCT01670877|583658636|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161619548|NCT01670877|583658631|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161619549|NCT01670877|583658632|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161619550|NCT01670877|583658633|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
161619551|NCT01670877|583658634|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161619552|NCT01670877|583658635|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161619553|NCT01670877|583658636|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161619554|NCT01670877|583658631|FG000|Part I and Part 2|Grade 2 vomiting|0|||
161619555|NCT01670877|583658632|FG001|Part I and Part 2|Grade 2 vomiting|0|||
161619556|NCT01670877|583658633|FG002|Part I and Part 2|Grade 2 vomiting|0|||
161619557|NCT01670877|583658634|FG003|Part I and Part 2|Grade 2 vomiting|1|||
161619558|NCT01670877|583658635|FG004|Part I and Part 2|Grade 2 vomiting|0|||
161619559|NCT01670877|583658636|FG005|Part I and Part 2|Grade 2 vomiting|0|||
161619560|NCT01670877|583658631|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161619561|NCT01670877|583658632|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161619562|NCT01670877|583658633|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161619563|NCT01670877|583658634|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
161619564|NCT01670877|583658635|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161619565|NCT01670877|583658636|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161619566|NCT01670877|583658631|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161619567|NCT01670877|583658632|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161619568|NCT01670877|583658633|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161619569|NCT01670877|583658634|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
161619570|NCT01670877|583658635|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161619571|NCT01670877|583658636|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161619572|NCT02309892|583658637|FG000|Overall Study|Physician Decision|1|||
161619573|NCT02309892|583658638|FG001|Overall Study|Physician Decision|0|||
161619574|NCT02309892|583658639|FG002|Overall Study|Physician Decision|0|||
161619575|NCT02309892|583658640|FG003|Overall Study|Physician Decision|0|||
161619576|NCT02309892|583658641|FG004|Overall Study|Physician Decision|0|||
161619577|NCT02309892|583658642|FG005|Overall Study|Physician Decision|0|||
161832830|NCT01557842|584429639|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
161832831|NCT01557842|584429638|FG000|Overall Study|Study Terminated by Sponsor|3|||
161619578|NCT02309892|583658643|FG006|Overall Study|Physician Decision|0|||
161619579|NCT02309892|583658637|FG000|Overall Study|Adverse Event|1|||
161619580|NCT02309892|583658638|FG001|Overall Study|Adverse Event|0|||
161619581|NCT02309892|583658639|FG002|Overall Study|Adverse Event|1|||
161619582|NCT02309892|583658640|FG003|Overall Study|Adverse Event|0|||
161832832|NCT01557842|584429639|FG001|Overall Study|Study Terminated by Sponsor|4|||
161619583|NCT02309892|583658641|FG004|Overall Study|Adverse Event|0|||
161619584|NCT02309892|583658642|FG005|Overall Study|Adverse Event|0|||
161619585|NCT02309892|583658643|FG006|Overall Study|Adverse Event|0|||
161832833|NCT01557842|584429638|FG000|Overall Study|Not Ablated|2|||
161832834|NCT01557842|584429639|FG001|Overall Study|Not Ablated|0|||
161619586|NCT02309892|583658637|FG000|Overall Study|Progressive Disease|0|||
161619587|NCT02309892|583658638|FG001|Overall Study|Progressive Disease|1|||
161619588|NCT02309892|583658639|FG002|Overall Study|Progressive Disease|0|||
161619589|NCT02309892|583658640|FG003|Overall Study|Progressive Disease|0|||
161619590|NCT02309892|583658641|FG004|Overall Study|Progressive Disease|1|||
161619591|NCT02309892|583658642|FG005|Overall Study|Progressive Disease|0|||
161619592|NCT02309892|583658643|FG006|Overall Study|Progressive Disease|0|||
161619593|NCT02309892|583658637|FG000|Overall Study|Death|0|||
161832835|NCT05611996|584429640|FG000|Overall Study|Ineligible|1|||
161619594|NCT02309892|583658638|FG001|Overall Study|Death|0|||
161619595|NCT02309892|583658639|FG002|Overall Study|Death|0|||
161619596|NCT02309892|583658640|FG003|Overall Study|Death|0|||
161619597|NCT02309892|583658641|FG004|Overall Study|Death|0|||
161619598|NCT02309892|583658642|FG005|Overall Study|Death|1|||
161619599|NCT02309892|583658643|FG006|Overall Study|Death|0|||
161619600|NCT02721147|583658646|FG000|Overall Study|Lost to Follow-up|2|||
161619601|NCT02721147|583658647|FG001|Overall Study|Lost to Follow-up|0|||
161619602|NCT02721147|583658648|FG002|Overall Study|Lost to Follow-up|0|||
161619603|NCT05376397|583658649|FG000|Overall Study|Lost to Follow-up|1|||
161619604|NCT01722097|583658650|FG000|Overall Study|Patient sheets not returned|6|||
161619605|NCT01722097|583658651|FG001|Overall Study|Patient sheets not returned|5|||
161619606|NCT01535261|583658655|FG000|Overall Study|Physician Decision|8|||
161619607|NCT01535261|583658655|FG000|Overall Study|Protocol Violation|3|||
161619608|NCT01535261|583658655|FG000|Overall Study|Death|5|||
161619609|NCT01535261|583658655|FG000|Overall Study|Lost to Follow-up|8|||
161619610|NCT01535261|583658655|FG000|Overall Study|Withdrawal by Subject|14|||
161619611|NCT01535261|583658655|FG000|Overall Study|Adverse Event|12|||
161619612|NCT01137682|583658658|FG000|Overall Study|Adverse Event-CORE|2|||
161619613|NCT01137682|583658659|FG001|Overall Study|Adverse Event-CORE|4|||
161619614|NCT01137682|583658660|FG002|Overall Study|Adverse Event-CORE|0|||
161619615|NCT01137682|583658658|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
161619616|NCT01137682|583658659|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
161619617|NCT01137682|583658660|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
161619618|NCT01137682|583658658|FG000|Overall Study|Administrative problems-CORE|2|||
161619619|NCT01137682|583658659|FG001|Overall Study|Administrative problems-CORE|1|||
161619620|NCT01137682|583658660|FG002|Overall Study|Administrative problems-CORE|0|||
161619621|NCT01137682|583658658|FG000|Overall Study|Protocol Violation-CORE|0|||
161619622|NCT01137682|583658659|FG001|Overall Study|Protocol Violation-CORE|1|||
161619623|NCT01137682|583658660|FG002|Overall Study|Protocol Violation-CORE|1|||
161619624|NCT01137682|583658658|FG000|Overall Study|Adverse Event-Extension|4|||
161619625|NCT01137682|583658659|FG001|Overall Study|Adverse Event-Extension|8|||
161619626|NCT01137682|583658660|FG002|Overall Study|Adverse Event-Extension|7|||
161619627|NCT01137682|583658658|FG000|Overall Study|Lack of Efficacy-Extension|15|||
161619628|NCT01137682|583658659|FG001|Overall Study|Lack of Efficacy-Extension|9|||
161619629|NCT01137682|583658660|FG002|Overall Study|Lack of Efficacy-Extension|13|||
161619630|NCT01137682|583658658|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
161619631|NCT01137682|583658659|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
161619632|NCT01137682|583658660|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
161619633|NCT01137682|583658658|FG000|Overall Study|Lost to Follow Up-Extension|0|||
161619634|NCT01137682|583658659|FG001|Overall Study|Lost to Follow Up-Extension|1|||
161619635|NCT01137682|583658660|FG002|Overall Study|Lost to Follow Up-Extension|0|||
161619636|NCT01137682|583658658|FG000|Overall Study|Administrative problems-Extension|0|||
161619637|NCT01137682|583658659|FG001|Overall Study|Administrative problems-Extension|2|||
161619638|NCT01137682|583658660|FG002|Overall Study|Administrative problems-Extension|0|||
161619639|NCT01137682|583658658|FG000|Overall Study|Death-Extension|2|||
161619640|NCT01137682|583658659|FG001|Overall Study|Death-Extension|0|||
161619641|NCT01137682|583658660|FG002|Overall Study|Death-Extension|0|||
161619642|NCT01137682|583658658|FG000|Overall Study|Protocol Violation-Extension|2|||
161619643|NCT01137682|583658659|FG001|Overall Study|Protocol Violation-Extension|1|||
161619644|NCT01137682|583658660|FG002|Overall Study|Protocol Violation-Extension|0|||
161619645|NCT01137682|583658658|FG000|Overall Study|Did not enter extension|2|||
161619646|NCT01137682|583658659|FG001|Overall Study|Did not enter extension|3|||
161619647|NCT01137682|583658660|FG002|Overall Study|Did not enter extension|2|||
161619648|NCT01137682|583658658|FG000|Overall Study|Did not receive treatment in extension|0|||
161619649|NCT01137682|583658659|FG001|Overall Study|Did not receive treatment in extension|0|||
161619650|NCT01137682|583658660|FG002|Overall Study|Did not receive treatment in extension|1|||
161619651|NCT02009332|583658661|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161619652|NCT02009332|583658662|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
161619653|NCT02009332|583658663|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161619654|NCT02009332|583658664|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161619655|NCT02009332|583658665|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161619656|NCT02009332|583658666|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161619657|NCT02009332|583658661|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161619658|NCT02009332|583658662|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161619659|NCT02009332|583658663|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161619660|NCT02009332|583658664|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161619661|NCT02009332|583658665|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
161619662|NCT02009332|583658666|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161619663|NCT02009332|583658661|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161619664|NCT02009332|583658662|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161619665|NCT02009332|583658663|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161619666|NCT02009332|583658664|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161619667|NCT02009332|583658665|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161684744|NCT00942175|583897994|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
161684745|NCT00942175|583897995|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
161684746|NCT00942175|583897992|FG000|Overall Study|Low Platelet Count|0|||
161684747|NCT00942175|583897993|FG001|Overall Study|Low Platelet Count|2|||
161684748|NCT00942175|583897994|FG002|Overall Study|Low Platelet Count|0|||
161684749|NCT00942175|583897995|FG003|Overall Study|Low Platelet Count|0|||
161684750|NCT01066585|583897996|FG000|Overall Study|Protocol Violation|1|||
161684751|NCT01066585|583897997|FG001|Overall Study|Protocol Violation|0|||
161619668|NCT02009332|583658666|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
161619669|NCT01912599|583658667|FG000|Overall Study|Withdrawal by Subject|0|||
161619670|NCT01912599|583658668|FG001|Overall Study|Withdrawal by Subject|1|||
161619671|NCT01757288|583658670|FG000|Overall Study|Consent withdrawal|0|||
161619672|NCT01757288|583658671|FG001|Overall Study|Consent withdrawal|4|||
161619673|NCT01757288|583658672|FG002|Overall Study|Consent withdrawal|4|||
161619674|NCT01757288|583658670|FG000|Overall Study|Patient off study, IRB hold.|0|||
161619675|NCT01757288|583658671|FG001|Overall Study|Patient off study, IRB hold.|0|||
161619676|NCT01757288|583658672|FG002|Overall Study|Patient off study, IRB hold.|1|||
161619677|NCT01757288|583658670|FG000|Overall Study|Patient death prior to starting treatment|0|||
161619678|NCT01757288|583658671|FG001|Overall Study|Patient death prior to starting treatment|0|||
161619679|NCT01757288|583658672|FG002|Overall Study|Patient death prior to starting treatment|1|||
161619680|NCT01757288|583658670|FG000|Overall Study|Wrong medication administered|0|||
161619681|NCT01757288|583658671|FG001|Overall Study|Wrong medication administered|1|||
161619682|NCT01757288|583658672|FG002|Overall Study|Wrong medication administered|0|||
161619683|NCT01757288|583658670|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
161619684|NCT01757288|583658671|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
161619685|NCT01757288|583658672|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
161619686|NCT01757288|583658670|FG000|Overall Study|Not meeting protocol constraints|0|||
161619687|NCT01757288|583658671|FG001|Overall Study|Not meeting protocol constraints|1|||
161619688|NCT01757288|583658672|FG002|Overall Study|Not meeting protocol constraints|1|||
161619689|NCT01757288|583658670|FG000|Overall Study|Multiple missed appointments|0|||
161619690|NCT01757288|583658671|FG001|Overall Study|Multiple missed appointments|1|||
161619691|NCT01757288|583658672|FG002|Overall Study|Multiple missed appointments|0|||
161619692|NCT01757288|583658670|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
161619693|NCT01757288|583658671|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
161619694|NCT01757288|583658672|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
161619695|NCT01757288|583658670|FG000|Overall Study|>2 weeks treatment break|0|||
161619696|NCT01757288|583658671|FG001|Overall Study|>2 weeks treatment break|0|||
161619697|NCT01757288|583658672|FG002|Overall Study|>2 weeks treatment break|1|||
161619698|NCT02825550|583658674|FG000|Overall Study|Physician Decision|1|||
161619699|NCT03386344|583658675|FG000|Overall Study|Adverse Event|6|||
161619700|NCT03386344|583658676|FG001|Overall Study|Adverse Event|3|||
161619701|NCT03386344|583658677|FG002|Overall Study|Adverse Event|1|||
161619702|NCT03386344|583658675|FG000|Overall Study|Poor Compliance to Protocol|0|||
161619703|NCT03386344|583658676|FG001|Overall Study|Poor Compliance to Protocol|1|||
161619704|NCT03386344|583658677|FG002|Overall Study|Poor Compliance to Protocol|0|||
161619705|NCT03386344|583658675|FG000|Overall Study|Study Terminated by Sponsor|101|||
161619706|NCT03386344|583658676|FG001|Overall Study|Study Terminated by Sponsor|102|||
161619707|NCT03386344|583658677|FG002|Overall Study|Study Terminated by Sponsor|106|||
161619708|NCT03386344|583658675|FG000|Overall Study|Lost to Follow-up|3|||
161619709|NCT03386344|583658676|FG001|Overall Study|Lost to Follow-up|2|||
161619710|NCT03386344|583658677|FG002|Overall Study|Lost to Follow-up|1|||
161619711|NCT03386344|583658675|FG000|Overall Study|At the Participant's own Request|7|||
161619712|NCT03386344|583658676|FG001|Overall Study|At the Participant's own Request|7|||
161619713|NCT03386344|583658677|FG002|Overall Study|At the Participant's own Request|8|||
161619714|NCT03386344|583658675|FG000|Overall Study|Reason not Specified|0|||
161619715|NCT03386344|583658676|FG001|Overall Study|Reason not Specified|1|||
161619716|NCT03386344|583658677|FG002|Overall Study|Reason not Specified|0|||
161619717|NCT01077284|583658678|FG000|Overall Study|Adverse Event|2|||
161619718|NCT01077284|583658679|FG001|Overall Study|Adverse Event|0|||
161619719|NCT01077284|583658680|FG002|Overall Study|Adverse Event|1|||
161619720|NCT01077284|583658678|FG000|Overall Study|Lost to Follow-up|1|||
161619721|NCT01077284|583658679|FG001|Overall Study|Lost to Follow-up|2|||
161619722|NCT01077284|583658680|FG002|Overall Study|Lost to Follow-up|0|||
161684752|NCT01066585|583897996|FG000|Overall Study|Withdrawal by Subject|0|||
161684753|NCT01066585|583897997|FG001|Overall Study|Withdrawal by Subject|3|||
161684754|NCT00886600|583897999|FG000|Double-blind Monotherapy|Adverse Event|1|||
161684755|NCT00886600|583898000|FG001|Double-blind Monotherapy|Adverse Event|1|||
161619723|NCT01077284|583658678|FG000|Overall Study|Withdrawal by Subject|2|||
161619724|NCT01077284|583658679|FG001|Overall Study|Withdrawal by Subject|3|||
161619725|NCT01077284|583658680|FG002|Overall Study|Withdrawal by Subject|1|||
161619726|NCT01077284|583658678|FG000|Overall Study|Other|0|||
161619727|NCT01077284|583658679|FG001|Overall Study|Other|0|||
161684756|NCT00886600|583898001|FG002|Double-blind Monotherapy|Adverse Event|1|||
161684757|NCT00886600|583898002|FG003|Double-blind Monotherapy|Adverse Event|1|||
161619728|NCT01077284|583658680|FG002|Overall Study|Other|1|||
161619729|NCT01280721|583658684|FG000|Overall Study|Adverse Event|4|||
161619730|NCT01280721|583658684|FG000|Overall Study|Physician Decision|3|||
161619731|NCT01280721|583658684|FG000|Overall Study|Withdrawal by Subject|6|||
161619732|NCT01280721|583658684|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
161619733|NCT01280721|583658684|FG000|Overall Study|No tolerability for the lowest dose|2|||
161619734|NCT01180400|583658685|FG000|Overall Study|Withdrawal by Subject|5|||
161619735|NCT01180400|583658686|FG001|Overall Study|Withdrawal by Subject|6|||
161619736|NCT01180400|583658685|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161619737|NCT01180400|583658686|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161619738|NCT01180400|583658685|FG000|Overall Study|Adverse Event|12|||
161619739|NCT01180400|583658686|FG001|Overall Study|Adverse Event|10|||
161619740|NCT01180400|583658685|FG000|Overall Study|Severe non-compliance to protocol|1|||
161619741|NCT01180400|583658686|FG001|Overall Study|Severe non-compliance to protocol|2|||
161619742|NCT01180400|583658685|FG000|Overall Study|Condition under investigation worsened|2|||
161619743|NCT01180400|583658686|FG001|Overall Study|Condition under investigation worsened|1|||
161619744|NCT01180400|583658685|FG000|Overall Study|Lack of Efficacy|2|||
161619745|NCT01180400|583658686|FG001|Overall Study|Lack of Efficacy|0|||
161619746|NCT01180400|583658685|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161619747|NCT01180400|583658686|FG001|Overall Study|Study-specific withdrawal criteria|2|||
161619748|NCT01180400|583658685|FG000|Overall Study|Lost to Follow-up|2|||
161619749|NCT01180400|583658686|FG001|Overall Study|Lost to Follow-up|3|||
161619750|NCT01180400|583658685|FG000|Overall Study|Other|0|||
161619751|NCT01180400|583658686|FG001|Overall Study|Other|1|||
161619752|NCT00042939|583658688|FG000|Overall Study|Adverse Event|6|||
161619753|NCT00042939|583658689|FG001|Overall Study|Adverse Event|7|||
161619754|NCT00042939|583658688|FG000|Overall Study|Death|3|||
161619755|NCT00042939|583658689|FG001|Overall Study|Death|2|||
161619756|NCT00042939|583658688|FG000|Overall Study|Withdrawal by Subject|3|||
161619757|NCT00042939|583658689|FG001|Overall Study|Withdrawal by Subject|4|||
161619758|NCT00042939|583658688|FG000|Overall Study|Other disease|1|||
161619759|NCT00042939|583658689|FG001|Overall Study|Other disease|0|||
161619760|NCT00042939|583658688|FG000|Overall Study|Ineligible|2|||
161619761|NCT00042939|583658689|FG001|Overall Study|Ineligible|2|||
161619762|NCT00042939|583658688|FG000|Overall Study|Deterioration of health|3|||
161619763|NCT00042939|583658689|FG001|Overall Study|Deterioration of health|4|||
161619764|NCT00042939|583658688|FG000|Overall Study|QOL diminished|1|||
161619765|NCT00042939|583658689|FG001|Overall Study|QOL diminished|0|||
161619766|NCT00042939|583658688|FG000|Overall Study|Rising ca 19-9|1|||
161619767|NCT00042939|583658689|FG001|Overall Study|Rising ca 19-9|0|||
161619768|NCT00042939|583658688|FG000|Overall Study|Patient non-compliance|1|||
161619769|NCT00042939|583658689|FG001|Overall Study|Patient non-compliance|0|||
161619770|NCT00042939|583658688|FG000|Overall Study|Still on treatment|1|||
161619771|NCT00042939|583658689|FG001|Overall Study|Still on treatment|0|||
161619772|NCT00042939|583658688|FG000|Overall Study|Treatment break > 4 weeks|0|||
161619773|NCT00042939|583658689|FG001|Overall Study|Treatment break > 4 weeks|1|||
161619774|NCT00042939|583658688|FG000|Overall Study|Did not start treatment|2|||
161619775|NCT00042939|583658689|FG001|Overall Study|Did not start treatment|1|||
161619776|NCT00795639|583658690|FG000|Overall Study|Death|1|||
161619777|NCT00795639|583658691|FG001|Overall Study|Death|6|||
161619778|NCT00795639|583658690|FG000|Overall Study|Withdrawal by Subject|1|||
161619779|NCT00795639|583658691|FG001|Overall Study|Withdrawal by Subject|3|||
161619780|NCT00795639|583658690|FG000|Overall Study|Pregnancy|1|||
161619781|NCT00795639|583658691|FG001|Overall Study|Pregnancy|0|||
161619782|NCT00795639|583658690|FG000|Overall Study|Adverse Event|5|||
161619783|NCT00795639|583658691|FG001|Overall Study|Adverse Event|2|||
161619784|NCT00795639|583658690|FG000|Overall Study|Other|0|||
161619785|NCT00795639|583658691|FG001|Overall Study|Other|2|||
161619786|NCT00795639|583658690|FG000|Overall Study|Terminated by sponsor|13|||
161619787|NCT00795639|583658691|FG001|Overall Study|Terminated by sponsor|12|||
161619788|NCT00795639|583658690|FG000|Overall Study|Randomized and not treated|0|||
161619789|NCT00795639|583658691|FG001|Overall Study|Randomized and not treated|1|||
161619790|NCT03349476|583658692|FG000|Overall Study|Physician Decision|3|||
161619791|NCT04626128|583658693|FG000|Overall Study|Withdrawal by Subject|0|||
161619792|NCT04626128|583658694|FG001|Overall Study|Withdrawal by Subject|1|||
161619793|NCT04626128|583658695|FG002|Overall Study|Withdrawal by Subject|0|||
161619794|NCT04626128|583658696|FG003|Overall Study|Withdrawal by Subject|0|||
161619795|NCT03449979|583658699|FG000|Overall Study|Technical difficulty|0|||
161619796|NCT03449979|583658700|FG001|Overall Study|Technical difficulty|0|||
161619797|NCT03449979|583658701|FG002|Overall Study|Technical difficulty|0|||
161619798|NCT03449979|583658702|FG003|Overall Study|Technical difficulty|1|||
161619799|NCT01762345|583658703|FG000|Overall Study|Adverse Event|5|||
161619800|NCT01762345|583658703|FG000|Overall Study|Protocol Violation|2|||
161619801|NCT02379078|583658704|FG000|Overall Study|Lost to Follow-up|33|||
161619802|NCT02379078|583658705|FG001|Overall Study|Lost to Follow-up|30|||
161619803|NCT02379078|583658704|FG000|Overall Study|Withdrawal by Subject|6|||
161619804|NCT02379078|583658705|FG001|Overall Study|Withdrawal by Subject|5|||
161619805|NCT03481725|583658706|FG000|Overall Study|Withdrawal by Subject|1|||
161619806|NCT03481725|583658707|FG001|Overall Study|Withdrawal by Subject|0|||
161619807|NCT03444155|583658710|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
161619808|NCT03444155|583658711|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
161619809|NCT02877680|583658712|FG000|Overall Study|Lost to Follow-up|1|||
161619810|NCT02877680|583658713|FG001|Overall Study|Lost to Follow-up|1|||
161619811|NCT01133678|583658714|FG000|Overall Study|Death|1|||
161619812|NCT01133678|583658715|FG001|Overall Study|Death|1|||
161619813|NCT01864200|583658722|FG000|Overall Study|Lost to Follow-up|1|||
161619814|NCT01864200|583658723|FG001|Overall Study|Lost to Follow-up|3|||
161619815|NCT01864200|583658722|FG000|Overall Study|Protocol Violation|1|||
161619816|NCT01864200|583658723|FG001|Overall Study|Protocol Violation|0|||
161619817|NCT01419184|583658730|FG000|Overall Study|Site data not available|3|||
161619818|NCT01419184|583658731|FG001|Overall Study|Site data not available|2|||
161619819|NCT01419184|583658730|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
161619820|NCT01419184|583658731|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
161619821|NCT01419184|583658730|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
161619822|NCT01419184|583658731|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
161619823|NCT01419184|583658730|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
161619824|NCT01419184|583658731|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
161619825|NCT01419184|583658730|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
161619826|NCT01419184|583658731|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
161619827|NCT01419184|583658730|FG000|Overall Study|Participant randomized, not treated|1|||
161619828|NCT01419184|583658731|FG001|Overall Study|Participant randomized, not treated|0|||
161619829|NCT02170207|583658734|FG000|Overall Study|Case report forms unavailable|5|||
161619830|NCT00657709|583658735|FG000|Overall Study|AE or Death|7|||
161619831|NCT00657709|583658736|FG001|Overall Study|AE or Death|7|||
161619832|NCT00657709|583658737|FG002|Overall Study|AE or Death|6|||
161619833|NCT00657709|583658738|FG003|Overall Study|AE or Death|7|||
161619834|NCT00657709|583658739|FG004|Overall Study|AE or Death|1|||
161619835|NCT00657709|583658735|FG000|Overall Study|Withdrawal by Subject|7|||
161619836|NCT00657709|583658736|FG001|Overall Study|Withdrawal by Subject|15|||
161619837|NCT00657709|583658737|FG002|Overall Study|Withdrawal by Subject|15|||
161619838|NCT00657709|583658738|FG003|Overall Study|Withdrawal by Subject|5|||
161619839|NCT00657709|583658739|FG004|Overall Study|Withdrawal by Subject|9|||
161619840|NCT00657709|583658735|FG000|Overall Study|Lost to Follow-up|9|||
161619841|NCT00657709|583658736|FG001|Overall Study|Lost to Follow-up|9|||
161619842|NCT00657709|583658737|FG002|Overall Study|Lost to Follow-up|7|||
161619843|NCT00657709|583658738|FG003|Overall Study|Lost to Follow-up|1|||
161619844|NCT00657709|583658739|FG004|Overall Study|Lost to Follow-up|21|||
161619845|NCT00657709|583658735|FG000|Overall Study|Protocol Violation|0|||
161619846|NCT00657709|583658736|FG001|Overall Study|Protocol Violation|2|||
161619847|NCT00657709|583658737|FG002|Overall Study|Protocol Violation|0|||
161619848|NCT00657709|583658738|FG003|Overall Study|Protocol Violation|1|||
161619849|NCT00657709|583658739|FG004|Overall Study|Protocol Violation|2|||
161619850|NCT03122860|583658740|FG000|Overall Study|Discontinued Before Treatment|1|||
161619851|NCT03122860|583658741|FG001|Overall Study|Discontinued Before Treatment|1|||
161619852|NCT03122860|583658742|FG002|Overall Study|Discontinued Before Treatment|2|||
161619853|NCT03122860|583658743|FG003|Overall Study|Discontinued Before Treatment|0|||
161619854|NCT03122860|583658744|FG004|Overall Study|Discontinued Before Treatment|1|||
161619855|NCT03122860|583658745|FG005|Overall Study|Discontinued Before Treatment|0|||
161619856|NCT03122860|583658740|FG000|Overall Study|Adverse Event|1|||
161619857|NCT03122860|583658741|FG001|Overall Study|Adverse Event|0|||
161619858|NCT03122860|583658742|FG002|Overall Study|Adverse Event|1|||
161619859|NCT03122860|583658743|FG003|Overall Study|Adverse Event|1|||
161619860|NCT03122860|583658744|FG004|Overall Study|Adverse Event|0|||
161619861|NCT03122860|583658745|FG005|Overall Study|Adverse Event|0|||
161619862|NCT03122860|583658740|FG000|Overall Study|Lost to Follow-up|5|||
161619863|NCT03122860|583658741|FG001|Overall Study|Lost to Follow-up|2|||
161619864|NCT03122860|583658742|FG002|Overall Study|Lost to Follow-up|3|||
161619865|NCT03122860|583658743|FG003|Overall Study|Lost to Follow-up|3|||
161619866|NCT03122860|583658744|FG004|Overall Study|Lost to Follow-up|5|||
161619867|NCT03122860|583658745|FG005|Overall Study|Lost to Follow-up|4|||
161619868|NCT03122860|583658740|FG000|Overall Study|Subject Non-Compliance|0|||
161619869|NCT03122860|583658741|FG001|Overall Study|Subject Non-Compliance|0|||
161619870|NCT03122860|583658742|FG002|Overall Study|Subject Non-Compliance|1|||
161619871|NCT03122860|583658743|FG003|Overall Study|Subject Non-Compliance|0|||
161619872|NCT03122860|583658744|FG004|Overall Study|Subject Non-Compliance|0|||
161619873|NCT03122860|583658745|FG005|Overall Study|Subject Non-Compliance|0|||
161619874|NCT03122860|583658740|FG000|Overall Study|Withdrawal by Subject|3|||
161619875|NCT03122860|583658741|FG001|Overall Study|Withdrawal by Subject|2|||
161619876|NCT03122860|583658742|FG002|Overall Study|Withdrawal by Subject|5|||
161619877|NCT03122860|583658743|FG003|Overall Study|Withdrawal by Subject|7|||
161619878|NCT03122860|583658744|FG004|Overall Study|Withdrawal by Subject|9|||
161619879|NCT03122860|583658745|FG005|Overall Study|Withdrawal by Subject|8|||
161619880|NCT01138657|583658746|FG000|Overall Study|Adverse Event|3|||
161619881|NCT01138657|583658747|FG001|Overall Study|Adverse Event|10|||
161619882|NCT01138657|583658746|FG000|Overall Study|Lack of Efficacy|2|||
161619883|NCT01138657|583658747|FG001|Overall Study|Lack of Efficacy|1|||
161619884|NCT01138657|583658746|FG000|Overall Study|Lost to Follow-up|0|||
161619885|NCT01138657|583658747|FG001|Overall Study|Lost to Follow-up|3|||
161619886|NCT01138657|583658746|FG000|Overall Study|Miscellaneous Reasons|3|||
161619887|NCT01138657|583658747|FG001|Overall Study|Miscellaneous Reasons|4|||
161619888|NCT02574286|583658748|FG000|Overall Study|Adverse Event|3|||
161619889|NCT02574286|583658748|FG000|Overall Study|Withdrawal by Subject|2|||
161619890|NCT03055988|583658751|FG000|Period 1|Adverse Event|0|||
161619891|NCT03055988|583658752|FG001|Period 1|Adverse Event|1|||
161619892|NCT03055988|583658751|FG000|Period 1|Lost to Follow-up|1|||
161619893|NCT03055988|583658752|FG001|Period 1|Lost to Follow-up|0|||
161619894|NCT03055988|583658751|FG000|Period 1|Withdrawal by Subject|0|||
161619895|NCT03055988|583658752|FG001|Period 1|Withdrawal by Subject|4|||
161619896|NCT03055988|583658751|FG000|Period 2|Adverse Event|0|||
161619897|NCT03055988|583658752|FG001|Period 2|Adverse Event|1|||
161619898|NCT03055988|583658751|FG000|Period 2|Other than listed|1|||
161619899|NCT03055988|583658752|FG001|Period 2|Other than listed|1|||
161619900|NCT01681511|583658753|FG000|Overall Study|No Treatment Received|1|||
161619901|NCT01681511|583658754|FG001|Overall Study|No Treatment Received|3|||
161619902|NCT01681511|583658753|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
161619903|NCT01681511|583658754|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
161619904|NCT01681511|583658753|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
161619905|NCT01681511|583658754|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
161619906|NCT01681511|583658753|FG000|Overall Study|No Daily Urine Sample Collected|0|||
161619907|NCT01681511|583658754|FG001|Overall Study|No Daily Urine Sample Collected|1|||
161619908|NCT01681511|583658753|FG000|Overall Study|No post-catheter sample collected|11|||
161619909|NCT01681511|583658754|FG001|Overall Study|No post-catheter sample collected|4|||
161619910|NCT01156675|583658755|FG000|Overall Study|Death|5|||
161619911|NCT01156675|583658756|FG001|Overall Study|Death|3|||
161619912|NCT01156675|583658757|FG002|Overall Study|Death|0|||
161619913|NCT01156675|583658755|FG000|Overall Study|No data|29|||
161619914|NCT01156675|583658756|FG001|Overall Study|No data|22|||
161619915|NCT01156675|583658757|FG002|Overall Study|No data|2|||
161619916|NCT02161146|583658771|FG000|Overall Study|Adverse Event|1|||
161619917|NCT02161146|583658772|FG001|Overall Study|Adverse Event|1|||
161619918|NCT02161146|583658773|FG002|Overall Study|Adverse Event|0|||
161619919|NCT02161146|583658774|FG003|Overall Study|Adverse Event|1|||
161619920|NCT02161146|583658775|FG004|Overall Study|Adverse Event|0|||
161619921|NCT02161146|583658771|FG000|Overall Study|Lost to Follow-up|0|||
161619922|NCT02161146|583658772|FG001|Overall Study|Lost to Follow-up|1|||
161619923|NCT02161146|583658773|FG002|Overall Study|Lost to Follow-up|0|||
161619924|NCT02161146|583658774|FG003|Overall Study|Lost to Follow-up|0|||
161619925|NCT02161146|583658775|FG004|Overall Study|Lost to Follow-up|0|||
161619926|NCT02161146|583658771|FG000|Overall Study|Personal Reasons|0|||
161619927|NCT02161146|583658772|FG001|Overall Study|Personal Reasons|1|||
161619928|NCT02161146|583658773|FG002|Overall Study|Personal Reasons|0|||
161619929|NCT02161146|583658774|FG003|Overall Study|Personal Reasons|2|||
161619930|NCT02161146|583658775|FG004|Overall Study|Personal Reasons|1|||
161619931|NCT02161146|583658771|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161619932|NCT02161146|583658772|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161619933|NCT02161146|583658773|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161619934|NCT02161146|583658774|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161619935|NCT02161146|583658775|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161619936|NCT00845520|583658776|FG000|Overall Study|Death|1|||
161619937|NCT00845520|583658777|FG001|Overall Study|Death|2|||
161619938|NCT00845520|583658778|FG002|Overall Study|Death|0|||
161619939|NCT00845520|583658776|FG000|Overall Study|Lost to Follow-up|1|||
161619940|NCT00845520|583658777|FG001|Overall Study|Lost to Follow-up|0|||
161619941|NCT00845520|583658778|FG002|Overall Study|Lost to Follow-up|0|||
161619942|NCT00845520|583658776|FG000|Overall Study|Adverse Event|0|||
161619943|NCT00845520|583658777|FG001|Overall Study|Adverse Event|0|||
161363811|NCT00392288|582720029|FG001|Overall Study|Other|4|||
161619944|NCT00845520|583658778|FG002|Overall Study|Adverse Event|1|||
161619945|NCT02613403|583658779|FG000|Overall Study|Lost to Follow-up|0|||
161619946|NCT02613403|583658780|FG001|Overall Study|Lost to Follow-up|1|||
161619947|NCT02613403|583658781|FG002|Overall Study|Lost to Follow-up|0|||
161619948|NCT02613403|583658782|FG003|Overall Study|Lost to Follow-up|0|||
161619949|NCT02613403|583658783|FG004|Overall Study|Lost to Follow-up|0|||
161619950|NCT02613403|583658779|FG000|Overall Study|Withdrawal by Subject|2|||
161619951|NCT02613403|583658780|FG001|Overall Study|Withdrawal by Subject|0|||
161619952|NCT02613403|583658781|FG002|Overall Study|Withdrawal by Subject|0|||
161619953|NCT02613403|583658782|FG003|Overall Study|Withdrawal by Subject|0|||
161619954|NCT02613403|583658783|FG004|Overall Study|Withdrawal by Subject|0|||
161619955|NCT00800176|583658784|FG000|Overall Study|Adverse Event|2|||
161619956|NCT00800176|583658785|FG001|Overall Study|Adverse Event|1|||
161619957|NCT00800176|583658786|FG002|Overall Study|Adverse Event|0|||
161619958|NCT00800176|583658787|FG003|Overall Study|Adverse Event|2|||
161619959|NCT00800176|583658788|FG004|Overall Study|Adverse Event|1|||
161619960|NCT00800176|583658789|FG005|Overall Study|Adverse Event|1|||
161619961|NCT00800176|583658784|FG000|Overall Study|Refused treatment|3|||
161619962|NCT00800176|583658785|FG001|Overall Study|Refused treatment|2|||
161619963|NCT00800176|583658786|FG002|Overall Study|Refused treatment|0|||
161619964|NCT00800176|583658787|FG003|Overall Study|Refused treatment|0|||
161619965|NCT00800176|583658788|FG004|Overall Study|Refused treatment|1|||
161619966|NCT00800176|583658789|FG005|Overall Study|Refused treatment|4|||
161619967|NCT00800176|583658784|FG000|Overall Study|Failure to return|3|||
161619968|NCT00800176|583658785|FG001|Overall Study|Failure to return|3|||
161619969|NCT00800176|583658786|FG002|Overall Study|Failure to return|0|||
161619970|NCT00800176|583658787|FG003|Overall Study|Failure to return|2|||
161619971|NCT00800176|583658788|FG004|Overall Study|Failure to return|0|||
161619972|NCT00800176|583658789|FG005|Overall Study|Failure to return|0|||
161619973|NCT00800176|583658784|FG000|Overall Study|Other|1|||
161619974|NCT00800176|583658785|FG001|Overall Study|Other|0|||
161619975|NCT00800176|583658786|FG002|Overall Study|Other|0|||
161619976|NCT00800176|583658787|FG003|Overall Study|Other|0|||
161619977|NCT00800176|583658788|FG004|Overall Study|Other|2|||
161619978|NCT00800176|583658789|FG005|Overall Study|Other|0|||
161619979|NCT02326220|583658792|FG000|Double-blind Treatment Period|Adverse Event|1|||
161619980|NCT02326220|583658793|FG001|Double-blind Treatment Period|Adverse Event|2|||
161619981|NCT02326220|583658794|FG002|Double-blind Treatment Period|Adverse Event|0|||
161619982|NCT02326220|583658792|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161619983|NCT02326220|583658793|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161619984|NCT02326220|583658794|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161619985|NCT02326220|583658792|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161619986|NCT02326220|583658793|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161619987|NCT02326220|583658794|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161619988|NCT02326220|583658792|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161619989|NCT02326220|583658793|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161619990|NCT02326220|583658794|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
161619991|NCT02326220|583658792|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161619992|NCT02326220|583658793|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161619993|NCT02326220|583658794|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
161619994|NCT02699099|583658795|FG000|Overall Study|Adverse Event|1|||
161619995|NCT02699099|583658796|FG001|Overall Study|Adverse Event|0|||
161619996|NCT02699099|583658797|FG002|Overall Study|Adverse Event|2|||
161619997|NCT02699099|583658795|FG000|Overall Study|Lost to Follow-up|0|||
161619998|NCT02699099|583658796|FG001|Overall Study|Lost to Follow-up|1|||
161619999|NCT02699099|583658797|FG002|Overall Study|Lost to Follow-up|0|||
161620000|NCT02699099|583658795|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
161620001|NCT02699099|583658796|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161620002|NCT02699099|583658797|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
161620003|NCT04820491|583658802|FG000|Overall Study|Withdrawal by Subject|1|||
161620004|NCT04820491|583658803|FG001|Overall Study|Withdrawal by Subject|0|||
161620005|NCT00452452|583658804|FG000|Overall Study|Protocol Violation|0|||
161620006|NCT00452452|583658805|FG001|Overall Study|Protocol Violation|0|||
161620007|NCT00452452|583658806|FG002|Overall Study|Protocol Violation|1|||
161620008|NCT00452452|583658804|FG000|Overall Study|Withdrawal by Subject|1|||
161620009|NCT00452452|583658805|FG001|Overall Study|Withdrawal by Subject|0|||
161620010|NCT00452452|583658806|FG002|Overall Study|Withdrawal by Subject|0|||
161620011|NCT00452452|583658804|FG000|Overall Study|Lost to Follow-up|1|||
161620012|NCT00452452|583658805|FG001|Overall Study|Lost to Follow-up|0|||
161620013|NCT00452452|583658806|FG002|Overall Study|Lost to Follow-up|0|||
161620014|NCT03020914|583660462|FG000|Overall Study|Surgery Cancelled|1|||
161620015|NCT03020914|583660463|FG001|Overall Study|Surgery Cancelled|0|||
161620016|NCT04620733|583660464|FG000|Overall Study|Adverse Event|4|||
161620017|NCT04620733|583660465|FG001|Overall Study|Adverse Event|3|||
161620018|NCT04620733|583660464|FG000|Overall Study|Withdrawal by Subject|2|||
161620019|NCT04620733|583660465|FG001|Overall Study|Withdrawal by Subject|5|||
161620020|NCT04620733|583660464|FG000|Overall Study|Lost to Follow-up|1|||
161620021|NCT04620733|583660465|FG001|Overall Study|Lost to Follow-up|1|||
161620022|NCT04620733|583660464|FG000|Overall Study|Protocol Deviation|1|||
161620023|NCT04620733|583660465|FG001|Overall Study|Protocol Deviation|1|||
161620024|NCT04620733|583660464|FG000|Overall Study|Reason Not Specified|0|||
161620025|NCT04620733|583660465|FG001|Overall Study|Reason Not Specified|1|||
161620026|NCT03976102|583660469|FG000|Overall Study|Withdrawal by Subject|4|||
161620027|NCT03976102|583660470|FG001|Overall Study|Withdrawal by Subject|4|||
161620028|NCT03976102|583660469|FG000|Overall Study|Adverse Event|2|||
161620029|NCT03976102|583660470|FG001|Overall Study|Adverse Event|4|||
161620030|NCT03976102|583660469|FG000|Overall Study|Not related to Covid-19|9|||
161620031|NCT03976102|583660470|FG001|Overall Study|Not related to Covid-19|13|||
161620032|NCT03976102|583660469|FG000|Overall Study|Lost to Follow-up|0|||
161620033|NCT03976102|583660470|FG001|Overall Study|Lost to Follow-up|2|||
161620034|NCT03976102|583660469|FG000|Overall Study|Death|3|||
161620035|NCT03976102|583660470|FG001|Overall Study|Death|2|||
161620036|NCT03976102|583660469|FG000|Overall Study|Physician Decision|1|||
161832836|NCT05611996|584429640|FG000|Overall Study|Withdrawal by Subject|9|||
161832837|NCT04479475|584429644|FG000|Overall Study|Withdrawal by Subject|7|||
161832838|NCT00619359|584429647|FG000|Overall Study|Adverse Event|32|||
161832839|NCT00619359|584429648|FG001|Overall Study|Adverse Event|36|||
161832840|NCT00619359|584429647|FG000|Overall Study|Lost to Follow-up|12|||
161832841|NCT00619359|584429648|FG001|Overall Study|Lost to Follow-up|16|||
161832842|NCT00619359|584429647|FG000|Overall Study|Physician Decision|0|||
161832843|NCT00619359|584429648|FG001|Overall Study|Physician Decision|7|||
161832844|NCT00619359|584429647|FG000|Overall Study|Protocol Violation|1|||
161832845|NCT00619359|584429648|FG001|Overall Study|Protocol Violation|1|||
161832846|NCT00619359|584429647|FG000|Overall Study|Withdrawal by Subject|19|||
161832847|NCT00619359|584429648|FG001|Overall Study|Withdrawal by Subject|20|||
161832848|NCT00619359|584429647|FG000|Overall Study|Progressive Disease|3|||
161832849|NCT00619359|584429648|FG001|Overall Study|Progressive Disease|1|||
161832850|NCT06972251|584429649|FG000|Overall Study|Withdrawal by Subject|1|||
161832851|NCT06972251|584429650|FG001|Overall Study|Withdrawal by Subject|0|||
161832852|NCT06972251|584429649|FG000|Overall Study|Lost to Follow-up|10|||
161832853|NCT06972251|584429650|FG001|Overall Study|Lost to Follow-up|2|||
161832854|NCT00351351|584429652|FG000|Overall Study|surgical access pbs; device issues|9|||
161832855|NCT00351351|584429653|FG001|Overall Study|surgical access pbs; device issues|4|||
161832856|NCT03891329|584429654|FG000|Overall Study|Death|5|||
161832857|NCT03891329|584429654|FG000|Overall Study|Lost to Follow-up|4|||
161832858|NCT03891329|584429654|FG000|Overall Study|Physician Decision|4|||
161832859|NCT03891329|584429654|FG000|Overall Study|Device explanted|3|||
161832860|NCT03891329|584429654|FG000|Overall Study|No study device implanted|3|||
161832861|NCT03176784|584429655|FG000|Overall Study|Lost to Follow-up|77|||
161832862|NCT03176784|584429656|FG001|Overall Study|Lost to Follow-up|79|||
161832863|NCT03176784|584429657|FG002|Overall Study|Lost to Follow-up|79|||
161832864|NCT03176784|584429658|FG003|Overall Study|Lost to Follow-up|49|||
161832865|NCT03176784|584429655|FG000|Overall Study|Withdrawal by Subject|28|||
161832866|NCT03176784|584429656|FG001|Overall Study|Withdrawal by Subject|34|||
161832867|NCT03176784|584429657|FG002|Overall Study|Withdrawal by Subject|34|||
161832868|NCT03176784|584429658|FG003|Overall Study|Withdrawal by Subject|21|||
161832869|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
161832870|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
161832871|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
161832872|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
161832873|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
161832874|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
161832875|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
161832876|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
161832877|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
161832878|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
161832879|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
161363812|NCT00392288|582720030|FG002|Overall Study|Other|1|||
161620037|NCT03976102|583660470|FG001|Overall Study|Physician Decision|1|||
161620038|NCT00451906|583660472|FG000|Overall Study|Adverse Event|515|||
161620039|NCT00451906|583660472|FG000|Overall Study|Lost to Follow-up|31|||
161620040|NCT00451906|583660472|FG000|Overall Study|Withdrawal by Subject|111|||
161620041|NCT00451906|583660472|FG000|Overall Study|Protocol Violation|21|||
161620042|NCT00451906|583660472|FG000|Overall Study|Progressive disease|1328|||
161832880|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
161832881|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161620043|NCT00451906|583660472|FG000|Overall Study|Termination of the study|108|||
161832882|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832883|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161832884|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161620044|NCT00451906|583660472|FG000|Overall Study|Other Reasons|121|||
161620045|NCT00451906|583660472|FG000|Overall Study|Did not complete final visit|4|||
161620046|NCT03072238|583660477|FG000|Overall Study|Withdrawal by Subject|44|||
161620047|NCT03072238|583660478|FG001|Overall Study|Withdrawal by Subject|64|||
161620048|NCT03072238|583660477|FG000|Overall Study|Lost to Follow-up|14|||
161620049|NCT03072238|583660478|FG001|Overall Study|Lost to Follow-up|5|||
161620050|NCT03072238|583660477|FG000|Overall Study|Physician Decision|4|||
161620051|NCT03072238|583660478|FG001|Overall Study|Physician Decision|6|||
161620052|NCT03072238|583660477|FG000|Overall Study|Death|351|||
161620053|NCT03072238|583660478|FG001|Overall Study|Death|318|||
161620054|NCT03072238|583660477|FG000|Overall Study|Progressive Disease|3|||
161620055|NCT03072238|583660478|FG001|Overall Study|Progressive Disease|4|||
161620056|NCT03072238|583660477|FG000|Overall Study|Reason Not Specified|138|||
161620057|NCT03072238|583660478|FG001|Overall Study|Reason Not Specified|150|||
161620058|NCT02889900|583660484|FG000|Overall Study|Adverse Event|11|||
161620059|NCT02889900|583660484|FG000|Overall Study|Condition under investigation worsened|32|||
161620060|NCT02889900|583660484|FG000|Overall Study|Other|5|||
161620061|NCT02889900|583660484|FG000|Overall Study|Withdrawal by Subject|7|||
161620062|NCT02889900|583660484|FG000|Overall Study|Not treated|2|||
161620063|NCT00608959|583660485|FG000|Part 1|Did not meet eligibility criteria|1|||
161620064|NCT01416285|583660486|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
161620065|NCT01416285|583660487|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
161620066|NCT01005602|583660488|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
161620067|NCT01005602|583660489|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
161620068|NCT01248715|583660490|FG000|Overall Study|Not influenza positive|501|||
161620069|NCT01248715|583660491|FG001|Overall Study|Not influenza positive|510|||
161620070|NCT01919489|583660497|FG000|Overall Study|Rejected the need of injections|4|||
161620071|NCT01919489|583660498|FG001|Overall Study|Rejected the need of injections|7|||
161620072|NCT01919489|583660497|FG000|Overall Study|Adverse Event|10|||
161620073|NCT01919489|583660498|FG001|Overall Study|Adverse Event|0|||
161620074|NCT01919489|583660497|FG000|Overall Study|Hospital readmission|2|||
161620075|NCT01919489|583660498|FG001|Overall Study|Hospital readmission|9|||
161620076|NCT01919489|583660497|FG000|Overall Study|Death|2|||
161620077|NCT01919489|583660498|FG001|Overall Study|Death|1|||
161620078|NCT01919489|583660497|FG000|Overall Study|Lost to Follow-up|38|||
161620079|NCT01919489|583660498|FG001|Overall Study|Lost to Follow-up|27|||
161620080|NCT01807234|583660499|FG000|Overall Study|Lost to Follow-up|2|||
161620081|NCT01807234|583660500|FG001|Overall Study|Lost to Follow-up|5|||
161620082|NCT01807234|583660501|FG002|Overall Study|Lost to Follow-up|1|||
161620083|NCT01807234|583660502|FG003|Overall Study|Lost to Follow-up|1|||
161620084|NCT01807234|583660503|FG004|Overall Study|Lost to Follow-up|1|||
161620085|NCT01807234|583660504|FG005|Overall Study|Lost to Follow-up|2|||
161620086|NCT01807234|583660499|FG000|Overall Study|Withdrawal by Subject|3|||
161620087|NCT01807234|583660500|FG001|Overall Study|Withdrawal by Subject|1|||
161620088|NCT01807234|583660501|FG002|Overall Study|Withdrawal by Subject|1|||
161620089|NCT01807234|583660502|FG003|Overall Study|Withdrawal by Subject|1|||
161620090|NCT01807234|583660503|FG004|Overall Study|Withdrawal by Subject|2|||
161620091|NCT01807234|583660504|FG005|Overall Study|Withdrawal by Subject|1|||
161620092|NCT01807234|583660499|FG000|Overall Study|Lack of Efficacy|0|||
161620093|NCT01807234|583660500|FG001|Overall Study|Lack of Efficacy|0|||
161620094|NCT01807234|583660501|FG002|Overall Study|Lack of Efficacy|0|||
161620095|NCT01807234|583660502|FG003|Overall Study|Lack of Efficacy|0|||
161620096|NCT01807234|583660503|FG004|Overall Study|Lack of Efficacy|1|||
161620097|NCT01807234|583660504|FG005|Overall Study|Lack of Efficacy|1|||
161620098|NCT01540474|583660505|FG000|Vaccination Period|Lost to Follow-up|0|||
161620099|NCT01540474|583660506|FG001|Vaccination Period|Lost to Follow-up|1|||
161620100|NCT01540474|583660507|FG002|Vaccination Period|Lost to Follow-up|0|||
161620101|NCT01540474|583660508|FG003|Vaccination Period|Lost to Follow-up|0|||
161620102|NCT00857311|583660509|FG000|Overall Study|Lost to Follow-up|1|||
161620103|NCT00857311|583660510|FG001|Overall Study|Lost to Follow-up|0|||
161620104|NCT00857311|583660511|FG002|Overall Study|Lost to Follow-up|0|||
161620105|NCT00857311|583660512|FG003|Overall Study|Lost to Follow-up|0|||
161620106|NCT01587703|583660513|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
161620107|NCT01587703|583660514|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620108|NCT01587703|583660515|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620109|NCT01587703|583660516|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620110|NCT01587703|583660517|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620111|NCT01587703|583660518|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620112|NCT01587703|583660519|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620113|NCT01587703|583660520|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620114|NCT01587703|583660521|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620115|NCT01587703|583660522|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620116|NCT01587703|583660523|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620117|NCT01587703|583660524|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620118|NCT01587703|583660525|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620119|NCT01587703|583660526|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620120|NCT01587703|583660527|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620121|NCT01587703|583660528|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620122|NCT01587703|583660529|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620123|NCT01587703|583660530|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620124|NCT01587703|583660531|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161620125|NCT01587703|583660513|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620126|NCT01587703|583660514|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620127|NCT01587703|583660515|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620128|NCT01587703|583660516|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620129|NCT01587703|583660517|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620130|NCT01587703|583660518|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
161620131|NCT01587703|583660519|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620132|NCT01587703|583660520|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
161620133|NCT01587703|583660521|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620134|NCT01587703|583660522|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620135|NCT01587703|583660523|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620136|NCT01587703|583660524|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620137|NCT01587703|583660525|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620138|NCT01587703|583660526|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620139|NCT01587703|583660527|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620140|NCT01587703|583660528|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620141|NCT01587703|583660529|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620142|NCT01587703|583660530|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620143|NCT01587703|583660531|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161620144|NCT01587703|583660513|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620145|NCT01587703|583660514|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620146|NCT01587703|583660515|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620147|NCT01587703|583660516|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620148|NCT01587703|583660517|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620149|NCT01587703|583660518|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620150|NCT01587703|583660519|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
161620151|NCT01587703|583660520|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620152|NCT01587703|583660521|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620153|NCT01587703|583660522|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620154|NCT01587703|583660523|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620155|NCT01587703|583660524|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620156|NCT01587703|583660525|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620157|NCT01587703|583660526|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620158|NCT01587703|583660527|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620159|NCT01587703|583660528|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620160|NCT01587703|583660529|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620161|NCT01587703|583660530|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620162|NCT01587703|583660531|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161620163|NCT01587703|583660513|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
161832885|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
161832886|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
161620164|NCT01587703|583660514|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
161620165|NCT01587703|583660515|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
161620166|NCT01587703|583660516|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
161620167|NCT01587703|583660517|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
161620168|NCT01587703|583660518|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
161620169|NCT01587703|583660519|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
161620170|NCT01587703|583660520|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
161620171|NCT01587703|583660521|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620172|NCT01587703|583660522|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620173|NCT01587703|583660523|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620174|NCT01587703|583660524|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620175|NCT01587703|583660525|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620176|NCT01587703|583660526|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620177|NCT01587703|583660527|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620178|NCT01587703|583660528|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620179|NCT01587703|583660529|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620180|NCT01587703|583660530|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620181|NCT01587703|583660531|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161620182|NCT01587703|583660513|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620183|NCT01587703|583660514|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620184|NCT01587703|583660515|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620185|NCT01587703|583660516|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620186|NCT01587703|583660517|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620187|NCT01587703|583660518|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620188|NCT01587703|583660519|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620189|NCT01587703|583660520|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620190|NCT01587703|583660521|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
161620191|NCT01587703|583660522|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
161620192|NCT01587703|583660523|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
161620193|NCT01587703|583660524|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620194|NCT01587703|583660525|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620195|NCT01587703|583660526|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620196|NCT01587703|583660527|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620197|NCT01587703|583660528|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620198|NCT01587703|583660529|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620199|NCT01587703|583660530|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620200|NCT01587703|583660531|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161620201|NCT01587703|583660513|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620202|NCT01587703|583660514|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620203|NCT01587703|583660515|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620204|NCT01587703|583660516|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620205|NCT01587703|583660517|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620206|NCT01587703|583660518|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620207|NCT01587703|583660519|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620208|NCT01587703|583660520|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620209|NCT01587703|583660521|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
161620210|NCT01587703|583660522|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620211|NCT01587703|583660523|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
161620212|NCT01587703|583660524|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620213|NCT01587703|583660525|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620214|NCT01587703|583660526|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620215|NCT01587703|583660527|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620216|NCT01587703|583660528|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620217|NCT01587703|583660529|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161832887|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
161832888|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
161620218|NCT01587703|583660530|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620219|NCT01587703|583660531|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161620220|NCT01587703|583660513|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620221|NCT01587703|583660514|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620222|NCT01587703|583660515|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161832889|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
161620223|NCT01587703|583660516|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620224|NCT01587703|583660517|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620225|NCT01587703|583660518|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620226|NCT01587703|583660519|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620227|NCT01587703|583660520|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620228|NCT01587703|583660521|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620229|NCT01587703|583660522|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
161620230|NCT01587703|583660523|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
161620231|NCT01587703|583660524|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620232|NCT01587703|583660525|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620233|NCT01587703|583660526|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620234|NCT01587703|583660527|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620235|NCT01587703|583660528|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620236|NCT01587703|583660529|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620237|NCT01587703|583660530|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620238|NCT01587703|583660531|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161620239|NCT01587703|583660513|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620240|NCT01587703|583660514|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620241|NCT01587703|583660515|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620242|NCT01587703|583660516|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620243|NCT01587703|583660517|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620244|NCT01587703|583660518|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620245|NCT01587703|583660519|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620246|NCT01587703|583660520|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620247|NCT01587703|583660521|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
161620248|NCT01587703|583660522|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620249|NCT01587703|583660523|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620250|NCT01587703|583660524|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620251|NCT01587703|583660525|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620252|NCT01587703|583660526|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620253|NCT01587703|583660527|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620254|NCT01587703|583660528|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620255|NCT01587703|583660529|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620256|NCT01587703|583660530|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620257|NCT01587703|583660531|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161620258|NCT01587703|583660513|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620259|NCT01587703|583660514|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620260|NCT01587703|583660515|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620261|NCT01587703|583660516|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620262|NCT01587703|583660517|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620263|NCT01587703|583660518|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620264|NCT01587703|583660519|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620265|NCT01587703|583660520|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620266|NCT01587703|583660521|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620267|NCT01587703|583660522|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620268|NCT01587703|583660523|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620269|NCT01587703|583660524|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620270|NCT01587703|583660525|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620271|NCT01587703|583660526|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620272|NCT01587703|583660527|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620273|NCT01587703|583660528|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620274|NCT01587703|583660529|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620275|NCT01587703|583660530|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161620276|NCT01587703|583660531|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
161620277|NCT01587703|583660513|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620278|NCT01587703|583660514|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620279|NCT01587703|583660515|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620280|NCT01587703|583660516|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620281|NCT01587703|583660517|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620282|NCT01587703|583660518|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620283|NCT01587703|583660519|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620284|NCT01587703|583660520|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620285|NCT01587703|583660521|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161684758|NCT00886600|583897999|FG000|Double-blind Monotherapy|Protocol Violation|0|||
161684759|NCT00886600|583898000|FG001|Double-blind Monotherapy|Protocol Violation|0|||
161684760|NCT00886600|583898001|FG002|Double-blind Monotherapy|Protocol Violation|0|||
161684761|NCT00886600|583898002|FG003|Double-blind Monotherapy|Protocol Violation|1|||
161684762|NCT00886600|583897999|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
161684763|NCT00886600|583898000|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
161684764|NCT00886600|583898001|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
161684765|NCT00886600|583898002|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
161684766|NCT00886600|583897999|FG000|Combination Therapy Period|Adverse Event|0|||
161684767|NCT00886600|583898000|FG001|Combination Therapy Period|Adverse Event|0|||
161684768|NCT00886600|583898001|FG002|Combination Therapy Period|Adverse Event|1|||
161684769|NCT00886600|583898002|FG003|Combination Therapy Period|Adverse Event|0|||
161684770|NCT00886600|583897999|FG000|Combination Therapy Period|Protocol Violation|0|||
161684771|NCT00886600|583898000|FG001|Combination Therapy Period|Protocol Violation|0|||
161684772|NCT00886600|583898001|FG002|Combination Therapy Period|Protocol Violation|1|||
161684773|NCT00886600|583898002|FG003|Combination Therapy Period|Protocol Violation|0|||
161684774|NCT00578136|583898008|FG000|Overall Study|Not given intervention|1|||
161684775|NCT00578136|583898009|FG001|Overall Study|Not given intervention|1|||
161684776|NCT01840579|583898012|FG000|Overall Study|Status not recorded|0|||
161684777|NCT01840579|583898013|FG001|Overall Study|Status not recorded|0|||
161684778|NCT01840579|583898014|FG002|Overall Study|Status not recorded|2|||
161684779|NCT01840579|583898015|FG003|Overall Study|Status not recorded|3|||
161684780|NCT01840579|583898016|FG004|Overall Study|Status not recorded|4|||
161684781|NCT01840579|583898017|FG005|Overall Study|Status not recorded|3|||
161684782|NCT01840579|583898018|FG006|Overall Study|Status not recorded|0|||
161684783|NCT01840579|583898019|FG007|Overall Study|Status not recorded|3|||
161684784|NCT01840579|583898020|FG008|Overall Study|Status not recorded|3|||
161684785|NCT01840579|583898021|FG009|Overall Study|Status not recorded|3|||
161684786|NCT01840579|583898012|FG000|Overall Study|Progressive disease|3|||
161684787|NCT01840579|583898013|FG001|Overall Study|Progressive disease|5|||
161620286|NCT01587703|583660522|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620287|NCT01587703|583660523|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620288|NCT01587703|583660524|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620289|NCT01587703|583660525|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620290|NCT01587703|583660526|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620291|NCT01587703|583660527|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620292|NCT01587703|583660528|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620293|NCT01587703|583660529|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161620294|NCT01587703|583660530|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
161620295|NCT01587703|583660531|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
161620296|NCT01587703|583660513|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620297|NCT01587703|583660514|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620298|NCT01587703|583660515|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620299|NCT01587703|583660516|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620300|NCT01587703|583660517|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620301|NCT01587703|583660518|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620302|NCT01587703|583660519|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620303|NCT01587703|583660520|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620304|NCT01587703|583660521|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620305|NCT01587703|583660522|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620306|NCT01587703|583660523|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620307|NCT01587703|583660524|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620308|NCT01587703|583660525|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620309|NCT01587703|583660526|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620310|NCT01587703|583660527|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620311|NCT01587703|583660528|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
161684788|NCT01840579|583898014|FG002|Overall Study|Progressive disease|0|||
161684789|NCT01840579|583898015|FG003|Overall Study|Progressive disease|0|||
161684790|NCT01840579|583898016|FG004|Overall Study|Progressive disease|0|||
161832890|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
161684791|NCT01840579|583898017|FG005|Overall Study|Progressive disease|0|||
161684792|NCT01840579|583898018|FG006|Overall Study|Progressive disease|0|||
161684793|NCT01840579|583898019|FG007|Overall Study|Progressive disease|0|||
161620312|NCT01587703|583660529|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620313|NCT01587703|583660530|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620314|NCT01587703|583660531|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161620315|NCT01587703|583660513|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620316|NCT01587703|583660514|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620317|NCT01587703|583660515|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620318|NCT01587703|583660516|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620319|NCT01587703|583660517|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620320|NCT01587703|583660518|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620321|NCT01587703|583660519|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620322|NCT01587703|583660520|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620323|NCT01587703|583660521|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620324|NCT01587703|583660522|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620325|NCT01587703|583660523|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620326|NCT01587703|583660524|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
161620327|NCT01587703|583660525|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620328|NCT01587703|583660526|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620329|NCT01587703|583660527|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
161620330|NCT01587703|583660528|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161684794|NCT01840579|583898020|FG008|Overall Study|Progressive disease|0|||
161684795|NCT01840579|583898021|FG009|Overall Study|Progressive disease|0|||
161620331|NCT01587703|583660529|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620332|NCT01587703|583660530|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620333|NCT01587703|583660531|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161620334|NCT01587703|583660513|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620335|NCT01587703|583660514|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620336|NCT01587703|583660515|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620337|NCT01587703|583660516|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620338|NCT01587703|583660517|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620339|NCT01587703|583660518|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620340|NCT01587703|583660519|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620341|NCT01587703|583660520|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620342|NCT01587703|583660521|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620343|NCT01587703|583660522|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620344|NCT01587703|583660523|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620345|NCT01587703|583660524|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
161620346|NCT01587703|583660525|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
161620347|NCT01587703|583660526|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
161620348|NCT01587703|583660527|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
161620349|NCT01587703|583660528|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
161620350|NCT01587703|583660529|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
161620351|NCT01587703|583660530|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620352|NCT01587703|583660531|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161620353|NCT01587703|583660513|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620354|NCT01587703|583660514|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620355|NCT01587703|583660515|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620356|NCT01587703|583660516|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620357|NCT01587703|583660517|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620358|NCT01587703|583660518|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620359|NCT01587703|583660519|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620360|NCT01587703|583660520|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620361|NCT01587703|583660521|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620362|NCT01587703|583660522|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620363|NCT01587703|583660523|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620364|NCT01587703|583660524|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
161620365|NCT01587703|583660525|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
161620366|NCT01587703|583660526|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
161684796|NCT01840579|583898012|FG000|Overall Study|Ongoing in study|0|||
161684797|NCT01840579|583898013|FG001|Overall Study|Ongoing in study|1|||
161684798|NCT01840579|583898014|FG002|Overall Study|Ongoing in study|0|||
161684799|NCT01840579|583898015|FG003|Overall Study|Ongoing in study|0|||
161684800|NCT01840579|583898016|FG004|Overall Study|Ongoing in study|0|||
161684801|NCT01840579|583898017|FG005|Overall Study|Ongoing in study|0|||
161684802|NCT01840579|583898018|FG006|Overall Study|Ongoing in study|0|||
161684803|NCT01840579|583898019|FG007|Overall Study|Ongoing in study|0|||
161620367|NCT01587703|583660527|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
161620368|NCT01587703|583660528|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
161684804|NCT01840579|583898020|FG008|Overall Study|Ongoing in study|0|||
161684805|NCT01840579|583898021|FG009|Overall Study|Ongoing in study|0|||
161684806|NCT01840579|583898012|FG000|Overall Study|Death|0|||
161684807|NCT01840579|583898013|FG001|Overall Study|Death|0|||
161684808|NCT01840579|583898014|FG002|Overall Study|Death|0|||
161684809|NCT01840579|583898015|FG003|Overall Study|Death|0|||
161684810|NCT01840579|583898016|FG004|Overall Study|Death|0|||
161620369|NCT01587703|583660529|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
161620370|NCT01587703|583660530|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620371|NCT01587703|583660531|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
161620372|NCT01587703|583660513|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620373|NCT01587703|583660514|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620374|NCT01587703|583660515|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620375|NCT01587703|583660516|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620376|NCT01587703|583660517|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620377|NCT01587703|583660518|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620378|NCT01587703|583660519|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620379|NCT01587703|583660520|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620380|NCT01587703|583660521|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620381|NCT01587703|583660522|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620382|NCT01587703|583660523|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620383|NCT01587703|583660524|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
161620384|NCT01587703|583660525|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620385|NCT01587703|583660526|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620386|NCT01587703|583660527|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620387|NCT01587703|583660528|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620388|NCT01587703|583660529|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620389|NCT01587703|583660530|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620390|NCT01587703|583660531|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161620391|NCT00828139|583660532|FG000|Overall Study|Adverse Event|8|||
161620392|NCT00828139|583660533|FG001|Overall Study|Adverse Event|1|||
161620393|NCT00828139|583660534|FG002|Overall Study|Adverse Event|10|||
161620394|NCT00828139|583660535|FG003|Overall Study|Adverse Event|5|||
161620395|NCT00828139|583660532|FG000|Overall Study|Death|2|||
161620396|NCT00828139|583660533|FG001|Overall Study|Death|1|||
161620397|NCT00828139|583660534|FG002|Overall Study|Death|0|||
161620398|NCT00828139|583660535|FG003|Overall Study|Death|2|||
161620399|NCT00828139|583660532|FG000|Overall Study|Refusal unrelated to toxicity|3|||
161620400|NCT00828139|583660533|FG001|Overall Study|Refusal unrelated to toxicity|4|||
161620401|NCT00828139|583660534|FG002|Overall Study|Refusal unrelated to toxicity|5|||
161620402|NCT00828139|583660535|FG003|Overall Study|Refusal unrelated to toxicity|3|||
161620403|NCT00828139|583660532|FG000|Overall Study|Disease Progression|24|||
161620404|NCT00828139|583660533|FG001|Overall Study|Disease Progression|33|||
161620405|NCT00828139|583660534|FG002|Overall Study|Disease Progression|35|||
161620406|NCT00828139|583660535|FG003|Overall Study|Disease Progression|39|||
161620407|NCT00828139|583660532|FG000|Overall Study|Other|4|||
161620408|NCT00828139|583660533|FG001|Overall Study|Other|2|||
161620409|NCT00828139|583660534|FG002|Overall Study|Other|5|||
161620410|NCT00828139|583660535|FG003|Overall Study|Other|2|||
161620411|NCT04271254|583660539|FG000|Overall Study|Withdrawal by Subject|3|||
161620412|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
161620413|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
161620414|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
161620415|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
161620416|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
161620417|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
161620418|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
161620419|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
161620420|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
161620421|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
161620422|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
161620423|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
161620424|NCT01345253|583660540|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
161620425|NCT01345253|583660541|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
161620426|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
161620427|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
161620428|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
161620429|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
161620430|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
161620431|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
161620432|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
161620433|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
161684811|NCT01840579|583898017|FG005|Overall Study|Death|1|||
161684812|NCT01840579|583898018|FG006|Overall Study|Death|0|||
161620434|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
161620435|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
161620436|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
161620437|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
161620438|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
161620439|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
161620440|NCT01345253|583660540|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
161620441|NCT01345253|583660541|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
161620442|NCT04751929|583660542|FG000|Overall Study|Withdrawal by Subject|2|||
161620443|NCT04751929|583660543|FG001|Overall Study|Withdrawal by Subject|0|||
161620444|NCT04751929|583660544|FG002|Overall Study|Withdrawal by Subject|0|||
161620445|NCT04751929|583660545|FG003|Overall Study|Withdrawal by Subject|0|||
161620446|NCT04751929|583660542|FG000|Overall Study|Rising PSA|0|||
161620447|NCT04751929|583660543|FG001|Overall Study|Rising PSA|1|||
161620448|NCT04751929|583660544|FG002|Overall Study|Rising PSA|0|||
161620449|NCT04751929|583660545|FG003|Overall Study|Rising PSA|0|||
161620450|NCT04751929|583660542|FG000|Overall Study|Adverse Event|1|||
161620451|NCT04751929|583660543|FG001|Overall Study|Adverse Event|2|||
161620452|NCT04751929|583660544|FG002|Overall Study|Adverse Event|0|||
161620453|NCT04751929|583660545|FG003|Overall Study|Adverse Event|0|||
161620454|NCT04751929|583660542|FG000|Overall Study|Progressive Disease|3|||
161620455|NCT04751929|583660543|FG001|Overall Study|Progressive Disease|4|||
161620456|NCT04751929|583660544|FG002|Overall Study|Progressive Disease|4|||
161620457|NCT04751929|583660545|FG003|Overall Study|Progressive Disease|0|||
161620458|NCT04751929|583660542|FG000|Overall Study|Death|1|||
161620459|NCT04751929|583660543|FG001|Overall Study|Death|1|||
161620460|NCT04751929|583660544|FG002|Overall Study|Death|0|||
161620461|NCT04751929|583660545|FG003|Overall Study|Death|0|||
161620462|NCT00930644|583660546|FG000|Overall Study|Withdrawal by Subject|4|||
161620463|NCT00930644|583660546|FG000|Overall Study|Physician Decision|2|||
161620464|NCT00930644|583660546|FG000|Overall Study|Death|1|||
161620465|NCT00930644|583660546|FG000|Overall Study|Adverse Event|16|||
161620466|NCT00473512|583660551|FG000|Period 1 (Phase 1)|Adverse Event|0|||
161620467|NCT00473512|583660552|FG001|Period 1 (Phase 1)|Adverse Event|0|||
161620468|NCT00473512|583660553|FG002|Period 1 (Phase 1)|Adverse Event|0|||
161620469|NCT00473512|583660554|FG003|Period 1 (Phase 1)|Adverse Event|5|||
161620470|NCT00473512|583660555|FG004|Period 1 (Phase 1)|Adverse Event|0|||
161620471|NCT00473512|583660551|FG000|Period 1 (Phase 1)|Death|0|||
161620472|NCT00473512|583660552|FG001|Period 1 (Phase 1)|Death|0|||
161620473|NCT00473512|583660553|FG002|Period 1 (Phase 1)|Death|0|||
161620474|NCT00473512|583660554|FG003|Period 1 (Phase 1)|Death|1|||
161620475|NCT00473512|583660555|FG004|Period 1 (Phase 1)|Death|0|||
161620476|NCT00473512|583660551|FG000|Period 1 (Phase 1)|Disease Progression|1|||
161620477|NCT00473512|583660552|FG001|Period 1 (Phase 1)|Disease Progression|1|||
161620478|NCT00473512|583660553|FG002|Period 1 (Phase 1)|Disease Progression|0|||
161620479|NCT00473512|583660554|FG003|Period 1 (Phase 1)|Disease Progression|10|||
161620480|NCT00473512|583660555|FG004|Period 1 (Phase 1)|Disease Progression|1|||
161620481|NCT00473512|583660551|FG000|Period 1 (Phase 1)|Other|0|||
161620482|NCT00473512|583660552|FG001|Period 1 (Phase 1)|Other|0|||
161620483|NCT00473512|583660553|FG002|Period 1 (Phase 1)|Other|0|||
161620484|NCT00473512|583660554|FG003|Period 1 (Phase 1)|Other|1|||
161620485|NCT00473512|583660555|FG004|Period 1 (Phase 1)|Other|0|||
161620486|NCT00473512|583660551|FG000|Period 2 (Phase 2)|Adverse Event|0|||
161620487|NCT00473512|583660552|FG001|Period 2 (Phase 2)|Adverse Event|0|||
161620488|NCT00473512|583660553|FG002|Period 2 (Phase 2)|Adverse Event|0|||
161620489|NCT00473512|583660554|FG003|Period 2 (Phase 2)|Adverse Event|1|||
161620490|NCT00473512|583660555|FG004|Period 2 (Phase 2)|Adverse Event|0|||
161620491|NCT00473512|583660551|FG000|Period 2 (Phase 2)|Death|0|||
161620492|NCT00473512|583660552|FG001|Period 2 (Phase 2)|Death|0|||
161620493|NCT00473512|583660553|FG002|Period 2 (Phase 2)|Death|0|||
161620494|NCT00473512|583660554|FG003|Period 2 (Phase 2)|Death|1|||
161620495|NCT00473512|583660555|FG004|Period 2 (Phase 2)|Death|1|||
161620496|NCT00473512|583660551|FG000|Period 2 (Phase 2)|Disease Progression|0|||
161620497|NCT00473512|583660552|FG001|Period 2 (Phase 2)|Disease Progression|2|||
161620498|NCT00473512|583660553|FG002|Period 2 (Phase 2)|Disease Progression|2|||
161620499|NCT00473512|583660554|FG003|Period 2 (Phase 2)|Disease Progression|17|||
161620500|NCT00473512|583660555|FG004|Period 2 (Phase 2)|Disease Progression|1|||
161620501|NCT00473512|583660551|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161620502|NCT00473512|583660552|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161620503|NCT00473512|583660553|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161620504|NCT00473512|583660554|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
161620505|NCT00473512|583660555|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161620506|NCT00473512|583660551|FG000|Period 2 (Phase 2)|Other|1|||
161620507|NCT00473512|583660552|FG001|Period 2 (Phase 2)|Other|0|||
161620508|NCT00473512|583660553|FG002|Period 2 (Phase 2)|Other|0|||
161620509|NCT00473512|583660554|FG003|Period 2 (Phase 2)|Other|3|||
161620510|NCT00473512|583660555|FG004|Period 2 (Phase 2)|Other|0|||
161620511|NCT01129011|583660558|FG000|Overall Study|Adverse Event|20|||
161620512|NCT01129011|583660559|FG001|Overall Study|Adverse Event|30|||
161620513|NCT01129011|583660558|FG000|Overall Study|Withdrawal by Subject|24|||
161620514|NCT01129011|583660559|FG001|Overall Study|Withdrawal by Subject|8|||
161620515|NCT01129011|583660558|FG000|Overall Study|Lost to Follow-up|6|||
161620516|NCT01129011|583660559|FG001|Overall Study|Lost to Follow-up|7|||
161620517|NCT01129011|583660558|FG000|Overall Study|Duodenal Ulcer|2|||
161620518|NCT01129011|583660559|FG001|Overall Study|Duodenal Ulcer|8|||
161620519|NCT01129011|583660558|FG000|Overall Study|misc|7|||
161620520|NCT01129011|583660559|FG001|Overall Study|misc|4|||
161620521|NCT01369147|583660560|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
161620522|NCT01369147|583660561|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
161620523|NCT01369147|583660562|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
161620524|NCT00417885|583660563|FG000|Overall Study|Adverse Event|1|||
161620525|NCT00417885|583660563|FG000|Overall Study|Objective Progression or Relapse|3|||
161620526|NCT00417885|583660563|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
161620527|NCT00248794|583660567|FG000|Overall Study|Lost to Follow-up|6|||
161620528|NCT00248794|583660568|FG001|Overall Study|Lost to Follow-up|8|||
161620529|NCT00248794|583660569|FG002|Overall Study|Lost to Follow-up|3|||
161620530|NCT03209492|583660570|FG000|Overall Study|Case Report Forms Uncollected|5|||
161620531|NCT04908488|583660571|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161620532|NCT04908488|583660572|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161620533|NCT04908488|583660571|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
161620534|NCT04908488|583660572|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
161620535|NCT01107912|583660575|FG000|Period 1|Adverse Event|0|||
161620536|NCT01107912|583660576|FG001|Period 1|Adverse Event|0|||
161620537|NCT01107912|583660577|FG002|Period 1|Adverse Event|0|||
161620538|NCT01107912|583660578|FG003|Period 1|Adverse Event|0|||
161620539|NCT01107912|583660579|FG004|Period 1|Adverse Event|2|||
161620540|NCT01107912|583660580|FG005|Period 1|Adverse Event|0|||
161620541|NCT01107912|583660575|FG000|Period 1|Physician Decision|0|||
161620542|NCT01107912|583660576|FG001|Period 1|Physician Decision|0|||
161620543|NCT01107912|583660577|FG002|Period 1|Physician Decision|0|||
161620544|NCT01107912|583660578|FG003|Period 1|Physician Decision|0|||
161620545|NCT01107912|583660579|FG004|Period 1|Physician Decision|1|||
161620546|NCT01107912|583660580|FG005|Period 1|Physician Decision|0|||
161620547|NCT01107912|583660575|FG000|Period 1|Withdrawal by Subject|1|||
161620548|NCT01107912|583660576|FG001|Period 1|Withdrawal by Subject|0|||
161620549|NCT01107912|583660577|FG002|Period 1|Withdrawal by Subject|0|||
161620550|NCT01107912|583660578|FG003|Period 1|Withdrawal by Subject|0|||
161620551|NCT01107912|583660579|FG004|Period 1|Withdrawal by Subject|0|||
161620552|NCT01107912|583660580|FG005|Period 1|Withdrawal by Subject|0|||
161620553|NCT01107912|583660575|FG000|Period 2|Physician Decision|0|||
161620554|NCT01107912|583660576|FG001|Period 2|Physician Decision|0|||
161620555|NCT01107912|583660577|FG002|Period 2|Physician Decision|1|||
161620556|NCT01107912|583660578|FG003|Period 2|Physician Decision|0|||
161620557|NCT01107912|583660579|FG004|Period 2|Physician Decision|0|||
161620558|NCT01107912|583660580|FG005|Period 2|Physician Decision|0|||
161620559|NCT01107912|583660575|FG000|Period 3|Adverse Event|0|||
161620560|NCT01107912|583660576|FG001|Period 3|Adverse Event|1|||
161620561|NCT01107912|583660577|FG002|Period 3|Adverse Event|1|||
161620562|NCT01107912|583660578|FG003|Period 3|Adverse Event|0|||
161620563|NCT01107912|583660579|FG004|Period 3|Adverse Event|0|||
161620564|NCT01107912|583660580|FG005|Period 3|Adverse Event|0|||
161620565|NCT01107912|583660575|FG000|Period 3|Withdrawal by Subject|0|||
161620566|NCT01107912|583660576|FG001|Period 3|Withdrawal by Subject|0|||
161620567|NCT01107912|583660577|FG002|Period 3|Withdrawal by Subject|0|||
161620568|NCT01107912|583660578|FG003|Period 3|Withdrawal by Subject|1|||
161620569|NCT01107912|583660579|FG004|Period 3|Withdrawal by Subject|0|||
161620570|NCT01107912|583660580|FG005|Period 3|Withdrawal by Subject|0|||
161620571|NCT01894620|583660581|FG000|Overall Study|Withdrawal by Subject|0|||
161620572|NCT01894620|583660582|FG001|Overall Study|Withdrawal by Subject|1|||
161620573|NCT01124916|583660583|FG000|Overall Study|Lost to Follow-up|3|||
161620574|NCT01124916|583660584|FG001|Overall Study|Lost to Follow-up|2|||
161620575|NCT02206607|583660585|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
161620576|NCT02206607|583660586|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
161620577|NCT02206607|583660587|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
161620578|NCT02206607|583660588|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
161620579|NCT02206607|583660589|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
161620580|NCT02206607|583660585|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
161620581|NCT02206607|583660586|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
161620582|NCT02206607|583660587|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
161620583|NCT02206607|583660588|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
161620584|NCT02206607|583660589|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
161620585|NCT00879710|583660590|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
161620586|NCT00879710|583660591|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
161620587|NCT00879710|583660592|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
161620588|NCT00879710|583660593|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
161620589|NCT00879710|583660590|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
161684813|NCT01840579|583898019|FG007|Overall Study|Death|0|||
161684814|NCT01840579|583898020|FG008|Overall Study|Death|0|||
161684815|NCT01840579|583898021|FG009|Overall Study|Death|0|||
161684816|NCT01840579|583898012|FG000|Overall Study|Adverse Event|0|||
161684817|NCT01840579|583898013|FG001|Overall Study|Adverse Event|1|||
161684818|NCT01840579|583898014|FG002|Overall Study|Adverse Event|0|||
161684819|NCT01840579|583898015|FG003|Overall Study|Adverse Event|0|||
161684820|NCT01840579|583898016|FG004|Overall Study|Adverse Event|0|||
161684821|NCT01840579|583898017|FG005|Overall Study|Adverse Event|0|||
161684822|NCT01840579|583898018|FG006|Overall Study|Adverse Event|0|||
161620590|NCT00879710|583660591|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
161620591|NCT00879710|583660592|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
161620592|NCT00879710|583660593|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
161620593|NCT00761267|583660594|FG000|Overall Study|Death|1|||
161620594|NCT00761267|583660595|FG001|Overall Study|Death|2|||
161620595|NCT00761267|583660596|FG002|Overall Study|Death|5|||
161620596|NCT00761267|583660594|FG000|Overall Study|Lost to Follow-up|0|||
161620597|NCT00761267|583660595|FG001|Overall Study|Lost to Follow-up|0|||
161620598|NCT00761267|583660596|FG002|Overall Study|Lost to Follow-up|1|||
161620599|NCT00761267|583660594|FG000|Overall Study|Randomized but not treated|1|||
161620600|NCT00761267|583660595|FG001|Overall Study|Randomized but not treated|1|||
161620601|NCT00761267|583660596|FG002|Overall Study|Randomized but not treated|0|||
161620602|NCT00761267|583660594|FG000|Overall Study|Withdrawal by Subject|0|||
161620603|NCT00761267|583660595|FG001|Overall Study|Withdrawal by Subject|1|||
161620604|NCT00761267|583660596|FG002|Overall Study|Withdrawal by Subject|0|||
161620605|NCT00963924|583660599|FG000|Overall Study|Adverse Event|1|||
161620606|NCT00963924|583660600|FG001|Overall Study|Adverse Event|0|||
161620607|NCT00963924|583660599|FG000|Overall Study|Withdrawal by Subject|0|||
161620608|NCT00963924|583660600|FG001|Overall Study|Withdrawal by Subject|1|||
161620609|NCT00963924|583660599|FG000|Overall Study|Changed antipsychotic|0|||
161620610|NCT00963924|583660600|FG001|Overall Study|Changed antipsychotic|1|||
161620611|NCT00963924|583660599|FG000|Overall Study|Lost to Follow-up|0|||
161620612|NCT00963924|583660600|FG001|Overall Study|Lost to Follow-up|1|||
161620613|NCT00446095|583660602|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
161620614|NCT00446095|583660603|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
161620615|NCT00446095|583660604|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
161620616|NCT00446095|583660605|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
161620617|NCT00446095|583660606|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
161620618|NCT00446095|583660602|FG000|Phase II (8 Weeks)|Adverse Event|0|||
161620619|NCT00446095|583660603|FG001|Phase II (8 Weeks)|Adverse Event|1|||
161620620|NCT00446095|583660604|FG002|Phase II (8 Weeks)|Adverse Event|1|||
161620621|NCT00446095|583660605|FG003|Phase II (8 Weeks)|Adverse Event|0|||
161620622|NCT00446095|583660606|FG004|Phase II (8 Weeks)|Adverse Event|0|||
161620623|NCT00446095|583660602|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
161620624|NCT00446095|583660603|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161620625|NCT00446095|583660604|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161620626|NCT00446095|583660605|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161620627|NCT00446095|583660606|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161620628|NCT00446095|583660602|FG000|Phase II (8 Weeks)|Physician Decision|1|||
161620629|NCT00446095|583660603|FG001|Phase II (8 Weeks)|Physician Decision|0|||
161620630|NCT00446095|583660604|FG002|Phase II (8 Weeks)|Physician Decision|0|||
161620631|NCT00446095|583660605|FG003|Phase II (8 Weeks)|Physician Decision|0|||
161620632|NCT00446095|583660606|FG004|Phase II (8 Weeks)|Physician Decision|0|||
161620633|NCT00446095|583660602|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
161620634|NCT00446095|583660603|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
161620635|NCT00446095|583660604|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
161620636|NCT00446095|583660605|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
161620637|NCT00446095|583660606|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
161620638|NCT00446095|583660602|FG000|Phase II (8 Weeks)|Ongoing|0|||
161620639|NCT00446095|583660603|FG001|Phase II (8 Weeks)|Ongoing|0|||
161684823|NCT01840579|583898019|FG007|Overall Study|Adverse Event|0|||
161620640|NCT00446095|583660604|FG002|Phase II (8 Weeks)|Ongoing|1|||
161620641|NCT00446095|583660605|FG003|Phase II (8 Weeks)|Ongoing|0|||
161620642|NCT00446095|583660606|FG004|Phase II (8 Weeks)|Ongoing|0|||
161620643|NCT00446095|583660602|FG000|Phase I (28 Days)|Adverse Event|0|||
161620644|NCT00446095|583660603|FG001|Phase I (28 Days)|Adverse Event|0|||
161620645|NCT00446095|583660604|FG002|Phase I (28 Days)|Adverse Event|0|||
161684824|NCT01840579|583898020|FG008|Overall Study|Adverse Event|0|||
161684825|NCT01840579|583898021|FG009|Overall Study|Adverse Event|0|||
161620646|NCT00446095|583660605|FG003|Phase I (28 Days)|Adverse Event|1|||
161620647|NCT00446095|583660606|FG004|Phase I (28 Days)|Adverse Event|0|||
161620648|NCT00446095|583660602|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
161684826|NCT01840579|583898012|FG000|Overall Study|Follow-up ended by Sponsor|0|||
161684827|NCT01840579|583898013|FG001|Overall Study|Follow-up ended by Sponsor|0|||
161620649|NCT00446095|583660603|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
161620650|NCT00446095|583660604|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
161620651|NCT00446095|583660605|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
161620652|NCT00446095|583660606|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
161620653|NCT02159352|583660609|FG000|Overall Study|Adverse Event|3|||
161620654|NCT02159352|583660610|FG001|Overall Study|Adverse Event|1|||
161620655|NCT02159352|583660609|FG000|Overall Study|Withdrawal by Subject|0|||
161620656|NCT02159352|583660610|FG001|Overall Study|Withdrawal by Subject|1|||
161620657|NCT00529529|583660611|FG000|Overall Study|Adverse Event|12|||
161620658|NCT00529529|583660612|FG001|Overall Study|Adverse Event|17|||
161620659|NCT00529529|583660613|FG002|Overall Study|Adverse Event|8|||
161620660|NCT00529529|583660611|FG000|Overall Study|Subject withdrew consent|12|||
161620661|NCT00529529|583660612|FG001|Overall Study|Subject withdrew consent|9|||
161620662|NCT00529529|583660613|FG002|Overall Study|Subject withdrew consent|12|||
161620663|NCT00529529|583660611|FG000|Overall Study|Protocol deviation|8|||
161620664|NCT00529529|583660612|FG001|Overall Study|Protocol deviation|12|||
161620665|NCT00529529|583660613|FG002|Overall Study|Protocol deviation|5|||
161620666|NCT00529529|583660611|FG000|Overall Study|Lost to Follow-up|5|||
161620667|NCT00529529|583660612|FG001|Overall Study|Lost to Follow-up|3|||
161620668|NCT00529529|583660613|FG002|Overall Study|Lost to Follow-up|1|||
161620669|NCT00529529|583660611|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161620670|NCT00529529|583660612|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161620671|NCT00529529|583660613|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161620672|NCT00529529|583660611|FG000|Overall Study|Death|2|||
161620673|NCT00529529|583660612|FG001|Overall Study|Death|0|||
161620674|NCT00529529|583660613|FG002|Overall Study|Death|0|||
161620675|NCT00529529|583660611|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161620676|NCT00529529|583660612|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161620677|NCT00529529|583660613|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161620678|NCT00529529|583660611|FG000|Overall Study|Administrative problems|1|||
161620679|NCT00529529|583660612|FG001|Overall Study|Administrative problems|0|||
161620680|NCT00529529|583660613|FG002|Overall Study|Administrative problems|3|||
161620681|NCT00337610|583660614|FG000|Overall Study|Adverse Event|2|||
161620682|NCT00337610|583660615|FG001|Overall Study|Adverse Event|2|||
161620683|NCT00337610|583660614|FG000|Overall Study|Death|0|||
161620684|NCT00337610|583660615|FG001|Overall Study|Death|1|||
161620685|NCT00337610|583660614|FG000|Overall Study|Lack of Efficacy|6|||
161620686|NCT00337610|583660615|FG001|Overall Study|Lack of Efficacy|3|||
161620687|NCT00337610|583660614|FG000|Overall Study|Lost to Follow-up|3|||
161620688|NCT00337610|583660615|FG001|Overall Study|Lost to Follow-up|3|||
161620689|NCT00337610|583660614|FG000|Overall Study|Withdrawal by Subject|6|||
161620690|NCT00337610|583660615|FG001|Overall Study|Withdrawal by Subject|5|||
161620691|NCT02279732|583660620|FG000|Overall Study|Death|23|||
161620692|NCT02279732|583660621|FG001|Overall Study|Death|20|||
161620693|NCT02279732|583660620|FG000|Overall Study|Disease Progression|13|||
161620694|NCT02279732|583660621|FG001|Overall Study|Disease Progression|3|||
161620695|NCT02279732|583660620|FG000|Overall Study|Withdrawal by Subject|2|||
161620696|NCT02279732|583660621|FG001|Overall Study|Withdrawal by Subject|7|||
161620697|NCT02279732|583660620|FG000|Overall Study|Adverse Event|1|||
161832891|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
161620698|NCT02279732|583660621|FG001|Overall Study|Adverse Event|2|||
161620699|NCT02279732|583660620|FG000|Overall Study|Administrative Reason By Sponsor|0|||
161832892|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
161832893|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
161620700|NCT02279732|583660621|FG001|Overall Study|Administrative Reason By Sponsor|2|||
161620701|NCT02279732|583660620|FG000|Overall Study|Study Drug Toxicity|2|||
161620702|NCT02279732|583660621|FG001|Overall Study|Study Drug Toxicity|0|||
161620703|NCT02279732|583660620|FG000|Overall Study|Lost to Follow-up|0|||
161620704|NCT02279732|583660621|FG001|Overall Study|Lost to Follow-up|1|||
161620705|NCT02279732|583660620|FG000|Overall Study|Maximum Clinical Benefit|1|||
161620706|NCT02279732|583660621|FG001|Overall Study|Maximum Clinical Benefit|0|||
161620707|NCT02279732|583660620|FG000|Overall Study|Subject Requested to Discontinue|0|||
161620708|NCT02279732|583660621|FG001|Overall Study|Subject Requested to Discontinue|1|||
161620709|NCT02279732|583660620|FG000|Overall Study|Other|53|||
161620710|NCT02279732|583660621|FG001|Overall Study|Other|67|||
161620711|NCT02279732|583660620|FG000|Overall Study|Other|3|||
161620712|NCT02279732|583660621|FG001|Overall Study|Other|3|||
161620713|NCT02203513|583660625|FG000|Overall Study|Refused further treatment|2|||
161832894|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
161620714|NCT02203513|583660626|FG001|Overall Study|Refused further treatment|0|||
161620715|NCT02203513|583660627|FG002|Overall Study|Refused further treatment|1|||
161620716|NCT02203513|583660628|FG003|Overall Study|Refused further treatment|0|||
161620717|NCT02203513|583660629|FG004|Overall Study|Refused further treatment|0|||
161620718|NCT02203513|583660625|FG000|Overall Study|Switched to alternative treatment|3|||
161620719|NCT02203513|583660626|FG001|Overall Study|Switched to alternative treatment|4|||
161620720|NCT02203513|583660627|FG002|Overall Study|Switched to alternative treatment|0|||
161620721|NCT02203513|583660628|FG003|Overall Study|Switched to alternative treatment|0|||
161832895|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
161620722|NCT02203513|583660629|FG004|Overall Study|Switched to alternative treatment|4|||
161620723|NCT02203513|583660625|FG000|Overall Study|Did not receive investigational product (IP)|0|||
161620724|NCT02203513|583660626|FG001|Overall Study|Did not receive investigational product (IP)|1|||
161620725|NCT02203513|583660627|FG002|Overall Study|Did not receive investigational product (IP)|0|||
161620726|NCT02203513|583660628|FG003|Overall Study|Did not receive investigational product (IP)|0|||
161620727|NCT02203513|583660629|FG004|Overall Study|Did not receive investigational product (IP)|0|||
161832896|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
161832897|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Death|0|||
161832898|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Death|1|||
161832899|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Death|0|||
161620728|NCT02203513|583660625|FG000|Overall Study|Death (unrelated to study therapy)|1|||
161620729|NCT02203513|583660626|FG001|Overall Study|Death (unrelated to study therapy)|3|||
161620730|NCT02203513|583660627|FG002|Overall Study|Death (unrelated to study therapy)|1|||
161620731|NCT02203513|583660628|FG003|Overall Study|Death (unrelated to study therapy)|0|||
161620732|NCT02203513|583660629|FG004|Overall Study|Death (unrelated to study therapy)|2|||
161620733|NCT02203513|583660625|FG000|Overall Study|Lost to Follow-up|0|||
161620734|NCT02203513|583660626|FG001|Overall Study|Lost to Follow-up|0|||
161620735|NCT02203513|583660627|FG002|Overall Study|Lost to Follow-up|1|||
161620736|NCT02203513|583660628|FG003|Overall Study|Lost to Follow-up|1|||
161832900|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Death|0|||
161832901|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161832902|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
161832903|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161832904|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161832905|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
161832906|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
161832907|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
161832908|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
161832909|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Other|1|||
161832910|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Other|3|||
161832911|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Other|0|||
161832912|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Other|0|||
161832913|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
161832914|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
161832915|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
161832916|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
161832917|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Death|1|||
161832918|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Death|0|||
161832919|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Death|0|||
161832920|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Death|0|||
161832921|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
161832922|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
161832923|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
161832924|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
161832925|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
161832926|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
161620737|NCT02203513|583660629|FG004|Overall Study|Lost to Follow-up|0|||
161620738|NCT01441596|583660630|FG000|Overall Study|Other reason not defined below|0|||
161620739|NCT01441596|583660631|FG001|Overall Study|Other reason not defined below|2|||
161620740|NCT01441596|583660632|FG002|Overall Study|Other reason not defined below|1|||
161620741|NCT01441596|583660630|FG000|Overall Study|Withdrawal by Subject|4|||
161620742|NCT01441596|583660631|FG001|Overall Study|Withdrawal by Subject|0|||
161620743|NCT01441596|583660632|FG002|Overall Study|Withdrawal by Subject|2|||
161620744|NCT01441596|583660630|FG000|Overall Study|Not treated|0|||
161620745|NCT01441596|583660631|FG001|Overall Study|Not treated|1|||
161620746|NCT01441596|583660632|FG002|Overall Study|Not treated|1|||
161832927|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
161620747|NCT00116649|583660633|FG000|Overall Study|Adverse Event|20|||
161832928|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
161832929|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161832930|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
161832931|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161832932|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161832933|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
161832934|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
161832935|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
161832936|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
161832937|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832938|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161832939|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
161620748|NCT00116649|583660633|FG000|Overall Study|Lack of Efficacy|1|||
161620749|NCT00116649|583660633|FG000|Overall Study|Lost to Follow-up|32|||
161620750|NCT00116649|583660633|FG000|Overall Study|Withdrawal by Subject|68|||
161620751|NCT00116649|583660633|FG000|Overall Study|Local Skin Reaction|9|||
161620752|NCT00116649|583660633|FG000|Overall Study|Various Reasons|18|||
161620753|NCT00116649|583660633|FG000|Overall Study|Protocol Specified|7|||
161620754|NCT01131325|583662699|FG000|Overall Study|Adverse Event|1|||
161620755|NCT01131325|583662699|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
161620756|NCT03761849|583662700|FG000|Overall Study|transferred to OpenLabelExtension|35|||
161620757|NCT03761849|583662701|FG001|Overall Study|transferred to OpenLabelExtension|34|||
161620758|NCT03761849|583662702|FG002|Overall Study|transferred to OpenLabelExtension|36|||
161620759|NCT03761849|583662703|FG003|Overall Study|transferred to OpenLabelExtension|0|||
161620760|NCT03761849|583662704|FG004|Overall Study|transferred to OpenLabelExtension|0|||
161620761|NCT03761849|583662705|FG005|Overall Study|transferred to OpenLabelExtension|0|||
161620762|NCT03761849|583662700|FG000|Overall Study|Adverse Event|1|||
161620763|NCT03761849|583662701|FG001|Overall Study|Adverse Event|0|||
161620764|NCT03761849|583662702|FG002|Overall Study|Adverse Event|0|||
161620765|NCT03761849|583662703|FG003|Overall Study|Adverse Event|0|||
161620766|NCT03761849|583662704|FG004|Overall Study|Adverse Event|2|||
161620767|NCT03761849|583662705|FG005|Overall Study|Adverse Event|3|||
161620768|NCT03761849|583662700|FG000|Overall Study|Withdrawal by Subject|0|||
161620769|NCT03761849|583662701|FG001|Overall Study|Withdrawal by Subject|0|||
161620770|NCT03761849|583662702|FG002|Overall Study|Withdrawal by Subject|0|||
161620771|NCT03761849|583662703|FG003|Overall Study|Withdrawal by Subject|41|||
161620772|NCT03761849|583662704|FG004|Overall Study|Withdrawal by Subject|43|||
161620773|NCT03761849|583662705|FG005|Overall Study|Withdrawal by Subject|35|||
161620774|NCT03761849|583662700|FG000|Overall Study|Lost to Follow-up|0|||
161620775|NCT03761849|583662701|FG001|Overall Study|Lost to Follow-up|1|||
161620776|NCT03761849|583662702|FG002|Overall Study|Lost to Follow-up|0|||
161620777|NCT03761849|583662703|FG003|Overall Study|Lost to Follow-up|2|||
161620778|NCT03761849|583662704|FG004|Overall Study|Lost to Follow-up|4|||
161620779|NCT03761849|583662705|FG005|Overall Study|Lost to Follow-up|5|||
161620780|NCT03761849|583662700|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
161620781|NCT03761849|583662701|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
161620782|NCT03761849|583662702|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
161620783|NCT03761849|583662703|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
161620784|NCT03761849|583662704|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
161620785|NCT03761849|583662705|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
161620786|NCT03761849|583662700|FG000|Overall Study|Physician Decision|0|||
161620787|NCT03761849|583662701|FG001|Overall Study|Physician Decision|0|||
161620788|NCT03761849|583662702|FG002|Overall Study|Physician Decision|0|||
161620789|NCT03761849|583662703|FG003|Overall Study|Physician Decision|1|||
161620790|NCT03761849|583662704|FG004|Overall Study|Physician Decision|4|||
161620791|NCT03761849|583662705|FG005|Overall Study|Physician Decision|4|||
161620792|NCT03761849|583662700|FG000|Overall Study|Death|0|||
161620793|NCT03761849|583662701|FG001|Overall Study|Death|0|||
161620794|NCT03761849|583662702|FG002|Overall Study|Death|0|||
161620795|NCT03761849|583662703|FG003|Overall Study|Death|1|||
161620796|NCT03761849|583662704|FG004|Overall Study|Death|1|||
161620797|NCT03761849|583662705|FG005|Overall Study|Death|3|||
161620798|NCT03761849|583662700|FG000|Overall Study|Protocol Violation|0|||
161620799|NCT03761849|583662701|FG001|Overall Study|Protocol Violation|0|||
161620800|NCT03761849|583662702|FG002|Overall Study|Protocol Violation|0|||
161620801|NCT03761849|583662703|FG003|Overall Study|Protocol Violation|2|||
161620802|NCT03761849|583662704|FG004|Overall Study|Protocol Violation|2|||
161620803|NCT03761849|583662705|FG005|Overall Study|Protocol Violation|1|||
161620804|NCT03761849|583662700|FG000|Overall Study|Participant could not come to site|0|||
161620805|NCT03761849|583662701|FG001|Overall Study|Participant could not come to site|0|||
161620806|NCT03761849|583662702|FG002|Overall Study|Participant could not come to site|0|||
161620807|NCT03761849|583662703|FG003|Overall Study|Participant could not come to site|0|||
161620808|NCT03761849|583662704|FG004|Overall Study|Participant could not come to site|1|||
161620809|NCT03761849|583662705|FG005|Overall Study|Participant could not come to site|0|||
161620810|NCT03761849|583662700|FG000|Overall Study|SF- safety Finding|0|||
161620811|NCT03761849|583662701|FG001|Overall Study|SF- safety Finding|0|||
161620812|NCT03761849|583662702|FG002|Overall Study|SF- safety Finding|0|||
161620813|NCT03761849|583662703|FG003|Overall Study|SF- safety Finding|0|||
161620814|NCT03761849|583662704|FG004|Overall Study|SF- safety Finding|0|||
161684828|NCT01840579|583898014|FG002|Overall Study|Follow-up ended by Sponsor|0|||
161684829|NCT01840579|583898015|FG003|Overall Study|Follow-up ended by Sponsor|0|||
161620815|NCT03761849|583662705|FG005|Overall Study|SF- safety Finding|1|||
161620816|NCT03761849|583662700|FG000|Overall Study|Patient did not attend visit|0|||
161684830|NCT01840579|583898016|FG004|Overall Study|Follow-up ended by Sponsor|0|||
161684831|NCT01840579|583898017|FG005|Overall Study|Follow-up ended by Sponsor|0|||
161684832|NCT01840579|583898018|FG006|Overall Study|Follow-up ended by Sponsor|2|||
161684833|NCT01840579|583898019|FG007|Overall Study|Follow-up ended by Sponsor|0|||
161620817|NCT03761849|583662701|FG001|Overall Study|Patient did not attend visit|0|||
161620818|NCT03761849|583662702|FG002|Overall Study|Patient did not attend visit|0|||
161684834|NCT01840579|583898020|FG008|Overall Study|Follow-up ended by Sponsor|0|||
161620819|NCT03761849|583662703|FG003|Overall Study|Patient did not attend visit|0|||
161684835|NCT01840579|583898021|FG009|Overall Study|Follow-up ended by Sponsor|0|||
161620820|NCT03761849|583662704|FG004|Overall Study|Patient did not attend visit|0|||
161620821|NCT03761849|583662705|FG005|Overall Study|Patient did not attend visit|1|||
161620822|NCT03884478|583662706|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
161620823|NCT03884478|583662707|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
161620824|NCT03884478|583662708|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
161620825|NCT03884478|583662706|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
161620826|NCT03884478|583662707|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
161620827|NCT03884478|583662708|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
161620828|NCT03884478|583662706|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
161620829|NCT03884478|583662707|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
161620830|NCT03884478|583662708|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
161620831|NCT03884478|583662706|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
161620832|NCT03884478|583662707|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
161620833|NCT03884478|583662708|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
161620834|NCT03693989|583662711|FG000|Overall Study|Protocol Violation|3|||
161620835|NCT03693989|583662712|FG001|Overall Study|Protocol Violation|4|||
161620836|NCT01190436|583662713|FG000|Overall Study|Lost to Follow-up|35|||
161620837|NCT01190436|583662713|FG000|Overall Study|Other|4|||
161620838|NCT03146845|583662714|FG000|Overall Study|Reference ulcer healed|1|||
161620839|NCT03146845|583662715|FG001|Overall Study|Reference ulcer healed|0|||
161620840|NCT03146845|583662714|FG000|Overall Study|Physician Decision|1|||
161620841|NCT03146845|583662715|FG001|Overall Study|Physician Decision|0|||
161620842|NCT03146845|583662714|FG000|Overall Study|Adverse Event|1|||
161620843|NCT03146845|583662715|FG001|Overall Study|Adverse Event|0|||
161620844|NCT03146845|583662714|FG000|Overall Study|Withdrawal by Subject|2|||
161620845|NCT03146845|583662715|FG001|Overall Study|Withdrawal by Subject|0|||
161620846|NCT03146845|583662714|FG000|Overall Study|Noncompliance|0|||
161620847|NCT03146845|583662715|FG001|Overall Study|Noncompliance|1|||
161620848|NCT03146845|583662714|FG000|Overall Study|Protocol Violation|0|||
161620849|NCT03146845|583662715|FG001|Overall Study|Protocol Violation|2|||
161620850|NCT03146845|583662714|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
161620851|NCT03146845|583662715|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
161620852|NCT01052272|583662718|FG000|Overall Study|Death|0|||
161620853|NCT01052272|583662719|FG001|Overall Study|Death|0|||
161620854|NCT01052272|583662720|FG002|Overall Study|Death|1|||
161620855|NCT01052272|583662721|FG003|Overall Study|Death|1|||
161620856|NCT01052272|583662718|FG000|Overall Study|Physician Decision|0|||
161620857|NCT01052272|583662719|FG001|Overall Study|Physician Decision|1|||
161620858|NCT01052272|583662720|FG002|Overall Study|Physician Decision|0|||
161620859|NCT01052272|583662721|FG003|Overall Study|Physician Decision|0|||
161620860|NCT01052272|583662718|FG000|Overall Study|patient refuses follow-up|5|||
161620861|NCT01052272|583662719|FG001|Overall Study|patient refuses follow-up|4|||
161620862|NCT01052272|583662720|FG002|Overall Study|patient refuses follow-up|2|||
161620863|NCT01052272|583662721|FG003|Overall Study|patient refuses follow-up|4|||
161620864|NCT01052272|583662718|FG000|Overall Study|Withdrawal by Subject|0|||
161620865|NCT01052272|583662719|FG001|Overall Study|Withdrawal by Subject|2|||
161620866|NCT01052272|583662720|FG002|Overall Study|Withdrawal by Subject|3|||
161620867|NCT01052272|583662721|FG003|Overall Study|Withdrawal by Subject|2|||
161620868|NCT01052272|583662718|FG000|Overall Study|placed in long-term care|0|||
161620869|NCT01052272|583662719|FG001|Overall Study|placed in long-term care|0|||
161620870|NCT01052272|583662720|FG002|Overall Study|placed in long-term care|1|||
161620871|NCT01052272|583662721|FG003|Overall Study|placed in long-term care|0|||
161620872|NCT01052272|583662718|FG000|Overall Study|decline in health|0|||
161620873|NCT01052272|583662719|FG001|Overall Study|decline in health|0|||
161620874|NCT01052272|583662720|FG002|Overall Study|decline in health|1|||
161620875|NCT01052272|583662721|FG003|Overall Study|decline in health|0|||
161620876|NCT00113529|583662723|FG000|Overall Study|Adverse Event|4|||
161620877|NCT00113529|583662723|FG000|Overall Study|Lack of Efficacy|20|||
161620878|NCT00113529|583662723|FG000|Overall Study|Decision of sponsor|6|||
161620879|NCT00113529|583662723|FG000|Overall Study|Withdrawal by Subject|4|||
161620880|NCT00648895|583662725|FG000|Overall Study|Lack of Efficacy|0|||
161684836|NCT01585272|583898028|FG000|Overall Study|Adverse Event|22|||
161684837|NCT01585272|583898028|FG000|Overall Study|Protocol Violation|7|||
161684838|NCT01585272|583898028|FG000|Overall Study|Withdrawal by Subject|10|||
161684839|NCT00645593|583898029|FG000|Overall Study|Later found to be ineligible|1|||
161684840|NCT00645593|583898030|FG001|Overall Study|Later found to be ineligible|0|||
161620881|NCT00648895|583662726|FG001|Overall Study|Lack of Efficacy|1|||
161620882|NCT00841321|583662733|FG000|Overall Study|Lost to Follow-up|1|||
161620883|NCT00841321|583662734|FG001|Overall Study|Lost to Follow-up|1|||
161832940|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
161620884|NCT00841321|583662733|FG000|Overall Study|Adverse Event|0|||
161620885|NCT00841321|583662734|FG001|Overall Study|Adverse Event|2|||
161620886|NCT02632747|583662737|FG000|Wash-out Period|Adverse Event|1|||
161620887|NCT02632747|583662738|FG001|Wash-out Period|Adverse Event|0|||
161620888|NCT04421456|583662739|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
161620889|NCT04421456|583662740|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
161620890|NCT04421456|583662741|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
161620891|NCT04421456|583662739|FG000|Randomized Treatment Period|Adverse Event|0|||
161620892|NCT04421456|583662740|FG001|Randomized Treatment Period|Adverse Event|1|||
161620893|NCT04421456|583662741|FG002|Randomized Treatment Period|Adverse Event|0|||
161620894|NCT04421456|583662739|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
161620895|NCT04421456|583662740|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
161620896|NCT04421456|583662741|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
161620897|NCT04421456|583662739|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
161620898|NCT04421456|583662740|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
161620899|NCT04421456|583662741|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
161620900|NCT04421456|583662739|FG000|Randomized Treatment Period|Participant non-compliance|1|||
161620901|NCT04421456|583662740|FG001|Randomized Treatment Period|Participant non-compliance|1|||
161620902|NCT04421456|583662741|FG002|Randomized Treatment Period|Participant non-compliance|2|||
161620903|NCT04421456|583662739|FG000|Randomized Treatment Period|Other|0|||
161620904|NCT04421456|583662740|FG001|Randomized Treatment Period|Other|1|||
161620905|NCT04421456|583662741|FG002|Randomized Treatment Period|Other|3|||
161620906|NCT00379210|583662742|FG000|Overall Study|Withdrawal by Subject|10|||
161620907|NCT00379210|583662743|FG001|Overall Study|Withdrawal by Subject|7|||
161620908|NCT01358175|583662744|FG000|Overall Study|Death|1|||
161620909|NCT01358175|583662745|FG001|Overall Study|Death|0|||
161620910|NCT01358175|583662746|FG002|Overall Study|Death|1|||
161620911|NCT01358175|583662744|FG000|Overall Study|Withdrawal by Subject|9|||
161620912|NCT01358175|583662745|FG001|Overall Study|Withdrawal by Subject|5|||
161620913|NCT01358175|583662746|FG002|Overall Study|Withdrawal by Subject|10|||
161620914|NCT01358175|583662744|FG000|Overall Study|Technical issues|0|||
161620915|NCT01358175|583662745|FG001|Overall Study|Technical issues|1|||
161620916|NCT01358175|583662746|FG002|Overall Study|Technical issues|0|||
161620917|NCT01358175|583662744|FG000|Overall Study|Pregnancy|0|||
161620918|NCT01358175|583662745|FG001|Overall Study|Pregnancy|1|||
161620919|NCT01358175|583662746|FG002|Overall Study|Pregnancy|0|||
161620920|NCT01358175|583662744|FG000|Overall Study|Physician Decision|1|||
161620921|NCT01358175|583662745|FG001|Overall Study|Physician Decision|0|||
161620922|NCT01358175|583662746|FG002|Overall Study|Physician Decision|0|||
161620923|NCT01358175|583662744|FG000|Overall Study|Non Compliance with Study Treatment|0|||
161620924|NCT01358175|583662745|FG001|Overall Study|Non Compliance with Study Treatment|1|||
161620925|NCT01358175|583662746|FG002|Overall Study|Non Compliance with Study Treatment|1|||
161620926|NCT01358175|583662744|FG000|Overall Study|Lost to Follow-up|1|||
161620927|NCT01358175|583662745|FG001|Overall Study|Lost to Follow-up|1|||
161620928|NCT01358175|583662746|FG002|Overall Study|Lost to Follow-up|3|||
161620929|NCT01358175|583662744|FG000|Overall Study|Lack of Efficacy|3|||
161620930|NCT01358175|583662745|FG001|Overall Study|Lack of Efficacy|8|||
161620931|NCT01358175|583662746|FG002|Overall Study|Lack of Efficacy|6|||
161620932|NCT01358175|583662744|FG000|Overall Study|Adverse Event|6|||
161620933|NCT01358175|583662745|FG001|Overall Study|Adverse Event|11|||
161620934|NCT01358175|583662746|FG002|Overall Study|Adverse Event|11|||
161620935|NCT03875729|583662751|FG000|Overall Study|Adverse Event|0|||
161620936|NCT03875729|583662752|FG001|Overall Study|Adverse Event|5|||
161620937|NCT03875729|583662751|FG000|Overall Study|Withdrawal by Subject|8|||
161620938|NCT03875729|583662752|FG001|Overall Study|Withdrawal by Subject|11|||
161620939|NCT03875729|583662751|FG000|Overall Study|Pregnancy|0|||
161620940|NCT03875729|583662752|FG001|Overall Study|Pregnancy|1|||
161620941|NCT03875729|583662751|FG000|Overall Study|Lost to Follow-up|0|||
161620942|NCT03875729|583662752|FG001|Overall Study|Lost to Follow-up|5|||
161620943|NCT03875729|583662751|FG000|Overall Study|Personal reasons|2|||
161620944|NCT03875729|583662752|FG001|Overall Study|Personal reasons|0|||
161620945|NCT00753896|583662753|FG000|Overall Study|Adverse Event|4|||
161620946|NCT00753896|583662753|FG000|Overall Study|Death|1|||
161620947|NCT00753896|583662753|FG000|Overall Study|Lost to Follow-up|2|||
161620948|NCT00753896|583662753|FG000|Overall Study|Protocol Violation|1|||
161620949|NCT00753896|583662753|FG000|Overall Study|Withdrawal by Subject|4|||
161620950|NCT00753896|583662753|FG000|Overall Study|Entry Criteria Not Met|4|||
161620951|NCT01280656|583662754|FG000|Overall Study|Adverse Event|1|||
161620952|NCT01280656|583662755|FG001|Overall Study|Adverse Event|14|||
161620953|NCT01280656|583662756|FG002|Overall Study|Adverse Event|13|||
161620954|NCT01280656|583662754|FG000|Overall Study|Lack of Efficacy|1|||
161620955|NCT01280656|583662755|FG001|Overall Study|Lack of Efficacy|22|||
161620956|NCT01280656|583662756|FG002|Overall Study|Lack of Efficacy|38|||
161620957|NCT01280656|583662754|FG000|Overall Study|Treatment shortening (RGT)|0|||
161620958|NCT01280656|583662755|FG001|Overall Study|Treatment shortening (RGT)|4|||
161620959|NCT01280656|583662756|FG002|Overall Study|Treatment shortening (RGT)|5|||
161620960|NCT01280656|583662754|FG000|Overall Study|Other|1|||
161620961|NCT01280656|583662755|FG001|Overall Study|Other|7|||
161620962|NCT01280656|583662756|FG002|Overall Study|Other|7|||
161620963|NCT00952523|583662757|FG000|Overall Study|Withdrawal by Subject|7|||
161620964|NCT01029925|583662758|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
161620965|NCT01029925|583662758|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
161620966|NCT01029925|583662758|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
161620967|NCT05265247|583662759|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
161620968|NCT05265247|583662760|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
161620969|NCT05265247|583662759|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
161620970|NCT05265247|583662760|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
161620971|NCT05265247|583662759|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
161620972|NCT05265247|583662760|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
161620973|NCT00476957|583662761|FG000|Overall Study|Lost to Follow-up|176|||
161620974|NCT00476957|583662762|FG001|Overall Study|Lost to Follow-up|193|||
161620975|NCT02516202|583662763|FG000|Overall Study|Withdrawal by Subject|1|||
161620976|NCT02516202|583662764|FG001|Overall Study|Withdrawal by Subject|0|||
161620977|NCT02516202|583662765|FG002|Overall Study|Withdrawal by Subject|1|||
161620978|NCT02516202|583662763|FG000|Overall Study|Lost to Follow-up|1|||
161620979|NCT02516202|583662764|FG001|Overall Study|Lost to Follow-up|1|||
161620980|NCT02516202|583662765|FG002|Overall Study|Lost to Follow-up|1|||
161620981|NCT02516202|583662763|FG000|Overall Study|Stopped Follow-up|0|||
161620982|NCT02516202|583662764|FG001|Overall Study|Stopped Follow-up|0|||
161620983|NCT02516202|583662765|FG002|Overall Study|Stopped Follow-up|1|||
161620984|NCT01000649|583662768|FG000|Overall Study|Adverse Event|5|||
161620985|NCT01000649|583662769|FG001|Overall Study|Adverse Event|1|||
161620986|NCT01000649|583662770|FG002|Overall Study|Adverse Event|2|||
161620987|NCT01000649|583662771|FG003|Overall Study|Adverse Event|4|||
161620988|NCT01000649|583662768|FG000|Overall Study|Lost to Follow-up|0|||
161620989|NCT01000649|583662769|FG001|Overall Study|Lost to Follow-up|2|||
161620990|NCT01000649|583662770|FG002|Overall Study|Lost to Follow-up|0|||
161620991|NCT01000649|583662771|FG003|Overall Study|Lost to Follow-up|2|||
161620992|NCT01916109|583662772|FG000|Overall Study|Withdrawal by Subject|1|||
161620993|NCT00103857|583662773|FG000|54-Week Base Study|Adverse Event|12|||
161620994|NCT00103857|583662774|FG001|54-Week Base Study|Adverse Event|9|||
161620995|NCT00103857|583662775|FG002|54-Week Base Study|Adverse Event|11|||
161620996|NCT00103857|583662776|FG003|54-Week Base Study|Adverse Event|6|||
161620997|NCT00103857|583662777|FG004|54-Week Base Study|Adverse Event|5|||
161620998|NCT00103857|583662778|FG005|54-Week Base Study|Adverse Event|11|||
161620999|NCT00103857|583662779|FG006|54-Week Base Study|Adverse Event|3|||
161621000|NCT00103857|583662773|FG000|54-Week Base Study|Death|0|||
161621001|NCT00103857|583662774|FG001|54-Week Base Study|Death|0|||
161621002|NCT00103857|583662775|FG002|54-Week Base Study|Death|0|||
161621003|NCT00103857|583662776|FG003|54-Week Base Study|Death|0|||
161621004|NCT00103857|583662777|FG004|54-Week Base Study|Death|1|||
161621005|NCT00103857|583662778|FG005|54-Week Base Study|Death|1|||
161621006|NCT00103857|583662779|FG006|54-Week Base Study|Death|0|||
161621007|NCT00103857|583662773|FG000|54-Week Base Study|Lack of Efficacy|11|||
161621008|NCT00103857|583662774|FG001|54-Week Base Study|Lack of Efficacy|14|||
161621009|NCT00103857|583662775|FG002|54-Week Base Study|Lack of Efficacy|8|||
161621010|NCT00103857|583662776|FG003|54-Week Base Study|Lack of Efficacy|4|||
161621011|NCT00103857|583662777|FG004|54-Week Base Study|Lack of Efficacy|3|||
161621012|NCT00103857|583662778|FG005|54-Week Base Study|Lack of Efficacy|14|||
161621013|NCT00103857|583662779|FG006|54-Week Base Study|Lack of Efficacy|19|||
161621014|NCT00103857|583662773|FG000|54-Week Base Study|Lost to Follow-up|5|||
161621015|NCT00103857|583662774|FG001|54-Week Base Study|Lost to Follow-up|4|||
161621016|NCT00103857|583662775|FG002|54-Week Base Study|Lost to Follow-up|7|||
161621017|NCT00103857|583662776|FG003|54-Week Base Study|Lost to Follow-up|5|||
161621018|NCT00103857|583662777|FG004|54-Week Base Study|Lost to Follow-up|10|||
161621019|NCT00103857|583662778|FG005|54-Week Base Study|Lost to Follow-up|9|||
161621020|NCT00103857|583662779|FG006|54-Week Base Study|Lost to Follow-up|3|||
161621021|NCT00103857|583662773|FG000|54-Week Base Study|Physician Decision|1|||
161621022|NCT00103857|583662774|FG001|54-Week Base Study|Physician Decision|1|||
161621023|NCT00103857|583662775|FG002|54-Week Base Study|Physician Decision|0|||
161621024|NCT00103857|583662776|FG003|54-Week Base Study|Physician Decision|0|||
161621025|NCT00103857|583662777|FG004|54-Week Base Study|Physician Decision|1|||
161621026|NCT00103857|583662778|FG005|54-Week Base Study|Physician Decision|0|||
161621027|NCT00103857|583662779|FG006|54-Week Base Study|Physician Decision|0|||
161621028|NCT00103857|583662773|FG000|54-Week Base Study|Pregnancy|1|||
161621029|NCT00103857|583662774|FG001|54-Week Base Study|Pregnancy|0|||
161621030|NCT00103857|583662775|FG002|54-Week Base Study|Pregnancy|0|||
161621031|NCT00103857|583662776|FG003|54-Week Base Study|Pregnancy|0|||
161621032|NCT00103857|583662777|FG004|54-Week Base Study|Pregnancy|1|||
161621033|NCT00103857|583662778|FG005|54-Week Base Study|Pregnancy|0|||
161621034|NCT00103857|583662779|FG006|54-Week Base Study|Pregnancy|1|||
161621035|NCT00103857|583662773|FG000|54-Week Base Study|Protocol Violation|6|||
161621036|NCT00103857|583662774|FG001|54-Week Base Study|Protocol Violation|4|||
161621037|NCT00103857|583662775|FG002|54-Week Base Study|Protocol Violation|2|||
161621038|NCT00103857|583662776|FG003|54-Week Base Study|Protocol Violation|4|||
161621039|NCT00103857|583662777|FG004|54-Week Base Study|Protocol Violation|0|||
161621040|NCT00103857|583662778|FG005|54-Week Base Study|Protocol Violation|3|||
161621041|NCT00103857|583662779|FG006|54-Week Base Study|Protocol Violation|3|||
161621042|NCT00103857|583662773|FG000|54-Week Base Study|Withdrawal by Subject|17|||
161621043|NCT00103857|583662774|FG001|54-Week Base Study|Withdrawal by Subject|16|||
161621044|NCT00103857|583662775|FG002|54-Week Base Study|Withdrawal by Subject|16|||
161621045|NCT00103857|583662776|FG003|54-Week Base Study|Withdrawal by Subject|15|||
161621046|NCT00103857|583662777|FG004|54-Week Base Study|Withdrawal by Subject|10|||
161621047|NCT00103857|583662778|FG005|54-Week Base Study|Withdrawal by Subject|15|||
161621048|NCT00103857|583662779|FG006|54-Week Base Study|Withdrawal by Subject|4|||
161621049|NCT00103857|583662773|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
161621050|NCT00103857|583662774|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
161621051|NCT00103857|583662775|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
161621052|NCT00103857|583662776|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
161621053|NCT00103857|583662777|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
161621054|NCT00103857|583662778|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
161621055|NCT00103857|583662779|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
161621056|NCT00103857|583662773|FG000|54-Week Base Study|patient moved|0|||
161621057|NCT00103857|583662774|FG001|54-Week Base Study|patient moved|1|||
161621058|NCT00103857|583662775|FG002|54-Week Base Study|patient moved|1|||
161621059|NCT00103857|583662776|FG003|54-Week Base Study|patient moved|2|||
161621060|NCT00103857|583662777|FG004|54-Week Base Study|patient moved|3|||
161621061|NCT00103857|583662778|FG005|54-Week Base Study|patient moved|1|||
161621062|NCT00103857|583662779|FG006|54-Week Base Study|patient moved|0|||
161621063|NCT00103857|583662773|FG000|54-Week Base Study|non-compliance with study procedures|1|||
161621064|NCT00103857|583662774|FG001|54-Week Base Study|non-compliance with study procedures|2|||
161621065|NCT00103857|583662775|FG002|54-Week Base Study|non-compliance with study procedures|0|||
161621066|NCT00103857|583662776|FG003|54-Week Base Study|non-compliance with study procedures|0|||
161621067|NCT00103857|583662777|FG004|54-Week Base Study|non-compliance with study procedures|0|||
161621068|NCT00103857|583662778|FG005|54-Week Base Study|non-compliance with study procedures|2|||
161621069|NCT00103857|583662779|FG006|54-Week Base Study|non-compliance with study procedures|0|||
161621070|NCT00103857|583662773|FG000|54-Week Base Study|patient incarcerated|0|||
161621071|NCT00103857|583662774|FG001|54-Week Base Study|patient incarcerated|0|||
161621072|NCT00103857|583662775|FG002|54-Week Base Study|patient incarcerated|0|||
161621073|NCT00103857|583662776|FG003|54-Week Base Study|patient incarcerated|0|||
161621074|NCT00103857|583662777|FG004|54-Week Base Study|patient incarcerated|1|||
161621075|NCT00103857|583662778|FG005|54-Week Base Study|patient incarcerated|1|||
161621076|NCT00103857|583662779|FG006|54-Week Base Study|patient incarcerated|0|||
161621077|NCT00103857|583662773|FG000|54-Week Base Study|laboratory reporting error|0|||
161621078|NCT00103857|583662774|FG001|54-Week Base Study|laboratory reporting error|0|||
161621079|NCT00103857|583662775|FG002|54-Week Base Study|laboratory reporting error|0|||
161621080|NCT00103857|583662776|FG003|54-Week Base Study|laboratory reporting error|0|||
161621081|NCT00103857|583662777|FG004|54-Week Base Study|laboratory reporting error|1|||
161621082|NCT00103857|583662778|FG005|54-Week Base Study|laboratory reporting error|0|||
161621083|NCT00103857|583662779|FG006|54-Week Base Study|laboratory reporting error|0|||
161621084|NCT00103857|583662773|FG000|54-Week Base Study|site error|0|||
161621085|NCT00103857|583662774|FG001|54-Week Base Study|site error|0|||
161621086|NCT00103857|583662775|FG002|54-Week Base Study|site error|0|||
161621087|NCT00103857|583662776|FG003|54-Week Base Study|site error|0|||
161621088|NCT00103857|583662777|FG004|54-Week Base Study|site error|0|||
161621089|NCT00103857|583662778|FG005|54-Week Base Study|site error|1|||
161621090|NCT00103857|583662779|FG006|54-Week Base Study|site error|0|||
161621091|NCT00103857|583662773|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
161621092|NCT00103857|583662774|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
161621093|NCT00103857|583662775|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
161621094|NCT00103857|583662776|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
161832941|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
161621095|NCT00103857|583662777|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
161621096|NCT00103857|583662778|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
161621097|NCT00103857|583662779|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
161621098|NCT00103857|583662773|FG000|50-Week Extension Study|Adverse Event|2|||
161621099|NCT00103857|583662774|FG001|50-Week Extension Study|Adverse Event|3|||
161832942|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
161621100|NCT00103857|583662775|FG002|50-Week Extension Study|Adverse Event|2|||
161621101|NCT00103857|583662776|FG003|50-Week Extension Study|Adverse Event|0|||
161621102|NCT00103857|583662777|FG004|50-Week Extension Study|Adverse Event|1|||
161684841|NCT04013529|583898033|FG000|Overall Study|Withdrawal by Subject|1|||
161684842|NCT04013529|583898034|FG001|Overall Study|Withdrawal by Subject|1|||
161684843|NCT00609791|583899571|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
161684844|NCT02484911|583899573|FG000|Overall Study|Withdrawal by Subject|2|||
161684845|NCT02484911|583899574|FG001|Overall Study|Withdrawal by Subject|1|||
161621103|NCT00103857|583662778|FG005|50-Week Extension Study|Adverse Event|1|||
161621104|NCT00103857|583662779|FG006|50-Week Extension Study|Adverse Event|0|||
161621105|NCT00103857|583662773|FG000|50-Week Extension Study|Death|0|||
161621106|NCT00103857|583662774|FG001|50-Week Extension Study|Death|0|||
161621107|NCT00103857|583662775|FG002|50-Week Extension Study|Death|0|||
161621108|NCT00103857|583662776|FG003|50-Week Extension Study|Death|1|||
161621109|NCT00103857|583662777|FG004|50-Week Extension Study|Death|0|||
161621110|NCT00103857|583662778|FG005|50-Week Extension Study|Death|1|||
161621111|NCT00103857|583662779|FG006|50-Week Extension Study|Death|0|||
161621112|NCT00103857|583662773|FG000|50-Week Extension Study|Lack of Efficacy|26|||
161621113|NCT00103857|583662774|FG001|50-Week Extension Study|Lack of Efficacy|15|||
161621114|NCT00103857|583662775|FG002|50-Week Extension Study|Lack of Efficacy|13|||
161621115|NCT00103857|583662776|FG003|50-Week Extension Study|Lack of Efficacy|16|||
161621116|NCT00103857|583662777|FG004|50-Week Extension Study|Lack of Efficacy|8|||
161621117|NCT00103857|583662778|FG005|50-Week Extension Study|Lack of Efficacy|8|||
161621118|NCT00103857|583662779|FG006|50-Week Extension Study|Lack of Efficacy|0|||
161621119|NCT00103857|583662773|FG000|50-Week Extension Study|Lost to Follow-up|4|||
161621120|NCT00103857|583662774|FG001|50-Week Extension Study|Lost to Follow-up|0|||
161621121|NCT00103857|583662775|FG002|50-Week Extension Study|Lost to Follow-up|1|||
161621122|NCT00103857|583662776|FG003|50-Week Extension Study|Lost to Follow-up|4|||
161621123|NCT00103857|583662777|FG004|50-Week Extension Study|Lost to Follow-up|3|||
161621124|NCT00103857|583662778|FG005|50-Week Extension Study|Lost to Follow-up|3|||
161621125|NCT00103857|583662779|FG006|50-Week Extension Study|Lost to Follow-up|0|||
161621126|NCT00103857|583662773|FG000|50-Week Extension Study|Physician Decision|0|||
161621127|NCT00103857|583662774|FG001|50-Week Extension Study|Physician Decision|1|||
161621128|NCT00103857|583662775|FG002|50-Week Extension Study|Physician Decision|1|||
161621129|NCT00103857|583662776|FG003|50-Week Extension Study|Physician Decision|0|||
161621130|NCT00103857|583662777|FG004|50-Week Extension Study|Physician Decision|0|||
161621131|NCT00103857|583662778|FG005|50-Week Extension Study|Physician Decision|0|||
161621132|NCT00103857|583662779|FG006|50-Week Extension Study|Physician Decision|0|||
161621133|NCT00103857|583662773|FG000|50-Week Extension Study|Pregnancy|0|||
161621134|NCT00103857|583662774|FG001|50-Week Extension Study|Pregnancy|0|||
161621135|NCT00103857|583662775|FG002|50-Week Extension Study|Pregnancy|1|||
161621136|NCT00103857|583662776|FG003|50-Week Extension Study|Pregnancy|0|||
161621137|NCT00103857|583662777|FG004|50-Week Extension Study|Pregnancy|1|||
161621138|NCT00103857|583662778|FG005|50-Week Extension Study|Pregnancy|0|||
161621139|NCT00103857|583662779|FG006|50-Week Extension Study|Pregnancy|0|||
161621140|NCT00103857|583662773|FG000|50-Week Extension Study|Protocol Violation|1|||
161621141|NCT00103857|583662774|FG001|50-Week Extension Study|Protocol Violation|1|||
161621142|NCT00103857|583662775|FG002|50-Week Extension Study|Protocol Violation|1|||
161621143|NCT00103857|583662776|FG003|50-Week Extension Study|Protocol Violation|2|||
161621144|NCT00103857|583662777|FG004|50-Week Extension Study|Protocol Violation|0|||
161621145|NCT00103857|583662778|FG005|50-Week Extension Study|Protocol Violation|1|||
161621146|NCT00103857|583662779|FG006|50-Week Extension Study|Protocol Violation|0|||
161621147|NCT00103857|583662773|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
161621148|NCT00103857|583662774|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
161621149|NCT00103857|583662775|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
161621150|NCT00103857|583662776|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
161621151|NCT00103857|583662777|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
161621152|NCT00103857|583662778|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
161621153|NCT00103857|583662779|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
161684846|NCT02484911|583899573|FG000|Overall Study|Protocol Violation|2|||
161684847|NCT02484911|583899574|FG001|Overall Study|Protocol Violation|1|||
161684848|NCT04129528|583899578|FG000|Overall Study|Adverse Event|1|||
161684849|NCT04129528|583899579|FG001|Overall Study|Adverse Event|0|||
161621154|NCT00103857|583662773|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
161621155|NCT00103857|583662774|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
161621156|NCT00103857|583662775|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
161621157|NCT00103857|583662776|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
161621158|NCT00103857|583662777|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
161621159|NCT00103857|583662778|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
161621160|NCT00103857|583662779|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
161621161|NCT00103857|583662773|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
161684850|NCT04129528|583899578|FG000|Overall Study|Physician Decision|1|||
161684851|NCT04129528|583899579|FG001|Overall Study|Physician Decision|1|||
161621162|NCT00103857|583662774|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
161621163|NCT00103857|583662775|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
161621164|NCT00103857|583662776|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
161621165|NCT00103857|583662777|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
161621166|NCT00103857|583662778|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
161621167|NCT00103857|583662779|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
161621168|NCT00103857|583662773|FG000|50-Week Extension Study|patient moved|0|||
161621169|NCT00103857|583662774|FG001|50-Week Extension Study|patient moved|0|||
161621170|NCT00103857|583662775|FG002|50-Week Extension Study|patient moved|1|||
161621171|NCT00103857|583662776|FG003|50-Week Extension Study|patient moved|2|||
161621172|NCT00103857|583662777|FG004|50-Week Extension Study|patient moved|0|||
161621173|NCT00103857|583662778|FG005|50-Week Extension Study|patient moved|0|||
161621174|NCT00103857|583662779|FG006|50-Week Extension Study|patient moved|0|||
161621175|NCT00103857|583662773|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
161621176|NCT00103857|583662774|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
161621177|NCT00103857|583662775|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
161621178|NCT00103857|583662776|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
161621179|NCT00103857|583662777|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
161621180|NCT00103857|583662778|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
161621181|NCT00103857|583662779|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
161621182|NCT00103857|583662773|FG000|50-Week Extension Study|reason unspecified|0|||
161621183|NCT00103857|583662774|FG001|50-Week Extension Study|reason unspecified|0|||
161621184|NCT00103857|583662775|FG002|50-Week Extension Study|reason unspecified|0|||
161621185|NCT00103857|583662776|FG003|50-Week Extension Study|reason unspecified|0|||
161621186|NCT00103857|583662777|FG004|50-Week Extension Study|reason unspecified|1|||
161621187|NCT00103857|583662778|FG005|50-Week Extension Study|reason unspecified|0|||
161621188|NCT00103857|583662779|FG006|50-Week Extension Study|reason unspecified|0|||
161621189|NCT02707952|583662782|FG000|Overall Study|Adverse Event|1|||
161621190|NCT02707952|583662783|FG001|Overall Study|Adverse Event|0|||
161621191|NCT02707952|583662784|FG002|Overall Study|Adverse Event|0|||
161621192|NCT02707952|583662785|FG003|Overall Study|Adverse Event|0|||
161621193|NCT02707952|583662782|FG000|Overall Study|Lost to Follow-up|1|||
161621194|NCT02707952|583662783|FG001|Overall Study|Lost to Follow-up|0|||
161621195|NCT02707952|583662784|FG002|Overall Study|Lost to Follow-up|0|||
161621196|NCT02707952|583662785|FG003|Overall Study|Lost to Follow-up|0|||
161621197|NCT02707952|583662782|FG000|Overall Study|Withdrawal by Subject|0|||
161621198|NCT02707952|583662783|FG001|Overall Study|Withdrawal by Subject|1|||
161621199|NCT02707952|583662784|FG002|Overall Study|Withdrawal by Subject|2|||
161621200|NCT02707952|583662785|FG003|Overall Study|Withdrawal by Subject|0|||
161621201|NCT01287832|583662787|FG000|Overall Study|Adverse Event|1|||
161621202|NCT01287832|583662788|FG001|Overall Study|Adverse Event|0|||
161621203|NCT01287832|583662787|FG000|Overall Study|Death|0|||
161621204|NCT01287832|583662788|FG001|Overall Study|Death|1|||
161621205|NCT03065400|583662791|FG000|Overall Study|Adverse Event|1|||
161621206|NCT03065400|583662791|FG000|Overall Study|Physician Decision|3|||
161621207|NCT03065400|583662791|FG000|Overall Study|Withdrawal by Subject|1|||
161621208|NCT03065400|583662791|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
161621209|NCT03072862|583662792|FG000|Overall Study|Withdrawal by Subject|4|||
161621210|NCT03072862|583662792|FG000|Overall Study|Lost to Follow-up|6|||
161621211|NCT03072862|583662792|FG000|Overall Study|Protocol Violation|4|||
161621212|NCT03072862|583662792|FG000|Overall Study|Physician Decision|2|||
161621213|NCT03072862|583662792|FG000|Overall Study|Death|1|||
161621214|NCT03072862|583662792|FG000|Overall Study|Adverse Event|1|||
161621215|NCT00632736|583662793|FG000|Overall Study|Adverse Event|104|||
161621216|NCT00632736|583662793|FG000|Overall Study|Lost to Follow-up|15|||
161621217|NCT00632736|583662793|FG000|Overall Study|Protocol Violation|14|||
161621218|NCT00632736|583662793|FG000|Overall Study|Withdrawal by Subject|99|||
161621219|NCT00632736|583662793|FG000|Overall Study|Lack of Efficacy|5|||
161621220|NCT00632736|583662793|FG000|Overall Study|Sponsor terminated study|5|||
161621221|NCT00632736|583662793|FG000|Overall Study|Non-compliance|10|||
161621222|NCT00632736|583662793|FG000|Overall Study|Other|16|||
161621223|NCT03347396|583662794|FG000|Part A (26 Weeks)|Adverse Event|1|||
161621224|NCT03347396|583662795|FG001|Part A (26 Weeks)|Adverse Event|0|||
161621225|NCT03347396|583662794|FG000|Part A (26 Weeks)|Death|0|||
161621226|NCT03347396|583662795|FG001|Part A (26 Weeks)|Death|1|||
161621227|NCT03347396|583662794|FG000|Part B (149 Weeks)|Adverse Event|1|||
161621228|NCT03347396|583662795|FG001|Part B (149 Weeks)|Adverse Event|1|||
161621229|NCT03347396|583662794|FG000|Part B (149 Weeks)|Death|1|||
161621230|NCT03347396|583662795|FG001|Part B (149 Weeks)|Death|0|||
161621231|NCT03015220|583662798|FG000|Overall Study|Withdrawal by Subject|3|||
161621232|NCT03015220|583662799|FG001|Overall Study|Withdrawal by Subject|2|||
161621233|NCT03015220|583662800|FG002|Overall Study|Withdrawal by Subject|2|||
161621234|NCT03015220|583662801|FG003|Overall Study|Withdrawal by Subject|2|||
161621235|NCT03015220|583662798|FG000|Overall Study|Lost to Follow-up|0|||
161621236|NCT03015220|583662799|FG001|Overall Study|Lost to Follow-up|0|||
161621237|NCT03015220|583662800|FG002|Overall Study|Lost to Follow-up|1|||
161621238|NCT03015220|583662801|FG003|Overall Study|Lost to Follow-up|0|||
161621239|NCT01670526|583662802|FG000|Overall Study|Withdrawal by Subject|3|||
161621240|NCT01670526|583662803|FG001|Overall Study|Withdrawal by Subject|1|||
161621241|NCT01670526|583662802|FG000|Overall Study|Lost to Follow-up|9|||
161621242|NCT01670526|583662803|FG001|Overall Study|Lost to Follow-up|5|||
161621243|NCT00392197|583662804|FG000|Overall Study|Adverse Event|4|||
161621244|NCT00392197|583662805|FG001|Overall Study|Adverse Event|12|||
161621245|NCT00392197|583662804|FG000|Overall Study|Lack of Efficacy|3|||
161621246|NCT00392197|583662805|FG001|Overall Study|Lack of Efficacy|4|||
161621247|NCT00392197|583662804|FG000|Overall Study|Lost to Follow-up|0|||
161621248|NCT00392197|583662805|FG001|Overall Study|Lost to Follow-up|1|||
161621249|NCT00392197|583662804|FG000|Overall Study|Physician Decision|3|||
161621250|NCT00392197|583662805|FG001|Overall Study|Physician Decision|2|||
161621251|NCT00392197|583662804|FG000|Overall Study|Protocol Violation|7|||
161621252|NCT00392197|583662805|FG001|Overall Study|Protocol Violation|5|||
161621253|NCT00392197|583662804|FG000|Overall Study|Withdrawal by Subject|4|||
161621254|NCT00392197|583662805|FG001|Overall Study|Withdrawal by Subject|6|||
161621255|NCT01794689|583662806|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
161621256|NCT01794689|583662807|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
161621257|NCT01794689|583662808|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
161621258|NCT01794689|583662809|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
161621259|NCT01794689|583662806|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
161621260|NCT01794689|583662807|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
161621261|NCT01794689|583662808|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
161621262|NCT01794689|583662809|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
161621263|NCT01794689|583662806|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
161621264|NCT01794689|583662807|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
161621265|NCT01794689|583662808|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
161621266|NCT01794689|583662809|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
161621267|NCT01794689|583662806|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
161621268|NCT01794689|583662807|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
161621269|NCT01794689|583662808|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
161621270|NCT01794689|583662809|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
161621271|NCT02312258|583662810|FG000|Overall Study|Lost to Follow-up|8|||
161621272|NCT02312258|583662811|FG001|Overall Study|Lost to Follow-up|8|||
161621273|NCT02312258|583662810|FG000|Overall Study|Withdrawal by Patient|49|||
161621274|NCT02312258|583662811|FG001|Overall Study|Withdrawal by Patient|76|||
161621275|NCT02312258|583662810|FG000|Overall Study|Reason not Specified|107|||
161621276|NCT02312258|583662811|FG001|Overall Study|Reason not Specified|159|||
161621277|NCT02312258|583662810|FG000|Overall Study|Missing|2|||
161621278|NCT02312258|583662811|FG001|Overall Study|Missing|1|||
161621279|NCT02312258|583662810|FG000|Overall Study|Death|115|||
161621280|NCT02312258|583662811|FG001|Overall Study|Death|181|||
161621281|NCT01697956|583662812|FG000|Overall Study|Protocol Violation|1|||
161621282|NCT01697956|583662813|FG001|Overall Study|Protocol Violation|1|||
161621283|NCT01528605|583662814|FG000|Overall Study|Lost to Follow-up|1|||
161621284|NCT01528605|583662815|FG001|Overall Study|Lost to Follow-up|0|||
161621285|NCT01528605|583662816|FG002|Overall Study|Lost to Follow-up|1|||
161621286|NCT01528605|583662817|FG003|Overall Study|Lost to Follow-up|1|||
161621287|NCT01528605|583662818|FG004|Overall Study|Lost to Follow-up|0|||
161621288|NCT01528605|583662819|FG005|Overall Study|Lost to Follow-up|0|||
161621289|NCT01528605|583662814|FG000|Overall Study|Death|1|||
161621290|NCT01528605|583662815|FG001|Overall Study|Death|0|||
161621291|NCT01528605|583662816|FG002|Overall Study|Death|0|||
161621292|NCT01528605|583662817|FG003|Overall Study|Death|0|||
161621293|NCT01528605|583662818|FG004|Overall Study|Death|0|||
161621294|NCT01528605|583662819|FG005|Overall Study|Death|0|||
161621295|NCT01970527|583662821|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
161621296|NCT01970527|583662822|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
161621297|NCT01970527|583662821|FG000|Treatment|Disease progression|0|||
161621298|NCT01970527|583662822|FG001|Treatment|Disease progression|1|||
161621299|NCT01970527|583662821|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
161621300|NCT01970527|583662822|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
161621301|NCT01970527|583662821|FG000|Treatment|Death|0|||
161621302|NCT01970527|583662822|FG001|Treatment|Death|1|||
161621303|NCT01970527|583662821|FG000|Follow-up Clinic Visit|Disease progression|1|||
161621304|NCT01970527|583662822|FG001|Follow-up Clinic Visit|Disease progression|1|||
161621305|NCT01970527|583662821|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
161621306|NCT01970527|583662822|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
161621307|NCT01970527|583662821|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
161621308|NCT01970527|583662822|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
161621309|NCT03060525|583662823|FG000|Overall Study|moved out of state|1|||
161621310|NCT03060525|583662824|FG001|Overall Study|moved out of state|1|||
161621311|NCT03060525|583662825|FG002|Overall Study|moved out of state|1|||
161621312|NCT03060525|583662826|FG003|Overall Study|moved out of state|1|||
161621313|NCT03060525|583662823|FG000|Overall Study|unable to meet time commitment required of study|2|||
161621314|NCT03060525|583662824|FG001|Overall Study|unable to meet time commitment required of study|3|||
161621315|NCT03060525|583662825|FG002|Overall Study|unable to meet time commitment required of study|3|||
161621316|NCT03060525|583662826|FG003|Overall Study|unable to meet time commitment required of study|1|||
161621317|NCT03060525|583662823|FG000|Overall Study|no longer interested in doing intervention|0|||
161621318|NCT03060525|583662824|FG001|Overall Study|no longer interested in doing intervention|0|||
161621319|NCT03060525|583662825|FG002|Overall Study|no longer interested in doing intervention|0|||
161621320|NCT03060525|583662826|FG003|Overall Study|no longer interested in doing intervention|1|||
161621321|NCT01964547|583662827|FG000|Overall Study|Adverse Event|8|||
161621322|NCT01964547|583662828|FG001|Overall Study|Adverse Event|2|||
161621323|NCT01964547|583662827|FG000|Overall Study|Withdrawal by Subject|4|||
161621324|NCT01964547|583662828|FG001|Overall Study|Withdrawal by Subject|7|||
161621325|NCT01964547|583662827|FG000|Overall Study|Lost to Follow-up|0|||
161621326|NCT01964547|583662828|FG001|Overall Study|Lost to Follow-up|1|||
161621327|NCT01964547|583662827|FG000|Overall Study|Withdrawal by Investigator|0|||
161621328|NCT01964547|583662828|FG001|Overall Study|Withdrawal by Investigator|1|||
161621329|NCT04447287|583662829|FG000|Period 1: Run-in Period|Adverse Event|3|||
161621330|NCT04447287|583662830|FG001|Period 1: Run-in Period|Adverse Event|0|||
161621331|NCT04447287|583662831|FG002|Period 1: Run-in Period|Adverse Event|0|||
161621332|NCT04447287|583662829|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
161621333|NCT04447287|583662830|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
161621334|NCT04447287|583662831|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
161621335|NCT04447287|583662829|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
161621336|NCT04447287|583662830|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
161621337|NCT04447287|583662831|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
161621338|NCT05700851|583662832|FG000|Overall Study|Received a kidney transplant|1|||
161621339|NCT05700851|583662832|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
161621340|NCT05700851|583662832|FG000|Overall Study|Withdrawal by Subject|1|||
161621341|NCT00655824|583662833|FG000|Overall Study|Adverse Event|3|||
161621342|NCT00655824|583662833|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
161621343|NCT00655824|583662833|FG000|Overall Study|Protocol Violation|1|||
161621344|NCT00655824|583662833|FG000|Overall Study|Withdrawal by Subject|4|||
161621345|NCT00655824|583662833|FG000|Overall Study|Deterioration of Trial Disease|2|||
161621346|NCT02978716|583662834|FG000|Overall Study|Death|25|||
161621347|NCT02978716|583662835|FG001|Overall Study|Death|13|||
161621348|NCT02978716|583662836|FG002|Overall Study|Death|20|||
161621349|NCT02978716|583662834|FG000|Overall Study|Lost to Follow-up|0|||
161621350|NCT02978716|583662835|FG001|Overall Study|Lost to Follow-up|0|||
161621351|NCT02978716|583662836|FG002|Overall Study|Lost to Follow-up|1|||
161621352|NCT02978716|583662834|FG000|Overall Study|Withdrawal by Subject|6|||
161621353|NCT02978716|583662835|FG001|Overall Study|Withdrawal by Subject|4|||
161621354|NCT02978716|583662836|FG002|Overall Study|Withdrawal by Subject|5|||
161621355|NCT02978716|583662834|FG000|Overall Study|Sponsor terminated|2|||
161621356|NCT02978716|583662835|FG001|Overall Study|Sponsor terminated|13|||
161621357|NCT02978716|583662836|FG002|Overall Study|Sponsor terminated|9|||
161621358|NCT02978716|583662834|FG000|Overall Study|Other|1|||
161621359|NCT02978716|583662835|FG001|Overall Study|Other|3|||
161621360|NCT02978716|583662836|FG002|Overall Study|Other|0|||
161621361|NCT00589628|583662837|FG000|Overall Study|Lost to Follow-up|0|||
161621362|NCT00589628|583662838|FG001|Overall Study|Lost to Follow-up|1|||
161621363|NCT00866619|583662851|FG000|Overall Study|Adverse Event|112|||
161621364|NCT00866619|583662852|FG001|Overall Study|Adverse Event|106|||
161621365|NCT00866619|583662853|FG002|Overall Study|Adverse Event|47|||
161621366|NCT00866619|583662854|FG003|Overall Study|Adverse Event|44|||
161621367|NCT00866619|583662851|FG000|Overall Study|Protocol Violation|2|||
161621368|NCT00866619|583662852|FG001|Overall Study|Protocol Violation|39|||
161621369|NCT00866619|583662853|FG002|Overall Study|Protocol Violation|2|||
161621370|NCT00866619|583662854|FG003|Overall Study|Protocol Violation|17|||
161621371|NCT00866619|583662851|FG000|Overall Study|Withdrawal by Subject|587|||
161621372|NCT00866619|583662852|FG001|Overall Study|Withdrawal by Subject|295|||
161621373|NCT00866619|583662853|FG002|Overall Study|Withdrawal by Subject|272|||
161621374|NCT00866619|583662854|FG003|Overall Study|Withdrawal by Subject|144|||
161621375|NCT00866619|583662851|FG000|Overall Study|Lost to Follow-up|1145|||
161621376|NCT00866619|583662852|FG001|Overall Study|Lost to Follow-up|830|||
161621377|NCT00866619|583662853|FG002|Overall Study|Lost to Follow-up|568|||
161621378|NCT00866619|583662854|FG003|Overall Study|Lost to Follow-up|425|||
161621379|NCT00882050|583662858|FG000|Overall Study|Physician Decision|1|||
161621380|NCT00882050|583662859|FG001|Overall Study|Physician Decision|0|||
161621381|NCT00882050|583662860|FG002|Overall Study|Physician Decision|0|||
161621382|NCT00805441|583662861|FG000|Overall Study|Adverse Event|5|||
161621383|NCT00805441|583662862|FG001|Overall Study|Adverse Event|2|||
161621384|NCT00805441|583662861|FG000|Overall Study|Lack of Efficacy|0|||
161621385|NCT00805441|583662862|FG001|Overall Study|Lack of Efficacy|2|||
161621386|NCT00805441|583662861|FG000|Overall Study|Protocol Violation|4|||
161621387|NCT00805441|583662862|FG001|Overall Study|Protocol Violation|8|||
161621388|NCT00805441|583662861|FG000|Overall Study|Lost to Follow-up|10|||
161621389|NCT00805441|583662862|FG001|Overall Study|Lost to Follow-up|13|||
161621390|NCT00805441|583662861|FG000|Overall Study|Withdrawal by Subject|15|||
161621391|NCT00805441|583662862|FG001|Overall Study|Withdrawal by Subject|9|||
161621392|NCT00805441|583662861|FG000|Overall Study|Physician Decision|0|||
161621393|NCT00805441|583662862|FG001|Overall Study|Physician Decision|1|||
161621394|NCT00805441|583662861|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
161621395|NCT00805441|583662862|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
161621396|NCT00946998|583664437|FG000|Overall Study|Exited prior to first outcome assessment|5|||
161621397|NCT00946998|583664438|FG001|Overall Study|Exited prior to first outcome assessment|3|||
161621398|NCT01945593|583664439|FG000|Overall Study|Adverse Event|0|||
161621399|NCT01945593|583664440|FG001|Overall Study|Adverse Event|0|||
161621400|NCT01945593|583664441|FG002|Overall Study|Adverse Event|0|||
161621401|NCT01945593|583664442|FG003|Overall Study|Adverse Event|5|||
161621402|NCT01945593|583664439|FG000|Overall Study|Physician Decision|0|||
161621403|NCT01945593|583664440|FG001|Overall Study|Physician Decision|0|||
161621404|NCT01945593|583664441|FG002|Overall Study|Physician Decision|1|||
161621405|NCT01945593|583664442|FG003|Overall Study|Physician Decision|1|||
161621406|NCT01945593|583664439|FG000|Overall Study|Withdrawal by Subject|0|||
161621407|NCT01945593|583664440|FG001|Overall Study|Withdrawal by Subject|2|||
161621408|NCT01945593|583664441|FG002|Overall Study|Withdrawal by Subject|0|||
161621409|NCT01945593|583664442|FG003|Overall Study|Withdrawal by Subject|4|||
161621410|NCT01945593|583664439|FG000|Overall Study|Protocol Violation|0|||
161621411|NCT01945593|583664440|FG001|Overall Study|Protocol Violation|2|||
161621412|NCT01945593|583664441|FG002|Overall Study|Protocol Violation|1|||
161621413|NCT01945593|583664442|FG003|Overall Study|Protocol Violation|3|||
161621414|NCT01945593|583664439|FG000|Overall Study|Death|0|||
161621415|NCT01945593|583664440|FG001|Overall Study|Death|0|||
161621416|NCT01945593|583664441|FG002|Overall Study|Death|1|||
161621417|NCT01945593|583664442|FG003|Overall Study|Death|0|||
161621418|NCT01945593|583664439|FG000|Overall Study|Other: Terminated|0|||
161621419|NCT01945593|583664440|FG001|Overall Study|Other: Terminated|0|||
161621420|NCT01945593|583664441|FG002|Overall Study|Other: Terminated|0|||
161621421|NCT01945593|583664442|FG003|Overall Study|Other: Terminated|1|||
161621422|NCT01945593|583664439|FG000|Overall Study|Other: Surgical Procedure|0|||
161621423|NCT01945593|583664440|FG001|Overall Study|Other: Surgical Procedure|2|||
161621424|NCT01945593|583664441|FG002|Overall Study|Other: Surgical Procedure|0|||
161621425|NCT01945593|583664442|FG003|Overall Study|Other: Surgical Procedure|6|||
161621426|NCT01945593|583664439|FG000|Overall Study|Other: Screen Failure|0|||
161621427|NCT01945593|583664440|FG001|Overall Study|Other: Screen Failure|2|||
161621428|NCT01945593|583664441|FG002|Overall Study|Other: Screen Failure|0|||
161621429|NCT01945593|583664442|FG003|Overall Study|Other: Screen Failure|0|||
161621430|NCT00228813|583664443|FG000|Overall Study|Death|4|||
161621431|NCT02213094|583664450|FG000|Overall Study|Adverse Event|1|||
161621432|NCT02213094|583664451|FG001|Overall Study|Adverse Event|0|||
161621433|NCT02163499|583664452|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
161621434|NCT02163499|583664452|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
161621435|NCT02163499|583664452|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
161621436|NCT02163499|583664452|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
161621437|NCT02163499|583664452|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
161621438|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
161621439|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
161684852|NCT04129528|583899578|FG000|Overall Study|Withdrawal by Subject|1|||
161621440|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
161621441|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
161621442|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
161621443|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
161621444|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
161621445|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
161621446|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
161621447|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Death|8|||
161621448|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
161621449|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
161621450|NCT02163499|583664452|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
161621451|NCT00555620|583664456|FG000|Overall Study|Death|0|||
161621452|NCT00555620|583664457|FG001|Overall Study|Death|1|||
161621453|NCT00555620|583664458|FG002|Overall Study|Death|0|||
161621454|NCT00555620|583664459|FG003|Overall Study|Death|0|||
161621455|NCT00555620|583664460|FG004|Overall Study|Death|0|||
161621456|NCT00555620|583664461|FG005|Overall Study|Death|1|||
161621457|NCT00555620|583664456|FG000|Overall Study|Study terminated by sponsor|0|||
161621458|NCT00555620|583664457|FG001|Overall Study|Study terminated by sponsor|0|||
161621459|NCT00555620|583664458|FG002|Overall Study|Study terminated by sponsor|1|||
161621460|NCT00555620|583664459|FG003|Overall Study|Study terminated by sponsor|0|||
161621461|NCT00555620|583664460|FG004|Overall Study|Study terminated by sponsor|0|||
161684853|NCT04129528|583899579|FG001|Overall Study|Withdrawal by Subject|1|||
161684854|NCT00490568|583899580|FG000|Overall Study|Adverse Event|116|||
161684855|NCT00490568|583899580|FG000|Overall Study|Lost to Follow-up|13|||
161621462|NCT00555620|583664461|FG005|Overall Study|Study terminated by sponsor|0|||
161621463|NCT00555620|583664456|FG000|Overall Study|Adverse Event|0|||
161621464|NCT00555620|583664457|FG001|Overall Study|Adverse Event|0|||
161621465|NCT00555620|583664458|FG002|Overall Study|Adverse Event|1|||
161621466|NCT00555620|583664459|FG003|Overall Study|Adverse Event|5|||
161621467|NCT00555620|583664460|FG004|Overall Study|Adverse Event|0|||
161621468|NCT00555620|583664461|FG005|Overall Study|Adverse Event|1|||
161621469|NCT00555620|583664456|FG000|Overall Study|Objective progression or relapse|6|||
161621470|NCT00555620|583664457|FG001|Overall Study|Objective progression or relapse|5|||
161621471|NCT00555620|583664458|FG002|Overall Study|Objective progression or relapse|12|||
161621472|NCT00555620|583664459|FG003|Overall Study|Objective progression or relapse|17|||
161621473|NCT00555620|583664460|FG004|Overall Study|Objective progression or relapse|3|||
161621474|NCT00555620|583664461|FG005|Overall Study|Objective progression or relapse|16|||
161621475|NCT00555620|583664456|FG000|Overall Study|Participant refused treatment|0|||
161684856|NCT00490568|583899580|FG000|Overall Study|Protocol Violation|45|||
161621476|NCT00555620|583664457|FG001|Overall Study|Participant refused treatment|1|||
161621477|NCT00555620|583664458|FG002|Overall Study|Participant refused treatment|1|||
161621478|NCT00555620|583664459|FG003|Overall Study|Participant refused treatment|0|||
161621479|NCT00555620|583664460|FG004|Overall Study|Participant refused treatment|0|||
161621480|NCT00555620|583664461|FG005|Overall Study|Participant refused treatment|1|||
161621481|NCT00555620|583664456|FG000|Overall Study|Other|0|||
161621482|NCT00555620|583664457|FG001|Overall Study|Other|0|||
161621483|NCT00555620|583664458|FG002|Overall Study|Other|0|||
161621484|NCT00555620|583664459|FG003|Overall Study|Other|1|||
161621485|NCT00555620|583664460|FG004|Overall Study|Other|0|||
161621486|NCT00555620|583664461|FG005|Overall Study|Other|3|||
161621487|NCT00476151|583664462|FG000|Overall Study|Adverse Event|0|||
161621488|NCT00476151|583664463|FG001|Overall Study|Adverse Event|2|||
161621489|NCT00476151|583664462|FG000|Overall Study|Protocol Violation|1|||
161621490|NCT00476151|583664463|FG001|Overall Study|Protocol Violation|3|||
161621491|NCT00476151|583664462|FG000|Overall Study|Withdrawal by Subject|2|||
161621492|NCT00476151|583664463|FG001|Overall Study|Withdrawal by Subject|0|||
161621493|NCT00476151|583664462|FG000|Overall Study|Physician Decision|0|||
161621494|NCT00476151|583664463|FG001|Overall Study|Physician Decision|2|||
161621495|NCT02068352|583664465|FG000|Overall Study|Lost to Follow-up|0|||
161621496|NCT02068352|583664466|FG001|Overall Study|Lost to Follow-up|2|||
161621497|NCT02068352|583664467|FG002|Overall Study|Lost to Follow-up|0|||
161621498|NCT02068352|583664465|FG000|Overall Study|Adverse Event|4|||
161621499|NCT02068352|583664466|FG001|Overall Study|Adverse Event|2|||
161621500|NCT02068352|583664467|FG002|Overall Study|Adverse Event|7|||
161621501|NCT02068352|583664465|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
161621502|NCT02068352|583664466|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
161621503|NCT02068352|583664467|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
161621504|NCT02068352|583664465|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
161621505|NCT02068352|583664466|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
161621506|NCT02068352|583664467|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
161621507|NCT02068352|583664465|FG000|Overall Study|Protocol Deviation|0|||
161621508|NCT02068352|583664466|FG001|Overall Study|Protocol Deviation|0|||
161621509|NCT02068352|583664467|FG002|Overall Study|Protocol Deviation|1|||
161621510|NCT01767376|583664471|FG000|Overall Study|Lost to Follow-up|3|||
161621511|NCT01767376|583664472|FG001|Overall Study|Lost to Follow-up|2|||
161621512|NCT01767376|583664473|FG002|Overall Study|Lost to Follow-up|0|||
161621513|NCT01767376|583664471|FG000|Overall Study|Withdrawal by Subject|1|||
161621514|NCT01767376|583664472|FG001|Overall Study|Withdrawal by Subject|1|||
161621515|NCT01767376|583664473|FG002|Overall Study|Withdrawal by Subject|0|||
161621516|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
161621517|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
161621518|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
161621519|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
161621520|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
161621521|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
161621522|NCT03557307|583664474|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
161621523|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
161621524|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|Death|3|||
161621525|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
161621526|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
161621527|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
161684857|NCT00490568|583899580|FG000|Overall Study|Withdrawal by Subject|135|||
161621528|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
161621529|NCT03557307|583664474|FG000|Period 2: Maintenance Phase|other|3|||
161621530|NCT03745651|583664475|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
161621531|NCT03745651|583664476|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
161621532|NCT03745651|583664477|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161621533|NCT03745651|583664478|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161621534|NCT03745651|583664479|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161621535|NCT03745651|583664480|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161621536|NCT03745651|583664481|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161621537|NCT03745651|583664475|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
161621538|NCT03745651|583664476|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
161621539|NCT03745651|583664477|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
161621540|NCT03745651|583664478|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161621541|NCT03745651|583664479|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161621542|NCT03745651|583664480|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161621543|NCT03745651|583664481|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161621544|NCT03745651|583664475|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
161621545|NCT03745651|583664476|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161621546|NCT03745651|583664477|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
161621547|NCT03745651|583664478|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161621548|NCT03745651|583664479|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161621549|NCT03745651|583664480|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161621550|NCT03745651|583664481|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161621551|NCT03745651|583664475|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161621552|NCT03745651|583664476|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
161621553|NCT03745651|583664477|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161621554|NCT03745651|583664478|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161621555|NCT03745651|583664479|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161684858|NCT00490568|583899580|FG000|Overall Study|Still in the study at termination|974|||
161621556|NCT03745651|583664480|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161621557|NCT03745651|583664481|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161621558|NCT03745651|583664475|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
161621559|NCT03745651|583664476|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
161621560|NCT03745651|583664477|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
161621561|NCT03745651|583664478|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161621562|NCT03745651|583664479|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161621563|NCT03745651|583664480|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161621564|NCT03745651|583664481|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161621565|NCT03745651|583664475|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
161621566|NCT03745651|583664476|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
161621567|NCT03745651|583664477|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
161621568|NCT03745651|583664478|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161621569|NCT03745651|583664479|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161621570|NCT03745651|583664480|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161621571|NCT03745651|583664481|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161621572|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161621573|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161621574|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161621575|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161621576|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161621577|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
161621578|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161684859|NCT00490568|583899580|FG000|Overall Study|Other|1|||
161684860|NCT00490568|583899580|FG000|Overall Study|Exclusion criteria met|1|||
161684861|NCT00490568|583899580|FG000|Overall Study|Caregiver related|20|||
161684862|NCT00490568|583899580|FG000|Overall Study|Abnormal ECG|25|||
161621579|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161621580|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161621581|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161621582|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
161621583|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161621584|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
161684863|NCT00490568|583899580|FG000|Overall Study|Participant refused follow-up|9|||
161621585|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
161621586|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161621587|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161621588|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161621589|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
161621590|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
161621591|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
161621592|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
161621593|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161621594|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161621595|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161621596|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
161621597|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161621598|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
161621599|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
161684864|NCT00490568|583899580|FG000|Overall Study|Legal representative withdrew consent|1|||
161684865|NCT00490568|583899580|FG000|Overall Study|Disease progression|4|||
161684866|NCT00490568|583899580|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
161621600|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161621601|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161621602|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161621603|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
161621604|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161621605|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161621606|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
161621607|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161621608|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161621609|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161621610|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161621611|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161621612|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
161621613|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161621614|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161621615|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161621616|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161621617|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
161621618|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
161621619|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
161621620|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
161621621|NCT03745651|583664475|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161621622|NCT03745651|583664476|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161621623|NCT03745651|583664477|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161621624|NCT03745651|583664478|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
161621625|NCT03745651|583664479|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
161621626|NCT03745651|583664480|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
161621627|NCT03745651|583664481|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161621628|NCT04175834|583664482|FG000|Overall Study|Withdrawal by Subject|1|||
161621629|NCT04175834|583664483|FG001|Overall Study|Withdrawal by Subject|0|||
161621630|NCT00946088|583664484|FG000|Overall Study|Withdrawal by Subject|0|||
161621631|NCT00946088|583664485|FG001|Overall Study|Withdrawal by Subject|1|||
161621632|NCT01322347|583664489|FG000|Overall Study|Adverse Event|7|||
161621633|NCT01322347|583664490|FG001|Overall Study|Adverse Event|2|||
161621634|NCT01322347|583664489|FG000|Overall Study|Death|5|||
161621635|NCT01322347|583664490|FG001|Overall Study|Death|3|||
161621636|NCT01322347|583664489|FG000|Overall Study|Physician Decision|2|||
161621637|NCT01322347|583664490|FG001|Overall Study|Physician Decision|1|||
161621638|NCT01322347|583664489|FG000|Overall Study|Protocol Violation|5|||
161684867|NCT00490568|583899580|FG000|Overall Study|Investigator decision|3|||
161684868|NCT00490568|583899580|FG000|Overall Study|Non-Compliance|7|||
161621639|NCT01322347|583664490|FG001|Overall Study|Protocol Violation|2|||
161621640|NCT01322347|583664489|FG000|Overall Study|Withdrawal by Subject|1|||
161621641|NCT01322347|583664490|FG001|Overall Study|Withdrawal by Subject|4|||
161621642|NCT01322347|583664489|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
161621643|NCT01322347|583664490|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
161621644|NCT01322347|583664489|FG000|Overall Study|blood transfusion|5|||
161621645|NCT01322347|583664490|FG001|Overall Study|blood transfusion|5|||
161621646|NCT01322347|583664489|FG000|Overall Study|sponsor decision|1|||
161621647|NCT01322347|583664490|FG001|Overall Study|sponsor decision|3|||
161621648|NCT01322347|583664489|FG000|Overall Study|ineligible|6|||
161621649|NCT01322347|583664490|FG001|Overall Study|ineligible|3|||
161621650|NCT01322347|583664489|FG000|Overall Study|kidney transplant|3|||
161621651|NCT01322347|583664490|FG001|Overall Study|kidney transplant|1|||
161621652|NCT01322347|583664489|FG000|Overall Study|study drug withheld > 12 wks|0|||
161621653|NCT01322347|583664490|FG001|Overall Study|study drug withheld > 12 wks|1|||
161621654|NCT01322347|583664489|FG000|Overall Study|moved/changed dialysis|2|||
161621655|NCT01322347|583664490|FG001|Overall Study|moved/changed dialysis|4|||
161621656|NCT01193283|583664491|FG000|Overall Study|Death|1|||
161621657|NCT04883541|583664492|FG000|Overall Study|Not attending regular yoga class|16|||
161621658|NCT04883541|583664493|FG001|Overall Study|Not attending regular yoga class|0|||
161621659|NCT04883541|583664492|FG000|Overall Study|Not attending the pregnancy school|0|||
161621660|NCT04883541|583664493|FG001|Overall Study|Not attending the pregnancy school|9|||
161621661|NCT04239911|583664494|FG000|Overall Study|Lost to Follow-up|2|||
161621662|NCT04239911|583664495|FG001|Overall Study|Lost to Follow-up|1|||
161621663|NCT02137785|583664496|FG000|Overall Study|Lost to Follow-up|1|||
161621664|NCT02137785|583664497|FG001|Overall Study|Lost to Follow-up|0|||
161621665|NCT02137785|583664496|FG000|Overall Study|Withdrawal by Subject|1|||
161621666|NCT02137785|583664497|FG001|Overall Study|Withdrawal by Subject|4|||
161621667|NCT02137785|583664496|FG000|Overall Study|subject moved out of state|1|||
161621668|NCT02137785|583664497|FG001|Overall Study|subject moved out of state|0|||
161621669|NCT03345407|583664499|FG000|Overall Study|Withdrawal by Subject|11|||
161621670|NCT03345407|583664500|FG001|Overall Study|Withdrawal by Subject|1|||
161621671|NCT03345407|583664501|FG002|Overall Study|Withdrawal by Subject|5|||
161621672|NCT03345407|583664502|FG003|Overall Study|Withdrawal by Subject|6|||
161621673|NCT03345407|583664503|FG004|Overall Study|Withdrawal by Subject|3|||
161621674|NCT03345407|583664504|FG005|Overall Study|Withdrawal by Subject|6|||
161621675|NCT03345407|583664505|FG006|Overall Study|Withdrawal by Subject|16|||
161621676|NCT03345407|583664499|FG000|Overall Study|Physician Decision|3|||
161621677|NCT03345407|583664500|FG001|Overall Study|Physician Decision|1|||
161621678|NCT03345407|583664501|FG002|Overall Study|Physician Decision|0|||
161621679|NCT03345407|583664502|FG003|Overall Study|Physician Decision|0|||
161621680|NCT03345407|583664503|FG004|Overall Study|Physician Decision|1|||
161621681|NCT03345407|583664504|FG005|Overall Study|Physician Decision|2|||
161621682|NCT03345407|583664505|FG006|Overall Study|Physician Decision|3|||
161621683|NCT03345407|583664499|FG000|Overall Study|Lost to Follow-up|2|||
161621684|NCT03345407|583664500|FG001|Overall Study|Lost to Follow-up|0|||
161621685|NCT03345407|583664501|FG002|Overall Study|Lost to Follow-up|1|||
161621686|NCT03345407|583664502|FG003|Overall Study|Lost to Follow-up|0|||
161621687|NCT03345407|583664503|FG004|Overall Study|Lost to Follow-up|1|||
161621688|NCT03345407|583664504|FG005|Overall Study|Lost to Follow-up|2|||
161621689|NCT03345407|583664505|FG006|Overall Study|Lost to Follow-up|3|||
161621690|NCT03345407|583664499|FG000|Overall Study|Protocol-defined stopping criteria|9|||
161621691|NCT03345407|583664500|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161621692|NCT03345407|583664501|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161621693|NCT03345407|583664502|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161621694|NCT03345407|583664503|FG004|Overall Study|Protocol-defined stopping criteria|2|||
161621695|NCT03345407|583664504|FG005|Overall Study|Protocol-defined stopping criteria|1|||
161621696|NCT03345407|583664505|FG006|Overall Study|Protocol-defined stopping criteria|1|||
161621697|NCT03345407|583664499|FG000|Overall Study|Protocol Violation|2|||
161621698|NCT03345407|583664500|FG001|Overall Study|Protocol Violation|0|||
161621699|NCT03345407|583664501|FG002|Overall Study|Protocol Violation|0|||
161621700|NCT03345407|583664502|FG003|Overall Study|Protocol Violation|0|||
161621701|NCT03345407|583664503|FG004|Overall Study|Protocol Violation|1|||
161621702|NCT03345407|583664504|FG005|Overall Study|Protocol Violation|0|||
161621703|NCT03345407|583664505|FG006|Overall Study|Protocol Violation|3|||
161621704|NCT03345407|583664499|FG000|Overall Study|Lack of Efficacy|1|||
161621705|NCT03345407|583664500|FG001|Overall Study|Lack of Efficacy|1|||
161621706|NCT03345407|583664501|FG002|Overall Study|Lack of Efficacy|1|||
161621707|NCT03345407|583664502|FG003|Overall Study|Lack of Efficacy|1|||
161621708|NCT03345407|583664503|FG004|Overall Study|Lack of Efficacy|1|||
161684869|NCT00490568|583899580|FG000|Overall Study|Efficacy related|3|||
161621709|NCT03345407|583664504|FG005|Overall Study|Lack of Efficacy|0|||
161621710|NCT03345407|583664505|FG006|Overall Study|Lack of Efficacy|3|||
161621711|NCT03345407|583664499|FG000|Overall Study|Adverse Event|4|||
161621712|NCT03345407|583664500|FG001|Overall Study|Adverse Event|0|||
161621713|NCT03345407|583664501|FG002|Overall Study|Adverse Event|5|||
161621714|NCT03345407|583664502|FG003|Overall Study|Adverse Event|4|||
161621715|NCT03345407|583664503|FG004|Overall Study|Adverse Event|6|||
161621716|NCT03345407|583664504|FG005|Overall Study|Adverse Event|5|||
161621717|NCT03345407|583664505|FG006|Overall Study|Adverse Event|16|||
161621718|NCT01584648|583664506|FG000|Overall Study|Death|136|||
161621719|NCT01584648|583664507|FG001|Overall Study|Death|146|||
161621720|NCT01584648|583664506|FG000|Overall Study|Lost to Follow-up|9|||
161621721|NCT01584648|583664507|FG001|Overall Study|Lost to Follow-up|9|||
161621722|NCT01584648|583664506|FG000|Overall Study|Investigator discretion|3|||
161621723|NCT01584648|583664507|FG001|Overall Study|Investigator discretion|2|||
161621724|NCT01584648|583664506|FG000|Overall Study|Withdrew consent|13|||
161621725|NCT01584648|583664507|FG001|Overall Study|Withdrew consent|4|||
161621726|NCT01584648|583664506|FG000|Overall Study|Study closed/terminated|50|||
161621727|NCT01584648|583664507|FG001|Overall Study|Study closed/terminated|23|||
161621728|NCT01584648|583664506|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
161621729|NCT01584648|583664507|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
161621730|NCT02256553|583664510|FG000|Period I|Adverse Event|5|||
161621731|NCT02256553|583664510|FG000|Period I|Protocol Violation|1|||
161621732|NCT02256553|583664510|FG000|Period II|Adverse Event|1|||
161621733|NCT02256553|583664510|FG000|Period II|Subject Moved|1|||
161621734|NCT02256553|583664510|FG000|Period III|Adverse Event|3|||
161621735|NCT00595959|583664511|FG000|Overall Study|Withdrawal by Subject|1|||
161621736|NCT00595959|583664511|FG000|Overall Study|Lost to Follow-up|1|||
161621737|NCT00886834|583664512|FG000|Overall Study|Protocol Violation|0|||
161621738|NCT00886834|583664513|FG001|Overall Study|Protocol Violation|3|||
161621739|NCT04085614|583664514|FG000|Overall Study|Protocol Violation|9|||
161621740|NCT04085614|583664515|FG001|Overall Study|Protocol Violation|6|||
161621741|NCT01405508|583664516|FG000|Overall Study|AE, non-serious non-fatal|1|||
161621742|NCT01405508|583664517|FG001|Overall Study|AE, non-serious non-fatal|1|||
161621743|NCT01405508|583664518|FG002|Overall Study|AE, non-serious non-fatal|0|||
161621744|NCT01405508|583664519|FG003|Overall Study|AE, non-serious non-fatal|0|||
161621745|NCT00409747|583664524|FG000|Overall Study|Withdrawal by Subject|1|||
161621746|NCT01115309|583664529|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
161621747|NCT01115309|583664529|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
161621748|NCT01115309|583664529|FG000|Long-term Follow-up|Lost to Follow-up|6|||
161621749|NCT02147093|583664532|FG000|Period 1|Lost to Follow-up|0|||
161621750|NCT02147093|583664533|FG001|Period 1|Lost to Follow-up|1|||
161621751|NCT02147093|583664532|FG000|Period 2|Protocol Violation|2|||
161621752|NCT02147093|583664533|FG001|Period 2|Protocol Violation|0|||
161621753|NCT03246724|583664534|FG000|Overall Study|Withdrawal by Subject|5|||
161621754|NCT03246724|583664535|FG001|Overall Study|Withdrawal by Subject|2|||
161621755|NCT03246724|583664536|FG002|Overall Study|Withdrawal by Subject|4|||
161621756|NCT03246724|583664537|FG003|Overall Study|Withdrawal by Subject|2|||
161621757|NCT03246724|583664534|FG000|Overall Study|Ineligible on day of surgery|7|||
161621758|NCT03246724|583664535|FG001|Overall Study|Ineligible on day of surgery|2|||
161621759|NCT03246724|583664536|FG002|Overall Study|Ineligible on day of surgery|0|||
161621760|NCT03246724|583664537|FG003|Overall Study|Ineligible on day of surgery|3|||
161621761|NCT03246724|583664534|FG000|Overall Study|Study completed before surgical date|2|||
161621762|NCT03246724|583664535|FG001|Overall Study|Study completed before surgical date|1|||
161621763|NCT03246724|583664536|FG002|Overall Study|Study completed before surgical date|8|||
161621764|NCT03246724|583664537|FG003|Overall Study|Study completed before surgical date|1|||
161621765|NCT03246724|583664534|FG000|Overall Study|Transferred to other arm|0|||
161621766|NCT03246724|583664535|FG001|Overall Study|Transferred to other arm|0|||
161621767|NCT03246724|583664536|FG002|Overall Study|Transferred to other arm|1|||
161621768|NCT03246724|583664537|FG003|Overall Study|Transferred to other arm|0|||
161621769|NCT03246724|583664534|FG000|Overall Study|Unable to obtain medication timely|0|||
161621770|NCT03246724|583664535|FG001|Overall Study|Unable to obtain medication timely|2|||
161621771|NCT03246724|583664536|FG002|Overall Study|Unable to obtain medication timely|2|||
161621772|NCT03246724|583664537|FG003|Overall Study|Unable to obtain medication timely|1|||
161621773|NCT03246724|583664534|FG000|Overall Study|Re-consented to participate|0|||
161621774|NCT03246724|583664535|FG001|Overall Study|Re-consented to participate|0|||
161621775|NCT03246724|583664536|FG002|Overall Study|Re-consented to participate|0|||
161621776|NCT03246724|583664537|FG003|Overall Study|Re-consented to participate|1|||
161621777|NCT02189759|583664538|FG000|Overall Study|Lost to Follow-up|0|||
161684870|NCT00490568|583899580|FG000|Overall Study|Participant died|1|||
161621778|NCT02189759|583664539|FG001|Overall Study|Lost to Follow-up|0|||
161621779|NCT02189759|583664540|FG002|Overall Study|Lost to Follow-up|2|||
161621780|NCT02189759|583664541|FG003|Overall Study|Lost to Follow-up|5|||
161621781|NCT03032198|583664542|FG000|Overall Study|Screen Fail|1|||
161621782|NCT02470806|583664543|FG000|Overall Study|Lost to Follow-up|1|||
161621783|NCT02470806|583664544|FG001|Overall Study|Lost to Follow-up|1|||
161621784|NCT02470806|583664543|FG000|Overall Study|Adverse Event|5|||
161621785|NCT02470806|583664544|FG001|Overall Study|Adverse Event|2|||
161621786|NCT02470806|583664543|FG000|Overall Study|Protocol Violation|4|||
161621787|NCT02470806|583664544|FG001|Overall Study|Protocol Violation|11|||
161621788|NCT02470806|583664543|FG000|Overall Study|Physician Decision|0|||
161621789|NCT02470806|583664544|FG001|Overall Study|Physician Decision|3|||
161621790|NCT02470806|583664543|FG000|Overall Study|Withdrawal by Subject|3|||
161621791|NCT02470806|583664544|FG001|Overall Study|Withdrawal by Subject|10|||
161621792|NCT02470806|583664543|FG000|Overall Study|Lack of Efficacy|5|||
161621793|NCT02470806|583664544|FG001|Overall Study|Lack of Efficacy|15|||
161621794|NCT02892019|583664549|FG000|Overall Study|randomized but not treated|0|||
161621795|NCT02892019|583664550|FG001|Overall Study|randomized but not treated|1|||
161621796|NCT02892019|583664549|FG000|Overall Study|Withdrawal by Subject|0|||
161621797|NCT02892019|583664550|FG001|Overall Study|Withdrawal by Subject|1|||
161621798|NCT02892019|583664549|FG000|Overall Study|Adverse Event|1|||
161621799|NCT02892019|583664550|FG001|Overall Study|Adverse Event|1|||
161621800|NCT03890484|583664551|FG000|Overall Study|Lost to Follow-up|1|||
161621801|NCT03890484|583664552|FG001|Overall Study|Lost to Follow-up|1|||
161621802|NCT00518206|583664553|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
161621803|NCT00518206|583664554|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
161621804|NCT00518206|583664553|FG000|Overall Study|Withdrawal by Subject|2|||
161621805|NCT00518206|583664554|FG001|Overall Study|Withdrawal by Subject|0|||
161621806|NCT00518206|583664553|FG000|Overall Study|Drug Supply Issue|1|||
161621807|NCT00518206|583664554|FG001|Overall Study|Drug Supply Issue|0|||
161621808|NCT00518206|583664553|FG000|Overall Study|Reason Unknown|1|||
161621809|NCT00518206|583664554|FG001|Overall Study|Reason Unknown|0|||
161621810|NCT00518206|583664553|FG000|Overall Study|Completion Status Unknown|1|||
161621811|NCT00518206|583664554|FG001|Overall Study|Completion Status Unknown|0|||
161621812|NCT03075878|583664555|FG000|Overall Study|Physician Decision|1|||
161621813|NCT02188459|583664556|FG000|Overall Study|Lost to Follow-up|3|||
161621814|NCT02188459|583664557|FG001|Overall Study|Lost to Follow-up|4|||
161621815|NCT02188459|583664556|FG000|Overall Study|Early Termination|0|||
161621816|NCT02188459|583664557|FG001|Overall Study|Early Termination|3|||
161621817|NCT02612285|583664562|FG000|Overall Study|Withdrawal by Subject|1|||
161621818|NCT02935894|583664563|FG000|Overall Study|Subject dismissed|1|||
161621819|NCT04895085|583664566|FG000|Overall Study|Death|1|||
161621820|NCT04895085|583664566|FG000|Overall Study|Withdrawal by Subject|1|||
161621821|NCT04895085|583664566|FG000|Overall Study|No longer eligible: Moved from area|1|||
161621822|NCT04919499|583664571|FG000|Overall Study|Adverse Event|0|||
161621823|NCT04919499|583664572|FG001|Overall Study|Adverse Event|0|||
161621824|NCT04919499|583664573|FG002|Overall Study|Adverse Event|0|||
161621825|NCT04919499|583664574|FG003|Overall Study|Adverse Event|0|||
161621826|NCT04919499|583664575|FG004|Overall Study|Adverse Event|2|||
161621827|NCT04919499|583664571|FG000|Overall Study|Not treated|0|||
161621828|NCT04919499|583664572|FG001|Overall Study|Not treated|0|||
161621829|NCT04919499|583664573|FG002|Overall Study|Not treated|0|||
161621830|NCT04919499|583664574|FG003|Overall Study|Not treated|1|||
161621831|NCT04919499|583664575|FG004|Overall Study|Not treated|0|||
161621832|NCT03456856|583666147|FG000|Overall Study|Lost to Follow-up|2|||
161621833|NCT03456856|583666147|FG000|Overall Study|Withdrawal by Subject|1|||
161621834|NCT02542696|583666149|FG000|Overall Study|Adverse Event|167|||
161621835|NCT02542696|583666149|FG000|Overall Study|Lack of Efficacy|26|||
161621836|NCT02542696|583666149|FG000|Overall Study|Lost to Follow-up|6|||
161621837|NCT02542696|583666149|FG000|Overall Study|Withdrawal by Subject|104|||
161621838|NCT02542696|583666149|FG000|Overall Study|Protocol Violation|5|||
161621839|NCT02542696|583666149|FG000|Overall Study|Death|8|||
161621840|NCT02542696|583666149|FG000|Overall Study|DECREASED OFF TIME|1|||
161621841|NCT02542696|583666149|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
161621842|NCT02542696|583666149|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
161621843|NCT02542696|583666149|FG000|Overall Study|MEDICAL HISTORY|1|||
161621844|NCT02542696|583666149|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
161621845|NCT02542696|583666149|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
161621846|NCT02542696|583666149|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
161621847|NCT02542696|583666149|FG000|Overall Study|SPONSOR DECISION|3|||
161621848|NCT02542696|583666149|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
161621849|NCT02542696|583666149|FG000|Overall Study|SUBJECT DECISION|2|||
161621850|NCT03262389|583666150|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
161621851|NCT03262389|583666150|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
161684871|NCT00490568|583899580|FG000|Overall Study|Participant withdrawal due to surgery|1|||
161621852|NCT03262389|583666150|FG000|Overall Study|opted out of PET/MR|1|||
161621853|NCT03651271|583666152|FG000|Overall Study|Death|4|||
161621854|NCT03651271|583666153|FG001|Overall Study|Death|37|||
161621855|NCT03651271|583666154|FG002|Overall Study|Death|0|||
161621856|NCT03651271|583666155|FG003|Overall Study|Death|2|||
161621857|NCT03651271|583666156|FG004|Overall Study|Death|6|||
161621858|NCT03651271|583666152|FG000|Overall Study|Lost to Follow-up|1|||
161621859|NCT03651271|583666153|FG001|Overall Study|Lost to Follow-up|5|||
161621860|NCT03651271|583666154|FG002|Overall Study|Lost to Follow-up|0|||
161621861|NCT03651271|583666155|FG003|Overall Study|Lost to Follow-up|1|||
161621862|NCT03651271|583666156|FG004|Overall Study|Lost to Follow-up|0|||
161621863|NCT03651271|583666152|FG000|Overall Study|Physician Decision|0|||
161621864|NCT03651271|583666153|FG001|Overall Study|Physician Decision|2|||
161621865|NCT03651271|583666154|FG002|Overall Study|Physician Decision|0|||
161621866|NCT03651271|583666155|FG003|Overall Study|Physician Decision|0|||
161621867|NCT03651271|583666156|FG004|Overall Study|Physician Decision|0|||
161621868|NCT03651271|583666152|FG000|Overall Study|Withdrawal by Subject|1|||
161621869|NCT03651271|583666153|FG001|Overall Study|Withdrawal by Subject|15|||
161621870|NCT03651271|583666154|FG002|Overall Study|Withdrawal by Subject|0|||
161621871|NCT03651271|583666155|FG003|Overall Study|Withdrawal by Subject|0|||
161621872|NCT03651271|583666156|FG004|Overall Study|Withdrawal by Subject|1|||
161621873|NCT03651271|583666152|FG000|Overall Study|Patient medically unable to continue|0|||
161621874|NCT03651271|583666153|FG001|Overall Study|Patient medically unable to continue|0|||
161621875|NCT03651271|583666154|FG002|Overall Study|Patient medically unable to continue|0|||
161621876|NCT03651271|583666155|FG003|Overall Study|Patient medically unable to continue|1|||
161621877|NCT03651271|583666156|FG004|Overall Study|Patient medically unable to continue|0|||
161621878|NCT00821093|583666157|FG000|Overall Study|Adverse Event|20|||
161621879|NCT00821093|583666158|FG001|Overall Study|Adverse Event|12|||
161621880|NCT00821093|583666157|FG000|Overall Study|Withdrawal by Subject|9|||
161832943|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
161832944|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
161832945|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
161832946|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
161832947|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
161832948|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
161832949|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
161832950|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
161832951|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
161832952|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
161832953|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
161832954|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
161684872|NCT01081912|583899588|FG000|Conversion/Titration|Adverse Event|47|||
161684873|NCT01081912|583899589|FG001|Conversion/Titration|Adverse Event|0|||
161621881|NCT00821093|583666158|FG001|Overall Study|Withdrawal by Subject|13|||
161621882|NCT00821093|583666157|FG000|Overall Study|Lost to Follow-up|9|||
161621883|NCT00821093|583666158|FG001|Overall Study|Lost to Follow-up|3|||
161621884|NCT00821093|583666157|FG000|Overall Study|Protocol deviation|3|||
161621885|NCT00821093|583666158|FG001|Overall Study|Protocol deviation|6|||
161621886|NCT00821093|583666157|FG000|Overall Study|Abnormal laboratory value(s)|2|||
161621887|NCT00821093|583666158|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161621888|NCT00821093|583666157|FG000|Overall Study|Lack of Efficacy|2|||
161621889|NCT00821093|583666158|FG001|Overall Study|Lack of Efficacy|2|||
161621890|NCT00821093|583666157|FG000|Overall Study|Death|2|||
161621891|NCT00821093|583666158|FG001|Overall Study|Death|1|||
161621892|NCT00821093|583666157|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161621893|NCT00821093|583666158|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161621894|NCT00821093|583666157|FG000|Overall Study|Administrative problems|1|||
161621895|NCT00821093|583666158|FG001|Overall Study|Administrative problems|2|||
161621896|NCT05104242|583666159|FG000|Overall Study|Withdrawal by Subject|1|||
161621897|NCT05104242|583666160|FG001|Overall Study|Withdrawal by Subject|5|||
161621898|NCT05104242|583666159|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
161621899|NCT05104242|583666160|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
161621900|NCT02469155|583666165|FG000|Overall Study|Adverse Event|6|||
161621901|NCT02469155|583666166|FG001|Overall Study|Adverse Event|0|||
161621902|NCT02469155|583666167|FG002|Overall Study|Adverse Event|1|||
161621903|NCT02469155|583666168|FG003|Overall Study|Adverse Event|10|||
161621904|NCT02469155|583666165|FG000|Overall Study|Lack of Efficacy|13|||
161621905|NCT02469155|583666166|FG001|Overall Study|Lack of Efficacy|10|||
161621906|NCT02469155|583666167|FG002|Overall Study|Lack of Efficacy|10|||
161621907|NCT02469155|583666168|FG003|Overall Study|Lack of Efficacy|8|||
161684874|NCT01081912|583899590|FG002|Conversion/Titration|Adverse Event|0|||
161684875|NCT01081912|583899588|FG000|Conversion/Titration|Lack of Efficacy|17|||
161684876|NCT01081912|583899589|FG001|Conversion/Titration|Lack of Efficacy|0|||
161684877|NCT01081912|583899590|FG002|Conversion/Titration|Lack of Efficacy|0|||
161684878|NCT01081912|583899588|FG000|Conversion/Titration|Lost to Follow-up|5|||
161684879|NCT01081912|583899589|FG001|Conversion/Titration|Lost to Follow-up|0|||
161684880|NCT01081912|583899590|FG002|Conversion/Titration|Lost to Follow-up|0|||
161684881|NCT01081912|583899588|FG000|Conversion/Titration|Physician Decision|2|||
161684882|NCT01081912|583899589|FG001|Conversion/Titration|Physician Decision|0|||
161832955|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
161832956|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
161832957|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Other|3|||
161832958|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Other|0|||
161832959|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Other|4|||
161621908|NCT02469155|583666165|FG000|Overall Study|Death|0|||
161621909|NCT02469155|583666166|FG001|Overall Study|Death|0|||
161621910|NCT02469155|583666167|FG002|Overall Study|Death|0|||
161621911|NCT02469155|583666168|FG003|Overall Study|Death|1|||
161621912|NCT02469155|583666165|FG000|Overall Study|Lost to Follow-up|5|||
161621913|NCT02469155|583666166|FG001|Overall Study|Lost to Follow-up|2|||
161621914|NCT02469155|583666167|FG002|Overall Study|Lost to Follow-up|7|||
161621915|NCT02469155|583666168|FG003|Overall Study|Lost to Follow-up|2|||
161621916|NCT02469155|583666165|FG000|Overall Study|Physician Decision|0|||
161621917|NCT02469155|583666166|FG001|Overall Study|Physician Decision|0|||
161684883|NCT01081912|583899590|FG002|Conversion/Titration|Physician Decision|0|||
161621918|NCT02469155|583666167|FG002|Overall Study|Physician Decision|1|||
161621919|NCT02469155|583666168|FG003|Overall Study|Physician Decision|0|||
161621920|NCT02469155|583666165|FG000|Overall Study|Withdrawal by Subject|34|||
161621921|NCT02469155|583666166|FG001|Overall Study|Withdrawal by Subject|30|||
161621922|NCT02469155|583666167|FG002|Overall Study|Withdrawal by Subject|20|||
161621923|NCT02469155|583666168|FG003|Overall Study|Withdrawal by Subject|37|||
161621924|NCT02469155|583666165|FG000|Overall Study|Other|3|||
161621925|NCT02469155|583666166|FG001|Overall Study|Other|3|||
161621926|NCT02469155|583666167|FG002|Overall Study|Other|2|||
161621927|NCT02469155|583666168|FG003|Overall Study|Other|10|||
161621928|NCT02469155|583666165|FG000|Overall Study|Protocol Violation|0|||
161621929|NCT02469155|583666166|FG001|Overall Study|Protocol Violation|1|||
161621930|NCT02469155|583666167|FG002|Overall Study|Protocol Violation|0|||
161621931|NCT02469155|583666168|FG003|Overall Study|Protocol Violation|1|||
161621932|NCT02991118|583666169|FG000|Overall Study|Death|3|||
161621933|NCT02991118|583666170|FG001|Overall Study|Death|8|||
161621934|NCT02991118|583666169|FG000|Overall Study|Protocol Violation|0|||
161621935|NCT02991118|583666170|FG001|Overall Study|Protocol Violation|3|||
161621936|NCT02991118|583666169|FG000|Overall Study|Physician Decision|0|||
161621937|NCT02991118|583666170|FG001|Overall Study|Physician Decision|1|||
161621938|NCT02991118|583666169|FG000|Overall Study|Moved out of the country|0|||
161621939|NCT02991118|583666170|FG001|Overall Study|Moved out of the country|1|||
161621940|NCT02991118|583666169|FG000|Overall Study|Adverse Event|2|||
161621941|NCT02991118|583666170|FG001|Overall Study|Adverse Event|2|||
161621942|NCT02991118|583666169|FG000|Overall Study|Withdrawal by Subject|1|||
161621943|NCT02991118|583666170|FG001|Overall Study|Withdrawal by Subject|7|||
161621944|NCT02991118|583666169|FG000|Overall Study|Could not attend study visits|0|||
161621945|NCT02991118|583666170|FG001|Overall Study|Could not attend study visits|1|||
161621946|NCT02991118|583666169|FG000|Overall Study|Lost to Follow-up|1|||
161621947|NCT02991118|583666170|FG001|Overall Study|Lost to Follow-up|9|||
161621948|NCT02764320|583666178|FG000|Overall Study|Withdrawal by Subject|35|||
161621949|NCT02764320|583666179|FG001|Overall Study|Withdrawal by Subject|38|||
161621950|NCT02764320|583666178|FG000|Overall Study|Protocol Violation|11|||
161621951|NCT02764320|583666179|FG001|Overall Study|Protocol Violation|6|||
161621952|NCT02764320|583666178|FG000|Overall Study|Adverse Event|2|||
161621953|NCT02764320|583666179|FG001|Overall Study|Adverse Event|0|||
161621954|NCT02764320|583666178|FG000|Overall Study|Health Issues unable to continue|2|||
161621955|NCT02764320|583666179|FG001|Overall Study|Health Issues unable to continue|0|||
161621956|NCT02764320|583666178|FG000|Overall Study|Did not meet inclusion criteria|1|||
161621957|NCT02764320|583666179|FG001|Overall Study|Did not meet inclusion criteria|0|||
161621958|NCT02764320|583666178|FG000|Overall Study|Subject moved|0|||
161621959|NCT02764320|583666179|FG001|Overall Study|Subject moved|2|||
161621960|NCT02764320|583666178|FG000|Overall Study|Overused medication unavailable|0|||
161621961|NCT02764320|583666179|FG001|Overall Study|Overused medication unavailable|1|||
161621962|NCT02764320|583666178|FG000|Overall Study|Seeking care outside site|0|||
161621963|NCT02764320|583666179|FG001|Overall Study|Seeking care outside site|1|||
161621964|NCT02764320|583666178|FG000|Overall Study|Technology barriers|0|||
161621965|NCT02764320|583666179|FG001|Overall Study|Technology barriers|1|||
161684884|NCT01081912|583899588|FG000|Conversion/Titration|Protocol Violation|67|||
161684885|NCT01081912|583899589|FG001|Conversion/Titration|Protocol Violation|0|||
161684886|NCT01081912|583899590|FG002|Conversion/Titration|Protocol Violation|0|||
161621966|NCT04765046|583666180|FG000|Overall Study|Screen Failure|2|||
161621967|NCT04765046|583666180|FG000|Overall Study|Withdrawal by Subject|4|||
161621968|NCT04765046|583666180|FG000|Overall Study|Physician Decision|4|||
161621969|NCT04765046|583666180|FG000|Overall Study|Surgery Cancelled|8|||
161621970|NCT03150589|583666182|FG000|Overall Study|Withdrawal by Subject|16|||
161621971|NCT03150589|583666183|FG001|Overall Study|Withdrawal by Subject|9|||
161621972|NCT03150589|583666182|FG000|Overall Study|Adverse Event|7|||
161621973|NCT03150589|583666183|FG001|Overall Study|Adverse Event|6|||
161621974|NCT03150589|583666182|FG000|Overall Study|Protocol Violation|4|||
161684887|NCT01081912|583899588|FG000|Conversion/Titration|Withdrawal by Subject|23|||
161621975|NCT03150589|583666183|FG001|Overall Study|Protocol Violation|3|||
161621976|NCT03150589|583666182|FG000|Overall Study|Lost to Follow-up|3|||
161621977|NCT03150589|583666183|FG001|Overall Study|Lost to Follow-up|3|||
161621978|NCT03150589|583666182|FG000|Overall Study|Death|2|||
161621979|NCT03150589|583666183|FG001|Overall Study|Death|3|||
161621980|NCT03150589|583666182|FG000|Overall Study|IP non-compliance and other reasons|12|||
161621981|NCT03150589|583666183|FG001|Overall Study|IP non-compliance and other reasons|3|||
161621982|NCT03529942|583666184|FG000|Overall Study|Withdrawal by Subject|13|||
161621983|NCT03529942|583666184|FG000|Overall Study|Physician Decision|1|||
161621984|NCT03529942|583666184|FG000|Overall Study|Lost to Follow-up|7|||
161621985|NCT03529942|583666184|FG000|Overall Study|Needle inserted but no drug administered|1|||
161621986|NCT03529942|583666184|FG000|Overall Study|Personal reasons|1|||
161621987|NCT01989156|583666191|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
161621988|NCT01989156|583666192|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161621989|NCT01989156|583666193|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
161621990|NCT01989156|583666191|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
161621991|NCT01989156|583666192|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
161621992|NCT01989156|583666193|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
161621993|NCT01989156|583666191|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
161621994|NCT01989156|583666192|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
161621995|NCT01989156|583666193|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
161621996|NCT01989156|583666191|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161621997|NCT01989156|583666192|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161621998|NCT01989156|583666193|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161621999|NCT01989156|583666191|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
161622000|NCT01989156|583666192|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
161622001|NCT01989156|583666193|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
161622002|NCT01989156|583666191|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
161622003|NCT01989156|583666192|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
161622004|NCT01989156|583666193|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
161622005|NCT01989156|583666191|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
161622006|NCT01989156|583666192|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
161622007|NCT01989156|583666193|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
161622008|NCT01989156|583666191|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
161622009|NCT01989156|583666192|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
161622010|NCT01989156|583666193|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
161622011|NCT03839355|583666194|FG000|Overall Study|Withdrawal by Subject|1|||
161622012|NCT03839355|583666195|FG001|Overall Study|Withdrawal by Subject|0|||
161622013|NCT03541369|583666197|FG000|Overall Study|Death|0|||
161622014|NCT03541369|583666198|FG001|Overall Study|Death|0|||
161622015|NCT03541369|583666199|FG002|Overall Study|Death|0|||
161622016|NCT03541369|583666200|FG003|Overall Study|Death|0|||
161622017|NCT03541369|583666201|FG004|Overall Study|Death|1|||
161622018|NCT03541369|583666202|FG005|Overall Study|Death|1|||
161622019|NCT03541369|583666203|FG006|Overall Study|Death|0|||
161622020|NCT03541369|583666204|FG007|Overall Study|Death|2|||
161622021|NCT03541369|583666205|FG008|Overall Study|Death|1|||
161622022|NCT03541369|583666206|FG009|Overall Study|Death|2|||
161622023|NCT03541369|583666207|FG010|Overall Study|Death|1|||
161622024|NCT03541369|583666208|FG011|Overall Study|Death|0|||
161622025|NCT03541369|583666209|FG012|Overall Study|Death|2|||
161622026|NCT03541369|583666210|FG013|Overall Study|Death|1|||
161622027|NCT03541369|583666211|FG014|Overall Study|Death|1|||
161622028|NCT03541369|583666212|FG015|Overall Study|Death|1|||
161622029|NCT03541369|583666213|FG016|Overall Study|Death|0|||
161622030|NCT03541369|583666214|FG017|Overall Study|Death|1|||
161622031|NCT03541369|583666197|FG000|Overall Study|Decision by sponsor|0|||
161622032|NCT03541369|583666198|FG001|Overall Study|Decision by sponsor|0|||
161622033|NCT03541369|583666199|FG002|Overall Study|Decision by sponsor|0|||
161832960|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Other|1|||
161832961|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161622034|NCT03541369|583666200|FG003|Overall Study|Decision by sponsor|1|||
161622035|NCT03541369|583666201|FG004|Overall Study|Decision by sponsor|0|||
161622036|NCT03541369|583666202|FG005|Overall Study|Decision by sponsor|2|||
161622037|NCT03541369|583666203|FG006|Overall Study|Decision by sponsor|0|||
161622038|NCT03541369|583666204|FG007|Overall Study|Decision by sponsor|1|||
161622039|NCT03541369|583666205|FG008|Overall Study|Decision by sponsor|2|||
161622040|NCT03541369|583666206|FG009|Overall Study|Decision by sponsor|0|||
161622041|NCT03541369|583666207|FG010|Overall Study|Decision by sponsor|0|||
161832962|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161622042|NCT03541369|583666208|FG011|Overall Study|Decision by sponsor|0|||
161622043|NCT03541369|583666209|FG012|Overall Study|Decision by sponsor|2|||
161622044|NCT03541369|583666210|FG013|Overall Study|Decision by sponsor|2|||
161622045|NCT03541369|583666211|FG014|Overall Study|Decision by sponsor|0|||
161622046|NCT03541369|583666212|FG015|Overall Study|Decision by sponsor|1|||
161622047|NCT03541369|583666213|FG016|Overall Study|Decision by sponsor|1|||
161622048|NCT03541369|583666214|FG017|Overall Study|Decision by sponsor|1|||
161622049|NCT03541369|583666197|FG000|Overall Study|Withdrawal by Subject|0|||
161622050|NCT03541369|583666198|FG001|Overall Study|Withdrawal by Subject|0|||
161622051|NCT03541369|583666199|FG002|Overall Study|Withdrawal by Subject|0|||
161622052|NCT03541369|583666200|FG003|Overall Study|Withdrawal by Subject|0|||
161622053|NCT03541369|583666201|FG004|Overall Study|Withdrawal by Subject|0|||
161622054|NCT03541369|583666202|FG005|Overall Study|Withdrawal by Subject|0|||
161622055|NCT03541369|583666203|FG006|Overall Study|Withdrawal by Subject|1|||
161622056|NCT03541369|583666204|FG007|Overall Study|Withdrawal by Subject|0|||
161622057|NCT03541369|583666205|FG008|Overall Study|Withdrawal by Subject|0|||
161622058|NCT03541369|583666206|FG009|Overall Study|Withdrawal by Subject|0|||
161622059|NCT03541369|583666207|FG010|Overall Study|Withdrawal by Subject|0|||
161622060|NCT03541369|583666208|FG011|Overall Study|Withdrawal by Subject|1|||
161622061|NCT03541369|583666209|FG012|Overall Study|Withdrawal by Subject|0|||
161622062|NCT03541369|583666210|FG013|Overall Study|Withdrawal by Subject|0|||
161622063|NCT03541369|583666211|FG014|Overall Study|Withdrawal by Subject|3|||
161622064|NCT03541369|583666212|FG015|Overall Study|Withdrawal by Subject|0|||
161622065|NCT03541369|583666213|FG016|Overall Study|Withdrawal by Subject|4|||
161622066|NCT03541369|583666214|FG017|Overall Study|Withdrawal by Subject|2|||
161622067|NCT03541369|583666197|FG000|Overall Study|Lost to Follow-up|0|||
161622068|NCT03541369|583666198|FG001|Overall Study|Lost to Follow-up|0|||
161622069|NCT03541369|583666199|FG002|Overall Study|Lost to Follow-up|0|||
161622070|NCT03541369|583666200|FG003|Overall Study|Lost to Follow-up|0|||
161622071|NCT03541369|583666201|FG004|Overall Study|Lost to Follow-up|1|||
161622072|NCT03541369|583666202|FG005|Overall Study|Lost to Follow-up|0|||
161622073|NCT03541369|583666203|FG006|Overall Study|Lost to Follow-up|0|||
161622074|NCT03541369|583666204|FG007|Overall Study|Lost to Follow-up|0|||
161622075|NCT03541369|583666205|FG008|Overall Study|Lost to Follow-up|1|||
161622076|NCT03541369|583666206|FG009|Overall Study|Lost to Follow-up|0|||
161622077|NCT03541369|583666207|FG010|Overall Study|Lost to Follow-up|0|||
161622078|NCT03541369|583666208|FG011|Overall Study|Lost to Follow-up|0|||
161622079|NCT03541369|583666209|FG012|Overall Study|Lost to Follow-up|1|||
161622080|NCT03541369|583666210|FG013|Overall Study|Lost to Follow-up|0|||
161622081|NCT03541369|583666211|FG014|Overall Study|Lost to Follow-up|0|||
161622082|NCT03541369|583666212|FG015|Overall Study|Lost to Follow-up|0|||
161622083|NCT03541369|583666213|FG016|Overall Study|Lost to Follow-up|0|||
161622084|NCT03541369|583666214|FG017|Overall Study|Lost to Follow-up|0|||
161622085|NCT01856569|583666215|FG000|Overall Study|Other|1|||
161622086|NCT01856569|583666215|FG000|Overall Study|Changed Site/Structure|1|||
161622087|NCT01856569|583666215|FG000|Overall Study|Lost to Follow-up|3|||
161622088|NCT01856569|583666215|FG000|Overall Study|Did not met inclusion criteria|8|||
161622089|NCT00696241|583666216|FG000|Overall Study|Adverse Event|11|||
161622090|NCT00696241|583666217|FG001|Overall Study|Adverse Event|3|||
161622091|NCT00696241|583666218|FG002|Overall Study|Adverse Event|6|||
161622092|NCT00696241|583666219|FG003|Overall Study|Adverse Event|4|||
161622093|NCT00696241|583666220|FG004|Overall Study|Adverse Event|5|||
161622094|NCT00696241|583666216|FG000|Overall Study|Protocol Violation|1|||
161622095|NCT00696241|583666217|FG001|Overall Study|Protocol Violation|1|||
161622096|NCT00696241|583666218|FG002|Overall Study|Protocol Violation|2|||
161622097|NCT00696241|583666219|FG003|Overall Study|Protocol Violation|0|||
161622098|NCT00696241|583666220|FG004|Overall Study|Protocol Violation|3|||
161622099|NCT00696241|583666216|FG000|Overall Study|Lost to Follow-up|1|||
161622100|NCT00696241|583666217|FG001|Overall Study|Lost to Follow-up|4|||
161622101|NCT00696241|583666218|FG002|Overall Study|Lost to Follow-up|1|||
161622102|NCT00696241|583666219|FG003|Overall Study|Lost to Follow-up|2|||
161622103|NCT00696241|583666220|FG004|Overall Study|Lost to Follow-up|0|||
161622104|NCT00696241|583666216|FG000|Overall Study|Withdrawal by Subject|4|||
161622105|NCT00696241|583666217|FG001|Overall Study|Withdrawal by Subject|8|||
161622106|NCT00696241|583666218|FG002|Overall Study|Withdrawal by Subject|6|||
161622107|NCT00696241|583666219|FG003|Overall Study|Withdrawal by Subject|1|||
161622108|NCT00696241|583666220|FG004|Overall Study|Withdrawal by Subject|0|||
161622109|NCT00696241|583666216|FG000|Overall Study|Lack of Efficacy|1|||
161622110|NCT00696241|583666217|FG001|Overall Study|Lack of Efficacy|5|||
161622111|NCT00696241|583666218|FG002|Overall Study|Lack of Efficacy|4|||
161622112|NCT00696241|583666219|FG003|Overall Study|Lack of Efficacy|5|||
161622113|NCT00696241|583666220|FG004|Overall Study|Lack of Efficacy|3|||
161622114|NCT00696241|583666216|FG000|Overall Study|Other|6|||
161622115|NCT00696241|583666217|FG001|Overall Study|Other|1|||
161622116|NCT00696241|583666218|FG002|Overall Study|Other|5|||
161622117|NCT00696241|583666219|FG003|Overall Study|Other|2|||
161622118|NCT00696241|583666220|FG004|Overall Study|Other|1|||
161622119|NCT01613599|583666221|FG000|Overall Study|Death|9|||
161622120|NCT01613599|583666221|FG000|Overall Study|Lost to Follow-up|5|||
161622121|NCT01613599|583666221|FG000|Overall Study|Withdrawal by Subject|8|||
161622122|NCT01613599|583666221|FG000|Overall Study|Reason not specified|3|||
161622123|NCT04749797|583666226|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
161622124|NCT04749797|583666227|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
161622125|NCT04749797|583666228|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
161622126|NCT02513667|583666229|FG000|Overall Study|Withdrawal by Subject|0|||
161622127|NCT02513667|583666230|FG001|Overall Study|Withdrawal by Subject|1|||
161622128|NCT00871715|583666241|FG000|Overall Study|Withdrawal by Subject|6|||
161622129|NCT00871715|583666242|FG001|Overall Study|Withdrawal by Subject|10|||
161622130|NCT00871715|583666243|FG002|Overall Study|Withdrawal by Subject|15|||
161622131|NCT00871715|583666241|FG000|Overall Study|Physician Decision|6|||
161622132|NCT00871715|583666242|FG001|Overall Study|Physician Decision|0|||
161622133|NCT00871715|583666243|FG002|Overall Study|Physician Decision|2|||
161622134|NCT00871715|583666241|FG000|Overall Study|Lost to Follow-up|3|||
161622135|NCT00871715|583666242|FG001|Overall Study|Lost to Follow-up|6|||
161622136|NCT00871715|583666243|FG002|Overall Study|Lost to Follow-up|9|||
161622137|NCT02291549|583666244|FG000|Overall Study|Lost to Follow-up|1|||
161622138|NCT02291549|583666245|FG001|Overall Study|Lost to Follow-up|0|||
161622139|NCT02291549|583666244|FG000|Overall Study|Withdrawal by Subject|0|||
161622140|NCT02291549|583666245|FG001|Overall Study|Withdrawal by Subject|1|||
161622141|NCT00537914|583666246|FG000|Overall Study|Death|1|||
161622142|NCT00537914|583666246|FG000|Overall Study|Adverse Event|7|||
161622143|NCT00537914|583666246|FG000|Overall Study|Treatment failure|10|||
161622144|NCT00537914|583666246|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
161622145|NCT00537914|583666246|FG000|Overall Study|Lost to Follow-up|19|||
161622146|NCT00537914|583666246|FG000|Overall Study|Withdrawal of informed consent|59|||
161622147|NCT01147471|583666250|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
161622148|NCT01147471|583666251|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
161622149|NCT01147471|583666250|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
161622150|NCT01147471|583666251|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
161622151|NCT01147471|583666250|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
161622152|NCT01147471|583666251|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
161622153|NCT01147471|583666250|FG000|3 Month Follow Up|Lost to Follow-up|1|||
161622154|NCT01147471|583666251|FG001|3 Month Follow Up|Lost to Follow-up|1|||
161622155|NCT01147471|583666250|FG000|3 Month Follow Up|Physician Decision|0|||
161622156|NCT01147471|583666251|FG001|3 Month Follow Up|Physician Decision|1|||
161622157|NCT01147471|583666250|FG000|6 Month Follow Up|Lost to Follow-up|4|||
161622158|NCT01147471|583666251|FG001|6 Month Follow Up|Lost to Follow-up|2|||
161622159|NCT01307800|583666254|FG000|Overall Study|Adverse Event|9|||
161622160|NCT01307800|583666255|FG001|Overall Study|Adverse Event|8|||
161622161|NCT01307800|583666256|FG002|Overall Study|Adverse Event|10|||
161622162|NCT01307800|583666257|FG003|Overall Study|Adverse Event|14|||
161622163|NCT01307800|583666254|FG000|Overall Study|Entry Criteria Not Met|0|||
161622164|NCT01307800|583666255|FG001|Overall Study|Entry Criteria Not Met|0|||
161622165|NCT01307800|583666256|FG002|Overall Study|Entry Criteria Not Met|0|||
161622166|NCT01307800|583666257|FG003|Overall Study|Entry Criteria Not Met|2|||
161622167|NCT01307800|583666254|FG000|Overall Study|Lost to Follow-up|5|||
161622168|NCT01307800|583666255|FG001|Overall Study|Lost to Follow-up|6|||
161684888|NCT01081912|583899589|FG001|Conversion/Titration|Withdrawal by Subject|0|||
161684889|NCT01081912|583899590|FG002|Conversion/Titration|Withdrawal by Subject|0|||
161622169|NCT01307800|583666256|FG002|Overall Study|Lost to Follow-up|2|||
161622170|NCT01307800|583666257|FG003|Overall Study|Lost to Follow-up|8|||
161622171|NCT01307800|583666254|FG000|Overall Study|Perceived Lack of Efficacy|24|||
161622172|NCT01307800|583666255|FG001|Overall Study|Perceived Lack of Efficacy|23|||
161622173|NCT01307800|583666256|FG002|Overall Study|Perceived Lack of Efficacy|20|||
161622174|NCT01307800|583666257|FG003|Overall Study|Perceived Lack of Efficacy|33|||
161622175|NCT01307800|583666254|FG000|Overall Study|Protocol Violation|0|||
161684890|NCT01081912|583899588|FG000|Conversion/Titration|Non-Compliance|47|||
161684891|NCT01081912|583899589|FG001|Conversion/Titration|Non-Compliance|0|||
161684892|NCT01081912|583899590|FG002|Conversion/Titration|Non-Compliance|0|||
161684893|NCT01081912|583899588|FG000|Maintenance Treatment|Adverse Event|0|||
161684894|NCT01081912|583899589|FG001|Maintenance Treatment|Adverse Event|2|||
161622176|NCT01307800|583666255|FG001|Overall Study|Protocol Violation|3|||
161622177|NCT01307800|583666256|FG002|Overall Study|Protocol Violation|4|||
161622178|NCT01307800|583666257|FG003|Overall Study|Protocol Violation|5|||
161684895|NCT01081912|583899590|FG002|Maintenance Treatment|Adverse Event|12|||
161684896|NCT01081912|583899588|FG000|Maintenance Treatment|Lack of Efficacy|0|||
161622179|NCT01307800|583666254|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
161622180|NCT01307800|583666255|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
161622181|NCT01307800|583666256|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
161622182|NCT01307800|583666257|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
161622183|NCT01307800|583666254|FG000|Overall Study|Sponsor Decision|6|||
161622184|NCT01307800|583666255|FG001|Overall Study|Sponsor Decision|9|||
161622185|NCT01307800|583666256|FG002|Overall Study|Sponsor Decision|12|||
161684897|NCT01081912|583899589|FG001|Maintenance Treatment|Lack of Efficacy|14|||
161684898|NCT01081912|583899590|FG002|Maintenance Treatment|Lack of Efficacy|64|||
161684899|NCT01081912|583899588|FG000|Maintenance Treatment|Lost to Follow-up|0|||
161622186|NCT01307800|583666257|FG003|Overall Study|Sponsor Decision|28|||
161622187|NCT01307800|583666254|FG000|Overall Study|Withdrawal by Subject|10|||
161622188|NCT01307800|583666255|FG001|Overall Study|Withdrawal by Subject|11|||
161622189|NCT01307800|583666256|FG002|Overall Study|Withdrawal by Subject|8|||
161622190|NCT01307800|583666257|FG003|Overall Study|Withdrawal by Subject|15|||
161622191|NCT01307800|583666254|FG000|Overall Study|Participant Moved|0|||
161622192|NCT01307800|583666255|FG001|Overall Study|Participant Moved|2|||
161622193|NCT01307800|583666256|FG002|Overall Study|Participant Moved|1|||
161622194|NCT01307800|583666257|FG003|Overall Study|Participant Moved|3|||
161622195|NCT00689351|583666258|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
161622196|NCT00689351|583666259|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
161622197|NCT00689351|583666258|FG000|Infant Series of Dosing|Adverse Event|1|||
161622198|NCT00689351|583666259|FG001|Infant Series of Dosing|Adverse Event|0|||
161622199|NCT00689351|583666258|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
161622200|NCT00689351|583666259|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
161622201|NCT00689351|583666258|FG000|After Infant Series|Parent/legal guardian request|1|||
161622202|NCT00689351|583666259|FG001|After Infant Series|Parent/legal guardian request|0|||
161622203|NCT01766206|583666260|FG000|Overall Study|Withdrawal by Subject|22|||
161622204|NCT01766206|583666260|FG000|Overall Study|Lost to Follow-up|10|||
161622205|NCT01766206|583666260|FG000|Overall Study|Inappropriate enrollment|18|||
161622206|NCT01766206|583666260|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
161622207|NCT01662505|583666261|FG000|Overall Study|Progressive disease|6|||
161622208|NCT01662505|583666262|FG001|Overall Study|Progressive disease|1|||
161622209|NCT01662505|583666263|FG002|Overall Study|Progressive disease|5|||
161622210|NCT01662505|583666261|FG000|Overall Study|Refused cont. medication|0|||
161622211|NCT01662505|583666262|FG001|Overall Study|Refused cont. medication|0|||
161622212|NCT01662505|583666263|FG002|Overall Study|Refused cont. medication|1|||
161622213|NCT01662505|583666261|FG000|Overall Study|Not specified above|1|||
161622214|NCT01662505|583666262|FG001|Overall Study|Not specified above|3|||
161622215|NCT01662505|583666263|FG002|Overall Study|Not specified above|2|||
161622216|NCT01313663|583666264|FG000|Overall Study|Study Closed/Terminated|2|||
161622217|NCT01313663|583666265|FG001|Overall Study|Study Closed/Terminated|4|||
161622218|NCT01313663|583666264|FG000|Overall Study|Lost to Follow-up|0|||
161622219|NCT01313663|583666265|FG001|Overall Study|Lost to Follow-up|1|||
161622220|NCT01313663|583666264|FG000|Overall Study|Physician Decision|0|||
161622221|NCT01313663|583666265|FG001|Overall Study|Physician Decision|2|||
161622222|NCT01313663|583666264|FG000|Overall Study|Withdrawal by Subject|2|||
161622223|NCT01313663|583666265|FG001|Overall Study|Withdrawal by Subject|1|||
161622224|NCT01229176|583666266|FG000|Overall Study|Withdrawal by Subject|0|||
161622225|NCT01229176|583666267|FG001|Overall Study|Withdrawal by Subject|0|||
161622226|NCT01229176|583666268|FG002|Overall Study|Withdrawal by Subject|0|||
161622227|NCT01229176|583666269|FG003|Overall Study|Withdrawal by Subject|1|||
161622228|NCT01229176|583666270|FG004|Overall Study|Withdrawal by Subject|1|||
161622229|NCT01229176|583666271|FG005|Overall Study|Withdrawal by Subject|1|||
161622230|NCT01229176|583666272|FG006|Overall Study|Withdrawal by Subject|0|||
161622231|NCT01229176|583666273|FG007|Overall Study|Withdrawal by Subject|1|||
161622232|NCT01229176|583666266|FG000|Overall Study|Lost to Follow-up|0|||
161622233|NCT01229176|583666267|FG001|Overall Study|Lost to Follow-up|3|||
161622234|NCT01229176|583666268|FG002|Overall Study|Lost to Follow-up|0|||
161622235|NCT01229176|583666269|FG003|Overall Study|Lost to Follow-up|0|||
161622236|NCT01229176|583666270|FG004|Overall Study|Lost to Follow-up|1|||
161622237|NCT01229176|583666271|FG005|Overall Study|Lost to Follow-up|1|||
161622238|NCT01229176|583666272|FG006|Overall Study|Lost to Follow-up|0|||
161684900|NCT01081912|583899589|FG001|Maintenance Treatment|Lost to Follow-up|1|||
161684901|NCT01081912|583899590|FG002|Maintenance Treatment|Lost to Follow-up|0|||
161684902|NCT01081912|583899588|FG000|Maintenance Treatment|Physician Decision|0|||
161684903|NCT01081912|583899589|FG001|Maintenance Treatment|Physician Decision|0|||
161622239|NCT01229176|583666273|FG007|Overall Study|Lost to Follow-up|2|||
161622240|NCT02367794|583666279|FG000|Overall Study|Death|252|||
161622241|NCT02367794|583666280|FG001|Overall Study|Death|245|||
161622242|NCT02367794|583666281|FG002|Overall Study|Death|243|||
161622243|NCT02367794|583666279|FG000|Overall Study|Lost to Follow-up|1|||
161622244|NCT02367794|583666280|FG001|Overall Study|Lost to Follow-up|2|||
161622245|NCT02367794|583666281|FG002|Overall Study|Lost to Follow-up|2|||
161622246|NCT02367794|583666279|FG000|Overall Study|Physician Decision|0|||
161622247|NCT02367794|583666280|FG001|Overall Study|Physician Decision|5|||
161622248|NCT02367794|583666281|FG002|Overall Study|Physician Decision|3|||
161622249|NCT02367794|583666279|FG000|Overall Study|Protocol Violation|1|||
161622250|NCT02367794|583666280|FG001|Overall Study|Protocol Violation|0|||
161622251|NCT02367794|583666281|FG002|Overall Study|Protocol Violation|1|||
161622252|NCT02367794|583666279|FG000|Overall Study|Withdrawal by Subject|25|||
161684904|NCT01081912|583899590|FG002|Maintenance Treatment|Physician Decision|1|||
161622253|NCT02367794|583666280|FG001|Overall Study|Withdrawal by Subject|12|||
161622254|NCT02367794|583666281|FG002|Overall Study|Withdrawal by Subject|20|||
161622255|NCT02367794|583666279|FG000|Overall Study|Brain metastasis|1|||
161622256|NCT02367794|583666280|FG001|Overall Study|Brain metastasis|0|||
161622257|NCT02367794|583666281|FG002|Overall Study|Brain metastasis|0|||
161684905|NCT01081912|583899588|FG000|Maintenance Treatment|Protocol Violation|0|||
161622258|NCT02367794|583666279|FG000|Overall Study|Randomized in error|0|||
161622259|NCT02367794|583666280|FG001|Overall Study|Randomized in error|0|||
161622260|NCT02367794|583666281|FG002|Overall Study|Randomized in error|1|||
161622261|NCT02367794|583666279|FG000|Overall Study|Patient unable to receive carboplatin|0|||
161622262|NCT02367794|583666280|FG001|Overall Study|Patient unable to receive carboplatin|0|||
161622263|NCT02367794|583666281|FG002|Overall Study|Patient unable to receive carboplatin|1|||
161622264|NCT02367794|583666279|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
161622265|NCT02367794|583666280|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
161622266|NCT02367794|583666281|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
161622267|NCT02367794|583666279|FG000|Overall Study|Adverse Event|0|||
161622268|NCT02367794|583666280|FG001|Overall Study|Adverse Event|0|||
161622269|NCT02367794|583666281|FG002|Overall Study|Adverse Event|2|||
161622270|NCT02367794|583666279|FG000|Overall Study|Study Terminated By Sponsor|0|||
161622271|NCT02367794|583666280|FG001|Overall Study|Study Terminated By Sponsor|1|||
161622272|NCT02367794|583666281|FG002|Overall Study|Study Terminated By Sponsor|1|||
161622273|NCT02367794|583666279|FG000|Overall Study|Moved to Roll-Over Study|0|||
161622274|NCT02367794|583666280|FG001|Overall Study|Moved to Roll-Over Study|15|||
161622275|NCT02367794|583666281|FG002|Overall Study|Moved to Roll-Over Study|13|||
161622276|NCT02367794|583666279|FG000|Overall Study|Sponsor Request|60|||
161622277|NCT02367794|583666280|FG001|Overall Study|Sponsor Request|57|||
161622278|NCT02367794|583666281|FG002|Overall Study|Sponsor Request|45|||
161622279|NCT02367794|583666279|FG000|Overall Study|Moved into PTAP Study|0|||
161622280|NCT02367794|583666280|FG001|Overall Study|Moved into PTAP Study|2|||
161622281|NCT02367794|583666281|FG002|Overall Study|Moved into PTAP Study|3|||
161622282|NCT02367794|583666279|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
161622283|NCT02367794|583666280|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
161622284|NCT02367794|583666281|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
161622285|NCT02367794|583666279|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
161622286|NCT02367794|583666280|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
161622287|NCT02367794|583666281|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
161622288|NCT02367794|583666279|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
161622289|NCT02367794|583666280|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
161622290|NCT02367794|583666281|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
161622291|NCT02367794|583666279|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
161622292|NCT02367794|583666280|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
161622293|NCT02367794|583666281|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
161622294|NCT02010684|583666282|FG000|Overall Study|Lost to Follow-up|8|||
161622295|NCT02010684|583666283|FG001|Overall Study|Lost to Follow-up|18|||
161622296|NCT02010684|583666282|FG000|Overall Study|Withdrawal by Subject|4|||
161622297|NCT02010684|583666283|FG001|Overall Study|Withdrawal by Subject|5|||
161622298|NCT01986348|583666284|FG000|Overall Study|Death|8|||
161622299|NCT01986348|583666285|FG001|Overall Study|Death|22|||
161622300|NCT01986348|583666286|FG002|Overall Study|Death|10|||
161622301|NCT01986348|583666287|FG003|Overall Study|Death|21|||
161622302|NCT01986348|583666284|FG000|Overall Study|Lost to Follow-up|0|||
161622303|NCT01986348|583666285|FG001|Overall Study|Lost to Follow-up|0|||
161622304|NCT01986348|583666286|FG002|Overall Study|Lost to Follow-up|0|||
161622305|NCT01986348|583666287|FG003|Overall Study|Lost to Follow-up|2|||
161622306|NCT01986348|583666284|FG000|Overall Study|Physician Decision|0|||
161622307|NCT01986348|583666285|FG001|Overall Study|Physician Decision|0|||
161622308|NCT01986348|583666286|FG002|Overall Study|Physician Decision|0|||
161622309|NCT01986348|583666287|FG003|Overall Study|Physician Decision|1|||
161622310|NCT01986348|583666284|FG000|Overall Study|Progressive Disease|0|||
161622311|NCT01986348|583666285|FG001|Overall Study|Progressive Disease|0|||
161622312|NCT01986348|583666286|FG002|Overall Study|Progressive Disease|2|||
161684906|NCT01081912|583899589|FG001|Maintenance Treatment|Protocol Violation|1|||
161684907|NCT01081912|583899590|FG002|Maintenance Treatment|Protocol Violation|2|||
161684908|NCT01081912|583899588|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
161684909|NCT01081912|583899589|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
161684910|NCT01081912|583899590|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
161684911|NCT01081912|583899588|FG000|Maintenance Treatment|Non-Compliance|0|||
161622313|NCT01986348|583666287|FG003|Overall Study|Progressive Disease|0|||
161622314|NCT01986348|583666284|FG000|Overall Study|Withdrawal by Participant|0|||
161622315|NCT01986348|583666285|FG001|Overall Study|Withdrawal by Participant|1|||
161622316|NCT01986348|583666286|FG002|Overall Study|Withdrawal by Participant|2|||
161622317|NCT01986348|583666287|FG003|Overall Study|Withdrawal by Participant|1|||
161622318|NCT01986348|583666284|FG000|Overall Study|Study Terminated by Sponsor|0|||
161622319|NCT01986348|583666285|FG001|Overall Study|Study Terminated by Sponsor|0|||
161622320|NCT01986348|583666286|FG002|Overall Study|Study Terminated by Sponsor|0|||
161622321|NCT01986348|583666287|FG003|Overall Study|Study Terminated by Sponsor|3|||
161622322|NCT01986348|583666284|FG000|Overall Study|Other-unspecified|0|||
161622323|NCT01986348|583666285|FG001|Overall Study|Other-unspecified|1|||
161622324|NCT01986348|583666286|FG002|Overall Study|Other-unspecified|0|||
161622325|NCT01986348|583666287|FG003|Overall Study|Other-unspecified|2|||
161622326|NCT01884571|583666292|FG000|Overall Study|Adverse Event|1|||
161622327|NCT01884571|583666292|FG000|Overall Study|Death|2|||
161622328|NCT01884571|583666292|FG000|Overall Study|Withdrawal by Subject|2|||
161622329|NCT01884571|583666292|FG000|Overall Study|Disease progression|3|||
161622330|NCT00853957|583666293|FG000|Overall Study|Adverse Event|9|||
161622331|NCT00853957|583666294|FG001|Overall Study|Adverse Event|3|||
161622332|NCT00853957|583666293|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161622333|NCT00853957|583666294|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161622334|NCT00853957|583666293|FG000|Overall Study|Subject withdrew consent|4|||
161622335|NCT00853957|583666294|FG001|Overall Study|Subject withdrew consent|5|||
161622336|NCT00853957|583666293|FG000|Overall Study|Lost to Follow-up|1|||
161622337|NCT00853957|583666294|FG001|Overall Study|Lost to Follow-up|6|||
161622338|NCT00853957|583666293|FG000|Overall Study|Protocol deviation|0|||
161622339|NCT00853957|583666294|FG001|Overall Study|Protocol deviation|3|||
161622340|NCT02942771|583666297|FG000|Overall Study|Adverse Event|1|||
161622341|NCT02942771|583666298|FG001|Overall Study|Adverse Event|0|||
161622342|NCT02942771|583666299|FG002|Overall Study|Adverse Event|0|||
161622343|NCT02942771|583666300|FG003|Overall Study|Adverse Event|0|||
161622344|NCT02942771|583666301|FG004|Overall Study|Adverse Event|2|||
161622345|NCT02942771|583666297|FG000|Overall Study|Lost to Follow-up|1|||
161622346|NCT02942771|583666298|FG001|Overall Study|Lost to Follow-up|0|||
161622347|NCT02942771|583666299|FG002|Overall Study|Lost to Follow-up|0|||
161622348|NCT02942771|583666300|FG003|Overall Study|Lost to Follow-up|0|||
161622349|NCT02942771|583666301|FG004|Overall Study|Lost to Follow-up|0|||
161622350|NCT02942771|583666297|FG000|Overall Study|Withdrawal by Subject|1|||
161622351|NCT02942771|583666298|FG001|Overall Study|Withdrawal by Subject|0|||
161622352|NCT02942771|583666299|FG002|Overall Study|Withdrawal by Subject|0|||
161622353|NCT02942771|583666300|FG003|Overall Study|Withdrawal by Subject|0|||
161622354|NCT02942771|583666301|FG004|Overall Study|Withdrawal by Subject|2|||
161622355|NCT02158806|583666302|FG000|Overall Study|Death|2|||
161622356|NCT02158806|583666303|FG001|Overall Study|Death|0|||
161622357|NCT02158806|583666302|FG000|Overall Study|Withdrawal by Subject|2|||
161622358|NCT02158806|583666303|FG001|Overall Study|Withdrawal by Subject|0|||
161622359|NCT02158806|583666302|FG000|Overall Study|Lost to Follow-up|0|||
161622360|NCT02158806|583666303|FG001|Overall Study|Lost to Follow-up|3|||
161622361|NCT02158806|583666302|FG000|Overall Study|Moved out of area|0|||
161622362|NCT02158806|583666303|FG001|Overall Study|Moved out of area|1|||
161622363|NCT02158806|583666302|FG000|Overall Study|Transferred to palliative care|0|||
161622364|NCT02158806|583666303|FG001|Overall Study|Transferred to palliative care|1|||
161622365|NCT01898299|583666304|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
161622366|NCT01898299|583666305|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
161622367|NCT02340806|583666309|FG000|Overall Study|Protocol Violation|2|||
161622368|NCT02340806|583666310|FG001|Overall Study|Protocol Violation|0|||
161622369|NCT02340806|583666309|FG000|Overall Study|epidural catheter replaced|2|||
161622370|NCT02340806|583666310|FG001|Overall Study|epidural catheter replaced|1|||
161622371|NCT02340806|583666309|FG000|Overall Study|history of chronic pain medication|1|||
161622372|NCT02340806|583666310|FG001|Overall Study|history of chronic pain medication|0|||
161622373|NCT02340806|583666309|FG000|Overall Study|re-dose < 90 min of CSE|1|||
161622374|NCT02340806|583666310|FG001|Overall Study|re-dose < 90 min of CSE|3|||
161622375|NCT01186809|583666311|FG000|Overall Study|Death|30|||
161622376|NCT01159600|583666312|FG000|Overall Study|Not treated|0|||
161622377|NCT01159600|583666313|FG001|Overall Study|Not treated|0|||
161622378|NCT01159600|583666314|FG002|Overall Study|Not treated|1|||
161622379|NCT01159600|583666315|FG003|Overall Study|Not treated|0|||
161622380|NCT01159600|583666316|FG004|Overall Study|Not treated|0|||
161622381|NCT01159600|583666317|FG005|Overall Study|Not treated|1|||
161684912|NCT01081912|583899589|FG001|Maintenance Treatment|Non-Compliance|4|||
161622382|NCT01159600|583666318|FG006|Overall Study|Not treated|2|||
161622383|NCT01159600|583666319|FG007|Overall Study|Not treated|2|||
161622384|NCT01159600|583666312|FG000|Overall Study|Adverse Event|7|||
161622385|NCT01159600|583666313|FG001|Overall Study|Adverse Event|2|||
161622386|NCT01159600|583666314|FG002|Overall Study|Adverse Event|5|||
161684913|NCT01081912|583899590|FG002|Maintenance Treatment|Non-Compliance|7|||
161622387|NCT01159600|583666315|FG003|Overall Study|Adverse Event|1|||
161622388|NCT01159600|583666316|FG004|Overall Study|Adverse Event|8|||
161684914|NCT01081912|583899588|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
161622389|NCT01159600|583666317|FG005|Overall Study|Adverse Event|6|||
161622390|NCT01159600|583666318|FG006|Overall Study|Adverse Event|7|||
161622391|NCT01159600|583666319|FG007|Overall Study|Adverse Event|5|||
161622392|NCT01159600|583666312|FG000|Overall Study|Lack of Efficacy|0|||
161622393|NCT01159600|583666313|FG001|Overall Study|Lack of Efficacy|0|||
161622394|NCT01159600|583666314|FG002|Overall Study|Lack of Efficacy|0|||
161622395|NCT01159600|583666315|FG003|Overall Study|Lack of Efficacy|0|||
161622396|NCT01159600|583666316|FG004|Overall Study|Lack of Efficacy|2|||
161622397|NCT01159600|583666317|FG005|Overall Study|Lack of Efficacy|0|||
161622398|NCT01159600|583666318|FG006|Overall Study|Lack of Efficacy|0|||
161622399|NCT01159600|583666319|FG007|Overall Study|Lack of Efficacy|1|||
161684915|NCT01081912|583899589|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
161622400|NCT01159600|583666312|FG000|Overall Study|Non compliant with protocol|2|||
161622401|NCT01159600|583666313|FG001|Overall Study|Non compliant with protocol|1|||
161622402|NCT01159600|583666314|FG002|Overall Study|Non compliant with protocol|0|||
161622403|NCT01159600|583666315|FG003|Overall Study|Non compliant with protocol|0|||
161622404|NCT01159600|583666316|FG004|Overall Study|Non compliant with protocol|2|||
161622405|NCT01159600|583666317|FG005|Overall Study|Non compliant with protocol|0|||
161622406|NCT01159600|583666318|FG006|Overall Study|Non compliant with protocol|2|||
161622407|NCT01159600|583666319|FG007|Overall Study|Non compliant with protocol|0|||
161622408|NCT01159600|583666312|FG000|Overall Study|Lost to Follow-up|2|||
161622409|NCT01159600|583666313|FG001|Overall Study|Lost to Follow-up|3|||
161622410|NCT01159600|583666314|FG002|Overall Study|Lost to Follow-up|4|||
161622411|NCT01159600|583666315|FG003|Overall Study|Lost to Follow-up|3|||
161622412|NCT01159600|583666316|FG004|Overall Study|Lost to Follow-up|3|||
161622413|NCT01159600|583666317|FG005|Overall Study|Lost to Follow-up|0|||
161622414|NCT01159600|583666318|FG006|Overall Study|Lost to Follow-up|3|||
161622415|NCT01159600|583666319|FG007|Overall Study|Lost to Follow-up|2|||
161622416|NCT01159600|583666312|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
161622417|NCT01159600|583666313|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
161622418|NCT01159600|583666314|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
161622419|NCT01159600|583666315|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
161622420|NCT01159600|583666316|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
161622421|NCT01159600|583666317|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
161622422|NCT01159600|583666318|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
161622423|NCT01159600|583666319|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
161622424|NCT01159600|583666312|FG000|Overall Study|Other reason not defined above|3|||
161622425|NCT01159600|583666313|FG001|Overall Study|Other reason not defined above|0|||
161622426|NCT01159600|583666314|FG002|Overall Study|Other reason not defined above|4|||
161622427|NCT01159600|583666315|FG003|Overall Study|Other reason not defined above|2|||
161622428|NCT01159600|583666316|FG004|Overall Study|Other reason not defined above|5|||
161622429|NCT01159600|583666317|FG005|Overall Study|Other reason not defined above|7|||
161622430|NCT01159600|583666318|FG006|Overall Study|Other reason not defined above|3|||
161622431|NCT01159600|583666319|FG007|Overall Study|Other reason not defined above|3|||
161622432|NCT05356130|583667955|FG000|Overall Study|Withdrawal by Subject|0|||
161622433|NCT05356130|583667956|FG001|Overall Study|Withdrawal by Subject|0|||
161622434|NCT05356130|583667957|FG002|Overall Study|Withdrawal by Subject|3|||
161622435|NCT04820023|583667960|FG000|Overall Study|Death|0|||
161622436|NCT04820023|583667961|FG001|Overall Study|Death|0|||
161622437|NCT04820023|583667962|FG002|Overall Study|Death|0|||
161622438|NCT04820023|583667963|FG003|Overall Study|Death|0|||
161622439|NCT04820023|583667964|FG004|Overall Study|Death|0|||
161622440|NCT04820023|583667965|FG005|Overall Study|Death|0|||
161622441|NCT04820023|583667966|FG006|Overall Study|Death|1|||
161622442|NCT04820023|583667967|FG007|Overall Study|Death|0|||
161622443|NCT04820023|583667968|FG008|Overall Study|Death|1|||
161622444|NCT04820023|583667960|FG000|Overall Study|Withdrawal by Subject|1|||
161622445|NCT04820023|583667961|FG001|Overall Study|Withdrawal by Subject|2|||
161622446|NCT04820023|583667962|FG002|Overall Study|Withdrawal by Subject|2|||
161622447|NCT04820023|583667963|FG003|Overall Study|Withdrawal by Subject|1|||
161622448|NCT04820023|583667964|FG004|Overall Study|Withdrawal by Subject|4|||
161622449|NCT04820023|583667965|FG005|Overall Study|Withdrawal by Subject|3|||
161622450|NCT04820023|583667966|FG006|Overall Study|Withdrawal by Subject|3|||
161622451|NCT04820023|583667967|FG007|Overall Study|Withdrawal by Subject|6|||
161622452|NCT04820023|583667968|FG008|Overall Study|Withdrawal by Subject|5|||
161622453|NCT04820023|583667960|FG000|Overall Study|Progressive Disease|3|||
161622454|NCT04820023|583667961|FG001|Overall Study|Progressive Disease|0|||
161622455|NCT04820023|583667962|FG002|Overall Study|Progressive Disease|2|||
161622456|NCT04820023|583667963|FG003|Overall Study|Progressive Disease|2|||
161622457|NCT04820023|583667964|FG004|Overall Study|Progressive Disease|2|||
161622458|NCT04820023|583667965|FG005|Overall Study|Progressive Disease|0|||
161622459|NCT04820023|583667966|FG006|Overall Study|Progressive Disease|1|||
161622460|NCT04820023|583667967|FG007|Overall Study|Progressive Disease|1|||
161622461|NCT04820023|583667968|FG008|Overall Study|Progressive Disease|0|||
161622462|NCT04820023|583667960|FG000|Overall Study|New anti-cancer therapy|0|||
161622463|NCT04820023|583667961|FG001|Overall Study|New anti-cancer therapy|0|||
161622464|NCT04820023|583667962|FG002|Overall Study|New anti-cancer therapy|0|||
161622465|NCT04820023|583667963|FG003|Overall Study|New anti-cancer therapy|0|||
161622466|NCT04820023|583667964|FG004|Overall Study|New anti-cancer therapy|2|||
161622467|NCT04820023|583667965|FG005|Overall Study|New anti-cancer therapy|0|||
161622468|NCT04820023|583667966|FG006|Overall Study|New anti-cancer therapy|0|||
161622469|NCT04820023|583667967|FG007|Overall Study|New anti-cancer therapy|0|||
161622470|NCT04820023|583667968|FG008|Overall Study|New anti-cancer therapy|0|||
161622471|NCT04820023|583667960|FG000|Overall Study|Other|0|||
161622472|NCT04820023|583667961|FG001|Overall Study|Other|1|||
161622473|NCT04820023|583667962|FG002|Overall Study|Other|0|||
161622474|NCT04820023|583667963|FG003|Overall Study|Other|0|||
161622475|NCT04820023|583667964|FG004|Overall Study|Other|0|||
161622476|NCT04820023|583667965|FG005|Overall Study|Other|0|||
161622477|NCT04820023|583667966|FG006|Overall Study|Other|0|||
161622478|NCT04820023|583667967|FG007|Overall Study|Other|2|||
161622479|NCT04820023|583667968|FG008|Overall Study|Other|0|||
161622480|NCT02109172|583667979|FG000|Overall Study|Withdrawal by Subject|1|||
161622481|NCT02109172|583667980|FG001|Overall Study|Withdrawal by Subject|0|||
161622482|NCT02109172|583667981|FG002|Overall Study|Withdrawal by Subject|0|||
161622483|NCT02109172|583667982|FG003|Overall Study|Withdrawal by Subject|1|||
161622484|NCT02109172|583667983|FG004|Overall Study|Withdrawal by Subject|0|||
161622485|NCT02109172|583667984|FG005|Overall Study|Withdrawal by Subject|0|||
161622486|NCT02109172|583667979|FG000|Overall Study|Adverse Event|0|||
161622487|NCT02109172|583667980|FG001|Overall Study|Adverse Event|0|||
161622488|NCT02109172|583667981|FG002|Overall Study|Adverse Event|1|||
161622489|NCT02109172|583667982|FG003|Overall Study|Adverse Event|0|||
161622490|NCT02109172|583667983|FG004|Overall Study|Adverse Event|0|||
161622491|NCT02109172|583667984|FG005|Overall Study|Adverse Event|1|||
161622492|NCT02109172|583667979|FG000|Overall Study|Death|0|||
161622493|NCT02109172|583667980|FG001|Overall Study|Death|0|||
161622494|NCT02109172|583667981|FG002|Overall Study|Death|0|||
161622495|NCT02109172|583667982|FG003|Overall Study|Death|0|||
161622496|NCT02109172|583667983|FG004|Overall Study|Death|1|||
161622497|NCT02109172|583667984|FG005|Overall Study|Death|0|||
161622498|NCT00538629|583667985|FG000|Overall Study|At subject's request|1|||
161622499|NCT00538629|583667985|FG000|Overall Study|Adverse Event|2|||
161622500|NCT00538629|583667985|FG000|Overall Study|Lack of Efficacy|12|||
161622501|NCT00538629|583667985|FG000|Overall Study|Lost to Follow-up|6|||
161622502|NCT00538629|583667985|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
161622503|NCT04454125|583667988|FG000|Overall Study|Lost to Follow-up|0|||
161622504|NCT04454125|583667989|FG001|Overall Study|Lost to Follow-up|1|||
161622505|NCT01922102|583667990|FG000|Overall Study|Withdrawal by Subject|7|||
161622506|NCT01922102|583667991|FG001|Overall Study|Withdrawal by Subject|3|||
161622507|NCT01922102|583667992|FG002|Overall Study|Withdrawal by Subject|7|||
161622508|NCT01922102|583667990|FG000|Overall Study|Physician Decision|0|||
161622509|NCT01922102|583667991|FG001|Overall Study|Physician Decision|2|||
161622510|NCT01922102|583667992|FG002|Overall Study|Physician Decision|1|||
161622511|NCT01922102|583667990|FG000|Overall Study|Adverse Event|1|||
161622512|NCT01922102|583667991|FG001|Overall Study|Adverse Event|2|||
161622513|NCT01922102|583667992|FG002|Overall Study|Adverse Event|0|||
161622514|NCT01922102|583667990|FG000|Overall Study|Lost to Follow-up|1|||
161622515|NCT01922102|583667991|FG001|Overall Study|Lost to Follow-up|0|||
161622516|NCT01922102|583667992|FG002|Overall Study|Lost to Follow-up|0|||
161622517|NCT01922102|583667990|FG000|Overall Study|Administrative problems|0|||
161622518|NCT01922102|583667991|FG001|Overall Study|Administrative problems|2|||
161622519|NCT01922102|583667992|FG002|Overall Study|Administrative problems|0|||
161622520|NCT05203822|583667993|FG000|Overall Study|Adverse Event|1|||
161622521|NCT05203822|583667993|FG000|Overall Study|Withdrawal by Subject|1|||
161622522|NCT01816165|583668000|FG000|Overall Study|Adverse Event|1|||
161622523|NCT01816165|583668001|FG001|Overall Study|Adverse Event|0|||
161622524|NCT01816165|583668002|FG002|Overall Study|Adverse Event|0|||
161622525|NCT01816165|583668003|FG003|Overall Study|Adverse Event|0|||
161622526|NCT00447499|583668004|FG000|Overall Study|Adverse Event|1|||
161622527|NCT00447499|583668004|FG000|Overall Study|Patient Decision|4|||
161622528|NCT00447499|583668004|FG000|Overall Study|Sponsor Decision|1|||
161622529|NCT00447499|583668004|FG000|Overall Study|Physician Decision|1|||
161622530|NCT03360071|583668006|FG000|Overall Study|Lost to Follow-up|1|||
161622531|NCT03360071|583668007|FG001|Overall Study|Lost to Follow-up|0|||
161622532|NCT03184519|583668016|FG000|Overall Study|Lost to Follow-up|6|||
161622533|NCT03184519|583668016|FG000|Overall Study|Physician Decision|21|||
161622534|NCT02823574|583668020|FG000|Randomization|Disease Progression|0|||
161622535|NCT02823574|583668021|FG001|Randomization|Disease Progression|0|||
161622536|NCT02823574|583668022|FG002|Randomization|Disease Progression|1|||
161622537|NCT02823574|583668023|FG003|Randomization|Disease Progression|0|||
161622538|NCT02823574|583668020|FG000|Randomization|AE unrelated to Study Drug|1|||
161622539|NCT02823574|583668021|FG001|Randomization|AE unrelated to Study Drug|0|||
161622540|NCT02823574|583668022|FG002|Randomization|AE unrelated to Study Drug|0|||
161622541|NCT02823574|583668023|FG003|Randomization|AE unrelated to Study Drug|0|||
161622542|NCT02823574|583668020|FG000|Treatment Period|Poor/Non Compliance|1|||
161622543|NCT02823574|583668021|FG001|Treatment Period|Poor/Non Compliance|0|||
161622544|NCT02823574|583668022|FG002|Treatment Period|Poor/Non Compliance|0|||
161622545|NCT02823574|583668023|FG003|Treatment Period|Poor/Non Compliance|1|||
161622546|NCT02823574|583668020|FG000|Treatment Period|Maximum Clinical Benefit|8|||
161622547|NCT02823574|583668021|FG001|Treatment Period|Maximum Clinical Benefit|4|||
161622548|NCT02823574|583668022|FG002|Treatment Period|Maximum Clinical Benefit|7|||
161622549|NCT02823574|583668023|FG003|Treatment Period|Maximum Clinical Benefit|1|||
161622550|NCT02823574|583668020|FG000|Treatment Period|Lost to Follow-up|1|||
161622551|NCT02823574|583668021|FG001|Treatment Period|Lost to Follow-up|1|||
161622552|NCT02823574|583668022|FG002|Treatment Period|Lost to Follow-up|0|||
161622553|NCT02823574|583668023|FG003|Treatment Period|Lost to Follow-up|0|||
161622554|NCT02823574|583668020|FG000|Treatment Period|Participant withdrew consent|4|||
161622555|NCT02823574|583668021|FG001|Treatment Period|Participant withdrew consent|0|||
161622556|NCT02823574|583668022|FG002|Treatment Period|Participant withdrew consent|0|||
161622557|NCT02823574|583668023|FG003|Treatment Period|Participant withdrew consent|1|||
161622558|NCT02823574|583668020|FG000|Treatment Period|Participant request to discontinue|5|||
161622559|NCT02823574|583668021|FG001|Treatment Period|Participant request to discontinue|0|||
161622560|NCT02823574|583668022|FG002|Treatment Period|Participant request to discontinue|3|||
161622561|NCT02823574|583668023|FG003|Treatment Period|Participant request to discontinue|2|||
161622562|NCT02823574|583668020|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
161622563|NCT02823574|583668021|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
161622564|NCT02823574|583668022|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
161622565|NCT02823574|583668023|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
161622566|NCT02823574|583668020|FG000|Treatment Period|Study Drug Toxicity|11|||
161622567|NCT02823574|583668021|FG001|Treatment Period|Study Drug Toxicity|2|||
161622568|NCT02823574|583668022|FG002|Treatment Period|Study Drug Toxicity|14|||
161622569|NCT02823574|583668023|FG003|Treatment Period|Study Drug Toxicity|4|||
161622570|NCT02823574|583668020|FG000|Treatment Period|Disease Progression|113|||
161622571|NCT02823574|583668021|FG001|Treatment Period|Disease Progression|64|||
161622572|NCT02823574|583668022|FG002|Treatment Period|Disease Progression|82|||
161622573|NCT02823574|583668023|FG003|Treatment Period|Disease Progression|43|||
161622574|NCT02823574|583668020|FG000|Treatment Period|Other reasons|5|||
161622575|NCT02823574|583668021|FG001|Treatment Period|Other reasons|9|||
161622576|NCT02823574|583668022|FG002|Treatment Period|Other reasons|3|||
161622577|NCT02823574|583668023|FG003|Treatment Period|Other reasons|6|||
161622578|NCT02823574|583668020|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161622579|NCT02823574|583668021|FG001|Treatment Period|Participant no longer meets study criteria|0|||
161622580|NCT02823574|583668022|FG002|Treatment Period|Participant no longer meets study criteria|1|||
161622581|NCT02823574|583668023|FG003|Treatment Period|Participant no longer meets study criteria|0|||
161622582|NCT02823574|583668020|FG000|Treatment Period|Death|0|||
161622583|NCT02823574|583668021|FG001|Treatment Period|Death|0|||
161622584|NCT02823574|583668022|FG002|Treatment Period|Death|3|||
161622585|NCT02823574|583668023|FG003|Treatment Period|Death|1|||
161622586|NCT00590759|583668024|FG000|Overall Study|Death|52|||
161622587|NCT00590759|583668024|FG000|Overall Study|Lost to Follow-up|28|||
161622588|NCT02092909|583668029|FG000|Overall Study|Adverse Event|0|||
161622589|NCT02092909|583668030|FG001|Overall Study|Adverse Event|0|||
161622590|NCT02092909|583668031|FG002|Overall Study|Adverse Event|4|||
161622591|NCT02092909|583668032|FG003|Overall Study|Adverse Event|2|||
161622592|NCT02092909|583668029|FG000|Overall Study|Lack of Efficacy|0|||
161622593|NCT02092909|583668030|FG001|Overall Study|Lack of Efficacy|2|||
161622594|NCT02092909|583668031|FG002|Overall Study|Lack of Efficacy|1|||
161622595|NCT02092909|583668032|FG003|Overall Study|Lack of Efficacy|0|||
161622596|NCT02092909|583668029|FG000|Overall Study|Withdrawal by Subject|0|||
161622597|NCT02092909|583668030|FG001|Overall Study|Withdrawal by Subject|0|||
161622598|NCT02092909|583668031|FG002|Overall Study|Withdrawal by Subject|2|||
161622599|NCT02092909|583668032|FG003|Overall Study|Withdrawal by Subject|1|||
161622600|NCT02092909|583668029|FG000|Overall Study|Study terminated by Sponsor|0|||
161622601|NCT02092909|583668030|FG001|Overall Study|Study terminated by Sponsor|0|||
161622602|NCT02092909|583668031|FG002|Overall Study|Study terminated by Sponsor|0|||
161622603|NCT02092909|583668032|FG003|Overall Study|Study terminated by Sponsor|2|||
161622604|NCT02092909|583668029|FG000|Overall Study|Miscellaneous|1|||
161622605|NCT02092909|583668030|FG001|Overall Study|Miscellaneous|1|||
161622606|NCT02092909|583668031|FG002|Overall Study|Miscellaneous|2|||
161622607|NCT02092909|583668032|FG003|Overall Study|Miscellaneous|1|||
161622608|NCT02865083|583668033|FG000|Overall Study|Early Termination|3|||
161622609|NCT02865083|583668034|FG001|Overall Study|Early Termination|1|||
161622610|NCT00096278|583668035|FG000|Overall Study|No follow-up data|15|||
161622611|NCT00096278|583668036|FG001|Overall Study|No follow-up data|18|||
161622612|NCT00096278|583668035|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
161622613|NCT00096278|583668036|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
161622614|NCT02105688|583668037|FG000|Part A: Double-Blind|Adverse Event|1|||
161622615|NCT02105688|583668038|FG001|Part A: Double-Blind|Adverse Event|0|||
161622616|NCT02105688|583668037|FG000|Part A: Double-Blind|Death|0|||
161622617|NCT02105688|583668038|FG001|Part A: Double-Blind|Death|1|||
161622618|NCT02105688|583668037|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
161622619|NCT02105688|583668038|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
161622620|NCT02105688|583668037|FG000|Part A: Double-Blind|Physician Decision|0|||
161622621|NCT02105688|583668038|FG001|Part A: Double-Blind|Physician Decision|1|||
161622622|NCT02105688|583668037|FG000|Part A: Double-Blind|Status Unknown|0|||
161622623|NCT02105688|583668038|FG001|Part A: Double-Blind|Status Unknown|2|||
161622624|NCT02105688|583668037|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
161622625|NCT02105688|583668038|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
161622626|NCT02105688|583668037|FG000|Part B: Observational Follow-up|Death|2|||
161622627|NCT02105688|583668038|FG001|Part B: Observational Follow-up|Death|1|||
161622628|NCT02105688|583668037|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
161622629|NCT02105688|583668038|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
161622630|NCT02105688|583668037|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
161622631|NCT02105688|583668038|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
161622632|NCT02105688|583668037|FG000|Part B: Observational Follow-up|Physician Decision|3|||
161622633|NCT02105688|583668038|FG001|Part B: Observational Follow-up|Physician Decision|1|||
161622634|NCT02959866|583668044|FG000|Overall Study|Withdrawal by Subject|1|||
161622635|NCT00636168|583668049|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
161622636|NCT00636168|583668050|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
161622637|NCT00636168|583668049|FG000|Randomized to Study Drug|Adverse Event|1|||
161622638|NCT00636168|583668050|FG001|Randomized to Study Drug|Adverse Event|0|||
161622639|NCT00636168|583668049|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
161622640|NCT00636168|583668050|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
161622641|NCT00636168|583668049|FG000|Treated With Study Drug|Recurrence of disease|135|||
161622642|NCT00636168|583668050|FG001|Treated With Study Drug|Recurrence of disease|282|||
161622643|NCT00636168|583668049|FG000|Treated With Study Drug|Adverse Event|250|||
161622644|NCT00636168|583668050|FG001|Treated With Study Drug|Adverse Event|22|||
161622645|NCT00636168|583668049|FG000|Treated With Study Drug|Participant withdrew consent|16|||
161622646|NCT00636168|583668050|FG001|Treated With Study Drug|Participant withdrew consent|21|||
161622647|NCT00636168|583668049|FG000|Treated With Study Drug|Poor/non-compliance|1|||
161622648|NCT00636168|583668050|FG001|Treated With Study Drug|Poor/non-compliance|3|||
161622649|NCT00636168|583668049|FG000|Treated With Study Drug|Death|3|||
161622650|NCT00636168|583668050|FG001|Treated With Study Drug|Death|0|||
161622651|NCT00636168|583668049|FG000|Treated With Study Drug|Pregnancy|1|||
161622652|NCT00636168|583668050|FG001|Treated With Study Drug|Pregnancy|0|||
161622653|NCT00636168|583668049|FG000|Treated With Study Drug|No longer meets study criteria|1|||
161622654|NCT00636168|583668050|FG001|Treated With Study Drug|No longer meets study criteria|0|||
161622655|NCT00636168|583668049|FG000|Treated With Study Drug|Other reason|1|||
161622656|NCT00636168|583668050|FG001|Treated With Study Drug|Other reason|3|||
161622657|NCT00636168|583668049|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
161622658|NCT00636168|583668050|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
161622659|NCT00636168|583668049|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
161622660|NCT00636168|583668050|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
161622661|NCT00636168|583668049|FG000|Long Term Follow-Up|Death|8|||
161622662|NCT00636168|583668050|FG001|Long Term Follow-Up|Death|9|||
161622663|NCT04529941|583668054|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
161622664|NCT04529941|583668055|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
161622665|NCT01005914|583668056|FG000|Overall Study|Adverse Event|4|||
161622666|NCT01005914|583668056|FG000|Overall Study|Death|4|||
161622667|NCT01005914|583668056|FG000|Overall Study|Lack of Efficacy|1|||
161622668|NCT01005914|583668056|FG000|Overall Study|Withdrawal by Subject|1|||
161622669|NCT01240785|583668057|FG000|Overall Study|Lost to Follow-up|1|||
161622670|NCT01240785|583668058|FG001|Overall Study|Lost to Follow-up|0|||
161622671|NCT01240785|583668057|FG000|Overall Study|Protocol Violation|0|||
161622672|NCT01240785|583668058|FG001|Overall Study|Protocol Violation|3|||
161622673|NCT02006641|583668059|FG000|Overall Study|Withdrawal before treatment|2|||
161622674|NCT02006641|583668060|FG001|Overall Study|Withdrawal before treatment|5|||
161622675|NCT02006641|583668061|FG002|Overall Study|Withdrawal before treatment|3|||
161622676|NCT02006641|583668059|FG000|Overall Study|Adverse Event|15|||
161622677|NCT02006641|583668060|FG001|Overall Study|Adverse Event|11|||
161622678|NCT02006641|583668061|FG002|Overall Study|Adverse Event|15|||
161622679|NCT02006641|583668059|FG000|Overall Study|Protocol Violation|0|||
161622680|NCT02006641|583668060|FG001|Overall Study|Protocol Violation|2|||
161622681|NCT02006641|583668061|FG002|Overall Study|Protocol Violation|2|||
161622682|NCT02006641|583668059|FG000|Overall Study|Lost to Follow-up|0|||
161622683|NCT02006641|583668060|FG001|Overall Study|Lost to Follow-up|1|||
161622684|NCT02006641|583668061|FG002|Overall Study|Lost to Follow-up|0|||
161622685|NCT02006641|583668059|FG000|Overall Study|Withdrawal by Subject|7|||
161622686|NCT02006641|583668060|FG001|Overall Study|Withdrawal by Subject|12|||
161622687|NCT02006641|583668061|FG002|Overall Study|Withdrawal by Subject|11|||
161622688|NCT02006641|583668059|FG000|Overall Study|Other reason: patient didn't show up|1|||
161622689|NCT02006641|583668060|FG001|Overall Study|Other reason: patient didn't show up|0|||
161622690|NCT02006641|583668061|FG002|Overall Study|Other reason: patient didn't show up|0|||
161622691|NCT02006641|583668059|FG000|Overall Study|Other reason:patient didn't want to come|0|||
161622692|NCT02006641|583668060|FG001|Overall Study|Other reason:patient didn't want to come|0|||
161622693|NCT02006641|583668061|FG002|Overall Study|Other reason:patient didn't want to come|1|||
161622694|NCT02006641|583668059|FG000|Overall Study|Other reason: patient has moved|1|||
161622695|NCT02006641|583668060|FG001|Overall Study|Other reason: patient has moved|0|||
161622696|NCT02006641|583668061|FG002|Overall Study|Other reason: patient has moved|1|||
161622697|NCT02006641|583668059|FG000|Overall Study|Other reason: caregiver in hospital|0|||
161622698|NCT02006641|583668060|FG001|Overall Study|Other reason: caregiver in hospital|1|||
161622699|NCT02006641|583668061|FG002|Overall Study|Other reason: caregiver in hospital|0|||
161622700|NCT02006641|583668059|FG000|Overall Study|Other reason: patient's wife has died|0|||
161622701|NCT02006641|583668060|FG001|Overall Study|Other reason: patient's wife has died|0|||
161622702|NCT02006641|583668061|FG002|Overall Study|Other reason: patient's wife has died|1|||
161622703|NCT02006641|583668059|FG000|Overall Study|Other reason: hospitalisation|0|||
161622704|NCT02006641|583668060|FG001|Overall Study|Other reason: hospitalisation|1|||
161622705|NCT02006641|583668061|FG002|Overall Study|Other reason: hospitalisation|0|||
161622706|NCT02006641|583668059|FG000|Overall Study|Other reason: caregiver impossibility|0|||
161622707|NCT02006641|583668060|FG001|Overall Study|Other reason: caregiver impossibility|0|||
161622708|NCT02006641|583668061|FG002|Overall Study|Other reason: caregiver impossibility|1|||
161622709|NCT02006641|583668059|FG000|Overall Study|Other reason: protocol non-compliance|0|||
161622710|NCT02006641|583668060|FG001|Overall Study|Other reason: protocol non-compliance|0|||
161622711|NCT02006641|583668061|FG002|Overall Study|Other reason: protocol non-compliance|1|||
161622712|NCT02132195|583668062|FG000|Initial Assignment|Relapsed|14|||
161622713|NCT02132195|583668063|FG001|Initial Assignment|Relapsed|0|||
161622714|NCT02132195|583668064|FG002|Initial Assignment|Relapsed|0|||
161622715|NCT02132195|583668062|FG000|Rescue Therapy|Relapsed|0|||
161622716|NCT02132195|583668063|FG001|Rescue Therapy|Relapsed|0|||
161622717|NCT02132195|583668064|FG002|Rescue Therapy|Relapsed|7|||
161622718|NCT02132195|583668062|FG000|Rescue Therapy|Physician Decision|0|||
161622719|NCT02132195|583668063|FG001|Rescue Therapy|Physician Decision|0|||
161622720|NCT02132195|583668064|FG002|Rescue Therapy|Physician Decision|1|||
161622721|NCT02132195|583668062|FG000|Rescue Therapy|Withdrawal by Subject|0|||
161622722|NCT02132195|583668063|FG001|Rescue Therapy|Withdrawal by Subject|0|||
161622723|NCT02132195|583668064|FG002|Rescue Therapy|Withdrawal by Subject|1|||
161622724|NCT02132195|583668062|FG000|Rescue Therapy|Adverse Event|0|||
161622725|NCT02132195|583668063|FG001|Rescue Therapy|Adverse Event|0|||
161622726|NCT02132195|583668064|FG002|Rescue Therapy|Adverse Event|2|||
161622727|NCT02561195|583668066|FG000|Vaccination 1 to 3|Adverse Event|4|||
161622728|NCT02561195|583668067|FG001|Vaccination 1 to 3|Adverse Event|5|||
161622729|NCT02561195|583668068|FG002|Vaccination 1 to 3|Adverse Event|0|||
161622730|NCT02561195|583668069|FG003|Vaccination 1 to 3|Adverse Event|3|||
161622731|NCT02561195|583668070|FG004|Vaccination 1 to 3|Adverse Event|4|||
161622732|NCT02561195|583668071|FG005|Vaccination 1 to 3|Adverse Event|0|||
161622733|NCT02561195|583668072|FG006|Vaccination 1 to 3|Adverse Event|0|||
161622734|NCT02561195|583668073|FG007|Vaccination 1 to 3|Adverse Event|0|||
161622735|NCT02561195|583668074|FG008|Vaccination 1 to 3|Adverse Event|0|||
161622736|NCT02561195|583668075|FG009|Vaccination 1 to 3|Adverse Event|0|||
161622737|NCT02561195|583668076|FG010|Vaccination 1 to 3|Adverse Event|0|||
161622738|NCT02561195|583668077|FG011|Vaccination 1 to 3|Adverse Event|0|||
161622739|NCT02561195|583668078|FG012|Vaccination 1 to 3|Adverse Event|0|||
161622740|NCT02561195|583668079|FG013|Vaccination 1 to 3|Adverse Event|0|||
161622741|NCT02561195|583668066|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
161622742|NCT02561195|583668067|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
161622743|NCT02561195|583668068|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
161622744|NCT02561195|583668069|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
161622745|NCT02561195|583668070|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
161622746|NCT02561195|583668071|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
161622747|NCT02561195|583668072|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
161622748|NCT02561195|583668073|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
161622749|NCT02561195|583668074|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
161622750|NCT02561195|583668075|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
161622751|NCT02561195|583668076|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
161622752|NCT02561195|583668077|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
161622753|NCT02561195|583668078|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
161622754|NCT02561195|583668079|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
161622755|NCT02561195|583668066|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622756|NCT02561195|583668067|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
161622757|NCT02561195|583668068|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622758|NCT02561195|583668069|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
161622759|NCT02561195|583668070|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
161622760|NCT02561195|583668071|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
161622761|NCT02561195|583668072|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622762|NCT02561195|583668073|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622763|NCT02561195|583668074|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622764|NCT02561195|583668075|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161363813|NCT02544763|582720031|FG000|Overall Study|Adverse Event|8|||
161832963|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161622765|NCT02561195|583668076|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622766|NCT02561195|583668077|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622767|NCT02561195|583668078|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622768|NCT02561195|583668079|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161622769|NCT02561195|583668066|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
161622770|NCT02561195|583668067|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
161622771|NCT02561195|583668068|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
161622772|NCT02561195|583668069|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
161622773|NCT02561195|583668070|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
161622774|NCT02561195|583668071|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
161622775|NCT02561195|583668072|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
161622776|NCT02561195|583668073|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
161622777|NCT02561195|583668074|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
161622778|NCT02561195|583668075|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
161622779|NCT02561195|583668076|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
161622780|NCT02561195|583668077|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
161622781|NCT02561195|583668078|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
161622782|NCT02561195|583668079|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
161622783|NCT02561195|583668066|FG000|Vaccination 1 to 3|Other|7|||
161622784|NCT02561195|583668067|FG001|Vaccination 1 to 3|Other|3|||
161622785|NCT02561195|583668068|FG002|Vaccination 1 to 3|Other|1|||
161622786|NCT02561195|583668069|FG003|Vaccination 1 to 3|Other|7|||
161622787|NCT02561195|583668070|FG004|Vaccination 1 to 3|Other|5|||
161622788|NCT02561195|583668071|FG005|Vaccination 1 to 3|Other|1|||
161622789|NCT02561195|583668072|FG006|Vaccination 1 to 3|Other|0|||
161622790|NCT02561195|583668073|FG007|Vaccination 1 to 3|Other|0|||
161622791|NCT02561195|583668074|FG008|Vaccination 1 to 3|Other|0|||
161622792|NCT02561195|583668075|FG009|Vaccination 1 to 3|Other|0|||
161622793|NCT02561195|583668076|FG010|Vaccination 1 to 3|Other|0|||
161622794|NCT02561195|583668077|FG011|Vaccination 1 to 3|Other|0|||
161622795|NCT02561195|583668078|FG012|Vaccination 1 to 3|Other|0|||
161622796|NCT02561195|583668079|FG013|Vaccination 1 to 3|Other|0|||
161622797|NCT02561195|583668066|FG000|Vaccination 1 to 3|Protocol Violation|1|||
161622798|NCT02561195|583668067|FG001|Vaccination 1 to 3|Protocol Violation|0|||
161622799|NCT02561195|583668068|FG002|Vaccination 1 to 3|Protocol Violation|1|||
161622800|NCT02561195|583668069|FG003|Vaccination 1 to 3|Protocol Violation|2|||
161622801|NCT02561195|583668070|FG004|Vaccination 1 to 3|Protocol Violation|5|||
161622802|NCT02561195|583668071|FG005|Vaccination 1 to 3|Protocol Violation|2|||
161622803|NCT02561195|583668072|FG006|Vaccination 1 to 3|Protocol Violation|0|||
161622804|NCT02561195|583668073|FG007|Vaccination 1 to 3|Protocol Violation|0|||
161622805|NCT02561195|583668074|FG008|Vaccination 1 to 3|Protocol Violation|0|||
161622806|NCT02561195|583668075|FG009|Vaccination 1 to 3|Protocol Violation|0|||
161622807|NCT02561195|583668076|FG010|Vaccination 1 to 3|Protocol Violation|0|||
161622808|NCT02561195|583668077|FG011|Vaccination 1 to 3|Protocol Violation|0|||
161622809|NCT02561195|583668078|FG012|Vaccination 1 to 3|Protocol Violation|0|||
161622810|NCT02561195|583668079|FG013|Vaccination 1 to 3|Protocol Violation|0|||
161622811|NCT02561195|583668066|FG000|Vaccination 1 to 3|Death|2|||
161622812|NCT02561195|583668067|FG001|Vaccination 1 to 3|Death|1|||
161622813|NCT02561195|583668068|FG002|Vaccination 1 to 3|Death|0|||
161622814|NCT02561195|583668069|FG003|Vaccination 1 to 3|Death|2|||
161622815|NCT02561195|583668070|FG004|Vaccination 1 to 3|Death|0|||
161622816|NCT02561195|583668071|FG005|Vaccination 1 to 3|Death|0|||
161622817|NCT02561195|583668072|FG006|Vaccination 1 to 3|Death|0|||
161622818|NCT02561195|583668073|FG007|Vaccination 1 to 3|Death|0|||
161622819|NCT02561195|583668074|FG008|Vaccination 1 to 3|Death|0|||
161622820|NCT02561195|583668075|FG009|Vaccination 1 to 3|Death|0|||
161622821|NCT02561195|583668076|FG010|Vaccination 1 to 3|Death|0|||
161622822|NCT02561195|583668077|FG011|Vaccination 1 to 3|Death|0|||
161622823|NCT02561195|583668078|FG012|Vaccination 1 to 3|Death|0|||
161622824|NCT02561195|583668079|FG013|Vaccination 1 to 3|Death|0|||
161622825|NCT02561195|583668066|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
161622826|NCT02561195|583668067|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
161622827|NCT02561195|583668068|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
161622828|NCT02561195|583668069|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
161622829|NCT02561195|583668070|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
161622830|NCT02561195|583668071|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622831|NCT02561195|583668072|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622832|NCT02561195|583668073|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622833|NCT02561195|583668074|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622834|NCT02561195|583668075|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622835|NCT02561195|583668076|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622836|NCT02561195|583668077|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622837|NCT02561195|583668078|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622838|NCT02561195|583668079|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
161622839|NCT02561195|583668066|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
161622840|NCT02561195|583668067|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
161622841|NCT02561195|583668068|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
161622842|NCT02561195|583668069|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
161622843|NCT02561195|583668070|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
161622844|NCT02561195|583668071|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
161622845|NCT02561195|583668072|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
161622846|NCT02561195|583668073|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
161622847|NCT02561195|583668074|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
161622848|NCT02561195|583668075|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
161622849|NCT02561195|583668076|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
161622850|NCT02561195|583668077|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
161622851|NCT02561195|583668078|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
161622852|NCT02561195|583668079|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
161622853|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622854|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622855|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622856|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622857|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622858|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622859|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622860|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622861|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
161622862|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
161622863|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
161622864|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
161622865|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
161622866|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161622867|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622868|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622869|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622870|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622871|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622872|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622873|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622874|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622875|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622876|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622877|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622878|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622879|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
161622880|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
161622881|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|Death|0|||
161622882|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|Death|0|||
161622883|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|Death|0|||
161622884|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|Death|0|||
161622885|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|Death|0|||
161622886|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|Death|0|||
161622887|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|Death|0|||
161622888|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|Death|0|||
161622889|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|Death|0|||
161622890|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|Death|1|||
161622891|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|Death|0|||
161622892|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|Death|0|||
161622893|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|Death|0|||
161622894|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|Death|0|||
161622895|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622896|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622897|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622898|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622899|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622900|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622901|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161622902|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161622903|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622904|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161622905|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
161622906|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161622907|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
161622908|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161622909|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622910|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622911|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622912|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622913|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622914|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622915|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622916|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622917|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622918|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622919|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161622920|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161622921|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161622922|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161622923|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|Other|0|||
161622924|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|Other|0|||
161622925|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|Other|0|||
161622926|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|Other|0|||
161622927|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|Other|0|||
161622928|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|Other|0|||
161622929|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|Other|0|||
161622930|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|Other|0|||
161622931|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|Other|0|||
161622932|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|Other|0|||
161622933|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|Other|2|||
161622934|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|Other|2|||
161622935|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|Other|1|||
161622936|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|Other|0|||
161622937|NCT02561195|583668066|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622938|NCT02561195|583668067|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622939|NCT02561195|583668068|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622940|NCT02561195|583668069|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622941|NCT02561195|583668070|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622942|NCT02561195|583668071|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622943|NCT02561195|583668072|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
161622944|NCT02561195|583668073|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622945|NCT02561195|583668074|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622946|NCT02561195|583668075|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622947|NCT02561195|583668076|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
161622948|NCT02561195|583668077|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
161622949|NCT02561195|583668078|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161622950|NCT02561195|583668079|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
161622951|NCT03905512|583668080|FG000|Overall Study|Withdrawal by Subject|9|||
161622952|NCT03905512|583668081|FG001|Overall Study|Withdrawal by Subject|8|||
161622953|NCT03905512|583668080|FG000|Overall Study|Adverse Event|1|||
161622954|NCT03905512|583668081|FG001|Overall Study|Adverse Event|2|||
161622955|NCT03905512|583668080|FG000|Overall Study|Lost to Follow-up|4|||
161622956|NCT03905512|583668081|FG001|Overall Study|Lost to Follow-up|3|||
161622957|NCT03905512|583668080|FG000|Overall Study|Other than Specified|7|||
161622958|NCT03905512|583668081|FG001|Overall Study|Other than Specified|4|||
161622959|NCT00736502|583668088|FG000|Overall Study|Adverse Event|22|||
161622960|NCT00736502|583668088|FG000|Overall Study|Lack of Efficacy|16|||
161622961|NCT00736502|583668088|FG000|Overall Study|Lost to Follow-up|27|||
161622962|NCT00070317|583668089|FG000|Overall Study|Inevaluable (Never Treated)|1|||
161622963|NCT00070317|583668089|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
161622964|NCT00070317|583668089|FG000|Overall Study|Ineligible required test not done|1|||
161622965|NCT00070317|583668089|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
161622966|NCT00070317|583668089|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
161622967|NCT03987074|583668091|FG000|Overall Study|Withdrew Consent|1|||
161622968|NCT03987074|583668092|FG001|Overall Study|Withdrew Consent|1|||
161622969|NCT03987074|583668093|FG002|Overall Study|Withdrew Consent|0|||
161622970|NCT03987074|583668094|FG003|Overall Study|Withdrew Consent|2|||
161622971|NCT03987074|583668095|FG004|Overall Study|Withdrew Consent|1|||
161622972|NCT03987074|583668091|FG000|Overall Study|Adverse Event|2|||
161622973|NCT03987074|583668092|FG001|Overall Study|Adverse Event|1|||
161622974|NCT03987074|583668093|FG002|Overall Study|Adverse Event|0|||
161622975|NCT03987074|583668094|FG003|Overall Study|Adverse Event|0|||
161622976|NCT03987074|583668095|FG004|Overall Study|Adverse Event|1|||
161622977|NCT03987074|583668091|FG000|Overall Study|Lost to Follow-up|0|||
161622978|NCT03987074|583668092|FG001|Overall Study|Lost to Follow-up|0|||
161622979|NCT03987074|583668093|FG002|Overall Study|Lost to Follow-up|1|||
161622980|NCT03987074|583668094|FG003|Overall Study|Lost to Follow-up|1|||
161622981|NCT03987074|583668095|FG004|Overall Study|Lost to Follow-up|0|||
161622982|NCT03987074|583668091|FG000|Overall Study|Investigator's Discretion|0|||
161684916|NCT01081912|583899590|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
161684917|NCT01140451|583899591|FG000|Overall Study|Withdrawal by Subject|26|||
161684918|NCT01140451|583899592|FG001|Overall Study|Withdrawal by Subject|33|||
161684919|NCT01140451|583899591|FG000|Overall Study|Adverse Event|2|||
161684920|NCT01140451|583899592|FG001|Overall Study|Adverse Event|6|||
161684921|NCT01140451|583899591|FG000|Overall Study|Physician Decision|5|||
161684922|NCT01140451|583899592|FG001|Overall Study|Physician Decision|3|||
161684923|NCT01140451|583899591|FG000|Overall Study|Lost to Follow-up|2|||
161684924|NCT01140451|583899592|FG001|Overall Study|Lost to Follow-up|0|||
161684925|NCT01140451|583899591|FG000|Overall Study|Participants Planning Pregnancy|3|||
161622983|NCT03987074|583668092|FG001|Overall Study|Investigator's Discretion|0|||
161622984|NCT03987074|583668093|FG002|Overall Study|Investigator's Discretion|0|||
161622985|NCT03987074|583668094|FG003|Overall Study|Investigator's Discretion|1|||
161622986|NCT03987074|583668095|FG004|Overall Study|Investigator's Discretion|0|||
161622987|NCT00508144|583668096|FG000|Overall Study|Not eligible|6|||
161622988|NCT00508144|583668096|FG000|Overall Study|Death|5|||
161622989|NCT01661972|583668099|FG000|Overall Study|Adverse Event|1|||
161622990|NCT01661972|583668100|FG001|Overall Study|Adverse Event|2|||
161622991|NCT01661972|583668099|FG000|Overall Study|Death during Treatment period|1|||
161622992|NCT01661972|583668100|FG001|Overall Study|Death during Treatment period|1|||
161622993|NCT01661972|583668099|FG000|Overall Study|Withdrawal by Subject|0|||
161622994|NCT01661972|583668100|FG001|Overall Study|Withdrawal by Subject|1|||
161622995|NCT02138838|583668101|FG000|Overall Study|Study Closure|7|||
161622996|NCT02138838|583668102|FG001|Overall Study|Study Closure|6|||
161622997|NCT02138838|583668101|FG000|Overall Study|Withdrawal by Subject|1|||
161622998|NCT02138838|583668102|FG001|Overall Study|Withdrawal by Subject|5|||
161622999|NCT01084772|583668104|FG000|Baseline|Withdrawal by Subject|7|||
161623000|NCT01084772|583668105|FG001|Baseline|Withdrawal by Subject|6|||
161623001|NCT01084772|583668104|FG000|3 Months|Death|1|||
161623002|NCT01084772|583668105|FG001|3 Months|Death|0|||
161623003|NCT01084772|583668104|FG000|3 Months|Study Termination|2|||
161623004|NCT01084772|583668105|FG001|3 Months|Study Termination|2|||
161623005|NCT01084772|583668104|FG000|1 Year|Withdrawal by Subject|0|||
161623006|NCT01084772|583668105|FG001|1 Year|Withdrawal by Subject|1|||
161623007|NCT01084772|583668104|FG000|1 Year|Lost to Follow-up|3|||
161623008|NCT01084772|583668105|FG001|1 Year|Lost to Follow-up|0|||
161623009|NCT01084772|583668104|FG000|1 Year|Study Termination|0|||
161623010|NCT01084772|583668105|FG001|1 Year|Study Termination|7|||
161623011|NCT01084772|583668104|FG000|2 Years|Withdrawal by Subject|1|||
161623012|NCT01084772|583668105|FG001|2 Years|Withdrawal by Subject|0|||
161623013|NCT01084772|583668104|FG000|2 Years|Lost to Follow-up|5|||
161623014|NCT01084772|583668105|FG001|2 Years|Lost to Follow-up|2|||
161623015|NCT01084772|583668104|FG000|2 Years|Study Termination|3|||
161623016|NCT01084772|583668105|FG001|2 Years|Study Termination|2|||
161623017|NCT01294644|583668106|FG000|Overall Study|Adverse Event|2|||
161623018|NCT01294644|583668107|FG001|Overall Study|Adverse Event|0|||
161623019|NCT01294644|583668108|FG002|Overall Study|Adverse Event|1|||
161623020|NCT01294644|583668106|FG000|Overall Study|Withdrawal by Subject|3|||
161623021|NCT01294644|583668107|FG001|Overall Study|Withdrawal by Subject|7|||
161623022|NCT01294644|583668108|FG002|Overall Study|Withdrawal by Subject|4|||
161684926|NCT01140451|583899592|FG001|Overall Study|Participants Planning Pregnancy|0|||
161684927|NCT00441974|583899593|FG000|Overall Study|Adverse Event|6|||
161684928|NCT00441974|583899593|FG000|Overall Study|Consent Withdrawn|35|||
161623023|NCT01294644|583668106|FG000|Overall Study|Lost to Follow-up|3|||
161623024|NCT01294644|583668107|FG001|Overall Study|Lost to Follow-up|2|||
161623025|NCT01294644|583668108|FG002|Overall Study|Lost to Follow-up|5|||
161623026|NCT01294644|583668106|FG000|Overall Study|Miscellaneous Reason|2|||
161623027|NCT01294644|583668107|FG001|Overall Study|Miscellaneous Reason|1|||
161623028|NCT01294644|583668108|FG002|Overall Study|Miscellaneous Reason|4|||
161623029|NCT04520256|583668112|FG000|Overall Study|Lost to Follow-up|6|||
161684929|NCT00441974|583899593|FG000|Overall Study|Lost to Follow-up|80|||
161684930|NCT00441974|583899593|FG000|Overall Study|Protocol Violation|7|||
161684931|NCT01146873|583899601|FG000|Overall Study|Transfer out|0|||
161684932|NCT01146873|583899602|FG001|Overall Study|Transfer out|6|||
161684933|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Death|0|||
161623030|NCT04520256|583668113|FG001|Overall Study|Lost to Follow-up|4|||
161623031|NCT04520256|583668114|FG002|Overall Study|Lost to Follow-up|2|||
161623032|NCT04520256|583668115|FG003|Overall Study|Lost to Follow-up|3|||
161623033|NCT04520256|583668116|FG004|Overall Study|Lost to Follow-up|6|||
161623034|NCT04520256|583668117|FG005|Overall Study|Lost to Follow-up|6|||
161623035|NCT04520256|583668118|FG006|Overall Study|Lost to Follow-up|4|||
161623036|NCT04520256|583668119|FG007|Overall Study|Lost to Follow-up|6|||
161623037|NCT04520256|583668120|FG008|Overall Study|Lost to Follow-up|1|||
161623038|NCT04520256|583668121|FG009|Overall Study|Lost to Follow-up|3|||
161623039|NCT04520256|583668122|FG010|Overall Study|Lost to Follow-up|3|||
161623040|NCT04520256|583668123|FG011|Overall Study|Lost to Follow-up|2|||
161623041|NCT04520256|583668124|FG012|Overall Study|Lost to Follow-up|5|||
161623042|NCT04520256|583668125|FG013|Overall Study|Lost to Follow-up|3|||
161623043|NCT04520256|583668126|FG014|Overall Study|Lost to Follow-up|3|||
161623044|NCT04520256|583668127|FG015|Overall Study|Lost to Follow-up|6|||
161623045|NCT04520256|583668128|FG016|Overall Study|Lost to Follow-up|6|||
161623046|NCT04520256|583668129|FG017|Overall Study|Lost to Follow-up|4|||
161623047|NCT04520256|583668130|FG018|Overall Study|Lost to Follow-up|3|||
161623048|NCT04520256|583668131|FG019|Overall Study|Lost to Follow-up|3|||
161623049|NCT04520256|583668132|FG020|Overall Study|Lost to Follow-up|7|||
161623050|NCT04520256|583668133|FG021|Overall Study|Lost to Follow-up|3|||
161623051|NCT04520256|583668134|FG022|Overall Study|Lost to Follow-up|3|||
161623052|NCT04520256|583668135|FG023|Overall Study|Lost to Follow-up|8|||
161623053|NCT04520256|583668136|FG024|Overall Study|Lost to Follow-up|5|||
161623054|NCT04520256|583668137|FG025|Overall Study|Lost to Follow-up|4|||
161623055|NCT04520256|583668138|FG026|Overall Study|Lost to Follow-up|3|||
161623056|NCT04520256|583668139|FG027|Overall Study|Lost to Follow-up|4|||
161623057|NCT04520256|583668140|FG028|Overall Study|Lost to Follow-up|3|||
161623058|NCT04520256|583668141|FG029|Overall Study|Lost to Follow-up|4|||
161623059|NCT04520256|583668142|FG030|Overall Study|Lost to Follow-up|4|||
161623060|NCT04520256|583668143|FG031|Overall Study|Lost to Follow-up|4|||
161623061|NCT00760877|583669105|FG000|Overall Study|Protocol Violation|1|||
161623062|NCT00760877|583669106|FG001|Overall Study|Protocol Violation|0|||
161623063|NCT00760877|583669105|FG000|Overall Study|Non-compliance with protocol treatment|2|||
161623064|NCT00760877|583669106|FG001|Overall Study|Non-compliance with protocol treatment|1|||
161623065|NCT00760877|583669105|FG000|Overall Study|Pregnancy|1|||
161623066|NCT00760877|583669106|FG001|Overall Study|Pregnancy|4|||
161623067|NCT00760877|583669105|FG000|Overall Study|Death|2|||
161623068|NCT00760877|583669106|FG001|Overall Study|Death|1|||
161623069|NCT00760877|583669105|FG000|Overall Study|Withdrawal by Subject|7|||
161623070|NCT00760877|583669106|FG001|Overall Study|Withdrawal by Subject|3|||
161623071|NCT00760877|583669105|FG000|Overall Study|Adverse Event|19|||
161623072|NCT00760877|583669106|FG001|Overall Study|Adverse Event|12|||
161623073|NCT00760877|583669105|FG000|Overall Study|Participant diagnosed with AML|0|||
161623074|NCT00760877|583669106|FG001|Overall Study|Participant diagnosed with AML|1|||
161623075|NCT00760877|583669105|FG000|Overall Study|Participant not eligible to cross-over|0|||
161623076|NCT00760877|583669106|FG001|Overall Study|Participant not eligible to cross-over|1|||
161623077|NCT00760877|583669105|FG000|Overall Study|Physician Decision|1|||
161623078|NCT00760877|583669106|FG001|Overall Study|Physician Decision|2|||
161623079|NCT00760877|583669105|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
161623080|NCT00760877|583669106|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
161623081|NCT00760877|583669105|FG000|Overall Study|Treatment failure|1|||
161623082|NCT00760877|583669106|FG001|Overall Study|Treatment failure|0|||
161623083|NCT04413149|583669109|FG000|Overall Study|Death|10|||
161623084|NCT04413149|583669110|FG001|Overall Study|Death|5|||
161623085|NCT04413149|583669109|FG000|Overall Study|Lung transplantation|1|||
161623086|NCT04413149|583669110|FG001|Overall Study|Lung transplantation|0|||
161623087|NCT02878590|583669111|FG000|Overall Study|Withdrawal by Subject|2|||
161623088|NCT01730118|583669112|FG000|Dose Escalation|Death on study|5|||
161623089|NCT01730118|583669113|FG001|Dose Escalation|Death on study|7|||
161623090|NCT01730118|583669114|FG002|Dose Escalation|Death on study|2|||
161623091|NCT01730118|583669115|FG003|Dose Escalation|Death on study|6|||
161623092|NCT01730118|583669116|FG004|Dose Escalation|Death on study|0|||
161623093|NCT01730118|583669117|FG005|Dose Escalation|Death on study|0|||
161623094|NCT01730118|583669118|FG006|Dose Escalation|Death on study|0|||
161623095|NCT01730118|583669112|FG000|Dose Escalation|Died before treatment|0|||
161623096|NCT01730118|583669113|FG001|Dose Escalation|Died before treatment|0|||
161623097|NCT01730118|583669114|FG002|Dose Escalation|Died before treatment|0|||
161623098|NCT01730118|583669115|FG003|Dose Escalation|Died before treatment|0|||
161623099|NCT01730118|583669116|FG004|Dose Escalation|Died before treatment|0|||
161623100|NCT01730118|583669117|FG005|Dose Escalation|Died before treatment|0|||
161623101|NCT01730118|583669118|FG006|Dose Escalation|Died before treatment|1|||
161623102|NCT01730118|583669112|FG000|Dose Escalation|Chose to start a different treatment|1|||
161623103|NCT01730118|583669113|FG001|Dose Escalation|Chose to start a different treatment|0|||
161623104|NCT01730118|583669114|FG002|Dose Escalation|Chose to start a different treatment|0|||
161623105|NCT01730118|583669115|FG003|Dose Escalation|Chose to start a different treatment|0|||
161623106|NCT01730118|583669116|FG004|Dose Escalation|Chose to start a different treatment|0|||
161623107|NCT01730118|583669117|FG005|Dose Escalation|Chose to start a different treatment|0|||
161623108|NCT01730118|583669118|FG006|Dose Escalation|Chose to start a different treatment|0|||
161623109|NCT01730118|583669112|FG000|Dose Escalation|Withdrawal by Subject|0|||
161623110|NCT01730118|583669113|FG001|Dose Escalation|Withdrawal by Subject|0|||
161623111|NCT01730118|583669114|FG002|Dose Escalation|Withdrawal by Subject|1|||
161623112|NCT01730118|583669115|FG003|Dose Escalation|Withdrawal by Subject|0|||
161623113|NCT01730118|583669116|FG004|Dose Escalation|Withdrawal by Subject|0|||
161623114|NCT01730118|583669117|FG005|Dose Escalation|Withdrawal by Subject|0|||
161623115|NCT01730118|583669118|FG006|Dose Escalation|Withdrawal by Subject|0|||
161623116|NCT01730118|583669112|FG000|Dose Escalation|Disease progression prior to treatment|0|||
161623117|NCT01730118|583669113|FG001|Dose Escalation|Disease progression prior to treatment|0|||
161623118|NCT01730118|583669114|FG002|Dose Escalation|Disease progression prior to treatment|0|||
161623119|NCT01730118|583669115|FG003|Dose Escalation|Disease progression prior to treatment|0|||
161623120|NCT01730118|583669116|FG004|Dose Escalation|Disease progression prior to treatment|0|||
161623121|NCT01730118|583669117|FG005|Dose Escalation|Disease progression prior to treatment|0|||
161623122|NCT01730118|583669118|FG006|Dose Escalation|Disease progression prior to treatment|1|||
161623123|NCT01730118|583669112|FG000|Dose Expansion|Death|0|||
161623124|NCT01730118|583669113|FG001|Dose Expansion|Death|0|||
161623125|NCT01730118|583669114|FG002|Dose Expansion|Death|0|||
161623126|NCT01730118|583669115|FG003|Dose Expansion|Death|0|||
161623127|NCT01730118|583669116|FG004|Dose Expansion|Death|1|||
161623128|NCT01730118|583669117|FG005|Dose Expansion|Death|0|||
161623129|NCT01730118|583669118|FG006|Dose Expansion|Death|0|||
161623130|NCT01730118|583669112|FG000|Dose Expansion|Other medical condition|0|||
161623131|NCT01730118|583669113|FG001|Dose Expansion|Other medical condition|0|||
161623132|NCT01730118|583669114|FG002|Dose Expansion|Other medical condition|0|||
161623133|NCT01730118|583669115|FG003|Dose Expansion|Other medical condition|0|||
161623134|NCT01730118|583669116|FG004|Dose Expansion|Other medical condition|1|||
161623135|NCT01730118|583669117|FG005|Dose Expansion|Other medical condition|0|||
161623136|NCT01730118|583669118|FG006|Dose Expansion|Other medical condition|0|||
161623137|NCT01730118|583669112|FG000|Dose Expansion|Withdrawal by Subject|0|||
161623138|NCT01730118|583669113|FG001|Dose Expansion|Withdrawal by Subject|0|||
161623139|NCT01730118|583669114|FG002|Dose Expansion|Withdrawal by Subject|0|||
161623140|NCT01730118|583669115|FG003|Dose Expansion|Withdrawal by Subject|0|||
161623141|NCT01730118|583669116|FG004|Dose Expansion|Withdrawal by Subject|1|||
161623142|NCT01730118|583669117|FG005|Dose Expansion|Withdrawal by Subject|0|||
161623143|NCT01730118|583669118|FG006|Dose Expansion|Withdrawal by Subject|0|||
161623144|NCT01730118|583669112|FG000|Dose Expansion|Disease progression|0|||
161623145|NCT01730118|583669113|FG001|Dose Expansion|Disease progression|0|||
161623146|NCT01730118|583669114|FG002|Dose Expansion|Disease progression|0|||
161623147|NCT01730118|583669115|FG003|Dose Expansion|Disease progression|0|||
161623148|NCT01730118|583669116|FG004|Dose Expansion|Disease progression|0|||
161623149|NCT01730118|583669117|FG005|Dose Expansion|Disease progression|1|||
161623150|NCT01730118|583669118|FG006|Dose Expansion|Disease progression|0|||
161623151|NCT01730118|583669112|FG000|Dose Expansion|Inability to return|0|||
161832964|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
161832965|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
161832966|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
161832967|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
161832968|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
161832969|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161832970|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
161832971|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161623152|NCT01730118|583669113|FG001|Dose Expansion|Inability to return|0|||
161832972|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161623153|NCT01730118|583669114|FG002|Dose Expansion|Inability to return|0|||
161623154|NCT01730118|583669115|FG003|Dose Expansion|Inability to return|0|||
161623155|NCT01730118|583669116|FG004|Dose Expansion|Inability to return|0|||
161623156|NCT01730118|583669117|FG005|Dose Expansion|Inability to return|1|||
161623157|NCT01730118|583669118|FG006|Dose Expansion|Inability to return|0|||
161684934|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Death|2|||
161684935|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Death|0|||
161832973|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832974|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161832975|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832976|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832977|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
161832978|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
161832979|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
161832980|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
161832981|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
161832982|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
161832983|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
161832984|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
161623158|NCT01730118|583669112|FG000|Dose Expansion|Physician Decision|0|||
161623159|NCT01730118|583669113|FG001|Dose Expansion|Physician Decision|0|||
161623160|NCT01730118|583669114|FG002|Dose Expansion|Physician Decision|0|||
161623161|NCT01730118|583669115|FG003|Dose Expansion|Physician Decision|0|||
161623162|NCT01730118|583669116|FG004|Dose Expansion|Physician Decision|0|||
161623163|NCT01730118|583669117|FG005|Dose Expansion|Physician Decision|1|||
161623164|NCT01730118|583669118|FG006|Dose Expansion|Physician Decision|0|||
161623165|NCT05379400|583669124|FG000|Overall Study|Lost to Follow-up|1|||
161623166|NCT05379400|583669125|FG001|Overall Study|Lost to Follow-up|1|||
161623167|NCT04851587|583669127|FG000|Overall Study|Lost to Follow-up|18|||
161623168|NCT01020487|583669131|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
161623169|NCT01020487|583669132|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
161623170|NCT01020487|583669133|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
161623171|NCT01020487|583669131|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
161623172|NCT01020487|583669132|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
161623173|NCT01020487|583669133|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
161623174|NCT01020487|583669131|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
161623175|NCT01020487|583669132|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
161623176|NCT01020487|583669133|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
161623177|NCT01020487|583669131|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
161623178|NCT01020487|583669132|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
161623179|NCT01020487|583669133|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
161623180|NCT01020487|583669131|FG000|Part 2 Open-label Period|Adverse Event|0|||
161623181|NCT01020487|583669132|FG001|Part 2 Open-label Period|Adverse Event|4|||
161623182|NCT01020487|583669133|FG002|Part 2 Open-label Period|Adverse Event|1|||
161623183|NCT04049578|583669134|FG000|Overall Study|Physician Decision|1|||
161623184|NCT05878990|583669135|FG000|Overall Study|Lost to Follow-up|7|||
161623185|NCT05878990|583669135|FG000|Overall Study|Withdrawal by Subject|1|||
161623186|NCT03409276|583669136|FG000|Overall Study|Withdrawal by Subject|0|||
161623187|NCT03409276|583669137|FG001|Overall Study|Withdrawal by Subject|0|||
161623188|NCT03409276|583669138|FG002|Overall Study|Withdrawal by Subject|0|||
161623189|NCT03409276|583669139|FG003|Overall Study|Withdrawal by Subject|0|||
161623190|NCT03409276|583669140|FG004|Overall Study|Withdrawal by Subject|1|||
161623191|NCT03409276|583669136|FG000|Overall Study|Lost to Follow-up|0|||
161623192|NCT03409276|583669137|FG001|Overall Study|Lost to Follow-up|0|||
161623193|NCT03409276|583669138|FG002|Overall Study|Lost to Follow-up|0|||
161623194|NCT03409276|583669139|FG003|Overall Study|Lost to Follow-up|2|||
161623195|NCT03409276|583669140|FG004|Overall Study|Lost to Follow-up|2|||
161623196|NCT03605745|583669141|FG000|Overall Study|Study was terminated for business reasons|47|||
161623197|NCT01279447|583669142|FG000|Overall Study|Lost to Follow-up|3|||
161623198|NCT01279447|583669143|FG001|Overall Study|Lost to Follow-up|1|||
161623199|NCT01074229|583669144|FG000|Overall Study|Lost to Follow-up|1|||
161623200|NCT01074229|583669145|FG001|Overall Study|Lost to Follow-up|0|||
161623201|NCT01074229|583669146|FG002|Overall Study|Lost to Follow-up|0|||
161623202|NCT01074229|583669144|FG000|Overall Study|Change to open surgical procedure|1|||
161623203|NCT01074229|583669145|FG001|Overall Study|Change to open surgical procedure|3|||
161623204|NCT01074229|583669146|FG002|Overall Study|Change to open surgical procedure|4|||
161623205|NCT01183013|583669147|FG000|Overall Study|Adverse Event|6|||
161623206|NCT01183013|583669148|FG001|Overall Study|Adverse Event|8|||
161623207|NCT01183013|583669149|FG002|Overall Study|Adverse Event|5|||
161623208|NCT01183013|583669150|FG003|Overall Study|Adverse Event|5|||
161623209|NCT01183013|583669151|FG004|Overall Study|Adverse Event|10|||
161623210|NCT01183013|583669152|FG005|Overall Study|Adverse Event|10|||
161623211|NCT01183013|583669153|FG006|Overall Study|Adverse Event|6|||
161623212|NCT01183013|583669147|FG000|Overall Study|Lack of Efficacy|3|||
161623213|NCT01183013|583669148|FG001|Overall Study|Lack of Efficacy|2|||
161623214|NCT01183013|583669149|FG002|Overall Study|Lack of Efficacy|1|||
161623215|NCT01183013|583669150|FG003|Overall Study|Lack of Efficacy|2|||
161623216|NCT01183013|583669151|FG004|Overall Study|Lack of Efficacy|1|||
161623217|NCT01183013|583669152|FG005|Overall Study|Lack of Efficacy|2|||
161623218|NCT01183013|583669153|FG006|Overall Study|Lack of Efficacy|0|||
161684936|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
161684937|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
161684938|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
161684939|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
161684940|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
161623219|NCT01183013|583669147|FG000|Overall Study|Protocol Violation|5|||
161623220|NCT01183013|583669148|FG001|Overall Study|Protocol Violation|2|||
161623221|NCT01183013|583669149|FG002|Overall Study|Protocol Violation|4|||
161623222|NCT01183013|583669150|FG003|Overall Study|Protocol Violation|0|||
161623223|NCT01183013|583669151|FG004|Overall Study|Protocol Violation|4|||
161623224|NCT01183013|583669152|FG005|Overall Study|Protocol Violation|3|||
161623225|NCT01183013|583669153|FG006|Overall Study|Protocol Violation|3|||
161623226|NCT01183013|583669147|FG000|Overall Study|Lost to Follow-up|7|||
161684941|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
161623227|NCT01183013|583669148|FG001|Overall Study|Lost to Follow-up|3|||
161623228|NCT01183013|583669149|FG002|Overall Study|Lost to Follow-up|4|||
161623229|NCT01183013|583669150|FG003|Overall Study|Lost to Follow-up|3|||
161623230|NCT01183013|583669151|FG004|Overall Study|Lost to Follow-up|2|||
161623231|NCT01183013|583669152|FG005|Overall Study|Lost to Follow-up|6|||
161623232|NCT01183013|583669153|FG006|Overall Study|Lost to Follow-up|5|||
161623233|NCT01183013|583669147|FG000|Overall Study|Withdrawal by Subject|9|||
161623234|NCT01183013|583669148|FG001|Overall Study|Withdrawal by Subject|13|||
161623235|NCT01183013|583669149|FG002|Overall Study|Withdrawal by Subject|10|||
161623236|NCT01183013|583669150|FG003|Overall Study|Withdrawal by Subject|8|||
161623237|NCT01183013|583669151|FG004|Overall Study|Withdrawal by Subject|7|||
161623238|NCT01183013|583669152|FG005|Overall Study|Withdrawal by Subject|9|||
161623239|NCT01183013|583669153|FG006|Overall Study|Withdrawal by Subject|10|||
161623240|NCT01183013|583669147|FG000|Overall Study|Reasons other than stated above|15|||
161623241|NCT01183013|583669148|FG001|Overall Study|Reasons other than stated above|11|||
161623242|NCT01183013|583669149|FG002|Overall Study|Reasons other than stated above|17|||
161623243|NCT01183013|583669150|FG003|Overall Study|Reasons other than stated above|12|||
161623244|NCT01183013|583669151|FG004|Overall Study|Reasons other than stated above|12|||
161623245|NCT01183013|583669152|FG005|Overall Study|Reasons other than stated above|15|||
161623246|NCT01183013|583669153|FG006|Overall Study|Reasons other than stated above|13|||
161623247|NCT01951105|583669156|FG000|Overall Study|Adverse Event|0|||
161623248|NCT01951105|583669157|FG001|Overall Study|Adverse Event|5|||
161623249|NCT01951105|583669158|FG002|Overall Study|Adverse Event|0|||
161623250|NCT01951105|583669156|FG000|Overall Study|Lost to Follow-up|0|||
161623251|NCT01951105|583669157|FG001|Overall Study|Lost to Follow-up|1|||
161623252|NCT01951105|583669158|FG002|Overall Study|Lost to Follow-up|0|||
161623253|NCT01951105|583669156|FG000|Overall Study|Protocol Violation|1|||
161623254|NCT01951105|583669157|FG001|Overall Study|Protocol Violation|1|||
161623255|NCT01951105|583669158|FG002|Overall Study|Protocol Violation|1|||
161623256|NCT01951105|583669156|FG000|Overall Study|Withdrawal by Subject|0|||
161623257|NCT01951105|583669157|FG001|Overall Study|Withdrawal by Subject|3|||
161623258|NCT01951105|583669158|FG002|Overall Study|Withdrawal by Subject|1|||
161623259|NCT02727998|583669159|FG000|Overall Study|Lost to Follow-up|3|||
161623260|NCT02727998|583669160|FG001|Overall Study|Lost to Follow-up|3|||
161623261|NCT02727998|583669159|FG000|Overall Study|Withdrawal by Subject|0|||
161623262|NCT02727998|583669160|FG001|Overall Study|Withdrawal by Subject|1|||
161623263|NCT00901459|583669165|FG000|Overall Study|Withdrawal by Subject|6|||
161623264|NCT00910871|583669173|FG000|Overall Study|Adverse Event|5|||
161623265|NCT00910871|583669173|FG000|Overall Study|Death|12|||
161623266|NCT00910871|583669173|FG000|Overall Study|Lost to Follow-up|8|||
161623267|NCT00910871|583669173|FG000|Overall Study|Protocol Violation|11|||
161623268|NCT00910871|583669173|FG000|Overall Study|Withdrawal by Subject|12|||
161623269|NCT00910871|583669173|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
161623270|NCT00910871|583669173|FG000|Overall Study|Undefined|1|||
161684942|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
161684943|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
161832985|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161832986|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161832987|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
161623271|NCT00850993|583669174|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
161623272|NCT00850993|583669175|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
161623273|NCT00850993|583669176|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
161623274|NCT00850993|583669177|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
161623275|NCT04501614|583669183|FG000|Overall Study|Study Terminated by Sponsor|6|||
161623276|NCT04501614|583669184|FG001|Overall Study|Study Terminated by Sponsor|3|||
161623277|NCT04501614|583669183|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
161623278|NCT04501614|583669184|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
161623279|NCT02555397|583669188|FG000|Overall Study|Withdrawal by Subject|1|||
161623280|NCT02555397|583669189|FG001|Overall Study|Withdrawal by Subject|0|||
161623281|NCT02555397|583669190|FG002|Overall Study|Withdrawal by Subject|0|||
161623282|NCT02555397|583669191|FG003|Overall Study|Withdrawal by Subject|0|||
161623283|NCT02555397|583669192|FG004|Overall Study|Withdrawal by Subject|0|||
161623284|NCT00237809|583669198|FG000|Overall Study|Lost to Follow-up|11|||
161623285|NCT00237809|583669199|FG001|Overall Study|Lost to Follow-up|10|||
161623286|NCT00237809|583669200|FG002|Overall Study|Lost to Follow-up|9|||
161623287|NCT00237809|583669201|FG003|Overall Study|Lost to Follow-up|9|||
161623288|NCT00321555|583669207|FG000|Overall Study|Developed antibodies|1|||
161623289|NCT00321555|583669207|FG000|Overall Study|Switched to alternative treatment|3|||
161623290|NCT00321555|583669207|FG000|Overall Study|Physician Decision|1|||
161623291|NCT00321555|583669207|FG000|Overall Study|Disease progression on study|1|||
161623292|NCT02066389|583669208|FG000|Overall Study|Adverse Event|1|||
161623293|NCT02066389|583669209|FG001|Overall Study|Adverse Event|1|||
161623294|NCT02066389|583669210|FG002|Overall Study|Adverse Event|1|||
161623295|NCT02066389|583669211|FG003|Overall Study|Adverse Event|1|||
161623296|NCT02066389|583669212|FG004|Overall Study|Adverse Event|5|||
161623297|NCT02066389|583669213|FG005|Overall Study|Adverse Event|1|||
161623298|NCT02066389|583669208|FG000|Overall Study|Withdrawal by Subject|4|||
161623299|NCT02066389|583669209|FG001|Overall Study|Withdrawal by Subject|0|||
161623300|NCT02066389|583669210|FG002|Overall Study|Withdrawal by Subject|5|||
161623301|NCT02066389|583669211|FG003|Overall Study|Withdrawal by Subject|1|||
161623302|NCT02066389|583669212|FG004|Overall Study|Withdrawal by Subject|1|||
161623303|NCT02066389|583669213|FG005|Overall Study|Withdrawal by Subject|2|||
161623304|NCT02066389|583669208|FG000|Overall Study|Lost to Follow-up|0|||
161623305|NCT02066389|583669209|FG001|Overall Study|Lost to Follow-up|0|||
161623306|NCT02066389|583669210|FG002|Overall Study|Lost to Follow-up|0|||
161623307|NCT02066389|583669211|FG003|Overall Study|Lost to Follow-up|1|||
161623308|NCT02066389|583669212|FG004|Overall Study|Lost to Follow-up|1|||
161623309|NCT02066389|583669213|FG005|Overall Study|Lost to Follow-up|1|||
161623310|NCT02066389|583669208|FG000|Overall Study|Randomized in Error|0|||
161623311|NCT02066389|583669209|FG001|Overall Study|Randomized in Error|0|||
161684944|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
161684945|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
161684946|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
161684947|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
161623312|NCT02066389|583669210|FG002|Overall Study|Randomized in Error|0|||
161623313|NCT02066389|583669211|FG003|Overall Study|Randomized in Error|0|||
161623314|NCT02066389|583669212|FG004|Overall Study|Randomized in Error|0|||
161623315|NCT02066389|583669213|FG005|Overall Study|Randomized in Error|1|||
161623316|NCT01517282|583669219|FG000|Overall Study|Consent withdrawn|0|||
161623317|NCT01517282|583669220|FG001|Overall Study|Consent withdrawn|1|||
161623318|NCT01517282|583669221|FG002|Overall Study|Consent withdrawn|1|||
161623319|NCT01517282|583669222|FG003|Overall Study|Consent withdrawn|1|||
161623320|NCT01517282|583669219|FG000|Overall Study|Physician Decision|1|||
161623321|NCT01517282|583669220|FG001|Overall Study|Physician Decision|0|||
161623322|NCT01517282|583669221|FG002|Overall Study|Physician Decision|0|||
161623323|NCT01517282|583669222|FG003|Overall Study|Physician Decision|0|||
161623324|NCT04433091|583669224|FG000|Overall Study|Lost to Follow-up|1|||
161623325|NCT04433091|583669225|FG001|Overall Study|Lost to Follow-up|0|||
161623326|NCT04433091|583669224|FG000|Overall Study|Withdrawn .|2|||
161623327|NCT04433091|583669225|FG001|Overall Study|Withdrawn .|4|||
161623328|NCT02880293|583670523|FG000|Overall Study|Inevaluable|5|||
161623329|NCT02101554|583670526|FG000|Overall Study|Protocol Violation|0|||
161623330|NCT02101554|583670527|FG001|Overall Study|Protocol Violation|1|||
161623331|NCT02101554|583670528|FG002|Overall Study|Protocol Violation|0|||
161623332|NCT02101554|583670526|FG000|Overall Study|Insufficient Clinical Response|0|||
161623333|NCT02101554|583670527|FG001|Overall Study|Insufficient Clinical Response|2|||
161623334|NCT02101554|583670528|FG002|Overall Study|Insufficient Clinical Response|0|||
161684948|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Death|1|||
161623335|NCT02101554|583670526|FG000|Overall Study|Adverse Event|2|||
161623336|NCT02101554|583670527|FG001|Overall Study|Adverse Event|1|||
161684949|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Death|1|||
161684950|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Death|1|||
161623337|NCT02101554|583670528|FG002|Overall Study|Adverse Event|1|||
161623338|NCT02101554|583670526|FG000|Overall Study|Lost to Follow-up|0|||
161623339|NCT02101554|583670527|FG001|Overall Study|Lost to Follow-up|1|||
161623340|NCT02101554|583670528|FG002|Overall Study|Lost to Follow-up|0|||
161623341|NCT02101554|583670526|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
161623342|NCT02101554|583670527|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
161623343|NCT02101554|583670528|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
161623344|NCT00668746|583670529|FG000|Overall Study|Lost to Follow-up|2|||
161623345|NCT00668746|583670530|FG001|Overall Study|Lost to Follow-up|1|||
161623346|NCT05361304|583670540|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
161623347|NCT05361304|583670541|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
161623348|NCT05361304|583670540|FG000|Overall Study|COVID-19 Related|1|||
161623349|NCT05361304|583670541|FG001|Overall Study|COVID-19 Related|2|||
161623350|NCT05361304|583670540|FG000|Overall Study|Withdrawal by Subject|1|||
161623351|NCT05361304|583670541|FG001|Overall Study|Withdrawal by Subject|0|||
161623352|NCT03320941|583670542|FG000|Overall Study|subject/guardian decision|0|||
161623353|NCT03320941|583670543|FG001|Overall Study|subject/guardian decision|0|||
161623354|NCT03320941|583670544|FG002|Overall Study|subject/guardian decision|0|||
161623355|NCT03320941|583670545|FG003|Overall Study|subject/guardian decision|1|||
161623356|NCT03320941|583670546|FG004|Overall Study|subject/guardian decision|0|||
161623357|NCT02368691|583670548|FG000|Overall Study|Death|13|||
161623358|NCT02368691|583670548|FG000|Overall Study|Lack of Efficacy|15|||
161623359|NCT02368691|583670548|FG000|Overall Study|Physician Decision|4|||
161623360|NCT03314233|583670549|FG000|Overall Study|No longer eligible at time of delivery|1|||
161623361|NCT01797705|583670550|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
161623362|NCT01797705|583670550|FG000|Overall Study|Withdrawal by Subject|1|||
161623363|NCT01838447|583670551|FG000|Overall Study|Change in surgical plan|1|||
161623364|NCT01838447|583670552|FG001|Overall Study|Change in surgical plan|2|||
161623365|NCT01838447|583670551|FG000|Overall Study|Withdrawal by Subject|1|||
161623366|NCT01838447|583670552|FG001|Overall Study|Withdrawal by Subject|1|||
161623367|NCT01114217|583670554|FG000|Overall Study|Adverse Event|5|||
161623368|NCT01114217|583670555|FG001|Overall Study|Adverse Event|3|||
161623369|NCT01114217|583670554|FG000|Overall Study|Lost to Follow-up|17|||
161623370|NCT01114217|583670555|FG001|Overall Study|Lost to Follow-up|33|||
161623371|NCT01114217|583670554|FG000|Overall Study|Withdrawal by Subject|21|||
161623372|NCT01114217|583670555|FG001|Overall Study|Withdrawal by Subject|28|||
161623373|NCT01114217|583670554|FG000|Overall Study|Other-Clerical Error|3|||
161623374|NCT01114217|583670555|FG001|Overall Study|Other-Clerical Error|0|||
161623375|NCT01114217|583670554|FG000|Overall Study|Other-Early termination|6|||
161623376|NCT01114217|583670555|FG001|Overall Study|Other-Early termination|10|||
161623377|NCT01114217|583670554|FG000|Overall Study|Other-Procedure|1|||
161623378|NCT01114217|583670555|FG001|Overall Study|Other-Procedure|1|||
161623379|NCT01114217|583670554|FG000|Overall Study|Other-Pregnancy|2|||
161623380|NCT01114217|583670555|FG001|Overall Study|Other-Pregnancy|4|||
161623381|NCT01114217|583670554|FG000|Overall Study|Other-Protocol Violation|1|||
161623382|NCT01114217|583670555|FG001|Overall Study|Other-Protocol Violation|3|||
161623383|NCT01114217|583670554|FG000|Overall Study|Other-Lack of Efficacy|1|||
161623384|NCT01114217|583670555|FG001|Overall Study|Other-Lack of Efficacy|0|||
161623385|NCT01114217|583670554|FG000|Overall Study|Other-Non Compliance|2|||
161623386|NCT01114217|583670555|FG001|Overall Study|Other-Non Compliance|0|||
161623387|NCT01114217|583670554|FG000|Overall Study|Other-Physician Decision|1|||
161623388|NCT01114217|583670555|FG001|Overall Study|Other-Physician Decision|1|||
161623389|NCT01114217|583670554|FG000|Overall Study|Other-Sponsor Decision|10|||
161623390|NCT01114217|583670555|FG001|Overall Study|Other-Sponsor Decision|12|||
161623391|NCT01114217|583670554|FG000|Overall Study|Other-Study Termination|0|||
161623392|NCT01114217|583670555|FG001|Overall Study|Other-Study Termination|1|||
161623393|NCT01114217|583670554|FG000|Overall Study|Other-Study Withdrawn|1|||
161623394|NCT01114217|583670555|FG001|Overall Study|Other-Study Withdrawn|1|||
161623395|NCT01114217|583670554|FG000|Overall Study|Other-Site Stopped Communicating|2|||
161623396|NCT01114217|583670555|FG001|Overall Study|Other-Site Stopped Communicating|0|||
161623397|NCT01114217|583670554|FG000|Overall Study|Other-Lost to Follow-up|1|||
161623398|NCT01114217|583670555|FG001|Overall Study|Other-Lost to Follow-up|0|||
161623399|NCT01114217|583670554|FG000|Overall Study|Other-Withdrawal by Subject|1|||
161623400|NCT01114217|583670555|FG001|Overall Study|Other-Withdrawal by Subject|1|||
161623401|NCT01837719|583670556|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
161623402|NCT01837719|583670556|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
161623403|NCT01703988|583670557|FG000|Overall Study|Investigator Judgment|0|||
161623404|NCT01703988|583670558|FG001|Overall Study|Investigator Judgment|0|||
161623405|NCT01703988|583670559|FG002|Overall Study|Investigator Judgment|0|||
161623406|NCT01703988|583670560|FG003|Overall Study|Investigator Judgment|1|||
161623407|NCT06247488|583670561|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
161623408|NCT06247488|583670562|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161623409|NCT06247488|583670563|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161623410|NCT06247488|583670564|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161623411|NCT06247488|583670565|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161623412|NCT06247488|583670566|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161623413|NCT06247488|583670561|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161623414|NCT06247488|583670562|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161623415|NCT06247488|583670563|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161623416|NCT06247488|583670564|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
161623417|NCT06247488|583670565|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161623418|NCT06247488|583670566|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161623419|NCT06247488|583670561|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
161623420|NCT06247488|583670562|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161623421|NCT06247488|583670563|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161623422|NCT06247488|583670564|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161623423|NCT06247488|583670565|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161623424|NCT06247488|583670566|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161623425|NCT06247488|583670561|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161623426|NCT06247488|583670562|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161623427|NCT06247488|583670563|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161623428|NCT06247488|583670564|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
161623429|NCT06247488|583670565|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161623430|NCT06247488|583670566|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161623431|NCT06247488|583670561|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161623432|NCT06247488|583670562|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161623433|NCT06247488|583670563|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161623434|NCT06247488|583670564|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161623435|NCT06247488|583670565|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161623436|NCT06247488|583670566|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
161623437|NCT06247488|583670561|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
161623438|NCT06247488|583670562|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161623439|NCT06247488|583670563|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161623440|NCT06247488|583670564|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
161623441|NCT06247488|583670565|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
161623442|NCT06247488|583670566|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161623443|NCT06247488|583670561|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161623444|NCT06247488|583670562|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161623445|NCT06247488|583670563|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161623446|NCT06247488|583670564|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161623447|NCT06247488|583670565|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161623448|NCT06247488|583670566|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
161623449|NCT00584909|583670572|FG000|Overall Study|Adverse Event|4|||
161623450|NCT03436797|583670573|FG000|Main Study|Withdrawal by Subject|2|||
161623451|NCT03436797|583670573|FG000|Main Study|Adverse Event|4|||
161623452|NCT03436797|583670573|FG000|Main Study|Lost to Follow-up|1|||
161623453|NCT03436797|583670573|FG000|Main Study|Death|1|||
161623454|NCT03436797|583670573|FG000|Main Study|Non-Specific|2|||
161623455|NCT03436797|583670573|FG000|Extended Dosing|Patient decision|1|||
161623456|NCT04739306|583670574|FG000|Main Study Period|Adverse Event|6|||
161623457|NCT04739306|583670575|FG001|Main Study Period|Adverse Event|7|||
161623458|NCT04739306|583670574|FG000|Main Study Period|Lost to Follow-up|4|||
161623459|NCT04739306|583670575|FG001|Main Study Period|Lost to Follow-up|6|||
161623460|NCT04739306|583670574|FG000|Main Study Period|Physician Decision|1|||
161623461|NCT04739306|583670575|FG001|Main Study Period|Physician Decision|1|||
161623462|NCT04739306|583670574|FG000|Main Study Period|Withdrawal by Subject|8|||
161623463|NCT04739306|583670575|FG001|Main Study Period|Withdrawal by Subject|6|||
161623464|NCT04739306|583670574|FG000|Main Study Period|Protocol Violation|0|||
161623465|NCT04739306|583670575|FG001|Main Study Period|Protocol Violation|1|||
161623466|NCT04739306|583670574|FG000|Main Study Period|War in Ukraine|1|||
161623467|NCT04739306|583670575|FG001|Main Study Period|War in Ukraine|1|||
161623468|NCT04175392|583670578|FG000|Overall Study|Withdrawal by Subject|3|||
161623469|NCT04175392|583670579|FG001|Overall Study|Withdrawal by Subject|2|||
161623470|NCT01103141|583670580|FG000|Overall Study|Death|0|||
161623471|NCT01103141|583670581|FG001|Overall Study|Death|1|||
161623472|NCT01103141|583670580|FG000|Overall Study|Lost to Follow-up|2|||
161623473|NCT01103141|583670581|FG001|Overall Study|Lost to Follow-up|1|||
161623474|NCT05072795|583670582|FG000|Overall Study|Lost to Follow-up|5|||
161623475|NCT00422162|583670586|FG000|Overall Study|Adverse Event|11|||
161832988|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161832989|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161832990|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161623476|NCT00422162|583670587|FG001|Overall Study|Adverse Event|9|||
161623477|NCT00422162|583670586|FG000|Overall Study|Lack of Efficacy|4|||
161623478|NCT00422162|583670587|FG001|Overall Study|Lack of Efficacy|10|||
161832991|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161623479|NCT00422162|583670586|FG000|Overall Study|Withdrawal by Subject|7|||
161623480|NCT00422162|583670587|FG001|Overall Study|Withdrawal by Subject|6|||
161623481|NCT00422162|583670586|FG000|Overall Study|Lost to Follow-up|1|||
161623482|NCT00422162|583670587|FG001|Overall Study|Lost to Follow-up|2|||
161623483|NCT00422162|583670586|FG000|Overall Study|Non-Compliant with Protocol|1|||
161623484|NCT00422162|583670587|FG001|Overall Study|Non-Compliant with Protocol|1|||
161623485|NCT00422162|583670586|FG000|Overall Study|Other|0|||
161623486|NCT00422162|583670587|FG001|Overall Study|Other|1|||
161623487|NCT00422162|583670586|FG000|Overall Study|Didn't Receive Treatment|0|||
161623488|NCT00422162|583670587|FG001|Overall Study|Didn't Receive Treatment|1|||
161623489|NCT05274906|583670588|FG000|Overall Study|Withdrawal by Subject|2|||
161623490|NCT05274906|583670589|FG001|Overall Study|Withdrawal by Subject|1|||
161623491|NCT00848198|583670590|FG000|Overall Study|Incomplete Case Report Forms|15|||
161832992|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
161832993|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161832994|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161832995|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
161832996|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161832997|NCT02654587|584429663|FG000|Overall Study|patient alive at end of study|22|||
161832998|NCT02654587|584429664|FG001|Overall Study|patient alive at end of study|8|||
161832999|NCT02654587|584429663|FG000|Overall Study|Withdrawal by Subject|1|||
161833000|NCT02654587|584429664|FG001|Overall Study|Withdrawal by Subject|7|||
161833001|NCT01825837|584429665|FG000|PART I|Withdrawal by Subject|0|||
161833002|NCT01825837|584429666|FG001|PART I|Withdrawal by Subject|0|||
161833003|NCT01825837|584429667|FG002|PART I|Withdrawal by Subject|0|||
161833004|NCT01825837|584429668|FG003|PART I|Withdrawal by Subject|6|||
161623492|NCT02062827|583670594|FG000|Overall Study|Death|1|||
161623493|NCT02062827|583670595|FG001|Overall Study|Death|0|||
161623494|NCT02062827|583670596|FG002|Overall Study|Death|0|||
161623495|NCT02062827|583670597|FG003|Overall Study|Death|0|||
161623496|NCT02062827|583670598|FG004|Overall Study|Death|0|||
161623497|NCT02062827|583670599|FG005|Overall Study|Death|0|||
161623498|NCT02062827|583670600|FG006|Overall Study|Death|0|||
161623499|NCT02062827|583670601|FG007|Overall Study|Death|0|||
161623500|NCT02062827|583670594|FG000|Overall Study|Withdrawal by Subject|3|||
161623501|NCT02062827|583670595|FG001|Overall Study|Withdrawal by Subject|1|||
161623502|NCT02062827|583670596|FG002|Overall Study|Withdrawal by Subject|1|||
161623503|NCT02062827|583670597|FG003|Overall Study|Withdrawal by Subject|2|||
161623504|NCT02062827|583670598|FG004|Overall Study|Withdrawal by Subject|6|||
161623505|NCT02062827|583670599|FG005|Overall Study|Withdrawal by Subject|0|||
161623506|NCT02062827|583670600|FG006|Overall Study|Withdrawal by Subject|5|||
161623507|NCT02062827|583670601|FG007|Overall Study|Withdrawal by Subject|0|||
161623508|NCT02062827|583670594|FG000|Overall Study|Screen Fail|0|||
161833005|NCT01825837|584429665|FG000|PART I|Patient non-compliance|0|||
161623509|NCT02062827|583670595|FG001|Overall Study|Screen Fail|0|||
161623510|NCT02062827|583670596|FG002|Overall Study|Screen Fail|0|||
161623511|NCT02062827|583670597|FG003|Overall Study|Screen Fail|0|||
161623512|NCT02062827|583670598|FG004|Overall Study|Screen Fail|0|||
161623513|NCT02062827|583670599|FG005|Overall Study|Screen Fail|0|||
161623514|NCT02062827|583670600|FG006|Overall Study|Screen Fail|0|||
161623515|NCT02062827|583670601|FG007|Overall Study|Screen Fail|8|||
161623516|NCT04930263|583670602|FG000|Overall Study|Withdrawal by Subject|3|||
161623517|NCT04930263|583670603|FG001|Overall Study|Withdrawal by Subject|5|||
161623518|NCT02812706|583670605|FG000|Phase 1|Adverse Event|0|||
161623519|NCT02812706|583670606|FG001|Phase 1|Adverse Event|2|||
161623520|NCT02812706|583670607|FG002|Phase 1|Adverse Event|0|||
161623521|NCT02812706|583670605|FG000|Phase 1|Progressive disease|3|||
161623522|NCT02812706|583670606|FG001|Phase 1|Progressive disease|3|||
161623523|NCT02812706|583670607|FG002|Phase 1|Progressive disease|0|||
161623524|NCT02812706|583670605|FG000|Phase 2|Adverse Event|0|||
161623525|NCT02812706|583670606|FG001|Phase 2|Adverse Event|0|||
161623526|NCT02812706|583670607|FG002|Phase 2|Adverse Event|2|||
161623527|NCT02812706|583670605|FG000|Phase 2|Progressive disease|0|||
161623528|NCT02812706|583670606|FG001|Phase 2|Progressive disease|0|||
161623529|NCT02812706|583670607|FG002|Phase 2|Progressive disease|22|||
161623530|NCT02812706|583670605|FG000|Phase 2|Other-Unspecified|0|||
161623531|NCT02812706|583670606|FG001|Phase 2|Other-Unspecified|0|||
161623532|NCT02812706|583670607|FG002|Phase 2|Other-Unspecified|4|||
161623533|NCT02213458|583670608|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
161623534|NCT02213458|583670609|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
161623535|NCT02213458|583670608|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
161623536|NCT02213458|583670609|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
161623537|NCT02213458|583670608|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
161623538|NCT02213458|583670609|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
161623539|NCT02213458|583670608|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
161623540|NCT02213458|583670609|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
161623541|NCT02213458|583670608|FG000|Overall Study|Refused re-consent|6|||
161623542|NCT02213458|583670609|FG001|Overall Study|Refused re-consent|0|||
161623543|NCT02213458|583670608|FG000|Overall Study|Lost to Follow-up|2|||
161623544|NCT02213458|583670609|FG001|Overall Study|Lost to Follow-up|2|||
161623545|NCT02213458|583670608|FG000|Overall Study|Withdrawal by Subject|26|||
161623546|NCT02213458|583670609|FG001|Overall Study|Withdrawal by Subject|8|||
161623547|NCT01622088|583670610|FG000|Overall Study|Adverse Event|20|||
161623548|NCT01622088|583670610|FG000|Overall Study|Lost to Follow-up|1|||
161623549|NCT01622088|583670610|FG000|Overall Study|Withdrawal by Subject|20|||
161623550|NCT01622088|583670610|FG000|Overall Study|Investigator Decision|1|||
161623551|NCT01622088|583670610|FG000|Overall Study|Death|53|||
161833006|NCT01825837|584429666|FG001|PART I|Patient non-compliance|0|||
161833007|NCT01825837|584429667|FG002|PART I|Patient non-compliance|0|||
161833008|NCT01825837|584429668|FG003|PART I|Patient non-compliance|1|||
161833009|NCT01825837|584429665|FG000|PART I|Treatment failure|0|||
161833010|NCT01825837|584429666|FG001|PART I|Treatment failure|0|||
161833011|NCT01825837|584429667|FG002|PART I|Treatment failure|0|||
161833012|NCT01825837|584429668|FG003|PART I|Treatment failure|7|||
161833013|NCT01825837|584429665|FG000|PART I|reason unspecified|0|||
161833014|NCT01825837|584429666|FG001|PART I|reason unspecified|0|||
161833015|NCT01825837|584429667|FG002|PART I|reason unspecified|0|||
161833016|NCT01825837|584429668|FG003|PART I|reason unspecified|3|||
161833017|NCT01825837|584429665|FG000|PART II|Withdrawal by Subject|3|||
161833018|NCT01825837|584429666|FG001|PART II|Withdrawal by Subject|3|||
161833019|NCT01825837|584429667|FG002|PART II|Withdrawal by Subject|7|||
161833020|NCT01825837|584429668|FG003|PART II|Withdrawal by Subject|0|||
161833021|NCT01825837|584429665|FG000|PART II|Patient non-compliance|5|||
161833022|NCT01825837|584429666|FG001|PART II|Patient non-compliance|2|||
161833023|NCT01825837|584429667|FG002|PART II|Patient non-compliance|4|||
161833024|NCT01825837|584429668|FG003|PART II|Patient non-compliance|0|||
161833025|NCT01825837|584429665|FG000|PART II|Adverse Event|3|||
161833026|NCT01825837|584429666|FG001|PART II|Adverse Event|3|||
161833027|NCT01825837|584429667|FG002|PART II|Adverse Event|1|||
161833028|NCT01825837|584429668|FG003|PART II|Adverse Event|0|||
161833029|NCT01825837|584429665|FG000|PART II|Treatment failure|6|||
161833030|NCT01825837|584429666|FG001|PART II|Treatment failure|4|||
161833031|NCT01825837|584429667|FG002|PART II|Treatment failure|5|||
161833032|NCT01825837|584429668|FG003|PART II|Treatment failure|0|||
161833033|NCT01825837|584429665|FG000|PART II|reason unspecified|2|||
161833034|NCT01825837|584429666|FG001|PART II|reason unspecified|2|||
161833035|NCT01825837|584429667|FG002|PART II|reason unspecified|2|||
161833036|NCT01825837|584429668|FG003|PART II|reason unspecified|0|||
161833037|NCT00904748|584429671|FG000|Overall Study|Withdrawal by Subject|1|||
161833038|NCT00904748|584429672|FG001|Overall Study|Withdrawal by Subject|1|||
161833039|NCT00904748|584429673|FG002|Overall Study|Withdrawal by Subject|1|||
161833040|NCT00904748|584429674|FG003|Overall Study|Withdrawal by Subject|2|||
161833041|NCT00904748|584429675|FG004|Overall Study|Withdrawal by Subject|0|||
161833042|NCT00904748|584429676|FG005|Overall Study|Withdrawal by Subject|0|||
161833043|NCT00904748|584429671|FG000|Overall Study|Adverse Event|0|||
161833044|NCT00904748|584429672|FG001|Overall Study|Adverse Event|0|||
161833045|NCT00904748|584429673|FG002|Overall Study|Adverse Event|0|||
161833046|NCT00904748|584429674|FG003|Overall Study|Adverse Event|0|||
161833047|NCT00904748|584429675|FG004|Overall Study|Adverse Event|1|||
161833048|NCT00904748|584429676|FG005|Overall Study|Adverse Event|0|||
161833049|NCT01682148|584429677|FG000|Overall Study|Withdrawal by Subject|2|||
161833050|NCT01682148|584429678|FG001|Overall Study|Withdrawal by Subject|0|||
161833051|NCT01682148|584429677|FG000|Overall Study|Lost to Follow-up|1|||
161833052|NCT01682148|584429678|FG001|Overall Study|Lost to Follow-up|2|||
161833053|NCT01682148|584429677|FG000|Overall Study|Protocol Violation|1|||
161833054|NCT01682148|584429678|FG001|Overall Study|Protocol Violation|1|||
161833055|NCT01202877|584429679|FG000|Overall Study|Disease Progression|0|||
161833056|NCT01202877|584429680|FG001|Overall Study|Disease Progression|1|||
161833057|NCT01202877|584429681|FG002|Overall Study|Disease Progression|2|||
161833058|NCT01202877|584429679|FG000|Overall Study|Adverse Event|0|||
161833059|NCT01202877|584429680|FG001|Overall Study|Adverse Event|0|||
161833060|NCT01202877|584429681|FG002|Overall Study|Adverse Event|2|||
161833061|NCT01202877|584429679|FG000|Overall Study|Withdrawal by Subject|0|||
161833062|NCT01202877|584429680|FG001|Overall Study|Withdrawal by Subject|0|||
161833063|NCT01202877|584429681|FG002|Overall Study|Withdrawal by Subject|1|||
161833064|NCT01202877|584429679|FG000|Overall Study|Death|0|||
161833065|NCT01202877|584429680|FG001|Overall Study|Death|0|||
161833066|NCT01202877|584429681|FG002|Overall Study|Death|1|||
161833067|NCT04403763|584429682|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
161833068|NCT04403763|584429683|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
161833069|NCT04403763|584429684|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833070|NCT04403763|584429685|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833071|NCT04403763|584429686|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833072|NCT04403763|584429687|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833073|NCT04403763|584429688|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833074|NCT04403763|584429682|FG000|Stage 1|Early termination due to PK tube failure|0|||
161833075|NCT04403763|584429683|FG001|Stage 1|Early termination due to PK tube failure|0|||
161833076|NCT04403763|584429684|FG002|Stage 1|Early termination due to PK tube failure|1|||
161833077|NCT04403763|584429685|FG003|Stage 1|Early termination due to PK tube failure|0|||
161833078|NCT04403763|584429686|FG004|Stage 1|Early termination due to PK tube failure|0|||
161833079|NCT04403763|584429687|FG005|Stage 1|Early termination due to PK tube failure|0|||
161833080|NCT04403763|584429688|FG006|Stage 1|Early termination due to PK tube failure|0|||
161623552|NCT01622088|583670610|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
161623553|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
161623554|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
161623555|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
161623556|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
161623557|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
161623558|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
161623559|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
161623560|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
161623561|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
161623562|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
161623563|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
161623564|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
161623565|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
161623566|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
161623567|NCT02971683|583670611|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
161623568|NCT02971683|583670612|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
161623569|NCT02971683|583670611|FG000|Open-Label|Lost to Follow-up|1|||
161623570|NCT02971683|583670612|FG001|Open-Label|Lost to Follow-up|0|||
161623571|NCT02971683|583670611|FG000|Open-Label|Participants withdrew consent|0|||
161623572|NCT02971683|583670612|FG001|Open-Label|Participants withdrew consent|2|||
161623573|NCT02971683|583670611|FG000|Open-Label|Participant request to discontinue study treatment|1|||
161623574|NCT02971683|583670612|FG001|Open-Label|Participant request to discontinue study treatment|0|||
161623575|NCT02971683|583670611|FG000|Open-Label|Lack of Efficacy|2|||
161623576|NCT02971683|583670612|FG001|Open-Label|Lack of Efficacy|0|||
161623577|NCT02971683|583670611|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
161623578|NCT02971683|583670612|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
161623579|NCT02971683|583670611|FG000|Long-Term Open Label|Participant withdrew consent|1|||
161623580|NCT02971683|583670612|FG001|Long-Term Open Label|Participant withdrew consent|0|||
161623581|NCT02971683|583670611|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
161623582|NCT02971683|583670612|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
161623583|NCT02971683|583670611|FG000|Long-Term Open Label|Adverse Event|1|||
161623584|NCT02971683|583670612|FG001|Long-Term Open Label|Adverse Event|2|||
161623585|NCT02971683|583670611|FG000|Long-Term Open Label|Lack of Efficacy|1|||
161623586|NCT02971683|583670612|FG001|Long-Term Open Label|Lack of Efficacy|1|||
161623587|NCT01699178|583670613|FG000|Overall Study|Adverse Event|1|||
161623588|NCT01699178|583670614|FG001|Overall Study|Adverse Event|5|||
161623589|NCT01699178|583670613|FG000|Overall Study|Lost to Follow-up|1|||
161623590|NCT01699178|583670614|FG001|Overall Study|Lost to Follow-up|6|||
161623591|NCT01699178|583670613|FG000|Overall Study|Non-compliance with Study Drug|3|||
161623592|NCT01699178|583670614|FG001|Overall Study|Non-compliance with Study Drug|1|||
161623593|NCT01699178|583670613|FG000|Overall Study|Physician Decision|1|||
161623594|NCT01699178|583670614|FG001|Overall Study|Physician Decision|0|||
161623595|NCT01699178|583670613|FG000|Overall Study|Withdrawal by Subject|4|||
161623596|NCT01699178|583670614|FG001|Overall Study|Withdrawal by Subject|12|||
161623597|NCT01699178|583670613|FG000|Overall Study|Hematocrit >54%|1|||
161623598|NCT01699178|583670614|FG001|Overall Study|Hematocrit >54%|1|||
161623599|NCT01699178|583670613|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
161623600|NCT01699178|583670614|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
161623601|NCT01699178|583670613|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
161623602|NCT01699178|583670614|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
161833081|NCT04403763|584429682|FG000|Stage 2A|Adverse Event|0|||
161833082|NCT04403763|584429683|FG001|Stage 2A|Adverse Event|0|||
161833083|NCT04403763|584429684|FG002|Stage 2A|Adverse Event|0|||
161833084|NCT04403763|584429685|FG003|Stage 2A|Adverse Event|0|||
161623603|NCT01468597|583670620|FG000|Overall Study|Found ineligible|17|||
161623604|NCT01468597|583670620|FG000|Overall Study|concomitant valves|12|||
161623605|NCT01468597|583670620|FG000|Overall Study|off-pump CABG|1|||
161623606|NCT01468597|583670620|FG000|Overall Study|no platelet function data|5|||
161623607|NCT00912964|583670621|FG000|Overall Study|Eligibility criterion not met|1|||
161623608|NCT00912964|583670622|FG001|Overall Study|Eligibility criterion not met|1|||
161623609|NCT00912964|583670623|FG002|Overall Study|Eligibility criterion not met|0|||
161623610|NCT00912964|583670621|FG000|Overall Study|Adverse Event|15|||
161623611|NCT00912964|583670622|FG001|Overall Study|Adverse Event|18|||
161623612|NCT00912964|583670623|FG002|Overall Study|Adverse Event|12|||
161623613|NCT00912964|583670621|FG000|Overall Study|Lack of Efficacy|11|||
161623614|NCT00912964|583670622|FG001|Overall Study|Lack of Efficacy|4|||
161623615|NCT00912964|583670623|FG002|Overall Study|Lack of Efficacy|3|||
161623616|NCT00912964|583670621|FG000|Overall Study|Withdrawal by Subject|20|||
161623617|NCT00912964|583670622|FG001|Overall Study|Withdrawal by Subject|12|||
161833085|NCT04403763|584429686|FG004|Stage 2A|Adverse Event|0|||
161684951|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
161684952|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
161684953|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
161623618|NCT00912964|583670623|FG002|Overall Study|Withdrawal by Subject|18|||
161623619|NCT00912964|583670621|FG000|Overall Study|Lost to Follow-up|4|||
161623620|NCT00912964|583670622|FG001|Overall Study|Lost to Follow-up|3|||
161623621|NCT00912964|583670623|FG002|Overall Study|Lost to Follow-up|3|||
161623622|NCT00912964|583670621|FG000|Overall Study|Protocol Violation|5|||
161623623|NCT00912964|583670622|FG001|Overall Study|Protocol Violation|3|||
161623624|NCT00912964|583670623|FG002|Overall Study|Protocol Violation|8|||
161623625|NCT00912964|583670621|FG000|Overall Study|Taking exclusionary medications|7|||
161623626|NCT00912964|583670622|FG001|Overall Study|Taking exclusionary medications|4|||
161623627|NCT00912964|583670623|FG002|Overall Study|Taking exclusionary medications|8|||
161623628|NCT00912964|583670621|FG000|Overall Study|Medical History|1|||
161623629|NCT00912964|583670622|FG001|Overall Study|Medical History|0|||
161623630|NCT00912964|583670623|FG002|Overall Study|Medical History|0|||
161623631|NCT00912964|583670621|FG000|Overall Study|Non-compliance with study procedures|2|||
161623632|NCT00912964|583670622|FG001|Overall Study|Non-compliance with study procedures|0|||
161623633|NCT00912964|583670623|FG002|Overall Study|Non-compliance with study procedures|0|||
161623634|NCT00912964|583670621|FG000|Overall Study|Violation of exclusion criterion|0|||
161623635|NCT00912964|583670622|FG001|Overall Study|Violation of exclusion criterion|0|||
161623636|NCT00912964|583670623|FG002|Overall Study|Violation of exclusion criterion|2|||
161623637|NCT00912964|583670621|FG000|Overall Study|Randomized but never received study drug|0|||
161623638|NCT00912964|583670622|FG001|Overall Study|Randomized but never received study drug|1|||
161623639|NCT00912964|583670623|FG002|Overall Study|Randomized but never received study drug|0|||
161623640|NCT00645411|583670626|FG000|Overall Study|Adverse Event|0|||
161623641|NCT00645411|583670627|FG001|Overall Study|Adverse Event|0|||
161623642|NCT00645411|583670628|FG002|Overall Study|Adverse Event|0|||
161623643|NCT00645411|583670629|FG003|Overall Study|Adverse Event|2|||
161623644|NCT00645411|583670626|FG000|Overall Study|Withdrawal by Subject|2|||
161623645|NCT00645411|583670627|FG001|Overall Study|Withdrawal by Subject|1|||
161623646|NCT00645411|583670628|FG002|Overall Study|Withdrawal by Subject|19|||
161623647|NCT00645411|583670629|FG003|Overall Study|Withdrawal by Subject|21|||
161623648|NCT00645411|583670626|FG000|Overall Study|Lost to Follow-up|10|||
161684954|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
161684955|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
161684956|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
161684957|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
161684958|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
161623649|NCT00645411|583670627|FG001|Overall Study|Lost to Follow-up|5|||
161623650|NCT00645411|583670628|FG002|Overall Study|Lost to Follow-up|124|||
161623651|NCT00645411|583670629|FG003|Overall Study|Lost to Follow-up|75|||
161623652|NCT00645411|583670626|FG000|Overall Study|Protocol Violation|1|||
161623653|NCT00645411|583670627|FG001|Overall Study|Protocol Violation|0|||
161623654|NCT00645411|583670628|FG002|Overall Study|Protocol Violation|1|||
161623655|NCT00645411|583670629|FG003|Overall Study|Protocol Violation|0|||
161623656|NCT00645411|583670626|FG000|Overall Study|Inappropriate enrollment|0|||
161623657|NCT00645411|583670627|FG001|Overall Study|Inappropriate enrollment|0|||
161623658|NCT00645411|583670628|FG002|Overall Study|Inappropriate enrollment|4|||
161623659|NCT00645411|583670629|FG003|Overall Study|Inappropriate enrollment|1|||
161623660|NCT00645411|583670626|FG000|Overall Study|Unable to classify|0|||
161623661|NCT00645411|583670627|FG001|Overall Study|Unable to classify|0|||
161623662|NCT00645411|583670628|FG002|Overall Study|Unable to classify|3|||
161623663|NCT00645411|583670629|FG003|Overall Study|Unable to classify|4|||
161623664|NCT03100370|583670633|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161623665|NCT03100370|583670634|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161623666|NCT03100370|583670635|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161623667|NCT03100370|583670636|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161623668|NCT03100370|583670637|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161623669|NCT03100370|583670638|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161623670|NCT02674399|583670639|FG000|Overall Study|Lost to Follow-up|2|||
161623671|NCT02674399|583670640|FG001|Overall Study|Lost to Follow-up|0|||
161623672|NCT01199302|583670644|FG000|Overall Study|Adverse Event|1|||
161623673|NCT01199302|583670645|FG001|Overall Study|Adverse Event|1|||
161623674|NCT01199302|583670646|FG002|Overall Study|Adverse Event|2|||
161623675|NCT01199302|583670647|FG003|Overall Study|Adverse Event|0|||
161623676|NCT01199302|583670644|FG000|Overall Study|Withdrawal by Subject|2|||
161623677|NCT01199302|583670645|FG001|Overall Study|Withdrawal by Subject|2|||
161623678|NCT01199302|583670646|FG002|Overall Study|Withdrawal by Subject|3|||
161623679|NCT01199302|583670647|FG003|Overall Study|Withdrawal by Subject|0|||
161623680|NCT01199302|583670644|FG000|Overall Study|Disease Progression|3|||
161623681|NCT01199302|583670645|FG001|Overall Study|Disease Progression|4|||
161623682|NCT01199302|583670646|FG002|Overall Study|Disease Progression|4|||
161623683|NCT01199302|583670647|FG003|Overall Study|Disease Progression|2|||
161623684|NCT01199302|583670644|FG000|Overall Study|Study Termination|13|||
161623685|NCT01199302|583670645|FG001|Overall Study|Study Termination|8|||
161623686|NCT01199302|583670646|FG002|Overall Study|Study Termination|11|||
161623687|NCT01199302|583670647|FG003|Overall Study|Study Termination|9|||
161623688|NCT01199302|583670644|FG000|Overall Study|Lost to Follow-up|0|||
161623689|NCT01199302|583670645|FG001|Overall Study|Lost to Follow-up|1|||
161623690|NCT01199302|583670646|FG002|Overall Study|Lost to Follow-up|0|||
161623691|NCT01199302|583670647|FG003|Overall Study|Lost to Follow-up|0|||
161623692|NCT01199302|583670644|FG000|Overall Study|Other|1|||
161623693|NCT01199302|583670645|FG001|Overall Study|Other|0|||
161684959|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
161684960|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
161684961|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
161684962|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
161684963|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Death|1|||
161684964|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Death|1|||
161684965|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Death|1|||
161684966|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
161684967|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
161684968|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
161684969|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
161684970|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
161684971|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
161684972|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
161684973|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
161684974|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
161684975|NCT00405067|583899608|FG000|Overall Study|Adverse Event|4|||
161684976|NCT00405067|583899609|FG001|Overall Study|Adverse Event|9|||
161684977|NCT00405067|583899610|FG002|Overall Study|Adverse Event|4|||
161684978|NCT00405067|583899608|FG000|Overall Study|Lost to Follow-up|0|||
161684979|NCT00405067|583899609|FG001|Overall Study|Lost to Follow-up|0|||
161684980|NCT00405067|583899610|FG002|Overall Study|Lost to Follow-up|1|||
161684981|NCT00552175|583899611|FG000|Overall Study|Lack of Efficacy|2|||
161684982|NCT00552175|583899612|FG001|Overall Study|Lack of Efficacy|0|||
161623694|NCT01199302|583670646|FG002|Overall Study|Other|0|||
161623695|NCT01199302|583670647|FG003|Overall Study|Other|0|||
161623696|NCT03070301|583670648|FG000|Overall Study|Progression of disease|16|||
161623697|NCT03070301|583670648|FG000|Overall Study|Physician Decision|3|||
161623698|NCT03070301|583670648|FG000|Overall Study|Withdrawal by Subject|1|||
161623699|NCT03820024|583670649|FG000|Overall Study|Physician Decision|1|||
161623700|NCT03820024|583670650|FG001|Overall Study|Physician Decision|2|||
161623701|NCT00676195|583671956|FG000|Overall Study|Lost to Follow-up|1|||
161623702|NCT00676195|583671956|FG000|Overall Study|Adverse Event|1|||
161623703|NCT00676195|583671956|FG000|Overall Study|Physician Decision|1|||
161623704|NCT00814632|583671957|FG000|Overall Study|Lack of Efficacy|2|||
161623705|NCT03978130|583671963|FG000|Overall Study|Lost to Follow-up|13|||
161623706|NCT03978130|583671964|FG001|Overall Study|Lost to Follow-up|14|||
161623707|NCT03978130|583671963|FG000|Overall Study|Withdrawal by Subject|12|||
161623708|NCT03978130|583671964|FG001|Overall Study|Withdrawal by Subject|2|||
161623709|NCT03978130|583671963|FG000|Overall Study|Adverse Event|2|||
161623710|NCT03978130|583671964|FG001|Overall Study|Adverse Event|1|||
161623711|NCT04198428|583671965|FG000|Overall Study|Withdrawal by Subject|150|||
161623712|NCT04198428|583671966|FG001|Overall Study|Withdrawal by Subject|156|||
161623713|NCT02069366|583671975|FG000|Overall Study|Lost to Follow-up|0|||
161623714|NCT02069366|583671976|FG001|Overall Study|Lost to Follow-up|0|||
161623715|NCT02069366|583671977|FG002|Overall Study|Lost to Follow-up|1|||
161623716|NCT02069366|583671978|FG003|Overall Study|Lost to Follow-up|0|||
161623717|NCT02069366|583671979|FG004|Overall Study|Lost to Follow-up|0|||
161623718|NCT02069366|583671980|FG005|Overall Study|Lost to Follow-up|2|||
161623719|NCT02069366|583671975|FG000|Overall Study|Protocol Violation|0|||
161623720|NCT02069366|583671976|FG001|Overall Study|Protocol Violation|0|||
161623721|NCT02069366|583671977|FG002|Overall Study|Protocol Violation|1|||
161623722|NCT02069366|583671978|FG003|Overall Study|Protocol Violation|0|||
161623723|NCT02069366|583671979|FG004|Overall Study|Protocol Violation|0|||
161623724|NCT02069366|583671980|FG005|Overall Study|Protocol Violation|0|||
161623725|NCT02069366|583671975|FG000|Overall Study|Withdrawal by Subject|1|||
161623726|NCT02069366|583671976|FG001|Overall Study|Withdrawal by Subject|0|||
161623727|NCT02069366|583671977|FG002|Overall Study|Withdrawal by Subject|1|||
161623728|NCT02069366|583671978|FG003|Overall Study|Withdrawal by Subject|2|||
161623729|NCT02069366|583671979|FG004|Overall Study|Withdrawal by Subject|0|||
161623730|NCT02069366|583671980|FG005|Overall Study|Withdrawal by Subject|0|||
161623731|NCT02030847|583671982|FG000|Overall Study|Death|10|||
161623732|NCT02030847|583671982|FG000|Overall Study|Disease Progression|15|||
161623733|NCT02030847|583671982|FG000|Overall Study|New Cancer Therapy|8|||
161623734|NCT02030847|583671982|FG000|Overall Study|Physician Decision|3|||
161623735|NCT02030847|583671982|FG000|Overall Study|Withdrawal by Subject|1|||
161623736|NCT00168805|583671983|FG000|Overall Study|Adverse Event|7|||
161623737|NCT00168805|583671984|FG001|Overall Study|Adverse Event|11|||
161623738|NCT00168805|583671985|FG002|Overall Study|Adverse Event|16|||
161623739|NCT00168805|583671983|FG000|Overall Study|Protocol Violation|12|||
161623740|NCT00168805|583671984|FG001|Overall Study|Protocol Violation|11|||
161623741|NCT00168805|583671985|FG002|Overall Study|Protocol Violation|8|||
161623742|NCT00168805|583671983|FG000|Overall Study|Lost to Follow-up|12|||
161623743|NCT00168805|583671984|FG001|Overall Study|Lost to Follow-up|17|||
161684983|NCT00552175|583899613|FG002|Overall Study|Lack of Efficacy|1|||
161684984|NCT00552175|583899611|FG000|Overall Study|Adverse Event|9|||
161684985|NCT00552175|583899612|FG001|Overall Study|Adverse Event|9|||
161684986|NCT00552175|583899613|FG002|Overall Study|Adverse Event|10|||
161684987|NCT00552175|583899611|FG000|Overall Study|Withdrawal by Subject|2|||
161684988|NCT00552175|583899612|FG001|Overall Study|Withdrawal by Subject|2|||
161684989|NCT00552175|583899613|FG002|Overall Study|Withdrawal by Subject|1|||
161684990|NCT00552175|583899611|FG000|Overall Study|Lost to Follow-up|0|||
161684991|NCT00552175|583899612|FG001|Overall Study|Lost to Follow-up|0|||
161684992|NCT00552175|583899613|FG002|Overall Study|Lost to Follow-up|1|||
161684993|NCT00552175|583899611|FG000|Overall Study|Entry Criteria Not Met|1|||
161684994|NCT00552175|583899612|FG001|Overall Study|Entry Criteria Not Met|1|||
161684995|NCT00552175|583899613|FG002|Overall Study|Entry Criteria Not Met|0|||
161684996|NCT00552175|583899611|FG000|Overall Study|Reason Not Specified|3|||
161684997|NCT00552175|583899612|FG001|Overall Study|Reason Not Specified|1|||
161684998|NCT00552175|583899613|FG002|Overall Study|Reason Not Specified|1|||
161833086|NCT04403763|584429687|FG005|Stage 2A|Adverse Event|0|||
161623744|NCT00168805|583671985|FG002|Overall Study|Lost to Follow-up|11|||
161623745|NCT00168805|583671983|FG000|Overall Study|Withdrawal by Subject|16|||
161684999|NCT00631020|583899614|FG000|Overall Study|Lost to Follow-up|7|||
161685000|NCT00631020|583899614|FG000|Overall Study|Incarcerated|1|||
161623746|NCT00168805|583671984|FG001|Overall Study|Withdrawal by Subject|18|||
161623747|NCT00168805|583671985|FG002|Overall Study|Withdrawal by Subject|21|||
161623748|NCT00168805|583671983|FG000|Overall Study|Other|24|||
161623749|NCT00168805|583671984|FG001|Overall Study|Other|21|||
161623750|NCT00168805|583671985|FG002|Overall Study|Other|22|||
161623751|NCT00168805|583671983|FG000|Treatment|Adverse Event|25|||
161623752|NCT00168805|583671984|FG001|Treatment|Adverse Event|26|||
161623753|NCT00168805|583671985|FG002|Treatment|Adverse Event|32|||
161623754|NCT00168805|583671983|FG000|Treatment|Protocol Violation|3|||
161623755|NCT00168805|583671984|FG001|Treatment|Protocol Violation|5|||
161623756|NCT00168805|583671985|FG002|Treatment|Protocol Violation|5|||
161623757|NCT00168805|583671983|FG000|Treatment|Withdrawal by Subject|3|||
161623758|NCT00168805|583671984|FG001|Treatment|Withdrawal by Subject|7|||
161623759|NCT00168805|583671985|FG002|Treatment|Withdrawal by Subject|8|||
161623760|NCT00168805|583671983|FG000|Treatment|Other|18|||
161623761|NCT00168805|583671984|FG001|Treatment|Other|18|||
161623762|NCT00168805|583671985|FG002|Treatment|Other|17|||
161623763|NCT02995733|583671986|FG000|Overall Study|Study site closed|9|||
161623764|NCT02995733|583671987|FG001|Overall Study|Study site closed|10|||
161623765|NCT02995733|583671986|FG000|Overall Study|Death|3|||
161623766|NCT02995733|583671987|FG001|Overall Study|Death|4|||
161623767|NCT02995733|583671986|FG000|Overall Study|Withdrawal by Subject|6|||
161685001|NCT02614859|583899615|FG000|Overall Study|Physician Decision|0|||
161685002|NCT02614859|583899616|FG001|Overall Study|Physician Decision|1|||
161685003|NCT04677959|583899618|FG000|Overall Study|Adverse Event|1|||
161685004|NCT04677959|583899619|FG001|Overall Study|Adverse Event|9|||
161685005|NCT04677959|583899618|FG000|Overall Study|Withdrawal by Subject|2|||
161685006|NCT04677959|583899619|FG001|Overall Study|Withdrawal by Subject|15|||
161685007|NCT04677959|583899618|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161685008|NCT04677959|583899619|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161685009|NCT04677959|583899618|FG000|Overall Study|Non-compliance with study drug|0|||
161685010|NCT04677959|583899619|FG001|Overall Study|Non-compliance with study drug|2|||
161685011|NCT04677959|583899618|FG000|Overall Study|Protocol deviation|0|||
161685012|NCT04677959|583899619|FG001|Overall Study|Protocol deviation|11|||
161685013|NCT04677959|583899618|FG000|Overall Study|Lost to Follow-up|9|||
161685014|NCT04677959|583899619|FG001|Overall Study|Lost to Follow-up|13|||
161685015|NCT04677959|583899618|FG000|Overall Study|Other than specified|0|||
161685016|NCT04677959|583899619|FG001|Overall Study|Other than specified|8|||
161685017|NCT01399788|583899626|FG000|First Intervention Period|Adverse Event|1|||
161685018|NCT01399788|583899627|FG001|First Intervention Period|Adverse Event|0|||
161685019|NCT01389752|583899628|FG000|Study Period 1|Sponsor decision|0|||
161685020|NCT01389752|583899629|FG001|Study Period 1|Sponsor decision|2|||
161685021|NCT01389752|583899628|FG000|Study Period 2|Sponsor decision|1|||
161685022|NCT01389752|583899629|FG001|Study Period 2|Sponsor decision|0|||
161685023|NCT01576549|583899630|FG000|Overall Study|Sponsor Decision|2|||
161685024|NCT00053417|583899631|FG000|Overall Study|Adverse Event|1|||
161685025|NCT00053417|583899632|FG001|Overall Study|Adverse Event|0|||
161685026|NCT00053417|583899633|FG002|Overall Study|Adverse Event|1|||
161685027|NCT00053417|583899634|FG003|Overall Study|Adverse Event|5|||
161685028|NCT00053417|583899631|FG000|Overall Study|Non-Compliance|0|||
161685029|NCT00053417|583899632|FG001|Overall Study|Non-Compliance|0|||
161685030|NCT00053417|583899633|FG002|Overall Study|Non-Compliance|0|||
161685031|NCT00053417|583899634|FG003|Overall Study|Non-Compliance|1|||
161685032|NCT00053417|583899631|FG000|Overall Study|Withdrawal by Subject|0|||
161685033|NCT00053417|583899632|FG001|Overall Study|Withdrawal by Subject|1|||
161685034|NCT00053417|583899633|FG002|Overall Study|Withdrawal by Subject|0|||
161685035|NCT00053417|583899634|FG003|Overall Study|Withdrawal by Subject|0|||
161685036|NCT00053417|583899631|FG000|Overall Study|Lost to Follow-up|1|||
161623768|NCT02995733|583671987|FG001|Overall Study|Withdrawal by Subject|2|||
161623769|NCT02995733|583671986|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
161623770|NCT02995733|583671987|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
161623771|NCT02995733|583671986|FG000|Overall Study|Lost to Follow-up|48|||
161623772|NCT02995733|583671987|FG001|Overall Study|Lost to Follow-up|37|||
161623773|NCT02995733|583671986|FG000|Overall Study|Other|0|||
161623774|NCT02995733|583671987|FG001|Overall Study|Other|1|||
161623775|NCT03785210|583671988|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
161623776|NCT03785210|583671989|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
161623777|NCT04468633|583671990|FG000|Overall Study|Withdrawal by Subject|4|||
161623778|NCT04468633|583671991|FG001|Overall Study|Withdrawal by Subject|0|||
161623779|NCT00460434|583671994|FG000|Overall Study|Lost to Follow-up|3|||
161623780|NCT00460434|583671995|FG001|Overall Study|Lost to Follow-up|7|||
161623781|NCT01498445|583671996|FG000|Overall Study|Lack of Efficacy|0|||
161685037|NCT00053417|583899632|FG001|Overall Study|Lost to Follow-up|1|||
161685038|NCT00053417|583899633|FG002|Overall Study|Lost to Follow-up|0|||
161685039|NCT00053417|583899634|FG003|Overall Study|Lost to Follow-up|0|||
161623782|NCT01498445|583671997|FG001|Overall Study|Lack of Efficacy|0|||
161623783|NCT01498445|583671998|FG002|Overall Study|Lack of Efficacy|1|||
161623784|NCT01498445|583671999|FG003|Overall Study|Lack of Efficacy|2|||
161685040|NCT04081363|583899635|FG000|Overall Study|Withdrawal by Subject|1|||
161685041|NCT04081363|583899636|FG001|Overall Study|Withdrawal by Subject|0|||
161685042|NCT02409290|583899637|FG000|Overall Study|Protocol Violation|3|||
161623785|NCT01498445|583672000|FG004|Overall Study|Lack of Efficacy|0|||
161623786|NCT01498445|583672001|FG005|Overall Study|Lack of Efficacy|0|||
161623787|NCT01498445|583671996|FG000|Overall Study|Screen Failure|0|||
161685043|NCT02409290|583899638|FG001|Overall Study|Protocol Violation|6|||
161833087|NCT04403763|584429688|FG006|Stage 2A|Adverse Event|1|||
161833088|NCT00350402|584429689|FG000|Overall Study|Lost to Follow-up|1|||
161833089|NCT00350402|584429690|FG001|Overall Study|Lost to Follow-up|1|||
161833090|NCT01376310|584429691|FG000|Overall Study|Study closed/terminated|1|||
161833091|NCT01376310|584429692|FG001|Overall Study|Study closed/terminated|2|||
161833092|NCT01376310|584429691|FG000|Overall Study|Withdrawal by Subject|8|||
161833093|NCT01376310|584429692|FG001|Overall Study|Withdrawal by Subject|2|||
161833094|NCT01376310|584429691|FG000|Overall Study|Physician Decision|26|||
161833095|NCT01376310|584429692|FG001|Overall Study|Physician Decision|7|||
161833096|NCT01376310|584429691|FG000|Overall Study|Lost to Follow-up|1|||
161833097|NCT01376310|584429692|FG001|Overall Study|Lost to Follow-up|0|||
161833098|NCT01534637|584429695|FG000|Overall Study|Physician Decision|3|||
161833099|NCT01534637|584429695|FG000|Overall Study|Lack of Efficacy|3|||
161833100|NCT01534637|584429695|FG000|Overall Study|Withdrawal by Subject|1|||
161833101|NCT01534637|584429695|FG000|Overall Study|Adverse Event|1|||
161833102|NCT01534637|584429695|FG000|Overall Study|Liver Mets before treatment|1|||
161833103|NCT00834899|584429696|FG000|Overall Study|Withdrawal by Subject|1|||
161833104|NCT00834899|584429697|FG001|Overall Study|Withdrawal by Subject|1|||
161833105|NCT00606502|584429698|FG000|Randomization|Randomized but not treated|3|||
161833106|NCT00606502|584429699|FG001|Randomization|Randomized but not treated|0|||
161833107|NCT00606502|584429698|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
161833108|NCT00606502|584429699|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
161833109|NCT02377921|584429702|FG000|Overall Study|Subject non-compliance|1|||
161833110|NCT02377921|584429703|FG001|Overall Study|Subject non-compliance|1|||
161833111|NCT02443545|584429704|FG000|Overall Study|Adverse Event|1|||
161833112|NCT02443545|584429705|FG001|Overall Study|Adverse Event|1|||
161833113|NCT02443545|584429704|FG000|Overall Study|Lost to Follow-up|0|||
161833114|NCT02443545|584429705|FG001|Overall Study|Lost to Follow-up|2|||
161833115|NCT02443545|584429704|FG000|Overall Study|Physician Decision|3|||
161833116|NCT02443545|584429705|FG001|Overall Study|Physician Decision|0|||
161833117|NCT02443545|584429704|FG000|Overall Study|Protocol Violation|8|||
161833118|NCT02443545|584429705|FG001|Overall Study|Protocol Violation|1|||
161833119|NCT02443545|584429704|FG000|Overall Study|Pregnancy|1|||
161833120|NCT02443545|584429705|FG001|Overall Study|Pregnancy|1|||
161833121|NCT02443545|584429704|FG000|Overall Study|Withdrawal by Subject|6|||
161833122|NCT02443545|584429705|FG001|Overall Study|Withdrawal by Subject|3|||
161833123|NCT02443545|584429704|FG000|Overall Study|Termination of study|20|||
161833124|NCT02443545|584429705|FG001|Overall Study|Termination of study|11|||
161833125|NCT04179019|584429711|FG000|Overall Study|Lost to Follow-up|2|||
161833126|NCT04179019|584429711|FG000|Overall Study|Physician Decision|2|||
161833127|NCT04179019|584429711|FG000|Overall Study|Withdrawal by Subject|5|||
161833128|NCT04179019|584429711|FG000|Overall Study|Adverse Event|4|||
161833129|NCT01560507|584429712|FG000|Overall Study|Lost to Follow-up|3|||
161833130|NCT01560507|584429713|FG001|Overall Study|Lost to Follow-up|1|||
161833131|NCT01560507|584429714|FG002|Overall Study|Lost to Follow-up|2|||
161833132|NCT01560507|584429712|FG000|Overall Study|Withdrawal by Subject|1|||
161833133|NCT01560507|584429713|FG001|Overall Study|Withdrawal by Subject|1|||
161833134|NCT01560507|584429714|FG002|Overall Study|Withdrawal by Subject|0|||
161833135|NCT00440115|584429715|FG000|Overall Study|Death|7|||
161833136|NCT00440115|584429716|FG001|Overall Study|Death|9|||
161833137|NCT00440115|584429717|FG002|Overall Study|Death|5|||
161833138|NCT00440115|584429715|FG000|Overall Study|Incarceration|0|||
161833139|NCT00440115|584429716|FG001|Overall Study|Incarceration|2|||
161833140|NCT00440115|584429717|FG002|Overall Study|Incarceration|1|||
161833141|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
161833142|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
161833143|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
161833144|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
161833145|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
161623788|NCT01498445|583671997|FG001|Overall Study|Screen Failure|0|||
161623789|NCT01498445|583671998|FG002|Overall Study|Screen Failure|0|||
161833146|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
161833147|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
161833148|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
161833149|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
161833150|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
161623790|NCT01498445|583671999|FG003|Overall Study|Screen Failure|0|||
161833151|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
161833152|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
161833153|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
161833154|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
161833155|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
161833156|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
161623791|NCT01498445|583672000|FG004|Overall Study|Screen Failure|1|||
161623792|NCT01498445|583672001|FG005|Overall Study|Screen Failure|1|||
161623793|NCT02722278|583672002|FG000|Overall Study|Withdrawal by Subject|5|||
161623794|NCT02722278|583672003|FG001|Overall Study|Withdrawal by Subject|3|||
161623795|NCT02722278|583672002|FG000|Overall Study|Adverse Event|4|||
161623796|NCT02722278|583672003|FG001|Overall Study|Adverse Event|1|||
161623797|NCT02722278|583672002|FG000|Overall Study|Lost to Follow-up|2|||
161623798|NCT02722278|583672003|FG001|Overall Study|Lost to Follow-up|0|||
161623799|NCT02722278|583672002|FG000|Overall Study|Protocol Violation|1|||
161623800|NCT02722278|583672003|FG001|Overall Study|Protocol Violation|0|||
161623801|NCT02722278|583672002|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
161623802|NCT02722278|583672003|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
161623803|NCT02722278|583672002|FG000|Overall Study|Subject declined after tx assignment|0|||
161623804|NCT02722278|583672003|FG001|Overall Study|Subject declined after tx assignment|1|||
161623805|NCT02722278|583672002|FG000|Overall Study|Site closure not study related|0|||
161623806|NCT02722278|583672003|FG001|Overall Study|Site closure not study related|1|||
161623807|NCT02465866|583672004|FG000|Period 3|Withdrawal by Subject|0|||
161623808|NCT02465866|583672005|FG001|Period 3|Withdrawal by Subject|1|||
161623809|NCT02465866|583672006|FG002|Period 3|Withdrawal by Subject|0|||
161623810|NCT02465866|583672007|FG003|Period 3|Withdrawal by Subject|0|||
161623811|NCT00203502|583672008|FG000|Overall Study|Death|1|||
161623812|NCT02023099|583672009|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
161623813|NCT02023099|583672010|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
161623814|NCT02023099|583672011|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
161623815|NCT02023099|583672009|FG000|Overall Study|Withdrawn Consent|3|||
161623816|NCT02023099|583672010|FG001|Overall Study|Withdrawn Consent|0|||
161623817|NCT02023099|583672011|FG002|Overall Study|Withdrawn Consent|1|||
161623818|NCT02023099|583672009|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
161623819|NCT02023099|583672010|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
161623820|NCT02023099|583672011|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
161623821|NCT01469819|583672012|FG000|Overall Study|Withdrawal by Subject|1|||
161623822|NCT01469819|583672012|FG000|Overall Study|Did not meet inclusionary criteria|2|||
161623823|NCT01469819|583672012|FG000|Overall Study|Could not swallow SmartPill|2|||
161623824|NCT01469819|583672012|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
161623825|NCT00561678|583672013|FG000|Overall Study|Withdrawal by Subject|4|||
161623826|NCT00561678|583672014|FG001|Overall Study|Withdrawal by Subject|3|||
161623827|NCT00561678|583672013|FG000|Overall Study|surgery cancelled|1|||
161623828|NCT00561678|583672014|FG001|Overall Study|surgery cancelled|1|||
161623829|NCT00561678|583672013|FG000|Overall Study|surgery rescheduled to different site|2|||
161623830|NCT00561678|583672014|FG001|Overall Study|surgery rescheduled to different site|2|||
161623831|NCT00561678|583672013|FG000|Overall Study|anesthesia provider refusal|1|||
161623832|NCT00561678|583672014|FG001|Overall Study|anesthesia provider refusal|0|||
161623833|NCT01403805|583672015|FG000|Overall Study|Withdrawal by Subject|0|||
161623834|NCT01403805|583672016|FG001|Overall Study|Withdrawal by Subject|4|||
161623835|NCT01403805|583672015|FG000|Overall Study|Lost to Follow-up|0|||
161623836|NCT01403805|583672016|FG001|Overall Study|Lost to Follow-up|2|||
161623837|NCT01403805|583672015|FG000|Overall Study|Death|0|||
161623838|NCT01403805|583672016|FG001|Overall Study|Death|1|||
161623839|NCT01695993|583672019|FG000|Overall Study|Lost to Follow-up|2|||
161623840|NCT01695993|583672020|FG001|Overall Study|Lost to Follow-up|1|||
161623841|NCT01695993|583672021|FG002|Overall Study|Lost to Follow-up|3|||
161623842|NCT01695993|583672019|FG000|Overall Study|Withdrawal by Subject|2|||
161623843|NCT01695993|583672020|FG001|Overall Study|Withdrawal by Subject|2|||
161685044|NCT02409290|583899639|FG002|Overall Study|Protocol Violation|9|||
161685045|NCT02409290|583899640|FG003|Overall Study|Protocol Violation|4|||
161623844|NCT01695993|583672021|FG002|Overall Study|Withdrawal by Subject|2|||
161623845|NCT01695993|583672019|FG000|Overall Study|To ill to continue|1|||
161623846|NCT01695993|583672020|FG001|Overall Study|To ill to continue|2|||
161623847|NCT01695993|583672021|FG002|Overall Study|To ill to continue|0|||
161623848|NCT01695993|583672019|FG000|Overall Study|Changed Medical Facility|0|||
161623849|NCT01695993|583672020|FG001|Overall Study|Changed Medical Facility|0|||
161623850|NCT01695993|583672021|FG002|Overall Study|Changed Medical Facility|1|||
161623851|NCT00472199|583672022|FG000|Overall Study|Adverse Event|19|||
161623852|NCT00472199|583672023|FG001|Overall Study|Adverse Event|23|||
161623853|NCT00472199|583672022|FG000|Overall Study|Lack of Efficacy|4|||
161623854|NCT00472199|583672023|FG001|Overall Study|Lack of Efficacy|25|||
161623855|NCT00472199|583672022|FG000|Overall Study|Lost to Follow-up|2|||
161623856|NCT00472199|583672023|FG001|Overall Study|Lost to Follow-up|4|||
161623857|NCT00472199|583672022|FG000|Overall Study|Protocol Violation|3|||
161623858|NCT00472199|583672023|FG001|Overall Study|Protocol Violation|2|||
161623859|NCT00472199|583672022|FG000|Overall Study|Withdrawal by Subject|6|||
161623860|NCT00472199|583672023|FG001|Overall Study|Withdrawal by Subject|5|||
161623861|NCT00472199|583672022|FG000|Overall Study|personal reason|0|||
161623862|NCT00472199|583672023|FG001|Overall Study|personal reason|1|||
161685046|NCT02409290|583899637|FG000|Overall Study|No positive culture/no baseline sample|3|||
161623863|NCT00472199|583672022|FG000|Overall Study|patient was asymptomatic|1|||
161623864|NCT00472199|583672023|FG001|Overall Study|patient was asymptomatic|0|||
161623865|NCT01601821|583672027|FG000|Overall Study|Death|2|||
161623866|NCT01601821|583672028|FG001|Overall Study|Death|5|||
161623867|NCT01601821|583672027|FG000|Overall Study|Protocol Violation|2|||
161623868|NCT01601821|583672028|FG001|Overall Study|Protocol Violation|2|||
161623869|NCT01601821|583672027|FG000|Overall Study|Lost to Follow-up|6|||
161623870|NCT01601821|583672028|FG001|Overall Study|Lost to Follow-up|14|||
161623871|NCT01601821|583672027|FG000|Overall Study|Withdrawal by Subject|1|||
161623872|NCT01601821|583672028|FG001|Overall Study|Withdrawal by Subject|0|||
161623873|NCT01601821|583672027|FG000|Overall Study|Graft Loss|6|||
161623874|NCT01601821|583672028|FG001|Overall Study|Graft Loss|6|||
161623875|NCT01601821|583672027|FG000|Overall Study|Study Events|7|||
161623876|NCT01601821|583672028|FG001|Overall Study|Study Events|1|||
161623877|NCT01601821|583672027|FG000|Overall Study|Other|5|||
161623878|NCT01601821|583672028|FG001|Overall Study|Other|1|||
161623879|NCT01901302|583672029|FG000|Overall Study|Adverse Event|2|||
161623880|NCT01901302|583672030|FG001|Overall Study|Adverse Event|1|||
161623881|NCT01901302|583672029|FG000|Overall Study|Lack of Efficacy|0|||
161623882|NCT01901302|583672030|FG001|Overall Study|Lack of Efficacy|2|||
161623883|NCT01901302|583672029|FG000|Overall Study|Study Terminated by Sponsor|23|||
161623884|NCT01901302|583672030|FG001|Overall Study|Study Terminated by Sponsor|20|||
161623885|NCT01901302|583672029|FG000|Overall Study|Withdrawal by Subject|2|||
161623886|NCT01901302|583672030|FG001|Overall Study|Withdrawal by Subject|0|||
161623887|NCT03708744|583672034|FG000|Overall Study|Withdrawal by Subject|0|||
161623888|NCT03708744|583672035|FG001|Overall Study|Withdrawal by Subject|0|||
161623889|NCT03708744|583672036|FG002|Overall Study|Withdrawal by Subject|1|||
161623890|NCT03708744|583672037|FG003|Overall Study|Withdrawal by Subject|0|||
161623891|NCT03166215|583672044|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
161623892|NCT03166215|583672045|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
161623893|NCT03166215|583672046|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
161623894|NCT03166215|583672044|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
161623895|NCT03166215|583672045|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
161623896|NCT03166215|583672046|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
161623897|NCT04985604|583672049|FG000|Overall Study|Death|4|||
161623898|NCT04985604|583672050|FG001|Overall Study|Death|6|||
161623899|NCT04985604|583672049|FG000|Overall Study|Withdrawal by Subject|0|||
161623900|NCT04985604|583672050|FG001|Overall Study|Withdrawal by Subject|1|||
161623901|NCT04598776|583672051|FG000|Overall Study|Protocol Violation|5|||
161685047|NCT02409290|583899638|FG001|Overall Study|No positive culture/no baseline sample|9|||
161685048|NCT02409290|583899639|FG002|Overall Study|No positive culture/no baseline sample|6|||
161833157|NCT01688726|584429720|FG000|Overall Study|Adverse Event|1|||
161623902|NCT04598776|583672051|FG000|Overall Study|Physician Decision|4|||
161623903|NCT02282761|583672052|FG000|Overall Study|Death|0|||
161623904|NCT02282761|583672053|FG001|Overall Study|Death|0|||
161623905|NCT02282761|583672054|FG002|Overall Study|Death|1|||
161623906|NCT02282761|583672052|FG000|Overall Study|Adverse Event|6|||
161623907|NCT02282761|583672053|FG001|Overall Study|Adverse Event|2|||
161623908|NCT02282761|583672054|FG002|Overall Study|Adverse Event|0|||
161623909|NCT02282761|583672052|FG000|Overall Study|Lack of Efficacy|11|||
161623910|NCT02282761|583672053|FG001|Overall Study|Lack of Efficacy|6|||
161623911|NCT02282761|583672054|FG002|Overall Study|Lack of Efficacy|17|||
161623912|NCT02282761|583672052|FG000|Overall Study|Lost to Follow-up|2|||
161623913|NCT02282761|583672053|FG001|Overall Study|Lost to Follow-up|2|||
161623914|NCT02282761|583672054|FG002|Overall Study|Lost to Follow-up|1|||
161623915|NCT02282761|583672052|FG000|Overall Study|Physician Decision|0|||
161623916|NCT02282761|583672053|FG001|Overall Study|Physician Decision|0|||
161623917|NCT02282761|583672054|FG002|Overall Study|Physician Decision|2|||
161623918|NCT02282761|583672052|FG000|Overall Study|Withdrawal by Subject|8|||
161623919|NCT02282761|583672053|FG001|Overall Study|Withdrawal by Subject|10|||
161623920|NCT02282761|583672054|FG002|Overall Study|Withdrawal by Subject|16|||
161623921|NCT02282761|583672052|FG000|Overall Study|Other|3|||
161623922|NCT02282761|583672053|FG001|Overall Study|Other|2|||
161623923|NCT02282761|583672054|FG002|Overall Study|Other|1|||
161623924|NCT00658632|583672057|FG000|Overall Study|Adverse Event|13|||
161623925|NCT00658632|583672058|FG001|Overall Study|Adverse Event|11|||
161623926|NCT00658632|583672057|FG000|Overall Study|Lost to Follow-up|25|||
161623927|NCT00658632|583672058|FG001|Overall Study|Lost to Follow-up|23|||
161623928|NCT00658632|583672057|FG000|Overall Study|Withdrawal by Subject|10|||
161623929|NCT00658632|583672058|FG001|Overall Study|Withdrawal by Subject|7|||
161623930|NCT00658632|583672057|FG000|Overall Study|Lack of Efficacy|0|||
161623931|NCT00658632|583672058|FG001|Overall Study|Lack of Efficacy|1|||
161623932|NCT00658632|583672057|FG000|Overall Study|Withdrawal of consent|8|||
161623933|NCT00658632|583672058|FG001|Overall Study|Withdrawal of consent|14|||
161623934|NCT00658632|583672057|FG000|Overall Study|Pregnancy|1|||
161623935|NCT00658632|583672058|FG001|Overall Study|Pregnancy|1|||
161623936|NCT00658632|583672057|FG000|Overall Study|Other|7|||
161623937|NCT00658632|583672058|FG001|Overall Study|Other|8|||
161623938|NCT06312566|583672059|FG000|Overall Study|Protocol Violation|0|||
161623939|NCT06312566|583672060|FG001|Overall Study|Protocol Violation|1|||
161623940|NCT04551053|583672061|FG000|Overall Study|Death|10|||
161623941|NCT04551053|583672062|FG001|Overall Study|Death|9|||
161623942|NCT04551053|583672061|FG000|Overall Study|Lost to Follow-up|0|||
161623943|NCT04551053|583672062|FG001|Overall Study|Lost to Follow-up|2|||
161623944|NCT04551053|583672061|FG000|Overall Study|Study Terminated by Sponsor|57|||
161623945|NCT04551053|583672062|FG001|Overall Study|Study Terminated by Sponsor|65|||
161623946|NCT04551053|583672061|FG000|Overall Study|Withdrawal by Subject|12|||
161623947|NCT04551053|583672062|FG001|Overall Study|Withdrawal by Subject|5|||
161623948|NCT04551053|583672061|FG000|Overall Study|Adverse Event|2|||
161623949|NCT04551053|583672062|FG001|Overall Study|Adverse Event|0|||
161623950|NCT04551053|583672061|FG000|Overall Study|Lack of Efficacy|2|||
161623951|NCT04551053|583672062|FG001|Overall Study|Lack of Efficacy|1|||
161623952|NCT04551053|583672061|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
161623953|NCT04551053|583672062|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
161623954|NCT04551053|583672061|FG000|Overall Study|Splenapendectomi|1|||
161623955|NCT04551053|583672062|FG001|Overall Study|Splenapendectomi|0|||
161623956|NCT04551053|583672061|FG000|Overall Study|Medical Decision|1|||
161623957|NCT04551053|583672062|FG001|Overall Study|Medical Decision|1|||
161623958|NCT03861078|583672063|FG000|Overall Study|COVID-19 shut down|4|||
161623959|NCT03861078|583672063|FG000|Overall Study|Lost to Follow-up|1|||
161623960|NCT03861078|583672063|FG000|Overall Study|Protocol Violation|2|||
161623961|NCT03861078|583672063|FG000|Overall Study|lack of venous access|1|||
161623962|NCT04016415|583672065|FG000|Overall Study|Adverse Event|2|||
161623963|NCT04016415|583672066|FG001|Overall Study|Adverse Event|1|||
161623964|NCT04016415|583672065|FG000|Overall Study|Lost to Follow-up|6|||
161623965|NCT04016415|583672066|FG001|Overall Study|Lost to Follow-up|2|||
161623966|NCT04016415|583672065|FG000|Overall Study|Physician Decision|5|||
161623967|NCT04016415|583672066|FG001|Overall Study|Physician Decision|1|||
161623968|NCT04016415|583672065|FG000|Overall Study|Pregnancy|0|||
161623969|NCT04016415|583672066|FG001|Overall Study|Pregnancy|1|||
161623970|NCT04016415|583672065|FG000|Overall Study|Withdrawal by Subject|24|||
161623971|NCT04016415|583672066|FG001|Overall Study|Withdrawal by Subject|27|||
161623972|NCT04016415|583672065|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
161623973|NCT04016415|583672066|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
161623974|NCT03547167|583672067|FG000|Overall Study|Withdrawal by Subject|34|||
161623975|NCT03547167|583672068|FG001|Overall Study|Withdrawal by Subject|12|||
161623976|NCT03547167|583672067|FG000|Overall Study|Screen Failure|0|||
161623977|NCT03547167|583672068|FG001|Overall Study|Screen Failure|1|||
161623978|NCT03547167|583672067|FG000|Overall Study|Lost to Follow-up|59|||
161623979|NCT03547167|583672068|FG001|Overall Study|Lost to Follow-up|15|||
161623980|NCT03547167|583672067|FG000|Overall Study|Death|4|||
161623981|NCT03547167|583672068|FG001|Overall Study|Death|2|||
161623982|NCT01885559|583672069|FG000|Overall Study|Lost to Follow-up|15|||
161623983|NCT01885559|583672070|FG001|Overall Study|Lost to Follow-up|16|||
161623984|NCT01885559|583672069|FG000|Overall Study|Less than full participation|9|||
161623985|NCT01885559|583672070|FG001|Overall Study|Less than full participation|19|||
161623986|NCT01885559|583672069|FG000|Overall Study|Protocol Violation|0|||
161623987|NCT01885559|583672070|FG001|Overall Study|Protocol Violation|1|||
161623988|NCT01867307|583672071|FG000|Overall Study|Protocol Violation|2|||
161623989|NCT01867307|583672072|FG001|Overall Study|Protocol Violation|0|||
161623990|NCT01867307|583672071|FG000|Overall Study|Other Adverse Event|1|||
161623991|NCT01867307|583672072|FG001|Overall Study|Other Adverse Event|3|||
161623992|NCT00091572|583672082|FG000|Overall Study|Lost to Follow-up|1|||
161623993|NCT00091572|583672083|FG001|Overall Study|Lost to Follow-up|1|||
161623994|NCT00091572|583672082|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
161623995|NCT00091572|583672083|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
161623996|NCT00091572|583672082|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
161623997|NCT00091572|583672083|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
161623998|NCT00091572|583672082|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
161623999|NCT00091572|583672083|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
161624000|NCT00091572|583672082|FG000|Overall Study|Other Reason|6|||
161624001|NCT00091572|583672083|FG001|Overall Study|Other Reason|13|||
161624002|NCT00091572|583672082|FG000|Overall Study|Ongoing (still on treatment)|8|||
161624003|NCT00091572|583672083|FG001|Overall Study|Ongoing (still on treatment)|12|||
161624004|NCT00091572|583672082|FG000|Overall Study|Major Protocol Violation|2|||
161624005|NCT00091572|583672083|FG001|Overall Study|Major Protocol Violation|0|||
161624006|NCT00091572|583672082|FG000|Overall Study|Toxicity (Related AE)|53|||
161624007|NCT00091572|583672083|FG001|Overall Study|Toxicity (Related AE)|9|||
161624008|NCT03122548|583672088|FG000|Overall Study|Death|2|||
161624009|NCT03122548|583672088|FG000|Overall Study|Progression - subject went into hospice|1|||
161624010|NCT03122548|583672088|FG000|Overall Study|Study Terminated by Sponsor|2|||
161624011|NCT01634165|583672092|FG000|Period 2|Adverse Event|0|||
161624012|NCT01634165|583672093|FG001|Period 2|Adverse Event|1|||
161624013|NCT01634165|583672094|FG002|Period 2|Adverse Event|0|||
161624014|NCT01634165|583672095|FG003|Period 2|Adverse Event|0|||
161624015|NCT04097535|583672098|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
161624016|NCT03322514|583673400|FG000|Overall Study|Withdrawal by Subject|1|||
161624017|NCT03322514|583673401|FG001|Overall Study|Withdrawal by Subject|1|||
161624018|NCT00088452|583673402|FG000|Overall Study|Did not receive intervention|1|||
161624019|NCT00088452|583673403|FG001|Overall Study|Did not receive intervention|0|||
161624020|NCT00088452|583673404|FG002|Overall Study|Did not receive intervention|1|||
161624021|NCT02081196|583673406|FG000|Overall Study|Lost to Follow-up|1|||
161624022|NCT02514577|583673414|FG000|Overall Study|Lost to Follow-up|6|||
161624023|NCT02514577|583673415|FG001|Overall Study|Lost to Follow-up|6|||
161624024|NCT02514577|583673414|FG000|Overall Study|Protocol Violation|1|||
161624025|NCT02514577|583673415|FG001|Overall Study|Protocol Violation|0|||
161624026|NCT02514577|583673414|FG000|Overall Study|Withdrawal by Subject|6|||
161624027|NCT02514577|583673415|FG001|Overall Study|Withdrawal by Subject|6|||
161624028|NCT02514577|583673414|FG000|Overall Study|Adverse Event|1|||
161624029|NCT02514577|583673415|FG001|Overall Study|Adverse Event|1|||
161624030|NCT00489489|583673416|FG000|Overall Study|Not treated due to protocol violation|0|||
161624031|NCT00489489|583673417|FG001|Overall Study|Not treated due to protocol violation|1|||
161624032|NCT00489489|583673418|FG002|Overall Study|Not treated due to protocol violation|1|||
161624033|NCT00489489|583673416|FG000|Overall Study|Adverse Event|1|||
161624034|NCT00489489|583673417|FG001|Overall Study|Adverse Event|1|||
161624035|NCT00489489|583673418|FG002|Overall Study|Adverse Event|1|||
161624036|NCT00489489|583673416|FG000|Overall Study|Protocol Violation|1|||
161624037|NCT00489489|583673417|FG001|Overall Study|Protocol Violation|0|||
161624038|NCT00489489|583673418|FG002|Overall Study|Protocol Violation|1|||
161624039|NCT00489489|583673416|FG000|Overall Study|Progressive disease|0|||
161624040|NCT00489489|583673417|FG001|Overall Study|Progressive disease|1|||
161624041|NCT00489489|583673418|FG002|Overall Study|Progressive disease|0|||
161624042|NCT00489489|583673416|FG000|Overall Study|Participant did not wish to continue|1|||
161624043|NCT00489489|583673417|FG001|Overall Study|Participant did not wish to continue|1|||
161624044|NCT00489489|583673418|FG002|Overall Study|Participant did not wish to continue|0|||
161624045|NCT00489489|583673416|FG000|Overall Study|Other than above|0|||
161624046|NCT00489489|583673417|FG001|Overall Study|Other than above|1|||
161624047|NCT00489489|583673418|FG002|Overall Study|Other than above|0|||
161624048|NCT02136797|583673419|FG000|Overall Study|Not Treated|8|||
161624049|NCT04523571|583673420|FG000|Received 2 Doses|Withdrawal by Subject|0|||
161624050|NCT04523571|583673421|FG001|Received 2 Doses|Withdrawal by Subject|0|||
161624051|NCT04523571|583673422|FG002|Received 2 Doses|Withdrawal by Subject|0|||
161624052|NCT04523571|583673423|FG003|Received 2 Doses|Withdrawal by Subject|1|||
161624053|NCT04523571|583673424|FG004|Received 2 Doses|Withdrawal by Subject|1|||
161624054|NCT04523571|583673425|FG005|Received 2 Doses|Withdrawal by Subject|0|||
161624055|NCT04523571|583673420|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
161624056|NCT04523571|583673421|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161624057|NCT04523571|583673422|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
161624058|NCT04523571|583673423|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161624059|NCT04523571|583673424|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161624060|NCT04523571|583673425|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161624061|NCT04523571|583673420|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161624062|NCT04523571|583673421|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161624063|NCT04523571|583673422|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161624064|NCT04523571|583673423|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161624065|NCT04523571|583673424|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161624066|NCT04523571|583673425|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
161624067|NCT04523571|583673420|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161624068|NCT04523571|583673421|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161624069|NCT04523571|583673422|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161624070|NCT04523571|583673423|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
161624071|NCT04523571|583673424|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
161624072|NCT04523571|583673425|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161624073|NCT00627523|583673426|FG000|Overall Study|Lack of Efficacy|1|||
161624074|NCT00627523|583673427|FG001|Overall Study|Lack of Efficacy|0|||
161624075|NCT00627523|583673426|FG000|Overall Study|Withdrawal by Subject|0|||
161624076|NCT00627523|583673427|FG001|Overall Study|Withdrawal by Subject|2|||
161624077|NCT00627523|583673426|FG000|Overall Study|Other|1|||
161624078|NCT00627523|583673427|FG001|Overall Study|Other|0|||
161624079|NCT04385849|583673430|FG000|Overall Study|Lost to Follow-up|1|||
161624080|NCT04385849|583673431|FG001|Overall Study|Lost to Follow-up|0|||
161624081|NCT02011568|583673434|FG000|Overall Study|Withdrawal by Subject|8|||
161624082|NCT02011568|583673435|FG001|Overall Study|Withdrawal by Subject|10|||
161624083|NCT02011568|583673434|FG000|Overall Study|Physician Decision|1|||
161624084|NCT02011568|583673435|FG001|Overall Study|Physician Decision|3|||
161624085|NCT01038128|583673436|FG000|Overall Study|Lack of Efficacy|1|||
161624086|NCT01038128|583673436|FG000|Overall Study|Lost to Follow-up|1|||
161624087|NCT01038128|583673436|FG000|Overall Study|Withdrawal by Subject|2|||
161624088|NCT03344458|583673441|FG000|Overall Study|Physician Decision|1|||
161624089|NCT03344458|583673441|FG000|Overall Study|Withdrawal by Subject|16|||
161624090|NCT03344458|583673441|FG000|Overall Study|Other reasons|10|||
161624091|NCT03344458|583673441|FG000|Overall Study|Lost to Follow-up|9|||
161624092|NCT03344458|583673441|FG000|Overall Study|Protocol Violation|3|||
161624093|NCT00396409|583673442|FG000|Period 1 - 2007|Adverse Event|0|||
161624094|NCT00396409|583673443|FG001|Period 1 - 2007|Adverse Event|1|||
161624095|NCT00396409|583673442|FG000|Period 1 - 2007|Lack of Efficacy|0|||
161624096|NCT00396409|583673443|FG001|Period 1 - 2007|Lack of Efficacy|1|||
161624097|NCT00396409|583673442|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
161624098|NCT00396409|583673443|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
161624099|NCT00396409|583673442|FG000|Period 1 - 2007|Lost to Follow-up|2|||
161624100|NCT00396409|583673443|FG001|Period 1 - 2007|Lost to Follow-up|3|||
161624101|NCT00396409|583673442|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
161624102|NCT00396409|583673443|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
161624103|NCT00396409|583673442|FG000|Period 2 - 2008|Protocol Violation|1|||
161624104|NCT00396409|583673443|FG001|Period 2 - 2008|Protocol Violation|0|||
161624105|NCT00396409|583673442|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
161624106|NCT00396409|583673443|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
161624107|NCT00396409|583673442|FG000|Period 2 - 2008|Lost to Follow-up|3|||
161624108|NCT00396409|583673443|FG001|Period 2 - 2008|Lost to Follow-up|1|||
161624109|NCT00331799|583673444|FG000|Overall Study|Withdrawal by Subject|2|||
161624110|NCT00331799|583673444|FG000|Overall Study|Sedation|1|||
161624111|NCT02889809|583673445|FG000|Overall Study|Withdrawal by Subject|30|||
161624112|NCT02889809|583673446|FG001|Overall Study|Withdrawal by Subject|21|||
161624113|NCT02889809|583673445|FG000|Overall Study|Lost to Follow-up|1|||
161624114|NCT02889809|583673446|FG001|Overall Study|Lost to Follow-up|1|||
161624115|NCT02889809|583673445|FG000|Overall Study|Site Closed|12|||
161624116|NCT02889809|583673446|FG001|Overall Study|Site Closed|11|||
161624117|NCT04203199|583673447|FG000|First Intervention Period|Lost to Follow-up|0|||
161624118|NCT04203199|583673448|FG001|First Intervention Period|Lost to Follow-up|1|||
161624119|NCT04203199|583673447|FG000|Second Intervention Period|Medication change|1|||
161624120|NCT04203199|583673448|FG001|Second Intervention Period|Medication change|0|||
161624121|NCT03960437|583673449|FG000|Overall Study|Removed by PI|4|||
161624122|NCT03960437|583673449|FG000|Overall Study|Lost to Follow-up|2|||
161624123|NCT03960437|583673449|FG000|Overall Study|Withdrawal by Subject|1|||
161624124|NCT03960437|583673449|FG000|Overall Study|Death|2|||
161624125|NCT01838499|583673455|FG000|Overall Study|Protocol Violation|0|||
161624126|NCT01838499|583673456|FG001|Overall Study|Protocol Violation|1|||
161624127|NCT01838499|583673455|FG000|Overall Study|Lost to Follow-up|2|||
161624128|NCT01838499|583673456|FG001|Overall Study|Lost to Follow-up|4|||
161624129|NCT01838499|583673455|FG000|Overall Study|Lack of Efficacy|1|||
161624130|NCT01838499|583673456|FG001|Overall Study|Lack of Efficacy|2|||
161624131|NCT01838499|583673455|FG000|Overall Study|Adverse Event|2|||
161624132|NCT01838499|583673456|FG001|Overall Study|Adverse Event|1|||
161624133|NCT01838499|583673455|FG000|Overall Study|Withdrawal by Subject|19|||
161624134|NCT01838499|583673456|FG001|Overall Study|Withdrawal by Subject|9|||
161624135|NCT03614923|583673457|FG000|Overall Study|Withdrawal by Subject|2|||
161624136|NCT03614923|583673458|FG001|Overall Study|Withdrawal by Subject|1|||
161685049|NCT02409290|583899640|FG003|Overall Study|No positive culture/no baseline sample|5|||
161833158|NCT01688726|584429721|FG001|Overall Study|Adverse Event|0|||
161833159|NCT01688726|584429720|FG000|Overall Study|Relocated abroad|0|||
161624137|NCT03614923|583673459|FG002|Overall Study|Withdrawal by Subject|1|||
161624138|NCT03614923|583673457|FG000|Overall Study|Adverse Event|0|||
161624139|NCT03614923|583673458|FG001|Overall Study|Adverse Event|2|||
161624140|NCT03614923|583673459|FG002|Overall Study|Adverse Event|1|||
161624141|NCT03614923|583673457|FG000|Overall Study|Lost to Follow-up|1|||
161624142|NCT03614923|583673458|FG001|Overall Study|Lost to Follow-up|0|||
161624143|NCT03614923|583673459|FG002|Overall Study|Lost to Follow-up|1|||
161624144|NCT03614923|583673457|FG000|Overall Study|Lack of Efficacy|2|||
161624145|NCT03614923|583673458|FG001|Overall Study|Lack of Efficacy|0|||
161624146|NCT03614923|583673459|FG002|Overall Study|Lack of Efficacy|1|||
161624147|NCT03614923|583673457|FG000|Overall Study|Non-compliance|0|||
161624148|NCT03614923|583673458|FG001|Overall Study|Non-compliance|1|||
161624149|NCT03614923|583673459|FG002|Overall Study|Non-compliance|0|||
161624150|NCT03614923|583673457|FG000|Overall Study|Other|0|||
161624151|NCT03614923|583673458|FG001|Overall Study|Other|1|||
161624152|NCT03614923|583673459|FG002|Overall Study|Other|1|||
161624153|NCT01136733|583673460|FG000|Phase 1b|Adverse Event|0|||
161624154|NCT01136733|583673461|FG001|Phase 1b|Adverse Event|3|||
161624155|NCT01136733|583673462|FG002|Phase 1b|Adverse Event|1|||
161624156|NCT01136733|583673463|FG003|Phase 1b|Adverse Event|0|||
161624157|NCT01136733|583673464|FG004|Phase 1b|Adverse Event|0|||
161624158|NCT01136733|583673465|FG005|Phase 1b|Adverse Event|0|||
161624159|NCT01136733|583673466|FG006|Phase 1b|Adverse Event|0|||
161624160|NCT01136733|583673460|FG000|Phase 1b|Participant Choice|0|||
161624161|NCT01136733|583673461|FG001|Phase 1b|Participant Choice|0|||
161624162|NCT01136733|583673462|FG002|Phase 1b|Participant Choice|1|||
161624163|NCT01136733|583673463|FG003|Phase 1b|Participant Choice|0|||
161624164|NCT01136733|583673464|FG004|Phase 1b|Participant Choice|0|||
161624165|NCT01136733|583673465|FG005|Phase 1b|Participant Choice|0|||
161624166|NCT01136733|583673466|FG006|Phase 1b|Participant Choice|0|||
161624167|NCT01136733|583673460|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
161624168|NCT01136733|583673461|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
161624169|NCT01136733|583673462|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
161624170|NCT01136733|583673463|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
161624171|NCT01136733|583673464|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
161624172|NCT01136733|583673465|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
161624173|NCT01136733|583673466|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
161624174|NCT01136733|583673460|FG000|Phase 1b|Clinical Progression|1|||
161624175|NCT01136733|583673461|FG001|Phase 1b|Clinical Progression|1|||
161624176|NCT01136733|583673462|FG002|Phase 1b|Clinical Progression|0|||
161624177|NCT01136733|583673463|FG003|Phase 1b|Clinical Progression|0|||
161624178|NCT01136733|583673464|FG004|Phase 1b|Clinical Progression|0|||
161624179|NCT01136733|583673465|FG005|Phase 1b|Clinical Progression|0|||
161624180|NCT01136733|583673466|FG006|Phase 1b|Clinical Progression|0|||
161624181|NCT01136733|583673460|FG000|Phase 2|Disease Progression|0|||
161624182|NCT01136733|583673461|FG001|Phase 2|Disease Progression|0|||
161624183|NCT01136733|583673462|FG002|Phase 2|Disease Progression|0|||
161624184|NCT01136733|583673463|FG003|Phase 2|Disease Progression|0|||
161624185|NCT01136733|583673464|FG004|Phase 2|Disease Progression|30|||
161624186|NCT01136733|583673465|FG005|Phase 2|Disease Progression|32|||
161624187|NCT01136733|583673466|FG006|Phase 2|Disease Progression|38|||
161624188|NCT01136733|583673460|FG000|Phase 2|Adverse Event|0|||
161624189|NCT01136733|583673461|FG001|Phase 2|Adverse Event|0|||
161624190|NCT01136733|583673462|FG002|Phase 2|Adverse Event|0|||
161624191|NCT01136733|583673463|FG003|Phase 2|Adverse Event|0|||
161624192|NCT01136733|583673464|FG004|Phase 2|Adverse Event|11|||
161624193|NCT01136733|583673465|FG005|Phase 2|Adverse Event|13|||
161624194|NCT01136733|583673466|FG006|Phase 2|Adverse Event|5|||
161624195|NCT01136733|583673460|FG000|Phase 2|Participant Choice|0|||
161624196|NCT01136733|583673461|FG001|Phase 2|Participant Choice|0|||
161624197|NCT01136733|583673462|FG002|Phase 2|Participant Choice|0|||
161624198|NCT01136733|583673463|FG003|Phase 2|Participant Choice|0|||
161624199|NCT01136733|583673464|FG004|Phase 2|Participant Choice|3|||
161624200|NCT01136733|583673465|FG005|Phase 2|Participant Choice|0|||
161624201|NCT01136733|583673466|FG006|Phase 2|Participant Choice|1|||
161624202|NCT01136733|583673460|FG000|Phase 2|Administrative-Withdrew Consent|0|||
161624203|NCT01136733|583673461|FG001|Phase 2|Administrative-Withdrew Consent|0|||
161624204|NCT01136733|583673462|FG002|Phase 2|Administrative-Withdrew Consent|0|||
161624205|NCT01136733|583673463|FG003|Phase 2|Administrative-Withdrew Consent|0|||
161624206|NCT01136733|583673464|FG004|Phase 2|Administrative-Withdrew Consent|1|||
161624207|NCT01136733|583673465|FG005|Phase 2|Administrative-Withdrew Consent|0|||
161624208|NCT01136733|583673466|FG006|Phase 2|Administrative-Withdrew Consent|0|||
161624209|NCT01136733|583673460|FG000|Phase 2|Other|0|||
161624210|NCT01136733|583673461|FG001|Phase 2|Other|0|||
161624211|NCT01136733|583673462|FG002|Phase 2|Other|0|||
161624212|NCT01136733|583673463|FG003|Phase 2|Other|0|||
161624213|NCT01136733|583673464|FG004|Phase 2|Other|6|||
161624214|NCT01136733|583673465|FG005|Phase 2|Other|7|||
161624215|NCT01136733|583673466|FG006|Phase 2|Other|6|||
161624216|NCT01882088|583673468|FG000|Overall Study|Intolerance of esophageal manometry|1|||
161624217|NCT01882088|583673468|FG000|Overall Study|no possibility to place the catheter|1|||
161624218|NCT01882088|583673468|FG000|Overall Study|Protocol Violation|1|||
161624219|NCT01882088|583673468|FG000|Overall Study|inadequate pH-impedance tracings|2|||
161624220|NCT02186015|583673469|FG000|Overall Study|Physician Decision|1|||
161624221|NCT02186015|583673470|FG001|Overall Study|Physician Decision|0|||
161624222|NCT01533181|583673473|FG000|Overall Study|Disease progression pre-active treatment|0|||
161624223|NCT01533181|583673474|FG001|Overall Study|Disease progression pre-active treatment|1|||
161624224|NCT01533181|583673473|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
161624225|NCT01533181|583673474|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
161624226|NCT02720198|583673475|FG000|Overall Study|Withdrawal by Subject|0|||
161624227|NCT02720198|583673476|FG001|Overall Study|Withdrawal by Subject|1|||
161624228|NCT02592434|583673479|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
161624229|NCT02592434|583673480|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
161624230|NCT02592434|583673481|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
161624231|NCT02592434|583673479|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
161624232|NCT02592434|583673480|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
161624233|NCT02592434|583673481|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
161624234|NCT02592434|583673479|FG000|Open-Label Phase (18 Weeks)|Other|3|||
161624235|NCT02592434|583673480|FG001|Open-Label Phase (18 Weeks)|Other|0|||
161624236|NCT02592434|583673481|FG002|Open-Label Phase (18 Weeks)|Other|0|||
161624237|NCT02592434|583673479|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
161624238|NCT02592434|583673480|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
161624239|NCT02592434|583673481|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
161624240|NCT02592434|583673479|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
161624241|NCT02592434|583673480|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
161624242|NCT02592434|583673481|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
161624243|NCT02592434|583673479|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
161624244|NCT02592434|583673480|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
161624245|NCT02592434|583673481|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
161624246|NCT02592434|583673479|FG000|Double Blind Phase (26 Weeks)|Other|0|||
161624247|NCT02592434|583673480|FG001|Double Blind Phase (26 Weeks)|Other|1|||
161624248|NCT02592434|583673481|FG002|Double Blind Phase (26 Weeks)|Other|0|||
161624249|NCT02592434|583673479|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
161624250|NCT02592434|583673480|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
161624251|NCT02592434|583673481|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
161624252|NCT02592434|583673479|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
161624253|NCT02592434|583673480|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
161624254|NCT02592434|583673481|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
161624255|NCT02592434|583673479|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
161624256|NCT02592434|583673480|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
161624257|NCT02592434|583673481|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
161624258|NCT00147745|583673482|FG000|Overall Study|Withdrawal by Subject|1|||
161624259|NCT00147745|583673483|FG001|Overall Study|Withdrawal by Subject|0|||
161624260|NCT00147745|583673484|FG002|Overall Study|Withdrawal by Subject|0|||
161624261|NCT01757171|583673485|FG000|Overall Study|Adverse Event|5|||
161624262|NCT01757171|583673486|FG001|Overall Study|Adverse Event|1|||
161624263|NCT01757171|583673485|FG000|Overall Study|Disease Progression|1|||
161624264|NCT01757171|583673486|FG001|Overall Study|Disease Progression|0|||
161624265|NCT01757171|583673485|FG000|Overall Study|Hospitalization|1|||
161624266|NCT01757171|583673486|FG001|Overall Study|Hospitalization|0|||
161624267|NCT01757171|583673485|FG000|Overall Study|ECOG decline|1|||
161624268|NCT01757171|583673486|FG001|Overall Study|ECOG decline|0|||
161624269|NCT00510783|583673489|FG000|Overall Study|Lost to Follow-up|29|||
161624270|NCT00510783|583673490|FG001|Overall Study|Lost to Follow-up|25|||
161624271|NCT00510783|583673489|FG000|Overall Study|Withdrawal by Subject|2|||
161624272|NCT00510783|583673490|FG001|Overall Study|Withdrawal by Subject|3|||
161624273|NCT00510783|583673489|FG000|Overall Study|Protocol Violation|0|||
161624274|NCT00510783|583673490|FG001|Overall Study|Protocol Violation|1|||
161624275|NCT00316121|583673491|FG000|Overall Study|Death|1|||
161624276|NCT00316121|583673492|FG001|Overall Study|Death|0|||
161624277|NCT00316121|583673491|FG000|Overall Study|Lost to Follow-up|14|||
161624278|NCT00316121|583673492|FG001|Overall Study|Lost to Follow-up|8|||
161624279|NCT00316121|583673491|FG000|Overall Study|Withdrawal by Subject|2|||
161624280|NCT00316121|583673492|FG001|Overall Study|Withdrawal by Subject|0|||
161624281|NCT00316121|583673491|FG000|Overall Study|Reason is missing|1|||
161624282|NCT00316121|583673492|FG001|Overall Study|Reason is missing|0|||
161624283|NCT00316121|583673491|FG000|Overall Study|Subject relocated|1|||
161624284|NCT00316121|583673492|FG001|Overall Study|Subject relocated|1|||
161624285|NCT00316121|583673491|FG000|Overall Study|Subject refused to return|1|||
161624286|NCT00316121|583673492|FG001|Overall Study|Subject refused to return|0|||
161624287|NCT00316121|583673491|FG000|Overall Study|Subject no show for visit x 3|1|||
161624288|NCT00316121|583673492|FG001|Overall Study|Subject no show for visit x 3|0|||
161833160|NCT01688726|584429721|FG001|Overall Study|Relocated abroad|1|||
161833161|NCT03821272|584431004|FG000|Overall Study|Death|1|||
161624289|NCT00316121|583673491|FG000|Overall Study|Subject did not have 24 month visit|1|||
161624290|NCT00316121|583673492|FG001|Overall Study|Subject did not have 24 month visit|0|||
161624291|NCT00460577|583673498|FG000|Overall Study|Protocol Violation|2|||
161624292|NCT00460577|583673499|FG001|Overall Study|Protocol Violation|6|||
161624293|NCT04043806|583673500|FG000|Overall Study|Commercial drug is available for participants|13|||
161624294|NCT04043806|583673500|FG000|Overall Study|Physician Decision|2|||
161833162|NCT03821272|584431005|FG001|Overall Study|Death|0|||
161624295|NCT04043806|583673500|FG000|Overall Study|Other|12|||
161624296|NCT04043806|583673500|FG000|Overall Study|Adverse Event|2|||
161624297|NCT04043806|583673500|FG000|Overall Study|Lost to Follow-up|6|||
161624298|NCT04043806|583673500|FG000|Overall Study|Other non-compliance|2|||
161624299|NCT04043806|583673500|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
161624300|NCT04043806|583673500|FG000|Overall Study|Never Dosed|1|||
161624301|NCT04362176|583673501|FG000|Overall Study|Lost to Follow-up|5|||
161624302|NCT04362176|583673502|FG001|Overall Study|Lost to Follow-up|8|||
161624303|NCT04362176|583673501|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
161624304|NCT04362176|583673502|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
161624305|NCT02632045|583673504|FG000|Overall Study|Withdrawal by Subject|1|||
161624306|NCT02632045|583673505|FG001|Overall Study|Withdrawal by Subject|2|||
161624307|NCT00596960|583673507|FG000|Overall Study|Death|1|||
161624308|NCT00596960|583673508|FG001|Overall Study|Death|2|||
161624309|NCT00596960|583673507|FG000|Overall Study|Lost to Follow-up|6|||
161624310|NCT00596960|583673508|FG001|Overall Study|Lost to Follow-up|5|||
161624311|NCT00596960|583673507|FG000|Overall Study|Withdrawal by Subject|1|||
161833163|NCT03821272|584431004|FG000|Overall Study|Physician Decision|1|||
161624312|NCT00596960|583673508|FG001|Overall Study|Withdrawal by Subject|0|||
161624313|NCT00596960|583673507|FG000|Overall Study|Incarcerated|2|||
161624314|NCT00596960|583673508|FG001|Overall Study|Incarcerated|0|||
161624315|NCT00596960|583673507|FG000|Overall Study|Physician Decision|1|||
161624316|NCT00596960|583673508|FG001|Overall Study|Physician Decision|0|||
161624317|NCT00596960|583673507|FG000|Overall Study|Protocol Violation|0|||
161624318|NCT00596960|583673508|FG001|Overall Study|Protocol Violation|1|||
161624319|NCT00596960|583673507|FG000|Overall Study|No alcohol use data|0|||
161624320|NCT00596960|583673508|FG001|Overall Study|No alcohol use data|1|||
161624321|NCT03503188|583673509|FG000|Overall Study|Non eligible in the sub study|0|||
161624322|NCT03503188|583673510|FG001|Overall Study|Non eligible in the sub study|1|||
161624323|NCT02260154|583673512|FG000|Overall Study|Screening failure|2|||
161624324|NCT03560206|583673513|FG000|Overall Study|Lost to Follow-up|19|||
161624325|NCT03560206|583673514|FG001|Overall Study|Lost to Follow-up|11|||
161624326|NCT03560206|583673513|FG000|Overall Study|Withdrawal by Subject|2|||
161624327|NCT03560206|583673514|FG001|Overall Study|Withdrawal by Subject|4|||
161624328|NCT03560206|583673513|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
161624329|NCT03560206|583673514|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
161624330|NCT03560206|583673513|FG000|Overall Study|Busy schedule|14|||
161624331|NCT03560206|583673514|FG001|Overall Study|Busy schedule|2|||
161624332|NCT03560206|583673513|FG000|Overall Study|patients' new health condition such as cancer|10|||
161624333|NCT03560206|583673514|FG001|Overall Study|patients' new health condition such as cancer|1|||
161624334|NCT00738400|583673515|FG000|Overall Study|Adverse Event|3|||
161624335|NCT00738400|583673516|FG001|Overall Study|Adverse Event|1|||
161624336|NCT00738400|583673515|FG000|Overall Study|Withdrawal by Subject|0|||
161624337|NCT00738400|583673516|FG001|Overall Study|Withdrawal by Subject|1|||
161624338|NCT00738400|583673515|FG000|Overall Study|Lack of Efficacy|0|||
161624339|NCT00738400|583673516|FG001|Overall Study|Lack of Efficacy|1|||
161624340|NCT00738400|583673515|FG000|Overall Study|Lost to Follow-up|0|||
161624341|NCT00738400|583673516|FG001|Overall Study|Lost to Follow-up|3|||
161624342|NCT00738400|583673515|FG000|Overall Study|Protocol Violation|1|||
161624343|NCT00738400|583673516|FG001|Overall Study|Protocol Violation|0|||
161624344|NCT00738400|583673515|FG000|Overall Study|Non-compliant with study medication|0|||
161624345|NCT00738400|583673516|FG001|Overall Study|Non-compliant with study medication|1|||
161624346|NCT02255474|583673517|FG000|Overall Study|Lost to Follow-up|1|||
161624347|NCT02255474|583673518|FG001|Overall Study|Lost to Follow-up|1|||
161624348|NCT02255474|583673519|FG002|Overall Study|Lost to Follow-up|3|||
161624349|NCT02255474|583673517|FG000|Overall Study|Withdrawal by Subject|1|||
161624350|NCT02255474|583673518|FG001|Overall Study|Withdrawal by Subject|1|||
161624351|NCT02255474|583673519|FG002|Overall Study|Withdrawal by Subject|0|||
161624352|NCT02993926|583673520|FG000|Enantone Treatment Phase|Adverse Event|1|||
161624353|NCT02993926|583673521|FG001|Enantone Treatment Phase|Adverse Event|0|||
161624354|NCT02993926|583673522|FG002|Enantone Treatment Phase|Adverse Event|0|||
161624355|NCT02993926|583673520|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
161624356|NCT02993926|583673521|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
161624357|NCT02993926|583673522|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
161624358|NCT02993926|583673520|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
161624359|NCT02993926|583673521|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
161624360|NCT02993926|583673522|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
161624361|NCT02993926|583673520|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
161624362|NCT02993926|583673521|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
161624363|NCT02993926|583673522|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
161685050|NCT02409290|583899637|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
161685051|NCT02409290|583899638|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161624364|NCT01760876|583673523|FG000|Overall Study|Non-cardiac death (head injury)|1|||
161624365|NCT01760876|583673523|FG000|Overall Study|Carcinoma of prostate|1|||
161624366|NCT01760876|583673523|FG000|Overall Study|Impaired renal function|1|||
161624367|NCT01760876|583673523|FG000|Overall Study|Major depression|1|||
161624368|NCT01760876|583673523|FG000|Overall Study|Very poor baseline OCT quality|2|||
161624369|NCT04295499|583673527|FG000|Overall Study|moving out of state|1|||
161624370|NCT04295499|583673528|FG001|Overall Study|moving out of state|0|||
161624371|NCT04295499|583673527|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
161624372|NCT04295499|583673528|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
161624373|NCT00308113|583673529|FG000|Overall Study|Protocol closure|0|||
161624374|NCT00308113|583673530|FG001|Overall Study|Protocol closure|0|||
161624375|NCT00308113|583673531|FG002|Overall Study|Protocol closure|0|||
161624376|NCT00308113|583673532|FG003|Overall Study|Protocol closure|1|||
161624377|NCT02332889|583673533|FG000|Overall Study|Physician Decision|1|||
161624378|NCT02135445|583673536|FG000|Overall Study|Lost to Follow-up|1|||
161624379|NCT02135445|583673537|FG001|Overall Study|Lost to Follow-up|0|||
161624380|NCT02135445|583673536|FG000|Overall Study|Withdrawal by Subject|1|||
161624381|NCT02135445|583673537|FG001|Overall Study|Withdrawal by Subject|0|||
161624382|NCT03556891|583673538|FG000|Initial Pivotal Study|Adverse Event|4|||
161624383|NCT03556891|583673538|FG000|Initial Pivotal Study|MRI Need|3|||
161624384|NCT03556891|583673538|FG000|Initial Pivotal Study|Device Failure|1|||
161624385|NCT03556891|583673538|FG000|Initial Pivotal Study|Death|1|||
161624386|NCT03556891|583673538|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
161624387|NCT03556891|583673538|FG000|Initial Pivotal Study|Missing at random|1|||
161624388|NCT03556891|583673538|FG000|Initial Pivotal Study|Missing due to COVID|1|||
161624389|NCT03556891|583673538|FG000|Initial Pivotal Study|Protocol Violation|1|||
161624390|NCT00705614|583675263|FG000|Initial Intervention|Adverse Event|40|||
161624391|NCT00705614|583675264|FG001|Initial Intervention|Adverse Event|21|||
161624392|NCT00705614|583675263|FG000|Initial Intervention|Lost to Follow-up|310|||
161624393|NCT00705614|583675264|FG001|Initial Intervention|Lost to Follow-up|191|||
161624394|NCT00705614|583675263|FG000|Initial Intervention|Withdrawal by Subject|114|||
161624395|NCT00705614|583675264|FG001|Initial Intervention|Withdrawal by Subject|71|||
161624396|NCT00705614|583675263|FG000|Initial Intervention|Administrative Reason|51|||
161624397|NCT00705614|583675264|FG001|Initial Intervention|Administrative Reason|38|||
161624398|NCT00705614|583675263|FG000|Initial Intervention|Status completion unknown|3|||
161624399|NCT00705614|583675264|FG001|Initial Intervention|Status completion unknown|0|||
161624400|NCT00705614|583675263|FG000|Switch to Remicade|Adverse Event|0|||
161624401|NCT00705614|583675264|FG001|Switch to Remicade|Adverse Event|5|||
161624402|NCT00705614|583675263|FG000|Switch to Remicade|Lost to Follow-up|0|||
161624403|NCT00705614|583675264|FG001|Switch to Remicade|Lost to Follow-up|23|||
161624404|NCT00705614|583675263|FG000|Switch to Remicade|Withdrawal by Subject|0|||
161624405|NCT00705614|583675264|FG001|Switch to Remicade|Withdrawal by Subject|12|||
161624406|NCT00705614|583675263|FG000|Switch to Remicade|Administrative Reason|0|||
161624407|NCT00705614|583675264|FG001|Switch to Remicade|Administrative Reason|9|||
161624408|NCT02661490|583675265|FG000|Overall Study|Lost to Follow-up|0|||
161624409|NCT02661490|583675266|FG001|Overall Study|Lost to Follow-up|1|||
161624410|NCT02661490|583675267|FG002|Overall Study|Lost to Follow-up|0|||
161624411|NCT02661490|583675268|FG003|Overall Study|Lost to Follow-up|0|||
161624412|NCT02661490|583675269|FG004|Overall Study|Lost to Follow-up|2|||
161624413|NCT02661490|583675265|FG000|Overall Study|Withdrawal by Subject|2|||
161624414|NCT02661490|583675266|FG001|Overall Study|Withdrawal by Subject|0|||
161624415|NCT02661490|583675267|FG002|Overall Study|Withdrawal by Subject|2|||
161624416|NCT02661490|583675268|FG003|Overall Study|Withdrawal by Subject|0|||
161624417|NCT02661490|583675269|FG004|Overall Study|Withdrawal by Subject|0|||
161624418|NCT02661490|583675265|FG000|Overall Study|Death|1|||
161624419|NCT02661490|583675266|FG001|Overall Study|Death|1|||
161624420|NCT02661490|583675267|FG002|Overall Study|Death|0|||
161624421|NCT02661490|583675268|FG003|Overall Study|Death|1|||
161624422|NCT02661490|583675269|FG004|Overall Study|Death|0|||
161624423|NCT02661490|583675265|FG000|Overall Study|Reason not Specified|0|||
161624424|NCT02661490|583675266|FG001|Overall Study|Reason not Specified|0|||
161624425|NCT02661490|583675267|FG002|Overall Study|Reason not Specified|0|||
161624426|NCT02661490|583675268|FG003|Overall Study|Reason not Specified|0|||
161624427|NCT02661490|583675269|FG004|Overall Study|Reason not Specified|1|||
161624428|NCT00961298|583675270|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
161624429|NCT00961298|583675270|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
161624430|NCT00961298|583675270|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
161624431|NCT01232569|583675273|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
161624432|NCT01232569|583675274|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161624433|NCT01232569|583675275|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161624434|NCT01232569|583675276|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
161624435|NCT01232569|583675273|FG000|Double-blind Treatment Period|Escape|2|||
161624436|NCT01232569|583675274|FG001|Double-blind Treatment Period|Escape|2|||
161624437|NCT01232569|583675275|FG002|Double-blind Treatment Period|Escape|0|||
161624438|NCT01232569|583675276|FG003|Double-blind Treatment Period|Escape|0|||
161624439|NCT01232569|583675273|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
161624440|NCT01232569|583675274|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161624441|NCT01232569|583675275|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161624442|NCT01232569|583675276|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161624443|NCT01232569|583675273|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
161624444|NCT01232569|583675274|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
161624445|NCT01232569|583675275|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161624446|NCT01232569|583675276|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161624447|NCT01232569|583675273|FG000|Double-blind Treatment Period|Physician Decision|1|||
161624448|NCT01232569|583675274|FG001|Double-blind Treatment Period|Physician Decision|0|||
161624449|NCT01232569|583675275|FG002|Double-blind Treatment Period|Physician Decision|0|||
161624450|NCT01232569|583675276|FG003|Double-blind Treatment Period|Physician Decision|0|||
161833164|NCT03821272|584431005|FG001|Overall Study|Physician Decision|0|||
161833165|NCT03821272|584431004|FG000|Overall Study|Withdrawal by Subject|1|||
161624451|NCT01232569|583675273|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
161624452|NCT01232569|583675274|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
161624453|NCT01232569|583675275|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
161624454|NCT01232569|583675276|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
161624455|NCT01232569|583675273|FG000|Double-blind Treatment Period|Death|2|||
161624456|NCT01232569|583675274|FG001|Double-blind Treatment Period|Death|0|||
161624457|NCT01232569|583675275|FG002|Double-blind Treatment Period|Death|0|||
161624458|NCT01232569|583675276|FG003|Double-blind Treatment Period|Death|0|||
161624459|NCT04044352|583675277|FG000|Overall Study|Lost to Follow-up|9|||
161624460|NCT04044352|583675277|FG000|Overall Study|Withdrawal by Subject|2|||
161624461|NCT02388932|583675282|FG000|Overall Study|Death|1|||
161624462|NCT05335005|583675285|FG000|Overall Study|Lost to Follow-up|1|||
161624463|NCT05927753|583675286|FG000|Overall Study|Withdrawal by Subject|0|||
161624464|NCT05927753|583675287|FG001|Overall Study|Withdrawal by Subject|2|||
161624465|NCT05927753|583675286|FG000|Overall Study|Physician Decision|0|||
161624466|NCT05927753|583675287|FG001|Overall Study|Physician Decision|1|||
161624467|NCT00409006|583675291|FG000|Overall Study|Death|15|||
161624468|NCT00409006|583675292|FG001|Overall Study|Death|6|||
161624469|NCT00409006|583675291|FG000|Overall Study|Lost to Follow-up|1|||
161624470|NCT00409006|583675292|FG001|Overall Study|Lost to Follow-up|2|||
161624471|NCT00409006|583675291|FG000|Overall Study|Withdrawal by Subject|3|||
161624472|NCT00409006|583675292|FG001|Overall Study|Withdrawal by Subject|2|||
161624473|NCT00409006|583675291|FG000|Overall Study|Physician Decision|1|||
161624474|NCT00409006|583675292|FG001|Overall Study|Physician Decision|2|||
161624475|NCT02123797|583675293|FG000|Baseline Intervention|Death|9|||
161624476|NCT02123797|583675294|FG001|Baseline Intervention|Death|16|||
161624477|NCT02123797|583675295|FG002|Baseline Intervention|Death|0|||
161624478|NCT02123797|583675296|FG003|Baseline Intervention|Death|0|||
161624479|NCT02123797|583675297|FG004|Baseline Intervention|Death|0|||
161624480|NCT02123797|583675293|FG000|Baseline Intervention|Withdrawal by Subject|2|||
161624481|NCT02123797|583675294|FG001|Baseline Intervention|Withdrawal by Subject|8|||
161624482|NCT02123797|583675295|FG002|Baseline Intervention|Withdrawal by Subject|0|||
161624483|NCT02123797|583675296|FG003|Baseline Intervention|Withdrawal by Subject|0|||
161624484|NCT02123797|583675297|FG004|Baseline Intervention|Withdrawal by Subject|0|||
161624485|NCT02123797|583675293|FG000|Baseline Intervention|Relocation|2|||
161624486|NCT02123797|583675294|FG001|Baseline Intervention|Relocation|0|||
161624487|NCT02123797|583675295|FG002|Baseline Intervention|Relocation|0|||
161624488|NCT02123797|583675296|FG003|Baseline Intervention|Relocation|0|||
161624489|NCT02123797|583675297|FG004|Baseline Intervention|Relocation|0|||
161624490|NCT02123797|583675293|FG000|Baseline Intervention|Out of window for initial survey|6|||
161624491|NCT02123797|583675294|FG001|Baseline Intervention|Out of window for initial survey|13|||
161624492|NCT02123797|583675295|FG002|Baseline Intervention|Out of window for initial survey|0|||
161624493|NCT02123797|583675296|FG003|Baseline Intervention|Out of window for initial survey|0|||
161624494|NCT02123797|583675297|FG004|Baseline Intervention|Out of window for initial survey|0|||
161624495|NCT02123797|583675293|FG000|Baseline Intervention|Lost to Follow-up|0|||
161624496|NCT02123797|583675294|FG001|Baseline Intervention|Lost to Follow-up|5|||
161624497|NCT02123797|583675295|FG002|Baseline Intervention|Lost to Follow-up|0|||
161624498|NCT02123797|583675296|FG003|Baseline Intervention|Lost to Follow-up|0|||
161624499|NCT02123797|583675297|FG004|Baseline Intervention|Lost to Follow-up|0|||
161624500|NCT02123797|583675293|FG000|Baseline Intervention|Other Disease|3|||
161685052|NCT02409290|583899639|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161833166|NCT03821272|584431005|FG001|Overall Study|Withdrawal by Subject|0|||
161833167|NCT05904769|584431006|FG000|Overall Study|Physician Decision|0|||
161833168|NCT05904769|584431007|FG001|Overall Study|Physician Decision|6|||
161833169|NCT05626803|584431013|FG000|Overall Study|Lost to Follow-up|0|||
161833170|NCT05626803|584431014|FG001|Overall Study|Lost to Follow-up|1|||
161833171|NCT05626803|584431015|FG002|Overall Study|Lost to Follow-up|0|||
161833172|NCT05626803|584431016|FG003|Overall Study|Lost to Follow-up|0|||
161624501|NCT02123797|583675294|FG001|Baseline Intervention|Other Disease|0|||
161624502|NCT02123797|583675295|FG002|Baseline Intervention|Other Disease|0|||
161833173|NCT04974619|584431017|FG000|Overall Study|Lost to Follow-up|0|||
161833174|NCT04974619|584431018|FG001|Overall Study|Lost to Follow-up|0|||
161833175|NCT04974619|584431019|FG002|Overall Study|Lost to Follow-up|1|||
161833176|NCT04974619|584431017|FG000|Overall Study|Withdrawal by Subject|0|||
161624503|NCT02123797|583675296|FG003|Baseline Intervention|Other Disease|0|||
161624504|NCT02123797|583675297|FG004|Baseline Intervention|Other Disease|0|||
161624505|NCT02123797|583675293|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
161624506|NCT02123797|583675294|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
161624507|NCT02123797|583675295|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
161624508|NCT02123797|583675296|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
161624509|NCT02123797|583675297|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
161624510|NCT02123797|583675293|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
161624511|NCT02123797|583675294|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
161624512|NCT02123797|583675295|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
161624513|NCT02123797|583675296|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
161624514|NCT02123797|583675297|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
161624515|NCT02123797|583675293|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
161624516|NCT02123797|583675294|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
161624517|NCT02123797|583675295|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161624518|NCT02123797|583675296|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161624519|NCT02123797|583675297|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161624520|NCT02123797|583675293|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
161624521|NCT02123797|583675294|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
161624522|NCT02123797|583675295|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
161624523|NCT02123797|583675296|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
161624524|NCT02123797|583675297|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
161624525|NCT02123797|583675293|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
161624526|NCT02123797|583675294|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
161624527|NCT02123797|583675295|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
161624528|NCT02123797|583675296|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
161624529|NCT02123797|583675297|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
161624530|NCT02123797|583675293|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
161624531|NCT02123797|583675294|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
161624532|NCT02123797|583675295|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
161624533|NCT02123797|583675296|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
161624534|NCT02123797|583675297|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
161624535|NCT02123797|583675293|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
161624536|NCT02123797|583675294|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
161624537|NCT02123797|583675295|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
161624538|NCT02123797|583675296|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
161624539|NCT02123797|583675297|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
161624540|NCT02123797|583675293|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
161624541|NCT02123797|583675294|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
161624542|NCT02123797|583675295|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161624543|NCT02123797|583675296|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161624544|NCT02123797|583675297|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161624545|NCT02123797|583675293|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
161624546|NCT02123797|583675294|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
161624547|NCT02123797|583675295|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
161624548|NCT02123797|583675296|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
161624549|NCT02123797|583675297|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
161624550|NCT01375777|583675303|FG000|Overall Study|Withdrawal by Subject|0|||
161624551|NCT01375777|583675304|FG001|Overall Study|Withdrawal by Subject|2|||
161624552|NCT01375777|583675305|FG002|Overall Study|Withdrawal by Subject|1|||
161624553|NCT01375777|583675306|FG003|Overall Study|Withdrawal by Subject|0|||
161624554|NCT01375777|583675307|FG004|Overall Study|Withdrawal by Subject|1|||
161624555|NCT01375777|583675308|FG005|Overall Study|Withdrawal by Subject|1|||
161624556|NCT01375777|583675309|FG006|Overall Study|Withdrawal by Subject|1|||
161624557|NCT01375777|583675310|FG007|Overall Study|Withdrawal by Subject|2|||
161624558|NCT01375777|583675311|FG008|Overall Study|Withdrawal by Subject|1|||
161624559|NCT01375777|583675303|FG000|Overall Study|Lost to Follow-up|1|||
161624560|NCT01375777|583675304|FG001|Overall Study|Lost to Follow-up|0|||
161624561|NCT01375777|583675305|FG002|Overall Study|Lost to Follow-up|0|||
161624562|NCT01375777|583675306|FG003|Overall Study|Lost to Follow-up|0|||
161624563|NCT01375777|583675307|FG004|Overall Study|Lost to Follow-up|0|||
161624564|NCT01375777|583675308|FG005|Overall Study|Lost to Follow-up|0|||
161624565|NCT01375777|583675309|FG006|Overall Study|Lost to Follow-up|1|||
161624566|NCT01375777|583675310|FG007|Overall Study|Lost to Follow-up|0|||
161624567|NCT01375777|583675311|FG008|Overall Study|Lost to Follow-up|0|||
161624568|NCT01375777|583675303|FG000|Overall Study|Other|1|||
161624569|NCT01375777|583675304|FG001|Overall Study|Other|1|||
161624570|NCT01375777|583675305|FG002|Overall Study|Other|0|||
161624571|NCT01375777|583675306|FG003|Overall Study|Other|0|||
161624572|NCT01375777|583675307|FG004|Overall Study|Other|0|||
161624573|NCT01375777|583675308|FG005|Overall Study|Other|0|||
161624574|NCT01375777|583675309|FG006|Overall Study|Other|0|||
161624575|NCT01375777|583675310|FG007|Overall Study|Other|0|||
161833177|NCT04974619|584431018|FG001|Overall Study|Withdrawal by Subject|0|||
161624576|NCT01375777|583675311|FG008|Overall Study|Other|1|||
161624577|NCT00355784|583675312|FG000|Overall Study|Withdrawal by Subject|0|||
161624578|NCT00355784|583675313|FG001|Overall Study|Withdrawal by Subject|0|||
161624579|NCT00355784|583675314|FG002|Overall Study|Withdrawal by Subject|2|||
161624580|NCT03602053|583675321|FG000|Overall Study|Withdrawal by Subject|7|||
161624581|NCT03602053|583675322|FG001|Overall Study|Withdrawal by Subject|9|||
161624582|NCT03602053|583675323|FG002|Overall Study|Withdrawal by Subject|7|||
161624583|NCT03602053|583675321|FG000|Overall Study|Lost to Follow-up|5|||
161624584|NCT03602053|583675322|FG001|Overall Study|Lost to Follow-up|6|||
161624585|NCT03602053|583675323|FG002|Overall Study|Lost to Follow-up|0|||
161624586|NCT03602053|583675321|FG000|Overall Study|Protocol Violation|3|||
161624587|NCT03602053|583675322|FG001|Overall Study|Protocol Violation|0|||
161624588|NCT03602053|583675323|FG002|Overall Study|Protocol Violation|4|||
161624589|NCT03602053|583675321|FG000|Overall Study|Physician Decision|1|||
161624590|NCT03602053|583675322|FG001|Overall Study|Physician Decision|0|||
161624591|NCT03602053|583675323|FG002|Overall Study|Physician Decision|0|||
161624592|NCT03602053|583675321|FG000|Overall Study|migration|2|||
161624593|NCT03602053|583675322|FG001|Overall Study|migration|3|||
161624594|NCT03602053|583675323|FG002|Overall Study|migration|0|||
161624595|NCT03602053|583675321|FG000|Overall Study|Other|1|||
161624596|NCT03602053|583675322|FG001|Overall Study|Other|0|||
161624597|NCT03602053|583675323|FG002|Overall Study|Other|0|||
161624598|NCT01234675|583675330|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
161624599|NCT01234675|583675331|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
161624600|NCT01234675|583675330|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161624601|NCT01234675|583675331|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
161624602|NCT03696342|583675332|FG000|Overall Study|Lost to Follow-up|1|||
161624603|NCT03696342|583675333|FG001|Overall Study|Lost to Follow-up|0|||
161624604|NCT02409732|583675334|FG000|Overall Study|Withdrawal by Subject|4|||
161624605|NCT02409732|583675334|FG000|Overall Study|Lost to Follow-up|2|||
161624606|NCT01870999|583675336|FG000|Overall Study|Adverse Event|0|||
161624607|NCT01870999|583675337|FG001|Overall Study|Adverse Event|4|||
161624608|NCT01870999|583675338|FG002|Overall Study|Adverse Event|1|||
161624609|NCT01870999|583675336|FG000|Overall Study|Subject met withdrawal criteria|3|||
161624610|NCT01870999|583675337|FG001|Overall Study|Subject met withdrawal criteria|2|||
161624611|NCT01870999|583675338|FG002|Overall Study|Subject met withdrawal criteria|0|||
161624612|NCT01870999|583675336|FG000|Overall Study|Subject withdrawn by Investigator|1|||
161624613|NCT01870999|583675337|FG001|Overall Study|Subject withdrawn by Investigator|0|||
161624614|NCT01870999|583675338|FG002|Overall Study|Subject withdrawn by Investigator|0|||
161624615|NCT01870999|583675336|FG000|Overall Study|Withdrawal by Subject|0|||
161624616|NCT01870999|583675337|FG001|Overall Study|Withdrawal by Subject|2|||
161624617|NCT01870999|583675338|FG002|Overall Study|Withdrawal by Subject|5|||
161624618|NCT01870999|583675336|FG000|Overall Study|Protocol Violation|0|||
161624619|NCT01870999|583675337|FG001|Overall Study|Protocol Violation|0|||
161624620|NCT01870999|583675338|FG002|Overall Study|Protocol Violation|1|||
161624621|NCT03034772|583675339|FG000|Overall Study|Adverse Event|0|||
161624622|NCT03034772|583675340|FG001|Overall Study|Adverse Event|1|||
161624623|NCT03034772|583675339|FG000|Overall Study|Withdrawal by Subject|0|||
161624624|NCT03034772|583675340|FG001|Overall Study|Withdrawal by Subject|1|||
161624625|NCT00116584|583675341|FG000|Overall Study|Withdrawal by Subject|1|||
161624626|NCT00116584|583675342|FG001|Overall Study|Withdrawal by Subject|0|||
161624627|NCT00116584|583675341|FG000|Overall Study|Protocol Violation|1|||
161624628|NCT00116584|583675342|FG001|Overall Study|Protocol Violation|1|||
161624629|NCT00105521|583675348|FG000|Overall Study|Other|1|||
161624630|NCT00105521|583675349|FG001|Overall Study|Other|1|||
161624631|NCT00105521|583675350|FG002|Overall Study|Other|2|||
161624632|NCT00105521|583675351|FG003|Overall Study|Other|0|||
161624633|NCT00105521|583675348|FG000|Overall Study|Adverse Event|10|||
161624634|NCT00105521|583675349|FG001|Overall Study|Adverse Event|4|||
161624635|NCT00105521|583675350|FG002|Overall Study|Adverse Event|10|||
161624636|NCT00105521|583675351|FG003|Overall Study|Adverse Event|8|||
161624637|NCT00105521|583675348|FG000|Overall Study|Withdrawal by Subject|1|||
161624638|NCT00105521|583675349|FG001|Overall Study|Withdrawal by Subject|0|||
161624639|NCT00105521|583675350|FG002|Overall Study|Withdrawal by Subject|1|||
161624640|NCT00105521|583675351|FG003|Overall Study|Withdrawal by Subject|4|||
161624641|NCT00105521|583675348|FG000|Overall Study|Lack of Efficacy|0|||
161624642|NCT00105521|583675349|FG001|Overall Study|Lack of Efficacy|0|||
161624643|NCT00105521|583675350|FG002|Overall Study|Lack of Efficacy|0|||
161685053|NCT02409290|583899640|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161624644|NCT00105521|583675351|FG003|Overall Study|Lack of Efficacy|1|||
161685054|NCT04251910|583899645|FG000|Overall Study|Covid 19 lockdown|0|||
161624645|NCT00105521|583675348|FG000|Overall Study|Protocol Violation|3|||
161624646|NCT00105521|583675349|FG001|Overall Study|Protocol Violation|5|||
161624647|NCT00105521|583675350|FG002|Overall Study|Protocol Violation|4|||
161624648|NCT00105521|583675351|FG003|Overall Study|Protocol Violation|4|||
161624649|NCT00105521|583675348|FG000|Overall Study|Lost to Follow-up|0|||
161624650|NCT00105521|583675349|FG001|Overall Study|Lost to Follow-up|1|||
161624651|NCT00105521|583675350|FG002|Overall Study|Lost to Follow-up|0|||
161624652|NCT00105521|583675351|FG003|Overall Study|Lost to Follow-up|0|||
161624653|NCT00385697|583675353|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
161624654|NCT00385697|583675354|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
161624655|NCT00385697|583675355|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
161624656|NCT00385697|583675356|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
161624657|NCT00385697|583675357|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
161624658|NCT00385697|583675353|FG000|Open-label Segment 1|Lost to Follow-up|1|||
161624659|NCT00385697|583675354|FG001|Open-label Segment 1|Lost to Follow-up|0|||
161624660|NCT00385697|583675355|FG002|Open-label Segment 1|Lost to Follow-up|0|||
161624661|NCT00385697|583675356|FG003|Open-label Segment 1|Lost to Follow-up|0|||
161624662|NCT00385697|583675357|FG004|Open-label Segment 1|Lost to Follow-up|0|||
161624663|NCT00385697|583675353|FG000|Double-blind Segment 2|Adverse Event|0|||
161624664|NCT00385697|583675354|FG001|Double-blind Segment 2|Adverse Event|3|||
161624665|NCT00385697|583675355|FG002|Double-blind Segment 2|Adverse Event|1|||
161624666|NCT00385697|583675356|FG003|Double-blind Segment 2|Adverse Event|0|||
161624667|NCT00385697|583675357|FG004|Double-blind Segment 2|Adverse Event|0|||
161624668|NCT00385697|583675353|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
161624669|NCT00385697|583675354|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
161624670|NCT00385697|583675355|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
161624671|NCT00385697|583675356|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
161624672|NCT00385697|583675357|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
161624673|NCT00385697|583675353|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
161624674|NCT00385697|583675354|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
161624675|NCT00385697|583675355|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
161624676|NCT00385697|583675356|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
161624677|NCT00385697|583675357|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
161624678|NCT00385697|583675353|FG000|Double-blind Segment 2|Other|0|||
161624679|NCT00385697|583675354|FG001|Double-blind Segment 2|Other|2|||
161624680|NCT00385697|583675355|FG002|Double-blind Segment 2|Other|0|||
161624681|NCT00385697|583675356|FG003|Double-blind Segment 2|Other|0|||
161624682|NCT00385697|583675357|FG004|Double-blind Segment 2|Other|0|||
161624683|NCT01721109|583675368|FG000|Overall Study|Lack of Efficacy|1|||
161624684|NCT01721109|583675368|FG000|Overall Study|Non- Compliance with Study Drug|3|||
161624685|NCT01721109|583675368|FG000|Overall Study|Withdrew Consent|1|||
161624686|NCT01721109|583675368|FG000|Overall Study|Lost to Follow-up|2|||
161624687|NCT03045302|583675369|FG000|Overall Study|Pre-treatment adverse event|1|||
161624688|NCT00134056|583675370|FG000|Randomization|Not eligible for assigned treatment|22|||
161624689|NCT00134056|583675371|FG001|Randomization|Not eligible for assigned treatment|20|||
161624690|NCT00134056|583675370|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
161624691|NCT00134056|583675371|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
161624692|NCT00134056|583675370|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
161624693|NCT00134056|583675371|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
161624694|NCT00134056|583675370|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
161624695|NCT00134056|583675371|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
161624696|NCT00134056|583675370|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
161624697|NCT00134056|583675371|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
161624698|NCT00742560|583675373|FG000|Overall Study|Adverse Event|0|||
161624699|NCT00742560|583675374|FG001|Overall Study|Adverse Event|0|||
161624700|NCT00742560|583675375|FG002|Overall Study|Adverse Event|1|||
161624701|NCT00742560|583675376|FG003|Overall Study|Adverse Event|1|||
161624702|NCT00742560|583675377|FG004|Overall Study|Adverse Event|1|||
161624703|NCT00742560|583675373|FG000|Overall Study|Death|0|||
161624704|NCT00742560|583675374|FG001|Overall Study|Death|2|||
161624705|NCT00742560|583675375|FG002|Overall Study|Death|0|||
161624706|NCT00742560|583675376|FG003|Overall Study|Death|2|||
161624707|NCT00742560|583675377|FG004|Overall Study|Death|3|||
161624708|NCT00742560|583675373|FG000|Overall Study|Subject's Decision|1|||
161685055|NCT04251910|583899646|FG001|Overall Study|Covid 19 lockdown|5|||
161685056|NCT04251910|583899647|FG002|Overall Study|Covid 19 lockdown|0|||
161685057|NCT04251910|583899648|FG003|Overall Study|Covid 19 lockdown|4|||
161624709|NCT00742560|583675374|FG001|Overall Study|Subject's Decision|0|||
161624710|NCT00742560|583675375|FG002|Overall Study|Subject's Decision|2|||
161624711|NCT00742560|583675376|FG003|Overall Study|Subject's Decision|3|||
161624712|NCT00742560|583675377|FG004|Overall Study|Subject's Decision|3|||
161624713|NCT00742560|583675373|FG000|Overall Study|Investigator's Decision|0|||
161624714|NCT00742560|583675374|FG001|Overall Study|Investigator's Decision|0|||
161624715|NCT00742560|583675375|FG002|Overall Study|Investigator's Decision|4|||
161624716|NCT00742560|583675376|FG003|Overall Study|Investigator's Decision|1|||
161624717|NCT00742560|583675377|FG004|Overall Study|Investigator's Decision|0|||
161624718|NCT00742560|583675373|FG000|Overall Study|Disease Progression|1|||
161624719|NCT00742560|583675374|FG001|Overall Study|Disease Progression|0|||
161624720|NCT00742560|583675375|FG002|Overall Study|Disease Progression|5|||
161624721|NCT00742560|583675376|FG003|Overall Study|Disease Progression|17|||
161624722|NCT00742560|583675377|FG004|Overall Study|Disease Progression|16|||
161624723|NCT00742560|583675373|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
161624724|NCT00742560|583675374|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
161624725|NCT00742560|583675375|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
161833178|NCT04974619|584431019|FG002|Overall Study|Withdrawal by Subject|1|||
161833179|NCT04974619|584431017|FG000|Overall Study|Protocol Violation|0|||
161833180|NCT04974619|584431018|FG001|Overall Study|Protocol Violation|1|||
161833181|NCT04974619|584431019|FG002|Overall Study|Protocol Violation|0|||
161833182|NCT01688466|584431020|FG000|Overall Study|Withdrawal by Subject|2|||
161833183|NCT01688466|584431021|FG001|Overall Study|Withdrawal by Subject|1|||
161833184|NCT01688466|584431020|FG000|Overall Study|Death|0|||
161833185|NCT01688466|584431021|FG001|Overall Study|Death|1|||
161833186|NCT01688466|584431020|FG000|Overall Study|Adverse Event|0|||
161833187|NCT01688466|584431021|FG001|Overall Study|Adverse Event|4|||
161833188|NCT01688466|584431020|FG000|Overall Study|Not evaluable|0|||
161833189|NCT01688466|584431021|FG001|Overall Study|Not evaluable|1|||
161833190|NCT02516410|584431024|FG000|Overall Study|Adverse Event|0|||
161833191|NCT02516410|584431025|FG001|Overall Study|Adverse Event|1|||
161833192|NCT02516410|584431024|FG000|Overall Study|Withdrawal by Subject|0|||
161833193|NCT02516410|584431025|FG001|Overall Study|Withdrawal by Subject|1|||
161833194|NCT01286558|584431026|FG000|Overall Study|Adverse Event|1|||
161833195|NCT01286558|584431027|FG001|Overall Study|Adverse Event|1|||
161833196|NCT01286558|584431026|FG000|Overall Study|Withdrawal by Subject|0|||
161833197|NCT01286558|584431027|FG001|Overall Study|Withdrawal by Subject|1|||
161833198|NCT01220297|584431028|FG000|Overall Study|Death|2|||
161833199|NCT01220297|584431028|FG000|Overall Study|Lost to Follow-up|1|||
161833200|NCT01787279|584431030|FG000|Overall Study|Lost to Follow-up|2|||
161833201|NCT01787279|584431030|FG000|Overall Study|Lack of Efficacy|1|||
161833202|NCT02148913|584431031|FG000|Overall Study|Death|0|||
161833203|NCT02148913|584431032|FG001|Overall Study|Death|1|||
161833204|NCT02148913|584431033|FG002|Overall Study|Death|0|||
161833205|NCT02148913|584431034|FG003|Overall Study|Death|0|||
161833206|NCT01287039|584431036|FG000|Overall Study|Noncompliance with study procedures|0|||
161833207|NCT01287039|584431037|FG001|Overall Study|Noncompliance with study procedures|1|||
161833208|NCT01287039|584431036|FG000|Overall Study|Change of location/residence|0|||
161833209|NCT01287039|584431037|FG001|Overall Study|Change of location/residence|3|||
161833210|NCT01287039|584431036|FG000|Overall Study|Elective surgery|0|||
161833211|NCT01287039|584431037|FG001|Overall Study|Elective surgery|1|||
161833212|NCT01287039|584431036|FG000|Overall Study|Protocol Violation|2|||
161833213|NCT01287039|584431037|FG001|Overall Study|Protocol Violation|3|||
161833214|NCT01287039|584431036|FG000|Overall Study|Excluded medication taken|1|||
161833215|NCT01287039|584431037|FG001|Overall Study|Excluded medication taken|0|||
161833216|NCT01287039|584431036|FG000|Overall Study|Noncompliance with study medication|0|||
161833217|NCT01287039|584431037|FG001|Overall Study|Noncompliance with study medication|1|||
161833218|NCT01287039|584431036|FG000|Overall Study|Problem with travel|0|||
161833219|NCT01287039|584431037|FG001|Overall Study|Problem with travel|1|||
161833220|NCT01287039|584431036|FG000|Overall Study|Death|1|||
161833221|NCT01287039|584431037|FG001|Overall Study|Death|0|||
161833222|NCT01287039|584431036|FG000|Overall Study|Change of residence|1|||
161833223|NCT01287039|584431037|FG001|Overall Study|Change of residence|0|||
161833224|NCT01287039|584431036|FG000|Overall Study|Adverse Event|7|||
161833225|NCT01287039|584431037|FG001|Overall Study|Adverse Event|4|||
161833226|NCT01287039|584431036|FG000|Overall Study|Withdrawal by Subject|14|||
161833227|NCT01287039|584431037|FG001|Overall Study|Withdrawal by Subject|11|||
161833228|NCT01287039|584431036|FG000|Overall Study|Lost to Follow-up|3|||
161833229|NCT01287039|584431037|FG001|Overall Study|Lost to Follow-up|2|||
161833230|NCT01360866|584431038|FG000|Overall Study|Lost to Follow-up|11|||
161833231|NCT01360866|584431039|FG001|Overall Study|Lost to Follow-up|28|||
161833232|NCT01360866|584431040|FG002|Overall Study|Lost to Follow-up|41|||
161833233|NCT01360866|584431041|FG003|Overall Study|Lost to Follow-up|0|||
161833234|NCT01360866|584431038|FG000|Overall Study|Adverse Event|56|||
161833235|NCT01360866|584431039|FG001|Overall Study|Adverse Event|61|||
161833236|NCT01360866|584431040|FG002|Overall Study|Adverse Event|134|||
161833237|NCT01360866|584431041|FG003|Overall Study|Adverse Event|6|||
161833238|NCT01360866|584431038|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
161833239|NCT01360866|584431039|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
161833240|NCT01360866|584431040|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
161833241|NCT01360866|584431041|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
161833242|NCT01360866|584431038|FG000|Overall Study|Withdrawn by Investigator|9|||
161833243|NCT01360866|584431039|FG001|Overall Study|Withdrawn by Investigator|8|||
161833244|NCT01360866|584431040|FG002|Overall Study|Withdrawn by Investigator|31|||
161624726|NCT00742560|583675376|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
161624727|NCT00742560|583675377|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
161833245|NCT01360866|584431041|FG003|Overall Study|Withdrawn by Investigator|2|||
161833246|NCT01360866|584431038|FG000|Overall Study|Withdrawal by participant|79|||
161833247|NCT01360866|584431039|FG001|Overall Study|Withdrawal by participant|89|||
161833248|NCT01360866|584431040|FG002|Overall Study|Withdrawal by participant|168|||
161833249|NCT01360866|584431041|FG003|Overall Study|Withdrawal by participant|8|||
161833250|NCT01360866|584431038|FG000|Overall Study|Protocol Deviation|25|||
161833251|NCT01360866|584431039|FG001|Overall Study|Protocol Deviation|33|||
161833252|NCT01360866|584431040|FG002|Overall Study|Protocol Deviation|61|||
161833253|NCT01360866|584431041|FG003|Overall Study|Protocol Deviation|2|||
161833254|NCT01360866|584431038|FG000|Overall Study|Lack of Efficacy|30|||
161833255|NCT01360866|584431039|FG001|Overall Study|Lack of Efficacy|40|||
161833256|NCT01360866|584431040|FG002|Overall Study|Lack of Efficacy|30|||
161833257|NCT01360866|584431041|FG003|Overall Study|Lack of Efficacy|4|||
161833258|NCT05016622|584431042|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
161833259|NCT05016622|584431042|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
161833260|NCT03575871|584431051|FG000|Overall Study|Adverse Event|5|||
161833261|NCT03575871|584431052|FG001|Overall Study|Adverse Event|5|||
161833262|NCT03575871|584431053|FG002|Overall Study|Adverse Event|8|||
161833263|NCT03575871|584431051|FG000|Overall Study|Death|1|||
161833264|NCT03575871|584431052|FG001|Overall Study|Death|0|||
161833265|NCT03575871|584431053|FG002|Overall Study|Death|0|||
161833266|NCT03575871|584431051|FG000|Overall Study|Lack of Efficacy|5|||
161833267|NCT03575871|584431052|FG001|Overall Study|Lack of Efficacy|4|||
161833268|NCT03575871|584431053|FG002|Overall Study|Lack of Efficacy|7|||
161833269|NCT03575871|584431051|FG000|Overall Study|Lost to Follow-up|1|||
161833270|NCT03575871|584431052|FG001|Overall Study|Lost to Follow-up|1|||
161833271|NCT03575871|584431053|FG002|Overall Study|Lost to Follow-up|1|||
161833272|NCT03575871|584431051|FG000|Overall Study|Protocol Deviation|1|||
161833273|NCT03575871|584431052|FG001|Overall Study|Protocol Deviation|1|||
161833274|NCT03575871|584431053|FG002|Overall Study|Protocol Deviation|1|||
161833275|NCT03575871|584431051|FG000|Overall Study|Withdrawal by Subject|6|||
161624728|NCT00742560|583675373|FG000|Overall Study|Other|0|||
161624729|NCT00742560|583675374|FG001|Overall Study|Other|1|||
161624730|NCT00742560|583675375|FG002|Overall Study|Other|8|||
161624731|NCT00742560|583675376|FG003|Overall Study|Other|9|||
161624732|NCT00742560|583675377|FG004|Overall Study|Other|9|||
161624733|NCT00742560|583675373|FG000|Overall Study|MIssing|0|||
161624734|NCT00742560|583675374|FG001|Overall Study|MIssing|0|||
161624735|NCT00742560|583675375|FG002|Overall Study|MIssing|0|||
161624736|NCT00742560|583675376|FG003|Overall Study|MIssing|0|||
161624737|NCT00742560|583675377|FG004|Overall Study|MIssing|1|||
161624738|NCT01536795|583675378|FG000|Overall Study|Lost to Follow-up|0|||
161624739|NCT01536795|583675379|FG001|Overall Study|Lost to Follow-up|2|||
161624740|NCT01536795|583675378|FG000|Overall Study|Lack of Efficacy|1|||
161624741|NCT01536795|583675379|FG001|Overall Study|Lack of Efficacy|0|||
161624742|NCT02267746|583675380|FG000|Overall Study|Adverse Event|0|||
161624743|NCT02267746|583675381|FG001|Overall Study|Adverse Event|2|||
161624744|NCT02267746|583675382|FG002|Overall Study|Adverse Event|1|||
161624745|NCT02267746|583675380|FG000|Overall Study|Protocol Violation|8|||
161624746|NCT02267746|583675381|FG001|Overall Study|Protocol Violation|7|||
161624747|NCT02267746|583675382|FG002|Overall Study|Protocol Violation|3|||
161624748|NCT02267746|583675380|FG000|Overall Study|Lack of Efficacy|11|||
161624749|NCT02267746|583675381|FG001|Overall Study|Lack of Efficacy|11|||
161624750|NCT02267746|583675382|FG002|Overall Study|Lack of Efficacy|15|||
161624751|NCT02267746|583675380|FG000|Overall Study|Protocol Violation|1|||
161624752|NCT02267746|583675381|FG001|Overall Study|Protocol Violation|2|||
161624753|NCT02267746|583675382|FG002|Overall Study|Protocol Violation|1|||
161624754|NCT02267746|583675380|FG000|Overall Study|Miscellaneous|1|||
161624755|NCT02267746|583675381|FG001|Overall Study|Miscellaneous|0|||
161624756|NCT02267746|583675382|FG002|Overall Study|Miscellaneous|1|||
161624757|NCT05008224|583675383|FG000|Overall Study|Death|3|||
161833276|NCT03575871|584431052|FG001|Overall Study|Withdrawal by Subject|1|||
161833277|NCT03575871|584431053|FG002|Overall Study|Withdrawal by Subject|9|||
161833278|NCT03575871|584431051|FG000|Overall Study|Other than specified|2|||
161833279|NCT03575871|584431052|FG001|Overall Study|Other than specified|2|||
161833280|NCT03575871|584431053|FG002|Overall Study|Other than specified|0|||
161833281|NCT05506358|584431054|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
161624758|NCT05008224|583675383|FG000|Overall Study|Lost to Follow-up|2|||
161624759|NCT05008224|583675383|FG000|Overall Study|Did Not Continue on Extension Study|39|||
161624760|NCT05008224|583675383|FG000|Overall Study|Transferred to Extension Study|100|||
161624761|NCT05008224|583675383|FG000|Overall Study|Withdrawal by Subject|2|||
161833282|NCT05506358|584431055|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161833283|NCT05506358|584431056|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161833284|NCT05506358|584431057|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161833285|NCT05506358|584431058|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161624762|NCT00348283|583675384|FG000|Induction|Adverse Event|0|||
161624763|NCT00348283|583675385|FG001|Induction|Adverse Event|2|||
161624764|NCT00348283|583675384|FG000|Induction|Protocol Violation|0|||
161624765|NCT00348283|583675385|FG001|Induction|Protocol Violation|4|||
161624766|NCT00348283|583675384|FG000|Double Blind|Adverse Event|2|||
161624767|NCT00348283|583675385|FG001|Double Blind|Adverse Event|5|||
161624768|NCT00348283|583675384|FG000|Double Blind|Withdrawal by Subject|1|||
161624769|NCT00348283|583675385|FG001|Double Blind|Withdrawal by Subject|1|||
161624770|NCT00348283|583675384|FG000|Double Blind|Protocol Violation|0|||
161685058|NCT04251910|583899649|FG004|Overall Study|Covid 19 lockdown|0|||
161624771|NCT00348283|583675385|FG001|Double Blind|Protocol Violation|1|||
161624772|NCT00348283|583675384|FG000|Double Blind|Lack of Efficacy|2|||
161624773|NCT00348283|583675385|FG001|Double Blind|Lack of Efficacy|2|||
161624774|NCT00348283|583675384|FG000|Double Blind|Pregnancy|0|||
161624775|NCT00348283|583675385|FG001|Double Blind|Pregnancy|1|||
161624776|NCT00348283|583675384|FG000|Open Label|Adverse Event|0|||
161624777|NCT00348283|583675385|FG001|Open Label|Adverse Event|8|||
161624778|NCT00348283|583675384|FG000|Open Label|Withdrawal by Subject|0|||
161624779|NCT00348283|583675385|FG001|Open Label|Withdrawal by Subject|4|||
161624780|NCT00348283|583675384|FG000|Open Label|Lost to Follow-up|0|||
161624781|NCT00348283|583675385|FG001|Open Label|Lost to Follow-up|1|||
161624782|NCT00348283|583675384|FG000|Open Label|Lack of Efficacy|0|||
161624783|NCT00348283|583675385|FG001|Open Label|Lack of Efficacy|13|||
161624784|NCT00348283|583675384|FG000|Open Label|Administrative reasons|0|||
161624785|NCT00348283|583675385|FG001|Open Label|Administrative reasons|5|||
161624786|NCT00348283|583675384|FG000|Open Label|Subject moved to the United States|0|||
161624787|NCT00348283|583675385|FG001|Open Label|Subject moved to the United States|1|||
161624788|NCT00348283|583675384|FG000|Open Label|Pregnancy|0|||
161624789|NCT00348283|583675385|FG001|Open Label|Pregnancy|1|||
161624790|NCT00348283|583675384|FG000|Open Label|Sponsor decision|0|||
161624791|NCT00348283|583675385|FG001|Open Label|Sponsor decision|1|||
161624792|NCT05878522|583675389|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624793|NCT05878522|583675390|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624794|NCT05878522|583675391|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624795|NCT05878522|583675392|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624796|NCT05878522|583675393|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624797|NCT05878522|583675394|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624798|NCT05878522|583675395|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624799|NCT05878522|583675396|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624800|NCT05878522|583675397|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
161624801|NCT05878522|583675398|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624802|NCT05878522|583675399|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624803|NCT05878522|583675400|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161624804|NCT05878522|583675389|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
161624805|NCT05878522|583675390|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624806|NCT05878522|583675391|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624807|NCT05878522|583675392|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624808|NCT05878522|583675393|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624809|NCT05878522|583675394|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624810|NCT05878522|583675395|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624811|NCT05878522|583675396|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624812|NCT05878522|583675397|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624813|NCT05878522|583675398|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
161624814|NCT05878522|583675399|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624815|NCT05878522|583675400|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161624816|NCT05878522|583675389|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624817|NCT05878522|583675390|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
161624818|NCT05878522|583675391|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624819|NCT05878522|583675392|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
161624820|NCT05878522|583675393|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624821|NCT05878522|583675394|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624822|NCT05878522|583675395|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624823|NCT05878522|583675396|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161685059|NCT04251910|583899650|FG005|Overall Study|Covid 19 lockdown|0|||
161685060|NCT04251910|583899645|FG000|Overall Study|Assisted living facility was closed|0|||
161685061|NCT04251910|583899646|FG001|Overall Study|Assisted living facility was closed|0|||
161624824|NCT05878522|583675397|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624825|NCT05878522|583675398|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624826|NCT05878522|583675399|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624827|NCT05878522|583675400|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161624828|NCT05878522|583675389|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624829|NCT05878522|583675390|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624830|NCT05878522|583675391|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624831|NCT05878522|583675392|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624832|NCT05878522|583675393|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
161624833|NCT05878522|583675394|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624834|NCT05878522|583675395|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161685062|NCT04251910|583899647|FG002|Overall Study|Assisted living facility was closed|0|||
161624835|NCT05878522|583675396|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624836|NCT05878522|583675397|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624837|NCT05878522|583675398|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624838|NCT05878522|583675399|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624839|NCT05878522|583675400|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161624840|NCT05263492|583675401|FG000|Overall Study|Adverse Event|1|||
161624841|NCT05263492|583675401|FG000|Overall Study|Disease progression during active treatment|3|||
161624842|NCT02058992|583675404|FG000|Overall Study|Lost to Follow-up|4|||
161624843|NCT02058992|583675404|FG000|Overall Study|Protocol Violation|92|||
161624844|NCT02058992|583675404|FG000|Overall Study|CRF Uncollected|20|||
161624845|NCT03747575|583675405|FG000|Overall Study|Withdrawal by Subject|6|||
161624846|NCT03747575|583675406|FG001|Overall Study|Withdrawal by Subject|3|||
161624847|NCT03747575|583675405|FG000|Overall Study|Lost to Follow-up|3|||
161624848|NCT03747575|583675406|FG001|Overall Study|Lost to Follow-up|3|||
161624849|NCT03747575|583675405|FG000|Overall Study|Adverse Event|0|||
161624850|NCT03747575|583675406|FG001|Overall Study|Adverse Event|1|||
161624851|NCT01549951|583675407|FG000|Overall Study|Adverse Event|15|||
161624852|NCT01549951|583675407|FG000|Overall Study|Withdrawal by Subject|2|||
161624853|NCT01549951|583675407|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161624854|NCT01549951|583675407|FG000|Overall Study|Progressive disease|29|||
161624855|NCT01549951|583675407|FG000|Overall Study|Symptomatic deterioration|1|||
161363814|NCT02544763|582720032|FG001|Overall Study|Adverse Event|8|||
161624856|NCT01549951|583675407|FG000|Overall Study|Other|2|||
161624857|NCT02009865|583675416|FG000|Overall Study|Adverse Event|0|||
161624858|NCT02009865|583675417|FG001|Overall Study|Adverse Event|2|||
161624859|NCT02009865|583675416|FG000|Overall Study|Protocol Violation|0|||
161624860|NCT02009865|583675417|FG001|Overall Study|Protocol Violation|2|||
161624861|NCT02009865|583675416|FG000|Overall Study|Withdrawal by Subject|1|||
161624862|NCT02009865|583675417|FG001|Overall Study|Withdrawal by Subject|1|||
161624863|NCT03689452|583675419|FG000|Overall Study|Lost to Follow-up|1|||
161624864|NCT03689452|583675420|FG001|Overall Study|Lost to Follow-up|1|||
161624865|NCT00525915|583675421|FG000|Overall Study|Non-Compliance|0|||
161624866|NCT00525915|583675422|FG001|Overall Study|Non-Compliance|1|||
161624867|NCT00525915|583675421|FG000|Overall Study|Disease Progression|5|||
161624868|NCT00525915|583675422|FG001|Overall Study|Disease Progression|6|||
161624869|NCT00525915|583675421|FG000|Overall Study|Withdrawal by Subject|1|||
161624870|NCT00525915|583675422|FG001|Overall Study|Withdrawal by Subject|0|||
161624871|NCT00525915|583675421|FG000|Overall Study|Refused Surgery|1|||
161624872|NCT00525915|583675422|FG001|Overall Study|Refused Surgery|2|||
161624873|NCT00525915|583675421|FG000|Overall Study|Unrelated illness|1|||
161624874|NCT00525915|583675422|FG001|Overall Study|Unrelated illness|0|||
161624875|NCT00732498|583675423|FG000|Overall Study|Ineligible|1|||
161624876|NCT00732498|583675423|FG000|Overall Study|Adverse Event|2|||
161624877|NCT00732498|583675423|FG000|Overall Study|Physician Decision|3|||
161624878|NCT03394508|583675426|FG000|Overall Study|Protocol Violation|0|||
161624879|NCT03394508|583675427|FG001|Overall Study|Protocol Violation|3|||
161624880|NCT03394508|583675426|FG000|Overall Study|Lost to Follow-up|1|||
161624881|NCT03394508|583675427|FG001|Overall Study|Lost to Follow-up|0|||
161624882|NCT00267865|583675428|FG000|Induction Treatment|Died before completing.|2|||
161624883|NCT00267865|583675428|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
161624884|NCT01755598|583675429|FG000|Overall Study|Other|109|||
161624885|NCT01755598|583675430|FG001|Overall Study|Other|109|||
161624886|NCT01755598|583675429|FG000|Overall Study|Lost to Follow-up|32|||
161624887|NCT01755598|583675430|FG001|Overall Study|Lost to Follow-up|43|||
161624888|NCT01755598|583675429|FG000|Overall Study|Migrated/moved from study area|76|||
161624889|NCT01755598|583675430|FG001|Overall Study|Migrated/moved from study area|65|||
161624890|NCT01755598|583675429|FG000|Overall Study|Withdrawal by Subject|22|||
161624891|NCT01755598|583675430|FG001|Overall Study|Withdrawal by Subject|31|||
161624892|NCT01755598|583675429|FG000|Overall Study|Protocol Violation|7|||
161624893|NCT01755598|583675430|FG001|Overall Study|Protocol Violation|7|||
161624894|NCT01755598|583675429|FG000|Overall Study|Adverse Event|19|||
161624895|NCT01755598|583675430|FG001|Overall Study|Adverse Event|28|||
161624896|NCT01002547|583677316|FG000|Overall Study|Withdrawal by Subject|4|||
161624897|NCT01002547|583677317|FG001|Overall Study|Withdrawal by Subject|0|||
161624898|NCT01002547|583677318|FG002|Overall Study|Withdrawal by Subject|5|||
161624899|NCT01002547|583677316|FG000|Overall Study|Lost to Follow-up|2|||
161624900|NCT01002547|583677317|FG001|Overall Study|Lost to Follow-up|1|||
161624901|NCT01002547|583677318|FG002|Overall Study|Lost to Follow-up|1|||
161624902|NCT01002547|583677316|FG000|Overall Study|Physician Decision|1|||
161624903|NCT01002547|583677317|FG001|Overall Study|Physician Decision|0|||
161624904|NCT01002547|583677318|FG002|Overall Study|Physician Decision|0|||
161624905|NCT01002547|583677316|FG000|Overall Study|Death|0|||
161624906|NCT01002547|583677317|FG001|Overall Study|Death|2|||
161624907|NCT01002547|583677318|FG002|Overall Study|Death|2|||
161624908|NCT01002547|583677316|FG000|Overall Study|Adverse Event|1|||
161624909|NCT01002547|583677317|FG001|Overall Study|Adverse Event|0|||
161624910|NCT01002547|583677318|FG002|Overall Study|Adverse Event|0|||
161624911|NCT01184859|583677326|FG000|Period 1: Single Dose|Insufficient urine production|0|||
161624912|NCT01184859|583677327|FG001|Period 1: Single Dose|Insufficient urine production|1|||
161624913|NCT01184859|583677328|FG002|Period 1: Single Dose|Insufficient urine production|0|||
161624914|NCT01184859|583677329|FG003|Period 1: Single Dose|Insufficient urine production|0|||
161624915|NCT01184859|583677330|FG004|Period 1: Single Dose|Insufficient urine production|0|||
161624916|NCT01184859|583677326|FG000|Period 1: Single Dose|Protocol Violation|0|||
161624917|NCT01184859|583677327|FG001|Period 1: Single Dose|Protocol Violation|1|||
161624918|NCT01184859|583677328|FG002|Period 1: Single Dose|Protocol Violation|0|||
161624919|NCT01184859|583677329|FG003|Period 1: Single Dose|Protocol Violation|0|||
161624920|NCT01184859|583677330|FG004|Period 1: Single Dose|Protocol Violation|0|||
161624921|NCT01184859|583677326|FG000|Period 1: Single Dose|Adverse Event|0|||
161624922|NCT01184859|583677327|FG001|Period 1: Single Dose|Adverse Event|0|||
161624923|NCT01184859|583677328|FG002|Period 1: Single Dose|Adverse Event|0|||
161624924|NCT01184859|583677329|FG003|Period 1: Single Dose|Adverse Event|0|||
161624925|NCT01184859|583677330|FG004|Period 1: Single Dose|Adverse Event|1|||
161685063|NCT04251910|583899648|FG003|Overall Study|Assisted living facility was closed|0|||
161624926|NCT01184859|583677326|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161624927|NCT01184859|583677327|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161624928|NCT01184859|583677328|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161624929|NCT01184859|583677329|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161624930|NCT01184859|583677330|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
161624931|NCT01184859|583677326|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
161624932|NCT01184859|583677327|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161624933|NCT01184859|583677328|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161624934|NCT01184859|583677329|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161624935|NCT01184859|583677330|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161624936|NCT00958711|583677340|FG000|Overall Study|Withdrawal by Subject|0|||
161624937|NCT00958711|583677341|FG001|Overall Study|Withdrawal by Subject|4|||
161624938|NCT00958711|583677340|FG000|Overall Study|Physician Decision|5|||
161624939|NCT00958711|583677341|FG001|Overall Study|Physician Decision|7|||
161624940|NCT00958711|583677340|FG000|Overall Study|Lost to Follow-up|4|||
161624941|NCT00958711|583677341|FG001|Overall Study|Lost to Follow-up|1|||
161624942|NCT00958711|583677340|FG000|Overall Study|Other|2|||
161624943|NCT00958711|583677341|FG001|Overall Study|Other|5|||
161624944|NCT00958711|583677340|FG000|Overall Study|Death|1|||
161624945|NCT00958711|583677341|FG001|Overall Study|Death|2|||
161624946|NCT00958711|583677340|FG000|Overall Study|Adverse Event|1|||
161624947|NCT00958711|583677341|FG001|Overall Study|Adverse Event|2|||
161624948|NCT03722485|583677342|FG000|Overall Study|Withdrawal by Subject|1|||
161624949|NCT03722485|583677343|FG001|Overall Study|Withdrawal by Subject|0|||
161624950|NCT03722485|583677342|FG000|Overall Study|Adverse Event|0|||
161624951|NCT03722485|583677343|FG001|Overall Study|Adverse Event|2|||
161624952|NCT03722485|583677342|FG000|Overall Study|subject discharged prior to study completion|1|||
161624953|NCT03722485|583677343|FG001|Overall Study|subject discharged prior to study completion|5|||
161624954|NCT03722485|583677342|FG000|Overall Study|eligibility criteria not met|2|||
161624955|NCT03722485|583677343|FG001|Overall Study|eligibility criteria not met|0|||
161624956|NCT03087851|583677346|FG000|Overall Study|Withdraw on medical grounds|0|||
161624957|NCT03087851|583677347|FG001|Overall Study|Withdraw on medical grounds|1|||
161624958|NCT03087851|583677348|FG002|Overall Study|Withdraw on medical grounds|2|||
161624959|NCT03672188|583677349|FG000|Overall Study|Withdrawal by Subject|0|||
161624960|NCT03672188|583677350|FG001|Overall Study|Withdrawal by Subject|0|||
161624961|NCT03672188|583677351|FG002|Overall Study|Withdrawal by Subject|0|||
161624962|NCT03672188|583677352|FG003|Overall Study|Withdrawal by Subject|3|||
161624963|NCT03672188|583677353|FG004|Overall Study|Withdrawal by Subject|0|||
161624964|NCT03672188|583677354|FG005|Overall Study|Withdrawal by Subject|0|||
161624965|NCT03672188|583677355|FG006|Overall Study|Withdrawal by Subject|0|||
161624966|NCT03672188|583677356|FG007|Overall Study|Withdrawal by Subject|0|||
161624967|NCT03672188|583677357|FG008|Overall Study|Withdrawal by Subject|0|||
161624968|NCT03672188|583677358|FG009|Overall Study|Withdrawal by Subject|0|||
161624969|NCT03672188|583677359|FG010|Overall Study|Withdrawal by Subject|0|||
161624970|NCT03672188|583677360|FG011|Overall Study|Withdrawal by Subject|0|||
161624971|NCT03672188|583677361|FG012|Overall Study|Withdrawal by Subject|0|||
161624972|NCT03672188|583677362|FG013|Overall Study|Withdrawal by Subject|0|||
161624973|NCT03672188|583677363|FG014|Overall Study|Withdrawal by Subject|0|||
161624974|NCT03672188|583677349|FG000|Overall Study|Death|0|||
161624975|NCT03672188|583677350|FG001|Overall Study|Death|0|||
161624976|NCT03672188|583677351|FG002|Overall Study|Death|0|||
161624977|NCT03672188|583677352|FG003|Overall Study|Death|0|||
161624978|NCT03672188|583677353|FG004|Overall Study|Death|0|||
161624979|NCT03672188|583677354|FG005|Overall Study|Death|0|||
161624980|NCT03672188|583677355|FG006|Overall Study|Death|0|||
161624981|NCT03672188|583677356|FG007|Overall Study|Death|0|||
161624982|NCT03672188|583677357|FG008|Overall Study|Death|0|||
161624983|NCT03672188|583677358|FG009|Overall Study|Death|0|||
161624984|NCT03672188|583677359|FG010|Overall Study|Death|0|||
161624985|NCT03672188|583677360|FG011|Overall Study|Death|0|||
161624986|NCT03672188|583677361|FG012|Overall Study|Death|1|||
161624987|NCT03672188|583677362|FG013|Overall Study|Death|0|||
161624988|NCT03672188|583677363|FG014|Overall Study|Death|0|||
161624989|NCT03672188|583677349|FG000|Overall Study|Lost to Follow-up|0|||
161624990|NCT03672188|583677350|FG001|Overall Study|Lost to Follow-up|0|||
161624991|NCT03672188|583677351|FG002|Overall Study|Lost to Follow-up|1|||
161624992|NCT03672188|583677352|FG003|Overall Study|Lost to Follow-up|0|||
161624993|NCT03672188|583677353|FG004|Overall Study|Lost to Follow-up|0|||
161624994|NCT03672188|583677354|FG005|Overall Study|Lost to Follow-up|0|||
161624995|NCT03672188|583677355|FG006|Overall Study|Lost to Follow-up|0|||
161624996|NCT03672188|583677356|FG007|Overall Study|Lost to Follow-up|0|||
161624997|NCT03672188|583677357|FG008|Overall Study|Lost to Follow-up|0|||
161624998|NCT03672188|583677358|FG009|Overall Study|Lost to Follow-up|0|||
161624999|NCT03672188|583677359|FG010|Overall Study|Lost to Follow-up|0|||
161625000|NCT03672188|583677360|FG011|Overall Study|Lost to Follow-up|0|||
161625001|NCT03672188|583677361|FG012|Overall Study|Lost to Follow-up|0|||
161625002|NCT03672188|583677362|FG013|Overall Study|Lost to Follow-up|0|||
161625003|NCT03672188|583677363|FG014|Overall Study|Lost to Follow-up|0|||
161625004|NCT03997409|583677364|FG000|Overall Study|Protocol Violation|1|||
161625005|NCT03997409|583677365|FG001|Overall Study|Protocol Violation|1|||
161625006|NCT03997409|583677366|FG002|Overall Study|Protocol Violation|0|||
161625007|NCT03997409|583677364|FG000|Overall Study|Withdrawal by Subject|3|||
161625008|NCT03997409|583677365|FG001|Overall Study|Withdrawal by Subject|0|||
161625009|NCT03997409|583677366|FG002|Overall Study|Withdrawal by Subject|0|||
161625010|NCT03997409|583677364|FG000|Overall Study|Lost to Follow-up|0|||
161625011|NCT03997409|583677365|FG001|Overall Study|Lost to Follow-up|0|||
161625012|NCT03997409|583677366|FG002|Overall Study|Lost to Follow-up|1|||
161625013|NCT01753323|583677367|FG000|Overall Study|Lack of Efficacy|0|||
161625014|NCT01753323|583677368|FG001|Overall Study|Lack of Efficacy|0|||
161625015|NCT01753323|583677369|FG002|Overall Study|Lack of Efficacy|8|||
161625016|NCT01753323|583677367|FG000|Overall Study|Protocol deviation|1|||
161625017|NCT01753323|583677368|FG001|Overall Study|Protocol deviation|0|||
161625018|NCT01753323|583677369|FG002|Overall Study|Protocol deviation|0|||
161625019|NCT01753323|583677367|FG000|Overall Study|Adverse Event|0|||
161625020|NCT01753323|583677368|FG001|Overall Study|Adverse Event|0|||
161625021|NCT01753323|583677369|FG002|Overall Study|Adverse Event|1|||
161625022|NCT01636258|583677370|FG000|Overall Study|Lost to Follow-up|1|||
161625023|NCT01636258|583677371|FG001|Overall Study|Lost to Follow-up|0|||
161625024|NCT01745380|583677382|FG000|Overall Study|Lost to Follow-up|1|||
161625025|NCT01745380|583677383|FG001|Overall Study|Lost to Follow-up|0|||
161625026|NCT01745380|583677382|FG000|Overall Study|Lack of Efficacy|0|||
161625027|NCT01745380|583677383|FG001|Overall Study|Lack of Efficacy|1|||
161625028|NCT02660034|583677384|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
161625029|NCT02660034|583677385|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
161625030|NCT02660034|583677386|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
161625031|NCT02660034|583677387|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
161625032|NCT02660034|583677388|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
161625033|NCT02660034|583677389|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
161625034|NCT02660034|583677390|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
161625035|NCT02660034|583677391|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
161625036|NCT02660034|583677392|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
161625037|NCT02660034|583677393|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
161625038|NCT02660034|583677394|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
161625039|NCT02660034|583677395|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
161625040|NCT02660034|583677396|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
161625041|NCT02660034|583677397|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
161685064|NCT04251910|583899649|FG004|Overall Study|Assisted living facility was closed|1|||
161685065|NCT04251910|583899650|FG005|Overall Study|Assisted living facility was closed|0|||
161685066|NCT02830776|583899653|FG000|Overall Study|Lost to Follow-up|1|||
161685067|NCT05289570|583899662|FG000|Overall Study|Physician Decision|1|||
161685068|NCT01765920|583899667|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
161685069|NCT01765920|583899668|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
161685070|NCT01765920|583899667|FG000|Overall Study|Patient code disclosure|0|||
161685071|NCT01765920|583899668|FG001|Overall Study|Patient code disclosure|1|||
161685072|NCT00777101|583899669|FG000|Overall Study|Death|48|||
161685073|NCT00777101|583899670|FG001|Overall Study|Death|43|||
161685074|NCT00777101|583899669|FG000|Overall Study|Withdrawal by Subject|11|||
161685075|NCT00777101|583899670|FG001|Overall Study|Withdrawal by Subject|6|||
161685076|NCT00777101|583899669|FG000|Overall Study|Lost to Follow-up|2|||
161685077|NCT00777101|583899670|FG001|Overall Study|Lost to Follow-up|1|||
161685078|NCT00777101|583899669|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161685079|NCT00777101|583899670|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161625042|NCT02660034|583677384|FG000|Overall Study|Progressive Disease (Clinical)|7|||
161625043|NCT02660034|583677385|FG001|Overall Study|Progressive Disease (Clinical)|8|||
161625044|NCT02660034|583677386|FG002|Overall Study|Progressive Disease (Clinical)|3|||
161625045|NCT02660034|583677387|FG003|Overall Study|Progressive Disease (Clinical)|9|||
161625046|NCT02660034|583677388|FG004|Overall Study|Progressive Disease (Clinical)|3|||
161625047|NCT02660034|583677389|FG005|Overall Study|Progressive Disease (Clinical)|0|||
161625048|NCT02660034|583677390|FG006|Overall Study|Progressive Disease (Clinical)|0|||
161625049|NCT02660034|583677391|FG007|Overall Study|Progressive Disease (Clinical)|0|||
161685080|NCT00777101|583899669|FG000|Overall Study|Failed to Return|0|||
161685081|NCT00777101|583899670|FG001|Overall Study|Failed to Return|1|||
161685082|NCT00282334|583899673|FG000|Overall Study|Withdrawal by Subject|8|||
161625050|NCT02660034|583677392|FG008|Overall Study|Progressive Disease (Clinical)|0|||
161625051|NCT02660034|583677393|FG009|Overall Study|Progressive Disease (Clinical)|0|||
161625052|NCT02660034|583677394|FG010|Overall Study|Progressive Disease (Clinical)|0|||
161625053|NCT02660034|583677395|FG011|Overall Study|Progressive Disease (Clinical)|0|||
161625054|NCT02660034|583677396|FG012|Overall Study|Progressive Disease (Clinical)|0|||
161625055|NCT02660034|583677397|FG013|Overall Study|Progressive Disease (Clinical)|0|||
161685083|NCT00282334|583899674|FG001|Overall Study|Withdrawal by Subject|5|||
161685084|NCT00964743|583899683|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
161685085|NCT03317795|583899686|FG000|Overall Study|IUD Expulsion|1|||
161685086|NCT03317795|583899687|FG001|Overall Study|IUD Expulsion|0|||
161685087|NCT03317795|583899686|FG000|Overall Study|Lost to Follow-up|1|||
161625056|NCT02660034|583677384|FG000|Overall Study|Lost to Follow-up|0|||
161625057|NCT02660034|583677385|FG001|Overall Study|Lost to Follow-up|0|||
161625058|NCT02660034|583677386|FG002|Overall Study|Lost to Follow-up|1|||
161625059|NCT02660034|583677387|FG003|Overall Study|Lost to Follow-up|1|||
161625060|NCT02660034|583677388|FG004|Overall Study|Lost to Follow-up|0|||
161625061|NCT02660034|583677389|FG005|Overall Study|Lost to Follow-up|0|||
161625062|NCT02660034|583677390|FG006|Overall Study|Lost to Follow-up|0|||
161625063|NCT02660034|583677391|FG007|Overall Study|Lost to Follow-up|0|||
161625064|NCT02660034|583677392|FG008|Overall Study|Lost to Follow-up|0|||
161625065|NCT02660034|583677393|FG009|Overall Study|Lost to Follow-up|1|||
161625066|NCT02660034|583677394|FG010|Overall Study|Lost to Follow-up|1|||
161625067|NCT02660034|583677395|FG011|Overall Study|Lost to Follow-up|1|||
161625068|NCT02660034|583677396|FG012|Overall Study|Lost to Follow-up|0|||
161625069|NCT02660034|583677397|FG013|Overall Study|Lost to Follow-up|0|||
161625070|NCT02660034|583677384|FG000|Overall Study|Participant moved into special access scheme|1|||
161625071|NCT02660034|583677385|FG001|Overall Study|Participant moved into special access scheme|2|||
161625072|NCT02660034|583677386|FG002|Overall Study|Participant moved into special access scheme|0|||
161625073|NCT02660034|583677387|FG003|Overall Study|Participant moved into special access scheme|0|||
161625074|NCT02660034|583677388|FG004|Overall Study|Participant moved into special access scheme|0|||
161625075|NCT02660034|583677389|FG005|Overall Study|Participant moved into special access scheme|0|||
161625076|NCT02660034|583677390|FG006|Overall Study|Participant moved into special access scheme|0|||
161625077|NCT02660034|583677391|FG007|Overall Study|Participant moved into special access scheme|0|||
161625078|NCT02660034|583677392|FG008|Overall Study|Participant moved into special access scheme|0|||
161625079|NCT02660034|583677393|FG009|Overall Study|Participant moved into special access scheme|0|||
161625080|NCT02660034|583677394|FG010|Overall Study|Participant moved into special access scheme|0|||
161625081|NCT02660034|583677395|FG011|Overall Study|Participant moved into special access scheme|0|||
161625082|NCT02660034|583677396|FG012|Overall Study|Participant moved into special access scheme|0|||
161625083|NCT02660034|583677397|FG013|Overall Study|Participant moved into special access scheme|0|||
161625084|NCT02660034|583677384|FG000|Overall Study|Adverse Event|1|||
161625085|NCT02660034|583677385|FG001|Overall Study|Adverse Event|0|||
161625086|NCT02660034|583677386|FG002|Overall Study|Adverse Event|0|||
161625087|NCT02660034|583677387|FG003|Overall Study|Adverse Event|0|||
161625088|NCT02660034|583677388|FG004|Overall Study|Adverse Event|0|||
161625089|NCT02660034|583677389|FG005|Overall Study|Adverse Event|0|||
161625090|NCT02660034|583677390|FG006|Overall Study|Adverse Event|0|||
161625091|NCT02660034|583677391|FG007|Overall Study|Adverse Event|0|||
161625092|NCT02660034|583677392|FG008|Overall Study|Adverse Event|0|||
161625093|NCT02660034|583677393|FG009|Overall Study|Adverse Event|0|||
161625094|NCT02660034|583677394|FG010|Overall Study|Adverse Event|0|||
161625095|NCT02660034|583677395|FG011|Overall Study|Adverse Event|0|||
161625096|NCT02660034|583677396|FG012|Overall Study|Adverse Event|0|||
161625097|NCT02660034|583677397|FG013|Overall Study|Adverse Event|0|||
161625098|NCT02660034|583677384|FG000|Overall Study|Sponsor Decision|0|||
161625099|NCT02660034|583677385|FG001|Overall Study|Sponsor Decision|1|||
161625100|NCT02660034|583677386|FG002|Overall Study|Sponsor Decision|2|||
161625101|NCT02660034|583677387|FG003|Overall Study|Sponsor Decision|2|||
161625102|NCT02660034|583677388|FG004|Overall Study|Sponsor Decision|3|||
161625103|NCT02660034|583677389|FG005|Overall Study|Sponsor Decision|0|||
161625104|NCT02660034|583677390|FG006|Overall Study|Sponsor Decision|0|||
161625105|NCT02660034|583677391|FG007|Overall Study|Sponsor Decision|0|||
161625106|NCT02660034|583677392|FG008|Overall Study|Sponsor Decision|0|||
161625107|NCT02660034|583677393|FG009|Overall Study|Sponsor Decision|0|||
161625108|NCT02660034|583677394|FG010|Overall Study|Sponsor Decision|0|||
161625109|NCT02660034|583677395|FG011|Overall Study|Sponsor Decision|0|||
161625110|NCT02660034|583677396|FG012|Overall Study|Sponsor Decision|0|||
161625111|NCT02660034|583677397|FG013|Overall Study|Sponsor Decision|1|||
161625112|NCT02660034|583677384|FG000|Overall Study|Withdrawal by Subject|0|||
161625113|NCT02660034|583677385|FG001|Overall Study|Withdrawal by Subject|0|||
161625114|NCT02660034|583677386|FG002|Overall Study|Withdrawal by Subject|0|||
161625115|NCT02660034|583677387|FG003|Overall Study|Withdrawal by Subject|0|||
161625116|NCT02660034|583677388|FG004|Overall Study|Withdrawal by Subject|0|||
161625117|NCT02660034|583677389|FG005|Overall Study|Withdrawal by Subject|0|||
161625118|NCT02660034|583677390|FG006|Overall Study|Withdrawal by Subject|1|||
161625119|NCT02660034|583677391|FG007|Overall Study|Withdrawal by Subject|1|||
161625120|NCT02660034|583677392|FG008|Overall Study|Withdrawal by Subject|1|||
161625121|NCT02660034|583677393|FG009|Overall Study|Withdrawal by Subject|0|||
161625122|NCT02660034|583677394|FG010|Overall Study|Withdrawal by Subject|0|||
161625123|NCT02660034|583677395|FG011|Overall Study|Withdrawal by Subject|1|||
161625124|NCT02660034|583677396|FG012|Overall Study|Withdrawal by Subject|2|||
161625125|NCT02660034|583677397|FG013|Overall Study|Withdrawal by Subject|0|||
161625126|NCT02660034|583677384|FG000|Overall Study|Death|0|||
161625127|NCT02660034|583677385|FG001|Overall Study|Death|0|||
161625128|NCT02660034|583677386|FG002|Overall Study|Death|0|||
161625129|NCT02660034|583677387|FG003|Overall Study|Death|0|||
161625130|NCT02660034|583677388|FG004|Overall Study|Death|0|||
161625131|NCT02660034|583677389|FG005|Overall Study|Death|13|||
161625132|NCT02660034|583677390|FG006|Overall Study|Death|14|||
161625133|NCT02660034|583677391|FG007|Overall Study|Death|10|||
161625134|NCT02660034|583677392|FG008|Overall Study|Death|9|||
161625135|NCT02660034|583677393|FG009|Overall Study|Death|21|||
161625136|NCT02660034|583677394|FG010|Overall Study|Death|17|||
161625137|NCT02660034|583677395|FG011|Overall Study|Death|15|||
161625138|NCT02660034|583677396|FG012|Overall Study|Death|18|||
161625139|NCT02660034|583677397|FG013|Overall Study|Death|7|||
161625140|NCT02660034|583677384|FG000|Overall Study|Physician Decision|0|||
161625141|NCT02660034|583677385|FG001|Overall Study|Physician Decision|0|||
161625142|NCT02660034|583677386|FG002|Overall Study|Physician Decision|0|||
161625143|NCT02660034|583677387|FG003|Overall Study|Physician Decision|0|||
161625144|NCT02660034|583677388|FG004|Overall Study|Physician Decision|0|||
161625145|NCT02660034|583677389|FG005|Overall Study|Physician Decision|0|||
161625146|NCT02660034|583677390|FG006|Overall Study|Physician Decision|0|||
161625147|NCT02660034|583677391|FG007|Overall Study|Physician Decision|0|||
161625148|NCT02660034|583677392|FG008|Overall Study|Physician Decision|0|||
161625149|NCT02660034|583677393|FG009|Overall Study|Physician Decision|0|||
161625150|NCT02660034|583677394|FG010|Overall Study|Physician Decision|0|||
161625151|NCT02660034|583677395|FG011|Overall Study|Physician Decision|0|||
161625152|NCT02660034|583677396|FG012|Overall Study|Physician Decision|0|||
161625153|NCT02660034|583677397|FG013|Overall Study|Physician Decision|1|||
161625154|NCT02660034|583677384|FG000|Overall Study|Participants transferred to LTE|0|||
161625155|NCT02660034|583677385|FG001|Overall Study|Participants transferred to LTE|0|||
161625156|NCT02660034|583677386|FG002|Overall Study|Participants transferred to LTE|0|||
161625157|NCT02660034|583677387|FG003|Overall Study|Participants transferred to LTE|0|||
161625158|NCT02660034|583677388|FG004|Overall Study|Participants transferred to LTE|0|||
161625159|NCT02660034|583677389|FG005|Overall Study|Participants transferred to LTE|10|||
161625160|NCT02660034|583677390|FG006|Overall Study|Participants transferred to LTE|8|||
161625161|NCT02660034|583677391|FG007|Overall Study|Participants transferred to LTE|8|||
161625162|NCT02660034|583677392|FG008|Overall Study|Participants transferred to LTE|10|||
161625163|NCT02660034|583677393|FG009|Overall Study|Participants transferred to LTE|1|||
161625164|NCT02660034|583677394|FG010|Overall Study|Participants transferred to LTE|2|||
161625165|NCT02660034|583677395|FG011|Overall Study|Participants transferred to LTE|4|||
161625166|NCT02660034|583677396|FG012|Overall Study|Participants transferred to LTE|1|||
161625167|NCT02660034|583677397|FG013|Overall Study|Participants transferred to LTE|1|||
161625168|NCT04879823|583677405|FG000|Overall Study|Physician Decision|3|||
161625169|NCT04879823|583677406|FG001|Overall Study|Physician Decision|1|||
161625170|NCT04879823|583677405|FG000|Overall Study|Protocol Violation|2|||
161625171|NCT04879823|583677406|FG001|Overall Study|Protocol Violation|3|||
161625172|NCT04879823|583677405|FG000|Overall Study|Lost to Follow-up|43|||
161625173|NCT04879823|583677406|FG001|Overall Study|Lost to Follow-up|35|||
161625174|NCT00730925|583677407|FG000|Overall Study|Progressive Disease|21|||
161625175|NCT00730925|583677407|FG000|Overall Study|Dose reducing Event|2|||
161625176|NCT00730925|583677407|FG000|Overall Study|Other Averse Event|7|||
161625177|NCT00730925|583677407|FG000|Overall Study|Protocol Violation|1|||
161625178|NCT00730925|583677407|FG000|Overall Study|Withdrawal by Subject|1|||
161625179|NCT00730925|583677407|FG000|Overall Study|Switch to combination therapy|8|||
161625180|NCT00730925|583677407|FG000|Overall Study|Other|1|||
161625181|NCT02137239|583677408|FG000|Overall Study|Discontinued Study Treatment|0|||
161625182|NCT02137239|583677409|FG001|Overall Study|Discontinued Study Treatment|3|||
161625183|NCT02137239|583677408|FG000|Overall Study|Withdrew Consent|1|||
161625184|NCT02137239|583677409|FG001|Overall Study|Withdrew Consent|1|||
161625185|NCT02137239|583677408|FG000|Overall Study|Adverse Event|2|||
161625186|NCT02137239|583677409|FG001|Overall Study|Adverse Event|2|||
161625187|NCT04057937|583677410|FG000|Placebo-controlled Phase|Adverse Event|3|||
161625188|NCT04057937|583677411|FG001|Placebo-controlled Phase|Adverse Event|0|||
161625189|NCT04057937|583677410|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
161625190|NCT04057937|583677411|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
161625191|NCT04057937|583677410|FG000|Active-treatment Phase|Pregnancy|0|||
161625192|NCT04057937|583677411|FG001|Active-treatment Phase|Pregnancy|1|||
161625193|NCT04057937|583677410|FG000|Active-treatment Phase|Physician Decision|0|||
161625194|NCT04057937|583677411|FG001|Active-treatment Phase|Physician Decision|1|||
161625195|NCT02029521|583677412|FG000|Overall Study|Protocol Violation|1|||
161625196|NCT02029521|583677413|FG001|Overall Study|Protocol Violation|0|||
161625197|NCT02029521|583677412|FG000|Overall Study|Withdrawal by Subject|1|||
161685088|NCT03317795|583899687|FG001|Overall Study|Lost to Follow-up|3|||
161685089|NCT03317795|583899686|FG000|Overall Study|Treatment change|0|||
161685090|NCT03317795|583899687|FG001|Overall Study|Treatment change|3|||
161625198|NCT02029521|583677413|FG001|Overall Study|Withdrawal by Subject|1|||
161685091|NCT03317795|583899686|FG000|Overall Study|Intolerance of medication|0|||
161685092|NCT03317795|583899687|FG001|Overall Study|Intolerance of medication|1|||
161625199|NCT01072396|583677414|FG000|Period One|Adverse Event|1|||
161625200|NCT01072396|583677415|FG001|Period One|Adverse Event|1|||
161625201|NCT01072396|583677414|FG000|Period One|Protocol Violation|2|||
161625202|NCT01072396|583677415|FG001|Period One|Protocol Violation|1|||
161625203|NCT01072396|583677414|FG000|Period One|Withdrawal by Subject|2|||
161625204|NCT01072396|583677415|FG001|Period One|Withdrawal by Subject|0|||
161625205|NCT01072396|583677414|FG000|Washout Period|Missing termination information|0|||
161625206|NCT01072396|583677415|FG001|Washout Period|Missing termination information|1|||
161625207|NCT01072396|583677414|FG000|Period Two|Adverse Event|0|||
161625208|NCT01072396|583677415|FG001|Period Two|Adverse Event|3|||
161625209|NCT01072396|583677414|FG000|Period Two|Lost to Follow-up|1|||
161625210|NCT01072396|583677415|FG001|Period Two|Lost to Follow-up|0|||
161625211|NCT02446912|583677416|FG000|Overall Study|Adverse Event|3|||
161625212|NCT02446912|583677417|FG001|Overall Study|Adverse Event|13|||
161625213|NCT02446912|583677418|FG002|Overall Study|Adverse Event|5|||
161625214|NCT02446912|583677416|FG000|Overall Study|Condition under investigation worsened|0|||
161625215|NCT02446912|583677417|FG001|Overall Study|Condition under investigation worsened|1|||
161625216|NCT02446912|583677418|FG002|Overall Study|Condition under investigation worsened|1|||
161625217|NCT02446912|583677416|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161625218|NCT02446912|583677417|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161625219|NCT02446912|583677418|FG002|Overall Study|Study-specific withdrawal criteria|0|||
161625220|NCT02446912|583677416|FG000|Overall Study|Lack of Efficacy|1|||
161625221|NCT02446912|583677417|FG001|Overall Study|Lack of Efficacy|4|||
161625222|NCT02446912|583677418|FG002|Overall Study|Lack of Efficacy|7|||
161625223|NCT02446912|583677416|FG000|Overall Study|Lost to Follow-up|0|||
161625224|NCT02446912|583677417|FG001|Overall Study|Lost to Follow-up|0|||
161625225|NCT02446912|583677418|FG002|Overall Study|Lost to Follow-up|2|||
161625226|NCT02446912|583677416|FG000|Overall Study|Severe non-compliance to protocol|1|||
161625227|NCT02446912|583677417|FG001|Overall Study|Severe non-compliance to protocol|0|||
161625228|NCT02446912|583677418|FG002|Overall Study|Severe non-compliance to protocol|1|||
161625229|NCT02446912|583677416|FG000|Overall Study|Withdrawal by Subject|10|||
161625230|NCT02446912|583677417|FG001|Overall Study|Withdrawal by Subject|15|||
161625231|NCT02446912|583677418|FG002|Overall Study|Withdrawal by Subject|15|||
161625232|NCT02446912|583677416|FG000|Overall Study|Miscellaneous|2|||
161625233|NCT02446912|583677417|FG001|Overall Study|Miscellaneous|2|||
161625234|NCT02446912|583677418|FG002|Overall Study|Miscellaneous|4|||
161625235|NCT01268488|583677419|FG000|Overall Study|Adverse Event|3|||
161625236|NCT01268488|583677419|FG000|Overall Study|Physician Decision|2|||
161625237|NCT01106586|583677422|FG000|Overall Study|Adverse Event|9|||
161625238|NCT01106586|583677423|FG001|Overall Study|Adverse Event|15|||
161625239|NCT01106586|583677422|FG000|Overall Study|Death|1|||
161625240|NCT01106586|583677423|FG001|Overall Study|Death|3|||
161625241|NCT01106586|583677422|FG000|Overall Study|Pregnancy|2|||
161625242|NCT01106586|583677423|FG001|Overall Study|Pregnancy|2|||
161625243|NCT01106586|583677422|FG000|Overall Study|Lack of Efficacy|1|||
161625244|NCT01106586|583677423|FG001|Overall Study|Lack of Efficacy|0|||
161625245|NCT01106586|583677422|FG000|Overall Study|Investigator's Discretion|5|||
161625246|NCT01106586|583677423|FG001|Overall Study|Investigator's Discretion|8|||
161625247|NCT01106586|583677422|FG000|Overall Study|Withdrew Consent|18|||
161625248|NCT01106586|583677423|FG001|Overall Study|Withdrew Consent|30|||
161625249|NCT01106586|583677422|FG000|Overall Study|Lost to Follow-up|24|||
161625250|NCT01106586|583677423|FG001|Overall Study|Lost to Follow-up|20|||
161625251|NCT01106586|583677422|FG000|Overall Study|Participant Noncompliance|12|||
161625252|NCT01106586|583677423|FG001|Overall Study|Participant Noncompliance|10|||
161625253|NCT01106586|583677422|FG000|Overall Study|Protocol Violation|1|||
161625254|NCT01106586|583677423|FG001|Overall Study|Protocol Violation|0|||
161625255|NCT01106586|583677422|FG000|Overall Study|Participant Transferred to Another Study|212|||
161625256|NCT01106586|583677423|FG001|Overall Study|Participant Transferred to Another Study|197|||
161625257|NCT03906240|583677429|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
161625258|NCT03906240|583677430|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
161625259|NCT03906240|583677429|FG000|Overall Study|Lost to Follow-up|1|||
161625260|NCT03906240|583677430|FG001|Overall Study|Lost to Follow-up|0|||
161625261|NCT03906240|583677429|FG000|Overall Study|Withdrawal by Subject|0|||
161625262|NCT03906240|583677430|FG001|Overall Study|Withdrawal by Subject|1|||
161625263|NCT01426217|583677431|FG000|Overall Study|lost sample|8|||
161625264|NCT01426217|583677432|FG001|Overall Study|lost sample|14|||
161625265|NCT05216835|583677433|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161625266|NCT05216835|583677434|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161625267|NCT05216835|583677435|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161625268|NCT05216835|583677436|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161625269|NCT05216835|583677437|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
161625270|NCT05216835|583677438|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
161625271|NCT05216835|583677439|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
161625272|NCT05216835|583677440|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
161625273|NCT05216835|583677433|FG000|Overall Study|Death|0|||
161625274|NCT05216835|583677434|FG001|Overall Study|Death|0|||
161625275|NCT05216835|583677435|FG002|Overall Study|Death|0|||
161625276|NCT05216835|583677436|FG003|Overall Study|Death|1|||
161625277|NCT05216835|583677437|FG004|Overall Study|Death|1|||
161625278|NCT05216835|583677438|FG005|Overall Study|Death|1|||
161625279|NCT05216835|583677439|FG006|Overall Study|Death|1|||
161625280|NCT05216835|583677440|FG007|Overall Study|Death|1|||
161625281|NCT05216835|583677433|FG000|Overall Study|Physician Decision|0|||
161625282|NCT05216835|583677434|FG001|Overall Study|Physician Decision|0|||
161625283|NCT05216835|583677435|FG002|Overall Study|Physician Decision|0|||
161625284|NCT05216835|583677436|FG003|Overall Study|Physician Decision|0|||
161625285|NCT05216835|583677437|FG004|Overall Study|Physician Decision|0|||
161625286|NCT05216835|583677438|FG005|Overall Study|Physician Decision|1|||
161625287|NCT05216835|583677439|FG006|Overall Study|Physician Decision|1|||
161625288|NCT05216835|583677440|FG007|Overall Study|Physician Decision|0|||
161625289|NCT05216835|583677433|FG000|Overall Study|Study terminated by Sponsor|0|||
161625290|NCT05216835|583677434|FG001|Overall Study|Study terminated by Sponsor|0|||
161625291|NCT05216835|583677435|FG002|Overall Study|Study terminated by Sponsor|0|||
161625292|NCT05216835|583677436|FG003|Overall Study|Study terminated by Sponsor|0|||
161625293|NCT05216835|583677437|FG004|Overall Study|Study terminated by Sponsor|0|||
161625294|NCT05216835|583677438|FG005|Overall Study|Study terminated by Sponsor|0|||
161625295|NCT05216835|583677439|FG006|Overall Study|Study terminated by Sponsor|0|||
161625296|NCT05216835|583677440|FG007|Overall Study|Study terminated by Sponsor|1|||
161625297|NCT05216835|583677433|FG000|Overall Study|Withdrawal by Subject|1|||
161625298|NCT05216835|583677434|FG001|Overall Study|Withdrawal by Subject|0|||
161625299|NCT05216835|583677435|FG002|Overall Study|Withdrawal by Subject|1|||
161625300|NCT05216835|583677436|FG003|Overall Study|Withdrawal by Subject|0|||
161625301|NCT05216835|583677437|FG004|Overall Study|Withdrawal by Subject|1|||
161625302|NCT05216835|583677438|FG005|Overall Study|Withdrawal by Subject|0|||
161625303|NCT05216835|583677439|FG006|Overall Study|Withdrawal by Subject|0|||
161625304|NCT05216835|583677440|FG007|Overall Study|Withdrawal by Subject|1|||
161625305|NCT05216835|583677433|FG000|Overall Study|Other|0|||
161625306|NCT05216835|583677434|FG001|Overall Study|Other|1|||
161625307|NCT05216835|583677435|FG002|Overall Study|Other|0|||
161625308|NCT05216835|583677436|FG003|Overall Study|Other|0|||
161625309|NCT05216835|583677437|FG004|Overall Study|Other|0|||
161625310|NCT05216835|583677438|FG005|Overall Study|Other|0|||
161625311|NCT05216835|583677439|FG006|Overall Study|Other|0|||
161625312|NCT05216835|583677440|FG007|Overall Study|Other|0|||
161625313|NCT01075815|583677441|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
161625314|NCT01075815|583677442|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
161625315|NCT01075815|583677441|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
161625316|NCT01075815|583677442|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
161625317|NCT01075815|583677441|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
161625318|NCT01075815|583677442|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
161625319|NCT00617708|583677443|FG000|Overall Study|Adverse Event|0|||
161625320|NCT00617708|583677444|FG001|Overall Study|Adverse Event|6|||
161625321|NCT00617708|583677445|FG002|Overall Study|Adverse Event|9|||
161625322|NCT00617708|583677443|FG000|Overall Study|Withdrawal by Subject|1|||
161625323|NCT00617708|583677444|FG001|Overall Study|Withdrawal by Subject|1|||
161625324|NCT00617708|583677445|FG002|Overall Study|Withdrawal by Subject|7|||
161625325|NCT00617708|583677443|FG000|Overall Study|Death|0|||
161625326|NCT00617708|583677444|FG001|Overall Study|Death|6|||
161625327|NCT00617708|583677445|FG002|Overall Study|Death|5|||
161625328|NCT00617708|583677443|FG000|Overall Study|Progression/Relapse|7|||
161625329|NCT00617708|583677444|FG001|Overall Study|Progression/Relapse|40|||
161625330|NCT00617708|583677445|FG002|Overall Study|Progression/Relapse|36|||
161625331|NCT00617708|583677443|FG000|Overall Study|Not protocol specified|1|||
161625332|NCT00617708|583677444|FG001|Overall Study|Not protocol specified|4|||
161625333|NCT00617708|583677445|FG002|Overall Study|Not protocol specified|2|||
161625334|NCT00617708|583677443|FG000|Overall Study|Not eligible|1|||
161625335|NCT00617708|583677444|FG001|Overall Study|Not eligible|3|||
161625336|NCT00617708|583677445|FG002|Overall Study|Not eligible|5|||
161625337|NCT02991456|583677446|FG000|Overall Study|Adverse Event|2|||
161625338|NCT02991456|583677447|FG001|Overall Study|Adverse Event|0|||
161625339|NCT02991456|583677446|FG000|Overall Study|Lost to Follow-up|0|||
161625340|NCT02991456|583677447|FG001|Overall Study|Lost to Follow-up|2|||
161625341|NCT02991456|583677446|FG000|Overall Study|Withdrawal by Subject|1|||
161625342|NCT02991456|583677447|FG001|Overall Study|Withdrawal by Subject|0|||
161625343|NCT02374476|583677451|FG000|VT Induced Ablation|Screening Failures|36|||
161625344|NCT02374476|583677452|FG001|VT Induced Ablation|Screening Failures|0|||
161625345|NCT02374476|583677453|FG002|VT Induced Ablation|Screening Failures|0|||
161625346|NCT02374476|583677451|FG000|Arm Assignment|Withdrawal by Subject|0|||
161625347|NCT02374476|583677452|FG001|Arm Assignment|Withdrawal by Subject|0|||
161625348|NCT02374476|583677453|FG002|Arm Assignment|Withdrawal by Subject|1|||
161625349|NCT02924051|583677454|FG000|Overall Study|Withdrawal by Subject|1|||
161833286|NCT05506358|584431054|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
161833287|NCT05506358|584431055|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833288|NCT05506358|584431056|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833289|NCT05506358|584431057|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833290|NCT05506358|584431058|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833291|NCT05506358|584431054|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833292|NCT05506358|584431055|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833293|NCT05506358|584431056|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833294|NCT05506358|584431057|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
161625350|NCT02924051|583677455|FG001|Overall Study|Withdrawal by Subject|9|||
161625351|NCT02130401|583677456|FG000|Overall Study|Poor enrollment|6|||
161625352|NCT03953079|583677457|FG000|Core Study|Withdrawal by Subject|1|||
161625353|NCT03953079|583677458|FG001|Core Study|Withdrawal by Subject|2|||
161625354|NCT03953079|583677459|FG002|Core Study|Withdrawal by Subject|1|||
161625355|NCT03953079|583677457|FG000|Core Study|COVID-19|0|||
161625356|NCT03953079|583677458|FG001|Core Study|COVID-19|1|||
161625357|NCT03953079|583677459|FG002|Core Study|COVID-19|0|||
161625358|NCT03953079|583677457|FG000|Core Study|Difficulties leaving the house|0|||
161625359|NCT03953079|583677458|FG001|Core Study|Difficulties leaving the house|1|||
161625360|NCT03953079|583677459|FG002|Core Study|Difficulties leaving the house|0|||
161625361|NCT03953079|583677457|FG000|Extension Study|Withdrawal by Subject|1|||
161625362|NCT03953079|583677458|FG001|Extension Study|Withdrawal by Subject|0|||
161625363|NCT03953079|583677459|FG002|Extension Study|Withdrawal by Subject|0|||
161625364|NCT03953079|583677457|FG000|Extension Study|Received Rescue Treatment|5|||
161625365|NCT03953079|583677458|FG001|Extension Study|Received Rescue Treatment|6|||
161625366|NCT03953079|583677459|FG002|Extension Study|Received Rescue Treatment|5|||
161625367|NCT00936065|583677460|FG000|Overall Study|Adverse Event|1|||
161625368|NCT00936065|583677461|FG001|Overall Study|Adverse Event|0|||
161625369|NCT00936065|583677462|FG002|Overall Study|Adverse Event|1|||
161625370|NCT00936065|583677460|FG000|Overall Study|Lack of Efficacy|1|||
161625371|NCT00936065|583677461|FG001|Overall Study|Lack of Efficacy|0|||
161625372|NCT00936065|583677462|FG002|Overall Study|Lack of Efficacy|1|||
161625373|NCT00936065|583677460|FG000|Overall Study|Lost to Follow-up|1|||
161625374|NCT00936065|583677461|FG001|Overall Study|Lost to Follow-up|0|||
161625375|NCT00936065|583677462|FG002|Overall Study|Lost to Follow-up|0|||
161625376|NCT00936065|583677460|FG000|Overall Study|Protocol Violation|1|||
161625377|NCT00936065|583677461|FG001|Overall Study|Protocol Violation|2|||
161625378|NCT00936065|583677462|FG002|Overall Study|Protocol Violation|1|||
161625379|NCT00936065|583677460|FG000|Overall Study|Withdrawal by Subject|0|||
161625380|NCT00936065|583677461|FG001|Overall Study|Withdrawal by Subject|2|||
161625381|NCT00936065|583677462|FG002|Overall Study|Withdrawal by Subject|4|||
161625382|NCT02819141|583677468|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
161625383|NCT02819141|583677469|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
161625384|NCT00925288|583679197|FG000|Overall Study|Lost to Follow-up|9|||
161625385|NCT00925288|583679198|FG001|Overall Study|Lost to Follow-up|7|||
161625386|NCT00434577|583679199|FG000|Months 0-3|Serious Adverse Event|0|||
161625387|NCT00434577|583679200|FG001|Months 0-3|Serious Adverse Event|0|||
161625388|NCT00434577|583679201|FG002|Months 0-3|Serious Adverse Event|1|||
161625389|NCT00434577|583679202|FG003|Months 0-3|Serious Adverse Event|0|||
161625390|NCT00434577|583679203|FG004|Months 0-3|Serious Adverse Event|0|||
161625391|NCT00434577|583679199|FG000|Months 0-3|Adverse Event|0|||
161833295|NCT05506358|584431058|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833296|NCT05506358|584431054|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
161833297|NCT05506358|584431055|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
161625392|NCT00434577|583679200|FG001|Months 0-3|Adverse Event|1|||
161625393|NCT00434577|583679201|FG002|Months 0-3|Adverse Event|1|||
161625394|NCT00434577|583679202|FG003|Months 0-3|Adverse Event|0|||
161625395|NCT00434577|583679203|FG004|Months 0-3|Adverse Event|0|||
161625396|NCT00434577|583679199|FG000|Months 0-3|Lost to Follow-up|0|||
161625397|NCT00434577|583679200|FG001|Months 0-3|Lost to Follow-up|0|||
161625398|NCT00434577|583679201|FG002|Months 0-3|Lost to Follow-up|0|||
161625399|NCT00434577|583679202|FG003|Months 0-3|Lost to Follow-up|0|||
161625400|NCT00434577|583679203|FG004|Months 0-3|Lost to Follow-up|2|||
161625401|NCT00434577|583679199|FG000|Months 0-3|Protocol Violation|1|||
161625402|NCT00434577|583679200|FG001|Months 0-3|Protocol Violation|0|||
161625403|NCT00434577|583679201|FG002|Months 0-3|Protocol Violation|1|||
161625404|NCT00434577|583679202|FG003|Months 0-3|Protocol Violation|0|||
161625405|NCT00434577|583679203|FG004|Months 0-3|Protocol Violation|0|||
161625406|NCT00434577|583679199|FG000|Months 0-3|Withdrawal by Subject|2|||
161625407|NCT00434577|583679200|FG001|Months 0-3|Withdrawal by Subject|1|||
161625408|NCT00434577|583679201|FG002|Months 0-3|Withdrawal by Subject|1|||
161625409|NCT00434577|583679202|FG003|Months 0-3|Withdrawal by Subject|1|||
161625410|NCT00434577|583679203|FG004|Months 0-3|Withdrawal by Subject|1|||
161625411|NCT02176356|583679207|FG000|Overall Study|Screen Failure|14|||
161625412|NCT02176356|583679207|FG000|Overall Study|Lost to Follow-up|4|||
161625413|NCT02176356|583679207|FG000|Overall Study|Personal Reasons|3|||
161625414|NCT02176356|583679207|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161625415|NCT00381888|583679208|FG000|Overall Study|Death|1|||
161625416|NCT00381888|583679208|FG000|Overall Study|Withdrawal by Subject|1|||
161625417|NCT00381888|583679208|FG000|Overall Study|Physician Decision|1|||
161625418|NCT00381888|583679208|FG000|Overall Study|Protocol Violation|9|||
161625419|NCT00381888|583679208|FG000|Overall Study|Had laparoscopic surgery|2|||
161625420|NCT00381888|583679208|FG000|Overall Study|Surgery was cancelled|2|||
161625421|NCT00381888|583679208|FG000|Overall Study|Adverse Event|1|||
161625422|NCT01537120|583679212|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
161625423|NCT01537120|583679212|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
161625424|NCT02151643|583679213|FG000|Overall Study|Adverse Event|2|||
161625425|NCT02151643|583679214|FG001|Overall Study|Adverse Event|0|||
161625426|NCT02151643|583679215|FG002|Overall Study|Adverse Event|1|||
161625427|NCT02151643|583679216|FG003|Overall Study|Adverse Event|4|||
161625428|NCT02151643|583679217|FG004|Overall Study|Adverse Event|0|||
161625429|NCT02151643|583679213|FG000|Overall Study|Withdrawal by Subject|0|||
161625430|NCT02151643|583679214|FG001|Overall Study|Withdrawal by Subject|1|||
161625431|NCT02151643|583679215|FG002|Overall Study|Withdrawal by Subject|1|||
161625432|NCT02151643|583679216|FG003|Overall Study|Withdrawal by Subject|1|||
161625433|NCT02151643|583679217|FG004|Overall Study|Withdrawal by Subject|1|||
161625434|NCT02151643|583679213|FG000|Overall Study|Hyperphosphataemia|1|||
161625435|NCT02151643|583679214|FG001|Overall Study|Hyperphosphataemia|0|||
161625436|NCT02151643|583679215|FG002|Overall Study|Hyperphosphataemia|0|||
161625437|NCT02151643|583679216|FG003|Overall Study|Hyperphosphataemia|0|||
161625438|NCT02151643|583679217|FG004|Overall Study|Hyperphosphataemia|1|||
161625439|NCT02151643|583679213|FG000|Overall Study|High Ferritin levels|3|||
161625440|NCT02151643|583679214|FG001|Overall Study|High Ferritin levels|3|||
161625441|NCT02151643|583679215|FG002|Overall Study|High Ferritin levels|2|||
161625442|NCT02151643|583679216|FG003|Overall Study|High Ferritin levels|2|||
161625443|NCT02151643|583679217|FG004|Overall Study|High Ferritin levels|1|||
161625444|NCT00644332|583679218|FG000|Overall Study|Adverse Event|11|||
161625445|NCT00644332|583679218|FG000|Overall Study|Withdrawal by Subject|6|||
161625446|NCT00644332|583679218|FG000|Overall Study|Completion Status Unknown|2|||
161625447|NCT00644332|583679218|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
161625448|NCT00644332|583679218|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
161625449|NCT03694210|583679219|FG000|Overall Study|Death|1|||
161625450|NCT03694210|583679219|FG000|Overall Study|Screen Failure|7|||
161625451|NCT03050372|583679222|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
161625452|NCT03050372|583679223|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
161625453|NCT03050372|583679222|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
161625454|NCT03050372|583679223|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
161625455|NCT00443755|583679226|FG000|Overall Study|Withdrawal by Subject|2|||
161625456|NCT00443755|583679227|FG001|Overall Study|Withdrawal by Subject|1|||
161625457|NCT02775214|583679228|FG000|Overall Study|Withdrawal by Subject|2|||
161625458|NCT02775214|583679229|FG001|Overall Study|Withdrawal by Subject|0|||
161625459|NCT02706834|583679230|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161625460|NCT02706834|583679231|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161625461|NCT02706834|583679232|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161625462|NCT02706834|583679233|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
161625463|NCT02706834|583679234|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161625464|NCT02706834|583679235|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
161833298|NCT05506358|584431056|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
161833299|NCT05506358|584431057|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
161833300|NCT05506358|584431058|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
161833301|NCT05506358|584431054|FG000|Overall Study|HbE trait|0|||
161625465|NCT02706834|583679236|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
161625466|NCT02706834|583679237|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
161625467|NCT02706834|583679238|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
161625468|NCT02706834|583679239|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
161625469|NCT02706834|583679240|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
161625470|NCT02706834|583679230|FG000|Overall Study|Lost to Follow-up|0|||
161625471|NCT02706834|583679231|FG001|Overall Study|Lost to Follow-up|0|||
161625472|NCT02706834|583679232|FG002|Overall Study|Lost to Follow-up|1|||
161625473|NCT02706834|583679233|FG003|Overall Study|Lost to Follow-up|0|||
161625474|NCT02706834|583679234|FG004|Overall Study|Lost to Follow-up|0|||
161625475|NCT02706834|583679235|FG005|Overall Study|Lost to Follow-up|0|||
161625476|NCT02706834|583679236|FG006|Overall Study|Lost to Follow-up|0|||
161625477|NCT02706834|583679237|FG007|Overall Study|Lost to Follow-up|0|||
161625478|NCT02706834|583679238|FG008|Overall Study|Lost to Follow-up|0|||
161625479|NCT02706834|583679239|FG009|Overall Study|Lost to Follow-up|0|||
161625480|NCT02706834|583679240|FG010|Overall Study|Lost to Follow-up|0|||
161625481|NCT02706834|583679230|FG000|Overall Study|Voluntary Withdrawal|1|||
161625482|NCT02706834|583679231|FG001|Overall Study|Voluntary Withdrawal|0|||
161625483|NCT02706834|583679232|FG002|Overall Study|Voluntary Withdrawal|0|||
161625484|NCT02706834|583679233|FG003|Overall Study|Voluntary Withdrawal|0|||
161625485|NCT02706834|583679234|FG004|Overall Study|Voluntary Withdrawal|0|||
161625486|NCT02706834|583679235|FG005|Overall Study|Voluntary Withdrawal|0|||
161625487|NCT02706834|583679236|FG006|Overall Study|Voluntary Withdrawal|0|||
161625488|NCT02706834|583679237|FG007|Overall Study|Voluntary Withdrawal|0|||
161625489|NCT02706834|583679238|FG008|Overall Study|Voluntary Withdrawal|0|||
161625490|NCT02706834|583679239|FG009|Overall Study|Voluntary Withdrawal|1|||
161625491|NCT02706834|583679240|FG010|Overall Study|Voluntary Withdrawal|0|||
161625492|NCT02706834|583679230|FG000|Overall Study|Other Reason Not Specified|1|||
161625493|NCT02706834|583679231|FG001|Overall Study|Other Reason Not Specified|0|||
161833302|NCT05506358|584431055|FG001|Overall Study|HbE trait|0|||
161833303|NCT05506358|584431056|FG002|Overall Study|HbE trait|0|||
161833304|NCT05506358|584431057|FG003|Overall Study|HbE trait|1|||
161833305|NCT05506358|584431058|FG004|Overall Study|HbE trait|0|||
161833306|NCT01173471|584431064|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161833307|NCT01173471|584431065|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161833308|NCT01173471|584431066|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161625494|NCT02706834|583679232|FG002|Overall Study|Other Reason Not Specified|0|||
161625495|NCT02706834|583679233|FG003|Overall Study|Other Reason Not Specified|0|||
161625496|NCT02706834|583679234|FG004|Overall Study|Other Reason Not Specified|1|||
161625497|NCT02706834|583679235|FG005|Overall Study|Other Reason Not Specified|0|||
161625498|NCT02706834|583679236|FG006|Overall Study|Other Reason Not Specified|0|||
161625499|NCT02706834|583679237|FG007|Overall Study|Other Reason Not Specified|0|||
161625500|NCT02706834|583679238|FG008|Overall Study|Other Reason Not Specified|0|||
161625501|NCT02706834|583679239|FG009|Overall Study|Other Reason Not Specified|0|||
161625502|NCT02706834|583679240|FG010|Overall Study|Other Reason Not Specified|0|||
161625503|NCT00678899|583679242|FG000|Overall Study|Adverse Event|1|||
161833309|NCT01173471|584431067|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161833310|NCT01173471|584431064|FG000|Overall Study|Condition under investigation worsened|2|||
161833311|NCT01173471|584431065|FG001|Overall Study|Condition under investigation worsened|0|||
161833312|NCT01173471|584431066|FG002|Overall Study|Condition under investigation worsened|0|||
161833313|NCT01173471|584431067|FG003|Overall Study|Condition under investigation worsened|0|||
161833314|NCT01173471|584431064|FG000|Overall Study|Lost to Follow-up|0|||
161833315|NCT01173471|584431065|FG001|Overall Study|Lost to Follow-up|0|||
161833316|NCT01173471|584431066|FG002|Overall Study|Lost to Follow-up|1|||
161833317|NCT01173471|584431067|FG003|Overall Study|Lost to Follow-up|0|||
161833318|NCT01173471|584431064|FG000|Overall Study|Reason given as Other|0|||
161833319|NCT01173471|584431065|FG001|Overall Study|Reason given as Other|0|||
161833320|NCT01173471|584431066|FG002|Overall Study|Reason given as Other|1|||
161833321|NCT01173471|584431067|FG003|Overall Study|Reason given as Other|0|||
161833322|NCT00584844|584431069|FG000|Overall Study|Withdrawal by Subject|59|||
161833323|NCT00584844|584431069|FG000|Overall Study|Screen Failure|20|||
161833324|NCT03028740|584431070|FG000|Overall Study|Did not Receive Study Drug|4|||
161833325|NCT03028740|584431071|FG001|Overall Study|Did not Receive Study Drug|5|||
161833326|NCT03028740|584431070|FG000|Overall Study|Adverse Event|8|||
161833327|NCT03028740|584431071|FG001|Overall Study|Adverse Event|26|||
161833328|NCT03028740|584431070|FG000|Overall Study|Lack of Efficacy|0|||
161833329|NCT03028740|584431071|FG001|Overall Study|Lack of Efficacy|1|||
161833330|NCT03028740|584431070|FG000|Overall Study|Withdrawal by Subject|48|||
161833331|NCT03028740|584431071|FG001|Overall Study|Withdrawal by Subject|101|||
161833332|NCT03028740|584431070|FG000|Overall Study|Lost to Follow-up|30|||
161833333|NCT03028740|584431071|FG001|Overall Study|Lost to Follow-up|54|||
161833334|NCT03028740|584431070|FG000|Overall Study|Physician Decision|4|||
161833335|NCT03028740|584431071|FG001|Overall Study|Physician Decision|11|||
161833336|NCT03028740|584431070|FG000|Overall Study|Protocol Violation|4|||
161833337|NCT03028740|584431071|FG001|Overall Study|Protocol Violation|8|||
161833338|NCT03028740|584431070|FG000|Overall Study|Non-compliance with Study Drug|0|||
161625504|NCT02543294|583679243|FG000|Overall Study|Lost to Follow-up|3|||
161625505|NCT02543294|583679243|FG000|Overall Study|Physician Decision|2|||
161625506|NCT02543294|583679243|FG000|Overall Study|Withdrawal by Subject|7|||
161625507|NCT01107353|583679249|FG000|Overall Study|Positive Drug Screen|1|||
161625508|NCT01107353|583679250|FG001|Overall Study|Positive Drug Screen|0|||
161625509|NCT02798861|583679253|FG000|Overall Study|Lost to Follow-up|22|||
161625510|NCT02798861|583679253|FG000|Overall Study|Withdrawal by Subject|1|||
161625511|NCT02475733|583679276|FG000|Overall Study|Withdrawal by Subject|1|||
161625512|NCT02475733|583679277|FG001|Overall Study|Withdrawal by Subject|0|||
161833339|NCT03028740|584431071|FG001|Overall Study|Non-compliance with Study Drug|2|||
161833340|NCT03028740|584431070|FG000|Overall Study|Study Terminated by Sponsor|467|||
161833341|NCT03028740|584431071|FG001|Overall Study|Study Terminated by Sponsor|917|||
161833342|NCT03028740|584431070|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
161625513|NCT02475733|583679276|FG000|Overall Study|Physician Decision|1|||
161625514|NCT02475733|583679277|FG001|Overall Study|Physician Decision|0|||
161625515|NCT02131155|583679278|FG000|Overall Study|Adverse Event|1|||
161625516|NCT02131155|583679279|FG001|Overall Study|Adverse Event|0|||
161625517|NCT02131155|583679278|FG000|Overall Study|Treatment completed|1|||
161625518|NCT02131155|583679279|FG001|Overall Study|Treatment completed|0|||
161625519|NCT02131155|583679278|FG000|Overall Study|Primary tumour recurrence|2|||
161625520|NCT02131155|583679279|FG001|Overall Study|Primary tumour recurrence|1|||
161625521|NCT02131155|583679278|FG000|Overall Study|Refused to continue study medication|1|||
161625522|NCT02131155|583679279|FG001|Overall Study|Refused to continue study medication|0|||
161625523|NCT02131155|583679278|FG000|Overall Study|Study early termination|20|||
161625524|NCT02131155|583679279|FG001|Overall Study|Study early termination|10|||
161625525|NCT01887418|583679280|FG000|Overall Study|Travelling difficulties|0|||
161625526|NCT01887418|583679281|FG001|Overall Study|Travelling difficulties|0|||
161625527|NCT01887418|583679282|FG002|Overall Study|Travelling difficulties|1|||
161625528|NCT01014013|583679283|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
161625529|NCT01014013|583679284|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
161625530|NCT01014013|583679283|FG000|Overall Study|Clinical adverse experience|4|||
161625531|NCT01014013|583679284|FG001|Overall Study|Clinical adverse experience|2|||
161625532|NCT01014013|583679283|FG000|Overall Study|Laboratory adverse experience|1|||
161625533|NCT01014013|583679284|FG001|Overall Study|Laboratory adverse experience|1|||
161625534|NCT01014013|583679283|FG000|Overall Study|Protocol Violation|1|||
161625535|NCT01014013|583679284|FG001|Overall Study|Protocol Violation|3|||
161625536|NCT01014013|583679283|FG000|Overall Study|Withdrawal by Subject|7|||
161625537|NCT01014013|583679284|FG001|Overall Study|Withdrawal by Subject|4|||
161625538|NCT01014013|583679283|FG000|Overall Study|Clinical/microbiologic failure|1|||
161625539|NCT01014013|583679284|FG001|Overall Study|Clinical/microbiologic failure|2|||
161625540|NCT01014013|583679283|FG000|Overall Study|Pathogen culture = no growth|26|||
161625541|NCT01014013|583679284|FG001|Overall Study|Pathogen culture = no growth|34|||
161625542|NCT01014013|583679283|FG000|Overall Study|Negative urine culture|2|||
161625543|NCT01014013|583679284|FG001|Overall Study|Negative urine culture|0|||
161625544|NCT01014013|583679283|FG000|Overall Study|Pathogen resistant|7|||
161625545|NCT01014013|583679284|FG001|Overall Study|Pathogen resistant|4|||
161625546|NCT01014013|583679283|FG000|Overall Study|Physician Decision|0|||
161625547|NCT01014013|583679284|FG001|Overall Study|Physician Decision|1|||
161625548|NCT01014013|583679283|FG000|Overall Study|Another antibiotic therapy required|0|||
161625549|NCT01014013|583679284|FG001|Overall Study|Another antibiotic therapy required|1|||
161625550|NCT01014013|583679283|FG000|Overall Study|Appendectomy|1|||
161625551|NCT01014013|583679284|FG001|Overall Study|Appendectomy|0|||
161625552|NCT01014013|583679283|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
161625553|NCT01014013|583679284|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
161625554|NCT00442559|583679291|FG000|Overall Study|Lost to Follow-up|32|||
161625555|NCT00442559|583679292|FG001|Overall Study|Lost to Follow-up|34|||
161625556|NCT00442559|583679291|FG000|Overall Study|Protocol Violation|1|||
161625557|NCT00442559|583679292|FG001|Overall Study|Protocol Violation|1|||
161625558|NCT00442559|583679291|FG000|Overall Study|Withdrawal by Subject|1|||
161625559|NCT00442559|583679292|FG001|Overall Study|Withdrawal by Subject|0|||
161625560|NCT03575572|583679293|FG000|Overall Study|Withdrawal by Subject|2|||
161625561|NCT03575572|583679293|FG000|Overall Study|Physician Decision|2|||
161625562|NCT03647709|583679297|FG000|Overall Study|Lost to Follow-up|5|||
161625563|NCT03647709|583679297|FG000|Overall Study|Physician Decision|6|||
161625564|NCT03647709|583679297|FG000|Overall Study|Withdrawal by Subject|3|||
161625565|NCT05287178|583679298|FG000|Overall Study|Lost to Follow-up|2|||
161625566|NCT01920178|583679299|FG000|Overall Study|Lost to Follow-up|2|||
161625567|NCT01920178|583679300|FG001|Overall Study|Lost to Follow-up|1|||
161625568|NCT03023878|583679301|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
161625569|NCT03023878|583679301|FG000|Pre-Study Run-In Period|Death|1|||
161625570|NCT03023878|583679301|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
161625571|NCT03023878|583679301|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
161625572|NCT03023878|583679301|FG000|Treatment Period|Disease Progression|1|||
161625573|NCT03023878|583679301|FG000|Treatment Period|Withdrawal by Subject|1|||
161625574|NCT03023878|583679301|FG000|Treatment Period|Adverse Event|1|||
161625575|NCT03023878|583679301|FG000|Long Term Follow-Up Period|Death|2|||
161625576|NCT01812837|583679302|FG000|Overall Study|Lost to Follow-up|1|||
161625577|NCT01812837|583679303|FG001|Overall Study|Lost to Follow-up|1|||
161625578|NCT01812837|583679304|FG002|Overall Study|Lost to Follow-up|0|||
161625579|NCT01812837|583679302|FG000|Overall Study|Protocol Violation|1|||
161625580|NCT01812837|583679303|FG001|Overall Study|Protocol Violation|0|||
161625581|NCT01812837|583679304|FG002|Overall Study|Protocol Violation|0|||
161625582|NCT00288353|583679309|FG000|Overall Study|Lack of Efficacy|2|||
161625583|NCT00288353|583679310|FG001|Overall Study|Lack of Efficacy|2|||
161625584|NCT00288353|583679309|FG000|Overall Study|Withdrawal by Subject|5|||
161625585|NCT00288353|583679310|FG001|Overall Study|Withdrawal by Subject|5|||
161625586|NCT05234632|583679311|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
161625587|NCT05234632|583679312|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
161625588|NCT05234632|583679311|FG000|Overall Study|Withdrawal by Subject|2|||
161833343|NCT03028740|584431071|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
161833344|NCT03028740|584431070|FG000|Overall Study|Reason not Specified|1|||
161833345|NCT03028740|584431071|FG001|Overall Study|Reason not Specified|5|||
161833346|NCT05224544|584431074|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
161833347|NCT05224544|584431075|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
161833348|NCT01341587|584431076|FG000|Overall Study|Lost to Follow-up|2|||
161833349|NCT01341587|584431077|FG001|Overall Study|Lost to Follow-up|0|||
161833350|NCT01341587|584431076|FG000|Overall Study|stopped using the meters|2|||
161833351|NCT01341587|584431077|FG001|Overall Study|stopped using the meters|10|||
161833352|NCT00645944|584431080|FG000|Randomized|Withdrawal by Subject|1|||
161833353|NCT00645944|584431081|FG001|Randomized|Withdrawal by Subject|2|||
161833354|NCT00645944|584431080|FG000|Received Medication|Adverse Event|2|||
161833355|NCT00645944|584431081|FG001|Received Medication|Adverse Event|1|||
161833356|NCT00645944|584431080|FG000|Received Medication|Withdrawal by Subject|1|||
161833357|NCT00645944|584431081|FG001|Received Medication|Withdrawal by Subject|1|||
161833358|NCT00645944|584431080|FG000|Received Medication|Lost to Follow-up|1|||
161833359|NCT00645944|584431081|FG001|Received Medication|Lost to Follow-up|0|||
161833360|NCT00645944|584431080|FG000|Received Medication|Protocol Violation|2|||
161833361|NCT00645944|584431081|FG001|Received Medication|Protocol Violation|1|||
161833362|NCT02080832|584431089|FG000|Overall Study|Excluded from analysis by MRI|9|||
161833363|NCT02080832|584431090|FG001|Overall Study|Excluded from analysis by MRI|10|||
161833364|NCT02080832|584431091|FG002|Overall Study|Excluded from analysis by MRI|14|||
161833365|NCT02080832|584431089|FG000|Overall Study|Lost to Follow-up|0|||
161833366|NCT02080832|584431090|FG001|Overall Study|Lost to Follow-up|2|||
161833367|NCT02080832|584431091|FG002|Overall Study|Lost to Follow-up|2|||
161833368|NCT00560937|584431092|FG000|Overall Study|Withdrawal by Subject|0|||
161833369|NCT00560937|584431093|FG001|Overall Study|Withdrawal by Subject|1|||
161833370|NCT00560937|584431092|FG000|Overall Study|Physician Decision|1|||
161833371|NCT00560937|584431093|FG001|Overall Study|Physician Decision|1|||
161833372|NCT03069417|584431094|FG000|Overall Study|Lost to Follow-up|2|||
161833373|NCT03069417|584431095|FG001|Overall Study|Lost to Follow-up|0|||
161833374|NCT03069417|584431094|FG000|Overall Study|Reason Unknown|4|||
161625589|NCT05234632|583679312|FG001|Overall Study|Withdrawal by Subject|0|||
161625590|NCT05234632|583679311|FG000|Overall Study|Adverse Event|0|||
161625591|NCT05234632|583679312|FG001|Overall Study|Adverse Event|4|||
161625592|NCT05234632|583679311|FG000|Overall Study|Physician Decision|1|||
161625593|NCT05234632|583679312|FG001|Overall Study|Physician Decision|1|||
161625594|NCT05234632|583679311|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
161625595|NCT05234632|583679312|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
161625596|NCT05234632|583679311|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
161625597|NCT05234632|583679312|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
161625598|NCT04799587|583679313|FG000|Overall Study|Withdrawal by Subject|0|||
161625599|NCT04799587|583679314|FG001|Overall Study|Withdrawal by Subject|1|||
161625600|NCT00728884|583679315|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
161625601|NCT00728884|583679315|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
161625602|NCT02849509|583679317|FG000|Overall Study|Worsening of disease under study|1|||
161625603|NCT02849509|583679318|FG001|Overall Study|Worsening of disease under study|1|||
161625604|NCT02849509|583679319|FG002|Overall Study|Worsening of disease under study|1|||
161625605|NCT02849509|583679317|FG000|Overall Study|Worsening of other pre-existing disease|0|||
161625606|NCT02849509|583679318|FG001|Overall Study|Worsening of other pre-existing disease|1|||
161625607|NCT02849509|583679319|FG002|Overall Study|Worsening of other pre-existing disease|2|||
161833375|NCT03069417|584431095|FG001|Overall Study|Reason Unknown|7|||
161833376|NCT01660022|584431097|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833377|NCT01660022|584431098|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
161833378|NCT01660022|584431099|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833379|NCT01660022|584431100|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
161833380|NCT01660022|584431101|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833381|NCT01660022|584431102|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833382|NCT01660022|584431097|FG000|First Sequence (7 Days)|Adverse Event|0|||
161625608|NCT02849509|583679317|FG000|Overall Study|Other adverse event|36|||
161625609|NCT02849509|583679318|FG001|Overall Study|Other adverse event|41|||
161625610|NCT02849509|583679319|FG002|Overall Study|Other adverse event|8|||
161625611|NCT02849509|583679317|FG000|Overall Study|Withdrawal by Subject|6|||
161625612|NCT02849509|583679318|FG001|Overall Study|Withdrawal by Subject|17|||
161625613|NCT02849509|583679319|FG002|Overall Study|Withdrawal by Subject|12|||
161625614|NCT02849509|583679317|FG000|Overall Study|Lost to Follow-up|27|||
161625615|NCT02849509|583679318|FG001|Overall Study|Lost to Follow-up|67|||
161625616|NCT02849509|583679319|FG002|Overall Study|Lost to Follow-up|36|||
161625617|NCT02849509|583679317|FG000|Overall Study|Other, reason not specified|14|||
161625618|NCT02849509|583679318|FG001|Overall Study|Other, reason not specified|29|||
161625619|NCT02849509|583679319|FG002|Overall Study|Other, reason not specified|25|||
161625620|NCT02849509|583679317|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
161625621|NCT02849509|583679318|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
161625622|NCT02849509|583679319|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
161625623|NCT05431543|583679331|FG000|Overall Study|Medical History|1|||
161625624|NCT05431543|583679332|FG001|Overall Study|Medical History|0|||
161625625|NCT05431543|583679333|FG002|Overall Study|Medical History|0|||
161625626|NCT02784535|583679334|FG000|Overall Study|Adverse Event|1|||
161625627|NCT02784535|583679335|FG001|Overall Study|Adverse Event|0|||
161625628|NCT02784535|583679334|FG000|Overall Study|Withdrawal by Subject|0|||
161625629|NCT02784535|583679335|FG001|Overall Study|Withdrawal by Subject|1|||
161625630|NCT02784535|583679334|FG000|Overall Study|Physician Decision|0|||
161625631|NCT02784535|583679335|FG001|Overall Study|Physician Decision|1|||
161625632|NCT00914732|583679339|FG000|Overall Study|Lost to Follow-up|6|||
161625633|NCT00914732|583679340|FG001|Overall Study|Lost to Follow-up|7|||
161625634|NCT00914732|583679341|FG002|Overall Study|Lost to Follow-up|9|||
161625635|NCT00914732|583679339|FG000|Overall Study|Withdrawal by Subject|3|||
161625636|NCT00914732|583679340|FG001|Overall Study|Withdrawal by Subject|0|||
161625637|NCT00914732|583679341|FG002|Overall Study|Withdrawal by Subject|2|||
161625638|NCT00914732|583679339|FG000|Overall Study|Adverse Event|1|||
161625639|NCT00914732|583679340|FG001|Overall Study|Adverse Event|0|||
161625640|NCT00914732|583679341|FG002|Overall Study|Adverse Event|0|||
161625641|NCT05615870|583679342|FG000|Overall Study|Lost to Follow-up|10|||
161625642|NCT05615870|583679343|FG001|Overall Study|Lost to Follow-up|13|||
161625643|NCT05615870|583679342|FG000|Overall Study|Physician Decision|2|||
161625644|NCT05615870|583679343|FG001|Overall Study|Physician Decision|0|||
161625645|NCT05615870|583679342|FG000|Overall Study|Withdrawal by Subject|0|||
161625646|NCT05615870|583679343|FG001|Overall Study|Withdrawal by Subject|2|||
161625647|NCT05615870|583679342|FG000|Overall Study|Protocol Violation|0|||
161625648|NCT05615870|583679343|FG001|Overall Study|Protocol Violation|3|||
161625649|NCT05615870|583679342|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
161625650|NCT05615870|583679343|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
161625651|NCT05615870|583679342|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
161625652|NCT05615870|583679343|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
161625653|NCT05615870|583679342|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
161625654|NCT05615870|583679343|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
161625655|NCT00145496|583679346|FG000|Overall Study|Adverse Event|42|||
161625656|NCT00145496|583679347|FG001|Overall Study|Adverse Event|30|||
161625657|NCT00145496|583679346|FG000|Overall Study|Lack of Efficacy|12|||
161625658|NCT00145496|583679347|FG001|Overall Study|Lack of Efficacy|7|||
161625659|NCT00145496|583679346|FG000|Overall Study|Withdrawal by Subject|32|||
161625660|NCT00145496|583679347|FG001|Overall Study|Withdrawal by Subject|26|||
161625661|NCT00145496|583679346|FG000|Overall Study|Lost to Follow-up|12|||
161625662|NCT00145496|583679347|FG001|Overall Study|Lost to Follow-up|5|||
161625663|NCT00145496|583679346|FG000|Overall Study|Other|25|||
161625664|NCT00145496|583679347|FG001|Overall Study|Other|13|||
161625665|NCT01334606|583679351|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
161625666|NCT00990314|583679352|FG000|Overall Study|Death|2|||
161625667|NCT00990314|583679352|FG000|Overall Study|Adverse Event|2|||
161625668|NCT00990314|583679352|FG000|Overall Study|Withdrawal by Subject|3|||
161625669|NCT00990314|583679352|FG000|Overall Study|Non-Compliance|1|||
161625670|NCT00990314|583679352|FG000|Overall Study|Physician Decision|3|||
161625671|NCT00990314|583679352|FG000|Overall Study|Lack of Efficacy|1|||
161625672|NCT02676778|583679353|FG000|Overall Study|Disease Progression|7|||
161625673|NCT02676778|583679354|FG001|Overall Study|Disease Progression|3|||
161625674|NCT02676778|583679355|FG002|Overall Study|Disease Progression|1|||
161625675|NCT02676778|583679353|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
161625676|NCT02676778|583679354|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
161625677|NCT02676778|583679355|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
161625678|NCT02676778|583679353|FG000|Overall Study|Withdrawal by Subject|3|||
161833383|NCT01660022|584431098|FG001|First Sequence (7 Days)|Adverse Event|0|||
161833384|NCT01660022|584431099|FG002|First Sequence (7 Days)|Adverse Event|0|||
161833385|NCT01660022|584431100|FG003|First Sequence (7 Days)|Adverse Event|0|||
161625679|NCT02676778|583679354|FG001|Overall Study|Withdrawal by Subject|2|||
161625680|NCT02676778|583679355|FG002|Overall Study|Withdrawal by Subject|0|||
161625681|NCT02676778|583679353|FG000|Overall Study|Other|4|||
161625682|NCT02676778|583679354|FG001|Overall Study|Other|3|||
161625683|NCT02676778|583679355|FG002|Overall Study|Other|0|||
161625684|NCT02676778|583679353|FG000|Overall Study|Adverse Event|2|||
161625685|NCT02676778|583679354|FG001|Overall Study|Adverse Event|3|||
161625686|NCT02676778|583679355|FG002|Overall Study|Adverse Event|0|||
161625687|NCT03214198|583679360|FG000|Overall Study|Case Report Forms Uncollected|18|||
161625688|NCT03214198|583679360|FG000|Overall Study|Protocol Deviation|18|||
161625689|NCT03686176|583679361|FG000|Overall Study|Procedure cancelled|1|||
161625690|NCT03686176|583679362|FG001|Overall Study|Procedure cancelled|0|||
161625691|NCT03686176|583679363|FG002|Overall Study|Procedure cancelled|0|||
161625692|NCT03686176|583679361|FG000|Overall Study|VR Malfunction|1|||
161625693|NCT03686176|583679362|FG001|Overall Study|VR Malfunction|0|||
161625694|NCT03686176|583679363|FG002|Overall Study|VR Malfunction|0|||
161625695|NCT00635570|583681110|FG000|Overall Study|Lost to Follow-up|8|||
161625696|NCT00635570|583681111|FG001|Overall Study|Lost to Follow-up|8|||
161625697|NCT00635570|583681110|FG000|Overall Study|Withdrawal by Subject|1|||
161625698|NCT00635570|583681111|FG001|Overall Study|Withdrawal by Subject|1|||
161625699|NCT00635570|583681110|FG000|Overall Study|Adverse Event|2|||
161625700|NCT00635570|583681111|FG001|Overall Study|Adverse Event|0|||
161625701|NCT00635570|583681110|FG000|Overall Study|Physician Decision|1|||
161625702|NCT00635570|583681111|FG001|Overall Study|Physician Decision|0|||
161625703|NCT00635570|583681110|FG000|Overall Study|Did not complete survey|2|||
161625704|NCT00635570|583681111|FG001|Overall Study|Did not complete survey|1|||
161625705|NCT00635570|583681110|FG000|Overall Study|Early termination(No sexual activity)|1|||
161625706|NCT00635570|583681111|FG001|Overall Study|Early termination(No sexual activity)|1|||
161625707|NCT04816708|583681112|FG000|Overall Study|Lost to Follow-up|10|||
161625708|NCT04816708|583681113|FG001|Overall Study|Lost to Follow-up|4|||
161625709|NCT02255435|583681114|FG000|Overall Study|Patient's Limited Time Availability|0|||
161625710|NCT02255435|583681115|FG001|Overall Study|Patient's Limited Time Availability|0|||
161625711|NCT02255435|583681116|FG002|Overall Study|Patient's Limited Time Availability|0|||
161625712|NCT02255435|583681117|FG003|Overall Study|Patient's Limited Time Availability|0|||
161625713|NCT02255435|583681118|FG004|Overall Study|Patient's Limited Time Availability|0|||
161625714|NCT02255435|583681119|FG005|Overall Study|Patient's Limited Time Availability|0|||
161625715|NCT02255435|583681120|FG006|Overall Study|Patient's Limited Time Availability|0|||
161625716|NCT02255435|583681121|FG007|Overall Study|Patient's Limited Time Availability|1|||
161625717|NCT02255435|583681122|FG008|Overall Study|Patient's Limited Time Availability|0|||
161625718|NCT02255435|583681123|FG009|Overall Study|Patient's Limited Time Availability|0|||
161625719|NCT02255435|583681114|FG000|Overall Study|Withdrawal by Subject|0|||
161625720|NCT02255435|583681115|FG001|Overall Study|Withdrawal by Subject|0|||
161625721|NCT02255435|583681116|FG002|Overall Study|Withdrawal by Subject|0|||
161625722|NCT02255435|583681117|FG003|Overall Study|Withdrawal by Subject|0|||
161625723|NCT02255435|583681118|FG004|Overall Study|Withdrawal by Subject|0|||
161625724|NCT02255435|583681119|FG005|Overall Study|Withdrawal by Subject|0|||
161625725|NCT02255435|583681120|FG006|Overall Study|Withdrawal by Subject|0|||
161625726|NCT02255435|583681121|FG007|Overall Study|Withdrawal by Subject|0|||
161625727|NCT02255435|583681122|FG008|Overall Study|Withdrawal by Subject|1|||
161625728|NCT02255435|583681123|FG009|Overall Study|Withdrawal by Subject|4|||
161625729|NCT02255435|583681114|FG000|Overall Study|Administrative reasons|0|||
161625730|NCT02255435|583681115|FG001|Overall Study|Administrative reasons|0|||
161625731|NCT02255435|583681116|FG002|Overall Study|Administrative reasons|0|||
161625732|NCT02255435|583681117|FG003|Overall Study|Administrative reasons|0|||
161625733|NCT02255435|583681118|FG004|Overall Study|Administrative reasons|0|||
161625734|NCT02255435|583681119|FG005|Overall Study|Administrative reasons|0|||
161625735|NCT02255435|583681120|FG006|Overall Study|Administrative reasons|0|||
161625736|NCT02255435|583681121|FG007|Overall Study|Administrative reasons|0|||
161625737|NCT02255435|583681122|FG008|Overall Study|Administrative reasons|0|||
161625738|NCT02255435|583681123|FG009|Overall Study|Administrative reasons|2|||
161625739|NCT03596905|583681124|FG000|Overall Study|Protocol Violation|0|||
161625740|NCT03596905|583681125|FG001|Overall Study|Protocol Violation|0|||
161625741|NCT03596905|583681126|FG002|Overall Study|Protocol Violation|0|||
161625742|NCT03596905|583681127|FG003|Overall Study|Protocol Violation|0|||
161833386|NCT01660022|584431101|FG004|First Sequence (7 Days)|Adverse Event|1|||
161625743|NCT03596905|583681128|FG004|Overall Study|Protocol Violation|1|||
161625744|NCT03596905|583681129|FG005|Overall Study|Protocol Violation|0|||
161625745|NCT03596905|583681130|FG006|Overall Study|Protocol Violation|0|||
161833387|NCT01660022|584431102|FG005|First Sequence (7 Days)|Adverse Event|3|||
161625746|NCT03596905|583681124|FG000|Overall Study|Withdrawal by Subject|0|||
161625747|NCT03596905|583681125|FG001|Overall Study|Withdrawal by Subject|2|||
161625748|NCT03596905|583681126|FG002|Overall Study|Withdrawal by Subject|1|||
161625749|NCT03596905|583681127|FG003|Overall Study|Withdrawal by Subject|0|||
161625750|NCT03596905|583681128|FG004|Overall Study|Withdrawal by Subject|2|||
161625751|NCT03596905|583681129|FG005|Overall Study|Withdrawal by Subject|0|||
161625752|NCT03596905|583681130|FG006|Overall Study|Withdrawal by Subject|0|||
161625753|NCT03596905|583681124|FG000|Overall Study|Participant moved and was unable to complete study|0|||
161625754|NCT03596905|583681125|FG001|Overall Study|Participant moved and was unable to complete study|1|||
161625755|NCT03596905|583681126|FG002|Overall Study|Participant moved and was unable to complete study|0|||
161625756|NCT03596905|583681127|FG003|Overall Study|Participant moved and was unable to complete study|0|||
161625757|NCT03596905|583681128|FG004|Overall Study|Participant moved and was unable to complete study|0|||
161625758|NCT03596905|583681129|FG005|Overall Study|Participant moved and was unable to complete study|0|||
161625759|NCT03596905|583681130|FG006|Overall Study|Participant moved and was unable to complete study|0|||
161625760|NCT03596905|583681124|FG000|Overall Study|Adverse Event|0|||
161625761|NCT03596905|583681125|FG001|Overall Study|Adverse Event|0|||
161625762|NCT03596905|583681126|FG002|Overall Study|Adverse Event|0|||
161625763|NCT03596905|583681127|FG003|Overall Study|Adverse Event|0|||
161625764|NCT03596905|583681128|FG004|Overall Study|Adverse Event|0|||
161625765|NCT03596905|583681129|FG005|Overall Study|Adverse Event|0|||
161625766|NCT03596905|583681130|FG006|Overall Study|Adverse Event|1|||
161625767|NCT03596905|583681124|FG000|Overall Study|Non-Compliance with eDiary|1|||
161625768|NCT03596905|583681125|FG001|Overall Study|Non-Compliance with eDiary|0|||
161625769|NCT03596905|583681126|FG002|Overall Study|Non-Compliance with eDiary|0|||
161625770|NCT03596905|583681127|FG003|Overall Study|Non-Compliance with eDiary|0|||
161625771|NCT03596905|583681128|FG004|Overall Study|Non-Compliance with eDiary|1|||
161625772|NCT03596905|583681129|FG005|Overall Study|Non-Compliance with eDiary|0|||
161625773|NCT03596905|583681130|FG006|Overall Study|Non-Compliance with eDiary|2|||
161625774|NCT03596905|583681124|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161625775|NCT03596905|583681125|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161625776|NCT03596905|583681126|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161625777|NCT03596905|583681127|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161625778|NCT03596905|583681128|FG004|Overall Study|Non-Compliance with Study Drug|1|||
161625779|NCT03596905|583681129|FG005|Overall Study|Non-Compliance with Study Drug|0|||
161625780|NCT03596905|583681130|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161625781|NCT03596905|583681124|FG000|Overall Study|Lost to Follow-up|0|||
161685093|NCT00501007|583899688|FG000|Overall Study|Inclusion criteria not met.|29|||
161685094|NCT00501007|583899689|FG001|Overall Study|Inclusion criteria not met.|25|||
161685095|NCT03917823|583899690|FG000|Overall Study|Lost to Follow-up|1|||
161685096|NCT03917823|583899691|FG001|Overall Study|Lost to Follow-up|1|||
161685097|NCT03917823|583899690|FG000|Overall Study|Withdrawal by Subject|0|||
161685098|NCT03917823|583899691|FG001|Overall Study|Withdrawal by Subject|1|||
161685099|NCT02424253|583899694|FG000|Overall Study|Other, unspecified|1|||
161685100|NCT02424253|583899695|FG001|Overall Study|Other, unspecified|0|||
161685101|NCT02424253|583899694|FG000|Overall Study|Compliance problems|1|||
161685102|NCT02424253|583899695|FG001|Overall Study|Compliance problems|0|||
161685103|NCT02424253|583899694|FG000|Overall Study|Physician Decision|2|||
161685104|NCT02424253|583899695|FG001|Overall Study|Physician Decision|0|||
161685105|NCT02424253|583899694|FG000|Overall Study|Lack of Efficacy|0|||
161685106|NCT02424253|583899695|FG001|Overall Study|Lack of Efficacy|7|||
161685107|NCT02424253|583899694|FG000|Overall Study|Adverse Event|2|||
161685108|NCT02424253|583899695|FG001|Overall Study|Adverse Event|0|||
161685109|NCT02424253|583899694|FG000|Overall Study|Consent withdrawn by subject|4|||
161685110|NCT02424253|583899695|FG001|Overall Study|Consent withdrawn by subject|1|||
161685111|NCT02424253|583899694|FG000|Overall Study|Lost to Follow-up|1|||
161625782|NCT03596905|583681125|FG001|Overall Study|Lost to Follow-up|0|||
161625783|NCT03596905|583681126|FG002|Overall Study|Lost to Follow-up|0|||
161625784|NCT03596905|583681127|FG003|Overall Study|Lost to Follow-up|0|||
161625785|NCT03596905|583681128|FG004|Overall Study|Lost to Follow-up|0|||
161625786|NCT03596905|583681129|FG005|Overall Study|Lost to Follow-up|1|||
161685112|NCT02424253|583899695|FG001|Overall Study|Lost to Follow-up|1|||
161685113|NCT00473343|583899696|FG000|Overall Study|Adverse Event|9|||
161685114|NCT00473343|583899696|FG000|Overall Study|Lost to Follow-up|8|||
161685115|NCT00473343|583899696|FG000|Overall Study|Treatment failure|27|||
161625787|NCT03596905|583681130|FG006|Overall Study|Lost to Follow-up|0|||
161685116|NCT00473343|583899696|FG000|Overall Study|Withdrew consent|3|||
161625788|NCT04307134|583681131|FG000|Overall Study|Lost to Follow-up|2|||
161625789|NCT04307134|583681131|FG000|Overall Study|Withdrawal by Subject|3|||
161625790|NCT04307134|583681131|FG000|Overall Study|Other|3|||
161625791|NCT04307134|583681131|FG000|Overall Study|Death|21|||
161625792|NCT04307134|583681131|FG000|Overall Study|Enrolled but not Treated|1|||
161625793|NCT01809691|583681132|FG000|Overall Study|Currently on Treatment|192|||
161625794|NCT01809691|583681133|FG001|Overall Study|Currently on Treatment|100|||
161625795|NCT01809691|583681132|FG000|Overall Study|No Protocol Treatment|10|||
161625796|NCT01809691|583681133|FG001|Overall Study|No Protocol Treatment|11|||
161625797|NCT01809691|583681132|FG000|Overall Study|Adverse Event|80|||
161625798|NCT01809691|583681133|FG001|Overall Study|Adverse Event|21|||
161625799|NCT01809691|583681132|FG000|Overall Study|Disease Progression|226|||
161625800|NCT01809691|583681133|FG001|Overall Study|Disease Progression|372|||
161625801|NCT01809691|583681132|FG000|Overall Study|Death|26|||
161625802|NCT01809691|583681133|FG001|Overall Study|Death|13|||
161625803|NCT01809691|583681132|FG000|Overall Study|Participant Refusal|70|||
161625804|NCT01809691|583681133|FG001|Overall Study|Participant Refusal|72|||
161625805|NCT01809691|583681132|FG000|Overall Study|Other, Not Specified|34|||
161625806|NCT01809691|583681133|FG001|Overall Study|Other, Not Specified|52|||
161625807|NCT00907517|583681136|FG000|Overall Study|Progressive Disease|3|||
161625808|NCT00907517|583681137|FG001|Overall Study|Progressive Disease|3|||
161625809|NCT00907517|583681138|FG002|Overall Study|Progressive Disease|4|||
161833388|NCT01660022|584431097|FG000|First Sequence (7 Days)|Protocol Violation|0|||
161833389|NCT01660022|584431098|FG001|First Sequence (7 Days)|Protocol Violation|0|||
161625810|NCT00907517|583681139|FG003|Overall Study|Progressive Disease|4|||
161625811|NCT00907517|583681140|FG004|Overall Study|Progressive Disease|4|||
161625812|NCT00907517|583681136|FG000|Overall Study|Symptomatic Deterioration|0|||
161625813|NCT00907517|583681137|FG001|Overall Study|Symptomatic Deterioration|0|||
161625814|NCT00907517|583681138|FG002|Overall Study|Symptomatic Deterioration|0|||
161625815|NCT00907517|583681139|FG003|Overall Study|Symptomatic Deterioration|0|||
161625816|NCT00907517|583681140|FG004|Overall Study|Symptomatic Deterioration|1|||
161625817|NCT01732627|583681141|FG000|Overall Study|Withdrawal by Subject|1|||
161625818|NCT01732627|583681142|FG001|Overall Study|Withdrawal by Subject|0|||
161625819|NCT03541200|583681146|FG000|Overall Study|Adverse Event|19|||
161625820|NCT03541200|583681146|FG000|Overall Study|Death|1|||
161625821|NCT03541200|583681146|FG000|Overall Study|Lost to Follow-up|10|||
161625822|NCT03541200|583681146|FG000|Overall Study|Physician Decision|1|||
161625823|NCT03541200|583681146|FG000|Overall Study|Protocol Violation|51|||
161625824|NCT03541200|583681146|FG000|Overall Study|Withdrawal by Subject|23|||
161625825|NCT03541200|583681146|FG000|Overall Study|other|8|||
161625826|NCT02305797|583681147|FG000|Overall Study|Adverse Event|11|||
161625827|NCT02305797|583681148|FG001|Overall Study|Adverse Event|2|||
161625828|NCT02305797|583681147|FG000|Overall Study|Withdrawal by Subject|9|||
161625829|NCT02305797|583681148|FG001|Overall Study|Withdrawal by Subject|10|||
161625830|NCT02305797|583681147|FG000|Overall Study|Lack of Efficacy|6|||
161625831|NCT02305797|583681148|FG001|Overall Study|Lack of Efficacy|0|||
161625832|NCT02305797|583681147|FG000|Overall Study|Lost to Follow-up|5|||
161625833|NCT02305797|583681148|FG001|Overall Study|Lost to Follow-up|11|||
161625834|NCT02305797|583681147|FG000|Overall Study|Pregnancy|0|||
161625835|NCT02305797|583681148|FG001|Overall Study|Pregnancy|2|||
161625836|NCT02305797|583681147|FG000|Overall Study|Noncompliance|14|||
161625837|NCT02305797|583681148|FG001|Overall Study|Noncompliance|12|||
161625838|NCT02305797|583681147|FG000|Overall Study|Reason not collected|0|||
161625839|NCT02305797|583681148|FG001|Overall Study|Reason not collected|1|||
161625840|NCT03508830|583681149|FG000|Overall Study|Withdrawal by Subject|3|||
161625841|NCT03508830|583681150|FG001|Overall Study|Withdrawal by Subject|4|||
161625842|NCT03508830|583681149|FG000|Overall Study|Physician Decision|2|||
161833390|NCT01660022|584431099|FG002|First Sequence (7 Days)|Protocol Violation|0|||
161833391|NCT01660022|584431100|FG003|First Sequence (7 Days)|Protocol Violation|0|||
161833392|NCT01660022|584431101|FG004|First Sequence (7 Days)|Protocol Violation|0|||
161833393|NCT01660022|584431102|FG005|First Sequence (7 Days)|Protocol Violation|1|||
161833394|NCT03545191|584431105|FG000|Overall Study|Death|1|||
161625843|NCT03508830|583681150|FG001|Overall Study|Physician Decision|2|||
161625844|NCT02522299|583681151|FG000|Overall Study|Adverse Event|2|||
161625845|NCT02522299|583681152|FG001|Overall Study|Adverse Event|0|||
161625846|NCT02522299|583681151|FG000|Overall Study|Physician Decision|0|||
161625847|NCT02522299|583681152|FG001|Overall Study|Physician Decision|1|||
161625848|NCT02522299|583681151|FG000|Overall Study|Withdrawal by Subject|2|||
161625849|NCT02522299|583681152|FG001|Overall Study|Withdrawal by Subject|0|||
161625850|NCT02097056|583681153|FG000|Overall Study|Protocol Violation|2|||
161625851|NCT02097056|583681153|FG000|Overall Study|Withdrawal by Subject|15|||
161625852|NCT02097056|583681153|FG000|Overall Study|Lost to Follow-up|2|||
161625853|NCT02097056|583681153|FG000|Overall Study|Adverse Event|37|||
161625854|NCT02097056|583681153|FG000|Overall Study|Other|2|||
161625855|NCT04908800|583681156|FG000|Overall Study|Adverse Event|0|||
161625856|NCT04908800|583681157|FG001|Overall Study|Adverse Event|0|||
161625857|NCT04908800|583681158|FG002|Overall Study|Adverse Event|0|||
161625858|NCT04908800|583681159|FG003|Overall Study|Adverse Event|0|||
161625859|NCT04908800|583681160|FG004|Overall Study|Adverse Event|0|||
161625860|NCT04908800|583681161|FG005|Overall Study|Adverse Event|0|||
161625861|NCT04908800|583681162|FG006|Overall Study|Adverse Event|0|||
161625862|NCT04908800|583681163|FG007|Overall Study|Adverse Event|0|||
161625863|NCT04908800|583681164|FG008|Overall Study|Adverse Event|0|||
161625864|NCT04908800|583681165|FG009|Overall Study|Adverse Event|0|||
161625865|NCT04908800|583681166|FG010|Overall Study|Adverse Event|1|||
161625866|NCT04908800|583681167|FG011|Overall Study|Adverse Event|0|||
161625867|NCT04908800|583681168|FG012|Overall Study|Adverse Event|0|||
161625868|NCT03751280|583681169|FG000|Overall Study|Adverse Event|0|||
161625869|NCT03751280|583681170|FG001|Overall Study|Adverse Event|1|||
161625870|NCT03751280|583681169|FG000|Overall Study|Lost to Follow-up|3|||
161625871|NCT03751280|583681170|FG001|Overall Study|Lost to Follow-up|5|||
161625872|NCT03751280|583681169|FG000|Overall Study|Physician Decision|0|||
161625873|NCT03751280|583681170|FG001|Overall Study|Physician Decision|2|||
161625874|NCT03751280|583681169|FG000|Overall Study|Protocol Violation|0|||
161625875|NCT03751280|583681170|FG001|Overall Study|Protocol Violation|2|||
161625876|NCT03751280|583681169|FG000|Overall Study|Withdrawal by Subject|5|||
161625877|NCT03751280|583681170|FG001|Overall Study|Withdrawal by Subject|2|||
161625878|NCT00296504|583681172|FG000|Interim Analysis|Withdrawal by Subject|8|||
161625879|NCT00296504|583681173|FG001|Interim Analysis|Withdrawal by Subject|0|||
161625880|NCT00296504|583681174|FG002|Interim Analysis|Withdrawal by Subject|12|||
161625881|NCT00296504|583681175|FG003|Interim Analysis|Withdrawal by Subject|0|||
161625882|NCT00296504|583681176|FG004|Interim Analysis|Withdrawal by Subject|5|||
161625883|NCT00296504|583681177|FG005|Interim Analysis|Withdrawal by Subject|5|||
161625884|NCT00296504|583681178|FG006|Interim Analysis|Withdrawal by Subject|9|||
161625885|NCT00296504|583681179|FG007|Interim Analysis|Withdrawal by Subject|3|||
161625886|NCT00296504|583681180|FG008|Interim Analysis|Withdrawal by Subject|0|||
161625887|NCT00296504|583681172|FG000|Interim Analysis|Lost to Follow-up|13|||
161625888|NCT00296504|583681173|FG001|Interim Analysis|Lost to Follow-up|3|||
161625889|NCT00296504|583681174|FG002|Interim Analysis|Lost to Follow-up|26|||
161625890|NCT00296504|583681175|FG003|Interim Analysis|Lost to Follow-up|8|||
161625891|NCT00296504|583681176|FG004|Interim Analysis|Lost to Follow-up|14|||
161625892|NCT00296504|583681177|FG005|Interim Analysis|Lost to Follow-up|4|||
161625893|NCT00296504|583681178|FG006|Interim Analysis|Lost to Follow-up|11|||
161625894|NCT00296504|583681179|FG007|Interim Analysis|Lost to Follow-up|4|||
161625895|NCT00296504|583681180|FG008|Interim Analysis|Lost to Follow-up|0|||
161625896|NCT00296504|583681172|FG000|Interim Analysis|Clinical Progression|1|||
161625897|NCT00296504|583681173|FG001|Interim Analysis|Clinical Progression|0|||
161625898|NCT00296504|583681174|FG002|Interim Analysis|Clinical Progression|1|||
161625899|NCT00296504|583681175|FG003|Interim Analysis|Clinical Progression|1|||
161625900|NCT00296504|583681176|FG004|Interim Analysis|Clinical Progression|0|||
161625901|NCT00296504|583681177|FG005|Interim Analysis|Clinical Progression|2|||
161625902|NCT00296504|583681178|FG006|Interim Analysis|Clinical Progression|1|||
161625903|NCT00296504|583681179|FG007|Interim Analysis|Clinical Progression|2|||
161625904|NCT00296504|583681180|FG008|Interim Analysis|Clinical Progression|0|||
161625905|NCT00296504|583681172|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
161625906|NCT00296504|583681173|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
161625907|NCT00296504|583681174|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
161625908|NCT00296504|583681175|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
161625909|NCT00296504|583681176|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
161625910|NCT00296504|583681177|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
161685117|NCT00473343|583899696|FG000|Overall Study|Other un-specified reason|3|||
161685118|NCT02290873|583899697|FG000|Overall Study|Withdrawal by Subject|0|||
161685119|NCT02290873|583899698|FG001|Overall Study|Withdrawal by Subject|1|||
161685120|NCT02290873|583899699|FG002|Overall Study|Withdrawal by Subject|1|||
161625911|NCT00296504|583681178|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
161625912|NCT00296504|583681179|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
161625913|NCT00296504|583681180|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
161625914|NCT00296504|583681172|FG000|Interim Analysis|Adverse Event|0|||
161625915|NCT00296504|583681173|FG001|Interim Analysis|Adverse Event|0|||
161625916|NCT00296504|583681174|FG002|Interim Analysis|Adverse Event|13|||
161625917|NCT00296504|583681175|FG003|Interim Analysis|Adverse Event|4|||
161625918|NCT00296504|583681176|FG004|Interim Analysis|Adverse Event|6|||
161625919|NCT00296504|583681177|FG005|Interim Analysis|Adverse Event|3|||
161625920|NCT00296504|583681178|FG006|Interim Analysis|Adverse Event|4|||
161625921|NCT00296504|583681179|FG007|Interim Analysis|Adverse Event|5|||
161625922|NCT00296504|583681180|FG008|Interim Analysis|Adverse Event|0|||
161625923|NCT00296504|583681172|FG000|Interim Analysis|Protocol Violation|0|||
161625924|NCT00296504|583681173|FG001|Interim Analysis|Protocol Violation|0|||
161625925|NCT00296504|583681174|FG002|Interim Analysis|Protocol Violation|2|||
161625926|NCT00296504|583681175|FG003|Interim Analysis|Protocol Violation|0|||
161625927|NCT00296504|583681176|FG004|Interim Analysis|Protocol Violation|1|||
161625928|NCT00296504|583681177|FG005|Interim Analysis|Protocol Violation|0|||
161625929|NCT00296504|583681178|FG006|Interim Analysis|Protocol Violation|0|||
161625930|NCT00296504|583681179|FG007|Interim Analysis|Protocol Violation|1|||
161625931|NCT00296504|583681180|FG008|Interim Analysis|Protocol Violation|0|||
161625932|NCT00296504|583681172|FG000|Interim Analysis|Insufficient CD4 Response|0|||
161625933|NCT00296504|583681173|FG001|Interim Analysis|Insufficient CD4 Response|0|||
161625934|NCT00296504|583681174|FG002|Interim Analysis|Insufficient CD4 Response|0|||
161625935|NCT00296504|583681175|FG003|Interim Analysis|Insufficient CD4 Response|0|||
161625936|NCT00296504|583681176|FG004|Interim Analysis|Insufficient CD4 Response|1|||
161625937|NCT00296504|583681177|FG005|Interim Analysis|Insufficient CD4 Response|1|||
161625938|NCT00296504|583681178|FG006|Interim Analysis|Insufficient CD4 Response|0|||
161625939|NCT00296504|583681179|FG007|Interim Analysis|Insufficient CD4 Response|0|||
161625940|NCT00296504|583681180|FG008|Interim Analysis|Insufficient CD4 Response|0|||
161625941|NCT00296504|583681172|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
161625942|NCT00296504|583681173|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
161625943|NCT00296504|583681174|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
161625944|NCT00296504|583681175|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
161625945|NCT00296504|583681176|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
161625946|NCT00296504|583681177|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
161625947|NCT00296504|583681178|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
161625948|NCT00296504|583681179|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
161625949|NCT00296504|583681180|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
161625950|NCT00296504|583681172|FG000|Interim Analysis|Pregnancy|4|||
161625951|NCT00296504|583681173|FG001|Interim Analysis|Pregnancy|1|||
161625952|NCT00296504|583681174|FG002|Interim Analysis|Pregnancy|4|||
161625953|NCT00296504|583681175|FG003|Interim Analysis|Pregnancy|2|||
161625954|NCT00296504|583681176|FG004|Interim Analysis|Pregnancy|0|||
161625955|NCT00296504|583681177|FG005|Interim Analysis|Pregnancy|1|||
161625956|NCT00296504|583681178|FG006|Interim Analysis|Pregnancy|1|||
161625957|NCT00296504|583681179|FG007|Interim Analysis|Pregnancy|1|||
161625958|NCT00296504|583681180|FG008|Interim Analysis|Pregnancy|0|||
161625959|NCT00296504|583681172|FG000|Interim Analysis|Death|1|||
161625960|NCT00296504|583681173|FG001|Interim Analysis|Death|0|||
161625961|NCT00296504|583681174|FG002|Interim Analysis|Death|3|||
161625962|NCT00296504|583681175|FG003|Interim Analysis|Death|0|||
161625963|NCT00296504|583681176|FG004|Interim Analysis|Death|0|||
161625964|NCT00296504|583681177|FG005|Interim Analysis|Death|0|||
161625965|NCT00296504|583681178|FG006|Interim Analysis|Death|0|||
161625966|NCT00296504|583681179|FG007|Interim Analysis|Death|0|||
161625967|NCT00296504|583681180|FG008|Interim Analysis|Death|0|||
161625968|NCT00296504|583681172|FG000|Interim Analysis|Participant Non-compliant|0|||
161625969|NCT00296504|583681173|FG001|Interim Analysis|Participant Non-compliant|1|||
161625970|NCT00296504|583681174|FG002|Interim Analysis|Participant Non-compliant|2|||
161625971|NCT00296504|583681175|FG003|Interim Analysis|Participant Non-compliant|1|||
161625972|NCT00296504|583681176|FG004|Interim Analysis|Participant Non-compliant|1|||
161625973|NCT00296504|583681177|FG005|Interim Analysis|Participant Non-compliant|3|||
161833395|NCT03545191|584431106|FG001|Overall Study|Death|0|||
161833396|NCT03545191|584431107|FG002|Overall Study|Death|0|||
161625974|NCT00296504|583681178|FG006|Interim Analysis|Participant Non-compliant|6|||
161625975|NCT00296504|583681179|FG007|Interim Analysis|Participant Non-compliant|2|||
161625976|NCT00296504|583681180|FG008|Interim Analysis|Participant Non-compliant|0|||
161625977|NCT00296504|583681172|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625978|NCT00296504|583681173|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625979|NCT00296504|583681174|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
161625980|NCT00296504|583681175|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625981|NCT00296504|583681176|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625982|NCT00296504|583681177|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
161625983|NCT00296504|583681178|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625984|NCT00296504|583681179|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625985|NCT00296504|583681180|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161625986|NCT00296504|583681172|FG000|Interim Analysis|To Simplify Treatment|0|||
161625987|NCT00296504|583681173|FG001|Interim Analysis|To Simplify Treatment|0|||
161625988|NCT00296504|583681174|FG002|Interim Analysis|To Simplify Treatment|1|||
161625989|NCT00296504|583681175|FG003|Interim Analysis|To Simplify Treatment|0|||
161625990|NCT00296504|583681176|FG004|Interim Analysis|To Simplify Treatment|0|||
161625991|NCT00296504|583681177|FG005|Interim Analysis|To Simplify Treatment|0|||
161625992|NCT00296504|583681178|FG006|Interim Analysis|To Simplify Treatment|2|||
161625993|NCT00296504|583681179|FG007|Interim Analysis|To Simplify Treatment|0|||
161625994|NCT00296504|583681180|FG008|Interim Analysis|To Simplify Treatment|0|||
161625995|NCT00296504|583681172|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
161625996|NCT00296504|583681173|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
161625997|NCT00296504|583681174|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
161625998|NCT00296504|583681175|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
161625999|NCT00296504|583681176|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
161626000|NCT00296504|583681177|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
161626001|NCT00296504|583681178|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
161626002|NCT00296504|583681179|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
161626003|NCT00296504|583681180|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
161626004|NCT00296504|583681172|FG000|Interim Analysis|Participant Moved|1|||
161626005|NCT00296504|583681173|FG001|Interim Analysis|Participant Moved|0|||
161626006|NCT00296504|583681174|FG002|Interim Analysis|Participant Moved|1|||
161626007|NCT00296504|583681175|FG003|Interim Analysis|Participant Moved|0|||
161626008|NCT00296504|583681176|FG004|Interim Analysis|Participant Moved|0|||
161626009|NCT00296504|583681177|FG005|Interim Analysis|Participant Moved|1|||
161626010|NCT00296504|583681178|FG006|Interim Analysis|Participant Moved|1|||
161626011|NCT00296504|583681179|FG007|Interim Analysis|Participant Moved|0|||
161626012|NCT00296504|583681180|FG008|Interim Analysis|Participant Moved|0|||
161626013|NCT00296504|583681172|FG000|Interim Analysis|Participant Was Incarcerated|2|||
161626014|NCT00296504|583681173|FG001|Interim Analysis|Participant Was Incarcerated|0|||
161626015|NCT00296504|583681174|FG002|Interim Analysis|Participant Was Incarcerated|1|||
161626016|NCT00296504|583681175|FG003|Interim Analysis|Participant Was Incarcerated|0|||
161626017|NCT00296504|583681176|FG004|Interim Analysis|Participant Was Incarcerated|0|||
161626018|NCT00296504|583681177|FG005|Interim Analysis|Participant Was Incarcerated|0|||
161626019|NCT00296504|583681178|FG006|Interim Analysis|Participant Was Incarcerated|0|||
161626020|NCT00296504|583681179|FG007|Interim Analysis|Participant Was Incarcerated|0|||
161626021|NCT00296504|583681180|FG008|Interim Analysis|Participant Was Incarcerated|0|||
161626022|NCT00296504|583681172|FG000|Interim Analysis|Resistance to FPV|0|||
161626023|NCT00296504|583681173|FG001|Interim Analysis|Resistance to FPV|0|||
161626024|NCT00296504|583681174|FG002|Interim Analysis|Resistance to FPV|1|||
161626025|NCT00296504|583681175|FG003|Interim Analysis|Resistance to FPV|0|||
161626026|NCT00296504|583681176|FG004|Interim Analysis|Resistance to FPV|0|||
161626027|NCT00296504|583681177|FG005|Interim Analysis|Resistance to FPV|0|||
161626028|NCT00296504|583681178|FG006|Interim Analysis|Resistance to FPV|0|||
161626029|NCT00296504|583681179|FG007|Interim Analysis|Resistance to FPV|0|||
161626030|NCT00296504|583681180|FG008|Interim Analysis|Resistance to FPV|0|||
161626031|NCT00296504|583681172|FG000|Interim Analysis|Physician Decision|0|||
161626032|NCT00296504|583681173|FG001|Interim Analysis|Physician Decision|0|||
161626033|NCT00296504|583681174|FG002|Interim Analysis|Physician Decision|1|||
161626034|NCT00296504|583681175|FG003|Interim Analysis|Physician Decision|0|||
161626035|NCT00296504|583681176|FG004|Interim Analysis|Physician Decision|0|||
161626036|NCT00296504|583681177|FG005|Interim Analysis|Physician Decision|0|||
161626037|NCT00296504|583681178|FG006|Interim Analysis|Physician Decision|0|||
161626038|NCT00296504|583681179|FG007|Interim Analysis|Physician Decision|0|||
161626039|NCT00296504|583681180|FG008|Interim Analysis|Physician Decision|0|||
161626040|NCT00296504|583681172|FG000|Interim Analysis|Principle Investigator Discretion|2|||
161626041|NCT00296504|583681173|FG001|Interim Analysis|Principle Investigator Discretion|0|||
161626042|NCT00296504|583681174|FG002|Interim Analysis|Principle Investigator Discretion|1|||
161626043|NCT00296504|583681175|FG003|Interim Analysis|Principle Investigator Discretion|1|||
161626044|NCT00296504|583681176|FG004|Interim Analysis|Principle Investigator Discretion|0|||
161626045|NCT00296504|583681177|FG005|Interim Analysis|Principle Investigator Discretion|0|||
161626046|NCT00296504|583681178|FG006|Interim Analysis|Principle Investigator Discretion|0|||
161626047|NCT00296504|583681179|FG007|Interim Analysis|Principle Investigator Discretion|0|||
161626048|NCT00296504|583681180|FG008|Interim Analysis|Principle Investigator Discretion|0|||
161626049|NCT00296504|583681172|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
161626050|NCT00296504|583681173|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
161626051|NCT00296504|583681174|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
161626052|NCT00296504|583681175|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
161626053|NCT00296504|583681176|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
161626054|NCT00296504|583681177|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
161626055|NCT00296504|583681178|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
161626056|NCT00296504|583681179|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
161626057|NCT00296504|583681180|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
161626058|NCT00296504|583681172|FG000|Interim Analysis|Non-adherence|2|||
161626059|NCT00296504|583681173|FG001|Interim Analysis|Non-adherence|0|||
161626060|NCT00296504|583681174|FG002|Interim Analysis|Non-adherence|0|||
161626061|NCT00296504|583681175|FG003|Interim Analysis|Non-adherence|0|||
161626062|NCT00296504|583681176|FG004|Interim Analysis|Non-adherence|1|||
161626063|NCT00296504|583681177|FG005|Interim Analysis|Non-adherence|0|||
161626064|NCT00296504|583681178|FG006|Interim Analysis|Non-adherence|0|||
161626065|NCT00296504|583681179|FG007|Interim Analysis|Non-adherence|1|||
161626066|NCT00296504|583681180|FG008|Interim Analysis|Non-adherence|0|||
161626067|NCT00296504|583681172|FG000|Interim Analysis|Site Closing|1|||
161626068|NCT00296504|583681173|FG001|Interim Analysis|Site Closing|0|||
161626069|NCT00296504|583681174|FG002|Interim Analysis|Site Closing|0|||
161626070|NCT00296504|583681175|FG003|Interim Analysis|Site Closing|0|||
161626071|NCT00296504|583681176|FG004|Interim Analysis|Site Closing|0|||
161626072|NCT00296504|583681177|FG005|Interim Analysis|Site Closing|1|||
161626073|NCT00296504|583681178|FG006|Interim Analysis|Site Closing|2|||
161626074|NCT00296504|583681179|FG007|Interim Analysis|Site Closing|0|||
161626075|NCT00296504|583681180|FG008|Interim Analysis|Site Closing|0|||
161626076|NCT00296504|583681172|FG000|Interim Analysis|Lack of Personnel at Site|1|||
161626077|NCT00296504|583681173|FG001|Interim Analysis|Lack of Personnel at Site|0|||
161626078|NCT00296504|583681174|FG002|Interim Analysis|Lack of Personnel at Site|0|||
161626079|NCT00296504|583681175|FG003|Interim Analysis|Lack of Personnel at Site|0|||
161626080|NCT00296504|583681176|FG004|Interim Analysis|Lack of Personnel at Site|0|||
161626081|NCT00296504|583681177|FG005|Interim Analysis|Lack of Personnel at Site|0|||
161626082|NCT00296504|583681178|FG006|Interim Analysis|Lack of Personnel at Site|0|||
161626083|NCT00296504|583681179|FG007|Interim Analysis|Lack of Personnel at Site|0|||
161626084|NCT00296504|583681180|FG008|Interim Analysis|Lack of Personnel at Site|0|||
161626085|NCT00296504|583681172|FG000|Interim Analysis|Missed Schedule Date|1|||
161626086|NCT00296504|583681173|FG001|Interim Analysis|Missed Schedule Date|0|||
161626087|NCT00296504|583681174|FG002|Interim Analysis|Missed Schedule Date|0|||
161626088|NCT00296504|583681175|FG003|Interim Analysis|Missed Schedule Date|0|||
161626089|NCT00296504|583681176|FG004|Interim Analysis|Missed Schedule Date|0|||
161626090|NCT00296504|583681177|FG005|Interim Analysis|Missed Schedule Date|0|||
161626091|NCT00296504|583681178|FG006|Interim Analysis|Missed Schedule Date|0|||
161626092|NCT00296504|583681179|FG007|Interim Analysis|Missed Schedule Date|0|||
161626093|NCT00296504|583681180|FG008|Interim Analysis|Missed Schedule Date|0|||
161626094|NCT00296504|583681172|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
161626095|NCT00296504|583681173|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
161626096|NCT00296504|583681174|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
161626097|NCT00296504|583681175|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
161626098|NCT00296504|583681176|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
161626099|NCT00296504|583681177|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
161626100|NCT00296504|583681178|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
161626101|NCT00296504|583681179|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
161626102|NCT00296504|583681180|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
161626103|NCT00296504|583681172|FG000|Interim Analysis|Participant Stopped|0|||
161626104|NCT00296504|583681173|FG001|Interim Analysis|Participant Stopped|0|||
161626105|NCT00296504|583681174|FG002|Interim Analysis|Participant Stopped|0|||
161626106|NCT00296504|583681175|FG003|Interim Analysis|Participant Stopped|0|||
161626107|NCT00296504|583681176|FG004|Interim Analysis|Participant Stopped|1|||
161626108|NCT00296504|583681177|FG005|Interim Analysis|Participant Stopped|0|||
161626109|NCT00296504|583681178|FG006|Interim Analysis|Participant Stopped|0|||
161626110|NCT00296504|583681179|FG007|Interim Analysis|Participant Stopped|0|||
161626111|NCT00296504|583681180|FG008|Interim Analysis|Participant Stopped|0|||
161626112|NCT00296504|583681172|FG000|Interim Analysis|Physician and Participant Decision|0|||
161626113|NCT00296504|583681173|FG001|Interim Analysis|Physician and Participant Decision|0|||
161626114|NCT00296504|583681174|FG002|Interim Analysis|Physician and Participant Decision|0|||
161626115|NCT00296504|583681175|FG003|Interim Analysis|Physician and Participant Decision|0|||
161626116|NCT00296504|583681176|FG004|Interim Analysis|Physician and Participant Decision|0|||
161626117|NCT00296504|583681177|FG005|Interim Analysis|Physician and Participant Decision|1|||
161626118|NCT00296504|583681178|FG006|Interim Analysis|Physician and Participant Decision|0|||
161626119|NCT00296504|583681179|FG007|Interim Analysis|Physician and Participant Decision|0|||
161626120|NCT00296504|583681180|FG008|Interim Analysis|Physician and Participant Decision|0|||
161626121|NCT00296504|583681172|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
161626122|NCT00296504|583681173|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
161626123|NCT00296504|583681174|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
161626124|NCT00296504|583681175|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
161626125|NCT00296504|583681176|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
161626126|NCT00296504|583681177|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
161626127|NCT00296504|583681178|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
161626128|NCT00296504|583681179|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
161626129|NCT00296504|583681180|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
161626130|NCT00296504|583681172|FG000|Interim Analysis|Study Ended|0|||
161626131|NCT00296504|583681173|FG001|Interim Analysis|Study Ended|0|||
161626132|NCT00296504|583681174|FG002|Interim Analysis|Study Ended|0|||
161626133|NCT00296504|583681175|FG003|Interim Analysis|Study Ended|0|||
161626134|NCT00296504|583681176|FG004|Interim Analysis|Study Ended|0|||
161626135|NCT00296504|583681177|FG005|Interim Analysis|Study Ended|0|||
161626136|NCT00296504|583681178|FG006|Interim Analysis|Study Ended|1|||
161626137|NCT00296504|583681179|FG007|Interim Analysis|Study Ended|0|||
161626138|NCT00296504|583681180|FG008|Interim Analysis|Study Ended|0|||
161626139|NCT00296504|583681172|FG000|Interim Analysis|Participant Needed Interferon|0|||
161626140|NCT00296504|583681173|FG001|Interim Analysis|Participant Needed Interferon|0|||
161626141|NCT00296504|583681174|FG002|Interim Analysis|Participant Needed Interferon|0|||
161626142|NCT00296504|583681175|FG003|Interim Analysis|Participant Needed Interferon|0|||
161626143|NCT00296504|583681176|FG004|Interim Analysis|Participant Needed Interferon|0|||
161626144|NCT00296504|583681177|FG005|Interim Analysis|Participant Needed Interferon|0|||
161626145|NCT00296504|583681178|FG006|Interim Analysis|Participant Needed Interferon|0|||
161626146|NCT00296504|583681179|FG007|Interim Analysis|Participant Needed Interferon|1|||
161626147|NCT00296504|583681180|FG008|Interim Analysis|Participant Needed Interferon|0|||
161626148|NCT00296504|583681172|FG000|Interim Analysis|Ongoing|32|||
161626149|NCT00296504|583681173|FG001|Interim Analysis|Ongoing|12|||
161626150|NCT00296504|583681174|FG002|Interim Analysis|Ongoing|16|||
161626151|NCT00296504|583681175|FG003|Interim Analysis|Ongoing|22|||
161626152|NCT00296504|583681176|FG004|Interim Analysis|Ongoing|0|||
161626153|NCT00296504|583681177|FG005|Interim Analysis|Ongoing|0|||
161626154|NCT00296504|583681178|FG006|Interim Analysis|Ongoing|30|||
161626155|NCT00296504|583681179|FG007|Interim Analysis|Ongoing|1|||
161626156|NCT00296504|583681180|FG008|Interim Analysis|Ongoing|0|||
161626157|NCT00296504|583681172|FG000|Final Analysis|Withdrawal by Subject|0|||
161626158|NCT00296504|583681173|FG001|Final Analysis|Withdrawal by Subject|0|||
161626159|NCT00296504|583681174|FG002|Final Analysis|Withdrawal by Subject|0|||
161626160|NCT00296504|583681175|FG003|Final Analysis|Withdrawal by Subject|0|||
161626161|NCT00296504|583681176|FG004|Final Analysis|Withdrawal by Subject|0|||
161626162|NCT00296504|583681177|FG005|Final Analysis|Withdrawal by Subject|0|||
161626163|NCT00296504|583681178|FG006|Final Analysis|Withdrawal by Subject|0|||
161626164|NCT00296504|583681179|FG007|Final Analysis|Withdrawal by Subject|0|||
161626165|NCT00296504|583681180|FG008|Final Analysis|Withdrawal by Subject|1|||
161626166|NCT00296504|583681172|FG000|Final Analysis|Lost to Follow-up|0|||
161626167|NCT00296504|583681173|FG001|Final Analysis|Lost to Follow-up|0|||
161626168|NCT00296504|583681174|FG002|Final Analysis|Lost to Follow-up|0|||
161626169|NCT00296504|583681175|FG003|Final Analysis|Lost to Follow-up|0|||
161626170|NCT00296504|583681176|FG004|Final Analysis|Lost to Follow-up|0|||
161626171|NCT00296504|583681177|FG005|Final Analysis|Lost to Follow-up|0|||
161626172|NCT00296504|583681178|FG006|Final Analysis|Lost to Follow-up|0|||
161626173|NCT00296504|583681179|FG007|Final Analysis|Lost to Follow-up|0|||
161626174|NCT00296504|583681180|FG008|Final Analysis|Lost to Follow-up|5|||
161626175|NCT00296504|583681172|FG000|Final Analysis|Insufficient Viral Load Response|0|||
161626176|NCT00296504|583681173|FG001|Final Analysis|Insufficient Viral Load Response|0|||
161626177|NCT00296504|583681174|FG002|Final Analysis|Insufficient Viral Load Response|0|||
161626178|NCT00296504|583681175|FG003|Final Analysis|Insufficient Viral Load Response|0|||
161626179|NCT00296504|583681176|FG004|Final Analysis|Insufficient Viral Load Response|0|||
161626180|NCT00296504|583681177|FG005|Final Analysis|Insufficient Viral Load Response|0|||
161626181|NCT00296504|583681178|FG006|Final Analysis|Insufficient Viral Load Response|0|||
161626182|NCT00296504|583681179|FG007|Final Analysis|Insufficient Viral Load Response|0|||
161626183|NCT00296504|583681180|FG008|Final Analysis|Insufficient Viral Load Response|6|||
161626184|NCT00296504|583681172|FG000|Final Analysis|Adverse Event|0|||
161626185|NCT00296504|583681173|FG001|Final Analysis|Adverse Event|0|||
161626186|NCT00296504|583681174|FG002|Final Analysis|Adverse Event|0|||
161626187|NCT00296504|583681175|FG003|Final Analysis|Adverse Event|0|||
161626188|NCT00296504|583681176|FG004|Final Analysis|Adverse Event|0|||
161626189|NCT00296504|583681177|FG005|Final Analysis|Adverse Event|0|||
161626190|NCT00296504|583681178|FG006|Final Analysis|Adverse Event|0|||
161626191|NCT00296504|583681179|FG007|Final Analysis|Adverse Event|0|||
161626192|NCT00296504|583681180|FG008|Final Analysis|Adverse Event|2|||
161626193|NCT00296504|583681172|FG000|Final Analysis|Pregnancy|0|||
161626194|NCT00296504|583681173|FG001|Final Analysis|Pregnancy|0|||
161626195|NCT00296504|583681174|FG002|Final Analysis|Pregnancy|0|||
161626196|NCT00296504|583681175|FG003|Final Analysis|Pregnancy|0|||
161626197|NCT00296504|583681176|FG004|Final Analysis|Pregnancy|0|||
161626198|NCT00296504|583681177|FG005|Final Analysis|Pregnancy|0|||
161626199|NCT00296504|583681178|FG006|Final Analysis|Pregnancy|0|||
161626200|NCT00296504|583681179|FG007|Final Analysis|Pregnancy|0|||
161626201|NCT00296504|583681180|FG008|Final Analysis|Pregnancy|4|||
161626202|NCT00296504|583681172|FG000|Final Analysis|Tuberculosis|0|||
161626203|NCT00296504|583681173|FG001|Final Analysis|Tuberculosis|0|||
161626204|NCT00296504|583681174|FG002|Final Analysis|Tuberculosis|0|||
161833397|NCT03545191|584431105|FG000|Overall Study|Adverse Event|4|||
161833398|NCT03545191|584431106|FG001|Overall Study|Adverse Event|2|||
161833399|NCT03545191|584431107|FG002|Overall Study|Adverse Event|7|||
161833400|NCT03545191|584431105|FG000|Overall Study|Other reasons|3|||
161833401|NCT03545191|584431106|FG001|Overall Study|Other reasons|11|||
161626205|NCT00296504|583681175|FG003|Final Analysis|Tuberculosis|0|||
161626206|NCT00296504|583681176|FG004|Final Analysis|Tuberculosis|0|||
161626207|NCT00296504|583681177|FG005|Final Analysis|Tuberculosis|0|||
161626208|NCT00296504|583681178|FG006|Final Analysis|Tuberculosis|0|||
161626209|NCT00296504|583681179|FG007|Final Analysis|Tuberculosis|0|||
161626210|NCT00296504|583681180|FG008|Final Analysis|Tuberculosis|1|||
161626211|NCT00296504|583681172|FG000|Final Analysis|Participant Moved to Another Country|0|||
161626212|NCT00296504|583681173|FG001|Final Analysis|Participant Moved to Another Country|0|||
161626213|NCT00296504|583681174|FG002|Final Analysis|Participant Moved to Another Country|0|||
161626214|NCT00296504|583681175|FG003|Final Analysis|Participant Moved to Another Country|0|||
161833402|NCT03545191|584431107|FG002|Overall Study|Other reasons|8|||
161626215|NCT00296504|583681176|FG004|Final Analysis|Participant Moved to Another Country|0|||
161626216|NCT00296504|583681177|FG005|Final Analysis|Participant Moved to Another Country|0|||
161626217|NCT00296504|583681178|FG006|Final Analysis|Participant Moved to Another Country|0|||
161626218|NCT00296504|583681179|FG007|Final Analysis|Participant Moved to Another Country|0|||
161833403|NCT03545191|584431105|FG000|Overall Study|Withdrawal by Subject|13|||
161833404|NCT03545191|584431106|FG001|Overall Study|Withdrawal by Subject|10|||
161626219|NCT00296504|583681180|FG008|Final Analysis|Participant Moved to Another Country|1|||
161626220|NCT00296504|583681172|FG000|Final Analysis|Poor Adherence|0|||
161626221|NCT00296504|583681173|FG001|Final Analysis|Poor Adherence|0|||
161626222|NCT00296504|583681174|FG002|Final Analysis|Poor Adherence|0|||
161626223|NCT00296504|583681175|FG003|Final Analysis|Poor Adherence|0|||
161626224|NCT00296504|583681176|FG004|Final Analysis|Poor Adherence|0|||
161626225|NCT00296504|583681177|FG005|Final Analysis|Poor Adherence|0|||
161626226|NCT00296504|583681178|FG006|Final Analysis|Poor Adherence|0|||
161626227|NCT00296504|583681179|FG007|Final Analysis|Poor Adherence|0|||
161626228|NCT00296504|583681180|FG008|Final Analysis|Poor Adherence|1|||
161626229|NCT01323309|583681181|FG000|Overall Study|Death|9|||
161626230|NCT01323309|583681182|FG001|Overall Study|Death|15|||
161626231|NCT01323309|583681183|FG002|Overall Study|Death|5|||
161626232|NCT01323309|583681181|FG000|Overall Study|Lost to Follow-up|11|||
161626233|NCT01323309|583681182|FG001|Overall Study|Lost to Follow-up|14|||
161626234|NCT01323309|583681183|FG002|Overall Study|Lost to Follow-up|24|||
161626235|NCT01323309|583681181|FG000|Overall Study|Withdrawal by Subject|14|||
161626236|NCT01323309|583681182|FG001|Overall Study|Withdrawal by Subject|14|||
161626237|NCT01323309|583681183|FG002|Overall Study|Withdrawal by Subject|18|||
161626238|NCT01323309|583681181|FG000|Overall Study|Disease progression|5|||
161626239|NCT01323309|583681182|FG001|Overall Study|Disease progression|11|||
161626240|NCT01323309|583681183|FG002|Overall Study|Disease progression|4|||
161626241|NCT02162771|583681192|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
161626242|NCT02162771|583681193|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
161626243|NCT02162771|583681192|FG000|Core Study Period (Part 2)|Adverse Event|4|||
161626244|NCT02162771|583681193|FG001|Core Study Period (Part 2)|Adverse Event|1|||
161626245|NCT02162771|583681192|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
161626246|NCT02162771|583681193|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
161626247|NCT02162771|583681192|FG000|Core Study Period (Part 2)|Physician Decision|0|||
161626248|NCT02162771|583681193|FG001|Core Study Period (Part 2)|Physician Decision|2|||
161626249|NCT02162771|583681192|FG000|Core Study Period (Part 2)|Death|1|||
161626250|NCT02162771|583681193|FG001|Core Study Period (Part 2)|Death|0|||
161626251|NCT02162771|583681192|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
161626252|NCT02162771|583681193|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
161626253|NCT02162771|583681192|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
161626254|NCT02162771|583681193|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
161626255|NCT02162771|583681192|FG000|Maintenance Study Period (Part 2)|Death|2|||
161626256|NCT02162771|583681193|FG001|Maintenance Study Period (Part 2)|Death|1|||
161626257|NCT02162771|583681192|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
161626258|NCT02162771|583681193|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
161626259|NCT02162771|583681192|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
161626260|NCT02162771|583681193|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
161626261|NCT02162771|583681192|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
161626262|NCT02162771|583681193|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
161626263|NCT01078571|583681194|FG000|Overall Study|Adverse Event|36|||
161626264|NCT01078571|583681194|FG000|Overall Study|Lack of effectiveness|36|||
161626265|NCT01078571|583681194|FG000|Overall Study|Reason not reported|21|||
161626266|NCT01078571|583681194|FG000|Overall Study|Withdrawal by Subject|12|||
161626267|NCT01078571|583681194|FG000|Overall Study|Lost to Follow-up|8|||
161626268|NCT01078571|583681194|FG000|Overall Study|Protocol Violation|2|||
161626269|NCT01047306|583681198|FG000|Overall Study|Withdrawal by Subject|2|||
161626270|NCT01047306|583681199|FG001|Overall Study|Withdrawal by Subject|0|||
161626271|NCT01047306|583681198|FG000|Overall Study|Lost to Follow-up|1|||
161626272|NCT01047306|583681199|FG001|Overall Study|Lost to Follow-up|0|||
161626273|NCT01878253|583681200|FG000|Overall Study|Death|1|||
161626274|NCT01878253|583681200|FG000|Overall Study|SIdus System Removal|3|||
161626275|NCT01878253|583681200|FG000|Overall Study|Withdrawal by Subject|1|||
161626276|NCT01878253|583681200|FG000|Overall Study|Lost to Follow-up|2|||
161626277|NCT01878253|583681200|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
161626278|NCT00449033|583681205|FG000|Treatment Period|Adverse Event|117|||
161626279|NCT00449033|583681206|FG001|Treatment Period|Adverse Event|83|||
161626280|NCT00449033|583681205|FG000|Treatment Period|Death|21|||
161626281|NCT00449033|583681206|FG001|Treatment Period|Death|12|||
161626282|NCT00449033|583681205|FG000|Treatment Period|Lost to Follow-up|0|||
161626283|NCT00449033|583681206|FG001|Treatment Period|Lost to Follow-up|2|||
161626284|NCT00449033|583681205|FG000|Treatment Period|Physician Decision|4|||
161626285|NCT00449033|583681206|FG001|Treatment Period|Physician Decision|5|||
161626286|NCT00449033|583681205|FG000|Treatment Period|Protocol Violation|8|||
161626287|NCT00449033|583681206|FG001|Treatment Period|Protocol Violation|7|||
161626288|NCT00449033|583681205|FG000|Treatment Period|Disease Progression|231|||
161626289|NCT00449033|583681206|FG001|Treatment Period|Disease Progression|288|||
161626290|NCT00449033|583681205|FG000|Treatment Period|Consent Withdrawn|36|||
161626291|NCT00449033|583681206|FG001|Treatment Period|Consent Withdrawn|20|||
161626292|NCT00449033|583681205|FG000|Treatment Period|Amended Protocol Criteria|22|||
161626293|NCT00449033|583681206|FG001|Treatment Period|Amended Protocol Criteria|18|||
161626294|NCT00449033|583681205|FG000|Treatment Period|Non-compliance|7|||
161626295|NCT00449033|583681206|FG001|Treatment Period|Non-compliance|8|||
161626296|NCT00449033|583681205|FG000|Treatment Period|Second Malignancy|0|||
161626297|NCT00449033|583681206|FG001|Treatment Period|Second Malignancy|1|||
161626298|NCT00449033|583681205|FG000|Treatment Period|Reason Missing|0|||
161626299|NCT00449033|583681206|FG001|Treatment Period|Reason Missing|4|||
161626300|NCT00449033|583681205|FG000|Treatment Period|Treatment Ongoing|6|||
161626301|NCT00449033|583681206|FG001|Treatment Period|Treatment Ongoing|4|||
161626302|NCT00449033|583681205|FG000|Follow-up Period|Death|299|||
161626303|NCT00449033|583681206|FG001|Follow-up Period|Death|311|||
161626304|NCT00449033|583681205|FG000|Follow-up Period|Lost to Follow-up|6|||
161626305|NCT00449033|583681206|FG001|Follow-up Period|Lost to Follow-up|10|||
161626306|NCT00449033|583681205|FG000|Follow-up Period|Reason Missing|120|||
161626307|NCT00449033|583681206|FG001|Follow-up Period|Reason Missing|113|||
161626308|NCT04393779|583681209|FG000|Overall Study|Death|1|||
161626309|NCT04393779|583681209|FG000|Overall Study|Device reintervention or explant|4|||
161626310|NCT03802513|583681210|FG000|Overall Study|Lost to Follow-up|1|||
161626311|NCT01648699|583681214|FG000|Overall Study|Death|1|||
161626312|NCT01648699|583681214|FG000|Overall Study|Lost to Follow-up|2|||
161626313|NCT01648699|583681214|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
161626314|NCT04803214|583681215|FG000|Overall Study|Adverse Event|1|||
161626315|NCT04803214|583681216|FG001|Overall Study|Adverse Event|0|||
161626316|NCT04803214|583681215|FG000|Overall Study|Withdrawal by Subject|1|||
161626317|NCT04803214|583681216|FG001|Overall Study|Withdrawal by Subject|2|||
161626318|NCT04803214|583681215|FG000|Overall Study|Lost to Follow-up|2|||
161626319|NCT04803214|583681216|FG001|Overall Study|Lost to Follow-up|4|||
161626320|NCT04803214|583681215|FG000|Overall Study|Physician Decision|1|||
161626321|NCT04803214|583681216|FG001|Overall Study|Physician Decision|1|||
161626322|NCT04803214|583681215|FG000|Overall Study|Missed 12 month visit|0|||
161626323|NCT04803214|583681216|FG001|Overall Study|Missed 12 month visit|3|||
161626324|NCT03219216|583681217|FG000|Overall Study|Lost to Follow-up|0|||
161626325|NCT03219216|583681218|FG001|Overall Study|Lost to Follow-up|1|||
161626326|NCT03520036|583681222|FG000|Overall Study|Adverse Event|1|||
161626327|NCT03520036|583681223|FG001|Overall Study|Adverse Event|2|||
161626328|NCT03520036|583681224|FG002|Overall Study|Adverse Event|0|||
161626329|NCT03520036|583681222|FG000|Overall Study|Protocol Violation|1|||
161626330|NCT03520036|583681223|FG001|Overall Study|Protocol Violation|0|||
161833405|NCT03545191|584431107|FG002|Overall Study|Withdrawal by Subject|12|||
161626331|NCT03520036|583681224|FG002|Overall Study|Protocol Violation|0|||
161626332|NCT03520036|583681222|FG000|Overall Study|Withdrawal by Subject|0|||
161626333|NCT03520036|583681223|FG001|Overall Study|Withdrawal by Subject|1|||
161626334|NCT03520036|583681224|FG002|Overall Study|Withdrawal by Subject|4|||
161626335|NCT03520036|583681222|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
161626336|NCT03520036|583681223|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
161833406|NCT03545191|584431105|FG000|Overall Study|Lost to Follow-up|1|||
161833407|NCT03545191|584431106|FG001|Overall Study|Lost to Follow-up|2|||
161833408|NCT03545191|584431107|FG002|Overall Study|Lost to Follow-up|3|||
161833409|NCT01277718|584431110|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
161833410|NCT01277718|584431111|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
161833411|NCT01277718|584431110|FG000|Period 2 - Second Intervention|Physician Decision|0|||
161833412|NCT01277718|584431111|FG001|Period 2 - Second Intervention|Physician Decision|2|||
161833413|NCT03919162|584431114|FG000|Overall Study|Adverse Event|3|||
161626337|NCT03520036|583681224|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
161626338|NCT03005106|583681225|FG000|Overall Study|Lost to Follow-up|16|||
161626339|NCT03005106|583681225|FG000|Overall Study|Adverse Event|1|||
161626340|NCT03005106|583681225|FG000|Overall Study|Physician Decision|1|||
161626341|NCT03005106|583681225|FG000|Overall Study|Death|2|||
161626342|NCT01855399|583681226|FG000|6 Month|Lost to Follow-up|12|||
161626343|NCT01855399|583681227|FG001|6 Month|Lost to Follow-up|9|||
161626344|NCT01855399|583681226|FG000|6 Month|Withdrawal by Subject|8|||
161626345|NCT01855399|583681227|FG001|6 Month|Withdrawal by Subject|6|||
161626346|NCT01855399|583681226|FG000|12 Month|Lost to Follow-up|7|||
161626347|NCT01855399|583681227|FG001|12 Month|Lost to Follow-up|11|||
161626348|NCT00321672|583681228|FG000|Overall Study|Withdrawal by Subject|5|||
161626349|NCT00321672|583681229|FG001|Overall Study|Withdrawal by Subject|1|||
161626350|NCT00321672|583681230|FG002|Overall Study|Withdrawal by Subject|2|||
161626351|NCT00321672|583681231|FG003|Overall Study|Withdrawal by Subject|0|||
161626352|NCT00321672|583681228|FG000|Overall Study|Noncompliance|1|||
161626353|NCT00321672|583681229|FG001|Overall Study|Noncompliance|2|||
161626354|NCT00321672|583681230|FG002|Overall Study|Noncompliance|1|||
161626355|NCT00321672|583681231|FG003|Overall Study|Noncompliance|0|||
161626356|NCT00321672|583681228|FG000|Overall Study|Adverse Event|1|||
161626357|NCT00321672|583681229|FG001|Overall Study|Adverse Event|1|||
161626358|NCT00321672|583681230|FG002|Overall Study|Adverse Event|0|||
161626359|NCT00321672|583681231|FG003|Overall Study|Adverse Event|0|||
161626360|NCT00321672|583681228|FG000|Overall Study|Lack of Efficacy|1|||
161626361|NCT00321672|583681229|FG001|Overall Study|Lack of Efficacy|1|||
161626362|NCT00321672|583681230|FG002|Overall Study|Lack of Efficacy|0|||
161626363|NCT00321672|583681231|FG003|Overall Study|Lack of Efficacy|0|||
161626364|NCT00321672|583681228|FG000|Overall Study|Lost to Follow-up|2|||
161626365|NCT00321672|583681229|FG001|Overall Study|Lost to Follow-up|0|||
161626366|NCT00321672|583681230|FG002|Overall Study|Lost to Follow-up|4|||
161626367|NCT00321672|583681231|FG003|Overall Study|Lost to Follow-up|2|||
161626368|NCT00321672|583681228|FG000|Overall Study|Death|1|||
161626369|NCT00321672|583681229|FG001|Overall Study|Death|0|||
161626370|NCT00321672|583681230|FG002|Overall Study|Death|0|||
161626371|NCT00321672|583681231|FG003|Overall Study|Death|0|||
161626372|NCT00321672|583681228|FG000|Overall Study|Too far to travel for visits|1|||
161626373|NCT00321672|583681229|FG001|Overall Study|Too far to travel for visits|0|||
161626374|NCT00321672|583681230|FG002|Overall Study|Too far to travel for visits|0|||
161626375|NCT00321672|583681231|FG003|Overall Study|Too far to travel for visits|0|||
161626376|NCT00321672|583681228|FG000|Overall Study|Incarcerated|0|||
161626377|NCT00321672|583681229|FG001|Overall Study|Incarcerated|0|||
161626378|NCT00321672|583681230|FG002|Overall Study|Incarcerated|2|||
161626379|NCT00321672|583681231|FG003|Overall Study|Incarcerated|0|||
161626380|NCT00321672|583681228|FG000|Overall Study|Moved out of state|0|||
161626381|NCT00321672|583681229|FG001|Overall Study|Moved out of state|1|||
161626382|NCT00321672|583681230|FG002|Overall Study|Moved out of state|1|||
161626383|NCT00321672|583681231|FG003|Overall Study|Moved out of state|0|||
161626384|NCT00321672|583681228|FG000|Overall Study|Protocol Violation|0|||
161626385|NCT00321672|583681229|FG001|Overall Study|Protocol Violation|0|||
161626386|NCT00321672|583681230|FG002|Overall Study|Protocol Violation|1|||
161626387|NCT00321672|583681231|FG003|Overall Study|Protocol Violation|0|||
161626388|NCT00321672|583681228|FG000|Overall Study|Diagnosis of testicular cancer|0|||
161626389|NCT00321672|583681229|FG001|Overall Study|Diagnosis of testicular cancer|1|||
161833414|NCT03919162|584431115|FG001|Overall Study|Adverse Event|2|||
161833415|NCT03919162|584431114|FG000|Overall Study|Death|2|||
161833416|NCT03919162|584431115|FG001|Overall Study|Death|0|||
161833417|NCT03919162|584431114|FG000|Overall Study|Lost to Follow-up|1|||
161833418|NCT03919162|584431115|FG001|Overall Study|Lost to Follow-up|0|||
161626390|NCT00321672|583681230|FG002|Overall Study|Diagnosis of testicular cancer|0|||
161626391|NCT00321672|583681231|FG003|Overall Study|Diagnosis of testicular cancer|0|||
161626392|NCT00321672|583681228|FG000|Overall Study|Extensive travel required for new job|0|||
161626393|NCT00321672|583681229|FG001|Overall Study|Extensive travel required for new job|1|||
161626394|NCT00321672|583681230|FG002|Overall Study|Extensive travel required for new job|0|||
161626395|NCT00321672|583681231|FG003|Overall Study|Extensive travel required for new job|0|||
161626396|NCT00512902|583681232|FG000|Overall Study|Adverse Event|7|||
161626397|NCT00512902|583681232|FG000|Overall Study|Lost to Follow-up|1|||
161626398|NCT03019289|583681233|FG000|Overall Study|Adverse Event|1|||
161833419|NCT03919162|584431114|FG000|Overall Study|Withdrawal by Subject|12|||
161626399|NCT03019289|583681234|FG001|Overall Study|Adverse Event|0|||
161626400|NCT03019289|583681235|FG002|Overall Study|Adverse Event|0|||
161626401|NCT03019289|583681236|FG003|Overall Study|Adverse Event|0|||
161626402|NCT03019289|583681237|FG004|Overall Study|Adverse Event|0|||
161626403|NCT03019289|583681238|FG005|Overall Study|Adverse Event|0|||
161626404|NCT03019289|583681239|FG006|Overall Study|Adverse Event|0|||
161626405|NCT03019289|583681240|FG007|Overall Study|Adverse Event|0|||
161626406|NCT03019289|583681241|FG008|Overall Study|Adverse Event|1|||
161626407|NCT03019289|583681233|FG000|Overall Study|Other|1|||
161626408|NCT03019289|583681234|FG001|Overall Study|Other|0|||
161626409|NCT03019289|583681235|FG002|Overall Study|Other|0|||
161626410|NCT03019289|583681236|FG003|Overall Study|Other|0|||
161626411|NCT03019289|583681237|FG004|Overall Study|Other|0|||
161626412|NCT03019289|583681238|FG005|Overall Study|Other|0|||
161626413|NCT03019289|583681239|FG006|Overall Study|Other|0|||
161626414|NCT03019289|583681240|FG007|Overall Study|Other|0|||
161626415|NCT03019289|583681241|FG008|Overall Study|Other|0|||
161626416|NCT02389894|583681242|FG000|Overall Study|Death|4|||
161626417|NCT02389894|583681243|FG001|Overall Study|Death|5|||
161626418|NCT02389894|583681244|FG002|Overall Study|Death|3|||
161626419|NCT02389894|583681242|FG000|Overall Study|Withdrawal by Subject|2|||
161626420|NCT02389894|583681243|FG001|Overall Study|Withdrawal by Subject|4|||
161626421|NCT02389894|583681244|FG002|Overall Study|Withdrawal by Subject|5|||
161626422|NCT02389894|583681242|FG000|Overall Study|Lost to Follow-up|2|||
161626423|NCT02389894|583681243|FG001|Overall Study|Lost to Follow-up|1|||
161626424|NCT02389894|583681244|FG002|Overall Study|Lost to Follow-up|1|||
161626425|NCT01429285|583681246|FG000|Overall Study|Protocol Violation|9|||
161626426|NCT01429285|583681247|FG001|Overall Study|Protocol Violation|4|||
161626427|NCT01429285|583681246|FG000|Overall Study|Missing Data|5|||
161626428|NCT01429285|583681247|FG001|Overall Study|Missing Data|3|||
161626429|NCT01429285|583681246|FG000|Overall Study|Erroneously Enrolled Twice|8|||
161626430|NCT01429285|583681247|FG001|Overall Study|Erroneously Enrolled Twice|2|||
161626431|NCT02312245|583681248|FG000|Overall Study|Death|0|||
161626432|NCT02312245|583681249|FG001|Overall Study|Death|0|||
161626433|NCT02312245|583681250|FG002|Overall Study|Death|0|||
161626434|NCT02312245|583681251|FG003|Overall Study|Death|1|||
161626435|NCT02312245|583681248|FG000|Overall Study|Withdrawal by Subject|1|||
161626436|NCT02312245|583681249|FG001|Overall Study|Withdrawal by Subject|1|||
161626437|NCT02312245|583681250|FG002|Overall Study|Withdrawal by Subject|0|||
161626438|NCT02312245|583681251|FG003|Overall Study|Withdrawal by Subject|2|||
161626439|NCT02312245|583681248|FG000|Overall Study|Alternative Therapy|1|||
161626440|NCT02312245|583681249|FG001|Overall Study|Alternative Therapy|0|||
161626441|NCT02312245|583681250|FG002|Overall Study|Alternative Therapy|0|||
161626442|NCT02312245|583681251|FG003|Overall Study|Alternative Therapy|0|||
161626443|NCT02312245|583681248|FG000|Overall Study|Progression|0|||
161626444|NCT02312245|583681249|FG001|Overall Study|Progression|0|||
161626445|NCT02312245|583681250|FG002|Overall Study|Progression|0|||
161626446|NCT02312245|583681251|FG003|Overall Study|Progression|5|||
161626447|NCT02312245|583681248|FG000|Overall Study|Patient went to hospice|0|||
161626448|NCT02312245|583681249|FG001|Overall Study|Patient went to hospice|0|||
161626449|NCT02312245|583681250|FG002|Overall Study|Patient went to hospice|0|||
161626450|NCT02312245|583681251|FG003|Overall Study|Patient went to hospice|1|||
161626451|NCT02312245|583681248|FG000|Overall Study|Ineligible|1|||
161626452|NCT02312245|583681249|FG001|Overall Study|Ineligible|0|||
161626453|NCT02312245|583681250|FG002|Overall Study|Ineligible|0|||
161626454|NCT02312245|583681251|FG003|Overall Study|Ineligible|0|||
161626455|NCT01288729|583681260|FG000|Overall Study|Withdrawal by Subject|1|||
161626456|NCT01288729|583681261|FG001|Overall Study|Withdrawal by Subject|0|||
161626457|NCT02442622|583681266|FG000|Overall Study|Withdrawal by Subject|3|||
161626458|NCT02442622|583681267|FG001|Overall Study|Withdrawal by Subject|1|||
161626459|NCT02938520|583681268|FG000|Overall Study|On-going at the time of analysis|258|||
161626460|NCT02938520|583681269|FG001|Overall Study|On-going at the time of analysis|261|||
161626461|NCT02938520|583681268|FG000|Overall Study|Physician Decision|2|||
161626462|NCT02938520|583681269|FG001|Overall Study|Physician Decision|5|||
161626463|NCT02938520|583681268|FG000|Overall Study|Lost to Follow-up|2|||
161626464|NCT02938520|583681269|FG001|Overall Study|Lost to Follow-up|2|||
161626465|NCT02938520|583681268|FG000|Overall Study|Withdrawal by Subject|7|||
161626466|NCT02938520|583681269|FG001|Overall Study|Withdrawal by Subject|7|||
161626467|NCT02938520|583681268|FG000|Overall Study|Protocol Violation|0|||
161626468|NCT02938520|583681269|FG001|Overall Study|Protocol Violation|1|||
161626469|NCT02938520|583681268|FG000|Overall Study|Lack of Efficacy|5|||
161626470|NCT02938520|583681269|FG001|Overall Study|Lack of Efficacy|3|||
161626471|NCT02938520|583681268|FG000|Overall Study|Adverse Event|9|||
161626472|NCT02938520|583681269|FG001|Overall Study|Adverse Event|4|||
161626473|NCT02236598|583682794|FG000|Overall Study|Adverse Event|0|||
161626474|NCT02236598|583682795|FG001|Overall Study|Adverse Event|1|||
161626475|NCT02236598|583682794|FG000|Overall Study|Withdrawal by Subject|0|||
161626476|NCT02236598|583682795|FG001|Overall Study|Withdrawal by Subject|1|||
161626477|NCT01446042|583682806|FG000|Overall Study|Withdrawal by Subject|12|||
161626478|NCT01446042|583682807|FG001|Overall Study|Withdrawal by Subject|2|||
161626479|NCT01446042|583682808|FG002|Overall Study|Withdrawal by Subject|4|||
161626480|NCT01446042|583682806|FG000|Overall Study|Adverse Event|1|||
161626481|NCT01446042|583682807|FG001|Overall Study|Adverse Event|0|||
161626482|NCT01446042|583682808|FG002|Overall Study|Adverse Event|4|||
161626483|NCT01446042|583682806|FG000|Overall Study|Lost to Follow-up|5|||
161626484|NCT01446042|583682807|FG001|Overall Study|Lost to Follow-up|0|||
161626485|NCT01446042|583682808|FG002|Overall Study|Lost to Follow-up|0|||
161626486|NCT01446042|583682806|FG000|Overall Study|Other reasons|2|||
161626487|NCT01446042|583682807|FG001|Overall Study|Other reasons|1|||
161626488|NCT01446042|583682808|FG002|Overall Study|Other reasons|1|||
161626489|NCT05714345|583682815|FG000|Overall Study|Death|1|||
161626490|NCT05714345|583682816|FG001|Overall Study|Death|1|||
161626491|NCT01257698|583682826|FG000|Overall Study|Protocol Violation|4|||
161626492|NCT01257698|583682827|FG001|Overall Study|Protocol Violation|0|||
161626493|NCT00274846|583682833|FG000|Overall Study|Did not receive adequate NK cells|1|||
161626494|NCT01190228|583682834|FG000|Overall Study|Protocol Violation|4|||
161626495|NCT01190228|583682835|FG001|Overall Study|Protocol Violation|0|||
161626496|NCT01190228|583682836|FG002|Overall Study|Protocol Violation|0|||
161626497|NCT01190228|583682834|FG000|Overall Study|Withdrawal by Subject|1|||
161626498|NCT01190228|583682835|FG001|Overall Study|Withdrawal by Subject|0|||
161626499|NCT01190228|583682836|FG002|Overall Study|Withdrawal by Subject|0|||
161626500|NCT01395914|583682842|FG000|Overall Study|Unrelated to study drug AE|6|||
161626501|NCT01395914|583682843|FG001|Overall Study|Unrelated to study drug AE|1|||
161626502|NCT01395914|583682842|FG000|Overall Study|Death|23|||
161626503|NCT01395914|583682843|FG001|Overall Study|Death|17|||
161626504|NCT01395914|583682842|FG000|Overall Study|Other|9|||
161626505|NCT01395914|583682843|FG001|Overall Study|Other|3|||
161626506|NCT01395914|583682842|FG000|Overall Study|Withdrawal by patient|27|||
161626507|NCT01395914|583682843|FG001|Overall Study|Withdrawal by patient|14|||
161626508|NCT01395914|583682842|FG000|Overall Study|Study drug-related AE|1|||
161626509|NCT01395914|583682843|FG001|Overall Study|Study drug-related AE|0|||
161626510|NCT01395914|583682842|FG000|Overall Study|Lost to Follow-up|6|||
161626511|NCT01395914|583682843|FG001|Overall Study|Lost to Follow-up|2|||
161626512|NCT04601857|583682844|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
161626513|NCT04601857|583682845|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
161626514|NCT04601857|583682844|FG000|Overall Study|Disease Progression|2|||
161626515|NCT04601857|583682845|FG001|Overall Study|Disease Progression|4|||
161626516|NCT04601857|583682844|FG000|Overall Study|Clinical Disease Progression|2|||
161626517|NCT04601857|583682845|FG001|Overall Study|Clinical Disease Progression|1|||
161626518|NCT04601857|583682844|FG000|Overall Study|Radiological Progression|4|||
161626519|NCT04601857|583682845|FG001|Overall Study|Radiological Progression|11|||
161626520|NCT04601857|583682844|FG000|Overall Study|Death|1|||
161626521|NCT04601857|583682845|FG001|Overall Study|Death|0|||
161626522|NCT04601857|583682844|FG000|Overall Study|Reason Not Specified|0|||
161626523|NCT04601857|583682845|FG001|Overall Study|Reason Not Specified|1|||
161626524|NCT04601857|583682844|FG000|Overall Study|At the Participant's Request|0|||
161626525|NCT04601857|583682845|FG001|Overall Study|At the Participant's Request|1|||
161626526|NCT00980954|583682846|FG000|Overall Study|Protocol Violation|9|||
161626527|NCT00980954|583682847|FG001|Overall Study|Protocol Violation|15|||
161626528|NCT04115319|583682848|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
161626529|NCT04115319|583682849|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
161626530|NCT04115319|583682848|FG000|Overall Study|Withdrawal by participant|17|||
161626531|NCT04115319|583682849|FG001|Overall Study|Withdrawal by participant|9|||
161626532|NCT04115319|583682848|FG000|Overall Study|Geopolitical Conflict Related|2|||
161626533|NCT04115319|583682849|FG001|Overall Study|Geopolitical Conflict Related|1|||
161626534|NCT04115319|583682848|FG000|Overall Study|COVID-19 Related|1|||
161626535|NCT04115319|583682849|FG001|Overall Study|COVID-19 Related|0|||
161626536|NCT04115319|583682848|FG000|Overall Study|Adverse Event|48|||
161626537|NCT04115319|583682849|FG001|Overall Study|Adverse Event|21|||
161626538|NCT04115319|583682848|FG000|Overall Study|Noncompliance with Study Drug|5|||
161626539|NCT04115319|583682849|FG001|Overall Study|Noncompliance with Study Drug|1|||
161626540|NCT04115319|583682848|FG000|Overall Study|Lack of Efficacy|6|||
161626541|NCT04115319|583682849|FG001|Overall Study|Lack of Efficacy|2|||
161626542|NCT04115319|583682848|FG000|Overall Study|Lost to Follow-up|6|||
161626543|NCT04115319|583682849|FG001|Overall Study|Lost to Follow-up|7|||
161626544|NCT04115319|583682848|FG000|Overall Study|Protocol Deviation|5|||
161626545|NCT04115319|583682849|FG001|Overall Study|Protocol Deviation|1|||
161626546|NCT04115319|583682848|FG000|Overall Study|Participant relocated|5|||
161626547|NCT04115319|583682849|FG001|Overall Study|Participant relocated|2|||
161626548|NCT04115319|583682848|FG000|Overall Study|Personal Reasons|0|||
161626549|NCT04115319|583682849|FG001|Overall Study|Personal Reasons|1|||
161626550|NCT04115319|583682848|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
161626551|NCT04115319|583682849|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
161626552|NCT02256488|583682855|FG000|Overall Study|Lost to Follow-up|6|||
161626553|NCT02256488|583682856|FG001|Overall Study|Lost to Follow-up|6|||
161626554|NCT02256488|583682857|FG002|Overall Study|Lost to Follow-up|9|||
161626555|NCT02256488|583682858|FG003|Overall Study|Lost to Follow-up|3|||
161626556|NCT02256488|583682855|FG000|Overall Study|OTHER|1|||
161626557|NCT02256488|583682856|FG001|Overall Study|OTHER|0|||
161626558|NCT02256488|583682857|FG002|Overall Study|OTHER|1|||
161626559|NCT02256488|583682858|FG003|Overall Study|OTHER|1|||
161626560|NCT02256488|583682855|FG000|Overall Study|Withdrawal by Subject|1|||
161626561|NCT02256488|583682856|FG001|Overall Study|Withdrawal by Subject|0|||
161626562|NCT02256488|583682857|FG002|Overall Study|Withdrawal by Subject|0|||
161626563|NCT02256488|583682858|FG003|Overall Study|Withdrawal by Subject|2|||
161626564|NCT04930445|583682859|FG000|Overall Study|Adverse Event|7|||
161626565|NCT04930445|583682859|FG000|Overall Study|Lost to Follow-up|1|||
161626566|NCT04930445|583682859|FG000|Overall Study|Physician Decision|1|||
161626567|NCT04930445|583682859|FG000|Overall Study|Lack of Efficacy|1|||
161626568|NCT04930445|583682859|FG000|Overall Study|Study Terminated by Sponsor|245|||
161626569|NCT04930445|583682859|FG000|Overall Study|Screen Failure|8|||
161626570|NCT04930445|583682859|FG000|Overall Study|Other|2|||
161626571|NCT00975130|583682860|FG000|Study Part 1|Adverse Event|150|||
161626572|NCT00975130|583682861|FG001|Study Part 1|Adverse Event|0|||
161626573|NCT00975130|583682862|FG002|Study Part 1|Adverse Event|0|||
161626574|NCT00975130|583682860|FG000|Study Part 1|Lost to Follow-up|19|||
161626575|NCT00975130|583682861|FG001|Study Part 1|Lost to Follow-up|0|||
161626576|NCT00975130|583682862|FG002|Study Part 1|Lost to Follow-up|0|||
161626577|NCT00975130|583682860|FG000|Study Part 1|Withdrawal by Subject|61|||
161626578|NCT00975130|583682861|FG001|Study Part 1|Withdrawal by Subject|0|||
161626579|NCT00975130|583682862|FG002|Study Part 1|Withdrawal by Subject|0|||
161626580|NCT00975130|583682860|FG000|Study Part 1|Protocol Violation|13|||
161626581|NCT00975130|583682861|FG001|Study Part 1|Protocol Violation|0|||
161626582|NCT00975130|583682862|FG002|Study Part 1|Protocol Violation|0|||
161626583|NCT00975130|583682860|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
161626584|NCT00975130|583682861|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
161626585|NCT00975130|583682862|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
161626586|NCT00975130|583682860|FG000|Study Part 1|Administrative|4|||
161626587|NCT00975130|583682861|FG001|Study Part 1|Administrative|0|||
161626588|NCT00975130|583682862|FG002|Study Part 1|Administrative|0|||
161626589|NCT00975130|583682860|FG000|Study Part 1|Withdrew Consent|24|||
161626590|NCT00975130|583682861|FG001|Study Part 1|Withdrew Consent|0|||
161626591|NCT00975130|583682862|FG002|Study Part 1|Withdrew Consent|0|||
161626592|NCT00975130|583682860|FG000|Study Part 2|Adverse Event|0|||
161626593|NCT00975130|583682861|FG001|Study Part 2|Adverse Event|14|||
161626594|NCT00975130|583682862|FG002|Study Part 2|Adverse Event|7|||
161626595|NCT00975130|583682860|FG000|Study Part 2|Lost to Follow-up|0|||
161626596|NCT00975130|583682861|FG001|Study Part 2|Lost to Follow-up|0|||
161626597|NCT00975130|583682862|FG002|Study Part 2|Lost to Follow-up|1|||
161626598|NCT00975130|583682860|FG000|Study Part 2|Withdrawal by Subject|0|||
161626599|NCT00975130|583682861|FG001|Study Part 2|Withdrawal by Subject|13|||
161626600|NCT00975130|583682862|FG002|Study Part 2|Withdrawal by Subject|5|||
161626601|NCT00975130|583682860|FG000|Study Part 2|Withdrew Consent|0|||
161626602|NCT00975130|583682861|FG001|Study Part 2|Withdrew Consent|6|||
161626603|NCT00975130|583682862|FG002|Study Part 2|Withdrew Consent|2|||
161626604|NCT00975130|583682860|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
161626605|NCT00975130|583682861|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
161626606|NCT00975130|583682862|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
161626607|NCT00975130|583682860|FG000|Study Part 2|Administrative|0|||
161626608|NCT00975130|583682861|FG001|Study Part 2|Administrative|1|||
161626609|NCT00975130|583682862|FG002|Study Part 2|Administrative|0|||
161626610|NCT00975130|583682860|FG000|Study Part 2|Protocol Violation|0|||
161626611|NCT00975130|583682861|FG001|Study Part 2|Protocol Violation|0|||
161626612|NCT00975130|583682862|FG002|Study Part 2|Protocol Violation|1|||
161626613|NCT01261793|583682863|FG000|Overall Study|Lack of Efficacy|44|||
161626614|NCT01261793|583682864|FG001|Overall Study|Lack of Efficacy|37|||
161626615|NCT01261793|583682865|FG002|Overall Study|Lack of Efficacy|32|||
161626616|NCT01261793|583682863|FG000|Overall Study|Protocol Violation|3|||
161626617|NCT01261793|583682864|FG001|Overall Study|Protocol Violation|5|||
161626618|NCT01261793|583682865|FG002|Overall Study|Protocol Violation|6|||
161626619|NCT01261793|583682863|FG000|Overall Study|Lost to Follow-up|10|||
161626620|NCT01261793|583682864|FG001|Overall Study|Lost to Follow-up|3|||
161626621|NCT01261793|583682865|FG002|Overall Study|Lost to Follow-up|7|||
161626622|NCT01261793|583682863|FG000|Overall Study|Withdrawal by Subject|12|||
161626623|NCT01261793|583682864|FG001|Overall Study|Withdrawal by Subject|14|||
161626624|NCT01261793|583682865|FG002|Overall Study|Withdrawal by Subject|14|||
161626625|NCT01261793|583682863|FG000|Overall Study|Death|3|||
161626626|NCT01261793|583682864|FG001|Overall Study|Death|1|||
161626627|NCT01261793|583682865|FG002|Overall Study|Death|0|||
161626628|NCT01261793|583682863|FG000|Overall Study|Adverse Event|9|||
161626629|NCT01261793|583682864|FG001|Overall Study|Adverse Event|24|||
161626630|NCT01261793|583682865|FG002|Overall Study|Adverse Event|19|||
161626631|NCT01261793|583682863|FG000|Overall Study|Patient non-availability|1|||
161626632|NCT01261793|583682864|FG001|Overall Study|Patient non-availability|1|||
161626633|NCT01261793|583682865|FG002|Overall Study|Patient non-availability|1|||
161626634|NCT01261793|583682863|FG000|Overall Study|Suspected pregnancy|1|||
161626635|NCT01261793|583682864|FG001|Overall Study|Suspected pregnancy|1|||
161626636|NCT01261793|583682865|FG002|Overall Study|Suspected pregnancy|0|||
161626637|NCT01261793|583682863|FG000|Overall Study|Patient non-compliance|1|||
161626638|NCT01261793|583682864|FG001|Overall Study|Patient non-compliance|0|||
161626639|NCT01261793|583682865|FG002|Overall Study|Patient non-compliance|1|||
161626640|NCT01261793|583682863|FG000|Overall Study|Patient pregnant|1|||
161626641|NCT01261793|583682864|FG001|Overall Study|Patient pregnant|0|||
161626642|NCT01261793|583682865|FG002|Overall Study|Patient pregnant|0|||
161626643|NCT01261793|583682863|FG000|Overall Study|Outside the study area|0|||
161626644|NCT01261793|583682864|FG001|Overall Study|Outside the study area|2|||
161626645|NCT01261793|583682865|FG002|Overall Study|Outside the study area|1|||
161626646|NCT01261793|583682863|FG000|Overall Study|Lack of efficacy & patient not available|0|||
161626647|NCT01261793|583682864|FG001|Overall Study|Lack of efficacy & patient not available|1|||
161626648|NCT01261793|583682865|FG002|Overall Study|Lack of efficacy & patient not available|0|||
161626649|NCT01261793|583682863|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
161626650|NCT01261793|583682864|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
161626651|NCT01261793|583682865|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
161626652|NCT01261793|583682863|FG000|Overall Study|Randomization error|0|||
161626653|NCT01261793|583682864|FG001|Overall Study|Randomization error|1|||
161626654|NCT01261793|583682865|FG002|Overall Study|Randomization error|0|||
161626655|NCT01261793|583682863|FG000|Overall Study|Patient unable to start IV line|0|||
161626656|NCT01261793|583682864|FG001|Overall Study|Patient unable to start IV line|0|||
161626657|NCT01261793|583682865|FG002|Overall Study|Patient unable to start IV line|1|||
161626658|NCT03305458|583682866|FG000|Overall Study|Withdrawal by Subject|50|||
161626659|NCT03305458|583682867|FG001|Overall Study|Withdrawal by Subject|46|||
161626660|NCT03305458|583682868|FG002|Overall Study|Withdrawal by Subject|93|||
161626661|NCT03305458|583682866|FG000|Overall Study|Lost to Follow-up|85|||
161626662|NCT03305458|583682867|FG001|Overall Study|Lost to Follow-up|85|||
161626663|NCT03305458|583682868|FG002|Overall Study|Lost to Follow-up|35|||
161626664|NCT02332824|583682869|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
161626665|NCT02332824|583682870|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161626666|NCT02332824|583682871|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161626667|NCT02332824|583682872|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161626668|NCT02332824|583682873|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
161626669|NCT02332824|583682874|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
161626670|NCT02332824|583682869|FG000|Overall Study|Voluntary Withdrawal|1|||
161626671|NCT02332824|583682870|FG001|Overall Study|Voluntary Withdrawal|0|||
161626672|NCT02332824|583682871|FG002|Overall Study|Voluntary Withdrawal|0|||
161626673|NCT02332824|583682872|FG003|Overall Study|Voluntary Withdrawal|0|||
161626674|NCT02332824|583682873|FG004|Overall Study|Voluntary Withdrawal|0|||
161626675|NCT02332824|583682874|FG005|Overall Study|Voluntary Withdrawal|0|||
161626676|NCT02332824|583682869|FG000|Overall Study|Inconvenient schedule|1|||
161626677|NCT02332824|583682870|FG001|Overall Study|Inconvenient schedule|1|||
161626678|NCT02332824|583682871|FG002|Overall Study|Inconvenient schedule|0|||
161626679|NCT02332824|583682872|FG003|Overall Study|Inconvenient schedule|0|||
161626680|NCT02332824|583682873|FG004|Overall Study|Inconvenient schedule|0|||
161626681|NCT02332824|583682874|FG005|Overall Study|Inconvenient schedule|0|||
161626682|NCT02332824|583682869|FG000|Overall Study|Transfer|0|||
161626683|NCT02332824|583682870|FG001|Overall Study|Transfer|0|||
161626684|NCT02332824|583682871|FG002|Overall Study|Transfer|1|||
161626685|NCT02332824|583682872|FG003|Overall Study|Transfer|1|||
161626686|NCT02332824|583682873|FG004|Overall Study|Transfer|0|||
161626687|NCT02332824|583682874|FG005|Overall Study|Transfer|0|||
161626688|NCT03562117|583682875|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
161626689|NCT03562117|583682876|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
161626690|NCT03562117|583682877|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
161626691|NCT03928821|583682878|FG000|Overall Study|Death|0|||
161626692|NCT03928821|583682879|FG001|Overall Study|Death|1|||
161626693|NCT03928821|583682880|FG002|Overall Study|Death|0|||
161626694|NCT03928821|583682881|FG003|Overall Study|Death|0|||
161626695|NCT03928821|583682878|FG000|Overall Study|Lost to Follow-up|0|||
161626696|NCT03928821|583682879|FG001|Overall Study|Lost to Follow-up|2|||
161626697|NCT03928821|583682880|FG002|Overall Study|Lost to Follow-up|3|||
161626698|NCT03928821|583682881|FG003|Overall Study|Lost to Follow-up|0|||
161626699|NCT03928821|583682878|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161626700|NCT03928821|583682879|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161626701|NCT03928821|583682880|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161626702|NCT03928821|583682881|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161626703|NCT04743999|583682888|FG000|3-month Questionnaire|Death|1|||
161626704|NCT04743999|583682888|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
161626705|NCT04743999|583682888|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
161626706|NCT04743999|583682888|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
161626707|NCT01721759|583682889|FG000|Treatment Period|Disease Progression|85|||
161626708|NCT01721759|583682889|FG000|Treatment Period|Study drug toxicity|14|||
161626709|NCT01721759|583682889|FG000|Treatment Period|Death|1|||
161626710|NCT01721759|583682889|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
161626711|NCT01721759|583682889|FG000|Treatment Period|Participant request to withdraw|3|||
161626712|NCT01721759|583682889|FG000|Treatment Period|Other Reasons|3|||
161626713|NCT01721759|583682889|FG000|End of Study Period|Participant Withdrew Consent|5|||
161626714|NCT01721759|583682889|FG000|End of Study Period|Death|101|||
161626715|NCT01721759|583682889|FG000|End of Study Period|Lost to Follow-up|1|||
161626716|NCT01721759|583682889|FG000|End of Study Period|Other Reasons|10|||
161626717|NCT03926117|583682890|FG000|Overall Study|Unclassified|1|||
161626718|NCT03926117|583682891|FG001|Overall Study|Unclassified|4|||
161626719|NCT03926117|583682892|FG002|Overall Study|Unclassified|1|||
161626720|NCT03926117|583682893|FG003|Overall Study|Unclassified|4|||
161626721|NCT03926117|583682890|FG000|Overall Study|Withdrawal by Subject|3|||
161626722|NCT03926117|583682891|FG001|Overall Study|Withdrawal by Subject|0|||
161626723|NCT03926117|583682892|FG002|Overall Study|Withdrawal by Subject|1|||
161626724|NCT03926117|583682893|FG003|Overall Study|Withdrawal by Subject|1|||
161626725|NCT03926117|583682890|FG000|Overall Study|Lost to Follow-up|0|||
161626726|NCT03926117|583682891|FG001|Overall Study|Lost to Follow-up|2|||
161626727|NCT03926117|583682892|FG002|Overall Study|Lost to Follow-up|1|||
161626728|NCT03926117|583682893|FG003|Overall Study|Lost to Follow-up|0|||
161626729|NCT03926117|583682890|FG000|Overall Study|Adverse Event|1|||
161626730|NCT03926117|583682891|FG001|Overall Study|Adverse Event|2|||
161626731|NCT03926117|583682892|FG002|Overall Study|Adverse Event|3|||
161626732|NCT03926117|583682893|FG003|Overall Study|Adverse Event|1|||
161626733|NCT03926117|583682890|FG000|Overall Study|Randomized but not treated|1|||
161833420|NCT03919162|584431115|FG001|Overall Study|Withdrawal by Subject|12|||
161626734|NCT03926117|583682891|FG001|Overall Study|Randomized but not treated|1|||
161626735|NCT03926117|583682892|FG002|Overall Study|Randomized but not treated|0|||
161626736|NCT03926117|583682893|FG003|Overall Study|Randomized but not treated|1|||
161626737|NCT03138499|583682894|FG000|Overall Study|Lost to Follow-up|1|||
161626738|NCT03138499|583682895|FG001|Overall Study|Lost to Follow-up|0|||
161626739|NCT03138499|583682894|FG000|Overall Study|Participants withdrew consent|1|||
161626740|NCT03138499|583682895|FG001|Overall Study|Participants withdrew consent|0|||
161626741|NCT03138499|583682894|FG000|Overall Study|Participant discontinued study before treatment|0|||
161626742|NCT03138499|583682895|FG001|Overall Study|Participant discontinued study before treatment|1|||
161626743|NCT03138499|583682894|FG000|Overall Study|Disease Progression|2|||
161626744|NCT03138499|583682895|FG001|Overall Study|Disease Progression|6|||
161626745|NCT03138499|583682894|FG000|Overall Study|Study drug toxicity|2|||
161626746|NCT03138499|583682895|FG001|Overall Study|Study drug toxicity|2|||
161626747|NCT03138499|583682894|FG000|Overall Study|Participant request to discontinue study treatment|1|||
161626748|NCT03138499|583682895|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161626749|NCT03138499|583682894|FG000|Overall Study|Other reasons|2|||
161626750|NCT03138499|583682895|FG001|Overall Study|Other reasons|0|||
161626751|NCT01123200|583682896|FG000|Overall Study|Withdrawal by Subject|1|||
161626752|NCT02577315|583682899|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161626753|NCT02577315|583682900|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161626754|NCT01636778|583682901|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
161626755|NCT01636778|583682902|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
161626756|NCT01636778|583682903|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
161626757|NCT01636778|583682901|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
161626758|NCT01636778|583682902|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
161626759|NCT01636778|583682903|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
161833421|NCT03919162|584431114|FG000|Overall Study|Study terminated by Sponsor|20|||
161833422|NCT03919162|584431115|FG001|Overall Study|Study terminated by Sponsor|24|||
161833423|NCT03919162|584431114|FG000|Overall Study|Screen failure|1|||
161833424|NCT03919162|584431115|FG001|Overall Study|Screen failure|0|||
161833425|NCT03919162|584431114|FG000|Overall Study|Missing|1|||
161833426|NCT03919162|584431115|FG001|Overall Study|Missing|1|||
161833427|NCT02746627|584431117|FG000|Overall Study|Withdrawal by Subject|1|||
161833428|NCT02746627|584431118|FG001|Overall Study|Withdrawal by Subject|1|||
161833429|NCT02746627|584431119|FG002|Overall Study|Withdrawal by Subject|1|||
161833430|NCT00233987|584431124|FG000|Overall Study|Withdrawal by Subject|1|||
161833431|NCT00233987|584431124|FG000|Overall Study|Lack of Efficacy|2|||
161833432|NCT00233987|584431124|FG000|Overall Study|Reason Under Review|1|||
161833433|NCT00233987|584431124|FG000|Overall Study|Other - Not Protocol Specified|5|||
161833434|NCT00233987|584431124|FG000|Overall Study|Eligible but No Treatment Received|2|||
161833435|NCT00233987|584431124|FG000|Overall Study|Ineligible|4|||
161833436|NCT04553913|584431127|FG000|Overall Study|patient's block resolved prior to PACU|1|||
161833437|NCT04553913|584431127|FG000|Overall Study|did not use the device properly|5|||
161833438|NCT01481324|584431129|FG000|Overall Study|Missing Data|0|||
161833439|NCT01481324|584431130|FG001|Overall Study|Missing Data|2|||
161833440|NCT01481324|584431131|FG002|Overall Study|Missing Data|2|||
161833441|NCT00710749|584431133|FG000|First Intervention|Withdrawal by Subject|1|||
161626760|NCT01636778|583682901|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
161626761|NCT01636778|583682902|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
161626762|NCT01636778|583682903|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
161626763|NCT01636778|583682901|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
161626764|NCT01636778|583682902|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
161626765|NCT01636778|583682903|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
161626766|NCT01636778|583682901|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
161833442|NCT00710749|584431134|FG001|First Intervention|Withdrawal by Subject|0|||
161833443|NCT05478252|584431135|FG000|Overall Study|Withdrawal by Subject|2|||
161833444|NCT05478252|584431136|FG001|Overall Study|Withdrawal by Subject|3|||
161833445|NCT05478252|584431135|FG000|Overall Study|Lost to Follow-up|4|||
161833446|NCT05478252|584431136|FG001|Overall Study|Lost to Follow-up|2|||
161833447|NCT05478252|584431135|FG000|Overall Study|Physician Decision|1|||
161833448|NCT05478252|584431136|FG001|Overall Study|Physician Decision|1|||
161833449|NCT05478252|584431135|FG000|Overall Study|Death|1|||
161833450|NCT05478252|584431136|FG001|Overall Study|Death|0|||
161833451|NCT04846881|584431137|FG000|Overall Study|Adverse Event|14|||
161833452|NCT04846881|584431138|FG001|Overall Study|Adverse Event|15|||
161626767|NCT01636778|583682902|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
161833453|NCT04846881|584431137|FG000|Overall Study|Burden of study procedures|7|||
161626768|NCT01636778|583682903|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
161626769|NCT01636778|583682901|FG000|Follow-up Period After Part 2|Other|0|||
161626770|NCT01636778|583682902|FG001|Follow-up Period After Part 2|Other|0|||
161626771|NCT01636778|583682903|FG002|Follow-up Period After Part 2|Other|1|||
161626772|NCT01636778|583682901|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
161626773|NCT01636778|583682902|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
161626774|NCT01636778|583682903|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
161626775|NCT01636778|583682901|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
161626776|NCT01636778|583682902|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
161626777|NCT01636778|583682903|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
161626778|NCT00990821|583682907|FG000|Overall Study|Withdrawal by Subject|0|||
161626779|NCT00990821|583682908|FG001|Overall Study|Withdrawal by Subject|2|||
161626780|NCT00990821|583682909|FG002|Overall Study|Withdrawal by Subject|0|||
161626781|NCT00990821|583682910|FG003|Overall Study|Withdrawal by Subject|0|||
161626782|NCT00990821|583682911|FG004|Overall Study|Withdrawal by Subject|3|||
161626783|NCT00990821|583682912|FG005|Overall Study|Withdrawal by Subject|3|||
161626784|NCT00990821|583682913|FG006|Overall Study|Withdrawal by Subject|1|||
161626785|NCT00990821|583682914|FG007|Overall Study|Withdrawal by Subject|0|||
161626786|NCT00990821|583682915|FG008|Overall Study|Withdrawal by Subject|0|||
161626787|NCT00990821|583682916|FG009|Overall Study|Withdrawal by Subject|1|||
161626788|NCT00990821|583682917|FG010|Overall Study|Withdrawal by Subject|3|||
161626789|NCT00990821|583682918|FG011|Overall Study|Withdrawal by Subject|5|||
161626790|NCT00990821|583682919|FG012|Overall Study|Withdrawal by Subject|2|||
161626791|NCT00990821|583682920|FG013|Overall Study|Withdrawal by Subject|1|||
161626792|NCT03530345|583682921|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161626793|NCT03530345|583682922|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
161626794|NCT03530345|583682921|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
161626795|NCT03530345|583682922|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
161626796|NCT03530345|583682921|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
161626797|NCT03530345|583682922|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
161626798|NCT03530345|583682921|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
161626799|NCT03530345|583682922|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
161626800|NCT00170950|583682923|FG000|Overall Study|Death|236|||
161626801|NCT00170950|583682924|FG001|Overall Study|Death|274|||
161626802|NCT00170950|583682923|FG000|Overall Study|Withdrawal by Subject|496|||
161626803|NCT00170950|583682924|FG001|Overall Study|Withdrawal by Subject|498|||
161626804|NCT00170950|583682923|FG000|Overall Study|Lost to Follow-up|134|||
161626805|NCT00170950|583682924|FG001|Overall Study|Lost to Follow-up|115|||
161626806|NCT00170950|583682923|FG000|Overall Study|Missing|2|||
161626807|NCT00170950|583682924|FG001|Overall Study|Missing|1|||
161626808|NCT00170950|583682923|FG000|Overall Study|Termination Data Not Recorded|17|||
161626809|NCT00170950|583682924|FG001|Overall Study|Termination Data Not Recorded|22|||
161626810|NCT00748098|583682925|FG000|First Treatment Intervention Period|Adverse Event|1|||
161626811|NCT00748098|583682926|FG001|First Treatment Intervention Period|Adverse Event|1|||
161626812|NCT00748098|583682925|FG000|First Treatment Intervention Period|Protocol Violation|1|||
161626813|NCT00748098|583682926|FG001|First Treatment Intervention Period|Protocol Violation|0|||
161626814|NCT00748098|583682925|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
161626815|NCT00748098|583682926|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
161685121|NCT02290873|583899697|FG000|Overall Study|Nellcor device error|1|||
161685122|NCT02290873|583899698|FG001|Overall Study|Nellcor device error|0|||
161685123|NCT02290873|583899699|FG002|Overall Study|Nellcor device error|0|||
161685124|NCT02290873|583899697|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
161685125|NCT02290873|583899698|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
161685126|NCT02290873|583899699|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
161685127|NCT02290873|583899697|FG000|Overall Study|Protocol Violation|0|||
161685128|NCT02290873|583899698|FG001|Overall Study|Protocol Violation|0|||
161685129|NCT02290873|583899699|FG002|Overall Study|Protocol Violation|1|||
161685130|NCT03715153|583899700|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
161685131|NCT03715153|583899701|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
161685132|NCT03715153|583899700|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
161685133|NCT03715153|583899701|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
161685134|NCT03715153|583899700|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
161685135|NCT03715153|583899701|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
161685136|NCT03715153|583899700|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
161685137|NCT03715153|583899701|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
161685138|NCT03715153|583899700|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
161685139|NCT03715153|583899701|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
161685140|NCT03715153|583899700|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
161685141|NCT03715153|583899701|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
161685142|NCT01519765|583899702|FG000|Overall Study|Adverse Event|0|||
161685143|NCT01519765|583899703|FG001|Overall Study|Adverse Event|1|||
161685144|NCT01519765|583899702|FG000|Overall Study|Lack of Efficacy|2|||
161685145|NCT01519765|583899703|FG001|Overall Study|Lack of Efficacy|0|||
161685146|NCT01519765|583899702|FG000|Overall Study|Protocol Violation|1|||
161685147|NCT01519765|583899703|FG001|Overall Study|Protocol Violation|0|||
161685148|NCT01519765|583899702|FG000|Overall Study|Withdrawal by Subject|0|||
161685149|NCT01519765|583899703|FG001|Overall Study|Withdrawal by Subject|1|||
161685150|NCT04126083|583899704|FG000|Overall Study|Withdrawal by Subject|1|||
161685151|NCT01892163|583899707|FG000|Overall Study|Death|1|||
161685152|NCT01892163|583899708|FG001|Overall Study|Death|1|||
161685153|NCT01892163|583899707|FG000|Overall Study|Lost to Follow-up|1|||
161685154|NCT01892163|583899708|FG001|Overall Study|Lost to Follow-up|0|||
161685155|NCT02577146|583899709|FG000|Overall Study|Lost to Follow-up|8|||
161685156|NCT02577146|583899709|FG000|Overall Study|Physician Decision|3|||
161685157|NCT02577146|583899709|FG000|Overall Study|Screen Failure|17|||
161685158|NCT03116698|583899710|FG000|Overall Study|Adverse Event|1|||
161833454|NCT04846881|584431138|FG001|Overall Study|Burden of study procedures|3|||
161833455|NCT04846881|584431137|FG000|Overall Study|Protocol deviation|6|||
161833456|NCT04846881|584431138|FG001|Overall Study|Protocol deviation|4|||
161833457|NCT04846881|584431137|FG000|Overall Study|Perceived lack of efficacy|5|||
161833458|NCT04846881|584431138|FG001|Overall Study|Perceived lack of efficacy|2|||
161833459|NCT04846881|584431137|FG000|Overall Study|Change of residence|2|||
161833460|NCT04846881|584431138|FG001|Overall Study|Change of residence|0|||
161833461|NCT04846881|584431137|FG000|Overall Study|Technical problems|0|||
161833462|NCT04846881|584431138|FG001|Overall Study|Technical problems|1|||
161626816|NCT00748098|583682925|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
161626817|NCT00748098|583682926|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
161626818|NCT00748098|583682925|FG000|First Taper Period|Protocol Violation|1|||
161626819|NCT00748098|583682926|FG001|First Taper Period|Protocol Violation|0|||
161626820|NCT00748098|583682925|FG000|First Taper Period|Withdrawal by Subject|2|||
161626821|NCT00748098|583682926|FG001|First Taper Period|Withdrawal by Subject|0|||
161626822|NCT00748098|583682925|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
161626823|NCT00748098|583682926|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
161626824|NCT00748098|583682925|FG000|1-Week Washout Period|Adverse Event|0|||
161626825|NCT00748098|583682926|FG001|1-Week Washout Period|Adverse Event|1|||
161626826|NCT00748098|583682925|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
161626827|NCT00748098|583682926|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
161626828|NCT00748098|583682925|FG000|Second Treatment Intervention Period|Adverse Event|4|||
161626829|NCT00748098|583682926|FG001|Second Treatment Intervention Period|Adverse Event|1|||
161626830|NCT00748098|583682925|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
161685159|NCT03116698|583899711|FG001|Overall Study|Adverse Event|1|||
161685160|NCT03116698|583899712|FG002|Overall Study|Adverse Event|1|||
161685161|NCT03116698|583899713|FG003|Overall Study|Adverse Event|0|||
161685162|NCT03116698|583899710|FG000|Overall Study|Withdrawal by Subject|1|||
161833463|NCT04846881|584431137|FG000|Overall Study|Other than listed|3|||
161833464|NCT04846881|584431138|FG001|Overall Study|Other than listed|10|||
161685163|NCT03116698|583899711|FG001|Overall Study|Withdrawal by Subject|4|||
161685164|NCT03116698|583899712|FG002|Overall Study|Withdrawal by Subject|5|||
161833465|NCT04846881|584431137|FG000|Overall Study|No reason available|1|||
161626831|NCT00748098|583682926|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
161626832|NCT00748098|583682925|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
161626833|NCT00748098|583682926|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
161626834|NCT04448561|583682932|FG000|Overall Study|Noncompliance|1|||
161626835|NCT04448561|583682933|FG001|Overall Study|Noncompliance|0|||
161626836|NCT00506922|583683952|FG000|Overall Study|Physician Decision|0|||
161626837|NCT00506922|583683953|FG001|Overall Study|Physician Decision|0|||
161626838|NCT00506922|583683954|FG002|Overall Study|Physician Decision|0|||
161626839|NCT00506922|583683955|FG003|Overall Study|Physician Decision|2|||
161626840|NCT00506922|583683956|FG004|Overall Study|Physician Decision|0|||
161626841|NCT00506922|583683952|FG000|Overall Study|Withdrawal by Subject|0|||
161626842|NCT00506922|583683953|FG001|Overall Study|Withdrawal by Subject|0|||
161626843|NCT00506922|583683954|FG002|Overall Study|Withdrawal by Subject|0|||
161626844|NCT00506922|583683955|FG003|Overall Study|Withdrawal by Subject|0|||
161626845|NCT00506922|583683956|FG004|Overall Study|Withdrawal by Subject|1|||
161626846|NCT05244226|583683957|FG000|Overall Study|Adverse Event|1|||
161626847|NCT05244226|583683958|FG001|Overall Study|Adverse Event|0|||
161626848|NCT05244226|583683959|FG002|Overall Study|Adverse Event|0|||
161626849|NCT05244226|583683957|FG000|Overall Study|Lost to Follow-up|0|||
161626850|NCT05244226|583683958|FG001|Overall Study|Lost to Follow-up|0|||
161626851|NCT05244226|583683959|FG002|Overall Study|Lost to Follow-up|1|||
161626852|NCT05244226|583683957|FG000|Overall Study|Protocol Violation|0|||
161626853|NCT05244226|583683958|FG001|Overall Study|Protocol Violation|2|||
161626854|NCT05244226|583683959|FG002|Overall Study|Protocol Violation|2|||
161626855|NCT00508274|583683965|FG000|Overall Study|Adverse Event|5|||
161626856|NCT00508274|583683965|FG000|Overall Study|Death|7|||
161626857|NCT00508274|583683965|FG000|Overall Study|Disease progression|32|||
161626858|NCT00508274|583683965|FG000|Overall Study|Withdrawal by Subject|1|||
161626859|NCT00508274|583683965|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
161626860|NCT00508274|583683965|FG000|Overall Study|Missing|3|||
161626861|NCT00197106|583683966|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
161626862|NCT00197106|583683967|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
161626863|NCT00197106|583683968|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
161626864|NCT00197106|583683966|FG000|Overall Treatment Period|Lack of Efficacy|0|||
161626865|NCT00197106|583683967|FG001|Overall Treatment Period|Lack of Efficacy|1|||
161626866|NCT00197106|583683968|FG002|Overall Treatment Period|Lack of Efficacy|0|||
161626867|NCT00197106|583683966|FG000|Overall Treatment Period|Lost to Follow-up|0|||
161626868|NCT00197106|583683967|FG001|Overall Treatment Period|Lost to Follow-up|0|||
161626869|NCT00197106|583683968|FG002|Overall Treatment Period|Lost to Follow-up|2|||
161626870|NCT00197106|583683966|FG000|Overall Treatment Period|Protocol Violation|0|||
161626871|NCT00197106|583683967|FG001|Overall Treatment Period|Protocol Violation|0|||
161626872|NCT00197106|583683968|FG002|Overall Treatment Period|Protocol Violation|2|||
161626873|NCT00197106|583683966|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
161626874|NCT00197106|583683967|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
161685165|NCT03116698|583899713|FG003|Overall Study|Withdrawal by Subject|2|||
161685166|NCT03116698|583899710|FG000|Overall Study|Lost to Follow-up|2|||
161626875|NCT00197106|583683968|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
161626876|NCT04050722|583683969|FG000|Overall Study|Withdrawal by Subject|1|||
161626877|NCT04050722|583683970|FG001|Overall Study|Withdrawal by Subject|0|||
161626878|NCT02531126|583683971|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
161626879|NCT02531126|583683972|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
161626880|NCT02531126|583683973|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
161626881|NCT02531126|583683974|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
161363815|NCT02544763|582720033|FG002|Overall Study|Adverse Event|0|||
161626882|NCT02531126|583683971|FG000|Overall Study|Adverse Event|16|||
161626883|NCT02531126|583683972|FG001|Overall Study|Adverse Event|13|||
161626884|NCT02531126|583683973|FG002|Overall Study|Adverse Event|27|||
161626885|NCT02531126|583683974|FG003|Overall Study|Adverse Event|4|||
161626886|NCT02531126|583683971|FG000|Overall Study|Lack of Efficacy|50|||
161626887|NCT02531126|583683972|FG001|Overall Study|Lack of Efficacy|32|||
161626888|NCT02531126|583683973|FG002|Overall Study|Lack of Efficacy|121|||
161626889|NCT02531126|583683974|FG003|Overall Study|Lack of Efficacy|0|||
161626890|NCT02531126|583683971|FG000|Overall Study|Withdrawal by Subject|38|||
161626891|NCT02531126|583683972|FG001|Overall Study|Withdrawal by Subject|31|||
161626892|NCT02531126|583683973|FG002|Overall Study|Withdrawal by Subject|96|||
161626893|NCT02531126|583683974|FG003|Overall Study|Withdrawal by Subject|6|||
161626894|NCT02531126|583683971|FG000|Overall Study|Pregnancy|2|||
161626895|NCT02531126|583683972|FG001|Overall Study|Pregnancy|3|||
161626896|NCT02531126|583683973|FG002|Overall Study|Pregnancy|2|||
161626897|NCT02531126|583683974|FG003|Overall Study|Pregnancy|0|||
161626898|NCT02531126|583683971|FG000|Overall Study|Switched to commercial drug|2|||
161626899|NCT02531126|583683972|FG001|Overall Study|Switched to commercial drug|4|||
161626900|NCT02531126|583683973|FG002|Overall Study|Switched to commercial drug|4|||
161626901|NCT02531126|583683974|FG003|Overall Study|Switched to commercial drug|0|||
161626902|NCT02531126|583683971|FG000|Overall Study|Other reasons|23|||
161626903|NCT02531126|583683972|FG001|Overall Study|Other reasons|29|||
161626904|NCT02531126|583683973|FG002|Overall Study|Other reasons|27|||
161626905|NCT02531126|583683974|FG003|Overall Study|Other reasons|15|||
161626906|NCT02531126|583683971|FG000|Overall Study|Physician Decision|6|||
161626907|NCT02531126|583683972|FG001|Overall Study|Physician Decision|6|||
161626908|NCT02531126|583683973|FG002|Overall Study|Physician Decision|28|||
161626909|NCT02531126|583683974|FG003|Overall Study|Physician Decision|0|||
161626910|NCT02531126|583683971|FG000|Overall Study|Non-compliance with investigational drug|1|||
161626911|NCT02531126|583683972|FG001|Overall Study|Non-compliance with investigational drug|0|||
161626912|NCT02531126|583683973|FG002|Overall Study|Non-compliance with investigational drug|0|||
161626913|NCT02531126|583683974|FG003|Overall Study|Non-compliance with investigational drug|0|||
161626914|NCT00382408|583683975|FG000|Overall Study|Did not meet protocol requirement|3|||
161626915|NCT00382408|583683976|FG001|Overall Study|Did not meet protocol requirement|3|||
161626916|NCT00382408|583683975|FG000|Overall Study|Protocol Violation|2|||
161626917|NCT00382408|583683976|FG001|Overall Study|Protocol Violation|2|||
161626918|NCT00382408|583683975|FG000|Overall Study|Physician Decision|1|||
161626919|NCT00382408|583683976|FG001|Overall Study|Physician Decision|0|||
161626920|NCT00382408|583683975|FG000|Overall Study|Withdrawal by Subject|17|||
161626921|NCT00382408|583683976|FG001|Overall Study|Withdrawal by Subject|6|||
161626922|NCT00382408|583683975|FG000|Overall Study|Pregnancy|2|||
161626923|NCT00382408|583683976|FG001|Overall Study|Pregnancy|0|||
161626924|NCT00382408|583683975|FG000|Overall Study|Lost to Follow-up|19|||
161626925|NCT00382408|583683976|FG001|Overall Study|Lost to Follow-up|8|||
161626926|NCT00382408|583683975|FG000|Overall Study|Other|100|||
161626927|NCT00382408|583683976|FG001|Overall Study|Other|35|||
161626928|NCT00762723|583683977|FG000|Overall Study|Study Terminated slow enrollement|5|||
161626929|NCT00762723|583683978|FG001|Overall Study|Study Terminated slow enrollement|5|||
161626930|NCT00762723|583683979|FG002|Overall Study|Study Terminated slow enrollement|3|||
161626931|NCT03085433|583683980|FG000|Overall Study|Withdrawal by Subject|2|||
161626932|NCT03085433|583683981|FG001|Overall Study|Withdrawal by Subject|4|||
161626933|NCT03085433|583683980|FG000|Overall Study|Physician Decision|33|||
161626934|NCT03085433|583683981|FG001|Overall Study|Physician Decision|50|||
161626935|NCT03809039|583683982|FG000|Part 1|Withdrawal by Subject|1|||
161626936|NCT03809039|583683983|FG001|Part 1|Withdrawal by Subject|0|||
161626937|NCT03809039|583683984|FG002|Part 1|Withdrawal by Subject|0|||
161626938|NCT03809039|583683985|FG003|Part 1|Withdrawal by Subject|1|||
161626939|NCT03809039|583683986|FG004|Part 1|Withdrawal by Subject|0|||
161626940|NCT03809039|583683987|FG005|Part 1|Withdrawal by Subject|0|||
161626941|NCT03809039|583683988|FG006|Part 1|Withdrawal by Subject|0|||
161685167|NCT03116698|583899711|FG001|Overall Study|Lost to Follow-up|0|||
161685168|NCT03116698|583899712|FG002|Overall Study|Lost to Follow-up|0|||
161685169|NCT03116698|583899713|FG003|Overall Study|Lost to Follow-up|0|||
161626942|NCT03809039|583683989|FG007|Part 1|Withdrawal by Subject|0|||
161626943|NCT03809039|583683990|FG008|Part 1|Withdrawal by Subject|0|||
161626944|NCT03809039|583683982|FG000|Part 3|Withdrawn by study termination|0|||
161626945|NCT03809039|583683983|FG001|Part 3|Withdrawn by study termination|0|||
161626946|NCT03809039|583683984|FG002|Part 3|Withdrawn by study termination|0|||
161626947|NCT03809039|583683985|FG003|Part 3|Withdrawn by study termination|0|||
161626948|NCT03809039|583683986|FG004|Part 3|Withdrawn by study termination|0|||
161626949|NCT03809039|583683987|FG005|Part 3|Withdrawn by study termination|0|||
161626950|NCT03809039|583683988|FG006|Part 3|Withdrawn by study termination|0|||
161626951|NCT03809039|583683989|FG007|Part 3|Withdrawn by study termination|2|||
161626952|NCT03809039|583683990|FG008|Part 3|Withdrawn by study termination|6|||
161626953|NCT05271552|583683991|FG000|Overall Study|Adverse Event|4|||
161626954|NCT05271552|583683992|FG001|Overall Study|Adverse Event|6|||
161626955|NCT05271552|583683993|FG002|Overall Study|Adverse Event|3|||
161833466|NCT04846881|584431138|FG001|Overall Study|No reason available|3|||
161626956|NCT05271552|583683991|FG000|Overall Study|Death|1|||
161626957|NCT05271552|583683992|FG001|Overall Study|Death|1|||
161626958|NCT05271552|583683993|FG002|Overall Study|Death|1|||
161626959|NCT05271552|583683991|FG000|Overall Study|Lost to Follow-up|1|||
161626960|NCT05271552|583683992|FG001|Overall Study|Lost to Follow-up|5|||
161626961|NCT05271552|583683993|FG002|Overall Study|Lost to Follow-up|4|||
161626962|NCT05271552|583683991|FG000|Overall Study|Withdrawal by Subject|0|||
161626963|NCT05271552|583683992|FG001|Overall Study|Withdrawal by Subject|4|||
161626964|NCT05271552|583683993|FG002|Overall Study|Withdrawal by Subject|7|||
161626965|NCT05271552|583683991|FG000|Overall Study|Other medical reason.|1|||
161626966|NCT05271552|583683992|FG001|Overall Study|Other medical reason.|2|||
161626967|NCT05271552|583683993|FG002|Overall Study|Other medical reason.|0|||
161626968|NCT05271552|583683991|FG000|Overall Study|Other|3|||
161626969|NCT05271552|583683992|FG001|Overall Study|Other|3|||
161626970|NCT05271552|583683993|FG002|Overall Study|Other|6|||
161626971|NCT03840993|583683996|FG000|Overall Study|Adverse Event|1|||
161626972|NCT03840993|583683997|FG001|Overall Study|Adverse Event|0|||
161626973|NCT03840993|583683996|FG000|Overall Study|Lost to Follow-up|4|||
161626974|NCT03840993|583683997|FG001|Overall Study|Lost to Follow-up|0|||
161626975|NCT03840993|583683996|FG000|Overall Study|Physician Decision|0|||
161626976|NCT03840993|583683997|FG001|Overall Study|Physician Decision|1|||
161626977|NCT03840993|583683996|FG000|Overall Study|Pregnancy|0|||
161685170|NCT03116698|583899710|FG000|Overall Study|Physician Decision|1|||
161685171|NCT03116698|583899711|FG001|Overall Study|Physician Decision|1|||
161685172|NCT03116698|583899712|FG002|Overall Study|Physician Decision|0|||
161685173|NCT03116698|583899713|FG003|Overall Study|Physician Decision|0|||
161685174|NCT03116698|583899710|FG000|Overall Study|Protocol Violation|1|||
161685175|NCT03116698|583899711|FG001|Overall Study|Protocol Violation|0|||
161685176|NCT03116698|583899712|FG002|Overall Study|Protocol Violation|0|||
161685177|NCT03116698|583899713|FG003|Overall Study|Protocol Violation|0|||
161685178|NCT03116698|583899710|FG000|Overall Study|Death|0|||
161685179|NCT03116698|583899711|FG001|Overall Study|Death|0|||
161685180|NCT03116698|583899712|FG002|Overall Study|Death|2|||
161685181|NCT03116698|583899713|FG003|Overall Study|Death|0|||
161685182|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
161685183|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
161685184|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
161685185|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
161685186|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
161685187|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
161685188|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
161685189|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
161685190|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to death|4|||
161685191|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to death|3|||
161685192|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
161685193|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
161685194|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
161685195|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
161685196|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
161685197|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
161685198|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
161685199|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
161685200|NCT02258451|583899714|FG000|Overall Study|Other reason|1|||
161685201|NCT02258451|583899715|FG001|Overall Study|Other reason|1|||
161685202|NCT02258451|583899714|FG000|Overall Study|Never treated|2|||
161685203|NCT02258451|583899715|FG001|Overall Study|Never treated|3|||
161685204|NCT00517751|583899720|FG000|Overall Study|Death|3|||
161685205|NCT00517751|583899720|FG000|Overall Study|Withdrawal by Subject|37|||
161685206|NCT00517751|583899720|FG000|Overall Study|Lost to Follow-up|4|||
161685207|NCT00517751|583899720|FG000|Overall Study|patient not over due|6|||
161685208|NCT00517751|583899720|FG000|Overall Study|Patient not due for visit|76|||
161626978|NCT03840993|583683997|FG001|Overall Study|Pregnancy|1|||
161626979|NCT03840993|583683996|FG000|Overall Study|Withdrawal by Subject|1|||
161685209|NCT00517751|583899720|FG000|Overall Study|Missing|3|||
161685210|NCT03021499|583899723|FG000|Overall Study|Adverse Event|1|||
161685211|NCT03021499|583899724|FG001|Overall Study|Adverse Event|0|||
161685212|NCT03021499|583899723|FG000|Overall Study|Death|1|||
161685213|NCT03021499|583899724|FG001|Overall Study|Death|5|||
161685214|NCT03021499|583899723|FG000|Overall Study|Lack of Efficacy|0|||
161685215|NCT03021499|583899724|FG001|Overall Study|Lack of Efficacy|1|||
161833467|NCT04846881|584431137|FG000|Overall Study|Patient randomised in error|1|||
161626980|NCT03840993|583683997|FG001|Overall Study|Withdrawal by Subject|3|||
161626981|NCT03840993|583683996|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
161626982|NCT03840993|583683997|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
161626983|NCT01572493|583683998|FG000|Overall Study|Physician Decision|1|||
161626984|NCT01572493|583683999|FG001|Overall Study|Physician Decision|0|||
161626985|NCT01572493|583684000|FG002|Overall Study|Physician Decision|0|||
161626986|NCT01572493|583684001|FG003|Overall Study|Physician Decision|0|||
161626987|NCT01572493|583684002|FG004|Overall Study|Physician Decision|0|||
161626988|NCT01572493|583684003|FG005|Overall Study|Physician Decision|0|||
161626989|NCT01572493|583684004|FG006|Overall Study|Physician Decision|0|||
161626990|NCT01572493|583684005|FG007|Overall Study|Physician Decision|0|||
161626991|NCT01572493|583684006|FG008|Overall Study|Physician Decision|0|||
161626992|NCT01572493|583683998|FG000|Overall Study|Switched to alternative treatment|0|||
161626993|NCT01572493|583683999|FG001|Overall Study|Switched to alternative treatment|1|||
161626994|NCT01572493|583684000|FG002|Overall Study|Switched to alternative treatment|2|||
161626995|NCT01572493|583684001|FG003|Overall Study|Switched to alternative treatment|1|||
161626996|NCT01572493|583684002|FG004|Overall Study|Switched to alternative treatment|2|||
161626997|NCT01572493|583684003|FG005|Overall Study|Switched to alternative treatment|0|||
161626998|NCT01572493|583684004|FG006|Overall Study|Switched to alternative treatment|2|||
161626999|NCT01572493|583684005|FG007|Overall Study|Switched to alternative treatment|0|||
161627000|NCT01572493|583684006|FG008|Overall Study|Switched to alternative treatment|2|||
161627001|NCT01572493|583683998|FG000|Overall Study|Death|0|||
161627002|NCT01572493|583683999|FG001|Overall Study|Death|0|||
161627003|NCT01572493|583684000|FG002|Overall Study|Death|0|||
161627004|NCT01572493|583684001|FG003|Overall Study|Death|1|||
161627005|NCT01572493|583684002|FG004|Overall Study|Death|0|||
161627006|NCT01572493|583684003|FG005|Overall Study|Death|1|||
161627007|NCT01572493|583684004|FG006|Overall Study|Death|0|||
161627008|NCT01572493|583684005|FG007|Overall Study|Death|0|||
161627009|NCT01572493|583684006|FG008|Overall Study|Death|0|||
161627010|NCT01572493|583683998|FG000|Overall Study|Adverse Event|0|||
161627011|NCT01572493|583683999|FG001|Overall Study|Adverse Event|0|||
161627012|NCT01572493|583684000|FG002|Overall Study|Adverse Event|0|||
161627013|NCT01572493|583684001|FG003|Overall Study|Adverse Event|0|||
161627014|NCT01572493|583684002|FG004|Overall Study|Adverse Event|0|||
161627015|NCT01572493|583684003|FG005|Overall Study|Adverse Event|0|||
161627016|NCT01572493|583684004|FG006|Overall Study|Adverse Event|1|||
161627017|NCT01572493|583684005|FG007|Overall Study|Adverse Event|0|||
161627018|NCT01572493|583684006|FG008|Overall Study|Adverse Event|0|||
161627019|NCT00609245|583684007|FG000|Overall Study|Adverse Event|1|||
161627020|NCT01090076|583684008|FG000|Overall Study|Death|1|||
161627021|NCT01090076|583684009|FG001|Overall Study|Death|1|||
161627022|NCT01090076|583684008|FG000|Overall Study|Withdrawal by Subject|0|||
161627023|NCT01090076|583684009|FG001|Overall Study|Withdrawal by Subject|1|||
161627024|NCT03022045|583684010|FG000|Overall Study|Adverse Event|0|||
161627025|NCT03022045|583684011|FG001|Overall Study|Adverse Event|1|||
161627026|NCT03022045|583684010|FG000|Overall Study|Withdrawal by Subject|1|||
161627027|NCT03022045|583684011|FG001|Overall Study|Withdrawal by Subject|1|||
161627028|NCT01284634|583684014|FG000|Overall Study|Adverse Event|1|||
161627029|NCT01284634|583684015|FG001|Overall Study|Adverse Event|0|||
161627030|NCT01284634|583684016|FG002|Overall Study|Adverse Event|2|||
161627031|NCT01284634|583684017|FG003|Overall Study|Adverse Event|1|||
161627032|NCT03807700|583684018|FG000|Overall Study|Withdrawal by Subject|2|||
161627033|NCT03807700|583684019|FG001|Overall Study|Withdrawal by Subject|1|||
161627034|NCT03132753|583684023|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
161627035|NCT03132753|583684024|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
161627036|NCT03132753|583684023|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
161627037|NCT03132753|583684024|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
161627038|NCT00084747|583684025|FG000|Overall Study|Relapsed|8|||
161627039|NCT00084747|583684025|FG000|Overall Study|Death|3|||
161627040|NCT00084747|583684025|FG000|Overall Study|Withdrawal by Subject|2|||
161627041|NCT04203160|583684026|FG000|Overall Study|Alternative Therapy|3|||
161627042|NCT04203160|583684027|FG001|Overall Study|Alternative Therapy|0|||
161627043|NCT04203160|583684028|FG002|Overall Study|Alternative Therapy|1|||
161627044|NCT04203160|583684029|FG003|Overall Study|Alternative Therapy|0|||
161627045|NCT04203160|583684030|FG004|Overall Study|Alternative Therapy|0|||
161627046|NCT04203160|583684031|FG005|Overall Study|Alternative Therapy|2|||
161627047|NCT04203160|583684026|FG000|Overall Study|Withdrawal by Subject|4|||
161627048|NCT04203160|583684027|FG001|Overall Study|Withdrawal by Subject|5|||
161627049|NCT04203160|583684028|FG002|Overall Study|Withdrawal by Subject|0|||
161627050|NCT04203160|583684029|FG003|Overall Study|Withdrawal by Subject|0|||
161627051|NCT04203160|583684030|FG004|Overall Study|Withdrawal by Subject|0|||
161627052|NCT04203160|583684031|FG005|Overall Study|Withdrawal by Subject|4|||
161627053|NCT04203160|583684026|FG000|Overall Study|Adverse Event|7|||
161627054|NCT04203160|583684027|FG001|Overall Study|Adverse Event|5|||
161627055|NCT04203160|583684028|FG002|Overall Study|Adverse Event|0|||
161627056|NCT04203160|583684029|FG003|Overall Study|Adverse Event|0|||
161627057|NCT04203160|583684030|FG004|Overall Study|Adverse Event|0|||
161627058|NCT04203160|583684031|FG005|Overall Study|Adverse Event|0|||
161627059|NCT04203160|583684026|FG000|Overall Study|Sponsor Termination|1|||
161627060|NCT04203160|583684027|FG001|Overall Study|Sponsor Termination|0|||
161627061|NCT04203160|583684028|FG002|Overall Study|Sponsor Termination|0|||
161627062|NCT04203160|583684029|FG003|Overall Study|Sponsor Termination|0|||
161627063|NCT04203160|583684030|FG004|Overall Study|Sponsor Termination|0|||
161627064|NCT04203160|583684031|FG005|Overall Study|Sponsor Termination|0|||
161627065|NCT04203160|583684026|FG000|Overall Study|Physician Decision|3|||
161627066|NCT04203160|583684027|FG001|Overall Study|Physician Decision|2|||
161627067|NCT04203160|583684028|FG002|Overall Study|Physician Decision|0|||
161627068|NCT04203160|583684029|FG003|Overall Study|Physician Decision|0|||
161627069|NCT04203160|583684030|FG004|Overall Study|Physician Decision|0|||
161627070|NCT04203160|583684031|FG005|Overall Study|Physician Decision|0|||
161627071|NCT00679549|583684032|FG000|Overall Study|dropout|2|||
161627072|NCT00679549|583684033|FG001|Overall Study|dropout|4|||
161627073|NCT00679549|583684032|FG000|Overall Study|missing outcome echocardiograms|4|||
161627074|NCT00679549|583684033|FG001|Overall Study|missing outcome echocardiograms|5|||
161627075|NCT03048058|583684038|FG000|Overall Study|Lost to Follow-up|4|||
161627076|NCT03048058|583684039|FG001|Overall Study|Lost to Follow-up|0|||
161627077|NCT03048058|583684038|FG000|Overall Study|Withdrawal by Subject|0|||
161627078|NCT03048058|583684039|FG001|Overall Study|Withdrawal by Subject|4|||
161627079|NCT04150250|583684040|FG000|Overall Study|Lost to Follow-up|0|||
161627080|NCT04150250|583684041|FG001|Overall Study|Lost to Follow-up|2|||
161627081|NCT05379023|583684048|FG000|Overall Study|Lost to Follow-up|1|||
161627082|NCT05379023|583684049|FG001|Overall Study|Lost to Follow-up|0|||
161627083|NCT05379023|583684050|FG002|Overall Study|Lost to Follow-up|0|||
161627084|NCT05379023|583684048|FG000|Overall Study|Withdrawal by Subject|2|||
161627085|NCT05379023|583684049|FG001|Overall Study|Withdrawal by Subject|0|||
161627086|NCT05379023|583684050|FG002|Overall Study|Withdrawal by Subject|0|||
161627087|NCT05147662|583684051|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161627088|NCT05147662|583684051|FG000|Overall Study|Assigned to treatment but never treated|1|||
161627089|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
161627090|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
161627091|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
161627092|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
161627093|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
161627094|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161627095|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161627096|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161627097|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
161627098|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
161627099|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
161627100|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
161627101|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
161627102|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
161627103|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
161627104|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
161627105|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
161627106|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
161627107|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
161627108|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
161627109|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
161627110|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
161627111|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
161627112|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
161627113|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
161627114|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
161627115|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
161627116|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
161627117|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
161627118|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
161627119|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
161627120|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
161627121|NCT03602859|583684053|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
161627122|NCT03602859|583684054|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
161627123|NCT03602859|583684055|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
161627124|NCT03602859|583684056|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
161627125|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
161627126|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
161627127|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
161627128|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
161627129|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
161627130|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
161627131|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
161627132|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
161627133|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
161627134|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
161627135|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
161627136|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
161627137|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
161627138|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
161627139|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
161627140|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
161627141|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
161627142|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
161627143|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
161627144|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
161627145|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
161627146|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
161627147|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
161627148|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
161627149|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
161627150|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
161627151|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
161627152|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
161627153|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
161627154|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
161627155|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
161627156|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
161627157|NCT03602859|583684053|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
161627158|NCT03602859|583684054|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
161627159|NCT03602859|583684055|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
161627160|NCT03602859|583684056|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
161627161|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
161627162|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
161627163|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
161627164|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
161627165|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
161627166|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
161627167|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
161627168|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
161627169|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
161627170|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
161627171|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
161627172|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
161627173|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
161627174|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
161627175|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
161627176|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
161627177|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
161627178|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
161627179|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
161627180|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
161627181|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
161627182|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
161627183|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
161627184|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
161627185|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
161627186|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
161627187|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
161627188|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
161627189|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
161627190|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
161627191|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
161627192|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
161627193|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
161627194|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
161627195|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
161627196|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
161627197|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
161627198|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
161627199|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
161627200|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
161627201|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161627202|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161627203|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161627204|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
161627205|NCT03602859|583684053|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
161627206|NCT03602859|583684054|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
161627207|NCT03602859|583684055|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
161627208|NCT03602859|583684056|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
161627209|NCT00111839|583685132|FG000|Overall Study|Disease Progression|30|||
161627210|NCT00111839|583685133|FG001|Overall Study|Disease Progression|33|||
161627211|NCT00111839|583685134|FG002|Overall Study|Disease Progression|33|||
161627212|NCT00111839|583685132|FG000|Overall Study|Adverse Event|5|||
161627213|NCT00111839|583685133|FG001|Overall Study|Adverse Event|3|||
161627214|NCT00111839|583685134|FG002|Overall Study|Adverse Event|1|||
161627215|NCT00111839|583685132|FG000|Overall Study|Protocol Violation|2|||
161627216|NCT00111839|583685133|FG001|Overall Study|Protocol Violation|4|||
161627217|NCT00111839|583685134|FG002|Overall Study|Protocol Violation|2|||
161627218|NCT00111839|583685132|FG000|Overall Study|Death|1|||
161627219|NCT00111839|583685133|FG001|Overall Study|Death|1|||
161627220|NCT00111839|583685134|FG002|Overall Study|Death|6|||
161627221|NCT00111839|583685132|FG000|Overall Study|Withdrawal by Subject|2|||
161627222|NCT00111839|583685133|FG001|Overall Study|Withdrawal by Subject|2|||
161627223|NCT00111839|583685134|FG002|Overall Study|Withdrawal by Subject|2|||
161627224|NCT00111839|583685132|FG000|Overall Study|Lost to Follow-up|1|||
161627225|NCT00111839|583685133|FG001|Overall Study|Lost to Follow-up|0|||
161627226|NCT00111839|583685134|FG002|Overall Study|Lost to Follow-up|0|||
161627227|NCT00111839|583685132|FG000|Overall Study|Logistical Constraint|1|||
161833468|NCT04846881|584431138|FG001|Overall Study|Patient randomised in error|0|||
161833469|NCT01000610|584433131|FG000|Overall Study|Adverse Event|1|||
161627228|NCT00111839|583685133|FG001|Overall Study|Logistical Constraint|0|||
161627229|NCT00111839|583685134|FG002|Overall Study|Logistical Constraint|0|||
161627230|NCT00111839|583685132|FG000|Overall Study|Other|6|||
161627231|NCT00111839|583685133|FG001|Overall Study|Other|3|||
161627232|NCT00111839|583685134|FG002|Overall Study|Other|3|||
161627233|NCT00111839|583685132|FG000|Overall Study|Randomized but Not Treated|0|||
161627234|NCT00111839|583685133|FG001|Overall Study|Randomized but Not Treated|0|||
161627235|NCT00111839|583685134|FG002|Overall Study|Randomized but Not Treated|2|||
161627236|NCT00377312|583685135|FG000|Overall Study|Adverse Event|1|||
161627237|NCT00377312|583685136|FG001|Overall Study|Adverse Event|1|||
161627238|NCT03924947|583685139|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161627239|NCT03924947|583685140|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161627240|NCT03924947|583685141|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
161627241|NCT03924947|583685142|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161627242|NCT03924947|583685143|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161627243|NCT03924947|583685144|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161627244|NCT03451292|583685145|FG000|Overall Study|Death|44|||
161627245|NCT03451292|583685146|FG001|Overall Study|Death|59|||
161627246|NCT03451292|583685145|FG000|Overall Study|Withdrawal by Subject|18|||
161627247|NCT03451292|583685146|FG001|Overall Study|Withdrawal by Subject|13|||
161627248|NCT03451292|583685145|FG000|Overall Study|Transplantation|18|||
161627249|NCT03451292|583685146|FG001|Overall Study|Transplantation|12|||
161627250|NCT03451292|583685145|FG000|Overall Study|Lost to Follow-up|4|||
161627251|NCT03451292|583685146|FG001|Overall Study|Lost to Follow-up|12|||
161627252|NCT03451292|583685145|FG000|Overall Study|Physician Decision|4|||
161627253|NCT03451292|583685146|FG001|Overall Study|Physician Decision|3|||
161627254|NCT03451292|583685145|FG000|Overall Study|Adverse Event|3|||
161627255|NCT03451292|583685146|FG001|Overall Study|Adverse Event|3|||
161627256|NCT03451292|583685145|FG000|Overall Study|Non-compliance with Study Drug|2|||
161627257|NCT03451292|583685146|FG001|Overall Study|Non-compliance with Study Drug|0|||
161627258|NCT02176018|583685152|FG000|Overall Study|Adverse Event|0|||
161627259|NCT02176018|583685153|FG001|Overall Study|Adverse Event|2|||
161627260|NCT02176018|583685152|FG000|Overall Study|Lost to Follow-up|3|||
161627261|NCT02176018|583685153|FG001|Overall Study|Lost to Follow-up|1|||
161833470|NCT01000610|584433131|FG000|Overall Study|Lost to Follow-up|4|||
161627262|NCT02176018|583685152|FG000|Overall Study|Protocol Violation|1|||
161627263|NCT02176018|583685153|FG001|Overall Study|Protocol Violation|1|||
161627264|NCT02176018|583685152|FG000|Overall Study|Withdrawal by Subject|1|||
161627265|NCT02176018|583685153|FG001|Overall Study|Withdrawal by Subject|2|||
161627266|NCT02986659|583685155|FG000|First Intervention Period|Adverse Event|3|||
161833471|NCT01000610|584433131|FG000|Overall Study|Treatment failure|1|||
161627267|NCT02986659|583685156|FG001|First Intervention Period|Adverse Event|1|||
161627268|NCT02986659|583685155|FG000|First Intervention Period|Lost to Follow-up|1|||
161627269|NCT02986659|583685156|FG001|First Intervention Period|Lost to Follow-up|0|||
161627270|NCT02986659|583685155|FG000|First Intervention Period|Withdrawal by Subject|0|||
161627271|NCT02986659|583685156|FG001|First Intervention Period|Withdrawal by Subject|1|||
161627272|NCT02986659|583685155|FG000|Second Intervention Period|Adverse Event|0|||
161627273|NCT02986659|583685156|FG001|Second Intervention Period|Adverse Event|6|||
161627274|NCT02253147|583685157|FG000|Overall Study|Protocol Violation|30|||
161627275|NCT02253147|583685157|FG000|Overall Study|Did not consent to study extension|9|||
161627276|NCT02253147|583685157|FG000|Overall Study|Conditional re-treatment at W52|5|||
161627277|NCT02253147|583685157|FG000|Overall Study|Lost to Follow-up|2|||
161627278|NCT02253147|583685157|FG000|Overall Study|Withdrawal by Subject|1|||
161627279|NCT02973477|583685158|FG000|First Intervention|Lost to Follow-up|0|||
161627280|NCT02973477|583685159|FG001|First Intervention|Lost to Follow-up|2|||
161627281|NCT02973477|583685158|FG000|Washout|Withdrawal by Subject|1|||
161627282|NCT02973477|583685159|FG001|Washout|Withdrawal by Subject|0|||
161627283|NCT02973477|583685158|FG000|Second Intervention|Lost to Follow-up|1|||
161627284|NCT02973477|583685159|FG001|Second Intervention|Lost to Follow-up|0|||
161627285|NCT02402465|583685160|FG000|Overall Study|Withdrawal by Subject|0|||
161627286|NCT02402465|583685161|FG001|Overall Study|Withdrawal by Subject|0|||
161627287|NCT02402465|583685162|FG002|Overall Study|Withdrawal by Subject|0|||
161627288|NCT02402465|583685163|FG003|Overall Study|Withdrawal by Subject|0|||
161627289|NCT02402465|583685164|FG004|Overall Study|Withdrawal by Subject|0|||
161627290|NCT02402465|583685165|FG005|Overall Study|Withdrawal by Subject|1|||
161627291|NCT02402465|583685160|FG000|Overall Study|Lost to Follow-up|0|||
161627292|NCT02402465|583685161|FG001|Overall Study|Lost to Follow-up|1|||
161627293|NCT02402465|583685162|FG002|Overall Study|Lost to Follow-up|0|||
161627294|NCT02402465|583685163|FG003|Overall Study|Lost to Follow-up|0|||
161627295|NCT02402465|583685164|FG004|Overall Study|Lost to Follow-up|1|||
161627296|NCT02402465|583685165|FG005|Overall Study|Lost to Follow-up|0|||
161627297|NCT01059526|583685166|FG000|Overall Study|Patient enrolled but not treated|20|||
161627298|NCT01059526|583685167|FG001|Overall Study|Patient enrolled but not treated|17|||
161627299|NCT01059526|583685166|FG000|Overall Study|Adverse Event|2|||
161627300|NCT01059526|583685167|FG001|Overall Study|Adverse Event|2|||
161627301|NCT01059526|583685166|FG000|Overall Study|Protocol Violation|0|||
161627302|NCT01059526|583685167|FG001|Overall Study|Protocol Violation|1|||
161627303|NCT01059526|583685166|FG000|Overall Study|Withdrawal by Subject|3|||
161627304|NCT01059526|583685167|FG001|Overall Study|Withdrawal by Subject|1|||
161627305|NCT01059526|583685166|FG000|Overall Study|Lost to Follow-up|4|||
161627306|NCT01059526|583685167|FG001|Overall Study|Lost to Follow-up|1|||
161833472|NCT01010126|584433132|FG000|Overall Study|Withdrawal by Subject|1|||
161627307|NCT01059526|583685166|FG000|Overall Study|Patient found to be dermatographic|1|||
161627308|NCT01059526|583685167|FG001|Overall Study|Patient found to be dermatographic|0|||
161627309|NCT01732588|583685168|FG000|First Intervention (7 Days)|Adverse Event|0|||
161627310|NCT01732588|583685169|FG001|First Intervention (7 Days)|Adverse Event|1|||
161627311|NCT01732588|583685170|FG002|First Intervention (7 Days)|Adverse Event|0|||
161627312|NCT02720081|583685171|FG000|Overall Study|Adverse Event|0|||
161627313|NCT02720081|583685172|FG001|Overall Study|Adverse Event|3|||
161627314|NCT02720081|583685171|FG000|Overall Study|Protocol Violation|4|||
161627315|NCT02720081|583685172|FG001|Overall Study|Protocol Violation|1|||
161627316|NCT02504502|583685174|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
161627317|NCT02504502|583685175|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
161627318|NCT02504502|583685174|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
161627319|NCT02504502|583685175|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
161627320|NCT03042559|583685176|FG000|Overall Study|drop out|1|||
161627321|NCT03042559|583685177|FG001|Overall Study|drop out|1|||
161627322|NCT01536535|583685182|FG000|Overall Study|Withdrawal by Subject|10|||
161627323|NCT01536535|583685183|FG001|Overall Study|Withdrawal by Subject|5|||
161627324|NCT01536535|583685182|FG000|Overall Study|Lost to Follow-up|4|||
161627325|NCT01536535|583685183|FG001|Overall Study|Lost to Follow-up|6|||
161627326|NCT01536535|583685182|FG000|Overall Study|Physician Decision|1|||
161627327|NCT01536535|583685183|FG001|Overall Study|Physician Decision|1|||
161627328|NCT01536535|583685182|FG000|Overall Study|Participant moved|0|||
161627329|NCT01536535|583685183|FG001|Overall Study|Participant moved|1|||
161833473|NCT01010126|584433133|FG001|Overall Study|Withdrawal by Subject|0|||
161627330|NCT00428441|583685184|FG000|Overall Study|Lost to Follow-up|1|||
161627331|NCT00404547|583685185|FG000|Overall Study|Adverse Event|39|||
161627332|NCT00404547|583685186|FG001|Overall Study|Adverse Event|6|||
161627333|NCT00404547|583685185|FG000|Overall Study|Withdrawal by Subject|19|||
161627334|NCT00404547|583685186|FG001|Overall Study|Withdrawal by Subject|2|||
161627335|NCT00404547|583685185|FG000|Overall Study|Protocol Violation|0|||
161627336|NCT00404547|583685186|FG001|Overall Study|Protocol Violation|1|||
161627337|NCT00404547|583685185|FG000|Overall Study|Lost to Follow-up|20|||
161627338|NCT00404547|583685186|FG001|Overall Study|Lost to Follow-up|9|||
161627339|NCT00404547|583685185|FG000|Overall Study|Lack of compliance|5|||
161627340|NCT00404547|583685186|FG001|Overall Study|Lack of compliance|1|||
161627341|NCT00404547|583685185|FG000|Overall Study|Other|4|||
161627342|NCT00404547|583685186|FG001|Overall Study|Other|0|||
161627343|NCT00404547|583685185|FG000|Overall Study|Reason not stated|3|||
161627344|NCT00404547|583685186|FG001|Overall Study|Reason not stated|6|||
161627345|NCT01485991|583685187|FG000|Overall Study|Adverse Event|0|||
161627346|NCT01485991|583685188|FG001|Overall Study|Adverse Event|4|||
161627347|NCT01485991|583685187|FG000|Overall Study|Lost to Follow-up|13|||
161627348|NCT01485991|583685188|FG001|Overall Study|Lost to Follow-up|10|||
161627349|NCT01485991|583685187|FG000|Overall Study|Withdrawal by Subject|13|||
161627350|NCT01485991|583685188|FG001|Overall Study|Withdrawal by Subject|20|||
161627351|NCT01485991|583685187|FG000|Overall Study|randomized but not treated|6|||
161627352|NCT01485991|583685188|FG001|Overall Study|randomized but not treated|2|||
161627353|NCT01475370|583685189|FG000|Overall Study|Exacerbation of primary disease|2|||
161627354|NCT01475370|583685190|FG001|Overall Study|Exacerbation of primary disease|2|||
161627355|NCT01475370|583685191|FG002|Overall Study|Exacerbation of primary disease|2|||
161627356|NCT01475370|583685189|FG000|Overall Study|Study drug administration difficult|0|||
161627357|NCT01475370|583685190|FG001|Overall Study|Study drug administration difficult|1|||
161627358|NCT01475370|583685191|FG002|Overall Study|Study drug administration difficult|1|||
161627359|NCT01475370|583685189|FG000|Overall Study|Other than specified|1|||
161627360|NCT01475370|583685190|FG001|Overall Study|Other than specified|0|||
161627361|NCT01475370|583685191|FG002|Overall Study|Other than specified|0|||
161627362|NCT00125853|583685193|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
161627363|NCT00125853|583685194|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
161627364|NCT02744898|583685197|FG000|Overall Study|Progressive Disease|2|||
161627365|NCT02744898|583685197|FG000|Overall Study|Physician Decision|1|||
161627366|NCT02744898|583685197|FG000|Overall Study|Toxicity|1|||
161627367|NCT00157209|583685198|FG000|Overall Study|Ongoing at data cut-off|10|||
161627368|NCT00157209|583685199|FG001|Overall Study|Ongoing at data cut-off|0|||
161627369|NCT04474691|583685200|FG000|Overall Study|Withdrawal by Subject|9|||
161627370|NCT01348763|583685201|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
161627371|NCT01348763|583685201|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
161627372|NCT04372186|583685202|FG000|Overall Study|Death|24|||
161627373|NCT04372186|583685203|FG001|Overall Study|Death|11|||
161627374|NCT04372186|583685202|FG000|Overall Study|Transferred to a different facility for care|0|||
161627375|NCT04372186|583685203|FG001|Overall Study|Transferred to a different facility for care|2|||
161627376|NCT04736472|583685204|FG000|Overall Study|Lost to Follow-up|1|||
161627377|NCT04736472|583685205|FG001|Overall Study|Lost to Follow-up|0|||
161627378|NCT04736472|583685206|FG002|Overall Study|Lost to Follow-up|0|||
161627379|NCT04736472|583685204|FG000|Overall Study|Withdrawal by Subject|2|||
161627380|NCT04736472|583685205|FG001|Overall Study|Withdrawal by Subject|0|||
161627381|NCT04736472|583685206|FG002|Overall Study|Withdrawal by Subject|0|||
161627382|NCT04736472|583685204|FG000|Overall Study|Protocol Violation|48|||
161627383|NCT04736472|583685205|FG001|Overall Study|Protocol Violation|0|||
161627384|NCT04736472|583685206|FG002|Overall Study|Protocol Violation|6|||
161627385|NCT02268526|583685207|FG000|Overall Study|Adverse Event|0|||
161627386|NCT02268526|583685208|FG001|Overall Study|Adverse Event|2|||
161627387|NCT02268526|583685209|FG002|Overall Study|Adverse Event|1|||
161627388|NCT02268526|583685207|FG000|Overall Study|Death|1|||
161627389|NCT02268526|583685208|FG001|Overall Study|Death|11|||
161627390|NCT02268526|583685209|FG002|Overall Study|Death|0|||
161627391|NCT02268526|583685207|FG000|Overall Study|protocol deviation|0|||
161627392|NCT02268526|583685208|FG001|Overall Study|protocol deviation|1|||
161627393|NCT02268526|583685209|FG002|Overall Study|protocol deviation|0|||
161627394|NCT02268526|583685207|FG000|Overall Study|Physician Decision|0|||
161627395|NCT02268526|583685208|FG001|Overall Study|Physician Decision|0|||
161627396|NCT02268526|583685209|FG002|Overall Study|Physician Decision|1|||
161627397|NCT02268526|583685207|FG000|Overall Study|Subject/guardian decision|0|||
161627398|NCT02268526|583685208|FG001|Overall Study|Subject/guardian decision|7|||
161627399|NCT02268526|583685209|FG002|Overall Study|Subject/guardian decision|3|||
161627400|NCT00498797|583685212|FG000|Overall Study|Withdrawal by Subject|4|||
161627401|NCT00498797|583685213|FG001|Overall Study|Withdrawal by Subject|2|||
161627402|NCT00498797|583685212|FG000|Overall Study|Adverse Event|12|||
161627403|NCT00498797|583685213|FG001|Overall Study|Adverse Event|5|||
161627404|NCT00498797|583685212|FG000|Overall Study|Condition under investigation worsened|19|||
161627405|NCT00498797|583685213|FG001|Overall Study|Condition under investigation worsened|21|||
161627406|NCT00498797|583685212|FG000|Overall Study|Other|3|||
161627407|NCT00498797|583685213|FG001|Overall Study|Other|1|||
161627408|NCT00448344|583685217|FG000|Overall Study|Lost to Follow-up|20|||
161627409|NCT00448344|583685218|FG001|Overall Study|Lost to Follow-up|22|||
161627410|NCT00448344|583685217|FG000|Overall Study|Withdrawal by Subject|6|||
161627411|NCT00448344|583685218|FG001|Overall Study|Withdrawal by Subject|8|||
161627412|NCT00448344|583685217|FG000|Overall Study|Death|3|||
161627413|NCT00448344|583685218|FG001|Overall Study|Death|4|||
161627414|NCT00448344|583685217|FG000|Overall Study|Physician Decision|1|||
161627415|NCT00448344|583685218|FG001|Overall Study|Physician Decision|2|||
161627416|NCT01052714|583685224|FG000|Overall Study|Adverse Event|6|||
161627417|NCT01052714|583685225|FG001|Overall Study|Adverse Event|3|||
161627418|NCT01052714|583685226|FG002|Overall Study|Adverse Event|0|||
161627419|NCT01052714|583685224|FG000|Overall Study|Death|1|||
161627420|NCT01052714|583685225|FG001|Overall Study|Death|2|||
161627421|NCT01052714|583685226|FG002|Overall Study|Death|0|||
161627422|NCT01052714|583685224|FG000|Overall Study|Lost to Follow-up|2|||
161627423|NCT01052714|583685225|FG001|Overall Study|Lost to Follow-up|3|||
161627424|NCT01052714|583685226|FG002|Overall Study|Lost to Follow-up|0|||
161627425|NCT01052714|583685224|FG000|Overall Study|Physician Decision|9|||
161627426|NCT01052714|583685225|FG001|Overall Study|Physician Decision|9|||
161627427|NCT01052714|583685226|FG002|Overall Study|Physician Decision|1|||
161627428|NCT01052714|583685224|FG000|Overall Study|Withdrawal by Subject|7|||
161627429|NCT01052714|583685225|FG001|Overall Study|Withdrawal by Subject|12|||
161627430|NCT01052714|583685226|FG002|Overall Study|Withdrawal by Subject|1|||
161627431|NCT00417989|583685230|FG000|Overall Study|Withdrawal by Subject|13|||
161627432|NCT00417989|583685231|FG001|Overall Study|Withdrawal by Subject|13|||
161627433|NCT00417989|583685230|FG000|Overall Study|Lost to Follow-up|1|||
161627434|NCT00417989|583685231|FG001|Overall Study|Lost to Follow-up|6|||
161627435|NCT00417989|583685230|FG000|Overall Study|Protocol Violation|1|||
161627436|NCT00417989|583685231|FG001|Overall Study|Protocol Violation|0|||
161627437|NCT00417989|583685230|FG000|Overall Study|Death|0|||
161627438|NCT00417989|583685231|FG001|Overall Study|Death|1|||
161627439|NCT00417989|583685230|FG000|Overall Study|Physician Decision|5|||
161627440|NCT00417989|583685231|FG001|Overall Study|Physician Decision|2|||
161627441|NCT04212299|583685232|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
161627442|NCT02951052|583685233|FG000|Overall Study|Adverse Event|13|||
161627443|NCT02951052|583685234|FG001|Overall Study|Adverse Event|5|||
161627444|NCT02951052|583685233|FG000|Overall Study|Withdrawal by Subject|1|||
161627445|NCT02951052|583685234|FG001|Overall Study|Withdrawal by Subject|5|||
161627446|NCT02951052|583685233|FG000|Overall Study|Physician Decision|2|||
161627447|NCT02951052|583685234|FG001|Overall Study|Physician Decision|0|||
161627448|NCT02951052|583685233|FG000|Overall Study|Lost to Follow-up|1|||
161627449|NCT02951052|583685234|FG001|Overall Study|Lost to Follow-up|1|||
161627450|NCT02951052|583685233|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
161627451|NCT02951052|583685234|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
161627452|NCT02951052|583685233|FG000|Overall Study|Protocol Violation|5|||
161627453|NCT02951052|583685234|FG001|Overall Study|Protocol Violation|3|||
161627454|NCT02951052|583685233|FG000|Overall Study|Lack of Efficacy|3|||
161627455|NCT02951052|583685234|FG001|Overall Study|Lack of Efficacy|4|||
161627456|NCT02951052|583685233|FG000|Overall Study|Ongoing|1|||
161627457|NCT02951052|583685234|FG001|Overall Study|Ongoing|0|||
161627458|NCT00651937|583686768|FG000|Overall Study|Withdrawal by Subject|4|||
161627459|NCT00651937|583686769|FG001|Overall Study|Withdrawal by Subject|1|||
161627460|NCT01904019|583686772|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
161627461|NCT01904019|583686772|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
161627462|NCT01904019|583686772|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
161627463|NCT01904019|583686772|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
161627464|NCT01904019|583686772|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
161627465|NCT01904019|583686772|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
161627466|NCT00509821|583686773|FG000|Study Period 1 (Induction)|Death|0|||
161627467|NCT00509821|583686774|FG001|Study Period 1 (Induction)|Death|1|||
161627468|NCT00509821|583686773|FG000|Study Period 1 (Induction)|Adverse Event|0|||
161627469|NCT00509821|583686774|FG001|Study Period 1 (Induction)|Adverse Event|2|||
161627470|NCT00509821|583686773|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
161627471|NCT00509821|583686774|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
161627472|NCT00552513|583686775|FG000|Overall Study|Lost to Follow-up|5|||
161627473|NCT00552513|583686776|FG001|Overall Study|Lost to Follow-up|1|||
161627474|NCT01816685|583686779|FG000|Overall Study|Lost to Follow-up|7|||
161627475|NCT01816685|583686780|FG001|Overall Study|Lost to Follow-up|9|||
161627476|NCT01816685|583686779|FG000|Overall Study|Surgery Cancelled|3|||
161627477|NCT01816685|583686780|FG001|Overall Study|Surgery Cancelled|2|||
161627478|NCT01157351|583686781|FG000|Overall Study|Adverse Event|5|||
161627479|NCT01157351|583686782|FG001|Overall Study|Adverse Event|4|||
161627480|NCT01157351|583686781|FG000|Overall Study|Death|1|||
161627481|NCT01157351|583686782|FG001|Overall Study|Death|0|||
161627482|NCT01157351|583686781|FG000|Overall Study|Lost to Follow-up|53|||
161627483|NCT01157351|583686782|FG001|Overall Study|Lost to Follow-up|55|||
161627484|NCT01157351|583686781|FG000|Overall Study|Withdrawal by Subject|37|||
161627485|NCT01157351|583686782|FG001|Overall Study|Withdrawal by Subject|27|||
161627486|NCT01157351|583686781|FG000|Overall Study|Physician Decision|5|||
161627487|NCT01157351|583686782|FG001|Overall Study|Physician Decision|4|||
161627488|NCT01157351|583686781|FG000|Overall Study|Protocol Violation|0|||
161627489|NCT01157351|583686782|FG001|Overall Study|Protocol Violation|1|||
161833474|NCT01010126|584433134|FG002|Overall Study|Withdrawal by Subject|1|||
161627490|NCT01157351|583686781|FG000|Overall Study|Other|32|||
161627491|NCT01157351|583686782|FG001|Overall Study|Other|36|||
161627492|NCT01157351|583686781|FG000|Overall Study|Noncompliance with Study Drug|0|||
161627493|NCT01157351|583686782|FG001|Overall Study|Noncompliance with Study Drug|3|||
161627494|NCT01157351|583686781|FG000|Overall Study|Randomized but not Treated|4|||
161627495|NCT01157351|583686782|FG001|Overall Study|Randomized but not Treated|2|||
161627496|NCT01589523|583686783|FG000|Overall Study|Withdrawal by Subject|1|||
161627497|NCT00332488|583686784|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
161627498|NCT00332488|583686785|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
161627499|NCT00332488|583686786|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
161627500|NCT00332488|583686784|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
161627501|NCT00332488|583686785|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
161627502|NCT00332488|583686786|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
161627503|NCT00332488|583686784|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
161627504|NCT00332488|583686785|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
161627505|NCT00332488|583686786|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
161627506|NCT00332488|583686784|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
161627507|NCT00332488|583686785|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
161627508|NCT00332488|583686786|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
161627509|NCT00332488|583686784|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
161627510|NCT00332488|583686785|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
161627511|NCT00332488|583686786|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
161627512|NCT00332488|583686784|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
161627513|NCT00332488|583686785|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
161627514|NCT00332488|583686786|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
161627515|NCT00332488|583686784|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
161627516|NCT00332488|583686785|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
161627517|NCT00332488|583686786|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
161627518|NCT00332488|583686784|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
161627519|NCT00332488|583686785|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
161627520|NCT00332488|583686786|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
161627521|NCT00332488|583686784|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
161627522|NCT00332488|583686785|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
161627523|NCT00332488|583686786|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
161627524|NCT00332488|583686784|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
161627525|NCT00332488|583686785|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
161627526|NCT00332488|583686786|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
161627527|NCT00332488|583686784|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
161627528|NCT00332488|583686785|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
161627529|NCT00332488|583686786|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
161627530|NCT00332488|583686784|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
161627531|NCT00332488|583686785|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
161627532|NCT00332488|583686786|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
161627533|NCT00792259|583686787|FG000|Overall Study|Poor Quality Scans|1|||
161627534|NCT00792259|583686788|FG001|Overall Study|Poor Quality Scans|0|||
161627535|NCT00792259|583686789|FG002|Overall Study|Poor Quality Scans|0|||
161627536|NCT00371462|583686790|FG000|Overall Study|Withdrawal by Subject|1|||
161627537|NCT00371462|583686791|FG001|Overall Study|Withdrawal by Subject|0|||
161627538|NCT00371462|583686790|FG000|Overall Study|Other|7|||
161627539|NCT00371462|583686791|FG001|Overall Study|Other|8|||
161627540|NCT03721978|583686792|FG000|Overall Study|Withdrawal by Subject|6|||
161627541|NCT03721978|583686793|FG001|Overall Study|Withdrawal by Subject|1|||
161627542|NCT03721978|583686792|FG000|Overall Study|Adverse Event|1|||
161627543|NCT03721978|583686793|FG001|Overall Study|Adverse Event|1|||
161627544|NCT03721978|583686792|FG000|Overall Study|Progressive Disease|1|||
161627545|NCT03721978|583686793|FG001|Overall Study|Progressive Disease|0|||
161685216|NCT03021499|583899723|FG000|Overall Study|Lost to Follow-up|1|||
161685217|NCT03021499|583899724|FG001|Overall Study|Lost to Follow-up|3|||
161685218|NCT03021499|583899723|FG000|Overall Study|Physician Decision|2|||
161685219|NCT03021499|583899724|FG001|Overall Study|Physician Decision|3|||
161685220|NCT03021499|583899723|FG000|Overall Study|Pregnancy|1|||
161627546|NCT03721978|583686792|FG000|Overall Study|Lost to Follow-up|5|||
161627547|NCT03721978|583686793|FG001|Overall Study|Lost to Follow-up|1|||
161627548|NCT03721978|583686792|FG000|Overall Study|Reason not Specified|0|||
161685221|NCT03021499|583899724|FG001|Overall Study|Pregnancy|0|||
161833475|NCT01010126|584433135|FG003|Overall Study|Withdrawal by Subject|0|||
161627549|NCT03721978|583686793|FG001|Overall Study|Reason not Specified|2|||
161627550|NCT02675998|583686794|FG000|8-Week Treatment Period|Adverse Event|6|||
161627551|NCT02675998|583686795|FG001|8-Week Treatment Period|Adverse Event|5|||
161627552|NCT02675998|583686796|FG002|8-Week Treatment Period|Adverse Event|6|||
161833476|NCT01010126|584433136|FG004|Overall Study|Withdrawal by Subject|3|||
161685222|NCT03021499|583899723|FG000|Overall Study|Withdrawal by Subject|7|||
161685223|NCT03021499|583899724|FG001|Overall Study|Withdrawal by Subject|14|||
161833477|NCT01010126|584433137|FG005|Overall Study|Withdrawal by Subject|0|||
161627553|NCT02675998|583686797|FG003|8-Week Treatment Period|Adverse Event|0|||
161627554|NCT02675998|583686794|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
161627555|NCT02675998|583686795|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
161627556|NCT02675998|583686796|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
161627557|NCT02675998|583686797|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
161627558|NCT02675998|583686794|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
161627559|NCT02675998|583686795|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
161627560|NCT02675998|583686796|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
161627561|NCT02675998|583686797|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
161627562|NCT02675998|583686794|FG000|8-Week Treatment Period|Physician Decision|1|||
161627563|NCT02675998|583686795|FG001|8-Week Treatment Period|Physician Decision|0|||
161627564|NCT02675998|583686796|FG002|8-Week Treatment Period|Physician Decision|2|||
161627565|NCT02675998|583686797|FG003|8-Week Treatment Period|Physician Decision|0|||
161627566|NCT02675998|583686794|FG000|8-Week Treatment Period|GI side Effects|1|||
161627567|NCT02675998|583686795|FG001|8-Week Treatment Period|GI side Effects|4|||
161627568|NCT02675998|583686796|FG002|8-Week Treatment Period|GI side Effects|2|||
161627569|NCT02675998|583686797|FG003|8-Week Treatment Period|GI side Effects|0|||
161627570|NCT02675998|583686794|FG000|8-Week Treatment Period|Protocol Violation|1|||
161627571|NCT02675998|583686795|FG001|8-Week Treatment Period|Protocol Violation|1|||
161627572|NCT02675998|583686796|FG002|8-Week Treatment Period|Protocol Violation|1|||
161627573|NCT02675998|583686797|FG003|8-Week Treatment Period|Protocol Violation|0|||
161685224|NCT03021499|583899723|FG000|Overall Study|Prohibited medication required|1|||
161685225|NCT03021499|583899724|FG001|Overall Study|Prohibited medication required|0|||
161685226|NCT03021499|583899723|FG000|Overall Study|Protocol non-compliance|1|||
161685227|NCT03021499|583899724|FG001|Overall Study|Protocol non-compliance|1|||
161685228|NCT03021499|583899723|FG000|Overall Study|None of the above|0|||
161685229|NCT03021499|583899724|FG001|Overall Study|None of the above|4|||
161685230|NCT03021499|583899723|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
161833478|NCT04495283|584433140|FG000|Overall Study|Physician Decision|0|||
161833479|NCT04495283|584433141|FG001|Overall Study|Physician Decision|0|||
161833480|NCT04495283|584433142|FG002|Overall Study|Physician Decision|1|||
161833481|NCT04495283|584433140|FG000|Overall Study|Withdrawal by Subject|0|||
161627574|NCT02675998|583686794|FG000|8-Week Treatment Period|Other|3|||
161627575|NCT02675998|583686795|FG001|8-Week Treatment Period|Other|1|||
161627576|NCT02675998|583686796|FG002|8-Week Treatment Period|Other|2|||
161685231|NCT03021499|583899724|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
161685232|NCT00495820|583899725|FG000|Overall Study|Adverse Event|1|||
161627577|NCT02675998|583686797|FG003|8-Week Treatment Period|Other|0|||
161627578|NCT02675998|583686794|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
161833482|NCT04495283|584433141|FG001|Overall Study|Withdrawal by Subject|1|||
161627579|NCT02675998|583686795|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
161627580|NCT02675998|583686796|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
161627581|NCT02675998|583686797|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
161627582|NCT02675998|583686794|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
161627583|NCT02675998|583686795|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
161627584|NCT02675998|583686796|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
161627585|NCT02675998|583686797|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
161627586|NCT02675998|583686794|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161627587|NCT02675998|583686795|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161627588|NCT02675998|583686796|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161685233|NCT00495820|583899726|FG001|Overall Study|Adverse Event|1|||
161685234|NCT00820950|583899727|FG000|Overall Study|Scheduling Conflict|0|||
161685235|NCT00820950|583899728|FG001|Overall Study|Scheduling Conflict|0|||
161685236|NCT00820950|583899729|FG002|Overall Study|Scheduling Conflict|0|||
161685237|NCT00820950|583899730|FG003|Overall Study|Scheduling Conflict|0|||
161685238|NCT00820950|583899731|FG004|Overall Study|Scheduling Conflict|0|||
161685239|NCT00820950|583899732|FG005|Overall Study|Scheduling Conflict|0|||
161685240|NCT00820950|583899733|FG006|Overall Study|Scheduling Conflict|1|||
161685241|NCT00820950|583899734|FG007|Overall Study|Scheduling Conflict|1|||
161685242|NCT00820950|583899735|FG008|Overall Study|Scheduling Conflict|0|||
161685243|NCT00820950|583899736|FG009|Overall Study|Scheduling Conflict|0|||
161685244|NCT00820950|583899727|FG000|Overall Study|Protocol Violation|1|||
161685245|NCT00820950|583899728|FG001|Overall Study|Protocol Violation|1|||
161685246|NCT00820950|583899729|FG002|Overall Study|Protocol Violation|0|||
161685247|NCT00820950|583899730|FG003|Overall Study|Protocol Violation|0|||
161685248|NCT00820950|583899731|FG004|Overall Study|Protocol Violation|0|||
161685249|NCT00820950|583899732|FG005|Overall Study|Protocol Violation|0|||
161685250|NCT00820950|583899733|FG006|Overall Study|Protocol Violation|0|||
161685251|NCT00820950|583899734|FG007|Overall Study|Protocol Violation|0|||
161685252|NCT00820950|583899735|FG008|Overall Study|Protocol Violation|0|||
161685253|NCT00820950|583899736|FG009|Overall Study|Protocol Violation|0|||
161627589|NCT02675998|583686797|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
161627590|NCT02675998|583686794|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
161627591|NCT02675998|583686795|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
161627592|NCT02675998|583686796|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
161627593|NCT02675998|583686797|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
161627594|NCT02675998|583686794|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
161627595|NCT02675998|583686795|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
161627596|NCT02675998|583686796|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
161627597|NCT02675998|583686797|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
161627598|NCT02561078|583686806|FG000|Overall Study|Adverse Event|5|||
161627599|NCT02561078|583686807|FG001|Overall Study|Adverse Event|2|||
161627600|NCT02561078|583686806|FG000|Overall Study|Death|2|||
161627601|NCT02561078|583686807|FG001|Overall Study|Death|1|||
161627602|NCT02561078|583686806|FG000|Overall Study|Lost to Follow-up|2|||
161627603|NCT02561078|583686807|FG001|Overall Study|Lost to Follow-up|6|||
161627604|NCT02561078|583686806|FG000|Overall Study|Non-Compliance with Study Drug|6|||
161627605|NCT02561078|583686807|FG001|Overall Study|Non-Compliance with Study Drug|3|||
161627606|NCT02561078|583686806|FG000|Overall Study|Physician Decision|2|||
161627607|NCT02561078|583686807|FG001|Overall Study|Physician Decision|3|||
161627608|NCT02561078|583686806|FG000|Overall Study|Withdrawal by Subject|13|||
161627609|NCT02561078|583686807|FG001|Overall Study|Withdrawal by Subject|10|||
161627610|NCT00598871|583686808|FG000|Overall Study|Adverse Event|0|||
161627611|NCT00598871|583686809|FG001|Overall Study|Adverse Event|1|||
161627612|NCT01194271|583686810|FG000|Overall Study|Withdrawal by Subject|1|||
161627613|NCT01194271|583686810|FG000|Overall Study|Ineligible, Screen Failure|1|||
161627614|NCT01194271|583686810|FG000|Overall Study|Death|1|||
161627615|NCT00443898|583686811|FG000|Overall Study|Adverse Event|0|||
161627616|NCT00443898|583686812|FG001|Overall Study|Adverse Event|0|||
161627617|NCT00443898|583686813|FG002|Overall Study|Adverse Event|1|||
161627618|NCT00443898|583686814|FG003|Overall Study|Adverse Event|1|||
161627619|NCT00443898|583686811|FG000|Overall Study|Lack of Efficacy|2|||
161627620|NCT00443898|583686812|FG001|Overall Study|Lack of Efficacy|3|||
161627621|NCT00443898|583686813|FG002|Overall Study|Lack of Efficacy|3|||
161627622|NCT00443898|583686814|FG003|Overall Study|Lack of Efficacy|1|||
161627623|NCT00443898|583686811|FG000|Overall Study|Protocol Violation|1|||
161627624|NCT00443898|583686812|FG001|Overall Study|Protocol Violation|1|||
161627625|NCT00443898|583686813|FG002|Overall Study|Protocol Violation|1|||
161627626|NCT00443898|583686814|FG003|Overall Study|Protocol Violation|0|||
161627627|NCT00443898|583686811|FG000|Overall Study|Withdrawal by Subject|11|||
161627628|NCT00443898|583686812|FG001|Overall Study|Withdrawal by Subject|10|||
161627629|NCT00443898|583686813|FG002|Overall Study|Withdrawal by Subject|10|||
161627630|NCT00443898|583686814|FG003|Overall Study|Withdrawal by Subject|6|||
161627631|NCT00443898|583686811|FG000|Overall Study|Lost to Follow-up|10|||
161627632|NCT00443898|583686812|FG001|Overall Study|Lost to Follow-up|10|||
161627633|NCT00443898|583686813|FG002|Overall Study|Lost to Follow-up|14|||
161627634|NCT00443898|583686814|FG003|Overall Study|Lost to Follow-up|10|||
161627635|NCT00443898|583686811|FG000|Overall Study|Death|0|||
161627636|NCT00443898|583686812|FG001|Overall Study|Death|1|||
161627637|NCT00443898|583686813|FG002|Overall Study|Death|0|||
161627638|NCT00443898|583686814|FG003|Overall Study|Death|0|||
161627639|NCT00043186|583686815|FG000|Overall Study|Physician Decision|0|||
161627640|NCT00043186|583686816|FG001|Overall Study|Physician Decision|0|||
161627641|NCT00043186|583686817|FG002|Overall Study|Physician Decision|3|||
161627642|NCT00043186|583686818|FG003|Overall Study|Physician Decision|0|||
161627643|NCT00043186|583686819|FG004|Overall Study|Physician Decision|1|||
161627644|NCT00043186|583686820|FG005|Overall Study|Physician Decision|0|||
161627645|NCT00043186|583686821|FG006|Overall Study|Physician Decision|0|||
161627646|NCT00043186|583686822|FG007|Overall Study|Physician Decision|1|||
161627647|NCT00043186|583686823|FG008|Overall Study|Physician Decision|1|||
161627648|NCT00043186|583686815|FG000|Overall Study|Adverse Event|2|||
161627649|NCT00043186|583686816|FG001|Overall Study|Adverse Event|2|||
161627650|NCT00043186|583686817|FG002|Overall Study|Adverse Event|2|||
161627651|NCT00043186|583686818|FG003|Overall Study|Adverse Event|3|||
161627652|NCT00043186|583686819|FG004|Overall Study|Adverse Event|2|||
161627653|NCT00043186|583686820|FG005|Overall Study|Adverse Event|1|||
161627654|NCT00043186|583686821|FG006|Overall Study|Adverse Event|2|||
161627655|NCT00043186|583686822|FG007|Overall Study|Adverse Event|1|||
161627656|NCT00043186|583686823|FG008|Overall Study|Adverse Event|3|||
161627657|NCT00043186|583686815|FG000|Overall Study|Withdrawal by Subject|11|||
161627658|NCT00043186|583686816|FG001|Overall Study|Withdrawal by Subject|8|||
161627659|NCT00043186|583686817|FG002|Overall Study|Withdrawal by Subject|11|||
161627660|NCT00043186|583686818|FG003|Overall Study|Withdrawal by Subject|13|||
161627661|NCT00043186|583686819|FG004|Overall Study|Withdrawal by Subject|14|||
161627662|NCT00043186|583686820|FG005|Overall Study|Withdrawal by Subject|6|||
161627663|NCT00043186|583686821|FG006|Overall Study|Withdrawal by Subject|12|||
161627664|NCT00043186|583686822|FG007|Overall Study|Withdrawal by Subject|9|||
161627665|NCT00043186|583686823|FG008|Overall Study|Withdrawal by Subject|10|||
161627666|NCT00043186|583686815|FG000|Overall Study|Death|0|||
161627667|NCT00043186|583686816|FG001|Overall Study|Death|0|||
161627668|NCT00043186|583686817|FG002|Overall Study|Death|1|||
161627669|NCT00043186|583686818|FG003|Overall Study|Death|0|||
161627670|NCT00043186|583686819|FG004|Overall Study|Death|0|||
161627671|NCT00043186|583686820|FG005|Overall Study|Death|0|||
161627672|NCT00043186|583686821|FG006|Overall Study|Death|2|||
161627673|NCT00043186|583686822|FG007|Overall Study|Death|0|||
161627674|NCT00043186|583686823|FG008|Overall Study|Death|0|||
161627675|NCT00043186|583686815|FG000|Overall Study|Disease progression|1|||
161627676|NCT00043186|583686816|FG001|Overall Study|Disease progression|0|||
161627677|NCT00043186|583686817|FG002|Overall Study|Disease progression|0|||
161627678|NCT00043186|583686818|FG003|Overall Study|Disease progression|3|||
161627679|NCT00043186|583686819|FG004|Overall Study|Disease progression|0|||
161627680|NCT00043186|583686820|FG005|Overall Study|Disease progression|0|||
161627681|NCT00043186|583686821|FG006|Overall Study|Disease progression|0|||
161627682|NCT00043186|583686822|FG007|Overall Study|Disease progression|4|||
161627683|NCT00043186|583686823|FG008|Overall Study|Disease progression|0|||
161627684|NCT00043186|583686815|FG000|Overall Study|Ineligibility determined|0|||
161627685|NCT00043186|583686816|FG001|Overall Study|Ineligibility determined|0|||
161627686|NCT00043186|583686817|FG002|Overall Study|Ineligibility determined|0|||
161627687|NCT00043186|583686818|FG003|Overall Study|Ineligibility determined|0|||
161627688|NCT00043186|583686819|FG004|Overall Study|Ineligibility determined|0|||
161627689|NCT00043186|583686820|FG005|Overall Study|Ineligibility determined|0|||
161627690|NCT00043186|583686821|FG006|Overall Study|Ineligibility determined|0|||
161627691|NCT00043186|583686822|FG007|Overall Study|Ineligibility determined|0|||
161627692|NCT00043186|583686823|FG008|Overall Study|Ineligibility determined|1|||
161627693|NCT00043186|583686815|FG000|Overall Study|Lost to Follow-up|3|||
161627694|NCT00043186|583686816|FG001|Overall Study|Lost to Follow-up|5|||
161627695|NCT00043186|583686817|FG002|Overall Study|Lost to Follow-up|1|||
161627696|NCT00043186|583686818|FG003|Overall Study|Lost to Follow-up|1|||
161627697|NCT00043186|583686819|FG004|Overall Study|Lost to Follow-up|1|||
161627698|NCT00043186|583686820|FG005|Overall Study|Lost to Follow-up|1|||
161627699|NCT00043186|583686821|FG006|Overall Study|Lost to Follow-up|1|||
161627700|NCT00043186|583686822|FG007|Overall Study|Lost to Follow-up|1|||
161627701|NCT00043186|583686823|FG008|Overall Study|Lost to Follow-up|2|||
161627702|NCT00043186|583686815|FG000|Overall Study|Noncompliance|0|||
161627703|NCT00043186|583686816|FG001|Overall Study|Noncompliance|0|||
161627704|NCT00043186|583686817|FG002|Overall Study|Noncompliance|1|||
161627705|NCT00043186|583686818|FG003|Overall Study|Noncompliance|1|||
161627706|NCT00043186|583686819|FG004|Overall Study|Noncompliance|0|||
161627707|NCT00043186|583686820|FG005|Overall Study|Noncompliance|0|||
161627708|NCT00043186|583686821|FG006|Overall Study|Noncompliance|0|||
161627709|NCT00043186|583686822|FG007|Overall Study|Noncompliance|0|||
161685254|NCT05885737|583899739|FG000|DB Period|Adverse Event|4|||
161685255|NCT05885737|583899740|FG001|DB Period|Adverse Event|4|||
161685256|NCT05885737|583899739|FG000|DB Period|Lost to Follow-up|0|||
161685257|NCT05885737|583899740|FG001|DB Period|Lost to Follow-up|1|||
161685258|NCT05885737|583899739|FG000|DB Period|Physician Decision|2|||
161685259|NCT05885737|583899740|FG001|DB Period|Physician Decision|0|||
161685260|NCT05885737|583899739|FG000|DB Period|Withdrawal by Subject|12|||
161685261|NCT05885737|583899740|FG001|DB Period|Withdrawal by Subject|6|||
161685262|NCT05885737|583899739|FG000|DB Period|Other: Unspecified|2|||
161627710|NCT00043186|583686823|FG008|Overall Study|Noncompliance|0|||
161627711|NCT00043186|583686815|FG000|Overall Study|Other|0|||
161627712|NCT00043186|583686816|FG001|Overall Study|Other|0|||
161627713|NCT00043186|583686817|FG002|Overall Study|Other|1|||
161627714|NCT00043186|583686818|FG003|Overall Study|Other|1|||
161627715|NCT00043186|583686819|FG004|Overall Study|Other|0|||
161627716|NCT00043186|583686820|FG005|Overall Study|Other|0|||
161627717|NCT00043186|583686821|FG006|Overall Study|Other|0|||
161627718|NCT00043186|583686822|FG007|Overall Study|Other|0|||
161627719|NCT00043186|583686823|FG008|Overall Study|Other|0|||
161627720|NCT01350102|583686831|FG000|Overall Study|Adverse Event|0|||
161627721|NCT01350102|583686832|FG001|Overall Study|Adverse Event|0|||
161627722|NCT01350102|583686833|FG002|Overall Study|Adverse Event|1|||
161627723|NCT01350102|583686834|FG003|Overall Study|Adverse Event|0|||
161627724|NCT00550771|583686835|FG000|Overall Study|Adverse Event|11|||
161685263|NCT05885737|583899740|FG001|DB Period|Other: Unspecified|2|||
161685264|NCT05885737|583899739|FG000|OLE Period|Adverse Event|3|||
161627725|NCT00550771|583686836|FG001|Overall Study|Adverse Event|3|||
161627726|NCT00550771|583686835|FG000|Overall Study|Discontinued for study-related reasons|0|||
161685265|NCT05885737|583899740|FG001|OLE Period|Adverse Event|2|||
161685266|NCT05885737|583899739|FG000|OLE Period|Physician Decision|1|||
161627727|NCT00550771|583686836|FG001|Overall Study|Discontinued for study-related reasons|1|||
161627728|NCT00550771|583686835|FG000|Overall Study|Physician Decision|2|||
161627729|NCT00550771|583686836|FG001|Overall Study|Physician Decision|0|||
161627730|NCT00550771|583686835|FG000|Overall Study|Withdrawal by Subject|0|||
161627731|NCT00550771|583686836|FG001|Overall Study|Withdrawal by Subject|1|||
161627732|NCT00550771|583686835|FG000|Overall Study|Protocol Violation|4|||
161627733|NCT00550771|583686836|FG001|Overall Study|Protocol Violation|5|||
161627734|NCT03681353|583686839|FG000|Overall Study|Lost to Follow-up|2|||
161627735|NCT03681353|583686839|FG000|Overall Study|Withdrawal by Subject|3|||
161627736|NCT03681353|583686839|FG000|Overall Study|withdrawn by PI|2|||
161627737|NCT00726388|583686842|FG000|Overall Study|Withdrawal by Subject|5|||
161627738|NCT00726388|583686842|FG000|Overall Study|Adverse Event|3|||
161627739|NCT00726388|583686842|FG000|Overall Study|Lost to Follow-up|10|||
161627740|NCT00726388|583686842|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
161627741|NCT00726388|583686842|FG000|Overall Study|Other|5|||
161627742|NCT00726388|583686842|FG000|Overall Study|Enrolled, Not Treated|79|||
161627743|NCT01145417|583686846|FG000|Overall Study|Death|1|||
161627744|NCT01145417|583686847|FG001|Overall Study|Death|0|||
161627745|NCT01145417|583686846|FG000|Overall Study|Lost to Follow-up|2|||
161627746|NCT01145417|583686847|FG001|Overall Study|Lost to Follow-up|1|||
161627747|NCT01145417|583686846|FG000|Overall Study|Withdrawal by Subject|1|||
161627748|NCT01145417|583686847|FG001|Overall Study|Withdrawal by Subject|2|||
161627749|NCT01145417|583686846|FG000|Overall Study|Pregnancy|1|||
161627750|NCT01145417|583686847|FG001|Overall Study|Pregnancy|0|||
161627751|NCT01145417|583686846|FG000|Overall Study|Adverse Event|0|||
161627752|NCT01145417|583686847|FG001|Overall Study|Adverse Event|1|||
161627753|NCT01145417|583686846|FG000|Overall Study|Study terminated by sponsor|35|||
161627754|NCT01145417|583686847|FG001|Overall Study|Study terminated by sponsor|43|||
161627755|NCT01145417|583686846|FG000|Overall Study|Other|1|||
161627756|NCT01145417|583686847|FG001|Overall Study|Other|0|||
161627757|NCT01441583|583686848|FG000|Overall Study|Withdrawal by Subject|1|||
161627758|NCT01441583|583686849|FG001|Overall Study|Withdrawal by Subject|1|||
161627759|NCT01441583|583686850|FG002|Overall Study|Withdrawal by Subject|1|||
161627760|NCT01441583|583686848|FG000|Overall Study|Death|1|||
161627761|NCT01441583|583686849|FG001|Overall Study|Death|0|||
161627762|NCT01441583|583686850|FG002|Overall Study|Death|4|||
161627763|NCT01441583|583686848|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
161627764|NCT01441583|583686849|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
161627765|NCT01441583|583686850|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
161627766|NCT03275402|583686851|FG000|Overall Study|Death|17|||
161627767|NCT03275402|583686851|FG000|Overall Study|Study terminated by sponsor|21|||
161627768|NCT03275402|583686851|FG000|Overall Study|Withdrawal by Subject|1|||
161627769|NCT02469077|583686853|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
161627770|NCT02469077|583686854|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
161627771|NCT02469077|583686853|FG000|Post Randomization/Intervention Period|Relocated|1|||
161627772|NCT02469077|583686854|FG001|Post Randomization/Intervention Period|Relocated|1|||
161627773|NCT02469077|583686853|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
161627774|NCT02469077|583686854|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
161627775|NCT02469077|583686853|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
161627776|NCT02469077|583686854|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
161627777|NCT05012397|583686855|FG000|Overall Study|Death|10|||
161685267|NCT05885737|583899740|FG001|OLE Period|Physician Decision|0|||
161685268|NCT05885737|583899739|FG000|OLE Period|Withdrawal by Subject|5|||
161685269|NCT05885737|583899740|FG001|OLE Period|Withdrawal by Subject|5|||
161685270|NCT05885737|583899739|FG000|OLE Period|Other: Unspecified|2|||
161685271|NCT05885737|583899740|FG001|OLE Period|Other: Unspecified|1|||
161685272|NCT03927105|583901822|FG000|Overall Study|Death|1|||
161685273|NCT03927105|583901822|FG000|Overall Study|In observation for potential re-treatment|2|||
161627778|NCT05012397|583686855|FG000|Overall Study|Physician Decision|9|||
161627779|NCT05012397|583686855|FG000|Overall Study|Withdrawal by Subject|5|||
161627780|NCT05012397|583686855|FG000|Overall Study|Lost to Follow-up|2|||
161627781|NCT03334747|583686856|FG000|Treatment Phase|Technical problems|0|||
161627782|NCT03334747|583686857|FG001|Treatment Phase|Technical problems|0|||
161627783|NCT03334747|583686858|FG002|Treatment Phase|Technical problems|0|||
161627784|NCT03334747|583686859|FG003|Treatment Phase|Technical problems|0|||
161627785|NCT03334747|583686860|FG004|Treatment Phase|Technical problems|1|||
161627786|NCT03334747|583686861|FG005|Treatment Phase|Technical problems|0|||
161627787|NCT03334747|583686862|FG006|Treatment Phase|Technical problems|0|||
161627788|NCT03334747|583686863|FG007|Treatment Phase|Technical problems|0|||
161685274|NCT03927105|583901822|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
161685275|NCT00789529|583901823|FG000|Overall Study|Withdrawal by Subject|0|||
161685276|NCT00789529|583901824|FG001|Overall Study|Withdrawal by Subject|1|||
161685277|NCT00789529|583901823|FG000|Overall Study|Other Reason|1|||
161685278|NCT00789529|583901824|FG001|Overall Study|Other Reason|0|||
161685279|NCT01870401|583901825|FG000|Overall Study|Death|48|||
161685280|NCT01870401|583901826|FG001|Overall Study|Death|24|||
161685281|NCT01870401|583901825|FG000|Overall Study|Withdrawal by Subject|39|||
161685282|NCT01870401|583901826|FG001|Overall Study|Withdrawal by Subject|26|||
161685283|NCT01870401|583901825|FG000|Overall Study|Lost to Follow-up|19|||
161627789|NCT03334747|583686864|FG008|Treatment Phase|Technical problems|0|||
161685284|NCT01870401|583901826|FG001|Overall Study|Lost to Follow-up|14|||
161685285|NCT01870401|583901825|FG000|Overall Study|Other|9|||
161685286|NCT01870401|583901826|FG001|Overall Study|Other|7|||
161685287|NCT01870401|583901825|FG000|Overall Study|On-going in the Study|35|||
161627790|NCT03334747|583686856|FG000|Treatment Phase|Subject/guardian decision|1|||
161627791|NCT03334747|583686857|FG001|Treatment Phase|Subject/guardian decision|0|||
161627792|NCT03334747|583686858|FG002|Treatment Phase|Subject/guardian decision|0|||
161627793|NCT03334747|583686859|FG003|Treatment Phase|Subject/guardian decision|0|||
161627794|NCT03334747|583686860|FG004|Treatment Phase|Subject/guardian decision|0|||
161627795|NCT03334747|583686861|FG005|Treatment Phase|Subject/guardian decision|1|||
161627796|NCT03334747|583686862|FG006|Treatment Phase|Subject/guardian decision|0|||
161627797|NCT03334747|583686863|FG007|Treatment Phase|Subject/guardian decision|0|||
161627798|NCT03334747|583686864|FG008|Treatment Phase|Subject/guardian decision|0|||
161627799|NCT03334747|583686856|FG000|Follow-Up Phase|Subject/guardian decision|0|||
161627800|NCT03334747|583686857|FG001|Follow-Up Phase|Subject/guardian decision|0|||
161627801|NCT03334747|583686858|FG002|Follow-Up Phase|Subject/guardian decision|0|||
161627802|NCT03334747|583686859|FG003|Follow-Up Phase|Subject/guardian decision|0|||
161627803|NCT03334747|583686860|FG004|Follow-Up Phase|Subject/guardian decision|0|||
161627804|NCT03334747|583686861|FG005|Follow-Up Phase|Subject/guardian decision|0|||
161627805|NCT03334747|583686862|FG006|Follow-Up Phase|Subject/guardian decision|1|||
161627806|NCT03334747|583686863|FG007|Follow-Up Phase|Subject/guardian decision|0|||
161627807|NCT03334747|583686864|FG008|Follow-Up Phase|Subject/guardian decision|1|||
161627808|NCT00191984|583686865|FG000|Overall Study|Disease Progression|21|||
161627809|NCT00191984|583686865|FG000|Overall Study|Adverse Event|4|||
161627810|NCT00191984|583686865|FG000|Overall Study|Death|2|||
161627811|NCT00191984|583686865|FG000|Overall Study|Entry Criteria Exclusion|1|||
161627812|NCT00191984|583686865|FG000|Overall Study|Withdrawal by Subject|7|||
161627813|NCT00191984|583686865|FG000|Overall Study|Physician Decision|4|||
161627814|NCT03303521|583686866|FG000|Overall Study|Withdrawal by Subject|2|||
161627815|NCT03303521|583686867|FG001|Overall Study|Withdrawal by Subject|0|||
161627816|NCT03303521|583686866|FG000|Overall Study|Death|1|||
161627817|NCT03303521|583686867|FG001|Overall Study|Death|0|||
161627818|NCT03303521|583686866|FG000|Overall Study|Kidney transplantation|0|||
161627819|NCT03303521|583686867|FG001|Overall Study|Kidney transplantation|1|||
161627820|NCT03303521|583686866|FG000|Overall Study|Investigational product discontinuation|0|||
161627821|NCT03303521|583686867|FG001|Overall Study|Investigational product discontinuation|1|||
161627822|NCT03303521|583686866|FG000|Overall Study|Transferred to non-study dialysis center|1|||
161627823|NCT03303521|583686867|FG001|Overall Study|Transferred to non-study dialysis center|0|||
161627824|NCT03303521|583686866|FG000|Overall Study|Non-comliance to study protocol|0|||
161627825|NCT03303521|583686867|FG001|Overall Study|Non-comliance to study protocol|1|||
161627826|NCT03303521|583686866|FG000|Overall Study|Adverse Event|1|||
161627827|NCT03303521|583686867|FG001|Overall Study|Adverse Event|0|||
161627828|NCT01654289|583686868|FG000|Overall Study|Withdrawal by Subject|10|||
161627829|NCT01654289|583686869|FG001|Overall Study|Withdrawal by Subject|8|||
161627830|NCT01654289|583686870|FG002|Overall Study|Withdrawal by Subject|5|||
161627831|NCT01654289|583686868|FG000|Overall Study|Withdrew from intervention only|17|||
161627832|NCT01654289|583686869|FG001|Overall Study|Withdrew from intervention only|20|||
161627833|NCT01654289|583686870|FG002|Overall Study|Withdrew from intervention only|0|||
161627834|NCT00005908|583686872|FG000|Overall Study|Withdrawal by Subject|1|||
161627835|NCT00005908|583686873|FG001|Overall Study|Withdrawal by Subject|0|||
161627836|NCT04748445|583686876|FG000|Overall Study|No longer met eligibility criteria|12|||
161627837|NCT04748445|583686876|FG000|Overall Study|Other|36|||
161627838|NCT04748445|583686876|FG000|Overall Study|Withdrawal by Subject|553|||
161627839|NCT04748445|583686876|FG000|Overall Study|Lost to Follow-up|30|||
161627840|NCT04736602|583686881|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
161627841|NCT04736602|583686881|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
161627842|NCT00938041|583686884|FG000|Overall Study|Lost to Follow-up|6|||
161627843|NCT00938041|583686884|FG000|Overall Study|Received Alternative Therapy|1|||
161627844|NCT00938041|583686884|FG000|Overall Study|Progressive Disease|5|||
161627845|NCT00938041|583686884|FG000|Overall Study|Death|12|||
161627846|NCT00938041|583686884|FG000|Overall Study|Adrenal Insufficiency|3|||
161685288|NCT01870401|583901826|FG001|Overall Study|On-going in the Study|25|||
161685289|NCT01135498|583901828|FG000|Overall Study|Adverse Event|20|||
161627847|NCT00577096|583686885|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
161627848|NCT00577096|583686886|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
161627849|NCT00577096|583686885|FG000|Short Term Participation|Withdrawal by Subject|3|||
161627850|NCT00577096|583686886|FG001|Short Term Participation|Withdrawal by Subject|5|||
161627851|NCT00577096|583686885|FG000|Short Term Participation|Death|1|||
161627852|NCT00577096|583686886|FG001|Short Term Participation|Death|1|||
161627853|NCT00832650|583686887|FG000|Overall Study|Randomized but not treated|0|||
161627854|NCT00832650|583686888|FG001|Overall Study|Randomized but not treated|0|||
161627855|NCT00832650|583686889|FG002|Overall Study|Randomized but not treated|1|||
161627856|NCT00440037|583686891|FG000|Overall Study|Withdrawal by Subject|6|||
161627857|NCT00440037|583686891|FG000|Overall Study|Administrative decision|3|||
161627858|NCT03740919|583686894|FG000|Lead-in Period|Lost to Follow-up|1|||
161627859|NCT03740919|583686895|FG001|Lead-in Period|Lost to Follow-up|0|||
161627860|NCT03740919|583686896|FG002|Lead-in Period|Lost to Follow-up|0|||
161685290|NCT01135498|583901828|FG000|Overall Study|Progressive disease|38|||
161685291|NCT01135498|583901828|FG000|Overall Study|Investigator judgement|25|||
161685292|NCT01135498|583901828|FG000|Overall Study|Withdrawal by Subject|4|||
161685293|NCT01135498|583901828|FG000|Overall Study|Death|1|||
161685294|NCT01135498|583901828|FG000|Overall Study|Ongoing at time of analysis|2|||
161685295|NCT01192022|583901829|FG000|Overall Study|Withdrawal of Consent|3|||
161685296|NCT01192022|583901830|FG001|Overall Study|Withdrawal of Consent|1|||
161685297|NCT01192022|583901831|FG002|Overall Study|Withdrawal of Consent|0|||
161685298|NCT01192022|583901832|FG003|Overall Study|Withdrawal of Consent|0|||
161685299|NCT01192022|583901833|FG004|Overall Study|Withdrawal of Consent|0|||
161685300|NCT01192022|583901829|FG000|Overall Study|Lost to Follow-up|4|||
161685301|NCT01192022|583901830|FG001|Overall Study|Lost to Follow-up|2|||
161685302|NCT01192022|583901831|FG002|Overall Study|Lost to Follow-up|1|||
161833483|NCT04495283|584433142|FG002|Overall Study|Withdrawal by Subject|1|||
161833484|NCT04495283|584433140|FG000|Overall Study|Other|1|||
161685303|NCT01192022|583901832|FG003|Overall Study|Lost to Follow-up|1|||
161685304|NCT01192022|583901833|FG004|Overall Study|Lost to Follow-up|0|||
161685305|NCT01192022|583901829|FG000|Overall Study|Adverse Event|1|||
161685306|NCT01192022|583901830|FG001|Overall Study|Adverse Event|0|||
161685307|NCT01192022|583901831|FG002|Overall Study|Adverse Event|0|||
161685308|NCT01192022|583901832|FG003|Overall Study|Adverse Event|0|||
161685309|NCT01192022|583901833|FG004|Overall Study|Adverse Event|0|||
161685310|NCT01192022|583901829|FG000|Overall Study|Fatal Adverse Event|4|||
161685311|NCT01192022|583901830|FG001|Overall Study|Fatal Adverse Event|6|||
161685312|NCT01192022|583901831|FG002|Overall Study|Fatal Adverse Event|0|||
161685313|NCT01192022|583901832|FG003|Overall Study|Fatal Adverse Event|0|||
161685314|NCT01192022|583901833|FG004|Overall Study|Fatal Adverse Event|1|||
161685315|NCT01192022|583901829|FG000|Overall Study|Physician withdrew-patient hardship|1|||
161833485|NCT04495283|584433141|FG001|Overall Study|Other|0|||
161833486|NCT04495283|584433142|FG002|Overall Study|Other|1|||
161833487|NCT03341000|584433156|FG000|Overall Study|Adverse Event|1|||
161833488|NCT04718194|584433157|FG000|Overall Study|Withdrawal by Subject|3|||
161833489|NCT04718194|584433158|FG001|Overall Study|Withdrawal by Subject|0|||
161833490|NCT04718194|584433157|FG000|Overall Study|Lost to Follow-up|3|||
161685316|NCT01192022|583901830|FG001|Overall Study|Physician withdrew-patient hardship|0|||
161685317|NCT01192022|583901831|FG002|Overall Study|Physician withdrew-patient hardship|0|||
161833491|NCT04718194|584433158|FG001|Overall Study|Lost to Follow-up|0|||
161833492|NCT01215513|584433159|FG000|Overall Study|Not completed CS42|9|||
161833493|NCT01215513|584433159|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
161685318|NCT01192022|583901832|FG003|Overall Study|Physician withdrew-patient hardship|0|||
161685319|NCT01192022|583901833|FG004|Overall Study|Physician withdrew-patient hardship|0|||
161685320|NCT01192022|583901829|FG000|Overall Study|Patient too sick from chemotherapy|0|||
161685321|NCT01192022|583901830|FG001|Overall Study|Patient too sick from chemotherapy|1|||
161833494|NCT01215513|584433159|FG000|Overall Study|Adverse event (CS42A)|2|||
161833495|NCT01215513|584433159|FG000|Overall Study|Physician decision (CS42A)|6|||
161833496|NCT01215513|584433159|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
161627861|NCT03740919|583686897|FG003|Lead-in Period|Lost to Follow-up|0|||
161627862|NCT03740919|583686894|FG000|Lead-in Period|Physician Decision|2|||
161627863|NCT03740919|583686895|FG001|Lead-in Period|Physician Decision|0|||
161627864|NCT03740919|583686896|FG002|Lead-in Period|Physician Decision|0|||
161627865|NCT03740919|583686897|FG003|Lead-in Period|Physician Decision|0|||
161627866|NCT03740919|583686894|FG000|Lead-in Period|Protocol Violation|1|||
161627867|NCT03740919|583686895|FG001|Lead-in Period|Protocol Violation|0|||
161627868|NCT03740919|583686896|FG002|Lead-in Period|Protocol Violation|0|||
161685322|NCT01192022|583901831|FG002|Overall Study|Patient too sick from chemotherapy|0|||
161685323|NCT01192022|583901832|FG003|Overall Study|Patient too sick from chemotherapy|0|||
161685324|NCT01192022|583901833|FG004|Overall Study|Patient too sick from chemotherapy|0|||
161685325|NCT01192022|583901829|FG000|Overall Study|Patient needed surgery|0|||
161685326|NCT01192022|583901830|FG001|Overall Study|Patient needed surgery|1|||
161685327|NCT01192022|583901831|FG002|Overall Study|Patient needed surgery|0|||
161685328|NCT01192022|583901832|FG003|Overall Study|Patient needed surgery|0|||
161685329|NCT01192022|583901833|FG004|Overall Study|Patient needed surgery|0|||
161685330|NCT01192022|583901829|FG000|Overall Study|Parents did not allow all follow up|0|||
161685331|NCT01192022|583901830|FG001|Overall Study|Parents did not allow all follow up|0|||
161685332|NCT01192022|583901831|FG002|Overall Study|Parents did not allow all follow up|0|||
161685333|NCT01192022|583901832|FG003|Overall Study|Parents did not allow all follow up|1|||
161685334|NCT01192022|583901833|FG004|Overall Study|Parents did not allow all follow up|0|||
161685335|NCT01351389|583901834|FG000|Overall Study|Withdrawal by Subject|7|||
161685336|NCT01351389|583901835|FG001|Overall Study|Withdrawal by Subject|0|||
161685337|NCT01351389|583901834|FG000|Overall Study|did not complete intervention|23|||
161685338|NCT01351389|583901835|FG001|Overall Study|did not complete intervention|15|||
161685339|NCT04839978|583901836|FG000|Overall Study|Lost to Follow-up|135|||
161685340|NCT04839978|583901837|FG001|Overall Study|Lost to Follow-up|147|||
161685341|NCT03551509|583901842|FG000|Overall Study|Lost to Follow-up|0|||
161685342|NCT03551509|583901843|FG001|Overall Study|Lost to Follow-up|1|||
161685343|NCT03551509|583901844|FG002|Overall Study|Lost to Follow-up|0|||
161685344|NCT01902966|583901845|FG000|Overall Study|Death|1|||
161685345|NCT01902966|583901845|FG000|Overall Study|Physician Decision|1|||
161685346|NCT01902966|583901845|FG000|Overall Study|Withdrawal by Subject|1|||
161685347|NCT01549275|583901846|FG000|Overall Study|Lost to Follow-up|1|||
161685348|NCT01549275|583901847|FG001|Overall Study|Lost to Follow-up|0|||
161685349|NCT00122681|583901848|FG000|Overall Study|Adverse Event|20|||
161685350|NCT00122681|583901849|FG001|Overall Study|Adverse Event|16|||
161685351|NCT00122681|583901848|FG000|Overall Study|Lost to Follow-up|1080|||
161685352|NCT00122681|583901849|FG001|Overall Study|Lost to Follow-up|1097|||
161685353|NCT00122681|583901848|FG000|Overall Study|Protocol Violation|7|||
161685354|NCT00122681|583901849|FG001|Overall Study|Protocol Violation|10|||
161685355|NCT00122681|583901848|FG000|Overall Study|Withdrawal by Subject|257|||
161685356|NCT00122681|583901849|FG001|Overall Study|Withdrawal by Subject|251|||
161685357|NCT00122681|583901848|FG000|Overall Study|Personal reasons|150|||
161685358|NCT00122681|583901849|FG001|Overall Study|Personal reasons|147|||
161685359|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
161685360|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
161685361|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
161685362|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
161685363|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
161685364|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
161685365|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
161685366|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
161685367|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
161685368|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
161685369|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
161685370|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
161685371|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
161685372|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
161833497|NCT01215513|584433159|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
161685373|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
161685374|NCT00783094|583901856|FG000|Open-Label Extension Period|Adverse Event|12|||
161627869|NCT03740919|583686897|FG003|Lead-in Period|Protocol Violation|0|||
161627870|NCT03740919|583686894|FG000|Lead-in Period|Withdrawal by Subject|10|||
161685375|NCT00783094|583901857|FG001|Open-Label Extension Period|Adverse Event|7|||
161685376|NCT00783094|583901858|FG002|Open-Label Extension Period|Adverse Event|16|||
161685377|NCT00783094|583901856|FG000|Open-Label Extension Period|Death|0|||
161685378|NCT00783094|583901857|FG001|Open-Label Extension Period|Death|0|||
161685379|NCT00783094|583901858|FG002|Open-Label Extension Period|Death|1|||
161685380|NCT00783094|583901856|FG000|Open-Label Extension Period|Protocol Violation|4|||
161627871|NCT03740919|583686895|FG001|Lead-in Period|Withdrawal by Subject|0|||
161627872|NCT03740919|583686896|FG002|Lead-in Period|Withdrawal by Subject|0|||
161627873|NCT03740919|583686897|FG003|Lead-in Period|Withdrawal by Subject|0|||
161627874|NCT03740919|583686894|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
161627875|NCT03740919|583686895|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
161627876|NCT03740919|583686896|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
161627877|NCT03740919|583686897|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
161627878|NCT03740919|583686894|FG000|Lead-in Period|Study Task Too Burdensome|1|||
161627879|NCT03740919|583686895|FG001|Lead-in Period|Study Task Too Burdensome|0|||
161627880|NCT03740919|583686896|FG002|Lead-in Period|Study Task Too Burdensome|0|||
161627881|NCT03740919|583686897|FG003|Lead-in Period|Study Task Too Burdensome|0|||
161627882|NCT03740919|583686894|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
161627883|NCT03740919|583686895|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
161627884|NCT03740919|583686896|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
161627885|NCT03740919|583686897|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
161627886|NCT03740919|583686894|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
161627887|NCT03740919|583686895|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
161627888|NCT03740919|583686896|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
161627889|NCT03740919|583686897|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
161627890|NCT03740919|583686894|FG000|Treatment Period|Adverse Event|0|||
161627891|NCT03740919|583686895|FG001|Treatment Period|Adverse Event|0|||
161685381|NCT00783094|583901857|FG001|Open-Label Extension Period|Protocol Violation|5|||
161685382|NCT00783094|583901858|FG002|Open-Label Extension Period|Protocol Violation|7|||
161685383|NCT00783094|583901856|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
161685384|NCT00783094|583901857|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
161685385|NCT00783094|583901858|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
161685386|NCT00783094|583901856|FG000|Open-Label Extension Period|Physician Decision|4|||
161685387|NCT00783094|583901857|FG001|Open-Label Extension Period|Physician Decision|2|||
161685388|NCT00783094|583901858|FG002|Open-Label Extension Period|Physician Decision|3|||
161685389|NCT00783094|583901856|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
161685390|NCT00783094|583901857|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
161685391|NCT00783094|583901858|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
161685392|NCT01324232|583901859|FG000|Overall Study|Protocol Violation|0|||
161685393|NCT01324232|583901860|FG001|Overall Study|Protocol Violation|0|||
161685394|NCT01324232|583901861|FG002|Overall Study|Protocol Violation|0|||
161685395|NCT01324232|583901862|FG003|Overall Study|Protocol Violation|2|||
161685396|NCT01324232|583901859|FG000|Overall Study|Missing|0|||
161685397|NCT01324232|583901860|FG001|Overall Study|Missing|0|||
161685398|NCT01324232|583901861|FG002|Overall Study|Missing|1|||
161685399|NCT01324232|583901862|FG003|Overall Study|Missing|0|||
161685400|NCT01324232|583901859|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
161685401|NCT01324232|583901860|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
161685402|NCT01324232|583901861|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
161627892|NCT03740919|583686896|FG002|Treatment Period|Adverse Event|2|||
161627893|NCT03740919|583686897|FG003|Treatment Period|Adverse Event|0|||
161627894|NCT03740919|583686894|FG000|Treatment Period|Protocol Violation|0|||
161627895|NCT03740919|583686895|FG001|Treatment Period|Protocol Violation|1|||
161627896|NCT03740919|583686896|FG002|Treatment Period|Protocol Violation|0|||
161627897|NCT03740919|583686897|FG003|Treatment Period|Protocol Violation|0|||
161627898|NCT03740919|583686894|FG000|Treatment Period|Withdrawal by Subject|0|||
161627899|NCT03740919|583686895|FG001|Treatment Period|Withdrawal by Subject|7|||
161627900|NCT03740919|583686896|FG002|Treatment Period|Withdrawal by Subject|6|||
161627901|NCT03740919|583686897|FG003|Treatment Period|Withdrawal by Subject|2|||
161627902|NCT03740919|583686894|FG000|Treatment Period|Terminated by Sponsor|0|||
161627903|NCT03740919|583686895|FG001|Treatment Period|Terminated by Sponsor|1|||
161627904|NCT03740919|583686896|FG002|Treatment Period|Terminated by Sponsor|0|||
161627905|NCT03740919|583686897|FG003|Treatment Period|Terminated by Sponsor|0|||
161627906|NCT03740919|583686894|FG000|Treatment Period|Issue with Insulin Pump|0|||
161627907|NCT03740919|583686895|FG001|Treatment Period|Issue with Insulin Pump|1|||
161627908|NCT03740919|583686896|FG002|Treatment Period|Issue with Insulin Pump|0|||
161627909|NCT03740919|583686897|FG003|Treatment Period|Issue with Insulin Pump|0|||
161627910|NCT03740919|583686894|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
161627911|NCT03740919|583686895|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
161627912|NCT03740919|583686896|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
161627913|NCT03740919|583686897|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
161627914|NCT03740919|583686894|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
161627915|NCT03740919|583686895|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
161627916|NCT03740919|583686896|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
161627917|NCT03740919|583686897|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
161627918|NCT03740919|583686894|FG000|Treatment Period|Not Completing Diary|0|||
161627919|NCT03740919|583686895|FG001|Treatment Period|Not Completing Diary|0|||
161627920|NCT03740919|583686896|FG002|Treatment Period|Not Completing Diary|1|||
161627921|NCT03740919|583686897|FG003|Treatment Period|Not Completing Diary|0|||
161627922|NCT03740919|583686894|FG000|Treatment Period|Insulin Painful to Participant|0|||
161627923|NCT03740919|583686895|FG001|Treatment Period|Insulin Painful to Participant|0|||
161627924|NCT03740919|583686896|FG002|Treatment Period|Insulin Painful to Participant|1|||
161627925|NCT03740919|583686897|FG003|Treatment Period|Insulin Painful to Participant|0|||
161627926|NCT01911819|583686900|FG000|Overall Study|Adverse Event|0|||
161627927|NCT01911819|583686901|FG001|Overall Study|Adverse Event|1|||
161627928|NCT01911819|583686902|FG002|Overall Study|Adverse Event|0|||
161627929|NCT01911819|583686900|FG000|Overall Study|Withdrawal by Subject|1|||
161627930|NCT01911819|583686901|FG001|Overall Study|Withdrawal by Subject|1|||
161627931|NCT01911819|583686902|FG002|Overall Study|Withdrawal by Subject|0|||
161627932|NCT01207453|583686903|FG000|First Intervention|Adverse Event|2|||
161627933|NCT01207453|583686904|FG001|First Intervention|Adverse Event|1|||
161627934|NCT01207453|583686903|FG000|Washout|Adverse Event|1|||
161627935|NCT01207453|583686904|FG001|Washout|Adverse Event|0|||
161627936|NCT01207453|583686903|FG000|Washout|Lost to Follow-up|1|||
161627937|NCT01207453|583686904|FG001|Washout|Lost to Follow-up|0|||
161627938|NCT01207453|583686903|FG000|2nd Intervention|Adverse Event|1|||
161627939|NCT01207453|583686904|FG001|2nd Intervention|Adverse Event|2|||
161627940|NCT01207453|583686903|FG000|2nd Intervention|Lost to Follow-up|1|||
161627941|NCT01207453|583686904|FG001|2nd Intervention|Lost to Follow-up|0|||
161627942|NCT04374253|583686909|FG000|Overall Study|Adverse Event|0|||
161627943|NCT04374253|583686910|FG001|Overall Study|Adverse Event|26|||
161627944|NCT04374253|583686911|FG002|Overall Study|Adverse Event|2|||
161627945|NCT04374253|583686912|FG003|Overall Study|Adverse Event|12|||
161627946|NCT04374253|583686909|FG000|Overall Study|Study terminated by sponsor|13|||
161627947|NCT04374253|583686910|FG001|Overall Study|Study terminated by sponsor|593|||
161627948|NCT04374253|583686911|FG002|Overall Study|Study terminated by sponsor|21|||
161627949|NCT04374253|583686912|FG003|Overall Study|Study terminated by sponsor|567|||
161627950|NCT04374253|583686909|FG000|Overall Study|Withdrawal by Subject|0|||
161627951|NCT04374253|583686910|FG001|Overall Study|Withdrawal by Subject|55|||
161627952|NCT04374253|583686911|FG002|Overall Study|Withdrawal by Subject|3|||
161627953|NCT04374253|583686912|FG003|Overall Study|Withdrawal by Subject|40|||
161627954|NCT04374253|583686909|FG000|Overall Study|Physician Decision|1|||
161627955|NCT04374253|583686910|FG001|Overall Study|Physician Decision|10|||
161627956|NCT04374253|583686911|FG002|Overall Study|Physician Decision|1|||
161627957|NCT04374253|583686912|FG003|Overall Study|Physician Decision|10|||
161627958|NCT04374253|583686909|FG000|Overall Study|Protocol Violation|0|||
161627959|NCT04374253|583686910|FG001|Overall Study|Protocol Violation|0|||
161627960|NCT04374253|583686911|FG002|Overall Study|Protocol Violation|0|||
161627961|NCT04374253|583686912|FG003|Overall Study|Protocol Violation|2|||
161627962|NCT04374253|583686909|FG000|Overall Study|Death|0|||
161627963|NCT04374253|583686910|FG001|Overall Study|Death|3|||
161627964|NCT04374253|583686911|FG002|Overall Study|Death|1|||
161627965|NCT04374253|583686912|FG003|Overall Study|Death|1|||
161627966|NCT04374253|583686909|FG000|Overall Study|Lack of Efficacy|0|||
161627967|NCT04374253|583686910|FG001|Overall Study|Lack of Efficacy|0|||
161627968|NCT04374253|583686911|FG002|Overall Study|Lack of Efficacy|0|||
161627969|NCT04374253|583686912|FG003|Overall Study|Lack of Efficacy|1|||
161627970|NCT04374253|583686909|FG000|Overall Study|Lost to Follow-up|1|||
161627971|NCT04374253|583686910|FG001|Overall Study|Lost to Follow-up|1|||
161627972|NCT04374253|583686911|FG002|Overall Study|Lost to Follow-up|0|||
161627973|NCT04374253|583686912|FG003|Overall Study|Lost to Follow-up|2|||
161627974|NCT04374253|583686909|FG000|Overall Study|Reason Not Specified|0|||
161627975|NCT04374253|583686910|FG001|Overall Study|Reason Not Specified|8|||
161627976|NCT04374253|583686911|FG002|Overall Study|Reason Not Specified|0|||
161627977|NCT04374253|583686912|FG003|Overall Study|Reason Not Specified|8|||
161627978|NCT04382053|583686915|FG000|Overall Study|Death|6|||
161627979|NCT04382053|583686916|FG001|Overall Study|Death|8|||
161627980|NCT04382053|583686915|FG000|Overall Study|Lost to Follow-up|0|||
161627981|NCT04382053|583686916|FG001|Overall Study|Lost to Follow-up|2|||
161627982|NCT04382053|583686915|FG000|Overall Study|Protocol Deviation|1|||
161627983|NCT04382053|583686916|FG001|Overall Study|Protocol Deviation|2|||
161627984|NCT04382053|583686915|FG000|Overall Study|Withdrawal by Subject|2|||
161627985|NCT04382053|583686916|FG001|Overall Study|Withdrawal by Subject|1|||
161627986|NCT01399905|583686919|FG000|Overall Study|Withdrawal by Subject|1|||
161627987|NCT01399905|583686920|FG001|Overall Study|Withdrawal by Subject|1|||
161627988|NCT01786551|583686924|FG000|Overall Study|Participant withdrew consent|2|||
161627989|NCT01945086|583686925|FG000|Overall Study|Withdrawal by Subject|1|||
161627990|NCT01945086|583686926|FG001|Overall Study|Withdrawal by Subject|0|||
161627991|NCT01945086|583686927|FG002|Overall Study|Withdrawal by Subject|1|||
161627992|NCT01945086|583686925|FG000|Overall Study|Adverse Event|0|||
161627993|NCT01945086|583686926|FG001|Overall Study|Adverse Event|0|||
161627994|NCT01945086|583686927|FG002|Overall Study|Adverse Event|1|||
161627995|NCT01524887|583686928|FG000|Overall Study|Withdrawal by Subject|6|||
161627996|NCT01524887|583686929|FG001|Overall Study|Withdrawal by Subject|2|||
161627997|NCT01524887|583686930|FG002|Overall Study|Withdrawal by Subject|3|||
161627998|NCT01524887|583686928|FG000|Overall Study|Adverse Event|5|||
161627999|NCT01524887|583686929|FG001|Overall Study|Adverse Event|1|||
161628000|NCT01524887|583686930|FG002|Overall Study|Adverse Event|1|||
161628001|NCT01524887|583686928|FG000|Overall Study|Protocol Violation|0|||
161628002|NCT01524887|583686929|FG001|Overall Study|Protocol Violation|0|||
161628003|NCT01524887|583686930|FG002|Overall Study|Protocol Violation|1|||
161628004|NCT01524887|583686928|FG000|Overall Study|Study termination|73|||
161628005|NCT01524887|583686929|FG001|Overall Study|Study termination|87|||
161628006|NCT01524887|583686930|FG002|Overall Study|Study termination|79|||
161628007|NCT01524887|583686928|FG000|Overall Study|Withdrawal by Caregiver|0|||
161628008|NCT01524887|583686929|FG001|Overall Study|Withdrawal by Caregiver|0|||
161628009|NCT01524887|583686930|FG002|Overall Study|Withdrawal by Caregiver|2|||
161628010|NCT01524887|583686928|FG000|Overall Study|Use of prohibited medication|1|||
161628011|NCT01524887|583686929|FG001|Overall Study|Use of prohibited medication|0|||
161628012|NCT01524887|583686930|FG002|Overall Study|Use of prohibited medication|0|||
161628013|NCT02093897|583688573|FG000|Overall Study|Physician Decision|1|||
161628014|NCT02093897|583688573|FG000|Overall Study|Planned age group closure - no's reached|17|||
161628015|NCT02093897|583688573|FG000|Overall Study|Adverse event, non-fatal|1|||
161628016|NCT02972242|583688574|FG000|Overall Study|Withdrawal by Subject|1|||
161628017|NCT02972242|583688575|FG001|Overall Study|Withdrawal by Subject|0|||
161628018|NCT04572997|583688576|FG000|Overall Study|Adverse Event|1|||
161628019|NCT03098797|583688577|FG000|Part 2 Open Label Extension|Adverse Event|2|||
161628020|NCT03098797|583688578|FG001|Part 2 Open Label Extension|Adverse Event|0|||
161628021|NCT02956278|583688579|FG000|Overall Study|Withdrawal by Subject|6|||
161628022|NCT02956278|583688580|FG001|Overall Study|Withdrawal by Subject|2|||
161685403|NCT01324232|583901862|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
161833498|NCT03861481|584433161|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
161628023|NCT02956278|583688581|FG002|Overall Study|Withdrawal by Subject|0|||
161628024|NCT01967719|583688582|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
161628025|NCT01967719|583688583|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
161628026|NCT01967719|583688584|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161628027|NCT01967719|583688585|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
161628028|NCT01967719|583688582|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161628029|NCT01967719|583688583|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
161628030|NCT01967719|583688584|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161628031|NCT01967719|583688585|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161628032|NCT02329223|583688586|FG000|Overall Study|Withdrawal by Subject|1|||
161628033|NCT02329223|583688587|FG001|Overall Study|Withdrawal by Subject|2|||
161628034|NCT02329223|583688588|FG002|Overall Study|Withdrawal by Subject|5|||
161628035|NCT02329223|583688586|FG000|Overall Study|Physician Decision|0|||
161628036|NCT02329223|583688587|FG001|Overall Study|Physician Decision|0|||
161628037|NCT02329223|583688588|FG002|Overall Study|Physician Decision|1|||
161628038|NCT02329223|583688586|FG000|Overall Study|Adverse Event|0|||
161628039|NCT02329223|583688587|FG001|Overall Study|Adverse Event|1|||
161628040|NCT02329223|583688588|FG002|Overall Study|Adverse Event|0|||
161628041|NCT02720185|583688594|FG000|Overall Study|Lost to Follow-up|1|||
161628042|NCT02507687|583688597|FG000|Overall Study|Adverse Event|3|||
161628043|NCT02507687|583688598|FG001|Overall Study|Adverse Event|2|||
161628044|NCT02507687|583688599|FG002|Overall Study|Adverse Event|2|||
161628045|NCT02507687|583688600|FG003|Overall Study|Adverse Event|2|||
161628046|NCT02507687|583688597|FG000|Overall Study|Withdrawal by Subject|1|||
161628047|NCT02507687|583688598|FG001|Overall Study|Withdrawal by Subject|4|||
161628048|NCT02507687|583688599|FG002|Overall Study|Withdrawal by Subject|6|||
161628049|NCT02507687|583688600|FG003|Overall Study|Withdrawal by Subject|6|||
161628050|NCT02507687|583688597|FG000|Overall Study|Protocol Violation|1|||
161628051|NCT02507687|583688598|FG001|Overall Study|Protocol Violation|0|||
161628052|NCT02507687|583688599|FG002|Overall Study|Protocol Violation|2|||
161628053|NCT02507687|583688600|FG003|Overall Study|Protocol Violation|0|||
161833499|NCT03861481|584433162|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
161833500|NCT03861481|584433161|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
161628054|NCT02507687|583688597|FG000|Overall Study|Lost to Follow-up|0|||
161628055|NCT02507687|583688598|FG001|Overall Study|Lost to Follow-up|0|||
161628056|NCT02507687|583688599|FG002|Overall Study|Lost to Follow-up|2|||
161628057|NCT02507687|583688600|FG003|Overall Study|Lost to Follow-up|1|||
161628058|NCT02507687|583688597|FG000|Overall Study|Screen Failure|0|||
161628059|NCT02507687|583688598|FG001|Overall Study|Screen Failure|0|||
161628060|NCT02507687|583688599|FG002|Overall Study|Screen Failure|1|||
161628061|NCT02507687|583688600|FG003|Overall Study|Screen Failure|0|||
161628062|NCT02507687|583688597|FG000|Overall Study|Other, Not Specified|0|||
161628063|NCT02507687|583688598|FG001|Overall Study|Other, Not Specified|0|||
161628064|NCT02507687|583688599|FG002|Overall Study|Other, Not Specified|2|||
161628065|NCT02507687|583688600|FG003|Overall Study|Other, Not Specified|4|||
161628066|NCT00275301|583688601|FG000|Overall Study|Adverse Event|5|||
161628067|NCT04357964|583688602|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
161628068|NCT04357964|583688603|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
161628069|NCT04357964|583688602|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
161628070|NCT04357964|583688603|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
161628071|NCT04357964|583688602|FG000|Overall Study|Adipose sample was insufficient quality|0|||
161628072|NCT04357964|583688603|FG001|Overall Study|Adipose sample was insufficient quality|1|||
161628073|NCT00848393|583688606|FG000|Overall Study|Protocol Violation|0|||
161628074|NCT00848393|583688607|FG001|Overall Study|Protocol Violation|0|||
161628075|NCT00848393|583688608|FG002|Overall Study|Protocol Violation|1|||
161628076|NCT00848393|583688606|FG000|Overall Study|surgical complications unrelated to stud|0|||
161628077|NCT00848393|583688607|FG001|Overall Study|surgical complications unrelated to stud|0|||
161628078|NCT00848393|583688608|FG002|Overall Study|surgical complications unrelated to stud|2|||
161628079|NCT00349622|583688615|FG000|Overall Study|Death|168|||
161628080|NCT00349622|583688616|FG001|Overall Study|Death|86|||
161628081|NCT00349622|583688615|FG000|Overall Study|Lost to Follow-up|5|||
161628082|NCT00349622|583688616|FG001|Overall Study|Lost to Follow-up|1|||
161628083|NCT00349622|583688615|FG000|Overall Study|Withdrawal by Subject|5|||
161628084|NCT00349622|583688616|FG001|Overall Study|Withdrawal by Subject|9|||
161628085|NCT03296566|583688617|FG000|Overall Study|Lost to Follow-up|19|||
161628086|NCT03296566|583688618|FG001|Overall Study|Lost to Follow-up|46|||
161628087|NCT03296566|583688617|FG000|Overall Study|Withdrawal by Subject|0|||
161628088|NCT03296566|583688618|FG001|Overall Study|Withdrawal by Subject|3|||
161628089|NCT01503515|583688622|FG000|Overall Study|Adverse Event|4|||
161628090|NCT01503515|583688623|FG001|Overall Study|Adverse Event|5|||
161628091|NCT01503515|583688622|FG000|Overall Study|Death|0|||
161628092|NCT01503515|583688623|FG001|Overall Study|Death|1|||
161628093|NCT01503515|583688622|FG000|Overall Study|Physician Decision|14|||
161628094|NCT01503515|583688623|FG001|Overall Study|Physician Decision|23|||
161628095|NCT01503515|583688622|FG000|Overall Study|Withdrawal by Subject|0|||
161628096|NCT01503515|583688623|FG001|Overall Study|Withdrawal by Subject|1|||
161628097|NCT01503515|583688622|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
161628098|NCT01503515|583688623|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
161628099|NCT01503515|583688622|FG000|Overall Study|Ineligible|1|||
161628100|NCT01503515|583688623|FG001|Overall Study|Ineligible|1|||
161628101|NCT00520403|583688626|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
161628102|NCT00520403|583688626|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
161628103|NCT00520403|583688626|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
161628104|NCT00520403|583688626|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
161628105|NCT00520403|583688626|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
161628106|NCT00520403|583688626|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
161685404|NCT01324232|583901859|FG000|Overall Study|Lack of Efficacy|2|||
161833501|NCT03861481|584433162|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
161628107|NCT00520403|583688626|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
161628108|NCT00520403|583688626|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
161628109|NCT01797562|583688627|FG000|Overall Study|Protocol Violation|5|||
161628110|NCT00917462|583688630|FG000|Overall Study|Clinical Deterioration|1|||
161628111|NCT03341312|583688631|FG000|Period 1|Withdrawal by Subject|0|||
161628112|NCT03341312|583688632|FG001|Period 1|Withdrawal by Subject|1|||
161628113|NCT03341312|583688633|FG002|Period 1|Withdrawal by Subject|0|||
161628114|NCT03341312|583688634|FG003|Period 1|Withdrawal by Subject|0|||
161628115|NCT00744796|583688635|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
161628116|NCT05372913|583688639|FG000|Overall Study|Withdrawal by Subject|0|||
161628117|NCT05372913|583688640|FG001|Overall Study|Withdrawal by Subject|2|||
161628118|NCT05372913|583688639|FG000|Overall Study|Protocol Violation|2|||
161628119|NCT05372913|583688640|FG001|Overall Study|Protocol Violation|2|||
161628120|NCT05372913|583688639|FG000|Overall Study|Adverse Event|0|||
161628121|NCT05372913|583688640|FG001|Overall Study|Adverse Event|1|||
161628122|NCT05135156|583688644|FG000|Overall Study|Lost to Follow-up|0|||
161628123|NCT05135156|583688645|FG001|Overall Study|Lost to Follow-up|0|||
161628124|NCT05135156|583688646|FG002|Overall Study|Lost to Follow-up|2|||
161628125|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Adverse Event|3|||
161628126|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Adverse Event|0|||
161628127|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
161628128|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
161628129|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Disease Progression|23|||
161628130|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Disease Progression|22|||
161628131|NCT01379521|583688647|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
161628132|NCT01379521|583688648|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
161628133|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
161628134|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
161628135|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
161628136|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
161628137|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
161628138|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
161628139|NCT01379521|583688647|FG000|Overall Study -Treatment Period|Death|2|||
161628140|NCT01379521|583688648|FG001|Overall Study -Treatment Period|Death|1|||
161628141|NCT01379521|583688647|FG000|Post-Treatment Evaluations|Disease Progression|22|||
161628142|NCT01379521|583688648|FG001|Post-Treatment Evaluations|Disease Progression|20|||
161628143|NCT01379521|583688647|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
161628144|NCT01379521|583688648|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
161628145|NCT01379521|583688647|FG000|Post-Treatment Evaluations|Death|1|||
161628146|NCT01379521|583688648|FG001|Post-Treatment Evaluations|Death|0|||
161628147|NCT02538471|583688651|FG000|Overall Study|Progression of disease|2|||
161628148|NCT00475735|583688652|FG000|Treatment Period 1|Adverse Event|2|||
161628149|NCT00475735|583688653|FG001|Treatment Period 1|Adverse Event|0|||
161628150|NCT00475735|583688654|FG002|Treatment Period 1|Adverse Event|0|||
161628151|NCT00475735|583688655|FG003|Treatment Period 1|Adverse Event|0|||
161628152|NCT00475735|583688656|FG004|Treatment Period 1|Adverse Event|0|||
161628153|NCT00475735|583688657|FG005|Treatment Period 1|Adverse Event|0|||
161628154|NCT00475735|583688652|FG000|Treatment Period 1|Lack of Efficacy|1|||
161628155|NCT00475735|583688653|FG001|Treatment Period 1|Lack of Efficacy|0|||
161628156|NCT00475735|583688654|FG002|Treatment Period 1|Lack of Efficacy|0|||
161628157|NCT00475735|583688655|FG003|Treatment Period 1|Lack of Efficacy|0|||
161628158|NCT00475735|583688656|FG004|Treatment Period 1|Lack of Efficacy|0|||
161628159|NCT00475735|583688657|FG005|Treatment Period 1|Lack of Efficacy|0|||
161628160|NCT00475735|583688652|FG000|Treatment Period 1|Lost to Follow-up|0|||
161628161|NCT00475735|583688653|FG001|Treatment Period 1|Lost to Follow-up|0|||
161628162|NCT00475735|583688654|FG002|Treatment Period 1|Lost to Follow-up|0|||
161628163|NCT00475735|583688655|FG003|Treatment Period 1|Lost to Follow-up|0|||
161628164|NCT00475735|583688656|FG004|Treatment Period 1|Lost to Follow-up|0|||
161628165|NCT00475735|583688657|FG005|Treatment Period 1|Lost to Follow-up|1|||
161628166|NCT00475735|583688652|FG000|Treatment Period 1|Protocol Violation|0|||
161628167|NCT00475735|583688653|FG001|Treatment Period 1|Protocol Violation|0|||
161628168|NCT00475735|583688654|FG002|Treatment Period 1|Protocol Violation|0|||
161628169|NCT00475735|583688655|FG003|Treatment Period 1|Protocol Violation|1|||
161628170|NCT00475735|583688656|FG004|Treatment Period 1|Protocol Violation|0|||
161628171|NCT00475735|583688657|FG005|Treatment Period 1|Protocol Violation|0|||
161628172|NCT00475735|583688652|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161628173|NCT00475735|583688653|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161628174|NCT00475735|583688654|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161628175|NCT00475735|583688655|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161628176|NCT00475735|583688656|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161628177|NCT00475735|583688657|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161628178|NCT00475735|583688652|FG000|Treatment Period 1|DC due to AE but continuing|0|||
161628179|NCT00475735|583688653|FG001|Treatment Period 1|DC due to AE but continuing|0|||
161628180|NCT00475735|583688654|FG002|Treatment Period 1|DC due to AE but continuing|0|||
161628181|NCT00475735|583688655|FG003|Treatment Period 1|DC due to AE but continuing|1|||
161628182|NCT00475735|583688656|FG004|Treatment Period 1|DC due to AE but continuing|2|||
161628183|NCT00475735|583688657|FG005|Treatment Period 1|DC due to AE but continuing|2|||
161628184|NCT00475735|583688652|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161628185|NCT00475735|583688653|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
161628186|NCT00475735|583688654|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161628187|NCT00475735|583688655|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161628188|NCT00475735|583688656|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161628189|NCT00475735|583688657|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161628190|NCT00475735|583688652|FG000|Treatment Washout|Lost to Follow-up|0|||
161628191|NCT00475735|583688653|FG001|Treatment Washout|Lost to Follow-up|1|||
161628192|NCT00475735|583688654|FG002|Treatment Washout|Lost to Follow-up|0|||
161628193|NCT00475735|583688655|FG003|Treatment Washout|Lost to Follow-up|0|||
161628194|NCT00475735|583688656|FG004|Treatment Washout|Lost to Follow-up|0|||
161628195|NCT00475735|583688657|FG005|Treatment Washout|Lost to Follow-up|0|||
161628196|NCT00475735|583688652|FG000|Treatment Washout|Protocol Violation|0|||
161628197|NCT00475735|583688653|FG001|Treatment Washout|Protocol Violation|1|||
161628198|NCT00475735|583688654|FG002|Treatment Washout|Protocol Violation|0|||
161628199|NCT00475735|583688655|FG003|Treatment Washout|Protocol Violation|0|||
161628200|NCT00475735|583688656|FG004|Treatment Washout|Protocol Violation|0|||
161628201|NCT00475735|583688657|FG005|Treatment Washout|Protocol Violation|0|||
161628202|NCT00475735|583688652|FG000|Treatment Period 2|Adverse Event|0|||
161628203|NCT00475735|583688653|FG001|Treatment Period 2|Adverse Event|1|||
161628204|NCT00475735|583688654|FG002|Treatment Period 2|Adverse Event|0|||
161628205|NCT00475735|583688655|FG003|Treatment Period 2|Adverse Event|2|||
161628206|NCT00475735|583688656|FG004|Treatment Period 2|Adverse Event|0|||
161628207|NCT00475735|583688657|FG005|Treatment Period 2|Adverse Event|0|||
161628208|NCT00475735|583688652|FG000|Treatment Period 2|Lack of Efficacy|0|||
161628209|NCT00475735|583688653|FG001|Treatment Period 2|Lack of Efficacy|0|||
161628210|NCT00475735|583688654|FG002|Treatment Period 2|Lack of Efficacy|0|||
161628211|NCT00475735|583688655|FG003|Treatment Period 2|Lack of Efficacy|0|||
161628212|NCT00475735|583688656|FG004|Treatment Period 2|Lack of Efficacy|0|||
161628213|NCT00475735|583688657|FG005|Treatment Period 2|Lack of Efficacy|1|||
161628214|NCT00475735|583688652|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161628215|NCT00475735|583688653|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161628216|NCT00475735|583688654|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161685405|NCT01324232|583901860|FG001|Overall Study|Lack of Efficacy|1|||
161628217|NCT00475735|583688655|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161628218|NCT00475735|583688656|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161685406|NCT01324232|583901861|FG002|Overall Study|Lack of Efficacy|2|||
161628219|NCT00475735|583688657|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161628220|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
161685407|NCT01324232|583901862|FG003|Overall Study|Lack of Efficacy|2|||
161685408|NCT01324232|583901859|FG000|Overall Study|Participant Refused Medication|0|||
161628221|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161628222|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161685409|NCT01324232|583901860|FG001|Overall Study|Participant Refused Medication|1|||
161628223|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161628224|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161628225|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
161628226|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161628227|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161628228|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161628229|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161628230|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
161628231|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161628232|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161628233|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161628234|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161628235|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
161628236|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161628237|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161628238|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161628239|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161628240|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
161628241|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161628242|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161628243|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161628244|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161628245|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
161628246|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161628247|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161628248|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161628249|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161628250|NCT01187407|583688658|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
161628251|NCT01187407|583688659|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161628252|NCT01187407|583688660|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161628253|NCT01187407|583688661|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161628254|NCT01187407|583688662|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161628255|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
161628256|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
161628257|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
161628258|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
161628259|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
161628260|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
161628261|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
161628262|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
161628263|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
161628264|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
161628265|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161628266|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
161685410|NCT01324232|583901861|FG002|Overall Study|Participant Refused Medication|0|||
161685411|NCT01324232|583901862|FG003|Overall Study|Participant Refused Medication|0|||
161685412|NCT01324232|583901859|FG000|Overall Study|Intercurrent illness|0|||
161685413|NCT01324232|583901860|FG001|Overall Study|Intercurrent illness|0|||
161833502|NCT03861481|584433161|FG000|Overall Study|Relapse|1|||
161833503|NCT03861481|584433162|FG001|Overall Study|Relapse|0|||
161833504|NCT03861481|584433161|FG000|Overall Study|Withdrawal by Subject|0|||
161833505|NCT03861481|584433162|FG001|Overall Study|Withdrawal by Subject|1|||
161833506|NCT03861481|584433161|FG000|Overall Study|Lack of Efficacy|4|||
161833507|NCT03861481|584433162|FG001|Overall Study|Lack of Efficacy|5|||
161833508|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
161833509|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
161833510|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
161833511|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
161833512|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
161833513|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
161833514|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
161628267|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
161685414|NCT01324232|583901861|FG002|Overall Study|Intercurrent illness|0|||
161685415|NCT01324232|583901862|FG003|Overall Study|Intercurrent illness|1|||
161833515|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
161833516|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
161833517|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
161833518|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
161628268|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
161628269|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
161628270|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161628271|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161628272|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161628273|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161628274|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161628275|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
161628276|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
161833519|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
161833520|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
161833521|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
161833522|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
161833523|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
161833524|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161833525|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161833526|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
161833527|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833528|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833529|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833530|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833531|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833532|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
161833533|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833534|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833535|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
161833536|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833537|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833538|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
161833539|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
161833540|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
161833541|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161833542|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161833543|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161833544|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833545|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833546|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833547|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833548|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
161833549|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
161833550|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161833551|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
161833552|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161833553|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161833554|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
161833555|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
161833556|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161833557|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
161833558|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
161833559|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
161833560|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161833561|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161833562|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161833563|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
161833564|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
161833565|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161833566|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161833567|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
161833568|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161628277|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161628278|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
161628279|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
161628280|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
161628281|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
161628282|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
161685416|NCT01324232|583901859|FG000|Overall Study|Adverse Event|2|||
161628283|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
161628284|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
161833569|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
161833570|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
161833571|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161833572|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161833573|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161833574|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
161833575|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833576|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833577|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161628285|NCT01187407|583688658|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161628286|NCT01187407|583688659|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161628287|NCT01187407|583688660|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161628288|NCT01187407|583688661|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161628289|NCT01187407|583688662|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
161628290|NCT02382406|583688665|FG000|Study Treatment|Disease Progression|8|||
161628291|NCT02382406|583688666|FG001|Study Treatment|Disease Progression|0|||
161628292|NCT02382406|583688667|FG002|Study Treatment|Disease Progression|20|||
161628293|NCT02382406|583688665|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
161628294|NCT02382406|583688666|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
161628295|NCT02382406|583688667|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
161628296|NCT02382406|583688665|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
161833578|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
161833579|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833580|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
161833581|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
161833582|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
161833583|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
161833584|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
161833585|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
161833586|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833587|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833588|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833589|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833590|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
161833591|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
161833592|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
161833593|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
161833594|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
161833595|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
161833596|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
161833597|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
161833598|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
161833599|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
161833600|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
161833601|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
161833602|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
161833603|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
161833604|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
161833605|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
161628297|NCT02382406|583688666|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
161628298|NCT02382406|583688667|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
161628299|NCT02382406|583688665|FG000|Study Treatment|symptomatic deterioration|1|||
161628300|NCT02382406|583688666|FG001|Study Treatment|symptomatic deterioration|0|||
161628301|NCT02382406|583688667|FG002|Study Treatment|symptomatic deterioration|1|||
161628302|NCT02382406|583688665|FG000|Study Treatment|Death|0|||
161628303|NCT02382406|583688666|FG001|Study Treatment|Death|0|||
161628304|NCT02382406|583688667|FG002|Study Treatment|Death|2|||
161628305|NCT02382406|583688665|FG000|Follow up|Death|11|||
161628306|NCT02382406|583688666|FG001|Follow up|Death|0|||
161628307|NCT02382406|583688667|FG002|Follow up|Death|19|||
161628308|NCT02382406|583688665|FG000|Follow up|Symptomatic deterioration|1|||
161628309|NCT02382406|583688666|FG001|Follow up|Symptomatic deterioration|0|||
161628310|NCT02382406|583688667|FG002|Follow up|Symptomatic deterioration|1|||
161628311|NCT02382406|583688665|FG000|Follow up|Patient Refused Follow-up|1|||
161628312|NCT02382406|583688666|FG001|Follow up|Patient Refused Follow-up|0|||
161685417|NCT01324232|583901860|FG001|Overall Study|Adverse Event|5|||
161685418|NCT01324232|583901861|FG002|Overall Study|Adverse Event|6|||
161685419|NCT01324232|583901862|FG003|Overall Study|Adverse Event|6|||
161685420|NCT01324232|583901859|FG000|Overall Study|Withdrawal by Subject|0|||
161685421|NCT01324232|583901860|FG001|Overall Study|Withdrawal by Subject|3|||
161685422|NCT01324232|583901861|FG002|Overall Study|Withdrawal by Subject|4|||
161628313|NCT02382406|583688667|FG002|Follow up|Patient Refused Follow-up|0|||
161628314|NCT02382406|583688665|FG000|Follow up|Study Terminated|1|||
161628315|NCT02382406|583688666|FG001|Follow up|Study Terminated|0|||
161628316|NCT02382406|583688667|FG002|Follow up|Study Terminated|8|||
161628317|NCT02382406|583688665|FG000|Follow up|Withdrawal by Subject|0|||
161628318|NCT02382406|583688666|FG001|Follow up|Withdrawal by Subject|0|||
161628319|NCT02382406|583688667|FG002|Follow up|Withdrawal by Subject|2|||
161628320|NCT01713998|583688668|FG000|Overall Study|Lost to Follow-up|2|||
161628321|NCT01713998|583688669|FG001|Overall Study|Lost to Follow-up|0|||
161628322|NCT01713998|583688670|FG002|Overall Study|Lost to Follow-up|2|||
161628323|NCT01713998|583688668|FG000|Overall Study|Withdrawal by Subject|1|||
161628324|NCT01713998|583688669|FG001|Overall Study|Withdrawal by Subject|0|||
161628325|NCT01713998|583688670|FG002|Overall Study|Withdrawal by Subject|0|||
161628326|NCT02350127|583688671|FG000|4-Month Assessment|Withdrawal by Subject|10|||
161628327|NCT02350127|583688672|FG001|4-Month Assessment|Withdrawal by Subject|9|||
161628328|NCT02350127|583688671|FG000|4-Month Assessment|Death|1|||
161628329|NCT02350127|583688672|FG001|4-Month Assessment|Death|0|||
161628330|NCT02350127|583688671|FG000|8-Month Assessment|Death|1|||
161628331|NCT02350127|583688672|FG001|8-Month Assessment|Death|1|||
161628332|NCT02350127|583688671|FG000|8-Month Assessment|Withdrawal by Subject|5|||
161628333|NCT02350127|583688672|FG001|8-Month Assessment|Withdrawal by Subject|8|||
161628334|NCT00050167|583688684|FG000|Overall Study|not eligible not invasive|1|||
161628335|NCT00050167|583688685|FG001|Overall Study|not eligible not invasive|1|||
161628336|NCT01363297|583688686|FG000|Overall Study|Other|0|||
161628337|NCT01363297|583688687|FG001|Overall Study|Other|0|||
161628338|NCT01363297|583688688|FG002|Overall Study|Other|0|||
161628339|NCT01363297|583688689|FG003|Overall Study|Other|0|||
161628340|NCT01363297|583688690|FG004|Overall Study|Other|1|||
161628341|NCT01363297|583688686|FG000|Overall Study|Death|3|||
161628342|NCT01363297|583688687|FG001|Overall Study|Death|6|||
161628343|NCT01363297|583688688|FG002|Overall Study|Death|6|||
161628344|NCT01363297|583688689|FG003|Overall Study|Death|10|||
161628345|NCT01363297|583688690|FG004|Overall Study|Death|30|||
161628346|NCT02038803|583688694|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
161628347|NCT02038803|583688694|FG000|Overall Study|Lost to Follow-up|1|||
161628348|NCT04754594|583688695|FG000|Blinded Period|Withdrawal by Subject|4|||
161628349|NCT04754594|583688696|FG001|Blinded Period|Withdrawal by Subject|9|||
161628350|NCT04754594|583688697|FG002|Blinded Period|Withdrawal by Subject|0|||
161628351|NCT04754594|583688698|FG003|Blinded Period|Withdrawal by Subject|0|||
161628352|NCT04754594|583688695|FG000|Blinded Period|Protocol Violation|2|||
161628353|NCT04754594|583688696|FG001|Blinded Period|Protocol Violation|2|||
161628354|NCT04754594|583688697|FG002|Blinded Period|Protocol Violation|0|||
161628355|NCT04754594|583688698|FG003|Blinded Period|Protocol Violation|0|||
161628356|NCT04754594|583688695|FG000|Blinded Period|Lost to Follow-up|1|||
161628357|NCT04754594|583688696|FG001|Blinded Period|Lost to Follow-up|1|||
161628358|NCT04754594|583688697|FG002|Blinded Period|Lost to Follow-up|0|||
161628359|NCT04754594|583688698|FG003|Blinded Period|Lost to Follow-up|0|||
161628360|NCT04754594|583688695|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
161628361|NCT04754594|583688696|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
161685423|NCT01324232|583901862|FG003|Overall Study|Withdrawal by Subject|0|||
161628362|NCT04754594|583688697|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
161628363|NCT04754594|583688698|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
161628364|NCT04754594|583688695|FG000|Unblinded Period|Withdrawal by Subject|6|||
161628365|NCT04754594|583688696|FG001|Unblinded Period|Withdrawal by Subject|8|||
161628366|NCT04754594|583688697|FG002|Unblinded Period|Withdrawal by Subject|0|||
161628367|NCT04754594|583688698|FG003|Unblinded Period|Withdrawal by Subject|0|||
161628368|NCT04754594|583688695|FG000|Unblinded Period|Lost to Follow-up|5|||
161628369|NCT04754594|583688696|FG001|Unblinded Period|Lost to Follow-up|3|||
161628370|NCT04754594|583688697|FG002|Unblinded Period|Lost to Follow-up|0|||
161628371|NCT04754594|583688698|FG003|Unblinded Period|Lost to Follow-up|0|||
161628372|NCT04754594|583688695|FG000|Unblinded Period|Protocol Violation|2|||
161628373|NCT04754594|583688696|FG001|Unblinded Period|Protocol Violation|4|||
161628374|NCT04754594|583688697|FG002|Unblinded Period|Protocol Violation|0|||
161628375|NCT04754594|583688698|FG003|Unblinded Period|Protocol Violation|0|||
161628376|NCT04754594|583688695|FG000|Unblinded Period|Other|3|||
161628377|NCT04754594|583688696|FG001|Unblinded Period|Other|0|||
161628378|NCT04754594|583688697|FG002|Unblinded Period|Other|0|||
161628379|NCT04754594|583688698|FG003|Unblinded Period|Other|0|||
161628380|NCT04754594|583688695|FG000|Infant Participants|Withdrawal by Subject|0|||
161628381|NCT04754594|583688696|FG001|Infant Participants|Withdrawal by Subject|0|||
161685424|NCT01324232|583901859|FG000|Overall Study|Lost to Follow-up|1|||
161685425|NCT01324232|583901860|FG001|Overall Study|Lost to Follow-up|0|||
161685426|NCT01324232|583901861|FG002|Overall Study|Lost to Follow-up|0|||
161685427|NCT01324232|583901862|FG003|Overall Study|Lost to Follow-up|0|||
161685428|NCT02513329|583901863|FG000|Overall Study|Lost to Follow-up|5|||
161685429|NCT02513329|583901864|FG001|Overall Study|Lost to Follow-up|2|||
161685430|NCT05440539|583901865|FG000|Overall Study|Lost to Follow-up|4|||
161685431|NCT05440539|583901866|FG001|Overall Study|Lost to Follow-up|4|||
161685432|NCT05440539|583901865|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
161685433|NCT05440539|583901866|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
161685434|NCT01265615|583901867|FG000|Overall Study|Protocol Violation|2|||
161685435|NCT01265615|583901868|FG001|Overall Study|Protocol Violation|2|||
161685436|NCT01265615|583901869|FG002|Overall Study|Protocol Violation|4|||
161685437|NCT01265615|583901870|FG003|Overall Study|Protocol Violation|3|||
161685438|NCT01732796|583901871|FG000|Overall Study|Adverse Event|16|||
161685439|NCT01732796|583901872|FG001|Overall Study|Adverse Event|16|||
161685440|NCT01732796|583901873|FG002|Overall Study|Adverse Event|4|||
161685441|NCT01732796|583901871|FG000|Overall Study|Lack of Efficacy|21|||
161685442|NCT01732796|583901872|FG001|Overall Study|Lack of Efficacy|18|||
161685443|NCT01732796|583901873|FG002|Overall Study|Lack of Efficacy|5|||
161685444|NCT01732796|583901871|FG000|Overall Study|Lost to Follow-up|2|||
161685445|NCT01732796|583901872|FG001|Overall Study|Lost to Follow-up|0|||
161628382|NCT04754594|583688697|FG002|Infant Participants|Withdrawal by Subject|9|||
161628383|NCT04754594|583688698|FG003|Infant Participants|Withdrawal by Subject|17|||
161628384|NCT04754594|583688695|FG000|Infant Participants|Lost to Follow-up|0|||
161685446|NCT01732796|583901873|FG002|Overall Study|Lost to Follow-up|0|||
161685447|NCT01732796|583901871|FG000|Overall Study|Withdrawal by Subject|6|||
161628385|NCT04754594|583688696|FG001|Infant Participants|Lost to Follow-up|0|||
161628386|NCT04754594|583688697|FG002|Infant Participants|Lost to Follow-up|4|||
161628387|NCT04754594|583688698|FG003|Infant Participants|Lost to Follow-up|10|||
161628388|NCT04754594|583688695|FG000|Infant Participants|Death|0|||
161628389|NCT04754594|583688696|FG001|Infant Participants|Death|0|||
161628390|NCT04754594|583688697|FG002|Infant Participants|Death|1|||
161628391|NCT04754594|583688698|FG003|Infant Participants|Death|1|||
161628392|NCT04754594|583688695|FG000|Infant Participants|Other|0|||
161628393|NCT04754594|583688696|FG001|Infant Participants|Other|0|||
161628394|NCT04754594|583688697|FG002|Infant Participants|Other|1|||
161628395|NCT04754594|583688698|FG003|Infant Participants|Other|1|||
161628396|NCT01247922|583688699|FG000|Overall Study|Disease progression|4|||
161628397|NCT02116582|583688700|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
161628398|NCT02116582|583688700|FG000|Overall Study|Adverse Event|22|||
161628399|NCT02116582|583688700|FG000|Overall Study|Death|9|||
161628400|NCT02116582|583688700|FG000|Overall Study|Progressive Disease|148|||
161628401|NCT02116582|583688700|FG000|Overall Study|Protocol Violation|3|||
161628402|NCT02116582|583688700|FG000|Overall Study|Withdrawal by Subject|8|||
161628403|NCT02116582|583688700|FG000|Overall Study|Other: Miscellaneous|11|||
161628404|NCT02116582|583688700|FG000|Overall Study|Lost to Follow-up|1|||
161628405|NCT02116582|583688700|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
161628406|NCT01876823|583688701|FG000|Overall Study|Withdrawal by Subject|5|||
161628407|NCT01876823|583688701|FG000|Overall Study|Physician Decision|2|||
161628408|NCT01876823|583688701|FG000|Overall Study|Patients moved|2|||
161628409|NCT00794573|583688706|FG000|Overall Study|Death|3|||
161628410|NCT00794573|583688707|FG001|Overall Study|Death|0|||
161628411|NCT00794573|583688706|FG000|Overall Study|Withdrawal by Subject|9|||
161628412|NCT00794573|583688707|FG001|Overall Study|Withdrawal by Subject|12|||
161628413|NCT00794573|583688706|FG000|Overall Study|Lost to Follow-up|26|||
161628414|NCT00794573|583688707|FG001|Overall Study|Lost to Follow-up|33|||
161628415|NCT03356145|583688708|FG000|Overall Study|Withdrawal by Subject|2|||
161628416|NCT03356145|583688709|FG001|Overall Study|Withdrawal by Subject|1|||
161628417|NCT03356145|583688708|FG000|Overall Study|Did not meet inclusion criteria|1|||
161628418|NCT03356145|583688709|FG001|Overall Study|Did not meet inclusion criteria|0|||
161628419|NCT00905255|583688712|FG000|Overall Study|Adverse Event|7|||
161628420|NCT00905255|583688713|FG001|Overall Study|Adverse Event|5|||
161628421|NCT00905255|583688712|FG000|Overall Study|Withdrawal by Subject|5|||
161628422|NCT00905255|583688713|FG001|Overall Study|Withdrawal by Subject|4|||
161628423|NCT00905255|583688712|FG000|Overall Study|Familial and Personal Reasons|1|||
161628424|NCT00905255|583688713|FG001|Overall Study|Familial and Personal Reasons|0|||
161628425|NCT01774929|583688714|FG000|Overall Study|Adverse Event|3|||
161628426|NCT02418819|583688718|FG000|Overall Study|Adverse Event|0|||
161628427|NCT02418819|583688719|FG001|Overall Study|Adverse Event|0|||
161628428|NCT02418819|583688720|FG002|Overall Study|Adverse Event|1|||
161628429|NCT02418819|583688721|FG003|Overall Study|Adverse Event|0|||
161628430|NCT02418819|583688718|FG000|Overall Study|Lost to Follow-up|1|||
161628431|NCT02418819|583688719|FG001|Overall Study|Lost to Follow-up|0|||
161628432|NCT02418819|583688720|FG002|Overall Study|Lost to Follow-up|0|||
161628433|NCT02418819|583688721|FG003|Overall Study|Lost to Follow-up|0|||
161628434|NCT02418819|583688718|FG000|Overall Study|No longer meets eligibility criteria|0|||
161628435|NCT02418819|583688719|FG001|Overall Study|No longer meets eligibility criteria|0|||
161628436|NCT02418819|583688720|FG002|Overall Study|No longer meets eligibility criteria|1|||
161628437|NCT02418819|583688721|FG003|Overall Study|No longer meets eligibility criteria|0|||
161628438|NCT02418819|583688718|FG000|Overall Study|No longer willing to participate|0|||
161628439|NCT02418819|583688719|FG001|Overall Study|No longer willing to participate|0|||
161628440|NCT02418819|583688720|FG002|Overall Study|No longer willing to participate|2|||
161628441|NCT02418819|583688721|FG003|Overall Study|No longer willing to participate|1|||
161628442|NCT01332318|583688725|FG000|Overall Study|Adverse Event|0|||
161628443|NCT01332318|583688726|FG001|Overall Study|Adverse Event|3|||
161628444|NCT01332318|583688727|FG002|Overall Study|Adverse Event|0|||
161628445|NCT01332318|583688728|FG003|Overall Study|Adverse Event|0|||
161628446|NCT01332318|583688725|FG000|Overall Study|Withdrawal by Subject|1|||
161628447|NCT01332318|583688726|FG001|Overall Study|Withdrawal by Subject|1|||
161628448|NCT01332318|583688727|FG002|Overall Study|Withdrawal by Subject|0|||
161628449|NCT01332318|583688728|FG003|Overall Study|Withdrawal by Subject|1|||
161628450|NCT01332318|583688725|FG000|Overall Study|Protocol Violation|1|||
161628451|NCT01332318|583688726|FG001|Overall Study|Protocol Violation|0|||
161628452|NCT01332318|583688727|FG002|Overall Study|Protocol Violation|1|||
161628453|NCT01332318|583688728|FG003|Overall Study|Protocol Violation|1|||
161833606|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
161628454|NCT02040532|583688729|FG000|Overall Study|Lost to Follow-up|1|||
161628455|NCT02040532|583688729|FG000|Overall Study|Physician Decision|4|||
161628456|NCT02040532|583688729|FG000|Overall Study|Adverse Event|4|||
161628457|NCT02040532|583688729|FG000|Overall Study|Withdrawal by Subject|3|||
161628458|NCT01808144|583688732|FG000|Overall Study|Death|1|||
161628459|NCT01808144|583688733|FG001|Overall Study|Death|0|||
161628460|NCT01808144|583688732|FG000|Overall Study|Withdrawal by Subject|16|||
161628461|NCT01808144|583688733|FG001|Overall Study|Withdrawal by Subject|23|||
161628462|NCT01808144|583688732|FG000|Overall Study|Lost to Follow-up|6|||
161628463|NCT01808144|583688733|FG001|Overall Study|Lost to Follow-up|3|||
161628464|NCT01808144|583688732|FG000|Overall Study|Protocol Violation|6|||
161628465|NCT01808144|583688733|FG001|Overall Study|Protocol Violation|6|||
161628466|NCT01808144|583688732|FG000|Overall Study|Gout flare|0|||
161628467|NCT01808144|583688733|FG001|Overall Study|Gout flare|1|||
161628468|NCT01808144|583688732|FG000|Overall Study|Adverse Event|11|||
161628469|NCT01808144|583688733|FG001|Overall Study|Adverse Event|15|||
161628470|NCT03993054|583688734|FG000|Overall Study|PI Decision|1|||
161628471|NCT00383500|583688735|FG000|Overall Study|Withdrawal by Subject|8|||
161628472|NCT00383500|583688736|FG001|Overall Study|Withdrawal by Subject|3|||
161628473|NCT00383500|583688737|FG002|Overall Study|Withdrawal by Subject|0|||
161628474|NCT00383500|583688735|FG000|Overall Study|Lost to Follow-up|0|||
161628475|NCT00383500|583688736|FG001|Overall Study|Lost to Follow-up|0|||
161628476|NCT00383500|583688737|FG002|Overall Study|Lost to Follow-up|2|||
161628477|NCT00733226|583690635|FG000|Overall Study|Withdrawal by Subject|1|||
161628478|NCT00733226|583690636|FG001|Overall Study|Withdrawal by Subject|0|||
161628479|NCT00733226|583690635|FG000|Overall Study|Lost to Follow-up|2|||
161628480|NCT00733226|583690636|FG001|Overall Study|Lost to Follow-up|0|||
161628481|NCT00733226|583690635|FG000|Overall Study|moved to another place|2|||
161628482|NCT00733226|583690636|FG001|Overall Study|moved to another place|0|||
161628483|NCT03511378|583690637|FG000|Overall Study|Withdrawal by Subject|2|||
161628484|NCT03511378|583690638|FG001|Overall Study|Withdrawal by Subject|2|||
161628485|NCT03511378|583690637|FG000|Overall Study|Patient not coming or schedule visit|1|||
161628486|NCT03511378|583690638|FG001|Overall Study|Patient not coming or schedule visit|0|||
161628487|NCT02229396|583690640|FG000|Overall Study|Adverse Event|6|||
161628488|NCT02229396|583690641|FG001|Overall Study|Adverse Event|12|||
161628489|NCT02229396|583690642|FG002|Overall Study|Adverse Event|12|||
161628490|NCT02229396|583690640|FG000|Overall Study|Death|2|||
161628491|NCT02229396|583690641|FG001|Overall Study|Death|3|||
161628492|NCT02229396|583690642|FG002|Overall Study|Death|1|||
161628493|NCT02229396|583690640|FG000|Overall Study|Lost to Follow-up|14|||
161628494|NCT02229396|583690641|FG001|Overall Study|Lost to Follow-up|14|||
161628495|NCT02229396|583690642|FG002|Overall Study|Lost to Follow-up|21|||
161628496|NCT02229396|583690640|FG000|Overall Study|Protocol Violation|2|||
161628497|NCT02229396|583690641|FG001|Overall Study|Protocol Violation|1|||
161628498|NCT02229396|583690642|FG002|Overall Study|Protocol Violation|0|||
161628499|NCT02229396|583690640|FG000|Overall Study|Patient Incorrectly Randomized|0|||
161628500|NCT02229396|583690641|FG001|Overall Study|Patient Incorrectly Randomized|0|||
161628501|NCT02229396|583690642|FG002|Overall Study|Patient Incorrectly Randomized|1|||
161628502|NCT02229396|583690640|FG000|Overall Study|Other|10|||
161628503|NCT02229396|583690641|FG001|Overall Study|Other|18|||
161628504|NCT02229396|583690642|FG002|Overall Study|Other|15|||
161628505|NCT02229396|583690640|FG000|Overall Study|Withdrawal by Subject|42|||
161628506|NCT02229396|583690641|FG001|Overall Study|Withdrawal by Subject|28|||
161628507|NCT02229396|583690642|FG002|Overall Study|Withdrawal by Subject|41|||
161628508|NCT02229396|583690640|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
161628509|NCT02229396|583690641|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161628510|NCT02229396|583690642|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
161628511|NCT02229396|583690640|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
161628512|NCT02229396|583690641|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
161628513|NCT02229396|583690642|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
161628514|NCT03022578|583690646|FG000|Overall Study|Adverse Event|1|||
161628515|NCT03022578|583690646|FG000|Overall Study|Lack of Efficacy|2|||
161628516|NCT03022578|583690646|FG000|Overall Study|Withdrawal by Subject|1|||
161628517|NCT02679079|583690647|FG000|Overall Study|Adverse Event|2|||
161628518|NCT02679079|583690648|FG001|Overall Study|Adverse Event|0|||
161628519|NCT02679079|583690649|FG002|Overall Study|Adverse Event|2|||
161628520|NCT02679079|583690647|FG000|Overall Study|Protocol Violation|0|||
161628521|NCT02679079|583690648|FG001|Overall Study|Protocol Violation|1|||
161628522|NCT02679079|583690649|FG002|Overall Study|Protocol Violation|0|||
161628523|NCT02679079|583690647|FG000|Overall Study|Withdrawal by Subject|2|||
161628524|NCT02679079|583690648|FG001|Overall Study|Withdrawal by Subject|1|||
161628525|NCT02679079|583690649|FG002|Overall Study|Withdrawal by Subject|0|||
161628526|NCT00805285|583690652|FG000|Overall Study|Lack of Efficacy|1|||
161628527|NCT00839306|583690656|FG000|Overall Study|Adverse Event|3|||
161628528|NCT00839306|583690657|FG001|Overall Study|Adverse Event|5|||
161628529|NCT00839306|583690656|FG000|Overall Study|Lost to Follow-up|6|||
161628530|NCT00839306|583690657|FG001|Overall Study|Lost to Follow-up|9|||
161628531|NCT00839306|583690656|FG000|Overall Study|Withdrawal by Subject|5|||
161628532|NCT00839306|583690657|FG001|Overall Study|Withdrawal by Subject|7|||
161628533|NCT00839306|583690656|FG000|Overall Study|Lack of Efficacy|5|||
161628534|NCT00839306|583690657|FG001|Overall Study|Lack of Efficacy|4|||
161628535|NCT00839306|583690656|FG000|Overall Study|Other|6|||
161628536|NCT00839306|583690657|FG001|Overall Study|Other|18|||
161628537|NCT01812707|583690658|FG000|Overall Study|Adverse Event|0|||
161628538|NCT01812707|583690659|FG001|Overall Study|Adverse Event|0|||
161628539|NCT01812707|583690660|FG002|Overall Study|Adverse Event|0|||
161628540|NCT01812707|583690661|FG003|Overall Study|Adverse Event|2|||
161628541|NCT01812707|583690658|FG000|Overall Study|Poor compliance to protocol|1|||
161628542|NCT01812707|583690659|FG001|Overall Study|Poor compliance to protocol|0|||
161628543|NCT01812707|583690660|FG002|Overall Study|Poor compliance to protocol|0|||
161628544|NCT01812707|583690661|FG003|Overall Study|Poor compliance to protocol|0|||
161628545|NCT01812707|583690658|FG000|Overall Study|Consent withdrawn by participant|1|||
161628546|NCT01812707|583690659|FG001|Overall Study|Consent withdrawn by participant|0|||
161628547|NCT01812707|583690660|FG002|Overall Study|Consent withdrawn by participant|0|||
161628548|NCT01812707|583690661|FG003|Overall Study|Consent withdrawn by participant|0|||
161628549|NCT05060237|583690663|FG000|Overall Study|Withdrawal by Subject|4|||
161628550|NCT05060237|583690663|FG000|Overall Study|Screening failure|8|||
161628551|NCT01066897|583690664|FG000|Overall Study|Withdrawal by Subject|1|||
161628552|NCT01066897|583690665|FG001|Overall Study|Withdrawal by Subject|0|||
161628553|NCT01066897|583690664|FG000|Overall Study|stopped study after developing the flu.|1|||
161628554|NCT01066897|583690665|FG001|Overall Study|stopped study after developing the flu.|0|||
161628555|NCT01697592|583690668|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
161628556|NCT01697592|583690669|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628557|NCT01697592|583690670|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628558|NCT01697592|583690671|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628559|NCT01697592|583690672|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628560|NCT01697592|583690673|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628561|NCT01697592|583690674|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628562|NCT01697592|583690675|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628563|NCT01697592|583690676|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628564|NCT01697592|583690677|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161628565|NCT01697592|583690668|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628566|NCT01697592|583690669|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628567|NCT01697592|583690670|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628568|NCT01697592|583690671|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628569|NCT01697592|583690672|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628570|NCT01697592|583690673|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
161628571|NCT01697592|583690674|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628572|NCT01697592|583690675|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628573|NCT01697592|583690676|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628574|NCT01697592|583690677|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161628575|NCT01697592|583690668|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
161628576|NCT01697592|583690669|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628577|NCT01697592|583690670|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628578|NCT01697592|583690671|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628579|NCT01697592|583690672|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628580|NCT01697592|583690673|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628581|NCT01697592|583690674|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628582|NCT01697592|583690675|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628583|NCT01697592|583690676|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628584|NCT01697592|583690677|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161628585|NCT01697592|583690668|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161628586|NCT01697592|583690669|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161628587|NCT01697592|583690670|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161628588|NCT01697592|583690671|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161628589|NCT01697592|583690672|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161628590|NCT01697592|583690673|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161628591|NCT01697592|583690674|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161628592|NCT01697592|583690675|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161628593|NCT01697592|583690676|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161628594|NCT01697592|583690677|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161628595|NCT01697592|583690668|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161628596|NCT01697592|583690669|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161628597|NCT01697592|583690670|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
161628598|NCT01697592|583690671|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161628599|NCT01697592|583690672|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161628600|NCT01697592|583690673|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161628601|NCT01697592|583690674|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
161628602|NCT01697592|583690675|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161628603|NCT01697592|583690676|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161628604|NCT01697592|583690677|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
161628605|NCT01697592|583690668|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
161628606|NCT01697592|583690669|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628607|NCT01697592|583690670|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628608|NCT01697592|583690671|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
161628609|NCT01697592|583690672|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628610|NCT01697592|583690673|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628611|NCT01697592|583690674|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628612|NCT01697592|583690675|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161685448|NCT01732796|583901872|FG001|Overall Study|Withdrawal by Subject|8|||
161685449|NCT01732796|583901873|FG002|Overall Study|Withdrawal by Subject|2|||
161685450|NCT01732796|583901871|FG000|Overall Study|Other reason not defined above|1|||
161685451|NCT01732796|583901872|FG001|Overall Study|Other reason not defined above|0|||
161685452|NCT01732796|583901873|FG002|Overall Study|Other reason not defined above|2|||
161685453|NCT00876187|583901875|FG000|Overall Study|Adverse Event|14|||
161685454|NCT00876187|583901876|FG001|Overall Study|Adverse Event|12|||
161685455|NCT00876187|583901877|FG002|Overall Study|Adverse Event|19|||
161685456|NCT00876187|583901878|FG003|Overall Study|Adverse Event|29|||
161685457|NCT00876187|583901879|FG004|Overall Study|Adverse Event|10|||
161685458|NCT00876187|583901875|FG000|Overall Study|Lack of Efficacy|59|||
161685459|NCT00876187|583901876|FG001|Overall Study|Lack of Efficacy|34|||
161685460|NCT00876187|583901877|FG002|Overall Study|Lack of Efficacy|45|||
161685461|NCT00876187|583901878|FG003|Overall Study|Lack of Efficacy|34|||
161685462|NCT00876187|583901879|FG004|Overall Study|Lack of Efficacy|59|||
161685463|NCT00876187|583901875|FG000|Overall Study|Lost to Follow-up|9|||
161685464|NCT00876187|583901876|FG001|Overall Study|Lost to Follow-up|10|||
161628613|NCT01697592|583690676|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628614|NCT01697592|583690677|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161628615|NCT01697592|583690668|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
161685465|NCT00876187|583901877|FG002|Overall Study|Lost to Follow-up|8|||
161685466|NCT00876187|583901878|FG003|Overall Study|Lost to Follow-up|8|||
161685467|NCT00876187|583901879|FG004|Overall Study|Lost to Follow-up|11|||
161685468|NCT00876187|583901875|FG000|Overall Study|Protocol Violation|6|||
161833607|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
161833608|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
161685469|NCT00876187|583901876|FG001|Overall Study|Protocol Violation|7|||
161628616|NCT01697592|583690669|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628617|NCT01697592|583690670|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628618|NCT01697592|583690671|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628619|NCT01697592|583690672|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628620|NCT01697592|583690673|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
161628621|NCT01697592|583690674|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628622|NCT01697592|583690675|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
161628623|NCT01697592|583690676|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628624|NCT01697592|583690677|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161628625|NCT01697592|583690668|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
161628626|NCT01697592|583690669|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161628627|NCT01697592|583690670|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161628628|NCT01697592|583690671|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
161628629|NCT01697592|583690672|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
161833609|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
161628630|NCT01697592|583690673|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161833610|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Other|0|||
161628631|NCT01697592|583690674|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161628632|NCT01697592|583690675|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
161628633|NCT01697592|583690676|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
161628634|NCT01697592|583690677|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
161628635|NCT02396758|583690678|FG000|Overall Study|Withdrawal by Subject|2|||
161628636|NCT02396758|583690679|FG001|Overall Study|Withdrawal by Subject|0|||
161628637|NCT02396758|583690680|FG002|Overall Study|Withdrawal by Subject|0|||
161628638|NCT02396758|583690681|FG003|Overall Study|Withdrawal by Subject|1|||
161628639|NCT02396758|583690678|FG000|Overall Study|Lost to Follow-up|8|||
161628640|NCT02396758|583690679|FG001|Overall Study|Lost to Follow-up|5|||
161628641|NCT02396758|583690680|FG002|Overall Study|Lost to Follow-up|3|||
161628642|NCT02396758|583690681|FG003|Overall Study|Lost to Follow-up|3|||
161628643|NCT02396758|583690678|FG000|Overall Study|Death|1|||
161628644|NCT02396758|583690679|FG001|Overall Study|Death|1|||
161628645|NCT02396758|583690680|FG002|Overall Study|Death|0|||
161628646|NCT02396758|583690681|FG003|Overall Study|Death|1|||
161628647|NCT02396758|583690678|FG000|Overall Study|Randomized but not treated|1|||
161628648|NCT02396758|583690679|FG001|Overall Study|Randomized but not treated|0|||
161628649|NCT02396758|583690680|FG002|Overall Study|Randomized but not treated|1|||
161628650|NCT02396758|583690681|FG003|Overall Study|Randomized but not treated|0|||
161628651|NCT01631825|583690682|FG000|Overall Study|Adverse Event|42|||
161628652|NCT01631825|583690682|FG000|Overall Study|Lack of Efficacy|7|||
161628653|NCT01631825|583690682|FG000|Overall Study|Withdrawal by Subject|9|||
161628654|NCT01631825|583690682|FG000|Overall Study|Protocol Violation|4|||
161628655|NCT01631825|583690682|FG000|Overall Study|Discontinuation criteria|1|||
161628656|NCT01631825|583690682|FG000|Overall Study|Physician Decision|2|||
161628657|NCT02110225|583690683|FG000|Overall Study|Lost to Follow-up|0|||
161628658|NCT02110225|583690684|FG001|Overall Study|Lost to Follow-up|1|||
161628659|NCT02110225|583690685|FG002|Overall Study|Lost to Follow-up|0|||
161628660|NCT00265096|583690686|FG000|Overall Study|Adverse Event|14|||
161628661|NCT00265096|583690687|FG001|Overall Study|Adverse Event|18|||
161628662|NCT00265096|583690688|FG002|Overall Study|Adverse Event|18|||
161628663|NCT00265096|583690686|FG000|Overall Study|Lost to Follow-up|2|||
161628664|NCT00265096|583690687|FG001|Overall Study|Lost to Follow-up|5|||
161628665|NCT00265096|583690688|FG002|Overall Study|Lost to Follow-up|3|||
161628666|NCT00265096|583690686|FG000|Overall Study|Death|0|||
161628667|NCT00265096|583690687|FG001|Overall Study|Death|1|||
161628668|NCT00265096|583690688|FG002|Overall Study|Death|2|||
161628669|NCT00265096|583690686|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161628670|NCT00265096|583690687|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161628671|NCT00265096|583690688|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
161628672|NCT00265096|583690686|FG000|Overall Study|Other|11|||
161628673|NCT00265096|583690687|FG001|Overall Study|Other|19|||
161628674|NCT00265096|583690688|FG002|Overall Study|Other|10|||
161628675|NCT01116440|583690689|FG000|Treatment|Withdrawal by Subject|2|||
161628676|NCT01116440|583690690|FG001|Treatment|Withdrawal by Subject|2|||
161628677|NCT01116440|583690689|FG000|Treatment|Lost to Follow-up|1|||
161628678|NCT01116440|583690690|FG001|Treatment|Lost to Follow-up|1|||
161628679|NCT01116440|583690689|FG000|Treatment|Protocol Violation|0|||
161628680|NCT01116440|583690690|FG001|Treatment|Protocol Violation|2|||
161628681|NCT01116440|583690689|FG000|Treatment|Lack of Efficacy|0|||
161628682|NCT01116440|583690690|FG001|Treatment|Lack of Efficacy|1|||
161628683|NCT01116440|583690689|FG000|Treatment|Adverse Event|0|||
161628684|NCT01116440|583690690|FG001|Treatment|Adverse Event|1|||
161628685|NCT01116440|583690689|FG000|Withdrawal|Withdrawal by Subject|0|||
161628686|NCT01116440|583690690|FG001|Withdrawal|Withdrawal by Subject|1|||
161628687|NCT01116440|583690689|FG000|Withdrawal|Lost to Follow-up|0|||
161628688|NCT01116440|583690690|FG001|Withdrawal|Lost to Follow-up|1|||
161628689|NCT01116440|583690689|FG000|Follow-up|Lost to Follow-up|0|||
161628690|NCT01116440|583690690|FG001|Follow-up|Lost to Follow-up|1|||
161628691|NCT01116440|583690689|FG000|Follow-up|Withdrawal by Subject|0|||
161628692|NCT01116440|583690690|FG001|Follow-up|Withdrawal by Subject|1|||
161628693|NCT00774306|583690691|FG000|Overall Study|Adverse Event|3|||
161628694|NCT00774306|583690692|FG001|Overall Study|Adverse Event|0|||
161628695|NCT00774306|583690693|FG002|Overall Study|Adverse Event|0|||
161628696|NCT00774306|583690694|FG003|Overall Study|Adverse Event|0|||
161628697|NCT00774306|583690691|FG000|Overall Study|Protocol Violation|2|||
161628698|NCT00774306|583690692|FG001|Overall Study|Protocol Violation|0|||
161628699|NCT00774306|583690693|FG002|Overall Study|Protocol Violation|3|||
161628700|NCT00774306|583690694|FG003|Overall Study|Protocol Violation|0|||
161628701|NCT00774306|583690691|FG000|Overall Study|Withdrawal by Subject|6|||
161628702|NCT00774306|583690692|FG001|Overall Study|Withdrawal by Subject|1|||
161628703|NCT00774306|583690693|FG002|Overall Study|Withdrawal by Subject|1|||
161628704|NCT00774306|583690694|FG003|Overall Study|Withdrawal by Subject|0|||
161628705|NCT00774306|583690691|FG000|Overall Study|Lost to Follow-up|6|||
161628706|NCT00774306|583690692|FG001|Overall Study|Lost to Follow-up|0|||
161628707|NCT00774306|583690693|FG002|Overall Study|Lost to Follow-up|4|||
161628708|NCT00774306|583690694|FG003|Overall Study|Lost to Follow-up|5|||
161628709|NCT00774306|583690691|FG000|Overall Study|Death|1|||
161628710|NCT00774306|583690692|FG001|Overall Study|Death|1|||
161628711|NCT00774306|583690693|FG002|Overall Study|Death|0|||
161628712|NCT00774306|583690694|FG003|Overall Study|Death|0|||
161628713|NCT03568708|583690700|FG000|Overall Study|Withdrawal by Subject|1|||
161628714|NCT03568708|583690701|FG001|Overall Study|Withdrawal by Subject|1|||
161628715|NCT03568708|583690700|FG000|Overall Study|Lost to Follow-up|0|||
161628716|NCT03568708|583690701|FG001|Overall Study|Lost to Follow-up|1|||
161628717|NCT01126879|583690702|FG000|Overall Study|Progressive Disease|3|||
161628718|NCT01126879|583690703|FG001|Overall Study|Progressive Disease|1|||
161628719|NCT01126879|583690702|FG000|Overall Study|Withdrawal by Subject|1|||
161628720|NCT01126879|583690703|FG001|Overall Study|Withdrawal by Subject|0|||
161628721|NCT01126879|583690702|FG000|Overall Study|Adverse Event|0|||
161628722|NCT01126879|583690703|FG001|Overall Study|Adverse Event|1|||
161628723|NCT01126879|583690702|FG000|Overall Study|Physician Decision|1|||
161628724|NCT01126879|583690703|FG001|Overall Study|Physician Decision|0|||
161628725|NCT00666835|583690704|FG000|Overall Study|Withdrawal by Subject|5|||
161628726|NCT00666835|583690705|FG001|Overall Study|Withdrawal by Subject|2|||
161628727|NCT00666835|583690704|FG000|Overall Study|Lack of Efficacy|0|||
161628728|NCT00666835|583690705|FG001|Overall Study|Lack of Efficacy|1|||
161628729|NCT00666835|583690704|FG000|Overall Study|Incl./excl. not fulfilled|7|||
161628730|NCT00666835|583690705|FG001|Overall Study|Incl./excl. not fulfilled|2|||
161628731|NCT00666835|583690704|FG000|Overall Study|Adverse Event|7|||
161628732|NCT00666835|583690705|FG001|Overall Study|Adverse Event|6|||
161628733|NCT00666835|583690704|FG000|Overall Study|Protocol Violation|2|||
161628734|NCT00666835|583690705|FG001|Overall Study|Protocol Violation|0|||
161628735|NCT00666835|583690704|FG000|Overall Study|Death|15|||
161628736|NCT00666835|583690705|FG001|Overall Study|Death|4|||
161628737|NCT00666835|583690704|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
161628738|NCT00666835|583690705|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
161628739|NCT00666835|583690704|FG000|Overall Study|Hemoglobulin concentration|4|||
161628740|NCT00666835|583690705|FG001|Overall Study|Hemoglobulin concentration|3|||
161628741|NCT00666835|583690704|FG000|Overall Study|Planned operation|2|||
161628742|NCT00666835|583690705|FG001|Overall Study|Planned operation|0|||
161628743|NCT00666835|583690704|FG000|Overall Study|Physician Decision|1|||
161628744|NCT00666835|583690705|FG001|Overall Study|Physician Decision|2|||
161628745|NCT00511147|583690708|FG000|Overall Study|Withdrawal by Subject|1|||
161628746|NCT00511147|583690708|FG000|Overall Study|Disease progression|5|||
161628747|NCT00511147|583690708|FG000|Overall Study|Required platelet transfusion|1|||
161628748|NCT00899379|583690709|FG000|Overall Study|Adverse Event|2|||
161628749|NCT00899379|583690710|FG001|Overall Study|Adverse Event|2|||
161628750|NCT00899379|583690711|FG002|Overall Study|Adverse Event|1|||
161628751|NCT00899379|583690712|FG003|Overall Study|Adverse Event|1|||
161628752|NCT00899379|583690713|FG004|Overall Study|Adverse Event|2|||
161628753|NCT00899379|583690709|FG000|Overall Study|Lack of Efficacy|0|||
161628754|NCT00899379|583690710|FG001|Overall Study|Lack of Efficacy|4|||
161628755|NCT00899379|583690711|FG002|Overall Study|Lack of Efficacy|3|||
161628756|NCT00899379|583690712|FG003|Overall Study|Lack of Efficacy|0|||
161628757|NCT00899379|583690713|FG004|Overall Study|Lack of Efficacy|1|||
161628758|NCT00899379|583690709|FG000|Overall Study|Lost to Follow-up|9|||
161628759|NCT00899379|583690710|FG001|Overall Study|Lost to Follow-up|3|||
161628760|NCT00899379|583690711|FG002|Overall Study|Lost to Follow-up|0|||
161628761|NCT00899379|583690712|FG003|Overall Study|Lost to Follow-up|6|||
161628762|NCT00899379|583690713|FG004|Overall Study|Lost to Follow-up|2|||
161628763|NCT00899379|583690709|FG000|Overall Study|Protocol Violation|0|||
161628764|NCT00899379|583690710|FG001|Overall Study|Protocol Violation|0|||
161628765|NCT00899379|583690711|FG002|Overall Study|Protocol Violation|1|||
161628766|NCT00899379|583690712|FG003|Overall Study|Protocol Violation|1|||
161628767|NCT00899379|583690713|FG004|Overall Study|Protocol Violation|0|||
161628768|NCT00899379|583690709|FG000|Overall Study|Withdrawal by Subject|2|||
161628769|NCT00899379|583690710|FG001|Overall Study|Withdrawal by Subject|4|||
161628770|NCT00899379|583690711|FG002|Overall Study|Withdrawal by Subject|2|||
161628771|NCT00899379|583690712|FG003|Overall Study|Withdrawal by Subject|3|||
161628772|NCT00899379|583690713|FG004|Overall Study|Withdrawal by Subject|6|||
161628773|NCT00899379|583690709|FG000|Overall Study|Pregnancy|0|||
161628774|NCT00899379|583690710|FG001|Overall Study|Pregnancy|0|||
161628775|NCT00899379|583690711|FG002|Overall Study|Pregnancy|1|||
161628776|NCT00899379|583690712|FG003|Overall Study|Pregnancy|0|||
161628777|NCT00899379|583690713|FG004|Overall Study|Pregnancy|1|||
161628778|NCT00899379|583690709|FG000|Overall Study|Patient Uncooperative|0|||
161628779|NCT00899379|583690710|FG001|Overall Study|Patient Uncooperative|1|||
161628780|NCT00899379|583690711|FG002|Overall Study|Patient Uncooperative|0|||
161628781|NCT00899379|583690712|FG003|Overall Study|Patient Uncooperative|1|||
161628782|NCT00899379|583690713|FG004|Overall Study|Patient Uncooperative|2|||
161628783|NCT00899379|583690709|FG000|Overall Study|Abnormal Baseline ECG|0|||
161628784|NCT00899379|583690710|FG001|Overall Study|Abnormal Baseline ECG|0|||
161628785|NCT00899379|583690711|FG002|Overall Study|Abnormal Baseline ECG|0|||
161628786|NCT00899379|583690712|FG003|Overall Study|Abnormal Baseline ECG|1|||
161628787|NCT00899379|583690713|FG004|Overall Study|Abnormal Baseline ECG|0|||
161628788|NCT00899379|583690709|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161628789|NCT00899379|583690710|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161628790|NCT00899379|583690711|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161628791|NCT00899379|583690712|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161628792|NCT00899379|583690713|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161628793|NCT00899379|583690709|FG000|Overall Study|Not Completed/Entered Extn|5|||
161628794|NCT00899379|583690710|FG001|Overall Study|Not Completed/Entered Extn|1|||
161628795|NCT00899379|583690711|FG002|Overall Study|Not Completed/Entered Extn|6|||
161628796|NCT00899379|583690712|FG003|Overall Study|Not Completed/Entered Extn|4|||
161628797|NCT00899379|583690713|FG004|Overall Study|Not Completed/Entered Extn|3|||
161628798|NCT00899379|583690709|FG000|Overall Study|Study Terminated|3|||
161628799|NCT00899379|583690710|FG001|Overall Study|Study Terminated|0|||
161628800|NCT00899379|583690711|FG002|Overall Study|Study Terminated|3|||
161628801|NCT00899379|583690712|FG003|Overall Study|Study Terminated|3|||
161628802|NCT00899379|583690713|FG004|Overall Study|Study Terminated|1|||
161628803|NCT00899379|583690709|FG000|Overall Study|Lost to Follow-up|3|||
161628804|NCT00899379|583690710|FG001|Overall Study|Lost to Follow-up|1|||
161628805|NCT00899379|583690711|FG002|Overall Study|Lost to Follow-up|0|||
161628806|NCT00899379|583690712|FG003|Overall Study|Lost to Follow-up|2|||
161628807|NCT00899379|583690713|FG004|Overall Study|Lost to Follow-up|5|||
161628808|NCT00899379|583690709|FG000|Overall Study|Withdrawal by Subject|4|||
161628809|NCT00899379|583690710|FG001|Overall Study|Withdrawal by Subject|7|||
161628810|NCT00899379|583690711|FG002|Overall Study|Withdrawal by Subject|4|||
161628811|NCT00899379|583690712|FG003|Overall Study|Withdrawal by Subject|7|||
161628812|NCT00899379|583690713|FG004|Overall Study|Withdrawal by Subject|2|||
161628813|NCT00899379|583690709|FG000|Overall Study|Pregnancy|1|||
161628814|NCT00899379|583690710|FG001|Overall Study|Pregnancy|0|||
161628815|NCT00899379|583690711|FG002|Overall Study|Pregnancy|0|||
161628816|NCT00899379|583690712|FG003|Overall Study|Pregnancy|0|||
161628817|NCT00899379|583690713|FG004|Overall Study|Pregnancy|0|||
161628818|NCT00899379|583690709|FG000|Overall Study|Patient Uncooperative|0|||
161628819|NCT00899379|583690710|FG001|Overall Study|Patient Uncooperative|0|||
161628820|NCT00899379|583690711|FG002|Overall Study|Patient Uncooperative|0|||
161685470|NCT00876187|583901877|FG002|Overall Study|Protocol Violation|7|||
161685471|NCT00876187|583901878|FG003|Overall Study|Protocol Violation|6|||
161685472|NCT00876187|583901879|FG004|Overall Study|Protocol Violation|3|||
161685473|NCT00876187|583901875|FG000|Overall Study|Withdrawal by Subject|16|||
161685474|NCT00876187|583901876|FG001|Overall Study|Withdrawal by Subject|26|||
161628821|NCT00899379|583690712|FG003|Overall Study|Patient Uncooperative|1|||
161685475|NCT00876187|583901877|FG002|Overall Study|Withdrawal by Subject|32|||
161685476|NCT00876187|583901878|FG003|Overall Study|Withdrawal by Subject|38|||
161685477|NCT00876187|583901879|FG004|Overall Study|Withdrawal by Subject|37|||
161685478|NCT00876187|583901875|FG000|Overall Study|Entered extension study|101|||
161685479|NCT00876187|583901876|FG001|Overall Study|Entered extension study|120|||
161685480|NCT00876187|583901877|FG002|Overall Study|Entered extension study|156|||
161628822|NCT00899379|583690713|FG004|Overall Study|Patient Uncooperative|0|||
161628823|NCT00899379|583690709|FG000|Overall Study|Abnormal Prestudy Labs|0|||
161628824|NCT00899379|583690710|FG001|Overall Study|Abnormal Prestudy Labs|0|||
161628825|NCT00899379|583690711|FG002|Overall Study|Abnormal Prestudy Labs|0|||
161628826|NCT00899379|583690712|FG003|Overall Study|Abnormal Prestudy Labs|0|||
161628827|NCT00899379|583690713|FG004|Overall Study|Abnormal Prestudy Labs|2|||
161628828|NCT00899379|583690709|FG000|Overall Study|Abnormal Baseline ECG|0|||
161628829|NCT00899379|583690710|FG001|Overall Study|Abnormal Baseline ECG|0|||
161628830|NCT00899379|583690711|FG002|Overall Study|Abnormal Baseline ECG|1|||
161628831|NCT00899379|583690712|FG003|Overall Study|Abnormal Baseline ECG|1|||
161628832|NCT00899379|583690713|FG004|Overall Study|Abnormal Baseline ECG|0|||
161685481|NCT00876187|583901878|FG003|Overall Study|Entered extension study|151|||
161685482|NCT00876187|583901879|FG004|Overall Study|Entered extension study|144|||
161628833|NCT00899379|583690709|FG000|Overall Study|No Attack Pretreatment|3|||
161628834|NCT00899379|583690710|FG001|Overall Study|No Attack Pretreatment|5|||
161628835|NCT00899379|583690711|FG002|Overall Study|No Attack Pretreatment|5|||
161628836|NCT00899379|583690712|FG003|Overall Study|No Attack Pretreatment|6|||
161628837|NCT00899379|583690713|FG004|Overall Study|No Attack Pretreatment|4|||
161628838|NCT00899379|583690709|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161628839|NCT00899379|583690710|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161628840|NCT00899379|583690711|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161628841|NCT00899379|583690712|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161628842|NCT00899379|583690713|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161628843|NCT00899379|583690709|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
161628844|NCT00899379|583690710|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
161628845|NCT00899379|583690711|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
161628846|NCT00899379|583690712|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
161628847|NCT00899379|583690713|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
161628848|NCT00809783|583690716|FG000|Overall Study|Death|1|||
161628849|NCT00809783|583690717|FG001|Overall Study|Death|0|||
161628850|NCT00809783|583690718|FG002|Overall Study|Death|0|||
161628851|NCT00809783|583690716|FG000|Overall Study|Adverse Event|34|||
161628852|NCT00809783|583690717|FG001|Overall Study|Adverse Event|52|||
161628853|NCT00809783|583690718|FG002|Overall Study|Adverse Event|71|||
161685483|NCT00876187|583901875|FG000|Overall Study|Randomized but not treated|3|||
161685484|NCT00876187|583901876|FG001|Overall Study|Randomized but not treated|1|||
161685485|NCT00876187|583901877|FG002|Overall Study|Randomized but not treated|3|||
161685486|NCT00876187|583901878|FG003|Overall Study|Randomized but not treated|2|||
161685487|NCT00876187|583901879|FG004|Overall Study|Randomized but not treated|3|||
161685488|NCT00876187|583901875|FG000|Overall Study|Other|2|||
161685489|NCT00876187|583901876|FG001|Overall Study|Other|5|||
161685490|NCT00876187|583901877|FG002|Overall Study|Other|9|||
161685491|NCT00876187|583901878|FG003|Overall Study|Other|7|||
161685492|NCT00876187|583901879|FG004|Overall Study|Other|4|||
161685493|NCT03287219|583901883|FG000|Overall Study|Protocol Violation|0|||
161685494|NCT03287219|583901884|FG001|Overall Study|Protocol Violation|2|||
161685495|NCT00957008|583901885|FG000|Overall Study|Withdrawal by Subject|13|||
161685496|NCT00957008|583901886|FG001|Overall Study|Withdrawal by Subject|10|||
161685497|NCT00957008|583901887|FG002|Overall Study|Withdrawal by Subject|12|||
161685498|NCT00957008|583901888|FG003|Overall Study|Withdrawal by Subject|16|||
161685499|NCT00957008|583901885|FG000|Overall Study|Lost to Follow-up|3|||
161685500|NCT00957008|583901886|FG001|Overall Study|Lost to Follow-up|1|||
161685501|NCT00957008|583901887|FG002|Overall Study|Lost to Follow-up|3|||
161685502|NCT00957008|583901888|FG003|Overall Study|Lost to Follow-up|4|||
161685503|NCT00957008|583901885|FG000|Overall Study|Physician Decision|1|||
161685504|NCT00957008|583901886|FG001|Overall Study|Physician Decision|0|||
161685505|NCT00957008|583901887|FG002|Overall Study|Physician Decision|1|||
161685506|NCT00957008|583901888|FG003|Overall Study|Physician Decision|1|||
161685507|NCT00957008|583901885|FG000|Overall Study|Relocated; Family conflict|4|||
161685508|NCT00957008|583901886|FG001|Overall Study|Relocated; Family conflict|1|||
161685509|NCT00957008|583901887|FG002|Overall Study|Relocated; Family conflict|1|||
161685510|NCT00957008|583901888|FG003|Overall Study|Relocated; Family conflict|3|||
161685511|NCT03571646|583901896|FG000|Overall Study|Adverse Event|1|||
161685512|NCT03571646|583901897|FG001|Overall Study|Adverse Event|0|||
161685513|NCT03571646|583901896|FG000|Overall Study|Withdrawal by Subject|1|||
161685514|NCT03571646|583901897|FG001|Overall Study|Withdrawal by Subject|1|||
161685515|NCT03972969|583901898|FG000|3-month Follow-up|Death|1|||
161685516|NCT03972969|583901899|FG001|3-month Follow-up|Death|1|||
161685517|NCT03972969|583901900|FG002|3-month Follow-up|Death|0|||
161685518|NCT03972969|583901898|FG000|6-month Follow-up|Death|1|||
161685519|NCT03972969|583901899|FG001|6-month Follow-up|Death|1|||
161685520|NCT03972969|583901900|FG002|6-month Follow-up|Death|1|||
161685521|NCT03972969|583901898|FG000|6-month Follow-up|Lost to Follow-up|2|||
161685522|NCT03972969|583901899|FG001|6-month Follow-up|Lost to Follow-up|2|||
161685523|NCT03972969|583901900|FG002|6-month Follow-up|Lost to Follow-up|2|||
161685524|NCT00732303|583901901|FG000|Overall Study|Study Terminated|2|||
161685525|NCT00283595|583901902|FG000|Overall Study|Withdrawal by Subject|1|||
161685526|NCT00283595|583901903|FG001|Overall Study|Withdrawal by Subject|2|||
161628854|NCT00809783|583690716|FG000|Overall Study|Lack of Efficacy|39|||
161628855|NCT00809783|583690717|FG001|Overall Study|Lack of Efficacy|52|||
161628856|NCT00809783|583690718|FG002|Overall Study|Lack of Efficacy|63|||
161685527|NCT04718974|583901907|FG000|Overall Study|Death|0|||
161685528|NCT04718974|583901908|FG001|Overall Study|Death|2|||
161685529|NCT04718974|583901907|FG000|Overall Study|Lost to Follow-up|10|||
161685530|NCT04718974|583901908|FG001|Overall Study|Lost to Follow-up|20|||
161685531|NCT04718974|583901907|FG000|Overall Study|Transferred out|2|||
161685532|NCT04718974|583901908|FG001|Overall Study|Transferred out|4|||
161685533|NCT00845728|583901909|FG000|Overall Study|Abnormal laboratory value (s)|2|||
161685534|NCT00845728|583901910|FG001|Overall Study|Abnormal laboratory value (s)|2|||
161685535|NCT00845728|583901909|FG000|Overall Study|Patient's inability to use the device|4|||
161628857|NCT00809783|583690716|FG000|Overall Study|Lost to Follow-up|0|||
161628858|NCT00809783|583690717|FG001|Overall Study|Lost to Follow-up|3|||
161628859|NCT00809783|583690718|FG002|Overall Study|Lost to Follow-up|4|||
161628860|NCT00809783|583690716|FG000|Overall Study|Withdrawal by Subject|47|||
161628861|NCT00809783|583690717|FG001|Overall Study|Withdrawal by Subject|72|||
161628862|NCT00809783|583690718|FG002|Overall Study|Withdrawal by Subject|64|||
161628863|NCT00809783|583690716|FG000|Overall Study|Protocol Violation|2|||
161628864|NCT00809783|583690717|FG001|Overall Study|Protocol Violation|6|||
161628865|NCT00809783|583690718|FG002|Overall Study|Protocol Violation|5|||
161628866|NCT00809783|583690716|FG000|Overall Study|Randomized, but not treated|3|||
161628867|NCT00809783|583690717|FG001|Overall Study|Randomized, but not treated|0|||
161628868|NCT00809783|583690718|FG002|Overall Study|Randomized, but not treated|2|||
161628869|NCT00809783|583690716|FG000|Overall Study|Study Terminated by Sponsor|378|||
161628870|NCT00809783|583690717|FG001|Overall Study|Study Terminated by Sponsor|626|||
161628871|NCT00809783|583690718|FG002|Overall Study|Study Terminated by Sponsor|565|||
161628872|NCT00809783|583690716|FG000|Overall Study|Other|21|||
161628873|NCT00809783|583690717|FG001|Overall Study|Other|21|||
161628874|NCT00809783|583690718|FG002|Overall Study|Other|16|||
161628875|NCT00126555|583690719|FG000|Overall Study|Withdrawal by Subject|1|||
161628876|NCT00126555|583690719|FG000|Overall Study|Adverse Event|2|||
161628877|NCT00126555|583690719|FG000|Overall Study|Progressive Disease|3|||
161628878|NCT01780545|583690726|FG000|Overall Study|Withdrawal by Subject|3|||
161628879|NCT01780545|583690727|FG001|Overall Study|Withdrawal by Subject|1|||
161628880|NCT01780545|583690726|FG000|Overall Study|Lost to Follow-up|1|||
161628881|NCT01780545|583690727|FG001|Overall Study|Lost to Follow-up|1|||
161628882|NCT03441789|583690728|FG000|Overall Study|Withdrawal by Subject|1|||
161628883|NCT03441789|583690729|FG001|Overall Study|Withdrawal by Subject|1|||
161628884|NCT03441789|583690728|FG000|Overall Study|Adverse Event|0|||
161628885|NCT03441789|583690729|FG001|Overall Study|Adverse Event|1|||
161628886|NCT03441789|583690728|FG000|Overall Study|Protocol Violation|0|||
161628887|NCT03441789|583690729|FG001|Overall Study|Protocol Violation|1|||
161628888|NCT03441789|583690728|FG000|Overall Study|Lost to Follow-up|0|||
161628889|NCT03441789|583690729|FG001|Overall Study|Lost to Follow-up|1|||
161628890|NCT02581189|583690734|FG000|Overall Study|Failure to return|36|||
161628891|NCT02581189|583690734|FG000|Overall Study|Withdrew consent|5|||
161628892|NCT02581189|583690734|FG000|Overall Study|Death|3|||
161628893|NCT02581189|583690734|FG000|Overall Study|Insufficient virological response|2|||
161628894|NCT02581189|583690734|FG000|Overall Study|Other, not specified|7|||
161628895|NCT01514864|583690739|FG000|Overall Study|Disease progression|7|||
161628896|NCT01514864|583690740|FG001|Overall Study|Disease progression|5|||
161628897|NCT01514864|583690739|FG000|Overall Study|Study drug toxicity|2|||
161628898|NCT01514864|583690740|FG001|Overall Study|Study drug toxicity|0|||
161628899|NCT02254681|583690748|FG000|Overall Study|Lack of Efficacy|6|||
161628900|NCT00396097|583690749|FG000|Overall Study|Withdrawal by Subject|17|||
161628901|NCT00396097|583690750|FG001|Overall Study|Withdrawal by Subject|17|||
161628902|NCT00396097|583690749|FG000|Overall Study|Lost to Follow-up|4|||
161628903|NCT00396097|583690750|FG001|Overall Study|Lost to Follow-up|9|||
161628904|NCT00396097|583690749|FG000|Overall Study|Other|3|||
161628905|NCT00396097|583690750|FG001|Overall Study|Other|5|||
161628906|NCT00396097|583690749|FG000|Overall Study|Protocol Violation|0|||
161628907|NCT00396097|583690750|FG001|Overall Study|Protocol Violation|6|||
161628908|NCT00396097|583690749|FG000|Overall Study|Adverse Event|1|||
161628909|NCT00396097|583690750|FG001|Overall Study|Adverse Event|5|||
161628910|NCT00396097|583690749|FG000|Overall Study|Insufficient Clinical Response|1|||
161628911|NCT00396097|583690750|FG001|Overall Study|Insufficient Clinical Response|4|||
161628912|NCT03461211|583690751|FG000|Overall Study|Adverse Event|1|||
161628913|NCT03461211|583690752|FG001|Overall Study|Adverse Event|1|||
161628914|NCT03461211|583690751|FG000|Overall Study|Lack of Efficacy|0|||
161628915|NCT03461211|583690752|FG001|Overall Study|Lack of Efficacy|1|||
161628916|NCT02316847|583690754|FG000|Overall Study|Adverse Event|0|||
161628917|NCT02316847|583690755|FG001|Overall Study|Adverse Event|3|||
161628918|NCT02316847|583690754|FG000|Overall Study|Lost to Follow-up|0|||
161628919|NCT02316847|583690755|FG001|Overall Study|Lost to Follow-up|2|||
161628920|NCT02316847|583690754|FG000|Overall Study|Physician Decision|0|||
161628921|NCT02316847|583690755|FG001|Overall Study|Physician Decision|1|||
161628922|NCT02316847|583690754|FG000|Overall Study|Pregnancy|0|||
161628923|NCT02316847|583690755|FG001|Overall Study|Pregnancy|1|||
161628924|NCT02316847|583690754|FG000|Overall Study|Withdrawal by Subject|2|||
161628925|NCT02316847|583690755|FG001|Overall Study|Withdrawal by Subject|9|||
161628926|NCT02316847|583690754|FG000|Overall Study|Noncompliance with study drug|0|||
161628927|NCT02316847|583690755|FG001|Overall Study|Noncompliance with study drug|3|||
161628928|NCT02316847|583690754|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
161628929|NCT02316847|583690755|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
161628930|NCT01370018|583690756|FG000|Overall Study|Did not meet criteria for analysis|1|||
161628931|NCT02204319|583690757|FG000|Overall Study|Pregnancy|1|||
161628932|NCT02204319|583690757|FG000|Overall Study|Withdrawal by Subject|2|||
161628933|NCT02959177|583690758|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
161628934|NCT02959177|583690759|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
161628935|NCT02959177|583690760|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161628936|NCT02959177|583690758|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
161628937|NCT02959177|583690759|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
161628938|NCT02959177|583690760|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
161628939|NCT02959177|583690758|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
161628940|NCT02959177|583690759|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161628941|NCT02959177|583690760|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161628942|NCT02959177|583690758|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161628943|NCT02959177|583690759|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161628944|NCT02959177|583690760|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161628945|NCT02959177|583690758|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
161628946|NCT02959177|583690759|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
161628947|NCT02959177|583690760|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
161628948|NCT02959177|583690758|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
161628949|NCT02959177|583690759|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
161628950|NCT02959177|583690760|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
161628951|NCT02959177|583690758|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
161628952|NCT02959177|583690759|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
161628953|NCT02959177|583690760|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
161628954|NCT00588341|583690762|FG000|Overall Study|Withdrawal by Subject|3|||
161628955|NCT00588341|583690762|FG000|Overall Study|Not treated due to metastatic disease|1|||
161628956|NCT00588341|583690762|FG000|Overall Study|Patient ineligible|1|||
161628957|NCT02642159|583690763|FG000|Overall Study|Randomized but not treated|1|||
161628958|NCT02642159|583690764|FG001|Overall Study|Randomized but not treated|0|||
161628959|NCT02642159|583690763|FG000|Overall Study|Adverse Event|10|||
161628960|NCT02642159|583690764|FG001|Overall Study|Adverse Event|4|||
161628961|NCT02642159|583690763|FG000|Overall Study|Withdrawal by Subject|9|||
161628962|NCT02642159|583690764|FG001|Overall Study|Withdrawal by Subject|1|||
161628963|NCT02642159|583690763|FG000|Overall Study|Poor compliance to study protocol|1|||
161628964|NCT02642159|583690764|FG001|Overall Study|Poor compliance to study protocol|0|||
161628965|NCT02642159|583690763|FG000|Overall Study|Other than specified above|10|||
161628966|NCT02642159|583690764|FG001|Overall Study|Other than specified above|3|||
161685536|NCT00845728|583901910|FG001|Overall Study|Patient's inability to use the device|6|||
161685537|NCT00845728|583901909|FG000|Overall Study|Abnormal test procedure result (s)|7|||
161685538|NCT00845728|583901910|FG001|Overall Study|Abnormal test procedure result (s)|2|||
161685539|NCT00845728|583901909|FG000|Overall Study|Lost to Follow-up|22|||
161685540|NCT00845728|583901910|FG001|Overall Study|Lost to Follow-up|13|||
161685541|NCT00845728|583901909|FG000|Overall Study|Death|24|||
161685542|NCT00845728|583901910|FG001|Overall Study|Death|26|||
161685543|NCT00845728|583901909|FG000|Overall Study|Administrative Problems|34|||
161628967|NCT03746483|583690765|FG000|Overall Study|Adverse Event|0|||
161628968|NCT03746483|583690766|FG001|Overall Study|Adverse Event|1|||
161685544|NCT00845728|583901910|FG001|Overall Study|Administrative Problems|26|||
161628969|NCT03746483|583690765|FG000|Overall Study|Lack of Efficacy|3|||
161628970|NCT03746483|583690766|FG001|Overall Study|Lack of Efficacy|2|||
161628971|NCT03746483|583690765|FG000|Overall Study|Lost to Follow-up|1|||
161628972|NCT03746483|583690766|FG001|Overall Study|Lost to Follow-up|0|||
161628973|NCT03746483|583690765|FG000|Overall Study|Protocol Violation|2|||
161628974|NCT03746483|583690766|FG001|Overall Study|Protocol Violation|0|||
161628975|NCT00853021|583690767|FG000|Overall Study|Adverse Event|2|||
161628976|NCT00853021|583690767|FG000|Overall Study|Withdrawal by Subject|2|||
161628977|NCT00853021|583690767|FG000|Overall Study|Death|1|||
161628978|NCT02864147|583690768|FG000|Overall Study|Withdrawal by Subject|3|||
161628979|NCT02864147|583690769|FG001|Overall Study|Withdrawal by Subject|2|||
161628980|NCT02864147|583690770|FG002|Overall Study|Withdrawal by Subject|1|||
161628981|NCT02864147|583690768|FG000|Overall Study|Lost to Follow-up|0|||
161628982|NCT02864147|583690769|FG001|Overall Study|Lost to Follow-up|4|||
161628983|NCT02864147|583690770|FG002|Overall Study|Lost to Follow-up|0|||
161628984|NCT02864147|583690768|FG000|Overall Study|Adverse Event|0|||
161628985|NCT02864147|583690769|FG001|Overall Study|Adverse Event|1|||
161628986|NCT02864147|583690770|FG002|Overall Study|Adverse Event|0|||
161628987|NCT02864147|583690768|FG000|Overall Study|Pregnancy|4|||
161628988|NCT02864147|583690769|FG001|Overall Study|Pregnancy|0|||
161628989|NCT02864147|583690770|FG002|Overall Study|Pregnancy|0|||
161628990|NCT02864147|583690768|FG000|Overall Study|Physician Decision|0|||
161628991|NCT02864147|583690769|FG001|Overall Study|Physician Decision|0|||
161628992|NCT02864147|583690770|FG002|Overall Study|Physician Decision|1|||
161628993|NCT02864147|583690768|FG000|Overall Study|Opted for excisional procedures|0|||
161628994|NCT02864147|583690769|FG001|Overall Study|Opted for excisional procedures|0|||
161628995|NCT02864147|583690770|FG002|Overall Study|Opted for excisional procedures|3|||
161628996|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
161628997|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
161628998|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
161628999|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
161629000|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
161629001|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
161629002|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
161629003|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
161629004|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
161629005|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
161629006|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
161629007|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
161629008|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
161629009|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
161629010|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
161629011|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
161629012|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
161629013|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
161629014|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
161629015|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
161629016|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
161629017|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
161629018|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
161629019|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
161629020|NCT02269917|583690771|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
161629021|NCT02269917|583690772|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
161629022|NCT02269917|583690773|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
161629023|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
161629024|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
161629025|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
161629026|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
161629027|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
161629028|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
161629029|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
161685545|NCT00845728|583901909|FG000|Overall Study|Protocol Violation|36|||
161685546|NCT00845728|583901910|FG001|Overall Study|Protocol Violation|24|||
161685547|NCT00845728|583901909|FG000|Overall Study|Lack of Efficacy|51|||
161685548|NCT00845728|583901910|FG001|Overall Study|Lack of Efficacy|39|||
161685549|NCT00845728|583901909|FG000|Overall Study|Adverse Event|101|||
161629030|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
161629031|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
161629032|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
161629033|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
161685550|NCT00845728|583901910|FG001|Overall Study|Adverse Event|96|||
161549287|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Adverse Event|0|||
161549288|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Adverse Event|0|||
161549289|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Adverse Event|0|||
161549290|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Adverse Event|1|||
161549291|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Adverse Event|1|||
161549292|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Adverse Event|0|||
161549293|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Adverse Event|0|||
161549294|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Adverse Event|0|||
161549295|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Adverse Event|0|||
161549296|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Adverse Event|0|||
161549297|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Adverse Event|0|||
161549298|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Adverse Event|0|||
161549299|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549300|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
161549301|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549302|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549303|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
161549304|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
161549305|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549306|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
161549307|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549308|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549309|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
161549310|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
161549311|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
161549312|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
161549313|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
161549314|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
161549315|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
161549316|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
161549317|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
161549318|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
161549319|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
161549320|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
161549321|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
161549322|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
161549323|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
161549324|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
161549325|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Physician Decision|0|||
161549326|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Physician Decision|2|||
161549327|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Physician Decision|0|||
161549328|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Physician Decision|0|||
161549329|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Physician Decision|3|||
161549330|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Physician Decision|0|||
161549331|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Physician Decision|0|||
161549332|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Physician Decision|0|||
161549333|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Physician Decision|0|||
161549334|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Physician Decision|0|||
161549335|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Physician Decision|1|||
161549336|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Physician Decision|3|||
161549337|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Physician Decision|0|||
161549338|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Not Treated|0|||
161549339|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Not Treated|0|||
161549340|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Not Treated|2|||
161549341|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Not Treated|0|||
161549342|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Not Treated|0|||
161549343|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Not Treated|0|||
161549344|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Not Treated|0|||
161549345|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Not Treated|0|||
161549346|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Not Treated|0|||
161549347|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Not Treated|0|||
161549348|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Not Treated|0|||
161549349|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Not Treated|0|||
161549350|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Not Treated|0|||
161549351|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549352|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
161549353|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549354|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549355|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549356|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549357|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161629034|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
161629035|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
161629036|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
161629037|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
161629038|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
161629039|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
161629040|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
161629041|NCT02269917|583690771|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161629042|NCT02269917|583690772|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161629043|NCT02269917|583690773|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
161629044|NCT01770509|583690774|FG000|Overall Study|Injury|0|||
161629045|NCT01770509|583690775|FG001|Overall Study|Injury|1|||
161629046|NCT01770509|583690774|FG000|Overall Study|Lost to Follow-up|1|||
161629047|NCT01770509|583690775|FG001|Overall Study|Lost to Follow-up|2|||
161629048|NCT02865135|583690779|FG000|Overall Study|Death|0|||
161629049|NCT02865135|583690780|FG001|Overall Study|Death|1|||
161629050|NCT02865135|583690781|FG002|Overall Study|Death|0|||
161629051|NCT02865135|583690779|FG000|Overall Study|Progression|6|||
161629052|NCT02865135|583690780|FG001|Overall Study|Progression|2|||
161629053|NCT02865135|583690781|FG002|Overall Study|Progression|2|||
161629054|NCT00985621|583690782|FG000|Overall Study|Adverse Event|2|||
161629055|NCT00985621|583690783|FG001|Overall Study|Adverse Event|3|||
161629056|NCT00985621|583690784|FG002|Overall Study|Adverse Event|4|||
161629057|NCT00985621|583690785|FG003|Overall Study|Adverse Event|16|||
161629058|NCT00985621|583690782|FG000|Overall Study|Lack of Efficacy|10|||
161629059|NCT00985621|583690783|FG001|Overall Study|Lack of Efficacy|6|||
161629060|NCT00985621|583690784|FG002|Overall Study|Lack of Efficacy|5|||
161629061|NCT00985621|583690785|FG003|Overall Study|Lack of Efficacy|12|||
161629062|NCT00985621|583690782|FG000|Overall Study|Lost to Follow-up|2|||
161629063|NCT00985621|583690783|FG001|Overall Study|Lost to Follow-up|3|||
161629064|NCT00985621|583690784|FG002|Overall Study|Lost to Follow-up|4|||
161629065|NCT00985621|583690785|FG003|Overall Study|Lost to Follow-up|4|||
161629066|NCT00985621|583690782|FG000|Overall Study|Study Terminated by Sponsor|89|||
161629067|NCT00985621|583690783|FG001|Overall Study|Study Terminated by Sponsor|108|||
161629068|NCT00985621|583690784|FG002|Overall Study|Study Terminated by Sponsor|99|||
161629069|NCT00985621|583690785|FG003|Overall Study|Study Terminated by Sponsor|92|||
161629070|NCT00985621|583690782|FG000|Overall Study|Protocol Violation|1|||
161629071|NCT00985621|583690783|FG001|Overall Study|Protocol Violation|1|||
161629072|NCT00985621|583690784|FG002|Overall Study|Protocol Violation|1|||
161629073|NCT00985621|583690785|FG003|Overall Study|Protocol Violation|0|||
161629074|NCT00985621|583690782|FG000|Overall Study|Withdrawal by Subject|8|||
161629075|NCT00985621|583690783|FG001|Overall Study|Withdrawal by Subject|10|||
161629076|NCT00985621|583690784|FG002|Overall Study|Withdrawal by Subject|8|||
161629077|NCT00985621|583690785|FG003|Overall Study|Withdrawal by Subject|12|||
161629078|NCT00985621|583690782|FG000|Overall Study|Other|1|||
161629079|NCT00985621|583690783|FG001|Overall Study|Other|0|||
161629080|NCT00985621|583690784|FG002|Overall Study|Other|0|||
161629081|NCT00985621|583690785|FG003|Overall Study|Other|0|||
161629082|NCT00985621|583690782|FG000|Overall Study|Randomized but not Treated|1|||
161629083|NCT00985621|583690783|FG001|Overall Study|Randomized but not Treated|0|||
161629084|NCT00985621|583690784|FG002|Overall Study|Randomized but not Treated|2|||
161629085|NCT00985621|583690785|FG003|Overall Study|Randomized but not Treated|1|||
161629086|NCT04394624|583690789|FG000|Overall Study|Adverse Event|6|||
161629087|NCT04394624|583690790|FG001|Overall Study|Adverse Event|0|||
161629088|NCT04394624|583690789|FG000|Overall Study|Progressive disease|24|||
161629089|NCT04394624|583690790|FG001|Overall Study|Progressive disease|0|||
161629090|NCT04394624|583690789|FG000|Overall Study|Not related to COVID-19|1|||
161629091|NCT04394624|583690790|FG001|Overall Study|Not related to COVID-19|0|||
161629092|NCT00676663|583690791|FG000|Overall Study|Death|43|||
161629093|NCT00676663|583690792|FG001|Overall Study|Death|27|||
161629094|NCT00676663|583690791|FG000|Overall Study|Withdrew Consent|1|||
161629095|NCT00676663|583690792|FG001|Overall Study|Withdrew Consent|8|||
161629096|NCT00676663|583690791|FG000|Overall Study|Lost to Follow-up|1|||
161629097|NCT00676663|583690792|FG001|Overall Study|Lost to Follow-up|3|||
161629098|NCT00714688|583690798|FG000|Overall Study|Lack of Efficacy|14|||
161629099|NCT00714688|583690799|FG001|Overall Study|Lack of Efficacy|1|||
161629100|NCT00714688|583690800|FG002|Overall Study|Lack of Efficacy|4|||
161629101|NCT00714688|583690798|FG000|Overall Study|Withdrawal by Subject|4|||
161629102|NCT00714688|583690799|FG001|Overall Study|Withdrawal by Subject|3|||
161629103|NCT00714688|583690800|FG002|Overall Study|Withdrawal by Subject|3|||
161629104|NCT00714688|583690798|FG000|Overall Study|Lost to Follow-up|5|||
161629105|NCT00714688|583690799|FG001|Overall Study|Lost to Follow-up|2|||
161629106|NCT00714688|583690800|FG002|Overall Study|Lost to Follow-up|0|||
161629107|NCT00714688|583690798|FG000|Overall Study|Adverse Event|2|||
161629108|NCT00714688|583690799|FG001|Overall Study|Adverse Event|15|||
161629109|NCT00714688|583690800|FG002|Overall Study|Adverse Event|19|||
161629110|NCT00714688|583690798|FG000|Overall Study|Subject Non-compliant|3|||
161629111|NCT00714688|583690799|FG001|Overall Study|Subject Non-compliant|5|||
161629112|NCT00714688|583690800|FG002|Overall Study|Subject Non-compliant|5|||
161685551|NCT00845728|583901909|FG000|Overall Study|Withdrawal by Subject|105|||
161685552|NCT00845728|583901910|FG001|Overall Study|Withdrawal by Subject|108|||
161629113|NCT00714688|583690798|FG000|Overall Study|Ineligible to Continue the Study|0|||
161629114|NCT00714688|583690799|FG001|Overall Study|Ineligible to Continue the Study|1|||
161629115|NCT00714688|583690800|FG002|Overall Study|Ineligible to Continue the Study|1|||
161629116|NCT00714688|583690798|FG000|Overall Study|Sponsor's Decision|0|||
161629117|NCT00714688|583690799|FG001|Overall Study|Sponsor's Decision|2|||
161629118|NCT00714688|583690800|FG002|Overall Study|Sponsor's Decision|0|||
161629119|NCT00714688|583690798|FG000|Overall Study|Other|1|||
161629120|NCT00714688|583690799|FG001|Overall Study|Other|6|||
161629121|NCT00714688|583690800|FG002|Overall Study|Other|5|||
161629122|NCT00500539|583690801|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
161629123|NCT00500539|583690801|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
161629124|NCT00500539|583690801|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
161629125|NCT00500539|583690801|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
161629126|NCT00500539|583690801|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
161629127|NCT00500539|583690801|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
161629128|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
161629129|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
161629130|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
161629131|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
161629132|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Death|1|||
161629133|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
161629134|NCT00500539|583690801|FG000|Follow-up Period (16 Weeks)|Missing|3|||
161629135|NCT04853394|583690802|FG000|Follow-up Interviews|Lost to Follow-up|22|||
161629136|NCT04853394|583690803|FG001|Follow-up Interviews|Lost to Follow-up|15|||
161629137|NCT01772147|583692528|FG000|Overall Study|Adverse Event|13|||
161629138|NCT01772147|583692529|FG001|Overall Study|Adverse Event|10|||
161629139|NCT01772147|583692530|FG002|Overall Study|Adverse Event|6|||
161629140|NCT01772147|583692528|FG000|Overall Study|Withdrew Consent|7|||
161629141|NCT01772147|583692529|FG001|Overall Study|Withdrew Consent|8|||
161629142|NCT01772147|583692530|FG002|Overall Study|Withdrew Consent|4|||
161629143|NCT01772147|583692528|FG000|Overall Study|Lost to Follow-up|1|||
161629144|NCT01772147|583692529|FG001|Overall Study|Lost to Follow-up|0|||
161629145|NCT01772147|583692530|FG002|Overall Study|Lost to Follow-up|1|||
161629146|NCT01772147|583692528|FG000|Overall Study|Protocol Deviation|2|||
161629147|NCT01772147|583692529|FG001|Overall Study|Protocol Deviation|1|||
161629148|NCT01772147|583692530|FG002|Overall Study|Protocol Deviation|1|||
161629149|NCT01772147|583692528|FG000|Overall Study|Lack of Efficacy|8|||
161629150|NCT01772147|583692529|FG001|Overall Study|Lack of Efficacy|6|||
161629151|NCT01772147|583692530|FG002|Overall Study|Lack of Efficacy|6|||
161629152|NCT00961896|583692543|FG000|Overall Study|Abnormal laboratory value|0|||
161629153|NCT00961896|583692544|FG001|Overall Study|Abnormal laboratory value|0|||
161629154|NCT00961896|583692545|FG002|Overall Study|Abnormal laboratory value|1|||
161629155|NCT01983462|583692546|FG000|Overall Study|Adverse Event|1|||
161629156|NCT01983462|583692547|FG001|Overall Study|Adverse Event|0|||
161629157|NCT01983462|583692548|FG002|Overall Study|Adverse Event|0|||
161629158|NCT00755716|583692549|FG000|Overall Study|Adverse Event|1|||
161629159|NCT00755716|583692550|FG001|Overall Study|Adverse Event|4|||
161629160|NCT00755716|583692551|FG002|Overall Study|Adverse Event|1|||
161629161|NCT00755716|583692549|FG000|Overall Study|Lack of Efficacy|2|||
161629162|NCT00755716|583692550|FG001|Overall Study|Lack of Efficacy|0|||
161629163|NCT00755716|583692551|FG002|Overall Study|Lack of Efficacy|0|||
161629164|NCT00755716|583692549|FG000|Overall Study|Lost to Follow-up|5|||
161629165|NCT00755716|583692550|FG001|Overall Study|Lost to Follow-up|3|||
161629166|NCT00755716|583692551|FG002|Overall Study|Lost to Follow-up|1|||
161629167|NCT00755716|583692549|FG000|Overall Study|work schedule issues|0|||
161629168|NCT00755716|583692550|FG001|Overall Study|work schedule issues|1|||
161629169|NCT00755716|583692551|FG002|Overall Study|work schedule issues|1|||
161629170|NCT00843115|583692552|FG000|Overall Study|Death|4|||
161629171|NCT00843115|583692552|FG000|Overall Study|Adverse Event|30|||
161629172|NCT00843115|583692552|FG000|Overall Study|Lost to Follow-up|4|||
161685553|NCT03259074|583901911|FG000|Overall Study|Adverse Event|9|||
161629173|NCT00843115|583692552|FG000|Overall Study|Withdrawal by Subject|17|||
161629174|NCT00843115|583692552|FG000|Overall Study|Family wanted meds stopped|1|||
161629175|NCT00843115|583692552|FG000|Overall Study|Family does not want continuation|1|||
161629176|NCT00843115|583692552|FG000|Overall Study|Patient forgot to take meds|1|||
161629177|NCT00843115|583692552|FG000|Overall Study|Does not meet entrance criteria|1|||
161629178|NCT00843115|583692552|FG000|Overall Study|Physician Decision|1|||
161629179|NCT00843115|583692552|FG000|Overall Study|Family discontinued meds|1|||
161629180|NCT00843115|583692552|FG000|Overall Study|patient took for 2 days then stopped|1|||
161629181|NCT00843115|583692552|FG000|Overall Study|patient never took the medication|1|||
161629182|NCT00843115|583692552|FG000|Overall Study|hospitalized due to deterioration|1|||
161629183|NCT00843115|583692552|FG000|Overall Study|week 12 not done|1|||
161629184|NCT00843115|583692552|FG000|Overall Study|Syndrome De Glissement|1|||
161629185|NCT02005029|583692553|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
161629186|NCT02005029|583692554|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
161629187|NCT02621047|583692555|FG000|Overall Study|Adverse Event|0|||
161629188|NCT02621047|583692556|FG001|Overall Study|Adverse Event|0|||
161629189|NCT02621047|583692557|FG002|Overall Study|Adverse Event|1|||
161629190|NCT03772041|583692560|FG000|Overall Study|Adverse Event|8|||
161629191|NCT03772041|583692561|FG001|Overall Study|Adverse Event|3|||
161629192|NCT03772041|583692560|FG000|Overall Study|Withdrawal by Subject|0|||
161629193|NCT03772041|583692561|FG001|Overall Study|Withdrawal by Subject|2|||
161629194|NCT03772041|583692560|FG000|Overall Study|Protocol Violation|4|||
161685554|NCT03259074|583901912|FG001|Overall Study|Adverse Event|12|||
161685555|NCT03259074|583901913|FG002|Overall Study|Adverse Event|8|||
161685556|NCT03259074|583901911|FG000|Overall Study|Death|1|||
161685557|NCT03259074|583901912|FG001|Overall Study|Death|1|||
161685558|NCT03259074|583901913|FG002|Overall Study|Death|3|||
161685559|NCT03259074|583901911|FG000|Overall Study|Lost to Follow-up|2|||
161629195|NCT03772041|583692561|FG001|Overall Study|Protocol Violation|2|||
161629196|NCT03772041|583692560|FG000|Overall Study|Physician Decision|2|||
161685560|NCT03259074|583901912|FG001|Overall Study|Lost to Follow-up|4|||
161685561|NCT03259074|583901913|FG002|Overall Study|Lost to Follow-up|3|||
161685562|NCT03259074|583901911|FG000|Overall Study|New Therapy For Study Indication|1|||
161685563|NCT03259074|583901912|FG001|Overall Study|New Therapy For Study Indication|2|||
161685564|NCT03259074|583901913|FG002|Overall Study|New Therapy For Study Indication|2|||
161685565|NCT03259074|583901911|FG000|Overall Study|Physician Decision|4|||
161685566|NCT03259074|583901912|FG001|Overall Study|Physician Decision|12|||
161685567|NCT03259074|583901913|FG002|Overall Study|Physician Decision|10|||
161685568|NCT03259074|583901911|FG000|Overall Study|Pregnancy|1|||
161685569|NCT03259074|583901912|FG001|Overall Study|Pregnancy|1|||
161685570|NCT03259074|583901913|FG002|Overall Study|Pregnancy|0|||
161685571|NCT03259074|583901911|FG000|Overall Study|Progressive Disease|1|||
161685572|NCT03259074|583901912|FG001|Overall Study|Progressive Disease|0|||
161685573|NCT03259074|583901913|FG002|Overall Study|Progressive Disease|0|||
161685574|NCT03259074|583901911|FG000|Overall Study|Protocol Deviation|1|||
161629197|NCT03772041|583692561|FG001|Overall Study|Physician Decision|3|||
161629198|NCT01525641|583692562|FG000|Overall Study|Case report form not collected|25|||
161629199|NCT01525641|583692562|FG000|Overall Study|No visit since the first visit|16|||
161629200|NCT01525641|583692562|FG000|Overall Study|Adverse Event|73|||
161629201|NCT01525641|583692562|FG000|Overall Study|Lack of Efficacy|24|||
161629202|NCT01525641|583692562|FG000|Overall Study|Improvement|5|||
161629203|NCT01525641|583692562|FG000|Overall Study|Lost to follow-up (relocation)|1|||
161629204|NCT01525641|583692562|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
161629205|NCT01525641|583692562|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
161685575|NCT03259074|583901912|FG001|Overall Study|Protocol Deviation|1|||
161685576|NCT03259074|583901913|FG002|Overall Study|Protocol Deviation|3|||
161685577|NCT03259074|583901911|FG000|Overall Study|Subject/Guardian Decision|13|||
161685578|NCT03259074|583901912|FG001|Overall Study|Subject/Guardian Decision|16|||
161685579|NCT03259074|583901913|FG002|Overall Study|Subject/Guardian Decision|14|||
161685580|NCT00705783|583901924|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
161629206|NCT01525641|583692562|FG000|Overall Study|Other than stated above|7|||
161629207|NCT03371485|583692567|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
161629208|NCT03371485|583692567|FG000|2-year Follow-up|Death|5|||
161629209|NCT01264887|583692568|FG000|Overall Study|Adverse Event|5|||
161629210|NCT01264887|583692568|FG000|Overall Study|Death|7|||
161629211|NCT01264887|583692568|FG000|Overall Study|Lack of Efficacy|5|||
161629212|NCT01264887|583692568|FG000|Overall Study|Physician Decision|4|||
161629213|NCT01264887|583692568|FG000|Overall Study|Withdrawal by Subject|6|||
161629214|NCT01264887|583692568|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
161629215|NCT01264887|583692568|FG000|Overall Study|Other|2|||
161629216|NCT02853305|583692572|FG000|Overall Study|Death|287|||
161629217|NCT02853305|583692573|FG001|Overall Study|Death|249|||
161629218|NCT02853305|583692574|FG002|Overall Study|Death|300|||
161629219|NCT02853305|583692572|FG000|Overall Study|Withdrawal by Subject|2|||
161629220|NCT02853305|583692573|FG001|Overall Study|Withdrawal by Subject|8|||
161629221|NCT02853305|583692574|FG002|Overall Study|Withdrawal by Subject|3|||
161629222|NCT02853305|583692572|FG000|Overall Study|Transferred to Extension Study|46|||
161629223|NCT02853305|583692573|FG001|Overall Study|Transferred to Extension Study|30|||
161629224|NCT02853305|583692574|FG002|Overall Study|Transferred to Extension Study|25|||
161629225|NCT02853305|583692572|FG000|Overall Study|Did Not Continue on Extension Study|16|||
161629226|NCT02853305|583692573|FG001|Overall Study|Did Not Continue on Extension Study|20|||
161629227|NCT02853305|583692574|FG002|Overall Study|Did Not Continue on Extension Study|24|||
161629228|NCT02381652|583692577|FG000|Overall Study|Withdrawal by Subject|0|||
161629229|NCT02381652|583692578|FG001|Overall Study|Withdrawal by Subject|0|||
161629230|NCT02381652|583692579|FG002|Overall Study|Withdrawal by Subject|1|||
161629231|NCT03544229|583692580|FG000|Overall Study|Adverse Event|1|||
161629232|NCT03544229|583692581|FG001|Overall Study|Adverse Event|0|||
161629233|NCT03544229|583692582|FG002|Overall Study|Adverse Event|1|||
161629234|NCT03544229|583692583|FG003|Overall Study|Adverse Event|0|||
161629235|NCT03544229|583692580|FG000|Overall Study|Protocol Deviation|0|||
161629236|NCT03544229|583692581|FG001|Overall Study|Protocol Deviation|0|||
161629237|NCT03544229|583692582|FG002|Overall Study|Protocol Deviation|1|||
161629238|NCT03544229|583692583|FG003|Overall Study|Protocol Deviation|0|||
161629239|NCT03544229|583692580|FG000|Overall Study|Lost to Follow-up|3|||
161629240|NCT03544229|583692581|FG001|Overall Study|Lost to Follow-up|0|||
161629241|NCT03544229|583692582|FG002|Overall Study|Lost to Follow-up|0|||
161629242|NCT03544229|583692583|FG003|Overall Study|Lost to Follow-up|2|||
161629243|NCT03544229|583692580|FG000|Overall Study|Voluntary Withdrawal|2|||
161629244|NCT03544229|583692581|FG001|Overall Study|Voluntary Withdrawal|1|||
161629245|NCT03544229|583692582|FG002|Overall Study|Voluntary Withdrawal|3|||
161629246|NCT03544229|583692583|FG003|Overall Study|Voluntary Withdrawal|0|||
161629247|NCT03544229|583692580|FG000|Overall Study|Lack of Efficacy|0|||
161629248|NCT03544229|583692581|FG001|Overall Study|Lack of Efficacy|1|||
161629249|NCT03544229|583692582|FG002|Overall Study|Lack of Efficacy|0|||
161629250|NCT03544229|583692583|FG003|Overall Study|Lack of Efficacy|0|||
161629251|NCT01836198|583692584|FG000|Part A, Period 2|Protocol Violation|0|||
161629252|NCT01836198|583692585|FG001|Part A, Period 2|Protocol Violation|1|||
161629253|NCT01836198|583692586|FG002|Part A, Period 2|Protocol Violation|0|||
161629254|NCT03187353|583692587|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
161629255|NCT03187353|583692588|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
161629256|NCT03187353|583692587|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
161629257|NCT03187353|583692588|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161629258|NCT03187353|583692587|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161629259|NCT03187353|583692588|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
161629260|NCT03187353|583692587|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161629261|NCT03187353|583692588|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
161629262|NCT03187353|583692587|FG000|Washout (2 Weeks)|Adverse Event|2|||
161629263|NCT03187353|583692588|FG001|Washout (2 Weeks)|Adverse Event|0|||
161629264|NCT03187353|583692587|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
161629265|NCT03187353|583692588|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
161629266|NCT02460562|583692593|FG000|Overall Study|Lost to Follow-up|15|||
161629267|NCT02460562|583692594|FG001|Overall Study|Lost to Follow-up|16|||
161629268|NCT01061775|583692595|FG000|Overall Study|Physician Decision|2|||
161629269|NCT01061775|583692595|FG000|Overall Study|Lost to Follow-up|1|||
161685581|NCT00705783|583901925|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
161629270|NCT01924806|583692600|FG000|Overall Study|Physician Decision|2|||
161629271|NCT01924806|583692601|FG001|Overall Study|Physician Decision|1|||
161629272|NCT01954771|583692602|FG000|Overall Study|Missing HbA1c of end-point|1|||
161629273|NCT01954771|583692603|FG001|Overall Study|Missing HbA1c of end-point|1|||
161629274|NCT01954771|583692604|FG002|Overall Study|Missing HbA1c of end-point|0|||
161629275|NCT01954771|583692602|FG000|Overall Study|Missing CGMS of end-point|1|||
161629276|NCT01954771|583692603|FG001|Overall Study|Missing CGMS of end-point|1|||
161629277|NCT01954771|583692604|FG002|Overall Study|Missing CGMS of end-point|0|||
161629278|NCT01954771|583692602|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
161629279|NCT01954771|583692603|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
161685582|NCT00705783|583901926|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
161629280|NCT01954771|583692604|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
161629281|NCT02498418|583692608|FG000|Overall Study|Lack of Efficacy|0|||
161629282|NCT02498418|583692609|FG001|Overall Study|Lack of Efficacy|0|||
161629283|NCT02498418|583692610|FG002|Overall Study|Lack of Efficacy|1|||
161629284|NCT02498418|583692608|FG000|Overall Study|Withdrawal by Subject|2|||
161629285|NCT02498418|583692609|FG001|Overall Study|Withdrawal by Subject|0|||
161629286|NCT02498418|583692610|FG002|Overall Study|Withdrawal by Subject|3|||
161629287|NCT02498418|583692608|FG000|Overall Study|Lost to Follow-up|0|||
161629288|NCT02498418|583692609|FG001|Overall Study|Lost to Follow-up|1|||
161629289|NCT02498418|583692610|FG002|Overall Study|Lost to Follow-up|1|||
161629290|NCT02498418|583692608|FG000|Overall Study|Participant taken prohibited medication|0|||
161629291|NCT02498418|583692609|FG001|Overall Study|Participant taken prohibited medication|1|||
161629292|NCT02498418|583692610|FG002|Overall Study|Participant taken prohibited medication|1|||
161629293|NCT01026103|583692611|FG000|Overall Study|Physician Decision|1|||
161629294|NCT01026103|583692611|FG000|Overall Study|did not receive study device bc of error|1|||
161629295|NCT03635775|583692613|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
161629296|NCT03635775|583692614|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
161629297|NCT03635775|583692615|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
161629298|NCT03635775|583692616|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
161629299|NCT00762502|583692617|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
161629300|NCT00762502|583692618|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
161629301|NCT00762502|583692619|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
161629302|NCT00762502|583692617|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
161629303|NCT00762502|583692618|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
161629304|NCT00762502|583692619|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
161629305|NCT00762502|583692617|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
161629306|NCT00762502|583692618|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
161629307|NCT00762502|583692619|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
161629308|NCT02996097|583692626|FG000|Overall Study|Lost to Follow-up|11|||
161685583|NCT00705783|583901924|FG000|Conversion Phase|Lost to Follow-up|13|||
161685584|NCT00705783|583901925|FG001|Conversion Phase|Lost to Follow-up|0|||
161685585|NCT00705783|583901926|FG002|Conversion Phase|Lost to Follow-up|0|||
161685586|NCT00705783|583901924|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
161685587|NCT00705783|583901925|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
161685588|NCT00705783|583901926|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
161685589|NCT00705783|583901924|FG000|Conversion Phase|Withdrawn by Investigator|4|||
161685590|NCT00705783|583901925|FG001|Conversion Phase|Withdrawn by Investigator|0|||
161685591|NCT00705783|583901926|FG002|Conversion Phase|Withdrawn by Investigator|0|||
161685592|NCT00705783|583901924|FG000|Conversion Phase|Withdrew Consent|24|||
161685593|NCT00705783|583901925|FG001|Conversion Phase|Withdrew Consent|0|||
161685594|NCT00705783|583901926|FG002|Conversion Phase|Withdrew Consent|0|||
161685595|NCT00705783|583901924|FG000|Conversion Phase|Protocol Deviation|2|||
161685596|NCT00705783|583901925|FG001|Conversion Phase|Protocol Deviation|0|||
161685597|NCT00705783|583901926|FG002|Conversion Phase|Protocol Deviation|0|||
161685598|NCT00705783|583901924|FG000|Conversion Phase|Adverse Event|11|||
161685599|NCT00705783|583901925|FG001|Conversion Phase|Adverse Event|0|||
161685600|NCT00705783|583901926|FG002|Conversion Phase|Adverse Event|0|||
161685601|NCT00705783|583901924|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
161685602|NCT00705783|583901925|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161685603|NCT00705783|583901926|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161685604|NCT00705783|583901924|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
161685605|NCT00705783|583901925|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161685606|NCT00705783|583901926|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161685607|NCT00705783|583901924|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
161685608|NCT00705783|583901925|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
161685609|NCT00705783|583901926|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
161685610|NCT00705783|583901924|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
161685611|NCT00705783|583901925|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
161685612|NCT00705783|583901926|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
161685613|NCT00705783|583901924|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
161685614|NCT00705783|583901925|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161685615|NCT00705783|583901926|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161685616|NCT00705783|583901924|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
161685617|NCT00705783|583901925|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161685618|NCT00705783|583901926|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161629309|NCT02996097|583692627|FG001|Overall Study|Lost to Follow-up|11|||
161629310|NCT03638258|583692628|FG000|Overall Study|Adverse Event|1|||
161629311|NCT03638258|583692629|FG001|Overall Study|Adverse Event|0|||
161629312|NCT03638258|583692630|FG002|Overall Study|Adverse Event|2|||
161629313|NCT03638258|583692628|FG000|Overall Study|Lost to Follow-up|2|||
161629314|NCT03638258|583692629|FG001|Overall Study|Lost to Follow-up|4|||
161685619|NCT00705783|583901924|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
161629315|NCT03638258|583692630|FG002|Overall Study|Lost to Follow-up|5|||
161629316|NCT03638258|583692628|FG000|Overall Study|Pregnancy|0|||
161629317|NCT03638258|583692629|FG001|Overall Study|Pregnancy|0|||
161629318|NCT03638258|583692630|FG002|Overall Study|Pregnancy|1|||
161629319|NCT03638258|583692628|FG000|Overall Study|Protocol Violation|0|||
161629320|NCT03638258|583692629|FG001|Overall Study|Protocol Violation|0|||
161629321|NCT03638258|583692630|FG002|Overall Study|Protocol Violation|1|||
161629322|NCT03638258|583692628|FG000|Overall Study|Withdrawal by Subject|4|||
161629323|NCT03638258|583692629|FG001|Overall Study|Withdrawal by Subject|5|||
161629324|NCT03638258|583692630|FG002|Overall Study|Withdrawal by Subject|12|||
161629325|NCT03638258|583692628|FG000|Overall Study|Lack of Efficacy|0|||
161629326|NCT03638258|583692629|FG001|Overall Study|Lack of Efficacy|0|||
161629327|NCT03638258|583692630|FG002|Overall Study|Lack of Efficacy|2|||
161629328|NCT02205476|583692631|FG000|Overall Study|Study termination by Sponsor|7|||
161629329|NCT02205476|583692632|FG001|Overall Study|Study termination by Sponsor|3|||
161629330|NCT02391545|583692645|FG000|Overall Study|Death|0|||
161629331|NCT02391545|583692646|FG001|Overall Study|Death|2|||
161629332|NCT02391545|583692645|FG000|Overall Study|Lost to Follow-up|0|||
161629333|NCT02391545|583692646|FG001|Overall Study|Lost to Follow-up|1|||
161629334|NCT02391545|583692645|FG000|Overall Study|Termination of study by sponsor|20|||
161629335|NCT02391545|583692646|FG001|Overall Study|Termination of study by sponsor|20|||
161629336|NCT02391545|583692645|FG000|Overall Study|Withdrawal by Subject|0|||
161629337|NCT02391545|583692646|FG001|Overall Study|Withdrawal by Subject|1|||
161629338|NCT02391545|583692645|FG000|Overall Study|Other Reasons|6|||
161629339|NCT02391545|583692646|FG001|Overall Study|Other Reasons|4|||
161629340|NCT02016690|583692647|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
161629341|NCT02016690|583692647|FG000|Overall Study|Excluded from SAS: Duplication|2|||
161629342|NCT02016690|583692647|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
161629343|NCT02016690|583692647|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
161629344|NCT02016690|583692647|FG000|Overall Study|Did not meet inclusion criteria|13|||
161629345|NCT02016690|583692647|FG000|Overall Study|Hospitalized for RSV at study start|3|||
161629346|NCT01222078|583692648|FG000|Overall Study|Early termination of the study|1|||
161629347|NCT04089332|583692649|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
161629348|NCT04089332|583692649|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
161629349|NCT04089332|583692649|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
161629350|NCT02588027|583692658|FG000|Overall Study|Withdrawal by Subject|1|||
161629351|NCT02588027|583692659|FG001|Overall Study|Withdrawal by Subject|3|||
161629352|NCT02588027|583692658|FG000|Overall Study|Protocol Violation|4|||
161629353|NCT02588027|583692659|FG001|Overall Study|Protocol Violation|1|||
161629354|NCT00603278|583692663|FG000|Overall Study|Lack of Efficacy|35|||
161629355|NCT00603278|583692664|FG001|Overall Study|Lack of Efficacy|10|||
161629356|NCT00603278|583692665|FG002|Overall Study|Lack of Efficacy|11|||
161629357|NCT00603278|583692666|FG003|Overall Study|Lack of Efficacy|8|||
161629358|NCT00603278|583692667|FG004|Overall Study|Lack of Efficacy|7|||
161629359|NCT00603278|583692668|FG005|Overall Study|Lack of Efficacy|14|||
161629360|NCT00603278|583692663|FG000|Overall Study|Adverse Event|0|||
161629361|NCT00603278|583692664|FG001|Overall Study|Adverse Event|3|||
161629362|NCT00603278|583692665|FG002|Overall Study|Adverse Event|1|||
161629363|NCT00603278|583692666|FG003|Overall Study|Adverse Event|0|||
161629364|NCT00603278|583692667|FG004|Overall Study|Adverse Event|2|||
161629365|NCT00603278|583692668|FG005|Overall Study|Adverse Event|1|||
161629366|NCT00603278|583692663|FG000|Overall Study|Withdrawal by Subject|2|||
161629367|NCT00603278|583692664|FG001|Overall Study|Withdrawal by Subject|3|||
161629368|NCT00603278|583692665|FG002|Overall Study|Withdrawal by Subject|1|||
161629369|NCT00603278|583692666|FG003|Overall Study|Withdrawal by Subject|2|||
161629370|NCT00603278|583692667|FG004|Overall Study|Withdrawal by Subject|1|||
161629371|NCT00603278|583692668|FG005|Overall Study|Withdrawal by Subject|2|||
161685620|NCT00705783|583901925|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
161629372|NCT00603278|583692663|FG000|Overall Study|Protocol Violation|3|||
161629373|NCT00603278|583692664|FG001|Overall Study|Protocol Violation|0|||
161629374|NCT00603278|583692665|FG002|Overall Study|Protocol Violation|1|||
161629375|NCT00603278|583692666|FG003|Overall Study|Protocol Violation|1|||
161629376|NCT00603278|583692667|FG004|Overall Study|Protocol Violation|0|||
161629377|NCT00603278|583692668|FG005|Overall Study|Protocol Violation|1|||
161629378|NCT00603278|583692663|FG000|Overall Study|Physician Decision|0|||
161629379|NCT00603278|583692664|FG001|Overall Study|Physician Decision|1|||
161629380|NCT00603278|583692665|FG002|Overall Study|Physician Decision|0|||
161629381|NCT00603278|583692666|FG003|Overall Study|Physician Decision|0|||
161629382|NCT00603278|583692667|FG004|Overall Study|Physician Decision|2|||
161629383|NCT00603278|583692668|FG005|Overall Study|Physician Decision|1|||
161629384|NCT00603278|583692663|FG000|Overall Study|Lost to Follow-up|1|||
161629385|NCT00603278|583692664|FG001|Overall Study|Lost to Follow-up|0|||
161629386|NCT00603278|583692665|FG002|Overall Study|Lost to Follow-up|0|||
161629387|NCT00603278|583692666|FG003|Overall Study|Lost to Follow-up|0|||
161629388|NCT00603278|583692667|FG004|Overall Study|Lost to Follow-up|1|||
161629389|NCT00603278|583692668|FG005|Overall Study|Lost to Follow-up|0|||
161629390|NCT01123642|583692669|FG000|Overall Study|Lost to Follow-up|23|||
161629391|NCT01123642|583692669|FG000|Overall Study|Withdrawal by Subject|9|||
161629392|NCT01123642|583692669|FG000|Overall Study|ineligible at baseline assessment|36|||
161629393|NCT04853238|583692670|FG000|Overall Study|Death|4|||
161629394|NCT04853238|583692671|FG001|Overall Study|Death|0|||
161629395|NCT04853238|583692672|FG002|Overall Study|Death|2|||
161629396|NCT04853238|583692670|FG000|Overall Study|Lost to Follow-up|16|||
161629397|NCT04853238|583692671|FG001|Overall Study|Lost to Follow-up|2|||
161629398|NCT04853238|583692672|FG002|Overall Study|Lost to Follow-up|37|||
161629399|NCT04853238|583692670|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
161629400|NCT04853238|583692671|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
161629401|NCT04853238|583692672|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
161629402|NCT04853238|583692670|FG000|Overall Study|Withdrawal by Subject|6|||
161629403|NCT04853238|583692671|FG001|Overall Study|Withdrawal by Subject|0|||
161629404|NCT04853238|583692672|FG002|Overall Study|Withdrawal by Subject|21|||
161629405|NCT04853238|583692670|FG000|Overall Study|Physician Decision|0|||
161629406|NCT04853238|583692671|FG001|Overall Study|Physician Decision|0|||
161629407|NCT04853238|583692672|FG002|Overall Study|Physician Decision|2|||
161629408|NCT04853238|583692670|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
161629409|NCT04853238|583692671|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
161629410|NCT04853238|583692672|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
161629411|NCT00796614|583694297|FG000|Overall Study|Adverse Event|1|||
161629412|NCT00796614|583694298|FG001|Overall Study|Adverse Event|2|||
161629413|NCT00796614|583694299|FG002|Overall Study|Adverse Event|0|||
161629414|NCT00796614|583694300|FG003|Overall Study|Adverse Event|0|||
161629415|NCT00796614|583694297|FG000|Overall Study|Protocol Violation|0|||
161629416|NCT00796614|583694298|FG001|Overall Study|Protocol Violation|0|||
161629417|NCT00796614|583694299|FG002|Overall Study|Protocol Violation|2|||
161629418|NCT00796614|583694300|FG003|Overall Study|Protocol Violation|0|||
161629419|NCT00796614|583694297|FG000|Overall Study|Lost to Follow-up|2|||
161629420|NCT00796614|583694298|FG001|Overall Study|Lost to Follow-up|2|||
161629421|NCT00796614|583694299|FG002|Overall Study|Lost to Follow-up|1|||
161629422|NCT00796614|583694300|FG003|Overall Study|Lost to Follow-up|0|||
161629423|NCT00796614|583694297|FG000|Overall Study|Withdrawal by Subject|1|||
161629424|NCT00796614|583694298|FG001|Overall Study|Withdrawal by Subject|0|||
161629425|NCT00796614|583694299|FG002|Overall Study|Withdrawal by Subject|0|||
161629426|NCT00796614|583694300|FG003|Overall Study|Withdrawal by Subject|1|||
161629427|NCT00796614|583694297|FG000|Overall Study|Other than stated|1|||
161629428|NCT00796614|583694298|FG001|Overall Study|Other than stated|0|||
161629429|NCT00796614|583694299|FG002|Overall Study|Other than stated|0|||
161629430|NCT00796614|583694300|FG003|Overall Study|Other than stated|0|||
161629431|NCT00740597|583694301|FG000|Overall Study|insurance would not cover treatment|1|||
161629432|NCT00746785|583694303|FG000|Overall Study|Lost to Follow-up|29|||
161629433|NCT00746785|583694304|FG001|Overall Study|Lost to Follow-up|25|||
161629434|NCT00746785|583694305|FG002|Overall Study|Lost to Follow-up|27|||
161629435|NCT01231464|583694306|FG000|Overall Study|Adverse Event|0|||
161629436|NCT01231464|583694307|FG001|Overall Study|Adverse Event|1|||
161629437|NCT01231464|583694306|FG000|Overall Study|Protocol Violation|1|||
161629438|NCT01231464|583694307|FG001|Overall Study|Protocol Violation|2|||
161629439|NCT01231464|583694306|FG000|Overall Study|Lost to Follow-up|1|||
161629440|NCT01231464|583694307|FG001|Overall Study|Lost to Follow-up|2|||
161629441|NCT01231464|583694306|FG000|Overall Study|Withdrawal by Subject|3|||
161629442|NCT01231464|583694307|FG001|Overall Study|Withdrawal by Subject|2|||
161629443|NCT00957996|583694308|FG000|Overall Study|Death|4|||
161629444|NCT00957996|583694309|FG001|Overall Study|Death|10|||
161629445|NCT00957996|583694308|FG000|Overall Study|Lost to Follow-up|4|||
161685621|NCT00705783|583901926|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
161685622|NCT00705783|583901924|FG000|Oral Stabilization Phase|Adverse Event|14|||
161685623|NCT00705783|583901925|FG001|Oral Stabilization Phase|Adverse Event|0|||
161685624|NCT00705783|583901926|FG002|Oral Stabilization Phase|Adverse Event|0|||
161685625|NCT00705783|583901924|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
161685626|NCT00705783|583901925|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685627|NCT00705783|583901926|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685628|NCT00705783|583901924|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
161685629|NCT00705783|583901925|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161685630|NCT00705783|583901926|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161685631|NCT00705783|583901924|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
161685632|NCT00705783|583901925|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
161685633|NCT00705783|583901926|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
161685634|NCT00705783|583901924|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
161685635|NCT00705783|583901925|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
161685636|NCT00705783|583901926|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
161685637|NCT00705783|583901924|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
161685638|NCT00705783|583901925|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
161685639|NCT00705783|583901926|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
161685640|NCT00705783|583901924|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
161685641|NCT00705783|583901925|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
161685642|NCT00705783|583901926|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
161685643|NCT00705783|583901924|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
161685644|NCT00705783|583901925|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
161685645|NCT00705783|583901926|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
161685646|NCT00705783|583901924|FG000|Depot Stabilization Phase|Adverse Event|17|||
161685647|NCT00705783|583901925|FG001|Depot Stabilization Phase|Adverse Event|0|||
161685648|NCT00705783|583901926|FG002|Depot Stabilization Phase|Adverse Event|0|||
161629446|NCT00957996|583694309|FG001|Overall Study|Lost to Follow-up|7|||
161629447|NCT00957996|583694308|FG000|Overall Study|Withdrawal by Subject|9|||
161629448|NCT00957996|583694309|FG001|Overall Study|Withdrawal by Subject|2|||
161629449|NCT00957996|583694308|FG000|Overall Study|Adverse Event|2|||
161629450|NCT00957996|583694309|FG001|Overall Study|Adverse Event|1|||
161629451|NCT00957996|583694308|FG000|Overall Study|Physician Decision|1|||
161629452|NCT00957996|583694309|FG001|Overall Study|Physician Decision|1|||
161629453|NCT00957996|583694308|FG000|Overall Study|Influenza-related complication|0|||
161629454|NCT00957996|583694309|FG001|Overall Study|Influenza-related complication|1|||
161629455|NCT00957996|583694308|FG000|Overall Study|Missing|1|||
161629456|NCT00957996|583694309|FG001|Overall Study|Missing|0|||
161629457|NCT00957996|583694308|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
161629458|NCT00957996|583694309|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
161629459|NCT00381797|583694317|FG000|Overall Study|Withdrawal by Subject|1|||
161629460|NCT00381797|583694318|FG001|Overall Study|Withdrawal by Subject|1|||
161629461|NCT00381797|583694319|FG002|Overall Study|Withdrawal by Subject|0|||
161629462|NCT00381797|583694320|FG003|Overall Study|Withdrawal by Subject|0|||
161629463|NCT00381797|583694321|FG004|Overall Study|Withdrawal by Subject|2|||
161629464|NCT00381797|583694317|FG000|Overall Study|Ineligible|0|||
161629465|NCT00381797|583694318|FG001|Overall Study|Ineligible|0|||
161629466|NCT00381797|583694319|FG002|Overall Study|Ineligible|0|||
161629467|NCT00381797|583694320|FG003|Overall Study|Ineligible|1|||
161629468|NCT00381797|583694321|FG004|Overall Study|Ineligible|0|||
161629469|NCT00684203|583694322|FG000|Overall Study|Adverse Event|6|||
161629470|NCT00684203|583694323|FG001|Overall Study|Adverse Event|4|||
161629471|NCT00684203|583694324|FG002|Overall Study|Adverse Event|8|||
161629472|NCT00684203|583694325|FG003|Overall Study|Adverse Event|0|||
161629473|NCT00684203|583694326|FG004|Overall Study|Adverse Event|0|||
161629474|NCT00684203|583694327|FG005|Overall Study|Adverse Event|0|||
161629475|NCT00684203|583694322|FG000|Overall Study|Protocol-defined clinical event|3|||
161685649|NCT00705783|583901924|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
161685650|NCT00705783|583901925|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685651|NCT00705783|583901926|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161629476|NCT00684203|583694323|FG001|Overall Study|Protocol-defined clinical event|1|||
161629477|NCT00684203|583694324|FG002|Overall Study|Protocol-defined clinical event|0|||
161685652|NCT00705783|583901924|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
161685653|NCT00705783|583901925|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161685654|NCT00705783|583901926|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161629478|NCT00684203|583694325|FG003|Overall Study|Protocol-defined clinical event|0|||
161629479|NCT00684203|583694326|FG004|Overall Study|Protocol-defined clinical event|0|||
161629480|NCT00684203|583694327|FG005|Overall Study|Protocol-defined clinical event|0|||
161629481|NCT00684203|583694322|FG000|Overall Study|Withdrawal by Subject|0|||
161629482|NCT00684203|583694323|FG001|Overall Study|Withdrawal by Subject|2|||
161629483|NCT00684203|583694324|FG002|Overall Study|Withdrawal by Subject|1|||
161629484|NCT00684203|583694325|FG003|Overall Study|Withdrawal by Subject|0|||
161629485|NCT00684203|583694326|FG004|Overall Study|Withdrawal by Subject|0|||
161629486|NCT00684203|583694327|FG005|Overall Study|Withdrawal by Subject|0|||
161629487|NCT00684203|583694322|FG000|Overall Study|Did not meet protocol eligibility|0|||
161629488|NCT00684203|583694323|FG001|Overall Study|Did not meet protocol eligibility|1|||
161629489|NCT00684203|583694324|FG002|Overall Study|Did not meet protocol eligibility|0|||
161629490|NCT00684203|583694325|FG003|Overall Study|Did not meet protocol eligibility|0|||
161629491|NCT00684203|583694326|FG004|Overall Study|Did not meet protocol eligibility|0|||
161629492|NCT00684203|583694327|FG005|Overall Study|Did not meet protocol eligibility|0|||
161629493|NCT01902381|583694330|FG000|Overall Study|Withdrawal by Subject|1|||
161629494|NCT02762500|583694333|FG000|Overall Study|Lack of Efficacy|1|||
161629495|NCT02762500|583694334|FG001|Overall Study|Lack of Efficacy|0|||
161629496|NCT02762500|583694333|FG000|Overall Study|Withdrawal by Subject|1|||
161629497|NCT02762500|583694334|FG001|Overall Study|Withdrawal by Subject|1|||
161629498|NCT02762500|583694333|FG000|Overall Study|Adverse Event|0|||
161629499|NCT02762500|583694334|FG001|Overall Study|Adverse Event|2|||
161629500|NCT00730847|583694335|FG000|Overall Study|Adverse Event|1|||
161629501|NCT00730847|583694335|FG000|Overall Study|Protocol Violation|2|||
161629502|NCT00730847|583694335|FG000|Overall Study|Withdrawal by Subject|16|||
161629503|NCT00730847|583694335|FG000|Overall Study|Lost to Follow-up|67|||
161629504|NCT00730847|583694335|FG000|Overall Study|Unknown completion status|21|||
161629505|NCT00730847|583694335|FG000|Overall Study|Other|24|||
161629506|NCT00280683|583694336|FG000|Overall Study|Withdrawal by Subject|1|||
161629507|NCT00280683|583694337|FG001|Overall Study|Withdrawal by Subject|2|||
161629508|NCT00280683|583694336|FG000|Overall Study|Adverse Event|1|||
161629509|NCT00280683|583694337|FG001|Overall Study|Adverse Event|1|||
161629510|NCT01243411|583694338|FG000|Overall Study|Withdrawal by Subject|18|||
161629511|NCT01243411|583694338|FG000|Overall Study|Lost to Follow-up|10|||
161629512|NCT01243411|583694338|FG000|Overall Study|Adverse Event|5|||
161629513|NCT01243411|583694338|FG000|Overall Study|Other|8|||
161629514|NCT00488319|583694346|FG000|Overall Study|Adverse Event|1|||
161629515|NCT00488319|583694347|FG001|Overall Study|Adverse Event|2|||
161629516|NCT00488319|583694348|FG002|Overall Study|Adverse Event|23|||
161629517|NCT00488319|583694346|FG000|Overall Study|Lack of Efficacy|6|||
161629518|NCT00488319|583694347|FG001|Overall Study|Lack of Efficacy|12|||
161629519|NCT00488319|583694348|FG002|Overall Study|Lack of Efficacy|27|||
161629520|NCT00488319|583694346|FG000|Overall Study|Lost to Follow-up|3|||
161629521|NCT00488319|583694347|FG001|Overall Study|Lost to Follow-up|5|||
161629522|NCT00488319|583694348|FG002|Overall Study|Lost to Follow-up|16|||
161629523|NCT00488319|583694346|FG000|Overall Study|Withdrawal by Subject|5|||
161629524|NCT00488319|583694347|FG001|Overall Study|Withdrawal by Subject|20|||
161629525|NCT00488319|583694348|FG002|Overall Study|Withdrawal by Subject|44|||
161629526|NCT00488319|583694346|FG000|Overall Study|Other reasons for withdrawal|0|||
161629527|NCT00488319|583694347|FG001|Overall Study|Other reasons for withdrawal|4|||
161629528|NCT00488319|583694348|FG002|Overall Study|Other reasons for withdrawal|12|||
161629529|NCT00632931|583694359|FG000|Part 1, Period 1|Protocol Violation|1|||
161629530|NCT00632931|583694360|FG001|Part 1, Period 1|Protocol Violation|0|||
161629531|NCT00632931|583694361|FG002|Part 1, Period 1|Protocol Violation|0|||
161629532|NCT00632931|583694359|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
161629533|NCT00632931|583694360|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
161629534|NCT00632931|583694361|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
161629535|NCT00632931|583694359|FG000|Part 2|Adverse Event|0|||
161629536|NCT00632931|583694360|FG001|Part 2|Adverse Event|0|||
161629537|NCT00632931|583694361|FG002|Part 2|Adverse Event|3|||
161629538|NCT00632931|583694359|FG000|Part 2|Death|0|||
161629539|NCT00632931|583694360|FG001|Part 2|Death|0|||
161629540|NCT00632931|583694361|FG002|Part 2|Death|1|||
161629541|NCT00632931|583694359|FG000|Part 2|Lack of Efficacy|0|||
161629542|NCT00632931|583694360|FG001|Part 2|Lack of Efficacy|0|||
161629543|NCT00632931|583694361|FG002|Part 2|Lack of Efficacy|17|||
161629544|NCT00632931|583694359|FG000|Part 2|Withdrawal by Subject|0|||
161629545|NCT00632931|583694360|FG001|Part 2|Withdrawal by Subject|0|||
161629546|NCT00632931|583694361|FG002|Part 2|Withdrawal by Subject|3|||
161629547|NCT02499835|583694367|FG000|Overall Study|Withdrawal by Subject|1|||
161629548|NCT02499835|583694368|FG001|Overall Study|Withdrawal by Subject|0|||
161629549|NCT02499835|583694369|FG002|Overall Study|Withdrawal by Subject|0|||
161629550|NCT02499835|583694370|FG003|Overall Study|Withdrawal by Subject|1|||
161629551|NCT02499835|583694367|FG000|Overall Study|Physician Decision|0|||
161629552|NCT02499835|583694368|FG001|Overall Study|Physician Decision|3|||
161629553|NCT02499835|583694369|FG002|Overall Study|Physician Decision|18|||
161629554|NCT02499835|583694370|FG003|Overall Study|Physician Decision|7|||
161629555|NCT02499835|583694367|FG000|Overall Study|Adverse Event|0|||
161629556|NCT02499835|583694368|FG001|Overall Study|Adverse Event|0|||
161629557|NCT02499835|583694369|FG002|Overall Study|Adverse Event|0|||
161629558|NCT02499835|583694370|FG003|Overall Study|Adverse Event|1|||
161629559|NCT02499835|583694367|FG000|Overall Study|Disease progression|2|||
161629560|NCT02499835|583694368|FG001|Overall Study|Disease progression|1|||
161629561|NCT02499835|583694369|FG002|Overall Study|Disease progression|0|||
161629562|NCT02499835|583694370|FG003|Overall Study|Disease progression|7|||
161629563|NCT03319719|583694378|FG000|Overall Study|Lost to Follow-up|1|||
161629564|NCT03193216|583694379|FG000|Overall Study|Lost to Follow-up|1|||
161629565|NCT03193216|583694380|FG001|Overall Study|Lost to Follow-up|0|||
161629566|NCT03193216|583694379|FG000|Overall Study|Withdrawal by Subject|5|||
161629567|NCT03193216|583694380|FG001|Overall Study|Withdrawal by Subject|0|||
161629568|NCT03193216|583694379|FG000|Overall Study|Physician Decision|4|||
161629569|NCT03193216|583694380|FG001|Overall Study|Physician Decision|0|||
161629570|NCT02490878|583694381|FG000|Overall Study|deemed ineligible|0|||
161629571|NCT02490878|583694382|FG001|Overall Study|deemed ineligible|1|||
161629572|NCT02490878|583694381|FG000|Overall Study|progression prior to treatment|0|||
161629573|NCT02490878|583694382|FG001|Overall Study|progression prior to treatment|1|||
161629574|NCT02490878|583694381|FG000|Overall Study|only submitted baseline QOL|0|||
161629575|NCT02490878|583694382|FG001|Overall Study|only submitted baseline QOL|1|||
161629576|NCT00317603|583694383|FG000|Overall Study|Progressive Disease|3|||
161629577|NCT00523549|583694386|FG000|Overall Study|Adverse Event|6|||
161629578|NCT00523549|583694387|FG001|Overall Study|Adverse Event|3|||
161629579|NCT00523549|583694386|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161629580|NCT00523549|583694387|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161629581|NCT00523549|583694386|FG000|Overall Study|Protocol Deviation|3|||
161629582|NCT00523549|583694387|FG001|Overall Study|Protocol Deviation|1|||
161629583|NCT00523549|583694386|FG000|Overall Study|Patient withdrew consent|7|||
161629584|NCT00523549|583694387|FG001|Overall Study|Patient withdrew consent|6|||
161629585|NCT00523549|583694386|FG000|Overall Study|Lost to Follow-up|3|||
161629586|NCT00523549|583694387|FG001|Overall Study|Lost to Follow-up|5|||
161629587|NCT00677092|583694392|FG000|Overall Study|Adverse Event|1|||
161629588|NCT00677092|583694392|FG000|Overall Study|Lost to Follow-up|1|||
161629589|NCT00677092|583694392|FG000|Overall Study|Withdrawal by Subject|3|||
161629590|NCT00677092|583694392|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
161629591|NCT04772313|583694395|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
161629592|NCT04772313|583694395|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
161629593|NCT02215954|583694396|FG000|Overall Study|Adverse Event|0|||
161629594|NCT02215954|583694397|FG001|Overall Study|Adverse Event|0|||
161629595|NCT02215954|583694398|FG002|Overall Study|Adverse Event|1|||
161629596|NCT02215954|583694396|FG000|Overall Study|Withdrawal by Subject|0|||
161629597|NCT02215954|583694397|FG001|Overall Study|Withdrawal by Subject|0|||
161629598|NCT02215954|583694398|FG002|Overall Study|Withdrawal by Subject|2|||
161629599|NCT02215954|583694396|FG000|Overall Study|Not exposed|1|||
161629600|NCT02215954|583694397|FG001|Overall Study|Not exposed|1|||
161629601|NCT02215954|583694398|FG002|Overall Study|Not exposed|3|||
161629602|NCT00784277|583694400|FG000|IR Treatment|Adverse Event|4|||
161629603|NCT00784277|583694401|FG001|IR Treatment|Adverse Event|8|||
161629604|NCT00784277|583694402|FG002|IR Treatment|Adverse Event|19|||
161629605|NCT00784277|583694403|FG003|IR Treatment|Adverse Event|35|||
161685655|NCT00705783|583901924|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
161685656|NCT00705783|583901925|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
161685657|NCT00705783|583901926|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
161629606|NCT00784277|583694404|FG004|IR Treatment|Adverse Event|0|||
161629607|NCT00784277|583694405|FG005|IR Treatment|Adverse Event|0|||
161629608|NCT00784277|583694406|FG006|IR Treatment|Adverse Event|0|||
161629609|NCT00784277|583694400|FG000|IR Treatment|Lack of Efficacy|4|||
161629610|NCT00784277|583694401|FG001|IR Treatment|Lack of Efficacy|4|||
161629611|NCT00784277|583694402|FG002|IR Treatment|Lack of Efficacy|1|||
161629612|NCT00784277|583694403|FG003|IR Treatment|Lack of Efficacy|0|||
161629613|NCT00784277|583694404|FG004|IR Treatment|Lack of Efficacy|0|||
161629614|NCT00784277|583694405|FG005|IR Treatment|Lack of Efficacy|0|||
161629615|NCT00784277|583694406|FG006|IR Treatment|Lack of Efficacy|0|||
161629616|NCT00784277|583694400|FG000|IR Treatment|Lost to Follow-up|1|||
161629617|NCT00784277|583694401|FG001|IR Treatment|Lost to Follow-up|0|||
161629618|NCT00784277|583694402|FG002|IR Treatment|Lost to Follow-up|1|||
161629619|NCT00784277|583694403|FG003|IR Treatment|Lost to Follow-up|0|||
161629620|NCT00784277|583694404|FG004|IR Treatment|Lost to Follow-up|0|||
161629621|NCT00784277|583694405|FG005|IR Treatment|Lost to Follow-up|0|||
161629622|NCT00784277|583694406|FG006|IR Treatment|Lost to Follow-up|0|||
161629623|NCT00784277|583694400|FG000|IR Treatment|Withdrawal by Subject|5|||
161629624|NCT00784277|583694401|FG001|IR Treatment|Withdrawal by Subject|1|||
161629625|NCT00784277|583694402|FG002|IR Treatment|Withdrawal by Subject|4|||
161629626|NCT00784277|583694403|FG003|IR Treatment|Withdrawal by Subject|6|||
161629627|NCT00784277|583694404|FG004|IR Treatment|Withdrawal by Subject|0|||
161629628|NCT00784277|583694405|FG005|IR Treatment|Withdrawal by Subject|0|||
161629629|NCT00784277|583694406|FG006|IR Treatment|Withdrawal by Subject|0|||
161629630|NCT00784277|583694400|FG000|IR Treatment|Resolution Of Pain|0|||
161629631|NCT00784277|583694401|FG001|IR Treatment|Resolution Of Pain|1|||
161629632|NCT00784277|583694402|FG002|IR Treatment|Resolution Of Pain|0|||
161629633|NCT00784277|583694403|FG003|IR Treatment|Resolution Of Pain|0|||
161629634|NCT00784277|583694404|FG004|IR Treatment|Resolution Of Pain|0|||
161629635|NCT00784277|583694405|FG005|IR Treatment|Resolution Of Pain|0|||
161629636|NCT00784277|583694406|FG006|IR Treatment|Resolution Of Pain|0|||
161629637|NCT00784277|583694400|FG000|IR Treatment|Other|2|||
161629638|NCT00784277|583694401|FG001|IR Treatment|Other|3|||
161629639|NCT00784277|583694402|FG002|IR Treatment|Other|3|||
161629640|NCT00784277|583694403|FG003|IR Treatment|Other|2|||
161629641|NCT00784277|583694404|FG004|IR Treatment|Other|0|||
161629642|NCT00784277|583694405|FG005|IR Treatment|Other|0|||
161629643|NCT00784277|583694406|FG006|IR Treatment|Other|0|||
161629644|NCT00784277|583694400|FG000|ER Treatment|Adverse Event|0|||
161629645|NCT00784277|583694401|FG001|ER Treatment|Adverse Event|0|||
161629646|NCT00784277|583694402|FG002|ER Treatment|Adverse Event|0|||
161629647|NCT00784277|583694403|FG003|ER Treatment|Adverse Event|0|||
161629648|NCT00784277|583694404|FG004|ER Treatment|Adverse Event|1|||
161629649|NCT00784277|583694405|FG005|ER Treatment|Adverse Event|7|||
161629650|NCT00784277|583694406|FG006|ER Treatment|Adverse Event|7|||
161629651|NCT00784277|583694400|FG000|ER Treatment|Lack of Efficacy|0|||
161629652|NCT00784277|583694401|FG001|ER Treatment|Lack of Efficacy|0|||
161629653|NCT00784277|583694402|FG002|ER Treatment|Lack of Efficacy|0|||
161629654|NCT00784277|583694403|FG003|ER Treatment|Lack of Efficacy|0|||
161629655|NCT00784277|583694404|FG004|ER Treatment|Lack of Efficacy|3|||
161629656|NCT00784277|583694405|FG005|ER Treatment|Lack of Efficacy|4|||
161629657|NCT00784277|583694406|FG006|ER Treatment|Lack of Efficacy|0|||
161629658|NCT00784277|583694400|FG000|ER Treatment|Lost to Follow-up|0|||
161629659|NCT00784277|583694401|FG001|ER Treatment|Lost to Follow-up|0|||
161629660|NCT00784277|583694402|FG002|ER Treatment|Lost to Follow-up|0|||
161629661|NCT00784277|583694403|FG003|ER Treatment|Lost to Follow-up|0|||
161629662|NCT00784277|583694404|FG004|ER Treatment|Lost to Follow-up|0|||
161629663|NCT00784277|583694405|FG005|ER Treatment|Lost to Follow-up|2|||
161629664|NCT00784277|583694406|FG006|ER Treatment|Lost to Follow-up|0|||
161629665|NCT00784277|583694400|FG000|ER Treatment|Withdrawal by Subject|0|||
161629666|NCT00784277|583694401|FG001|ER Treatment|Withdrawal by Subject|0|||
161629667|NCT00784277|583694402|FG002|ER Treatment|Withdrawal by Subject|0|||
161629668|NCT00784277|583694403|FG003|ER Treatment|Withdrawal by Subject|0|||
161629669|NCT00784277|583694404|FG004|ER Treatment|Withdrawal by Subject|2|||
161629670|NCT00784277|583694405|FG005|ER Treatment|Withdrawal by Subject|5|||
161629671|NCT00784277|583694406|FG006|ER Treatment|Withdrawal by Subject|3|||
161629672|NCT00784277|583694400|FG000|ER Treatment|Study Medication Non-Compliant|0|||
161629673|NCT00784277|583694401|FG001|ER Treatment|Study Medication Non-Compliant|0|||
161629674|NCT00784277|583694402|FG002|ER Treatment|Study Medication Non-Compliant|0|||
161629675|NCT00784277|583694403|FG003|ER Treatment|Study Medication Non-Compliant|0|||
161629676|NCT00784277|583694404|FG004|ER Treatment|Study Medication Non-Compliant|2|||
161629677|NCT00784277|583694405|FG005|ER Treatment|Study Medication Non-Compliant|3|||
161629678|NCT00784277|583694406|FG006|ER Treatment|Study Medication Non-Compliant|3|||
161629679|NCT00784277|583694400|FG000|ER Treatment|Other|0|||
161629680|NCT00784277|583694401|FG001|ER Treatment|Other|0|||
161629681|NCT00784277|583694402|FG002|ER Treatment|Other|0|||
161629682|NCT00784277|583694403|FG003|ER Treatment|Other|0|||
161629683|NCT00784277|583694404|FG004|ER Treatment|Other|1|||
161629684|NCT00784277|583694405|FG005|ER Treatment|Other|3|||
161629685|NCT00784277|583694406|FG006|ER Treatment|Other|2|||
161629686|NCT01093222|583694407|FG000|Overall Study|Ineligible|6|||
161629687|NCT01093222|583694407|FG000|Overall Study|Adverse Event|7|||
161629688|NCT01093222|583694407|FG000|Overall Study|Progression/relapse|24|||
161629689|NCT01093222|583694407|FG000|Overall Study|Death|2|||
161629690|NCT01093222|583694407|FG000|Overall Study|Not protocol specified|1|||
161629691|NCT04194541|583694408|FG000|Day 1 Through 13|Lost to Follow-up|3|||
161629692|NCT04194541|583694408|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
161629693|NCT04194541|583694408|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
161629694|NCT02567227|583694409|FG000|9 Weeks|Adverse Event|5|||
161629695|NCT02567227|583694410|FG001|9 Weeks|Adverse Event|5|||
161629696|NCT02567227|583694409|FG000|9 Weeks|Withdrawal by Subject|18|||
161629697|NCT02567227|583694410|FG001|9 Weeks|Withdrawal by Subject|8|||
161629698|NCT02567227|583694409|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
161629699|NCT02567227|583694410|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
161629700|NCT02567227|583694409|FG000|6 Month|Death|2|||
161629701|NCT02567227|583694410|FG001|6 Month|Death|0|||
161629702|NCT02567227|583694409|FG000|6 Month|Lost to Follow-up|43|||
161629703|NCT02567227|583694410|FG001|6 Month|Lost to Follow-up|40|||
161629704|NCT02567227|583694409|FG000|12 Months|Lost to Follow-up|31|||
161629705|NCT02567227|583694410|FG001|12 Months|Lost to Follow-up|32|||
161629706|NCT02567227|583694409|FG000|12 Months|Death|0|||
161629707|NCT02567227|583694410|FG001|12 Months|Death|2|||
161629708|NCT00187135|583694411|FG000|Visit One|Withdrawal by Subject|1|||
161629709|NCT00187135|583694412|FG001|Visit One|Withdrawal by Subject|0|||
161629710|NCT00187135|583694413|FG002|Visit One|Withdrawal by Subject|0|||
161629711|NCT00187135|583694414|FG003|Visit One|Withdrawal by Subject|0|||
161629712|NCT00187135|583694415|FG004|Visit One|Withdrawal by Subject|0|||
161629713|NCT00187135|583694416|FG005|Visit One|Withdrawal by Subject|1|||
161629714|NCT00187135|583694411|FG000|Visit One|Physician Decision|3|||
161629715|NCT00187135|583694412|FG001|Visit One|Physician Decision|1|||
161629716|NCT00187135|583694413|FG002|Visit One|Physician Decision|0|||
161629717|NCT00187135|583694414|FG003|Visit One|Physician Decision|0|||
161629718|NCT00187135|583694415|FG004|Visit One|Physician Decision|0|||
161629719|NCT00187135|583694416|FG005|Visit One|Physician Decision|1|||
161629720|NCT00187135|583694411|FG000|Visit Two|Death|0|||
161629721|NCT00187135|583694412|FG001|Visit Two|Death|0|||
161629722|NCT00187135|583694413|FG002|Visit Two|Death|0|||
161629723|NCT00187135|583694414|FG003|Visit Two|Death|1|||
161629724|NCT00187135|583694415|FG004|Visit Two|Death|0|||
161629725|NCT00187135|583694416|FG005|Visit Two|Death|1|||
161629726|NCT00187135|583694411|FG000|Visit Two|Physician Decision|1|||
161629727|NCT00187135|583694412|FG001|Visit Two|Physician Decision|0|||
161629728|NCT00187135|583694413|FG002|Visit Two|Physician Decision|0|||
161629729|NCT00187135|583694414|FG003|Visit Two|Physician Decision|0|||
161629730|NCT00187135|583694415|FG004|Visit Two|Physician Decision|0|||
161629731|NCT00187135|583694416|FG005|Visit Two|Physician Decision|0|||
161629732|NCT00187135|583694411|FG000|Visit Two|Withdrawal by Subject|1|||
161629733|NCT00187135|583694412|FG001|Visit Two|Withdrawal by Subject|1|||
161629734|NCT00187135|583694413|FG002|Visit Two|Withdrawal by Subject|1|||
161629735|NCT00187135|583694414|FG003|Visit Two|Withdrawal by Subject|0|||
161629736|NCT00187135|583694415|FG004|Visit Two|Withdrawal by Subject|1|||
161629737|NCT00187135|583694416|FG005|Visit Two|Withdrawal by Subject|1|||
161629738|NCT00187135|583694411|FG000|Visit Two|Study Discontinued|3|||
161629739|NCT00187135|583694412|FG001|Visit Two|Study Discontinued|2|||
161629740|NCT00187135|583694413|FG002|Visit Two|Study Discontinued|1|||
161629741|NCT00187135|583694414|FG003|Visit Two|Study Discontinued|7|||
161629742|NCT00187135|583694415|FG004|Visit Two|Study Discontinued|5|||
161629743|NCT00187135|583694416|FG005|Visit Two|Study Discontinued|6|||
161629744|NCT00187135|583694411|FG000|Visit Three|Death|0|||
161629745|NCT00187135|583694412|FG001|Visit Three|Death|0|||
161629746|NCT00187135|583694413|FG002|Visit Three|Death|1|||
161629747|NCT00187135|583694414|FG003|Visit Three|Death|0|||
161629748|NCT00187135|583694415|FG004|Visit Three|Death|1|||
161629749|NCT00187135|583694416|FG005|Visit Three|Death|0|||
161629750|NCT00187135|583694411|FG000|Visit Three|Withdrawal by Subject|0|||
161629751|NCT00187135|583694412|FG001|Visit Three|Withdrawal by Subject|1|||
161629752|NCT00187135|583694413|FG002|Visit Three|Withdrawal by Subject|1|||
161629753|NCT00187135|583694414|FG003|Visit Three|Withdrawal by Subject|2|||
161629754|NCT00187135|583694415|FG004|Visit Three|Withdrawal by Subject|0|||
161629755|NCT00187135|583694416|FG005|Visit Three|Withdrawal by Subject|0|||
161629756|NCT00187135|583694411|FG000|Visit Three|Study Discontinued|7|||
161629757|NCT00187135|583694412|FG001|Visit Three|Study Discontinued|6|||
161629758|NCT00187135|583694413|FG002|Visit Three|Study Discontinued|7|||
161629759|NCT00187135|583694414|FG003|Visit Three|Study Discontinued|7|||
161629760|NCT00187135|583694415|FG004|Visit Three|Study Discontinued|7|||
161629761|NCT00187135|583694416|FG005|Visit Three|Study Discontinued|6|||
161629762|NCT01675050|583694419|FG000|Period One Treatment|Withdrawal by Subject|1|||
161629763|NCT01675050|583694420|FG001|Period One Treatment|Withdrawal by Subject|0|||
161629764|NCT00745121|583694421|FG000|Overall Study|Death|3|||
161629765|NCT00745121|583694422|FG001|Overall Study|Death|0|||
161629766|NCT00745121|583694421|FG000|Overall Study|Adverse Event|1|||
161629767|NCT00745121|583694422|FG001|Overall Study|Adverse Event|0|||
161629768|NCT00745121|583694421|FG000|Overall Study|Lost to Follow-up|1|||
161629769|NCT00745121|583694422|FG001|Overall Study|Lost to Follow-up|0|||
161629770|NCT00745121|583694421|FG000|Overall Study|Withdrawal by Subject|4|||
161629771|NCT00745121|583694422|FG001|Overall Study|Withdrawal by Subject|2|||
161629772|NCT03280108|583694424|FG000|Overall Study|Lost to Follow-up|2|||
161629773|NCT03280108|583694425|FG001|Overall Study|Lost to Follow-up|0|||
161629774|NCT01820637|583694426|FG000|Overall Study|Death|2|||
161629775|NCT01820637|583694426|FG000|Overall Study|Withdrawal by Subject|1|||
161629776|NCT00264498|583694427|FG000|Randomized Treatment|Death|0|||
161629777|NCT00264498|583694428|FG001|Randomized Treatment|Death|3|||
161629778|NCT00264498|583694427|FG000|Randomized Treatment|Withdrawal by Subject|0|||
161629779|NCT00264498|583694428|FG001|Randomized Treatment|Withdrawal by Subject|1|||
161629780|NCT00264498|583694427|FG000|Randomized Treatment|Objective disease Progression|13|||
161629781|NCT00264498|583694428|FG001|Randomized Treatment|Objective disease Progression|14|||
161629782|NCT00264498|583694427|FG000|Randomized Treatment|Physician Decision|1|||
161629783|NCT00264498|583694428|FG001|Randomized Treatment|Physician Decision|0|||
161629784|NCT00264498|583694427|FG000|Randomized Treatment|Incorrectly randomized|1|||
161629785|NCT00264498|583694428|FG001|Randomized Treatment|Incorrectly randomized|0|||
161629786|NCT00264498|583694427|FG000|Randomized Treatment|Study Closure|1|||
161629787|NCT00264498|583694428|FG001|Randomized Treatment|Study Closure|0|||
161629788|NCT00264498|583694427|FG000|Randomized Treatment|Protocol Violation|1|||
161629789|NCT00264498|583694428|FG001|Randomized Treatment|Protocol Violation|0|||
161629790|NCT00264498|583694427|FG000|Crossover Treatment|Death|1|||
161629791|NCT00264498|583694428|FG001|Crossover Treatment|Death|3|||
161629792|NCT00264498|583694427|FG000|Crossover Treatment|Objective disease progression|4|||
161629793|NCT00264498|583694428|FG001|Crossover Treatment|Objective disease progression|5|||
161629794|NCT00264498|583694427|FG000|Crossover Treatment|Study closure|0|||
161629795|NCT00264498|583694428|FG001|Crossover Treatment|Study closure|1|||
161629796|NCT00264498|583694427|FG000|Crossover Treatment|Withdrawal by Subject|1|||
161629797|NCT00264498|583694428|FG001|Crossover Treatment|Withdrawal by Subject|0|||
161629798|NCT03794609|583694429|FG000|Overall Study|Other|10|||
161629799|NCT03794609|583694429|FG000|Overall Study|Withdrawal by Subject|66|||
161629800|NCT03794609|583694429|FG000|Overall Study|The child is enrolled in an interventional study|70|||
161629801|NCT03794609|583694429|FG000|Overall Study|Inclusion/exclusion criteria|8|||
161629802|NCT03794609|583694429|FG000|Overall Study|At sponsor's request|151|||
161629803|NCT03794609|583694429|FG000|Overall Study|Physician Decision|1|||
161629804|NCT03794609|583694429|FG000|Overall Study|Lost to Follow-up|5|||
161629805|NCT04543942|583694430|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
161629806|NCT04543942|583694431|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
161629807|NCT04543942|583694430|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
161629808|NCT04543942|583694431|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
161629809|NCT00139659|583694434|FG000|Overall Study|Adverse Event|12|||
161629810|NCT00139659|583694435|FG001|Overall Study|Adverse Event|1|||
161629811|NCT00139659|583694434|FG000|Overall Study|Lack of Efficacy|1|||
161629812|NCT00139659|583694435|FG001|Overall Study|Lack of Efficacy|1|||
161629813|NCT00139659|583694434|FG000|Overall Study|Lost to Follow-up|7|||
161629814|NCT00139659|583694435|FG001|Overall Study|Lost to Follow-up|3|||
161629815|NCT00139659|583694434|FG000|Overall Study|Reason not Specified|6|||
161629816|NCT00139659|583694435|FG001|Overall Study|Reason not Specified|3|||
161629817|NCT00139659|583694434|FG000|Overall Study|Withdrawal by Subject|14|||
161629818|NCT00139659|583694435|FG001|Overall Study|Withdrawal by Subject|10|||
161629819|NCT02625922|583694441|FG000|Overall Study|Non-availability of IMP|1|||
161629820|NCT02625922|583694442|FG001|Overall Study|Non-availability of IMP|1|||
161629821|NCT02625922|583694441|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
161629822|NCT02625922|583694442|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
161629823|NCT00640042|583694443|FG000|Enrollment|Did not receive study drug|83|||
161629824|NCT02359552|583694444|FG000|Overall Study|Lost to Follow-up|3|||
161629825|NCT02359552|583694445|FG001|Overall Study|Lost to Follow-up|4|||
161629826|NCT02391116|583694458|FG000|Treatment|Withdrawal by Subject|1|||
161629827|NCT02391116|583694458|FG000|Treatment|Protocol Violation|1|||
161629828|NCT02391116|583694458|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
161629829|NCT02391116|583694458|FG000|Treatment|AE with Clinical PD|3|||
161629830|NCT02391116|583694458|FG000|Safety Follow-up|Adverse Event|1|||
161629831|NCT02391116|583694458|FG000|Safety Follow-up|Withdrawal by Subject|4|||
161629832|NCT02391116|583694458|FG000|Safety Follow-up|Switching to Other Therapy|4|||
161629833|NCT02391116|583694458|FG000|Safety Follow-up|No Follow Up|1|||
161629834|NCT02391116|583694458|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
161685658|NCT00705783|583901924|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
161629835|NCT02391116|583694458|FG000|Active Follow-up|Withdrawal by Subject|1|||
161629836|NCT02391116|583694458|FG000|Active Follow-up|Switching to Other Therapy|2|||
161629837|NCT02391116|583694458|FG000|Survival Follow-up|Withdrawal by Subject|3|||
161629838|NCT02391116|583694458|FG000|Survival Follow-up|Switching to Other Therapy|1|||
161629839|NCT01747629|583694460|FG000|Overall Study|Adverse Event|1|||
161629840|NCT01747629|583694461|FG001|Overall Study|Adverse Event|2|||
161629841|NCT01747629|583694460|FG000|Overall Study|Withdrawal by Subject|2|||
161629842|NCT01747629|583694461|FG001|Overall Study|Withdrawal by Subject|2|||
161629843|NCT01747629|583694460|FG000|Overall Study|Noncompliance|1|||
161629844|NCT01747629|583694461|FG001|Overall Study|Noncompliance|1|||
161685659|NCT00705783|583901925|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
161629845|NCT01747629|583694460|FG000|Overall Study|Inclusion criteria not met|1|||
161629846|NCT01747629|583694461|FG001|Overall Study|Inclusion criteria not met|0|||
161629847|NCT01747629|583694460|FG000|Overall Study|Not treated|1|||
161629848|NCT01747629|583694461|FG001|Overall Study|Not treated|0|||
161629849|NCT01747629|583694460|FG000|Overall Study|Other|2|||
161629850|NCT01747629|583694461|FG001|Overall Study|Other|1|||
161629851|NCT00607789|583694462|FG000|Overall Study|Adverse Event|3|||
161629852|NCT00607789|583694463|FG001|Overall Study|Adverse Event|0|||
161629853|NCT00607789|583694462|FG000|Overall Study|Lack of Efficacy|0|||
161629854|NCT00607789|583694463|FG001|Overall Study|Lack of Efficacy|1|||
161629855|NCT00607789|583694462|FG000|Overall Study|Inadequate adherence|3|||
161629856|NCT00607789|583694463|FG001|Overall Study|Inadequate adherence|0|||
161629857|NCT00607789|583694462|FG000|Overall Study|Lost to Follow-up|0|||
161629858|NCT00607789|583694463|FG001|Overall Study|Lost to Follow-up|5|||
161629859|NCT00607789|583694462|FG000|Overall Study|Withdrawal by Subject|1|||
161629860|NCT00607789|583694463|FG001|Overall Study|Withdrawal by Subject|0|||
161629861|NCT01313299|583694464|FG000|Overall Study|Adverse Event|3|||
161629862|NCT01313299|583694465|FG001|Overall Study|Adverse Event|1|||
161629863|NCT01313299|583694466|FG002|Overall Study|Adverse Event|1|||
161629864|NCT01313299|583694464|FG000|Overall Study|Lost to Follow-up|1|||
161629865|NCT01313299|583694465|FG001|Overall Study|Lost to Follow-up|0|||
161629866|NCT01313299|583694466|FG002|Overall Study|Lost to Follow-up|0|||
161629867|NCT01313299|583694464|FG000|Overall Study|Protocol Violation|2|||
161629868|NCT01313299|583694465|FG001|Overall Study|Protocol Violation|0|||
161629869|NCT01313299|583694466|FG002|Overall Study|Protocol Violation|0|||
161629870|NCT01313299|583694464|FG000|Overall Study|Withdrawal by Subject|1|||
161629871|NCT01313299|583694465|FG001|Overall Study|Withdrawal by Subject|0|||
161629872|NCT01313299|583694466|FG002|Overall Study|Withdrawal by Subject|2|||
161629873|NCT01313299|583694464|FG000|Overall Study|Family reason and moved out of state|0|||
161629874|NCT01313299|583694465|FG001|Overall Study|Family reason and moved out of state|2|||
161629875|NCT01313299|583694466|FG002|Overall Study|Family reason and moved out of state|0|||
161629876|NCT01313299|583694464|FG000|Overall Study|Lack of subject compliance|0|||
161629877|NCT01313299|583694465|FG001|Overall Study|Lack of subject compliance|0|||
161629878|NCT01313299|583694466|FG002|Overall Study|Lack of subject compliance|1|||
161629879|NCT02506881|583694467|FG000|First Intervention (Day 1)|Protocol Violation|0|||
161629880|NCT02506881|583694468|FG001|First Intervention (Day 1)|Protocol Violation|0|||
161629881|NCT02506881|583694469|FG002|First Intervention (Day 1)|Protocol Violation|1|||
161629882|NCT02506881|583694470|FG003|First Intervention (Day 1)|Protocol Violation|0|||
161629883|NCT02506881|583694467|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161629884|NCT02506881|583694468|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
161629885|NCT02506881|583694469|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161629886|NCT02506881|583694470|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161629887|NCT02506881|583694467|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
161629888|NCT02506881|583694468|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
161629889|NCT02506881|583694469|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
161629890|NCT02506881|583694470|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
161629891|NCT01919398|583694471|FG000|Overall Study|Progressive Disease|0|||
161629892|NCT01919398|583694472|FG001|Overall Study|Progressive Disease|0|||
161629893|NCT01919398|583694473|FG002|Overall Study|Progressive Disease|4|||
161629894|NCT00922441|583696265|FG000|Overall Study|Protocol Violation|0|||
161629895|NCT00922441|583696266|FG001|Overall Study|Protocol Violation|0|||
161629896|NCT00922441|583696267|FG002|Overall Study|Protocol Violation|2|||
161629897|NCT00922441|583696265|FG000|Overall Study|Withdrawal by Subject|0|||
161629898|NCT00922441|583696266|FG001|Overall Study|Withdrawal by Subject|0|||
161629899|NCT00922441|583696267|FG002|Overall Study|Withdrawal by Subject|1|||
161629900|NCT00468858|583696273|FG000|Overall Study|Adverse Event|0|||
161629901|NCT00468858|583696274|FG001|Overall Study|Adverse Event|1|||
161629902|NCT00468858|583696275|FG002|Overall Study|Adverse Event|0|||
161629903|NCT00468858|583696273|FG000|Overall Study|Withdrawal by Subject|7|||
161629904|NCT00468858|583696274|FG001|Overall Study|Withdrawal by Subject|4|||
161629905|NCT00468858|583696275|FG002|Overall Study|Withdrawal by Subject|5|||
161629906|NCT00468858|583696273|FG000|Overall Study|Relocation|1|||
161629907|NCT00468858|583696274|FG001|Overall Study|Relocation|3|||
161629908|NCT00468858|583696275|FG002|Overall Study|Relocation|3|||
161629909|NCT00468858|583696273|FG000|Overall Study|Lost to Follow-up|1|||
161629910|NCT00468858|583696274|FG001|Overall Study|Lost to Follow-up|2|||
161629911|NCT00468858|583696275|FG002|Overall Study|Lost to Follow-up|5|||
161629912|NCT00468858|583696273|FG000|Overall Study|Other|0|||
161629913|NCT00468858|583696274|FG001|Overall Study|Other|0|||
161629914|NCT00468858|583696275|FG002|Overall Study|Other|1|||
161629915|NCT01885936|583696278|FG000|Overall Study|Withdrawal by Subject|1|||
161629916|NCT01885936|583696279|FG001|Overall Study|Withdrawal by Subject|0|||
161629917|NCT03214250|583696280|FG000|Overall Study|Death|5|||
161629918|NCT03214250|583696281|FG001|Overall Study|Death|5|||
161629919|NCT03214250|583696282|FG002|Overall Study|Death|7|||
161629920|NCT03214250|583696283|FG003|Overall Study|Death|4|||
161629921|NCT03214250|583696284|FG004|Overall Study|Death|23|||
161629922|NCT03214250|583696285|FG005|Overall Study|Death|23|||
161629923|NCT03214250|583696286|FG006|Overall Study|Death|24|||
161629924|NCT03214250|583696280|FG000|Overall Study|Lost to Follow-up|0|||
161629925|NCT03214250|583696281|FG001|Overall Study|Lost to Follow-up|0|||
161629926|NCT03214250|583696282|FG002|Overall Study|Lost to Follow-up|0|||
161629927|NCT03214250|583696283|FG003|Overall Study|Lost to Follow-up|1|||
161629928|NCT03214250|583696284|FG004|Overall Study|Lost to Follow-up|1|||
161629929|NCT03214250|583696285|FG005|Overall Study|Lost to Follow-up|2|||
161629930|NCT03214250|583696286|FG006|Overall Study|Lost to Follow-up|0|||
161629931|NCT03214250|583696280|FG000|Overall Study|Other|0|||
161629932|NCT03214250|583696281|FG001|Overall Study|Other|0|||
161629933|NCT03214250|583696282|FG002|Overall Study|Other|0|||
161629934|NCT03214250|583696283|FG003|Overall Study|Other|0|||
161629935|NCT03214250|583696284|FG004|Overall Study|Other|1|||
161629936|NCT03214250|583696285|FG005|Overall Study|Other|1|||
161629937|NCT03214250|583696286|FG006|Overall Study|Other|2|||
161629938|NCT03214250|583696280|FG000|Overall Study|Remains on Study|2|||
161629939|NCT03214250|583696281|FG001|Overall Study|Remains on Study|2|||
161629940|NCT03214250|583696282|FG002|Overall Study|Remains on Study|0|||
161629941|NCT03214250|583696283|FG003|Overall Study|Remains on Study|1|||
161629942|NCT03214250|583696284|FG004|Overall Study|Remains on Study|7|||
161629943|NCT03214250|583696285|FG005|Overall Study|Remains on Study|5|||
161629944|NCT03214250|583696286|FG006|Overall Study|Remains on Study|3|||
161629945|NCT03214250|583696280|FG000|Overall Study|Withdrawal by Subject|0|||
161629946|NCT03214250|583696281|FG001|Overall Study|Withdrawal by Subject|0|||
161629947|NCT03214250|583696282|FG002|Overall Study|Withdrawal by Subject|1|||
161629948|NCT03214250|583696283|FG003|Overall Study|Withdrawal by Subject|2|||
161629949|NCT03214250|583696284|FG004|Overall Study|Withdrawal by Subject|5|||
161629950|NCT03214250|583696285|FG005|Overall Study|Withdrawal by Subject|0|||
161629951|NCT03214250|583696286|FG006|Overall Study|Withdrawal by Subject|2|||
161629952|NCT00797511|583696287|FG000|Overall Study|Withdrawal by Subject|1|||
161629953|NCT00427778|583696292|FG000|First Intervention (4 Weeks)|no longer interested|1|||
161629954|NCT00427778|583696293|FG001|First Intervention (4 Weeks)|no longer interested|0|||
161629955|NCT00427778|583696292|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
161629956|NCT00427778|583696293|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
161629957|NCT00427778|583696292|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
161629958|NCT00427778|583696293|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
161629959|NCT00427778|583696292|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
161629960|NCT00427778|583696293|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
161629961|NCT00439647|583696294|FG000|Overall Study|Withdrawal by Subject|25|||
161629962|NCT00439647|583696295|FG001|Overall Study|Withdrawal by Subject|22|||
161629963|NCT00439647|583696294|FG000|Overall Study|Death|15|||
161629964|NCT00439647|583696295|FG001|Overall Study|Death|18|||
161629965|NCT00439647|583696294|FG000|Overall Study|Adverse Event|11|||
161629966|NCT00439647|583696295|FG001|Overall Study|Adverse Event|11|||
161629967|NCT00439647|583696294|FG000|Overall Study|Lost to Follow-up|4|||
161629968|NCT00439647|583696295|FG001|Overall Study|Lost to Follow-up|12|||
161629969|NCT00439647|583696294|FG000|Overall Study|Protocol Violation|3|||
161629970|NCT00439647|583696295|FG001|Overall Study|Protocol Violation|4|||
161629971|NCT00439647|583696294|FG000|Overall Study|Lack of Efficacy|0|||
161629972|NCT00439647|583696295|FG001|Overall Study|Lack of Efficacy|4|||
161629973|NCT02845375|583696297|FG000|Overall Study|upper airway obstruction|1|||
161629974|NCT02845375|583696298|FG001|Overall Study|upper airway obstruction|2|||
161629975|NCT02845375|583696299|FG002|Overall Study|upper airway obstruction|1|||
161629976|NCT00225277|583696300|FG000|Overall Study|Adverse Event|30|||
161629977|NCT00225277|583696301|FG001|Overall Study|Adverse Event|34|||
161629978|NCT00225277|583696300|FG000|Overall Study|Lack of Efficacy|4|||
161629979|NCT00225277|583696301|FG001|Overall Study|Lack of Efficacy|1|||
161629980|NCT00225277|583696300|FG000|Overall Study|Lost to Follow-up|4|||
161629981|NCT00225277|583696301|FG001|Overall Study|Lost to Follow-up|6|||
161629982|NCT00225277|583696300|FG000|Overall Study|Physician Decision|6|||
161629983|NCT00225277|583696301|FG001|Overall Study|Physician Decision|8|||
161629984|NCT00225277|583696300|FG000|Overall Study|Protocol Violation|6|||
161629985|NCT00225277|583696301|FG001|Overall Study|Protocol Violation|3|||
161629986|NCT00225277|583696300|FG000|Overall Study|Withdrawal by Subject|40|||
161629987|NCT00225277|583696301|FG001|Overall Study|Withdrawal by Subject|34|||
161629988|NCT00225277|583696300|FG000|Overall Study|Other|7|||
161629989|NCT00225277|583696301|FG001|Overall Study|Other|9|||
161629990|NCT02171130|583696307|FG000|Overall Study|Death|1|||
161629991|NCT02171130|583696307|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
161629992|NCT02171130|583696307|FG000|Overall Study|Discontinued; Site Termination|5|||
161629993|NCT02171130|583696307|FG000|Overall Study|Withdrawal by Subject|3|||
161629994|NCT02171130|583696307|FG000|Overall Study|Physician Decision|1|||
161629995|NCT02171130|583696307|FG000|Overall Study|Lost to Follow-up|1|||
161629996|NCT02171130|583696307|FG000|Overall Study|Met Exclusion Criteria|1|||
161629997|NCT00591409|583696308|FG000|Overall Study|Not Treated|0|||
161629998|NCT00591409|583696309|FG001|Overall Study|Not Treated|0|||
161629999|NCT00591409|583696310|FG002|Overall Study|Not Treated|0|||
161630000|NCT00591409|583696311|FG003|Overall Study|Not Treated|0|||
161630001|NCT00591409|583696312|FG004|Overall Study|Not Treated|1|||
161630002|NCT00591409|583696313|FG005|Overall Study|Not Treated|0|||
161630003|NCT00591409|583696314|FG006|Overall Study|Not Treated|0|||
161630004|NCT00591409|583696315|FG007|Overall Study|Not Treated|0|||
161630005|NCT00591409|583696316|FG008|Overall Study|Not Treated|0|||
161630006|NCT00591409|583696317|FG009|Overall Study|Not Treated|1|||
161630007|NCT02109107|583696320|FG000|Overall Study|Lost to Follow-up|2|||
161630008|NCT00495612|583696322|FG000|Overall Study|Lost to Follow-up|1|||
161630009|NCT00495612|583696323|FG001|Overall Study|Lost to Follow-up|0|||
161630010|NCT00495612|583696322|FG000|Overall Study|Subject's Decision to Withdraw|3|||
161630011|NCT00495612|583696323|FG001|Overall Study|Subject's Decision to Withdraw|0|||
161630012|NCT06016127|583696326|FG000|Overall Study|Withdrawal by Subject|4|||
161630013|NCT06016127|583696327|FG001|Overall Study|Withdrawal by Subject|3|||
161630014|NCT03340766|583696332|FG000|Overall Study|Withdrawal by Subject|2|||
161630015|NCT03340766|583696333|FG001|Overall Study|Withdrawal by Subject|1|||
161630016|NCT03340766|583696334|FG002|Overall Study|Withdrawal by Subject|3|||
161630017|NCT03340766|583696332|FG000|Overall Study|Lost to Follow-up|0|||
161630018|NCT03340766|583696333|FG001|Overall Study|Lost to Follow-up|0|||
161630019|NCT03340766|583696334|FG002|Overall Study|Lost to Follow-up|1|||
161630020|NCT03340766|583696332|FG000|Overall Study|Death|6|||
161630021|NCT03340766|583696333|FG001|Overall Study|Death|7|||
161630022|NCT03340766|583696334|FG002|Overall Study|Death|4|||
161630023|NCT00240097|583696335|FG000|Part I|Adverse Event|1|||
161630024|NCT00240097|583696335|FG000|Part I|Death|1|||
161630025|NCT00240097|583696335|FG000|Part I|histology|1|||
161630026|NCT00240097|583696335|FG000|Part I|unevaluable|1|||
161630027|NCT00240097|583696335|FG000|Part II|did not continue from Part I|23|||
161630028|NCT02383927|583696336|FG000|Overall Study|Disease Progression|8|||
161630029|NCT02383927|583696337|FG001|Overall Study|Disease Progression|8|||
161630030|NCT02383927|583696338|FG002|Overall Study|Disease Progression|15|||
161685660|NCT00705783|583901926|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
161685661|NCT00705783|583901924|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
161685662|NCT00705783|583901925|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
161685663|NCT00705783|583901926|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
161685664|NCT00705783|583901924|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
161685665|NCT00705783|583901925|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161685666|NCT00705783|583901926|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
161685667|NCT00705783|583901924|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
161685668|NCT00705783|583901925|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
161685669|NCT00705783|583901926|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
161685670|NCT00705783|583901924|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
161685671|NCT00705783|583901925|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
161685672|NCT00705783|583901926|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
161685673|NCT00705783|583901924|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
161685674|NCT00705783|583901925|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
161685675|NCT00705783|583901926|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
161685676|NCT00705783|583901924|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
161685677|NCT00705783|583901925|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
161685678|NCT00705783|583901926|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
161685679|NCT00705783|583901924|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
161685680|NCT00705783|583901925|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
161685681|NCT00705783|583901926|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
161685682|NCT02182687|583901927|FG000|Overall Study|Withdrawal by Subject|4|||
161685683|NCT02182687|583901928|FG001|Overall Study|Withdrawal by Subject|0|||
161685684|NCT02182687|583901927|FG000|Overall Study|Adverse Event|1|||
161685685|NCT02182687|583901928|FG001|Overall Study|Adverse Event|0|||
161685686|NCT02182687|583901927|FG000|Overall Study|Lost to Follow-up|0|||
161685687|NCT02182687|583901928|FG001|Overall Study|Lost to Follow-up|1|||
161685688|NCT02025907|583901935|FG000|Overall Study|Lack of Efficacy|1|||
161630031|NCT02383927|583696339|FG003|Overall Study|Disease Progression|4|||
161630032|NCT02383927|583696336|FG000|Overall Study|Physician Decision|0|||
161630033|NCT02383927|583696337|FG001|Overall Study|Physician Decision|0|||
161630034|NCT02383927|583696338|FG002|Overall Study|Physician Decision|2|||
161630035|NCT02383927|583696339|FG003|Overall Study|Physician Decision|0|||
161630036|NCT02383927|583696336|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
161630037|NCT02383927|583696337|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
161685689|NCT02025907|583901936|FG001|Overall Study|Lack of Efficacy|0|||
161685690|NCT02025907|583901935|FG000|Overall Study|Withdrawal by Subject|15|||
161630038|NCT02383927|583696338|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
161630039|NCT02383927|583696339|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
161630040|NCT02383927|583696336|FG000|Overall Study|Adverse Event|4|||
161630041|NCT02383927|583696337|FG001|Overall Study|Adverse Event|1|||
161630042|NCT02383927|583696338|FG002|Overall Study|Adverse Event|3|||
161630043|NCT02383927|583696339|FG003|Overall Study|Adverse Event|5|||
161630044|NCT02383927|583696336|FG000|Overall Study|Miscellaneous|1|||
161630045|NCT02383927|583696337|FG001|Overall Study|Miscellaneous|0|||
161630046|NCT02383927|583696338|FG002|Overall Study|Miscellaneous|0|||
161630047|NCT02383927|583696339|FG003|Overall Study|Miscellaneous|1|||
161630048|NCT02383927|583696336|FG000|Overall Study|Withdrawal by Subject|0|||
161630049|NCT02383927|583696337|FG001|Overall Study|Withdrawal by Subject|1|||
161630050|NCT02383927|583696338|FG002|Overall Study|Withdrawal by Subject|4|||
161630051|NCT02383927|583696339|FG003|Overall Study|Withdrawal by Subject|0|||
161630052|NCT00734851|583696340|FG000|Overall Study|Withdrawal by Subject|2|||
161630053|NCT00734851|583696340|FG000|Overall Study|Lost to Follow-up|1|||
161630054|NCT00734851|583696340|FG000|Overall Study|Physician Decision|18|||
161630055|NCT00818519|583696344|FG000|Overall Study|Adverse Event|2|||
161833611|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Other|0|||
161833612|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Other|1|||
161630056|NCT00818519|583696345|FG001|Overall Study|Adverse Event|2|||
161630057|NCT00818519|583696344|FG000|Overall Study|Lost to Follow-up|4|||
161630058|NCT00818519|583696345|FG001|Overall Study|Lost to Follow-up|6|||
161630059|NCT00818519|583696344|FG000|Overall Study|Protocol Violation|2|||
161630060|NCT00818519|583696345|FG001|Overall Study|Protocol Violation|1|||
161630061|NCT00818519|583696344|FG000|Overall Study|Pregnancy|0|||
161630062|NCT00818519|583696345|FG001|Overall Study|Pregnancy|1|||
161630063|NCT00818519|583696344|FG000|Overall Study|Withdrawal by Subject|4|||
161630064|NCT00818519|583696345|FG001|Overall Study|Withdrawal by Subject|9|||
161630065|NCT00818519|583696344|FG000|Overall Study|participant recovered completely|1|||
161630066|NCT00818519|583696345|FG001|Overall Study|participant recovered completely|0|||
161630067|NCT00818519|583696344|FG000|Overall Study|participant will leave for long tme|1|||
161630068|NCT00818519|583696345|FG001|Overall Study|participant will leave for long tme|0|||
161630069|NCT00981578|583696346|FG000|Overall Study|Death|1|||
161630070|NCT00981578|583696346|FG000|Overall Study|Withdrawal by Subject|2|||
161630071|NCT01294358|583696351|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161630072|NCT01294358|583696352|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
161630073|NCT01294358|583696353|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161630074|NCT01294358|583696354|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161630075|NCT01294358|583696355|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161630076|NCT01294358|583696351|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161630077|NCT01294358|583696352|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161630078|NCT01294358|583696353|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
161630079|NCT01294358|583696354|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161630080|NCT01294358|583696355|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161630081|NCT01294358|583696351|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161630082|NCT01294358|583696352|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161630083|NCT01294358|583696353|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161630084|NCT01294358|583696354|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
161630085|NCT01294358|583696355|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161630086|NCT01294358|583696351|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161630087|NCT01294358|583696352|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161630088|NCT01294358|583696353|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161630089|NCT01294358|583696354|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161630090|NCT01294358|583696355|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
161630091|NCT03613454|583696356|FG000|Overall Study|Protocol Violation|1|||
161630092|NCT03613454|583696357|FG001|Overall Study|Protocol Violation|0|||
161630093|NCT03613454|583696356|FG000|Overall Study|Protocol Violation|0|||
161630094|NCT03613454|583696357|FG001|Overall Study|Protocol Violation|1|||
161630095|NCT02963922|583696358|FG000|Overall Study|Adverse Event|15|||
161630096|NCT02963922|583696359|FG001|Overall Study|Adverse Event|6|||
161630097|NCT02963922|583696358|FG000|Overall Study|Protocol deviation|6|||
161833613|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Other|2|||
161630098|NCT02963922|583696359|FG001|Overall Study|Protocol deviation|6|||
161630099|NCT02963922|583696358|FG000|Overall Study|Lack of Efficacy|1|||
161630100|NCT02963922|583696359|FG001|Overall Study|Lack of Efficacy|1|||
161630101|NCT02963922|583696358|FG000|Overall Study|Lost to Follow-up|2|||
161630102|NCT02963922|583696359|FG001|Overall Study|Lost to Follow-up|3|||
161630103|NCT02963922|583696358|FG000|Overall Study|Other|8|||
161630104|NCT02963922|583696359|FG001|Overall Study|Other|14|||
161630105|NCT01180790|583696369|FG000|Overall Study|Adverse Event|1|||
161630106|NCT01180790|583696370|FG001|Overall Study|Adverse Event|1|||
161630107|NCT01180790|583696371|FG002|Overall Study|Adverse Event|2|||
161630108|NCT01180790|583696372|FG003|Overall Study|Adverse Event|0|||
161630109|NCT01180790|583696373|FG004|Overall Study|Adverse Event|1|||
161630110|NCT01180790|583696374|FG005|Overall Study|Adverse Event|3|||
161630111|NCT01180790|583696375|FG006|Overall Study|Adverse Event|0|||
161630112|NCT01180790|583696369|FG000|Overall Study|Withdrawal by Subject|3|||
161630113|NCT01180790|583696370|FG001|Overall Study|Withdrawal by Subject|0|||
161630114|NCT01180790|583696371|FG002|Overall Study|Withdrawal by Subject|5|||
161630115|NCT01180790|583696372|FG003|Overall Study|Withdrawal by Subject|0|||
161630116|NCT01180790|583696373|FG004|Overall Study|Withdrawal by Subject|2|||
161630117|NCT01180790|583696374|FG005|Overall Study|Withdrawal by Subject|1|||
161630118|NCT01180790|583696375|FG006|Overall Study|Withdrawal by Subject|0|||
161630119|NCT01180790|583696369|FG000|Overall Study|Lost to Follow-up|3|||
161630120|NCT01180790|583696370|FG001|Overall Study|Lost to Follow-up|1|||
161630121|NCT01180790|583696371|FG002|Overall Study|Lost to Follow-up|0|||
161630122|NCT01180790|583696372|FG003|Overall Study|Lost to Follow-up|2|||
161630123|NCT01180790|583696373|FG004|Overall Study|Lost to Follow-up|1|||
161630124|NCT01180790|583696374|FG005|Overall Study|Lost to Follow-up|0|||
161630125|NCT01180790|583696375|FG006|Overall Study|Lost to Follow-up|1|||
161630126|NCT01180790|583696369|FG000|Overall Study|Physician Decision|1|||
161630127|NCT01180790|583696370|FG001|Overall Study|Physician Decision|0|||
161630128|NCT01180790|583696371|FG002|Overall Study|Physician Decision|0|||
161630129|NCT01180790|583696372|FG003|Overall Study|Physician Decision|1|||
161630130|NCT01180790|583696373|FG004|Overall Study|Physician Decision|0|||
161630131|NCT01180790|583696374|FG005|Overall Study|Physician Decision|0|||
161630132|NCT01180790|583696375|FG006|Overall Study|Physician Decision|0|||
161630133|NCT01180790|583696369|FG000|Overall Study|Lack of Efficacy|1|||
161630134|NCT01180790|583696370|FG001|Overall Study|Lack of Efficacy|2|||
161630135|NCT01180790|583696371|FG002|Overall Study|Lack of Efficacy|5|||
161630136|NCT01180790|583696372|FG003|Overall Study|Lack of Efficacy|6|||
161630137|NCT01180790|583696373|FG004|Overall Study|Lack of Efficacy|1|||
161630138|NCT01180790|583696374|FG005|Overall Study|Lack of Efficacy|3|||
161630139|NCT01180790|583696375|FG006|Overall Study|Lack of Efficacy|0|||
161630140|NCT01180790|583696369|FG000|Overall Study|compliance|0|||
161630141|NCT01180790|583696370|FG001|Overall Study|compliance|1|||
161630142|NCT01180790|583696371|FG002|Overall Study|compliance|0|||
161630143|NCT01180790|583696372|FG003|Overall Study|compliance|0|||
161630144|NCT01180790|583696373|FG004|Overall Study|compliance|0|||
161630145|NCT01180790|583696374|FG005|Overall Study|compliance|0|||
161630146|NCT01180790|583696375|FG006|Overall Study|compliance|0|||
161630147|NCT01180790|583696369|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
161630148|NCT01180790|583696370|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
161630149|NCT01180790|583696371|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
161630150|NCT01180790|583696372|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
161630151|NCT01180790|583696373|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
161630152|NCT01180790|583696374|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
161630153|NCT01180790|583696375|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
161630154|NCT00655668|583696376|FG000|Overall Study|Adverse Event|6|||
161630155|NCT00655668|583696376|FG000|Overall Study|Death|5|||
161630156|NCT00655668|583696376|FG000|Overall Study|Disease Progression|27|||
161630157|NCT00655668|583696376|FG000|Overall Study|Study Terminated|9|||
161630158|NCT00655668|583696376|FG000|Overall Study|Other|1|||
161630159|NCT00655668|583696376|FG000|Overall Study|New Lymphoma Treatment Started|4|||
161630160|NCT00655668|583696376|FG000|Overall Study|Withdrawal by Subject|2|||
161630161|NCT02335242|583696377|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
161630162|NCT02335242|583696378|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
161630163|NCT02335242|583696377|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
161630164|NCT02335242|583696378|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161630165|NCT02335242|583696377|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
161630166|NCT02335242|583696378|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
161630167|NCT04167085|583696379|FG000|Baseline|Withdrawal by Subject|2|||
161630168|NCT04167085|583696380|FG001|Baseline|Withdrawal by Subject|1|||
161630169|NCT04167085|583696379|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
161630170|NCT04167085|583696380|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
161630171|NCT03615404|583696381|FG000|Overall Study|Death|1|||
161630172|NCT03615404|583696381|FG000|Overall Study|vaccine did not pass quality assurance|1|||
161630173|NCT00257556|583696382|FG000|Overall Study|Adverse Event|1|||
161630174|NCT00257556|583696383|FG001|Overall Study|Adverse Event|4|||
161630175|NCT00257556|583696382|FG000|Overall Study|Physician Decision|6|||
161630176|NCT00257556|583696383|FG001|Overall Study|Physician Decision|0|||
161630177|NCT00257556|583696382|FG000|Overall Study|Did not meet hCG criterion|3|||
161630178|NCT00257556|583696383|FG001|Overall Study|Did not meet hCG criterion|0|||
161630179|NCT00257556|583696382|FG000|Overall Study|other reason|4|||
161630180|NCT00257556|583696383|FG001|Overall Study|other reason|6|||
161630181|NCT03873038|583696384|FG000|Part 2|Withdrawal by Subject|0|||
161630182|NCT03873038|583696385|FG001|Part 2|Withdrawal by Subject|0|||
161630183|NCT03873038|583696386|FG002|Part 2|Withdrawal by Subject|0|||
161630184|NCT03873038|583696387|FG003|Part 2|Withdrawal by Subject|0|||
161630185|NCT03873038|583696388|FG004|Part 2|Withdrawal by Subject|0|||
161630186|NCT03873038|583696389|FG005|Part 2|Withdrawal by Subject|1|||
161630187|NCT03873038|583696384|FG000|Part 2|Unknon|0|||
161630188|NCT03873038|583696385|FG001|Part 2|Unknon|0|||
161630189|NCT03873038|583696386|FG002|Part 2|Unknon|0|||
161630190|NCT03873038|583696387|FG003|Part 2|Unknon|0|||
161630191|NCT03873038|583696388|FG004|Part 2|Unknon|1|||
161630192|NCT03873038|583696389|FG005|Part 2|Unknon|0|||
161630193|NCT00595764|583696390|FG000|Overall Study|Protocol Violation|24|||
161630194|NCT00595764|583696391|FG001|Overall Study|Protocol Violation|19|||
161630195|NCT00595764|583696390|FG000|Overall Study|Missed Medication >1 week|10|||
161630196|NCT00595764|583696391|FG001|Overall Study|Missed Medication >1 week|17|||
161630197|NCT00595764|583696390|FG000|Overall Study|Missed 3 PM visits|1|||
161630198|NCT00595764|583696391|FG001|Overall Study|Missed 3 PM visits|7|||
161630199|NCT00595764|583696390|FG000|Overall Study|Withdrawal by Subject|4|||
161630200|NCT00595764|583696391|FG001|Overall Study|Withdrawal by Subject|0|||
161630201|NCT04222088|583696392|FG000|Overall Study|Lost to Follow-up|5|||
161630202|NCT04222088|583696393|FG001|Overall Study|Lost to Follow-up|1|||
161630203|NCT04222088|583696392|FG000|Overall Study|Withdrawal by Subject|4|||
161630204|NCT04222088|583696393|FG001|Overall Study|Withdrawal by Subject|0|||
161630205|NCT02820298|583696397|FG000|Overall Study|Withdrawal by Subject|0|||
161630206|NCT02820298|583696398|FG001|Overall Study|Withdrawal by Subject|1|||
161630207|NCT02820298|583696397|FG000|Overall Study|Physician Decision|1|||
161630208|NCT02820298|583696398|FG001|Overall Study|Physician Decision|0|||
161630209|NCT02820298|583696397|FG000|Overall Study|Protocol Violation|0|||
161630210|NCT02820298|583696398|FG001|Overall Study|Protocol Violation|1|||
161630211|NCT01780584|583696401|FG000|Overall Study|Death|1|||
161630212|NCT01780584|583696402|FG001|Overall Study|Death|0|||
161630213|NCT01780584|583696403|FG002|Overall Study|Death|1|||
161630214|NCT01780584|583696401|FG000|Overall Study|Adverse Event|0|||
161630215|NCT01780584|583696402|FG001|Overall Study|Adverse Event|1|||
161630216|NCT01780584|583696403|FG002|Overall Study|Adverse Event|0|||
161630217|NCT01780584|583696401|FG000|Overall Study|Protocol Violation|0|||
161630218|NCT01780584|583696402|FG001|Overall Study|Protocol Violation|0|||
161630219|NCT01780584|583696403|FG002|Overall Study|Protocol Violation|1|||
161630220|NCT00141271|583696408|FG000|Overall Study|Adverse Event|31|||
161630221|NCT00141271|583696409|FG001|Overall Study|Adverse Event|19|||
161630222|NCT00141271|583696410|FG002|Overall Study|Adverse Event|17|||
161630223|NCT00141271|583696408|FG000|Overall Study|Laboratory Abnormality|2|||
161630224|NCT00141271|583696409|FG001|Overall Study|Laboratory Abnormality|1|||
161630225|NCT00141271|583696410|FG002|Overall Study|Laboratory Abnormality|1|||
161630226|NCT00141271|583696408|FG000|Overall Study|Lack of Efficacy|7|||
161630227|NCT00141271|583696409|FG001|Overall Study|Lack of Efficacy|7|||
161630228|NCT00141271|583696410|FG002|Overall Study|Lack of Efficacy|3|||
161630229|NCT00141271|583696408|FG000|Overall Study|Lost to Follow-up|15|||
161630230|NCT00141271|583696409|FG001|Overall Study|Lost to Follow-up|15|||
161630231|NCT00141271|583696410|FG002|Overall Study|Lost to Follow-up|21|||
161630232|NCT00141271|583696408|FG000|Overall Study|Withdrawal by Subject|14|||
161630233|NCT00141271|583696409|FG001|Overall Study|Withdrawal by Subject|9|||
161630234|NCT00141271|583696410|FG002|Overall Study|Withdrawal by Subject|10|||
161630235|NCT00141271|583696408|FG000|Overall Study|Other|11|||
161630236|NCT00141271|583696409|FG001|Overall Study|Other|12|||
161630237|NCT00141271|583696410|FG002|Overall Study|Other|5|||
161630238|NCT01544153|583696411|FG000|Overall Study|Under 18|0|||
161630239|NCT01544153|583696412|FG001|Overall Study|Under 18|1|||
161630240|NCT01544153|583696413|FG002|Overall Study|Under 18|0|||
161630241|NCT01544153|583696414|FG003|Overall Study|Under 18|0|||
161630242|NCT01544153|583696411|FG000|Overall Study|Non-smoker|0|||
161630243|NCT01544153|583696412|FG001|Overall Study|Non-smoker|0|||
161630244|NCT01544153|583696413|FG002|Overall Study|Non-smoker|1|||
161630245|NCT01544153|583696414|FG003|Overall Study|Non-smoker|0|||
161630246|NCT00390806|583696419|FG000|Overall Study|Lost to Follow-up|7|||
161630247|NCT00390806|583696420|FG001|Overall Study|Lost to Follow-up|6|||
161630248|NCT00390806|583696419|FG000|Overall Study|Protocol Violation|2|||
161630249|NCT00390806|583696420|FG001|Overall Study|Protocol Violation|2|||
161630250|NCT00390806|583696419|FG000|Overall Study|Withdrawal by Subject|12|||
161630251|NCT00390806|583696420|FG001|Overall Study|Withdrawal by Subject|15|||
161630252|NCT00390806|583696419|FG000|Overall Study|Investigator Decision|4|||
161630253|NCT00390806|583696420|FG001|Overall Study|Investigator Decision|6|||
161630254|NCT00390806|583696419|FG000|Overall Study|Death|1|||
161630255|NCT00390806|583696420|FG001|Overall Study|Death|0|||
161630256|NCT00390806|583696419|FG000|Overall Study|Physician Decision|0|||
161630257|NCT00390806|583696420|FG001|Overall Study|Physician Decision|1|||
161630258|NCT00390806|583696419|FG000|Overall Study|Ongoing|4|||
161630259|NCT00390806|583696420|FG001|Overall Study|Ongoing|2|||
161630260|NCT04783519|583696423|FG000|Overall Study|Withdrawal by Subject|2|||
161630261|NCT04783519|583696424|FG001|Overall Study|Withdrawal by Subject|7|||
161630262|NCT04783519|583696425|FG002|Overall Study|Withdrawal by Subject|3|||
161630263|NCT04783519|583696423|FG000|Overall Study|Lost to Follow-up|9|||
161630264|NCT04783519|583696424|FG001|Overall Study|Lost to Follow-up|7|||
161630265|NCT04783519|583696425|FG002|Overall Study|Lost to Follow-up|6|||
161630266|NCT00884793|583696426|FG000|Overall Study|Withdrawal by Subject|1|||
161630267|NCT03169530|583696427|FG000|Overall Study|Study ended by NIH|15|||
161630268|NCT03169530|583696428|FG001|Overall Study|Study ended by NIH|17|||
161630269|NCT01032200|583696429|FG000|Overall Study|Death|1|||
161630270|NCT01032200|583696430|FG001|Overall Study|Death|1|||
161630271|NCT01032200|583696429|FG000|Overall Study|Withdrawal by Subject|1|||
161630272|NCT01032200|583696430|FG001|Overall Study|Withdrawal by Subject|3|||
161630273|NCT01032200|583696429|FG000|Overall Study|Toxicity|0|||
161630274|NCT01032200|583696430|FG001|Overall Study|Toxicity|2|||
161630275|NCT01032200|583696429|FG000|Overall Study|Progression|1|||
161630276|NCT01032200|583696430|FG001|Overall Study|Progression|0|||
161630277|NCT01032200|583696429|FG000|Overall Study|Multiple|1|||
161630278|NCT01032200|583696430|FG001|Overall Study|Multiple|1|||
161630279|NCT00727259|583696434|FG000|Overall Study|Not all questionnaires completed|1055|||
161630280|NCT01021683|583696435|FG000|Overall Study|Lack of Efficacy|12|||
161630281|NCT01021683|583696435|FG000|Overall Study|Recovery of neutrophil count|51|||
161630282|NCT01021683|583696435|FG000|Overall Study|Other|8|||
161630283|NCT01374971|583696436|FG000|Overall Study|Withdrawal by Subject|1|||
161630284|NCT02273180|583696437|FG000|Overall Study|Adverse Event|2|||
161630285|NCT02273180|583696438|FG001|Overall Study|Adverse Event|2|||
161630286|NCT02273180|583696437|FG000|Overall Study|Lack of Efficacy|1|||
161630287|NCT02273180|583696438|FG001|Overall Study|Lack of Efficacy|0|||
161630288|NCT02273180|583696437|FG000|Overall Study|Protocol Violation|1|||
161630289|NCT02273180|583696438|FG001|Overall Study|Protocol Violation|7|||
161630290|NCT02273180|583696437|FG000|Overall Study|Randomized but not treated|1|||
161630291|NCT02273180|583696438|FG001|Overall Study|Randomized but not treated|0|||
161630292|NCT02273180|583696437|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
161630293|NCT02273180|583696438|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
161630294|NCT02273180|583696437|FG000|Overall Study|Other than specified above|21|||
161630295|NCT02273180|583696438|FG001|Overall Study|Other than specified above|10|||
161630296|NCT04531813|583696439|FG000|Overall Study|Protocol Violation|1|||
161630297|NCT04531813|583696439|FG000|Overall Study|Withdrawal by Subject|1|||
161630298|NCT04341584|583696442|FG000|Overall Study|Withdrew consent|0|||
161630299|NCT04341584|583696443|FG001|Overall Study|Withdrew consent|2|||
161630300|NCT04341584|583696444|FG002|Overall Study|Withdrew consent|2|||
161630301|NCT04341584|583696445|FG003|Overall Study|Withdrew consent|1|||
161630302|NCT03449134|583698160|FG000|52-Week Treatment Period|Death|2|||
161630303|NCT03449134|583698161|FG001|52-Week Treatment Period|Death|1|||
161630304|NCT03449134|583698162|FG002|52-Week Treatment Period|Death|0|||
161630305|NCT03449134|583698160|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
161630306|NCT03449134|583698161|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
161630307|NCT03449134|583698162|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
161630308|NCT03449134|583698160|FG000|52-Week Treatment Period|Physician Decision|2|||
161630309|NCT03449134|583698161|FG001|52-Week Treatment Period|Physician Decision|3|||
161630310|NCT03449134|583698162|FG002|52-Week Treatment Period|Physician Decision|3|||
161630311|NCT03449134|583698160|FG000|52-Week Treatment Period|Screen Failure|1|||
161630312|NCT03449134|583698161|FG001|52-Week Treatment Period|Screen Failure|0|||
161630313|NCT03449134|583698162|FG002|52-Week Treatment Period|Screen Failure|1|||
161630314|NCT03449134|583698160|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
161630315|NCT03449134|583698161|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
161630316|NCT03449134|583698162|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
161630317|NCT03449134|583698160|FG000|52-Week Treatment Period|Site Closure|1|||
161630318|NCT03449134|583698161|FG001|52-Week Treatment Period|Site Closure|0|||
161630319|NCT03449134|583698162|FG002|52-Week Treatment Period|Site Closure|0|||
161630320|NCT01821729|583698163|FG000|Overall Study|Withdrawal by Subject|1|||
161630321|NCT01990313|583698167|FG000|Overall Study|Lost to Follow-up|1|||
161630322|NCT02412111|583698168|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
161630323|NCT02412111|583698169|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
161630324|NCT02412111|583698170|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
161630325|NCT02412111|583698168|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
161630326|NCT02412111|583698169|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
161630327|NCT02412111|583698170|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
161630328|NCT02412111|583698168|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
161630329|NCT02412111|583698169|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
161630330|NCT02412111|583698170|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
161630331|NCT02412111|583698168|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
161630332|NCT02412111|583698169|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
161630333|NCT02412111|583698170|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
161630334|NCT02412111|583698168|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
161630335|NCT02412111|583698169|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
161630336|NCT02412111|583698170|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
161630337|NCT02412111|583698168|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
161630338|NCT02412111|583698169|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
161630339|NCT02412111|583698170|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
161630340|NCT02412111|583698168|FG000|Active Comparator Period (8 Weeks)|Other|0|||
161630341|NCT02412111|583698169|FG001|Active Comparator Period (8 Weeks)|Other|0|||
161630342|NCT02412111|583698170|FG002|Active Comparator Period (8 Weeks)|Other|2|||
161630343|NCT00837096|583698172|FG000|Overall Study|Physician Decision|1|||
161630344|NCT00837096|583698173|FG001|Overall Study|Physician Decision|1|||
161630345|NCT00837096|583698172|FG000|Overall Study|Not reported|9|||
161630346|NCT00837096|583698173|FG001|Overall Study|Not reported|8|||
161630347|NCT00721214|583698174|FG000|Overall Study|Chose another center for transplant|1|||
161630348|NCT00721214|583698174|FG000|Overall Study|Death|3|||
161630349|NCT00983905|583698175|FG000|Theophylline Alone|Adverse Event|1|||
161630350|NCT00983905|583698175|FG000|Colchicine Alone|Adverse Event|2|||
161630351|NCT01169636|583698176|FG000|Overall Study|Adverse Event|0|||
161630352|NCT01169636|583698177|FG001|Overall Study|Adverse Event|0|||
161630353|NCT01169636|583698178|FG002|Overall Study|Adverse Event|1|||
161630354|NCT01169636|583698179|FG003|Overall Study|Adverse Event|1|||
161630355|NCT01169636|583698180|FG004|Overall Study|Adverse Event|0|||
161630356|NCT01169636|583698176|FG000|Overall Study|Screen failure|0|||
161630357|NCT01169636|583698177|FG001|Overall Study|Screen failure|0|||
161630358|NCT01169636|583698178|FG002|Overall Study|Screen failure|2|||
161630359|NCT01169636|583698179|FG003|Overall Study|Screen failure|0|||
161630360|NCT01169636|583698180|FG004|Overall Study|Screen failure|0|||
161630361|NCT01169636|583698176|FG000|Overall Study|Withdrawal by Subject|0|||
161630362|NCT01169636|583698177|FG001|Overall Study|Withdrawal by Subject|0|||
161630363|NCT01169636|583698178|FG002|Overall Study|Withdrawal by Subject|0|||
161630364|NCT01169636|583698179|FG003|Overall Study|Withdrawal by Subject|0|||
161630365|NCT01169636|583698180|FG004|Overall Study|Withdrawal by Subject|3|||
161630366|NCT02396953|583698181|FG000|Overall Study|Withdrawal by Subject|0|||
161630367|NCT02396953|583698182|FG001|Overall Study|Withdrawal by Subject|0|||
161685691|NCT02025907|583901936|FG001|Overall Study|Withdrawal by Subject|8|||
161685692|NCT02025907|583901935|FG000|Overall Study|Protocol Violation|2|||
161685693|NCT02025907|583901936|FG001|Overall Study|Protocol Violation|0|||
161685694|NCT02025907|583901935|FG000|Overall Study|Physician Decision|2|||
161685695|NCT02025907|583901936|FG001|Overall Study|Physician Decision|0|||
161685696|NCT02025907|583901935|FG000|Overall Study|Lost to Follow-up|2|||
161685697|NCT02025907|583901936|FG001|Overall Study|Lost to Follow-up|2|||
161685698|NCT02025907|583901935|FG000|Overall Study|Adverse Event|3|||
161685699|NCT02025907|583901936|FG001|Overall Study|Adverse Event|1|||
161685700|NCT02025907|583901935|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
161685701|NCT02025907|583901936|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
161685702|NCT02411539|583901937|FG000|Overall Study|Lost to Follow-up|2|||
161685703|NCT02411539|583901938|FG001|Overall Study|Lost to Follow-up|0|||
161685704|NCT02411539|583901937|FG000|Overall Study|Confounding medical condition|0|||
161685705|NCT02411539|583901938|FG001|Overall Study|Confounding medical condition|1|||
161685706|NCT01422915|583901939|FG000|Overall Study|Adverse Event|1|||
161685707|NCT01549002|583901940|FG000|Overall Study|Excessive pain|0|||
161685708|NCT01549002|583901941|FG001|Overall Study|Excessive pain|2|||
161685709|NCT01549002|583901940|FG000|Overall Study|Moderate sedation required|0|||
161685710|NCT01549002|583901941|FG001|Overall Study|Moderate sedation required|2|||
161685711|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
161685712|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
161685713|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
161685714|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
161685715|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
161685716|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
161685717|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
161685718|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
161685719|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
161685720|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
161685721|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
161685722|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
161685723|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
161630368|NCT02396953|583698183|FG002|Overall Study|Withdrawal by Subject|1|||
161630369|NCT02396953|583698181|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
161630370|NCT02396953|583698182|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
161630371|NCT02396953|583698183|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
161630372|NCT02396953|583698181|FG000|Overall Study|Personal Reasons|1|||
161630373|NCT02396953|583698182|FG001|Overall Study|Personal Reasons|1|||
161630374|NCT02396953|583698183|FG002|Overall Study|Personal Reasons|0|||
161630375|NCT02624869|583698184|FG000|Overall Study|Lost to Follow-up|0|||
161630376|NCT02624869|583698185|FG001|Overall Study|Lost to Follow-up|0|||
161685724|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
161685725|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
161630377|NCT02624869|583698186|FG002|Overall Study|Lost to Follow-up|1|||
161685726|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
161630378|NCT02624869|583698184|FG000|Overall Study|Withdrawal by Subject|1|||
161630379|NCT02624869|583698185|FG001|Overall Study|Withdrawal by Subject|3|||
161630380|NCT02624869|583698186|FG002|Overall Study|Withdrawal by Subject|1|||
161630381|NCT00510198|583698187|FG000|Overall Study|Withdrawal by Subject|5|||
161630382|NCT00510198|583698188|FG001|Overall Study|Withdrawal by Subject|4|||
161630383|NCT02994784|583698190|FG000|6 Months Follow-up|Lost to Follow-up|3|||
161630384|NCT00494026|583698191|FG000|Overall Study|Sponsor Decision|4|||
161630385|NCT02466243|583698192|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
161630386|NCT02466243|583698193|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
161630387|NCT02466243|583698192|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
161630388|NCT02466243|583698193|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
161630389|NCT02466243|583698192|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
161630390|NCT02466243|583698193|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
161630391|NCT02466243|583698192|FG000|Part B Open-label Treatment Period|Missing|2|||
161630392|NCT02466243|583698193|FG001|Part B Open-label Treatment Period|Missing|2|||
161630393|NCT01649557|583698197|FG000|Overall Study|Lost to Follow-up|5|||
161630394|NCT01649557|583698198|FG001|Overall Study|Lost to Follow-up|0|||
161630395|NCT01649557|583698199|FG002|Overall Study|Lost to Follow-up|3|||
161630396|NCT01649557|583698197|FG000|Overall Study|Adverse Event|7|||
161630397|NCT01649557|583698198|FG001|Overall Study|Adverse Event|5|||
161630398|NCT01649557|583698199|FG002|Overall Study|Adverse Event|1|||
161630399|NCT01649557|583698197|FG000|Overall Study|Met withdrawal criteria|4|||
161630400|NCT01649557|583698198|FG001|Overall Study|Met withdrawal criteria|0|||
161630401|NCT01649557|583698199|FG002|Overall Study|Met withdrawal criteria|0|||
161630402|NCT01649557|583698197|FG000|Overall Study|Physician Decision|8|||
161630403|NCT01649557|583698198|FG001|Overall Study|Physician Decision|2|||
161630404|NCT01649557|583698199|FG002|Overall Study|Physician Decision|1|||
161630405|NCT01649557|583698197|FG000|Overall Study|Withdrawal by Subject|15|||
161630406|NCT01649557|583698198|FG001|Overall Study|Withdrawal by Subject|5|||
161630407|NCT01649557|583698199|FG002|Overall Study|Withdrawal by Subject|4|||
161630408|NCT01649557|583698197|FG000|Overall Study|Protocol deviation|0|||
161630409|NCT01649557|583698198|FG001|Overall Study|Protocol deviation|2|||
161630410|NCT01649557|583698199|FG002|Overall Study|Protocol deviation|0|||
161630411|NCT01649557|583698197|FG000|Overall Study|Lack of Efficacy|5|||
161630412|NCT01649557|583698198|FG001|Overall Study|Lack of Efficacy|0|||
161630413|NCT01649557|583698199|FG002|Overall Study|Lack of Efficacy|0|||
161630414|NCT01011049|583698200|FG000|Overall Study|Protocol Violation|0|||
161630415|NCT01011049|583698201|FG001|Overall Study|Protocol Violation|0|||
161630416|NCT01011049|583698202|FG002|Overall Study|Protocol Violation|2|||
161630417|NCT01011049|583698203|FG003|Overall Study|Protocol Violation|0|||
161630418|NCT01011049|583698200|FG000|Overall Study|Lost to Follow-up|1|||
161630419|NCT01011049|583698201|FG001|Overall Study|Lost to Follow-up|2|||
161630420|NCT01011049|583698202|FG002|Overall Study|Lost to Follow-up|1|||
161630421|NCT01011049|583698203|FG003|Overall Study|Lost to Follow-up|0|||
161630422|NCT01011049|583698200|FG000|Overall Study|Withdrawal by Subject|0|||
161630423|NCT01011049|583698201|FG001|Overall Study|Withdrawal by Subject|0|||
161630424|NCT01011049|583698202|FG002|Overall Study|Withdrawal by Subject|1|||
161630425|NCT01011049|583698203|FG003|Overall Study|Withdrawal by Subject|0|||
161630426|NCT02815735|583698204|FG000|First Intervention (4 Weeks)|Discomfort|1|||
161630427|NCT02815735|583698205|FG001|First Intervention (4 Weeks)|Discomfort|0|||
161630428|NCT02815735|583698204|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161630429|NCT02815735|583698205|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161630430|NCT02815735|583698204|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
161630431|NCT02815735|583698205|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
161630432|NCT02815735|583698204|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
161630433|NCT02815735|583698205|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
161630434|NCT00352053|583698206|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
161630435|NCT00352053|583698207|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
161630436|NCT00352053|583698206|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
161630437|NCT00352053|583698207|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
161630438|NCT00352053|583698206|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
161630439|NCT00352053|583698207|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
161630440|NCT00352053|583698206|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
161630441|NCT00352053|583698207|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
161630442|NCT00352053|583698206|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
161630443|NCT00352053|583698207|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
161630444|NCT00352053|583698206|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
161630445|NCT00352053|583698207|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
161630446|NCT00352053|583698206|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
161630447|NCT00352053|583698207|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
161630448|NCT00352053|583698206|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
161630449|NCT00352053|583698207|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
161630450|NCT00352053|583698206|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
161630451|NCT00352053|583698207|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
161630452|NCT00352053|583698206|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
161630453|NCT00352053|583698207|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
161630454|NCT00352053|583698206|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
161630455|NCT00352053|583698207|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
161630456|NCT00352053|583698206|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
161630457|NCT00352053|583698207|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
161630458|NCT00352053|583698206|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
161630459|NCT00352053|583698207|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
161630460|NCT02435381|583698208|FG000|Overall Study|Lost to Follow-up|2|||
161630461|NCT02435381|583698209|FG001|Overall Study|Lost to Follow-up|1|||
161630462|NCT00833898|583698210|FG000|Overall Study|Withdrawal by Subject|33|||
161630463|NCT00833898|583698211|FG001|Overall Study|Withdrawal by Subject|27|||
161630464|NCT00833898|583698210|FG000|Overall Study|Lost to Follow-up|7|||
161630465|NCT00833898|583698211|FG001|Overall Study|Lost to Follow-up|7|||
161630466|NCT00833898|583698210|FG000|Overall Study|Patient did not receive transplant|0|||
161630467|NCT00833898|583698211|FG001|Overall Study|Patient did not receive transplant|2|||
161630468|NCT02895360|583698216|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
161630469|NCT02895360|583698217|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161630470|NCT02895360|583698218|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161630471|NCT02895360|583698219|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161630472|NCT02895360|583698220|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161630473|NCT02895360|583698221|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161630474|NCT02895360|583698216|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161630475|NCT02895360|583698217|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
161630476|NCT02895360|583698218|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161685727|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
161685728|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
161685729|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
161685730|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
161685731|NCT01439204|583901946|FG000|Overall Study|Withdrawal by Subject|0|||
161685732|NCT01439204|583901947|FG001|Overall Study|Withdrawal by Subject|1|||
161685733|NCT01439204|583901946|FG000|Overall Study|Lost to Follow-up|0|||
161685734|NCT01439204|583901947|FG001|Overall Study|Lost to Follow-up|2|||
161685735|NCT01439204|583901946|FG000|Overall Study|No longer meets study criteria|1|||
161685736|NCT01439204|583901947|FG001|Overall Study|No longer meets study criteria|0|||
161685737|NCT01439204|583901946|FG000|Overall Study|poor/non-compliance|3|||
161685738|NCT01439204|583901947|FG001|Overall Study|poor/non-compliance|0|||
161685739|NCT01251367|583901948|FG000|Overall Study|Protocol Violation|1|||
161685740|NCT01251367|583901948|FG000|Overall Study|Lack of Efficacy|2|||
161685741|NCT01251367|583901948|FG000|Overall Study|Adverse Event|19|||
161685742|NCT01251367|583901948|FG000|Overall Study|Withdrawal by Subject|36|||
161685743|NCT01251367|583901948|FG000|Overall Study|Lost to Follow-up|5|||
161685744|NCT01251367|583901948|FG000|Overall Study|Subject Required Alternative Treatment|7|||
161685745|NCT01251367|583901948|FG000|Overall Study|No Study Drug Available|1|||
161685746|NCT01251367|583901948|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
161685747|NCT01251367|583901948|FG000|Overall Study|End of Study Visit Performed in Error|1|||
161685748|NCT02255409|583901949|FG000|Overall Study|Administrative Reason|3|||
161685749|NCT02255409|583901950|FG001|Overall Study|Administrative Reason|7|||
161685750|NCT02255409|583901949|FG000|Overall Study|Withdrawal by Subject|1|||
161685751|NCT02255409|583901950|FG001|Overall Study|Withdrawal by Subject|5|||
161685752|NCT02255409|583901949|FG000|Overall Study|Lost to Follow-up|10|||
161685753|NCT02255409|583901950|FG001|Overall Study|Lost to Follow-up|19|||
161685754|NCT00135668|583901952|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
161685755|NCT00135668|583901953|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
161685756|NCT00135668|583901954|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
161685757|NCT00135668|583901955|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
161685758|NCT02370615|583901958|FG000|Overall Study|Adverse Event|1|||
161630477|NCT02895360|583698219|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161630478|NCT02895360|583698220|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161630479|NCT02895360|583698221|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161630480|NCT02895360|583698216|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161630481|NCT02895360|583698217|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161630482|NCT02895360|583698218|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
161630483|NCT02895360|583698219|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161630484|NCT02895360|583698220|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161630485|NCT02895360|583698221|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161630486|NCT02895360|583698216|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161630487|NCT02895360|583698217|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161630488|NCT02895360|583698218|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
161630489|NCT02895360|583698219|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161630490|NCT02895360|583698220|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161630491|NCT02895360|583698221|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161630492|NCT02895360|583698216|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161630493|NCT02895360|583698217|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161630494|NCT02895360|583698218|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161630495|NCT02895360|583698219|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
161630496|NCT02895360|583698220|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161630497|NCT02895360|583698221|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161630498|NCT02895360|583698216|FG000|Phase 2a|Adverse Event|0|||
161630499|NCT02895360|583698217|FG001|Phase 2a|Adverse Event|0|||
161630500|NCT02895360|583698218|FG002|Phase 2a|Adverse Event|0|||
161630501|NCT02895360|583698219|FG003|Phase 2a|Adverse Event|0|||
161630502|NCT02895360|583698220|FG004|Phase 2a|Adverse Event|0|||
161630503|NCT02895360|583698221|FG005|Phase 2a|Adverse Event|1|||
161630504|NCT02895360|583698216|FG000|Phase 2a|Progressive disease|0|||
161630505|NCT02895360|583698217|FG001|Phase 2a|Progressive disease|0|||
161630506|NCT02895360|583698218|FG002|Phase 2a|Progressive disease|0|||
161630507|NCT02895360|583698219|FG003|Phase 2a|Progressive disease|0|||
161630508|NCT02895360|583698220|FG004|Phase 2a|Progressive disease|11|||
161630509|NCT02895360|583698221|FG005|Phase 2a|Progressive disease|11|||
161630510|NCT00307164|583698224|FG000|Overall Study|Death|1|||
161630511|NCT00307164|583698225|FG001|Overall Study|Death|0|||
161630512|NCT00307164|583698224|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161630513|NCT00307164|583698225|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161630514|NCT00307164|583698224|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
161630515|NCT00307164|583698225|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
161630516|NCT00307164|583698224|FG000|Overall Study|Withdrawal by Subject|1|||
161630517|NCT00307164|583698225|FG001|Overall Study|Withdrawal by Subject|8|||
161630518|NCT00307164|583698224|FG000|Overall Study|Not compliant with requirements|4|||
161630519|NCT00307164|583698225|FG001|Overall Study|Not compliant with requirements|4|||
161630520|NCT00307164|583698224|FG000|Overall Study|Lost to Follow-up|6|||
161630521|NCT00307164|583698225|FG001|Overall Study|Lost to Follow-up|1|||
161630522|NCT03972137|583698230|FG000|Overall Study|Lost to Follow-up|2|||
161630523|NCT03972137|583698230|FG000|Overall Study|Withdrawal by Subject|4|||
161630524|NCT03226353|583698231|FG000|Overall Study|Withdrawal by Subject|1|||
161630525|NCT03226353|583698231|FG000|Overall Study|Screen Failure|5|||
161630526|NCT03168425|583698234|FG000|Overall Study|Lost to Follow-up|5|||
161630527|NCT03168425|583698235|FG001|Overall Study|Lost to Follow-up|8|||
161630528|NCT03168425|583698234|FG000|Overall Study|unable to confirm post op opioids|2|||
161630529|NCT03168425|583698235|FG001|Overall Study|unable to confirm post op opioids|3|||
161630530|NCT03029234|583698236|FG000|Overall Study|Sponsor Decision|1|||
161630531|NCT03029234|583698236|FG000|Overall Study|Withdrawal by Subject|5|||
161630532|NCT03029234|583698236|FG000|Overall Study|Death|91|||
161630533|NCT03029234|583698236|FG000|Overall Study|Lost to Follow-up|2|||
161630534|NCT00498433|583698237|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
161630535|NCT00498433|583698238|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
161630536|NCT00498433|583698239|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
161630537|NCT00498433|583698237|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
161630538|NCT00498433|583698238|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
161630539|NCT00498433|583698239|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
161630540|NCT00498433|583698237|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
161630541|NCT00498433|583698238|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
161630542|NCT00498433|583698239|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
161630543|NCT00498433|583698237|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
161630544|NCT00498433|583698238|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
161630545|NCT00498433|583698239|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
161630546|NCT01960114|583698240|FG000|Overall Study|Adverse Event|1|||
161630547|NCT01960114|583698241|FG001|Overall Study|Adverse Event|0|||
161630548|NCT01960114|583698240|FG000|Overall Study|Could not swallow study medication|0|||
161685759|NCT02370615|583901959|FG001|Overall Study|Adverse Event|0|||
161630549|NCT01960114|583698241|FG001|Overall Study|Could not swallow study medication|1|||
161630550|NCT01340300|583698250|FG000|Overall Study|Lost to Follow-up|3|||
161630551|NCT01340300|583698251|FG001|Overall Study|Lost to Follow-up|0|||
161630552|NCT01340300|583698252|FG002|Overall Study|Lost to Follow-up|5|||
161630553|NCT01340300|583698253|FG003|Overall Study|Lost to Follow-up|10|||
161630554|NCT01340300|583698250|FG000|Overall Study|Withdrawal by Subject|5|||
161630555|NCT01340300|583698251|FG001|Overall Study|Withdrawal by Subject|6|||
161630556|NCT01340300|583698252|FG002|Overall Study|Withdrawal by Subject|6|||
161630557|NCT01340300|583698253|FG003|Overall Study|Withdrawal by Subject|3|||
161630558|NCT01340300|583698250|FG000|Overall Study|Adverse Event|1|||
161630559|NCT01340300|583698251|FG001|Overall Study|Adverse Event|0|||
161630560|NCT01340300|583698252|FG002|Overall Study|Adverse Event|4|||
161630561|NCT01340300|583698253|FG003|Overall Study|Adverse Event|0|||
161630562|NCT01340300|583698250|FG000|Overall Study|Physician Decision|0|||
161630563|NCT01340300|583698251|FG001|Overall Study|Physician Decision|1|||
161630564|NCT01340300|583698252|FG002|Overall Study|Physician Decision|0|||
161630565|NCT01340300|583698253|FG003|Overall Study|Physician Decision|0|||
161630566|NCT01340300|583698250|FG000|Overall Study|Unrelated sickness|0|||
161630567|NCT01340300|583698251|FG001|Overall Study|Unrelated sickness|2|||
161630568|NCT01340300|583698252|FG002|Overall Study|Unrelated sickness|0|||
161630569|NCT01340300|583698253|FG003|Overall Study|Unrelated sickness|1|||
161630570|NCT01951261|583698254|FG000|Overall Study|Death|1|||
161630571|NCT01951261|583698255|FG001|Overall Study|Death|0|||
161630572|NCT01951261|583698254|FG000|Overall Study|Lost to Follow-up|4|||
161630573|NCT01951261|583698255|FG001|Overall Study|Lost to Follow-up|3|||
161630574|NCT01951261|583698254|FG000|Overall Study|Protocol Violation|4|||
161630575|NCT01951261|583698255|FG001|Overall Study|Protocol Violation|3|||
161630576|NCT03927222|583698259|FG000|Overall Study|Progression|3|||
161630577|NCT03927222|583698259|FG000|Overall Study|CMV testing results inconclusive|1|||
161630578|NCT03927222|583698259|FG000|Overall Study|Unable to generate enough vaccines|1|||
161630579|NCT03927222|583698259|FG000|Overall Study|Early study termination|1|||
161630580|NCT03723915|583698265|FG000|Screening|Failed to meet screening requirements.|2|||
161630581|NCT03723915|583698265|FG000|On Treatment|Failed to meet treatment requirements|2|||
161630582|NCT02201771|583698266|FG000|Overall Study|Death|3|||
161630583|NCT02201771|583698267|FG001|Overall Study|Death|2|||
161630584|NCT02201771|583698268|FG002|Overall Study|Death|0|||
161630585|NCT02201771|583698266|FG000|Overall Study|Protocol Violation|10|||
161630586|NCT02201771|583698267|FG001|Overall Study|Protocol Violation|8|||
161630587|NCT02201771|583698268|FG002|Overall Study|Protocol Violation|10|||
161630588|NCT01287416|583698271|FG000|Pre-post Training|Withdrawal by Subject|17|||
161630589|NCT01287416|583698272|FG001|Pre-post Training|Withdrawal by Subject|24|||
161630590|NCT01287416|583698271|FG000|Pre-post Training|Lost to Follow-up|5|||
161630591|NCT01287416|583698272|FG001|Pre-post Training|Lost to Follow-up|1|||
161630592|NCT01287416|583698271|FG000|6 Month Follow-up|Lost to Follow-up|3|||
161630593|NCT01287416|583698272|FG001|6 Month Follow-up|Lost to Follow-up|2|||
161630594|NCT03840148|583698278|FG000|Study Drug Disposition|Adverse Event|13|||
161630595|NCT03840148|583698279|FG001|Study Drug Disposition|Adverse Event|2|||
161630596|NCT03840148|583698278|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
161630597|NCT03840148|583698279|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
161630598|NCT03840148|583698278|FG000|Study Drug Disposition|Lack of Efficacy|3|||
161630599|NCT03840148|583698279|FG001|Study Drug Disposition|Lack of Efficacy|0|||
161630600|NCT03840148|583698278|FG000|Study Drug Disposition|Physician Decision|2|||
161630601|NCT03840148|583698279|FG001|Study Drug Disposition|Physician Decision|0|||
161630602|NCT03840148|583698278|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
161630603|NCT03840148|583698279|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
161630604|NCT03840148|583698278|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
161630605|NCT03840148|583698279|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
161630606|NCT03840148|583698278|FG000|Study Completion Disposition|Physician Decision|2|||
161630607|NCT03840148|583698279|FG001|Study Completion Disposition|Physician Decision|0|||
161630608|NCT03840148|583698278|FG000|Study Completion Disposition|Covid-19 related|2|||
161630609|NCT03840148|583698279|FG001|Study Completion Disposition|Covid-19 related|0|||
161630610|NCT03840148|583698278|FG000|Study Completion Disposition|Lost to Follow-up|1|||
161630611|NCT03840148|583698279|FG001|Study Completion Disposition|Lost to Follow-up|1|||
161630612|NCT03840148|583698278|FG000|Study Completion Disposition|Death|1|||
161630613|NCT03840148|583698279|FG001|Study Completion Disposition|Death|0|||
161630614|NCT03840148|583698278|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
161630615|NCT03840148|583698279|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
161630616|NCT03849300|583698281|FG000|Overall Study|move out to different area|1|||
161630617|NCT03849300|583698282|FG001|Overall Study|move out to different area|3|||
161630618|NCT03849300|583698283|FG002|Overall Study|move out to different area|1|||
161833614|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Other|0|||
161833615|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Other|1|||
161833616|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833617|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833618|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161630619|NCT03849300|583698284|FG003|Overall Study|move out to different area|4|||
161833619|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
161833620|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833621|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161630620|NCT03849300|583698281|FG000|Overall Study|scheduling/transportation conflict|4|||
161630621|NCT03849300|583698282|FG001|Overall Study|scheduling/transportation conflict|4|||
161630622|NCT03849300|583698283|FG002|Overall Study|scheduling/transportation conflict|3|||
161630623|NCT03849300|583698284|FG003|Overall Study|scheduling/transportation conflict|2|||
161630624|NCT04839289|583698285|FG000|Overall Study|Withdrawal by Subject|1|||
161630625|NCT04839289|583698286|FG001|Overall Study|Withdrawal by Subject|0|||
161630626|NCT00464737|583698287|FG000|Overall Study|Adverse Event|12|||
161630627|NCT00464737|583698288|FG001|Overall Study|Adverse Event|17|||
161630628|NCT00464737|583698289|FG002|Overall Study|Adverse Event|33|||
161630629|NCT00464737|583698287|FG000|Overall Study|Lack of Efficacy|7|||
161630630|NCT00464737|583698288|FG001|Overall Study|Lack of Efficacy|7|||
161630631|NCT00464737|583698289|FG002|Overall Study|Lack of Efficacy|4|||
161630632|NCT00464737|583698287|FG000|Overall Study|Withdrawal by Subject|5|||
161630633|NCT00464737|583698288|FG001|Overall Study|Withdrawal by Subject|3|||
161630634|NCT00464737|583698289|FG002|Overall Study|Withdrawal by Subject|5|||
161630635|NCT00464737|583698287|FG000|Overall Study|Protocol Violation|1|||
161630636|NCT00464737|583698288|FG001|Overall Study|Protocol Violation|1|||
161630637|NCT00464737|583698289|FG002|Overall Study|Protocol Violation|5|||
161630638|NCT00464737|583698287|FG000|Overall Study|Non-compliance|0|||
161630639|NCT00464737|583698288|FG001|Overall Study|Non-compliance|1|||
161630640|NCT00464737|583698289|FG002|Overall Study|Non-compliance|1|||
161630641|NCT00464737|583698287|FG000|Overall Study|Lost to Follow-up|5|||
161630642|NCT00464737|583698288|FG001|Overall Study|Lost to Follow-up|2|||
161630643|NCT00464737|583698289|FG002|Overall Study|Lost to Follow-up|5|||
161630644|NCT00464737|583698287|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
161630645|NCT00464737|583698288|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
161630646|NCT00464737|583698289|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
161630647|NCT00464737|583698287|FG000|Overall Study|Other: Subject left town; family illness|1|||
161630648|NCT00464737|583698288|FG001|Overall Study|Other: Subject left town; family illness|0|||
161630649|NCT00464737|583698289|FG002|Overall Study|Other: Subject left town; family illness|0|||
161630650|NCT00464737|583698287|FG000|Overall Study|Other: Study demands too great|0|||
161630651|NCT00464737|583698288|FG001|Overall Study|Other: Study demands too great|1|||
161630652|NCT00464737|583698289|FG002|Overall Study|Other: Study demands too great|0|||
161630653|NCT00464737|583698287|FG000|Overall Study|Other: Personal family reasons|0|||
161630654|NCT00464737|583698288|FG001|Overall Study|Other: Personal family reasons|0|||
161630655|NCT00464737|583698289|FG002|Overall Study|Other: Personal family reasons|1|||
161630656|NCT00464737|583698287|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
161630657|NCT00464737|583698288|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
161630658|NCT00464737|583698289|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
161630659|NCT00580047|583698292|FG000|Overall Study|Lost to Follow-up|1|||
161630660|NCT00580047|583698293|FG001|Overall Study|Lost to Follow-up|1|||
161630661|NCT00580047|583698294|FG002|Overall Study|Lost to Follow-up|0|||
161630662|NCT00580047|583698292|FG000|Overall Study|Withdrawal by Subject|1|||
161630663|NCT00580047|583698293|FG001|Overall Study|Withdrawal by Subject|1|||
161630664|NCT00580047|583698294|FG002|Overall Study|Withdrawal by Subject|2|||
161630665|NCT00580047|583698292|FG000|Overall Study|Withdrawal by Subject|1|||
161630666|NCT00580047|583698293|FG001|Overall Study|Withdrawal by Subject|0|||
161630667|NCT00580047|583698294|FG002|Overall Study|Withdrawal by Subject|0|||
161630668|NCT03406507|583698300|FG000|Extension Period|Lack of Efficacy|0|||
161630669|NCT03406507|583698301|FG001|Extension Period|Lack of Efficacy|1|||
161630670|NCT04130061|583698302|FG000|Overall Study|OR team forgot to request membrane|1|||
161630671|NCT04130061|583698303|FG001|Overall Study|OR team forgot to request membrane|0|||
161630672|NCT01878383|583700292|FG000|Overall Study|Lost to Follow-up|0|||
161630673|NCT01878383|583700293|FG001|Overall Study|Lost to Follow-up|1499|||
161630674|NCT03464383|583700294|FG000|Overall Study|Lost to Follow-up|1|||
161630675|NCT03464383|583700295|FG001|Overall Study|Lost to Follow-up|0|||
161630676|NCT03464383|583700296|FG002|Overall Study|Lost to Follow-up|0|||
161630677|NCT03464383|583700294|FG000|Overall Study|Withdrawal by Subject|0|||
161630678|NCT03464383|583700295|FG001|Overall Study|Withdrawal by Subject|1|||
161630679|NCT03464383|583700296|FG002|Overall Study|Withdrawal by Subject|0|||
161630680|NCT01960348|583700304|FG000|Overall Study|Adverse event, not serious|2|||
161630681|NCT01960348|583700305|FG001|Overall Study|Adverse event, not serious|2|||
161630682|NCT01960348|583700304|FG000|Overall Study|Adverse event, serious fatal|6|||
161630683|NCT01960348|583700305|FG001|Overall Study|Adverse event, serious fatal|5|||
161630684|NCT01960348|583700304|FG000|Overall Study|Adverse event, serious non-fatal|0|||
161630685|NCT01960348|583700305|FG001|Overall Study|Adverse event, serious non-fatal|3|||
161630686|NCT01960348|583700304|FG000|Overall Study|Withdrawal by Subject|1|||
161630687|NCT01960348|583700305|FG001|Overall Study|Withdrawal by Subject|11|||
161685760|NCT00078325|583901960|FG000|Overall Study|Adverse Event|15|||
161685761|NCT00078325|583901961|FG001|Overall Study|Adverse Event|10|||
161833622|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161630688|NCT01960348|583700304|FG000|Overall Study|Physician Decision|0|||
161630689|NCT01960348|583700305|FG001|Overall Study|Physician Decision|1|||
161630690|NCT01960348|583700304|FG000|Overall Study|Protocol Violation|1|||
161630691|NCT01960348|583700305|FG001|Overall Study|Protocol Violation|0|||
161630692|NCT01093599|583700311|FG000|Overall Study|Lost to Follow-up|32|||
161630693|NCT01093599|583700312|FG001|Overall Study|Lost to Follow-up|46|||
161630694|NCT01644188|583700313|FG000|Overall Study|Adverse Event|44|||
161630695|NCT01644188|583700314|FG001|Overall Study|Adverse Event|20|||
161630696|NCT01644188|583700313|FG000|Overall Study|Poor compliance to protocol|26|||
161685762|NCT00078325|583901962|FG002|Overall Study|Adverse Event|5|||
161630697|NCT01644188|583700314|FG001|Overall Study|Poor compliance to protocol|14|||
161630698|NCT01644188|583700313|FG000|Overall Study|Physician Decision|1|||
161630699|NCT01644188|583700314|FG001|Overall Study|Physician Decision|3|||
161630700|NCT01644188|583700313|FG000|Overall Study|Participant moved|7|||
161630701|NCT01644188|583700314|FG001|Overall Study|Participant moved|2|||
161630702|NCT01644188|583700313|FG000|Overall Study|Related to auto-injector administration|2|||
161630703|NCT01644188|583700314|FG001|Overall Study|Related to auto-injector administration|2|||
161630704|NCT01644188|583700313|FG000|Overall Study|Consent withdrawn by participant|14|||
161630705|NCT01644188|583700314|FG001|Overall Study|Consent withdrawn by participant|7|||
161630706|NCT01644188|583700313|FG000|Overall Study|Selection criteria finally not met|2|||
161630707|NCT01644188|583700314|FG001|Overall Study|Selection criteria finally not met|0|||
161630708|NCT01644188|583700313|FG000|Overall Study|Lost to Follow-up|1|||
161630709|NCT01644188|583700314|FG001|Overall Study|Lost to Follow-up|0|||
161630710|NCT01644188|583700313|FG000|Overall Study|Death|4|||
161630711|NCT01644188|583700314|FG001|Overall Study|Death|3|||
161630712|NCT01644188|583700313|FG000|Overall Study|Last visit outside protocol visit window|14|||
161630713|NCT01644188|583700314|FG001|Overall Study|Last visit outside protocol visit window|16|||
161630714|NCT01644188|583700313|FG000|Overall Study|Site closure|1|||
161630715|NCT01644188|583700314|FG001|Overall Study|Site closure|1|||
161630716|NCT01644188|583700313|FG000|Overall Study|Other than specified above|6|||
161630717|NCT01644188|583700314|FG001|Overall Study|Other than specified above|7|||
161630718|NCT01845649|583700320|FG000|Overall Study|Adverse Event|7|||
161630719|NCT01845649|583700321|FG001|Overall Study|Adverse Event|10|||
161630720|NCT01845649|583700320|FG000|Overall Study|Lack of Efficacy|1|||
161630721|NCT01845649|583700321|FG001|Overall Study|Lack of Efficacy|1|||
161630722|NCT01845649|583700320|FG000|Overall Study|Lost to Follow-up|2|||
161630723|NCT01845649|583700321|FG001|Overall Study|Lost to Follow-up|2|||
161630724|NCT01845649|583700320|FG000|Overall Study|Withdrew Consent|12|||
161630725|NCT01845649|583700321|FG001|Overall Study|Withdrew Consent|4|||
161630726|NCT01845649|583700320|FG000|Overall Study|Protocol Deviation|7|||
161630727|NCT01845649|583700321|FG001|Overall Study|Protocol Deviation|4|||
161630728|NCT01845649|583700320|FG000|Overall Study|Reason not Specified|2|||
161630729|NCT01845649|583700321|FG001|Overall Study|Reason not Specified|1|||
161630730|NCT00719212|583700324|FG000|Overall Study|Death|41|||
161630731|NCT00719212|583700324|FG000|Overall Study|Lost to Follow-up|2|||
161630732|NCT00719212|583700324|FG000|Overall Study|Withdrawal by Subject|1|||
161630733|NCT00526097|583700328|FG000|Overall Study|Adverse Event|6|||
161630734|NCT00526097|583700329|FG001|Overall Study|Adverse Event|44|||
161630735|NCT00526097|583700328|FG000|Overall Study|Protocol Violation|4|||
161630736|NCT00526097|583700329|FG001|Overall Study|Protocol Violation|10|||
161630737|NCT00526097|583700328|FG000|Overall Study|Withdrawal by Subject|3|||
161630738|NCT00526097|583700329|FG001|Overall Study|Withdrawal by Subject|1|||
161630739|NCT00526097|583700328|FG000|Overall Study|Other|2|||
161630740|NCT00526097|583700329|FG001|Overall Study|Other|1|||
161630741|NCT00966979|583700330|FG000|Overall Study|Death|1|||
161630742|NCT00966979|583700330|FG000|Overall Study|Lost to Follow-up|6|||
161630743|NCT00966979|583700330|FG000|Overall Study|Withdrawal by Subject|14|||
161630744|NCT00966979|583700330|FG000|Overall Study|Adverse Event|5|||
161630745|NCT00966979|583700330|FG000|Overall Study|Sponsor terminated early|49|||
161630746|NCT00966979|583700330|FG000|Overall Study|Censored because surgery not done|2|||
161630747|NCT00966979|583700330|FG000|Overall Study|Censored because study device was not implanted|14|||
161630748|NCT00966979|583700330|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
161630749|NCT03713281|583700331|FG000|Overall Study|Lens handling difficuluties|2|||
161630750|NCT03713281|583700331|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
161630751|NCT00329550|583700333|FG000|Overall Study|Adverse Event|3|||
161630752|NCT00329550|583700334|FG001|Overall Study|Adverse Event|4|||
161630753|NCT00329550|583700335|FG002|Overall Study|Adverse Event|2|||
161630754|NCT00329550|583700333|FG000|Overall Study|Withdrawal of Consent|1|||
161630755|NCT00329550|583700334|FG001|Overall Study|Withdrawal of Consent|0|||
161630756|NCT00329550|583700335|FG002|Overall Study|Withdrawal of Consent|1|||
161630757|NCT00329550|583700333|FG000|Overall Study|Due to Relocation|0|||
161630758|NCT00329550|583700334|FG001|Overall Study|Due to Relocation|0|||
161630759|NCT00329550|583700335|FG002|Overall Study|Due to Relocation|1|||
161630760|NCT04150341|583700338|FG000|Overall Study|Physician Decision|0|||
161630761|NCT04150341|583700339|FG001|Overall Study|Physician Decision|0|||
161630762|NCT04150341|583700340|FG002|Overall Study|Physician Decision|1|||
161630763|NCT04150341|583700341|FG003|Overall Study|Physician Decision|0|||
161630764|NCT04150341|583700342|FG004|Overall Study|Physician Decision|0|||
161630765|NCT04150341|583700343|FG005|Overall Study|Physician Decision|0|||
161630766|NCT04150341|583700338|FG000|Overall Study|Adverse Event|0|||
161630767|NCT04150341|583700339|FG001|Overall Study|Adverse Event|0|||
161630768|NCT04150341|583700340|FG002|Overall Study|Adverse Event|0|||
161630769|NCT04150341|583700341|FG003|Overall Study|Adverse Event|0|||
161630770|NCT04150341|583700342|FG004|Overall Study|Adverse Event|1|||
161630771|NCT04150341|583700343|FG005|Overall Study|Adverse Event|0|||
161630772|NCT00875615|583700344|FG000|Overall Study|Withdrawal by Subject|1|||
161630773|NCT00405912|583700346|FG000|Overall Study|Withdrawal by Subject|12|||
161630774|NCT00405912|583700347|FG001|Overall Study|Withdrawal by Subject|11|||
161630775|NCT00405912|583700348|FG002|Overall Study|Withdrawal by Subject|12|||
161630776|NCT00405912|583700346|FG000|Overall Study|Lost to Follow-up|4|||
161630777|NCT00405912|583700347|FG001|Overall Study|Lost to Follow-up|8|||
161630778|NCT00405912|583700348|FG002|Overall Study|Lost to Follow-up|4|||
161630779|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
161630780|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
161630781|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
161630782|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
161630783|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
161630784|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
161630785|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
161630786|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
161630787|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Death|6|||
161630788|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Death|2|||
161630789|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Death|2|||
161630790|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Death|9|||
161630791|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
161630792|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161833623|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161833624|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
161833625|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
161833626|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161833627|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161833628|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833629|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833630|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
161833631|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
161833632|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833633|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833634|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833635|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833636|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
161833637|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
161833638|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833639|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833640|NCT00856830|584433172|FG000|Irinotecan & Bendamustine|Death|0|||
161630793|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161630794|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
161630795|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
161630796|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
161630797|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
161630798|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
161630799|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
161630800|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
161630801|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
161630802|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
161630803|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
161630804|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161630805|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
161630806|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
161630807|NCT03730662|583700349|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
161630808|NCT03730662|583700350|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
161630809|NCT03730662|583700351|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
161630810|NCT03730662|583700352|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
161630811|NCT03730662|583700349|FG000|Variable Treatment Period|Adverse Event|1|||
161630812|NCT03730662|583700350|FG001|Variable Treatment Period|Adverse Event|2|||
161630813|NCT03730662|583700351|FG002|Variable Treatment Period|Adverse Event|0|||
161630814|NCT03730662|583700352|FG003|Variable Treatment Period|Adverse Event|7|||
161630815|NCT03730662|583700349|FG000|Variable Treatment Period|Death|9|||
161630816|NCT03730662|583700350|FG001|Variable Treatment Period|Death|0|||
161630817|NCT03730662|583700351|FG002|Variable Treatment Period|Death|6|||
161630818|NCT03730662|583700352|FG003|Variable Treatment Period|Death|26|||
161630819|NCT03730662|583700349|FG000|Variable Treatment Period|Lost to Follow-up|2|||
161630820|NCT03730662|583700350|FG001|Variable Treatment Period|Lost to Follow-up|1|||
161630821|NCT03730662|583700351|FG002|Variable Treatment Period|Lost to Follow-up|4|||
161630822|NCT03730662|583700352|FG003|Variable Treatment Period|Lost to Follow-up|11|||
161630823|NCT03730662|583700349|FG000|Variable Treatment Period|Personal Reason|0|||
161630824|NCT03730662|583700350|FG001|Variable Treatment Period|Personal Reason|2|||
161630825|NCT03730662|583700351|FG002|Variable Treatment Period|Personal Reason|1|||
161630826|NCT03730662|583700352|FG003|Variable Treatment Period|Personal Reason|6|||
161630827|NCT03730662|583700349|FG000|Variable Treatment Period|Physician Decision|0|||
161630828|NCT03730662|583700350|FG001|Variable Treatment Period|Physician Decision|0|||
161630829|NCT03730662|583700351|FG002|Variable Treatment Period|Physician Decision|0|||
161630830|NCT03730662|583700352|FG003|Variable Treatment Period|Physician Decision|3|||
161630831|NCT03730662|583700349|FG000|Variable Treatment Period|Protocol Violation|0|||
161630832|NCT03730662|583700350|FG001|Variable Treatment Period|Protocol Violation|1|||
161630833|NCT03730662|583700351|FG002|Variable Treatment Period|Protocol Violation|1|||
161630834|NCT03730662|583700352|FG003|Variable Treatment Period|Protocol Violation|1|||
161630835|NCT03730662|583700349|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
161630836|NCT03730662|583700350|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
161630837|NCT03730662|583700351|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
161630838|NCT03730662|583700352|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
161630839|NCT03712449|583700357|FG000|Overall Study|Withdraw Consent|0|||
161630840|NCT03712449|583700358|FG001|Overall Study|Withdraw Consent|1|||
161630841|NCT00666198|583700359|FG000|Overall Study|Protocol Violation|10|||
161630842|NCT00666198|583700359|FG000|Overall Study|No Visit After First Day of Treatment|13|||
161630843|NCT00666198|583700359|FG000|Overall Study|Safety Not Assessable|6|||
161630844|NCT00666198|583700359|FG000|Overall Study|No Drug Administration|4|||
161630845|NCT05153499|583700360|FG000|Overall Study|Withdrawal by Subject|1|||
161630846|NCT05153499|583700361|FG001|Overall Study|Withdrawal by Subject|0|||
161630847|NCT05153499|583700360|FG000|Overall Study|Clinical Hold|1|||
161630848|NCT05153499|583700361|FG001|Overall Study|Clinical Hold|0|||
161630849|NCT05153499|583700360|FG000|Overall Study|Study Termination|6|||
161630850|NCT05153499|583700361|FG001|Overall Study|Study Termination|5|||
161630851|NCT05109117|583700364|FG000|Overall Study|Lost to Follow-up|1|||
161630852|NCT05109117|583700364|FG000|Overall Study|Discontinued for non-compliance|1|||
161630853|NCT03220776|583700365|FG000|Overall Study|Claustrophobia|0|||
161630854|NCT03220776|583700366|FG001|Overall Study|Claustrophobia|1|||
161630855|NCT03220776|583700367|FG002|Overall Study|Claustrophobia|1|||
161630856|NCT03220776|583700368|FG003|Overall Study|Claustrophobia|0|||
161630857|NCT03220776|583700369|FG004|Overall Study|Claustrophobia|1|||
161630858|NCT03220776|583700370|FG005|Overall Study|Claustrophobia|0|||
161630859|NCT03220776|583700365|FG000|Overall Study|MRI Equipment Failure|1|||
161630860|NCT03220776|583700366|FG001|Overall Study|MRI Equipment Failure|0|||
161630861|NCT03220776|583700367|FG002|Overall Study|MRI Equipment Failure|0|||
161630862|NCT03220776|583700368|FG003|Overall Study|MRI Equipment Failure|0|||
161630863|NCT03220776|583700369|FG004|Overall Study|MRI Equipment Failure|0|||
161630864|NCT03220776|583700370|FG005|Overall Study|MRI Equipment Failure|0|||
161630865|NCT03220776|583700365|FG000|Overall Study|Inclimate Weather|0|||
161630866|NCT03220776|583700366|FG001|Overall Study|Inclimate Weather|0|||
161630867|NCT03220776|583700367|FG002|Overall Study|Inclimate Weather|0|||
161630868|NCT03220776|583700368|FG003|Overall Study|Inclimate Weather|0|||
161685763|NCT00078325|583901960|FG000|Overall Study|Protocol Violation|2|||
161630869|NCT03220776|583700369|FG004|Overall Study|Inclimate Weather|0|||
161630870|NCT03220776|583700370|FG005|Overall Study|Inclimate Weather|1|||
161630871|NCT03220776|583700365|FG000|Overall Study|Physician Decision|0|||
161685764|NCT00078325|583901961|FG001|Overall Study|Protocol Violation|2|||
161685765|NCT00078325|583901962|FG002|Overall Study|Protocol Violation|0|||
161630872|NCT03220776|583700366|FG001|Overall Study|Physician Decision|0|||
161630873|NCT03220776|583700367|FG002|Overall Study|Physician Decision|0|||
161630874|NCT03220776|583700368|FG003|Overall Study|Physician Decision|1|||
161630875|NCT03220776|583700369|FG004|Overall Study|Physician Decision|0|||
161630876|NCT03220776|583700370|FG005|Overall Study|Physician Decision|0|||
161630877|NCT03220776|583700365|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161685766|NCT00078325|583901960|FG000|Overall Study|Withdrawal by Subject|1|||
161630878|NCT03220776|583700366|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161630879|NCT03220776|583700367|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161630880|NCT03220776|583700368|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
161630881|NCT03220776|583700369|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161630882|NCT03220776|583700370|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161630883|NCT03220776|583700365|FG000|Overall Study|Protocol Violation|0|||
161630884|NCT03220776|583700366|FG001|Overall Study|Protocol Violation|0|||
161630885|NCT03220776|583700367|FG002|Overall Study|Protocol Violation|0|||
161630886|NCT03220776|583700368|FG003|Overall Study|Protocol Violation|2|||
161630887|NCT03220776|583700369|FG004|Overall Study|Protocol Violation|0|||
161630888|NCT03220776|583700370|FG005|Overall Study|Protocol Violation|1|||
161630889|NCT03220776|583700365|FG000|Overall Study|Withdrawal by Subject|1|||
161630890|NCT03220776|583700366|FG001|Overall Study|Withdrawal by Subject|0|||
161630891|NCT03220776|583700367|FG002|Overall Study|Withdrawal by Subject|0|||
161630892|NCT03220776|583700368|FG003|Overall Study|Withdrawal by Subject|0|||
161630893|NCT03220776|583700369|FG004|Overall Study|Withdrawal by Subject|0|||
161630894|NCT03220776|583700370|FG005|Overall Study|Withdrawal by Subject|0|||
161630895|NCT04491006|583700372|FG000|Overall Study|Adverse Event|0|||
161630896|NCT04491006|583700373|FG001|Overall Study|Adverse Event|3|||
161630897|NCT04491006|583700374|FG002|Overall Study|Adverse Event|5|||
161630898|NCT04491006|583700372|FG000|Overall Study|Withdrawal by Subject|1|||
161630899|NCT04491006|583700373|FG001|Overall Study|Withdrawal by Subject|0|||
161630900|NCT04491006|583700374|FG002|Overall Study|Withdrawal by Subject|2|||
161630901|NCT02166047|583700375|FG000|Overall Study|Withdrawal by Participant|0|||
161630902|NCT02166047|583700376|FG001|Overall Study|Withdrawal by Participant|1|||
161630903|NCT02166047|583700377|FG002|Overall Study|Withdrawal by Participant|2|||
161630904|NCT02166047|583700378|FG003|Overall Study|Withdrawal by Participant|0|||
161630905|NCT02166047|583700379|FG004|Overall Study|Withdrawal by Participant|0|||
161630906|NCT02166047|583700380|FG005|Overall Study|Withdrawal by Participant|0|||
161630907|NCT02166047|583700381|FG006|Overall Study|Withdrawal by Participant|1|||
161630908|NCT02166047|583700382|FG007|Overall Study|Withdrawal by Participant|0|||
161630909|NCT02166047|583700383|FG008|Overall Study|Withdrawal by Participant|0|||
161630910|NCT02166047|583700384|FG009|Overall Study|Withdrawal by Participant|0|||
161630911|NCT02166047|583700385|FG010|Overall Study|Withdrawal by Participant|0|||
161630912|NCT02166047|583700386|FG011|Overall Study|Withdrawal by Participant|0|||
161630913|NCT02166047|583700375|FG000|Overall Study|Adverse Event|0|||
161630914|NCT02166047|583700376|FG001|Overall Study|Adverse Event|0|||
161630915|NCT02166047|583700377|FG002|Overall Study|Adverse Event|0|||
161630916|NCT02166047|583700378|FG003|Overall Study|Adverse Event|0|||
161630917|NCT02166047|583700379|FG004|Overall Study|Adverse Event|1|||
161630918|NCT02166047|583700380|FG005|Overall Study|Adverse Event|0|||
161630919|NCT02166047|583700381|FG006|Overall Study|Adverse Event|1|||
161630920|NCT02166047|583700382|FG007|Overall Study|Adverse Event|0|||
161630921|NCT02166047|583700383|FG008|Overall Study|Adverse Event|0|||
161630922|NCT02166047|583700384|FG009|Overall Study|Adverse Event|0|||
161630923|NCT02166047|583700385|FG010|Overall Study|Adverse Event|2|||
161630924|NCT02166047|583700386|FG011|Overall Study|Adverse Event|0|||
161630925|NCT00451555|583700392|FG000|Overall Study|Protocol Violation|2|||
161630926|NCT00451555|583700393|FG001|Overall Study|Protocol Violation|2|||
161630927|NCT00451555|583700392|FG000|Overall Study|Adverse Event|3|||
161630928|NCT00451555|583700393|FG001|Overall Study|Adverse Event|1|||
161630929|NCT00451555|583700392|FG000|Overall Study|Withdrawal by Subject|6|||
161630930|NCT00451555|583700393|FG001|Overall Study|Withdrawal by Subject|0|||
161630931|NCT00451555|583700392|FG000|Overall Study|Physician Decision|2|||
161630932|NCT00451555|583700393|FG001|Overall Study|Physician Decision|1|||
161630933|NCT01177137|583700394|FG000|Overall Study|Withdrawal by Subject|10|||
161630934|NCT01177137|583700395|FG001|Overall Study|Withdrawal by Subject|10|||
161630935|NCT01177137|583700396|FG002|Overall Study|Withdrawal by Subject|2|||
161630936|NCT00583115|583700397|FG000|Overall Study|Death|1|||
161630937|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161630938|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
161630939|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
161630940|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161833641|NCT00856830|584433173|FG001|Irinotecan & Bendamustine|Death|0|||
161833642|NCT00856830|584433174|FG002|Irinotecan & Bendamustine|Death|0|||
161630941|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161630942|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161630943|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
161833643|NCT00856830|584433175|FG003|Irinotecan & Bendamustine|Death|2|||
161833644|NCT00856830|584433172|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
161833645|NCT00856830|584433173|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
161630944|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
161630945|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
161630946|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
161630947|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
161630948|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
161630949|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161630950|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161630951|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161630952|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
161630953|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
161630954|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
161630955|NCT03569475|583700398|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
161630956|NCT03569475|583700399|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
161630957|NCT03569475|583700400|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
161630958|NCT03569475|583700398|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
161630959|NCT03569475|583700399|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
161630960|NCT03569475|583700400|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
161630961|NCT03569475|583700398|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
161630962|NCT03569475|583700399|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
161630963|NCT03569475|583700400|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
161630964|NCT02630706|583700404|FG000|Overall Study|Adverse Event|2|||
161630965|NCT02630706|583700405|FG001|Overall Study|Adverse Event|1|||
161630966|NCT02630706|583700406|FG002|Overall Study|Adverse Event|1|||
161630967|NCT02630706|583700404|FG000|Overall Study|Lost to Follow-up|0|||
161630968|NCT02630706|583700405|FG001|Overall Study|Lost to Follow-up|1|||
161630969|NCT02630706|583700406|FG002|Overall Study|Lost to Follow-up|2|||
161630970|NCT02630706|583700404|FG000|Overall Study|Physician Decision|1|||
161630971|NCT02630706|583700405|FG001|Overall Study|Physician Decision|1|||
161630972|NCT02630706|583700406|FG002|Overall Study|Physician Decision|0|||
161630973|NCT02630706|583700404|FG000|Overall Study|Pregnancy|0|||
161630974|NCT02630706|583700405|FG001|Overall Study|Pregnancy|1|||
161630975|NCT02630706|583700406|FG002|Overall Study|Pregnancy|0|||
161630976|NCT02630706|583700404|FG000|Overall Study|Withdrawal by Subject|4|||
161630977|NCT02630706|583700405|FG001|Overall Study|Withdrawal by Subject|5|||
161630978|NCT02630706|583700406|FG002|Overall Study|Withdrawal by Subject|7|||
161630979|NCT01678898|583700408|FG000|PB-102-F01|Adverse Event|0|||
161630980|NCT01678898|583700409|FG001|PB-102-F01|Adverse Event|1|||
161630981|NCT01678898|583700410|FG002|PB-102-F01|Adverse Event|0|||
161630982|NCT01678898|583700408|FG000|PB-102-F01|Physician Decision|0|||
161630983|NCT01678898|583700409|FG001|PB-102-F01|Physician Decision|1|||
161630984|NCT01678898|583700410|FG002|PB-102-F01|Physician Decision|0|||
161630985|NCT01894256|583700422|FG000|Part A|Adverse Event|0|||
161630986|NCT01894256|583700423|FG001|Part A|Adverse Event|1|||
161630987|NCT01894256|583700424|FG002|Part A|Adverse Event|0|||
161630988|NCT01894256|583700422|FG000|Part B|Death|0|||
161630989|NCT01894256|583700423|FG001|Part B|Death|1|||
161630990|NCT01894256|583700424|FG002|Part B|Death|1|||
161630991|NCT01894256|583700422|FG000|Part B|Withdrawal by Subject|0|||
161630992|NCT01894256|583700423|FG001|Part B|Withdrawal by Subject|1|||
161630993|NCT01894256|583700424|FG002|Part B|Withdrawal by Subject|0|||
161630994|NCT01894256|583700422|FG000|Part B|Lack of Efficacy|15|||
161630995|NCT01894256|583700423|FG001|Part B|Lack of Efficacy|12|||
161630996|NCT01894256|583700424|FG002|Part B|Lack of Efficacy|13|||
161630997|NCT00645099|583700425|FG000|Overall Study|Lack of Efficacy|15|||
161630998|NCT00645099|583700426|FG001|Overall Study|Lack of Efficacy|6|||
161630999|NCT00645099|583700425|FG000|Overall Study|Withdrawal by Subject|30|||
161631000|NCT00645099|583700426|FG001|Overall Study|Withdrawal by Subject|22|||
161631001|NCT00645099|583700425|FG000|Overall Study|Lost to Follow-up|6|||
161631002|NCT00645099|583700426|FG001|Overall Study|Lost to Follow-up|4|||
161631003|NCT00645099|583700425|FG000|Overall Study|Adverse Event|11|||
161631004|NCT00645099|583700426|FG001|Overall Study|Adverse Event|5|||
161631005|NCT00645099|583700425|FG000|Overall Study|Other|9|||
161631006|NCT00645099|583700426|FG001|Overall Study|Other|5|||
161631007|NCT01201915|583700427|FG000|Overall Study|Adverse Event|2|||
161631008|NCT01201915|583700428|FG001|Overall Study|Adverse Event|1|||
161631009|NCT01201915|583700429|FG002|Overall Study|Adverse Event|1|||
161631010|NCT01201915|583700427|FG000|Overall Study|Lost to Follow-up|0|||
161631011|NCT01201915|583700428|FG001|Overall Study|Lost to Follow-up|4|||
161631012|NCT01201915|583700429|FG002|Overall Study|Lost to Follow-up|0|||
161631013|NCT01201915|583700427|FG000|Overall Study|Physician Decision|3|||
161631014|NCT01201915|583700428|FG001|Overall Study|Physician Decision|0|||
161631015|NCT01201915|583700429|FG002|Overall Study|Physician Decision|0|||
161631016|NCT01201915|583700427|FG000|Overall Study|Subject Decision|3|||
161631017|NCT01201915|583700428|FG001|Overall Study|Subject Decision|3|||
161631018|NCT01201915|583700429|FG002|Overall Study|Subject Decision|5|||
161631019|NCT01201915|583700427|FG000|Overall Study|Target Lesion Progression|0|||
161631020|NCT01201915|583700428|FG001|Overall Study|Target Lesion Progression|3|||
161631021|NCT01201915|583700429|FG002|Overall Study|Target Lesion Progression|0|||
161631022|NCT02154516|583700430|FG000|Overall Study|Withdrawal by Subject|0|||
161631023|NCT02154516|583700431|FG001|Overall Study|Withdrawal by Subject|1|||
161631024|NCT02154516|583700430|FG000|Overall Study|Lost to Follow-up|1|||
161631025|NCT02154516|583700431|FG001|Overall Study|Lost to Follow-up|0|||
161631026|NCT02154516|583700430|FG000|Overall Study|Removal/revision of device|1|||
161631027|NCT02154516|583700431|FG001|Overall Study|Removal/revision of device|0|||
161631028|NCT02154516|583700430|FG000|Overall Study|Death|2|||
161631029|NCT02154516|583700431|FG001|Overall Study|Death|1|||
161631030|NCT00663923|583700432|FG000|Overall Study|Lost to Follow-up|2|||
161631031|NCT02316171|583700436|FG000|Overall Study|difficulties with urinary catheter|1|||
161631032|NCT02316171|583700437|FG001|Overall Study|difficulties with urinary catheter|0|||
161631033|NCT02316171|583700438|FG002|Overall Study|difficulties with urinary catheter|0|||
161631034|NCT02316171|583700439|FG003|Overall Study|difficulties with urinary catheter|0|||
161631035|NCT01804140|583700441|FG000|Overall Study|No sampling or biopsy procedures done|114|||
161631036|NCT00547300|583700442|FG000|Overall Study|Study was Administratively Terminated|25|||
161631037|NCT00547300|583700443|FG001|Overall Study|Study was Administratively Terminated|24|||
161631038|NCT00547300|583700442|FG000|Overall Study|Did not Meet Entry Criteria|0|||
161631039|NCT00547300|583700443|FG001|Overall Study|Did not Meet Entry Criteria|2|||
161631040|NCT02785900|583700444|FG000|Overall Study|Study Termination by Sponsor|64|||
161631041|NCT02785900|583700445|FG001|Overall Study|Study Termination by Sponsor|81|||
161631042|NCT02785900|583700444|FG000|Overall Study|Death|46|||
161631043|NCT02785900|583700445|FG001|Overall Study|Death|32|||
161631044|NCT02785900|583700444|FG000|Overall Study|Withdrawal by Subject|4|||
161631045|NCT02785900|583700445|FG001|Overall Study|Withdrawal by Subject|8|||
161631046|NCT02785900|583700444|FG000|Overall Study|Physician Decision|3|||
161631047|NCT02785900|583700445|FG001|Overall Study|Physician Decision|2|||
161631048|NCT04435522|583700448|FG000|Overall Study|Withdrawal by Subject|2|||
161631049|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
161631050|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
161631051|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
161631052|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
161631053|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
161631054|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
161631055|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
161631056|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
161631057|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
161631058|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
161631059|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
161631060|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
161631061|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
161631062|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
161631063|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
161631064|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
161631065|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
161631066|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
161631067|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
161631068|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
161631069|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
161631070|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
161631071|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
161631072|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
161631073|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
161631074|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
161631075|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
161631076|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
161631077|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
161631078|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
161631079|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
161631080|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
161631081|NCT00092521|583701585|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
161631082|NCT00092521|583701586|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
161631083|NCT00092521|583701587|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
161631084|NCT00092521|583701588|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
161631085|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
161631086|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
161631087|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
161631088|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
161631089|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
161631090|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
161631091|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
161631092|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
161631093|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
161631094|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
161631095|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
161631096|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
161631097|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Death|2|||
161631098|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Death|0|||
161631099|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Death|1|||
161631100|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Death|0|||
161631101|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
161631102|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
161631103|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
161631104|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
161631105|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
161631106|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
161631107|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
161631108|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
161631109|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
161631110|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
161631111|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
161631112|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
161631113|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Moved|32|||
161631114|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Moved|2|||
161631115|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Moved|28|||
161631116|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Moved|0|||
161631117|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
161631118|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
161631119|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
161631120|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
161631121|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Travel|2|||
161631122|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Travel|0|||
161631123|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Travel|0|||
161631124|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Travel|0|||
161631125|NCT00092521|583701585|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
161631126|NCT00092521|583701586|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
161631127|NCT00092521|583701587|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
161631128|NCT00092521|583701588|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
161631129|NCT00092521|583701585|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
161631130|NCT00092521|583701586|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
161631131|NCT00092521|583701587|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
161631132|NCT00092521|583701588|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
161631133|NCT00092521|583701585|FG000|Extension Study (Group 4)|Adverse Event|0|||
161631134|NCT00092521|583701586|FG001|Extension Study (Group 4)|Adverse Event|0|||
161631135|NCT00092521|583701587|FG002|Extension Study (Group 4)|Adverse Event|0|||
161631136|NCT00092521|583701588|FG003|Extension Study (Group 4)|Adverse Event|2|||
161631137|NCT00092521|583701585|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
161631138|NCT00092521|583701586|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
161631139|NCT00092521|583701587|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
161631140|NCT00092521|583701588|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
161631141|NCT00092521|583701585|FG000|Extension Study (Group 4)|Pregnancy|0|||
161631142|NCT00092521|583701586|FG001|Extension Study (Group 4)|Pregnancy|0|||
161833646|NCT00856830|584433174|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
161833647|NCT00856830|584433175|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
161833648|NCT03768726|584433176|FG000|Treatment Phase|Adverse Event|2|||
161833649|NCT03768726|584433177|FG001|Treatment Phase|Adverse Event|2|||
161833650|NCT03768726|584433176|FG000|Treatment Phase|Lost to Follow-up|1|||
161833651|NCT03768726|584433177|FG001|Treatment Phase|Lost to Follow-up|0|||
161833652|NCT03768726|584433176|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
161833653|NCT03768726|584433177|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
161833654|NCT03768726|584433176|FG000|Treatment Phase|Withdrawal by Subject|3|||
161833655|NCT03768726|584433177|FG001|Treatment Phase|Withdrawal by Subject|1|||
161833656|NCT03768726|584433176|FG000|Follow-Up|Adverse Event|2|||
161833657|NCT03768726|584433177|FG001|Follow-Up|Adverse Event|2|||
161833658|NCT03768726|584433176|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
161833659|NCT03768726|584433177|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
161833660|NCT03768726|584433176|FG000|Follow-Up|Withdrawal by Subject|2|||
161833661|NCT03768726|584433177|FG001|Follow-Up|Withdrawal by Subject|0|||
161833662|NCT03768726|584433176|FG000|Follow-Up|Other|1|||
161833663|NCT03768726|584433177|FG001|Follow-Up|Other|0|||
161833664|NCT01744093|584433179|FG000|Overall Study|Withdrawal by Subject|6|||
161833665|NCT01744093|584433180|FG001|Overall Study|Withdrawal by Subject|1|||
161833666|NCT02006628|584433181|FG000|Overall Study|Adverse Event|1|||
161631143|NCT00092521|583701587|FG002|Extension Study (Group 4)|Pregnancy|0|||
161631144|NCT00092521|583701588|FG003|Extension Study (Group 4)|Pregnancy|4|||
161631145|NCT00092521|583701585|FG000|Extension Study (Group 4)|Protocol Violation|0|||
161631146|NCT00092521|583701586|FG001|Extension Study (Group 4)|Protocol Violation|0|||
161631147|NCT00092521|583701587|FG002|Extension Study (Group 4)|Protocol Violation|0|||
161631148|NCT00092521|583701588|FG003|Extension Study (Group 4)|Protocol Violation|2|||
161631149|NCT00092521|583701585|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
161631150|NCT00092521|583701586|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
161631151|NCT00092521|583701587|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
161631152|NCT00092521|583701588|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
161631153|NCT00092521|583701585|FG000|Extension Study (Group 4)|Moved|0|||
161631154|NCT00092521|583701586|FG001|Extension Study (Group 4)|Moved|0|||
161631155|NCT00092521|583701587|FG002|Extension Study (Group 4)|Moved|0|||
161631156|NCT00092521|583701588|FG003|Extension Study (Group 4)|Moved|16|||
161631157|NCT00092521|583701585|FG000|Extension Study (Group 4)|Site Terminated|0|||
161631158|NCT00092521|583701586|FG001|Extension Study (Group 4)|Site Terminated|0|||
161631159|NCT00092521|583701587|FG002|Extension Study (Group 4)|Site Terminated|0|||
161631160|NCT00092521|583701588|FG003|Extension Study (Group 4)|Site Terminated|4|||
161631161|NCT00092521|583701585|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
161631162|NCT00092521|583701586|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
161631163|NCT00092521|583701587|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
161631164|NCT00092521|583701588|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
161631165|NCT00560313|583701589|FG000|Overall Study|Adverse Events or Death|2|||
161631166|NCT00560313|583701589|FG000|Overall Study|Withdrawal by Subject|2|||
161631167|NCT00560313|583701589|FG000|Overall Study|Lost to Follow-up|1|||
161631168|NCT00560313|583701589|FG000|Overall Study|Protocol Violation|1|||
161631169|NCT00605566|583701590|FG000|Overall Study|Adverse Event|1|||
161631170|NCT00605566|583701590|FG000|Overall Study|Clinical deterioration|1|||
161685767|NCT00078325|583901961|FG001|Overall Study|Withdrawal by Subject|5|||
161685768|NCT00078325|583901962|FG002|Overall Study|Withdrawal by Subject|3|||
161685769|NCT00078325|583901960|FG000|Overall Study|Lost to Follow-up|0|||
161685770|NCT00078325|583901961|FG001|Overall Study|Lost to Follow-up|1|||
161685771|NCT00078325|583901962|FG002|Overall Study|Lost to Follow-up|1|||
161685772|NCT00078325|583901960|FG000|Overall Study|Physician Decision|2|||
161685773|NCT00078325|583901961|FG001|Overall Study|Physician Decision|0|||
161685774|NCT00078325|583901962|FG002|Overall Study|Physician Decision|1|||
161685775|NCT00078325|583901960|FG000|Overall Study|Miscellaneous|1|||
161685776|NCT00078325|583901961|FG001|Overall Study|Miscellaneous|1|||
161631171|NCT00605566|583701590|FG000|Overall Study|Poor compliance in run-in period|1|||
161631172|NCT03475056|583701591|FG000|Overall Study|Lost to Follow-up|0|||
161631173|NCT03475056|583701592|FG001|Overall Study|Lost to Follow-up|1|||
161631174|NCT03475056|583701591|FG000|Overall Study|Moved from Area|0|||
161685777|NCT00078325|583901962|FG002|Overall Study|Miscellaneous|1|||
161833667|NCT02006628|584433182|FG001|Overall Study|Adverse Event|1|||
161833668|NCT02006628|584433181|FG000|Overall Study|Withdrawal by Subject|2|||
161833669|NCT02006628|584433182|FG001|Overall Study|Withdrawal by Subject|1|||
161833670|NCT03578237|584433185|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
161631175|NCT03475056|583701592|FG001|Overall Study|Moved from Area|2|||
161631176|NCT00113269|583701595|FG000|Overall Study|Not transplanted, donor issues|4|||
161631177|NCT00113269|583701596|FG001|Overall Study|Not transplanted, donor issues|0|||
161631178|NCT00113269|583701597|FG002|Overall Study|Not transplanted, donor issues|2|||
161631179|NCT00113269|583701598|FG003|Overall Study|Not transplanted, donor issues|2|||
161631180|NCT00113269|583701595|FG000|Overall Study|Not transplanted, recipient issues|2|||
161631181|NCT00113269|583701596|FG001|Overall Study|Not transplanted, recipient issues|1|||
161685778|NCT01473563|583901963|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
161685779|NCT03610724|583901964|FG000|Overall Study|Death|17|||
161685780|NCT03610724|583901964|FG000|Overall Study|Lost to Follow-up|1|||
161685781|NCT03610724|583901964|FG000|Overall Study|Physician Decision|1|||
161685782|NCT03610724|583901964|FG000|Overall Study|Died prior to infusion|1|||
161685783|NCT02943564|583901965|FG000|Overall Study|Miscellaneous Reasons|0|||
161685784|NCT02943564|583901966|FG001|Overall Study|Miscellaneous Reasons|0|||
161685785|NCT02943564|583901967|FG002|Overall Study|Miscellaneous Reasons|3|||
161685786|NCT02943564|583901965|FG000|Overall Study|Site terminated by sponsor|0|||
161685787|NCT02943564|583901966|FG001|Overall Study|Site terminated by sponsor|1|||
161685788|NCT02943564|583901967|FG002|Overall Study|Site terminated by sponsor|0|||
161685789|NCT02943564|583901965|FG000|Overall Study|Non-compliance with study drug|0|||
161685790|NCT02943564|583901966|FG001|Overall Study|Non-compliance with study drug|1|||
161685791|NCT02943564|583901967|FG002|Overall Study|Non-compliance with study drug|0|||
161685792|NCT02943564|583901965|FG000|Overall Study|Pregnancy|0|||
161685793|NCT02943564|583901966|FG001|Overall Study|Pregnancy|1|||
161685794|NCT02943564|583901967|FG002|Overall Study|Pregnancy|1|||
161685795|NCT02943564|583901965|FG000|Overall Study|Protocol Violation|2|||
161685796|NCT02943564|583901966|FG001|Overall Study|Protocol Violation|2|||
161685797|NCT02943564|583901967|FG002|Overall Study|Protocol Violation|2|||
161685798|NCT02943564|583901965|FG000|Overall Study|Lost to Follow-up|1|||
161685799|NCT02943564|583901966|FG001|Overall Study|Lost to Follow-up|0|||
161685800|NCT02943564|583901967|FG002|Overall Study|Lost to Follow-up|0|||
161685801|NCT02943564|583901965|FG000|Overall Study|Withdrawal by Subject|6|||
161685802|NCT02943564|583901966|FG001|Overall Study|Withdrawal by Subject|5|||
161685803|NCT02943564|583901967|FG002|Overall Study|Withdrawal by Subject|2|||
161685804|NCT02943564|583901965|FG000|Overall Study|Adverse Event|1|||
161685805|NCT02943564|583901966|FG001|Overall Study|Adverse Event|2|||
161685806|NCT02943564|583901967|FG002|Overall Study|Adverse Event|1|||
161631182|NCT00113269|583701597|FG002|Overall Study|Not transplanted, recipient issues|7|||
161631183|NCT00113269|583701598|FG003|Overall Study|Not transplanted, recipient issues|4|||
161631184|NCT00113269|583701595|FG000|Overall Study|Early graft loss, technical|0|||
161685807|NCT02943564|583901965|FG000|Overall Study|Lack of Efficacy|0|||
161685808|NCT02943564|583901966|FG001|Overall Study|Lack of Efficacy|1|||
161685809|NCT02943564|583901967|FG002|Overall Study|Lack of Efficacy|0|||
161685810|NCT00932360|583901968|FG000|Washout (One Week)|Withdrawal by Subject|0|||
161685811|NCT00932360|583901969|FG001|Washout (One Week)|Withdrawal by Subject|0|||
161685812|NCT00932360|583901970|FG002|Washout (One Week)|Withdrawal by Subject|0|||
161685813|NCT00932360|583901971|FG003|Washout (One Week)|Withdrawal by Subject|0|||
161685814|NCT00932360|583901972|FG004|Washout (One Week)|Withdrawal by Subject|2|||
161685815|NCT00932360|583901973|FG005|Washout (One Week)|Withdrawal by Subject|0|||
161685816|NCT04143009|583901974|FG000|Pilot Trial|Lost to Follow-up|0|||
161685817|NCT04143009|583901975|FG001|Pilot Trial|Lost to Follow-up|1|||
161685818|NCT04143009|583901976|FG002|Pilot Trial|Lost to Follow-up|1|||
161685819|NCT00781911|583901981|FG000|Overall Study|Adverse Event|4|||
161685820|NCT00781911|583901982|FG001|Overall Study|Adverse Event|4|||
161685821|NCT00781911|583901981|FG000|Overall Study|Withdrawal by Subject|1|||
161685822|NCT00781911|583901982|FG001|Overall Study|Withdrawal by Subject|2|||
161685823|NCT00781911|583901981|FG000|Overall Study|Physician Decision|0|||
161685824|NCT00781911|583901982|FG001|Overall Study|Physician Decision|2|||
161685825|NCT00781911|583901981|FG000|Overall Study|Sponsor Decision|1|||
161685826|NCT00781911|583901982|FG001|Overall Study|Sponsor Decision|0|||
161685827|NCT01357655|583901983|FG000|Overall Study|Administrative Reason by Sponsor|45|||
161685828|NCT01357655|583901984|FG001|Overall Study|Administrative Reason by Sponsor|0|||
161685829|NCT01357655|583901983|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161685830|NCT01357655|583901984|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161685831|NCT01357655|583901983|FG000|Overall Study|Disease Progression|1|||
161685832|NCT01357655|583901984|FG001|Overall Study|Disease Progression|0|||
161685833|NCT01357655|583901983|FG000|Overall Study|Lost to Follow-up|2|||
161685834|NCT01357655|583901984|FG001|Overall Study|Lost to Follow-up|0|||
161685835|NCT01357655|583901983|FG000|Overall Study|Maximum Clinical Benefit|2|||
161685836|NCT01357655|583901984|FG001|Overall Study|Maximum Clinical Benefit|0|||
161685837|NCT01357655|583901983|FG000|Overall Study|Reason Unspecified|1|||
161685838|NCT01357655|583901984|FG001|Overall Study|Reason Unspecified|0|||
161685839|NCT01357655|583901983|FG000|Overall Study|Study Drug Toxicity|11|||
161631185|NCT00113269|583701596|FG001|Overall Study|Early graft loss, technical|0|||
161685840|NCT01357655|583901984|FG001|Overall Study|Study Drug Toxicity|0|||
161685841|NCT01357655|583901983|FG000|Overall Study|Subject Withdrew Consent|1|||
161685842|NCT01357655|583901984|FG001|Overall Study|Subject Withdrew Consent|0|||
161685843|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
161631186|NCT00113269|583701597|FG002|Overall Study|Early graft loss, technical|2|||
161631187|NCT00113269|583701598|FG003|Overall Study|Early graft loss, technical|0|||
161631188|NCT00113269|583701595|FG000|Overall Study|Death in operating room|0|||
161631189|NCT00113269|583701596|FG001|Overall Study|Death in operating room|0|||
161631190|NCT00113269|583701597|FG002|Overall Study|Death in operating room|0|||
161631191|NCT00113269|583701598|FG003|Overall Study|Death in operating room|1|||
161631192|NCT00113269|583701595|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
161631193|NCT00113269|583701596|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
161631194|NCT00113269|583701597|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
161631195|NCT00113269|583701598|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
161631196|NCT00113269|583701595|FG000|Overall Study|Adverse Event|2|||
161631197|NCT00113269|583701596|FG001|Overall Study|Adverse Event|7|||
161631198|NCT00113269|583701597|FG002|Overall Study|Adverse Event|11|||
161631199|NCT00113269|583701598|FG003|Overall Study|Adverse Event|7|||
161631200|NCT00113269|583701595|FG000|Overall Study|Withdrawal by Subject|4|||
161631201|NCT00113269|583701596|FG001|Overall Study|Withdrawal by Subject|3|||
161631202|NCT00113269|583701597|FG002|Overall Study|Withdrawal by Subject|4|||
161631203|NCT00113269|583701598|FG003|Overall Study|Withdrawal by Subject|2|||
161631204|NCT00113269|583701595|FG000|Overall Study|Graft loss|6|||
161631205|NCT00113269|583701596|FG001|Overall Study|Graft loss|6|||
161631206|NCT00113269|583701597|FG002|Overall Study|Graft loss|4|||
161631207|NCT00113269|583701598|FG003|Overall Study|Graft loss|9|||
161631208|NCT00113269|583701595|FG000|Overall Study|Protocol Violation|1|||
161631209|NCT00113269|583701596|FG001|Overall Study|Protocol Violation|0|||
161631210|NCT00113269|583701597|FG002|Overall Study|Protocol Violation|4|||
161631211|NCT00113269|583701598|FG003|Overall Study|Protocol Violation|2|||
161631212|NCT00113269|583701595|FG000|Overall Study|Lost to Follow-up|2|||
161631213|NCT00113269|583701596|FG001|Overall Study|Lost to Follow-up|3|||
161631214|NCT00113269|583701597|FG002|Overall Study|Lost to Follow-up|6|||
161631215|NCT00113269|583701598|FG003|Overall Study|Lost to Follow-up|3|||
161631216|NCT00113269|583701595|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
161631217|NCT00113269|583701596|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
161631218|NCT00113269|583701597|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
161631219|NCT00113269|583701598|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
161631220|NCT00113269|583701595|FG000|Overall Study|Discontinued due to rejection|0|||
161631221|NCT00113269|583701596|FG001|Overall Study|Discontinued due to rejection|0|||
161631222|NCT00113269|583701597|FG002|Overall Study|Discontinued due to rejection|1|||
161631223|NCT00113269|583701598|FG003|Overall Study|Discontinued due to rejection|0|||
161631224|NCT00113269|583701595|FG000|Overall Study|Moved|0|||
161631225|NCT00113269|583701596|FG001|Overall Study|Moved|1|||
161631226|NCT00113269|583701597|FG002|Overall Study|Moved|0|||
161631227|NCT00113269|583701598|FG003|Overall Study|Moved|3|||
161631228|NCT00113269|583701595|FG000|Overall Study|Received pancreas transplant|0|||
161631229|NCT00113269|583701596|FG001|Overall Study|Received pancreas transplant|0|||
161631230|NCT00113269|583701597|FG002|Overall Study|Received pancreas transplant|0|||
161631231|NCT00113269|583701598|FG003|Overall Study|Received pancreas transplant|2|||
161631232|NCT00113269|583701595|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
161631233|NCT00113269|583701596|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
161631234|NCT00113269|583701597|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
161631235|NCT00113269|583701598|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
161631236|NCT00113269|583701595|FG000|Overall Study|Did not meet eligibility criteria|1|||
161631237|NCT00113269|583701596|FG001|Overall Study|Did not meet eligibility criteria|0|||
161631238|NCT00113269|583701597|FG002|Overall Study|Did not meet eligibility criteria|0|||
161631239|NCT00113269|583701598|FG003|Overall Study|Did not meet eligibility criteria|1|||
161631240|NCT00113269|583701595|FG000|Overall Study|Unable to return for follow up|2|||
161631241|NCT00113269|583701596|FG001|Overall Study|Unable to return for follow up|1|||
161631242|NCT00113269|583701597|FG002|Overall Study|Unable to return for follow up|0|||
161631243|NCT00113269|583701598|FG003|Overall Study|Unable to return for follow up|0|||
161631244|NCT03864341|583701602|FG000|Overall Study|Withdrawal by Subject|1|||
161631245|NCT01066936|583701603|FG000|Overall Study|Death|2|||
161631246|NCT01066936|583701603|FG000|Overall Study|Device revised/removed|1|||
161631247|NCT01066936|583701603|FG000|Overall Study|Lost to Follow-up|3|||
161631248|NCT01066936|583701603|FG000|Overall Study|Withdrawal by Subject|4|||
161631249|NCT01904136|583701604|FG000|Overall Study|Physician Decision|0|||
161631250|NCT01904136|583701605|FG001|Overall Study|Physician Decision|0|||
161631251|NCT01904136|583701606|FG002|Overall Study|Physician Decision|0|||
161631252|NCT01904136|583701607|FG003|Overall Study|Physician Decision|0|||
161631253|NCT01904136|583701608|FG004|Overall Study|Physician Decision|0|||
161631254|NCT01904136|583701609|FG005|Overall Study|Physician Decision|1|||
161631255|NCT01904136|583701610|FG006|Overall Study|Physician Decision|0|||
161631256|NCT01904136|583701611|FG007|Overall Study|Physician Decision|0|||
161631257|NCT01904136|583701612|FG008|Overall Study|Physician Decision|0|||
161631258|NCT00853372|583701613|FG000|Overall Study|Death|30|||
161631259|NCT00853372|583701614|FG001|Overall Study|Death|26|||
161631260|NCT00853372|583701613|FG000|Overall Study|Lost to Follow-up|1|||
161631261|NCT00853372|583701614|FG001|Overall Study|Lost to Follow-up|2|||
161631262|NCT00853372|583701613|FG000|Overall Study|Full Consent Withdrawn|1|||
161631263|NCT00853372|583701614|FG001|Overall Study|Full Consent Withdrawn|1|||
161631264|NCT01580995|583701615|FG000|Overall Study|Lost to Follow-up|2|||
161631265|NCT01580995|583701616|FG001|Overall Study|Lost to Follow-up|2|||
161631266|NCT02517528|583701618|FG000|Overall Study|Withdrawal by Subject|1|||
161631267|NCT02202109|583701620|FG000|Overall Study|Lost to Follow-up|88|||
161631268|NCT02202109|583701621|FG001|Overall Study|Lost to Follow-up|87|||
161631269|NCT02202109|583701620|FG000|Overall Study|Withdrawal by Subject|2|||
161631270|NCT02202109|583701621|FG001|Overall Study|Withdrawal by Subject|0|||
161631271|NCT01268098|583701624|FG000|Overall Study|Adverse Event|1|||
161631272|NCT01268098|583701625|FG001|Overall Study|Adverse Event|0|||
161631273|NCT04156399|583701632|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
161631274|NCT04156399|583701632|FG000|Overall Study|study suspension due to COVID pandemic|3|||
161631275|NCT01703845|583701633|FG000|Overall Study|Adverse Event|1|||
161631276|NCT01703845|583701634|FG001|Overall Study|Adverse Event|0|||
161631277|NCT01703845|583701633|FG000|Overall Study|Protocol Violation|1|||
161631278|NCT01703845|583701634|FG001|Overall Study|Protocol Violation|0|||
161631279|NCT01703845|583701633|FG000|Overall Study|other than stated above|1|||
161631280|NCT01703845|583701634|FG001|Overall Study|other than stated above|0|||
161631281|NCT03418493|583701635|FG000|Overall Study|Adverse Event|1|||
161631282|NCT03418493|583701636|FG001|Overall Study|Adverse Event|0|||
161631283|NCT03418493|583701637|FG002|Overall Study|Adverse Event|0|||
161631284|NCT03418493|583701638|FG003|Overall Study|Adverse Event|0|||
161631285|NCT03418493|583701639|FG004|Overall Study|Adverse Event|0|||
161631286|NCT03418493|583701640|FG005|Overall Study|Adverse Event|0|||
161631287|NCT03418493|583701641|FG006|Overall Study|Adverse Event|0|||
161631288|NCT03418493|583701642|FG007|Overall Study|Adverse Event|0|||
161631289|NCT03418493|583701643|FG008|Overall Study|Adverse Event|0|||
161631290|NCT03418493|583701644|FG009|Overall Study|Adverse Event|0|||
161631291|NCT03418493|583701645|FG010|Overall Study|Adverse Event|0|||
161631292|NCT03418493|583701635|FG000|Overall Study|Protocol Violation|0|||
161631293|NCT03418493|583701636|FG001|Overall Study|Protocol Violation|0|||
161631294|NCT03418493|583701637|FG002|Overall Study|Protocol Violation|0|||
161631295|NCT03418493|583701638|FG003|Overall Study|Protocol Violation|0|||
161631296|NCT03418493|583701639|FG004|Overall Study|Protocol Violation|0|||
161631297|NCT03418493|583701640|FG005|Overall Study|Protocol Violation|0|||
161631298|NCT03418493|583701641|FG006|Overall Study|Protocol Violation|0|||
161631299|NCT03418493|583701642|FG007|Overall Study|Protocol Violation|0|||
161631300|NCT03418493|583701643|FG008|Overall Study|Protocol Violation|0|||
161631301|NCT03418493|583701644|FG009|Overall Study|Protocol Violation|1|||
161631302|NCT03418493|583701645|FG010|Overall Study|Protocol Violation|0|||
161631303|NCT04140266|583701647|FG000|Overall Study|Physician Decision|2|||
161631304|NCT04140266|583701648|FG001|Overall Study|Physician Decision|0|||
161631305|NCT04140266|583701647|FG000|Overall Study|Withdrawal by Subject|4|||
161631306|NCT04140266|583701648|FG001|Overall Study|Withdrawal by Subject|2|||
161631307|NCT00943618|583701649|FG000|Overall Study|Lost to Follow-up|38|||
161631308|NCT00943618|583701650|FG001|Overall Study|Lost to Follow-up|48|||
161631309|NCT00943618|583701651|FG002|Overall Study|Lost to Follow-up|20|||
161631310|NCT00943618|583701649|FG000|Overall Study|Discontinued Medication|17|||
161833671|NCT03578237|584433186|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
161833672|NCT02370914|584433192|FG000|Overall Study|Protocol Violation|2|||
161833673|NCT00252174|584433193|FG000|Overall Study|Withdrawal by Subject|0|||
161833674|NCT00252174|584433194|FG001|Overall Study|Withdrawal by Subject|1|||
161833675|NCT00252174|584433195|FG002|Overall Study|Withdrawal by Subject|0|||
161833676|NCT01138826|584433196|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161833677|NCT01138826|584433197|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161631311|NCT00943618|583701650|FG001|Overall Study|Discontinued Medication|29|||
161833678|NCT01138826|584433198|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161833679|NCT01138826|584433199|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161833680|NCT01138826|584433200|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161833681|NCT01138826|584433201|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161833682|NCT02566993|584433202|FG000|Overall Study|Randomized but not treated|5|||
161631312|NCT00943618|583701651|FG002|Overall Study|Discontinued Medication|11|||
161631313|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
161631314|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
161631315|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
161631316|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
161631317|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
161631318|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
161631319|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
161631320|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
161631321|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
161631322|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
161631323|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
161631324|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
161631325|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
161631326|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
161833683|NCT02566993|584433203|FG001|Overall Study|Randomized but not treated|16|||
161833684|NCT02566993|584433202|FG000|Overall Study|Progressive disease|213|||
161833685|NCT02566993|584433203|FG001|Overall Study|Progressive disease|152|||
161833686|NCT02566993|584433202|FG000|Overall Study|Withdrawal by Subject|12|||
161833687|NCT02566993|584433203|FG001|Overall Study|Withdrawal by Subject|28|||
161833688|NCT02566993|584433202|FG000|Overall Study|Death|17|||
161833689|NCT02566993|584433203|FG001|Overall Study|Death|23|||
161833690|NCT02566993|584433202|FG000|Overall Study|Physician Decision|10|||
161833691|NCT02566993|584433203|FG001|Overall Study|Physician Decision|17|||
161833692|NCT02566993|584433202|FG000|Overall Study|Study drug-related adverse event|20|||
161833693|NCT02566993|584433203|FG001|Overall Study|Study drug-related adverse event|41|||
161833694|NCT02566993|584433202|FG000|Overall Study|Non study drug-related adverse event|9|||
161833695|NCT02566993|584433203|FG001|Overall Study|Non study drug-related adverse event|9|||
161833696|NCT02566993|584433202|FG000|Overall Study|Symptomatic deterioration|9|||
161833697|NCT02566993|584433203|FG001|Overall Study|Symptomatic deterioration|16|||
161685844|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161685845|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161685846|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
161833698|NCT02566993|584433202|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
161833699|NCT02566993|584433203|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
161631327|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
161631328|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
161631329|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
161631330|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
161631331|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
161631332|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
161631333|NCT02637856|583701662|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
161631334|NCT02637856|583701663|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
161631335|NCT02637856|583701662|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
161631336|NCT02637856|583701663|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
161631337|NCT02637856|583701662|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
161631338|NCT02637856|583701663|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
161631339|NCT02509312|583701664|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
161685847|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
161833700|NCT02566993|584433202|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
161833701|NCT02566993|584433203|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
161631340|NCT02509312|583701665|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
161631341|NCT02509312|583701664|FG000|Overall Study|Obstetrician refusal|0|||
161631342|NCT02509312|583701665|FG001|Overall Study|Obstetrician refusal|1|||
161631343|NCT02509312|583701664|FG000|Overall Study|Patient elected for TOLAC|1|||
161631344|NCT02509312|583701665|FG001|Overall Study|Patient elected for TOLAC|0|||
161631345|NCT02509312|583701664|FG000|Overall Study|Cesarean deemed stat|1|||
161631346|NCT02509312|583701665|FG001|Overall Study|Cesarean deemed stat|0|||
161631347|NCT02509312|583701664|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
161631348|NCT02509312|583701665|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
161631349|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
161631350|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
161631351|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
161631352|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
161631353|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Death|0|||
161631354|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Death|1|||
161631355|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
161631356|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
161631357|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
161631358|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
161631359|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
161631360|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
161631361|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
161631362|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
161631363|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
161631364|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
161631365|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
161631366|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
161631367|NCT01309243|583701666|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
161631368|NCT01309243|583701667|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
161631369|NCT01309243|583701666|FG000|Extension Phase|Lost to Follow-up|6|||
161631370|NCT01309243|583701667|FG001|Extension Phase|Lost to Follow-up|0|||
161631371|NCT01402063|583701670|FG000|Overall Study|Withdrawal by Subject|3|||
161631372|NCT01402063|583701671|FG001|Overall Study|Withdrawal by Subject|3|||
161631373|NCT01388478|583701678|FG000|Overall Study|Adverse Event|4|||
161631374|NCT01388478|583701678|FG000|Overall Study|Withdrawal by Subject|1|||
161631375|NCT01037413|583701679|FG000|Part A: Skin Testing|Adverse Event|1|||
161631376|NCT01037413|583701680|FG001|Part A: Skin Testing|Adverse Event|0|||
161631377|NCT01037413|583701679|FG000|Part A: Skin Testing|Protocol Violation|1|||
161631378|NCT01037413|583701680|FG001|Part A: Skin Testing|Protocol Violation|0|||
161631379|NCT01037413|583701679|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
161631380|NCT01037413|583701680|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
161631381|NCT01037413|583701679|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
161631382|NCT01037413|583701680|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
161631383|NCT01990664|583701681|FG000|Overall Study|Lost to Follow-up|2|||
161631384|NCT01990664|583701682|FG001|Overall Study|Lost to Follow-up|6|||
161631385|NCT01990664|583701681|FG000|Overall Study|Withdrawal by Subject|2|||
161631386|NCT01990664|583701682|FG001|Overall Study|Withdrawal by Subject|3|||
161631387|NCT01990664|583701681|FG000|Overall Study|Protocol Violation|1|||
161631388|NCT01990664|583701682|FG001|Overall Study|Protocol Violation|0|||
161631389|NCT01990664|583701681|FG000|Overall Study|Lens Discomfort|1|||
161631390|NCT01990664|583701682|FG001|Overall Study|Lens Discomfort|1|||
161631391|NCT01990664|583701681|FG000|Overall Study|Lens Handling Difficulties|1|||
161631392|NCT01990664|583701682|FG001|Overall Study|Lens Handling Difficulties|0|||
161631393|NCT01990664|583701681|FG000|Overall Study|Unsatisfactory Visual Response|0|||
161631394|NCT01990664|583701682|FG001|Overall Study|Unsatisfactory Visual Response|1|||
161631395|NCT00619983|583701683|FG000|Test Drug Alone|Withdrawal by Subject|1|||
161631396|NCT00619983|583701684|FG001|Test Drug Alone|Withdrawal by Subject|0|||
161631397|NCT00619983|583701685|FG002|Test Drug Alone|Withdrawal by Subject|0|||
161631398|NCT00619983|583701686|FG003|Test Drug Alone|Withdrawal by Subject|1|||
161631399|NCT00619983|583701683|FG000|Test Drug Alone|Failure of daily diary device|1|||
161631400|NCT00619983|583701684|FG001|Test Drug Alone|Failure of daily diary device|1|||
161631401|NCT00619983|583701685|FG002|Test Drug Alone|Failure of daily diary device|2|||
161631402|NCT00619983|583701686|FG003|Test Drug Alone|Failure of daily diary device|2|||
161631403|NCT00827775|583701688|FG000|Overall Study|Withdrawal by Subject|0|||
161631404|NCT00827775|583701689|FG001|Overall Study|Withdrawal by Subject|5|||
161631405|NCT00297778|583701698|FG000|Overall Study|Adverse Event|16|||
161631406|NCT00297778|583701699|FG001|Overall Study|Adverse Event|10|||
161631407|NCT00297778|583701698|FG000|Overall Study|Withdrawal by Subject|1|||
161631408|NCT00297778|583701699|FG001|Overall Study|Withdrawal by Subject|5|||
161631409|NCT00297778|583701698|FG000|Overall Study|Lack of Efficacy|2|||
161631410|NCT00297778|583701699|FG001|Overall Study|Lack of Efficacy|1|||
161631411|NCT00297778|583701698|FG000|Overall Study|Non-compliant with trial protocol|0|||
161631412|NCT00297778|583701699|FG001|Overall Study|Non-compliant with trial protocol|3|||
161631413|NCT00297778|583701698|FG000|Overall Study|Other|0|||
161631414|NCT00297778|583701699|FG001|Overall Study|Other|1|||
161631415|NCT00839332|583701701|FG000|Phase 1|Disease Progression|38|||
161631416|NCT00839332|583701702|FG001|Phase 1|Disease Progression|0|||
161631417|NCT00839332|583701703|FG002|Phase 1|Disease Progression|0|||
161631418|NCT00839332|583701701|FG000|Phase 1|Adverse Event|6|||
161631419|NCT00839332|583701702|FG001|Phase 1|Adverse Event|0|||
161631420|NCT00839332|583701703|FG002|Phase 1|Adverse Event|0|||
161631421|NCT00839332|583701701|FG000|Phase 1|Withdrawal by Subject|4|||
161631422|NCT00839332|583701702|FG001|Phase 1|Withdrawal by Subject|0|||
161631423|NCT00839332|583701703|FG002|Phase 1|Withdrawal by Subject|0|||
161631424|NCT00839332|583701701|FG000|Phase 1|Physician Decision|2|||
161631425|NCT00839332|583701702|FG001|Phase 1|Physician Decision|0|||
161631426|NCT00839332|583701703|FG002|Phase 1|Physician Decision|0|||
161631427|NCT00839332|583701701|FG000|Phase 2|Protocol Violation|0|||
161631428|NCT00839332|583701702|FG001|Phase 2|Protocol Violation|1|||
161631429|NCT00839332|583701703|FG002|Phase 2|Protocol Violation|0|||
161631430|NCT00839332|583701701|FG000|Phase 2|Disease Progression|0|||
161631431|NCT00839332|583701702|FG001|Phase 2|Disease Progression|46|||
161631432|NCT00839332|583701703|FG002|Phase 2|Disease Progression|21|||
161631433|NCT00839332|583701701|FG000|Phase 2|Adverse Event|0|||
161631434|NCT00839332|583701702|FG001|Phase 2|Adverse Event|8|||
161631435|NCT00839332|583701703|FG002|Phase 2|Adverse Event|6|||
161631436|NCT00839332|583701701|FG000|Phase 2|Death|0|||
161631437|NCT00839332|583701702|FG001|Phase 2|Death|4|||
161631438|NCT00839332|583701703|FG002|Phase 2|Death|2|||
161631439|NCT00839332|583701701|FG000|Phase 2|Withdrawal by Subject|0|||
161631440|NCT00839332|583701702|FG001|Phase 2|Withdrawal by Subject|5|||
161631441|NCT00839332|583701703|FG002|Phase 2|Withdrawal by Subject|8|||
161631442|NCT00839332|583701701|FG000|Phase 2|Physician Decision|0|||
161631443|NCT00839332|583701702|FG001|Phase 2|Physician Decision|4|||
161631444|NCT00839332|583701703|FG002|Phase 2|Physician Decision|1|||
161631445|NCT00839332|583701701|FG000|Phase 2|Lost to Follow-up|0|||
161631446|NCT00839332|583701702|FG001|Phase 2|Lost to Follow-up|0|||
161631447|NCT00839332|583701703|FG002|Phase 2|Lost to Follow-up|1|||
161631448|NCT01200485|583701704|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
161631449|NCT01200485|583701705|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
161631450|NCT01200485|583701706|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
161631451|NCT01200485|583701704|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
161631452|NCT01200485|583701705|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
161631453|NCT01200485|583701706|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
161631454|NCT03078751|583701707|FG000|Overall Study|Adverse Event|4|||
161631455|NCT03078751|583701708|FG001|Overall Study|Adverse Event|0|||
161631456|NCT03078751|583701707|FG000|Overall Study|Physician Decision|1|||
161631457|NCT03078751|583701708|FG001|Overall Study|Physician Decision|0|||
161631458|NCT03078751|583701707|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
161631459|NCT03078751|583701708|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
161631460|NCT03078751|583701707|FG000|Overall Study|Subject/guardian decision|8|||
161631461|NCT03078751|583701708|FG001|Overall Study|Subject/guardian decision|1|||
161631462|NCT03078751|583701707|FG000|Overall Study|Untreated|0|||
161631463|NCT03078751|583701708|FG001|Overall Study|Untreated|4|||
161631464|NCT04414397|583701709|FG000|Control Period|Withdrawal by Subject|2|||
161631465|NCT04414397|583701710|FG001|Control Period|Withdrawal by Subject|2|||
161631466|NCT04414397|583701709|FG000|Control Period|Lost to Follow-up|0|||
161631467|NCT04414397|583701710|FG001|Control Period|Lost to Follow-up|4|||
161631468|NCT04414397|583701709|FG000|Control Period|Protocol deviation|0|||
161631469|NCT04414397|583701710|FG001|Control Period|Protocol deviation|1|||
161631470|NCT04414397|583701709|FG000|Post-Control Period|Withdrawal by Subject|3|||
161685848|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
161685849|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161685850|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161833702|NCT02566993|584433202|FG000|Overall Study|Screening failure|2|||
161631471|NCT04414397|583701710|FG001|Post-Control Period|Withdrawal by Subject|6|||
161631472|NCT04414397|583701709|FG000|Post-Control Period|Lost to Follow-up|4|||
161631473|NCT04414397|583701710|FG001|Post-Control Period|Lost to Follow-up|9|||
161631474|NCT04414397|583701709|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
161631475|NCT04414397|583701710|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
161631476|NCT04414397|583701709|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
161631477|NCT04414397|583701710|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
161631478|NCT02515097|583701712|FG000|Overall Study|Lost to Follow-up|4|||
161631479|NCT02515097|583701713|FG001|Overall Study|Lost to Follow-up|2|||
161631480|NCT02515097|583701712|FG000|Overall Study|Withdrawal by Subject|1|||
161631481|NCT02515097|583701713|FG001|Overall Study|Withdrawal by Subject|3|||
161631482|NCT02515097|583701712|FG000|Overall Study|Adverse Event|2|||
161631483|NCT02515097|583701713|FG001|Overall Study|Adverse Event|1|||
161631484|NCT02551692|583701714|FG000|Overall Study|Lost to Follow-up|0|||
161631485|NCT02551692|583701715|FG001|Overall Study|Lost to Follow-up|1|||
161631486|NCT02551692|583701716|FG002|Overall Study|Lost to Follow-up|4|||
161631487|NCT02551692|583701714|FG000|Overall Study|Withdrawal by Subject|1|||
161631488|NCT02551692|583701715|FG001|Overall Study|Withdrawal by Subject|0|||
161631489|NCT02551692|583701716|FG002|Overall Study|Withdrawal by Subject|1|||
161631490|NCT02965599|583701717|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
161631491|NCT02965599|583701718|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
161631492|NCT00230971|583701719|FG000|Randomization|No study drug administered|3|||
161631493|NCT00230971|583701720|FG001|Randomization|No study drug administered|3|||
161631494|NCT00230971|583701719|FG000|Baseline Participants|Lost to Follow-up|5|||
161631495|NCT00230971|583701720|FG001|Baseline Participants|Lost to Follow-up|12|||
161631496|NCT00230971|583701719|FG000|Baseline Participants|Death|6|||
161631497|NCT00230971|583701720|FG001|Baseline Participants|Death|5|||
161631498|NCT00230971|583701719|FG000|Baseline Participants|Withdrawal by Subject|7|||
161631499|NCT00230971|583701720|FG001|Baseline Participants|Withdrawal by Subject|1|||
161631500|NCT00230971|583701719|FG000|Baseline Participants|Adverse Event|1|||
161631501|NCT00230971|583701720|FG001|Baseline Participants|Adverse Event|0|||
161631502|NCT00230971|583701719|FG000|Baseline Participants|No bacteria observed|1|||
161631503|NCT00230971|583701720|FG001|Baseline Participants|No bacteria observed|0|||
161631504|NCT00230971|583701719|FG000|Baseline Participants|Failure to return|1|||
161631505|NCT00230971|583701720|FG001|Baseline Participants|Failure to return|1|||
161631506|NCT00230971|583701719|FG000|Baseline Participants|Reintervention|1|||
161631507|NCT00230971|583701720|FG001|Baseline Participants|Reintervention|0|||
161631508|NCT04267393|583701727|FG000|Randomization|Adverse Event|1|||
161631509|NCT04267393|583701728|FG001|Randomization|Adverse Event|0|||
161631510|NCT04267393|583701729|FG002|Randomization|Adverse Event|0|||
161631511|NCT04267393|583701727|FG000|Randomization|Administrative Reasons by Sponsor|0|||
161631512|NCT04267393|583701728|FG001|Randomization|Administrative Reasons by Sponsor|1|||
161631513|NCT04267393|583701729|FG002|Randomization|Administrative Reasons by Sponsor|0|||
161631514|NCT04267393|583701727|FG000|Treatment Period|Adverse Event|0|||
161631515|NCT04267393|583701728|FG001|Treatment Period|Adverse Event|2|||
161631516|NCT04267393|583701729|FG002|Treatment Period|Adverse Event|3|||
161631517|NCT04267393|583701727|FG000|Treatment Period|Participant Withdrew Consent|0|||
161631518|NCT04267393|583701728|FG001|Treatment Period|Participant Withdrew Consent|0|||
161631519|NCT04267393|583701729|FG002|Treatment Period|Participant Withdrew Consent|1|||
161631520|NCT04267393|583701727|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
161631521|NCT04267393|583701728|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
161631522|NCT04267393|583701729|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
161631523|NCT02799745|583701730|FG000|Overall Study|Participant moved out of state|1|||
161631524|NCT02799745|583701731|FG001|Overall Study|Participant moved out of state|0|||
161631525|NCT02799745|583701730|FG000|Overall Study|Discontinued due to planned surgery|1|||
161631526|NCT02799745|583701731|FG001|Overall Study|Discontinued due to planned surgery|0|||
161631527|NCT02799745|583701730|FG000|Overall Study|Withdrawal by Subject|16|||
161631528|NCT02799745|583701731|FG001|Overall Study|Withdrawal by Subject|25|||
161631529|NCT02799745|583701730|FG000|Overall Study|Protocol Deviation|4|||
161631530|NCT02799745|583701731|FG001|Overall Study|Protocol Deviation|5|||
161631531|NCT02799745|583701730|FG000|Overall Study|Progressive Disease|28|||
161631532|NCT02799745|583701731|FG001|Overall Study|Progressive Disease|38|||
161631533|NCT02799745|583701730|FG000|Overall Study|Lost to Follow-up|3|||
161631534|NCT02799745|583701731|FG001|Overall Study|Lost to Follow-up|2|||
161631535|NCT02799745|583701730|FG000|Overall Study|Death|3|||
161631536|NCT02799745|583701731|FG001|Overall Study|Death|0|||
161631537|NCT02799745|583701730|FG000|Overall Study|Adverse Event|0|||
161631538|NCT02799745|583701731|FG001|Overall Study|Adverse Event|1|||
161685851|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161685852|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
161631539|NCT02210208|583703463|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
161631540|NCT02210208|583703463|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
161631541|NCT02210208|583703463|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
161631542|NCT01726049|583703464|FG000|Overall Study|Death|1|||
161631543|NCT01726049|583703465|FG001|Overall Study|Death|1|||
161631544|NCT01726049|583703464|FG000|Overall Study|Adverse Event|4|||
161631545|NCT01726049|583703465|FG001|Overall Study|Adverse Event|1|||
161631546|NCT01726049|583703464|FG000|Overall Study|refused second HC|0|||
161631547|NCT01726049|583703465|FG001|Overall Study|refused second HC|2|||
161631548|NCT01929876|583703466|FG000|Period 2|Non-Compliance|1|||
161631549|NCT01222533|583703468|FG000|Overall Study|Adverse Event|5|||
161631550|NCT01222533|583703468|FG000|Overall Study|Withdrawal by Subject|5|||
161631551|NCT01222533|583703468|FG000|Overall Study|Other|4|||
161631552|NCT03834623|583703469|FG000|Overall Study|Progression|0|||
161631553|NCT03834623|583703470|FG001|Overall Study|Progression|1|||
161631554|NCT01947517|583703471|FG000|Overall Study|Withdrawal by Subject|1|||
161631555|NCT01947517|583703472|FG001|Overall Study|Withdrawal by Subject|1|||
161631556|NCT00460564|583703473|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
161631557|NCT00460564|583703474|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
161631558|NCT00460564|583703475|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161631559|NCT00460564|583703476|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161631560|NCT00460564|583703477|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161631561|NCT00460564|583703478|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161631562|NCT00460564|583703479|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161631563|NCT00460564|583703480|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161631564|NCT00460564|583703473|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
161631565|NCT00460564|583703474|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631566|NCT00460564|583703475|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631567|NCT00460564|583703476|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631568|NCT00460564|583703477|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631569|NCT00460564|583703478|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631570|NCT00460564|583703479|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631571|NCT00460564|583703480|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161631572|NCT00460564|583703473|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161631573|NCT00460564|583703474|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161631574|NCT00460564|583703475|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161631575|NCT00460564|583703476|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161631576|NCT00460564|583703477|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
161631577|NCT00460564|583703478|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
161631578|NCT00460564|583703479|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
161631579|NCT00460564|583703480|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161631580|NCT00460564|583703473|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161631581|NCT00460564|583703474|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161631582|NCT00460564|583703475|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161631583|NCT00460564|583703476|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161631584|NCT00460564|583703477|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
161631585|NCT00460564|583703478|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
161631586|NCT00460564|583703479|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161631587|NCT00460564|583703480|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161631588|NCT00460564|583703473|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631589|NCT00460564|583703474|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631590|NCT00460564|583703475|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631591|NCT00460564|583703476|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631592|NCT00460564|583703477|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
161631593|NCT00460564|583703478|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631594|NCT00460564|583703479|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631595|NCT00460564|583703480|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161631596|NCT03226106|583703486|FG000|Overall Study|Withdrawal by Subject|2|||
161631597|NCT03226106|583703487|FG001|Overall Study|Withdrawal by Subject|0|||
161631598|NCT03226106|583703486|FG000|Overall Study|Adverse Event|1|||
161631599|NCT03226106|583703487|FG001|Overall Study|Adverse Event|0|||
161631600|NCT03226106|583703486|FG000|Overall Study|Lost to Follow-up|2|||
161631601|NCT03226106|583703487|FG001|Overall Study|Lost to Follow-up|0|||
161631602|NCT04349644|583703488|FG000|Allocation/Pretest|Lost to pretest|0|||
161631603|NCT04349644|583703489|FG001|Allocation/Pretest|Lost to pretest|3|||
161631604|NCT04349644|583703488|FG000|Posttest|Lost to posttest|0|||
161631605|NCT04349644|583703489|FG001|Posttest|Lost to posttest|8|||
161631606|NCT04349644|583703488|FG000|Posttest|Discontinued intervention|6|||
161631607|NCT04349644|583703489|FG001|Posttest|Discontinued intervention|0|||
161631608|NCT04349644|583703488|FG000|Follow-up|Lost to Follow-up|0|||
161631609|NCT04349644|583703489|FG001|Follow-up|Lost to Follow-up|2|||
161631610|NCT01084239|583703490|FG000|28-Day Follow-up|Lost to Follow-up|4|||
161631611|NCT01084239|583703491|FG001|28-Day Follow-up|Lost to Follow-up|9|||
161631612|NCT05006417|583703492|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
161631613|NCT00863798|583703493|FG000|Overall Study|Adverse Event|5|||
161631614|NCT00863798|583703494|FG001|Overall Study|Adverse Event|2|||
161631615|NCT00863798|583703495|FG002|Overall Study|Adverse Event|4|||
161631616|NCT00863798|583703493|FG000|Overall Study|Participant failed to return|2|||
161631617|NCT00863798|583703494|FG001|Overall Study|Participant failed to return|1|||
161631618|NCT00863798|583703495|FG002|Overall Study|Participant failed to return|0|||
161631619|NCT00863798|583703493|FG000|Overall Study|Investigator request|1|||
161631620|NCT00863798|583703494|FG001|Overall Study|Investigator request|2|||
161631621|NCT00863798|583703495|FG002|Overall Study|Investigator request|1|||
161631622|NCT00863798|583703493|FG000|Overall Study|Lack of Efficacy|4|||
161631623|NCT00863798|583703494|FG001|Overall Study|Lack of Efficacy|3|||
161631624|NCT00863798|583703495|FG002|Overall Study|Lack of Efficacy|6|||
161631625|NCT00863798|583703493|FG000|Overall Study|Lost to Follow-up|6|||
161631626|NCT00863798|583703494|FG001|Overall Study|Lost to Follow-up|9|||
161631627|NCT00863798|583703495|FG002|Overall Study|Lost to Follow-up|5|||
161631628|NCT00863798|583703493|FG000|Overall Study|Other|2|||
161631629|NCT00863798|583703494|FG001|Overall Study|Other|3|||
161631630|NCT00863798|583703495|FG002|Overall Study|Other|1|||
161631631|NCT00863798|583703493|FG000|Overall Study|Protocol Violation|0|||
161631632|NCT00863798|583703494|FG001|Overall Study|Protocol Violation|1|||
161631633|NCT00863798|583703495|FG002|Overall Study|Protocol Violation|1|||
161631634|NCT00863798|583703493|FG000|Overall Study|Withdrawal by Subject|8|||
161631635|NCT00863798|583703494|FG001|Overall Study|Withdrawal by Subject|7|||
161631636|NCT00863798|583703495|FG002|Overall Study|Withdrawal by Subject|4|||
161631637|NCT00863798|583703493|FG000|Overall Study|Randomized not treated|4|||
161631638|NCT00863798|583703494|FG001|Overall Study|Randomized not treated|2|||
161631639|NCT00863798|583703495|FG002|Overall Study|Randomized not treated|3|||
161631640|NCT04238520|583703496|FG000|Overall Study|Withdrawal by Subject|1|||
161631641|NCT04238520|583703497|FG001|Overall Study|Withdrawal by Subject|1|||
161631642|NCT04238520|583703496|FG000|Overall Study|Lost to Follow-up|1|||
161631643|NCT04238520|583703497|FG001|Overall Study|Lost to Follow-up|2|||
161631644|NCT04238520|583703496|FG000|Overall Study|Death|0|||
161631645|NCT04238520|583703497|FG001|Overall Study|Death|2|||
161631646|NCT04238520|583703496|FG000|Overall Study|Unsafe home environment for research staff|0|||
161631647|NCT04238520|583703497|FG001|Overall Study|Unsafe home environment for research staff|1|||
161631648|NCT01470599|583703498|FG000|Overall Study|Did not meet entrance criteria|1|||
161631649|NCT01470599|583703499|FG001|Overall Study|Did not meet entrance criteria|0|||
161631650|NCT01470599|583703498|FG000|Overall Study|Lost to Follow-up|2|||
161631651|NCT01470599|583703499|FG001|Overall Study|Lost to Follow-up|1|||
161631652|NCT01470599|583703498|FG000|Overall Study|Withdrawal by Subject|3|||
161631653|NCT01470599|583703499|FG001|Overall Study|Withdrawal by Subject|4|||
161631654|NCT01470599|583703498|FG000|Overall Study|Other|1|||
161631655|NCT01470599|583703499|FG001|Overall Study|Other|0|||
161631656|NCT01470599|583703498|FG000|Overall Study|Protocol Violation|3|||
161631657|NCT01470599|583703499|FG001|Overall Study|Protocol Violation|1|||
161631658|NCT01470599|583703498|FG000|Overall Study|Adverse event related to study drug|2|||
161631659|NCT01470599|583703499|FG001|Overall Study|Adverse event related to study drug|5|||
161631660|NCT01470599|583703498|FG000|Overall Study|Insufficient clinical response|6|||
161631661|NCT01470599|583703499|FG001|Overall Study|Insufficient clinical response|27|||
161631662|NCT01470599|583703498|FG000|Overall Study|Adverse event not related to study drug|1|||
161631663|NCT01470599|583703499|FG001|Overall Study|Adverse event not related to study drug|5|||
161631664|NCT00195442|583703500|FG000|Overall Study|Less than expected therapeutic effect|38|||
161631665|NCT00195442|583703500|FG000|Overall Study|Lost to Follow-up|27|||
161631666|NCT00195442|583703500|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
161631667|NCT00195442|583703500|FG000|Overall Study|Intermittent product shortage|21|||
161631668|NCT00195442|583703500|FG000|Overall Study|Death|7|||
161631669|NCT00195442|583703500|FG000|Overall Study|No reason specified|4|||
161631670|NCT00195442|583703500|FG000|Overall Study|Poor cooperation|2|||
161631671|NCT00195442|583703500|FG000|Overall Study|Other|14|||
161631672|NCT01917006|583703501|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
161631673|NCT01917006|583703502|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
161631674|NCT01917006|583703503|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
161631675|NCT01917006|583703504|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
161631676|NCT01917006|583703505|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
161631677|NCT01917006|583703506|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
161631678|NCT01917006|583703507|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
161631679|NCT01917006|583703508|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
161631680|NCT01917006|583703501|FG000|Randomized-treatment Period|Personal Reasons|0|||
161631681|NCT01917006|583703502|FG001|Randomized-treatment Period|Personal Reasons|0|||
161631682|NCT01917006|583703503|FG002|Randomized-treatment Period|Personal Reasons|0|||
161631683|NCT01917006|583703504|FG003|Randomized-treatment Period|Personal Reasons|0|||
161631684|NCT01917006|583703505|FG004|Randomized-treatment Period|Personal Reasons|0|||
161631685|NCT01917006|583703506|FG005|Randomized-treatment Period|Personal Reasons|1|||
161631686|NCT01917006|583703507|FG006|Randomized-treatment Period|Personal Reasons|0|||
161631687|NCT01917006|583703508|FG007|Randomized-treatment Period|Personal Reasons|0|||
161631688|NCT01917006|583703501|FG000|Randomized-treatment Period|Protocol Violation|1|||
161631689|NCT01917006|583703502|FG001|Randomized-treatment Period|Protocol Violation|0|||
161631690|NCT01917006|583703503|FG002|Randomized-treatment Period|Protocol Violation|0|||
161631691|NCT01917006|583703504|FG003|Randomized-treatment Period|Protocol Violation|0|||
161631692|NCT01917006|583703505|FG004|Randomized-treatment Period|Protocol Violation|0|||
161631693|NCT01917006|583703506|FG005|Randomized-treatment Period|Protocol Violation|0|||
161685853|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161631694|NCT01917006|583703507|FG006|Randomized-treatment Period|Protocol Violation|0|||
161631695|NCT01917006|583703508|FG007|Randomized-treatment Period|Protocol Violation|0|||
161631696|NCT01917006|583703501|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631697|NCT01917006|583703502|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631698|NCT01917006|583703503|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631699|NCT01917006|583703504|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631700|NCT01917006|583703505|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631701|NCT01917006|583703506|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631702|NCT01917006|583703507|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
161631703|NCT01917006|583703508|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161631704|NCT01917006|583703501|FG000|Open-label Period|Adverse Event|0|||
161631705|NCT01917006|583703502|FG001|Open-label Period|Adverse Event|0|||
161631706|NCT01917006|583703503|FG002|Open-label Period|Adverse Event|0|||
161631707|NCT01917006|583703504|FG003|Open-label Period|Adverse Event|0|||
161631708|NCT01917006|583703505|FG004|Open-label Period|Adverse Event|0|||
161631709|NCT01917006|583703506|FG005|Open-label Period|Adverse Event|0|||
161631710|NCT01917006|583703507|FG006|Open-label Period|Adverse Event|0|||
161631711|NCT01917006|583703508|FG007|Open-label Period|Adverse Event|1|||
161631712|NCT01917006|583703501|FG000|Open-label Period|Lost to Follow-up|0|||
161631713|NCT01917006|583703502|FG001|Open-label Period|Lost to Follow-up|0|||
161631714|NCT01917006|583703503|FG002|Open-label Period|Lost to Follow-up|0|||
161631715|NCT01917006|583703504|FG003|Open-label Period|Lost to Follow-up|0|||
161631716|NCT01917006|583703505|FG004|Open-label Period|Lost to Follow-up|0|||
161631717|NCT01917006|583703506|FG005|Open-label Period|Lost to Follow-up|0|||
161631718|NCT01917006|583703507|FG006|Open-label Period|Lost to Follow-up|0|||
161631719|NCT01917006|583703508|FG007|Open-label Period|Lost to Follow-up|1|||
161631720|NCT02158247|583703514|FG000|Overall Study|Invisible vocal cords|5|||
161631721|NCT00702650|583703515|FG000|Overall Study|Withdrawal by Subject|9|||
161631722|NCT00702650|583703515|FG000|Overall Study|Non-Compliance of Study Drug|3|||
161631723|NCT00702650|583703515|FG000|Overall Study|Lost to Follow-up|2|||
161631724|NCT00702650|583703515|FG000|Overall Study|Non-Compliance with Site Directives|1|||
161631725|NCT00702650|583703515|FG000|Overall Study|Sponsor Request|1|||
161631726|NCT00702650|583703515|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
161631727|NCT00702650|583703515|FG000|Overall Study|Adverse Event|3|||
161631728|NCT00943722|583703517|FG000|Base Study|Adverse Event|0|||
161631729|NCT00943722|583703518|FG001|Base Study|Adverse Event|0|||
161631730|NCT00943722|583703519|FG002|Base Study|Adverse Event|0|||
161631731|NCT00943722|583703520|FG003|Base Study|Adverse Event|1|||
161631732|NCT00943722|583703521|FG004|Base Study|Adverse Event|0|||
161631733|NCT00943722|583703522|FG005|Base Study|Adverse Event|0|||
161631734|NCT00943722|583703523|FG006|Base Study|Adverse Event|0|||
161631735|NCT00943722|583703517|FG000|Base Study|Lost to Follow-up|12|||
161631736|NCT00943722|583703518|FG001|Base Study|Lost to Follow-up|8|||
161631737|NCT00943722|583703519|FG002|Base Study|Lost to Follow-up|10|||
161631738|NCT00943722|583703520|FG003|Base Study|Lost to Follow-up|8|||
161631739|NCT00943722|583703521|FG004|Base Study|Lost to Follow-up|11|||
161631740|NCT00943722|583703522|FG005|Base Study|Lost to Follow-up|0|||
161631741|NCT00943722|583703523|FG006|Base Study|Lost to Follow-up|0|||
161631742|NCT00943722|583703517|FG000|Base Study|Physician Decision|1|||
161631743|NCT00943722|583703518|FG001|Base Study|Physician Decision|0|||
161631744|NCT00943722|583703519|FG002|Base Study|Physician Decision|0|||
161631745|NCT00943722|583703520|FG003|Base Study|Physician Decision|0|||
161631746|NCT00943722|583703521|FG004|Base Study|Physician Decision|1|||
161631747|NCT00943722|583703522|FG005|Base Study|Physician Decision|0|||
161631748|NCT00943722|583703523|FG006|Base Study|Physician Decision|0|||
161631749|NCT00943722|583703517|FG000|Base Study|Pregnancy|0|||
161631750|NCT00943722|583703518|FG001|Base Study|Pregnancy|0|||
161631751|NCT00943722|583703519|FG002|Base Study|Pregnancy|1|||
161631752|NCT00943722|583703520|FG003|Base Study|Pregnancy|0|||
161631753|NCT00943722|583703521|FG004|Base Study|Pregnancy|2|||
161631754|NCT00943722|583703522|FG005|Base Study|Pregnancy|0|||
161631755|NCT00943722|583703523|FG006|Base Study|Pregnancy|0|||
161631756|NCT00943722|583703517|FG000|Base Study|Protocol Violation|0|||
161631757|NCT00943722|583703518|FG001|Base Study|Protocol Violation|1|||
161631758|NCT00943722|583703519|FG002|Base Study|Protocol Violation|0|||
161631759|NCT00943722|583703520|FG003|Base Study|Protocol Violation|0|||
161631760|NCT00943722|583703521|FG004|Base Study|Protocol Violation|2|||
161631761|NCT00943722|583703522|FG005|Base Study|Protocol Violation|0|||
161631762|NCT00943722|583703523|FG006|Base Study|Protocol Violation|0|||
161631763|NCT00943722|583703517|FG000|Base Study|Withdrawal by Subject|12|||
161631764|NCT00943722|583703518|FG001|Base Study|Withdrawal by Subject|13|||
161631765|NCT00943722|583703519|FG002|Base Study|Withdrawal by Subject|2|||
161631766|NCT00943722|583703520|FG003|Base Study|Withdrawal by Subject|13|||
161631767|NCT00943722|583703521|FG004|Base Study|Withdrawal by Subject|8|||
161631768|NCT00943722|583703522|FG005|Base Study|Withdrawal by Subject|0|||
161631769|NCT00943722|583703523|FG006|Base Study|Withdrawal by Subject|0|||
161631770|NCT00943722|583703517|FG000|Base Study|Month 12 visit not completed|0|||
161631771|NCT00943722|583703518|FG001|Base Study|Month 12 visit not completed|0|||
161833703|NCT02566993|584433203|FG001|Overall Study|Screening failure|0|||
161833704|NCT02566993|584433202|FG000|Overall Study|Lost to Follow-up|0|||
161833705|NCT02566993|584433203|FG001|Overall Study|Lost to Follow-up|1|||
161833706|NCT02566993|584433202|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
161833707|NCT02566993|584433203|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
161833708|NCT05206448|584433204|FG000|Overall Study|Lost to Follow-up|2|||
161833709|NCT05206448|584433205|FG001|Overall Study|Lost to Follow-up|2|||
161833710|NCT05206448|584433204|FG000|Overall Study|Withdrawal by Subject|2|||
161833711|NCT05206448|584433205|FG001|Overall Study|Withdrawal by Subject|0|||
161631772|NCT00943722|583703519|FG002|Base Study|Month 12 visit not completed|0|||
161631773|NCT00943722|583703520|FG003|Base Study|Month 12 visit not completed|0|||
161631774|NCT00943722|583703521|FG004|Base Study|Month 12 visit not completed|2|||
161631775|NCT00943722|583703522|FG005|Base Study|Month 12 visit not completed|0|||
161631776|NCT00943722|583703523|FG006|Base Study|Month 12 visit not completed|0|||
161631777|NCT00943722|583703517|FG000|First Extension Study: EXT 1|Adverse Event|0|||
161631778|NCT00943722|583703518|FG001|First Extension Study: EXT 1|Adverse Event|0|||
161631779|NCT00943722|583703519|FG002|First Extension Study: EXT 1|Adverse Event|0|||
161631780|NCT00943722|583703520|FG003|First Extension Study: EXT 1|Adverse Event|0|||
161631781|NCT00943722|583703521|FG004|First Extension Study: EXT 1|Adverse Event|0|||
161631782|NCT00943722|583703522|FG005|First Extension Study: EXT 1|Adverse Event|1|||
161631783|NCT00943722|583703523|FG006|First Extension Study: EXT 1|Adverse Event|0|||
161631784|NCT00943722|583703517|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
161631785|NCT00943722|583703518|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
161631786|NCT00943722|583703519|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
161631787|NCT00943722|583703520|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
161631788|NCT00943722|583703521|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
161631789|NCT00943722|583703522|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
161631790|NCT00943722|583703523|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
161631791|NCT00943722|583703517|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161631792|NCT00943722|583703518|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161631793|NCT00943722|583703519|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161631794|NCT00943722|583703520|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161631795|NCT00943722|583703521|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161631796|NCT00943722|583703522|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
161833712|NCT05206448|584433204|FG000|Overall Study|found ineligible after randomization|1|||
161833713|NCT05206448|584433205|FG001|Overall Study|found ineligible after randomization|1|||
161833714|NCT05206448|584433204|FG000|Overall Study|unable to complete study due to personal constraints|1|||
161833715|NCT05206448|584433205|FG001|Overall Study|unable to complete study due to personal constraints|0|||
161833716|NCT05206448|584433204|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
161833717|NCT05206448|584433205|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
161833718|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Adverse Event|1|||
161833719|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Adverse Event|2|||
161833720|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Adverse Event|0|||
161833721|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Adverse Event|0|||
161833722|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Subject choice|0|||
161833723|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Subject choice|2|||
161833724|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Subject choice|0|||
161833725|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Subject choice|0|||
161833726|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
161833727|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
161833728|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
161833729|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
161833730|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
161833731|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
161631797|NCT00943722|583703523|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
161631798|NCT00943722|583703517|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
161631799|NCT00943722|583703518|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
161631800|NCT00943722|583703519|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
161631801|NCT00943722|583703520|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
161631802|NCT00943722|583703521|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
161631803|NCT00943722|583703522|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
161631804|NCT00943722|583703523|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
161631805|NCT00943722|583703517|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
161631806|NCT00943722|583703518|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
161631807|NCT00943722|583703519|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
161631808|NCT00943722|583703520|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
161631809|NCT00943722|583703521|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
161631810|NCT00943722|583703522|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
161631811|NCT00943722|583703523|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
161833732|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
161631812|NCT00943722|583703517|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161631813|NCT00943722|583703518|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161631814|NCT00943722|583703519|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161631815|NCT00943722|583703520|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161631816|NCT00943722|583703521|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161631817|NCT00943722|583703522|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
161631818|NCT00943722|583703523|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
161631819|NCT00943722|583703517|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
161631820|NCT00943722|583703518|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
161631821|NCT00943722|583703519|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
161631822|NCT00943722|583703520|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
161631823|NCT00943722|583703521|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
161631824|NCT00943722|583703522|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
161631825|NCT00943722|583703523|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
161631826|NCT00943722|583703517|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
161631827|NCT00943722|583703518|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
161631828|NCT00943722|583703519|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
161631829|NCT00943722|583703520|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
161631830|NCT00943722|583703521|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
161631831|NCT00943722|583703522|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
161631832|NCT00943722|583703523|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
161631833|NCT00943722|583703517|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161631834|NCT00943722|583703518|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161631835|NCT00943722|583703519|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161631836|NCT00943722|583703520|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161631837|NCT00943722|583703521|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161631838|NCT00943722|583703522|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
161631839|NCT00943722|583703523|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
161631840|NCT01772823|583703524|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
161631841|NCT01772823|583703525|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
161631842|NCT01772823|583703524|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
161631843|NCT01772823|583703525|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
161631844|NCT01772823|583703524|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
161631845|NCT01772823|583703525|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
161631846|NCT01772823|583703524|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
161631847|NCT01772823|583703525|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
161631848|NCT01772823|583703524|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
161631849|NCT01772823|583703525|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
161631850|NCT01772823|583703524|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
161631851|NCT01772823|583703525|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
161631852|NCT01772823|583703524|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
161631853|NCT01772823|583703525|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
161631854|NCT01772823|583703524|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
161631855|NCT01772823|583703525|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
161631856|NCT01772823|583703524|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
161631857|NCT01772823|583703525|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
161631858|NCT01772823|583703524|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
161631859|NCT01772823|583703525|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
161631860|NCT01772823|583703524|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
161631861|NCT01772823|583703525|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
161631862|NCT01772823|583703524|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
161631863|NCT01772823|583703525|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
161631864|NCT01772823|583703524|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
161631865|NCT01772823|583703525|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
161631866|NCT01772823|583703524|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
161631867|NCT01772823|583703525|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
161631868|NCT01772823|583703524|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
161631869|NCT01772823|583703525|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
161631870|NCT01772823|583703524|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
161631871|NCT01772823|583703525|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
161631872|NCT01004185|583703526|FG000|Overall Study|Adverse Event|1|||
161631873|NCT01004185|583703527|FG001|Overall Study|Adverse Event|1|||
161631874|NCT01004185|583703526|FG000|Overall Study|Lost to Follow-up|0|||
161631875|NCT01004185|583703527|FG001|Overall Study|Lost to Follow-up|1|||
161631876|NCT01004185|583703526|FG000|Overall Study|Lack of Efficacy|2|||
161685854|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161631877|NCT01004185|583703527|FG001|Overall Study|Lack of Efficacy|1|||
161631878|NCT01004185|583703526|FG000|Overall Study|Sponsor Terminated Study|4|||
161631879|NCT01004185|583703527|FG001|Overall Study|Sponsor Terminated Study|5|||
161631880|NCT01004185|583703526|FG000|Overall Study|Withdrawal by Subject|2|||
161631881|NCT01004185|583703527|FG001|Overall Study|Withdrawal by Subject|1|||
161631882|NCT02560389|583703532|FG000|Overall Study|Lost to Follow-up|1|||
161631883|NCT02560389|583703533|FG001|Overall Study|Lost to Follow-up|2|||
161631884|NCT02560389|583703534|FG002|Overall Study|Lost to Follow-up|2|||
161631885|NCT02560389|583703532|FG000|Overall Study|Tested positive for illicit substance|0|||
161631886|NCT02560389|583703533|FG001|Overall Study|Tested positive for illicit substance|1|||
161631887|NCT02560389|583703534|FG002|Overall Study|Tested positive for illicit substance|0|||
161631888|NCT02716298|583703535|FG000|First Intervention (1 Month)|Lens discomfort|1|||
161631889|NCT02716298|583703536|FG001|First Intervention (1 Month)|Lens discomfort|1|||
161631890|NCT00713206|583703539|FG000|Overall Study|Lost to Follow-up|4|||
161631891|NCT00713206|583703540|FG001|Overall Study|Lost to Follow-up|4|||
161631892|NCT00713206|583703539|FG000|Overall Study|Death|1|||
161631893|NCT00713206|583703540|FG001|Overall Study|Death|0|||
161631894|NCT04081389|583703547|FG000|Overall Study|Withdrawal by Subject|0|||
161631895|NCT04081389|583703548|FG001|Overall Study|Withdrawal by Subject|0|||
161631896|NCT04081389|583703549|FG002|Overall Study|Withdrawal by Subject|1|||
161631897|NCT04081389|583703550|FG003|Overall Study|Withdrawal by Subject|0|||
161631898|NCT01114672|583703551|FG000|Overall Study|Death|0|||
161631899|NCT01114672|583703552|FG001|Overall Study|Death|1|||
161631900|NCT01114672|583703551|FG000|Overall Study|Withdrawal by Subject|2|||
161631901|NCT01114672|583703552|FG001|Overall Study|Withdrawal by Subject|1|||
161631902|NCT01114672|583703551|FG000|Overall Study|Lost to Follow-up|1|||
161631903|NCT01114672|583703552|FG001|Overall Study|Lost to Follow-up|0|||
161631904|NCT01114672|583703551|FG000|Overall Study|transplanted|1|||
161631905|NCT01114672|583703552|FG001|Overall Study|transplanted|0|||
161631906|NCT02212301|583703553|FG000|Period 1|Lost to Follow-up|0|||
161631907|NCT02212301|583703554|FG001|Period 1|Lost to Follow-up|1|||
161631908|NCT00866918|583703557|FG000|Overall Study|Death|1|||
161631909|NCT00866918|583703558|FG001|Overall Study|Death|5|||
161631910|NCT00866918|583703557|FG000|Overall Study|Lack of Efficacy|1|||
161631911|NCT00866918|583703558|FG001|Overall Study|Lack of Efficacy|1|||
161631912|NCT00866918|583703557|FG000|Overall Study|Physician Decision|10|||
161631913|NCT00866918|583703558|FG001|Overall Study|Physician Decision|2|||
161631914|NCT00866918|583703557|FG000|Overall Study|Ineligible|2|||
161631915|NCT00866918|583703558|FG001|Overall Study|Ineligible|4|||
161631916|NCT00866918|583703557|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
161631917|NCT00866918|583703558|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
161631918|NCT00866918|583703557|FG000|Overall Study|Secondary malignancy|1|||
161631919|NCT00866918|583703558|FG001|Overall Study|Secondary malignancy|0|||
161631920|NCT03041701|583703560|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
161631921|NCT03041701|583703561|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
161631922|NCT03041701|583703562|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
161631923|NCT03041701|583703560|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
161631924|NCT03041701|583703561|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
161631925|NCT03041701|583703562|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
161631926|NCT00527514|583703563|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
161631927|NCT00527514|583703563|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
161631928|NCT00527514|583703563|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
161631929|NCT00527514|583703563|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
161631930|NCT00527514|583703563|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
161631931|NCT00527514|583703563|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
161631932|NCT00527514|583703563|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
161631933|NCT00920699|583703569|FG000|Overall Study|Withdrawal by Subject|2|||
161631934|NCT00920699|583703570|FG001|Overall Study|Withdrawal by Subject|0|||
161631935|NCT00920699|583703571|FG002|Overall Study|Withdrawal by Subject|2|||
161631936|NCT00920699|583703569|FG000|Overall Study|no longer met eligibility|0|||
161631937|NCT00920699|583703570|FG001|Overall Study|no longer met eligibility|1|||
161631938|NCT00920699|583703571|FG002|Overall Study|no longer met eligibility|0|||
161631939|NCT00920699|583703569|FG000|Overall Study|Lost to Follow-up|0|||
161631940|NCT00920699|583703570|FG001|Overall Study|Lost to Follow-up|0|||
161631941|NCT00920699|583703571|FG002|Overall Study|Lost to Follow-up|2|||
161685855|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
161833733|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
161631942|NCT02287883|583703575|FG000|Overall Study|Death|8|||
161631943|NCT02287883|583703576|FG001|Overall Study|Death|7|||
161631944|NCT02287883|583703575|FG000|Overall Study|No longer eligible|222|||
161631945|NCT02287883|583703576|FG001|Overall Study|No longer eligible|182|||
161631946|NCT02287883|583703575|FG000|Overall Study|Non-response to survey|229|||
161631947|NCT02287883|583703576|FG001|Overall Study|Non-response to survey|237|||
161631948|NCT00802438|583703582|FG000|Overall Study|Screen Failure|20|||
161631949|NCT00802438|583703582|FG000|Overall Study|Withdrawal by Subject|7|||
161631950|NCT00802438|583703582|FG000|Overall Study|Physician Decision|1|||
161631951|NCT01281917|583703583|FG000|Overall Study|Withdrawal by Subject|1|||
161631952|NCT04016805|583703585|FG000|Overall Study|Sponsor's Discretion|30|||
161631953|NCT04016805|583703586|FG001|Overall Study|Sponsor's Discretion|6|||
161631954|NCT04016805|583703587|FG002|Overall Study|Sponsor's Discretion|5|||
161631955|NCT02101268|583703590|FG000|Randomized Treatment Phase|Subject Decision|8|||
161631956|NCT02101268|583703591|FG001|Randomized Treatment Phase|Subject Decision|4|||
161631957|NCT02101268|583703592|FG002|Randomized Treatment Phase|Subject Decision|0|||
161631958|NCT02101268|583703593|FG003|Randomized Treatment Phase|Subject Decision|0|||
161631959|NCT02101268|583703590|FG000|Randomized Treatment Phase|Physician Decision|4|||
161631960|NCT02101268|583703591|FG001|Randomized Treatment Phase|Physician Decision|1|||
161631961|NCT02101268|583703592|FG002|Randomized Treatment Phase|Physician Decision|0|||
161631962|NCT02101268|583703593|FG003|Randomized Treatment Phase|Physician Decision|0|||
161631963|NCT02101268|583703590|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
161631964|NCT02101268|583703591|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
161631965|NCT02101268|583703592|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
161631966|NCT02101268|583703593|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
161631967|NCT02101268|583703590|FG000|Randomized Treatment Phase|Adverse Event|6|||
161631968|NCT02101268|583703591|FG001|Randomized Treatment Phase|Adverse Event|0|||
161631969|NCT02101268|583703592|FG002|Randomized Treatment Phase|Adverse Event|0|||
161631970|NCT02101268|583703593|FG003|Randomized Treatment Phase|Adverse Event|0|||
161631971|NCT02101268|583703590|FG000|Randomized Treatment Phase|Death|5|||
161631972|NCT02101268|583703591|FG001|Randomized Treatment Phase|Death|4|||
161631973|NCT02101268|583703592|FG002|Randomized Treatment Phase|Death|0|||
161631974|NCT02101268|583703593|FG003|Randomized Treatment Phase|Death|0|||
161631975|NCT02101268|583703590|FG000|Randomized Treatment Phase|Disease Progression|4|||
161631976|NCT02101268|583703591|FG001|Randomized Treatment Phase|Disease Progression|1|||
161631977|NCT02101268|583703592|FG002|Randomized Treatment Phase|Disease Progression|0|||
161631978|NCT02101268|583703593|FG003|Randomized Treatment Phase|Disease Progression|0|||
161631979|NCT02101268|583703590|FG000|Extended Treatment Phase|Subject Decision|0|||
161631980|NCT02101268|583703591|FG001|Extended Treatment Phase|Subject Decision|0|||
161631981|NCT02101268|583703592|FG002|Extended Treatment Phase|Subject Decision|3|||
161631982|NCT02101268|583703593|FG003|Extended Treatment Phase|Subject Decision|2|||
161631983|NCT02101268|583703590|FG000|Extended Treatment Phase|Physician Decision|0|||
161631984|NCT02101268|583703591|FG001|Extended Treatment Phase|Physician Decision|0|||
161631985|NCT02101268|583703592|FG002|Extended Treatment Phase|Physician Decision|5|||
161631986|NCT02101268|583703593|FG003|Extended Treatment Phase|Physician Decision|2|||
161631987|NCT02101268|583703590|FG000|Extended Treatment Phase|Adverse Event|0|||
161631988|NCT02101268|583703591|FG001|Extended Treatment Phase|Adverse Event|0|||
161631989|NCT02101268|583703592|FG002|Extended Treatment Phase|Adverse Event|14|||
161631990|NCT02101268|583703593|FG003|Extended Treatment Phase|Adverse Event|18|||
161631991|NCT02101268|583703590|FG000|Extended Treatment Phase|Death|0|||
161631992|NCT02101268|583703591|FG001|Extended Treatment Phase|Death|0|||
161631993|NCT02101268|583703592|FG002|Extended Treatment Phase|Death|5|||
161631994|NCT02101268|583703593|FG003|Extended Treatment Phase|Death|1|||
161631995|NCT02101268|583703590|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
161631996|NCT02101268|583703591|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
161631997|NCT02101268|583703592|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
161631998|NCT02101268|583703593|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
161685856|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161685857|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
161685858|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161685859|NCT01624662|583901988|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161685860|NCT01624662|583901989|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161685861|NCT01624662|583901990|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161685862|NCT01624662|583901991|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161685863|NCT01624662|583901988|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161685864|NCT01624662|583901989|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
161631999|NCT02101268|583703590|FG000|Extended Treatment Phase|Disease Progression|0|||
161632000|NCT02101268|583703591|FG001|Extended Treatment Phase|Disease Progression|0|||
161632001|NCT02101268|583703592|FG002|Extended Treatment Phase|Disease Progression|13|||
161632002|NCT02101268|583703593|FG003|Extended Treatment Phase|Disease Progression|6|||
161632003|NCT02101268|583703590|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
161632004|NCT02101268|583703591|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
161632005|NCT02101268|583703592|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
161632006|NCT02101268|583703593|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
161632007|NCT00740870|583703594|FG000|Overall Study|Not Catheterized|4|||
161632008|NCT00740870|583703594|FG000|Overall Study|Further testing contraindicated implant|17|||
161632009|NCT00819013|583703595|FG000|Overall Study|Not meeting continuing study eligibility|2|||
161632010|NCT00819013|583703596|FG001|Overall Study|Not meeting continuing study eligibility|1|||
161632011|NCT00819013|583703597|FG002|Overall Study|Not meeting continuing study eligibility|2|||
161632012|NCT00819013|583703598|FG003|Overall Study|Not meeting continuing study eligibility|1|||
161632013|NCT00819013|583703595|FG000|Overall Study|Adverse Event|0|||
161632014|NCT00819013|583703596|FG001|Overall Study|Adverse Event|0|||
161632015|NCT00819013|583703597|FG002|Overall Study|Adverse Event|1|||
161632016|NCT00819013|583703598|FG003|Overall Study|Adverse Event|0|||
161632017|NCT00819013|583703595|FG000|Overall Study|Withdrawal by Subject|1|||
161632018|NCT00819013|583703596|FG001|Overall Study|Withdrawal by Subject|0|||
161632019|NCT00819013|583703597|FG002|Overall Study|Withdrawal by Subject|1|||
161632020|NCT00819013|583703598|FG003|Overall Study|Withdrawal by Subject|0|||
161632021|NCT00819013|583703595|FG000|Overall Study|Lost to Follow-up|0|||
161632022|NCT00819013|583703596|FG001|Overall Study|Lost to Follow-up|0|||
161632023|NCT00819013|583703597|FG002|Overall Study|Lost to Follow-up|1|||
161632024|NCT00819013|583703598|FG003|Overall Study|Lost to Follow-up|2|||
161632025|NCT00819013|583703595|FG000|Overall Study|Death|0|||
161632026|NCT00819013|583703596|FG001|Overall Study|Death|0|||
161632027|NCT00819013|583703597|FG002|Overall Study|Death|0|||
161632028|NCT00819013|583703598|FG003|Overall Study|Death|1|||
161632029|NCT00576823|583703599|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
161632030|NCT00576823|583703600|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
161632031|NCT00576823|583703601|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
161632032|NCT00576823|583703599|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
161632033|NCT00576823|583703600|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
161632034|NCT00576823|583703601|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
161632035|NCT02132117|583703603|FG000|Overall Study|Adverse Event|6|||
161632036|NCT02132117|583703604|FG001|Overall Study|Adverse Event|1|||
161632037|NCT02132117|583703603|FG000|Overall Study|Lost to Follow-up|2|||
161632038|NCT02132117|583703604|FG001|Overall Study|Lost to Follow-up|2|||
161632039|NCT02132117|583703603|FG000|Overall Study|Personal Reasons|1|||
161632040|NCT02132117|583703604|FG001|Overall Study|Personal Reasons|2|||
161632041|NCT02132117|583703603|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161632042|NCT02132117|583703604|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161632043|NCT04947436|583703606|FG000|Overall Study|Lost to Follow-up|3|||
161632044|NCT04947436|583703607|FG001|Overall Study|Lost to Follow-up|7|||
161632045|NCT04947436|583703608|FG002|Overall Study|Lost to Follow-up|5|||
161632046|NCT04947436|583703606|FG000|Overall Study|Death|1|||
161632047|NCT04947436|583703607|FG001|Overall Study|Death|1|||
161632048|NCT04947436|583703608|FG002|Overall Study|Death|1|||
161632049|NCT01544309|583703611|FG000|Overall Study|Withdrawal by Subject|12|||
161632050|NCT01544309|583703612|FG001|Overall Study|Withdrawal by Subject|7|||
161632051|NCT01544309|583703611|FG000|Overall Study|Protocol Violation|2|||
161632052|NCT01544309|583703612|FG001|Overall Study|Protocol Violation|1|||
161632053|NCT01544309|583703611|FG000|Overall Study|Physician Decision|4|||
161632054|NCT01544309|583703612|FG001|Overall Study|Physician Decision|1|||
161632055|NCT01544309|583703611|FG000|Overall Study|Not performed pre-dose examination|1|||
161632056|NCT01544309|583703612|FG001|Overall Study|Not performed pre-dose examination|2|||
161632057|NCT01544309|583703611|FG000|Overall Study|Administered prohibit prior medication|1|||
161632058|NCT01544309|583703612|FG001|Overall Study|Administered prohibit prior medication|0|||
161632059|NCT01196741|583703613|FG000|Overall Study|Disease progression|34|||
161632060|NCT01196741|583703614|FG001|Overall Study|Disease progression|14|||
161632061|NCT01196741|583703613|FG000|Overall Study|Adverse Event|10|||
161632062|NCT01196741|583703614|FG001|Overall Study|Adverse Event|6|||
161632063|NCT01196741|583703613|FG000|Overall Study|Serious Adverse Event|3|||
161632064|NCT01196741|583703614|FG001|Overall Study|Serious Adverse Event|1|||
161632065|NCT01196741|583703613|FG000|Overall Study|Dose limiting Adverse Event|2|||
161632066|NCT01196741|583703614|FG001|Overall Study|Dose limiting Adverse Event|1|||
161632067|NCT01196741|583703613|FG000|Overall Study|Withdrawal by Subject|3|||
161632068|NCT01196741|583703614|FG001|Overall Study|Withdrawal by Subject|0|||
161632069|NCT01196741|583703613|FG000|Overall Study|Other reason|3|||
161632070|NCT01196741|583703614|FG001|Overall Study|Other reason|3|||
161632071|NCT01196741|583703613|FG000|Overall Study|Other|3|||
161632072|NCT01196741|583703614|FG001|Overall Study|Other|2|||
161632073|NCT01196741|583703613|FG000|Overall Study|Protocol Violation|2|||
161632074|NCT01196741|583703614|FG001|Overall Study|Protocol Violation|1|||
161632075|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
161632076|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
161632077|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
161632078|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Other|1|||
161632079|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Other|0|||
161632080|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Other|0|||
161632081|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Physician Decision|3|||
161632082|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Physician Decision|0|||
161632083|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Physician Decision|0|||
161632084|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
161632085|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
161632086|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
161632087|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
161632088|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
161632089|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
161632090|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Adverse Event|18|||
161632091|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Adverse Event|0|||
161632092|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Adverse Event|0|||
161632093|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
161632094|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
161632095|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
161632096|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
161632097|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
161632098|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
161632099|NCT03030599|583703615|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
161632100|NCT03030599|583703616|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
161632101|NCT03030599|583703617|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
161632102|NCT03030599|583703615|FG000|Stable Dose|Protocol deviation|3|||
161632103|NCT03030599|583703616|FG001|Stable Dose|Protocol deviation|0|||
161632104|NCT03030599|583703617|FG002|Stable Dose|Protocol deviation|0|||
161632105|NCT03030599|583703615|FG000|Stable Dose|Adverse Event|1|||
161632106|NCT03030599|583703616|FG001|Stable Dose|Adverse Event|0|||
161632107|NCT03030599|583703617|FG002|Stable Dose|Adverse Event|0|||
161632108|NCT03030599|583703615|FG000|Stable Dose|Lost to Follow-up|1|||
161632109|NCT03030599|583703616|FG001|Stable Dose|Lost to Follow-up|0|||
161632110|NCT03030599|583703617|FG002|Stable Dose|Lost to Follow-up|0|||
161632111|NCT03030599|583703615|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
161632112|NCT03030599|583703616|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
161632113|NCT03030599|583703617|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
161632114|NCT03030599|583703615|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
161632115|NCT03030599|583703616|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
161632116|NCT03030599|583703617|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
161632117|NCT03030599|583703615|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
161632118|NCT03030599|583703616|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
161833734|NCT01661881|584433212|FG000|Overall Study|Disease Progression|1|||
161632119|NCT03030599|583703617|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
161632120|NCT03030599|583703615|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
161632121|NCT03030599|583703616|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
161632122|NCT03030599|583703617|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
161632123|NCT03030599|583703615|FG000|Open-label Extension|Adverse Event|3|||
161632124|NCT03030599|583703616|FG001|Open-label Extension|Adverse Event|0|||
161632125|NCT03030599|583703617|FG002|Open-label Extension|Adverse Event|0|||
161632126|NCT03030599|583703615|FG000|Open-label Extension|Lost to Follow-up|2|||
161632127|NCT03030599|583703616|FG001|Open-label Extension|Lost to Follow-up|0|||
161632128|NCT03030599|583703617|FG002|Open-label Extension|Lost to Follow-up|0|||
161632129|NCT03030599|583703615|FG000|Open-label Extension|Lack of Efficacy|1|||
161632130|NCT03030599|583703616|FG001|Open-label Extension|Lack of Efficacy|0|||
161632131|NCT03030599|583703617|FG002|Open-label Extension|Lack of Efficacy|0|||
161632132|NCT03030599|583703615|FG000|Open-label Extension|Other Reason|1|||
161632133|NCT03030599|583703616|FG001|Open-label Extension|Other Reason|0|||
161632134|NCT03030599|583703617|FG002|Open-label Extension|Other Reason|0|||
161632135|NCT01592383|583703618|FG000|Overall Study|Adverse Event|1|||
161632136|NCT04582864|583703619|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
161632137|NCT04582864|583703619|FG000|Overall Study|Death|1|||
161632138|NCT01064856|583703620|FG000|Double-blind (DB) Period|Adverse Event|1|||
161632139|NCT01064856|583703621|FG001|Double-blind (DB) Period|Adverse Event|0|||
161632140|NCT01064856|583703622|FG002|Double-blind (DB) Period|Adverse Event|0|||
161632141|NCT01064856|583703623|FG003|Double-blind (DB) Period|Adverse Event|0|||
161632142|NCT01064856|583703620|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
161632143|NCT01064856|583703621|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
161632144|NCT01064856|583703622|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
161632145|NCT01064856|583703623|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
161632146|NCT01064856|583703620|FG000|Open-label (OL) Period|Adverse Event|0|||
161632147|NCT01064856|583703621|FG001|Open-label (OL) Period|Adverse Event|0|||
161632148|NCT01064856|583703622|FG002|Open-label (OL) Period|Adverse Event|12|||
161632149|NCT01064856|583703623|FG003|Open-label (OL) Period|Adverse Event|6|||
161632150|NCT01064856|583703620|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
161632151|NCT01064856|583703621|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
161632152|NCT01064856|583703622|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
161632153|NCT01064856|583703623|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
161632154|NCT01064856|583703620|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
161632155|NCT01064856|583703621|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
161632156|NCT01064856|583703622|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
161632157|NCT01064856|583703623|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
161632158|NCT01064856|583703620|FG000|Open-label (OL) Period|Other|0|||
161685865|NCT01624662|583901990|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161685866|NCT01624662|583901991|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161685867|NCT01624662|583901988|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161685868|NCT01624662|583901989|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161685869|NCT01624662|583901990|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161685870|NCT01624662|583901991|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161685871|NCT00361270|583901992|FG000|Overall Study|Death|0|||
161685872|NCT00361270|583901993|FG001|Overall Study|Death|0|||
161685873|NCT00361270|583901994|FG002|Overall Study|Death|0|||
161685874|NCT00361270|583901995|FG003|Overall Study|Death|2|||
161632159|NCT01064856|583703621|FG001|Open-label (OL) Period|Other|0|||
161632160|NCT01064856|583703622|FG002|Open-label (OL) Period|Other|7|||
161632161|NCT01064856|583703623|FG003|Open-label (OL) Period|Other|7|||
161632162|NCT02133131|583703624|FG000|Overall Study|Adverse Event|0|||
161632163|NCT02133131|583703625|FG001|Overall Study|Adverse Event|0|||
161632164|NCT02133131|583703626|FG002|Overall Study|Adverse Event|0|||
161632165|NCT02133131|583703627|FG003|Overall Study|Adverse Event|1|||
161632166|NCT02133131|583703628|FG004|Overall Study|Adverse Event|0|||
161685875|NCT00361270|583901992|FG000|Overall Study|Lost to Follow-up|4|||
161685876|NCT00361270|583901993|FG001|Overall Study|Lost to Follow-up|1|||
161632167|NCT02133131|583703629|FG005|Overall Study|Adverse Event|0|||
161632168|NCT02133131|583703630|FG006|Overall Study|Adverse Event|0|||
161632169|NCT02133131|583703624|FG000|Overall Study|Lost to Follow-up|1|||
161632170|NCT02133131|583703625|FG001|Overall Study|Lost to Follow-up|0|||
161632171|NCT02133131|583703626|FG002|Overall Study|Lost to Follow-up|0|||
161632172|NCT02133131|583703627|FG003|Overall Study|Lost to Follow-up|1|||
161632173|NCT02133131|583703628|FG004|Overall Study|Lost to Follow-up|0|||
161632174|NCT02133131|583703629|FG005|Overall Study|Lost to Follow-up|0|||
161632175|NCT02133131|583703630|FG006|Overall Study|Lost to Follow-up|0|||
161632176|NCT02133131|583703624|FG000|Overall Study|Status not recorded|4|||
161632177|NCT02133131|583703625|FG001|Overall Study|Status not recorded|5|||
161632178|NCT02133131|583703626|FG002|Overall Study|Status not recorded|1|||
161632179|NCT02133131|583703627|FG003|Overall Study|Status not recorded|4|||
161632180|NCT02133131|583703628|FG004|Overall Study|Status not recorded|0|||
161632181|NCT02133131|583703629|FG005|Overall Study|Status not recorded|0|||
161632182|NCT02133131|583703630|FG006|Overall Study|Status not recorded|0|||
161632183|NCT02133131|583703624|FG000|Overall Study|Ongoing in study|0|||
161632184|NCT02133131|583703625|FG001|Overall Study|Ongoing in study|0|||
161632185|NCT02133131|583703626|FG002|Overall Study|Ongoing in study|0|||
161632186|NCT02133131|583703627|FG003|Overall Study|Ongoing in study|0|||
161632187|NCT02133131|583703628|FG004|Overall Study|Ongoing in study|15|||
161632188|NCT02133131|583703629|FG005|Overall Study|Ongoing in study|14|||
161632189|NCT02133131|583703630|FG006|Overall Study|Ongoing in study|11|||
161632190|NCT02133131|583703624|FG000|Overall Study|Protocol Violation|0|||
161632191|NCT02133131|583703625|FG001|Overall Study|Protocol Violation|0|||
161632192|NCT02133131|583703626|FG002|Overall Study|Protocol Violation|0|||
161632193|NCT02133131|583703627|FG003|Overall Study|Protocol Violation|0|||
161632194|NCT02133131|583703628|FG004|Overall Study|Protocol Violation|0|||
161632195|NCT02133131|583703629|FG005|Overall Study|Protocol Violation|0|||
161632196|NCT02133131|583703630|FG006|Overall Study|Protocol Violation|1|||
161632197|NCT01679613|583703633|FG000|Overall Study|other than stated above|0|||
161632198|NCT01679613|583703634|FG001|Overall Study|other than stated above|1|||
161632199|NCT01679613|583703635|FG002|Overall Study|other than stated above|2|||
161632200|NCT01679613|583703636|FG003|Overall Study|other than stated above|2|||
161632201|NCT00509925|583703638|FG000|Overall Study|Personal reasons|0|||
161632202|NCT00509925|583703639|FG001|Overall Study|Personal reasons|1|||
161632203|NCT00951171|583703642|FG000|Overall Study|Adverse Event|2|||
161632204|NCT00951171|583703643|FG001|Overall Study|Adverse Event|0|||
161632205|NCT01932762|583705564|FG000|Overall Study|Withdrawal by Subject|1|||
161632206|NCT01932762|583705565|FG001|Overall Study|Withdrawal by Subject|2|||
161632207|NCT01932762|583705566|FG002|Overall Study|Withdrawal by Subject|0|||
161632208|NCT01932762|583705567|FG003|Overall Study|Withdrawal by Subject|0|||
161632209|NCT01932762|583705564|FG000|Overall Study|Lost to Follow-up|4|||
161632210|NCT01932762|583705565|FG001|Overall Study|Lost to Follow-up|0|||
161632211|NCT01932762|583705566|FG002|Overall Study|Lost to Follow-up|0|||
161632212|NCT01932762|583705567|FG003|Overall Study|Lost to Follow-up|1|||
161632213|NCT01932762|583705564|FG000|Overall Study|Physician Decision|1|||
161632214|NCT01932762|583705565|FG001|Overall Study|Physician Decision|0|||
161632215|NCT01932762|583705566|FG002|Overall Study|Physician Decision|0|||
161632216|NCT01932762|583705567|FG003|Overall Study|Physician Decision|0|||
161632217|NCT00695136|583705568|FG000|Overall Study|Withdrawal by Subject|1|||
161632218|NCT00695136|583705568|FG000|Overall Study|unrelated adverse event|1|||
161632219|NCT01333111|583705572|FG000|Overall Study|patient undergoing major surgery|0|||
161632220|NCT01333111|583705573|FG001|Overall Study|patient undergoing major surgery|2|||
161632221|NCT01333111|583705574|FG002|Overall Study|patient undergoing major surgery|0|||
161632222|NCT01333111|583705572|FG000|Overall Study|personal reasons|0|||
161632223|NCT01333111|583705573|FG001|Overall Study|personal reasons|0|||
161632224|NCT01333111|583705574|FG002|Overall Study|personal reasons|1|||
161632225|NCT01333111|583705572|FG000|Overall Study|unclassified|1|||
161632226|NCT01333111|583705573|FG001|Overall Study|unclassified|0|||
161632227|NCT01333111|583705574|FG002|Overall Study|unclassified|0|||
161632228|NCT01333111|583705572|FG000|Overall Study|withdrawal criteria|0|||
161632229|NCT01333111|583705573|FG001|Overall Study|withdrawal criteria|1|||
161632230|NCT01333111|583705574|FG002|Overall Study|withdrawal criteria|0|||
161632231|NCT01333111|583705572|FG000|Overall Study|Non-compliance|1|||
161632232|NCT01333111|583705573|FG001|Overall Study|Non-compliance|0|||
161632233|NCT01333111|583705574|FG002|Overall Study|Non-compliance|0|||
161632234|NCT01333111|583705572|FG000|Overall Study|Ineffective therapy|0|||
161632235|NCT01333111|583705573|FG001|Overall Study|Ineffective therapy|0|||
161632236|NCT01333111|583705574|FG002|Overall Study|Ineffective therapy|1|||
161632237|NCT02161406|583705575|FG000|Overall Study|Death|2|||
161632238|NCT02161406|583705576|FG001|Overall Study|Death|1|||
161632239|NCT02161406|583705575|FG000|Overall Study|Lost to Follow-up|2|||
161632240|NCT02161406|583705576|FG001|Overall Study|Lost to Follow-up|1|||
161632241|NCT02161406|583705575|FG000|Overall Study|Withdrawal by Subject|2|||
161632242|NCT02161406|583705576|FG001|Overall Study|Withdrawal by Subject|4|||
161632243|NCT02161406|583705575|FG000|Overall Study|investigator withdrew subject|3|||
161632244|NCT02161406|583705576|FG001|Overall Study|investigator withdrew subject|1|||
161632245|NCT02161406|583705575|FG000|Overall Study|Lack of Efficacy|1|||
161632246|NCT02161406|583705576|FG001|Overall Study|Lack of Efficacy|1|||
161632247|NCT02161406|583705575|FG000|Overall Study|relocation|0|||
161632248|NCT02161406|583705576|FG001|Overall Study|relocation|1|||
161632249|NCT00664105|583705577|FG000|Overall Study|Death|3|||
161632250|NCT00664105|583705577|FG000|Overall Study|Withdrawal by Subject|5|||
161632251|NCT00664105|583705577|FG000|Overall Study|Adverse Event|9|||
161632252|NCT00664105|583705577|FG000|Overall Study|Disease progression|7|||
161632253|NCT01468077|583705580|FG000|Overall Study|Adverse Event|2|||
161632254|NCT01468077|583705581|FG001|Overall Study|Adverse Event|2|||
161632255|NCT01468077|583705580|FG000|Overall Study|Lack of Efficacy|1|||
161632256|NCT01468077|583705581|FG001|Overall Study|Lack of Efficacy|1|||
161632257|NCT01468077|583705580|FG000|Overall Study|Physician Decision|1|||
161632258|NCT01468077|583705581|FG001|Overall Study|Physician Decision|0|||
161632259|NCT05446714|583705582|FG000|Overall Study|Lost to Follow-up|1|||
161632260|NCT05446714|583705583|FG001|Overall Study|Lost to Follow-up|3|||
161632261|NCT05446714|583705584|FG002|Overall Study|Lost to Follow-up|2|||
161632262|NCT05446714|583705582|FG000|Overall Study|Protocol Violation|2|||
161632263|NCT05446714|583705583|FG001|Overall Study|Protocol Violation|0|||
161632264|NCT05446714|583705584|FG002|Overall Study|Protocol Violation|0|||
161632265|NCT03024996|583705585|FG000|Overall Study|Death|57|||
161632266|NCT03024996|583705586|FG001|Overall Study|Death|55|||
161632267|NCT03024996|583705585|FG000|Overall Study|Disease relapse|1|||
161632268|NCT03024996|583705586|FG001|Overall Study|Disease relapse|0|||
161632269|NCT03024996|583705585|FG000|Overall Study|Lost to Follow-up|5|||
161632270|NCT03024996|583705586|FG001|Overall Study|Lost to Follow-up|10|||
161632271|NCT03024996|583705585|FG000|Overall Study|Other|3|||
161632272|NCT03024996|583705586|FG001|Overall Study|Other|3|||
161632273|NCT03024996|583705585|FG000|Overall Study|Physician Decision|0|||
161632274|NCT03024996|583705586|FG001|Overall Study|Physician Decision|1|||
161632275|NCT03024996|583705585|FG000|Overall Study|Study terminated by sponsor|303|||
161632276|NCT03024996|583705586|FG001|Overall Study|Study terminated by sponsor|283|||
161632277|NCT03024996|583705585|FG000|Overall Study|Withdrawal by Subject|21|||
161632278|NCT03024996|583705586|FG001|Overall Study|Withdrawal by Subject|36|||
161632279|NCT02418845|583705589|FG000|Overall Study|Lost to Follow-up|7|||
161632280|NCT02418845|583705590|FG001|Overall Study|Lost to Follow-up|2|||
161632281|NCT02418845|583705589|FG000|Overall Study|Lack of Efficacy|0|||
161632282|NCT02418845|583705590|FG001|Overall Study|Lack of Efficacy|3|||
161632283|NCT02418845|583705589|FG000|Overall Study|Physician Decision|5|||
161685877|NCT00361270|583901994|FG002|Overall Study|Lost to Follow-up|0|||
161685878|NCT00361270|583901995|FG003|Overall Study|Lost to Follow-up|0|||
161685879|NCT00361270|583901992|FG000|Overall Study|Physician Decision|0|||
161685880|NCT00361270|583901993|FG001|Overall Study|Physician Decision|0|||
161685881|NCT00361270|583901994|FG002|Overall Study|Physician Decision|1|||
161685882|NCT00361270|583901995|FG003|Overall Study|Physician Decision|0|||
161685883|NCT00361270|583901992|FG000|Overall Study|Protocol Violation|9|||
161685884|NCT00361270|583901993|FG001|Overall Study|Protocol Violation|4|||
161685885|NCT00361270|583901994|FG002|Overall Study|Protocol Violation|5|||
161685886|NCT00361270|583901995|FG003|Overall Study|Protocol Violation|4|||
161685887|NCT00361270|583901992|FG000|Overall Study|Withdrawal by Subject|6|||
161685888|NCT00361270|583901993|FG001|Overall Study|Withdrawal by Subject|6|||
161685889|NCT00361270|583901994|FG002|Overall Study|Withdrawal by Subject|3|||
161632284|NCT02418845|583705590|FG001|Overall Study|Physician Decision|5|||
161632285|NCT02418845|583705589|FG000|Overall Study|Protocol Violation|1|||
161632286|NCT02418845|583705590|FG001|Overall Study|Protocol Violation|0|||
161632287|NCT02418845|583705589|FG000|Overall Study|Withdrawal by Subject|3|||
161632288|NCT02418845|583705590|FG001|Overall Study|Withdrawal by Subject|2|||
161632289|NCT00478647|583705591|FG000|Overall Study|Adverse Event|1|||
161632290|NCT00478647|583705591|FG000|Overall Study|Withdrawal by Subject|1|||
161632291|NCT04333147|583705592|FG000|Overall Study|Adverse Event|43|||
161632292|NCT04333147|583705593|FG001|Overall Study|Adverse Event|40|||
161632293|NCT04333147|583705592|FG000|Overall Study|Lack of Efficacy|49|||
161632294|NCT04333147|583705593|FG001|Overall Study|Lack of Efficacy|48|||
161632295|NCT04333147|583705592|FG000|Overall Study|Lost to Follow-up|19|||
161632296|NCT04333147|583705593|FG001|Overall Study|Lost to Follow-up|16|||
161632297|NCT04333147|583705592|FG000|Overall Study|Physician Decision|17|||
161632298|NCT04333147|583705593|FG001|Overall Study|Physician Decision|20|||
161632299|NCT04333147|583705592|FG000|Overall Study|Withdrawal by Subject|65|||
161632300|NCT04333147|583705593|FG001|Overall Study|Withdrawal by Subject|68|||
161632301|NCT04333147|583705592|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
161632302|NCT04333147|583705593|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
161632303|NCT04333147|583705592|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
161632304|NCT04333147|583705593|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
161632305|NCT04333147|583705592|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
161632306|NCT04333147|583705593|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
161632307|NCT00487552|583705603|FG000|Overall Study|Unsuccessful magnet placements|3|||
161632308|NCT00487552|583705603|FG000|Overall Study|Death due to progressive malignancy|2|||
161632309|NCT00487552|583705603|FG000|Overall Study|Stent not placed|1|||
161632310|NCT03119688|583705604|FG000|Overall Study|Adverse Event|4|||
161632311|NCT00320398|583705605|FG000|Overall Study|Adverse Event|1|||
161632312|NCT00320398|583705606|FG001|Overall Study|Adverse Event|4|||
161632313|NCT00320398|583705605|FG000|Overall Study|Other|1|||
161632314|NCT00320398|583705606|FG001|Overall Study|Other|0|||
161632315|NCT00630552|583705607|FG000|Overall Study|Adverse Event|0|||
161632316|NCT00630552|583705608|FG001|Overall Study|Adverse Event|1|||
161632317|NCT00630552|583705609|FG002|Overall Study|Adverse Event|5|||
161632318|NCT00630552|583705610|FG003|Overall Study|Adverse Event|4|||
161632319|NCT00630552|583705611|FG004|Overall Study|Adverse Event|2|||
161632320|NCT00630552|583705607|FG000|Overall Study|Disease progression|5|||
161632321|NCT00630552|583705608|FG001|Overall Study|Disease progression|6|||
161632322|NCT00630552|583705609|FG002|Overall Study|Disease progression|27|||
161632323|NCT00630552|583705610|FG003|Overall Study|Disease progression|22|||
161632324|NCT00630552|583705611|FG004|Overall Study|Disease progression|31|||
161632325|NCT00630552|583705607|FG000|Overall Study|Never received IP|0|||
161632326|NCT00630552|583705608|FG001|Overall Study|Never received IP|0|||
161632327|NCT00630552|583705609|FG002|Overall Study|Never received IP|0|||
161632328|NCT00630552|583705610|FG003|Overall Study|Never received IP|2|||
161632329|NCT00630552|583705611|FG004|Overall Study|Never received IP|2|||
161632330|NCT00630552|583705607|FG000|Overall Study|Ineligibility determined|0|||
161632331|NCT00630552|583705608|FG001|Overall Study|Ineligibility determined|0|||
161632332|NCT00630552|583705609|FG002|Overall Study|Ineligibility determined|0|||
161632333|NCT00630552|583705610|FG003|Overall Study|Ineligibility determined|0|||
161632334|NCT00630552|583705611|FG004|Overall Study|Ineligibility determined|1|||
161632335|NCT00630552|583705607|FG000|Overall Study|Protocol Violation|0|||
161632336|NCT00630552|583705608|FG001|Overall Study|Protocol Violation|0|||
161632337|NCT00630552|583705609|FG002|Overall Study|Protocol Violation|0|||
161632338|NCT00630552|583705610|FG003|Overall Study|Protocol Violation|1|||
161632339|NCT00630552|583705611|FG004|Overall Study|Protocol Violation|0|||
161632340|NCT00630552|583705607|FG000|Overall Study|Physician Decision|0|||
161632341|NCT00630552|583705608|FG001|Overall Study|Physician Decision|0|||
161632342|NCT00630552|583705609|FG002|Overall Study|Physician Decision|0|||
161632343|NCT00630552|583705610|FG003|Overall Study|Physician Decision|0|||
161632344|NCT00630552|583705611|FG004|Overall Study|Physician Decision|1|||
161632345|NCT00630552|583705607|FG000|Overall Study|Death|0|||
161632346|NCT00630552|583705608|FG001|Overall Study|Death|0|||
161632347|NCT00630552|583705609|FG002|Overall Study|Death|1|||
161632348|NCT00630552|583705610|FG003|Overall Study|Death|2|||
161632349|NCT00630552|583705611|FG004|Overall Study|Death|2|||
161632350|NCT00630552|583705607|FG000|Overall Study|Withdrawal by Subject|0|||
161632351|NCT00630552|583705608|FG001|Overall Study|Withdrawal by Subject|0|||
161632352|NCT00630552|583705609|FG002|Overall Study|Withdrawal by Subject|0|||
161632353|NCT00630552|583705610|FG003|Overall Study|Withdrawal by Subject|1|||
161632354|NCT00630552|583705611|FG004|Overall Study|Withdrawal by Subject|0|||
161632355|NCT00630552|583705607|FG000|Overall Study|Other|0|||
161632356|NCT00630552|583705608|FG001|Overall Study|Other|0|||
161632357|NCT00630552|583705609|FG002|Overall Study|Other|4|||
161632358|NCT00630552|583705610|FG003|Overall Study|Other|2|||
161632359|NCT00630552|583705611|FG004|Overall Study|Other|0|||
161632360|NCT02705625|583705614|FG000|Overall Study|Protocol Violation|1|||
161632361|NCT02705625|583705615|FG001|Overall Study|Protocol Violation|0|||
161632362|NCT02705625|583705616|FG002|Overall Study|Protocol Violation|0|||
161833735|NCT01790113|584433213|FG000|Overall Study|Adverse Event|2|||
161833736|NCT01790113|584433214|FG001|Overall Study|Adverse Event|7|||
161833737|NCT01790113|584433213|FG000|Overall Study|Study ended due to FDA clearance|1|||
161833738|NCT01790113|584433214|FG001|Overall Study|Study ended due to FDA clearance|68|||
161833739|NCT03451006|584433215|FG000|Overall Study|Withdrawal by Subject|2|||
161833740|NCT03451006|584433216|FG001|Overall Study|Withdrawal by Subject|2|||
161833741|NCT00775606|584433217|FG000|Overall Study|Study sponsor terminated funding|3|||
161833742|NCT00775606|584433218|FG001|Overall Study|Study sponsor terminated funding|0|||
161833743|NCT02278718|584433219|FG000|Overall Study|Adverse Event|1|||
161833744|NCT02278718|584433220|FG001|Overall Study|Adverse Event|0|||
161833745|NCT02278718|584433219|FG000|Overall Study|Lost to Follow-up|2|||
161833746|NCT02278718|584433220|FG001|Overall Study|Lost to Follow-up|4|||
161833747|NCT02278718|584433219|FG000|Overall Study|Withdrawal by Subject|1|||
161833748|NCT02278718|584433220|FG001|Overall Study|Withdrawal by Subject|4|||
161833749|NCT02278718|584433219|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
161833750|NCT02278718|584433220|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
161833751|NCT02278718|584433219|FG000|Overall Study|Missing|0|||
161833752|NCT02278718|584433220|FG001|Overall Study|Missing|1|||
161833753|NCT04440449|584433221|FG000|Overall Study|Lost to Follow-up|2|||
161833754|NCT04440449|584433222|FG001|Overall Study|Lost to Follow-up|0|||
161833755|NCT02547766|584433223|FG000|Overall Study|Withdrawal by Subject|1|||
161833756|NCT03212794|584433224|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
161833757|NCT03212794|584433225|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
161833758|NCT03212794|584433224|FG000|Overall Study|Lost to Follow-up|5|||
161833759|NCT03212794|584433225|FG001|Overall Study|Lost to Follow-up|6|||
161833760|NCT03212794|584433224|FG000|Overall Study|Incarcerated; unable to participate|2|||
161833761|NCT03212794|584433225|FG001|Overall Study|Incarcerated; unable to participate|0|||
161833762|NCT03212794|584433224|FG000|Overall Study|Withdrawal by Subject|1|||
161833763|NCT03212794|584433225|FG001|Overall Study|Withdrawal by Subject|0|||
161833764|NCT03212794|584433224|FG000|Overall Study|Death|0|||
161833765|NCT03212794|584433225|FG001|Overall Study|Death|1|||
161833766|NCT03212794|584433224|FG000|Overall Study|Found to be ineligible after allocation|0|||
161833767|NCT03212794|584433225|FG001|Overall Study|Found to be ineligible after allocation|1|||
161833768|NCT03212794|584433224|FG000|Overall Study|Relocated out of area|2|||
161833769|NCT03212794|584433225|FG001|Overall Study|Relocated out of area|0|||
161833770|NCT00897949|584433228|FG000|Overall Study|Adverse Event|1|||
161833771|NCT00897949|584433229|FG001|Overall Study|Adverse Event|1|||
161833772|NCT00897949|584433230|FG002|Overall Study|Adverse Event|0|||
161833773|NCT00897949|584433228|FG000|Overall Study|Lost to Follow-up|0|||
161833774|NCT00897949|584433229|FG001|Overall Study|Lost to Follow-up|2|||
161833775|NCT00897949|584433230|FG002|Overall Study|Lost to Follow-up|1|||
161833776|NCT00897949|584433228|FG000|Overall Study|Protocol Violation|6|||
161833777|NCT00897949|584433229|FG001|Overall Study|Protocol Violation|3|||
161833778|NCT00897949|584433230|FG002|Overall Study|Protocol Violation|1|||
161833779|NCT00897949|584433228|FG000|Overall Study|Withdrawal by Subject|1|||
161833780|NCT00897949|584433229|FG001|Overall Study|Withdrawal by Subject|2|||
161833781|NCT00897949|584433230|FG002|Overall Study|Withdrawal by Subject|0|||
161833782|NCT00897949|584433228|FG000|Overall Study|Patient Uncoorperative|0|||
161833783|NCT00897949|584433229|FG001|Overall Study|Patient Uncoorperative|2|||
161833784|NCT00897949|584433230|FG002|Overall Study|Patient Uncoorperative|1|||
161833785|NCT00897949|584433228|FG000|Overall Study|Lost to Follow-up|30|||
161833786|NCT00897949|584433229|FG001|Overall Study|Lost to Follow-up|23|||
161833787|NCT00897949|584433230|FG002|Overall Study|Lost to Follow-up|17|||
161833788|NCT00897949|584433228|FG000|Overall Study|Withdrawal by Subject|24|||
161833789|NCT00897949|584433229|FG001|Overall Study|Withdrawal by Subject|31|||
161833790|NCT00897949|584433230|FG002|Overall Study|Withdrawal by Subject|17|||
161833791|NCT00897949|584433228|FG000|Overall Study|Abnormal Prestudy Labs|2|||
161833792|NCT00897949|584433229|FG001|Overall Study|Abnormal Prestudy Labs|3|||
161833793|NCT00897949|584433230|FG002|Overall Study|Abnormal Prestudy Labs|4|||
161833794|NCT00897949|584433228|FG000|Overall Study|Abnormal Baseline ECG|2|||
161632363|NCT02705625|583705614|FG000|Overall Study|Adverse Event|6|||
161833795|NCT00897949|584433229|FG001|Overall Study|Abnormal Baseline ECG|2|||
161833796|NCT00897949|584433230|FG002|Overall Study|Abnormal Baseline ECG|4|||
161833797|NCT00897949|584433228|FG000|Overall Study|Need for Concom. Med.|0|||
161632364|NCT02705625|583705615|FG001|Overall Study|Adverse Event|5|||
161632365|NCT02705625|583705616|FG002|Overall Study|Adverse Event|2|||
161833798|NCT00897949|584433229|FG001|Overall Study|Need for Concom. Med.|1|||
161833799|NCT00897949|584433230|FG002|Overall Study|Need for Concom. Med.|1|||
161833800|NCT00897949|584433228|FG000|Overall Study|Lack of Migraine Attack|29|||
161833801|NCT00897949|584433229|FG001|Overall Study|Lack of Migraine Attack|30|||
161632366|NCT02705625|583705614|FG000|Overall Study|Death|0|||
161833802|NCT00897949|584433230|FG002|Overall Study|Lack of Migraine Attack|19|||
161833803|NCT00897949|584433228|FG000|Overall Study|Did not take study drug|9|||
161833804|NCT00897949|584433229|FG001|Overall Study|Did not take study drug|3|||
161632367|NCT02705625|583705615|FG001|Overall Study|Death|0|||
161632368|NCT02705625|583705616|FG002|Overall Study|Death|1|||
161632369|NCT02705625|583705614|FG000|Overall Study|Withdrawal by Subject|1|||
161632370|NCT02705625|583705615|FG001|Overall Study|Withdrawal by Subject|4|||
161632371|NCT02705625|583705616|FG002|Overall Study|Withdrawal by Subject|5|||
161632372|NCT02705625|583705614|FG000|Overall Study|Lost to Follow-up|0|||
161632373|NCT02705625|583705615|FG001|Overall Study|Lost to Follow-up|0|||
161632374|NCT02705625|583705616|FG002|Overall Study|Lost to Follow-up|1|||
161632375|NCT02705625|583705614|FG000|Overall Study|Non-compliance|0|||
161632376|NCT02705625|583705615|FG001|Overall Study|Non-compliance|1|||
161632377|NCT02705625|583705616|FG002|Overall Study|Non-compliance|1|||
161685890|NCT00361270|583901995|FG003|Overall Study|Withdrawal by Subject|7|||
161685891|NCT00361270|583901992|FG000|Overall Study|Afraid of Hypnosis|1|||
161685892|NCT00361270|583901993|FG001|Overall Study|Afraid of Hypnosis|2|||
161685893|NCT00361270|583901994|FG002|Overall Study|Afraid of Hypnosis|0|||
161685894|NCT00361270|583901995|FG003|Overall Study|Afraid of Hypnosis|0|||
161685895|NCT00361270|583901992|FG000|Overall Study|Problems with Transportation|4|||
161685896|NCT00361270|583901993|FG001|Overall Study|Problems with Transportation|0|||
161685897|NCT00361270|583901994|FG002|Overall Study|Problems with Transportation|0|||
161685898|NCT00361270|583901995|FG003|Overall Study|Problems with Transportation|0|||
161685899|NCT00361270|583901992|FG000|Overall Study|Adverse Event|0|||
161685900|NCT00361270|583901993|FG001|Overall Study|Adverse Event|1|||
161685901|NCT00361270|583901994|FG002|Overall Study|Adverse Event|1|||
161685902|NCT00361270|583901995|FG003|Overall Study|Adverse Event|0|||
161685903|NCT01423851|583901999|FG000|Whole Study|Disease progression|2|||
161685904|NCT01423851|583902000|FG001|Whole Study|Disease progression|1|||
161685905|NCT01423851|583902001|FG002|Whole Study|Disease progression|1|||
161685906|NCT01423851|583902002|FG003|Whole Study|Disease progression|4|||
161685907|NCT01423851|583902003|FG004|Whole Study|Disease progression|1|||
161685908|NCT01423851|583902004|FG005|Whole Study|Disease progression|3|||
161685909|NCT01423851|583902005|FG006|Whole Study|Disease progression|1|||
161685910|NCT01423851|583902006|FG007|Whole Study|Disease progression|4|||
161685911|NCT01423851|583902007|FG008|Whole Study|Disease progression|0|||
161685912|NCT01423851|583902008|FG009|Whole Study|Disease progression|2|||
161685913|NCT01423851|583902009|FG010|Whole Study|Disease progression|10|||
161685914|NCT01423851|583901999|FG000|Whole Study|Physician Decision|0|||
161685915|NCT01423851|583902000|FG001|Whole Study|Physician Decision|1|||
161685916|NCT01423851|583902001|FG002|Whole Study|Physician Decision|2|||
161685917|NCT01423851|583902002|FG003|Whole Study|Physician Decision|0|||
161685918|NCT01423851|583902003|FG004|Whole Study|Physician Decision|2|||
161685919|NCT01423851|583902004|FG005|Whole Study|Physician Decision|0|||
161685920|NCT01423851|583902005|FG006|Whole Study|Physician Decision|2|||
161685921|NCT01423851|583902006|FG007|Whole Study|Physician Decision|1|||
161685922|NCT01423851|583902007|FG008|Whole Study|Physician Decision|3|||
161685923|NCT01423851|583902008|FG009|Whole Study|Physician Decision|4|||
161685924|NCT01423851|583902009|FG010|Whole Study|Physician Decision|12|||
161685925|NCT01423851|583901999|FG000|Whole Study|Withdrawal by Subject|1|||
161685926|NCT01423851|583902000|FG001|Whole Study|Withdrawal by Subject|1|||
161685927|NCT01423851|583902001|FG002|Whole Study|Withdrawal by Subject|0|||
161685928|NCT01423851|583902002|FG003|Whole Study|Withdrawal by Subject|0|||
161685929|NCT01423851|583902003|FG004|Whole Study|Withdrawal by Subject|0|||
161685930|NCT01423851|583902004|FG005|Whole Study|Withdrawal by Subject|0|||
161685931|NCT01423851|583902005|FG006|Whole Study|Withdrawal by Subject|0|||
161685932|NCT01423851|583902006|FG007|Whole Study|Withdrawal by Subject|0|||
161685933|NCT01423851|583902007|FG008|Whole Study|Withdrawal by Subject|2|||
161685934|NCT01423851|583902008|FG009|Whole Study|Withdrawal by Subject|0|||
161685935|NCT01423851|583902009|FG010|Whole Study|Withdrawal by Subject|4|||
161685936|NCT01423851|583901999|FG000|Whole Study|Adverse Event|0|||
161685937|NCT01423851|583902000|FG001|Whole Study|Adverse Event|0|||
161685938|NCT01423851|583902001|FG002|Whole Study|Adverse Event|0|||
161685939|NCT01423851|583902002|FG003|Whole Study|Adverse Event|2|||
161833805|NCT00897949|584433230|FG002|Overall Study|Did not take study drug|4|||
161632378|NCT02705625|583705614|FG000|Overall Study|Overdosing|0|||
161632379|NCT02705625|583705615|FG001|Overall Study|Overdosing|0|||
161833806|NCT01763918|584433231|FG000|Overall Study|Withdrawal by Subject|2|||
161632380|NCT02705625|583705616|FG002|Overall Study|Overdosing|1|||
161632381|NCT00847132|583705617|FG000|Overall Study|Death|1|||
161685940|NCT01423851|583902003|FG004|Whole Study|Adverse Event|0|||
161685941|NCT01423851|583902004|FG005|Whole Study|Adverse Event|0|||
161685942|NCT01423851|583902005|FG006|Whole Study|Adverse Event|0|||
161685943|NCT01423851|583902006|FG007|Whole Study|Adverse Event|3|||
161685944|NCT01423851|583902007|FG008|Whole Study|Adverse Event|3|||
161685945|NCT01423851|583902008|FG009|Whole Study|Adverse Event|2|||
161632382|NCT00847132|583705618|FG001|Overall Study|Death|1|||
161632383|NCT01057251|583705620|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
161632384|NCT01057251|583705621|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
161632385|NCT01057251|583705620|FG000|Overall Study|Adverse Event|4|||
161632386|NCT01057251|583705621|FG001|Overall Study|Adverse Event|2|||
161685946|NCT01423851|583902009|FG010|Whole Study|Adverse Event|3|||
161685947|NCT00874120|583903267|FG000|First Intervention|Adverse Event|0|||
161833807|NCT01763918|584433232|FG001|Overall Study|Withdrawal by Subject|1|||
161632387|NCT01057251|583705620|FG000|Overall Study|Lack of Efficacy|2|||
161632388|NCT01057251|583705621|FG001|Overall Study|Lack of Efficacy|11|||
161632389|NCT01057251|583705620|FG000|Overall Study|Protocol Violation|6|||
161632390|NCT01057251|583705621|FG001|Overall Study|Protocol Violation|2|||
161632391|NCT01057251|583705620|FG000|Overall Study|Withdrawal by Subject|4|||
161632392|NCT01057251|583705621|FG001|Overall Study|Withdrawal by Subject|5|||
161632393|NCT01057251|583705620|FG000|Overall Study|Lost to Follow-up|7|||
161632394|NCT01057251|583705621|FG001|Overall Study|Lost to Follow-up|6|||
161632395|NCT01057251|583705620|FG000|Overall Study|Other Reason|1|||
161632396|NCT01057251|583705621|FG001|Overall Study|Other Reason|1|||
161632397|NCT00784147|583705622|FG000|Overall Study|Lost to Follow-up|2|||
161632398|NCT00784147|583705623|FG001|Overall Study|Lost to Follow-up|4|||
161632399|NCT00784147|583705622|FG000|Overall Study|Withdrawal by Subject|1|||
161632400|NCT00784147|583705623|FG001|Overall Study|Withdrawal by Subject|3|||
161632401|NCT00784147|583705622|FG000|Overall Study|Physician Decision|2|||
161632402|NCT00784147|583705623|FG001|Overall Study|Physician Decision|1|||
161632403|NCT00784147|583705622|FG000|Overall Study|Protocol Violation|1|||
161632404|NCT00784147|583705623|FG001|Overall Study|Protocol Violation|1|||
161632405|NCT00784147|583705622|FG000|Overall Study|Death|2|||
161632406|NCT00784147|583705623|FG001|Overall Study|Death|0|||
161632407|NCT03596242|583705625|FG000|Overall Study|Lost to Follow-up|2|||
161632408|NCT03596242|583705626|FG001|Overall Study|Lost to Follow-up|2|||
161632409|NCT04544865|583705627|FG000|Overall Study|Death|0|||
161632410|NCT04544865|583705628|FG001|Overall Study|Death|2|||
161632411|NCT04544865|583705627|FG000|Overall Study|Lost to Follow-up|11|||
161632412|NCT04544865|583705628|FG001|Overall Study|Lost to Follow-up|7|||
161632413|NCT04544865|583705627|FG000|Overall Study|Withdrawal by Subject|0|||
161632414|NCT04544865|583705628|FG001|Overall Study|Withdrawal by Subject|1|||
161632415|NCT04544865|583705627|FG000|Overall Study|Other|0|||
161632416|NCT04544865|583705628|FG001|Overall Study|Other|1|||
161632417|NCT03357471|583705634|FG000|Overall Study|Adverse Event|1|||
161632418|NCT03357471|583705635|FG001|Overall Study|Adverse Event|0|||
161632419|NCT03357471|583705634|FG000|Overall Study|Lost to Follow-up|1|||
161632420|NCT03357471|583705635|FG001|Overall Study|Lost to Follow-up|0|||
161632421|NCT02973802|583705636|FG000|Overall Study|Lost to Follow-up|1|||
161632422|NCT02973802|583705636|FG000|Overall Study|Withdrawal by Subject|1|||
161632423|NCT00706914|583705637|FG000|Overall Study|Lack of Efficacy|0|||
161632424|NCT00706914|583705638|FG001|Overall Study|Lack of Efficacy|1|||
161632425|NCT00706914|583705639|FG002|Overall Study|Lack of Efficacy|0|||
161632426|NCT00706914|583705637|FG000|Overall Study|Lost to Follow-up|1|||
161632427|NCT00706914|583705638|FG001|Overall Study|Lost to Follow-up|0|||
161632428|NCT00706914|583705639|FG002|Overall Study|Lost to Follow-up|0|||
161632429|NCT00706914|583705637|FG000|Overall Study|Adverse Event|2|||
161632430|NCT00706914|583705638|FG001|Overall Study|Adverse Event|2|||
161632431|NCT00706914|583705639|FG002|Overall Study|Adverse Event|0|||
161632432|NCT00706914|583705637|FG000|Overall Study|Protocol Violation|3|||
161632433|NCT00706914|583705638|FG001|Overall Study|Protocol Violation|1|||
161632434|NCT00706914|583705639|FG002|Overall Study|Protocol Violation|1|||
161632435|NCT01850823|583705640|FG000|Overall Study|Early Visit Window|0|||
161632436|NCT01850823|583705641|FG001|Overall Study|Early Visit Window|1|||
161632437|NCT01850823|583705642|FG002|Overall Study|Early Visit Window|4|||
161632438|NCT01850823|583705640|FG000|Overall Study|Enrolled in Error|0|||
161632439|NCT01850823|583705641|FG001|Overall Study|Enrolled in Error|1|||
161632440|NCT01850823|583705642|FG002|Overall Study|Enrolled in Error|2|||
161632441|NCT01850823|583705640|FG000|Overall Study|Lack of Efficacy|1|||
161632442|NCT01850823|583705641|FG001|Overall Study|Lack of Efficacy|0|||
161632443|NCT01850823|583705642|FG002|Overall Study|Lack of Efficacy|0|||
161632444|NCT01850823|583705640|FG000|Overall Study|Lost to Follow-up|0|||
161632445|NCT01850823|583705641|FG001|Overall Study|Lost to Follow-up|0|||
161632446|NCT01850823|583705642|FG002|Overall Study|Lost to Follow-up|1|||
161632447|NCT01850823|583705640|FG000|Overall Study|Restricted Medication|0|||
161632448|NCT01850823|583705641|FG001|Overall Study|Restricted Medication|0|||
161632449|NCT01850823|583705642|FG002|Overall Study|Restricted Medication|2|||
161632450|NCT01850823|583705640|FG000|Overall Study|Significant worstening of SAR|0|||
161632451|NCT01850823|583705641|FG001|Overall Study|Significant worstening of SAR|1|||
161632452|NCT01850823|583705642|FG002|Overall Study|Significant worstening of SAR|0|||
161632453|NCT01850823|583705640|FG000|Overall Study|Withdrawal by Subject|2|||
161632454|NCT01850823|583705641|FG001|Overall Study|Withdrawal by Subject|0|||
161632455|NCT01850823|583705642|FG002|Overall Study|Withdrawal by Subject|1|||
161632456|NCT00913523|583705643|FG000|Overall Study|Withdrawal by Subject|3|||
161632457|NCT00913523|583705644|FG001|Overall Study|Withdrawal by Subject|2|||
161632458|NCT00913523|583705645|FG002|Overall Study|Withdrawal by Subject|2|||
161632459|NCT00913523|583705643|FG000|Overall Study|Lost to Follow-up|1|||
161632460|NCT00913523|583705644|FG001|Overall Study|Lost to Follow-up|1|||
161632461|NCT00913523|583705645|FG002|Overall Study|Lost to Follow-up|1|||
161632462|NCT00913523|583705643|FG000|Overall Study|Adverse Event|1|||
161632463|NCT00913523|583705644|FG001|Overall Study|Adverse Event|0|||
161632464|NCT00913523|583705645|FG002|Overall Study|Adverse Event|0|||
161632465|NCT00913523|583705643|FG000|Overall Study|Protocol Violation|5|||
161632466|NCT00913523|583705644|FG001|Overall Study|Protocol Violation|8|||
161632467|NCT00913523|583705645|FG002|Overall Study|Protocol Violation|8|||
161632468|NCT00913523|583705643|FG000|Overall Study|Pregnancy|1|||
161632469|NCT00913523|583705644|FG001|Overall Study|Pregnancy|3|||
161632470|NCT00913523|583705645|FG002|Overall Study|Pregnancy|0|||
161632471|NCT00913523|583705643|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
161632472|NCT00913523|583705644|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
161632473|NCT00913523|583705645|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
161632474|NCT01649297|583705647|FG000|Overall Study|Adverse Event|5|||
161632475|NCT01649297|583705648|FG001|Overall Study|Adverse Event|5|||
161632476|NCT01649297|583705649|FG002|Overall Study|Adverse Event|4|||
161632477|NCT01649297|583705650|FG003|Overall Study|Adverse Event|13|||
161632478|NCT01649297|583705651|FG004|Overall Study|Adverse Event|1|||
161632479|NCT01649297|583705647|FG000|Overall Study|Lack of Efficacy|0|||
161632480|NCT01649297|583705648|FG001|Overall Study|Lack of Efficacy|0|||
161632481|NCT01649297|583705649|FG002|Overall Study|Lack of Efficacy|0|||
161632482|NCT01649297|583705650|FG003|Overall Study|Lack of Efficacy|0|||
161632483|NCT01649297|583705651|FG004|Overall Study|Lack of Efficacy|1|||
161632484|NCT01649297|583705647|FG000|Overall Study|Non compliant with Protocol|1|||
161632485|NCT01649297|583705648|FG001|Overall Study|Non compliant with Protocol|0|||
161632486|NCT01649297|583705649|FG002|Overall Study|Non compliant with Protocol|3|||
161632487|NCT01649297|583705650|FG003|Overall Study|Non compliant with Protocol|2|||
161685948|NCT00874120|583903268|FG001|First Intervention|Adverse Event|1|||
161632488|NCT01649297|583705651|FG004|Overall Study|Non compliant with Protocol|1|||
161632489|NCT01649297|583705647|FG000|Overall Study|Lost to Follow-up|1|||
161632490|NCT01649297|583705648|FG001|Overall Study|Lost to Follow-up|1|||
161632491|NCT01649297|583705649|FG002|Overall Study|Lost to Follow-up|4|||
161632492|NCT01649297|583705650|FG003|Overall Study|Lost to Follow-up|3|||
161632493|NCT01649297|583705651|FG004|Overall Study|Lost to Follow-up|0|||
161632494|NCT01649297|583705647|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
161632495|NCT01649297|583705648|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
161632496|NCT01649297|583705649|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
161632497|NCT01649297|583705650|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
161632498|NCT01649297|583705651|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
161632499|NCT01649297|583705647|FG000|Overall Study|For other reason|4|||
161632500|NCT01649297|583705648|FG001|Overall Study|For other reason|1|||
161632501|NCT01649297|583705649|FG002|Overall Study|For other reason|2|||
161632502|NCT01649297|583705650|FG003|Overall Study|For other reason|0|||
161632503|NCT01649297|583705651|FG004|Overall Study|For other reason|0|||
161632504|NCT01685047|583705652|FG000|Overall Study|Withdrawal by Subject|20|||
161632505|NCT01685047|583705652|FG000|Overall Study|Death|26|||
161632506|NCT01685047|583705652|FG000|Overall Study|Lost to Follow-up|8|||
161632507|NCT01685047|583705652|FG000|Overall Study|Physician Decision|25|||
161632508|NCT01685047|583705652|FG000|Overall Study|Adverse Event|5|||
161632509|NCT01685047|583705652|FG000|Overall Study|patient withdrawn by sponsor|1|||
161632510|NCT01202409|583705654|FG000|Overall Study|Adverse Event|1|||
161632511|NCT01202409|583705654|FG000|Overall Study|Ineligible - KRAS mutants|7|||
161632512|NCT01732926|583705657|FG000|Overall Study|Study Terminated by Sponsor|168|||
161632513|NCT01732926|583705658|FG001|Overall Study|Study Terminated by Sponsor|80|||
161632514|NCT01732926|583705657|FG000|Overall Study|Withdrawal by Subject|46|||
161632515|NCT01732926|583705658|FG001|Overall Study|Withdrawal by Subject|8|||
161632516|NCT01732926|583705657|FG000|Overall Study|Physician Decision|24|||
161632517|NCT01732926|583705658|FG001|Overall Study|Physician Decision|11|||
161632518|NCT01732926|583705657|FG000|Overall Study|Other Reason|21|||
161632519|NCT01732926|583705658|FG001|Overall Study|Other Reason|4|||
161632520|NCT01732926|583705657|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
161632521|NCT01732926|583705658|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
161632522|NCT01732926|583705657|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
161632523|NCT01732926|583705658|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
161632524|NCT01746108|583705661|FG000|Overall Study|Migrated /moved from study area|0|||
161632525|NCT01746108|583705662|FG001|Overall Study|Migrated /moved from study area|1|||
161632526|NCT01746108|583705663|FG002|Overall Study|Migrated /moved from study area|0|||
161632527|NCT01746108|583705661|FG000|Overall Study|Adverse event, non-fatal|0|||
161632528|NCT01746108|583705662|FG001|Overall Study|Adverse event, non-fatal|1|||
161632529|NCT01746108|583705663|FG002|Overall Study|Adverse event, non-fatal|0|||
161632530|NCT01746108|583705661|FG000|Overall Study|Withdrawal by Subject|0|||
161632531|NCT01746108|583705662|FG001|Overall Study|Withdrawal by Subject|1|||
161632532|NCT01746108|583705663|FG002|Overall Study|Withdrawal by Subject|0|||
161632533|NCT01746108|583705661|FG000|Overall Study|Lost to Follow-up|0|||
161632534|NCT01746108|583705662|FG001|Overall Study|Lost to Follow-up|1|||
161632535|NCT01746108|583705663|FG002|Overall Study|Lost to Follow-up|0|||
161632536|NCT03036150|583705664|FG000|Overall Study|Withdrawal by Subject|8|||
161632537|NCT03036150|583705665|FG001|Overall Study|Withdrawal by Subject|3|||
161632538|NCT03036150|583705664|FG000|Overall Study|Lost to Follow-up|2|||
161632539|NCT03036150|583705665|FG001|Overall Study|Lost to Follow-up|2|||
161632540|NCT00053352|583705674|FG000|Overall Study|Lost to Follow-up|0|||
161632541|NCT00053352|583705675|FG001|Overall Study|Lost to Follow-up|1|||
161632542|NCT00053352|583705674|FG000|Overall Study|Physician Decision|11|||
161632543|NCT00053352|583705675|FG001|Overall Study|Physician Decision|1|||
161632544|NCT00053352|583705674|FG000|Overall Study|Withdrawal by Subject|1|||
161632545|NCT00053352|583705675|FG001|Overall Study|Withdrawal by Subject|0|||
161632546|NCT00053352|583705674|FG000|Overall Study|Ineligible|8|||
161632547|NCT00053352|583705675|FG001|Overall Study|Ineligible|8|||
161632548|NCT00053352|583705674|FG000|Overall Study|Disease at new site|1|||
161632549|NCT00053352|583705675|FG001|Overall Study|Disease at new site|0|||
161632550|NCT00931918|583705678|FG000|Overall Study|Adverse Event|4|||
161632551|NCT00931918|583705679|FG001|Overall Study|Adverse Event|6|||
161632552|NCT00931918|583705678|FG000|Overall Study|Progressive Disease|2|||
161632553|NCT00931918|583705679|FG001|Overall Study|Progressive Disease|1|||
161632554|NCT00931918|583705678|FG000|Overall Study|Symptomatic Deterioration|1|||
161632555|NCT00931918|583705679|FG001|Overall Study|Symptomatic Deterioration|0|||
161632556|NCT00931918|583705678|FG000|Overall Study|Withdrawal by Patient|3|||
161632557|NCT00931918|583705679|FG001|Overall Study|Withdrawal by Patient|4|||
161632558|NCT00931918|583705678|FG000|Overall Study|Other Reason not Specified|4|||
161632559|NCT00931918|583705679|FG001|Overall Study|Other Reason not Specified|4|||
161632560|NCT00931918|583705678|FG000|Overall Study|Did not receive study drug|3|||
161632561|NCT00931918|583705679|FG001|Overall Study|Did not receive study drug|2|||
161632562|NCT00809341|583705680|FG000|Overall Study|Physician Decision|0|||
161632563|NCT00809341|583705681|FG001|Overall Study|Physician Decision|1|||
161632564|NCT00570921|583705684|FG000|Overall Study|Protocol Violation|1|||
161632565|NCT00570921|583705684|FG000|Overall Study|Physician Decision|1|||
161632566|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
161632567|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
161632568|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
161833808|NCT01763918|584433233|FG002|Overall Study|Withdrawal by Subject|1|||
161632569|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
161632570|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
161685949|NCT00874120|583903267|FG000|First Intervention|Withdrawal by Subject|2|||
161833809|NCT01763918|584433234|FG003|Overall Study|Withdrawal by Subject|2|||
161632571|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
161632572|NCT03201900|583705685|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
161632573|NCT03201900|583705685|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
161632574|NCT03201900|583705685|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
161685950|NCT00874120|583903268|FG001|First Intervention|Withdrawal by Subject|0|||
161632575|NCT03201900|583705685|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
161632576|NCT03201900|583705685|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
161632577|NCT03201900|583705685|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
161632578|NCT03201900|583705685|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
161632579|NCT00550446|583705686|FG000|Up To Week 12|Adverse Event|2|||
161632580|NCT00550446|583705687|FG001|Up To Week 12|Adverse Event|2|||
161632581|NCT00550446|583705688|FG002|Up To Week 12|Adverse Event|0|||
161632582|NCT00550446|583705689|FG003|Up To Week 12|Adverse Event|0|||
161632583|NCT00550446|583705690|FG004|Up To Week 12|Adverse Event|2|||
161632584|NCT00550446|583705691|FG005|Up To Week 12|Adverse Event|2|||
161632585|NCT00550446|583705692|FG006|Up To Week 12|Adverse Event|1|||
161632586|NCT00550446|583705693|FG007|Up To Week 12|Adverse Event|0|||
161632587|NCT00550446|583705694|FG008|Up To Week 12|Adverse Event|0|||
161632588|NCT00550446|583705695|FG009|Up To Week 12|Adverse Event|0|||
161632589|NCT00550446|583705696|FG010|Up To Week 12|Adverse Event|0|||
161632590|NCT00550446|583705686|FG000|Up To Week 12|Lack of Efficacy|3|||
161632591|NCT00550446|583705687|FG001|Up To Week 12|Lack of Efficacy|1|||
161632592|NCT00550446|583705688|FG002|Up To Week 12|Lack of Efficacy|0|||
161632593|NCT00550446|583705689|FG003|Up To Week 12|Lack of Efficacy|1|||
161632594|NCT00550446|583705690|FG004|Up To Week 12|Lack of Efficacy|0|||
161632595|NCT00550446|583705691|FG005|Up To Week 12|Lack of Efficacy|3|||
161632596|NCT00550446|583705692|FG006|Up To Week 12|Lack of Efficacy|3|||
161632597|NCT00550446|583705693|FG007|Up To Week 12|Lack of Efficacy|0|||
161632598|NCT00550446|583705694|FG008|Up To Week 12|Lack of Efficacy|0|||
161632599|NCT00550446|583705695|FG009|Up To Week 12|Lack of Efficacy|0|||
161632600|NCT00550446|583705696|FG010|Up To Week 12|Lack of Efficacy|0|||
161632601|NCT00550446|583705686|FG000|Up To Week 12|Lost to Follow-up|0|||
161632602|NCT00550446|583705687|FG001|Up To Week 12|Lost to Follow-up|1|||
161632603|NCT00550446|583705688|FG002|Up To Week 12|Lost to Follow-up|0|||
161632604|NCT00550446|583705689|FG003|Up To Week 12|Lost to Follow-up|0|||
161632605|NCT00550446|583705690|FG004|Up To Week 12|Lost to Follow-up|1|||
161632606|NCT00550446|583705691|FG005|Up To Week 12|Lost to Follow-up|1|||
161632607|NCT00550446|583705692|FG006|Up To Week 12|Lost to Follow-up|2|||
161632608|NCT00550446|583705693|FG007|Up To Week 12|Lost to Follow-up|0|||
161632609|NCT00550446|583705694|FG008|Up To Week 12|Lost to Follow-up|0|||
161632610|NCT00550446|583705695|FG009|Up To Week 12|Lost to Follow-up|0|||
161632611|NCT00550446|583705696|FG010|Up To Week 12|Lost to Follow-up|0|||
161632612|NCT00550446|583705686|FG000|Up To Week 12|Withdrawal by Subject|2|||
161632613|NCT00550446|583705687|FG001|Up To Week 12|Withdrawal by Subject|0|||
161632614|NCT00550446|583705688|FG002|Up To Week 12|Withdrawal by Subject|3|||
161632615|NCT00550446|583705689|FG003|Up To Week 12|Withdrawal by Subject|2|||
161632616|NCT00550446|583705690|FG004|Up To Week 12|Withdrawal by Subject|0|||
161632617|NCT00550446|583705691|FG005|Up To Week 12|Withdrawal by Subject|1|||
161632618|NCT00550446|583705692|FG006|Up To Week 12|Withdrawal by Subject|3|||
161632619|NCT00550446|583705693|FG007|Up To Week 12|Withdrawal by Subject|0|||
161632620|NCT00550446|583705694|FG008|Up To Week 12|Withdrawal by Subject|0|||
161632621|NCT00550446|583705695|FG009|Up To Week 12|Withdrawal by Subject|0|||
161632622|NCT00550446|583705696|FG010|Up To Week 12|Withdrawal by Subject|0|||
161632623|NCT00550446|583705686|FG000|Up To Week 12|Other|3|||
161632624|NCT00550446|583705687|FG001|Up To Week 12|Other|0|||
161632625|NCT00550446|583705688|FG002|Up To Week 12|Other|0|||
161632626|NCT00550446|583705689|FG003|Up To Week 12|Other|0|||
161632627|NCT00550446|583705690|FG004|Up To Week 12|Other|0|||
161685951|NCT00874120|583903267|FG000|First Intervention|Lost to Follow-up|0|||
161685952|NCT00874120|583903268|FG001|First Intervention|Lost to Follow-up|1|||
161685953|NCT00874120|583903267|FG000|First Intervention|Protocol Violation|3|||
161685954|NCT00874120|583903268|FG001|First Intervention|Protocol Violation|0|||
161685955|NCT00874120|583903267|FG000|First Intervention|positive drug test|1|||
161685956|NCT00874120|583903268|FG001|First Intervention|positive drug test|0|||
161685957|NCT00874120|583903267|FG000|Second Intervention|Withdrawal by Subject|1|||
161685958|NCT00874120|583903268|FG001|Second Intervention|Withdrawal by Subject|0|||
161632628|NCT00550446|583705691|FG005|Up To Week 12|Other|1|||
161632629|NCT00550446|583705692|FG006|Up To Week 12|Other|4|||
161632630|NCT00550446|583705693|FG007|Up To Week 12|Other|0|||
161632631|NCT00550446|583705694|FG008|Up To Week 12|Other|0|||
161685959|NCT00874120|583903267|FG000|Second Intervention|Protocol Violation|1|||
161632632|NCT00550446|583705695|FG009|Up To Week 12|Other|0|||
161632633|NCT00550446|583705696|FG010|Up To Week 12|Other|0|||
161632634|NCT00550446|583705686|FG000|Up To Week 12|Randomized not treated|0|||
161685960|NCT00874120|583903268|FG001|Second Intervention|Protocol Violation|0|||
161632635|NCT00550446|583705687|FG001|Up To Week 12|Randomized not treated|1|||
161632636|NCT00550446|583705688|FG002|Up To Week 12|Randomized not treated|1|||
161632637|NCT00550446|583705689|FG003|Up To Week 12|Randomized not treated|0|||
161632638|NCT00550446|583705690|FG004|Up To Week 12|Randomized not treated|0|||
161632639|NCT00550446|583705691|FG005|Up To Week 12|Randomized not treated|0|||
161632640|NCT00550446|583705692|FG006|Up To Week 12|Randomized not treated|0|||
161632641|NCT00550446|583705693|FG007|Up To Week 12|Randomized not treated|0|||
161685961|NCT00105443|583903274|FG000|Double-Blind Treatment|Adverse Event|1|||
161632642|NCT00550446|583705694|FG008|Up To Week 12|Randomized not treated|0|||
161632643|NCT00550446|583705695|FG009|Up To Week 12|Randomized not treated|0|||
161632644|NCT00550446|583705696|FG010|Up To Week 12|Randomized not treated|0|||
161632645|NCT00550446|583705686|FG000|Post Week 12|Adverse Event|2|||
161632646|NCT00550446|583705687|FG001|Post Week 12|Adverse Event|1|||
161632647|NCT00550446|583705688|FG002|Post Week 12|Adverse Event|1|||
161632648|NCT00550446|583705689|FG003|Post Week 12|Adverse Event|1|||
161632649|NCT00550446|583705690|FG004|Post Week 12|Adverse Event|1|||
161632650|NCT00550446|583705691|FG005|Post Week 12|Adverse Event|1|||
161632651|NCT00550446|583705692|FG006|Post Week 12|Adverse Event|0|||
161632652|NCT00550446|583705693|FG007|Post Week 12|Adverse Event|0|||
161632653|NCT00550446|583705694|FG008|Post Week 12|Adverse Event|0|||
161632654|NCT00550446|583705695|FG009|Post Week 12|Adverse Event|4|||
161632655|NCT00550446|583705696|FG010|Post Week 12|Adverse Event|0|||
161632656|NCT00550446|583705686|FG000|Post Week 12|Lack of Efficacy|0|||
161632657|NCT00550446|583705687|FG001|Post Week 12|Lack of Efficacy|0|||
161632658|NCT00550446|583705688|FG002|Post Week 12|Lack of Efficacy|1|||
161632659|NCT00550446|583705689|FG003|Post Week 12|Lack of Efficacy|0|||
161632660|NCT00550446|583705690|FG004|Post Week 12|Lack of Efficacy|0|||
161632661|NCT00550446|583705691|FG005|Post Week 12|Lack of Efficacy|0|||
161632662|NCT00550446|583705692|FG006|Post Week 12|Lack of Efficacy|0|||
161632663|NCT00550446|583705693|FG007|Post Week 12|Lack of Efficacy|1|||
161632664|NCT00550446|583705694|FG008|Post Week 12|Lack of Efficacy|1|||
161632665|NCT00550446|583705695|FG009|Post Week 12|Lack of Efficacy|2|||
161632666|NCT00550446|583705696|FG010|Post Week 12|Lack of Efficacy|1|||
161632667|NCT00550446|583705686|FG000|Post Week 12|Lost to Follow-up|0|||
161632668|NCT00550446|583705687|FG001|Post Week 12|Lost to Follow-up|0|||
161632669|NCT00550446|583705688|FG002|Post Week 12|Lost to Follow-up|1|||
161632670|NCT00550446|583705689|FG003|Post Week 12|Lost to Follow-up|1|||
161632671|NCT00550446|583705690|FG004|Post Week 12|Lost to Follow-up|0|||
161632672|NCT00550446|583705691|FG005|Post Week 12|Lost to Follow-up|0|||
161632673|NCT00550446|583705692|FG006|Post Week 12|Lost to Follow-up|1|||
161632674|NCT00550446|583705693|FG007|Post Week 12|Lost to Follow-up|0|||
161632675|NCT00550446|583705694|FG008|Post Week 12|Lost to Follow-up|0|||
161632676|NCT00550446|583705695|FG009|Post Week 12|Lost to Follow-up|0|||
161632677|NCT00550446|583705696|FG010|Post Week 12|Lost to Follow-up|0|||
161632678|NCT00550446|583705686|FG000|Post Week 12|Withdrawal by Subject|0|||
161632679|NCT00550446|583705687|FG001|Post Week 12|Withdrawal by Subject|0|||
161632680|NCT00550446|583705688|FG002|Post Week 12|Withdrawal by Subject|0|||
161632681|NCT00550446|583705689|FG003|Post Week 12|Withdrawal by Subject|0|||
161632682|NCT00550446|583705690|FG004|Post Week 12|Withdrawal by Subject|1|||
161632683|NCT00550446|583705691|FG005|Post Week 12|Withdrawal by Subject|0|||
161632684|NCT00550446|583705692|FG006|Post Week 12|Withdrawal by Subject|0|||
161632685|NCT00550446|583705693|FG007|Post Week 12|Withdrawal by Subject|0|||
161632686|NCT00550446|583705694|FG008|Post Week 12|Withdrawal by Subject|0|||
161632687|NCT00550446|583705695|FG009|Post Week 12|Withdrawal by Subject|0|||
161632688|NCT00550446|583705696|FG010|Post Week 12|Withdrawal by Subject|0|||
161632689|NCT00550446|583705686|FG000|Post Week 12|Other|1|||
161632690|NCT00550446|583705687|FG001|Post Week 12|Other|1|||
161632691|NCT00550446|583705688|FG002|Post Week 12|Other|0|||
161632692|NCT00550446|583705689|FG003|Post Week 12|Other|1|||
161685962|NCT00105443|583903275|FG001|Double-Blind Treatment|Adverse Event|0|||
161685963|NCT00105443|583903276|FG002|Double-Blind Treatment|Adverse Event|0|||
161833810|NCT01763918|584433231|FG000|Overall Study|Sponsor Decision|4|||
161632693|NCT00550446|583705690|FG004|Post Week 12|Other|0|||
161632694|NCT00550446|583705691|FG005|Post Week 12|Other|0|||
161632695|NCT00550446|583705692|FG006|Post Week 12|Other|1|||
161632696|NCT00550446|583705693|FG007|Post Week 12|Other|0|||
161632697|NCT00550446|583705694|FG008|Post Week 12|Other|1|||
161632698|NCT00550446|583705695|FG009|Post Week 12|Other|1|||
161632699|NCT00550446|583705696|FG010|Post Week 12|Other|0|||
161833811|NCT01763918|584433232|FG001|Overall Study|Sponsor Decision|0|||
161632700|NCT00025506|583705697|FG000|Overall Study|Ineligible: clerical error|1|||
161632701|NCT00025506|583705697|FG000|Overall Study|Ineligible: wrong cell type|5|||
161632702|NCT00025506|583705697|FG000|Overall Study|Ineligible: inadequate pathology|2|||
161833812|NCT01763918|584433233|FG002|Overall Study|Sponsor Decision|9|||
161833813|NCT01763918|584433234|FG003|Overall Study|Sponsor Decision|0|||
161833814|NCT01553747|584433235|FG000|Overall Study|Protocol Violation|0|||
161833815|NCT01553747|584433236|FG001|Overall Study|Protocol Violation|2|||
161833816|NCT01553747|584433237|FG002|Overall Study|Protocol Violation|0|||
161833817|NCT01553747|584433235|FG000|Overall Study|Voluntarily withdrew|70|||
161833818|NCT01553747|584433236|FG001|Overall Study|Voluntarily withdrew|66|||
161833819|NCT01553747|584433237|FG002|Overall Study|Voluntarily withdrew|74|||
161833820|NCT01553747|584433235|FG000|Overall Study|Adverse event or SAE|32|||
161833821|NCT01553747|584433236|FG001|Overall Study|Adverse event or SAE|28|||
161833822|NCT01553747|584433237|FG002|Overall Study|Adverse event or SAE|19|||
161833823|NCT01553747|584433235|FG000|Overall Study|Physician decision: other|10|||
161833824|NCT01553747|584433236|FG001|Overall Study|Physician decision: other|8|||
161833825|NCT01553747|584433237|FG002|Overall Study|Physician decision: other|7|||
161833826|NCT01553747|584433235|FG000|Overall Study|Lost to Follow-up|11|||
161833827|NCT01553747|584433236|FG001|Overall Study|Lost to Follow-up|5|||
161833828|NCT01553747|584433237|FG002|Overall Study|Lost to Follow-up|6|||
161833829|NCT01553747|584433235|FG000|Overall Study|Sponsor decision, specify|7|||
161632703|NCT00025506|583705697|FG000|Overall Study|Never Treated|2|||
161632704|NCT03891641|583705705|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
161632705|NCT03891641|583705706|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
161632706|NCT00578318|583705707|FG000|Overall Study|Lost to Follow-up|2|||
161632707|NCT00578318|583705708|FG001|Overall Study|Lost to Follow-up|0|||
161632708|NCT00578318|583705707|FG000|Overall Study|Physician Decision|1|||
161632709|NCT00578318|583705708|FG001|Overall Study|Physician Decision|0|||
161632710|NCT00001941|583705709|FG000|Overall Study|not treated- rapidly progressing disease|0|||
161632711|NCT00001941|583705710|FG001|Overall Study|not treated- rapidly progressing disease|0|||
161632712|NCT00001941|583705711|FG002|Overall Study|not treated- rapidly progressing disease|0|||
161632713|NCT00001941|583705712|FG003|Overall Study|not treated- rapidly progressing disease|0|||
161632714|NCT00001941|583705713|FG004|Overall Study|not treated- rapidly progressing disease|1|||
161833830|NCT01553747|584433236|FG001|Overall Study|Sponsor decision, specify|5|||
161833831|NCT01553747|584433237|FG002|Overall Study|Sponsor decision, specify|0|||
161632715|NCT00510146|583705714|FG000|Double-Blind Treatment|Adverse Event|30|||
161632716|NCT00510146|583705715|FG001|Double-Blind Treatment|Adverse Event|13|||
161632717|NCT00510146|583705714|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
161632718|NCT00510146|583705715|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
161632719|NCT00510146|583705714|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
161833832|NCT01553747|584433235|FG000|Overall Study|Physician decision: lack of efficacy|1|||
161833833|NCT01553747|584433236|FG001|Overall Study|Physician decision: lack of efficacy|5|||
161833834|NCT01553747|584433237|FG002|Overall Study|Physician decision: lack of efficacy|3|||
161833835|NCT00102687|584433238|FG000|Initial Period|Withdrawal by Subject|6|||
161833836|NCT00102687|584433239|FG001|Initial Period|Withdrawal by Subject|3|||
161833837|NCT00102687|584433240|FG002|Initial Period|Withdrawal by Subject|5|||
161833838|NCT00102687|584433241|FG003|Initial Period|Withdrawal by Subject|0|||
161833839|NCT00102687|584433242|FG004|Initial Period|Withdrawal by Subject|0|||
161833840|NCT00102687|584433238|FG000|Initial Period|Adverse Event|4|||
161833841|NCT00102687|584433239|FG001|Initial Period|Adverse Event|7|||
161833842|NCT00102687|584433240|FG002|Initial Period|Adverse Event|9|||
161833843|NCT00102687|584433241|FG003|Initial Period|Adverse Event|0|||
161833844|NCT00102687|584433242|FG004|Initial Period|Adverse Event|0|||
161833845|NCT00102687|584433238|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
161833846|NCT00102687|584433239|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
161833847|NCT00102687|584433240|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
161833848|NCT00102687|584433241|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
161833849|NCT00102687|584433242|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
161833850|NCT00102687|584433238|FG000|Initial Period|Protocol Violation|0|||
161833851|NCT00102687|584433239|FG001|Initial Period|Protocol Violation|0|||
161833852|NCT00102687|584433240|FG002|Initial Period|Protocol Violation|2|||
161833853|NCT00102687|584433241|FG003|Initial Period|Protocol Violation|0|||
161833854|NCT00102687|584433242|FG004|Initial Period|Protocol Violation|0|||
161833855|NCT00102687|584433238|FG000|Initial Period|Physician Decision|2|||
161833856|NCT00102687|584433239|FG001|Initial Period|Physician Decision|9|||
161632720|NCT00510146|583705715|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
161632721|NCT00510146|583705714|FG000|Double-Blind Treatment|Physician Decision|6|||
161632722|NCT00510146|583705715|FG001|Double-Blind Treatment|Physician Decision|0|||
161632723|NCT00510146|583705714|FG000|Double-Blind Treatment|Protocol Violation|1|||
161833857|NCT00102687|584433240|FG002|Initial Period|Physician Decision|6|||
161833858|NCT00102687|584433241|FG003|Initial Period|Physician Decision|0|||
161833859|NCT00102687|584433242|FG004|Initial Period|Physician Decision|0|||
161833860|NCT00102687|584433238|FG000|Initial Period|Sponsor's decision|0|||
161833861|NCT00102687|584433239|FG001|Initial Period|Sponsor's decision|1|||
161833862|NCT00102687|584433240|FG002|Initial Period|Sponsor's decision|1|||
161833863|NCT00102687|584433241|FG003|Initial Period|Sponsor's decision|0|||
161833864|NCT00102687|584433242|FG004|Initial Period|Sponsor's decision|0|||
161632724|NCT00510146|583705715|FG001|Double-Blind Treatment|Protocol Violation|2|||
161632725|NCT00510146|583705714|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
161632726|NCT00510146|583705715|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
161632727|NCT00510146|583705714|FG000|Double-Blind Treatment|Clinical Relapse|0|||
161632728|NCT00510146|583705715|FG001|Double-Blind Treatment|Clinical Relapse|1|||
161632729|NCT00510146|583705714|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
161632730|NCT00510146|583705715|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
161632731|NCT00510146|583705714|FG000|Open-Label Treatment|Adverse Event|22|||
161632732|NCT00510146|583705715|FG001|Open-Label Treatment|Adverse Event|8|||
161632733|NCT00510146|583705714|FG000|Open-Label Treatment|Death|1|||
161632734|NCT00510146|583705715|FG001|Open-Label Treatment|Death|1|||
161632735|NCT00510146|583705714|FG000|Open-Label Treatment|Lack of Efficacy|4|||
161632736|NCT00510146|583705715|FG001|Open-Label Treatment|Lack of Efficacy|0|||
161632737|NCT00510146|583705714|FG000|Open-Label Treatment|Lost to Follow-up|10|||
161632738|NCT00510146|583705715|FG001|Open-Label Treatment|Lost to Follow-up|1|||
161632739|NCT00510146|583705714|FG000|Open-Label Treatment|Physician Decision|3|||
161632740|NCT00510146|583705715|FG001|Open-Label Treatment|Physician Decision|1|||
161632741|NCT00510146|583705714|FG000|Open-Label Treatment|Protocol Violation|4|||
161632742|NCT00510146|583705715|FG001|Open-Label Treatment|Protocol Violation|2|||
161632743|NCT00510146|583705714|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
161632744|NCT00510146|583705715|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
161632745|NCT00510146|583705714|FG000|Open-Label Treatment|Clinical Relapse|1|||
161632746|NCT00510146|583705715|FG001|Open-Label Treatment|Clinical Relapse|1|||
161632747|NCT00510146|583705714|FG000|Open-Label Treatment|Sponsor Decision|2|||
161632748|NCT00510146|583705715|FG001|Open-Label Treatment|Sponsor Decision|0|||
161632749|NCT03640754|583705716|FG000|Overall Study|Withdrawal by Subject|1|||
161632750|NCT03640754|583705717|FG001|Overall Study|Withdrawal by Subject|0|||
161632751|NCT03640754|583705716|FG000|Overall Study|Lost to Follow-up|0|||
161632752|NCT03640754|583705717|FG001|Overall Study|Lost to Follow-up|1|||
161632753|NCT04380688|583705718|FG000|Overall Study|Death|2|||
161632754|NCT04380688|583705719|FG001|Overall Study|Death|2|||
161632755|NCT04380688|583705718|FG000|Overall Study|Lost to Follow-up|2|||
161632756|NCT04380688|583705719|FG001|Overall Study|Lost to Follow-up|4|||
161632757|NCT04380688|583705718|FG000|Overall Study|Withdrawal by Subject|3|||
161632758|NCT04380688|583705719|FG001|Overall Study|Withdrawal by Subject|3|||
161632759|NCT00919061|583705720|FG000|Overall Study|Adverse Event|1|||
161632760|NCT00919061|583705720|FG000|Overall Study|Withdrawal by Subject|1|||
161632761|NCT05294328|583705721|FG000|Overall Study|Adverse Event|1|||
161632762|NCT05294328|583705722|FG001|Overall Study|Adverse Event|0|||
161632763|NCT05294328|583705723|FG002|Overall Study|Adverse Event|0|||
161632764|NCT05294328|583705721|FG000|Overall Study|Physician Decision|1|||
161632765|NCT05294328|583705722|FG001|Overall Study|Physician Decision|1|||
161632766|NCT05294328|583705723|FG002|Overall Study|Physician Decision|0|||
161632767|NCT05294328|583705721|FG000|Overall Study|Withdrawal by Subject|0|||
161632768|NCT05294328|583705722|FG001|Overall Study|Withdrawal by Subject|2|||
161632769|NCT05294328|583705723|FG002|Overall Study|Withdrawal by Subject|1|||
161632770|NCT05294328|583705721|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
161632771|NCT05294328|583705722|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
161632772|NCT05294328|583705723|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
161632773|NCT02056873|583705724|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
161632774|NCT00988533|583707867|FG000|Overall Study|Lost to Follow-up|3|||
161632775|NCT02544113|583707870|FG000|Overall Study|Death|3|||
161632776|NCT02544113|583707871|FG001|Overall Study|Death|4|||
161632777|NCT02847637|583707875|FG000|Overall Study|Withdrawal by Subject|0|||
161632778|NCT02847637|583707876|FG001|Overall Study|Withdrawal by Subject|1|||
161632779|NCT02847637|583707877|FG002|Overall Study|Withdrawal by Subject|1|||
161632780|NCT02847637|583707878|FG003|Overall Study|Withdrawal by Subject|0|||
161632781|NCT02847637|583707875|FG000|Overall Study|Lost to Follow-up|1|||
161632782|NCT02847637|583707876|FG001|Overall Study|Lost to Follow-up|1|||
161632783|NCT02847637|583707877|FG002|Overall Study|Lost to Follow-up|0|||
161632784|NCT02847637|583707878|FG003|Overall Study|Lost to Follow-up|0|||
161632785|NCT02741713|583707879|FG000|Overall Study|Surgery type changed intra-operatively|2|||
161632786|NCT02741713|583707880|FG001|Overall Study|Surgery type changed intra-operatively|1|||
161632787|NCT00496626|583707881|FG000|Overall Study|Lost to Follow-up|0|||
161632788|NCT00496626|583707882|FG001|Overall Study|Lost to Follow-up|1|||
161632789|NCT00496626|583707881|FG000|Overall Study|Protocol Violation|1|||
161632790|NCT00496626|583707882|FG001|Overall Study|Protocol Violation|0|||
161632791|NCT00496626|583707881|FG000|Overall Study|Withdrawal by Subject|5|||
161632792|NCT00496626|583707882|FG001|Overall Study|Withdrawal by Subject|4|||
161632793|NCT00496626|583707881|FG000|Overall Study|Relocated|0|||
161632794|NCT00496626|583707882|FG001|Overall Study|Relocated|1|||
161632795|NCT04191148|583707885|FG000|Overall Study|Withdrawal by Subject|1|||
161632796|NCT04191148|583707886|FG001|Overall Study|Withdrawal by Subject|0|||
161632797|NCT04191148|583707885|FG000|Overall Study|Adverse Event|1|||
161632798|NCT04191148|583707886|FG001|Overall Study|Adverse Event|0|||
161632799|NCT02647788|583707887|FG000|Overall Study|Lost to Follow-up|13|||
161632800|NCT02647788|583707888|FG001|Overall Study|Lost to Follow-up|11|||
161632801|NCT02647788|583707887|FG000|Overall Study|Did not want opiate|0|||
161632802|NCT02647788|583707888|FG001|Overall Study|Did not want opiate|1|||
161632803|NCT02647788|583707887|FG000|Overall Study|Withdrawal by Subject|1|||
161632804|NCT02647788|583707888|FG001|Overall Study|Withdrawal by Subject|0|||
161632805|NCT02647788|583707887|FG000|Overall Study|Felt itchy with assigned medication|1|||
161632806|NCT02647788|583707888|FG001|Overall Study|Felt itchy with assigned medication|0|||
161632807|NCT02647788|583707887|FG000|Overall Study|Felt nauseous with assigned medication|1|||
161632808|NCT02647788|583707888|FG001|Overall Study|Felt nauseous with assigned medication|1|||
161632809|NCT01274559|583707889|FG000|Overall Study|Adverse Event|57|||
161632810|NCT01274559|583707890|FG001|Overall Study|Adverse Event|13|||
161632811|NCT01274559|583707889|FG000|Overall Study|Death|1|||
161632812|NCT01274559|583707890|FG001|Overall Study|Death|1|||
161632813|NCT01274559|583707889|FG000|Overall Study|Lost to Follow-up|3|||
161632814|NCT01274559|583707890|FG001|Overall Study|Lost to Follow-up|3|||
161632815|NCT01274559|583707889|FG000|Overall Study|Non-compliance with Study Drug|2|||
161632816|NCT01274559|583707890|FG001|Overall Study|Non-compliance with Study Drug|4|||
161632817|NCT01274559|583707889|FG000|Overall Study|Physician Decision|2|||
161632818|NCT01274559|583707890|FG001|Overall Study|Physician Decision|1|||
161632819|NCT01274559|583707889|FG000|Overall Study|Protocol Violation|28|||
161632820|NCT01274559|583707890|FG001|Overall Study|Protocol Violation|23|||
161632821|NCT01274559|583707889|FG000|Overall Study|Study Terminated by Sponsor|79|||
161632822|NCT01274559|583707890|FG001|Overall Study|Study Terminated by Sponsor|87|||
161632823|NCT01274559|583707889|FG000|Overall Study|Withdrawal by Subject|25|||
161632824|NCT01274559|583707890|FG001|Overall Study|Withdrawal by Subject|13|||
161632825|NCT01233999|583707891|FG000|Overall Study|Withdrawal by Subject|1|||
161632826|NCT01233999|583707891|FG000|Overall Study|Lost to Follow-up|1|||
161632827|NCT00129649|583707905|FG000|Overall Study|Withdrawal by Subject|76|||
161632828|NCT00129649|583707906|FG001|Overall Study|Withdrawal by Subject|65|||
161632829|NCT02482935|583707907|FG000|Period 1|Withdrawal by Subject|1|||
161632830|NCT02482935|583707908|FG001|Period 1|Withdrawal by Subject|0|||
161632831|NCT03503162|583707909|FG000|Overall Study|did not meet eligibility|1|||
161632832|NCT02835092|583707910|FG000|Overall Study|Withdrawal by Subject|3|||
161632833|NCT02835092|583707911|FG001|Overall Study|Withdrawal by Subject|6|||
161632834|NCT02835092|583707912|FG002|Overall Study|Withdrawal by Subject|3|||
161632835|NCT02835092|583707910|FG000|Overall Study|Lost to Follow-up|0|||
161632836|NCT02835092|583707911|FG001|Overall Study|Lost to Follow-up|2|||
161632837|NCT02835092|583707912|FG002|Overall Study|Lost to Follow-up|0|||
161632838|NCT01321723|583707913|FG000|Overall Study|Adverse Event|3|||
161632839|NCT01321723|583707914|FG001|Overall Study|Adverse Event|5|||
161632840|NCT01321723|583707915|FG002|Overall Study|Adverse Event|2|||
161632841|NCT01321723|583707913|FG000|Overall Study|Withdrawal by Subject|2|||
161632842|NCT01321723|583707914|FG001|Overall Study|Withdrawal by Subject|0|||
161632843|NCT01321723|583707915|FG002|Overall Study|Withdrawal by Subject|2|||
161632844|NCT02246218|583707916|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161632845|NCT02246218|583707917|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161632846|NCT02246218|583707916|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
161632847|NCT02246218|583707917|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
161632848|NCT02246218|583707916|FG000|Overall Study|Adverse Event|1|||
161632849|NCT02246218|583707917|FG001|Overall Study|Adverse Event|1|||
161632850|NCT02246218|583707916|FG000|Overall Study|Lost to Follow-up|1|||
161632851|NCT02246218|583707917|FG001|Overall Study|Lost to Follow-up|0|||
161632852|NCT02561806|583707918|FG000|Induction Period|Adverse Event|0|||
161632853|NCT02561806|583707919|FG001|Induction Period|Adverse Event|2|||
161632854|NCT02561806|583707918|FG000|Induction Period|Lack of Efficacy|1|||
161632855|NCT02561806|583707919|FG001|Induction Period|Lack of Efficacy|0|||
161632856|NCT02561806|583707918|FG000|Induction Period|Withdrawal by Subject|0|||
161632857|NCT02561806|583707919|FG001|Induction Period|Withdrawal by Subject|2|||
161632858|NCT02561806|583707918|FG000|Induction Period|Site staff became unblinded|1|||
161632859|NCT02561806|583707919|FG001|Induction Period|Site staff became unblinded|0|||
161833865|NCT00102687|584433238|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
161632860|NCT02561806|583707918|FG000|Induction Period|Randomized but not treated|0|||
161632861|NCT02561806|583707919|FG001|Induction Period|Randomized but not treated|1|||
161632862|NCT02561806|583707918|FG000|Maintenance Period|Adverse Event|2|||
161632863|NCT02561806|583707919|FG001|Maintenance Period|Adverse Event|1|||
161632864|NCT02561806|583707918|FG000|Maintenance Period|Lack of Efficacy|3|||
161632865|NCT02561806|583707919|FG001|Maintenance Period|Lack of Efficacy|1|||
161632866|NCT02561806|583707918|FG000|Maintenance Period|Lost to Follow-up|2|||
161632867|NCT02561806|583707919|FG001|Maintenance Period|Lost to Follow-up|2|||
161632868|NCT02561806|583707918|FG000|Maintenance Period|Protocol Violation|1|||
161632869|NCT02561806|583707919|FG001|Maintenance Period|Protocol Violation|0|||
161632870|NCT02561806|583707918|FG000|Maintenance Period|Withdrawal by Subject|5|||
161632871|NCT02561806|583707919|FG001|Maintenance Period|Withdrawal by Subject|3|||
161632872|NCT02561806|583707918|FG000|Maintenance Period|Site staff became unblinded|0|||
161632873|NCT02561806|583707919|FG001|Maintenance Period|Site staff became unblinded|1|||
161632874|NCT02561806|583707918|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
161632875|NCT02561806|583707919|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
161632876|NCT02561806|583707918|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
161632877|NCT02561806|583707919|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
161632878|NCT02547441|583707920|FG000|Double-Blind Study Period|Adverse Event|4|||
161632879|NCT02547441|583707921|FG001|Double-Blind Study Period|Adverse Event|9|||
161632880|NCT02547441|583707920|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
161632881|NCT02547441|583707921|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
161632882|NCT02547441|583707920|FG000|Double-Blind Study Period|Physician Decision|1|||
161632883|NCT02547441|583707921|FG001|Double-Blind Study Period|Physician Decision|0|||
161632884|NCT02547441|583707920|FG000|Double-Blind Study Period|Protocol Violation|1|||
161632885|NCT02547441|583707921|FG001|Double-Blind Study Period|Protocol Violation|2|||
161632886|NCT02547441|583707920|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
161632887|NCT02547441|583707921|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
161632888|NCT02547441|583707920|FG000|Double-Blind Study Period|Sponsor Decision|1|||
161632889|NCT02547441|583707921|FG001|Double-Blind Study Period|Sponsor Decision|0|||
161632890|NCT02547441|583707920|FG000|Open-Label Study Period|Adverse Event|10|||
161632891|NCT02547441|583707921|FG001|Open-Label Study Period|Adverse Event|11|||
161632892|NCT02547441|583707920|FG000|Open-Label Study Period|Lack of Efficacy|3|||
161685964|NCT00105443|583903277|FG003|Double-Blind Treatment|Adverse Event|0|||
161685965|NCT00105443|583903274|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
161685966|NCT00105443|583903275|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
161632893|NCT02547441|583707921|FG001|Open-Label Study Period|Lack of Efficacy|2|||
161685967|NCT00105443|583903276|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
161632894|NCT02547441|583707920|FG000|Open-Label Study Period|Lost to Follow-up|7|||
161632895|NCT02547441|583707921|FG001|Open-Label Study Period|Lost to Follow-up|8|||
161632896|NCT02547441|583707920|FG000|Open-Label Study Period|Physician Decision|1|||
161632897|NCT02547441|583707921|FG001|Open-Label Study Period|Physician Decision|0|||
161632898|NCT02547441|583707920|FG000|Open-Label Study Period|Protocol Violation|2|||
161632899|NCT02547441|583707921|FG001|Open-Label Study Period|Protocol Violation|0|||
161632900|NCT02547441|583707920|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
161632901|NCT02547441|583707921|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
161632902|NCT02547441|583707920|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
161632903|NCT02547441|583707921|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
161632904|NCT01322009|583707922|FG000|Overall Study|Death|0|||
161632905|NCT01322009|583707923|FG001|Overall Study|Death|1|||
161632906|NCT01322009|583707922|FG000|Overall Study|Adverse Event|0|||
161632907|NCT01322009|583707923|FG001|Overall Study|Adverse Event|1|||
161632908|NCT01322009|583707922|FG000|Overall Study|ng tube discontinued|0|||
161632909|NCT01322009|583707923|FG001|Overall Study|ng tube discontinued|1|||
161632910|NCT01657877|583707924|FG000|Overall Study|Withdrawal by Subject|4|||
161632911|NCT01657877|583707924|FG000|Overall Study|Protocol Violation|6|||
161632912|NCT01657877|583707924|FG000|Overall Study|Adverse Event|2|||
161632913|NCT01657877|583707924|FG000|Overall Study|Other Reason|2|||
161632914|NCT00905034|583707925|FG000|Overall Study|Withdrawal by Subject|1|||
161632915|NCT00394589|583707926|FG000|Overall Study|Adverse Event|2|||
161632916|NCT00394589|583707927|FG001|Overall Study|Adverse Event|1|||
161632917|NCT00394589|583707928|FG002|Overall Study|Adverse Event|2|||
161632918|NCT00394589|583707926|FG000|Overall Study|Lack of Efficacy|2|||
161632919|NCT00394589|583707927|FG001|Overall Study|Lack of Efficacy|2|||
161632920|NCT00394589|583707928|FG002|Overall Study|Lack of Efficacy|3|||
161632921|NCT00394589|583707926|FG000|Overall Study|Protocol Violation|4|||
161632922|NCT00394589|583707927|FG001|Overall Study|Protocol Violation|0|||
161632923|NCT00394589|583707928|FG002|Overall Study|Protocol Violation|2|||
161632924|NCT03409731|583707929|FG000|Overall Study|Withdrawal by Subject|17|||
161632925|NCT03409731|583707929|FG000|Overall Study|Death|4|||
161632926|NCT01710800|583707932|FG000|Overall Study|Withdrawal by Subject|21|||
161632927|NCT01710800|583707932|FG000|Overall Study|Protocol Violation|1|||
161632928|NCT01585298|583707936|FG000|Overall Study|Study completion was not documented.|1|||
161632929|NCT01585298|583707936|FG000|Overall Study|Protocol deviation|1|||
161632930|NCT01585298|583707936|FG000|Overall Study|Administrative problems|4|||
161632931|NCT01585298|583707936|FG000|Overall Study|Lost to Follow-up|2|||
161632932|NCT01585298|583707936|FG000|Overall Study|Withdrawal by Subject|4|||
161632933|NCT01585298|583707936|FG000|Overall Study|Abnormal test procedure results|1|||
161632934|NCT01585298|583707936|FG000|Overall Study|Adverse Event|24|||
161632935|NCT01670188|583707937|FG000|Overall Study|Death|0|||
161685968|NCT00105443|583903277|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
161685969|NCT00105443|583903274|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
161685970|NCT00105443|583903275|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
161685971|NCT00105443|583903276|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
161685972|NCT00105443|583903277|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
161685973|NCT00105443|583903274|FG000|Double-Blind Treatment|Physician Decision|1|||
161685974|NCT00105443|583903275|FG001|Double-Blind Treatment|Physician Decision|0|||
161685975|NCT00105443|583903276|FG002|Double-Blind Treatment|Physician Decision|2|||
161833866|NCT00102687|584433239|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
161632936|NCT01670188|583707938|FG001|Overall Study|Death|1|||
161632937|NCT02427958|583707943|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
161632938|NCT02427958|583707943|FG000|Overall Study|Lost to Follow-up|6|||
161632939|NCT02427958|583707943|FG000|Overall Study|Withdrawal by Subject|14|||
161632940|NCT02427958|583707943|FG000|Overall Study|Lack of Efficacy|1|||
161632941|NCT02025985|583707944|FG000|Overall Study|Consent withdrawn|0|||
161632942|NCT02025985|583707945|FG001|Overall Study|Consent withdrawn|0|||
161632943|NCT02025985|583707946|FG002|Overall Study|Consent withdrawn|1|||
161685976|NCT00105443|583903277|FG003|Double-Blind Treatment|Physician Decision|0|||
161685977|NCT00105443|583903274|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
161685978|NCT00105443|583903275|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
161685979|NCT00105443|583903276|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
161685980|NCT00105443|583903277|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
161685981|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
161685982|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
161685983|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
161685984|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
161685985|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
161685986|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
161685987|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
161685988|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
161685989|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
161685990|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
161685991|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
161685992|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
161685993|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
161685994|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
161685995|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
161685996|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
161685997|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
161685998|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
161685999|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
161686000|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
161686001|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161686002|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
161632944|NCT02025985|583707947|FG003|Overall Study|Consent withdrawn|0|||
161632945|NCT02025985|583707948|FG004|Overall Study|Consent withdrawn|0|||
161632946|NCT02025985|583707944|FG000|Overall Study|Termination of study by Sponsor|4|||
161632947|NCT02025985|583707945|FG001|Overall Study|Termination of study by Sponsor|3|||
161632948|NCT02025985|583707946|FG002|Overall Study|Termination of study by Sponsor|1|||
161632949|NCT02025985|583707947|FG003|Overall Study|Termination of study by Sponsor|1|||
161632950|NCT02025985|583707948|FG004|Overall Study|Termination of study by Sponsor|3|||
161632951|NCT02025985|583707944|FG000|Overall Study|Death|21|||
161632952|NCT02025985|583707945|FG001|Overall Study|Death|20|||
161632953|NCT02025985|583707946|FG002|Overall Study|Death|23|||
161632954|NCT02025985|583707947|FG003|Overall Study|Death|20|||
161686003|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161686004|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161686005|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
161686006|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
161686007|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
161632955|NCT02025985|583707948|FG004|Overall Study|Death|17|||
161632956|NCT03175198|583707949|FG000|Overall Study|Adverse Event|480|||
161632957|NCT03175198|583707949|FG000|Overall Study|No actual visit|120|||
161632958|NCT03175198|583707949|FG000|Overall Study|Registration rule not followed|4|||
161833867|NCT00102687|584433240|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
161632959|NCT03175198|583707949|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
161632960|NCT03175198|583707949|FG000|Overall Study|Other personal reason|509|||
161632961|NCT03175198|583707949|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
161632962|NCT03175198|583707949|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
161632963|NCT03175198|583707949|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
161632964|NCT03175198|583707949|FG000|Overall Study|To conduct invasive treatment of operation|53|||
161632965|NCT03175198|583707949|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
161632966|NCT00545571|583707950|FG000|Overall Study|Administrative Reasons|1|||
161632967|NCT00545571|583707950|FG000|Overall Study|Adverse Event|2|||
161632968|NCT00545571|583707950|FG000|Overall Study|Death|5|||
161632969|NCT00545571|583707950|FG000|Overall Study|Lack of Efficacy|1|||
161632970|NCT00545571|583707950|FG000|Overall Study|Protocol Violation|2|||
161632971|NCT00545571|583707950|FG000|Overall Study|Refused Treatment|1|||
161632972|NCT00545571|583707950|FG000|Overall Study|Screen Failure|16|||
161632973|NCT00545571|583707950|FG000|Overall Study|Transfusion|12|||
161632974|NCT00545571|583707950|FG000|Overall Study|Early Termination of Study|24|||
161632975|NCT00545571|583707950|FG000|Overall Study|Kidney Transplantation|3|||
161632976|NCT01978236|583707951|FG000|Overall Study|Discontinued due to study close|2|||
161632977|NCT00874497|583707952|FG000|Overall Study|Lost to Follow-up|2|||
161632978|NCT00874497|583707953|FG001|Overall Study|Lost to Follow-up|4|||
161632979|NCT00874497|583707952|FG000|Overall Study|Adverse Event|9|||
161632980|NCT00874497|583707953|FG001|Overall Study|Adverse Event|4|||
161632981|NCT00874497|583707952|FG000|Overall Study|Sponsor Discontinued Trial|7|||
161632982|NCT00874497|583707953|FG001|Overall Study|Sponsor Discontinued Trial|3|||
161632983|NCT00874497|583707952|FG000|Overall Study|Met Withdrawal Criteria|4|||
161632984|NCT00874497|583707953|FG001|Overall Study|Met Withdrawal Criteria|2|||
161632985|NCT00874497|583707952|FG000|Overall Study|Physician Decision|1|||
161632986|NCT00874497|583707953|FG001|Overall Study|Physician Decision|1|||
161632987|NCT00874497|583707952|FG000|Overall Study|Withdrawal by Subject|5|||
161632988|NCT00874497|583707953|FG001|Overall Study|Withdrawal by Subject|4|||
161632989|NCT00591591|583707954|FG000|Overall Study|Withdrawal by Subject|1|||
161632990|NCT00591591|583707955|FG001|Overall Study|Withdrawal by Subject|37|||
161632991|NCT00591591|583707954|FG000|Overall Study|Lack of Efficacy|10|||
161632992|NCT00591591|583707955|FG001|Overall Study|Lack of Efficacy|2|||
161632993|NCT01013740|583707956|FG000|Overall Study|Lost to Follow-up|3|||
161632994|NCT01013740|583707957|FG001|Overall Study|Lost to Follow-up|5|||
161632995|NCT01013740|583707956|FG000|Overall Study|Physician Decision|2|||
161632996|NCT01013740|583707957|FG001|Overall Study|Physician Decision|0|||
161632997|NCT01013740|583707956|FG000|Overall Study|Withdrawal by Subject|2|||
161632998|NCT01013740|583707957|FG001|Overall Study|Withdrawal by Subject|10|||
161632999|NCT01013740|583707956|FG000|Overall Study|study close / terminated : done in error|2|||
161633000|NCT01013740|583707957|FG001|Overall Study|study close / terminated : done in error|1|||
161633001|NCT01013740|583707956|FG000|Overall Study|Missing|2|||
161633002|NCT01013740|583707957|FG001|Overall Study|Missing|1|||
161633003|NCT01013740|583707956|FG000|Overall Study|Ongoing: Study records not completed|0|||
161633004|NCT01013740|583707957|FG001|Overall Study|Ongoing: Study records not completed|2|||
161633005|NCT00002597|583707958|FG000|Overall Study|Protocol Violation|19|||
161633006|NCT00002597|583707959|FG001|Overall Study|Protocol Violation|17|||
161633007|NCT00002597|583707958|FG000|Overall Study|Withdrawal by Subject|7|||
161633008|NCT00002597|583707959|FG001|Overall Study|Withdrawal by Subject|6|||
161633009|NCT00607997|583707960|FG000|Overall Study|Lack of Efficacy|6|||
161633010|NCT00607997|583707961|FG001|Overall Study|Lack of Efficacy|20|||
161633011|NCT00607997|583707962|FG002|Overall Study|Lack of Efficacy|14|||
161633012|NCT00607997|583707963|FG003|Overall Study|Lack of Efficacy|10|||
161633013|NCT00607997|583707960|FG000|Overall Study|Death|8|||
161633014|NCT00607997|583707961|FG001|Overall Study|Death|5|||
161633015|NCT00607997|583707962|FG002|Overall Study|Death|2|||
161633016|NCT00607997|583707963|FG003|Overall Study|Death|5|||
161633017|NCT00607997|583707960|FG000|Overall Study|Adverse Event|3|||
161633018|NCT00607997|583707961|FG001|Overall Study|Adverse Event|1|||
161633019|NCT00607997|583707962|FG002|Overall Study|Adverse Event|2|||
161633020|NCT00607997|583707963|FG003|Overall Study|Adverse Event|0|||
161633021|NCT00607997|583707960|FG000|Overall Study|Physician Decision|4|||
161633022|NCT00607997|583707961|FG001|Overall Study|Physician Decision|1|||
161633023|NCT00607997|583707962|FG002|Overall Study|Physician Decision|0|||
161633024|NCT00607997|583707963|FG003|Overall Study|Physician Decision|0|||
161633025|NCT00607997|583707960|FG000|Overall Study|Relapse, recurrent illness|4|||
161633026|NCT00607997|583707961|FG001|Overall Study|Relapse, recurrent illness|0|||
161633027|NCT00607997|583707962|FG002|Overall Study|Relapse, recurrent illness|2|||
161633028|NCT00607997|583707963|FG003|Overall Study|Relapse, recurrent illness|0|||
161633029|NCT00607997|583707960|FG000|Overall Study|Other without explanation|2|||
161633030|NCT00607997|583707961|FG001|Overall Study|Other without explanation|0|||
161833868|NCT00102687|584433241|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
161633031|NCT00607997|583707962|FG002|Overall Study|Other without explanation|4|||
161633032|NCT00607997|583707963|FG003|Overall Study|Other without explanation|1|||
161686008|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
161633033|NCT03811834|583707964|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
161633034|NCT01242371|583707965|FG000|Overall Study|Withdrawal by Subject|2|||
161633035|NCT01242371|583707966|FG001|Overall Study|Withdrawal by Subject|2|||
161633036|NCT01242371|583707965|FG000|Overall Study|Protocol Violation|0|||
161633037|NCT01242371|583707966|FG001|Overall Study|Protocol Violation|3|||
161633038|NCT06080438|583707969|FG000|Overall Study|Lost to Follow-up|2|||
161633039|NCT03589300|583707970|FG000|Overall Study|Adverse Event|2|||
161633040|NCT03589300|583707970|FG000|Overall Study|Death|4|||
161633041|NCT03589300|583707970|FG000|Overall Study|Lost to Follow-up|12|||
161633042|NCT03589300|583707970|FG000|Overall Study|Withdrawal by Subject|5|||
161633043|NCT01527500|583707971|FG000|Part A|Administrative|11|||
161633044|NCT01527500|583707972|FG001|Part A|Administrative|7|||
161633045|NCT01527500|583707971|FG000|Part A|Adverse Event|4|||
161633046|NCT01527500|583707972|FG001|Part A|Adverse Event|2|||
161633047|NCT01527500|583707971|FG000|Part A|Death|4|||
161633048|NCT01527500|583707972|FG001|Part A|Death|1|||
161633049|NCT01527500|583707971|FG000|Part A|Lost to Follow-up|0|||
161633050|NCT01527500|583707972|FG001|Part A|Lost to Follow-up|1|||
161633051|NCT01527500|583707971|FG000|Part A|Protocol Deviation|9|||
161633052|NCT01527500|583707972|FG001|Part A|Protocol Deviation|2|||
161633053|NCT01527500|583707971|FG000|Part A|Withdrawal by Subject|2|||
161633054|NCT01527500|583707972|FG001|Part A|Withdrawal by Subject|0|||
161633055|NCT01527500|583707971|FG000|Part B|Adverse Event|1|||
161633056|NCT01527500|583707972|FG001|Part B|Adverse Event|0|||
161633057|NCT00372255|583707973|FG000|Overall Study|Withdrawn for other reasons|2|||
161633058|NCT00372255|583707974|FG001|Overall Study|Withdrawn for other reasons|1|||
161633059|NCT00776984|583707975|FG000|Overall Study|Adverse Event|8|||
161633060|NCT00776984|583707976|FG001|Overall Study|Adverse Event|2|||
161633061|NCT00776984|583707975|FG000|Overall Study|Protocol Violation|4|||
161633062|NCT00776984|583707976|FG001|Overall Study|Protocol Violation|2|||
161633063|NCT00776984|583707975|FG000|Overall Study|Lost to Follow-up|2|||
161633064|NCT00776984|583707976|FG001|Overall Study|Lost to Follow-up|0|||
161633065|NCT00776984|583707975|FG000|Overall Study|Withdrawal by Subject|12|||
161633066|NCT00776984|583707976|FG001|Overall Study|Withdrawal by Subject|7|||
161633067|NCT00776984|583707975|FG000|Overall Study|Lack of Efficacy|0|||
161633068|NCT00776984|583707976|FG001|Overall Study|Lack of Efficacy|1|||
161633069|NCT00776984|583707975|FG000|Overall Study|Other|5|||
161633070|NCT00776984|583707976|FG001|Overall Study|Other|9|||
161633071|NCT02573883|583707982|FG000|Six Month Follow Up|Lost to Follow-up|1|||
161633072|NCT02573883|583707983|FG001|Six Month Follow Up|Lost to Follow-up|0|||
161633073|NCT02573883|583707984|FG002|Six Month Follow Up|Lost to Follow-up|0|||
161633074|NCT02573883|583707985|FG003|Six Month Follow Up|Lost to Follow-up|0|||
161633075|NCT02573883|583707982|FG000|One Year Follow Up|Lost to Follow-up|2|||
161633076|NCT02573883|583707983|FG001|One Year Follow Up|Lost to Follow-up|1|||
161633077|NCT02573883|583707984|FG002|One Year Follow Up|Lost to Follow-up|0|||
161633078|NCT02573883|583707985|FG003|One Year Follow Up|Lost to Follow-up|0|||
161633079|NCT00582114|583707986|FG000|Overall Study|Death|4|||
161633080|NCT00582114|583707987|FG001|Overall Study|Death|4|||
161633081|NCT00582114|583707986|FG000|Overall Study|Kidney Transplant|3|||
161633082|NCT00582114|583707987|FG001|Overall Study|Kidney Transplant|1|||
161633083|NCT00582114|583707986|FG000|Overall Study|Lost to Follow-up|7|||
161633084|NCT00582114|583707987|FG001|Overall Study|Lost to Follow-up|6|||
161686009|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
161686010|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
161686011|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
161686012|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
161686013|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
161633085|NCT00582114|583707986|FG000|Overall Study|Withdrawal by Subject|8|||
161633086|NCT00582114|583707987|FG001|Overall Study|Withdrawal by Subject|16|||
161633087|NCT00582114|583707986|FG000|Overall Study|Adverse Event|1|||
161633088|NCT00582114|583707987|FG001|Overall Study|Adverse Event|1|||
161633089|NCT00582114|583707986|FG000|Overall Study|Physician Decision|0|||
161633090|NCT00582114|583707987|FG001|Overall Study|Physician Decision|6|||
161633091|NCT00582114|583707986|FG000|Overall Study|Stopped by data safety monitoring board|19|||
161633092|NCT00582114|583707987|FG001|Overall Study|Stopped by data safety monitoring board|20|||
161633093|NCT00130728|583707995|FG000|Overall Study|Death|258|||
161633094|NCT00130728|583707996|FG001|Overall Study|Death|258|||
161633095|NCT00130728|583707995|FG000|Overall Study|Lost to Follow-up|4|||
161633096|NCT00130728|583707996|FG001|Overall Study|Lost to Follow-up|0|||
161633097|NCT00130728|583707995|FG000|Overall Study|Withdrawal by Subject|0|||
161633098|NCT00130728|583707996|FG001|Overall Study|Withdrawal by Subject|2|||
161633099|NCT02212197|583707997|FG000|Overall Study|Need for radiotherapy|1|||
161633100|NCT02212197|583707998|FG001|Overall Study|Need for radiotherapy|0|||
161633101|NCT02212197|583707999|FG002|Overall Study|Need for radiotherapy|0|||
161633102|NCT01078584|583708002|FG000|Overall Study|Final Status Unknown|1073|||
161633103|NCT01078584|583708002|FG000|Overall Study|Lost to Follow-up|670|||
161633104|NCT01078584|583708002|FG000|Overall Study|Non-serious Adverse Event|577|||
161633105|NCT01078584|583708002|FG000|Overall Study|Withdrawal of Consent|244|||
161633106|NCT01078584|583708002|FG000|Overall Study|Physician Withdrew from Study|90|||
161633107|NCT01078584|583708002|FG000|Overall Study|Non-compliance|67|||
161633108|NCT01078584|583708002|FG000|Overall Study|Blood Pressure Controlled|49|||
161633109|NCT01078584|583708002|FG000|Overall Study|Physician Switched Medication|26|||
161633110|NCT01078584|583708002|FG000|Overall Study|Physician Discontinued Patient|12|||
161633111|NCT01078584|583708002|FG000|Overall Study|Lack of Efficacy|98|||
161633112|NCT01078584|583708002|FG000|Overall Study|Protocol Violation|75|||
161633113|NCT01078584|583708002|FG000|Overall Study|Serious Adverse Event|27|||
161633114|NCT01078584|583708002|FG000|Overall Study|Multiple Reasons|2|||
161633115|NCT01208870|583708003|FG000|Overall Study|Lost to Follow-up|2|||
161633116|NCT01208870|583708004|FG001|Overall Study|Lost to Follow-up|8|||
161633117|NCT00356759|583708005|FG000|Overall Study|Death|5|||
161633118|NCT00356759|583708006|FG001|Overall Study|Death|2|||
161633119|NCT00356759|583708005|FG000|Overall Study|Withdrawal by Subject|2|||
161633120|NCT00356759|583708006|FG001|Overall Study|Withdrawal by Subject|2|||
161633121|NCT00356759|583708005|FG000|Overall Study|Adverse Event|1|||
161633122|NCT00356759|583708006|FG001|Overall Study|Adverse Event|3|||
161633123|NCT00356759|583708005|FG000|Overall Study|Lost to Follow-up|1|||
161633124|NCT00356759|583708006|FG001|Overall Study|Lost to Follow-up|1|||
161633125|NCT00356759|583708005|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
161633126|NCT00356759|583708006|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
161633127|NCT01204775|583708007|FG000|Overall Study|Poor/non-compliance|0|||
161633128|NCT01204775|583708008|FG001|Overall Study|Poor/non-compliance|1|||
161633129|NCT01204775|583708007|FG000|Overall Study|Withdrawal by Subject|1|||
161633130|NCT01204775|583708008|FG001|Overall Study|Withdrawal by Subject|0|||
161633131|NCT00276016|583708009|FG000|Intervention 1|Withdrawal by Subject|0|||
161633132|NCT00276016|583708010|FG001|Intervention 1|Withdrawal by Subject|1|||
161633133|NCT00276016|583708011|FG002|Intervention 1|Withdrawal by Subject|0|||
161633134|NCT00276016|583708012|FG003|Intervention 1|Withdrawal by Subject|0|||
161633135|NCT00276016|583708013|FG004|Intervention 1|Withdrawal by Subject|0|||
161633136|NCT00276016|583708014|FG005|Intervention 1|Withdrawal by Subject|0|||
161633137|NCT05041439|583708015|FG000|Overall Study|Withdrawal by Subject|1|||
161633138|NCT05041439|583708016|FG001|Overall Study|Withdrawal by Subject|1|||
161633139|NCT05041439|583708015|FG000|Overall Study|Death|1|||
161633140|NCT05041439|583708016|FG001|Overall Study|Death|0|||
161833869|NCT00102687|584433242|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
161833870|NCT00102687|584433238|FG000|Initial Period|Death|1|||
161633141|NCT02979613|583708017|FG000|Double-Blind Phase|Withdrew Consent|2|||
161633142|NCT02979613|583708018|FG001|Double-Blind Phase|Withdrew Consent|4|||
161633143|NCT02979613|583708017|FG000|Double-Blind Phase|Pregnancy|2|||
161633144|NCT02979613|583708018|FG001|Double-Blind Phase|Pregnancy|2|||
161633145|NCT02979613|583708017|FG000|Double-Blind Phase|Adverse Event|2|||
161633146|NCT02979613|583708018|FG001|Double-Blind Phase|Adverse Event|0|||
161633147|NCT02979613|583708017|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161633148|NCT02979613|583708018|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161633149|NCT02979613|583708017|FG000|Double-Blind Phase|Protocol Violation|1|||
161633150|NCT02979613|583708018|FG001|Double-Blind Phase|Protocol Violation|1|||
161633151|NCT02979613|583708017|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
161633152|NCT02979613|583708018|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
161633153|NCT02979613|583708017|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
161633154|NCT02979613|583708018|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
161633155|NCT02979613|583708017|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
161633156|NCT02979613|583708018|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161633157|NCT02979613|583708017|FG000|Open-Label Extension (OLE) Phase|Death|0|||
161633158|NCT02979613|583708018|FG001|Open-Label Extension (OLE) Phase|Death|1|||
161633159|NCT02979613|583708017|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
161633160|NCT02979613|583708018|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
161633161|NCT01181609|583709861|FG000|Overall Study|Adverse Event|1|||
161633162|NCT01181609|583709861|FG000|Overall Study|Withdrawal by Subject|1|||
161633163|NCT01181609|583709861|FG000|Overall Study|Lost to Follow-up|1|||
161633164|NCT01181609|583709861|FG000|Overall Study|Death|50|||
161633165|NCT03991988|583709865|FG000|Overall Study|Withdrawal by Subject|2|||
161633166|NCT03991988|583709866|FG001|Overall Study|Withdrawal by Subject|2|||
161633167|NCT00408928|583709870|FG000|Overall Study|Withdrawal by Subject|1|||
161633168|NCT00408928|583709870|FG000|Overall Study|Death|1|||
161633169|NCT00408928|583709870|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
161633170|NCT01751165|583709871|FG000|Overall Study|Adverse event, serious fatal|1|||
161633171|NCT01751165|583709872|FG001|Overall Study|Adverse event, serious fatal|0|||
161633172|NCT01751165|583709873|FG002|Overall Study|Adverse event, serious fatal|1|||
161633173|NCT01751165|583709871|FG000|Overall Study|Withdrawal by Subject|0|||
161633174|NCT01751165|583709872|FG001|Overall Study|Withdrawal by Subject|0|||
161633175|NCT01751165|583709873|FG002|Overall Study|Withdrawal by Subject|1|||
161633176|NCT01751165|583709871|FG000|Overall Study|Serious adverse event|0|||
161633177|NCT01751165|583709872|FG001|Overall Study|Serious adverse event|2|||
161633178|NCT01751165|583709873|FG002|Overall Study|Serious adverse event|0|||
161633179|NCT01751165|583709871|FG000|Overall Study|Lost to Follow-up|1|||
161633180|NCT01751165|583709872|FG001|Overall Study|Lost to Follow-up|1|||
161633181|NCT01751165|583709873|FG002|Overall Study|Lost to Follow-up|1|||
161633182|NCT01036165|583709874|FG000|Overall Study|Adverse Event|6|||
161633183|NCT01036165|583709874|FG000|Overall Study|Lost to Follow-up|2|||
161633184|NCT01036165|583709874|FG000|Overall Study|Withdrawal by Subject|3|||
161633185|NCT01036165|583709874|FG000|Overall Study|Device Related Issues|3|||
161633186|NCT01036165|583709874|FG000|Overall Study|Problems finding proper area to inject|1|||
161633187|NCT01475461|583709876|FG000|Run-in Period|Not meet eligibility criteria|16|||
161633188|NCT01475461|583709877|FG001|Run-in Period|Not meet eligibility criteria|0|||
161633189|NCT01475461|583709878|FG002|Run-in Period|Not meet eligibility criteria|0|||
161633190|NCT01475461|583709879|FG003|Run-in Period|Not meet eligibility criteria|0|||
161633191|NCT01475461|583709880|FG004|Run-in Period|Not meet eligibility criteria|0|||
161633192|NCT01475461|583709881|FG005|Run-in Period|Not meet eligibility criteria|0|||
161633193|NCT01475461|583709882|FG006|Run-in Period|Not meet eligibility criteria|0|||
161633194|NCT01475461|583709876|FG000|Run-in Period|Lost to Follow-up|7|||
161633195|NCT01475461|583709877|FG001|Run-in Period|Lost to Follow-up|0|||
161633196|NCT01475461|583709878|FG002|Run-in Period|Lost to Follow-up|0|||
161633197|NCT01475461|583709879|FG003|Run-in Period|Lost to Follow-up|0|||
161633198|NCT01475461|583709880|FG004|Run-in Period|Lost to Follow-up|0|||
161633199|NCT01475461|583709881|FG005|Run-in Period|Lost to Follow-up|0|||
161633200|NCT01475461|583709882|FG006|Run-in Period|Lost to Follow-up|0|||
161633201|NCT01475461|583709876|FG000|Run-in Period|Withdrawal by Subject|11|||
161633202|NCT01475461|583709877|FG001|Run-in Period|Withdrawal by Subject|0|||
161633203|NCT01475461|583709878|FG002|Run-in Period|Withdrawal by Subject|0|||
161633204|NCT01475461|583709879|FG003|Run-in Period|Withdrawal by Subject|0|||
161633205|NCT01475461|583709880|FG004|Run-in Period|Withdrawal by Subject|0|||
161633206|NCT01475461|583709881|FG005|Run-in Period|Withdrawal by Subject|0|||
161633207|NCT01475461|583709882|FG006|Run-in Period|Withdrawal by Subject|0|||
161633208|NCT01475461|583709876|FG000|Run-in Period|Other|3|||
161633209|NCT01475461|583709877|FG001|Run-in Period|Other|0|||
161633210|NCT01475461|583709878|FG002|Run-in Period|Other|0|||
161633211|NCT01475461|583709879|FG003|Run-in Period|Other|0|||
161633212|NCT01475461|583709880|FG004|Run-in Period|Other|0|||
161633213|NCT01475461|583709881|FG005|Run-in Period|Other|0|||
161633214|NCT01475461|583709882|FG006|Run-in Period|Other|0|||
161633215|NCT01475461|583709876|FG000|Run-in Period|Protocol Violation|4|||
161633216|NCT01475461|583709877|FG001|Run-in Period|Protocol Violation|0|||
161633217|NCT01475461|583709878|FG002|Run-in Period|Protocol Violation|0|||
161633218|NCT01475461|583709879|FG003|Run-in Period|Protocol Violation|0|||
161633219|NCT01475461|583709880|FG004|Run-in Period|Protocol Violation|0|||
161633220|NCT01475461|583709881|FG005|Run-in Period|Protocol Violation|0|||
161633221|NCT01475461|583709882|FG006|Run-in Period|Protocol Violation|0|||
161633222|NCT01475461|583709876|FG000|Treatment Period|Death|0|||
161633223|NCT01475461|583709877|FG001|Treatment Period|Death|0|||
161633224|NCT01475461|583709878|FG002|Treatment Period|Death|0|||
161633225|NCT01475461|583709879|FG003|Treatment Period|Death|1|||
161633226|NCT01475461|583709880|FG004|Treatment Period|Death|0|||
161633227|NCT01475461|583709881|FG005|Treatment Period|Death|0|||
161633228|NCT01475461|583709882|FG006|Treatment Period|Death|0|||
161633229|NCT01475461|583709876|FG000|Treatment Period|Lost to Follow-up|0|||
161633230|NCT01475461|583709877|FG001|Treatment Period|Lost to Follow-up|3|||
161633231|NCT01475461|583709878|FG002|Treatment Period|Lost to Follow-up|2|||
161633232|NCT01475461|583709879|FG003|Treatment Period|Lost to Follow-up|3|||
161633233|NCT01475461|583709880|FG004|Treatment Period|Lost to Follow-up|1|||
161633234|NCT01475461|583709881|FG005|Treatment Period|Lost to Follow-up|2|||
161633235|NCT01475461|583709882|FG006|Treatment Period|Lost to Follow-up|1|||
161633236|NCT01475461|583709876|FG000|Treatment Period|Withdrawal by Subject|0|||
161633237|NCT01475461|583709877|FG001|Treatment Period|Withdrawal by Subject|2|||
161633238|NCT01475461|583709878|FG002|Treatment Period|Withdrawal by Subject|2|||
161633239|NCT01475461|583709879|FG003|Treatment Period|Withdrawal by Subject|0|||
161633240|NCT01475461|583709880|FG004|Treatment Period|Withdrawal by Subject|2|||
161633241|NCT01475461|583709881|FG005|Treatment Period|Withdrawal by Subject|2|||
161633242|NCT01475461|583709882|FG006|Treatment Period|Withdrawal by Subject|0|||
161633243|NCT01475461|583709876|FG000|Treatment Period|Other|0|||
161633244|NCT01475461|583709877|FG001|Treatment Period|Other|1|||
161633245|NCT01475461|583709878|FG002|Treatment Period|Other|0|||
161633246|NCT01475461|583709879|FG003|Treatment Period|Other|0|||
161633247|NCT01475461|583709880|FG004|Treatment Period|Other|0|||
161633248|NCT01475461|583709881|FG005|Treatment Period|Other|0|||
161633249|NCT01475461|583709882|FG006|Treatment Period|Other|0|||
161633250|NCT01475461|583709876|FG000|Treatment Period|Protocol Violation|0|||
161633251|NCT01475461|583709877|FG001|Treatment Period|Protocol Violation|1|||
161633252|NCT01475461|583709878|FG002|Treatment Period|Protocol Violation|0|||
161633253|NCT01475461|583709879|FG003|Treatment Period|Protocol Violation|0|||
161633254|NCT01475461|583709880|FG004|Treatment Period|Protocol Violation|0|||
161633255|NCT01475461|583709881|FG005|Treatment Period|Protocol Violation|0|||
161633256|NCT01475461|583709882|FG006|Treatment Period|Protocol Violation|1|||
161633257|NCT01475461|583709876|FG000|Treatment Period|Lack of Efficacy|0|||
161633258|NCT01475461|583709877|FG001|Treatment Period|Lack of Efficacy|2|||
161633259|NCT01475461|583709878|FG002|Treatment Period|Lack of Efficacy|0|||
161633260|NCT01475461|583709879|FG003|Treatment Period|Lack of Efficacy|2|||
161633261|NCT01475461|583709880|FG004|Treatment Period|Lack of Efficacy|1|||
161633262|NCT01475461|583709881|FG005|Treatment Period|Lack of Efficacy|1|||
161633263|NCT01475461|583709882|FG006|Treatment Period|Lack of Efficacy|0|||
161633264|NCT01475461|583709876|FG000|Treatment Period|Medication Error|0|||
161633265|NCT01475461|583709877|FG001|Treatment Period|Medication Error|0|||
161633266|NCT01475461|583709878|FG002|Treatment Period|Medication Error|0|||
161633267|NCT01475461|583709879|FG003|Treatment Period|Medication Error|1|||
161633268|NCT01475461|583709880|FG004|Treatment Period|Medication Error|0|||
161633269|NCT01475461|583709881|FG005|Treatment Period|Medication Error|0|||
161633270|NCT01475461|583709882|FG006|Treatment Period|Medication Error|0|||
161633271|NCT01475461|583709876|FG000|Treatment Period|Adverse Event|0|||
161633272|NCT01475461|583709877|FG001|Treatment Period|Adverse Event|0|||
161833871|NCT00102687|584433239|FG001|Initial Period|Death|1|||
161833872|NCT00102687|584433240|FG002|Initial Period|Death|1|||
161833873|NCT00102687|584433241|FG003|Initial Period|Death|0|||
161833874|NCT00102687|584433242|FG004|Initial Period|Death|0|||
161833875|NCT00102687|584433238|FG000|Maintenance Period|Withdrawal by Subject|4|||
161833876|NCT00102687|584433239|FG001|Maintenance Period|Withdrawal by Subject|0|||
161833877|NCT00102687|584433240|FG002|Maintenance Period|Withdrawal by Subject|2|||
161833878|NCT00102687|584433241|FG003|Maintenance Period|Withdrawal by Subject|3|||
161833879|NCT00102687|584433242|FG004|Maintenance Period|Withdrawal by Subject|1|||
161633273|NCT01475461|583709878|FG002|Treatment Period|Adverse Event|0|||
161633274|NCT01475461|583709879|FG003|Treatment Period|Adverse Event|1|||
161633275|NCT01475461|583709880|FG004|Treatment Period|Adverse Event|0|||
161633276|NCT01475461|583709881|FG005|Treatment Period|Adverse Event|0|||
161633277|NCT01475461|583709882|FG006|Treatment Period|Adverse Event|0|||
161633278|NCT04051242|583709883|FG000|Overall Study|Withdrawal by Subject|1|||
161633279|NCT04051242|583709883|FG000|Overall Study|Physician Decision|1|||
161633280|NCT02262364|583709886|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
161633281|NCT01049984|583709887|FG000|Overall Study|Withdrawal by Subject|1|||
161833880|NCT00102687|584433238|FG000|Maintenance Period|Adverse Event|1|||
161833881|NCT00102687|584433239|FG001|Maintenance Period|Adverse Event|0|||
161833882|NCT00102687|584433240|FG002|Maintenance Period|Adverse Event|0|||
161633282|NCT01049984|583709888|FG001|Overall Study|Withdrawal by Subject|5|||
161633283|NCT01049984|583709887|FG000|Overall Study|Protocol Violation|3|||
161633284|NCT01049984|583709888|FG001|Overall Study|Protocol Violation|4|||
161633285|NCT01049984|583709887|FG000|Overall Study|Lost to Follow-up|2|||
161633286|NCT01049984|583709888|FG001|Overall Study|Lost to Follow-up|1|||
161633287|NCT01049984|583709887|FG000|Overall Study|Adverse Event|13|||
161633288|NCT01049984|583709888|FG001|Overall Study|Adverse Event|7|||
161633289|NCT01049984|583709887|FG000|Overall Study|Treatment failure|0|||
161633290|NCT01049984|583709888|FG001|Overall Study|Treatment failure|2|||
161633291|NCT02512861|583709889|FG000|Overall Study|Protocol Violation|3|||
161833883|NCT00102687|584433241|FG003|Maintenance Period|Adverse Event|1|||
161833884|NCT00102687|584433242|FG004|Maintenance Period|Adverse Event|3|||
161633292|NCT02512861|583709890|FG001|Overall Study|Protocol Violation|7|||
161633293|NCT02512861|583709889|FG000|Overall Study|Physician Decision|3|||
161633294|NCT02512861|583709890|FG001|Overall Study|Physician Decision|1|||
161633295|NCT02512861|583709889|FG000|Overall Study|Withdrawal by Subject|0|||
161633296|NCT02512861|583709890|FG001|Overall Study|Withdrawal by Subject|1|||
161633297|NCT00337285|583709891|FG000|Overall Study|Withdrawal by Subject|42|||
161633298|NCT00337285|583709891|FG000|Overall Study|Lost to Follow-up|41|||
161633299|NCT00337285|583709891|FG000|Overall Study|Adverse Event|28|||
161633300|NCT00337285|583709891|FG000|Overall Study|Protocol Violation|27|||
161633301|NCT00337285|583709891|FG000|Overall Study|Lack of Efficacy|11|||
161633302|NCT00337285|583709891|FG000|Overall Study|Death|1|||
161633303|NCT00337285|583709891|FG000|Overall Study|Physician Decision|1|||
161633304|NCT00337285|583709891|FG000|Overall Study|Lack of protocol compliance|7|||
161633305|NCT00553605|583709892|FG000|Overall Study|Did not meet entrance criteria|1|||
161633306|NCT00553605|583709893|FG001|Overall Study|Did not meet entrance criteria|3|||
161633307|NCT00553605|583709892|FG000|Overall Study|Did not receive full dose|1|||
161633308|NCT00553605|583709893|FG001|Overall Study|Did not receive full dose|0|||
161633309|NCT00553605|583709892|FG000|Overall Study|Randomized but not treated|2|||
161633310|NCT00553605|583709893|FG001|Overall Study|Randomized but not treated|0|||
161633311|NCT01040403|583709897|FG000|Overall Study|Adverse Event|10|||
161633312|NCT01040403|583709897|FG000|Overall Study|Protocol Violation|2|||
161633313|NCT01040403|583709897|FG000|Overall Study|Lost to Follow-up|1|||
161633314|NCT01040403|583709897|FG000|Overall Study|Not treated|1|||
161633315|NCT01040403|583709897|FG000|Overall Study|Other reason not defined above|6|||
161633316|NCT00292981|583709899|FG000|Overall Study|Adverse Event|1|||
161633317|NCT00292981|583709899|FG000|Overall Study|Lost to Follow-up|13|||
161633318|NCT00292981|583709899|FG000|Overall Study|Withdrawal by Subject|22|||
161633319|NCT00292981|583709899|FG000|Overall Study|Other|3|||
161633320|NCT01085812|583709900|FG000|Open-Label Period|Adverse Event|0|||
161633321|NCT01085812|583709901|FG001|Open-Label Period|Adverse Event|80|||
161633322|NCT01085812|583709900|FG000|Open-Label Period|Lack of Efficacy|0|||
161633323|NCT01085812|583709901|FG001|Open-Label Period|Lack of Efficacy|26|||
161633324|NCT01085812|583709900|FG000|Open-Label Period|Protocol Violation|0|||
161633325|NCT01085812|583709901|FG001|Open-Label Period|Protocol Violation|39|||
161633326|NCT01085812|583709900|FG000|Open-Label Period|Withdrawal by Subject|0|||
161633327|NCT01085812|583709901|FG001|Open-Label Period|Withdrawal by Subject|53|||
161633328|NCT01085812|583709900|FG000|Open-Label Period|Lost to Follow-up|0|||
161633329|NCT01085812|583709901|FG001|Open-Label Period|Lost to Follow-up|42|||
161633330|NCT01085812|583709900|FG000|Double-Blind Period|Adverse Event|3|||
161633331|NCT01085812|583709901|FG001|Double-Blind Period|Adverse Event|8|||
161633332|NCT01085812|583709900|FG000|Double-Blind Period|Protocol Violation|2|||
161633333|NCT01085812|583709901|FG001|Double-Blind Period|Protocol Violation|7|||
161633334|NCT01085812|583709900|FG000|Double-Blind Period|Withdrawal by Subject|11|||
161633335|NCT01085812|583709901|FG001|Double-Blind Period|Withdrawal by Subject|24|||
161633336|NCT01085812|583709900|FG000|Double-Blind Period|Lost to Follow-up|5|||
161633337|NCT01085812|583709901|FG001|Double-Blind Period|Lost to Follow-up|17|||
161633338|NCT01085812|583709900|FG000|Double-Blind Period|Other Reasons|0|||
161633339|NCT01085812|583709901|FG001|Double-Blind Period|Other Reasons|2|||
161633340|NCT01085812|583709900|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
161633341|NCT01085812|583709901|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
161633342|NCT01085812|583709900|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
161633343|NCT01085812|583709901|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
161633344|NCT01085812|583709900|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
161633345|NCT01085812|583709901|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
161633346|NCT01085812|583709900|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
161633347|NCT01085812|583709901|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
161633348|NCT01085812|583709900|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
161633349|NCT01085812|583709901|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
161633350|NCT00594178|583709904|FG000|Overall Study|Physician Decision|5|||
161633351|NCT04582669|583709913|FG000|Overall Study|Subject missed appointment(s).|1|||
161633352|NCT04582669|583709914|FG001|Overall Study|Subject missed appointment(s).|0|||
161633353|NCT04582669|583709915|FG002|Overall Study|Subject missed appointment(s).|1|||
161633354|NCT04582669|583709916|FG003|Overall Study|Subject missed appointment(s).|2|||
161633355|NCT04582669|583709913|FG000|Overall Study|Protocol Violation|0|||
161633356|NCT04582669|583709914|FG001|Overall Study|Protocol Violation|1|||
161633357|NCT04582669|583709915|FG002|Overall Study|Protocol Violation|1|||
161633358|NCT04582669|583709916|FG003|Overall Study|Protocol Violation|0|||
161633359|NCT01874665|583709917|FG000|Overall Study|Adverse Event|6|||
161633360|NCT01874665|583709918|FG001|Overall Study|Adverse Event|2|||
161633361|NCT01874665|583709917|FG000|Overall Study|Withdrawal by Subject|4|||
161633362|NCT01874665|583709918|FG001|Overall Study|Withdrawal by Subject|1|||
161633363|NCT01874665|583709917|FG000|Overall Study|Physician Decision|3|||
161633364|NCT01874665|583709918|FG001|Overall Study|Physician Decision|0|||
161633365|NCT01874665|583709917|FG000|Overall Study|Clinical Progressive Disease|4|||
161633366|NCT01874665|583709918|FG001|Overall Study|Clinical Progressive Disease|3|||
161633367|NCT01874665|583709917|FG000|Overall Study|Study Terminated by Sponsor|0|||
161633368|NCT01874665|583709918|FG001|Overall Study|Study Terminated by Sponsor|2|||
161633369|NCT01874665|583709917|FG000|Overall Study|Documented Progressive Disease|11|||
161633370|NCT01874665|583709918|FG001|Overall Study|Documented Progressive Disease|7|||
161633371|NCT01874665|583709917|FG000|Overall Study|Other|2|||
161633372|NCT01874665|583709918|FG001|Overall Study|Other|0|||
161633373|NCT02447432|583709919|FG000|Epoch 001|Adverse Event|1|||
161633374|NCT02447432|583709920|FG001|Epoch 001|Adverse Event|1|||
161633375|NCT02447432|583709919|FG000|Epoch 001|Withdrawal by Subject|0|||
161633376|NCT02447432|583709920|FG001|Epoch 001|Withdrawal by Subject|4|||
161633377|NCT02447432|583709919|FG000|Epoch 001|Migrated/moved from study area|3|||
161633378|NCT02447432|583709920|FG001|Epoch 001|Migrated/moved from study area|5|||
161633379|NCT02447432|583709919|FG000|Epoch 001|Lost to Follow-up|1|||
161633380|NCT02447432|583709920|FG001|Epoch 001|Lost to Follow-up|3|||
161633381|NCT03245619|583709923|FG000|Part A (Up to Day 22)|Physician Decision|4|||
161633382|NCT03245619|583709924|FG001|Part A (Up to Day 22)|Physician Decision|6|||
161633383|NCT03245619|583709925|FG002|Part A (Up to Day 22)|Physician Decision|6|||
161633384|NCT03245619|583709926|FG003|Part A (Up to Day 22)|Physician Decision|0|||
161633385|NCT03245619|583709927|FG004|Part A (Up to Day 22)|Physician Decision|0|||
161633386|NCT03245619|583709928|FG005|Part A (Up to Day 22)|Physician Decision|0|||
161633387|NCT03245619|583709929|FG006|Part A (Up to Day 22)|Physician Decision|0|||
161633388|NCT03245619|583709930|FG007|Part A (Up to Day 22)|Physician Decision|0|||
161633389|NCT03245619|583709931|FG008|Part A (Up to Day 22)|Physician Decision|0|||
161633390|NCT03245619|583709932|FG009|Part A (Up to Day 22)|Physician Decision|0|||
161633391|NCT03245619|583709933|FG010|Part A (Up to Day 22)|Physician Decision|0|||
161633392|NCT03245619|583709934|FG011|Part A (Up to Day 22)|Physician Decision|0|||
161633393|NCT03245619|583709935|FG012|Part A (Up to Day 22)|Physician Decision|0|||
161633394|NCT03245619|583709936|FG013|Part A (Up to Day 22)|Physician Decision|0|||
161633395|NCT03245619|583709937|FG014|Part A (Up to Day 22)|Physician Decision|0|||
161633396|NCT03245619|583709938|FG015|Part A (Up to Day 22)|Physician Decision|0|||
161633397|NCT03245619|583709939|FG016|Part A (Up to Day 22)|Physician Decision|0|||
161633398|NCT00776659|583709956|FG000|Overall Study|Lost to Follow-up|15|||
161633399|NCT00776659|583709956|FG000|Overall Study|Withdrawal by Subject|10|||
161633400|NCT00776659|583709956|FG000|Overall Study|Study Terminated by Sponsor|1|||
161633401|NCT02971228|583709957|FG000|Overall Study|Withdrawal by Subject|1|||
161633402|NCT02971228|583709958|FG001|Overall Study|Withdrawal by Subject|1|||
161633403|NCT02971228|583709959|FG002|Overall Study|Withdrawal by Subject|0|||
161633404|NCT02971228|583709960|FG003|Overall Study|Withdrawal by Subject|0|||
161633405|NCT02971228|583709961|FG004|Overall Study|Withdrawal by Subject|0|||
161633406|NCT02971228|583709957|FG000|Overall Study|Logistical challenges|0|||
161633407|NCT02971228|583709958|FG001|Overall Study|Logistical challenges|1|||
161633408|NCT02971228|583709959|FG002|Overall Study|Logistical challenges|0|||
161633409|NCT02971228|583709960|FG003|Overall Study|Logistical challenges|0|||
161633410|NCT02971228|583709961|FG004|Overall Study|Logistical challenges|0|||
161633411|NCT01167192|583709964|FG000|Overall Study|Adverse Event|1|||
161633412|NCT01167192|583709964|FG000|Overall Study|Death|1|||
161633413|NCT01167192|583709964|FG000|Overall Study|Withdrawal by Subject|1|||
161633414|NCT01167192|583709964|FG000|Overall Study|Insurance denial|1|||
161633415|NCT01336205|583709965|FG000|Overall Study|Other|22|||
161633416|NCT01336205|583709966|FG001|Overall Study|Other|9|||
161633417|NCT01336205|583709965|FG000|Overall Study|Lost to Follow-up|40|||
161633418|NCT01336205|583709966|FG001|Overall Study|Lost to Follow-up|20|||
161633419|NCT01336205|583709965|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
161633420|NCT01336205|583709966|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
161633421|NCT01336205|583709965|FG000|Overall Study|Lack of Efficacy|4|||
161633422|NCT01336205|583709966|FG001|Overall Study|Lack of Efficacy|0|||
161633423|NCT01336205|583709965|FG000|Overall Study|Severe noncompliance with protocol|9|||
161633424|NCT01336205|583709966|FG001|Overall Study|Severe noncompliance with protocol|2|||
161633425|NCT01336205|583709965|FG000|Overall Study|Adverse Event|56|||
161633426|NCT01336205|583709966|FG001|Overall Study|Adverse Event|6|||
161633427|NCT01336205|583709965|FG000|Overall Study|Death|1|||
161633428|NCT01336205|583709966|FG001|Overall Study|Death|1|||
161633429|NCT01336205|583709965|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
161633430|NCT01336205|583709966|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
161633431|NCT01336205|583709965|FG000|Overall Study|Withdrawal by Subject|72|||
161633432|NCT01336205|583709966|FG001|Overall Study|Withdrawal by Subject|38|||
161633433|NCT01336205|583709965|FG000|Overall Study|Did not receive treatment|4|||
161633434|NCT01336205|583709966|FG001|Overall Study|Did not receive treatment|0|||
161633435|NCT04952701|583709967|FG000|Control Lens|Physician Decision|4|||
161633436|NCT04952701|583709967|FG000|Test Lens|Physician Decision|1|||
161633437|NCT04545476|583709970|FG000|Overall Study|Lost to Follow-up|1|||
161633438|NCT04545476|583709971|FG001|Overall Study|Lost to Follow-up|1|||
161633439|NCT04545476|583709972|FG002|Overall Study|Lost to Follow-up|0|||
161633440|NCT04545476|583709973|FG003|Overall Study|Lost to Follow-up|0|||
161633441|NCT00505414|583709979|FG000|Titration Phase|Adverse Event|0|||
161633442|NCT00505414|583709980|FG001|Titration Phase|Adverse Event|0|||
161633443|NCT00505414|583709981|FG002|Titration Phase|Adverse Event|0|||
161633444|NCT00505414|583709982|FG003|Titration Phase|Adverse Event|8|||
161633445|NCT00505414|583709983|FG004|Titration Phase|Adverse Event|3|||
161633446|NCT00505414|583709979|FG000|Titration Phase|Death|0|||
161633447|NCT00505414|583709980|FG001|Titration Phase|Death|0|||
161633448|NCT00505414|583709981|FG002|Titration Phase|Death|0|||
161633449|NCT00505414|583709982|FG003|Titration Phase|Death|2|||
161633450|NCT00505414|583709983|FG004|Titration Phase|Death|0|||
161633451|NCT00505414|583709979|FG000|Titration Phase|Lack of Efficacy|0|||
161633452|NCT00505414|583709980|FG001|Titration Phase|Lack of Efficacy|0|||
161633453|NCT00505414|583709981|FG002|Titration Phase|Lack of Efficacy|0|||
161633454|NCT00505414|583709982|FG003|Titration Phase|Lack of Efficacy|10|||
161633455|NCT00505414|583709983|FG004|Titration Phase|Lack of Efficacy|1|||
161633456|NCT00505414|583709979|FG000|Titration Phase|Protocol Violation|0|||
161633457|NCT00505414|583709980|FG001|Titration Phase|Protocol Violation|0|||
161633458|NCT00505414|583709981|FG002|Titration Phase|Protocol Violation|0|||
161633459|NCT00505414|583709982|FG003|Titration Phase|Protocol Violation|0|||
161633460|NCT00505414|583709983|FG004|Titration Phase|Protocol Violation|1|||
161633461|NCT00505414|583709979|FG000|Titration Phase|Withdrawal by Subject|0|||
161633462|NCT00505414|583709980|FG001|Titration Phase|Withdrawal by Subject|0|||
161633463|NCT00505414|583709981|FG002|Titration Phase|Withdrawal by Subject|0|||
161633464|NCT00505414|583709982|FG003|Titration Phase|Withdrawal by Subject|3|||
161633465|NCT00505414|583709983|FG004|Titration Phase|Withdrawal by Subject|4|||
161633466|NCT00505414|583709979|FG000|Titration Phase|Underlying disease and therapy required|0|||
161633467|NCT00505414|583709980|FG001|Titration Phase|Underlying disease and therapy required|0|||
161633468|NCT00505414|583709981|FG002|Titration Phase|Underlying disease and therapy required|0|||
161633469|NCT00505414|583709982|FG003|Titration Phase|Underlying disease and therapy required|7|||
161833885|NCT00102687|584433238|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161833886|NCT00102687|584433239|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
161633470|NCT00505414|583709983|FG004|Titration Phase|Underlying disease and therapy required|3|||
161633471|NCT00505414|583709979|FG000|Maintenance Phase|Adverse Event|2|||
161833887|NCT00102687|584433240|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161833888|NCT00102687|584433241|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
161833889|NCT00102687|584433242|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161833890|NCT00102687|584433238|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161833891|NCT00102687|584433239|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161833892|NCT00102687|584433240|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161833893|NCT00102687|584433241|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
161833894|NCT00102687|584433242|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
161833895|NCT00102687|584433238|FG000|Maintenance Period|Death|0|||
161833896|NCT00102687|584433239|FG001|Maintenance Period|Death|0|||
161833897|NCT00102687|584433240|FG002|Maintenance Period|Death|0|||
161633472|NCT00505414|583709980|FG001|Maintenance Phase|Adverse Event|2|||
161633473|NCT00505414|583709981|FG002|Maintenance Phase|Adverse Event|3|||
161633474|NCT00505414|583709982|FG003|Maintenance Phase|Adverse Event|0|||
161833898|NCT00102687|584433241|FG003|Maintenance Period|Death|1|||
161833899|NCT00102687|584433242|FG004|Maintenance Period|Death|1|||
161833900|NCT00102687|584433238|FG000|Maintenance Period|Physician Decision|1|||
161633475|NCT00505414|583709983|FG004|Maintenance Phase|Adverse Event|0|||
161633476|NCT00505414|583709979|FG000|Maintenance Phase|Death|2|||
161633477|NCT00505414|583709980|FG001|Maintenance Phase|Death|0|||
161833901|NCT00102687|584433239|FG001|Maintenance Period|Physician Decision|2|||
161633478|NCT00505414|583709981|FG002|Maintenance Phase|Death|1|||
161633479|NCT00505414|583709982|FG003|Maintenance Phase|Death|0|||
161633480|NCT00505414|583709983|FG004|Maintenance Phase|Death|0|||
161633481|NCT00505414|583709979|FG000|Maintenance Phase|Lack of Efficacy|2|||
161833902|NCT00102687|584433240|FG002|Maintenance Period|Physician Decision|3|||
161833903|NCT00102687|584433241|FG003|Maintenance Period|Physician Decision|0|||
161833904|NCT00102687|584433242|FG004|Maintenance Period|Physician Decision|4|||
161833905|NCT03253744|584433248|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
161833906|NCT03253744|584433249|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
161833907|NCT03253744|584433250|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
161833908|NCT03253744|584433251|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
161833909|NCT06279871|584433252|FG000|Overall Study|Death|0|||
161833910|NCT06279871|584433253|FG001|Overall Study|Death|0|||
161833911|NCT06279871|584433254|FG002|Overall Study|Death|0|||
161833912|NCT06279871|584433255|FG003|Overall Study|Death|0|||
161833913|NCT06279871|584433256|FG004|Overall Study|Death|0|||
161833914|NCT06279871|584433257|FG005|Overall Study|Death|1|||
161833915|NCT06279871|584433258|FG006|Overall Study|Death|0|||
161833916|NCT06279871|584433252|FG000|Overall Study|Other than Specified|1|||
161833917|NCT06279871|584433253|FG001|Overall Study|Other than Specified|0|||
161833918|NCT06279871|584433254|FG002|Overall Study|Other than Specified|4|||
161833919|NCT06279871|584433255|FG003|Overall Study|Other than Specified|0|||
161833920|NCT06279871|584433256|FG004|Overall Study|Other than Specified|0|||
161833921|NCT06279871|584433257|FG005|Overall Study|Other than Specified|0|||
161833922|NCT06279871|584433258|FG006|Overall Study|Other than Specified|0|||
161833923|NCT06279871|584433252|FG000|Overall Study|Withdrawal by Subject|4|||
161833924|NCT06279871|584433253|FG001|Overall Study|Withdrawal by Subject|8|||
161833925|NCT06279871|584433254|FG002|Overall Study|Withdrawal by Subject|4|||
161833926|NCT06279871|584433255|FG003|Overall Study|Withdrawal by Subject|2|||
161833927|NCT06279871|584433256|FG004|Overall Study|Withdrawal by Subject|0|||
161833928|NCT06279871|584433257|FG005|Overall Study|Withdrawal by Subject|0|||
161833929|NCT06279871|584433258|FG006|Overall Study|Withdrawal by Subject|0|||
161833930|NCT06279871|584433252|FG000|Overall Study|Lost to Follow-up|11|||
161833931|NCT06279871|584433253|FG001|Overall Study|Lost to Follow-up|10|||
161833932|NCT06279871|584433254|FG002|Overall Study|Lost to Follow-up|8|||
161833933|NCT06279871|584433255|FG003|Overall Study|Lost to Follow-up|0|||
161833934|NCT06279871|584433256|FG004|Overall Study|Lost to Follow-up|0|||
161833935|NCT06279871|584433257|FG005|Overall Study|Lost to Follow-up|0|||
161833936|NCT06279871|584433258|FG006|Overall Study|Lost to Follow-up|0|||
161833937|NCT06279871|584433252|FG000|Overall Study|Adverse Event|0|||
161833938|NCT06279871|584433253|FG001|Overall Study|Adverse Event|1|||
161633482|NCT00505414|583709980|FG001|Maintenance Phase|Lack of Efficacy|1|||
161633483|NCT00505414|583709981|FG002|Maintenance Phase|Lack of Efficacy|1|||
161833939|NCT06279871|584433254|FG002|Overall Study|Adverse Event|0|||
161833940|NCT06279871|584433255|FG003|Overall Study|Adverse Event|0|||
161833941|NCT06279871|584433256|FG004|Overall Study|Adverse Event|0|||
161833942|NCT06279871|584433257|FG005|Overall Study|Adverse Event|0|||
161833943|NCT06279871|584433258|FG006|Overall Study|Adverse Event|0|||
161833944|NCT03847194|584433261|FG000|Overall Study|Lost to Follow-up|2|||
161833945|NCT03847194|584433262|FG001|Overall Study|Lost to Follow-up|5|||
161833946|NCT03847194|584433261|FG000|Overall Study|Withdrawal by Subject|1|||
161633484|NCT00505414|583709982|FG003|Maintenance Phase|Lack of Efficacy|0|||
161833947|NCT03847194|584433262|FG001|Overall Study|Withdrawal by Subject|2|||
161833948|NCT03847194|584433261|FG000|Overall Study|Death|0|||
161833949|NCT03847194|584433262|FG001|Overall Study|Death|1|||
161833950|NCT01144403|584433266|FG000|Overall Study|Lost to Follow-up|3|||
161686014|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
161686015|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
161686016|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
161686017|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161686018|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161686019|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
161686020|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161686021|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
161686022|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161686023|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161686024|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161686025|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161686026|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161686027|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161686028|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
161686029|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
161686030|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
161686031|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
161686032|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
161686033|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
161686034|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
161686035|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
161686036|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
161686037|NCT01623271|583903280|FG000|Overall Study|Withdrawal by Subject|2|||
161686038|NCT02037295|583903283|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
161686039|NCT02037295|583903284|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
161686040|NCT02037295|583903285|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
161686041|NCT02037295|583903286|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
161686042|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Adverse Event|0|||
161686043|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Adverse Event|1|||
161686044|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Adverse Event|1|||
161686045|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Adverse Event|0|||
161686046|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
161686047|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
161686048|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
161686049|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
161686050|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
161686051|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
161686052|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
161686053|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
161686054|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
161633485|NCT00505414|583709983|FG004|Maintenance Phase|Lack of Efficacy|0|||
161633486|NCT00505414|583709979|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161633487|NCT00505414|583709980|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161633488|NCT00505414|583709981|FG002|Maintenance Phase|Withdrawal by Subject|1|||
161633489|NCT00505414|583709982|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161633490|NCT00505414|583709983|FG004|Maintenance Phase|Withdrawal by Subject|0|||
161633491|NCT00505414|583709979|FG000|Maintenance Phase|underlying disease and therapy required|0|||
161633492|NCT00505414|583709980|FG001|Maintenance Phase|underlying disease and therapy required|2|||
161633493|NCT00505414|583709981|FG002|Maintenance Phase|underlying disease and therapy required|2|||
161633494|NCT00505414|583709982|FG003|Maintenance Phase|underlying disease and therapy required|0|||
161633495|NCT00505414|583709983|FG004|Maintenance Phase|underlying disease and therapy required|0|||
161633496|NCT00846768|583709985|FG000|Overall Study|Adverse Event|0|||
161633497|NCT00846768|583709986|FG001|Overall Study|Adverse Event|1|||
161633498|NCT00846768|583709987|FG002|Overall Study|Adverse Event|0|||
161633499|NCT00846768|583709988|FG003|Overall Study|Adverse Event|0|||
161633500|NCT00634920|583709990|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
161633501|NCT00634920|583709991|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
161633502|NCT00634920|583709992|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
161633503|NCT00634920|583709990|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
161633504|NCT00634920|583709991|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
161633505|NCT00634920|583709992|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
161633506|NCT00634920|583709990|FG000|Period 1 - Pre-Randomization|Rejections|0|||
161633507|NCT00634920|583709991|FG001|Period 1 - Pre-Randomization|Rejections|0|||
161633508|NCT00634920|583709992|FG002|Period 1 - Pre-Randomization|Rejections|55|||
161633509|NCT00634920|583709990|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
161633510|NCT00634920|583709991|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
161633511|NCT00634920|583709992|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
161633512|NCT00634920|583709990|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
161633513|NCT00634920|583709991|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
161633514|NCT00634920|583709992|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
161633515|NCT00634920|583709990|FG000|Period 1 - Pre-Randomization|Other issues|0|||
161633516|NCT00634920|583709991|FG001|Period 1 - Pre-Randomization|Other issues|0|||
161633517|NCT00634920|583709992|FG002|Period 1 - Pre-Randomization|Other issues|6|||
161633518|NCT00634920|583709990|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
161633519|NCT00634920|583709991|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
161633520|NCT00634920|583709992|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
161633521|NCT00634920|583709990|FG000|Period 2 - Post-Randomization|Rejection|11|||
161633522|NCT00634920|583709991|FG001|Period 2 - Post-Randomization|Rejection|5|||
161633523|NCT00634920|583709992|FG002|Period 2 - Post-Randomization|Rejection|0|||
161633524|NCT00634920|583709990|FG000|Period 2 - Post-Randomization|Death|2|||
161633525|NCT00634920|583709991|FG001|Period 2 - Post-Randomization|Death|5|||
161633526|NCT00634920|583709992|FG002|Period 2 - Post-Randomization|Death|0|||
161633527|NCT00634920|583709990|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
161633528|NCT00634920|583709991|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
161633529|NCT00634920|583709992|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
161633530|NCT00634920|583709990|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
161633531|NCT00634920|583709991|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
161633532|NCT00634920|583709992|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
161633533|NCT04358068|583709993|FG000|Overall Study|Did not initiate study treatment|2|||
161633534|NCT04358068|583709994|FG001|Overall Study|Did not initiate study treatment|2|||
161633535|NCT04353817|583709995|FG000|Overall Study|Adverse Event|0|||
161633536|NCT04353817|583709996|FG001|Overall Study|Adverse Event|1|||
161633537|NCT01193218|583709997|FG000|0-12 Weeks|Adverse Event|6|||
161633538|NCT01193218|583709998|FG001|0-12 Weeks|Adverse Event|0|||
161633539|NCT01193218|583709999|FG002|0-12 Weeks|Adverse Event|1|||
161633540|NCT01193218|583710000|FG003|0-12 Weeks|Adverse Event|0|||
161633541|NCT01193218|583710001|FG004|0-12 Weeks|Adverse Event|0|||
161633542|NCT01193218|583710002|FG005|0-12 Weeks|Adverse Event|2|||
161633543|NCT01193218|583710003|FG006|0-12 Weeks|Adverse Event|2|||
161633544|NCT01193218|583710004|FG007|0-12 Weeks|Adverse Event|0|||
161633545|NCT01193218|583709997|FG000|0-12 Weeks|Protocol Violation|0|||
161633546|NCT01193218|583709998|FG001|0-12 Weeks|Protocol Violation|0|||
161633547|NCT01193218|583709999|FG002|0-12 Weeks|Protocol Violation|0|||
161633548|NCT01193218|583710000|FG003|0-12 Weeks|Protocol Violation|0|||
161633549|NCT01193218|583710001|FG004|0-12 Weeks|Protocol Violation|1|||
161633550|NCT01193218|583710002|FG005|0-12 Weeks|Protocol Violation|1|||
161633551|NCT01193218|583710003|FG006|0-12 Weeks|Protocol Violation|0|||
161633552|NCT01193218|583710004|FG007|0-12 Weeks|Protocol Violation|0|||
161633553|NCT01193218|583709997|FG000|0-12 Weeks|Withdrawal by Subject|3|||
161633554|NCT01193218|583709998|FG001|0-12 Weeks|Withdrawal by Subject|0|||
161633555|NCT01193218|583709999|FG002|0-12 Weeks|Withdrawal by Subject|2|||
161633556|NCT01193218|583710000|FG003|0-12 Weeks|Withdrawal by Subject|0|||
161633557|NCT01193218|583710001|FG004|0-12 Weeks|Withdrawal by Subject|0|||
161633558|NCT01193218|583710002|FG005|0-12 Weeks|Withdrawal by Subject|0|||
161633559|NCT01193218|583710003|FG006|0-12 Weeks|Withdrawal by Subject|1|||
161633560|NCT01193218|583710004|FG007|0-12 Weeks|Withdrawal by Subject|0|||
161633561|NCT01193218|583709997|FG000|12-52 Weeks|Adverse Event|1|||
161633562|NCT01193218|583709998|FG001|12-52 Weeks|Adverse Event|0|||
161633563|NCT01193218|583709999|FG002|12-52 Weeks|Adverse Event|1|||
161633564|NCT01193218|583710000|FG003|12-52 Weeks|Adverse Event|2|||
161633565|NCT01193218|583710001|FG004|12-52 Weeks|Adverse Event|3|||
161633566|NCT01193218|583710002|FG005|12-52 Weeks|Adverse Event|3|||
161633567|NCT01193218|583710003|FG006|12-52 Weeks|Adverse Event|1|||
161633568|NCT01193218|583710004|FG007|12-52 Weeks|Adverse Event|2|||
161633569|NCT01193218|583709997|FG000|12-52 Weeks|Lack of Efficacy|0|||
161633570|NCT01193218|583709998|FG001|12-52 Weeks|Lack of Efficacy|0|||
161633571|NCT01193218|583709999|FG002|12-52 Weeks|Lack of Efficacy|0|||
161633572|NCT01193218|583710000|FG003|12-52 Weeks|Lack of Efficacy|0|||
161633573|NCT01193218|583710001|FG004|12-52 Weeks|Lack of Efficacy|0|||
161633574|NCT01193218|583710002|FG005|12-52 Weeks|Lack of Efficacy|0|||
161633575|NCT01193218|583710003|FG006|12-52 Weeks|Lack of Efficacy|1|||
161633576|NCT01193218|583710004|FG007|12-52 Weeks|Lack of Efficacy|0|||
161633577|NCT01193218|583709997|FG000|12-52 Weeks|Withdrawal by Subject|3|||
161633578|NCT01193218|583709998|FG001|12-52 Weeks|Withdrawal by Subject|0|||
161633579|NCT01193218|583709999|FG002|12-52 Weeks|Withdrawal by Subject|3|||
161633580|NCT01193218|583710000|FG003|12-52 Weeks|Withdrawal by Subject|0|||
161633581|NCT01193218|583710001|FG004|12-52 Weeks|Withdrawal by Subject|0|||
161633582|NCT01193218|583710002|FG005|12-52 Weeks|Withdrawal by Subject|2|||
161633583|NCT01193218|583710003|FG006|12-52 Weeks|Withdrawal by Subject|1|||
161633584|NCT01193218|583710004|FG007|12-52 Weeks|Withdrawal by Subject|2|||
161633585|NCT01193218|583709997|FG000|12-52 Weeks|Other reason than above|1|||
161633586|NCT01193218|583709998|FG001|12-52 Weeks|Other reason than above|0|||
161633587|NCT01193218|583709999|FG002|12-52 Weeks|Other reason than above|0|||
161633588|NCT01193218|583710000|FG003|12-52 Weeks|Other reason than above|1|||
161633589|NCT01193218|583710001|FG004|12-52 Weeks|Other reason than above|1|||
161633590|NCT01193218|583710002|FG005|12-52 Weeks|Other reason than above|0|||
161633591|NCT01193218|583710003|FG006|12-52 Weeks|Other reason than above|0|||
161633592|NCT01193218|583710004|FG007|12-52 Weeks|Other reason than above|0|||
161633593|NCT00665223|583710007|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
161633594|NCT00665223|583710008|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
161633595|NCT00665223|583710009|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
161633596|NCT00665223|583710007|FG000|Randomized Phase (26 Weeks)|Death|0|||
161633597|NCT00665223|583710008|FG001|Randomized Phase (26 Weeks)|Death|0|||
161633598|NCT00665223|583710009|FG002|Randomized Phase (26 Weeks)|Death|1|||
161633599|NCT00665223|583710007|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
161633600|NCT00665223|583710008|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
161633601|NCT00665223|583710009|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
161833951|NCT01144403|584433266|FG000|Overall Study|Death|1|||
161633602|NCT00665223|583710007|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
161633603|NCT00665223|583710008|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
161633604|NCT00665223|583710009|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
161633605|NCT00665223|583710007|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
161833952|NCT01144403|584433266|FG000|Overall Study|Adverse Event|1|||
161833953|NCT02339740|584433270|FG000|Overall Study|Death|1|||
161833954|NCT02339740|584433271|FG001|Overall Study|Death|0|||
161633606|NCT00665223|583710008|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
161633607|NCT00665223|583710009|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
161633608|NCT00665223|583710007|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
161633609|NCT00665223|583710008|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
161633610|NCT00665223|583710009|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
161633611|NCT00665223|583710007|FG000|Open-Label Period (26 Weeks)|Death|0|||
161633612|NCT00665223|583710008|FG001|Open-Label Period (26 Weeks)|Death|1|||
161833955|NCT02339740|584433270|FG000|Overall Study|Physician Decision|0|||
161833956|NCT02339740|584433271|FG001|Overall Study|Physician Decision|2|||
161633613|NCT00665223|583710009|FG002|Open-Label Period (26 Weeks)|Death|0|||
161633614|NCT00665223|583710007|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
161633615|NCT00665223|583710008|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
161633616|NCT00665223|583710009|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
161633617|NCT00665223|583710007|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
161633618|NCT00665223|583710008|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
161633619|NCT00665223|583710009|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
161633620|NCT00665223|583710007|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
161633621|NCT00665223|583710008|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
161633622|NCT00665223|583710009|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
161633623|NCT00665223|583710007|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
161633624|NCT00665223|583710008|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
161633625|NCT00665223|583710009|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
161633626|NCT00363649|583710010|FG000|Overall Study|Withdrawal by Subject|1|||
161633627|NCT00363649|583710011|FG001|Overall Study|Withdrawal by Subject|1|||
161633628|NCT00363649|583710010|FG000|Overall Study|Adverse Event|6|||
161633629|NCT00363649|583710011|FG001|Overall Study|Adverse Event|0|||
161633630|NCT00912223|583710012|FG000|Overall Study|Withdrawal by Subject|1|||
161633631|NCT00912223|583710012|FG000|Overall Study|Not transplanted|1|||
161633632|NCT00912223|583710012|FG000|Overall Study|Transformed disease|1|||
161633633|NCT00025662|583710016|FG000|Overall Study|Withdrawal by Subject|2|||
161633634|NCT00025662|583710016|FG000|Overall Study|Technical failure of manipulation|1|||
161633635|NCT02161185|583710017|FG000|Treatment Phase|Administrative/Other|7|||
161633636|NCT00519285|583710025|FG000|Overall Study|Adverse Event|127|||
161633637|NCT00519285|583710026|FG001|Overall Study|Adverse Event|266|||
161633638|NCT00519285|583710025|FG000|Overall Study|Disease progression|334|||
161633639|NCT00519285|583710026|FG001|Overall Study|Disease progression|186|||
161633640|NCT00519285|583710025|FG000|Overall Study|Physician Decision|75|||
161633641|NCT00519285|583710026|FG001|Overall Study|Physician Decision|47|||
161633642|NCT00519285|583710025|FG000|Overall Study|Participant's request|53|||
161633643|NCT00519285|583710026|FG001|Overall Study|Participant's request|84|||
161633644|NCT00519285|583710025|FG000|Overall Study|Consent withdrawn|4|||
161633645|NCT00519285|583710026|FG001|Overall Study|Consent withdrawn|5|||
161633646|NCT00519285|583710025|FG000|Overall Study|Poor compliance to protocol|5|||
161633647|NCT00519285|583710026|FG001|Overall Study|Poor compliance to protocol|7|||
161633648|NCT00519285|583710025|FG000|Overall Study|Reason unspecified|5|||
161633649|NCT00519285|583710026|FG001|Overall Study|Reason unspecified|8|||
161633650|NCT00519285|583710025|FG000|Overall Study|Not treated|8|||
161633651|NCT00519285|583710026|FG001|Overall Study|Not treated|7|||
161633652|NCT00519285|583710025|FG000|Overall Study|Treatment ongoing|1|||
161633653|NCT00519285|583710026|FG001|Overall Study|Treatment ongoing|2|||
161633654|NCT02970305|583710027|FG000|Overall Study|Adverse Event|10|||
161633655|NCT02970305|583710028|FG001|Overall Study|Adverse Event|6|||
161633656|NCT02970305|583710027|FG000|Overall Study|Lack of Efficacy|1|||
161633657|NCT02970305|583710028|FG001|Overall Study|Lack of Efficacy|1|||
161633658|NCT02970305|583710027|FG000|Overall Study|Noncompliance with study drug|2|||
161633659|NCT02970305|583710028|FG001|Overall Study|Noncompliance with study drug|4|||
161633660|NCT02970305|583710027|FG000|Overall Study|Protocol Violation|2|||
161633661|NCT02970305|583710028|FG001|Overall Study|Protocol Violation|2|||
161633662|NCT02970305|583710027|FG000|Overall Study|Withdrawal by Subject|12|||
161633663|NCT02970305|583710028|FG001|Overall Study|Withdrawal by Subject|11|||
161633664|NCT02970305|583710027|FG000|Overall Study|Not further specified|1|||
161633665|NCT02970305|583710028|FG001|Overall Study|Not further specified|2|||
161633666|NCT02970305|583710027|FG000|Overall Study|Lost to Follow-up|1|||
161633667|NCT02970305|583710028|FG001|Overall Study|Lost to Follow-up|2|||
161633668|NCT02175745|583710029|FG000|Overall Study|Not Eligible|1|||
161633669|NCT00808899|583710031|FG000|Overall Study|Death|1|||
161633670|NCT00808899|583710031|FG000|Overall Study|Physician Decision|3|||
161633671|NCT04088500|583710032|FG000|Overall Study|Reason unknown|1|||
161633672|NCT04088500|583710032|FG000|Overall Study|Participant withdrew consent|1|||
161633673|NCT04088500|583710032|FG000|Overall Study|Disease progression|3|||
161633674|NCT00612352|583711794|FG000|Overall Study|Adverse Event|1|||
161633675|NCT00612352|583711795|FG001|Overall Study|Adverse Event|0|||
161633676|NCT00612352|583711794|FG000|Overall Study|Withdrawal by Subject|3|||
161633677|NCT00612352|583711795|FG001|Overall Study|Withdrawal by Subject|5|||
161633678|NCT00612352|583711794|FG000|Overall Study|moved out of state|1|||
161633679|NCT00612352|583711795|FG001|Overall Study|moved out of state|0|||
161549358|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549359|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549360|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549361|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549362|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549363|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161549364|NCT02291289|583401009|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
161549365|NCT02291289|583401010|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
161549366|NCT02291289|583401011|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
161549367|NCT02291289|583401012|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
161549368|NCT02291289|583401013|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
161549369|NCT02291289|583401014|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
161549370|NCT02291289|583401015|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
161549371|NCT02291289|583401016|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
161549372|NCT02291289|583401017|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
161549373|NCT02291289|583401018|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
161549374|NCT02291289|583401019|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
161549375|NCT02291289|583401020|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
161549376|NCT02291289|583401021|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
161549377|NCT02291289|583401009|FG000|Early Disease Progression|Death|0|||
161549378|NCT02291289|583401010|FG001|Early Disease Progression|Death|0|||
161549379|NCT02291289|583401011|FG002|Early Disease Progression|Death|0|||
161549380|NCT02291289|583401012|FG003|Early Disease Progression|Death|0|||
161549381|NCT02291289|583401013|FG004|Early Disease Progression|Death|0|||
161549382|NCT02291289|583401014|FG005|Early Disease Progression|Death|0|||
161549383|NCT02291289|583401015|FG006|Early Disease Progression|Death|0|||
161549384|NCT02291289|583401016|FG007|Early Disease Progression|Death|0|||
161549385|NCT02291289|583401017|FG008|Early Disease Progression|Death|0|||
161549386|NCT02291289|583401018|FG009|Early Disease Progression|Death|0|||
161549387|NCT02291289|583401019|FG010|Early Disease Progression|Death|0|||
161549388|NCT02291289|583401020|FG011|Early Disease Progression|Death|0|||
161549389|NCT02291289|583401021|FG012|Early Disease Progression|Death|10|||
161549390|NCT02291289|583401009|FG000|Early Disease Progression|Lost to Follow-up|0|||
161549391|NCT02291289|583401010|FG001|Early Disease Progression|Lost to Follow-up|0|||
161686055|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
161686056|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
161686057|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
161686058|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
161633680|NCT00612352|583711794|FG000|Overall Study|didn't return calls/show up on test date|4|||
161633681|NCT00612352|583711795|FG001|Overall Study|didn't return calls/show up on test date|1|||
161633682|NCT00263211|583711796|FG000|Overall Study|Death|1|||
161633683|NCT00263211|583711797|FG001|Overall Study|Death|0|||
161633684|NCT00263211|583711796|FG000|Overall Study|Withdrawal by Subject|3|||
161633685|NCT00263211|583711797|FG001|Overall Study|Withdrawal by Subject|0|||
161633686|NCT00263211|583711796|FG000|Overall Study|Protocol Violation|1|||
161633687|NCT00263211|583711797|FG001|Overall Study|Protocol Violation|0|||
161633688|NCT00263211|583711796|FG000|Overall Study|Disease Progression|0|||
161633689|NCT00263211|583711797|FG001|Overall Study|Disease Progression|1|||
161633690|NCT02820597|583711798|FG000|Overall Study|Lost to Follow-up|12|||
161633691|NCT04606199|583711799|FG000|Overall Study|Withdrawal by Subject|2|||
161633692|NCT00644878|583711806|FG000|Overall Study|Adverse Event|2|||
161633693|NCT00644878|583711806|FG000|Overall Study|Abnormal laboratory value|3|||
161633694|NCT00644878|583711806|FG000|Overall Study|Protocol deviation|2|||
161633695|NCT00644878|583711806|FG000|Overall Study|Treatment duration completed as per protocol|11|||
161633696|NCT02143063|583711809|FG000|Overall Study|Lost to Follow-up|16|||
161633697|NCT02143063|583711810|FG001|Overall Study|Lost to Follow-up|28|||
161633698|NCT02143063|583711811|FG002|Overall Study|Lost to Follow-up|29|||
161633699|NCT02143063|583711809|FG000|Overall Study|Withdrawal by Subject|0|||
161633700|NCT02143063|583711810|FG001|Overall Study|Withdrawal by Subject|1|||
161633701|NCT02143063|583711811|FG002|Overall Study|Withdrawal by Subject|0|||
161633702|NCT02143063|583711809|FG000|Overall Study|Death|0|||
161633703|NCT02143063|583711810|FG001|Overall Study|Death|1|||
161633704|NCT02143063|583711811|FG002|Overall Study|Death|1|||
161633705|NCT03517111|583711812|FG000|Enrolled|Withdrawal by Subject|0|||
161633706|NCT03517111|583711813|FG001|Enrolled|Withdrawal by Subject|1|||
161633707|NCT03517111|583711814|FG002|Enrolled|Withdrawal by Subject|0|||
161633708|NCT03517111|583711812|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
161633709|NCT03517111|583711813|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
161633710|NCT03517111|583711814|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
161633711|NCT03517111|583711812|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
161633712|NCT03517111|583711813|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
161633713|NCT03517111|583711814|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
161633714|NCT03517111|583711812|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
161633715|NCT03517111|583711813|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
161633716|NCT03517111|583711814|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
161633717|NCT03517111|583711812|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
161633718|NCT03517111|583711813|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
161633719|NCT03517111|583711814|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
161633720|NCT02062645|583711817|FG000|Overall Study|Adverse Event|2|||
161633721|NCT02062645|583711817|FG000|Overall Study|Protocol Violation|8|||
161633722|NCT02062645|583711817|FG000|Overall Study|Lost to Follow-up|5|||
161633723|NCT02864342|583711819|FG000|Overall Study|Eligibility Criteria Deviation|2|||
161633724|NCT02864342|583711820|FG001|Overall Study|Eligibility Criteria Deviation|3|||
161633725|NCT02864342|583711819|FG000|Overall Study|Withdrawal by Subject|4|||
161633726|NCT02864342|583711820|FG001|Overall Study|Withdrawal by Subject|2|||
161633727|NCT02864342|583711819|FG000|Overall Study|Device Technology Issue|6|||
161633728|NCT02864342|583711820|FG001|Overall Study|Device Technology Issue|7|||
161633729|NCT02864342|583711819|FG000|Overall Study|Death|0|||
161633730|NCT02864342|583711820|FG001|Overall Study|Death|1|||
161633731|NCT02864342|583711819|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
161633732|NCT02864342|583711820|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
161633733|NCT02864342|583711819|FG000|Overall Study|Lost to Follow-up|1|||
161633734|NCT02864342|583711820|FG001|Overall Study|Lost to Follow-up|5|||
161633735|NCT02864342|583711819|FG000|Overall Study|Lost Device|1|||
161633736|NCT02864342|583711820|FG001|Overall Study|Lost Device|0|||
161633737|NCT02864342|583711819|FG000|Overall Study|Adverse Event|1|||
161633738|NCT02864342|583711820|FG001|Overall Study|Adverse Event|0|||
161633739|NCT02261285|583711821|FG000|Overall Study|Disease progression|0|||
161633740|NCT02261285|583711822|FG001|Overall Study|Disease progression|0|||
161633741|NCT02261285|583711823|FG002|Overall Study|Disease progression|1|||
161633742|NCT00927901|583711824|FG000|Treatment Period 1|Subject withdrew consent|0|||
161633743|NCT00927901|583711825|FG001|Treatment Period 1|Subject withdrew consent|0|||
161633744|NCT00927901|583711826|FG002|Treatment Period 1|Subject withdrew consent|1|||
161633745|NCT00927901|583711827|FG003|Treatment Period 1|Subject withdrew consent|0|||
161633746|NCT00927901|583711824|FG000|Treatment Period 4|Adverse Event|0|||
161633747|NCT00927901|583711825|FG001|Treatment Period 4|Adverse Event|0|||
161633748|NCT00927901|583711826|FG002|Treatment Period 4|Adverse Event|0|||
161633749|NCT00927901|583711827|FG003|Treatment Period 4|Adverse Event|1|||
161633750|NCT00927901|583711824|FG000|Treatment Period 4|Subject withdrew consent|0|||
161633751|NCT00927901|583711825|FG001|Treatment Period 4|Subject withdrew consent|0|||
161633752|NCT00927901|583711826|FG002|Treatment Period 4|Subject withdrew consent|1|||
161633753|NCT00927901|583711827|FG003|Treatment Period 4|Subject withdrew consent|0|||
161633754|NCT01209286|583711828|FG000|Overall Study|Adverse Event|4|||
161633755|NCT01209286|583711829|FG001|Overall Study|Adverse Event|3|||
161633756|NCT01209286|583711830|FG002|Overall Study|Adverse Event|1|||
161633757|NCT01209286|583711828|FG000|Overall Study|Hematological Relapse After Remission|0|||
161633758|NCT01209286|583711829|FG001|Overall Study|Hematological Relapse After Remission|1|||
161633759|NCT01209286|583711830|FG002|Overall Study|Hematological Relapse After Remission|1|||
161633760|NCT01209286|583711828|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
161633761|NCT01209286|583711829|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
161633762|NCT01209286|583711830|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
161633763|NCT01209286|583711828|FG000|Overall Study|Physician Decision|0|||
161633764|NCT01209286|583711829|FG001|Overall Study|Physician Decision|2|||
161633765|NCT01209286|583711830|FG002|Overall Study|Physician Decision|0|||
161633766|NCT01209286|583711828|FG000|Overall Study|Other|0|||
161633767|NCT01209286|583711829|FG001|Overall Study|Other|1|||
161633768|NCT01209286|583711830|FG002|Overall Study|Other|0|||
161633769|NCT01349036|583711831|FG000|Overall Study|Disease progression|13|||
161633770|NCT01349036|583711832|FG001|Overall Study|Disease progression|22|||
161633771|NCT01349036|583711831|FG000|Overall Study|Other|1|||
161633772|NCT01349036|583711832|FG001|Overall Study|Other|0|||
161633773|NCT01349036|583711831|FG000|Overall Study|Withdrawal by Subject|0|||
161633774|NCT01349036|583711832|FG001|Overall Study|Withdrawal by Subject|2|||
161633775|NCT03796208|583711833|FG000|Overall Study|Withdrawal by Subject|3|||
161633776|NCT03796208|583711834|FG001|Overall Study|Withdrawal by Subject|0|||
161633777|NCT03796208|583711833|FG000|Overall Study|Loss of pregnancy|1|||
161686059|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
161686060|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
161686061|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
161686062|NCT03776175|583903287|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161686063|NCT03776175|583903288|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161686064|NCT03776175|583903289|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161686065|NCT03776175|583903290|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
161686066|NCT02770547|583903294|FG000|Overall Study|Patient non-compliant|1|||
161686067|NCT02770547|583903295|FG001|Overall Study|Patient non-compliant|0|||
161686068|NCT02770547|583903294|FG000|Overall Study|Adverse Event|0|||
161686069|NCT02770547|583903295|FG001|Overall Study|Adverse Event|1|||
161686070|NCT00661531|583903296|FG000|Overall Study|Withdrawal by Subject|3|||
161686071|NCT03134599|583903298|FG000|Week 1|Lost to Follow-up|0|||
161686072|NCT03134599|583903299|FG001|Week 1|Lost to Follow-up|0|||
161686073|NCT03134599|583903300|FG002|Week 1|Lost to Follow-up|0|||
161686074|NCT03134599|583903301|FG003|Week 1|Lost to Follow-up|0|||
161686075|NCT03134599|583903302|FG004|Week 1|Lost to Follow-up|1|||
161686076|NCT03134599|583903303|FG005|Week 1|Lost to Follow-up|0|||
161686077|NCT03134599|583903298|FG000|Week 2|Lost to Follow-up|1|||
161686078|NCT03134599|583903299|FG001|Week 2|Lost to Follow-up|0|||
161686079|NCT03134599|583903300|FG002|Week 2|Lost to Follow-up|0|||
161686080|NCT03134599|583903301|FG003|Week 2|Lost to Follow-up|1|||
161686081|NCT03134599|583903302|FG004|Week 2|Lost to Follow-up|1|||
161686082|NCT03134599|583903303|FG005|Week 2|Lost to Follow-up|0|||
161686083|NCT03134599|583903298|FG000|Week 3|Lost to Follow-up|0|||
161686084|NCT03134599|583903299|FG001|Week 3|Lost to Follow-up|0|||
161686085|NCT03134599|583903300|FG002|Week 3|Lost to Follow-up|0|||
161686086|NCT03134599|583903301|FG003|Week 3|Lost to Follow-up|1|||
161686087|NCT03134599|583903302|FG004|Week 3|Lost to Follow-up|0|||
161686088|NCT03134599|583903303|FG005|Week 3|Lost to Follow-up|1|||
161686089|NCT00393887|583903304|FG000|Overall Study|Physician Decision|5|||
161686090|NCT00393887|583903305|FG001|Overall Study|Physician Decision|0|||
161686091|NCT00393887|583903304|FG000|Overall Study|Lost to Follow-up|11|||
161686092|NCT00393887|583903305|FG001|Overall Study|Lost to Follow-up|9|||
161686093|NCT02004262|583903308|FG000|Overall Study|Death|67|||
161686094|NCT02004262|583903309|FG001|Overall Study|Death|64|||
161686095|NCT02004262|583903310|FG002|Overall Study|Death|66|||
161686096|NCT02004262|583903311|FG003|Overall Study|Death|28|||
161686097|NCT02004262|583903312|FG004|Overall Study|Death|29|||
161686098|NCT02004262|583903313|FG005|Overall Study|Death|22|||
161686099|NCT02004262|583903308|FG000|Overall Study|Withdrawal by Subject|1|||
161686100|NCT02004262|583903309|FG001|Overall Study|Withdrawal by Subject|0|||
161686101|NCT02004262|583903310|FG002|Overall Study|Withdrawal by Subject|4|||
161686102|NCT02004262|583903311|FG003|Overall Study|Withdrawal by Subject|0|||
161686103|NCT02004262|583903312|FG004|Overall Study|Withdrawal by Subject|1|||
161686104|NCT02004262|583903313|FG005|Overall Study|Withdrawal by Subject|3|||
161686105|NCT02004262|583903308|FG000|Overall Study|Lost to Follow-up|1|||
161686106|NCT02004262|583903309|FG001|Overall Study|Lost to Follow-up|1|||
161686107|NCT02004262|583903310|FG002|Overall Study|Lost to Follow-up|0|||
161686108|NCT02004262|583903311|FG003|Overall Study|Lost to Follow-up|0|||
161686109|NCT02004262|583903312|FG004|Overall Study|Lost to Follow-up|0|||
161686110|NCT02004262|583903313|FG005|Overall Study|Lost to Follow-up|0|||
161686111|NCT02004262|583903308|FG000|Overall Study|Study Terminated by Sponsor|4|||
161686112|NCT02004262|583903309|FG001|Overall Study|Study Terminated by Sponsor|3|||
161686113|NCT02004262|583903310|FG002|Overall Study|Study Terminated by Sponsor|2|||
161686114|NCT02004262|583903311|FG003|Overall Study|Study Terminated by Sponsor|1|||
161686115|NCT02004262|583903312|FG004|Overall Study|Study Terminated by Sponsor|1|||
161686116|NCT02004262|583903313|FG005|Overall Study|Study Terminated by Sponsor|5|||
161686117|NCT03703102|583903314|FG000|Overall Study|Adverse Event|4|||
161686118|NCT03703102|583903315|FG001|Overall Study|Adverse Event|3|||
161686119|NCT03703102|583903316|FG002|Overall Study|Adverse Event|7|||
161686120|NCT03703102|583903317|FG003|Overall Study|Adverse Event|3|||
161686121|NCT03703102|583903318|FG004|Overall Study|Adverse Event|13|||
161686122|NCT03703102|583903314|FG000|Overall Study|Lack of Efficacy|4|||
161686123|NCT03703102|583903315|FG001|Overall Study|Lack of Efficacy|0|||
161686124|NCT03703102|583903316|FG002|Overall Study|Lack of Efficacy|1|||
161686125|NCT03703102|583903317|FG003|Overall Study|Lack of Efficacy|4|||
161686126|NCT03703102|583903318|FG004|Overall Study|Lack of Efficacy|1|||
161686127|NCT03703102|583903314|FG000|Overall Study|Lost to Follow-up|0|||
161686128|NCT03703102|583903315|FG001|Overall Study|Lost to Follow-up|0|||
161686129|NCT03703102|583903316|FG002|Overall Study|Lost to Follow-up|1|||
161686130|NCT03703102|583903317|FG003|Overall Study|Lost to Follow-up|2|||
161686131|NCT03703102|583903318|FG004|Overall Study|Lost to Follow-up|2|||
161833957|NCT02339740|584433270|FG000|Overall Study|Withdrawal by Subject|5|||
161833958|NCT02339740|584433271|FG001|Overall Study|Withdrawal by Subject|1|||
161833959|NCT02339740|584433270|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
161833960|NCT02339740|584433271|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
161833961|NCT01807117|584433273|FG000|Overall Study|Physician Decision|2|||
161833962|NCT01807117|584433273|FG000|Overall Study|Disease diagnosis not a study disease|1|||
161833963|NCT02777918|584433274|FG000|Overall Study|Medical reasons|1|||
161833964|NCT02777918|584433275|FG001|Overall Study|Medical reasons|2|||
161833965|NCT02777918|584433274|FG000|Overall Study|Too busy / stressed|1|||
161833966|NCT02777918|584433275|FG001|Overall Study|Too busy / stressed|1|||
161833967|NCT02777918|584433274|FG000|Overall Study|Withdrawal by Subject|1|||
161833968|NCT02777918|584433275|FG001|Overall Study|Withdrawal by Subject|1|||
161833969|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
161833970|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
161833971|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
161686132|NCT03703102|583903314|FG000|Overall Study|Physician Decision|2|||
161686133|NCT03703102|583903315|FG001|Overall Study|Physician Decision|2|||
161686134|NCT03703102|583903316|FG002|Overall Study|Physician Decision|2|||
161686135|NCT03703102|583903317|FG003|Overall Study|Physician Decision|2|||
161686136|NCT03703102|583903318|FG004|Overall Study|Physician Decision|4|||
161686137|NCT03703102|583903314|FG000|Overall Study|Withdrawal by Subject|7|||
161686138|NCT03703102|583903315|FG001|Overall Study|Withdrawal by Subject|5|||
161686139|NCT03703102|583903316|FG002|Overall Study|Withdrawal by Subject|5|||
161686140|NCT03703102|583903317|FG003|Overall Study|Withdrawal by Subject|5|||
161633778|NCT03796208|583711834|FG001|Overall Study|Loss of pregnancy|1|||
161633779|NCT03796208|583711833|FG000|Overall Study|Changed prenatal clinics|0|||
161633780|NCT03796208|583711834|FG001|Overall Study|Changed prenatal clinics|5|||
161633781|NCT03796208|583711833|FG000|Overall Study|Lost to Follow-up|20|||
161633782|NCT03796208|583711834|FG001|Overall Study|Lost to Follow-up|16|||
161633783|NCT01161628|583711835|FG000|Overall Study|Death|6|||
161633784|NCT01161628|583711835|FG000|Overall Study|Lack of Efficacy|2|||
161686141|NCT03703102|583903318|FG004|Overall Study|Withdrawal by Subject|9|||
161686142|NCT03703102|583903314|FG000|Overall Study|Ineligibility|0|||
161686143|NCT03703102|583903315|FG001|Overall Study|Ineligibility|0|||
161686144|NCT03703102|583903316|FG002|Overall Study|Ineligibility|1|||
161686145|NCT03703102|583903317|FG003|Overall Study|Ineligibility|0|||
161686146|NCT03703102|583903318|FG004|Overall Study|Ineligibility|0|||
161686147|NCT03703102|583903314|FG000|Overall Study|Protocol Deviation|4|||
161686148|NCT03703102|583903315|FG001|Overall Study|Protocol Deviation|4|||
161686149|NCT03703102|583903316|FG002|Overall Study|Protocol Deviation|3|||
161686150|NCT03703102|583903317|FG003|Overall Study|Protocol Deviation|0|||
161686151|NCT03703102|583903318|FG004|Overall Study|Protocol Deviation|0|||
161686152|NCT03703102|583903314|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161686153|NCT03703102|583903315|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161686154|NCT03703102|583903316|FG002|Overall Study|Non-Compliance with Study Drug|2|||
161686155|NCT03703102|583903317|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161686156|NCT03703102|583903318|FG004|Overall Study|Non-Compliance with Study Drug|4|||
161686157|NCT02311153|583903319|FG000|Overall Study|Lost to Follow-up|5|||
161633785|NCT00746356|583711839|FG000|Overall Study|Withdrawal by Subject|2|||
161633786|NCT00746356|583711840|FG001|Overall Study|Withdrawal by Subject|3|||
161633787|NCT00746356|583711839|FG000|Overall Study|Death|7|||
161633788|NCT00746356|583711840|FG001|Overall Study|Death|3|||
161833972|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
161833973|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
161833974|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
161633789|NCT00746356|583711839|FG000|Overall Study|Lost to Follow-up|1|||
161633790|NCT00746356|583711840|FG001|Overall Study|Lost to Follow-up|0|||
161633791|NCT00746356|583711839|FG000|Overall Study|Removal of Device|0|||
161633792|NCT00746356|583711840|FG001|Overall Study|Removal of Device|1|||
161633793|NCT00746356|583711839|FG000|Overall Study|Patient relocated|1|||
161633794|NCT00746356|583711840|FG001|Overall Study|Patient relocated|0|||
161633795|NCT01263925|583711841|FG000|Overall Study|Protocol Violation|1|||
161633796|NCT01263925|583711842|FG001|Overall Study|Protocol Violation|0|||
161633797|NCT01263925|583711841|FG000|Overall Study|Lack of Efficacy|0|||
161633798|NCT01263925|583711842|FG001|Overall Study|Lack of Efficacy|1|||
161633799|NCT01263925|583711841|FG000|Overall Study|Adverse Event|23|||
161633800|NCT01263925|583711842|FG001|Overall Study|Adverse Event|22|||
161633801|NCT01263925|583711841|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
161633802|NCT01263925|583711842|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
161633803|NCT01263925|583711841|FG000|Overall Study|Withdrawal by Subject|6|||
161633804|NCT01263925|583711842|FG001|Overall Study|Withdrawal by Subject|8|||
161633805|NCT01263925|583711841|FG000|Overall Study|Other|4|||
161633806|NCT01263925|583711842|FG001|Overall Study|Other|4|||
161633807|NCT01263925|583711841|FG000|Overall Study|Lost to Follow-up|3|||
161633808|NCT01263925|583711842|FG001|Overall Study|Lost to Follow-up|1|||
161633809|NCT01263925|583711841|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
161633810|NCT01263925|583711842|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
161633811|NCT01263925|583711841|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
161633812|NCT01263925|583711842|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
161633813|NCT01263925|583711841|FG000|Overall Study|AE/ Withdrawal|1|||
161633814|NCT01263925|583711842|FG001|Overall Study|AE/ Withdrawal|4|||
161633815|NCT01263925|583711841|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
161633816|NCT01263925|583711842|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
161633817|NCT01263925|583711841|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
161633818|NCT01263925|583711842|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
161633819|NCT01263925|583711841|FG000|Overall Study|Withdrawal/ Not specified|0|||
161633820|NCT01263925|583711842|FG001|Overall Study|Withdrawal/ Not specified|1|||
161633821|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
161633822|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
161633823|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
161633824|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
161633825|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
161633826|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
161833975|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
161833976|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
161833977|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
161833978|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
161833979|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
161833980|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
161833981|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
161833982|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
161833983|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
161833984|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
161833985|NCT02510014|584433278|FG000|Treatment Period|Adverse Event|11|||
161633827|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
161633828|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
161633829|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
161633830|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
161633831|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
161633832|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
161833986|NCT02510014|584433279|FG001|Treatment Period|Adverse Event|4|||
161833987|NCT02510014|584433278|FG000|Treatment Period|Withdrawal symptoms|3|||
161833988|NCT02510014|584433279|FG001|Treatment Period|Withdrawal symptoms|0|||
161833989|NCT02510014|584433278|FG000|Treatment Period|Lost to Follow-up|80|||
161833990|NCT02510014|584433279|FG001|Treatment Period|Lost to Follow-up|19|||
161833991|NCT02510014|584433278|FG000|Treatment Period|Physician Decision|5|||
161833992|NCT02510014|584433279|FG001|Treatment Period|Physician Decision|0|||
161833993|NCT02510014|584433278|FG000|Treatment Period|Withdrawal by Subject|67|||
161833994|NCT02510014|584433279|FG001|Treatment Period|Withdrawal by Subject|24|||
161833995|NCT02510014|584433278|FG000|Treatment Period|Withdrawn by the investigator|7|||
161833996|NCT02510014|584433279|FG001|Treatment Period|Withdrawn by the investigator|1|||
161833997|NCT02510014|584433278|FG000|Treatment Period|Protocol Violation|4|||
161833998|NCT02510014|584433279|FG001|Treatment Period|Protocol Violation|4|||
161833999|NCT02510014|584433278|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
161834000|NCT02510014|584433279|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
161633833|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
161633834|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
161633835|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
161633836|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
161633837|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
161633838|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
161633839|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
161633840|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
161633841|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
161633842|NCT01125566|583711843|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
161633843|NCT01125566|583711844|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
161633844|NCT01125566|583711845|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
161633845|NCT01125566|583711843|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
161834001|NCT01949116|584433281|FG000|Overall Study|Death|2|||
161834002|NCT01949116|584433282|FG001|Overall Study|Death|0|||
161834003|NCT01949116|584433281|FG000|Overall Study|Lost to Follow-up|1|||
161834004|NCT01949116|584433282|FG001|Overall Study|Lost to Follow-up|3|||
161834005|NCT01949116|584433281|FG000|Overall Study|Withdrawal by Subject|5|||
161834006|NCT01949116|584433282|FG001|Overall Study|Withdrawal by Subject|3|||
161633846|NCT01125566|583711844|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
161633847|NCT01125566|583711845|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
161633848|NCT01125566|583711843|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
161633849|NCT01125566|583711844|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
161633850|NCT01125566|583711845|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
161633851|NCT01125566|583711843|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
161633852|NCT01125566|583711844|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
161633853|NCT01125566|583711845|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
161633854|NCT01125566|583711843|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
161633855|NCT01125566|583711844|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
161633856|NCT01125566|583711845|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
161633857|NCT01560585|583711846|FG000|Overall Study|Physician Decision|3|||
161633858|NCT00983892|583711847|FG000|Overall Study|Withdrawal by Subject|10|||
161633859|NCT00983892|583711848|FG001|Overall Study|Withdrawal by Subject|12|||
161633860|NCT01726517|583711851|FG000|Overall Study|Withdrawal by Subject|0|||
161633861|NCT01726517|583711852|FG001|Overall Study|Withdrawal by Subject|0|||
161633862|NCT01726517|583711853|FG002|Overall Study|Withdrawal by Subject|1|||
161633863|NCT01726517|583711854|FG003|Overall Study|Withdrawal by Subject|0|||
161633864|NCT01726517|583711855|FG004|Overall Study|Withdrawal by Subject|0|||
161633865|NCT03765164|583711862|FG000|Pre-intervention|Withdrawal by Subject|5|||
161633866|NCT03765164|583711863|FG001|Pre-intervention|Withdrawal by Subject|6|||
161633867|NCT02484547|583711864|FG000|Placebo-Controlled Period|Adverse Event|10|||
161633868|NCT02484547|583711865|FG001|Placebo-Controlled Period|Adverse Event|13|||
161633869|NCT02484547|583711866|FG002|Placebo-Controlled Period|Adverse Event|20|||
161633870|NCT02484547|583711867|FG003|Placebo-Controlled Period|Adverse Event|0|||
161633871|NCT02484547|583711868|FG004|Placebo-Controlled Period|Adverse Event|0|||
161633872|NCT02484547|583711869|FG005|Placebo-Controlled Period|Adverse Event|0|||
161633873|NCT02484547|583711870|FG006|Placebo-Controlled Period|Adverse Event|0|||
161633874|NCT02484547|583711864|FG000|Placebo-Controlled Period|Change of Treatment|0|||
161633875|NCT02484547|583711865|FG001|Placebo-Controlled Period|Change of Treatment|0|||
161834007|NCT05486065|584433284|FG000|Overall Study|Withdrawal by Subject|1|||
161633876|NCT02484547|583711866|FG002|Placebo-Controlled Period|Change of Treatment|1|||
161633877|NCT02484547|583711867|FG003|Placebo-Controlled Period|Change of Treatment|0|||
161633878|NCT02484547|583711868|FG004|Placebo-Controlled Period|Change of Treatment|0|||
161834008|NCT05486065|584433285|FG001|Overall Study|Withdrawal by Subject|5|||
161834009|NCT05486065|584433286|FG002|Overall Study|Withdrawal by Subject|4|||
161834010|NCT05486065|584433287|FG003|Overall Study|Withdrawal by Subject|3|||
161834011|NCT05486065|584433284|FG000|Overall Study|Lost to Follow-up|4|||
161834012|NCT05486065|584433285|FG001|Overall Study|Lost to Follow-up|2|||
161834013|NCT05486065|584433286|FG002|Overall Study|Lost to Follow-up|2|||
161834014|NCT05486065|584433287|FG003|Overall Study|Lost to Follow-up|2|||
161633879|NCT02484547|583711869|FG005|Placebo-Controlled Period|Change of Treatment|0|||
161633880|NCT02484547|583711870|FG006|Placebo-Controlled Period|Change of Treatment|0|||
161633881|NCT02484547|583711864|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
161633882|NCT02484547|583711865|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
161633883|NCT02484547|583711866|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
161633884|NCT02484547|583711867|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
161633885|NCT02484547|583711868|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
161633886|NCT02484547|583711869|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
161633887|NCT02484547|583711870|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
161633888|NCT02484547|583711864|FG000|Placebo-Controlled Period|Death|5|||
161633889|NCT02484547|583711865|FG001|Placebo-Controlled Period|Death|0|||
161633890|NCT02484547|583711866|FG002|Placebo-Controlled Period|Death|6|||
161633891|NCT02484547|583711867|FG003|Placebo-Controlled Period|Death|0|||
161633892|NCT02484547|583711868|FG004|Placebo-Controlled Period|Death|0|||
161633893|NCT02484547|583711869|FG005|Placebo-Controlled Period|Death|0|||
161633894|NCT02484547|583711870|FG006|Placebo-Controlled Period|Death|0|||
161633895|NCT02484547|583711864|FG000|Placebo-Controlled Period|Disease Progression|2|||
161633896|NCT02484547|583711865|FG001|Placebo-Controlled Period|Disease Progression|0|||
161633897|NCT02484547|583711866|FG002|Placebo-Controlled Period|Disease Progression|1|||
161633898|NCT02484547|583711867|FG003|Placebo-Controlled Period|Disease Progression|0|||
161633899|NCT02484547|583711868|FG004|Placebo-Controlled Period|Disease Progression|0|||
161633900|NCT02484547|583711869|FG005|Placebo-Controlled Period|Disease Progression|0|||
161633901|NCT02484547|583711870|FG006|Placebo-Controlled Period|Disease Progression|0|||
161633902|NCT02484547|583711864|FG000|Placebo-Controlled Period|Investigator Decision|2|||
161633903|NCT02484547|583711865|FG001|Placebo-Controlled Period|Investigator Decision|2|||
161633904|NCT02484547|583711866|FG002|Placebo-Controlled Period|Investigator Decision|5|||
161633905|NCT02484547|583711867|FG003|Placebo-Controlled Period|Investigator Decision|0|||
161633906|NCT02484547|583711868|FG004|Placebo-Controlled Period|Investigator Decision|0|||
161633907|NCT02484547|583711869|FG005|Placebo-Controlled Period|Investigator Decision|0|||
161633908|NCT02484547|583711870|FG006|Placebo-Controlled Period|Investigator Decision|0|||
161633909|NCT02484547|583711864|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
161633910|NCT02484547|583711865|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
161633911|NCT02484547|583711866|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
161633912|NCT02484547|583711867|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
161633913|NCT02484547|583711868|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
161834015|NCT05486065|584433284|FG000|Overall Study|Physician Decision|0|||
161633914|NCT02484547|583711869|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
161633915|NCT02484547|583711870|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
161633916|NCT02484547|583711864|FG000|Placebo-Controlled Period|Relocation|1|||
161633917|NCT02484547|583711865|FG001|Placebo-Controlled Period|Relocation|1|||
161633918|NCT02484547|583711866|FG002|Placebo-Controlled Period|Relocation|1|||
161633919|NCT02484547|583711867|FG003|Placebo-Controlled Period|Relocation|0|||
161633920|NCT02484547|583711868|FG004|Placebo-Controlled Period|Relocation|0|||
161633921|NCT02484547|583711869|FG005|Placebo-Controlled Period|Relocation|0|||
161633922|NCT02484547|583711870|FG006|Placebo-Controlled Period|Relocation|0|||
161633923|NCT02484547|583711864|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
161633924|NCT02484547|583711865|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
161633925|NCT02484547|583711866|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
161633926|NCT02484547|583711867|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
161633927|NCT02484547|583711868|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
161633928|NCT02484547|583711869|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
161633929|NCT02484547|583711870|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
161633930|NCT02484547|583711864|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
161633931|NCT02484547|583711865|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161633932|NCT02484547|583711866|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161633933|NCT02484547|583711867|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161633934|NCT02484547|583711868|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161633935|NCT02484547|583711869|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161633936|NCT02484547|583711870|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161633937|NCT02484547|583711864|FG000|Placebo-Controlled Period|Reason not Specified|216|||
161633938|NCT02484547|583711865|FG001|Placebo-Controlled Period|Reason not Specified|194|||
161633939|NCT02484547|583711866|FG002|Placebo-Controlled Period|Reason not Specified|183|||
161633940|NCT02484547|583711867|FG003|Placebo-Controlled Period|Reason not Specified|0|||
161633941|NCT02484547|583711868|FG004|Placebo-Controlled Period|Reason not Specified|0|||
161633942|NCT02484547|583711869|FG005|Placebo-Controlled Period|Reason not Specified|0|||
161633943|NCT02484547|583711870|FG006|Placebo-Controlled Period|Reason not Specified|0|||
161633944|NCT02484547|583711864|FG000|Long-Term Extension Period|Adverse Event|0|||
161633945|NCT02484547|583711865|FG001|Long-Term Extension Period|Adverse Event|0|||
161633946|NCT02484547|583711866|FG002|Long-Term Extension Period|Adverse Event|0|||
161633947|NCT02484547|583711867|FG003|Long-Term Extension Period|Adverse Event|0|||
161633948|NCT02484547|583711868|FG004|Long-Term Extension Period|Adverse Event|1|||
161633949|NCT02484547|583711869|FG005|Long-Term Extension Period|Adverse Event|3|||
161633950|NCT02484547|583711870|FG006|Long-Term Extension Period|Adverse Event|2|||
161633951|NCT02484547|583711864|FG000|Long-Term Extension Period|Death|0|||
161633952|NCT02484547|583711865|FG001|Long-Term Extension Period|Death|0|||
161633953|NCT02484547|583711866|FG002|Long-Term Extension Period|Death|0|||
161633954|NCT02484547|583711867|FG003|Long-Term Extension Period|Death|0|||
161633955|NCT02484547|583711868|FG004|Long-Term Extension Period|Death|0|||
161633956|NCT02484547|583711869|FG005|Long-Term Extension Period|Death|3|||
161633957|NCT02484547|583711870|FG006|Long-Term Extension Period|Death|0|||
161633958|NCT02484547|583711864|FG000|Long-Term Extension Period|Disease Progression|0|||
161633959|NCT02484547|583711865|FG001|Long-Term Extension Period|Disease Progression|0|||
161633960|NCT02484547|583711866|FG002|Long-Term Extension Period|Disease Progression|0|||
161633961|NCT02484547|583711867|FG003|Long-Term Extension Period|Disease Progression|0|||
161633962|NCT02484547|583711868|FG004|Long-Term Extension Period|Disease Progression|2|||
161633963|NCT02484547|583711869|FG005|Long-Term Extension Period|Disease Progression|4|||
161633964|NCT02484547|583711870|FG006|Long-Term Extension Period|Disease Progression|0|||
161633965|NCT02484547|583711864|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
161633966|NCT02484547|583711865|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
161633967|NCT02484547|583711866|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
161633968|NCT02484547|583711867|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
161633969|NCT02484547|583711868|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
161633970|NCT02484547|583711869|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
161633971|NCT02484547|583711870|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
161633972|NCT02484547|583711864|FG000|Long-Term Extension Period|Loss of Capacity|0|||
161633973|NCT02484547|583711865|FG001|Long-Term Extension Period|Loss of Capacity|0|||
161633974|NCT02484547|583711866|FG002|Long-Term Extension Period|Loss of Capacity|0|||
161633975|NCT02484547|583711867|FG003|Long-Term Extension Period|Loss of Capacity|0|||
161633976|NCT02484547|583711868|FG004|Long-Term Extension Period|Loss of Capacity|1|||
161633977|NCT02484547|583711869|FG005|Long-Term Extension Period|Loss of Capacity|0|||
161633978|NCT02484547|583711870|FG006|Long-Term Extension Period|Loss of Capacity|0|||
161633979|NCT02484547|583711864|FG000|Long-Term Extension Period|Change of Treatment|0|||
161633980|NCT02484547|583711865|FG001|Long-Term Extension Period|Change of Treatment|0|||
161633981|NCT02484547|583711866|FG002|Long-Term Extension Period|Change of Treatment|0|||
161633982|NCT02484547|583711867|FG003|Long-Term Extension Period|Change of Treatment|0|||
161686158|NCT02311153|583903320|FG001|Overall Study|Lost to Follow-up|7|||
161633983|NCT02484547|583711868|FG004|Long-Term Extension Period|Change of Treatment|0|||
161633984|NCT02484547|583711869|FG005|Long-Term Extension Period|Change of Treatment|0|||
161633985|NCT02484547|583711870|FG006|Long-Term Extension Period|Change of Treatment|1|||
161633986|NCT02484547|583711864|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
161633987|NCT02484547|583711865|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
161633988|NCT02484547|583711866|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
161633989|NCT02484547|583711867|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
161633990|NCT02484547|583711868|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
161633991|NCT02484547|583711869|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
161633992|NCT02484547|583711870|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
161633993|NCT02484547|583711864|FG000|Long-Term Extension Period|Investigator Decision|0|||
161633994|NCT02484547|583711865|FG001|Long-Term Extension Period|Investigator Decision|0|||
161633995|NCT02484547|583711866|FG002|Long-Term Extension Period|Investigator Decision|0|||
161633996|NCT02484547|583711867|FG003|Long-Term Extension Period|Investigator Decision|2|||
161633997|NCT02484547|583711868|FG004|Long-Term Extension Period|Investigator Decision|1|||
161633998|NCT02484547|583711869|FG005|Long-Term Extension Period|Investigator Decision|0|||
161686159|NCT01967628|583903321|FG000|Overall Study|Withdrawal by Subject|2|||
161633999|NCT02484547|583711870|FG006|Long-Term Extension Period|Investigator Decision|1|||
161634000|NCT02484547|583711864|FG000|Long-Term Extension Period|Relocation|0|||
161634001|NCT02484547|583711865|FG001|Long-Term Extension Period|Relocation|0|||
161634002|NCT02484547|583711866|FG002|Long-Term Extension Period|Relocation|0|||
161634003|NCT02484547|583711867|FG003|Long-Term Extension Period|Relocation|1|||
161634004|NCT02484547|583711868|FG004|Long-Term Extension Period|Relocation|1|||
161634005|NCT02484547|583711869|FG005|Long-Term Extension Period|Relocation|0|||
161834016|NCT05486065|584433285|FG001|Overall Study|Physician Decision|1|||
161834017|NCT05486065|584433286|FG002|Overall Study|Physician Decision|1|||
161634006|NCT02484547|583711870|FG006|Long-Term Extension Period|Relocation|0|||
161634007|NCT02484547|583711864|FG000|Long-Term Extension Period|Study Visit Burden|0|||
161634008|NCT02484547|583711865|FG001|Long-Term Extension Period|Study Visit Burden|0|||
161634009|NCT02484547|583711866|FG002|Long-Term Extension Period|Study Visit Burden|0|||
161634010|NCT02484547|583711867|FG003|Long-Term Extension Period|Study Visit Burden|2|||
161634011|NCT02484547|583711868|FG004|Long-Term Extension Period|Study Visit Burden|0|||
161634012|NCT02484547|583711869|FG005|Long-Term Extension Period|Study Visit Burden|0|||
161634013|NCT02484547|583711870|FG006|Long-Term Extension Period|Study Visit Burden|3|||
161634014|NCT02484547|583711864|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161634015|NCT02484547|583711865|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161634016|NCT02484547|583711866|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161634017|NCT02484547|583711867|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161634018|NCT02484547|583711868|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
161634019|NCT02484547|583711869|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
161634020|NCT02484547|583711870|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
161634021|NCT02484547|583711864|FG000|Long-Term Extension Period|Reason not Specified|0|||
161634022|NCT02484547|583711865|FG001|Long-Term Extension Period|Reason not Specified|0|||
161634023|NCT02484547|583711866|FG002|Long-Term Extension Period|Reason not Specified|0|||
161634024|NCT02484547|583711867|FG003|Long-Term Extension Period|Reason not Specified|119|||
161634025|NCT02484547|583711868|FG004|Long-Term Extension Period|Reason not Specified|117|||
161634026|NCT02484547|583711869|FG005|Long-Term Extension Period|Reason not Specified|223|||
161634027|NCT02484547|583711870|FG006|Long-Term Extension Period|Reason not Specified|231|||
161634028|NCT01813305|583711871|FG000|Overall Study|Withdrawal by Subject|12|||
161634029|NCT01813305|583711872|FG001|Overall Study|Withdrawal by Subject|5|||
161634030|NCT01813305|583711871|FG000|Overall Study|Safety Concern|4|||
161634031|NCT01813305|583711872|FG001|Overall Study|Safety Concern|0|||
161634032|NCT01813305|583711871|FG000|Overall Study|Ulcer became worse|4|||
161634033|NCT01813305|583711872|FG001|Overall Study|Ulcer became worse|0|||
161634034|NCT01813305|583711871|FG000|Overall Study|Physician Decision|4|||
161634035|NCT01813305|583711872|FG001|Overall Study|Physician Decision|0|||
161634036|NCT01813305|583711871|FG000|Overall Study|Lost to Follow-up|3|||
161634037|NCT01813305|583711872|FG001|Overall Study|Lost to Follow-up|1|||
161634038|NCT01813305|583711871|FG000|Overall Study|Protocol Violation|1|||
161634039|NCT01813305|583711872|FG001|Overall Study|Protocol Violation|0|||
161634040|NCT01813305|583711871|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
161634041|NCT01813305|583711872|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
161634042|NCT03448536|583711873|FG000|Overall Study|Protocol Violation|2|||
161634043|NCT03448536|583711874|FG001|Overall Study|Protocol Violation|0|||
161634044|NCT03448536|583711873|FG000|Overall Study|Pregnancy|1|||
161634045|NCT03448536|583711874|FG001|Overall Study|Pregnancy|0|||
161634046|NCT03448536|583711873|FG000|Overall Study|Withdrawal by Subject|1|||
161634047|NCT03448536|583711874|FG001|Overall Study|Withdrawal by Subject|2|||
161634048|NCT03448536|583711873|FG000|Overall Study|Lost to Follow-up|3|||
161634049|NCT03448536|583711874|FG001|Overall Study|Lost to Follow-up|2|||
161634050|NCT03448536|583711873|FG000|Overall Study|Inadequate pain reporter|1|||
161634051|NCT03448536|583711874|FG001|Overall Study|Inadequate pain reporter|0|||
161634052|NCT03448536|583711873|FG000|Overall Study|Other|3|||
161634053|NCT03448536|583711874|FG001|Overall Study|Other|0|||
161634054|NCT03448536|583711873|FG000|Overall Study|Physician Decision|1|||
161634055|NCT03448536|583711874|FG001|Overall Study|Physician Decision|0|||
161634056|NCT01665599|583711875|FG000|Overall Study|Adverse Event|1|||
161634057|NCT01665599|583711875|FG000|Overall Study|Consent Withdrawn|1|||
161634058|NCT01665599|583711875|FG000|Overall Study|Investigator/Sponsor decision|1|||
161634059|NCT01665599|583711875|FG000|Overall Study|Death|1|||
161634060|NCT01665599|583711875|FG000|Overall Study|Lost to Follow-up|2|||
161634061|NCT01665599|583711875|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
161634062|NCT01665599|583711875|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
161634063|NCT00770588|583711876|FG000|Overall Study|Adverse Event|9|||
161634064|NCT00770588|583711877|FG001|Overall Study|Adverse Event|2|||
161634065|NCT00770588|583711876|FG000|Overall Study|Death caused by progression of disease|70|||
161686160|NCT01967628|583903322|FG001|Overall Study|Withdrawal by Subject|0|||
161634066|NCT00770588|583711877|FG001|Overall Study|Death caused by progression of disease|91|||
161634067|NCT00770588|583711876|FG000|Overall Study|Lost to Follow-up|1|||
161634068|NCT00770588|583711877|FG001|Overall Study|Lost to Follow-up|1|||
161634069|NCT00770588|583711876|FG000|Overall Study|Withdrawal by Subject|1|||
161634070|NCT00770588|583711877|FG001|Overall Study|Withdrawal by Subject|1|||
161634071|NCT01424189|583711878|FG000|Overall Study|Adverse Event|1|||
161634072|NCT01424189|583711879|FG001|Overall Study|Adverse Event|0|||
161634073|NCT01424189|583711878|FG000|Overall Study|Lost to Follow-up|4|||
161634074|NCT01424189|583711879|FG001|Overall Study|Lost to Follow-up|1|||
161634075|NCT01424189|583711878|FG000|Overall Study|Withdrawal by Subject|4|||
161834018|NCT05486065|584433287|FG003|Overall Study|Physician Decision|0|||
161634076|NCT01424189|583711879|FG001|Overall Study|Withdrawal by Subject|4|||
161634077|NCT01424189|583711878|FG000|Overall Study|Subject moved|1|||
161634078|NCT01424189|583711879|FG001|Overall Study|Subject moved|0|||
161634079|NCT01424189|583711878|FG000|Overall Study|Death|3|||
161634080|NCT01424189|583711879|FG001|Overall Study|Death|1|||
161634081|NCT03120949|583711880|FG000|Overall Study|randomized in error|1|||
161634082|NCT03120949|583711881|FG001|Overall Study|randomized in error|0|||
161634083|NCT03120949|583711880|FG000|Overall Study|Death|13|||
161634084|NCT03120949|583711881|FG001|Overall Study|Death|13|||
161634085|NCT03120949|583711880|FG000|Overall Study|Lost to Follow-up|23|||
161634086|NCT03120949|583711881|FG001|Overall Study|Lost to Follow-up|13|||
161634087|NCT03120949|583711880|FG000|Overall Study|Withdrawal by Subject|139|||
161634088|NCT03120949|583711881|FG001|Overall Study|Withdrawal by Subject|124|||
161634089|NCT03120949|583711880|FG000|Overall Study|Covid-19|43|||
161634090|NCT03120949|583711881|FG001|Overall Study|Covid-19|34|||
161634091|NCT03120949|583711880|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
161634092|NCT03120949|583711881|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
161634093|NCT03120949|583711880|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
161634094|NCT03120949|583711881|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
161634095|NCT03120949|583711880|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
161634096|NCT03120949|583711881|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
161634097|NCT03120949|583711880|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
161634098|NCT03120949|583711881|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
161634099|NCT03120949|583711880|FG000|Overall Study|Site was closed|2|||
161634100|NCT03120949|583711881|FG001|Overall Study|Site was closed|3|||
161634101|NCT03120949|583711880|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
161634102|NCT03120949|583711881|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
161634103|NCT03120949|583711880|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
161634104|NCT03120949|583711881|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
161634105|NCT03120949|583711880|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
161634106|NCT03120949|583711881|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
161634107|NCT03120949|583711880|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
161634108|NCT03120949|583711881|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
161634109|NCT03120949|583711880|FG000|Overall Study|Other: Adverse Event|0|||
161634110|NCT03120949|583711881|FG001|Overall Study|Other: Adverse Event|1|||
161634111|NCT03120949|583711880|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
161634112|NCT03120949|583711881|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
161634113|NCT03120949|583711880|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
161634114|NCT03120949|583711881|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
161634115|NCT03120949|583711880|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
161634116|NCT03120949|583711881|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
161634117|NCT03120949|583711880|FG000|Overall Study|Personal Reasons|0|||
161634118|NCT03120949|583711881|FG001|Overall Study|Personal Reasons|1|||
161634119|NCT03120949|583711880|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
161634120|NCT03120949|583711881|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
161634121|NCT03120949|583711880|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
161634122|NCT03120949|583711881|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
161634123|NCT03120949|583711880|FG000|Overall Study|Compliance With Medication|0|||
161634124|NCT03120949|583711881|FG001|Overall Study|Compliance With Medication|1|||
161634125|NCT03120949|583711880|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
161634126|NCT03120949|583711881|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
161634127|NCT03120949|583711880|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
161634128|NCT03120949|583711881|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
161634129|NCT03120949|583711880|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
161634130|NCT03120949|583711881|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
161634131|NCT01705145|583711882|FG000|Part B|Adverse Event|1|||
161634132|NCT00988117|583711883|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
161634133|NCT00988117|583711883|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
161686161|NCT01967628|583903321|FG000|Overall Study|Unable to complete bronchoscopy|4|||
161686162|NCT01967628|583903322|FG001|Overall Study|Unable to complete bronchoscopy|6|||
161686163|NCT01967628|583903321|FG000|Overall Study|Lost to Follow-up|1|||
161686164|NCT01967628|583903322|FG001|Overall Study|Lost to Follow-up|0|||
161634134|NCT01203956|583711884|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
161634135|NCT01203956|583711885|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
161634136|NCT02230306|583711888|FG000|Overall Study|Did not receive study treatment|1|||
161634137|NCT00312845|583711890|FG000|Overall Study|Adverse Event|19|||
161634138|NCT00312845|583711891|FG001|Overall Study|Adverse Event|5|||
161634139|NCT00312845|583711890|FG000|Overall Study|Death|2|||
161634140|NCT00312845|583711891|FG001|Overall Study|Death|2|||
161634141|NCT00312845|583711890|FG000|Overall Study|Withdrawal by Subject|14|||
161634142|NCT00312845|583711891|FG001|Overall Study|Withdrawal by Subject|6|||
161634143|NCT00312845|583711890|FG000|Overall Study|Disease Progression|56|||
161634144|NCT00312845|583711891|FG001|Overall Study|Disease Progression|77|||
161634145|NCT00312845|583711890|FG000|Overall Study|Lost to Follow-up|2|||
161634146|NCT00312845|583711891|FG001|Overall Study|Lost to Follow-up|0|||
161634147|NCT00312845|583711890|FG000|Overall Study|Other|6|||
161634148|NCT00312845|583711891|FG001|Overall Study|Other|5|||
161634149|NCT04206384|583711892|FG000|Overall Study|Withdrawal by Subject|8|||
161634150|NCT04206384|583711892|FG000|Overall Study|Adverse Event|2|||
161634151|NCT01121185|583711893|FG000|Overall Study|Not infused|0|||
161634152|NCT01121185|583711894|FG001|Overall Study|Not infused|1|||
161634153|NCT01121185|583711893|FG000|Overall Study|Not transplanted|1|||
161634154|NCT01121185|583711894|FG001|Overall Study|Not transplanted|0|||
161634155|NCT00424177|583711896|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
161634156|NCT00424177|583711896|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
161634157|NCT00424177|583711896|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
161634158|NCT00424177|583711896|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
161634159|NCT00424177|583711896|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
161634160|NCT00424177|583711896|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
161634161|NCT00424177|583711896|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
161634162|NCT00424177|583711896|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
161634163|NCT00424177|583711896|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
161634164|NCT00424177|583711896|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
161634165|NCT01260142|583711897|FG000|Treatment Period 1|Study on hold|1|||
161634166|NCT01260142|583711898|FG001|Treatment Period 1|Study on hold|1|||
161634167|NCT01260142|583711899|FG002|Treatment Period 1|Study on hold|0|||
161686165|NCT01967628|583903321|FG000|Overall Study|Low protein concentration in sample|20|||
161686166|NCT01967628|583903322|FG001|Overall Study|Low protein concentration in sample|25|||
161686167|NCT00838331|583903323|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
161686168|NCT01379274|583903324|FG000|Overall Study|funding withdrawn|1|||
161634168|NCT01260142|583711900|FG003|Treatment Period 1|Study on hold|0|||
161634169|NCT01260142|583711901|FG004|Treatment Period 1|Study on hold|1|||
161634170|NCT01260142|583711902|FG005|Treatment Period 1|Study on hold|2|||
161634171|NCT01260142|583711897|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
161634172|NCT01260142|583711898|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
161634173|NCT01260142|583711899|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
161634174|NCT01260142|583711900|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
161634175|NCT01260142|583711901|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
161634176|NCT01260142|583711902|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
161634177|NCT01260142|583711897|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161634178|NCT01260142|583711898|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161634179|NCT01260142|583711899|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161634180|NCT01260142|583711900|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161634181|NCT01260142|583711901|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161634182|NCT01260142|583711902|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161634183|NCT00496834|583711910|FG000|Overall Study|Withdrawal by Subject|4|||
161634184|NCT00496834|583711911|FG001|Overall Study|Withdrawal by Subject|6|||
161634185|NCT00496834|583711910|FG000|Overall Study|Contraindicated medication administered|0|||
161634186|NCT00496834|583711911|FG001|Overall Study|Contraindicated medication administered|1|||
161634187|NCT00496834|583711910|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
161634188|NCT00496834|583711911|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
161634189|NCT00496834|583711910|FG000|Overall Study|Adverse Event|5|||
161634190|NCT00496834|583711911|FG001|Overall Study|Adverse Event|3|||
161634191|NCT00496834|583711910|FG000|Overall Study|IP administration violation|2|||
161634192|NCT00496834|583711911|FG001|Overall Study|IP administration violation|0|||
161634193|NCT00496834|583711910|FG000|Overall Study|Lost to Follow-up|2|||
161634194|NCT00496834|583711911|FG001|Overall Study|Lost to Follow-up|0|||
161634195|NCT00496834|583711910|FG000|Overall Study|Blood Pressure control failure|2|||
161634196|NCT00496834|583711911|FG001|Overall Study|Blood Pressure control failure|1|||
161634197|NCT01503164|583711912|FG000|Overall Study|Withdrawal by Subject|2|||
161634198|NCT01503164|583711913|FG001|Overall Study|Withdrawal by Subject|1|||
161634199|NCT01227928|583711914|FG000|Overall Study|Lost to Follow-up|4|||
161634200|NCT01227928|583711915|FG001|Overall Study|Lost to Follow-up|2|||
161634201|NCT01227928|583711914|FG000|Overall Study|Withdrawal by Subject|4|||
161634202|NCT01227928|583711915|FG001|Overall Study|Withdrawal by Subject|3|||
161634203|NCT01227928|583711914|FG000|Overall Study|Death|14|||
161634204|NCT01227928|583711915|FG001|Overall Study|Death|12|||
161634205|NCT04088136|583711918|FG000|Overall Study|Withdrawal by Subject|5|||
161634206|NCT04088136|583711919|FG001|Overall Study|Withdrawal by Subject|0|||
161634207|NCT04088136|583711918|FG000|Overall Study|Lack of Efficacy|0|||
161634208|NCT04088136|583711919|FG001|Overall Study|Lack of Efficacy|1|||
161634209|NCT01494298|583711920|FG000|Overall Study|Protocol Violation|2|||
161634210|NCT01494298|583711921|FG001|Overall Study|Protocol Violation|8|||
161634211|NCT04159805|583711922|FG000|Overall Study|Withdrawal by Subject|0|||
161634212|NCT04159805|583711923|FG001|Overall Study|Withdrawal by Subject|2|||
161634213|NCT04159805|583711924|FG002|Overall Study|Withdrawal by Subject|2|||
161634214|NCT02930837|583711925|FG000|Overall Study|Adverse Event|6|||
161634215|NCT02930837|583711925|FG000|Overall Study|Lost to Follow-up|5|||
161634216|NCT02930837|583711925|FG000|Overall Study|Withdrawal by Subject|1|||
161634217|NCT01393613|583711926|FG000|Overall Study|Adverse Event|11|||
161634218|NCT01393613|583711927|FG001|Overall Study|Adverse Event|11|||
161634219|NCT01393613|583711928|FG002|Overall Study|Adverse Event|13|||
161634220|NCT01393613|583711929|FG003|Overall Study|Adverse Event|22|||
161634221|NCT01393613|583711926|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
161634222|NCT01393613|583711927|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
161634223|NCT01393613|583711928|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
161634224|NCT01393613|583711929|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161634225|NCT01393613|583711926|FG000|Overall Study|Physician Decision|2|||
161634226|NCT01393613|583711927|FG001|Overall Study|Physician Decision|0|||
161634227|NCT01393613|583711928|FG002|Overall Study|Physician Decision|0|||
161634228|NCT01393613|583711929|FG003|Overall Study|Physician Decision|1|||
161634229|NCT01393613|583711926|FG000|Overall Study|Withdrawal by Subject|15|||
161634230|NCT01393613|583711927|FG001|Overall Study|Withdrawal by Subject|25|||
161634231|NCT01393613|583711928|FG002|Overall Study|Withdrawal by Subject|23|||
161634232|NCT01393613|583711929|FG003|Overall Study|Withdrawal by Subject|21|||
161634233|NCT01393613|583711926|FG000|Overall Study|Protocol Deviation|2|||
161634234|NCT01393613|583711927|FG001|Overall Study|Protocol Deviation|1|||
161634235|NCT01393613|583711928|FG002|Overall Study|Protocol Deviation|0|||
161634236|NCT01393613|583711929|FG003|Overall Study|Protocol Deviation|0|||
161634237|NCT01393613|583711926|FG000|Overall Study|Lack of Efficacy|9|||
161634238|NCT01393613|583711927|FG001|Overall Study|Lack of Efficacy|20|||
161634239|NCT01393613|583711928|FG002|Overall Study|Lack of Efficacy|16|||
161634240|NCT01393613|583711929|FG003|Overall Study|Lack of Efficacy|21|||
161634241|NCT02998918|583711933|FG000|Overall Study|Withdrawal by Subject|1|||
161634242|NCT02998918|583711934|FG001|Overall Study|Withdrawal by Subject|0|||
161834019|NCT05486065|584433284|FG000|Overall Study|Failure to meet randomization criteria|0|||
161834020|NCT05486065|584433285|FG001|Overall Study|Failure to meet randomization criteria|0|||
161834021|NCT05486065|584433286|FG002|Overall Study|Failure to meet randomization criteria|0|||
161834022|NCT05486065|584433287|FG003|Overall Study|Failure to meet randomization criteria|1|||
161834023|NCT02858726|584433292|FG000|Overall Study|Adverse Event|4|||
161834024|NCT02858726|584433293|FG001|Overall Study|Adverse Event|4|||
161834025|NCT02858726|584433294|FG002|Overall Study|Adverse Event|9|||
161834026|NCT02858726|584433295|FG003|Overall Study|Adverse Event|1|||
161834027|NCT02858726|584433292|FG000|Overall Study|Physician Decision|0|||
161834028|NCT02858726|584433293|FG001|Overall Study|Physician Decision|0|||
161834029|NCT02858726|584433294|FG002|Overall Study|Physician Decision|1|||
161834030|NCT02858726|584433295|FG003|Overall Study|Physician Decision|0|||
161634243|NCT01071317|583711935|FG000|Overall Study|Lost to Follow-up|2|||
161834031|NCT02858726|584433292|FG000|Overall Study|Protocol Violation|0|||
161834032|NCT02858726|584433293|FG001|Overall Study|Protocol Violation|0|||
161834033|NCT02858726|584433294|FG002|Overall Study|Protocol Violation|0|||
161834034|NCT02858726|584433295|FG003|Overall Study|Protocol Violation|1|||
161834035|NCT02858726|584433292|FG000|Overall Study|Study Terminated by Sponsor|0|||
161834036|NCT02858726|584433293|FG001|Overall Study|Study Terminated by Sponsor|0|||
161834037|NCT02858726|584433294|FG002|Overall Study|Study Terminated by Sponsor|0|||
161834038|NCT02858726|584433295|FG003|Overall Study|Study Terminated by Sponsor|1|||
161834039|NCT02858726|584433292|FG000|Overall Study|Withdrawal by Subject|1|||
161834040|NCT02858726|584433293|FG001|Overall Study|Withdrawal by Subject|2|||
161834041|NCT02858726|584433294|FG002|Overall Study|Withdrawal by Subject|1|||
161834042|NCT02858726|584433295|FG003|Overall Study|Withdrawal by Subject|0|||
161834043|NCT02858726|584433292|FG000|Overall Study|Noncompliance|0|||
161834044|NCT02858726|584433293|FG001|Overall Study|Noncompliance|1|||
161834045|NCT02858726|584433294|FG002|Overall Study|Noncompliance|0|||
161834046|NCT02858726|584433295|FG003|Overall Study|Noncompliance|0|||
161834047|NCT04560998|584433296|FG000|Overall Study|Withdrawal by Subject|18|||
161834048|NCT04560998|584433297|FG001|Overall Study|Withdrawal by Subject|12|||
161834049|NCT04560998|584433296|FG000|Overall Study|Lost to Follow-up|8|||
161834050|NCT04560998|584433297|FG001|Overall Study|Lost to Follow-up|5|||
161834051|NCT04560998|584433296|FG000|Overall Study|Physician Decision|4|||
161834052|NCT04560998|584433297|FG001|Overall Study|Physician Decision|0|||
161634244|NCT01071317|583711936|FG001|Overall Study|Lost to Follow-up|2|||
161634245|NCT01283971|583711941|FG000|Overall Study|Adverse Event|3|||
161634246|NCT01283971|583711942|FG001|Overall Study|Adverse Event|5|||
161634247|NCT01283971|583711941|FG000|Overall Study|Insufficient therapeutic responses|3|||
161634248|NCT01283971|583711942|FG001|Overall Study|Insufficient therapeutic responses|3|||
161634249|NCT01283971|583711941|FG000|Overall Study|Protocol Violation|5|||
161834053|NCT00493246|584435543|FG000|Overall Study|Withdrawal by Subject|0|||
161834054|NCT00493246|584435544|FG001|Overall Study|Withdrawal by Subject|0|||
161834055|NCT00493246|584435545|FG002|Overall Study|Withdrawal by Subject|0|||
161834056|NCT00493246|584435546|FG003|Overall Study|Withdrawal by Subject|0|||
161634250|NCT01283971|583711942|FG001|Overall Study|Protocol Violation|1|||
161634251|NCT01283971|583711941|FG000|Overall Study|Refused treatment|3|||
161634252|NCT01283971|583711942|FG001|Overall Study|Refused treatment|1|||
161834057|NCT00493246|584435547|FG004|Overall Study|Withdrawal by Subject|1|||
161634253|NCT01283971|583711941|FG000|Overall Study|Failure to return|0|||
161634254|NCT01283971|583711942|FG001|Overall Study|Failure to return|1|||
161634255|NCT01283971|583711941|FG000|Overall Study|Administrative reasons|1|||
161634256|NCT01283971|583711942|FG001|Overall Study|Administrative reasons|1|||
161634257|NCT02598934|583711951|FG000|Overall Study|Adverse Event|11|||
161634258|NCT02598934|583711952|FG001|Overall Study|Adverse Event|13|||
161634259|NCT02598934|583711951|FG000|Overall Study|Failure to Return|3|||
161634260|NCT02598934|583711952|FG001|Overall Study|Failure to Return|3|||
161634261|NCT02598934|583711951|FG000|Overall Study|Withdrawal by Subject|2|||
161634262|NCT02598934|583711952|FG001|Overall Study|Withdrawal by Subject|3|||
161634263|NCT02598934|583711951|FG000|Overall Study|Administrative|2|||
161634264|NCT02598934|583711952|FG001|Overall Study|Administrative|1|||
161634265|NCT02598934|583711951|FG000|Overall Study|Protocol Violation|1|||
161634266|NCT02598934|583711952|FG001|Overall Study|Protocol Violation|2|||
161634267|NCT00702520|583711954|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
161634268|NCT00702520|583711955|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
161634269|NCT00702520|583711956|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
161634270|NCT00702520|583711957|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
161634271|NCT00702520|583711954|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
161634272|NCT00702520|583711955|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
161634273|NCT00702520|583711956|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
161686169|NCT01265797|583903331|FG000|Run-in Month|Withdrawal by Subject|0|||
161686170|NCT01265797|583903332|FG001|Run-in Month|Withdrawal by Subject|4|||
161686171|NCT01265797|583903331|FG000|Run-in Month|1st seizure during run-in month|0|||
161686172|NCT01265797|583903332|FG001|Run-in Month|1st seizure during run-in month|1|||
161686173|NCT01265797|583903331|FG000|Blinded Month|Lack of Efficacy|5|||
161686174|NCT01265797|583903332|FG001|Blinded Month|Lack of Efficacy|0|||
161686175|NCT01265797|583903331|FG000|Blinded Month|Lost to Follow-up|1|||
161686176|NCT01265797|583903332|FG001|Blinded Month|Lost to Follow-up|0|||
161634274|NCT00702520|583711957|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
161634275|NCT00702520|583711954|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
161634276|NCT00702520|583711955|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
161634277|NCT00702520|583711956|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
161634278|NCT00702520|583711957|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
161634279|NCT02154347|583711958|FG000|Double-blind Period|Adverse Event|1|||
161634280|NCT02154347|583711959|FG001|Double-blind Period|Adverse Event|2|||
161634281|NCT02154347|583711958|FG000|Double-blind Period|Lack of Efficacy|1|||
161634282|NCT02154347|583711959|FG001|Double-blind Period|Lack of Efficacy|0|||
161686177|NCT01265797|583903331|FG000|Blinded Month|Protocol Violation|2|||
161634283|NCT02154347|583711958|FG000|Double-blind Period|Physician Decision|0|||
161634284|NCT02154347|583711959|FG001|Double-blind Period|Physician Decision|1|||
161686178|NCT01265797|583903332|FG001|Blinded Month|Protocol Violation|1|||
161634285|NCT02154347|583711958|FG000|Double-blind Period|Withdrawal by Subject|1|||
161634286|NCT02154347|583711959|FG001|Double-blind Period|Withdrawal by Subject|1|||
161634287|NCT02154347|583711958|FG000|Open-label Period|Adverse Event|3|||
161634288|NCT02154347|583711959|FG001|Open-label Period|Adverse Event|4|||
161634289|NCT02154347|583711958|FG000|Open-label Period|Lack of Efficacy|4|||
161634290|NCT02154347|583711959|FG001|Open-label Period|Lack of Efficacy|19|||
161634291|NCT02154347|583711958|FG000|Open-label Period|Protocol Violation|0|||
161634292|NCT02154347|583711959|FG001|Open-label Period|Protocol Violation|1|||
161634293|NCT02154347|583711958|FG000|Open-label Period|Withdrawal by Subject|0|||
161634294|NCT02154347|583711959|FG001|Open-label Period|Withdrawal by Subject|1|||
161634295|NCT02481934|583711960|FG000|Overall Study|Death|2|||
161634296|NCT02473913|583711961|FG000|Overall Study|Lost to Follow-up|3|||
161634297|NCT02473913|583711962|FG001|Overall Study|Lost to Follow-up|3|||
161634298|NCT02250183|583711965|FG000|Overall Study|Withdrawal by Subject|2|||
161634299|NCT02250183|583711965|FG000|Overall Study|Adverse Event|5|||
161634300|NCT02250183|583711965|FG000|Overall Study|Lost to Follow-up|1|||
161634301|NCT02388347|583713343|FG000|Overall Study|Withdrawal by Subject|0|||
161634302|NCT02388347|583713344|FG001|Overall Study|Withdrawal by Subject|0|||
161634303|NCT02388347|583713345|FG002|Overall Study|Withdrawal by Subject|1|||
161634304|NCT02388347|583713346|FG003|Overall Study|Withdrawal by Subject|0|||
161634305|NCT02388347|583713347|FG004|Overall Study|Withdrawal by Subject|0|||
161634306|NCT00497874|583713348|FG000|Overall Study|Withdrawal by Subject|48|||
161634307|NCT00497874|583713349|FG001|Overall Study|Withdrawal by Subject|17|||
161634308|NCT00497874|583713348|FG000|Overall Study|Illness|8|||
161634309|NCT00497874|583713349|FG001|Overall Study|Illness|4|||
161634310|NCT00497874|583713348|FG000|Overall Study|Death|2|||
161634311|NCT00497874|583713349|FG001|Overall Study|Death|4|||
161634312|NCT00497874|583713348|FG000|Overall Study|Unable to contact|52|||
161634313|NCT00497874|583713349|FG001|Overall Study|Unable to contact|67|||
161634314|NCT00497874|583713348|FG000|Overall Study|Unable to schedule|37|||
161634315|NCT00497874|583713349|FG001|Overall Study|Unable to schedule|24|||
161634316|NCT01101334|583713350|FG000|Overall Study|Adverse Event|9|||
161634317|NCT01101334|583713351|FG001|Overall Study|Adverse Event|4|||
161634318|NCT01101334|583713350|FG000|Overall Study|Death|7|||
161634319|NCT01101334|583713351|FG001|Overall Study|Death|1|||
161634320|NCT01101334|583713350|FG000|Overall Study|Withdrawal by Subject|4|||
161634321|NCT01101334|583713351|FG001|Overall Study|Withdrawal by Subject|3|||
161634322|NCT01101334|583713350|FG000|Overall Study|Withdrawal by Sponsor|1|||
161634323|NCT01101334|583713351|FG001|Overall Study|Withdrawal by Sponsor|1|||
161634324|NCT01101334|583713350|FG000|Overall Study|Progressive Disease|22|||
161634325|NCT01101334|583713351|FG001|Overall Study|Progressive Disease|35|||
161634326|NCT01101334|583713350|FG000|Overall Study|Other|2|||
161634327|NCT01101334|583713351|FG001|Overall Study|Other|1|||
161634328|NCT04843579|583713356|FG000|Overall Study|Adverse Event|1|||
161634329|NCT04843579|583713356|FG000|Overall Study|Disease Progression|1|||
161634330|NCT04398368|583713357|FG000|Overall Study|Withdrawal by Subject|2|||
161634331|NCT00030823|583713360|FG000|Overall Study|Withdrawal by Subject|1|||
161634332|NCT02106195|583713365|FG000|Overall Study|Adverse Event|2|||
161634333|NCT02106195|583713365|FG000|Overall Study|Protocol Violation|1|||
161634334|NCT01114139|583713367|FG000|Overall Study|Adverse Event|3|||
161634335|NCT01114139|583713368|FG001|Overall Study|Adverse Event|2|||
161634336|NCT01114139|583713367|FG000|Overall Study|Lost to Follow-up|15|||
161834058|NCT00493246|584435548|FG005|Overall Study|Withdrawal by Subject|0|||
161549392|NCT02291289|583401011|FG002|Early Disease Progression|Lost to Follow-up|0|||
161549393|NCT02291289|583401012|FG003|Early Disease Progression|Lost to Follow-up|0|||
161549394|NCT02291289|583401013|FG004|Early Disease Progression|Lost to Follow-up|0|||
161549395|NCT02291289|583401014|FG005|Early Disease Progression|Lost to Follow-up|0|||
161549396|NCT02291289|583401015|FG006|Early Disease Progression|Lost to Follow-up|0|||
161549397|NCT02291289|583401016|FG007|Early Disease Progression|Lost to Follow-up|0|||
161549398|NCT02291289|583401017|FG008|Early Disease Progression|Lost to Follow-up|0|||
161549399|NCT02291289|583401018|FG009|Early Disease Progression|Lost to Follow-up|0|||
161549400|NCT02291289|583401019|FG010|Early Disease Progression|Lost to Follow-up|0|||
161549401|NCT02291289|583401020|FG011|Early Disease Progression|Lost to Follow-up|0|||
161549402|NCT02291289|583401021|FG012|Early Disease Progression|Lost to Follow-up|1|||
161549403|NCT01017120|583401022|FG000|Overall Study|Adverse Event|9|||
161834059|NCT00493246|584435549|FG006|Overall Study|Withdrawal by Subject|0|||
161834060|NCT00493246|584435550|FG007|Overall Study|Withdrawal by Subject|0|||
161634337|NCT01114139|583713368|FG001|Overall Study|Lost to Follow-up|3|||
161634338|NCT01114139|583713367|FG000|Overall Study|Withdrawal by Subject|17|||
161634339|NCT01114139|583713368|FG001|Overall Study|Withdrawal by Subject|6|||
161634340|NCT01114139|583713367|FG000|Overall Study|Other-Missed 1 visit|1|||
161634341|NCT01114139|583713368|FG001|Overall Study|Other-Missed 1 visit|0|||
161634342|NCT01114139|583713367|FG000|Overall Study|Other-Protocol Violation|1|||
161634343|NCT01114139|583713368|FG001|Overall Study|Other-Protocol Violation|0|||
161634344|NCT01114139|583713367|FG000|Overall Study|Other-Out of window for study drug dose|1|||
161634345|NCT01114139|583713368|FG001|Overall Study|Other-Out of window for study drug dose|0|||
161634346|NCT01114139|583713367|FG000|Overall Study|Other-Participant falsified records|0|||
161634347|NCT01114139|583713368|FG001|Overall Study|Other-Participant falsified records|1|||
161634348|NCT01114139|583713367|FG000|Overall Study|Other-Participant went on hospice|0|||
161634349|NCT01114139|583713368|FG001|Overall Study|Other-Participant went on hospice|1|||
161634350|NCT01114139|583713367|FG000|Overall Study|Other-Physician changed treatment|1|||
161634351|NCT01114139|583713368|FG001|Overall Study|Other-Physician changed treatment|0|||
161634352|NCT01114139|583713367|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
161634353|NCT01114139|583713368|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
161634354|NCT00477464|583713370|FG000|Overall Study|Lost to Follow-up|1|||
161634355|NCT00477464|583713370|FG000|Overall Study|Death|36|||
161834061|NCT00493246|584435543|FG000|Overall Study|No access to draw blood|0|||
161634356|NCT00477464|583713370|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
161634357|NCT03568812|583713371|FG000|Overall Study|Physician Decision|0|||
161634358|NCT03568812|583713372|FG001|Overall Study|Physician Decision|1|||
161634359|NCT00639769|583713374|FG000|Overall Study|Death|2|||
161834062|NCT00493246|584435544|FG001|Overall Study|No access to draw blood|0|||
161834063|NCT00493246|584435545|FG002|Overall Study|No access to draw blood|0|||
161634360|NCT00639769|583713374|FG000|Overall Study|Adverse Event|7|||
161634361|NCT00639769|583713374|FG000|Overall Study|Lack of Efficacy|1|||
161634362|NCT00639769|583713374|FG000|Overall Study|Disease progression|26|||
161634363|NCT00639769|583713374|FG000|Overall Study|Withdrawal by Subject|4|||
161634364|NCT01774019|583713376|FG000|Overall Study|No longer meets protocol criteria|2|||
161634365|NCT01774019|583713377|FG001|Overall Study|No longer meets protocol criteria|0|||
161634366|NCT01774019|583713376|FG000|Overall Study|Withdrawal by Subject|1|||
161634367|NCT01774019|583713377|FG001|Overall Study|Withdrawal by Subject|0|||
161634368|NCT01774019|583713376|FG000|Overall Study|Surgery delayed > 120 days|1|||
161634369|NCT01774019|583713377|FG001|Overall Study|Surgery delayed > 120 days|0|||
161634370|NCT01774019|583713376|FG000|Overall Study|Patient refused surgery|1|||
161634371|NCT01774019|583713377|FG001|Overall Study|Patient refused surgery|1|||
161634372|NCT01774019|583713376|FG000|Overall Study|Unable to implant study device|1|||
161634373|NCT01774019|583713377|FG001|Overall Study|Unable to implant study device|0|||
161634374|NCT01774019|583713376|FG000|Overall Study|Lost to Follow-up|0|||
161634375|NCT01774019|583713377|FG001|Overall Study|Lost to Follow-up|3|||
161634376|NCT03470545|583713380|FG000|Overall Study|Death|0|||
161634377|NCT03470545|583713381|FG001|Overall Study|Death|1|||
161634378|NCT03470545|583713380|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
161634379|NCT03470545|583713381|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
161634380|NCT03470545|583713380|FG000|Overall Study|Adverse Event|2|||
161634381|NCT03470545|583713381|FG001|Overall Study|Adverse Event|0|||
161634382|NCT03470545|583713380|FG000|Overall Study|Withdrawal by Subject|1|||
161634383|NCT03470545|583713381|FG001|Overall Study|Withdrawal by Subject|1|||
161634384|NCT03470545|583713380|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
161634385|NCT03470545|583713381|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
161634386|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
161634387|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
161634388|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
161634389|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
161634390|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
161634391|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
161634392|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
161634393|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
161634394|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
161634395|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
161634396|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
161634397|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
161634398|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
161634399|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
161634400|NCT01664923|583713382|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
161634401|NCT01664923|583713383|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
161634402|NCT01664923|583713382|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
161634403|NCT01664923|583713383|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
161634404|NCT01664923|583713382|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
161634405|NCT01664923|583713383|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
161634406|NCT01664923|583713382|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
161634407|NCT01664923|583713383|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
161634408|NCT01664923|583713382|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
161634409|NCT01664923|583713383|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
161634410|NCT01664923|583713382|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
161634411|NCT01664923|583713383|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
161634412|NCT01664923|583713382|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
161634413|NCT01664923|583713383|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
161634414|NCT00937521|583713386|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161634415|NCT00937521|583713387|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161634416|NCT00937521|583713388|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
161634417|NCT00937521|583713389|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161634418|NCT00937521|583713390|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161634419|NCT00937521|583713391|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161634420|NCT00937521|583713392|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
161634421|NCT00937521|583713393|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161634422|NCT00937521|583713386|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
161634423|NCT00937521|583713387|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161634424|NCT00937521|583713388|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
161634425|NCT00937521|583713389|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
161634426|NCT00937521|583713390|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161634427|NCT00937521|583713391|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
161634428|NCT00937521|583713392|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
161634429|NCT00937521|583713393|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161634430|NCT00937521|583713386|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161634431|NCT00937521|583713387|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161634432|NCT00937521|583713388|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
161634433|NCT00937521|583713389|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
161634434|NCT00937521|583713390|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161634435|NCT00937521|583713391|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161634436|NCT00937521|583713392|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161634437|NCT00937521|583713393|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161634438|NCT00937521|583713386|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161634439|NCT00937521|583713387|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
161634440|NCT00937521|583713388|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161634441|NCT00937521|583713389|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161634442|NCT00937521|583713390|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
161686179|NCT01265797|583903331|FG000|Blinded Month|Adverse Event|2|||
161686180|NCT01265797|583903332|FG001|Blinded Month|Adverse Event|0|||
161549404|NCT01017120|583401023|FG001|Overall Study|Adverse Event|0|||
161549405|NCT01017120|583401022|FG000|Overall Study|Lost to Follow-up|13|||
161549406|NCT01017120|583401023|FG001|Overall Study|Lost to Follow-up|11|||
161549407|NCT01017120|583401022|FG000|Overall Study|Lack of Efficacy|1|||
161549408|NCT01017120|583401023|FG001|Overall Study|Lack of Efficacy|0|||
161549409|NCT01017120|583401022|FG000|Overall Study|Withdrawal by Subject|39|||
161549410|NCT01017120|583401023|FG001|Overall Study|Withdrawal by Subject|21|||
161549411|NCT01017120|583401022|FG000|Overall Study|Pregnancy|1|||
161549412|NCT01017120|583401023|FG001|Overall Study|Pregnancy|1|||
161549413|NCT01017120|583401022|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161549414|NCT01017120|583401023|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161549415|NCT01017120|583401022|FG000|Overall Study|Relocated Out of Town|0|||
161549416|NCT01017120|583401023|FG001|Overall Study|Relocated Out of Town|2|||
161549417|NCT01017120|583401022|FG000|Overall Study|Protocol Violation|1|||
161549418|NCT01017120|583401023|FG001|Overall Study|Protocol Violation|0|||
161549419|NCT01017120|583401022|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
161549420|NCT01017120|583401023|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
161549421|NCT01642602|583401024|FG000|Overall Study|Adverse Event|2|||
161549422|NCT01112514|583401025|FG000|Overall Study|Lost to Follow-up|1|||
161549423|NCT01024959|583401026|FG000|Overall Study|ineligible|12|||
161549424|NCT01024959|583401026|FG000|Overall Study|results not evaluable|12|||
161549425|NCT01024959|583401026|FG000|Overall Study|missing results required for analysis|17|||
161549426|NCT01118455|583401027|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
161549427|NCT01118455|583401028|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
161549428|NCT03377790|583401033|FG000|Overall Study|Withdrawal by Subject|1|||
161549429|NCT03377790|583401034|FG001|Overall Study|Withdrawal by Subject|0|||
161549430|NCT03377790|583401033|FG000|Overall Study|Adverse Event|1|||
161549431|NCT03377790|583401034|FG001|Overall Study|Adverse Event|0|||
161549432|NCT03377790|583401033|FG000|Overall Study|Lost to Follow-up|0|||
161549433|NCT03377790|583401034|FG001|Overall Study|Lost to Follow-up|2|||
161549434|NCT03377790|583401033|FG000|Overall Study|Randomized but not treated|1|||
161549435|NCT03377790|583401034|FG001|Overall Study|Randomized but not treated|0|||
161549436|NCT03377790|583401033|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
161549437|NCT03377790|583401034|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
161549438|NCT00919893|583401037|FG000|Overall Study|Protocol Violation|19|||
161549439|NCT00919893|583401038|FG001|Overall Study|Protocol Violation|9|||
161549440|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
161549441|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
161549442|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161549443|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
161549444|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
161549445|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
161549446|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
161549447|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
161549448|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
161549449|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
161549450|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
161549451|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
161549452|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
161549453|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
161634443|NCT00937521|583713391|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
161634444|NCT00937521|583713392|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
161634445|NCT00937521|583713393|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161634446|NCT00937521|583713386|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
161634447|NCT00937521|583713387|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161634448|NCT00937521|583713388|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161634449|NCT00937521|583713389|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161634450|NCT00937521|583713390|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161634451|NCT00937521|583713391|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161634452|NCT00937521|583713392|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
161634453|NCT00937521|583713393|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161634454|NCT00937521|583713386|FG000|Booster Phase|Adverse Event|0|||
161634455|NCT00937521|583713387|FG001|Booster Phase|Adverse Event|0|||
161634456|NCT00937521|583713388|FG002|Booster Phase|Adverse Event|0|||
161634457|NCT00937521|583713389|FG003|Booster Phase|Adverse Event|0|||
161634458|NCT00937521|583713390|FG004|Booster Phase|Adverse Event|0|||
161634459|NCT00937521|583713391|FG005|Booster Phase|Adverse Event|0|||
161634460|NCT00937521|583713392|FG006|Booster Phase|Adverse Event|1|||
161634461|NCT00937521|583713393|FG007|Booster Phase|Adverse Event|0|||
161634462|NCT00937521|583713386|FG000|Booster Phase|Withdrawal by Subject|1|||
161634463|NCT00937521|583713387|FG001|Booster Phase|Withdrawal by Subject|0|||
161634464|NCT00937521|583713388|FG002|Booster Phase|Withdrawal by Subject|0|||
161634465|NCT00937521|583713389|FG003|Booster Phase|Withdrawal by Subject|1|||
161634466|NCT00937521|583713390|FG004|Booster Phase|Withdrawal by Subject|0|||
161634467|NCT00937521|583713391|FG005|Booster Phase|Withdrawal by Subject|0|||
161634468|NCT00937521|583713392|FG006|Booster Phase|Withdrawal by Subject|0|||
161634469|NCT00937521|583713393|FG007|Booster Phase|Withdrawal by Subject|2|||
161634470|NCT00937521|583713386|FG000|Booster Phase|Lost to Follow-up|2|||
161634471|NCT00937521|583713387|FG001|Booster Phase|Lost to Follow-up|2|||
161634472|NCT00937521|583713388|FG002|Booster Phase|Lost to Follow-up|4|||
161634473|NCT00937521|583713389|FG003|Booster Phase|Lost to Follow-up|2|||
161634474|NCT00937521|583713390|FG004|Booster Phase|Lost to Follow-up|4|||
161634475|NCT00937521|583713391|FG005|Booster Phase|Lost to Follow-up|4|||
161634476|NCT00937521|583713392|FG006|Booster Phase|Lost to Follow-up|3|||
161634477|NCT00937521|583713393|FG007|Booster Phase|Lost to Follow-up|0|||
161634478|NCT00937521|583713386|FG000|Booster Phase|Administrative Reason|0|||
161634479|NCT00937521|583713387|FG001|Booster Phase|Administrative Reason|0|||
161634480|NCT00937521|583713388|FG002|Booster Phase|Administrative Reason|1|||
161634481|NCT00937521|583713389|FG003|Booster Phase|Administrative Reason|0|||
161634482|NCT00937521|583713390|FG004|Booster Phase|Administrative Reason|1|||
161634483|NCT00937521|583713391|FG005|Booster Phase|Administrative Reason|1|||
161634484|NCT00937521|583713392|FG006|Booster Phase|Administrative Reason|0|||
161634485|NCT00937521|583713393|FG007|Booster Phase|Administrative Reason|0|||
161634486|NCT00937521|583713386|FG000|Booster Phase|Protocol Deviation|0|||
161634487|NCT00937521|583713387|FG001|Booster Phase|Protocol Deviation|0|||
161634488|NCT00937521|583713388|FG002|Booster Phase|Protocol Deviation|0|||
161634489|NCT00937521|583713389|FG003|Booster Phase|Protocol Deviation|0|||
161634490|NCT00937521|583713390|FG004|Booster Phase|Protocol Deviation|0|||
161634491|NCT00937521|583713391|FG005|Booster Phase|Protocol Deviation|0|||
161634492|NCT00937521|583713392|FG006|Booster Phase|Protocol Deviation|1|||
161634493|NCT00937521|583713393|FG007|Booster Phase|Protocol Deviation|0|||
161634494|NCT04035577|583713394|FG000|Overall Study|Lost to Follow-up|1|||
161634495|NCT04035577|583713394|FG000|Overall Study|Withdrawal by Subject|1|||
161834064|NCT00493246|584435546|FG003|Overall Study|No access to draw blood|0|||
161634496|NCT01426113|583713397|FG000|Overall Study|Study Discontinued|1|||
161634497|NCT01426113|583713398|FG001|Overall Study|Study Discontinued|1|||
161549454|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
161549455|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
161549456|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
161549457|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
161549458|NCT00365378|583401045|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
161549459|NCT00365378|583401046|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
161549460|NCT00365378|583401047|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
161549461|NCT00365378|583401045|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
161549462|NCT00365378|583401046|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
161549463|NCT00365378|583401047|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
161549464|NCT00365378|583401045|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
161549465|NCT00365378|583401046|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
161549466|NCT00365378|583401047|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
161549467|NCT00365378|583401045|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
161549468|NCT00365378|583401046|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
161549469|NCT00365378|583401047|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
161549470|NCT00365378|583401045|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
161549471|NCT00365378|583401046|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
161549472|NCT00365378|583401047|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
161549473|NCT00365378|583401045|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
161549474|NCT00365378|583401046|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
161549475|NCT00365378|583401047|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
161549476|NCT00365378|583401045|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
161549477|NCT00365378|583401046|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
161549478|NCT00365378|583401047|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
161549479|NCT00365378|583401045|FG000|Extension|Adverse Event|0|||
161549480|NCT00365378|583401046|FG001|Extension|Adverse Event|0|||
161549481|NCT00365378|583401047|FG002|Extension|Adverse Event|1|||
161549482|NCT00365378|583401045|FG000|Extension|Moved|0|||
161549483|NCT00365378|583401046|FG001|Extension|Moved|0|||
161549484|NCT00365378|583401047|FG002|Extension|Moved|8|||
161549485|NCT00365378|583401045|FG000|Extension|Lost to Follow-up|0|||
161549486|NCT00365378|583401046|FG001|Extension|Lost to Follow-up|0|||
161549487|NCT00365378|583401047|FG002|Extension|Lost to Follow-up|57|||
161549488|NCT00365378|583401045|FG000|Extension|Protocol Violation|0|||
161549489|NCT00365378|583401046|FG001|Extension|Protocol Violation|0|||
161549490|NCT00365378|583401047|FG002|Extension|Protocol Violation|2|||
161549491|NCT00365378|583401045|FG000|Extension|Withdrawal by Subject|0|||
161634498|NCT01426113|583713397|FG000|Overall Study|Adverse Event|0|||
161634499|NCT01426113|583713398|FG001|Overall Study|Adverse Event|1|||
161634500|NCT00878553|583713399|FG000|Sleep Study|Withdrawal by Subject|2|||
161634501|NCT00878553|583713400|FG001|Sleep Study|Withdrawal by Subject|0|||
161634502|NCT00878553|583713401|FG002|Sleep Study|Withdrawal by Subject|0|||
161634503|NCT00878553|583713402|FG003|Sleep Study|Withdrawal by Subject|0|||
161634504|NCT00878553|583713403|FG004|Sleep Study|Withdrawal by Subject|0|||
161634505|NCT00878553|583713399|FG000|Sleep Study|Lost to Follow-up|1|||
161634506|NCT00878553|583713400|FG001|Sleep Study|Lost to Follow-up|0|||
161634507|NCT00878553|583713401|FG002|Sleep Study|Lost to Follow-up|0|||
161634508|NCT00878553|583713402|FG003|Sleep Study|Lost to Follow-up|0|||
161634509|NCT00878553|583713403|FG004|Sleep Study|Lost to Follow-up|0|||
161634510|NCT00878553|583713399|FG000|Sleep Study|car accident|1|||
161634511|NCT00878553|583713400|FG001|Sleep Study|car accident|0|||
161634512|NCT00878553|583713401|FG002|Sleep Study|car accident|0|||
161634513|NCT00878553|583713402|FG003|Sleep Study|car accident|0|||
161634514|NCT00878553|583713403|FG004|Sleep Study|car accident|0|||
161634515|NCT00878553|583713399|FG000|Sleep Study|family emergency|1|||
161634516|NCT00878553|583713400|FG001|Sleep Study|family emergency|0|||
161634517|NCT00878553|583713401|FG002|Sleep Study|family emergency|0|||
161634518|NCT00878553|583713402|FG003|Sleep Study|family emergency|0|||
161634519|NCT00878553|583713403|FG004|Sleep Study|family emergency|0|||
161634520|NCT00878553|583713399|FG000|PK Study|Withdrawal by Subject|0|||
161634521|NCT00878553|583713400|FG001|PK Study|Withdrawal by Subject|0|||
161634522|NCT00878553|583713401|FG002|PK Study|Withdrawal by Subject|0|||
161634523|NCT00878553|583713402|FG003|PK Study|Withdrawal by Subject|1|||
161634524|NCT00878553|583713403|FG004|PK Study|Withdrawal by Subject|0|||
161634525|NCT00909532|583713406|FG000|Overall Study|Adverse Event|4|||
161634526|NCT00909532|583713407|FG001|Overall Study|Adverse Event|1|||
161634527|NCT00909532|583713406|FG000|Overall Study|Pregnancy|0|||
161634528|NCT00909532|583713407|FG001|Overall Study|Pregnancy|1|||
161634529|NCT00909532|583713406|FG000|Overall Study|Prohibited Medication|2|||
161634530|NCT00909532|583713407|FG001|Overall Study|Prohibited Medication|1|||
161634531|NCT00909532|583713406|FG000|Overall Study|Withdrawal of Consent|1|||
161634532|NCT00909532|583713407|FG001|Overall Study|Withdrawal of Consent|1|||
161634533|NCT00909532|583713406|FG000|Overall Study|Noncompliance with Study Requirements|0|||
161634534|NCT00909532|583713407|FG001|Overall Study|Noncompliance with Study Requirements|2|||
161634535|NCT00909532|583713406|FG000|Overall Study|Physician Decision|1|||
161686181|NCT01265797|583903331|FG000|Blinded Month|Diary data incomplete|0|||
161686182|NCT01265797|583903332|FG001|Blinded Month|Diary data incomplete|1|||
161686183|NCT01265797|583903331|FG000|Open Label Month|Lost to Follow-up|0|||
161686184|NCT01265797|583903332|FG001|Open Label Month|Lost to Follow-up|1|||
161686185|NCT00939783|583903334|FG000|Overall Study|Death|6|||
161686186|NCT00939783|583903334|FG000|Overall Study|Adverse Event|39|||
161686187|NCT00939783|583903334|FG000|Overall Study|Study Terminated by Sponsor|498|||
161686188|NCT00939783|583903334|FG000|Overall Study|Withdrawal by Subject|78|||
161686189|NCT00939783|583903334|FG000|Overall Study|Other|16|||
161686190|NCT00939783|583903334|FG000|Overall Study|Lost to Follow-up|8|||
161686191|NCT00939783|583903334|FG000|Overall Study|Protocol Violation|3|||
161686192|NCT00939783|583903334|FG000|Overall Study|Enrolled but not treated|1|||
161686193|NCT02250274|583903342|FG000|Overall Study|Insufficient blood draw amount|7|||
161686194|NCT02250274|583903343|FG001|Overall Study|Insufficient blood draw amount|6|||
161686195|NCT00583362|583903344|FG000|Overall Study|Adverse Event|44|||
161686196|NCT00583362|583903344|FG000|Overall Study|Lack of Efficacy|22|||
161686197|NCT00583362|583903344|FG000|Overall Study|Lost to Follow-up|4|||
161686198|NCT00583362|583903344|FG000|Overall Study|Non-compliance with study drug|28|||
161686199|NCT00583362|583903344|FG000|Overall Study|Pregnancy|7|||
161686200|NCT00583362|583903344|FG000|Overall Study|Miscommunication of visit window|5|||
161686201|NCT00583362|583903344|FG000|Overall Study|Current site closed|7|||
161686202|NCT00583362|583903344|FG000|Overall Study|Subject not dosed in LBSL99|1|||
161686203|NCT00583362|583903344|FG000|Overall Study|Subject moved out of the country/state|2|||
161686204|NCT00583362|583903344|FG000|Overall Study|Missed visits due to staff changes|1|||
161686205|NCT00583362|583903344|FG000|Overall Study|Misunderstanding of protocol|1|||
161686206|NCT00583362|583903344|FG000|Overall Study|Behavioral problems and non-compliance|1|||
161634536|NCT00909532|583713407|FG001|Overall Study|Physician Decision|0|||
161634537|NCT00909532|583713406|FG000|Overall Study|Wrong Genotype|1|||
161634538|NCT00909532|583713407|FG001|Overall Study|Wrong Genotype|0|||
161634539|NCT00909532|583713406|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
161634540|NCT00909532|583713407|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
161634541|NCT03188536|583713409|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
161634542|NCT03188536|583713409|FG000|Overall Study|Not participated/met inclusion criteria|1|||
161634543|NCT00118703|583713412|FG000|Overall Study|Protocol Violation|1|||
161634544|NCT00118703|583713413|FG001|Overall Study|Protocol Violation|0|||
161634545|NCT00118703|583713412|FG000|Overall Study|Adverse Event|1|||
161634546|NCT00118703|583713413|FG001|Overall Study|Adverse Event|1|||
161634547|NCT00118703|583713412|FG000|Overall Study|Participant took two different treatment|0|||
161634548|NCT00118703|583713413|FG001|Overall Study|Participant took two different treatment|1|||
161634549|NCT00118703|583713412|FG000|Overall Study|Withdrawal by Subject|2|||
161634550|NCT00118703|583713413|FG001|Overall Study|Withdrawal by Subject|5|||
161634551|NCT00118703|583713412|FG000|Overall Study|Lost to Follow-up|1|||
161634552|NCT00118703|583713413|FG001|Overall Study|Lost to Follow-up|2|||
161634553|NCT00461123|583713414|FG000|Overall Study|Adverse Event|1|||
161634554|NCT00461123|583713415|FG001|Overall Study|Adverse Event|0|||
161634555|NCT00461123|583713414|FG000|Overall Study|Lost to Follow-up|1|||
161634556|NCT00461123|583713415|FG001|Overall Study|Lost to Follow-up|1|||
161634557|NCT00461123|583713414|FG000|Overall Study|Protocol Violation|3|||
161634558|NCT00461123|583713415|FG001|Overall Study|Protocol Violation|2|||
161634559|NCT00461123|583713414|FG000|Overall Study|Withdrawal by Subject|1|||
161634560|NCT00461123|583713415|FG001|Overall Study|Withdrawal by Subject|3|||
161634561|NCT02024750|583713416|FG000|Overall Study|Withdrawal by Subject|2|||
161634562|NCT02024750|583713417|FG001|Overall Study|Withdrawal by Subject|1|||
161634563|NCT02344173|583713418|FG000|Procedure|Ablation Procedure Not Performed|7|||
161634564|NCT02344173|583713418|FG000|12-month Visit|Death|8|||
161634565|NCT02344173|583713418|FG000|12-month Visit|Withdrawal by Subject|30|||
161634566|NCT02344173|583713418|FG000|12-month Visit|Lost to Follow-up|58|||
161634567|NCT01891890|583713420|FG000|Overall Study|Lost to Follow-up|0|||
161634568|NCT01891890|583713421|FG001|Overall Study|Lost to Follow-up|0|||
161634569|NCT01891890|583713422|FG002|Overall Study|Lost to Follow-up|1|||
161634570|NCT01891890|583713420|FG000|Overall Study|Study ended before endpoint reached|7|||
161634571|NCT01891890|583713421|FG001|Overall Study|Study ended before endpoint reached|3|||
161549492|NCT00365378|583401046|FG001|Extension|Withdrawal by Subject|0|||
161549493|NCT00365378|583401047|FG002|Extension|Withdrawal by Subject|98|||
161549494|NCT00365378|583401045|FG000|Extension|Other|0|||
161549495|NCT00365378|583401046|FG001|Extension|Other|0|||
161549496|NCT00365378|583401047|FG002|Extension|Other|31|||
161549497|NCT04741802|583401048|FG000|Overall Study|Death|1|||
161549498|NCT04741802|583401048|FG000|Overall Study|Lost to Follow-up|11|||
161549499|NCT00452413|583401060|FG000|Overall Study|Progressive Disease|4|||
161549500|NCT00452413|583401061|FG001|Overall Study|Progressive Disease|11|||
161549501|NCT00452413|583401062|FG002|Overall Study|Progressive Disease|30|||
161549502|NCT00452413|583401060|FG000|Overall Study|Withdrawal by Subject|0|||
161549503|NCT00452413|583401061|FG001|Overall Study|Withdrawal by Subject|1|||
161549504|NCT00452413|583401062|FG002|Overall Study|Withdrawal by Subject|4|||
161549505|NCT00452413|583401060|FG000|Overall Study|Adverse Event|0|||
161549506|NCT00452413|583401061|FG001|Overall Study|Adverse Event|0|||
161549507|NCT00452413|583401062|FG002|Overall Study|Adverse Event|5|||
161549508|NCT00452413|583401060|FG000|Overall Study|Physician Decision|0|||
161549509|NCT00452413|583401061|FG001|Overall Study|Physician Decision|0|||
161549510|NCT00452413|583401062|FG002|Overall Study|Physician Decision|4|||
161549511|NCT00452413|583401060|FG000|Overall Study|Death due to study disease|0|||
161549512|NCT00452413|583401061|FG001|Overall Study|Death due to study disease|0|||
161549513|NCT00452413|583401062|FG002|Overall Study|Death due to study disease|2|||
161549514|NCT00452413|583401060|FG000|Overall Study|Death due to adverse event (AE)|0|||
161549515|NCT00452413|583401061|FG001|Overall Study|Death due to adverse event (AE)|0|||
161549516|NCT00452413|583401062|FG002|Overall Study|Death due to adverse event (AE)|1|||
161549517|NCT00452413|583401060|FG000|Overall Study|On treatment|0|||
161549518|NCT00452413|583401061|FG001|Overall Study|On treatment|0|||
161549519|NCT00452413|583401062|FG002|Overall Study|On treatment|3|||
161549520|NCT01539863|583401071|FG000|Overall Study|Lost to Follow-up|5|||
161549521|NCT01539863|583401072|FG001|Overall Study|Lost to Follow-up|4|||
161549522|NCT02226172|583401077|FG000|Overall Study|Participant refused further follow-up|4|||
161634572|NCT01891890|583713422|FG002|Overall Study|Study ended before endpoint reached|6|||
161634573|NCT03605368|583713430|FG000|Overall Study|Lost to Follow-up|2|||
161634574|NCT03605368|583713431|FG001|Overall Study|Lost to Follow-up|1|||
161634575|NCT03605368|583713432|FG002|Overall Study|Lost to Follow-up|3|||
161634576|NCT03605368|583713433|FG003|Overall Study|Lost to Follow-up|2|||
161634577|NCT03605368|583713430|FG000|Overall Study|Withdrawal by Subject|0|||
161634578|NCT03605368|583713431|FG001|Overall Study|Withdrawal by Subject|0|||
161634579|NCT03605368|583713432|FG002|Overall Study|Withdrawal by Subject|4|||
161634580|NCT03605368|583713433|FG003|Overall Study|Withdrawal by Subject|3|||
161634581|NCT01215032|583713434|FG000|Overall Study|Adverse Event|3|||
161634582|NCT01215032|583713434|FG000|Overall Study|Lack of Efficacy|17|||
161634583|NCT01020747|583713435|FG000|Overall Study|Withdrawal by Subject|1|||
161634584|NCT02881047|583713440|FG000|Overall Study|Adverse Event|1|||
161634585|NCT02881047|583713440|FG000|Overall Study|Withdrawal by Subject|1|||
161634586|NCT03028012|583713441|FG000|Overall Study|Lost to Follow-up|2|||
161634587|NCT03028012|583713442|FG001|Overall Study|Lost to Follow-up|3|||
161634588|NCT03028012|583713443|FG002|Overall Study|Lost to Follow-up|3|||
161634589|NCT01077622|583713447|FG000|Overall Study|Physician Decision|2|||
161634590|NCT01077622|583713447|FG000|Overall Study|Withdrawal by Subject|1|||
161634591|NCT01091519|583713450|FG000|Overall Study|Adverse Event|12|||
161634592|NCT01091519|583713451|FG001|Overall Study|Adverse Event|16|||
161634593|NCT01091519|583713450|FG000|Overall Study|Death|1|||
161634594|NCT01091519|583713451|FG001|Overall Study|Death|0|||
161634595|NCT01091519|583713450|FG000|Overall Study|Lack of Efficacy|16|||
161634596|NCT01091519|583713451|FG001|Overall Study|Lack of Efficacy|19|||
161634597|NCT01091519|583713450|FG000|Overall Study|Lost to Follow-up|14|||
161634598|NCT01091519|583713451|FG001|Overall Study|Lost to Follow-up|24|||
161634599|NCT01091519|583713450|FG000|Overall Study|Withdrawal by Subject|2|||
161634600|NCT01091519|583713451|FG001|Overall Study|Withdrawal by Subject|2|||
161686207|NCT00583362|583903344|FG000|Overall Study|Sponsor request due to missed doses|1|||
161686208|NCT00583362|583903344|FG000|Overall Study|Physician Decision|19|||
161634601|NCT01091519|583713450|FG000|Overall Study|Other|6|||
161634602|NCT01091519|583713451|FG001|Overall Study|Other|8|||
161634603|NCT01091519|583713450|FG000|Overall Study|Randomized not treated|4|||
161834065|NCT00493246|584435547|FG004|Overall Study|No access to draw blood|0|||
161834066|NCT00493246|584435548|FG005|Overall Study|No access to draw blood|1|||
161686209|NCT00583362|583903344|FG000|Overall Study|Protocol Violation|2|||
161686210|NCT00583362|583903344|FG000|Overall Study|Withdrawal by Subject|57|||
161634604|NCT01091519|583713451|FG001|Overall Study|Randomized not treated|4|||
161634605|NCT00316589|583713454|FG000|Overall Study|Withdrawal by Subject|0|||
161634606|NCT00316589|583713455|FG001|Overall Study|Withdrawal by Subject|5|||
161634607|NCT00316589|583713456|FG002|Overall Study|Withdrawal by Subject|0|||
161634608|NCT00316589|583713457|FG003|Overall Study|Withdrawal by Subject|1|||
161834067|NCT00493246|584435549|FG006|Overall Study|No access to draw blood|0|||
161634609|NCT00316589|583713454|FG000|Overall Study|Subject unwilling/unable to comply|0|||
161634610|NCT00316589|583713455|FG001|Overall Study|Subject unwilling/unable to comply|6|||
161634611|NCT00316589|583713456|FG002|Overall Study|Subject unwilling/unable to comply|0|||
161634612|NCT00316589|583713457|FG003|Overall Study|Subject unwilling/unable to comply|2|||
161634613|NCT00316589|583713454|FG000|Overall Study|Adverse Event|1|||
161634614|NCT00316589|583713455|FG001|Overall Study|Adverse Event|0|||
161634615|NCT00316589|583713456|FG002|Overall Study|Adverse Event|0|||
161634616|NCT00316589|583713457|FG003|Overall Study|Adverse Event|1|||
161634617|NCT00316589|583713454|FG000|Overall Study|Physician Decision|0|||
161634618|NCT00316589|583713455|FG001|Overall Study|Physician Decision|1|||
161634619|NCT00316589|583713456|FG002|Overall Study|Physician Decision|0|||
161634620|NCT00316589|583713457|FG003|Overall Study|Physician Decision|0|||
161634621|NCT00316589|583713454|FG000|Overall Study|Other reason|0|||
161634622|NCT00316589|583713455|FG001|Overall Study|Other reason|12|||
161634623|NCT00316589|583713456|FG002|Overall Study|Other reason|1|||
161634624|NCT00316589|583713457|FG003|Overall Study|Other reason|1|||
161634625|NCT00562484|583713458|FG000|Overall Study|Adverse Event|6|||
161634626|NCT00562484|583713459|FG001|Overall Study|Adverse Event|1|||
161634627|NCT00562484|583713458|FG000|Overall Study|Protocol Violation|11|||
161634628|NCT00562484|583713459|FG001|Overall Study|Protocol Violation|2|||
161634629|NCT00562484|583713458|FG000|Overall Study|Withdrawal by Subject|12|||
161634630|NCT00562484|583713459|FG001|Overall Study|Withdrawal by Subject|9|||
161634631|NCT00562484|583713458|FG000|Overall Study|Moved away from the study area|20|||
161634632|NCT00562484|583713459|FG001|Overall Study|Moved away from the study area|9|||
161634633|NCT00562484|583713458|FG000|Overall Study|Lost to Follow-up|132|||
161634634|NCT00562484|583713459|FG001|Overall Study|Lost to Follow-up|71|||
161634635|NCT00562484|583713458|FG000|Overall Study|Reason not provided or not specified|25|||
161634636|NCT00562484|583713459|FG001|Overall Study|Reason not provided or not specified|12|||
161634637|NCT03282799|583713463|FG000|Overall Study|Pregnancy|1|||
161634638|NCT03282799|583713464|FG001|Overall Study|Pregnancy|0|||
161634639|NCT03282799|583713463|FG000|Overall Study|Physician Decision|1|||
161634640|NCT03282799|583713464|FG001|Overall Study|Physician Decision|0|||
161634641|NCT03749616|583713465|FG000|Overall Study|Lost to Follow-up|4|||
161634642|NCT03749616|583713466|FG001|Overall Study|Lost to Follow-up|7|||
161634643|NCT03749616|583713465|FG000|Overall Study|Screen Failure|1|||
161634644|NCT03749616|583713466|FG001|Overall Study|Screen Failure|1|||
161634645|NCT03749616|583713465|FG000|Overall Study|Withdrawal by Subject|2|||
161634646|NCT03749616|583713466|FG001|Overall Study|Withdrawal by Subject|0|||
161634647|NCT03302559|583713467|FG000|Overall Study|Adverse Event|2|||
161634648|NCT03302559|583713467|FG000|Overall Study|Lost to Follow-up|1|||
161634649|NCT03302559|583713467|FG000|Overall Study|Withdrew Consent|3|||
161634650|NCT01171183|583715419|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
161634651|NCT01171183|583715420|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
161634652|NCT01171183|583715419|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
161634653|NCT01171183|583715420|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
161634654|NCT01171183|583715419|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
161634655|NCT01171183|583715420|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
161634656|NCT01171183|583715419|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
161634657|NCT01171183|583715420|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
161634658|NCT01171183|583715419|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
161634659|NCT01171183|583715420|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
161634660|NCT01171183|583715419|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
161634661|NCT01171183|583715420|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
161634662|NCT03440047|583715425|FG000|Overall Study|Withdrawal by Subject|2|||
161634663|NCT01053247|583715431|FG000|Overall Study|Withdrawal by Subject|9|||
161634664|NCT01053247|583715432|FG001|Overall Study|Withdrawal by Subject|4|||
161634665|NCT01053247|583715433|FG002|Overall Study|Withdrawal by Subject|15|||
161686211|NCT00506883|583903360|FG000|Overall Study|Lost to Follow-up|1|||
161686212|NCT00506883|583903361|FG001|Overall Study|Lost to Follow-up|1|||
161686213|NCT00506883|583903362|FG002|Overall Study|Lost to Follow-up|1|||
161686214|NCT00506883|583903360|FG000|Overall Study|Withdrawal by Subject|1|||
161686215|NCT00506883|583903361|FG001|Overall Study|Withdrawal by Subject|0|||
161686216|NCT00506883|583903362|FG002|Overall Study|Withdrawal by Subject|1|||
161686217|NCT00506883|583903360|FG000|Overall Study|Lack of Efficacy|0|||
161686218|NCT00506883|583903361|FG001|Overall Study|Lack of Efficacy|1|||
161834068|NCT00493246|584435550|FG007|Overall Study|No access to draw blood|0|||
161834069|NCT00493246|584435543|FG000|Overall Study|Lost to Follow-up|0|||
161834070|NCT00493246|584435544|FG001|Overall Study|Lost to Follow-up|0|||
161634666|NCT01053247|583715431|FG000|Overall Study|Lack of Efficacy|1|||
161834071|NCT00493246|584435545|FG002|Overall Study|Lost to Follow-up|0|||
161634667|NCT01053247|583715432|FG001|Overall Study|Lack of Efficacy|0|||
161634668|NCT01053247|583715433|FG002|Overall Study|Lack of Efficacy|1|||
161634669|NCT01053247|583715431|FG000|Overall Study|Protocol Violation|2|||
161634670|NCT01053247|583715432|FG001|Overall Study|Protocol Violation|1|||
161634671|NCT01053247|583715433|FG002|Overall Study|Protocol Violation|2|||
161634672|NCT01053247|583715431|FG000|Overall Study|Lost to Follow-up|8|||
161686219|NCT00506883|583903362|FG002|Overall Study|Lack of Efficacy|1|||
161686220|NCT00506883|583903360|FG000|Overall Study|Other|5|||
161686221|NCT00506883|583903361|FG001|Overall Study|Other|1|||
161634673|NCT01053247|583715432|FG001|Overall Study|Lost to Follow-up|5|||
161634674|NCT01053247|583715433|FG002|Overall Study|Lost to Follow-up|7|||
161634675|NCT01053247|583715431|FG000|Overall Study|Adverse Event|0|||
161634676|NCT01053247|583715432|FG001|Overall Study|Adverse Event|9|||
161634677|NCT01053247|583715433|FG002|Overall Study|Adverse Event|3|||
161634678|NCT03458728|583715434|FG000|Overall Study|Adverse Event|1|||
161634679|NCT03458728|583715435|FG001|Overall Study|Adverse Event|0|||
161634680|NCT03458728|583715434|FG000|Overall Study|Physician Decision|1|||
161634681|NCT03458728|583715435|FG001|Overall Study|Physician Decision|0|||
161634682|NCT03458728|583715434|FG000|Overall Study|Progressive disease - clinical assessment|1|||
161634683|NCT03458728|583715435|FG001|Overall Study|Progressive disease - clinical assessment|0|||
161634684|NCT03458728|583715434|FG000|Overall Study|Progressive disease - radiological progression|21|||
161634685|NCT03458728|583715435|FG001|Overall Study|Progressive disease - radiological progression|6|||
161634686|NCT03458728|583715434|FG000|Overall Study|Withdrawal by Subject|0|||
161634687|NCT03458728|583715435|FG001|Overall Study|Withdrawal by Subject|1|||
161634688|NCT03898700|583715438|FG000|Overall Study|Withdrawal by Subject|2|||
161634689|NCT00701909|583715442|FG000|Overall Study|Withdrawal by Subject|0|||
161634690|NCT00701909|583715443|FG001|Overall Study|Withdrawal by Subject|1|||
161634691|NCT00908349|583715444|FG000|Overall Study|Adverse Event|10|||
161634692|NCT00908349|583715444|FG000|Overall Study|Withdrawal by Subject|9|||
161634693|NCT00908349|583715444|FG000|Overall Study|Physician Decision|5|||
161634694|NCT00908349|583715444|FG000|Overall Study|Lost to Follow-up|5|||
161634695|NCT00908349|583715444|FG000|Overall Study|Various|6|||
161634696|NCT00971997|583715445|FG000|Overall Study|Adverse Event|2|||
161634697|NCT00971997|583715445|FG000|Overall Study|Death|1|||
161634698|NCT00971997|583715445|FG000|Overall Study|Protocol Violation|4|||
161634699|NCT00971997|583715445|FG000|Overall Study|Withdrawal by Subject|5|||
161634700|NCT00971997|583715445|FG000|Overall Study|Physician Decision|7|||
161634701|NCT04009629|583715449|FG000|Overall Study|Withdrawal by Subject|2|||
161634702|NCT04009629|583715450|FG001|Overall Study|Withdrawal by Subject|0|||
161634703|NCT00761956|583715454|FG000|Overall Study|Lost to Follow-up|6|||
161634704|NCT00761956|583715455|FG001|Overall Study|Lost to Follow-up|11|||
161634705|NCT00761956|583715454|FG000|Overall Study|Withdrawal by Subject|3|||
161634706|NCT00761956|583715455|FG001|Overall Study|Withdrawal by Subject|8|||
161634707|NCT00761956|583715454|FG000|Overall Study|Death|0|||
161634708|NCT00761956|583715455|FG001|Overall Study|Death|1|||
161634709|NCT00761956|583715454|FG000|Overall Study|Adverse Event|26|||
161634710|NCT00761956|583715455|FG001|Overall Study|Adverse Event|34|||
161634711|NCT03602586|583715458|FG000|Overall Study|Withdrawal by Subject|3|||
161634712|NCT00511836|583715461|FG000|Double-blind Period|Lost to Follow-up|1|||
161634713|NCT00511836|583715462|FG001|Double-blind Period|Lost to Follow-up|0|||
161634714|NCT01755546|583715464|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
161634715|NCT01755546|583715464|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
161634716|NCT01755546|583715464|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
161634717|NCT01755546|583715464|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
161634718|NCT01755546|583715464|FG000|Titration Phase|Adverse Event|11|||
161634719|NCT01755546|583715464|FG000|Titration Phase|Lack of Efficacy|18|||
161634720|NCT01755546|583715464|FG000|Titration Phase|Protocol Violation|9|||
161634721|NCT01755546|583715464|FG000|Titration Phase|Lost to Follow-up|2|||
161634722|NCT01755546|583715464|FG000|Titration Phase|Other and Continuing|22|||
161634723|NCT01755546|583715464|FG000|Titration Phase|Withdrawal by Subject|8|||
161634724|NCT01755546|583715464|FG000|Long Term Treatment|Adverse Event|12|||
161634725|NCT01755546|583715464|FG000|Long Term Treatment|Lack of Efficacy|6|||
161634726|NCT01755546|583715464|FG000|Long Term Treatment|Protocol Violation|10|||
161634727|NCT01755546|583715464|FG000|Long Term Treatment|Withdrawal by Subject|35|||
161634728|NCT01755546|583715464|FG000|Long Term Treatment|Lost to Follow-up|17|||
161634729|NCT01755546|583715464|FG000|Long Term Treatment|other and ongoing|41|||
161634730|NCT00891046|583715465|FG000|Overall Study|Protocol Violation|1|||
161634731|NCT00891046|583715466|FG001|Overall Study|Protocol Violation|1|||
161634732|NCT00891046|583715467|FG002|Overall Study|Protocol Violation|0|||
161634733|NCT00891046|583715468|FG003|Overall Study|Protocol Violation|0|||
161634734|NCT00891046|583715469|FG004|Overall Study|Protocol Violation|1|||
161634735|NCT00891046|583715465|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161634736|NCT00891046|583715466|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161634737|NCT00891046|583715467|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
161634738|NCT00891046|583715468|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161634739|NCT00891046|583715469|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
161634740|NCT00891046|583715465|FG000|Overall Study|Administrative problems|0|||
161634741|NCT00891046|583715466|FG001|Overall Study|Administrative problems|0|||
161634742|NCT00891046|583715467|FG002|Overall Study|Administrative problems|0|||
161634743|NCT00891046|583715468|FG003|Overall Study|Administrative problems|0|||
161634744|NCT00891046|583715469|FG004|Overall Study|Administrative problems|1|||
161686222|NCT00506883|583903362|FG002|Overall Study|Other|1|||
161634745|NCT00891046|583715465|FG000|Overall Study|Participant no longer required drug|0|||
161634746|NCT00891046|583715466|FG001|Overall Study|Participant no longer required drug|2|||
161634747|NCT00891046|583715467|FG002|Overall Study|Participant no longer required drug|0|||
161634748|NCT00891046|583715468|FG003|Overall Study|Participant no longer required drug|0|||
161634749|NCT00891046|583715469|FG004|Overall Study|Participant no longer required drug|1|||
161634750|NCT00891046|583715465|FG000|Overall Study|Adverse Event|4|||
161634751|NCT00891046|583715466|FG001|Overall Study|Adverse Event|3|||
161686223|NCT00455013|583903364|FG000|Short Term Period|Adverse Event|2|||
161686224|NCT00455013|583903365|FG001|Short Term Period|Adverse Event|5|||
161686225|NCT00455013|583903366|FG002|Short Term Period|Adverse Event|0|||
161686226|NCT00455013|583903364|FG000|Short Term Period|Withdrawal by Subject|0|||
161686227|NCT00455013|583903365|FG001|Short Term Period|Withdrawal by Subject|0|||
161686228|NCT00455013|583903366|FG002|Short Term Period|Withdrawal by Subject|1|||
161686229|NCT00455013|583903364|FG000|Short Term Period|Lack of Efficacy|4|||
161686230|NCT00455013|583903365|FG001|Short Term Period|Lack of Efficacy|0|||
161686231|NCT00455013|583903366|FG002|Short Term Period|Lack of Efficacy|0|||
161686232|NCT00455013|583903364|FG000|Short Term Period|Other|0|||
161686233|NCT00455013|583903365|FG001|Short Term Period|Other|0|||
161686234|NCT00455013|583903366|FG002|Short Term Period|Other|1|||
161686235|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Adverse Event|0|||
161686236|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Adverse Event|1|||
161686237|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Adverse Event|1|||
161686238|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
161686239|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
161686240|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
161686241|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Death|1|||
161686242|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Death|1|||
161686243|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Death|0|||
161686244|NCT00455013|583903364|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
161686245|NCT00455013|583903365|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
161686246|NCT00455013|583903366|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
161686247|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
161686248|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
161686249|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
161686250|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
161686251|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
161686252|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
161686253|NCT00455013|583903364|FG000|Long Term Extension (LTE)|non-specified|0|||
161686254|NCT00455013|583903365|FG001|Long Term Extension (LTE)|non-specified|0|||
161686255|NCT00455013|583903366|FG002|Long Term Extension (LTE)|non-specified|1|||
161686256|NCT00786565|583903370|FG000|Enrollment Prior to Surgery|Site Closed|3|||
161686257|NCT00786565|583903370|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
161686258|NCT00786565|583903370|FG000|Post Surgery|Abnormal macular pucker|1|||
161686259|NCT00786565|583903370|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
161686260|NCT05513625|583903373|FG000|Overall Study|Withdrawal by Subject|1|||
161686261|NCT00754793|583903375|FG000|Overall Study|voluntary withdrawn from study|0|||
161686262|NCT00754793|583903376|FG001|Overall Study|voluntary withdrawn from study|1|||
161686263|NCT02536313|583903378|FG000|Overall Study|Lack of Efficacy|0|||
161634752|NCT00891046|583715467|FG002|Overall Study|Adverse Event|2|||
161686264|NCT02536313|583903379|FG001|Overall Study|Lack of Efficacy|1|||
161686265|NCT00917150|583903380|FG000|Overall Study|Adverse Event|12|||
161686266|NCT00917150|583903381|FG001|Overall Study|Adverse Event|7|||
161686267|NCT00917150|583903382|FG002|Overall Study|Adverse Event|12|||
161686268|NCT00917150|583903383|FG003|Overall Study|Adverse Event|11|||
161686269|NCT00917150|583903380|FG000|Overall Study|Death|1|||
161686270|NCT00917150|583903381|FG001|Overall Study|Death|4|||
161686271|NCT00917150|583903382|FG002|Overall Study|Death|3|||
161686272|NCT00917150|583903383|FG003|Overall Study|Death|2|||
161686273|NCT00917150|583903380|FG000|Overall Study|Lost to Follow-up|1|||
161686274|NCT00917150|583903381|FG001|Overall Study|Lost to Follow-up|0|||
161686275|NCT00917150|583903382|FG002|Overall Study|Lost to Follow-up|4|||
161686276|NCT00917150|583903383|FG003|Overall Study|Lost to Follow-up|2|||
161686277|NCT00917150|583903380|FG000|Overall Study|Physician Decision|0|||
161686278|NCT00917150|583903381|FG001|Overall Study|Physician Decision|2|||
161686279|NCT00917150|583903382|FG002|Overall Study|Physician Decision|0|||
161686280|NCT00917150|583903383|FG003|Overall Study|Physician Decision|1|||
161686281|NCT00917150|583903380|FG000|Overall Study|Protocol Violation|5|||
161686282|NCT00917150|583903381|FG001|Overall Study|Protocol Violation|5|||
161686283|NCT00917150|583903382|FG002|Overall Study|Protocol Violation|3|||
161686284|NCT00917150|583903383|FG003|Overall Study|Protocol Violation|5|||
161686285|NCT00917150|583903380|FG000|Overall Study|Withdrawal by Subject|15|||
161834072|NCT00493246|584435546|FG003|Overall Study|Lost to Follow-up|0|||
161634753|NCT00891046|583715468|FG003|Overall Study|Adverse Event|0|||
161686286|NCT00917150|583903381|FG001|Overall Study|Withdrawal by Subject|16|||
161686287|NCT00917150|583903382|FG002|Overall Study|Withdrawal by Subject|18|||
161686288|NCT00917150|583903383|FG003|Overall Study|Withdrawal by Subject|11|||
161834073|NCT00493246|584435547|FG004|Overall Study|Lost to Follow-up|0|||
161834074|NCT00493246|584435548|FG005|Overall Study|Lost to Follow-up|0|||
161834075|NCT00493246|584435549|FG006|Overall Study|Lost to Follow-up|1|||
161834076|NCT00493246|584435550|FG007|Overall Study|Lost to Follow-up|0|||
161834077|NCT00595335|584435551|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
161834078|NCT00595335|584435552|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
161834079|NCT00595335|584435551|FG000|Baseline to Six Months|Disease Progression|1|||
161834080|NCT00595335|584435552|FG001|Baseline to Six Months|Disease Progression|1|||
161834081|NCT00595335|584435551|FG000|Baseline to Six Months|Adverse Event|1|||
161834082|NCT00595335|584435552|FG001|Baseline to Six Months|Adverse Event|0|||
161834083|NCT00595335|584435551|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
161834084|NCT00595335|584435552|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
161834085|NCT00595335|584435551|FG000|Six Months to Twelve Months|Disease Progression|1|||
161834086|NCT00595335|584435552|FG001|Six Months to Twelve Months|Disease Progression|0|||
161834087|NCT01013649|584435555|FG000|First Step|Withdrawal by Subject|36|||
161634754|NCT00891046|583715469|FG004|Overall Study|Adverse Event|14|||
161634755|NCT00891046|583715465|FG000|Overall Study|Withdrawal by Subject|2|||
161634756|NCT00891046|583715466|FG001|Overall Study|Withdrawal by Subject|1|||
161634757|NCT00891046|583715467|FG002|Overall Study|Withdrawal by Subject|2|||
161634758|NCT00891046|583715468|FG003|Overall Study|Withdrawal by Subject|1|||
161634759|NCT00891046|583715469|FG004|Overall Study|Withdrawal by Subject|1|||
161634760|NCT00891046|583715465|FG000|Overall Study|Lost to Follow-up|0|||
161634761|NCT00891046|583715466|FG001|Overall Study|Lost to Follow-up|0|||
161634762|NCT00891046|583715467|FG002|Overall Study|Lost to Follow-up|0|||
161634763|NCT00891046|583715468|FG003|Overall Study|Lost to Follow-up|0|||
161634764|NCT00891046|583715469|FG004|Overall Study|Lost to Follow-up|1|||
161634765|NCT00362375|583715470|FG000|Overall Study|Lost to Follow-up|40|||
161634766|NCT00362375|583715471|FG001|Overall Study|Lost to Follow-up|35|||
161634767|NCT04984239|583715472|FG000|Overall Study|Lost to Follow-up|1|||
161634768|NCT04702893|583715473|FG000|Overall Study|Other reasons than listed|11|||
161634769|NCT04702893|583715473|FG000|Overall Study|Withdrawal by Subject|3|||
161634770|NCT04702893|583715473|FG000|Overall Study|Lost to Follow-up|7|||
161634771|NCT04702893|583715473|FG000|Overall Study|Death|10|||
161634772|NCT04702893|583715473|FG000|Overall Study|Not treated|6|||
161634773|NCT01951378|583715474|FG000|Overall Study|Study Terminated-Not completed|23|||
161634774|NCT01951378|583715475|FG001|Overall Study|Study Terminated-Not completed|17|||
161634775|NCT00634842|583715476|FG000|Overall Study|Adverse Event|2|||
161634776|NCT00634842|583715477|FG001|Overall Study|Adverse Event|3|||
161634777|NCT00634842|583715476|FG000|Overall Study|Protocol Violation|8|||
161634778|NCT00634842|583715477|FG001|Overall Study|Protocol Violation|4|||
161634779|NCT00634842|583715476|FG000|Overall Study|Move to another state|1|||
161634780|NCT00634842|583715477|FG001|Overall Study|Move to another state|0|||
161634781|NCT00634842|583715476|FG000|Overall Study|Inclusion criteria were not met|1|||
161634782|NCT00634842|583715477|FG001|Overall Study|Inclusion criteria were not met|0|||
161634783|NCT00634842|583715476|FG000|Overall Study|Lost to Follow-up|1|||
161634784|NCT00634842|583715477|FG001|Overall Study|Lost to Follow-up|2|||
161634785|NCT00634842|583715476|FG000|Overall Study|Physician Decision|1|||
161634786|NCT00634842|583715477|FG001|Overall Study|Physician Decision|0|||
161634787|NCT00634842|583715476|FG000|Overall Study|Withdrawal by Subject|1|||
161634788|NCT00634842|583715477|FG001|Overall Study|Withdrawal by Subject|3|||
161634789|NCT00634842|583715476|FG000|Overall Study|Lack of time and intolerance to drug|0|||
161634790|NCT00634842|583715477|FG001|Overall Study|Lack of time and intolerance to drug|1|||
161634791|NCT00634842|583715476|FG000|Overall Study|Discontinued due to injection|0|||
161634792|NCT00634842|583715477|FG001|Overall Study|Discontinued due to injection|2|||
161634793|NCT00634842|583715476|FG000|Overall Study|No need of study drug to treat diabetes|0|||
161634794|NCT00634842|583715477|FG001|Overall Study|No need of study drug to treat diabetes|1|||
161634795|NCT00634842|583715476|FG000|Overall Study|No wish to keep taking Avandia|0|||
161634796|NCT00634842|583715477|FG001|Overall Study|No wish to keep taking Avandia|1|||
161634797|NCT00634842|583715476|FG000|Overall Study|Subject off study drug for too long|0|||
161634798|NCT00634842|583715477|FG001|Overall Study|Subject off study drug for too long|1|||
161634799|NCT03294941|583715478|FG000|Overall Study|Withdrawal by Subject|0|||
161634800|NCT03294941|583715479|FG001|Overall Study|Withdrawal by Subject|2|||
161634801|NCT04629443|583715480|FG000|Overall Study|Adverse Event|2|||
161634802|NCT04629443|583715481|FG001|Overall Study|Adverse Event|1|||
161634803|NCT04629443|583715482|FG002|Overall Study|Adverse Event|2|||
161634804|NCT04629443|583715480|FG000|Overall Study|Progressive Disease|2|||
161634805|NCT04629443|583715481|FG001|Overall Study|Progressive Disease|3|||
161634806|NCT04629443|583715482|FG002|Overall Study|Progressive Disease|3|||
161634807|NCT04629443|583715480|FG000|Overall Study|Physician Decision|1|||
161634808|NCT04629443|583715481|FG001|Overall Study|Physician Decision|3|||
161634809|NCT04629443|583715482|FG002|Overall Study|Physician Decision|0|||
161834088|NCT01013649|584435556|FG001|First Step|Withdrawal by Subject|19|||
161834089|NCT01013649|584435557|FG002|First Step|Withdrawal by Subject|0|||
161834090|NCT01013649|584435558|FG003|First Step|Withdrawal by Subject|0|||
161634810|NCT01844726|583715488|FG000|Overall Study|Withdrawal by Subject|0|||
161834091|NCT01013649|584435555|FG000|First Step|Progression|58|||
161634811|NCT01844726|583715489|FG001|Overall Study|Withdrawal by Subject|1|||
161634812|NCT01844726|583715488|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
161634813|NCT01844726|583715489|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
161634814|NCT00916305|583715490|FG000|Overall Study|Lost to Follow-up|21|||
161634815|NCT00916305|583715491|FG001|Overall Study|Lost to Follow-up|27|||
161634816|NCT00916305|583715490|FG000|Overall Study|Withdrawal by Subject|0|||
161634817|NCT00916305|583715491|FG001|Overall Study|Withdrawal by Subject|1|||
161634818|NCT00858247|583715496|FG000|Baseline Assessment|Withdrawal by Subject|1|||
161634819|NCT00858247|583715497|FG001|Baseline Assessment|Withdrawal by Subject|1|||
161634820|NCT00858247|583715496|FG000|Baseline Assessment|Poor IV access|1|||
161634821|NCT00858247|583715497|FG001|Baseline Assessment|Poor IV access|0|||
161634822|NCT00858247|583715496|FG000|Baseline Assessment|Protocol Violation|0|||
161634823|NCT00858247|583715497|FG001|Baseline Assessment|Protocol Violation|1|||
161634824|NCT00858247|583715496|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
161634825|NCT00858247|583715497|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
161634826|NCT01379703|583715498|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
161634827|NCT01379703|583715499|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
161634828|NCT01379703|583715500|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
161634829|NCT01379703|583715498|FG000|Study Start Through 9 Months|Adverse Event|0|||
161634830|NCT01379703|583715499|FG001|Study Start Through 9 Months|Adverse Event|14|||
161634831|NCT01379703|583715500|FG002|Study Start Through 9 Months|Adverse Event|10|||
161634832|NCT01379703|583715498|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
161634833|NCT01379703|583715499|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
161634834|NCT01379703|583715500|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
161634835|NCT01379703|583715498|FG000|Study Start Through 9 Months|Treatment Failure|0|||
161634836|NCT01379703|583715499|FG001|Study Start Through 9 Months|Treatment Failure|2|||
161634837|NCT01379703|583715500|FG002|Study Start Through 9 Months|Treatment Failure|2|||
161634838|NCT01379703|583715498|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
161634839|NCT01379703|583715499|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
161634840|NCT01379703|583715500|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
161634841|NCT01379703|583715498|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
161634842|NCT01379703|583715499|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
161634843|NCT01379703|583715500|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
161634844|NCT01379703|583715498|FG000|Study Start Through 9 Months|Medication not available|0|||
161634845|NCT01379703|583715499|FG001|Study Start Through 9 Months|Medication not available|2|||
161634846|NCT01379703|583715500|FG002|Study Start Through 9 Months|Medication not available|1|||
161634847|NCT01379703|583715498|FG000|Study Start Through 9 Months|Poor general condition|0|||
161634848|NCT01379703|583715499|FG001|Study Start Through 9 Months|Poor general condition|1|||
161634849|NCT01379703|583715500|FG002|Study Start Through 9 Months|Poor general condition|0|||
161634850|NCT01379703|583715498|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
161634851|NCT01379703|583715499|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
161634852|NCT01379703|583715500|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
161634853|NCT01379703|583715498|FG000|Study Start Through 9 Months|Reason unknown|2|||
161634854|NCT01379703|583715499|FG001|Study Start Through 9 Months|Reason unknown|31|||
161634855|NCT01379703|583715500|FG002|Study Start Through 9 Months|Reason unknown|24|||
161634856|NCT01379703|583715498|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
161634857|NCT01379703|583715499|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
161634858|NCT01379703|583715500|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
161634859|NCT01379703|583715498|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
161634860|NCT01379703|583715499|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
161634861|NCT01379703|583715500|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
161634862|NCT01379703|583715498|FG000|9 Months Through 18 Months|Adverse Event|0|||
161634863|NCT01379703|583715499|FG001|9 Months Through 18 Months|Adverse Event|6|||
161634864|NCT01379703|583715500|FG002|9 Months Through 18 Months|Adverse Event|0|||
161634865|NCT01379703|583715498|FG000|9 Months Through 18 Months|Treatment failure|0|||
161634866|NCT01379703|583715499|FG001|9 Months Through 18 Months|Treatment failure|5|||
161634867|NCT01379703|583715500|FG002|9 Months Through 18 Months|Treatment failure|0|||
161634868|NCT01379703|583715498|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
161634869|NCT01379703|583715499|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
161634870|NCT01379703|583715500|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
161834092|NCT01013649|584435556|FG001|First Step|Progression|23|||
161634871|NCT01379703|583715498|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
161634872|NCT01379703|583715499|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
161634873|NCT01379703|583715500|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
161634874|NCT01379703|583715498|FG000|9 Months Through 18 Months|Fatigue|0|||
161634875|NCT01379703|583715499|FG001|9 Months Through 18 Months|Fatigue|1|||
161634876|NCT01379703|583715500|FG002|9 Months Through 18 Months|Fatigue|0|||
161634877|NCT01379703|583715498|FG000|9 Months Through 18 Months|Reason Unknown|0|||
161634878|NCT01379703|583715499|FG001|9 Months Through 18 Months|Reason Unknown|23|||
161634879|NCT01379703|583715500|FG002|9 Months Through 18 Months|Reason Unknown|0|||
161634880|NCT03481556|583715501|FG000|Overall Study|Adverse Event|1|||
161634881|NCT03481556|583715502|FG001|Overall Study|Adverse Event|0|||
161634882|NCT03481556|583715503|FG002|Overall Study|Adverse Event|0|||
161634883|NCT03481556|583715504|FG003|Overall Study|Adverse Event|0|||
161634884|NCT03481556|583715501|FG000|Overall Study|Death|4|||
161634885|NCT03481556|583715502|FG001|Overall Study|Death|2|||
161634886|NCT03481556|583715503|FG002|Overall Study|Death|3|||
161634887|NCT03481556|583715504|FG003|Overall Study|Death|16|||
161634888|NCT03481556|583715501|FG000|Overall Study|Study Terminated by Sponsor|10|||
161634889|NCT03481556|583715502|FG001|Overall Study|Study Terminated by Sponsor|5|||
161634890|NCT03481556|583715503|FG002|Overall Study|Study Terminated by Sponsor|2|||
161634891|NCT03481556|583715504|FG003|Overall Study|Study Terminated by Sponsor|9|||
161634892|NCT01172639|583715505|FG000|Overall Study|Death|1|||
161634893|NCT01172639|583715506|FG001|Overall Study|Death|1|||
161634894|NCT01172639|583715507|FG002|Overall Study|Death|0|||
161634895|NCT01172639|583715508|FG003|Overall Study|Death|0|||
161634896|NCT01172639|583715509|FG004|Overall Study|Death|0|||
161549523|NCT02226172|583401077|FG000|Overall Study|Other|5|||
161549524|NCT02226172|583401077|FG000|Overall Study|Death|1|||
161549525|NCT02226172|583401077|FG000|Overall Study|Study terminated by sponsor|1|||
161549526|NCT02226172|583401077|FG000|Overall Study|Adverse Event|6|||
161549527|NCT00758160|583401084|FG000|Overall Study|No Longer Requires Study Medication|4|||
161549528|NCT00758160|583401084|FG000|Overall Study|Administration Problems|3|||
161549529|NCT00758160|583401084|FG000|Overall Study|Adverse Event|15|||
161549530|NCT00758160|583401084|FG000|Overall Study|Lack of Efficacy|10|||
161549531|NCT00758160|583401084|FG000|Overall Study|Lost to Follow-up|14|||
161549532|NCT00758160|583401084|FG000|Overall Study|Protocol Violation|12|||
161549533|NCT00758160|583401084|FG000|Overall Study|Withdrawal by Subject|8|||
161549534|NCT01108510|583401088|FG000|Overall Study|Randomized but Not Treated|5|||
161549535|NCT01108510|583401089|FG001|Overall Study|Randomized but Not Treated|1|||
161549536|NCT01108510|583401088|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
161549537|NCT01108510|583401089|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
161549538|NCT01108510|583401088|FG000|Overall Study|Adverse Event|26|||
161549539|NCT01108510|583401089|FG001|Overall Study|Adverse Event|19|||
161549540|NCT01108510|583401088|FG000|Overall Study|Lost to Follow-up|20|||
161549541|NCT01108510|583401089|FG001|Overall Study|Lost to Follow-up|17|||
161549542|NCT01108510|583401088|FG000|Overall Study|Withdrew Consent|21|||
161549543|NCT01108510|583401089|FG001|Overall Study|Withdrew Consent|15|||
161549544|NCT01108510|583401088|FG000|Overall Study|Investigator's Discretion|12|||
161549545|NCT01108510|583401089|FG001|Overall Study|Investigator's Discretion|10|||
161549546|NCT01108510|583401088|FG000|Overall Study|Participant Noncompliance|5|||
161549547|NCT01108510|583401089|FG001|Overall Study|Participant Noncompliance|7|||
161549548|NCT01108510|583401088|FG000|Overall Study|Lack of Efficacy|3|||
161549549|NCT01108510|583401089|FG001|Overall Study|Lack of Efficacy|0|||
161549550|NCT01108510|583401088|FG000|Overall Study|Pregnancy|0|||
161549551|NCT01108510|583401089|FG001|Overall Study|Pregnancy|3|||
161549552|NCT01108510|583401088|FG000|Overall Study|Death|1|||
161549553|NCT01108510|583401089|FG001|Overall Study|Death|1|||
161549554|NCT01258660|583401090|FG000|Overall Study|Adverse Event|2|||
161549555|NCT01258660|583401091|FG001|Overall Study|Adverse Event|4|||
161549556|NCT01258660|583401090|FG000|Overall Study|Withdrawal by Subject|3|||
161549557|NCT01258660|583401091|FG001|Overall Study|Withdrawal by Subject|0|||
161549558|NCT01258660|583401090|FG000|Overall Study|due to relocation|2|||
161549559|NCT01258660|583401091|FG001|Overall Study|due to relocation|0|||
161549560|NCT01258660|583401090|FG000|Overall Study|Protocol Violation|0|||
161549561|NCT01258660|583401091|FG001|Overall Study|Protocol Violation|1|||
161549562|NCT01258660|583401090|FG000|Overall Study|Invalid for primary analysis data set|4|||
161549563|NCT01258660|583401091|FG001|Overall Study|Invalid for primary analysis data set|6|||
161549564|NCT00582491|583401092|FG000|Overall Study|Withdrawal by Subject|1|||
161549565|NCT00582491|583401093|FG001|Overall Study|Withdrawal by Subject|0|||
161549566|NCT04192630|583401096|FG000|Overall Study|Discontinued before surgery|2|||
161549567|NCT04192630|583401097|FG001|Overall Study|Discontinued before surgery|0|||
161549568|NCT04192630|583401096|FG000|Overall Study|Discontinued after surgery|5|||
161549569|NCT04192630|583401097|FG001|Overall Study|Discontinued after surgery|3|||
161549570|NCT01193582|583401098|FG000|Vaccination Series|Withdrawal by Subject|11|||
161549571|NCT01193582|583401099|FG001|Vaccination Series|Withdrawal by Subject|13|||
161549572|NCT01193582|583401100|FG002|Vaccination Series|Withdrawal by Subject|8|||
161549573|NCT01193582|583401101|FG003|Vaccination Series|Withdrawal by Subject|3|||
161549574|NCT01193582|583401098|FG000|12 Month Follow-up|Death|0|||
161549575|NCT01193582|583401099|FG001|12 Month Follow-up|Death|0|||
161549576|NCT01193582|583401100|FG002|12 Month Follow-up|Death|1|||
161549577|NCT01193582|583401101|FG003|12 Month Follow-up|Death|0|||
161549578|NCT01193582|583401098|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
161549579|NCT01193582|583401099|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
161549580|NCT01193582|583401100|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
161549581|NCT01193582|583401101|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
161549582|NCT00779584|583401102|FG000|Overall Study|Protocol Violation|0|||
161549583|NCT00779584|583401103|FG001|Overall Study|Protocol Violation|0|||
161549584|NCT00779584|583401104|FG002|Overall Study|Protocol Violation|0|||
161549585|NCT00779584|583401105|FG003|Overall Study|Protocol Violation|0|||
161549586|NCT00779584|583401106|FG004|Overall Study|Protocol Violation|0|||
161549587|NCT00779584|583401107|FG005|Overall Study|Protocol Violation|1|||
161549588|NCT00779584|583401108|FG006|Overall Study|Protocol Violation|0|||
161549589|NCT00779584|583401109|FG007|Overall Study|Protocol Violation|0|||
161549590|NCT00779584|583401110|FG008|Overall Study|Protocol Violation|0|||
161549591|NCT00779584|583401102|FG000|Overall Study|Withdrawal by Subject|1|||
161549592|NCT00779584|583401103|FG001|Overall Study|Withdrawal by Subject|1|||
161634897|NCT01172639|583715505|FG000|Overall Study|Lost to Follow-up|9|||
161634898|NCT01172639|583715506|FG001|Overall Study|Lost to Follow-up|7|||
161634899|NCT01172639|583715507|FG002|Overall Study|Lost to Follow-up|11|||
161634900|NCT01172639|583715508|FG003|Overall Study|Lost to Follow-up|6|||
161634901|NCT01172639|583715509|FG004|Overall Study|Lost to Follow-up|6|||
161634902|NCT01172639|583715505|FG000|Overall Study|Withdrawal by Subject|3|||
161634903|NCT01172639|583715506|FG001|Overall Study|Withdrawal by Subject|3|||
161634904|NCT01172639|583715507|FG002|Overall Study|Withdrawal by Subject|5|||
161634905|NCT01172639|583715508|FG003|Overall Study|Withdrawal by Subject|5|||
161634906|NCT01172639|583715509|FG004|Overall Study|Withdrawal by Subject|0|||
161634907|NCT01316887|583715510|FG000|Overall Study|Adverse Event|13|||
161634908|NCT01316887|583715511|FG001|Overall Study|Adverse Event|21|||
161634909|NCT01316887|583715512|FG002|Overall Study|Adverse Event|17|||
161634910|NCT01316887|583715510|FG000|Overall Study|Lack of Efficacy|9|||
161634911|NCT01316887|583715511|FG001|Overall Study|Lack of Efficacy|3|||
161634912|NCT01316887|583715512|FG002|Overall Study|Lack of Efficacy|1|||
161634913|NCT01316887|583715510|FG000|Overall Study|Protocol Violation|2|||
161634914|NCT01316887|583715511|FG001|Overall Study|Protocol Violation|6|||
161634915|NCT01316887|583715512|FG002|Overall Study|Protocol Violation|6|||
161634916|NCT01316887|583715510|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
161634917|NCT01316887|583715511|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
161634918|NCT01316887|583715512|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
161634919|NCT01316887|583715510|FG000|Overall Study|Study Closed/Terminated|2|||
161634920|NCT01316887|583715511|FG001|Overall Study|Study Closed/Terminated|4|||
161634921|NCT01316887|583715512|FG002|Overall Study|Study Closed/Terminated|3|||
161634922|NCT01316887|583715510|FG000|Overall Study|Lost to Follow-up|1|||
161634923|NCT01316887|583715511|FG001|Overall Study|Lost to Follow-up|7|||
161634924|NCT01316887|583715512|FG002|Overall Study|Lost to Follow-up|5|||
161634925|NCT01316887|583715510|FG000|Overall Study|Withdrawal by Subject|8|||
161634926|NCT01316887|583715511|FG001|Overall Study|Withdrawal by Subject|16|||
161634927|NCT01316887|583715512|FG002|Overall Study|Withdrawal by Subject|15|||
161634928|NCT02172950|583715513|FG000|Overall Study|Physician Decision|3|||
161634929|NCT02172950|583715514|FG001|Overall Study|Physician Decision|3|||
161634930|NCT02172950|583715513|FG000|Overall Study|Lack of Efficacy|1|||
161634931|NCT02172950|583715514|FG001|Overall Study|Lack of Efficacy|0|||
161634932|NCT02172950|583715513|FG000|Overall Study|Adverse Event|4|||
161634933|NCT02172950|583715514|FG001|Overall Study|Adverse Event|1|||
161634934|NCT02172950|583715513|FG000|Overall Study|Withdrawal by Subject|10|||
161634935|NCT02172950|583715514|FG001|Overall Study|Withdrawal by Subject|0|||
161634936|NCT02172950|583715513|FG000|Overall Study|Protocol Violation|1|||
161634937|NCT02172950|583715514|FG001|Overall Study|Protocol Violation|0|||
161634938|NCT02172950|583715513|FG000|Overall Study|Lost to Follow-up|1|||
161634939|NCT02172950|583715514|FG001|Overall Study|Lost to Follow-up|0|||
161634940|NCT02172950|583715513|FG000|Overall Study|Death|1|||
161634941|NCT02172950|583715514|FG001|Overall Study|Death|0|||
161634942|NCT02172950|583715513|FG000|Overall Study|Patient traveling|1|||
161634943|NCT02172950|583715514|FG001|Overall Study|Patient traveling|0|||
161634944|NCT02172950|583715513|FG000|Overall Study|Patient went to other country|1|||
161634945|NCT02172950|583715514|FG001|Overall Study|Patient went to other country|0|||
161634946|NCT02172950|583715513|FG000|Overall Study|Patient relocated overseas|1|||
161634947|NCT02172950|583715514|FG001|Overall Study|Patient relocated overseas|1|||
161634948|NCT02172950|583715513|FG000|Overall Study|Patient moving|1|||
161634949|NCT02172950|583715514|FG001|Overall Study|Patient moving|0|||
161634950|NCT00469456|583715515|FG000|Overall Study|Adverse Event|4|||
161834093|NCT01013649|584435557|FG002|First Step|Progression|0|||
161834094|NCT01013649|584435558|FG003|First Step|Progression|0|||
161834095|NCT01013649|584435555|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
161834096|NCT01013649|584435556|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
161634951|NCT00469456|583715516|FG001|Overall Study|Adverse Event|3|||
161634952|NCT00469456|583715515|FG000|Overall Study|Protocol Violation|1|||
161634953|NCT00469456|583715516|FG001|Overall Study|Protocol Violation|0|||
161634954|NCT00469456|583715515|FG000|Overall Study|Withdrawal by Subject|4|||
161634955|NCT00469456|583715516|FG001|Overall Study|Withdrawal by Subject|1|||
161634956|NCT01086384|583715526|FG000|2-week Run-in Period|Adverse Event|1|||
161634957|NCT01086384|583715527|FG001|2-week Run-in Period|Adverse Event|0|||
161634958|NCT01086384|583715528|FG002|2-week Run-in Period|Adverse Event|0|||
161634959|NCT01086384|583715526|FG000|2-week Run-in Period|Protocol Violation|1|||
161634960|NCT01086384|583715527|FG001|2-week Run-in Period|Protocol Violation|0|||
161834097|NCT01013649|584435557|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
161634961|NCT01086384|583715528|FG002|2-week Run-in Period|Protocol Violation|0|||
161634962|NCT01086384|583715526|FG000|2-week Run-in Period|Lost to Follow-up|1|||
161634963|NCT01086384|583715527|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161634964|NCT01086384|583715528|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161634965|NCT01086384|583715526|FG000|2-week Run-in Period|Physician Decision|6|||
161634966|NCT01086384|583715527|FG001|2-week Run-in Period|Physician Decision|0|||
161634967|NCT01086384|583715528|FG002|2-week Run-in Period|Physician Decision|0|||
161634968|NCT01086384|583715526|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
161634969|NCT01086384|583715527|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161634970|NCT01086384|583715528|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161634971|NCT01086384|583715526|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
161634972|NCT01086384|583715527|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
161634973|NCT01086384|583715528|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
161634974|NCT01086384|583715526|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
161634975|NCT01086384|583715527|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
161634976|NCT01086384|583715528|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
161634977|NCT01086384|583715526|FG000|2-week Run-in Period|Randomized in Error|1|||
161634978|NCT01086384|583715527|FG001|2-week Run-in Period|Randomized in Error|0|||
161634979|NCT01086384|583715528|FG002|2-week Run-in Period|Randomized in Error|0|||
161634980|NCT01086384|583715526|FG000|Treatment Period|Withdrawal by Subject|0|||
161634981|NCT01086384|583715527|FG001|Treatment Period|Withdrawal by Subject|53|||
161634982|NCT01086384|583715528|FG002|Treatment Period|Withdrawal by Subject|55|||
161634983|NCT01086384|583715526|FG000|Treatment Period|Protocol Violation|0|||
161634984|NCT01086384|583715527|FG001|Treatment Period|Protocol Violation|26|||
161634985|NCT01086384|583715528|FG002|Treatment Period|Protocol Violation|17|||
161634986|NCT01086384|583715526|FG000|Treatment Period|Lack of Efficacy|0|||
161634987|NCT01086384|583715527|FG001|Treatment Period|Lack of Efficacy|22|||
161634988|NCT01086384|583715528|FG002|Treatment Period|Lack of Efficacy|13|||
161634989|NCT01086384|583715526|FG000|Treatment Period|Adverse Event|0|||
161634990|NCT01086384|583715527|FG001|Treatment Period|Adverse Event|19|||
161634991|NCT01086384|583715528|FG002|Treatment Period|Adverse Event|15|||
161634992|NCT01086384|583715526|FG000|Treatment Period|Lost to Follow-up|0|||
161634993|NCT01086384|583715527|FG001|Treatment Period|Lost to Follow-up|11|||
161634994|NCT01086384|583715528|FG002|Treatment Period|Lost to Follow-up|9|||
161634995|NCT01086384|583715526|FG000|Treatment Period|Physician Decision|0|||
161634996|NCT01086384|583715527|FG001|Treatment Period|Physician Decision|9|||
161634997|NCT01086384|583715528|FG002|Treatment Period|Physician Decision|6|||
161634998|NCT01086384|583715526|FG000|Treatment Period|Study Closed/Terminated|0|||
161634999|NCT01086384|583715527|FG001|Treatment Period|Study Closed/Terminated|7|||
161635000|NCT01086384|583715528|FG002|Treatment Period|Study Closed/Terminated|8|||
161635001|NCT01086384|583715526|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
161635002|NCT01086384|583715527|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
161635003|NCT01086384|583715528|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
161635004|NCT01086384|583715526|FG000|Treatment Period|Received Treatment in Error|0|||
161635005|NCT01086384|583715527|FG001|Treatment Period|Received Treatment in Error|1|||
161635006|NCT01086384|583715528|FG002|Treatment Period|Received Treatment in Error|0|||
161635007|NCT02586415|583715531|FG000|Overall Study|Death|13|||
161635008|NCT02586415|583715532|FG001|Overall Study|Death|23|||
161635009|NCT02586415|583715531|FG000|Overall Study|Lost to Follow-up|1|||
161635010|NCT02586415|583715532|FG001|Overall Study|Lost to Follow-up|2|||
161635011|NCT00832000|583715533|FG000|Overall Study|Adverse Event|2|||
161635012|NCT00832000|583715534|FG001|Overall Study|Adverse Event|0|||
161635013|NCT00832000|583715533|FG000|Overall Study|Withdrawal by Subject|1|||
161635014|NCT00832000|583715534|FG001|Overall Study|Withdrawal by Subject|0|||
161635015|NCT00832000|583715533|FG000|Overall Study|No calls to IVR in either period|1|||
161635016|NCT00832000|583715534|FG001|Overall Study|No calls to IVR in either period|1|||
161635017|NCT00832000|583715533|FG000|Overall Study|No calls to IVR in period 2|2|||
161635018|NCT00832000|583715534|FG001|Overall Study|No calls to IVR in period 2|0|||
161635019|NCT03974100|583715535|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
161635020|NCT03974100|583715536|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
161635021|NCT03974100|583715537|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
161635022|NCT03974100|583715538|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
161635023|NCT03974100|583715539|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
161635024|NCT03974100|583715535|FG000|TP1 - Day 1 to Week 52|Death|1|||
161635025|NCT03974100|583715536|FG001|TP1 - Day 1 to Week 52|Death|0|||
161635026|NCT03974100|583715537|FG002|TP1 - Day 1 to Week 52|Death|0|||
161635027|NCT03974100|583715538|FG003|TP1 - Day 1 to Week 52|Death|0|||
161635028|NCT03974100|583715539|FG004|TP1 - Day 1 to Week 52|Death|0|||
161635029|NCT03974100|583715535|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161635030|NCT03974100|583715536|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
161635031|NCT03974100|583715537|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161635032|NCT03974100|583715538|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161635033|NCT03974100|583715539|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161635034|NCT03974100|583715535|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
161635035|NCT03974100|583715536|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
161635036|NCT03974100|583715537|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
161635037|NCT03974100|583715538|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
161635038|NCT03974100|583715539|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
161635039|NCT03974100|583715535|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
161635040|NCT03974100|583715536|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
161635041|NCT03974100|583715537|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
161635042|NCT03974100|583715538|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
161635043|NCT03974100|583715539|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
161635044|NCT03974100|583715535|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161635045|NCT03974100|583715536|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161635046|NCT03974100|583715537|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161635047|NCT03974100|583715538|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
161635048|NCT03974100|583715539|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161635049|NCT03974100|583715535|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
161635050|NCT03974100|583715536|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
161635051|NCT03974100|583715537|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
161635052|NCT03974100|583715538|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
161635053|NCT03974100|583715539|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
161635054|NCT03318783|583715540|FG000|Overall Study|Withdrawal by Subject|0|||
161635055|NCT03318783|583715541|FG001|Overall Study|Withdrawal by Subject|1|||
161635056|NCT03318783|583715540|FG000|Overall Study|Death|0|||
161635057|NCT03318783|583715541|FG001|Overall Study|Death|1|||
161635058|NCT03856047|583715542|FG000|Overall Study|Withdrawal by Subject|0|||
161635059|NCT03856047|583715543|FG001|Overall Study|Withdrawal by Subject|1|||
161635060|NCT03856047|583715544|FG002|Overall Study|Withdrawal by Subject|1|||
161635061|NCT03856047|583715545|FG003|Overall Study|Withdrawal by Subject|0|||
161635062|NCT03856047|583715546|FG004|Overall Study|Withdrawal by Subject|3|||
161635063|NCT03856047|583715547|FG005|Overall Study|Withdrawal by Subject|0|||
161635064|NCT03856047|583715548|FG006|Overall Study|Withdrawal by Subject|2|||
161635065|NCT03856047|583715542|FG000|Overall Study|Lost to Follow-up|4|||
161635066|NCT03856047|583715543|FG001|Overall Study|Lost to Follow-up|2|||
161635067|NCT03856047|583715544|FG002|Overall Study|Lost to Follow-up|3|||
161635068|NCT03856047|583715545|FG003|Overall Study|Lost to Follow-up|1|||
161635069|NCT03856047|583715546|FG004|Overall Study|Lost to Follow-up|4|||
161635070|NCT03856047|583715547|FG005|Overall Study|Lost to Follow-up|4|||
161635071|NCT03856047|583715548|FG006|Overall Study|Lost to Follow-up|4|||
161635072|NCT00338949|583715549|FG000|Subject Screening|Screen failures|11|||
161635073|NCT00338949|583715550|FG001|Subject Screening|Screen failures|11|||
161635074|NCT00338949|583715549|FG000|Randomization|Withdrawal by Subject|1|||
161635075|NCT00338949|583715550|FG001|Randomization|Withdrawal by Subject|0|||
161635076|NCT00338949|583715549|FG000|Randomization|Adverse Event|0|||
161635077|NCT00338949|583715550|FG001|Randomization|Adverse Event|5|||
161635078|NCT00436956|583715553|FG000|Overall Study|Not evaluable|1|||
161635079|NCT00436956|583715554|FG001|Overall Study|Not evaluable|0|||
161635080|NCT02719743|583715561|FG000|Overall Study|Consent withdrawal|0|||
161635081|NCT02719743|583715562|FG001|Overall Study|Consent withdrawal|2|||
161635082|NCT02719743|583715563|FG002|Overall Study|Consent withdrawal|0|||
161635083|NCT02719743|583715564|FG003|Overall Study|Consent withdrawal|1|||
161635084|NCT02719743|583715565|FG004|Overall Study|Consent withdrawal|0|||
161635085|NCT02719743|583715561|FG000|Overall Study|Migrated/moved from study area|0|||
161635086|NCT02719743|583715562|FG001|Overall Study|Migrated/moved from study area|0|||
161635087|NCT02719743|583715563|FG002|Overall Study|Migrated/moved from study area|0|||
161635088|NCT02719743|583715564|FG003|Overall Study|Migrated/moved from study area|0|||
161635089|NCT02719743|583715565|FG004|Overall Study|Migrated/moved from study area|2|||
161635090|NCT02719743|583715561|FG000|Overall Study|Lost to Follow-up|1|||
161635091|NCT02719743|583715562|FG001|Overall Study|Lost to Follow-up|1|||
161635092|NCT02719743|583715563|FG002|Overall Study|Lost to Follow-up|0|||
161635093|NCT02719743|583715564|FG003|Overall Study|Lost to Follow-up|0|||
161635094|NCT02719743|583715565|FG004|Overall Study|Lost to Follow-up|0|||
161635095|NCT01930214|583715566|FG000|Overall Study|Death|4|||
161635096|NCT01930214|583715567|FG001|Overall Study|Death|4|||
161635097|NCT01930214|583715568|FG002|Overall Study|Death|11|||
161635098|NCT01930214|583715566|FG000|Overall Study|Lost to Follow-up|12|||
161635099|NCT01930214|583715567|FG001|Overall Study|Lost to Follow-up|13|||
161635100|NCT01930214|583715568|FG002|Overall Study|Lost to Follow-up|12|||
161635101|NCT01930214|583715566|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
161635102|NCT01930214|583715567|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
161635103|NCT01930214|583715568|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
161635104|NCT01930214|583715566|FG000|Overall Study|Physician Decision|2|||
161635105|NCT01930214|583715567|FG001|Overall Study|Physician Decision|0|||
161635106|NCT01930214|583715568|FG002|Overall Study|Physician Decision|0|||
161686289|NCT00917150|583903380|FG000|Overall Study|Other than specified|3|||
161686290|NCT00917150|583903381|FG001|Overall Study|Other than specified|3|||
161635107|NCT02601209|583715569|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
161635108|NCT02601209|583715570|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
161635109|NCT02601209|583715571|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
161635110|NCT02601209|583715572|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161635111|NCT02601209|583715573|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161635112|NCT02601209|583715574|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161635113|NCT02601209|583715575|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161635114|NCT02601209|583715576|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161635115|NCT02601209|583715577|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161635116|NCT02601209|583715569|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161635117|NCT02601209|583715570|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161635118|NCT02601209|583715571|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161635119|NCT02601209|583715572|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161635120|NCT02601209|583715573|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
161635121|NCT02601209|583715574|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
161635122|NCT02601209|583715575|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
161635123|NCT02601209|583715576|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161635124|NCT02601209|583715577|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161635125|NCT02604342|583715579|FG000|Overall Study|Death|32|||
161635126|NCT02604342|583715580|FG001|Overall Study|Death|16|||
161635127|NCT02604342|583715579|FG000|Overall Study|Progression of disease|1|||
161635128|NCT02604342|583715580|FG001|Overall Study|Progression of disease|0|||
161635129|NCT02604342|583715579|FG000|Overall Study|Withdrawal by Subject|5|||
161635130|NCT02604342|583715580|FG001|Overall Study|Withdrawal by Subject|6|||
161635131|NCT02604342|583715579|FG000|Overall Study|Other|1|||
161635132|NCT02604342|583715580|FG001|Overall Study|Other|0|||
161635133|NCT02604342|583715579|FG000|Overall Study|Study Termination by Sponsor|1|||
161635134|NCT02604342|583715580|FG001|Overall Study|Study Termination by Sponsor|0|||
161635135|NCT02604342|583715579|FG000|Overall Study|Lost to Follow-up|1|||
161635136|NCT02604342|583715580|FG001|Overall Study|Lost to Follow-up|1|||
161635137|NCT02604342|583715579|FG000|Overall Study|Physician Decision|2|||
161635138|NCT02604342|583715580|FG001|Overall Study|Physician Decision|0|||
161635139|NCT01702519|583715581|FG000|Washout Period|Lost to Follow-up|1|||
161635140|NCT01702519|583715582|FG001|Washout Period|Lost to Follow-up|0|||
161635141|NCT01702519|583715581|FG000|Washout Period|Withdrawal by Subject|0|||
161635142|NCT01702519|583715582|FG001|Washout Period|Withdrawal by Subject|2|||
161635143|NCT03029819|583715583|FG000|Overall Study|Lost to Follow-up|3|||
161635144|NCT03029819|583715584|FG001|Overall Study|Lost to Follow-up|5|||
161635145|NCT03029819|583715583|FG000|Overall Study|Removed due to disruptive behavior|0|||
161635146|NCT03029819|583715584|FG001|Overall Study|Removed due to disruptive behavior|1|||
161635147|NCT03015181|583715585|FG000|Overall Study|Enrolled, but product never administered|1|||
161635148|NCT03015181|583715586|FG001|Overall Study|Enrolled, but product never administered|0|||
161635149|NCT03015181|583715587|FG002|Overall Study|Enrolled, but product never administered|0|||
161635150|NCT03015181|583715588|FG003|Overall Study|Enrolled, but product never administered|0|||
161635151|NCT03015181|583715589|FG004|Overall Study|Enrolled, but product never administered|0|||
161635152|NCT03015181|583715590|FG005|Overall Study|Enrolled, but product never administered|0|||
161635153|NCT03015181|583715591|FG006|Overall Study|Enrolled, but product never administered|0|||
161635154|NCT03015181|583715585|FG000|Overall Study|Withdrawal by Subject|0|||
161635155|NCT03015181|583715586|FG001|Overall Study|Withdrawal by Subject|0|||
161635156|NCT03015181|583715587|FG002|Overall Study|Withdrawal by Subject|0|||
161635157|NCT03015181|583715588|FG003|Overall Study|Withdrawal by Subject|0|||
161635158|NCT03015181|583715589|FG004|Overall Study|Withdrawal by Subject|0|||
161635159|NCT03015181|583715590|FG005|Overall Study|Withdrawal by Subject|1|||
161635160|NCT03015181|583715591|FG006|Overall Study|Withdrawal by Subject|0|||
161635161|NCT03015181|583715585|FG000|Overall Study|Physician Decision|0|||
161635162|NCT03015181|583715586|FG001|Overall Study|Physician Decision|0|||
161635163|NCT03015181|583715587|FG002|Overall Study|Physician Decision|0|||
161635164|NCT03015181|583715588|FG003|Overall Study|Physician Decision|0|||
161635165|NCT03015181|583715589|FG004|Overall Study|Physician Decision|0|||
161635166|NCT03015181|583715590|FG005|Overall Study|Physician Decision|0|||
161635167|NCT03015181|583715591|FG006|Overall Study|Physician Decision|1|||
161635168|NCT01177228|583715601|FG000|Overall Study|Positive tuberculosis test|0|||
161635169|NCT01177228|583715602|FG001|Overall Study|Positive tuberculosis test|1|||
161635170|NCT01177228|583715603|FG002|Overall Study|Positive tuberculosis test|0|||
161635171|NCT01177228|583715604|FG003|Overall Study|Positive tuberculosis test|0|||
161635172|NCT01177228|583715601|FG000|Overall Study|Worsening disease activity|1|||
161834098|NCT01013649|584435558|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
161549593|NCT00779584|583401104|FG002|Overall Study|Withdrawal by Subject|2|||
161549594|NCT00779584|583401105|FG003|Overall Study|Withdrawal by Subject|0|||
161549595|NCT00779584|583401106|FG004|Overall Study|Withdrawal by Subject|0|||
161549596|NCT00779584|583401107|FG005|Overall Study|Withdrawal by Subject|2|||
161549597|NCT00779584|583401108|FG006|Overall Study|Withdrawal by Subject|1|||
161549598|NCT00779584|583401109|FG007|Overall Study|Withdrawal by Subject|0|||
161549599|NCT00779584|583401110|FG008|Overall Study|Withdrawal by Subject|0|||
161549600|NCT00779584|583401102|FG000|Overall Study|Lost to Follow-up|0|||
161549601|NCT00779584|583401103|FG001|Overall Study|Lost to Follow-up|0|||
161549602|NCT00779584|583401104|FG002|Overall Study|Lost to Follow-up|0|||
161549603|NCT00779584|583401105|FG003|Overall Study|Lost to Follow-up|0|||
161549604|NCT00779584|583401106|FG004|Overall Study|Lost to Follow-up|1|||
161549605|NCT00779584|583401107|FG005|Overall Study|Lost to Follow-up|0|||
161549606|NCT00779584|583401108|FG006|Overall Study|Lost to Follow-up|0|||
161549607|NCT00779584|583401109|FG007|Overall Study|Lost to Follow-up|0|||
161549608|NCT00779584|583401110|FG008|Overall Study|Lost to Follow-up|0|||
161549609|NCT00779584|583401102|FG000|Overall Study|Progression of Disease|0|||
161549610|NCT00779584|583401103|FG001|Overall Study|Progression of Disease|1|||
161549611|NCT00779584|583401104|FG002|Overall Study|Progression of Disease|2|||
161549612|NCT00779584|583401105|FG003|Overall Study|Progression of Disease|6|||
161549613|NCT00779584|583401106|FG004|Overall Study|Progression of Disease|5|||
161549614|NCT00779584|583401107|FG005|Overall Study|Progression of Disease|1|||
161549615|NCT00779584|583401108|FG006|Overall Study|Progression of Disease|4|||
161549616|NCT00779584|583401109|FG007|Overall Study|Progression of Disease|2|||
161549617|NCT00779584|583401110|FG008|Overall Study|Progression of Disease|1|||
161549618|NCT00779584|583401102|FG000|Overall Study|Adverse Event|1|||
161549619|NCT00779584|583401103|FG001|Overall Study|Adverse Event|0|||
161549620|NCT00779584|583401104|FG002|Overall Study|Adverse Event|2|||
161549621|NCT00779584|583401105|FG003|Overall Study|Adverse Event|0|||
161549622|NCT00779584|583401106|FG004|Overall Study|Adverse Event|0|||
161549623|NCT00779584|583401107|FG005|Overall Study|Adverse Event|0|||
161549624|NCT00779584|583401108|FG006|Overall Study|Adverse Event|2|||
161549625|NCT00779584|583401109|FG007|Overall Study|Adverse Event|1|||
161549626|NCT00779584|583401110|FG008|Overall Study|Adverse Event|1|||
161549627|NCT00779584|583401102|FG000|Overall Study|Symptomatic Deterioration|1|||
161549628|NCT00779584|583401103|FG001|Overall Study|Symptomatic Deterioration|1|||
161549629|NCT00779584|583401104|FG002|Overall Study|Symptomatic Deterioration|1|||
161549630|NCT00779584|583401105|FG003|Overall Study|Symptomatic Deterioration|0|||
161549631|NCT00779584|583401106|FG004|Overall Study|Symptomatic Deterioration|0|||
161549632|NCT00779584|583401107|FG005|Overall Study|Symptomatic Deterioration|1|||
161549633|NCT00779584|583401108|FG006|Overall Study|Symptomatic Deterioration|1|||
161549634|NCT00779584|583401109|FG007|Overall Study|Symptomatic Deterioration|0|||
161549635|NCT00779584|583401110|FG008|Overall Study|Symptomatic Deterioration|0|||
161549636|NCT00779584|583401102|FG000|Overall Study|Ongoing in Study|0|||
161549637|NCT00779584|583401103|FG001|Overall Study|Ongoing in Study|0|||
161549638|NCT00779584|583401104|FG002|Overall Study|Ongoing in Study|0|||
161549639|NCT00779584|583401105|FG003|Overall Study|Ongoing in Study|0|||
161549640|NCT00779584|583401106|FG004|Overall Study|Ongoing in Study|1|||
161549641|NCT00779584|583401107|FG005|Overall Study|Ongoing in Study|1|||
161549642|NCT00779584|583401108|FG006|Overall Study|Ongoing in Study|0|||
161549643|NCT00779584|583401109|FG007|Overall Study|Ongoing in Study|0|||
161549644|NCT00779584|583401110|FG008|Overall Study|Ongoing in Study|0|||
161549645|NCT01775930|583401111|FG000|Overall Study|Futility stopping boundary met|1|||
161549646|NCT01208415|583401112|FG000|Overall Study|Death|1|||
161549647|NCT01208415|583401112|FG000|Overall Study|Lost to Follow-up|2|||
161549648|NCT01208415|583401112|FG000|Overall Study|Withdrawal by Subject|3|||
161549649|NCT01208415|583401112|FG000|Overall Study|Device not placed|1|||
161549650|NCT01208415|583401112|FG000|Overall Study|Still be eligible for follow-up|33|||
161549651|NCT02340520|583401113|FG000|Overall Study|Lost to Follow-up|1|||
161549652|NCT02340520|583401113|FG000|Overall Study|Patient did not take drug as specified|1|||
161549653|NCT02340520|583401113|FG000|Overall Study|Withdrawal by Subject|1|||
161549654|NCT01586338|583401115|FG000|Overall Study|Adverse Event|3|||
161549655|NCT01586338|583401115|FG000|Overall Study|Lost to Follow-up|1|||
161549656|NCT01586338|583401115|FG000|Overall Study|Withdrawal by participant|3|||
161549657|NCT01586338|583401115|FG000|Overall Study|Other|1|||
161549658|NCT01868074|583401120|FG000|Overall Study|Lost to Follow-up|3|||
161549659|NCT01868074|583401121|FG001|Overall Study|Lost to Follow-up|2|||
161549660|NCT01868074|583401120|FG000|Overall Study|Withdrawal by Subject|4|||
161549661|NCT01868074|583401121|FG001|Overall Study|Withdrawal by Subject|2|||
161549662|NCT03306043|583401122|FG000|Overall Study|Adverse Event|1|||
161549663|NCT03306043|583401122|FG000|Overall Study|Lost to Follow-up|1|||
161549664|NCT03306043|583401122|FG000|Overall Study|Withdrawal by Subject|2|||
161549665|NCT01544491|583401123|FG000|Overall Study|Withdrawal by Subject|3|||
161549666|NCT01544491|583401124|FG001|Overall Study|Withdrawal by Subject|2|||
161549667|NCT01544491|583401123|FG000|Overall Study|Lost to Follow-up|0|||
161549668|NCT01544491|583401124|FG001|Overall Study|Lost to Follow-up|1|||
161635173|NCT01177228|583715602|FG001|Overall Study|Worsening disease activity|0|||
161635174|NCT01177228|583715603|FG002|Overall Study|Worsening disease activity|0|||
161635175|NCT01177228|583715604|FG003|Overall Study|Worsening disease activity|0|||
161635176|NCT01177228|583715601|FG000|Overall Study|Withdrawal by Subject|0|||
161635177|NCT01177228|583715602|FG001|Overall Study|Withdrawal by Subject|1|||
161635178|NCT01177228|583715603|FG002|Overall Study|Withdrawal by Subject|0|||
161635179|NCT01177228|583715604|FG003|Overall Study|Withdrawal by Subject|0|||
161635180|NCT01251887|583715605|FG000|Overall Study|Scheduling conflict|1|||
161635181|NCT01251887|583715606|FG001|Overall Study|Scheduling conflict|2|||
161635182|NCT01251887|583715607|FG002|Overall Study|Scheduling conflict|2|||
161635183|NCT01251887|583715605|FG000|Overall Study|Physician Decision|0|||
161635184|NCT01251887|583715606|FG001|Overall Study|Physician Decision|1|||
161635185|NCT01251887|583715607|FG002|Overall Study|Physician Decision|0|||
161635186|NCT02080403|583716594|FG000|Overall Study|Adverse Event|5|||
161635187|NCT02080403|583716595|FG001|Overall Study|Adverse Event|1|||
161635188|NCT02080403|583716594|FG000|Overall Study|Death|0|||
161635189|NCT02080403|583716595|FG001|Overall Study|Death|2|||
161635190|NCT02080403|583716594|FG000|Overall Study|Lost to Follow-up|2|||
161635191|NCT02080403|583716595|FG001|Overall Study|Lost to Follow-up|0|||
161635192|NCT02080403|583716594|FG000|Overall Study|Pregnancy|0|||
161635193|NCT02080403|583716595|FG001|Overall Study|Pregnancy|1|||
161635194|NCT02080403|583716594|FG000|Overall Study|Protocol Violation|3|||
161635195|NCT02080403|583716595|FG001|Overall Study|Protocol Violation|7|||
161635196|NCT02080403|583716594|FG000|Overall Study|Withdrawal by Subject|5|||
161635197|NCT02080403|583716595|FG001|Overall Study|Withdrawal by Subject|1|||
161635198|NCT01999972|583716596|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
161635199|NCT01999972|583716597|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
161635200|NCT01999972|583716598|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
161635201|NCT01999972|583716599|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
161635202|NCT01999972|583716600|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
161686291|NCT00917150|583903382|FG002|Overall Study|Other than specified|2|||
161686292|NCT00917150|583903383|FG003|Overall Study|Other than specified|2|||
161686293|NCT03891264|583903385|FG000|Overall Study|Adverse Event|1|||
161686294|NCT03891264|583903385|FG000|Overall Study|Withdrawal by Subject|2|||
161686295|NCT03891264|583903385|FG000|Overall Study|Physician Decision|2|||
161686296|NCT01924182|583903386|FG000|Overall Study|Withdrawal by Subject|1|||
161686297|NCT01924182|583903387|FG001|Overall Study|Withdrawal by Subject|0|||
161686298|NCT00993265|583903389|FG000|Overall Study|Adverse Event|1|||
161686299|NCT00993265|583903390|FG001|Overall Study|Adverse Event|0|||
161686300|NCT00993265|583903389|FG000|Overall Study|Changed dose of concomitant drug|2|||
161686301|NCT00993265|583903390|FG001|Overall Study|Changed dose of concomitant drug|0|||
161686302|NCT00993265|583903389|FG000|Overall Study|Non-compliant with study medication|1|||
161686303|NCT00993265|583903390|FG001|Overall Study|Non-compliant with study medication|0|||
161686304|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
161686305|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
161686306|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
161686307|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
161686308|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
161686309|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
161686310|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
161686311|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
161686312|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
161686313|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
161686314|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
161686315|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
161686316|NCT00219284|583903391|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
161686317|NCT00219284|583903392|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
161686318|NCT00219284|583903391|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
161686319|NCT00219284|583903392|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
161686320|NCT00219284|583903391|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
161686321|NCT00219284|583903392|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
161834099|NCT01013649|584435555|FG000|First Step|Death|3|||
161834100|NCT01013649|584435556|FG001|First Step|Death|4|||
161635203|NCT01999972|583716601|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
161635204|NCT01999972|583716596|FG000|Dose Escalation Part|Death|0|||
161635205|NCT01999972|583716597|FG001|Dose Escalation Part|Death|1|||
161635206|NCT01999972|583716598|FG002|Dose Escalation Part|Death|0|||
161686322|NCT05003622|583903393|FG000|Overall Study|Progressive disease|2|||
161686323|NCT05003622|583903393|FG000|Overall Study|Withdrawal by Subject|1|||
161686324|NCT01692275|583903394|FG000|Overall Study|Lost to Follow-up|57|||
161686325|NCT01692275|583903395|FG001|Overall Study|Lost to Follow-up|48|||
161834101|NCT01013649|584435557|FG002|First Step|Death|0|||
161834102|NCT01013649|584435558|FG003|First Step|Death|0|||
161834103|NCT01013649|584435555|FG000|First Step|Adverse Event|9|||
161834104|NCT01013649|584435556|FG001|First Step|Adverse Event|5|||
161635207|NCT01999972|583716599|FG003|Dose Escalation Part|Death|0|||
161686326|NCT01692275|583903394|FG000|Overall Study|Withdrawal by Subject|9|||
161686327|NCT01692275|583903395|FG001|Overall Study|Withdrawal by Subject|11|||
161686328|NCT05264740|583903403|FG000|Baseline|Withdrawal by Subject|0|||
161686329|NCT05264740|583903404|FG001|Baseline|Withdrawal by Subject|1|||
161686330|NCT05264740|583903403|FG000|Follow Up 1|Lost to Follow-up|1|||
161686331|NCT05264740|583903404|FG001|Follow Up 1|Lost to Follow-up|1|||
161686332|NCT05264740|583903403|FG000|Follow Up 1|Withdrawal by Subject|0|||
161686333|NCT05264740|583903404|FG001|Follow Up 1|Withdrawal by Subject|1|||
161686334|NCT05264740|583903403|FG000|Follow Up 2|Lost to Follow-up|1|||
161686335|NCT05264740|583903404|FG001|Follow Up 2|Lost to Follow-up|4|||
161686336|NCT05264740|583903403|FG000|Follow Up 3|Lost to Follow-up|7|||
161686337|NCT05264740|583903404|FG001|Follow Up 3|Lost to Follow-up|4|||
161686338|NCT02356562|583904802|FG000|Overall Study|Withdrawal by Subject|0|||
161686339|NCT02356562|583904803|FG001|Overall Study|Withdrawal by Subject|1|||
161686340|NCT02356562|583904802|FG000|Overall Study|Re-entered treatment in a previous study|1|||
161686341|NCT02356562|583904803|FG001|Overall Study|Re-entered treatment in a previous study|0|||
161686342|NCT02356562|583904802|FG000|Overall Study|site closure|1|||
161686343|NCT02356562|583904803|FG001|Overall Study|site closure|0|||
161686344|NCT00412750|583904804|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161686345|NCT00412750|583904805|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161686346|NCT00412750|583904806|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161686347|NCT00412750|583904804|FG000|Overall Study|Administrative problems|21|||
161686348|NCT00412750|583904805|FG001|Overall Study|Administrative problems|17|||
161686349|NCT00412750|583904806|FG002|Overall Study|Administrative problems|14|||
161686350|NCT00412750|583904804|FG000|Overall Study|Adverse Event|8|||
161686351|NCT00412750|583904805|FG001|Overall Study|Adverse Event|3|||
161686352|NCT00412750|583904806|FG002|Overall Study|Adverse Event|3|||
161686353|NCT00412750|583904804|FG000|Overall Study|Lost to Follow-up|1|||
161686354|NCT00412750|583904805|FG001|Overall Study|Lost to Follow-up|0|||
161686355|NCT00412750|583904806|FG002|Overall Study|Lost to Follow-up|1|||
161686356|NCT00412750|583904804|FG000|Overall Study|Withdrawal by Subject|0|||
161686357|NCT00412750|583904805|FG001|Overall Study|Withdrawal by Subject|1|||
161686358|NCT00412750|583904806|FG002|Overall Study|Withdrawal by Subject|2|||
161686359|NCT00412750|583904804|FG000|Overall Study|Lack of Efficacy|0|||
161686360|NCT00412750|583904805|FG001|Overall Study|Lack of Efficacy|0|||
161686361|NCT00412750|583904806|FG002|Overall Study|Lack of Efficacy|3|||
161686362|NCT01611974|583904813|FG000|Overall Study|Death|10|||
161686363|NCT01611974|583904814|FG001|Overall Study|Death|12|||
161686364|NCT01611974|583904815|FG002|Overall Study|Death|10|||
161686365|NCT01611974|583904813|FG000|Overall Study|Lost to Follow-up|0|||
161686366|NCT01611974|583904814|FG001|Overall Study|Lost to Follow-up|1|||
161686367|NCT01611974|583904815|FG002|Overall Study|Lost to Follow-up|0|||
161686368|NCT01611974|583904813|FG000|Overall Study|Physician Decision|5|||
161686369|NCT01611974|583904814|FG001|Overall Study|Physician Decision|1|||
161686370|NCT01611974|583904815|FG002|Overall Study|Physician Decision|2|||
161686371|NCT01611974|583904813|FG000|Overall Study|Withdrawal by Subject|0|||
161686372|NCT01611974|583904814|FG001|Overall Study|Withdrawal by Subject|1|||
161686373|NCT01611974|583904815|FG002|Overall Study|Withdrawal by Subject|4|||
161686374|NCT00522431|583904816|FG000|Overall Study|Adverse Event|5|||
161686375|NCT00522431|583904816|FG000|Overall Study|Protocol Violation|2|||
161686376|NCT00522431|583904816|FG000|Overall Study|Withdrawal by Subject|2|||
161686377|NCT00522431|583904816|FG000|Overall Study|Subject non-compliance|1|||
161686378|NCT00522431|583904816|FG000|Overall Study|Other/unknown|1|||
161686379|NCT00132132|583904817|FG000|Overall Study|Lost to Follow-up|7|||
161686380|NCT00132132|583904818|FG001|Overall Study|Lost to Follow-up|2|||
161686381|NCT03808077|583904819|FG000|Overall Study|Physician Decision|2|||
161686382|NCT03808077|583904820|FG001|Overall Study|Physician Decision|3|||
161686383|NCT03808077|583904819|FG000|Overall Study|Withdrawal by Subject|1|||
161686384|NCT03808077|583904820|FG001|Overall Study|Withdrawal by Subject|0|||
161686385|NCT03808077|583904819|FG000|Overall Study|Equipment Issues|2|||
161686386|NCT03808077|583904820|FG001|Overall Study|Equipment Issues|1|||
161686387|NCT00930761|583904825|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
161686388|NCT00930761|583904826|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
161686389|NCT00930761|583904825|FG000|Overall Study|less than 3 music therapy sessions|0|||
161686390|NCT00930761|583904826|FG001|Overall Study|less than 3 music therapy sessions|3|||
161686391|NCT00811135|583904827|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
161686392|NCT00811135|583904827|FG000|Overall Study|Death|3|||
161686393|NCT00811135|583904827|FG000|Overall Study|Protocol Violation|2|||
161686394|NCT00811135|583904827|FG000|Overall Study|Violation of Selection Criteria|1|||
161686395|NCT00811135|583904827|FG000|Overall Study|Refused Treatment|1|||
161686396|NCT00811135|583904827|FG000|Overall Study|Withdrawal by Subject|3|||
161686397|NCT00811135|583904827|FG000|Overall Study|Administrative/Other Unspecified|11|||
161686398|NCT00811135|583904827|FG000|Overall Study|Ongoing|59|||
161686399|NCT01118351|583904828|FG000|Overall Study|Adverse Event|3|||
161686400|NCT01118351|583904828|FG000|Overall Study|Withdrawal by Subject|1|||
161686401|NCT02192827|583904830|FG000|Overall Study|Lost to Follow-up|25|||
161686402|NCT02192827|583904831|FG001|Overall Study|Lost to Follow-up|27|||
161549669|NCT01544491|583401123|FG000|Overall Study|administrative problems|2|||
161549670|NCT01544491|583401124|FG001|Overall Study|administrative problems|0|||
161549671|NCT02494206|583401125|FG000|Overall Study|Adverse Event|1|||
161549672|NCT02494206|583401125|FG000|Overall Study|Disease Progression|1|||
161549673|NCT01013792|583401126|FG000|Overall Study|Study suspended|2|||
161549674|NCT01013792|583401127|FG001|Overall Study|Study suspended|1|||
161549675|NCT01013792|583401126|FG000|Overall Study|Adverse Event|0|||
161549676|NCT01013792|583401127|FG001|Overall Study|Adverse Event|3|||
161549677|NCT01013792|583401126|FG000|Overall Study|Lost to Follow-up|0|||
161549678|NCT01013792|583401127|FG001|Overall Study|Lost to Follow-up|1|||
161549679|NCT01234649|583401128|FG000|Overall Study|Withdrawal by Subject|32|||
161549680|NCT01234649|583401129|FG001|Overall Study|Withdrawal by Subject|26|||
161549681|NCT01234649|583401128|FG000|Overall Study|Pregnancy|6|||
161549682|NCT01234649|583401129|FG001|Overall Study|Pregnancy|6|||
161549683|NCT01234649|583401128|FG000|Overall Study|intolerant to side effects|4|||
161549684|NCT01234649|583401129|FG001|Overall Study|intolerant to side effects|3|||
161549685|NCT01234649|583401128|FG000|Overall Study|Allergic reaction|1|||
161549686|NCT01234649|583401129|FG001|Overall Study|Allergic reaction|0|||
161549687|NCT01234649|583401128|FG000|Overall Study|Lack of Efficacy|0|||
161549688|NCT01234649|583401129|FG001|Overall Study|Lack of Efficacy|3|||
161549689|NCT00680056|583401133|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
161549690|NCT00680056|583401134|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
161549691|NCT00680056|583401133|FG000|Second Intervention|Protocol Violation|3|||
161549692|NCT00680056|583401134|FG001|Second Intervention|Protocol Violation|1|||
161549693|NCT03688711|583401135|FG000|Overall Study|Withdrawal by Subject|0|||
161549694|NCT03688711|583401136|FG001|Overall Study|Withdrawal by Subject|1|||
161549695|NCT05229653|583401137|FG000|Overall Study|Lost to Follow-up|1|||
161549696|NCT05229653|583401138|FG001|Overall Study|Lost to Follow-up|0|||
161549697|NCT01370005|583401139|FG000|Overall Study|Not treated|1|||
161549698|NCT01370005|583401140|FG001|Overall Study|Not treated|0|||
161549699|NCT01370005|583401141|FG002|Overall Study|Not treated|0|||
161549700|NCT01370005|583401139|FG000|Overall Study|Adverse Event|5|||
161549701|NCT01370005|583401140|FG001|Overall Study|Adverse Event|5|||
161549702|NCT01370005|583401141|FG002|Overall Study|Adverse Event|6|||
161549703|NCT01370005|583401139|FG000|Overall Study|Lack of Efficacy|1|||
161549704|NCT01370005|583401140|FG001|Overall Study|Lack of Efficacy|0|||
161549705|NCT01370005|583401141|FG002|Overall Study|Lack of Efficacy|0|||
161549706|NCT01370005|583401139|FG000|Overall Study|Non compliant with protocol|0|||
161549707|NCT01370005|583401140|FG001|Overall Study|Non compliant with protocol|1|||
161549708|NCT01370005|583401141|FG002|Overall Study|Non compliant with protocol|2|||
161549709|NCT01370005|583401139|FG000|Overall Study|Lost to Follow-up|1|||
161549710|NCT01370005|583401140|FG001|Overall Study|Lost to Follow-up|1|||
161549711|NCT01370005|583401141|FG002|Overall Study|Lost to Follow-up|1|||
161549712|NCT01370005|583401139|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
161549713|NCT01370005|583401140|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
161549714|NCT01370005|583401141|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
161549715|NCT01370005|583401139|FG000|Overall Study|Other reason not defined above|3|||
161549716|NCT01370005|583401140|FG001|Overall Study|Other reason not defined above|0|||
161549717|NCT01370005|583401141|FG002|Overall Study|Other reason not defined above|2|||
161549718|NCT03691948|583401142|FG000|Overall Study|Lost to Follow-up|1|||
161549719|NCT03691948|583401143|FG001|Overall Study|Lost to Follow-up|3|||
161549720|NCT02009696|583401144|FG000|Overall Study|Withdrawal by Subject|2|||
161549721|NCT01018563|583401146|FG000|Overall Study|Termination of the study by Sponsor|2|||
161549722|NCT01018563|583401147|FG001|Overall Study|Termination of the study by Sponsor|1|||
161549723|NCT02344537|583401148|FG000|Overall Study|Protocol Violation|1|||
161549724|NCT02344537|583401149|FG001|Overall Study|Protocol Violation|1|||
161549725|NCT02344537|583401148|FG000|Overall Study|Subject started another treatment after wk 6|1|||
161549726|NCT02344537|583401149|FG001|Overall Study|Subject started another treatment after wk 6|0|||
161834105|NCT01013649|584435557|FG002|First Step|Adverse Event|0|||
161834106|NCT01013649|584435558|FG003|First Step|Adverse Event|0|||
161834107|NCT01013649|584435555|FG000|First Step|Other|4|||
161834108|NCT01013649|584435556|FG001|First Step|Other|6|||
161834109|NCT01013649|584435557|FG002|First Step|Other|0|||
161834110|NCT01013649|584435558|FG003|First Step|Other|0|||
161834111|NCT01647958|584435559|FG000|Initial Study|Lost to Follow-up|2|||
161834112|NCT01647958|584435560|FG001|Initial Study|Lost to Follow-up|3|||
161834113|NCT01647958|584435559|FG000|Continuation Phase|treatment received during Overall Study|39|||
161834114|NCT01647958|584435560|FG001|Continuation Phase|treatment received during Overall Study|0|||
161834115|NCT01647958|584435559|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
161834116|NCT01647958|584435560|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
161635208|NCT01999972|583716600|FG004|Dose Escalation Part|Death|0|||
161635209|NCT01999972|583716601|FG005|Dose Escalation Part|Death|0|||
161635210|NCT01999972|583716596|FG000|Dose Escalation Part|Enrolled but not treated|0|||
161635211|NCT01999972|583716597|FG001|Dose Escalation Part|Enrolled but not treated|0|||
161635212|NCT01999972|583716598|FG002|Dose Escalation Part|Enrolled but not treated|1|||
161635213|NCT01999972|583716599|FG003|Dose Escalation Part|Enrolled but not treated|1|||
161834117|NCT01131299|584435561|FG000|Overall Study|Withdrawal by Subject|4|||
161834118|NCT01131299|584435562|FG001|Overall Study|Withdrawal by Subject|7|||
161834119|NCT01207440|584435570|FG000|Overall Study|Adverse Event|46|||
161834120|NCT01207440|584435571|FG001|Overall Study|Adverse Event|11|||
161834121|NCT01207440|584435572|FG002|Overall Study|Adverse Event|7|||
161834122|NCT01207440|584435573|FG003|Overall Study|Adverse Event|2|||
161834123|NCT01207440|584435574|FG004|Overall Study|Adverse Event|6|||
161834124|NCT01207440|584435575|FG005|Overall Study|Adverse Event|6|||
161834125|NCT01207440|584435576|FG006|Overall Study|Adverse Event|2|||
161834126|NCT01207440|584435570|FG000|Overall Study|Death|6|||
161834127|NCT01207440|584435571|FG001|Overall Study|Death|3|||
161834128|NCT01207440|584435572|FG002|Overall Study|Death|2|||
161834129|NCT01207440|584435573|FG003|Overall Study|Death|2|||
161834130|NCT01207440|584435574|FG004|Overall Study|Death|7|||
161834131|NCT01207440|584435575|FG005|Overall Study|Death|5|||
161834132|NCT01207440|584435576|FG006|Overall Study|Death|1|||
161834133|NCT01207440|584435570|FG000|Overall Study|Lack of Efficacy|13|||
161834134|NCT01207440|584435571|FG001|Overall Study|Lack of Efficacy|2|||
161834135|NCT01207440|584435572|FG002|Overall Study|Lack of Efficacy|5|||
161834136|NCT01207440|584435573|FG003|Overall Study|Lack of Efficacy|1|||
161834137|NCT01207440|584435574|FG004|Overall Study|Lack of Efficacy|2|||
161834138|NCT01207440|584435575|FG005|Overall Study|Lack of Efficacy|3|||
161635214|NCT01999972|583716600|FG004|Dose Escalation Part|Enrolled but not treated|0|||
161635215|NCT01999972|583716601|FG005|Dose Escalation Part|Enrolled but not treated|0|||
161635216|NCT01999972|583716596|FG000|Dose Escalation Part|Disease progression|3|||
161635217|NCT01999972|583716597|FG001|Dose Escalation Part|Disease progression|2|||
161635218|NCT01999972|583716598|FG002|Dose Escalation Part|Disease progression|3|||
161635219|NCT01999972|583716599|FG003|Dose Escalation Part|Disease progression|6|||
161635220|NCT01999972|583716600|FG004|Dose Escalation Part|Disease progression|0|||
161635221|NCT01999972|583716601|FG005|Dose Escalation Part|Disease progression|0|||
161635222|NCT01999972|583716596|FG000|Dose Escalation Part|Adverse Event|0|||
161635223|NCT01999972|583716597|FG001|Dose Escalation Part|Adverse Event|0|||
161635224|NCT01999972|583716598|FG002|Dose Escalation Part|Adverse Event|0|||
161635225|NCT01999972|583716599|FG003|Dose Escalation Part|Adverse Event|2|||
161635226|NCT01999972|583716600|FG004|Dose Escalation Part|Adverse Event|0|||
161635227|NCT01999972|583716601|FG005|Dose Escalation Part|Adverse Event|0|||
161635228|NCT01999972|583716596|FG000|Dose Escalation Part|Global deterioration of health status|1|||
161635229|NCT01999972|583716597|FG001|Dose Escalation Part|Global deterioration of health status|0|||
161686403|NCT02192827|583904830|FG000|Overall Study|Given additional steroids with admission|13|||
161834139|NCT01207440|584435576|FG006|Overall Study|Lack of Efficacy|0|||
161635230|NCT01999972|583716598|FG002|Dose Escalation Part|Global deterioration of health status|0|||
161686404|NCT02192827|583904831|FG001|Overall Study|Given additional steroids with admission|11|||
161834140|NCT01207440|584435570|FG000|Overall Study|Lost to Follow-up|0|||
161834141|NCT01207440|584435571|FG001|Overall Study|Lost to Follow-up|0|||
161834142|NCT01207440|584435572|FG002|Overall Study|Lost to Follow-up|2|||
161834143|NCT01207440|584435573|FG003|Overall Study|Lost to Follow-up|1|||
161834144|NCT01207440|584435574|FG004|Overall Study|Lost to Follow-up|0|||
161834145|NCT01207440|584435575|FG005|Overall Study|Lost to Follow-up|0|||
161834146|NCT01207440|584435576|FG006|Overall Study|Lost to Follow-up|0|||
161834147|NCT01207440|584435570|FG000|Overall Study|Non-compliance with Study Drug|3|||
161834148|NCT01207440|584435571|FG001|Overall Study|Non-compliance with Study Drug|0|||
161834149|NCT01207440|584435572|FG002|Overall Study|Non-compliance with Study Drug|1|||
161686405|NCT03699007|583904834|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
161686406|NCT03699007|583904835|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
161686407|NCT03699007|583904834|FG000|6-month Follow Up|Lost to Follow-up|2|||
161686408|NCT03699007|583904835|FG001|6-month Follow Up|Lost to Follow-up|3|||
161686409|NCT01970995|583904836|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161686410|NCT01970995|583904837|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161686411|NCT01970995|583904838|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161686412|NCT01970995|583904836|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
161686413|NCT01970995|583904837|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
161549727|NCT02344537|583401148|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
161549728|NCT02344537|583401149|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
161549729|NCT05490329|583401152|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
161549730|NCT05490329|583401153|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
161549731|NCT05490329|583401152|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
161549732|NCT05490329|583401153|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
161549733|NCT05490329|583401152|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
161549734|NCT05490329|583401153|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
161549735|NCT04524598|583401154|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
161549736|NCT04524598|583401155|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
161549737|NCT04524598|583401156|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
161549738|NCT04524598|583401157|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
161549739|NCT04524598|583401158|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
161549740|NCT04524598|583401154|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
161549741|NCT04524598|583401155|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
161549742|NCT04524598|583401156|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549743|NCT04524598|583401157|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549744|NCT04524598|583401158|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549745|NCT04524598|583401154|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
161549746|NCT04524598|583401155|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
161549747|NCT04524598|583401156|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
161549748|NCT04524598|583401157|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
161549749|NCT04524598|583401158|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
161635231|NCT01999972|583716599|FG003|Dose Escalation Part|Global deterioration of health status|1|||
161635232|NCT01999972|583716600|FG004|Dose Escalation Part|Global deterioration of health status|0|||
161635233|NCT01999972|583716601|FG005|Dose Escalation Part|Global deterioration of health status|0|||
161635234|NCT01999972|583716596|FG000|Dose Expansion Part|Death|0|||
161635235|NCT01999972|583716597|FG001|Dose Expansion Part|Death|0|||
161635236|NCT01999972|583716598|FG002|Dose Expansion Part|Death|0|||
161635237|NCT01999972|583716599|FG003|Dose Expansion Part|Death|0|||
161635238|NCT01999972|583716600|FG004|Dose Expansion Part|Death|2|||
161635239|NCT01999972|583716601|FG005|Dose Expansion Part|Death|1|||
161635240|NCT01999972|583716596|FG000|Dose Expansion Part|Disease progression|0|||
161635241|NCT01999972|583716597|FG001|Dose Expansion Part|Disease progression|0|||
161635242|NCT01999972|583716598|FG002|Dose Expansion Part|Disease progression|0|||
161635243|NCT01999972|583716599|FG003|Dose Expansion Part|Disease progression|0|||
161635244|NCT01999972|583716600|FG004|Dose Expansion Part|Disease progression|9|||
161635245|NCT01999972|583716601|FG005|Dose Expansion Part|Disease progression|3|||
161635246|NCT01999972|583716596|FG000|Dose Expansion Part|Sponsor decision|0|||
161635247|NCT01999972|583716597|FG001|Dose Expansion Part|Sponsor decision|0|||
161635248|NCT01999972|583716598|FG002|Dose Expansion Part|Sponsor decision|0|||
161635249|NCT01999972|583716599|FG003|Dose Expansion Part|Sponsor decision|0|||
161635250|NCT01999972|583716600|FG004|Dose Expansion Part|Sponsor decision|1|||
161635251|NCT01999972|583716601|FG005|Dose Expansion Part|Sponsor decision|0|||
161635252|NCT01999972|583716596|FG000|Dose Expansion Part|Adverse Event|0|||
161635253|NCT01999972|583716597|FG001|Dose Expansion Part|Adverse Event|0|||
161635254|NCT01999972|583716598|FG002|Dose Expansion Part|Adverse Event|0|||
161635255|NCT01999972|583716599|FG003|Dose Expansion Part|Adverse Event|0|||
161635256|NCT01999972|583716600|FG004|Dose Expansion Part|Adverse Event|4|||
161635257|NCT01999972|583716601|FG005|Dose Expansion Part|Adverse Event|2|||
161635258|NCT01999972|583716596|FG000|Dose Expansion Part|Participant's non-compliance|0|||
161635259|NCT01999972|583716597|FG001|Dose Expansion Part|Participant's non-compliance|0|||
161635260|NCT01999972|583716598|FG002|Dose Expansion Part|Participant's non-compliance|0|||
161635261|NCT01999972|583716599|FG003|Dose Expansion Part|Participant's non-compliance|0|||
161635262|NCT01999972|583716600|FG004|Dose Expansion Part|Participant's non-compliance|0|||
161686414|NCT01970995|583904838|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
161686415|NCT01709435|583904839|FG000|Overall Study|Adverse Event|1|||
161686416|NCT01709435|583904840|FG001|Overall Study|Adverse Event|1|||
161686417|NCT01709435|583904841|FG002|Overall Study|Adverse Event|1|||
161686418|NCT01709435|583904842|FG003|Overall Study|Adverse Event|0|||
161686419|NCT01709435|583904843|FG004|Overall Study|Adverse Event|0|||
161686420|NCT01709435|583904844|FG005|Overall Study|Adverse Event|1|||
161686421|NCT01709435|583904839|FG000|Overall Study|Lack of Efficacy|5|||
161686422|NCT01709435|583904840|FG001|Overall Study|Lack of Efficacy|7|||
161686423|NCT01709435|583904841|FG002|Overall Study|Lack of Efficacy|2|||
161686424|NCT01709435|583904842|FG003|Overall Study|Lack of Efficacy|2|||
161686425|NCT01709435|583904843|FG004|Overall Study|Lack of Efficacy|6|||
161686426|NCT01709435|583904844|FG005|Overall Study|Lack of Efficacy|3|||
161686427|NCT01709435|583904839|FG000|Overall Study|Physician Decision|0|||
161686428|NCT01709435|583904840|FG001|Overall Study|Physician Decision|1|||
161686429|NCT01709435|583904841|FG002|Overall Study|Physician Decision|0|||
161686430|NCT01709435|583904842|FG003|Overall Study|Physician Decision|1|||
161686431|NCT01709435|583904843|FG004|Overall Study|Physician Decision|2|||
161686432|NCT01709435|583904844|FG005|Overall Study|Physician Decision|0|||
161686433|NCT01709435|583904839|FG000|Overall Study|Withdrawal by Subject|0|||
161686434|NCT01709435|583904840|FG001|Overall Study|Withdrawal by Subject|0|||
161686435|NCT01709435|583904841|FG002|Overall Study|Withdrawal by Subject|3|||
161686436|NCT01709435|583904842|FG003|Overall Study|Withdrawal by Subject|0|||
161686437|NCT01709435|583904843|FG004|Overall Study|Withdrawal by Subject|2|||
161686438|NCT01709435|583904844|FG005|Overall Study|Withdrawal by Subject|2|||
161686439|NCT01263639|583904845|FG000|Overall Study|Lost to Follow-up|66|||
161686440|NCT01263639|583904846|FG001|Overall Study|Lost to Follow-up|70|||
161686441|NCT01263639|583904845|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
161686442|NCT01263639|583904846|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
161686443|NCT01780662|583904847|FG000|Overall Study|Adverse Event|1|||
161686444|NCT01780662|583904848|FG001|Overall Study|Adverse Event|0|||
161635263|NCT01999972|583716601|FG005|Dose Expansion Part|Participant's non-compliance|1|||
161686445|NCT01780662|583904849|FG002|Overall Study|Adverse Event|2|||
161686446|NCT01780662|583904847|FG000|Overall Study|Physician Decision|0|||
161686447|NCT01780662|583904848|FG001|Overall Study|Physician Decision|5|||
161686448|NCT01780662|583904849|FG002|Overall Study|Physician Decision|7|||
161686449|NCT01780662|583904847|FG000|Overall Study|Protocol Violation|0|||
161686450|NCT01780662|583904848|FG001|Overall Study|Protocol Violation|1|||
161686451|NCT01780662|583904849|FG002|Overall Study|Protocol Violation|0|||
161686452|NCT01780662|583904847|FG000|Overall Study|Ineligible|0|||
161549750|NCT04524598|583401154|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
161549751|NCT04524598|583401155|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
161549752|NCT04524598|583401156|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
161549753|NCT04524598|583401157|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
161549754|NCT04524598|583401158|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
161549755|NCT04524598|583401154|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549756|NCT04524598|583401155|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549757|NCT04524598|583401156|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
161549758|NCT04524598|583401157|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
161549759|NCT04524598|583401158|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549760|NCT04524598|583401154|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
161549761|NCT04524598|583401155|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
161549762|NCT04524598|583401156|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
161549763|NCT04524598|583401157|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
161549764|NCT04524598|583401158|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
161549765|NCT04524598|583401154|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549766|NCT04524598|583401155|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549767|NCT04524598|583401156|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549768|NCT04524598|583401157|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
161549769|NCT04524598|583401158|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
161549770|NCT02306122|583401159|FG000|Initial Physician Randomization|Physician Decision|0|||
161549771|NCT02306122|583401160|FG001|Initial Physician Randomization|Physician Decision|0|||
161549772|NCT02306122|583401161|FG002|Initial Physician Randomization|Physician Decision|0|||
161549773|NCT02306122|583401162|FG003|Initial Physician Randomization|Physician Decision|0|||
161549774|NCT02306122|583401163|FG004|Initial Physician Randomization|Physician Decision|0|||
161549775|NCT02306122|583401164|FG005|Initial Physician Randomization|Physician Decision|0|||
161549776|NCT02306122|583401165|FG006|Initial Physician Randomization|Physician Decision|0|||
161549777|NCT02306122|583401166|FG007|Initial Physician Randomization|Physician Decision|0|||
161549778|NCT02306122|583401167|FG008|Initial Physician Randomization|Physician Decision|1|||
161549779|NCT02306122|583401168|FG009|Initial Physician Randomization|Physician Decision|0|||
161549780|NCT02306122|583401169|FG010|Initial Physician Randomization|Physician Decision|0|||
161549781|NCT02322814|583401170|FG000|Overall Study|Death|7|||
161549782|NCT02322814|583401171|FG001|Overall Study|Death|29|||
161686453|NCT01780662|583904848|FG001|Overall Study|Ineligible|0|||
161635264|NCT01999972|583716596|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
161635265|NCT01999972|583716597|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
161635266|NCT01999972|583716598|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
161635267|NCT01999972|583716599|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
161635268|NCT01999972|583716600|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
161635269|NCT01999972|583716601|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
161635270|NCT01999972|583716596|FG000|Dose Expansion Part|Changed to standard of care|0|||
161635271|NCT01999972|583716597|FG001|Dose Expansion Part|Changed to standard of care|0|||
161635272|NCT01999972|583716598|FG002|Dose Expansion Part|Changed to standard of care|0|||
161635273|NCT01999972|583716599|FG003|Dose Expansion Part|Changed to standard of care|0|||
161635274|NCT01999972|583716600|FG004|Dose Expansion Part|Changed to standard of care|1|||
161635275|NCT01999972|583716601|FG005|Dose Expansion Part|Changed to standard of care|0|||
161635276|NCT02826798|583716602|FG000|Overall Study|Withdrawal by Subject|0|||
161635277|NCT02826798|583716603|FG001|Overall Study|Withdrawal by Subject|1|||
161635278|NCT02826798|583716604|FG002|Overall Study|Withdrawal by Subject|0|||
161635279|NCT02826798|583716605|FG003|Overall Study|Withdrawal by Subject|1|||
161635280|NCT02826798|583716606|FG004|Overall Study|Withdrawal by Subject|0|||
161635281|NCT02806505|583716608|FG000|Overall Study|Adverse event/intercurrent illness|1|||
161635282|NCT02806505|583716609|FG001|Overall Study|Adverse event/intercurrent illness|3|||
161635283|NCT02806505|583716608|FG000|Overall Study|Death|4|||
161635284|NCT02806505|583716609|FG001|Overall Study|Death|0|||
161635285|NCT02806505|583716608|FG000|Overall Study|Did not cooperate/refused treatment|3|||
161635286|NCT02806505|583716609|FG001|Overall Study|Did not cooperate/refused treatment|3|||
161635287|NCT02806505|583716608|FG000|Overall Study|Failure to return|0|||
161635288|NCT02806505|583716609|FG001|Overall Study|Failure to return|1|||
161635289|NCT02806505|583716608|FG000|Overall Study|Insufficient therapeutic response|2|||
161635290|NCT02806505|583716609|FG001|Overall Study|Insufficient therapeutic response|4|||
161635291|NCT01722045|583716611|FG000|Overall Study|Adverse Event|8|||
161635292|NCT01722045|583716611|FG000|Overall Study|Death|3|||
161635293|NCT01722045|583716611|FG000|Overall Study|Withdrawal by Subject|8|||
161635294|NCT01722045|583716611|FG000|Overall Study|Lost to Follow-up|4|||
161635295|NCT01722045|583716611|FG000|Overall Study|Protocol Deviation|1|||
161635296|NCT01722045|583716611|FG000|Overall Study|Physician Decision|3|||
161635297|NCT01722045|583716611|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
161635298|NCT02034162|583716612|FG000|Double-blind|Lost to Follow-up|3|||
161635299|NCT02034162|583716613|FG001|Double-blind|Lost to Follow-up|0|||
161635300|NCT02034162|583716614|FG002|Double-blind|Lost to Follow-up|0|||
161635301|NCT02034162|583716612|FG000|Double-blind|Physician Decision|1|||
161635302|NCT02034162|583716613|FG001|Double-blind|Physician Decision|0|||
161635303|NCT02034162|583716614|FG002|Double-blind|Physician Decision|0|||
161635304|NCT02034162|583716612|FG000|Double-blind|Protocol Violation|0|||
161635305|NCT02034162|583716613|FG001|Double-blind|Protocol Violation|1|||
161635306|NCT02034162|583716614|FG002|Double-blind|Protocol Violation|0|||
161635307|NCT02034162|583716612|FG000|Double-blind|Withdrawal by Subject|5|||
161635308|NCT02034162|583716613|FG001|Double-blind|Withdrawal by Subject|7|||
161635309|NCT02034162|583716614|FG002|Double-blind|Withdrawal by Subject|0|||
161635310|NCT00760513|583716615|FG000|Overall Study|Withdrawal by Subject|5|||
161635311|NCT00760513|583716616|FG001|Overall Study|Withdrawal by Subject|7|||
161635312|NCT02808975|583716618|FG000|Overall Study|Adverse Event|3|||
161635313|NCT02808975|583716619|FG001|Overall Study|Adverse Event|4|||
161635314|NCT02808975|583716618|FG000|Overall Study|Withdrew consent|9|||
161635315|NCT02808975|583716619|FG001|Overall Study|Withdrew consent|8|||
161635316|NCT02808975|583716618|FG000|Overall Study|Lost to Follow-up|4|||
161635317|NCT02808975|583716619|FG001|Overall Study|Lost to Follow-up|6|||
161635318|NCT02808975|583716618|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
161635319|NCT02808975|583716619|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
161635320|NCT02808975|583716618|FG000|Overall Study|Other, not specified|5|||
161635321|NCT02808975|583716619|FG001|Overall Study|Other, not specified|1|||
161635322|NCT01513330|583716620|FG000|SenSura Mio First,|Adverse Event|2|||
161635323|NCT01513330|583716621|FG001|SenSura Mio First,|Adverse Event|0|||
161635324|NCT01513330|583716620|FG000|SenSura Mio First,|Lack of Efficacy|0|||
161635325|NCT01513330|583716621|FG001|SenSura Mio First,|Lack of Efficacy|1|||
161635326|NCT01513330|583716620|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
161635327|NCT01513330|583716621|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
161635328|NCT01513330|583716620|FG000|SenSura Mio First,|Other|1|||
161635329|NCT01513330|583716621|FG001|SenSura Mio First,|Other|0|||
161635330|NCT01513330|583716620|FG000|Standard Care First,|Lack of Efficacy|2|||
161635331|NCT01513330|583716621|FG001|Standard Care First,|Lack of Efficacy|2|||
161635332|NCT01513330|583716620|FG000|Standard Care First,|Withdrawal by Subject|1|||
161635333|NCT01513330|583716621|FG001|Standard Care First,|Withdrawal by Subject|2|||
161635334|NCT01513330|583716620|FG000|Standard Care First,|Other|1|||
161635335|NCT01513330|583716621|FG001|Standard Care First,|Other|0|||
161635336|NCT01288209|583716626|FG000|Overall Study|Withdrawal by Subject|1|||
161635337|NCT01288209|583716627|FG001|Overall Study|Withdrawal by Subject|3|||
161635338|NCT01288209|583716626|FG000|Overall Study|Other|1|||
161635339|NCT01288209|583716627|FG001|Overall Study|Other|0|||
161635340|NCT01646385|583716628|FG000|Overall Study|Death|202|||
161635341|NCT01646385|583716629|FG001|Overall Study|Death|222|||
161635342|NCT01646385|583716628|FG000|Overall Study|Switched to alternate biologic|636|||
161635343|NCT01646385|583716629|FG001|Overall Study|Switched to alternate biologic|649|||
161686454|NCT01780662|583904849|FG002|Overall Study|Ineligible|1|||
161686455|NCT03975920|583904850|FG000|Overall Study|Lost to Follow-up|1|||
161686456|NCT03975920|583904851|FG001|Overall Study|Lost to Follow-up|2|||
161686457|NCT03975920|583904850|FG000|Overall Study|Protocol Violation|1|||
161686458|NCT03975920|583904851|FG001|Overall Study|Protocol Violation|1|||
161686459|NCT03975920|583904850|FG000|Overall Study|Did not complete survey|2|||
161686460|NCT03975920|583904851|FG001|Overall Study|Did not complete survey|1|||
161686461|NCT03882970|583904852|FG000|Overall Study|Adverse Event|5|||
161686462|NCT03882970|583904853|FG001|Overall Study|Adverse Event|7|||
161686463|NCT03882970|583904854|FG002|Overall Study|Adverse Event|3|||
161686464|NCT03882970|583904855|FG003|Overall Study|Adverse Event|1|||
161686465|NCT03882970|583904852|FG000|Overall Study|Death|1|||
161635356|NCT01101997|583716634|FG000|Overall Study|Withdrawal by Subject|2|||
161635357|NCT00704171|583716635|FG000|Overall Study|Withdrawal by Subject|1|||
161635358|NCT00704171|583716636|FG001|Overall Study|Withdrawal by Subject|0|||
161635359|NCT00813098|583716639|FG000|Overall Study|Adverse Event|2|||
161635360|NCT00813098|583716640|FG001|Overall Study|Adverse Event|4|||
161635361|NCT00813098|583716641|FG002|Overall Study|Adverse Event|1|||
161635362|NCT00813098|583716639|FG000|Overall Study|Withdrawal by Subject|0|||
161635363|NCT00813098|583716640|FG001|Overall Study|Withdrawal by Subject|1|||
161635364|NCT00813098|583716641|FG002|Overall Study|Withdrawal by Subject|0|||
161635365|NCT00813098|583716639|FG000|Overall Study|Inability to complete study procedures|1|||
161635366|NCT00813098|583716640|FG001|Overall Study|Inability to complete study procedures|0|||
161635367|NCT00813098|583716641|FG002|Overall Study|Inability to complete study procedures|0|||
161635368|NCT00813098|583716639|FG000|Overall Study|Lost to Follow-up|0|||
161635369|NCT00813098|583716640|FG001|Overall Study|Lost to Follow-up|1|||
161635370|NCT00813098|583716641|FG002|Overall Study|Lost to Follow-up|0|||
161635371|NCT00813098|583716639|FG000|Overall Study|Protocol Violation|0|||
161635372|NCT00813098|583716640|FG001|Overall Study|Protocol Violation|0|||
161635373|NCT00813098|583716641|FG002|Overall Study|Protocol Violation|1|||
161635374|NCT00813098|583716639|FG000|Overall Study|Principal Investigator decision|0|||
161635375|NCT00813098|583716640|FG001|Overall Study|Principal Investigator decision|1|||
161635376|NCT00813098|583716641|FG002|Overall Study|Principal Investigator decision|0|||
161635377|NCT00813098|583716639|FG000|Overall Study|Withdrew Consent|0|||
161635378|NCT00813098|583716640|FG001|Overall Study|Withdrew Consent|1|||
161635379|NCT00813098|583716641|FG002|Overall Study|Withdrew Consent|0|||
161635380|NCT01772563|583716642|FG000|Cycle 1|Dose limiting toxicity|2|||
161635381|NCT01772563|583716642|FG000|Cycle 1|Progressive disease|2|||
161635382|NCT01772563|583716642|FG000|Cycle 2 and Beyond|Progressive disease|17|||
161635383|NCT01772563|583716642|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
161635384|NCT01772563|583716642|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
161635385|NCT01898442|583716645|FG000|Overall Study|Hemolysis/technical problems|1|||
161635386|NCT01898442|583716646|FG001|Overall Study|Hemolysis/technical problems|2|||
161635387|NCT01898442|583716647|FG002|Overall Study|Hemolysis/technical problems|2|||
161635388|NCT01898442|583716645|FG000|Overall Study|Patient vomited pills|0|||
161635389|NCT01898442|583716646|FG001|Overall Study|Patient vomited pills|0|||
161635390|NCT01898442|583716647|FG002|Overall Study|Patient vomited pills|1|||
161635391|NCT02980705|583716655|FG000|Overall Study|Adverse Event|0|||
161635392|NCT02980705|583716656|FG001|Overall Study|Adverse Event|1|||
161686466|NCT03882970|583904853|FG001|Overall Study|Death|2|||
161686467|NCT03882970|583904854|FG002|Overall Study|Death|1|||
161635393|NCT02980705|583716655|FG000|Overall Study|Withdrawal by Subject|6|||
161635394|NCT02980705|583716656|FG001|Overall Study|Withdrawal by Subject|9|||
161635395|NCT02980705|583716655|FG000|Overall Study|withdrew participation|0|||
161635396|NCT02980705|583716656|FG001|Overall Study|withdrew participation|1|||
161635397|NCT02980705|583716655|FG000|Overall Study|Lost to Follow-up|2|||
161635398|NCT02980705|583716656|FG001|Overall Study|Lost to Follow-up|0|||
161635399|NCT00263575|583716657|FG000|Titration Period|Adverse Event|14|||
161635400|NCT00263575|583716657|FG000|Titration Period|Withdrawal by Subject|10|||
161635401|NCT00263575|583716657|FG000|Titration Period|Protocol Violation|9|||
161834150|NCT01207440|584435573|FG003|Overall Study|Non-compliance with Study Drug|0|||
161834151|NCT01207440|584435574|FG004|Overall Study|Non-compliance with Study Drug|0|||
161834152|NCT01207440|584435575|FG005|Overall Study|Non-compliance with Study Drug|0|||
161834153|NCT01207440|584435576|FG006|Overall Study|Non-compliance with Study Drug|0|||
161834154|NCT01207440|584435570|FG000|Overall Study|Physician Decision|6|||
161834155|NCT01207440|584435571|FG001|Overall Study|Physician Decision|5|||
161834156|NCT01207440|584435572|FG002|Overall Study|Physician Decision|5|||
161834157|NCT01207440|584435573|FG003|Overall Study|Physician Decision|0|||
161834158|NCT01207440|584435574|FG004|Overall Study|Physician Decision|1|||
161834159|NCT01207440|584435575|FG005|Overall Study|Physician Decision|0|||
161834160|NCT01207440|584435576|FG006|Overall Study|Physician Decision|0|||
161834161|NCT01207440|584435570|FG000|Overall Study|Progressive Disease|19|||
161834162|NCT01207440|584435571|FG001|Overall Study|Progressive Disease|10|||
161834163|NCT01207440|584435572|FG002|Overall Study|Progressive Disease|19|||
161834164|NCT01207440|584435573|FG003|Overall Study|Progressive Disease|7|||
161834165|NCT01207440|584435574|FG004|Overall Study|Progressive Disease|23|||
161834166|NCT01207440|584435575|FG005|Overall Study|Progressive Disease|27|||
161834167|NCT01207440|584435576|FG006|Overall Study|Progressive Disease|0|||
161834168|NCT01207440|584435570|FG000|Overall Study|Protocol Violation|2|||
161834169|NCT01207440|584435571|FG001|Overall Study|Protocol Violation|0|||
161834170|NCT01207440|584435572|FG002|Overall Study|Protocol Violation|0|||
161834171|NCT01207440|584435573|FG003|Overall Study|Protocol Violation|0|||
161834172|NCT01207440|584435574|FG004|Overall Study|Protocol Violation|0|||
161834173|NCT01207440|584435575|FG005|Overall Study|Protocol Violation|0|||
161834174|NCT01207440|584435576|FG006|Overall Study|Protocol Violation|0|||
161834175|NCT01207440|584435570|FG000|Overall Study|Site Terminated by Sponsor|69|||
161834176|NCT01207440|584435571|FG001|Overall Study|Site Terminated by Sponsor|19|||
161834177|NCT01207440|584435572|FG002|Overall Study|Site Terminated by Sponsor|12|||
161834178|NCT01207440|584435573|FG003|Overall Study|Site Terminated by Sponsor|2|||
161834179|NCT01207440|584435574|FG004|Overall Study|Site Terminated by Sponsor|3|||
161834180|NCT01207440|584435575|FG005|Overall Study|Site Terminated by Sponsor|0|||
161834181|NCT01207440|584435576|FG006|Overall Study|Site Terminated by Sponsor|2|||
161834182|NCT01207440|584435570|FG000|Overall Study|Withdrawal by Subject|29|||
161834183|NCT01207440|584435571|FG001|Overall Study|Withdrawal by Subject|4|||
161834184|NCT01207440|584435572|FG002|Overall Study|Withdrawal by Subject|5|||
161834185|NCT01207440|584435573|FG003|Overall Study|Withdrawal by Subject|3|||
161834186|NCT01207440|584435574|FG004|Overall Study|Withdrawal by Subject|2|||
161834187|NCT01207440|584435575|FG005|Overall Study|Withdrawal by Subject|2|||
161834188|NCT01207440|584435576|FG006|Overall Study|Withdrawal by Subject|0|||
161834189|NCT01207440|584435570|FG000|Overall Study|Reason Not Specified|10|||
161834190|NCT01207440|584435571|FG001|Overall Study|Reason Not Specified|10|||
161834191|NCT01207440|584435572|FG002|Overall Study|Reason Not Specified|7|||
161834192|NCT01207440|584435573|FG003|Overall Study|Reason Not Specified|0|||
161834193|NCT01207440|584435574|FG004|Overall Study|Reason Not Specified|4|||
161834194|NCT01207440|584435575|FG005|Overall Study|Reason Not Specified|3|||
161834195|NCT01207440|584435576|FG006|Overall Study|Reason Not Specified|0|||
161834196|NCT01592721|584435577|FG000|Long-term Follow-up|Death|1|||
161834197|NCT00821873|584435584|FG000|Overall Study|Lost to Follow-up|4|||
161834198|NCT02698865|584435589|FG000|Overall Study|Other|11|||
161834199|NCT02698865|584435590|FG001|Overall Study|Other|11|||
161834200|NCT02698865|584435589|FG000|Overall Study|Withdrawal by Subject|20|||
161834201|NCT02698865|584435590|FG001|Overall Study|Withdrawal by Subject|16|||
161834202|NCT02698865|584435589|FG000|Overall Study|Physician Decision|0|||
161834203|NCT02698865|584435590|FG001|Overall Study|Physician Decision|4|||
161834204|NCT02698865|584435589|FG000|Overall Study|Lost to Follow-up|4|||
161834205|NCT02698865|584435590|FG001|Overall Study|Lost to Follow-up|2|||
161834206|NCT01386684|584435594|FG000|Overall Study|Lost to Follow-up|51|||
161834207|NCT01386684|584435594|FG000|Overall Study|Other|51|||
161834208|NCT01386684|584435594|FG000|Overall Study|Death|47|||
161834209|NCT01386684|584435594|FG000|Overall Study|Withdrawal of Consent|44|||
161834210|NCT01386684|584435594|FG000|Overall Study|Alternative Therapy Required|37|||
161834211|NCT01386684|584435594|FG000|Overall Study|Disease Progression|28|||
161834212|NCT01386684|584435594|FG000|Overall Study|Adverse Event|20|||
161834213|NCT01386684|584435594|FG000|Overall Study|Noncompliance|8|||
161834214|NCT01386684|584435594|FG000|Overall Study|Protocol Violation|4|||
161834215|NCT01386684|584435594|FG000|Overall Study|Missing|3|||
161834216|NCT02694549|584435600|FG000|Overall Study|screen failures|2|||
161834217|NCT01996332|584435601|FG000|Overall Study|Adverse Event|117|||
161834218|NCT01996332|584435601|FG000|Overall Study|Lack of Efficacy|1245|||
161834219|NCT01996332|584435601|FG000|Overall Study|Death|264|||
161834220|NCT01996332|584435601|FG000|Overall Study|Protocol Violation|9|||
161686468|NCT03882970|583904855|FG003|Overall Study|Death|1|||
161686469|NCT03882970|583904852|FG000|Overall Study|Lost to Follow-up|8|||
161686470|NCT03882970|583904853|FG001|Overall Study|Lost to Follow-up|9|||
161686471|NCT03882970|583904854|FG002|Overall Study|Lost to Follow-up|5|||
161686472|NCT03882970|583904855|FG003|Overall Study|Lost to Follow-up|5|||
161686473|NCT03882970|583904852|FG000|Overall Study|Physician Decision|0|||
161686474|NCT03882970|583904853|FG001|Overall Study|Physician Decision|2|||
161686475|NCT03882970|583904854|FG002|Overall Study|Physician Decision|2|||
161686476|NCT03882970|583904855|FG003|Overall Study|Physician Decision|2|||
161686477|NCT03882970|583904852|FG000|Overall Study|Protocol Violation|2|||
161686478|NCT03882970|583904853|FG001|Overall Study|Protocol Violation|0|||
161686479|NCT03882970|583904854|FG002|Overall Study|Protocol Violation|0|||
161686480|NCT03882970|583904855|FG003|Overall Study|Protocol Violation|0|||
161686481|NCT03882970|583904852|FG000|Overall Study|Withdrawal by Subject|8|||
161686482|NCT03882970|583904853|FG001|Overall Study|Withdrawal by Subject|17|||
161686483|NCT03882970|583904854|FG002|Overall Study|Withdrawal by Subject|7|||
161686484|NCT03882970|583904855|FG003|Overall Study|Withdrawal by Subject|22|||
161686485|NCT03882970|583904852|FG000|Overall Study|Personal Reason|2|||
161686486|NCT03882970|583904853|FG001|Overall Study|Personal Reason|3|||
161686487|NCT03882970|583904854|FG002|Overall Study|Personal Reason|1|||
161686488|NCT03882970|583904855|FG003|Overall Study|Personal Reason|3|||
161686489|NCT02863809|583904856|FG000|Overall Study|Adverse Event|8|||
161686490|NCT02863809|583904857|FG001|Overall Study|Adverse Event|8|||
161686491|NCT02863809|583904856|FG000|Overall Study|Withdrawal by Subject|0|||
161686492|NCT02863809|583904857|FG001|Overall Study|Withdrawal by Subject|1|||
161686493|NCT02863809|583904856|FG000|Overall Study|Lost to Follow-up|1|||
161686494|NCT02863809|583904857|FG001|Overall Study|Lost to Follow-up|1|||
161686495|NCT02863809|583904856|FG000|Overall Study|Death|1|||
161686496|NCT02863809|583904857|FG001|Overall Study|Death|0|||
161686497|NCT01081249|583904860|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
161686498|NCT01081249|583904861|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
161686499|NCT02813694|583904862|FG000|Overall Study|Physician Decision|0|||
161686500|NCT02813694|583904863|FG001|Overall Study|Physician Decision|1|||
161686501|NCT02813694|583904862|FG000|Overall Study|Withdrawal by Subject|10|||
161686502|NCT02813694|583904863|FG001|Overall Study|Withdrawal by Subject|9|||
161686503|NCT02813694|583904862|FG000|Overall Study|Lost to Follow-up|1|||
161686504|NCT02813694|583904863|FG001|Overall Study|Lost to Follow-up|1|||
161686505|NCT02813694|583904862|FG000|Overall Study|Death|3|||
161686506|NCT02813694|583904863|FG001|Overall Study|Death|3|||
161686507|NCT02813694|583904862|FG000|Overall Study|Randomized- did not receive study drug|2|||
161686508|NCT02813694|583904863|FG001|Overall Study|Randomized- did not receive study drug|0|||
161686509|NCT02813694|583904862|FG000|Overall Study|Patient hospitalized|1|||
161635402|NCT00263575|583716657|FG000|Titration Period|Sponsor Decision|2|||
161635403|NCT00263575|583716657|FG000|Titration Period|Other|2|||
161635404|NCT00263575|583716657|FG000|Titration Period|Lack of Efficacy|6|||
161635405|NCT00263575|583716657|FG000|Maintence Period|Adverse Event|23|||
161635406|NCT00263575|583716657|FG000|Maintence Period|Withdrawal by Subject|8|||
161635407|NCT00263575|583716657|FG000|Maintence Period|Protocol Violation|4|||
161635408|NCT00263575|583716657|FG000|Maintence Period|Lack of Efficacy|4|||
161635409|NCT00263575|583716657|FG000|Maintence Period|Physician Decision|6|||
161635410|NCT00263575|583716657|FG000|Maintence Period|Lost to Follow-up|1|||
161635411|NCT00263575|583716657|FG000|Maintence Period|Sponsor Decision|24|||
161635412|NCT00263575|583716657|FG000|Maintence Period|Other|7|||
161635413|NCT01841112|583716658|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
161635414|NCT01841112|583716659|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
161635415|NCT01841112|583716660|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
161635416|NCT01841112|583716661|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
161635417|NCT01841112|583716662|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
161635418|NCT01880437|583716666|FG000|Overall Study|Death|12|||
161635419|NCT01880437|583716667|FG001|Overall Study|Death|4|||
161635420|NCT01880437|583716668|FG002|Overall Study|Death|17|||
161686510|NCT02813694|583904863|FG001|Overall Study|Patient hospitalized|0|||
161686511|NCT02980224|583904865|FG000|Overall Study|Adverse Event|4|||
161686512|NCT02980224|583904866|FG001|Overall Study|Adverse Event|1|||
161686513|NCT02980224|583904865|FG000|Overall Study|Withdrawal by Subject|0|||
161635421|NCT01880437|583716666|FG000|Overall Study|Study terminated by Sponsor|3|||
161635422|NCT01880437|583716667|FG001|Overall Study|Study terminated by Sponsor|0|||
161635423|NCT01880437|583716668|FG002|Overall Study|Study terminated by Sponsor|2|||
161686514|NCT02980224|583904866|FG001|Overall Study|Withdrawal by Subject|2|||
161686515|NCT00606320|583904869|FG000|Overall Study|Adverse Event|3|||
161686516|NCT00606320|583904869|FG000|Overall Study|Lack of Efficacy|5|||
161686517|NCT00606320|583904869|FG000|Overall Study|Physician Decision|7|||
161686518|NCT00606320|583904869|FG000|Overall Study|Protocol Violation|8|||
161635424|NCT01209598|583716669|FG000|Overall Study|Withdrawal by Subject|1|||
161635425|NCT01209598|583716670|FG001|Overall Study|Withdrawal by Subject|0|||
161635426|NCT01438840|583716671|FG000|Core Study|Adverse Event|0|||
161686519|NCT00606320|583904869|FG000|Overall Study|Withdrawal by Subject|10|||
161635427|NCT01438840|583716672|FG001|Core Study|Adverse Event|3|||
161635428|NCT01438840|583716673|FG002|Core Study|Adverse Event|0|||
161686520|NCT00606320|583904869|FG000|Overall Study|Progression to depressive phase|4|||
161686521|NCT04839380|583904870|FG000|Overall Study|Withdrawal by Subject|2|||
161686522|NCT04839380|583904870|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
161686523|NCT00879645|583904871|FG000|Overall Study|Adverse Event|1|||
161686524|NCT00879645|583904872|FG001|Overall Study|Adverse Event|0|||
161686525|NCT00879645|583904873|FG002|Overall Study|Adverse Event|0|||
161686526|NCT00879645|583904874|FG003|Overall Study|Adverse Event|0|||
161686527|NCT00749996|583904875|FG000|Overall Study|Lost to Follow-up|7|||
161686528|NCT00749996|583904876|FG001|Overall Study|Lost to Follow-up|4|||
161686529|NCT00749996|583904875|FG000|Overall Study|Withdrawal by Subject|5|||
161686530|NCT00749996|583904876|FG001|Overall Study|Withdrawal by Subject|4|||
161686531|NCT00749996|583904875|FG000|Overall Study|Protocol Violation|2|||
161686532|NCT00749996|583904876|FG001|Overall Study|Protocol Violation|3|||
161686533|NCT00749996|583904875|FG000|Overall Study|Physician Decision|2|||
161686534|NCT00749996|583904876|FG001|Overall Study|Physician Decision|0|||
161686535|NCT00749996|583904875|FG000|Overall Study|Pregnancy|0|||
161686536|NCT00749996|583904876|FG001|Overall Study|Pregnancy|2|||
161686537|NCT00749996|583904875|FG000|Overall Study|Adverse Event|1|||
161686538|NCT00749996|583904876|FG001|Overall Study|Adverse Event|0|||
161686539|NCT00749996|583904875|FG000|Overall Study|Death|1|||
161686540|NCT00749996|583904876|FG001|Overall Study|Death|0|||
161686541|NCT00996944|583904877|FG000|Double-blind Treatment Period|Adverse Event|2|||
161686542|NCT00996944|583904878|FG001|Double-blind Treatment Period|Adverse Event|1|||
161686543|NCT00996944|583904877|FG000|Double-blind Treatment Period|Protocol Violation|1|||
161686544|NCT00996944|583904878|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161686545|NCT00996944|583904877|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
161686546|NCT00996944|583904878|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
161686547|NCT00996944|583904877|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161686548|NCT00996944|583904878|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161686549|NCT00996944|583904877|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
161686550|NCT00996944|583904878|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
161686551|NCT03775421|583904881|FG000|Overall Study|Lost to Follow-up|2|||
161686552|NCT03775421|583904881|FG000|Overall Study|Withdrawal by Subject|10|||
161686553|NCT03775421|583904881|FG000|Overall Study|Physician Decision|3|||
161686554|NCT03775421|583904881|FG000|Overall Study|Death|1|||
161686555|NCT03775421|583904881|FG000|Overall Study|Study Terminated by Sponsor|94|||
161686556|NCT01227044|583904884|FG000|Overall Study|Lost to Follow-up|5|||
161686557|NCT01227044|583904885|FG001|Overall Study|Lost to Follow-up|7|||
161686558|NCT01227044|583904884|FG000|Overall Study|Discontinued Intervention|1|||
161686559|NCT01227044|583904885|FG001|Overall Study|Discontinued Intervention|2|||
161686560|NCT04247061|583904886|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
161686561|NCT04247061|583904886|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
161686562|NCT04247061|583904886|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
161686563|NCT01378104|583904889|FG000|Overall Study|Adverse Event|8|||
161686564|NCT01378104|583904890|FG001|Overall Study|Adverse Event|8|||
161686565|NCT01378104|583904889|FG000|Overall Study|Lack of Efficacy|7|||
161686566|NCT01378104|583904890|FG001|Overall Study|Lack of Efficacy|5|||
161686567|NCT01378104|583904889|FG000|Overall Study|Withdrawal by Subject|12|||
161686568|NCT01378104|583904890|FG001|Overall Study|Withdrawal by Subject|13|||
161686569|NCT02287623|583904891|FG000|Overall Study|Protocol Violation|0|||
161686570|NCT02287623|583904892|FG001|Overall Study|Protocol Violation|1|||
161686571|NCT02700997|583904893|FG000|Overall Study|Did not undergo CT imaging|1|||
161686572|NCT02700997|583904893|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
161686573|NCT00205855|583904896|FG000|Overall Study|Only received temporary implants|16|||
161686574|NCT00205855|583904896|FG000|Overall Study|Withdrawal by Subject|5|||
161686575|NCT01445951|583904897|FG000|Overall Study|Adverse Event|16|||
161686576|NCT01445951|583904898|FG001|Overall Study|Adverse Event|9|||
161686577|NCT01445951|583904899|FG002|Overall Study|Adverse Event|0|||
161686578|NCT01445951|583904897|FG000|Overall Study|Protocol Violation|2|||
161686579|NCT01445951|583904898|FG001|Overall Study|Protocol Violation|2|||
161686580|NCT01445951|583904899|FG002|Overall Study|Protocol Violation|2|||
161686581|NCT01445951|583904897|FG000|Overall Study|Withdrawal by Subject|21|||
161686582|NCT01445951|583904898|FG001|Overall Study|Withdrawal by Subject|16|||
161686583|NCT01445951|583904899|FG002|Overall Study|Withdrawal by Subject|8|||
161686584|NCT01445951|583904897|FG000|Overall Study|Physician Decision|3|||
161686585|NCT01445951|583904898|FG001|Overall Study|Physician Decision|1|||
161686586|NCT01445951|583904899|FG002|Overall Study|Physician Decision|0|||
161686587|NCT01445951|583904897|FG000|Overall Study|Lost to Follow-up|1|||
161686588|NCT01445951|583904898|FG001|Overall Study|Lost to Follow-up|2|||
161686589|NCT01445951|583904899|FG002|Overall Study|Lost to Follow-up|4|||
161635429|NCT01438840|583716671|FG000|Core Study|Lack of Efficacy|15|||
161635430|NCT01438840|583716672|FG001|Core Study|Lack of Efficacy|7|||
161635431|NCT01438840|583716673|FG002|Core Study|Lack of Efficacy|0|||
161635432|NCT01438840|583716671|FG000|Core Study|Withdrawal of consent|1|||
161635433|NCT01438840|583716672|FG001|Core Study|Withdrawal of consent|0|||
161635434|NCT01438840|583716673|FG002|Core Study|Withdrawal of consent|0|||
161635435|NCT01438840|583716671|FG000|Extension Phase|Adverse Event|0|||
161635436|NCT01438840|583716672|FG001|Extension Phase|Adverse Event|0|||
161686590|NCT01445951|583904897|FG000|Overall Study|Pregnancy|0|||
161686591|NCT01445951|583904898|FG001|Overall Study|Pregnancy|1|||
161686592|NCT01445951|583904899|FG002|Overall Study|Pregnancy|4|||
161686593|NCT01445951|583904897|FG000|Overall Study|Death|0|||
161686594|NCT01445951|583904898|FG001|Overall Study|Death|0|||
161686595|NCT01445951|583904899|FG002|Overall Study|Death|1|||
161686596|NCT01445951|583904897|FG000|Overall Study|Non-compliance with study drug|1|||
161686597|NCT01445951|583904898|FG001|Overall Study|Non-compliance with study drug|2|||
161686598|NCT01445951|583904899|FG002|Overall Study|Non-compliance with study drug|0|||
161686599|NCT01445951|583904897|FG000|Overall Study|Non-compliance with protocol|0|||
161686600|NCT01445951|583904898|FG001|Overall Study|Non-compliance with protocol|1|||
161686601|NCT01445951|583904899|FG002|Overall Study|Non-compliance with protocol|0|||
161686602|NCT01445951|583904897|FG000|Overall Study|Sponsor decision - subject travel|0|||
161686603|NCT01445951|583904898|FG001|Overall Study|Sponsor decision - subject travel|1|||
161686604|NCT01445951|583904899|FG002|Overall Study|Sponsor decision - subject travel|0|||
161686605|NCT01445951|583904897|FG000|Overall Study|Cough|0|||
161686606|NCT01445951|583904898|FG001|Overall Study|Cough|1|||
161686607|NCT01445951|583904899|FG002|Overall Study|Cough|0|||
161686608|NCT02739620|583904902|FG000|Overall Study|Lost to Follow-up|3|||
161686609|NCT02739620|583904903|FG001|Overall Study|Lost to Follow-up|1|||
161686610|NCT02739620|583904902|FG000|Overall Study|Adverse Event|0|||
161686611|NCT02739620|583904903|FG001|Overall Study|Adverse Event|1|||
161686612|NCT02039375|583904910|FG000|Overall Study|Lost to Follow-up|2|||
161686613|NCT03765138|583904911|FG000|Overall Study|Lost to Follow-up|1|||
161686614|NCT03099187|583904920|FG000|Double-blind Treatment|Adverse Event|19|||
161686615|NCT03099187|583904921|FG001|Double-blind Treatment|Adverse Event|1|||
161686616|NCT03099187|583904922|FG002|Double-blind Treatment|Adverse Event|0|||
161686617|NCT03099187|583904923|FG003|Double-blind Treatment|Adverse Event|0|||
161686618|NCT03099187|583904920|FG000|Double-blind Treatment|Death|1|||
161686619|NCT03099187|583904921|FG001|Double-blind Treatment|Death|3|||
161686620|NCT03099187|583904922|FG002|Double-blind Treatment|Death|0|||
161686621|NCT03099187|583904923|FG003|Double-blind Treatment|Death|0|||
161686622|NCT03099187|583904920|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161686623|NCT03099187|583904921|FG001|Double-blind Treatment|Lack of Efficacy|0|||
161686624|NCT03099187|583904922|FG002|Double-blind Treatment|Lack of Efficacy|0|||
161686625|NCT03099187|583904923|FG003|Double-blind Treatment|Lack of Efficacy|0|||
161686626|NCT03099187|583904920|FG000|Double-blind Treatment|Physician Decision|2|||
161686627|NCT03099187|583904921|FG001|Double-blind Treatment|Physician Decision|1|||
161686628|NCT03099187|583904922|FG002|Double-blind Treatment|Physician Decision|0|||
161686629|NCT03099187|583904923|FG003|Double-blind Treatment|Physician Decision|0|||
161686630|NCT03099187|583904920|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
161686631|NCT03099187|583904921|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
161686632|NCT03099187|583904922|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
161686633|NCT03099187|583904923|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
161686634|NCT03099187|583904920|FG000|Double-blind Treatment|Lung transplantation|0|||
161686635|NCT03099187|583904921|FG001|Double-blind Treatment|Lung transplantation|1|||
161686636|NCT03099187|583904922|FG002|Double-blind Treatment|Lung transplantation|0|||
161686637|NCT03099187|583904923|FG003|Double-blind Treatment|Lung transplantation|0|||
161686638|NCT03099187|583904920|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
161686639|NCT03099187|583904921|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
161686640|NCT03099187|583904922|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
161686641|NCT03099187|583904923|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
161635437|NCT01438840|583716673|FG002|Extension Phase|Adverse Event|3|||
161686642|NCT03099187|583904920|FG000|Double-blind Treatment|Disease progression|0|||
161686643|NCT03099187|583904921|FG001|Double-blind Treatment|Disease progression|1|||
161686644|NCT03099187|583904922|FG002|Double-blind Treatment|Disease progression|0|||
161686645|NCT03099187|583904923|FG003|Double-blind Treatment|Disease progression|0|||
161686646|NCT03099187|583904920|FG000|Double-blind Treatment|Randomization error|0|||
161635438|NCT01438840|583716671|FG000|Extension Phase|Lost to Follow-up|0|||
161686647|NCT03099187|583904921|FG001|Double-blind Treatment|Randomization error|2|||
161635439|NCT01438840|583716672|FG001|Extension Phase|Lost to Follow-up|0|||
161635440|NCT01438840|583716673|FG002|Extension Phase|Lost to Follow-up|1|||
161635441|NCT01438840|583716671|FG000|Extension Phase|Withdrawal by Subject|0|||
161635442|NCT01438840|583716672|FG001|Extension Phase|Withdrawal by Subject|0|||
161635443|NCT01438840|583716673|FG002|Extension Phase|Withdrawal by Subject|3|||
161635444|NCT01438840|583716671|FG000|Extension Phase|Lack of Efficacy|0|||
161635445|NCT01438840|583716672|FG001|Extension Phase|Lack of Efficacy|0|||
161635446|NCT01438840|583716673|FG002|Extension Phase|Lack of Efficacy|2|||
161635447|NCT01438840|583716671|FG000|Extension Phase|Other|0|||
161635448|NCT01438840|583716672|FG001|Extension Phase|Other|0|||
161686648|NCT03099187|583904922|FG002|Double-blind Treatment|Randomization error|0|||
161686649|NCT03099187|583904923|FG003|Double-blind Treatment|Randomization error|0|||
161686650|NCT03099187|583904920|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
161686651|NCT03099187|583904921|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
161686652|NCT03099187|583904922|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
161686653|NCT03099187|583904923|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
161686654|NCT03099187|583904920|FG000|12-month Safety Follow-up|Adverse Event|0|||
161686655|NCT03099187|583904921|FG001|12-month Safety Follow-up|Adverse Event|0|||
161686656|NCT03099187|583904922|FG002|12-month Safety Follow-up|Adverse Event|5|||
161686657|NCT03099187|583904923|FG003|12-month Safety Follow-up|Adverse Event|12|||
161686658|NCT03099187|583904920|FG000|12-month Safety Follow-up|Death|0|||
161686659|NCT03099187|583904921|FG001|12-month Safety Follow-up|Death|0|||
161686660|NCT03099187|583904922|FG002|12-month Safety Follow-up|Death|7|||
161686661|NCT03099187|583904923|FG003|12-month Safety Follow-up|Death|9|||
161686662|NCT03099187|583904920|FG000|12-month Safety Follow-up|Lung transplantation|0|||
161686663|NCT03099187|583904921|FG001|12-month Safety Follow-up|Lung transplantation|0|||
161686664|NCT03099187|583904922|FG002|12-month Safety Follow-up|Lung transplantation|2|||
161686665|NCT03099187|583904923|FG003|12-month Safety Follow-up|Lung transplantation|1|||
161686666|NCT03099187|583904920|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
161686667|NCT03099187|583904921|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
161686668|NCT03099187|583904922|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
161686669|NCT03099187|583904923|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
161686670|NCT03099187|583904920|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
161686671|NCT03099187|583904921|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
161686672|NCT03099187|583904922|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
161686673|NCT03099187|583904923|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
161686674|NCT03099187|583904920|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
161686675|NCT03099187|583904921|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
161686676|NCT03099187|583904922|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
161686677|NCT03099187|583904923|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
161686678|NCT03099187|583904920|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
161686679|NCT03099187|583904921|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
161686680|NCT03099187|583904922|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
161686681|NCT03099187|583904923|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
161686682|NCT03885089|583904924|FG000|Overall Study|No informed consent for publication of study results|2|||
161686683|NCT01210690|583904927|FG000|Overall Study|Adverse Event|7|||
161686684|NCT01210690|583904927|FG000|Overall Study|Lack of Efficacy|12|||
161686685|NCT01210690|583904927|FG000|Overall Study|Lost to Follow-up|3|||
161686686|NCT01210690|583904927|FG000|Overall Study|Disease Remission|1|||
161834221|NCT01996332|584435601|FG000|Overall Study|Withdrawal by Subject|71|||
161834222|NCT01996332|584435601|FG000|Overall Study|Other|20|||
161549783|NCT02322814|583401172|FG002|Overall Study|Death|32|||
161549784|NCT02322814|583401173|FG003|Overall Study|Death|23|||
161549785|NCT02322814|583401174|FG004|Overall Study|Death|14|||
161549786|NCT02322814|583401170|FG000|Overall Study|Lost to Follow-up|1|||
161549787|NCT02322814|583401171|FG001|Overall Study|Lost to Follow-up|3|||
161549788|NCT02322814|583401172|FG002|Overall Study|Lost to Follow-up|3|||
161549789|NCT02322814|583401173|FG003|Overall Study|Lost to Follow-up|1|||
161549790|NCT02322814|583401174|FG004|Overall Study|Lost to Follow-up|0|||
161549791|NCT02322814|583401170|FG000|Overall Study|Various Reasons|2|||
161549792|NCT02322814|583401171|FG001|Overall Study|Various Reasons|0|||
161549793|NCT02322814|583401172|FG002|Overall Study|Various Reasons|1|||
161549794|NCT02322814|583401173|FG003|Overall Study|Various Reasons|1|||
161549795|NCT02322814|583401174|FG004|Overall Study|Various Reasons|0|||
161549796|NCT02322814|583401170|FG000|Overall Study|Progressive Disease|0|||
161635449|NCT01438840|583716673|FG002|Extension Phase|Other|1|||
161549797|NCT02322814|583401171|FG001|Overall Study|Progressive Disease|0|||
161549798|NCT02322814|583401172|FG002|Overall Study|Progressive Disease|0|||
161549799|NCT02322814|583401173|FG003|Overall Study|Progressive Disease|1|||
161635450|NCT00085566|583716674|FG000|Overall Study|Adverse Event|0|||
161635451|NCT00085566|583716675|FG001|Overall Study|Adverse Event|0|||
161549800|NCT02322814|583401174|FG004|Overall Study|Progressive Disease|1|||
161635452|NCT00085566|583716676|FG002|Overall Study|Adverse Event|10|||
161635453|NCT00085566|583716674|FG000|Overall Study|Patient Not treated|0|||
161549801|NCT02322814|583401170|FG000|Overall Study|Protocol Violation|1|||
161549802|NCT02322814|583401171|FG001|Overall Study|Protocol Violation|0|||
161549803|NCT02322814|583401172|FG002|Overall Study|Protocol Violation|0|||
161549804|NCT02322814|583401173|FG003|Overall Study|Protocol Violation|0|||
161549805|NCT02322814|583401174|FG004|Overall Study|Protocol Violation|0|||
161549806|NCT02322814|583401170|FG000|Overall Study|Study Terminated by Sponsor|0|||
161549807|NCT02322814|583401171|FG001|Overall Study|Study Terminated by Sponsor|7|||
161549808|NCT02322814|583401172|FG002|Overall Study|Study Terminated by Sponsor|9|||
161549809|NCT02322814|583401173|FG003|Overall Study|Study Terminated by Sponsor|5|||
161549810|NCT02322814|583401174|FG004|Overall Study|Study Terminated by Sponsor|13|||
161549811|NCT02322814|583401170|FG000|Overall Study|Withdrawal by Subject|5|||
161549812|NCT02322814|583401171|FG001|Overall Study|Withdrawal by Subject|4|||
161549813|NCT02322814|583401172|FG002|Overall Study|Withdrawal by Subject|2|||
161549814|NCT02322814|583401173|FG003|Overall Study|Withdrawal by Subject|1|||
161549815|NCT02322814|583401174|FG004|Overall Study|Withdrawal by Subject|3|||
161549816|NCT02998021|583401180|FG000|Overall Study|Withdrawal by Subject|3|||
161549817|NCT02998021|583401181|FG001|Overall Study|Withdrawal by Subject|1|||
161549818|NCT02998021|583401180|FG000|Overall Study|unsafe home|0|||
161549819|NCT02998021|583401181|FG001|Overall Study|unsafe home|1|||
161549820|NCT03713021|583401182|FG000|Overall Study|Did not have CT sim scan available|6|||
161549821|NCT03713021|583401182|FG000|Overall Study|Not eligible|4|||
161549822|NCT03713021|583401182|FG000|Overall Study|Issues with TraceIT markers|5|||
161549823|NCT01340482|583402985|FG000|Overall Study|Adverse Event|2|||
161549824|NCT01340482|583402986|FG001|Overall Study|Adverse Event|0|||
161549825|NCT01340482|583402987|FG002|Overall Study|Adverse Event|0|||
161549826|NCT00603265|583402991|FG000|Overall Study|Adverse Event|2|||
161549827|NCT00603265|583402992|FG001|Overall Study|Adverse Event|11|||
161686687|NCT01210690|583904927|FG000|Overall Study|Withdrawal by Subject|1|||
161686688|NCT01210690|583904927|FG000|Overall Study|Patient refused to swallow|1|||
161686689|NCT01210690|583904927|FG000|Overall Study|Patient could not take glucose|1|||
161686690|NCT00470054|583904928|FG000|Overall Study|Ineligible|1|||
161686691|NCT01439555|583904929|FG000|Overall Study|Protocol Violation|1|||
161686692|NCT04869345|583904930|FG000|Overall Study|Lost to Follow-up|8|||
161686693|NCT04869345|583904931|FG001|Overall Study|Lost to Follow-up|3|||
161686694|NCT04194528|583904939|FG000|Overall Study|Adverse Event|1|||
161686695|NCT00528021|583904940|FG000|Overall Study|Lack of Efficacy|17|||
161686696|NCT00528021|583904941|FG001|Overall Study|Lack of Efficacy|13|||
161686697|NCT00528021|583904942|FG002|Overall Study|Lack of Efficacy|7|||
161686698|NCT00528021|583904943|FG003|Overall Study|Lack of Efficacy|9|||
161686699|NCT03921424|583904950|FG000|Overall Study|Lost to Follow-up|0|||
161686700|NCT03921424|583904951|FG001|Overall Study|Lost to Follow-up|1|||
161686701|NCT03921424|583904950|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161686702|NCT03921424|583904951|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161686703|NCT01246583|583904960|FG000|Overall Study|Lost to Follow-up|0|||
161635454|NCT00085566|583716675|FG001|Overall Study|Patient Not treated|0|||
161635455|NCT00085566|583716676|FG002|Overall Study|Patient Not treated|3|||
161635456|NCT00085566|583716674|FG000|Overall Study|Clinical progression|0|||
161635457|NCT00085566|583716675|FG001|Overall Study|Clinical progression|0|||
161635458|NCT00085566|583716676|FG002|Overall Study|Clinical progression|1|||
161635459|NCT02725008|583716683|FG000|Overall Study|Lost to Follow-up|7|||
161635460|NCT02725008|583716684|FG001|Overall Study|Lost to Follow-up|9|||
161635461|NCT02725008|583716683|FG000|Overall Study|Withdrawal by Subject|2|||
161635462|NCT02725008|583716684|FG001|Overall Study|Withdrawal by Subject|2|||
161635463|NCT02725008|583716683|FG000|Overall Study|Admitted to hospital|0|||
161635464|NCT02725008|583716684|FG001|Overall Study|Admitted to hospital|1|||
161635465|NCT04688086|583716685|FG000|Overall Study|Lost to Follow-up|164|||
161635466|NCT04688086|583716685|FG000|Overall Study|Imaging error;|64|||
161686704|NCT01246583|583904961|FG001|Overall Study|Lost to Follow-up|0|||
161686705|NCT01246583|583904962|FG002|Overall Study|Lost to Follow-up|0|||
161686706|NCT01246583|583904963|FG003|Overall Study|Lost to Follow-up|1|||
161635467|NCT01329419|583716688|FG000|Overall Study|Protocol Violation|235|||
161635468|NCT00934700|583716693|FG000|Overall Study|missing scan|5|||
161686707|NCT01246583|583904960|FG000|Overall Study|Protocol Violation|0|||
161686708|NCT01246583|583904961|FG001|Overall Study|Protocol Violation|0|||
161635469|NCT00934700|583716694|FG001|Overall Study|missing scan|9|||
161635470|NCT00934700|583716693|FG000|Overall Study|Death|8|||
161635471|NCT00934700|583716694|FG001|Overall Study|Death|3|||
161686709|NCT01246583|583904962|FG002|Overall Study|Protocol Violation|1|||
161686710|NCT01246583|583904963|FG003|Overall Study|Protocol Violation|0|||
161686711|NCT01246583|583904960|FG000|Overall Study|Withdrawal by Subject|1|||
161686712|NCT01246583|583904961|FG001|Overall Study|Withdrawal by Subject|0|||
161549828|NCT00603265|583402993|FG002|Overall Study|Adverse Event|1|||
161549829|NCT00603265|583402991|FG000|Overall Study|Withdrawal by Subject|1|||
161549830|NCT00603265|583402992|FG001|Overall Study|Withdrawal by Subject|2|||
161686713|NCT01246583|583904962|FG002|Overall Study|Withdrawal by Subject|0|||
161549831|NCT00603265|583402993|FG002|Overall Study|Withdrawal by Subject|1|||
161635472|NCT01831726|583716695|FG000|Overall Study|Adverse Event|16|||
161635473|NCT01831726|583716695|FG000|Overall Study|Death|7|||
161635474|NCT01831726|583716695|FG000|Overall Study|Disease Progression|49|||
161635475|NCT01831726|583716695|FG000|Overall Study|Physician Decision|1|||
161635476|NCT01831726|583716695|FG000|Overall Study|Subject/guardian decision|7|||
161635477|NCT00514813|583716698|FG000|Overall Study|Study terminated|14|||
161635478|NCT00514813|583716699|FG001|Overall Study|Study terminated|74|||
161635479|NCT00514813|583716700|FG002|Overall Study|Study terminated|40|||
161635480|NCT00514813|583716701|FG003|Overall Study|Study terminated|2|||
161635481|NCT00514813|583716698|FG000|Overall Study|Adverse Event|0|||
161635482|NCT00514813|583716699|FG001|Overall Study|Adverse Event|2|||
161635483|NCT00514813|583716700|FG002|Overall Study|Adverse Event|2|||
161635484|NCT00514813|583716701|FG003|Overall Study|Adverse Event|0|||
161635485|NCT00514813|583716698|FG000|Overall Study|Protocol Violation|1|||
161635486|NCT00514813|583716699|FG001|Overall Study|Protocol Violation|0|||
161635487|NCT00514813|583716700|FG002|Overall Study|Protocol Violation|0|||
161635488|NCT00514813|583716701|FG003|Overall Study|Protocol Violation|0|||
161635489|NCT00514813|583716698|FG000|Overall Study|Withdrawal by Subject|0|||
161635490|NCT00514813|583716699|FG001|Overall Study|Withdrawal by Subject|1|||
161635491|NCT00514813|583716700|FG002|Overall Study|Withdrawal by Subject|0|||
161635492|NCT00514813|583716701|FG003|Overall Study|Withdrawal by Subject|0|||
161635493|NCT00514813|583716698|FG000|Overall Study|Lack of Efficacy|0|||
161635494|NCT00514813|583716699|FG001|Overall Study|Lack of Efficacy|1|||
161635495|NCT00514813|583716700|FG002|Overall Study|Lack of Efficacy|0|||
161635496|NCT00514813|583716701|FG003|Overall Study|Lack of Efficacy|0|||
161635497|NCT00514813|583716698|FG000|Overall Study|Kidney transplant|0|||
161635498|NCT00514813|583716699|FG001|Overall Study|Kidney transplant|6|||
161635499|NCT00514813|583716700|FG002|Overall Study|Kidney transplant|2|||
161635500|NCT00514813|583716701|FG003|Overall Study|Kidney transplant|0|||
161635501|NCT00514813|583716698|FG000|Overall Study|Death|0|||
161635502|NCT00514813|583716699|FG001|Overall Study|Death|2|||
161635503|NCT00514813|583716700|FG002|Overall Study|Death|3|||
161635504|NCT00514813|583716701|FG003|Overall Study|Death|2|||
161635505|NCT01075100|583716704|FG000|Overall Study|Adverse Event|15|||
161635506|NCT01075100|583716705|FG001|Overall Study|Adverse Event|18|||
161635507|NCT01075100|583716704|FG000|Overall Study|Patient Request|4|||
161635508|NCT01075100|583716705|FG001|Overall Study|Patient Request|4|||
161635509|NCT01075100|583716704|FG000|Overall Study|Investigator Request|2|||
161635510|NCT01075100|583716705|FG001|Overall Study|Investigator Request|1|||
161635511|NCT01075100|583716704|FG000|Overall Study|Disease Progression|25|||
161635512|NCT01075100|583716705|FG001|Overall Study|Disease Progression|29|||
161635513|NCT01075100|583716704|FG000|Overall Study|Other|3|||
161635514|NCT01075100|583716705|FG001|Overall Study|Other|1|||
161635515|NCT00966264|583718065|FG000|Overall Study|Lost to Follow-up|4|||
161635516|NCT00966264|583718066|FG001|Overall Study|Lost to Follow-up|3|||
161635517|NCT03614676|583718067|FG000|Overall Study|Delivery before planned visit|2|||
161635518|NCT03614676|583718068|FG001|Overall Study|Delivery before planned visit|0|||
161635519|NCT03614676|583718067|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
161635520|NCT03614676|583718068|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
161635521|NCT03614676|583718067|FG000|Overall Study|Migrated / moved from the study area|30|||
161635522|NCT03614676|583718068|FG001|Overall Study|Migrated / moved from the study area|22|||
161635523|NCT03614676|583718067|FG000|Overall Study|Lost to Follow-up|17|||
161635524|NCT03614676|583718068|FG001|Overall Study|Lost to Follow-up|42|||
161635525|NCT03614676|583718067|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
161635526|NCT03614676|583718068|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
161635527|NCT03614676|583718067|FG000|Overall Study|Other|16|||
161635528|NCT03614676|583718068|FG001|Overall Study|Other|47|||
161635529|NCT03614676|583718067|FG000|Overall Study|Protocol Violation|0|||
161635530|NCT03614676|583718068|FG001|Overall Study|Protocol Violation|2|||
161635531|NCT03614676|583718067|FG000|Overall Study|Neonatal event of interest|0|||
161635532|NCT03614676|583718068|FG001|Overall Study|Neonatal event of interest|6|||
161635533|NCT03614676|583718067|FG000|Overall Study|Death in infant greater than 28 days old|0|||
161635534|NCT03614676|583718068|FG001|Overall Study|Death in infant greater than 28 days old|12|||
161635535|NCT03614676|583718067|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
161635536|NCT03614676|583718068|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
161635537|NCT00416598|583718078|FG000|Induction & Intensification|Adverse Event|38|||
161635538|NCT00416598|583718078|FG000|Induction & Intensification|Death|32|||
161635539|NCT00416598|583718078|FG000|Induction & Intensification|Withdrawal by Subject|46|||
161635540|NCT00416598|583718078|FG000|Induction & Intensification|Alternative Treatment|135|||
161635541|NCT00416598|583718078|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
161635542|NCT00416598|583718078|FG000|Induction & Intensification|Relapse/progression|29|||
161635543|NCT00416598|583718078|FG000|Induction & Intensification|Failed induction|87|||
161635544|NCT00416598|583718078|FG000|Decitabine Maintenance|Adverse Event|5|||
161635545|NCT00416598|583718078|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
161635546|NCT00416598|583718078|FG000|Decitabine Maintenance|Progression/relapse|38|||
161635547|NCT00416598|583718078|FG000|Decitabine Maintenance|Alternative treatment|2|||
161635548|NCT00416598|583718078|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
161834223|NCT01996332|584435601|FG000|Overall Study|Clinical Deterioration|28|||
161834224|NCT01996332|584435601|FG000|Overall Study|Physician Decision|17|||
161834225|NCT01996332|584435601|FG000|Overall Study|Lost to Follow-up|34|||
161834226|NCT02113189|584435602|FG000|Overall Study|Lost to follow up|2|||
161834227|NCT02113189|584435603|FG001|Overall Study|Lost to follow up|1|||
161834228|NCT02113189|584435604|FG002|Overall Study|Lost to follow up|3|||
161834229|NCT00099268|584435607|FG000|Overall Study|Withdrawal by Subject|46|||
161834230|NCT00099268|584435608|FG001|Overall Study|Withdrawal by Subject|28|||
161834231|NCT00099268|584435607|FG000|Overall Study|Adverse Event|19|||
161834232|NCT00099268|584435608|FG001|Overall Study|Adverse Event|19|||
161834233|NCT00099268|584435607|FG000|Overall Study|Protocol Violation|9|||
161834234|NCT00099268|584435608|FG001|Overall Study|Protocol Violation|8|||
161834235|NCT00099268|584435607|FG000|Overall Study|Lost to Follow-up|6|||
161834236|NCT00099268|584435608|FG001|Overall Study|Lost to Follow-up|4|||
161834237|NCT00099268|584435607|FG000|Overall Study|Lack of Efficacy|5|||
161834238|NCT00099268|584435608|FG001|Overall Study|Lack of Efficacy|18|||
161834239|NCT00099268|584435607|FG000|Overall Study|Administrative problems|4|||
161834240|NCT00099268|584435608|FG001|Overall Study|Administrative problems|4|||
161834241|NCT00099268|584435607|FG000|Overall Study|Death|3|||
161834242|NCT00099268|584435608|FG001|Overall Study|Death|1|||
161834243|NCT03702049|584435609|FG000|Overall Study|Lost to Follow-up|4|||
161834244|NCT03702049|584435609|FG000|Overall Study|Physician Decision|1|||
161834245|NCT02954159|584435610|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
161834246|NCT02954159|584435611|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
161834247|NCT02954159|584435610|FG000|Overall Study|Withdrawal by Subject|0|||
161834248|NCT02954159|584435611|FG001|Overall Study|Withdrawal by Subject|1|||
161834249|NCT03438396|584435612|FG000|Overall Study|Reason Not Specified|9|||
161834250|NCT03438396|584435612|FG000|Overall Study|Withdrawal by Subject|5|||
161834251|NCT03438396|584435612|FG000|Overall Study|Lost to Follow-up|2|||
161834252|NCT03438396|584435612|FG000|Overall Study|Death|85|||
161834253|NCT03438396|584435612|FG000|Overall Study|Not treated|1|||
161834254|NCT00262041|584435613|FG000|Overall Study|Withdrawal by Subject|0|||
161834255|NCT00262041|584435614|FG001|Overall Study|Withdrawal by Subject|3|||
161834256|NCT00262041|584435615|FG002|Overall Study|Withdrawal by Subject|1|||
161834257|NCT00262041|584435613|FG000|Overall Study|Lost to Follow-up|1|||
161834258|NCT00262041|584435614|FG001|Overall Study|Lost to Follow-up|1|||
161834259|NCT00262041|584435615|FG002|Overall Study|Lost to Follow-up|5|||
161834260|NCT00262041|584435613|FG000|Overall Study|Unable to classify|1|||
161834261|NCT00262041|584435614|FG001|Overall Study|Unable to classify|0|||
161834262|NCT00262041|584435615|FG002|Overall Study|Unable to classify|0|||
161834263|NCT04132336|584435616|FG000|Overall Study|Investigator Decision|0|||
161834264|NCT04132336|584435617|FG001|Overall Study|Investigator Decision|1|||
161834265|NCT04132336|584435618|FG002|Overall Study|Investigator Decision|0|||
161834266|NCT04132336|584435619|FG003|Overall Study|Investigator Decision|0|||
161834267|NCT04132336|584435620|FG004|Overall Study|Investigator Decision|0|||
161834268|NCT04132336|584435621|FG005|Overall Study|Investigator Decision|0|||
161834269|NCT04132336|584435622|FG006|Overall Study|Investigator Decision|0|||
161834270|NCT02488330|584435623|FG000|Overall Study|Adverse Event|1|||
161834271|NCT02488330|584435623|FG000|Overall Study|Physician Decision|2|||
161834272|NCT02488330|584435623|FG000|Overall Study|Death|2|||
161834273|NCT02488330|584435623|FG000|Overall Study|Disease Progression|3|||
161834274|NCT02488330|584435623|FG000|Overall Study|Study Termination by Sponsor|4|||
161834275|NCT02384941|584435626|FG000|Overall Study|Adverse Event|11|||
161834276|NCT02384941|584435627|FG001|Overall Study|Adverse Event|13|||
161834277|NCT02384941|584435628|FG002|Overall Study|Adverse Event|17|||
161834278|NCT02384941|584435626|FG000|Overall Study|Lost to Follow-up|3|||
161834279|NCT02384941|584435627|FG001|Overall Study|Lost to Follow-up|2|||
161834280|NCT02384941|584435628|FG002|Overall Study|Lost to Follow-up|1|||
161834281|NCT02384941|584435626|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161834282|NCT02384941|584435627|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161834283|NCT02384941|584435628|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161834284|NCT02384941|584435626|FG000|Overall Study|Physician Decision|1|||
161834285|NCT02384941|584435627|FG001|Overall Study|Physician Decision|1|||
161834286|NCT02384941|584435628|FG002|Overall Study|Physician Decision|0|||
161834287|NCT02384941|584435626|FG000|Overall Study|Protocol Violation|3|||
161834288|NCT02384941|584435627|FG001|Overall Study|Protocol Violation|0|||
161834289|NCT02384941|584435628|FG002|Overall Study|Protocol Violation|0|||
161834290|NCT02384941|584435626|FG000|Overall Study|Withdrawal by Subject|26|||
161834291|NCT02384941|584435627|FG001|Overall Study|Withdrawal by Subject|19|||
161834292|NCT02384941|584435628|FG002|Overall Study|Withdrawal by Subject|20|||
161834293|NCT02384941|584435626|FG000|Overall Study|Pregnancy|0|||
161834294|NCT02384941|584435627|FG001|Overall Study|Pregnancy|0|||
161834295|NCT02384941|584435628|FG002|Overall Study|Pregnancy|1|||
161834296|NCT02384941|584435626|FG000|Overall Study|Other than specified above|4|||
161834297|NCT02384941|584435627|FG001|Overall Study|Other than specified above|0|||
161635549|NCT02166476|583718085|FG000|Overall Study|Withdrawal by Subject|5|||
161635550|NCT02166476|583718086|FG001|Overall Study|Withdrawal by Subject|7|||
161635551|NCT02166476|583718085|FG000|Overall Study|Adverse Event|3|||
161635552|NCT02166476|583718086|FG001|Overall Study|Adverse Event|3|||
161635553|NCT02166476|583718085|FG000|Overall Study|Lost to Follow-up|5|||
161635554|NCT02166476|583718086|FG001|Overall Study|Lost to Follow-up|10|||
161635555|NCT02166476|583718085|FG000|Overall Study|Physician Decision|1|||
161635556|NCT02166476|583718086|FG001|Overall Study|Physician Decision|0|||
161635557|NCT02166476|583718085|FG000|Overall Study|Unable to Come for Visit|0|||
161635558|NCT02166476|583718086|FG001|Overall Study|Unable to Come for Visit|3|||
161635559|NCT04367480|583718093|FG000|Overall Study|Adverse Event|1|||
161635560|NCT04367480|583718094|FG001|Overall Study|Adverse Event|1|||
161635561|NCT04367480|583718093|FG000|Overall Study|Death|1|||
161635562|NCT04367480|583718094|FG001|Overall Study|Death|0|||
161635563|NCT04367480|583718093|FG000|Overall Study|Lost to Follow-up|1|||
161635564|NCT04367480|583718094|FG001|Overall Study|Lost to Follow-up|1|||
161635565|NCT04367480|583718093|FG000|Overall Study|Withdrawal by Subject|0|||
161635566|NCT04367480|583718094|FG001|Overall Study|Withdrawal by Subject|3|||
161635567|NCT04367480|583718093|FG000|Overall Study|App glitch during the study|1|||
161635568|NCT04367480|583718094|FG001|Overall Study|App glitch during the study|0|||
161635569|NCT04367480|583718093|FG000|Overall Study|Device Distribution Error|0|||
161635570|NCT04367480|583718094|FG001|Overall Study|Device Distribution Error|2|||
161635571|NCT04367480|583718093|FG000|Overall Study|Ineligible after Randomization|0|||
161635572|NCT04367480|583718094|FG001|Overall Study|Ineligible after Randomization|1|||
161635573|NCT04367480|583718093|FG000|Overall Study|Other Medical Reasons|0|||
161635574|NCT04367480|583718094|FG001|Overall Study|Other Medical Reasons|2|||
161635575|NCT03382561|583718095|FG000|Overall Study|Disease progression|47|||
161635576|NCT03382561|583718096|FG001|Overall Study|Disease progression|6|||
161635577|NCT03382561|583718095|FG000|Overall Study|Adverse Event|10|||
161635578|NCT03382561|583718096|FG001|Overall Study|Adverse Event|2|||
161635579|NCT03382561|583718095|FG000|Overall Study|Death|8|||
161635580|NCT03382561|583718096|FG001|Overall Study|Death|3|||
161635581|NCT03382561|583718095|FG000|Overall Study|Withdrawal by Subject|6|||
161635582|NCT03382561|583718096|FG001|Overall Study|Withdrawal by Subject|5|||
161635583|NCT03382561|583718095|FG000|Overall Study|Alternative therapy|2|||
161635584|NCT03382561|583718096|FG001|Overall Study|Alternative therapy|8|||
161635585|NCT03382561|583718095|FG000|Overall Study|Never started treatment|3|||
161635586|NCT03382561|583718096|FG001|Overall Study|Never started treatment|6|||
161635587|NCT03382561|583718095|FG000|Overall Study|Lack of Efficacy|0|||
161635588|NCT03382561|583718096|FG001|Overall Study|Lack of Efficacy|1|||
161635589|NCT03382561|583718095|FG000|Overall Study|Physician Decision|0|||
161635590|NCT03382561|583718096|FG001|Overall Study|Physician Decision|1|||
161635591|NCT03382561|583718095|FG000|Overall Study|Other complicating disease|0|||
161635592|NCT03382561|583718096|FG001|Overall Study|Other complicating disease|1|||
161635593|NCT01131104|583718097|FG000|Overall Study|Withdrawal by Subject|3|||
161635594|NCT01131104|583718097|FG000|Overall Study|Physician Decision|4|||
161635595|NCT01131104|583718097|FG000|Overall Study|Information Not Available|5|||
161635596|NCT01131104|583718097|FG000|Overall Study|No Information on Index Date of Onset|1|||
161635597|NCT04523207|583718101|FG000|Overall Study|Adverse Event|5|||
161635598|NCT04523207|583718102|FG001|Overall Study|Adverse Event|1|||
161635599|NCT04523207|583718101|FG000|Overall Study|Lost to Follow-up|2|||
161635600|NCT04523207|583718102|FG001|Overall Study|Lost to Follow-up|0|||
161635601|NCT04523207|583718101|FG000|Overall Study|Withdrawal by Subject|2|||
161635602|NCT04523207|583718102|FG001|Overall Study|Withdrawal by Subject|0|||
161635603|NCT04523207|583718101|FG000|Overall Study|Progressive Disease|2|||
161635604|NCT04523207|583718102|FG001|Overall Study|Progressive Disease|1|||
161686714|NCT01246583|583904963|FG003|Overall Study|Withdrawal by Subject|0|||
161686715|NCT02595450|583904966|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
161686716|NCT02595450|583904966|FG000|Overall Study|Enrolled, but not treated|8|||
161635605|NCT04523207|583718101|FG000|Overall Study|Other|7|||
161635606|NCT04523207|583718102|FG001|Overall Study|Other|1|||
161635607|NCT03113383|583718103|FG000|Overall Study|Death|4|||
161635608|NCT03113383|583718104|FG001|Overall Study|Death|0|||
161635609|NCT04469465|583718105|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
161635610|NCT04469465|583718106|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
161635611|NCT04469465|583718105|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
161635612|NCT04469465|583718106|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
161635613|NCT04469465|583718105|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
161635614|NCT04469465|583718106|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
161635615|NCT04469465|583718105|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
161635616|NCT04469465|583718106|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
161635617|NCT04469465|583718105|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
161635618|NCT04469465|583718106|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
161635619|NCT04469465|583718105|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
161635620|NCT04469465|583718106|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
161635621|NCT04469465|583718105|FG000|Long-Term Extension (LTE)|Death|0|||
161635622|NCT04469465|583718106|FG001|Long-Term Extension (LTE)|Death|1|||
161635623|NCT04469465|583718105|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
161635624|NCT04469465|583718106|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
161635625|NCT02438371|583718107|FG000|Overall Study|Lost to Follow-up|3|||
161635626|NCT02438371|583718108|FG001|Overall Study|Lost to Follow-up|2|||
161635627|NCT02438371|583718107|FG000|Overall Study|Withdrawal by Subject|1|||
161635628|NCT02438371|583718108|FG001|Overall Study|Withdrawal by Subject|1|||
161635629|NCT03065933|583718112|FG000|Overall Study|study terminated|5|||
161635630|NCT02536742|583718113|FG000|Overall Study|Did not start protocol therapy|1|||
161635631|NCT02536742|583718113|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
161635632|NCT01010204|583718114|FG000|Overall Study|Lost to Follow-up|2|||
161635633|NCT01010204|583718115|FG001|Overall Study|Lost to Follow-up|2|||
161635634|NCT01010204|583718114|FG000|Overall Study|Adverse Event|1|||
161635635|NCT01010204|583718115|FG001|Overall Study|Adverse Event|3|||
161635636|NCT01010204|583718114|FG000|Overall Study|Withdrawal by Subject|2|||
161635637|NCT01010204|583718115|FG001|Overall Study|Withdrawal by Subject|3|||
161635638|NCT01010204|583718114|FG000|Overall Study|psychiatric hospitalization|2|||
161635639|NCT01010204|583718115|FG001|Overall Study|psychiatric hospitalization|1|||
161635640|NCT01519778|583718116|FG000|Overall Study|Withdrawal by Subject|3|||
161635641|NCT01519778|583718116|FG000|Overall Study|Lost to Follow-up|10|||
161635642|NCT01519778|583718116|FG000|Overall Study|Physician Decision|1|||
161635643|NCT01547117|583718117|FG000|Overall Study|Physician Decision|0|||
161635644|NCT01547117|583718118|FG001|Overall Study|Physician Decision|1|||
161635645|NCT01547117|583718119|FG002|Overall Study|Physician Decision|1|||
161635646|NCT01547117|583718120|FG003|Overall Study|Physician Decision|3|||
161635647|NCT01547117|583718117|FG000|Overall Study|Withdrawal by Subject|1|||
161635648|NCT01547117|583718118|FG001|Overall Study|Withdrawal by Subject|2|||
161635649|NCT01547117|583718119|FG002|Overall Study|Withdrawal by Subject|1|||
161635650|NCT01547117|583718120|FG003|Overall Study|Withdrawal by Subject|2|||
161635651|NCT02229578|583718121|FG000|Overall Study|Withdrawal by Subject|1|||
161635652|NCT02229578|583718122|FG001|Overall Study|Withdrawal by Subject|3|||
161635653|NCT02229578|583718121|FG000|Overall Study|Protocol Violation|2|||
161635654|NCT02229578|583718122|FG001|Overall Study|Protocol Violation|0|||
161635655|NCT01496365|583718123|FG000|Overall Study|Adverse Event|2|||
161635656|NCT01496365|583718124|FG001|Overall Study|Adverse Event|3|||
161635657|NCT01496365|583718125|FG002|Overall Study|Adverse Event|3|||
161635658|NCT01496365|583718126|FG003|Overall Study|Adverse Event|2|||
161635659|NCT01496365|583718127|FG004|Overall Study|Adverse Event|5|||
161635660|NCT01496365|583718128|FG005|Overall Study|Adverse Event|6|||
161635661|NCT01496365|583718129|FG006|Overall Study|Adverse Event|4|||
161635662|NCT01496365|583718123|FG000|Overall Study|Withdrawal by Subject|6|||
161635663|NCT01496365|583718124|FG001|Overall Study|Withdrawal by Subject|6|||
161635664|NCT01496365|583718125|FG002|Overall Study|Withdrawal by Subject|0|||
161635665|NCT01496365|583718126|FG003|Overall Study|Withdrawal by Subject|1|||
161635666|NCT01496365|583718127|FG004|Overall Study|Withdrawal by Subject|3|||
161635667|NCT01496365|583718128|FG005|Overall Study|Withdrawal by Subject|2|||
161635668|NCT01496365|583718129|FG006|Overall Study|Withdrawal by Subject|1|||
161635669|NCT01496365|583718123|FG000|Overall Study|Protocol Violation|2|||
161635670|NCT01496365|583718124|FG001|Overall Study|Protocol Violation|1|||
161635671|NCT01496365|583718125|FG002|Overall Study|Protocol Violation|1|||
161635672|NCT01496365|583718126|FG003|Overall Study|Protocol Violation|0|||
161635673|NCT01496365|583718127|FG004|Overall Study|Protocol Violation|0|||
161635674|NCT01496365|583718128|FG005|Overall Study|Protocol Violation|1|||
161635675|NCT01496365|583718129|FG006|Overall Study|Protocol Violation|0|||
161635676|NCT01496365|583718123|FG000|Overall Study|Lack of Efficacy|1|||
161635677|NCT01496365|583718124|FG001|Overall Study|Lack of Efficacy|0|||
161635678|NCT01496365|583718125|FG002|Overall Study|Lack of Efficacy|0|||
161635679|NCT01496365|583718126|FG003|Overall Study|Lack of Efficacy|0|||
161635680|NCT01496365|583718127|FG004|Overall Study|Lack of Efficacy|0|||
161635681|NCT01496365|583718128|FG005|Overall Study|Lack of Efficacy|1|||
161635682|NCT01496365|583718129|FG006|Overall Study|Lack of Efficacy|0|||
161635683|NCT01496365|583718123|FG000|Overall Study|Lost to Follow-up|0|||
161686717|NCT00102960|583904972|FG000|Overall Study|Death|23|||
161686718|NCT00102960|583904973|FG001|Overall Study|Death|11|||
161686719|NCT00102960|583904974|FG002|Overall Study|Death|11|||
161686720|NCT00102960|583904972|FG000|Overall Study|Lost to Follow-up|6|||
161686721|NCT00102960|583904973|FG001|Overall Study|Lost to Follow-up|12|||
161686722|NCT00102960|583904974|FG002|Overall Study|Lost to Follow-up|16|||
161635684|NCT01496365|583718124|FG001|Overall Study|Lost to Follow-up|1|||
161635685|NCT01496365|583718125|FG002|Overall Study|Lost to Follow-up|0|||
161635686|NCT01496365|583718126|FG003|Overall Study|Lost to Follow-up|0|||
161635687|NCT01496365|583718127|FG004|Overall Study|Lost to Follow-up|2|||
161635688|NCT01496365|583718128|FG005|Overall Study|Lost to Follow-up|0|||
161635689|NCT01496365|583718129|FG006|Overall Study|Lost to Follow-up|0|||
161635690|NCT01496365|583718123|FG000|Overall Study|Other|4|||
161635691|NCT01496365|583718124|FG001|Overall Study|Other|4|||
161635692|NCT01496365|583718125|FG002|Overall Study|Other|2|||
161635693|NCT01496365|583718126|FG003|Overall Study|Other|1|||
161635694|NCT01496365|583718127|FG004|Overall Study|Other|3|||
161635695|NCT01496365|583718128|FG005|Overall Study|Other|0|||
161834298|NCT02384941|584435628|FG002|Overall Study|Other than specified above|1|||
161834299|NCT02493777|584435629|FG000|Overall Study|Lost to Follow-up|0|||
161834300|NCT02493777|584435630|FG001|Overall Study|Lost to Follow-up|1|||
161635696|NCT01496365|583718129|FG006|Overall Study|Other|1|||
161635697|NCT01015677|583718130|FG000|Overall Study|Adverse Event|0|||
161635698|NCT01015677|583718131|FG001|Overall Study|Adverse Event|1|||
161635699|NCT01015677|583718132|FG002|Overall Study|Adverse Event|0|||
161635700|NCT01015677|583718130|FG000|Overall Study|Lack of Efficacy|0|||
161834301|NCT00468728|584435631|FG000|Treatment|criteria for mITT population|4|||
161834302|NCT00468728|584435632|FG001|Treatment|criteria for mITT population|11|||
161834303|NCT00468728|584435631|FG000|Follow-up|mITT failure|34|||
161834304|NCT00468728|584435632|FG001|Follow-up|mITT failure|31|||
161834305|NCT01705236|584435633|FG000|Overall Study|Lost to Follow-up|1|||
161834306|NCT01705236|584435633|FG000|Overall Study|Administrative problems|2|||
161834307|NCT01705236|584435633|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161834308|NCT01705236|584435633|FG000|Overall Study|Protocol Violation|3|||
161834309|NCT01705236|584435633|FG000|Overall Study|Abnormal test procedure result(s)|4|||
161834310|NCT01705236|584435633|FG000|Overall Study|Abnormal laboratory value(s)|4|||
161834311|NCT01705236|584435633|FG000|Overall Study|Withdrawal by Subject|5|||
161834312|NCT01705236|584435633|FG000|Overall Study|Adverse Event|5|||
161834313|NCT06005597|584435634|FG000|Overall Study|Lost to Follow-up|1|||
161834314|NCT06005597|584435635|FG001|Overall Study|Lost to Follow-up|2|||
161834315|NCT06005597|584435636|FG002|Overall Study|Lost to Follow-up|1|||
161834316|NCT06005597|584435637|FG003|Overall Study|Lost to Follow-up|2|||
161834317|NCT06005597|584435634|FG000|Overall Study|Death|1|||
161834318|NCT06005597|584435635|FG001|Overall Study|Death|1|||
161834319|NCT06005597|584435636|FG002|Overall Study|Death|1|||
161834320|NCT06005597|584435637|FG003|Overall Study|Death|0|||
161834321|NCT02224573|584435638|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
161834322|NCT02224573|584435639|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
161834323|NCT02224573|584435638|FG000|Treatment Phase|Started on Other IMP|1|||
161834324|NCT02224573|584435639|FG001|Treatment Phase|Started on Other IMP|0|||
161834325|NCT02224573|584435638|FG000|Treatment Phase|Participant Discontinued IMP|0|||
161834326|NCT02224573|584435639|FG001|Treatment Phase|Participant Discontinued IMP|1|||
161834327|NCT02224573|584435638|FG000|Treatment Phase|Lack of Efficacy|15|||
161834328|NCT02224573|584435639|FG001|Treatment Phase|Lack of Efficacy|8|||
161834329|NCT02224573|584435638|FG000|Treatment Phase|Began Commercial Product|1|||
161834330|NCT02224573|584435639|FG001|Treatment Phase|Began Commercial Product|0|||
161834331|NCT02224573|584435638|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
161834332|NCT02224573|584435639|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
161834333|NCT02224573|584435638|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
161834334|NCT02224573|584435639|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
161834335|NCT02224573|584435638|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
161834336|NCT02224573|584435639|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
161834337|NCT02224573|584435638|FG000|Treatment Phase|Continued Compassionate Use|1|||
161834338|NCT02224573|584435639|FG001|Treatment Phase|Continued Compassionate Use|0|||
161834339|NCT02224573|584435638|FG000|Treatment Phase|Lack of Efficiency|2|||
161834340|NCT02224573|584435639|FG001|Treatment Phase|Lack of Efficiency|1|||
161834341|NCT02224573|584435638|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
161834342|NCT02224573|584435639|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
161834343|NCT02224573|584435638|FG000|Treatment Phase|Participant Moved|2|||
161834344|NCT02224573|584435639|FG001|Treatment Phase|Participant Moved|0|||
161834345|NCT02224573|584435638|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
161834346|NCT02224573|584435639|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
161834347|NCT02224573|584435638|FG000|Treatment Phase|Refused Medication|1|||
161834348|NCT02224573|584435639|FG001|Treatment Phase|Refused Medication|1|||
161834349|NCT02224573|584435638|FG000|Treatment Phase|Adverse Event|26|||
161834350|NCT02224573|584435639|FG001|Treatment Phase|Adverse Event|38|||
161834351|NCT02224573|584435638|FG000|Treatment Phase|Placed in Group Home|0|||
161834352|NCT02224573|584435639|FG001|Treatment Phase|Placed in Group Home|1|||
161834353|NCT02224573|584435638|FG000|Treatment Phase|Pursued Other Trials|1|||
161834354|NCT02224573|584435639|FG001|Treatment Phase|Pursued Other Trials|0|||
161635701|NCT01015677|583718131|FG001|Overall Study|Lack of Efficacy|1|||
161834355|NCT02224573|584435638|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
161834356|NCT02224573|584435639|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
161834357|NCT02224573|584435638|FG000|Treatment Phase|Lost to Follow-up|2|||
161834358|NCT02224573|584435639|FG001|Treatment Phase|Lost to Follow-up|1|||
161834359|NCT02224573|584435638|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
161834360|NCT02224573|584435639|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
161834361|NCT02224573|584435638|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
161834362|NCT02224573|584435639|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
161635702|NCT01015677|583718132|FG002|Overall Study|Lack of Efficacy|0|||
161635703|NCT01015677|583718130|FG000|Overall Study|Protocol Violation|0|||
161635704|NCT01015677|583718131|FG001|Overall Study|Protocol Violation|1|||
161635705|NCT01015677|583718132|FG002|Overall Study|Protocol Violation|0|||
161635706|NCT01015677|583718130|FG000|Overall Study|Withdrawal by Subject|1|||
161635707|NCT01015677|583718131|FG001|Overall Study|Withdrawal by Subject|1|||
161635708|NCT01015677|583718132|FG002|Overall Study|Withdrawal by Subject|0|||
161635709|NCT01660256|583718133|FG000|Overall Study|Adverse Event|4|||
161635710|NCT01660256|583718134|FG001|Overall Study|Adverse Event|0|||
161635711|NCT01660256|583718135|FG002|Overall Study|Adverse Event|2|||
161686723|NCT00102960|583904972|FG000|Overall Study|Withdrawal by Subject|1|||
161686724|NCT00102960|583904973|FG001|Overall Study|Withdrawal by Subject|0|||
161686725|NCT00102960|583904974|FG002|Overall Study|Withdrawal by Subject|1|||
161686726|NCT03040999|583907062|FG000|Overall Study|Lost to Follow-up|2|||
161686727|NCT03040999|583907063|FG001|Overall Study|Lost to Follow-up|2|||
161686728|NCT03040999|583907062|FG000|Overall Study|Withdrawal by Subject|12|||
161686729|NCT03040999|583907063|FG001|Overall Study|Withdrawal by Subject|13|||
161635712|NCT01660256|583718133|FG000|Overall Study|Withdrawal by Subject|1|||
161635713|NCT01660256|583718134|FG001|Overall Study|Withdrawal by Subject|0|||
161635714|NCT01660256|583718135|FG002|Overall Study|Withdrawal by Subject|2|||
161635715|NCT03603639|583718138|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161686730|NCT03040999|583907062|FG000|Overall Study|Death|155|||
161686731|NCT03040999|583907063|FG001|Overall Study|Death|171|||
161686732|NCT03040999|583907062|FG000|Overall Study|Physician Decision|0|||
161686733|NCT03040999|583907063|FG001|Overall Study|Physician Decision|3|||
161686734|NCT01395394|583907064|FG000|Baseline Study Visit|Protocol Violation|1|||
161686735|NCT01395394|583907065|FG001|Baseline Study Visit|Protocol Violation|0|||
161686736|NCT01395394|583907066|FG002|Baseline Study Visit|Protocol Violation|0|||
161686737|NCT05121480|583907067|FG000|Overall Study|Lack of Efficacy|2|||
161686738|NCT05121480|583907068|FG001|Overall Study|Lack of Efficacy|2|||
161686739|NCT05121480|583907069|FG002|Overall Study|Lack of Efficacy|1|||
161686740|NCT05121480|583907070|FG003|Overall Study|Lack of Efficacy|4|||
161686741|NCT05121480|583907071|FG004|Overall Study|Lack of Efficacy|0|||
161686742|NCT05121480|583907072|FG005|Overall Study|Lack of Efficacy|1|||
161686743|NCT05121480|583907073|FG006|Overall Study|Lack of Efficacy|0|||
161686744|NCT05121480|583907074|FG007|Overall Study|Lack of Efficacy|2|||
161686745|NCT05121480|583907067|FG000|Overall Study|Treatment Failure|0|||
161686746|NCT05121480|583907068|FG001|Overall Study|Treatment Failure|2|||
161686747|NCT05121480|583907069|FG002|Overall Study|Treatment Failure|0|||
161686748|NCT05121480|583907070|FG003|Overall Study|Treatment Failure|1|||
161686749|NCT05121480|583907071|FG004|Overall Study|Treatment Failure|0|||
161686750|NCT05121480|583907072|FG005|Overall Study|Treatment Failure|0|||
161686751|NCT05121480|583907073|FG006|Overall Study|Treatment Failure|0|||
161686752|NCT05121480|583907074|FG007|Overall Study|Treatment Failure|0|||
161686753|NCT05121480|583907067|FG000|Overall Study|Adverse Event|0|||
161686754|NCT05121480|583907068|FG001|Overall Study|Adverse Event|1|||
161686755|NCT05121480|583907069|FG002|Overall Study|Adverse Event|0|||
161686756|NCT05121480|583907070|FG003|Overall Study|Adverse Event|5|||
161686757|NCT05121480|583907071|FG004|Overall Study|Adverse Event|3|||
161686758|NCT05121480|583907072|FG005|Overall Study|Adverse Event|2|||
161686759|NCT05121480|583907073|FG006|Overall Study|Adverse Event|0|||
161635716|NCT03603639|583718139|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161686760|NCT05121480|583907074|FG007|Overall Study|Adverse Event|4|||
161686761|NCT05121480|583907067|FG000|Overall Study|Withdrawal by Subject|4|||
161686762|NCT05121480|583907068|FG001|Overall Study|Withdrawal by Subject|9|||
161686763|NCT05121480|583907069|FG002|Overall Study|Withdrawal by Subject|1|||
161635717|NCT03603639|583718140|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161635718|NCT03603639|583718141|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
161635719|NCT03603639|583718142|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161635720|NCT03603639|583718143|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161635721|NCT03603639|583718138|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
161635722|NCT03603639|583718139|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
161635723|NCT03603639|583718140|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
161635724|NCT03603639|583718141|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
161635725|NCT03603639|583718142|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
161635726|NCT03603639|583718143|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
161635727|NCT02165397|583718149|FG000|Overall Study|Death|7|||
161635728|NCT02165397|583718150|FG001|Overall Study|Death|10|||
161635729|NCT02165397|583718151|FG002|Overall Study|Death|8|||
161635730|NCT02165397|583718149|FG000|Overall Study|Lost to Follow-up|1|||
161635731|NCT02165397|583718150|FG001|Overall Study|Lost to Follow-up|3|||
161635732|NCT02165397|583718151|FG002|Overall Study|Lost to Follow-up|0|||
161635733|NCT02165397|583718149|FG000|Overall Study|Withdrawal by Subject|6|||
161635734|NCT02165397|583718150|FG001|Overall Study|Withdrawal by Subject|6|||
161635735|NCT02165397|583718151|FG002|Overall Study|Withdrawal by Subject|1|||
161635736|NCT02165397|583718149|FG000|Overall Study|Other, Not Specified|0|||
161635737|NCT02165397|583718150|FG001|Overall Study|Other, Not Specified|0|||
161635738|NCT02165397|583718151|FG002|Overall Study|Other, Not Specified|1|||
161635739|NCT03898960|583718152|FG000|Overall Study|Death|10|||
161635740|NCT03463577|583718155|FG000|Overall Study|Lost to Follow-up|238|||
161635741|NCT03463577|583718156|FG001|Overall Study|Lost to Follow-up|435|||
161635742|NCT03463577|583718157|FG002|Overall Study|Lost to Follow-up|0|||
161635743|NCT03463577|583718158|FG003|Overall Study|Lost to Follow-up|0|||
161635744|NCT03463577|583718159|FG004|Overall Study|Lost to Follow-up|0|||
161635745|NCT03463577|583718160|FG005|Overall Study|Lost to Follow-up|0|||
161635746|NCT03463577|583718155|FG000|Overall Study|With unknown pregnancy outcome|0|||
161635747|NCT03463577|583718156|FG001|Overall Study|With unknown pregnancy outcome|5|||
161635748|NCT03463577|583718157|FG002|Overall Study|With unknown pregnancy outcome|0|||
161635749|NCT03463577|583718158|FG003|Overall Study|With unknown pregnancy outcome|0|||
161635750|NCT03463577|583718159|FG004|Overall Study|With unknown pregnancy outcome|0|||
161635751|NCT03463577|583718160|FG005|Overall Study|With unknown pregnancy outcome|0|||
161635752|NCT03463577|583718155|FG000|Overall Study|Maternal death|2|||
161635753|NCT03463577|583718156|FG001|Overall Study|Maternal death|0|||
161635754|NCT03463577|583718157|FG002|Overall Study|Maternal death|0|||
161635755|NCT03463577|583718158|FG003|Overall Study|Maternal death|0|||
161635756|NCT03463577|583718159|FG004|Overall Study|Maternal death|0|||
161635757|NCT03463577|583718160|FG005|Overall Study|Maternal death|0|||
161635758|NCT03463577|583718155|FG000|Overall Study|Neonatal death|0|||
161635759|NCT03463577|583718156|FG001|Overall Study|Neonatal death|0|||
161635760|NCT03463577|583718157|FG002|Overall Study|Neonatal death|0|||
161635761|NCT03463577|583718158|FG003|Overall Study|Neonatal death|15|||
161635762|NCT03463577|583718159|FG004|Overall Study|Neonatal death|17|||
161635763|NCT03463577|583718160|FG005|Overall Study|Neonatal death|0|||
161635764|NCT00236184|583718161|FG000|Overall Study|Adverse Event|5|||
161635765|NCT00236184|583718162|FG001|Overall Study|Adverse Event|2|||
161635766|NCT00236184|583718161|FG000|Overall Study|Lack of Efficacy|0|||
161635767|NCT00236184|583718162|FG001|Overall Study|Lack of Efficacy|1|||
161635768|NCT00236184|583718161|FG000|Overall Study|Lost to Follow-up|3|||
161635769|NCT00236184|583718162|FG001|Overall Study|Lost to Follow-up|4|||
161635770|NCT00236184|583718161|FG000|Overall Study|Physician Decision|1|||
161635771|NCT00236184|583718162|FG001|Overall Study|Physician Decision|1|||
161635772|NCT00236184|583718161|FG000|Overall Study|Withdrawal by Subject|3|||
161635773|NCT00236184|583718162|FG001|Overall Study|Withdrawal by Subject|0|||
161635774|NCT00236184|583718161|FG000|Overall Study|Protocol Violation|3|||
161686764|NCT05121480|583907070|FG003|Overall Study|Withdrawal by Subject|8|||
161635775|NCT00236184|583718162|FG001|Overall Study|Protocol Violation|0|||
161686765|NCT05121480|583907071|FG004|Overall Study|Withdrawal by Subject|0|||
161686766|NCT05121480|583907072|FG005|Overall Study|Withdrawal by Subject|9|||
161686767|NCT05121480|583907073|FG006|Overall Study|Withdrawal by Subject|0|||
161635776|NCT00236184|583718161|FG000|Overall Study|non-compliance with study drug|2|||
161635777|NCT00236184|583718162|FG001|Overall Study|non-compliance with study drug|1|||
161635778|NCT00236184|583718161|FG000|Overall Study|other|1|||
161635779|NCT00236184|583718162|FG001|Overall Study|other|2|||
161635780|NCT01841697|583718163|FG000|Overall Study|Death|0|||
161635781|NCT01841697|583718164|FG001|Overall Study|Death|1|||
161635782|NCT01841697|583718163|FG000|Overall Study|Lost to Follow-up|4|||
161635783|NCT01841697|583718164|FG001|Overall Study|Lost to Follow-up|1|||
161635784|NCT01841697|583718163|FG000|Overall Study|Withdrawal by Subject|16|||
161635785|NCT01841697|583718164|FG001|Overall Study|Withdrawal by Subject|16|||
161635786|NCT01777490|583718165|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
161635787|NCT01777490|583718166|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
161635788|NCT01777490|583718167|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
161635789|NCT01777490|583718168|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
161635790|NCT00255944|583718172|FG000|Overall Study|Lost to Follow-up|797|||
161635791|NCT00255944|583718173|FG001|Overall Study|Lost to Follow-up|834|||
161635792|NCT00935259|583718181|FG000|Period 1|Administrative (scheduling conflict)|1|||
161635793|NCT00935259|583718182|FG001|Period 1|Administrative (scheduling conflict)|1|||
161635794|NCT01721746|583718183|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
161635795|NCT01721746|583718184|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
161834363|NCT02224573|584435638|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
161834364|NCT02224573|584435639|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
161834365|NCT02224573|584435638|FG000|Taper Phase|Adverse Event|1|||
161834366|NCT02224573|584435639|FG001|Taper Phase|Adverse Event|1|||
161834367|NCT02546362|584435640|FG000|4-week Treatment Period|Lost to Follow-up|1|||
161834368|NCT02546362|584435640|FG000|4-week Treatment Period|Change in medication|2|||
161834369|NCT02546362|584435640|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
161834370|NCT02546362|584435640|FG000|12-week Treatment Period|Lost to Follow-up|2|||
161834371|NCT02546362|584435640|FG000|12-week Treatment Period|Change in medication|1|||
161834372|NCT02025010|584435641|FG000|Overall Study|Symptomatic or radiographic progression|36|||
161834373|NCT02025010|584435641|FG000|Overall Study|Adverse Event|6|||
161834374|NCT02025010|584435641|FG000|Overall Study|Physician Decision|7|||
161834375|NCT02025010|584435641|FG000|Overall Study|Withdrawal by Subject|3|||
161834376|NCT02025010|584435641|FG000|Overall Study|Intercurrent illness|3|||
161834377|NCT02025010|584435641|FG000|Overall Study|Patients still on treatment|3|||
161834378|NCT02025010|584435641|FG000|Overall Study|Never initiate the treatment|2|||
161834379|NCT01134627|584435646|FG000|Overall Study|Adverse Event|47|||
161834380|NCT01134627|584435647|FG001|Overall Study|Adverse Event|31|||
161834381|NCT01134627|584435646|FG000|Overall Study|Lost to Follow-up|1|||
161834382|NCT01134627|584435647|FG001|Overall Study|Lost to Follow-up|2|||
161834383|NCT01134627|584435646|FG000|Overall Study|Protocol Violation|3|||
161834384|NCT01134627|584435647|FG001|Overall Study|Protocol Violation|5|||
161834385|NCT01134627|584435646|FG000|Overall Study|Lack of Efficacy|2|||
161834386|NCT01134627|584435647|FG001|Overall Study|Lack of Efficacy|12|||
161834387|NCT01134627|584435646|FG000|Overall Study|Withdrawal by Subject|4|||
161834388|NCT01134627|584435647|FG001|Overall Study|Withdrawal by Subject|3|||
161834389|NCT01134627|584435646|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
161834390|NCT01134627|584435647|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
161834391|NCT01134627|584435646|FG000|Overall Study|Other|11|||
161834392|NCT01134627|584435647|FG001|Overall Study|Other|14|||
161834393|NCT01010750|584435648|FG000|Second Intervention|Adverse Event|0|||
161834394|NCT01010750|584435649|FG001|Second Intervention|Adverse Event|1|||
161834395|NCT01010750|584435650|FG002|Second Intervention|Adverse Event|0|||
161834396|NCT01010750|584435651|FG003|Second Intervention|Adverse Event|0|||
161834397|NCT01010750|584435652|FG004|Second Intervention|Adverse Event|0|||
161834398|NCT01010750|584435653|FG005|Second Intervention|Adverse Event|0|||
161834399|NCT01056640|584435654|FG000|Overall Study|Withdrawal by Subject|11|||
161834400|NCT01056640|584435655|FG001|Overall Study|Withdrawal by Subject|8|||
161834401|NCT01056640|584435654|FG000|Overall Study|Death|15|||
161834402|NCT01056640|584435655|FG001|Overall Study|Death|4|||
161834403|NCT01803269|584435656|FG000|Overall Study|Withdrawal by Subject|3|||
161834404|NCT01803269|584435657|FG001|Overall Study|Withdrawal by Subject|0|||
161834405|NCT01803269|584435658|FG002|Overall Study|Withdrawal by Subject|0|||
161834406|NCT00466726|584435661|FG000|Overall Study|Not evaluable for response|14|||
161834407|NCT02696031|584435662|FG000|Up to Week 24|Adverse Event|2|||
161834408|NCT02696031|584435663|FG001|Up to Week 24|Adverse Event|4|||
161635796|NCT01721746|583718183|FG000|Pre-Treatment|Withdrawal by Subject|1|||
161635797|NCT01721746|583718184|FG001|Pre-Treatment|Withdrawal by Subject|16|||
161635798|NCT01721746|583718183|FG000|Pre-Treatment|Poor/Non-compliance|1|||
161635799|NCT01721746|583718184|FG001|Pre-Treatment|Poor/Non-compliance|0|||
161635800|NCT01721746|583718183|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
161635801|NCT01721746|583718184|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
161635802|NCT01721746|583718183|FG000|Treatment|Disease Progression|192|||
161635803|NCT01721746|583718184|FG001|Treatment|Disease Progression|74|||
161635804|NCT01721746|583718183|FG000|Treatment|Study Drug Toxicity|19|||
161635805|NCT01721746|583718184|FG001|Treatment|Study Drug Toxicity|11|||
161635806|NCT01721746|583718183|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
161635807|NCT01721746|583718184|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
161635808|NCT01721746|583718183|FG000|Treatment|Participant request to discontinue Study treatment|26|||
161834409|NCT02696031|584435664|FG002|Up to Week 24|Adverse Event|2|||
161834410|NCT02696031|584435665|FG003|Up to Week 24|Adverse Event|0|||
161834411|NCT02696031|584435666|FG004|Up to Week 24|Adverse Event|0|||
161834412|NCT02696031|584435667|FG005|Up to Week 24|Adverse Event|0|||
161635809|NCT01721746|583718184|FG001|Treatment|Participant request to discontinue Study treatment|7|||
161635810|NCT01721746|583718183|FG000|Treatment|Participant withdrew consent|4|||
161834413|NCT02696031|584435662|FG000|Up to Week 24|Lack of Efficacy|2|||
161834414|NCT02696031|584435663|FG001|Up to Week 24|Lack of Efficacy|1|||
161635811|NCT01721746|583718184|FG001|Treatment|Participant withdrew consent|2|||
161635812|NCT01721746|583718183|FG000|Treatment|Maximum Clinical Benefit|9|||
161635813|NCT01721746|583718184|FG001|Treatment|Maximum Clinical Benefit|3|||
161635814|NCT01721746|583718183|FG000|Treatment|Poor/Non-compliance|2|||
161635815|NCT01721746|583718184|FG001|Treatment|Poor/Non-compliance|0|||
161635816|NCT01721746|583718183|FG000|Treatment|Participant no longer met Study criteria|4|||
161635817|NCT01721746|583718184|FG001|Treatment|Participant no longer met Study criteria|0|||
161635818|NCT01721746|583718183|FG000|Treatment|Other reasons|6|||
161635819|NCT01721746|583718184|FG001|Treatment|Other reasons|2|||
161635820|NCT00361842|583718188|FG000|Overall Study|Withdrawal by Subject|2|||
161635821|NCT00361842|583718189|FG001|Overall Study|Withdrawal by Subject|3|||
161635822|NCT00361842|583718188|FG000|Overall Study|Death|2|||
161635823|NCT00361842|583718189|FG001|Overall Study|Death|1|||
161635824|NCT00361842|583718188|FG000|Overall Study|Disease progression|19|||
161635825|NCT00361842|583718189|FG001|Overall Study|Disease progression|20|||
161635826|NCT00361842|583718188|FG000|Overall Study|Adverse Event|2|||
161635827|NCT00361842|583718189|FG001|Overall Study|Adverse Event|3|||
161635828|NCT00361842|583718188|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
161635829|NCT00361842|583718189|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
161635830|NCT00361842|583718188|FG000|Overall Study|Other|1|||
161635831|NCT00361842|583718189|FG001|Overall Study|Other|0|||
161635832|NCT00361842|583718188|FG000|Overall Study|Other|0|||
161635833|NCT00361842|583718189|FG001|Overall Study|Other|2|||
161635834|NCT03821064|583718190|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
161635835|NCT00474383|583718191|FG000|Main Study|Adverse Event|11|||
161635836|NCT00474383|583718192|FG001|Main Study|Adverse Event|0|||
161635837|NCT00474383|583718191|FG000|Main Study|Symptomatic Deterioration|1|||
161635838|NCT00474383|583718192|FG001|Main Study|Symptomatic Deterioration|0|||
161635839|NCT00474383|583718191|FG000|Main Study|Progressive Disease|23|||
161686768|NCT05121480|583907074|FG007|Overall Study|Withdrawal by Subject|4|||
161686769|NCT05121480|583907067|FG000|Overall Study|Non-compliance with the protocol|0|||
161686770|NCT05121480|583907068|FG001|Overall Study|Non-compliance with the protocol|0|||
161686771|NCT05121480|583907069|FG002|Overall Study|Non-compliance with the protocol|0|||
161686772|NCT05121480|583907070|FG003|Overall Study|Non-compliance with the protocol|0|||
161686773|NCT05121480|583907071|FG004|Overall Study|Non-compliance with the protocol|1|||
161686774|NCT05121480|583907072|FG005|Overall Study|Non-compliance with the protocol|6|||
161686775|NCT05121480|583907073|FG006|Overall Study|Non-compliance with the protocol|0|||
161686776|NCT05121480|583907074|FG007|Overall Study|Non-compliance with the protocol|1|||
161686777|NCT05121480|583907067|FG000|Overall Study|Lost to Follow-up|0|||
161686778|NCT05121480|583907068|FG001|Overall Study|Lost to Follow-up|4|||
161686779|NCT05121480|583907069|FG002|Overall Study|Lost to Follow-up|1|||
161686780|NCT05121480|583907070|FG003|Overall Study|Lost to Follow-up|3|||
161686781|NCT05121480|583907071|FG004|Overall Study|Lost to Follow-up|1|||
161686782|NCT05121480|583907072|FG005|Overall Study|Lost to Follow-up|1|||
161686783|NCT05121480|583907073|FG006|Overall Study|Lost to Follow-up|1|||
161686784|NCT05121480|583907074|FG007|Overall Study|Lost to Follow-up|4|||
161686785|NCT05121480|583907067|FG000|Overall Study|Physician Decision|0|||
161686786|NCT05121480|583907068|FG001|Overall Study|Physician Decision|0|||
161686787|NCT05121480|583907069|FG002|Overall Study|Physician Decision|0|||
161686788|NCT05121480|583907070|FG003|Overall Study|Physician Decision|0|||
161686789|NCT05121480|583907071|FG004|Overall Study|Physician Decision|0|||
161686790|NCT05121480|583907072|FG005|Overall Study|Physician Decision|1|||
161686791|NCT05121480|583907073|FG006|Overall Study|Physician Decision|0|||
161686792|NCT05121480|583907074|FG007|Overall Study|Physician Decision|1|||
161686793|NCT05121480|583907067|FG000|Overall Study|Other Reason|0|||
161686794|NCT05121480|583907068|FG001|Overall Study|Other Reason|0|||
161686795|NCT05121480|583907069|FG002|Overall Study|Other Reason|0|||
161686796|NCT05121480|583907070|FG003|Overall Study|Other Reason|0|||
161834415|NCT02696031|584435664|FG002|Up to Week 24|Lack of Efficacy|2|||
161834416|NCT02696031|584435665|FG003|Up to Week 24|Lack of Efficacy|0|||
161686797|NCT05121480|583907071|FG004|Overall Study|Other Reason|0|||
161686798|NCT05121480|583907072|FG005|Overall Study|Other Reason|1|||
161834417|NCT02696031|584435666|FG004|Up to Week 24|Lack of Efficacy|0|||
161834418|NCT02696031|584435667|FG005|Up to Week 24|Lack of Efficacy|0|||
161635840|NCT00474383|583718192|FG001|Main Study|Progressive Disease|0|||
161635841|NCT00474383|583718191|FG000|Main Study|Other|1|||
161635842|NCT00474383|583718192|FG001|Main Study|Other|0|||
161635843|NCT00474383|583718191|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
161635844|NCT00474383|583718192|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
161635845|NCT00474383|583718191|FG000|Extension|Progressive Disease|0|||
161635846|NCT00474383|583718192|FG001|Extension|Progressive Disease|5|||
161635847|NCT01482819|583718196|FG000|Overall Study|Lost to Follow-up|2|||
161635848|NCT01502371|583718199|FG000|Overall Study|Withdrawal by Subject|1|||
161635849|NCT01502371|583718200|FG001|Overall Study|Withdrawal by Subject|2|||
161686799|NCT05121480|583907073|FG006|Overall Study|Other Reason|1|||
161686800|NCT05121480|583907074|FG007|Overall Study|Other Reason|1|||
161834419|NCT02696031|584435662|FG000|Up to Week 24|Lost to Follow-up|0|||
161834420|NCT02696031|584435663|FG001|Up to Week 24|Lost to Follow-up|1|||
161834421|NCT02696031|584435664|FG002|Up to Week 24|Lost to Follow-up|1|||
161834422|NCT02696031|584435665|FG003|Up to Week 24|Lost to Follow-up|0|||
161834423|NCT02696031|584435666|FG004|Up to Week 24|Lost to Follow-up|0|||
161834424|NCT02696031|584435667|FG005|Up to Week 24|Lost to Follow-up|0|||
161834425|NCT02696031|584435662|FG000|Up to Week 24|Physician Decision|1|||
161834426|NCT02696031|584435663|FG001|Up to Week 24|Physician Decision|0|||
161834427|NCT02696031|584435664|FG002|Up to Week 24|Physician Decision|1|||
161834428|NCT02696031|584435665|FG003|Up to Week 24|Physician Decision|0|||
161834429|NCT02696031|584435666|FG004|Up to Week 24|Physician Decision|0|||
161834430|NCT02696031|584435667|FG005|Up to Week 24|Physician Decision|0|||
161834431|NCT02696031|584435662|FG000|Up to Week 24|Protocol Violation|1|||
161834432|NCT02696031|584435663|FG001|Up to Week 24|Protocol Violation|0|||
161834433|NCT02696031|584435664|FG002|Up to Week 24|Protocol Violation|0|||
161834434|NCT02696031|584435665|FG003|Up to Week 24|Protocol Violation|0|||
161834435|NCT02696031|584435666|FG004|Up to Week 24|Protocol Violation|0|||
161834436|NCT02696031|584435667|FG005|Up to Week 24|Protocol Violation|0|||
161834437|NCT02696031|584435662|FG000|Up to Week 24|Withdrawal by Subject|4|||
161834438|NCT02696031|584435663|FG001|Up to Week 24|Withdrawal by Subject|1|||
161834439|NCT02696031|584435664|FG002|Up to Week 24|Withdrawal by Subject|5|||
161834440|NCT02696031|584435665|FG003|Up to Week 24|Withdrawal by Subject|0|||
161834441|NCT02696031|584435666|FG004|Up to Week 24|Withdrawal by Subject|0|||
161834442|NCT02696031|584435667|FG005|Up to Week 24|Withdrawal by Subject|0|||
161834443|NCT02696031|584435662|FG000|Up to Week 52|Adverse Event|4|||
161834444|NCT02696031|584435663|FG001|Up to Week 52|Adverse Event|5|||
161834445|NCT02696031|584435664|FG002|Up to Week 52|Adverse Event|3|||
161834446|NCT02696031|584435665|FG003|Up to Week 52|Adverse Event|0|||
161834447|NCT02696031|584435666|FG004|Up to Week 52|Adverse Event|0|||
161834448|NCT02696031|584435667|FG005|Up to Week 52|Adverse Event|0|||
161834449|NCT02696031|584435662|FG000|Up to Week 52|Lack of Efficacy|10|||
161834450|NCT02696031|584435663|FG001|Up to Week 52|Lack of Efficacy|7|||
161834451|NCT02696031|584435664|FG002|Up to Week 52|Lack of Efficacy|11|||
161834452|NCT02696031|584435665|FG003|Up to Week 52|Lack of Efficacy|0|||
161834453|NCT02696031|584435666|FG004|Up to Week 52|Lack of Efficacy|0|||
161834454|NCT02696031|584435667|FG005|Up to Week 52|Lack of Efficacy|0|||
161834455|NCT02696031|584435662|FG000|Up to Week 52|Lost to Follow-up|1|||
161834456|NCT02696031|584435663|FG001|Up to Week 52|Lost to Follow-up|1|||
161834457|NCT02696031|584435664|FG002|Up to Week 52|Lost to Follow-up|1|||
161834458|NCT02696031|584435665|FG003|Up to Week 52|Lost to Follow-up|0|||
161834459|NCT02696031|584435666|FG004|Up to Week 52|Lost to Follow-up|0|||
161834460|NCT02696031|584435667|FG005|Up to Week 52|Lost to Follow-up|0|||
161834461|NCT02696031|584435662|FG000|Up to Week 52|Physician Decision|1|||
161834462|NCT02696031|584435663|FG001|Up to Week 52|Physician Decision|1|||
161834463|NCT02696031|584435664|FG002|Up to Week 52|Physician Decision|2|||
161834464|NCT02696031|584435665|FG003|Up to Week 52|Physician Decision|0|||
161834465|NCT02696031|584435666|FG004|Up to Week 52|Physician Decision|0|||
161834466|NCT02696031|584435667|FG005|Up to Week 52|Physician Decision|0|||
161834467|NCT02696031|584435662|FG000|Up to Week 52|Pregnancy|0|||
161834468|NCT02696031|584435663|FG001|Up to Week 52|Pregnancy|2|||
161834469|NCT02696031|584435664|FG002|Up to Week 52|Pregnancy|0|||
161834470|NCT02696031|584435665|FG003|Up to Week 52|Pregnancy|0|||
161834471|NCT02696031|584435666|FG004|Up to Week 52|Pregnancy|0|||
161834472|NCT02696031|584435667|FG005|Up to Week 52|Pregnancy|0|||
161834473|NCT02696031|584435662|FG000|Up to Week 52|Protocol Violation|1|||
161834474|NCT02696031|584435663|FG001|Up to Week 52|Protocol Violation|0|||
161834475|NCT02696031|584435664|FG002|Up to Week 52|Protocol Violation|0|||
161834476|NCT02696031|584435665|FG003|Up to Week 52|Protocol Violation|0|||
161834477|NCT02696031|584435666|FG004|Up to Week 52|Protocol Violation|0|||
161834478|NCT02696031|584435667|FG005|Up to Week 52|Protocol Violation|0|||
161834479|NCT02696031|584435662|FG000|Up to Week 52|Withdrawal by Subject|12|||
161834480|NCT02696031|584435663|FG001|Up to Week 52|Withdrawal by Subject|3|||
161834481|NCT02696031|584435664|FG002|Up to Week 52|Withdrawal by Subject|9|||
161834482|NCT02696031|584435665|FG003|Up to Week 52|Withdrawal by Subject|0|||
161834483|NCT02696031|584435666|FG004|Up to Week 52|Withdrawal by Subject|0|||
161834484|NCT02696031|584435667|FG005|Up to Week 52|Withdrawal by Subject|0|||
161834485|NCT02696031|584435662|FG000|Up to Week 104|Pregnancy|0|||
161834486|NCT02696031|584435663|FG001|Up to Week 104|Pregnancy|2|||
161834487|NCT02696031|584435664|FG002|Up to Week 104|Pregnancy|1|||
161834488|NCT02696031|584435665|FG003|Up to Week 104|Pregnancy|0|||
161834489|NCT02696031|584435666|FG004|Up to Week 104|Pregnancy|0|||
161834490|NCT02696031|584435667|FG005|Up to Week 104|Pregnancy|0|||
161834491|NCT02696031|584435662|FG000|Up to Week 104|Withdrawal by Subject|15|||
161834492|NCT02696031|584435663|FG001|Up to Week 104|Withdrawal by Subject|10|||
161834493|NCT02696031|584435664|FG002|Up to Week 104|Withdrawal by Subject|16|||
161834494|NCT02696031|584435665|FG003|Up to Week 104|Withdrawal by Subject|0|||
161834495|NCT02696031|584435666|FG004|Up to Week 104|Withdrawal by Subject|0|||
161834496|NCT02696031|584435667|FG005|Up to Week 104|Withdrawal by Subject|0|||
161834497|NCT02696031|584435662|FG000|Up to Week 104|Protocol Violation|1|||
161834498|NCT02696031|584435663|FG001|Up to Week 104|Protocol Violation|0|||
161834499|NCT02696031|584435664|FG002|Up to Week 104|Protocol Violation|0|||
161834500|NCT02696031|584435665|FG003|Up to Week 104|Protocol Violation|0|||
161834501|NCT02696031|584435666|FG004|Up to Week 104|Protocol Violation|0|||
161834502|NCT02696031|584435667|FG005|Up to Week 104|Protocol Violation|0|||
161834503|NCT02696031|584435662|FG000|Up to Week 104|Physician Decision|1|||
161834504|NCT02696031|584435663|FG001|Up to Week 104|Physician Decision|2|||
161834505|NCT02696031|584435664|FG002|Up to Week 104|Physician Decision|3|||
161834506|NCT02696031|584435665|FG003|Up to Week 104|Physician Decision|0|||
161834507|NCT02696031|584435666|FG004|Up to Week 104|Physician Decision|0|||
161834508|NCT02696031|584435667|FG005|Up to Week 104|Physician Decision|0|||
161834509|NCT02696031|584435662|FG000|Up to Week 104|Lost to Follow-up|2|||
161834510|NCT02696031|584435663|FG001|Up to Week 104|Lost to Follow-up|3|||
161834511|NCT02696031|584435664|FG002|Up to Week 104|Lost to Follow-up|1|||
161834512|NCT02696031|584435665|FG003|Up to Week 104|Lost to Follow-up|0|||
161834513|NCT02696031|584435666|FG004|Up to Week 104|Lost to Follow-up|0|||
161834514|NCT02696031|584435667|FG005|Up to Week 104|Lost to Follow-up|0|||
161834515|NCT02696031|584435662|FG000|Up to Week 104|Lack of Efficacy|13|||
161834516|NCT02696031|584435663|FG001|Up to Week 104|Lack of Efficacy|12|||
161834517|NCT02696031|584435664|FG002|Up to Week 104|Lack of Efficacy|11|||
161834518|NCT02696031|584435665|FG003|Up to Week 104|Lack of Efficacy|0|||
161834519|NCT02696031|584435666|FG004|Up to Week 104|Lack of Efficacy|0|||
161834520|NCT02696031|584435667|FG005|Up to Week 104|Lack of Efficacy|0|||
161834521|NCT02696031|584435662|FG000|Up to Week 104|Adverse Event|7|||
161834522|NCT02696031|584435663|FG001|Up to Week 104|Adverse Event|11|||
161834523|NCT02696031|584435664|FG002|Up to Week 104|Adverse Event|5|||
161834524|NCT02696031|584435665|FG003|Up to Week 104|Adverse Event|0|||
161834525|NCT02696031|584435666|FG004|Up to Week 104|Adverse Event|0|||
161834526|NCT02696031|584435667|FG005|Up to Week 104|Adverse Event|0|||
161834527|NCT02696031|584435662|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834528|NCT02696031|584435663|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
161834529|NCT02696031|584435664|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834530|NCT02696031|584435665|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834531|NCT02696031|584435666|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834532|NCT02696031|584435667|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834533|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161834534|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161834535|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161834536|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
161834537|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
161834538|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
161834539|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834540|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834541|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834542|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
161834543|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
161834544|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834545|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834546|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834547|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834548|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
161834549|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834550|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834551|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834552|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834553|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834554|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834555|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
161834556|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834557|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161834558|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161834559|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161834560|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
161635850|NCT01502371|583718201|FG002|Overall Study|Withdrawal by Subject|1|||
161635851|NCT01502371|583718202|FG003|Overall Study|Withdrawal by Subject|1|||
161635852|NCT01502371|583718203|FG004|Overall Study|Withdrawal by Subject|1|||
161635853|NCT01502371|583718199|FG000|Overall Study|Adverse Event|2|||
161635854|NCT01502371|583718200|FG001|Overall Study|Adverse Event|1|||
161635855|NCT01502371|583718201|FG002|Overall Study|Adverse Event|0|||
161635856|NCT01502371|583718202|FG003|Overall Study|Adverse Event|4|||
161635857|NCT01502371|583718203|FG004|Overall Study|Adverse Event|3|||
161635858|NCT01502371|583718199|FG000|Overall Study|Treatment Failure|22|||
161635859|NCT01502371|583718200|FG001|Overall Study|Treatment Failure|20|||
161635860|NCT01502371|583718201|FG002|Overall Study|Treatment Failure|12|||
161635861|NCT01502371|583718202|FG003|Overall Study|Treatment Failure|19|||
161635862|NCT01502371|583718203|FG004|Overall Study|Treatment Failure|30|||
161635863|NCT01502371|583718199|FG000|Overall Study|Lack of Efficacy|3|||
161635864|NCT01502371|583718200|FG001|Overall Study|Lack of Efficacy|3|||
161635865|NCT01502371|583718201|FG002|Overall Study|Lack of Efficacy|2|||
161635866|NCT01502371|583718202|FG003|Overall Study|Lack of Efficacy|2|||
161686801|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
161686802|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
161686803|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161686804|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161686805|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161686806|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
161686807|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
161686808|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161686809|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161686810|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161686811|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
161686812|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
161686813|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161686814|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161686815|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161686816|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
161686817|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
161686818|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161686819|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161686820|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161686821|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
161686822|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
161686823|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161686824|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161686825|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161686826|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
161686827|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
161686828|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161686829|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161686830|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161686831|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
161686832|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
161686833|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161686834|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161686835|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161686836|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
161686837|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
161686838|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161686839|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161686840|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161686841|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161686842|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161686843|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
161635867|NCT01502371|583718203|FG004|Overall Study|Lack of Efficacy|4|||
161635868|NCT01502371|583718199|FG000|Overall Study|Physician Decision|3|||
161686844|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
161686845|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161686846|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161686847|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161686848|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
161686849|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
161635869|NCT01502371|583718200|FG001|Overall Study|Physician Decision|0|||
161635870|NCT01502371|583718201|FG002|Overall Study|Physician Decision|0|||
161635871|NCT01502371|583718202|FG003|Overall Study|Physician Decision|0|||
161635872|NCT01502371|583718203|FG004|Overall Study|Physician Decision|1|||
161635873|NCT01502371|583718199|FG000|Overall Study|Noncompliance with Study Drug|0|||
161635874|NCT01502371|583718200|FG001|Overall Study|Noncompliance with Study Drug|0|||
161635875|NCT01502371|583718201|FG002|Overall Study|Noncompliance with Study Drug|1|||
161635876|NCT01502371|583718202|FG003|Overall Study|Noncompliance with Study Drug|2|||
161635877|NCT01502371|583718203|FG004|Overall Study|Noncompliance with Study Drug|1|||
161635878|NCT01502371|583718199|FG000|Overall Study|Technical Problems|1|||
161635879|NCT01502371|583718200|FG001|Overall Study|Technical Problems|0|||
161635880|NCT01502371|583718201|FG002|Overall Study|Technical Problems|2|||
161635881|NCT01502371|583718202|FG003|Overall Study|Technical Problems|4|||
161635882|NCT01502371|583718203|FG004|Overall Study|Technical Problems|1|||
161635883|NCT01502371|583718199|FG000|Overall Study|Protocol Violation|9|||
161686850|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161686851|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686852|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686853|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686854|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
161686855|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686856|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161686857|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161686858|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
161686859|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
161686860|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161686861|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161686862|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161686863|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
161686864|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
161686865|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161686866|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161635884|NCT01502371|583718200|FG001|Overall Study|Protocol Violation|5|||
161635885|NCT01502371|583718201|FG002|Overall Study|Protocol Violation|6|||
161635886|NCT01502371|583718202|FG003|Overall Study|Protocol Violation|5|||
161635887|NCT01502371|583718203|FG004|Overall Study|Protocol Violation|10|||
161635888|NCT01502371|583718199|FG000|Overall Study|Excluded Medication|0|||
161686867|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161686868|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
161686869|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
161686870|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161686871|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161686872|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161686873|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
161686874|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
161686875|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161686876|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161686877|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161686878|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161635889|NCT01502371|583718200|FG001|Overall Study|Excluded Medication|1|||
161635890|NCT01502371|583718201|FG002|Overall Study|Excluded Medication|1|||
161635891|NCT01502371|583718202|FG003|Overall Study|Excluded Medication|0|||
161635892|NCT01502371|583718203|FG004|Overall Study|Excluded Medication|1|||
161635893|NCT03325608|583718206|FG000|Overall Study|Lost to Follow-up|23|||
161635894|NCT03325608|583718207|FG001|Overall Study|Lost to Follow-up|23|||
161635895|NCT03325608|583718208|FG002|Overall Study|Lost to Follow-up|30|||
161635896|NCT03325608|583718209|FG003|Overall Study|Lost to Follow-up|30|||
161635897|NCT03325608|583718206|FG000|Overall Study|Death of Caregiver|0|||
161635898|NCT03325608|583718207|FG001|Overall Study|Death of Caregiver|0|||
161635899|NCT03325608|583718208|FG002|Overall Study|Death of Caregiver|2|||
161635900|NCT03325608|583718209|FG003|Overall Study|Death of Caregiver|2|||
161635901|NCT03325608|583718206|FG000|Overall Study|Death of Care Recipient|34|||
161635902|NCT03325608|583718207|FG001|Overall Study|Death of Care Recipient|34|||
161635903|NCT03325608|583718208|FG002|Overall Study|Death of Care Recipient|28|||
161635904|NCT03325608|583718209|FG003|Overall Study|Death of Care Recipient|28|||
161635905|NCT03325608|583718206|FG000|Overall Study|Withdrawal by Subject|49|||
161635906|NCT03325608|583718207|FG001|Overall Study|Withdrawal by Subject|49|||
161635907|NCT03325608|583718208|FG002|Overall Study|Withdrawal by Subject|35|||
161635908|NCT03325608|583718209|FG003|Overall Study|Withdrawal by Subject|35|||
161635909|NCT03325608|583718206|FG000|Overall Study|Ineligible|7|||
161635910|NCT03325608|583718207|FG001|Overall Study|Ineligible|7|||
161635911|NCT03325608|583718208|FG002|Overall Study|Ineligible|5|||
161635912|NCT03325608|583718209|FG003|Overall Study|Ineligible|5|||
161635913|NCT00942188|583718210|FG000|Overall Study|Adverse Event|0|||
161635914|NCT00942188|583718211|FG001|Overall Study|Adverse Event|3|||
161635915|NCT00942188|583718212|FG002|Overall Study|Adverse Event|2|||
161635916|NCT00942188|583718213|FG003|Overall Study|Adverse Event|0|||
161635917|NCT00942188|583718210|FG000|Overall Study|Lack of Efficacy|0|||
161635918|NCT00942188|583718211|FG001|Overall Study|Lack of Efficacy|0|||
161635919|NCT00942188|583718212|FG002|Overall Study|Lack of Efficacy|0|||
161635920|NCT00942188|583718213|FG003|Overall Study|Lack of Efficacy|1|||
161635921|NCT00942188|583718210|FG000|Overall Study|Protocol Violation|1|||
161635922|NCT00942188|583718211|FG001|Overall Study|Protocol Violation|1|||
161635923|NCT00942188|583718212|FG002|Overall Study|Protocol Violation|0|||
161635924|NCT00942188|583718213|FG003|Overall Study|Protocol Violation|0|||
161635925|NCT00942188|583718210|FG000|Overall Study|Lost to Follow-up|2|||
161635926|NCT00942188|583718211|FG001|Overall Study|Lost to Follow-up|1|||
161635927|NCT00942188|583718212|FG002|Overall Study|Lost to Follow-up|2|||
161635928|NCT00942188|583718213|FG003|Overall Study|Lost to Follow-up|0|||
161635929|NCT00942188|583718210|FG000|Overall Study|Withdrawal by Subject|1|||
161635930|NCT00942188|583718211|FG001|Overall Study|Withdrawal by Subject|3|||
161635931|NCT00942188|583718212|FG002|Overall Study|Withdrawal by Subject|4|||
161635932|NCT00942188|583718213|FG003|Overall Study|Withdrawal by Subject|2|||
161635933|NCT00942188|583718210|FG000|Overall Study|Physician Decision|0|||
161635934|NCT00942188|583718211|FG001|Overall Study|Physician Decision|0|||
161635935|NCT00942188|583718212|FG002|Overall Study|Physician Decision|1|||
161635936|NCT00942188|583718213|FG003|Overall Study|Physician Decision|0|||
161635937|NCT00942188|583718210|FG000|Overall Study|Sponsor Decision|0|||
161635938|NCT00942188|583718211|FG001|Overall Study|Sponsor Decision|2|||
161635939|NCT00942188|583718212|FG002|Overall Study|Sponsor Decision|0|||
161635940|NCT00942188|583718213|FG003|Overall Study|Sponsor Decision|1|||
161635941|NCT02188784|583718214|FG000|Overall Study|Death|3|||
161635942|NCT02188784|583718215|FG001|Overall Study|Death|1|||
161635943|NCT02188784|583718214|FG000|Overall Study|Lost to Follow-up|1|||
161635944|NCT02188784|583718215|FG001|Overall Study|Lost to Follow-up|0|||
161635945|NCT02188784|583718214|FG000|Overall Study|Withdrawal by Subject|3|||
161635946|NCT02188784|583718215|FG001|Overall Study|Withdrawal by Subject|9|||
161635947|NCT02188784|583718214|FG000|Overall Study|Physician Decision|2|||
161635948|NCT02188784|583718215|FG001|Overall Study|Physician Decision|3|||
161635949|NCT04811339|583718219|FG000|Overall Study|lack of transportation not wanting to return|4|||
161635950|NCT04811339|583718220|FG001|Overall Study|lack of transportation not wanting to return|8|||
161635951|NCT04811339|583718221|FG002|Overall Study|lack of transportation not wanting to return|0|||
161635952|NCT04811339|583718219|FG000|Overall Study|Adverse Event|3|||
161635953|NCT04811339|583718220|FG001|Overall Study|Adverse Event|0|||
161635954|NCT04811339|583718221|FG002|Overall Study|Adverse Event|0|||
161635955|NCT04811339|583718219|FG000|Overall Study|Lost to Follow-up|1|||
161635956|NCT04811339|583718220|FG001|Overall Study|Lost to Follow-up|0|||
161635957|NCT04811339|583718221|FG002|Overall Study|Lost to Follow-up|0|||
161686879|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161635958|NCT04811339|583718219|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
161635959|NCT04811339|583718220|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
161635960|NCT04811339|583718221|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
161635961|NCT04811339|583718219|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
161635962|NCT04811339|583718220|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
161635963|NCT04811339|583718221|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
161635964|NCT04811339|583718219|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
161635965|NCT04811339|583718220|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
161635966|NCT04811339|583718221|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
161635967|NCT04811339|583718219|FG000|Overall Study|Withdrawal by Subject|0|||
161635968|NCT04811339|583718220|FG001|Overall Study|Withdrawal by Subject|3|||
161635969|NCT04811339|583718221|FG002|Overall Study|Withdrawal by Subject|0|||
161635970|NCT04811339|583718219|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
161635971|NCT04811339|583718220|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
161635972|NCT04811339|583718221|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
161635973|NCT04811339|583718219|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
161635974|NCT04811339|583718220|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
161635975|NCT04811339|583718221|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
161635976|NCT00143598|583718222|FG000|Overall Study|Lost to Follow-up|23|||
161635977|NCT00143598|583718223|FG001|Overall Study|Lost to Follow-up|21|||
161635978|NCT00143598|583718222|FG000|Overall Study|Withdrawal by Subject|33|||
161635979|NCT00143598|583718223|FG001|Overall Study|Withdrawal by Subject|37|||
161635980|NCT00143598|583718222|FG000|Overall Study|Death|36|||
161635981|NCT00143598|583718223|FG001|Overall Study|Death|36|||
161635982|NCT04944784|583718226|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
161635983|NCT04944784|583718227|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
161635984|NCT04944784|583718228|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
161635985|NCT04944784|583718229|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
161635986|NCT04944784|583718226|FG000|Double-blind Period|Adverse Event|20|||
161635987|NCT04944784|583718227|FG001|Double-blind Period|Adverse Event|4|||
161635988|NCT04944784|583718228|FG002|Double-blind Period|Adverse Event|0|||
161635989|NCT04944784|583718229|FG003|Double-blind Period|Adverse Event|0|||
161635990|NCT04944784|583718226|FG000|Double-blind Period|Withdrawal by Subject|15|||
161635991|NCT04944784|583718227|FG001|Double-blind Period|Withdrawal by Subject|4|||
161635992|NCT04944784|583718228|FG002|Double-blind Period|Withdrawal by Subject|0|||
161635993|NCT04944784|583718229|FG003|Double-blind Period|Withdrawal by Subject|0|||
161635994|NCT04944784|583718226|FG000|Double-blind Period|Death|7|||
161635995|NCT04944784|583718227|FG001|Double-blind Period|Death|2|||
161635996|NCT04944784|583718228|FG002|Double-blind Period|Death|0|||
161635997|NCT04944784|583718229|FG003|Double-blind Period|Death|0|||
161635998|NCT04944784|583718226|FG000|Double-blind Period|Physician Decision|2|||
161635999|NCT04944784|583718227|FG001|Double-blind Period|Physician Decision|1|||
161636000|NCT04944784|583718228|FG002|Double-blind Period|Physician Decision|0|||
161636001|NCT04944784|583718229|FG003|Double-blind Period|Physician Decision|0|||
161636002|NCT04944784|583718226|FG000|Double-blind Period|Lack of Efficacy|0|||
161636003|NCT04944784|583718227|FG001|Double-blind Period|Lack of Efficacy|1|||
161636004|NCT04944784|583718228|FG002|Double-blind Period|Lack of Efficacy|0|||
161636005|NCT04944784|583718229|FG003|Double-blind Period|Lack of Efficacy|0|||
161636006|NCT04944784|583718226|FG000|Double-blind Period|Sponsor Request|2|||
161636007|NCT04944784|583718227|FG001|Double-blind Period|Sponsor Request|1|||
161636008|NCT04944784|583718228|FG002|Double-blind Period|Sponsor Request|0|||
161636009|NCT04944784|583718229|FG003|Double-blind Period|Sponsor Request|0|||
161636010|NCT04944784|583718226|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
161636011|NCT04944784|583718227|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
161636012|NCT04944784|583718228|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
161636013|NCT04944784|583718229|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
161636014|NCT04944784|583718226|FG000|Double-blind Period|Participant Choice|1|||
161636015|NCT04944784|583718227|FG001|Double-blind Period|Participant Choice|1|||
161636016|NCT04944784|583718228|FG002|Double-blind Period|Participant Choice|0|||
161636017|NCT04944784|583718229|FG003|Double-blind Period|Participant Choice|0|||
161636018|NCT04944784|583718226|FG000|Double-blind Period|Progressive Disease|2|||
161636019|NCT04944784|583718227|FG001|Double-blind Period|Progressive Disease|2|||
161636020|NCT04944784|583718228|FG002|Double-blind Period|Progressive Disease|0|||
161636021|NCT04944784|583718229|FG003|Double-blind Period|Progressive Disease|0|||
161636022|NCT04944784|583718226|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
161636023|NCT04944784|583718227|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
161636024|NCT04944784|583718228|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
161636025|NCT04944784|583718229|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
161636026|NCT04944784|583718226|FG000|Active Drug Period|Adverse Event|0|||
161636027|NCT04944784|583718227|FG001|Active Drug Period|Adverse Event|0|||
161636028|NCT04944784|583718228|FG002|Active Drug Period|Adverse Event|3|||
161636029|NCT04944784|583718229|FG003|Active Drug Period|Adverse Event|6|||
161636030|NCT04944784|583718226|FG000|Active Drug Period|Withdrawal by Subject|0|||
161636031|NCT04944784|583718227|FG001|Active Drug Period|Withdrawal by Subject|0|||
161636032|NCT04944784|583718228|FG002|Active Drug Period|Withdrawal by Subject|4|||
161636033|NCT04944784|583718229|FG003|Active Drug Period|Withdrawal by Subject|7|||
161636034|NCT04944784|583718226|FG000|Active Drug Period|Death|0|||
161636035|NCT04944784|583718227|FG001|Active Drug Period|Death|0|||
161636036|NCT04944784|583718228|FG002|Active Drug Period|Death|3|||
161636037|NCT04944784|583718229|FG003|Active Drug Period|Death|4|||
161636038|NCT04944784|583718226|FG000|Active Drug Period|Lack of Efficacy|0|||
161636039|NCT04944784|583718227|FG001|Active Drug Period|Lack of Efficacy|0|||
161636040|NCT04944784|583718228|FG002|Active Drug Period|Lack of Efficacy|2|||
161636041|NCT04944784|583718229|FG003|Active Drug Period|Lack of Efficacy|2|||
161636042|NCT04944784|583718226|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
161636043|NCT04944784|583718227|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
161636044|NCT04944784|583718228|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
161636045|NCT04944784|583718229|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
161636046|NCT04944784|583718226|FG000|Active Drug Period|Participant Choice|0|||
161636047|NCT04944784|583718227|FG001|Active Drug Period|Participant Choice|0|||
161636048|NCT04944784|583718228|FG002|Active Drug Period|Participant Choice|0|||
161636049|NCT04944784|583718229|FG003|Active Drug Period|Participant Choice|1|||
161636050|NCT04944784|583718226|FG000|Active Drug Period|Progressive Disease|0|||
161636051|NCT04944784|583718227|FG001|Active Drug Period|Progressive Disease|0|||
161636052|NCT04944784|583718228|FG002|Active Drug Period|Progressive Disease|4|||
161636053|NCT04944784|583718229|FG003|Active Drug Period|Progressive Disease|4|||
161636054|NCT04944784|583718226|FG000|Active Drug Period|Lost to Follow-up|0|||
161636055|NCT04944784|583718227|FG001|Active Drug Period|Lost to Follow-up|0|||
161636056|NCT04944784|583718228|FG002|Active Drug Period|Lost to Follow-up|0|||
161636057|NCT04944784|583718229|FG003|Active Drug Period|Lost to Follow-up|1|||
161636058|NCT03900715|583718230|FG000|Overall Study|Protocol Deviation|1|||
161636059|NCT03900715|583718230|FG000|Overall Study|Lack of Efficacy|1|||
161686880|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
161686881|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686882|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686883|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686884|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686885|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
161686886|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686887|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686888|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686889|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686890|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
161686891|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686892|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686893|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686894|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686895|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
161686896|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686897|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686898|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686899|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686900|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
161686901|NCT00150592|583907086|FG000|Overall Study|Adverse Event|4|||
161834561|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
161834562|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
161834563|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161834564|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161834565|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161834566|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
161834567|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
161834568|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
161834569|NCT00597116|584435668|FG000|Overall Study|Adverse Event|2|||
161834570|NCT00597116|584435669|FG001|Overall Study|Adverse Event|1|||
161834571|NCT00597116|584435668|FG000|Overall Study|Withdrawal by Subject|0|||
161636060|NCT03900715|583718230|FG000|Overall Study|Progressive Disease|6|||
161636061|NCT03900715|583718230|FG000|Overall Study|Adverse Event|2|||
161636062|NCT03900715|583718230|FG000|Overall Study|Other reasons|11|||
161636063|NCT01568112|583718231|FG000|Overall Study|Randomized But Not Treated|0|||
161636064|NCT01568112|583718232|FG001|Overall Study|Randomized But Not Treated|1|||
161834572|NCT00597116|584435669|FG001|Overall Study|Withdrawal by Subject|2|||
161834573|NCT00597116|584435668|FG000|Overall Study|Physician Decision|0|||
161834574|NCT00597116|584435669|FG001|Overall Study|Physician Decision|1|||
161834575|NCT00597116|584435668|FG000|Overall Study|Death|0|||
161834576|NCT00597116|584435669|FG001|Overall Study|Death|1|||
161834577|NCT00597116|584435668|FG000|Overall Study|Lost to Follow-up|1|||
161834578|NCT00597116|584435669|FG001|Overall Study|Lost to Follow-up|0|||
161834579|NCT00597116|584435668|FG000|Overall Study|Progressive disease|11|||
161834580|NCT00597116|584435669|FG001|Overall Study|Progressive disease|6|||
161834581|NCT00063882|584435672|FG000|Overall Study|Protocol Violation|3|||
161834582|NCT00063882|584435673|FG001|Overall Study|Protocol Violation|3|||
161834583|NCT00063882|584435672|FG000|Overall Study|Withdrawal by Subject|2|||
161834584|NCT00063882|584435673|FG001|Overall Study|Withdrawal by Subject|1|||
161636065|NCT01568112|583718233|FG002|Overall Study|Randomized But Not Treated|0|||
161636066|NCT01568112|583718234|FG003|Overall Study|Randomized But Not Treated|0|||
161636067|NCT01568112|583718231|FG000|Overall Study|Withdrew due to Adverse Event|2|||
161636068|NCT01568112|583718232|FG001|Overall Study|Withdrew due to Adverse Event|4|||
161636069|NCT01568112|583718233|FG002|Overall Study|Withdrew due to Adverse Event|6|||
161636070|NCT01568112|583718234|FG003|Overall Study|Withdrew due to Adverse Event|3|||
161636071|NCT01568112|583718231|FG000|Overall Study|Lost to Follow-up|0|||
161636072|NCT01568112|583718232|FG001|Overall Study|Lost to Follow-up|0|||
161636073|NCT01568112|583718233|FG002|Overall Study|Lost to Follow-up|0|||
161636074|NCT01568112|583718234|FG003|Overall Study|Lost to Follow-up|1|||
161636075|NCT01568112|583718231|FG000|Overall Study|Withdrawal by Subject|2|||
161636076|NCT01568112|583718232|FG001|Overall Study|Withdrawal by Subject|3|||
161636077|NCT01568112|583718233|FG002|Overall Study|Withdrawal by Subject|0|||
161636078|NCT01568112|583718234|FG003|Overall Study|Withdrawal by Subject|7|||
161636079|NCT01568112|583718231|FG000|Overall Study|Withdrawal by Physician|1|||
161636080|NCT01568112|583718232|FG001|Overall Study|Withdrawal by Physician|0|||
161636081|NCT01568112|583718233|FG002|Overall Study|Withdrawal by Physician|1|||
161636082|NCT01568112|583718234|FG003|Overall Study|Withdrawal by Physician|1|||
161636083|NCT02641587|583720709|FG000|Confinement Period|Adverse Event|1|||
161636084|NCT02641587|583720710|FG001|Confinement Period|Adverse Event|0|||
161636085|NCT02641587|583720709|FG000|Confinement Period|Withdrawal by Subject|2|||
161636086|NCT02641587|583720710|FG001|Confinement Period|Withdrawal by Subject|1|||
161636087|NCT02641587|583720709|FG000|Ambulatory Period|Withdrawal by Subject|1|||
161636088|NCT02641587|583720710|FG001|Ambulatory Period|Withdrawal by Subject|0|||
161636089|NCT01150045|583720714|FG000|Overall Study|Protocol Violation|0|||
161636090|NCT01150045|583720715|FG001|Overall Study|Protocol Violation|1|||
161636091|NCT01150045|583720716|FG002|Overall Study|Protocol Violation|0|||
161636092|NCT01150045|583720717|FG003|Overall Study|Protocol Violation|1|||
161636093|NCT03194867|583720718|FG000|Overall Study|Incorrect completion of end of study form|0|||
161636094|NCT03194867|583720719|FG001|Overall Study|Incorrect completion of end of study form|0|||
161636095|NCT03194867|583720720|FG002|Overall Study|Incorrect completion of end of study form|1|||
161636096|NCT03194867|583720721|FG003|Overall Study|Incorrect completion of end of study form|0|||
161636097|NCT00464945|583720722|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
161636098|NCT00464945|583720723|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
161636099|NCT00464945|583720722|FG000|Infant Series|Protocol Violation|1|||
161636100|NCT00464945|583720723|FG001|Infant Series|Protocol Violation|0|||
161636101|NCT00464945|583720722|FG000|Infant Series|Lost to Follow-up|1|||
161636102|NCT00464945|583720723|FG001|Infant Series|Lost to Follow-up|0|||
161636103|NCT00464945|583720722|FG000|After Infant Series|Withdrawal by Subject|0|||
161636104|NCT00464945|583720723|FG001|After Infant Series|Withdrawal by Subject|2|||
161636105|NCT00464945|583720722|FG000|Toddler Dose|Lost to Follow-up|0|||
161636106|NCT00464945|583720723|FG001|Toddler Dose|Lost to Follow-up|1|||
161636107|NCT00543062|583720724|FG000|Overall Study|Withdrawal by Subject|1|||
161636108|NCT00543062|583720725|FG001|Overall Study|Withdrawal by Subject|0|||
161636109|NCT00543062|583720726|FG002|Overall Study|Withdrawal by Subject|2|||
161636110|NCT00543062|583720727|FG003|Overall Study|Withdrawal by Subject|0|||
161636111|NCT00543062|583720724|FG000|Overall Study|Adverse Event|0|||
161636112|NCT00543062|583720725|FG001|Overall Study|Adverse Event|1|||
161834585|NCT02903238|584435674|FG000|Overall Study|Lost to Follow-up|4|||
161834586|NCT01855048|584435694|FG000|Overall Study|Withdrawal by Subject|0|||
161636113|NCT00543062|583720726|FG002|Overall Study|Adverse Event|1|||
161636114|NCT00543062|583720727|FG003|Overall Study|Adverse Event|1|||
161636115|NCT00543062|583720724|FG000|Overall Study|Protocol Violation|1|||
161636116|NCT00543062|583720725|FG001|Overall Study|Protocol Violation|0|||
161636117|NCT00543062|583720726|FG002|Overall Study|Protocol Violation|0|||
161834587|NCT01855048|584435695|FG001|Overall Study|Withdrawal by Subject|1|||
161834588|NCT01855048|584435696|FG002|Overall Study|Withdrawal by Subject|0|||
161834589|NCT01855048|584435697|FG003|Overall Study|Withdrawal by Subject|0|||
161636118|NCT00543062|583720727|FG003|Overall Study|Protocol Violation|0|||
161636119|NCT01663506|583720731|FG000|Overall Study|Lack of Efficacy|3|||
161636120|NCT01663506|583720731|FG000|Overall Study|Consent Withdrawal by Subject|1|||
161636121|NCT01663506|583720731|FG000|Overall Study|Lost to Follow-up|1|||
161636122|NCT01663506|583720731|FG000|Overall Study|Adverse Event|1|||
161636123|NCT01663506|583720731|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
161636124|NCT02094898|583720737|FG000|Overall Study|Clinical Worsening|2|||
161636125|NCT02094898|583720737|FG000|Overall Study|Adverse Event|2|||
161636126|NCT02094898|583720737|FG000|Overall Study|Lack of Efficacy|1|||
161636127|NCT03520075|583720738|FG000|Phase 1 (Dose Escalation)|Death|2|||
161636128|NCT03520075|583720739|FG001|Phase 1 (Dose Escalation)|Death|2|||
161636129|NCT03520075|583720740|FG002|Phase 1 (Dose Escalation)|Death|3|||
161636130|NCT03520075|583720741|FG003|Phase 1 (Dose Escalation)|Death|2|||
161636131|NCT03520075|583720742|FG004|Phase 1 (Dose Escalation)|Death|6|||
161636132|NCT03520075|583720743|FG005|Phase 1 (Dose Escalation)|Death|5|||
161636133|NCT03520075|583720744|FG006|Phase 1 (Dose Escalation)|Death|3|||
161636134|NCT03520075|583720745|FG007|Phase 1 (Dose Escalation)|Death|2|||
161636135|NCT03520075|583720746|FG008|Phase 1 (Dose Escalation)|Death|3|||
161636136|NCT03520075|583720747|FG009|Phase 1 (Dose Escalation)|Death|1|||
161636137|NCT03520075|583720748|FG010|Phase 1 (Dose Escalation)|Death|5|||
161636138|NCT03520075|583720749|FG011|Phase 1 (Dose Escalation)|Death|7|||
161636139|NCT03520075|583720750|FG012|Phase 1 (Dose Escalation)|Death|11|||
161636140|NCT03520075|583720751|FG013|Phase 1 (Dose Escalation)|Death|0|||
161636141|NCT03520075|583720752|FG014|Phase 1 (Dose Escalation)|Death|0|||
161636142|NCT03520075|583720753|FG015|Phase 1 (Dose Escalation)|Death|0|||
161636143|NCT03520075|583720754|FG016|Phase 1 (Dose Escalation)|Death|0|||
161636144|NCT03520075|583720755|FG017|Phase 1 (Dose Escalation)|Death|0|||
161636145|NCT03520075|583720756|FG018|Phase 1 (Dose Escalation)|Death|0|||
161636146|NCT03520075|583720738|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161636147|NCT03520075|583720739|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636148|NCT03520075|583720740|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636149|NCT03520075|583720741|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
161636150|NCT03520075|583720742|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
161636151|NCT03520075|583720743|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
161636152|NCT03520075|583720744|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636153|NCT03520075|583720745|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161636154|NCT03520075|583720746|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636155|NCT03520075|583720747|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161636156|NCT03520075|583720748|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636157|NCT03520075|583720749|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636158|NCT03520075|583720750|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
161636159|NCT03520075|583720751|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636160|NCT03520075|583720752|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636161|NCT03520075|583720753|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636162|NCT03520075|583720754|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636163|NCT03520075|583720755|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636164|NCT03520075|583720756|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161636165|NCT03520075|583720738|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636166|NCT03520075|583720739|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161636167|NCT03520075|583720740|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636168|NCT03520075|583720741|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161636169|NCT03520075|583720742|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161636170|NCT03520075|583720743|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636171|NCT03520075|583720744|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636172|NCT03520075|583720745|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636173|NCT03520075|583720746|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636174|NCT03520075|583720747|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636175|NCT03520075|583720748|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161636176|NCT03520075|583720749|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636177|NCT03520075|583720750|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161636178|NCT03520075|583720751|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636179|NCT03520075|583720752|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636180|NCT03520075|583720753|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636181|NCT03520075|583720754|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161834590|NCT01855048|584435698|FG004|Overall Study|Withdrawal by Subject|1|||
161636182|NCT03520075|583720755|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636183|NCT03520075|583720756|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161636184|NCT03520075|583720738|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636185|NCT03520075|583720739|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636186|NCT03520075|583720740|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636187|NCT03520075|583720741|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161686902|NCT00150592|583907087|FG001|Overall Study|Adverse Event|1|||
161686903|NCT00150592|583907086|FG000|Overall Study|Protocol Violation|1|||
161686904|NCT00150592|583907087|FG001|Overall Study|Protocol Violation|0|||
161686905|NCT00150592|583907086|FG000|Overall Study|Withdrawal by Subject|1|||
161686906|NCT00150592|583907087|FG001|Overall Study|Withdrawal by Subject|2|||
161686907|NCT00150592|583907086|FG000|Overall Study|Non-compliance|1|||
161686908|NCT00150592|583907087|FG001|Overall Study|Non-compliance|0|||
161686909|NCT01823679|583907088|FG000|Overall Study|Death|1|||
161686910|NCT01157078|583907089|FG000|Overall Study|Withdrawal by Subject|12|||
161686911|NCT01157078|583907090|FG001|Overall Study|Withdrawal by Subject|14|||
161686912|NCT01157078|583907089|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161686913|NCT01157078|583907090|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161686914|NCT01157078|583907089|FG000|Overall Study|Adverse Event|6|||
161686915|NCT01157078|583907090|FG001|Overall Study|Adverse Event|6|||
161686916|NCT01157078|583907089|FG000|Overall Study|Severe non-compliance to protocol|2|||
161686917|NCT01157078|583907090|FG001|Overall Study|Severe non-compliance to protocol|4|||
161686918|NCT01157078|583907089|FG000|Overall Study|Condition under investigation worsened|0|||
161686919|NCT01157078|583907090|FG001|Overall Study|Condition under investigation worsened|1|||
161686920|NCT01157078|583907089|FG000|Overall Study|Lack of Efficacy|2|||
161686921|NCT01157078|583907090|FG001|Overall Study|Lack of Efficacy|0|||
161686922|NCT01157078|583907089|FG000|Overall Study|Study-specific withdrawal criteria|2|||
161686923|NCT01157078|583907090|FG001|Overall Study|Study-specific withdrawal criteria|2|||
161686924|NCT01157078|583907089|FG000|Overall Study|Lost to Follow-up|7|||
161686925|NCT01157078|583907090|FG001|Overall Study|Lost to Follow-up|5|||
161686926|NCT01157078|583907089|FG000|Overall Study|Other|2|||
161686927|NCT01157078|583907090|FG001|Overall Study|Other|4|||
161686928|NCT02495844|583907092|FG000|Overall Study|Lack of Efficacy|1|||
161686929|NCT02495844|583907093|FG001|Overall Study|Lack of Efficacy|2|||
161686930|NCT02495844|583907092|FG000|Overall Study|AE, non-fatal|0|||
161686931|NCT02495844|583907093|FG001|Overall Study|AE, non-fatal|1|||
161686932|NCT02495844|583907092|FG000|Overall Study|Hepatitis Positivity|0|||
161686933|NCT02495844|583907093|FG001|Overall Study|Hepatitis Positivity|1|||
161686934|NCT02145741|583907095|FG000|Overall Study|Progressive disease|3|||
161686935|NCT02145741|583907096|FG001|Overall Study|Progressive disease|6|||
161686936|NCT02145741|583907097|FG002|Overall Study|Progressive disease|6|||
161686937|NCT02145741|583907095|FG000|Overall Study|quality issue with the administered drug|3|||
161686938|NCT02145741|583907096|FG001|Overall Study|quality issue with the administered drug|0|||
161686939|NCT02145741|583907097|FG002|Overall Study|quality issue with the administered drug|0|||
161686940|NCT01594853|583907098|FG000|Overall Study|Withdrawal by Subject|1|||
161686941|NCT01594853|583907099|FG001|Overall Study|Withdrawal by Subject|1|||
161686942|NCT01594853|583907098|FG000|Overall Study|Lost to Follow-up|1|||
161686943|NCT01594853|583907099|FG001|Overall Study|Lost to Follow-up|1|||
161686944|NCT01594853|583907098|FG000|Overall Study|noncompliance with exercise|0|||
161686945|NCT01594853|583907099|FG001|Overall Study|noncompliance with exercise|1|||
161686946|NCT00769002|583907100|FG000|Overall Study|Study was not completed, no data|9|||
161686947|NCT00769002|583907101|FG001|Overall Study|Study was not completed, no data|9|||
161686948|NCT00847912|583907107|FG000|Overall Study|Protocol Violation|6|||
161686949|NCT00847912|583907108|FG001|Overall Study|Protocol Violation|7|||
161686950|NCT00847912|583907107|FG000|Overall Study|Withdrawal by Subject|3|||
161686951|NCT00847912|583907108|FG001|Overall Study|Withdrawal by Subject|6|||
161686952|NCT01496885|583907109|FG000|Overall Study|Lost to Follow-up|13|||
161686953|NCT01496885|583907109|FG000|Overall Study|Withdrawal by Subject|7|||
161686954|NCT01496885|583907109|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
161686955|NCT01496885|583907109|FG000|Overall Study|Death|1|||
161686956|NCT03273166|583907110|FG000|Overall Study|Withdrawn prior to Completion|31|||
161686957|NCT01294670|583907111|FG000|Overall Study|Not treated|1|||
161686958|NCT01294670|583907112|FG001|Overall Study|Not treated|0|||
161686959|NCT01294670|583907113|FG002|Overall Study|Not treated|0|||
161686960|NCT01294670|583907114|FG003|Overall Study|Not treated|0|||
161686961|NCT01294670|583907115|FG004|Overall Study|Not treated|0|||
161686962|NCT02412787|583907116|FG000|Overall Study|Withdrawal by Subject|9|||
161686963|NCT02412787|583907116|FG000|Overall Study|Participation Terminated by Investigator|1|||
161686964|NCT02412787|583907116|FG000|Overall Study|Site Terminated by Sponsor|21|||
161686965|NCT02412787|583907116|FG000|Overall Study|Technical Problems|1|||
161686966|NCT02412787|583907116|FG000|Overall Study|Reason Not Specified|1|||
161686967|NCT03246958|583907117|FG000|Overall Study|Withdrawal by Subject|0|||
161686968|NCT03246958|583907118|FG001|Overall Study|Withdrawal by Subject|1|||
161686969|NCT03246958|583907119|FG002|Overall Study|Withdrawal by Subject|0|||
161686970|NCT03246958|583907120|FG003|Overall Study|Withdrawal by Subject|0|||
161686971|NCT03246958|583907121|FG004|Overall Study|Withdrawal by Subject|0|||
161686972|NCT03246958|583907122|FG005|Overall Study|Withdrawal by Subject|1|||
161686973|NCT03246958|583907123|FG006|Overall Study|Withdrawal by Subject|0|||
161686974|NCT03246958|583907117|FG000|Overall Study|Progression|13|||
161686975|NCT03246958|583907118|FG001|Overall Study|Progression|9|||
161686976|NCT03246958|583907119|FG002|Overall Study|Progression|3|||
161686977|NCT03246958|583907120|FG003|Overall Study|Progression|2|||
161686978|NCT03246958|583907121|FG004|Overall Study|Progression|1|||
161636188|NCT03520075|583720742|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636189|NCT03520075|583720743|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636190|NCT03520075|583720744|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636191|NCT03520075|583720745|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636192|NCT03520075|583720746|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636193|NCT03520075|583720747|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
161636194|NCT03520075|583720748|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636195|NCT03520075|583720749|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636196|NCT03520075|583720750|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
161636197|NCT03520075|583720751|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636198|NCT03520075|583720752|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636199|NCT03520075|583720753|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636200|NCT03520075|583720754|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636201|NCT03520075|583720755|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636202|NCT03520075|583720756|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161636203|NCT03520075|583720738|FG000|Phase 2 (Dose Expansion)|Death|0|||
161636204|NCT03520075|583720739|FG001|Phase 2 (Dose Expansion)|Death|0|||
161636205|NCT03520075|583720740|FG002|Phase 2 (Dose Expansion)|Death|0|||
161636206|NCT03520075|583720741|FG003|Phase 2 (Dose Expansion)|Death|0|||
161636207|NCT03520075|583720742|FG004|Phase 2 (Dose Expansion)|Death|0|||
161636208|NCT03520075|583720743|FG005|Phase 2 (Dose Expansion)|Death|0|||
161636209|NCT03520075|583720744|FG006|Phase 2 (Dose Expansion)|Death|0|||
161636210|NCT03520075|583720745|FG007|Phase 2 (Dose Expansion)|Death|0|||
161636211|NCT03520075|583720746|FG008|Phase 2 (Dose Expansion)|Death|0|||
161636212|NCT03520075|583720747|FG009|Phase 2 (Dose Expansion)|Death|0|||
161636213|NCT03520075|583720748|FG010|Phase 2 (Dose Expansion)|Death|0|||
161636214|NCT03520075|583720749|FG011|Phase 2 (Dose Expansion)|Death|0|||
161636215|NCT03520075|583720750|FG012|Phase 2 (Dose Expansion)|Death|0|||
161636216|NCT03520075|583720751|FG013|Phase 2 (Dose Expansion)|Death|20|||
161636217|NCT03520075|583720752|FG014|Phase 2 (Dose Expansion)|Death|13|||
161636218|NCT03520075|583720753|FG015|Phase 2 (Dose Expansion)|Death|9|||
161636219|NCT03520075|583720754|FG016|Phase 2 (Dose Expansion)|Death|5|||
161636220|NCT03520075|583720755|FG017|Phase 2 (Dose Expansion)|Death|14|||
161636221|NCT03520075|583720756|FG018|Phase 2 (Dose Expansion)|Death|12|||
161636222|NCT03520075|583720738|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636223|NCT03520075|583720739|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636224|NCT03520075|583720740|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636225|NCT03520075|583720741|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636226|NCT03520075|583720742|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636227|NCT03520075|583720743|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636228|NCT03520075|583720744|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636229|NCT03520075|583720745|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636230|NCT03520075|583720746|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636231|NCT03520075|583720747|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636232|NCT03520075|583720748|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636233|NCT03520075|583720749|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636234|NCT03520075|583720750|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636235|NCT03520075|583720751|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161636236|NCT03520075|583720752|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
161636237|NCT03520075|583720753|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
161636238|NCT03520075|583720754|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
161636239|NCT03520075|583720755|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
161636240|NCT03520075|583720756|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
161636241|NCT03520075|583720738|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636242|NCT03520075|583720739|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636243|NCT03520075|583720740|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636244|NCT03520075|583720741|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161686979|NCT03246958|583907122|FG005|Overall Study|Progression|2|||
161686980|NCT03246958|583907123|FG006|Overall Study|Progression|1|||
161686981|NCT03246958|583907117|FG000|Overall Study|Adverse Event|2|||
161686982|NCT03246958|583907118|FG001|Overall Study|Adverse Event|2|||
161686983|NCT03246958|583907119|FG002|Overall Study|Adverse Event|0|||
161636245|NCT03520075|583720742|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636246|NCT03520075|583720743|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636247|NCT03520075|583720744|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161686984|NCT03246958|583907120|FG003|Overall Study|Adverse Event|1|||
161636248|NCT03520075|583720745|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636249|NCT03520075|583720746|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636250|NCT03520075|583720747|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161834591|NCT01855048|584435699|FG005|Overall Study|Withdrawal by Subject|0|||
161834592|NCT02972502|584435704|FG000|Overall Study|Lost to Follow-up|3|||
161834593|NCT02972502|584435705|FG001|Overall Study|Lost to Follow-up|1|||
161834594|NCT02972502|584435704|FG000|Overall Study|Withdrawal by Subject|1|||
161834595|NCT02972502|584435705|FG001|Overall Study|Withdrawal by Subject|1|||
161834596|NCT03832738|584435706|FG000|Overall Study|Withdrawal by Subject|6|||
161834597|NCT03832738|584435707|FG001|Overall Study|Withdrawal by Subject|7|||
161834598|NCT03832738|584435708|FG002|Overall Study|Withdrawal by Subject|16|||
161834599|NCT03832738|584435706|FG000|Overall Study|Physician Decision|0|||
161834600|NCT03832738|584435707|FG001|Overall Study|Physician Decision|1|||
161834601|NCT03832738|584435708|FG002|Overall Study|Physician Decision|2|||
161834602|NCT03832738|584435706|FG000|Overall Study|Adverse Event|2|||
161834603|NCT03832738|584435707|FG001|Overall Study|Adverse Event|3|||
161834604|NCT03832738|584435708|FG002|Overall Study|Adverse Event|1|||
161834605|NCT03832738|584435706|FG000|Overall Study|Pregnancy|0|||
161834606|NCT03832738|584435707|FG001|Overall Study|Pregnancy|1|||
161834607|NCT03832738|584435708|FG002|Overall Study|Pregnancy|0|||
161834608|NCT03852459|584435709|FG000|Overall Study|Adverse Event|2|||
161834609|NCT03852459|584435710|FG001|Overall Study|Adverse Event|2|||
161834610|NCT03852459|584435709|FG000|Overall Study|Withdrawal by Subject|1|||
161834611|NCT03852459|584435710|FG001|Overall Study|Withdrawal by Subject|1|||
161636251|NCT03520075|583720748|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161834612|NCT00049842|584435711|FG000|Treatment Phase|Adverse Event|47|||
161834613|NCT00049842|584435712|FG001|Treatment Phase|Adverse Event|12|||
161834614|NCT00049842|584435711|FG000|Treatment Phase|Withdrawal by Subject|35|||
161834615|NCT00049842|584435712|FG001|Treatment Phase|Withdrawal by Subject|46|||
161834616|NCT00049842|584435711|FG000|Treatment Phase|Non-compliance with protocol|7|||
161834617|NCT00049842|584435712|FG001|Treatment Phase|Non-compliance with protocol|8|||
161834618|NCT00049842|584435711|FG000|Treatment Phase|Lost to Follow-up|4|||
161834619|NCT00049842|584435712|FG001|Treatment Phase|Lost to Follow-up|8|||
161834620|NCT00049842|584435711|FG000|Treatment Phase|Administrative|0|||
161834621|NCT00049842|584435712|FG001|Treatment Phase|Administrative|3|||
161636252|NCT03520075|583720749|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636253|NCT03520075|583720750|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636254|NCT03520075|583720751|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636255|NCT03520075|583720752|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161636256|NCT03520075|583720753|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161636257|NCT03520075|583720754|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636258|NCT03520075|583720755|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161636259|NCT03520075|583720756|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161636260|NCT03520075|583720738|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636261|NCT03520075|583720739|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636262|NCT03520075|583720740|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636263|NCT03520075|583720741|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636264|NCT03520075|583720742|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636265|NCT03520075|583720743|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636266|NCT03520075|583720744|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636267|NCT03520075|583720745|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636268|NCT03520075|583720746|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636269|NCT03520075|583720747|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636270|NCT03520075|583720748|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636271|NCT03520075|583720749|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636272|NCT03520075|583720750|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636273|NCT03520075|583720751|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
161636274|NCT03520075|583720752|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636275|NCT03520075|583720753|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636276|NCT03520075|583720754|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
161636277|NCT03520075|583720755|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
161636278|NCT03520075|583720756|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161636279|NCT01432626|583720759|FG000|Overall Study|LV function recovered|2|||
161636280|NCT01432626|583720759|FG000|Overall Study|Withdrawal by Subject|2|||
161636281|NCT01432626|583720759|FG000|Overall Study|Only 1 image competed|2|||
161636282|NCT01432626|583720759|FG000|Overall Study|Imaging agent not available|1|||
161636283|NCT00328562|583720760|FG000|Overall Study|Disease progression|1|||
161636284|NCT03305809|583720761|FG000|Overall Study|Adverse Event|2|||
161636285|NCT03305809|583720762|FG001|Overall Study|Adverse Event|2|||
161636286|NCT03305809|583720763|FG002|Overall Study|Adverse Event|6|||
161636287|NCT03305809|583720764|FG003|Overall Study|Adverse Event|6|||
161636288|NCT03305809|583720761|FG000|Overall Study|Death|0|||
161636289|NCT03305809|583720762|FG001|Overall Study|Death|0|||
161636290|NCT03305809|583720763|FG002|Overall Study|Death|1|||
161834622|NCT00049842|584435711|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
161834623|NCT00049842|584435712|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
161834624|NCT00049842|584435711|FG000|Follow-up Phase|Adverse Event|6|||
161636291|NCT03305809|583720764|FG003|Overall Study|Death|1|||
161636292|NCT03305809|583720761|FG000|Overall Study|Lost to Follow-up|1|||
161636293|NCT03305809|583720762|FG001|Overall Study|Lost to Follow-up|2|||
161636294|NCT03305809|583720763|FG002|Overall Study|Lost to Follow-up|0|||
161636295|NCT03305809|583720764|FG003|Overall Study|Lost to Follow-up|0|||
161636296|NCT03305809|583720761|FG000|Overall Study|Sponsor Decision|1|||
161636297|NCT03305809|583720762|FG001|Overall Study|Sponsor Decision|0|||
161636298|NCT03305809|583720763|FG002|Overall Study|Sponsor Decision|1|||
161636299|NCT03305809|583720764|FG003|Overall Study|Sponsor Decision|8|||
161636300|NCT03305809|583720761|FG000|Overall Study|Physician Decision|0|||
161636301|NCT03305809|583720762|FG001|Overall Study|Physician Decision|0|||
161636302|NCT03305809|583720763|FG002|Overall Study|Physician Decision|2|||
161636303|NCT03305809|583720764|FG003|Overall Study|Physician Decision|4|||
161636304|NCT03305809|583720761|FG000|Overall Study|Progressive Disease|0|||
161636305|NCT03305809|583720762|FG001|Overall Study|Progressive Disease|0|||
161636306|NCT03305809|583720763|FG002|Overall Study|Progressive Disease|1|||
161636307|NCT03305809|583720764|FG003|Overall Study|Progressive Disease|0|||
161834625|NCT00049842|584435712|FG001|Follow-up Phase|Adverse Event|1|||
161834626|NCT00049842|584435711|FG000|Follow-up Phase|Other|1|||
161636308|NCT03305809|583720761|FG000|Overall Study|Protocol Violation|1|||
161636309|NCT03305809|583720762|FG001|Overall Study|Protocol Violation|0|||
161636310|NCT03305809|583720763|FG002|Overall Study|Protocol Violation|2|||
161636311|NCT03305809|583720764|FG003|Overall Study|Protocol Violation|3|||
161636312|NCT03305809|583720761|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
161636313|NCT03305809|583720762|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
161636314|NCT03305809|583720763|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
161636315|NCT03305809|583720764|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
161636316|NCT03305809|583720761|FG000|Overall Study|Withdrawal by Subject|2|||
161636317|NCT03305809|583720762|FG001|Overall Study|Withdrawal by Subject|4|||
161636318|NCT03305809|583720763|FG002|Overall Study|Withdrawal by Subject|5|||
161636319|NCT03305809|583720764|FG003|Overall Study|Withdrawal by Subject|2|||
161636320|NCT03305809|583720761|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
161636321|NCT03305809|583720762|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
161636322|NCT03305809|583720763|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
161636323|NCT03305809|583720764|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
161636324|NCT04014790|583720765|FG000|Overall Study|Death|4|||
161636325|NCT04014790|583720765|FG000|Overall Study|Adverse Event|1|||
161636326|NCT04014790|583720765|FG000|Overall Study|Withdrawal by Subject|1|||
161636327|NCT00816556|583720768|FG000|Overall Study|Adverse Event|1|||
161636328|NCT00816556|583720769|FG001|Overall Study|Adverse Event|1|||
161636329|NCT00816556|583720770|FG002|Overall Study|Adverse Event|1|||
161636330|NCT00816556|583720768|FG000|Overall Study|Withdrawal by Subject|1|||
161636331|NCT00816556|583720769|FG001|Overall Study|Withdrawal by Subject|1|||
161636332|NCT00816556|583720770|FG002|Overall Study|Withdrawal by Subject|1|||
161636333|NCT00816556|583720768|FG000|Overall Study|Lost to Follow-up|0|||
161636334|NCT00816556|583720769|FG001|Overall Study|Lost to Follow-up|0|||
161636335|NCT00816556|583720770|FG002|Overall Study|Lost to Follow-up|1|||
161636336|NCT03546816|583720771|FG000|Overall Study|Adverse Event|5|||
161636337|NCT03546816|583720772|FG001|Overall Study|Adverse Event|3|||
161636338|NCT03546816|583720771|FG000|Overall Study|Lack of Efficacy|2|||
161636339|NCT03546816|583720772|FG001|Overall Study|Lack of Efficacy|4|||
161636340|NCT03546816|583720771|FG000|Overall Study|Pregnancy|1|||
161636341|NCT03546816|583720772|FG001|Overall Study|Pregnancy|0|||
161636342|NCT03546816|583720771|FG000|Overall Study|Physician Decision|2|||
161636343|NCT03546816|583720772|FG001|Overall Study|Physician Decision|0|||
161636344|NCT03546816|583720771|FG000|Overall Study|Withdrawal by Subject|8|||
161636345|NCT03546816|583720772|FG001|Overall Study|Withdrawal by Subject|10|||
161636346|NCT03546816|583720771|FG000|Overall Study|Lost to Follow-up|3|||
161636347|NCT03546816|583720772|FG001|Overall Study|Lost to Follow-up|2|||
161636348|NCT01161446|583720773|FG000|Overall Study|Lost to Follow-up|18|||
161636349|NCT01161446|583720774|FG001|Overall Study|Lost to Follow-up|14|||
161636350|NCT01161446|583720773|FG000|Overall Study|Withdrawal by Subject|0|||
161636351|NCT01161446|583720774|FG001|Overall Study|Withdrawal by Subject|1|||
161636352|NCT00810342|583720775|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
161636353|NCT00810342|583720776|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
161636354|NCT00810342|583720775|FG000|Month 1 Follow-up|Pregnancy|1|||
161636355|NCT00810342|583720776|FG001|Month 1 Follow-up|Pregnancy|0|||
161636356|NCT00810342|583720775|FG000|6-month Follow-up|Lost to Follow-up|18|||
161636357|NCT00810342|583720776|FG001|6-month Follow-up|Lost to Follow-up|6|||
161636358|NCT00810342|583720775|FG000|6-month Follow-up|Pregnancy|6|||
161636359|NCT00810342|583720776|FG001|6-month Follow-up|Pregnancy|2|||
161636360|NCT00810342|583720775|FG000|12-month Followup|Pregnancy|9|||
161636361|NCT00810342|583720776|FG001|12-month Followup|Pregnancy|10|||
161636362|NCT00810342|583720775|FG000|12-month Followup|Lost to Follow-up|3|||
161636363|NCT00810342|583720776|FG001|12-month Followup|Lost to Follow-up|1|||
161636364|NCT02270671|583720777|FG000|Overall Study|Withdrawal by Subject|1|||
161834627|NCT00049842|584435712|FG001|Follow-up Phase|Other|4|||
161636365|NCT02270671|583720778|FG001|Overall Study|Withdrawal by Subject|1|||
161636366|NCT02270671|583720777|FG000|Overall Study|Protocol Violation|0|||
161636367|NCT02270671|583720778|FG001|Overall Study|Protocol Violation|1|||
161636368|NCT02270671|583720777|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
161636369|NCT02270671|583720778|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
161636370|NCT02270671|583720777|FG000|Overall Study|Lost to Follow-up|2|||
161636371|NCT02270671|583720778|FG001|Overall Study|Lost to Follow-up|1|||
161636372|NCT01657799|583720781|FG000|Overall Study|Adverse Event Related to progression|6|||
161636373|NCT01657799|583720782|FG001|Overall Study|Adverse Event Related to progression|8|||
161636374|NCT01657799|583720783|FG002|Overall Study|Adverse Event Related to progression|12|||
161636375|NCT01657799|583720781|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
161636376|NCT01657799|583720782|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
161636377|NCT01657799|583720783|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
161636378|NCT01657799|583720781|FG000|Overall Study|Withdrawal by Subject|13|||
161636379|NCT01657799|583720782|FG001|Overall Study|Withdrawal by Subject|10|||
161636380|NCT01657799|583720783|FG002|Overall Study|Withdrawal by Subject|10|||
161636381|NCT01657799|583720781|FG000|Overall Study|Lost to Follow-up|1|||
161636382|NCT01657799|583720782|FG001|Overall Study|Lost to Follow-up|0|||
161636383|NCT01657799|583720783|FG002|Overall Study|Lost to Follow-up|1|||
161636384|NCT01657799|583720781|FG000|Overall Study|Disease Progression|2|||
161636385|NCT01657799|583720782|FG001|Overall Study|Disease Progression|4|||
161636386|NCT01657799|583720783|FG002|Overall Study|Disease Progression|4|||
161636387|NCT01657799|583720781|FG000|Overall Study|Progressive Disease Clinical|7|||
161636388|NCT01657799|583720782|FG001|Overall Study|Progressive Disease Clinical|4|||
161636389|NCT01657799|583720783|FG002|Overall Study|Progressive Disease Clinical|7|||
161636390|NCT01657799|583720781|FG000|Overall Study|Radiographic & Clinical Progression|16|||
161636391|NCT01657799|583720782|FG001|Overall Study|Radiographic & Clinical Progression|11|||
161636392|NCT01657799|583720783|FG002|Overall Study|Radiographic & Clinical Progression|15|||
161636393|NCT01657799|583720781|FG000|Overall Study|Other|52|||
161636394|NCT01657799|583720782|FG001|Overall Study|Other|62|||
161636395|NCT01657799|583720783|FG002|Overall Study|Other|49|||
161636396|NCT03927690|583720784|FG000|Overall Study|Withdrawal by Subject|3|||
161636397|NCT03927690|583720785|FG001|Overall Study|Withdrawal by Subject|1|||
161636398|NCT03927690|583720786|FG002|Overall Study|Withdrawal by Subject|1|||
161636399|NCT03927690|583720784|FG000|Overall Study|Adverse Event|1|||
161636400|NCT03927690|583720785|FG001|Overall Study|Adverse Event|0|||
161636401|NCT03927690|583720786|FG002|Overall Study|Adverse Event|0|||
161636402|NCT03927690|583720784|FG000|Overall Study|Death|1|||
161636403|NCT03927690|583720785|FG001|Overall Study|Death|0|||
161636404|NCT03927690|583720786|FG002|Overall Study|Death|0|||
161636405|NCT03927690|583720784|FG000|Overall Study|Lost to Follow-up|2|||
161636406|NCT03927690|583720785|FG001|Overall Study|Lost to Follow-up|2|||
161636407|NCT03927690|583720786|FG002|Overall Study|Lost to Follow-up|1|||
161636408|NCT00174447|583720789|FG000|Overall Study|Adverse Event|19|||
161636409|NCT00174447|583720789|FG000|Overall Study|Withdrawal by Subject|15|||
161636410|NCT00174447|583720789|FG000|Overall Study|Protocol Violation|1|||
161636411|NCT00174447|583720789|FG000|Overall Study|Lack of Efficacy|1|||
161636412|NCT00174447|583720789|FG000|Overall Study|Administrative reason/Other|2|||
161636413|NCT00551135|583720800|FG000|Overall Study|Adverse Event|1|||
161636414|NCT00551135|583720801|FG001|Overall Study|Adverse Event|0|||
161636415|NCT00551135|583720802|FG002|Overall Study|Adverse Event|1|||
161636416|NCT00551135|583720803|FG003|Overall Study|Adverse Event|1|||
161636417|NCT00551135|583720800|FG000|Overall Study|Lost to Follow-up|0|||
161636418|NCT00551135|583720801|FG001|Overall Study|Lost to Follow-up|0|||
161636419|NCT00551135|583720802|FG002|Overall Study|Lost to Follow-up|0|||
161636420|NCT00551135|583720803|FG003|Overall Study|Lost to Follow-up|1|||
161636421|NCT00551135|583720800|FG000|Overall Study|Other|3|||
161636422|NCT00551135|583720801|FG001|Overall Study|Other|2|||
161636423|NCT00551135|583720802|FG002|Overall Study|Other|1|||
161636424|NCT00551135|583720803|FG003|Overall Study|Other|2|||
161636425|NCT00551135|583720800|FG000|Overall Study|Withdrawal by Subject|1|||
161636426|NCT00551135|583720801|FG001|Overall Study|Withdrawal by Subject|0|||
161636427|NCT00551135|583720802|FG002|Overall Study|Withdrawal by Subject|3|||
161636428|NCT00551135|583720803|FG003|Overall Study|Withdrawal by Subject|1|||
161636429|NCT01588366|583720804|FG000|Overall Study|Adverse Event|0|||
161636430|NCT01588366|583720805|FG001|Overall Study|Adverse Event|1|||
161636431|NCT01588366|583720806|FG002|Overall Study|Adverse Event|0|||
161636432|NCT01588366|583720807|FG003|Overall Study|Adverse Event|1|||
161636433|NCT01588366|583720808|FG004|Overall Study|Adverse Event|0|||
161636434|NCT01588366|583720809|FG005|Overall Study|Adverse Event|2|||
161636435|NCT04962698|583720810|FG000|Motor Imagery|Technical difficulty|1|||
161636436|NCT04962698|583720811|FG001|Motor Imagery|Technical difficulty|0|||
161686985|NCT03246958|583907121|FG004|Overall Study|Adverse Event|1|||
161686986|NCT03246958|583907122|FG005|Overall Study|Adverse Event|0|||
161686987|NCT03246958|583907123|FG006|Overall Study|Adverse Event|2|||
161686988|NCT03246958|583907117|FG000|Overall Study|Death|0|||
161686989|NCT03246958|583907118|FG001|Overall Study|Death|1|||
161636437|NCT04962698|583720810|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
161636438|NCT04962698|583720811|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
161686990|NCT03246958|583907119|FG002|Overall Study|Death|0|||
161686991|NCT03246958|583907120|FG003|Overall Study|Death|0|||
161686992|NCT03246958|583907121|FG004|Overall Study|Death|0|||
161686993|NCT03246958|583907122|FG005|Overall Study|Death|0|||
161686994|NCT03246958|583907123|FG006|Overall Study|Death|0|||
161686995|NCT03246958|583907117|FG000|Overall Study|Physician Decision|0|||
161636439|NCT04962698|583720810|FG000|Kinesthetic MI|Technical difficulty|1|||
161636440|NCT04962698|583720811|FG001|Kinesthetic MI|Technical difficulty|0|||
161636441|NCT04962698|583720810|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
161636442|NCT04962698|583720811|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
161636443|NCT04962698|583720810|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
161636444|NCT04962698|583720811|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
161636445|NCT04962698|583720810|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
161636446|NCT04962698|583720811|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
161636447|NCT04962698|583720810|FG000|Virtual-hand Interaction|Technical difficulty|1|||
161636448|NCT04962698|583720811|FG001|Virtual-hand Interaction|Technical difficulty|0|||
161636449|NCT04962698|583720810|FG000|Robotic Action Observation|Technical difficulty|1|||
161636450|NCT04962698|583720811|FG001|Robotic Action Observation|Technical difficulty|0|||
161636451|NCT04962698|583720810|FG000|Rest|Technical difficulty|1|||
161636452|NCT04962698|583720811|FG001|Rest|Technical difficulty|0|||
161636453|NCT04962698|583720810|FG000|Rest|Exclusion criteria met after enrollment|0|||
161636454|NCT04962698|583720811|FG001|Rest|Exclusion criteria met after enrollment|2|||
161636455|NCT00585975|583720812|FG000|Overall Study|Withdrawal by Subject|3|||
161636456|NCT00585975|583720813|FG001|Overall Study|Withdrawal by Subject|3|||
161636457|NCT00585975|583720812|FG000|Overall Study|Lost to Follow-up|2|||
161636458|NCT00585975|583720813|FG001|Overall Study|Lost to Follow-up|1|||
161636459|NCT00585975|583720812|FG000|Overall Study|Enrollment met/over-enrolled|10|||
161636460|NCT00585975|583720813|FG001|Overall Study|Enrollment met/over-enrolled|9|||
161636461|NCT03082612|583720816|FG000|Overall Study|Lost to Follow-up|2|||
161636462|NCT03082612|583720817|FG001|Overall Study|Lost to Follow-up|0|||
161636463|NCT01006616|583720820|FG000|Period 1 (6 Months)|Adverse Event|10|||
161636464|NCT01006616|583720821|FG001|Period 1 (6 Months)|Adverse Event|31|||
161636465|NCT01006616|583720822|FG002|Period 1 (6 Months)|Adverse Event|37|||
161636466|NCT01006616|583720823|FG003|Period 1 (6 Months)|Adverse Event|9|||
161636467|NCT01006616|583720820|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
161636468|NCT01006616|583720821|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
161636469|NCT01006616|583720822|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
161636470|NCT01006616|583720823|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
161636471|NCT01006616|583720820|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
161636472|NCT01006616|583720821|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
161636473|NCT01006616|583720822|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
161636474|NCT01006616|583720823|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
161636475|NCT01006616|583720820|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
161636476|NCT01006616|583720821|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
161636477|NCT01006616|583720822|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
161636478|NCT01006616|583720823|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
161636479|NCT01006616|583720820|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
161686996|NCT03246958|583907118|FG001|Overall Study|Physician Decision|0|||
161686997|NCT03246958|583907119|FG002|Overall Study|Physician Decision|0|||
161686998|NCT03246958|583907120|FG003|Overall Study|Physician Decision|1|||
161686999|NCT03246958|583907121|FG004|Overall Study|Physician Decision|0|||
161687000|NCT03246958|583907122|FG005|Overall Study|Physician Decision|0|||
161687001|NCT03246958|583907123|FG006|Overall Study|Physician Decision|0|||
161687002|NCT03246958|583907117|FG000|Overall Study|Never start treatment|1|||
161687003|NCT03246958|583907118|FG001|Overall Study|Never start treatment|0|||
161687004|NCT03246958|583907119|FG002|Overall Study|Never start treatment|0|||
161834628|NCT01813071|584435713|FG000|Overall Study|Protocol Violation|0|||
161834629|NCT01813071|584435714|FG001|Overall Study|Protocol Violation|0|||
161834630|NCT01813071|584435715|FG002|Overall Study|Protocol Violation|0|||
161636480|NCT01006616|583720821|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
161636481|NCT01006616|583720822|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
161636482|NCT01006616|583720823|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
161636483|NCT01006616|583720820|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
161636484|NCT01006616|583720821|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
161687005|NCT03246958|583907120|FG003|Overall Study|Never start treatment|0|||
161687006|NCT03246958|583907121|FG004|Overall Study|Never start treatment|0|||
161834631|NCT01813071|584435716|FG003|Overall Study|Protocol Violation|0|||
161636485|NCT01006616|583720822|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
161636486|NCT01006616|583720823|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
161636487|NCT01006616|583720820|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
161636488|NCT01006616|583720821|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
161636489|NCT01006616|583720822|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
161636490|NCT01006616|583720823|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
161636491|NCT01006616|583720820|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
161636492|NCT01006616|583720821|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
161636493|NCT01006616|583720822|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
161636494|NCT01006616|583720823|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
161636495|NCT01006616|583720820|FG000|Period 1 (6 Months)|Not Treated|0|||
161636496|NCT01006616|583720821|FG001|Period 1 (6 Months)|Not Treated|0|||
161636497|NCT01006616|583720822|FG002|Period 1 (6 Months)|Not Treated|1|||
161636498|NCT01006616|583720823|FG003|Period 1 (6 Months)|Not Treated|1|||
161636499|NCT01006616|583720820|FG000|Period 2 (18 Months)|Adverse Event|6|||
161636500|NCT01006616|583720821|FG001|Period 2 (18 Months)|Adverse Event|6|||
161636501|NCT01006616|583720822|FG002|Period 2 (18 Months)|Adverse Event|6|||
161636502|NCT01006616|583720823|FG003|Period 2 (18 Months)|Adverse Event|4|||
161636503|NCT01006616|583720820|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
161636504|NCT01006616|583720821|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
161636505|NCT01006616|583720822|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
161636506|NCT01006616|583720823|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
161636507|NCT01006616|583720820|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
161636508|NCT01006616|583720821|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
161636509|NCT01006616|583720822|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
161636510|NCT01006616|583720823|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
161636511|NCT01006616|583720820|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
161636512|NCT01006616|583720821|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
161636513|NCT01006616|583720822|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
161636514|NCT01006616|583720823|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
161636515|NCT01006616|583720820|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
161636516|NCT01006616|583720821|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
161636517|NCT01006616|583720822|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
161636518|NCT01006616|583720823|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
161636519|NCT01006616|583720820|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
161636520|NCT01006616|583720821|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
161636521|NCT01006616|583720822|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
161636522|NCT01006616|583720823|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
161636523|NCT01006616|583720820|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
161636524|NCT01006616|583720821|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
161636525|NCT01006616|583720822|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
161636526|NCT01006616|583720823|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
161636527|NCT01006616|583720820|FG000|Period 2 (18 Months)|Study Terminated|63|||
161636528|NCT01006616|583720821|FG001|Period 2 (18 Months)|Study Terminated|46|||
161636529|NCT01006616|583720822|FG002|Period 2 (18 Months)|Study Terminated|44|||
161636530|NCT01006616|583720823|FG003|Period 2 (18 Months)|Study Terminated|70|||
161636531|NCT03672175|583720824|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
161636532|NCT03672175|583720825|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
161636533|NCT03672175|583720826|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
161636534|NCT03672175|583720824|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
161636535|NCT03672175|583720825|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
161636536|NCT03672175|583720826|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
161636537|NCT03672175|583720824|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
161636538|NCT03672175|583720825|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
161636539|NCT03672175|583720826|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
161636540|NCT03672175|583720824|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
161636541|NCT03672175|583720825|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
161636542|NCT03672175|583720826|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
161636543|NCT03672175|583720824|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
161636544|NCT03672175|583720825|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
161636545|NCT03672175|583720826|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
161636546|NCT03672175|583720824|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
161636547|NCT03672175|583720825|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
161636548|NCT03672175|583720826|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
161636549|NCT03672175|583720824|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
161636550|NCT03672175|583720825|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
161636551|NCT03672175|583720826|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
161636552|NCT03672175|583720824|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
161636553|NCT03672175|583720825|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
161687007|NCT03246958|583907122|FG005|Overall Study|Never start treatment|0|||
161834632|NCT01813071|584435717|FG004|Overall Study|Protocol Violation|1|||
161834633|NCT01813071|584435718|FG005|Overall Study|Protocol Violation|4|||
161834634|NCT01813071|584435719|FG006|Overall Study|Protocol Violation|2|||
161834635|NCT01813071|584435720|FG007|Overall Study|Protocol Violation|4|||
161834636|NCT01813071|584435721|FG008|Overall Study|Protocol Violation|2|||
161834637|NCT01813071|584435713|FG000|Overall Study|Withdrawal by Subject|0|||
161834638|NCT01813071|584435714|FG001|Overall Study|Withdrawal by Subject|0|||
161834639|NCT01813071|584435715|FG002|Overall Study|Withdrawal by Subject|0|||
161834640|NCT01813071|584435716|FG003|Overall Study|Withdrawal by Subject|0|||
161834641|NCT01813071|584435717|FG004|Overall Study|Withdrawal by Subject|0|||
161834642|NCT01813071|584435718|FG005|Overall Study|Withdrawal by Subject|1|||
161834643|NCT01813071|584435719|FG006|Overall Study|Withdrawal by Subject|0|||
161834644|NCT01813071|584435720|FG007|Overall Study|Withdrawal by Subject|0|||
161834645|NCT01813071|584435721|FG008|Overall Study|Withdrawal by Subject|0|||
161834646|NCT01813071|584435713|FG000|Overall Study|Adverse Event|0|||
161834647|NCT01813071|584435714|FG001|Overall Study|Adverse Event|0|||
161834648|NCT01813071|584435715|FG002|Overall Study|Adverse Event|0|||
161834649|NCT01813071|584435716|FG003|Overall Study|Adverse Event|0|||
161834650|NCT01813071|584435717|FG004|Overall Study|Adverse Event|0|||
161636554|NCT03672175|583720826|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
161636555|NCT03672175|583720824|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
161636556|NCT03672175|583720825|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
161636557|NCT03672175|583720826|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
161636558|NCT03672175|583720824|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
161636559|NCT03672175|583720825|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
161636560|NCT03672175|583720826|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
161636561|NCT03672175|583720824|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
161636562|NCT03672175|583720825|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
161636563|NCT03672175|583720826|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
161636564|NCT03672175|583720824|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
161636565|NCT03672175|583720825|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
161636566|NCT03672175|583720826|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
161636567|NCT01129115|583720830|FG000|Overall Study|Adverse Event|1|||
161636568|NCT01129115|583720831|FG001|Overall Study|Adverse Event|2|||
161636569|NCT01129115|583720832|FG002|Overall Study|Adverse Event|3|||
161636570|NCT01129115|583720833|FG003|Overall Study|Adverse Event|3|||
161636571|NCT01129115|583720830|FG000|Overall Study|Withdrawal by Subject|1|||
161636572|NCT01129115|583720831|FG001|Overall Study|Withdrawal by Subject|3|||
161636573|NCT01129115|583720832|FG002|Overall Study|Withdrawal by Subject|1|||
161636574|NCT01129115|583720833|FG003|Overall Study|Withdrawal by Subject|4|||
161636575|NCT01129115|583720830|FG000|Overall Study|Protocol Violation|0|||
161636576|NCT01129115|583720831|FG001|Overall Study|Protocol Violation|2|||
161636577|NCT01129115|583720832|FG002|Overall Study|Protocol Violation|2|||
161636578|NCT01129115|583720833|FG003|Overall Study|Protocol Violation|2|||
161636579|NCT01747837|583720834|FG000|Overall Study|Lost to Follow-up|5|||
161636580|NCT01747837|583720835|FG001|Overall Study|Lost to Follow-up|2|||
161636581|NCT01747837|583720834|FG000|Overall Study|Death|4|||
161636582|NCT01747837|583720835|FG001|Overall Study|Death|4|||
161636583|NCT01121913|583720836|FG000|First Intervention Period|Adverse Event|0|||
161636584|NCT01121913|583720837|FG001|First Intervention Period|Adverse Event|0|||
161636585|NCT01121913|583720838|FG002|First Intervention Period|Adverse Event|1|||
161636586|NCT01121913|583720839|FG003|First Intervention Period|Adverse Event|0|||
161636587|NCT01121913|583720836|FG000|First Washout Period|Withdrawal by Subject|1|||
161636588|NCT01121913|583720837|FG001|First Washout Period|Withdrawal by Subject|0|||
161636589|NCT01121913|583720838|FG002|First Washout Period|Withdrawal by Subject|0|||
161636590|NCT01121913|583720839|FG003|First Washout Period|Withdrawal by Subject|0|||
161636591|NCT01121913|583720836|FG000|Second Intervention Period|Adverse Event|0|||
161636592|NCT01121913|583720837|FG001|Second Intervention Period|Adverse Event|0|||
161636593|NCT01121913|583720838|FG002|Second Intervention Period|Adverse Event|1|||
161636594|NCT01121913|583720839|FG003|Second Intervention Period|Adverse Event|0|||
161636595|NCT01121913|583720836|FG000|Second Washout Period|Withdrawal by Subject|0|||
161636596|NCT01121913|583720837|FG001|Second Washout Period|Withdrawal by Subject|0|||
161636597|NCT01121913|583720838|FG002|Second Washout Period|Withdrawal by Subject|1|||
161636598|NCT01121913|583720839|FG003|Second Washout Period|Withdrawal by Subject|0|||
161636599|NCT01121913|583720836|FG000|Third Washout Period|Adverse Event|1|||
161636600|NCT01121913|583720837|FG001|Third Washout Period|Adverse Event|0|||
161636601|NCT01121913|583720838|FG002|Third Washout Period|Adverse Event|0|||
161636602|NCT01121913|583720839|FG003|Third Washout Period|Adverse Event|0|||
161636603|NCT00690378|583720840|FG000|Overall Study|Adverse Event|1|||
161687008|NCT03246958|583907123|FG006|Overall Study|Never start treatment|0|||
161834651|NCT01813071|584435718|FG005|Overall Study|Adverse Event|1|||
161834652|NCT01813071|584435719|FG006|Overall Study|Adverse Event|0|||
161834653|NCT01813071|584435720|FG007|Overall Study|Adverse Event|0|||
161834654|NCT01813071|584435721|FG008|Overall Study|Adverse Event|0|||
161687009|NCT03246958|583907117|FG000|Overall Study|Over enrollment|0|||
161687010|NCT03246958|583907118|FG001|Overall Study|Over enrollment|2|||
161687011|NCT03246958|583907119|FG002|Overall Study|Over enrollment|0|||
161549832|NCT00603265|583402991|FG000|Overall Study|Lack of Efficacy|3|||
161549833|NCT00603265|583402992|FG001|Overall Study|Lack of Efficacy|0|||
161549834|NCT00603265|583402993|FG002|Overall Study|Lack of Efficacy|3|||
161549835|NCT00603265|583402991|FG000|Overall Study|Lost to Follow-up|0|||
161549836|NCT00603265|583402992|FG001|Overall Study|Lost to Follow-up|1|||
161549837|NCT00603265|583402993|FG002|Overall Study|Lost to Follow-up|0|||
161549838|NCT00603265|583402991|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
161549839|NCT00603265|583402992|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
161549840|NCT00603265|583402993|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
161549841|NCT00603265|583402991|FG000|Overall Study|Participant Left Country, No Responses|0|||
161549842|NCT00603265|583402992|FG001|Overall Study|Participant Left Country, No Responses|1|||
161549843|NCT00603265|583402993|FG002|Overall Study|Participant Left Country, No Responses|0|||
161549844|NCT00603265|583402991|FG000|Overall Study|Protocol Violation|1|||
161549845|NCT00603265|583402992|FG001|Overall Study|Protocol Violation|0|||
161549846|NCT00603265|583402993|FG002|Overall Study|Protocol Violation|0|||
161549847|NCT04399551|583402994|FG000|Overall Study|Adverse Event|15|||
161549848|NCT04399551|583402994|FG000|Overall Study|Withdrawal by Subject|6|||
161549849|NCT04399551|583402994|FG000|Overall Study|Physician Decision|3|||
161549850|NCT04399551|583402994|FG000|Overall Study|Lost to Follow-up|2|||
161549851|NCT04399551|583402994|FG000|Overall Study|Protocol Deviation|2|||
161549852|NCT01912781|583403001|FG000|Overall Study|Withdrawal by Subject|2|||
161549853|NCT01912781|583403002|FG001|Overall Study|Withdrawal by Subject|0|||
161549854|NCT01533714|583403005|FG000|Overall Study|Adverse Event|0|||
161549855|NCT01533714|583403006|FG001|Overall Study|Adverse Event|1|||
161549856|NCT01533714|583403007|FG002|Overall Study|Adverse Event|2|||
161549857|NCT01533714|583403008|FG003|Overall Study|Adverse Event|2|||
161549858|NCT01533714|583403009|FG004|Overall Study|Adverse Event|2|||
161549859|NCT01533714|583403010|FG005|Overall Study|Adverse Event|1|||
161549860|NCT01533714|583403005|FG000|Overall Study|Lack of Efficacy|0|||
161549861|NCT01533714|583403006|FG001|Overall Study|Lack of Efficacy|0|||
161549862|NCT01533714|583403007|FG002|Overall Study|Lack of Efficacy|0|||
161549863|NCT01533714|583403008|FG003|Overall Study|Lack of Efficacy|0|||
161549864|NCT01533714|583403009|FG004|Overall Study|Lack of Efficacy|0|||
161549865|NCT01533714|583403010|FG005|Overall Study|Lack of Efficacy|1|||
161549866|NCT01533714|583403005|FG000|Overall Study|Withdrawal by Subject|0|||
161549867|NCT01533714|583403006|FG001|Overall Study|Withdrawal by Subject|1|||
161549868|NCT01533714|583403007|FG002|Overall Study|Withdrawal by Subject|0|||
161549869|NCT01533714|583403008|FG003|Overall Study|Withdrawal by Subject|1|||
161549870|NCT01533714|583403009|FG004|Overall Study|Withdrawal by Subject|1|||
161549871|NCT01533714|583403010|FG005|Overall Study|Withdrawal by Subject|0|||
161549872|NCT01533714|583403005|FG000|Overall Study|Exclusion criteria|0|||
161549873|NCT01533714|583403006|FG001|Overall Study|Exclusion criteria|1|||
161549874|NCT01533714|583403007|FG002|Overall Study|Exclusion criteria|0|||
161549875|NCT01533714|583403008|FG003|Overall Study|Exclusion criteria|0|||
161549876|NCT01533714|583403009|FG004|Overall Study|Exclusion criteria|0|||
161549877|NCT01533714|583403010|FG005|Overall Study|Exclusion criteria|0|||
161549878|NCT01533714|583403005|FG000|Overall Study|Positive for purified protein derivative|0|||
161549879|NCT01533714|583403006|FG001|Overall Study|Positive for purified protein derivative|0|||
161549880|NCT01533714|583403007|FG002|Overall Study|Positive for purified protein derivative|1|||
161549881|NCT01533714|583403008|FG003|Overall Study|Positive for purified protein derivative|0|||
161549882|NCT01533714|583403009|FG004|Overall Study|Positive for purified protein derivative|1|||
161549883|NCT01533714|583403010|FG005|Overall Study|Positive for purified protein derivative|0|||
161549884|NCT01533714|583403005|FG000|Overall Study|Withdrawal criteria|0|||
161549885|NCT01533714|583403006|FG001|Overall Study|Withdrawal criteria|0|||
161549886|NCT01533714|583403007|FG002|Overall Study|Withdrawal criteria|1|||
161549887|NCT01533714|583403008|FG003|Overall Study|Withdrawal criteria|0|||
161549888|NCT01533714|583403009|FG004|Overall Study|Withdrawal criteria|3|||
161549889|NCT01533714|583403010|FG005|Overall Study|Withdrawal criteria|1|||
161549890|NCT01533714|583403005|FG000|Overall Study|Ineligibility reason|0|||
161549891|NCT01533714|583403006|FG001|Overall Study|Ineligibility reason|0|||
161549892|NCT01533714|583403007|FG002|Overall Study|Ineligibility reason|0|||
161549893|NCT01533714|583403008|FG003|Overall Study|Ineligibility reason|1|||
161549894|NCT01533714|583403009|FG004|Overall Study|Ineligibility reason|0|||
161549895|NCT01533714|583403010|FG005|Overall Study|Ineligibility reason|0|||
161549896|NCT05033743|583403011|FG000|Overall Study|Lost to Follow-up|1|||
161549897|NCT05033743|583403011|FG000|Overall Study|Protocol Violation|2|||
161549898|NCT05033743|583403011|FG000|Overall Study|Withdrawal by Subject|1|||
161549899|NCT02564055|583403012|FG000|Overall Study|Adverse Event|1|||
161549900|NCT02564055|583403013|FG001|Overall Study|Adverse Event|0|||
161549901|NCT02564055|583403014|FG002|Overall Study|Adverse Event|4|||
161636604|NCT00690378|583720841|FG001|Overall Study|Adverse Event|0|||
161636605|NCT00690378|583720840|FG000|Overall Study|Withdrawal by Subject|2|||
161636606|NCT00690378|583720841|FG001|Overall Study|Withdrawal by Subject|0|||
161636607|NCT00690378|583720840|FG000|Overall Study|Protocol Violation|1|||
161636608|NCT00690378|583720841|FG001|Overall Study|Protocol Violation|0|||
161636609|NCT00690378|583720840|FG000|Overall Study|Lost to Follow-up|2|||
161636610|NCT00690378|583720841|FG001|Overall Study|Lost to Follow-up|3|||
161636611|NCT00690378|583720840|FG000|Overall Study|Did not meet inc/exc criteria|13|||
161636612|NCT00690378|583720841|FG001|Overall Study|Did not meet inc/exc criteria|11|||
161636613|NCT00690378|583720840|FG000|Overall Study|Social problem|1|||
161636614|NCT00690378|583720841|FG001|Overall Study|Social problem|0|||
161636615|NCT02019641|583720845|FG000|10-Week Follow up|Withdrawal by investigator|2|||
161636616|NCT02019641|583720846|FG001|10-Week Follow up|Withdrawal by investigator|0|||
161636617|NCT02019641|583720847|FG002|10-Week Follow up|Withdrawal by investigator|0|||
161636618|NCT02019641|583720845|FG000|10-Week Follow up|Withdrawal by Subject|1|||
161636619|NCT02019641|583720846|FG001|10-Week Follow up|Withdrawal by Subject|1|||
161636620|NCT02019641|583720847|FG002|10-Week Follow up|Withdrawal by Subject|0|||
161636621|NCT02019641|583720845|FG000|20-Week Follow up|Withdrawal by investigator|0|||
161636622|NCT02019641|583720846|FG001|20-Week Follow up|Withdrawal by investigator|0|||
161636623|NCT02019641|583720847|FG002|20-Week Follow up|Withdrawal by investigator|1|||
161636624|NCT03410108|583720850|FG000|Overall Study|Ongoing|41|||
161636625|NCT03410108|583720850|FG000|Overall Study|Adverse Event|4|||
161636626|NCT03410108|583720850|FG000|Overall Study|Progressive Disease|58|||
161636627|NCT03410108|583720850|FG000|Overall Study|Withdrawal by Subject|1|||
161636628|NCT01313624|583720852|FG000|Double-Blind Phase|Adverse Event|27|||
161636629|NCT01313624|583720853|FG001|Double-Blind Phase|Adverse Event|4|||
161636630|NCT01313624|583720852|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
161636631|NCT01313624|583720853|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
161636632|NCT01313624|583720852|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161636633|NCT01313624|583720853|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161636634|NCT01313624|583720852|FG000|Double-Blind Phase|Physician Decision|1|||
161636635|NCT01313624|583720853|FG001|Double-Blind Phase|Physician Decision|0|||
161636636|NCT01313624|583720852|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161636637|NCT01313624|583720853|FG001|Double-Blind Phase|Lack of Efficacy|0|||
161636638|NCT01313624|583720852|FG000|Open-Label Phase|Adverse Event|1|||
161636639|NCT01313624|583720853|FG001|Open-Label Phase|Adverse Event|10|||
161636640|NCT01313624|583720852|FG000|Open-Label Phase|Withdrawal by Subject|2|||
161636641|NCT01313624|583720853|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161636642|NCT01313624|583720852|FG000|Open-Label Phase|Lost to Follow-up|1|||
161636643|NCT01313624|583720853|FG001|Open-Label Phase|Lost to Follow-up|1|||
161636644|NCT05043883|583720854|FG000|Overall Study|Minimum required measurements could not be taken|4|||
161636645|NCT02447718|583720857|FG000|Overall Study|Lost to Follow-up|8|||
161636646|NCT02447718|583720858|FG001|Overall Study|Lost to Follow-up|0|||
161636647|NCT02447718|583720857|FG000|Overall Study|Withdrawal by Subject|3|||
161636648|NCT02447718|583720858|FG001|Overall Study|Withdrawal by Subject|0|||
161636649|NCT02447718|583720857|FG000|Overall Study|Screen Failure|1|||
161636650|NCT02447718|583720858|FG001|Overall Study|Screen Failure|0|||
161636651|NCT00468130|583720861|FG000|Overall Study|Adverse Event|2|||
161636652|NCT00468130|583720862|FG001|Overall Study|Adverse Event|1|||
161636653|NCT00468130|583720861|FG000|Overall Study|Withdrawal by Subject|0|||
161636654|NCT00468130|583720862|FG001|Overall Study|Withdrawal by Subject|1|||
161636655|NCT03772613|583720863|FG000|Overall Study|Lost to Follow-up|0|||
161636656|NCT03772613|583720864|FG001|Overall Study|Lost to Follow-up|1|||
161636657|NCT03772613|583720865|FG002|Overall Study|Lost to Follow-up|1|||
161636658|NCT01837797|583720874|FG000|Period 1|Adverse Event|9|||
161636659|NCT01837797|583720875|FG001|Period 1|Adverse Event|0|||
161636660|NCT01837797|583720876|FG002|Period 1|Adverse Event|0|||
161636661|NCT01837797|583720877|FG003|Period 1|Adverse Event|0|||
161636662|NCT01837797|583720878|FG004|Period 1|Adverse Event|0|||
161636663|NCT01837797|583720874|FG000|Period 1|Withdrawal by Subject|6|||
161636664|NCT01837797|583720875|FG001|Period 1|Withdrawal by Subject|0|||
161636665|NCT01837797|583720876|FG002|Period 1|Withdrawal by Subject|0|||
161636666|NCT01837797|583720877|FG003|Period 1|Withdrawal by Subject|0|||
161636667|NCT01837797|583720878|FG004|Period 1|Withdrawal by Subject|0|||
161636668|NCT01837797|583720874|FG000|Period 1|Administrative reasons|76|||
161636669|NCT01837797|583720875|FG001|Period 1|Administrative reasons|0|||
161636670|NCT01837797|583720876|FG002|Period 1|Administrative reasons|0|||
161636671|NCT01837797|583720877|FG003|Period 1|Administrative reasons|0|||
161636672|NCT01837797|583720878|FG004|Period 1|Administrative reasons|0|||
161636673|NCT01837797|583720874|FG000|Period 1|Withdrawal of consent before treatment|1|||
161636674|NCT01837797|583720875|FG001|Period 1|Withdrawal of consent before treatment|0|||
161636675|NCT01837797|583720876|FG002|Period 1|Withdrawal of consent before treatment|0|||
161636676|NCT01837797|583720877|FG003|Period 1|Withdrawal of consent before treatment|0|||
161636677|NCT01837797|583720878|FG004|Period 1|Withdrawal of consent before treatment|0|||
161687012|NCT03246958|583907120|FG003|Overall Study|Over enrollment|0|||
161636678|NCT01837797|583720874|FG000|Period 1|Other|10|||
161636679|NCT01837797|583720875|FG001|Period 1|Other|0|||
161636680|NCT01837797|583720876|FG002|Period 1|Other|0|||
161636681|NCT01837797|583720877|FG003|Period 1|Other|0|||
161636682|NCT01837797|583720878|FG004|Period 1|Other|0|||
161636683|NCT01837797|583720874|FG000|Period 2|Administrative or other reasons|0|||
161636684|NCT01837797|583720875|FG001|Period 2|Administrative or other reasons|5|||
161636685|NCT01837797|583720876|FG002|Period 2|Administrative or other reasons|2|||
161636686|NCT01837797|583720877|FG003|Period 2|Administrative or other reasons|4|||
161636687|NCT01837797|583720878|FG004|Period 2|Administrative or other reasons|0|||
161636688|NCT01837797|583720874|FG000|Period 2|Adverse Event|0|||
161636689|NCT01837797|583720875|FG001|Period 2|Adverse Event|0|||
161636690|NCT01837797|583720876|FG002|Period 2|Adverse Event|0|||
161636691|NCT01837797|583720877|FG003|Period 2|Adverse Event|1|||
161636692|NCT01837797|583720878|FG004|Period 2|Adverse Event|0|||
161636693|NCT01837797|583720874|FG000|Period 3|Adverse Event|0|||
161636694|NCT01837797|583720875|FG001|Period 3|Adverse Event|0|||
161636695|NCT01837797|583720876|FG002|Period 3|Adverse Event|0|||
161636696|NCT01837797|583720877|FG003|Period 3|Adverse Event|0|||
161636697|NCT01837797|583720878|FG004|Period 3|Adverse Event|1|||
161636698|NCT01837797|583720874|FG000|Period 3|Administrative reasons|0|||
161636699|NCT01837797|583720875|FG001|Period 3|Administrative reasons|0|||
161636700|NCT01837797|583720876|FG002|Period 3|Administrative reasons|0|||
161636701|NCT01837797|583720877|FG003|Period 3|Administrative reasons|0|||
161636702|NCT01837797|583720878|FG004|Period 3|Administrative reasons|20|||
161636703|NCT01837797|583720874|FG000|Period 3|Other|0|||
161636704|NCT01837797|583720875|FG001|Period 3|Other|0|||
161636705|NCT01837797|583720876|FG002|Period 3|Other|0|||
161636706|NCT01837797|583720877|FG003|Period 3|Other|0|||
161636707|NCT01837797|583720878|FG004|Period 3|Other|2|||
161636708|NCT03797989|583720899|FG000|VAC069A|Withdrawal by Subject|0|||
161636709|NCT03797989|583720900|FG001|VAC069A|Withdrawal by Subject|0|||
161636710|NCT03797989|583720901|FG002|VAC069A|Withdrawal by Subject|1|||
161636711|NCT03797989|583720902|FG003|VAC069A|Withdrawal by Subject|0|||
161636712|NCT03797989|583720903|FG004|VAC069A|Withdrawal by Subject|0|||
161636713|NCT03797989|583720904|FG005|VAC069A|Withdrawal by Subject|0|||
161636714|NCT03797989|583720905|FG006|VAC069A|Withdrawal by Subject|0|||
161636715|NCT03797989|583720906|FG007|VAC069A|Withdrawal by Subject|0|||
161636716|NCT03797989|583720907|FG008|VAC069A|Withdrawal by Subject|0|||
161636717|NCT03797989|583720908|FG009|VAC069A|Withdrawal by Subject|0|||
161636718|NCT03797989|583720909|FG010|VAC069A|Withdrawal by Subject|0|||
161636719|NCT03797989|583720910|FG011|VAC069A|Withdrawal by Subject|0|||
161636720|NCT04052997|583720912|FG000|Overall Study|Withdrawal by Subject|17|||
161636721|NCT04052997|583720912|FG000|Overall Study|Physician Decision|50|||
161636722|NCT04052997|583720912|FG000|Overall Study|Death|43|||
161636723|NCT04052997|583720912|FG000|Overall Study|Lost to Follow-up|5|||
161636724|NCT04052997|583720912|FG000|Overall Study|Progression of Disease|1|||
161636725|NCT04522778|583720913|FG000|Overall Study|Patient did not want to wear the device|1|||
161636726|NCT04522778|583720914|FG001|Overall Study|Patient did not want to wear the device|0|||
161636727|NCT04522778|583720913|FG000|Overall Study|Lost to Follow-up|0|||
161636728|NCT04522778|583720914|FG001|Overall Study|Lost to Follow-up|1|||
161636729|NCT00069277|583720915|FG000|Overall Study|Adverse Event|3|||
161636730|NCT00069277|583720915|FG000|Overall Study|Withdrawal by Subject|1|||
161636731|NCT00069277|583720915|FG000|Overall Study|Progressive Disease|15|||
161636732|NCT00069277|583720915|FG000|Overall Study|Physician Decision|2|||
161636733|NCT04594733|583720916|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161636734|NCT04594733|583720917|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161636735|NCT04594733|583720916|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
161636736|NCT04594733|583720917|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
161636737|NCT04594733|583720916|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
161636738|NCT04594733|583720917|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161636739|NCT01225159|583720922|FG000|Overall Study|Change operation|1|||
161636740|NCT01225159|583720923|FG001|Overall Study|Change operation|0|||
161636741|NCT01220856|583720926|FG000|Overall Study|graft loss|3|||
161636742|NCT01220856|583720927|FG001|Overall Study|graft loss|3|||
161636743|NCT01220856|583720926|FG000|Overall Study|Lost to Follow-up|1|||
161636744|NCT01220856|583720927|FG001|Overall Study|Lost to Follow-up|0|||
161636745|NCT01024036|583720928|FG000|Blinded Treatment|Adverse Event|1|||
161636746|NCT01024036|583720929|FG001|Blinded Treatment|Adverse Event|1|||
161636747|NCT01024036|583720928|FG000|Blinded Treatment|Lack of Efficacy|16|||
161636748|NCT01024036|583720929|FG001|Blinded Treatment|Lack of Efficacy|14|||
161636749|NCT01024036|583720928|FG000|Blinded Treatment|Physician Decision|1|||
161636750|NCT01024036|583720929|FG001|Blinded Treatment|Physician Decision|0|||
161636751|NCT01024036|583720928|FG000|Blinded Treatment|Death|0|||
161636752|NCT01024036|583720929|FG001|Blinded Treatment|Death|2|||
161636753|NCT01024036|583720928|FG000|Blinded Treatment|Withdrawal by Subject|4|||
161636754|NCT01024036|583720929|FG001|Blinded Treatment|Withdrawal by Subject|3|||
161636755|NCT01024036|583720928|FG000|Unblinded Treatment|Adverse Event|0|||
161636756|NCT01024036|583720929|FG001|Unblinded Treatment|Adverse Event|1|||
161834655|NCT01813071|584435713|FG000|Overall Study|Physician Decision|0|||
161834656|NCT01813071|584435714|FG001|Overall Study|Physician Decision|0|||
161834657|NCT01813071|584435715|FG002|Overall Study|Physician Decision|0|||
161834658|NCT01813071|584435716|FG003|Overall Study|Physician Decision|0|||
161834659|NCT01813071|584435717|FG004|Overall Study|Physician Decision|0|||
161834660|NCT01813071|584435718|FG005|Overall Study|Physician Decision|0|||
161834661|NCT01813071|584435719|FG006|Overall Study|Physician Decision|1|||
161834662|NCT01813071|584435720|FG007|Overall Study|Physician Decision|0|||
161834663|NCT01813071|584435721|FG008|Overall Study|Physician Decision|0|||
161834664|NCT01813071|584435713|FG000|Overall Study|Met inc/exc criteria|0|||
161834665|NCT01813071|584435714|FG001|Overall Study|Met inc/exc criteria|0|||
161834666|NCT01813071|584435715|FG002|Overall Study|Met inc/exc criteria|0|||
161834667|NCT01813071|584435716|FG003|Overall Study|Met inc/exc criteria|0|||
161834668|NCT01813071|584435717|FG004|Overall Study|Met inc/exc criteria|0|||
161834669|NCT01813071|584435718|FG005|Overall Study|Met inc/exc criteria|1|||
161834670|NCT01813071|584435719|FG006|Overall Study|Met inc/exc criteria|0|||
161834671|NCT01813071|584435720|FG007|Overall Study|Met inc/exc criteria|1|||
161834672|NCT01813071|584435721|FG008|Overall Study|Met inc/exc criteria|1|||
161834673|NCT00307931|584435722|FG000|Overall Study|Adverse Event|1|||
161834674|NCT02442271|584435729|FG000|Overall Study|Adverse Event|1|||
161834675|NCT02442271|584435729|FG000|Overall Study|Withdrew Consent|1|||
161834676|NCT02442271|584435729|FG000|Overall Study|Lost to Follow-up|1|||
161834677|NCT02442271|584435729|FG000|Overall Study|Other|1|||
161834678|NCT00831623|584435733|FG000|Overall Study|Withdrawal by Subject|9|||
161834679|NCT00831623|584435733|FG000|Overall Study|Lost to Follow-up|1|||
161834680|NCT00831623|584435733|FG000|Overall Study|Not 2 years post-treatment|12|||
161834681|NCT01138111|584435735|FG000|Overall Study|Withdrawal by Subject|5|||
161834682|NCT01138111|584435735|FG000|Overall Study|Adverse Event|1|||
161834683|NCT01138111|584435735|FG000|Overall Study|Death|1|||
161834684|NCT01138111|584435735|FG000|Overall Study|Lost to Follow-up|2|||
161834685|NCT01118117|584435736|FG000|Overall Study|Death|8|||
161834686|NCT01118117|584435737|FG001|Overall Study|Death|0|||
161834687|NCT01118117|584435736|FG000|Overall Study|Lost to Follow-up|6|||
161834688|NCT01118117|584435737|FG001|Overall Study|Lost to Follow-up|0|||
161834689|NCT01118117|584435736|FG000|Overall Study|Missed 12 Month Visit|7|||
161834690|NCT01118117|584435737|FG001|Overall Study|Missed 12 Month Visit|0|||
161834691|NCT02149121|584435738|FG000|Main Study Period|Lack of Efficacy|2|||
161834692|NCT02149121|584435739|FG001|Main Study Period|Lack of Efficacy|2|||
161834693|NCT02149121|584435740|FG002|Main Study Period|Lack of Efficacy|1|||
161834694|NCT02149121|584435741|FG003|Main Study Period|Lack of Efficacy|0|||
161834695|NCT02149121|584435742|FG004|Main Study Period|Lack of Efficacy|0|||
161834696|NCT02149121|584435743|FG005|Main Study Period|Lack of Efficacy|0|||
161834697|NCT02149121|584435744|FG006|Main Study Period|Lack of Efficacy|0|||
161834698|NCT02149121|584435738|FG000|Main Study Period|Withdrawal by Subject|9|||
161834699|NCT02149121|584435739|FG001|Main Study Period|Withdrawal by Subject|5|||
161834700|NCT02149121|584435740|FG002|Main Study Period|Withdrawal by Subject|1|||
161834701|NCT02149121|584435741|FG003|Main Study Period|Withdrawal by Subject|0|||
161834702|NCT02149121|584435742|FG004|Main Study Period|Withdrawal by Subject|0|||
161834703|NCT02149121|584435743|FG005|Main Study Period|Withdrawal by Subject|0|||
161834704|NCT02149121|584435744|FG006|Main Study Period|Withdrawal by Subject|0|||
161834705|NCT02149121|584435738|FG000|Main Study Period|Adverse Event|2|||
161834706|NCT02149121|584435739|FG001|Main Study Period|Adverse Event|5|||
161834707|NCT02149121|584435740|FG002|Main Study Period|Adverse Event|1|||
161834708|NCT02149121|584435741|FG003|Main Study Period|Adverse Event|0|||
161834709|NCT02149121|584435742|FG004|Main Study Period|Adverse Event|0|||
161834710|NCT02149121|584435743|FG005|Main Study Period|Adverse Event|0|||
161834711|NCT02149121|584435744|FG006|Main Study Period|Adverse Event|0|||
161834712|NCT02149121|584435738|FG000|Main Study Period|Protocol Violation|2|||
161834713|NCT02149121|584435739|FG001|Main Study Period|Protocol Violation|0|||
161834714|NCT02149121|584435740|FG002|Main Study Period|Protocol Violation|0|||
161834715|NCT02149121|584435741|FG003|Main Study Period|Protocol Violation|0|||
161834716|NCT02149121|584435742|FG004|Main Study Period|Protocol Violation|0|||
161834717|NCT02149121|584435743|FG005|Main Study Period|Protocol Violation|0|||
161834718|NCT02149121|584435744|FG006|Main Study Period|Protocol Violation|0|||
161834719|NCT02149121|584435738|FG000|Main Study Period|Lost to Follow-up|2|||
161834720|NCT02149121|584435739|FG001|Main Study Period|Lost to Follow-up|1|||
161834721|NCT02149121|584435740|FG002|Main Study Period|Lost to Follow-up|0|||
161834722|NCT02149121|584435741|FG003|Main Study Period|Lost to Follow-up|0|||
161834723|NCT02149121|584435742|FG004|Main Study Period|Lost to Follow-up|0|||
161834724|NCT02149121|584435743|FG005|Main Study Period|Lost to Follow-up|0|||
161834725|NCT02149121|584435744|FG006|Main Study Period|Lost to Follow-up|0|||
161834726|NCT02149121|584435738|FG000|Main Study Period|Death|1|||
161834727|NCT02149121|584435739|FG001|Main Study Period|Death|0|||
161834728|NCT02149121|584435740|FG002|Main Study Period|Death|0|||
161834729|NCT02149121|584435741|FG003|Main Study Period|Death|0|||
161834730|NCT02149121|584435742|FG004|Main Study Period|Death|0|||
161834731|NCT02149121|584435743|FG005|Main Study Period|Death|0|||
161834732|NCT02149121|584435744|FG006|Main Study Period|Death|0|||
161834733|NCT02149121|584435738|FG000|Main Study Period|Physician Decision|1|||
161636757|NCT01024036|583720928|FG000|Unblinded Treatment|Lack of Efficacy|0|||
161636758|NCT01024036|583720929|FG001|Unblinded Treatment|Lack of Efficacy|2|||
161636759|NCT01024036|583720928|FG000|Follow-Up Period|Lost to Follow-up|1|||
161636760|NCT01024036|583720929|FG001|Follow-Up Period|Lost to Follow-up|1|||
161636761|NCT01024036|583720928|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161636762|NCT01024036|583720929|FG001|Follow-Up Period|Withdrawal by Subject|1|||
161636763|NCT01024036|583720928|FG000|Follow-Up Period|Adverse Event|4|||
161636764|NCT01024036|583720929|FG001|Follow-Up Period|Adverse Event|1|||
161636765|NCT03512288|583720934|FG000|Overall Study|Adverse Event|1|||
161636766|NCT03512288|583720935|FG001|Overall Study|Adverse Event|0|||
161636767|NCT03512288|583720934|FG000|Overall Study|Lost to Follow-up|12|||
161636768|NCT03512288|583720935|FG001|Overall Study|Lost to Follow-up|15|||
161636769|NCT03512288|583720934|FG000|Overall Study|Physician Decision|0|||
161636770|NCT03512288|583720935|FG001|Overall Study|Physician Decision|2|||
161636771|NCT03512288|583720934|FG000|Overall Study|Protocol Violation|6|||
161636772|NCT03512288|583720935|FG001|Overall Study|Protocol Violation|4|||
161636773|NCT03512288|583720934|FG000|Overall Study|Medication error without associated adverse event|1|||
161636774|NCT03512288|583720935|FG001|Overall Study|Medication error without associated adverse event|0|||
161636775|NCT03512288|583720934|FG000|Overall Study|No longer met eligibility criteria|5|||
161636776|NCT03512288|583720935|FG001|Overall Study|No longer met eligibility criteria|2|||
161636777|NCT03512288|583720934|FG000|Overall Study|Withdrawal by parent/guardian|14|||
161636778|NCT03512288|583720935|FG001|Overall Study|Withdrawal by parent/guardian|18|||
161636779|NCT03512288|583720934|FG000|Overall Study|Other|1|||
161636780|NCT03512288|583720935|FG001|Overall Study|Other|1|||
161636781|NCT03512288|583720934|FG000|Overall Study|Randomized but not treated|1|||
161636782|NCT03512288|583720935|FG001|Overall Study|Randomized but not treated|1|||
161636783|NCT04814992|583720936|FG000|Overall Study|Withdrawal by Subject|6|||
161636784|NCT04814992|583720937|FG001|Overall Study|Withdrawal by Subject|3|||
161636785|NCT04814992|583720936|FG000|Overall Study|Lost to Follow-up|1|||
161636786|NCT04814992|583720937|FG001|Overall Study|Lost to Follow-up|4|||
161687013|NCT03246958|583907121|FG004|Overall Study|Over enrollment|0|||
161687014|NCT03246958|583907122|FG005|Overall Study|Over enrollment|0|||
161687015|NCT03246958|583907123|FG006|Overall Study|Over enrollment|0|||
161687016|NCT01650636|583907126|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
161687017|NCT01650636|583907127|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
161687018|NCT01650636|583907126|FG000|Washout up to 5 Months|Physician Decision|2|||
161687019|NCT01650636|583907127|FG001|Washout up to 5 Months|Physician Decision|2|||
161687020|NCT01650636|583907126|FG000|Washout up to 5 Months|Death|1|||
161687021|NCT01650636|583907127|FG001|Washout up to 5 Months|Death|0|||
161687022|NCT01650636|583907126|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
161687023|NCT01650636|583907127|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
161687024|NCT01650636|583907126|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
161687025|NCT01650636|583907127|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
161687026|NCT01650636|583907126|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
161687027|NCT01650636|583907127|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
161687028|NCT01560780|583907128|FG000|Overall Study|Death|2|||
161687029|NCT01560780|583907129|FG001|Overall Study|Death|1|||
161687030|NCT01560780|583907128|FG000|Overall Study|Patient Preference|11|||
161687031|NCT01560780|583907129|FG001|Overall Study|Patient Preference|11|||
161687032|NCT01500278|583907130|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
161687033|NCT01500278|583907131|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
161687034|NCT01500278|583907130|FG000|Week 0 - Week 12|Protocol Violation|10|||
161687035|NCT01500278|583907131|FG001|Week 0 - Week 12|Protocol Violation|16|||
161687036|NCT01500278|583907130|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
161687037|NCT01500278|583907131|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
161687038|NCT01500278|583907130|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
161687039|NCT01500278|583907131|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
161687040|NCT01500278|583907130|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
161687041|NCT01500278|583907131|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
161687042|NCT01500278|583907130|FG000|Week 0 - Week 12|Patient decision|1|||
161687043|NCT01500278|583907131|FG001|Week 0 - Week 12|Patient decision|0|||
161687044|NCT01500278|583907130|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
161687045|NCT01500278|583907131|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
161687046|NCT01500278|583907130|FG000|Week 0 - Week 12|Investigator decision|1|||
161687047|NCT01500278|583907131|FG001|Week 0 - Week 12|Investigator decision|0|||
161687048|NCT01500278|583907130|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
161687049|NCT01500278|583907131|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
161687050|NCT01500278|583907130|FG000|Week 0 - Week 12|Sponsor decision|1|||
161687051|NCT01500278|583907131|FG001|Week 0 - Week 12|Sponsor decision|0|||
161687052|NCT01500278|583907130|FG000|Week 0 - Week 12|Personal reason|0|||
161687053|NCT01500278|583907131|FG001|Week 0 - Week 12|Personal reason|1|||
161687054|NCT01500278|583907130|FG000|Week 0 - Week 12|Other serious disease|0|||
161687055|NCT01500278|583907131|FG001|Week 0 - Week 12|Other serious disease|1|||
161687056|NCT01500278|583907130|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
161687057|NCT01500278|583907131|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
161834734|NCT02149121|584435739|FG001|Main Study Period|Physician Decision|0|||
161834735|NCT02149121|584435740|FG002|Main Study Period|Physician Decision|0|||
161834736|NCT02149121|584435741|FG003|Main Study Period|Physician Decision|0|||
161834737|NCT02149121|584435742|FG004|Main Study Period|Physician Decision|0|||
161834738|NCT02149121|584435743|FG005|Main Study Period|Physician Decision|0|||
161834739|NCT02149121|584435744|FG006|Main Study Period|Physician Decision|0|||
161834740|NCT02149121|584435738|FG000|Main Study Period|Developed any malignancy|0|||
161834741|NCT02149121|584435739|FG001|Main Study Period|Developed any malignancy|1|||
161834742|NCT02149121|584435740|FG002|Main Study Period|Developed any malignancy|1|||
161834743|NCT02149121|584435741|FG003|Main Study Period|Developed any malignancy|0|||
161834744|NCT02149121|584435742|FG004|Main Study Period|Developed any malignancy|0|||
161834745|NCT02149121|584435743|FG005|Main Study Period|Developed any malignancy|0|||
161834746|NCT02149121|584435744|FG006|Main Study Period|Developed any malignancy|0|||
161834747|NCT02149121|584435738|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
161834748|NCT02149121|584435739|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
161834749|NCT02149121|584435740|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
161834750|NCT02149121|584435741|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
161834751|NCT02149121|584435742|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
161834752|NCT02149121|584435743|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
161834753|NCT02149121|584435744|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
161834754|NCT02149121|584435738|FG000|Main Study Period|Disease progression|0|||
161834755|NCT02149121|584435739|FG001|Main Study Period|Disease progression|1|||
161834756|NCT02149121|584435740|FG002|Main Study Period|Disease progression|0|||
161834757|NCT02149121|584435741|FG003|Main Study Period|Disease progression|0|||
161834758|NCT02149121|584435742|FG004|Main Study Period|Disease progression|0|||
161834759|NCT02149121|584435743|FG005|Main Study Period|Disease progression|0|||
161834760|NCT02149121|584435744|FG006|Main Study Period|Disease progression|0|||
161687058|NCT01500278|583907130|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
161687059|NCT01500278|583907131|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
161687060|NCT01500278|583907130|FG000|Week 13 - Week 104|Protocol Violation|6|||
161687061|NCT01500278|583907131|FG001|Week 13 - Week 104|Protocol Violation|6|||
161687062|NCT01500278|583907130|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
161687063|NCT01500278|583907131|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
161687064|NCT01500278|583907130|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
161687065|NCT01500278|583907131|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
161687066|NCT01500278|583907130|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
161687067|NCT01500278|583907131|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
161834761|NCT02149121|584435738|FG000|Extension Study Period|Withdrawal by Subject|0|||
161834762|NCT02149121|584435739|FG001|Extension Study Period|Withdrawal by Subject|0|||
161834763|NCT02149121|584435740|FG002|Extension Study Period|Withdrawal by Subject|0|||
161834764|NCT02149121|584435741|FG003|Extension Study Period|Withdrawal by Subject|1|||
161834765|NCT02149121|584435742|FG004|Extension Study Period|Withdrawal by Subject|0|||
161834766|NCT02149121|584435743|FG005|Extension Study Period|Withdrawal by Subject|2|||
161834767|NCT02149121|584435744|FG006|Extension Study Period|Withdrawal by Subject|0|||
161834768|NCT01408563|584437146|FG000|Overall Study|Ineligible after consent/ registration|2|||
161834769|NCT02119286|584437151|FG000|Overall Study|Adverse Event|9|||
161834770|NCT02119286|584437152|FG001|Overall Study|Adverse Event|7|||
161834771|NCT02119286|584437153|FG002|Overall Study|Adverse Event|2|||
161834772|NCT02119286|584437151|FG000|Overall Study|Lack of Efficacy|11|||
161834773|NCT02119286|584437152|FG001|Overall Study|Lack of Efficacy|3|||
161834774|NCT02119286|584437153|FG002|Overall Study|Lack of Efficacy|4|||
161834775|NCT02119286|584437151|FG000|Overall Study|Lost to Follow-up|2|||
161834776|NCT02119286|584437152|FG001|Overall Study|Lost to Follow-up|0|||
161834777|NCT02119286|584437153|FG002|Overall Study|Lost to Follow-up|1|||
161834778|NCT02119286|584437151|FG000|Overall Study|Withdrawal by Subject|4|||
161834779|NCT02119286|584437152|FG001|Overall Study|Withdrawal by Subject|1|||
161834780|NCT02119286|584437153|FG002|Overall Study|Withdrawal by Subject|0|||
161834781|NCT04109313|584437154|FG000|Overall Study|Pregnancy|1|||
161834782|NCT04109313|584437154|FG000|Overall Study|Adverse Event|11|||
161834783|NCT04109313|584437154|FG000|Overall Study|Lack of Efficacy|11|||
161834784|NCT04109313|584437154|FG000|Overall Study|Lost to Follow-up|1|||
161687068|NCT01500278|583907130|FG000|Week 13 - Week 104|Non/bad compliance|7|||
161834785|NCT04109313|584437154|FG000|Overall Study|Physician Decision|2|||
161834786|NCT04109313|584437154|FG000|Overall Study|Subject Decision|13|||
161834787|NCT04109313|584437154|FG000|Overall Study|Covid-19 situation|2|||
161834788|NCT01272921|584437155|FG000|Overall Study|Protocol Violation|2|||
161834789|NCT01272921|584437156|FG001|Overall Study|Protocol Violation|1|||
161834790|NCT01132664|584437157|FG000|Phase lb|Adverse Event|0|||
161834791|NCT01132664|584437158|FG001|Phase lb|Adverse Event|1|||
161834792|NCT01132664|584437159|FG002|Phase lb|Adverse Event|0|||
161834793|NCT01132664|584437160|FG003|Phase lb|Adverse Event|0|||
161834794|NCT01132664|584437161|FG004|Phase lb|Adverse Event|0|||
161834795|NCT01132664|584437157|FG000|Phase lb|Withdrawal by Subject|1|||
161834796|NCT01132664|584437158|FG001|Phase lb|Withdrawal by Subject|2|||
161834797|NCT01132664|584437159|FG002|Phase lb|Withdrawal by Subject|0|||
161834798|NCT01132664|584437160|FG003|Phase lb|Withdrawal by Subject|0|||
161834799|NCT01132664|584437161|FG004|Phase lb|Withdrawal by Subject|0|||
161834800|NCT01132664|584437157|FG000|Phase lb|Disease Progression|4|||
161834801|NCT01132664|584437158|FG001|Phase lb|Disease Progression|9|||
161834802|NCT01132664|584437159|FG002|Phase lb|Disease Progression|0|||
161834803|NCT01132664|584437160|FG003|Phase lb|Disease Progression|0|||
161834804|NCT01132664|584437161|FG004|Phase lb|Disease Progression|0|||
161834805|NCT01132664|584437157|FG000|Phase ll|Death|0|||
161834806|NCT01132664|584437158|FG001|Phase ll|Death|0|||
161834807|NCT01132664|584437159|FG002|Phase ll|Death|2|||
161834808|NCT01132664|584437160|FG003|Phase ll|Death|0|||
161834809|NCT01132664|584437161|FG004|Phase ll|Death|0|||
161834810|NCT01132664|584437157|FG000|Phase ll|Adverse Event|0|||
161834811|NCT01132664|584437158|FG001|Phase ll|Adverse Event|0|||
161834812|NCT01132664|584437159|FG002|Phase ll|Adverse Event|10|||
161834813|NCT01132664|584437160|FG003|Phase ll|Adverse Event|0|||
161834814|NCT01132664|584437161|FG004|Phase ll|Adverse Event|0|||
161834815|NCT01132664|584437157|FG000|Phase ll|Withdrawal by Subject|0|||
161834816|NCT01132664|584437158|FG001|Phase ll|Withdrawal by Subject|0|||
161834817|NCT01132664|584437159|FG002|Phase ll|Withdrawal by Subject|3|||
161834818|NCT01132664|584437160|FG003|Phase ll|Withdrawal by Subject|0|||
161834819|NCT01132664|584437161|FG004|Phase ll|Withdrawal by Subject|0|||
161834820|NCT01132664|584437157|FG000|Phase ll|Disease progression|0|||
161834821|NCT01132664|584437158|FG001|Phase ll|Disease progression|0|||
161834822|NCT01132664|584437159|FG002|Phase ll|Disease progression|35|||
161834823|NCT01132664|584437160|FG003|Phase ll|Disease progression|0|||
161834824|NCT01132664|584437161|FG004|Phase ll|Disease progression|0|||
161834825|NCT01132664|584437157|FG000|BM Cohort|Disease progression|0|||
161834826|NCT01132664|584437158|FG001|BM Cohort|Disease progression|0|||
161834827|NCT01132664|584437159|FG002|BM Cohort|Disease progression|0|||
161834828|NCT01132664|584437160|FG003|BM Cohort|Disease progression|3|||
161834829|NCT01132664|584437161|FG004|BM Cohort|Disease progression|4|||
161834830|NCT01132664|584437157|FG000|BM Cohort|Adverse Event|0|||
161834831|NCT01132664|584437158|FG001|BM Cohort|Adverse Event|0|||
161834832|NCT01132664|584437159|FG002|BM Cohort|Adverse Event|0|||
161834833|NCT01132664|584437160|FG003|BM Cohort|Adverse Event|0|||
161834834|NCT01132664|584437161|FG004|BM Cohort|Adverse Event|1|||
161834835|NCT01132664|584437157|FG000|BM Cohort|Withdrawal by Subject|0|||
161834836|NCT01132664|584437158|FG001|BM Cohort|Withdrawal by Subject|0|||
161834837|NCT01132664|584437159|FG002|BM Cohort|Withdrawal by Subject|0|||
161834838|NCT01132664|584437160|FG003|BM Cohort|Withdrawal by Subject|0|||
161687069|NCT01500278|583907131|FG001|Week 13 - Week 104|Non/bad compliance|5|||
161834839|NCT01132664|584437161|FG004|BM Cohort|Withdrawal by Subject|1|||
161834840|NCT04271735|584437163|FG000|Overall Study|Physician Decision|2|||
161834841|NCT04271735|584437164|FG001|Overall Study|Physician Decision|0|||
161834842|NCT04268316|584437165|FG000|Overall Study|Withdrawal by Subject|2|||
161834843|NCT04268316|584437166|FG001|Overall Study|Withdrawal by Subject|1|||
161834844|NCT04268316|584437167|FG002|Overall Study|Withdrawal by Subject|0|||
161834845|NCT02040779|584437169|FG000|Overall Study|Adverse Event|1|||
161834846|NCT02040779|584437170|FG001|Overall Study|Adverse Event|0|||
161834847|NCT02040779|584437171|FG002|Overall Study|Adverse Event|0|||
161834848|NCT02040779|584437169|FG000|Overall Study|Withdrawal by Subject|4|||
161834849|NCT02040779|584437170|FG001|Overall Study|Withdrawal by Subject|1|||
161834850|NCT02040779|584437171|FG002|Overall Study|Withdrawal by Subject|3|||
161834851|NCT02040779|584437169|FG000|Overall Study|Non-compliance|0|||
161834852|NCT02040779|584437170|FG001|Overall Study|Non-compliance|1|||
161834853|NCT02040779|584437171|FG002|Overall Study|Non-compliance|0|||
161834854|NCT02040779|584437169|FG000|Overall Study|Protocol Violation|2|||
161834855|NCT02040779|584437170|FG001|Overall Study|Protocol Violation|1|||
161834856|NCT02040779|584437171|FG002|Overall Study|Protocol Violation|0|||
161834857|NCT02040779|584437169|FG000|Overall Study|Lost to Follow-up|1|||
161834858|NCT02040779|584437170|FG001|Overall Study|Lost to Follow-up|2|||
161834859|NCT02040779|584437171|FG002|Overall Study|Lost to Follow-up|1|||
161834860|NCT02040779|584437169|FG000|Overall Study|Lack of Efficacy|4|||
161834861|NCT02040779|584437170|FG001|Overall Study|Lack of Efficacy|2|||
161834862|NCT02040779|584437171|FG002|Overall Study|Lack of Efficacy|0|||
161834863|NCT02132637|584437172|FG000|Study Period 1|Withdrawal by Subject|0|||
161834864|NCT02132637|584437173|FG001|Study Period 1|Withdrawal by Subject|4|||
161834865|NCT02132637|584437172|FG000|Study Period 1|Physician Decision|1|||
161834866|NCT02132637|584437173|FG001|Study Period 1|Physician Decision|0|||
161834867|NCT02132637|584437172|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
161834868|NCT02132637|584437173|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
161834869|NCT02132637|584437172|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
161834870|NCT02132637|584437173|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
161834871|NCT00922272|584437176|FG000|Open-label Phase|Adverse Event|5|||
161834872|NCT00922272|584437177|FG001|Open-label Phase|Adverse Event|0|||
161834873|NCT00922272|584437176|FG000|Open-label Phase|Protocol Violation|1|||
161834874|NCT00922272|584437177|FG001|Open-label Phase|Protocol Violation|0|||
161834875|NCT00922272|584437176|FG000|Open-label Phase|Withdrawal by Subject|11|||
161834876|NCT00922272|584437177|FG001|Open-label Phase|Withdrawal by Subject|0|||
161834877|NCT00922272|584437176|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
161834878|NCT00922272|584437177|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
161834879|NCT00922272|584437176|FG000|Open-label Phase|Withdrawal criteria met|5|||
161834880|NCT00922272|584437177|FG001|Open-label Phase|Withdrawal criteria met|0|||
161834881|NCT00922272|584437176|FG000|Double-blind Phase|Adverse Event|1|||
161834882|NCT00922272|584437177|FG001|Double-blind Phase|Adverse Event|1|||
161834883|NCT00922272|584437176|FG000|Double-blind Phase|Withdrawal by Subject|1|||
161834884|NCT00922272|584437177|FG001|Double-blind Phase|Withdrawal by Subject|1|||
161834885|NCT00922272|584437176|FG000|Double-blind Phase|Lost to Follow-up|2|||
161834886|NCT00922272|584437177|FG001|Double-blind Phase|Lost to Follow-up|1|||
161834887|NCT00922272|584437176|FG000|Double-blind Phase|Withdrawal criteria met|1|||
161834888|NCT00922272|584437177|FG001|Double-blind Phase|Withdrawal criteria met|1|||
161834889|NCT00922272|584437176|FG000|Double-blind Phase|Noncompliance|1|||
161834890|NCT00922272|584437177|FG001|Double-blind Phase|Noncompliance|1|||
161834891|NCT00922272|584437176|FG000|Double-blind Phase|Positive urine drug screen|1|||
161834892|NCT00922272|584437177|FG001|Double-blind Phase|Positive urine drug screen|1|||
161834893|NCT03197558|584437178|FG000|Overall Study|Tubes not placed|1|||
161834894|NCT02581163|584437180|FG000|Overall Study|Failure to return|15|||
161834895|NCT02581163|584437180|FG000|Overall Study|Insufficient virological response|3|||
161636787|NCT02366143|583722995|FG000|Overall Study|Death|307|||
161834896|NCT02581163|584437180|FG000|Overall Study|Withdrew consent|1|||
161834897|NCT02581163|584437180|FG000|Overall Study|Death|1|||
161636788|NCT02366143|583722996|FG001|Overall Study|Death|278|||
161834898|NCT02581163|584437180|FG000|Overall Study|Other, not specified|9|||
161834899|NCT00977431|584437188|FG000|Overall Study|Other than listed|1|||
161834900|NCT00977431|584437189|FG001|Overall Study|Other than listed|0|||
161834901|NCT00977431|584437190|FG002|Overall Study|Other than listed|0|||
161834902|NCT00977431|584437191|FG003|Overall Study|Other than listed|0|||
161834903|NCT00977431|584437192|FG004|Overall Study|Other than listed|2|||
161834904|NCT00977431|584437188|FG000|Overall Study|Protocol Violation|0|||
161636789|NCT02366143|583722997|FG002|Overall Study|Death|280|||
161834905|NCT00977431|584437189|FG001|Overall Study|Protocol Violation|0|||
161834906|NCT00977431|584437190|FG002|Overall Study|Protocol Violation|1|||
161636790|NCT02366143|583722995|FG000|Overall Study|Lost to Follow-up|2|||
161636791|NCT02366143|583722996|FG001|Overall Study|Lost to Follow-up|4|||
161636792|NCT02366143|583722997|FG002|Overall Study|Lost to Follow-up|2|||
161636793|NCT02366143|583722995|FG000|Overall Study|Physician Decision|1|||
161636794|NCT02366143|583722996|FG001|Overall Study|Physician Decision|2|||
161636795|NCT02366143|583722997|FG002|Overall Study|Physician Decision|1|||
161636796|NCT02366143|583722995|FG000|Overall Study|Protocol Violation|0|||
161636797|NCT02366143|583722996|FG001|Overall Study|Protocol Violation|0|||
161636798|NCT02366143|583722997|FG002|Overall Study|Protocol Violation|2|||
161636799|NCT02366143|583722995|FG000|Overall Study|Withdrawal by Subject|16|||
161636800|NCT02366143|583722996|FG001|Overall Study|Withdrawal by Subject|17|||
161636801|NCT02366143|583722997|FG002|Overall Study|Withdrawal by Subject|22|||
161636802|NCT02366143|583722995|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
161636803|NCT02366143|583722996|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
161636804|NCT02366143|583722997|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
161636805|NCT02366143|583722995|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
161636806|NCT02366143|583722996|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
161636807|NCT02366143|583722997|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
161636808|NCT02366143|583722995|FG000|Overall Study|Randomization Error|1|||
161636809|NCT02366143|583722996|FG001|Overall Study|Randomization Error|0|||
161636810|NCT02366143|583722997|FG002|Overall Study|Randomization Error|0|||
161636811|NCT02366143|583722995|FG000|Overall Study|PI Move and Site Closure|1|||
161636812|NCT02366143|583722996|FG001|Overall Study|PI Move and Site Closure|0|||
161636813|NCT02366143|583722997|FG002|Overall Study|PI Move and Site Closure|1|||
161636814|NCT02366143|583722995|FG000|Overall Study|Study Terminated By Sponsor|0|||
161636815|NCT02366143|583722996|FG001|Overall Study|Study Terminated By Sponsor|0|||
161636816|NCT02366143|583722997|FG002|Overall Study|Study Terminated By Sponsor|2|||
161636817|NCT02366143|583722995|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
161636818|NCT02366143|583722996|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
161636819|NCT02366143|583722997|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
161636820|NCT02366143|583722995|FG000|Overall Study|Patient moved to roll-over study|1|||
161636821|NCT02366143|583722996|FG001|Overall Study|Patient moved to roll-over study|19|||
161636822|NCT02366143|583722997|FG002|Overall Study|Patient moved to roll-over study|28|||
161636823|NCT02366143|583722995|FG000|Overall Study|Patient moved to commercial stock|0|||
161636824|NCT02366143|583722996|FG001|Overall Study|Patient moved to commercial stock|0|||
161636825|NCT02366143|583722997|FG002|Overall Study|Patient moved to commercial stock|1|||
161636826|NCT02366143|583722995|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
161636827|NCT02366143|583722996|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
161636828|NCT02366143|583722997|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
161636829|NCT02366143|583722995|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
161636830|NCT02366143|583722996|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
161636831|NCT02366143|583722997|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
161636832|NCT02366143|583722995|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
161636833|NCT02366143|583722996|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
161636834|NCT02366143|583722997|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
161636835|NCT02366143|583722995|FG000|Overall Study|Requester's instructions|1|||
161636836|NCT02366143|583722996|FG001|Overall Study|Requester's instructions|1|||
161636837|NCT02366143|583722997|FG002|Overall Study|Requester's instructions|1|||
161636838|NCT02366143|583722995|FG000|Overall Study|Uneligible|0|||
161636839|NCT02366143|583722996|FG001|Overall Study|Uneligible|1|||
161636840|NCT02366143|583722997|FG002|Overall Study|Uneligible|0|||
161636841|NCT02366143|583722995|FG000|Overall Study|Post Trial Migration|0|||
161636842|NCT02366143|583722996|FG001|Overall Study|Post Trial Migration|1|||
161636843|NCT02366143|583722997|FG002|Overall Study|Post Trial Migration|0|||
161636844|NCT02366143|583722995|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
161636845|NCT02366143|583722996|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
161636846|NCT02366143|583722997|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
161636847|NCT02366143|583722995|FG000|Overall Study|Patient switched to PTAP|0|||
161636848|NCT02366143|583722996|FG001|Overall Study|Patient switched to PTAP|1|||
161636849|NCT02366143|583722997|FG002|Overall Study|Patient switched to PTAP|0|||
161636850|NCT02366143|583722995|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
161636851|NCT02366143|583722996|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
161636852|NCT02366143|583722997|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
161636853|NCT01266018|583722998|FG000|Overall Study|Physician Decision|1|||
161636854|NCT01266018|583722999|FG001|Overall Study|Physician Decision|0|||
161636855|NCT01266018|583722998|FG000|Overall Study|Progressive disease|0|||
161636856|NCT01266018|583722999|FG001|Overall Study|Progressive disease|1|||
161636857|NCT03167151|583723000|FG000|Overall Study|Withdrawal by Subject|1|||
161636858|NCT03167151|583723001|FG001|Overall Study|Withdrawal by Subject|0|||
161687070|NCT01500278|583907130|FG000|Week 13 - Week 104|Recurrent infections|1|||
161687071|NCT01500278|583907131|FG001|Week 13 - Week 104|Recurrent infections|0|||
161687072|NCT01500278|583907130|FG000|Week 13 - Week 104|False positive test|1|||
161687073|NCT01500278|583907131|FG001|Week 13 - Week 104|False positive test|2|||
161687074|NCT01500278|583907130|FG000|Week 13 - Week 104|Sponsor request|4|||
161687075|NCT01500278|583907131|FG001|Week 13 - Week 104|Sponsor request|0|||
161687076|NCT01500278|583907130|FG000|Week 13 - Week 104|Withdrawn in error|1|||
161687077|NCT01500278|583907131|FG001|Week 13 - Week 104|Withdrawn in error|0|||
161687078|NCT01500278|583907130|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
161687079|NCT01500278|583907131|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
161687080|NCT01500278|583907130|FG000|Week 13 - Week 104|Protocol deviation|1|||
161687081|NCT01500278|583907131|FG001|Week 13 - Week 104|Protocol deviation|0|||
161687082|NCT01500278|583907130|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
161636859|NCT03167151|583723002|FG002|Overall Study|Withdrawal by Subject|0|||
161636860|NCT03167151|583723000|FG000|Overall Study|No evidence of tumour at surgery|0|||
161636861|NCT03167151|583723001|FG001|Overall Study|No evidence of tumour at surgery|1|||
161636862|NCT03167151|583723002|FG002|Overall Study|No evidence of tumour at surgery|1|||
161636863|NCT01458522|583723003|FG000|Overall Study|Withdrawal by Subject|2|||
161636864|NCT01458522|583723004|FG001|Overall Study|Withdrawal by Subject|2|||
161636865|NCT01458522|583723003|FG000|Overall Study|Physician Decision|1|||
161636866|NCT01458522|583723004|FG001|Overall Study|Physician Decision|9|||
161636867|NCT00516139|583723005|FG000|Overall Study|Adverse Event|27|||
161636868|NCT00516139|583723005|FG000|Overall Study|Lost to Follow-up|1|||
161636869|NCT00516139|583723005|FG000|Overall Study|Protocol Violation|1|||
161636870|NCT00516139|583723005|FG000|Overall Study|Withdrawal by Subject|8|||
161636871|NCT00516139|583723005|FG000|Overall Study|Lack of Efficacy|1|||
161636872|NCT00589303|583723006|FG000|Overall Study|Withdrawal by Subject|2|||
161687083|NCT01500278|583907131|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
161687084|NCT01500278|583907130|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
161687085|NCT01500278|583907131|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
161687086|NCT01500278|583907130|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
161687087|NCT01500278|583907131|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
161687088|NCT01500278|583907130|FG000|Week 13 - Week 104|Relocation|0|||
161687089|NCT01500278|583907131|FG001|Week 13 - Week 104|Relocation|1|||
161687090|NCT01500278|583907130|FG000|Week 13 - Week 104|Sponsor decision|0|||
161687091|NCT01500278|583907131|FG001|Week 13 - Week 104|Sponsor decision|2|||
161687092|NCT01500278|583907130|FG000|Week 13 - Week 104|Medical monitor decision|0|||
161687093|NCT01500278|583907131|FG001|Week 13 - Week 104|Medical monitor decision|2|||
161687094|NCT01500278|583907130|FG000|Week 13 - Week 104|Personal reason|0|||
161687095|NCT01500278|583907131|FG001|Week 13 - Week 104|Personal reason|1|||
161687096|NCT01500278|583907130|FG000|Week 13 - Week 104|Not completed|0|||
161687097|NCT01500278|583907131|FG001|Week 13 - Week 104|Not completed|1|||
161687098|NCT01500278|583907130|FG000|Week 13 - Week 104|Death|2|||
161687099|NCT01500278|583907131|FG001|Week 13 - Week 104|Death|4|||
161687100|NCT01500278|583907130|FG000|Week 13 - Week 104|Adverse Event|54|||
161687101|NCT01500278|583907131|FG001|Week 13 - Week 104|Adverse Event|54|||
161687102|NCT00414453|583907132|FG000|Overall Study|Abnormal lab work|16|||
161687103|NCT01157364|583907133|FG000|Overall Study|Other Reasons|1|||
161687104|NCT01157364|583907134|FG001|Overall Study|Other Reasons|1|||
161687105|NCT01157364|583907135|FG002|Overall Study|Other Reasons|2|||
161687106|NCT01157364|583907136|FG003|Overall Study|Other Reasons|1|||
161687107|NCT01157364|583907137|FG004|Overall Study|Other Reasons|0|||
161687108|NCT01157364|583907138|FG005|Overall Study|Other Reasons|0|||
161687109|NCT01157364|583907133|FG000|Overall Study|Personal Reasons|0|||
161687110|NCT01157364|583907134|FG001|Overall Study|Personal Reasons|2|||
161687111|NCT01157364|583907135|FG002|Overall Study|Personal Reasons|0|||
161687112|NCT01157364|583907136|FG003|Overall Study|Personal Reasons|0|||
161687113|NCT01157364|583907137|FG004|Overall Study|Personal Reasons|1|||
161687114|NCT01157364|583907138|FG005|Overall Study|Personal Reasons|1|||
161636873|NCT00589303|583723007|FG001|Overall Study|Withdrawal by Subject|1|||
161636874|NCT00730015|583723008|FG000|Overall Study|Adverse Event|11|||
161636875|NCT00730015|583723009|FG001|Overall Study|Adverse Event|10|||
161687115|NCT01157364|583907133|FG000|Overall Study|Lost to Follow-up|1|||
161687116|NCT01157364|583907134|FG001|Overall Study|Lost to Follow-up|0|||
161687117|NCT01157364|583907135|FG002|Overall Study|Lost to Follow-up|1|||
161687118|NCT01157364|583907136|FG003|Overall Study|Lost to Follow-up|0|||
161687119|NCT01157364|583907137|FG004|Overall Study|Lost to Follow-up|0|||
161687120|NCT01157364|583907138|FG005|Overall Study|Lost to Follow-up|0|||
161636876|NCT00730015|583723010|FG002|Overall Study|Adverse Event|8|||
161687121|NCT01157364|583907133|FG000|Overall Study|Lack of Efficacy|0|||
161687122|NCT01157364|583907134|FG001|Overall Study|Lack of Efficacy|0|||
161636877|NCT00730015|583723008|FG000|Overall Study|Protocol Violation|2|||
161636878|NCT00730015|583723009|FG001|Overall Study|Protocol Violation|6|||
161636879|NCT00730015|583723010|FG002|Overall Study|Protocol Violation|4|||
161636880|NCT00730015|583723008|FG000|Overall Study|Withdrawal by Subject|12|||
161636881|NCT00730015|583723009|FG001|Overall Study|Withdrawal by Subject|12|||
161636882|NCT00730015|583723010|FG002|Overall Study|Withdrawal by Subject|8|||
161636883|NCT00730015|583723008|FG000|Overall Study|Lost to Follow-up|4|||
161636884|NCT00730015|583723009|FG001|Overall Study|Lost to Follow-up|10|||
161636885|NCT00730015|583723010|FG002|Overall Study|Lost to Follow-up|3|||
161636886|NCT00730015|583723008|FG000|Overall Study|Lack of Efficacy|1|||
161636887|NCT00730015|583723009|FG001|Overall Study|Lack of Efficacy|2|||
161636888|NCT00730015|583723010|FG002|Overall Study|Lack of Efficacy|8|||
161636889|NCT00730015|583723008|FG000|Overall Study|Other Reason|1|||
161636890|NCT00730015|583723009|FG001|Overall Study|Other Reason|0|||
161636891|NCT00730015|583723010|FG002|Overall Study|Other Reason|1|||
161636892|NCT03062449|583723011|FG000|Overall Study|Withdrawal by Subject|7|||
161636893|NCT03062449|583723012|FG001|Overall Study|Withdrawal by Subject|1|||
161636894|NCT02370251|583723013|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
161636895|NCT02370251|583723013|FG000|Overall Study|Death|4|||
161636896|NCT04120376|583723014|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
161636897|NCT04120376|583723015|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
161636898|NCT02053610|583723016|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
161636899|NCT02053610|583723017|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
161636900|NCT02053610|583723016|FG000|Overall Study|Withdrew Consent|2|||
161636901|NCT02053610|583723017|FG001|Overall Study|Withdrew Consent|9|||
161636902|NCT02053610|583723016|FG000|Overall Study|Death|5|||
161636903|NCT02053610|583723017|FG001|Overall Study|Death|5|||
161636904|NCT02053610|583723016|FG000|Overall Study|Administrative/Other|1|||
161636905|NCT02053610|583723017|FG001|Overall Study|Administrative/Other|1|||
161636906|NCT02053610|583723016|FG000|Overall Study|Disease Progression|2|||
161636907|NCT02053610|583723017|FG001|Overall Study|Disease Progression|3|||
161636908|NCT02053610|583723016|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
161636909|NCT02053610|583723017|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
161636910|NCT02053610|583723016|FG000|Overall Study|Did not Receive Treatment|4|||
161636911|NCT02053610|583723017|FG001|Overall Study|Did not Receive Treatment|2|||
161636912|NCT02053610|583723016|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161636913|NCT02053610|583723017|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161636914|NCT02053610|583723016|FG000|Overall Study|Violation of Selection Criteria|1|||
161636915|NCT02053610|583723017|FG001|Overall Study|Violation of Selection Criteria|0|||
161636916|NCT01165177|583723018|FG000|Overall Study|Serious Adverse Event|227|||
161636917|NCT01165177|583723019|FG001|Overall Study|Serious Adverse Event|235|||
161636918|NCT01165177|583723018|FG000|Overall Study|Withdrawal by Subject|368|||
161636919|NCT01165177|583723019|FG001|Overall Study|Withdrawal by Subject|354|||
161636920|NCT01165177|583723018|FG000|Overall Study|Protocol Violation|19|||
161636921|NCT01165177|583723019|FG001|Overall Study|Protocol Violation|21|||
161636922|NCT01165177|583723018|FG000|Overall Study|Non-serious adverse event|30|||
161636923|NCT01165177|583723019|FG001|Overall Study|Non-serious adverse event|18|||
161636924|NCT01165177|583723018|FG000|Overall Study|Other unspecified reasons|47|||
161636925|NCT01165177|583723019|FG001|Overall Study|Other unspecified reasons|35|||
161636926|NCT01165177|583723018|FG000|Overall Study|Suspected HZ episode|0|||
161636927|NCT01165177|583723019|FG001|Overall Study|Suspected HZ episode|2|||
161636928|NCT01165177|583723018|FG000|Overall Study|Lost to Follow-up|183|||
161636929|NCT01165177|583723019|FG001|Overall Study|Lost to Follow-up|194|||
161636930|NCT01165177|583723018|FG000|Overall Study|Migrated/ moved from study area|48|||
161636931|NCT01165177|583723019|FG001|Overall Study|Migrated/ moved from study area|43|||
161636932|NCT05499130|583723020|FG000|Overall Study|Adverse Event|2|||
161636933|NCT05499130|583723021|FG001|Overall Study|Adverse Event|0|||
161636934|NCT05499130|583723022|FG002|Overall Study|Adverse Event|1|||
161636935|NCT05499130|583723023|FG003|Overall Study|Adverse Event|0|||
161636936|NCT05499130|583723024|FG004|Overall Study|Adverse Event|1|||
161636937|NCT05499130|583723025|FG005|Overall Study|Adverse Event|4|||
161636938|NCT05499130|583723026|FG006|Overall Study|Adverse Event|1|||
161636939|NCT05499130|583723027|FG007|Overall Study|Adverse Event|0|||
161636940|NCT05499130|583723020|FG000|Overall Study|Lack of Efficacy|1|||
161636941|NCT05499130|583723021|FG001|Overall Study|Lack of Efficacy|0|||
161636942|NCT05499130|583723022|FG002|Overall Study|Lack of Efficacy|0|||
161636943|NCT05499130|583723023|FG003|Overall Study|Lack of Efficacy|0|||
161636944|NCT05499130|583723024|FG004|Overall Study|Lack of Efficacy|5|||
161636945|NCT05499130|583723025|FG005|Overall Study|Lack of Efficacy|0|||
161636946|NCT05499130|583723026|FG006|Overall Study|Lack of Efficacy|1|||
161636947|NCT05499130|583723027|FG007|Overall Study|Lack of Efficacy|0|||
161636948|NCT05499130|583723020|FG000|Overall Study|Withdrawal by Subject|2|||
161636949|NCT05499130|583723021|FG001|Overall Study|Withdrawal by Subject|0|||
161636950|NCT05499130|583723022|FG002|Overall Study|Withdrawal by Subject|0|||
161636951|NCT05499130|583723023|FG003|Overall Study|Withdrawal by Subject|0|||
161636952|NCT05499130|583723024|FG004|Overall Study|Withdrawal by Subject|1|||
161687123|NCT01157364|583907135|FG002|Overall Study|Lack of Efficacy|0|||
161834907|NCT00977431|584437191|FG003|Overall Study|Protocol Violation|0|||
161834908|NCT00977431|584437192|FG004|Overall Study|Protocol Violation|0|||
161834909|NCT00977431|584437188|FG000|Overall Study|Adverse Event|3|||
161834910|NCT00977431|584437189|FG001|Overall Study|Adverse Event|0|||
161834911|NCT00977431|584437190|FG002|Overall Study|Adverse Event|4|||
161834912|NCT00977431|584437191|FG003|Overall Study|Adverse Event|0|||
161834913|NCT00977431|584437192|FG004|Overall Study|Adverse Event|6|||
161834914|NCT00977431|584437188|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
161834915|NCT00977431|584437189|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
161834916|NCT00977431|584437190|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
161834917|NCT00977431|584437191|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
161834918|NCT00977431|584437192|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
161834919|NCT00977431|584437188|FG000|Overall Study|Progressive disease|2|||
161834920|NCT00977431|584437189|FG001|Overall Study|Progressive disease|6|||
161834921|NCT00977431|584437190|FG002|Overall Study|Progressive disease|1|||
161834922|NCT00977431|584437191|FG003|Overall Study|Progressive disease|3|||
161834923|NCT00977431|584437192|FG004|Overall Study|Progressive disease|5|||
161834924|NCT03739138|584437199|FG000|Overall Study|Death|0|||
161834925|NCT03739138|584437200|FG001|Overall Study|Death|7|||
161834926|NCT03739138|584437201|FG002|Overall Study|Death|4|||
161834927|NCT03739138|584437202|FG003|Overall Study|Death|13|||
161834928|NCT03739138|584437203|FG004|Overall Study|Death|0|||
161834929|NCT03739138|584437199|FG000|Overall Study|Lost to Follow-up|0|||
161834930|NCT03739138|584437200|FG001|Overall Study|Lost to Follow-up|0|||
161834931|NCT03739138|584437201|FG002|Overall Study|Lost to Follow-up|1|||
161834932|NCT03739138|584437202|FG003|Overall Study|Lost to Follow-up|0|||
161834933|NCT03739138|584437203|FG004|Overall Study|Lost to Follow-up|0|||
161834934|NCT03739138|584437199|FG000|Overall Study|Study Terminated By Sponsor|0|||
161834935|NCT03739138|584437200|FG001|Overall Study|Study Terminated By Sponsor|0|||
161834936|NCT03739138|584437201|FG002|Overall Study|Study Terminated By Sponsor|0|||
161834937|NCT03739138|584437202|FG003|Overall Study|Study Terminated By Sponsor|4|||
161834938|NCT03739138|584437203|FG004|Overall Study|Study Terminated By Sponsor|0|||
161834939|NCT03739138|584437199|FG000|Overall Study|Withdrawal by Subject|0|||
161834940|NCT03739138|584437200|FG001|Overall Study|Withdrawal by Subject|0|||
161636953|NCT05499130|583723025|FG005|Overall Study|Withdrawal by Subject|2|||
161636954|NCT05499130|583723026|FG006|Overall Study|Withdrawal by Subject|0|||
161636955|NCT05499130|583723027|FG007|Overall Study|Withdrawal by Subject|0|||
161834941|NCT03739138|584437201|FG002|Overall Study|Withdrawal by Subject|0|||
161834942|NCT03739138|584437202|FG003|Overall Study|Withdrawal by Subject|1|||
161834943|NCT03739138|584437203|FG004|Overall Study|Withdrawal by Subject|0|||
161834944|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
161834945|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
161834946|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
161834947|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
161834948|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
161834949|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
161834950|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
161834951|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
161834952|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
161834953|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
161834954|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Subject decision|1|||
161834955|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Subject decision|1|||
161834956|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
161834957|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
161834958|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
161834959|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
161834960|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
161834961|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
161636956|NCT05499130|583723020|FG000|Overall Study|Lost to Follow-up|0|||
161636957|NCT05499130|583723021|FG001|Overall Study|Lost to Follow-up|0|||
161636958|NCT05499130|583723022|FG002|Overall Study|Lost to Follow-up|0|||
161834962|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
161834963|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
161636959|NCT05499130|583723023|FG003|Overall Study|Lost to Follow-up|0|||
161636960|NCT05499130|583723024|FG004|Overall Study|Lost to Follow-up|0|||
161636961|NCT05499130|583723025|FG005|Overall Study|Lost to Follow-up|2|||
161834964|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
161834965|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
161834966|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
161834967|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
161834968|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
161834969|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
161834970|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
161636962|NCT05499130|583723026|FG006|Overall Study|Lost to Follow-up|0|||
161636963|NCT05499130|583723027|FG007|Overall Study|Lost to Follow-up|0|||
161636964|NCT05499130|583723020|FG000|Overall Study|Other Than Specified|0|||
161636965|NCT05499130|583723021|FG001|Overall Study|Other Than Specified|0|||
161636966|NCT05499130|583723022|FG002|Overall Study|Other Than Specified|0|||
161636967|NCT05499130|583723023|FG003|Overall Study|Other Than Specified|0|||
161636968|NCT05499130|583723024|FG004|Overall Study|Other Than Specified|1|||
161636969|NCT05499130|583723025|FG005|Overall Study|Other Than Specified|1|||
161636970|NCT05499130|583723026|FG006|Overall Study|Other Than Specified|2|||
161636971|NCT05499130|583723027|FG007|Overall Study|Other Than Specified|0|||
161636972|NCT05499130|583723020|FG000|Overall Study|Protocol Violation|0|||
161636973|NCT05499130|583723021|FG001|Overall Study|Protocol Violation|0|||
161636974|NCT05499130|583723022|FG002|Overall Study|Protocol Violation|0|||
161636975|NCT05499130|583723023|FG003|Overall Study|Protocol Violation|0|||
161636976|NCT05499130|583723024|FG004|Overall Study|Protocol Violation|1|||
161636977|NCT05499130|583723025|FG005|Overall Study|Protocol Violation|0|||
161636978|NCT05499130|583723026|FG006|Overall Study|Protocol Violation|0|||
161636979|NCT05499130|583723027|FG007|Overall Study|Protocol Violation|0|||
161636980|NCT00781937|583723029|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
161636981|NCT00781937|583723030|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
161636982|NCT00781937|583723029|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
161636983|NCT00781937|583723030|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
161636984|NCT00781937|583723029|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
161636985|NCT00781937|583723030|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
161636986|NCT00781937|583723029|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
161636987|NCT00781937|583723030|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
161636988|NCT00781937|583723029|FG000|Main Trial Period Through Week 56|Unclassified|10|||
161636989|NCT00781937|583723030|FG001|Main Trial Period Through Week 56|Unclassified|15|||
161636990|NCT00781937|583723029|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
161636991|NCT00781937|583723030|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
161636992|NCT00781937|583723029|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
161636993|NCT00781937|583723030|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
161636994|NCT00013611|583723031|FG000|Overall Study|Lost to Follow-up|91|||
161636995|NCT00013611|583723032|FG001|Overall Study|Lost to Follow-up|100|||
161636996|NCT02330562|583723035|FG000|Overall Study|Adverse Event|0|||
161636997|NCT02330562|583723036|FG001|Overall Study|Adverse Event|0|||
161636998|NCT02330562|583723037|FG002|Overall Study|Adverse Event|3|||
161636999|NCT02330562|583723038|FG003|Overall Study|Adverse Event|0|||
161637000|NCT02330562|583723039|FG004|Overall Study|Adverse Event|3|||
161637001|NCT02330562|583723040|FG005|Overall Study|Adverse Event|1|||
161637002|NCT02330562|583723041|FG006|Overall Study|Adverse Event|0|||
161637003|NCT02330562|583723042|FG007|Overall Study|Adverse Event|0|||
161637004|NCT02330562|583723043|FG008|Overall Study|Adverse Event|0|||
161637005|NCT02330562|583723044|FG009|Overall Study|Adverse Event|1|||
161637006|NCT02330562|583723045|FG010|Overall Study|Adverse Event|1|||
161637007|NCT02330562|583723035|FG000|Overall Study|Participant decision|1|||
161637008|NCT02330562|583723036|FG001|Overall Study|Participant decision|0|||
161637009|NCT02330562|583723037|FG002|Overall Study|Participant decision|4|||
161637010|NCT02330562|583723038|FG003|Overall Study|Participant decision|1|||
161637011|NCT02330562|583723039|FG004|Overall Study|Participant decision|5|||
161637012|NCT02330562|583723040|FG005|Overall Study|Participant decision|2|||
161637013|NCT02330562|583723041|FG006|Overall Study|Participant decision|0|||
161637014|NCT02330562|583723042|FG007|Overall Study|Participant decision|0|||
161637015|NCT02330562|583723043|FG008|Overall Study|Participant decision|0|||
161834971|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
161834972|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
161637016|NCT02330562|583723044|FG009|Overall Study|Participant decision|3|||
161637017|NCT02330562|583723045|FG010|Overall Study|Participant decision|0|||
161637018|NCT02330562|583723035|FG000|Overall Study|Disease progression|5|||
161637019|NCT02330562|583723036|FG001|Overall Study|Disease progression|3|||
161637020|NCT02330562|583723037|FG002|Overall Study|Disease progression|20|||
161637021|NCT02330562|583723038|FG003|Overall Study|Disease progression|28|||
161637022|NCT02330562|583723039|FG004|Overall Study|Disease progression|23|||
161637023|NCT02330562|583723040|FG005|Overall Study|Disease progression|7|||
161637024|NCT02330562|583723041|FG006|Overall Study|Disease progression|1|||
161637025|NCT02330562|583723042|FG007|Overall Study|Disease progression|1|||
161637026|NCT02330562|583723043|FG008|Overall Study|Disease progression|1|||
161637027|NCT02330562|583723044|FG009|Overall Study|Disease progression|0|||
161637028|NCT02330562|583723045|FG010|Overall Study|Disease progression|5|||
161637029|NCT02330562|583723035|FG000|Overall Study|Other reasons|0|||
161637030|NCT02330562|583723036|FG001|Overall Study|Other reasons|0|||
161637031|NCT02330562|583723037|FG002|Overall Study|Other reasons|0|||
161637032|NCT02330562|583723038|FG003|Overall Study|Other reasons|1|||
161637033|NCT02330562|583723039|FG004|Overall Study|Other reasons|0|||
161637034|NCT02330562|583723040|FG005|Overall Study|Other reasons|0|||
161637035|NCT02330562|583723041|FG006|Overall Study|Other reasons|0|||
161834973|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
161834974|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
161834975|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
161834976|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
161834977|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
161834978|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
161834979|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
161637036|NCT02330562|583723042|FG007|Overall Study|Other reasons|0|||
161637037|NCT02330562|583723043|FG008|Overall Study|Other reasons|0|||
161637038|NCT02330562|583723044|FG009|Overall Study|Other reasons|0|||
161637039|NCT02330562|583723045|FG010|Overall Study|Other reasons|0|||
161834980|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
161834981|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
161834982|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
161834983|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
161834984|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
161834985|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
161834986|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
161834987|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
161834988|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
161834989|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
161834990|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
161834991|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
161834992|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
161834993|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
161834994|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
161834995|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
161834996|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
161834997|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
161834998|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
161834999|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
161835000|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161835001|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161835002|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
161835003|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
161835004|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
161835005|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
161835006|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
161835007|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
161835008|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
161835009|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
161835010|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
161835011|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
161835012|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
161835013|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
161835014|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
161835015|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
161835016|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
161835017|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
161835018|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
161835019|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
161835020|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
161835021|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
161835022|NCT02096588|584437209|FG000|Overall Study|Lack of Efficacy|2|||
161835023|NCT02096588|584437210|FG001|Overall Study|Lack of Efficacy|0|||
161835024|NCT02096588|584437209|FG000|Overall Study|Withdrawal by Subject|0|||
161835025|NCT02096588|584437210|FG001|Overall Study|Withdrawal by Subject|1|||
161835026|NCT01258101|584437211|FG000|Overall Study|Adverse Event|5|||
161637040|NCT02330562|583723035|FG000|Overall Study|Withdrawal by Subject|0|||
161637041|NCT02330562|583723036|FG001|Overall Study|Withdrawal by Subject|0|||
161637042|NCT02330562|583723037|FG002|Overall Study|Withdrawal by Subject|0|||
161637043|NCT02330562|583723038|FG003|Overall Study|Withdrawal by Subject|0|||
161637044|NCT02330562|583723039|FG004|Overall Study|Withdrawal by Subject|0|||
161637045|NCT02330562|583723040|FG005|Overall Study|Withdrawal by Subject|0|||
161637046|NCT02330562|583723041|FG006|Overall Study|Withdrawal by Subject|0|||
161835027|NCT01258101|584437212|FG001|Overall Study|Adverse Event|6|||
161835028|NCT01258101|584437213|FG002|Overall Study|Adverse Event|0|||
161835029|NCT01258101|584437214|FG003|Overall Study|Adverse Event|0|||
161637047|NCT02330562|583723042|FG007|Overall Study|Withdrawal by Subject|0|||
161637048|NCT02330562|583723043|FG008|Overall Study|Withdrawal by Subject|0|||
161637049|NCT02330562|583723044|FG009|Overall Study|Withdrawal by Subject|1|||
161637050|NCT02330562|583723045|FG010|Overall Study|Withdrawal by Subject|0|||
161637051|NCT00126659|583723048|FG000|Overall Study|Adverse Event|0|||
161637052|NCT00126659|583723049|FG001|Overall Study|Adverse Event|0|||
161637053|NCT00126659|583723050|FG002|Overall Study|Adverse Event|2|||
161637054|NCT03491215|583723052|FG000|Overall Study|Death|6|||
161637055|NCT03491215|583723053|FG001|Overall Study|Death|2|||
161637056|NCT03491215|583723054|FG002|Overall Study|Death|1|||
161637057|NCT03491215|583723055|FG003|Overall Study|Death|0|||
161637058|NCT03491215|583723052|FG000|Overall Study|Physician Decision|1|||
161637059|NCT03491215|583723053|FG001|Overall Study|Physician Decision|0|||
161637060|NCT03491215|583723054|FG002|Overall Study|Physician Decision|0|||
161637061|NCT03491215|583723055|FG003|Overall Study|Physician Decision|0|||
161637062|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
161637063|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
161637064|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
161637065|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
161637066|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
161637067|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
161637068|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
161637069|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
161637070|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
161637071|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
161637072|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
161637073|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
161637074|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
161637075|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
161637076|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
161637077|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
161637078|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
161637079|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
161637080|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
161637081|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
161637082|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
161637083|NCT04599855|583723058|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
161637084|NCT04599855|583723059|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
161637085|NCT04599855|583723060|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
161637086|NCT04599855|583723058|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
161637087|NCT04599855|583723059|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
161637088|NCT04599855|583723060|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
161637089|NCT04599855|583723058|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
161637090|NCT04599855|583723059|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
161637091|NCT04599855|583723060|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
161637092|NCT04599855|583723058|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
161637093|NCT04599855|583723059|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
161637094|NCT04599855|583723060|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
161637095|NCT04599855|583723058|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
161637096|NCT04599855|583723059|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
161637097|NCT04599855|583723060|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
161637098|NCT04599855|583723058|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
161637099|NCT04599855|583723059|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
161637100|NCT04599855|583723060|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
161637101|NCT04599855|583723058|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
161637102|NCT04599855|583723059|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
161637103|NCT04599855|583723060|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
161637104|NCT04294667|583723061|FG000|Overall Study|Lack of Efficacy|4|||
161637105|NCT04294667|583723062|FG001|Overall Study|Lack of Efficacy|4|||
161637106|NCT04294667|583723061|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
161637107|NCT04294667|583723062|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
161637108|NCT04294667|583723061|FG000|Overall Study|Patient has a Renal Flare|1|||
161637109|NCT04294667|583723062|FG001|Overall Study|Patient has a Renal Flare|0|||
161637110|NCT04294667|583723061|FG000|Overall Study|SLE Worsening|0|||
161637111|NCT04294667|583723062|FG001|Overall Study|SLE Worsening|1|||
161687124|NCT01157364|583907136|FG003|Overall Study|Lack of Efficacy|1|||
161687125|NCT01157364|583907137|FG004|Overall Study|Lack of Efficacy|0|||
161637112|NCT04294667|583723061|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
161687126|NCT01157364|583907138|FG005|Overall Study|Lack of Efficacy|0|||
161687127|NCT01157364|583907133|FG000|Overall Study|Adverse Event|0|||
161637113|NCT04294667|583723062|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
161687128|NCT01157364|583907134|FG001|Overall Study|Adverse Event|1|||
161637114|NCT04294667|583723061|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
161637115|NCT04294667|583723062|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
161637116|NCT04294667|583723061|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
161637117|NCT04294667|583723062|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
161637118|NCT04294667|583723061|FG000|Overall Study|Subject Moved to Another State|0|||
161637119|NCT04294667|583723062|FG001|Overall Study|Subject Moved to Another State|1|||
161637120|NCT04294667|583723061|FG000|Overall Study|Adverse event, serious fatal|0|||
161835030|NCT01258101|584437211|FG000|Overall Study|Extra exclusion criterion amended|2|||
161835031|NCT01258101|584437212|FG001|Overall Study|Extra exclusion criterion amended|1|||
161835032|NCT01258101|584437213|FG002|Overall Study|Extra exclusion criterion amended|1|||
161835033|NCT01258101|584437214|FG003|Overall Study|Extra exclusion criterion amended|1|||
161835034|NCT01258101|584437211|FG000|Overall Study|Informed consent has been withdrawn|2|||
161835035|NCT01258101|584437212|FG001|Overall Study|Informed consent has been withdrawn|2|||
161835036|NCT01258101|584437213|FG002|Overall Study|Informed consent has been withdrawn|1|||
161835037|NCT01258101|584437214|FG003|Overall Study|Informed consent has been withdrawn|1|||
161835038|NCT01258101|584437211|FG000|Overall Study|Patient is not able to attend visits|8|||
161835039|NCT01258101|584437212|FG001|Overall Study|Patient is not able to attend visits|9|||
161835040|NCT01258101|584437213|FG002|Overall Study|Patient is not able to attend visits|7|||
161835041|NCT01258101|584437214|FG003|Overall Study|Patient is not able to attend visits|6|||
161835042|NCT01258101|584437211|FG000|Overall Study|Patient´s compliance|4|||
161835043|NCT01258101|584437212|FG001|Overall Study|Patient´s compliance|3|||
161835044|NCT01258101|584437213|FG002|Overall Study|Patient´s compliance|1|||
161835045|NCT01258101|584437214|FG003|Overall Study|Patient´s compliance|2|||
161835046|NCT01258101|584437211|FG000|Overall Study|Lost to Follow-up|5|||
161835047|NCT01258101|584437212|FG001|Overall Study|Lost to Follow-up|5|||
161835048|NCT01258101|584437213|FG002|Overall Study|Lost to Follow-up|0|||
161835049|NCT01258101|584437214|FG003|Overall Study|Lost to Follow-up|6|||
161835050|NCT01258101|584437211|FG000|Overall Study|PCR positive at week 24|0|||
161835051|NCT01258101|584437212|FG001|Overall Study|PCR positive at week 24|0|||
161835052|NCT01258101|584437213|FG002|Overall Study|PCR positive at week 24|0|||
161835053|NCT01258101|584437214|FG003|Overall Study|PCR positive at week 24|1|||
161835054|NCT01258101|584437211|FG000|Overall Study|Other reason|7|||
161835055|NCT01258101|584437212|FG001|Overall Study|Other reason|8|||
161835056|NCT01258101|584437213|FG002|Overall Study|Other reason|1|||
161835057|NCT01258101|584437214|FG003|Overall Study|Other reason|8|||
161835058|NCT01020799|584437220|FG000|Overall Study|Adverse Event|4|||
161835059|NCT01020799|584437221|FG001|Overall Study|Adverse Event|3|||
161835060|NCT01020799|584437222|FG002|Overall Study|Adverse Event|2|||
161835061|NCT01020799|584437220|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
161835062|NCT01020799|584437221|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
161835063|NCT01020799|584437222|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
161835064|NCT01020799|584437220|FG000|Overall Study|Protocol Violation|3|||
161835065|NCT01020799|584437221|FG001|Overall Study|Protocol Violation|2|||
161835066|NCT01020799|584437222|FG002|Overall Study|Protocol Violation|0|||
161835067|NCT01020799|584437220|FG000|Overall Study|Withdrawal by Subject|2|||
161835068|NCT01020799|584437221|FG001|Overall Study|Withdrawal by Subject|2|||
161835069|NCT01020799|584437222|FG002|Overall Study|Withdrawal by Subject|3|||
161835070|NCT01020799|584437220|FG000|Overall Study|Lost to Follow-up|6|||
161835071|NCT01020799|584437221|FG001|Overall Study|Lost to Follow-up|4|||
161835072|NCT01020799|584437222|FG002|Overall Study|Lost to Follow-up|2|||
161835073|NCT02556307|584437225|FG000|Overall Study|Premature treatment interruption|11|||
161835074|NCT02556307|584437225|FG000|Overall Study|Lost to Follow-up|36|||
161835075|NCT02556307|584437225|FG000|Overall Study|Change to triple therapy|4|||
161835076|NCT02556307|584437225|FG000|Overall Study|Enrolled but not treated|2|||
161835077|NCT03438227|584437226|FG000|Overall Study|Withdrawal by Subject|10|||
161835078|NCT03438227|584437227|FG001|Overall Study|Withdrawal by Subject|5|||
161835079|NCT00706992|584437228|FG000|Overall Study|Study termination|5|||
161835080|NCT00706992|584437229|FG001|Overall Study|Study termination|5|||
161835081|NCT00706992|584437230|FG002|Overall Study|Study termination|6|||
161835082|NCT00706992|584437231|FG003|Overall Study|Study termination|2|||
161835083|NCT00706992|584437232|FG004|Overall Study|Study termination|3|||
161835084|NCT00706992|584437233|FG005|Overall Study|Study termination|2|||
161835085|NCT00706992|584437234|FG006|Overall Study|Study termination|3|||
161835086|NCT00706992|584437228|FG000|Overall Study|Disease progression before treatment|0|||
161835087|NCT00706992|584437229|FG001|Overall Study|Disease progression before treatment|0|||
161835088|NCT00706992|584437230|FG002|Overall Study|Disease progression before treatment|0|||
161835089|NCT00706992|584437231|FG003|Overall Study|Disease progression before treatment|0|||
161637121|NCT04294667|583723062|FG001|Overall Study|Adverse event, serious fatal|1|||
161835090|NCT00706992|584437232|FG004|Overall Study|Disease progression before treatment|1|||
161835091|NCT00706992|584437233|FG005|Overall Study|Disease progression before treatment|0|||
161835092|NCT00706992|584437234|FG006|Overall Study|Disease progression before treatment|0|||
161835093|NCT01244061|584437237|FG000|Overall Study|Death|1|||
161637122|NCT04294667|583723061|FG000|Overall Study|Adverse event, non-fatal|3|||
161687129|NCT01157364|583907135|FG002|Overall Study|Adverse Event|1|||
161687130|NCT01157364|583907136|FG003|Overall Study|Adverse Event|0|||
161687131|NCT01157364|583907137|FG004|Overall Study|Adverse Event|1|||
161687132|NCT01157364|583907138|FG005|Overall Study|Adverse Event|0|||
161687133|NCT00183274|583907141|FG000|Phase 1: Open-Label|Adverse Event|31|||
161687134|NCT00183274|583907142|FG001|Phase 1: Open-Label|Adverse Event|0|||
161687135|NCT00183274|583907143|FG002|Phase 1: Open-Label|Adverse Event|0|||
161687136|NCT00183274|583907144|FG003|Phase 1: Open-Label|Adverse Event|0|||
161687137|NCT00183274|583907145|FG004|Phase 1: Open-Label|Adverse Event|0|||
161687138|NCT00183274|583907146|FG005|Phase 1: Open-Label|Adverse Event|0|||
161687139|NCT00183274|583907141|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
161687140|NCT00183274|583907142|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
161687141|NCT00183274|583907143|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
161687142|NCT00183274|583907144|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
161687143|NCT00183274|583907145|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
161687144|NCT00183274|583907146|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
161687145|NCT00183274|583907141|FG000|Phase 1: Open-Label|Protocol Violation|11|||
161687146|NCT00183274|583907142|FG001|Phase 1: Open-Label|Protocol Violation|0|||
161687147|NCT00183274|583907143|FG002|Phase 1: Open-Label|Protocol Violation|0|||
161687148|NCT00183274|583907144|FG003|Phase 1: Open-Label|Protocol Violation|0|||
161687149|NCT00183274|583907145|FG004|Phase 1: Open-Label|Protocol Violation|0|||
161687150|NCT00183274|583907146|FG005|Phase 1: Open-Label|Protocol Violation|0|||
161687151|NCT00183274|583907141|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
161687152|NCT00183274|583907142|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687153|NCT00183274|583907143|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687154|NCT00183274|583907144|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687155|NCT00183274|583907145|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
161835094|NCT01244061|584437238|FG001|Overall Study|Death|0|||
161835095|NCT01244061|584437237|FG000|Overall Study|Did not meet entrance criteria|1|||
161835096|NCT01244061|584437238|FG001|Overall Study|Did not meet entrance criteria|0|||
161687156|NCT00183274|583907146|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687157|NCT00183274|583907141|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
161687158|NCT00183274|583907142|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
161687159|NCT00183274|583907143|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
161687160|NCT00183274|583907144|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
161687161|NCT00183274|583907145|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
161687162|NCT00183274|583907146|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
161687163|NCT00183274|583907141|FG000|Phase 1: Open-Label|Other|9|||
161687164|NCT00183274|583907142|FG001|Phase 1: Open-Label|Other|0|||
161687165|NCT00183274|583907143|FG002|Phase 1: Open-Label|Other|0|||
161687166|NCT00183274|583907144|FG003|Phase 1: Open-Label|Other|0|||
161835097|NCT01244061|584437237|FG000|Overall Study|Lack of Efficacy|1|||
161835098|NCT01244061|584437238|FG001|Overall Study|Lack of Efficacy|3|||
161835099|NCT01244061|584437237|FG000|Overall Study|Lost to Follow-up|34|||
161835100|NCT01244061|584437238|FG001|Overall Study|Lost to Follow-up|30|||
161835101|NCT01244061|584437237|FG000|Overall Study|Withdrawal by Subject|29|||
161835102|NCT01244061|584437238|FG001|Overall Study|Withdrawal by Subject|46|||
161835103|NCT01244061|584437237|FG000|Overall Study|Other|8|||
161835104|NCT01244061|584437238|FG001|Overall Study|Other|19|||
161835105|NCT01244061|584437237|FG000|Overall Study|Protocol Violation|1|||
161835106|NCT01244061|584437238|FG001|Overall Study|Protocol Violation|1|||
161835107|NCT01244061|584437237|FG000|Overall Study|Adverse Event|5|||
161835108|NCT01244061|584437238|FG001|Overall Study|Adverse Event|2|||
161835109|NCT01244061|584437237|FG000|Overall Study|Randomized but not treated|2|||
161835110|NCT01244061|584437238|FG001|Overall Study|Randomized but not treated|2|||
161687167|NCT00183274|583907145|FG004|Phase 1: Open-Label|Other|0|||
161687168|NCT00183274|583907146|FG005|Phase 1: Open-Label|Other|0|||
161687169|NCT00183274|583907141|FG000|Phase 2: Double-Blind|Relapsed|0|||
161687170|NCT00183274|583907142|FG001|Phase 2: Double-Blind|Relapsed|8|||
161687171|NCT00183274|583907143|FG002|Phase 2: Double-Blind|Relapsed|29|||
161687172|NCT00183274|583907144|FG003|Phase 2: Double-Blind|Relapsed|0|||
161687173|NCT00183274|583907145|FG004|Phase 2: Double-Blind|Relapsed|0|||
161687174|NCT00183274|583907146|FG005|Phase 2: Double-Blind|Relapsed|0|||
161687175|NCT00183274|583907141|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161687176|NCT00183274|583907142|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
161687177|NCT00183274|583907143|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
161835111|NCT03166124|584437239|FG000|Treatment Period 1|Adverse Event|0|||
161835112|NCT03166124|584437240|FG001|Treatment Period 1|Adverse Event|0|||
161835113|NCT03166124|584437241|FG002|Treatment Period 1|Adverse Event|1|||
161835114|NCT03166124|584437242|FG003|Treatment Period 1|Adverse Event|0|||
161835115|NCT03166124|584437239|FG000|Wash-out Period|Withdrawal by Subject|0|||
161687178|NCT00183274|583907144|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161835116|NCT03166124|584437240|FG001|Wash-out Period|Withdrawal by Subject|1|||
161835117|NCT03166124|584437241|FG002|Wash-out Period|Withdrawal by Subject|0|||
161835118|NCT03166124|584437242|FG003|Wash-out Period|Withdrawal by Subject|1|||
161835119|NCT03166124|584437239|FG000|Wash-out Period|Adverse Event|0|||
161835120|NCT03166124|584437240|FG001|Wash-out Period|Adverse Event|1|||
161687179|NCT00183274|583907145|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161637123|NCT04294667|583723062|FG001|Overall Study|Adverse event, non-fatal|4|||
161637124|NCT00548847|583723063|FG000|Overall Study|Disease progression|7|||
161637125|NCT00727415|583723064|FG000|Phase I|Dose Limiting Toxicity|2|||
161637126|NCT00302159|583723067|FG000|Overall Study|pt declined before treatment started|1|||
161637127|NCT00302159|583723067|FG000|Overall Study|pt started Avastin|1|||
161637128|NCT00853229|583723070|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
161637129|NCT00853229|583723071|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
161637130|NCT02312206|583723078|FG000|Overall Study|Adverse Event|3|||
161637131|NCT02312206|583723079|FG001|Overall Study|Adverse Event|6|||
161637132|NCT02312206|583723078|FG000|Overall Study|Withdrawal by Subject|6|||
161637133|NCT02312206|583723079|FG001|Overall Study|Withdrawal by Subject|6|||
161637134|NCT02312206|583723078|FG000|Overall Study|Physician Decision|7|||
161637135|NCT02312206|583723079|FG001|Overall Study|Physician Decision|6|||
161637136|NCT02312206|583723078|FG000|Overall Study|Death|31|||
161637137|NCT02312206|583723079|FG001|Overall Study|Death|36|||
161637138|NCT02312206|583723078|FG000|Overall Study|Study Terminated by Sponsor|81|||
161637139|NCT02312206|583723079|FG001|Overall Study|Study Terminated by Sponsor|74|||
161637140|NCT02312206|583723078|FG000|Overall Study|Patient transferred to hospice|0|||
161637141|NCT02312206|583723079|FG001|Overall Study|Patient transferred to hospice|1|||
161637142|NCT02312206|583723078|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
161637143|NCT02312206|583723079|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
161637144|NCT02312206|583723078|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
161637145|NCT02312206|583723079|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
161637146|NCT02312206|583723078|FG000|Overall Study|Disease Progression|1|||
161637147|NCT02312206|583723079|FG001|Overall Study|Disease Progression|0|||
161637148|NCT03414047|583723080|FG000|Overall Study|Adverse Event|0|||
161637149|NCT03414047|583723081|FG001|Overall Study|Adverse Event|0|||
161637150|NCT03414047|583723082|FG002|Overall Study|Adverse Event|1|||
161637151|NCT03414047|583723083|FG003|Overall Study|Adverse Event|1|||
161637152|NCT03414047|583723080|FG000|Overall Study|Physician Decision|1|||
161637153|NCT03414047|583723081|FG001|Overall Study|Physician Decision|0|||
161637154|NCT03414047|583723082|FG002|Overall Study|Physician Decision|0|||
161637155|NCT03414047|583723083|FG003|Overall Study|Physician Decision|1|||
161637156|NCT03414047|583723080|FG000|Overall Study|Withdrawal by Subject|1|||
161637157|NCT03414047|583723081|FG001|Overall Study|Withdrawal by Subject|0|||
161637158|NCT03414047|583723082|FG002|Overall Study|Withdrawal by Subject|2|||
161637159|NCT03414047|583723083|FG003|Overall Study|Withdrawal by Subject|0|||
161637160|NCT03269695|583723085|FG000|Overall Study|Adverse Event|2|||
161637161|NCT03269695|583723086|FG001|Overall Study|Adverse Event|1|||
161637162|NCT03269695|583723085|FG000|Overall Study|Lack of Efficacy|0|||
161637163|NCT03269695|583723086|FG001|Overall Study|Lack of Efficacy|1|||
161637164|NCT03269695|583723085|FG000|Overall Study|Withdrawal by Subject|0|||
161637165|NCT03269695|583723086|FG001|Overall Study|Withdrawal by Subject|1|||
161637166|NCT01017263|583723087|FG000|Overall Study|not eligible|12|||
161637167|NCT00239681|583723088|FG000|Overall Study|Adverse Event|100|||
161637168|NCT00239681|583723089|FG001|Overall Study|Adverse Event|99|||
161637169|NCT00239681|583723088|FG000|Overall Study|Withdrawal by Subject|458|||
161637170|NCT00239681|583723089|FG001|Overall Study|Withdrawal by Subject|489|||
161637171|NCT00239681|583723088|FG000|Overall Study|Lost to Follow-up|28|||
161637172|NCT00239681|583723089|FG001|Overall Study|Lost to Follow-up|22|||
161637173|NCT00239681|583723088|FG000|Overall Study|Protocol Violation|4|||
161637174|NCT00239681|583723089|FG001|Overall Study|Protocol Violation|4|||
161637175|NCT00239681|583723088|FG000|Overall Study|Physician Decision|13|||
161687180|NCT00183274|583907146|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161637176|NCT00239681|583723089|FG001|Overall Study|Physician Decision|17|||
161637177|NCT00239681|583723088|FG000|Overall Study|No information chacked on CaseReportForm|90|||
161687181|NCT00183274|583907141|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161687182|NCT00183274|583907142|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161637178|NCT00239681|583723089|FG001|Overall Study|No information chacked on CaseReportForm|84|||
161637179|NCT00905359|583723092|FG000|Overall Study|Lost to Follow-up|17|||
161637180|NCT00905359|583723093|FG001|Overall Study|Lost to Follow-up|10|||
161637181|NCT00905359|583723092|FG000|Overall Study|Death|2|||
161637182|NCT00905359|583723093|FG001|Overall Study|Death|0|||
161637183|NCT00905359|583723092|FG000|Overall Study|Withdrawal consent|5|||
161637184|NCT00905359|583723093|FG001|Overall Study|Withdrawal consent|6|||
161637185|NCT02654132|583723094|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
161637186|NCT02654132|583723095|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
161637187|NCT02654132|583723094|FG000|Treatment Period|Disease progression|43|||
161637188|NCT02654132|583723095|FG001|Treatment Period|Disease progression|38|||
161637189|NCT02654132|583723094|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
161637190|NCT02654132|583723095|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
161637191|NCT02654132|583723094|FG000|Treatment Period|Other reasons|4|||
161637192|NCT02654132|583723095|FG001|Treatment Period|Other reasons|2|||
161637193|NCT02654132|583723094|FG000|Treatment Period|Study drug toxicity|2|||
161637194|NCT02654132|583723095|FG001|Treatment Period|Study drug toxicity|2|||
161637195|NCT02654132|583723094|FG000|Treatment Period|Withdrawal by Subject|2|||
161637196|NCT02654132|583723095|FG001|Treatment Period|Withdrawal by Subject|1|||
161637197|NCT02654132|583723094|FG000|Treatment Period|Maximum Clinical Benefit|0|||
161637198|NCT02654132|583723095|FG001|Treatment Period|Maximum Clinical Benefit|2|||
161637199|NCT02654132|583723094|FG000|Treatment Period|Participant request to discontinue|2|||
161637200|NCT02654132|583723095|FG001|Treatment Period|Participant request to discontinue|0|||
161637201|NCT02654132|583723094|FG000|Treatment Period|Administrative reasons by sponsor|0|||
161637202|NCT02654132|583723095|FG001|Treatment Period|Administrative reasons by sponsor|1|||
161637203|NCT02654132|583723094|FG000|Treatment Period|Death|1|||
161637204|NCT02654132|583723095|FG001|Treatment Period|Death|0|||
161637205|NCT02485899|583723096|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
161637206|NCT02485899|583723097|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161637207|NCT02485899|583723096|FG000|Overall Study|Withdrawal by Subject|1|||
161637208|NCT02485899|583723097|FG001|Overall Study|Withdrawal by Subject|0|||
161637209|NCT02485899|583723096|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
161637210|NCT02485899|583723097|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
161637211|NCT00623363|583723098|FG000|Overall Study|Adverse Event|2|||
161637212|NCT00623363|583723099|FG001|Overall Study|Adverse Event|2|||
161637213|NCT04706793|583723100|FG000|Treatment|Disease worsening|10|||
161637214|NCT04706793|583723101|FG001|Treatment|Disease worsening|10|||
161637215|NCT04706793|583723100|FG000|Follow-up|Lack of Efficacy|1|||
161637216|NCT04706793|583723101|FG001|Follow-up|Lack of Efficacy|0|||
161637217|NCT04706793|583723100|FG000|Follow-up|Disease worsening|8|||
161637218|NCT04706793|583723101|FG001|Follow-up|Disease worsening|10|||
161637219|NCT04706793|583723100|FG000|Follow-up|Adverse Event|1|||
161637220|NCT04706793|583723101|FG001|Follow-up|Adverse Event|0|||
161637221|NCT03713320|583723102|FG000|Randomized Period|Adverse Event|1|||
161637222|NCT03713320|583723103|FG001|Randomized Period|Adverse Event|5|||
161637223|NCT03713320|583723104|FG002|Randomized Period|Adverse Event|0|||
161637224|NCT03713320|583723102|FG000|Randomized Period|Physician Decision|1|||
161637225|NCT03713320|583723103|FG001|Randomized Period|Physician Decision|1|||
161637226|NCT03713320|583723104|FG002|Randomized Period|Physician Decision|0|||
161637227|NCT03713320|583723102|FG000|Randomized Period|Withdrawal by Subject|4|||
161637228|NCT03713320|583723103|FG001|Randomized Period|Withdrawal by Subject|0|||
161637229|NCT03713320|583723104|FG002|Randomized Period|Withdrawal by Subject|0|||
161637230|NCT03713320|583723102|FG000|Randomized Period|Participant decision|3|||
161637231|NCT03713320|583723103|FG001|Randomized Period|Participant decision|1|||
161637232|NCT03713320|583723104|FG002|Randomized Period|Participant decision|0|||
161637233|NCT03713320|583723102|FG000|Randomized Period|Study terminated by sponsor|6|||
161637234|NCT03713320|583723103|FG001|Randomized Period|Study terminated by sponsor|3|||
161637235|NCT03713320|583723104|FG002|Randomized Period|Study terminated by sponsor|0|||
161637236|NCT03713320|583723102|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
161637237|NCT03713320|583723103|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
161637238|NCT03713320|583723104|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
161637239|NCT03713320|583723102|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
161637240|NCT03713320|583723103|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
161637241|NCT03713320|583723104|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
161637242|NCT02725528|583723105|FG000|Overall Study|Lost to Follow-up|1|||
161637243|NCT02725528|583723106|FG001|Overall Study|Lost to Follow-up|4|||
161637244|NCT02725528|583723105|FG000|Overall Study|Withdrawal by Subject|0|||
161637245|NCT02725528|583723106|FG001|Overall Study|Withdrawal by Subject|1|||
161637246|NCT04354168|583723107|FG000|Overall Study|Lost to Follow-up|22|||
161637247|NCT01781832|583723108|FG000|Overall Study|Withdrawal by Subject|1|||
161637248|NCT02287233|583723109|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
161637249|NCT02287233|583723110|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
161637250|NCT02287233|583723111|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
161637251|NCT02287233|583723109|FG000|Overall Study|Adverse Event Related to Progression|0|||
161637252|NCT02287233|583723110|FG001|Overall Study|Adverse Event Related to Progression|2|||
161637253|NCT02287233|583723111|FG002|Overall Study|Adverse Event Related to Progression|8|||
161637254|NCT02287233|583723109|FG000|Overall Study|Physician Decision|1|||
161637255|NCT02287233|583723110|FG001|Overall Study|Physician Decision|2|||
161637256|NCT02287233|583723111|FG002|Overall Study|Physician Decision|4|||
161637257|NCT02287233|583723109|FG000|Overall Study|Progressive Disease with Death|0|||
161637258|NCT02287233|583723110|FG001|Overall Study|Progressive Disease with Death|0|||
161637259|NCT02287233|583723111|FG002|Overall Study|Progressive Disease with Death|10|||
161637260|NCT02287233|583723109|FG000|Overall Study|Progressive Disease Without Death|2|||
161637261|NCT02287233|583723110|FG001|Overall Study|Progressive Disease Without Death|3|||
161637262|NCT02287233|583723111|FG002|Overall Study|Progressive Disease Without Death|20|||
161637263|NCT02287233|583723109|FG000|Overall Study|Withdrawal by Subject|1|||
161637264|NCT02287233|583723110|FG001|Overall Study|Withdrawal by Subject|1|||
161637265|NCT02287233|583723111|FG002|Overall Study|Withdrawal by Subject|7|||
161637266|NCT02287233|583723109|FG000|Overall Study|Other|3|||
161637267|NCT02287233|583723110|FG001|Overall Study|Other|0|||
161637268|NCT02287233|583723111|FG002|Overall Study|Other|15|||
161637269|NCT02287233|583723109|FG000|Overall Study|Did Not Receive Treatment|0|||
161637270|NCT02287233|583723110|FG001|Overall Study|Did Not Receive Treatment|0|||
161637271|NCT02287233|583723111|FG002|Overall Study|Did Not Receive Treatment|2|||
161637272|NCT02706847|583723112|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
161637273|NCT02706847|583723113|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
161637274|NCT02706847|583723114|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
161637275|NCT02706847|583723115|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
161637276|NCT02706847|583723112|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
161637277|NCT02706847|583723113|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
161637278|NCT02706847|583723114|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
161637279|NCT02706847|583723115|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
161637280|NCT02706847|583723112|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
161637281|NCT02706847|583723113|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
161637282|NCT02706847|583723114|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
161637283|NCT02706847|583723115|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
161637284|NCT02706847|583723112|FG000|Period 1: Day 1 to Week 12|Other|4|||
161637285|NCT02706847|583723113|FG001|Period 1: Day 1 to Week 12|Other|4|||
161637286|NCT02706847|583723114|FG002|Period 1: Day 1 to Week 12|Other|2|||
161637287|NCT02706847|583723115|FG003|Period 1: Day 1 to Week 12|Other|2|||
161637288|NCT02706847|583723112|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
161637289|NCT02706847|583723113|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
161637290|NCT02706847|583723114|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
161637291|NCT02706847|583723115|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
161637292|NCT02706847|583723112|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
161637293|NCT02706847|583723113|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
161637294|NCT02706847|583723114|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
161637295|NCT02706847|583723115|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
161637296|NCT02706847|583723112|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
161637297|NCT02706847|583723113|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
161637298|NCT02706847|583723114|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
161637299|NCT02706847|583723115|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
161637300|NCT02706847|583723112|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
161637301|NCT02706847|583723113|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
161637302|NCT02706847|583723114|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
161637303|NCT02706847|583723115|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
161637304|NCT02706847|583723112|FG000|Period 1: Week 12 to Week 24|Other|1|||
161637305|NCT02706847|583723113|FG001|Period 1: Week 12 to Week 24|Other|0|||
161637306|NCT02706847|583723114|FG002|Period 1: Week 12 to Week 24|Other|1|||
161637307|NCT02706847|583723115|FG003|Period 1: Week 12 to Week 24|Other|4|||
161637308|NCT02706847|583723112|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
161637309|NCT02706847|583723113|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
161549902|NCT02564055|583403015|FG003|Overall Study|Adverse Event|1|||
161549903|NCT02564055|583403016|FG004|Overall Study|Adverse Event|4|||
161549904|NCT02564055|583403017|FG005|Overall Study|Adverse Event|1|||
161549905|NCT02564055|583403012|FG000|Overall Study|Protocol Violation|1|||
161549906|NCT02564055|583403013|FG001|Overall Study|Protocol Violation|0|||
161549907|NCT02564055|583403014|FG002|Overall Study|Protocol Violation|0|||
161549908|NCT02564055|583403015|FG003|Overall Study|Protocol Violation|0|||
161549909|NCT02564055|583403016|FG004|Overall Study|Protocol Violation|0|||
161549910|NCT02564055|583403017|FG005|Overall Study|Protocol Violation|0|||
161549911|NCT02564055|583403012|FG000|Overall Study|Reached stopping criteria|0|||
161549912|NCT02564055|583403013|FG001|Overall Study|Reached stopping criteria|0|||
161549913|NCT02564055|583403014|FG002|Overall Study|Reached stopping criteria|0|||
161549914|NCT02564055|583403015|FG003|Overall Study|Reached stopping criteria|0|||
161549915|NCT02564055|583403016|FG004|Overall Study|Reached stopping criteria|0|||
161549916|NCT02564055|583403017|FG005|Overall Study|Reached stopping criteria|1|||
161549917|NCT02564055|583403012|FG000|Overall Study|Lost to Follow-up|0|||
161549918|NCT02564055|583403013|FG001|Overall Study|Lost to Follow-up|1|||
161549919|NCT02564055|583403014|FG002|Overall Study|Lost to Follow-up|4|||
161549920|NCT02564055|583403015|FG003|Overall Study|Lost to Follow-up|2|||
161549921|NCT02564055|583403016|FG004|Overall Study|Lost to Follow-up|1|||
161549922|NCT02564055|583403017|FG005|Overall Study|Lost to Follow-up|0|||
161549923|NCT02564055|583403012|FG000|Overall Study|Physician Decision|0|||
161549924|NCT02564055|583403013|FG001|Overall Study|Physician Decision|0|||
161549925|NCT02564055|583403014|FG002|Overall Study|Physician Decision|1|||
161549926|NCT02564055|583403015|FG003|Overall Study|Physician Decision|0|||
161549927|NCT02564055|583403016|FG004|Overall Study|Physician Decision|0|||
161549928|NCT02564055|583403017|FG005|Overall Study|Physician Decision|0|||
161549929|NCT02564055|583403012|FG000|Overall Study|Withdrawal by Subject|4|||
161549930|NCT02564055|583403013|FG001|Overall Study|Withdrawal by Subject|4|||
161549931|NCT02564055|583403014|FG002|Overall Study|Withdrawal by Subject|3|||
161549932|NCT02564055|583403015|FG003|Overall Study|Withdrawal by Subject|3|||
161549933|NCT02564055|583403016|FG004|Overall Study|Withdrawal by Subject|10|||
161549934|NCT02564055|583403017|FG005|Overall Study|Withdrawal by Subject|10|||
161549935|NCT01375959|583403019|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
161549936|NCT01375959|583403020|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
161549937|NCT01375959|583403019|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
161549938|NCT01375959|583403020|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
161549939|NCT01375959|583403019|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
161549940|NCT01375959|583403020|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
161549941|NCT04161807|583403024|FG000|Overall Study|Withdrawal by Subject|2|||
161549942|NCT04161807|583403024|FG000|Overall Study|Performed only 1 treatment|2|||
161549943|NCT00708305|583403031|FG000|Period 1|Protocol Violation|1|||
161549944|NCT00708305|583403032|FG001|Period 1|Protocol Violation|0|||
161549945|NCT00708305|583403033|FG002|Period 1|Protocol Violation|1|||
161549946|NCT00708305|583403034|FG003|Period 1|Protocol Violation|0|||
161549947|NCT00708305|583403031|FG000|Period 1|Other Reason|0|||
161549948|NCT00708305|583403032|FG001|Period 1|Other Reason|0|||
161549949|NCT00708305|583403033|FG002|Period 1|Other Reason|0|||
161549950|NCT00708305|583403034|FG003|Period 1|Other Reason|2|||
161549951|NCT00708305|583403031|FG000|Period 2|Lost to Follow-up|0|||
161549952|NCT00708305|583403032|FG001|Period 2|Lost to Follow-up|1|||
161549953|NCT00708305|583403033|FG002|Period 2|Lost to Follow-up|0|||
161549954|NCT00708305|583403034|FG003|Period 2|Lost to Follow-up|0|||
161549955|NCT00708305|583403031|FG000|Period 2|Protocol Violation|0|||
161549956|NCT00708305|583403032|FG001|Period 2|Protocol Violation|1|||
161549957|NCT00708305|583403033|FG002|Period 2|Protocol Violation|0|||
161549958|NCT00708305|583403034|FG003|Period 2|Protocol Violation|0|||
161549959|NCT00708305|583403031|FG000|Period 2|Other Reason|1|||
161549960|NCT00708305|583403032|FG001|Period 2|Other Reason|0|||
161549961|NCT00708305|583403033|FG002|Period 2|Other Reason|0|||
161549962|NCT00708305|583403034|FG003|Period 2|Other Reason|1|||
161549963|NCT00708305|583403031|FG000|Period 3|Protocol Violation|0|||
161549964|NCT00708305|583403032|FG001|Period 3|Protocol Violation|2|||
161549965|NCT00708305|583403033|FG002|Period 3|Protocol Violation|0|||
161549966|NCT00708305|583403034|FG003|Period 3|Protocol Violation|0|||
161549967|NCT00708305|583403031|FG000|Period 3|Other Reason|1|||
161549968|NCT00708305|583403032|FG001|Period 3|Other Reason|0|||
161549969|NCT00708305|583403033|FG002|Period 3|Other Reason|0|||
161549970|NCT00708305|583403034|FG003|Period 3|Other Reason|0|||
161549971|NCT00192023|583403039|FG000|Period III - Double-Blind|Adverse Event|3|||
161549972|NCT00192023|583403040|FG001|Period III - Double-Blind|Adverse Event|0|||
161549973|NCT00192023|583403039|FG000|Period III - Double-Blind|Physician Decision|2|||
161549974|NCT00192023|583403040|FG001|Period III - Double-Blind|Physician Decision|0|||
161549975|NCT00192023|583403039|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
161549976|NCT00192023|583403040|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
161549977|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
161549978|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
161549979|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
161549980|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
161549981|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
161549982|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
161549983|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
161549984|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
161549985|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
161549986|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
161549987|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
161549988|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
161549989|NCT00192023|583403039|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
161549990|NCT00192023|583403040|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
161549991|NCT02572817|583403065|FG000|Overall Study|Death|6|||
161549992|NCT02572817|583403066|FG001|Overall Study|Death|3|||
161549993|NCT02572817|583403065|FG000|Overall Study|Lost to Follow-up|3|||
161549994|NCT02572817|583403066|FG001|Overall Study|Lost to Follow-up|3|||
161549995|NCT00896454|583403088|FG000|Overall Study|Death|10|||
161549996|NCT00896454|583403088|FG000|Overall Study|Adverse Event|8|||
161549997|NCT00896454|583403088|FG000|Overall Study|Disease Progression|5|||
161549998|NCT00896454|583403088|FG000|Overall Study|Other|4|||
161549999|NCT00896454|583403088|FG000|Overall Study|Requirement for alternative therapy|3|||
161550000|NCT00896454|583403088|FG000|Overall Study|Ongoing in study|2|||
161550001|NCT00896454|583403088|FG000|Overall Study|Withdrawal by Subject|1|||
161637310|NCT02706847|583723114|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
161550002|NCT04175912|583403096|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
161637311|NCT02706847|583723115|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
161637312|NCT02706847|583723112|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
161550003|NCT04175912|583403097|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
161550004|NCT04175912|583403096|FG000|Overall Study|Adverse Event|0|||
161550005|NCT04175912|583403097|FG001|Overall Study|Adverse Event|3|||
161550006|NCT04175912|583403096|FG000|Overall Study|Never started treatment|3|||
161550007|NCT04175912|583403097|FG001|Overall Study|Never started treatment|3|||
161550008|NCT04175912|583403096|FG000|Overall Study|Death|0|||
161550009|NCT04175912|583403097|FG001|Overall Study|Death|1|||
161550010|NCT00856661|583403098|FG000|Overall Study|Death|15|||
161550011|NCT00856661|583403099|FG001|Overall Study|Death|18|||
161550012|NCT00856661|583403098|FG000|Overall Study|Protocol Violation|2|||
161550013|NCT00856661|583403099|FG001|Overall Study|Protocol Violation|1|||
161550014|NCT00856661|583403098|FG000|Overall Study|Withdrawal by Subject|1|||
161550015|NCT00856661|583403099|FG001|Overall Study|Withdrawal by Subject|2|||
161550016|NCT00856661|583403098|FG000|Overall Study|Lost to Follow-up|1|||
161550017|NCT00856661|583403099|FG001|Overall Study|Lost to Follow-up|3|||
161550018|NCT00856661|583403098|FG000|Overall Study|Physician Judgement|8|||
161550019|NCT00856661|583403099|FG001|Overall Study|Physician Judgement|5|||
161550020|NCT03936777|583403100|FG000|Overall Study|Adverse Event|3|||
161550021|NCT03936777|583403100|FG000|Overall Study|Death|3|||
161550022|NCT03936777|583403100|FG000|Overall Study|Lack of Efficacy|24|||
161550023|NCT03936777|583403100|FG000|Overall Study|Lost to Follow-up|3|||
161550024|NCT03936777|583403100|FG000|Overall Study|Physician Decision|1|||
161550025|NCT03936777|583403100|FG000|Overall Study|Withdrawal by Subject|11|||
161550026|NCT03936777|583403100|FG000|Overall Study|Subjected Weaned of ZX008|1|||
161550027|NCT03936777|583403100|FG000|Overall Study|Missing|6|||
161550028|NCT02301156|583403101|FG000|Overall Study|Adverse Event|13|||
161550029|NCT02301156|583403102|FG001|Overall Study|Adverse Event|14|||
161550030|NCT02301156|583403101|FG000|Overall Study|Death|1|||
161550031|NCT02301156|583403102|FG001|Overall Study|Death|5|||
161550032|NCT02301156|583403101|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
161550033|NCT02301156|583403102|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
161550034|NCT02301156|583403101|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
161550035|NCT02301156|583403102|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
161550036|NCT02301156|583403101|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
161550037|NCT02301156|583403102|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
161550038|NCT02301156|583403101|FG000|Overall Study|Reason not Specified|6|||
161550039|NCT02301156|583403102|FG001|Overall Study|Reason not Specified|3|||
161550040|NCT03734991|583403107|FG000|Overall Study|Adverse Event|4|||
161550041|NCT03734991|583403108|FG001|Overall Study|Adverse Event|0|||
161550042|NCT03734991|583403107|FG000|Overall Study|Lost to Follow-up|4|||
161550043|NCT03734991|583403108|FG001|Overall Study|Lost to Follow-up|0|||
161637313|NCT02706847|583723113|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
161637314|NCT02706847|583723114|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
161637315|NCT02706847|583723115|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
161637316|NCT02706847|583723112|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
161637317|NCT02706847|583723113|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
161637318|NCT02706847|583723114|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
161687183|NCT00183274|583907143|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161687184|NCT00183274|583907144|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
161687185|NCT00183274|583907145|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
161637319|NCT02706847|583723115|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
161637320|NCT02706847|583723112|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
161637321|NCT02706847|583723113|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
161637322|NCT02706847|583723114|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
161637323|NCT02706847|583723115|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
161637324|NCT02706847|583723112|FG000|Period 2: Week 24 to Week 260|Other|8|||
161637325|NCT02706847|583723113|FG001|Period 2: Week 24 to Week 260|Other|5|||
161550044|NCT03734991|583403107|FG000|Overall Study|Physician Decision|0|||
161550045|NCT03734991|583403108|FG001|Overall Study|Physician Decision|1|||
161550046|NCT03734991|583403107|FG000|Overall Study|Pregnancy|1|||
161550047|NCT03734991|583403108|FG001|Overall Study|Pregnancy|0|||
161550048|NCT03734991|583403107|FG000|Overall Study|Withdrawal by Subject|6|||
161550049|NCT03734991|583403108|FG001|Overall Study|Withdrawal by Subject|3|||
161550050|NCT03734991|583403107|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
161550051|NCT03734991|583403108|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
161550052|NCT03734991|583403107|FG000|Overall Study|Other|2|||
161550053|NCT03734991|583403108|FG001|Overall Study|Other|2|||
161550054|NCT02638623|583403109|FG000|Overall Study|Surgery timing|5|||
161550055|NCT02638623|583403110|FG001|Overall Study|Surgery timing|6|||
161550056|NCT02638623|583403109|FG000|Overall Study|Not given intervention|2|||
161550057|NCT02638623|583403110|FG001|Overall Study|Not given intervention|0|||
161550058|NCT03797326|583403116|FG000|Overall Study|Lost to Follow-up|1|||
161550059|NCT03797326|583403117|FG001|Overall Study|Lost to Follow-up|0|||
161550060|NCT03797326|583403118|FG002|Overall Study|Lost to Follow-up|0|||
161550061|NCT03797326|583403119|FG003|Overall Study|Lost to Follow-up|1|||
161550062|NCT03797326|583403120|FG004|Overall Study|Lost to Follow-up|0|||
161550063|NCT03797326|583403121|FG005|Overall Study|Lost to Follow-up|0|||
161550064|NCT03797326|583403122|FG006|Overall Study|Lost to Follow-up|0|||
161550065|NCT03797326|583403123|FG007|Overall Study|Lost to Follow-up|0|||
161550066|NCT03797326|583403116|FG000|Overall Study|Withdrawal by Subject|0|||
161550067|NCT03797326|583403117|FG001|Overall Study|Withdrawal by Subject|0|||
161550068|NCT03797326|583403118|FG002|Overall Study|Withdrawal by Subject|1|||
161550069|NCT03797326|583403119|FG003|Overall Study|Withdrawal by Subject|3|||
161550070|NCT03797326|583403120|FG004|Overall Study|Withdrawal by Subject|0|||
161550071|NCT03797326|583403121|FG005|Overall Study|Withdrawal by Subject|2|||
161550072|NCT03797326|583403122|FG006|Overall Study|Withdrawal by Subject|2|||
161550073|NCT03797326|583403123|FG007|Overall Study|Withdrawal by Subject|3|||
161550074|NCT03797326|583403116|FG000|Overall Study|Sponsor Decision|3|||
161550075|NCT03797326|583403117|FG001|Overall Study|Sponsor Decision|3|||
161550076|NCT03797326|583403118|FG002|Overall Study|Sponsor Decision|3|||
161550077|NCT03797326|583403119|FG003|Overall Study|Sponsor Decision|6|||
161550078|NCT03797326|583403120|FG004|Overall Study|Sponsor Decision|0|||
161550079|NCT03797326|583403121|FG005|Overall Study|Sponsor Decision|3|||
161550080|NCT03797326|583403122|FG006|Overall Study|Sponsor Decision|3|||
161550081|NCT03797326|583403123|FG007|Overall Study|Sponsor Decision|2|||
161550082|NCT03797326|583403116|FG000|Overall Study|Death|27|||
161550083|NCT03797326|583403117|FG001|Overall Study|Death|28|||
161550084|NCT03797326|583403118|FG002|Overall Study|Death|95|||
161550085|NCT03797326|583403119|FG003|Overall Study|Death|95|||
161550086|NCT03797326|583403120|FG004|Overall Study|Death|30|||
161550087|NCT03797326|583403121|FG005|Overall Study|Death|96|||
161550088|NCT03797326|583403122|FG006|Overall Study|Death|97|||
161550089|NCT03797326|583403123|FG007|Overall Study|Death|98|||
161550090|NCT03797326|583403116|FG000|Overall Study|Enrolled in error|0|||
161637326|NCT02706847|583723114|FG002|Period 2: Week 24 to Week 260|Other|15|||
161637327|NCT02706847|583723115|FG003|Period 2: Week 24 to Week 260|Other|15|||
161637328|NCT01174264|583723116|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
161637329|NCT01174264|583723117|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
161637330|NCT01174264|583723118|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
161637331|NCT01174264|583723116|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
161637332|NCT01174264|583723117|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
161637333|NCT01174264|583723118|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
161637334|NCT01174264|583723116|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
161550091|NCT03797326|583403117|FG001|Overall Study|Enrolled in error|0|||
161550092|NCT03797326|583403118|FG002|Overall Study|Enrolled in error|3|||
161550093|NCT03797326|583403119|FG003|Overall Study|Enrolled in error|2|||
161550094|NCT03797326|583403120|FG004|Overall Study|Enrolled in error|2|||
161550095|NCT03797326|583403121|FG005|Overall Study|Enrolled in error|1|||
161550096|NCT03797326|583403122|FG006|Overall Study|Enrolled in error|1|||
161550097|NCT03797326|583403123|FG007|Overall Study|Enrolled in error|0|||
161550098|NCT03012061|583403124|FG000|Overall Study|Withdrawal by Subject|1|||
161550099|NCT03012061|583403125|FG001|Overall Study|Withdrawal by Subject|5|||
161550100|NCT03012061|583403126|FG002|Overall Study|Withdrawal by Subject|4|||
161550101|NCT03012061|583403124|FG000|Overall Study|Investigator Site Closed|1|||
161550102|NCT03012061|583403125|FG001|Overall Study|Investigator Site Closed|2|||
161550103|NCT03012061|583403126|FG002|Overall Study|Investigator Site Closed|0|||
161550104|NCT03012061|583403124|FG000|Overall Study|Lost to Follow-up|2|||
161550105|NCT03012061|583403125|FG001|Overall Study|Lost to Follow-up|1|||
161550106|NCT03012061|583403126|FG002|Overall Study|Lost to Follow-up|0|||
161550107|NCT03012061|583403124|FG000|Overall Study|Study closed/ Terminated|0|||
161550108|NCT03012061|583403125|FG001|Overall Study|Study closed/ Terminated|0|||
161550109|NCT03012061|583403126|FG002|Overall Study|Study closed/ Terminated|1|||
161550110|NCT03012061|583403124|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
161550111|NCT03012061|583403125|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
161550112|NCT03012061|583403126|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
161550113|NCT03012061|583403124|FG000|Overall Study|Protocol Violation|0|||
161550114|NCT03012061|583403125|FG001|Overall Study|Protocol Violation|0|||
161550115|NCT03012061|583403126|FG002|Overall Study|Protocol Violation|2|||
161550116|NCT03012061|583403124|FG000|Overall Study|Lack of Efficacy|0|||
161550117|NCT03012061|583403125|FG001|Overall Study|Lack of Efficacy|1|||
161550118|NCT03012061|583403126|FG002|Overall Study|Lack of Efficacy|0|||
161550119|NCT03012061|583403124|FG000|Overall Study|Adverse Event|2|||
161550120|NCT03012061|583403125|FG001|Overall Study|Adverse Event|0|||
161550121|NCT03012061|583403126|FG002|Overall Study|Adverse Event|0|||
161550122|NCT04152343|583403127|FG000|Overall Study|Transplanted|5|||
161550123|NCT04152343|583403127|FG000|Overall Study|Death|20|||
161550124|NCT04152343|583403127|FG000|Overall Study|Lost to Follow-up|3|||
161550125|NCT01164228|583403128|FG000|Overall Study|Progression|24|||
161550126|NCT01164228|583403129|FG001|Overall Study|Progression|25|||
161550127|NCT01164228|583403128|FG000|Overall Study|Adverse Event|13|||
161550128|NCT01164228|583403129|FG001|Overall Study|Adverse Event|7|||
161550129|NCT01164228|583403128|FG000|Overall Study|Death|1|||
161550130|NCT01164228|583403129|FG001|Overall Study|Death|1|||
161550131|NCT01164228|583403128|FG000|Overall Study|Withdrawal by Subject|2|||
161550132|NCT01164228|583403129|FG001|Overall Study|Withdrawal by Subject|0|||
161550133|NCT01164228|583403128|FG000|Overall Study|Physician Decision|1|||
161550134|NCT01164228|583403129|FG001|Overall Study|Physician Decision|2|||
161550135|NCT01164228|583403128|FG000|Overall Study|Symptomatic deterioration|1|||
161550136|NCT01164228|583403129|FG001|Overall Study|Symptomatic deterioration|0|||
161550137|NCT01164228|583403128|FG000|Overall Study|Never started treatment|1|||
161550138|NCT01164228|583403129|FG001|Overall Study|Never started treatment|3|||
161550139|NCT01164228|583403128|FG000|Overall Study|Ineligible|1|||
161550140|NCT01164228|583403129|FG001|Overall Study|Ineligible|0|||
161550141|NCT01965938|583403130|FG000|Overall Study|Withdrawal by Subject|1|||
161550142|NCT01965938|583403131|FG001|Overall Study|Withdrawal by Subject|0|||
161550143|NCT03342053|583403133|FG000|Overall Study|Adverse Event|2|||
161637335|NCT01174264|583723117|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
161637336|NCT01174264|583723118|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
161637337|NCT03432390|583723119|FG000|Apnea Period|Protocol Violation|2|||
161637338|NCT03432390|583723120|FG001|Apnea Period|Protocol Violation|2|||
161637339|NCT02058836|583723122|FG000|Overall Study|Withdrawal by Subject|1|||
161637340|NCT02058836|583723123|FG001|Overall Study|Withdrawal by Subject|1|||
161637341|NCT01774305|583723127|FG000|Overall Study|Physician Decision|1|||
161637342|NCT01774305|583723128|FG001|Overall Study|Physician Decision|0|||
161637343|NCT01185171|583723137|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
161637344|NCT01185171|583723137|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
161637345|NCT01185171|583723137|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
161637346|NCT01185171|583723137|FG000|Maintenance|Elevated liver transaminases|3|||
161637347|NCT01185171|583723137|FG000|Maintenance|Rush|2|||
161637348|NCT01185171|583723137|FG000|Maintenance|Diarrhea|1|||
161637349|NCT01185171|583723137|FG000|Maintenance|Xerostomia|1|||
161637350|NCT01185171|583723137|FG000|Maintenance|Nausea|1|||
161637351|NCT01185171|583723137|FG000|Maintenance|Comorbid Illness|2|||
161637352|NCT01185171|583723137|FG000|Maintenance|Withdrawal by Subject|1|||
161637353|NCT01185171|583723137|FG000|Maintenance|Disease Recurrence|1|||
161637354|NCT01482429|583723138|FG000|Care Usual|Protocol Violation|0|||
161637355|NCT01482429|583723139|FG001|Care Usual|Protocol Violation|172|||
161637356|NCT01482429|583723138|FG000|Care Usual|Lost to Follow-up|0|||
161637357|NCT01482429|583723139|FG001|Care Usual|Lost to Follow-up|1|||
161637358|NCT01482429|583723138|FG000|Protocol|Protocol Violation|275|||
161637359|NCT01482429|583723139|FG001|Protocol|Protocol Violation|0|||
161637360|NCT03561597|583723140|FG000|Overall Study|Lost to Follow-up|20|||
161637361|NCT00573651|583723141|FG000|Overall Study|Lost to Follow-up|3|||
161637362|NCT00573651|583723141|FG000|Overall Study|Withdrawal by Subject|1|||
161637363|NCT00691678|583723149|FG000|Overall Study|Adverse Event|5|||
161637364|NCT00691678|583723149|FG000|Overall Study|life events, pain|11|||
161637365|NCT03049306|583723150|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
161637366|NCT03049306|583723151|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
161637367|NCT05347485|583723154|FG000|Overall Study|Death|14|||
161637368|NCT05347485|583723154|FG000|Overall Study|Lost to Follow-up|2|||
161637369|NCT05347485|583723154|FG000|Overall Study|Withdrawal by Subject|13|||
161637370|NCT05347485|583723154|FG000|Overall Study|Progressive Disease|1|||
161637371|NCT05347485|583723154|FG000|Overall Study|Study Terminated by Sponsor|49|||
161637372|NCT05347485|583723154|FG000|Overall Study|Other|1|||
161637373|NCT05347485|583723154|FG000|Overall Study|Enrolled (consented) but not treated|4|||
161637374|NCT05347485|583723154|FG000|Overall Study|Disease Relapse|2|||
161687186|NCT00183274|583907146|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
161687187|NCT00183274|583907141|FG000|Phase 3: Double-Blind|Relapsed|0|||
161687188|NCT00183274|583907142|FG001|Phase 3: Double-Blind|Relapsed|0|||
161637375|NCT05896696|583723155|FG000|Overall Study|Screening Failure|7|||
161637376|NCT05896696|583723155|FG000|Overall Study|Withdrawal by Subject|2|||
161637377|NCT00487825|583725094|FG000|Overall Study|Adverse Event|2|||
161637378|NCT00487825|583725095|FG001|Overall Study|Adverse Event|2|||
161687189|NCT00183274|583907143|FG002|Phase 3: Double-Blind|Relapsed|0|||
161637379|NCT00487825|583725094|FG000|Overall Study|Lack of Efficacy|1|||
161637380|NCT00487825|583725095|FG001|Overall Study|Lack of Efficacy|1|||
161637381|NCT00487825|583725094|FG000|Overall Study|Other|3|||
161637382|NCT00487825|583725095|FG001|Overall Study|Other|2|||
161637383|NCT01639742|583725096|FG000|Overall Study|Study Ongoing|17|||
161637384|NCT01639742|583725096|FG000|Overall Study|Lost to Follow-up|1|||
161637385|NCT01256671|583725097|FG000|Overall Study|Adverse Event|29|||
161637386|NCT01256671|583725097|FG000|Overall Study|Lost to Follow-up|16|||
161550144|NCT03342053|583403134|FG001|Overall Study|Adverse Event|0|||
161550145|NCT03342053|583403133|FG000|Overall Study|Withdrawal by Subject|0|||
161687190|NCT00183274|583907144|FG003|Phase 3: Double-Blind|Relapsed|1|||
161687191|NCT00183274|583907145|FG004|Phase 3: Double-Blind|Relapsed|11|||
161687192|NCT00183274|583907146|FG005|Phase 3: Double-Blind|Relapsed|2|||
161687193|NCT00586495|583907151|FG000|Treatment Period|Adverse Event|11|||
161687194|NCT00586495|583907151|FG000|Treatment Period|Death|1|||
161687195|NCT00586495|583907151|FG000|Treatment Period|Protocol Violation|1|||
161687196|NCT00586495|583907151|FG000|Treatment Period|Withdrawal by Subject|1|||
161687197|NCT00586495|583907151|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
161687198|NCT00586495|583907151|FG000|Treatment Period|Switch to commercial drug|10|||
161687199|NCT00586495|583907151|FG000|Follow-up|Death|40|||
161687200|NCT00586495|583907151|FG000|Follow-up|Lost to Follow-up|1|||
161835121|NCT03166124|584437241|FG002|Wash-out Period|Adverse Event|1|||
161637387|NCT01256671|583725097|FG000|Overall Study|Withdrawal by Subject|31|||
161637388|NCT01256671|583725097|FG000|Overall Study|Physician Decision|3|||
161637389|NCT01256671|583725097|FG000|Overall Study|Lack of Efficacy|4|||
161637390|NCT01256671|583725097|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
161637391|NCT01986114|583725098|FG000|Overall Study|Adverse Event|59|||
161637392|NCT01986114|583725098|FG000|Overall Study|Lack of Efficacy|23|||
161637393|NCT01986114|583725098|FG000|Overall Study|Withdrawal by Subject|58|||
161637394|NCT01986114|583725098|FG000|Overall Study|Noncompliance|3|||
161550146|NCT03342053|583403134|FG001|Overall Study|Withdrawal by Subject|1|||
161550147|NCT02294474|583403135|FG000|Overall Study|Adverse Event|7|||
161550148|NCT02294474|583403136|FG001|Overall Study|Adverse Event|7|||
161550149|NCT02294474|583403135|FG000|Overall Study|Lack of Efficacy|2|||
161550150|NCT02294474|583403136|FG001|Overall Study|Lack of Efficacy|1|||
161550151|NCT02294474|583403135|FG000|Overall Study|Protocol Violation|4|||
161550152|NCT02294474|583403136|FG001|Overall Study|Protocol Violation|2|||
161550153|NCT02294474|583403135|FG000|Overall Study|Other than specified above|12|||
161550154|NCT02294474|583403136|FG001|Overall Study|Other than specified above|12|||
161550155|NCT02961374|583403137|FG000|Overall Study|Adverse Event|4|||
161550156|NCT00171873|583403140|FG000|Overall Study|Withdrawal by Subject|4|||
161550157|NCT00171873|583403141|FG001|Overall Study|Withdrawal by Subject|2|||
161550158|NCT00171873|583403140|FG000|Overall Study|Adverse Event|5|||
161550159|NCT00171873|583403141|FG001|Overall Study|Adverse Event|0|||
161550160|NCT00171873|583403140|FG000|Overall Study|Switched to Octreotide|0|||
161550161|NCT00171873|583403141|FG001|Overall Study|Switched to Octreotide|1|||
161550162|NCT02041923|583403142|FG000|Overall Study|Lost to Follow-up|26|||
161550163|NCT02041923|583403143|FG001|Overall Study|Lost to Follow-up|30|||
161550164|NCT00309608|583403146|FG000|Overall Study|Adverse Event|1|||
161637395|NCT01986114|583725098|FG000|Overall Study|Protocol Violation|1|||
161637396|NCT01986114|583725098|FG000|Overall Study|Lost to Follow-up|5|||
161687201|NCT00586495|583907151|FG000|Follow-up|Withdrawal by Subject|4|||
161687202|NCT00586495|583907151|FG000|Follow-up|Protocol driven decision point|37|||
161687203|NCT00586495|583907151|FG000|Follow-up|Switch to commercial drug|10|||
161687204|NCT01046877|583907154|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
161835122|NCT03166124|584437242|FG003|Wash-out Period|Adverse Event|0|||
161835123|NCT00788593|584437243|FG000|Placebo Run-in Phase|Adverse Event|2|||
161835124|NCT00788593|584437244|FG001|Placebo Run-in Phase|Adverse Event|0|||
161835125|NCT00788593|584437245|FG002|Placebo Run-in Phase|Adverse Event|0|||
161835126|NCT00788593|584437243|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
161835127|NCT00788593|584437244|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
161835128|NCT00788593|584437245|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
161835129|NCT00788593|584437243|FG000|Placebo Run-in Phase|Protocol Violation|2|||
161835130|NCT00788593|584437244|FG001|Placebo Run-in Phase|Protocol Violation|0|||
161835131|NCT00788593|584437245|FG002|Placebo Run-in Phase|Protocol Violation|0|||
161835132|NCT00788593|584437243|FG000|First Intervention Period|Adverse Event|0|||
161835133|NCT00788593|584437244|FG001|First Intervention Period|Adverse Event|1|||
161687205|NCT01046877|583907154|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
161687206|NCT04770389|583907160|FG000|Overall Study|Adverse Event|1|||
161687207|NCT04770389|583907161|FG001|Overall Study|Adverse Event|2|||
161687208|NCT04770389|583907162|FG002|Overall Study|Adverse Event|0|||
161835134|NCT00788593|584437245|FG002|First Intervention Period|Adverse Event|0|||
161637397|NCT01986114|583725098|FG000|Overall Study|Other reason|7|||
161637398|NCT01190644|583725099|FG000|Overall Study|Death|2|||
161637399|NCT01190644|583725099|FG000|Overall Study|Disease progression|1|||
161637400|NCT04411186|583725100|FG000|Overall Study|Withdrawn due to protocol violation|0|||
161687209|NCT04770389|583907163|FG003|Overall Study|Adverse Event|1|||
161687210|NCT04770389|583907160|FG000|Overall Study|Withdrawal by Subject|0|||
161550165|NCT00309608|583403147|FG001|Overall Study|Adverse Event|5|||
161637401|NCT04411186|583725101|FG001|Overall Study|Withdrawn due to protocol violation|1|||
161637402|NCT02172911|583725102|FG000|Overall Study|Serious Adverse Event|0|||
161550166|NCT00309608|583403148|FG002|Overall Study|Adverse Event|3|||
161550167|NCT00309608|583403149|FG003|Overall Study|Adverse Event|2|||
161550168|NCT00309608|583403150|FG004|Overall Study|Adverse Event|3|||
161550169|NCT00309608|583403146|FG000|Overall Study|Protocol Violation|2|||
161550170|NCT00309608|583403147|FG001|Overall Study|Protocol Violation|0|||
161550171|NCT00309608|583403148|FG002|Overall Study|Protocol Violation|0|||
161550172|NCT00309608|583403149|FG003|Overall Study|Protocol Violation|0|||
161550173|NCT00309608|583403150|FG004|Overall Study|Protocol Violation|0|||
161550174|NCT00309608|583403146|FG000|Overall Study|Lost to Follow-up|0|||
161550175|NCT00309608|583403147|FG001|Overall Study|Lost to Follow-up|0|||
161550176|NCT00309608|583403148|FG002|Overall Study|Lost to Follow-up|2|||
161550177|NCT00309608|583403149|FG003|Overall Study|Lost to Follow-up|0|||
161550178|NCT00309608|583403150|FG004|Overall Study|Lost to Follow-up|1|||
161550179|NCT00309608|583403146|FG000|Overall Study|Withdrawal by Subject|1|||
161550180|NCT00309608|583403147|FG001|Overall Study|Withdrawal by Subject|4|||
161550181|NCT00309608|583403148|FG002|Overall Study|Withdrawal by Subject|2|||
161550182|NCT00309608|583403149|FG003|Overall Study|Withdrawal by Subject|0|||
161550183|NCT00309608|583403150|FG004|Overall Study|Withdrawal by Subject|0|||
161550184|NCT00309608|583403146|FG000|Overall Study|Other incl. Lack of efficacy|10|||
161550185|NCT00309608|583403147|FG001|Overall Study|Other incl. Lack of efficacy|4|||
161550186|NCT00309608|583403148|FG002|Overall Study|Other incl. Lack of efficacy|3|||
161550187|NCT00309608|583403149|FG003|Overall Study|Other incl. Lack of efficacy|4|||
161550188|NCT00309608|583403150|FG004|Overall Study|Other incl. Lack of efficacy|0|||
161550189|NCT00127413|583403151|FG000|Overall Study|Lost to Follow-up|6|||
161550190|NCT00127413|583403152|FG001|Overall Study|Lost to Follow-up|4|||
161550191|NCT00127413|583403153|FG002|Overall Study|Lost to Follow-up|8|||
161550192|NCT00127413|583403154|FG003|Overall Study|Lost to Follow-up|2|||
161637403|NCT02172911|583725103|FG001|Overall Study|Serious Adverse Event|1|||
161637404|NCT02172911|583725102|FG000|Overall Study|Progression of Disease|0|||
161637405|NCT02172911|583725103|FG001|Overall Study|Progression of Disease|1|||
161637406|NCT02172911|583725102|FG000|Overall Study|Loss of insurance coverage|1|||
161835135|NCT00788593|584437243|FG000|Second Intervention Period|Lost to Follow-up|0|||
161835136|NCT00788593|584437244|FG001|Second Intervention Period|Lost to Follow-up|1|||
161835137|NCT00788593|584437245|FG002|Second Intervention Period|Lost to Follow-up|0|||
161835138|NCT00788593|584437243|FG000|Second Intervention Period|Other|0|||
161835139|NCT00788593|584437244|FG001|Second Intervention Period|Other|0|||
161835140|NCT00788593|584437245|FG002|Second Intervention Period|Other|1|||
161835141|NCT01392326|584437246|FG000|Overall Study|Death|2|||
161835142|NCT01392326|584437247|FG001|Overall Study|Death|0|||
161835143|NCT01392326|584437248|FG002|Overall Study|Death|0|||
161835144|NCT01392326|584437246|FG000|Overall Study|Withdrawal by Subject|12|||
161637407|NCT02172911|583725103|FG001|Overall Study|Loss of insurance coverage|0|||
161637408|NCT00575042|583725106|FG000|Overall Study|Adverse Event|2|||
161637409|NCT00575042|583725106|FG000|Overall Study|Lost to Follow-up|1|||
161637410|NCT04795336|583725109|FG000|Overall Study|Withdrawal by Subject|3|||
161637411|NCT04795336|583725110|FG001|Overall Study|Withdrawal by Subject|4|||
161637412|NCT04795336|583725111|FG002|Overall Study|Withdrawal by Subject|3|||
161637413|NCT04795336|583725112|FG003|Overall Study|Withdrawal by Subject|12|||
161637414|NCT04795336|583725109|FG000|Overall Study|Lost study logs|0|||
161637415|NCT04795336|583725110|FG001|Overall Study|Lost study logs|1|||
161637416|NCT04795336|583725111|FG002|Overall Study|Lost study logs|0|||
161637417|NCT04795336|583725112|FG003|Overall Study|Lost study logs|2|||
161637418|NCT04795336|583725109|FG000|Overall Study|Did not take study medication|2|||
161637419|NCT04795336|583725110|FG001|Overall Study|Did not take study medication|0|||
161637420|NCT04795336|583725111|FG002|Overall Study|Did not take study medication|0|||
161637421|NCT04795336|583725112|FG003|Overall Study|Did not take study medication|0|||
161637422|NCT03021551|583725114|FG000|Overall Study|Equipment Issues|2|||
161637423|NCT03021551|583725114|FG000|Overall Study|Protocol Violation|1|||
161637424|NCT00490945|583725117|FG000|Overall Study|Adverse Event|0|||
161637425|NCT00490945|583725118|FG001|Overall Study|Adverse Event|1|||
161637426|NCT00490945|583725119|FG002|Overall Study|Adverse Event|0|||
161637427|NCT00490945|583725120|FG003|Overall Study|Adverse Event|0|||
161637428|NCT00490945|583725121|FG004|Overall Study|Adverse Event|0|||
161637429|NCT02706951|583725123|FG000|Period 1|Adverse Event|1|||
161637430|NCT02706951|583725124|FG001|Period 1|Adverse Event|5|||
161637431|NCT02706951|583725125|FG002|Period 1|Adverse Event|3|||
161637432|NCT02706951|583725126|FG003|Period 1|Adverse Event|0|||
161637433|NCT02706951|583725127|FG004|Period 1|Adverse Event|0|||
161835145|NCT01392326|584437247|FG001|Overall Study|Withdrawal by Subject|11|||
161637434|NCT02706951|583725123|FG000|Period 1|Withdrawal by Subject|10|||
161637435|NCT02706951|583725124|FG001|Period 1|Withdrawal by Subject|6|||
161637436|NCT02706951|583725125|FG002|Period 1|Withdrawal by Subject|6|||
161637437|NCT02706951|583725126|FG003|Period 1|Withdrawal by Subject|0|||
161637438|NCT02706951|583725127|FG004|Period 1|Withdrawal by Subject|0|||
161637439|NCT02706951|583725123|FG000|Period 1|Lost to Follow-up|0|||
161637440|NCT02706951|583725124|FG001|Period 1|Lost to Follow-up|4|||
161637441|NCT02706951|583725125|FG002|Period 1|Lost to Follow-up|1|||
161637442|NCT02706951|583725126|FG003|Period 1|Lost to Follow-up|0|||
161637443|NCT02706951|583725127|FG004|Period 1|Lost to Follow-up|0|||
161637444|NCT02706951|583725123|FG000|Period 1|Other|2|||
161637445|NCT02706951|583725124|FG001|Period 1|Other|1|||
161637446|NCT02706951|583725125|FG002|Period 1|Other|0|||
161637447|NCT02706951|583725126|FG003|Period 1|Other|0|||
161637448|NCT02706951|583725127|FG004|Period 1|Other|0|||
161637449|NCT02706951|583725123|FG000|Period 2|Adverse Event|0|||
161637450|NCT02706951|583725124|FG001|Period 2|Adverse Event|0|||
161637451|NCT02706951|583725125|FG002|Period 2|Adverse Event|0|||
161637452|NCT02706951|583725126|FG003|Period 2|Adverse Event|25|||
161637453|NCT02706951|583725127|FG004|Period 2|Adverse Event|34|||
161637454|NCT02706951|583725123|FG000|Period 2|Withdrawal by Subject|0|||
161637455|NCT02706951|583725124|FG001|Period 2|Withdrawal by Subject|0|||
161637456|NCT02706951|583725125|FG002|Period 2|Withdrawal by Subject|0|||
161637457|NCT02706951|583725126|FG003|Period 2|Withdrawal by Subject|38|||
161637458|NCT02706951|583725127|FG004|Period 2|Withdrawal by Subject|44|||
161637459|NCT02706951|583725123|FG000|Period 2|Lost to Follow-up|0|||
161637460|NCT02706951|583725124|FG001|Period 2|Lost to Follow-up|0|||
161637461|NCT02706951|583725125|FG002|Period 2|Lost to Follow-up|0|||
161637462|NCT02706951|583725126|FG003|Period 2|Lost to Follow-up|17|||
161637463|NCT02706951|583725127|FG004|Period 2|Lost to Follow-up|9|||
161637464|NCT02706951|583725123|FG000|Period 2|COVID-19 Related|0|||
161637465|NCT02706951|583725124|FG001|Period 2|COVID-19 Related|0|||
161637466|NCT02706951|583725125|FG002|Period 2|COVID-19 Related|0|||
161637467|NCT02706951|583725126|FG003|Period 2|COVID-19 Related|1|||
161637468|NCT02706951|583725127|FG004|Period 2|COVID-19 Related|2|||
161637469|NCT02706951|583725123|FG000|Period 2|Other|0|||
161637470|NCT02706951|583725124|FG001|Period 2|Other|0|||
161637471|NCT02706951|583725125|FG002|Period 2|Other|0|||
161637472|NCT02706951|583725126|FG003|Period 2|Other|37|||
161637473|NCT02706951|583725127|FG004|Period 2|Other|31|||
161637474|NCT03297398|583725132|FG000|Overall Study|Sponsor's decision|6|||
161637475|NCT03297398|583725133|FG001|Overall Study|Sponsor's decision|9|||
161637476|NCT03297398|583725134|FG002|Overall Study|Sponsor's decision|7|||
161637477|NCT03297398|583725132|FG000|Overall Study|Adverse Event|1|||
161637478|NCT03297398|583725133|FG001|Overall Study|Adverse Event|4|||
161637479|NCT03297398|583725134|FG002|Overall Study|Adverse Event|4|||
161637480|NCT03297398|583725132|FG000|Overall Study|Withdrawal by Subject|1|||
161637481|NCT03297398|583725133|FG001|Overall Study|Withdrawal by Subject|2|||
161637482|NCT03297398|583725134|FG002|Overall Study|Withdrawal by Subject|2|||
161637483|NCT03297398|583725132|FG000|Overall Study|Protocol Violation|0|||
161637484|NCT03297398|583725133|FG001|Overall Study|Protocol Violation|2|||
161637485|NCT03297398|583725134|FG002|Overall Study|Protocol Violation|0|||
161637486|NCT03297398|583725132|FG000|Overall Study|Physician Decision|0|||
161637487|NCT03297398|583725133|FG001|Overall Study|Physician Decision|0|||
161835146|NCT01392326|584437248|FG002|Overall Study|Withdrawal by Subject|15|||
161637488|NCT03297398|583725134|FG002|Overall Study|Physician Decision|1|||
161637489|NCT03297398|583725132|FG000|Overall Study|Lost to Follow-up|0|||
161637490|NCT03297398|583725133|FG001|Overall Study|Lost to Follow-up|0|||
161637491|NCT03297398|583725134|FG002|Overall Study|Lost to Follow-up|1|||
161637492|NCT00611715|583725137|FG000|Overall Study|Disease Progression|24|||
161637493|NCT00611715|583725138|FG001|Overall Study|Disease Progression|4|||
161637494|NCT00611715|583725137|FG000|Overall Study|Withdrawal by Subject|5|||
161637495|NCT00611715|583725138|FG001|Overall Study|Withdrawal by Subject|1|||
161637496|NCT00611715|583725137|FG000|Overall Study|Adverse Event|9|||
161637497|NCT00611715|583725138|FG001|Overall Study|Adverse Event|1|||
161637498|NCT00611715|583725137|FG000|Overall Study|Death|1|||
161637499|NCT00611715|583725138|FG001|Overall Study|Death|0|||
161637500|NCT00611715|583725137|FG000|Overall Study|two patients are still on treatment|2|||
161637501|NCT00611715|583725138|FG001|Overall Study|two patients are still on treatment|0|||
161637502|NCT03634839|583725140|FG000|First Intervention (2 Hours)|Adverse Event|0|||
161637503|NCT03634839|583725141|FG001|First Intervention (2 Hours)|Adverse Event|2|||
161637504|NCT00350298|583725142|FG000|Overall Study|Death|7|||
161637505|NCT00350298|583725143|FG001|Overall Study|Death|8|||
161637506|NCT00350298|583725142|FG000|Overall Study|Lost to Follow-up|1|||
161637507|NCT00350298|583725143|FG001|Overall Study|Lost to Follow-up|2|||
161637508|NCT00350298|583725142|FG000|Overall Study|Withdrawal by Subject|1|||
161637509|NCT00350298|583725143|FG001|Overall Study|Withdrawal by Subject|3|||
161637510|NCT00233389|583725146|FG000|Overall Study|Adverse Event|5|||
161637511|NCT00233389|583725147|FG001|Overall Study|Adverse Event|5|||
161637512|NCT00233389|583725146|FG000|Overall Study|Lack of Efficacy|11|||
161637513|NCT00233389|583725147|FG001|Overall Study|Lack of Efficacy|8|||
161637514|NCT00233389|583725146|FG000|Overall Study|Lost to Follow-up|1|||
161637515|NCT00233389|583725147|FG001|Overall Study|Lost to Follow-up|1|||
161637516|NCT00233389|583725146|FG000|Overall Study|Physician Decision|1|||
161637517|NCT00233389|583725147|FG001|Overall Study|Physician Decision|0|||
161637518|NCT00233389|583725146|FG000|Overall Study|Protocol Violation|0|||
161637519|NCT00233389|583725147|FG001|Overall Study|Protocol Violation|1|||
161637520|NCT00233389|583725146|FG000|Overall Study|Withdrawal by Subject|0|||
161637521|NCT00233389|583725147|FG001|Overall Study|Withdrawal by Subject|1|||
161637522|NCT00719043|583725153|FG000|Overall Study|Adverse Event|5|||
161637523|NCT00719043|583725154|FG001|Overall Study|Adverse Event|1|||
161637524|NCT00719043|583725155|FG002|Overall Study|Adverse Event|2|||
161637525|NCT00719043|583725156|FG003|Overall Study|Adverse Event|2|||
161637526|NCT00719043|583725157|FG004|Overall Study|Adverse Event|1|||
161637527|NCT00719043|583725158|FG005|Overall Study|Adverse Event|4|||
161637528|NCT00719043|583725159|FG006|Overall Study|Adverse Event|4|||
161637529|NCT00719043|583725153|FG000|Overall Study|Lost to Follow-up|14|||
161637530|NCT00719043|583725154|FG001|Overall Study|Lost to Follow-up|10|||
161637531|NCT00719043|583725155|FG002|Overall Study|Lost to Follow-up|8|||
161637532|NCT00719043|583725156|FG003|Overall Study|Lost to Follow-up|9|||
161637533|NCT00719043|583725157|FG004|Overall Study|Lost to Follow-up|10|||
161637534|NCT00719043|583725158|FG005|Overall Study|Lost to Follow-up|9|||
161637535|NCT00719043|583725159|FG006|Overall Study|Lost to Follow-up|9|||
161637536|NCT00719043|583725153|FG000|Overall Study|Protocol Violation|0|||
161637537|NCT00719043|583725154|FG001|Overall Study|Protocol Violation|0|||
161637538|NCT00719043|583725155|FG002|Overall Study|Protocol Violation|0|||
161637539|NCT00719043|583725156|FG003|Overall Study|Protocol Violation|0|||
161637540|NCT00719043|583725157|FG004|Overall Study|Protocol Violation|0|||
161637541|NCT00719043|583725158|FG005|Overall Study|Protocol Violation|1|||
161637542|NCT00719043|583725159|FG006|Overall Study|Protocol Violation|0|||
161637543|NCT00719043|583725153|FG000|Overall Study|Other|1|||
161637544|NCT00719043|583725154|FG001|Overall Study|Other|0|||
161637545|NCT00719043|583725155|FG002|Overall Study|Other|1|||
161637546|NCT00719043|583725156|FG003|Overall Study|Other|2|||
161637547|NCT00719043|583725157|FG004|Overall Study|Other|0|||
161637548|NCT00719043|583725158|FG005|Overall Study|Other|2|||
161637549|NCT00719043|583725159|FG006|Overall Study|Other|1|||
161637550|NCT00719043|583725153|FG000|Overall Study|Withdrawal by Subject|12|||
161637551|NCT00719043|583725154|FG001|Overall Study|Withdrawal by Subject|14|||
161637552|NCT00719043|583725155|FG002|Overall Study|Withdrawal by Subject|9|||
161637553|NCT00719043|583725156|FG003|Overall Study|Withdrawal by Subject|10|||
161637554|NCT00719043|583725157|FG004|Overall Study|Withdrawal by Subject|16|||
161637555|NCT00719043|583725158|FG005|Overall Study|Withdrawal by Subject|18|||
161637556|NCT00719043|583725159|FG006|Overall Study|Withdrawal by Subject|14|||
161637557|NCT04593823|583725160|FG000|Overall Study|Withdrawal by Subject|1|||
161637558|NCT04593823|583725161|FG001|Overall Study|Withdrawal by Subject|1|||
161637559|NCT04593823|583725160|FG000|Overall Study|Lost to Follow-up|0|||
161637560|NCT04593823|583725161|FG001|Overall Study|Lost to Follow-up|1|||
161637561|NCT00952848|583725168|FG000|Overall Study|Withdrawal by Subject|4|||
161637562|NCT00458393|583725169|FG000|Overall Study|Withdrawal by Subject|67|||
161835147|NCT01392326|584437246|FG000|Overall Study|Protocol Violation|2|||
161835148|NCT01392326|584437247|FG001|Overall Study|Protocol Violation|0|||
161637563|NCT00458393|583725170|FG001|Overall Study|Withdrawal by Subject|80|||
161637564|NCT00458393|583725169|FG000|Overall Study|Physician Decision|31|||
161637565|NCT00458393|583725170|FG001|Overall Study|Physician Decision|22|||
161637566|NCT00458393|583725169|FG000|Overall Study|Relocated|77|||
161637567|NCT00458393|583725170|FG001|Overall Study|Relocated|81|||
161637568|NCT00458393|583725169|FG000|Overall Study|Lost to Follow-up|115|||
161637569|NCT00458393|583725170|FG001|Overall Study|Lost to Follow-up|92|||
161637570|NCT00458393|583725169|FG000|Overall Study|Sites marked other on the form.|19|||
161637571|NCT00458393|583725170|FG001|Overall Study|Sites marked other on the form.|20|||
161637572|NCT02725567|583725171|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
161637573|NCT02725567|583725172|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
161637574|NCT02725567|583725171|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
161637575|NCT02725567|583725172|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
161637576|NCT02725567|583725171|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
161637577|NCT02725567|583725172|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
161637578|NCT02777242|583725173|FG000|Overall Study|Other|2|||
161637579|NCT02777242|583725173|FG000|Overall Study|Lost to Follow-up|1|||
161637580|NCT02777242|583725173|FG000|Overall Study|Multiple|1|||
161637581|NCT02777242|583725173|FG000|Overall Study|Sponsor's request|1|||
161637582|NCT02777242|583725173|FG000|Overall Study|Withdrawal by Subject|1|||
161637583|NCT01253447|583725175|FG000|Overall Study|Adverse Event|2|||
161637584|NCT02299427|583725176|FG000|Overall Study|Withdrawal by Subject|1|||
161637585|NCT02299427|583725177|FG001|Overall Study|Withdrawal by Subject|0|||
161637586|NCT02299427|583725176|FG000|Overall Study|Lost to Follow-up|1|||
161637587|NCT02299427|583725177|FG001|Overall Study|Lost to Follow-up|3|||
161637588|NCT02299427|583725176|FG000|Overall Study|not adherent to dog website use|21|||
161637589|NCT02299427|583725177|FG001|Overall Study|not adherent to dog website use|0|||
161637590|NCT01182181|583725185|FG000|First Intervention|Adverse Event|1|||
161637591|NCT01182181|583725186|FG001|First Intervention|Adverse Event|0|||
161637592|NCT01182181|583725185|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
161637593|NCT01182181|583725186|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
161637594|NCT00511797|583725187|FG000|Overall Study|Adverse Event|1|||
161637595|NCT00511797|583725188|FG001|Overall Study|Adverse Event|2|||
161637596|NCT00511797|583725189|FG002|Overall Study|Adverse Event|2|||
161637597|NCT00511797|583725190|FG003|Overall Study|Adverse Event|2|||
161637598|NCT00511797|583725187|FG000|Overall Study|Lost to Follow-up|1|||
161637599|NCT00511797|583725188|FG001|Overall Study|Lost to Follow-up|0|||
161637600|NCT00511797|583725189|FG002|Overall Study|Lost to Follow-up|0|||
161637601|NCT00511797|583725190|FG003|Overall Study|Lost to Follow-up|1|||
161637602|NCT00511797|583725187|FG000|Overall Study|Pregnancy|0|||
161637603|NCT00511797|583725188|FG001|Overall Study|Pregnancy|0|||
161637604|NCT00511797|583725189|FG002|Overall Study|Pregnancy|0|||
161637605|NCT00511797|583725190|FG003|Overall Study|Pregnancy|1|||
161637606|NCT00511797|583725187|FG000|Overall Study|Protocol Violation|0|||
161637607|NCT00511797|583725188|FG001|Overall Study|Protocol Violation|2|||
161637608|NCT00511797|583725189|FG002|Overall Study|Protocol Violation|2|||
161637609|NCT00511797|583725190|FG003|Overall Study|Protocol Violation|3|||
161637610|NCT00511797|583725187|FG000|Overall Study|Withdrawal by Subject|3|||
161637611|NCT00511797|583725188|FG001|Overall Study|Withdrawal by Subject|3|||
161637612|NCT00511797|583725189|FG002|Overall Study|Withdrawal by Subject|4|||
161637613|NCT00511797|583725190|FG003|Overall Study|Withdrawal by Subject|2|||
161637614|NCT00511797|583725187|FG000|Overall Study|Never dispensed|1|||
161637615|NCT00511797|583725188|FG001|Overall Study|Never dispensed|0|||
161637616|NCT00511797|583725189|FG002|Overall Study|Never dispensed|1|||
161637617|NCT00511797|583725190|FG003|Overall Study|Never dispensed|3|||
161637618|NCT00511797|583725187|FG000|Overall Study|Study drug not taken|0|||
161637619|NCT00511797|583725188|FG001|Overall Study|Study drug not taken|1|||
161637620|NCT00511797|583725189|FG002|Overall Study|Study drug not taken|0|||
161637621|NCT00511797|583725190|FG003|Overall Study|Study drug not taken|1|||
161637622|NCT00511797|583725187|FG000|Overall Study|Partially missing diary|0|||
161637623|NCT00511797|583725188|FG001|Overall Study|Partially missing diary|0|||
161637624|NCT00511797|583725189|FG002|Overall Study|Partially missing diary|1|||
161637625|NCT00511797|583725190|FG003|Overall Study|Partially missing diary|0|||
161637626|NCT00511797|583725187|FG000|Overall Study|Other (moving etc)|1|||
161637627|NCT00511797|583725188|FG001|Overall Study|Other (moving etc)|0|||
161637628|NCT00511797|583725189|FG002|Overall Study|Other (moving etc)|1|||
161637629|NCT00511797|583725190|FG003|Overall Study|Other (moving etc)|2|||
161637630|NCT02413593|583725191|FG000|Overall Study|Lost to Follow-up|3|||
161637631|NCT02413593|583725191|FG000|Overall Study|Adverse Event|1|||
161637632|NCT03845075|583725192|FG000|Part 1 - DB|Withdrawal by Subject|1|||
161637633|NCT03845075|583725193|FG001|Part 1 - DB|Withdrawal by Subject|1|||
161637634|NCT03845075|583725194|FG002|Part 1 - DB|Withdrawal by Subject|0|||
161637635|NCT03845075|583725195|FG003|Part 1 - DB|Withdrawal by Subject|0|||
161637636|NCT03845075|583725192|FG000|Part 1 - DB|Adverse Event|0|||
161637637|NCT03845075|583725193|FG001|Part 1 - DB|Adverse Event|1|||
161637638|NCT03845075|583725194|FG002|Part 1 - DB|Adverse Event|0|||
161637639|NCT03845075|583725195|FG003|Part 1 - DB|Adverse Event|0|||
161637640|NCT03845075|583725192|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
161637641|NCT03845075|583725193|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
161637642|NCT03845075|583725194|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
161637643|NCT03845075|583725195|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
161637644|NCT02564718|583725196|FG000|Overall Study|Withdrew from treatment|0|||
161637645|NCT02564718|583725197|FG001|Overall Study|Withdrew from treatment|1|||
161637646|NCT00104637|583725198|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
161637647|NCT00104637|583725199|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
161637648|NCT00409409|583725200|FG000|Overall Study|Adverse Event|7|||
161637649|NCT00409409|583725201|FG001|Overall Study|Adverse Event|2|||
161637650|NCT00409409|583725200|FG000|Overall Study|Withdrawal by Subject|1|||
161637651|NCT00409409|583725201|FG001|Overall Study|Withdrawal by Subject|1|||
161637652|NCT00409409|583725200|FG000|Overall Study|Any other reason not above-mentioned|0|||
161637653|NCT00409409|583725201|FG001|Overall Study|Any other reason not above-mentioned|1|||
161637654|NCT03599622|583725202|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161637655|NCT03599622|583725203|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
161637656|NCT03599622|583725204|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
161637657|NCT03599622|583725205|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
161637658|NCT03599622|583725202|FG000|Pre-Treatment Period|Other reasons|1|||
161637659|NCT03599622|583725203|FG001|Pre-Treatment Period|Other reasons|1|||
161637660|NCT03599622|583725204|FG002|Pre-Treatment Period|Other reasons|1|||
161637661|NCT03599622|583725205|FG003|Pre-Treatment Period|Other reasons|0|||
161637662|NCT03599622|583725202|FG000|Treatment Period|Adverse Event|11|||
161637663|NCT03599622|583725203|FG001|Treatment Period|Adverse Event|20|||
161637664|NCT03599622|583725204|FG002|Treatment Period|Adverse Event|18|||
161637665|NCT03599622|583725205|FG003|Treatment Period|Adverse Event|2|||
161637666|NCT03599622|583725202|FG000|Treatment Period|Lack of Efficacy|18|||
161637667|NCT03599622|583725203|FG001|Treatment Period|Lack of Efficacy|12|||
161637668|NCT03599622|583725204|FG002|Treatment Period|Lack of Efficacy|13|||
161637669|NCT03599622|583725205|FG003|Treatment Period|Lack of Efficacy|2|||
161637670|NCT03599622|583725202|FG000|Treatment Period|Withdrawal by Subject|5|||
161637671|NCT03599622|583725203|FG001|Treatment Period|Withdrawal by Subject|11|||
161637672|NCT03599622|583725204|FG002|Treatment Period|Withdrawal by Subject|16|||
161637673|NCT03599622|583725205|FG003|Treatment Period|Withdrawal by Subject|1|||
161637674|NCT03599622|583725202|FG000|Treatment Period|Other reasons|4|||
161637675|NCT03599622|583725203|FG001|Treatment Period|Other reasons|6|||
161637676|NCT03599622|583725204|FG002|Treatment Period|Other reasons|7|||
161637677|NCT03599622|583725205|FG003|Treatment Period|Other reasons|0|||
161637678|NCT03599622|583725202|FG000|Treatment Period|Lost to Follow-up|1|||
161637679|NCT03599622|583725203|FG001|Treatment Period|Lost to Follow-up|0|||
161637680|NCT03599622|583725204|FG002|Treatment Period|Lost to Follow-up|0|||
161637681|NCT03599622|583725205|FG003|Treatment Period|Lost to Follow-up|0|||
161637682|NCT03599622|583725202|FG000|Treatment Period|Study terminated by sponsor|7|||
161637683|NCT03599622|583725203|FG001|Treatment Period|Study terminated by sponsor|20|||
161637684|NCT03599622|583725204|FG002|Treatment Period|Study terminated by sponsor|15|||
161637685|NCT03599622|583725205|FG003|Treatment Period|Study terminated by sponsor|0|||
161637686|NCT03599622|583725202|FG000|Treatment Period|Site terminated by sponsor|0|||
161637687|NCT03599622|583725203|FG001|Treatment Period|Site terminated by sponsor|1|||
161637688|NCT03599622|583725204|FG002|Treatment Period|Site terminated by sponsor|0|||
161637689|NCT03599622|583725205|FG003|Treatment Period|Site terminated by sponsor|0|||
161637690|NCT01006889|583725206|FG000|Overall Study|Withdrawal by Subject|3|||
161637691|NCT00823836|583725207|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
161637692|NCT00823836|583725208|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
161637693|NCT00823836|583725207|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
161637694|NCT00823836|583725208|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
161637695|NCT00823836|583725207|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
161637696|NCT00823836|583725208|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
161637697|NCT00823836|583725207|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
161637698|NCT00823836|583725208|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
161637699|NCT00823836|583725207|FG000|Long-term Phase|Adverse Event|3|||
161637700|NCT00823836|583725208|FG001|Long-term Phase|Adverse Event|2|||
161637701|NCT00823836|583725207|FG000|Long-term Phase|Physician Decision|1|||
161637702|NCT00823836|583725208|FG001|Long-term Phase|Physician Decision|2|||
161637703|NCT00823836|583725207|FG000|Long-term Phase|Withdrawal by Subject|1|||
161637704|NCT00823836|583725208|FG001|Long-term Phase|Withdrawal by Subject|1|||
161637705|NCT01130168|583725209|FG000|Period 1|Withdrawal by Subject|0|||
161637706|NCT01130168|583725210|FG001|Period 1|Withdrawal by Subject|1|||
161637707|NCT01130168|583725211|FG002|Period 1|Withdrawal by Subject|0|||
161637708|NCT01130168|583725212|FG003|Period 1|Withdrawal by Subject|1|||
161637709|NCT01130168|583725213|FG004|Period 1|Withdrawal by Subject|0|||
161637710|NCT01130168|583725214|FG005|Period 1|Withdrawal by Subject|0|||
161637711|NCT01130168|583725209|FG000|Period 1|Discontinued For Other Reason|0|||
161637712|NCT01130168|583725210|FG001|Period 1|Discontinued For Other Reason|0|||
161637713|NCT01130168|583725211|FG002|Period 1|Discontinued For Other Reason|1|||
161637714|NCT01130168|583725212|FG003|Period 1|Discontinued For Other Reason|1|||
161637715|NCT01130168|583725213|FG004|Period 1|Discontinued For Other Reason|0|||
161637716|NCT01130168|583725214|FG005|Period 1|Discontinued For Other Reason|0|||
161637717|NCT01130168|583725209|FG000|Period 1|Adverse Event|0|||
161637718|NCT01130168|583725210|FG001|Period 1|Adverse Event|0|||
161637719|NCT01130168|583725211|FG002|Period 1|Adverse Event|0|||
161637720|NCT01130168|583725212|FG003|Period 1|Adverse Event|1|||
161637721|NCT01130168|583725213|FG004|Period 1|Adverse Event|0|||
161637722|NCT01130168|583725214|FG005|Period 1|Adverse Event|0|||
161637723|NCT02635386|583725215|FG000|Overall Study|Pregnancy|2|||
161637724|NCT02635386|583725216|FG001|Overall Study|Pregnancy|0|||
161637725|NCT02635386|583725217|FG002|Overall Study|Pregnancy|0|||
161637726|NCT02635386|583725218|FG003|Overall Study|Pregnancy|0|||
161637727|NCT02635386|583725219|FG004|Overall Study|Pregnancy|2|||
161637728|NCT02635386|583725215|FG000|Overall Study|Withdrawal by Subject|1|||
161637729|NCT02635386|583725216|FG001|Overall Study|Withdrawal by Subject|1|||
161637730|NCT02635386|583725217|FG002|Overall Study|Withdrawal by Subject|0|||
161637731|NCT02635386|583725218|FG003|Overall Study|Withdrawal by Subject|1|||
161637732|NCT02635386|583725219|FG004|Overall Study|Withdrawal by Subject|0|||
161637733|NCT02635386|583725215|FG000|Overall Study|Physician Decision|0|||
161637734|NCT02635386|583725216|FG001|Overall Study|Physician Decision|1|||
161637735|NCT02635386|583725217|FG002|Overall Study|Physician Decision|0|||
161637736|NCT02635386|583725218|FG003|Overall Study|Physician Decision|0|||
161637737|NCT02635386|583725219|FG004|Overall Study|Physician Decision|0|||
161637738|NCT02635386|583725215|FG000|Overall Study|Moved Out of State|0|||
161637739|NCT02635386|583725216|FG001|Overall Study|Moved Out of State|1|||
161637740|NCT02635386|583725217|FG002|Overall Study|Moved Out of State|0|||
161637741|NCT02635386|583725218|FG003|Overall Study|Moved Out of State|0|||
161637742|NCT02635386|583725219|FG004|Overall Study|Moved Out of State|0|||
161637743|NCT02635386|583725215|FG000|Overall Study|Noncompliant|0|||
161637744|NCT02635386|583725216|FG001|Overall Study|Noncompliant|2|||
161637745|NCT02635386|583725217|FG002|Overall Study|Noncompliant|1|||
161637746|NCT02635386|583725218|FG003|Overall Study|Noncompliant|1|||
161637747|NCT02635386|583725219|FG004|Overall Study|Noncompliant|1|||
161637748|NCT02635386|583725215|FG000|Overall Study|side effects|0|||
161637749|NCT02635386|583725216|FG001|Overall Study|side effects|0|||
161637750|NCT02635386|583725217|FG002|Overall Study|side effects|1|||
161637751|NCT02635386|583725218|FG003|Overall Study|side effects|4|||
161637752|NCT02635386|583725219|FG004|Overall Study|side effects|6|||
161637753|NCT02635386|583725215|FG000|Overall Study|needed other major surgery|0|||
161637754|NCT02635386|583725216|FG001|Overall Study|needed other major surgery|1|||
161637755|NCT02635386|583725217|FG002|Overall Study|needed other major surgery|0|||
161637756|NCT02635386|583725218|FG003|Overall Study|needed other major surgery|0|||
161637757|NCT02635386|583725219|FG004|Overall Study|needed other major surgery|0|||
161637758|NCT02635386|583725215|FG000|Overall Study|Other medical problems not drug related|0|||
161637759|NCT02635386|583725216|FG001|Overall Study|Other medical problems not drug related|0|||
161637760|NCT02635386|583725217|FG002|Overall Study|Other medical problems not drug related|0|||
161637761|NCT02635386|583725218|FG003|Overall Study|Other medical problems not drug related|1|||
161637762|NCT02635386|583725219|FG004|Overall Study|Other medical problems not drug related|0|||
161637763|NCT00745498|583725220|FG000|Overall Study|Lost to Follow-up|1|||
161637764|NCT00745498|583725221|FG001|Overall Study|Lost to Follow-up|1|||
161637765|NCT00745498|583725222|FG002|Overall Study|Lost to Follow-up|3|||
161637766|NCT00745498|583725220|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
161637767|NCT00745498|583725221|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
161637768|NCT00745498|583725222|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
161637769|NCT00745498|583725220|FG000|Overall Study|Non-PDR related VH|0|||
161637770|NCT00745498|583725221|FG001|Overall Study|Non-PDR related VH|1|||
161637771|NCT00745498|583725222|FG002|Overall Study|Non-PDR related VH|1|||
161637772|NCT00745498|583725220|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
161637773|NCT00745498|583725221|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
161637774|NCT00745498|583725222|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
161637775|NCT02804399|583725225|FG000|Period 2|Adverse Event|0|||
161637776|NCT02804399|583725226|FG001|Period 2|Adverse Event|1|||
161637777|NCT00725543|583725227|FG000|Overall Study|Adverse Event|10|||
161637778|NCT00725543|583725227|FG000|Overall Study|Lack of Efficacy|3|||
161637779|NCT00725543|583725227|FG000|Overall Study|Withdrawal by Subject|10|||
161637780|NCT00725543|583725227|FG000|Overall Study|Physician Decision|5|||
161637781|NCT00725543|583725227|FG000|Overall Study|Lost to Follow-up|4|||
161637782|NCT00725543|583725227|FG000|Overall Study|Non-compliance|2|||
161637783|NCT00725543|583725227|FG000|Overall Study|Other|119|||
161637784|NCT01157377|583725228|FG000|Overall Study|Lost to Follow-up|0|||
161637785|NCT01157377|583725229|FG001|Overall Study|Lost to Follow-up|0|||
161637786|NCT01157377|583725230|FG002|Overall Study|Lost to Follow-up|1|||
161637787|NCT01157377|583725231|FG003|Overall Study|Lost to Follow-up|0|||
161637788|NCT01157377|583725232|FG004|Overall Study|Lost to Follow-up|1|||
161637789|NCT01157377|583725233|FG005|Overall Study|Lost to Follow-up|1|||
161637790|NCT01157377|583725234|FG006|Overall Study|Lost to Follow-up|0|||
161637791|NCT01157377|583725228|FG000|Overall Study|Personal Reasons|2|||
161637792|NCT01157377|583725229|FG001|Overall Study|Personal Reasons|1|||
161637793|NCT01157377|583725230|FG002|Overall Study|Personal Reasons|0|||
161637794|NCT01157377|583725231|FG003|Overall Study|Personal Reasons|1|||
161637795|NCT01157377|583725232|FG004|Overall Study|Personal Reasons|0|||
161637796|NCT01157377|583725233|FG005|Overall Study|Personal Reasons|0|||
161637797|NCT01157377|583725234|FG006|Overall Study|Personal Reasons|0|||
161637798|NCT01157377|583725228|FG000|Overall Study|Protocol Violation|0|||
161687211|NCT04770389|583907161|FG001|Overall Study|Withdrawal by Subject|2|||
161687212|NCT04770389|583907162|FG002|Overall Study|Withdrawal by Subject|1|||
161687213|NCT04770389|583907163|FG003|Overall Study|Withdrawal by Subject|0|||
161687214|NCT04770389|583907160|FG000|Overall Study|Failed attempt to draw blood|1|||
161687215|NCT04770389|583907161|FG001|Overall Study|Failed attempt to draw blood|0|||
161687216|NCT04770389|583907162|FG002|Overall Study|Failed attempt to draw blood|0|||
161687217|NCT04770389|583907163|FG003|Overall Study|Failed attempt to draw blood|0|||
161687218|NCT04770389|583907160|FG000|Overall Study|Left the country|0|||
161687219|NCT04770389|583907161|FG001|Overall Study|Left the country|0|||
161835149|NCT01392326|584437248|FG002|Overall Study|Protocol Violation|0|||
161637799|NCT01157377|583725229|FG001|Overall Study|Protocol Violation|0|||
161687220|NCT04770389|583907162|FG002|Overall Study|Left the country|1|||
161637800|NCT01157377|583725230|FG002|Overall Study|Protocol Violation|0|||
161687221|NCT04770389|583907163|FG003|Overall Study|Left the country|2|||
161835150|NCT01392326|584437246|FG000|Overall Study|Pregnancy|0|||
161637801|NCT01157377|583725231|FG003|Overall Study|Protocol Violation|0|||
161637802|NCT01157377|583725232|FG004|Overall Study|Protocol Violation|0|||
161687222|NCT04770389|583907160|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
161835151|NCT01392326|584437247|FG001|Overall Study|Pregnancy|0|||
161637803|NCT01157377|583725233|FG005|Overall Study|Protocol Violation|1|||
161637804|NCT01157377|583725234|FG006|Overall Study|Protocol Violation|0|||
161835152|NCT01392326|584437248|FG002|Overall Study|Pregnancy|1|||
161637805|NCT01157377|583725228|FG000|Overall Study|Lack of Efficacy|0|||
161637806|NCT01157377|583725229|FG001|Overall Study|Lack of Efficacy|0|||
161637807|NCT01157377|583725230|FG002|Overall Study|Lack of Efficacy|0|||
161637808|NCT01157377|583725231|FG003|Overall Study|Lack of Efficacy|0|||
161637809|NCT01157377|583725232|FG004|Overall Study|Lack of Efficacy|0|||
161637810|NCT01157377|583725233|FG005|Overall Study|Lack of Efficacy|0|||
161637811|NCT01157377|583725234|FG006|Overall Study|Lack of Efficacy|1|||
161637812|NCT01157377|583725228|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161637813|NCT01157377|583725229|FG001|Overall Study|Other Miscellaneous Reasons|2|||
161637814|NCT01157377|583725230|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161637815|NCT01157377|583725231|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161637816|NCT01157377|583725232|FG004|Overall Study|Other Miscellaneous Reasons|1|||
161637817|NCT01157377|583725233|FG005|Overall Study|Other Miscellaneous Reasons|1|||
161637818|NCT01157377|583725234|FG006|Overall Study|Other Miscellaneous Reasons|1|||
161637819|NCT00087555|583725235|FG000|Overall Study|Adverse Event|3|||
161637820|NCT00087555|583725236|FG001|Overall Study|Adverse Event|6|||
161637821|NCT00087555|583725237|FG002|Overall Study|Adverse Event|14|||
161637822|NCT00087555|583725235|FG000|Overall Study|Lost to Follow-up|0|||
161637823|NCT00087555|583725236|FG001|Overall Study|Lost to Follow-up|1|||
161637824|NCT00087555|583725237|FG002|Overall Study|Lost to Follow-up|1|||
161637825|NCT00087555|583725235|FG000|Overall Study|Non - Compliance|1|||
161637826|NCT00087555|583725236|FG001|Overall Study|Non - Compliance|0|||
161637827|NCT00087555|583725237|FG002|Overall Study|Non - Compliance|0|||
161637828|NCT00087555|583725235|FG000|Overall Study|Protocol Violation|0|||
161637829|NCT00087555|583725236|FG001|Overall Study|Protocol Violation|0|||
161637830|NCT00087555|583725237|FG002|Overall Study|Protocol Violation|2|||
161637831|NCT00087555|583725235|FG000|Overall Study|Screen Failure|1|||
161637832|NCT00087555|583725236|FG001|Overall Study|Screen Failure|1|||
161637833|NCT00087555|583725237|FG002|Overall Study|Screen Failure|0|||
161637834|NCT00087555|583725235|FG000|Overall Study|Pregnancy|0|||
161637835|NCT00087555|583725236|FG001|Overall Study|Pregnancy|1|||
161637836|NCT00087555|583725237|FG002|Overall Study|Pregnancy|1|||
161637837|NCT00087555|583725235|FG000|Overall Study|Withdrawal by Subject|3|||
161637838|NCT00087555|583725236|FG001|Overall Study|Withdrawal by Subject|2|||
161637839|NCT00087555|583725237|FG002|Overall Study|Withdrawal by Subject|1|||
161637840|NCT00087555|583725235|FG000|Overall Study|Lack of Efficacy|2|||
161637841|NCT00087555|583725236|FG001|Overall Study|Lack of Efficacy|0|||
161637842|NCT00087555|583725237|FG002|Overall Study|Lack of Efficacy|1|||
161687223|NCT04770389|583907161|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
161687224|NCT04770389|583907162|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
161637843|NCT00087555|583725235|FG000|Overall Study|Non Compliance|0|||
161637844|NCT00087555|583725236|FG001|Overall Study|Non Compliance|0|||
161637845|NCT00087555|583725237|FG002|Overall Study|Non Compliance|1|||
161637846|NCT00087555|583725235|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
161637847|NCT00087555|583725236|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
161637848|NCT00087555|583725237|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
161637849|NCT00087555|583725235|FG000|Overall Study|Patient wanted to go back on Med|1|||
161637850|NCT00087555|583725236|FG001|Overall Study|Patient wanted to go back on Med|0|||
161637851|NCT00087555|583725237|FG002|Overall Study|Patient wanted to go back on Med|0|||
161637852|NCT01062971|583725238|FG000|Overall Study|Protocol Violation|1|||
161637853|NCT01062971|583725239|FG001|Overall Study|Protocol Violation|3|||
161637854|NCT01062971|583725238|FG000|Overall Study|Lost to Follow-up|3|||
161637855|NCT01062971|583725239|FG001|Overall Study|Lost to Follow-up|4|||
161637856|NCT03738397|583725250|FG000|Overall Study|Adverse Event|3|||
161637857|NCT03738397|583725251|FG001|Overall Study|Adverse Event|7|||
161687225|NCT04770389|583907163|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
161687226|NCT04770389|583907160|FG000|Overall Study|Lost to Follow-up|0|||
161687227|NCT04770389|583907161|FG001|Overall Study|Lost to Follow-up|0|||
161687228|NCT04770389|583907162|FG002|Overall Study|Lost to Follow-up|0|||
161687229|NCT04770389|583907163|FG003|Overall Study|Lost to Follow-up|1|||
161687230|NCT04770389|583907160|FG000|Overall Study|Moved away from study site|0|||
161687231|NCT04770389|583907161|FG001|Overall Study|Moved away from study site|1|||
161687232|NCT04770389|583907162|FG002|Overall Study|Moved away from study site|0|||
161687233|NCT04770389|583907163|FG003|Overall Study|Moved away from study site|0|||
161687234|NCT00794157|583907164|FG000|Overall Study|Adverse Event|4|||
161687235|NCT00794157|583907165|FG001|Overall Study|Adverse Event|1|||
161687236|NCT00794157|583907166|FG002|Overall Study|Adverse Event|8|||
161637858|NCT03738397|583725250|FG000|Overall Study|Withdrawal by Subject|8|||
161637859|NCT03738397|583725251|FG001|Overall Study|Withdrawal by Subject|11|||
161637860|NCT03738397|583725250|FG000|Overall Study|Lost to Follow-up|7|||
161637861|NCT03738397|583725251|FG001|Overall Study|Lost to Follow-up|5|||
161637862|NCT03738397|583725250|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161637863|NCT03738397|583725251|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161687237|NCT00794157|583907164|FG000|Overall Study|Subject withdrew consent|2|||
161637864|NCT03738397|583725250|FG000|Overall Study|Other|4|||
161637865|NCT03738397|583725251|FG001|Overall Study|Other|6|||
161637866|NCT00904722|583725252|FG000|Overall Study|Physician Decision|1|||
161637867|NCT00661713|583725253|FG000|Overall Study|Death|1|||
161637868|NCT00661713|583725254|FG001|Overall Study|Death|0|||
161637869|NCT00661713|583725255|FG002|Overall Study|Death|0|||
161637870|NCT00661713|583725256|FG003|Overall Study|Death|0|||
161637871|NCT00661713|583725257|FG004|Overall Study|Death|1|||
161637872|NCT00661713|583725258|FG005|Overall Study|Death|0|||
161637873|NCT00661713|583725259|FG006|Overall Study|Death|0|||
161637874|NCT00661713|583725260|FG007|Overall Study|Death|0|||
161637875|NCT00661713|583725253|FG000|Overall Study|Unable to Classify|1|||
161835153|NCT01392326|584437246|FG000|Overall Study|Physician Decision|7|||
161637876|NCT00661713|583725254|FG001|Overall Study|Unable to Classify|0|||
161637877|NCT00661713|583725255|FG002|Overall Study|Unable to Classify|0|||
161637878|NCT00661713|583725256|FG003|Overall Study|Unable to Classify|0|||
161637879|NCT00661713|583725257|FG004|Overall Study|Unable to Classify|0|||
161637880|NCT00661713|583725258|FG005|Overall Study|Unable to Classify|0|||
161637881|NCT00661713|583725259|FG006|Overall Study|Unable to Classify|0|||
161637882|NCT00661713|583725260|FG007|Overall Study|Unable to Classify|0|||
161637883|NCT00661713|583725253|FG000|Overall Study|Protocol Violation|1|||
161637884|NCT00661713|583725254|FG001|Overall Study|Protocol Violation|6|||
161637885|NCT00661713|583725255|FG002|Overall Study|Protocol Violation|3|||
161637886|NCT00661713|583725256|FG003|Overall Study|Protocol Violation|3|||
161637887|NCT00661713|583725257|FG004|Overall Study|Protocol Violation|0|||
161637888|NCT00661713|583725258|FG005|Overall Study|Protocol Violation|2|||
161637889|NCT00661713|583725259|FG006|Overall Study|Protocol Violation|2|||
161637890|NCT00661713|583725260|FG007|Overall Study|Protocol Violation|1|||
161637891|NCT00661713|583725253|FG000|Overall Study|Withdrawal by Subject|11|||
161637892|NCT00661713|583725254|FG001|Overall Study|Withdrawal by Subject|25|||
161637893|NCT00661713|583725255|FG002|Overall Study|Withdrawal by Subject|12|||
161637894|NCT00661713|583725256|FG003|Overall Study|Withdrawal by Subject|21|||
161637895|NCT00661713|583725257|FG004|Overall Study|Withdrawal by Subject|12|||
161637896|NCT00661713|583725258|FG005|Overall Study|Withdrawal by Subject|26|||
161637897|NCT00661713|583725259|FG006|Overall Study|Withdrawal by Subject|45|||
161637898|NCT00661713|583725260|FG007|Overall Study|Withdrawal by Subject|9|||
161637899|NCT00661713|583725253|FG000|Overall Study|Lost to Follow-up|2|||
161637900|NCT00661713|583725254|FG001|Overall Study|Lost to Follow-up|7|||
161637901|NCT00661713|583725255|FG002|Overall Study|Lost to Follow-up|2|||
161637902|NCT00661713|583725256|FG003|Overall Study|Lost to Follow-up|2|||
161637903|NCT00661713|583725257|FG004|Overall Study|Lost to Follow-up|5|||
161637904|NCT00661713|583725258|FG005|Overall Study|Lost to Follow-up|7|||
161637905|NCT00661713|583725259|FG006|Overall Study|Lost to Follow-up|14|||
161835154|NCT01392326|584437247|FG001|Overall Study|Physician Decision|5|||
161835155|NCT01392326|584437248|FG002|Overall Study|Physician Decision|2|||
161835156|NCT01392326|584437246|FG000|Overall Study|Lost to Follow-up|1|||
161835157|NCT01392326|584437247|FG001|Overall Study|Lost to Follow-up|3|||
161637906|NCT00661713|583725260|FG007|Overall Study|Lost to Follow-up|1|||
161637907|NCT00661713|583725253|FG000|Overall Study|Administrative Reason|0|||
161637908|NCT00661713|583725254|FG001|Overall Study|Administrative Reason|1|||
161637909|NCT00661713|583725255|FG002|Overall Study|Administrative Reason|0|||
161637910|NCT00661713|583725256|FG003|Overall Study|Administrative Reason|2|||
161637911|NCT00661713|583725257|FG004|Overall Study|Administrative Reason|2|||
161637912|NCT00661713|583725258|FG005|Overall Study|Administrative Reason|2|||
161637913|NCT00661713|583725259|FG006|Overall Study|Administrative Reason|1|||
161637914|NCT00661713|583725260|FG007|Overall Study|Administrative Reason|0|||
161637915|NCT00661713|583725253|FG000|Overall Study|Adverse Event|0|||
161637916|NCT00661713|583725254|FG001|Overall Study|Adverse Event|0|||
161637917|NCT00661713|583725255|FG002|Overall Study|Adverse Event|0|||
161637918|NCT00661713|583725256|FG003|Overall Study|Adverse Event|0|||
161637919|NCT00661713|583725257|FG004|Overall Study|Adverse Event|0|||
161637920|NCT00661713|583725258|FG005|Overall Study|Adverse Event|0|||
161637921|NCT00661713|583725259|FG006|Overall Study|Adverse Event|1|||
161637922|NCT00661713|583725260|FG007|Overall Study|Adverse Event|0|||
161637923|NCT00661713|583725253|FG000|Overall Study|Inappropriate Enrollment|0|||
161637924|NCT00661713|583725254|FG001|Overall Study|Inappropriate Enrollment|0|||
161637925|NCT00661713|583725255|FG002|Overall Study|Inappropriate Enrollment|0|||
161637926|NCT00661713|583725256|FG003|Overall Study|Inappropriate Enrollment|0|||
161637927|NCT00661713|583725257|FG004|Overall Study|Inappropriate Enrollment|0|||
161687238|NCT00794157|583907165|FG001|Overall Study|Subject withdrew consent|0|||
161687239|NCT00794157|583907166|FG002|Overall Study|Subject withdrew consent|3|||
161637928|NCT00661713|583725258|FG005|Overall Study|Inappropriate Enrollment|0|||
161637929|NCT00661713|583725259|FG006|Overall Study|Inappropriate Enrollment|1|||
161637930|NCT00661713|583725260|FG007|Overall Study|Inappropriate Enrollment|0|||
161637931|NCT01801982|583725263|FG000|Overall Study|Lost to Follow-up|1|||
161637932|NCT00727506|583725264|FG000|Overall Study|Adverse Event|0|||
161637933|NCT00727506|583725265|FG001|Overall Study|Adverse Event|0|||
161637934|NCT00727506|583725266|FG002|Overall Study|Adverse Event|4|||
161637935|NCT00727506|583725267|FG003|Overall Study|Adverse Event|4|||
161637936|NCT00727506|583725268|FG004|Overall Study|Adverse Event|1|||
161637937|NCT00727506|583725269|FG005|Overall Study|Adverse Event|8|||
161687240|NCT00794157|583907164|FG000|Overall Study|Lost to Follow-up|2|||
161637938|NCT00727506|583725264|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161687241|NCT00794157|583907165|FG001|Overall Study|Lost to Follow-up|0|||
161687242|NCT00794157|583907166|FG002|Overall Study|Lost to Follow-up|1|||
161687243|NCT00794157|583907164|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161687244|NCT00794157|583907165|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161687245|NCT00794157|583907166|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161687246|NCT00794157|583907164|FG000|Overall Study|Administrative problems|1|||
161687247|NCT00794157|583907165|FG001|Overall Study|Administrative problems|7|||
161687248|NCT00794157|583907166|FG002|Overall Study|Administrative problems|4|||
161687249|NCT00794157|583907164|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161637939|NCT00727506|583725265|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161637940|NCT00727506|583725266|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161637941|NCT00727506|583725267|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161637942|NCT00727506|583725268|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161637943|NCT00727506|583725269|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161637944|NCT00727506|583725264|FG000|Overall Study|Progressive disease|4|||
161637945|NCT00727506|583725265|FG001|Overall Study|Progressive disease|7|||
161637946|NCT00727506|583725266|FG002|Overall Study|Progressive disease|9|||
161637947|NCT00727506|583725267|FG003|Overall Study|Progressive disease|28|||
161637948|NCT00727506|583725268|FG004|Overall Study|Progressive disease|38|||
161637949|NCT00727506|583725269|FG005|Overall Study|Progressive disease|28|||
161637950|NCT00727506|583725264|FG000|Overall Study|Refused to continue medication|0|||
161637951|NCT00727506|583725265|FG001|Overall Study|Refused to continue medication|1|||
161637952|NCT00727506|583725266|FG002|Overall Study|Refused to continue medication|2|||
161637953|NCT00727506|583725267|FG003|Overall Study|Refused to continue medication|3|||
161637954|NCT00727506|583725268|FG004|Overall Study|Refused to continue medication|1|||
161637955|NCT00727506|583725269|FG005|Overall Study|Refused to continue medication|2|||
161637956|NCT00727506|583725264|FG000|Overall Study|Other reason not described above|0|||
161637957|NCT00727506|583725265|FG001|Overall Study|Other reason not described above|0|||
161637958|NCT00727506|583725266|FG002|Overall Study|Other reason not described above|1|||
161637959|NCT00727506|583725267|FG003|Overall Study|Other reason not described above|4|||
161637960|NCT00727506|583725268|FG004|Overall Study|Other reason not described above|1|||
161637961|NCT00727506|583725269|FG005|Overall Study|Other reason not described above|1|||
161637962|NCT02650466|583725271|FG000|Overall Study|Physician Decision|1|||
161637963|NCT02650466|583725271|FG000|Overall Study|Withdrawal by Subject|5|||
161637964|NCT02650466|583725271|FG000|Overall Study|Lost to Follow-up|1|||
161637965|NCT01214421|583725275|FG000|Overall Study|Lost to Follow-up|7|||
161637966|NCT01214421|583725276|FG001|Overall Study|Lost to Follow-up|3|||
161637967|NCT01214421|583725277|FG002|Overall Study|Lost to Follow-up|7|||
161637968|NCT01214421|583725278|FG003|Overall Study|Lost to Follow-up|3|||
161637969|NCT01214421|583725275|FG000|Overall Study|Adverse Event|16|||
161637970|NCT01214421|583725276|FG001|Overall Study|Adverse Event|35|||
161637971|NCT01214421|583725277|FG002|Overall Study|Adverse Event|14|||
161637972|NCT01214421|583725278|FG003|Overall Study|Adverse Event|3|||
161637973|NCT01214421|583725275|FG000|Overall Study|Sponsor Discontinued Site|1|||
161637974|NCT01214421|583725276|FG001|Overall Study|Sponsor Discontinued Site|2|||
161637975|NCT01214421|583725277|FG002|Overall Study|Sponsor Discontinued Site|0|||
161637976|NCT01214421|583725278|FG003|Overall Study|Sponsor Discontinued Site|0|||
161637977|NCT01214421|583725275|FG000|Overall Study|Withdrawal Criteria Met|3|||
161637978|NCT01214421|583725276|FG001|Overall Study|Withdrawal Criteria Met|0|||
161637979|NCT01214421|583725277|FG002|Overall Study|Withdrawal Criteria Met|2|||
161687250|NCT00794157|583907165|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161687251|NCT00794157|583907166|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161687252|NCT00794157|583907164|FG000|Overall Study|Protocol deviation|0|||
161687253|NCT00794157|583907165|FG001|Overall Study|Protocol deviation|1|||
161637980|NCT01214421|583725278|FG003|Overall Study|Withdrawal Criteria Met|1|||
161637981|NCT01214421|583725275|FG000|Overall Study|Physician Decision|2|||
161637982|NCT01214421|583725276|FG001|Overall Study|Physician Decision|0|||
161637983|NCT01214421|583725277|FG002|Overall Study|Physician Decision|4|||
161637984|NCT01214421|583725278|FG003|Overall Study|Physician Decision|0|||
161637985|NCT01214421|583725275|FG000|Overall Study|Withdrawal by Subject|21|||
161637986|NCT01214421|583725276|FG001|Overall Study|Withdrawal by Subject|18|||
161637987|NCT01214421|583725277|FG002|Overall Study|Withdrawal by Subject|11|||
161637988|NCT01214421|583725278|FG003|Overall Study|Withdrawal by Subject|2|||
161637989|NCT03783689|583725280|FG000|Overall Study|Adverse Event|2|||
161637990|NCT03783689|583725281|FG001|Overall Study|Adverse Event|0|||
161637991|NCT03783689|583725280|FG000|Overall Study|Lost to Follow-up|2|||
161637992|NCT03783689|583725281|FG001|Overall Study|Lost to Follow-up|1|||
161637993|NCT03783689|583725280|FG000|Overall Study|Physician Decision|2|||
161637994|NCT03783689|583725281|FG001|Overall Study|Physician Decision|1|||
161637995|NCT03783689|583725280|FG000|Overall Study|Withdrawal by Subject|3|||
161637996|NCT03783689|583725281|FG001|Overall Study|Withdrawal by Subject|3|||
161637997|NCT02392104|583725282|FG000|Overall Study|discontinuation of warfarin|3|||
161637998|NCT02392104|583725282|FG000|Overall Study|bleeding event|1|||
161637999|NCT02392104|583725282|FG000|Overall Study|transferred care to another doctor|2|||
161638000|NCT02392104|583725282|FG000|Overall Study|INR goal range changed|1|||
161638001|NCT02392104|583725282|FG000|Overall Study|admitted to skilled nursing facility|3|||
161638002|NCT02392104|583725282|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
161638003|NCT04887506|583725283|FG000|Overall Study|Death|1|||
161638004|NCT04887506|583725284|FG001|Overall Study|Death|1|||
161638005|NCT04887506|583725283|FG000|Overall Study|Withdrawal by Subject|0|||
161638006|NCT04887506|583725284|FG001|Overall Study|Withdrawal by Subject|3|||
161638007|NCT04887506|583725283|FG000|Overall Study|Adverse Event|4|||
161638008|NCT04887506|583725284|FG001|Overall Study|Adverse Event|3|||
161638009|NCT04887506|583725283|FG000|Overall Study|Other - Not Reported|1|||
161638010|NCT04887506|583725284|FG001|Overall Study|Other - Not Reported|1|||
161638011|NCT03522389|583725285|FG000|Overall Study|Lost to Follow-up|1|||
161638012|NCT03522389|583725286|FG001|Overall Study|Lost to Follow-up|1|||
161638013|NCT03522389|583725287|FG002|Overall Study|Lost to Follow-up|2|||
161638014|NCT03522389|583725285|FG000|Overall Study|had herniated nucleus pulposus|0|||
161638015|NCT03522389|583725286|FG001|Overall Study|had herniated nucleus pulposus|1|||
161638016|NCT03522389|583725287|FG002|Overall Study|had herniated nucleus pulposus|0|||
161638017|NCT03522389|583725285|FG000|Overall Study|go to work in other province|1|||
161638018|NCT03522389|583725286|FG001|Overall Study|go to work in other province|0|||
161638019|NCT03522389|583725287|FG002|Overall Study|go to work in other province|0|||
161638020|NCT02242643|583725290|FG000|Overall Study|Protocol Violation|1|||
161638021|NCT02242643|583725291|FG001|Overall Study|Protocol Violation|2|||
161638022|NCT02242643|583725290|FG000|Overall Study|Withdrawal by Subject|15|||
161638023|NCT02242643|583725291|FG001|Overall Study|Withdrawal by Subject|10|||
161638024|NCT02242643|583725290|FG000|Overall Study|Migrated/moved from study area|1|||
161638025|NCT02242643|583725291|FG001|Overall Study|Migrated/moved from study area|3|||
161638026|NCT02242643|583725290|FG000|Overall Study|Lost to Follow-up|54|||
161638027|NCT02242643|583725291|FG001|Overall Study|Lost to Follow-up|61|||
161638028|NCT02242643|583725290|FG000|Overall Study|Child placed in foster care by family|0|||
161638029|NCT02242643|583725291|FG001|Overall Study|Child placed in foster care by family|1|||
161638030|NCT02242643|583725290|FG000|Overall Study|Non-compliance|1|||
161638031|NCT02242643|583725291|FG001|Overall Study|Non-compliance|0|||
161638032|NCT02242643|583725290|FG000|Overall Study|Consent withdrawal by parent|1|||
161638033|NCT02242643|583725291|FG001|Overall Study|Consent withdrawal by parent|0|||
161638034|NCT02242643|583725290|FG000|Overall Study|Protocol requirements not followed|1|||
161638035|NCT02242643|583725291|FG001|Overall Study|Protocol requirements not followed|0|||
161638036|NCT02242643|583725290|FG000|Overall Study|Language barrier|1|||
161638037|NCT02242643|583725291|FG001|Overall Study|Language barrier|0|||
161638038|NCT02242643|583725290|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
161638039|NCT02242643|583725291|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
161638040|NCT03526679|583727037|FG000|Overall Study|still under treatment|2|||
161638041|NCT00903760|583727038|FG000|Overall Study|Disease Progression/Death|8|||
161638042|NCT00903760|583727039|FG001|Overall Study|Disease Progression/Death|6|||
161638043|NCT00903760|583727038|FG000|Overall Study|Stem Cell Transplant|8|||
161638044|NCT00903760|583727039|FG001|Overall Study|Stem Cell Transplant|4|||
161687254|NCT00794157|583907166|FG002|Overall Study|Protocol deviation|1|||
161687255|NCT04486950|583907174|FG000|Overall Study|Lost to Follow-up|0|||
161687256|NCT04486950|583907175|FG001|Overall Study|Lost to Follow-up|0|||
161638045|NCT00903760|583727038|FG000|Overall Study|Physician Decision|1|||
161638046|NCT00903760|583727039|FG001|Overall Study|Physician Decision|2|||
161638047|NCT00903760|583727038|FG000|Overall Study|Death|0|||
161638048|NCT00903760|583727039|FG001|Overall Study|Death|1|||
161638049|NCT00903760|583727038|FG000|Overall Study|Lost to Follow-up|1|||
161638050|NCT00903760|583727039|FG001|Overall Study|Lost to Follow-up|0|||
161638051|NCT00903760|583727038|FG000|Overall Study|Withdrawal by Subject|1|||
161638052|NCT00903760|583727039|FG001|Overall Study|Withdrawal by Subject|2|||
161638053|NCT00903760|583727038|FG000|Overall Study|Off treatment for long period|0|||
161638054|NCT00903760|583727039|FG001|Overall Study|Off treatment for long period|1|||
161638055|NCT01638390|583727041|FG000|Overall Study|screening failures|21|||
161638056|NCT01536587|583727044|FG000|Overall Study|Adverse Event|2|||
161638057|NCT02666664|583727045|FG000|Overall Study|Physician Decision|0|||
161638058|NCT02666664|583727046|FG001|Overall Study|Physician Decision|1|||
161638059|NCT02666664|583727045|FG000|Overall Study|Protocol Violation|0|||
161638060|NCT02666664|583727046|FG001|Overall Study|Protocol Violation|2|||
161638061|NCT02666664|583727045|FG000|Overall Study|Other|0|||
161638062|NCT02666664|583727046|FG001|Overall Study|Other|1|||
161638063|NCT02666664|583727045|FG000|Overall Study|Adverse Event|12|||
161638064|NCT02666664|583727046|FG001|Overall Study|Adverse Event|37|||
161638065|NCT02666664|583727045|FG000|Overall Study|Withdrawal by participant|23|||
161638066|NCT02666664|583727046|FG001|Overall Study|Withdrawal by participant|40|||
161638067|NCT02666664|583727045|FG000|Overall Study|Sponsor decision|0|||
161638068|NCT02666664|583727046|FG001|Overall Study|Sponsor decision|1|||
161638069|NCT02666664|583727045|FG000|Overall Study|Lost to Follow-up|1|||
161638070|NCT02666664|583727046|FG001|Overall Study|Lost to Follow-up|2|||
161638071|NCT04836559|583727047|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161638072|NCT04836559|583727048|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
161638073|NCT04836559|583727049|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
161638074|NCT04836559|583727050|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
161638075|NCT04836559|583727051|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161638076|NCT04836559|583727052|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161638077|NCT04836559|583727053|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161638078|NCT04836559|583727054|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161638079|NCT04836559|583727047|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161638080|NCT04836559|583727048|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
161638081|NCT04836559|583727049|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
161638082|NCT04836559|583727050|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
161638083|NCT04836559|583727051|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161638084|NCT04836559|583727052|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161638085|NCT04836559|583727053|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161638086|NCT04836559|583727054|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161638087|NCT04836559|583727047|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
161638088|NCT04836559|583727048|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638089|NCT04836559|583727049|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638090|NCT04836559|583727050|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638091|NCT04836559|583727051|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638092|NCT04836559|583727052|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638093|NCT04836559|583727053|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638094|NCT04836559|583727054|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161638095|NCT04836559|583727047|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
161638096|NCT04836559|583727048|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638097|NCT04836559|583727049|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638098|NCT04836559|583727050|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638099|NCT04836559|583727051|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638100|NCT04836559|583727052|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638101|NCT04836559|583727053|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638102|NCT04836559|583727054|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
161638103|NCT04836559|583727047|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638104|NCT04836559|583727048|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638105|NCT04836559|583727049|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638106|NCT04836559|583727050|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
161638107|NCT04836559|583727051|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638108|NCT04836559|583727052|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638109|NCT04836559|583727053|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638110|NCT04836559|583727054|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161638111|NCT04836559|583727047|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161638112|NCT04836559|583727048|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161835158|NCT01392326|584437248|FG002|Overall Study|Lost to Follow-up|4|||
161835159|NCT01392326|584437246|FG000|Overall Study|Lack of Efficacy|14|||
161835160|NCT01392326|584437247|FG001|Overall Study|Lack of Efficacy|10|||
161835161|NCT01392326|584437248|FG002|Overall Study|Lack of Efficacy|15|||
161835162|NCT01392326|584437246|FG000|Overall Study|Adverse Event|9|||
161638113|NCT04836559|583727049|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161638114|NCT04836559|583727050|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161638115|NCT04836559|583727051|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
161638116|NCT04836559|583727052|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
161638117|NCT04836559|583727053|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
161638118|NCT04836559|583727054|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
161638119|NCT04836559|583727047|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161638120|NCT04836559|583727048|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161638121|NCT04836559|583727049|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161638122|NCT04836559|583727050|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161638123|NCT04836559|583727051|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
161638124|NCT04836559|583727052|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
161638125|NCT04836559|583727053|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
161638126|NCT04836559|583727054|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
161638127|NCT04836559|583727047|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161638128|NCT04836559|583727048|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161638129|NCT04836559|583727049|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161638130|NCT04836559|583727050|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161638131|NCT04836559|583727051|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
161638132|NCT04836559|583727052|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
161638133|NCT04836559|583727053|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161638134|NCT04836559|583727054|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
161638135|NCT04836559|583727047|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638136|NCT04836559|583727048|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638137|NCT04836559|583727049|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638138|NCT04836559|583727050|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638139|NCT04836559|583727051|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638140|NCT04836559|583727052|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638141|NCT04836559|583727053|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161638142|NCT04836559|583727054|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
161638143|NCT04978350|583727055|FG000|Overall Study|Lost to Follow-up|6|||
161638144|NCT03210519|583727056|FG000|Overall Study|Adverse Event|2|||
161638145|NCT03210519|583727057|FG001|Overall Study|Adverse Event|0|||
161638146|NCT03865953|583727062|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
161638147|NCT03865953|583727063|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161638148|NCT03865953|583727062|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
161638149|NCT03865953|583727063|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
161638150|NCT03865953|583727062|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
161638151|NCT03865953|583727063|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
161638152|NCT00412880|583727074|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
161638153|NCT00412880|583727074|FG000|Overall Study|Consent withdrawn|1|||
161638154|NCT00412880|583727074|FG000|Overall Study|Adverse Event|1|||
161638155|NCT00412880|583727074|FG000|Overall Study|Progressive disease|20|||
161638156|NCT02232399|583727075|FG000|Overall Study|Adverse Event|1|||
161638157|NCT02232399|583727076|FG001|Overall Study|Adverse Event|0|||
161638158|NCT02232399|583727075|FG000|Overall Study|Withdrawal by Subject|0|||
161638159|NCT02232399|583727076|FG001|Overall Study|Withdrawal by Subject|1|||
161638160|NCT01162135|583727084|FG000|Overall Study|Withdrawal by Subject|1|||
161638161|NCT01162135|583727084|FG000|Overall Study|Severe back pain|1|||
161638162|NCT01162135|583727084|FG000|Overall Study|Ineligible|1|||
161638163|NCT01777334|583727085|FG000|Overall Study|Adverse Event|18|||
161638164|NCT01777334|583727086|FG001|Overall Study|Adverse Event|14|||
161638165|NCT01777334|583727085|FG000|Overall Study|Lack of Efficacy|15|||
161638166|NCT01777334|583727086|FG001|Overall Study|Lack of Efficacy|29|||
161638167|NCT01777334|583727085|FG000|Overall Study|Protocol Violation|3|||
161638168|NCT01777334|583727086|FG001|Overall Study|Protocol Violation|7|||
161638169|NCT01777334|583727085|FG000|Overall Study|Lost to Follow-up|3|||
161638170|NCT01777334|583727086|FG001|Overall Study|Lost to Follow-up|2|||
161638171|NCT01777334|583727085|FG000|Overall Study|Withdrawal by Subject|14|||
161638172|NCT01777334|583727086|FG001|Overall Study|Withdrawal by Subject|11|||
161638173|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
161638174|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
161638175|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
161638176|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
161638177|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
161638178|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
161638179|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
161638180|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
161638181|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
161638182|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
161638183|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
161638184|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
161638185|NCT01216072|583727094|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
161638186|NCT01216072|583727095|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
161638187|NCT01216072|583727094|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
161638188|NCT01216072|583727095|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
161638189|NCT01216072|583727094|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
161638190|NCT01216072|583727095|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
161638191|NCT01216072|583727094|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
161638192|NCT01216072|583727095|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
161638193|NCT04799418|583727099|FG000|Overall Study|Death|1|||
161638194|NCT04799418|583727100|FG001|Overall Study|Death|1|||
161638195|NCT04799418|583727099|FG000|Overall Study|Lack of Efficacy|14|||
161638196|NCT04799418|583727100|FG001|Overall Study|Lack of Efficacy|14|||
161638197|NCT04799418|583727099|FG000|Overall Study|Withdrawal by Subject|10|||
161638198|NCT04799418|583727100|FG001|Overall Study|Withdrawal by Subject|7|||
161638199|NCT04799418|583727099|FG000|Overall Study|Adverse Event|3|||
161638200|NCT04799418|583727100|FG001|Overall Study|Adverse Event|2|||
161638201|NCT00107978|583727103|FG000|Overall Study|Adverse Event|1|||
161638202|NCT00107978|583727104|FG001|Overall Study|Adverse Event|5|||
161638203|NCT00107978|583727103|FG000|Overall Study|Death|3|||
161638204|NCT00107978|583727104|FG001|Overall Study|Death|3|||
161638205|NCT00107978|583727103|FG000|Overall Study|Lost to Follow-up|20|||
161638206|NCT00107978|583727104|FG001|Overall Study|Lost to Follow-up|28|||
161638207|NCT00107978|583727103|FG000|Overall Study|Withdrawal by Subject|4|||
161638208|NCT00107978|583727104|FG001|Overall Study|Withdrawal by Subject|9|||
161638209|NCT00107978|583727103|FG000|Overall Study|Protocol Violation|0|||
161638210|NCT00107978|583727104|FG001|Overall Study|Protocol Violation|1|||
161638211|NCT00107978|583727103|FG000|Overall Study|Other|5|||
161638212|NCT00107978|583727104|FG001|Overall Study|Other|4|||
161638213|NCT02669407|583727105|FG000|Overall Study|Physician Decision|3|||
161638214|NCT02947100|583727109|FG000|Overall Study|study terminated early|3|||
161638215|NCT02947100|583727109|FG000|Overall Study|did not meet inclusion criteria|1|||
161638216|NCT00822770|583727110|FG000|Overall Study|Not treated|1|||
161638217|NCT00822770|583727111|FG001|Overall Study|Not treated|0|||
161638218|NCT00822770|583727110|FG000|Overall Study|Complication/Incomplete treatment|1|||
161638219|NCT00822770|583727111|FG001|Overall Study|Complication/Incomplete treatment|0|||
161638220|NCT00822770|583727110|FG000|Overall Study|Death|1|||
161638221|NCT00822770|583727111|FG001|Overall Study|Death|1|||
161638222|NCT01296555|583727112|FG000|Overall Study|Adverse Event|0|||
161638223|NCT01296555|583727113|FG001|Overall Study|Adverse Event|0|||
161638224|NCT01296555|583727114|FG002|Overall Study|Adverse Event|1|||
161638225|NCT01296555|583727115|FG003|Overall Study|Adverse Event|1|||
161638226|NCT01296555|583727116|FG004|Overall Study|Adverse Event|2|||
161638227|NCT01296555|583727117|FG005|Overall Study|Adverse Event|4|||
161638228|NCT01296555|583727118|FG006|Overall Study|Adverse Event|1|||
161638229|NCT01296555|583727119|FG007|Overall Study|Adverse Event|4|||
161638230|NCT01296555|583727120|FG008|Overall Study|Adverse Event|3|||
161638231|NCT01296555|583727121|FG009|Overall Study|Adverse Event|1|||
161638232|NCT01296555|583727122|FG010|Overall Study|Adverse Event|0|||
161638233|NCT01296555|583727123|FG011|Overall Study|Adverse Event|4|||
161638234|NCT01296555|583727124|FG012|Overall Study|Adverse Event|1|||
161687257|NCT04486950|583907176|FG002|Overall Study|Lost to Follow-up|0|||
161687258|NCT04486950|583907177|FG003|Overall Study|Lost to Follow-up|0|||
161687259|NCT04486950|583907178|FG004|Overall Study|Lost to Follow-up|0|||
161687260|NCT04486950|583907179|FG005|Overall Study|Lost to Follow-up|1|||
161687261|NCT04486950|583907180|FG006|Overall Study|Lost to Follow-up|0|||
161687262|NCT02821715|583907181|FG000|Overall Study|Protocol Violation|1|||
161687263|NCT02821715|583907182|FG001|Overall Study|Protocol Violation|0|||
161687264|NCT02821715|583907183|FG002|Overall Study|Protocol Violation|0|||
161687265|NCT02821715|583907184|FG003|Overall Study|Protocol Violation|0|||
161687266|NCT02821715|583907185|FG004|Overall Study|Protocol Violation|0|||
161638235|NCT01296555|583727125|FG013|Overall Study|Adverse Event|4|||
161638236|NCT01296555|583727126|FG014|Overall Study|Adverse Event|0|||
161687267|NCT02821715|583907186|FG005|Overall Study|Protocol Violation|0|||
161687268|NCT00640328|583907187|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687269|NCT00640328|583907188|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
161687270|NCT00640328|583907189|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687271|NCT00640328|583907190|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687272|NCT00640328|583907191|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687273|NCT00640328|583907192|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687274|NCT00640328|583907187|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687275|NCT00640328|583907188|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687276|NCT00640328|583907189|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687277|NCT00640328|583907190|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687278|NCT00640328|583907191|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
161687279|NCT00640328|583907192|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687280|NCT00640328|583907187|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687281|NCT00640328|583907188|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687282|NCT00640328|583907189|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
161687283|NCT00640328|583907190|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161835163|NCT01392326|584437247|FG001|Overall Study|Adverse Event|6|||
161835164|NCT01392326|584437248|FG002|Overall Study|Adverse Event|11|||
161638237|NCT01296555|583727127|FG015|Overall Study|Adverse Event|0|||
161638238|NCT01296555|583727128|FG016|Overall Study|Adverse Event|0|||
161638239|NCT01296555|583727129|FG017|Overall Study|Adverse Event|0|||
161638240|NCT01296555|583727130|FG018|Overall Study|Adverse Event|0|||
161638241|NCT01296555|583727131|FG019|Overall Study|Adverse Event|1|||
161638242|NCT01296555|583727132|FG020|Overall Study|Adverse Event|0|||
161638243|NCT01296555|583727133|FG021|Overall Study|Adverse Event|0|||
161638244|NCT01296555|583727134|FG022|Overall Study|Adverse Event|0|||
161638245|NCT01296555|583727135|FG023|Overall Study|Adverse Event|0|||
161638246|NCT01296555|583727136|FG024|Overall Study|Adverse Event|0|||
161638247|NCT01296555|583727137|FG025|Overall Study|Adverse Event|0|||
161638248|NCT01296555|583727138|FG026|Overall Study|Adverse Event|0|||
161638249|NCT01296555|583727139|FG027|Overall Study|Adverse Event|0|||
161638250|NCT01296555|583727140|FG028|Overall Study|Adverse Event|0|||
161638251|NCT01296555|583727112|FG000|Overall Study|Reason Not Specified|0|||
161638252|NCT01296555|583727113|FG001|Overall Study|Reason Not Specified|0|||
161638253|NCT01296555|583727114|FG002|Overall Study|Reason Not Specified|0|||
161638254|NCT01296555|583727115|FG003|Overall Study|Reason Not Specified|0|||
161638255|NCT01296555|583727116|FG004|Overall Study|Reason Not Specified|0|||
161638256|NCT01296555|583727117|FG005|Overall Study|Reason Not Specified|0|||
161638257|NCT01296555|583727118|FG006|Overall Study|Reason Not Specified|0|||
161638258|NCT01296555|583727119|FG007|Overall Study|Reason Not Specified|0|||
161638259|NCT01296555|583727120|FG008|Overall Study|Reason Not Specified|0|||
161638260|NCT01296555|583727121|FG009|Overall Study|Reason Not Specified|0|||
161638261|NCT01296555|583727122|FG010|Overall Study|Reason Not Specified|0|||
161638262|NCT01296555|583727123|FG011|Overall Study|Reason Not Specified|0|||
161638263|NCT01296555|583727124|FG012|Overall Study|Reason Not Specified|0|||
161638264|NCT01296555|583727125|FG013|Overall Study|Reason Not Specified|1|||
161638265|NCT01296555|583727126|FG014|Overall Study|Reason Not Specified|2|||
161638266|NCT01296555|583727127|FG015|Overall Study|Reason Not Specified|3|||
161638267|NCT01296555|583727128|FG016|Overall Study|Reason Not Specified|7|||
161638268|NCT01296555|583727129|FG017|Overall Study|Reason Not Specified|4|||
161638269|NCT01296555|583727130|FG018|Overall Study|Reason Not Specified|3|||
161638270|NCT01296555|583727131|FG019|Overall Study|Reason Not Specified|7|||
161638271|NCT01296555|583727132|FG020|Overall Study|Reason Not Specified|11|||
161638272|NCT01296555|583727133|FG021|Overall Study|Reason Not Specified|5|||
161638273|NCT01296555|583727134|FG022|Overall Study|Reason Not Specified|5|||
161638274|NCT01296555|583727135|FG023|Overall Study|Reason Not Specified|7|||
161638275|NCT01296555|583727136|FG024|Overall Study|Reason Not Specified|2|||
161638276|NCT01296555|583727137|FG025|Overall Study|Reason Not Specified|2|||
161638277|NCT01296555|583727138|FG026|Overall Study|Reason Not Specified|19|||
161638278|NCT01296555|583727139|FG027|Overall Study|Reason Not Specified|11|||
161638279|NCT01296555|583727140|FG028|Overall Study|Reason Not Specified|9|||
161638280|NCT01296555|583727112|FG000|Overall Study|Physician Decision|0|||
161638281|NCT01296555|583727113|FG001|Overall Study|Physician Decision|0|||
161638282|NCT01296555|583727114|FG002|Overall Study|Physician Decision|0|||
161638283|NCT01296555|583727115|FG003|Overall Study|Physician Decision|0|||
161638284|NCT01296555|583727116|FG004|Overall Study|Physician Decision|1|||
161638285|NCT01296555|583727117|FG005|Overall Study|Physician Decision|0|||
161638286|NCT01296555|583727118|FG006|Overall Study|Physician Decision|0|||
161638287|NCT01296555|583727119|FG007|Overall Study|Physician Decision|0|||
161638288|NCT01296555|583727120|FG008|Overall Study|Physician Decision|0|||
161638289|NCT01296555|583727121|FG009|Overall Study|Physician Decision|0|||
161638290|NCT01296555|583727122|FG010|Overall Study|Physician Decision|0|||
161638291|NCT01296555|583727123|FG011|Overall Study|Physician Decision|0|||
161638292|NCT01296555|583727124|FG012|Overall Study|Physician Decision|0|||
161638293|NCT01296555|583727125|FG013|Overall Study|Physician Decision|1|||
161638294|NCT01296555|583727126|FG014|Overall Study|Physician Decision|0|||
161638295|NCT01296555|583727127|FG015|Overall Study|Physician Decision|0|||
161638296|NCT01296555|583727128|FG016|Overall Study|Physician Decision|0|||
161638297|NCT01296555|583727129|FG017|Overall Study|Physician Decision|0|||
161638298|NCT01296555|583727130|FG018|Overall Study|Physician Decision|0|||
161638299|NCT01296555|583727131|FG019|Overall Study|Physician Decision|1|||
161638300|NCT01296555|583727132|FG020|Overall Study|Physician Decision|0|||
161638301|NCT01296555|583727133|FG021|Overall Study|Physician Decision|0|||
161638302|NCT01296555|583727134|FG022|Overall Study|Physician Decision|0|||
161638303|NCT01296555|583727135|FG023|Overall Study|Physician Decision|0|||
161638304|NCT01296555|583727136|FG024|Overall Study|Physician Decision|0|||
161638305|NCT01296555|583727137|FG025|Overall Study|Physician Decision|0|||
161638306|NCT01296555|583727138|FG026|Overall Study|Physician Decision|0|||
161638307|NCT01296555|583727139|FG027|Overall Study|Physician Decision|0|||
161638308|NCT01296555|583727140|FG028|Overall Study|Physician Decision|0|||
161638309|NCT01296555|583727112|FG000|Overall Study|Progressive Disease|6|||
161638310|NCT01296555|583727113|FG001|Overall Study|Progressive Disease|3|||
161638311|NCT01296555|583727114|FG002|Overall Study|Progressive Disease|3|||
161638312|NCT01296555|583727115|FG003|Overall Study|Progressive Disease|7|||
161638313|NCT01296555|583727116|FG004|Overall Study|Progressive Disease|6|||
161638314|NCT01296555|583727117|FG005|Overall Study|Progressive Disease|16|||
161638315|NCT01296555|583727118|FG006|Overall Study|Progressive Disease|16|||
161638316|NCT01296555|583727119|FG007|Overall Study|Progressive Disease|8|||
161638317|NCT01296555|583727120|FG008|Overall Study|Progressive Disease|7|||
161638318|NCT01296555|583727121|FG009|Overall Study|Progressive Disease|18|||
161638319|NCT01296555|583727122|FG010|Overall Study|Progressive Disease|7|||
161638320|NCT01296555|583727123|FG011|Overall Study|Progressive Disease|14|||
161638321|NCT01296555|583727124|FG012|Overall Study|Progressive Disease|5|||
161638322|NCT01296555|583727125|FG013|Overall Study|Progressive Disease|12|||
161638323|NCT01296555|583727126|FG014|Overall Study|Progressive Disease|1|||
161638324|NCT01296555|583727127|FG015|Overall Study|Progressive Disease|1|||
161638325|NCT01296555|583727128|FG016|Overall Study|Progressive Disease|0|||
161638326|NCT01296555|583727129|FG017|Overall Study|Progressive Disease|0|||
161638327|NCT01296555|583727130|FG018|Overall Study|Progressive Disease|0|||
161638328|NCT01296555|583727131|FG019|Overall Study|Progressive Disease|1|||
161638329|NCT01296555|583727132|FG020|Overall Study|Progressive Disease|0|||
161638330|NCT01296555|583727133|FG021|Overall Study|Progressive Disease|0|||
161638331|NCT01296555|583727134|FG022|Overall Study|Progressive Disease|0|||
161638332|NCT01296555|583727135|FG023|Overall Study|Progressive Disease|0|||
161638333|NCT01296555|583727136|FG024|Overall Study|Progressive Disease|1|||
161638334|NCT01296555|583727137|FG025|Overall Study|Progressive Disease|0|||
161638335|NCT01296555|583727138|FG026|Overall Study|Progressive Disease|5|||
161638336|NCT01296555|583727139|FG027|Overall Study|Progressive Disease|1|||
161638337|NCT01296555|583727140|FG028|Overall Study|Progressive Disease|0|||
161638338|NCT01296555|583727112|FG000|Overall Study|Protocol Violation|0|||
161638339|NCT01296555|583727113|FG001|Overall Study|Protocol Violation|0|||
161638340|NCT01296555|583727114|FG002|Overall Study|Protocol Violation|0|||
161638341|NCT01296555|583727115|FG003|Overall Study|Protocol Violation|0|||
161638342|NCT01296555|583727116|FG004|Overall Study|Protocol Violation|0|||
161638343|NCT01296555|583727117|FG005|Overall Study|Protocol Violation|0|||
161638344|NCT01296555|583727118|FG006|Overall Study|Protocol Violation|0|||
161638345|NCT01296555|583727119|FG007|Overall Study|Protocol Violation|0|||
161638346|NCT01296555|583727120|FG008|Overall Study|Protocol Violation|0|||
161638347|NCT01296555|583727121|FG009|Overall Study|Protocol Violation|0|||
161638348|NCT01296555|583727122|FG010|Overall Study|Protocol Violation|0|||
161638349|NCT01296555|583727123|FG011|Overall Study|Protocol Violation|0|||
161638350|NCT01296555|583727124|FG012|Overall Study|Protocol Violation|0|||
161638351|NCT01296555|583727125|FG013|Overall Study|Protocol Violation|1|||
161638352|NCT01296555|583727126|FG014|Overall Study|Protocol Violation|0|||
161638353|NCT01296555|583727127|FG015|Overall Study|Protocol Violation|0|||
161638354|NCT01296555|583727128|FG016|Overall Study|Protocol Violation|0|||
161638355|NCT01296555|583727129|FG017|Overall Study|Protocol Violation|0|||
161638356|NCT01296555|583727130|FG018|Overall Study|Protocol Violation|0|||
161638357|NCT01296555|583727131|FG019|Overall Study|Protocol Violation|0|||
161638358|NCT01296555|583727132|FG020|Overall Study|Protocol Violation|0|||
161638359|NCT01296555|583727133|FG021|Overall Study|Protocol Violation|0|||
161638360|NCT01296555|583727134|FG022|Overall Study|Protocol Violation|0|||
161638361|NCT01296555|583727135|FG023|Overall Study|Protocol Violation|0|||
161638362|NCT01296555|583727136|FG024|Overall Study|Protocol Violation|0|||
161638363|NCT01296555|583727137|FG025|Overall Study|Protocol Violation|0|||
161638364|NCT01296555|583727138|FG026|Overall Study|Protocol Violation|0|||
161638365|NCT01296555|583727139|FG027|Overall Study|Protocol Violation|0|||
161638366|NCT01296555|583727140|FG028|Overall Study|Protocol Violation|0|||
161638367|NCT01296555|583727112|FG000|Overall Study|Study Terminated By Sponsor|0|||
161638368|NCT01296555|583727113|FG001|Overall Study|Study Terminated By Sponsor|0|||
161638369|NCT01296555|583727114|FG002|Overall Study|Study Terminated By Sponsor|0|||
161638370|NCT01296555|583727115|FG003|Overall Study|Study Terminated By Sponsor|0|||
161638371|NCT01296555|583727116|FG004|Overall Study|Study Terminated By Sponsor|0|||
161638372|NCT01296555|583727117|FG005|Overall Study|Study Terminated By Sponsor|0|||
161638373|NCT01296555|583727118|FG006|Overall Study|Study Terminated By Sponsor|0|||
161638374|NCT01296555|583727119|FG007|Overall Study|Study Terminated By Sponsor|0|||
161638375|NCT01296555|583727120|FG008|Overall Study|Study Terminated By Sponsor|0|||
161638376|NCT01296555|583727121|FG009|Overall Study|Study Terminated By Sponsor|0|||
161638377|NCT01296555|583727122|FG010|Overall Study|Study Terminated By Sponsor|0|||
161638378|NCT01296555|583727123|FG011|Overall Study|Study Terminated By Sponsor|0|||
161638379|NCT01296555|583727124|FG012|Overall Study|Study Terminated By Sponsor|0|||
161638380|NCT01296555|583727125|FG013|Overall Study|Study Terminated By Sponsor|0|||
161638381|NCT01296555|583727126|FG014|Overall Study|Study Terminated By Sponsor|0|||
161638382|NCT01296555|583727127|FG015|Overall Study|Study Terminated By Sponsor|0|||
161638383|NCT01296555|583727128|FG016|Overall Study|Study Terminated By Sponsor|0|||
161638384|NCT01296555|583727129|FG017|Overall Study|Study Terminated By Sponsor|0|||
161638385|NCT01296555|583727130|FG018|Overall Study|Study Terminated By Sponsor|0|||
161638386|NCT01296555|583727131|FG019|Overall Study|Study Terminated By Sponsor|0|||
161638387|NCT01296555|583727132|FG020|Overall Study|Study Terminated By Sponsor|0|||
161638388|NCT01296555|583727133|FG021|Overall Study|Study Terminated By Sponsor|0|||
161638389|NCT01296555|583727134|FG022|Overall Study|Study Terminated By Sponsor|0|||
161638390|NCT01296555|583727135|FG023|Overall Study|Study Terminated By Sponsor|0|||
161638391|NCT01296555|583727136|FG024|Overall Study|Study Terminated By Sponsor|0|||
161638392|NCT01296555|583727137|FG025|Overall Study|Study Terminated By Sponsor|1|||
161638393|NCT01296555|583727138|FG026|Overall Study|Study Terminated By Sponsor|0|||
161638394|NCT01296555|583727139|FG027|Overall Study|Study Terminated By Sponsor|0|||
161638395|NCT01296555|583727140|FG028|Overall Study|Study Terminated By Sponsor|0|||
161638396|NCT01296555|583727112|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161835165|NCT03487848|584437251|FG000|Overall Study|Lost to Follow-up|1|||
161638397|NCT01296555|583727113|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638398|NCT01296555|583727114|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638399|NCT01296555|583727115|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638400|NCT01296555|583727116|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638401|NCT01296555|583727117|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638402|NCT01296555|583727118|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638403|NCT01296555|583727119|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638404|NCT01296555|583727120|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638405|NCT01296555|583727121|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638406|NCT01296555|583727122|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638407|NCT01296555|583727123|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638408|NCT01296555|583727124|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638409|NCT01296555|583727125|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161835166|NCT00123955|584437252|FG000|Overall Study|Adverse Event|1|||
161638410|NCT01296555|583727126|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638411|NCT01296555|583727127|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638412|NCT01296555|583727128|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638413|NCT01296555|583727129|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638414|NCT01296555|583727130|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638415|NCT01296555|583727131|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
161638416|NCT01296555|583727132|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638417|NCT01296555|583727133|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638418|NCT01296555|583727134|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638419|NCT01296555|583727135|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638420|NCT01296555|583727136|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638421|NCT01296555|583727137|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638422|NCT01296555|583727138|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638423|NCT01296555|583727139|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638424|NCT01296555|583727140|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161638425|NCT01296555|583727112|FG000|Overall Study|Death|0|||
161638426|NCT01296555|583727113|FG001|Overall Study|Death|0|||
161638427|NCT01296555|583727114|FG002|Overall Study|Death|0|||
161638428|NCT01296555|583727115|FG003|Overall Study|Death|2|||
161638429|NCT01296555|583727116|FG004|Overall Study|Death|1|||
161638430|NCT01296555|583727117|FG005|Overall Study|Death|0|||
161638431|NCT01296555|583727118|FG006|Overall Study|Death|2|||
161638432|NCT01296555|583727119|FG007|Overall Study|Death|0|||
161638433|NCT01296555|583727120|FG008|Overall Study|Death|0|||
161638434|NCT01296555|583727121|FG009|Overall Study|Death|1|||
161638435|NCT01296555|583727122|FG010|Overall Study|Death|0|||
161638436|NCT01296555|583727123|FG011|Overall Study|Death|1|||
161638437|NCT01296555|583727124|FG012|Overall Study|Death|0|||
161638438|NCT01296555|583727125|FG013|Overall Study|Death|2|||
161638439|NCT01296555|583727126|FG014|Overall Study|Death|27|||
161638440|NCT01296555|583727127|FG015|Overall Study|Death|15|||
161638441|NCT01296555|583727128|FG016|Overall Study|Death|11|||
161638442|NCT01296555|583727129|FG017|Overall Study|Death|11|||
161638443|NCT01296555|583727130|FG018|Overall Study|Death|17|||
161638444|NCT01296555|583727131|FG019|Overall Study|Death|12|||
161638445|NCT01296555|583727132|FG020|Overall Study|Death|13|||
161638446|NCT01296555|583727133|FG021|Overall Study|Death|12|||
161638447|NCT01296555|583727134|FG022|Overall Study|Death|12|||
161638448|NCT01296555|583727135|FG023|Overall Study|Death|13|||
161835167|NCT00123955|584437253|FG001|Overall Study|Adverse Event|0|||
161835168|NCT00123955|584437252|FG000|Overall Study|Withdrawal by Subject|4|||
161835169|NCT00123955|584437253|FG001|Overall Study|Withdrawal by Subject|3|||
161835170|NCT00123955|584437252|FG000|Overall Study|Death|0|||
161835171|NCT00123955|584437253|FG001|Overall Study|Death|1|||
161638449|NCT01296555|583727136|FG024|Overall Study|Death|7|||
161638450|NCT01296555|583727137|FG025|Overall Study|Death|7|||
161835172|NCT00094094|584437256|FG000|Overall Study|Death|2|||
161638451|NCT01296555|583727138|FG026|Overall Study|Death|35|||
161638452|NCT01296555|583727139|FG027|Overall Study|Death|92|||
161638453|NCT01296555|583727140|FG028|Overall Study|Death|44|||
161638454|NCT01296555|583727112|FG000|Overall Study|Lost to Follow-up|0|||
161638455|NCT01296555|583727113|FG001|Overall Study|Lost to Follow-up|0|||
161638456|NCT01296555|583727114|FG002|Overall Study|Lost to Follow-up|0|||
161638457|NCT01296555|583727115|FG003|Overall Study|Lost to Follow-up|0|||
161638458|NCT01296555|583727116|FG004|Overall Study|Lost to Follow-up|0|||
161638459|NCT01296555|583727117|FG005|Overall Study|Lost to Follow-up|0|||
161638460|NCT01296555|583727118|FG006|Overall Study|Lost to Follow-up|0|||
161835173|NCT00094094|584437256|FG000|Overall Study|Lack of Efficacy|23|||
161638461|NCT01296555|583727119|FG007|Overall Study|Lost to Follow-up|0|||
161638462|NCT01296555|583727120|FG008|Overall Study|Lost to Follow-up|0|||
161835174|NCT00094094|584437256|FG000|Overall Study|Adverse Event|7|||
161835175|NCT04459715|584437259|FG000|Overall Study|Adverse Event|3|||
161835176|NCT04459715|584437260|FG001|Overall Study|Adverse Event|3|||
161835177|NCT04459715|584437259|FG000|Overall Study|Death|111|||
161638463|NCT01296555|583727121|FG009|Overall Study|Lost to Follow-up|0|||
161638464|NCT01296555|583727122|FG010|Overall Study|Lost to Follow-up|0|||
161835178|NCT04459715|584437260|FG001|Overall Study|Death|93|||
161835179|NCT04459715|584437259|FG000|Overall Study|Lost to Follow-up|10|||
161638465|NCT01296555|583727123|FG011|Overall Study|Lost to Follow-up|0|||
161638466|NCT01296555|583727124|FG012|Overall Study|Lost to Follow-up|0|||
161638467|NCT01296555|583727125|FG013|Overall Study|Lost to Follow-up|0|||
161638468|NCT01296555|583727126|FG014|Overall Study|Lost to Follow-up|2|||
161638469|NCT01296555|583727127|FG015|Overall Study|Lost to Follow-up|1|||
161638470|NCT01296555|583727128|FG016|Overall Study|Lost to Follow-up|0|||
161638471|NCT01296555|583727129|FG017|Overall Study|Lost to Follow-up|2|||
161638472|NCT01296555|583727130|FG018|Overall Study|Lost to Follow-up|0|||
161638473|NCT01296555|583727131|FG019|Overall Study|Lost to Follow-up|2|||
161638474|NCT01296555|583727132|FG020|Overall Study|Lost to Follow-up|3|||
161638475|NCT01296555|583727133|FG021|Overall Study|Lost to Follow-up|2|||
161638476|NCT01296555|583727134|FG022|Overall Study|Lost to Follow-up|0|||
161638477|NCT01296555|583727135|FG023|Overall Study|Lost to Follow-up|0|||
161638478|NCT01296555|583727136|FG024|Overall Study|Lost to Follow-up|0|||
161638479|NCT01296555|583727137|FG025|Overall Study|Lost to Follow-up|0|||
161638480|NCT01296555|583727138|FG026|Overall Study|Lost to Follow-up|3|||
161638481|NCT01296555|583727139|FG027|Overall Study|Lost to Follow-up|13|||
161638482|NCT01296555|583727140|FG028|Overall Study|Lost to Follow-up|5|||
161638483|NCT01296555|583727112|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161638484|NCT01296555|583727113|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161638485|NCT01296555|583727114|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161638486|NCT01296555|583727115|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161638487|NCT01296555|583727116|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161638488|NCT01296555|583727117|FG005|Overall Study|Non-Compliance With Study Drug|0|||
161638489|NCT01296555|583727118|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161638490|NCT01296555|583727119|FG007|Overall Study|Non-Compliance With Study Drug|1|||
161638491|NCT01296555|583727120|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161638492|NCT01296555|583727121|FG009|Overall Study|Non-Compliance With Study Drug|0|||
161638493|NCT01296555|583727122|FG010|Overall Study|Non-Compliance With Study Drug|0|||
161638494|NCT01296555|583727123|FG011|Overall Study|Non-Compliance With Study Drug|0|||
161638495|NCT01296555|583727124|FG012|Overall Study|Non-Compliance With Study Drug|0|||
161638496|NCT01296555|583727125|FG013|Overall Study|Non-Compliance With Study Drug|0|||
161638497|NCT01296555|583727126|FG014|Overall Study|Non-Compliance With Study Drug|0|||
161638498|NCT01296555|583727127|FG015|Overall Study|Non-Compliance With Study Drug|0|||
161638499|NCT01296555|583727128|FG016|Overall Study|Non-Compliance With Study Drug|0|||
161638500|NCT01296555|583727129|FG017|Overall Study|Non-Compliance With Study Drug|0|||
161638501|NCT01296555|583727130|FG018|Overall Study|Non-Compliance With Study Drug|0|||
161638502|NCT01296555|583727131|FG019|Overall Study|Non-Compliance With Study Drug|0|||
161638503|NCT01296555|583727132|FG020|Overall Study|Non-Compliance With Study Drug|0|||
161638504|NCT01296555|583727133|FG021|Overall Study|Non-Compliance With Study Drug|0|||
161638505|NCT01296555|583727134|FG022|Overall Study|Non-Compliance With Study Drug|0|||
161638506|NCT01296555|583727135|FG023|Overall Study|Non-Compliance With Study Drug|0|||
161638507|NCT01296555|583727136|FG024|Overall Study|Non-Compliance With Study Drug|0|||
161638508|NCT01296555|583727137|FG025|Overall Study|Non-Compliance With Study Drug|0|||
161638509|NCT01296555|583727138|FG026|Overall Study|Non-Compliance With Study Drug|0|||
161638510|NCT01296555|583727139|FG027|Overall Study|Non-Compliance With Study Drug|0|||
161638511|NCT01296555|583727140|FG028|Overall Study|Non-Compliance With Study Drug|0|||
161638512|NCT01296555|583727112|FG000|Overall Study|Withdrawal by Subject|0|||
161638513|NCT01296555|583727113|FG001|Overall Study|Withdrawal by Subject|0|||
161638514|NCT01296555|583727114|FG002|Overall Study|Withdrawal by Subject|0|||
161638515|NCT01296555|583727115|FG003|Overall Study|Withdrawal by Subject|0|||
161638516|NCT01296555|583727116|FG004|Overall Study|Withdrawal by Subject|1|||
161638517|NCT01296555|583727117|FG005|Overall Study|Withdrawal by Subject|0|||
161638518|NCT01296555|583727118|FG006|Overall Study|Withdrawal by Subject|1|||
161638519|NCT01296555|583727119|FG007|Overall Study|Withdrawal by Subject|0|||
161638520|NCT01296555|583727120|FG008|Overall Study|Withdrawal by Subject|0|||
161638521|NCT01296555|583727121|FG009|Overall Study|Withdrawal by Subject|0|||
161638522|NCT01296555|583727122|FG010|Overall Study|Withdrawal by Subject|1|||
161638523|NCT01296555|583727123|FG011|Overall Study|Withdrawal by Subject|1|||
161638524|NCT01296555|583727124|FG012|Overall Study|Withdrawal by Subject|0|||
161638525|NCT01296555|583727125|FG013|Overall Study|Withdrawal by Subject|0|||
161638526|NCT01296555|583727126|FG014|Overall Study|Withdrawal by Subject|3|||
161638527|NCT01296555|583727127|FG015|Overall Study|Withdrawal by Subject|0|||
161638528|NCT01296555|583727128|FG016|Overall Study|Withdrawal by Subject|2|||
161638529|NCT01296555|583727129|FG017|Overall Study|Withdrawal by Subject|1|||
161638530|NCT01296555|583727130|FG018|Overall Study|Withdrawal by Subject|0|||
161638531|NCT01296555|583727131|FG019|Overall Study|Withdrawal by Subject|1|||
161638532|NCT01296555|583727132|FG020|Overall Study|Withdrawal by Subject|1|||
161638533|NCT01296555|583727133|FG021|Overall Study|Withdrawal by Subject|1|||
161638534|NCT01296555|583727134|FG022|Overall Study|Withdrawal by Subject|3|||
161638535|NCT01296555|583727135|FG023|Overall Study|Withdrawal by Subject|0|||
161638536|NCT01296555|583727136|FG024|Overall Study|Withdrawal by Subject|0|||
161638537|NCT01296555|583727137|FG025|Overall Study|Withdrawal by Subject|0|||
161638538|NCT01296555|583727138|FG026|Overall Study|Withdrawal by Subject|8|||
161638539|NCT01296555|583727139|FG027|Overall Study|Withdrawal by Subject|4|||
161638540|NCT01296555|583727140|FG028|Overall Study|Withdrawal by Subject|2|||
161638541|NCT00992992|583727141|FG000|Overall Study|Lost to Follow-up|3|||
161638542|NCT00992992|583727141|FG000|Overall Study|Death|16|||
161638543|NCT00992992|583727141|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
161638544|NCT00992992|583727141|FG000|Overall Study|Sponsor Closed the Study|4|||
161638545|NCT00217022|583727143|FG000|Overall Study|Withdrawal by Subject|1|||
161638546|NCT00217022|583727144|FG001|Overall Study|Withdrawal by Subject|1|||
161638547|NCT05178979|583727146|FG000|Overall Study|Death|0|||
161638548|NCT05178979|583727147|FG001|Overall Study|Death|5|||
161638549|NCT05178979|583727148|FG002|Overall Study|Death|0|||
161638550|NCT05178979|583727149|FG003|Overall Study|Death|3|||
161638551|NCT05178979|583727146|FG000|Overall Study|Adverse Event|0|||
161638552|NCT05178979|583727147|FG001|Overall Study|Adverse Event|1|||
161638553|NCT05178979|583727148|FG002|Overall Study|Adverse Event|0|||
161638554|NCT05178979|583727149|FG003|Overall Study|Adverse Event|0|||
161638555|NCT05178979|583727146|FG000|Overall Study|Lost to Follow-up|1|||
161638556|NCT05178979|583727147|FG001|Overall Study|Lost to Follow-up|8|||
161638557|NCT05178979|583727148|FG002|Overall Study|Lost to Follow-up|3|||
161638558|NCT05178979|583727149|FG003|Overall Study|Lost to Follow-up|8|||
161638559|NCT00817336|583727150|FG000|Overall Study|Withdrawal by Subject|1|||
161638560|NCT00817336|583727151|FG001|Overall Study|Withdrawal by Subject|1|||
161638561|NCT02108652|583727152|FG000|Overall Study|Death|253|||
161638562|NCT02108652|583727152|FG000|Overall Study|Lost to Follow-up|2|||
161638563|NCT02108652|583727152|FG000|Overall Study|Withdrawal by Subject|16|||
161638564|NCT02108652|583727152|FG000|Overall Study|Study Terminated By Sponsor|31|||
161638565|NCT02108652|583727152|FG000|Overall Study|Non-Compliance|1|||
161638566|NCT02108652|583727152|FG000|Overall Study|Physician Decision|6|||
161638567|NCT02108652|583727152|FG000|Overall Study|Progression Of Disease|1|||
161638568|NCT01704547|583727153|FG000|Overall Study|Physician Decision|4|||
161638569|NCT01704547|583727153|FG000|Overall Study|Withdrawal by Subject|1|||
161638570|NCT02138253|583727157|FG000|Overall Study|Adverse Event|3|||
161638571|NCT02138253|583727158|FG001|Overall Study|Adverse Event|3|||
161638572|NCT02138253|583727157|FG000|Overall Study|Lost to Follow-up|2|||
161638573|NCT02138253|583727158|FG001|Overall Study|Lost to Follow-up|1|||
161638574|NCT02138253|583727157|FG000|Overall Study|Physician Decision|2|||
161638575|NCT02138253|583727158|FG001|Overall Study|Physician Decision|0|||
161638576|NCT02138253|583727157|FG000|Overall Study|Non compliance|1|||
161638577|NCT02138253|583727158|FG001|Overall Study|Non compliance|0|||
161638578|NCT02138253|583727157|FG000|Overall Study|Withdrawal by Subject|1|||
161638579|NCT02138253|583727158|FG001|Overall Study|Withdrawal by Subject|0|||
161638580|NCT01918371|583727159|FG000|Overall Study|Missing Data|1|||
161638581|NCT01918371|583727160|FG001|Overall Study|Missing Data|1|||
161638582|NCT01390441|583727165|FG000|Treatment Period|Protocol Violation|0|||
161638583|NCT01390441|583727166|FG001|Treatment Period|Protocol Violation|1|||
161638584|NCT01390441|583727167|FG002|Treatment Period|Protocol Violation|0|||
161638585|NCT01390441|583727168|FG003|Treatment Period|Protocol Violation|0|||
161638586|NCT01390441|583727169|FG004|Treatment Period|Protocol Violation|0|||
161638587|NCT01390441|583727165|FG000|Treatment Period|Physician Decision|0|||
161638588|NCT01390441|583727166|FG001|Treatment Period|Physician Decision|0|||
161638589|NCT01390441|583727167|FG002|Treatment Period|Physician Decision|0|||
161638590|NCT01390441|583727168|FG003|Treatment Period|Physician Decision|1|||
161638591|NCT01390441|583727169|FG004|Treatment Period|Physician Decision|0|||
161638592|NCT01390441|583727165|FG000|Treatment Period|Lack of Efficacy|0|||
161638593|NCT01390441|583727166|FG001|Treatment Period|Lack of Efficacy|0|||
161638594|NCT01390441|583727167|FG002|Treatment Period|Lack of Efficacy|0|||
161638595|NCT01390441|583727168|FG003|Treatment Period|Lack of Efficacy|0|||
161638596|NCT01390441|583727169|FG004|Treatment Period|Lack of Efficacy|1|||
161638597|NCT01390441|583727165|FG000|Treatment Period|Unknown due to early stopping of study|0|||
161638598|NCT01390441|583727166|FG001|Treatment Period|Unknown due to early stopping of study|0|||
161638599|NCT01390441|583727167|FG002|Treatment Period|Unknown due to early stopping of study|8|||
161638600|NCT01390441|583727168|FG003|Treatment Period|Unknown due to early stopping of study|11|||
161638601|NCT01390441|583727169|FG004|Treatment Period|Unknown due to early stopping of study|7|||
161638602|NCT01390441|583727165|FG000|Treatment Period|Adverse Event|0|||
161638603|NCT01390441|583727166|FG001|Treatment Period|Adverse Event|0|||
161638604|NCT01390441|583727167|FG002|Treatment Period|Adverse Event|1|||
161638605|NCT01390441|583727168|FG003|Treatment Period|Adverse Event|1|||
161638606|NCT01390441|583727169|FG004|Treatment Period|Adverse Event|2|||
161638607|NCT01390441|583727165|FG000|Treatment Period|Withdrawal by Subject|0|||
161638608|NCT01390441|583727166|FG001|Treatment Period|Withdrawal by Subject|0|||
161638609|NCT01390441|583727167|FG002|Treatment Period|Withdrawal by Subject|1|||
161638610|NCT01390441|583727168|FG003|Treatment Period|Withdrawal by Subject|0|||
161638611|NCT01390441|583727169|FG004|Treatment Period|Withdrawal by Subject|1|||
161638612|NCT01390441|583727165|FG000|Treatment Period|Lost to Follow-up|1|||
161638613|NCT01390441|583727166|FG001|Treatment Period|Lost to Follow-up|0|||
161638614|NCT01390441|583727167|FG002|Treatment Period|Lost to Follow-up|0|||
161638615|NCT01390441|583727168|FG003|Treatment Period|Lost to Follow-up|0|||
161638616|NCT01390441|583727169|FG004|Treatment Period|Lost to Follow-up|0|||
161638617|NCT01390441|583727165|FG000|Extension Period|Protocol Violation|3|||
161638618|NCT01390441|583727166|FG001|Extension Period|Protocol Violation|1|||
161638619|NCT01390441|583727167|FG002|Extension Period|Protocol Violation|0|||
161638620|NCT01390441|583727168|FG003|Extension Period|Protocol Violation|1|||
161638621|NCT01390441|583727169|FG004|Extension Period|Protocol Violation|0|||
161638622|NCT03802617|583727170|FG000|Overall Study|Adverse Event|0|||
161638623|NCT03802617|583727171|FG001|Overall Study|Adverse Event|4|||
161638624|NCT03802617|583727172|FG002|Overall Study|Adverse Event|5|||
161638625|NCT03802617|583727173|FG003|Overall Study|Adverse Event|1|||
161638626|NCT03802617|583727170|FG000|Overall Study|Lack of Efficacy|0|||
161638627|NCT03802617|583727171|FG001|Overall Study|Lack of Efficacy|1|||
161638628|NCT03802617|583727172|FG002|Overall Study|Lack of Efficacy|0|||
161638629|NCT03802617|583727173|FG003|Overall Study|Lack of Efficacy|2|||
161638630|NCT03802617|583727170|FG000|Overall Study|Protocol Violation|1|||
161638631|NCT03802617|583727171|FG001|Overall Study|Protocol Violation|1|||
161638632|NCT03802617|583727172|FG002|Overall Study|Protocol Violation|1|||
161638633|NCT03802617|583727173|FG003|Overall Study|Protocol Violation|0|||
161638634|NCT03802617|583727170|FG000|Overall Study|Withdrawal by Subject|1|||
161638635|NCT03802617|583727171|FG001|Overall Study|Withdrawal by Subject|1|||
161638636|NCT03802617|583727172|FG002|Overall Study|Withdrawal by Subject|1|||
161638637|NCT03802617|583727173|FG003|Overall Study|Withdrawal by Subject|0|||
161638638|NCT03802617|583727170|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
161638639|NCT03802617|583727171|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
161638640|NCT03802617|583727172|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
161638641|NCT03802617|583727173|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
161638642|NCT00621192|583727174|FG000|Overall Study|Withdrawal by Subject|0|||
161638643|NCT00621192|583727175|FG001|Overall Study|Withdrawal by Subject|0|||
161638644|NCT00621192|583727176|FG002|Overall Study|Withdrawal by Subject|2|||
161638645|NCT00621192|583727177|FG003|Overall Study|Withdrawal by Subject|0|||
161638646|NCT00621192|583727174|FG000|Overall Study|Physician Decision|1|||
161638647|NCT00621192|583727175|FG001|Overall Study|Physician Decision|3|||
161638648|NCT00621192|583727176|FG002|Overall Study|Physician Decision|0|||
161638649|NCT00621192|583727177|FG003|Overall Study|Physician Decision|0|||
161638650|NCT00621192|583727174|FG000|Overall Study|Protocol Violation|1|||
161638651|NCT00621192|583727175|FG001|Overall Study|Protocol Violation|0|||
161638652|NCT00621192|583727176|FG002|Overall Study|Protocol Violation|0|||
161638653|NCT00621192|583727177|FG003|Overall Study|Protocol Violation|1|||
161638654|NCT00621192|583727174|FG000|Overall Study|Adverse Event|0|||
161638655|NCT00621192|583727175|FG001|Overall Study|Adverse Event|1|||
161638656|NCT00621192|583727176|FG002|Overall Study|Adverse Event|0|||
161638657|NCT00621192|583727177|FG003|Overall Study|Adverse Event|1|||
161638658|NCT00621192|583727174|FG000|Overall Study|Death|2|||
161638659|NCT00621192|583727175|FG001|Overall Study|Death|5|||
161638660|NCT00621192|583727176|FG002|Overall Study|Death|0|||
161638661|NCT00621192|583727177|FG003|Overall Study|Death|0|||
161638662|NCT00621192|583727174|FG000|Overall Study|Final Assessments not Completed|0|||
161835180|NCT04459715|584437260|FG001|Overall Study|Lost to Follow-up|9|||
161638663|NCT00621192|583727175|FG001|Overall Study|Final Assessments not Completed|0|||
161638664|NCT00621192|583727176|FG002|Overall Study|Final Assessments not Completed|3|||
161638665|NCT00621192|583727177|FG003|Overall Study|Final Assessments not Completed|1|||
161638666|NCT00267098|583727182|FG000|Overall Study|Death|0|||
161638667|NCT00267098|583727183|FG001|Overall Study|Death|0|||
161638668|NCT00267098|583727184|FG002|Overall Study|Death|57|||
161638669|NCT00267098|583727185|FG003|Overall Study|Death|66|||
161638670|NCT00267098|583727186|FG004|Overall Study|Death|14|||
161638671|NCT00267098|583727187|FG005|Overall Study|Death|23|||
161638672|NCT00267098|583727188|FG006|Overall Study|Death|28|||
161638673|NCT00267098|583727189|FG007|Overall Study|Death|9|||
161638674|NCT00267098|583727182|FG000|Overall Study|Lost to Follow-up|0|||
161638675|NCT00267098|583727183|FG001|Overall Study|Lost to Follow-up|0|||
161638676|NCT00267098|583727184|FG002|Overall Study|Lost to Follow-up|6|||
161638677|NCT00267098|583727185|FG003|Overall Study|Lost to Follow-up|5|||
161638678|NCT00267098|583727186|FG004|Overall Study|Lost to Follow-up|2|||
161638679|NCT00267098|583727187|FG005|Overall Study|Lost to Follow-up|3|||
161638680|NCT00267098|583727188|FG006|Overall Study|Lost to Follow-up|1|||
161638681|NCT00267098|583727189|FG007|Overall Study|Lost to Follow-up|1|||
161638682|NCT00267098|583727182|FG000|Overall Study|Withdrawal by Subject|8|||
161638683|NCT00267098|583727183|FG001|Overall Study|Withdrawal by Subject|0|||
161638684|NCT00267098|583727184|FG002|Overall Study|Withdrawal by Subject|24|||
161638685|NCT00267098|583727185|FG003|Overall Study|Withdrawal by Subject|21|||
161638686|NCT00267098|583727186|FG004|Overall Study|Withdrawal by Subject|12|||
161638687|NCT00267098|583727187|FG005|Overall Study|Withdrawal by Subject|9|||
161638688|NCT00267098|583727188|FG006|Overall Study|Withdrawal by Subject|12|||
161638689|NCT00267098|583727189|FG007|Overall Study|Withdrawal by Subject|5|||
161638690|NCT00267098|583727182|FG000|Overall Study|Physician Decision|5|||
161638691|NCT00267098|583727183|FG001|Overall Study|Physician Decision|0|||
161638692|NCT00267098|583727184|FG002|Overall Study|Physician Decision|7|||
161638693|NCT00267098|583727185|FG003|Overall Study|Physician Decision|11|||
161638694|NCT00267098|583727186|FG004|Overall Study|Physician Decision|5|||
161638695|NCT00267098|583727187|FG005|Overall Study|Physician Decision|4|||
161638696|NCT00267098|583727188|FG006|Overall Study|Physician Decision|3|||
161638697|NCT00267098|583727189|FG007|Overall Study|Physician Decision|0|||
161638698|NCT00267098|583727182|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
161638699|NCT00267098|583727183|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161638700|NCT00267098|583727184|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161638701|NCT00267098|583727185|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161638702|NCT00267098|583727186|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
161638703|NCT00267098|583727187|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161638704|NCT00267098|583727188|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161638705|NCT00267098|583727189|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161638706|NCT00267098|583727182|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638707|NCT00267098|583727183|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
161638708|NCT00267098|583727184|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638709|NCT00267098|583727185|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638710|NCT00267098|583727186|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638711|NCT00267098|583727187|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638712|NCT00267098|583727188|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638713|NCT00267098|583727189|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161638714|NCT00267098|583727182|FG000|Overall Study|Site closure|0|||
161638715|NCT00267098|583727183|FG001|Overall Study|Site closure|0|||
161638716|NCT00267098|583727184|FG002|Overall Study|Site closure|0|||
161638717|NCT00267098|583727185|FG003|Overall Study|Site closure|1|||
161638718|NCT00267098|583727186|FG004|Overall Study|Site closure|0|||
161638719|NCT00267098|583727187|FG005|Overall Study|Site closure|1|||
161638720|NCT00267098|583727188|FG006|Overall Study|Site closure|1|||
161638721|NCT00267098|583727189|FG007|Overall Study|Site closure|0|||
161638722|NCT00267098|583727182|FG000|Overall Study|Explanted Medtronic device|0|||
161638723|NCT00267098|583727183|FG001|Overall Study|Explanted Medtronic device|0|||
161638724|NCT00267098|583727184|FG002|Overall Study|Explanted Medtronic device|0|||
161638725|NCT00267098|583727185|FG003|Overall Study|Explanted Medtronic device|1|||
161638726|NCT00267098|583727186|FG004|Overall Study|Explanted Medtronic device|0|||
161638727|NCT00267098|583727187|FG005|Overall Study|Explanted Medtronic device|0|||
161638728|NCT00267098|583727188|FG006|Overall Study|Explanted Medtronic device|0|||
161638729|NCT00267098|583727189|FG007|Overall Study|Explanted Medtronic device|0|||
161638730|NCT00267098|583727182|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638731|NCT00267098|583727183|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638732|NCT00267098|583727184|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638733|NCT00267098|583727185|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638734|NCT00267098|583727186|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
161638735|NCT00267098|583727187|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638736|NCT00267098|583727188|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638737|NCT00267098|583727189|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161638738|NCT00267098|583727182|FG000|Overall Study|Subject listed for heart transplant|0|||
161638739|NCT00267098|583727183|FG001|Overall Study|Subject listed for heart transplant|0|||
161638740|NCT00267098|583727184|FG002|Overall Study|Subject listed for heart transplant|0|||
161638741|NCT00267098|583727185|FG003|Overall Study|Subject listed for heart transplant|0|||
161638742|NCT00267098|583727186|FG004|Overall Study|Subject listed for heart transplant|0|||
161638743|NCT00267098|583727187|FG005|Overall Study|Subject listed for heart transplant|0|||
161638744|NCT00267098|583727188|FG006|Overall Study|Subject listed for heart transplant|1|||
161638745|NCT00267098|583727189|FG007|Overall Study|Subject listed for heart transplant|0|||
161638746|NCT00267098|583727182|FG000|Overall Study|Sponsor withdrew subject|0|||
161638747|NCT00267098|583727183|FG001|Overall Study|Sponsor withdrew subject|0|||
161638748|NCT00267098|583727184|FG002|Overall Study|Sponsor withdrew subject|0|||
161638749|NCT00267098|583727185|FG003|Overall Study|Sponsor withdrew subject|1|||
161638750|NCT00267098|583727186|FG004|Overall Study|Sponsor withdrew subject|0|||
161638751|NCT00267098|583727187|FG005|Overall Study|Sponsor withdrew subject|0|||
161638752|NCT00267098|583727188|FG006|Overall Study|Sponsor withdrew subject|0|||
161638753|NCT00267098|583727189|FG007|Overall Study|Sponsor withdrew subject|0|||
161638754|NCT04211389|583727191|FG000|Overall Study|Adverse Event|1|||
161638755|NCT04211389|583727192|FG001|Overall Study|Adverse Event|2|||
161638756|NCT04211389|583727191|FG000|Overall Study|Lost to Follow-up|15|||
161638757|NCT04211389|583727192|FG001|Overall Study|Lost to Follow-up|7|||
161638758|NCT04211389|583727191|FG000|Overall Study|Protocol Violation|0|||
161638759|NCT04211389|583727192|FG001|Overall Study|Protocol Violation|1|||
161638760|NCT04211389|583727191|FG000|Overall Study|Withdrawal by Subject|10|||
161638761|NCT04211389|583727192|FG001|Overall Study|Withdrawal by Subject|11|||
161638762|NCT00547534|583727196|FG000|Overall Study|Adverse Event|7|||
161638763|NCT00547534|583727196|FG000|Overall Study|Disease Progression|4|||
161638764|NCT02168478|583727202|FG000|Overall Study|Withdrawal by Subject|1|||
161638765|NCT02168478|583727202|FG000|Overall Study|Did Not Consent to Participation|2|||
161638766|NCT02168478|583727202|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
161638767|NCT05523219|583727203|FG000|Overall Study|Wrong inclusion|1|||
161638768|NCT05523219|583727203|FG000|Overall Study|Lost to Follow-up|7|||
161638769|NCT02760485|583727204|FG000|Phase 1|Death|3|||
161638770|NCT02760485|583727205|FG001|Phase 1|Death|6|||
161638771|NCT02760485|583727206|FG002|Phase 1|Death|0|||
161638772|NCT02760485|583727204|FG000|Phase 1|Withdrawal by Subject|2|||
161638773|NCT02760485|583727205|FG001|Phase 1|Withdrawal by Subject|0|||
161638774|NCT02760485|583727206|FG002|Phase 1|Withdrawal by Subject|0|||
161638775|NCT02760485|583727204|FG000|Phase 1|Progressive Disease|1|||
161638776|NCT02760485|583727205|FG001|Phase 1|Progressive Disease|0|||
161638777|NCT02760485|583727206|FG002|Phase 1|Progressive Disease|0|||
161638778|NCT02760485|583727204|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
161638779|NCT02760485|583727205|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
161638780|NCT02760485|583727206|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
161638781|NCT02760485|583727204|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
161638782|NCT02760485|583727205|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
161638783|NCT02760485|583727206|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
161638784|NCT02760485|583727204|FG000|Phase 2|Death|0|||
161638785|NCT02760485|583727205|FG001|Phase 2|Death|0|||
161687284|NCT00640328|583907191|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687285|NCT00640328|583907192|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687286|NCT00640328|583907187|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687287|NCT00640328|583907188|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
161687288|NCT00640328|583907189|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687289|NCT00640328|583907190|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
161835181|NCT04459715|584437259|FG000|Overall Study|Other Reasons|4|||
161835182|NCT04459715|584437260|FG001|Overall Study|Other Reasons|5|||
161835183|NCT04459715|584437259|FG000|Overall Study|PROTOCOL DEVIATION|0|||
161835184|NCT04459715|584437260|FG001|Overall Study|PROTOCOL DEVIATION|1|||
161638786|NCT02760485|583727206|FG002|Phase 2|Death|12|||
161638787|NCT02760485|583727204|FG000|Phase 2|Withdrawal by Subject|0|||
161638788|NCT02760485|583727205|FG001|Phase 2|Withdrawal by Subject|0|||
161638789|NCT02760485|583727206|FG002|Phase 2|Withdrawal by Subject|3|||
161638790|NCT02760485|583727204|FG000|Phase 2|Progressive Disease|0|||
161638791|NCT02760485|583727205|FG001|Phase 2|Progressive Disease|0|||
161638792|NCT02760485|583727206|FG002|Phase 2|Progressive Disease|1|||
161638793|NCT02760485|583727204|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
161638794|NCT02760485|583727205|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
161638795|NCT02760485|583727206|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
161638796|NCT01182207|583727207|FG000|First Intervention|Positive Hepatitis Results|0|||
161638797|NCT01182207|583727208|FG001|First Intervention|Positive Hepatitis Results|1|||
161638798|NCT01182207|583727207|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
161638799|NCT01182207|583727208|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
161638800|NCT01087814|583727209|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
161638801|NCT01087814|583727210|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
161638802|NCT01087814|583727209|FG000|Second Intervention (5 Days)|Physician Decision|1|||
161638803|NCT01087814|583727210|FG001|Second Intervention (5 Days)|Physician Decision|0|||
161638804|NCT01427738|583727211|FG000|Overall Study|Death|12|||
161638805|NCT01427738|583727212|FG001|Overall Study|Death|9|||
161638806|NCT01427738|583727211|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161638807|NCT01427738|583727212|FG001|Overall Study|Severe debilitation, unable to continue|1|||
161638808|NCT01427738|583727211|FG000|Overall Study|Subject unable to get to clinic|5|||
161638809|NCT01427738|583727212|FG001|Overall Study|Subject unable to get to clinic|2|||
161638810|NCT01427738|583727211|FG000|Overall Study|Withdrawal by Subject|0|||
161638811|NCT01427738|583727212|FG001|Overall Study|Withdrawal by Subject|2|||
161638812|NCT01427738|583727211|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
161638813|NCT01427738|583727212|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
161638814|NCT01427738|583727211|FG000|Overall Study|Lost to Follow-up|1|||
161638815|NCT01427738|583727212|FG001|Overall Study|Lost to Follow-up|5|||
161638816|NCT05314374|583727213|FG000|Overall Study|Adverse Event|2|||
161638817|NCT05314374|583727214|FG001|Overall Study|Adverse Event|2|||
161638818|NCT04590404|583727215|FG000|Overall Study|Death|16|||
161638819|NCT04590404|583727216|FG001|Overall Study|Death|17|||
161638820|NCT04590404|583727215|FG000|Overall Study|Withdrawal by Subject|7|||
161638821|NCT04590404|583727216|FG001|Overall Study|Withdrawal by Subject|2|||
161638822|NCT03912532|583727217|FG000|Overall Study|Adverse Event|3|||
161638823|NCT03912532|583727218|FG001|Overall Study|Adverse Event|3|||
161638824|NCT03912532|583727219|FG002|Overall Study|Adverse Event|2|||
161638825|NCT03912532|583727220|FG003|Overall Study|Adverse Event|2|||
161638826|NCT03912532|583727217|FG000|Overall Study|Lost to Follow-up|3|||
161638827|NCT03912532|583727218|FG001|Overall Study|Lost to Follow-up|2|||
161638828|NCT03912532|583727219|FG002|Overall Study|Lost to Follow-up|1|||
161638829|NCT03912532|583727220|FG003|Overall Study|Lost to Follow-up|2|||
161638830|NCT03912532|583727217|FG000|Overall Study|Withdrawal by Subject|1|||
161638831|NCT03912532|583727218|FG001|Overall Study|Withdrawal by Subject|1|||
161638832|NCT03912532|583727219|FG002|Overall Study|Withdrawal by Subject|2|||
161638833|NCT03912532|583727220|FG003|Overall Study|Withdrawal by Subject|0|||
161638834|NCT03912532|583727217|FG000|Overall Study|Physician Decision|1|||
161638835|NCT03912532|583727218|FG001|Overall Study|Physician Decision|0|||
161638836|NCT03912532|583727219|FG002|Overall Study|Physician Decision|0|||
161638837|NCT03912532|583727220|FG003|Overall Study|Physician Decision|3|||
161638838|NCT03912532|583727217|FG000|Overall Study|Other|0|||
161638839|NCT03912532|583727218|FG001|Overall Study|Other|1|||
161638840|NCT03912532|583727219|FG002|Overall Study|Other|1|||
161638841|NCT03912532|583727220|FG003|Overall Study|Other|0|||
161638842|NCT03783871|583727223|FG000|Overall Study|Withdrawal by Subject|15|||
161638843|NCT03783871|583727223|FG000|Overall Study|Death|13|||
161638844|NCT03783871|583727223|FG000|Overall Study|Lost to Follow-up|2|||
161638845|NCT05990387|583727224|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
161638846|NCT05990387|583727225|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
161638847|NCT00604188|583727226|FG000|Overall Study|Adverse Event|1|||
161638848|NCT00604188|583727227|FG001|Overall Study|Adverse Event|4|||
161638849|NCT00604188|583727226|FG000|Overall Study|Lost to Follow-up|17|||
161638850|NCT00604188|583727227|FG001|Overall Study|Lost to Follow-up|15|||
161638851|NCT00604188|583727226|FG000|Overall Study|Withdrawal by Subject|5|||
161638852|NCT00604188|583727227|FG001|Overall Study|Withdrawal by Subject|1|||
161638853|NCT00604188|583727226|FG000|Overall Study|Non-compliance with protocol|4|||
161638854|NCT00604188|583727227|FG001|Overall Study|Non-compliance with protocol|4|||
161638855|NCT00604188|583727226|FG000|Overall Study|Did not receive study drug|0|||
161638856|NCT00604188|583727227|FG001|Overall Study|Did not receive study drug|1|||
161638857|NCT01689363|583728660|FG000|Overall Study|Protocol Violation|0|||
161638858|NCT01689363|583728661|FG001|Overall Study|Protocol Violation|1|||
161638859|NCT01689363|583728662|FG002|Overall Study|Protocol Violation|0|||
161638860|NCT01689363|583728663|FG003|Overall Study|Protocol Violation|0|||
161638861|NCT01689363|583728664|FG004|Overall Study|Protocol Violation|0|||
161638862|NCT01689363|583728665|FG005|Overall Study|Protocol Violation|0|||
161638863|NCT01689363|583728666|FG006|Overall Study|Protocol Violation|0|||
161638864|NCT01689363|583728667|FG007|Overall Study|Protocol Violation|0|||
161638865|NCT00321685|583728668|FG000|Overall Study|Adverse Event|18|||
161638866|NCT00321685|583728668|FG000|Overall Study|Death|2|||
161638867|NCT00321685|583728668|FG000|Overall Study|Withdrawal by Subject|8|||
161638868|NCT00321685|583728668|FG000|Overall Study|Alternative therapy|1|||
161638869|NCT00321685|583728668|FG000|Overall Study|Complicating disese|1|||
161638870|NCT00321685|583728668|FG000|Overall Study|Other|5|||
161638871|NCT00321685|583728668|FG000|Overall Study|Not start protocol therapy|2|||
161638872|NCT00321685|583728668|FG000|Overall Study|Ineligible|2|||
161638873|NCT03023722|583728672|FG000|Overall Study|No follow-up assessment|4|||
161638874|NCT03616964|583728673|FG000|Overall Study|Adverse Event|15|||
161638875|NCT03616964|583728674|FG001|Overall Study|Adverse Event|10|||
161638876|NCT03616964|583728675|FG002|Overall Study|Adverse Event|16|||
161638877|NCT03616964|583728673|FG000|Overall Study|Death|3|||
161638878|NCT03616964|583728674|FG001|Overall Study|Death|0|||
161638879|NCT03616964|583728675|FG002|Overall Study|Death|4|||
161638880|NCT03616964|583728673|FG000|Overall Study|Lack of Efficacy|4|||
161638881|NCT03616964|583728674|FG001|Overall Study|Lack of Efficacy|8|||
161638882|NCT03616964|583728675|FG002|Overall Study|Lack of Efficacy|8|||
161638883|NCT03616964|583728673|FG000|Overall Study|Lost to Follow-up|2|||
161638884|NCT03616964|583728674|FG001|Overall Study|Lost to Follow-up|1|||
161638885|NCT03616964|583728675|FG002|Overall Study|Lost to Follow-up|3|||
161638886|NCT03616964|583728673|FG000|Overall Study|Withdrawal by Subject|18|||
161638887|NCT03616964|583728674|FG001|Overall Study|Withdrawal by Subject|14|||
161638888|NCT03616964|583728675|FG002|Overall Study|Withdrawal by Subject|21|||
161638889|NCT03616964|583728673|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
161638890|NCT03616964|583728674|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
161638891|NCT03616964|583728675|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
161638892|NCT03616964|583728673|FG000|Overall Study|Sponsor's Decision|1|||
161638893|NCT03616964|583728674|FG001|Overall Study|Sponsor's Decision|0|||
161638894|NCT03616964|583728675|FG002|Overall Study|Sponsor's Decision|0|||
161638895|NCT03616964|583728673|FG000|Overall Study|Physician Decision|0|||
161638896|NCT03616964|583728674|FG001|Overall Study|Physician Decision|2|||
161638897|NCT03616964|583728675|FG002|Overall Study|Physician Decision|0|||
161638898|NCT03616964|583728673|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
161638899|NCT03616964|583728674|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
161638900|NCT03616964|583728675|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
161638901|NCT03616964|583728673|FG000|Overall Study|Protocol Violation|0|||
161638902|NCT03616964|583728674|FG001|Overall Study|Protocol Violation|1|||
161638903|NCT03616964|583728675|FG002|Overall Study|Protocol Violation|0|||
161638904|NCT03616964|583728673|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
161638905|NCT03616964|583728674|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
161638906|NCT03616964|583728675|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
161638907|NCT03616964|583728673|FG000|Overall Study|Randomized but Never Treated|1|||
161638908|NCT03616964|583728674|FG001|Overall Study|Randomized but Never Treated|1|||
161638909|NCT03616964|583728675|FG002|Overall Study|Randomized but Never Treated|1|||
161638910|NCT04596995|583728676|FG000|Overall Study|Lack of Efficacy|8|||
161638911|NCT04596995|583728676|FG000|Overall Study|Lost to Follow-up|3|||
161638912|NCT04596995|583728676|FG000|Overall Study|Withdrawal by Subject|12|||
161638913|NCT04596995|583728676|FG000|Overall Study|Sponsor decision|3|||
161638914|NCT04596995|583728676|FG000|Overall Study|Enrolled in managed access program|3|||
161638915|NCT00129935|583728677|FG000|Overall Study|Adverse Event|18|||
161638916|NCT00129935|583728678|FG001|Overall Study|Adverse Event|56|||
161638917|NCT00129935|583728677|FG000|Overall Study|Death|1|||
161638918|NCT00129935|583728678|FG001|Overall Study|Death|1|||
161638919|NCT00129935|583728677|FG000|Overall Study|Withdrawal by Subject|7|||
161638920|NCT00129935|583728678|FG001|Overall Study|Withdrawal by Subject|20|||
161638921|NCT00129935|583728677|FG000|Overall Study|Protocol Violation|0|||
161638922|NCT00129935|583728678|FG001|Overall Study|Protocol Violation|4|||
161638923|NCT00129935|583728677|FG000|Overall Study|Physician Decision|3|||
161638924|NCT00129935|583728678|FG001|Overall Study|Physician Decision|4|||
161638925|NCT00129935|583728677|FG000|Overall Study|Recurrence|1|||
161638926|NCT00129935|583728678|FG001|Overall Study|Recurrence|3|||
161638927|NCT00129935|583728677|FG000|Overall Study|Second primary|0|||
161638928|NCT00129935|583728678|FG001|Overall Study|Second primary|1|||
161687290|NCT00640328|583907191|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687291|NCT00640328|583907192|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687292|NCT02374099|583907193|FG000|Overall Study|Adverse Event|1|||
161638929|NCT00129935|583728677|FG000|Overall Study|Other|3|||
161638930|NCT00129935|583728678|FG001|Overall Study|Other|2|||
161638931|NCT00129935|583728677|FG000|Overall Study|Crossed to the other arm|2|||
161638932|NCT00129935|583728678|FG001|Overall Study|Crossed to the other arm|1|||
161638933|NCT00129935|583728677|FG000|Overall Study|Incorrect study treatment|1|||
161638934|NCT00129935|583728678|FG001|Overall Study|Incorrect study treatment|0|||
161638935|NCT00590564|583728680|FG000|Overall Study|Withdrawal by Subject|4|||
161638936|NCT00590564|583728680|FG000|Overall Study|Lost to Follow-up|6|||
161638937|NCT00590564|583728680|FG000|Overall Study|Protocol Violation|1|||
161638938|NCT00590564|583728680|FG000|Overall Study|Patient Found to be Ineligible|1|||
161638939|NCT00590564|583728680|FG000|Overall Study|Patient Non-compliance|6|||
161638940|NCT02056626|583728681|FG000|Overall Study|patient did not follow directions|3|||
161638941|NCT02056626|583728682|FG001|Overall Study|patient did not follow directions|1|||
161638942|NCT02056626|583728683|FG002|Overall Study|patient did not follow directions|0|||
161638943|NCT02056626|583728684|FG003|Overall Study|patient did not follow directions|0|||
161638944|NCT04916002|583728686|FG000|Overall Study|Adverse Event|0|||
161638945|NCT04916002|583728687|FG001|Overall Study|Adverse Event|1|||
161638946|NCT04916002|583728688|FG002|Overall Study|Adverse Event|0|||
161638947|NCT04916002|583728689|FG003|Overall Study|Adverse Event|1|||
161638948|NCT04916002|583728690|FG004|Overall Study|Adverse Event|0|||
161638949|NCT04916002|583728686|FG000|Overall Study|Withdrawal by Subject|3|||
161638950|NCT04916002|583728687|FG001|Overall Study|Withdrawal by Subject|1|||
161638951|NCT04916002|583728688|FG002|Overall Study|Withdrawal by Subject|0|||
161638952|NCT04916002|583728689|FG003|Overall Study|Withdrawal by Subject|1|||
161638953|NCT04916002|583728690|FG004|Overall Study|Withdrawal by Subject|0|||
161638954|NCT04916002|583728686|FG000|Overall Study|Death|8|||
161638955|NCT04916002|583728687|FG001|Overall Study|Death|7|||
161638956|NCT04916002|583728688|FG002|Overall Study|Death|4|||
161638957|NCT04916002|583728689|FG003|Overall Study|Death|9|||
161638958|NCT04916002|583728690|FG004|Overall Study|Death|0|||
161638959|NCT04916002|583728686|FG000|Overall Study|Study Terminated by Sponsor|11|||
161638960|NCT04916002|583728687|FG001|Overall Study|Study Terminated by Sponsor|10|||
161638961|NCT04916002|583728688|FG002|Overall Study|Study Terminated by Sponsor|8|||
161638962|NCT04916002|583728689|FG003|Overall Study|Study Terminated by Sponsor|5|||
161638963|NCT04916002|583728690|FG004|Overall Study|Study Terminated by Sponsor|4|||
161638964|NCT04916002|583728686|FG000|Overall Study|End of trial|1|||
161638965|NCT04916002|583728687|FG001|Overall Study|End of trial|0|||
161638966|NCT04916002|583728688|FG002|Overall Study|End of trial|0|||
161638967|NCT04916002|583728689|FG003|Overall Study|End of trial|0|||
161638968|NCT04916002|583728690|FG004|Overall Study|End of trial|0|||
161638969|NCT04916002|583728686|FG000|Overall Study|Progressive disease|0|||
161638970|NCT04916002|583728687|FG001|Overall Study|Progressive disease|0|||
161638971|NCT04916002|583728688|FG002|Overall Study|Progressive disease|1|||
161638972|NCT04916002|583728689|FG003|Overall Study|Progressive disease|0|||
161638973|NCT04916002|583728690|FG004|Overall Study|Progressive disease|0|||
161638974|NCT04916002|583728686|FG000|Overall Study|Participant non-compliance|2|||
161638975|NCT04916002|583728687|FG001|Overall Study|Participant non-compliance|0|||
161638976|NCT04916002|583728688|FG002|Overall Study|Participant non-compliance|0|||
161638977|NCT04916002|583728689|FG003|Overall Study|Participant non-compliance|0|||
161638978|NCT04916002|583728690|FG004|Overall Study|Participant non-compliance|0|||
161638979|NCT05923112|583728691|FG000|Overall Study|Protocol Violation|4|||
161638980|NCT05923112|583728691|FG000|Overall Study|No informed consent on publication of study results|243|||
161638981|NCT04991766|583728692|FG000|Overall Study|Withdrawal by Subject|2|||
161638982|NCT04991766|583728693|FG001|Overall Study|Withdrawal by Subject|0|||
161638983|NCT05147350|583728699|FG000|Overall Study|Death|2|||
161638984|NCT05147350|583728700|FG001|Overall Study|Death|3|||
161638985|NCT05147350|583728701|FG002|Overall Study|Death|3|||
161638986|NCT05147350|583728702|FG003|Overall Study|Death|2|||
161638987|NCT05147350|583728703|FG004|Overall Study|Death|2|||
161638988|NCT05147350|583728704|FG005|Overall Study|Death|1|||
161638989|NCT05147350|583728705|FG006|Overall Study|Death|1|||
161638990|NCT05147350|583728706|FG007|Overall Study|Death|3|||
161638991|NCT05147350|583728699|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
161638992|NCT05147350|583728700|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
161638993|NCT05147350|583728701|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
161638994|NCT05147350|583728702|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
161638995|NCT05147350|583728703|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
161638996|NCT05147350|583728704|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
161638997|NCT05147350|583728705|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
161638998|NCT05147350|583728706|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
161638999|NCT05147350|583728699|FG000|Overall Study|Withdrawal by Subject|0|||
161639000|NCT05147350|583728700|FG001|Overall Study|Withdrawal by Subject|0|||
161639001|NCT05147350|583728701|FG002|Overall Study|Withdrawal by Subject|3|||
161639002|NCT05147350|583728702|FG003|Overall Study|Withdrawal by Subject|1|||
161639003|NCT05147350|583728703|FG004|Overall Study|Withdrawal by Subject|1|||
161639004|NCT05147350|583728704|FG005|Overall Study|Withdrawal by Subject|0|||
161639005|NCT05147350|583728705|FG006|Overall Study|Withdrawal by Subject|1|||
161639006|NCT05147350|583728706|FG007|Overall Study|Withdrawal by Subject|0|||
161639007|NCT05147350|583728699|FG000|Overall Study|Other Reasons|0|||
161639008|NCT05147350|583728700|FG001|Overall Study|Other Reasons|0|||
161639009|NCT05147350|583728701|FG002|Overall Study|Other Reasons|2|||
161639010|NCT05147350|583728702|FG003|Overall Study|Other Reasons|0|||
161639011|NCT05147350|583728703|FG004|Overall Study|Other Reasons|0|||
161639012|NCT05147350|583728704|FG005|Overall Study|Other Reasons|2|||
161639013|NCT05147350|583728705|FG006|Overall Study|Other Reasons|1|||
161639014|NCT05147350|583728706|FG007|Overall Study|Other Reasons|1|||
161639015|NCT06136897|583728707|FG000|Overall Study|Ineligible|3|||
161639016|NCT06136897|583728707|FG000|Overall Study|Mutation status not confirmed|7|||
161639017|NCT06136897|583728707|FG000|Overall Study|Adverse Event|2|||
161639018|NCT06136897|583728707|FG000|Overall Study|Death|1|||
161639019|NCT06136897|583728707|FG000|Overall Study|Disease progression|18|||
161639020|NCT06136897|583728707|FG000|Overall Study|Other complicating disease|1|||
161639021|NCT06136897|583728707|FG000|Overall Study|Withdrawal by Subject|1|||
161639022|NCT06136897|583728707|FG000|Overall Study|Still on treatment|1|||
161639023|NCT06136897|583728707|FG000|Overall Study|Lost to Follow-up|1|||
161639024|NCT00857233|583728711|FG000|Overall Study|Adverse Event|24|||
161639025|NCT00857233|583728711|FG000|Overall Study|Lack of Efficacy|1|||
161639026|NCT00857233|583728711|FG000|Overall Study|Non-compliance|1|||
161639027|NCT00857233|583728711|FG000|Overall Study|Withdrawal of Consent|9|||
161639028|NCT00857233|583728711|FG000|Overall Study|Lost to Follow-up|4|||
161639029|NCT00857233|583728711|FG000|Overall Study|Nursing Home Placement|14|||
161639030|NCT00857233|583728711|FG000|Overall Study|Other Reasons|2|||
161639031|NCT01560871|583728712|FG000|Overall Study|transportation issues|2|||
161639032|NCT01560871|583728713|FG001|Overall Study|transportation issues|1|||
161639033|NCT01560871|583728712|FG000|Overall Study|relocation|1|||
161639034|NCT01560871|583728713|FG001|Overall Study|relocation|0|||
161639035|NCT01560871|583728712|FG000|Overall Study|readmission to a hospital|2|||
161639036|NCT01560871|583728713|FG001|Overall Study|readmission to a hospital|1|||
161639037|NCT01560871|583728712|FG000|Overall Study|Lost to Follow-up|1|||
161639038|NCT01560871|583728713|FG001|Overall Study|Lost to Follow-up|0|||
161639039|NCT01587118|583728714|FG000|Overall Study|Adverse Event|3|||
161639040|NCT01587118|583728714|FG000|Overall Study|Lost to Follow-up|2|||
161639041|NCT01587118|583728714|FG000|Overall Study|Relocation|1|||
161639042|NCT01587118|583728714|FG000|Overall Study|nonresponse|1|||
161639043|NCT01278615|583728716|FG000|Overall Study|Withdrawal by Subject|2|||
161639044|NCT00224029|583728718|FG000|Overall Study|Lost to Follow-up|1|||
161639045|NCT00224029|583728718|FG000|Overall Study|Withdrawal by Subject|4|||
161639046|NCT00224029|583728718|FG000|Overall Study|Other|1|||
161639047|NCT00243022|583728719|FG000|Overall Study|Withdrawal by Subject|1|||
161639048|NCT00243022|583728720|FG001|Overall Study|Withdrawal by Subject|0|||
161639049|NCT00243022|583728719|FG000|Overall Study|Death|1|||
161639050|NCT00243022|583728720|FG001|Overall Study|Death|0|||
161639051|NCT00243022|583728719|FG000|Overall Study|Difficult Travel Distance|0|||
161639052|NCT00243022|583728720|FG001|Overall Study|Difficult Travel Distance|1|||
161639053|NCT01099579|583728721|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
161639054|NCT01099579|583728722|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
161639055|NCT01099579|583728723|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
161639056|NCT01099579|583728721|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
161639057|NCT01099579|583728722|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
161639058|NCT01099579|583728723|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
161639059|NCT01099579|583728721|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
161639060|NCT01099579|583728722|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
161639061|NCT01099579|583728723|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
161639062|NCT01099579|583728721|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
161639063|NCT01099579|583728722|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
161639064|NCT01099579|583728723|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
161639065|NCT01099579|583728721|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
161639066|NCT01099579|583728722|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
161639067|NCT01099579|583728723|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
161639068|NCT01099579|583728721|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161639069|NCT01099579|583728722|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161639070|NCT01099579|583728723|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161639071|NCT01099579|583728721|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
161639072|NCT01099579|583728722|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
161639073|NCT01099579|583728723|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
161639074|NCT01099579|583728721|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
161639075|NCT01099579|583728722|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
161639076|NCT01099579|583728723|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
161639077|NCT01099579|583728721|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
161639078|NCT01099579|583728722|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
161639079|NCT01099579|583728723|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
161639080|NCT01099579|583728721|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
161639081|NCT01099579|583728722|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
161639082|NCT01099579|583728723|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
161639083|NCT02569957|583728724|FG000|Overall Study|Withdrawal by Subject|0|||
161639084|NCT02569957|583728725|FG001|Overall Study|Withdrawal by Subject|1|||
161639085|NCT04788511|583728728|FG000|Overall Study|Withdrawal by Subject|2|||
161639086|NCT04788511|583728729|FG001|Overall Study|Withdrawal by Subject|1|||
161639087|NCT04788511|583728728|FG000|Overall Study|Lost to Follow-up|2|||
161639088|NCT04788511|583728729|FG001|Overall Study|Lost to Follow-up|7|||
161639089|NCT04788511|583728728|FG000|Overall Study|Death|3|||
161639090|NCT04788511|583728729|FG001|Overall Study|Death|4|||
161639091|NCT03174782|583728730|FG000|Overall Study|Protocol Violation|1|||
161639092|NCT03174782|583728731|FG001|Overall Study|Protocol Violation|0|||
161687293|NCT02374099|583907194|FG001|Overall Study|Adverse Event|0|||
161639093|NCT03174782|583728730|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
161639094|NCT03174782|583728731|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
161639095|NCT00778921|583728732|FG000|Overall Study|Adverse Event|9|||
161639096|NCT00778921|583728733|FG001|Overall Study|Adverse Event|10|||
161639097|NCT00778921|583728734|FG002|Overall Study|Adverse Event|14|||
161639098|NCT00778921|583728732|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161639099|NCT00778921|583728733|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
161639100|NCT00778921|583728734|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161639101|NCT00778921|583728732|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
161639102|NCT00778921|583728733|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161639103|NCT00778921|583728734|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
161639104|NCT00778921|583728732|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161639105|NCT00778921|583728733|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
161639106|NCT00778921|583728734|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
161639107|NCT00778921|583728732|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
161639108|NCT00778921|583728733|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
161639109|NCT00778921|583728734|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
161639110|NCT00778921|583728732|FG000|Overall Study|Patient withdrew request|3|||
161639111|NCT00778921|583728733|FG001|Overall Study|Patient withdrew request|1|||
161639112|NCT00778921|583728734|FG002|Overall Study|Patient withdrew request|6|||
161639113|NCT00778921|583728732|FG000|Overall Study|Lost to Follow-up|0|||
161639114|NCT00778921|583728733|FG001|Overall Study|Lost to Follow-up|2|||
161639115|NCT00778921|583728734|FG002|Overall Study|Lost to Follow-up|1|||
161639116|NCT00778921|583728732|FG000|Overall Study|Administrative Problems|1|||
161639117|NCT00778921|583728733|FG001|Overall Study|Administrative Problems|2|||
161639118|NCT00778921|583728734|FG002|Overall Study|Administrative Problems|0|||
161639119|NCT00778921|583728732|FG000|Overall Study|Protocol Violation|3|||
161639120|NCT00778921|583728733|FG001|Overall Study|Protocol Violation|0|||
161639121|NCT00778921|583728734|FG002|Overall Study|Protocol Violation|2|||
161639122|NCT00778921|583728732|FG000|Overall Study|Not treated|0|||
161639123|NCT00778921|583728733|FG001|Overall Study|Not treated|2|||
161639124|NCT00778921|583728734|FG002|Overall Study|Not treated|2|||
161639125|NCT03178045|583728735|FG000|Overall Study|Withdrawal by Subject|5|||
161639126|NCT03178045|583728736|FG001|Overall Study|Withdrawal by Subject|7|||
161639127|NCT03178045|583728735|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
161639128|NCT03178045|583728736|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
161639129|NCT03178045|583728735|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
161639130|NCT03178045|583728736|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
161639131|NCT01078922|583728737|FG000|Overall Study|Adverse Event|1|||
161639132|NCT02353468|583728738|FG000|Overall Study|Study terminated|3|||
161639133|NCT00003477|583728741|FG000|Overall Study|Not evalauable|4|||
161639134|NCT00798304|583728742|FG000|Overall Study|Adverse Event|0|||
161639135|NCT00798304|583728743|FG001|Overall Study|Adverse Event|1|||
161639136|NCT00798304|583728744|FG002|Overall Study|Adverse Event|1|||
161639137|NCT00798304|583728742|FG000|Overall Study|Discontinuation by Sponsor|14|||
161639138|NCT00798304|583728743|FG001|Overall Study|Discontinuation by Sponsor|21|||
161639139|NCT00798304|583728744|FG002|Overall Study|Discontinuation by Sponsor|9|||
161639140|NCT02031536|583728745|FG000|Overall Study|ineligible|1|||
161639141|NCT02031536|583728746|FG001|Overall Study|ineligible|0|||
161639142|NCT04206085|583728748|FG000|Overall Study|Lost to Follow-up|0|||
161687294|NCT02374099|583907193|FG000|Overall Study|Progressive Disease|35|||
161687295|NCT02374099|583907194|FG001|Overall Study|Progressive Disease|40|||
161687296|NCT02374099|583907193|FG000|Overall Study|Withdrawal by Subject|5|||
161687297|NCT02374099|583907194|FG001|Overall Study|Withdrawal by Subject|1|||
161687298|NCT02374099|583907193|FG000|Overall Study|Miscellaneous|2|||
161687299|NCT02374099|583907194|FG001|Overall Study|Miscellaneous|3|||
161835185|NCT04459715|584437259|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
161639143|NCT04206085|583728749|FG001|Overall Study|Lost to Follow-up|1|||
161639144|NCT04206085|583728750|FG002|Overall Study|Lost to Follow-up|0|||
161639145|NCT04206085|583728748|FG000|Overall Study|Lost to Follow-up|0|||
161639146|NCT04206085|583728749|FG001|Overall Study|Lost to Follow-up|0|||
161639147|NCT04206085|583728750|FG002|Overall Study|Lost to Follow-up|1|||
161639148|NCT03845023|583728751|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
161639149|NCT03845023|583728752|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
161639150|NCT03845023|583728753|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
161639151|NCT03845023|583728754|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
161687300|NCT02374099|583907193|FG000|Overall Study|Randomized, but not treated|2|||
161639152|NCT03845023|583728751|FG000|Follow-Up (14 Days)|Adverse Event|0|||
161639153|NCT03845023|583728752|FG001|Follow-Up (14 Days)|Adverse Event|0|||
161639154|NCT03845023|583728753|FG002|Follow-Up (14 Days)|Adverse Event|1|||
161639155|NCT03845023|583728754|FG003|Follow-Up (14 Days)|Adverse Event|1|||
161639156|NCT02658175|583728755|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
161639157|NCT02658175|583728756|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
161639158|NCT02658175|583728757|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
161639159|NCT02658175|583728755|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
161639160|NCT02658175|583728756|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
161639161|NCT02658175|583728757|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
161639162|NCT02658175|583728755|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
161639163|NCT02658175|583728756|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
161639164|NCT02658175|583728757|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
161639165|NCT02658175|583728755|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
161639166|NCT02658175|583728756|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
161639167|NCT02658175|583728757|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
161639168|NCT02658175|583728755|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
161639169|NCT02658175|583728756|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
161639170|NCT02658175|583728757|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
161639171|NCT02658175|583728755|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
161639172|NCT02658175|583728756|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
161639173|NCT02658175|583728757|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
161639174|NCT02658175|583728755|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
161639175|NCT02658175|583728756|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
161639176|NCT02658175|583728757|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
161639177|NCT02658175|583728755|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
161639178|NCT02658175|583728756|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
161639179|NCT02658175|583728757|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
161639180|NCT02658175|583728755|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
161639181|NCT02658175|583728756|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
161639182|NCT02658175|583728757|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
161639183|NCT02658175|583728755|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
161639184|NCT02658175|583728756|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
161639185|NCT02658175|583728757|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
161639186|NCT02918292|583728761|FG000|Study Enrollment Prior to Transplant|Death|1|||
161639187|NCT02918292|583728761|FG000|Study Follow up After Transplant|Death|6|||
161639188|NCT02165826|583728765|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
161639189|NCT02165826|583728766|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
161639190|NCT02165826|583728767|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
161639191|NCT02165826|583728765|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
161639192|NCT02165826|583728766|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
161639193|NCT02165826|583728767|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
161639194|NCT02165826|583728765|FG000|Main Treatment Period|Lost to Follow-up|4|||
161639195|NCT02165826|583728766|FG001|Main Treatment Period|Lost to Follow-up|2|||
161639196|NCT02165826|583728767|FG002|Main Treatment Period|Lost to Follow-up|1|||
161639197|NCT02165826|583728765|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
161639198|NCT02165826|583728766|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
161639199|NCT02165826|583728767|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
161639200|NCT02165826|583728765|FG000|Main Treatment Period|Lack of Efficacy|2|||
161639201|NCT02165826|583728766|FG001|Main Treatment Period|Lack of Efficacy|0|||
161639202|NCT02165826|583728767|FG002|Main Treatment Period|Lack of Efficacy|0|||
161639203|NCT02165826|583728765|FG000|Main Treatment Period|Reason Not Specified|8|||
161639204|NCT02165826|583728766|FG001|Main Treatment Period|Reason Not Specified|5|||
161639205|NCT02165826|583728767|FG002|Main Treatment Period|Reason Not Specified|16|||
161639206|NCT02165826|583728765|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
161639207|NCT02165826|583728766|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
161639208|NCT02165826|583728767|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
161639209|NCT02165826|583728765|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
161639210|NCT02165826|583728766|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
161639211|NCT02165826|583728767|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
161639212|NCT02165826|583728765|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
161639213|NCT02165826|583728766|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
161639214|NCT02165826|583728767|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
161639215|NCT02165826|583728765|FG000|Down-Titration Period|Reason Not Specified|1|||
161639216|NCT02165826|583728766|FG001|Down-Titration Period|Reason Not Specified|0|||
161639217|NCT02165826|583728767|FG002|Down-Titration Period|Reason Not Specified|2|||
161639218|NCT02636608|583728771|FG000|Overall Study|Failure to Return|4|||
161639219|NCT02636608|583728771|FG000|Overall Study|Insufficient Virological Response|1|||
161639220|NCT02636608|583728771|FG000|Overall Study|Death|3|||
161639221|NCT02636608|583728771|FG000|Overall Study|Other|2|||
161639222|NCT02636608|583728771|FG000|Overall Study|Did Not Receive Treatment|1|||
161639223|NCT04913948|583728773|FG000|Overall Study|Withdrawal by Subject|2|||
161639224|NCT04913948|583728773|FG000|Overall Study|Sample processing issues|1|||
161639225|NCT04913948|583728773|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
161639226|NCT05739994|583728777|FG000|Overall Study|Withdrawal by Subject|2|||
161639227|NCT05739994|583728778|FG001|Overall Study|Withdrawal by Subject|2|||
161639228|NCT05739994|583728779|FG002|Overall Study|Withdrawal by Subject|4|||
161639229|NCT00815919|583728780|FG000|Overall Study|Unrelated Fungal Infection|1|||
161639230|NCT00815919|583728780|FG000|Overall Study|AML Relapse|1|||
161639231|NCT00815919|583728780|FG000|Overall Study|Lack of Efficacy|2|||
161639232|NCT04750577|583728781|FG000|Overall Study|Adverse Event|2|||
161639233|NCT04750577|583728782|FG001|Overall Study|Adverse Event|10|||
161639234|NCT04750577|583728783|FG002|Overall Study|Adverse Event|8|||
161639235|NCT04750577|583728784|FG003|Overall Study|Adverse Event|1|||
161639236|NCT04750577|583728781|FG000|Overall Study|Change of residence|0|||
161639237|NCT04750577|583728782|FG001|Overall Study|Change of residence|0|||
161639238|NCT04750577|583728783|FG002|Overall Study|Change of residence|1|||
161639239|NCT04750577|583728784|FG003|Overall Study|Change of residence|0|||
161639240|NCT04750577|583728781|FG000|Overall Study|Burden of study procedures|0|||
161639241|NCT04750577|583728782|FG001|Overall Study|Burden of study procedures|2|||
161639242|NCT04750577|583728783|FG002|Overall Study|Burden of study procedures|2|||
161639243|NCT04750577|583728784|FG003|Overall Study|Burden of study procedures|0|||
161639244|NCT04750577|583728781|FG000|Overall Study|Prematurely discontinued|0|||
161639245|NCT04750577|583728782|FG001|Overall Study|Prematurely discontinued|0|||
161639246|NCT04750577|583728783|FG002|Overall Study|Prematurely discontinued|0|||
161639247|NCT04750577|583728784|FG003|Overall Study|Prematurely discontinued|2|||
161639248|NCT04750577|583728781|FG000|Overall Study|Protocol deviation|1|||
161639249|NCT04750577|583728782|FG001|Overall Study|Protocol deviation|1|||
161639250|NCT04750577|583728783|FG002|Overall Study|Protocol deviation|1|||
161639251|NCT04750577|583728784|FG003|Overall Study|Protocol deviation|1|||
161639252|NCT04750577|583728781|FG000|Overall Study|Other than listed|3|||
161639253|NCT04750577|583728782|FG001|Overall Study|Other than listed|2|||
161639254|NCT04750577|583728783|FG002|Overall Study|Other than listed|2|||
161639255|NCT04750577|583728784|FG003|Overall Study|Other than listed|1|||
161639256|NCT04750577|583728781|FG000|Overall Study|Not treated|0|||
161639257|NCT04750577|583728782|FG001|Overall Study|Not treated|0|||
161639258|NCT04750577|583728783|FG002|Overall Study|Not treated|0|||
161639259|NCT04750577|583728784|FG003|Overall Study|Not treated|2|||
161639260|NCT02473042|583728786|FG000|Overall Study|Withdrawal by Subject|1|||
161639261|NCT02473042|583728787|FG001|Overall Study|Withdrawal by Subject|0|||
161639262|NCT02473042|583728786|FG000|Overall Study|Patient became ineligible after enrollment|2|||
161639263|NCT02473042|583728787|FG001|Overall Study|Patient became ineligible after enrollment|5|||
161639264|NCT02473042|583728786|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
161639265|NCT02473042|583728787|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
161639266|NCT02473042|583728786|FG000|Overall Study|PACU data unable to be collected|3|||
161639267|NCT02473042|583728787|FG001|Overall Study|PACU data unable to be collected|0|||
161639268|NCT04680637|583728790|FG000|Overall Study|Lost to Follow-up|0|||
161639269|NCT04680637|583728791|FG001|Overall Study|Lost to Follow-up|1|||
161639270|NCT04680637|583728792|FG002|Overall Study|Lost to Follow-up|0|||
161639271|NCT04680637|583728793|FG003|Overall Study|Lost to Follow-up|1|||
161639272|NCT04680637|583728790|FG000|Overall Study|Death|1|||
161639273|NCT04680637|583728791|FG001|Overall Study|Death|0|||
161639274|NCT04680637|583728792|FG002|Overall Study|Death|0|||
161639275|NCT04680637|583728793|FG003|Overall Study|Death|0|||
161639276|NCT04680637|583728790|FG000|Overall Study|Withdrawal by Subject|7|||
161639277|NCT04680637|583728791|FG001|Overall Study|Withdrawal by Subject|10|||
161639278|NCT04680637|583728792|FG002|Overall Study|Withdrawal by Subject|17|||
161639279|NCT04680637|583728793|FG003|Overall Study|Withdrawal by Subject|15|||
161639280|NCT04680637|583728790|FG000|Overall Study|Decision by Sponsor|21|||
161639281|NCT04680637|583728791|FG001|Overall Study|Decision by Sponsor|15|||
161639282|NCT04680637|583728792|FG002|Overall Study|Decision by Sponsor|7|||
161639283|NCT04680637|583728793|FG003|Overall Study|Decision by Sponsor|32|||
161639284|NCT01103232|583728796|FG000|Overall Study|Withdrawal by Subject|1|||
161639285|NCT01103232|583728797|FG001|Overall Study|Withdrawal by Subject|1|||
161639286|NCT01103232|583728796|FG000|Overall Study|Protocol Violation|0|||
161639287|NCT01103232|583728797|FG001|Overall Study|Protocol Violation|1|||
161639288|NCT00443599|583728798|FG000|Overall Study|Physician Decision|2|||
161639289|NCT00443599|583728799|FG001|Overall Study|Physician Decision|1|||
161639290|NCT00443599|583728798|FG000|Overall Study|Death|1|||
161639291|NCT00443599|583728799|FG001|Overall Study|Death|1|||
161639292|NCT00443599|583728798|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
161639293|NCT00443599|583728799|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
161639294|NCT05093504|583728800|FG000|Overall Study|Death|0|||
161639295|NCT05093504|583728801|FG001|Overall Study|Death|1|||
161639296|NCT03151551|583728802|FG000|Open-Label Treatment Period|Adverse Event|0|||
161639297|NCT03151551|583728803|FG001|Open-Label Treatment Period|Adverse Event|2|||
161639298|NCT03151551|583728802|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
161639299|NCT03151551|583728803|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
161639300|NCT03151551|583728802|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
161639301|NCT03151551|583728803|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
161639302|NCT03151551|583728802|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
161639303|NCT03151551|583728803|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
161639304|NCT03151551|583728802|FG000|Open-Label Treatment Period|Physician Decision|3|||
161639305|NCT03151551|583728803|FG001|Open-Label Treatment Period|Physician Decision|0|||
161639306|NCT03151551|583728802|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
161639307|NCT03151551|583728803|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
161639308|NCT03151551|583728802|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
161639309|NCT03151551|583728803|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
161639310|NCT03151551|583728802|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
161639311|NCT03151551|583728803|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161639312|NCT03151551|583728802|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
161639313|NCT03151551|583728803|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
161639314|NCT03151551|583728802|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
161639315|NCT03151551|583728803|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
161639316|NCT01190449|583728804|FG000|Overall Study|Ineligible|0|||
161639317|NCT01190449|583728805|FG001|Overall Study|Ineligible|4|||
161639318|NCT02035696|583730848|FG000|Overall Study|Lost to Follow-up|0|||
161639319|NCT02035696|583730849|FG001|Overall Study|Lost to Follow-up|3|||
161639320|NCT02035696|583730850|FG002|Overall Study|Lost to Follow-up|1|||
161639321|NCT02035696|583730851|FG003|Overall Study|Lost to Follow-up|2|||
161639322|NCT02035696|583730848|FG000|Overall Study|Withdrawal by Subject|3|||
161639323|NCT02035696|583730849|FG001|Overall Study|Withdrawal by Subject|0|||
161639324|NCT02035696|583730850|FG002|Overall Study|Withdrawal by Subject|2|||
161639325|NCT02035696|583730851|FG003|Overall Study|Withdrawal by Subject|1|||
161639326|NCT01246999|583730852|FG000|Overall Study|Lost to Follow-up|0|||
161639327|NCT01246999|583730853|FG001|Overall Study|Lost to Follow-up|1|||
161639328|NCT01246999|583730854|FG002|Overall Study|Lost to Follow-up|0|||
161639329|NCT01246999|583730855|FG003|Overall Study|Lost to Follow-up|0|||
161639330|NCT01246999|583730852|FG000|Overall Study|Withdrawal by Subject|0|||
161639331|NCT01246999|583730853|FG001|Overall Study|Withdrawal by Subject|0|||
161639332|NCT01246999|583730854|FG002|Overall Study|Withdrawal by Subject|0|||
161639333|NCT01246999|583730855|FG003|Overall Study|Withdrawal by Subject|2|||
161639334|NCT01867047|583730856|FG000|Overall Study|Lost to Follow-up|3|||
161639335|NCT01867047|583730857|FG001|Overall Study|Lost to Follow-up|3|||
161639336|NCT01867047|583730856|FG000|Overall Study|Withdrawal by Subject|2|||
161639337|NCT01867047|583730857|FG001|Overall Study|Withdrawal by Subject|0|||
161639338|NCT01867047|583730856|FG000|Overall Study|Physician Decision|2|||
161639339|NCT01867047|583730857|FG001|Overall Study|Physician Decision|0|||
161639340|NCT01867047|583730856|FG000|Overall Study|surgery not indicated in protocol|1|||
161639341|NCT01867047|583730857|FG001|Overall Study|surgery not indicated in protocol|2|||
161639342|NCT00307047|583730858|FG000|Overall Study|Lost to Follow-up|35|||
161639343|NCT00307047|583730859|FG001|Overall Study|Lost to Follow-up|24|||
161639344|NCT00307047|583730858|FG000|Overall Study|Withdrawal by Subject|6|||
161639345|NCT00307047|583730859|FG001|Overall Study|Withdrawal by Subject|6|||
161639346|NCT00307047|583730858|FG000|Overall Study|Physician Decision|1|||
161639347|NCT00307047|583730859|FG001|Overall Study|Physician Decision|2|||
161639348|NCT00307047|583730858|FG000|Overall Study|Lost to follow-up for other reasons|0|||
161639349|NCT00307047|583730859|FG001|Overall Study|Lost to follow-up for other reasons|1|||
161639350|NCT00307047|583730858|FG000|Overall Study|All death, all MI, all Revascularization|27|||
161639351|NCT00307047|583730859|FG001|Overall Study|All death, all MI, all Revascularization|16|||
161639352|NCT00379769|583730860|FG000|Main Study|Death|57|||
161639353|NCT00379769|583730861|FG001|Main Study|Death|67|||
161639354|NCT00379769|583730862|FG002|Main Study|Death|54|||
161639355|NCT00379769|583730863|FG003|Main Study|Death|72|||
161639356|NCT00379769|583730864|FG004|Main Study|Death|0|||
161639357|NCT00379769|583730865|FG005|Main Study|Death|0|||
161639358|NCT00379769|583730860|FG000|Main Study|Adverse Event|5|||
161639359|NCT00379769|583730861|FG001|Main Study|Adverse Event|8|||
161639360|NCT00379769|583730862|FG002|Main Study|Adverse Event|10|||
161639361|NCT00379769|583730863|FG003|Main Study|Adverse Event|11|||
161639362|NCT00379769|583730864|FG004|Main Study|Adverse Event|0|||
161639363|NCT00379769|583730865|FG005|Main Study|Adverse Event|0|||
161639364|NCT00379769|583730860|FG000|Main Study|Lost to Follow-up|29|||
161639365|NCT00379769|583730861|FG001|Main Study|Lost to Follow-up|29|||
161639366|NCT00379769|583730862|FG002|Main Study|Lost to Follow-up|25|||
161639367|NCT00379769|583730863|FG003|Main Study|Lost to Follow-up|26|||
161639368|NCT00379769|583730864|FG004|Main Study|Lost to Follow-up|0|||
161639369|NCT00379769|583730865|FG005|Main Study|Lost to Follow-up|0|||
161639370|NCT00379769|583730860|FG000|Main Study|Withdrawal by Subject|46|||
161639371|NCT00379769|583730861|FG001|Main Study|Withdrawal by Subject|56|||
161639372|NCT00379769|583730862|FG002|Main Study|Withdrawal by Subject|72|||
161639373|NCT00379769|583730863|FG003|Main Study|Withdrawal by Subject|70|||
161639374|NCT00379769|583730864|FG004|Main Study|Withdrawal by Subject|0|||
161639375|NCT00379769|583730865|FG005|Main Study|Withdrawal by Subject|0|||
161639376|NCT00379769|583730860|FG000|Main Study|Moved to survival status follow-up only|27|||
161639377|NCT00379769|583730861|FG001|Main Study|Moved to survival status follow-up only|25|||
161639378|NCT00379769|583730862|FG002|Main Study|Moved to survival status follow-up only|32|||
161639379|NCT00379769|583730863|FG003|Main Study|Moved to survival status follow-up only|36|||
161639380|NCT00379769|583730864|FG004|Main Study|Moved to survival status follow-up only|0|||
161639381|NCT00379769|583730865|FG005|Main Study|Moved to survival status follow-up only|0|||
161639382|NCT00379769|583730860|FG000|Main Study|Participant moved|3|||
161639383|NCT00379769|583730861|FG001|Main Study|Participant moved|2|||
161639384|NCT00379769|583730862|FG002|Main Study|Participant moved|3|||
161639385|NCT00379769|583730863|FG003|Main Study|Participant moved|3|||
161639386|NCT00379769|583730864|FG004|Main Study|Participant moved|0|||
161639387|NCT00379769|583730865|FG005|Main Study|Participant moved|0|||
161639388|NCT00379769|583730860|FG000|Main Study|Poor compliance|3|||
161639389|NCT00379769|583730861|FG001|Main Study|Poor compliance|2|||
161639390|NCT00379769|583730862|FG002|Main Study|Poor compliance|2|||
161639391|NCT00379769|583730863|FG003|Main Study|Poor compliance|1|||
161639392|NCT00379769|583730864|FG004|Main Study|Poor compliance|0|||
161639393|NCT00379769|583730865|FG005|Main Study|Poor compliance|0|||
161639394|NCT00379769|583730860|FG000|Main Study|Prohibited glucose lowering medication|0|||
161639395|NCT00379769|583730861|FG001|Main Study|Prohibited glucose lowering medication|3|||
161639396|NCT00379769|583730862|FG002|Main Study|Prohibited glucose lowering medication|0|||
161639397|NCT00379769|583730863|FG003|Main Study|Prohibited glucose lowering medication|1|||
161639398|NCT00379769|583730864|FG004|Main Study|Prohibited glucose lowering medication|0|||
161639399|NCT00379769|583730865|FG005|Main Study|Prohibited glucose lowering medication|0|||
161639400|NCT00379769|583730860|FG000|Main Study|Site closed|4|||
161639401|NCT00379769|583730861|FG001|Main Study|Site closed|4|||
161639402|NCT00379769|583730862|FG002|Main Study|Site closed|4|||
161639403|NCT00379769|583730863|FG003|Main Study|Site closed|8|||
161639404|NCT00379769|583730864|FG004|Main Study|Site closed|0|||
161639405|NCT00379769|583730865|FG005|Main Study|Site closed|0|||
161639406|NCT00379769|583730860|FG000|Main Study|Entry criteria violation|0|||
161639407|NCT00379769|583730861|FG001|Main Study|Entry criteria violation|0|||
161639408|NCT00379769|583730862|FG002|Main Study|Entry criteria violation|1|||
161639409|NCT00379769|583730863|FG003|Main Study|Entry criteria violation|1|||
161639410|NCT00379769|583730864|FG004|Main Study|Entry criteria violation|0|||
161639411|NCT00379769|583730865|FG005|Main Study|Entry criteria violation|0|||
161639412|NCT00379769|583730860|FG000|Main Study|Participant did not take study drug|0|||
161639413|NCT00379769|583730861|FG001|Main Study|Participant did not take study drug|0|||
161639414|NCT00379769|583730862|FG002|Main Study|Participant did not take study drug|1|||
161639415|NCT00379769|583730863|FG003|Main Study|Participant did not take study drug|0|||
161639416|NCT00379769|583730864|FG004|Main Study|Participant did not take study drug|0|||
161639417|NCT00379769|583730865|FG005|Main Study|Participant did not take study drug|0|||
161639418|NCT00379769|583730860|FG000|Main Study|Physician Decision|2|||
161639419|NCT00379769|583730861|FG001|Main Study|Physician Decision|2|||
161639420|NCT00379769|583730862|FG002|Main Study|Physician Decision|1|||
161639421|NCT00379769|583730863|FG003|Main Study|Physician Decision|1|||
161639422|NCT00379769|583730864|FG004|Main Study|Physician Decision|0|||
161639423|NCT00379769|583730865|FG005|Main Study|Physician Decision|0|||
161639424|NCT00379769|583730860|FG000|Main Study|Participant completed study at visit 27|1|||
161639425|NCT00379769|583730861|FG001|Main Study|Participant completed study at visit 27|0|||
161639426|NCT00379769|583730862|FG002|Main Study|Participant completed study at visit 27|0|||
161639427|NCT00379769|583730863|FG003|Main Study|Participant completed study at visit 27|0|||
161639428|NCT00379769|583730864|FG004|Main Study|Participant completed study at visit 27|0|||
161639429|NCT00379769|583730865|FG005|Main Study|Participant completed study at visit 27|0|||
161639430|NCT00379769|583730860|FG000|Main Study|Personal reasons|1|||
161639431|NCT00379769|583730861|FG001|Main Study|Personal reasons|0|||
161639432|NCT00379769|583730862|FG002|Main Study|Personal reasons|0|||
161687301|NCT02374099|583907194|FG001|Overall Study|Randomized, but not treated|1|||
161687302|NCT02374099|583907193|FG000|Overall Study|Study Terminated by Sponsor|3|||
161687303|NCT02374099|583907194|FG001|Overall Study|Study Terminated by Sponsor|4|||
161687304|NCT01033825|583907195|FG000|Overall Study|Withdrawal by Subject|2|||
161687305|NCT01033825|583907196|FG001|Overall Study|Withdrawal by Subject|3|||
161639433|NCT00379769|583730863|FG003|Main Study|Personal reasons|0|||
161639434|NCT00379769|583730864|FG004|Main Study|Personal reasons|0|||
161639435|NCT00379769|583730865|FG005|Main Study|Personal reasons|0|||
161639436|NCT00379769|583730860|FG000|Main Study|Risk of heart failure|0|||
161639437|NCT00379769|583730861|FG001|Main Study|Risk of heart failure|1|||
161639438|NCT00379769|583730862|FG002|Main Study|Risk of heart failure|0|||
161639439|NCT00379769|583730863|FG003|Main Study|Risk of heart failure|0|||
161639440|NCT00379769|583730864|FG004|Main Study|Risk of heart failure|0|||
161639441|NCT00379769|583730865|FG005|Main Study|Risk of heart failure|0|||
161639442|NCT00379769|583730860|FG000|Main Study|Investigator refused to log temperature|0|||
161639443|NCT00379769|583730861|FG001|Main Study|Investigator refused to log temperature|0|||
161639444|NCT00379769|583730862|FG002|Main Study|Investigator refused to log temperature|1|||
161639445|NCT00379769|583730863|FG003|Main Study|Investigator refused to log temperature|0|||
161639446|NCT00379769|583730864|FG004|Main Study|Investigator refused to log temperature|0|||
161639447|NCT00379769|583730865|FG005|Main Study|Investigator refused to log temperature|0|||
161639448|NCT00379769|583730860|FG000|Main Study|Reason unspecified|0|||
161639449|NCT00379769|583730861|FG001|Main Study|Reason unspecified|0|||
161639450|NCT00379769|583730862|FG002|Main Study|Reason unspecified|1|||
161639451|NCT00379769|583730863|FG003|Main Study|Reason unspecified|0|||
161639452|NCT00379769|583730864|FG004|Main Study|Reason unspecified|0|||
161639453|NCT00379769|583730865|FG005|Main Study|Reason unspecified|0|||
161639454|NCT00379769|583730860|FG000|Observational Follow-up|Death|0|||
161639455|NCT00379769|583730861|FG001|Observational Follow-up|Death|0|||
161639456|NCT00379769|583730862|FG002|Observational Follow-up|Death|0|||
161639457|NCT00379769|583730863|FG003|Observational Follow-up|Death|0|||
161639458|NCT00379769|583730864|FG004|Observational Follow-up|Death|78|||
161639459|NCT00379769|583730865|FG005|Observational Follow-up|Death|70|||
161639460|NCT00379769|583730860|FG000|Observational Follow-up|Adverse Event|0|||
161639461|NCT00379769|583730861|FG001|Observational Follow-up|Adverse Event|0|||
161639462|NCT00379769|583730862|FG002|Observational Follow-up|Adverse Event|0|||
161639463|NCT00379769|583730863|FG003|Observational Follow-up|Adverse Event|0|||
161835186|NCT04459715|584437260|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
161835187|NCT04459715|584437259|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
161835188|NCT04459715|584437260|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
161639464|NCT00379769|583730864|FG004|Observational Follow-up|Adverse Event|1|||
161639465|NCT00379769|583730865|FG005|Observational Follow-up|Adverse Event|0|||
161639466|NCT00379769|583730860|FG000|Observational Follow-up|Lost to Follow-up|0|||
161639467|NCT00379769|583730861|FG001|Observational Follow-up|Lost to Follow-up|0|||
161639468|NCT00379769|583730862|FG002|Observational Follow-up|Lost to Follow-up|0|||
161639469|NCT00379769|583730863|FG003|Observational Follow-up|Lost to Follow-up|0|||
161639470|NCT00379769|583730864|FG004|Observational Follow-up|Lost to Follow-up|25|||
161639471|NCT00379769|583730865|FG005|Observational Follow-up|Lost to Follow-up|27|||
161639472|NCT00379769|583730860|FG000|Observational Follow-up|Withdrawal by Subject|0|||
161639473|NCT00379769|583730861|FG001|Observational Follow-up|Withdrawal by Subject|0|||
161639474|NCT00379769|583730862|FG002|Observational Follow-up|Withdrawal by Subject|0|||
161639475|NCT00379769|583730863|FG003|Observational Follow-up|Withdrawal by Subject|0|||
161639476|NCT00379769|583730864|FG004|Observational Follow-up|Withdrawal by Subject|12|||
161639477|NCT00379769|583730865|FG005|Observational Follow-up|Withdrawal by Subject|12|||
161639478|NCT00379769|583730860|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
161639479|NCT00379769|583730861|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
161639480|NCT00379769|583730862|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
161639481|NCT00379769|583730863|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
161835189|NCT04459715|584437259|FG000|Overall Study|Withdrawal by Subject|22|||
161639482|NCT00379769|583730864|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
161639483|NCT00379769|583730865|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
161639484|NCT00379769|583730860|FG000|Observational Follow-up|Physician Decision|0|||
161639485|NCT00379769|583730861|FG001|Observational Follow-up|Physician Decision|0|||
161639486|NCT00379769|583730862|FG002|Observational Follow-up|Physician Decision|0|||
161639487|NCT00379769|583730863|FG003|Observational Follow-up|Physician Decision|0|||
161639488|NCT00379769|583730864|FG004|Observational Follow-up|Physician Decision|8|||
161835190|NCT04459715|584437260|FG001|Overall Study|Withdrawal by Subject|22|||
161639489|NCT00379769|583730865|FG005|Observational Follow-up|Physician Decision|8|||
161639490|NCT00379769|583730860|FG000|Observational Follow-up|Site Closed Early|0|||
161639491|NCT00379769|583730861|FG001|Observational Follow-up|Site Closed Early|0|||
161639492|NCT00379769|583730862|FG002|Observational Follow-up|Site Closed Early|0|||
161639493|NCT00379769|583730863|FG003|Observational Follow-up|Site Closed Early|0|||
161639494|NCT00379769|583730864|FG004|Observational Follow-up|Site Closed Early|6|||
161639495|NCT00379769|583730865|FG005|Observational Follow-up|Site Closed Early|7|||
161639496|NCT00379769|583730860|FG000|Observational Follow-up|Participant Moved|0|||
161835191|NCT02177136|584438874|FG000|DB Phase|Withdrawal by Subject|2|||
161835192|NCT02177136|584438875|FG001|DB Phase|Withdrawal by Subject|0|||
161639497|NCT00379769|583730861|FG001|Observational Follow-up|Participant Moved|0|||
161639498|NCT00379769|583730862|FG002|Observational Follow-up|Participant Moved|0|||
161639499|NCT00379769|583730863|FG003|Observational Follow-up|Participant Moved|0|||
161639500|NCT00379769|583730864|FG004|Observational Follow-up|Participant Moved|0|||
161639501|NCT00379769|583730865|FG005|Observational Follow-up|Participant Moved|1|||
161639502|NCT00379769|583730860|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
161639503|NCT00379769|583730861|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
161639504|NCT00379769|583730862|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
161639505|NCT00379769|583730863|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
161639506|NCT00379769|583730864|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
161639507|NCT00379769|583730865|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
161639508|NCT02825251|583730868|FG000|Overall Study|Adverse Event|0|||
161639509|NCT02825251|583730869|FG001|Overall Study|Adverse Event|1|||
161639510|NCT02825251|583730868|FG000|Overall Study|Lost to Follow-up|0|||
161639511|NCT02825251|583730869|FG001|Overall Study|Lost to Follow-up|1|||
161639512|NCT02825251|583730868|FG000|Overall Study|Withdrawal by Subject|1|||
161639513|NCT02825251|583730869|FG001|Overall Study|Withdrawal by Subject|4|||
161639514|NCT02825251|583730868|FG000|Overall Study|Unclassified|2|||
161639515|NCT02825251|583730869|FG001|Overall Study|Unclassified|0|||
161639516|NCT05064488|583730870|FG000|Overall Study|Withdrawal by Subject|2|||
161639517|NCT05064488|583730871|FG001|Overall Study|Withdrawal by Subject|0|||
161639518|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
161639519|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
161639520|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
161639521|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Death|4|||
161639522|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Death|2|||
161639523|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Death|3|||
161639524|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161639525|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161639526|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
161639527|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
161639528|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
161639529|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
161639530|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
161639531|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
161639532|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
161639533|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
161639534|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
161639535|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
161639536|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
161639537|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
161639538|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
161639539|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
161639540|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
161639541|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
161639542|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
161639543|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
161639544|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
161639545|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
161639546|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
161639547|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
161639548|NCT02783573|583730872|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
161639549|NCT02783573|583730873|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
161639550|NCT02783573|583730874|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
161639551|NCT02783573|583730872|FG000|Delayed-Start Period|Sponsor Decision|0|||
161639552|NCT02783573|583730873|FG001|Delayed-Start Period|Sponsor Decision|17|||
161639553|NCT02783573|583730874|FG002|Delayed-Start Period|Sponsor Decision|12|||
161639554|NCT01434680|583730879|FG000|Overall Study|Withdrawal by Subject|1|||
161639555|NCT01434680|583730880|FG001|Overall Study|Withdrawal by Subject|0|||
161639556|NCT01434680|583730881|FG002|Overall Study|Withdrawal by Subject|2|||
161639557|NCT01434680|583730882|FG003|Overall Study|Withdrawal by Subject|0|||
161639558|NCT01434680|583730879|FG000|Overall Study|Lost to Follow-up|1|||
161639559|NCT01434680|583730880|FG001|Overall Study|Lost to Follow-up|1|||
161639560|NCT01434680|583730881|FG002|Overall Study|Lost to Follow-up|0|||
161639561|NCT01434680|583730882|FG003|Overall Study|Lost to Follow-up|0|||
161639562|NCT01434680|583730879|FG000|Overall Study|Protocol Violation|1|||
161639563|NCT01434680|583730880|FG001|Overall Study|Protocol Violation|1|||
161639564|NCT01434680|583730881|FG002|Overall Study|Protocol Violation|0|||
161639565|NCT01434680|583730882|FG003|Overall Study|Protocol Violation|0|||
161639566|NCT04090528|583730884|FG000|Overall Study|participants still on study|9|||
161639567|NCT04090528|583730885|FG001|Overall Study|participants still on study|13|||
161639568|NCT04546217|583730886|FG000|Overall Study|Withdrawal by Subject|2|||
161639569|NCT04546217|583730887|FG001|Overall Study|Withdrawal by Subject|0|||
161639570|NCT04546217|583730886|FG000|Overall Study|Uncontrolled hypertension|1|||
161639571|NCT04546217|583730887|FG001|Overall Study|Uncontrolled hypertension|0|||
161639572|NCT02550938|583730888|FG000|Overall Study|Lost to Follow-up|8|||
161639573|NCT02550938|583730889|FG001|Overall Study|Lost to Follow-up|7|||
161639574|NCT02550938|583730890|FG002|Overall Study|Lost to Follow-up|12|||
161639575|NCT02550938|583730891|FG003|Overall Study|Lost to Follow-up|11|||
161639576|NCT01367847|583730892|FG000|Overall Study|Withdrawal by Subject|2|||
161639577|NCT01367847|583730893|FG001|Overall Study|Withdrawal by Subject|2|||
161639578|NCT02684123|583730894|FG000|Phase 1|Lack of Efficacy|5|||
161639579|NCT02684123|583730895|FG001|Phase 1|Lack of Efficacy|0|||
161639580|NCT02684123|583730894|FG000|Phase 1|Adverse Event|3|||
161639581|NCT02684123|583730895|FG001|Phase 1|Adverse Event|0|||
161639582|NCT02684123|583730894|FG000|Phase 1|Lost to Follow-up|0|||
161639583|NCT02684123|583730895|FG001|Phase 1|Lost to Follow-up|1|||
161639584|NCT02684123|583730894|FG000|Phase 2|Lack of Efficacy|1|||
161639585|NCT02684123|583730895|FG001|Phase 2|Lack of Efficacy|8|||
161639586|NCT02037477|583730902|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
161639587|NCT02037477|583730903|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
161639588|NCT02037477|583730904|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
161639589|NCT02037477|583730905|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
161639590|NCT01245140|583730906|FG000|Overall Study|Adverse Event|1|||
161639591|NCT01245140|583730907|FG001|Overall Study|Adverse Event|3|||
161639592|NCT01245140|583730906|FG000|Overall Study|Lack of Efficacy|2|||
161639593|NCT01245140|583730907|FG001|Overall Study|Lack of Efficacy|4|||
161687306|NCT01033825|583907197|FG002|Overall Study|Withdrawal by Subject|2|||
161687307|NCT01033825|583907198|FG003|Overall Study|Withdrawal by Subject|1|||
161687308|NCT01033825|583907199|FG004|Overall Study|Withdrawal by Subject|1|||
161687309|NCT01033825|583907200|FG005|Overall Study|Withdrawal by Subject|0|||
161687310|NCT01033825|583907201|FG006|Overall Study|Withdrawal by Subject|0|||
161639594|NCT01245140|583730906|FG000|Overall Study|Protocol Violation|0|||
161687311|NCT01033825|583907195|FG000|Overall Study|Adverse Event|0|||
161639595|NCT01245140|583730907|FG001|Overall Study|Protocol Violation|1|||
161687312|NCT01033825|583907196|FG001|Overall Study|Adverse Event|0|||
161687313|NCT01033825|583907197|FG002|Overall Study|Adverse Event|0|||
161639596|NCT01245140|583730906|FG000|Overall Study|Withdrawal by Subject|0|||
161687314|NCT01033825|583907198|FG003|Overall Study|Adverse Event|1|||
161687315|NCT01033825|583907199|FG004|Overall Study|Adverse Event|0|||
161639597|NCT01245140|583730907|FG001|Overall Study|Withdrawal by Subject|1|||
161639598|NCT01245140|583730906|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
161639599|NCT01245140|583730907|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
161639600|NCT02635360|583730908|FG000|Overall Study|Adverse Event|0|||
161639601|NCT02635360|583730909|FG001|Overall Study|Adverse Event|3|||
161639602|NCT02635360|583730908|FG000|Overall Study|Withdrawal by Subject|2|||
161687316|NCT01033825|583907200|FG005|Overall Study|Adverse Event|0|||
161639603|NCT02635360|583730909|FG001|Overall Study|Withdrawal by Subject|0|||
161639604|NCT02635360|583730908|FG000|Overall Study|Non-Compliance|3|||
161639605|NCT02635360|583730909|FG001|Overall Study|Non-Compliance|1|||
161639606|NCT02635360|583730908|FG000|Overall Study|Disease Progression|0|||
161639607|NCT02635360|583730909|FG001|Overall Study|Disease Progression|2|||
161639608|NCT02635360|583730908|FG000|Overall Study|Lost to Follow-up|1|||
161639609|NCT02635360|583730909|FG001|Overall Study|Lost to Follow-up|1|||
161639610|NCT04082429|583730910|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
161639611|NCT04082429|583730911|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161639612|NCT04082429|583730912|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
161639613|NCT04082429|583730913|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
161639614|NCT04082429|583730914|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
161639615|NCT04082429|583730915|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161639616|NCT04082429|583730916|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161639617|NCT04082429|583730917|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161639618|NCT04082429|583730918|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161639619|NCT04082429|583730910|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639620|NCT04082429|583730911|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639621|NCT04082429|583730912|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639622|NCT04082429|583730913|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639623|NCT04082429|583730914|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
161639624|NCT04082429|583730915|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639625|NCT04082429|583730916|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639626|NCT04082429|583730917|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639627|NCT04082429|583730918|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161639628|NCT04082429|583730910|FG000|Main Part (After the Treatment Pause)|Death|0|||
161639629|NCT04082429|583730911|FG001|Main Part (After the Treatment Pause)|Death|0|||
161639630|NCT04082429|583730912|FG002|Main Part (After the Treatment Pause)|Death|0|||
161639631|NCT04082429|583730913|FG003|Main Part (After the Treatment Pause)|Death|0|||
161639632|NCT04082429|583730914|FG004|Main Part (After the Treatment Pause)|Death|1|||
161639633|NCT04082429|583730915|FG005|Main Part (After the Treatment Pause)|Death|0|||
161639634|NCT04082429|583730916|FG006|Main Part (After the Treatment Pause)|Death|0|||
161639635|NCT04082429|583730917|FG007|Main Part (After the Treatment Pause)|Death|0|||
161639636|NCT04082429|583730918|FG008|Main Part (After the Treatment Pause)|Death|0|||
161639637|NCT04082429|583730910|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639638|NCT04082429|583730911|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639639|NCT04082429|583730912|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639640|NCT04082429|583730913|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
161639641|NCT04082429|583730914|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639642|NCT04082429|583730915|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
161687317|NCT01033825|583907201|FG006|Overall Study|Adverse Event|0|||
161639643|NCT04082429|583730916|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639644|NCT04082429|583730917|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639645|NCT04082429|583730918|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
161639646|NCT04082429|583730910|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161639647|NCT04082429|583730911|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161639648|NCT04082429|583730912|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
161639649|NCT04082429|583730913|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
161639650|NCT04082429|583730914|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161639651|NCT04082429|583730915|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161639652|NCT04082429|583730916|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161639653|NCT04082429|583730917|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
161639654|NCT04082429|583730918|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
161639655|NCT04082429|583730910|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
161639656|NCT04082429|583730911|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639657|NCT04082429|583730912|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639658|NCT04082429|583730913|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639659|NCT04082429|583730914|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639660|NCT04082429|583730915|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
161639661|NCT04082429|583730916|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639662|NCT04082429|583730917|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639663|NCT04082429|583730918|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161639664|NCT04082429|583730910|FG000|Extension Part|Ongoing|0|||
161639665|NCT04082429|583730911|FG001|Extension Part|Ongoing|7|||
161639666|NCT04082429|583730912|FG002|Extension Part|Ongoing|17|||
161639667|NCT04082429|583730913|FG003|Extension Part|Ongoing|6|||
161639668|NCT04082429|583730914|FG004|Extension Part|Ongoing|45|||
161639669|NCT04082429|583730915|FG005|Extension Part|Ongoing|0|||
161639670|NCT04082429|583730916|FG006|Extension Part|Ongoing|10|||
161639671|NCT04082429|583730917|FG007|Extension Part|Ongoing|23|||
161639672|NCT04082429|583730918|FG008|Extension Part|Ongoing|25|||
161639673|NCT00334542|583730919|FG000|Overall Study|Adverse Event|3|||
161639674|NCT00334542|583730919|FG000|Overall Study|Withdrawal by Subject|1|||
161639675|NCT00334542|583730919|FG000|Overall Study|New cancer diagnosis|1|||
161639676|NCT01952847|583730922|FG000|Overall Study|Ineligible|1|||
161639677|NCT01952847|583730923|FG001|Overall Study|Ineligible|0|||
161639678|NCT01952847|583730924|FG002|Overall Study|Ineligible|0|||
161639679|NCT01952847|583730925|FG003|Overall Study|Ineligible|0|||
161639680|NCT01952847|583730922|FG000|Overall Study|Lack of Insurance Coverage|0|||
161639681|NCT01952847|583730923|FG001|Overall Study|Lack of Insurance Coverage|1|||
161639682|NCT01952847|583730924|FG002|Overall Study|Lack of Insurance Coverage|0|||
161639683|NCT01952847|583730925|FG003|Overall Study|Lack of Insurance Coverage|0|||
161639684|NCT01952847|583730922|FG000|Overall Study|Withdrawal by Subject|1|||
161639685|NCT01952847|583730923|FG001|Overall Study|Withdrawal by Subject|1|||
161639686|NCT01952847|583730924|FG002|Overall Study|Withdrawal by Subject|0|||
161639687|NCT01952847|583730925|FG003|Overall Study|Withdrawal by Subject|1|||
161639688|NCT05382039|583730926|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
161639689|NCT05382039|583730927|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
161639690|NCT05382039|583730928|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
161639691|NCT05382039|583730926|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
161639692|NCT05382039|583730927|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
161639693|NCT05382039|583730928|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
161639694|NCT05382039|583730926|FG000|Overall Study|waiting for confirmation|0|||
161639695|NCT05382039|583730927|FG001|Overall Study|waiting for confirmation|0|||
161639696|NCT05382039|583730928|FG002|Overall Study|waiting for confirmation|1|||
161639697|NCT04464421|583730929|FG000|Overall Study|Lost to Follow-up|2|||
161639698|NCT04464421|583730930|FG001|Overall Study|Lost to Follow-up|2|||
161639699|NCT02577003|583730931|FG000|Overall Study|Adverse Event|2|||
161639700|NCT02577003|583730932|FG001|Overall Study|Adverse Event|4|||
161639701|NCT02577003|583730931|FG000|Overall Study|Withdrawal by Subject|0|||
161639702|NCT02577003|583730932|FG001|Overall Study|Withdrawal by Subject|1|||
161639703|NCT02786004|583730933|FG000|Overall Study|Withdrawal by Subject|0|||
161639704|NCT02786004|583730934|FG001|Overall Study|Withdrawal by Subject|1|||
161639705|NCT01234883|583730935|FG000|Overall Study|Early treatment release|8|||
161639706|NCT01234883|583730936|FG001|Overall Study|Early treatment release|10|||
161639707|NCT01234883|583730935|FG000|Overall Study|Parent/guardian withdrew consent|1|||
161639708|NCT01234883|583730936|FG001|Overall Study|Parent/guardian withdrew consent|2|||
161639709|NCT01234883|583730935|FG000|Overall Study|Technical difficulties with IV infusion|0|||
161639710|NCT01234883|583730936|FG001|Overall Study|Technical difficulties with IV infusion|1|||
161639711|NCT01234883|583730935|FG000|Overall Study|Inclusion/exclusion failure|1|||
161639712|NCT01234883|583730936|FG001|Overall Study|Inclusion/exclusion failure|0|||
161639713|NCT01013961|583730937|FG000|Overall Study|Adverse Event|2|||
161639714|NCT01013961|583730938|FG001|Overall Study|Adverse Event|2|||
161835193|NCT02177136|584438876|FG002|DB Phase|Withdrawal by Subject|0|||
161639715|NCT01013961|583730937|FG000|Overall Study|Withdrawal by Subject|1|||
161639716|NCT01013961|583730938|FG001|Overall Study|Withdrawal by Subject|0|||
161639717|NCT01013961|583730937|FG000|Overall Study|Physician Decision|0|||
161639718|NCT01013961|583730938|FG001|Overall Study|Physician Decision|1|||
161639719|NCT01271504|583730939|FG000|Overall Study|Death|7|||
161639720|NCT01271504|583730940|FG001|Overall Study|Death|6|||
161639721|NCT01271504|583730941|FG002|Overall Study|Death|32|||
161835194|NCT02177136|584438877|FG003|DB Phase|Withdrawal by Subject|0|||
161835195|NCT02177136|584438874|FG000|DB Phase|Discontinued Due to Pruritus|1|||
161835196|NCT02177136|584438875|FG001|DB Phase|Discontinued Due to Pruritus|3|||
161835197|NCT02177136|584438876|FG002|DB Phase|Discontinued Due to Pruritus|0|||
161835198|NCT02177136|584438877|FG003|DB Phase|Discontinued Due to Pruritus|0|||
161835199|NCT02177136|584438874|FG000|DB Phase|Adverse Event|3|||
161835200|NCT02177136|584438875|FG001|DB Phase|Adverse Event|2|||
161835201|NCT02177136|584438876|FG002|DB Phase|Adverse Event|3|||
161835202|NCT02177136|584438877|FG003|DB Phase|Adverse Event|0|||
161835203|NCT02177136|584438874|FG000|DB Phase|Protocol Violation|0|||
161835204|NCT02177136|584438875|FG001|DB Phase|Protocol Violation|0|||
161835205|NCT02177136|584438876|FG002|DB Phase|Protocol Violation|1|||
161835206|NCT02177136|584438877|FG003|DB Phase|Protocol Violation|0|||
161835207|NCT02177136|584438874|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
161835208|NCT02177136|584438875|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
161835209|NCT02177136|584438876|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
161835210|NCT02177136|584438877|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
161639722|NCT01271504|583730942|FG003|Overall Study|Death|32|||
161639723|NCT01271504|583730939|FG000|Overall Study|Lost to Follow-up|0|||
161639724|NCT01271504|583730940|FG001|Overall Study|Lost to Follow-up|1|||
161639725|NCT01271504|583730941|FG002|Overall Study|Lost to Follow-up|3|||
161639726|NCT01271504|583730942|FG003|Overall Study|Lost to Follow-up|1|||
161639727|NCT01271504|583730939|FG000|Overall Study|Protocol Violation|0|||
161639728|NCT01271504|583730940|FG001|Overall Study|Protocol Violation|0|||
161639729|NCT01271504|583730941|FG002|Overall Study|Protocol Violation|0|||
161639730|NCT01271504|583730942|FG003|Overall Study|Protocol Violation|2|||
161639731|NCT01271504|583730939|FG000|Overall Study|Administrative Reasons|0|||
161639732|NCT01271504|583730940|FG001|Overall Study|Administrative Reasons|0|||
161639733|NCT01271504|583730941|FG002|Overall Study|Administrative Reasons|6|||
161639734|NCT01271504|583730942|FG003|Overall Study|Administrative Reasons|5|||
161639735|NCT01271504|583730939|FG000|Overall Study|Withdrawal by Subject|0|||
161639736|NCT01271504|583730940|FG001|Overall Study|Withdrawal by Subject|0|||
161639737|NCT01271504|583730941|FG002|Overall Study|Withdrawal by Subject|1|||
161639738|NCT01271504|583730942|FG003|Overall Study|Withdrawal by Subject|3|||
161639739|NCT01271504|583730939|FG000|Overall Study|Other|0|||
161639740|NCT01271504|583730940|FG001|Overall Study|Other|1|||
161639741|NCT01271504|583730941|FG002|Overall Study|Other|2|||
161639742|NCT01271504|583730942|FG003|Overall Study|Other|0|||
161639743|NCT01790295|583730949|FG000|Overall Study|Adverse Event|1|||
161639744|NCT01790295|583730949|FG000|Overall Study|Death|4|||
161639745|NCT01790295|583730949|FG000|Overall Study|Lack of Efficacy|2|||
161639746|NCT01790295|583730949|FG000|Overall Study|Study closure|4|||
161639747|NCT00756457|583730954|FG000|Overall Study|Lost to Follow-up|1|||
161639748|NCT00756457|583730955|FG001|Overall Study|Lost to Follow-up|2|||
161639749|NCT02402322|583730956|FG000|Pretreatment|Withdrawal by Subject|3|||
161639750|NCT02402322|583730957|FG001|Pretreatment|Withdrawal by Subject|1|||
161639751|NCT02402322|583730958|FG002|Pretreatment|Withdrawal by Subject|1|||
161639752|NCT02402322|583730956|FG000|Follow-up|Withdrawal by Subject|6|||
161639753|NCT02402322|583730957|FG001|Follow-up|Withdrawal by Subject|3|||
161639754|NCT02402322|583730958|FG002|Follow-up|Withdrawal by Subject|24|||
161639755|NCT02818998|583730959|FG000|Overall Study|Adverse Event|3|||
161639756|NCT02818998|583730960|FG001|Overall Study|Adverse Event|2|||
161639757|NCT02818998|583730961|FG002|Overall Study|Adverse Event|1|||
161687318|NCT01033825|583907195|FG000|Overall Study|Protocol Violation|1|||
161835211|NCT02177136|584438874|FG000|LTSE Phase|Withdrawal by Subject|0|||
161835212|NCT02177136|584438875|FG001|LTSE Phase|Withdrawal by Subject|0|||
161835213|NCT02177136|584438876|FG002|LTSE Phase|Withdrawal by Subject|0|||
161835214|NCT02177136|584438877|FG003|LTSE Phase|Withdrawal by Subject|6|||
161835215|NCT02177136|584438874|FG000|LTSE Phase|Adverse Event|0|||
161835216|NCT02177136|584438875|FG001|LTSE Phase|Adverse Event|0|||
161835217|NCT02177136|584438876|FG002|LTSE Phase|Adverse Event|0|||
161835218|NCT02177136|584438877|FG003|LTSE Phase|Adverse Event|10|||
161835219|NCT02177136|584438874|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
161835220|NCT02177136|584438875|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
161639758|NCT02818998|583730959|FG000|Overall Study|Lost to Follow-up|4|||
161639759|NCT02818998|583730960|FG001|Overall Study|Lost to Follow-up|1|||
161639760|NCT02818998|583730961|FG002|Overall Study|Lost to Follow-up|2|||
161639761|NCT02818998|583730959|FG000|Overall Study|Withdrawal by sponsor|0|||
161639762|NCT02818998|583730960|FG001|Overall Study|Withdrawal by sponsor|1|||
161639763|NCT02818998|583730961|FG002|Overall Study|Withdrawal by sponsor|1|||
161639764|NCT02818998|583730959|FG000|Overall Study|Death|3|||
161639765|NCT02818998|583730960|FG001|Overall Study|Death|6|||
161639766|NCT02818998|583730961|FG002|Overall Study|Death|8|||
161639767|NCT02818998|583730959|FG000|Overall Study|Withdrawal by Subject|7|||
161639768|NCT02818998|583730960|FG001|Overall Study|Withdrawal by Subject|6|||
161835221|NCT02177136|584438876|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
161835222|NCT02177136|584438877|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
161639769|NCT02818998|583730961|FG002|Overall Study|Withdrawal by Subject|6|||
161639770|NCT02818998|583730959|FG000|Overall Study|Physician Decision|1|||
161639771|NCT02818998|583730960|FG001|Overall Study|Physician Decision|0|||
161639772|NCT02818998|583730961|FG002|Overall Study|Physician Decision|0|||
161639773|NCT02472145|583730962|FG000|Overall Study|Death|10|||
161639774|NCT02472145|583730963|FG001|Overall Study|Death|101|||
161639775|NCT02472145|583730964|FG002|Overall Study|Death|99|||
161639776|NCT02472145|583730962|FG000|Overall Study|Lost to Follow-up|0|||
161639777|NCT02472145|583730963|FG001|Overall Study|Lost to Follow-up|1|||
161639778|NCT02472145|583730964|FG002|Overall Study|Lost to Follow-up|0|||
161639779|NCT02472145|583730962|FG000|Overall Study|Withdrawal by Subject|0|||
161639780|NCT02472145|583730963|FG001|Overall Study|Withdrawal by Subject|9|||
161639781|NCT02472145|583730964|FG002|Overall Study|Withdrawal by Subject|13|||
161639782|NCT02472145|583730962|FG000|Overall Study|Sponsor decision|0|||
161639783|NCT02472145|583730963|FG001|Overall Study|Sponsor decision|3|||
161639784|NCT02472145|583730964|FG002|Overall Study|Sponsor decision|2|||
161639785|NCT02472145|583730962|FG000|Overall Study|Other|0|||
161639786|NCT02472145|583730963|FG001|Overall Study|Other|45|||
161639787|NCT02472145|583730964|FG002|Overall Study|Other|43|||
161639788|NCT01080326|583730965|FG000|Overall Study|Patient deterioration prior to procedure|3|||
161639789|NCT01080326|583730965|FG000|Overall Study|Surgeon decision|1|||
161639790|NCT00632021|583730967|FG000|Overall Study|Withdrawal/death|4|||
161639791|NCT00632021|583730968|FG001|Overall Study|Withdrawal/death|7|||
161639792|NCT02250534|583730971|FG000|Overall Study|Lost to Follow-up|18|||
161639793|NCT02250534|583730972|FG001|Overall Study|Lost to Follow-up|28|||
161639794|NCT02250534|583730973|FG002|Overall Study|Lost to Follow-up|33|||
161639795|NCT02250534|583730971|FG000|Overall Study|Personal reasons|7|||
161639796|NCT02250534|583730972|FG001|Overall Study|Personal reasons|8|||
161639797|NCT02250534|583730973|FG002|Overall Study|Personal reasons|14|||
161639798|NCT02250534|583730971|FG000|Overall Study|Adverse Event|6|||
161639799|NCT02250534|583730972|FG001|Overall Study|Adverse Event|3|||
161639800|NCT02250534|583730973|FG002|Overall Study|Adverse Event|8|||
161639801|NCT02250534|583730971|FG000|Overall Study|incarcerated|2|||
161639802|NCT02250534|583730972|FG001|Overall Study|incarcerated|1|||
161639803|NCT02250534|583730973|FG002|Overall Study|incarcerated|2|||
161639804|NCT02250534|583730971|FG000|Overall Study|Withdrawal by Subject|0|||
161639805|NCT02250534|583730972|FG001|Overall Study|Withdrawal by Subject|1|||
161639806|NCT02250534|583730973|FG002|Overall Study|Withdrawal by Subject|2|||
161639807|NCT02250534|583730971|FG000|Overall Study|Death|0|||
161639808|NCT02250534|583730972|FG001|Overall Study|Death|1|||
161639809|NCT02250534|583730973|FG002|Overall Study|Death|1|||
161639810|NCT02250534|583730971|FG000|Overall Study|Physician Decision|1|||
161639811|NCT02250534|583730972|FG001|Overall Study|Physician Decision|3|||
161639812|NCT02250534|583730973|FG002|Overall Study|Physician Decision|1|||
161639813|NCT02250534|583730971|FG000|Overall Study|Protocol Violation|1|||
161639814|NCT02250534|583730972|FG001|Overall Study|Protocol Violation|0|||
161639815|NCT02250534|583730973|FG002|Overall Study|Protocol Violation|1|||
161639816|NCT02250534|583730971|FG000|Overall Study|Reason unknown|1|||
161639817|NCT02250534|583730972|FG001|Overall Study|Reason unknown|0|||
161639818|NCT02250534|583730973|FG002|Overall Study|Reason unknown|0|||
161639819|NCT01628692|583730976|FG000|Overall Study|Lack of Efficacy|4|||
161639820|NCT01628692|583730977|FG001|Overall Study|Lack of Efficacy|4|||
161639821|NCT01628692|583730978|FG002|Overall Study|Lack of Efficacy|5|||
161639822|NCT01628692|583730979|FG003|Overall Study|Lack of Efficacy|1|||
161687319|NCT01033825|583907196|FG001|Overall Study|Protocol Violation|0|||
161687320|NCT01033825|583907197|FG002|Overall Study|Protocol Violation|0|||
161639823|NCT01628692|583730980|FG004|Overall Study|Lack of Efficacy|4|||
161639824|NCT01628692|583730981|FG005|Overall Study|Lack of Efficacy|7|||
161639825|NCT01628692|583730976|FG000|Overall Study|Adverse Event|2|||
161639826|NCT01628692|583730977|FG001|Overall Study|Adverse Event|0|||
161639827|NCT01628692|583730978|FG002|Overall Study|Adverse Event|2|||
161639828|NCT01628692|583730979|FG003|Overall Study|Adverse Event|0|||
161639829|NCT01628692|583730980|FG004|Overall Study|Adverse Event|0|||
161639830|NCT01628692|583730981|FG005|Overall Study|Adverse Event|0|||
161639831|NCT01628692|583730976|FG000|Overall Study|Withdrawal by Subject|0|||
161639832|NCT01628692|583730977|FG001|Overall Study|Withdrawal by Subject|1|||
161639833|NCT01628692|583730978|FG002|Overall Study|Withdrawal by Subject|1|||
161639834|NCT01628692|583730979|FG003|Overall Study|Withdrawal by Subject|0|||
161639835|NCT01628692|583730980|FG004|Overall Study|Withdrawal by Subject|0|||
161687321|NCT01033825|583907198|FG003|Overall Study|Protocol Violation|0|||
161835223|NCT02177136|584438874|FG000|LTSE Phase|Physician Decision|0|||
161835224|NCT02177136|584438875|FG001|LTSE Phase|Physician Decision|0|||
161835225|NCT02177136|584438876|FG002|LTSE Phase|Physician Decision|0|||
161835226|NCT02177136|584438877|FG003|LTSE Phase|Physician Decision|2|||
161835227|NCT02177136|584438874|FG000|LTSE Phase|Lost to Follow-up|0|||
161835228|NCT02177136|584438875|FG001|LTSE Phase|Lost to Follow-up|0|||
161835229|NCT02177136|584438876|FG002|LTSE Phase|Lost to Follow-up|0|||
161835230|NCT02177136|584438877|FG003|LTSE Phase|Lost to Follow-up|1|||
161835231|NCT02177136|584438874|FG000|LTSE Phase|Participant Moved|0|||
161835232|NCT02177136|584438875|FG001|LTSE Phase|Participant Moved|0|||
161835233|NCT02177136|584438876|FG002|LTSE Phase|Participant Moved|0|||
161835234|NCT02177136|584438877|FG003|LTSE Phase|Participant Moved|1|||
161835235|NCT02054130|584438878|FG000|Overall Study|Withdrawal by Subject|4|||
161835236|NCT02054130|584438879|FG001|Overall Study|Withdrawal by Subject|4|||
161835237|NCT02054130|584438880|FG002|Overall Study|Withdrawal by Subject|7|||
161835238|NCT02054130|584438881|FG003|Overall Study|Withdrawal by Subject|10|||
161835239|NCT02054130|584438878|FG000|Overall Study|Death|0|||
161835240|NCT02054130|584438879|FG001|Overall Study|Death|1|||
161835241|NCT02054130|584438880|FG002|Overall Study|Death|0|||
161835242|NCT02054130|584438881|FG003|Overall Study|Death|0|||
161835243|NCT02054130|584438878|FG000|Overall Study|Lost to Follow-up|0|||
161639836|NCT01628692|583730981|FG005|Overall Study|Withdrawal by Subject|0|||
161835244|NCT02054130|584438879|FG001|Overall Study|Lost to Follow-up|0|||
161835245|NCT02054130|584438880|FG002|Overall Study|Lost to Follow-up|1|||
161835246|NCT02054130|584438881|FG003|Overall Study|Lost to Follow-up|2|||
161835247|NCT02054130|584438878|FG000|Overall Study|Missed dose|4|||
161835248|NCT02054130|584438879|FG001|Overall Study|Missed dose|6|||
161835249|NCT02054130|584438880|FG002|Overall Study|Missed dose|7|||
161835250|NCT02054130|584438881|FG003|Overall Study|Missed dose|10|||
161835251|NCT01304693|584438896|FG000|Overall Study|Adverse Event|0|||
161835252|NCT01304693|584438897|FG001|Overall Study|Adverse Event|0|||
161835253|NCT01304693|584438898|FG002|Overall Study|Adverse Event|0|||
161835254|NCT01304693|584438899|FG003|Overall Study|Adverse Event|0|||
161639837|NCT01628692|583730976|FG000|Overall Study|Death|0|||
161639838|NCT01628692|583730977|FG001|Overall Study|Death|1|||
161639839|NCT01628692|583730978|FG002|Overall Study|Death|0|||
161639840|NCT01628692|583730979|FG003|Overall Study|Death|0|||
161639841|NCT01628692|583730980|FG004|Overall Study|Death|0|||
161639842|NCT01628692|583730981|FG005|Overall Study|Death|0|||
161639843|NCT01628692|583730976|FG000|Overall Study|Poor compliance/noncompliance|1|||
161639844|NCT01628692|583730977|FG001|Overall Study|Poor compliance/noncompliance|0|||
161639845|NCT01628692|583730978|FG002|Overall Study|Poor compliance/noncompliance|0|||
161639846|NCT01628692|583730979|FG003|Overall Study|Poor compliance/noncompliance|0|||
161639847|NCT01628692|583730980|FG004|Overall Study|Poor compliance/noncompliance|0|||
161639848|NCT01628692|583730981|FG005|Overall Study|Poor compliance/noncompliance|0|||
161639849|NCT01628692|583730976|FG000|Overall Study|Administrative reason by sponsor|0|||
161639850|NCT01628692|583730977|FG001|Overall Study|Administrative reason by sponsor|0|||
161639851|NCT01628692|583730978|FG002|Overall Study|Administrative reason by sponsor|0|||
161639852|NCT01628692|583730979|FG003|Overall Study|Administrative reason by sponsor|0|||
161639853|NCT01628692|583730980|FG004|Overall Study|Administrative reason by sponsor|0|||
161639854|NCT01628692|583730981|FG005|Overall Study|Administrative reason by sponsor|1|||
161639855|NCT01628692|583730976|FG000|Overall Study|Completed 12 Week only|0|||
161639856|NCT01628692|583730977|FG001|Overall Study|Completed 12 Week only|0|||
161639857|NCT01628692|583730978|FG002|Overall Study|Completed 12 Week only|0|||
161835255|NCT01304693|584438900|FG004|Overall Study|Adverse Event|1|||
161835256|NCT01304693|584438896|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
161835257|NCT01304693|584438897|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
161835258|NCT01304693|584438898|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
161639858|NCT01628692|583730979|FG003|Overall Study|Completed 12 Week only|0|||
161639859|NCT01628692|583730980|FG004|Overall Study|Completed 12 Week only|0|||
161639860|NCT01628692|583730981|FG005|Overall Study|Completed 12 Week only|1|||
161639861|NCT02437071|583730982|FG000|Overall Study|Withdrawal by Subject|1|||
161835259|NCT01304693|584438899|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
161835260|NCT01304693|584438900|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
161835261|NCT00931268|584438901|FG000|Overall Study|Lost to Follow-up|6|||
161639862|NCT02437071|583730983|FG001|Overall Study|Withdrawal by Subject|0|||
161687322|NCT01033825|583907199|FG004|Overall Study|Protocol Violation|0|||
161835262|NCT02072148|584438902|FG000|Overall Study|withdrew prior to surgery|23|||
161835263|NCT02072148|584438903|FG001|Overall Study|withdrew prior to surgery|0|||
161835264|NCT02072148|584438904|FG002|Overall Study|withdrew prior to surgery|0|||
161835265|NCT02072148|584438902|FG000|Overall Study|Death|0|||
161835266|NCT02072148|584438903|FG001|Overall Study|Death|0|||
161835267|NCT02072148|584438904|FG002|Overall Study|Death|1|||
161835268|NCT02072148|584438902|FG000|Overall Study|Withdrawal by Subject|0|||
161835269|NCT02072148|584438903|FG001|Overall Study|Withdrawal by Subject|13|||
161835270|NCT02072148|584438904|FG002|Overall Study|Withdrawal by Subject|12|||
161835271|NCT03656874|584438905|FG000|Overall Study|Lost to Follow-up|3|||
161835272|NCT03656874|584438906|FG001|Overall Study|Lost to Follow-up|17|||
161639863|NCT00537329|583730984|FG000|Overall Study|Death|10|||
161639864|NCT00537329|583730984|FG000|Overall Study|Adverse Event|3|||
161639865|NCT00537329|583730984|FG000|Overall Study|Lack of Efficacy|2|||
161639866|NCT00537329|583730984|FG000|Overall Study|Lost to Follow-up|6|||
161639867|NCT00537329|583730984|FG000|Overall Study|Withdrawal by Subject|4|||
161639868|NCT00537329|583730984|FG000|Overall Study|Other|1|||
161639869|NCT00572533|583730985|FG000|Overall Study|Death|4|||
161639870|NCT00572533|583730986|FG001|Overall Study|Death|1|||
161639871|NCT00572533|583730985|FG000|Overall Study|Received Kidney Transplant|2|||
161639872|NCT00572533|583730986|FG001|Overall Study|Received Kidney Transplant|1|||
161639873|NCT00572533|583730985|FG000|Overall Study|Social Issues|1|||
161639874|NCT00572533|583730986|FG001|Overall Study|Social Issues|0|||
161639875|NCT00572533|583730985|FG000|Overall Study|Transfer out of Facility|0|||
161639876|NCT00572533|583730986|FG001|Overall Study|Transfer out of Facility|1|||
161639877|NCT02688530|583730990|FG000|Overall Study|Withdrawal by Subject|0|||
161639878|NCT02688530|583730991|FG001|Overall Study|Withdrawal by Subject|1|||
161639879|NCT02688530|583730992|FG002|Overall Study|Withdrawal by Subject|0|||
161639880|NCT02688530|583730993|FG003|Overall Study|Withdrawal by Subject|0|||
161639881|NCT02688530|583730990|FG000|Overall Study|Lost to Follow-up|0|||
161639882|NCT02688530|583730991|FG001|Overall Study|Lost to Follow-up|0|||
161835273|NCT01206816|584438907|FG000|Overall Study|Protocol Violation|0|||
161835274|NCT01206816|584438908|FG001|Overall Study|Protocol Violation|0|||
161639883|NCT02688530|583730992|FG002|Overall Study|Lost to Follow-up|2|||
161835275|NCT01206816|584438909|FG002|Overall Study|Protocol Violation|1|||
161835276|NCT01206816|584438910|FG003|Overall Study|Protocol Violation|0|||
161639884|NCT02688530|583730993|FG003|Overall Study|Lost to Follow-up|0|||
161639885|NCT01658020|583730994|FG000|Overall Study|Adverse Event|3|||
161639886|NCT01658020|583730995|FG001|Overall Study|Adverse Event|3|||
161639887|NCT01658020|583730994|FG000|Overall Study|Lost to Follow-up|1|||
161835277|NCT01206816|584438911|FG004|Overall Study|Protocol Violation|0|||
161835278|NCT01206816|584438912|FG005|Overall Study|Protocol Violation|0|||
161639888|NCT01658020|583730995|FG001|Overall Study|Lost to Follow-up|0|||
161639889|NCT01658020|583730994|FG000|Overall Study|Withdrawal by Subject|4|||
161639890|NCT01658020|583730995|FG001|Overall Study|Withdrawal by Subject|5|||
161639891|NCT01658020|583730994|FG000|Overall Study|Protocol Violation|0|||
161639892|NCT01658020|583730995|FG001|Overall Study|Protocol Violation|1|||
161639893|NCT01530087|583731002|FG000|Overall Study|Physician Decision|2|||
161639894|NCT02353871|583731003|FG000|Overall Study|Protocol deviation|0|||
161639895|NCT02353871|583731004|FG001|Overall Study|Protocol deviation|1|||
161639896|NCT02353871|583731003|FG000|Overall Study|Consent withdrawn|1|||
161639897|NCT02353871|583731004|FG001|Overall Study|Consent withdrawn|8|||
161639898|NCT02353871|583731003|FG000|Overall Study|Lost to Follow-up|2|||
161639899|NCT02353871|583731004|FG001|Overall Study|Lost to Follow-up|0|||
161639900|NCT02554383|583731007|FG000|Overall Study|Ineligible|3|||
161639901|NCT02554383|583731008|FG001|Overall Study|Ineligible|2|||
161639902|NCT02554383|583731007|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
161639903|NCT02554383|583731008|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
161639904|NCT02554383|583731007|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
161639905|NCT02554383|583731008|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
161639906|NCT02554383|583731007|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
161639907|NCT02554383|583731008|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
161639908|NCT02581059|583731011|FG000|Study Treatment|Disease Progression|1|||
161639909|NCT02581059|583731012|FG001|Study Treatment|Disease Progression|1|||
161639910|NCT02581059|583731011|FG000|Study Treatment|Adverse Event|2|||
161639911|NCT02581059|583731012|FG001|Study Treatment|Adverse Event|1|||
161639912|NCT02581059|583731011|FG000|Study Treatment|Death|1|||
161639913|NCT02581059|583731012|FG001|Study Treatment|Death|1|||
161639914|NCT02581059|583731011|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161639915|NCT02581059|583731012|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161639916|NCT02581059|583731011|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
161639917|NCT02581059|583731012|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
161687323|NCT01033825|583907200|FG005|Overall Study|Protocol Violation|0|||
161687324|NCT01033825|583907201|FG006|Overall Study|Protocol Violation|0|||
161687325|NCT01033825|583907195|FG000|Overall Study|Other|0|||
161687326|NCT01033825|583907196|FG001|Overall Study|Other|0|||
161687327|NCT01033825|583907197|FG002|Overall Study|Other|0|||
161687328|NCT01033825|583907198|FG003|Overall Study|Other|0|||
161687329|NCT01033825|583907199|FG004|Overall Study|Other|1|||
161687330|NCT01033825|583907200|FG005|Overall Study|Other|0|||
161687331|NCT01033825|583907201|FG006|Overall Study|Other|0|||
161687332|NCT04294719|583907202|FG000|Overall Study|Withdrawal by Subject|1|||
161687333|NCT01714687|583907203|FG000|Overall Study|Withdrawal by Subject|1|||
161687334|NCT01714687|583907204|FG001|Overall Study|Withdrawal by Subject|0|||
161687335|NCT01714687|583907203|FG000|Overall Study|Lost to Follow-up|2|||
161687336|NCT01714687|583907204|FG001|Overall Study|Lost to Follow-up|4|||
161687337|NCT00788372|583907205|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
161687338|NCT00788372|583907205|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
161687339|NCT00788372|583907205|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
161687340|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
161687341|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
161687342|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
161687343|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
161687344|NCT01464307|583907210|FG000|Main Period|Death|0|||
161687345|NCT01464307|583907211|FG001|Main Period|Death|1|||
161687346|NCT01464307|583907210|FG000|Main Period|Adverse Event|6|||
161687347|NCT01464307|583907211|FG001|Main Period|Adverse Event|1|||
161687348|NCT01464307|583907210|FG000|Main Period|Lack of Efficacy|2|||
161687349|NCT01464307|583907211|FG001|Main Period|Lack of Efficacy|0|||
161687350|NCT01464307|583907210|FG000|Main Period|Withdrawal by Subject|5|||
161687351|NCT01464307|583907211|FG001|Main Period|Withdrawal by Subject|2|||
161687352|NCT01464307|583907210|FG000|Main Period|Predefined discontinuation criteria|2|||
161687353|NCT01464307|583907211|FG001|Main Period|Predefined discontinuation criteria|1|||
161835279|NCT01206816|584438913|FG006|Overall Study|Protocol Violation|0|||
161835280|NCT01206816|584438907|FG000|Overall Study|Withdrawal by Subject|0|||
161639918|NCT02581059|583731011|FG000|Follow up|Death|1|||
161639919|NCT02581059|583731012|FG001|Follow up|Death|3|||
161639920|NCT02581059|583731011|FG000|Follow up|study terminated|1|||
161639921|NCT02581059|583731012|FG001|Follow up|study terminated|1|||
161639922|NCT02581059|583731011|FG000|Follow up|screen failure|0|||
161639923|NCT02581059|583731012|FG001|Follow up|screen failure|1|||
161639924|NCT02581059|583731011|FG000|Follow up|Patient started new clinical trial|1|||
161639925|NCT02581059|583731012|FG001|Follow up|Patient started new clinical trial|0|||
161687354|NCT01464307|583907210|FG000|Open-Label Extension Period|Adverse Event|15|||
161687355|NCT01464307|583907211|FG001|Open-Label Extension Period|Adverse Event|0|||
161687356|NCT01464307|583907210|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
161687357|NCT01464307|583907211|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
161687358|NCT01464307|583907210|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
161687359|NCT01464307|583907211|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
161639926|NCT03698019|583731013|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
161639927|NCT03698019|583731014|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
161639928|NCT03698019|583731013|FG000|Step 1: Registration|Withdrawal by Subject|7|||
161639929|NCT03698019|583731014|FG001|Step 1: Registration|Withdrawal by Subject|2|||
161639930|NCT03698019|583731013|FG000|Step 1: Registration|Toxicity|0|||
161639931|NCT03698019|583731014|FG001|Step 1: Registration|Toxicity|1|||
161639932|NCT03698019|583731013|FG000|Step 1: Registration|Disease Progression|0|||
161639933|NCT03698019|583731014|FG001|Step 1: Registration|Disease Progression|12|||
161639934|NCT03698019|583731013|FG000|Step 1: Registration|Co-morbidities|0|||
161639935|NCT03698019|583731014|FG001|Step 1: Registration|Co-morbidities|1|||
161639936|NCT03698019|583731013|FG000|Step 1: Registration|Scheduling Issues|1|||
161639937|NCT03698019|583731014|FG001|Step 1: Registration|Scheduling Issues|0|||
161639938|NCT03698019|583731013|FG000|Step 1: Registration|Participant Refusal|0|||
161639939|NCT03698019|583731014|FG001|Step 1: Registration|Participant Refusal|1|||
161639940|NCT03698019|583731013|FG000|Step 2: Surgery|Participant Refusal|2|||
161639941|NCT03698019|583731014|FG001|Step 2: Surgery|Participant Refusal|1|||
161639942|NCT03698019|583731013|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
161639943|NCT03698019|583731014|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
161639944|NCT03698019|583731013|FG000|Step 2: Surgery|Metastatic Disease|16|||
161639945|NCT03698019|583731014|FG001|Step 2: Surgery|Metastatic Disease|9|||
161639946|NCT03698019|583731013|FG000|Step 2: Surgery|Residual Disease|2|||
161639947|NCT03698019|583731014|FG001|Step 2: Surgery|Residual Disease|1|||
161639948|NCT03698019|583731013|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
161639949|NCT03698019|583731014|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
161639950|NCT03698019|583731013|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
161639951|NCT03698019|583731014|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
161639952|NCT03698019|583731013|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
161639953|NCT03698019|583731014|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
161639954|NCT03698019|583731013|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
161639955|NCT03698019|583731014|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
161639956|NCT03698019|583731013|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
161639957|NCT03698019|583731014|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
161639958|NCT03698019|583731013|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
161639959|NCT03698019|583731014|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
161639960|NCT03698019|583731013|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
161639961|NCT03698019|583731014|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
161639962|NCT03698019|583731013|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
161639963|NCT03698019|583731014|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
161639964|NCT04340843|583731017|FG000|Overall Study|Adverse Event|0|||
161639965|NCT04340843|583731018|FG001|Overall Study|Adverse Event|2|||
161639966|NCT04340843|583731017|FG000|Overall Study|Withdrawal by Subject|0|||
161639967|NCT04340843|583731018|FG001|Overall Study|Withdrawal by Subject|2|||
161639968|NCT04021043|583732539|FG000|Overall Study|Adverse Event|3|||
161639969|NCT04021043|583732540|FG001|Overall Study|Adverse Event|1|||
161639970|NCT04021043|583732541|FG002|Overall Study|Adverse Event|1|||
161639971|NCT04021043|583732542|FG003|Overall Study|Adverse Event|0|||
161639972|NCT04021043|583732539|FG000|Overall Study|Death|2|||
161639973|NCT04021043|583732540|FG001|Overall Study|Death|3|||
161639974|NCT04021043|583732541|FG002|Overall Study|Death|1|||
161639975|NCT04021043|583732542|FG003|Overall Study|Death|3|||
161639976|NCT04021043|583732539|FG000|Overall Study|Withdrawal by Subject|1|||
161639977|NCT04021043|583732540|FG001|Overall Study|Withdrawal by Subject|1|||
161639978|NCT04021043|583732541|FG002|Overall Study|Withdrawal by Subject|1|||
161639979|NCT04021043|583732542|FG003|Overall Study|Withdrawal by Subject|6|||
161639980|NCT04021043|583732539|FG000|Overall Study|Discontinued due to disease progression|4|||
161639981|NCT04021043|583732540|FG001|Overall Study|Discontinued due to disease progression|5|||
161639982|NCT04021043|583732541|FG002|Overall Study|Discontinued due to disease progression|7|||
161639983|NCT04021043|583732542|FG003|Overall Study|Discontinued due to disease progression|10|||
161639984|NCT00826228|583732543|FG000|Overall Study|Withdrawal by Subject|1|||
161639985|NCT03118050|583732544|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
161639986|NCT03118050|583732545|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
161639987|NCT03118050|583732546|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
161639988|NCT03118050|583732547|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
161835281|NCT01206816|584438908|FG001|Overall Study|Withdrawal by Subject|0|||
161835282|NCT01206816|584438909|FG002|Overall Study|Withdrawal by Subject|1|||
161639989|NCT03118050|583732548|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
161639990|NCT03118050|583732549|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
161639991|NCT03118050|583732550|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
161639992|NCT01454739|583732552|FG000|Overall Study|Protocol Violation|2|||
161639993|NCT01454739|583732553|FG001|Overall Study|Protocol Violation|3|||
161639994|NCT01454739|583732552|FG000|Overall Study|Withdrawal by Subject|2|||
161835283|NCT01206816|584438910|FG003|Overall Study|Withdrawal by Subject|0|||
161835284|NCT01206816|584438911|FG004|Overall Study|Withdrawal by Subject|0|||
161835285|NCT01206816|584438912|FG005|Overall Study|Withdrawal by Subject|0|||
161835286|NCT01206816|584438913|FG006|Overall Study|Withdrawal by Subject|0|||
161835287|NCT01206816|584438907|FG000|Overall Study|Progressive disease|3|||
161835288|NCT01206816|584438908|FG001|Overall Study|Progressive disease|3|||
161639995|NCT01454739|583732553|FG001|Overall Study|Withdrawal by Subject|6|||
161639996|NCT01454739|583732552|FG000|Overall Study|Other|3|||
161639997|NCT01454739|583732553|FG001|Overall Study|Other|5|||
161639998|NCT01454739|583732552|FG000|Overall Study|Physician Decision|0|||
161639999|NCT01454739|583732553|FG001|Overall Study|Physician Decision|5|||
161640000|NCT01454739|583732552|FG000|Overall Study|Lost to Follow-up|0|||
161640001|NCT01454739|583732553|FG001|Overall Study|Lost to Follow-up|1|||
161640002|NCT01454739|583732552|FG000|Overall Study|Adverse Event|0|||
161640003|NCT01454739|583732553|FG001|Overall Study|Adverse Event|1|||
161640004|NCT05765435|583732554|FG000|Overall Study|Lost to Follow-up|0|||
161640005|NCT05765435|583732555|FG001|Overall Study|Lost to Follow-up|1|||
161640006|NCT05765435|583732556|FG002|Overall Study|Lost to Follow-up|0|||
161640007|NCT05765435|583732554|FG000|Overall Study|Withdrawal by Subject|0|||
161640008|NCT05765435|583732555|FG001|Overall Study|Withdrawal by Subject|0|||
161640009|NCT05765435|583732556|FG002|Overall Study|Withdrawal by Subject|1|||
161640010|NCT04351269|583732557|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
161640011|NCT04351269|583732558|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
161640012|NCT04351269|583732559|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
161640013|NCT04351269|583732557|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
161640014|NCT04351269|583732558|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
161640015|NCT04351269|583732559|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
161640016|NCT04351269|583732557|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
161640017|NCT04351269|583732558|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
161640018|NCT04351269|583732559|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
161640019|NCT04351269|583732557|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
161640020|NCT04351269|583732558|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
161640021|NCT04351269|583732559|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
161640022|NCT04351269|583732557|FG000|Overall Study|Lost to Follow-up|1|||
161640023|NCT04351269|583732558|FG001|Overall Study|Lost to Follow-up|3|||
161640024|NCT04351269|583732559|FG002|Overall Study|Lost to Follow-up|0|||
161640025|NCT02980523|583732569|FG000|Overall Study|Lost to Follow-up|1|||
161640026|NCT02980523|583732570|FG001|Overall Study|Lost to Follow-up|4|||
161640027|NCT02980523|583732571|FG002|Overall Study|Lost to Follow-up|1|||
161640028|NCT02980523|583732572|FG003|Overall Study|Lost to Follow-up|2|||
161640029|NCT02980523|583732573|FG004|Overall Study|Lost to Follow-up|1|||
161640030|NCT02980523|583732569|FG000|Overall Study|Excluded from analysis|1|||
161640031|NCT02980523|583732570|FG001|Overall Study|Excluded from analysis|3|||
161640032|NCT02980523|583732571|FG002|Overall Study|Excluded from analysis|1|||
161640033|NCT02980523|583732572|FG003|Overall Study|Excluded from analysis|1|||
161640034|NCT02980523|583732573|FG004|Overall Study|Excluded from analysis|1|||
161640035|NCT02980523|583732569|FG000|Overall Study|Lack of Efficacy|1|||
161640036|NCT02980523|583732570|FG001|Overall Study|Lack of Efficacy|4|||
161640037|NCT02980523|583732571|FG002|Overall Study|Lack of Efficacy|4|||
161640038|NCT02980523|583732572|FG003|Overall Study|Lack of Efficacy|5|||
161640039|NCT02980523|583732573|FG004|Overall Study|Lack of Efficacy|8|||
161640040|NCT02980523|583732569|FG000|Overall Study|Did not receive intervention|0|||
161640041|NCT02980523|583732570|FG001|Overall Study|Did not receive intervention|0|||
161640042|NCT02980523|583732571|FG002|Overall Study|Did not receive intervention|0|||
161640043|NCT02980523|583732572|FG003|Overall Study|Did not receive intervention|1|||
161640044|NCT02980523|583732573|FG004|Overall Study|Did not receive intervention|0|||
161640045|NCT00633945|583732574|FG000|Overall Study|Physician Decision|2|||
161640046|NCT00882115|583732575|FG000|Overall Study|Withdrawal by Subject|3|||
161640047|NCT00882115|583732575|FG000|Overall Study|did not respond to DEP challe|6|||
161640048|NCT02552147|583732576|FG000|First Intervention (7 Days)|Protocol Violation|1|||
161640049|NCT02552147|583732577|FG001|First Intervention (7 Days)|Protocol Violation|0|||
161640050|NCT02552147|583732576|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
161640051|NCT02552147|583732577|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
161640052|NCT01850589|583732582|FG000|Overall Study|Withdrawal by Subject|8|||
161640053|NCT01850589|583732583|FG001|Overall Study|Withdrawal by Subject|0|||
161640054|NCT03912662|583732584|FG000|Overall Study|Adverse Event|3|||
161640055|NCT03912662|583732584|FG000|Overall Study|Adverse Event and Death|1|||
161640056|NCT03912662|583732584|FG000|Overall Study|Death|1|||
161640057|NCT03912662|583732584|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
161640058|NCT03912662|583732584|FG000|Overall Study|Mesh Removal|1|||
161687360|NCT01464307|583907210|FG000|Open-Label Extension Period|Death|1|||
161835289|NCT01206816|584438909|FG002|Overall Study|Progressive disease|13|||
161640059|NCT03912662|583732584|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
161640060|NCT03912662|583732584|FG000|Overall Study|Early study termination|20|||
161640061|NCT03845140|583732585|FG000|Overall Study|Participant travelled outside study area|0|||
161640062|NCT03845140|583732586|FG001|Overall Study|Participant travelled outside study area|1|||
161640063|NCT03845140|583732587|FG002|Overall Study|Participant travelled outside study area|0|||
161640064|NCT03845140|583732588|FG003|Overall Study|Participant travelled outside study area|0|||
161640065|NCT03845140|583732589|FG004|Overall Study|Participant travelled outside study area|0|||
161640066|NCT03845140|583732590|FG005|Overall Study|Participant travelled outside study area|0|||
161640067|NCT01592045|583732598|FG000|Overall Study|Disease Progression|1|||
161640068|NCT01592045|583732599|FG001|Overall Study|Disease Progression|1|||
161640069|NCT01592045|583732598|FG000|Overall Study|Adverse Event|1|||
161640070|NCT01592045|583732599|FG001|Overall Study|Adverse Event|1|||
161640071|NCT01592045|583732598|FG000|Overall Study|Withdrawal by Subject|1|||
161640072|NCT01592045|583732599|FG001|Overall Study|Withdrawal by Subject|0|||
161640073|NCT01592045|583732598|FG000|Overall Study|Moved out of country|2|||
161640074|NCT01592045|583732599|FG001|Overall Study|Moved out of country|0|||
161640075|NCT03721705|583732602|FG000|Overall Study|Adverse Event|2|||
161640076|NCT03721705|583732603|FG001|Overall Study|Adverse Event|0|||
161640077|NCT03721705|583732602|FG000|Overall Study|Withdrawal by Subject|4|||
161640078|NCT03721705|583732603|FG001|Overall Study|Withdrawal by Subject|10|||
161640079|NCT03721705|583732602|FG000|Overall Study|No Suitable Study Partner|1|||
161640080|NCT03721705|583732603|FG001|Overall Study|No Suitable Study Partner|0|||
161640081|NCT03721705|583732602|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
161640082|NCT03721705|583732603|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
161640083|NCT03721705|583732602|FG000|Overall Study|Death|0|||
161640084|NCT03721705|583732603|FG001|Overall Study|Death|1|||
161640085|NCT01843777|583732604|FG000|Overall Study|Withdrawal by Subject|1|||
161640086|NCT01843777|583732605|FG001|Overall Study|Withdrawal by Subject|0|||
161640087|NCT00420784|583732611|FG000|Overall Study|Adverse Event|11|||
161640088|NCT00420784|583732612|FG001|Overall Study|Adverse Event|29|||
161640089|NCT00420784|583732613|FG002|Overall Study|Adverse Event|10|||
161640090|NCT00420784|583732614|FG003|Overall Study|Adverse Event|5|||
161640091|NCT00420784|583732611|FG000|Overall Study|Withdrawal by Subject|0|||
161640092|NCT00420784|583732612|FG001|Overall Study|Withdrawal by Subject|1|||
161640093|NCT00420784|583732613|FG002|Overall Study|Withdrawal by Subject|0|||
161640094|NCT00420784|583732614|FG003|Overall Study|Withdrawal by Subject|0|||
161640095|NCT00420784|583732611|FG000|Overall Study|Lost to Follow-up|0|||
161640096|NCT00420784|583732612|FG001|Overall Study|Lost to Follow-up|0|||
161640097|NCT00420784|583732613|FG002|Overall Study|Lost to Follow-up|2|||
161640098|NCT00420784|583732614|FG003|Overall Study|Lost to Follow-up|1|||
161640099|NCT00420784|583732611|FG000|Overall Study|Virologic Stopping Rule|17|||
161640100|NCT00420784|583732612|FG001|Overall Study|Virologic Stopping Rule|26|||
161640101|NCT00420784|583732613|FG002|Overall Study|Virologic Stopping Rule|41|||
161640102|NCT00420784|583732614|FG003|Overall Study|Virologic Stopping Rule|67|||
161640103|NCT00420784|583732611|FG000|Overall Study|Other|1|||
161640104|NCT00420784|583732612|FG001|Overall Study|Other|2|||
161640105|NCT00420784|583732613|FG002|Overall Study|Other|0|||
161640106|NCT00420784|583732614|FG003|Overall Study|Other|5|||
161640107|NCT02599688|583732617|FG000|Overall Study|Lack of Efficacy|1|||
161640108|NCT02599688|583732617|FG000|Overall Study|Withdrawal by Subject|1|||
161640109|NCT02599688|583732617|FG000|Overall Study|Termination by Sponsor|2|||
161640110|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
161640111|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
161640112|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
161640113|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
161640114|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
161640115|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
161640116|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
161640117|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
161640118|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
161640119|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
161640120|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
161640121|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
161640122|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
161640123|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
161835290|NCT01206816|584438910|FG003|Overall Study|Progressive disease|3|||
161640124|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
161640125|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
161640126|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
161640127|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
161640128|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Missing|2|||
161640129|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Missing|1|||
161640130|NCT00443209|583732619|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
161640131|NCT00443209|583732620|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
161640132|NCT00443209|583732619|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
161640133|NCT00443209|583732620|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
161640134|NCT00443209|583732619|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
161640135|NCT00443209|583732620|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
161640136|NCT00443209|583732619|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
161640137|NCT00443209|583732620|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
161640138|NCT00443209|583732619|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
161640139|NCT00443209|583732620|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
161640140|NCT00443209|583732619|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
161640141|NCT00443209|583732620|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
161640142|NCT00443209|583732619|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
161640143|NCT00443209|583732620|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
161640144|NCT01318876|583732621|FG000|Day 8 Survey|email address invalid|96|||
161640145|NCT01318876|583732621|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
161640146|NCT01318876|583732621|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
161640147|NCT01101061|583732624|FG000|Overall Study|Adverse Event|0|||
161640148|NCT01101061|583732625|FG001|Overall Study|Adverse Event|0|||
161640149|NCT01101061|583732626|FG002|Overall Study|Adverse Event|1|||
161640150|NCT01101061|583732627|FG003|Overall Study|Adverse Event|0|||
161640151|NCT01101061|583732628|FG004|Overall Study|Adverse Event|0|||
161640152|NCT01101061|583732629|FG005|Overall Study|Adverse Event|0|||
161640153|NCT02049515|583732630|FG000|Overall Study|Adverse Event|46|||
161640154|NCT02049515|583732631|FG001|Overall Study|Adverse Event|2|||
161640155|NCT02049515|583732630|FG000|Overall Study|Protocol-specified Disease Progression|23|||
161640156|NCT02049515|583732631|FG001|Overall Study|Protocol-specified Disease Progression|2|||
161640157|NCT02049515|583732630|FG000|Overall Study|Death|6|||
161640158|NCT02049515|583732631|FG001|Overall Study|Death|0|||
161640159|NCT02049515|583732630|FG000|Overall Study|Physician Decision|5|||
161640160|NCT02049515|583732631|FG001|Overall Study|Physician Decision|1|||
161640161|NCT02049515|583732630|FG000|Overall Study|Withdrawal by Subject|3|||
161640162|NCT02049515|583732631|FG001|Overall Study|Withdrawal by Subject|0|||
161640163|NCT02049515|583732630|FG000|Overall Study|Termination of the Study by Sponsor|2|||
161640164|NCT02049515|583732631|FG001|Overall Study|Termination of the Study by Sponsor|0|||
161640165|NCT02049515|583732630|FG000|Overall Study|Protocol Violation|1|||
161640166|NCT02049515|583732631|FG001|Overall Study|Protocol Violation|1|||
161640167|NCT02049515|583732630|FG000|Overall Study|Clinical Deterioration|1|||
161640168|NCT02049515|583732631|FG001|Overall Study|Clinical Deterioration|0|||
161640169|NCT02049515|583732630|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
161640170|NCT02049515|583732631|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
161640171|NCT02049515|583732630|FG000|Overall Study|Treatment Interruption >42 Days|1|||
161640172|NCT02049515|583732631|FG001|Overall Study|Treatment Interruption >42 Days|0|||
161640173|NCT02049515|583732630|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
161640174|NCT02049515|583732631|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
161640175|NCT03513068|583732633|FG000|Overall Study|Death|1|||
161640176|NCT03513068|583732634|FG001|Overall Study|Death|0|||
161640177|NCT03513068|583732633|FG000|Overall Study|Withdrawal by Subject|4|||
161640178|NCT03513068|583732634|FG001|Overall Study|Withdrawal by Subject|6|||
161640179|NCT03636373|583732636|FG000|Overall Study|Study closure due to Covid-19|1|||
161640180|NCT03636373|583732637|FG001|Overall Study|Study closure due to Covid-19|0|||
161640181|NCT01236352|583732641|FG000|Overall Study|Death|0|||
161640182|NCT01236352|583732642|FG001|Overall Study|Death|0|||
161640183|NCT01236352|583732643|FG002|Overall Study|Death|0|||
161640184|NCT01236352|583732644|FG003|Overall Study|Death|0|||
161640185|NCT01236352|583732645|FG004|Overall Study|Death|0|||
161640186|NCT01236352|583732646|FG005|Overall Study|Death|0|||
161640187|NCT01236352|583732647|FG006|Overall Study|Death|0|||
161640188|NCT01236352|583732648|FG007|Overall Study|Death|1|||
161640189|NCT01236352|583732649|FG008|Overall Study|Death|0|||
161640190|NCT01236352|583732650|FG009|Overall Study|Death|0|||
161640191|NCT01236352|583732651|FG010|Overall Study|Death|0|||
161640192|NCT01236352|583732641|FG000|Overall Study|Withdrawal by Subject|0|||
161640193|NCT01236352|583732642|FG001|Overall Study|Withdrawal by Subject|0|||
161687361|NCT01464307|583907211|FG001|Open-Label Extension Period|Death|0|||
161687362|NCT01464307|583907210|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161640194|NCT01236352|583732643|FG002|Overall Study|Withdrawal by Subject|0|||
161640195|NCT01236352|583732644|FG003|Overall Study|Withdrawal by Subject|0|||
161640196|NCT01236352|583732645|FG004|Overall Study|Withdrawal by Subject|0|||
161640197|NCT01236352|583732646|FG005|Overall Study|Withdrawal by Subject|0|||
161640198|NCT01236352|583732647|FG006|Overall Study|Withdrawal by Subject|0|||
161640199|NCT01236352|583732648|FG007|Overall Study|Withdrawal by Subject|0|||
161640200|NCT01236352|583732649|FG008|Overall Study|Withdrawal by Subject|0|||
161640201|NCT01236352|583732650|FG009|Overall Study|Withdrawal by Subject|2|||
161640202|NCT01236352|583732651|FG010|Overall Study|Withdrawal by Subject|1|||
161687363|NCT01464307|583907211|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
161640203|NCT01236352|583732641|FG000|Overall Study|Adverse Event|0|||
161640204|NCT01236352|583732642|FG001|Overall Study|Adverse Event|0|||
161640205|NCT01236352|583732643|FG002|Overall Study|Adverse Event|0|||
161640206|NCT01236352|583732644|FG003|Overall Study|Adverse Event|0|||
161640207|NCT01236352|583732645|FG004|Overall Study|Adverse Event|0|||
161640208|NCT01236352|583732646|FG005|Overall Study|Adverse Event|0|||
161640209|NCT01236352|583732647|FG006|Overall Study|Adverse Event|2|||
161640210|NCT01236352|583732648|FG007|Overall Study|Adverse Event|0|||
161640211|NCT01236352|583732649|FG008|Overall Study|Adverse Event|0|||
161640212|NCT01236352|583732650|FG009|Overall Study|Adverse Event|4|||
161640213|NCT01236352|583732651|FG010|Overall Study|Adverse Event|1|||
161640214|NCT01236352|583732641|FG000|Overall Study|Study drug toxicity|0|||
161640215|NCT01236352|583732642|FG001|Overall Study|Study drug toxicity|0|||
161640216|NCT01236352|583732643|FG002|Overall Study|Study drug toxicity|0|||
161640217|NCT01236352|583732644|FG003|Overall Study|Study drug toxicity|0|||
161640218|NCT01236352|583732645|FG004|Overall Study|Study drug toxicity|0|||
161640219|NCT01236352|583732646|FG005|Overall Study|Study drug toxicity|1|||
161640220|NCT01236352|583732647|FG006|Overall Study|Study drug toxicity|1|||
161640221|NCT01236352|583732648|FG007|Overall Study|Study drug toxicity|0|||
161640222|NCT01236352|583732649|FG008|Overall Study|Study drug toxicity|0|||
161640223|NCT01236352|583732650|FG009|Overall Study|Study drug toxicity|2|||
161640224|NCT01236352|583732651|FG010|Overall Study|Study drug toxicity|2|||
161640225|NCT01236352|583732641|FG000|Overall Study|Disease progression|1|||
161640226|NCT01236352|583732642|FG001|Overall Study|Disease progression|2|||
161640227|NCT01236352|583732643|FG002|Overall Study|Disease progression|1|||
161640228|NCT01236352|583732644|FG003|Overall Study|Disease progression|2|||
161640229|NCT01236352|583732645|FG004|Overall Study|Disease progression|2|||
161640230|NCT01236352|583732646|FG005|Overall Study|Disease progression|2|||
161640231|NCT01236352|583732647|FG006|Overall Study|Disease progression|1|||
161640232|NCT01236352|583732648|FG007|Overall Study|Disease progression|3|||
161640233|NCT01236352|583732649|FG008|Overall Study|Disease progression|2|||
161640234|NCT01236352|583732650|FG009|Overall Study|Disease progression|2|||
161640235|NCT01236352|583732651|FG010|Overall Study|Disease progression|2|||
161640236|NCT01236352|583732641|FG000|Overall Study|Poor/Non-compliance|1|||
161640237|NCT01236352|583732642|FG001|Overall Study|Poor/Non-compliance|0|||
161640238|NCT01236352|583732643|FG002|Overall Study|Poor/Non-compliance|0|||
161640239|NCT01236352|583732644|FG003|Overall Study|Poor/Non-compliance|0|||
161640240|NCT01236352|583732645|FG004|Overall Study|Poor/Non-compliance|0|||
161640241|NCT01236352|583732646|FG005|Overall Study|Poor/Non-compliance|0|||
161640242|NCT01236352|583732647|FG006|Overall Study|Poor/Non-compliance|0|||
161640243|NCT01236352|583732648|FG007|Overall Study|Poor/Non-compliance|0|||
161640244|NCT01236352|583732649|FG008|Overall Study|Poor/Non-compliance|0|||
161640245|NCT01236352|583732650|FG009|Overall Study|Poor/Non-compliance|0|||
161640246|NCT01236352|583732651|FG010|Overall Study|Poor/Non-compliance|0|||
161640247|NCT01236352|583732641|FG000|Overall Study|Maximum clinical benefit|1|||
161640248|NCT01236352|583732642|FG001|Overall Study|Maximum clinical benefit|1|||
161640249|NCT01236352|583732643|FG002|Overall Study|Maximum clinical benefit|1|||
161640250|NCT01236352|583732644|FG003|Overall Study|Maximum clinical benefit|0|||
161640251|NCT01236352|583732645|FG004|Overall Study|Maximum clinical benefit|2|||
161640252|NCT01236352|583732646|FG005|Overall Study|Maximum clinical benefit|0|||
161640253|NCT01236352|583732647|FG006|Overall Study|Maximum clinical benefit|3|||
161640254|NCT01236352|583732648|FG007|Overall Study|Maximum clinical benefit|1|||
161640255|NCT01236352|583732649|FG008|Overall Study|Maximum clinical benefit|1|||
161640256|NCT01236352|583732650|FG009|Overall Study|Maximum clinical benefit|4|||
161640257|NCT01236352|583732651|FG010|Overall Study|Maximum clinical benefit|2|||
161640258|NCT01236352|583732641|FG000|Overall Study|Subject request to discontinue treatment|0|||
161640259|NCT01236352|583732642|FG001|Overall Study|Subject request to discontinue treatment|0|||
161640260|NCT01236352|583732643|FG002|Overall Study|Subject request to discontinue treatment|1|||
161640261|NCT01236352|583732644|FG003|Overall Study|Subject request to discontinue treatment|1|||
161640262|NCT01236352|583732645|FG004|Overall Study|Subject request to discontinue treatment|0|||
161640263|NCT01236352|583732646|FG005|Overall Study|Subject request to discontinue treatment|1|||
161640264|NCT01236352|583732647|FG006|Overall Study|Subject request to discontinue treatment|0|||
161640265|NCT01236352|583732648|FG007|Overall Study|Subject request to discontinue treatment|0|||
161640266|NCT01236352|583732649|FG008|Overall Study|Subject request to discontinue treatment|0|||
161640267|NCT01236352|583732650|FG009|Overall Study|Subject request to discontinue treatment|1|||
161640268|NCT01236352|583732651|FG010|Overall Study|Subject request to discontinue treatment|4|||
161640269|NCT01236352|583732641|FG000|Overall Study|Subject to receive drug via EAP|1|||
161640270|NCT01236352|583732642|FG001|Overall Study|Subject to receive drug via EAP|1|||
161640271|NCT01236352|583732643|FG002|Overall Study|Subject to receive drug via EAP|1|||
161640272|NCT01236352|583732644|FG003|Overall Study|Subject to receive drug via EAP|0|||
161640273|NCT01236352|583732645|FG004|Overall Study|Subject to receive drug via EAP|0|||
161640274|NCT01236352|583732646|FG005|Overall Study|Subject to receive drug via EAP|0|||
161640275|NCT01236352|583732647|FG006|Overall Study|Subject to receive drug via EAP|0|||
161640276|NCT01236352|583732648|FG007|Overall Study|Subject to receive drug via EAP|2|||
161640277|NCT01236352|583732649|FG008|Overall Study|Subject to receive drug via EAP|0|||
161640278|NCT01236352|583732650|FG009|Overall Study|Subject to receive drug via EAP|4|||
161640279|NCT01236352|583732651|FG010|Overall Study|Subject to receive drug via EAP|0|||
161640280|NCT01236352|583732641|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
161640281|NCT01236352|583732642|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
161640282|NCT01236352|583732643|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
161640283|NCT01236352|583732644|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
161640284|NCT01236352|583732645|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
161640285|NCT01236352|583732646|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
161640286|NCT01236352|583732647|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
161640287|NCT01236352|583732648|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
161640288|NCT01236352|583732649|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
161640289|NCT01236352|583732650|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
161640290|NCT01236352|583732651|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
161640291|NCT01236352|583732641|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640292|NCT01236352|583732642|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640293|NCT01236352|583732643|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640294|NCT01236352|583732644|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640295|NCT01236352|583732645|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640296|NCT01236352|583732646|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640297|NCT01236352|583732647|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640298|NCT01236352|583732648|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640299|NCT01236352|583732649|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640300|NCT01236352|583732650|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161640301|NCT01236352|583732651|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
161640302|NCT01236352|583732641|FG000|Overall Study|Lack of response to drug|0|||
161640303|NCT01236352|583732642|FG001|Overall Study|Lack of response to drug|0|||
161640304|NCT01236352|583732643|FG002|Overall Study|Lack of response to drug|0|||
161640305|NCT01236352|583732644|FG003|Overall Study|Lack of response to drug|0|||
161640306|NCT01236352|583732645|FG004|Overall Study|Lack of response to drug|0|||
161640307|NCT01236352|583732646|FG005|Overall Study|Lack of response to drug|0|||
161640308|NCT01236352|583732647|FG006|Overall Study|Lack of response to drug|0|||
161640309|NCT01236352|583732648|FG007|Overall Study|Lack of response to drug|0|||
161640310|NCT01236352|583732649|FG008|Overall Study|Lack of response to drug|0|||
161640311|NCT01236352|583732650|FG009|Overall Study|Lack of response to drug|1|||
161640312|NCT01236352|583732651|FG010|Overall Study|Lack of response to drug|1|||
161640313|NCT01236352|583732641|FG000|Overall Study|Patient transferred to IST|0|||
161640314|NCT01236352|583732642|FG001|Overall Study|Patient transferred to IST|0|||
161640315|NCT01236352|583732643|FG002|Overall Study|Patient transferred to IST|0|||
161640316|NCT01236352|583732644|FG003|Overall Study|Patient transferred to IST|0|||
161640317|NCT01236352|583732645|FG004|Overall Study|Patient transferred to IST|0|||
161640318|NCT01236352|583732646|FG005|Overall Study|Patient transferred to IST|0|||
161640319|NCT01236352|583732647|FG006|Overall Study|Patient transferred to IST|0|||
161640320|NCT01236352|583732648|FG007|Overall Study|Patient transferred to IST|0|||
161640321|NCT01236352|583732649|FG008|Overall Study|Patient transferred to IST|0|||
161640322|NCT01236352|583732650|FG009|Overall Study|Patient transferred to IST|2|||
161640323|NCT01236352|583732651|FG010|Overall Study|Patient transferred to IST|6|||
161640324|NCT01575873|583732652|FG000|Overall Study|Withdrawal by Subject|15|||
161640325|NCT01575873|583732653|FG001|Overall Study|Withdrawal by Subject|20|||
161640326|NCT01575873|583732654|FG002|Overall Study|Withdrawal by Subject|34|||
161640327|NCT01575873|583732655|FG003|Overall Study|Withdrawal by Subject|34|||
161640328|NCT01575873|583732652|FG000|Overall Study|Adverse Event|7|||
161640329|NCT01575873|583732653|FG001|Overall Study|Adverse Event|7|||
161640330|NCT01575873|583732654|FG002|Overall Study|Adverse Event|9|||
161640331|NCT01575873|583732655|FG003|Overall Study|Adverse Event|12|||
161640332|NCT01575873|583732652|FG000|Overall Study|Lost to Follow-up|1|||
161640333|NCT01575873|583732653|FG001|Overall Study|Lost to Follow-up|3|||
161640334|NCT01575873|583732654|FG002|Overall Study|Lost to Follow-up|13|||
161640335|NCT01575873|583732655|FG003|Overall Study|Lost to Follow-up|5|||
161640336|NCT01575873|583732652|FG000|Overall Study|Death|3|||
161640337|NCT01575873|583732653|FG001|Overall Study|Death|2|||
161640338|NCT01575873|583732654|FG002|Overall Study|Death|8|||
161640339|NCT01575873|583732655|FG003|Overall Study|Death|9|||
161640340|NCT01575873|583732652|FG000|Overall Study|Noncompliance|1|||
161640341|NCT01575873|583732653|FG001|Overall Study|Noncompliance|2|||
161640342|NCT01575873|583732654|FG002|Overall Study|Noncompliance|4|||
161640343|NCT01575873|583732655|FG003|Overall Study|Noncompliance|3|||
161640344|NCT01575873|583732652|FG000|Overall Study|Administrative decision|1|||
161640345|NCT01575873|583732653|FG001|Overall Study|Administrative decision|1|||
161640346|NCT01575873|583732654|FG002|Overall Study|Administrative decision|1|||
161640347|NCT01575873|583732655|FG003|Overall Study|Administrative decision|0|||
161640348|NCT01575873|583732652|FG000|Overall Study|Protocol deviation|0|||
161640349|NCT01575873|583732653|FG001|Overall Study|Protocol deviation|1|||
161640350|NCT01575873|583732654|FG002|Overall Study|Protocol deviation|0|||
161640351|NCT01575873|583732655|FG003|Overall Study|Protocol deviation|1|||
161640352|NCT01575873|583732652|FG000|Overall Study|Requirement for Alternative Therapy|0|||
161640353|NCT01575873|583732653|FG001|Overall Study|Requirement for Alternative Therapy|0|||
161640354|NCT01575873|583732654|FG002|Overall Study|Requirement for Alternative Therapy|1|||
161640355|NCT01575873|583732655|FG003|Overall Study|Requirement for Alternative Therapy|1|||
161640356|NCT01575873|583732652|FG000|Overall Study|Other|0|||
161640357|NCT01575873|583732653|FG001|Overall Study|Other|0|||
161640358|NCT01575873|583732654|FG002|Overall Study|Other|4|||
161640359|NCT01575873|583732655|FG003|Overall Study|Other|2|||
161640360|NCT01850030|583732656|FG000|Overall Study|Adverse Event|64|||
161640361|NCT01850030|583732657|FG001|Overall Study|Adverse Event|82|||
161640362|NCT01850030|583732656|FG000|Overall Study|Lack of Efficacy|3|||
161640363|NCT01850030|583732657|FG001|Overall Study|Lack of Efficacy|1|||
161640364|NCT01850030|583732656|FG000|Overall Study|Lost to Follow-up|5|||
161640365|NCT01850030|583732657|FG001|Overall Study|Lost to Follow-up|5|||
161640366|NCT01850030|583732656|FG000|Overall Study|Withdrawal by Subject|3|||
161640367|NCT01850030|583732657|FG001|Overall Study|Withdrawal by Subject|4|||
161640368|NCT01850030|583732656|FG000|Overall Study|Protocol Violation|24|||
161640369|NCT01850030|583732657|FG001|Overall Study|Protocol Violation|28|||
161640370|NCT01850030|583732656|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
161640371|NCT01850030|583732657|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
161640372|NCT05903183|583732660|FG000|Main Trial Part (365 Days)|Death|1|||
161640373|NCT05903183|583732661|FG001|Main Trial Part (365 Days)|Death|0|||
161640374|NCT05903183|583732662|FG002|Main Trial Part (365 Days)|Death|0|||
161640375|NCT05903183|583732663|FG003|Main Trial Part (365 Days)|Death|0|||
161640376|NCT05903183|583732664|FG004|Main Trial Part (365 Days)|Death|0|||
161640377|NCT05903183|583732660|FG000|Main Trial Part (365 Days)|Other|1|||
161640378|NCT05903183|583732661|FG001|Main Trial Part (365 Days)|Other|2|||
161640379|NCT05903183|583732662|FG002|Main Trial Part (365 Days)|Other|1|||
161640380|NCT05903183|583732663|FG003|Main Trial Part (365 Days)|Other|0|||
161640381|NCT05903183|583732664|FG004|Main Trial Part (365 Days)|Other|0|||
161640382|NCT05903183|583732660|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161640383|NCT05903183|583732661|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161640384|NCT05903183|583732662|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
161640385|NCT05903183|583732663|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161640386|NCT05903183|583732664|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161640387|NCT05903183|583732660|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
161640388|NCT05903183|583732661|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161640389|NCT05903183|583732662|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161640390|NCT05903183|583732663|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161640391|NCT05903183|583732664|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161640392|NCT05903183|583732660|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
161640393|NCT05903183|583732661|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
161640394|NCT05903183|583732662|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
161640395|NCT05903183|583732663|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
161640396|NCT05903183|583732664|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
161640397|NCT02647645|583732665|FG000|Overall Study|Lost to Follow-up|2|||
161640398|NCT02647645|583732666|FG001|Overall Study|Lost to Follow-up|1|||
161640399|NCT04599907|583732669|FG000|Overall Study|Withdrawal by Subject|1|||
161640400|NCT04599907|583732670|FG001|Overall Study|Withdrawal by Subject|7|||
161640401|NCT04599907|583732671|FG002|Overall Study|Withdrawal by Subject|6|||
161640402|NCT04599907|583732669|FG000|Overall Study|Lost to Follow-up|0|||
161640403|NCT04599907|583732670|FG001|Overall Study|Lost to Follow-up|1|||
161640404|NCT04599907|583732671|FG002|Overall Study|Lost to Follow-up|0|||
161640405|NCT03007732|583732672|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
161640406|NCT03007732|583732673|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
161640407|NCT03007732|583732674|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
161640408|NCT03007732|583732675|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
161640409|NCT03371823|583732676|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
161640410|NCT03371823|583732677|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
161640411|NCT01466790|583732679|FG000|Overall Study|Adverse Event|1|||
161640412|NCT01466790|583732680|FG001|Overall Study|Adverse Event|0|||
161640413|NCT01466790|583732681|FG002|Overall Study|Adverse Event|0|||
161640414|NCT01466790|583732682|FG003|Overall Study|Adverse Event|0|||
161640415|NCT01466790|583732683|FG004|Overall Study|Adverse Event|2|||
161640416|NCT01466790|583732684|FG005|Overall Study|Adverse Event|0|||
161640417|NCT01466790|583732685|FG006|Overall Study|Adverse Event|0|||
161640418|NCT01466790|583732686|FG007|Overall Study|Adverse Event|0|||
161640419|NCT01466790|583732679|FG000|Overall Study|Lost to Follow-up|2|||
161640420|NCT01466790|583732680|FG001|Overall Study|Lost to Follow-up|0|||
161640421|NCT01466790|583732681|FG002|Overall Study|Lost to Follow-up|0|||
161640422|NCT01466790|583732682|FG003|Overall Study|Lost to Follow-up|0|||
161640423|NCT01466790|583732683|FG004|Overall Study|Lost to Follow-up|0|||
161640424|NCT01466790|583732684|FG005|Overall Study|Lost to Follow-up|0|||
161640425|NCT01466790|583732685|FG006|Overall Study|Lost to Follow-up|0|||
161640426|NCT01466790|583732686|FG007|Overall Study|Lost to Follow-up|0|||
161687364|NCT01464307|583907210|FG000|Open-Label Extension Period|Non-compliance|9|||
161687365|NCT01464307|583907211|FG001|Open-Label Extension Period|Non-compliance|0|||
161687366|NCT01464307|583907210|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
161687367|NCT01464307|583907211|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
161640427|NCT01466790|583732679|FG000|Overall Study|Withdrawal by Subject|1|||
161640428|NCT01466790|583732680|FG001|Overall Study|Withdrawal by Subject|1|||
161640429|NCT01466790|583732681|FG002|Overall Study|Withdrawal by Subject|0|||
161640430|NCT01466790|583732682|FG003|Overall Study|Withdrawal by Subject|0|||
161640431|NCT01466790|583732683|FG004|Overall Study|Withdrawal by Subject|1|||
161640432|NCT01466790|583732684|FG005|Overall Study|Withdrawal by Subject|0|||
161640433|NCT01466790|583732685|FG006|Overall Study|Withdrawal by Subject|1|||
161640434|NCT01466790|583732686|FG007|Overall Study|Withdrawal by Subject|1|||
161640435|NCT03668223|583732687|FG000|Overall Study|Death|10|||
161640436|NCT03668223|583732688|FG001|Overall Study|Death|5|||
161640437|NCT03668223|583732687|FG000|Overall Study|Lost to Follow-up|12|||
161640438|NCT03668223|583732688|FG001|Overall Study|Lost to Follow-up|12|||
161640439|NCT03668223|583732687|FG000|Overall Study|Withdrawal by Subject|8|||
161640440|NCT03668223|583732688|FG001|Overall Study|Withdrawal by Subject|3|||
161640441|NCT05502783|583732689|FG000|Overall Study|Lack of Efficacy|1|||
161640442|NCT04870957|583732690|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161640443|NCT04870957|583732691|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161640444|NCT04870957|583732692|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161640445|NCT04870957|583732693|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161640446|NCT04870957|583732694|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
161640447|NCT04870957|583732695|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161640448|NCT04870957|583732690|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161640449|NCT04870957|583732691|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161640450|NCT04870957|583732692|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161640451|NCT04870957|583732693|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161640452|NCT04870957|583732694|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
161640453|NCT04870957|583732695|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161640454|NCT04870957|583732690|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161640455|NCT04870957|583732691|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161640456|NCT04870957|583732692|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161640457|NCT04870957|583732693|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161640458|NCT04870957|583732694|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
161640459|NCT04870957|583732695|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161640460|NCT04870957|583732690|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161640461|NCT04870957|583732691|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161640462|NCT04870957|583732692|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161640463|NCT04870957|583732693|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161640464|NCT04870957|583732694|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
161640465|NCT04870957|583732695|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161640466|NCT04870957|583732690|FG000|T2 (Randomization) - T3|Adverse Event|1|||
161640467|NCT04870957|583732691|FG001|T2 (Randomization) - T3|Adverse Event|1|||
161640468|NCT04870957|583732692|FG002|T2 (Randomization) - T3|Adverse Event|0|||
161640469|NCT04870957|583732693|FG003|T2 (Randomization) - T3|Adverse Event|0|||
161640470|NCT04870957|583732694|FG004|T2 (Randomization) - T3|Adverse Event|0|||
161640471|NCT04870957|583732695|FG005|T2 (Randomization) - T3|Adverse Event|0|||
161687368|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Death|3|||
161687369|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Death|0|||
161640472|NCT04870957|583732690|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
161640473|NCT04870957|583732691|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
161640474|NCT04870957|583732692|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
161640475|NCT04870957|583732693|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
161640476|NCT04870957|583732694|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
161640477|NCT04870957|583732695|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
161640478|NCT04870957|583732690|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
161640479|NCT04870957|583732691|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
161640480|NCT04870957|583732692|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
161640481|NCT04870957|583732693|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
161640482|NCT04870957|583732694|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
161640483|NCT04870957|583732695|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
161640484|NCT04870957|583732690|FG000|T2 (Randomization) - T3|Physician Decision|0|||
161835291|NCT01206816|584438911|FG004|Overall Study|Progressive disease|3|||
161640485|NCT04870957|583732691|FG001|T2 (Randomization) - T3|Physician Decision|0|||
161640486|NCT04870957|583732692|FG002|T2 (Randomization) - T3|Physician Decision|2|||
161640487|NCT04870957|583732693|FG003|T2 (Randomization) - T3|Physician Decision|1|||
161640488|NCT04870957|583732694|FG004|T2 (Randomization) - T3|Physician Decision|0|||
161835292|NCT01206816|584438912|FG005|Overall Study|Progressive disease|16|||
161640489|NCT04870957|583732695|FG005|T2 (Randomization) - T3|Physician Decision|0|||
161640490|NCT04870957|583732690|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
161640491|NCT04870957|583732691|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
161640492|NCT04870957|583732692|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
161640493|NCT04870957|583732693|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
161640494|NCT04870957|583732694|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
161640495|NCT04870957|583732695|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
161640496|NCT04870957|583732690|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
161640497|NCT04870957|583732691|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
161640498|NCT04870957|583732692|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
161640499|NCT04870957|583732693|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
161640500|NCT04870957|583732694|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
161640501|NCT04870957|583732695|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
161640502|NCT04870957|583732690|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
161640503|NCT04870957|583732691|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
161640504|NCT04870957|583732692|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
161640505|NCT04870957|583732693|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
161640506|NCT04870957|583732694|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
161640507|NCT04870957|583732695|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
161640508|NCT04870957|583732690|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
161640509|NCT04870957|583732691|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
161640510|NCT04870957|583732692|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
161640511|NCT04870957|583732693|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
161640512|NCT04870957|583732694|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
161640513|NCT04870957|583732695|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
161640514|NCT04870957|583732690|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
161640515|NCT04870957|583732691|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
161640516|NCT04870957|583732692|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
161640517|NCT04870957|583732693|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
161640518|NCT04870957|583732694|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
161640519|NCT04870957|583732695|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
161640520|NCT04870957|583732690|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
161640521|NCT04870957|583732691|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
161640522|NCT04870957|583732692|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
161640523|NCT04870957|583732693|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
161640524|NCT04870957|583732694|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
161640525|NCT04870957|583732695|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
161640526|NCT04870957|583732690|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161640527|NCT04870957|583732691|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161640528|NCT04870957|583732692|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161640529|NCT04870957|583732693|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161640530|NCT04870957|583732694|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161640531|NCT04870957|583732695|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
161640532|NCT04870957|583732690|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161640533|NCT04870957|583732691|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161640534|NCT04870957|583732692|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161640535|NCT04870957|583732693|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161640536|NCT04870957|583732694|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161640537|NCT04870957|583732695|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
161640538|NCT04870957|583732690|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
161640539|NCT04870957|583732691|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
161640540|NCT04870957|583732692|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
161640541|NCT04870957|583732693|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
161640542|NCT04870957|583732694|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
161640543|NCT04870957|583732695|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
161640544|NCT03733899|583732698|FG000|Period 1|Protocol Violation|0|||
161640545|NCT03733899|583732699|FG001|Period 1|Protocol Violation|0|||
161640546|NCT03733899|583732700|FG002|Period 1|Protocol Violation|0|||
161835293|NCT01206816|584438913|FG006|Overall Study|Progressive disease|3|||
161640547|NCT03733899|583732701|FG003|Period 1|Protocol Violation|0|||
161640548|NCT03733899|583732702|FG004|Period 1|Protocol Violation|0|||
161640549|NCT03733899|583732703|FG005|Period 1|Protocol Violation|1|||
161640550|NCT03733899|583732698|FG000|Period 2|Unscuccessful Treatment|0|||
161640551|NCT03733899|583732699|FG001|Period 2|Unscuccessful Treatment|1|||
161640552|NCT03733899|583732700|FG002|Period 2|Unscuccessful Treatment|0|||
161835294|NCT01206816|584438907|FG000|Overall Study|Other AE|0|||
161640553|NCT03733899|583732701|FG003|Period 2|Unscuccessful Treatment|0|||
161640554|NCT03733899|583732702|FG004|Period 2|Unscuccessful Treatment|0|||
161640555|NCT03733899|583732703|FG005|Period 2|Unscuccessful Treatment|0|||
161640556|NCT03733899|583732698|FG000|Period 3|Withdrawal by Subject|1|||
161640557|NCT03733899|583732699|FG001|Period 3|Withdrawal by Subject|0|||
161640558|NCT03733899|583732700|FG002|Period 3|Withdrawal by Subject|0|||
161640559|NCT03733899|583732701|FG003|Period 3|Withdrawal by Subject|0|||
161640560|NCT03733899|583732702|FG004|Period 3|Withdrawal by Subject|0|||
161640561|NCT03733899|583732703|FG005|Period 3|Withdrawal by Subject|0|||
161640562|NCT02859064|583734261|FG000|Overall Study|Progressive Disease|3|||
161640563|NCT02859064|583734261|FG000|Overall Study|Physician Decision|1|||
161640564|NCT02859064|583734261|FG000|Overall Study|Withdrawal by Subject|1|||
161640565|NCT02859064|583734261|FG000|Overall Study|Death|1|||
161640566|NCT00667459|583734265|FG000|Overall Study|Death|0|||
161640567|NCT00667459|583734266|FG001|Overall Study|Death|2|||
161640568|NCT00667459|583734265|FG000|Overall Study|Lost to Follow-up|8|||
161640569|NCT00667459|583734266|FG001|Overall Study|Lost to Follow-up|43|||
161640570|NCT02568397|583734267|FG000|Period 2|Withdrawal by Subject|0|||
161640571|NCT02568397|583734268|FG001|Period 2|Withdrawal by Subject|1|||
161640572|NCT02568397|583734267|FG000|Period 2|Physician Decision|0|||
161640573|NCT02568397|583734268|FG001|Period 2|Physician Decision|1|||
161640574|NCT00078377|583734269|FG000|Overall Study|Adverse Event|2|||
161640575|NCT00078377|583734270|FG001|Overall Study|Adverse Event|5|||
161640576|NCT00078377|583734271|FG002|Overall Study|Adverse Event|1|||
161640577|NCT00078377|583734269|FG000|Overall Study|Lack of Efficacy|2|||
161640578|NCT00078377|583734270|FG001|Overall Study|Lack of Efficacy|0|||
161640579|NCT00078377|583734271|FG002|Overall Study|Lack of Efficacy|2|||
161640580|NCT00078377|583734269|FG000|Overall Study|Lost to Follow-up|0|||
161640581|NCT00078377|583734270|FG001|Overall Study|Lost to Follow-up|1|||
161640582|NCT00078377|583734271|FG002|Overall Study|Lost to Follow-up|1|||
161640583|NCT00078377|583734269|FG000|Overall Study|Physician Decision|2|||
161640584|NCT00078377|583734270|FG001|Overall Study|Physician Decision|0|||
161640585|NCT00078377|583734271|FG002|Overall Study|Physician Decision|0|||
161640586|NCT00078377|583734269|FG000|Overall Study|Withdrawal by Subject|3|||
161640587|NCT00078377|583734270|FG001|Overall Study|Withdrawal by Subject|4|||
161640588|NCT00078377|583734271|FG002|Overall Study|Withdrawal by Subject|4|||
161640589|NCT00078377|583734269|FG000|Overall Study|Miscellaneous|2|||
161640590|NCT00078377|583734270|FG001|Overall Study|Miscellaneous|6|||
161640591|NCT00078377|583734271|FG002|Overall Study|Miscellaneous|1|||
161640592|NCT00581893|583734272|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
161640593|NCT00581893|583734273|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
161640594|NCT01381575|583734274|FG000|Overall Study|Serious Adverse Event|1|||
161640595|NCT01381575|583734275|FG001|Overall Study|Serious Adverse Event|0|||
161640596|NCT01381575|583734276|FG002|Overall Study|Serious Adverse Event|0|||
161640597|NCT01381575|583734274|FG000|Overall Study|Non-Serious Adverse Event|0|||
161640598|NCT01381575|583734275|FG001|Overall Study|Non-Serious Adverse Event|0|||
161640599|NCT01381575|583734276|FG002|Overall Study|Non-Serious Adverse Event|1|||
161640600|NCT01381575|583734274|FG000|Overall Study|Protocol Violation|0|||
161640601|NCT01381575|583734275|FG001|Overall Study|Protocol Violation|1|||
161640602|NCT01381575|583734276|FG002|Overall Study|Protocol Violation|1|||
161640603|NCT01381575|583734274|FG000|Overall Study|Withdrawal by Subject|15|||
161640604|NCT01381575|583734275|FG001|Overall Study|Withdrawal by Subject|9|||
161640605|NCT01381575|583734276|FG002|Overall Study|Withdrawal by Subject|7|||
161640606|NCT01381575|583734274|FG000|Overall Study|Migrated/moved from study area|2|||
161640607|NCT01381575|583734275|FG001|Overall Study|Migrated/moved from study area|12|||
161640608|NCT01381575|583734276|FG002|Overall Study|Migrated/moved from study area|2|||
161640609|NCT01381575|583734274|FG000|Overall Study|Lost to Follow-up|8|||
161640610|NCT01381575|583734275|FG001|Overall Study|Lost to Follow-up|17|||
161640611|NCT01381575|583734276|FG002|Overall Study|Lost to Follow-up|9|||
161640612|NCT03020069|583734277|FG000|Overall Study|Lost to Follow-up|0|||
161640613|NCT03020069|583734278|FG001|Overall Study|Lost to Follow-up|1|||
161640614|NCT01920932|583734279|FG000|Overall Study|Death|1|||
161640615|NCT01920932|583734279|FG000|Overall Study|Withdrawal of consent|1|||
161640616|NCT04486313|583734280|FG000|Overall Study|Lost to Follow-up|7|||
161640617|NCT04486313|583734281|FG001|Overall Study|Lost to Follow-up|9|||
161640618|NCT04486313|583734280|FG000|Overall Study|Withdrawal by Subject|8|||
161640619|NCT04486313|583734281|FG001|Overall Study|Withdrawal by Subject|6|||
161640620|NCT04486313|583734280|FG000|Overall Study|Physician Decision|1|||
161640621|NCT04486313|583734281|FG001|Overall Study|Physician Decision|1|||
161640622|NCT04486313|583734280|FG000|Overall Study|Death|2|||
161640623|NCT04486313|583734281|FG001|Overall Study|Death|0|||
161640624|NCT04486313|583734280|FG000|Overall Study|Protocol Violation|1|||
161640625|NCT04486313|583734281|FG001|Overall Study|Protocol Violation|1|||
161640626|NCT01375751|583734282|FG000|Overall Study|Other|0|||
161640627|NCT01375751|583734283|FG001|Overall Study|Other|1|||
161640628|NCT01375751|583734284|FG002|Overall Study|Other|0|||
161640629|NCT00940875|583734285|FG000|Treatment Phase|Adverse Event|9|||
161640630|NCT00940875|583734286|FG001|Treatment Phase|Adverse Event|3|||
161640631|NCT00940875|583734285|FG000|Treatment Phase|Death|3|||
161640632|NCT00940875|583734286|FG001|Treatment Phase|Death|5|||
161640633|NCT00940875|583734285|FG000|Treatment Phase|Lack of Efficacy|1|||
161640634|NCT00940875|583734286|FG001|Treatment Phase|Lack of Efficacy|0|||
161640635|NCT00940875|583734285|FG000|Treatment Phase|Withdrawal by Subject|3|||
161640636|NCT00940875|583734286|FG001|Treatment Phase|Withdrawal by Subject|0|||
161640637|NCT00940875|583734285|FG000|Treatment Phase|Disease progression|9|||
161640638|NCT00940875|583734286|FG001|Treatment Phase|Disease progression|11|||
161640639|NCT00940875|583734285|FG000|Treatment Phase|Physician Decision|1|||
161640640|NCT00940875|583734286|FG001|Treatment Phase|Physician Decision|0|||
161640641|NCT00940875|583734285|FG000|Post-Study Treatment|Death|0|||
161640642|NCT00940875|583734286|FG001|Post-Study Treatment|Death|1|||
161640643|NCT00940875|583734285|FG000|Post-Study Treatment|Disease Progression|0|||
161640644|NCT00940875|583734286|FG001|Post-Study Treatment|Disease Progression|2|||
161640645|NCT00943787|583734287|FG000|Overall Study|Physician Decision|4|||
161640646|NCT00943787|583734287|FG000|Overall Study|Withdrawal by Subject|3|||
161640647|NCT01547598|583734288|FG000|Overall Study|Withdrew consent|1|||
161640648|NCT01547598|583734289|FG001|Overall Study|Withdrew consent|1|||
161640649|NCT01547598|583734288|FG000|Overall Study|Lost to Follow-up|1|||
161640650|NCT01547598|583734289|FG001|Overall Study|Lost to Follow-up|1|||
161640651|NCT01547598|583734288|FG000|Overall Study|Adverse Event|1|||
161640652|NCT01547598|583734289|FG001|Overall Study|Adverse Event|1|||
161640653|NCT01547598|583734288|FG000|Overall Study|Protocol Violation|1|||
161640654|NCT01547598|583734289|FG001|Overall Study|Protocol Violation|1|||
161640655|NCT01547598|583734288|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161640656|NCT01547598|583734289|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161640657|NCT00872001|583734291|FG000|Overall Study|Adverse Event|34|||
161640658|NCT00872001|583734292|FG001|Overall Study|Adverse Event|23|||
161640659|NCT00872001|583734291|FG000|Overall Study|Protocol Defined Clinical Event|5|||
161640660|NCT00872001|583734292|FG001|Overall Study|Protocol Defined Clinical Event|7|||
161640661|NCT00872001|583734291|FG000|Overall Study|Lost to Follow-up|13|||
161640662|NCT00872001|583734292|FG001|Overall Study|Lost to Follow-up|12|||
161640663|NCT00872001|583734291|FG000|Overall Study|Withdrawal by Subject|18|||
161640664|NCT00872001|583734292|FG001|Overall Study|Withdrawal by Subject|30|||
161640665|NCT00872001|583734291|FG000|Overall Study|Protocol Violation|5|||
161640666|NCT00872001|583734292|FG001|Overall Study|Protocol Violation|8|||
161640667|NCT00872001|583734291|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
161640668|NCT00872001|583734292|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
161640669|NCT00872001|583734291|FG000|Overall Study|Administrative|23|||
161640670|NCT00872001|583734292|FG001|Overall Study|Administrative|15|||
161640671|NCT04071301|583734293|FG000|Overall Study|Withdrawal by Subject|6|||
161640672|NCT04071301|583734293|FG000|Overall Study|Death|1|||
161640673|NCT05186311|583734294|FG000|Part A: Serum|Withdrawal by Subject|1|||
161640674|NCT02879383|583734295|FG000|First 24 Weeks|Physician Decision|0|||
161640675|NCT02879383|583734296|FG001|First 24 Weeks|Physician Decision|1|||
161640676|NCT02879383|583734297|FG002|First 24 Weeks|Physician Decision|0|||
161640677|NCT02879383|583734298|FG003|First 24 Weeks|Physician Decision|0|||
161640678|NCT02125279|583734299|FG000|Overall Study|Lack of Efficacy|2|||
161640679|NCT02125279|583734299|FG000|Overall Study|Withdrawal by Subject|6|||
161640680|NCT02125279|583734299|FG000|Overall Study|Protocol Violation|1|||
161640681|NCT02125279|583734299|FG000|Overall Study|Lost to Follow-up|4|||
161640682|NCT01607879|583734304|FG000|Overall Study|Death|1|||
161640683|NCT01607879|583734305|FG001|Overall Study|Death|0|||
161640684|NCT04016272|583734312|FG000|Overall Study|Withdrawal by Subject|1|||
161640685|NCT04016272|583734313|FG001|Overall Study|Withdrawal by Subject|2|||
161640686|NCT00825305|583734314|FG000|Overall Study|Adverse Event|1|||
161640687|NCT00825305|583734315|FG001|Overall Study|Adverse Event|1|||
161640688|NCT00825305|583734314|FG000|Overall Study|Withdrawal by Subject|6|||
161640689|NCT00825305|583734315|FG001|Overall Study|Withdrawal by Subject|12|||
161640690|NCT00825305|583734314|FG000|Overall Study|Inappropriate inclusion|1|||
161640691|NCT00825305|583734315|FG001|Overall Study|Inappropriate inclusion|0|||
161640692|NCT00825305|583734314|FG000|Overall Study|Protocol Violation|9|||
161640693|NCT00825305|583734315|FG001|Overall Study|Protocol Violation|9|||
161640694|NCT00825305|583734314|FG000|Overall Study|Can not be classified|0|||
161640695|NCT00825305|583734315|FG001|Overall Study|Can not be classified|1|||
161640696|NCT00246090|583734321|FG000|Overall Study|Adverse Event|25|||
161640697|NCT00246090|583734321|FG000|Overall Study|Withdrawal by Subject|7|||
161640698|NCT00246090|583734321|FG000|Overall Study|Progressive Disease|212|||
161640699|NCT00246090|583734321|FG000|Overall Study|Clinical Progression|30|||
161640700|NCT00246090|583734321|FG000|Overall Study|Physician Decision|11|||
161640701|NCT00246090|583734321|FG000|Overall Study|Not Otherwise Specified|10|||
161640702|NCT03332784|583734324|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640703|NCT03332784|583734325|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
161640704|NCT03332784|583734326|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640705|NCT03332784|583734327|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640706|NCT03332784|583734328|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640707|NCT03332784|583734329|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640708|NCT03332784|583734330|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640709|NCT03332784|583734331|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640710|NCT03332784|583734332|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640711|NCT03332784|583734333|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640712|NCT03332784|583734334|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640713|NCT03332784|583734335|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640714|NCT03332784|583734336|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640715|NCT03332784|583734337|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640716|NCT03332784|583734338|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
161640717|NCT03332784|583734339|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640718|NCT03332784|583734340|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640719|NCT03332784|583734341|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640720|NCT03332784|583734342|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640721|NCT03332784|583734343|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161640722|NCT00763451|583734349|FG000|Overall Study|Adverse Event|4|||
161640723|NCT00763451|583734350|FG001|Overall Study|Adverse Event|6|||
161640724|NCT00763451|583734351|FG002|Overall Study|Adverse Event|19|||
161640725|NCT00763451|583734352|FG003|Overall Study|Adverse Event|14|||
161640726|NCT00763451|583734349|FG000|Overall Study|Lack of Efficacy|1|||
161640727|NCT00763451|583734350|FG001|Overall Study|Lack of Efficacy|4|||
161640728|NCT00763451|583734351|FG002|Overall Study|Lack of Efficacy|3|||
161640729|NCT00763451|583734352|FG003|Overall Study|Lack of Efficacy|2|||
161640730|NCT00763451|583734349|FG000|Overall Study|Withdrawal by Subject|1|||
161640731|NCT00763451|583734350|FG001|Overall Study|Withdrawal by Subject|6|||
161640732|NCT00763451|583734351|FG002|Overall Study|Withdrawal by Subject|9|||
161640733|NCT00763451|583734352|FG003|Overall Study|Withdrawal by Subject|7|||
161640734|NCT00763451|583734349|FG000|Overall Study|Protocol Violation|0|||
161640735|NCT00763451|583734350|FG001|Overall Study|Protocol Violation|0|||
161640736|NCT00763451|583734351|FG002|Overall Study|Protocol Violation|1|||
161640737|NCT00763451|583734352|FG003|Overall Study|Protocol Violation|0|||
161640738|NCT00763451|583734349|FG000|Overall Study|Poor Compliance to Protocol|1|||
161640739|NCT00763451|583734350|FG001|Overall Study|Poor Compliance to Protocol|1|||
161640740|NCT00763451|583734351|FG002|Overall Study|Poor Compliance to Protocol|2|||
161640741|NCT00763451|583734352|FG003|Overall Study|Poor Compliance to Protocol|2|||
161640742|NCT00763451|583734349|FG000|Overall Study|Familial and Personal Reasons|5|||
161640743|NCT00763451|583734350|FG001|Overall Study|Familial and Personal Reasons|3|||
161640744|NCT00763451|583734351|FG002|Overall Study|Familial and Personal Reasons|5|||
161640745|NCT00763451|583734352|FG003|Overall Study|Familial and Personal Reasons|4|||
161640746|NCT00763451|583734349|FG000|Overall Study|Randomized but not Treated|1|||
161640747|NCT00763451|583734350|FG001|Overall Study|Randomized but not Treated|1|||
161640748|NCT00763451|583734351|FG002|Overall Study|Randomized but not Treated|0|||
161640749|NCT00763451|583734352|FG003|Overall Study|Randomized but not Treated|0|||
161640750|NCT00763451|583734349|FG000|Overall Study|Study Site Reason|0|||
161640751|NCT00763451|583734350|FG001|Overall Study|Study Site Reason|1|||
161640752|NCT00763451|583734351|FG002|Overall Study|Study Site Reason|1|||
161640753|NCT00763451|583734352|FG003|Overall Study|Study Site Reason|1|||
161640754|NCT02282917|583734356|FG000|Overall Study|Withdrawal by Subject|1|||
161640755|NCT02282917|583734356|FG000|Overall Study|Screen Failure/Not Eligible|1|||
161640756|NCT00115336|583734357|FG000|Overall Study|Hospital discharge before study drug|0|||
161640757|NCT00115336|583734358|FG001|Overall Study|Hospital discharge before study drug|1|||
161640758|NCT00569127|583734367|FG000|Overall Study|Adverse Event|57|||
161640759|NCT00569127|583734368|FG001|Overall Study|Adverse Event|47|||
161640760|NCT00569127|583734367|FG000|Overall Study|Withdrawal by Subject|13|||
161640761|NCT00569127|583734368|FG001|Overall Study|Withdrawal by Subject|27|||
161640762|NCT00569127|583734367|FG000|Overall Study|Progression|99|||
161640763|NCT00569127|583734368|FG001|Overall Study|Progression|100|||
161640764|NCT00569127|583734367|FG000|Overall Study|Death|4|||
161687370|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Adverse Event|12|||
161687371|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Adverse Event|6|||
161687372|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
161687373|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
161687374|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
161640765|NCT00569127|583734368|FG001|Overall Study|Death|3|||
161640766|NCT00569127|583734367|FG000|Overall Study|Other|20|||
161640767|NCT00569127|583734368|FG001|Overall Study|Other|19|||
161640768|NCT00569127|583734367|FG000|Overall Study|Lost to Follow-up|0|||
161640769|NCT00569127|583734368|FG001|Overall Study|Lost to Follow-up|3|||
161835295|NCT01206816|584438908|FG001|Overall Study|Other AE|0|||
161640770|NCT00569127|583734367|FG000|Overall Study|Not Eligible|14|||
161640771|NCT00569127|583734368|FG001|Overall Study|Not Eligible|11|||
161640772|NCT00569127|583734367|FG000|Overall Study|Still on Treatment|7|||
161640773|NCT00569127|583734368|FG001|Overall Study|Still on Treatment|3|||
161640774|NCT03149029|583734383|FG000|Overall Study|Adverse Event|2|||
161640775|NCT03149029|583734384|FG001|Overall Study|Adverse Event|0|||
161640776|NCT03735121|583734385|FG000|Overall Study|Death|3|||
161835296|NCT01206816|584438909|FG002|Overall Study|Other AE|4|||
161640777|NCT03735121|583734386|FG001|Overall Study|Death|6|||
161640778|NCT03735121|583734387|FG002|Overall Study|Death|19|||
161640779|NCT03735121|583734388|FG003|Overall Study|Death|97|||
161640780|NCT03735121|583734389|FG004|Overall Study|Death|205|||
161640781|NCT03735121|583734385|FG000|Overall Study|Lost to Follow-up|0|||
161640782|NCT03735121|583734386|FG001|Overall Study|Lost to Follow-up|0|||
161640783|NCT03735121|583734387|FG002|Overall Study|Lost to Follow-up|0|||
161640784|NCT03735121|583734388|FG003|Overall Study|Lost to Follow-up|2|||
161640785|NCT03735121|583734389|FG004|Overall Study|Lost to Follow-up|3|||
161640786|NCT03735121|583734385|FG000|Overall Study|New Therapy|0|||
161640787|NCT03735121|583734386|FG001|Overall Study|New Therapy|1|||
161640788|NCT03735121|583734387|FG002|Overall Study|New Therapy|0|||
161640789|NCT03735121|583734388|FG003|Overall Study|New Therapy|0|||
161640790|NCT03735121|583734389|FG004|Overall Study|New Therapy|0|||
161640791|NCT03735121|583734385|FG000|Overall Study|Study Ended by Sponsor|1|||
161640792|NCT03735121|583734386|FG001|Overall Study|Study Ended by Sponsor|0|||
161640793|NCT03735121|583734387|FG002|Overall Study|Study Ended by Sponsor|1|||
161640794|NCT03735121|583734388|FG003|Overall Study|Study Ended by Sponsor|17|||
161640795|NCT03735121|583734389|FG004|Overall Study|Study Ended by Sponsor|28|||
161640796|NCT03735121|583734385|FG000|Overall Study|Withdrawal by Subject|1|||
161640797|NCT03735121|583734386|FG001|Overall Study|Withdrawal by Subject|1|||
161640798|NCT03735121|583734387|FG002|Overall Study|Withdrawal by Subject|6|||
161640799|NCT03735121|583734388|FG003|Overall Study|Withdrawal by Subject|8|||
161640800|NCT03735121|583734389|FG004|Overall Study|Withdrawal by Subject|11|||
161640801|NCT02176863|583734390|FG000|Overall Study|Physician Decision|1|||
161640802|NCT02176863|583734391|FG001|Overall Study|Physician Decision|0|||
161640803|NCT02176863|583734392|FG002|Overall Study|Physician Decision|0|||
161640804|NCT02176863|583734393|FG003|Overall Study|Physician Decision|0|||
161640805|NCT02176863|583734394|FG004|Overall Study|Physician Decision|0|||
161640806|NCT02176863|583734390|FG000|Overall Study|Adverse Event|10|||
161687375|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
161687376|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
161687377|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
161687378|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
161687379|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
161687380|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Death|24|||
161687381|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Death|28|||
161687382|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
161687383|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
161687384|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
161687385|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
161687386|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
161687387|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
161687388|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
161687389|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
161687390|NCT03349099|583907216|FG000|Overall Study|Physician Decision|3|||
161687391|NCT03349099|583907217|FG001|Overall Study|Physician Decision|4|||
161687392|NCT03349099|583907216|FG000|Overall Study|Stone migrated from the kidney|1|||
161687393|NCT03349099|583907217|FG001|Overall Study|Stone migrated from the kidney|0|||
161687394|NCT00278993|583907218|FG000|Overall Study|Adverse Event|24|||
161687395|NCT00278993|583907218|FG000|Overall Study|Withdrawal by Subject|5|||
161687396|NCT00278993|583907218|FG000|Overall Study|Progressive Disease|65|||
161687397|NCT00278993|583907218|FG000|Overall Study|Physician Decision|9|||
161687398|NCT00278993|583907218|FG000|Overall Study|Not Otherwise Specified|4|||
161687399|NCT00894556|583907220|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
161687400|NCT00894556|583907221|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
161687401|NCT00894556|583907222|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
161687402|NCT00894556|583907223|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
161687403|NCT00894556|583907220|FG000|Treatment Phase|Lost to Follow-up|2|||
161640807|NCT02176863|583734391|FG001|Overall Study|Adverse Event|4|||
161640808|NCT02176863|583734392|FG002|Overall Study|Adverse Event|4|||
161640809|NCT02176863|583734393|FG003|Overall Study|Adverse Event|1|||
161687404|NCT00894556|583907221|FG001|Treatment Phase|Lost to Follow-up|3|||
161687405|NCT00894556|583907222|FG002|Treatment Phase|Lost to Follow-up|1|||
161687406|NCT00894556|583907223|FG003|Treatment Phase|Lost to Follow-up|0|||
161687407|NCT00894556|583907220|FG000|Treatment Phase|Lack of Qualifying Event|2|||
161640810|NCT02176863|583734394|FG004|Overall Study|Adverse Event|1|||
161640811|NCT02176863|583734390|FG000|Overall Study|Protocol Violation|2|||
161640812|NCT02176863|583734391|FG001|Overall Study|Protocol Violation|0|||
161640813|NCT02176863|583734392|FG002|Overall Study|Protocol Violation|1|||
161640814|NCT02176863|583734393|FG003|Overall Study|Protocol Violation|1|||
161640815|NCT02176863|583734394|FG004|Overall Study|Protocol Violation|0|||
161640816|NCT02176863|583734390|FG000|Overall Study|Withdrawal by Subject|4|||
161640817|NCT02176863|583734391|FG001|Overall Study|Withdrawal by Subject|2|||
161640818|NCT02176863|583734392|FG002|Overall Study|Withdrawal by Subject|2|||
161640819|NCT02176863|583734393|FG003|Overall Study|Withdrawal by Subject|3|||
161640820|NCT02176863|583734394|FG004|Overall Study|Withdrawal by Subject|4|||
161640821|NCT02176863|583734390|FG000|Overall Study|Reason not specified|0|||
161640822|NCT02176863|583734391|FG001|Overall Study|Reason not specified|1|||
161640823|NCT02176863|583734392|FG002|Overall Study|Reason not specified|1|||
161640824|NCT02176863|583734393|FG003|Overall Study|Reason not specified|2|||
161640825|NCT02176863|583734394|FG004|Overall Study|Reason not specified|1|||
161640826|NCT02176863|583734390|FG000|Overall Study|Lost to Follow-up|0|||
161640827|NCT02176863|583734391|FG001|Overall Study|Lost to Follow-up|1|||
161640828|NCT02176863|583734392|FG002|Overall Study|Lost to Follow-up|1|||
161640829|NCT02176863|583734393|FG003|Overall Study|Lost to Follow-up|0|||
161640830|NCT02176863|583734394|FG004|Overall Study|Lost to Follow-up|0|||
161640831|NCT02037256|583734395|FG000|Overall Study|Protocol Violation|0|||
161640832|NCT02037256|583734396|FG001|Overall Study|Protocol Violation|1|||
161640833|NCT02037256|583734395|FG000|Overall Study|Withdrawn prior to Velcade|0|||
161640834|NCT02037256|583734396|FG001|Overall Study|Withdrawn prior to Velcade|2|||
161640835|NCT00356811|583734399|FG000|Overall Study|Death|35|||
161640836|NCT00356811|583734399|FG000|Overall Study|Lost to Follow-up|2|||
161640837|NCT00356811|583734399|FG000|Overall Study|Withdrawal by Subject|6|||
161640838|NCT00356811|583734399|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
161640839|NCT00356811|583734399|FG000|Overall Study|Study Is Terminating|3|||
161640840|NCT00356811|583734399|FG000|Overall Study|Site Closed during Follow-up|2|||
161640841|NCT01310699|583734400|FG000|Overall Study|Patients did not complete tandem.|4|||
161640842|NCT01310699|583734401|FG001|Overall Study|Patients did not complete tandem.|6|||
161640843|NCT02386839|583734402|FG000|Overall Study|Death|1|||
161640844|NCT02386839|583734403|FG001|Overall Study|Death|0|||
161640845|NCT02386839|583734402|FG000|Overall Study|Withdrawal by Subject|9|||
161640846|NCT02386839|583734403|FG001|Overall Study|Withdrawal by Subject|10|||
161640847|NCT02386839|583734402|FG000|Overall Study|Lost to Follow-up|4|||
161640848|NCT02386839|583734403|FG001|Overall Study|Lost to Follow-up|4|||
161640849|NCT02386839|583734402|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
161640850|NCT02386839|583734403|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
161640851|NCT02386839|583734402|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
161640852|NCT02386839|583734403|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
161640853|NCT02386839|583734402|FG000|Overall Study|Other (unspecified)|1|||
161640854|NCT02386839|583734403|FG001|Overall Study|Other (unspecified)|0|||
161640855|NCT00926575|583734404|FG000|Overall Study|Adverse Event|1|||
161640856|NCT00926575|583734405|FG001|Overall Study|Adverse Event|1|||
161640857|NCT00926575|583734404|FG000|Overall Study|Death|4|||
161640858|NCT00926575|583734405|FG001|Overall Study|Death|4|||
161640859|NCT00926575|583734404|FG000|Overall Study|Lost to Follow-up|1|||
161640860|NCT00926575|583734405|FG001|Overall Study|Lost to Follow-up|1|||
161640861|NCT00926575|583734404|FG000|Overall Study|Physician Decision|1|||
161640862|NCT00926575|583734405|FG001|Overall Study|Physician Decision|2|||
161640863|NCT00926575|583734404|FG000|Overall Study|Protocol Violation|1|||
161640864|NCT00926575|583734405|FG001|Overall Study|Protocol Violation|0|||
161640865|NCT00926575|583734404|FG000|Overall Study|Withdrawal by Subject|8|||
161640866|NCT00926575|583734405|FG001|Overall Study|Withdrawal by Subject|9|||
161640867|NCT00490698|583734406|FG000|Overall Study|Withdrawal by Subject|1|||
161640868|NCT00490698|583734406|FG000|Overall Study|Disease Progression|7|||
161640869|NCT00490698|583734406|FG000|Overall Study|Physician Decision|2|||
161640870|NCT02101983|583734407|FG000|Overall Study|Physician Decision|1|||
161640871|NCT02101983|583734408|FG001|Overall Study|Physician Decision|0|||
161640872|NCT03725605|583734413|FG000|Overall Study|Unsuccessful TIL expansion|2|||
161640873|NCT00469859|583734414|FG000|Overall Study|Inevaluable|0|||
161640874|NCT00469859|583734415|FG001|Overall Study|Inevaluable|2|||
161640875|NCT04124471|583734416|FG000|Overall Study|screen failure|1|||
161640876|NCT01503086|583734417|FG000|Overall Study|Lost to Follow-up|0|||
161640877|NCT01503086|583734418|FG001|Overall Study|Lost to Follow-up|1|||
161640878|NCT01503086|583734419|FG002|Overall Study|Lost to Follow-up|0|||
161640879|NCT01503086|583734417|FG000|Overall Study|Did Not Start Treatment|4|||
161640880|NCT01503086|583734418|FG001|Overall Study|Did Not Start Treatment|3|||
161640881|NCT01503086|583734419|FG002|Overall Study|Did Not Start Treatment|3|||
161640882|NCT01503086|583734417|FG000|Overall Study|Progressive disease|3|||
161687408|NCT00894556|583907221|FG001|Treatment Phase|Lack of Qualifying Event|1|||
161640883|NCT01503086|583734418|FG001|Overall Study|Progressive disease|1|||
161640884|NCT01503086|583734419|FG002|Overall Study|Progressive disease|0|||
161640885|NCT01503086|583734417|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
161640886|NCT01503086|583734418|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
161640887|NCT01503086|583734419|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
161640888|NCT01503086|583734417|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
161640889|NCT01503086|583734418|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
161640890|NCT01503086|583734419|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
161640891|NCT05970640|583734422|FG000|Overall Study|Adverse Event|1|||
161640892|NCT05970640|583734423|FG001|Overall Study|Adverse Event|3|||
161640893|NCT05970640|583734424|FG002|Overall Study|Adverse Event|1|||
161640894|NCT05970640|583734425|FG003|Overall Study|Adverse Event|0|||
161640895|NCT05970640|583734422|FG000|Overall Study|Withdrawal by Subject|0|||
161640896|NCT05970640|583734423|FG001|Overall Study|Withdrawal by Subject|0|||
161640897|NCT05970640|583734424|FG002|Overall Study|Withdrawal by Subject|1|||
161640898|NCT05970640|583734425|FG003|Overall Study|Withdrawal by Subject|1|||
161640899|NCT05970640|583734422|FG000|Overall Study|Sponsor decision|0|||
161640900|NCT05970640|583734423|FG001|Overall Study|Sponsor decision|0|||
161640901|NCT05970640|583734424|FG002|Overall Study|Sponsor decision|1|||
161640902|NCT05970640|583734425|FG003|Overall Study|Sponsor decision|1|||
161640903|NCT02394925|583734426|FG000|Overall Study|Adverse Event|1|||
161640904|NCT02394925|583734426|FG000|Overall Study|Lens Discomfort|3|||
161640905|NCT02394925|583734426|FG000|Overall Study|Lens handling difficulities|5|||
161640906|NCT02394925|583734426|FG000|Overall Study|Lost to Follow-up|9|||
161640907|NCT02394925|583734426|FG000|Overall Study|Protocol Violation|5|||
161640908|NCT02394925|583734426|FG000|Overall Study|No longer meet eligibility criteria|1|||
161640909|NCT02394925|583734426|FG000|Overall Study|Unsatisfactory Visual Response|5|||
161640910|NCT04650698|583735850|FG000|Overall Study|Protocol Violation|2|||
161640911|NCT04650698|583735851|FG001|Overall Study|Protocol Violation|1|||
161640912|NCT04650698|583735850|FG000|Overall Study|Withdrawal by Subject|0|||
161640913|NCT04650698|583735851|FG001|Overall Study|Withdrawal by Subject|1|||
161640914|NCT02358668|583735852|FG000|Overall Study|Adverse Event|2|||
161640915|NCT02358668|583735853|FG001|Overall Study|Adverse Event|0|||
161640916|NCT02358668|583735854|FG002|Overall Study|Adverse Event|0|||
161640917|NCT02358668|583735852|FG000|Overall Study|Withdrawal by Subject|0|||
161640918|NCT02358668|583735853|FG001|Overall Study|Withdrawal by Subject|1|||
161640919|NCT02358668|583735854|FG002|Overall Study|Withdrawal by Subject|0|||
161640920|NCT02104505|583735855|FG000|First Intervention (14 Days)|Adverse Event|2|||
161640921|NCT02104505|583735856|FG001|First Intervention (14 Days)|Adverse Event|0|||
161640922|NCT02104505|583735855|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
161640923|NCT02104505|583735856|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
161640924|NCT02104505|583735855|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
161640925|NCT02104505|583735856|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
161640926|NCT02104505|583735855|FG000|First Intervention (14 Days)|exclusionary condition|0|||
161640927|NCT02104505|583735856|FG001|First Intervention (14 Days)|exclusionary condition|1|||
161640928|NCT02104505|583735855|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161640929|NCT02104505|583735856|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161640930|NCT02104505|583735855|FG000|Second Intervention (14 Days)|Adverse Event|2|||
161640931|NCT02104505|583735856|FG001|Second Intervention (14 Days)|Adverse Event|0|||
161640932|NCT01240551|583735857|FG000|Overall Study|Refused further treatment|3|||
161640933|NCT01240551|583735858|FG001|Overall Study|Refused further treatment|2|||
161640934|NCT01240551|583735857|FG000|Overall Study|Lost to Follow-up|1|||
161640935|NCT01240551|583735858|FG001|Overall Study|Lost to Follow-up|1|||
161640936|NCT01730950|583735861|FG000|Overall Study|Protocol Violation|6|||
161640937|NCT01730950|583735862|FG001|Overall Study|Protocol Violation|6|||
161640938|NCT02737826|583735863|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
161640939|NCT02737826|583735864|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
161640940|NCT02737826|583735865|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
161640941|NCT02354651|583735866|FG000|Overall Study|Withdrawal by Subject|2|||
161640942|NCT02354651|583735866|FG000|Overall Study|Physician Decision|1|||
161640943|NCT01317875|583735867|FG000|Overall Study|Other|0|||
161640944|NCT01317875|583735868|FG001|Overall Study|Other|0|||
161640945|NCT01317875|583735869|FG002|Overall Study|Other|1|||
161640946|NCT01317875|583735870|FG003|Overall Study|Other|0|||
161687409|NCT00894556|583907222|FG002|Treatment Phase|Lack of Qualifying Event|0|||
161687410|NCT00894556|583907223|FG003|Treatment Phase|Lack of Qualifying Event|0|||
161687411|NCT05054114|583907230|FG000|Overall Study|Protocol Violation|13|||
161687412|NCT05054114|583907231|FG001|Overall Study|Protocol Violation|1|||
161640947|NCT01317875|583735871|FG004|Overall Study|Other|0|||
161640948|NCT01317875|583735872|FG005|Overall Study|Other|0|||
161640949|NCT01317875|583735873|FG006|Overall Study|Other|0|||
161640950|NCT01317875|583735874|FG007|Overall Study|Other|0|||
161640951|NCT01317875|583735875|FG008|Overall Study|Other|0|||
161640952|NCT01317875|583735876|FG009|Overall Study|Other|0|||
161640953|NCT01317875|583735867|FG000|Overall Study|Noncompliance with study drug|0|||
161687413|NCT05054114|583907230|FG000|Overall Study|Pregnancy|0|||
161687414|NCT05054114|583907231|FG001|Overall Study|Pregnancy|1|||
161687415|NCT01806779|583907232|FG000|Overall Study|Physician Decision|2|||
161640954|NCT01317875|583735868|FG001|Overall Study|Noncompliance with study drug|0|||
161640955|NCT01317875|583735869|FG002|Overall Study|Noncompliance with study drug|1|||
161640956|NCT01317875|583735870|FG003|Overall Study|Noncompliance with study drug|0|||
161640957|NCT01317875|583735871|FG004|Overall Study|Noncompliance with study drug|0|||
161640958|NCT01317875|583735872|FG005|Overall Study|Noncompliance with study drug|0|||
161640959|NCT01317875|583735873|FG006|Overall Study|Noncompliance with study drug|0|||
161640960|NCT01317875|583735874|FG007|Overall Study|Noncompliance with study drug|0|||
161640961|NCT01317875|583735875|FG008|Overall Study|Noncompliance with study drug|0|||
161640962|NCT01317875|583735876|FG009|Overall Study|Noncompliance with study drug|0|||
161640963|NCT01317875|583735867|FG000|Overall Study|Progressive Disease|1|||
161640964|NCT01317875|583735868|FG001|Overall Study|Progressive Disease|0|||
161640965|NCT01317875|583735869|FG002|Overall Study|Progressive Disease|2|||
161640966|NCT01317875|583735870|FG003|Overall Study|Progressive Disease|0|||
161640967|NCT01317875|583735871|FG004|Overall Study|Progressive Disease|1|||
161640968|NCT01317875|583735872|FG005|Overall Study|Progressive Disease|0|||
161640969|NCT01317875|583735873|FG006|Overall Study|Progressive Disease|0|||
161640970|NCT01317875|583735874|FG007|Overall Study|Progressive Disease|1|||
161640971|NCT01317875|583735875|FG008|Overall Study|Progressive Disease|0|||
161640972|NCT01317875|583735876|FG009|Overall Study|Progressive Disease|0|||
161640973|NCT01317875|583735867|FG000|Overall Study|Withdrawal by Subject|0|||
161640974|NCT01317875|583735868|FG001|Overall Study|Withdrawal by Subject|0|||
161640975|NCT01317875|583735869|FG002|Overall Study|Withdrawal by Subject|0|||
161640976|NCT01317875|583735870|FG003|Overall Study|Withdrawal by Subject|0|||
161640977|NCT01317875|583735871|FG004|Overall Study|Withdrawal by Subject|1|||
161640978|NCT01317875|583735872|FG005|Overall Study|Withdrawal by Subject|0|||
161640979|NCT01317875|583735873|FG006|Overall Study|Withdrawal by Subject|0|||
161640980|NCT01317875|583735874|FG007|Overall Study|Withdrawal by Subject|3|||
161640981|NCT01317875|583735875|FG008|Overall Study|Withdrawal by Subject|0|||
161640982|NCT01317875|583735876|FG009|Overall Study|Withdrawal by Subject|0|||
161640983|NCT01317875|583735867|FG000|Overall Study|Physician Decision|0|||
161640984|NCT01317875|583735868|FG001|Overall Study|Physician Decision|1|||
161640985|NCT01317875|583735869|FG002|Overall Study|Physician Decision|1|||
161640986|NCT01317875|583735870|FG003|Overall Study|Physician Decision|0|||
161640987|NCT01317875|583735871|FG004|Overall Study|Physician Decision|2|||
161640988|NCT01317875|583735872|FG005|Overall Study|Physician Decision|0|||
161640989|NCT01317875|583735873|FG006|Overall Study|Physician Decision|0|||
161640990|NCT01317875|583735874|FG007|Overall Study|Physician Decision|2|||
161640991|NCT01317875|583735875|FG008|Overall Study|Physician Decision|0|||
161640992|NCT01317875|583735876|FG009|Overall Study|Physician Decision|0|||
161640993|NCT01317875|583735867|FG000|Overall Study|Death|0|||
161640994|NCT01317875|583735868|FG001|Overall Study|Death|0|||
161640995|NCT01317875|583735869|FG002|Overall Study|Death|2|||
161640996|NCT01317875|583735870|FG003|Overall Study|Death|1|||
161640997|NCT01317875|583735871|FG004|Overall Study|Death|0|||
161687416|NCT01806779|583907233|FG001|Overall Study|Physician Decision|0|||
161687417|NCT01806779|583907234|FG002|Overall Study|Physician Decision|1|||
161687418|NCT01806779|583907232|FG000|Overall Study|Lack of Efficacy|1|||
161640998|NCT01317875|583735872|FG005|Overall Study|Death|1|||
161640999|NCT01317875|583735873|FG006|Overall Study|Death|0|||
161641000|NCT01317875|583735874|FG007|Overall Study|Death|4|||
161641001|NCT01317875|583735875|FG008|Overall Study|Death|0|||
161641002|NCT01317875|583735876|FG009|Overall Study|Death|0|||
161687419|NCT01806779|583907233|FG001|Overall Study|Lack of Efficacy|1|||
161687420|NCT01806779|583907234|FG002|Overall Study|Lack of Efficacy|0|||
161641003|NCT01317875|583735867|FG000|Overall Study|Adverse Event|2|||
161641004|NCT01317875|583735868|FG001|Overall Study|Adverse Event|1|||
161641005|NCT01317875|583735869|FG002|Overall Study|Adverse Event|2|||
161641006|NCT01317875|583735870|FG003|Overall Study|Adverse Event|1|||
161641007|NCT01317875|583735871|FG004|Overall Study|Adverse Event|5|||
161641008|NCT01317875|583735872|FG005|Overall Study|Adverse Event|1|||
161641009|NCT01317875|583735873|FG006|Overall Study|Adverse Event|2|||
161641010|NCT01317875|583735874|FG007|Overall Study|Adverse Event|5|||
161641011|NCT01317875|583735875|FG008|Overall Study|Adverse Event|0|||
161641012|NCT01317875|583735876|FG009|Overall Study|Adverse Event|0|||
161641013|NCT01377389|583735877|FG000|Overall Study|Withdrawal by Subject|1|||
161641014|NCT01377389|583735877|FG000|Overall Study|Screen failure|2|||
161687421|NCT01806779|583907232|FG000|Overall Study|Lost to Follow-up|19|||
161641016|NCT00863512|583735888|FG000|Overall Study|Adverse Event|2|||
161641017|NCT00863512|583735889|FG001|Overall Study|Adverse Event|0|||
161641018|NCT00863512|583735888|FG000|Overall Study|Withdrawal by Subject|11|||
161641019|NCT00863512|583735889|FG001|Overall Study|Withdrawal by Subject|0|||
161641020|NCT00863512|583735888|FG000|Overall Study|Physician Decision|1|||
161641021|NCT00863512|583735889|FG001|Overall Study|Physician Decision|0|||
161641022|NCT05274750|583735893|FG000|Overall Study|Adverse Event|0|||
161641023|NCT05274750|583735894|FG001|Overall Study|Adverse Event|1|||
161641024|NCT05274750|583735893|FG000|Overall Study|Lost to Follow-up|2|||
161641025|NCT05274750|583735894|FG001|Overall Study|Lost to Follow-up|3|||
161641026|NCT05274750|583735893|FG000|Overall Study|Physician Decision|3|||
161641027|NCT05274750|583735894|FG001|Overall Study|Physician Decision|0|||
161641028|NCT05274750|583735893|FG000|Overall Study|Withdrawal by Subject|10|||
161641029|NCT05274750|583735894|FG001|Overall Study|Withdrawal by Subject|9|||
161641030|NCT05274750|583735893|FG000|Overall Study|GCP Violation|0|||
161641031|NCT05274750|583735894|FG001|Overall Study|GCP Violation|4|||
161641032|NCT05274750|583735893|FG000|Overall Study|Randomized, not treated|0|||
161641033|NCT05274750|583735894|FG001|Overall Study|Randomized, not treated|1|||
161641034|NCT04328623|583735899|FG000|Overall Study|Protocol Violation|0|||
161641035|NCT04328623|583735900|FG001|Overall Study|Protocol Violation|1|||
161641036|NCT04340947|583735901|FG000|7-day Washout Period|Lost to Follow-up|5|||
161641037|NCT04340947|583735902|FG001|7-day Washout Period|Lost to Follow-up|4|||
161641038|NCT02312557|583735903|FG000|Overall Study|Survival follow-up|4|||
161641039|NCT01437423|583735909|FG000|Overall Study|Lost to Follow-up|12|||
161641040|NCT01437423|583735909|FG000|Overall Study|Off label usage|3|||
161641041|NCT03721172|583735910|FG000|Placebo-controlled Phase|Adverse Event|7|||
161641042|NCT03721172|583735911|FG001|Placebo-controlled Phase|Adverse Event|7|||
161641043|NCT03721172|583735912|FG002|Placebo-controlled Phase|Adverse Event|0|||
161641044|NCT03721172|583735910|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
161641045|NCT03721172|583735911|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
161641046|NCT03721172|583735912|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161641047|NCT03721172|583735910|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
161641048|NCT03721172|583735911|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
161641049|NCT03721172|583735912|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
161641050|NCT03721172|583735910|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
161641051|NCT03721172|583735911|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
161835297|NCT01206816|584438910|FG003|Overall Study|Other AE|0|||
161835298|NCT01206816|584438911|FG004|Overall Study|Other AE|0|||
161835299|NCT01206816|584438912|FG005|Overall Study|Other AE|3|||
161835300|NCT01206816|584438913|FG006|Overall Study|Other AE|2|||
161641052|NCT03721172|583735912|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161641053|NCT03721172|583735910|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
161641054|NCT03721172|583735911|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
161641055|NCT03721172|583735912|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161641056|NCT03721172|583735910|FG000|Placebo-controlled Phase|Other|3|||
161641057|NCT03721172|583735911|FG001|Placebo-controlled Phase|Other|0|||
161641058|NCT03721172|583735912|FG002|Placebo-controlled Phase|Other|0|||
161641059|NCT03721172|583735910|FG000|Apremilast Extension Phase|Adverse Event|0|||
161641060|NCT03721172|583735911|FG001|Apremilast Extension Phase|Adverse Event|0|||
161641061|NCT03721172|583735912|FG002|Apremilast Extension Phase|Adverse Event|10|||
161641062|NCT03721172|583735910|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161641063|NCT03721172|583735911|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161641064|NCT03721172|583735912|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
161687422|NCT01806779|583907233|FG001|Overall Study|Lost to Follow-up|20|||
161687423|NCT01806779|583907234|FG002|Overall Study|Lost to Follow-up|0|||
161687424|NCT01806779|583907232|FG000|Overall Study|Withdrawal by Subject|20|||
161687425|NCT01806779|583907233|FG001|Overall Study|Withdrawal by Subject|23|||
161687426|NCT01806779|583907234|FG002|Overall Study|Withdrawal by Subject|22|||
161687427|NCT00805480|583907235|FG000|Overall Study|Withdrawal by Subject|13|||
161687428|NCT00805480|583907236|FG001|Overall Study|Withdrawal by Subject|5|||
161835301|NCT01206816|584438907|FG000|Overall Study|other than stated above|0|||
161835302|NCT01206816|584438908|FG001|Overall Study|other than stated above|0|||
161835303|NCT01206816|584438909|FG002|Overall Study|other than stated above|1|||
161835304|NCT01206816|584438910|FG003|Overall Study|other than stated above|0|||
161835305|NCT01206816|584438911|FG004|Overall Study|other than stated above|0|||
161835306|NCT01206816|584438912|FG005|Overall Study|other than stated above|0|||
161835307|NCT01206816|584438913|FG006|Overall Study|other than stated above|1|||
161835308|NCT02528123|584438915|FG000|Overall Study|Lost to Follow-up|1|||
161835309|NCT01939496|584438916|FG000|Overall Study|Adverse Event|2|||
161835310|NCT01939496|584438917|FG001|Overall Study|Adverse Event|0|||
161835311|NCT01939496|584438918|FG002|Overall Study|Adverse Event|0|||
161835312|NCT01939496|584438916|FG000|Overall Study|Lost to Follow-up|1|||
161835313|NCT01939496|584438917|FG001|Overall Study|Lost to Follow-up|1|||
161835314|NCT01939496|584438918|FG002|Overall Study|Lost to Follow-up|0|||
161835315|NCT01939496|584438916|FG000|Overall Study|Physician Decision|1|||
161835316|NCT01939496|584438917|FG001|Overall Study|Physician Decision|0|||
161835317|NCT01939496|584438918|FG002|Overall Study|Physician Decision|0|||
161835318|NCT01939496|584438916|FG000|Overall Study|Protocol Violation|3|||
161835319|NCT01939496|584438917|FG001|Overall Study|Protocol Violation|0|||
161835320|NCT01939496|584438918|FG002|Overall Study|Protocol Violation|0|||
161835321|NCT01939496|584438916|FG000|Overall Study|Withdrawal by Subject|0|||
161835322|NCT01939496|584438917|FG001|Overall Study|Withdrawal by Subject|1|||
161835323|NCT01939496|584438918|FG002|Overall Study|Withdrawal by Subject|1|||
161835324|NCT01939496|584438916|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
161835325|NCT01939496|584438917|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
161835326|NCT01939496|584438918|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
161835327|NCT01939496|584438916|FG000|Overall Study|Other|2|||
161835328|NCT01939496|584438917|FG001|Overall Study|Other|0|||
161835329|NCT01939496|584438918|FG002|Overall Study|Other|1|||
161835330|NCT00506129|584438921|FG000|Overall Study|Disease Progression/Relapse|15|||
161835331|NCT00506129|584438921|FG000|Overall Study|Death|7|||
161835332|NCT01642914|584438922|FG000|Overall Study|Adverse Event|11|||
161835333|NCT01642914|584438923|FG001|Overall Study|Adverse Event|7|||
161835334|NCT01642914|584438924|FG002|Overall Study|Adverse Event|15|||
161835335|NCT01642914|584438922|FG000|Overall Study|Lack of Efficacy|9|||
161835336|NCT01642914|584438923|FG001|Overall Study|Lack of Efficacy|4|||
161835337|NCT01642914|584438924|FG002|Overall Study|Lack of Efficacy|2|||
161835338|NCT01642914|584438922|FG000|Overall Study|Protocol Violation|15|||
161687429|NCT00805480|583907237|FG002|Overall Study|Withdrawal by Subject|11|||
161687430|NCT00805480|583907238|FG003|Overall Study|Withdrawal by Subject|5|||
161687431|NCT00805480|583907235|FG000|Overall Study|Lost to Follow-up|1|||
161687432|NCT00805480|583907236|FG001|Overall Study|Lost to Follow-up|2|||
161835339|NCT01642914|584438923|FG001|Overall Study|Protocol Violation|13|||
161835340|NCT01642914|584438924|FG002|Overall Study|Protocol Violation|6|||
161835341|NCT01642914|584438922|FG000|Overall Study|Withdrawal by Subject|5|||
161641065|NCT03721172|583735910|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
161641066|NCT03721172|583735911|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
161687433|NCT00805480|583907237|FG002|Overall Study|Lost to Follow-up|0|||
161687434|NCT00805480|583907238|FG003|Overall Study|Lost to Follow-up|0|||
161687435|NCT00805480|583907235|FG000|Overall Study|Adverse Event|0|||
161687436|NCT00805480|583907236|FG001|Overall Study|Adverse Event|0|||
161835342|NCT01642914|584438923|FG001|Overall Study|Withdrawal by Subject|5|||
161835343|NCT01642914|584438924|FG002|Overall Study|Withdrawal by Subject|10|||
161835344|NCT01642914|584438922|FG000|Overall Study|Lost to Follow-up|5|||
161835345|NCT01642914|584438923|FG001|Overall Study|Lost to Follow-up|3|||
161835346|NCT01642914|584438924|FG002|Overall Study|Lost to Follow-up|7|||
161835347|NCT01642914|584438922|FG000|Overall Study|Other Reason|1|||
161835348|NCT01642914|584438923|FG001|Overall Study|Other Reason|0|||
161835349|NCT01642914|584438924|FG002|Overall Study|Other Reason|0|||
161641067|NCT03721172|583735912|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
161641068|NCT03721172|583735910|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161641069|NCT03721172|583735911|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161641070|NCT03721172|583735912|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
161641071|NCT03721172|583735910|FG000|Apremilast Extension Phase|Protocol Violation|0|||
161641072|NCT03721172|583735911|FG001|Apremilast Extension Phase|Protocol Violation|0|||
161641073|NCT03721172|583735912|FG002|Apremilast Extension Phase|Protocol Violation|1|||
161641074|NCT03721172|583735910|FG000|Apremilast Extension Phase|Physician Decision|0|||
161641075|NCT03721172|583735911|FG001|Apremilast Extension Phase|Physician Decision|0|||
161641076|NCT03721172|583735912|FG002|Apremilast Extension Phase|Physician Decision|1|||
161641077|NCT03721172|583735910|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161641078|NCT03721172|583735911|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161641079|NCT03721172|583735912|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
161641080|NCT03721172|583735910|FG000|Apremilast Extension Phase|Other|0|||
161641081|NCT03721172|583735911|FG001|Apremilast Extension Phase|Other|0|||
161641082|NCT03721172|583735912|FG002|Apremilast Extension Phase|Other|3|||
161641083|NCT03721172|583735910|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
161641084|NCT03721172|583735911|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
161641085|NCT03721172|583735912|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
161641086|NCT03934099|583735913|FG000|Overall Study|Adverse Event|0|||
161641087|NCT03934099|583735914|FG001|Overall Study|Adverse Event|3|||
161641088|NCT03934099|583735915|FG002|Overall Study|Adverse Event|1|||
161641089|NCT03934099|583735916|FG003|Overall Study|Adverse Event|0|||
161641090|NCT03934099|583735913|FG000|Overall Study|Lost to Follow-up|1|||
161641091|NCT03934099|583735914|FG001|Overall Study|Lost to Follow-up|2|||
161641092|NCT03934099|583735915|FG002|Overall Study|Lost to Follow-up|1|||
161641093|NCT03934099|583735916|FG003|Overall Study|Lost to Follow-up|1|||
161641094|NCT03934099|583735913|FG000|Overall Study|Protocol Violation|1|||
161641095|NCT03934099|583735914|FG001|Overall Study|Protocol Violation|0|||
161641096|NCT03934099|583735915|FG002|Overall Study|Protocol Violation|0|||
161641097|NCT03934099|583735916|FG003|Overall Study|Protocol Violation|0|||
161641098|NCT03934099|583735913|FG000|Overall Study|Withdrawal by Subject|2|||
161641099|NCT03934099|583735914|FG001|Overall Study|Withdrawal by Subject|0|||
161641100|NCT03934099|583735915|FG002|Overall Study|Withdrawal by Subject|1|||
161641101|NCT03934099|583735916|FG003|Overall Study|Withdrawal by Subject|1|||
161641102|NCT03934099|583735913|FG000|Overall Study|Other reasons|0|||
161641103|NCT03934099|583735914|FG001|Overall Study|Other reasons|1|||
161641104|NCT03934099|583735915|FG002|Overall Study|Other reasons|0|||
161641105|NCT03934099|583735916|FG003|Overall Study|Other reasons|0|||
161641106|NCT02417441|583735917|FG000|Overall Study|Inconclusive due to missing data|52|||
161687437|NCT00805480|583907237|FG002|Overall Study|Adverse Event|1|||
161687438|NCT00805480|583907238|FG003|Overall Study|Adverse Event|0|||
161687439|NCT03077685|583907239|FG000|Overall Study|Lost to Follow-up|0|||
161687440|NCT03077685|583907240|FG001|Overall Study|Lost to Follow-up|0|||
161687441|NCT03077685|583907241|FG002|Overall Study|Lost to Follow-up|0|||
161687442|NCT03077685|583907242|FG003|Overall Study|Lost to Follow-up|0|||
161687443|NCT03077685|583907243|FG004|Overall Study|Lost to Follow-up|1|||
161687444|NCT03077685|583907239|FG000|Overall Study|Death|0|||
161687445|NCT03077685|583907240|FG001|Overall Study|Death|0|||
161687446|NCT03077685|583907241|FG002|Overall Study|Death|1|||
161687447|NCT03077685|583907242|FG003|Overall Study|Death|1|||
161687448|NCT03077685|583907243|FG004|Overall Study|Death|3|||
161687449|NCT03077685|583907239|FG000|Overall Study|Withdrawal by Subject|0|||
161687450|NCT03077685|583907240|FG001|Overall Study|Withdrawal by Subject|0|||
161687451|NCT03077685|583907241|FG002|Overall Study|Withdrawal by Subject|0|||
161687452|NCT03077685|583907242|FG003|Overall Study|Withdrawal by Subject|2|||
161687453|NCT03077685|583907243|FG004|Overall Study|Withdrawal by Subject|1|||
161687454|NCT03077685|583907239|FG000|Overall Study|Physician Decision|0|||
161687455|NCT03077685|583907240|FG001|Overall Study|Physician Decision|0|||
161687456|NCT03077685|583907241|FG002|Overall Study|Physician Decision|1|||
161687457|NCT03077685|583907242|FG003|Overall Study|Physician Decision|0|||
161687458|NCT03077685|583907243|FG004|Overall Study|Physician Decision|3|||
161687459|NCT03077685|583907239|FG000|Overall Study|Disease Progression|1|||
161687460|NCT03077685|583907240|FG001|Overall Study|Disease Progression|0|||
161687461|NCT03077685|583907241|FG002|Overall Study|Disease Progression|0|||
161687462|NCT03077685|583907242|FG003|Overall Study|Disease Progression|2|||
161641107|NCT02417441|583735918|FG001|Overall Study|Inconclusive due to missing data|19|||
161641108|NCT05628285|583735919|FG000|Overall Study|Lost to Follow-up|1|||
161641109|NCT00983853|583735920|FG000|Overall Study|Lost to Follow-up|1|||
161687463|NCT03077685|583907243|FG004|Overall Study|Disease Progression|1|||
161687464|NCT03077685|583907239|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
161687465|NCT03077685|583907240|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
161687466|NCT03077685|583907241|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
161687467|NCT03077685|583907242|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
161687468|NCT03077685|583907243|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
161687469|NCT03077685|583907239|FG000|Overall Study|Subject entered hospice care|0|||
161687470|NCT03077685|583907240|FG001|Overall Study|Subject entered hospice care|0|||
161835350|NCT02923674|584438925|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
161835351|NCT02923674|584438926|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
161835352|NCT02923674|584438927|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
161835353|NCT02923674|584438925|FG000|Overall Study|Lost to Follow-up|7|||
161835354|NCT02923674|584438926|FG001|Overall Study|Lost to Follow-up|12|||
161835355|NCT02923674|584438927|FG002|Overall Study|Lost to Follow-up|7|||
161641110|NCT00983853|583735921|FG001|Overall Study|Lost to Follow-up|1|||
161641111|NCT00983853|583735922|FG002|Overall Study|Lost to Follow-up|2|||
161641112|NCT00983853|583735923|FG003|Overall Study|Lost to Follow-up|2|||
161641113|NCT00983853|583735924|FG004|Overall Study|Lost to Follow-up|2|||
161641114|NCT00983853|583735925|FG005|Overall Study|Lost to Follow-up|1|||
161641115|NCT00983853|583735920|FG000|Overall Study|Withdrawal by Subject|0|||
161641116|NCT00983853|583735921|FG001|Overall Study|Withdrawal by Subject|0|||
161641117|NCT00983853|583735922|FG002|Overall Study|Withdrawal by Subject|1|||
161641118|NCT00983853|583735923|FG003|Overall Study|Withdrawal by Subject|0|||
161641119|NCT00983853|583735924|FG004|Overall Study|Withdrawal by Subject|1|||
161641120|NCT00983853|583735925|FG005|Overall Study|Withdrawal by Subject|0|||
161641121|NCT00983853|583735920|FG000|Overall Study|Unable to come to study follow-up visits|0|||
161641122|NCT00983853|583735921|FG001|Overall Study|Unable to come to study follow-up visits|1|||
161641123|NCT00983853|583735922|FG002|Overall Study|Unable to come to study follow-up visits|0|||
161641124|NCT00983853|583735923|FG003|Overall Study|Unable to come to study follow-up visits|0|||
161641125|NCT00983853|583735924|FG004|Overall Study|Unable to come to study follow-up visits|0|||
161641126|NCT00983853|583735925|FG005|Overall Study|Unable to come to study follow-up visits|0|||
161641127|NCT02339506|583735926|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
161641128|NCT02339506|583735927|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
161641129|NCT02339506|583735926|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
161641130|NCT02339506|583735927|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
161641131|NCT05555615|583735931|FG000|Overall Study|Adverse Event|7|||
161641132|NCT05555615|583735931|FG000|Overall Study|Lack of Efficacy|12|||
161641133|NCT05555615|583735931|FG000|Overall Study|Lost to Follow-up|10|||
161641134|NCT05555615|583735931|FG000|Overall Study|Noncompliance with study drug|5|||
161641135|NCT05555615|583735931|FG000|Overall Study|Physician Decision|2|||
161641136|NCT05555615|583735931|FG000|Overall Study|Study terminated by sponsor|80|||
161641137|NCT05555615|583735931|FG000|Overall Study|Prohibited medication use|2|||
161641138|NCT05555615|583735931|FG000|Overall Study|Withdrawal by Subject|20|||
161641139|NCT05555615|583735931|FG000|Overall Study|Not further specified|4|||
161641140|NCT03016598|583735932|FG000|Overall Study|Lost to Follow-up|0|||
161641141|NCT03016598|583735933|FG001|Overall Study|Lost to Follow-up|2|||
161641142|NCT00478205|583735937|FG000|Overall Study|Adverse Event|182|||
161641143|NCT00478205|583735938|FG001|Overall Study|Adverse Event|39|||
161641144|NCT00478205|583735937|FG000|Overall Study|Medication Non-compliance|9|||
161641145|NCT00478205|583735938|FG001|Overall Study|Medication Non-compliance|4|||
161641146|NCT00478205|583735937|FG000|Overall Study|Protocol Violation|15|||
161641147|NCT00478205|583735938|FG001|Overall Study|Protocol Violation|5|||
161641148|NCT00478205|583735937|FG000|Overall Study|Request of Investigator or Sponsor|4|||
161641149|NCT00478205|583735938|FG001|Overall Study|Request of Investigator or Sponsor|5|||
161641150|NCT00478205|583735937|FG000|Overall Study|Withdrawal by Subject|61|||
161641151|NCT00478205|583735938|FG001|Overall Study|Withdrawal by Subject|22|||
161641152|NCT00478205|583735937|FG000|Overall Study|Lack of Efficacy|1|||
161641153|NCT00478205|583735938|FG001|Overall Study|Lack of Efficacy|0|||
161641154|NCT00478205|583735937|FG000|Overall Study|Other|24|||
161641155|NCT00478205|583735938|FG001|Overall Study|Other|12|||
161641156|NCT01791413|583735939|FG000|Overall Study|Lost to Follow-up|5|||
161641157|NCT01791413|583735940|FG001|Overall Study|Lost to Follow-up|1|||
161641158|NCT01827046|583735950|FG000|Overall Study|Lost to Follow-up|1|||
161641159|NCT01827046|583735951|FG001|Overall Study|Lost to Follow-up|5|||
161641160|NCT01827046|583735950|FG000|Overall Study|Withdrawal by Subject|0|||
161641161|NCT01827046|583735951|FG001|Overall Study|Withdrawal by Subject|4|||
161641162|NCT05594589|583735952|FG000|Overall Study|Other|0|||
161641163|NCT05594589|583735953|FG001|Overall Study|Other|1|||
161641164|NCT05594589|583735954|FG002|Overall Study|Other|0|||
161835356|NCT02923674|584438925|FG000|Overall Study|Problem with intervention|2|||
161835357|NCT02923674|584438926|FG001|Overall Study|Problem with intervention|2|||
161641165|NCT00715117|583735958|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
161641166|NCT00715117|583735959|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
161687471|NCT03077685|583907241|FG002|Overall Study|Subject entered hospice care|0|||
161835358|NCT02923674|584438927|FG002|Overall Study|Problem with intervention|1|||
161641167|NCT01536171|583735963|FG000|Overall Study|Withdrawal by Subject|1|||
161641168|NCT01018732|583735964|FG000|Overall Study|Lost to Follow-up|0|||
161641169|NCT01018732|583735965|FG001|Overall Study|Lost to Follow-up|0|||
161641170|NCT01018732|583735966|FG002|Overall Study|Lost to Follow-up|3|||
161641171|NCT01018732|583735964|FG000|Overall Study|Protocol Violation|1|||
161641172|NCT01018732|583735965|FG001|Overall Study|Protocol Violation|1|||
161641173|NCT01018732|583735966|FG002|Overall Study|Protocol Violation|0|||
161835359|NCT02923674|584438925|FG000|Overall Study|Adverse Event|3|||
161641174|NCT01018732|583735964|FG000|Overall Study|Inappropriate Enrollment|0|||
161641175|NCT01018732|583735965|FG001|Overall Study|Inappropriate Enrollment|1|||
161641176|NCT01018732|583735966|FG002|Overall Study|Inappropriate Enrollment|0|||
161641177|NCT01018732|583735964|FG000|Overall Study|Unable to Classify|0|||
161641178|NCT01018732|583735965|FG001|Overall Study|Unable to Classify|0|||
161641179|NCT01018732|583735966|FG002|Overall Study|Unable to Classify|1|||
161641180|NCT01262092|583735967|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
161641181|NCT01262092|583735968|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
161641182|NCT01262092|583735967|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
161641183|NCT01262092|583735968|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
161641184|NCT01262092|583735967|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
161641185|NCT01262092|583735968|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
161641186|NCT01262092|583735967|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
161641187|NCT01262092|583735968|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
161641188|NCT03784820|583735969|FG000|Overall Study|Lost to Follow-up|5|||
161641189|NCT03784820|583735970|FG001|Overall Study|Lost to Follow-up|5|||
161687472|NCT03077685|583907242|FG003|Overall Study|Subject entered hospice care|0|||
161687473|NCT03077685|583907243|FG004|Overall Study|Subject entered hospice care|1|||
161687474|NCT02116777|583907244|FG000|Overall Study|Adverse Event|0|||
161687475|NCT02116777|583907245|FG001|Overall Study|Adverse Event|0|||
161641190|NCT03784820|583735971|FG002|Overall Study|Lost to Follow-up|3|||
161641191|NCT03784820|583735972|FG003|Overall Study|Lost to Follow-up|3|||
161641192|NCT02336425|583735973|FG000|Overall Study|Study terminated.|2|||
161687476|NCT02116777|583907246|FG002|Overall Study|Adverse Event|0|||
161687477|NCT02116777|583907247|FG003|Overall Study|Adverse Event|0|||
161687478|NCT02116777|583907248|FG004|Overall Study|Adverse Event|2|||
161687479|NCT02116777|583907249|FG005|Overall Study|Adverse Event|2|||
161687480|NCT02116777|583907250|FG006|Overall Study|Adverse Event|0|||
161687481|NCT02116777|583907244|FG000|Overall Study|Death|0|||
161687482|NCT02116777|583907245|FG001|Overall Study|Death|0|||
161687483|NCT02116777|583907246|FG002|Overall Study|Death|0|||
161687484|NCT02116777|583907247|FG003|Overall Study|Death|1|||
161687485|NCT02116777|583907248|FG004|Overall Study|Death|0|||
161687486|NCT02116777|583907249|FG005|Overall Study|Death|0|||
161687487|NCT02116777|583907250|FG006|Overall Study|Death|0|||
161687488|NCT02116777|583907244|FG000|Overall Study|Lack of Efficacy|3|||
161687489|NCT02116777|583907245|FG001|Overall Study|Lack of Efficacy|3|||
161687490|NCT02116777|583907246|FG002|Overall Study|Lack of Efficacy|3|||
161687491|NCT02116777|583907247|FG003|Overall Study|Lack of Efficacy|8|||
161687492|NCT02116777|583907248|FG004|Overall Study|Lack of Efficacy|4|||
161687493|NCT02116777|583907249|FG005|Overall Study|Lack of Efficacy|1|||
161687494|NCT02116777|583907250|FG006|Overall Study|Lack of Efficacy|9|||
161687495|NCT02116777|583907244|FG000|Overall Study|Physician Decision|0|||
161687496|NCT02116777|583907245|FG001|Overall Study|Physician Decision|0|||
161687497|NCT02116777|583907246|FG002|Overall Study|Physician Decision|0|||
161687498|NCT02116777|583907247|FG003|Overall Study|Physician Decision|2|||
161687499|NCT02116777|583907248|FG004|Overall Study|Physician Decision|0|||
161687500|NCT02116777|583907249|FG005|Overall Study|Physician Decision|0|||
161687501|NCT02116777|583907250|FG006|Overall Study|Physician Decision|0|||
161687502|NCT02116777|583907244|FG000|Overall Study|Protocol Violation|0|||
161687503|NCT02116777|583907245|FG001|Overall Study|Protocol Violation|0|||
161835360|NCT02923674|584438926|FG001|Overall Study|Adverse Event|1|||
161835361|NCT02923674|584438927|FG002|Overall Study|Adverse Event|1|||
161687504|NCT02116777|583907246|FG002|Overall Study|Protocol Violation|0|||
161687505|NCT02116777|583907247|FG003|Overall Study|Protocol Violation|1|||
161687506|NCT02116777|583907248|FG004|Overall Study|Protocol Violation|0|||
161687507|NCT02116777|583907249|FG005|Overall Study|Protocol Violation|0|||
161687508|NCT02116777|583907250|FG006|Overall Study|Protocol Violation|0|||
161687509|NCT02116777|583907244|FG000|Overall Study|Withdrawal by Subject|0|||
161641193|NCT02336425|583735974|FG001|Overall Study|Study terminated.|2|||
161641194|NCT02336425|583735975|FG002|Overall Study|Study terminated.|3|||
161641195|NCT02336425|583735976|FG003|Overall Study|Study terminated.|3|||
161641196|NCT00978562|583735977|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
161687510|NCT02116777|583907245|FG001|Overall Study|Withdrawal by Subject|0|||
161687511|NCT02116777|583907246|FG002|Overall Study|Withdrawal by Subject|0|||
161835362|NCT02923674|584438925|FG000|Overall Study|Withdrawal by Subject|2|||
161641197|NCT02394665|583735978|FG000|Overall Study|Physician Decision|1|||
161641198|NCT02394665|583735979|FG001|Overall Study|Physician Decision|0|||
161641199|NCT02394665|583735980|FG002|Overall Study|Physician Decision|0|||
161641200|NCT03569891|583735981|FG000|Lead-in|Ineligible during lead-in|8|||
161641201|NCT03569891|583735981|FG000|Lead-in|Withdrawal by Subject|3|||
161641202|NCT03569891|583735981|FG000|Lead-in|Risks related to COVID-19|2|||
161641203|NCT03569891|583735981|FG000|AMT-061|Adverse Event|1|||
161641204|NCT02201901|583735985|FG000|Overall Study|Randomized but never treated|0|||
161641205|NCT02201901|583735986|FG001|Overall Study|Randomized but never treated|1|||
161641206|NCT02201901|583735987|FG002|Overall Study|Randomized but never treated|0|||
161641207|NCT02201901|583735985|FG000|Overall Study|Lack of Efficacy|7|||
161641208|NCT02201901|583735986|FG001|Overall Study|Lack of Efficacy|1|||
161641209|NCT02201901|583735987|FG002|Overall Study|Lack of Efficacy|6|||
161641210|NCT02201901|583735985|FG000|Overall Study|Death|3|||
161641211|NCT02201901|583735986|FG001|Overall Study|Death|3|||
161641212|NCT02201901|583735987|FG002|Overall Study|Death|3|||
161641213|NCT02201901|583735985|FG000|Overall Study|Lost to Follow-up|2|||
161641214|NCT02201901|583735986|FG001|Overall Study|Lost to Follow-up|3|||
161641215|NCT02201901|583735987|FG002|Overall Study|Lost to Follow-up|2|||
161641216|NCT02201901|583735985|FG000|Overall Study|Withdrew Consent|2|||
161641217|NCT02201901|583735986|FG001|Overall Study|Withdrew Consent|0|||
161641218|NCT02201901|583735987|FG002|Overall Study|Withdrew Consent|2|||
161641219|NCT02201901|583735985|FG000|Overall Study|Adverse Event|1|||
161641220|NCT02201901|583735986|FG001|Overall Study|Adverse Event|1|||
161641221|NCT02201901|583735987|FG002|Overall Study|Adverse Event|0|||
161641222|NCT02419417|583737900|FG000|Overall Study|Disease progression|5|||
161641223|NCT02419417|583737901|FG001|Overall Study|Disease progression|4|||
161641224|NCT02419417|583737902|FG002|Overall Study|Disease progression|13|||
161641225|NCT02419417|583737903|FG003|Overall Study|Disease progression|10|||
161641226|NCT02419417|583737904|FG004|Overall Study|Disease progression|10|||
161641227|NCT02419417|583737905|FG005|Overall Study|Disease progression|3|||
161641228|NCT02419417|583737906|FG006|Overall Study|Disease progression|4|||
161641229|NCT02419417|583737907|FG007|Overall Study|Disease progression|5|||
161641230|NCT02419417|583737908|FG008|Overall Study|Disease progression|13|||
161641231|NCT02419417|583737909|FG009|Overall Study|Disease progression|9|||
161641232|NCT02419417|583737910|FG010|Overall Study|Disease progression|0|||
161641233|NCT02419417|583737900|FG000|Overall Study|Study drug toxicity|0|||
161641234|NCT02419417|583737901|FG001|Overall Study|Study drug toxicity|0|||
161641235|NCT02419417|583737902|FG002|Overall Study|Study drug toxicity|0|||
161641236|NCT02419417|583737903|FG003|Overall Study|Study drug toxicity|0|||
161641237|NCT02419417|583737904|FG004|Overall Study|Study drug toxicity|1|||
161641238|NCT02419417|583737905|FG005|Overall Study|Study drug toxicity|0|||
161641239|NCT02419417|583737906|FG006|Overall Study|Study drug toxicity|0|||
161641240|NCT02419417|583737907|FG007|Overall Study|Study drug toxicity|0|||
161641241|NCT02419417|583737908|FG008|Overall Study|Study drug toxicity|0|||
161641242|NCT02419417|583737909|FG009|Overall Study|Study drug toxicity|0|||
161641243|NCT02419417|583737910|FG010|Overall Study|Study drug toxicity|0|||
161641244|NCT02419417|583737900|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161641245|NCT02419417|583737901|FG001|Overall Study|Adverse event unrelated to study drug|0|||
161641246|NCT02419417|583737902|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161641247|NCT02419417|583737903|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161641248|NCT02419417|583737904|FG004|Overall Study|Adverse event unrelated to study drug|2|||
161641249|NCT02419417|583737905|FG005|Overall Study|Adverse event unrelated to study drug|1|||
161641250|NCT02419417|583737906|FG006|Overall Study|Adverse event unrelated to study drug|0|||
161641251|NCT02419417|583737907|FG007|Overall Study|Adverse event unrelated to study drug|1|||
161641252|NCT02419417|583737908|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161641253|NCT02419417|583737909|FG009|Overall Study|Adverse event unrelated to study drug|0|||
161641254|NCT02419417|583737910|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161641255|NCT02419417|583737900|FG000|Overall Study|Participant request to discontinue|0|||
161641256|NCT02419417|583737901|FG001|Overall Study|Participant request to discontinue|0|||
161641257|NCT02419417|583737902|FG002|Overall Study|Participant request to discontinue|0|||
161641258|NCT02419417|583737903|FG003|Overall Study|Participant request to discontinue|0|||
161641259|NCT02419417|583737904|FG004|Overall Study|Participant request to discontinue|0|||
161641260|NCT02419417|583737905|FG005|Overall Study|Participant request to discontinue|0|||
161641261|NCT02419417|583737906|FG006|Overall Study|Participant request to discontinue|0|||
161641262|NCT02419417|583737907|FG007|Overall Study|Participant request to discontinue|0|||
161641263|NCT02419417|583737908|FG008|Overall Study|Participant request to discontinue|0|||
161641264|NCT02419417|583737909|FG009|Overall Study|Participant request to discontinue|1|||
161641265|NCT02419417|583737910|FG010|Overall Study|Participant request to discontinue|0|||
161641266|NCT02419417|583737900|FG000|Overall Study|Withdrawal by Subject|0|||
161641267|NCT02419417|583737901|FG001|Overall Study|Withdrawal by Subject|0|||
161641268|NCT02419417|583737902|FG002|Overall Study|Withdrawal by Subject|0|||
161641269|NCT02419417|583737903|FG003|Overall Study|Withdrawal by Subject|0|||
161641270|NCT02419417|583737904|FG004|Overall Study|Withdrawal by Subject|0|||
161641271|NCT02419417|583737905|FG005|Overall Study|Withdrawal by Subject|0|||
161641272|NCT02419417|583737906|FG006|Overall Study|Withdrawal by Subject|0|||
161641273|NCT02419417|583737907|FG007|Overall Study|Withdrawal by Subject|0|||
161641274|NCT02419417|583737908|FG008|Overall Study|Withdrawal by Subject|0|||
161641275|NCT02419417|583737909|FG009|Overall Study|Withdrawal by Subject|0|||
161641276|NCT02419417|583737910|FG010|Overall Study|Withdrawal by Subject|1|||
161641277|NCT01385748|583737911|FG000|Overall Study|Withdrawal by Subject|7|||
161641278|NCT01385748|583737912|FG001|Overall Study|Withdrawal by Subject|4|||
161641279|NCT01385748|583737913|FG002|Overall Study|Withdrawal by Subject|5|||
161641280|NCT01385748|583737911|FG000|Overall Study|Noncompliance|3|||
161641281|NCT01385748|583737912|FG001|Overall Study|Noncompliance|1|||
161641282|NCT01385748|583737913|FG002|Overall Study|Noncompliance|6|||
161641283|NCT01385748|583737911|FG000|Overall Study|Other|1|||
161641284|NCT01385748|583737912|FG001|Overall Study|Other|7|||
161641285|NCT01385748|583737913|FG002|Overall Study|Other|1|||
161641286|NCT01385748|583737911|FG000|Overall Study|Adverse Event|4|||
161641287|NCT01385748|583737912|FG001|Overall Study|Adverse Event|2|||
161641288|NCT01385748|583737913|FG002|Overall Study|Adverse Event|1|||
161641289|NCT01200342|583737914|FG000|Overall Study|Disease Progression|1|||
161641290|NCT00121667|583737924|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
161641291|NCT00121667|583737925|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
161641292|NCT00121667|583737926|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
161641293|NCT00121667|583737927|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
161641294|NCT00121667|583737924|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
161641295|NCT00121667|583737925|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
161641296|NCT00121667|583737926|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
161641297|NCT00121667|583737927|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
161641298|NCT00121667|583737924|FG000|Short Term (ST) Period|Adverse Event|5|||
161641299|NCT00121667|583737925|FG001|Short Term (ST) Period|Adverse Event|6|||
161641300|NCT00121667|583737926|FG002|Short Term (ST) Period|Adverse Event|5|||
161641301|NCT00121667|583737927|FG003|Short Term (ST) Period|Adverse Event|3|||
161641302|NCT00121667|583737924|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
161641303|NCT00121667|583737925|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
161641304|NCT00121667|583737926|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
161641305|NCT00121667|583737927|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
161641306|NCT00121667|583737924|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
161641307|NCT00121667|583737925|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
161641308|NCT00121667|583737926|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
161641309|NCT00121667|583737927|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
161641310|NCT00121667|583737924|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
161641311|NCT00121667|583737925|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
161641312|NCT00121667|583737926|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
161641313|NCT00121667|583737927|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
161641314|NCT00121667|583737924|FG000|Short Term (ST) Period|Other Reason|3|||
161641315|NCT00121667|583737925|FG001|Short Term (ST) Period|Other Reason|0|||
161641316|NCT00121667|583737926|FG002|Short Term (ST) Period|Other Reason|0|||
161641317|NCT00121667|583737927|FG003|Short Term (ST) Period|Other Reason|0|||
161835363|NCT02923674|584438926|FG001|Overall Study|Withdrawal by Subject|2|||
161641318|NCT00121667|583737924|FG000|Short Term (ST) Period|Death|0|||
161641319|NCT00121667|583737925|FG001|Short Term (ST) Period|Death|0|||
161641320|NCT00121667|583737926|FG002|Short Term (ST) Period|Death|0|||
161641321|NCT00121667|583737927|FG003|Short Term (ST) Period|Death|1|||
161641322|NCT00121667|583737924|FG000|Short Term (ST) Period|Pregnancy|0|||
161641323|NCT00121667|583737925|FG001|Short Term (ST) Period|Pregnancy|0|||
161641324|NCT00121667|583737926|FG002|Short Term (ST) Period|Pregnancy|0|||
161641325|NCT00121667|583737927|FG003|Short Term (ST) Period|Pregnancy|1|||
161641326|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
161641327|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
161641328|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
161641329|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
161641330|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
161641331|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
161641332|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
161641333|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
161641334|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
161641335|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
161641336|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
161641337|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
161641338|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
161641339|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
161641340|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
161641341|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
161641342|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
161641343|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
161641344|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
161641345|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
161641346|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
161641347|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
161641348|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
161641349|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
161641350|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
161641351|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
161641352|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
161641353|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
161641354|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
161641355|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
161641356|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
161641357|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
161641358|NCT00121667|583737924|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
161641359|NCT00121667|583737925|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
161641360|NCT00121667|583737926|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
161641361|NCT00121667|583737927|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
161641362|NCT04468230|583737929|FG000|Overall Study|Adverse Event|2|||
161641363|NCT02869867|583737930|FG000|Overall Study|Protocol Violation|1|||
161641364|NCT02869867|583737931|FG001|Overall Study|Protocol Violation|0|||
161641365|NCT02869867|583737930|FG000|Overall Study|Lost to Follow-up|5|||
161641366|NCT02869867|583737931|FG001|Overall Study|Lost to Follow-up|5|||
161641367|NCT02872012|583737947|FG000|Overall Study|Withdrawal by Subject|1|||
161641368|NCT02872012|583737948|FG001|Overall Study|Withdrawal by Subject|0|||
161641369|NCT02872012|583737949|FG002|Overall Study|Withdrawal by Subject|0|||
161687512|NCT02116777|583907247|FG003|Overall Study|Withdrawal by Subject|1|||
161687513|NCT02116777|583907248|FG004|Overall Study|Withdrawal by Subject|0|||
161687514|NCT02116777|583907249|FG005|Overall Study|Withdrawal by Subject|0|||
161641370|NCT02872012|583737950|FG003|Overall Study|Withdrawal by Subject|0|||
161641371|NCT02872012|583737951|FG004|Overall Study|Withdrawal by Subject|0|||
161641372|NCT01728623|583737952|FG000|Overall Study|Disease progression|26|||
161641373|NCT01728623|583737952|FG000|Overall Study|Adverse Event|1|||
161641374|NCT01728623|583737952|FG000|Overall Study|Withdrawal by Subject|1|||
161641375|NCT03000348|583737953|FG000|Overall Study|Adverse Event|1|||
161641376|NCT03000348|583737954|FG001|Overall Study|Adverse Event|1|||
161641377|NCT03000348|583737955|FG002|Overall Study|Adverse Event|1|||
161641378|NCT03000348|583737956|FG003|Overall Study|Adverse Event|1|||
161641379|NCT03000348|583737957|FG004|Overall Study|Adverse Event|1|||
161641380|NCT03000348|583737958|FG005|Overall Study|Adverse Event|1|||
161641381|NCT03000348|583737953|FG000|Overall Study|Lost to Follow-up|0|||
161641382|NCT03000348|583737954|FG001|Overall Study|Lost to Follow-up|0|||
161641383|NCT03000348|583737955|FG002|Overall Study|Lost to Follow-up|1|||
161641384|NCT03000348|583737956|FG003|Overall Study|Lost to Follow-up|0|||
161641385|NCT03000348|583737957|FG004|Overall Study|Lost to Follow-up|0|||
161641386|NCT03000348|583737958|FG005|Overall Study|Lost to Follow-up|0|||
161641387|NCT03000348|583737953|FG000|Overall Study|Withdrawal by Subject|0|||
161641388|NCT03000348|583737954|FG001|Overall Study|Withdrawal by Subject|1|||
161641389|NCT03000348|583737955|FG002|Overall Study|Withdrawal by Subject|0|||
161641390|NCT03000348|583737956|FG003|Overall Study|Withdrawal by Subject|0|||
161641391|NCT03000348|583737957|FG004|Overall Study|Withdrawal by Subject|0|||
161641392|NCT03000348|583737958|FG005|Overall Study|Withdrawal by Subject|0|||
161641393|NCT03000348|583737953|FG000|Overall Study|Consent|0|||
161687515|NCT02116777|583907250|FG006|Overall Study|Withdrawal by Subject|0|||
161687516|NCT00733954|583907251|FG000|Overall Study|Lost to Follow-up|5|||
161687517|NCT00733954|583907252|FG001|Overall Study|Lost to Follow-up|2|||
161687518|NCT00733954|583907251|FG000|Overall Study|Protocol Violation|1|||
161687519|NCT00733954|583907252|FG001|Overall Study|Protocol Violation|0|||
161687520|NCT00733954|583907251|FG000|Overall Study|Withdrawal by Subject|2|||
161835364|NCT02923674|584438927|FG002|Overall Study|Withdrawal by Subject|2|||
161835365|NCT02712333|584438931|FG000|First Period|Withdrawal by Subject|3|||
161835366|NCT02712333|584438932|FG001|First Period|Withdrawal by Subject|2|||
161641394|NCT03000348|583737954|FG001|Overall Study|Consent|0|||
161641395|NCT03000348|583737955|FG002|Overall Study|Consent|0|||
161641396|NCT03000348|583737956|FG003|Overall Study|Consent|0|||
161641397|NCT03000348|583737957|FG004|Overall Study|Consent|1|||
161641398|NCT03000348|583737958|FG005|Overall Study|Consent|0|||
161687521|NCT00733954|583907252|FG001|Overall Study|Withdrawal by Subject|0|||
161687522|NCT02663453|583907253|FG000|Overall Study|Death|4|||
161687523|NCT02663453|583907254|FG001|Overall Study|Death|4|||
161687524|NCT02663453|583907253|FG000|Overall Study|Withdrawal by Subject|1|||
161687525|NCT02663453|583907254|FG001|Overall Study|Withdrawal by Subject|0|||
161835367|NCT03463993|584438933|FG000|Overall Study|Lost to Follow-up|7|||
161835368|NCT03463993|584438934|FG001|Overall Study|Lost to Follow-up|8|||
161835369|NCT03463993|584438933|FG000|Overall Study|Withdrawal by Subject|2|||
161835370|NCT03463993|584438934|FG001|Overall Study|Withdrawal by Subject|0|||
161835371|NCT03463993|584438933|FG000|Overall Study|Protocol Violation|4|||
161835372|NCT03463993|584438934|FG001|Overall Study|Protocol Violation|1|||
161835373|NCT03463993|584438933|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
161835374|NCT03463993|584438934|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
161835375|NCT03463993|584438933|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
161641399|NCT03000348|583737953|FG000|Overall Study|Failure to expectorate sputum|1|||
161641400|NCT03000348|583737954|FG001|Overall Study|Failure to expectorate sputum|0|||
161641401|NCT03000348|583737955|FG002|Overall Study|Failure to expectorate sputum|1|||
161641402|NCT03000348|583737956|FG003|Overall Study|Failure to expectorate sputum|0|||
161641403|NCT03000348|583737957|FG004|Overall Study|Failure to expectorate sputum|1|||
161641404|NCT03000348|583737958|FG005|Overall Study|Failure to expectorate sputum|0|||
161641405|NCT03000348|583737953|FG000|Overall Study|No gram negative|1|||
161641406|NCT03000348|583737954|FG001|Overall Study|No gram negative|2|||
161641407|NCT03000348|583737955|FG002|Overall Study|No gram negative|1|||
161641408|NCT03000348|583737956|FG003|Overall Study|No gram negative|1|||
161641409|NCT03000348|583737957|FG004|Overall Study|No gram negative|1|||
161641410|NCT03000348|583737958|FG005|Overall Study|No gram negative|1|||
161641411|NCT03000348|583737953|FG000|Overall Study|Patient had no transport|0|||
161641412|NCT03000348|583737954|FG001|Overall Study|Patient had no transport|0|||
161641413|NCT03000348|583737955|FG002|Overall Study|Patient had no transport|0|||
161641414|NCT03000348|583737956|FG003|Overall Study|Patient had no transport|1|||
161641415|NCT03000348|583737957|FG004|Overall Study|Patient had no transport|0|||
161641416|NCT03000348|583737958|FG005|Overall Study|Patient had no transport|0|||
161641417|NCT03000348|583737953|FG000|Overall Study|Dosing|0|||
161641418|NCT03000348|583737954|FG001|Overall Study|Dosing|0|||
161641419|NCT03000348|583737955|FG002|Overall Study|Dosing|0|||
161641420|NCT03000348|583737956|FG003|Overall Study|Dosing|0|||
161641421|NCT03000348|583737957|FG004|Overall Study|Dosing|1|||
161641422|NCT03000348|583737958|FG005|Overall Study|Dosing|0|||
161641423|NCT00723125|583737959|FG000|Overall Study|Met Dx|1|||
161641424|NCT00723125|583737960|FG001|Overall Study|Met Dx|0|||
161641425|NCT00723125|583737959|FG000|Overall Study|Withdrawal by Subject|15|||
161641426|NCT00723125|583737960|FG001|Overall Study|Withdrawal by Subject|6|||
161641427|NCT00723125|583737959|FG000|Overall Study|Adverse Event|2|||
161641428|NCT00723125|583737960|FG001|Overall Study|Adverse Event|0|||
161641429|NCT01667549|583737961|FG000|Overall Study|Withdrawal by Subject|3|||
161641430|NCT01667549|583737962|FG001|Overall Study|Withdrawal by Subject|5|||
161641431|NCT01667549|583737963|FG002|Overall Study|Withdrawal by Subject|7|||
161641432|NCT01667549|583737964|FG003|Overall Study|Withdrawal by Subject|6|||
161641433|NCT01667549|583737965|FG004|Overall Study|Withdrawal by Subject|1|||
161641434|NCT01407276|583737967|FG000|Overall Study|Withdrawal by Subject|0|||
161641435|NCT01407276|583737968|FG001|Overall Study|Withdrawal by Subject|0|||
161641436|NCT01407276|583737969|FG002|Overall Study|Withdrawal by Subject|0|||
161641437|NCT01407276|583737970|FG003|Overall Study|Withdrawal by Subject|0|||
161641438|NCT01407276|583737971|FG004|Overall Study|Withdrawal by Subject|0|||
161641439|NCT01407276|583737972|FG005|Overall Study|Withdrawal by Subject|0|||
161641440|NCT01407276|583737973|FG006|Overall Study|Withdrawal by Subject|0|||
161641441|NCT01407276|583737974|FG007|Overall Study|Withdrawal by Subject|1|||
161835376|NCT03463993|584438934|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
161641442|NCT01807182|583737976|FG000|Overall Study|Death|1|||
161641443|NCT01807182|583737976|FG000|Overall Study|New therapy|1|||
161641444|NCT01807182|583737976|FG000|Overall Study|Moved to hospice care|1|||
161641445|NCT04092452|583737978|FG000|Overall Study|Adverse Event|1|||
161641446|NCT04092452|583737979|FG001|Overall Study|Adverse Event|3|||
161641447|NCT04092452|583737980|FG002|Overall Study|Adverse Event|3|||
161641448|NCT04092452|583737981|FG003|Overall Study|Adverse Event|7|||
161641449|NCT04092452|583737978|FG000|Overall Study|Lack of Efficacy|1|||
161641450|NCT04092452|583737979|FG001|Overall Study|Lack of Efficacy|1|||
161641451|NCT04092452|583737980|FG002|Overall Study|Lack of Efficacy|1|||
161641452|NCT04092452|583737981|FG003|Overall Study|Lack of Efficacy|0|||
161641453|NCT04092452|583737978|FG000|Overall Study|Lost to Follow-up|4|||
161641454|NCT04092452|583737979|FG001|Overall Study|Lost to Follow-up|3|||
161641455|NCT04092452|583737980|FG002|Overall Study|Lost to Follow-up|5|||
161641456|NCT04092452|583737981|FG003|Overall Study|Lost to Follow-up|1|||
161641457|NCT04092452|583737978|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161641458|NCT04092452|583737979|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161641459|NCT04092452|583737980|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161641460|NCT04092452|583737981|FG003|Overall Study|Non-Compliance With Study Drug|1|||
161641461|NCT04092452|583737978|FG000|Overall Study|Physician Decision|1|||
161641462|NCT04092452|583737979|FG001|Overall Study|Physician Decision|0|||
161641463|NCT04092452|583737980|FG002|Overall Study|Physician Decision|1|||
161641464|NCT04092452|583737981|FG003|Overall Study|Physician Decision|0|||
161641465|NCT04092452|583737978|FG000|Overall Study|Pregnancy|2|||
161835377|NCT01231373|584438939|FG000|Overall Study|Withdrew consent prior to randomization|2|||
161641466|NCT04092452|583737979|FG001|Overall Study|Pregnancy|0|||
161641467|NCT04092452|583737980|FG002|Overall Study|Pregnancy|0|||
161641468|NCT04092452|583737981|FG003|Overall Study|Pregnancy|0|||
161641469|NCT04092452|583737978|FG000|Overall Study|Protocol Deviation|1|||
161641470|NCT04092452|583737979|FG001|Overall Study|Protocol Deviation|0|||
161641471|NCT04092452|583737980|FG002|Overall Study|Protocol Deviation|0|||
161641472|NCT04092452|583737981|FG003|Overall Study|Protocol Deviation|0|||
161835378|NCT01231373|584438940|FG001|Overall Study|Withdrew consent prior to randomization|1|||
161835379|NCT01231373|584438941|FG002|Overall Study|Withdrew consent prior to randomization|0|||
161835380|NCT01231373|584438942|FG003|Overall Study|Withdrew consent prior to randomization|0|||
161835381|NCT01231373|584438939|FG000|Overall Study|Lost to Follow-up|0|||
161835382|NCT01231373|584438940|FG001|Overall Study|Lost to Follow-up|0|||
161835383|NCT01231373|584438941|FG002|Overall Study|Lost to Follow-up|0|||
161835384|NCT01231373|584438942|FG003|Overall Study|Lost to Follow-up|1|||
161835385|NCT01231373|584438939|FG000|Overall Study|Withdrew Consent|1|||
161835386|NCT01231373|584438940|FG001|Overall Study|Withdrew Consent|0|||
161835387|NCT01231373|584438941|FG002|Overall Study|Withdrew Consent|0|||
161835388|NCT01231373|584438942|FG003|Overall Study|Withdrew Consent|0|||
161835389|NCT01621191|584438947|FG000|Overall Study|Adverse Event|9|||
161835390|NCT01621191|584438947|FG000|Overall Study|Withdrawal by Subject|8|||
161835391|NCT01621191|584438947|FG000|Overall Study|Lack of Efficacy|6|||
161835392|NCT01621191|584438947|FG000|Overall Study|Lost to Follow-up|1|||
161835393|NCT01621191|584438947|FG000|Overall Study|Site Removed From Study|1|||
161835394|NCT04355663|584438949|FG000|Overall Study|Physician Decision|2|||
161835395|NCT04355663|584438950|FG001|Overall Study|Physician Decision|7|||
161641473|NCT04092452|583737978|FG000|Overall Study|Withdrawal by Subject|3|||
161641474|NCT04092452|583737979|FG001|Overall Study|Withdrawal by Subject|10|||
161835396|NCT04355663|584438951|FG002|Overall Study|Physician Decision|0|||
161641475|NCT04092452|583737980|FG002|Overall Study|Withdrawal by Subject|3|||
161641476|NCT04092452|583737981|FG003|Overall Study|Withdrawal by Subject|5|||
161641477|NCT04092452|583737978|FG000|Overall Study|Other|0|||
161641478|NCT04092452|583737979|FG001|Overall Study|Other|0|||
161641479|NCT04092452|583737980|FG002|Overall Study|Other|1|||
161641480|NCT04092452|583737981|FG003|Overall Study|Other|2|||
161641481|NCT01012947|583737989|FG000|Overall Study|Lost to Follow-up|131|||
161641482|NCT01012947|583737990|FG001|Overall Study|Lost to Follow-up|135|||
161641483|NCT01012947|583737991|FG002|Overall Study|Lost to Follow-up|130|||
161641484|NCT01012947|583737992|FG003|Overall Study|Lost to Follow-up|118|||
161641485|NCT01012947|583737993|FG004|Overall Study|Lost to Follow-up|142|||
161641486|NCT02127125|583737994|FG000|Overall Study|Lost to Follow-up|0|||
161641487|NCT02127125|583737995|FG001|Overall Study|Lost to Follow-up|0|||
161641488|NCT02127125|583737996|FG002|Overall Study|Lost to Follow-up|0|||
161641489|NCT02127125|583737997|FG003|Overall Study|Lost to Follow-up|0|||
161641490|NCT02127125|583737998|FG004|Overall Study|Lost to Follow-up|2|||
161641491|NCT02127125|583737999|FG005|Overall Study|Lost to Follow-up|1|||
161641492|NCT02127125|583738000|FG006|Overall Study|Lost to Follow-up|0|||
161641493|NCT02127125|583738001|FG007|Overall Study|Lost to Follow-up|0|||
161641494|NCT02127125|583738002|FG008|Overall Study|Lost to Follow-up|0|||
161641495|NCT02127125|583737994|FG000|Overall Study|Withdrawal by Subject|0|||
161641496|NCT02127125|583737995|FG001|Overall Study|Withdrawal by Subject|0|||
161641497|NCT02127125|583737996|FG002|Overall Study|Withdrawal by Subject|0|||
161641498|NCT02127125|583737997|FG003|Overall Study|Withdrawal by Subject|1|||
161641499|NCT02127125|583737998|FG004|Overall Study|Withdrawal by Subject|0|||
161641500|NCT02127125|583737999|FG005|Overall Study|Withdrawal by Subject|0|||
161641501|NCT02127125|583738000|FG006|Overall Study|Withdrawal by Subject|0|||
161641502|NCT02127125|583738001|FG007|Overall Study|Withdrawal by Subject|0|||
161641503|NCT02127125|583738002|FG008|Overall Study|Withdrawal by Subject|0|||
161641504|NCT02127125|583737994|FG000|Overall Study|Physician Decision|0|||
161641505|NCT02127125|583737995|FG001|Overall Study|Physician Decision|0|||
161641506|NCT02127125|583737996|FG002|Overall Study|Physician Decision|1|||
161641507|NCT02127125|583737997|FG003|Overall Study|Physician Decision|0|||
161641508|NCT02127125|583737998|FG004|Overall Study|Physician Decision|1|||
161641509|NCT02127125|583737999|FG005|Overall Study|Physician Decision|2|||
161641510|NCT02127125|583738000|FG006|Overall Study|Physician Decision|0|||
161641511|NCT02127125|583738001|FG007|Overall Study|Physician Decision|0|||
161641512|NCT02127125|583738002|FG008|Overall Study|Physician Decision|0|||
161641513|NCT02498236|583738006|FG000|Overall Study|Did not show for testing|1|||
161641514|NCT02498236|583738007|FG001|Overall Study|Did not show for testing|0|||
161835397|NCT04355663|584438949|FG000|Overall Study|Adverse Event|0|||
161641515|NCT02498236|583738008|FG002|Overall Study|Did not show for testing|0|||
161835398|NCT04355663|584438950|FG001|Overall Study|Adverse Event|0|||
161641516|NCT02498236|583738009|FG003|Overall Study|Did not show for testing|0|||
161641517|NCT02498236|583738010|FG004|Overall Study|Did not show for testing|0|||
161641518|NCT02498236|583738011|FG005|Overall Study|Did not show for testing|0|||
161641519|NCT02498236|583738012|FG006|Overall Study|Did not show for testing|0|||
161641520|NCT02498236|583738013|FG007|Overall Study|Did not show for testing|1|||
161835399|NCT04355663|584438951|FG002|Overall Study|Adverse Event|1|||
161835400|NCT04355663|584438949|FG000|Overall Study|Withdrawal by Subject|0|||
161835401|NCT04355663|584438950|FG001|Overall Study|Withdrawal by Subject|8|||
161641521|NCT02498236|583738006|FG000|Overall Study|Equipment failure|0|||
161641522|NCT02498236|583738007|FG001|Overall Study|Equipment failure|0|||
161641523|NCT02498236|583738008|FG002|Overall Study|Equipment failure|0|||
161641524|NCT02498236|583738009|FG003|Overall Study|Equipment failure|0|||
161641525|NCT02498236|583738010|FG004|Overall Study|Equipment failure|0|||
161641526|NCT02498236|583738011|FG005|Overall Study|Equipment failure|0|||
161641527|NCT02498236|583738012|FG006|Overall Study|Equipment failure|1|||
161641528|NCT02498236|583738013|FG007|Overall Study|Equipment failure|0|||
161641529|NCT02498236|583738006|FG000|Overall Study|Withdrawal by Subject|0|||
161641530|NCT02498236|583738007|FG001|Overall Study|Withdrawal by Subject|0|||
161641531|NCT02498236|583738008|FG002|Overall Study|Withdrawal by Subject|0|||
161641532|NCT02498236|583738009|FG003|Overall Study|Withdrawal by Subject|0|||
161641533|NCT02498236|583738010|FG004|Overall Study|Withdrawal by Subject|1|||
161641534|NCT02498236|583738011|FG005|Overall Study|Withdrawal by Subject|0|||
161641535|NCT02498236|583738012|FG006|Overall Study|Withdrawal by Subject|0|||
161641536|NCT02498236|583738013|FG007|Overall Study|Withdrawal by Subject|0|||
161641537|NCT03566979|583738015|FG000|Overall Study|Withdrawal by Subject|2|||
161641538|NCT03566979|583738016|FG001|Overall Study|Withdrawal by Subject|0|||
161641539|NCT03566979|583738017|FG002|Overall Study|Withdrawal by Subject|1|||
161641540|NCT03566979|583738018|FG003|Overall Study|Withdrawal by Subject|1|||
161641541|NCT03566979|583738015|FG000|Overall Study|Lost to Follow-up|2|||
161641542|NCT03566979|583738016|FG001|Overall Study|Lost to Follow-up|7|||
161641543|NCT03566979|583738017|FG002|Overall Study|Lost to Follow-up|9|||
161641544|NCT03566979|583738018|FG003|Overall Study|Lost to Follow-up|5|||
161641545|NCT03566979|583738015|FG000|Overall Study|Adverse Event|1|||
161641546|NCT03566979|583738016|FG001|Overall Study|Adverse Event|0|||
161641547|NCT03566979|583738017|FG002|Overall Study|Adverse Event|0|||
161641548|NCT03566979|583738018|FG003|Overall Study|Adverse Event|0|||
161641549|NCT01255761|583738019|FG000|Overall Study|Adverse Event|29|||
161641550|NCT01255761|583738020|FG001|Overall Study|Adverse Event|43|||
161641551|NCT01255761|583738019|FG000|Overall Study|Lack of Efficacy|86|||
161641552|NCT01255761|583738020|FG001|Overall Study|Lack of Efficacy|74|||
161641553|NCT01255761|583738019|FG000|Overall Study|Protocol Violation|9|||
161641554|NCT01255761|583738020|FG001|Overall Study|Protocol Violation|5|||
161641555|NCT01255761|583738019|FG000|Overall Study|Lost to Follow-up|10|||
161641556|NCT01255761|583738020|FG001|Overall Study|Lost to Follow-up|8|||
161641557|NCT01255761|583738019|FG000|Overall Study|Withdrawal by Subject|11|||
161641558|NCT01255761|583738020|FG001|Overall Study|Withdrawal by Subject|27|||
161641559|NCT01255761|583738019|FG000|Overall Study|Other Reasons|37|||
161641560|NCT01255761|583738020|FG001|Overall Study|Other Reasons|18|||
161641561|NCT00658606|583738021|FG000|Overall Study|Adverse Event|2|||
161641562|NCT00658606|583738022|FG001|Overall Study|Adverse Event|1|||
161641563|NCT00658606|583738021|FG000|Overall Study|Lack of Efficacy|6|||
161641564|NCT00658606|583738022|FG001|Overall Study|Lack of Efficacy|3|||
161641565|NCT00658606|583738021|FG000|Overall Study|Lost to Follow-up|1|||
161641566|NCT00658606|583738022|FG001|Overall Study|Lost to Follow-up|0|||
161641567|NCT00658606|583738021|FG000|Overall Study|Withdrawal by Subject|7|||
161641568|NCT00658606|583738022|FG001|Overall Study|Withdrawal by Subject|16|||
161641569|NCT00658606|583738021|FG000|Overall Study|Lack of Compliance|0|||
161641570|NCT00658606|583738022|FG001|Overall Study|Lack of Compliance|3|||
161641571|NCT01191008|583738023|FG000|Overall Study|Protocol Violation|7|||
161641572|NCT01191008|583738023|FG000|Overall Study|Lost to Follow-up|8|||
161641573|NCT03348631|583738026|FG000|Overall Study|Not Eligible, No treatment|0|||
161641574|NCT03348631|583738027|FG001|Overall Study|Not Eligible, No treatment|1|||
161641575|NCT03348631|583738026|FG000|Overall Study|Not Eligible, Treated|2|||
161641576|NCT03348631|583738027|FG001|Overall Study|Not Eligible, Treated|0|||
161641577|NCT03348631|583738026|FG000|Overall Study|Eligible, No Treatment|1|||
161641578|NCT03348631|583738027|FG001|Overall Study|Eligible, No Treatment|0|||
161641579|NCT01068210|583738028|FG000|Overall Study|Lost to Follow-up|1|||
161641580|NCT01068210|583738029|FG001|Overall Study|Lost to Follow-up|2|||
161641581|NCT01068210|583738030|FG002|Overall Study|Lost to Follow-up|2|||
161641582|NCT01068210|583738031|FG003|Overall Study|Lost to Follow-up|1|||
161641583|NCT01068210|583738028|FG000|Overall Study|Second cancer|0|||
161641584|NCT01068210|583738029|FG001|Overall Study|Second cancer|1|||
161641585|NCT01068210|583738030|FG002|Overall Study|Second cancer|0|||
161641586|NCT01068210|583738031|FG003|Overall Study|Second cancer|0|||
161641587|NCT01068210|583738028|FG000|Overall Study|Disease progression|0|||
161641588|NCT01068210|583738029|FG001|Overall Study|Disease progression|0|||
161641589|NCT01068210|583738030|FG002|Overall Study|Disease progression|0|||
161641590|NCT01068210|583738031|FG003|Overall Study|Disease progression|2|||
161641591|NCT03299959|583738040|FG000|Overall Study|Lost to Follow-up|7|||
161641592|NCT03299959|583738041|FG001|Overall Study|Lost to Follow-up|9|||
161641593|NCT03299959|583738040|FG000|Overall Study|Death|1|||
161641594|NCT03299959|583738041|FG001|Overall Study|Death|0|||
161641595|NCT03299959|583738040|FG000|Overall Study|Withdrawal by Subject|13|||
161641596|NCT03299959|583738041|FG001|Overall Study|Withdrawal by Subject|9|||
161641597|NCT03299959|583738040|FG000|Overall Study|Changes in study team and government regulations|1|||
161641598|NCT03299959|583738041|FG001|Overall Study|Changes in study team and government regulations|1|||
161641599|NCT03299959|583738040|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
161641600|NCT03299959|583738041|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
161641601|NCT01431950|583738042|FG000|Overall Study|Study Site Closed/Terminated|7|||
161641602|NCT01431950|583738043|FG001|Overall Study|Study Site Closed/Terminated|3|||
161641603|NCT01431950|583738042|FG000|Overall Study|Withdrawal by Subject|4|||
161641604|NCT01431950|583738043|FG001|Overall Study|Withdrawal by Subject|3|||
161641605|NCT01431950|583738042|FG000|Overall Study|Protocol Violation|2|||
161641606|NCT01431950|583738043|FG001|Overall Study|Protocol Violation|3|||
161641607|NCT01431950|583738042|FG000|Overall Study|Adverse Event|2|||
161641608|NCT01431950|583738043|FG001|Overall Study|Adverse Event|2|||
161641609|NCT01431950|583738042|FG000|Overall Study|Physician Decision|2|||
161641610|NCT01431950|583738043|FG001|Overall Study|Physician Decision|1|||
161641611|NCT01431950|583738042|FG000|Overall Study|Lack of Efficacy|2|||
161641612|NCT01431950|583738043|FG001|Overall Study|Lack of Efficacy|1|||
161641613|NCT01431950|583738042|FG000|Overall Study|Lost to Follow-up|0|||
161641614|NCT01431950|583738043|FG001|Overall Study|Lost to Follow-up|1|||
161641615|NCT01431950|583738042|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161641616|NCT01431950|583738043|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161641617|NCT00738283|583738046|FG000|Overall Study|Death|1|||
161641618|NCT00738283|583738046|FG000|Overall Study|Transfer to another facility|2|||
161641619|NCT00738283|583738046|FG000|Overall Study|Discharge home prior to end of study|1|||
161641620|NCT01210651|583738047|FG000|Overall Study|Lost to Follow-up|1|||
161641621|NCT01210651|583738048|FG001|Overall Study|Lost to Follow-up|1|||
161641622|NCT01210651|583738047|FG000|Overall Study|schedule conflicts|1|||
161641623|NCT01210651|583738048|FG001|Overall Study|schedule conflicts|5|||
161641624|NCT01210651|583738047|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
161641625|NCT01210651|583738048|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
161641626|NCT01210651|583738047|FG000|Overall Study|Withdrawal by Subject|1|||
161641627|NCT01210651|583738048|FG001|Overall Study|Withdrawal by Subject|1|||
161641628|NCT01210651|583738047|FG000|Overall Study|Injury outside study|2|||
161641629|NCT01210651|583738048|FG001|Overall Study|Injury outside study|0|||
161641630|NCT03494985|583738049|FG000|Overall Study|Adverse Event|3|||
161641631|NCT03494985|583738050|FG001|Overall Study|Adverse Event|2|||
161641632|NCT03494985|583738051|FG002|Overall Study|Adverse Event|3|||
161641633|NCT03494985|583738052|FG003|Overall Study|Adverse Event|0|||
161641634|NCT03494985|583738049|FG000|Overall Study|Other (Withdrawal of consent)|2|||
161641635|NCT03494985|583738050|FG001|Overall Study|Other (Withdrawal of consent)|3|||
161641636|NCT03494985|583738051|FG002|Overall Study|Other (Withdrawal of consent)|2|||
161641637|NCT03494985|583738052|FG003|Overall Study|Other (Withdrawal of consent)|5|||
161641638|NCT03494985|583738049|FG000|Overall Study|Other (Not specified)|0|||
161641639|NCT03494985|583738050|FG001|Overall Study|Other (Not specified)|1|||
161641640|NCT03494985|583738051|FG002|Overall Study|Other (Not specified)|1|||
161641641|NCT03494985|583738052|FG003|Overall Study|Other (Not specified)|0|||
161641642|NCT02282059|583738055|FG000|Overall Study|Other|15|||
161641643|NCT02282059|583738056|FG001|Overall Study|Other|3|||
161641644|NCT02282059|583738055|FG000|Overall Study|Participant refused further follow-up|8|||
161641645|NCT02282059|583738056|FG001|Overall Study|Participant refused further follow-up|4|||
161641646|NCT02282059|583738055|FG000|Overall Study|Lost to Follow-up|19|||
161641647|NCT02282059|583738056|FG001|Overall Study|Lost to Follow-up|3|||
161641648|NCT02282059|583738055|FG000|Overall Study|Death|40|||
161641649|NCT02282059|583738056|FG001|Overall Study|Death|8|||
161641650|NCT03459846|583738057|FG000|Overall Study|Death|52|||
161641651|NCT03459846|583738058|FG001|Overall Study|Death|46|||
161641652|NCT03459846|583738057|FG000|Overall Study|Study terminated by sponsor|24|||
161641653|NCT03459846|583738058|FG001|Overall Study|Study terminated by sponsor|28|||
161641654|NCT03459846|583738057|FG000|Overall Study|Withdrawal by Subject|2|||
161641655|NCT03459846|583738058|FG001|Overall Study|Withdrawal by Subject|2|||
161641656|NCT04886518|583738065|FG000|Overall Study|Noncompliance with study drug|1|||
161641657|NCT04886518|583738066|FG001|Overall Study|Noncompliance with study drug|0|||
161641658|NCT04886518|583738067|FG002|Overall Study|Noncompliance with study drug|0|||
161641659|NCT04886518|583738065|FG000|Overall Study|Adverse Event|0|||
161641660|NCT04886518|583738066|FG001|Overall Study|Adverse Event|1|||
161641661|NCT04886518|583738067|FG002|Overall Study|Adverse Event|0|||
161641662|NCT04886518|583738065|FG000|Overall Study|Withdrawal by Subject|1|||
161641663|NCT04886518|583738066|FG001|Overall Study|Withdrawal by Subject|0|||
161641664|NCT04886518|583738067|FG002|Overall Study|Withdrawal by Subject|0|||
161641665|NCT01090011|583740466|FG000|Overall Study|Progressive disease|128|||
161641666|NCT01090011|583740466|FG000|Overall Study|Adverse Event|32|||
161641667|NCT01090011|583740466|FG000|Overall Study|Protocol Violation|1|||
161641668|NCT01090011|583740466|FG000|Overall Study|Refusal to start/continue medication|5|||
161641669|NCT01090011|583740466|FG000|Overall Study|Other reason not defined above|5|||
161641670|NCT03778294|583740467|FG000|Overall Study|Death|1|||
161641671|NCT03778294|583740467|FG000|Overall Study|Issues with insurance|1|||
161641672|NCT03778294|583740467|FG000|Overall Study|disease progression before treatment|2|||
161641673|NCT01845805|583740468|FG000|Overall Study|Withdrawal by Subject|1|||
161641674|NCT01845805|583740469|FG001|Overall Study|Withdrawal by Subject|2|||
161641675|NCT01845805|583740468|FG000|Overall Study|Disease Progression|13|||
161641676|NCT01845805|583740469|FG001|Overall Study|Disease Progression|14|||
161641677|NCT01845805|583740468|FG000|Overall Study|Drug-related Toxicity|4|||
161641678|NCT01845805|583740469|FG001|Overall Study|Drug-related Toxicity|0|||
161641679|NCT00127842|583740470|FG000|Overall Study|Adverse Event|15|||
161641680|NCT00127842|583740470|FG000|Overall Study|Withdrawal by Subject|3|||
161641681|NCT00127842|583740470|FG000|Overall Study|Lost to Follow-up|1|||
161641682|NCT00127842|583740470|FG000|Overall Study|Lack of Efficacy|12|||
161641683|NCT00127842|583740470|FG000|Overall Study|Noncompliance|2|||
161641684|NCT00127842|583740470|FG000|Overall Study|Protocol Violation|1|||
161641685|NCT00127842|583740470|FG000|Overall Study|Other|5|||
161641686|NCT01443403|583740471|FG000|Overall Study|Adverse Event|1|||
161641687|NCT01443403|583740472|FG001|Overall Study|Adverse Event|1|||
161641688|NCT01443403|583740473|FG002|Overall Study|Adverse Event|4|||
161641689|NCT01443403|583740474|FG003|Overall Study|Adverse Event|5|||
161641690|NCT01443403|583740471|FG000|Overall Study|Withdrawal by Subject|0|||
161641691|NCT01443403|583740472|FG001|Overall Study|Withdrawal by Subject|1|||
161641692|NCT01443403|583740473|FG002|Overall Study|Withdrawal by Subject|2|||
161641693|NCT01443403|583740474|FG003|Overall Study|Withdrawal by Subject|1|||
161641694|NCT01443403|583740471|FG000|Overall Study|Lost to Follow-up|0|||
161641695|NCT01443403|583740472|FG001|Overall Study|Lost to Follow-up|0|||
161641696|NCT01443403|583740473|FG002|Overall Study|Lost to Follow-up|0|||
161641697|NCT01443403|583740474|FG003|Overall Study|Lost to Follow-up|1|||
161641698|NCT01443403|583740471|FG000|Overall Study|Protocol Violation|2|||
161641699|NCT01443403|583740472|FG001|Overall Study|Protocol Violation|1|||
161641700|NCT01443403|583740473|FG002|Overall Study|Protocol Violation|1|||
161641701|NCT01443403|583740474|FG003|Overall Study|Protocol Violation|1|||
161641702|NCT01443403|583740471|FG000|Overall Study|Use of Prohibited Treatment|2|||
161641703|NCT01443403|583740472|FG001|Overall Study|Use of Prohibited Treatment|3|||
161641704|NCT01443403|583740473|FG002|Overall Study|Use of Prohibited Treatment|0|||
161641705|NCT01443403|583740474|FG003|Overall Study|Use of Prohibited Treatment|0|||
161641706|NCT01443403|583740471|FG000|Overall Study|Other - Miscellaneous|1|||
161641707|NCT01443403|583740472|FG001|Overall Study|Other - Miscellaneous|0|||
161641708|NCT01443403|583740473|FG002|Overall Study|Other - Miscellaneous|0|||
161641709|NCT01443403|583740474|FG003|Overall Study|Other - Miscellaneous|1|||
161641710|NCT03945773|583740475|FG000|Overall Study|Consent Withdrawn|1|||
161641711|NCT03945773|583740476|FG001|Overall Study|Consent Withdrawn|1|||
161641712|NCT03945773|583740475|FG000|Overall Study|Lost to Follow-up|1|||
161641713|NCT03945773|583740476|FG001|Overall Study|Lost to Follow-up|0|||
161641714|NCT03945773|583740475|FG000|Overall Study|Death|46|||
161641715|NCT03945773|583740476|FG001|Overall Study|Death|22|||
161641716|NCT03945773|583740475|FG000|Overall Study|Physician Decision|1|||
161641717|NCT03945773|583740476|FG001|Overall Study|Physician Decision|0|||
161641718|NCT03945773|583740475|FG000|Overall Study|Other|1|||
161641719|NCT03945773|583740476|FG001|Overall Study|Other|0|||
161641720|NCT03945773|583740475|FG000|Overall Study|Ongoing at the time of DCO|4|||
161641721|NCT03945773|583740476|FG001|Overall Study|Ongoing at the time of DCO|3|||
161641722|NCT00725712|583740479|FG000|Overall Study|Withdrawal by Subject|2|||
161641723|NCT00725712|583740480|FG001|Overall Study|Withdrawal by Subject|1|||
161641724|NCT00725712|583740479|FG000|Overall Study|Protocol Violation|1|||
161641725|NCT00725712|583740480|FG001|Overall Study|Protocol Violation|0|||
161641726|NCT00725712|583740479|FG000|Overall Study|Progressive disease|37|||
161641727|NCT00725712|583740480|FG001|Overall Study|Progressive disease|16|||
161641728|NCT00725712|583740479|FG000|Overall Study|Clinical progression not based on RECIST|0|||
161641729|NCT00725712|583740480|FG001|Overall Study|Clinical progression not based on RECIST|3|||
161641730|NCT00725712|583740479|FG000|Overall Study|Adverse Event|5|||
161641731|NCT00725712|583740480|FG001|Overall Study|Adverse Event|5|||
161641732|NCT00725712|583740479|FG000|Overall Study|Death|2|||
161641733|NCT00725712|583740480|FG001|Overall Study|Death|0|||
161641734|NCT00725712|583740479|FG000|Overall Study|Other: Death|1|||
161641735|NCT00725712|583740480|FG001|Overall Study|Other: Death|0|||
161641736|NCT00725712|583740479|FG000|Overall Study|Hospitalized, unable to continue|0|||
161641737|NCT00725712|583740480|FG001|Overall Study|Hospitalized, unable to continue|1|||
161641738|NCT03595124|583740484|FG000|Overall Study|Physician Decision|1|||
161641739|NCT03595124|583740485|FG001|Overall Study|Physician Decision|1|||
161641740|NCT03595124|583740486|FG002|Overall Study|Physician Decision|1|||
161641741|NCT03595124|583740484|FG000|Overall Study|Ineligible|1|||
161641742|NCT03595124|583740485|FG001|Overall Study|Ineligible|1|||
161641743|NCT03595124|583740486|FG002|Overall Study|Ineligible|0|||
161641744|NCT03595124|583740484|FG000|Overall Study|Disease Progression|4|||
161641745|NCT03595124|583740485|FG001|Overall Study|Disease Progression|1|||
161641746|NCT03595124|583740486|FG002|Overall Study|Disease Progression|4|||
161641747|NCT01439867|583740487|FG000|Overall Study|Non-compliance|0|||
161641748|NCT01439867|583740488|FG001|Overall Study|Non-compliance|1|||
161641749|NCT01439867|583740487|FG000|Overall Study|Withdrawal by Subject|1|||
161641750|NCT01439867|583740488|FG001|Overall Study|Withdrawal by Subject|2|||
161687526|NCT03770260|583908428|FG000|Overall Study|Disease progression|0|||
161687527|NCT03770260|583908429|FG001|Overall Study|Disease progression|1|||
161687528|NCT03770260|583908430|FG002|Overall Study|Disease progression|0|||
161687529|NCT03770260|583908431|FG003|Overall Study|Disease progression|0|||
161687530|NCT01964352|583908433|FG000|Overall Study|Adverse Event|13|||
161687531|NCT01964352|583908434|FG001|Overall Study|Adverse Event|3|||
161835402|NCT04355663|584438951|FG002|Overall Study|Withdrawal by Subject|3|||
161835403|NCT02787408|584438957|FG000|Overall Study|Death|16|||
161835404|NCT02787408|584438957|FG000|Overall Study|Withdrawal by Subject|1|||
161641751|NCT01439867|583740487|FG000|Overall Study|Administrative Decision|4|||
161641752|NCT01439867|583740488|FG001|Overall Study|Administrative Decision|5|||
161641753|NCT01439867|583740487|FG000|Overall Study|Protocol-specified Criteria|1|||
161641754|NCT01439867|583740488|FG001|Overall Study|Protocol-specified Criteria|0|||
161641755|NCT03607422|583740489|FG000|Overall Study|Adverse Event|7|||
161641756|NCT03607422|583740490|FG001|Overall Study|Adverse Event|3|||
161641757|NCT03607422|583740491|FG002|Overall Study|Adverse Event|2|||
161641758|NCT03607422|583740492|FG003|Overall Study|Adverse Event|0|||
161641759|NCT03607422|583740493|FG004|Overall Study|Adverse Event|2|||
161641760|NCT03607422|583740494|FG005|Overall Study|Adverse Event|0|||
161641761|NCT03607422|583740489|FG000|Overall Study|Withdrawal by Subject|11|||
161641762|NCT03607422|583740490|FG001|Overall Study|Withdrawal by Subject|3|||
161641763|NCT03607422|583740491|FG002|Overall Study|Withdrawal by Subject|6|||
161641764|NCT03607422|583740492|FG003|Overall Study|Withdrawal by Subject|2|||
161641765|NCT03607422|583740493|FG004|Overall Study|Withdrawal by Subject|0|||
161641766|NCT03607422|583740494|FG005|Overall Study|Withdrawal by Subject|0|||
161641767|NCT03607422|583740489|FG000|Overall Study|Lost to Follow-up|0|||
161641768|NCT03607422|583740490|FG001|Overall Study|Lost to Follow-up|0|||
161641769|NCT03607422|583740491|FG002|Overall Study|Lost to Follow-up|1|||
161641770|NCT03607422|583740492|FG003|Overall Study|Lost to Follow-up|0|||
161641771|NCT03607422|583740493|FG004|Overall Study|Lost to Follow-up|0|||
161641772|NCT03607422|583740494|FG005|Overall Study|Lost to Follow-up|0|||
161641773|NCT03607422|583740489|FG000|Overall Study|Other|12|||
161641774|NCT03607422|583740490|FG001|Overall Study|Other|4|||
161641775|NCT03607422|583740491|FG002|Overall Study|Other|1|||
161641776|NCT03607422|583740492|FG003|Overall Study|Other|2|||
161641777|NCT03607422|583740493|FG004|Overall Study|Other|0|||
161641778|NCT03607422|583740494|FG005|Overall Study|Other|2|||
161641779|NCT03607422|583740489|FG000|Overall Study|Ongoing at Time of Analysis|8|||
161641780|NCT03607422|583740490|FG001|Overall Study|Ongoing at Time of Analysis|0|||
161641781|NCT03607422|583740491|FG002|Overall Study|Ongoing at Time of Analysis|2|||
161641782|NCT03607422|583740492|FG003|Overall Study|Ongoing at Time of Analysis|1|||
161641783|NCT03607422|583740493|FG004|Overall Study|Ongoing at Time of Analysis|1|||
161641784|NCT03607422|583740494|FG005|Overall Study|Ongoing at Time of Analysis|1|||
161641785|NCT03258723|583740497|FG000|Overall Study|COVID Interruption of study|54|||
161641786|NCT03258723|583740497|FG000|Overall Study|Lost to Follow-up|8|||
161641787|NCT04832971|583740498|FG000|Double-Blind (DB) Treatment Period|Death|1|||
161641788|NCT04832971|583740499|FG001|Double-Blind (DB) Treatment Period|Death|0|||
161641789|NCT04832971|583740500|FG002|Double-Blind (DB) Treatment Period|Death|0|||
161641790|NCT04832971|583740501|FG003|Double-Blind (DB) Treatment Period|Death|0|||
161641791|NCT04832971|583740502|FG004|Double-Blind (DB) Treatment Period|Death|0|||
161641792|NCT04832971|583740503|FG005|Double-Blind (DB) Treatment Period|Death|0|||
161641793|NCT04832971|583740504|FG006|Double-Blind (DB) Treatment Period|Death|0|||
161641794|NCT04832971|583740505|FG007|Double-Blind (DB) Treatment Period|Death|0|||
161641795|NCT04832971|583740506|FG008|Double-Blind (DB) Treatment Period|Death|0|||
161641796|NCT04832971|583740507|FG009|Double-Blind (DB) Treatment Period|Death|0|||
161641797|NCT04832971|583740498|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161641798|NCT04832971|583740499|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161641799|NCT04832971|583740500|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161641800|NCT04832971|583740501|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641801|NCT04832971|583740502|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641802|NCT04832971|583740503|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641803|NCT04832971|583740504|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641804|NCT04832971|583740505|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641805|NCT04832971|583740506|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641806|NCT04832971|583740507|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161641807|NCT04832971|583740498|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161641808|NCT04832971|583740499|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161641809|NCT04832971|583740500|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161687532|NCT01964352|583908435|FG002|Overall Study|Adverse Event|4|||
161687533|NCT01964352|583908436|FG003|Overall Study|Adverse Event|3|||
161687534|NCT01964352|583908433|FG000|Overall Study|Lack of Efficacy|6|||
161641810|NCT04832971|583740501|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161641811|NCT04832971|583740502|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161687535|NCT01964352|583908434|FG001|Overall Study|Lack of Efficacy|0|||
161641812|NCT04832971|583740503|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161641813|NCT04832971|583740504|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161641814|NCT04832971|583740505|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161641815|NCT04832971|583740506|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161641816|NCT04832971|583740507|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161641817|NCT04832971|583740498|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641818|NCT04832971|583740499|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
161641819|NCT04832971|583740500|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641820|NCT04832971|583740501|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641821|NCT04832971|583740502|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641822|NCT04832971|583740503|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641823|NCT04832971|583740504|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641824|NCT04832971|583740505|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641825|NCT04832971|583740506|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641826|NCT04832971|583740507|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161641827|NCT04832971|583740498|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
161641828|NCT04832971|583740499|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
161641829|NCT04832971|583740500|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
161641830|NCT04832971|583740501|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
161641831|NCT04832971|583740502|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
161641832|NCT04832971|583740503|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
161641833|NCT04832971|583740504|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
161641834|NCT04832971|583740505|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
161641835|NCT04832971|583740506|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
161687536|NCT01964352|583908435|FG002|Overall Study|Lack of Efficacy|0|||
161687537|NCT01964352|583908436|FG003|Overall Study|Lack of Efficacy|0|||
161687538|NCT01964352|583908433|FG000|Overall Study|Protocol Violation|2|||
161687539|NCT01964352|583908434|FG001|Overall Study|Protocol Violation|4|||
161687540|NCT01964352|583908435|FG002|Overall Study|Protocol Violation|0|||
161687541|NCT01964352|583908436|FG003|Overall Study|Protocol Violation|2|||
161687542|NCT01964352|583908433|FG000|Overall Study|Lost to Follow-up|1|||
161687543|NCT01964352|583908434|FG001|Overall Study|Lost to Follow-up|0|||
161687544|NCT01964352|583908435|FG002|Overall Study|Lost to Follow-up|0|||
161687545|NCT01964352|583908436|FG003|Overall Study|Lost to Follow-up|1|||
161687546|NCT01964352|583908433|FG000|Overall Study|Withdrawal by Subject|4|||
161687547|NCT01964352|583908434|FG001|Overall Study|Withdrawal by Subject|2|||
161687548|NCT01964352|583908435|FG002|Overall Study|Withdrawal by Subject|1|||
161687549|NCT01964352|583908436|FG003|Overall Study|Withdrawal by Subject|0|||
161687550|NCT01964352|583908433|FG000|Overall Study|Other than stated above|0|||
161687551|NCT01964352|583908434|FG001|Overall Study|Other than stated above|2|||
161687552|NCT01964352|583908435|FG002|Overall Study|Other than stated above|1|||
161687553|NCT01964352|583908436|FG003|Overall Study|Other than stated above|2|||
161687554|NCT00477165|583908439|FG000|Overall Study|Adverse Event|7|||
161687555|NCT00477165|583908440|FG001|Overall Study|Adverse Event|2|||
161687556|NCT02135692|583908444|FG000|Overall Study|Adverse Event|3|||
161687557|NCT02135692|583908444|FG000|Overall Study|Lack of Efficacy|2|||
161687558|NCT02135692|583908444|FG000|Overall Study|Protocol Violation|2|||
161687559|NCT02135692|583908444|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
161687560|NCT02135692|583908444|FG000|Overall Study|Product commercially available|159|||
161687561|NCT02135692|583908444|FG000|Overall Study|Study closed/terminated|153|||
161687562|NCT02135692|583908444|FG000|Overall Study|Lost to Follow-up|4|||
161687563|NCT02135692|583908444|FG000|Overall Study|Withdrawal by Subject|15|||
161687564|NCT01097746|583908446|FG000|Overall Study|Adverse Event|4|||
161687565|NCT01097746|583908446|FG000|Overall Study|taken off study before any treatment given|1|||
161835405|NCT02787408|584438957|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
161835406|NCT05444543|584438960|FG000|Overall Study|Withdrawal by Subject|1|||
161835407|NCT05444543|584438961|FG001|Overall Study|Withdrawal by Subject|0|||
161641836|NCT04832971|583740507|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
161641837|NCT04832971|583740498|FG000|Open-Label Extension (OLE) Period|Death|0|||
161641838|NCT04832971|583740499|FG001|Open-Label Extension (OLE) Period|Death|0|||
161641839|NCT04832971|583740500|FG002|Open-Label Extension (OLE) Period|Death|0|||
161687566|NCT01514682|583908447|FG000|Overall Study|Withdrawal by Subject|2|||
161687567|NCT01514682|583908448|FG001|Overall Study|Withdrawal by Subject|3|||
161687568|NCT01514682|583908447|FG000|Overall Study|Physician Decision|4|||
161687569|NCT01514682|583908448|FG001|Overall Study|Physician Decision|3|||
161687570|NCT00647556|583908449|FG000|Overall Study|Adverse Event|0|||
161687571|NCT00647556|583908450|FG001|Overall Study|Adverse Event|1|||
161687572|NCT00647556|583908449|FG000|Overall Study|Lost to Follow-up|1|||
161687573|NCT00647556|583908450|FG001|Overall Study|Lost to Follow-up|0|||
161687574|NCT00647556|583908449|FG000|Overall Study|Protocol Violation|0|||
161687575|NCT00647556|583908450|FG001|Overall Study|Protocol Violation|1|||
161687576|NCT00647556|583908449|FG000|Overall Study|Withdrawal by Subject|1|||
161687577|NCT00647556|583908450|FG001|Overall Study|Withdrawal by Subject|0|||
161687578|NCT00647556|583908449|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
161641840|NCT04832971|583740501|FG003|Open-Label Extension (OLE) Period|Death|0|||
161641841|NCT04832971|583740502|FG004|Open-Label Extension (OLE) Period|Death|0|||
161641842|NCT04832971|583740503|FG005|Open-Label Extension (OLE) Period|Death|0|||
161641843|NCT04832971|583740504|FG006|Open-Label Extension (OLE) Period|Death|0|||
161641844|NCT04832971|583740505|FG007|Open-Label Extension (OLE) Period|Death|1|||
161641845|NCT04832971|583740506|FG008|Open-Label Extension (OLE) Period|Death|0|||
161641846|NCT04832971|583740507|FG009|Open-Label Extension (OLE) Period|Death|0|||
161641847|NCT04832971|583740498|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641848|NCT04832971|583740499|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641849|NCT04832971|583740500|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641850|NCT04832971|583740501|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641851|NCT04832971|583740502|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641852|NCT04832971|583740503|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641853|NCT04832971|583740504|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
161641854|NCT04832971|583740505|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
161641855|NCT04832971|583740506|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641856|NCT04832971|583740507|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161641857|NCT04832971|583740498|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161641858|NCT04832971|583740499|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161641859|NCT04832971|583740500|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161641860|NCT04832971|583740501|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161641861|NCT04832971|583740502|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
161641862|NCT04832971|583740503|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
161641863|NCT04832971|583740504|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
161641864|NCT04832971|583740505|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
161641865|NCT04832971|583740506|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
161641866|NCT04832971|583740507|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
161641867|NCT04832971|583740498|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161641868|NCT04832971|583740499|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161641869|NCT04832971|583740500|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161641870|NCT04832971|583740501|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161641871|NCT04832971|583740502|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161641872|NCT04832971|583740503|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161687579|NCT00647556|583908450|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
161687580|NCT00623480|583908451|FG000|Overall Study|Lost to Follow-up|0|||
161687581|NCT00623480|583908452|FG001|Overall Study|Lost to Follow-up|1|||
161687582|NCT00623480|583908451|FG000|Overall Study|Withdrawal by Subject|2|||
161687583|NCT00623480|583908452|FG001|Overall Study|Withdrawal by Subject|4|||
161687584|NCT00623480|583908451|FG000|Overall Study|Lack of Efficacy|1|||
161687585|NCT00623480|583908452|FG001|Overall Study|Lack of Efficacy|0|||
161687586|NCT00623480|583908451|FG000|Overall Study|Non-compliant with study medication|4|||
161687587|NCT00623480|583908452|FG001|Overall Study|Non-compliant with study medication|0|||
161687588|NCT00623480|583908451|FG000|Overall Study|Protocol Violation|0|||
161687589|NCT00623480|583908452|FG001|Overall Study|Protocol Violation|1|||
161687590|NCT00623480|583908451|FG000|Overall Study|Site closed by sponsor|0|||
161687591|NCT00623480|583908452|FG001|Overall Study|Site closed by sponsor|1|||
161687592|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
161687593|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
161687594|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
161687595|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
161687596|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
161687597|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
161687598|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
161687599|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
161687600|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
161687601|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
161835408|NCT05444543|584438960|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
161835409|NCT05444543|584438961|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
161835410|NCT05444543|584438960|FG000|Overall Study|Adverse Event|0|||
161835411|NCT05444543|584438961|FG001|Overall Study|Adverse Event|1|||
161835412|NCT05444543|584438960|FG000|Overall Study|Family relocating at a distance from study site|0|||
161835413|NCT05444543|584438961|FG001|Overall Study|Family relocating at a distance from study site|1|||
161687602|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
161687603|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
161687604|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
161835414|NCT02408120|584438964|FG000|Overall Study|Withdrawal by Subject|0|||
161835415|NCT02408120|584438965|FG001|Overall Study|Withdrawal by Subject|1|||
161641873|NCT04832971|583740504|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161641874|NCT04832971|583740505|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161641875|NCT04832971|583740506|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161641876|NCT04832971|583740507|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
161641877|NCT04832971|583740498|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641878|NCT04832971|583740499|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641879|NCT04832971|583740500|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641880|NCT04832971|583740501|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641881|NCT04832971|583740502|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641882|NCT04832971|583740503|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641883|NCT04832971|583740504|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
161641884|NCT04832971|583740505|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
161641885|NCT04832971|583740506|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161641886|NCT04832971|583740507|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
161641887|NCT01107899|583740508|FG000|Overall Study|Physician Decision|5|||
161641888|NCT01107899|583740509|FG001|Overall Study|Physician Decision|0|||
161641889|NCT01107899|583740510|FG002|Overall Study|Physician Decision|3|||
161641890|NCT01107899|583740508|FG000|Overall Study|Withdrawal by Subject|0|||
161641891|NCT01107899|583740509|FG001|Overall Study|Withdrawal by Subject|0|||
161641892|NCT01107899|583740510|FG002|Overall Study|Withdrawal by Subject|1|||
161641893|NCT03584152|583740511|FG000|Overall Study|Discontinued intervention|7|||
161641894|NCT03584152|583740512|FG001|Overall Study|Discontinued intervention|4|||
161641895|NCT04024462|583740513|FG000|Overall Study|Withdrawal by Subject|6|||
161641896|NCT04024462|583740514|FG001|Overall Study|Withdrawal by Subject|7|||
161641897|NCT04024462|583740513|FG000|Overall Study|Progressive Disease|0|||
161641898|NCT04024462|583740514|FG001|Overall Study|Progressive Disease|1|||
161641899|NCT04024462|583740513|FG000|Overall Study|Adverse Event|0|||
161641900|NCT04024462|583740514|FG001|Overall Study|Adverse Event|1|||
161641901|NCT04024462|583740513|FG000|Overall Study|Death|0|||
161641902|NCT04024462|583740514|FG001|Overall Study|Death|1|||
161641903|NCT04024462|583740513|FG000|Overall Study|Lost to Follow-up|1|||
161641904|NCT04024462|583740514|FG001|Overall Study|Lost to Follow-up|0|||
161641905|NCT04024462|583740513|FG000|Overall Study|Ongoing in the Study|94|||
161641906|NCT04024462|583740514|FG001|Overall Study|Ongoing in the Study|89|||
161641907|NCT00983749|583740519|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
161641908|NCT00983749|583740520|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
161641909|NCT04292470|583740521|FG000|Overall Study|Withdrawal by Subject|0|||
161641910|NCT04292470|583740522|FG001|Overall Study|Withdrawal by Subject|1|||
161641911|NCT02906020|583740536|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
161641912|NCT02906020|583740537|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
161641913|NCT02906020|583740538|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
161641914|NCT02906020|583740539|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
161641915|NCT02906020|583740540|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
161641916|NCT02906020|583740541|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
161641917|NCT02906020|583740542|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
161641918|NCT02906020|583740543|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
161641919|NCT02906020|583740544|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
161641920|NCT02906020|583740545|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
161641921|NCT02906020|583740546|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
161641922|NCT02906020|583740547|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
161641923|NCT02906020|583740548|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
161641924|NCT02906020|583740549|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
161641925|NCT02906020|583740550|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
161641926|NCT02906020|583740551|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
161641927|NCT02906020|583740536|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641928|NCT02906020|583740537|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641929|NCT02906020|583740538|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641930|NCT02906020|583740539|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641931|NCT02906020|583740540|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641932|NCT02906020|583740541|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641933|NCT02906020|583740542|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641934|NCT02906020|583740543|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641935|NCT02906020|583740544|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
161641936|NCT02906020|583740545|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
161641937|NCT02906020|583740546|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161687605|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
161641938|NCT02906020|583740547|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641939|NCT02906020|583740548|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641940|NCT02906020|583740549|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641941|NCT02906020|583740550|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641942|NCT02906020|583740551|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161641943|NCT02906020|583740536|FG000|Part 2: Double-blind Treatment Period|Other|0|||
161641944|NCT02906020|583740537|FG001|Part 2: Double-blind Treatment Period|Other|0|||
161641945|NCT02906020|583740538|FG002|Part 2: Double-blind Treatment Period|Other|0|||
161641946|NCT02906020|583740539|FG003|Part 2: Double-blind Treatment Period|Other|0|||
161641947|NCT02906020|583740540|FG004|Part 2: Double-blind Treatment Period|Other|0|||
161641948|NCT02906020|583740541|FG005|Part 2: Double-blind Treatment Period|Other|0|||
161641949|NCT02906020|583740542|FG006|Part 2: Double-blind Treatment Period|Other|0|||
161641950|NCT02906020|583740543|FG007|Part 2: Double-blind Treatment Period|Other|0|||
161641951|NCT02906020|583740544|FG008|Part 2: Double-blind Treatment Period|Other|6|||
161641952|NCT02906020|583740545|FG009|Part 2: Double-blind Treatment Period|Other|10|||
161641953|NCT02906020|583740546|FG010|Part 2: Double-blind Treatment Period|Other|0|||
161641954|NCT02906020|583740547|FG011|Part 2: Double-blind Treatment Period|Other|0|||
161641955|NCT02906020|583740548|FG012|Part 2: Double-blind Treatment Period|Other|0|||
161641956|NCT02906020|583740549|FG013|Part 2: Double-blind Treatment Period|Other|0|||
161641957|NCT02906020|583740550|FG014|Part 2: Double-blind Treatment Period|Other|0|||
161641958|NCT02906020|583740551|FG015|Part 2: Double-blind Treatment Period|Other|0|||
161641959|NCT02906020|583740536|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641960|NCT02906020|583740537|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641961|NCT02906020|583740538|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641962|NCT02906020|583740539|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641963|NCT02906020|583740540|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641964|NCT02906020|583740541|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641965|NCT02906020|583740542|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641966|NCT02906020|583740543|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641967|NCT02906020|583740544|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161835416|NCT02408120|584438964|FG000|Overall Study|Treatment Refusal|1|||
161835417|NCT02408120|584438965|FG001|Overall Study|Treatment Refusal|0|||
161835418|NCT02408120|584438964|FG000|Overall Study|Received Steroids|1|||
161641968|NCT02906020|583740545|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641969|NCT02906020|583740546|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161835419|NCT02408120|584438965|FG001|Overall Study|Received Steroids|1|||
161641970|NCT02906020|583740547|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641971|NCT02906020|583740548|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
161641972|NCT02906020|583740549|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
161641973|NCT02906020|583740550|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641974|NCT02906020|583740551|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161641975|NCT02906020|583740536|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641976|NCT02906020|583740537|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641977|NCT02906020|583740538|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641978|NCT02906020|583740539|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641979|NCT02906020|583740540|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641980|NCT02906020|583740541|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641981|NCT02906020|583740542|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641982|NCT02906020|583740543|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641983|NCT02906020|583740544|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641984|NCT02906020|583740545|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641985|NCT02906020|583740546|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641986|NCT02906020|583740547|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641987|NCT02906020|583740548|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
161641988|NCT02906020|583740549|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
161641989|NCT02906020|583740550|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161641990|NCT02906020|583740551|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
161641991|NCT02906020|583740536|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641992|NCT02906020|583740537|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641993|NCT02906020|583740538|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641994|NCT02906020|583740539|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641995|NCT02906020|583740540|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641996|NCT02906020|583740541|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641997|NCT02906020|583740542|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641998|NCT02906020|583740543|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161641999|NCT02906020|583740544|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161642000|NCT02906020|583740545|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161642001|NCT02906020|583740546|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161642002|NCT02906020|583740547|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161642003|NCT02906020|583740548|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
161642004|NCT02906020|583740549|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
161642005|NCT02906020|583740550|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161642006|NCT02906020|583740551|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161642007|NCT02906020|583740536|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642008|NCT02906020|583740537|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642009|NCT02906020|583740538|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642010|NCT02906020|583740539|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642011|NCT02906020|583740540|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642012|NCT02906020|583740541|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642013|NCT02906020|583740542|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642014|NCT02906020|583740543|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642015|NCT02906020|583740544|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642016|NCT02906020|583740545|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642017|NCT02906020|583740546|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642018|NCT02906020|583740547|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642019|NCT02906020|583740548|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
161642020|NCT02906020|583740549|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
161642021|NCT02906020|583740550|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642022|NCT02906020|583740551|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161642023|NCT02906020|583740536|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642024|NCT02906020|583740537|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642025|NCT02906020|583740538|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642026|NCT02906020|583740539|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642027|NCT02906020|583740540|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642028|NCT02906020|583740541|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642029|NCT02906020|583740542|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642030|NCT02906020|583740543|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642031|NCT02906020|583740544|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642032|NCT02906020|583740545|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642033|NCT02906020|583740546|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642034|NCT02906020|583740547|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161642035|NCT02906020|583740548|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
161642036|NCT02906020|583740549|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
161642037|NCT02906020|583740550|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
161642038|NCT02906020|583740551|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
161642039|NCT02906020|583740536|FG000|Part 2: Long-term Follow-up Period|Other|0|||
161642040|NCT02906020|583740537|FG001|Part 2: Long-term Follow-up Period|Other|0|||
161642041|NCT02906020|583740538|FG002|Part 2: Long-term Follow-up Period|Other|0|||
161642042|NCT02906020|583740539|FG003|Part 2: Long-term Follow-up Period|Other|0|||
161642043|NCT02906020|583740540|FG004|Part 2: Long-term Follow-up Period|Other|0|||
161642044|NCT02906020|583740541|FG005|Part 2: Long-term Follow-up Period|Other|0|||
161642045|NCT02906020|583740542|FG006|Part 2: Long-term Follow-up Period|Other|0|||
161642046|NCT02906020|583740543|FG007|Part 2: Long-term Follow-up Period|Other|0|||
161642047|NCT02906020|583740544|FG008|Part 2: Long-term Follow-up Period|Other|0|||
161642048|NCT02906020|583740545|FG009|Part 2: Long-term Follow-up Period|Other|0|||
161642049|NCT02906020|583740546|FG010|Part 2: Long-term Follow-up Period|Other|0|||
161642050|NCT02906020|583740547|FG011|Part 2: Long-term Follow-up Period|Other|0|||
161642051|NCT02906020|583740548|FG012|Part 2: Long-term Follow-up Period|Other|13|||
161642052|NCT02906020|583740549|FG013|Part 2: Long-term Follow-up Period|Other|8|||
161642053|NCT02906020|583740550|FG014|Part 2: Long-term Follow-up Period|Other|3|||
161642054|NCT02906020|583740551|FG015|Part 2: Long-term Follow-up Period|Other|2|||
161642055|NCT01375673|583740557|FG000|Overall Study|Withdrawal by Subject|0|||
161642056|NCT01375673|583740558|FG001|Overall Study|Withdrawal by Subject|1|||
161642057|NCT04698915|583740563|FG000|Overall Study|Adverse Event|2|||
161642058|NCT04698915|583740564|FG001|Overall Study|Adverse Event|0|||
161642059|NCT04698915|583740563|FG000|Overall Study|Death|23|||
161642060|NCT04698915|583740564|FG001|Overall Study|Death|20|||
161642061|NCT04698915|583740563|FG000|Overall Study|Physician Decision|1|||
161642062|NCT04698915|583740564|FG001|Overall Study|Physician Decision|1|||
161642063|NCT04698915|583740563|FG000|Overall Study|Lost to Follow-up|1|||
161642064|NCT04698915|583740564|FG001|Overall Study|Lost to Follow-up|0|||
161642065|NCT04698915|583740563|FG000|Overall Study|Study Terminated by Sponsor|55|||
161642066|NCT04698915|583740564|FG001|Overall Study|Study Terminated by Sponsor|60|||
161642067|NCT04698915|583740563|FG000|Overall Study|Withdrawal by Subject|2|||
161642068|NCT04698915|583740564|FG001|Overall Study|Withdrawal by Subject|3|||
161835420|NCT02408120|584438964|FG000|Overall Study|Discharged same day|1|||
161642069|NCT01907906|583740565|FG000|Overall Study|Withdrawal by Subject|1|||
161642070|NCT01907906|583740566|FG001|Overall Study|Withdrawal by Subject|0|||
161642071|NCT01907906|583740565|FG000|Overall Study|Physician Decision|3|||
161642072|NCT01907906|583740566|FG001|Overall Study|Physician Decision|1|||
161642073|NCT00979953|583740567|FG000|Overall Study|Adverse Event|5|||
161642074|NCT00979953|583740568|FG001|Overall Study|Adverse Event|2|||
161642075|NCT00979953|583740569|FG002|Overall Study|Adverse Event|17|||
161642076|NCT00979953|583740570|FG003|Overall Study|Adverse Event|4|||
161642077|NCT00979953|583740567|FG000|Overall Study|Lack of Efficacy|1|||
161642078|NCT00979953|583740568|FG001|Overall Study|Lack of Efficacy|2|||
161642079|NCT00979953|583740569|FG002|Overall Study|Lack of Efficacy|0|||
161642080|NCT00979953|583740570|FG003|Overall Study|Lack of Efficacy|0|||
161642081|NCT00979953|583740567|FG000|Overall Study|Lost to Follow-up|1|||
161642082|NCT00979953|583740568|FG001|Overall Study|Lost to Follow-up|1|||
161642083|NCT00979953|583740569|FG002|Overall Study|Lost to Follow-up|1|||
161642084|NCT00979953|583740570|FG003|Overall Study|Lost to Follow-up|0|||
161642085|NCT00979953|583740567|FG000|Overall Study|Withdrawal by Subject|0|||
161642086|NCT00979953|583740568|FG001|Overall Study|Withdrawal by Subject|0|||
161642087|NCT00979953|583740569|FG002|Overall Study|Withdrawal by Subject|2|||
161642088|NCT00979953|583740570|FG003|Overall Study|Withdrawal by Subject|1|||
161642089|NCT00979953|583740567|FG000|Overall Study|Protocol Violation|1|||
161642090|NCT00979953|583740568|FG001|Overall Study|Protocol Violation|0|||
161642091|NCT00979953|583740569|FG002|Overall Study|Protocol Violation|2|||
161687606|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
161642092|NCT00979953|583740570|FG003|Overall Study|Protocol Violation|2|||
161642093|NCT01124097|583740571|FG000|Overall Study|Withdrawal by Subject|4|||
161642094|NCT01124097|583740572|FG001|Overall Study|Withdrawal by Subject|3|||
161687607|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
161642095|NCT01124097|583740573|FG002|Overall Study|Withdrawal by Subject|2|||
161642096|NCT01124097|583740574|FG003|Overall Study|Withdrawal by Subject|3|||
161642097|NCT01124097|583740571|FG000|Overall Study|Lack of Efficacy|2|||
161642098|NCT01124097|583740572|FG001|Overall Study|Lack of Efficacy|3|||
161642099|NCT01124097|583740573|FG002|Overall Study|Lack of Efficacy|1|||
161642100|NCT01124097|583740574|FG003|Overall Study|Lack of Efficacy|3|||
161642101|NCT01124097|583740571|FG000|Overall Study|Adverse Event|24|||
161642102|NCT01124097|583740572|FG001|Overall Study|Adverse Event|15|||
161642103|NCT01124097|583740573|FG002|Overall Study|Adverse Event|15|||
161642104|NCT01124097|583740574|FG003|Overall Study|Adverse Event|7|||
161642105|NCT01124097|583740571|FG000|Overall Study|Protocol Violation|2|||
161642106|NCT01124097|583740572|FG001|Overall Study|Protocol Violation|0|||
161642107|NCT01124097|583740573|FG002|Overall Study|Protocol Violation|2|||
161642108|NCT01124097|583740574|FG003|Overall Study|Protocol Violation|1|||
161642109|NCT01124097|583740571|FG000|Overall Study|Physician Decision|2|||
161642110|NCT01124097|583740572|FG001|Overall Study|Physician Decision|1|||
161642111|NCT01124097|583740573|FG002|Overall Study|Physician Decision|0|||
161642112|NCT01124097|583740574|FG003|Overall Study|Physician Decision|0|||
161642113|NCT05687032|583740575|FG000|Treatment Phase|Adverse Event|13|||
161642114|NCT05687032|583740575|FG000|Treatment Phase|Death|1|||
161642115|NCT05687032|583740575|FG000|Treatment Phase|Physician Decision|3|||
161642116|NCT05687032|583740575|FG000|Treatment Phase|Progressive disease|9|||
161642117|NCT05687032|583740575|FG000|Treatment Phase|Withdrawal by Subject|5|||
161642118|NCT05687032|583740575|FG000|Follow-Up Phase|Death|16|||
161642119|NCT05687032|583740575|FG000|Follow-Up Phase|Ongoing|26|||
161642120|NCT04829747|583740579|FG000|Overall Study|Protocol Violation|1|||
161642121|NCT02367352|583740582|FG000|Overall Study|Progressive disease|7|||
161835421|NCT02408120|584438965|FG001|Overall Study|Discharged same day|1|||
161835422|NCT02408120|584438964|FG000|Overall Study|Did not receive insulin|1|||
161642122|NCT02367352|583740583|FG001|Overall Study|Progressive disease|0|||
161642123|NCT02367352|583740584|FG002|Overall Study|Progressive disease|0|||
161642124|NCT02367352|583740582|FG000|Overall Study|Participant Received Alternative Therapy|1|||
161642125|NCT02367352|583740583|FG001|Overall Study|Participant Received Alternative Therapy|0|||
161642126|NCT02367352|583740584|FG002|Overall Study|Participant Received Alternative Therapy|0|||
161642127|NCT02367352|583740582|FG000|Overall Study|Adverse Event|1|||
161642128|NCT02367352|583740583|FG001|Overall Study|Adverse Event|0|||
161642129|NCT02367352|583740584|FG002|Overall Study|Adverse Event|0|||
161642130|NCT05878873|583740585|FG000|Overall Study|Lost to Follow-up|2|||
161642131|NCT05878873|583740586|FG001|Overall Study|Lost to Follow-up|0|||
161642132|NCT02375347|583740588|FG000|Overall Study|Protocol Violation|1|||
161642133|NCT00193479|583740589|FG000|Induction Chemotherapy|Adverse Event|2|||
161642134|NCT00193479|583740589|FG000|Induction Chemotherapy|Disease Progression|1|||
161642135|NCT00193479|583740589|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
161642136|NCT00193479|583740589|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
161642137|NCT00425607|583740590|FG000|Overall Study|Death|1|||
161642138|NCT00425607|583740590|FG000|Overall Study|Withdrawal by Subject|1|||
161642139|NCT00079339|583740591|FG000|Overall Study|Adverse Event|1|||
161642140|NCT00079339|583740592|FG001|Overall Study|Adverse Event|7|||
161642141|NCT00079339|583740593|FG002|Overall Study|Adverse Event|2|||
161642142|NCT00079339|583740591|FG000|Overall Study|Death|1|||
161642143|NCT00079339|583740592|FG001|Overall Study|Death|0|||
161642144|NCT00079339|583740593|FG002|Overall Study|Death|0|||
161642145|NCT00079339|583740591|FG000|Overall Study|Non-compliance|0|||
161642146|NCT00079339|583740592|FG001|Overall Study|Non-compliance|0|||
161642147|NCT00079339|583740593|FG002|Overall Study|Non-compliance|1|||
161642148|NCT00079339|583740591|FG000|Overall Study|Withdrawal by Subject|0|||
161642149|NCT00079339|583740592|FG001|Overall Study|Withdrawal by Subject|4|||
161642150|NCT00079339|583740593|FG002|Overall Study|Withdrawal by Subject|1|||
161642151|NCT00079339|583740591|FG000|Overall Study|Disease progression|3|||
161642152|NCT00079339|583740592|FG001|Overall Study|Disease progression|28|||
161642153|NCT00079339|583740593|FG002|Overall Study|Disease progression|2|||
161642154|NCT02563548|583740594|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
161642155|NCT02563548|583740595|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161642156|NCT02563548|583740596|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161642157|NCT02563548|583740597|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
161642158|NCT02563548|583740598|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161642159|NCT02563548|583740599|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161642160|NCT02563548|583740594|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
161642161|NCT02563548|583740595|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
161642162|NCT02563548|583740596|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
161642163|NCT02563548|583740597|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
161642164|NCT02563548|583740598|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
161642165|NCT02563548|583740599|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
161642166|NCT02563548|583740594|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161642167|NCT02563548|583740595|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161642168|NCT02563548|583740596|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
161642169|NCT02563548|583740597|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161642170|NCT02563548|583740598|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161642171|NCT02563548|583740599|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161642172|NCT02563548|583740594|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161642173|NCT02563548|583740595|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161642174|NCT02563548|583740596|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
161835423|NCT02408120|584438965|FG001|Overall Study|Did not receive insulin|2|||
161642175|NCT02563548|583740597|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
161642176|NCT02563548|583740598|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161642177|NCT02563548|583740599|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161642178|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161642179|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161642180|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161687608|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
161642181|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161642182|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
161642183|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
161642184|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161642185|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161642186|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161642187|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161642188|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
161687609|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
161687610|NCT00960661|583908453|FG000|Interventional Phase|Adverse Event|0|||
161687611|NCT00960661|583908454|FG001|Interventional Phase|Adverse Event|17|||
161687612|NCT00960661|583908455|FG002|Interventional Phase|Adverse Event|8|||
161687613|NCT00960661|583908453|FG000|Interventional Phase|Death|0|||
161687614|NCT00960661|583908454|FG001|Interventional Phase|Death|1|||
161687615|NCT00960661|583908455|FG002|Interventional Phase|Death|0|||
161687616|NCT00960661|583908453|FG000|Interventional Phase|Lost to Follow-up|0|||
161687617|NCT00960661|583908454|FG001|Interventional Phase|Lost to Follow-up|0|||
161687618|NCT00960661|583908455|FG002|Interventional Phase|Lost to Follow-up|2|||
161835424|NCT00958126|584438966|FG000|Overall Study|Serious Adverse Event|0|||
161687619|NCT00960661|583908453|FG000|Interventional Phase|entry criteria not met|0|||
161835425|NCT00958126|584438967|FG001|Overall Study|Serious Adverse Event|2|||
161835426|NCT00958126|584438968|FG002|Overall Study|Serious Adverse Event|0|||
161835427|NCT00958126|584438969|FG003|Overall Study|Serious Adverse Event|0|||
161642189|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
161642190|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161642191|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161642192|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161642193|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161642194|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
161642195|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161642196|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161642197|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161642198|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161642199|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161642200|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
161642201|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
161642202|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161642203|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161642204|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161642205|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161642206|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161642207|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
161642208|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161642209|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161642210|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161642211|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161642212|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161642213|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
161642214|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161642215|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161642216|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161642217|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161642218|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161642219|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
161642220|NCT02563548|583740594|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161642221|NCT02563548|583740595|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161642222|NCT02563548|583740596|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161642223|NCT02563548|583740597|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161642224|NCT02563548|583740598|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
161642225|NCT02563548|583740599|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161642226|NCT00559377|583740601|FG000|Overall Study|Withdrawal by Subject|9|||
161642227|NCT00203047|583740607|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
161642228|NCT00203047|583740608|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
161642229|NCT00203047|583740607|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
161642230|NCT00203047|583740608|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
161642231|NCT00203047|583740607|FG000|Overall Study|Withdrawal by Subject|13|||
161642232|NCT00203047|583740608|FG001|Overall Study|Withdrawal by Subject|47|||
161642233|NCT00203047|583740607|FG000|Overall Study|Teva requested participant withdrawal|1|||
161642234|NCT00203047|583740608|FG001|Overall Study|Teva requested participant withdrawal|1|||
161642235|NCT00203047|583740607|FG000|Overall Study|Physician Decision|8|||
161642236|NCT00203047|583740608|FG001|Overall Study|Physician Decision|7|||
161642237|NCT00203047|583740607|FG000|Overall Study|Non-compliance|4|||
161642238|NCT00203047|583740608|FG001|Overall Study|Non-compliance|8|||
161642239|NCT00203047|583740607|FG000|Overall Study|Protocol Violation|1|||
161642240|NCT00203047|583740608|FG001|Overall Study|Protocol Violation|0|||
161642241|NCT00203047|583740607|FG000|Overall Study|Lost to Follow-up|11|||
161642242|NCT00203047|583740608|FG001|Overall Study|Lost to Follow-up|5|||
161642243|NCT00203047|583740607|FG000|Overall Study|Adverse Event|8|||
161642244|NCT00203047|583740608|FG001|Overall Study|Adverse Event|18|||
161687620|NCT00960661|583908454|FG001|Interventional Phase|entry criteria not met|3|||
161687621|NCT00960661|583908455|FG002|Interventional Phase|entry criteria not met|0|||
161687622|NCT00960661|583908453|FG000|Interventional Phase|Protocol Violation|0|||
161687623|NCT00960661|583908454|FG001|Interventional Phase|Protocol Violation|7|||
161687624|NCT00960661|583908455|FG002|Interventional Phase|Protocol Violation|2|||
161687625|NCT00960661|583908453|FG000|Interventional Phase|Withdrawal by Subject|0|||
161687626|NCT00960661|583908454|FG001|Interventional Phase|Withdrawal by Subject|18|||
161687627|NCT00960661|583908455|FG002|Interventional Phase|Withdrawal by Subject|29|||
161687628|NCT00960661|583908453|FG000|Interventional Phase|Physician Decision|0|||
161687629|NCT00960661|583908454|FG001|Interventional Phase|Physician Decision|3|||
161687630|NCT00960661|583908455|FG002|Interventional Phase|Physician Decision|5|||
161687631|NCT00960661|583908453|FG000|Interventional Phase|sponsor decision|0|||
161687632|NCT00960661|583908454|FG001|Interventional Phase|sponsor decision|1|||
161687633|NCT00960661|583908455|FG002|Interventional Phase|sponsor decision|0|||
161687634|NCT00960661|583908453|FG000|Interventional Phase|Lack of Efficacy|0|||
161687635|NCT00960661|583908454|FG001|Interventional Phase|Lack of Efficacy|2|||
161687636|NCT00960661|583908455|FG002|Interventional Phase|Lack of Efficacy|0|||
161687637|NCT02699892|583908456|FG000|Overall Study|Other|36|||
161687638|NCT00711100|583908457|FG000|Overall Study|Lack of Efficacy|5|||
161642245|NCT00203047|583740607|FG000|Overall Study|Death|1|||
161687639|NCT00711100|583908457|FG000|Overall Study|Withdrawal by Subject|8|||
161687640|NCT02083380|583908458|FG000|Overall Study|Lack of Efficacy|68|||
161687641|NCT02083380|583908459|FG001|Overall Study|Lack of Efficacy|79|||
161835428|NCT00958126|584438970|FG004|Overall Study|Serious Adverse Event|0|||
161835429|NCT00958126|584438971|FG005|Overall Study|Serious Adverse Event|0|||
161642246|NCT00203047|583740608|FG001|Overall Study|Death|2|||
161642247|NCT00203047|583740607|FG000|Overall Study|Pregnancy|3|||
161642248|NCT00203047|583740608|FG001|Overall Study|Pregnancy|0|||
161642249|NCT00203047|583740607|FG000|Overall Study|Other|5|||
161642250|NCT00203047|583740608|FG001|Overall Study|Other|5|||
161642251|NCT02229227|583740609|FG000|Overall Study|Adverse Event|14|||
161642252|NCT02229227|583740610|FG001|Overall Study|Adverse Event|9|||
161642253|NCT02229227|583740609|FG000|Overall Study|Lack of Efficacy|3|||
161642254|NCT02229227|583740610|FG001|Overall Study|Lack of Efficacy|3|||
161642255|NCT02229227|583740609|FG000|Overall Study|Protocol Violation|6|||
161642256|NCT02229227|583740610|FG001|Overall Study|Protocol Violation|8|||
161642257|NCT02229227|583740609|FG000|Overall Study|Protocol defined stopping criteria|1|||
161642258|NCT02229227|583740610|FG001|Overall Study|Protocol defined stopping criteria|3|||
161642259|NCT02229227|583740609|FG000|Overall Study|Lost to Follow-up|3|||
161642260|NCT02229227|583740610|FG001|Overall Study|Lost to Follow-up|3|||
161642261|NCT02229227|583740609|FG000|Overall Study|Study terminated by sponsor|11|||
161642262|NCT02229227|583740610|FG001|Overall Study|Study terminated by sponsor|11|||
161642263|NCT02229227|583740609|FG000|Overall Study|Withdrawal by Subject|8|||
161642264|NCT02229227|583740610|FG001|Overall Study|Withdrawal by Subject|12|||
161642265|NCT02229227|583740609|FG000|Overall Study|Other|0|||
161642266|NCT02229227|583740610|FG001|Overall Study|Other|1|||
161642267|NCT02229227|583740609|FG000|Overall Study|Physician Decision|5|||
161642268|NCT02229227|583740610|FG001|Overall Study|Physician Decision|12|||
161642269|NCT00340704|583740613|FG000|PK Study|Adverse Event|0|||
161642270|NCT00340704|583740614|FG001|PK Study|Adverse Event|1|||
161642271|NCT00340704|583740615|FG002|PK Study|Adverse Event|0|||
161642272|NCT00340704|583740616|FG003|PK Study|Adverse Event|0|||
161642273|NCT00340704|583740617|FG004|PK Study|Adverse Event|0|||
161642274|NCT00340704|583740618|FG005|PK Study|Adverse Event|0|||
161642275|NCT00340704|583740619|FG006|PK Study|Adverse Event|0|||
161642276|NCT00340704|583740620|FG007|PK Study|Adverse Event|0|||
161642277|NCT00340704|583740621|FG008|PK Study|Adverse Event|0|||
161642278|NCT00340704|583740613|FG000|PK Study|Not treated|0|||
161642279|NCT00340704|583740614|FG001|PK Study|Not treated|0|||
161642280|NCT00340704|583740615|FG002|PK Study|Not treated|1|||
161642281|NCT00340704|583740616|FG003|PK Study|Not treated|0|||
161642282|NCT00340704|583740617|FG004|PK Study|Not treated|0|||
161642283|NCT00340704|583740618|FG005|PK Study|Not treated|0|||
161642284|NCT00340704|583740619|FG006|PK Study|Not treated|0|||
161642285|NCT00340704|583740620|FG007|PK Study|Not treated|0|||
161642286|NCT00340704|583740621|FG008|PK Study|Not treated|0|||
161642287|NCT00340704|583740613|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161642288|NCT00340704|583740614|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161642289|NCT00340704|583740615|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161642290|NCT00340704|583740616|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
161642291|NCT00340704|583740617|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
161642292|NCT00340704|583740618|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161642293|NCT00340704|583740619|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161642294|NCT00340704|583740620|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
161642295|NCT00340704|583740621|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
161642296|NCT00340704|583740613|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642297|NCT00340704|583740614|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642298|NCT00340704|583740615|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642299|NCT00340704|583740616|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642300|NCT00340704|583740617|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642301|NCT00340704|583740618|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
161642302|NCT00340704|583740619|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642303|NCT00340704|583740620|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642304|NCT00340704|583740621|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161642305|NCT00340704|583740613|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161642306|NCT00340704|583740614|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161642307|NCT00340704|583740615|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161642308|NCT00340704|583740616|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161642309|NCT00340704|583740617|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
161642310|NCT00340704|583740618|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
161642311|NCT00340704|583740619|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161687642|NCT02083380|583908460|FG002|Overall Study|Lack of Efficacy|64|||
161687643|NCT02083380|583908458|FG000|Overall Study|Withdrawal by Subject|9|||
161687644|NCT02083380|583908459|FG001|Overall Study|Withdrawal by Subject|3|||
161687645|NCT02083380|583908460|FG002|Overall Study|Withdrawal by Subject|7|||
161687646|NCT02083380|583908458|FG000|Overall Study|Physician Decision|1|||
161687647|NCT02083380|583908459|FG001|Overall Study|Physician Decision|6|||
161642312|NCT00340704|583740620|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161642313|NCT00340704|583740621|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161642314|NCT00340704|583740613|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161642315|NCT00340704|583740614|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161642316|NCT00340704|583740615|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161642317|NCT00340704|583740616|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161642318|NCT00340704|583740617|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161642319|NCT00340704|583740618|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
161642320|NCT00340704|583740619|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
161642321|NCT00340704|583740620|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
161642322|NCT00340704|583740621|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
161642323|NCT01453023|583740622|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
161642324|NCT01453023|583740623|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
161642325|NCT01453023|583740622|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
161642326|NCT01453023|583740623|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
161642327|NCT01453023|583740622|FG000|Treatment Period 2|Protocol Violation|0|||
161642328|NCT01453023|583740623|FG001|Treatment Period 2|Protocol Violation|1|||
161642329|NCT01056263|583740638|FG000|Overall Study|Adverse Event|12|||
161642330|NCT01056263|583740638|FG000|Overall Study|Death|1|||
161687648|NCT02083380|583908460|FG002|Overall Study|Physician Decision|3|||
161687649|NCT02083380|583908458|FG000|Overall Study|Adverse Event|0|||
161687650|NCT02083380|583908459|FG001|Overall Study|Adverse Event|0|||
161687651|NCT02083380|583908460|FG002|Overall Study|Adverse Event|1|||
161687652|NCT02083380|583908458|FG000|Overall Study|Lost to Follow-up|5|||
161687653|NCT02083380|583908459|FG001|Overall Study|Lost to Follow-up|3|||
161687654|NCT02083380|583908460|FG002|Overall Study|Lost to Follow-up|3|||
161687655|NCT02083380|583908458|FG000|Overall Study|Other|8|||
161687656|NCT02083380|583908459|FG001|Overall Study|Other|4|||
161687657|NCT02083380|583908460|FG002|Overall Study|Other|6|||
161687658|NCT00001379|583908461|FG000|Initial Treatment|Disease progression|21|||
161687659|NCT00001379|583908462|FG001|Initial Treatment|Disease progression|3|||
161687660|NCT00001379|583908463|FG002|Initial Treatment|Disease progression|0|||
161687661|NCT00001379|583908464|FG003|Initial Treatment|Disease progression|0|||
161687662|NCT00001379|583908461|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
161687663|NCT00001379|583908462|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
161687664|NCT00001379|583908463|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
161687665|NCT00001379|583908464|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
161687666|NCT00001379|583908461|FG000|Initial Treatment|Received alternative treatment|2|||
161687667|NCT00001379|583908462|FG001|Initial Treatment|Received alternative treatment|1|||
161687668|NCT00001379|583908463|FG002|Initial Treatment|Received alternative treatment|0|||
161687669|NCT00001379|583908464|FG003|Initial Treatment|Received alternative treatment|0|||
161687670|NCT00001379|583908461|FG000|Initial Treatment|Refused further treatment|2|||
161687671|NCT00001379|583908462|FG001|Initial Treatment|Refused further treatment|0|||
161687672|NCT00001379|583908463|FG002|Initial Treatment|Refused further treatment|0|||
161687673|NCT00001379|583908464|FG003|Initial Treatment|Refused further treatment|0|||
161687674|NCT00001379|583908461|FG000|Initial Treatment|Did not receive protocol treatment|0|||
161687675|NCT00001379|583908462|FG001|Initial Treatment|Did not receive protocol treatment|0|||
161687676|NCT00001379|583908463|FG002|Initial Treatment|Did not receive protocol treatment|5|||
161687677|NCT00001379|583908464|FG003|Initial Treatment|Did not receive protocol treatment|0|||
161687678|NCT00001379|583908461|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161687679|NCT00001379|583908462|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161687680|NCT00001379|583908463|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161687681|NCT00001379|583908464|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
161687682|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
161687683|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
161687684|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
161687685|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
161687686|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
161642331|NCT01056263|583740638|FG000|Overall Study|Withdrawal by Subject|1|||
161642332|NCT01056263|583740638|FG000|Overall Study|Lack of Efficacy|29|||
161642333|NCT01056263|583740638|FG000|Overall Study|Progressive disease|2|||
161642334|NCT01056263|583740638|FG000|Overall Study|Neoplasm progression|1|||
161642335|NCT01056263|583740638|FG000|Overall Study|Objective progression or relapse|1|||
161642336|NCT01056263|583740638|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
161642337|NCT00365547|583740641|FG000|Overall Study|Insurance did not cover Avastin|1|||
161642338|NCT00365547|583740641|FG000|Overall Study|Screen failure|1|||
161642339|NCT00365547|583740641|FG000|Overall Study|Withdrawal by Subject|1|||
161642344|NCT03170518|583740643|FG000|Overall Study|Lost to Follow-up|4|||
161642345|NCT03170518|583740644|FG001|Overall Study|Lost to Follow-up|1|||
161642346|NCT03170518|583740645|FG002|Overall Study|Lost to Follow-up|0|||
161642347|NCT03170518|583740643|FG000|Overall Study|Physician Decision|1|||
161642348|NCT03170518|583740644|FG001|Overall Study|Physician Decision|0|||
161642349|NCT03170518|583740645|FG002|Overall Study|Physician Decision|0|||
161642350|NCT03170518|583740643|FG000|Overall Study|Withdrawal by Subject|4|||
161642351|NCT03170518|583740644|FG001|Overall Study|Withdrawal by Subject|5|||
161642352|NCT03170518|583740645|FG002|Overall Study|Withdrawal by Subject|2|||
161642353|NCT03170518|583740643|FG000|Overall Study|Site terminated by sponsor|0|||
161687687|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
161835430|NCT00958126|584438972|FG006|Overall Study|Serious Adverse Event|1|||
161835431|NCT00958126|584438973|FG007|Overall Study|Serious Adverse Event|0|||
161835432|NCT00958126|584438966|FG000|Overall Study|Withdrawal by Subject|0|||
161835433|NCT00958126|584438967|FG001|Overall Study|Withdrawal by Subject|2|||
161835434|NCT00958126|584438968|FG002|Overall Study|Withdrawal by Subject|0|||
161835435|NCT00958126|584438969|FG003|Overall Study|Withdrawal by Subject|0|||
161835436|NCT00958126|584438970|FG004|Overall Study|Withdrawal by Subject|0|||
161835437|NCT00958126|584438971|FG005|Overall Study|Withdrawal by Subject|0|||
161835438|NCT00958126|584438972|FG006|Overall Study|Withdrawal by Subject|0|||
161835439|NCT00958126|584438973|FG007|Overall Study|Withdrawal by Subject|0|||
161835440|NCT00958126|584438966|FG000|Overall Study|Moved away from study area|0|||
161835441|NCT00958126|584438967|FG001|Overall Study|Moved away from study area|0|||
161835442|NCT00958126|584438968|FG002|Overall Study|Moved away from study area|1|||
161835443|NCT00958126|584438969|FG003|Overall Study|Moved away from study area|1|||
161835444|NCT00958126|584438970|FG004|Overall Study|Moved away from study area|0|||
161687688|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
161835445|NCT00958126|584438971|FG005|Overall Study|Moved away from study area|0|||
161835446|NCT00958126|584438972|FG006|Overall Study|Moved away from study area|0|||
161642354|NCT03170518|583740644|FG001|Overall Study|Site terminated by sponsor|1|||
161642355|NCT03170518|583740645|FG002|Overall Study|Site terminated by sponsor|0|||
161835447|NCT00958126|584438973|FG007|Overall Study|Moved away from study area|0|||
161835448|NCT00958126|584438966|FG000|Overall Study|Lost to Follow-up|1|||
161835449|NCT00958126|584438967|FG001|Overall Study|Lost to Follow-up|5|||
161835450|NCT00958126|584438968|FG002|Overall Study|Lost to Follow-up|9|||
161835451|NCT00958126|584438969|FG003|Overall Study|Lost to Follow-up|8|||
161642356|NCT03170518|583740643|FG000|Overall Study|Non-compliance with study drug|1|||
161642357|NCT03170518|583740644|FG001|Overall Study|Non-compliance with study drug|0|||
161642358|NCT03170518|583740645|FG002|Overall Study|Non-compliance with study drug|1|||
161642359|NCT03170518|583740643|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161642360|NCT03170518|583740644|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161642361|NCT03170518|583740645|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161642362|NCT00546078|583740646|FG000|Overall Study|Lost to Follow-up|1|||
161642363|NCT00546078|583740647|FG001|Overall Study|Lost to Follow-up|3|||
161642364|NCT00546078|583740646|FG000|Overall Study|Withdrawal by Subject|2|||
161642365|NCT00546078|583740647|FG001|Overall Study|Withdrawal by Subject|3|||
161642366|NCT00546078|583740646|FG000|Overall Study|Other reason|1|||
161642367|NCT00546078|583740647|FG001|Overall Study|Other reason|1|||
161642368|NCT03512197|583740648|FG000|Overall Study|Guardian decision|1|||
161642369|NCT03512197|583740649|FG001|Overall Study|Guardian decision|1|||
161642370|NCT03512197|583740648|FG000|Overall Study|Lack of Efficacy|19|||
161642371|NCT03512197|583740649|FG001|Overall Study|Lack of Efficacy|11|||
161642372|NCT03512197|583740648|FG000|Overall Study|New Therapy for Study Indication|16|||
161835452|NCT00958126|584438970|FG004|Overall Study|Lost to Follow-up|0|||
161835453|NCT00958126|584438971|FG005|Overall Study|Lost to Follow-up|0|||
161835454|NCT00958126|584438972|FG006|Overall Study|Lost to Follow-up|0|||
161835455|NCT00958126|584438973|FG007|Overall Study|Lost to Follow-up|0|||
161835456|NCT00958126|584438966|FG000|Overall Study|Sponsor/Investigator decision|0|||
161835457|NCT00958126|584438967|FG001|Overall Study|Sponsor/Investigator decision|0|||
161835458|NCT00958126|584438968|FG002|Overall Study|Sponsor/Investigator decision|0|||
161835459|NCT00958126|584438969|FG003|Overall Study|Sponsor/Investigator decision|1|||
161835460|NCT00958126|584438970|FG004|Overall Study|Sponsor/Investigator decision|0|||
161642373|NCT03512197|583740649|FG001|Overall Study|New Therapy for Study Indication|16|||
161642374|NCT03512197|583740648|FG000|Overall Study|Physician Decision|60|||
161642375|NCT03512197|583740649|FG001|Overall Study|Physician Decision|60|||
161642376|NCT03512197|583740648|FG000|Overall Study|Protocol Violation|0|||
161642377|NCT03512197|583740649|FG001|Overall Study|Protocol Violation|2|||
161642378|NCT03512197|583740648|FG000|Overall Study|Terminated by Sponsored|46|||
161642379|NCT03512197|583740649|FG001|Overall Study|Terminated by Sponsored|50|||
161642380|NCT03512197|583740648|FG000|Overall Study|Subject Decision|15|||
161642381|NCT03512197|583740649|FG001|Overall Study|Subject Decision|12|||
161642382|NCT03512197|583740648|FG000|Overall Study|Withdrawal of informed consent|20|||
161642383|NCT03512197|583740649|FG001|Overall Study|Withdrawal of informed consent|14|||
161835461|NCT00958126|584438971|FG005|Overall Study|Sponsor/Investigator decision|0|||
161835462|NCT00958126|584438972|FG006|Overall Study|Sponsor/Investigator decision|0|||
161642384|NCT03512197|583740648|FG000|Overall Study|Adverse Event|30|||
161642385|NCT03512197|583740649|FG001|Overall Study|Adverse Event|34|||
161642386|NCT03512197|583740648|FG000|Overall Study|Death|14|||
161642387|NCT03512197|583740649|FG001|Overall Study|Death|9|||
161642388|NCT03512197|583740648|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
161642389|NCT03512197|583740649|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
161642390|NCT03512197|583740648|FG000|Overall Study|Missing|3|||
161642391|NCT03512197|583740649|FG001|Overall Study|Missing|13|||
161642392|NCT03842436|583740650|FG000|Overall Study|Lost to Follow-up|1|||
161642393|NCT01806389|583740651|FG000|Overall Study|Withdrawal by Subject|4|||
161642394|NCT01948076|583740652|FG000|Overall Study|Withdrawal by Subject|0|||
161642395|NCT01948076|583740653|FG001|Overall Study|Withdrawal by Subject|1|||
161642396|NCT00936598|583740659|FG000|Overall Study|Withdrawal by Subject|1|||
161642397|NCT00936598|583740660|FG001|Overall Study|Withdrawal by Subject|0|||
161642398|NCT00936598|583740659|FG000|Overall Study|Ineligible after consent|1|||
161642399|NCT00936598|583740660|FG001|Overall Study|Ineligible after consent|0|||
161642400|NCT00486252|583740661|FG000|Overall Study|Adverse Event|7|||
161835463|NCT00958126|584438973|FG007|Overall Study|Sponsor/Investigator decision|0|||
161835464|NCT00958126|584438966|FG000|Overall Study|Other Reason|0|||
161835465|NCT00958126|584438967|FG001|Overall Study|Other Reason|0|||
161835466|NCT00958126|584438968|FG002|Overall Study|Other Reason|0|||
161835467|NCT00958126|584438969|FG003|Overall Study|Other Reason|1|||
161835468|NCT00958126|584438970|FG004|Overall Study|Other Reason|0|||
161835469|NCT00958126|584438971|FG005|Overall Study|Other Reason|1|||
161835470|NCT00958126|584438972|FG006|Overall Study|Other Reason|0|||
161835471|NCT00958126|584438973|FG007|Overall Study|Other Reason|0|||
161835472|NCT00720226|584438974|FG000|Overall Study|Withdrawal by Subject|7|||
161835473|NCT00720226|584438975|FG001|Overall Study|Withdrawal by Subject|4|||
161835474|NCT00733369|584438976|FG000|Overall Study|Lost to Follow-up|2|||
161835475|NCT00733369|584438977|FG001|Overall Study|Lost to Follow-up|1|||
161835476|NCT00733369|584438976|FG000|Overall Study|Adverse Event|4|||
161835477|NCT00733369|584438977|FG001|Overall Study|Adverse Event|4|||
161835478|NCT00733369|584438976|FG000|Overall Study|Protocol Violation|4|||
161835479|NCT00733369|584438977|FG001|Overall Study|Protocol Violation|4|||
161835480|NCT03401073|584438980|FG000|Overall Study|Lost to Follow-up|1|||
161835481|NCT03401073|584438981|FG001|Overall Study|Lost to Follow-up|2|||
161835482|NCT01470612|584438982|FG000|Overall Study|Adverse Event|20|||
161835483|NCT01470612|584438983|FG001|Overall Study|Adverse Event|80|||
161835484|NCT01470612|584438982|FG000|Overall Study|Death|0|||
161835485|NCT01470612|584438983|FG001|Overall Study|Death|1|||
161835486|NCT01470612|584438982|FG000|Overall Study|Lack of Efficacy|20|||
161835487|NCT01470612|584438983|FG001|Overall Study|Lack of Efficacy|326|||
161835488|NCT01470612|584438982|FG000|Overall Study|Lost to Follow-up|2|||
161835489|NCT01470612|584438983|FG001|Overall Study|Lost to Follow-up|5|||
161835490|NCT01470612|584438982|FG000|Overall Study|Did not meet entrance criteria|0|||
161835491|NCT01470612|584438983|FG001|Overall Study|Did not meet entrance criteria|1|||
161642401|NCT00486252|583740661|FG000|Overall Study|Lack of Efficacy|9|||
161642402|NCT00486252|583740661|FG000|Overall Study|Lost to Follow-up|24|||
161835492|NCT01470612|584438982|FG000|Overall Study|Pregnancy|2|||
161835493|NCT01470612|584438983|FG001|Overall Study|Pregnancy|10|||
161835494|NCT01470612|584438982|FG000|Overall Study|Protocol Violation|2|||
161835495|NCT01470612|584438983|FG001|Overall Study|Protocol Violation|7|||
161835496|NCT01470612|584438982|FG000|Overall Study|Withdrawal by Subject|24|||
161835497|NCT01470612|584438983|FG001|Overall Study|Withdrawal by Subject|79|||
161835498|NCT01470612|584438982|FG000|Overall Study|Other|14|||
161835499|NCT01470612|584438983|FG001|Overall Study|Other|156|||
161642403|NCT00486252|583740661|FG000|Overall Study|Other|18|||
161642404|NCT02559310|583740662|FG000|Overall Study|Death|4|||
161642405|NCT02559310|583740663|FG001|Overall Study|Death|3|||
161642406|NCT02559310|583740662|FG000|Overall Study|Lost to Follow-up|5|||
161642407|NCT02559310|583740663|FG001|Overall Study|Lost to Follow-up|3|||
161642408|NCT02559310|583740662|FG000|Overall Study|Physician Decision|2|||
161642409|NCT02559310|583740663|FG001|Overall Study|Physician Decision|1|||
161642410|NCT02559310|583740662|FG000|Overall Study|Withdrawal by Subject|13|||
161642411|NCT02559310|583740663|FG001|Overall Study|Withdrawal by Subject|9|||
161642412|NCT02559310|583740662|FG000|Overall Study|Sponsor Decision|0|||
161642413|NCT02559310|583740663|FG001|Overall Study|Sponsor Decision|1|||
161642414|NCT02559310|583740662|FG000|Overall Study|Randomized but not treated|3|||
161642415|NCT02559310|583740663|FG001|Overall Study|Randomized but not treated|2|||
161642416|NCT04596540|583740664|FG000|Overall Study|Withdrawal by Subject|9|||
161642417|NCT04596540|583740665|FG001|Overall Study|Withdrawal by Subject|8|||
161642418|NCT04596540|583740666|FG002|Overall Study|Withdrawal by Subject|5|||
161642419|NCT04596540|583740664|FG000|Overall Study|Lost to Follow-up|1|||
161642420|NCT04596540|583740665|FG001|Overall Study|Lost to Follow-up|2|||
161642421|NCT04596540|583740666|FG002|Overall Study|Lost to Follow-up|1|||
161642422|NCT04596540|583740664|FG000|Overall Study|Sponsor Decision|2|||
161642423|NCT04596540|583740665|FG001|Overall Study|Sponsor Decision|0|||
161642424|NCT04596540|583740666|FG002|Overall Study|Sponsor Decision|0|||
161642425|NCT04596540|583740664|FG000|Overall Study|Physician Decision|0|||
161642426|NCT04596540|583740665|FG001|Overall Study|Physician Decision|1|||
161642427|NCT04596540|583740666|FG002|Overall Study|Physician Decision|1|||
161642428|NCT04596540|583740664|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
161642429|NCT04596540|583740665|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161642430|NCT04596540|583740666|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161642431|NCT04596540|583740664|FG000|Overall Study|Other Than Specified|5|||
161642432|NCT04596540|583740665|FG001|Overall Study|Other Than Specified|5|||
161642433|NCT04596540|583740666|FG002|Overall Study|Other Than Specified|2|||
161642434|NCT02633397|583740667|FG000|Overall Study|Adverse Event|8|||
161642435|NCT02633397|583740668|FG001|Overall Study|Adverse Event|8|||
161642436|NCT02633397|583740667|FG000|Overall Study|Study Burden|4|||
161642437|NCT02633397|583740668|FG001|Overall Study|Study Burden|1|||
161642438|NCT02633397|583740667|FG000|Overall Study|Treatment interruption|2|||
161642439|NCT02633397|583740668|FG001|Overall Study|Treatment interruption|5|||
161642440|NCT02633397|583740667|FG000|Overall Study|Death|2|||
161642441|NCT02633397|583740668|FG001|Overall Study|Death|2|||
161642442|NCT02633397|583740667|FG000|Overall Study|Physician Decision|0|||
161642443|NCT02633397|583740668|FG001|Overall Study|Physician Decision|1|||
161642444|NCT03595878|583740669|FG000|Overall Study|Death|2|||
161642445|NCT03595878|583740670|FG001|Overall Study|Death|1|||
161642446|NCT03595878|583740671|FG002|Overall Study|Death|0|||
161642447|NCT03595878|583740669|FG000|Overall Study|Disease progression|2|||
161642448|NCT03595878|583740670|FG001|Overall Study|Disease progression|1|||
161642449|NCT03595878|583740671|FG002|Overall Study|Disease progression|2|||
161642450|NCT03036124|583740672|FG000|Overall Study|Lost to Follow-up|0|||
161642451|NCT03036124|583740673|FG001|Overall Study|Lost to Follow-up|2|||
161642452|NCT03036124|583740672|FG000|Overall Study|Withdrawal by Subject|5|||
161642453|NCT03036124|583740673|FG001|Overall Study|Withdrawal by Subject|4|||
161642454|NCT04526665|583740674|FG000|Overall Study|Withdrawal by Subject|6|||
161642455|NCT04526665|583740675|FG001|Overall Study|Withdrawal by Subject|3|||
161642456|NCT04526665|583740674|FG000|Overall Study|Adverse Event|4|||
161642457|NCT04526665|583740675|FG001|Overall Study|Adverse Event|1|||
161642458|NCT04526665|583740674|FG000|Overall Study|Physician Decision|2|||
161642459|NCT04526665|583740675|FG001|Overall Study|Physician Decision|2|||
161642460|NCT04526665|583740674|FG000|Overall Study|Death|2|||
161642461|NCT04526665|583740675|FG001|Overall Study|Death|0|||
161642462|NCT04526665|583740674|FG000|Overall Study|Other|0|||
161642463|NCT04526665|583740675|FG001|Overall Study|Other|1|||
161642464|NCT04949802|583742088|FG000|Overall Study|Lost to Follow-up|3|||
161642465|NCT01020877|583742091|FG000|Second Intervention|Withdrawal by Subject|1|||
161642466|NCT01020877|583742092|FG001|Second Intervention|Withdrawal by Subject|0|||
161642467|NCT00433511|583742093|FG000|Step 1|Adverse Event|50|||
161642468|NCT00433511|583742094|FG001|Step 1|Adverse Event|157|||
161642469|NCT00433511|583742095|FG002|Step 1|Adverse Event|153|||
161642470|NCT00433511|583742093|FG000|Step 1|Withdrawal by Subject|45|||
161642471|NCT00433511|583742094|FG001|Step 1|Withdrawal by Subject|143|||
161642472|NCT00433511|583742095|FG002|Step 1|Withdrawal by Subject|154|||
161642473|NCT00433511|583742093|FG000|Step 1|Death|3|||
161642474|NCT00433511|583742094|FG001|Step 1|Death|1|||
161642475|NCT00433511|583742095|FG002|Step 1|Death|1|||
161642476|NCT00433511|583742093|FG000|Step 1|Physician Decision|1|||
161642477|NCT00433511|583742094|FG001|Step 1|Physician Decision|4|||
161642478|NCT00433511|583742095|FG002|Step 1|Physician Decision|3|||
161642479|NCT00433511|583742093|FG000|Step 1|Never started protocol therapy|28|||
161642480|NCT00433511|583742094|FG001|Step 1|Never started protocol therapy|64|||
161642481|NCT00433511|583742095|FG002|Step 1|Never started protocol therapy|66|||
161642482|NCT00433511|583742093|FG000|Step 1|Alternative therapy|2|||
161642483|NCT00433511|583742094|FG001|Step 1|Alternative therapy|1|||
161642484|NCT00433511|583742095|FG002|Step 1|Alternative therapy|3|||
161642485|NCT00433511|583742093|FG000|Step 1|Disease progression, relapse|5|||
161642486|NCT00433511|583742094|FG001|Step 1|Disease progression, relapse|3|||
161642487|NCT00433511|583742095|FG002|Step 1|Disease progression, relapse|3|||
161642488|NCT00433511|583742093|FG000|Step 1|Other complicating disease|2|||
161642489|NCT00433511|583742094|FG001|Step 1|Other complicating disease|6|||
161642490|NCT00433511|583742095|FG002|Step 1|Other complicating disease|3|||
161642491|NCT00433511|583742093|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
161642492|NCT00433511|583742094|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
161642493|NCT00433511|583742095|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
161642494|NCT00433511|583742093|FG000|Step 1|Suspected recurrence|0|||
161642495|NCT00433511|583742094|FG001|Step 1|Suspected recurrence|1|||
161642496|NCT00433511|583742095|FG002|Step 1|Suspected recurrence|0|||
161642497|NCT00433511|583742093|FG000|Step 1|Insurance/drug distribution issues|0|||
161687689|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
161835500|NCT02039414|584438984|FG000|Overall Study|Delivered|1|||
161835501|NCT02039414|584438985|FG001|Overall Study|Delivered|1|||
161642498|NCT00433511|583742094|FG001|Step 1|Insurance/drug distribution issues|1|||
161642499|NCT00433511|583742095|FG002|Step 1|Insurance/drug distribution issues|2|||
161642500|NCT00433511|583742093|FG000|Step 1|Patient moved|0|||
161642501|NCT00433511|583742094|FG001|Step 1|Patient moved|0|||
161642502|NCT00433511|583742095|FG002|Step 1|Patient moved|1|||
161642503|NCT00433511|583742093|FG000|Step 2 (Arm D)|Adverse Event|0|||
161642504|NCT00433511|583742094|FG001|Step 2 (Arm D)|Adverse Event|0|||
161642505|NCT00433511|583742095|FG002|Step 2 (Arm D)|Adverse Event|135|||
161642506|NCT00433511|583742093|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
161642507|NCT00433511|583742094|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
161642508|NCT00433511|583742095|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
161642509|NCT00433511|583742093|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
161642510|NCT00433511|583742094|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
161642511|NCT00433511|583742095|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
161642512|NCT00433511|583742093|FG000|Step 2 (Arm D)|Physician Decision|0|||
161642513|NCT00433511|583742094|FG001|Step 2 (Arm D)|Physician Decision|0|||
161642514|NCT00433511|583742095|FG002|Step 2 (Arm D)|Physician Decision|9|||
161642515|NCT00433511|583742093|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
161642516|NCT00433511|583742094|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
161642517|NCT00433511|583742095|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
161642518|NCT00433511|583742093|FG000|Step 2 (Arm D)|Other complicating disease|0|||
161642519|NCT00433511|583742094|FG001|Step 2 (Arm D)|Other complicating disease|0|||
161642520|NCT00433511|583742095|FG002|Step 2 (Arm D)|Other complicating disease|3|||
161642521|NCT00433511|583742093|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
161642522|NCT00433511|583742094|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
161642523|NCT00433511|583742095|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
161642524|NCT00433511|583742093|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
161642525|NCT00433511|583742094|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
161642526|NCT00433511|583742095|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
161642527|NCT00433511|583742093|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
161642528|NCT00433511|583742094|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
161642529|NCT00433511|583742095|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
161642530|NCT00433511|583742093|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
161642531|NCT00433511|583742094|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
161642532|NCT00433511|583742095|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
161642533|NCT01784523|583742096|FG000|Overall Study|Study closed early|7|||
161642534|NCT01784523|583742097|FG001|Overall Study|Study closed early|4|||
161642535|NCT04334278|583742102|FG000|Overall Study|Lost to Follow-up|0|||
161642536|NCT04334278|583742103|FG001|Overall Study|Lost to Follow-up|3|||
161642537|NCT04334278|583742102|FG000|Overall Study|Withdrawal by Subject|4|||
161642538|NCT04334278|583742103|FG001|Overall Study|Withdrawal by Subject|2|||
161642539|NCT01732549|583742108|FG000|Overall Study|Adverse Event|13|||
161642540|NCT01732549|583742109|FG001|Overall Study|Adverse Event|3|||
161642541|NCT01732549|583742108|FG000|Overall Study|Consent withdrawn|13|||
161642542|NCT01732549|583742109|FG001|Overall Study|Consent withdrawn|6|||
161642543|NCT01732549|583742108|FG000|Overall Study|Disease progression|37|||
161642544|NCT01732549|583742109|FG001|Overall Study|Disease progression|50|||
161642545|NCT01732549|583742108|FG000|Overall Study|Other|8|||
161642546|NCT01732549|583742109|FG001|Overall Study|Other|14|||
161642547|NCT01516749|583742110|FG000|Active Therapy|Lost to Follow-up|1|||
161642548|NCT01516749|583742110|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
161642549|NCT03994731|583742112|FG000|Pegloticase + IMM Period|Death|2|||
161642550|NCT03994731|583742113|FG001|Pegloticase + IMM Period|Death|0|||
161642551|NCT03994731|583742112|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
161642552|NCT03994731|583742113|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
161642553|NCT03994731|583742112|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
161642554|NCT03994731|583742113|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
161642555|NCT03377361|583742120|FG000|Pre-Treatment|Subject withdrew consent|0|||
161642556|NCT03377361|583742121|FG001|Pre-Treatment|Subject withdrew consent|0|||
161642557|NCT03377361|583742122|FG002|Pre-Treatment|Subject withdrew consent|0|||
161642558|NCT03377361|583742123|FG003|Pre-Treatment|Subject withdrew consent|0|||
161642559|NCT03377361|583742124|FG004|Pre-Treatment|Subject withdrew consent|0|||
161642560|NCT03377361|583742125|FG005|Pre-Treatment|Subject withdrew consent|0|||
161642561|NCT03377361|583742126|FG006|Pre-Treatment|Subject withdrew consent|0|||
161642562|NCT03377361|583742127|FG007|Pre-Treatment|Subject withdrew consent|3|||
161642563|NCT03377361|583742128|FG008|Pre-Treatment|Subject withdrew consent|1|||
161642564|NCT03377361|583742129|FG009|Pre-Treatment|Subject withdrew consent|0|||
161642565|NCT03377361|583742120|FG000|Pre-Treatment|Not Reported|0|||
161642566|NCT03377361|583742121|FG001|Pre-Treatment|Not Reported|0|||
161642567|NCT03377361|583742122|FG002|Pre-Treatment|Not Reported|0|||
161642568|NCT03377361|583742123|FG003|Pre-Treatment|Not Reported|0|||
161642569|NCT03377361|583742124|FG004|Pre-Treatment|Not Reported|0|||
161642570|NCT03377361|583742125|FG005|Pre-Treatment|Not Reported|0|||
161642571|NCT03377361|583742126|FG006|Pre-Treatment|Not Reported|0|||
161642572|NCT03377361|583742127|FG007|Pre-Treatment|Not Reported|0|||
161642573|NCT03377361|583742128|FG008|Pre-Treatment|Not Reported|3|||
161642574|NCT03377361|583742129|FG009|Pre-Treatment|Not Reported|0|||
161642575|NCT03377361|583742120|FG000|Treatment Period|Disease Progression|3|||
161642576|NCT03377361|583742121|FG001|Treatment Period|Disease Progression|2|||
161642577|NCT03377361|583742122|FG002|Treatment Period|Disease Progression|5|||
161642578|NCT03377361|583742123|FG003|Treatment Period|Disease Progression|3|||
161642579|NCT03377361|583742124|FG004|Treatment Period|Disease Progression|3|||
161642580|NCT03377361|583742125|FG005|Treatment Period|Disease Progression|3|||
161642581|NCT03377361|583742126|FG006|Treatment Period|Disease Progression|6|||
161642582|NCT03377361|583742127|FG007|Treatment Period|Disease Progression|106|||
161642583|NCT03377361|583742128|FG008|Treatment Period|Disease Progression|48|||
161642584|NCT03377361|583742129|FG009|Treatment Period|Disease Progression|59|||
161642585|NCT03377361|583742120|FG000|Treatment Period|Study Drug Toxicity|0|||
161642586|NCT03377361|583742121|FG001|Treatment Period|Study Drug Toxicity|0|||
161642587|NCT03377361|583742122|FG002|Treatment Period|Study Drug Toxicity|0|||
161642588|NCT03377361|583742123|FG003|Treatment Period|Study Drug Toxicity|1|||
161642589|NCT03377361|583742124|FG004|Treatment Period|Study Drug Toxicity|0|||
161642590|NCT03377361|583742125|FG005|Treatment Period|Study Drug Toxicity|0|||
161642591|NCT03377361|583742126|FG006|Treatment Period|Study Drug Toxicity|0|||
161642592|NCT03377361|583742127|FG007|Treatment Period|Study Drug Toxicity|7|||
161642593|NCT03377361|583742128|FG008|Treatment Period|Study Drug Toxicity|2|||
161642594|NCT03377361|583742129|FG009|Treatment Period|Study Drug Toxicity|16|||
161642595|NCT03377361|583742120|FG000|Treatment Period|Death|0|||
161835502|NCT02039414|584438984|FG000|Overall Study|Lost to Follow-up|2|||
161642596|NCT03377361|583742121|FG001|Treatment Period|Death|0|||
161642597|NCT03377361|583742122|FG002|Treatment Period|Death|1|||
161642598|NCT03377361|583742123|FG003|Treatment Period|Death|0|||
161642599|NCT03377361|583742124|FG004|Treatment Period|Death|0|||
161642600|NCT03377361|583742125|FG005|Treatment Period|Death|0|||
161642601|NCT03377361|583742126|FG006|Treatment Period|Death|0|||
161642602|NCT03377361|583742127|FG007|Treatment Period|Death|2|||
161642603|NCT03377361|583742128|FG008|Treatment Period|Death|1|||
161642604|NCT03377361|583742129|FG009|Treatment Period|Death|3|||
161642605|NCT03377361|583742120|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642606|NCT03377361|583742121|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642607|NCT03377361|583742122|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642608|NCT03377361|583742123|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642609|NCT03377361|583742124|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642610|NCT03377361|583742125|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642611|NCT03377361|583742126|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
161642612|NCT03377361|583742127|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
161642613|NCT03377361|583742128|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
161642614|NCT03377361|583742129|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161642615|NCT03377361|583742120|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
161642616|NCT03377361|583742121|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
161642617|NCT03377361|583742122|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
161642618|NCT03377361|583742123|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
161642619|NCT03377361|583742124|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
161642620|NCT03377361|583742125|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
161642621|NCT03377361|583742126|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
161642622|NCT03377361|583742127|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
161642623|NCT03377361|583742128|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
161642624|NCT03377361|583742129|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
161642625|NCT03377361|583742120|FG000|Treatment Period|Subject Withdrew Consent|0|||
161642626|NCT03377361|583742121|FG001|Treatment Period|Subject Withdrew Consent|0|||
161687690|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
161687691|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161687692|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161687693|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161687694|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
161642627|NCT03377361|583742122|FG002|Treatment Period|Subject Withdrew Consent|0|||
161642628|NCT03377361|583742123|FG003|Treatment Period|Subject Withdrew Consent|0|||
161642629|NCT03377361|583742124|FG004|Treatment Period|Subject Withdrew Consent|0|||
161687695|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
161687696|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
161687697|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
161687698|NCT01577186|583908467|FG000|Overall Study|Adverse Event|23|||
161687699|NCT01577186|583908467|FG000|Overall Study|Death|1|||
161687700|NCT01577186|583908467|FG000|Overall Study|Lost to Follow-up|28|||
161687701|NCT01577186|583908467|FG000|Overall Study|Withdrawal by Subject|35|||
161687702|NCT01577186|583908467|FG000|Overall Study|Insufficient Response|18|||
161687703|NCT01577186|583908467|FG000|Overall Study|Ineligible to Continue|15|||
161687704|NCT01577186|583908467|FG000|Overall Study|Non-Compliant|8|||
161687705|NCT01577186|583908467|FG000|Overall Study|Other|2|||
161687706|NCT01032915|583908468|FG000|Overall Study|Adverse Event|2|||
161687707|NCT01032915|583908469|FG001|Overall Study|Adverse Event|2|||
161687708|NCT01032915|583908470|FG002|Overall Study|Adverse Event|1|||
161687709|NCT01032915|583908471|FG003|Overall Study|Adverse Event|1|||
161687710|NCT01032915|583908468|FG000|Overall Study|Abnormal test procedure result|0|||
161687711|NCT01032915|583908469|FG001|Overall Study|Abnormal test procedure result|0|||
161835503|NCT02039414|584438985|FG001|Overall Study|Lost to Follow-up|0|||
161687712|NCT01032915|583908470|FG002|Overall Study|Abnormal test procedure result|1|||
161687713|NCT01032915|583908471|FG003|Overall Study|Abnormal test procedure result|0|||
161687714|NCT01032915|583908468|FG000|Overall Study|Withdrawal by Subject|0|||
161687715|NCT01032915|583908469|FG001|Overall Study|Withdrawal by Subject|3|||
161687716|NCT01032915|583908470|FG002|Overall Study|Withdrawal by Subject|1|||
161687717|NCT01032915|583908471|FG003|Overall Study|Withdrawal by Subject|1|||
161687718|NCT01032915|583908468|FG000|Overall Study|Administrative reasons|5|||
161687719|NCT01032915|583908469|FG001|Overall Study|Administrative reasons|6|||
161642630|NCT03377361|583742125|FG005|Treatment Period|Subject Withdrew Consent|0|||
161642631|NCT03377361|583742126|FG006|Treatment Period|Subject Withdrew Consent|0|||
161642632|NCT03377361|583742127|FG007|Treatment Period|Subject Withdrew Consent|0|||
161642633|NCT03377361|583742128|FG008|Treatment Period|Subject Withdrew Consent|2|||
161642634|NCT03377361|583742129|FG009|Treatment Period|Subject Withdrew Consent|1|||
161642635|NCT03377361|583742120|FG000|Treatment Period|No longer meets study criteria|0|||
161642636|NCT03377361|583742121|FG001|Treatment Period|No longer meets study criteria|1|||
161642637|NCT03377361|583742122|FG002|Treatment Period|No longer meets study criteria|0|||
161642638|NCT03377361|583742123|FG003|Treatment Period|No longer meets study criteria|0|||
161642639|NCT03377361|583742124|FG004|Treatment Period|No longer meets study criteria|0|||
161642640|NCT03377361|583742125|FG005|Treatment Period|No longer meets study criteria|0|||
161642641|NCT03377361|583742126|FG006|Treatment Period|No longer meets study criteria|0|||
161642642|NCT03377361|583742127|FG007|Treatment Period|No longer meets study criteria|1|||
161642643|NCT03377361|583742128|FG008|Treatment Period|No longer meets study criteria|0|||
161642644|NCT03377361|583742129|FG009|Treatment Period|No longer meets study criteria|0|||
161642645|NCT03377361|583742120|FG000|Treatment Period|Other Reasons|0|||
161642646|NCT03377361|583742121|FG001|Treatment Period|Other Reasons|0|||
161642647|NCT03377361|583742122|FG002|Treatment Period|Other Reasons|0|||
161642648|NCT03377361|583742123|FG003|Treatment Period|Other Reasons|3|||
161642649|NCT03377361|583742124|FG004|Treatment Period|Other Reasons|0|||
161642650|NCT03377361|583742125|FG005|Treatment Period|Other Reasons|0|||
161642651|NCT03377361|583742126|FG006|Treatment Period|Other Reasons|0|||
161642652|NCT03377361|583742127|FG007|Treatment Period|Other Reasons|2|||
161642653|NCT03377361|583742128|FG008|Treatment Period|Other Reasons|0|||
161642654|NCT03377361|583742129|FG009|Treatment Period|Other Reasons|1|||
161642655|NCT00742326|583742130|FG000|Overall Study|Physician Decision|0|||
161642656|NCT00742326|583742131|FG001|Overall Study|Physician Decision|1|||
161642657|NCT03698994|583742135|FG000|Overall Study|Adverse Event|2|||
161642658|NCT03698994|583742135|FG000|Overall Study|Death|1|||
161642659|NCT03698994|583742135|FG000|Overall Study|Physician Decision|1|||
161642660|NCT03698994|583742135|FG000|Overall Study|Withdrawal by Subject|3|||
161642661|NCT03698994|583742135|FG000|Overall Study|Progressive Disease|12|||
161642662|NCT03635086|583742138|FG000|Overall Study|Withdrawal of consent|0|||
161642663|NCT03635086|583742139|FG001|Overall Study|Withdrawal of consent|0|||
161642664|NCT03635086|583742140|FG002|Overall Study|Withdrawal of consent|1|||
161642665|NCT03635086|583742141|FG003|Overall Study|Withdrawal of consent|0|||
161642666|NCT03635086|583742142|FG004|Overall Study|Withdrawal of consent|0|||
161642667|NCT03635086|583742138|FG000|Overall Study|Adverse Event|0|||
161642668|NCT03635086|583742139|FG001|Overall Study|Adverse Event|1|||
161642669|NCT03635086|583742140|FG002|Overall Study|Adverse Event|0|||
161642670|NCT03635086|583742141|FG003|Overall Study|Adverse Event|0|||
161642671|NCT03635086|583742142|FG004|Overall Study|Adverse Event|0|||
161642672|NCT03635086|583742138|FG000|Overall Study|Lost to Follow-up|1|||
161642673|NCT03635086|583742139|FG001|Overall Study|Lost to Follow-up|0|||
161835504|NCT02039414|584438984|FG000|Overall Study|Protocol Violation|3|||
161835505|NCT02039414|584438985|FG001|Overall Study|Protocol Violation|1|||
161835506|NCT03977701|584438986|FG000|Overall Study|COVID-19 pandemic|0|||
161835507|NCT03977701|584438987|FG001|Overall Study|COVID-19 pandemic|0|||
161835508|NCT03977701|584438988|FG002|Overall Study|COVID-19 pandemic|0|||
161835509|NCT03977701|584438989|FG003|Overall Study|COVID-19 pandemic|0|||
161835510|NCT03977701|584438990|FG004|Overall Study|COVID-19 pandemic|0|||
161835511|NCT03977701|584438991|FG005|Overall Study|COVID-19 pandemic|1|||
161835512|NCT03977701|584438992|FG006|Overall Study|COVID-19 pandemic|0|||
161835513|NCT03977701|584438993|FG007|Overall Study|COVID-19 pandemic|1|||
161835514|NCT03977701|584438994|FG008|Overall Study|COVID-19 pandemic|0|||
161835515|NCT03977701|584438995|FG009|Overall Study|COVID-19 pandemic|0|||
161835516|NCT00430950|584438997|FG000|Overall Study|Adverse Event|7|||
161835517|NCT00430950|584438998|FG001|Overall Study|Adverse Event|6|||
161835518|NCT00430950|584438997|FG000|Overall Study|Withdrawal by Subject|1|||
161835519|NCT00430950|584438998|FG001|Overall Study|Withdrawal by Subject|0|||
161835520|NCT00430950|584438997|FG000|Overall Study|concomitant medication,etc.|5|||
161835521|NCT00430950|584438998|FG001|Overall Study|concomitant medication,etc.|7|||
161835522|NCT02429934|584438999|FG000|Overall Study|Withdrawal by Subject|0|||
161835523|NCT02429934|584439000|FG001|Overall Study|Withdrawal by Subject|2|||
161835524|NCT02429934|584438999|FG000|Overall Study|Adverse Event|2|||
161835525|NCT02429934|584439000|FG001|Overall Study|Adverse Event|0|||
161835526|NCT02429934|584438999|FG000|Overall Study|Lost to Follow-up|1|||
161835527|NCT02429934|584439000|FG001|Overall Study|Lost to Follow-up|1|||
161835528|NCT02429934|584438999|FG000|Overall Study|Physician Decision|1|||
161835529|NCT02429934|584439000|FG001|Overall Study|Physician Decision|0|||
161835530|NCT00869024|584439001|FG000|Overall Study|Death|2|||
161835531|NCT00869024|584439002|FG001|Overall Study|Death|3|||
161642674|NCT03635086|583742140|FG002|Overall Study|Lost to Follow-up|0|||
161642675|NCT03635086|583742141|FG003|Overall Study|Lost to Follow-up|0|||
161835532|NCT00869024|584439001|FG000|Overall Study|Lost to Follow-up|0|||
161642676|NCT03635086|583742142|FG004|Overall Study|Lost to Follow-up|0|||
161835533|NCT00869024|584439002|FG001|Overall Study|Lost to Follow-up|1|||
161642677|NCT02196077|583742143|FG000|Overall Study|Adverse Event|4|||
161835534|NCT00869024|584439001|FG000|Overall Study|Protocol Violation|0|||
161835535|NCT00869024|584439002|FG001|Overall Study|Protocol Violation|1|||
161835536|NCT00293202|584439003|FG000|Overall Study|Withdrawal by Subject|1|||
161835537|NCT00293202|584439004|FG001|Overall Study|Withdrawal by Subject|2|||
161835538|NCT00293202|584439003|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
161835539|NCT00293202|584439004|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
161642678|NCT02196077|583742143|FG000|Overall Study|Lack of Efficacy|1|||
161642679|NCT02196077|583742143|FG000|Overall Study|Withdrawal by Subject|14|||
161642680|NCT02196077|583742143|FG000|Overall Study|Physician Decision|1|||
161642681|NCT02196077|583742143|FG000|Overall Study|Lost to Follow-up|3|||
161642682|NCT02196077|583742143|FG000|Overall Study|Protocol Violation|24|||
161642683|NCT00732992|583742144|FG000|Overall Study|Adverse Event|1|||
161642684|NCT00732992|583742145|FG001|Overall Study|Adverse Event|1|||
161642685|NCT00732992|583742144|FG000|Overall Study|Objective Progression or Relapse|3|||
161642686|NCT00732992|583742145|FG001|Overall Study|Objective Progression or Relapse|5|||
161642687|NCT00732992|583742144|FG000|Overall Study|Global Deterioration of Health Status|1|||
161642688|NCT00732992|583742145|FG001|Overall Study|Global Deterioration of Health Status|0|||
161642689|NCT00732992|583742144|FG000|Overall Study|Withdrawal by Subject|1|||
161642690|NCT00732992|583742145|FG001|Overall Study|Withdrawal by Subject|0|||
161642691|NCT03482752|583742152|FG000|Overall Study|Withdrawal by Subject|2|||
161642692|NCT03482752|583742152|FG000|Overall Study|Lost to Follow-up|1|||
161642693|NCT03482752|583742152|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
161642694|NCT02844777|583742153|FG000|Overall Study|Withdrawal by Subject|2|||
161642695|NCT02844777|583742154|FG001|Overall Study|Withdrawal by Subject|0|||
161642696|NCT02844777|583742155|FG002|Overall Study|Withdrawal by Subject|0|||
161642697|NCT01776008|583742156|FG000|Overall Study|ineligible|2|||
161642698|NCT00150618|583742157|FG000|Overall Study|Adverse Event|2|||
161642699|NCT00150618|583742158|FG001|Overall Study|Adverse Event|2|||
161642700|NCT00150618|583742159|FG002|Overall Study|Adverse Event|6|||
161642701|NCT00150618|583742160|FG003|Overall Study|Adverse Event|9|||
161642702|NCT00150618|583742161|FG004|Overall Study|Adverse Event|5|||
161642703|NCT00150618|583742157|FG000|Overall Study|Withdrawal by Subject|6|||
161642704|NCT00150618|583742158|FG001|Overall Study|Withdrawal by Subject|8|||
161642705|NCT00150618|583742159|FG002|Overall Study|Withdrawal by Subject|8|||
161642706|NCT00150618|583742160|FG003|Overall Study|Withdrawal by Subject|4|||
161642707|NCT00150618|583742161|FG004|Overall Study|Withdrawal by Subject|5|||
161835540|NCT00293202|584439003|FG000|Overall Study|on-hold due to fistula maturation time|1|||
161835541|NCT00293202|584439004|FG001|Overall Study|on-hold due to fistula maturation time|0|||
161835542|NCT01564459|584439005|FG000|Run-In|Adverse Event|7|||
161835543|NCT01564459|584439006|FG001|Run-In|Adverse Event|0|||
161835544|NCT01564459|584439007|FG002|Run-In|Adverse Event|0|||
161835545|NCT01564459|584439005|FG000|Run-In|Lost to Follow-up|1|||
161835546|NCT01564459|584439006|FG001|Run-In|Lost to Follow-up|0|||
161835547|NCT01564459|584439007|FG002|Run-In|Lost to Follow-up|0|||
161642708|NCT00150618|583742157|FG000|Overall Study|Lost to Follow-up|4|||
161642709|NCT00150618|583742158|FG001|Overall Study|Lost to Follow-up|1|||
161642710|NCT00150618|583742159|FG002|Overall Study|Lost to Follow-up|5|||
161642711|NCT00150618|583742160|FG003|Overall Study|Lost to Follow-up|8|||
161642712|NCT00150618|583742161|FG004|Overall Study|Lost to Follow-up|4|||
161642713|NCT00150618|583742157|FG000|Overall Study|Protocol Violation|1|||
161642714|NCT00150618|583742158|FG001|Overall Study|Protocol Violation|0|||
161642715|NCT00150618|583742159|FG002|Overall Study|Protocol Violation|0|||
161642716|NCT00150618|583742160|FG003|Overall Study|Protocol Violation|0|||
161642717|NCT00150618|583742161|FG004|Overall Study|Protocol Violation|1|||
161642718|NCT00150618|583742157|FG000|Overall Study|Lack of Efficacy|1|||
161642719|NCT00150618|583742158|FG001|Overall Study|Lack of Efficacy|4|||
161642720|NCT00150618|583742159|FG002|Overall Study|Lack of Efficacy|7|||
161642721|NCT00150618|583742160|FG003|Overall Study|Lack of Efficacy|4|||
161642722|NCT00150618|583742161|FG004|Overall Study|Lack of Efficacy|6|||
161642723|NCT00150618|583742157|FG000|Overall Study|No study meds|0|||
161642724|NCT00150618|583742158|FG001|Overall Study|No study meds|0|||
161642725|NCT00150618|583742159|FG002|Overall Study|No study meds|0|||
161642726|NCT00150618|583742160|FG003|Overall Study|No study meds|0|||
161642727|NCT00150618|583742161|FG004|Overall Study|No study meds|2|||
161642728|NCT00150618|583742157|FG000|Overall Study|Physician Decision|0|||
161642729|NCT00150618|583742158|FG001|Overall Study|Physician Decision|2|||
161642730|NCT00150618|583742159|FG002|Overall Study|Physician Decision|0|||
161642731|NCT00150618|583742160|FG003|Overall Study|Physician Decision|0|||
161642732|NCT00150618|583742161|FG004|Overall Study|Physician Decision|1|||
161642733|NCT00150618|583742157|FG000|Overall Study|Lack of compliance|2|||
161642734|NCT00150618|583742158|FG001|Overall Study|Lack of compliance|1|||
161642735|NCT00150618|583742159|FG002|Overall Study|Lack of compliance|1|||
161642736|NCT00150618|583742160|FG003|Overall Study|Lack of compliance|0|||
161642737|NCT00150618|583742161|FG004|Overall Study|Lack of compliance|1|||
161642738|NCT00150618|583742157|FG000|Overall Study|Abnormal ECG|1|||
161642739|NCT00150618|583742158|FG001|Overall Study|Abnormal ECG|0|||
161642740|NCT00150618|583742159|FG002|Overall Study|Abnormal ECG|0|||
161642741|NCT00150618|583742160|FG003|Overall Study|Abnormal ECG|0|||
161642742|NCT00150618|583742161|FG004|Overall Study|Abnormal ECG|0|||
161642743|NCT00150618|583742157|FG000|Overall Study|Sponsor's decision|0|||
161642744|NCT00150618|583742158|FG001|Overall Study|Sponsor's decision|0|||
161642745|NCT00150618|583742159|FG002|Overall Study|Sponsor's decision|0|||
161642746|NCT00150618|583742160|FG003|Overall Study|Sponsor's decision|1|||
161642747|NCT00150618|583742161|FG004|Overall Study|Sponsor's decision|0|||
161642748|NCT02493946|583742162|FG000|DB Period|Withdrawal by Subject|8|||
161642749|NCT02493946|583742163|FG001|DB Period|Withdrawal by Subject|5|||
161642750|NCT02493946|583742164|FG002|DB Period|Withdrawal by Subject|0|||
161642751|NCT02493946|583742162|FG000|Open Label Period|Withdrawal by Subject|0|||
161642752|NCT02493946|583742163|FG001|Open Label Period|Withdrawal by Subject|0|||
161642753|NCT02493946|583742164|FG002|Open Label Period|Withdrawal by Subject|74|||
161835548|NCT01564459|584439005|FG000|Run-In|Non-compliance with study drug|2|||
161835549|NCT01564459|584439006|FG001|Run-In|Non-compliance with study drug|0|||
161642754|NCT02493946|583742162|FG000|Open Label Period|Adverse Event|0|||
161642755|NCT02493946|583742163|FG001|Open Label Period|Adverse Event|0|||
161642756|NCT02493946|583742164|FG002|Open Label Period|Adverse Event|4|||
161642757|NCT02493946|583742162|FG000|Open Label Period|Lost to Follow-up|0|||
161642758|NCT02493946|583742163|FG001|Open Label Period|Lost to Follow-up|0|||
161642759|NCT02493946|583742164|FG002|Open Label Period|Lost to Follow-up|1|||
161642760|NCT02493946|583742162|FG000|Open Label Period|Investigator decision, non-compliance|0|||
161642761|NCT02493946|583742163|FG001|Open Label Period|Investigator decision, non-compliance|0|||
161687720|NCT01032915|583908470|FG002|Overall Study|Administrative reasons|4|||
161835550|NCT01564459|584439007|FG002|Run-In|Non-compliance with study drug|0|||
161642762|NCT02493946|583742164|FG002|Open Label Period|Investigator decision, non-compliance|2|||
161642763|NCT02493946|583742162|FG000|Open Label Period|Investigator decision, non-availability|0|||
161642764|NCT02493946|583742163|FG001|Open Label Period|Investigator decision, non-availability|0|||
161642765|NCT02493946|583742164|FG002|Open Label Period|Investigator decision, non-availability|1|||
161642766|NCT02493946|583742162|FG000|Open Label Period|Pregnancy|0|||
161642767|NCT02493946|583742163|FG001|Open Label Period|Pregnancy|0|||
161642768|NCT02493946|583742164|FG002|Open Label Period|Pregnancy|3|||
161642769|NCT02493946|583742162|FG000|Open Label Period|Site error|0|||
161642770|NCT02493946|583742163|FG001|Open Label Period|Site error|0|||
161642771|NCT02493946|583742164|FG002|Open Label Period|Site error|1|||
161642772|NCT00965497|583742165|FG000|Overall Study|Physician Decision|1|||
161642773|NCT02689453|583742166|FG000|Overall Study|Progressive disease|0|||
161642774|NCT02689453|583742167|FG001|Overall Study|Progressive disease|1|||
161642775|NCT02689453|583742168|FG002|Overall Study|Progressive disease|1|||
161642776|NCT01162486|583742169|FG000|Overall Study|low ANC|1|||
161642777|NCT01162486|583742170|FG001|Overall Study|low ANC|0|||
161642778|NCT01162486|583742171|FG002|Overall Study|low ANC|0|||
161642779|NCT01162486|583742172|FG003|Overall Study|low ANC|0|||
161642780|NCT01162486|583742173|FG004|Overall Study|low ANC|0|||
161642781|NCT01162486|583742169|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
161642782|NCT01162486|583742170|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161642783|NCT01162486|583742171|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161642784|NCT01162486|583742172|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161642785|NCT01162486|583742173|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161642786|NCT01162486|583742169|FG000|Overall Study|elevated LFTs|0|||
161642787|NCT01162486|583742170|FG001|Overall Study|elevated LFTs|0|||
161642788|NCT01162486|583742171|FG002|Overall Study|elevated LFTs|1|||
161642789|NCT01162486|583742172|FG003|Overall Study|elevated LFTs|0|||
161642790|NCT01162486|583742173|FG004|Overall Study|elevated LFTs|0|||
161642791|NCT01162486|583742169|FG000|Overall Study|Pregnancy|0|||
161642792|NCT01162486|583742170|FG001|Overall Study|Pregnancy|0|||
161642793|NCT01162486|583742171|FG002|Overall Study|Pregnancy|0|||
161642794|NCT01162486|583742172|FG003|Overall Study|Pregnancy|1|||
161642795|NCT01162486|583742173|FG004|Overall Study|Pregnancy|0|||
161642796|NCT00794924|583742174|FG000|Overall Study|Lost to Follow-up|6|||
161642797|NCT00794924|583742175|FG001|Overall Study|Lost to Follow-up|8|||
161642798|NCT00794924|583742174|FG000|Overall Study|Withdrawal by Subject|48|||
161642799|NCT00794924|583742175|FG001|Overall Study|Withdrawal by Subject|60|||
161642800|NCT00794924|583742174|FG000|Overall Study|Adverse Event|6|||
161642801|NCT00794924|583742175|FG001|Overall Study|Adverse Event|2|||
161642802|NCT00953615|583742176|FG000|Overall Study|Adverse Event|1|||
161642803|NCT02296892|583742185|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
161642804|NCT02296892|583742186|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
161642805|NCT02296892|583742187|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
161642806|NCT02296892|583742185|FG000|Overall Study|Lost to Follow-up|5|||
161642807|NCT02296892|583742186|FG001|Overall Study|Lost to Follow-up|0|||
161642808|NCT02296892|583742187|FG002|Overall Study|Lost to Follow-up|1|||
161642809|NCT00383123|583742192|FG000|Overall Study|Adverse Event|1|||
161642810|NCT00383123|583742193|FG001|Overall Study|Adverse Event|0|||
161642811|NCT00383123|583742192|FG000|Overall Study|Lost to Follow-up|68|||
161642812|NCT00383123|583742193|FG001|Overall Study|Lost to Follow-up|61|||
161642813|NCT00383123|583742192|FG000|Overall Study|Protocol Violation|5|||
161642814|NCT00383123|583742193|FG001|Overall Study|Protocol Violation|1|||
161642815|NCT00383123|583742192|FG000|Overall Study|Withdrawal by Subject|27|||
161642816|NCT00383123|583742193|FG001|Overall Study|Withdrawal by Subject|18|||
161835551|NCT01564459|584439005|FG000|Run-In|Protocol Violation|1|||
161642817|NCT00383123|583742192|FG000|Overall Study|Other reason|10|||
161642818|NCT00383123|583742193|FG001|Overall Study|Other reason|6|||
161642819|NCT00250432|583742196|FG000|Overall Study|Adverse Event|25|||
161642820|NCT00250432|583742197|FG001|Overall Study|Adverse Event|29|||
161835552|NCT01564459|584439006|FG001|Run-In|Protocol Violation|0|||
161642821|NCT00250432|583742196|FG000|Overall Study|Lack of Efficacy|2|||
161642822|NCT00250432|583742197|FG001|Overall Study|Lack of Efficacy|1|||
161642823|NCT00250432|583742196|FG000|Overall Study|Lost to Follow-up|6|||
161642824|NCT00250432|583742197|FG001|Overall Study|Lost to Follow-up|5|||
161642825|NCT00250432|583742196|FG000|Overall Study|Patient Moved|0|||
161642826|NCT00250432|583742197|FG001|Overall Study|Patient Moved|1|||
161642827|NCT00250432|583742196|FG000|Overall Study|Protocol Violation|0|||
161642828|NCT00250432|583742197|FG001|Overall Study|Protocol Violation|3|||
161642829|NCT00250432|583742196|FG000|Overall Study|Withdrawal by Subject|6|||
161642830|NCT00250432|583742197|FG001|Overall Study|Withdrawal by Subject|2|||
161642831|NCT00250432|583742196|FG000|Overall Study|Pt died out of posttherapy report period|6|||
161642832|NCT00250432|583742197|FG001|Overall Study|Pt died out of posttherapy report period|5|||
161642833|NCT00250432|583742196|FG000|Overall Study|Pt was considered untreatable|0|||
161642834|NCT00250432|583742197|FG001|Overall Study|Pt was considered untreatable|1|||
161642835|NCT04147858|583742198|FG000|Overall Study|Adverse Event|6|||
161642836|NCT04147858|583742199|FG001|Overall Study|Adverse Event|6|||
161642837|NCT04147858|583742200|FG002|Overall Study|Adverse Event|6|||
161642838|NCT04147858|583742198|FG000|Overall Study|Lack of Efficacy|3|||
161687721|NCT01032915|583908471|FG003|Overall Study|Administrative reasons|4|||
161687722|NCT01032915|583908468|FG000|Overall Study|Protocol Violation|1|||
161687723|NCT01032915|583908469|FG001|Overall Study|Protocol Violation|0|||
161687724|NCT01032915|583908470|FG002|Overall Study|Protocol Violation|0|||
161687725|NCT01032915|583908471|FG003|Overall Study|Protocol Violation|1|||
161687726|NCT02797808|583908473|FG000|Overall Study|Withdrawal by Subject|1|||
161687727|NCT02797808|583908474|FG001|Overall Study|Withdrawal by Subject|1|||
161687728|NCT02797808|583908473|FG000|Overall Study|Physician Decision|6|||
161687729|NCT02797808|583908474|FG001|Overall Study|Physician Decision|2|||
161687730|NCT00535132|583908477|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
161687731|NCT00535132|583908478|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
161687732|NCT00535132|583908477|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
161687733|NCT00535132|583908478|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
161687734|NCT00264875|583908479|FG000|Overall Study|Adverse Event|6|||
161687735|NCT00264875|583908479|FG000|Overall Study|Lost to Follow-up|6|||
161687736|NCT00264875|583908479|FG000|Overall Study|Protocol Violation|11|||
161687737|NCT00264875|583908479|FG000|Overall Study|Withdrawal by Subject|7|||
161687738|NCT00143312|583908492|FG000|Overall Study|Death|11|||
161687739|NCT00143312|583908492|FG000|Overall Study|Adverse Event|2|||
161687740|NCT00143312|583908492|FG000|Overall Study|Lost to Follow-up|1|||
161687741|NCT00143312|583908492|FG000|Overall Study|Other|1|||
161687742|NCT00143312|583908492|FG000|Overall Study|Withdrawal by Subject|1|||
161687743|NCT01029366|583908493|FG000|Overall Study|Withdrawal by Subject|1|||
161687744|NCT01029366|583908494|FG001|Overall Study|Withdrawal by Subject|0|||
161687745|NCT01029366|583908493|FG000|Overall Study|Death|1|||
161687746|NCT01029366|583908494|FG001|Overall Study|Death|1|||
161687747|NCT01029366|583908493|FG000|Overall Study|disease progression|2|||
161687748|NCT01029366|583908494|FG001|Overall Study|disease progression|0|||
161687749|NCT01029366|583908493|FG000|Overall Study|manufacturing failure|0|||
161687750|NCT01029366|583908494|FG001|Overall Study|manufacturing failure|1|||
161687751|NCT01834274|583908495|FG000|Overall Study|Study Termination|41|||
161687752|NCT01834274|583908496|FG001|Overall Study|Study Termination|38|||
161687753|NCT01834274|583908495|FG000|Overall Study|Withdrawal by Subject|1|||
161687754|NCT01834274|583908496|FG001|Overall Study|Withdrawal by Subject|1|||
161687755|NCT01834274|583908495|FG000|Overall Study|Lost to Follow-up|3|||
161687756|NCT01834274|583908496|FG001|Overall Study|Lost to Follow-up|1|||
161687757|NCT01834274|583908495|FG000|Overall Study|Other|2|||
161687758|NCT01834274|583908496|FG001|Overall Study|Other|1|||
161687759|NCT01827670|583908497|FG000|Overall Study|Withdrawal of Consent|3|||
161687760|NCT01827670|583908498|FG001|Overall Study|Withdrawal of Consent|2|||
161687761|NCT01827670|583908497|FG000|Overall Study|Lost to Follow-up|0|||
161687762|NCT01827670|583908498|FG001|Overall Study|Lost to Follow-up|1|||
161687763|NCT02941627|583908499|FG000|Overall Study|Death|1|||
161687764|NCT02941627|583908499|FG000|Overall Study|Surgical failure|1|||
161687765|NCT02941627|583908499|FG000|Overall Study|cholesteatoma prevented implantation|1|||
161687766|NCT00563186|583908502|FG000|Overall Study|LOS<48 hours|97|||
161687767|NCT00563186|583908503|FG001|Overall Study|LOS<48 hours|74|||
161687768|NCT00563186|583908502|FG000|Overall Study|Incomplete data|1|||
161835553|NCT01564459|584439007|FG002|Run-In|Protocol Violation|0|||
161835554|NCT01564459|584439005|FG000|Run-In|Withdrawal by Subject|1|||
161835555|NCT01564459|584439006|FG001|Run-In|Withdrawal by Subject|0|||
161835556|NCT01564459|584439007|FG002|Run-In|Withdrawal by Subject|0|||
161835557|NCT01564459|584439005|FG000|Double-blind Treatment|Adverse Event|0|||
161835558|NCT01564459|584439006|FG001|Double-blind Treatment|Adverse Event|0|||
161835559|NCT01564459|584439007|FG002|Double-blind Treatment|Adverse Event|1|||
161687769|NCT00563186|583908503|FG001|Overall Study|Incomplete data|1|||
161687770|NCT00446511|583908504|FG000|Overall Study|Adverse Event|7|||
161687771|NCT00446511|583908505|FG001|Overall Study|Adverse Event|2|||
161687772|NCT00446511|583908506|FG002|Overall Study|Adverse Event|3|||
161835560|NCT00653991|584439013|FG000|3 Month Follow-up|Participant would not respond|150|||
161835561|NCT00653991|584439014|FG001|3 Month Follow-up|Participant would not respond|157|||
161642839|NCT04147858|583742199|FG001|Overall Study|Lack of Efficacy|3|||
161642840|NCT04147858|583742200|FG002|Overall Study|Lack of Efficacy|1|||
161687773|NCT00446511|583908507|FG003|Overall Study|Adverse Event|1|||
161687774|NCT00446511|583908504|FG000|Overall Study|Protocol Violation|0|||
161642841|NCT04147858|583742198|FG000|Overall Study|Lost to Follow-up|1|||
161687775|NCT00446511|583908505|FG001|Overall Study|Protocol Violation|0|||
161687776|NCT00446511|583908506|FG002|Overall Study|Protocol Violation|0|||
161835562|NCT00653991|584439013|FG000|6 Month Follow-up|Participant would not respond|133|||
161642842|NCT04147858|583742199|FG001|Overall Study|Lost to Follow-up|6|||
161642843|NCT04147858|583742200|FG002|Overall Study|Lost to Follow-up|2|||
161642844|NCT04147858|583742198|FG000|Overall Study|Withdrawal by Subject|3|||
161642845|NCT04147858|583742199|FG001|Overall Study|Withdrawal by Subject|4|||
161642846|NCT04147858|583742200|FG002|Overall Study|Withdrawal by Subject|10|||
161642847|NCT04147858|583742198|FG000|Overall Study|Subject Noncompliance, Other|4|||
161642848|NCT04147858|583742199|FG001|Overall Study|Subject Noncompliance, Other|3|||
161642849|NCT04147858|583742200|FG002|Overall Study|Subject Noncompliance, Other|1|||
161642850|NCT03375320|583742206|FG000|Overall Study|Adverse Event|34|||
161642851|NCT03375320|583742207|FG001|Overall Study|Adverse Event|9|||
161642852|NCT03375320|583742208|FG002|Overall Study|Adverse Event|10|||
161642853|NCT03375320|583742209|FG003|Overall Study|Adverse Event|0|||
161642854|NCT03375320|583742206|FG000|Overall Study|Death|6|||
161642855|NCT03375320|583742207|FG001|Overall Study|Death|3|||
161642856|NCT03375320|583742208|FG002|Overall Study|Death|0|||
161642857|NCT03375320|583742209|FG003|Overall Study|Death|0|||
161642858|NCT03375320|583742206|FG000|Overall Study|Withdrawal by Subject|7|||
161642859|NCT03375320|583742207|FG001|Overall Study|Withdrawal by Subject|4|||
161642860|NCT03375320|583742208|FG002|Overall Study|Withdrawal by Subject|5|||
161642861|NCT03375320|583742209|FG003|Overall Study|Withdrawal by Subject|4|||
161642862|NCT03375320|583742206|FG000|Overall Study|Progressive disease|55|||
161642863|NCT03375320|583742207|FG001|Overall Study|Progressive disease|41|||
161642864|NCT03375320|583742208|FG002|Overall Study|Progressive disease|29|||
161642865|NCT03375320|583742209|FG003|Overall Study|Progressive disease|24|||
161642866|NCT03375320|583742206|FG000|Overall Study|Alternative treatment|6|||
161642867|NCT03375320|583742207|FG001|Overall Study|Alternative treatment|1|||
161642868|NCT03375320|583742208|FG002|Overall Study|Alternative treatment|1|||
161642869|NCT03375320|583742209|FG003|Overall Study|Alternative treatment|0|||
161642870|NCT03375320|583742206|FG000|Overall Study|Other disease|1|||
161642871|NCT03375320|583742207|FG001|Overall Study|Other disease|1|||
161642872|NCT03375320|583742208|FG002|Overall Study|Other disease|3|||
161642873|NCT03375320|583742209|FG003|Overall Study|Other disease|0|||
161642874|NCT03375320|583742206|FG000|Overall Study|Withdrawal prior to initiation|2|||
161642875|NCT03375320|583742207|FG001|Overall Study|Withdrawal prior to initiation|2|||
161642876|NCT03375320|583742208|FG002|Overall Study|Withdrawal prior to initiation|1|||
161642877|NCT03375320|583742209|FG003|Overall Study|Withdrawal prior to initiation|0|||
161642878|NCT03375320|583742206|FG000|Overall Study|Physician Decision|1|||
161642879|NCT03375320|583742207|FG001|Overall Study|Physician Decision|1|||
161642880|NCT03375320|583742208|FG002|Overall Study|Physician Decision|1|||
161642881|NCT03375320|583742209|FG003|Overall Study|Physician Decision|1|||
161642882|NCT03375320|583742206|FG000|Overall Study|Non-compliance|1|||
161642883|NCT03375320|583742207|FG001|Overall Study|Non-compliance|0|||
161642884|NCT03375320|583742208|FG002|Overall Study|Non-compliance|0|||
161642885|NCT03375320|583742209|FG003|Overall Study|Non-compliance|0|||
161642886|NCT04907357|583742210|FG000|Overall Study|Death|0|||
161642887|NCT04907357|583742211|FG001|Overall Study|Death|1|||
161642888|NCT04907357|583742210|FG000|Overall Study|Lost to Follow-up|9|||
161642889|NCT04907357|583742211|FG001|Overall Study|Lost to Follow-up|18|||
161642890|NCT04907357|583742210|FG000|Overall Study|Physician Decision|1|||
161642891|NCT04907357|583742211|FG001|Overall Study|Physician Decision|0|||
161642892|NCT04907357|583742210|FG000|Overall Study|Withdrawal by Subject|0|||
161642893|NCT04907357|583742211|FG001|Overall Study|Withdrawal by Subject|1|||
161642894|NCT04907357|583742210|FG000|Overall Study|Unable to attend visits|1|||
161642895|NCT04907357|583742211|FG001|Overall Study|Unable to attend visits|0|||
161642896|NCT04907357|583742210|FG000|Overall Study|Incarcerated|1|||
161642897|NCT04907357|583742211|FG001|Overall Study|Incarcerated|1|||
161642898|NCT03358238|583742212|FG000|Overall Study|Withdrawal by Subject|0|||
161642899|NCT03358238|583742213|FG001|Overall Study|Withdrawal by Subject|1|||
161642900|NCT01340014|583742214|FG000|Period 1, First 7 Days|Adverse Event|1|||
161642901|NCT01340014|583742215|FG001|Period 1, First 7 Days|Adverse Event|0|||
161642902|NCT01340014|583742214|FG000|Period 1, First 7 Days|Personal Reasons|1|||
161642903|NCT01340014|583742215|FG001|Period 1, First 7 Days|Personal Reasons|0|||
161642904|NCT01340014|583742214|FG000|Period 2, Second 7 Days|Adverse Event|0|||
161642905|NCT01340014|583742215|FG001|Period 2, Second 7 Days|Adverse Event|1|||
161642906|NCT05101993|583742220|FG000|Overall Study|Withdrawal by Subject|1|||
161642907|NCT04577573|583742221|FG000|Overall Study|Technical - invalid protocol|0|||
161642908|NCT04577573|583742222|FG001|Overall Study|Technical - invalid protocol|2|||
161642909|NCT04577573|583742223|FG002|Overall Study|Technical - invalid protocol|0|||
161642910|NCT02113124|583744058|FG000|Overall Study|Unable to retrieve blood sample|1|||
161642911|NCT02113124|583744059|FG001|Overall Study|Unable to retrieve blood sample|1|||
161642912|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161642913|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161642914|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161642915|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
161642916|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161642917|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
161642918|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
161642919|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
161642920|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
161642921|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
161642922|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
161642923|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
161642924|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
161642925|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
161642926|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161642927|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161642928|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161642929|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161642930|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161642931|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161642932|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
161642933|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161642934|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161642935|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
161642936|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161642937|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161642938|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161642939|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161642940|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161642941|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161642942|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161642943|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161642944|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
161642945|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161642946|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161642947|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161642948|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
161642949|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161642950|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161642951|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161642952|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161642953|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161642954|NCT01888874|583744060|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161642955|NCT01888874|583744061|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
161642956|NCT01888874|583744062|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161642957|NCT01888874|583744063|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161642958|NCT01888874|583744064|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161642959|NCT01888874|583744065|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
161642960|NCT01888874|583744066|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161642961|NCT01888874|583744060|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
161642962|NCT01888874|583744061|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
161642963|NCT01888874|583744062|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
161642964|NCT01888874|583744063|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161642965|NCT01888874|583744064|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
161642966|NCT01888874|583744065|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161642967|NCT01888874|583744066|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161642968|NCT01888874|583744060|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161642969|NCT01888874|583744061|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161642970|NCT01888874|583744062|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161642971|NCT01888874|583744063|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161642972|NCT01888874|583744064|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
161687777|NCT00446511|583908507|FG003|Overall Study|Protocol Violation|1|||
161687778|NCT00446511|583908504|FG000|Overall Study|Withdrawal by Subject|0|||
161835563|NCT00653991|584439014|FG001|6 Month Follow-up|Participant would not respond|141|||
161835564|NCT00518622|584439019|FG000|Overall Study|Lost to Follow-up|0|||
161835565|NCT00518622|584439020|FG001|Overall Study|Lost to Follow-up|0|||
161642973|NCT01888874|583744065|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161642974|NCT01888874|583744066|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161687779|NCT00446511|583908505|FG001|Overall Study|Withdrawal by Subject|0|||
161687780|NCT00446511|583908506|FG002|Overall Study|Withdrawal by Subject|0|||
161687781|NCT00446511|583908507|FG003|Overall Study|Withdrawal by Subject|3|||
161687782|NCT00446511|583908504|FG000|Overall Study|Administrative Problems|3|||
161687783|NCT00446511|583908505|FG001|Overall Study|Administrative Problems|0|||
161687784|NCT00446511|583908506|FG002|Overall Study|Administrative Problems|4|||
161687785|NCT00446511|583908507|FG003|Overall Study|Administrative Problems|1|||
161687786|NCT01136655|583908508|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
161687787|NCT01136655|583908508|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
161687788|NCT01136655|583908508|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
161687789|NCT01136655|583908508|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
161687790|NCT01265550|583908509|FG000|Pre Randomization|Withdrawal by Subject|0|||
161687791|NCT01265550|583908510|FG001|Pre Randomization|Withdrawal by Subject|0|||
161687792|NCT01265550|583908511|FG002|Pre Randomization|Withdrawal by Subject|0|||
161687793|NCT01265550|583908512|FG003|Pre Randomization|Withdrawal by Subject|70|||
161687794|NCT01265550|583908509|FG000|Pre Randomization|Technical Exclusions|0|||
161687795|NCT01265550|583908510|FG001|Pre Randomization|Technical Exclusions|0|||
161687796|NCT01265550|583908511|FG002|Pre Randomization|Technical Exclusions|0|||
161687797|NCT01265550|583908512|FG003|Pre Randomization|Technical Exclusions|54|||
161687798|NCT01265550|583908509|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
161687799|NCT01265550|583908510|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
161687800|NCT01265550|583908511|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
161687801|NCT01265550|583908512|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
161687802|NCT01265550|583908509|FG000|Pre Randomization|Non-GERD organic disorders|0|||
161687803|NCT01265550|583908510|FG001|Pre Randomization|Non-GERD organic disorders|0|||
161687804|NCT01265550|583908511|FG002|Pre Randomization|Non-GERD organic disorders|0|||
161687805|NCT01265550|583908512|FG003|Pre Randomization|Non-GERD organic disorders|23|||
161687806|NCT01265550|583908509|FG000|Pre Randomization|Functional heartburn|0|||
161687807|NCT01265550|583908510|FG001|Pre Randomization|Functional heartburn|0|||
161687808|NCT01265550|583908511|FG002|Pre Randomization|Functional heartburn|0|||
161687809|NCT01265550|583908512|FG003|Pre Randomization|Functional heartburn|99|||
161687810|NCT01073267|583908513|FG000|Overall Study|Disease Progression|3|||
161687811|NCT01970501|583908514|FG000|Overall Study|Discontinuation of study by sponsor|16|||
161687812|NCT01970501|583908515|FG001|Overall Study|Discontinuation of study by sponsor|14|||
161687813|NCT01970501|583908514|FG000|Overall Study|Withdrawal by Subject|6|||
161687814|NCT01970501|583908515|FG001|Overall Study|Withdrawal by Subject|7|||
161687815|NCT01970501|583908514|FG000|Overall Study|Adverse Event|2|||
161687816|NCT01970501|583908515|FG001|Overall Study|Adverse Event|4|||
161835566|NCT00518622|584439021|FG002|Overall Study|Lost to Follow-up|1|||
161835567|NCT00518622|584439022|FG003|Overall Study|Lost to Follow-up|0|||
161835568|NCT00518622|584439023|FG004|Overall Study|Lost to Follow-up|0|||
161835569|NCT00518622|584439024|FG005|Overall Study|Lost to Follow-up|0|||
161835570|NCT00518622|584439025|FG006|Overall Study|Lost to Follow-up|0|||
161835571|NCT00518622|584439026|FG007|Overall Study|Lost to Follow-up|0|||
161835572|NCT00518622|584439019|FG000|Overall Study|Study medication taken incorrectly|0|||
161835573|NCT00518622|584439020|FG001|Overall Study|Study medication taken incorrectly|1|||
161835574|NCT00518622|584439021|FG002|Overall Study|Study medication taken incorrectly|0|||
161835575|NCT00518622|584439022|FG003|Overall Study|Study medication taken incorrectly|0|||
161642975|NCT01888874|583744060|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161642976|NCT01888874|583744061|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161642977|NCT01888874|583744062|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
161642978|NCT01888874|583744063|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161642979|NCT01888874|583744064|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161642980|NCT01888874|583744065|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
161642981|NCT01888874|583744066|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161642982|NCT01888874|583744060|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161642983|NCT01888874|583744061|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161687817|NCT01970501|583908514|FG000|Overall Study|Death|1|||
161687818|NCT01970501|583908515|FG001|Overall Study|Death|3|||
161687819|NCT01970501|583908514|FG000|Overall Study|Physician Decision|2|||
161687820|NCT01970501|583908515|FG001|Overall Study|Physician Decision|0|||
161687821|NCT00708123|583908516|FG000|Period 1|Protocol Violation|0|||
161687822|NCT00708123|583908517|FG001|Period 1|Protocol Violation|1|||
161687823|NCT00708123|583908518|FG002|Period 1|Protocol Violation|0|||
161687824|NCT00708123|583908519|FG003|Period 1|Protocol Violation|1|||
161835576|NCT00518622|584439023|FG004|Overall Study|Study medication taken incorrectly|0|||
161835577|NCT00518622|584439024|FG005|Overall Study|Study medication taken incorrectly|0|||
161835578|NCT00518622|584439025|FG006|Overall Study|Study medication taken incorrectly|0|||
161835579|NCT00518622|584439026|FG007|Overall Study|Study medication taken incorrectly|0|||
161835580|NCT03499119|584439027|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
161835581|NCT03499119|584439028|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
161835582|NCT03499119|584439029|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
161835583|NCT03499119|584439030|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
161835584|NCT03499119|584439027|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
161642984|NCT01888874|583744062|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
161642985|NCT01888874|583744063|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161642986|NCT01888874|583744064|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161642987|NCT01888874|583744065|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161642988|NCT01888874|583744066|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161642989|NCT01888874|583744060|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161642990|NCT01888874|583744061|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
161642991|NCT01888874|583744062|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161642992|NCT01888874|583744063|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161642993|NCT01888874|583744064|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
161642994|NCT01888874|583744065|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
161642995|NCT01888874|583744066|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161642996|NCT01888874|583744060|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161642997|NCT01888874|583744061|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
161642998|NCT01888874|583744062|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161642999|NCT01888874|583744063|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161643000|NCT01888874|583744064|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161643001|NCT01888874|583744065|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
161643002|NCT01888874|583744066|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161643003|NCT02763215|583744067|FG000|Overall Study|Participants withdrew from study|3|||
161643004|NCT02763215|583744067|FG000|Overall Study|Missed visit|1|||
161643005|NCT02763215|583744067|FG000|Overall Study|Visit outside visit-window|1|||
161643006|NCT02763215|583744067|FG000|Overall Study|Death|1|||
161643007|NCT02763215|583744067|FG000|Overall Study|Lost to Follow-up|1|||
161643008|NCT02963090|583744069|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
161643009|NCT02963090|583744070|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
161643010|NCT00709228|583744071|FG000|Overall Study|Not treated|14|||
161643011|NCT00709228|583744071|FG000|Overall Study|Eligibility criteria not met|281|||
161643012|NCT00709228|583744071|FG000|Overall Study|Adverse events|2|||
161643013|NCT00709228|583744071|FG000|Overall Study|Discontinued treatment|14|||
161643014|NCT00709228|583744071|FG000|Overall Study|Did not enter follow-up|4|||
161643015|NCT00709228|583744071|FG000|Overall Study|Discontinued follow-up|5|||
161643016|NCT00709228|583744071|FG000|Overall Study|Disease progression|1|||
161643017|NCT00709228|583744071|FG000|Overall Study|Lost to Follow-up|6|||
161643018|NCT00709228|583744071|FG000|Overall Study|Non-compliance|5|||
161643019|NCT02179177|583744074|FG000|Overall Study|Lost to Follow-up|1|||
161643020|NCT02179177|583744075|FG001|Overall Study|Lost to Follow-up|1|||
161643021|NCT02179177|583744074|FG000|Overall Study|Withdrawal by Subject|1|||
161643022|NCT02179177|583744075|FG001|Overall Study|Withdrawal by Subject|1|||
161643023|NCT00022659|583744076|FG000|Overall Study|Ineligible: wrong primary|1|||
161643024|NCT00022659|583744076|FG000|Overall Study|Never treated|1|||
161643025|NCT00884650|583744077|FG000|Overall Study|Did not return complete pain diaries|7|||
161643026|NCT00884650|583744078|FG001|Overall Study|Did not return complete pain diaries|7|||
161643027|NCT00884650|583744077|FG000|Overall Study|Admitted Post-Op|1|||
161643028|NCT00884650|583744078|FG001|Overall Study|Admitted Post-Op|0|||
161643029|NCT00884650|583744077|FG000|Overall Study|Femoral Stress Fracture|1|||
161643030|NCT00884650|583744078|FG001|Overall Study|Femoral Stress Fracture|0|||
161643031|NCT00884650|583744077|FG000|Overall Study|Pain Pump Complication|0|||
161643032|NCT00884650|583744078|FG001|Overall Study|Pain Pump Complication|1|||
161643033|NCT04052425|583744079|FG000|24-Week Double-blind Period|Adverse Event|0|||
161643034|NCT04052425|583744080|FG001|24-Week Double-blind Period|Adverse Event|1|||
161643035|NCT04052425|583744081|FG002|24-Week Double-blind Period|Adverse Event|0|||
161643036|NCT04052425|583744082|FG003|24-Week Double-blind Period|Adverse Event|0|||
161643037|NCT04052425|583744079|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
161643038|NCT04052425|583744080|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
161643039|NCT04052425|583744081|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
161643040|NCT04052425|583744082|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
161643041|NCT04052425|583744079|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
161643042|NCT04052425|583744080|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
161643043|NCT04052425|583744081|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
161643044|NCT04052425|583744082|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
161643045|NCT04052425|583744079|FG000|24-Week Double-blind Period|Physician Decision|1|||
161643046|NCT04052425|583744080|FG001|24-Week Double-blind Period|Physician Decision|0|||
161643047|NCT04052425|583744081|FG002|24-Week Double-blind Period|Physician Decision|0|||
161643048|NCT04052425|583744082|FG003|24-Week Double-blind Period|Physician Decision|0|||
161643049|NCT04052425|583744079|FG000|24-Week Double-blind Period|Protocol Violation|1|||
161643050|NCT04052425|583744080|FG001|24-Week Double-blind Period|Protocol Violation|0|||
161643051|NCT04052425|583744081|FG002|24-Week Double-blind Period|Protocol Violation|0|||
161643052|NCT04052425|583744082|FG003|24-Week Double-blind Period|Protocol Violation|0|||
161835585|NCT03499119|584439028|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
161643053|NCT04052425|583744079|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
161643054|NCT04052425|583744080|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
161643055|NCT04052425|583744081|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
161643056|NCT04052425|583744082|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
161643057|NCT04052425|583744079|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
161643058|NCT04052425|583744080|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
161643059|NCT04052425|583744081|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
161643060|NCT04052425|583744082|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
161643061|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
161643062|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
161643063|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
161643064|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
161643065|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
161643066|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
161643067|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
161643068|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
161643069|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161643070|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161643071|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
161643072|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
161643073|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
161643074|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
161643075|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
161643076|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
161643077|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161643078|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161643079|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
161643080|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
161643081|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
161643082|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
161643083|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
161643084|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
161643085|NCT04052425|583744079|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
161643086|NCT04052425|583744080|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
161643087|NCT04052425|583744081|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
161643088|NCT04052425|583744082|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
161643089|NCT00945672|583744085|FG000|Overall Study|Withdrawal by Subject|0|||
161643090|NCT00945672|583744086|FG001|Overall Study|Withdrawal by Subject|0|||
161643091|NCT00945672|583744087|FG002|Overall Study|Withdrawal by Subject|0|||
161643092|NCT00945672|583744088|FG003|Overall Study|Withdrawal by Subject|1|||
161643093|NCT01681992|583744091|FG000|Overall Study|Adverse Event|3|||
161643094|NCT01681992|583744092|FG001|Overall Study|Adverse Event|2|||
161643095|NCT01681992|583744093|FG002|Overall Study|Adverse Event|3|||
161643096|NCT01681992|583744091|FG000|Overall Study|Lost to Follow-up|36|||
161643097|NCT01681992|583744092|FG001|Overall Study|Lost to Follow-up|38|||
161643098|NCT01681992|583744093|FG002|Overall Study|Lost to Follow-up|53|||
161643099|NCT01681992|583744091|FG000|Overall Study|As Per Sponsor Decision|0|||
161643100|NCT01681992|583744092|FG001|Overall Study|As Per Sponsor Decision|0|||
161643101|NCT01681992|583744093|FG002|Overall Study|As Per Sponsor Decision|1|||
161643102|NCT01681992|583744091|FG000|Overall Study|Protocol Violation|0|||
161643103|NCT01681992|583744092|FG001|Overall Study|Protocol Violation|0|||
161643104|NCT01681992|583744093|FG002|Overall Study|Protocol Violation|1|||
161643105|NCT01681992|583744091|FG000|Overall Study|Withdrawal by Subject|27|||
161643106|NCT01681992|583744092|FG001|Overall Study|Withdrawal by Subject|30|||
161643107|NCT01681992|583744093|FG002|Overall Study|Withdrawal by Subject|25|||
161643108|NCT00447590|583744096|FG000|Overall Study|Withdrawal by Subject|26|||
161643109|NCT00447590|583744096|FG000|Overall Study|Lost to Follow-up|24|||
161643110|NCT00447590|583744096|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
161643111|NCT03880019|583744097|FG000|Overall Study|Competing disease|1|||
161643112|NCT01163474|583744103|FG000|Overall Study|Withdrawal by Subject|1|||
161643113|NCT01163474|583744103|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
161643114|NCT01163474|583744103|FG000|Overall Study|Lost to Follow-up|3|||
161643115|NCT02878603|583744104|FG000|Overall Study|Lost to Follow-up|4|||
161643116|NCT02878603|583744105|FG001|Overall Study|Lost to Follow-up|1|||
161643117|NCT02878603|583744104|FG000|Overall Study|Withdrawal by Subject|1|||
161643118|NCT02878603|583744105|FG001|Overall Study|Withdrawal by Subject|1|||
161643119|NCT02878603|583744104|FG000|Overall Study|Death|1|||
161643120|NCT02878603|583744105|FG001|Overall Study|Death|0|||
161643121|NCT02878603|583744104|FG000|Overall Study|Physician Decision|0|||
161643122|NCT02878603|583744105|FG001|Overall Study|Physician Decision|3|||
161643123|NCT03274895|583744106|FG000|Overall Study|Lack of Efficacy|1|||
161643124|NCT03274895|583744107|FG001|Overall Study|Lack of Efficacy|0|||
161643125|NCT03274895|583744106|FG000|Overall Study|Adverse Event|8|||
161643126|NCT03274895|583744107|FG001|Overall Study|Adverse Event|7|||
161643127|NCT03274895|583744106|FG000|Overall Study|Lost to Follow-up|1|||
161643128|NCT03274895|583744107|FG001|Overall Study|Lost to Follow-up|0|||
161643129|NCT03274895|583744106|FG000|Overall Study|Diagnosis not confirmed|3|||
161643130|NCT03274895|583744107|FG001|Overall Study|Diagnosis not confirmed|4|||
161643131|NCT01969851|583744108|FG000|Overall Study|Adverse Event|0|||
161643132|NCT01969851|583744109|FG001|Overall Study|Adverse Event|0|||
161643133|NCT01969851|583744110|FG002|Overall Study|Adverse Event|3|||
161643134|NCT01969851|583744108|FG000|Overall Study|Lack of Efficacy|0|||
161643135|NCT01969851|583744109|FG001|Overall Study|Lack of Efficacy|3|||
161643136|NCT01969851|583744110|FG002|Overall Study|Lack of Efficacy|1|||
161643137|NCT01969851|583744108|FG000|Overall Study|Withdrawal by Subject|1|||
161643138|NCT01969851|583744109|FG001|Overall Study|Withdrawal by Subject|0|||
161643139|NCT01969851|583744110|FG002|Overall Study|Withdrawal by Subject|1|||
161643140|NCT01969851|583744108|FG000|Overall Study|No effective dose in Titration period|0|||
161643141|NCT01969851|583744109|FG001|Overall Study|No effective dose in Titration period|0|||
161643142|NCT01969851|583744110|FG002|Overall Study|No effective dose in Titration period|1|||
161643143|NCT01969851|583744108|FG000|Overall Study|Sponsor decision|0|||
161643144|NCT01969851|583744109|FG001|Overall Study|Sponsor decision|0|||
161643145|NCT01969851|583744110|FG002|Overall Study|Sponsor decision|1|||
161643146|NCT01294436|583744111|FG000|Overall Study|Adverse Event|10|||
161643147|NCT01294436|583744112|FG001|Overall Study|Adverse Event|17|||
161643148|NCT01294436|583744111|FG000|Overall Study|Withdrawal by Subject|11|||
161643149|NCT01294436|583744112|FG001|Overall Study|Withdrawal by Subject|28|||
161643150|NCT01294436|583744111|FG000|Overall Study|subject no longer meets study criteria|5|||
161643151|NCT01294436|583744112|FG001|Overall Study|subject no longer meets study criteria|20|||
161643152|NCT01294436|583744111|FG000|Overall Study|poor/non-compliance|2|||
161643153|NCT01294436|583744112|FG001|Overall Study|poor/non-compliance|5|||
161643154|NCT02389764|583744113|FG000|Overall Study|Lack of Efficacy|9|||
161643155|NCT00585078|583744116|FG000|Overall Study|Withdrawal by Subject|4|||
161643156|NCT00585078|583744116|FG000|Overall Study|Poor performance status|1|||
161643157|NCT00585078|583744116|FG000|Overall Study|Disease Progression|24|||
161643158|NCT00585078|583744116|FG000|Overall Study|Adverse Event|10|||
161643159|NCT00585078|583744116|FG000|Overall Study|Death|1|||
161643160|NCT01814072|583744117|FG000|Overall Study|Lost to Follow-up|2|||
161643161|NCT01814072|583744118|FG001|Overall Study|Lost to Follow-up|2|||
161643162|NCT01814072|583744119|FG002|Overall Study|Lost to Follow-up|2|||
161643163|NCT01814072|583744120|FG003|Overall Study|Lost to Follow-up|0|||
161643164|NCT01814072|583744121|FG004|Overall Study|Lost to Follow-up|2|||
161643165|NCT01814072|583744122|FG005|Overall Study|Lost to Follow-up|3|||
161643166|NCT01814072|583744123|FG006|Overall Study|Lost to Follow-up|3|||
161643167|NCT01814072|583744124|FG007|Overall Study|Lost to Follow-up|1|||
161643168|NCT01814072|583744125|FG008|Overall Study|Lost to Follow-up|2|||
161643169|NCT01814072|583744126|FG009|Overall Study|Lost to Follow-up|3|||
161643170|NCT01814072|583744127|FG010|Overall Study|Lost to Follow-up|1|||
161643171|NCT01814072|583744128|FG011|Overall Study|Lost to Follow-up|2|||
161643172|NCT01814072|583744129|FG012|Overall Study|Lost to Follow-up|2|||
161643173|NCT01814072|583744130|FG013|Overall Study|Lost to Follow-up|1|||
161643174|NCT01814072|583744131|FG014|Overall Study|Lost to Follow-up|2|||
161643175|NCT01814072|583744132|FG015|Overall Study|Lost to Follow-up|1|||
161643176|NCT01814072|583744133|FG016|Overall Study|Lost to Follow-up|3|||
161643177|NCT01814072|583744134|FG017|Overall Study|Lost to Follow-up|1|||
161643178|NCT01814072|583744135|FG018|Overall Study|Lost to Follow-up|3|||
161643179|NCT01814072|583744136|FG019|Overall Study|Lost to Follow-up|3|||
161643180|NCT01814072|583744137|FG020|Overall Study|Lost to Follow-up|2|||
161643181|NCT01814072|583744138|FG021|Overall Study|Lost to Follow-up|1|||
161643182|NCT01814072|583744139|FG022|Overall Study|Lost to Follow-up|3|||
161643183|NCT01814072|583744140|FG023|Overall Study|Lost to Follow-up|1|||
161643184|NCT01814072|583744141|FG024|Overall Study|Lost to Follow-up|4|||
161643185|NCT01814072|583744142|FG025|Overall Study|Lost to Follow-up|1|||
161835586|NCT03499119|584439029|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
161643186|NCT01814072|583744143|FG026|Overall Study|Lost to Follow-up|1|||
161643187|NCT01814072|583744144|FG027|Overall Study|Lost to Follow-up|2|||
161643188|NCT01814072|583744145|FG028|Overall Study|Lost to Follow-up|3|||
161643189|NCT01814072|583744146|FG029|Overall Study|Lost to Follow-up|3|||
161643190|NCT01814072|583744147|FG030|Overall Study|Lost to Follow-up|2|||
161643191|NCT01814072|583744148|FG031|Overall Study|Lost to Follow-up|0|||
161643192|NCT01814072|583744117|FG000|Overall Study|Withdrawal by Subject|2|||
161643193|NCT01814072|583744118|FG001|Overall Study|Withdrawal by Subject|0|||
161643194|NCT01814072|583744119|FG002|Overall Study|Withdrawal by Subject|1|||
161643195|NCT01814072|583744120|FG003|Overall Study|Withdrawal by Subject|0|||
161643196|NCT01814072|583744121|FG004|Overall Study|Withdrawal by Subject|2|||
161643197|NCT01814072|583744122|FG005|Overall Study|Withdrawal by Subject|3|||
161643198|NCT01814072|583744123|FG006|Overall Study|Withdrawal by Subject|1|||
161643199|NCT01814072|583744124|FG007|Overall Study|Withdrawal by Subject|0|||
161643200|NCT01814072|583744125|FG008|Overall Study|Withdrawal by Subject|1|||
161643201|NCT01814072|583744126|FG009|Overall Study|Withdrawal by Subject|2|||
161643202|NCT01814072|583744127|FG010|Overall Study|Withdrawal by Subject|0|||
161643203|NCT01814072|583744128|FG011|Overall Study|Withdrawal by Subject|0|||
161643204|NCT01814072|583744129|FG012|Overall Study|Withdrawal by Subject|1|||
161643205|NCT01814072|583744130|FG013|Overall Study|Withdrawal by Subject|1|||
161643206|NCT01814072|583744131|FG014|Overall Study|Withdrawal by Subject|1|||
161643207|NCT01814072|583744132|FG015|Overall Study|Withdrawal by Subject|1|||
161643208|NCT01814072|583744133|FG016|Overall Study|Withdrawal by Subject|0|||
161643209|NCT01814072|583744134|FG017|Overall Study|Withdrawal by Subject|0|||
161643210|NCT01814072|583744135|FG018|Overall Study|Withdrawal by Subject|0|||
161643211|NCT01814072|583744136|FG019|Overall Study|Withdrawal by Subject|2|||
161643212|NCT01814072|583744137|FG020|Overall Study|Withdrawal by Subject|0|||
161643213|NCT01814072|583744138|FG021|Overall Study|Withdrawal by Subject|0|||
161643214|NCT01814072|583744139|FG022|Overall Study|Withdrawal by Subject|1|||
161643215|NCT01814072|583744140|FG023|Overall Study|Withdrawal by Subject|0|||
161643216|NCT01814072|583744141|FG024|Overall Study|Withdrawal by Subject|2|||
161643217|NCT01814072|583744142|FG025|Overall Study|Withdrawal by Subject|1|||
161643218|NCT01814072|583744143|FG026|Overall Study|Withdrawal by Subject|1|||
161643219|NCT01814072|583744144|FG027|Overall Study|Withdrawal by Subject|2|||
161643220|NCT01814072|583744145|FG028|Overall Study|Withdrawal by Subject|1|||
161643221|NCT01814072|583744146|FG029|Overall Study|Withdrawal by Subject|0|||
161643222|NCT01814072|583744147|FG030|Overall Study|Withdrawal by Subject|0|||
161643223|NCT01814072|583744148|FG031|Overall Study|Withdrawal by Subject|0|||
161643224|NCT02781311|583744149|FG000|Overall Study|Adverse Event|2|||
161643225|NCT02781311|583744150|FG001|Overall Study|Adverse Event|6|||
161643226|NCT02781311|583744151|FG002|Overall Study|Adverse Event|1|||
161643227|NCT02781311|583744149|FG000|Overall Study|Withdrawal of Consent|11|||
161643228|NCT02781311|583744150|FG001|Overall Study|Withdrawal of Consent|12|||
161643229|NCT02781311|583744151|FG002|Overall Study|Withdrawal of Consent|2|||
161643230|NCT02781311|583744149|FG000|Overall Study|Lost to Follow-up|11|||
161643231|NCT02781311|583744150|FG001|Overall Study|Lost to Follow-up|8|||
161643232|NCT02781311|583744151|FG002|Overall Study|Lost to Follow-up|1|||
161643233|NCT02781311|583744149|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161643234|NCT02781311|583744150|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161643235|NCT02781311|583744151|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161643236|NCT01011868|583744156|FG000|After Week 18 Follow-up|Adverse Event|8|||
161643237|NCT01011868|583744157|FG001|After Week 18 Follow-up|Adverse Event|6|||
161643238|NCT01011868|583744158|FG002|After Week 18 Follow-up|Adverse Event|13|||
161643239|NCT01011868|583744156|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
161643240|NCT01011868|583744157|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
161643241|NCT01011868|583744158|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
161643242|NCT01011868|583744156|FG000|After Week 18 Follow-up|Protocol Violation|1|||
161643243|NCT01011868|583744157|FG001|After Week 18 Follow-up|Protocol Violation|1|||
161643244|NCT01011868|583744158|FG002|After Week 18 Follow-up|Protocol Violation|1|||
161643245|NCT01011868|583744156|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
161643246|NCT01011868|583744157|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
161643247|NCT01011868|583744158|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
161643248|NCT01011868|583744156|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
161643249|NCT01011868|583744157|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
161643250|NCT01011868|583744158|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
161643251|NCT01011868|583744156|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
161643252|NCT01011868|583744157|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
161643253|NCT01011868|583744158|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
161643254|NCT01011868|583744156|FG000|After Week 78 Follow-up|Adverse Event|14|||
161643255|NCT01011868|583744157|FG001|After Week 78 Follow-up|Adverse Event|18|||
161643256|NCT01011868|583744158|FG002|After Week 78 Follow-up|Adverse Event|21|||
161643257|NCT01011868|583744156|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
161687825|NCT00708123|583908520|FG004|Period 1|Protocol Violation|0|||
161687826|NCT00708123|583908516|FG000|Period 1|Adverse Event|0|||
161687827|NCT00708123|583908517|FG001|Period 1|Adverse Event|0|||
161687828|NCT00708123|583908518|FG002|Period 1|Adverse Event|1|||
161687829|NCT00708123|583908519|FG003|Period 1|Adverse Event|0|||
161643258|NCT01011868|583744157|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
161643259|NCT01011868|583744158|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
161643260|NCT01011868|583744156|FG000|After Week 78 Follow-up|Protocol Violation|9|||
161643261|NCT01011868|583744157|FG001|After Week 78 Follow-up|Protocol Violation|1|||
161643262|NCT01011868|583744158|FG002|After Week 78 Follow-up|Protocol Violation|2|||
161643263|NCT01011868|583744156|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
161643264|NCT01011868|583744157|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
161643265|NCT01011868|583744158|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
161687830|NCT00708123|583908520|FG004|Period 1|Adverse Event|0|||
161687831|NCT00708123|583908516|FG000|Period 2|Protocol Violation|0|||
161643266|NCT01011868|583744156|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
161643267|NCT01011868|583744157|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
161643268|NCT01011868|583744158|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
161643269|NCT01011868|583744156|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
161643270|NCT01011868|583744157|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
161643271|NCT01011868|583744158|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
161643272|NCT02615938|583744159|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
161643273|NCT02615938|583744160|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
161643274|NCT02615938|583744161|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161643275|NCT02615938|583744162|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161643276|NCT02615938|583744159|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
161643277|NCT02615938|583744160|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
161643278|NCT02615938|583744161|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
161643279|NCT02615938|583744162|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
161643280|NCT02615938|583744159|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161643281|NCT02615938|583744160|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161643282|NCT02615938|583744161|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
161643283|NCT02615938|583744162|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161643284|NCT04905849|583744164|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
161643285|NCT04905849|583744165|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
161643286|NCT00838929|583744170|FG000|Overall Study|Protocol Violation|0|||
161643287|NCT00838929|583744171|FG001|Overall Study|Protocol Violation|1|||
161643288|NCT00838929|583744172|FG002|Overall Study|Protocol Violation|0|||
161643289|NCT00838929|583744170|FG000|Overall Study|Disease progression|0|||
161643290|NCT00838929|583744171|FG001|Overall Study|Disease progression|2|||
161643291|NCT00838929|583744172|FG002|Overall Study|Disease progression|1|||
161643292|NCT04199052|583744180|FG000|Overall Study|Lost to Follow-up|11|||
161643293|NCT04199052|583744181|FG001|Overall Study|Lost to Follow-up|18|||
161643294|NCT00699842|583744182|FG000|Overall Study|Death|0|||
161643295|NCT00699842|583744183|FG001|Overall Study|Death|1|||
161643296|NCT00699842|583744184|FG002|Overall Study|Death|0|||
161643297|NCT01358331|583744185|FG000|Overall Study|Lost to Follow-up|0|||
161643298|NCT01358331|583744186|FG001|Overall Study|Lost to Follow-up|0|||
161643299|NCT01358331|583744187|FG002|Overall Study|Lost to Follow-up|0|||
161643300|NCT01358331|583744188|FG003|Overall Study|Lost to Follow-up|1|||
161643301|NCT01358331|583744189|FG004|Overall Study|Lost to Follow-up|0|||
161643302|NCT01358331|583744190|FG005|Overall Study|Lost to Follow-up|0|||
161643303|NCT01358331|583744185|FG000|Overall Study|Withdrawal by Subject|0|||
161643304|NCT01358331|583744186|FG001|Overall Study|Withdrawal by Subject|0|||
161643305|NCT01358331|583744187|FG002|Overall Study|Withdrawal by Subject|0|||
161643306|NCT01358331|583744188|FG003|Overall Study|Withdrawal by Subject|1|||
161643307|NCT01358331|583744189|FG004|Overall Study|Withdrawal by Subject|1|||
161643308|NCT01358331|583744190|FG005|Overall Study|Withdrawal by Subject|1|||
161643309|NCT01358331|583744185|FG000|Overall Study|Adverse Events|1|||
161643310|NCT01358331|583744186|FG001|Overall Study|Adverse Events|1|||
161643311|NCT01358331|583744187|FG002|Overall Study|Adverse Events|1|||
161643312|NCT01358331|583744188|FG003|Overall Study|Adverse Events|0|||
161643313|NCT01358331|583744189|FG004|Overall Study|Adverse Events|1|||
161643314|NCT01358331|583744190|FG005|Overall Study|Adverse Events|5|||
161643315|NCT01358331|583744185|FG000|Overall Study|Symptomatic Deterioration|0|||
161643316|NCT01358331|583744186|FG001|Overall Study|Symptomatic Deterioration|0|||
161643317|NCT01358331|583744187|FG002|Overall Study|Symptomatic Deterioration|0|||
161643318|NCT01358331|583744188|FG003|Overall Study|Symptomatic Deterioration|0|||
161643319|NCT01358331|583744189|FG004|Overall Study|Symptomatic Deterioration|1|||
161643320|NCT01358331|583744190|FG005|Overall Study|Symptomatic Deterioration|0|||
161643321|NCT01358331|583744185|FG000|Overall Study|Participants did not wish to continue|0|||
161643322|NCT01358331|583744186|FG001|Overall Study|Participants did not wish to continue|0|||
161643323|NCT01358331|583744187|FG002|Overall Study|Participants did not wish to continue|0|||
161643324|NCT01358331|583744188|FG003|Overall Study|Participants did not wish to continue|0|||
161643325|NCT01358331|583744189|FG004|Overall Study|Participants did not wish to continue|1|||
161643326|NCT01358331|583744190|FG005|Overall Study|Participants did not wish to continue|0|||
161643327|NCT01358331|583744185|FG000|Overall Study|Progress of disease under investigation|1|||
161643328|NCT01358331|583744186|FG001|Overall Study|Progress of disease under investigation|2|||
161643329|NCT01358331|583744187|FG002|Overall Study|Progress of disease under investigation|3|||
161643330|NCT01358331|583744188|FG003|Overall Study|Progress of disease under investigation|1|||
161643331|NCT01358331|583744189|FG004|Overall Study|Progress of disease under investigation|3|||
161687832|NCT00708123|583908517|FG001|Period 2|Protocol Violation|0|||
161687833|NCT00708123|583908518|FG002|Period 2|Protocol Violation|0|||
161643332|NCT01358331|583744190|FG005|Overall Study|Progress of disease under investigation|0|||
161643333|NCT04946942|583744191|FG000|Overall Study|Lost to Follow-up|6|||
161643334|NCT04946942|583744192|FG001|Overall Study|Lost to Follow-up|2|||
161687834|NCT00708123|583908519|FG003|Period 2|Protocol Violation|1|||
161643335|NCT04946942|583744193|FG002|Overall Study|Lost to Follow-up|0|||
161643336|NCT03342196|583744194|FG000|Overall Study|Physician Decision|1|||
161643337|NCT02257918|583744195|FG000|Overall Study|Lost to Follow-up|4|||
161643338|NCT02257918|583744196|FG001|Overall Study|Lost to Follow-up|1|||
161643339|NCT02257918|583744197|FG002|Overall Study|Lost to Follow-up|0|||
161643340|NCT02257918|583744195|FG000|Overall Study|Withdrawal by Subject|0|||
161643341|NCT02257918|583744196|FG001|Overall Study|Withdrawal by Subject|0|||
161643342|NCT02257918|583744197|FG002|Overall Study|Withdrawal by Subject|1|||
161643343|NCT02257918|583744195|FG000|Overall Study|Pregnancy|0|||
161643344|NCT02257918|583744196|FG001|Overall Study|Pregnancy|0|||
161643345|NCT02257918|583744197|FG002|Overall Study|Pregnancy|1|||
161643346|NCT03023423|583744200|FG000|Overall Study|Death|5|||
161643347|NCT03023423|583744201|FG001|Overall Study|Death|12|||
161643348|NCT03023423|583744202|FG002|Overall Study|Death|20|||
161643349|NCT03023423|583744200|FG000|Overall Study|Other|0|||
161643350|NCT03023423|583744201|FG001|Overall Study|Other|2|||
161643351|NCT03023423|583744202|FG002|Overall Study|Other|2|||
161643352|NCT03023423|583744200|FG000|Overall Study|Ongoing|2|||
161643353|NCT03023423|583744201|FG001|Overall Study|Ongoing|32|||
161643354|NCT03023423|583744202|FG002|Overall Study|Ongoing|24|||
161643355|NCT01151423|583744203|FG000|Overall Study|Study terminated by Sponsor|9|||
161643356|NCT01151423|583744204|FG001|Overall Study|Study terminated by Sponsor|10|||
161643357|NCT01151423|583744203|FG000|Overall Study|Protocol Violation|0|||
161643358|NCT01151423|583744204|FG001|Overall Study|Protocol Violation|1|||
161643359|NCT01151423|583744203|FG000|Overall Study|Physician Decision|1|||
161643360|NCT01151423|583744204|FG001|Overall Study|Physician Decision|1|||
161643361|NCT01151423|583744203|FG000|Overall Study|Pregnancy|0|||
161643362|NCT01151423|583744204|FG001|Overall Study|Pregnancy|1|||
161643363|NCT01151423|583744203|FG000|Overall Study|Death|0|||
161643364|NCT01151423|583744204|FG001|Overall Study|Death|1|||
161643365|NCT01151423|583744203|FG000|Overall Study|Adverse Event|3|||
161643366|NCT01151423|583744204|FG001|Overall Study|Adverse Event|0|||
161643367|NCT01151423|583744203|FG000|Overall Study|Withdrawal by Subject|1|||
161643368|NCT01151423|583744204|FG001|Overall Study|Withdrawal by Subject|3|||
161643369|NCT01151423|583744203|FG000|Overall Study|Lost to Follow-up|1|||
161643370|NCT01151423|583744204|FG001|Overall Study|Lost to Follow-up|0|||
161643371|NCT01151423|583744203|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
161643372|NCT01151423|583744204|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
161643373|NCT01151423|583744203|FG000|Overall Study|Participated in other clinical trial|1|||
161643374|NCT01151423|583744204|FG001|Overall Study|Participated in other clinical trial|0|||
161643375|NCT01263054|583744205|FG000|Overall Study|Death|1|||
161643376|NCT01263054|583744206|FG001|Overall Study|Death|0|||
161643377|NCT01263054|583744205|FG000|Overall Study|Lost to Follow-up|2|||
161643378|NCT01263054|583744206|FG001|Overall Study|Lost to Follow-up|2|||
161643379|NCT01263054|583744205|FG000|Overall Study|Withdrawal by Subject|1|||
161643380|NCT01263054|583744206|FG001|Overall Study|Withdrawal by Subject|3|||
161643381|NCT01263054|583744205|FG000|Overall Study|Qualification Violation|1|||
161643382|NCT01263054|583744206|FG001|Overall Study|Qualification Violation|0|||
161643383|NCT01263054|583744205|FG000|Overall Study|Other|0|||
161643384|NCT01263054|583744206|FG001|Overall Study|Other|1|||
161643385|NCT00681668|583744207|FG000|Overall Study|Protocol Violation|1|||
161643386|NCT00681668|583744207|FG000|Overall Study|Withdrawal by Subject|1|||
161643387|NCT04277507|583744209|FG000|Overall Study|Lost to Follow-up|17|||
161643388|NCT04277507|583744209|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
161643389|NCT04277507|583744209|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
161643390|NCT04277507|583744209|FG000|Overall Study|Withdrawal by Subject|3|||
161643391|NCT04277507|583744209|FG000|Overall Study|Death due to COVID-19|1|||
161643392|NCT04277507|583744209|FG000|Overall Study|Data missing for full evaluation|5|||
161643393|NCT05226130|583744217|FG000|Overall Study|Lost to Follow-up|0|||
161643394|NCT05226130|583744218|FG001|Overall Study|Lost to Follow-up|1|||
161687835|NCT00708123|583908520|FG004|Period 2|Protocol Violation|0|||
161687836|NCT00708123|583908516|FG000|Period 2|Other Reason|1|||
161643395|NCT05226130|583744217|FG000|Overall Study|Not treatment adherent|0|||
161643396|NCT05226130|583744218|FG001|Overall Study|Not treatment adherent|2|||
161643397|NCT03358472|583744219|FG000|Overall Study|Death|6|||
161643398|NCT03358472|583744220|FG001|Overall Study|Death|3|||
161643399|NCT03358472|583744221|FG002|Overall Study|Death|10|||
161643400|NCT03358472|583744219|FG000|Overall Study|Physician Decision|0|||
161643401|NCT03358472|583744220|FG001|Overall Study|Physician Decision|1|||
161643402|NCT03358472|583744221|FG002|Overall Study|Physician Decision|0|||
161835587|NCT03499119|584439030|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
161643403|NCT03358472|583744219|FG000|Overall Study|Withdrawal by Subject|0|||
161643404|NCT03358472|583744220|FG001|Overall Study|Withdrawal by Subject|0|||
161643405|NCT03358472|583744221|FG002|Overall Study|Withdrawal by Subject|1|||
161643406|NCT03358472|583744219|FG000|Overall Study|On-going at clinical cut off date|9|||
161643407|NCT03358472|583744220|FG001|Overall Study|On-going at clinical cut off date|6|||
161643408|NCT03358472|583744221|FG002|Overall Study|On-going at clinical cut off date|5|||
161687837|NCT00708123|583908517|FG001|Period 2|Other Reason|0|||
161687838|NCT00708123|583908518|FG002|Period 2|Other Reason|0|||
161643409|NCT03974022|583744222|FG000|Overall Study|Death|0|||
161643410|NCT03974022|583744223|FG001|Overall Study|Death|1|||
161643411|NCT03974022|583744224|FG002|Overall Study|Death|0|||
161643412|NCT03974022|583744225|FG003|Overall Study|Death|2|||
161643413|NCT03974022|583744226|FG004|Overall Study|Death|0|||
161643414|NCT03974022|583744227|FG005|Overall Study|Death|1|||
161643415|NCT03974022|583744228|FG006|Overall Study|Death|0|||
161643416|NCT03974022|583744229|FG007|Overall Study|Death|2|||
161643417|NCT03974022|583744230|FG008|Overall Study|Death|1|||
161643418|NCT03974022|583744231|FG009|Overall Study|Death|4|||
161643419|NCT03974022|583744232|FG010|Overall Study|Death|0|||
161643420|NCT03974022|583744233|FG011|Overall Study|Death|0|||
161643421|NCT03974022|583744234|FG012|Overall Study|Death|0|||
161643422|NCT03974022|583744235|FG013|Overall Study|Death|33|||
161643423|NCT03974022|583744236|FG014|Overall Study|Death|40|||
161643424|NCT03974022|583744222|FG000|Overall Study|Withdrawal by Subject|0|||
161643425|NCT03974022|583744223|FG001|Overall Study|Withdrawal by Subject|0|||
161643426|NCT03974022|583744224|FG002|Overall Study|Withdrawal by Subject|0|||
161643427|NCT03974022|583744225|FG003|Overall Study|Withdrawal by Subject|0|||
161643428|NCT03974022|583744226|FG004|Overall Study|Withdrawal by Subject|0|||
161643429|NCT03974022|583744227|FG005|Overall Study|Withdrawal by Subject|4|||
161643430|NCT03974022|583744228|FG006|Overall Study|Withdrawal by Subject|4|||
161643431|NCT03974022|583744229|FG007|Overall Study|Withdrawal by Subject|2|||
161643432|NCT03974022|583744230|FG008|Overall Study|Withdrawal by Subject|2|||
161643433|NCT03974022|583744231|FG009|Overall Study|Withdrawal by Subject|3|||
161643434|NCT03974022|583744232|FG010|Overall Study|Withdrawal by Subject|0|||
161643435|NCT03974022|583744233|FG011|Overall Study|Withdrawal by Subject|1|||
161643436|NCT03974022|583744234|FG012|Overall Study|Withdrawal by Subject|0|||
161643437|NCT03974022|583744235|FG013|Overall Study|Withdrawal by Subject|3|||
161643438|NCT03974022|583744236|FG014|Overall Study|Withdrawal by Subject|9|||
161643439|NCT03974022|583744222|FG000|Overall Study|Lost to Follow-up|0|||
161643440|NCT03974022|583744223|FG001|Overall Study|Lost to Follow-up|0|||
161643441|NCT03974022|583744224|FG002|Overall Study|Lost to Follow-up|0|||
161643442|NCT03974022|583744225|FG003|Overall Study|Lost to Follow-up|0|||
161643443|NCT03974022|583744226|FG004|Overall Study|Lost to Follow-up|0|||
161643444|NCT03974022|583744227|FG005|Overall Study|Lost to Follow-up|0|||
161643445|NCT03974022|583744228|FG006|Overall Study|Lost to Follow-up|1|||
161643446|NCT03974022|583744229|FG007|Overall Study|Lost to Follow-up|0|||
161643447|NCT03974022|583744230|FG008|Overall Study|Lost to Follow-up|0|||
161643448|NCT03974022|583744231|FG009|Overall Study|Lost to Follow-up|0|||
161643449|NCT03974022|583744232|FG010|Overall Study|Lost to Follow-up|0|||
161643450|NCT03974022|583744233|FG011|Overall Study|Lost to Follow-up|0|||
161643451|NCT03974022|583744234|FG012|Overall Study|Lost to Follow-up|0|||
161687839|NCT00708123|583908519|FG003|Period 2|Other Reason|0|||
161687840|NCT00708123|583908520|FG004|Period 2|Other Reason|0|||
161687841|NCT00708123|583908516|FG000|Period 3|Lost to Follow-up|0|||
161687842|NCT00708123|583908517|FG001|Period 3|Lost to Follow-up|0|||
161687843|NCT00708123|583908518|FG002|Period 3|Lost to Follow-up|1|||
161687844|NCT00708123|583908519|FG003|Period 3|Lost to Follow-up|1|||
161687845|NCT00708123|583908520|FG004|Period 3|Lost to Follow-up|0|||
161687846|NCT00708123|583908516|FG000|Period 4|Protocol Violation|0|||
161687847|NCT00708123|583908517|FG001|Period 4|Protocol Violation|1|||
161643452|NCT03974022|583744235|FG013|Overall Study|Lost to Follow-up|1|||
161643453|NCT03974022|583744236|FG014|Overall Study|Lost to Follow-up|1|||
161643454|NCT03974022|583744222|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
161643455|NCT03974022|583744223|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
161643456|NCT03974022|583744224|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
161643457|NCT03974022|583744225|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
161643458|NCT03974022|583744226|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
161643459|NCT03974022|583744227|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
161643460|NCT03974022|583744228|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
161643461|NCT03974022|583744229|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
161643462|NCT03974022|583744230|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
161643463|NCT03974022|583744231|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
161643464|NCT03974022|583744232|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
161643465|NCT03974022|583744233|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
161643466|NCT03974022|583744234|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
161643467|NCT03974022|583744235|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
161643468|NCT03974022|583744236|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
161687848|NCT00708123|583908518|FG002|Period 4|Protocol Violation|0|||
161687849|NCT00708123|583908519|FG003|Period 4|Protocol Violation|0|||
161687850|NCT00708123|583908520|FG004|Period 4|Protocol Violation|0|||
161643469|NCT02520310|583744237|FG000|At 6 Months Clinical Follow-up|Death|1|||
161643470|NCT02520310|583744237|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
161643471|NCT02520310|583744237|FG000|AT 3 Year Clinical Follow-up|Death|2|||
161643472|NCT02520310|583744237|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
161643473|NCT02520310|583744237|FG000|AT 4 Year Clinical Follow-up|Death|1|||
161643474|NCT02520310|583744237|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
161643475|NCT02065882|583744240|FG000|Part I: PK/PD|Screening failure|5|||
161643476|NCT02065882|583744240|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
161643477|NCT02065882|583744240|FG000|Part I: PK/PD|Adverse Event|1|||
161643478|NCT02065882|583744240|FG000|Part II: Clinical Efficacy|Screening failure|7|||
161643479|NCT02065882|583744240|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
161643480|NCT02065882|583744240|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
161643481|NCT02065882|583744240|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
161643482|NCT02065882|583744240|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
161643483|NCT02065882|583744240|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
161643484|NCT01667926|583745534|FG000|Overall Study|Withdrawal by Subject|1|||
161643485|NCT01667926|583745535|FG001|Overall Study|Withdrawal by Subject|2|||
161643486|NCT01667926|583745536|FG002|Overall Study|Withdrawal by Subject|2|||
161643487|NCT01667926|583745534|FG000|Overall Study|Physician Decision|0|||
161643488|NCT01667926|583745535|FG001|Overall Study|Physician Decision|0|||
161643489|NCT01667926|583745536|FG002|Overall Study|Physician Decision|1|||
161643490|NCT01667926|583745534|FG000|Overall Study|Time committment|0|||
161643491|NCT01667926|583745535|FG001|Overall Study|Time committment|0|||
161643492|NCT01667926|583745536|FG002|Overall Study|Time committment|2|||
161643493|NCT01667926|583745534|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
161643494|NCT01667926|583745535|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161643495|NCT01667926|583745536|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
161643496|NCT01667926|583745534|FG000|Overall Study|Lost to Follow-up|1|||
161643497|NCT01667926|583745535|FG001|Overall Study|Lost to Follow-up|2|||
161643498|NCT01667926|583745536|FG002|Overall Study|Lost to Follow-up|1|||
161643499|NCT01667926|583745534|FG000|Overall Study|Side effects|3|||
161643500|NCT01667926|583745535|FG001|Overall Study|Side effects|0|||
161643501|NCT01667926|583745536|FG002|Overall Study|Side effects|0|||
161643502|NCT01411241|583745540|FG000|Overall Study|Protocol Violation|0|||
161643503|NCT01411241|583745541|FG001|Overall Study|Protocol Violation|5|||
161643504|NCT01411241|583745540|FG000|Overall Study|Withdrawal by Subject|9|||
161643505|NCT01411241|583745541|FG001|Overall Study|Withdrawal by Subject|10|||
161643506|NCT01411241|583745540|FG000|Overall Study|Serious Adverse Event|0|||
161643507|NCT01411241|583745541|FG001|Overall Study|Serious Adverse Event|3|||
161643508|NCT01411241|583745540|FG000|Overall Study|Lost to Follow-up|2|||
161643509|NCT01411241|583745541|FG001|Overall Study|Lost to Follow-up|4|||
161643510|NCT02980042|583745544|FG000|Overall Study|Lost to Follow-up|5|||
161643511|NCT02980042|583745545|FG001|Overall Study|Lost to Follow-up|0|||
161643512|NCT02980042|583745544|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
161643513|NCT02980042|583745545|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
161643514|NCT03812029|583745550|FG000|Overall Study|Protocol Violation|1|||
161643515|NCT03812029|583745551|FG001|Overall Study|Protocol Violation|0|||
161643516|NCT03812029|583745552|FG002|Overall Study|Protocol Violation|0|||
161643517|NCT03812029|583745553|FG003|Overall Study|Protocol Violation|1|||
161643518|NCT03812029|583745554|FG004|Overall Study|Protocol Violation|0|||
161643519|NCT03812029|583745550|FG000|Overall Study|Withdrawal by Subject|1|||
161643520|NCT03812029|583745551|FG001|Overall Study|Withdrawal by Subject|0|||
161643521|NCT03812029|583745552|FG002|Overall Study|Withdrawal by Subject|0|||
161643522|NCT03812029|583745553|FG003|Overall Study|Withdrawal by Subject|2|||
161643523|NCT03812029|583745554|FG004|Overall Study|Withdrawal by Subject|2|||
161643524|NCT03812029|583745550|FG000|Overall Study|Stopping rules|0|||
161687851|NCT02970292|583908521|FG000|Overall Study|Physician Decision|1|||
161687852|NCT02970292|583908522|FG001|Overall Study|Physician Decision|1|||
161687853|NCT02970292|583908521|FG000|Overall Study|Withdrawal by Subject|11|||
161687854|NCT02970292|583908522|FG001|Overall Study|Withdrawal by Subject|5|||
161687855|NCT02970292|583908521|FG000|Overall Study|Noncompliance with study drug|2|||
161687856|NCT02970292|583908522|FG001|Overall Study|Noncompliance with study drug|2|||
161687857|NCT02970292|583908521|FG000|Overall Study|Adverse Event|5|||
161687858|NCT02970292|583908522|FG001|Overall Study|Adverse Event|0|||
161643525|NCT03812029|583745551|FG001|Overall Study|Stopping rules|1|||
161643526|NCT03812029|583745552|FG002|Overall Study|Stopping rules|0|||
161643527|NCT03812029|583745553|FG003|Overall Study|Stopping rules|0|||
161643528|NCT03812029|583745554|FG004|Overall Study|Stopping rules|0|||
161643529|NCT03812029|583745550|FG000|Overall Study|Adverse Event|0|||
161643530|NCT03812029|583745551|FG001|Overall Study|Adverse Event|9|||
161643531|NCT03812029|583745552|FG002|Overall Study|Adverse Event|0|||
161643532|NCT03812029|583745553|FG003|Overall Study|Adverse Event|3|||
161643533|NCT03812029|583745554|FG004|Overall Study|Adverse Event|5|||
161687859|NCT02970292|583908521|FG000|Overall Study|Lack of Efficacy|1|||
161687860|NCT02970292|583908522|FG001|Overall Study|Lack of Efficacy|0|||
161643534|NCT03812029|583745550|FG000|Overall Study|Lost to Follow-up|0|||
161643535|NCT03812029|583745551|FG001|Overall Study|Lost to Follow-up|0|||
161643536|NCT03812029|583745552|FG002|Overall Study|Lost to Follow-up|0|||
161835588|NCT03499119|584439027|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
161835589|NCT03499119|584439028|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
161835590|NCT03499119|584439029|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
161835591|NCT03499119|584439030|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
161835592|NCT03499119|584439027|FG000|Optional Extension Phase|Lost to Follow-up|0|||
161835593|NCT03499119|584439028|FG001|Optional Extension Phase|Lost to Follow-up|0|||
161835594|NCT03499119|584439029|FG002|Optional Extension Phase|Lost to Follow-up|0|||
161835595|NCT03499119|584439030|FG003|Optional Extension Phase|Lost to Follow-up|1|||
161835596|NCT03499119|584439027|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
161835597|NCT03499119|584439028|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
161835598|NCT03499119|584439029|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
161835599|NCT03499119|584439030|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
161835600|NCT03499119|584439027|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
161835601|NCT03499119|584439028|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
161835602|NCT03499119|584439029|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
161835603|NCT03499119|584439030|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
161835604|NCT01558297|584439031|FG000|Overall Study|Withdrawal by Subject|2|||
161835605|NCT01558297|584439032|FG001|Overall Study|Withdrawal by Subject|2|||
161835606|NCT01558297|584439033|FG002|Overall Study|Withdrawal by Subject|1|||
161835607|NCT02655016|584439036|FG000|Overall Study|Disease progression|6|||
161835608|NCT02655016|584439037|FG001|Overall Study|Disease progression|4|||
161835609|NCT02655016|584439036|FG000|Overall Study|Site closed|0|||
161835610|NCT02655016|584439037|FG001|Overall Study|Site closed|1|||
161835611|NCT02655016|584439036|FG000|Overall Study|Death|30|||
161835612|NCT02655016|584439037|FG001|Overall Study|Death|48|||
161835613|NCT02655016|584439036|FG000|Overall Study|Lost to Follow-up|1|||
161835614|NCT02655016|584439037|FG001|Overall Study|Lost to Follow-up|1|||
161835615|NCT02655016|584439036|FG000|Overall Study|Withdrawal by Subject|18|||
161835616|NCT02655016|584439037|FG001|Overall Study|Withdrawal by Subject|36|||
161835617|NCT02427984|584439040|FG000|Overall Study|Lost to Follow-up|13|||
161835618|NCT02427984|584439041|FG001|Overall Study|Lost to Follow-up|5|||
161835619|NCT02427984|584439042|FG002|Overall Study|Lost to Follow-up|18|||
161835620|NCT03959527|584440748|FG000|Overall Study|Withdrawal by Subject|8|||
161835621|NCT03959527|584440749|FG001|Overall Study|Withdrawal by Subject|3|||
161835622|NCT03959527|584440748|FG000|Overall Study|Lost to Follow-up|31|||
161835623|NCT03959527|584440749|FG001|Overall Study|Lost to Follow-up|15|||
161835624|NCT03959527|584440748|FG000|Overall Study|Did not meet eligibility criteria|1|||
161835625|NCT03959527|584440749|FG001|Overall Study|Did not meet eligibility criteria|1|||
161835626|NCT03959527|584440748|FG000|Overall Study|Protocol Violation|10|||
161835627|NCT03959527|584440749|FG001|Overall Study|Protocol Violation|5|||
161835628|NCT06029959|584440750|FG000|Overall Study|Physician Decision|6|||
161835629|NCT02960893|584440755|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
161835630|NCT02960893|584440756|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
161835631|NCT02960893|584440757|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
161643537|NCT03812029|583745553|FG003|Overall Study|Lost to Follow-up|0|||
161643538|NCT03812029|583745554|FG004|Overall Study|Lost to Follow-up|3|||
161643539|NCT02362503|583745558|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
161643540|NCT02362503|583745559|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
161643541|NCT02362503|583745560|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
161643542|NCT02362503|583745558|FG000|Double-blind Period-Up to 8 Days|Death|1|||
161643543|NCT02362503|583745559|FG001|Double-blind Period-Up to 8 Days|Death|0|||
161643544|NCT02362503|583745560|FG002|Double-blind Period-Up to 8 Days|Death|0|||
161643545|NCT02362503|583745558|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
161643546|NCT02362503|583745559|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
161643547|NCT02362503|583745560|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
161643548|NCT02362503|583745558|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
161643549|NCT02362503|583745559|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
161643550|NCT02362503|583745560|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
161643551|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
161643552|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
161835632|NCT02960893|584440758|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
161835633|NCT02960893|584440755|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
161835634|NCT02960893|584440756|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
161835635|NCT02960893|584440757|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
161835636|NCT02960893|584440758|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
161835637|NCT02960893|584440755|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161835638|NCT02960893|584440756|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
161835639|NCT02960893|584440757|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161835640|NCT02960893|584440758|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161835641|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
161835642|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
161835643|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
161643553|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
161643554|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
161643555|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
161643556|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
161643557|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
161643558|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
161643559|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
161643560|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
161643561|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
161643562|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
161643563|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
161643564|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
161643565|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
161643566|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
161643567|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
161643568|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
161643569|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
161643570|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
161643571|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
161643572|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
161643573|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
161643574|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
161643575|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
161643576|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
161643577|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
161643578|NCT02362503|583745558|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
161643579|NCT02362503|583745559|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
161643580|NCT02362503|583745560|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
161643581|NCT04042077|583745561|FG000|Overall Study|Adverse Event|0|||
161643582|NCT04042077|583745562|FG001|Overall Study|Adverse Event|1|||
161643583|NCT04042077|583745561|FG000|Overall Study|Death|2|||
161643584|NCT04042077|583745562|FG001|Overall Study|Death|1|||
161643585|NCT04042077|583745561|FG000|Overall Study|Physician Decision|2|||
161643586|NCT04042077|583745562|FG001|Overall Study|Physician Decision|0|||
161643587|NCT04042077|583745561|FG000|Overall Study|Withdrawal by Subject|3|||
161643588|NCT04042077|583745562|FG001|Overall Study|Withdrawal by Subject|2|||
161643589|NCT04042077|583745561|FG000|Overall Study|Lack of Efficacy|0|||
161643590|NCT04042077|583745562|FG001|Overall Study|Lack of Efficacy|1|||
161643591|NCT01080300|583745563|FG000|Overall Study|Adverse Event|49|||
161643592|NCT01080300|583745564|FG001|Overall Study|Adverse Event|35|||
161643593|NCT01080300|583745563|FG000|Overall Study|Lack of Efficacy|12|||
161643594|NCT01080300|583745564|FG001|Overall Study|Lack of Efficacy|15|||
161643595|NCT01080300|583745563|FG000|Overall Study|Protocol Violation|7|||
161643596|NCT01080300|583745564|FG001|Overall Study|Protocol Violation|13|||
161643597|NCT01080300|583745563|FG000|Overall Study|Lost to Follow-up|10|||
161643598|NCT01080300|583745564|FG001|Overall Study|Lost to Follow-up|6|||
161643599|NCT01080300|583745563|FG000|Overall Study|Death|0|||
161643600|NCT01080300|583745564|FG001|Overall Study|Death|1|||
161643601|NCT01080300|583745563|FG000|Overall Study|Withdrawal by Subject|12|||
161643602|NCT01080300|583745564|FG001|Overall Study|Withdrawal by Subject|28|||
161643603|NCT01080300|583745563|FG000|Overall Study|Reasons not specified|4|||
161643604|NCT01080300|583745564|FG001|Overall Study|Reasons not specified|6|||
161643605|NCT02269423|583745570|FG000|Overall Study|Discontinued due to change in residence|0|||
161643606|NCT02269423|583745571|FG001|Overall Study|Discontinued due to change in residence|1|||
161643607|NCT02269423|583745572|FG002|Overall Study|Discontinued due to change in residence|0|||
161643608|NCT02269423|583745573|FG003|Overall Study|Discontinued due to change in residence|1|||
161643609|NCT01305239|583745574|FG000|Overall Study|Adverse Event|22|||
161643610|NCT01305239|583745574|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
161643611|NCT01754753|583745576|FG000|Overall Study|Study close|43|||
161643612|NCT01754753|583745577|FG001|Overall Study|Study close|44|||
161643613|NCT01754753|583745576|FG000|Overall Study|Lost to Follow-up|9|||
161643614|NCT01754753|583745577|FG001|Overall Study|Lost to Follow-up|5|||
161643615|NCT03229486|583745578|FG000|Overall Study|Protocol Violation|0|||
161643616|NCT03229486|583745579|FG001|Overall Study|Protocol Violation|1|||
161643617|NCT00856245|583745580|FG000|Overall Study|Was not transplanted|5|||
161643618|NCT04547023|583745585|FG000|Overall Study|Did Not Receive Intervention|3|||
161643619|NCT04547023|583745586|FG001|Overall Study|Did Not Receive Intervention|2|||
161643620|NCT04547023|583745585|FG000|Overall Study|Lost to Follow-up|1|||
161643621|NCT04547023|583745586|FG001|Overall Study|Lost to Follow-up|1|||
161643622|NCT01782690|583745589|FG000|Overall Study|Not reported|7|||
161643623|NCT01782690|583745589|FG000|Overall Study|Toxicity of gemcitabine|1|||
161643624|NCT01782690|583745589|FG000|Overall Study|Toxicity of erlotinib|1|||
161643625|NCT01782690|583745589|FG000|Overall Study|Lost to Follow-up|31|||
161687861|NCT02970292|583908521|FG000|Overall Study|Lost to Follow-up|1|||
161643626|NCT01782690|583745589|FG000|Overall Study|Withdrawal of informed consent|2|||
161643627|NCT01782690|583745589|FG000|Overall Study|Absent rash|9|||
161643628|NCT01782690|583745589|FG000|Overall Study|Physician Decision|13|||
161643629|NCT01782690|583745589|FG000|Overall Study|Patient's wish|21|||
161643630|NCT01782690|583745589|FG000|Overall Study|Tumor progression|74|||
161643631|NCT01782690|583745589|FG000|Overall Study|Death|133|||
161643632|NCT01782690|583745589|FG000|Overall Study|Study completion unknown|7|||
161643633|NCT01637077|583745595|FG000|Overall Study|Cancel|1|||
161643634|NCT01637077|583745596|FG001|Overall Study|Cancel|1|||
161643635|NCT01637077|583745595|FG000|Overall Study|Withdrawal by Subject|1|||
161643636|NCT01637077|583745596|FG001|Overall Study|Withdrawal by Subject|0|||
161643637|NCT01637077|583745595|FG000|Overall Study|No cycle 1 questionnaire data|2|||
161643638|NCT01637077|583745596|FG001|Overall Study|No cycle 1 questionnaire data|0|||
161643639|NCT02638103|583745597|FG000|Overall Study|Adverse Event|13|||
161643640|NCT02638103|583745598|FG001|Overall Study|Adverse Event|12|||
161643641|NCT02638103|583745599|FG002|Overall Study|Adverse Event|19|||
161643642|NCT02638103|583745600|FG003|Overall Study|Adverse Event|12|||
161643643|NCT02638103|583745597|FG000|Overall Study|Withdrawal by Subject|43|||
161643644|NCT02638103|583745598|FG001|Overall Study|Withdrawal by Subject|53|||
161643645|NCT02638103|583745599|FG002|Overall Study|Withdrawal by Subject|30|||
161643646|NCT02638103|583745600|FG003|Overall Study|Withdrawal by Subject|61|||
161643647|NCT02638103|583745597|FG000|Overall Study|Protocol Violation|1|||
161643648|NCT02638103|583745598|FG001|Overall Study|Protocol Violation|2|||
161643649|NCT02638103|583745599|FG002|Overall Study|Protocol Violation|1|||
161643650|NCT02638103|583745600|FG003|Overall Study|Protocol Violation|4|||
161643651|NCT02638103|583745597|FG000|Overall Study|Pregnancy|2|||
161643652|NCT02638103|583745598|FG001|Overall Study|Pregnancy|3|||
161643653|NCT02638103|583745599|FG002|Overall Study|Pregnancy|0|||
161643654|NCT02638103|583745600|FG003|Overall Study|Pregnancy|1|||
161643655|NCT02638103|583745597|FG000|Overall Study|Non-compliance to Study Procedures|2|||
161643656|NCT02638103|583745598|FG001|Overall Study|Non-compliance to Study Procedures|1|||
161643657|NCT02638103|583745599|FG002|Overall Study|Non-compliance to Study Procedures|1|||
161643658|NCT02638103|583745600|FG003|Overall Study|Non-compliance to Study Procedures|1|||
161643659|NCT02638103|583745597|FG000|Overall Study|Lost to Follow-up|26|||
161643660|NCT02638103|583745598|FG001|Overall Study|Lost to Follow-up|33|||
161643661|NCT02638103|583745599|FG002|Overall Study|Lost to Follow-up|20|||
161643662|NCT02638103|583745600|FG003|Overall Study|Lost to Follow-up|37|||
161643663|NCT02638103|583745597|FG000|Overall Study|Lack of Efficacy|14|||
161643664|NCT02638103|583745598|FG001|Overall Study|Lack of Efficacy|10|||
161643665|NCT02638103|583745599|FG002|Overall Study|Lack of Efficacy|12|||
161643666|NCT02638103|583745600|FG003|Overall Study|Lack of Efficacy|22|||
161643667|NCT02638103|583745597|FG000|Overall Study|Other than specified|5|||
161643668|NCT02638103|583745598|FG001|Overall Study|Other than specified|4|||
161643669|NCT02638103|583745599|FG002|Overall Study|Other than specified|2|||
161643670|NCT02638103|583745600|FG003|Overall Study|Other than specified|4|||
161643671|NCT00583947|583745604|FG000|Cross-over Period|Adverse Event|2|||
161643672|NCT00583947|583745605|FG001|Cross-over Period|Adverse Event|0|||
161643673|NCT00583947|583745604|FG000|Cross-over Period|Withdrawal by Subject|2|||
161643674|NCT00583947|583745605|FG001|Cross-over Period|Withdrawal by Subject|0|||
161643675|NCT00583947|583745604|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
161643676|NCT00583947|583745605|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
161835644|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
161835645|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
161643677|NCT00583947|583745604|FG000|Cross-over Period|Other|1|||
161643678|NCT00583947|583745605|FG001|Cross-over Period|Other|1|||
161643679|NCT01261247|583745607|FG000|Overall Study|Ineligible|2|||
161643680|NCT01740154|583745608|FG000|Overall Study|Adverse Event|1|||
161643681|NCT04013971|583745611|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
161643682|NCT04013971|583745612|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
161643683|NCT04013971|583745611|FG000|Overall Study|Missing biomechanical data|0|||
161643684|NCT04013971|583745612|FG001|Overall Study|Missing biomechanical data|1|||
161643685|NCT05032066|583745615|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
161643686|NCT05032066|583745616|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
161643687|NCT05032066|583745617|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
161643688|NCT05032066|583745615|FG000|Part 1: Core Phase|Physician Decision|0|||
161643689|NCT05032066|583745616|FG001|Part 1: Core Phase|Physician Decision|1|||
161643690|NCT05032066|583745617|FG002|Part 1: Core Phase|Physician Decision|1|||
161687862|NCT02970292|583908522|FG001|Overall Study|Lost to Follow-up|0|||
161687863|NCT02970292|583908521|FG000|Overall Study|Protocol Violation|2|||
161643691|NCT05032066|583745615|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
161643692|NCT05032066|583745616|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
161835646|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
161643693|NCT05032066|583745617|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
161643694|NCT05032066|583745615|FG000|Part 1: Core Phase|Death|3|||
161643695|NCT05032066|583745616|FG001|Part 1: Core Phase|Death|4|||
161643696|NCT05032066|583745617|FG002|Part 1: Core Phase|Death|2|||
161643697|NCT05032066|583745615|FG000|Part 1: Core Phase|Adverse Event|2|||
161643698|NCT05032066|583745616|FG001|Part 1: Core Phase|Adverse Event|3|||
161643699|NCT05032066|583745617|FG002|Part 1: Core Phase|Adverse Event|0|||
161643700|NCT05032066|583745615|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
161643701|NCT05032066|583745616|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
161643702|NCT05032066|583745617|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
161643703|NCT05032066|583745615|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
161643704|NCT05032066|583745616|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
161643705|NCT05032066|583745617|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
161643706|NCT05032066|583745615|FG000|Part 2: Extension Phase|Physician Decision|1|||
161643707|NCT05032066|583745616|FG001|Part 2: Extension Phase|Physician Decision|2|||
161643708|NCT05032066|583745617|FG002|Part 2: Extension Phase|Physician Decision|0|||
161643709|NCT05032066|583745615|FG000|Part 2: Extension Phase|Death|2|||
161643710|NCT05032066|583745616|FG001|Part 2: Extension Phase|Death|4|||
161643711|NCT05032066|583745617|FG002|Part 2: Extension Phase|Death|5|||
161643712|NCT01124838|583745618|FG000|Overall Study|Miscellaneous|4|||
161643713|NCT01124838|583745619|FG001|Overall Study|Miscellaneous|2|||
161643714|NCT01124838|583745618|FG000|Overall Study|Adverse Event|7|||
161643715|NCT01124838|583745619|FG001|Overall Study|Adverse Event|11|||
161643716|NCT01124838|583745618|FG000|Overall Study|Lack of Efficacy|2|||
161643717|NCT01124838|583745619|FG001|Overall Study|Lack of Efficacy|0|||
161643718|NCT01124838|583745618|FG000|Overall Study|Withdrawal by Subject|3|||
161643719|NCT01124838|583745619|FG001|Overall Study|Withdrawal by Subject|2|||
161643720|NCT01124838|583745618|FG000|Overall Study|Lost to Follow-up|2|||
161643721|NCT01124838|583745619|FG001|Overall Study|Lost to Follow-up|0|||
161643722|NCT06719986|583745620|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
161643723|NCT06719986|583745621|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
161643724|NCT06719986|583745622|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
161643725|NCT06719986|583745620|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
161643726|NCT06719986|583745621|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
161643727|NCT06719986|583745622|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
161643728|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
161643729|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
161643730|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
161643731|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
161643732|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
161643733|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
161643734|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
161643735|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
161643736|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
161643737|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
161643738|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
161643739|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
161643740|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
161643741|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
161643742|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
161643743|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
161643744|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
161643745|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
161643746|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
161643747|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
161643748|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
161643749|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
161643750|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
161643751|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
161643752|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
161643753|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
161643754|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
161643755|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
161643756|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161643757|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161643758|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161643759|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
161643760|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
161643761|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
161643762|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
161643763|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
161643764|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
161643765|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
161643766|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
161643767|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
161643768|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
161643769|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
161643770|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
161643771|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
161643772|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
161643773|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
161643774|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
161643775|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
161643776|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
161643777|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
161643778|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
161643779|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
161643780|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
161643781|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
161643782|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
161643783|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
161643784|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
161643785|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
161643786|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
161643787|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
161643788|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
161643789|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
161643790|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
161643791|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
161643792|NCT00217737|583745623|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
161643793|NCT00217737|583745624|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
161643794|NCT00217737|583745625|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
161643795|NCT00217737|583745626|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
161643796|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
161643797|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
161643798|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
161643799|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
161643800|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
161643801|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
161643802|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
161643803|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
161643804|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Study suspension|0|||
161643805|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Study suspension|45|||
161643806|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Study suspension|0|||
161643807|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Study suspension|0|||
161643808|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
161643809|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
161643810|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
161643811|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
161643812|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Death|2|||
161643813|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Death|3|||
161643814|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Death|0|||
161643815|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Death|0|||
161643816|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
161643817|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
161643818|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
161643819|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
161643820|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
161643821|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
161643822|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
161643823|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
161643824|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
161643825|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
161643826|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
161687864|NCT02970292|583908522|FG001|Overall Study|Protocol Violation|0|||
161643827|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
161687865|NCT02970292|583908521|FG000|Overall Study|Other|1|||
161835647|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
161835648|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
161835649|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
161835650|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
161835651|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
161643828|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
161643829|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
161643830|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
161643831|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
161643832|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
161643833|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
161643834|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
161643835|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
161643836|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
161643837|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
161643838|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
161643839|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
161643840|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
161643841|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
161643842|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
161643843|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
161643844|NCT00217737|583745623|FG000|Step 2 Randomization/Registration|Other|1|||
161643845|NCT00217737|583745624|FG001|Step 2 Randomization/Registration|Other|2|||
161643846|NCT00217737|583745625|FG002|Step 2 Randomization/Registration|Other|0|||
161643847|NCT00217737|583745626|FG003|Step 2 Randomization/Registration|Other|0|||
161643848|NCT03213704|583745628|FG000|Overall Study|Physician Decision|3|||
161643849|NCT03213704|583745628|FG000|Overall Study|Protocol Violation|1|||
161643850|NCT03213704|583745628|FG000|Overall Study|Progressive disease|4|||
161643851|NCT01183390|583747500|FG000|First Intervention|Adverse Event|0|||
161643852|NCT01183390|583747501|FG001|First Intervention|Adverse Event|1|||
161643853|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Adverse Event|2|||
161643854|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Adverse Event|0|||
161643855|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Adverse Event|0|||
161643856|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Adverse Event|0|||
161643857|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
161643858|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
161643859|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
161643860|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
161643861|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
161643862|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
161643863|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
161643864|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
161643865|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Physician Decision|1|||
161643866|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Physician Decision|0|||
161643867|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Physician Decision|0|||
161643868|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Physician Decision|0|||
161643869|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Pregnancy|1|||
161643870|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Pregnancy|0|||
161643871|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Pregnancy|0|||
161643872|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Pregnancy|0|||
161643873|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
161643874|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
161643875|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161643876|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161643877|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
161643878|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
161643879|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
161643880|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
161835652|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
161835653|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
161835654|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
161643881|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
161643882|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
161835655|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
161835656|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
161835657|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
161643883|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
161643884|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
161643885|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
161643886|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
161643887|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
161643888|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
161643889|NCT04057573|583747504|FG000|24-Week Double-Blind Period|Not Treated|1|||
161643890|NCT04057573|583747505|FG001|24-Week Double-Blind Period|Not Treated|0|||
161643891|NCT04057573|583747506|FG002|24-Week Double-Blind Period|Not Treated|0|||
161643892|NCT04057573|583747507|FG003|24-Week Double-Blind Period|Not Treated|0|||
161643893|NCT04057573|583747504|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
161643894|NCT04057573|583747505|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
161643895|NCT04057573|583747506|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
161643896|NCT04057573|583747507|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
161643897|NCT04057573|583747504|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
161643898|NCT04057573|583747505|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
161643899|NCT04057573|583747506|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
161643900|NCT04057573|583747507|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
161643901|NCT04057573|583747504|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
161643902|NCT04057573|583747505|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
161643903|NCT04057573|583747506|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
161643904|NCT04057573|583747507|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
161643905|NCT04057573|583747504|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
161643906|NCT04057573|583747505|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
161643907|NCT04057573|583747506|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
161643908|NCT04057573|583747507|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
161643909|NCT04057573|583747504|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
161643910|NCT04057573|583747505|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
161643911|NCT04057573|583747506|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
161643912|NCT04057573|583747507|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
161643913|NCT04991753|583747508|FG000|Overall Study|Withdrawal by Subject|0|||
161643914|NCT04991753|583747509|FG001|Overall Study|Withdrawal by Subject|1|||
161643915|NCT00233480|583747512|FG000|Overall Study|Underwent status II heart transplant|0|||
161643916|NCT00233480|583747513|FG001|Overall Study|Underwent status II heart transplant|1|||
161643917|NCT00474526|583747514|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
161643918|NCT00474526|583747515|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
161643919|NCT00474526|583747516|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
161643920|NCT00474526|583747517|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
161643921|NCT00474526|583747518|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
161643922|NCT00474526|583747519|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
161643923|NCT00474526|583747520|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
161643924|NCT00474526|583747521|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
161643925|NCT00474526|583747522|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
161643926|NCT00474526|583747523|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
161643927|NCT00474526|583747524|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
161643928|NCT00474526|583747525|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
161643929|NCT00474526|583747526|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
161643930|NCT00474526|583747527|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
161643931|NCT00474526|583747528|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
161643932|NCT00474526|583747529|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
161643933|NCT00474526|583747530|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
161643934|NCT00474526|583747514|FG000|Overall Study|Adverse Event|2|||
161643935|NCT00474526|583747515|FG001|Overall Study|Adverse Event|0|||
161643936|NCT00474526|583747516|FG002|Overall Study|Adverse Event|2|||
161643937|NCT00474526|583747517|FG003|Overall Study|Adverse Event|4|||
161643938|NCT00474526|583747518|FG004|Overall Study|Adverse Event|2|||
161643939|NCT00474526|583747519|FG005|Overall Study|Adverse Event|1|||
161643940|NCT00474526|583747520|FG006|Overall Study|Adverse Event|1|||
161643941|NCT00474526|583747521|FG007|Overall Study|Adverse Event|0|||
161643942|NCT00474526|583747522|FG008|Overall Study|Adverse Event|0|||
161643943|NCT00474526|583747523|FG009|Overall Study|Adverse Event|0|||
161643944|NCT00474526|583747524|FG010|Overall Study|Adverse Event|0|||
161643945|NCT00474526|583747525|FG011|Overall Study|Adverse Event|0|||
161643946|NCT00474526|583747526|FG012|Overall Study|Adverse Event|0|||
161643947|NCT00474526|583747527|FG013|Overall Study|Adverse Event|0|||
161643948|NCT00474526|583747528|FG014|Overall Study|Adverse Event|1|||
161643949|NCT00474526|583747529|FG015|Overall Study|Adverse Event|1|||
161643950|NCT00474526|583747530|FG016|Overall Study|Adverse Event|0|||
161643951|NCT00474526|583747514|FG000|Overall Study|Death|0|||
161687866|NCT02970292|583908522|FG001|Overall Study|Other|0|||
161687867|NCT00814892|583908523|FG000|Overall Study|Disease Progression|1|||
161643952|NCT00474526|583747515|FG001|Overall Study|Death|0|||
161643953|NCT00474526|583747516|FG002|Overall Study|Death|0|||
161643954|NCT00474526|583747517|FG003|Overall Study|Death|0|||
161643955|NCT00474526|583747518|FG004|Overall Study|Death|0|||
161643956|NCT00474526|583747519|FG005|Overall Study|Death|0|||
161643957|NCT00474526|583747520|FG006|Overall Study|Death|0|||
161643958|NCT00474526|583747521|FG007|Overall Study|Death|0|||
161643959|NCT00474526|583747522|FG008|Overall Study|Death|0|||
161643960|NCT00474526|583747523|FG009|Overall Study|Death|0|||
161643961|NCT00474526|583747524|FG010|Overall Study|Death|0|||
161643962|NCT00474526|583747525|FG011|Overall Study|Death|0|||
161643963|NCT00474526|583747526|FG012|Overall Study|Death|0|||
161643964|NCT00474526|583747527|FG013|Overall Study|Death|3|||
161643965|NCT00474526|583747528|FG014|Overall Study|Death|0|||
161643966|NCT00474526|583747529|FG015|Overall Study|Death|0|||
161643967|NCT00474526|583747530|FG016|Overall Study|Death|0|||
161643968|NCT00474526|583747514|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643969|NCT00474526|583747515|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
161643970|NCT00474526|583747516|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643971|NCT00474526|583747517|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
161643972|NCT00474526|583747518|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
161643973|NCT00474526|583747519|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643974|NCT00474526|583747520|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643975|NCT00474526|583747521|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161687868|NCT00814892|583908523|FG000|Overall Study|Study Termination|1|||
161687869|NCT00845650|583908524|FG000|Overall Study|Withdrawal by Subject|0|||
161687870|NCT00845650|583908525|FG001|Overall Study|Withdrawal by Subject|0|||
161687871|NCT00845650|583908526|FG002|Overall Study|Withdrawal by Subject|0|||
161687872|NCT00845650|583908527|FG003|Overall Study|Withdrawal by Subject|0|||
161687873|NCT00845650|583908528|FG004|Overall Study|Withdrawal by Subject|2|||
161687874|NCT00845650|583908529|FG005|Overall Study|Withdrawal by Subject|0|||
161687875|NCT00845650|583908524|FG000|Overall Study|Lost to Follow-up|0|||
161687876|NCT00845650|583908525|FG001|Overall Study|Lost to Follow-up|0|||
161687877|NCT00845650|583908526|FG002|Overall Study|Lost to Follow-up|3|||
161687878|NCT00845650|583908527|FG003|Overall Study|Lost to Follow-up|1|||
161687879|NCT00845650|583908528|FG004|Overall Study|Lost to Follow-up|0|||
161687880|NCT00845650|583908529|FG005|Overall Study|Lost to Follow-up|1|||
161687881|NCT00845650|583908524|FG000|Overall Study|Sponsor hold on dosing|0|||
161687882|NCT00845650|583908525|FG001|Overall Study|Sponsor hold on dosing|0|||
161687883|NCT00845650|583908526|FG002|Overall Study|Sponsor hold on dosing|0|||
161687884|NCT00845650|583908527|FG003|Overall Study|Sponsor hold on dosing|0|||
161687885|NCT00845650|583908528|FG004|Overall Study|Sponsor hold on dosing|1|||
161687886|NCT00845650|583908529|FG005|Overall Study|Sponsor hold on dosing|1|||
161687887|NCT00845650|583908524|FG000|Overall Study|Unable to access IV line|1|||
161687888|NCT00845650|583908525|FG001|Overall Study|Unable to access IV line|0|||
161687889|NCT00845650|583908526|FG002|Overall Study|Unable to access IV line|0|||
161687890|NCT00845650|583908527|FG003|Overall Study|Unable to access IV line|0|||
161687891|NCT00845650|583908528|FG004|Overall Study|Unable to access IV line|0|||
161687892|NCT00845650|583908529|FG005|Overall Study|Unable to access IV line|0|||
161687893|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Adverse Event|2|||
161687894|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Adverse Event|0|||
161687895|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Adverse Event|1|||
161687896|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Adverse Event|1|||
161687897|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Other|1|||
161687898|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Other|4|||
161687899|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Other|4|||
161687900|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Other|0|||
161687901|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
161687902|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
161687903|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
161643976|NCT00474526|583747522|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161687904|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
161687905|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
161687906|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
161835658|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
161835659|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
161835660|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
161835661|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
161835662|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
161687907|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
161687908|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
161643977|NCT00474526|583747523|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643978|NCT00474526|583747524|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643979|NCT00474526|583747525|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643980|NCT00474526|583747526|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643981|NCT00474526|583747527|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
161643982|NCT00474526|583747528|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
161643983|NCT00474526|583747529|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643984|NCT00474526|583747530|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161643985|NCT00474526|583747514|FG000|Overall Study|Lost to Follow-up|8|||
161643986|NCT00474526|583747515|FG001|Overall Study|Lost to Follow-up|6|||
161643987|NCT00474526|583747516|FG002|Overall Study|Lost to Follow-up|13|||
161643988|NCT00474526|583747517|FG003|Overall Study|Lost to Follow-up|29|||
161643989|NCT00474526|583747518|FG004|Overall Study|Lost to Follow-up|11|||
161643990|NCT00474526|583747519|FG005|Overall Study|Lost to Follow-up|5|||
161643991|NCT00474526|583747520|FG006|Overall Study|Lost to Follow-up|8|||
161643992|NCT00474526|583747521|FG007|Overall Study|Lost to Follow-up|1|||
161643993|NCT00474526|583747522|FG008|Overall Study|Lost to Follow-up|0|||
161643994|NCT00474526|583747523|FG009|Overall Study|Lost to Follow-up|6|||
161643995|NCT00474526|583747524|FG010|Overall Study|Lost to Follow-up|2|||
161643996|NCT00474526|583747525|FG011|Overall Study|Lost to Follow-up|4|||
161643997|NCT00474526|583747526|FG012|Overall Study|Lost to Follow-up|6|||
161643998|NCT00474526|583747527|FG013|Overall Study|Lost to Follow-up|74|||
161643999|NCT00474526|583747528|FG014|Overall Study|Lost to Follow-up|29|||
161644000|NCT00474526|583747529|FG015|Overall Study|Lost to Follow-up|4|||
161644001|NCT00474526|583747530|FG016|Overall Study|Lost to Follow-up|5|||
161644002|NCT00474526|583747514|FG000|Overall Study|Protocol Violation|2|||
161644003|NCT00474526|583747515|FG001|Overall Study|Protocol Violation|6|||
161644004|NCT00474526|583747516|FG002|Overall Study|Protocol Violation|4|||
161644005|NCT00474526|583747517|FG003|Overall Study|Protocol Violation|12|||
161644006|NCT00474526|583747518|FG004|Overall Study|Protocol Violation|3|||
161644007|NCT00474526|583747519|FG005|Overall Study|Protocol Violation|1|||
161644008|NCT00474526|583747520|FG006|Overall Study|Protocol Violation|3|||
161644009|NCT00474526|583747521|FG007|Overall Study|Protocol Violation|0|||
161644010|NCT00474526|583747522|FG008|Overall Study|Protocol Violation|0|||
161644011|NCT00474526|583747523|FG009|Overall Study|Protocol Violation|4|||
161644012|NCT00474526|583747524|FG010|Overall Study|Protocol Violation|2|||
161644013|NCT00474526|583747525|FG011|Overall Study|Protocol Violation|2|||
161644014|NCT00474526|583747526|FG012|Overall Study|Protocol Violation|4|||
161644015|NCT00474526|583747527|FG013|Overall Study|Protocol Violation|19|||
161644016|NCT00474526|583747528|FG014|Overall Study|Protocol Violation|9|||
161644017|NCT00474526|583747529|FG015|Overall Study|Protocol Violation|6|||
161644018|NCT00474526|583747530|FG016|Overall Study|Protocol Violation|2|||
161644019|NCT00474526|583747514|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
161644020|NCT00474526|583747515|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
161644021|NCT00474526|583747516|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
161644022|NCT00474526|583747517|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
161644023|NCT00474526|583747518|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
161644024|NCT00474526|583747519|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
161644025|NCT00474526|583747520|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
161644026|NCT00474526|583747521|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
161644027|NCT00474526|583747522|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
161644028|NCT00474526|583747523|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
161644029|NCT00474526|583747524|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
161644030|NCT00474526|583747525|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
161644031|NCT00474526|583747526|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
161644032|NCT00474526|583747527|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
161644033|NCT00474526|583747528|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
161644034|NCT00474526|583747529|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
161644035|NCT00474526|583747530|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
161644036|NCT00474526|583747514|FG000|Overall Study|Withdrawal by Subject|9|||
161644037|NCT00474526|583747515|FG001|Overall Study|Withdrawal by Subject|24|||
161644038|NCT00474526|583747516|FG002|Overall Study|Withdrawal by Subject|21|||
161644039|NCT00474526|583747517|FG003|Overall Study|Withdrawal by Subject|52|||
161644040|NCT00474526|583747518|FG004|Overall Study|Withdrawal by Subject|38|||
161644041|NCT00474526|583747519|FG005|Overall Study|Withdrawal by Subject|6|||
161644042|NCT00474526|583747520|FG006|Overall Study|Withdrawal by Subject|12|||
161687909|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
161835663|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
161835664|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
161644043|NCT00474526|583747521|FG007|Overall Study|Withdrawal by Subject|4|||
161835665|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
161835666|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
161644044|NCT00474526|583747522|FG008|Overall Study|Withdrawal by Subject|4|||
161644045|NCT00474526|583747523|FG009|Overall Study|Withdrawal by Subject|13|||
161644046|NCT00474526|583747524|FG010|Overall Study|Withdrawal by Subject|5|||
161644047|NCT00474526|583747525|FG011|Overall Study|Withdrawal by Subject|4|||
161644048|NCT00474526|583747526|FG012|Overall Study|Withdrawal by Subject|4|||
161644049|NCT00474526|583747527|FG013|Overall Study|Withdrawal by Subject|37|||
161644050|NCT00474526|583747528|FG014|Overall Study|Withdrawal by Subject|22|||
161644051|NCT00474526|583747529|FG015|Overall Study|Withdrawal by Subject|1|||
161644052|NCT00474526|583747530|FG016|Overall Study|Withdrawal by Subject|1|||
161644053|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
161644054|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
161644055|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
161644056|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
161644057|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
161644058|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
161644059|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
161644060|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
161644061|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
161644062|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
161644063|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
161644064|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
161644065|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
161644066|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
161644067|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
161644068|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
161644069|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
161644070|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
161644071|NCT00132678|583747533|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
161644072|NCT00132678|583747534|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
161644073|NCT00132678|583747535|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
161644074|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Death|2|||
161644075|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Death|0|||
161644076|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Death|0|||
161644077|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
161644078|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
161644079|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
161644080|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
161644081|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
161644082|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
161644083|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
161644084|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
161644085|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
161644086|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
161644087|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
161644088|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
161644089|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
161644090|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
161644091|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
161644092|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
161644093|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
161644094|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
161644095|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
161644096|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
161644097|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
161644098|NCT00132678|583747533|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
161644099|NCT00132678|583747534|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
161644100|NCT00132678|583747535|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
161644101|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
161644102|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
161644103|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
161644104|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
161644105|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
161644106|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
161644107|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
161644108|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
161644109|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
161644110|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
161644111|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
161644112|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
161687910|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
161835667|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
161835668|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
161835669|NCT02631876|584440761|FG000|Overall Study|Death|96|||
161644113|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
161644114|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
161644115|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
161644116|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
161644117|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
161644118|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
161644119|NCT00132678|583747533|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
161644120|NCT00132678|583747534|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
161644121|NCT00132678|583747535|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
161644122|NCT00953147|583747538|FG000|Overall Study|Adverse Event|8|||
161644123|NCT00953147|583747539|FG001|Overall Study|Adverse Event|16|||
161644124|NCT00953147|583747540|FG002|Overall Study|Adverse Event|6|||
161644125|NCT00953147|583747538|FG000|Overall Study|Protocol Violation|2|||
161644126|NCT00953147|583747539|FG001|Overall Study|Protocol Violation|8|||
161644127|NCT00953147|583747540|FG002|Overall Study|Protocol Violation|4|||
161644128|NCT00953147|583747538|FG000|Overall Study|Withdrawal by Subject|13|||
161644129|NCT00953147|583747539|FG001|Overall Study|Withdrawal by Subject|15|||
161644130|NCT00953147|583747540|FG002|Overall Study|Withdrawal by Subject|12|||
161644131|NCT00953147|583747538|FG000|Overall Study|Lost to Follow-up|8|||
161644132|NCT00953147|583747539|FG001|Overall Study|Lost to Follow-up|9|||
161644133|NCT00953147|583747540|FG002|Overall Study|Lost to Follow-up|4|||
161644134|NCT00953147|583747538|FG000|Overall Study|Physician Decision|2|||
161644135|NCT00953147|583747539|FG001|Overall Study|Physician Decision|7|||
161644136|NCT00953147|583747540|FG002|Overall Study|Physician Decision|3|||
161644137|NCT00953147|583747538|FG000|Overall Study|Other|4|||
161644138|NCT00953147|583747539|FG001|Overall Study|Other|11|||
161644139|NCT00953147|583747540|FG002|Overall Study|Other|13|||
161644140|NCT02514239|583747541|FG000|Overall Study|Refused to continue trial medication|0|||
161644141|NCT02514239|583747542|FG001|Overall Study|Refused to continue trial medication|0|||
161644142|NCT02514239|583747543|FG002|Overall Study|Refused to continue trial medication|0|||
161644143|NCT02514239|583747544|FG003|Overall Study|Refused to continue trial medication|0|||
161644144|NCT02514239|583747545|FG004|Overall Study|Refused to continue trial medication|0|||
161644145|NCT02514239|583747546|FG005|Overall Study|Refused to continue trial medication|0|||
161644146|NCT02514239|583747547|FG006|Overall Study|Refused to continue trial medication|0|||
161644147|NCT02514239|583747548|FG007|Overall Study|Refused to continue trial medication|0|||
161644148|NCT02514239|583747549|FG008|Overall Study|Refused to continue trial medication|0|||
161644149|NCT02514239|583747550|FG009|Overall Study|Refused to continue trial medication|1|||
161644150|NCT02514239|583747541|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644151|NCT02514239|583747542|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644152|NCT02514239|583747543|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644153|NCT02514239|583747544|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644154|NCT02514239|583747545|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644155|NCT02514239|583747546|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644156|NCT02514239|583747547|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644157|NCT02514239|583747548|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
161644158|NCT02514239|583747549|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
161835670|NCT02631876|584440762|FG001|Overall Study|Death|50|||
161835671|NCT02631876|584440761|FG000|Overall Study|Investigator's discretion|1|||
161835672|NCT02631876|584440762|FG001|Overall Study|Investigator's discretion|0|||
161835673|NCT02631876|584440761|FG000|Overall Study|Lost to Follow-up|2|||
161835674|NCT02631876|584440762|FG001|Overall Study|Lost to Follow-up|0|||
161835675|NCT02631876|584440761|FG000|Overall Study|Withdrawal by Subject|16|||
161835676|NCT02631876|584440762|FG001|Overall Study|Withdrawal by Subject|9|||
161835677|NCT02631876|584440761|FG000|Overall Study|Other than specified|4|||
161835678|NCT02631876|584440762|FG001|Overall Study|Other than specified|4|||
161835679|NCT04285567|584440763|FG000|Overall Study|Death|3|||
161644159|NCT02514239|583747550|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
161644160|NCT02514239|583747541|FG000|Overall Study|Not treated|0|||
161644161|NCT02514239|583747542|FG001|Overall Study|Not treated|1|||
161644162|NCT02514239|583747543|FG002|Overall Study|Not treated|0|||
161644163|NCT02514239|583747544|FG003|Overall Study|Not treated|0|||
161644164|NCT02514239|583747545|FG004|Overall Study|Not treated|0|||
161644165|NCT02514239|583747546|FG005|Overall Study|Not treated|0|||
161644166|NCT02514239|583747547|FG006|Overall Study|Not treated|0|||
161644167|NCT02514239|583747548|FG007|Overall Study|Not treated|0|||
161687911|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
161687912|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
161644168|NCT02514239|583747549|FG008|Overall Study|Not treated|0|||
161644169|NCT02514239|583747550|FG009|Overall Study|Not treated|0|||
161644170|NCT02514239|583747541|FG000|Overall Study|Other Adverse Events|2|||
161644171|NCT02514239|583747542|FG001|Overall Study|Other Adverse Events|0|||
161644172|NCT02514239|583747543|FG002|Overall Study|Other Adverse Events|0|||
161644173|NCT02514239|583747544|FG003|Overall Study|Other Adverse Events|1|||
161644174|NCT02514239|583747545|FG004|Overall Study|Other Adverse Events|0|||
161835680|NCT04285567|584440764|FG001|Overall Study|Death|3|||
161644175|NCT02514239|583747546|FG005|Overall Study|Other Adverse Events|1|||
161644176|NCT02514239|583747547|FG006|Overall Study|Other Adverse Events|0|||
161644177|NCT02514239|583747548|FG007|Overall Study|Other Adverse Events|1|||
161644178|NCT02514239|583747549|FG008|Overall Study|Other Adverse Events|2|||
161644179|NCT02514239|583747550|FG009|Overall Study|Other Adverse Events|0|||
161644180|NCT02514239|583747541|FG000|Overall Study|Progressive disease|3|||
161644181|NCT02514239|583747542|FG001|Overall Study|Progressive disease|3|||
161644182|NCT02514239|583747543|FG002|Overall Study|Progressive disease|2|||
161644183|NCT02514239|583747544|FG003|Overall Study|Progressive disease|2|||
161644184|NCT02514239|583747545|FG004|Overall Study|Progressive disease|3|||
161644185|NCT02514239|583747546|FG005|Overall Study|Progressive disease|3|||
161644186|NCT02514239|583747547|FG006|Overall Study|Progressive disease|4|||
161644187|NCT02514239|583747548|FG007|Overall Study|Progressive disease|2|||
161644188|NCT02514239|583747549|FG008|Overall Study|Progressive disease|5|||
161644189|NCT02514239|583747550|FG009|Overall Study|Progressive disease|0|||
161644190|NCT03299049|583747551|FG000|Overall Study|On-going|486|||
161644191|NCT03299049|583747552|FG001|Overall Study|On-going|481|||
161644192|NCT03299049|583747551|FG000|Overall Study|Withdrawal by Subject|6|||
161644193|NCT03299049|583747552|FG001|Overall Study|Withdrawal by Subject|21|||
161644194|NCT03299049|583747551|FG000|Overall Study|Physician Decision|5|||
161644195|NCT03299049|583747552|FG001|Overall Study|Physician Decision|1|||
161644196|NCT03299049|583747551|FG000|Overall Study|Lost to Follow-up|2|||
161644197|NCT03299049|583747552|FG001|Overall Study|Lost to Follow-up|0|||
161644198|NCT03299049|583747551|FG000|Overall Study|Pregnancy|1|||
161644199|NCT03299049|583747552|FG001|Overall Study|Pregnancy|3|||
161644200|NCT03299049|583747551|FG000|Overall Study|Protocol Violation|1|||
161644201|NCT03299049|583747552|FG001|Overall Study|Protocol Violation|1|||
161644202|NCT03299049|583747551|FG000|Overall Study|Lack of Efficacy|9|||
161644203|NCT03299049|583747552|FG001|Overall Study|Lack of Efficacy|3|||
161644204|NCT03299049|583747551|FG000|Overall Study|Adverse Event|12|||
161644205|NCT03299049|583747552|FG001|Overall Study|Adverse Event|13|||
161644206|NCT00699153|583747553|FG000|Overall Study|Lost to Follow-up|1|||
161644207|NCT00699153|583747554|FG001|Overall Study|Lost to Follow-up|0|||
161644208|NCT00699153|583747553|FG000|Overall Study|Adverse Event|0|||
161644209|NCT00699153|583747554|FG001|Overall Study|Adverse Event|2|||
161644210|NCT00699153|583747553|FG000|Overall Study|Protocol Violation|1|||
161644211|NCT00699153|583747554|FG001|Overall Study|Protocol Violation|0|||
161644212|NCT00699153|583747553|FG000|Overall Study|Travel Problem|1|||
161644213|NCT00699153|583747554|FG001|Overall Study|Travel Problem|0|||
161644214|NCT02521363|583747556|FG000|Overall Study|Withdrawal by Subject|1|||
161644215|NCT02521363|583747557|FG001|Overall Study|Withdrawal by Subject|2|||
161644216|NCT00953771|583747561|FG000|Overall Study|Death|1|||
161644217|NCT00953771|583747562|FG001|Overall Study|Death|0|||
161644218|NCT00974259|583747563|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
161644219|NCT00974259|583747564|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
161644220|NCT04201288|583747570|FG000|Overall Study|Death|1|||
161644221|NCT04201288|583747571|FG001|Overall Study|Death|1|||
161644222|NCT04201288|583747570|FG000|Overall Study|Lost to Follow-up|5|||
161644223|NCT04201288|583747571|FG001|Overall Study|Lost to Follow-up|3|||
161644224|NCT04201288|583747570|FG000|Overall Study|Withdrawal by Subject|1|||
161644225|NCT04201288|583747571|FG001|Overall Study|Withdrawal by Subject|0|||
161644226|NCT00592293|583747572|FG000|Overall Study|Withdrawal by Subject|1|||
161644227|NCT01606319|583747575|FG000|Overall Study|Lost to Follow-up|17|||
161644228|NCT01606319|583747576|FG001|Overall Study|Lost to Follow-up|14|||
161644229|NCT01606319|583747575|FG000|Overall Study|Withdrawal by Subject|9|||
161644230|NCT01606319|583747576|FG001|Overall Study|Withdrawal by Subject|12|||
161644231|NCT01606319|583747575|FG000|Overall Study|Physician Decision|1|||
161644232|NCT01606319|583747576|FG001|Overall Study|Physician Decision|2|||
161644233|NCT01606319|583747575|FG000|Overall Study|Lack of Efficacy|6|||
161644234|NCT01606319|583747576|FG001|Overall Study|Lack of Efficacy|8|||
161644235|NCT01606319|583747575|FG000|Overall Study|Adverse Event|1|||
161644236|NCT01606319|583747576|FG001|Overall Study|Adverse Event|4|||
161644237|NCT01270828|583747577|FG000|Pregabalin CR SB|Reason Unspecified|0|||
161644238|NCT01270828|583747578|FG001|Pregabalin CR SB|Reason Unspecified|0|||
161644239|NCT01270828|583747579|FG002|Pregabalin CR SB|Reason Unspecified|8|||
161644240|NCT01270828|583747577|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
161644241|NCT01270828|583747578|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
161644242|NCT01270828|583747579|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
161644243|NCT01270828|583747577|FG000|Pregabalin CR SB|Related adverse event|0|||
161644244|NCT01270828|583747578|FG001|Pregabalin CR SB|Related adverse event|0|||
161644245|NCT01270828|583747579|FG002|Pregabalin CR SB|Related adverse event|46|||
161644246|NCT01270828|583747577|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
161644247|NCT01270828|583747578|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
161644248|NCT01270828|583747579|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
161644249|NCT01270828|583747577|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
161644250|NCT01270828|583747578|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
161644251|NCT01270828|583747579|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
161644252|NCT01270828|583747577|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
161835681|NCT04285567|584440763|FG000|Overall Study|Lost to Follow-up|1|||
161835682|NCT04285567|584440764|FG001|Overall Study|Lost to Follow-up|1|||
161835683|NCT04285567|584440763|FG000|Overall Study|Reason Not Specified|1|||
161835684|NCT04285567|584440764|FG001|Overall Study|Reason Not Specified|1|||
161835685|NCT04285567|584440763|FG000|Overall Study|Physician Decision|2|||
161835686|NCT04285567|584440764|FG001|Overall Study|Physician Decision|1|||
161644253|NCT01270828|583747578|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
161644254|NCT01270828|583747579|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
161644255|NCT01270828|583747577|FG000|Pregabalin CR SB|Unrelated AE|0|||
161644256|NCT01270828|583747578|FG001|Pregabalin CR SB|Unrelated AE|0|||
161644257|NCT01270828|583747579|FG002|Pregabalin CR SB|Unrelated AE|8|||
161644258|NCT01270828|583747577|FG000|Pregabalin CR SB|Protocol Violation|0|||
161644259|NCT01270828|583747578|FG001|Pregabalin CR SB|Protocol Violation|0|||
161644260|NCT01270828|583747579|FG002|Pregabalin CR SB|Protocol Violation|8|||
161644261|NCT01270828|583747577|FG000|Double Blind Phase|Death|0|||
161644262|NCT01270828|583747578|FG001|Double Blind Phase|Death|1|||
161644263|NCT01270828|583747579|FG002|Double Blind Phase|Death|0|||
161644264|NCT01270828|583747577|FG000|Double Blind Phase|Protocol Violation|0|||
161644265|NCT01270828|583747578|FG001|Double Blind Phase|Protocol Violation|1|||
161644266|NCT01270828|583747579|FG002|Double Blind Phase|Protocol Violation|0|||
161644267|NCT01270828|583747577|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
161644268|NCT01270828|583747578|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
161644269|NCT01270828|583747579|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
161644270|NCT01270828|583747577|FG000|Double Blind Phase|Reason Unspecified|7|||
161644271|NCT01270828|583747578|FG001|Double Blind Phase|Reason Unspecified|4|||
161644272|NCT01270828|583747579|FG002|Double Blind Phase|Reason Unspecified|0|||
161644273|NCT01270828|583747577|FG000|Double Blind Phase|Withdrawal by Subject|6|||
161644274|NCT01270828|583747578|FG001|Double Blind Phase|Withdrawal by Subject|15|||
161644275|NCT01270828|583747579|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161644276|NCT01270828|583747577|FG000|Double Blind Phase|Lost to Follow-up|1|||
161644277|NCT01270828|583747578|FG001|Double Blind Phase|Lost to Follow-up|2|||
161644278|NCT01270828|583747579|FG002|Double Blind Phase|Lost to Follow-up|0|||
161644279|NCT01270828|583747577|FG000|Double Blind Phase|Lack of Efficacy|2|||
161644280|NCT01270828|583747578|FG001|Double Blind Phase|Lack of Efficacy|11|||
161644281|NCT01270828|583747579|FG002|Double Blind Phase|Lack of Efficacy|0|||
161644282|NCT01270828|583747577|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
161644283|NCT01270828|583747578|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
161687913|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
161687914|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
161687915|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
161687916|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
161687917|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Other|1|||
161687918|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Other|1|||
161687919|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Other|0|||
161687920|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Other|0|||
161687921|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161687922|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161687923|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161687924|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
161835687|NCT04285567|584440763|FG000|Overall Study|Withdrawal by Subject|2|||
161835688|NCT04285567|584440764|FG001|Overall Study|Withdrawal by Subject|6|||
161835689|NCT04285567|584440763|FG000|Overall Study|Adverse Event|1|||
161835690|NCT04285567|584440764|FG001|Overall Study|Adverse Event|0|||
161835691|NCT04285567|584440763|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
161835692|NCT04285567|584440764|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
161835693|NCT00493779|584440765|FG000|Overall Study|Logistical issue at site|1|||
161835694|NCT02091141|584440767|FG000|Overall Study|Death|280|||
161835695|NCT02091141|584440768|FG001|Overall Study|Death|118|||
161835696|NCT02091141|584440769|FG002|Overall Study|Death|46|||
161835697|NCT02091141|584440770|FG003|Overall Study|Death|13|||
161835698|NCT02091141|584440771|FG004|Overall Study|Death|31|||
161835699|NCT02091141|584440772|FG005|Overall Study|Death|16|||
161835700|NCT02091141|584440773|FG006|Overall Study|Death|12|||
161835701|NCT02091141|584440767|FG000|Overall Study|Withdrawal by Subject|21|||
161835702|NCT02091141|584440768|FG001|Overall Study|Withdrawal by Subject|13|||
161835703|NCT02091141|584440769|FG002|Overall Study|Withdrawal by Subject|3|||
161835704|NCT02091141|584440770|FG003|Overall Study|Withdrawal by Subject|2|||
161835705|NCT02091141|584440771|FG004|Overall Study|Withdrawal by Subject|2|||
161644284|NCT01270828|583747579|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
161644285|NCT01270828|583747577|FG000|Double Blind Phase|Adverse event related to study drug|5|||
161644286|NCT01270828|583747578|FG001|Double Blind Phase|Adverse event related to study drug|7|||
161644287|NCT01270828|583747579|FG002|Double Blind Phase|Adverse event related to study drug|0|||
161644288|NCT02870972|583747583|FG000|Overall Study|Adverse Event|1|||
161644289|NCT02870972|583747584|FG001|Overall Study|Adverse Event|0|||
161644290|NCT02870972|583747585|FG002|Overall Study|Adverse Event|0|||
161644291|NCT02870972|583747586|FG003|Overall Study|Adverse Event|0|||
161644292|NCT02870972|583747587|FG004|Overall Study|Adverse Event|0|||
161644293|NCT01821937|583747592|FG000|Overall Study|Adverse Event|0|||
161644294|NCT01821937|583747593|FG001|Overall Study|Adverse Event|3|||
161644295|NCT02615509|583747594|FG000|Overall Study|Lost to Follow-up|134|||
161644296|NCT02615509|583747594|FG000|Overall Study|Death|4|||
161644297|NCT02615509|583747594|FG000|Overall Study|Withdrawal by Subject|8|||
161644298|NCT03334253|583747595|FG000|Overall Study|Withdrawal by Subject|1|||
161644299|NCT03334253|583747596|FG001|Overall Study|Withdrawal by Subject|0|||
161644300|NCT03334253|583747595|FG000|Overall Study|Lost to Follow-up|4|||
161644301|NCT03334253|583747596|FG001|Overall Study|Lost to Follow-up|3|||
161644302|NCT03334253|583747595|FG000|Overall Study|Moved residence|2|||
161644303|NCT03334253|583747596|FG001|Overall Study|Moved residence|2|||
161644304|NCT00968526|583747597|FG000|Overall Study|Adverse Event|2|||
161644305|NCT00968526|583747598|FG001|Overall Study|Adverse Event|0|||
161644306|NCT00968526|583747597|FG000|Overall Study|Migrated/moved from study area|1|||
161644307|NCT00968526|583747598|FG001|Overall Study|Migrated/moved from study area|0|||
161644308|NCT02030002|583747602|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
161644309|NCT02030002|583747602|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
161644310|NCT02030002|583747602|FG000|Follow-up|Lost to Follow-up|2|||
161644311|NCT00609947|583747603|FG000|Overall Study|Death|1|||
161644312|NCT00504075|583747604|FG000|Overall Study|Adverse Event|1|||
161644313|NCT00504075|583747604|FG000|Overall Study|Lost to Follow-up|5|||
161644314|NCT00504075|583747604|FG000|Overall Study|Withdrawal by Subject|1|||
161644315|NCT00504075|583747604|FG000|Overall Study|Required other therapeutic intervention|1|||
161644316|NCT02406248|583747605|FG000|Overall Study|Death|7|||
161644317|NCT02406248|583747605|FG000|Overall Study|Withdrawal by Subject|2|||
161644318|NCT01689857|583747607|FG000|Overall Study|Lost to Follow-up|5|||
161644319|NCT01689857|583747608|FG001|Overall Study|Lost to Follow-up|2|||
161644320|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
161644321|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
161644322|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
161644323|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
161644324|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
161644325|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
161644326|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
161644327|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
161644328|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
161644329|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
161644330|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
161644331|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
161644332|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
161644333|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
161644334|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
161644335|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
161644336|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
161644337|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
161644338|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
161644339|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
161644340|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
161644341|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
161644342|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
161644343|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
161644344|NCT00479882|583747611|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
161644345|NCT00479882|583747612|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
161644346|NCT00479882|583747613|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
161644347|NCT00479882|583747614|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
161644348|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
161644349|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
161644350|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
161644351|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
161644352|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
161835706|NCT02091141|584440772|FG005|Overall Study|Withdrawal by Subject|3|||
161835707|NCT02091141|584440773|FG006|Overall Study|Withdrawal by Subject|0|||
161835708|NCT02091141|584440767|FG000|Overall Study|Lost to Follow-up|21|||
161835709|NCT02091141|584440768|FG001|Overall Study|Lost to Follow-up|5|||
161835710|NCT02091141|584440769|FG002|Overall Study|Lost to Follow-up|1|||
161835711|NCT02091141|584440770|FG003|Overall Study|Lost to Follow-up|0|||
161835712|NCT02091141|584440771|FG004|Overall Study|Lost to Follow-up|1|||
161835713|NCT02091141|584440772|FG005|Overall Study|Lost to Follow-up|2|||
161835714|NCT02091141|584440773|FG006|Overall Study|Lost to Follow-up|0|||
161835715|NCT02091141|584440767|FG000|Overall Study|Reason Not Specified|6|||
161835716|NCT02091141|584440768|FG001|Overall Study|Reason Not Specified|5|||
161835717|NCT02091141|584440769|FG002|Overall Study|Reason Not Specified|2|||
161835718|NCT02091141|584440770|FG003|Overall Study|Reason Not Specified|0|||
161644353|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
161644354|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
161644355|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
161644356|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
161644357|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
161644358|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
161644359|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
161644360|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
161644361|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
161644362|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
161644363|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
161644364|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
161644365|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
161644366|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
161644367|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
161644368|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
161644369|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
161644370|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
161644371|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
161644372|NCT00479882|583747611|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
161644373|NCT00479882|583747612|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
161644374|NCT00479882|583747613|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
161644375|NCT00479882|583747614|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
161644376|NCT03106753|583747615|FG000|Overall Study|Withdrawal by Subject|0|||
161644377|NCT03106753|583747616|FG001|Overall Study|Withdrawal by Subject|1|||
161644378|NCT03149042|583747617|FG000|Overall Study|Invasive FFR not performed|21|||
161644379|NCT03149042|583747617|FG000|Overall Study|Poor CT Image Quality|1|||
161644380|NCT03149042|583747617|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
161644381|NCT01643044|583747618|FG000|Overall Study|Lost to Follow-up|1|||
161644382|NCT01643044|583747619|FG001|Overall Study|Lost to Follow-up|1|||
161644383|NCT01643044|583747618|FG000|Overall Study|Miscarried baby|2|||
161644384|NCT01643044|583747619|FG001|Overall Study|Miscarried baby|2|||
161644385|NCT01643044|583747618|FG000|Overall Study|Delivered outside of hospital|1|||
161644386|NCT01643044|583747619|FG001|Overall Study|Delivered outside of hospital|2|||
161644387|NCT01023958|583747620|FG000|Overall Study|Progressive disease|48|||
161644388|NCT01023958|583747620|FG000|Overall Study|Other adverse event|1|||
161644389|NCT01023958|583747620|FG000|Overall Study|Refused to continue medication|1|||
161644390|NCT00762476|583747621|FG000|Overall Study|Adverse Event|7|||
161644391|NCT00762476|583747622|FG001|Overall Study|Adverse Event|1|||
161644392|NCT00762476|583747621|FG000|Overall Study|Lost to Follow-up|2|||
161644393|NCT00762476|583747622|FG001|Overall Study|Lost to Follow-up|0|||
161644394|NCT00762476|583747621|FG000|Overall Study|Protocol Violation|5|||
161644395|NCT00762476|583747622|FG001|Overall Study|Protocol Violation|6|||
161644396|NCT00762476|583747621|FG000|Overall Study|Physician Decision|2|||
161835719|NCT02091141|584440771|FG004|Overall Study|Reason Not Specified|0|||
161835720|NCT02091141|584440772|FG005|Overall Study|Reason Not Specified|0|||
161835721|NCT02091141|584440773|FG006|Overall Study|Reason Not Specified|1|||
161835722|NCT02091141|584440767|FG000|Overall Study|Study Ended by Sponsor|1|||
161644397|NCT00762476|583747622|FG001|Overall Study|Physician Decision|14|||
161644398|NCT00762476|583747621|FG000|Overall Study|Withdrawal by Subject|6|||
161644399|NCT00762476|583747622|FG001|Overall Study|Withdrawal by Subject|12|||
161644400|NCT00762476|583747621|FG000|Overall Study|antibiotic use|0|||
161644401|NCT00762476|583747622|FG001|Overall Study|antibiotic use|1|||
161644402|NCT00762476|583747621|FG000|Overall Study|non-compliance with study visits|0|||
161835723|NCT02091141|584440768|FG001|Overall Study|Study Ended by Sponsor|9|||
161835724|NCT02091141|584440769|FG002|Overall Study|Study Ended by Sponsor|0|||
161644403|NCT00762476|583747622|FG001|Overall Study|non-compliance with study visits|2|||
161644404|NCT00762476|583747621|FG000|Overall Study|Seasonal allergies|1|||
161644405|NCT00762476|583747622|FG001|Overall Study|Seasonal allergies|0|||
161644406|NCT02838134|583747623|FG000|Overall Study|Lost to Follow-up|1|||
161644407|NCT02838134|583747624|FG001|Overall Study|Lost to Follow-up|2|||
161644408|NCT02838134|583747623|FG000|Overall Study|logistic problems|1|||
161644409|NCT02838134|583747624|FG001|Overall Study|logistic problems|1|||
161644410|NCT01912404|583747628|FG000|Overall Study|Due to personal reasons|1|||
161644411|NCT01912404|583747629|FG001|Overall Study|Due to personal reasons|0|||
161644412|NCT01430468|583747630|FG000|Overall Study|Physician Decision|2|||
161644413|NCT01430468|583747631|FG001|Overall Study|Physician Decision|1|||
161644414|NCT01430468|583747630|FG000|Overall Study|Withdrawal by Subject|5|||
161644415|NCT01430468|583747631|FG001|Overall Study|Withdrawal by Subject|5|||
161644416|NCT01281839|583747632|FG000|Overall Study|Lost to Follow-up|6|||
161644417|NCT01281839|583747633|FG001|Overall Study|Lost to Follow-up|3|||
161644418|NCT01281839|583747632|FG000|Overall Study|Withdrawal by Subject|4|||
161644419|NCT01281839|583747633|FG001|Overall Study|Withdrawal by Subject|10|||
161644420|NCT01281839|583747632|FG000|Overall Study|Reason not specified|0|||
161644421|NCT01281839|583747633|FG001|Overall Study|Reason not specified|1|||
161644422|NCT01443923|583747634|FG000|Overall Study|Adverse Event|1|||
161644423|NCT01443923|583747635|FG001|Overall Study|Adverse Event|0|||
161644424|NCT01245374|583747636|FG000|Overall Study|Protocol Violation|1|||
161644425|NCT01245374|583747636|FG000|Overall Study|Withdrawal by Subject|3|||
161644426|NCT04674189|583747637|FG000|Overall Study|Adverse Event|0|||
161644427|NCT04674189|583747638|FG001|Overall Study|Adverse Event|0|||
161644428|NCT04674189|583747639|FG002|Overall Study|Adverse Event|1|||
161644429|NCT04674189|583747637|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
161644430|NCT04674189|583747638|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
161644431|NCT04674189|583747639|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
161644432|NCT04674189|583747637|FG000|Overall Study|Physician Decision|1|||
161644433|NCT04674189|583747638|FG001|Overall Study|Physician Decision|0|||
161644434|NCT04674189|583747639|FG002|Overall Study|Physician Decision|0|||
161644435|NCT04674189|583747637|FG000|Overall Study|Withdrawal by Participant|83|||
161644436|NCT04674189|583747638|FG001|Overall Study|Withdrawal by Participant|71|||
161644437|NCT04674189|583747639|FG002|Overall Study|Withdrawal by Participant|142|||
161644438|NCT04674189|583747637|FG000|Overall Study|Lost to Follow-up|55|||
161644439|NCT04674189|583747638|FG001|Overall Study|Lost to Follow-up|53|||
161644440|NCT04674189|583747639|FG002|Overall Study|Lost to Follow-up|44|||
161644441|NCT04674189|583747637|FG000|Overall Study|Miscellaneous|27|||
161644442|NCT04674189|583747638|FG001|Overall Study|Miscellaneous|23|||
161644443|NCT04674189|583747639|FG002|Overall Study|Miscellaneous|207|||
161644444|NCT04674189|583747637|FG000|Overall Study|Did Not Receive Treatment|3|||
161644445|NCT04674189|583747638|FG001|Overall Study|Did Not Receive Treatment|1|||
161644446|NCT04674189|583747639|FG002|Overall Study|Did Not Receive Treatment|2|||
161644447|NCT02600897|583747644|FG000|Overall Study|Death|1|||
161644448|NCT02600897|583747645|FG001|Overall Study|Death|2|||
161644449|NCT02600897|583747646|FG002|Overall Study|Death|1|||
161644450|NCT02600897|583747647|FG003|Overall Study|Death|2|||
161644451|NCT02600897|583747648|FG004|Overall Study|Death|3|||
161644452|NCT02600897|583747649|FG005|Overall Study|Death|2|||
161644453|NCT02600897|583747650|FG006|Overall Study|Death|10|||
161644454|NCT02600897|583747651|FG007|Overall Study|Death|7|||
161644455|NCT02600897|583747652|FG008|Overall Study|Death|20|||
161644456|NCT02600897|583747644|FG000|Overall Study|Lost to Follow-up|1|||
161644457|NCT02600897|583747645|FG001|Overall Study|Lost to Follow-up|0|||
161644458|NCT02600897|583747646|FG002|Overall Study|Lost to Follow-up|0|||
161835725|NCT02091141|584440770|FG003|Overall Study|Study Ended by Sponsor|0|||
161835726|NCT02091141|584440771|FG004|Overall Study|Study Ended by Sponsor|0|||
161835727|NCT02091141|584440772|FG005|Overall Study|Study Ended by Sponsor|0|||
161644459|NCT02600897|583747647|FG003|Overall Study|Lost to Follow-up|0|||
161644460|NCT02600897|583747648|FG004|Overall Study|Lost to Follow-up|0|||
161644461|NCT02600897|583747649|FG005|Overall Study|Lost to Follow-up|0|||
161644462|NCT02600897|583747650|FG006|Overall Study|Lost to Follow-up|0|||
161644463|NCT02600897|583747651|FG007|Overall Study|Lost to Follow-up|1|||
161644464|NCT02600897|583747652|FG008|Overall Study|Lost to Follow-up|0|||
161644465|NCT02600897|583747644|FG000|Overall Study|Withdrawal by Subject|0|||
161644466|NCT02600897|583747645|FG001|Overall Study|Withdrawal by Subject|0|||
161644467|NCT02600897|583747646|FG002|Overall Study|Withdrawal by Subject|0|||
161644468|NCT02600897|583747647|FG003|Overall Study|Withdrawal by Subject|0|||
161644469|NCT02600897|583747648|FG004|Overall Study|Withdrawal by Subject|0|||
161644470|NCT02600897|583747649|FG005|Overall Study|Withdrawal by Subject|0|||
161644471|NCT02600897|583747650|FG006|Overall Study|Withdrawal by Subject|0|||
161644472|NCT02600897|583747651|FG007|Overall Study|Withdrawal by Subject|4|||
161644473|NCT02600897|583747652|FG008|Overall Study|Withdrawal by Subject|2|||
161644474|NCT02600897|583747644|FG000|Overall Study|Reason Not Specified|0|||
161644475|NCT02600897|583747645|FG001|Overall Study|Reason Not Specified|0|||
161644476|NCT02600897|583747646|FG002|Overall Study|Reason Not Specified|0|||
161644477|NCT02600897|583747647|FG003|Overall Study|Reason Not Specified|0|||
161644478|NCT02600897|583747648|FG004|Overall Study|Reason Not Specified|0|||
161644479|NCT02600897|583747649|FG005|Overall Study|Reason Not Specified|0|||
161644480|NCT02600897|583747650|FG006|Overall Study|Reason Not Specified|0|||
161644481|NCT02600897|583747651|FG007|Overall Study|Reason Not Specified|0|||
161644482|NCT02600897|583747652|FG008|Overall Study|Reason Not Specified|1|||
161644483|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Adverse Event|10|||
161644484|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Adverse Event|9|||
161644485|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Adverse Event|7|||
161644486|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
161644487|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
161644488|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
161644489|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
161644490|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
161835728|NCT02091141|584440773|FG006|Overall Study|Study Ended by Sponsor|0|||
161835729|NCT02091141|584440767|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
161644491|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
161644492|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Physician Decision|7|||
161644493|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Physician Decision|3|||
161644494|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Physician Decision|2|||
161644495|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Pregnancy|2|||
161644496|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Pregnancy|1|||
161644497|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Pregnancy|3|||
161644498|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
161644499|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
161644500|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
161644501|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
161644502|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
161644503|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
161644504|NCT02614183|583747655|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
161644505|NCT02614183|583747656|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
161644506|NCT02614183|583747657|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
161644507|NCT02614183|583747655|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
161644508|NCT02614183|583747656|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161644509|NCT02614183|583747657|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
161644510|NCT02614183|583747655|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
161644511|NCT02614183|583747656|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
161644512|NCT02614183|583747657|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
161644513|NCT02614183|583747655|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
161644514|NCT02614183|583747656|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
161644515|NCT02614183|583747657|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
161644516|NCT02614183|583747655|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
161644517|NCT02614183|583747656|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
161644518|NCT02614183|583747657|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
161644519|NCT04680533|583747658|FG000|Overall Study|Screen failure|1|||
161644520|NCT01484431|583749203|FG000|Period 1: High Dose|Physician Decision|0|||
161644521|NCT01484431|583749204|FG001|Period 1: High Dose|Physician Decision|1|||
161644522|NCT01484431|583749205|FG002|Period 1: High Dose|Physician Decision|0|||
161644523|NCT01484431|583749203|FG000|Period 2|Death|0|||
161644524|NCT01484431|583749204|FG001|Period 2|Death|1|||
161644525|NCT01484431|583749205|FG002|Period 2|Death|1|||
161644526|NCT01484431|583749203|FG000|Period 2|Physician Decision|0|||
161644527|NCT01484431|583749204|FG001|Period 2|Physician Decision|0|||
161644528|NCT01484431|583749205|FG002|Period 2|Physician Decision|1|||
161644529|NCT01484431|583749203|FG000|Period 2|Non-Compliance with Study Drug|1|||
161687925|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161687926|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161687927|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161835730|NCT02091141|584440768|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
161835731|NCT02091141|584440769|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835732|NCT02091141|584440770|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835733|NCT02091141|584440771|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835734|NCT02091141|584440772|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835735|NCT02091141|584440773|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835736|NCT02246439|584440774|FG000|Overall Study|Adverse Event|3|||
161835737|NCT02246439|584440775|FG001|Overall Study|Adverse Event|0|||
161835738|NCT02246439|584440774|FG000|Overall Study|Lost to Follow-up|7|||
161835739|NCT02246439|584440775|FG001|Overall Study|Lost to Follow-up|5|||
161835740|NCT02246439|584440774|FG000|Overall Study|Protocol Violation|0|||
161835741|NCT02246439|584440775|FG001|Overall Study|Protocol Violation|2|||
161835742|NCT02246439|584440774|FG000|Overall Study|Physician Decision|0|||
161835743|NCT02246439|584440775|FG001|Overall Study|Physician Decision|1|||
161835744|NCT02246439|584440774|FG000|Overall Study|Unkonwn|1|||
161835745|NCT02246439|584440775|FG001|Overall Study|Unkonwn|3|||
161835746|NCT02246439|584440774|FG000|Overall Study|Withdrawal by Subject|1|||
161835747|NCT02246439|584440775|FG001|Overall Study|Withdrawal by Subject|0|||
161835748|NCT03439852|584440778|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
161835749|NCT03439852|584440779|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
161835750|NCT03439852|584440778|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
161835751|NCT03439852|584440779|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
161835752|NCT03439852|584440778|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
161835753|NCT03439852|584440779|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
161835754|NCT04551911|584440780|FG000|Overall Study|Lost to Follow-up|2|||
161835755|NCT04551911|584440781|FG001|Overall Study|Lost to Follow-up|1|||
161835756|NCT04551911|584440780|FG000|Overall Study|Withdrawal by Subject|10|||
161835757|NCT04551911|584440781|FG001|Overall Study|Withdrawal by Subject|10|||
161835758|NCT04551911|584440780|FG000|Overall Study|Did not receive the study drug|3|||
161835759|NCT04551911|584440781|FG001|Overall Study|Did not receive the study drug|4|||
161835760|NCT00866658|584440792|FG000|Overall Study|Adverse Event|5|||
161835761|NCT00866658|584440793|FG001|Overall Study|Adverse Event|14|||
161835762|NCT00866658|584440792|FG000|Overall Study|Lack of Efficacy|2|||
161835763|NCT00866658|584440793|FG001|Overall Study|Lack of Efficacy|1|||
161835764|NCT00866658|584440792|FG000|Overall Study|Withdrawal by Subject|1|||
161835765|NCT00866658|584440793|FG001|Overall Study|Withdrawal by Subject|0|||
161835766|NCT00866658|584440792|FG000|Overall Study|Protocol Violation|1|||
161835767|NCT00866658|584440793|FG001|Overall Study|Protocol Violation|1|||
161644530|NCT01484431|583749204|FG001|Period 2|Non-Compliance with Study Drug|0|||
161644531|NCT01484431|583749205|FG002|Period 2|Non-Compliance with Study Drug|0|||
161644532|NCT01251770|583749206|FG000|Overall Study|Protocol Violation|13|||
161644533|NCT01251770|583749207|FG001|Overall Study|Protocol Violation|7|||
161644534|NCT01901419|583749208|FG000|Overall Study|Protocol Violation|2|||
161644535|NCT01901419|583749209|FG001|Overall Study|Protocol Violation|6|||
161644536|NCT01901419|583749208|FG000|Overall Study|unavailable researchers|6|||
161644537|NCT01901419|583749209|FG001|Overall Study|unavailable researchers|3|||
161644538|NCT00475644|583749210|FG000|Overall Study|Protocol Violation|13|||
161644539|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
161644540|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
161644541|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
161644542|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
161644543|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
161644544|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
161644545|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
161644546|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
161644547|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
161644548|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
161644549|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
161644550|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
161644551|NCT00790400|583749217|FG000|Double-blind Period (Core Phase)|Death|1|||
161644552|NCT00790400|583749218|FG001|Double-blind Period (Core Phase)|Death|0|||
161644553|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
161644554|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
161644555|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
161644556|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
161644557|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
161644558|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
161644559|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
161644560|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
161644561|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
161644562|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
161644563|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Death|1|||
161644564|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Death|0|||
161644565|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
161644566|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
161644567|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
161644568|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
161644569|NCT00790400|583749217|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
161644570|NCT00790400|583749218|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
161644571|NCT02412735|583749221|FG000|Overall Study|Adverse Event|0|||
161644572|NCT02412735|583749222|FG001|Overall Study|Adverse Event|1|||
161644573|NCT02412735|583749223|FG002|Overall Study|Adverse Event|2|||
161644574|NCT02412735|583749221|FG000|Overall Study|Withdrawal by Subject|23|||
161644575|NCT02412735|583749222|FG001|Overall Study|Withdrawal by Subject|27|||
161644576|NCT02412735|583749223|FG002|Overall Study|Withdrawal by Subject|22|||
161644577|NCT02412735|583749221|FG000|Overall Study|Investigator Decision|3|||
161644578|NCT02412735|583749222|FG001|Overall Study|Investigator Decision|3|||
161644579|NCT02412735|583749223|FG002|Overall Study|Investigator Decision|2|||
161644580|NCT02412735|583749221|FG000|Overall Study|Lost to Follow-up|17|||
161644581|NCT02412735|583749222|FG001|Overall Study|Lost to Follow-up|11|||
161644582|NCT02412735|583749223|FG002|Overall Study|Lost to Follow-up|18|||
161644583|NCT02412735|583749221|FG000|Overall Study|Reason not Specified|3|||
161644584|NCT02412735|583749222|FG001|Overall Study|Reason not Specified|2|||
161644585|NCT02412735|583749223|FG002|Overall Study|Reason not Specified|2|||
161644586|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
161644587|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
161644588|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
161644589|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
161644590|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Death|13|||
161644591|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Death|12|||
161644592|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Progression|257|||
161644593|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Progression|218|||
161644594|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
161687928|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
161687929|NCT01883635|583908535|FG000|Overall Study|Withdrawal by Subject|4|||
161687930|NCT01883635|583908536|FG001|Overall Study|Withdrawal by Subject|0|||
161687931|NCT00761514|583908537|FG000|Overall Study|Adverse Event|1|||
161687932|NCT00761514|583908537|FG000|Overall Study|Withdrawal by Subject|2|||
161687933|NCT00761514|583908537|FG000|Overall Study|Lost to Follow-up|1|||
161687934|NCT00761514|583908537|FG000|Overall Study|Health insurance didn't cover study drug|1|||
161687935|NCT00761514|583908537|FG000|Overall Study|Problem complying with study visit|1|||
161687936|NCT00761514|583908537|FG000|Overall Study|Unable to pay for medications|1|||
161687937|NCT01979536|583908540|FG000|Overall Study|Physician Decision|2|||
161687938|NCT01979536|583908541|FG001|Overall Study|Physician Decision|3|||
161687939|NCT01979536|583908540|FG000|Overall Study|Withdrawal by Subject|0|||
161687940|NCT01979536|583908541|FG001|Overall Study|Withdrawal by Subject|1|||
161687941|NCT01979536|583908540|FG000|Overall Study|Refusal|0|||
161687942|NCT01979536|583908541|FG001|Overall Study|Refusal|1|||
161687943|NCT01979536|583908540|FG000|Overall Study|Relapse|0|||
161687944|NCT01979536|583908541|FG001|Overall Study|Relapse|1|||
161687945|NCT01979536|583908540|FG000|Overall Study|Study terminated by Sponsor|0|||
161687946|NCT01979536|583908541|FG001|Overall Study|Study terminated by Sponsor|1|||
161687947|NCT01979536|583908540|FG000|Overall Study|Did not start treatment|0|||
161687948|NCT01979536|583908541|FG001|Overall Study|Did not start treatment|1|||
161687949|NCT04294901|583908543|FG000|Overall Study|Death|86|||
161687950|NCT04294901|583908544|FG001|Overall Study|Death|110|||
161687951|NCT04294901|583908543|FG000|Overall Study|Provider did not have historical control patients|581|||
161687952|NCT04294901|583908544|FG001|Overall Study|Provider did not have historical control patients|0|||
161687953|NCT04294901|583908543|FG000|Overall Study|Provider did not have intervention patients|0|||
161687954|NCT04294901|583908544|FG001|Overall Study|Provider did not have intervention patients|98|||
161687955|NCT01934556|583908547|FG000|Overall Study|Withdrawal by Subject|0|||
161687956|NCT01934556|583908548|FG001|Overall Study|Withdrawal by Subject|1|||
161687957|NCT01934556|583908549|FG002|Overall Study|Withdrawal by Subject|1|||
161687958|NCT01934556|583908547|FG000|Overall Study|Lost to Follow-up|4|||
161687959|NCT01934556|583908548|FG001|Overall Study|Lost to Follow-up|10|||
161687960|NCT01934556|583908549|FG002|Overall Study|Lost to Follow-up|7|||
161687961|NCT01934556|583908547|FG000|Overall Study|Death|1|||
161687962|NCT01934556|583908548|FG001|Overall Study|Death|5|||
161687963|NCT01934556|583908549|FG002|Overall Study|Death|2|||
161687964|NCT01908101|583909770|FG000|Overall Study|Physician Decision|1|||
161687965|NCT01908101|583909770|FG000|Overall Study|Withdrawal by Subject|1|||
161687966|NCT01908101|583909770|FG000|Overall Study|Incorrect Diagnosis|2|||
161687967|NCT01908101|583909770|FG000|Overall Study|Incorrect Starting Dose|1|||
161687968|NCT01908101|583909770|FG000|Overall Study|Did not complete the first cycle|4|||
161687969|NCT01394939|583909771|FG000|Overall Study|Adverse Event|1|||
161687970|NCT01394939|583909772|FG001|Overall Study|Adverse Event|3|||
161687971|NCT01394939|583909773|FG002|Overall Study|Adverse Event|0|||
161687972|NCT01394939|583909774|FG003|Overall Study|Adverse Event|2|||
161687973|NCT01394939|583909771|FG000|Overall Study|Death|0|||
161687974|NCT01394939|583909772|FG001|Overall Study|Death|2|||
161687975|NCT01394939|583909773|FG002|Overall Study|Death|0|||
161687976|NCT01394939|583909774|FG003|Overall Study|Death|0|||
161687977|NCT01394939|583909771|FG000|Overall Study|Physician Decision|0|||
161687978|NCT01394939|583909772|FG001|Overall Study|Physician Decision|1|||
161687979|NCT01394939|583909773|FG002|Overall Study|Physician Decision|0|||
161687980|NCT01394939|583909774|FG003|Overall Study|Physician Decision|0|||
161687981|NCT01394939|583909771|FG000|Overall Study|Withdrawal by Subject|0|||
161687982|NCT01394939|583909772|FG001|Overall Study|Withdrawal by Subject|2|||
161687983|NCT01394939|583909773|FG002|Overall Study|Withdrawal by Subject|0|||
161687984|NCT01394939|583909774|FG003|Overall Study|Withdrawal by Subject|2|||
161687985|NCT01394939|583909771|FG000|Overall Study|Others|0|||
161687986|NCT01394939|583909772|FG001|Overall Study|Others|2|||
161687987|NCT01394939|583909773|FG002|Overall Study|Others|0|||
161687988|NCT01394939|583909774|FG003|Overall Study|Others|3|||
161687989|NCT03657043|583909777|FG000|Overall Study|Withdrawal by Subject|1|||
161687990|NCT03657043|583909778|FG001|Overall Study|Withdrawal by Subject|1|||
161687991|NCT03657043|583909779|FG002|Overall Study|Withdrawal by Subject|0|||
161687992|NCT03657043|583909780|FG003|Overall Study|Withdrawal by Subject|0|||
161687993|NCT03657043|583909781|FG004|Overall Study|Withdrawal by Subject|4|||
161687994|NCT03657043|583909777|FG000|Overall Study|Study closure by Sponsor|0|||
161687995|NCT03657043|583909778|FG001|Overall Study|Study closure by Sponsor|2|||
161687996|NCT03657043|583909779|FG002|Overall Study|Study closure by Sponsor|0|||
161687997|NCT03657043|583909780|FG003|Overall Study|Study closure by Sponsor|0|||
161687998|NCT03657043|583909781|FG004|Overall Study|Study closure by Sponsor|17|||
161687999|NCT03657043|583909777|FG000|Overall Study|Lost to Follow-up|0|||
161688000|NCT03657043|583909778|FG001|Overall Study|Lost to Follow-up|0|||
161688001|NCT03657043|583909779|FG002|Overall Study|Lost to Follow-up|0|||
161688002|NCT03657043|583909780|FG003|Overall Study|Lost to Follow-up|0|||
161688003|NCT03657043|583909781|FG004|Overall Study|Lost to Follow-up|4|||
161688004|NCT03657043|583909777|FG000|Overall Study|Death|6|||
161644595|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
161644596|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
161644597|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
161644598|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
161644599|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
161644600|NCT01006980|583749224|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
161644601|NCT01006980|583749225|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
161644602|NCT01006980|583749224|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
161644603|NCT01006980|583749225|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
161644604|NCT01006980|583749224|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
161644605|NCT01006980|583749225|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
161644606|NCT01006980|583749224|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
161644607|NCT01006980|583749225|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
161644608|NCT01006980|583749224|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
161688005|NCT03657043|583909778|FG001|Overall Study|Death|5|||
161644609|NCT01006980|583749225|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
161644610|NCT01006980|583749224|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
161644611|NCT01006980|583749225|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
161644612|NCT00078338|583749226|FG000|Overall Study|Adverse Event|31|||
161644613|NCT00078338|583749227|FG001|Overall Study|Adverse Event|24|||
161644614|NCT00078338|583749226|FG000|Overall Study|Lost to Follow-up|17|||
161644615|NCT00078338|583749227|FG001|Overall Study|Lost to Follow-up|2|||
161644616|NCT00078338|583749226|FG000|Overall Study|Protocol Violation|2|||
161644617|NCT00078338|583749227|FG001|Overall Study|Protocol Violation|2|||
161644618|NCT00078338|583749226|FG000|Overall Study|Disease Progression|4|||
161644619|NCT00078338|583749227|FG001|Overall Study|Disease Progression|7|||
161644620|NCT00078338|583749226|FG000|Overall Study|Other|28|||
161644621|NCT00078338|583749227|FG001|Overall Study|Other|16|||
161644622|NCT00078338|583749226|FG000|Overall Study|Subjects randomized, but not treated|3|||
161644623|NCT00078338|583749227|FG001|Overall Study|Subjects randomized, but not treated|3|||
161644624|NCT02124811|583749228|FG000|Overall Study|Early termination|2|||
161644625|NCT02124811|583749229|FG001|Overall Study|Early termination|2|||
161644626|NCT02124811|583749228|FG000|Overall Study|Withdrawal by Subject|1|||
161644627|NCT02124811|583749229|FG001|Overall Study|Withdrawal by Subject|0|||
161644628|NCT03445533|583749232|FG000|Overall Study|Progressive Disease|48|||
161644629|NCT03445533|583749233|FG001|Overall Study|Progressive Disease|81|||
161644630|NCT03445533|583749232|FG000|Overall Study|Adverse Event|60|||
161644631|NCT03445533|583749233|FG001|Overall Study|Adverse Event|64|||
161644632|NCT03445533|583749232|FG000|Overall Study|Death|9|||
161644633|NCT03445533|583749233|FG001|Overall Study|Death|19|||
161644634|NCT03445533|583749232|FG000|Overall Study|Miscellaneous|0|||
161644635|NCT03445533|583749233|FG001|Overall Study|Miscellaneous|16|||
161644636|NCT03445533|583749232|FG000|Overall Study|Withdrawal by Subject|3|||
161644637|NCT03445533|583749233|FG001|Overall Study|Withdrawal by Subject|4|||
161644638|NCT03445533|583749232|FG000|Overall Study|Physician Decision|1|||
161644639|NCT03445533|583749233|FG001|Overall Study|Physician Decision|3|||
161644640|NCT03445533|583749232|FG000|Overall Study|Sponsor Decision|0|||
161644641|NCT03445533|583749233|FG001|Overall Study|Sponsor Decision|1|||
161644642|NCT03445533|583749232|FG000|Overall Study|Lost to Follow-up|0|||
161644643|NCT03445533|583749233|FG001|Overall Study|Lost to Follow-up|1|||
161644644|NCT03445533|583749232|FG000|Overall Study|Never Received any Study Treatment|7|||
161644645|NCT03445533|583749233|FG001|Overall Study|Never Received any Study Treatment|4|||
161644646|NCT03274453|583749234|FG000|Overall Study|Lost to Follow-up|2|||
161644647|NCT03274453|583749235|FG001|Overall Study|Lost to Follow-up|5|||
161644648|NCT03274453|583749236|FG002|Overall Study|Lost to Follow-up|4|||
161644649|NCT03274453|583749237|FG003|Overall Study|Lost to Follow-up|1|||
161644650|NCT03274453|583749234|FG000|Overall Study|Physician Decision|2|||
161644651|NCT03274453|583749235|FG001|Overall Study|Physician Decision|0|||
161644652|NCT03274453|583749236|FG002|Overall Study|Physician Decision|0|||
161644653|NCT03274453|583749237|FG003|Overall Study|Physician Decision|3|||
161644654|NCT03274453|583749234|FG000|Overall Study|Surgery Cancelled|0|||
161644655|NCT03274453|583749235|FG001|Overall Study|Surgery Cancelled|1|||
161644656|NCT03274453|583749236|FG002|Overall Study|Surgery Cancelled|0|||
161644657|NCT03274453|583749237|FG003|Overall Study|Surgery Cancelled|0|||
161644658|NCT01294397|583749239|FG000|Overall Study|Withdrawal by Subject|1|||
161644659|NCT01294397|583749239|FG000|Overall Study|Administrative Decision|1|||
161644660|NCT01967069|583749240|FG000|Overall Study|Adverse Event|2|||
161644661|NCT01967069|583749241|FG001|Overall Study|Adverse Event|2|||
161644662|NCT01967069|583749240|FG000|Overall Study|Lost to Follow-up|5|||
161644663|NCT01967069|583749241|FG001|Overall Study|Lost to Follow-up|2|||
161644664|NCT01967069|583749240|FG000|Overall Study|Withdrawal by Subject|1|||
161644665|NCT01967069|583749241|FG001|Overall Study|Withdrawal by Subject|3|||
161644666|NCT01967069|583749240|FG000|Overall Study|Lack of Efficacy|0|||
161644667|NCT01967069|583749241|FG001|Overall Study|Lack of Efficacy|1|||
161644668|NCT05569421|583749242|FG000|Overall Study|Withdrawal by Subject|1|||
161644669|NCT05569421|583749243|FG001|Overall Study|Withdrawal by Subject|0|||
161644670|NCT05569421|583749244|FG002|Overall Study|Withdrawal by Subject|0|||
161644671|NCT01736540|583749246|FG000|Overall Study|Did not complete scan within 45 days|2|||
161644672|NCT01736540|583749246|FG000|Overall Study|Death|1|||
161644673|NCT01736540|583749246|FG000|Overall Study|Abnormal test procedure|1|||
161644674|NCT01736540|583749246|FG000|Overall Study|Withdrawal by Subject|5|||
161644675|NCT01736540|583749246|FG000|Overall Study|Protocol Violation|1|||
161644676|NCT01736540|583749246|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
161644677|NCT01736540|583749246|FG000|Overall Study|No show for MRI appointment|1|||
161644678|NCT01736540|583749246|FG000|Overall Study|Unable to make MRI appointment|3|||
161644679|NCT00790205|583749256|FG000|Overall Study|Lost to Follow-up|61|||
161644680|NCT00790205|583749257|FG001|Overall Study|Lost to Follow-up|71|||
161644681|NCT00790205|583749256|FG000|Overall Study|Withdrawal by Subject|299|||
161644682|NCT00790205|583749257|FG001|Overall Study|Withdrawal by Subject|363|||
161644683|NCT01031628|583749258|FG000|Overall Study|Study terminated early|0|||
161644684|NCT01031628|583749259|FG001|Overall Study|Study terminated early|1|||
161644685|NCT01031628|583749260|FG002|Overall Study|Study terminated early|3|||
161644686|NCT01031628|583749261|FG003|Overall Study|Study terminated early|0|||
161688006|NCT03657043|583909779|FG002|Overall Study|Death|0|||
161688007|NCT03657043|583909780|FG003|Overall Study|Death|0|||
161688008|NCT03657043|583909781|FG004|Overall Study|Death|53|||
161688009|NCT03657043|583909777|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
161688010|NCT03657043|583909778|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
161688011|NCT03657043|583909779|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
161688012|NCT03657043|583909780|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
161688013|NCT03657043|583909781|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
161688014|NCT03657043|583909777|FG000|Overall Study|Adverse Event|0|||
161688015|NCT03657043|583909778|FG001|Overall Study|Adverse Event|0|||
161688016|NCT03657043|583909779|FG002|Overall Study|Adverse Event|0|||
161688017|NCT03657043|583909780|FG003|Overall Study|Adverse Event|0|||
161688018|NCT03657043|583909781|FG004|Overall Study|Adverse Event|2|||
161688019|NCT03657043|583909777|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
161688020|NCT03657043|583909778|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
161688021|NCT03657043|583909779|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
161688022|NCT03657043|583909780|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
161688023|NCT03657043|583909781|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
161688024|NCT03657043|583909777|FG000|Overall Study|Withdrawal - declined follow-up|0|||
161688025|NCT03657043|583909778|FG001|Overall Study|Withdrawal - declined follow-up|0|||
161688026|NCT03657043|583909779|FG002|Overall Study|Withdrawal - declined follow-up|0|||
161688027|NCT03657043|583909780|FG003|Overall Study|Withdrawal - declined follow-up|0|||
161688028|NCT03657043|583909781|FG004|Overall Study|Withdrawal - declined follow-up|1|||
161688029|NCT01995071|583909782|FG000|Overall Study|Adverse Event|0|||
161688030|NCT01995071|583909783|FG001|Overall Study|Adverse Event|0|||
161688031|NCT01995071|583909784|FG002|Overall Study|Adverse Event|0|||
161688032|NCT01995071|583909785|FG003|Overall Study|Adverse Event|0|||
161688033|NCT01995071|583909786|FG004|Overall Study|Adverse Event|0|||
161688034|NCT01995071|583909787|FG005|Overall Study|Adverse Event|0|||
161688035|NCT01995071|583909788|FG006|Overall Study|Adverse Event|1|||
161688036|NCT01995071|583909789|FG007|Overall Study|Adverse Event|0|||
161688037|NCT01995071|583909790|FG008|Overall Study|Adverse Event|0|||
161688038|NCT01995071|583909791|FG009|Overall Study|Adverse Event|0|||
161688039|NCT01995071|583909792|FG010|Overall Study|Adverse Event|0|||
161688040|NCT01995071|583909793|FG011|Overall Study|Adverse Event|0|||
161688041|NCT01995071|583909782|FG000|Overall Study|Moved|0|||
161688042|NCT01995071|583909783|FG001|Overall Study|Moved|0|||
161688043|NCT01995071|583909784|FG002|Overall Study|Moved|1|||
161688044|NCT01995071|583909785|FG003|Overall Study|Moved|0|||
161688045|NCT01995071|583909786|FG004|Overall Study|Moved|1|||
161688046|NCT01995071|583909787|FG005|Overall Study|Moved|0|||
161688047|NCT01995071|583909788|FG006|Overall Study|Moved|0|||
161688048|NCT01995071|583909789|FG007|Overall Study|Moved|0|||
161688049|NCT01995071|583909790|FG008|Overall Study|Moved|0|||
161688050|NCT01995071|583909791|FG009|Overall Study|Moved|0|||
161688051|NCT01995071|583909792|FG010|Overall Study|Moved|1|||
161688052|NCT01995071|583909793|FG011|Overall Study|Moved|0|||
161688053|NCT01995071|583909782|FG000|Overall Study|Lost to Follow-up|1|||
161688054|NCT01995071|583909783|FG001|Overall Study|Lost to Follow-up|0|||
161688055|NCT01995071|583909784|FG002|Overall Study|Lost to Follow-up|0|||
161688056|NCT01995071|583909785|FG003|Overall Study|Lost to Follow-up|0|||
161688057|NCT01995071|583909786|FG004|Overall Study|Lost to Follow-up|0|||
161688058|NCT01995071|583909787|FG005|Overall Study|Lost to Follow-up|0|||
161688059|NCT01995071|583909788|FG006|Overall Study|Lost to Follow-up|0|||
161688060|NCT01995071|583909789|FG007|Overall Study|Lost to Follow-up|1|||
161688061|NCT01995071|583909790|FG008|Overall Study|Lost to Follow-up|1|||
161688062|NCT01995071|583909791|FG009|Overall Study|Lost to Follow-up|0|||
161688063|NCT01995071|583909792|FG010|Overall Study|Lost to Follow-up|0|||
161688064|NCT01995071|583909793|FG011|Overall Study|Lost to Follow-up|0|||
161688065|NCT01995071|583909782|FG000|Overall Study|Incarcerated|0|||
161688066|NCT01995071|583909783|FG001|Overall Study|Incarcerated|0|||
161688067|NCT01995071|583909784|FG002|Overall Study|Incarcerated|0|||
161688068|NCT01995071|583909785|FG003|Overall Study|Incarcerated|0|||
161644687|NCT02643628|583749264|FG000|Overall Study|Lost to Follow-up|1|||
161644688|NCT02643628|583749265|FG001|Overall Study|Lost to Follow-up|4|||
161644689|NCT02643628|583749264|FG000|Overall Study|Withdrawal by Subject|0|||
161644690|NCT02643628|583749265|FG001|Overall Study|Withdrawal by Subject|1|||
161644691|NCT02643628|583749264|FG000|Overall Study|Relocated out of state|0|||
161644692|NCT02643628|583749265|FG001|Overall Study|Relocated out of state|1|||
161644693|NCT05143138|583749266|FG000|Overall Study|Death|5|||
161644694|NCT05143138|583749267|FG001|Overall Study|Death|35|||
161688069|NCT01995071|583909786|FG004|Overall Study|Incarcerated|0|||
161688070|NCT01995071|583909787|FG005|Overall Study|Incarcerated|0|||
161688071|NCT01995071|583909788|FG006|Overall Study|Incarcerated|0|||
161688072|NCT01995071|583909789|FG007|Overall Study|Incarcerated|1|||
161688073|NCT01995071|583909790|FG008|Overall Study|Incarcerated|0|||
161644695|NCT05143138|583749268|FG002|Overall Study|Death|1|||
161644696|NCT05143138|583749266|FG000|Overall Study|Lost to Follow-up|2|||
161688074|NCT01995071|583909791|FG009|Overall Study|Incarcerated|0|||
161688075|NCT01995071|583909792|FG010|Overall Study|Incarcerated|0|||
161688076|NCT01995071|583909793|FG011|Overall Study|Incarcerated|0|||
161688077|NCT01659320|583909798|FG000|Overall Study|Withdrawal by Subject|2|||
161688078|NCT01659320|583909798|FG000|Overall Study|Physician Decision|1|||
161688079|NCT00590590|583909799|FG000|Overall Study|Lack of Efficacy|1|||
161688080|NCT00590590|583909800|FG001|Overall Study|Lack of Efficacy|2|||
161688081|NCT00590590|583909801|FG002|Overall Study|Lack of Efficacy|0|||
161688082|NCT00590590|583909799|FG000|Overall Study|Adverse Event|1|||
161688083|NCT00590590|583909800|FG001|Overall Study|Adverse Event|0|||
161688084|NCT00590590|583909801|FG002|Overall Study|Adverse Event|0|||
161688085|NCT00590590|583909799|FG000|Overall Study|Protocol Violation|0|||
161688086|NCT00590590|583909800|FG001|Overall Study|Protocol Violation|0|||
161688087|NCT00590590|583909801|FG002|Overall Study|Protocol Violation|2|||
161688088|NCT00590590|583909799|FG000|Overall Study|Lost to Follow-up|4|||
161688089|NCT00590590|583909800|FG001|Overall Study|Lost to Follow-up|1|||
161688090|NCT00590590|583909801|FG002|Overall Study|Lost to Follow-up|2|||
161688091|NCT00590590|583909799|FG000|Overall Study|Withdrawal by Subject|0|||
161688092|NCT00590590|583909800|FG001|Overall Study|Withdrawal by Subject|1|||
161688093|NCT00590590|583909801|FG002|Overall Study|Withdrawal by Subject|1|||
161688094|NCT00590590|583909799|FG000|Overall Study|Did not complete due to study closure|1|||
161688095|NCT00590590|583909800|FG001|Overall Study|Did not complete due to study closure|1|||
161688096|NCT00590590|583909801|FG002|Overall Study|Did not complete due to study closure|1|||
161688097|NCT00590590|583909799|FG000|Overall Study|Did not complete study|0|||
161688098|NCT00590590|583909800|FG001|Overall Study|Did not complete study|1|||
161688099|NCT00590590|583909801|FG002|Overall Study|Did not complete study|0|||
161688100|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
161688101|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161688102|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161688103|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161688104|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
161688105|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161688106|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161688107|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161688108|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
161688109|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161688110|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161688111|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161688112|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
161688113|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161688114|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161688115|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161688116|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
161688117|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161688118|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161688119|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161688120|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
161688121|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161688122|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161688123|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161688124|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
161688125|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161688126|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161688127|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161688128|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
161688129|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161688130|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161688131|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161688132|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
161688133|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161688134|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161688135|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161688136|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
161644697|NCT05143138|583749267|FG001|Overall Study|Lost to Follow-up|4|||
161644698|NCT05143138|583749268|FG002|Overall Study|Lost to Follow-up|0|||
161644699|NCT05143138|583749266|FG000|Overall Study|withdrawal|1|||
161835768|NCT00866658|584440792|FG000|Overall Study|Familial and Personal Reasons|4|||
161644700|NCT05143138|583749267|FG001|Overall Study|withdrawal|1|||
161644701|NCT05143138|583749268|FG002|Overall Study|withdrawal|0|||
161644702|NCT04245345|583749271|FG000|Overall Study|Death|1|||
161644703|NCT04245345|583749271|FG000|Overall Study|Exited prior to implant|5|||
161644704|NCT04245345|583749271|FG000|Overall Study|Exited prior to 1-month|9|||
161644705|NCT04245345|583749271|FG000|Overall Study|Missed 1-month visit|3|||
161644706|NCT04245345|583749271|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
161644707|NCT04245345|583749271|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
161644708|NCT04805073|583749275|FG000|Overall Study|study personnel not available|2|||
161644709|NCT04805073|583749276|FG001|Overall Study|study personnel not available|0|||
161644710|NCT04805073|583749275|FG000|Overall Study|spinal anesthesia failure|0|||
161644711|NCT04805073|583749276|FG001|Overall Study|spinal anesthesia failure|1|||
161644712|NCT04805073|583749275|FG000|Overall Study|Lost to Follow-up|0|||
161644713|NCT04805073|583749276|FG001|Overall Study|Lost to Follow-up|2|||
161644714|NCT00422734|583749280|FG000|Overall Study|Physician Decision|1|||
161644715|NCT00422734|583749281|FG001|Overall Study|Physician Decision|1|||
161644716|NCT00422734|583749280|FG000|Overall Study|Protocol Violation|1|||
161644717|NCT00422734|583749281|FG001|Overall Study|Protocol Violation|6|||
161644718|NCT00422734|583749280|FG000|Overall Study|Withdrawal by Subject|12|||
161644719|NCT00422734|583749281|FG001|Overall Study|Withdrawal by Subject|8|||
161644720|NCT00422734|583749280|FG000|Overall Study|Adverse Event|0|||
161644721|NCT00422734|583749281|FG001|Overall Study|Adverse Event|3|||
161644722|NCT00422734|583749280|FG000|Overall Study|Partner Decision|0|||
161644723|NCT00422734|583749281|FG001|Overall Study|Partner Decision|3|||
161644724|NCT01081886|583749282|FG000|Overall Study|Study termination|11|||
161644725|NCT01081886|583749283|FG001|Overall Study|Study termination|13|||
161644726|NCT02975102|583749287|FG000|Overall Study|Adverse Event|2|||
161835769|NCT00866658|584440793|FG001|Overall Study|Familial and Personal Reasons|5|||
161835770|NCT00430495|584440795|FG000|Overall Study|Adverse Event|2|||
161644727|NCT02975102|583749288|FG001|Overall Study|Adverse Event|1|||
161644728|NCT03017742|583749289|FG000|Overall Study|Protocol Violation|36|||
161644729|NCT03017742|583749289|FG000|Overall Study|Withdrawal by Subject|37|||
161644730|NCT04148651|583749292|FG000|Overall Study|Lost to Follow-up|2|||
161644731|NCT05262751|583749295|FG000|Washout Period 2|Adverse Event|1|||
161644732|NCT05262751|583749296|FG001|Washout Period 2|Adverse Event|0|||
161644733|NCT05262751|583749297|FG002|Washout Period 2|Adverse Event|0|||
161644734|NCT05262751|583749298|FG003|Washout Period 2|Adverse Event|0|||
161644735|NCT05262751|583749299|FG004|Washout Period 2|Adverse Event|0|||
161644736|NCT05262751|583749300|FG005|Washout Period 2|Adverse Event|0|||
161644737|NCT05262751|583749295|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
161644738|NCT05262751|583749296|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
161644739|NCT05262751|583749297|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
161644740|NCT05262751|583749298|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
161644741|NCT05262751|583749299|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
161644742|NCT05262751|583749300|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
161644743|NCT03690427|583749301|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
161644744|NCT03690427|583749302|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
161644745|NCT02609672|583749305|FG000|Overall Study|Lost to Follow-up|3|||
161644746|NCT02609672|583749306|FG001|Overall Study|Lost to Follow-up|1|||
161644747|NCT03392168|583749308|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
161644748|NCT03392168|583749309|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
161644749|NCT03392168|583749310|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
161644750|NCT03392168|583749311|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
161644751|NCT03392168|583749308|FG000|Period 2: Cohort 2|Other|0|||
161644752|NCT03392168|583749309|FG001|Period 2: Cohort 2|Other|1|||
161644753|NCT03392168|583749310|FG002|Period 2: Cohort 2|Other|0|||
161644754|NCT03392168|583749311|FG003|Period 2: Cohort 2|Other|0|||
161835771|NCT00430495|584440796|FG001|Overall Study|Adverse Event|3|||
161835772|NCT00430495|584440797|FG002|Overall Study|Adverse Event|2|||
161835773|NCT00430495|584440798|FG003|Overall Study|Adverse Event|0|||
161835774|NCT00430495|584440795|FG000|Overall Study|Death|0|||
161835775|NCT00430495|584440796|FG001|Overall Study|Death|0|||
161835776|NCT00430495|584440797|FG002|Overall Study|Death|1|||
161835777|NCT00430495|584440798|FG003|Overall Study|Death|0|||
161835778|NCT00430495|584440795|FG000|Overall Study|Lost to Follow-up|0|||
161835779|NCT00430495|584440796|FG001|Overall Study|Lost to Follow-up|1|||
161835780|NCT00430495|584440797|FG002|Overall Study|Lost to Follow-up|4|||
161835781|NCT00430495|584440798|FG003|Overall Study|Lost to Follow-up|0|||
161835782|NCT00430495|584440795|FG000|Overall Study|Protocol Violation|1|||
161835783|NCT00430495|584440796|FG001|Overall Study|Protocol Violation|0|||
161835784|NCT00430495|584440797|FG002|Overall Study|Protocol Violation|1|||
161835785|NCT00430495|584440798|FG003|Overall Study|Protocol Violation|0|||
161835786|NCT00430495|584440795|FG000|Overall Study|Disease Progression|1|||
161835787|NCT00430495|584440796|FG001|Overall Study|Disease Progression|1|||
161835788|NCT00430495|584440797|FG002|Overall Study|Disease Progression|0|||
161835789|NCT00430495|584440798|FG003|Overall Study|Disease Progression|0|||
161835790|NCT00430495|584440795|FG000|Overall Study|Other|8|||
161835791|NCT00430495|584440796|FG001|Overall Study|Other|2|||
161835792|NCT00430495|584440797|FG002|Overall Study|Other|5|||
161835793|NCT00430495|584440798|FG003|Overall Study|Other|4|||
161835794|NCT00430495|584440795|FG000|Overall Study|Randomized but not Treated|2|||
161835795|NCT00430495|584440796|FG001|Overall Study|Randomized but not Treated|0|||
161835796|NCT00430495|584440797|FG002|Overall Study|Randomized but not Treated|0|||
161835797|NCT00430495|584440798|FG003|Overall Study|Randomized but not Treated|0|||
161835798|NCT00158756|584440799|FG000|Overall Study|Withdrawal by Subject|5|||
161835799|NCT00158756|584440800|FG001|Overall Study|Withdrawal by Subject|0|||
161835800|NCT00158756|584440801|FG002|Overall Study|Withdrawal by Subject|6|||
161835801|NCT00158756|584440802|FG003|Overall Study|Withdrawal by Subject|1|||
161835802|NCT00158756|584440803|FG004|Overall Study|Withdrawal by Subject|3|||
161835803|NCT00158756|584440799|FG000|Overall Study|Adverse Event|0|||
161644755|NCT03519204|583749312|FG000|Overall Study|Lost to Follow-up|3|||
161644756|NCT03519204|583749313|FG001|Overall Study|Lost to Follow-up|8|||
161644757|NCT03519204|583749312|FG000|Overall Study|Withdrawal by Subject|9|||
161644758|NCT03519204|583749313|FG001|Overall Study|Withdrawal by Subject|7|||
161644759|NCT03519204|583749312|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161644760|NCT03519204|583749313|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161644761|NCT01441635|583749314|FG000|Overall Study|Adverse Event|4|||
161644762|NCT01441635|583749315|FG001|Overall Study|Adverse Event|3|||
161644763|NCT01441635|583749316|FG002|Overall Study|Adverse Event|1|||
161644764|NCT01441635|583749317|FG003|Overall Study|Adverse Event|5|||
161644765|NCT01441635|583749318|FG004|Overall Study|Adverse Event|1|||
161644766|NCT01441635|583749319|FG005|Overall Study|Adverse Event|2|||
161644767|NCT01441635|583749320|FG006|Overall Study|Adverse Event|2|||
161644768|NCT01441635|583749321|FG007|Overall Study|Adverse Event|2|||
161644769|NCT01441635|583749322|FG008|Overall Study|Adverse Event|1|||
161835804|NCT00158756|584440800|FG001|Overall Study|Adverse Event|0|||
161835805|NCT00158756|584440801|FG002|Overall Study|Adverse Event|1|||
161835806|NCT00158756|584440802|FG003|Overall Study|Adverse Event|0|||
161835807|NCT00158756|584440803|FG004|Overall Study|Adverse Event|0|||
161644770|NCT01441635|583749323|FG009|Overall Study|Adverse Event|0|||
161644771|NCT01441635|583749314|FG000|Overall Study|Withdrawal by Subject|1|||
161644772|NCT01441635|583749315|FG001|Overall Study|Withdrawal by Subject|1|||
161644773|NCT01441635|583749316|FG002|Overall Study|Withdrawal by Subject|0|||
161644774|NCT01441635|583749317|FG003|Overall Study|Withdrawal by Subject|1|||
161644775|NCT01441635|583749318|FG004|Overall Study|Withdrawal by Subject|0|||
161644776|NCT01441635|583749319|FG005|Overall Study|Withdrawal by Subject|0|||
161644777|NCT01441635|583749320|FG006|Overall Study|Withdrawal by Subject|2|||
161644778|NCT01441635|583749321|FG007|Overall Study|Withdrawal by Subject|0|||
161644779|NCT01441635|583749322|FG008|Overall Study|Withdrawal by Subject|1|||
161644780|NCT01441635|583749323|FG009|Overall Study|Withdrawal by Subject|1|||
161644781|NCT01441635|583749314|FG000|Overall Study|Lost to Follow-up|0|||
161644782|NCT01441635|583749315|FG001|Overall Study|Lost to Follow-up|1|||
161644783|NCT01441635|583749316|FG002|Overall Study|Lost to Follow-up|1|||
161644784|NCT01441635|583749317|FG003|Overall Study|Lost to Follow-up|1|||
161644785|NCT01441635|583749318|FG004|Overall Study|Lost to Follow-up|1|||
161644786|NCT01441635|583749319|FG005|Overall Study|Lost to Follow-up|3|||
161644787|NCT01441635|583749320|FG006|Overall Study|Lost to Follow-up|1|||
161644788|NCT01441635|583749321|FG007|Overall Study|Lost to Follow-up|1|||
161644789|NCT01441635|583749322|FG008|Overall Study|Lost to Follow-up|0|||
161644790|NCT01441635|583749323|FG009|Overall Study|Lost to Follow-up|1|||
161644791|NCT01441635|583749314|FG000|Overall Study|Noncompliance|0|||
161644792|NCT01441635|583749315|FG001|Overall Study|Noncompliance|1|||
161644793|NCT01441635|583749316|FG002|Overall Study|Noncompliance|0|||
161644794|NCT01441635|583749317|FG003|Overall Study|Noncompliance|0|||
161644795|NCT01441635|583749318|FG004|Overall Study|Noncompliance|0|||
161644796|NCT01441635|583749319|FG005|Overall Study|Noncompliance|0|||
161644797|NCT01441635|583749320|FG006|Overall Study|Noncompliance|1|||
161644798|NCT01441635|583749321|FG007|Overall Study|Noncompliance|0|||
161644799|NCT01441635|583749322|FG008|Overall Study|Noncompliance|0|||
161644800|NCT01441635|583749323|FG009|Overall Study|Noncompliance|0|||
161644801|NCT01441635|583749314|FG000|Overall Study|Surgery or Invasive Intervention|0|||
161644802|NCT01441635|583749315|FG001|Overall Study|Surgery or Invasive Intervention|0|||
161644803|NCT01441635|583749316|FG002|Overall Study|Surgery or Invasive Intervention|1|||
161644804|NCT01441635|583749317|FG003|Overall Study|Surgery or Invasive Intervention|0|||
161644805|NCT01441635|583749318|FG004|Overall Study|Surgery or Invasive Intervention|0|||
161644806|NCT01441635|583749319|FG005|Overall Study|Surgery or Invasive Intervention|0|||
161644807|NCT01441635|583749320|FG006|Overall Study|Surgery or Invasive Intervention|0|||
161644808|NCT01441635|583749321|FG007|Overall Study|Surgery or Invasive Intervention|0|||
161644809|NCT01441635|583749322|FG008|Overall Study|Surgery or Invasive Intervention|0|||
161644810|NCT01441635|583749323|FG009|Overall Study|Surgery or Invasive Intervention|0|||
161644811|NCT01441635|583749314|FG000|Overall Study|Received Exclusionary Medication|1|||
161644812|NCT01441635|583749315|FG001|Overall Study|Received Exclusionary Medication|0|||
161644813|NCT01441635|583749316|FG002|Overall Study|Received Exclusionary Medication|0|||
161644814|NCT01441635|583749317|FG003|Overall Study|Received Exclusionary Medication|0|||
161644815|NCT01441635|583749318|FG004|Overall Study|Received Exclusionary Medication|0|||
161644816|NCT01441635|583749319|FG005|Overall Study|Received Exclusionary Medication|0|||
161644817|NCT01441635|583749320|FG006|Overall Study|Received Exclusionary Medication|0|||
161644818|NCT01441635|583749321|FG007|Overall Study|Received Exclusionary Medication|0|||
161644819|NCT01441635|583749322|FG008|Overall Study|Received Exclusionary Medication|0|||
161644820|NCT01441635|583749323|FG009|Overall Study|Received Exclusionary Medication|0|||
161644821|NCT01441635|583749314|FG000|Overall Study|Other|0|||
161644822|NCT01441635|583749315|FG001|Overall Study|Other|0|||
161644823|NCT01441635|583749316|FG002|Overall Study|Other|0|||
161644824|NCT01441635|583749317|FG003|Overall Study|Other|0|||
161644825|NCT01441635|583749318|FG004|Overall Study|Other|0|||
161644826|NCT01441635|583749319|FG005|Overall Study|Other|0|||
161644827|NCT01441635|583749320|FG006|Overall Study|Other|0|||
161644828|NCT01441635|583749321|FG007|Overall Study|Other|1|||
161644829|NCT01441635|583749322|FG008|Overall Study|Other|0|||
161644830|NCT01441635|583749323|FG009|Overall Study|Other|0|||
161644831|NCT02637323|583749325|FG000|Overall Study|Lost to Follow-up|2|||
161644832|NCT02637323|583749326|FG001|Overall Study|Lost to Follow-up|0|||
161644833|NCT02637323|583749325|FG000|Overall Study|Protocol Violation|0|||
161644834|NCT02637323|583749326|FG001|Overall Study|Protocol Violation|1|||
161644835|NCT01154140|583749327|FG000|Overall Study|Death|71|||
161644836|NCT01154140|583749328|FG001|Overall Study|Death|81|||
161688137|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
161688138|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
161688139|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
161688140|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
161688141|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
161688142|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
161835808|NCT00158756|584440799|FG000|Overall Study|Serious adverse event|0|||
161644837|NCT01154140|583749327|FG000|Overall Study|Lost to Follow-up|4|||
161644838|NCT01154140|583749328|FG001|Overall Study|Lost to Follow-up|5|||
161644839|NCT01154140|583749327|FG000|Overall Study|Withdrawal by Subject|12|||
161644840|NCT01154140|583749328|FG001|Overall Study|Withdrawal by Subject|13|||
161644841|NCT01154140|583749327|FG000|Overall Study|Other|3|||
161644842|NCT01154140|583749328|FG001|Overall Study|Other|1|||
161644843|NCT01154140|583749327|FG000|Overall Study|Randomized but not treated|1|||
161644844|NCT01154140|583749328|FG001|Overall Study|Randomized but not treated|2|||
161644845|NCT00358644|583749329|FG000|Overall Study|Progressive Disease|21|||
161644846|NCT00358644|583749329|FG000|Overall Study|Adverse Event|7|||
161644847|NCT00358644|583749329|FG000|Overall Study|Death|11|||
161644848|NCT00358644|583749329|FG000|Overall Study|Withdrawal by Subject|4|||
161644849|NCT00358644|583749329|FG000|Overall Study|Physician Decision|6|||
161644850|NCT00358644|583749329|FG000|Overall Study|Patient not eligible for study|1|||
161644851|NCT00368875|583749330|FG000|Overall Study|Adverse Event|0|||
161644852|NCT00368875|583749331|FG001|Overall Study|Adverse Event|12|||
161644853|NCT00368875|583749330|FG000|Overall Study|Progressive disease|3|||
161644854|NCT00368875|583749331|FG001|Overall Study|Progressive disease|27|||
161644855|NCT00368875|583749330|FG000|Overall Study|Withdrawal by Subject|2|||
161644856|NCT00368875|583749331|FG001|Overall Study|Withdrawal by Subject|6|||
161644857|NCT00368875|583749330|FG000|Overall Study|Other Reason|0|||
161644858|NCT00368875|583749331|FG001|Overall Study|Other Reason|2|||
161644859|NCT00368875|583749330|FG000|Overall Study|Alternative Therapy|1|||
161644860|NCT00368875|583749331|FG001|Overall Study|Alternative Therapy|1|||
161644861|NCT03327831|583749332|FG000|Overall Study|Lost to Follow-up|2|||
161644862|NCT02595372|583749333|FG000|Overall Study|Adverse Event|6|||
161644863|NCT02595372|583749333|FG000|Overall Study|Physician Decision|2|||
161644864|NCT02595372|583749333|FG000|Overall Study|Disease Progression|1|||
161644865|NCT00401258|583749336|FG000|Overall Study|Adverse Event|7|||
161644866|NCT04297618|583749346|FG000|Overall Study|Adverse Event|1|||
161644867|NCT04297618|583749346|FG000|Overall Study|Withdrawal by Subject|1|||
161644868|NCT04704219|583749347|FG000|Overall Study|Screen Failure|1|||
161644869|NCT04704219|583749347|FG000|Overall Study|Withdrawal by Subject|1|||
161644870|NCT04704219|583749347|FG000|Overall Study|Death|78|||
161644871|NCT04704219|583749347|FG000|Overall Study|Participants Ongoing|80|||
161644872|NCT03816761|583751435|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161644873|NCT03816761|583751436|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161644874|NCT03816761|583751437|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161644875|NCT03816761|583751438|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161644876|NCT03816761|583751439|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161644877|NCT03816761|583751440|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
161644878|NCT03816761|583751435|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
161644879|NCT03816761|583751436|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
161644880|NCT03816761|583751437|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
161644881|NCT03816761|583751438|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
161644882|NCT03816761|583751439|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
161644883|NCT03816761|583751440|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
161644884|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
161644885|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
161644886|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161644887|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
161644888|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161644889|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161644890|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161644891|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
161644892|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161644893|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161644894|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
161644895|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161644896|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161644897|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
161644898|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161644899|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
161644900|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
161644901|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
161644902|NCT00603525|583751450|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
161644903|NCT00603525|583751451|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
161644904|NCT00603525|583751452|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
161644905|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161644906|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
161644907|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161644908|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161644909|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
161644910|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161835809|NCT00158756|584440800|FG001|Overall Study|Serious adverse event|0|||
161644911|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161644912|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
161644913|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161644914|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161644915|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
161644916|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161644917|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161644918|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
161644919|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161644920|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161644921|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
161644922|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161644923|NCT00603525|583751450|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161644924|NCT00603525|583751451|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
161644925|NCT00603525|583751452|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161644926|NCT00603525|583751450|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
161644927|NCT00603525|583751451|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
161644928|NCT00603525|583751452|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
161644929|NCT01483144|583751453|FG000|Overall Study|Adverse Event|9|||
161644930|NCT01483144|583751454|FG001|Overall Study|Adverse Event|4|||
161644931|NCT01483144|583751455|FG002|Overall Study|Adverse Event|6|||
161644932|NCT01483144|583751453|FG000|Overall Study|Withdrawal by Subject|0|||
161644933|NCT01483144|583751454|FG001|Overall Study|Withdrawal by Subject|2|||
161644934|NCT01483144|583751455|FG002|Overall Study|Withdrawal by Subject|5|||
161644935|NCT01483144|583751453|FG000|Overall Study|Physician Decision|1|||
161644936|NCT01483144|583751454|FG001|Overall Study|Physician Decision|0|||
161644937|NCT01483144|583751455|FG002|Overall Study|Physician Decision|0|||
161644938|NCT01483144|583751453|FG000|Overall Study|Lost to Follow-up|2|||
161644939|NCT01483144|583751454|FG001|Overall Study|Lost to Follow-up|4|||
161644940|NCT01483144|583751455|FG002|Overall Study|Lost to Follow-up|1|||
161644941|NCT01483144|583751453|FG000|Overall Study|Protocol Violation|3|||
161644942|NCT01483144|583751454|FG001|Overall Study|Protocol Violation|3|||
161644943|NCT01483144|583751455|FG002|Overall Study|Protocol Violation|3|||
161644944|NCT02460575|583751456|FG000|Overall Study|Lost to Follow-up|1|||
161644945|NCT02460575|583751457|FG001|Overall Study|Lost to Follow-up|0|||
161644946|NCT04043143|583751458|FG000|Overall Study|Lost to Follow-up|5|||
161644947|NCT04043143|583751459|FG001|Overall Study|Lost to Follow-up|5|||
161644948|NCT04043143|583751458|FG000|Overall Study|screen failure|1|||
161644949|NCT04043143|583751459|FG001|Overall Study|screen failure|0|||
161644950|NCT04307940|583751460|FG000|Overall Study|Adverse Event|1|||
161644951|NCT04307940|583751461|FG001|Overall Study|Adverse Event|0|||
161644952|NCT04307940|583751462|FG002|Overall Study|Adverse Event|0|||
161644953|NCT04307940|583751460|FG000|Overall Study|Withdrawal by Subject|2|||
161644954|NCT04307940|583751461|FG001|Overall Study|Withdrawal by Subject|3|||
161644955|NCT04307940|583751462|FG002|Overall Study|Withdrawal by Subject|1|||
161644956|NCT04307940|583751460|FG000|Overall Study|Lost to Follow-up|2|||
161644957|NCT04307940|583751461|FG001|Overall Study|Lost to Follow-up|0|||
161644958|NCT04307940|583751462|FG002|Overall Study|Lost to Follow-up|1|||
161644959|NCT04624243|583751466|FG000|Overall Study|Death|0|||
161644960|NCT04624243|583751467|FG001|Overall Study|Death|1|||
161644961|NCT04624243|583751468|FG002|Overall Study|Death|0|||
161688143|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
161688144|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161688145|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161688146|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161688147|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161688148|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161688149|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161688150|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
161688151|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161688152|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
161688153|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
161688154|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
161688155|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
161688156|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
161688157|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
161688158|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
161644962|NCT04624243|583751469|FG003|Overall Study|Death|0|||
161644963|NCT04624243|583751470|FG004|Overall Study|Death|0|||
161644964|NCT04624243|583751466|FG000|Overall Study|Lost to Follow-up|2|||
161644965|NCT04624243|583751467|FG001|Overall Study|Lost to Follow-up|3|||
161644966|NCT04624243|583751468|FG002|Overall Study|Lost to Follow-up|7|||
161644967|NCT04624243|583751469|FG003|Overall Study|Lost to Follow-up|1|||
161644968|NCT04624243|583751470|FG004|Overall Study|Lost to Follow-up|3|||
161644969|NCT04624243|583751466|FG000|Overall Study|Physician Decision|3|||
161644970|NCT04624243|583751467|FG001|Overall Study|Physician Decision|8|||
161644971|NCT04624243|583751468|FG002|Overall Study|Physician Decision|15|||
161644972|NCT04624243|583751469|FG003|Overall Study|Physician Decision|2|||
161688159|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
161688160|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
161688161|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161688162|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161688163|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
161688164|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
161644973|NCT04624243|583751470|FG004|Overall Study|Physician Decision|11|||
161644974|NCT04624243|583751466|FG000|Overall Study|Withdrawal by Subject|19|||
161644975|NCT04624243|583751467|FG001|Overall Study|Withdrawal by Subject|44|||
161644976|NCT04624243|583751468|FG002|Overall Study|Withdrawal by Subject|40|||
161644977|NCT04624243|583751469|FG003|Overall Study|Withdrawal by Subject|21|||
161644978|NCT04624243|583751470|FG004|Overall Study|Withdrawal by Subject|39|||
161644979|NCT04624243|583751466|FG000|Overall Study|Miscellaneous|3|||
161644980|NCT04624243|583751467|FG001|Overall Study|Miscellaneous|12|||
161644981|NCT04624243|583751468|FG002|Overall Study|Miscellaneous|9|||
161644982|NCT04624243|583751469|FG003|Overall Study|Miscellaneous|4|||
161644983|NCT04624243|583751470|FG004|Overall Study|Miscellaneous|6|||
161644984|NCT04996004|583751471|FG000|Phase I|Death|1|||
161644985|NCT04996004|583751472|FG001|Phase I|Death|2|||
161644986|NCT04996004|583751473|FG002|Phase I|Death|1|||
161644987|NCT04996004|583751474|FG003|Phase I|Death|0|||
161644988|NCT04996004|583751475|FG004|Phase I|Death|0|||
161644989|NCT04996004|583751476|FG005|Phase I|Death|0|||
161644990|NCT04996004|583751471|FG000|Phase I|Study terminated by sponsor|2|||
161644991|NCT04996004|583751472|FG001|Phase I|Study terminated by sponsor|1|||
161688165|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
161688166|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
161688167|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
161688168|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
161688169|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
161688170|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
161688171|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
161688172|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
161688173|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
161688174|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
161688175|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
161688176|NCT03865706|583909809|FG000|Overall Study|Death|0|||
161688177|NCT03865706|583909810|FG001|Overall Study|Death|3|||
161688178|NCT03865706|583909811|FG002|Overall Study|Death|1|||
161644992|NCT04996004|583751473|FG002|Phase I|Study terminated by sponsor|2|||
161688179|NCT02095535|583909812|FG000|Recruitment|Protocol Violation|2|||
161644993|NCT04996004|583751474|FG003|Phase I|Study terminated by sponsor|0|||
161644994|NCT04996004|583751475|FG004|Phase I|Study terminated by sponsor|0|||
161644995|NCT04996004|583751476|FG005|Phase I|Study terminated by sponsor|0|||
161644996|NCT04996004|583751471|FG000|Phase II|Study terminated by sponsor|0|||
161644997|NCT04996004|583751472|FG001|Phase II|Study terminated by sponsor|0|||
161644998|NCT04996004|583751473|FG002|Phase II|Study terminated by sponsor|0|||
161644999|NCT04996004|583751474|FG003|Phase II|Study terminated by sponsor|20|||
161645000|NCT04996004|583751475|FG004|Phase II|Study terminated by sponsor|10|||
161645001|NCT04996004|583751476|FG005|Phase II|Study terminated by sponsor|10|||
161645002|NCT04996004|583751471|FG000|Phase II|Withdrawal by Subject|0|||
161645003|NCT04996004|583751472|FG001|Phase II|Withdrawal by Subject|0|||
161645004|NCT04996004|583751473|FG002|Phase II|Withdrawal by Subject|0|||
161645005|NCT04996004|583751474|FG003|Phase II|Withdrawal by Subject|0|||
161645006|NCT04996004|583751475|FG004|Phase II|Withdrawal by Subject|1|||
161645007|NCT04996004|583751476|FG005|Phase II|Withdrawal by Subject|2|||
161645008|NCT04996004|583751471|FG000|Phase II|Death|0|||
161645009|NCT04996004|583751472|FG001|Phase II|Death|0|||
161645010|NCT04996004|583751473|FG002|Phase II|Death|0|||
161645011|NCT04996004|583751474|FG003|Phase II|Death|12|||
161645012|NCT04996004|583751475|FG004|Phase II|Death|2|||
161645013|NCT04996004|583751476|FG005|Phase II|Death|9|||
161645014|NCT04996004|583751471|FG000|Phase II|Other|0|||
161645015|NCT04996004|583751472|FG001|Phase II|Other|0|||
161645016|NCT04996004|583751473|FG002|Phase II|Other|0|||
161645017|NCT04996004|583751474|FG003|Phase II|Other|0|||
161645018|NCT04996004|583751475|FG004|Phase II|Other|0|||
161645019|NCT04996004|583751476|FG005|Phase II|Other|1|||
161645020|NCT05543174|583751477|FG000|Overall Study|Ongoing|7|||
161645021|NCT03374488|583751478|FG000|Overall Study|Death|13|||
161645022|NCT03374488|583751479|FG001|Overall Study|Death|13|||
161645023|NCT03374488|583751478|FG000|Overall Study|Withdrawal by Subject|3|||
161645024|NCT03374488|583751479|FG001|Overall Study|Withdrawal by Subject|1|||
161645025|NCT03374488|583751478|FG000|Overall Study|Physician Decision|3|||
161645026|NCT03374488|583751479|FG001|Overall Study|Physician Decision|0|||
161645027|NCT03104075|583751480|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
161645028|NCT03104075|583751481|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
161645029|NCT04896008|583751482|FG000|Overall Study|Ongoing|70|||
161645030|NCT04896008|583751483|FG001|Overall Study|Ongoing|38|||
161645031|NCT04896008|583751482|FG000|Overall Study|Adverse Event|0|||
161645032|NCT04896008|583751483|FG001|Overall Study|Adverse Event|2|||
161645033|NCT04896008|583751482|FG000|Overall Study|Death|5|||
161645034|NCT04896008|583751483|FG001|Overall Study|Death|10|||
161645035|NCT04896008|583751482|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
161645036|NCT04896008|583751483|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
161645037|NCT04896008|583751482|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
161645038|NCT04896008|583751483|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
161645039|NCT04896008|583751482|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
161645040|NCT04896008|583751483|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
161645041|NCT04896008|583751482|FG000|Overall Study|Withdrawal by Subject|1|||
161645042|NCT04896008|583751483|FG001|Overall Study|Withdrawal by Subject|4|||
161645043|NCT04896008|583751482|FG000|Overall Study|Investigator Decision|2|||
161645044|NCT04896008|583751483|FG001|Overall Study|Investigator Decision|0|||
161645045|NCT04896008|583751482|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
161645046|NCT04896008|583751483|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
161645047|NCT00944229|583751486|FG000|Overall Study|Withdrawal by Subject|11|||
161645048|NCT00944229|583751486|FG000|Overall Study|Physician Decision|14|||
161645049|NCT01810939|583751489|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
161645050|NCT01810939|583751490|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
161645051|NCT01810939|583751491|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
161645052|NCT01810939|583751489|FG000|Part A Treatment Period|Protocol Violation|2|||
161645053|NCT01810939|583751490|FG001|Part A Treatment Period|Protocol Violation|0|||
161645054|NCT01810939|583751491|FG002|Part A Treatment Period|Protocol Violation|0|||
161645055|NCT01810939|583751489|FG000|Part A Treatment Period|Adverse Event|10|||
161645056|NCT01810939|583751490|FG001|Part A Treatment Period|Adverse Event|0|||
161645057|NCT01810939|583751491|FG002|Part A Treatment Period|Adverse Event|0|||
161645058|NCT01810939|583751489|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
161645059|NCT01810939|583751490|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
161645060|NCT01810939|583751491|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
161835810|NCT00158756|584440801|FG002|Overall Study|Serious adverse event|1|||
161835811|NCT00158756|584440802|FG003|Overall Study|Serious adverse event|0|||
161835812|NCT00158756|584440803|FG004|Overall Study|Serious adverse event|0|||
161835813|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
161835814|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
161835815|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
161835816|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
161835817|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
161835818|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
161835819|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
161835820|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
161835821|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
161835822|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
161835823|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
161835824|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
161645061|NCT01810939|583751489|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
161645062|NCT01810939|583751490|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
161645063|NCT01810939|583751491|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
161645064|NCT01810939|583751489|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
161645065|NCT01810939|583751490|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
161645066|NCT01810939|583751491|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
161645067|NCT01810939|583751489|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
161645068|NCT01810939|583751490|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
161645069|NCT01810939|583751491|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
161645070|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
161645071|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
161645072|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
161645073|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
161645074|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
161645075|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
161645076|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
161645077|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
161645078|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
161645079|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
161645080|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
161645081|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
161645082|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
161645083|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
161645084|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
161688180|NCT02646982|583909813|FG000|Overall Study|Adverse Event|1|||
161688181|NCT02646982|583909814|FG001|Overall Study|Adverse Event|1|||
161688182|NCT02646982|583909813|FG000|Overall Study|Withdrawal by Subject|2|||
161688183|NCT02646982|583909814|FG001|Overall Study|Withdrawal by Subject|1|||
161688184|NCT01877187|583909815|FG000|Overall Study|Death|2|||
161688185|NCT01877187|583909815|FG000|Overall Study|Withdrawal by Subject|4|||
161688186|NCT01877187|583909815|FG000|Overall Study|Lost to Follow-up|3|||
161688187|NCT01877187|583909815|FG000|Overall Study|Declining clinical status|11|||
161688188|NCT01877187|583909815|FG000|Overall Study|Liver transplant|2|||
161688189|NCT04677712|583909817|FG000|Overall Study|Lost to Follow-up|0|||
161688190|NCT04677712|583909818|FG001|Overall Study|Lost to Follow-up|1|||
161688191|NCT04677712|583909819|FG002|Overall Study|Lost to Follow-up|0|||
161688192|NCT04677712|583909820|FG003|Overall Study|Lost to Follow-up|0|||
161688193|NCT04677712|583909821|FG004|Overall Study|Lost to Follow-up|0|||
161688194|NCT04677712|583909822|FG005|Overall Study|Lost to Follow-up|0|||
161688195|NCT02915523|583909826|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
161688196|NCT02915523|583909827|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
161688197|NCT02915523|583909828|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
161688198|NCT02915523|583909829|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
161688199|NCT02915523|583909826|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
161688200|NCT02915523|583909827|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
161688201|NCT02915523|583909828|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
161688202|NCT02915523|583909829|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
161688203|NCT02915523|583909826|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161688204|NCT02915523|583909827|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
161688205|NCT02915523|583909828|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161688206|NCT02915523|583909829|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161688207|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Death|0|||
161688208|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Death|0|||
161688209|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Death|26|||
161688210|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Death|53|||
161688211|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
161835825|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
161835826|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
161835827|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
161835828|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
161835829|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
161645085|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
161688212|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
161688213|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
161835830|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
161688214|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
161688215|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
161688216|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
161688217|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
161688218|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
161688219|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161688220|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161688221|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161645086|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
161645087|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
161645088|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
161645089|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
161645090|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
161645091|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
161645092|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
161645093|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
161645094|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
161645095|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
161645096|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
161645097|NCT01810939|583751489|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
161645098|NCT01810939|583751490|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
161645099|NCT01810939|583751491|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
161645100|NCT04497389|583751494|FG000|Overall Study|Withdrawal by Subject|1|||
161645101|NCT04497389|583751495|FG001|Overall Study|Withdrawal by Subject|0|||
161645102|NCT04400487|583751496|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161645103|NCT04400487|583751496|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
161645104|NCT04400487|583751496|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
161645105|NCT03322540|583751502|FG000|Overall Study|Death|21|||
161645106|NCT03322540|583751503|FG001|Overall Study|Death|28|||
161645107|NCT03322540|583751502|FG000|Overall Study|Lost to Follow-up|0|||
161645108|NCT03322540|583751503|FG001|Overall Study|Lost to Follow-up|1|||
161645109|NCT03322540|583751502|FG000|Overall Study|Physician Decision|7|||
161645110|NCT03322540|583751503|FG001|Overall Study|Physician Decision|6|||
161688222|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
161688223|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
161688224|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
161688225|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
161688226|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
161688227|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
161688228|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
161688229|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
161688230|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
161688231|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
161688232|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
161688233|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
161688234|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
161688235|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
161688236|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
161688237|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
161688238|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
161688239|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
161688240|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
161688241|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
161688242|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
161688243|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
161688244|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
161688245|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
161688246|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
161688247|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
161688248|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
161688249|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
161688250|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
161688251|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
161688252|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
161688253|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
161645111|NCT03322540|583751502|FG000|Overall Study|Withdrawal by Subject|3|||
161645112|NCT03322540|583751503|FG001|Overall Study|Withdrawal by Subject|1|||
161645113|NCT03322540|583751502|FG000|Overall Study|Study terminated by sponsor|0|||
161645114|NCT03322540|583751503|FG001|Overall Study|Study terminated by sponsor|1|||
161645115|NCT01594827|583751506|FG000|Overall Study|Adverse Event|1|||
161645116|NCT01594827|583751507|FG001|Overall Study|Adverse Event|0|||
161645117|NCT01594827|583751506|FG000|Overall Study|Physician Decision|3|||
161645118|NCT01594827|583751507|FG001|Overall Study|Physician Decision|0|||
161645119|NCT01677299|583751508|FG000|Overall Study|Adverse Event|0|||
161645120|NCT01677299|583751509|FG001|Overall Study|Adverse Event|2|||
161645121|NCT01677299|583751510|FG002|Overall Study|Adverse Event|1|||
161645122|NCT01677299|583751511|FG003|Overall Study|Adverse Event|0|||
161645123|NCT01677299|583751508|FG000|Overall Study|Withdrawal by Subject|0|||
161645124|NCT01677299|583751509|FG001|Overall Study|Withdrawal by Subject|1|||
161645125|NCT01677299|583751510|FG002|Overall Study|Withdrawal by Subject|0|||
161645126|NCT01677299|583751511|FG003|Overall Study|Withdrawal by Subject|1|||
161645127|NCT02153905|583751512|FG000|Overall Study|Death|1|||
161645128|NCT02153905|583751513|FG001|Overall Study|Death|0|||
161645129|NCT00520845|583751514|FG000|Overall Study|Death|3|||
161645130|NCT00520845|583751514|FG000|Overall Study|Adverse Event|4|||
161645131|NCT00520845|583751514|FG000|Overall Study|Disease Progression, relapse|13|||
161645132|NCT00520845|583751514|FG000|Overall Study|Withdrawal by Subject|1|||
161645133|NCT00520845|583751514|FG000|Overall Study|Alternative Therapy|1|||
161645134|NCT00351377|583751516|FG000|Overall Study|Adverse Event|5|||
161645135|NCT00351377|583751516|FG000|Overall Study|Death|1|||
161645136|NCT00351377|583751516|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161645137|NCT02493062|583751518|FG000|Overall Study|Physician Decision|12|||
161645138|NCT03926195|583751519|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
161645139|NCT03926195|583751520|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
161645140|NCT03926195|583751519|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
161645141|NCT03926195|583751520|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
161645142|NCT03926195|583751519|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
161645143|NCT03926195|583751520|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
161645144|NCT03926195|583751519|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
161645145|NCT03926195|583751520|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
161645146|NCT03926195|583751519|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
161645147|NCT03926195|583751520|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
161645148|NCT03926195|583751519|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
161645149|NCT03926195|583751520|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
161645150|NCT03054337|583751521|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
161645151|NCT03054337|583751522|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
161645152|NCT03054337|583751523|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
161645153|NCT03054337|583751524|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
161645154|NCT03054337|583751525|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
161645155|NCT03054337|583751526|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
161645156|NCT01327612|583751527|FG000|Overall Study|Withdrawal by Subject|0|||
161645157|NCT01327612|583751528|FG001|Overall Study|Withdrawal by Subject|0|||
161645158|NCT01327612|583751529|FG002|Overall Study|Withdrawal by Subject|0|||
161645159|NCT01327612|583751530|FG003|Overall Study|Withdrawal by Subject|0|||
161645160|NCT01327612|583751531|FG004|Overall Study|Withdrawal by Subject|0|||
161645161|NCT01327612|583751532|FG005|Overall Study|Withdrawal by Subject|1|||
161645162|NCT01327612|583751533|FG006|Overall Study|Withdrawal by Subject|0|||
161645163|NCT01327612|583751527|FG000|Overall Study|Disease Progression|1|||
161645164|NCT01327612|583751528|FG001|Overall Study|Disease Progression|1|||
161645165|NCT01327612|583751529|FG002|Overall Study|Disease Progression|1|||
161645166|NCT01327612|583751530|FG003|Overall Study|Disease Progression|0|||
161645167|NCT01327612|583751531|FG004|Overall Study|Disease Progression|1|||
161645168|NCT01327612|583751532|FG005|Overall Study|Disease Progression|2|||
161645169|NCT01327612|583751533|FG006|Overall Study|Disease Progression|2|||
161645170|NCT01327612|583751527|FG000|Overall Study|Administrative Decision|0|||
161645171|NCT01327612|583751528|FG001|Overall Study|Administrative Decision|0|||
161645172|NCT01327612|583751529|FG002|Overall Study|Administrative Decision|0|||
161645173|NCT01327612|583751530|FG003|Overall Study|Administrative Decision|1|||
161645174|NCT01327612|583751531|FG004|Overall Study|Administrative Decision|0|||
161645175|NCT01327612|583751532|FG005|Overall Study|Administrative Decision|0|||
161645176|NCT01327612|583751533|FG006|Overall Study|Administrative Decision|0|||
161645177|NCT01327612|583751527|FG000|Overall Study|Death|0|||
161645178|NCT01327612|583751528|FG001|Overall Study|Death|0|||
161645179|NCT01327612|583751529|FG002|Overall Study|Death|0|||
161645180|NCT01327612|583751530|FG003|Overall Study|Death|0|||
161645181|NCT01327612|583751531|FG004|Overall Study|Death|1|||
161645182|NCT01327612|583751532|FG005|Overall Study|Death|0|||
161645183|NCT01327612|583751533|FG006|Overall Study|Death|0|||
161645184|NCT01661205|583751536|FG000|Overall Study|Physician Decision|2|||
161645185|NCT00874731|583751538|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
161645186|NCT00874731|583751539|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
161645187|NCT00874731|583751540|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
161645188|NCT00874731|583751538|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
161645189|NCT00874731|583751539|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
161645190|NCT00874731|583751540|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
161645191|NCT00874731|583751538|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
161645192|NCT00874731|583751539|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
161645193|NCT00874731|583751540|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
161645194|NCT00955708|583751541|FG000|Overall Study|Death|269|||
161645195|NCT00955708|583751541|FG000|Overall Study|Lost to Follow-up|72|||
161645196|NCT00955708|583751541|FG000|Overall Study|Physician Decision|36|||
161645197|NCT00955708|583751541|FG000|Overall Study|Protocol Violation|134|||
161645198|NCT00955708|583751541|FG000|Overall Study|Registry Conclusion|186|||
161645199|NCT00955708|583751541|FG000|Overall Study|Product removed from service|94|||
161645200|NCT00955708|583751541|FG000|Overall Study|Patient Refused to participate further|116|||
161645201|NCT00955708|583751541|FG000|Overall Study|Closure of study location|60|||
161645202|NCT00955708|583751541|FG000|Overall Study|Patient changed care provider/moved|91|||
161645203|NCT05105087|583751542|FG000|Overall Study|Withdrawal by Subject|2|||
161645204|NCT05105087|583751542|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
161645205|NCT00581477|583751547|FG000|Overall Study|Physician Decision|2|||
161645206|NCT01735175|583751548|FG000|Overall Study|Withdrawal by Subject|9|||
161645207|NCT01735175|583751549|FG001|Overall Study|Withdrawal by Subject|2|||
161645208|NCT01735175|583751548|FG000|Overall Study|Lost to Follow-up|4|||
161645209|NCT01735175|583751549|FG001|Overall Study|Lost to Follow-up|2|||
161645210|NCT01735175|583751548|FG000|Overall Study|Death|3|||
161645211|NCT01735175|583751549|FG001|Overall Study|Death|2|||
161645212|NCT01735175|583751548|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
161645213|NCT01735175|583751549|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
161645214|NCT00755417|583751550|FG000|Overall Study|Adverse Event|28|||
161645215|NCT00755417|583751551|FG001|Overall Study|Adverse Event|20|||
161645216|NCT00755417|583751552|FG002|Overall Study|Adverse Event|7|||
161645217|NCT00755417|583751550|FG000|Overall Study|Lack of Efficacy|8|||
161645218|NCT00755417|583751551|FG001|Overall Study|Lack of Efficacy|4|||
161645219|NCT00755417|583751552|FG002|Overall Study|Lack of Efficacy|9|||
161645220|NCT00755417|583751550|FG000|Overall Study|Protocol Violation|2|||
161645221|NCT00755417|583751551|FG001|Overall Study|Protocol Violation|1|||
161688254|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
161688255|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
161688256|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
161688257|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
161688258|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
161688259|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
161688260|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
161688261|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
161688262|NCT00708500|583909832|FG000|FOLLOWUP|Adverse Event|0|||
161688263|NCT00708500|583909833|FG001|FOLLOWUP|Adverse Event|1|||
161688264|NCT00708500|583909834|FG002|FOLLOWUP|Adverse Event|0|||
161688265|NCT00708500|583909832|FG000|FOLLOWUP|Lost to Follow-up|1|||
161688266|NCT00708500|583909833|FG001|FOLLOWUP|Lost to Follow-up|6|||
161688267|NCT00708500|583909834|FG002|FOLLOWUP|Lost to Follow-up|4|||
161645222|NCT00755417|583751552|FG002|Overall Study|Protocol Violation|1|||
161645223|NCT00755417|583751550|FG000|Overall Study|Lost to Follow-up|3|||
161645224|NCT00755417|583751551|FG001|Overall Study|Lost to Follow-up|0|||
161645225|NCT00755417|583751552|FG002|Overall Study|Lost to Follow-up|1|||
161645226|NCT00755417|583751550|FG000|Overall Study|Withdrawal by Subject|12|||
161645227|NCT00755417|583751551|FG001|Overall Study|Withdrawal by Subject|12|||
161645228|NCT00755417|583751552|FG002|Overall Study|Withdrawal by Subject|12|||
161645229|NCT00755417|583751550|FG000|Overall Study|Not specified or missing data|9|||
161645230|NCT00755417|583751551|FG001|Overall Study|Not specified or missing data|18|||
161645231|NCT00755417|583751552|FG002|Overall Study|Not specified or missing data|12|||
161645232|NCT02803593|583751553|FG000|Overall Study|Lost to Follow-up|17|||
161645233|NCT02803593|583751554|FG001|Overall Study|Lost to Follow-up|35|||
161688268|NCT00708500|583909832|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
161645234|NCT03933462|583751555|FG000|Overall Study|Adverse Event|2|||
161645235|NCT03933462|583751556|FG001|Overall Study|Adverse Event|0|||
161645236|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
161688269|NCT00708500|583909833|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
161688270|NCT00708500|583909834|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
161645237|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
161645238|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
161645239|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
161645240|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
161645241|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161645242|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
161645243|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
161645244|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
161645245|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
161645246|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
161645247|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
161645248|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
161645249|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
161645250|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
161645251|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
161645252|NCT04210843|583751557|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
161645253|NCT04210843|583751558|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
161645254|NCT04210843|583751557|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
161645255|NCT04210843|583751558|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
161645256|NCT04210843|583751557|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
161645257|NCT04210843|583751558|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
161645258|NCT04210843|583751557|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
161645259|NCT04210843|583751558|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161645260|NCT04210843|583751557|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
161645261|NCT04210843|583751558|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
161645262|NCT04210843|583751557|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
161645263|NCT04210843|583751558|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
161645264|NCT04210843|583751557|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
161645265|NCT04210843|583751558|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
161645266|NCT04210843|583751557|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
161645267|NCT04210843|583751558|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
161645268|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
161645269|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
161645270|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
161645271|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
161645272|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
161645273|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
161645274|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
161688271|NCT00708500|583909832|FG000|FOLLOWUP|Subject withdrew consent|31|||
161688272|NCT00708500|583909833|FG001|FOLLOWUP|Subject withdrew consent|4|||
161688273|NCT00708500|583909834|FG002|FOLLOWUP|Subject withdrew consent|5|||
161645275|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
161645276|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
161645277|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
161688274|NCT00708500|583909832|FG000|FOLLOWUP|Non-compliance with protocol|5|||
161688275|NCT00708500|583909833|FG001|FOLLOWUP|Non-compliance with protocol|0|||
161688276|NCT00708500|583909834|FG002|FOLLOWUP|Non-compliance with protocol|1|||
161835831|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
161688277|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
161645278|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
161645279|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
161645280|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
161645281|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
161645282|NCT04210843|583751557|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
161645283|NCT04210843|583751558|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
161645284|NCT01266161|583751565|FG000|Overall Study|Ineligible|1|||
161645285|NCT01266161|583751566|FG001|Overall Study|Ineligible|0|||
161645286|NCT01266161|583751565|FG000|Overall Study|Lack of Efficacy|0|||
161645287|NCT01266161|583751566|FG001|Overall Study|Lack of Efficacy|1|||
161645288|NCT01266161|583751565|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
161645289|NCT01266161|583751566|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
161645290|NCT01436305|583751567|FG000|Overall Study|Death|1|||
161645291|NCT01436305|583751568|FG001|Overall Study|Death|0|||
161645292|NCT01436305|583751569|FG002|Overall Study|Death|0|||
161645293|NCT01436305|583751567|FG000|Overall Study|Lost to Follow-up|0|||
161645294|NCT01436305|583751568|FG001|Overall Study|Lost to Follow-up|1|||
161645295|NCT01436305|583751569|FG002|Overall Study|Lost to Follow-up|0|||
161645296|NCT01436305|583751567|FG000|Overall Study|Withdrawal by Subject|1|||
161645297|NCT01436305|583751568|FG001|Overall Study|Withdrawal by Subject|3|||
161645298|NCT01436305|583751569|FG002|Overall Study|Withdrawal by Subject|0|||
161645299|NCT01485120|583751572|FG000|Overall Study|Withdrawal by Subject|2|||
161645300|NCT02344342|583751573|FG000|Overall Study|Industry partner dropped out|11|||
161645301|NCT02344342|583751574|FG001|Overall Study|Industry partner dropped out|9|||
161645302|NCT02344342|583751575|FG002|Overall Study|Industry partner dropped out|14|||
161645303|NCT02344342|583751576|FG003|Overall Study|Industry partner dropped out|10|||
161645304|NCT00848484|583751577|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
161645305|NCT00848484|583751578|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
161645306|NCT00848484|583751577|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
161645307|NCT00848484|583751578|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
161645308|NCT00848484|583751577|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
161645309|NCT00848484|583751578|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
161645310|NCT00848484|583751577|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
161645311|NCT00848484|583751578|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
161645312|NCT00848484|583751577|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
161645313|NCT00848484|583751578|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
161645314|NCT02567708|583751580|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
161645315|NCT02567708|583751581|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
161645316|NCT02567708|583751580|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
161645317|NCT02567708|583751581|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
161645318|NCT02567708|583751580|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
161645319|NCT02567708|583751581|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
161645320|NCT02567708|583751580|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
161645321|NCT02567708|583751581|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
161645322|NCT00706654|583751582|FG000|Conversion Phase|Lost to Follow-up|4|||
161645323|NCT00706654|583751583|FG001|Conversion Phase|Lost to Follow-up|0|||
161645324|NCT00706654|583751584|FG002|Conversion Phase|Lost to Follow-up|0|||
161645325|NCT00706654|583751585|FG003|Conversion Phase|Lost to Follow-up|0|||
161645326|NCT00706654|583751582|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
161645327|NCT00706654|583751583|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
161645328|NCT00706654|583751584|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
161645329|NCT00706654|583751585|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
161645330|NCT00706654|583751582|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
161645331|NCT00706654|583751583|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
161645332|NCT00706654|583751584|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
161645333|NCT00706654|583751585|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
161645334|NCT00706654|583751582|FG000|Conversion Phase|Withdrawn by Investigator|14|||
161645335|NCT00706654|583751583|FG001|Conversion Phase|Withdrawn by Investigator|0|||
161645336|NCT00706654|583751584|FG002|Conversion Phase|Withdrawn by Investigator|0|||
161645337|NCT00706654|583751585|FG003|Conversion Phase|Withdrawn by Investigator|0|||
161645338|NCT00706654|583751582|FG000|Conversion Phase|Withdrew Consent|38|||
161688278|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
161688279|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
161688280|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
161688281|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
161688282|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
161835832|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
161835833|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
161835834|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
161835835|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
161835836|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
161835837|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
161835838|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
161835839|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
161835840|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
161835841|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
161835842|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
161835843|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
161835844|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
161835845|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
161835846|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
161835847|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
161835848|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
161835849|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
161835850|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
161835851|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
161835852|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
161835853|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
161835854|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
161835855|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
161835856|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
161835857|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
161835858|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
161835859|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
161835860|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
161835861|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
161835862|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
161835863|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
161835864|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
161835865|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
161835866|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
161835867|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
161835868|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
161835869|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
161835870|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
161835871|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
161835872|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
161835873|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
161835874|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
161835875|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
161835876|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
161835877|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
161835878|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
161835879|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
161835880|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
161835881|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
161835882|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
161835883|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
161835884|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
161835885|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
161835886|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
161835887|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
161835888|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
161835889|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
161688283|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
161835890|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
161835891|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161835892|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161688284|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
161688285|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
161688286|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
161688287|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
161688288|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
161688289|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
161835893|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161645339|NCT00706654|583751583|FG001|Conversion Phase|Withdrew Consent|0|||
161645340|NCT00706654|583751584|FG002|Conversion Phase|Withdrew Consent|0|||
161645341|NCT00706654|583751585|FG003|Conversion Phase|Withdrew Consent|0|||
161645342|NCT00706654|583751582|FG000|Conversion Phase|Adverse Event|18|||
161645343|NCT00706654|583751583|FG001|Conversion Phase|Adverse Event|0|||
161645344|NCT00706654|583751584|FG002|Conversion Phase|Adverse Event|0|||
161645345|NCT00706654|583751585|FG003|Conversion Phase|Adverse Event|0|||
161645346|NCT00706654|583751582|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
161645347|NCT00706654|583751583|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161645348|NCT00706654|583751584|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161645349|NCT00706654|583751585|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161645350|NCT00706654|583751582|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
161645351|NCT00706654|583751583|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161645352|NCT00706654|583751584|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161645353|NCT00706654|583751585|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161645354|NCT00706654|583751582|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
161645355|NCT00706654|583751583|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
161645356|NCT00706654|583751584|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
161645357|NCT00706654|583751585|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
161645358|NCT00706654|583751582|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
161645359|NCT00706654|583751583|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
161645360|NCT00706654|583751584|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
161645361|NCT00706654|583751585|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
161645362|NCT00706654|583751582|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
161645363|NCT00706654|583751583|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161645364|NCT00706654|583751584|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161645365|NCT00706654|583751585|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161645366|NCT00706654|583751582|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
161645367|NCT00706654|583751583|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161645368|NCT00706654|583751584|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161645369|NCT00706654|583751585|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161645370|NCT00706654|583751582|FG000|Oral Stabilization Phase|Withdrew consent|55|||
161645371|NCT00706654|583751583|FG001|Oral Stabilization Phase|Withdrew consent|0|||
161645372|NCT00706654|583751584|FG002|Oral Stabilization Phase|Withdrew consent|0|||
161645373|NCT00706654|583751585|FG003|Oral Stabilization Phase|Withdrew consent|0|||
161645374|NCT00706654|583751582|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
161645375|NCT00706654|583751583|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
161645376|NCT00706654|583751584|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
161645377|NCT00706654|583751585|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
161645378|NCT00706654|583751582|FG000|Oral Stabilization Phase|Adverse Event|21|||
161645379|NCT00706654|583751583|FG001|Oral Stabilization Phase|Adverse Event|0|||
161645380|NCT00706654|583751584|FG002|Oral Stabilization Phase|Adverse Event|0|||
161645381|NCT00706654|583751585|FG003|Oral Stabilization Phase|Adverse Event|0|||
161645382|NCT00706654|583751582|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
161645383|NCT00706654|583751583|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161645384|NCT00706654|583751584|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161645385|NCT00706654|583751585|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161645386|NCT00706654|583751582|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
161645387|NCT00706654|583751583|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161645388|NCT00706654|583751584|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161645389|NCT00706654|583751585|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161645390|NCT00706654|583751582|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
161645391|NCT00706654|583751583|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
161645392|NCT00706654|583751584|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
161645393|NCT00706654|583751585|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
161645394|NCT00706654|583751582|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
161645395|NCT00706654|583751583|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
161645396|NCT00706654|583751584|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
161645397|NCT00706654|583751585|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
161645398|NCT00706654|583751582|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
161645399|NCT00706654|583751583|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161645400|NCT00706654|583751584|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
161645401|NCT00706654|583751585|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161645402|NCT00706654|583751582|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
161645403|NCT00706654|583751583|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
161645404|NCT00706654|583751584|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
161645405|NCT00706654|583751585|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
161645406|NCT00706654|583751582|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
161645407|NCT00706654|583751583|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
161645408|NCT00706654|583751584|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
161645409|NCT00706654|583751585|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
161645410|NCT00706654|583751582|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
161645411|NCT00706654|583751583|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
161645412|NCT00706654|583751584|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
161645413|NCT00706654|583751585|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
161645414|NCT00706654|583751582|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
161645415|NCT00706654|583751583|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
161645416|NCT00706654|583751584|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
161645417|NCT00706654|583751585|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
161645418|NCT00706654|583751582|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
161645419|NCT00706654|583751583|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
161688290|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
161688291|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
161688292|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
161688293|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
161688294|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
161645420|NCT00706654|583751584|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
161645421|NCT00706654|583751585|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
161645422|NCT01001390|583751586|FG000|Overall Study|Failure to wear AFO device|2|||
161645423|NCT01001390|583751587|FG001|Overall Study|Failure to wear AFO device|0|||
161645424|NCT01151215|583751591|FG000|Overall Study|Worsening of condition under study|1|||
161645425|NCT01151215|583751592|FG001|Overall Study|Worsening of condition under study|1|||
161645426|NCT01151215|583751593|FG002|Overall Study|Worsening of condition under study|1|||
161645427|NCT01151215|583751591|FG000|Overall Study|Death|16|||
161645428|NCT01151215|583751592|FG001|Overall Study|Death|20|||
161645429|NCT01151215|583751593|FG002|Overall Study|Death|11|||
161645430|NCT01151215|583751591|FG000|Overall Study|Lost to Follow-up|0|||
161645431|NCT01151215|583751592|FG001|Overall Study|Lost to Follow-up|0|||
161645432|NCT01151215|583751593|FG002|Overall Study|Lost to Follow-up|3|||
161645433|NCT01151215|583751591|FG000|Overall Study|Withdrawal by Subject|3|||
161645434|NCT01151215|583751592|FG001|Overall Study|Withdrawal by Subject|1|||
161645435|NCT01151215|583751593|FG002|Overall Study|Withdrawal by Subject|2|||
161645436|NCT01151215|583751591|FG000|Overall Study|Disease progression|0|||
161645437|NCT01151215|583751592|FG001|Overall Study|Disease progression|1|||
161645438|NCT01151215|583751593|FG002|Overall Study|Disease progression|1|||
161645439|NCT01151215|583751591|FG000|Overall Study|Safety as judged by the investigator|0|||
161645440|NCT01151215|583751592|FG001|Overall Study|Safety as judged by the investigator|0|||
161645441|NCT01151215|583751593|FG002|Overall Study|Safety as judged by the investigator|1|||
161645442|NCT02956837|583751594|FG000|Overall Study|Serious Adverse Events|0|||
161645443|NCT02956837|583751595|FG001|Overall Study|Serious Adverse Events|1|||
161645444|NCT02956837|583751596|FG002|Overall Study|Serious Adverse Events|0|||
161645445|NCT02956837|583751597|FG003|Overall Study|Serious Adverse Events|0|||
161645446|NCT02956837|583751594|FG000|Overall Study|Withdrawal by Subject|0|||
161645447|NCT02956837|583751595|FG001|Overall Study|Withdrawal by Subject|1|||
161645448|NCT02956837|583751596|FG002|Overall Study|Withdrawal by Subject|0|||
161645449|NCT02956837|583751597|FG003|Overall Study|Withdrawal by Subject|3|||
161645450|NCT02956837|583751594|FG000|Overall Study|Lost to Follow-up|0|||
161645451|NCT02956837|583751595|FG001|Overall Study|Lost to Follow-up|1|||
161645452|NCT02956837|583751596|FG002|Overall Study|Lost to Follow-up|2|||
161645453|NCT02956837|583751597|FG003|Overall Study|Lost to Follow-up|0|||
161645454|NCT02597712|583751598|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
161645455|NCT02597712|583751599|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
161645456|NCT02597712|583751598|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
161645457|NCT02597712|583751599|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
161645458|NCT02597712|583751598|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
161645459|NCT02597712|583751599|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
161645460|NCT01727505|583751607|FG000|First 24 Hours|Adverse Event|0|||
161645461|NCT01727505|583751608|FG001|First 24 Hours|Adverse Event|1|||
161645462|NCT01727505|583751607|FG000|Second 24 Hours|Missing data|0|||
161645463|NCT01727505|583751608|FG001|Second 24 Hours|Missing data|1|||
161835894|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
161835895|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
161835896|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
161835897|NCT04505293|584440807|FG000|Overall Study|Lost to Follow-up|2|||
161835898|NCT04505293|584440807|FG000|Overall Study|Withdrawal by Subject|6|||
161835899|NCT04505293|584440807|FG000|Overall Study|CT scan unreadable|277|||
161835900|NCT04295135|584440808|FG000|Overall Study|Withdrawal by Subject|2|||
161835901|NCT04295135|584440809|FG001|Overall Study|Withdrawal by Subject|1|||
161835902|NCT04295135|584440808|FG000|Overall Study|Subject left organization|8|||
161835903|NCT04295135|584440809|FG001|Overall Study|Subject left organization|4|||
161835904|NCT01300052|584440812|FG000|Overall Study|Adverse Event|3|||
161835905|NCT01300052|584440813|FG001|Overall Study|Adverse Event|0|||
161835906|NCT01300052|584440812|FG000|Overall Study|Withdrawal by Subject|2|||
161835907|NCT01300052|584440813|FG001|Overall Study|Withdrawal by Subject|2|||
161835908|NCT01300052|584440812|FG000|Overall Study|Protocol Violation|1|||
161835909|NCT01300052|584440813|FG001|Overall Study|Protocol Violation|1|||
161835910|NCT01550744|584440814|FG000|Open-Label|Lost to Follow-up|7|||
161835911|NCT01550744|584440815|FG001|Open-Label|Lost to Follow-up|0|||
161835912|NCT01550744|584440816|FG002|Open-Label|Lost to Follow-up|0|||
161835913|NCT01550744|584440814|FG000|Open-Label|Withdrawal by Subject|13|||
161835914|NCT01550744|584440815|FG001|Open-Label|Withdrawal by Subject|0|||
161835915|NCT01550744|584440816|FG002|Open-Label|Withdrawal by Subject|0|||
161835916|NCT01550744|584440814|FG000|Open-Label|Adverse Event|11|||
161835917|NCT01550744|584440815|FG001|Open-Label|Adverse Event|0|||
161835918|NCT01550744|584440816|FG002|Open-Label|Adverse Event|0|||
161835919|NCT01550744|584440814|FG000|Open-Label|Lack of Efficacy|4|||
161835920|NCT01550744|584440815|FG001|Open-Label|Lack of Efficacy|0|||
161835921|NCT01550744|584440816|FG002|Open-Label|Lack of Efficacy|0|||
161835922|NCT01550744|584440814|FG000|Open-Label|Protocol Violation|4|||
161835923|NCT01550744|584440815|FG001|Open-Label|Protocol Violation|0|||
161645464|NCT00513708|583751609|FG000|Overall Study|Lost to Follow-up|4|||
161645465|NCT00513708|583751610|FG001|Overall Study|Lost to Follow-up|4|||
161645466|NCT00513708|583751611|FG002|Overall Study|Lost to Follow-up|4|||
161645467|NCT01564277|583751612|FG000|Overall Study|Protocol Violation|0|||
161645468|NCT01564277|583751613|FG001|Overall Study|Protocol Violation|1|||
161645469|NCT01564277|583751612|FG000|Overall Study|Physician Decision|1|||
161645470|NCT01564277|583751613|FG001|Overall Study|Physician Decision|0|||
161645471|NCT01594970|583751614|FG000|Overall Study|Non-Adverse Event Related|4|||
161645472|NCT01594970|583751615|FG001|Overall Study|Non-Adverse Event Related|5|||
161645473|NCT01594970|583751616|FG002|Overall Study|Non-Adverse Event Related|6|||
161645474|NCT01594970|583751614|FG000|Overall Study|Adverse Event|17|||
161645475|NCT01594970|583751615|FG001|Overall Study|Adverse Event|23|||
161645476|NCT01594970|583751616|FG002|Overall Study|Adverse Event|23|||
161645477|NCT01594970|583751614|FG000|Overall Study|Lost to Follow-up|54|||
161645478|NCT01594970|583751615|FG001|Overall Study|Lost to Follow-up|54|||
161645479|NCT01594970|583751616|FG002|Overall Study|Lost to Follow-up|37|||
161645480|NCT04276051|583751619|FG000|Overall Study|Lost to Follow-up|0|||
161645481|NCT04276051|583751620|FG001|Overall Study|Lost to Follow-up|1|||
161645482|NCT04276051|583751619|FG000|Overall Study|Physician Decision|0|||
161645483|NCT04276051|583751620|FG001|Overall Study|Physician Decision|1|||
161645484|NCT04276051|583751619|FG000|Overall Study|Withdrawal by Subject|1|||
161645485|NCT04276051|583751620|FG001|Overall Study|Withdrawal by Subject|1|||
161645486|NCT01299480|583751621|FG000|Overall Study|No longer willing to participate|19|||
161645487|NCT01299480|583751622|FG001|Overall Study|No longer willing to participate|17|||
161645488|NCT01299480|583751623|FG002|Overall Study|No longer willing to participate|14|||
161645489|NCT01299480|583751624|FG003|Overall Study|No longer willing to participate|13|||
161645490|NCT01299480|583751625|FG004|Overall Study|No longer willing to participate|10|||
161645491|NCT01299480|583751621|FG000|Overall Study|Protocol Violation|7|||
161645492|NCT01299480|583751622|FG001|Overall Study|Protocol Violation|5|||
161645493|NCT01299480|583751623|FG002|Overall Study|Protocol Violation|8|||
161645494|NCT01299480|583751624|FG003|Overall Study|Protocol Violation|1|||
161645495|NCT01299480|583751625|FG004|Overall Study|Protocol Violation|1|||
161645496|NCT01299480|583751621|FG000|Overall Study|Withdrawal by Subject|3|||
161645497|NCT01299480|583751622|FG001|Overall Study|Withdrawal by Subject|4|||
161835924|NCT01550744|584440816|FG002|Open-Label|Protocol Violation|0|||
161835925|NCT01550744|584440814|FG000|Open-Label|Not all 3 study drug injections received|2|||
161835926|NCT01550744|584440815|FG001|Open-Label|Not all 3 study drug injections received|0|||
161835927|NCT01550744|584440816|FG002|Open-Label|Not all 3 study drug injections received|0|||
161835928|NCT01550744|584440814|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
161835929|NCT01550744|584440815|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
161645498|NCT01299480|583751623|FG002|Overall Study|Withdrawal by Subject|7|||
161645499|NCT01299480|583751624|FG003|Overall Study|Withdrawal by Subject|3|||
161645500|NCT01299480|583751625|FG004|Overall Study|Withdrawal by Subject|4|||
161645501|NCT01299480|583751621|FG000|Overall Study|Adverse Event|6|||
161645502|NCT01299480|583751622|FG001|Overall Study|Adverse Event|4|||
161645503|NCT01299480|583751623|FG002|Overall Study|Adverse Event|5|||
161645504|NCT01299480|583751624|FG003|Overall Study|Adverse Event|4|||
161645505|NCT01299480|583751625|FG004|Overall Study|Adverse Event|0|||
161645506|NCT01299480|583751621|FG000|Overall Study|Withdrawal due to pregnancy|0|||
161645507|NCT01299480|583751622|FG001|Overall Study|Withdrawal due to pregnancy|1|||
161645508|NCT01299480|583751623|FG002|Overall Study|Withdrawal due to pregnancy|1|||
161645509|NCT01299480|583751624|FG003|Overall Study|Withdrawal due to pregnancy|0|||
161645510|NCT01299480|583751625|FG004|Overall Study|Withdrawal due to pregnancy|0|||
161645511|NCT01299480|583751621|FG000|Overall Study|Physician Decision|1|||
161645512|NCT01299480|583751622|FG001|Overall Study|Physician Decision|1|||
161645513|NCT01299480|583751623|FG002|Overall Study|Physician Decision|0|||
161688295|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
161688296|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
161688297|NCT00794677|583909846|FG000|First Intervention|Withdrawal by Subject|2|||
161688298|NCT00794677|583909847|FG001|First Intervention|Withdrawal by Subject|0|||
161688299|NCT01965262|583909860|FG000|Second Intervention (7 Days)|Discontinued|0|||
161688300|NCT01965262|583909861|FG001|Second Intervention (7 Days)|Discontinued|1|||
161688301|NCT01965262|583909860|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
161688302|NCT01965262|583909861|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
161688303|NCT01965262|583909860|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
161688304|NCT01965262|583909861|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
161688305|NCT00607386|583909862|FG000|Overall Study|Physician Decision|1|||
161688306|NCT00440947|583909863|FG000|36-Week Induction Phase|Adverse Event|16|||
161688307|NCT00440947|583909864|FG001|36-Week Induction Phase|Adverse Event|0|||
161688308|NCT00440947|583909865|FG002|36-Week Induction Phase|Adverse Event|0|||
161688309|NCT00440947|583909866|FG003|36-Week Induction Phase|Adverse Event|0|||
161688310|NCT00440947|583909867|FG004|36-Week Induction Phase|Adverse Event|0|||
161688311|NCT00440947|583909863|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
161688312|NCT00440947|583909864|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688313|NCT00440947|583909865|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688314|NCT00440947|583909866|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688315|NCT00440947|583909867|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688316|NCT00440947|583909863|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
161688317|NCT00440947|583909864|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688318|NCT00440947|583909865|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688319|NCT00440947|583909866|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688320|NCT00440947|583909867|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688321|NCT00440947|583909863|FG000|36-Week Induction Phase|Non-compliance|10|||
161688322|NCT00440947|583909864|FG001|36-Week Induction Phase|Non-compliance|0|||
161688323|NCT00440947|583909865|FG002|36-Week Induction Phase|Non-compliance|0|||
161688324|NCT00440947|583909866|FG003|36-Week Induction Phase|Non-compliance|0|||
161688325|NCT00440947|583909867|FG004|36-Week Induction Phase|Non-compliance|0|||
161688326|NCT00440947|583909863|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
161688327|NCT00440947|583909864|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
161688328|NCT00440947|583909865|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
161688329|NCT00440947|583909866|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
161688330|NCT00440947|583909867|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
161688331|NCT00440947|583909863|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
161688332|NCT00440947|583909864|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
161688333|NCT00440947|583909865|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
161688334|NCT00440947|583909866|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
161688335|NCT00440947|583909867|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
161688336|NCT00440947|583909863|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
161835930|NCT01550744|584440816|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
161835931|NCT01550744|584440814|FG000|Open-Label|Other|1|||
161688337|NCT00440947|583909864|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688338|NCT00440947|583909865|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688339|NCT00440947|583909866|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688340|NCT00440947|583909867|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688341|NCT00440947|583909863|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
161688342|NCT00440947|583909864|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
161835932|NCT01550744|584440815|FG001|Open-Label|Other|0|||
161645514|NCT01299480|583751624|FG003|Overall Study|Physician Decision|2|||
161645515|NCT01299480|583751625|FG004|Overall Study|Physician Decision|0|||
161645516|NCT01299480|583751621|FG000|Overall Study|Lost to Follow-up|3|||
161645517|NCT01299480|583751622|FG001|Overall Study|Lost to Follow-up|1|||
161645518|NCT01299480|583751623|FG002|Overall Study|Lost to Follow-up|2|||
161645519|NCT01299480|583751624|FG003|Overall Study|Lost to Follow-up|1|||
161645520|NCT01299480|583751625|FG004|Overall Study|Lost to Follow-up|2|||
161645521|NCT01299480|583751621|FG000|Overall Study|Other|3|||
161645522|NCT01299480|583751622|FG001|Overall Study|Other|2|||
161645523|NCT01299480|583751623|FG002|Overall Study|Other|3|||
161645524|NCT01299480|583751624|FG003|Overall Study|Other|0|||
161645525|NCT01299480|583751625|FG004|Overall Study|Other|3|||
161645526|NCT01299480|583751621|FG000|Overall Study|Started, but not vaccinated|0|||
161645527|NCT01299480|583751622|FG001|Overall Study|Started, but not vaccinated|0|||
161645528|NCT01299480|583751623|FG002|Overall Study|Started, but not vaccinated|1|||
161645529|NCT01299480|583751624|FG003|Overall Study|Started, but not vaccinated|1|||
161645530|NCT01299480|583751625|FG004|Overall Study|Started, but not vaccinated|0|||
161645531|NCT03838731|583753492|FG000|Overall Study|Pregnancy|0|||
161645532|NCT03838731|583753493|FG001|Overall Study|Pregnancy|1|||
161645533|NCT03838731|583753492|FG000|Overall Study|Withdrawal of consent|1|||
161645534|NCT03838731|583753493|FG001|Overall Study|Withdrawal of consent|0|||
161645535|NCT02706405|583753502|FG000|Overall Study|Death|3|||
161645536|NCT02706405|583753503|FG001|Overall Study|Death|2|||
161645537|NCT02706405|583753504|FG002|Overall Study|Death|0|||
161645538|NCT02706405|583753505|FG003|Overall Study|Death|1|||
161645539|NCT02706405|583753506|FG004|Overall Study|Death|0|||
161645540|NCT02706405|583753507|FG005|Overall Study|Death|0|||
161688343|NCT00440947|583909865|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
161645541|NCT02706405|583753508|FG006|Overall Study|Death|3|||
161645542|NCT02706405|583753509|FG007|Overall Study|Death|4|||
161645543|NCT02706405|583753502|FG000|Overall Study|Disease progression|0|||
161645544|NCT02706405|583753503|FG001|Overall Study|Disease progression|0|||
161645545|NCT02706405|583753504|FG002|Overall Study|Disease progression|0|||
161645546|NCT02706405|583753505|FG003|Overall Study|Disease progression|0|||
161645547|NCT02706405|583753506|FG004|Overall Study|Disease progression|0|||
161645548|NCT02706405|583753507|FG005|Overall Study|Disease progression|0|||
161645549|NCT02706405|583753508|FG006|Overall Study|Disease progression|0|||
161645550|NCT02706405|583753509|FG007|Overall Study|Disease progression|1|||
161688344|NCT00440947|583909866|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
161688345|NCT00440947|583909867|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
161688346|NCT00440947|583909863|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
161688347|NCT00440947|583909864|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688348|NCT00440947|583909865|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688349|NCT00440947|583909866|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688350|NCT00440947|583909867|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688351|NCT00440947|583909863|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
161688352|NCT00440947|583909864|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688353|NCT00440947|583909865|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688354|NCT00440947|583909866|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688355|NCT00440947|583909867|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688356|NCT00440947|583909863|FG000|36-Week Induction Phase|Incarceration|3|||
161688357|NCT00440947|583909864|FG001|36-Week Induction Phase|Incarceration|0|||
161688358|NCT00440947|583909865|FG002|36-Week Induction Phase|Incarceration|0|||
161835933|NCT01550744|584440816|FG002|Open-Label|Other|0|||
161688359|NCT00440947|583909866|FG003|36-Week Induction Phase|Incarceration|0|||
161645551|NCT02706405|583753502|FG000|Overall Study|Pt moved to new therapy|0|||
161645552|NCT02706405|583753503|FG001|Overall Study|Pt moved to new therapy|0|||
161645553|NCT02706405|583753504|FG002|Overall Study|Pt moved to new therapy|0|||
161645554|NCT02706405|583753505|FG003|Overall Study|Pt moved to new therapy|0|||
161645555|NCT02706405|583753506|FG004|Overall Study|Pt moved to new therapy|0|||
161645556|NCT02706405|583753507|FG005|Overall Study|Pt moved to new therapy|1|||
161645557|NCT02706405|583753508|FG006|Overall Study|Pt moved to new therapy|0|||
161645558|NCT02706405|583753509|FG007|Overall Study|Pt moved to new therapy|1|||
161645559|NCT02706405|583753502|FG000|Overall Study|Physician Decision|1|||
161645560|NCT02706405|583753503|FG001|Overall Study|Physician Decision|0|||
161645561|NCT02706405|583753504|FG002|Overall Study|Physician Decision|0|||
161645562|NCT02706405|583753505|FG003|Overall Study|Physician Decision|0|||
161645563|NCT02706405|583753506|FG004|Overall Study|Physician Decision|0|||
161645564|NCT02706405|583753507|FG005|Overall Study|Physician Decision|0|||
161645565|NCT02706405|583753508|FG006|Overall Study|Physician Decision|0|||
161645566|NCT02706405|583753509|FG007|Overall Study|Physician Decision|0|||
161645567|NCT00789360|583753516|FG000|Overall Study|Protocol Violation|3|||
161645568|NCT00789360|583753517|FG001|Overall Study|Protocol Violation|1|||
161645569|NCT03559062|583753518|FG000|Overall Study|Other|0|||
161645570|NCT03559062|583753519|FG001|Overall Study|Other|1|||
161645571|NCT03559062|583753520|FG002|Overall Study|Other|0|||
161645572|NCT01757197|583753521|FG000|Overall Study|Death|2|||
161645573|NCT03443414|583753522|FG000|Overall Study|Adverse Event|6|||
161645574|NCT03443414|583753523|FG001|Overall Study|Adverse Event|0|||
161645575|NCT03443414|583753524|FG002|Overall Study|Adverse Event|4|||
161645576|NCT03443414|583753525|FG003|Overall Study|Adverse Event|2|||
161645577|NCT03443414|583753526|FG004|Overall Study|Adverse Event|3|||
161645578|NCT03443414|583753522|FG000|Overall Study|Withdrawal by Subject|3|||
161645579|NCT03443414|583753523|FG001|Overall Study|Withdrawal by Subject|2|||
161645580|NCT03443414|583753524|FG002|Overall Study|Withdrawal by Subject|2|||
161645581|NCT03443414|583753525|FG003|Overall Study|Withdrawal by Subject|2|||
161645582|NCT03443414|583753526|FG004|Overall Study|Withdrawal by Subject|1|||
161645583|NCT03443414|583753522|FG000|Overall Study|Death|0|||
161645584|NCT03443414|583753523|FG001|Overall Study|Death|1|||
161645585|NCT03443414|583753524|FG002|Overall Study|Death|0|||
161645586|NCT03443414|583753525|FG003|Overall Study|Death|1|||
161645587|NCT03443414|583753526|FG004|Overall Study|Death|0|||
161645588|NCT03443414|583753522|FG000|Overall Study|Reason not specified|2|||
161645589|NCT03443414|583753523|FG001|Overall Study|Reason not specified|0|||
161645590|NCT03443414|583753524|FG002|Overall Study|Reason not specified|0|||
161645591|NCT03443414|583753525|FG003|Overall Study|Reason not specified|0|||
161645592|NCT03443414|583753526|FG004|Overall Study|Reason not specified|1|||
161645593|NCT02522728|583753530|FG000|Overall Study|Withdrawal by Subject|6|||
161645594|NCT02522728|583753531|FG001|Overall Study|Withdrawal by Subject|6|||
161645595|NCT02522728|583753530|FG000|Overall Study|Death|4|||
161645596|NCT02522728|583753531|FG001|Overall Study|Death|3|||
161645597|NCT02522728|583753530|FG000|Overall Study|Adverse Event|2|||
161645598|NCT02522728|583753531|FG001|Overall Study|Adverse Event|1|||
161645599|NCT02522728|583753530|FG000|Overall Study|Did not receive randomized study device|0|||
161645600|NCT02522728|583753531|FG001|Overall Study|Did not receive randomized study device|1|||
161645601|NCT01099917|583753532|FG000|Overall Study|Adverse Event|3|||
161645602|NCT01099917|583753532|FG000|Overall Study|Not Treated|24|||
161645603|NCT03355209|583753533|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
161645604|NCT03355209|583753534|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
161645605|NCT03355209|583753535|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
161645606|NCT03355209|583753536|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
161645607|NCT03355209|583753537|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
161645608|NCT03355209|583753538|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
161645609|NCT03355209|583753533|FG000|Part 1: Double-Blind Period|Death|0|||
161645610|NCT03355209|583753534|FG001|Part 1: Double-Blind Period|Death|0|||
161645611|NCT03355209|583753535|FG002|Part 1: Double-Blind Period|Death|1|||
161645612|NCT03355209|583753536|FG003|Part 1: Double-Blind Period|Death|0|||
161835934|NCT01550744|584440814|FG000|Double-Blind|Lost to Follow-up|0|||
161645613|NCT03355209|583753537|FG004|Part 1: Double-Blind Period|Death|0|||
161645614|NCT03355209|583753538|FG005|Part 1: Double-Blind Period|Death|0|||
161645615|NCT03355209|583753533|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
161645616|NCT03355209|583753534|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
161645617|NCT03355209|583753535|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
161645618|NCT03355209|583753536|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
161645619|NCT03355209|583753537|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
161645620|NCT03355209|583753538|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
161645621|NCT03355209|583753533|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
161645622|NCT03355209|583753534|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
161645623|NCT03355209|583753535|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
161645624|NCT03355209|583753536|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161645625|NCT03355209|583753537|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161645626|NCT03355209|583753538|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161645627|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
161645628|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
161645629|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
161645630|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
161645631|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
161645632|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
161645633|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161645634|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
161645635|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161645636|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161645637|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161645638|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161645639|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
161645640|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
161645641|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
161645642|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
161645643|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
161645644|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
161645645|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
161645646|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
161645647|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
161645648|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
161645649|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
161645650|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
161645651|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
161645652|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
161645653|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
161645654|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161645655|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161645656|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161645657|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161645658|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161645659|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161645660|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
161645661|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161645662|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
161645663|NCT03355209|583753533|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
161645664|NCT03355209|583753534|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161645665|NCT03355209|583753535|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
161645666|NCT03355209|583753536|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161645667|NCT03355209|583753537|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161645668|NCT03355209|583753538|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161645669|NCT00604708|583753544|FG000|Overall Study|Withdrawal by Subject|9|||
161645670|NCT00604708|583753545|FG001|Overall Study|Withdrawal by Subject|10|||
161645671|NCT00604708|583753544|FG000|Overall Study|Protocol Violation|2|||
161645672|NCT00604708|583753545|FG001|Overall Study|Protocol Violation|8|||
161645673|NCT00604708|583753544|FG000|Overall Study|Lost to Follow-up|5|||
161645674|NCT00604708|583753545|FG001|Overall Study|Lost to Follow-up|5|||
161645675|NCT00604708|583753544|FG000|Overall Study|administrative reasons|9|||
161645676|NCT00604708|583753545|FG001|Overall Study|administrative reasons|11|||
161645677|NCT00604708|583753544|FG000|Overall Study|Adverse Event|6|||
161645678|NCT00604708|583753545|FG001|Overall Study|Adverse Event|6|||
161645679|NCT01277887|583753547|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
161645680|NCT01277887|583753548|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
161645681|NCT01277887|583753547|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
161645682|NCT01277887|583753548|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
161645683|NCT01277887|583753547|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
161645684|NCT01277887|583753548|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
161645685|NCT00415051|583753549|FG000|Overall Study|Protocol Violation|1|||
161645686|NCT04916730|583753551|FG000|Overall Study|Withdrawal by Subject|4|||
161645687|NCT04916730|583753552|FG001|Overall Study|Withdrawal by Subject|2|||
161645688|NCT04916730|583753551|FG000|Overall Study|Lost to Follow-up|0|||
161645689|NCT04916730|583753552|FG001|Overall Study|Lost to Follow-up|2|||
161645690|NCT04916730|583753551|FG000|Overall Study|Physician Decision|1|||
161645691|NCT04916730|583753552|FG001|Overall Study|Physician Decision|0|||
161645692|NCT00617929|583753555|FG000|Overall Study|Physician Decision|1|||
161645693|NCT00760747|583753565|FG000|Study Period II|Adverse Event|3|||
161645694|NCT00760747|583753566|FG001|Study Period II|Adverse Event|4|||
161645695|NCT00760747|583753565|FG000|Study Period II|Lack of Efficacy|0|||
161645696|NCT00760747|583753566|FG001|Study Period II|Lack of Efficacy|6|||
161645697|NCT00760747|583753565|FG000|Study Period II|Parent/Caregiver Decision|3|||
161645698|NCT00760747|583753566|FG001|Study Period II|Parent/Caregiver Decision|0|||
161645699|NCT00760747|583753565|FG000|Study Period II|Protocol Violation|6|||
161645700|NCT00760747|583753566|FG001|Study Period II|Protocol Violation|3|||
161645701|NCT00760747|583753565|FG000|Study Period II|Withdrawal by Subject|1|||
161645702|NCT00760747|583753566|FG001|Study Period II|Withdrawal by Subject|0|||
161645703|NCT00760747|583753565|FG000|Study Period II|No drug administered|0|||
161645704|NCT00760747|583753566|FG001|Study Period II|No drug administered|1|||
161645705|NCT00760747|583753565|FG000|Study Period III|Adverse Event|1|||
161645706|NCT00760747|583753566|FG001|Study Period III|Adverse Event|0|||
161645707|NCT00760747|583753565|FG000|Study Period III|Lack of Efficacy|1|||
161645708|NCT00760747|583753566|FG001|Study Period III|Lack of Efficacy|0|||
161645709|NCT00760747|583753565|FG000|Study Period III|Parent/Caregiver Decision|0|||
161645710|NCT00760747|583753566|FG001|Study Period III|Parent/Caregiver Decision|1|||
161645711|NCT00760747|583753565|FG000|Study Period III|Protocol Violation|1|||
161645712|NCT00760747|583753566|FG001|Study Period III|Protocol Violation|1|||
161645713|NCT00760747|583753565|FG000|Study Period III|Physician Decision|0|||
161645714|NCT00760747|583753566|FG001|Study Period III|Physician Decision|1|||
161645715|NCT00844597|583753567|FG000|Overall Study|Adverse Event|0|||
161645716|NCT00844597|583753568|FG001|Overall Study|Adverse Event|0|||
161645717|NCT00844597|583753569|FG002|Overall Study|Adverse Event|0|||
161645718|NCT00844597|583753570|FG003|Overall Study|Adverse Event|1|||
161645719|NCT00844597|583753571|FG004|Overall Study|Adverse Event|0|||
161645720|NCT00844597|583753572|FG005|Overall Study|Adverse Event|0|||
161645721|NCT04160988|583753573|FG000|Overall Study|poor image quality|28|||
161645722|NCT01250509|583753574|FG000|Overall Study|Lost to Follow-up|5|||
161645723|NCT01250509|583753575|FG001|Overall Study|Lost to Follow-up|2|||
161645724|NCT01228175|583753580|FG000|Overall Study|Lost to Follow-up|64|||
161645725|NCT01228175|583753581|FG001|Overall Study|Lost to Follow-up|50|||
161645726|NCT01228175|583753580|FG000|Overall Study|Withdrawal by Subject|1|||
161645727|NCT01228175|583753581|FG001|Overall Study|Withdrawal by Subject|2|||
161645728|NCT01228175|583753580|FG000|Overall Study|Physician Decision|1|||
161645729|NCT01228175|583753581|FG001|Overall Study|Physician Decision|1|||
161645730|NCT00108745|583753582|FG000|Overall Study|Withdrawal by Subject|19|||
161645731|NCT00108745|583753583|FG001|Overall Study|Withdrawal by Subject|12|||
161645732|NCT00108745|583753584|FG002|Overall Study|Withdrawal by Subject|12|||
161645733|NCT00108745|583753582|FG000|Overall Study|Never Treated|8|||
161645734|NCT00108745|583753583|FG001|Overall Study|Never Treated|10|||
161645735|NCT00108745|583753584|FG002|Overall Study|Never Treated|12|||
161645736|NCT00108745|583753582|FG000|Overall Study|Ineligible|7|||
161645737|NCT00108745|583753583|FG001|Overall Study|Ineligible|13|||
161645738|NCT00108745|583753584|FG002|Overall Study|Ineligible|13|||
161645739|NCT00243074|583753587|FG000|Overall Study|Ineligible|6|||
161645740|NCT00243074|583753587|FG000|Overall Study|Adverse Event|6|||
161645741|NCT00243074|583753587|FG000|Overall Study|Withdrawal by Subject|2|||
161645742|NCT00243074|583753587|FG000|Overall Study|Lack of Efficacy|36|||
161645743|NCT00243074|583753587|FG000|Overall Study|Death|2|||
161645744|NCT00243074|583753587|FG000|Overall Study|not protocol specified|1|||
161645745|NCT00243074|583753587|FG000|Overall Study|Did not receive any treatment|1|||
161645746|NCT00402051|583753592|FG000|Overall Study|Progressive Disease|13|||
161645747|NCT00402051|583753593|FG001|Overall Study|Progressive Disease|20|||
161645748|NCT00402051|583753592|FG000|Overall Study|Adverse Event|11|||
161645749|NCT00402051|583753593|FG001|Overall Study|Adverse Event|4|||
161645750|NCT00402051|583753592|FG000|Overall Study|Physician Decision|7|||
161645751|NCT00402051|583753593|FG001|Overall Study|Physician Decision|3|||
161645752|NCT00402051|583753592|FG000|Overall Study|Withdrawal by Subject|3|||
161645753|NCT00402051|583753593|FG001|Overall Study|Withdrawal by Subject|3|||
161645754|NCT00402051|583753592|FG000|Overall Study|Death - Related to Study Drug|1|||
161835935|NCT01550744|584440815|FG001|Double-Blind|Lost to Follow-up|6|||
161645755|NCT00402051|583753593|FG001|Overall Study|Death - Related to Study Drug|2|||
161645756|NCT00402051|583753592|FG000|Overall Study|Death Due to Study Disease|2|||
161645757|NCT00402051|583753593|FG001|Overall Study|Death Due to Study Disease|1|||
161645758|NCT00402051|583753592|FG000|Overall Study|Death Due to Adverse Event|0|||
161645759|NCT00402051|583753593|FG001|Overall Study|Death Due to Adverse Event|2|||
161645760|NCT00402051|583753592|FG000|Overall Study|Lost to Follow-up|1|||
161645761|NCT00402051|583753593|FG001|Overall Study|Lost to Follow-up|0|||
161645762|NCT04463680|583753596|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
161645763|NCT04463680|583753596|FG000|Overall Study|Not eligible due to implant duration of use|1|||
161645764|NCT04463680|583753596|FG000|Overall Study|Withdrawal by Subject|3|||
161645765|NCT05239598|583753601|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
161645766|NCT05239598|583753602|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
161645767|NCT05239598|583753601|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
161645768|NCT05239598|583753602|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
161645769|NCT02592707|583753603|FG000|Overall Study|Consent Withdrawn|0|||
161645770|NCT02592707|583753604|FG001|Overall Study|Consent Withdrawn|1|||
161645771|NCT02592707|583753605|FG002|Overall Study|Consent Withdrawn|2|||
161645772|NCT02592707|583753606|FG003|Overall Study|Consent Withdrawn|0|||
161645773|NCT02592707|583753603|FG000|Overall Study|Death|1|||
161645774|NCT02592707|583753604|FG001|Overall Study|Death|0|||
161645775|NCT02592707|583753605|FG002|Overall Study|Death|0|||
161645776|NCT02592707|583753606|FG003|Overall Study|Death|0|||
161645777|NCT02592707|583753603|FG000|Overall Study|Progressive Disease|4|||
161645778|NCT02592707|583753604|FG001|Overall Study|Progressive Disease|4|||
161645779|NCT02592707|583753605|FG002|Overall Study|Progressive Disease|3|||
161645780|NCT02592707|583753606|FG003|Overall Study|Progressive Disease|3|||
161645781|NCT02592707|583753603|FG000|Overall Study|Other|0|||
161645782|NCT02592707|583753604|FG001|Overall Study|Other|0|||
161645783|NCT02592707|583753605|FG002|Overall Study|Other|1|||
161645784|NCT02592707|583753606|FG003|Overall Study|Other|2|||
161645785|NCT02592707|583753603|FG000|Overall Study|Never entered LTFU period|1|||
161645786|NCT02592707|583753604|FG001|Overall Study|Never entered LTFU period|0|||
161645787|NCT02592707|583753605|FG002|Overall Study|Never entered LTFU period|0|||
161645788|NCT02592707|583753606|FG003|Overall Study|Never entered LTFU period|2|||
161645789|NCT02998476|583753609|FG000|Overall Study|Lost to Follow-up|1|||
161645790|NCT02998476|583753610|FG001|Overall Study|Lost to Follow-up|0|||
161645791|NCT02998476|583753609|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
161645792|NCT02998476|583753610|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
161645793|NCT02998476|583753609|FG000|Overall Study|Withdrawal by Subject|1|||
161645794|NCT02998476|583753610|FG001|Overall Study|Withdrawal by Subject|2|||
161645795|NCT02998476|583753609|FG000|Overall Study|Death|45|||
161645796|NCT02998476|583753610|FG001|Overall Study|Death|2|||
161645797|NCT02998476|583753609|FG000|Overall Study|Other|6|||
161645798|NCT02998476|583753610|FG001|Overall Study|Other|1|||
161645799|NCT04855734|583753611|FG000|Overall Study|Lost to Follow-up|2|||
161645800|NCT04855734|583753612|FG001|Overall Study|Lost to Follow-up|2|||
161645801|NCT03832595|583753613|FG000|Overall Study|Death|142|||
161645802|NCT03832595|583753614|FG001|Overall Study|Death|130|||
161645803|NCT03832595|583753613|FG000|Overall Study|Medical management without dialysis|37|||
161835936|NCT01550744|584440816|FG002|Double-Blind|Lost to Follow-up|12|||
161835937|NCT01550744|584440814|FG000|Double-Blind|Withdrawal by Subject|0|||
161645804|NCT03832595|583753614|FG001|Overall Study|Medical management without dialysis|1|||
161835938|NCT01550744|584440815|FG001|Double-Blind|Withdrawal by Subject|2|||
161645805|NCT00344032|583753617|FG000|Overall Study|Adverse Event|0|||
161645806|NCT00344032|583753618|FG001|Overall Study|Adverse Event|1|||
161645807|NCT00344032|583753617|FG000|Overall Study|Withdrawal by Subject|6|||
161645808|NCT00344032|583753618|FG001|Overall Study|Withdrawal by Subject|2|||
161645809|NCT00344032|583753617|FG000|Overall Study|Lost to Follow-up|4|||
161645810|NCT00344032|583753618|FG001|Overall Study|Lost to Follow-up|6|||
161645811|NCT00344032|583753617|FG000|Overall Study|Physician Decision|4|||
161645812|NCT00344032|583753618|FG001|Overall Study|Physician Decision|1|||
161645813|NCT05131477|583753621|FG000|PART 1|Withdrawal by Subject|2|||
161645814|NCT05131477|583753622|FG001|PART 1|Withdrawal by Subject|9|||
161645815|NCT05131477|583753623|FG002|PART 1|Withdrawal by Subject|6|||
161645816|NCT05131477|583753624|FG003|PART 1|Withdrawal by Subject|2|||
161645817|NCT05131477|583753625|FG004|PART 1|Withdrawal by Subject|8|||
161645818|NCT05131477|583753626|FG005|PART 1|Withdrawal by Subject|0|||
161645819|NCT05131477|583753627|FG006|PART 1|Withdrawal by Subject|0|||
161645820|NCT05131477|583753628|FG007|PART 1|Withdrawal by Subject|0|||
161645821|NCT05131477|583753629|FG008|PART 1|Withdrawal by Subject|0|||
161645822|NCT05131477|583753630|FG009|PART 1|Withdrawal by Subject|0|||
161645823|NCT05131477|583753631|FG010|PART 1|Withdrawal by Subject|0|||
161645824|NCT05131477|583753632|FG011|PART 1|Withdrawal by Subject|0|||
161645825|NCT05131477|583753633|FG012|PART 1|Withdrawal by Subject|0|||
161645826|NCT05131477|583753634|FG013|PART 1|Withdrawal by Subject|0|||
161645827|NCT05131477|583753621|FG000|PART 1|Physician Decision|1|||
161645828|NCT05131477|583753622|FG001|PART 1|Physician Decision|0|||
161645829|NCT05131477|583753623|FG002|PART 1|Physician Decision|0|||
161645830|NCT05131477|583753624|FG003|PART 1|Physician Decision|0|||
161645831|NCT05131477|583753625|FG004|PART 1|Physician Decision|0|||
161645832|NCT05131477|583753626|FG005|PART 1|Physician Decision|0|||
161645833|NCT05131477|583753627|FG006|PART 1|Physician Decision|0|||
161645834|NCT05131477|583753628|FG007|PART 1|Physician Decision|0|||
161645835|NCT05131477|583753629|FG008|PART 1|Physician Decision|0|||
161645836|NCT05131477|583753630|FG009|PART 1|Physician Decision|0|||
161645837|NCT05131477|583753631|FG010|PART 1|Physician Decision|0|||
161645838|NCT05131477|583753632|FG011|PART 1|Physician Decision|0|||
161645839|NCT05131477|583753633|FG012|PART 1|Physician Decision|0|||
161645840|NCT05131477|583753634|FG013|PART 1|Physician Decision|0|||
161645841|NCT05131477|583753621|FG000|PART 1|Adverse Event|3|||
161645842|NCT05131477|583753622|FG001|PART 1|Adverse Event|5|||
161645843|NCT05131477|583753623|FG002|PART 1|Adverse Event|1|||
161645844|NCT05131477|583753624|FG003|PART 1|Adverse Event|6|||
161645845|NCT05131477|583753625|FG004|PART 1|Adverse Event|4|||
161645846|NCT05131477|583753626|FG005|PART 1|Adverse Event|0|||
161645847|NCT05131477|583753627|FG006|PART 1|Adverse Event|0|||
161645848|NCT05131477|583753628|FG007|PART 1|Adverse Event|0|||
161645849|NCT05131477|583753629|FG008|PART 1|Adverse Event|0|||
161645850|NCT05131477|583753630|FG009|PART 1|Adverse Event|0|||
161645851|NCT05131477|583753631|FG010|PART 1|Adverse Event|0|||
161645852|NCT05131477|583753632|FG011|PART 1|Adverse Event|0|||
161645853|NCT05131477|583753633|FG012|PART 1|Adverse Event|0|||
161645854|NCT05131477|583753634|FG013|PART 1|Adverse Event|0|||
161645855|NCT05131477|583753621|FG000|PART 1|unclassified|1|||
161645856|NCT05131477|583753622|FG001|PART 1|unclassified|1|||
161645857|NCT05131477|583753623|FG002|PART 1|unclassified|0|||
161645858|NCT05131477|583753624|FG003|PART 1|unclassified|0|||
161645859|NCT05131477|583753625|FG004|PART 1|unclassified|4|||
161645860|NCT05131477|583753626|FG005|PART 1|unclassified|0|||
161645861|NCT05131477|583753627|FG006|PART 1|unclassified|0|||
161645862|NCT05131477|583753628|FG007|PART 1|unclassified|0|||
161645863|NCT05131477|583753629|FG008|PART 1|unclassified|0|||
161645864|NCT05131477|583753630|FG009|PART 1|unclassified|0|||
161645865|NCT05131477|583753631|FG010|PART 1|unclassified|0|||
161645866|NCT05131477|583753632|FG011|PART 1|unclassified|0|||
161645867|NCT05131477|583753633|FG012|PART 1|unclassified|0|||
161645868|NCT05131477|583753634|FG013|PART 1|unclassified|0|||
161645869|NCT05131477|583753621|FG000|PART 1|Randomized and not treated|0|||
161645870|NCT05131477|583753622|FG001|PART 1|Randomized and not treated|0|||
161645871|NCT05131477|583753623|FG002|PART 1|Randomized and not treated|0|||
161645872|NCT05131477|583753624|FG003|PART 1|Randomized and not treated|1|||
161645873|NCT05131477|583753625|FG004|PART 1|Randomized and not treated|1|||
161645874|NCT05131477|583753626|FG005|PART 1|Randomized and not treated|0|||
161645875|NCT05131477|583753627|FG006|PART 1|Randomized and not treated|0|||
161645876|NCT05131477|583753628|FG007|PART 1|Randomized and not treated|0|||
161645877|NCT05131477|583753629|FG008|PART 1|Randomized and not treated|0|||
161645878|NCT05131477|583753630|FG009|PART 1|Randomized and not treated|0|||
161645879|NCT05131477|583753631|FG010|PART 1|Randomized and not treated|0|||
161645880|NCT05131477|583753632|FG011|PART 1|Randomized and not treated|0|||
161645881|NCT05131477|583753633|FG012|PART 1|Randomized and not treated|0|||
161645882|NCT05131477|583753634|FG013|PART 1|Randomized and not treated|0|||
161645883|NCT05131477|583753621|FG000|PART 1|Protocol Violation|2|||
161645884|NCT05131477|583753622|FG001|PART 1|Protocol Violation|0|||
161645885|NCT05131477|583753623|FG002|PART 1|Protocol Violation|0|||
161645886|NCT05131477|583753624|FG003|PART 1|Protocol Violation|1|||
161645887|NCT05131477|583753625|FG004|PART 1|Protocol Violation|0|||
161645888|NCT05131477|583753626|FG005|PART 1|Protocol Violation|0|||
161645889|NCT05131477|583753627|FG006|PART 1|Protocol Violation|0|||
161645890|NCT05131477|583753628|FG007|PART 1|Protocol Violation|0|||
161645891|NCT05131477|583753629|FG008|PART 1|Protocol Violation|0|||
161645892|NCT05131477|583753630|FG009|PART 1|Protocol Violation|0|||
161645893|NCT05131477|583753631|FG010|PART 1|Protocol Violation|0|||
161645894|NCT05131477|583753632|FG011|PART 1|Protocol Violation|0|||
161645895|NCT05131477|583753633|FG012|PART 1|Protocol Violation|0|||
161645896|NCT05131477|583753634|FG013|PART 1|Protocol Violation|0|||
161645897|NCT05131477|583753621|FG000|PART 1|Lack of Efficacy|0|||
161645898|NCT05131477|583753622|FG001|PART 1|Lack of Efficacy|1|||
161645899|NCT05131477|583753623|FG002|PART 1|Lack of Efficacy|1|||
161645900|NCT05131477|583753624|FG003|PART 1|Lack of Efficacy|2|||
161645901|NCT05131477|583753625|FG004|PART 1|Lack of Efficacy|5|||
161645902|NCT05131477|583753626|FG005|PART 1|Lack of Efficacy|0|||
161645903|NCT05131477|583753627|FG006|PART 1|Lack of Efficacy|0|||
161645904|NCT05131477|583753628|FG007|PART 1|Lack of Efficacy|0|||
161645905|NCT05131477|583753629|FG008|PART 1|Lack of Efficacy|0|||
161645906|NCT05131477|583753630|FG009|PART 1|Lack of Efficacy|0|||
161645907|NCT05131477|583753631|FG010|PART 1|Lack of Efficacy|0|||
161645908|NCT05131477|583753632|FG011|PART 1|Lack of Efficacy|0|||
161645909|NCT05131477|583753633|FG012|PART 1|Lack of Efficacy|0|||
161645910|NCT05131477|583753634|FG013|PART 1|Lack of Efficacy|0|||
161645911|NCT05131477|583753621|FG000|PART 2|Withdrawal by Subject|0|||
161645912|NCT05131477|583753622|FG001|PART 2|Withdrawal by Subject|0|||
161645913|NCT05131477|583753623|FG002|PART 2|Withdrawal by Subject|0|||
161645914|NCT05131477|583753624|FG003|PART 2|Withdrawal by Subject|0|||
161645915|NCT05131477|583753625|FG004|PART 2|Withdrawal by Subject|0|||
161645916|NCT05131477|583753626|FG005|PART 2|Withdrawal by Subject|0|||
161645917|NCT05131477|583753627|FG006|PART 2|Withdrawal by Subject|2|||
161645918|NCT05131477|583753628|FG007|PART 2|Withdrawal by Subject|0|||
161645919|NCT05131477|583753629|FG008|PART 2|Withdrawal by Subject|0|||
161645920|NCT05131477|583753630|FG009|PART 2|Withdrawal by Subject|0|||
161645921|NCT05131477|583753631|FG010|PART 2|Withdrawal by Subject|2|||
161645922|NCT05131477|583753632|FG011|PART 2|Withdrawal by Subject|0|||
161645923|NCT05131477|583753633|FG012|PART 2|Withdrawal by Subject|2|||
161645924|NCT05131477|583753634|FG013|PART 2|Withdrawal by Subject|2|||
161645925|NCT05131477|583753621|FG000|PART 2|Other|0|||
161645926|NCT05131477|583753622|FG001|PART 2|Other|0|||
161645927|NCT05131477|583753623|FG002|PART 2|Other|0|||
161645928|NCT05131477|583753624|FG003|PART 2|Other|0|||
161645929|NCT05131477|583753625|FG004|PART 2|Other|0|||
161645930|NCT05131477|583753626|FG005|PART 2|Other|0|||
161645931|NCT05131477|583753627|FG006|PART 2|Other|0|||
161645932|NCT05131477|583753628|FG007|PART 2|Other|0|||
161645933|NCT05131477|583753629|FG008|PART 2|Other|1|||
161645934|NCT05131477|583753630|FG009|PART 2|Other|1|||
161645935|NCT05131477|583753631|FG010|PART 2|Other|0|||
161645936|NCT05131477|583753632|FG011|PART 2|Other|0|||
161645937|NCT05131477|583753633|FG012|PART 2|Other|1|||
161645938|NCT05131477|583753634|FG013|PART 2|Other|0|||
161645939|NCT05131477|583753621|FG000|PART 2|Lack of Efficacy|0|||
161645940|NCT05131477|583753622|FG001|PART 2|Lack of Efficacy|0|||
161645941|NCT05131477|583753623|FG002|PART 2|Lack of Efficacy|0|||
161645942|NCT05131477|583753624|FG003|PART 2|Lack of Efficacy|0|||
161645943|NCT05131477|583753625|FG004|PART 2|Lack of Efficacy|0|||
161645944|NCT05131477|583753626|FG005|PART 2|Lack of Efficacy|1|||
161645945|NCT05131477|583753627|FG006|PART 2|Lack of Efficacy|1|||
161645946|NCT05131477|583753628|FG007|PART 2|Lack of Efficacy|0|||
161645947|NCT05131477|583753629|FG008|PART 2|Lack of Efficacy|3|||
161645948|NCT05131477|583753630|FG009|PART 2|Lack of Efficacy|0|||
161645949|NCT05131477|583753631|FG010|PART 2|Lack of Efficacy|1|||
161645950|NCT05131477|583753632|FG011|PART 2|Lack of Efficacy|0|||
161645951|NCT05131477|583753633|FG012|PART 2|Lack of Efficacy|2|||
161645952|NCT05131477|583753634|FG013|PART 2|Lack of Efficacy|0|||
161645953|NCT05131477|583753621|FG000|PART 2|Unclassified|0|||
161645954|NCT05131477|583753622|FG001|PART 2|Unclassified|0|||
161645955|NCT05131477|583753623|FG002|PART 2|Unclassified|0|||
161645956|NCT05131477|583753624|FG003|PART 2|Unclassified|0|||
161645957|NCT05131477|583753625|FG004|PART 2|Unclassified|0|||
161645958|NCT05131477|583753626|FG005|PART 2|Unclassified|0|||
161645959|NCT05131477|583753627|FG006|PART 2|Unclassified|0|||
161645960|NCT05131477|583753628|FG007|PART 2|Unclassified|0|||
161645961|NCT05131477|583753629|FG008|PART 2|Unclassified|0|||
161645962|NCT05131477|583753630|FG009|PART 2|Unclassified|0|||
161645963|NCT05131477|583753631|FG010|PART 2|Unclassified|1|||
161645964|NCT05131477|583753632|FG011|PART 2|Unclassified|0|||
161645965|NCT05131477|583753633|FG012|PART 2|Unclassified|0|||
161645966|NCT05131477|583753634|FG013|PART 2|Unclassified|0|||
161645967|NCT05131477|583753621|FG000|PART 2|Re-randomized and not treated|0|||
161645968|NCT05131477|583753622|FG001|PART 2|Re-randomized and not treated|0|||
161645969|NCT05131477|583753623|FG002|PART 2|Re-randomized and not treated|0|||
161645970|NCT05131477|583753624|FG003|PART 2|Re-randomized and not treated|0|||
161645971|NCT05131477|583753625|FG004|PART 2|Re-randomized and not treated|0|||
161645972|NCT05131477|583753626|FG005|PART 2|Re-randomized and not treated|0|||
161645973|NCT05131477|583753627|FG006|PART 2|Re-randomized and not treated|0|||
161645974|NCT05131477|583753628|FG007|PART 2|Re-randomized and not treated|1|||
161645975|NCT05131477|583753629|FG008|PART 2|Re-randomized and not treated|0|||
161645976|NCT05131477|583753630|FG009|PART 2|Re-randomized and not treated|0|||
161645977|NCT05131477|583753631|FG010|PART 2|Re-randomized and not treated|1|||
161645978|NCT05131477|583753632|FG011|PART 2|Re-randomized and not treated|0|||
161645979|NCT05131477|583753633|FG012|PART 2|Re-randomized and not treated|1|||
161645980|NCT05131477|583753634|FG013|PART 2|Re-randomized and not treated|1|||
161645981|NCT02194829|583753635|FG000|Overall Study|Adverse Event|2|||
161645982|NCT02194829|583753636|FG001|Overall Study|Adverse Event|2|||
161645983|NCT02194829|583753635|FG000|Overall Study|Death|0|||
161645984|NCT02194829|583753636|FG001|Overall Study|Death|1|||
161645985|NCT02194829|583753635|FG000|Overall Study|Disease progression|0|||
161645986|NCT02194829|583753636|FG001|Overall Study|Disease progression|1|||
161645987|NCT02194829|583753635|FG000|Overall Study|Withdrawal by Subject|0|||
161645988|NCT02194829|583753636|FG001|Overall Study|Withdrawal by Subject|1|||
161645989|NCT02194829|583753635|FG000|Overall Study|Never started protocol therapy|0|||
161645990|NCT02194829|583753636|FG001|Overall Study|Never started protocol therapy|1|||
161645991|NCT06840769|583753638|FG000|Overall Study|Withdrawal by Subject|1|||
161645992|NCT06840769|583753639|FG001|Overall Study|Withdrawal by Subject|0|||
161645993|NCT06840769|583753640|FG002|Overall Study|Withdrawal by Subject|0|||
161645994|NCT06840769|583753641|FG003|Overall Study|Withdrawal by Subject|0|||
161645995|NCT06840769|583753642|FG004|Overall Study|Withdrawal by Subject|0|||
161645996|NCT02726945|583753643|FG000|Overall Study|Withdrawal by Subject|0|||
161645997|NCT02726945|583753644|FG001|Overall Study|Withdrawal by Subject|0|||
161645998|NCT02726945|583753645|FG002|Overall Study|Withdrawal by Subject|1|||
161645999|NCT02726945|583753643|FG000|Overall Study|Elected to have total knee replacement|0|||
161646000|NCT02726945|583753644|FG001|Overall Study|Elected to have total knee replacement|1|||
161646001|NCT02726945|583753645|FG002|Overall Study|Elected to have total knee replacement|0|||
161646002|NCT05992922|583753646|FG000|Overall Study|Adverse Event|6|||
161646003|NCT05992922|583753647|FG001|Overall Study|Adverse Event|0|||
161646004|NCT05992922|583753646|FG000|Overall Study|Sponsor Termination of Study|14|||
161646005|NCT05992922|583753647|FG001|Overall Study|Sponsor Termination of Study|20|||
161646006|NCT03939689|583755253|FG000|Overall Study|Radiographic progression|14|||
161646007|NCT03939689|583755254|FG001|Overall Study|Radiographic progression|17|||
161646008|NCT03939689|583755253|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
161646009|NCT03939689|583755254|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
161646010|NCT03939689|583755253|FG000|Overall Study|Adverse Event|1|||
161646011|NCT03939689|583755254|FG001|Overall Study|Adverse Event|8|||
161646012|NCT03939689|583755253|FG000|Overall Study|Unequivocal clinical progression|2|||
161646013|NCT03939689|583755254|FG001|Overall Study|Unequivocal clinical progression|5|||
161646014|NCT03939689|583755253|FG000|Overall Study|Other|1|||
161646015|NCT03939689|583755254|FG001|Overall Study|Other|4|||
161646016|NCT03939689|583755253|FG000|Overall Study|Death|0|||
161646017|NCT03939689|583755254|FG001|Overall Study|Death|3|||
161646018|NCT03939689|583755253|FG000|Overall Study|Participant decision|0|||
161646019|NCT03939689|583755254|FG001|Overall Study|Participant decision|3|||
161646020|NCT03939689|583755253|FG000|Overall Study|Withdrawal of consent|2|||
161646021|NCT03939689|583755254|FG001|Overall Study|Withdrawal of consent|1|||
161646022|NCT03939689|583755253|FG000|Overall Study|Investigator decision|1|||
161646023|NCT03939689|583755254|FG001|Overall Study|Investigator decision|0|||
161646024|NCT04427280|583755255|FG000|Overall Study|Withdrawal by Subject|0|||
161646025|NCT04427280|583755256|FG001|Overall Study|Withdrawal by Subject|2|||
161646026|NCT02473965|583755258|FG000|Overall Study|Adverse Event|6|||
161646027|NCT02473965|583755259|FG001|Overall Study|Adverse Event|4|||
161646028|NCT02473965|583755258|FG000|Overall Study|MG worsening|4|||
161646029|NCT02473965|583755259|FG001|Overall Study|MG worsening|1|||
161646030|NCT02473965|583755258|FG000|Overall Study|Withdrawal by Subject|2|||
161646031|NCT02473965|583755259|FG001|Overall Study|Withdrawal by Subject|3|||
161646032|NCT02473965|583755258|FG000|Overall Study|Physician Decision|0|||
161646033|NCT02473965|583755259|FG001|Overall Study|Physician Decision|2|||
161646034|NCT01920477|583755262|FG000|Overall Study|Adverse Event|0|||
161646035|NCT01920477|583755263|FG001|Overall Study|Adverse Event|1|||
161646036|NCT01920477|583755262|FG000|Overall Study|Lack of Efficacy|1|||
161646037|NCT01920477|583755263|FG001|Overall Study|Lack of Efficacy|0|||
161646038|NCT01920477|583755262|FG000|Overall Study|Study closed/terminated|14|||
161646039|NCT01920477|583755263|FG001|Overall Study|Study closed/terminated|15|||
161646040|NCT01920477|583755262|FG000|Overall Study|Withdrawal by Subject|0|||
161646041|NCT01920477|583755263|FG001|Overall Study|Withdrawal by Subject|1|||
161646042|NCT01681277|583755264|FG000|Overall Study|Adverse Event|1|||
161646043|NCT01681277|583755265|FG001|Overall Study|Adverse Event|0|||
161646044|NCT01681277|583755266|FG002|Overall Study|Adverse Event|0|||
161646045|NCT01681277|583755267|FG003|Overall Study|Adverse Event|0|||
161646046|NCT01681277|583755268|FG004|Overall Study|Adverse Event|0|||
161646047|NCT02304705|583755269|FG000|Overall Study|Withdrawal by Subject|2|||
161646048|NCT02304705|583755270|FG001|Overall Study|Withdrawal by Subject|0|||
161646049|NCT02304705|583755269|FG000|Overall Study|Physician Decision|2|||
161646050|NCT02304705|583755270|FG001|Overall Study|Physician Decision|4|||
161646051|NCT02304705|583755269|FG000|Overall Study|Death|0|||
161646052|NCT02304705|583755270|FG001|Overall Study|Death|1|||
161646053|NCT02304705|583755269|FG000|Overall Study|Lost to Follow-up|0|||
161646054|NCT02304705|583755270|FG001|Overall Study|Lost to Follow-up|2|||
161646055|NCT02038842|583755271|FG000|Overall Study|Withdrawal by Subject|2|||
161646056|NCT02038842|583755272|FG001|Overall Study|Withdrawal by Subject|2|||
161646057|NCT02038842|583755273|FG002|Overall Study|Withdrawal by Subject|0|||
161646058|NCT02038842|583755274|FG003|Overall Study|Withdrawal by Subject|0|||
161646059|NCT02038842|583755271|FG000|Overall Study|Participant decision|0|||
161646060|NCT02038842|583755272|FG001|Overall Study|Participant decision|0|||
161646061|NCT02038842|583755273|FG002|Overall Study|Participant decision|2|||
161646062|NCT02038842|583755274|FG003|Overall Study|Participant decision|1|||
161646063|NCT02038842|583755271|FG000|Overall Study|Adverse Event|0|||
161646064|NCT02038842|583755272|FG001|Overall Study|Adverse Event|0|||
161646065|NCT02038842|583755273|FG002|Overall Study|Adverse Event|3|||
161646066|NCT02038842|583755274|FG003|Overall Study|Adverse Event|1|||
161646067|NCT02038842|583755271|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
161646068|NCT02038842|583755272|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
161646069|NCT02038842|583755273|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
161646070|NCT02038842|583755274|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
161646071|NCT00847626|583755280|FG000|Overall Study|Adverse Event|10|||
161646072|NCT00847626|583755281|FG001|Overall Study|Adverse Event|10|||
161646073|NCT00847626|583755282|FG002|Overall Study|Adverse Event|6|||
161646074|NCT00847626|583755283|FG003|Overall Study|Adverse Event|19|||
161646075|NCT00847626|583755284|FG004|Overall Study|Adverse Event|11|||
161646076|NCT00847626|583755285|FG005|Overall Study|Adverse Event|22|||
161646077|NCT00847626|583755286|FG006|Overall Study|Adverse Event|4|||
161646078|NCT00847626|583755287|FG007|Overall Study|Adverse Event|6|||
161646079|NCT00847626|583755288|FG008|Overall Study|Adverse Event|3|||
161646080|NCT00847626|583755289|FG009|Overall Study|Adverse Event|6|||
161646081|NCT00847626|583755290|FG010|Overall Study|Adverse Event|6|||
161646082|NCT00847626|583755280|FG000|Overall Study|Protocol Violation|2|||
161646083|NCT00847626|583755281|FG001|Overall Study|Protocol Violation|1|||
161646084|NCT00847626|583755282|FG002|Overall Study|Protocol Violation|2|||
161646085|NCT00847626|583755283|FG003|Overall Study|Protocol Violation|1|||
161646086|NCT00847626|583755284|FG004|Overall Study|Protocol Violation|1|||
161646087|NCT00847626|583755285|FG005|Overall Study|Protocol Violation|1|||
161646088|NCT00847626|583755286|FG006|Overall Study|Protocol Violation|1|||
161646089|NCT00847626|583755287|FG007|Overall Study|Protocol Violation|1|||
161646090|NCT00847626|583755288|FG008|Overall Study|Protocol Violation|0|||
161646091|NCT00847626|583755289|FG009|Overall Study|Protocol Violation|1|||
161646092|NCT00847626|583755290|FG010|Overall Study|Protocol Violation|1|||
161646093|NCT00847626|583755280|FG000|Overall Study|Lost to Follow-up|0|||
161646094|NCT00847626|583755281|FG001|Overall Study|Lost to Follow-up|1|||
161646095|NCT00847626|583755282|FG002|Overall Study|Lost to Follow-up|1|||
161646096|NCT00847626|583755283|FG003|Overall Study|Lost to Follow-up|1|||
161646097|NCT00847626|583755284|FG004|Overall Study|Lost to Follow-up|0|||
161646098|NCT00847626|583755285|FG005|Overall Study|Lost to Follow-up|3|||
161646099|NCT00847626|583755286|FG006|Overall Study|Lost to Follow-up|1|||
161646100|NCT00847626|583755287|FG007|Overall Study|Lost to Follow-up|3|||
161646101|NCT00847626|583755288|FG008|Overall Study|Lost to Follow-up|1|||
161646102|NCT00847626|583755289|FG009|Overall Study|Lost to Follow-up|0|||
161646103|NCT00847626|583755290|FG010|Overall Study|Lost to Follow-up|1|||
161646104|NCT00847626|583755280|FG000|Overall Study|Withdrawal by Subject|5|||
161646105|NCT00847626|583755281|FG001|Overall Study|Withdrawal by Subject|5|||
161646106|NCT00847626|583755282|FG002|Overall Study|Withdrawal by Subject|3|||
161646107|NCT00847626|583755283|FG003|Overall Study|Withdrawal by Subject|8|||
161646108|NCT00847626|583755284|FG004|Overall Study|Withdrawal by Subject|12|||
161646109|NCT00847626|583755285|FG005|Overall Study|Withdrawal by Subject|9|||
161646110|NCT00847626|583755286|FG006|Overall Study|Withdrawal by Subject|8|||
161646111|NCT00847626|583755287|FG007|Overall Study|Withdrawal by Subject|4|||
161646112|NCT00847626|583755288|FG008|Overall Study|Withdrawal by Subject|4|||
161646113|NCT00847626|583755289|FG009|Overall Study|Withdrawal by Subject|5|||
161646114|NCT00847626|583755290|FG010|Overall Study|Withdrawal by Subject|2|||
161646115|NCT00847626|583755280|FG000|Overall Study|Lack of Efficacy|3|||
161688360|NCT00440947|583909867|FG004|36-Week Induction Phase|Incarceration|0|||
161646116|NCT00847626|583755281|FG001|Overall Study|Lack of Efficacy|1|||
161646117|NCT00847626|583755282|FG002|Overall Study|Lack of Efficacy|0|||
161646118|NCT00847626|583755283|FG003|Overall Study|Lack of Efficacy|1|||
161646119|NCT00847626|583755284|FG004|Overall Study|Lack of Efficacy|2|||
161646120|NCT00847626|583755285|FG005|Overall Study|Lack of Efficacy|0|||
161646121|NCT00847626|583755286|FG006|Overall Study|Lack of Efficacy|6|||
161646122|NCT00847626|583755287|FG007|Overall Study|Lack of Efficacy|2|||
161646123|NCT00847626|583755288|FG008|Overall Study|Lack of Efficacy|5|||
161646124|NCT00847626|583755289|FG009|Overall Study|Lack of Efficacy|1|||
161646125|NCT00847626|583755290|FG010|Overall Study|Lack of Efficacy|7|||
161646126|NCT00847626|583755280|FG000|Overall Study|Other|1|||
161646127|NCT00847626|583755281|FG001|Overall Study|Other|5|||
161646128|NCT00847626|583755282|FG002|Overall Study|Other|4|||
161646129|NCT00847626|583755283|FG003|Overall Study|Other|1|||
161688361|NCT00440947|583909863|FG000|36-Week Induction Phase|Pregnancy|1|||
161646130|NCT00847626|583755284|FG004|Overall Study|Other|2|||
161646131|NCT00847626|583755285|FG005|Overall Study|Other|2|||
161646132|NCT00847626|583755286|FG006|Overall Study|Other|2|||
161646133|NCT00847626|583755287|FG007|Overall Study|Other|3|||
161646134|NCT00847626|583755288|FG008|Overall Study|Other|1|||
161646135|NCT00847626|583755289|FG009|Overall Study|Other|1|||
161646136|NCT00847626|583755290|FG010|Overall Study|Other|3|||
161646137|NCT03057847|583755291|FG000|Overall Study|Lost to Follow-up|16|||
161646138|NCT02138786|583755297|FG000|Overall Study|Adverse Event|0|||
161646139|NCT02138786|583755298|FG001|Overall Study|Adverse Event|2|||
161646140|NCT02138786|583755299|FG002|Overall Study|Adverse Event|1|||
161646141|NCT02138786|583755297|FG000|Overall Study|Death|1|||
161646142|NCT02138786|583755298|FG001|Overall Study|Death|7|||
161646143|NCT02138786|583755299|FG002|Overall Study|Death|2|||
161646144|NCT02138786|583755297|FG000|Overall Study|Disease Progression|1|||
161646145|NCT02138786|583755298|FG001|Overall Study|Disease Progression|1|||
161646146|NCT02138786|583755299|FG002|Overall Study|Disease Progression|3|||
161646147|NCT02138786|583755297|FG000|Overall Study|Withdrawal by Subject|1|||
161646148|NCT02138786|583755298|FG001|Overall Study|Withdrawal by Subject|2|||
161646149|NCT02138786|583755299|FG002|Overall Study|Withdrawal by Subject|0|||
161646150|NCT02138786|583755297|FG000|Overall Study|Patient's Wish|0|||
161646151|NCT02138786|583755298|FG001|Overall Study|Patient's Wish|2|||
161646152|NCT02138786|583755299|FG002|Overall Study|Patient's Wish|0|||
161646153|NCT02138786|583755297|FG000|Overall Study|Sponsor Terminated Study|0|||
161646154|NCT02138786|583755298|FG001|Overall Study|Sponsor Terminated Study|1|||
161646155|NCT02138786|583755299|FG002|Overall Study|Sponsor Terminated Study|1|||
161646156|NCT02138786|583755297|FG000|Overall Study|Non-Compliance|0|||
161646157|NCT02138786|583755298|FG001|Overall Study|Non-Compliance|0|||
161646158|NCT02138786|583755299|FG002|Overall Study|Non-Compliance|1|||
161646159|NCT02088957|583755300|FG000|Overall Study|Lack of Efficacy|1|||
161646160|NCT02088957|583755301|FG001|Overall Study|Lack of Efficacy|0|||
161646161|NCT00426127|583755302|FG000|Overall Study|Adverse Event|1|||
161646162|NCT00426127|583755302|FG000|Overall Study|Removed due to disease progression|1|||
161646163|NCT03111095|583755303|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
161646164|NCT03111095|583755304|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
161646165|NCT03111095|583755303|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
161646166|NCT03111095|583755304|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
161646167|NCT04638660|583755310|FG000|Overall Study|Withdrawal by Subject|2|||
161646168|NCT04638660|583755311|FG001|Overall Study|Withdrawal by Subject|0|||
161646169|NCT04638660|583755310|FG000|Overall Study|Lost to Follow-up|1|||
161646170|NCT04638660|583755311|FG001|Overall Study|Lost to Follow-up|0|||
161646171|NCT04076943|583755316|FG000|Overall Study|Withdrawal by Subject|12|||
161646172|NCT04076943|583755316|FG000|Overall Study|Adverse Event|1|||
161646173|NCT04076943|583755316|FG000|Overall Study|Progressive Disease|2|||
161646174|NCT04076943|583755316|FG000|Overall Study|Death|13|||
161646175|NCT04076943|583755316|FG000|Overall Study|Other than specified|6|||
161646176|NCT03080493|583755317|FG000|Overall Study|Did not provide NRS pain results|1|||
161646177|NCT03080493|583755318|FG001|Overall Study|Did not provide NRS pain results|0|||
161646178|NCT03080493|583755317|FG000|Overall Study|Adverse Event|0|||
161646179|NCT03080493|583755318|FG001|Overall Study|Adverse Event|1|||
161646180|NCT03080493|583755317|FG000|Overall Study|Randomization error (parity group)|0|||
161646181|NCT03080493|583755318|FG001|Overall Study|Randomization error (parity group)|1|||
161646182|NCT01602510|583755319|FG000|Open Label Phase|Adverse Event|46|||
161646183|NCT01602510|583755320|FG001|Open Label Phase|Adverse Event|0|||
161646184|NCT01602510|583755321|FG002|Open Label Phase|Adverse Event|0|||
161646185|NCT01602510|583755319|FG000|Open Label Phase|Lack of Efficacy|22|||
161646186|NCT01602510|583755320|FG001|Open Label Phase|Lack of Efficacy|0|||
161646187|NCT01602510|583755321|FG002|Open Label Phase|Lack of Efficacy|0|||
161646188|NCT01602510|583755319|FG000|Open Label Phase|Protocol Violation|15|||
161646189|NCT01602510|583755320|FG001|Open Label Phase|Protocol Violation|0|||
161646190|NCT01602510|583755321|FG002|Open Label Phase|Protocol Violation|0|||
161646191|NCT01602510|583755319|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
161646192|NCT01602510|583755320|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
161646193|NCT01602510|583755321|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
161646194|NCT01602510|583755319|FG000|Open Label Phase|Lost to Follow-up|22|||
161646195|NCT01602510|583755320|FG001|Open Label Phase|Lost to Follow-up|0|||
161646196|NCT01602510|583755321|FG002|Open Label Phase|Lost to Follow-up|0|||
161646197|NCT01602510|583755319|FG000|Open Label Phase|Physician Decision|19|||
161646198|NCT01602510|583755320|FG001|Open Label Phase|Physician Decision|0|||
161646199|NCT01602510|583755321|FG002|Open Label Phase|Physician Decision|0|||
161646200|NCT01602510|583755319|FG000|Open Label Phase|Withdrawal by Subject|57|||
161646201|NCT01602510|583755320|FG001|Open Label Phase|Withdrawal by Subject|0|||
161646202|NCT01602510|583755321|FG002|Open Label Phase|Withdrawal by Subject|0|||
161646203|NCT01602510|583755319|FG000|Randomized Phase|Adverse Event|0|||
161646204|NCT01602510|583755320|FG001|Randomized Phase|Adverse Event|2|||
161646205|NCT01602510|583755321|FG002|Randomized Phase|Adverse Event|6|||
161646206|NCT01602510|583755319|FG000|Randomized Phase|Lack of Efficacy|0|||
161646207|NCT01602510|583755320|FG001|Randomized Phase|Lack of Efficacy|4|||
161646208|NCT01602510|583755321|FG002|Randomized Phase|Lack of Efficacy|4|||
161646209|NCT01602510|583755319|FG000|Randomized Phase|Protocol Violation|0|||
161646210|NCT01602510|583755320|FG001|Randomized Phase|Protocol Violation|3|||
161646211|NCT01602510|583755321|FG002|Randomized Phase|Protocol Violation|3|||
161646212|NCT01602510|583755319|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
161646213|NCT01602510|583755320|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
161646214|NCT01602510|583755321|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
161646215|NCT01602510|583755319|FG000|Randomized Phase|Lost to Follow-up|0|||
161646216|NCT01602510|583755320|FG001|Randomized Phase|Lost to Follow-up|1|||
161646217|NCT01602510|583755321|FG002|Randomized Phase|Lost to Follow-up|3|||
161646218|NCT01602510|583755319|FG000|Randomized Phase|Physician Decision|0|||
161646219|NCT01602510|583755320|FG001|Randomized Phase|Physician Decision|0|||
161646220|NCT01602510|583755321|FG002|Randomized Phase|Physician Decision|2|||
161646221|NCT01602510|583755319|FG000|Randomized Phase|Withdrawal by Subject|0|||
161646222|NCT01602510|583755320|FG001|Randomized Phase|Withdrawal by Subject|6|||
161646223|NCT01602510|583755321|FG002|Randomized Phase|Withdrawal by Subject|7|||
161646224|NCT01261000|583755322|FG000|Overall Study|Screen failure|1|||
161646225|NCT01825577|583755323|FG000|Overall Study|Physician Decision|2|||
161646226|NCT01825577|583755323|FG000|Overall Study|Withdrawal by Subject|1|||
161646227|NCT01825577|583755323|FG000|Overall Study|Withdrawn by family members|2|||
161646228|NCT01825577|583755323|FG000|Overall Study|Lack of Efficacy|3|||
161646229|NCT01427725|583755328|FG000|Overall Study|Lost to Follow-up|17|||
161646230|NCT01427725|583755328|FG000|Overall Study|Protocol Violation|1|||
161646231|NCT01427725|583755328|FG000|Overall Study|Drug not administered|1|||
161646232|NCT01427725|583755328|FG000|Overall Study|Failure to visit|7|||
161646233|NCT01427725|583755328|FG000|Overall Study|Adverse Event|46|||
161646234|NCT01427725|583755328|FG000|Overall Study|Failure to visit after administration|40|||
161646235|NCT01427725|583755328|FG000|Overall Study|Patient's rejection|27|||
161646236|NCT01427725|583755328|FG000|Overall Study|Transfer to a different hospital|17|||
161646237|NCT01427725|583755328|FG000|Overall Study|Lack of Efficacy|8|||
161646238|NCT01427725|583755328|FG000|Overall Study|Death|7|||
161646239|NCT01427725|583755328|FG000|Overall Study|Symptom improvement|6|||
161646240|NCT01427725|583755328|FG000|Overall Study|AE and Patient's rejection|5|||
161646241|NCT01427725|583755328|FG000|Overall Study|Physician Decision|5|||
161646242|NCT01427725|583755328|FG000|Overall Study|Exacerbation of underlying disease|5|||
161646243|NCT01427725|583755328|FG000|Overall Study|Oral feeding difficulty|5|||
161646244|NCT01427725|583755328|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
161646245|NCT01427725|583755328|FG000|Overall Study|Forgetting prescription|1|||
161646246|NCT01427725|583755328|FG000|Overall Study|Other|2|||
161646247|NCT01374568|583755329|FG000|Overall Study|Lab unable to analyze BTM|0|||
161646248|NCT01374568|583755330|FG001|Overall Study|Lab unable to analyze BTM|2|||
161646249|NCT04230122|583755331|FG000|Overall Study|Lost to Follow-up|1|||
161646250|NCT04230122|583755332|FG001|Overall Study|Lost to Follow-up|0|||
161646251|NCT01361594|583755334|FG000|Overall Study|Withdrawal by Subject|1|||
161646252|NCT01361594|583755335|FG001|Overall Study|Withdrawal by Subject|2|||
161688362|NCT00440947|583909864|FG001|36-Week Induction Phase|Pregnancy|0|||
161688363|NCT00440947|583909865|FG002|36-Week Induction Phase|Pregnancy|0|||
161688364|NCT00440947|583909866|FG003|36-Week Induction Phase|Pregnancy|0|||
161688365|NCT00440947|583909867|FG004|36-Week Induction Phase|Pregnancy|0|||
161688366|NCT00440947|583909863|FG000|48-Week Randomization Phase|Adverse Event|0|||
161688367|NCT00440947|583909864|FG001|48-Week Randomization Phase|Adverse Event|2|||
161646253|NCT02762903|583755337|FG000|Overall Study|Lost to Follow-up|0|||
161646254|NCT02762903|583755338|FG001|Overall Study|Lost to Follow-up|1|||
161646255|NCT00570908|583755341|FG000|Overall Study|Adverse Event|5|||
161646256|NCT00570908|583755341|FG000|Overall Study|Withdrawal by Subject|2|||
161646257|NCT00277095|583755342|FG000|Overall Study|Death|2|||
161646258|NCT00277095|583755342|FG000|Overall Study|Explanted|7|||
161646259|NCT00277095|583755342|FG000|Overall Study|Lost to Follow-up|2|||
161646260|NCT00277095|583755342|FG000|Overall Study|Missed Follow-up|9|||
161646261|NCT00277095|583755342|FG000|Overall Study|Physician Decision|1|||
161646262|NCT01213524|583755343|FG000|Baseline|Withdrawal by Subject|5|||
161646263|NCT01213524|583755343|FG000|Baseline|high breath alcohol levels|1|||
161646264|NCT01213524|583755343|FG000|Baseline|Physician Decision|1|||
161646265|NCT01213524|583755343|FG000|Session 2|Withdrawal by Subject|5|||
161646266|NCT01213524|583755343|FG000|Session 3|Withdrawal by Subject|4|||
161646267|NCT01213524|583755343|FG000|Session 4|Physician Decision|1|||
161646268|NCT01213524|583755343|FG000|Session 4|Withdrawal by Subject|2|||
161646269|NCT05415748|583755350|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
161646270|NCT05415748|583755351|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
161646271|NCT05415748|583755352|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
161646272|NCT05415748|583755353|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
161646273|NCT05415748|583755350|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
161646274|NCT05415748|583755351|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
161646275|NCT05415748|583755352|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
161646276|NCT05415748|583755353|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
161646277|NCT01447576|583755354|FG000|Overall Study|Lost to Follow-up|52|||
161646278|NCT01447576|583755354|FG000|Overall Study|Adverse Event|127|||
161646279|NCT01447576|583755354|FG000|Overall Study|Participant met withdrawal criteria|40|||
161646280|NCT01447576|583755354|FG000|Overall Study|Withdrawal by Subject|100|||
161646281|NCT01447576|583755354|FG000|Overall Study|Protocol deviation|83|||
161646282|NCT01447576|583755354|FG000|Overall Study|Lack of Efficacy|68|||
161646283|NCT01447576|583755354|FG000|Overall Study|Physician Decision|6|||
161646284|NCT00975676|583755355|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
161646285|NCT00975676|583755356|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
161646286|NCT02209181|583755357|FG000|Overall Study|Adverse Event|1|||
161646287|NCT02209181|583755358|FG001|Overall Study|Adverse Event|0|||
161646288|NCT02209181|583755359|FG002|Overall Study|Adverse Event|1|||
161646289|NCT02209181|583755360|FG003|Overall Study|Adverse Event|0|||
161646290|NCT02209181|583755357|FG000|Overall Study|Withdrawal by Subject|0|||
161646291|NCT02209181|583755358|FG001|Overall Study|Withdrawal by Subject|1|||
161646292|NCT02209181|583755359|FG002|Overall Study|Withdrawal by Subject|0|||
161646293|NCT02209181|583755360|FG003|Overall Study|Withdrawal by Subject|0|||
161646294|NCT02548078|583755361|FG000|Overall Study|Serious adverse event/Adverse event|1|||
161646295|NCT02548078|583755362|FG001|Overall Study|Serious adverse event/Adverse event|0|||
161646296|NCT02548078|583755361|FG000|Overall Study|Moved from study area|3|||
161646297|NCT02548078|583755362|FG001|Overall Study|Moved from study area|3|||
161646298|NCT02548078|583755361|FG000|Overall Study|Lost to Follow-up|1|||
161646299|NCT02548078|583755362|FG001|Overall Study|Lost to Follow-up|3|||
161646300|NCT02579772|583755363|FG000|Overall Study|Withdrawal by Subject|0|||
161646301|NCT02579772|583755364|FG001|Overall Study|Withdrawal by Subject|1|||
161646302|NCT02579772|583755363|FG000|Overall Study|Usage of additional antioxidants|1|||
161646303|NCT02579772|583755364|FG001|Overall Study|Usage of additional antioxidants|0|||
161646304|NCT02579772|583755363|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
161646305|NCT02579772|583755364|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
161646306|NCT01040169|583755365|FG000|Overall Study|Lost to Follow-up|3|||
161646307|NCT01040169|583755366|FG001|Overall Study|Lost to Follow-up|8|||
161646308|NCT00350727|583755367|FG000|Phase I: Dose Escalation|Adverse Event|4|||
161646309|NCT00350727|583755368|FG001|Phase I: Dose Escalation|Adverse Event|0|||
161646310|NCT00350727|583755369|FG002|Phase I: Dose Escalation|Adverse Event|0|||
161646311|NCT00350727|583755367|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
161646312|NCT00350727|583755368|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
161646313|NCT00350727|583755369|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
161646314|NCT00350727|583755367|FG000|Phase I: Dose Escalation|Death|1|||
161646315|NCT00350727|583755368|FG001|Phase I: Dose Escalation|Death|0|||
161646316|NCT00350727|583755369|FG002|Phase I: Dose Escalation|Death|0|||
161646317|NCT00350727|583755367|FG000|Phase I: Dose Escalation|Physician Decision|1|||
161646318|NCT00350727|583755368|FG001|Phase I: Dose Escalation|Physician Decision|0|||
161646319|NCT00350727|583755369|FG002|Phase I: Dose Escalation|Physician Decision|0|||
161646320|NCT00350727|583755367|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
161646321|NCT00350727|583755368|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
161646322|NCT00350727|583755369|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
161646323|NCT00350727|583755367|FG000|Phase II|Disease Progression|0|||
161646324|NCT00350727|583755368|FG001|Phase II|Disease Progression|15|||
161646325|NCT00350727|583755369|FG002|Phase II|Disease Progression|16|||
161646326|NCT00350727|583755367|FG000|Phase II|Clinical Deterioration|0|||
161646327|NCT00350727|583755368|FG001|Phase II|Clinical Deterioration|1|||
161646328|NCT00350727|583755369|FG002|Phase II|Clinical Deterioration|0|||
161646329|NCT00350727|583755367|FG000|Phase II|Withdrawal by Subject|0|||
161646330|NCT00350727|583755368|FG001|Phase II|Withdrawal by Subject|2|||
161646331|NCT00350727|583755369|FG002|Phase II|Withdrawal by Subject|1|||
161646332|NCT00350727|583755367|FG000|Phase II|Adverse Event|0|||
161688368|NCT00440947|583909865|FG002|48-Week Randomization Phase|Adverse Event|5|||
161688369|NCT00440947|583909866|FG003|48-Week Randomization Phase|Adverse Event|0|||
161646333|NCT00350727|583755368|FG001|Phase II|Adverse Event|1|||
161646334|NCT00350727|583755369|FG002|Phase II|Adverse Event|1|||
161646335|NCT00350727|583755367|FG000|Phase II|Death|0|||
161646336|NCT00350727|583755368|FG001|Phase II|Death|0|||
161646337|NCT00350727|583755369|FG002|Phase II|Death|2|||
161646338|NCT00350727|583755367|FG000|Phase II|Sponsor Terminated Study|0|||
161646339|NCT00350727|583755368|FG001|Phase II|Sponsor Terminated Study|0|||
161646340|NCT00350727|583755369|FG002|Phase II|Sponsor Terminated Study|1|||
161646341|NCT00350727|583755367|FG000|Phase II|Enrolled in Rollover Study|0|||
161646342|NCT00350727|583755368|FG001|Phase II|Enrolled in Rollover Study|0|||
161646343|NCT00350727|583755369|FG002|Phase II|Enrolled in Rollover Study|1|||
161646344|NCT03128671|583755370|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
161646345|NCT03128671|583755371|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
161646346|NCT03128671|583755370|FG000|Allocation|Death|1|||
161646347|NCT03128671|583755371|FG001|Allocation|Death|0|||
161646348|NCT03128671|583755370|FG000|Allocation|Withdrawal by Subject|4|||
161646349|NCT03128671|583755371|FG001|Allocation|Withdrawal by Subject|0|||
161646350|NCT03128671|583755370|FG000|Intervention|Withdrawal by Subject|11|||
161646351|NCT03128671|583755371|FG001|Intervention|Withdrawal by Subject|10|||
161646352|NCT03128671|583755370|FG000|Intervention|Palliative/hospice care initiated|9|||
161646353|NCT03128671|583755371|FG001|Intervention|Palliative/hospice care initiated|10|||
161646354|NCT03128671|583755370|FG000|Intervention|Death|13|||
161646355|NCT03128671|583755371|FG001|Intervention|Death|11|||
161646356|NCT03128671|583755370|FG000|Intervention|Interrupted by hurricane|1|||
161646357|NCT03128671|583755371|FG001|Intervention|Interrupted by hurricane|0|||
161646358|NCT03128671|583755370|FG000|Intervention|Physician Decision|2|||
161646359|NCT03128671|583755371|FG001|Intervention|Physician Decision|3|||
161646360|NCT04641962|583755372|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
161646361|NCT04641962|583755373|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
161646362|NCT04641962|583755374|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
161646363|NCT04641962|583755375|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
161646364|NCT04641962|583755376|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
161646365|NCT04641962|583755372|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161646366|NCT04641962|583755373|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161646367|NCT04641962|583755374|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161646368|NCT04641962|583755375|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
161646369|NCT04641962|583755376|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161646370|NCT04641962|583755372|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
161646371|NCT04641962|583755373|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
161646372|NCT04641962|583755374|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
161646373|NCT04641962|583755375|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
161646374|NCT04641962|583755376|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
161646375|NCT04641962|583755372|FG000|DBT Period: Up to 52 Weeks|Death|1|||
161646376|NCT04641962|583755373|FG001|DBT Period: Up to 52 Weeks|Death|0|||
161646377|NCT04641962|583755374|FG002|DBT Period: Up to 52 Weeks|Death|0|||
161646378|NCT04641962|583755375|FG003|DBT Period: Up to 52 Weeks|Death|0|||
161646379|NCT04641962|583755376|FG004|DBT Period: Up to 52 Weeks|Death|0|||
161646380|NCT04641962|583755372|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
161646381|NCT04641962|583755373|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
161646382|NCT04641962|583755374|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
161646383|NCT04641962|583755375|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
161646384|NCT04641962|583755376|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
161646385|NCT04641962|583755372|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
161646386|NCT04641962|583755373|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
161646387|NCT04641962|583755374|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
161646388|NCT04641962|583755375|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
161646389|NCT04641962|583755376|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
161646390|NCT04641962|583755372|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161646391|NCT04641962|583755373|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161646392|NCT04641962|583755374|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
161646393|NCT04641962|583755375|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161646394|NCT04641962|583755376|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161646395|NCT00862836|583755377|FG000|Overall Study|Withdrawal by Subject|1|||
161646396|NCT03277352|583755380|FG000|Overall Study|Study Terminated By Sponsor|2|||
161646397|NCT03277352|583755380|FG000|Overall Study|Withdrawal by Subject|4|||
161646398|NCT03277352|583755380|FG000|Overall Study|Death|4|||
161688370|NCT00440947|583909867|FG004|48-Week Randomization Phase|Adverse Event|0|||
161688371|NCT00440947|583909863|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161646399|NCT02271984|583757295|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646400|NCT02271984|583757296|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646401|NCT02271984|583757297|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646402|NCT02271984|583757298|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646403|NCT02271984|583757299|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646404|NCT02271984|583757300|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
161646405|NCT02271984|583757301|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646406|NCT02271984|583757302|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
161646407|NCT02271984|583757303|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646408|NCT02271984|583757304|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646409|NCT02271984|583757305|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646410|NCT02271984|583757306|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161646411|NCT01088984|583757307|FG000|Phase 1|Death|2|||
161646412|NCT01088984|583757308|FG001|Phase 1|Death|1|||
161646413|NCT01088984|583757307|FG000|Phase 1|Disease Progression|2|||
161646414|NCT01088984|583757308|FG001|Phase 1|Disease Progression|4|||
161646415|NCT01088984|583757307|FG000|Phase 1|Other|1|||
161646416|NCT01088984|583757308|FG001|Phase 1|Other|1|||
161646417|NCT01088984|583757307|FG000|Phase 2|Death|0|||
161646418|NCT01088984|583757308|FG001|Phase 2|Death|5|||
161646419|NCT01088984|583757307|FG000|Phase 2|Withdrawal by Subject|0|||
161646420|NCT01088984|583757308|FG001|Phase 2|Withdrawal by Subject|1|||
161646421|NCT01088984|583757307|FG000|Phase 2|DIsease Progression|0|||
161646422|NCT01088984|583757308|FG001|Phase 2|DIsease Progression|25|||
161646423|NCT01088984|583757307|FG000|Phase 2|Other|0|||
161646424|NCT01088984|583757308|FG001|Phase 2|Other|1|||
161646425|NCT01228318|583757309|FG000|Overall Study|Clinic no show to receive intervention|1|||
161646426|NCT01228318|583757310|FG001|Overall Study|Clinic no show to receive intervention|0|||
161646427|NCT01228318|583757309|FG000|Overall Study|Unable to contact|2|||
161646428|NCT01228318|583757310|FG001|Overall Study|Unable to contact|5|||
161646429|NCT01228318|583757309|FG000|Overall Study|Moved|0|||
161646430|NCT01228318|583757310|FG001|Overall Study|Moved|2|||
161646431|NCT01228318|583757309|FG000|Overall Study|Incarcerated|1|||
161646432|NCT01228318|583757310|FG001|Overall Study|Incarcerated|0|||
161646433|NCT00770029|583757311|FG000|Overall Study|Lost to Follow-up|2|||
161646434|NCT00770029|583757312|FG001|Overall Study|Lost to Follow-up|0|||
161646435|NCT00770029|583757311|FG000|Overall Study|Withdrawal by Subject|3|||
161646436|NCT00770029|583757312|FG001|Overall Study|Withdrawal by Subject|3|||
161646437|NCT00770029|583757311|FG000|Overall Study|Adverse Event|1|||
161646438|NCT00770029|583757312|FG001|Overall Study|Adverse Event|0|||
161646439|NCT03140280|583757313|FG000|Overall Study|Physician Decision|5|||
161646440|NCT05620108|583757324|FG000|Overall Study|Physician Decision|1|||
161646441|NCT05620108|583757325|FG001|Overall Study|Physician Decision|2|||
161646442|NCT05602727|583757326|FG000|Overall Study|Physician Decision|0|||
161646443|NCT05602727|583757327|FG001|Overall Study|Physician Decision|1|||
161646444|NCT05602727|583757328|FG002|Overall Study|Physician Decision|0|||
161646445|NCT05602727|583757326|FG000|Overall Study|Randomized by mistake without study medication|1|||
161646446|NCT05602727|583757327|FG001|Overall Study|Randomized by mistake without study medication|0|||
161646447|NCT05602727|583757328|FG002|Overall Study|Randomized by mistake without study medication|0|||
161646448|NCT05602727|583757326|FG000|Overall Study|Study termination by Sponsor|18|||
161646449|NCT05602727|583757327|FG001|Overall Study|Study termination by Sponsor|15|||
161646450|NCT05602727|583757328|FG002|Overall Study|Study termination by Sponsor|19|||
161646451|NCT05602727|583757326|FG000|Overall Study|Withdrawal by Subject|2|||
161646452|NCT05602727|583757327|FG001|Overall Study|Withdrawal by Subject|1|||
161688372|NCT00440947|583909864|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
161688373|NCT00440947|583909865|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
161688374|NCT00440947|583909866|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161688375|NCT00440947|583909867|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161688376|NCT00440947|583909863|FG000|48-Week Randomization Phase|Non-compliance|0|||
161688377|NCT00440947|583909864|FG001|48-Week Randomization Phase|Non-compliance|3|||
161688378|NCT00440947|583909865|FG002|48-Week Randomization Phase|Non-compliance|4|||
161688379|NCT00440947|583909866|FG003|48-Week Randomization Phase|Non-compliance|0|||
161688380|NCT00440947|583909867|FG004|48-Week Randomization Phase|Non-compliance|0|||
161688381|NCT00440947|583909863|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
161688382|NCT00440947|583909864|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
161688383|NCT00440947|583909865|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
161646453|NCT05602727|583757328|FG002|Overall Study|Withdrawal by Subject|1|||
161646454|NCT05602727|583757326|FG000|Overall Study|Various reasons|1|||
161646455|NCT05602727|583757327|FG001|Overall Study|Various reasons|6|||
161688384|NCT00440947|583909866|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
161688385|NCT00440947|583909867|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
161688386|NCT00440947|583909863|FG000|48-Week Randomization Phase|Protocol Violation|0|||
161688387|NCT00440947|583909864|FG001|48-Week Randomization Phase|Protocol Violation|0|||
161646456|NCT05602727|583757328|FG002|Overall Study|Various reasons|1|||
161646457|NCT03412773|583757332|FG000|Overall Study|Lost to Follow-up|0|||
161646458|NCT03412773|583757333|FG001|Overall Study|Lost to Follow-up|7|||
161646459|NCT03412773|583757334|FG002|Overall Study|Lost to Follow-up|6|||
161646460|NCT03412773|583757332|FG000|Overall Study|Withdrawal by Subject|0|||
161646461|NCT03412773|583757333|FG001|Overall Study|Withdrawal by Subject|15|||
161646462|NCT03412773|583757334|FG002|Overall Study|Withdrawal by Subject|19|||
161835939|NCT01550744|584440816|FG002|Double-Blind|Withdrawal by Subject|15|||
161835940|NCT01550744|584440814|FG000|Double-Blind|Adverse Event|0|||
161646463|NCT03412773|583757332|FG000|Overall Study|Study Closed By Sponsor|3|||
161646464|NCT03412773|583757333|FG001|Overall Study|Study Closed By Sponsor|46|||
161646465|NCT03412773|583757334|FG002|Overall Study|Study Closed By Sponsor|33|||
161646466|NCT03412773|583757332|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
161646467|NCT03412773|583757333|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
161646468|NCT03412773|583757334|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
161646469|NCT03412773|583757332|FG000|Overall Study|Death|7|||
161646470|NCT03412773|583757333|FG001|Overall Study|Death|259|||
161646471|NCT03412773|583757334|FG002|Overall Study|Death|273|||
161646472|NCT03412773|583757332|FG000|Overall Study|Physician Decision|0|||
161646473|NCT03412773|583757333|FG001|Overall Study|Physician Decision|0|||
161646474|NCT03412773|583757334|FG002|Overall Study|Physician Decision|1|||
161646475|NCT02643303|583757341|FG000|Overall Study|Progressive Disease|4|||
161646476|NCT02643303|583757342|FG001|Overall Study|Progressive Disease|4|||
161646477|NCT02643303|583757343|FG002|Overall Study|Progressive Disease|1|||
161646478|NCT02643303|583757344|FG003|Overall Study|Progressive Disease|12|||
161646479|NCT02643303|583757345|FG004|Overall Study|Progressive Disease|6|||
161646480|NCT02643303|583757346|FG005|Overall Study|Progressive Disease|4|||
161646481|NCT02643303|583757347|FG006|Overall Study|Progressive Disease|8|||
161646482|NCT02643303|583757348|FG007|Overall Study|Progressive Disease|2|||
161646483|NCT02643303|583757349|FG008|Overall Study|Progressive Disease|6|||
161646484|NCT02643303|583757341|FG000|Overall Study|Adverse Event|0|||
161646485|NCT02643303|583757342|FG001|Overall Study|Adverse Event|1|||
161646486|NCT02643303|583757343|FG002|Overall Study|Adverse Event|0|||
161646487|NCT02643303|583757344|FG003|Overall Study|Adverse Event|0|||
161646488|NCT02643303|583757345|FG004|Overall Study|Adverse Event|1|||
161646489|NCT02643303|583757346|FG005|Overall Study|Adverse Event|0|||
161646490|NCT02643303|583757347|FG006|Overall Study|Adverse Event|0|||
161646491|NCT02643303|583757348|FG007|Overall Study|Adverse Event|0|||
161646492|NCT02643303|583757349|FG008|Overall Study|Adverse Event|0|||
161646493|NCT02643303|583757341|FG000|Overall Study|Withdrawal by Subject|0|||
161646494|NCT02643303|583757342|FG001|Overall Study|Withdrawal by Subject|0|||
161646495|NCT02643303|583757343|FG002|Overall Study|Withdrawal by Subject|0|||
161646496|NCT02643303|583757344|FG003|Overall Study|Withdrawal by Subject|1|||
161646497|NCT02643303|583757345|FG004|Overall Study|Withdrawal by Subject|0|||
161646498|NCT02643303|583757346|FG005|Overall Study|Withdrawal by Subject|0|||
161646499|NCT02643303|583757347|FG006|Overall Study|Withdrawal by Subject|1|||
161646500|NCT02643303|583757348|FG007|Overall Study|Withdrawal by Subject|1|||
161646501|NCT02643303|583757349|FG008|Overall Study|Withdrawal by Subject|1|||
161646502|NCT00626197|583757352|FG000|Overall Study|Did not cooperate|2|||
161646503|NCT00626197|583757353|FG001|Overall Study|Did not cooperate|6|||
161646504|NCT00626197|583757354|FG002|Overall Study|Did not cooperate|1|||
161646505|NCT00626197|583757352|FG000|Overall Study|Failure to return|6|||
161835941|NCT01550744|584440815|FG001|Double-Blind|Adverse Event|4|||
161835942|NCT01550744|584440816|FG002|Double-Blind|Adverse Event|15|||
161835943|NCT01550744|584440814|FG000|Double-Blind|Death|0|||
161646506|NCT00626197|583757353|FG001|Overall Study|Failure to return|5|||
161646507|NCT00626197|583757354|FG002|Overall Study|Failure to return|6|||
161646508|NCT00626197|583757352|FG000|Overall Study|Adverse event, serious fatal|3|||
161646509|NCT00626197|583757353|FG001|Overall Study|Adverse event, serious fatal|6|||
161835944|NCT01550744|584440815|FG001|Double-Blind|Death|1|||
161835945|NCT01550744|584440816|FG002|Double-Blind|Death|0|||
161646510|NCT00626197|583757354|FG002|Overall Study|Adverse event, serious fatal|6|||
161646511|NCT00626197|583757352|FG000|Overall Study|Adverse Event|1|||
161646512|NCT00626197|583757353|FG001|Overall Study|Adverse Event|1|||
161646513|NCT00626197|583757354|FG002|Overall Study|Adverse Event|2|||
161835946|NCT01550744|584440814|FG000|Double-Blind|Lack of Efficacy|0|||
161835947|NCT01550744|584440815|FG001|Double-Blind|Lack of Efficacy|2|||
161646514|NCT00626197|583757352|FG000|Overall Study|Withdrawal by Subject|17|||
161646515|NCT00626197|583757353|FG001|Overall Study|Withdrawal by Subject|17|||
161646516|NCT00626197|583757354|FG002|Overall Study|Withdrawal by Subject|7|||
161646517|NCT00626197|583757352|FG000|Overall Study|Administrative reasons|15|||
161646518|NCT00626197|583757353|FG001|Overall Study|Administrative reasons|19|||
161646519|NCT00626197|583757354|FG002|Overall Study|Administrative reasons|55|||
161646520|NCT05332912|583757359|FG000|Overall Study|Withdrawal by Subject|0|||
161646521|NCT05332912|583757360|FG001|Overall Study|Withdrawal by Subject|1|||
161646522|NCT05332912|583757361|FG002|Overall Study|Withdrawal by Subject|2|||
161646523|NCT05332912|583757362|FG003|Overall Study|Withdrawal by Subject|0|||
161646524|NCT05332912|583757359|FG000|Overall Study|Lost to Follow-up|0|||
161646525|NCT05332912|583757360|FG001|Overall Study|Lost to Follow-up|0|||
161646526|NCT05332912|583757361|FG002|Overall Study|Lost to Follow-up|1|||
161646527|NCT05332912|583757362|FG003|Overall Study|Lost to Follow-up|0|||
161646528|NCT05282121|583757363|FG000|Overall Study|Adverse Event|1|||
161646529|NCT05282121|583757364|FG001|Overall Study|Adverse Event|1|||
161646530|NCT05282121|583757365|FG002|Overall Study|Adverse Event|4|||
161646531|NCT05282121|583757366|FG003|Overall Study|Adverse Event|1|||
161646532|NCT05282121|583757363|FG000|Overall Study|Study Terminated by Sponsor|1|||
161646533|NCT05282121|583757364|FG001|Overall Study|Study Terminated by Sponsor|2|||
161646534|NCT05282121|583757365|FG002|Overall Study|Study Terminated by Sponsor|2|||
161646535|NCT05282121|583757366|FG003|Overall Study|Study Terminated by Sponsor|2|||
161646536|NCT05282121|583757363|FG000|Overall Study|Other than listed|0|||
161646537|NCT05282121|583757364|FG001|Overall Study|Other than listed|0|||
161646538|NCT05282121|583757365|FG002|Overall Study|Other than listed|1|||
161646539|NCT05282121|583757366|FG003|Overall Study|Other than listed|0|||
161646540|NCT05282121|583757363|FG000|Overall Study|No reason available|0|||
161646541|NCT05282121|583757364|FG001|Overall Study|No reason available|0|||
161646542|NCT05282121|583757365|FG002|Overall Study|No reason available|1|||
161646543|NCT05282121|583757366|FG003|Overall Study|No reason available|0|||
161646544|NCT01174446|583757369|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
161646545|NCT01174446|583757370|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
161646546|NCT01174446|583757371|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
161646547|NCT01174446|583757372|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
161646548|NCT01174446|583757369|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
161646549|NCT01174446|583757370|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
161646550|NCT01174446|583757371|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
161646551|NCT01174446|583757372|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
161646552|NCT01174446|583757369|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
161646553|NCT01174446|583757370|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161646554|NCT01174446|583757371|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161646555|NCT01174446|583757372|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161646556|NCT01174446|583757369|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
161646557|NCT01174446|583757370|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
161646558|NCT01174446|583757371|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
161646559|NCT01174446|583757372|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
161646560|NCT03301155|583757373|FG000|Overall Study|Сompliance with exclusion criteria|8|||
161646561|NCT03301155|583757374|FG001|Overall Study|Сompliance with exclusion criteria|7|||
161646562|NCT03510455|583757375|FG000|Overall Study|Physician Decision|1|||
161646563|NCT00384189|583757376|FG000|Overall Study|Reason Not Specified|50|||
161646564|NCT00384189|583757377|FG001|Overall Study|Reason Not Specified|57|||
161646565|NCT00384189|583757378|FG002|Overall Study|Reason Not Specified|58|||
161646566|NCT00384189|583757379|FG003|Overall Study|Reason Not Specified|40|||
161646567|NCT04958642|583757380|FG000|Overall Study|Transferred to OLEX program|3|||
161646568|NCT04958642|583757381|FG001|Overall Study|Transferred to OLEX program|0|||
161646569|NCT04958642|583757382|FG002|Overall Study|Transferred to OLEX program|5|||
161646570|NCT04958642|583757380|FG000|Overall Study|Death|0|||
161646571|NCT04958642|583757381|FG001|Overall Study|Death|0|||
161646572|NCT04958642|583757382|FG002|Overall Study|Death|1|||
161646573|NCT04958642|583757380|FG000|Overall Study|Withdrawal by Subject|4|||
161646574|NCT04958642|583757381|FG001|Overall Study|Withdrawal by Subject|9|||
161646575|NCT04958642|583757382|FG002|Overall Study|Withdrawal by Subject|13|||
161646576|NCT04958642|583757380|FG000|Overall Study|Investigator's Decision|0|||
161646577|NCT04958642|583757381|FG001|Overall Study|Investigator's Decision|0|||
161646578|NCT04958642|583757382|FG002|Overall Study|Investigator's Decision|1|||
161646579|NCT04958642|583757380|FG000|Overall Study|Adverse Event|1|||
161646580|NCT04958642|583757381|FG001|Overall Study|Adverse Event|0|||
161646581|NCT04958642|583757382|FG002|Overall Study|Adverse Event|1|||
161646582|NCT04958642|583757380|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
161646583|NCT04958642|583757381|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
161646584|NCT04958642|583757382|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
161646585|NCT04958642|583757380|FG000|Overall Study|Lost to Follow-up|1|||
161646586|NCT04958642|583757381|FG001|Overall Study|Lost to Follow-up|0|||
161646587|NCT04958642|583757382|FG002|Overall Study|Lost to Follow-up|0|||
161646588|NCT04958642|583757380|FG000|Overall Study|Transferred to EAP following study termination|0|||
161646589|NCT04958642|583757381|FG001|Overall Study|Transferred to EAP following study termination|0|||
161646590|NCT04958642|583757382|FG002|Overall Study|Transferred to EAP following study termination|1|||
161646591|NCT04958642|583757380|FG000|Overall Study|Transferred to Expanded Access Program|1|||
161646592|NCT04958642|583757381|FG001|Overall Study|Transferred to Expanded Access Program|0|||
161646593|NCT04958642|583757382|FG002|Overall Study|Transferred to Expanded Access Program|0|||
161646594|NCT02942004|583757383|FG000|Overall Study|Withdrawal by Subject|0|||
161646595|NCT02942004|583757384|FG001|Overall Study|Withdrawal by Subject|2|||
161646596|NCT02942004|583757385|FG002|Overall Study|Withdrawal by Subject|3|||
161646597|NCT02942004|583757383|FG000|Overall Study|Lost to Follow-up|1|||
161646598|NCT02942004|583757384|FG001|Overall Study|Lost to Follow-up|1|||
161646599|NCT02942004|583757385|FG002|Overall Study|Lost to Follow-up|2|||
161646600|NCT02942004|583757383|FG000|Overall Study|Randomized but not dosed|3|||
161646601|NCT02942004|583757384|FG001|Overall Study|Randomized but not dosed|9|||
161646602|NCT02942004|583757385|FG002|Overall Study|Randomized but not dosed|4|||
161646603|NCT05627258|583757386|FG000|Overall Study|Lost to Follow-up|1|||
161646604|NCT05627258|583757387|FG001|Overall Study|Lost to Follow-up|0|||
161646605|NCT05627258|583757388|FG002|Overall Study|Lost to Follow-up|0|||
161646606|NCT05627258|583757389|FG003|Overall Study|Lost to Follow-up|0|||
161646607|NCT05627258|583757390|FG004|Overall Study|Lost to Follow-up|0|||
161646608|NCT05627258|583757391|FG005|Overall Study|Lost to Follow-up|0|||
161646609|NCT05627258|583757386|FG000|Overall Study|Withdrawal by Subject|0|||
161646610|NCT05627258|583757387|FG001|Overall Study|Withdrawal by Subject|0|||
161646611|NCT05627258|583757388|FG002|Overall Study|Withdrawal by Subject|0|||
161646612|NCT05627258|583757389|FG003|Overall Study|Withdrawal by Subject|0|||
161646613|NCT05627258|583757390|FG004|Overall Study|Withdrawal by Subject|2|||
161646614|NCT05627258|583757391|FG005|Overall Study|Withdrawal by Subject|0|||
161646615|NCT05627258|583757386|FG000|Overall Study|Enrolled, but product not administered|1|||
161646616|NCT05627258|583757387|FG001|Overall Study|Enrolled, but product not administered|0|||
161646617|NCT05627258|583757388|FG002|Overall Study|Enrolled, but product not administered|0|||
161646618|NCT05627258|583757389|FG003|Overall Study|Enrolled, but product not administered|0|||
161646619|NCT05627258|583757390|FG004|Overall Study|Enrolled, but product not administered|0|||
161646620|NCT05627258|583757391|FG005|Overall Study|Enrolled, but product not administered|0|||
161646621|NCT05627258|583757386|FG000|Overall Study|Other subject illness/injury|1|||
161646622|NCT05627258|583757387|FG001|Overall Study|Other subject illness/injury|0|||
161646623|NCT05627258|583757388|FG002|Overall Study|Other subject illness/injury|0|||
161646624|NCT05627258|583757389|FG003|Overall Study|Other subject illness/injury|0|||
161646625|NCT05627258|583757390|FG004|Overall Study|Other subject illness/injury|0|||
161646626|NCT05627258|583757391|FG005|Overall Study|Other subject illness/injury|0|||
161646627|NCT05627258|583757386|FG000|Overall Study|Subject moved from area|0|||
161646628|NCT05627258|583757387|FG001|Overall Study|Subject moved from area|0|||
161646629|NCT05627258|583757388|FG002|Overall Study|Subject moved from area|1|||
161646630|NCT05627258|583757389|FG003|Overall Study|Subject moved from area|0|||
161646631|NCT05627258|583757390|FG004|Overall Study|Subject moved from area|0|||
161646632|NCT05627258|583757391|FG005|Overall Study|Subject moved from area|0|||
161646633|NCT04517669|583757392|FG000|Overall Study|Lost to Follow-up|2|||
161646634|NCT04517669|583757392|FG000|Overall Study|Withdrawal by Subject|3|||
161646635|NCT04517669|583757392|FG000|Overall Study|Drug withdrawn|44|||
161646636|NCT04517669|583757392|FG000|Overall Study|Other|1|||
161646637|NCT04517669|583757392|FG000|Overall Study|Eligibility criteria not met|4|||
161688388|NCT00440947|583909865|FG002|48-Week Randomization Phase|Protocol Violation|1|||
161646638|NCT04517669|583757392|FG000|Overall Study|Did not receive treatment|3|||
161646639|NCT01923662|583757393|FG000|Overall Study|Withdrawal by Subject|1|||
161646640|NCT01199068|583757394|FG000|Overall Study|Unacceptable toxicity|0|||
161646641|NCT01199068|583757395|FG001|Overall Study|Unacceptable toxicity|0|||
161646642|NCT01199068|583757396|FG002|Overall Study|Unacceptable toxicity|2|||
161646643|NCT01199068|583757394|FG000|Overall Study|Progressive disease|3|||
161646644|NCT01199068|583757395|FG001|Overall Study|Progressive disease|3|||
161646645|NCT01199068|583757396|FG002|Overall Study|Progressive disease|6|||
161646646|NCT01199068|583757394|FG000|Overall Study|Withdrawal by Subject|0|||
161646647|NCT01199068|583757395|FG001|Overall Study|Withdrawal by Subject|0|||
161646648|NCT01199068|583757396|FG002|Overall Study|Withdrawal by Subject|1|||
161646649|NCT01250925|583757397|FG000|Overall Study|Lost to Follow-up|1|||
161646650|NCT01250925|583757398|FG001|Overall Study|Lost to Follow-up|1|||
161646651|NCT01250925|583757399|FG002|Overall Study|Lost to Follow-up|0|||
161646652|NCT01250925|583757397|FG000|Overall Study|Withdrawal by Subject|2|||
161646653|NCT01250925|583757398|FG001|Overall Study|Withdrawal by Subject|0|||
161646654|NCT01250925|583757399|FG002|Overall Study|Withdrawal by Subject|0|||
161646655|NCT01250925|583757397|FG000|Overall Study|Protocol Violation|2|||
161646656|NCT01250925|583757398|FG001|Overall Study|Protocol Violation|0|||
161646657|NCT01250925|583757399|FG002|Overall Study|Protocol Violation|0|||
161646658|NCT01250925|583757397|FG000|Overall Study|Physician Decision|0|||
161646659|NCT01250925|583757398|FG001|Overall Study|Physician Decision|2|||
161646660|NCT01250925|583757399|FG002|Overall Study|Physician Decision|1|||
161646661|NCT01250925|583757397|FG000|Overall Study|Adverse Event|0|||
161646662|NCT01250925|583757398|FG001|Overall Study|Adverse Event|0|||
161646663|NCT01250925|583757399|FG002|Overall Study|Adverse Event|1|||
161646664|NCT00678301|583757403|FG000|Overall Study|Non-compliance with study procedures|0|||
161646665|NCT00678301|583757404|FG001|Overall Study|Non-compliance with study procedures|1|||
161646666|NCT00678301|583757403|FG000|Overall Study|Adverse Event|1|||
161646667|NCT00678301|583757404|FG001|Overall Study|Adverse Event|0|||
161646668|NCT00678301|583757403|FG000|Overall Study|Withdrawal by Subject|4|||
161646669|NCT00678301|583757404|FG001|Overall Study|Withdrawal by Subject|0|||
161646670|NCT00678301|583757403|FG000|Overall Study|Lost to Follow-up|3|||
161646671|NCT00678301|583757404|FG001|Overall Study|Lost to Follow-up|1|||
161646672|NCT02476175|583757407|FG000|Overall Study|Adverse Event|2|||
161646673|NCT01016262|583757413|FG000|Double-blind Phase|Adverse Event|0|||
161646674|NCT01016262|583757414|FG001|Double-blind Phase|Adverse Event|0|||
161646675|NCT01016262|583757415|FG002|Double-blind Phase|Adverse Event|1|||
161646676|NCT01016262|583757416|FG003|Double-blind Phase|Adverse Event|0|||
161646677|NCT01016262|583757417|FG004|Double-blind Phase|Adverse Event|0|||
161646678|NCT01016262|583757418|FG005|Double-blind Phase|Adverse Event|0|||
161646679|NCT01016262|583757413|FG000|Double-blind Phase|Lack of Efficacy|1|||
161646680|NCT01016262|583757414|FG001|Double-blind Phase|Lack of Efficacy|0|||
161646681|NCT01016262|583757415|FG002|Double-blind Phase|Lack of Efficacy|5|||
161646682|NCT01016262|583757416|FG003|Double-blind Phase|Lack of Efficacy|0|||
161646683|NCT01016262|583757417|FG004|Double-blind Phase|Lack of Efficacy|0|||
161646684|NCT01016262|583757418|FG005|Double-blind Phase|Lack of Efficacy|0|||
161646685|NCT01016262|583757413|FG000|Double-blind Phase|Disease Progression|0|||
161646686|NCT01016262|583757414|FG001|Double-blind Phase|Disease Progression|1|||
161646687|NCT01016262|583757415|FG002|Double-blind Phase|Disease Progression|2|||
161646688|NCT01016262|583757416|FG003|Double-blind Phase|Disease Progression|0|||
161646689|NCT01016262|583757417|FG004|Double-blind Phase|Disease Progression|0|||
161646690|NCT01016262|583757418|FG005|Double-blind Phase|Disease Progression|0|||
161688389|NCT00440947|583909866|FG003|48-Week Randomization Phase|Protocol Violation|0|||
161688390|NCT00440947|583909867|FG004|48-Week Randomization Phase|Protocol Violation|0|||
161688391|NCT00440947|583909863|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
161835948|NCT01550744|584440816|FG002|Double-Blind|Lack of Efficacy|8|||
161835949|NCT01550744|584440814|FG000|Double-Blind|Protocol Violation|0|||
161835950|NCT01550744|584440815|FG001|Double-Blind|Protocol Violation|0|||
161835951|NCT01550744|584440816|FG002|Double-Blind|Protocol Violation|4|||
161835952|NCT01550744|584440814|FG000|Double-Blind|Pregnancy|0|||
161835953|NCT01550744|584440815|FG001|Double-Blind|Pregnancy|0|||
161835954|NCT01550744|584440816|FG002|Double-Blind|Pregnancy|3|||
161835955|NCT01550744|584440814|FG000|Double-Blind|Other|0|||
161835956|NCT01550744|584440815|FG001|Double-Blind|Other|2|||
161835957|NCT01550744|584440816|FG002|Double-Blind|Other|10|||
161835958|NCT01782482|584440817|FG000|Overall Study|Adverse Event|2|||
161835959|NCT01782482|584440818|FG001|Overall Study|Adverse Event|1|||
161646691|NCT01016262|583757413|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
161646692|NCT01016262|583757414|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
161646693|NCT01016262|583757415|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
161646694|NCT01016262|583757416|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
161646695|NCT01016262|583757417|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
161646696|NCT01016262|583757418|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
161646697|NCT01016262|583757413|FG000|Open-Label Phase|Adverse Event|0|||
161835960|NCT01782482|584440817|FG000|Overall Study|Lost to Follow-up|2|||
161646698|NCT01016262|583757414|FG001|Open-Label Phase|Adverse Event|0|||
161646699|NCT01016262|583757415|FG002|Open-Label Phase|Adverse Event|0|||
161646700|NCT01016262|583757416|FG003|Open-Label Phase|Adverse Event|1|||
161646701|NCT01016262|583757417|FG004|Open-Label Phase|Adverse Event|0|||
161646702|NCT01016262|583757418|FG005|Open-Label Phase|Adverse Event|0|||
161835961|NCT01782482|584440818|FG001|Overall Study|Lost to Follow-up|3|||
161646703|NCT01016262|583757413|FG000|Open-Label Phase|Lost to Follow-up|0|||
161646704|NCT01016262|583757414|FG001|Open-Label Phase|Lost to Follow-up|0|||
161646705|NCT01016262|583757415|FG002|Open-Label Phase|Lost to Follow-up|0|||
161646706|NCT01016262|583757416|FG003|Open-Label Phase|Lost to Follow-up|0|||
161646707|NCT01016262|583757417|FG004|Open-Label Phase|Lost to Follow-up|1|||
161646708|NCT01016262|583757418|FG005|Open-Label Phase|Lost to Follow-up|0|||
161646709|NCT01016262|583757413|FG000|Open-Label Phase|Lack of Efficacy|0|||
161646710|NCT01016262|583757414|FG001|Open-Label Phase|Lack of Efficacy|0|||
161646711|NCT01016262|583757415|FG002|Open-Label Phase|Lack of Efficacy|0|||
161646712|NCT01016262|583757416|FG003|Open-Label Phase|Lack of Efficacy|1|||
161646713|NCT01016262|583757417|FG004|Open-Label Phase|Lack of Efficacy|0|||
161646714|NCT01016262|583757418|FG005|Open-Label Phase|Lack of Efficacy|0|||
161646715|NCT01016262|583757413|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
161646716|NCT01016262|583757414|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
161646717|NCT01016262|583757415|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
161646718|NCT01016262|583757416|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
161646719|NCT01016262|583757417|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
161646720|NCT01016262|583757418|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
161646721|NCT03738475|583757419|FG000|Overall Study|Participant Non-Compliance|1|||
161646722|NCT03738475|583757420|FG001|Overall Study|Participant Non-Compliance|0|||
161646723|NCT00677534|583757421|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
161646724|NCT00677534|583757421|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
161646725|NCT00677534|583757421|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
161646726|NCT00667394|583757422|FG000|Overall Study|Adverse Event|3|||
161646727|NCT00667394|583757423|FG001|Overall Study|Adverse Event|0|||
161646728|NCT00667394|583757422|FG000|Overall Study|Progressive disease|1|||
161646729|NCT00667394|583757423|FG001|Overall Study|Progressive disease|0|||
161646730|NCT02224703|583757429|FG000|Overall Study|Adverse Event|0|||
161646731|NCT02224703|583757430|FG001|Overall Study|Adverse Event|5|||
161646732|NCT02224703|583757431|FG002|Overall Study|Adverse Event|0|||
161646733|NCT02224703|583757429|FG000|Overall Study|Withdrawn by investigator|1|||
161646734|NCT02224703|583757430|FG001|Overall Study|Withdrawn by investigator|0|||
161646735|NCT02224703|583757431|FG002|Overall Study|Withdrawn by investigator|0|||
161646736|NCT02224703|583757429|FG000|Overall Study|Advised by medical monitor|1|||
161646737|NCT02224703|583757430|FG001|Overall Study|Advised by medical monitor|0|||
161646738|NCT02224703|583757431|FG002|Overall Study|Advised by medical monitor|0|||
161646739|NCT02224703|583757429|FG000|Overall Study|Withdrawn by parent/guardian|0|||
161646740|NCT02224703|583757430|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161646741|NCT02224703|583757431|FG002|Overall Study|Withdrawn by parent/guardian|0|||
161646742|NCT02224703|583757429|FG000|Overall Study|Lack of Efficacy|1|||
161646743|NCT02224703|583757430|FG001|Overall Study|Lack of Efficacy|0|||
161646744|NCT02224703|583757431|FG002|Overall Study|Lack of Efficacy|0|||
161646745|NCT02922023|583757434|FG000|Overall Study|Lost to Follow-up|2|||
161646746|NCT02922023|583757435|FG001|Overall Study|Lost to Follow-up|0|||
161646747|NCT00863681|583757436|FG000|Overall Study|Other|2|||
161646748|NCT00863681|583757437|FG001|Overall Study|Other|0|||
161646749|NCT00863681|583757438|FG002|Overall Study|Other|0|||
161646750|NCT00863681|583757436|FG000|Overall Study|Missing|1|||
161646751|NCT00863681|583757437|FG001|Overall Study|Missing|0|||
161646752|NCT00863681|583757438|FG002|Overall Study|Missing|0|||
161646753|NCT00863681|583757436|FG000|Overall Study|Death|40|||
161646754|NCT00863681|583757437|FG001|Overall Study|Death|23|||
161646755|NCT00863681|583757438|FG002|Overall Study|Death|6|||
161646756|NCT00863681|583757436|FG000|Overall Study|Withdrawal by Subject|12|||
161646757|NCT00863681|583757437|FG001|Overall Study|Withdrawal by Subject|5|||
161646758|NCT00863681|583757438|FG002|Overall Study|Withdrawal by Subject|2|||
161646759|NCT00863681|583757436|FG000|Overall Study|Protocol Violation|2|||
161646760|NCT00863681|583757437|FG001|Overall Study|Protocol Violation|0|||
161646761|NCT00863681|583757438|FG002|Overall Study|Protocol Violation|0|||
161646762|NCT00863681|583757436|FG000|Overall Study|Lost to Follow-up|3|||
161646763|NCT00863681|583757437|FG001|Overall Study|Lost to Follow-up|0|||
161646764|NCT00863681|583757438|FG002|Overall Study|Lost to Follow-up|3|||
161646765|NCT00863681|583757436|FG000|Overall Study|Adverse Event|28|||
161646766|NCT00863681|583757437|FG001|Overall Study|Adverse Event|10|||
161646767|NCT00863681|583757438|FG002|Overall Study|Adverse Event|6|||
161646768|NCT00863681|583757436|FG000|Overall Study|Lack of Efficacy|2|||
161646769|NCT00863681|583757437|FG001|Overall Study|Lack of Efficacy|2|||
161646770|NCT00863681|583757438|FG002|Overall Study|Lack of Efficacy|1|||
161646771|NCT00863681|583757436|FG000|Overall Study|Non-compliance with study drug|1|||
161646772|NCT00863681|583757437|FG001|Overall Study|Non-compliance with study drug|3|||
161646773|NCT00863681|583757438|FG002|Overall Study|Non-compliance with study drug|0|||
161646774|NCT01304498|583757440|FG000|Overall Study|Adverse Event|1|||
161646775|NCT01304498|583757441|FG001|Overall Study|Adverse Event|1|||
161646776|NCT01304498|583757440|FG000|Overall Study|Withdrawal by Subject|2|||
161646777|NCT01304498|583757441|FG001|Overall Study|Withdrawal by Subject|3|||
161646778|NCT01304498|583757440|FG000|Overall Study|Protocol Violation|1|||
161646779|NCT01304498|583757441|FG001|Overall Study|Protocol Violation|0|||
161646780|NCT01304498|583757440|FG000|Overall Study|Lost to Follow-up|2|||
161646781|NCT01304498|583757441|FG001|Overall Study|Lost to Follow-up|1|||
161646782|NCT03325777|583757442|FG000|Overall Study|Lost to Follow-up|9|||
161646783|NCT03325777|583757443|FG001|Overall Study|Lost to Follow-up|12|||
161646784|NCT03004404|583757445|FG000|Period 2|Adverse Event|0|||
161646785|NCT03004404|583757446|FG001|Period 2|Adverse Event|0|||
161646786|NCT03004404|583757447|FG002|Period 2|Adverse Event|0|||
161646787|NCT03004404|583757448|FG003|Period 2|Adverse Event|0|||
161646788|NCT03004404|583757449|FG004|Period 2|Adverse Event|0|||
161646789|NCT03004404|583757450|FG005|Period 2|Adverse Event|0|||
161646790|NCT03004404|583757451|FG006|Period 2|Adverse Event|0|||
161646791|NCT03004404|583757452|FG007|Period 2|Adverse Event|0|||
161646792|NCT03004404|583757453|FG008|Period 2|Adverse Event|1|||
161646793|NCT03004404|583757454|FG009|Period 2|Adverse Event|0|||
161646794|NCT03004404|583757455|FG010|Period 2|Adverse Event|0|||
161646795|NCT03004404|583757456|FG011|Period 2|Adverse Event|0|||
161646796|NCT03004404|583757457|FG012|Period 2|Adverse Event|0|||
161646797|NCT03004404|583757458|FG013|Period 2|Adverse Event|0|||
161646798|NCT03004404|583757459|FG014|Period 2|Adverse Event|0|||
161646799|NCT03004404|583757460|FG015|Period 2|Adverse Event|1|||
161646800|NCT02990468|583757464|FG000|Phase 2: MTD|Change in treatment|0|||
161646801|NCT02990468|583757465|FG001|Phase 2: MTD|Change in treatment|0|||
161646802|NCT02990468|583757466|FG002|Phase 2: MTD|Change in treatment|1|||
161646803|NCT01721954|583757471|FG000|Overall Study|Death|58|||
161646804|NCT01721954|583757472|FG001|Overall Study|Death|64|||
161646805|NCT01721954|583757471|FG000|Overall Study|Withdrawal by Subject|8|||
161646806|NCT01721954|583757472|FG001|Overall Study|Withdrawal by Subject|4|||
161646807|NCT01721954|583757471|FG000|Overall Study|Adverse Event|2|||
161646808|NCT01721954|583757472|FG001|Overall Study|Adverse Event|0|||
161646809|NCT01721954|583757471|FG000|Overall Study|Lost to Follow-up|2|||
161646810|NCT01721954|583757472|FG001|Overall Study|Lost to Follow-up|1|||
161646811|NCT01195623|583757473|FG000|Overall Study|Lost to Follow-up|35|||
161646812|NCT01195623|583757474|FG001|Overall Study|Lost to Follow-up|37|||
161646813|NCT00534495|583757476|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
161646814|NCT00534495|583757477|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
161646815|NCT00534495|583757478|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
161646816|NCT00534495|583757476|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
161646817|NCT00534495|583757477|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
161646818|NCT00534495|583757478|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
161646819|NCT00534495|583757476|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
161646820|NCT00534495|583757477|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
161646821|NCT00534495|583757478|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
161646822|NCT00534495|583757476|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
161646823|NCT00534495|583757477|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
161646824|NCT00534495|583757478|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
161646825|NCT00534495|583757476|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
161646826|NCT00534495|583757477|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
161646827|NCT00534495|583757478|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
161646828|NCT00534495|583757476|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
161646829|NCT00534495|583757477|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
161646830|NCT00534495|583757478|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
161646831|NCT00534495|583757476|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
161646832|NCT00534495|583757477|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
161646833|NCT00534495|583757478|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
161646834|NCT00534495|583757476|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
161646835|NCT00534495|583757477|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
161646836|NCT00534495|583757478|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
161646837|NCT00534495|583757476|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
161646838|NCT00534495|583757477|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
161646839|NCT00534495|583757478|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
161646840|NCT02920970|583757481|FG000|First Intervention|Protocol Violation|0|||
161646841|NCT02920970|583757482|FG001|First Intervention|Protocol Violation|1|||
161646842|NCT02920970|583757481|FG000|First Intervention|Adverse Event|0|||
161646843|NCT02920970|583757482|FG001|First Intervention|Adverse Event|1|||
161646844|NCT02920970|583757481|FG000|Second Intervention|Poor Lens Fit|1|||
161646845|NCT02920970|583757482|FG001|Second Intervention|Poor Lens Fit|0|||
161646846|NCT01711853|583757483|FG000|Overall Study|Not treated|3|||
161646847|NCT04191616|583757484|FG000|Pre-assignment Period|Did not receive study treatment|2|||
161646848|NCT04191616|583757484|FG000|Treatment Period|Death|37|||
161646849|NCT04191616|583757484|FG000|Treatment Period|Sponsor decision|11|||
161646850|NCT04191616|583757484|FG000|Treatment Period|Withdrawal by Subject|4|||
161646851|NCT02670122|583757488|FG000|Overall Study|Lost to Follow-up|4|||
161646852|NCT00632502|583757489|FG000|Overall Study|Adverse Event|0|||
161646853|NCT00632502|583757490|FG001|Overall Study|Adverse Event|1|||
161646854|NCT00632502|583757489|FG000|Overall Study|Randomized not treated|3|||
161646855|NCT00632502|583757490|FG001|Overall Study|Randomized not treated|0|||
161646856|NCT04535544|583757491|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
161646857|NCT04535544|583757492|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
161646858|NCT04535544|583757493|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
161646859|NCT04535544|583757494|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
161646860|NCT04535544|583757491|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
161646861|NCT04535544|583757492|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
161646862|NCT04535544|583757493|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
161646863|NCT04535544|583757494|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
161646864|NCT04535544|583757491|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
161646865|NCT04535544|583757492|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
161646866|NCT04535544|583757493|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
161646867|NCT04535544|583757494|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
161646868|NCT04535544|583757491|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
161646869|NCT04535544|583757492|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
161646870|NCT04535544|583757493|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
161646871|NCT04535544|583757494|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
161646872|NCT04535544|583757491|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
161646873|NCT04535544|583757492|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
161646874|NCT04535544|583757493|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
161646875|NCT04535544|583757494|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
161646876|NCT04535544|583757491|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
161646877|NCT04535544|583757492|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
161646878|NCT04535544|583757493|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
161646879|NCT04535544|583757494|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
161646880|NCT04535544|583757491|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
161646881|NCT04535544|583757492|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
161646882|NCT04535544|583757493|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
161646883|NCT04535544|583757494|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
161646884|NCT04535544|583757491|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
161646885|NCT04535544|583757492|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
161646886|NCT04535544|583757493|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
161646887|NCT04535544|583757494|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
161688392|NCT00440947|583909864|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
161688393|NCT00440947|583909865|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
161688394|NCT00440947|583909866|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
161688395|NCT00440947|583909867|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
161688396|NCT00440947|583909863|FG000|48-Week Randomization Phase|Pregnancy|0|||
161688397|NCT00440947|583909864|FG001|48-Week Randomization Phase|Pregnancy|0|||
161688398|NCT00440947|583909865|FG002|48-Week Randomization Phase|Pregnancy|1|||
161688399|NCT00440947|583909866|FG003|48-Week Randomization Phase|Pregnancy|0|||
161688400|NCT00440947|583909867|FG004|48-Week Randomization Phase|Pregnancy|0|||
161688401|NCT00440947|583909863|FG000|48-Week Randomization Phase|Incarceration|0|||
161688402|NCT00440947|583909864|FG001|48-Week Randomization Phase|Incarceration|3|||
161688403|NCT00440947|583909865|FG002|48-Week Randomization Phase|Incarceration|0|||
161688404|NCT00440947|583909866|FG003|48-Week Randomization Phase|Incarceration|0|||
161688405|NCT00440947|583909867|FG004|48-Week Randomization Phase|Incarceration|0|||
161688406|NCT00440947|583909863|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688407|NCT00440947|583909864|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
161688408|NCT00440947|583909865|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688409|NCT00440947|583909866|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688410|NCT00440947|583909867|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688411|NCT00440947|583909863|FG000|48-Week Randomization Phase|Physician Decision|0|||
161688412|NCT00440947|583909864|FG001|48-Week Randomization Phase|Physician Decision|2|||
161688413|NCT00440947|583909865|FG002|48-Week Randomization Phase|Physician Decision|0|||
161688414|NCT00440947|583909866|FG003|48-Week Randomization Phase|Physician Decision|0|||
161688415|NCT00440947|583909867|FG004|48-Week Randomization Phase|Physician Decision|0|||
161688416|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
161688417|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
161688418|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
161688419|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
161688420|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
161688421|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161688422|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161688423|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161688424|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
161688425|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
161688426|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161688427|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161688428|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161688429|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
161688430|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
161688431|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
161688432|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
161688433|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
161688434|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
161688435|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
161688436|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161688437|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161688438|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161688439|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
161688440|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
161688441|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688442|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688443|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688444|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
161688445|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688446|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161688447|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161688448|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161688449|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
161688450|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
161688451|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
161688452|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
161688453|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
161688454|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
161688455|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
161688456|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
161688457|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
161688458|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
161688459|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
161688460|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
161688461|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
161688462|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
161688463|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
161688464|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
161688465|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
161688466|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161688467|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161688468|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161688469|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
161688470|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
161688471|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Other|0|||
161688472|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Other|0|||
161688473|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Other|0|||
161688474|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Other|1|||
161835962|NCT01782482|584440817|FG000|Overall Study|Physician Decision|1|||
161835963|NCT01782482|584440818|FG001|Overall Study|Physician Decision|0|||
161835964|NCT01782482|584440817|FG000|Overall Study|Protocol Violation|1|||
161835965|NCT01782482|584440818|FG001|Overall Study|Protocol Violation|0|||
161835966|NCT01782482|584440817|FG000|Overall Study|Withdrawal by Subject|2|||
161835967|NCT01782482|584440818|FG001|Overall Study|Withdrawal by Subject|3|||
161835968|NCT01782482|584440817|FG000|Overall Study|Randomized in Error|2|||
161835969|NCT01782482|584440818|FG001|Overall Study|Randomized in Error|2|||
161835970|NCT01782482|584440817|FG000|Overall Study|Habitually wearing toric lens OS|0|||
161835971|NCT01782482|584440818|FG001|Overall Study|Habitually wearing toric lens OS|1|||
161835972|NCT00767520|584440819|FG000|Overall Study|Participants still on treatment|11|||
161835973|NCT00767520|584440820|FG001|Overall Study|Participants still on treatment|15|||
161835974|NCT00767520|584440819|FG000|Overall Study|Randomized in error and Never treated|0|||
161835975|NCT00767520|584440820|FG001|Overall Study|Randomized in error and Never treated|2|||
161835976|NCT00757848|584440821|FG000|Overall Study|Voluntary discontinuation|1|||
161835977|NCT00757848|584440822|FG001|Overall Study|Voluntary discontinuation|0|||
161835978|NCT00757848|584440821|FG000|Overall Study|Adverse Event|1|||
161688475|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Other|0|||
161688476|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
161688477|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
161688478|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
161688479|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
161688480|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
161688481|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688482|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688483|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688484|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688485|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
161688486|NCT03681119|583909874|FG000|Overall Study|No specific reason|4|||
161688487|NCT03681119|583909875|FG001|Overall Study|No specific reason|0|||
161688488|NCT03681119|583909874|FG000|Overall Study|Sickness|2|||
161688489|NCT03681119|583909875|FG001|Overall Study|Sickness|0|||
161688490|NCT00513500|583909884|FG000|Overall Study|Lost to Follow-up|35|||
161688491|NCT00513500|583909885|FG001|Overall Study|Lost to Follow-up|39|||
161688492|NCT00513500|583909884|FG000|Overall Study|Death|2|||
161688493|NCT00513500|583909885|FG001|Overall Study|Death|1|||
161688494|NCT00513500|583909884|FG000|Overall Study|Hospitalized|4|||
161688495|NCT00513500|583909885|FG001|Overall Study|Hospitalized|14|||
161688496|NCT00517829|583909886|FG000|Overall Study|Adverse Event|22|||
161688497|NCT00517829|583909887|FG001|Overall Study|Adverse Event|34|||
161688498|NCT00517829|583909886|FG000|Overall Study|Disease Progression|39|||
161688499|NCT00517829|583909887|FG001|Overall Study|Disease Progression|32|||
161835979|NCT00757848|584440822|FG001|Overall Study|Adverse Event|2|||
161835980|NCT00757848|584440821|FG000|Overall Study|Incorrect enrolment|1|||
161835981|NCT00757848|584440822|FG001|Overall Study|Incorrect enrolment|0|||
161688500|NCT00517829|583909886|FG000|Overall Study|Patient Request|6|||
161688501|NCT00517829|583909887|FG001|Overall Study|Patient Request|5|||
161688502|NCT00517829|583909886|FG000|Overall Study|Investigator Request|5|||
161688503|NCT00517829|583909887|FG001|Overall Study|Investigator Request|3|||
161688504|NCT00517829|583909886|FG000|Overall Study|Other|3|||
161688505|NCT00517829|583909887|FG001|Overall Study|Other|1|||
161688506|NCT00606086|583909889|FG000|Overall Study|Adverse Event|1|||
161688507|NCT00606086|583909890|FG001|Overall Study|Adverse Event|1|||
161688508|NCT00606086|583909889|FG000|Overall Study|Lost to Follow-up|4|||
161688509|NCT00606086|583909890|FG001|Overall Study|Lost to Follow-up|8|||
161688510|NCT00606086|583909889|FG000|Overall Study|Protocol Violation|1|||
161688511|NCT00606086|583909890|FG001|Overall Study|Protocol Violation|0|||
161688512|NCT00606086|583909889|FG000|Overall Study|Withdrawal by Subject|5|||
161688513|NCT00606086|583909890|FG001|Overall Study|Withdrawal by Subject|3|||
161688514|NCT00606086|583909889|FG000|Overall Study|Non-compliance|0|||
161688515|NCT00606086|583909890|FG001|Overall Study|Non-compliance|1|||
161688516|NCT00606086|583909889|FG000|Overall Study|Randomized, not treated|1|||
161688517|NCT00606086|583909890|FG001|Overall Study|Randomized, not treated|2|||
161688518|NCT01929408|583909891|FG000|Overall Study|received HCT as initial treatment|8|||
161688519|NCT00652366|583909902|FG000|Overall Study|Adverse Event|8|||
161688520|NCT00652366|583909903|FG001|Overall Study|Adverse Event|4|||
161688521|NCT00652366|583909904|FG002|Overall Study|Adverse Event|7|||
161688522|NCT00652366|583909905|FG003|Overall Study|Adverse Event|17|||
161688523|NCT00652366|583909906|FG004|Overall Study|Adverse Event|13|||
161688524|NCT00652366|583909902|FG000|Overall Study|Death|5|||
161688525|NCT00652366|583909903|FG001|Overall Study|Death|4|||
161688526|NCT00652366|583909904|FG002|Overall Study|Death|1|||
161688527|NCT00652366|583909905|FG003|Overall Study|Death|8|||
161688528|NCT00652366|583909906|FG004|Overall Study|Death|5|||
161688529|NCT00652366|583909902|FG000|Overall Study|Lack of Efficacy|84|||
161688530|NCT00652366|583909903|FG001|Overall Study|Lack of Efficacy|58|||
161688531|NCT00652366|583909904|FG002|Overall Study|Lack of Efficacy|53|||
161688532|NCT00652366|583909905|FG003|Overall Study|Lack of Efficacy|133|||
161688533|NCT00652366|583909906|FG004|Overall Study|Lack of Efficacy|13|||
161688534|NCT00652366|583909902|FG000|Overall Study|Violation of Selection Criteria|0|||
161688535|NCT00652366|583909903|FG001|Overall Study|Violation of Selection Criteria|0|||
161688536|NCT00652366|583909904|FG002|Overall Study|Violation of Selection Criteria|1|||
161688537|NCT00652366|583909905|FG003|Overall Study|Violation of Selection Criteria|0|||
161688538|NCT00652366|583909906|FG004|Overall Study|Violation of Selection Criteria|0|||
161688539|NCT00652366|583909902|FG000|Overall Study|Protocol Violation|1|||
161688540|NCT00652366|583909903|FG001|Overall Study|Protocol Violation|0|||
161688541|NCT00652366|583909904|FG002|Overall Study|Protocol Violation|0|||
161688542|NCT00652366|583909905|FG003|Overall Study|Protocol Violation|0|||
161688543|NCT00652366|583909906|FG004|Overall Study|Protocol Violation|0|||
161688544|NCT00652366|583909902|FG000|Overall Study|Refused treatment|3|||
161688545|NCT00652366|583909903|FG001|Overall Study|Refused treatment|7|||
161688546|NCT00652366|583909904|FG002|Overall Study|Refused treatment|6|||
161688547|NCT00652366|583909905|FG003|Overall Study|Refused treatment|17|||
161688548|NCT00652366|583909906|FG004|Overall Study|Refused treatment|5|||
161688549|NCT00652366|583909902|FG000|Overall Study|Other|5|||
161688550|NCT00652366|583909903|FG001|Overall Study|Other|2|||
161688551|NCT00652366|583909904|FG002|Overall Study|Other|3|||
161688552|NCT00652366|583909905|FG003|Overall Study|Other|4|||
161688553|NCT00652366|583909906|FG004|Overall Study|Other|0|||
161688554|NCT03873714|583909907|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
161688555|NCT00677014|583909908|FG000|Overall Study|Lost to Follow-up|20|||
161835982|NCT01901874|584440834|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
161835983|NCT01901874|584440834|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
161688556|NCT00677014|583909909|FG001|Overall Study|Lost to Follow-up|12|||
161688557|NCT00677014|583909910|FG002|Overall Study|Lost to Follow-up|24|||
161688558|NCT00677014|583909908|FG000|Overall Study|Death|6|||
161688559|NCT00677014|583909909|FG001|Overall Study|Death|15|||
161688560|NCT00677014|583909910|FG002|Overall Study|Death|7|||
161688561|NCT00677014|583909908|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
161688562|NCT00677014|583909909|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
161688563|NCT00677014|583909910|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
161688564|NCT01326546|583909913|FG000|Overall Study|Lost to Follow-up|8|||
161688565|NCT01326546|583909914|FG001|Overall Study|Lost to Follow-up|7|||
161688566|NCT01326546|583909913|FG000|Overall Study|Protocol Violation|3|||
161688567|NCT01326546|583909914|FG001|Overall Study|Protocol Violation|4|||
161688568|NCT01326546|583909913|FG000|Overall Study|Pregnancy|0|||
161688569|NCT01326546|583909914|FG001|Overall Study|Pregnancy|1|||
161835984|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
161835985|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
161688570|NCT01326546|583909913|FG000|Overall Study|Adverse Event|1|||
161688571|NCT01326546|583909914|FG001|Overall Study|Adverse Event|0|||
161835986|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
161835987|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
161835988|NCT03078582|584440835|FG000|Overall Study|Adverse Event|0|||
161688572|NCT01326546|583909913|FG000|Overall Study|Withdrawal by Subject|5|||
161688573|NCT01326546|583909914|FG001|Overall Study|Withdrawal by Subject|1|||
161835989|NCT03078582|584440836|FG001|Overall Study|Adverse Event|8|||
161835990|NCT01491035|584440850|FG000|Overall Study|Lost to Follow-up|0|||
161835991|NCT01491035|584440851|FG001|Overall Study|Lost to Follow-up|0|||
161835992|NCT01491035|584440852|FG002|Overall Study|Lost to Follow-up|0|||
161835993|NCT01491035|584440853|FG003|Overall Study|Lost to Follow-up|0|||
161688574|NCT03152019|583909915|FG000|Overall Study|Adverse Event|0|||
161688575|NCT03152019|583909916|FG001|Overall Study|Adverse Event|1|||
161688576|NCT00081159|583909920|FG000|Overall Study|Withdrawal by Subject|0|||
161688577|NCT00081159|583909921|FG001|Overall Study|Withdrawal by Subject|3|||
161688578|NCT00081159|583909920|FG000|Overall Study|Myelosuppression prior to treatment|0|||
161688579|NCT00081159|583909921|FG001|Overall Study|Myelosuppression prior to treatment|1|||
161688580|NCT00081159|583909920|FG000|Overall Study|Lost to Follow-up|2|||
161688581|NCT00081159|583909921|FG001|Overall Study|Lost to Follow-up|1|||
161688582|NCT00923130|583909924|FG000|Overall Study|Stopped treatment due to progression|17|||
161688583|NCT00923130|583909924|FG000|Overall Study|Death|1|||
161688584|NCT00923130|583909924|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
161688585|NCT00923130|583909924|FG000|Overall Study|Switched to alternative treatment|2|||
161688586|NCT00923130|583909924|FG000|Overall Study|Refused further treatment|2|||
161688587|NCT03693625|583909925|FG000|Overall Study|Adverse Event|2|||
161688588|NCT03693625|583909926|FG001|Overall Study|Adverse Event|0|||
161688589|NCT03693625|583909925|FG000|Overall Study|Study Terminated By Sponsor|20|||
161688590|NCT03693625|583909926|FG001|Overall Study|Study Terminated By Sponsor|7|||
161688591|NCT03693625|583909925|FG000|Overall Study|Withdrawal by Subject|1|||
161688592|NCT03693625|583909926|FG001|Overall Study|Withdrawal by Subject|1|||
161688593|NCT01187953|583909927|FG000|Overall Study|Death|11|||
161688594|NCT01187953|583909928|FG001|Overall Study|Death|13|||
161688595|NCT01187953|583909927|FG000|Overall Study|Adverse Event|1|||
161688596|NCT01187953|583909928|FG001|Overall Study|Adverse Event|2|||
161688597|NCT01187953|583909927|FG000|Overall Study|Lost to Follow-up|0|||
161688598|NCT01187953|583909928|FG001|Overall Study|Lost to Follow-up|3|||
161688599|NCT01187953|583909927|FG000|Overall Study|Withdrawal by Subject|3|||
161688600|NCT01187953|583909928|FG001|Overall Study|Withdrawal by Subject|3|||
161688601|NCT02457637|583909931|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
161688602|NCT01035905|583909932|FG000|Overall Study|Lack of Efficacy|1|||
161688603|NCT01035905|583909933|FG001|Overall Study|Lack of Efficacy|1|||
161688604|NCT05038020|583909934|FG000|Overall Study|Early Termination|3|||
161688605|NCT05038020|583909935|FG001|Overall Study|Early Termination|0|||
161688606|NCT03416153|583909937|FG000|Overall Study|Physician Decision|1|||
161688607|NCT03416153|583909938|FG001|Overall Study|Physician Decision|1|||
161688608|NCT03416153|583909937|FG000|Overall Study|Withdrawal by Subject|1|||
161688609|NCT03416153|583909938|FG001|Overall Study|Withdrawal by Subject|0|||
161688610|NCT03468855|583911665|FG000|Overall Study|Adverse Event|2|||
161688611|NCT03468855|583911665|FG000|Overall Study|Lost to Follow-up|5|||
161688612|NCT03468855|583911665|FG000|Overall Study|Withdrawal by Subject|3|||
161688613|NCT03468855|583911665|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
161688614|NCT02068547|583911666|FG000|Overall Study|Lost to Follow-up|3|||
161688615|NCT02068547|583911667|FG001|Overall Study|Lost to Follow-up|3|||
161688616|NCT02068547|583911666|FG000|Overall Study|Physician Decision|1|||
161688617|NCT02068547|583911667|FG001|Overall Study|Physician Decision|0|||
161688618|NCT00880893|583911668|FG000|Overall Study|Protocol Violation|13|||
161688619|NCT00880893|583911669|FG001|Overall Study|Protocol Violation|1|||
161688620|NCT00880893|583911668|FG000|Overall Study|Withdrawal by Subject|15|||
161688621|NCT00880893|583911669|FG001|Overall Study|Withdrawal by Subject|11|||
161688622|NCT00880893|583911668|FG000|Overall Study|Lost to Follow-up|76|||
161688623|NCT00880893|583911669|FG001|Overall Study|Lost to Follow-up|33|||
161688624|NCT00880893|583911668|FG000|Overall Study|Serious adverse event|3|||
161688625|NCT00880893|583911669|FG001|Overall Study|Serious adverse event|0|||
161688626|NCT01736579|583911673|FG000|Overall Study|Termination of Study by Sponsor|2|||
161688627|NCT01736579|583911674|FG001|Overall Study|Termination of Study by Sponsor|2|||
161688628|NCT01979523|583911676|FG000|Overall Study|Withdrawal by Subject|1|||
161688629|NCT01979523|583911677|FG001|Overall Study|Withdrawal by Subject|0|||
161688630|NCT00772954|583911688|FG000|Overall Study|Adverse Event|0|||
161688631|NCT00772954|583911689|FG001|Overall Study|Adverse Event|0|||
161688632|NCT00772954|583911690|FG002|Overall Study|Adverse Event|1|||
161688633|NCT01661140|583911691|FG000|Open-Label Period|Adverse Event|44|||
161688634|NCT01661140|583911692|FG001|Open-Label Period|Adverse Event|0|||
161688635|NCT01661140|583911693|FG002|Open-Label Period|Adverse Event|0|||
161688636|NCT01661140|583911691|FG000|Open-Label Period|Protocol Violation|3|||
161688637|NCT01661140|583911692|FG001|Open-Label Period|Protocol Violation|0|||
161688638|NCT01661140|583911693|FG002|Open-Label Period|Protocol Violation|0|||
161688639|NCT01661140|583911691|FG000|Open-Label Period|Withdrawal by Subject|5|||
161688640|NCT01661140|583911692|FG001|Open-Label Period|Withdrawal by Subject|0|||
161688641|NCT01661140|583911693|FG002|Open-Label Period|Withdrawal by Subject|0|||
161688642|NCT01661140|583911691|FG000|Open-Label Period|Investigator Decision|3|||
161835994|NCT01491035|584440854|FG004|Overall Study|Lost to Follow-up|1|||
161688643|NCT01661140|583911692|FG001|Open-Label Period|Investigator Decision|0|||
161688644|NCT01661140|583911693|FG002|Open-Label Period|Investigator Decision|0|||
161688645|NCT01661140|583911691|FG000|Open-Label Period|Death|1|||
161688646|NCT01661140|583911692|FG001|Open-Label Period|Death|0|||
161688647|NCT01661140|583911693|FG002|Open-Label Period|Death|0|||
161688648|NCT01661140|583911691|FG000|Open-Label Period|Administrative/Other|1|||
161688649|NCT01661140|583911692|FG001|Open-Label Period|Administrative/Other|0|||
161688650|NCT01661140|583911693|FG002|Open-Label Period|Administrative/Other|0|||
161688651|NCT01661140|583911691|FG000|Open-Label Period|Sponsor termination|16|||
161688652|NCT01661140|583911692|FG001|Open-Label Period|Sponsor termination|0|||
161688653|NCT01661140|583911693|FG002|Open-Label Period|Sponsor termination|0|||
161835995|NCT01491035|584440855|FG005|Overall Study|Lost to Follow-up|0|||
161835996|NCT01491035|584440856|FG006|Overall Study|Lost to Follow-up|0|||
161835997|NCT01491035|584440857|FG007|Overall Study|Lost to Follow-up|0|||
161835998|NCT02025751|584440858|FG000|Overall Study|Lost to Follow-up|1|||
161835999|NCT02025751|584440859|FG001|Overall Study|Lost to Follow-up|0|||
161836000|NCT02025751|584440858|FG000|Overall Study|Adverse Event|0|||
161836001|NCT02025751|584440859|FG001|Overall Study|Adverse Event|1|||
161836002|NCT02025751|584440858|FG000|Overall Study|Physician Decision|0|||
161688654|NCT01661140|583911691|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
161688655|NCT01661140|583911692|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
161836003|NCT02025751|584440859|FG001|Overall Study|Physician Decision|1|||
161836004|NCT02025751|584440858|FG000|Overall Study|Withdrawal by Subject|0|||
161836005|NCT02025751|584440859|FG001|Overall Study|Withdrawal by Subject|1|||
161836006|NCT02687360|584440862|FG000|Overall Study|Withdrawal by Subject|3|||
161836007|NCT02687360|584440863|FG001|Overall Study|Withdrawal by Subject|0|||
161836008|NCT02181296|584440865|FG000|Overall Study|Lost to Follow-up|7|||
161836009|NCT02181296|584440866|FG001|Overall Study|Lost to Follow-up|6|||
161836010|NCT01568866|584440867|FG000|Overall Study|Disease Progression|208|||
161836011|NCT01568866|584440868|FG001|Overall Study|Disease Progression|183|||
161836012|NCT01568866|584440867|FG000|Overall Study|Adverse Event|94|||
161836013|NCT01568866|584440868|FG001|Overall Study|Adverse Event|96|||
161836014|NCT01568866|584440867|FG000|Overall Study|Patient Request|55|||
161836015|NCT01568866|584440868|FG001|Overall Study|Patient Request|71|||
161836016|NCT01568866|584440867|FG000|Overall Study|Physician Decision|40|||
161836017|NCT01568866|584440868|FG001|Overall Study|Physician Decision|32|||
161836018|NCT01568866|584440867|FG000|Overall Study|Withdrawal by Subject|19|||
161688656|NCT01661140|583911693|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
161688657|NCT01661140|583911691|FG000|Open-Label Period|Lost to Follow-up|2|||
161688658|NCT01661140|583911692|FG001|Open-Label Period|Lost to Follow-up|0|||
161688659|NCT01661140|583911693|FG002|Open-Label Period|Lost to Follow-up|0|||
161688660|NCT01661140|583911691|FG000|Double-Blind Period|Refused Treatment|0|||
161688661|NCT01661140|583911692|FG001|Double-Blind Period|Refused Treatment|0|||
161836019|NCT01568866|584440868|FG001|Overall Study|Withdrawal by Subject|11|||
161688662|NCT01661140|583911693|FG002|Double-Blind Period|Refused Treatment|1|||
161688663|NCT01661140|583911691|FG000|Double-Blind Period|Adverse Event|0|||
161836020|NCT01568866|584440867|FG000|Overall Study|Death|10|||
161836021|NCT01568866|584440868|FG001|Overall Study|Death|18|||
161836022|NCT01568866|584440867|FG000|Overall Study|Protocol Non-compliance|2|||
161688664|NCT01661140|583911692|FG001|Double-Blind Period|Adverse Event|16|||
161688665|NCT01661140|583911693|FG002|Double-Blind Period|Adverse Event|18|||
161688666|NCT01661140|583911691|FG000|Double-Blind Period|Protocol Violation|0|||
161688667|NCT01661140|583911692|FG001|Double-Blind Period|Protocol Violation|2|||
161688668|NCT01661140|583911693|FG002|Double-Blind Period|Protocol Violation|3|||
161688669|NCT01661140|583911691|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161688670|NCT01661140|583911692|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161688671|NCT01661140|583911693|FG002|Double-Blind Period|Withdrawal by Subject|3|||
161688672|NCT01661140|583911691|FG000|Double-Blind Period|Investigator's Decision|0|||
161688673|NCT01661140|583911692|FG001|Double-Blind Period|Investigator's Decision|1|||
161688674|NCT01661140|583911693|FG002|Double-Blind Period|Investigator's Decision|2|||
161688675|NCT01661140|583911691|FG000|Double-Blind Period|Sponsor Termination|0|||
161688676|NCT01661140|583911692|FG001|Double-Blind Period|Sponsor Termination|14|||
161688677|NCT01661140|583911693|FG002|Double-Blind Period|Sponsor Termination|17|||
161836023|NCT01568866|584440868|FG001|Overall Study|Protocol Non-compliance|4|||
161836024|NCT01568866|584440867|FG000|Overall Study|Lost to Follow-up|1|||
161836025|NCT01568866|584440868|FG001|Overall Study|Lost to Follow-up|0|||
161836026|NCT01568866|584440867|FG000|Overall Study|Randomized but Not Dosed|9|||
161648714|NCT03554629|583767467|FG000|Overall Study|Inadequate data|6|||
161648715|NCT01182441|583767470|FG000|Overall Study|Patient Still in Follow-up|152|||
161648716|NCT01182441|583767471|FG001|Overall Study|Patient Still in Follow-up|72|||
161648717|NCT01182441|583767470|FG000|Overall Study|Death|37|||
161648718|NCT01182441|583767471|FG001|Overall Study|Death|25|||
161648719|NCT01182441|583767470|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
161648720|NCT01182441|583767471|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
161648721|NCT01182441|583767470|FG000|Overall Study|Lost to Follow-up|5|||
161648722|NCT01182441|583767471|FG001|Overall Study|Lost to Follow-up|8|||
161648723|NCT01182441|583767470|FG000|Overall Study|Withdrawal by Subject|6|||
161648724|NCT01182441|583767471|FG001|Overall Study|Withdrawal by Subject|13|||
161648725|NCT01182441|583767470|FG000|Overall Study|Implant Not Attempted|4|||
161648726|NCT01182441|583767471|FG001|Overall Study|Implant Not Attempted|0|||
161648727|NCT01182441|583767470|FG000|Overall Study|Adverse Event|2|||
161648728|NCT01182441|583767471|FG001|Overall Study|Adverse Event|0|||
161648729|NCT01182441|583767470|FG000|Overall Study|Physician Decision|1|||
161648730|NCT01182441|583767471|FG001|Overall Study|Physician Decision|1|||
161648731|NCT03480932|583767472|FG000|Overall Study|Death|1|||
161648732|NCT03480932|583767473|FG001|Overall Study|Death|1|||
161648733|NCT03480932|583767474|FG002|Overall Study|Death|0|||
161648734|NCT03480932|583767472|FG000|Overall Study|Lost to Follow-up|0|||
161648735|NCT03480932|583767473|FG001|Overall Study|Lost to Follow-up|2|||
161648736|NCT03480932|583767474|FG002|Overall Study|Lost to Follow-up|3|||
161648737|NCT03480932|583767472|FG000|Overall Study|Incarcerated|2|||
161648738|NCT03480932|583767473|FG001|Overall Study|Incarcerated|2|||
161648739|NCT03480932|583767474|FG002|Overall Study|Incarcerated|2|||
161648740|NCT00663702|583767475|FG000|Overall Study|Adverse Event|8|||
161648741|NCT00663702|583767476|FG001|Overall Study|Adverse Event|4|||
161648742|NCT00663702|583767475|FG000|Overall Study|Withdrawal by Subject|3|||
161648743|NCT00663702|583767476|FG001|Overall Study|Withdrawal by Subject|1|||
161648744|NCT00663702|583767475|FG000|Overall Study|Pregnancy|0|||
161648745|NCT00663702|583767476|FG001|Overall Study|Pregnancy|1|||
161648746|NCT00663702|583767475|FG000|Overall Study|Lost to Follow-up|3|||
161648747|NCT00663702|583767476|FG001|Overall Study|Lost to Follow-up|0|||
161648748|NCT00663702|583767475|FG000|Overall Study|Death|1|||
161648749|NCT00663702|583767476|FG001|Overall Study|Death|1|||
161648750|NCT00663702|583767475|FG000|Overall Study|Lack of Efficacy|3|||
161648751|NCT00663702|583767476|FG001|Overall Study|Lack of Efficacy|3|||
161648752|NCT03056300|583767477|FG000|Overall Study|Surgical reason per study protocol|3|||
161648753|NCT05262517|583767484|FG000|Overall Study|Randomized but not treated|5|||
161648754|NCT05262517|583767485|FG001|Overall Study|Randomized but not treated|11|||
161648755|NCT05577715|583767486|FG000|Overall Study|Withdrawal by Subject|1|||
161648756|NCT05577715|583767486|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
161648757|NCT05577715|583767486|FG000|Overall Study|Lost to Follow-up|1|||
161648758|NCT05577715|583767486|FG000|Overall Study|Death|6|||
161648759|NCT05048238|583767487|FG000|Overall Study|Withdrawal by Subject|1|||
161648760|NCT00335140|583767493|FG000|Overall Study|Ineligible|1|||
161648761|NCT00737477|583767497|FG000|Overall Study|Adverse Event|9|||
161648762|NCT00737477|583767497|FG000|Overall Study|Death|9|||
161648763|NCT00737477|583767497|FG000|Overall Study|Treatment Refusal|1|||
161648764|NCT00737477|583767497|FG000|Overall Study|Withdrawal by Subject|1|||
161648765|NCT00737477|583767497|FG000|Overall Study|Renal Transplantation|10|||
161648766|NCT00737477|583767497|FG000|Overall Study|Other|4|||
161648767|NCT01132820|583767498|FG000|Overall Study|Ineligible: wrong cell type|1|||
161648768|NCT01132820|583767498|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
161648769|NCT01132820|583767498|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
161648770|NCT01132820|583767498|FG000|Overall Study|Never treated|1|||
161648771|NCT01132820|583767498|FG000|Overall Study|Inadequate data|1|||
161648772|NCT01370655|583767499|FG000|Period 1|Adverse Event|2|||
161648773|NCT01370655|583767500|FG001|Period 1|Adverse Event|0|||
161648774|NCT01370655|583767501|FG002|Period 1|Adverse Event|0|||
161648775|NCT01370655|583767502|FG003|Period 1|Adverse Event|0|||
161648776|NCT01370655|583767503|FG004|Period 1|Adverse Event|0|||
161648777|NCT01370655|583767504|FG005|Period 1|Adverse Event|0|||
161648778|NCT01370655|583767505|FG006|Period 1|Adverse Event|1|||
161648779|NCT01370655|583767506|FG007|Period 1|Adverse Event|0|||
161648780|NCT01370655|583767507|FG008|Period 1|Adverse Event|0|||
161648781|NCT01370655|583767508|FG009|Period 1|Adverse Event|0|||
161648782|NCT01370655|583767509|FG010|Period 1|Adverse Event|0|||
161648783|NCT01370655|583767510|FG011|Period 1|Adverse Event|0|||
161648784|NCT01370655|583767499|FG000|Period 2|Adverse Event|0|||
161648785|NCT01370655|583767500|FG001|Period 2|Adverse Event|0|||
161648786|NCT01370655|583767501|FG002|Period 2|Adverse Event|1|||
161648787|NCT01370655|583767502|FG003|Period 2|Adverse Event|0|||
161648788|NCT01370655|583767503|FG004|Period 2|Adverse Event|1|||
161648789|NCT01370655|583767504|FG005|Period 2|Adverse Event|0|||
161648790|NCT01370655|583767505|FG006|Period 2|Adverse Event|0|||
161648791|NCT01370655|583767506|FG007|Period 2|Adverse Event|1|||
161648792|NCT01370655|583767507|FG008|Period 2|Adverse Event|0|||
161648793|NCT01370655|583767508|FG009|Period 2|Adverse Event|0|||
161648794|NCT01370655|583767509|FG010|Period 2|Adverse Event|0|||
161648795|NCT01370655|583767510|FG011|Period 2|Adverse Event|0|||
161648796|NCT01370655|583767499|FG000|Period 2|met protocol specified stopping criteria|0|||
161648797|NCT01370655|583767500|FG001|Period 2|met protocol specified stopping criteria|0|||
161648798|NCT01370655|583767501|FG002|Period 2|met protocol specified stopping criteria|1|||
161648799|NCT01370655|583767502|FG003|Period 2|met protocol specified stopping criteria|0|||
161648800|NCT01370655|583767503|FG004|Period 2|met protocol specified stopping criteria|0|||
161648801|NCT01370655|583767504|FG005|Period 2|met protocol specified stopping criteria|0|||
161648802|NCT01370655|583767505|FG006|Period 2|met protocol specified stopping criteria|1|||
161648803|NCT01370655|583767506|FG007|Period 2|met protocol specified stopping criteria|0|||
161648804|NCT01370655|583767507|FG008|Period 2|met protocol specified stopping criteria|1|||
161648805|NCT01370655|583767508|FG009|Period 2|met protocol specified stopping criteria|0|||
161648806|NCT01370655|583767509|FG010|Period 2|met protocol specified stopping criteria|1|||
161648807|NCT01370655|583767510|FG011|Period 2|met protocol specified stopping criteria|0|||
161648808|NCT01370655|583767499|FG000|Period 2|Withdrawal by Subject|0|||
161648809|NCT01370655|583767500|FG001|Period 2|Withdrawal by Subject|0|||
161648810|NCT01370655|583767501|FG002|Period 2|Withdrawal by Subject|0|||
161648811|NCT01370655|583767502|FG003|Period 2|Withdrawal by Subject|0|||
161648812|NCT01370655|583767503|FG004|Period 2|Withdrawal by Subject|0|||
161648813|NCT01370655|583767504|FG005|Period 2|Withdrawal by Subject|0|||
161648814|NCT01370655|583767505|FG006|Period 2|Withdrawal by Subject|0|||
161648815|NCT01370655|583767506|FG007|Period 2|Withdrawal by Subject|0|||
161648816|NCT01370655|583767507|FG008|Period 2|Withdrawal by Subject|1|||
161648817|NCT01370655|583767508|FG009|Period 2|Withdrawal by Subject|0|||
161648818|NCT01370655|583767509|FG010|Period 2|Withdrawal by Subject|0|||
161648819|NCT01370655|583767510|FG011|Period 2|Withdrawal by Subject|0|||
161648820|NCT01730378|583767511|FG000|Overall Study|Lost to Follow-up|1|||
161648821|NCT01730378|583767512|FG001|Overall Study|Lost to Follow-up|0|||
161648822|NCT02687035|583767513|FG000|Overall Study|Withdrawal by Subject|1|||
161648823|NCT02687035|583767513|FG000|Overall Study|Death|87|||
161648824|NCT02687035|583767513|FG000|Overall Study|Lost to Follow-up|1|||
161648825|NCT02687035|583767513|FG000|Overall Study|Missed Visit|87|||
161648826|NCT02687035|583767513|FG000|Overall Study|Did not receive Study Device|8|||
161648827|NCT05000216|583767517|FG000|Stage 1|Lost to Follow-up|0|||
161648828|NCT05000216|583767518|FG001|Stage 1|Lost to Follow-up|0|||
161648829|NCT05000216|583767519|FG002|Stage 1|Lost to Follow-up|0|||
161648830|NCT05000216|583767520|FG003|Stage 1|Lost to Follow-up|0|||
161648831|NCT05000216|583767521|FG004|Stage 1|Lost to Follow-up|0|||
161648832|NCT05000216|583767522|FG005|Stage 1|Lost to Follow-up|0|||
161648833|NCT05000216|583767523|FG006|Stage 1|Lost to Follow-up|1|||
161648834|NCT05000216|583767524|FG007|Stage 1|Lost to Follow-up|1|||
161648835|NCT05000216|583767525|FG008|Stage 1|Lost to Follow-up|0|||
161648836|NCT05000216|583767526|FG009|Stage 1|Lost to Follow-up|2|||
161648837|NCT05000216|583767527|FG010|Stage 1|Lost to Follow-up|3|||
161648838|NCT05000216|583767528|FG011|Stage 1|Lost to Follow-up|0|||
161648839|NCT05000216|583767529|FG012|Stage 1|Lost to Follow-up|0|||
161648840|NCT05000216|583767530|FG013|Stage 1|Lost to Follow-up|0|||
161648841|NCT05000216|583767531|FG014|Stage 1|Lost to Follow-up|0|||
161648842|NCT05000216|583767532|FG015|Stage 1|Lost to Follow-up|0|||
161648843|NCT05000216|583767533|FG016|Stage 1|Lost to Follow-up|0|||
161648844|NCT05000216|583767534|FG017|Stage 1|Lost to Follow-up|0|||
161648845|NCT05000216|583767535|FG018|Stage 1|Lost to Follow-up|0|||
161648846|NCT05000216|583767536|FG019|Stage 1|Lost to Follow-up|0|||
161648847|NCT05000216|583767537|FG020|Stage 1|Lost to Follow-up|0|||
161648848|NCT05000216|583767538|FG021|Stage 1|Lost to Follow-up|0|||
161648849|NCT05000216|583767517|FG000|Stage 1|Physician Decision|0|||
161648850|NCT05000216|583767518|FG001|Stage 1|Physician Decision|0|||
161836027|NCT01568866|584440868|FG001|Overall Study|Randomized but Not Dosed|1|||
161836028|NCT01698775|584440869|FG000|Phase A|Adverse Event|2|||
161836029|NCT01698775|584440870|FG001|Phase A|Adverse Event|1|||
161836030|NCT01698775|584440869|FG000|Phase A|Death|1|||
161836031|NCT01698775|584440870|FG001|Phase A|Death|1|||
161836032|NCT01698775|584440869|FG000|Phase A|Lack of Efficacy|1|||
161836033|NCT01698775|584440870|FG001|Phase A|Lack of Efficacy|0|||
161648851|NCT05000216|583767519|FG002|Stage 1|Physician Decision|0|||
161648852|NCT05000216|583767520|FG003|Stage 1|Physician Decision|0|||
161648853|NCT05000216|583767521|FG004|Stage 1|Physician Decision|0|||
161648854|NCT05000216|583767522|FG005|Stage 1|Physician Decision|0|||
161648855|NCT05000216|583767523|FG006|Stage 1|Physician Decision|0|||
161648856|NCT05000216|583767524|FG007|Stage 1|Physician Decision|1|||
161648857|NCT05000216|583767525|FG008|Stage 1|Physician Decision|1|||
161648858|NCT05000216|583767526|FG009|Stage 1|Physician Decision|0|||
161648859|NCT05000216|583767527|FG010|Stage 1|Physician Decision|0|||
161648860|NCT05000216|583767528|FG011|Stage 1|Physician Decision|0|||
161648861|NCT05000216|583767529|FG012|Stage 1|Physician Decision|0|||
161648862|NCT05000216|583767530|FG013|Stage 1|Physician Decision|0|||
161648863|NCT05000216|583767531|FG014|Stage 1|Physician Decision|0|||
161648864|NCT05000216|583767532|FG015|Stage 1|Physician Decision|0|||
161648865|NCT05000216|583767533|FG016|Stage 1|Physician Decision|0|||
161836034|NCT01698775|584440869|FG000|Phase A|Lost to Follow-up|1|||
161836035|NCT01698775|584440870|FG001|Phase A|Lost to Follow-up|2|||
161836036|NCT01698775|584440869|FG000|Phase A|Protocol Violation|1|||
161648866|NCT05000216|583767534|FG017|Stage 1|Physician Decision|0|||
161648867|NCT05000216|583767535|FG018|Stage 1|Physician Decision|0|||
161648868|NCT05000216|583767536|FG019|Stage 1|Physician Decision|0|||
161648869|NCT05000216|583767537|FG020|Stage 1|Physician Decision|0|||
161648870|NCT05000216|583767538|FG021|Stage 1|Physician Decision|0|||
161648871|NCT05000216|583767517|FG000|Stage 1|Withdrawal by Subject|0|||
161648872|NCT05000216|583767518|FG001|Stage 1|Withdrawal by Subject|1|||
161648873|NCT05000216|583767519|FG002|Stage 1|Withdrawal by Subject|0|||
161648874|NCT05000216|583767520|FG003|Stage 1|Withdrawal by Subject|0|||
161648875|NCT05000216|583767521|FG004|Stage 1|Withdrawal by Subject|0|||
161648876|NCT05000216|583767522|FG005|Stage 1|Withdrawal by Subject|0|||
161648877|NCT05000216|583767523|FG006|Stage 1|Withdrawal by Subject|0|||
161648878|NCT05000216|583767524|FG007|Stage 1|Withdrawal by Subject|0|||
161648879|NCT05000216|583767525|FG008|Stage 1|Withdrawal by Subject|0|||
161648880|NCT05000216|583767526|FG009|Stage 1|Withdrawal by Subject|3|||
161648881|NCT05000216|583767527|FG010|Stage 1|Withdrawal by Subject|10|||
161648882|NCT05000216|583767528|FG011|Stage 1|Withdrawal by Subject|0|||
161648883|NCT05000216|583767529|FG012|Stage 1|Withdrawal by Subject|0|||
161648884|NCT05000216|583767530|FG013|Stage 1|Withdrawal by Subject|0|||
161648885|NCT05000216|583767531|FG014|Stage 1|Withdrawal by Subject|0|||
161648886|NCT05000216|583767532|FG015|Stage 1|Withdrawal by Subject|0|||
161648887|NCT05000216|583767533|FG016|Stage 1|Withdrawal by Subject|0|||
161648888|NCT05000216|583767534|FG017|Stage 1|Withdrawal by Subject|0|||
161648889|NCT05000216|583767535|FG018|Stage 1|Withdrawal by Subject|0|||
161648890|NCT05000216|583767536|FG019|Stage 1|Withdrawal by Subject|0|||
161648891|NCT05000216|583767537|FG020|Stage 1|Withdrawal by Subject|0|||
161648892|NCT05000216|583767538|FG021|Stage 1|Withdrawal by Subject|0|||
161648893|NCT05000216|583767517|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
161648894|NCT05000216|583767518|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
161648895|NCT05000216|583767519|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
161648896|NCT05000216|583767520|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
161648897|NCT05000216|583767521|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
161648898|NCT05000216|583767522|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
161648899|NCT05000216|583767523|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
161648900|NCT05000216|583767524|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
161648901|NCT05000216|583767525|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
161648902|NCT05000216|583767526|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
161648903|NCT05000216|583767527|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
161648904|NCT05000216|583767528|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
161648905|NCT05000216|583767529|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
161648906|NCT05000216|583767530|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
161648907|NCT05000216|583767531|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
161648908|NCT05000216|583767532|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
161648909|NCT05000216|583767533|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
161648910|NCT05000216|583767534|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
161648911|NCT05000216|583767535|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
161648912|NCT05000216|583767536|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
161648913|NCT05000216|583767537|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
161648914|NCT05000216|583767538|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
161648915|NCT05000216|583767517|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648916|NCT05000216|583767518|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648917|NCT05000216|583767519|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648918|NCT05000216|583767520|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648919|NCT05000216|583767521|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648920|NCT05000216|583767522|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648921|NCT05000216|583767523|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648922|NCT05000216|583767524|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648923|NCT05000216|583767525|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
161648924|NCT05000216|583767526|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648925|NCT05000216|583767527|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648926|NCT05000216|583767528|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648927|NCT05000216|583767529|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648928|NCT05000216|583767530|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161688678|NCT01661140|583911691|FG000|Double-Blind Period|Administrative/Other|0|||
161648929|NCT05000216|583767531|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648930|NCT05000216|583767532|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648931|NCT05000216|583767533|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648932|NCT05000216|583767534|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161688679|NCT01661140|583911692|FG001|Double-Blind Period|Administrative/Other|7|||
161648933|NCT05000216|583767535|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161836037|NCT01698775|584440870|FG001|Phase A|Protocol Violation|0|||
161648934|NCT05000216|583767536|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648935|NCT05000216|583767537|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648936|NCT05000216|583767538|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161648937|NCT05000216|583767517|FG000|Stage 1|Other|0|||
161648938|NCT05000216|583767518|FG001|Stage 1|Other|0|||
161648939|NCT05000216|583767519|FG002|Stage 1|Other|0|||
161648940|NCT05000216|583767520|FG003|Stage 1|Other|0|||
161648941|NCT05000216|583767521|FG004|Stage 1|Other|1|||
161648942|NCT05000216|583767522|FG005|Stage 1|Other|0|||
161648943|NCT05000216|583767523|FG006|Stage 1|Other|0|||
161648944|NCT05000216|583767524|FG007|Stage 1|Other|2|||
161648945|NCT05000216|583767525|FG008|Stage 1|Other|0|||
161648946|NCT05000216|583767526|FG009|Stage 1|Other|0|||
161648947|NCT05000216|583767527|FG010|Stage 1|Other|1|||
161648948|NCT05000216|583767528|FG011|Stage 1|Other|1|||
161648949|NCT05000216|583767529|FG012|Stage 1|Other|0|||
161648950|NCT05000216|583767530|FG013|Stage 1|Other|0|||
161648951|NCT05000216|583767531|FG014|Stage 1|Other|0|||
161648952|NCT05000216|583767532|FG015|Stage 1|Other|0|||
161648953|NCT05000216|583767533|FG016|Stage 1|Other|0|||
161648954|NCT05000216|583767534|FG017|Stage 1|Other|0|||
161648955|NCT05000216|583767535|FG018|Stage 1|Other|0|||
161648956|NCT05000216|583767536|FG019|Stage 1|Other|0|||
161648957|NCT05000216|583767537|FG020|Stage 1|Other|0|||
161648958|NCT05000216|583767538|FG021|Stage 1|Other|0|||
161648959|NCT05000216|583767517|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
161648960|NCT05000216|583767518|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
161648961|NCT05000216|583767519|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
161648962|NCT05000216|583767520|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
161648963|NCT05000216|583767521|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
161648964|NCT05000216|583767522|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
161648965|NCT05000216|583767523|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
161648966|NCT05000216|583767524|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
161648967|NCT05000216|583767525|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
161648968|NCT05000216|583767526|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
161648969|NCT05000216|583767527|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
161648970|NCT05000216|583767528|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
161648971|NCT05000216|583767529|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
161648972|NCT05000216|583767530|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
161648973|NCT05000216|583767531|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
161648974|NCT05000216|583767532|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
161648975|NCT05000216|583767533|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
161648976|NCT05000216|583767534|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
161648977|NCT05000216|583767535|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
161648978|NCT05000216|583767536|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
161648979|NCT05000216|583767537|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
161648980|NCT05000216|583767538|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
161648981|NCT05000216|583767517|FG000|Stage 2|Lost to Follow-up|0|||
161648982|NCT05000216|583767518|FG001|Stage 2|Lost to Follow-up|0|||
161648983|NCT05000216|583767519|FG002|Stage 2|Lost to Follow-up|0|||
161648984|NCT05000216|583767520|FG003|Stage 2|Lost to Follow-up|0|||
161648985|NCT05000216|583767521|FG004|Stage 2|Lost to Follow-up|0|||
161648986|NCT05000216|583767522|FG005|Stage 2|Lost to Follow-up|0|||
161648987|NCT05000216|583767523|FG006|Stage 2|Lost to Follow-up|0|||
161648988|NCT05000216|583767524|FG007|Stage 2|Lost to Follow-up|0|||
161648989|NCT05000216|583767525|FG008|Stage 2|Lost to Follow-up|0|||
161648990|NCT05000216|583767526|FG009|Stage 2|Lost to Follow-up|0|||
161648991|NCT05000216|583767527|FG010|Stage 2|Lost to Follow-up|0|||
161648992|NCT05000216|583767528|FG011|Stage 2|Lost to Follow-up|0|||
161648993|NCT05000216|583767529|FG012|Stage 2|Lost to Follow-up|0|||
161648994|NCT05000216|583767530|FG013|Stage 2|Lost to Follow-up|0|||
161648995|NCT05000216|583767531|FG014|Stage 2|Lost to Follow-up|0|||
161648996|NCT05000216|583767532|FG015|Stage 2|Lost to Follow-up|0|||
161648997|NCT05000216|583767533|FG016|Stage 2|Lost to Follow-up|4|||
161648998|NCT05000216|583767534|FG017|Stage 2|Lost to Follow-up|0|||
161648999|NCT05000216|583767535|FG018|Stage 2|Lost to Follow-up|0|||
161649000|NCT05000216|583767536|FG019|Stage 2|Lost to Follow-up|0|||
161649001|NCT05000216|583767537|FG020|Stage 2|Lost to Follow-up|0|||
161649002|NCT05000216|583767538|FG021|Stage 2|Lost to Follow-up|0|||
161649003|NCT05000216|583767517|FG000|Stage 2|Physician Decision|0|||
161649004|NCT05000216|583767518|FG001|Stage 2|Physician Decision|0|||
161649005|NCT05000216|583767519|FG002|Stage 2|Physician Decision|0|||
161649006|NCT05000216|583767520|FG003|Stage 2|Physician Decision|0|||
161649007|NCT05000216|583767521|FG004|Stage 2|Physician Decision|0|||
161649008|NCT05000216|583767522|FG005|Stage 2|Physician Decision|0|||
161649009|NCT05000216|583767523|FG006|Stage 2|Physician Decision|0|||
161649010|NCT05000216|583767524|FG007|Stage 2|Physician Decision|0|||
161649011|NCT05000216|583767525|FG008|Stage 2|Physician Decision|0|||
161649012|NCT05000216|583767526|FG009|Stage 2|Physician Decision|0|||
161649013|NCT05000216|583767527|FG010|Stage 2|Physician Decision|0|||
161649014|NCT05000216|583767528|FG011|Stage 2|Physician Decision|0|||
161649015|NCT05000216|583767529|FG012|Stage 2|Physician Decision|1|||
161649016|NCT05000216|583767530|FG013|Stage 2|Physician Decision|0|||
161649017|NCT05000216|583767531|FG014|Stage 2|Physician Decision|0|||
161649018|NCT05000216|583767532|FG015|Stage 2|Physician Decision|0|||
161649019|NCT05000216|583767533|FG016|Stage 2|Physician Decision|0|||
161649020|NCT05000216|583767534|FG017|Stage 2|Physician Decision|0|||
161649021|NCT05000216|583767535|FG018|Stage 2|Physician Decision|0|||
161649022|NCT05000216|583767536|FG019|Stage 2|Physician Decision|0|||
161649023|NCT05000216|583767537|FG020|Stage 2|Physician Decision|0|||
161649024|NCT05000216|583767538|FG021|Stage 2|Physician Decision|0|||
161649025|NCT05000216|583767517|FG000|Stage 2|Withdrawal by Subject|0|||
161649026|NCT05000216|583767518|FG001|Stage 2|Withdrawal by Subject|0|||
161649027|NCT05000216|583767519|FG002|Stage 2|Withdrawal by Subject|0|||
161649028|NCT05000216|583767520|FG003|Stage 2|Withdrawal by Subject|0|||
161649029|NCT05000216|583767521|FG004|Stage 2|Withdrawal by Subject|0|||
161649030|NCT05000216|583767522|FG005|Stage 2|Withdrawal by Subject|0|||
161649031|NCT05000216|583767523|FG006|Stage 2|Withdrawal by Subject|0|||
161649032|NCT05000216|583767524|FG007|Stage 2|Withdrawal by Subject|0|||
161649033|NCT05000216|583767525|FG008|Stage 2|Withdrawal by Subject|0|||
161649034|NCT05000216|583767526|FG009|Stage 2|Withdrawal by Subject|0|||
161649035|NCT05000216|583767527|FG010|Stage 2|Withdrawal by Subject|0|||
161649036|NCT05000216|583767528|FG011|Stage 2|Withdrawal by Subject|0|||
161649037|NCT05000216|583767529|FG012|Stage 2|Withdrawal by Subject|0|||
161649038|NCT05000216|583767530|FG013|Stage 2|Withdrawal by Subject|0|||
161649039|NCT05000216|583767531|FG014|Stage 2|Withdrawal by Subject|2|||
161649040|NCT05000216|583767532|FG015|Stage 2|Withdrawal by Subject|0|||
161649041|NCT05000216|583767533|FG016|Stage 2|Withdrawal by Subject|9|||
161649042|NCT05000216|583767534|FG017|Stage 2|Withdrawal by Subject|0|||
161649043|NCT05000216|583767535|FG018|Stage 2|Withdrawal by Subject|0|||
161649044|NCT05000216|583767536|FG019|Stage 2|Withdrawal by Subject|0|||
161649045|NCT05000216|583767537|FG020|Stage 2|Withdrawal by Subject|0|||
161649046|NCT05000216|583767538|FG021|Stage 2|Withdrawal by Subject|0|||
161649047|NCT05000216|583767517|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
161649048|NCT05000216|583767518|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
161649049|NCT05000216|583767519|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
161649050|NCT05000216|583767520|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
161649051|NCT05000216|583767521|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
161649052|NCT05000216|583767522|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
161649053|NCT05000216|583767523|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
161649054|NCT05000216|583767524|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
161649055|NCT05000216|583767525|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
161649056|NCT05000216|583767526|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
161649057|NCT05000216|583767527|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
161649058|NCT05000216|583767528|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
161649059|NCT05000216|583767529|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
161649060|NCT05000216|583767530|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
161649061|NCT05000216|583767531|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
161649062|NCT05000216|583767532|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
161649063|NCT05000216|583767533|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
161649064|NCT05000216|583767534|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
161688680|NCT01661140|583911693|FG002|Double-Blind Period|Administrative/Other|6|||
161836038|NCT01698775|584440869|FG000|Phase A|Withdrawal by Subject|3|||
161836039|NCT01698775|584440870|FG001|Phase A|Withdrawal by Subject|4|||
161836040|NCT01698775|584440869|FG000|Phase A|Kidney [transplant]|0|||
161836041|NCT01698775|584440870|FG001|Phase A|Kidney [transplant]|1|||
161649065|NCT05000216|583767535|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
161649066|NCT05000216|583767536|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
161649067|NCT05000216|583767537|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
161649068|NCT05000216|583767538|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
161649069|NCT05000216|583767517|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649070|NCT05000216|583767518|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649071|NCT05000216|583767519|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649072|NCT05000216|583767520|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649073|NCT05000216|583767521|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649074|NCT05000216|583767522|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649075|NCT05000216|583767523|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161836042|NCT01698775|584440869|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
161649076|NCT05000216|583767524|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649077|NCT05000216|583767525|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649078|NCT05000216|583767526|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649079|NCT05000216|583767527|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649080|NCT05000216|583767528|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649081|NCT05000216|583767529|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649082|NCT05000216|583767530|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649083|NCT05000216|583767531|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
161649084|NCT05000216|583767532|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649085|NCT05000216|583767533|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
161649086|NCT05000216|583767534|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649087|NCT05000216|583767535|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649088|NCT05000216|583767536|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649089|NCT05000216|583767537|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649090|NCT05000216|583767538|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161649091|NCT05000216|583767517|FG000|Stage 2|Other reason|0|||
161649092|NCT05000216|583767518|FG001|Stage 2|Other reason|0|||
161649093|NCT05000216|583767519|FG002|Stage 2|Other reason|0|||
161649094|NCT05000216|583767520|FG003|Stage 2|Other reason|0|||
161649095|NCT05000216|583767521|FG004|Stage 2|Other reason|0|||
161649096|NCT05000216|583767522|FG005|Stage 2|Other reason|0|||
161649097|NCT05000216|583767523|FG006|Stage 2|Other reason|0|||
161649098|NCT05000216|583767524|FG007|Stage 2|Other reason|0|||
161649099|NCT05000216|583767525|FG008|Stage 2|Other reason|0|||
161649100|NCT05000216|583767526|FG009|Stage 2|Other reason|0|||
161649101|NCT05000216|583767527|FG010|Stage 2|Other reason|0|||
161649102|NCT05000216|583767528|FG011|Stage 2|Other reason|0|||
161649103|NCT05000216|583767529|FG012|Stage 2|Other reason|0|||
161649104|NCT05000216|583767530|FG013|Stage 2|Other reason|0|||
161649105|NCT05000216|583767531|FG014|Stage 2|Other reason|0|||
161649106|NCT05000216|583767532|FG015|Stage 2|Other reason|0|||
161649107|NCT05000216|583767533|FG016|Stage 2|Other reason|1|||
161649108|NCT05000216|583767534|FG017|Stage 2|Other reason|0|||
161649109|NCT05000216|583767535|FG018|Stage 2|Other reason|0|||
161649110|NCT05000216|583767536|FG019|Stage 2|Other reason|0|||
161649111|NCT05000216|583767537|FG020|Stage 2|Other reason|0|||
161649112|NCT05000216|583767538|FG021|Stage 2|Other reason|0|||
161649113|NCT05000216|583767517|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
161649114|NCT05000216|583767518|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
161649115|NCT05000216|583767519|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
161649116|NCT05000216|583767520|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
161649117|NCT05000216|583767521|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
161649118|NCT05000216|583767522|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
161649119|NCT05000216|583767523|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
161649120|NCT05000216|583767524|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
161649121|NCT05000216|583767525|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
161649122|NCT05000216|583767526|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
161649123|NCT05000216|583767527|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
161649124|NCT05000216|583767528|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
161649125|NCT05000216|583767529|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
161649126|NCT05000216|583767530|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
161688681|NCT02239939|583911694|FG000|Overall Study|Adverse Event|1|||
161688682|NCT02239939|583911695|FG001|Overall Study|Adverse Event|0|||
161688683|NCT02239939|583911694|FG000|Overall Study|Withdrawal by Subject|1|||
161688684|NCT02239939|583911695|FG001|Overall Study|Withdrawal by Subject|1|||
161688685|NCT02239939|583911694|FG000|Overall Study|Lost to Follow-up|0|||
161836043|NCT01698775|584440870|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
161836044|NCT01698775|584440869|FG000|Phase B|Adverse Event|6|||
161836045|NCT01698775|584440870|FG001|Phase B|Adverse Event|3|||
161836046|NCT01698775|584440869|FG000|Phase B|Death|0|||
161649127|NCT05000216|583767531|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
161649128|NCT05000216|583767532|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
161649129|NCT05000216|583767533|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
161649130|NCT05000216|583767534|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
161649131|NCT05000216|583767535|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
161649132|NCT05000216|583767536|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
161649133|NCT05000216|583767537|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
161649134|NCT05000216|583767538|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
161649135|NCT05000216|583767517|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649136|NCT05000216|583767518|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649137|NCT05000216|583767519|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649138|NCT05000216|583767520|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649139|NCT05000216|583767521|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649140|NCT05000216|583767522|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649141|NCT05000216|583767523|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649142|NCT05000216|583767524|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649143|NCT05000216|583767525|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649144|NCT05000216|583767526|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
161688686|NCT02239939|583911695|FG001|Overall Study|Lost to Follow-up|1|||
161836047|NCT01698775|584440870|FG001|Phase B|Death|1|||
161649145|NCT05000216|583767527|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649146|NCT05000216|583767528|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649147|NCT05000216|583767529|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649148|NCT05000216|583767530|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649149|NCT05000216|583767531|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649150|NCT05000216|583767532|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
161649151|NCT05000216|583767533|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649152|NCT05000216|583767534|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649153|NCT05000216|583767535|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649154|NCT05000216|583767536|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649155|NCT05000216|583767537|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649156|NCT05000216|583767538|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
161649157|NCT05000216|583767517|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649158|NCT05000216|583767518|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649159|NCT05000216|583767519|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649160|NCT05000216|583767520|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649161|NCT05000216|583767521|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649162|NCT05000216|583767522|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649163|NCT05000216|583767523|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649164|NCT05000216|583767524|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649165|NCT05000216|583767525|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649166|NCT05000216|583767526|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649167|NCT05000216|583767527|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649168|NCT05000216|583767528|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649169|NCT05000216|583767529|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649170|NCT05000216|583767530|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
161649171|NCT05000216|583767531|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649172|NCT05000216|583767532|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
161649173|NCT05000216|583767533|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649174|NCT05000216|583767534|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649175|NCT05000216|583767535|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
161649176|NCT05000216|583767536|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649177|NCT05000216|583767537|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649178|NCT05000216|583767538|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161649179|NCT04481373|583767539|FG000|Overall Study|Protocol Violation|1|||
161649180|NCT04481373|583767540|FG001|Overall Study|Protocol Violation|0|||
161649181|NCT04481373|583767539|FG000|Overall Study|Viral load in hospital not over 1000|2|||
161649182|NCT04481373|583767540|FG001|Overall Study|Viral load in hospital not over 1000|1|||
161836048|NCT01698775|584440869|FG000|Phase B|Lack of Efficacy|0|||
161836049|NCT01698775|584440870|FG001|Phase B|Lack of Efficacy|1|||
161836050|NCT01698775|584440869|FG000|Phase B|Lost to Follow-up|0|||
161649183|NCT04481373|583767539|FG000|Overall Study|Death before hospital discharge|1|||
161649184|NCT04481373|583767540|FG001|Overall Study|Death before hospital discharge|0|||
161649185|NCT02057575|583767542|FG000|Overall Study|Adverse Event|0|||
161649186|NCT02057575|583767543|FG001|Overall Study|Adverse Event|2|||
161649187|NCT02057575|583767544|FG002|Overall Study|Adverse Event|0|||
161649188|NCT02057575|583767545|FG003|Overall Study|Adverse Event|1|||
161649189|NCT02057575|583767542|FG000|Overall Study|Withdrawal by Subject|1|||
161649190|NCT02057575|583767543|FG001|Overall Study|Withdrawal by Subject|0|||
161649191|NCT02057575|583767544|FG002|Overall Study|Withdrawal by Subject|0|||
161649192|NCT02057575|583767545|FG003|Overall Study|Withdrawal by Subject|0|||
161649193|NCT02057575|583767542|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
161649194|NCT02057575|583767543|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
161649195|NCT02057575|583767544|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
161649196|NCT02057575|583767545|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
161649197|NCT02057575|583767542|FG000|Overall Study|Protocol Violation|0|||
161649198|NCT02057575|583767543|FG001|Overall Study|Protocol Violation|1|||
161649199|NCT02057575|583767544|FG002|Overall Study|Protocol Violation|0|||
161649200|NCT02057575|583767545|FG003|Overall Study|Protocol Violation|0|||
161649201|NCT00332462|583767546|FG000|Overall Study|Adverse Event|5|||
161649202|NCT00332462|583767546|FG000|Overall Study|Abnormal Lab Value|1|||
161649203|NCT00332462|583767546|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161836051|NCT01698775|584440870|FG001|Phase B|Lost to Follow-up|1|||
161836052|NCT01698775|584440869|FG000|Phase B|Physician Decision|1|||
161649204|NCT00332462|583767546|FG000|Overall Study|no longer requires study drug|1|||
161649205|NCT00332462|583767546|FG000|Overall Study|Death|3|||
161649206|NCT00332462|583767546|FG000|Overall Study|Graft Loss|2|||
161649207|NCT02979249|583767550|FG000|Overall Study|Lost to Follow-up|2|||
161836053|NCT01698775|584440870|FG001|Phase B|Physician Decision|1|||
161649208|NCT02979249|583767550|FG000|Overall Study|Withdrawal by Subject|4|||
161649209|NCT01125046|583767551|FG000|First 6 Months of Treatment|Death|1|||
161836054|NCT01698775|584440869|FG000|Phase B|Protocol Violation|1|||
161649210|NCT01125046|583767551|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
161649211|NCT01125046|583767551|FG000|First 6 Months of Treatment|Non-compliance|1|||
161649212|NCT01125046|583767551|FG000|First 6 Months of Treatment|Surgery|1|||
161649213|NCT01125046|583767551|FG000|First 6 Months of Treatment|Progressive Disease|7|||
161649214|NCT01125046|583767551|FG000|First 6 Months of Treatment|Adverse Event|2|||
161649215|NCT01125046|583767551|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
161649216|NCT01125046|583767551|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
161649217|NCT01125046|583767551|FG000|Follow-up/Data Cut Off Point|Death|29|||
161649218|NCT01125046|583767551|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
161649219|NCT01685229|583767552|FG000|Overall Study|Subjects missing Study Exit form|3|||
161649220|NCT01685229|583767553|FG001|Overall Study|Subjects missing Study Exit form|1|||
161649221|NCT01685229|583767552|FG000|Overall Study|Lost to Follow-up|16|||
161649222|NCT01685229|583767553|FG001|Overall Study|Lost to Follow-up|10|||
161649223|NCT01685229|583767552|FG000|Overall Study|Withdrawal by Subject|6|||
161649224|NCT01685229|583767553|FG001|Overall Study|Withdrawal by Subject|5|||
161649225|NCT01685229|583767552|FG000|Overall Study|Death|1|||
161649226|NCT01685229|583767553|FG001|Overall Study|Death|0|||
161649227|NCT01853475|583767568|FG000|Overall Study|Withdrawal by Subject|0|||
161649228|NCT01853475|583767569|FG001|Overall Study|Withdrawal by Subject|1|||
161649229|NCT01853475|583767570|FG002|Overall Study|Withdrawal by Subject|0|||
161649230|NCT00659880|583767571|FG000|Overall Study|Lost to Follow-up|5|||
161649231|NCT02159040|583767572|FG000|Overall Study|Death|1|||
161649232|NCT02766777|583767576|FG000|Overall Study|Adverse Event|12|||
161649233|NCT02766777|583767576|FG000|Overall Study|Lost to Follow-up|16|||
161649234|NCT02766777|583767576|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161649235|NCT02766777|583767576|FG000|Overall Study|Protocol Violation|1|||
161649236|NCT02766777|583767576|FG000|Overall Study|Withdrawal by Subject|4|||
161649237|NCT01886287|583767577|FG000|Overall Study|Radiographic disease progression|1|||
161649238|NCT01886287|583767577|FG000|Overall Study|Clinical progression due to disease|1|||
161649239|NCT02964325|583767578|FG000|Overall Study|Lost to Follow-up|3|||
161649240|NCT02964325|583767579|FG001|Overall Study|Lost to Follow-up|3|||
161649241|NCT02964325|583767578|FG000|Overall Study|Physician Decision|5|||
161649242|NCT02964325|583767579|FG001|Overall Study|Physician Decision|4|||
161649243|NCT02964325|583767578|FG000|Overall Study|Death|1|||
161649244|NCT02964325|583767579|FG001|Overall Study|Death|3|||
161649245|NCT02964325|583767578|FG000|Overall Study|Withdrawal by Subject|2|||
161649246|NCT02964325|583767579|FG001|Overall Study|Withdrawal by Subject|1|||
161649247|NCT02964325|583767578|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
161649248|NCT02964325|583767579|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
161649249|NCT03596762|583767580|FG000|Overall Study|Protocol Violation|0|||
161649250|NCT03596762|583767581|FG001|Overall Study|Protocol Violation|0|||
161649251|NCT03596762|583767582|FG002|Overall Study|Protocol Violation|0|||
161649252|NCT03596762|583767583|FG003|Overall Study|Protocol Violation|0|||
161649253|NCT03596762|583767584|FG004|Overall Study|Protocol Violation|1|||
161649254|NCT03596762|583767580|FG000|Overall Study|Adverse Event|2|||
161649255|NCT03596762|583767581|FG001|Overall Study|Adverse Event|0|||
161649256|NCT03596762|583767582|FG002|Overall Study|Adverse Event|1|||
161649257|NCT03596762|583767583|FG003|Overall Study|Adverse Event|0|||
161649258|NCT03596762|583767584|FG004|Overall Study|Adverse Event|5|||
161649259|NCT03596762|583767580|FG000|Overall Study|Withdrawal by Subject|2|||
161649260|NCT03596762|583767581|FG001|Overall Study|Withdrawal by Subject|1|||
161649261|NCT03596762|583767582|FG002|Overall Study|Withdrawal by Subject|0|||
161649262|NCT03596762|583767583|FG003|Overall Study|Withdrawal by Subject|1|||
161649263|NCT03596762|583767584|FG004|Overall Study|Withdrawal by Subject|1|||
161649264|NCT02510040|583767585|FG000|Overall Study|Deemed no longer eligible|18|||
161649265|NCT02510040|583767586|FG001|Overall Study|Deemed no longer eligible|3|||
161649266|NCT02510040|583767587|FG002|Overall Study|Deemed no longer eligible|1|||
161649267|NCT03842228|583767588|FG000|Overall Study|Adverse Event|1|||
161649268|NCT03842228|583767589|FG001|Overall Study|Adverse Event|1|||
161649269|NCT03842228|583767590|FG002|Overall Study|Adverse Event|1|||
161649270|NCT03842228|583767591|FG003|Overall Study|Adverse Event|0|||
161649271|NCT03842228|583767592|FG004|Overall Study|Adverse Event|0|||
161649272|NCT03842228|583767593|FG005|Overall Study|Adverse Event|0|||
161649273|NCT03842228|583767594|FG006|Overall Study|Adverse Event|0|||
161649274|NCT03842228|583767588|FG000|Overall Study|Death|0|||
161649275|NCT03842228|583767589|FG001|Overall Study|Death|1|||
161649276|NCT03842228|583767590|FG002|Overall Study|Death|0|||
161649277|NCT03842228|583767591|FG003|Overall Study|Death|0|||
161649278|NCT03842228|583767592|FG004|Overall Study|Death|0|||
161649279|NCT03842228|583767593|FG005|Overall Study|Death|0|||
161649280|NCT03842228|583767594|FG006|Overall Study|Death|0|||
161649281|NCT03842228|583767588|FG000|Overall Study|Withdrawal by Subject|0|||
161649282|NCT03842228|583767589|FG001|Overall Study|Withdrawal by Subject|0|||
161649283|NCT03842228|583767590|FG002|Overall Study|Withdrawal by Subject|2|||
161649284|NCT03842228|583767591|FG003|Overall Study|Withdrawal by Subject|1|||
161649285|NCT03842228|583767592|FG004|Overall Study|Withdrawal by Subject|0|||
161649286|NCT03842228|583767593|FG005|Overall Study|Withdrawal by Subject|0|||
161649287|NCT03842228|583767594|FG006|Overall Study|Withdrawal by Subject|2|||
161649288|NCT03842228|583767588|FG000|Overall Study|Progression|8|||
161649289|NCT03842228|583767589|FG001|Overall Study|Progression|1|||
161649290|NCT03842228|583767590|FG002|Overall Study|Progression|7|||
161649291|NCT03842228|583767591|FG003|Overall Study|Progression|5|||
161649292|NCT03842228|583767592|FG004|Overall Study|Progression|4|||
161649293|NCT03842228|583767593|FG005|Overall Study|Progression|2|||
161649294|NCT03842228|583767594|FG006|Overall Study|Progression|3|||
161649295|NCT02195479|583767607|FG000|Overall Study|Lost to Follow-up|18|||
161649296|NCT02195479|583767608|FG001|Overall Study|Lost to Follow-up|15|||
161649297|NCT02195479|583767607|FG000|Overall Study|Death|217|||
161649298|NCT02195479|583767608|FG001|Overall Study|Death|171|||
161649299|NCT02195479|583767607|FG000|Overall Study|Physician Decision|1|||
161649300|NCT02195479|583767608|FG001|Overall Study|Physician Decision|0|||
161649301|NCT02195479|583767607|FG000|Overall Study|Withdrawal by Subject|30|||
161649302|NCT02195479|583767608|FG001|Overall Study|Withdrawal by Subject|30|||
161649303|NCT02195479|583767607|FG000|Overall Study|Other|3|||
161649304|NCT02195479|583767608|FG001|Overall Study|Other|4|||
161649305|NCT02195479|583767607|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
161649306|NCT02195479|583767608|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
161649307|NCT01834586|583767609|FG000|Overall Study|Adverse Event|1|||
161649308|NCT01263509|583767612|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
161649309|NCT01263509|583767613|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
161649310|NCT01263509|583767614|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
161649311|NCT01263509|583767615|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
161649312|NCT01263509|583767612|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161649313|NCT01263509|583767613|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
161649314|NCT01263509|583767614|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161649315|NCT01263509|583767615|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161649316|NCT01263509|583767612|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161649317|NCT01263509|583767613|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161649318|NCT01263509|583767614|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161649319|NCT01263509|583767615|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161649320|NCT01263509|583767612|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
161649321|NCT01263509|583767613|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
161649322|NCT01263509|583767614|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161649323|NCT01263509|583767615|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161649324|NCT01263509|583767612|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
161649325|NCT01263509|583767613|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
161649326|NCT01263509|583767614|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
161649327|NCT01263509|583767615|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
161649328|NCT01371825|583767623|FG000|Overall Study|Death|4|||
161649329|NCT00895895|583767624|FG000|Period 1|Adverse Event|7|||
161649330|NCT00895895|583767625|FG001|Period 1|Adverse Event|6|||
161649331|NCT00895895|583767626|FG002|Period 1|Adverse Event|4|||
161649332|NCT00895895|583767627|FG003|Period 1|Adverse Event|6|||
161649333|NCT00895895|583767628|FG004|Period 1|Adverse Event|7|||
161649334|NCT00895895|583767624|FG000|Period 1|Death|0|||
161649335|NCT00895895|583767625|FG001|Period 1|Death|0|||
161649336|NCT00895895|583767626|FG002|Period 1|Death|0|||
161649337|NCT00895895|583767627|FG003|Period 1|Death|0|||
161649338|NCT00895895|583767628|FG004|Period 1|Death|1|||
161649339|NCT00895895|583767624|FG000|Period 1|discontinued by sponsor|2|||
161649340|NCT00895895|583767625|FG001|Period 1|discontinued by sponsor|1|||
161649341|NCT00895895|583767626|FG002|Period 1|discontinued by sponsor|2|||
161649342|NCT00895895|583767627|FG003|Period 1|discontinued by sponsor|1|||
161649343|NCT00895895|583767628|FG004|Period 1|discontinued by sponsor|1|||
161649344|NCT00895895|583767624|FG000|Period 1|failed to return|0|||
161649345|NCT00895895|583767625|FG001|Period 1|failed to return|0|||
161649346|NCT00895895|583767626|FG002|Period 1|failed to return|1|||
161649347|NCT00895895|583767627|FG003|Period 1|failed to return|0|||
161649348|NCT00895895|583767628|FG004|Period 1|failed to return|1|||
161688687|NCT05594173|583911699|FG000|Overall Study|Adverse Event|1|||
161688688|NCT05594173|583911699|FG000|Overall Study|COVID-19 Pandemic|2|||
161688689|NCT00763139|583911700|FG000|Overall Study|Adverse Event|4|||
161688690|NCT00763139|583911701|FG001|Overall Study|Adverse Event|2|||
161649349|NCT00895895|583767624|FG000|Period 1|investigator request|0|||
161649350|NCT00895895|583767625|FG001|Period 1|investigator request|1|||
161649351|NCT00895895|583767626|FG002|Period 1|investigator request|0|||
161649352|NCT00895895|583767627|FG003|Period 1|investigator request|0|||
161649353|NCT00895895|583767628|FG004|Period 1|investigator request|0|||
161649354|NCT00895895|583767624|FG000|Period 1|Lost to Follow-up|2|||
161649355|NCT00895895|583767625|FG001|Period 1|Lost to Follow-up|1|||
161649356|NCT00895895|583767626|FG002|Period 1|Lost to Follow-up|3|||
161649357|NCT00895895|583767627|FG003|Period 1|Lost to Follow-up|2|||
161836055|NCT01698775|584440870|FG001|Phase B|Protocol Violation|1|||
161688691|NCT00763139|583911700|FG000|Overall Study|Withdrawal by Subject|0|||
161688692|NCT00763139|583911701|FG001|Overall Study|Withdrawal by Subject|1|||
161688693|NCT00763139|583911700|FG000|Overall Study|med change not allowed by protocol|1|||
161688694|NCT00763139|583911701|FG001|Overall Study|med change not allowed by protocol|0|||
161688695|NCT05634577|583911702|FG000|Overall Study|Lost to Follow-up|1|||
161649358|NCT00895895|583767628|FG004|Period 1|Lost to Follow-up|3|||
161649359|NCT00895895|583767624|FG000|Period 1|Other|1|||
161649360|NCT00895895|583767625|FG001|Period 1|Other|2|||
161649361|NCT00895895|583767626|FG002|Period 1|Other|1|||
161649362|NCT00895895|583767627|FG003|Period 1|Other|1|||
161649363|NCT00895895|583767628|FG004|Period 1|Other|1|||
161649364|NCT00895895|583767624|FG000|Period 1|Protocol Violation|0|||
161649365|NCT00895895|583767625|FG001|Period 1|Protocol Violation|1|||
161649366|NCT00895895|583767626|FG002|Period 1|Protocol Violation|0|||
161649367|NCT00895895|583767627|FG003|Period 1|Protocol Violation|0|||
161649368|NCT00895895|583767628|FG004|Period 1|Protocol Violation|0|||
161649369|NCT00895895|583767624|FG000|Period 1|Withdrawal by Subject|6|||
161649370|NCT00895895|583767625|FG001|Period 1|Withdrawal by Subject|6|||
161649371|NCT00895895|583767626|FG002|Period 1|Withdrawal by Subject|8|||
161649372|NCT00895895|583767627|FG003|Period 1|Withdrawal by Subject|2|||
161649373|NCT00895895|583767628|FG004|Period 1|Withdrawal by Subject|4|||
161649374|NCT00895895|583767624|FG000|Period 1|unsatisfactory response-efficacy|2|||
161649375|NCT00895895|583767625|FG001|Period 1|unsatisfactory response-efficacy|0|||
161649376|NCT00895895|583767626|FG002|Period 1|unsatisfactory response-efficacy|0|||
161649377|NCT00895895|583767627|FG003|Period 1|unsatisfactory response-efficacy|0|||
161649378|NCT00895895|583767628|FG004|Period 1|unsatisfactory response-efficacy|0|||
161649379|NCT00895895|583767624|FG000|Period 1|randomized and not treated|1|||
161649380|NCT00895895|583767625|FG001|Period 1|randomized and not treated|3|||
161649381|NCT00895895|583767626|FG002|Period 1|randomized and not treated|1|||
161649382|NCT00895895|583767627|FG003|Period 1|randomized and not treated|1|||
161649383|NCT00895895|583767628|FG004|Period 1|randomized and not treated|2|||
161649384|NCT00895895|583767624|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
161649385|NCT00895895|583767625|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
161649386|NCT00895895|583767626|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
161649387|NCT00895895|583767627|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
161649388|NCT00895895|583767628|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
161649389|NCT00895895|583767624|FG000|After Period 1, Prior to Period 2|Other|0|||
161649390|NCT00895895|583767625|FG001|After Period 1, Prior to Period 2|Other|0|||
161649391|NCT00895895|583767626|FG002|After Period 1, Prior to Period 2|Other|1|||
161688696|NCT05634577|583911702|FG000|Overall Study|Withdrawal by Subject|1|||
161688697|NCT03468309|583911703|FG000|Overall Study|Lost to Follow-up|4|||
161688698|NCT03468309|583911703|FG000|Overall Study|Withdrawal by Subject|2|||
161688699|NCT02631200|583911706|FG000|First Period|Death|1|||
161688700|NCT02631200|583911707|FG001|First Period|Death|2|||
161688701|NCT02631200|583911706|FG000|First Period|Patient ill-health|2|||
161688702|NCT02631200|583911707|FG001|First Period|Patient ill-health|4|||
161688703|NCT02631200|583911706|FG000|First Period|Withdrawal by Subject|4|||
161688704|NCT02631200|583911707|FG001|First Period|Withdrawal by Subject|1|||
161688705|NCT02631200|583911706|FG000|Deferred Period|Death|0|||
161688706|NCT02631200|583911707|FG001|Deferred Period|Death|1|||
161688707|NCT02631200|583911706|FG000|Deferred Period|Received kidney transplant|0|||
161688708|NCT02631200|583911707|FG001|Deferred Period|Received kidney transplant|1|||
161688709|NCT02631200|583911706|FG000|Deferred Period|Withdrawal by Subject|0|||
161688710|NCT02631200|583911707|FG001|Deferred Period|Withdrawal by Subject|2|||
161688711|NCT02631200|583911706|FG000|Deferred Period|Lost to Follow-up|0|||
161688712|NCT02631200|583911707|FG001|Deferred Period|Lost to Follow-up|1|||
161836056|NCT01698775|584440869|FG000|Phase B|Withdrawal by Subject|6|||
161649392|NCT00895895|583767627|FG003|After Period 1, Prior to Period 2|Other|0|||
161649393|NCT00895895|583767628|FG004|After Period 1, Prior to Period 2|Other|0|||
161649394|NCT00895895|583767624|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
161649395|NCT00895895|583767625|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
161688713|NCT03363321|583911712|FG000|Overall Study|Withdrawal by Subject|0|||
161688714|NCT03363321|583911713|FG001|Overall Study|Withdrawal by Subject|1|||
161649396|NCT00895895|583767626|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
161649397|NCT00895895|583767627|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
161688715|NCT03363321|583911714|FG002|Overall Study|Withdrawal by Subject|0|||
161688716|NCT03363321|583911715|FG003|Overall Study|Withdrawal by Subject|1|||
161688717|NCT03363321|583911716|FG004|Overall Study|Withdrawal by Subject|0|||
161688718|NCT00915681|583911717|FG000|Overall Study|Screening failures|46|||
161649398|NCT00895895|583767628|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
161649399|NCT00895895|583767624|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161649400|NCT00895895|583767625|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161649401|NCT00895895|583767626|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161649402|NCT00895895|583767627|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161649403|NCT00895895|583767628|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
161649404|NCT00895895|583767624|FG000|Period 2|Adverse Event|3|||
161649405|NCT00895895|583767625|FG001|Period 2|Adverse Event|3|||
161649406|NCT00895895|583767626|FG002|Period 2|Adverse Event|5|||
161649407|NCT00895895|583767627|FG003|Period 2|Adverse Event|2|||
161649408|NCT00895895|583767628|FG004|Period 2|Adverse Event|5|||
161649409|NCT00895895|583767624|FG000|Period 2|Death|0|||
161649410|NCT00895895|583767625|FG001|Period 2|Death|0|||
161649411|NCT00895895|583767626|FG002|Period 2|Death|1|||
161649412|NCT00895895|583767627|FG003|Period 2|Death|0|||
161649413|NCT00895895|583767628|FG004|Period 2|Death|0|||
161649414|NCT00895895|583767624|FG000|Period 2|discontinued by sponsor|44|||
161649415|NCT00895895|583767625|FG001|Period 2|discontinued by sponsor|44|||
161649416|NCT00895895|583767626|FG002|Period 2|discontinued by sponsor|38|||
161649417|NCT00895895|583767627|FG003|Period 2|discontinued by sponsor|46|||
161649418|NCT00895895|583767628|FG004|Period 2|discontinued by sponsor|37|||
161649419|NCT00895895|583767624|FG000|Period 2|failed to return|2|||
161649420|NCT00895895|583767625|FG001|Period 2|failed to return|0|||
161649421|NCT00895895|583767626|FG002|Period 2|failed to return|0|||
161649422|NCT00895895|583767627|FG003|Period 2|failed to return|0|||
161649423|NCT00895895|583767628|FG004|Period 2|failed to return|0|||
161649424|NCT00895895|583767624|FG000|Period 2|investigator request|2|||
161649425|NCT00895895|583767625|FG001|Period 2|investigator request|0|||
161649426|NCT00895895|583767626|FG002|Period 2|investigator request|0|||
161649427|NCT00895895|583767627|FG003|Period 2|investigator request|0|||
161649428|NCT00895895|583767628|FG004|Period 2|investigator request|0|||
161649429|NCT00895895|583767624|FG000|Period 2|Lost to Follow-up|1|||
161649430|NCT00895895|583767625|FG001|Period 2|Lost to Follow-up|2|||
161649431|NCT00895895|583767626|FG002|Period 2|Lost to Follow-up|1|||
161649432|NCT00895895|583767627|FG003|Period 2|Lost to Follow-up|1|||
161649433|NCT00895895|583767628|FG004|Period 2|Lost to Follow-up|0|||
161649434|NCT00895895|583767624|FG000|Period 2|Other|1|||
161649435|NCT00895895|583767625|FG001|Period 2|Other|1|||
161649436|NCT00895895|583767626|FG002|Period 2|Other|3|||
161649437|NCT00895895|583767627|FG003|Period 2|Other|1|||
161649438|NCT00895895|583767628|FG004|Period 2|Other|1|||
161649439|NCT00895895|583767624|FG000|Period 2|Protocol Violation|1|||
161649440|NCT00895895|583767625|FG001|Period 2|Protocol Violation|0|||
161649441|NCT00895895|583767626|FG002|Period 2|Protocol Violation|1|||
161649442|NCT00895895|583767627|FG003|Period 2|Protocol Violation|1|||
161649443|NCT00895895|583767628|FG004|Period 2|Protocol Violation|1|||
161649444|NCT00895895|583767624|FG000|Period 2|Withdrawal by Subject|0|||
161649445|NCT00895895|583767625|FG001|Period 2|Withdrawal by Subject|2|||
161649446|NCT00895895|583767626|FG002|Period 2|Withdrawal by Subject|0|||
161649447|NCT00895895|583767627|FG003|Period 2|Withdrawal by Subject|3|||
161649448|NCT00895895|583767628|FG004|Period 2|Withdrawal by Subject|5|||
161649449|NCT00895895|583767624|FG000|Period 2|unsatisfactory response-efficacy|2|||
161649450|NCT00895895|583767625|FG001|Period 2|unsatisfactory response-efficacy|1|||
161649451|NCT00895895|583767626|FG002|Period 2|unsatisfactory response-efficacy|0|||
161649452|NCT00895895|583767627|FG003|Period 2|unsatisfactory response-efficacy|0|||
161649453|NCT00895895|583767628|FG004|Period 2|unsatisfactory response-efficacy|0|||
161836057|NCT01698775|584440870|FG001|Phase B|Withdrawal by Subject|2|||
161649454|NCT03019640|583767629|FG000|Overall Study|Screen Failures|4|||
161649455|NCT03019640|583767629|FG000|Overall Study|Adverse Event|3|||
161649456|NCT03019640|583767629|FG000|Overall Study|Participant Relapsed|1|||
161649457|NCT01889069|583767632|FG000|Overall Study|Death|18|||
161649458|NCT01889069|583767632|FG000|Overall Study|Progression of Disease|14|||
161649459|NCT01889069|583767632|FG000|Overall Study|Lost to Follow-up|6|||
161649460|NCT01889069|583767632|FG000|Overall Study|Other|4|||
161649461|NCT01889069|583767632|FG000|Overall Study|Consent Withdrawal|3|||
161649462|NCT01426347|583767636|FG000|Overall Study|Lost to Follow-up|0|||
161649463|NCT01426347|583767637|FG001|Overall Study|Lost to Follow-up|3|||
161649464|NCT01426347|583767636|FG000|Overall Study|Protocol Violation|2|||
161649465|NCT01426347|583767637|FG001|Overall Study|Protocol Violation|0|||
161649466|NCT01426347|583767636|FG000|Overall Study|Withdrawal by Subject|5|||
161649467|NCT01426347|583767637|FG001|Overall Study|Withdrawal by Subject|0|||
161649468|NCT00455741|583767638|FG000|Overall Study|Physician Decision|0|||
161649469|NCT00455741|583767639|FG001|Overall Study|Physician Decision|1|||
161649470|NCT03041792|583767640|FG000|Overall Study|Adverse Event|4|||
161649471|NCT03041792|583767641|FG001|Overall Study|Adverse Event|0|||
161649472|NCT03041792|583767640|FG000|Overall Study|Death in the family|0|||
161649473|NCT03041792|583767641|FG001|Overall Study|Death in the family|2|||
161836058|NCT03864042|584440871|FG000|DDI Phase|Adverse Event|2|||
161836059|NCT03864042|584440872|FG001|DDI Phase|Adverse Event|0|||
161836060|NCT03864042|584440873|FG002|DDI Phase|Adverse Event|0|||
161836061|NCT03864042|584440871|FG000|DDI Phase|Physician Decision|1|||
161836062|NCT03864042|584440872|FG001|DDI Phase|Physician Decision|0|||
161836063|NCT03864042|584440873|FG002|DDI Phase|Physician Decision|0|||
161836064|NCT03864042|584440871|FG000|DDI Phase|Progressive Disease|1|||
161836065|NCT03864042|584440872|FG001|DDI Phase|Progressive Disease|0|||
161836066|NCT03864042|584440873|FG002|DDI Phase|Progressive Disease|0|||
161836067|NCT03864042|584440871|FG000|Post-DDI Phase|Adverse Event|5|||
161836068|NCT03864042|584440872|FG001|Post-DDI Phase|Adverse Event|3|||
161836069|NCT03864042|584440873|FG002|Post-DDI Phase|Adverse Event|2|||
161836070|NCT03864042|584440871|FG000|Post-DDI Phase|Progressive Disease|11|||
161836071|NCT03864042|584440872|FG001|Post-DDI Phase|Progressive Disease|6|||
161836072|NCT03864042|584440873|FG002|Post-DDI Phase|Progressive Disease|13|||
161836073|NCT03864042|584440871|FG000|Post-DDI Phase|Discretion of investigator|1|||
161836074|NCT03864042|584440872|FG001|Post-DDI Phase|Discretion of investigator|1|||
161836075|NCT03864042|584440873|FG002|Post-DDI Phase|Discretion of investigator|0|||
161836076|NCT03864042|584440871|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
161836077|NCT03864042|584440872|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
161836078|NCT03864042|584440873|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
161836079|NCT03864042|584440871|FG000|Post-DDI Phase|Withdrawal of consent|1|||
161836080|NCT03864042|584440872|FG001|Post-DDI Phase|Withdrawal of consent|2|||
161836081|NCT03864042|584440873|FG002|Post-DDI Phase|Withdrawal of consent|0|||
161836082|NCT00766831|584440876|FG000|Overall Study|Withdrawal by Subject|4|||
161836083|NCT00766831|584440876|FG000|Overall Study|Lost to Follow-up|3|||
161836084|NCT00766831|584440876|FG000|Overall Study|Adverse Event|20|||
161836085|NCT00766831|584440876|FG000|Overall Study|Protocol Violation|15|||
161836086|NCT00766831|584440876|FG000|Overall Study|Physician Decision|5|||
161649474|NCT03041792|583767640|FG000|Overall Study|Randomized but not treated|0|||
161649475|NCT03041792|583767641|FG001|Overall Study|Randomized but not treated|1|||
161649476|NCT04978090|583767642|FG000|Overall Study|unable to adequately fit device|2|||
161649477|NCT02227992|583767645|FG000|Overall Study|Lost to Follow-up|1|||
161649478|NCT02227992|583767646|FG001|Overall Study|Lost to Follow-up|1|||
161649479|NCT01509547|583767649|FG000|Overall Study|Lost to Follow-up|24|||
161649480|NCT01509547|583767650|FG001|Overall Study|Lost to Follow-up|14|||
161649481|NCT01509547|583767649|FG000|Overall Study|Withdrawal by Subject|11|||
161649482|NCT01509547|583767650|FG001|Overall Study|Withdrawal by Subject|24|||
161649483|NCT01509547|583767649|FG000|Overall Study|Physician Decision|0|||
161649484|NCT01509547|583767650|FG001|Overall Study|Physician Decision|1|||
161649485|NCT01371708|583767653|FG000|Overall Study|Insufficient clinical response|3|||
161649486|NCT01371708|583767654|FG001|Overall Study|Insufficient clinical response|2|||
161649487|NCT01371708|583767655|FG002|Overall Study|Insufficient clinical response|0|||
161649488|NCT01371708|583767653|FG000|Overall Study|Lost to Follow-up|5|||
161649489|NCT01371708|583767654|FG001|Overall Study|Lost to Follow-up|9|||
161649490|NCT01371708|583767655|FG002|Overall Study|Lost to Follow-up|7|||
161649491|NCT01371708|583767653|FG000|Overall Study|Protocol Violation|2|||
161649492|NCT01371708|583767654|FG001|Overall Study|Protocol Violation|1|||
161649493|NCT01371708|583767655|FG002|Overall Study|Protocol Violation|2|||
161649494|NCT01371708|583767653|FG000|Overall Study|No longer willing to participate|7|||
161649495|NCT01371708|583767654|FG001|Overall Study|No longer willing to participate|7|||
161649496|NCT01371708|583767655|FG002|Overall Study|No longer willing to participate|13|||
161649497|NCT01371708|583767653|FG000|Overall Study|Medication error/not related to AE|0|||
161649498|NCT01371708|583767654|FG001|Overall Study|Medication error/not related to AE|1|||
161649499|NCT01371708|583767655|FG002|Overall Study|Medication error/not related to AE|0|||
161649500|NCT01371708|583767653|FG000|Overall Study|Other|3|||
161649501|NCT01371708|583767654|FG001|Overall Study|Other|2|||
161649502|NCT01371708|583767655|FG002|Overall Study|Other|4|||
161649503|NCT01371708|583767653|FG000|Overall Study|Adverse Event|5|||
161649504|NCT01371708|583767654|FG001|Overall Study|Adverse Event|8|||
161649505|NCT01371708|583767655|FG002|Overall Study|Adverse Event|12|||
161649506|NCT01371708|583767653|FG000|Overall Study|Started but did not receive treatment|1|||
161649507|NCT01371708|583767654|FG001|Overall Study|Started but did not receive treatment|0|||
161649508|NCT01371708|583767655|FG002|Overall Study|Started but did not receive treatment|1|||
161836087|NCT00766831|584440876|FG000|Overall Study|Withdrawal of consent|26|||
161836088|NCT00766831|584440876|FG000|Overall Study|Non cooperation by participants|14|||
161649509|NCT02514551|583767656|FG000|Overall Study|Lost to Follow-up|0|||
161649510|NCT02514551|583767657|FG001|Overall Study|Lost to Follow-up|1|||
161649511|NCT02514551|583767656|FG000|Overall Study|Participant Never Treated|0|||
161836089|NCT00766831|584440876|FG000|Overall Study|Other|28|||
161836090|NCT00515034|584440879|FG000|Overall Study|Adverse Event|2|||
161836091|NCT00515034|584440880|FG001|Overall Study|Adverse Event|0|||
161836092|NCT00515034|584440881|FG002|Overall Study|Adverse Event|1|||
161836093|NCT00515034|584440882|FG003|Overall Study|Adverse Event|0|||
161649512|NCT02514551|583767657|FG001|Overall Study|Participant Never Treated|2|||
161649513|NCT03197766|583767668|FG000|Overall Study|Withdrawal by Subject|2|||
161649514|NCT03197766|583767669|FG001|Overall Study|Withdrawal by Subject|0|||
161649515|NCT00996606|583767670|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
161649516|NCT00996606|583767670|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161649517|NCT00996606|583767670|FG000|Overall Study|Protocol Violation|1|||
161649518|NCT00996606|583767670|FG000|Overall Study|Withdrawal by Subject|3|||
161649519|NCT02964013|583769744|FG000|Overall Study|Death|58|||
161649520|NCT02964013|583769745|FG001|Overall Study|Death|239|||
161649521|NCT02964013|583769746|FG002|Overall Study|Death|38|||
161649522|NCT02964013|583769747|FG003|Overall Study|Death|10|||
161649523|NCT02964013|583769748|FG004|Overall Study|Death|33|||
161649524|NCT02964013|583769744|FG000|Overall Study|Lost to Follow-up|1|||
161649525|NCT02964013|583769745|FG001|Overall Study|Lost to Follow-up|4|||
161649526|NCT02964013|583769746|FG002|Overall Study|Lost to Follow-up|2|||
161649527|NCT02964013|583769747|FG003|Overall Study|Lost to Follow-up|0|||
161649528|NCT02964013|583769748|FG004|Overall Study|Lost to Follow-up|0|||
161649529|NCT02964013|583769744|FG000|Overall Study|Physician Decision|0|||
161649530|NCT02964013|583769745|FG001|Overall Study|Physician Decision|1|||
161649531|NCT02964013|583769746|FG002|Overall Study|Physician Decision|0|||
161649532|NCT02964013|583769747|FG003|Overall Study|Physician Decision|0|||
161649533|NCT02964013|583769748|FG004|Overall Study|Physician Decision|0|||
161649534|NCT02964013|583769744|FG000|Overall Study|Sponsor Decision|3|||
161649535|NCT02964013|583769745|FG001|Overall Study|Sponsor Decision|22|||
161649536|NCT02964013|583769746|FG002|Overall Study|Sponsor Decision|11|||
161649537|NCT02964013|583769747|FG003|Overall Study|Sponsor Decision|0|||
161649538|NCT02964013|583769748|FG004|Overall Study|Sponsor Decision|7|||
161649539|NCT02964013|583769744|FG000|Overall Study|Withdrawal by Subject|6|||
161649540|NCT02964013|583769745|FG001|Overall Study|Withdrawal by Subject|27|||
161649541|NCT02964013|583769746|FG002|Overall Study|Withdrawal by Subject|9|||
161649542|NCT02964013|583769747|FG003|Overall Study|Withdrawal by Subject|0|||
161649543|NCT02964013|583769748|FG004|Overall Study|Withdrawal by Subject|0|||
161649544|NCT02964013|583769744|FG000|Overall Study|Not Treated|0|||
161649545|NCT02964013|583769745|FG001|Overall Study|Not Treated|2|||
161649546|NCT02964013|583769746|FG002|Overall Study|Not Treated|0|||
161649547|NCT02964013|583769747|FG003|Overall Study|Not Treated|1|||
161649548|NCT02964013|583769748|FG004|Overall Study|Not Treated|0|||
161649549|NCT01123070|583769749|FG000|Part B Double Blind Period|Protocol Violation|0|||
161649550|NCT01123070|583769750|FG001|Part B Double Blind Period|Protocol Violation|0|||
161649551|NCT01123070|583769751|FG002|Part B Double Blind Period|Protocol Violation|0|||
161649552|NCT01123070|583769752|FG003|Part B Double Blind Period|Protocol Violation|1|||
161649553|NCT01123070|583769749|FG000|Part B Double Blind Period|Adverse Event|0|||
161649554|NCT01123070|583769750|FG001|Part B Double Blind Period|Adverse Event|0|||
161649555|NCT01123070|583769751|FG002|Part B Double Blind Period|Adverse Event|2|||
161649556|NCT01123070|583769752|FG003|Part B Double Blind Period|Adverse Event|0|||
161649557|NCT01123070|583769749|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
161649558|NCT01123070|583769750|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
161649559|NCT01123070|583769751|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
161649560|NCT01123070|583769752|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
161649561|NCT04942366|583769753|FG000|Overall Study|Withdrawal by Subject|5|||
161649562|NCT04942366|583769754|FG001|Overall Study|Withdrawal by Subject|5|||
161649563|NCT00747227|583769757|FG000|Overall Study|Death|3|||
161649564|NCT00747227|583769758|FG001|Overall Study|Death|1|||
161649565|NCT00747227|583769757|FG000|Overall Study|Withdrawal by Subject|1|||
161649566|NCT00747227|583769758|FG001|Overall Study|Withdrawal by Subject|0|||
161649567|NCT00747227|583769757|FG000|Overall Study|Lost to Follow-up|1|||
161649568|NCT00747227|583769758|FG001|Overall Study|Lost to Follow-up|2|||
161649569|NCT00747227|583769757|FG000|Overall Study|Illness|1|||
161649570|NCT00747227|583769758|FG001|Overall Study|Illness|1|||
161649571|NCT03284229|583769759|FG000|Overall Study|Lost to Follow-up|3|||
161649572|NCT00918879|583769760|FG000|Overall Study|Withdrawal by Subject|4|||
161649573|NCT00918879|583769761|FG001|Overall Study|Withdrawal by Subject|4|||
161649574|NCT00918879|583769760|FG000|Overall Study|Lost to Follow-up|1|||
161649575|NCT00918879|583769761|FG001|Overall Study|Lost to Follow-up|1|||
161649576|NCT00918879|583769760|FG000|Overall Study|Severe non-compliance to protocol|1|||
161649577|NCT00918879|583769761|FG001|Overall Study|Severe non-compliance to protocol|1|||
161649578|NCT03339245|583769769|FG000|Overall Study|Adverse Event|1|||
161649579|NCT03339245|583769770|FG001|Overall Study|Adverse Event|1|||
161649580|NCT03339245|583769769|FG000|Overall Study|Withdrawal by Subject|1|||
161649581|NCT03339245|583769770|FG001|Overall Study|Withdrawal by Subject|0|||
161649582|NCT03435692|583769778|FG000|Overall Study|Lack of Efficacy|2|||
161649583|NCT03435692|583769779|FG001|Overall Study|Lack of Efficacy|2|||
161649584|NCT03435692|583769780|FG002|Overall Study|Lack of Efficacy|0|||
161649585|NCT01818531|583769786|FG000|Overall Study|Withdrawn for case delay after block|1|||
161649586|NCT01818531|583769787|FG001|Overall Study|Withdrawn for case delay after block|0|||
161649587|NCT01818531|583769786|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
161649588|NCT01818531|583769787|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
161649589|NCT01818531|583769786|FG000|Overall Study|Withdrawn for failure to place block|0|||
161649590|NCT01818531|583769787|FG001|Overall Study|Withdrawn for failure to place block|1|||
161649591|NCT00214019|583769788|FG000|Overall Study|Lost to Follow-up|11|||
161649592|NCT00214019|583769788|FG000|Overall Study|Withdrawal by Subject|2|||
161649593|NCT00214019|583769788|FG000|Overall Study|Screen Failed prior to randomization|17|||
161649594|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
161649595|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
161649596|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
161649597|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
161649598|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
161649599|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
161649600|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
161649601|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
161649602|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
161649603|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
161649604|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161649605|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161649606|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
161649607|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
161649608|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161649609|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161649610|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161649611|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161649612|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
161649613|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649614|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649615|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649616|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
161649617|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649618|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649619|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649620|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
161649621|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
161649622|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
161649623|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
161649624|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
161649625|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
161649626|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161649627|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161649628|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161649629|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161649630|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
161649631|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
161649632|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
161649633|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
161649634|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
161649635|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161649636|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161649637|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161649638|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161649639|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
161649640|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
161649641|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
161649642|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
161649643|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
161649644|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
161649645|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
161649646|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
161649647|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
161649648|NCT00477490|583769789|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
161649649|NCT00477490|583769790|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
161649650|NCT00477490|583769791|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
161649651|NCT00477490|583769792|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
161649652|NCT00477490|583769793|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
161649653|NCT00477490|583769794|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
161649654|NCT00477490|583769795|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
161649655|NCT00477490|583769796|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
161649656|NCT00477490|583769797|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
161649657|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
161649658|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
161649659|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
161649660|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
161649661|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
161649662|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
161649663|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
161649664|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
161649665|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
161649666|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
161649667|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
161649668|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
161649669|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161649670|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161649671|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161649672|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161649673|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161649674|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
161649675|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161649676|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
161649677|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
161649678|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161649679|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
161649680|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161649681|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
161649682|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161649683|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161649684|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161649685|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161649686|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161649687|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161649688|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
161649689|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161649690|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161649691|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
161649692|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
161649693|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649694|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
161649695|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649696|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649697|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649698|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649699|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649700|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649701|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161649702|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
161649703|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
161649704|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
161649705|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
161649706|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
161649707|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
161649708|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
161649709|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
161649710|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
161649711|NCT00477490|583769789|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161649712|NCT00477490|583769790|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
161649713|NCT00477490|583769791|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
161836094|NCT00515034|584440879|FG000|Overall Study|Death|4|||
161649714|NCT00477490|583769792|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161649715|NCT00477490|583769793|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
161649716|NCT00477490|583769794|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161649717|NCT00477490|583769795|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161649718|NCT00477490|583769796|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161649719|NCT00477490|583769797|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161649720|NCT01465763|583769800|FG000|Overall Study|Withdrawal by Subject|4|||
161649721|NCT01465763|583769801|FG001|Overall Study|Withdrawal by Subject|0|||
161649722|NCT01465763|583769802|FG002|Overall Study|Withdrawal by Subject|1|||
161649723|NCT01465763|583769800|FG000|Overall Study|Insufficient Clinical Response|11|||
161649724|NCT01465763|583769801|FG001|Overall Study|Insufficient Clinical Response|0|||
161649725|NCT01465763|583769802|FG002|Overall Study|Insufficient Clinical Response|1|||
161649726|NCT01465763|583769800|FG000|Overall Study|Adverse Event|9|||
161649727|NCT01465763|583769801|FG001|Overall Study|Adverse Event|0|||
161649728|NCT01465763|583769802|FG002|Overall Study|Adverse Event|1|||
161649729|NCT01465763|583769800|FG000|Overall Study|Other|2|||
161649730|NCT01465763|583769801|FG001|Overall Study|Other|0|||
161649731|NCT01465763|583769802|FG002|Overall Study|Other|0|||
161649732|NCT01465763|583769800|FG000|Overall Study|Protocol Violation|4|||
161649733|NCT01465763|583769801|FG001|Overall Study|Protocol Violation|1|||
161649734|NCT01465763|583769802|FG002|Overall Study|Protocol Violation|1|||
161649735|NCT01465763|583769800|FG000|Overall Study|Death|1|||
161649736|NCT01465763|583769801|FG001|Overall Study|Death|0|||
161649737|NCT01465763|583769802|FG002|Overall Study|Death|0|||
161649738|NCT01646177|583769803|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
161649739|NCT01646177|583769804|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
161649740|NCT01646177|583769805|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
161649741|NCT01646177|583769806|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
161649742|NCT01646177|583769807|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649743|NCT01646177|583769808|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649744|NCT01646177|583769809|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649745|NCT01646177|583769810|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649746|NCT01646177|583769811|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649747|NCT01646177|583769812|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649748|NCT01646177|583769813|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649749|NCT01646177|583769814|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161649750|NCT01646177|583769803|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
161649751|NCT01646177|583769804|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
161649752|NCT01646177|583769805|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
161649753|NCT01646177|583769806|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
161649754|NCT01646177|583769807|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649755|NCT01646177|583769808|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649756|NCT01646177|583769809|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649757|NCT01646177|583769810|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649758|NCT01646177|583769811|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649759|NCT01646177|583769812|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161688719|NCT03221751|583911722|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
161688720|NCT03221751|583911723|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
161688721|NCT02590588|583911726|FG000|Overall Study|Adverse Event|1|||
161688722|NCT01780831|583911734|FG000|Overall Study|Withdrawal by Subject|0|||
161688723|NCT01780831|583911735|FG001|Overall Study|Withdrawal by Subject|0|||
161688724|NCT01780831|583911736|FG002|Overall Study|Withdrawal by Subject|4|||
161688725|NCT01780831|583911737|FG003|Overall Study|Withdrawal by Subject|0|||
161649760|NCT01646177|583769813|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649761|NCT01646177|583769814|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161649762|NCT01646177|583769803|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
161649763|NCT01646177|583769804|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
161688726|NCT01780831|583911734|FG000|Overall Study|Lost to Follow-up|0|||
161688727|NCT01780831|583911735|FG001|Overall Study|Lost to Follow-up|0|||
161649764|NCT01646177|583769805|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
161688728|NCT01780831|583911736|FG002|Overall Study|Lost to Follow-up|0|||
161688729|NCT01780831|583911737|FG003|Overall Study|Lost to Follow-up|1|||
161688730|NCT01784861|583911738|FG000|Overall Study|Adverse Event|0|||
161688731|NCT01784861|583911739|FG001|Overall Study|Adverse Event|0|||
161649765|NCT01646177|583769806|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
161649766|NCT01646177|583769807|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649767|NCT01646177|583769808|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649768|NCT01646177|583769809|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649769|NCT01646177|583769810|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649770|NCT01646177|583769811|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649771|NCT01646177|583769812|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649772|NCT01646177|583769813|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649773|NCT01646177|583769814|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161649774|NCT01646177|583769803|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
161649775|NCT01646177|583769804|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
161649776|NCT01646177|583769805|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
161649777|NCT01646177|583769806|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
161649778|NCT01646177|583769807|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649779|NCT01646177|583769808|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649780|NCT01646177|583769809|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649781|NCT01646177|583769810|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649782|NCT01646177|583769811|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649783|NCT01646177|583769812|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649784|NCT01646177|583769813|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649785|NCT01646177|583769814|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161649786|NCT01646177|583769803|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649787|NCT01646177|583769804|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649788|NCT01646177|583769805|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
161649789|NCT01646177|583769806|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
161649790|NCT01646177|583769807|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649791|NCT01646177|583769808|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649792|NCT01646177|583769809|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649793|NCT01646177|583769810|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649794|NCT01646177|583769811|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649795|NCT01646177|583769812|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649796|NCT01646177|583769813|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649797|NCT01646177|583769814|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161649798|NCT01646177|583769803|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
161649799|NCT01646177|583769804|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
161649800|NCT01646177|583769805|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
161649801|NCT01646177|583769806|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649802|NCT01646177|583769807|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649803|NCT01646177|583769808|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649804|NCT01646177|583769809|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649805|NCT01646177|583769810|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649806|NCT01646177|583769811|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649807|NCT01646177|583769812|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649808|NCT01646177|583769813|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649809|NCT01646177|583769814|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161649810|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649811|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649812|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649813|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649814|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
161649815|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
161649816|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
161649817|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
161649818|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649819|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649820|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649821|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161649822|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649823|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649824|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649825|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649826|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
161649827|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
161688732|NCT01784861|583911740|FG002|Overall Study|Adverse Event|1|||
161649828|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
161649829|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
161649830|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649831|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649832|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649833|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161649834|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649835|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649836|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649837|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649838|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
161649839|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
161649840|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
161649841|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
161649842|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649843|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649844|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649845|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161649846|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649847|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649848|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649849|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649850|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
161649851|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
161649852|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
161649853|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
161649854|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649855|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649856|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649857|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161649858|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649859|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649860|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649861|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649862|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
161649863|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
161649864|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
161649865|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
161649866|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649867|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649868|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649869|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161649870|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649871|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649872|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649873|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649874|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
161649875|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
161649876|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649877|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
161649878|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649879|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649880|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649881|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161649882|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649883|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649884|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649885|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649886|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
161836095|NCT00515034|584440880|FG001|Overall Study|Death|2|||
161836096|NCT00515034|584440881|FG002|Overall Study|Death|1|||
161836097|NCT00515034|584440882|FG003|Overall Study|Death|3|||
161836098|NCT00515034|584440879|FG000|Overall Study|Withdrawal by Subject|1|||
161649887|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161649888|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161649889|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161649890|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649891|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649892|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649893|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161649894|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
161649895|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
161649896|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
161649897|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
161649898|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
161649899|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
161649900|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
161649901|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
161649902|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
161649903|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
161649904|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
161649905|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
161649906|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649907|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649908|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649909|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649910|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
161649911|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
161649912|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
161649913|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
161649914|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649915|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649916|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649917|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161649918|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649919|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649920|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649921|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649922|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649923|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649924|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649925|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
161649926|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649927|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649928|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649929|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161649930|NCT01646177|583769803|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649931|NCT01646177|583769804|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649932|NCT01646177|583769805|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649933|NCT01646177|583769806|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649934|NCT01646177|583769807|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161688733|NCT01784861|583911741|FG003|Overall Study|Adverse Event|2|||
161688734|NCT01784861|583911742|FG004|Overall Study|Adverse Event|1|||
161649935|NCT01646177|583769808|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
161649936|NCT01646177|583769809|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
161649937|NCT01646177|583769810|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
161649938|NCT01646177|583769811|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649939|NCT01646177|583769812|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161688735|NCT01784861|583911743|FG005|Overall Study|Adverse Event|0|||
161836099|NCT00515034|584440880|FG001|Overall Study|Withdrawal by Subject|0|||
161649940|NCT01646177|583769813|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649941|NCT01646177|583769814|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161649942|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649943|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649944|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649945|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649946|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649947|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649948|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649949|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161649950|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
161649951|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
161649952|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
161649953|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
161649954|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649955|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649956|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649957|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649958|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649959|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161836100|NCT00515034|584440881|FG002|Overall Study|Withdrawal by Subject|3|||
161649960|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649961|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161649962|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
161649963|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
161649964|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
161649965|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
161649966|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649967|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649968|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649969|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649970|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649971|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649972|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649973|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161649974|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
161649975|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
161649976|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
161649977|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
161649978|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649979|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649980|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649981|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649982|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649983|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649984|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649985|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161649986|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
161649987|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
161649988|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
161836101|NCT00515034|584440882|FG003|Overall Study|Withdrawal by Subject|0|||
161836102|NCT00515034|584440879|FG000|Overall Study|Physician Decision|0|||
161649989|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
161649990|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649991|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649992|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649993|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649994|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649995|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649996|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649997|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161649998|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
161649999|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
161650000|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
161650001|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
161650002|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650003|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650004|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650005|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650006|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650007|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650008|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650009|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161650010|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
161650011|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
161650012|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
161650013|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
161650014|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650015|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650016|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650017|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650018|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650019|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650020|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650021|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650022|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161650023|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
161650024|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
161650025|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
161650026|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650027|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650028|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650029|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650030|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650031|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650032|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650033|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650034|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161650035|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
161650036|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
161650037|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
161650038|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650039|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650040|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650041|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650042|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650043|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650044|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650045|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650046|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
161650047|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161650048|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
161650049|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
161650050|NCT01646177|583769803|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650051|NCT01646177|583769804|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650052|NCT01646177|583769805|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650053|NCT01646177|583769806|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650054|NCT01646177|583769807|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161836103|NCT00515034|584440880|FG001|Overall Study|Physician Decision|0|||
161836104|NCT00515034|584440881|FG002|Overall Study|Physician Decision|1|||
161836105|NCT00515034|584440882|FG003|Overall Study|Physician Decision|1|||
161836106|NCT00515034|584440879|FG000|Overall Study|Other|1|||
161650055|NCT01646177|583769808|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650056|NCT01646177|583769809|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650057|NCT01646177|583769810|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650058|NCT01646177|583769811|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650059|NCT01646177|583769812|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161650060|NCT01646177|583769813|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
161650061|NCT01646177|583769814|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
161650062|NCT01038427|583769817|FG000|Overall Study|Lost to follow up|1|||
161650063|NCT01038427|583769818|FG001|Overall Study|Lost to follow up|1|||
161650064|NCT01038427|583769819|FG002|Overall Study|Lost to follow up|0|||
161650065|NCT01038427|583769817|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161650066|NCT01038427|583769818|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161650067|NCT01038427|583769819|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
161650068|NCT01038427|583769817|FG000|Overall Study|Withdrew consent|0|||
161650069|NCT01038427|583769818|FG001|Overall Study|Withdrew consent|0|||
161650070|NCT01038427|583769819|FG002|Overall Study|Withdrew consent|1|||
161650071|NCT01038427|583769817|FG000|Overall Study|Adverse Event|2|||
161650072|NCT01038427|583769818|FG001|Overall Study|Adverse Event|2|||
161650073|NCT01038427|583769819|FG002|Overall Study|Adverse Event|1|||
161650074|NCT01038427|583769817|FG000|Overall Study|Enrolled in error|0|||
161650075|NCT01038427|583769818|FG001|Overall Study|Enrolled in error|1|||
161650076|NCT01038427|583769819|FG002|Overall Study|Enrolled in error|1|||
161650077|NCT01038427|583769817|FG000|Overall Study|Other|0|||
161650078|NCT01038427|583769818|FG001|Overall Study|Other|2|||
161650079|NCT01038427|583769819|FG002|Overall Study|Other|0|||
161650080|NCT02992691|583769820|FG000|Overall Study|Adverse Event|2|||
161650081|NCT02992691|583769820|FG000|Overall Study|Withdrawal by Subject|1|||
161650082|NCT00588692|583769821|FG000|Overall Study|Withdrawal by Subject|4|||
161650083|NCT00588692|583769822|FG001|Overall Study|Withdrawal by Subject|2|||
161650084|NCT00588692|583769821|FG000|Overall Study|Hip Surgery|0|||
161650085|NCT00588692|583769822|FG001|Overall Study|Hip Surgery|1|||
161650086|NCT00588692|583769821|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
161650087|NCT00588692|583769822|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
161650088|NCT00588692|583769821|FG000|Overall Study|Cancer|1|||
161650089|NCT00588692|583769822|FG001|Overall Study|Cancer|0|||
161650090|NCT00588692|583769821|FG000|Overall Study|Death|1|||
161836107|NCT00515034|584440880|FG001|Overall Study|Other|0|||
161650091|NCT00588692|583769822|FG001|Overall Study|Death|0|||
161650092|NCT00820170|583769824|FG000|Overall Study|Adverse Event|0|||
161650093|NCT00820170|583769825|FG001|Overall Study|Adverse Event|0|||
161650094|NCT00820170|583769826|FG002|Overall Study|Adverse Event|0|||
161650095|NCT00820170|583769827|FG003|Overall Study|Adverse Event|0|||
161650096|NCT00820170|583769828|FG004|Overall Study|Adverse Event|2|||
161650097|NCT00820170|583769824|FG000|Overall Study|Progressive Disease|0|||
161650098|NCT00820170|583769825|FG001|Overall Study|Progressive Disease|0|||
161650099|NCT00820170|583769826|FG002|Overall Study|Progressive Disease|0|||
161650100|NCT00820170|583769827|FG003|Overall Study|Progressive Disease|0|||
161650101|NCT00820170|583769828|FG004|Overall Study|Progressive Disease|2|||
161650102|NCT03538938|583769829|FG000|Overall Study|Death|0|||
161650103|NCT03538938|583769830|FG001|Overall Study|Death|0|||
161650104|NCT03538938|583769831|FG002|Overall Study|Death|2|||
161650105|NCT03538938|583769832|FG003|Overall Study|Death|0|||
161650106|NCT03538938|583769833|FG004|Overall Study|Death|0|||
161650107|NCT03538938|583769834|FG005|Overall Study|Death|1|||
161650108|NCT03538938|583769835|FG006|Overall Study|Death|0|||
161650109|NCT03538938|583769836|FG007|Overall Study|Death|1|||
161836108|NCT00515034|584440881|FG002|Overall Study|Other|2|||
161836109|NCT00515034|584440882|FG003|Overall Study|Other|1|||
161836110|NCT02340221|584440885|FG000|Overall Study|Death|100|||
161650110|NCT03538938|583769837|FG008|Overall Study|Death|1|||
161650111|NCT03538938|583769838|FG009|Overall Study|Death|1|||
161650112|NCT03538938|583769839|FG010|Overall Study|Death|0|||
161650113|NCT03538938|583769840|FG011|Overall Study|Death|0|||
161688736|NCT01784861|583911738|FG000|Overall Study|Withdrawal by Subject|0|||
161836111|NCT02340221|584440886|FG001|Overall Study|Death|197|||
161836112|NCT02340221|584440885|FG000|Overall Study|Withdrawal by Participant|24|||
161650114|NCT03538938|583769841|FG012|Overall Study|Death|1|||
161650115|NCT03538938|583769842|FG013|Overall Study|Death|1|||
161650116|NCT03538938|583769843|FG014|Overall Study|Death|0|||
161650117|NCT03538938|583769844|FG015|Overall Study|Death|1|||
161650118|NCT03538938|583769829|FG000|Overall Study|Withdrawal by Subject|4|||
161650119|NCT03538938|583769830|FG001|Overall Study|Withdrawal by Subject|6|||
161650120|NCT03538938|583769831|FG002|Overall Study|Withdrawal by Subject|5|||
161836113|NCT02340221|584440886|FG001|Overall Study|Withdrawal by Participant|37|||
161836114|NCT02340221|584440885|FG000|Overall Study|Lost to Follow-up|4|||
161650121|NCT03538938|583769832|FG003|Overall Study|Withdrawal by Subject|3|||
161650122|NCT03538938|583769833|FG004|Overall Study|Withdrawal by Subject|0|||
161650123|NCT03538938|583769834|FG005|Overall Study|Withdrawal by Subject|0|||
161650124|NCT03538938|583769835|FG006|Overall Study|Withdrawal by Subject|3|||
161650125|NCT03538938|583769836|FG007|Overall Study|Withdrawal by Subject|1|||
161650126|NCT03538938|583769837|FG008|Overall Study|Withdrawal by Subject|5|||
161650127|NCT03538938|583769838|FG009|Overall Study|Withdrawal by Subject|1|||
161650128|NCT03538938|583769839|FG010|Overall Study|Withdrawal by Subject|2|||
161650129|NCT03538938|583769840|FG011|Overall Study|Withdrawal by Subject|1|||
161650130|NCT03538938|583769841|FG012|Overall Study|Withdrawal by Subject|3|||
161650131|NCT03538938|583769842|FG013|Overall Study|Withdrawal by Subject|0|||
161650132|NCT03538938|583769843|FG014|Overall Study|Withdrawal by Subject|2|||
161650133|NCT03538938|583769844|FG015|Overall Study|Withdrawal by Subject|4|||
161650134|NCT03538938|583769829|FG000|Overall Study|Incarcerated|0|||
161650135|NCT03538938|583769830|FG001|Overall Study|Incarcerated|0|||
161650136|NCT03538938|583769831|FG002|Overall Study|Incarcerated|0|||
161650137|NCT03538938|583769832|FG003|Overall Study|Incarcerated|0|||
161650138|NCT03538938|583769833|FG004|Overall Study|Incarcerated|0|||
161650139|NCT03538938|583769834|FG005|Overall Study|Incarcerated|0|||
161650140|NCT03538938|583769835|FG006|Overall Study|Incarcerated|0|||
161650141|NCT03538938|583769836|FG007|Overall Study|Incarcerated|0|||
161650142|NCT03538938|583769837|FG008|Overall Study|Incarcerated|0|||
161650143|NCT03538938|583769838|FG009|Overall Study|Incarcerated|0|||
161650144|NCT03538938|583769839|FG010|Overall Study|Incarcerated|0|||
161650145|NCT03538938|583769840|FG011|Overall Study|Incarcerated|1|||
161650146|NCT03538938|583769841|FG012|Overall Study|Incarcerated|0|||
161650147|NCT03538938|583769842|FG013|Overall Study|Incarcerated|0|||
161650148|NCT03538938|583769843|FG014|Overall Study|Incarcerated|0|||
161650149|NCT03538938|583769844|FG015|Overall Study|Incarcerated|0|||
161650150|NCT00755105|583769845|FG000|Overall Study|Withdrawal by Subject|9|||
161650151|NCT00755105|583769846|FG001|Overall Study|Withdrawal by Subject|11|||
161650152|NCT00755105|583769847|FG002|Overall Study|Withdrawal by Subject|4|||
161650153|NCT03995316|583769848|FG000|Overall Study|Lost to Follow-up|10|||
161650154|NCT03995316|583769849|FG001|Overall Study|Lost to Follow-up|3|||
161650155|NCT02202785|583769850|FG000|Overall Study|Study Terminated by Sponsor|1|||
161650156|NCT02202785|583769851|FG001|Overall Study|Study Terminated by Sponsor|6|||
161650157|NCT02202785|583769852|FG002|Overall Study|Study Terminated by Sponsor|4|||
161650158|NCT02202785|583769850|FG000|Overall Study|Withdrawal by Subject|0|||
161650159|NCT02202785|583769851|FG001|Overall Study|Withdrawal by Subject|1|||
161650160|NCT02202785|583769852|FG002|Overall Study|Withdrawal by Subject|0|||
161650161|NCT02202785|583769850|FG000|Overall Study|Lost to Follow-up|0|||
161650162|NCT02202785|583769851|FG001|Overall Study|Lost to Follow-up|1|||
161650163|NCT02202785|583769852|FG002|Overall Study|Lost to Follow-up|0|||
161650164|NCT02202785|583769850|FG000|Overall Study|Reason not Specified|10|||
161650165|NCT02202785|583769851|FG001|Overall Study|Reason not Specified|7|||
161650166|NCT02202785|583769852|FG002|Overall Study|Reason not Specified|13|||
161650167|NCT02180243|583769853|FG000|Overall Study|Withdrawal by Subject|12|||
161650168|NCT02180243|583769854|FG001|Overall Study|Withdrawal by Subject|12|||
161650169|NCT02180243|583769853|FG000|Overall Study|Lost to Follow-up|12|||
161650170|NCT02180243|583769854|FG001|Overall Study|Lost to Follow-up|2|||
161650171|NCT01137578|583769855|FG000|Overall Study|Participant requested to Discontinue|3|||
161650172|NCT01137578|583769856|FG001|Overall Study|Participant requested to Discontinue|0|||
161650173|NCT01137578|583769857|FG002|Overall Study|Participant requested to Discontinue|0|||
161650174|NCT01137578|583769855|FG000|Overall Study|Withdrawal by Subject|1|||
161688737|NCT01784861|583911739|FG001|Overall Study|Withdrawal by Subject|0|||
161688738|NCT01784861|583911740|FG002|Overall Study|Withdrawal by Subject|0|||
161688739|NCT01784861|583911741|FG003|Overall Study|Withdrawal by Subject|1|||
161688740|NCT01784861|583911742|FG004|Overall Study|Withdrawal by Subject|0|||
161688741|NCT01784861|583911743|FG005|Overall Study|Withdrawal by Subject|0|||
161688742|NCT01784861|583911738|FG000|Overall Study|Physician Decision|0|||
161688743|NCT01784861|583911739|FG001|Overall Study|Physician Decision|0|||
161688744|NCT01784861|583911740|FG002|Overall Study|Physician Decision|0|||
161688745|NCT01784861|583911741|FG003|Overall Study|Physician Decision|2|||
161688746|NCT01784861|583911742|FG004|Overall Study|Physician Decision|0|||
161688747|NCT01784861|583911743|FG005|Overall Study|Physician Decision|1|||
161688748|NCT00906087|583911756|FG000|Initial Washout|Withdrawal by Subject|1|||
161650175|NCT01137578|583769856|FG001|Overall Study|Withdrawal by Subject|0|||
161650176|NCT01137578|583769857|FG002|Overall Study|Withdrawal by Subject|0|||
161650177|NCT01137578|583769855|FG000|Overall Study|Other|12|||
161650178|NCT01137578|583769856|FG001|Overall Study|Other|2|||
161650179|NCT01137578|583769857|FG002|Overall Study|Other|6|||
161650180|NCT03651700|583769858|FG000|Overall Study|Withdrawal by Subject|1|||
161650181|NCT03651700|583769859|FG001|Overall Study|Withdrawal by Subject|0|||
161650182|NCT05479734|583769861|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
161650183|NCT05479734|583769862|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
161688749|NCT00906087|583911756|FG000|Initial Washout|Physician Decision|1|||
161688750|NCT03016325|583911762|FG000|Treatment Period|Participant withdrew consent|0|||
161650184|NCT05479734|583769861|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
161650185|NCT05479734|583769862|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
161650186|NCT05479734|583769861|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
161650187|NCT05479734|583769862|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
161650188|NCT05479734|583769861|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
161650189|NCT05479734|583769862|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
161650190|NCT01461005|583769863|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
161650191|NCT00203268|583769864|FG000|Early Treatment|only treated one headache|2|||
161650192|NCT00203268|583769864|FG000|Early Treatment|Lost to Follow-up|1|||
161650193|NCT00203268|583769864|FG000|Early Treatment|Withdrawal by Subject|1|||
161650194|NCT00600613|583769865|FG000|Overall Study|Protocol Deviation|1|||
161650195|NCT00664534|583769868|FG000|Overall Study|Adverse Event|2|||
161650196|NCT00664534|583769869|FG001|Overall Study|Adverse Event|3|||
161650197|NCT00664534|583769868|FG000|Overall Study|Lost to Follow-up|6|||
161650198|NCT00664534|583769869|FG001|Overall Study|Lost to Follow-up|10|||
161650199|NCT00664534|583769868|FG000|Overall Study|Protocol Violation|10|||
161650200|NCT00664534|583769869|FG001|Overall Study|Protocol Violation|8|||
161650201|NCT00664534|583769868|FG000|Overall Study|Withdrawal by Subject|7|||
161650202|NCT00664534|583769869|FG001|Overall Study|Withdrawal by Subject|6|||
161650203|NCT00664534|583769868|FG000|Overall Study|Physician Decision|8|||
161650204|NCT00664534|583769869|FG001|Overall Study|Physician Decision|0|||
161650205|NCT00664534|583769868|FG000|Overall Study|Sponsor decision|8|||
161650206|NCT00664534|583769869|FG001|Overall Study|Sponsor decision|6|||
161650207|NCT00935532|583769872|FG000|Overall Study|Adverse Event|11|||
161650208|NCT00935532|583769873|FG001|Overall Study|Adverse Event|6|||
161650209|NCT00935532|583769872|FG000|Overall Study|Death|1|||
161650210|NCT00935532|583769873|FG001|Overall Study|Death|0|||
161650211|NCT00935532|583769872|FG000|Overall Study|Lost to Follow-up|1|||
161650212|NCT00935532|583769873|FG001|Overall Study|Lost to Follow-up|0|||
161650213|NCT00935532|583769872|FG000|Overall Study|Physician Decision|1|||
161650214|NCT00935532|583769873|FG001|Overall Study|Physician Decision|2|||
161650215|NCT00935532|583769872|FG000|Overall Study|Protocol Violation|2|||
161650216|NCT00935532|583769873|FG001|Overall Study|Protocol Violation|1|||
161650217|NCT00935532|583769872|FG000|Overall Study|Subject Decision|2|||
161650218|NCT00935532|583769873|FG001|Overall Study|Subject Decision|1|||
161650219|NCT00935532|583769872|FG000|Overall Study|Sponsor Decision|0|||
161650220|NCT00935532|583769873|FG001|Overall Study|Sponsor Decision|1|||
161650221|NCT00935532|583769872|FG000|Overall Study|Loss Glucose Control|4|||
161650222|NCT00935532|583769873|FG001|Overall Study|Loss Glucose Control|0|||
161650223|NCT01399918|583769875|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
161650224|NCT00245960|583769876|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
161650225|NCT00245960|583769877|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
161650226|NCT00245960|583769876|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
161650227|NCT00245960|583769877|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
161650228|NCT00245960|583769876|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
161650229|NCT00245960|583769877|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
161650230|NCT00245960|583769876|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
161650231|NCT00245960|583769877|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
161650232|NCT00245960|583769876|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
161650233|NCT00245960|583769877|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
161650234|NCT00245960|583769876|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
161650235|NCT00245960|583769877|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
161650236|NCT00245960|583769876|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
161650237|NCT00245960|583769877|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
161650238|NCT00245960|583769876|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
161650239|NCT00245960|583769877|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
161650240|NCT00245960|583769876|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
161650241|NCT00245960|583769877|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
161650242|NCT00245960|583769876|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
161650243|NCT00245960|583769877|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
161650244|NCT00245960|583769876|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
161650245|NCT00245960|583769877|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
161650246|NCT00245960|583769876|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
161688751|NCT03016325|583911763|FG001|Treatment Period|Participant withdrew consent|1|||
161688752|NCT03016325|583911764|FG002|Treatment Period|Participant withdrew consent|0|||
161836115|NCT02340221|584440886|FG001|Overall Study|Lost to Follow-up|15|||
161650247|NCT00245960|583769877|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
161650248|NCT01436253|583769879|FG000|Overall Study|Lost to Follow-up|182|||
161650249|NCT01436253|583769879|FG000|Overall Study|Not meeting all eligibility criteria|117|||
161650250|NCT03083665|583769881|FG000|Double-Blind Period|Adverse Event|5|||
161650251|NCT03083665|583769882|FG001|Double-Blind Period|Adverse Event|4|||
161650252|NCT03083665|583769883|FG002|Double-Blind Period|Adverse Event|5|||
161650253|NCT03083665|583769884|FG003|Double-Blind Period|Adverse Event|0|||
161650254|NCT03083665|583769885|FG004|Double-Blind Period|Adverse Event|0|||
161650255|NCT03083665|583769886|FG005|Double-Blind Period|Adverse Event|0|||
161650256|NCT03083665|583769881|FG000|Double-Blind Period|Lack of Efficacy|0|||
161650257|NCT03083665|583769882|FG001|Double-Blind Period|Lack of Efficacy|0|||
161650258|NCT03083665|583769883|FG002|Double-Blind Period|Lack of Efficacy|1|||
161650259|NCT03083665|583769884|FG003|Double-Blind Period|Lack of Efficacy|0|||
161650260|NCT03083665|583769885|FG004|Double-Blind Period|Lack of Efficacy|0|||
161650261|NCT03083665|583769886|FG005|Double-Blind Period|Lack of Efficacy|0|||
161650262|NCT03083665|583769881|FG000|Double-Blind Period|Protocol Violation|1|||
161650263|NCT03083665|583769882|FG001|Double-Blind Period|Protocol Violation|0|||
161650264|NCT03083665|583769883|FG002|Double-Blind Period|Protocol Violation|1|||
161650265|NCT03083665|583769884|FG003|Double-Blind Period|Protocol Violation|0|||
161650266|NCT03083665|583769885|FG004|Double-Blind Period|Protocol Violation|0|||
161650267|NCT03083665|583769886|FG005|Double-Blind Period|Protocol Violation|0|||
161650268|NCT03083665|583769881|FG000|Double-Blind Period|Lost to Follow-up|1|||
161650269|NCT03083665|583769882|FG001|Double-Blind Period|Lost to Follow-up|0|||
161650270|NCT03083665|583769883|FG002|Double-Blind Period|Lost to Follow-up|1|||
161650271|NCT03083665|583769884|FG003|Double-Blind Period|Lost to Follow-up|0|||
161650272|NCT03083665|583769885|FG004|Double-Blind Period|Lost to Follow-up|0|||
161650273|NCT03083665|583769886|FG005|Double-Blind Period|Lost to Follow-up|0|||
161650274|NCT03083665|583769881|FG000|Double-Blind Period|Withdrawal by Subject|3|||
161650275|NCT03083665|583769882|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161650276|NCT03083665|583769883|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161650277|NCT03083665|583769884|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161650278|NCT03083665|583769885|FG004|Double-Blind Period|Withdrawal by Subject|0|||
161650279|NCT03083665|583769886|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161650280|NCT03083665|583769881|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
161650281|NCT03083665|583769882|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161650282|NCT03083665|583769883|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161650283|NCT03083665|583769884|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161650284|NCT03083665|583769885|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161650285|NCT03083665|583769886|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161650286|NCT03083665|583769881|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
161650287|NCT03083665|583769882|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
161650288|NCT03083665|583769883|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
161650289|NCT03083665|583769884|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
161650290|NCT03083665|583769885|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
161650291|NCT03083665|583769886|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
161650292|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161650293|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161650294|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161650295|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
161650296|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161650297|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161650298|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161650299|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161650300|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161650301|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161650302|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161650303|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
161650304|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
161650305|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
161650306|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
161650307|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
161650308|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
161650309|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
161650310|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161650311|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161650312|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161650313|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161650314|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161650315|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
161650316|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161650317|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161650318|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161650319|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
161688753|NCT03016325|583911765|FG003|Treatment Period|Participant withdrew consent|0|||
161688754|NCT03016325|583911766|FG004|Treatment Period|Participant withdrew consent|0|||
161688755|NCT03016325|583911767|FG005|Treatment Period|Participant withdrew consent|0|||
161688756|NCT03016325|583911768|FG006|Treatment Period|Participant withdrew consent|0|||
161688757|NCT03016325|583911769|FG007|Treatment Period|Participant withdrew consent|0|||
161688758|NCT03016325|583911762|FG000|Treatment Period|Death|0|||
161688759|NCT03016325|583911763|FG001|Treatment Period|Death|0|||
161688760|NCT03016325|583911764|FG002|Treatment Period|Death|0|||
161688761|NCT03016325|583911765|FG003|Treatment Period|Death|0|||
161688762|NCT03016325|583911766|FG004|Treatment Period|Death|2|||
161688763|NCT03016325|583911767|FG005|Treatment Period|Death|0|||
161688764|NCT03016325|583911768|FG006|Treatment Period|Death|0|||
161688765|NCT03016325|583911769|FG007|Treatment Period|Death|0|||
161688766|NCT03016325|583911762|FG000|Treatment Period|Participant refuses assessments|0|||
161688767|NCT03016325|583911763|FG001|Treatment Period|Participant refuses assessments|0|||
161688768|NCT03016325|583911764|FG002|Treatment Period|Participant refuses assessments|1|||
161688769|NCT03016325|583911765|FG003|Treatment Period|Participant refuses assessments|0|||
161688770|NCT03016325|583911766|FG004|Treatment Period|Participant refuses assessments|0|||
161688771|NCT03016325|583911767|FG005|Treatment Period|Participant refuses assessments|0|||
161688772|NCT03016325|583911768|FG006|Treatment Period|Participant refuses assessments|0|||
161688773|NCT03016325|583911769|FG007|Treatment Period|Participant refuses assessments|0|||
161688774|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Death|2|||
161688775|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Death|0|||
161688776|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Death|5|||
161688777|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Death|6|||
161688778|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Death|3|||
161688779|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Death|0|||
161688780|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Death|0|||
161650320|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161650321|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161650322|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161650323|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161650324|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161650325|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161650326|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161650327|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
161650328|NCT03083665|583769881|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161650329|NCT03083665|583769882|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161650330|NCT03083665|583769883|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161650331|NCT03083665|583769884|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161650332|NCT03083665|583769885|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161650333|NCT03083665|583769886|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
161650334|NCT02519348|583769887|FG000|Overall Study|Death|31|||
161650335|NCT02519348|583769888|FG001|Overall Study|Death|74|||
161650336|NCT02519348|583769889|FG002|Overall Study|Death|47|||
161650337|NCT02519348|583769890|FG003|Overall Study|Death|54|||
161650338|NCT02519348|583769891|FG004|Overall Study|Death|63|||
161650339|NCT02519348|583769892|FG005|Overall Study|Death|18|||
161650340|NCT02519348|583769893|FG006|Overall Study|Death|2|||
161650341|NCT02519348|583769894|FG007|Overall Study|Death|5|||
161650342|NCT02519348|583769895|FG008|Overall Study|Death|5|||
161650343|NCT02519348|583769887|FG000|Overall Study|Withdrawal by Subject|4|||
161650344|NCT02519348|583769888|FG001|Overall Study|Withdrawal by Subject|7|||
161650345|NCT02519348|583769889|FG002|Overall Study|Withdrawal by Subject|4|||
161650346|NCT02519348|583769890|FG003|Overall Study|Withdrawal by Subject|3|||
161650347|NCT02519348|583769891|FG004|Overall Study|Withdrawal by Subject|3|||
161650348|NCT02519348|583769892|FG005|Overall Study|Withdrawal by Subject|2|||
161650349|NCT02519348|583769893|FG006|Overall Study|Withdrawal by Subject|0|||
161688781|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Death|0|||
161688782|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
161688783|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688784|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
161688785|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
161688786|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
161650350|NCT02519348|583769894|FG007|Overall Study|Withdrawal by Subject|0|||
161650351|NCT02519348|583769895|FG008|Overall Study|Withdrawal by Subject|1|||
161650352|NCT02519348|583769887|FG000|Overall Study|Lost to Follow-up|0|||
161688787|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688788|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688789|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688790|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
161688791|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
161836116|NCT02340221|584440885|FG000|Overall Study|Reason Not Specified|85|||
161836117|NCT02340221|584440886|FG001|Overall Study|Reason Not Specified|165|||
161836118|NCT02340221|584440885|FG000|Overall Study|Study Terminated by Sponsor|1|||
161836119|NCT02340221|584440886|FG001|Overall Study|Study Terminated by Sponsor|3|||
161836120|NCT00952276|584440887|FG000|Overall Study|Withdrawal by Subject|1|||
161836121|NCT00952276|584440888|FG001|Overall Study|Withdrawal by Subject|0|||
161650353|NCT02519348|583769888|FG001|Overall Study|Lost to Follow-up|0|||
161650354|NCT02519348|583769889|FG002|Overall Study|Lost to Follow-up|1|||
161650355|NCT02519348|583769890|FG003|Overall Study|Lost to Follow-up|0|||
161650356|NCT02519348|583769891|FG004|Overall Study|Lost to Follow-up|2|||
161650357|NCT02519348|583769892|FG005|Overall Study|Lost to Follow-up|1|||
161650358|NCT02519348|583769893|FG006|Overall Study|Lost to Follow-up|1|||
161650359|NCT02519348|583769894|FG007|Overall Study|Lost to Follow-up|0|||
161650360|NCT02519348|583769895|FG008|Overall Study|Lost to Follow-up|0|||
161650361|NCT02519348|583769887|FG000|Overall Study|Other|0|||
161650362|NCT02519348|583769888|FG001|Overall Study|Other|3|||
161650363|NCT02519348|583769889|FG002|Overall Study|Other|0|||
161650364|NCT02519348|583769890|FG003|Overall Study|Other|0|||
161650365|NCT02519348|583769891|FG004|Overall Study|Other|1|||
161650366|NCT02519348|583769892|FG005|Overall Study|Other|0|||
161650367|NCT02519348|583769893|FG006|Overall Study|Other|0|||
161650368|NCT02519348|583769894|FG007|Overall Study|Other|0|||
161650369|NCT02519348|583769895|FG008|Overall Study|Other|0|||
161650370|NCT02519348|583769887|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
161650371|NCT02519348|583769888|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
161650372|NCT02519348|583769889|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
161650373|NCT02519348|583769890|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
161650374|NCT02519348|583769891|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
161650375|NCT02519348|583769892|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
161650376|NCT02519348|583769893|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
161650377|NCT02519348|583769894|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
161650378|NCT02519348|583769895|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
161650379|NCT04844879|583769896|FG000|Overall Study|Death|1|||
161650380|NCT04844879|583769896|FG000|Overall Study|Withdrawal by Subject|1|||
161650381|NCT04844879|583769896|FG000|Overall Study|Adverse Event|1|||
161650382|NCT04103892|583769902|FG000|Overall Study|Adverse Event|0|||
161650383|NCT04103892|583769903|FG001|Overall Study|Adverse Event|0|||
161650384|NCT04103892|583769904|FG002|Overall Study|Adverse Event|0|||
161650385|NCT04103892|583769905|FG003|Overall Study|Adverse Event|3|||
161650386|NCT04103892|583769902|FG000|Overall Study|Lost to Follow-up|0|||
161650387|NCT04103892|583769903|FG001|Overall Study|Lost to Follow-up|0|||
161650388|NCT04103892|583769904|FG002|Overall Study|Lost to Follow-up|2|||
161650389|NCT04103892|583769905|FG003|Overall Study|Lost to Follow-up|0|||
161650390|NCT04103892|583769902|FG000|Overall Study|Protocol Violation|0|||
161650391|NCT04103892|583769903|FG001|Overall Study|Protocol Violation|0|||
161650392|NCT04103892|583769904|FG002|Overall Study|Protocol Violation|1|||
161650393|NCT04103892|583769905|FG003|Overall Study|Protocol Violation|1|||
161650394|NCT04103892|583769902|FG000|Overall Study|Withdrawal by Subject|1|||
161650395|NCT04103892|583769903|FG001|Overall Study|Withdrawal by Subject|0|||
161650396|NCT04103892|583769904|FG002|Overall Study|Withdrawal by Subject|2|||
161650397|NCT04103892|583769905|FG003|Overall Study|Withdrawal by Subject|5|||
161650398|NCT04103892|583769902|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
161650399|NCT04103892|583769903|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
161650400|NCT04103892|583769904|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
161650401|NCT04103892|583769905|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
161650402|NCT05576662|583769906|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
161650403|NCT05576662|583769907|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
161650404|NCT05576662|583769906|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
161650405|NCT05576662|583769907|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
161650406|NCT05576662|583769906|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
161650407|NCT05576662|583769907|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
161650408|NCT05576662|583769906|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
161650409|NCT05576662|583769907|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
161650410|NCT00281320|583769908|FG000|Overall Study|Adverse Event|12|||
161650411|NCT00281320|583769909|FG001|Overall Study|Adverse Event|9|||
161836122|NCT00952276|584440889|FG002|Overall Study|Withdrawal by Subject|0|||
161836123|NCT00952276|584440890|FG003|Overall Study|Withdrawal by Subject|1|||
161836124|NCT00952276|584440891|FG004|Overall Study|Withdrawal by Subject|0|||
161836125|NCT04189445|584442878|FG000|Overall Study|Withdrawal of consent|8|||
161836126|NCT04189445|584442879|FG001|Overall Study|Withdrawal of consent|1|||
161836127|NCT04189445|584442880|FG002|Overall Study|Withdrawal of consent|0|||
161836128|NCT04189445|584442878|FG000|Overall Study|Study Terminated by Sponsor|25|||
161836129|NCT04189445|584442879|FG001|Overall Study|Study Terminated by Sponsor|3|||
161650412|NCT00281320|583769908|FG000|Overall Study|Lack of Efficacy|4|||
161650413|NCT00281320|583769909|FG001|Overall Study|Lack of Efficacy|3|||
161650414|NCT00281320|583769908|FG000|Overall Study|Withdrawal by Subject|5|||
161650415|NCT00281320|583769909|FG001|Overall Study|Withdrawal by Subject|6|||
161650416|NCT00281320|583769908|FG000|Overall Study|Lost to Follow-up|1|||
161650417|NCT00281320|583769909|FG001|Overall Study|Lost to Follow-up|2|||
161650418|NCT00281320|583769908|FG000|Overall Study|Other|3|||
161650419|NCT00281320|583769909|FG001|Overall Study|Other|1|||
161650420|NCT03008005|583769912|FG000|Overall Study|Physician Decision|1|||
161650421|NCT03008005|583769913|FG001|Overall Study|Physician Decision|0|||
161650422|NCT03008005|583769914|FG002|Overall Study|Physician Decision|0|||
161650423|NCT03008005|583769912|FG000|Overall Study|Withdrawal by Subject|1|||
161650424|NCT03008005|583769913|FG001|Overall Study|Withdrawal by Subject|0|||
161650425|NCT03008005|583769914|FG002|Overall Study|Withdrawal by Subject|0|||
161650426|NCT03008005|583769912|FG000|Overall Study|Ineligible|0|||
161650427|NCT03008005|583769913|FG001|Overall Study|Ineligible|1|||
161650428|NCT03008005|583769914|FG002|Overall Study|Ineligible|0|||
161650429|NCT00475228|583769916|FG000|Overall Study|Lost to Follow-up|17|||
161650430|NCT00475228|583769917|FG001|Overall Study|Lost to Follow-up|17|||
161650431|NCT03633799|583769926|FG000|Overall Study|Adverse Event|349|||
161650432|NCT03633799|583769926|FG000|Overall Study|Withdrawal by Subject|288|||
161650433|NCT03633799|583769926|FG000|Overall Study|Lost to Follow-up|97|||
161650434|NCT03633799|583769926|FG000|Overall Study|Physician Decision|9|||
161650435|NCT03633799|583769926|FG000|Overall Study|Protocol Violation|4|||
161650436|NCT03633799|583769926|FG000|Overall Study|Pregnancy|20|||
161650437|NCT03633799|583769926|FG000|Overall Study|other|39|||
161650438|NCT03633799|583769926|FG000|Overall Study|ongoing within third year of study|106|||
161650439|NCT03633799|583769926|FG000|Overall Study|unsuccessful study drug placement|19|||
161650440|NCT03551691|583769929|FG000|Overall Study|Withdrawal by Subject|3|||
161650441|NCT03551691|583769930|FG001|Overall Study|Withdrawal by Subject|3|||
161650442|NCT02367040|583769931|FG000|Overall Study|Lost to Follow-up|1|||
161650443|NCT02367040|583769932|FG001|Overall Study|Lost to Follow-up|1|||
161650444|NCT02367040|583769931|FG000|Overall Study|Lack of Efficacy|1|||
161650445|NCT02367040|583769932|FG001|Overall Study|Lack of Efficacy|0|||
161650446|NCT02367040|583769931|FG000|Overall Study|Additional primary malignancy|1|||
161650447|NCT02367040|583769932|FG001|Overall Study|Additional primary malignancy|1|||
161650448|NCT02367040|583769931|FG000|Overall Study|AE not associated with clinical disease progression|117|||
161650449|NCT02367040|583769932|FG001|Overall Study|AE not associated with clinical disease progression|12|||
161650450|NCT02367040|583769931|FG000|Overall Study|AE associated with clinical disease progression|1|||
161650451|NCT02367040|583769932|FG001|Overall Study|AE associated with clinical disease progression|4|||
161650452|NCT02367040|583769931|FG000|Overall Study|Physician Decision|2|||
161650453|NCT02367040|583769932|FG001|Overall Study|Physician Decision|8|||
161650454|NCT02367040|583769931|FG000|Overall Study|Non-compliance to study drug|1|||
161650455|NCT02367040|583769932|FG001|Overall Study|Non-compliance to study drug|0|||
161650456|NCT02367040|583769931|FG000|Overall Study|Failure to meet continuation criteria|1|||
161650457|NCT02367040|583769932|FG001|Overall Study|Failure to meet continuation criteria|0|||
161650458|NCT02367040|583769931|FG000|Overall Study|Switching to other therapy|2|||
161650459|NCT02367040|583769932|FG001|Overall Study|Switching to other therapy|0|||
161650460|NCT02367040|583769931|FG000|Overall Study|Withdrawal by Subject|51|||
161650461|NCT02367040|583769932|FG001|Overall Study|Withdrawal by Subject|16|||
161650462|NCT02367040|583769931|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
161650463|NCT02367040|583769932|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161650464|NCT02367040|583769931|FG000|Overall Study|Patient decision|40|||
161650465|NCT02367040|583769932|FG001|Overall Study|Patient decision|14|||
161650466|NCT02367040|583769931|FG000|Overall Study|Required procedure failed|1|||
161650467|NCT02367040|583769932|FG001|Overall Study|Required procedure failed|0|||
161650468|NCT02367040|583769931|FG000|Overall Study|Randomized by mistake with study treatment|1|||
161650469|NCT02367040|583769932|FG001|Overall Study|Randomized by mistake with study treatment|0|||
161650470|NCT02367040|583769931|FG000|Overall Study|Protocol Violation|1|||
161650471|NCT02367040|583769932|FG001|Overall Study|Protocol Violation|0|||
161650472|NCT02367040|583769931|FG000|Overall Study|Progressive disease - radiological progression|54|||
161650473|NCT02367040|583769932|FG001|Overall Study|Progressive disease - radiological progression|80|||
161650474|NCT02367040|583769931|FG000|Overall Study|Progressive disease - clinical progression|6|||
161650475|NCT02367040|583769932|FG001|Overall Study|Progressive disease - clinical progression|6|||
161650476|NCT02367040|583769931|FG000|Overall Study|Drug not administered|3|||
161650477|NCT02367040|583769932|FG001|Overall Study|Drug not administered|2|||
161650478|NCT02367040|583769931|FG000|Overall Study|Progressive disease|0|||
161650479|NCT02367040|583769932|FG001|Overall Study|Progressive disease|1|||
161650480|NCT02367040|583769931|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
161650481|NCT02367040|583769932|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
161650482|NCT02367040|583769931|FG000|Overall Study|Death|2|||
161650483|NCT02367040|583769932|FG001|Overall Study|Death|0|||
161650484|NCT02367040|583769931|FG000|Overall Study|Study terminated by sponsor|19|||
161650485|NCT02367040|583769932|FG001|Overall Study|Study terminated by sponsor|2|||
161650486|NCT02477618|583769933|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
161650487|NCT02477618|583769934|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
161650488|NCT02477618|583769933|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
161650489|NCT02477618|583769934|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
161650490|NCT02477618|583769933|FG000|Overall Study|Adverse Event|1|||
161650491|NCT02477618|583769934|FG001|Overall Study|Adverse Event|1|||
161650492|NCT02477618|583769933|FG000|Overall Study|Transferred Away from Study Site|1|||
161650493|NCT02477618|583769934|FG001|Overall Study|Transferred Away from Study Site|0|||
161650494|NCT02477618|583769933|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
161650495|NCT02477618|583769934|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
161650496|NCT05855967|583769935|FG000|Overall Study|Withdrawal by Subject|7|||
161650497|NCT05855967|583769936|FG001|Overall Study|Withdrawal by Subject|5|||
161650498|NCT05855967|583769935|FG000|Overall Study|Lost to Follow-up|2|||
161650499|NCT05855967|583769936|FG001|Overall Study|Lost to Follow-up|1|||
161650500|NCT02446821|583769937|FG000|Overall Study|Adverse Event|28|||
161650501|NCT02446821|583769937|FG000|Overall Study|Withdrawal by Subject|6|||
161650502|NCT02446821|583769937|FG000|Overall Study|Lost to Follow-up|22|||
161650503|NCT02446821|583769937|FG000|Overall Study|other|9|||
161650504|NCT02446821|583769937|FG000|Overall Study|insertion failure|3|||
161650505|NCT02284009|583769941|FG000|Overall Study|Adverse Event|3|||
161650506|NCT02284009|583769942|FG001|Overall Study|Adverse Event|0|||
161650507|NCT02284009|583769941|FG000|Overall Study|Lost to Follow-up|1|||
161650508|NCT02284009|583769942|FG001|Overall Study|Lost to Follow-up|3|||
161650509|NCT02284009|583769941|FG000|Overall Study|Physician Decision|0|||
161650510|NCT02284009|583769942|FG001|Overall Study|Physician Decision|2|||
161650511|NCT02284009|583769941|FG000|Overall Study|Withdrawal by Subject|2|||
161650512|NCT02284009|583769942|FG001|Overall Study|Withdrawal by Subject|5|||
161650513|NCT04147195|583769943|FG000|Overall Study|Adverse Event|0|||
161650514|NCT04147195|583769944|FG001|Overall Study|Adverse Event|3|||
161650515|NCT04147195|583769943|FG000|Overall Study|Study Terminated by Sponsor|4|||
161650516|NCT04147195|583769944|FG001|Overall Study|Study Terminated by Sponsor|2|||
161650517|NCT04147195|583769943|FG000|Overall Study|Withdrawal by Subject|0|||
161650518|NCT04147195|583769944|FG001|Overall Study|Withdrawal by Subject|1|||
161650519|NCT03841526|583769945|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
161650520|NCT03841526|583769946|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161650521|NCT03841526|583769947|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161650522|NCT03841526|583769948|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
161650523|NCT03841526|583769949|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161650524|NCT03841526|583769950|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161650525|NCT03841526|583769945|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
161650526|NCT03841526|583769946|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
161650527|NCT03841526|583769947|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
161650528|NCT03841526|583769948|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
161650529|NCT03841526|583769949|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
161650530|NCT03841526|583769950|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
161650531|NCT03841526|583769945|FG000|Outpatient Phase Treatment|Physician Decision|0|||
161650532|NCT03841526|583769946|FG001|Outpatient Phase Treatment|Physician Decision|1|||
161650533|NCT03841526|583769947|FG002|Outpatient Phase Treatment|Physician Decision|0|||
161650534|NCT03841526|583769948|FG003|Outpatient Phase Treatment|Physician Decision|0|||
161650535|NCT03841526|583769949|FG004|Outpatient Phase Treatment|Physician Decision|0|||
161650536|NCT03841526|583769950|FG005|Outpatient Phase Treatment|Physician Decision|0|||
161650537|NCT03841526|583769945|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161650538|NCT03841526|583769946|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161650539|NCT03841526|583769947|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
161650540|NCT03841526|583769948|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161650541|NCT03841526|583769949|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161650542|NCT03841526|583769950|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
161650543|NCT01876082|583772384|FG000|Overall Study|Withdrawal by Subject|0|||
161650544|NCT01876082|583772385|FG001|Overall Study|Withdrawal by Subject|2|||
161650545|NCT01876082|583772384|FG000|Overall Study|Protocol Violation|1|||
161650546|NCT01876082|583772385|FG001|Overall Study|Protocol Violation|0|||
161650547|NCT01876082|583772384|FG000|Overall Study|Adverse Event|1|||
161650548|NCT01876082|583772385|FG001|Overall Study|Adverse Event|1|||
161650549|NCT01876082|583772384|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
161650550|NCT01876082|583772385|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
161650551|NCT03829501|583772396|FG000|Overall Study|Withdrawal of Consent|2|||
161650552|NCT03829501|583772397|FG001|Overall Study|Withdrawal of Consent|0|||
161650553|NCT03829501|583772398|FG002|Overall Study|Withdrawal of Consent|3|||
161650554|NCT03829501|583772399|FG003|Overall Study|Withdrawal of Consent|0|||
161650555|NCT03829501|583772400|FG004|Overall Study|Withdrawal of Consent|1|||
161650556|NCT03829501|583772401|FG005|Overall Study|Withdrawal of Consent|1|||
161650557|NCT03829501|583772402|FG006|Overall Study|Withdrawal of Consent|0|||
161650558|NCT03829501|583772403|FG007|Overall Study|Withdrawal of Consent|10|||
161688792|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688793|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
161688794|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
161688795|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688796|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688797|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688798|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
161688799|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
161688800|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
161688801|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
161688802|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
161688803|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
161688804|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
161688805|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
161688806|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688807|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688808|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
161650559|NCT03829501|583772404|FG008|Overall Study|Withdrawal of Consent|10|||
161650560|NCT03829501|583772405|FG009|Overall Study|Withdrawal of Consent|3|||
161650561|NCT03829501|583772406|FG010|Overall Study|Withdrawal of Consent|4|||
161650562|NCT03829501|583772407|FG011|Overall Study|Withdrawal of Consent|4|||
161650563|NCT03829501|583772408|FG012|Overall Study|Withdrawal of Consent|4|||
161650564|NCT03829501|583772409|FG013|Overall Study|Withdrawal of Consent|0|||
161650565|NCT03829501|583772410|FG014|Overall Study|Withdrawal of Consent|3|||
161650566|NCT03829501|583772411|FG015|Overall Study|Withdrawal of Consent|0|||
161650567|NCT03829501|583772412|FG016|Overall Study|Withdrawal of Consent|1|||
161650568|NCT03829501|583772413|FG017|Overall Study|Withdrawal of Consent|1|||
161650569|NCT03829501|583772414|FG018|Overall Study|Withdrawal of Consent|0|||
161650570|NCT03829501|583772415|FG019|Overall Study|Withdrawal of Consent|0|||
161650571|NCT03829501|583772416|FG020|Overall Study|Withdrawal of Consent|3|||
161650572|NCT03829501|583772417|FG021|Overall Study|Withdrawal of Consent|0|||
161650573|NCT03829501|583772418|FG022|Overall Study|Withdrawal of Consent|1|||
161650574|NCT03829501|583772396|FG000|Overall Study|PD|0|||
161650575|NCT03829501|583772397|FG001|Overall Study|PD|0|||
161650576|NCT03829501|583772398|FG002|Overall Study|PD|0|||
161650577|NCT03829501|583772399|FG003|Overall Study|PD|2|||
161650578|NCT03829501|583772400|FG004|Overall Study|PD|0|||
161650579|NCT03829501|583772401|FG005|Overall Study|PD|0|||
161650580|NCT03829501|583772402|FG006|Overall Study|PD|0|||
161650581|NCT03829501|583772403|FG007|Overall Study|PD|0|||
161650582|NCT03829501|583772404|FG008|Overall Study|PD|0|||
161650583|NCT03829501|583772405|FG009|Overall Study|PD|0|||
161650584|NCT03829501|583772406|FG010|Overall Study|PD|0|||
161650585|NCT03829501|583772407|FG011|Overall Study|PD|0|||
161650586|NCT03829501|583772408|FG012|Overall Study|PD|0|||
161650587|NCT03829501|583772409|FG013|Overall Study|PD|0|||
161650588|NCT03829501|583772410|FG014|Overall Study|PD|0|||
161650589|NCT03829501|583772411|FG015|Overall Study|PD|1|||
161650590|NCT03829501|583772412|FG016|Overall Study|PD|0|||
161650591|NCT03829501|583772413|FG017|Overall Study|PD|0|||
161650592|NCT03829501|583772414|FG018|Overall Study|PD|0|||
161650593|NCT03829501|583772415|FG019|Overall Study|PD|0|||
161650594|NCT03829501|583772416|FG020|Overall Study|PD|1|||
161650595|NCT03829501|583772417|FG021|Overall Study|PD|0|||
161650596|NCT03829501|583772418|FG022|Overall Study|PD|0|||
161650597|NCT03829501|583772396|FG000|Overall Study|Study Terminated by Sponsor|0|||
161650598|NCT03829501|583772397|FG001|Overall Study|Study Terminated by Sponsor|0|||
161650599|NCT03829501|583772398|FG002|Overall Study|Study Terminated by Sponsor|0|||
161650600|NCT03829501|583772399|FG003|Overall Study|Study Terminated by Sponsor|0|||
161688809|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688810|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
161650601|NCT03829501|583772400|FG004|Overall Study|Study Terminated by Sponsor|0|||
161650602|NCT03829501|583772401|FG005|Overall Study|Study Terminated by Sponsor|0|||
161650603|NCT03829501|583772402|FG006|Overall Study|Study Terminated by Sponsor|0|||
161650604|NCT03829501|583772403|FG007|Overall Study|Study Terminated by Sponsor|3|||
161650605|NCT03829501|583772404|FG008|Overall Study|Study Terminated by Sponsor|1|||
161650606|NCT03829501|583772405|FG009|Overall Study|Study Terminated by Sponsor|0|||
161650607|NCT03829501|583772406|FG010|Overall Study|Study Terminated by Sponsor|0|||
161650608|NCT03829501|583772407|FG011|Overall Study|Study Terminated by Sponsor|0|||
161650609|NCT03829501|583772408|FG012|Overall Study|Study Terminated by Sponsor|0|||
161650610|NCT03829501|583772409|FG013|Overall Study|Study Terminated by Sponsor|0|||
161650611|NCT03829501|583772410|FG014|Overall Study|Study Terminated by Sponsor|3|||
161650612|NCT03829501|583772411|FG015|Overall Study|Study Terminated by Sponsor|2|||
161650613|NCT03829501|583772412|FG016|Overall Study|Study Terminated by Sponsor|2|||
161650614|NCT03829501|583772413|FG017|Overall Study|Study Terminated by Sponsor|0|||
161650615|NCT03829501|583772414|FG018|Overall Study|Study Terminated by Sponsor|0|||
161688811|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688812|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
161688813|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688814|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688815|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688816|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
161688817|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688818|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688819|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688820|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688821|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688822|NCT03016325|583911762|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688823|NCT03016325|583911763|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
161688824|NCT03016325|583911764|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688825|NCT03016325|583911765|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688826|NCT03016325|583911766|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688827|NCT03016325|583911767|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688828|NCT03016325|583911768|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688829|NCT03016325|583911769|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688830|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Death|3|||
161688831|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Death|3|||
161688832|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Death|11|||
161688833|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Death|12|||
161688834|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Death|9|||
161688835|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Death|0|||
161688836|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Death|0|||
161688837|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Death|1|||
161688838|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
161688839|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688840|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688841|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688842|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688843|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688844|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688845|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688846|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688847|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688848|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688849|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688850|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
161688851|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688852|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
161688853|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688854|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161650616|NCT03829501|583772415|FG019|Overall Study|Study Terminated by Sponsor|0|||
161650617|NCT03829501|583772416|FG020|Overall Study|Study Terminated by Sponsor|1|||
161650618|NCT03829501|583772417|FG021|Overall Study|Study Terminated by Sponsor|0|||
161650619|NCT03829501|583772418|FG022|Overall Study|Study Terminated by Sponsor|3|||
161650620|NCT03829501|583772396|FG000|Overall Study|Lost to Follow Up|0|||
161650621|NCT03829501|583772397|FG001|Overall Study|Lost to Follow Up|0|||
161650622|NCT03829501|583772398|FG002|Overall Study|Lost to Follow Up|0|||
161650623|NCT03829501|583772399|FG003|Overall Study|Lost to Follow Up|0|||
161650624|NCT03829501|583772400|FG004|Overall Study|Lost to Follow Up|1|||
161650625|NCT03829501|583772401|FG005|Overall Study|Lost to Follow Up|0|||
161650626|NCT03829501|583772402|FG006|Overall Study|Lost to Follow Up|0|||
161650627|NCT03829501|583772403|FG007|Overall Study|Lost to Follow Up|2|||
161650628|NCT03829501|583772404|FG008|Overall Study|Lost to Follow Up|2|||
161650629|NCT03829501|583772405|FG009|Overall Study|Lost to Follow Up|0|||
161650630|NCT03829501|583772406|FG010|Overall Study|Lost to Follow Up|2|||
161650631|NCT03829501|583772407|FG011|Overall Study|Lost to Follow Up|1|||
161650632|NCT03829501|583772408|FG012|Overall Study|Lost to Follow Up|0|||
161650633|NCT03829501|583772409|FG013|Overall Study|Lost to Follow Up|1|||
161650634|NCT03829501|583772410|FG014|Overall Study|Lost to Follow Up|1|||
161650635|NCT03829501|583772411|FG015|Overall Study|Lost to Follow Up|0|||
161650636|NCT03829501|583772412|FG016|Overall Study|Lost to Follow Up|0|||
161650637|NCT03829501|583772413|FG017|Overall Study|Lost to Follow Up|0|||
161650638|NCT03829501|583772414|FG018|Overall Study|Lost to Follow Up|0|||
161650639|NCT03829501|583772415|FG019|Overall Study|Lost to Follow Up|0|||
161650640|NCT03829501|583772416|FG020|Overall Study|Lost to Follow Up|0|||
161650641|NCT03829501|583772417|FG021|Overall Study|Lost to Follow Up|0|||
161650642|NCT03829501|583772418|FG022|Overall Study|Lost to Follow Up|1|||
161650643|NCT03829501|583772396|FG000|Overall Study|Death|2|||
161650644|NCT03829501|583772397|FG001|Overall Study|Death|4|||
161650645|NCT03829501|583772398|FG002|Overall Study|Death|5|||
161650646|NCT03829501|583772399|FG003|Overall Study|Death|6|||
161650647|NCT03829501|583772400|FG004|Overall Study|Death|5|||
161650648|NCT03829501|583772401|FG005|Overall Study|Death|4|||
161650649|NCT03829501|583772402|FG006|Overall Study|Death|5|||
161650650|NCT03829501|583772403|FG007|Overall Study|Death|24|||
161650651|NCT03829501|583772404|FG008|Overall Study|Death|22|||
161650652|NCT03829501|583772405|FG009|Overall Study|Death|6|||
161650653|NCT03829501|583772406|FG010|Overall Study|Death|3|||
161650654|NCT03829501|583772407|FG011|Overall Study|Death|10|||
161650655|NCT03829501|583772408|FG012|Overall Study|Death|10|||
161650656|NCT03829501|583772409|FG013|Overall Study|Death|5|||
161650657|NCT03829501|583772410|FG014|Overall Study|Death|7|||
161650658|NCT03829501|583772411|FG015|Overall Study|Death|2|||
161650659|NCT03829501|583772412|FG016|Overall Study|Death|2|||
161650660|NCT03829501|583772413|FG017|Overall Study|Death|1|||
161650661|NCT03829501|583772414|FG018|Overall Study|Death|1|||
161650662|NCT03829501|583772415|FG019|Overall Study|Death|1|||
161650663|NCT03829501|583772416|FG020|Overall Study|Death|1|||
161650664|NCT03829501|583772417|FG021|Overall Study|Death|2|||
161650665|NCT03829501|583772418|FG022|Overall Study|Death|3|||
161650666|NCT03829501|583772396|FG000|Overall Study|Miscellaneous|0|||
161650667|NCT03829501|583772397|FG001|Overall Study|Miscellaneous|0|||
161650668|NCT03829501|583772398|FG002|Overall Study|Miscellaneous|1|||
161650669|NCT03829501|583772399|FG003|Overall Study|Miscellaneous|0|||
161650670|NCT03829501|583772400|FG004|Overall Study|Miscellaneous|0|||
161650671|NCT03829501|583772401|FG005|Overall Study|Miscellaneous|0|||
161650672|NCT03829501|583772402|FG006|Overall Study|Miscellaneous|0|||
161650673|NCT03829501|583772403|FG007|Overall Study|Miscellaneous|1|||
161650674|NCT03829501|583772404|FG008|Overall Study|Miscellaneous|0|||
161650675|NCT03829501|583772405|FG009|Overall Study|Miscellaneous|0|||
161650676|NCT03829501|583772406|FG010|Overall Study|Miscellaneous|0|||
161650677|NCT03829501|583772407|FG011|Overall Study|Miscellaneous|0|||
161650678|NCT03829501|583772408|FG012|Overall Study|Miscellaneous|0|||
161650679|NCT03829501|583772409|FG013|Overall Study|Miscellaneous|0|||
161650680|NCT03829501|583772410|FG014|Overall Study|Miscellaneous|0|||
161650681|NCT03829501|583772411|FG015|Overall Study|Miscellaneous|0|||
161650682|NCT03829501|583772412|FG016|Overall Study|Miscellaneous|0|||
161650683|NCT03829501|583772413|FG017|Overall Study|Miscellaneous|0|||
161650684|NCT03829501|583772414|FG018|Overall Study|Miscellaneous|0|||
161650685|NCT03829501|583772415|FG019|Overall Study|Miscellaneous|0|||
161650686|NCT03829501|583772416|FG020|Overall Study|Miscellaneous|0|||
161650687|NCT03829501|583772417|FG021|Overall Study|Miscellaneous|0|||
161650688|NCT03829501|583772418|FG022|Overall Study|Miscellaneous|1|||
161650689|NCT04707664|583772424|FG000|Overall Study|Adverse Event|2|||
161650690|NCT04707664|583772425|FG001|Overall Study|Adverse Event|0|||
161650691|NCT04707664|583772424|FG000|Overall Study|Death|1|||
161650692|NCT04707664|583772425|FG001|Overall Study|Death|2|||
161650693|NCT04707664|583772424|FG000|Overall Study|Withdrawal by Subject|13|||
161650694|NCT04707664|583772425|FG001|Overall Study|Withdrawal by Subject|21|||
161650695|NCT04707664|583772424|FG000|Overall Study|Lost to Follow-up|11|||
161650696|NCT04707664|583772425|FG001|Overall Study|Lost to Follow-up|13|||
161650697|NCT04707664|583772424|FG000|Overall Study|Not treated|2|||
161650698|NCT04707664|583772425|FG001|Overall Study|Not treated|0|||
161650699|NCT00357110|583772426|FG000|Overall Study|Early study termination|5|||
161650700|NCT00357110|583772427|FG001|Overall Study|Early study termination|5|||
161650701|NCT00288639|583772428|FG000|Overall Study|Adverse Event|5|||
161650702|NCT00288639|583772428|FG000|Overall Study|Lack of Efficacy|4|||
161650703|NCT00288639|583772428|FG000|Overall Study|Withdrawal by Subject|2|||
161650704|NCT00288639|583772428|FG000|Overall Study|Other|1|||
161650705|NCT01195948|583772429|FG000|Overall Study|Lost to Follow-up|0|||
161650706|NCT01195948|583772430|FG001|Overall Study|Lost to Follow-up|1|||
161836130|NCT04189445|584442880|FG002|Overall Study|Study Terminated by Sponsor|0|||
161650707|NCT01195948|583772431|FG002|Overall Study|Lost to Follow-up|2|||
161650708|NCT01498887|583772434|FG000|Overall Study|Administrative problems|1|||
161650709|NCT01498887|583772435|FG001|Overall Study|Administrative problems|0|||
161650710|NCT01498887|583772434|FG000|Overall Study|Lost to Follow-up|1|||
161650711|NCT01498887|583772435|FG001|Overall Study|Lost to Follow-up|1|||
161650712|NCT01498887|583772434|FG000|Overall Study|Withdrawal by Subject|1|||
161650713|NCT01498887|583772435|FG001|Overall Study|Withdrawal by Subject|0|||
161650714|NCT01498887|583772434|FG000|Overall Study|Protocol Violation|1|||
161650715|NCT01498887|583772435|FG001|Overall Study|Protocol Violation|3|||
161650716|NCT01498887|583772434|FG000|Overall Study|Lack of Efficacy|5|||
161650717|NCT01498887|583772435|FG001|Overall Study|Lack of Efficacy|3|||
161650718|NCT01498887|583772434|FG000|Overall Study|Abnormal result from test procedure|1|||
161650719|NCT01498887|583772435|FG001|Overall Study|Abnormal result from test procedure|1|||
161650720|NCT01498887|583772434|FG000|Overall Study|Abnormal laboratory value|2|||
161688855|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688856|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688857|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688858|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
161836131|NCT04189445|584442878|FG000|Overall Study|Death|54|||
161836132|NCT04189445|584442879|FG001|Overall Study|Death|24|||
161836133|NCT04189445|584442880|FG002|Overall Study|Death|0|||
161836134|NCT00003138|584442881|FG000|Step 1|Reasons off treatment not documented|60|||
161836135|NCT00003138|584442882|FG001|Step 1|Reasons off treatment not documented|57|||
161836136|NCT00003138|584442881|FG000|Step 1|Never started treatment|1|||
161836137|NCT00003138|584442882|FG001|Step 1|Never started treatment|0|||
161836138|NCT00003138|584442881|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
161836139|NCT00003138|584442882|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
161836140|NCT00003138|584442881|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
161836141|NCT00003138|584442882|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
161836142|NCT00003138|584442881|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
161836143|NCT00003138|584442882|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
161836144|NCT00003138|584442881|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
161836145|NCT00003138|584442882|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
161836146|NCT02522403|584442883|FG000|Overall Study|Lost to Follow-up|2|||
161836147|NCT02522403|584442884|FG001|Overall Study|Lost to Follow-up|2|||
161836148|NCT02522403|584442883|FG000|Overall Study|Withdrawal by Subject|2|||
161836149|NCT02522403|584442884|FG001|Overall Study|Withdrawal by Subject|4|||
161836150|NCT05142566|584442885|FG000|Overall Study|Protocol Violation|1|||
161836151|NCT04556552|584442886|FG000|Overall Study|Lost to Follow-up|1|||
161836152|NCT04556552|584442887|FG001|Overall Study|Lost to Follow-up|0|||
161836153|NCT04556552|584442886|FG000|Overall Study|Claustrophobia|0|||
161836154|NCT04556552|584442887|FG001|Overall Study|Claustrophobia|1|||
161836155|NCT04556552|584442886|FG000|Overall Study|Inability to continue|0|||
161650721|NCT01498887|583772435|FG001|Overall Study|Abnormal laboratory value|2|||
161650722|NCT01498887|583772434|FG000|Overall Study|Adverse Event|4|||
161650723|NCT01498887|583772435|FG001|Overall Study|Adverse Event|1|||
161650724|NCT04079868|583772436|FG000|Overall Study|Lost to Follow-up|100|||
161650725|NCT04079868|583772437|FG001|Overall Study|Lost to Follow-up|200|||
161650726|NCT04079868|583772436|FG000|Overall Study|Physician Decision|100|||
161650727|NCT04079868|583772437|FG001|Overall Study|Physician Decision|0|||
161650728|NCT04335591|583772438|FG000|Overall Study|Adverse Event|5|||
161650729|NCT04335591|583772439|FG001|Overall Study|Adverse Event|2|||
161650730|NCT04335591|583772440|FG002|Overall Study|Adverse Event|3|||
161650731|NCT04335591|583772441|FG003|Overall Study|Adverse Event|2|||
161650732|NCT04335591|583772438|FG000|Overall Study|Protocol Violation|1|||
161650733|NCT04335591|583772439|FG001|Overall Study|Protocol Violation|0|||
161650734|NCT04335591|583772440|FG002|Overall Study|Protocol Violation|0|||
161650735|NCT04335591|583772441|FG003|Overall Study|Protocol Violation|0|||
161650736|NCT04335591|583772438|FG000|Overall Study|Withdrawal by Subject|8|||
161650737|NCT04335591|583772439|FG001|Overall Study|Withdrawal by Subject|4|||
161650738|NCT04335591|583772440|FG002|Overall Study|Withdrawal by Subject|4|||
161650739|NCT04335591|583772441|FG003|Overall Study|Withdrawal by Subject|5|||
161650740|NCT04335591|583772438|FG000|Overall Study|Subject planning pregnancy|0|||
161650741|NCT04335591|583772439|FG001|Overall Study|Subject planning pregnancy|1|||
161650742|NCT04335591|583772440|FG002|Overall Study|Subject planning pregnancy|0|||
161650743|NCT04335591|583772441|FG003|Overall Study|Subject planning pregnancy|0|||
161650744|NCT04335591|583772438|FG000|Overall Study|Ukrainian Russian war conflict|4|||
161650745|NCT04335591|583772439|FG001|Overall Study|Ukrainian Russian war conflict|5|||
161650746|NCT04335591|583772440|FG002|Overall Study|Ukrainian Russian war conflict|2|||
161650747|NCT04335591|583772441|FG003|Overall Study|Ukrainian Russian war conflict|0|||
161650748|NCT01077128|583772451|FG000|Overall Study|Adverse Event|8|||
161650749|NCT01077128|583772451|FG000|Overall Study|Lack of Efficacy|1|||
161650750|NCT01077128|583772451|FG000|Overall Study|Disease exacerbation|1|||
161650751|NCT01077128|583772451|FG000|Overall Study|Adverse event and consent withdrawal|1|||
161650752|NCT01077128|583772451|FG000|Overall Study|Adverse event and disease exacerbation|1|||
161836156|NCT04556552|584442887|FG001|Overall Study|Inability to continue|1|||
161836157|NCT01553279|584442888|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
161836158|NCT01553279|584442889|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
161836159|NCT01553279|584442888|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
161650753|NCT01077128|583772451|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
161650754|NCT01077128|583772451|FG000|Overall Study|Other|54|||
161650755|NCT03338296|583772459|FG000|Overall Study|Adverse Event|0|||
161650756|NCT03338296|583772460|FG001|Overall Study|Adverse Event|1|||
161650757|NCT03338296|583772459|FG000|Overall Study|Withdrawal by Subject|14|||
161650758|NCT03338296|583772460|FG001|Overall Study|Withdrawal by Subject|13|||
161650759|NCT03338296|583772459|FG000|Overall Study|Lost to Follow-up|10|||
161650760|NCT03338296|583772460|FG001|Overall Study|Lost to Follow-up|10|||
161650761|NCT03338296|583772459|FG000|Overall Study|Study Terminated by Sponsor|77|||
161650762|NCT03338296|583772460|FG001|Overall Study|Study Terminated by Sponsor|76|||
161650763|NCT03338296|583772459|FG000|Overall Study|Other|2|||
161650764|NCT03338296|583772460|FG001|Overall Study|Other|7|||
161650765|NCT03338296|583772459|FG000|Overall Study|Missing|0|||
161650766|NCT03338296|583772460|FG001|Overall Study|Missing|1|||
161650767|NCT01939353|583772461|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
161650768|NCT01939353|583772461|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
161650769|NCT01939353|583772461|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
161650770|NCT01939353|583772461|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161650771|NCT01939353|583772461|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
161650772|NCT04421950|583772465|FG000|Overall Study|Dropped or lost to follow up|4|||
161650773|NCT04421950|583772466|FG001|Overall Study|Dropped or lost to follow up|2|||
161650774|NCT04546425|583772467|FG000|Overall Study|Protocol Violation|1|||
161650775|NCT04546425|583772468|FG001|Overall Study|Protocol Violation|1|||
161650776|NCT04546425|583772469|FG002|Overall Study|Protocol Violation|0|||
161650777|NCT04546425|583772470|FG003|Overall Study|Protocol Violation|0|||
161650778|NCT04546425|583772467|FG000|Overall Study|Adverse Event|3|||
161650779|NCT04546425|583772468|FG001|Overall Study|Adverse Event|0|||
161650780|NCT04546425|583772469|FG002|Overall Study|Adverse Event|0|||
161650781|NCT04546425|583772470|FG003|Overall Study|Adverse Event|0|||
161650782|NCT04546425|583772467|FG000|Overall Study|Lost to Follow-up|5|||
161650783|NCT04546425|583772468|FG001|Overall Study|Lost to Follow-up|4|||
161650784|NCT04546425|583772469|FG002|Overall Study|Lost to Follow-up|0|||
161650785|NCT04546425|583772470|FG003|Overall Study|Lost to Follow-up|0|||
161650786|NCT04546425|583772467|FG000|Overall Study|No Longer met eligibility criteria|3|||
161650787|NCT04546425|583772468|FG001|Overall Study|No Longer met eligibility criteria|3|||
161650788|NCT04546425|583772469|FG002|Overall Study|No Longer met eligibility criteria|1|||
161650789|NCT04546425|583772470|FG003|Overall Study|No Longer met eligibility criteria|1|||
161650790|NCT04546425|583772467|FG000|Overall Study|Withdrawal by parent/guardian|6|||
161650791|NCT04546425|583772468|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161650792|NCT04546425|583772469|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161650793|NCT04546425|583772470|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161650794|NCT00967005|583772471|FG000|Overall Study|Lost to Follow-up|7|||
161650795|NCT00967005|583772472|FG001|Overall Study|Lost to Follow-up|10|||
161650796|NCT05071053|583772473|FG000|Overall Study|Progressive disease|30|||
161650797|NCT05071053|583772473|FG000|Overall Study|Adverse Event|5|||
161650798|NCT02593123|583772474|FG000|Overall Study|Physician Decision|2|||
161650799|NCT02593123|583772475|FG001|Overall Study|Physician Decision|1|||
161650800|NCT02593123|583772474|FG000|Overall Study|Relapse|1|||
161650801|NCT02593123|583772475|FG001|Overall Study|Relapse|1|||
161650802|NCT03945825|583772482|FG000|Overall Study|Enrolled but treatment not administered|0|||
161650803|NCT03945825|583772483|FG001|Overall Study|Enrolled but treatment not administered|0|||
161650804|NCT03945825|583772484|FG002|Overall Study|Enrolled but treatment not administered|0|||
161650805|NCT03945825|583772485|FG003|Overall Study|Enrolled but treatment not administered|0|||
161650806|NCT03945825|583772486|FG004|Overall Study|Enrolled but treatment not administered|1|||
161650807|NCT03945825|583772487|FG005|Overall Study|Enrolled but treatment not administered|0|||
161650808|NCT03945825|583772482|FG000|Overall Study|Lost to Follow-up|1|||
161650809|NCT03945825|583772483|FG001|Overall Study|Lost to Follow-up|5|||
161650810|NCT03945825|583772484|FG002|Overall Study|Lost to Follow-up|0|||
161650811|NCT03945825|583772485|FG003|Overall Study|Lost to Follow-up|1|||
161650812|NCT03945825|583772486|FG004|Overall Study|Lost to Follow-up|2|||
161650813|NCT03945825|583772487|FG005|Overall Study|Lost to Follow-up|2|||
161650814|NCT03945825|583772482|FG000|Overall Study|Withdrawal by Subject|1|||
161688859|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161650815|NCT03945825|583772483|FG001|Overall Study|Withdrawal by Subject|0|||
161650816|NCT03945825|583772484|FG002|Overall Study|Withdrawal by Subject|1|||
161650817|NCT03945825|583772485|FG003|Overall Study|Withdrawal by Subject|1|||
161650818|NCT03945825|583772486|FG004|Overall Study|Withdrawal by Subject|0|||
161688860|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161836160|NCT01553279|584442889|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
161836161|NCT01553279|584442888|FG000|Interim Period|Withdrawal by Subject|2|||
161836162|NCT01553279|584442889|FG001|Interim Period|Withdrawal by Subject|2|||
161836163|NCT01553279|584442888|FG000|Interim Period|Lost to Follow-up|1|||
161650819|NCT03945825|583772487|FG005|Overall Study|Withdrawal by Subject|1|||
161650820|NCT00846807|583772490|FG000|Overall Study|Adverse Event|270|||
161650821|NCT00846807|583772490|FG000|Overall Study|Lost to Follow-up|94|||
161650822|NCT00846807|583772490|FG000|Overall Study|Withdrawal by Subject|56|||
161650823|NCT00846807|583772490|FG000|Overall Study|Non compliant with European label|7|||
161650824|NCT00846807|583772490|FG000|Overall Study|Switch to other anticoagulants|89|||
161650825|NCT00846807|583772490|FG000|Overall Study|No prescription after hospital discharge|56|||
161650826|NCT00846807|583772490|FG000|Overall Study|Other|60|||
161650827|NCT00737698|583772491|FG000|Overall Study|Withdrawal by Subject|6|||
161650828|NCT00737698|583772492|FG001|Overall Study|Withdrawal by Subject|5|||
161650829|NCT00737698|583772493|FG002|Overall Study|Withdrawal by Subject|3|||
161650830|NCT00737698|583772491|FG000|Overall Study|Death|0|||
161650831|NCT00737698|583772492|FG001|Overall Study|Death|0|||
161650832|NCT00737698|583772493|FG002|Overall Study|Death|1|||
161650833|NCT01067846|583772494|FG000|Overall Study|Lost to Follow-up|17|||
161650834|NCT01067846|583772495|FG001|Overall Study|Lost to Follow-up|19|||
161650835|NCT01067846|583772494|FG000|Overall Study|Withdrawal by Subject|1|||
161650836|NCT01067846|583772495|FG001|Overall Study|Withdrawal by Subject|0|||
161650837|NCT01067846|583772494|FG000|Overall Study|participation in other tx study|1|||
161650838|NCT01067846|583772495|FG001|Overall Study|participation in other tx study|0|||
161650839|NCT02817906|583772496|FG000|Overall Study|Adverse Event|3|||
161650840|NCT02817906|583772497|FG001|Overall Study|Adverse Event|0|||
161650841|NCT02817906|583772496|FG000|Overall Study|Lack of Efficacy|1|||
161650842|NCT02817906|583772497|FG001|Overall Study|Lack of Efficacy|0|||
161650843|NCT02817906|583772496|FG000|Overall Study|Protocol Violation|1|||
161650844|NCT02817906|583772497|FG001|Overall Study|Protocol Violation|1|||
161650845|NCT02817906|583772496|FG000|Overall Study|Study Terminated by Sponsor|2|||
161650846|NCT02817906|583772497|FG001|Overall Study|Study Terminated by Sponsor|2|||
161650847|NCT02817906|583772496|FG000|Overall Study|Withdrawal by Subject|7|||
161650848|NCT02817906|583772497|FG001|Overall Study|Withdrawal by Subject|0|||
161650849|NCT02817906|583772496|FG000|Overall Study|Other|2|||
161650850|NCT02817906|583772497|FG001|Overall Study|Other|2|||
161650851|NCT03686423|583772506|FG000|Overall Study|Withdrawal by Subject|9|||
161650852|NCT03686423|583772506|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
161650853|NCT04954326|583772507|FG000|Overall Study|Protocol Violation|0|||
161650854|NCT04954326|583772508|FG001|Overall Study|Protocol Violation|1|||
161650855|NCT04954326|583772507|FG000|Overall Study|Death|0|||
161650856|NCT04954326|583772508|FG001|Overall Study|Death|2|||
161650857|NCT04954326|583772507|FG000|Overall Study|Physician Decision|0|||
161650858|NCT04954326|583772508|FG001|Overall Study|Physician Decision|1|||
161650859|NCT01495598|583772511|FG000|Overall Study|Death during follow up period|2|||
161650860|NCT01495598|583772511|FG000|Overall Study|Death on study|1|||
161650861|NCT01495598|583772511|FG000|Overall Study|Lost to Follow-up|3|||
161650862|NCT01495598|583772511|FG000|Overall Study|Physician Decision|8|||
161650863|NCT01110408|583772514|FG000|Overall Study|Protocol Violation|1|||
161650864|NCT01110408|583772515|FG001|Overall Study|Protocol Violation|0|||
161650865|NCT00669877|583772516|FG000|Overall Study|Disease Progression/Death|4|||
161650866|NCT03635099|583772517|FG000|Period 1|Adverse Event|1|||
161650867|NCT03635099|583772518|FG001|Period 1|Adverse Event|0|||
161650868|NCT03635099|583772519|FG002|Period 1|Adverse Event|0|||
161650869|NCT03635099|583772520|FG003|Period 1|Adverse Event|1|||
161650870|NCT03635099|583772521|FG004|Period 1|Adverse Event|0|||
161650871|NCT03635099|583772522|FG005|Period 1|Adverse Event|0|||
161650872|NCT03635099|583772523|FG006|Period 1|Adverse Event|0|||
161650873|NCT03635099|583772524|FG007|Period 1|Adverse Event|0|||
161650874|NCT03635099|583772517|FG000|Period 1|Protocol Violation|0|||
161650875|NCT03635099|583772518|FG001|Period 1|Protocol Violation|0|||
161650876|NCT03635099|583772519|FG002|Period 1|Protocol Violation|1|||
161836164|NCT01553279|584442889|FG001|Interim Period|Lost to Follow-up|0|||
161650877|NCT03635099|583772520|FG003|Period 1|Protocol Violation|0|||
161650878|NCT03635099|583772521|FG004|Period 1|Protocol Violation|0|||
161650879|NCT03635099|583772522|FG005|Period 1|Protocol Violation|0|||
161650880|NCT03635099|583772523|FG006|Period 1|Protocol Violation|0|||
161650881|NCT03635099|583772524|FG007|Period 1|Protocol Violation|0|||
161650882|NCT03635099|583772517|FG000|Period 1|Lost to Follow-up|0|||
161650883|NCT03635099|583772518|FG001|Period 1|Lost to Follow-up|0|||
161650884|NCT03635099|583772519|FG002|Period 1|Lost to Follow-up|1|||
161650885|NCT03635099|583772520|FG003|Period 1|Lost to Follow-up|2|||
161650886|NCT03635099|583772521|FG004|Period 1|Lost to Follow-up|1|||
161650887|NCT03635099|583772522|FG005|Period 1|Lost to Follow-up|0|||
161650888|NCT03635099|583772523|FG006|Period 1|Lost to Follow-up|1|||
161650889|NCT03635099|583772524|FG007|Period 1|Lost to Follow-up|2|||
161836165|NCT01553279|584442888|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
161650890|NCT03635099|583772517|FG000|Period 1|Withdrawal by Subject|3|||
161650891|NCT03635099|583772518|FG001|Period 1|Withdrawal by Subject|3|||
161650892|NCT03635099|583772519|FG002|Period 1|Withdrawal by Subject|5|||
161650893|NCT03635099|583772520|FG003|Period 1|Withdrawal by Subject|2|||
161650894|NCT03635099|583772521|FG004|Period 1|Withdrawal by Subject|2|||
161650895|NCT03635099|583772522|FG005|Period 1|Withdrawal by Subject|0|||
161650896|NCT03635099|583772523|FG006|Period 1|Withdrawal by Subject|3|||
161650897|NCT03635099|583772524|FG007|Period 1|Withdrawal by Subject|0|||
161650898|NCT03635099|583772517|FG000|Period 1|History of suicidal ideation|0|||
161650899|NCT03635099|583772518|FG001|Period 1|History of suicidal ideation|0|||
161650900|NCT03635099|583772519|FG002|Period 1|History of suicidal ideation|1|||
161650901|NCT03635099|583772520|FG003|Period 1|History of suicidal ideation|0|||
161650902|NCT03635099|583772521|FG004|Period 1|History of suicidal ideation|0|||
161650903|NCT03635099|583772522|FG005|Period 1|History of suicidal ideation|0|||
161650904|NCT03635099|583772523|FG006|Period 1|History of suicidal ideation|0|||
161650905|NCT03635099|583772524|FG007|Period 1|History of suicidal ideation|0|||
161650906|NCT03635099|583772517|FG000|Period 1|pursue other treatment options|0|||
161650907|NCT03635099|583772518|FG001|Period 1|pursue other treatment options|0|||
161650908|NCT03635099|583772519|FG002|Period 1|pursue other treatment options|0|||
161650909|NCT03635099|583772520|FG003|Period 1|pursue other treatment options|0|||
161650910|NCT03635099|583772521|FG004|Period 1|pursue other treatment options|0|||
161650911|NCT03635099|583772522|FG005|Period 1|pursue other treatment options|1|||
161650912|NCT03635099|583772523|FG006|Period 1|pursue other treatment options|0|||
161650913|NCT03635099|583772524|FG007|Period 1|pursue other treatment options|0|||
161650914|NCT03635099|583772517|FG000|Not Eligible for Period 2|Pregnancy|0|||
161650915|NCT03635099|583772518|FG001|Not Eligible for Period 2|Pregnancy|0|||
161650916|NCT03635099|583772519|FG002|Not Eligible for Period 2|Pregnancy|0|||
161650917|NCT03635099|583772520|FG003|Not Eligible for Period 2|Pregnancy|1|||
161650918|NCT03635099|583772521|FG004|Not Eligible for Period 2|Pregnancy|0|||
161650919|NCT03635099|583772522|FG005|Not Eligible for Period 2|Pregnancy|0|||
161650920|NCT03635099|583772523|FG006|Not Eligible for Period 2|Pregnancy|0|||
161650921|NCT03635099|583772524|FG007|Not Eligible for Period 2|Pregnancy|0|||
161650922|NCT03635099|583772517|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
161650923|NCT03635099|583772518|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
161650924|NCT03635099|583772519|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
161650925|NCT03635099|583772520|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
161650926|NCT03635099|583772521|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
161650927|NCT03635099|583772522|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
161836166|NCT01553279|584442889|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
161836167|NCT01553279|584442888|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
161836168|NCT01553279|584442889|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
161836169|NCT00605865|584442890|FG000|Overall Study|Protocol Violation|115|||
161836170|NCT02856880|584442896|FG000|Overall Study|Withdrawal of consent|1|||
161836171|NCT00094458|584442897|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
161836172|NCT00094458|584442898|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
161836173|NCT00094458|584442899|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
161836174|NCT00094458|584442900|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
161836175|NCT00094458|584442901|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
161836176|NCT00094458|584442902|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
161836177|NCT00094458|584442897|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
161836178|NCT00094458|584442898|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
161836179|NCT00094458|584442899|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
161836180|NCT00094458|584442900|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
161836181|NCT00094458|584442901|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
161836182|NCT00094458|584442902|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
161836183|NCT00094458|584442897|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
161836184|NCT00094458|584442898|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
161836185|NCT00094458|584442899|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
161836186|NCT00094458|584442900|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
161836187|NCT00094458|584442901|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
161836188|NCT00094458|584442902|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
161836189|NCT00094458|584442897|FG000|Main Study: Through Week 30|Adverse Event|38|||
161836190|NCT00094458|584442898|FG001|Main Study: Through Week 30|Adverse Event|20|||
161836191|NCT00094458|584442899|FG002|Main Study: Through Week 30|Adverse Event|28|||
161836192|NCT00094458|584442900|FG003|Main Study: Through Week 30|Adverse Event|0|||
161836193|NCT00094458|584442901|FG004|Main Study: Through Week 30|Adverse Event|0|||
161836194|NCT00094458|584442902|FG005|Main Study: Through Week 30|Adverse Event|0|||
161650928|NCT03635099|583772523|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
161650929|NCT03635099|583772524|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
161836195|NCT00094458|584442897|FG000|Main Study: Through Week 30|Death|1|||
161836196|NCT00094458|584442898|FG001|Main Study: Through Week 30|Death|0|||
161836197|NCT00094458|584442899|FG002|Main Study: Through Week 30|Death|0|||
161836198|NCT00094458|584442900|FG003|Main Study: Through Week 30|Death|0|||
161836199|NCT00094458|584442901|FG004|Main Study: Through Week 30|Death|0|||
161650930|NCT03635099|583772517|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161650931|NCT03635099|583772518|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161650932|NCT03635099|583772519|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161650933|NCT03635099|583772520|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161650934|NCT03635099|583772521|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161650935|NCT03635099|583772522|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
161650936|NCT03635099|583772523|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
161650937|NCT03635099|583772524|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
161650938|NCT03635099|583772517|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
161650939|NCT03635099|583772518|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
161650940|NCT03635099|583772519|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
161650941|NCT03635099|583772520|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
161650942|NCT03635099|583772521|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161650943|NCT03635099|583772522|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161650944|NCT03635099|583772523|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161650945|NCT03635099|583772524|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161650946|NCT03635099|583772517|FG000|Period 2|Adverse Event|0|||
161650947|NCT03635099|583772518|FG001|Period 2|Adverse Event|0|||
161650948|NCT03635099|583772519|FG002|Period 2|Adverse Event|1|||
161650949|NCT03635099|583772520|FG003|Period 2|Adverse Event|0|||
161650950|NCT03635099|583772521|FG004|Period 2|Adverse Event|1|||
161650951|NCT03635099|583772522|FG005|Period 2|Adverse Event|0|||
161650952|NCT03635099|583772523|FG006|Period 2|Adverse Event|0|||
161650953|NCT03635099|583772524|FG007|Period 2|Adverse Event|0|||
161650954|NCT03635099|583772517|FG000|Period 2|Lost to Follow-up|0|||
161650955|NCT03635099|583772518|FG001|Period 2|Lost to Follow-up|0|||
161650956|NCT03635099|583772519|FG002|Period 2|Lost to Follow-up|1|||
161650957|NCT03635099|583772520|FG003|Period 2|Lost to Follow-up|0|||
161650958|NCT03635099|583772521|FG004|Period 2|Lost to Follow-up|4|||
161650959|NCT03635099|583772522|FG005|Period 2|Lost to Follow-up|0|||
161650960|NCT03635099|583772523|FG006|Period 2|Lost to Follow-up|0|||
161650961|NCT03635099|583772524|FG007|Period 2|Lost to Follow-up|0|||
161650962|NCT03635099|583772517|FG000|Period 2|Withdrawal by Subject|0|||
161650963|NCT03635099|583772518|FG001|Period 2|Withdrawal by Subject|0|||
161650964|NCT03635099|583772519|FG002|Period 2|Withdrawal by Subject|7|||
161650965|NCT03635099|583772520|FG003|Period 2|Withdrawal by Subject|4|||
161650966|NCT03635099|583772521|FG004|Period 2|Withdrawal by Subject|7|||
161650967|NCT03635099|583772522|FG005|Period 2|Withdrawal by Subject|0|||
161650968|NCT03635099|583772523|FG006|Period 2|Withdrawal by Subject|0|||
161650969|NCT03635099|583772524|FG007|Period 2|Withdrawal by Subject|0|||
161650970|NCT01289210|583772525|FG000|Overall Study|Adverse Event|1|||
161650971|NCT06285240|583772526|FG000|Overall Study|Withdrawal by Subject|2|||
161650972|NCT06285240|583772527|FG001|Overall Study|Withdrawal by Subject|0|||
161650973|NCT06285240|583772528|FG002|Overall Study|Withdrawal by Subject|0|||
161650974|NCT06285240|583772529|FG003|Overall Study|Withdrawal by Subject|0|||
161650975|NCT06285240|583772526|FG000|Overall Study|Serious Adverse Event|0|||
161650976|NCT06285240|583772527|FG001|Overall Study|Serious Adverse Event|0|||
161650977|NCT06285240|583772528|FG002|Overall Study|Serious Adverse Event|1|||
161650978|NCT06285240|583772529|FG003|Overall Study|Serious Adverse Event|0|||
161650979|NCT05140915|583772532|FG000|Overall Study|Lost to Follow-up|2|||
161650980|NCT05140915|583772533|FG001|Overall Study|Lost to Follow-up|1|||
161650981|NCT04879849|583772538|FG000|Overall Study|Lost to Follow-up|0|||
161650982|NCT04879849|583772539|FG001|Overall Study|Lost to Follow-up|0|||
161650983|NCT04879849|583772540|FG002|Overall Study|Lost to Follow-up|0|||
161650984|NCT04879849|583772541|FG003|Overall Study|Lost to Follow-up|1|||
161650985|NCT04879849|583772542|FG004|Overall Study|Lost to Follow-up|0|||
161650986|NCT04879849|583772543|FG005|Overall Study|Lost to Follow-up|0|||
161650987|NCT04879849|583772544|FG006|Overall Study|Lost to Follow-up|0|||
161650988|NCT04879849|583772545|FG007|Overall Study|Lost to Follow-up|0|||
161650989|NCT04879849|583772538|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
161650990|NCT04879849|583772539|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
161650991|NCT04879849|583772540|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
161650992|NCT04879849|583772541|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
161650993|NCT04879849|583772542|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
161650994|NCT04879849|583772543|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
161650995|NCT04879849|583772544|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
161650996|NCT04879849|583772545|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
161650997|NCT04879849|583772538|FG000|Overall Study|Withdrawal by Subject|0|||
161650998|NCT04879849|583772539|FG001|Overall Study|Withdrawal by Subject|0|||
161688861|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688862|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688863|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688864|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688865|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688866|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
161688867|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688868|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688869|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688870|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688871|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688872|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688873|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
161688874|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688875|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688876|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688877|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688878|NCT03016325|583911762|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688879|NCT03016325|583911763|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
161688880|NCT03016325|583911764|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688881|NCT03016325|583911765|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688882|NCT03016325|583911766|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688883|NCT03016325|583911767|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688884|NCT03016325|583911768|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688885|NCT03016325|583911769|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688886|NCT03016325|583911762|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688887|NCT03016325|583911763|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688888|NCT03016325|583911764|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688889|NCT03016325|583911765|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688890|NCT03016325|583911766|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688891|NCT03016325|583911767|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
161688892|NCT03016325|583911768|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
161688893|NCT03016325|583911769|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
161688894|NCT01152021|583911771|FG000|Overall Study|Adverse Event|4|||
161688895|NCT01152021|583911772|FG001|Overall Study|Adverse Event|4|||
161688896|NCT01152021|583911771|FG000|Overall Study|Study drug had expired|1|||
161688897|NCT01152021|583911772|FG001|Overall Study|Study drug had expired|0|||
161688898|NCT01152021|583911771|FG000|Overall Study|Physician Decision|1|||
161688899|NCT01152021|583911772|FG001|Overall Study|Physician Decision|1|||
161688900|NCT01152021|583911771|FG000|Overall Study|No access to study drug in Pharmacy|0|||
161688901|NCT01152021|583911772|FG001|Overall Study|No access to study drug in Pharmacy|1|||
161688902|NCT02595723|583911773|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
161688903|NCT02595723|583911774|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
161688904|NCT02595723|583911775|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
161688905|NCT02595723|583911773|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
161688906|NCT02595723|583911774|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
161688907|NCT02595723|583911775|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
161688908|NCT04288154|583911776|FG000|Overall Study|Withdrawal by Subject|9|||
161688909|NCT04288154|583911777|FG001|Overall Study|Withdrawal by Subject|9|||
161688910|NCT01902290|583911783|FG000|Overall Study|Withdrawal by Subject|19|||
161688911|NCT01902290|583911784|FG001|Overall Study|Withdrawal by Subject|27|||
161688912|NCT01902290|583911783|FG000|Overall Study|Lost to Follow-up|2|||
161688913|NCT01902290|583911784|FG001|Overall Study|Lost to Follow-up|2|||
161688914|NCT01902290|583911783|FG000|Overall Study|Death|1|||
161688915|NCT01902290|583911784|FG001|Overall Study|Death|0|||
161688916|NCT01902290|583911783|FG000|Overall Study|Sponsor Decision|26|||
161688917|NCT01902290|583911784|FG001|Overall Study|Sponsor Decision|24|||
161688918|NCT00769184|583911785|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
161688919|NCT00769184|583911786|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
161688920|NCT00769184|583911785|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
161688921|NCT00769184|583911786|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
161688922|NCT00769184|583911785|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
161688923|NCT00769184|583911786|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
161688924|NCT00385255|583911787|FG000|Overall Study|Serious Adverse Event|1|||
161688925|NCT00385255|583911788|FG001|Overall Study|Serious Adverse Event|2|||
161688926|NCT00385255|583911787|FG000|Overall Study|Protocol Violation|0|||
161688927|NCT00385255|583911788|FG001|Overall Study|Protocol Violation|4|||
161688928|NCT00385255|583911787|FG000|Overall Study|Withdrawal by Subject|0|||
161688929|NCT00385255|583911788|FG001|Overall Study|Withdrawal by Subject|8|||
161688930|NCT00385255|583911787|FG000|Overall Study|Migrated/moved from study area|0|||
161650999|NCT04879849|583772540|FG002|Overall Study|Withdrawal by Subject|0|||
161651000|NCT04879849|583772541|FG003|Overall Study|Withdrawal by Subject|0|||
161651001|NCT04879849|583772542|FG004|Overall Study|Withdrawal by Subject|2|||
161651002|NCT04879849|583772543|FG005|Overall Study|Withdrawal by Subject|0|||
161651003|NCT04879849|583772544|FG006|Overall Study|Withdrawal by Subject|1|||
161651004|NCT04879849|583772545|FG007|Overall Study|Withdrawal by Subject|0|||
161651005|NCT04879849|583772538|FG000|Overall Study|Progressive Disease|0|||
161651006|NCT04879849|583772539|FG001|Overall Study|Progressive Disease|0|||
161651007|NCT04879849|583772540|FG002|Overall Study|Progressive Disease|1|||
161651008|NCT04879849|583772541|FG003|Overall Study|Progressive Disease|0|||
161651009|NCT04879849|583772542|FG004|Overall Study|Progressive Disease|0|||
161651010|NCT04879849|583772543|FG005|Overall Study|Progressive Disease|0|||
161651011|NCT04879849|583772544|FG006|Overall Study|Progressive Disease|0|||
161651012|NCT04879849|583772545|FG007|Overall Study|Progressive Disease|0|||
161651013|NCT04879849|583772538|FG000|Overall Study|Death|0|||
161651014|NCT04879849|583772539|FG001|Overall Study|Death|0|||
161651015|NCT04879849|583772540|FG002|Overall Study|Death|1|||
161651016|NCT04879849|583772541|FG003|Overall Study|Death|1|||
161651017|NCT04879849|583772542|FG004|Overall Study|Death|1|||
161651018|NCT04879849|583772543|FG005|Overall Study|Death|2|||
161651019|NCT04879849|583772544|FG006|Overall Study|Death|1|||
161651020|NCT04879849|583772545|FG007|Overall Study|Death|2|||
161651021|NCT04879849|583772538|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
161651022|NCT04879849|583772539|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
161651023|NCT04879849|583772540|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
161651024|NCT04879849|583772541|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
161651025|NCT04879849|583772542|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
161651026|NCT04879849|583772543|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
161651027|NCT04879849|583772544|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
161651028|NCT04879849|583772545|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
161651029|NCT04879849|583772538|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651030|NCT04879849|583772539|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651031|NCT04879849|583772540|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651032|NCT04879849|583772541|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651033|NCT04879849|583772542|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651034|NCT04879849|583772543|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651035|NCT04879849|583772544|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
161651036|NCT04879849|583772545|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161651037|NCT04879849|583772538|FG000|Overall Study|Reason Not Specified|1|||
161651038|NCT04879849|583772539|FG001|Overall Study|Reason Not Specified|0|||
161651039|NCT04879849|583772540|FG002|Overall Study|Reason Not Specified|0|||
161651040|NCT04879849|583772541|FG003|Overall Study|Reason Not Specified|0|||
161651041|NCT04879849|583772542|FG004|Overall Study|Reason Not Specified|0|||
161651042|NCT04879849|583772543|FG005|Overall Study|Reason Not Specified|0|||
161651043|NCT04879849|583772544|FG006|Overall Study|Reason Not Specified|0|||
161651044|NCT04879849|583772545|FG007|Overall Study|Reason Not Specified|0|||
161651045|NCT05292586|583772550|FG000|Overall Study|Withdrawal by Subject|3|||
161651046|NCT05292586|583772551|FG001|Overall Study|Withdrawal by Subject|10|||
161651047|NCT05292586|583772550|FG000|Overall Study|Randomization error|3|||
161651048|NCT05292586|583772551|FG001|Overall Study|Randomization error|7|||
161651049|NCT05292586|583772550|FG000|Overall Study|Adverse Event|3|||
161651050|NCT05292586|583772551|FG001|Overall Study|Adverse Event|0|||
161651051|NCT05292586|583772550|FG000|Overall Study|Lost to Follow-up|0|||
161651052|NCT05292586|583772551|FG001|Overall Study|Lost to Follow-up|1|||
161651053|NCT05292586|583772550|FG000|Overall Study|Patient refused treatment|1|||
161651054|NCT05292586|583772551|FG001|Overall Study|Patient refused treatment|0|||
161651055|NCT05292586|583772550|FG000|Overall Study|Patient could not travel to the study site|1|||
161651056|NCT05292586|583772551|FG001|Overall Study|Patient could not travel to the study site|0|||
161651057|NCT05292586|583772550|FG000|Overall Study|Technical issues with the masterscope|0|||
161651058|NCT05292586|583772551|FG001|Overall Study|Technical issues with the masterscope|3|||
161651059|NCT05292586|583772550|FG000|Overall Study|Patient moved to a different state|0|||
161651060|NCT05292586|583772551|FG001|Overall Study|Patient moved to a different state|1|||
161651061|NCT03007420|583772564|FG000|Overall Study|Withdrawal by Subject|0|||
161651062|NCT03007420|583772565|FG001|Overall Study|Withdrawal by Subject|2|||
161651063|NCT03007420|583772564|FG000|Overall Study|Physician Decision|0|||
161688931|NCT00385255|583911788|FG001|Overall Study|Migrated/moved from study area|1|||
161688932|NCT00385255|583911787|FG000|Overall Study|Lost to Follow-up|20|||
161688933|NCT00385255|583911788|FG001|Overall Study|Lost to Follow-up|58|||
161688934|NCT00835237|583911793|FG000|Overall Study|Lost to Follow-up|4|||
161688935|NCT00835237|583911794|FG001|Overall Study|Lost to Follow-up|0|||
161688936|NCT00835237|583911793|FG000|Overall Study|Withdrawal by Subject|2|||
161688937|NCT00835237|583911794|FG001|Overall Study|Withdrawal by Subject|0|||
161688938|NCT01015768|583911799|FG000|Overall Study|Some subject data unuseable|4|||
161688939|NCT01015768|583911800|FG001|Overall Study|Some subject data unuseable|4|||
161688940|NCT01627860|583911801|FG000|Overall Study|Adverse Event|9|||
161688941|NCT01627860|583911802|FG001|Overall Study|Adverse Event|4|||
161688942|NCT01627860|583911801|FG000|Overall Study|Withdrawal by Subject|2|||
161688943|NCT01627860|583911802|FG001|Overall Study|Withdrawal by Subject|1|||
161688944|NCT01627860|583911801|FG000|Overall Study|Seizure frequency doubled|0|||
161688945|NCT01627860|583911802|FG001|Overall Study|Seizure frequency doubled|1|||
161688946|NCT01627860|583911801|FG000|Overall Study|Protocol Violation|1|||
161688947|NCT01627860|583911802|FG001|Overall Study|Protocol Violation|0|||
161688948|NCT01225731|583911803|FG000|Part 1|Did not meet eligibility criteria|1|||
161688949|NCT01225731|583911804|FG001|Part 1|Did not meet eligibility criteria|0|||
161688950|NCT01225731|583911805|FG002|Part 1|Did not meet eligibility criteria|0|||
161688951|NCT01225731|583911806|FG003|Part 1|Did not meet eligibility criteria|0|||
161688952|NCT01225731|583911807|FG004|Part 1|Did not meet eligibility criteria|1|||
161688953|NCT01225731|583911808|FG005|Part 1|Did not meet eligibility criteria|0|||
161688954|NCT01225731|583911809|FG006|Part 1|Did not meet eligibility criteria|0|||
161688955|NCT01225731|583911810|FG007|Part 1|Did not meet eligibility criteria|0|||
161688956|NCT01225731|583911811|FG008|Part 1|Did not meet eligibility criteria|0|||
161688957|NCT01225731|583911812|FG009|Part 1|Did not meet eligibility criteria|0|||
161688958|NCT01225731|583911813|FG010|Part 1|Did not meet eligibility criteria|0|||
161688959|NCT01225731|583911814|FG011|Part 1|Did not meet eligibility criteria|0|||
161688960|NCT01225731|583911815|FG012|Part 1|Did not meet eligibility criteria|0|||
161688961|NCT01225731|583911803|FG000|Part 1|Adverse Event|1|||
161688962|NCT01225731|583911804|FG001|Part 1|Adverse Event|2|||
161688963|NCT01225731|583911805|FG002|Part 1|Adverse Event|1|||
161688964|NCT01225731|583911806|FG003|Part 1|Adverse Event|1|||
161688965|NCT01225731|583911807|FG004|Part 1|Adverse Event|1|||
161688966|NCT01225731|583911808|FG005|Part 1|Adverse Event|0|||
161688967|NCT01225731|583911809|FG006|Part 1|Adverse Event|0|||
161688968|NCT01225731|583911810|FG007|Part 1|Adverse Event|0|||
161688969|NCT01225731|583911811|FG008|Part 1|Adverse Event|0|||
161688970|NCT01225731|583911812|FG009|Part 1|Adverse Event|0|||
161688971|NCT01225731|583911813|FG010|Part 1|Adverse Event|0|||
161688972|NCT01225731|583911814|FG011|Part 1|Adverse Event|0|||
161688973|NCT01225731|583911815|FG012|Part 1|Adverse Event|0|||
161688974|NCT01225731|583911803|FG000|Part 1|Withdrawal by Subject|0|||
161688975|NCT01225731|583911804|FG001|Part 1|Withdrawal by Subject|3|||
161688976|NCT01225731|583911805|FG002|Part 1|Withdrawal by Subject|0|||
161688977|NCT01225731|583911806|FG003|Part 1|Withdrawal by Subject|0|||
161688978|NCT01225731|583911807|FG004|Part 1|Withdrawal by Subject|4|||
161688979|NCT01225731|583911808|FG005|Part 1|Withdrawal by Subject|0|||
161688980|NCT01225731|583911809|FG006|Part 1|Withdrawal by Subject|0|||
161688981|NCT01225731|583911810|FG007|Part 1|Withdrawal by Subject|0|||
161688982|NCT01225731|583911811|FG008|Part 1|Withdrawal by Subject|0|||
161688983|NCT01225731|583911812|FG009|Part 1|Withdrawal by Subject|0|||
161688984|NCT01225731|583911813|FG010|Part 1|Withdrawal by Subject|0|||
161688985|NCT01225731|583911814|FG011|Part 1|Withdrawal by Subject|0|||
161688986|NCT01225731|583911815|FG012|Part 1|Withdrawal by Subject|0|||
161688987|NCT01225731|583911803|FG000|Part 1|Protocol Violation|0|||
161688988|NCT01225731|583911804|FG001|Part 1|Protocol Violation|0|||
161688989|NCT01225731|583911805|FG002|Part 1|Protocol Violation|0|||
161688990|NCT01225731|583911806|FG003|Part 1|Protocol Violation|1|||
161688991|NCT01225731|583911807|FG004|Part 1|Protocol Violation|0|||
161688992|NCT01225731|583911808|FG005|Part 1|Protocol Violation|0|||
161688993|NCT01225731|583911809|FG006|Part 1|Protocol Violation|0|||
161688994|NCT01225731|583911810|FG007|Part 1|Protocol Violation|0|||
161688995|NCT01225731|583911811|FG008|Part 1|Protocol Violation|0|||
161688996|NCT01225731|583911812|FG009|Part 1|Protocol Violation|0|||
161688997|NCT01225731|583911813|FG010|Part 1|Protocol Violation|0|||
161688998|NCT01225731|583911814|FG011|Part 1|Protocol Violation|0|||
161688999|NCT01225731|583911815|FG012|Part 1|Protocol Violation|0|||
161689000|NCT01225731|583911803|FG000|Part 2|Protocol Violation|0|||
161689001|NCT01225731|583911804|FG001|Part 2|Protocol Violation|0|||
161689002|NCT01225731|583911805|FG002|Part 2|Protocol Violation|0|||
161689003|NCT01225731|583911806|FG003|Part 2|Protocol Violation|0|||
161689004|NCT01225731|583911807|FG004|Part 2|Protocol Violation|0|||
161689005|NCT01225731|583911808|FG005|Part 2|Protocol Violation|1|||
161689006|NCT01225731|583911809|FG006|Part 2|Protocol Violation|0|||
161689007|NCT01225731|583911810|FG007|Part 2|Protocol Violation|0|||
161689008|NCT01225731|583911811|FG008|Part 2|Protocol Violation|1|||
161689009|NCT01225731|583911812|FG009|Part 2|Protocol Violation|0|||
161689010|NCT01225731|583911813|FG010|Part 2|Protocol Violation|0|||
161689011|NCT01225731|583911814|FG011|Part 2|Protocol Violation|0|||
161689012|NCT01225731|583911815|FG012|Part 2|Protocol Violation|0|||
161689013|NCT01225731|583911803|FG000|Part 2|Adverse Event|0|||
161651064|NCT03007420|583772565|FG001|Overall Study|Physician Decision|1|||
161651065|NCT01435772|583772568|FG000|Overall Study|Adverse Event|1|||
161651066|NCT01435772|583772569|FG001|Overall Study|Adverse Event|0|||
161651067|NCT01435772|583772570|FG002|Overall Study|Adverse Event|2|||
161651068|NCT01435772|583772568|FG000|Overall Study|Withdrawal by Subject|0|||
161651069|NCT01435772|583772569|FG001|Overall Study|Withdrawal by Subject|1|||
161651070|NCT01435772|583772570|FG002|Overall Study|Withdrawal by Subject|3|||
161651071|NCT01435772|583772568|FG000|Overall Study|Other - study termination|2|||
161651072|NCT01435772|583772569|FG001|Overall Study|Other - study termination|2|||
161651073|NCT01435772|583772570|FG002|Overall Study|Other - study termination|10|||
161651074|NCT03238963|583772571|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
161651075|NCT03238963|583772572|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
161651076|NCT03238963|583772571|FG000|Overall Study|Withdrawal by Subject|1|||
161651077|NCT03238963|583772572|FG001|Overall Study|Withdrawal by Subject|1|||
161651078|NCT03238963|583772571|FG000|Overall Study|Lost to Follow-up|1|||
161651079|NCT03238963|583772572|FG001|Overall Study|Lost to Follow-up|0|||
161651080|NCT03238963|583772571|FG000|Overall Study|Protocol Violation|1|||
161651081|NCT03238963|583772572|FG001|Overall Study|Protocol Violation|1|||
161651082|NCT03238963|583772571|FG000|Overall Study|Adverse Event|1|||
161651083|NCT03238963|583772572|FG001|Overall Study|Adverse Event|0|||
161651084|NCT05823012|583772573|FG000|Titration Period|Adverse Event|1|||
161651085|NCT05823012|583772573|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
161651086|NCT05823012|583772573|FG000|Maintenance Period|Adverse Event|1|||
161651087|NCT05823012|583772573|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
161651088|NCT05823012|583772573|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
161651089|NCT01424813|583772574|FG000|Overall Study|Withdrawal by Subject|3|||
161651090|NCT01424813|583772575|FG001|Overall Study|Withdrawal by Subject|0|||
161651091|NCT01424813|583772574|FG000|Overall Study|Protocol Violation|1|||
161651092|NCT01424813|583772575|FG001|Overall Study|Protocol Violation|0|||
161651093|NCT01424813|583772574|FG000|Overall Study|Other|1|||
161651094|NCT01424813|583772575|FG001|Overall Study|Other|2|||
161651095|NCT07149155|583772576|FG000|Overall Study|Lost to Follow-up|10|||
161651096|NCT00515671|583773822|FG000|Overall Study|Lost to Follow-up|13|||
161651097|NCT00515671|583773823|FG001|Overall Study|Lost to Follow-up|10|||
161651098|NCT00515671|583773822|FG000|Overall Study|Withdrawal by Subject|3|||
161651099|NCT00515671|583773823|FG001|Overall Study|Withdrawal by Subject|5|||
161651100|NCT00515671|583773822|FG000|Overall Study|incarcerated|1|||
161651101|NCT00515671|583773823|FG001|Overall Study|incarcerated|2|||
161651102|NCT02993406|583773834|FG000|Overall Study|Withdrawal by Subject|170|||
161651103|NCT02993406|583773835|FG001|Overall Study|Withdrawal by Subject|196|||
161651104|NCT02993406|583773834|FG000|Overall Study|Physician Decision|3|||
161651105|NCT02993406|583773835|FG001|Overall Study|Physician Decision|5|||
161651106|NCT02993406|583773834|FG000|Overall Study|Lost to Follow-up|12|||
161651107|NCT02993406|583773835|FG001|Overall Study|Lost to Follow-up|13|||
161651108|NCT02993406|583773834|FG000|Overall Study|Unclassifiable Response|105|||
161651109|NCT02993406|583773835|FG001|Overall Study|Unclassifiable Response|139|||
161651110|NCT02993406|583773834|FG000|Overall Study|Administrative decision|1|||
161651111|NCT02993406|583773835|FG001|Overall Study|Administrative decision|0|||
161651112|NCT02993406|583773834|FG000|Overall Study|Sponsor decision|4|||
161651113|NCT02993406|583773835|FG001|Overall Study|Sponsor decision|5|||
161651114|NCT02942277|583773836|FG000|Year 1|Withdrawal by Subject|0|||
161651115|NCT02942277|583773837|FG001|Year 1|Withdrawal by Subject|0|||
161651116|NCT02942277|583773838|FG002|Year 1|Withdrawal by Subject|0|||
161651117|NCT02942277|583773839|FG003|Year 1|Withdrawal by Subject|0|||
161651118|NCT02942277|583773840|FG004|Year 1|Withdrawal by Subject|1|||
161651119|NCT02942277|583773841|FG005|Year 1|Withdrawal by Subject|3|||
161651120|NCT02942277|583773842|FG006|Year 1|Withdrawal by Subject|0|||
161651121|NCT02942277|583773843|FG007|Year 1|Withdrawal by Subject|1|||
161651122|NCT02942277|583773844|FG008|Year 1|Withdrawal by Subject|0|||
161651123|NCT02942277|583773845|FG009|Year 1|Withdrawal by Subject|0|||
161651124|NCT02942277|583773846|FG010|Year 1|Withdrawal by Subject|3|||
161651125|NCT02942277|583773836|FG000|Year 1|Travel|0|||
161651126|NCT02942277|583773837|FG001|Year 1|Travel|1|||
161651127|NCT02942277|583773838|FG002|Year 1|Travel|0|||
161689014|NCT01225731|583911804|FG001|Part 2|Adverse Event|0|||
161689015|NCT01225731|583911805|FG002|Part 2|Adverse Event|0|||
161689016|NCT01225731|583911806|FG003|Part 2|Adverse Event|0|||
161689017|NCT01225731|583911807|FG004|Part 2|Adverse Event|0|||
161689018|NCT01225731|583911808|FG005|Part 2|Adverse Event|0|||
161689019|NCT01225731|583911809|FG006|Part 2|Adverse Event|4|||
161689020|NCT01225731|583911810|FG007|Part 2|Adverse Event|4|||
161689021|NCT01225731|583911811|FG008|Part 2|Adverse Event|2|||
161689022|NCT01225731|583911812|FG009|Part 2|Adverse Event|0|||
161689023|NCT01225731|583911813|FG010|Part 2|Adverse Event|0|||
161689024|NCT01225731|583911814|FG011|Part 2|Adverse Event|0|||
161689025|NCT01225731|583911815|FG012|Part 2|Adverse Event|0|||
161689026|NCT01225731|583911803|FG000|Part 2|Lack of Efficacy|0|||
161689027|NCT01225731|583911804|FG001|Part 2|Lack of Efficacy|0|||
161689028|NCT01225731|583911805|FG002|Part 2|Lack of Efficacy|0|||
161689029|NCT01225731|583911806|FG003|Part 2|Lack of Efficacy|0|||
161689030|NCT01225731|583911807|FG004|Part 2|Lack of Efficacy|0|||
161689031|NCT01225731|583911808|FG005|Part 2|Lack of Efficacy|1|||
161689032|NCT01225731|583911809|FG006|Part 2|Lack of Efficacy|0|||
161689033|NCT01225731|583911810|FG007|Part 2|Lack of Efficacy|12|||
161689034|NCT01225731|583911811|FG008|Part 2|Lack of Efficacy|3|||
161689035|NCT01225731|583911812|FG009|Part 2|Lack of Efficacy|0|||
161689036|NCT01225731|583911813|FG010|Part 2|Lack of Efficacy|0|||
161689037|NCT01225731|583911814|FG011|Part 2|Lack of Efficacy|0|||
161689038|NCT01225731|583911815|FG012|Part 2|Lack of Efficacy|0|||
161689039|NCT01225731|583911803|FG000|Part 2|Pregnancy|0|||
161689040|NCT01225731|583911804|FG001|Part 2|Pregnancy|0|||
161689041|NCT01225731|583911805|FG002|Part 2|Pregnancy|0|||
161689042|NCT01225731|583911806|FG003|Part 2|Pregnancy|0|||
161689043|NCT01225731|583911807|FG004|Part 2|Pregnancy|0|||
161689044|NCT01225731|583911808|FG005|Part 2|Pregnancy|0|||
161689045|NCT01225731|583911809|FG006|Part 2|Pregnancy|1|||
161689046|NCT01225731|583911810|FG007|Part 2|Pregnancy|0|||
161689047|NCT01225731|583911811|FG008|Part 2|Pregnancy|1|||
161689048|NCT01225731|583911812|FG009|Part 2|Pregnancy|0|||
161689049|NCT01225731|583911813|FG010|Part 2|Pregnancy|0|||
161689050|NCT01225731|583911814|FG011|Part 2|Pregnancy|0|||
161689051|NCT01225731|583911815|FG012|Part 2|Pregnancy|0|||
161689052|NCT01225731|583911803|FG000|Part 2|Lost to Follow-up|0|||
161689053|NCT01225731|583911804|FG001|Part 2|Lost to Follow-up|0|||
161689054|NCT01225731|583911805|FG002|Part 2|Lost to Follow-up|0|||
161689055|NCT01225731|583911806|FG003|Part 2|Lost to Follow-up|0|||
161689056|NCT01225731|583911807|FG004|Part 2|Lost to Follow-up|0|||
161689057|NCT01225731|583911808|FG005|Part 2|Lost to Follow-up|0|||
161689058|NCT01225731|583911809|FG006|Part 2|Lost to Follow-up|0|||
161689059|NCT01225731|583911810|FG007|Part 2|Lost to Follow-up|3|||
161689060|NCT01225731|583911811|FG008|Part 2|Lost to Follow-up|1|||
161689061|NCT01225731|583911812|FG009|Part 2|Lost to Follow-up|0|||
161689062|NCT01225731|583911813|FG010|Part 2|Lost to Follow-up|0|||
161689063|NCT01225731|583911814|FG011|Part 2|Lost to Follow-up|0|||
161689064|NCT01225731|583911815|FG012|Part 2|Lost to Follow-up|0|||
161689065|NCT01225731|583911803|FG000|Part 2|Physician Decision|0|||
161689066|NCT01225731|583911804|FG001|Part 2|Physician Decision|0|||
161689067|NCT01225731|583911805|FG002|Part 2|Physician Decision|0|||
161689068|NCT01225731|583911806|FG003|Part 2|Physician Decision|0|||
161689069|NCT01225731|583911807|FG004|Part 2|Physician Decision|0|||
161689070|NCT01225731|583911808|FG005|Part 2|Physician Decision|0|||
161689071|NCT01225731|583911809|FG006|Part 2|Physician Decision|0|||
161689072|NCT01225731|583911810|FG007|Part 2|Physician Decision|2|||
161689073|NCT01225731|583911811|FG008|Part 2|Physician Decision|2|||
161689074|NCT01225731|583911812|FG009|Part 2|Physician Decision|0|||
161689075|NCT01225731|583911813|FG010|Part 2|Physician Decision|0|||
161689076|NCT01225731|583911814|FG011|Part 2|Physician Decision|0|||
161689077|NCT01225731|583911815|FG012|Part 2|Physician Decision|0|||
161689078|NCT01225731|583911803|FG000|Part 2|Withdrawal by Subject|0|||
161689079|NCT01225731|583911804|FG001|Part 2|Withdrawal by Subject|0|||
161689080|NCT01225731|583911805|FG002|Part 2|Withdrawal by Subject|0|||
161689081|NCT01225731|583911806|FG003|Part 2|Withdrawal by Subject|0|||
161689082|NCT01225731|583911807|FG004|Part 2|Withdrawal by Subject|0|||
161689083|NCT01225731|583911808|FG005|Part 2|Withdrawal by Subject|1|||
161689084|NCT01225731|583911809|FG006|Part 2|Withdrawal by Subject|3|||
161689085|NCT01225731|583911810|FG007|Part 2|Withdrawal by Subject|4|||
161689086|NCT01225731|583911811|FG008|Part 2|Withdrawal by Subject|1|||
161689087|NCT01225731|583911812|FG009|Part 2|Withdrawal by Subject|0|||
161689088|NCT01225731|583911813|FG010|Part 2|Withdrawal by Subject|0|||
161689089|NCT01225731|583911814|FG011|Part 2|Withdrawal by Subject|0|||
161689090|NCT01225731|583911815|FG012|Part 2|Withdrawal by Subject|0|||
161689091|NCT01225731|583911803|FG000|Part 3|Adverse Event|0|||
161689092|NCT01225731|583911804|FG001|Part 3|Adverse Event|0|||
161689093|NCT01225731|583911805|FG002|Part 3|Adverse Event|0|||
161836200|NCT00094458|584442902|FG005|Main Study: Through Week 30|Death|0|||
161651128|NCT02942277|583773839|FG003|Year 1|Travel|0|||
161651129|NCT02942277|583773840|FG004|Year 1|Travel|4|||
161651130|NCT02942277|583773841|FG005|Year 1|Travel|5|||
161651131|NCT02942277|583773842|FG006|Year 1|Travel|0|||
161651132|NCT02942277|583773843|FG007|Year 1|Travel|0|||
161651133|NCT02942277|583773844|FG008|Year 1|Travel|0|||
161651134|NCT02942277|583773845|FG009|Year 1|Travel|0|||
161651135|NCT02942277|583773846|FG010|Year 1|Travel|8|||
161651136|NCT02942277|583773836|FG000|Year 1|Joined Army|0|||
161651137|NCT02942277|583773837|FG001|Year 1|Joined Army|1|||
161651138|NCT02942277|583773838|FG002|Year 1|Joined Army|0|||
161651139|NCT02942277|583773839|FG003|Year 1|Joined Army|0|||
161651140|NCT02942277|583773840|FG004|Year 1|Joined Army|0|||
161651141|NCT02942277|583773841|FG005|Year 1|Joined Army|0|||
161651142|NCT02942277|583773842|FG006|Year 1|Joined Army|0|||
161651143|NCT02942277|583773843|FG007|Year 1|Joined Army|0|||
161651144|NCT02942277|583773844|FG008|Year 1|Joined Army|0|||
161651145|NCT02942277|583773845|FG009|Year 1|Joined Army|0|||
161651146|NCT02942277|583773846|FG010|Year 1|Joined Army|0|||
161651147|NCT02942277|583773836|FG000|Year 1|Subject met withdrawal criteria|0|||
161651148|NCT02942277|583773837|FG001|Year 1|Subject met withdrawal criteria|0|||
161651149|NCT02942277|583773838|FG002|Year 1|Subject met withdrawal criteria|0|||
161651150|NCT02942277|583773839|FG003|Year 1|Subject met withdrawal criteria|1|||
161651151|NCT02942277|583773840|FG004|Year 1|Subject met withdrawal criteria|0|||
161651152|NCT02942277|583773841|FG005|Year 1|Subject met withdrawal criteria|0|||
161651153|NCT02942277|583773842|FG006|Year 1|Subject met withdrawal criteria|0|||
161651154|NCT02942277|583773843|FG007|Year 1|Subject met withdrawal criteria|0|||
161651155|NCT02942277|583773844|FG008|Year 1|Subject met withdrawal criteria|0|||
161651156|NCT02942277|583773845|FG009|Year 1|Subject met withdrawal criteria|0|||
161651157|NCT02942277|583773846|FG010|Year 1|Subject met withdrawal criteria|0|||
161651158|NCT02942277|583773836|FG000|Year 1|Lost to Follow-up|0|||
161651159|NCT02942277|583773837|FG001|Year 1|Lost to Follow-up|0|||
161651160|NCT02942277|583773838|FG002|Year 1|Lost to Follow-up|0|||
161836201|NCT00094458|584442897|FG000|Main Study: Through Week 30|Other|19|||
161836202|NCT00094458|584442898|FG001|Main Study: Through Week 30|Other|16|||
161836203|NCT00094458|584442899|FG002|Main Study: Through Week 30|Other|9|||
161651161|NCT02942277|583773839|FG003|Year 1|Lost to Follow-up|0|||
161651162|NCT02942277|583773840|FG004|Year 1|Lost to Follow-up|1|||
161651163|NCT02942277|583773841|FG005|Year 1|Lost to Follow-up|0|||
161651164|NCT02942277|583773842|FG006|Year 1|Lost to Follow-up|0|||
161651165|NCT02942277|583773843|FG007|Year 1|Lost to Follow-up|0|||
161651166|NCT02942277|583773844|FG008|Year 1|Lost to Follow-up|0|||
161651167|NCT02942277|583773845|FG009|Year 1|Lost to Follow-up|0|||
161651168|NCT02942277|583773846|FG010|Year 1|Lost to Follow-up|2|||
161651169|NCT02942277|583773836|FG000|Year 1|Protocol Violation|0|||
161651170|NCT02942277|583773837|FG001|Year 1|Protocol Violation|0|||
161651171|NCT02942277|583773838|FG002|Year 1|Protocol Violation|0|||
161651172|NCT02942277|583773839|FG003|Year 1|Protocol Violation|0|||
161651173|NCT02942277|583773840|FG004|Year 1|Protocol Violation|1|||
161651174|NCT02942277|583773841|FG005|Year 1|Protocol Violation|1|||
161651175|NCT02942277|583773842|FG006|Year 1|Protocol Violation|0|||
161651176|NCT02942277|583773843|FG007|Year 1|Protocol Violation|0|||
161651177|NCT02942277|583773844|FG008|Year 1|Protocol Violation|0|||
161651178|NCT02942277|583773845|FG009|Year 1|Protocol Violation|0|||
161651179|NCT02942277|583773846|FG010|Year 1|Protocol Violation|2|||
161651180|NCT02942277|583773836|FG000|Year 1|Pregnancy|0|||
161651181|NCT02942277|583773837|FG001|Year 1|Pregnancy|0|||
161651182|NCT02942277|583773838|FG002|Year 1|Pregnancy|0|||
161651183|NCT02942277|583773839|FG003|Year 1|Pregnancy|0|||
161651184|NCT02942277|583773840|FG004|Year 1|Pregnancy|0|||
161651185|NCT02942277|583773841|FG005|Year 1|Pregnancy|1|||
161651186|NCT02942277|583773842|FG006|Year 1|Pregnancy|0|||
161651187|NCT02942277|583773843|FG007|Year 1|Pregnancy|0|||
161651188|NCT02942277|583773844|FG008|Year 1|Pregnancy|0|||
161651189|NCT02942277|583773845|FG009|Year 1|Pregnancy|0|||
161651190|NCT02942277|583773846|FG010|Year 1|Pregnancy|0|||
161651191|NCT02942277|583773836|FG000|Year 2|Lost to Follow-up|0|||
161836204|NCT00094458|584442900|FG003|Main Study: Through Week 30|Other|0|||
161689094|NCT01225731|583911806|FG003|Part 3|Adverse Event|0|||
161689095|NCT01225731|583911807|FG004|Part 3|Adverse Event|0|||
161689096|NCT01225731|583911808|FG005|Part 3|Adverse Event|0|||
161689097|NCT01225731|583911809|FG006|Part 3|Adverse Event|0|||
161689098|NCT01225731|583911810|FG007|Part 3|Adverse Event|0|||
161689099|NCT01225731|583911811|FG008|Part 3|Adverse Event|0|||
161689100|NCT01225731|583911812|FG009|Part 3|Adverse Event|0|||
161689101|NCT01225731|583911813|FG010|Part 3|Adverse Event|1|||
161689102|NCT01225731|583911814|FG011|Part 3|Adverse Event|1|||
161689103|NCT01225731|583911815|FG012|Part 3|Adverse Event|0|||
161689104|NCT01225731|583911803|FG000|Part 3|Lost to Follow-up|0|||
161689105|NCT01225731|583911804|FG001|Part 3|Lost to Follow-up|0|||
161689106|NCT01225731|583911805|FG002|Part 3|Lost to Follow-up|0|||
161689107|NCT01225731|583911806|FG003|Part 3|Lost to Follow-up|0|||
161689108|NCT01225731|583911807|FG004|Part 3|Lost to Follow-up|0|||
161689109|NCT01225731|583911808|FG005|Part 3|Lost to Follow-up|0|||
161689110|NCT01225731|583911809|FG006|Part 3|Lost to Follow-up|0|||
161689111|NCT01225731|583911810|FG007|Part 3|Lost to Follow-up|0|||
161689112|NCT01225731|583911811|FG008|Part 3|Lost to Follow-up|0|||
161689113|NCT01225731|583911812|FG009|Part 3|Lost to Follow-up|0|||
161689114|NCT01225731|583911813|FG010|Part 3|Lost to Follow-up|1|||
161689115|NCT01225731|583911814|FG011|Part 3|Lost to Follow-up|2|||
161689116|NCT01225731|583911815|FG012|Part 3|Lost to Follow-up|1|||
161689117|NCT01225731|583911803|FG000|Part 3|Physician Decision|0|||
161689118|NCT01225731|583911804|FG001|Part 3|Physician Decision|0|||
161689119|NCT01225731|583911805|FG002|Part 3|Physician Decision|0|||
161689120|NCT01225731|583911806|FG003|Part 3|Physician Decision|0|||
161689121|NCT01225731|583911807|FG004|Part 3|Physician Decision|0|||
161689122|NCT01225731|583911808|FG005|Part 3|Physician Decision|0|||
161689123|NCT01225731|583911809|FG006|Part 3|Physician Decision|0|||
161689124|NCT01225731|583911810|FG007|Part 3|Physician Decision|0|||
161689125|NCT01225731|583911811|FG008|Part 3|Physician Decision|0|||
161689126|NCT01225731|583911812|FG009|Part 3|Physician Decision|0|||
161689127|NCT01225731|583911813|FG010|Part 3|Physician Decision|0|||
161689128|NCT01225731|583911814|FG011|Part 3|Physician Decision|1|||
161689129|NCT01225731|583911815|FG012|Part 3|Physician Decision|2|||
161689130|NCT01225731|583911803|FG000|Part 3|Withdrawal by Subject|0|||
161689131|NCT01225731|583911804|FG001|Part 3|Withdrawal by Subject|0|||
161689132|NCT01225731|583911805|FG002|Part 3|Withdrawal by Subject|0|||
161689133|NCT01225731|583911806|FG003|Part 3|Withdrawal by Subject|0|||
161689134|NCT01225731|583911807|FG004|Part 3|Withdrawal by Subject|0|||
161689135|NCT01225731|583911808|FG005|Part 3|Withdrawal by Subject|0|||
161689136|NCT01225731|583911809|FG006|Part 3|Withdrawal by Subject|0|||
161689137|NCT01225731|583911810|FG007|Part 3|Withdrawal by Subject|0|||
161689138|NCT01225731|583911811|FG008|Part 3|Withdrawal by Subject|0|||
161689139|NCT01225731|583911812|FG009|Part 3|Withdrawal by Subject|0|||
161689140|NCT01225731|583911813|FG010|Part 3|Withdrawal by Subject|4|||
161689141|NCT01225731|583911814|FG011|Part 3|Withdrawal by Subject|6|||
161689142|NCT01225731|583911815|FG012|Part 3|Withdrawal by Subject|4|||
161689143|NCT00577642|583911816|FG000|Overall Study|Clinical Disease Progression|1|||
161689144|NCT00542269|583911822|FG000|Overall Study|Adverse Event|10|||
161689145|NCT00542269|583911823|FG001|Overall Study|Adverse Event|4|||
161689146|NCT00542269|583911824|FG002|Overall Study|Adverse Event|5|||
161689147|NCT00542269|583911822|FG000|Overall Study|Protocol Violation|1|||
161689148|NCT00542269|583911823|FG001|Overall Study|Protocol Violation|1|||
161689149|NCT00542269|583911824|FG002|Overall Study|Protocol Violation|0|||
161689150|NCT00542269|583911822|FG000|Overall Study|Withdrawal by Subject|1|||
161689151|NCT00542269|583911823|FG001|Overall Study|Withdrawal by Subject|0|||
161689152|NCT00542269|583911824|FG002|Overall Study|Withdrawal by Subject|0|||
161689153|NCT00542269|583911822|FG000|Overall Study|Administrative problems|1|||
161836205|NCT00094458|584442901|FG004|Main Study: Through Week 30|Other|0|||
161836206|NCT00094458|584442902|FG005|Main Study: Through Week 30|Other|0|||
161836207|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
161689154|NCT00542269|583911823|FG001|Overall Study|Administrative problems|1|||
161689155|NCT00542269|583911824|FG002|Overall Study|Administrative problems|1|||
161689156|NCT02069899|583911825|FG000|Overall Study|Adverse Event|6|||
161689157|NCT02069899|583911826|FG001|Overall Study|Adverse Event|0|||
161689158|NCT02069899|583911827|FG002|Overall Study|Adverse Event|1|||
161689159|NCT02069899|583911825|FG000|Overall Study|Withdrawal by Participant|2|||
161689160|NCT02069899|583911826|FG001|Overall Study|Withdrawal by Participant|0|||
161689161|NCT02069899|583911827|FG002|Overall Study|Withdrawal by Participant|0|||
161689162|NCT02069899|583911825|FG000|Overall Study|Lost to Follow-up|1|||
161689163|NCT02069899|583911826|FG001|Overall Study|Lost to Follow-up|0|||
161689164|NCT02069899|583911827|FG002|Overall Study|Lost to Follow-up|1|||
161689165|NCT02069899|583911825|FG000|Overall Study|Other|4|||
161689166|NCT02069899|583911826|FG001|Overall Study|Other|0|||
161689167|NCT02069899|583911827|FG002|Overall Study|Other|0|||
161689168|NCT02069899|583911825|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
161689169|NCT02069899|583911826|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
161689170|NCT02069899|583911827|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
161689171|NCT02069899|583911825|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
161689172|NCT02069899|583911826|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
161689173|NCT02069899|583911827|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
161689174|NCT00490451|583911828|FG000|Overall Study|Adverse Event|3|||
161689175|NCT00490451|583911829|FG001|Overall Study|Adverse Event|3|||
161689176|NCT00490451|583911828|FG000|Overall Study|Death|3|||
161689177|NCT00490451|583911829|FG001|Overall Study|Death|1|||
161689178|NCT00490451|583911828|FG000|Overall Study|Withdrawal by Subject|2|||
161689179|NCT00490451|583911829|FG001|Overall Study|Withdrawal by Subject|0|||
161689180|NCT00490451|583911828|FG000|Overall Study|Investigator Decision|1|||
161689181|NCT00490451|583911829|FG001|Overall Study|Investigator Decision|0|||
161689182|NCT00490451|583911828|FG000|Overall Study|Protocol Violation|1|||
161689183|NCT00490451|583911829|FG001|Overall Study|Protocol Violation|0|||
161689184|NCT00490451|583911828|FG000|Overall Study|Progressive Disease|53|||
161689185|NCT00490451|583911829|FG001|Overall Study|Progressive Disease|34|||
161689186|NCT01181011|583911830|FG000|Overall Study|Adverse Event|2|||
161689187|NCT01181011|583911830|FG000|Overall Study|Lost to Follow-up|1|||
161689188|NCT00401375|583911833|FG000|Overall Study|Protocol Violation|2|||
161689189|NCT00401375|583911834|FG001|Overall Study|Protocol Violation|2|||
161689190|NCT00401375|583911835|FG002|Overall Study|Protocol Violation|1|||
161689191|NCT00401375|583911833|FG000|Overall Study|Adverse Event|6|||
161689192|NCT00401375|583911834|FG001|Overall Study|Adverse Event|11|||
161689193|NCT00401375|583911835|FG002|Overall Study|Adverse Event|10|||
161689194|NCT00401375|583911833|FG000|Overall Study|Withdrawal by Subject|9|||
161689195|NCT00401375|583911834|FG001|Overall Study|Withdrawal by Subject|7|||
161689196|NCT00401375|583911835|FG002|Overall Study|Withdrawal by Subject|7|||
161689197|NCT00401375|583911833|FG000|Overall Study|Lost to Follow-up|0|||
161689198|NCT00401375|583911834|FG001|Overall Study|Lost to Follow-up|1|||
161689199|NCT00401375|583911835|FG002|Overall Study|Lost to Follow-up|1|||
161689200|NCT00401375|583911833|FG000|Overall Study|Other than specified|2|||
161689201|NCT00401375|583911834|FG001|Overall Study|Other than specified|1|||
161689202|NCT00401375|583911835|FG002|Overall Study|Other than specified|3|||
161689203|NCT00401375|583911833|FG000|Overall Study|Randomized but not treated|3|||
161689204|NCT00401375|583911834|FG001|Overall Study|Randomized but not treated|3|||
161689205|NCT00401375|583911835|FG002|Overall Study|Randomized but not treated|3|||
161689206|NCT00950664|583911836|FG000|First Intervention|Lost to Follow-up|1|||
161689207|NCT00950664|583911837|FG001|First Intervention|Lost to Follow-up|3|||
161689208|NCT00950664|583911836|FG000|First Intervention|Withdrawal by Subject|2|||
161651192|NCT02942277|583773837|FG001|Year 2|Lost to Follow-up|0|||
161651193|NCT02942277|583773838|FG002|Year 2|Lost to Follow-up|0|||
161651194|NCT02942277|583773839|FG003|Year 2|Lost to Follow-up|0|||
161651195|NCT02942277|583773840|FG004|Year 2|Lost to Follow-up|2|||
161651196|NCT02942277|583773841|FG005|Year 2|Lost to Follow-up|1|||
161651197|NCT02942277|583773842|FG006|Year 2|Lost to Follow-up|0|||
161651198|NCT02942277|583773843|FG007|Year 2|Lost to Follow-up|0|||
161651199|NCT02942277|583773844|FG008|Year 2|Lost to Follow-up|0|||
161651200|NCT02942277|583773845|FG009|Year 2|Lost to Follow-up|0|||
161651201|NCT02942277|583773846|FG010|Year 2|Lost to Follow-up|0|||
161651202|NCT02942277|583773836|FG000|Year 2|Did not rescreen|0|||
161651203|NCT02942277|583773837|FG001|Year 2|Did not rescreen|0|||
161651204|NCT02942277|583773838|FG002|Year 2|Did not rescreen|1|||
161651205|NCT02942277|583773839|FG003|Year 2|Did not rescreen|1|||
161651206|NCT02942277|583773840|FG004|Year 2|Did not rescreen|9|||
161651207|NCT02942277|583773841|FG005|Year 2|Did not rescreen|6|||
161651208|NCT02942277|583773842|FG006|Year 2|Did not rescreen|0|||
161689209|NCT00950664|583911837|FG001|First Intervention|Withdrawal by Subject|2|||
161689210|NCT04703075|583911838|FG000|Overall Study|Adverse Event|11|||
161689211|NCT04703075|583911839|FG001|Overall Study|Adverse Event|7|||
161689212|NCT04703075|583911838|FG000|Overall Study|Lost to Follow-up|6|||
161689213|NCT04703075|583911839|FG001|Overall Study|Lost to Follow-up|12|||
161689214|NCT04703075|583911838|FG000|Overall Study|Physician Decision|3|||
161689215|NCT04703075|583911839|FG001|Overall Study|Physician Decision|0|||
161689216|NCT04703075|583911838|FG000|Overall Study|Moved|0|||
161689217|NCT04703075|583911839|FG001|Overall Study|Moved|2|||
161836208|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
161651209|NCT02942277|583773843|FG007|Year 2|Did not rescreen|1|||
161651210|NCT02942277|583773844|FG008|Year 2|Did not rescreen|0|||
161651211|NCT02942277|583773845|FG009|Year 2|Did not rescreen|0|||
161689218|NCT04703075|583911838|FG000|Overall Study|Index INH Resistant|0|||
161689219|NCT04703075|583911839|FG001|Overall Study|Index INH Resistant|1|||
161689220|NCT04703075|583911838|FG000|Overall Study|Lack of Efficacy|6|||
161689221|NCT04703075|583911839|FG001|Overall Study|Lack of Efficacy|18|||
161689222|NCT01273883|583911841|FG000|First Intervention|Adverse Event|2|||
161689223|NCT01273883|583911842|FG001|First Intervention|Adverse Event|1|||
161689224|NCT01273883|583911841|FG000|Second Intervention|Lost to Follow-up|1|||
161689225|NCT01273883|583911842|FG001|Second Intervention|Lost to Follow-up|1|||
161689226|NCT01273883|583911841|FG000|Second Intervention|Lack of Efficacy|1|||
161689227|NCT01273883|583911842|FG001|Second Intervention|Lack of Efficacy|0|||
161689228|NCT01553136|583911844|FG000|Overall Study|Adverse Event|3|||
161689229|NCT01553136|583911845|FG001|Overall Study|Adverse Event|2|||
161689230|NCT01553136|583911844|FG000|Overall Study|Withdrawal by Subject|2|||
161689231|NCT01553136|583911845|FG001|Overall Study|Withdrawal by Subject|3|||
161689232|NCT01553136|583911844|FG000|Overall Study|Lost to Follow-up|4|||
161689233|NCT01553136|583911845|FG001|Overall Study|Lost to Follow-up|10|||
161689234|NCT01553136|583911844|FG000|Overall Study|Physician Decision|2|||
161689235|NCT01553136|583911845|FG001|Overall Study|Physician Decision|3|||
161689236|NCT01553136|583911844|FG000|Overall Study|Scheduling Difficulties|5|||
161689237|NCT01553136|583911845|FG001|Overall Study|Scheduling Difficulties|4|||
161689238|NCT01783678|583913431|FG000|Overall Study|Randomized but Not Treated|0|||
161689239|NCT01783678|583913432|FG001|Overall Study|Randomized but Not Treated|0|||
161689240|NCT01783678|583913433|FG002|Overall Study|Randomized but Not Treated|0|||
161689241|NCT01783678|583913434|FG003|Overall Study|Randomized but Not Treated|1|||
161689242|NCT01783678|583913435|FG004|Overall Study|Randomized but Not Treated|0|||
161689243|NCT01783678|583913436|FG005|Overall Study|Randomized but Not Treated|0|||
161689244|NCT01783678|583913431|FG000|Overall Study|Lack of Efficacy|1|||
161689245|NCT01783678|583913432|FG001|Overall Study|Lack of Efficacy|13|||
161689246|NCT01783678|583913433|FG002|Overall Study|Lack of Efficacy|1|||
161689247|NCT01783678|583913434|FG003|Overall Study|Lack of Efficacy|3|||
161689248|NCT01783678|583913435|FG004|Overall Study|Lack of Efficacy|6|||
161689249|NCT01783678|583913436|FG005|Overall Study|Lack of Efficacy|5|||
161689250|NCT01783678|583913431|FG000|Overall Study|Lost to Follow-up|0|||
161689251|NCT01783678|583913432|FG001|Overall Study|Lost to Follow-up|4|||
161689252|NCT01783678|583913433|FG002|Overall Study|Lost to Follow-up|0|||
161689253|NCT01783678|583913434|FG003|Overall Study|Lost to Follow-up|2|||
161689254|NCT01783678|583913435|FG004|Overall Study|Lost to Follow-up|1|||
161689255|NCT01783678|583913436|FG005|Overall Study|Lost to Follow-up|0|||
161689256|NCT01783678|583913431|FG000|Overall Study|Withdrew Consent|1|||
161689257|NCT01783678|583913432|FG001|Overall Study|Withdrew Consent|1|||
161689258|NCT01783678|583913433|FG002|Overall Study|Withdrew Consent|0|||
161689259|NCT01783678|583913434|FG003|Overall Study|Withdrew Consent|2|||
161689260|NCT01783678|583913435|FG004|Overall Study|Withdrew Consent|0|||
161689261|NCT01783678|583913436|FG005|Overall Study|Withdrew Consent|0|||
161689262|NCT02404103|583913437|FG000|Overall Study|Adverse Event|1|||
161689263|NCT02404103|583913438|FG001|Overall Study|Adverse Event|0|||
161689264|NCT02404103|583913437|FG000|Overall Study|Lost to Follow-up|3|||
161689265|NCT02404103|583913438|FG001|Overall Study|Lost to Follow-up|3|||
161689266|NCT01408147|583913439|FG000|Overall Study|Withdrawal by Subject|0|||
161689267|NCT01408147|583913440|FG001|Overall Study|Withdrawal by Subject|1|||
161689268|NCT01042600|583913441|FG000|Overall Study|Ineligible|1|||
161689269|NCT01042600|583913442|FG001|Overall Study|Ineligible|0|||
161689270|NCT00621504|583913443|FG000|Overall Study|Adverse Event|1|||
161689271|NCT00621504|583913444|FG001|Overall Study|Adverse Event|3|||
161689272|NCT00621504|583913443|FG000|Overall Study|At the request of sponsor/investigator|1|||
161689273|NCT00621504|583913444|FG001|Overall Study|At the request of sponsor/investigator|0|||
161689274|NCT00621504|583913443|FG000|Overall Study|Withdrew consent|9|||
161689275|NCT00621504|583913444|FG001|Overall Study|Withdrew consent|6|||
161689276|NCT00621504|583913443|FG000|Overall Study|Lost to Follow-up|8|||
161689277|NCT00621504|583913444|FG001|Overall Study|Lost to Follow-up|10|||
161689278|NCT00621504|583913443|FG000|Overall Study|Other|1|||
161689279|NCT00621504|583913444|FG001|Overall Study|Other|0|||
161689280|NCT00621504|583913443|FG000|Overall Study|Death|6|||
161689281|NCT00621504|583913444|FG001|Overall Study|Death|6|||
161689282|NCT03311711|583913449|FG000|Overall Study|Death|1|||
161689283|NCT03311711|583913450|FG001|Overall Study|Death|0|||
161689284|NCT03311711|583913451|FG002|Overall Study|Death|0|||
161689285|NCT03311711|583913452|FG003|Overall Study|Death|0|||
161689286|NCT03311711|583913453|FG004|Overall Study|Death|0|||
161689287|NCT03311711|583913454|FG005|Overall Study|Death|0|||
161689288|NCT03311711|583913455|FG006|Overall Study|Death|1|||
161689289|NCT03311711|583913456|FG007|Overall Study|Death|0|||
161689290|NCT03311711|583913457|FG008|Overall Study|Death|1|||
161689291|NCT03311711|583913458|FG009|Overall Study|Death|0|||
161689292|NCT03311711|583913449|FG000|Overall Study|Death of dyad partner|0|||
161689293|NCT03311711|583913450|FG001|Overall Study|Death of dyad partner|1|||
161689294|NCT03311711|583913451|FG002|Overall Study|Death of dyad partner|0|||
161689295|NCT03311711|583913452|FG003|Overall Study|Death of dyad partner|0|||
161689296|NCT03311711|583913453|FG004|Overall Study|Death of dyad partner|0|||
161689297|NCT03311711|583913454|FG005|Overall Study|Death of dyad partner|0|||
161689298|NCT03311711|583913455|FG006|Overall Study|Death of dyad partner|0|||
161689299|NCT03311711|583913456|FG007|Overall Study|Death of dyad partner|1|||
161689300|NCT03311711|583913457|FG008|Overall Study|Death of dyad partner|0|||
161689301|NCT03311711|583913458|FG009|Overall Study|Death of dyad partner|1|||
161689302|NCT03311711|583913449|FG000|Overall Study|Lost to Follow-up|2|||
161689303|NCT03311711|583913450|FG001|Overall Study|Lost to Follow-up|2|||
161689304|NCT03311711|583913451|FG002|Overall Study|Lost to Follow-up|0|||
161689305|NCT03311711|583913452|FG003|Overall Study|Lost to Follow-up|0|||
161689306|NCT03311711|583913453|FG004|Overall Study|Lost to Follow-up|0|||
161689307|NCT03311711|583913454|FG005|Overall Study|Lost to Follow-up|0|||
161689308|NCT03311711|583913455|FG006|Overall Study|Lost to Follow-up|1|||
161689309|NCT03311711|583913456|FG007|Overall Study|Lost to Follow-up|1|||
161689310|NCT03311711|583913457|FG008|Overall Study|Lost to Follow-up|0|||
161689311|NCT03311711|583913458|FG009|Overall Study|Lost to Follow-up|0|||
161689312|NCT03311711|583913449|FG000|Overall Study|Withdrawal by Subject|1|||
161689313|NCT03311711|583913450|FG001|Overall Study|Withdrawal by Subject|1|||
161689314|NCT03311711|583913451|FG002|Overall Study|Withdrawal by Subject|0|||
161689315|NCT03311711|583913452|FG003|Overall Study|Withdrawal by Subject|0|||
161689316|NCT03311711|583913453|FG004|Overall Study|Withdrawal by Subject|0|||
161689317|NCT03311711|583913454|FG005|Overall Study|Withdrawal by Subject|0|||
161689318|NCT03311711|583913455|FG006|Overall Study|Withdrawal by Subject|3|||
161689319|NCT03311711|583913456|FG007|Overall Study|Withdrawal by Subject|3|||
161689320|NCT03311711|583913457|FG008|Overall Study|Withdrawal by Subject|0|||
161689321|NCT03311711|583913458|FG009|Overall Study|Withdrawal by Subject|0|||
161689322|NCT02229552|583913459|FG000|Baseline|Withdrawal by Subject|6|||
161689323|NCT02229552|583913459|FG000|1-year Follow up|Withdrawal by Subject|7|||
161689324|NCT02229552|583913459|FG000|1-year Follow up|Lost to Follow-up|18|||
161689325|NCT02229552|583913459|FG000|2-Year Follow up|Withdrawal by Subject|9|||
161689326|NCT02229552|583913459|FG000|2-Year Follow up|Lost to Follow-up|17|||
161689327|NCT00706134|583913460|FG000|Overall Study|Adverse Event|8|||
161689328|NCT00706134|583913461|FG001|Overall Study|Adverse Event|7|||
161689329|NCT00706134|583913462|FG002|Overall Study|Adverse Event|2|||
161689330|NCT00706134|583913463|FG003|Overall Study|Adverse Event|3|||
161689331|NCT00706134|583913460|FG000|Overall Study|Lost to Follow-up|0|||
161689332|NCT00706134|583913461|FG001|Overall Study|Lost to Follow-up|1|||
161689333|NCT00706134|583913462|FG002|Overall Study|Lost to Follow-up|0|||
161689334|NCT00706134|583913463|FG003|Overall Study|Lost to Follow-up|0|||
161689335|NCT00706134|583913460|FG000|Overall Study|Protocol Violation|0|||
161689336|NCT00706134|583913461|FG001|Overall Study|Protocol Violation|6|||
161689337|NCT00706134|583913462|FG002|Overall Study|Protocol Violation|0|||
161689338|NCT00706134|583913463|FG003|Overall Study|Protocol Violation|3|||
161689339|NCT00706134|583913460|FG000|Overall Study|Withdrawal by Subject|1|||
161689340|NCT00706134|583913461|FG001|Overall Study|Withdrawal by Subject|2|||
161689341|NCT00706134|583913462|FG002|Overall Study|Withdrawal by Subject|1|||
161689342|NCT00706134|583913463|FG003|Overall Study|Withdrawal by Subject|0|||
161689343|NCT00706134|583913460|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161689344|NCT00706134|583913461|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161689345|NCT00706134|583913462|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
161689346|NCT00706134|583913463|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
161689347|NCT00706134|583913460|FG000|Overall Study|Did not meet study criteria|2|||
161689348|NCT00706134|583913461|FG001|Overall Study|Did not meet study criteria|0|||
161689349|NCT00706134|583913462|FG002|Overall Study|Did not meet study criteria|0|||
161689350|NCT00706134|583913463|FG003|Overall Study|Did not meet study criteria|0|||
161689351|NCT00631371|583913471|FG000|Overall Study|Lost to Follow-up|24|||
161689352|NCT00631371|583913472|FG001|Overall Study|Lost to Follow-up|19|||
161689353|NCT00631371|583913471|FG000|Overall Study|Other reason|5|||
161689354|NCT00631371|583913472|FG001|Overall Study|Other reason|12|||
161689355|NCT00631371|583913471|FG000|Overall Study|subject request|38|||
161689356|NCT00631371|583913472|FG001|Overall Study|subject request|45|||
161689357|NCT00631371|583913471|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
161689358|NCT00631371|583913472|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
161689359|NCT00631371|583913471|FG000|Overall Study|Death|263|||
161689360|NCT00631371|583913472|FG001|Overall Study|Death|239|||
161689361|NCT03354663|583913473|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
161651212|NCT02942277|583773846|FG010|Year 2|Did not rescreen|21|||
161651213|NCT02942277|583773836|FG000|Year 2|Met withdrawal criteria|0|||
161651214|NCT02942277|583773837|FG001|Year 2|Met withdrawal criteria|0|||
161651215|NCT02942277|583773838|FG002|Year 2|Met withdrawal criteria|0|||
161651216|NCT02942277|583773839|FG003|Year 2|Met withdrawal criteria|0|||
161651217|NCT02942277|583773840|FG004|Year 2|Met withdrawal criteria|1|||
161651218|NCT02942277|583773841|FG005|Year 2|Met withdrawal criteria|2|||
161651219|NCT02942277|583773842|FG006|Year 2|Met withdrawal criteria|0|||
161651220|NCT02942277|583773843|FG007|Year 2|Met withdrawal criteria|0|||
161651221|NCT02942277|583773844|FG008|Year 2|Met withdrawal criteria|0|||
161651222|NCT02942277|583773845|FG009|Year 2|Met withdrawal criteria|0|||
161651223|NCT02942277|583773846|FG010|Year 2|Met withdrawal criteria|1|||
161651224|NCT02942277|583773836|FG000|Year 2|Travel|0|||
161651225|NCT02942277|583773837|FG001|Year 2|Travel|1|||
161651226|NCT02942277|583773838|FG002|Year 2|Travel|0|||
161651227|NCT02942277|583773839|FG003|Year 2|Travel|0|||
161651228|NCT02942277|583773840|FG004|Year 2|Travel|0|||
161651229|NCT02942277|583773841|FG005|Year 2|Travel|1|||
161651230|NCT02942277|583773842|FG006|Year 2|Travel|0|||
161651231|NCT02942277|583773843|FG007|Year 2|Travel|0|||
161651232|NCT02942277|583773844|FG008|Year 2|Travel|0|||
161651233|NCT02942277|583773845|FG009|Year 2|Travel|1|||
161651234|NCT02942277|583773846|FG010|Year 2|Travel|3|||
161651235|NCT02942277|583773836|FG000|Year 2|Non-compliant|0|||
161651236|NCT02942277|583773837|FG001|Year 2|Non-compliant|0|||
161651237|NCT02942277|583773838|FG002|Year 2|Non-compliant|0|||
161651238|NCT02942277|583773839|FG003|Year 2|Non-compliant|0|||
161651239|NCT02942277|583773840|FG004|Year 2|Non-compliant|1|||
161651240|NCT02942277|583773841|FG005|Year 2|Non-compliant|1|||
161651241|NCT02942277|583773842|FG006|Year 2|Non-compliant|0|||
161651242|NCT02942277|583773843|FG007|Year 2|Non-compliant|0|||
161651243|NCT02942277|583773844|FG008|Year 2|Non-compliant|0|||
161651244|NCT02942277|583773845|FG009|Year 2|Non-compliant|0|||
161651245|NCT02942277|583773846|FG010|Year 2|Non-compliant|0|||
161651246|NCT02942277|583773836|FG000|Year 2|Withdrawal by Subject|0|||
161651247|NCT02942277|583773837|FG001|Year 2|Withdrawal by Subject|0|||
161651248|NCT02942277|583773838|FG002|Year 2|Withdrawal by Subject|0|||
161651249|NCT02942277|583773839|FG003|Year 2|Withdrawal by Subject|0|||
161651250|NCT02942277|583773840|FG004|Year 2|Withdrawal by Subject|0|||
161651251|NCT02942277|583773841|FG005|Year 2|Withdrawal by Subject|0|||
161651252|NCT02942277|583773842|FG006|Year 2|Withdrawal by Subject|1|||
161651253|NCT02942277|583773843|FG007|Year 2|Withdrawal by Subject|0|||
161651254|NCT02942277|583773844|FG008|Year 2|Withdrawal by Subject|0|||
161651255|NCT02942277|583773845|FG009|Year 2|Withdrawal by Subject|0|||
161651256|NCT02942277|583773846|FG010|Year 2|Withdrawal by Subject|0|||
161651257|NCT04325282|583773847|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161651258|NCT04325282|583773848|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161651259|NCT04325282|583773847|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
161651260|NCT04325282|583773848|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
161651261|NCT04020185|583773853|FG000|Overall Study|Death|0|||
161651262|NCT04020185|583773854|FG001|Overall Study|Death|0|||
161651263|NCT04020185|583773855|FG002|Overall Study|Death|1|||
161651264|NCT04020185|583773856|FG003|Overall Study|Death|2|||
161651265|NCT04020185|583773857|FG004|Overall Study|Death|1|||
161651266|NCT04020185|583773858|FG005|Overall Study|Death|0|||
161651267|NCT04020185|583773859|FG006|Overall Study|Death|1|||
161651268|NCT04020185|583773860|FG007|Overall Study|Death|0|||
161651269|NCT04020185|583773853|FG000|Overall Study|Consent withdrawn|1|||
161651270|NCT04020185|583773854|FG001|Overall Study|Consent withdrawn|0|||
161651271|NCT04020185|583773855|FG002|Overall Study|Consent withdrawn|0|||
161651272|NCT04020185|583773856|FG003|Overall Study|Consent withdrawn|0|||
161651273|NCT04020185|583773857|FG004|Overall Study|Consent withdrawn|2|||
161651274|NCT04020185|583773858|FG005|Overall Study|Consent withdrawn|0|||
161651275|NCT04020185|583773859|FG006|Overall Study|Consent withdrawn|1|||
161651276|NCT04020185|583773860|FG007|Overall Study|Consent withdrawn|1|||
161651277|NCT04020185|583773853|FG000|Overall Study|Patient in hospice|0|||
161651278|NCT04020185|583773854|FG001|Overall Study|Patient in hospice|1|||
161651279|NCT04020185|583773855|FG002|Overall Study|Patient in hospice|0|||
161651280|NCT04020185|583773856|FG003|Overall Study|Patient in hospice|0|||
161651281|NCT04020185|583773857|FG004|Overall Study|Patient in hospice|0|||
161651282|NCT04020185|583773858|FG005|Overall Study|Patient in hospice|0|||
161651283|NCT04020185|583773859|FG006|Overall Study|Patient in hospice|0|||
161651284|NCT04020185|583773860|FG007|Overall Study|Patient in hospice|0|||
161651285|NCT04020185|583773853|FG000|Overall Study|Continuing on expanded access|0|||
161651286|NCT04020185|583773854|FG001|Overall Study|Continuing on expanded access|0|||
161651287|NCT04020185|583773855|FG002|Overall Study|Continuing on expanded access|0|||
161651288|NCT04020185|583773856|FG003|Overall Study|Continuing on expanded access|0|||
161651289|NCT04020185|583773857|FG004|Overall Study|Continuing on expanded access|0|||
161651290|NCT04020185|583773858|FG005|Overall Study|Continuing on expanded access|0|||
161651291|NCT04020185|583773859|FG006|Overall Study|Continuing on expanded access|1|||
161836209|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
161836210|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161689362|NCT03354663|583913473|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
161689363|NCT03354663|583913473|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
161689364|NCT03354663|583913473|FG000|Completed 30-day Visit|Missed Visit|1|||
161689365|NCT01391000|583913476|FG000|Overall Study|Lost to Follow-up|2|||
161689366|NCT01391000|583913477|FG001|Overall Study|Lost to Follow-up|0|||
161689367|NCT03860961|583913481|FG000|Overall Study|Withdrawal by Subject|6|||
161689368|NCT03860961|583913482|FG001|Overall Study|Withdrawal by Subject|11|||
161689369|NCT03860961|583913481|FG000|Overall Study|Death|10|||
161689370|NCT03860961|583913482|FG001|Overall Study|Death|6|||
161689371|NCT03860961|583913481|FG000|Overall Study|Incomplete two-year data|4|||
161689372|NCT03860961|583913482|FG001|Overall Study|Incomplete two-year data|0|||
161689373|NCT00493870|583913483|FG000|Overall Study|Lost to Follow-up|12|||
161689374|NCT00493870|583913484|FG001|Overall Study|Lost to Follow-up|15|||
161689375|NCT00272038|583913485|FG000|Overall Study|withdrew before they received 2 cycles|7|||
161689376|NCT03189446|583913486|FG000|Overall Study|Adverse Event|2|||
161689377|NCT03189446|583913486|FG000|Overall Study|Withdrawal by Subject|2|||
161689378|NCT03189446|583913486|FG000|Overall Study|Physician Decision|1|||
161689379|NCT00883337|583913487|FG000|Core Treatment Period|Adverse Event|9|||
161689380|NCT00883337|583913488|FG001|Core Treatment Period|Adverse Event|12|||
161689381|NCT00883337|583913489|FG002|Core Treatment Period|Adverse Event|22|||
161689382|NCT00883337|583913487|FG000|Core Treatment Period|Lack of Efficacy|7|||
161689383|NCT00883337|583913488|FG001|Core Treatment Period|Lack of Efficacy|4|||
161689384|NCT00883337|583913489|FG002|Core Treatment Period|Lack of Efficacy|2|||
161689385|NCT00883337|583913487|FG000|Core Treatment Period|Lost to Follow-up|1|||
161689386|NCT00883337|583913488|FG001|Core Treatment Period|Lost to Follow-up|1|||
161689387|NCT00883337|583913489|FG002|Core Treatment Period|Lost to Follow-up|0|||
161689388|NCT00883337|583913487|FG000|Core Treatment Period|Withdrawal by Subject|2|||
161689389|NCT00883337|583913488|FG001|Core Treatment Period|Withdrawal by Subject|2|||
161689390|NCT00883337|583913489|FG002|Core Treatment Period|Withdrawal by Subject|6|||
161689391|NCT00883337|583913487|FG000|Core Treatment Period|Wish to be pregnant|1|||
161689392|NCT00883337|583913488|FG001|Core Treatment Period|Wish to be pregnant|2|||
161689393|NCT00883337|583913489|FG002|Core Treatment Period|Wish to be pregnant|1|||
161689394|NCT00883337|583913487|FG000|Core Treatment Period|Poor compliance to protocol|0|||
161689395|NCT00883337|583913488|FG001|Core Treatment Period|Poor compliance to protocol|0|||
161689396|NCT00883337|583913489|FG002|Core Treatment Period|Poor compliance to protocol|1|||
161689397|NCT00883337|583913487|FG000|Core Treatment Period|Other than above|0|||
161689398|NCT00883337|583913488|FG001|Core Treatment Period|Other than above|1|||
161689399|NCT00883337|583913489|FG002|Core Treatment Period|Other than above|1|||
161689400|NCT00883337|583913487|FG000|Extension Treatment Period|Adverse Event|8|||
161689401|NCT00883337|583913488|FG001|Extension Treatment Period|Adverse Event|5|||
161689402|NCT00883337|583913489|FG002|Extension Treatment Period|Adverse Event|5|||
161689403|NCT00883337|583913487|FG000|Extension Treatment Period|Lack of Efficacy|8|||
161689404|NCT00883337|583913488|FG001|Extension Treatment Period|Lack of Efficacy|8|||
161689405|NCT00883337|583913489|FG002|Extension Treatment Period|Lack of Efficacy|8|||
161689406|NCT00883337|583913487|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
161689407|NCT00883337|583913488|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
161689408|NCT00883337|583913489|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
161689409|NCT00883337|583913487|FG000|Extension Treatment Period|Lost to Follow-up|1|||
161689410|NCT00883337|583913488|FG001|Extension Treatment Period|Lost to Follow-up|0|||
161689411|NCT00883337|583913489|FG002|Extension Treatment Period|Lost to Follow-up|0|||
161689412|NCT00883337|583913487|FG000|Extension Treatment Period|Other than above|10|||
161689413|NCT00883337|583913488|FG001|Extension Treatment Period|Other than above|9|||
161689414|NCT00883337|583913489|FG002|Extension Treatment Period|Other than above|5|||
161689415|NCT00713700|583913491|FG000|Overall Study|Lost to Follow-up|3|||
161689416|NCT00713700|583913491|FG000|Overall Study|Withdrawal by Subject|1|||
161689417|NCT00781456|583913492|FG000|Overall Study|Adverse Event|3|||
161689418|NCT00781456|583913493|FG001|Overall Study|Adverse Event|3|||
161689419|NCT00781456|583913492|FG000|Overall Study|Withdrawal by Subject|3|||
161836211|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161689420|NCT00781456|583913493|FG001|Overall Study|Withdrawal by Subject|5|||
161689421|NCT00781456|583913492|FG000|Overall Study|Protocol Violation|4|||
161689422|NCT00781456|583913493|FG001|Overall Study|Protocol Violation|1|||
161689423|NCT00781456|583913492|FG000|Overall Study|Noncompliance With Protocol|1|||
161689424|NCT00781456|583913493|FG001|Overall Study|Noncompliance With Protocol|1|||
161689425|NCT00781456|583913492|FG000|Overall Study|Lost to Follow-up|10|||
161689426|NCT00781456|583913493|FG001|Overall Study|Lost to Follow-up|5|||
161689427|NCT00781456|583913492|FG000|Overall Study|Other Reason, Unknown|0|||
161689428|NCT00781456|583913493|FG001|Overall Study|Other Reason, Unknown|1|||
161689429|NCT03548558|583913495|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
161689430|NCT03548558|583913496|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
161689431|NCT03548558|583913497|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689432|NCT03548558|583913498|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
161689433|NCT03548558|583913499|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689434|NCT03548558|583913500|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689435|NCT03548558|583913501|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689436|NCT03548558|583913495|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
161689437|NCT03548558|583913496|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
161689438|NCT03548558|583913497|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
161689439|NCT03548558|583913498|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
161689440|NCT03548558|583913499|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
161689441|NCT03548558|583913500|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
161689442|NCT03548558|583913501|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
161689443|NCT03548558|583913495|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
161689444|NCT03548558|583913496|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
161689445|NCT03548558|583913497|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
161689446|NCT03548558|583913498|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
161689447|NCT03548558|583913499|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
161689448|NCT03548558|583913500|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
161689449|NCT03548558|583913501|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
161689450|NCT03548558|583913495|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689451|NCT03548558|583913496|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689452|NCT03548558|583913497|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689453|NCT03548558|583913498|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689454|NCT03548558|583913499|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
161689455|NCT03548558|583913500|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
161689456|NCT03548558|583913501|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
161689457|NCT03548558|583913495|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161689458|NCT03548558|583913496|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161689459|NCT03548558|583913497|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161689460|NCT03548558|583913498|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161836212|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161836213|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
161836214|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161689461|NCT03548558|583913499|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
161689462|NCT03548558|583913500|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
161689463|NCT03548558|583913501|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
161689464|NCT03548558|583913495|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689465|NCT03548558|583913496|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689466|NCT03548558|583913497|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689467|NCT03548558|583913498|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689468|NCT03548558|583913499|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
161689469|NCT03548558|583913500|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
161689470|NCT03548558|583913501|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
161689471|NCT02669017|583913504|FG000|Overall Study|Death|1|||
161689472|NCT02669017|583913505|FG001|Overall Study|Death|2|||
161689473|NCT02669017|583913506|FG002|Overall Study|Death|2|||
161689474|NCT02669017|583913507|FG003|Overall Study|Death|3|||
161689475|NCT02669017|583913508|FG004|Overall Study|Death|8|||
161689476|NCT02669017|583913509|FG005|Overall Study|Death|18|||
161689477|NCT02669017|583913510|FG006|Overall Study|Death|10|||
161689478|NCT02669017|583913511|FG007|Overall Study|Death|47|||
161689479|NCT02669017|583913512|FG008|Overall Study|Death|20|||
161689480|NCT02669017|583913504|FG000|Overall Study|Withdrawal by Subject|0|||
161689481|NCT02669017|583913505|FG001|Overall Study|Withdrawal by Subject|0|||
161689482|NCT02669017|583913506|FG002|Overall Study|Withdrawal by Subject|0|||
161836215|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
161689483|NCT02669017|583913507|FG003|Overall Study|Withdrawal by Subject|1|||
161689484|NCT02669017|583913508|FG004|Overall Study|Withdrawal by Subject|2|||
161689485|NCT02669017|583913509|FG005|Overall Study|Withdrawal by Subject|0|||
161689486|NCT02669017|583913510|FG006|Overall Study|Withdrawal by Subject|0|||
161651292|NCT04020185|583773860|FG007|Overall Study|Continuing on expanded access|1|||
161651293|NCT00527787|583773862|FG000|Overall Study|Adverse Event|14|||
161651294|NCT00527787|583773863|FG001|Overall Study|Adverse Event|24|||
161651295|NCT00527787|583773862|FG000|Overall Study|Withdrawal by Subject|13|||
161651296|NCT00527787|583773863|FG001|Overall Study|Withdrawal by Subject|25|||
161651297|NCT00527787|583773862|FG000|Overall Study|Lost to Follow-up|5|||
161651298|NCT00527787|583773863|FG001|Overall Study|Lost to Follow-up|2|||
161651299|NCT00527787|583773862|FG000|Overall Study|Duodenal Ulcer|1|||
161651300|NCT00527787|583773863|FG001|Overall Study|Duodenal Ulcer|10|||
161651301|NCT00527787|583773862|FG000|Overall Study|misc|5|||
161651302|NCT00527787|583773863|FG001|Overall Study|misc|2|||
161651303|NCT01706705|583773866|FG000|Overall Study|Death|1|||
161651304|NCT01706705|583773866|FG000|Overall Study|Lack of Efficacy|13|||
161651305|NCT01706705|583773866|FG000|Overall Study|Non-clinical|6|||
161651306|NCT00608868|583773869|FG000|Overall Study|Withdrawal by Subject|7|||
161651307|NCT00608868|583773869|FG000|Overall Study|Protocol Violation|3|||
161651308|NCT00608868|583773869|FG000|Overall Study|Lost to Follow-up|2|||
161651309|NCT00608868|583773869|FG000|Overall Study|Adverse Event|1|||
161651310|NCT00608868|583773869|FG000|Overall Study|Physician Decision|2|||
161651311|NCT00702962|583773872|FG000|Overall Study|Progressive disease|0|||
161651312|NCT00702962|583773873|FG001|Overall Study|Progressive disease|1|||
161651313|NCT00702962|583773872|FG000|Overall Study|Hospitalized for other health disorder|1|||
161651314|NCT00702962|583773873|FG001|Overall Study|Hospitalized for other health disorder|0|||
161651315|NCT01252355|583773874|FG000|Overall Study|Adverse Event|9|||
161651316|NCT01252355|583773875|FG001|Overall Study|Adverse Event|17|||
161651317|NCT01252355|583773876|FG002|Overall Study|Adverse Event|22|||
161651318|NCT01252355|583773874|FG000|Overall Study|Lack of Efficacy|6|||
161651319|NCT01252355|583773875|FG001|Overall Study|Lack of Efficacy|4|||
161651320|NCT01252355|583773876|FG002|Overall Study|Lack of Efficacy|2|||
161651321|NCT01252355|583773874|FG000|Overall Study|Lost to Follow-up|0|||
161651322|NCT01252355|583773875|FG001|Overall Study|Lost to Follow-up|0|||
161651323|NCT01252355|583773876|FG002|Overall Study|Lost to Follow-up|1|||
161651324|NCT01252355|583773874|FG000|Overall Study|Poor Compliance to Protocol|1|||
161651325|NCT01252355|583773875|FG001|Overall Study|Poor Compliance to Protocol|1|||
161651326|NCT01252355|583773876|FG002|Overall Study|Poor Compliance to Protocol|1|||
161651327|NCT01252355|583773874|FG000|Overall Study|Progressive Disease|2|||
161651328|NCT01252355|583773875|FG001|Overall Study|Progressive Disease|0|||
161651329|NCT01252355|583773876|FG002|Overall Study|Progressive Disease|0|||
161651330|NCT01252355|583773874|FG000|Overall Study|Sponsor Early Termination of Study|149|||
161651331|NCT01252355|583773875|FG001|Overall Study|Sponsor Early Termination of Study|149|||
161651332|NCT01252355|583773876|FG002|Overall Study|Sponsor Early Termination of Study|146|||
161651333|NCT01252355|583773874|FG000|Overall Study|Randomized but not Treated|2|||
161651334|NCT01252355|583773875|FG001|Overall Study|Randomized but not Treated|0|||
161651335|NCT01252355|583773876|FG002|Overall Study|Randomized but not Treated|0|||
161651336|NCT01252355|583773874|FG000|Overall Study|Other Than Above|8|||
161651337|NCT01252355|583773875|FG001|Overall Study|Other Than Above|7|||
161651338|NCT01252355|583773876|FG002|Overall Study|Other Than Above|7|||
161651339|NCT02175641|583773878|FG000|Overall Study|Death|3|||
161651340|NCT02175641|583773879|FG001|Overall Study|Death|4|||
161651341|NCT02175641|583773878|FG000|Overall Study|Lost to Follow-up|4|||
161651342|NCT02175641|583773879|FG001|Overall Study|Lost to Follow-up|4|||
161651343|NCT02175641|583773878|FG000|Overall Study|Withdrawal by Subject|7|||
161651344|NCT02175641|583773879|FG001|Overall Study|Withdrawal by Subject|4|||
161651345|NCT02175641|583773878|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
161651346|NCT02175641|583773879|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
161651347|NCT02175641|583773878|FG000|Overall Study|Developed Contraindicated Condition|8|||
161651348|NCT02175641|583773879|FG001|Overall Study|Developed Contraindicated Condition|0|||
161651349|NCT01876901|583773882|FG000|Overall Study|Protocol Violation|10|||
161651350|NCT01876901|583773883|FG001|Overall Study|Protocol Violation|2|||
161651351|NCT01876901|583773882|FG000|Overall Study|No or other surgical intervention|7|||
161651352|NCT01876901|583773883|FG001|Overall Study|No or other surgical intervention|5|||
161651353|NCT02242097|583773886|FG000|Ibrutinib Treatment|Adverse Event|16|||
161651354|NCT02242097|583773886|FG000|Ibrutinib Treatment|Physician Decision|1|||
161836216|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161651355|NCT02242097|583773886|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
161651356|NCT02242097|583773886|FG000|Ibrutinib Treatment|Death|1|||
161651357|NCT02242097|583773886|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
161651358|NCT02242097|583773886|FG000|Post Therapy Follow Up|Death|3|||
161836217|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161836218|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161651359|NCT02242097|583773886|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
161651360|NCT03031496|583773888|FG000|Period 1|Adverse Event|2|||
161651361|NCT03031496|583773889|FG001|Period 1|Adverse Event|0|||
161651362|NCT03031496|583773888|FG000|Period 1|Withdrawal by Subject|0|||
161651363|NCT03031496|583773889|FG001|Period 1|Withdrawal by Subject|2|||
161651364|NCT03868787|583773891|FG000|Overall Study|Withdrawal by Subject|2|||
161651365|NCT03868787|583773892|FG001|Overall Study|Withdrawal by Subject|1|||
161689487|NCT02669017|583913511|FG007|Overall Study|Withdrawal by Subject|2|||
161689488|NCT02669017|583913512|FG008|Overall Study|Withdrawal by Subject|2|||
161689489|NCT02669017|583913504|FG000|Overall Study|Lost to Follow-up|0|||
161689490|NCT02669017|583913505|FG001|Overall Study|Lost to Follow-up|0|||
161689491|NCT02669017|583913506|FG002|Overall Study|Lost to Follow-up|0|||
161689492|NCT02669017|583913507|FG003|Overall Study|Lost to Follow-up|0|||
161689493|NCT02669017|583913508|FG004|Overall Study|Lost to Follow-up|0|||
161689494|NCT02669017|583913509|FG005|Overall Study|Lost to Follow-up|0|||
161689495|NCT02669017|583913510|FG006|Overall Study|Lost to Follow-up|0|||
161689496|NCT02669017|583913511|FG007|Overall Study|Lost to Follow-up|0|||
161689497|NCT02669017|583913512|FG008|Overall Study|Lost to Follow-up|1|||
161689498|NCT02669017|583913504|FG000|Overall Study|Miscellaneous|0|||
161689499|NCT02669017|583913505|FG001|Overall Study|Miscellaneous|0|||
161689500|NCT02669017|583913506|FG002|Overall Study|Miscellaneous|0|||
161689501|NCT02669017|583913507|FG003|Overall Study|Miscellaneous|0|||
161689502|NCT02669017|583913508|FG004|Overall Study|Miscellaneous|2|||
161689503|NCT02669017|583913509|FG005|Overall Study|Miscellaneous|1|||
161689504|NCT02669017|583913510|FG006|Overall Study|Miscellaneous|1|||
161689505|NCT02669017|583913511|FG007|Overall Study|Miscellaneous|13|||
161689506|NCT02669017|583913512|FG008|Overall Study|Miscellaneous|2|||
161689507|NCT04091087|583913513|FG000|Overall Study|Not treated|1|||
161689508|NCT04091087|583913514|FG001|Overall Study|Not treated|0|||
161689509|NCT04091087|583913513|FG000|Overall Study|Adverse Event|4|||
161689510|NCT04091087|583913514|FG001|Overall Study|Adverse Event|4|||
161689511|NCT04091087|583913513|FG000|Overall Study|Protocol Violation|0|||
161689512|NCT04091087|583913514|FG001|Overall Study|Protocol Violation|1|||
161689513|NCT04091087|583913513|FG000|Overall Study|Withdrawal by Subject|5|||
161689514|NCT04091087|583913514|FG001|Overall Study|Withdrawal by Subject|2|||
161689515|NCT04152161|583913515|FG000|Overall Study|Death|0|||
161689516|NCT04152161|583913516|FG001|Overall Study|Death|1|||
161689517|NCT04152161|583913515|FG000|Overall Study|Physician Decision|0|||
161689518|NCT04152161|583913516|FG001|Overall Study|Physician Decision|1|||
161689519|NCT04152161|583913515|FG000|Overall Study|Lost to Follow-up|9|||
161689520|NCT04152161|583913516|FG001|Overall Study|Lost to Follow-up|3|||
161689521|NCT04152161|583913515|FG000|Overall Study|Protocol Violation|1|||
161689522|NCT04152161|583913516|FG001|Overall Study|Protocol Violation|0|||
161689523|NCT04152161|583913515|FG000|Overall Study|Withdrawal by Subject|29|||
161689524|NCT04152161|583913516|FG001|Overall Study|Withdrawal by Subject|28|||
161689525|NCT04152161|583913515|FG000|Overall Study|Sponsor termination of study|750|||
161689526|NCT04152161|583913516|FG001|Overall Study|Sponsor termination of study|755|||
161689527|NCT04152161|583913515|FG000|Overall Study|Other|20|||
161689528|NCT04152161|583913516|FG001|Overall Study|Other|18|||
161689529|NCT02559687|583913517|FG000|Overall Study|Death|112|||
161689530|NCT02559687|583913517|FG000|Overall Study|Sponsor Decision|5|||
161689531|NCT02559687|583913517|FG000|Overall Study|Withdrawal by Subject|4|||
161689532|NCT01098071|583913526|FG000|Overall Study|Surgery (adenoidectomy)|2|||
161689533|NCT01098071|583913526|FG000|Overall Study|Lost to Follow-up|13|||
161689534|NCT02599961|583913530|FG000|Overall Study|Withdrawal by Subject|1|||
161689535|NCT02599961|583913530|FG000|Overall Study|Subject Non-Compliance|2|||
161689536|NCT02599961|583913530|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
161689537|NCT02599961|583913530|FG000|Overall Study|Other, Not Specified|3|||
161689538|NCT00618410|583913531|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
161689539|NCT00618410|583913532|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
161689540|NCT00464334|583913533|FG000|Overall Study|Adverse Event|0|||
161689541|NCT00464334|583913534|FG001|Overall Study|Adverse Event|0|||
161689542|NCT00464334|583913535|FG002|Overall Study|Adverse Event|0|||
161689543|NCT00464334|583913536|FG003|Overall Study|Adverse Event|1|||
161689544|NCT00464334|583913537|FG004|Overall Study|Adverse Event|1|||
161689545|NCT00464334|583913538|FG005|Overall Study|Adverse Event|1|||
161689546|NCT00464334|583913539|FG006|Overall Study|Adverse Event|0|||
161689547|NCT00464334|583913540|FG007|Overall Study|Adverse Event|0|||
161689548|NCT00464334|583913541|FG008|Overall Study|Adverse Event|2|||
161689549|NCT00464334|583913542|FG009|Overall Study|Adverse Event|1|||
161689550|NCT00464334|583913543|FG010|Overall Study|Adverse Event|2|||
161689551|NCT00464334|583913533|FG000|Overall Study|Lack of Efficacy|0|||
161689552|NCT00464334|583913534|FG001|Overall Study|Lack of Efficacy|1|||
161689553|NCT00464334|583913535|FG002|Overall Study|Lack of Efficacy|0|||
161689554|NCT00464334|583913536|FG003|Overall Study|Lack of Efficacy|0|||
161689555|NCT00464334|583913537|FG004|Overall Study|Lack of Efficacy|0|||
161689556|NCT00464334|583913538|FG005|Overall Study|Lack of Efficacy|0|||
161689557|NCT00464334|583913539|FG006|Overall Study|Lack of Efficacy|0|||
161689558|NCT00464334|583913540|FG007|Overall Study|Lack of Efficacy|0|||
161689559|NCT00464334|583913541|FG008|Overall Study|Lack of Efficacy|0|||
161689560|NCT00464334|583913542|FG009|Overall Study|Lack of Efficacy|0|||
161689561|NCT00464334|583913543|FG010|Overall Study|Lack of Efficacy|0|||
161689562|NCT00464334|583913533|FG000|Overall Study|Lost to Follow-up|0|||
161689563|NCT00464334|583913534|FG001|Overall Study|Lost to Follow-up|0|||
161689564|NCT00464334|583913535|FG002|Overall Study|Lost to Follow-up|1|||
161689565|NCT00464334|583913536|FG003|Overall Study|Lost to Follow-up|0|||
161689566|NCT00464334|583913537|FG004|Overall Study|Lost to Follow-up|1|||
161689567|NCT00464334|583913538|FG005|Overall Study|Lost to Follow-up|0|||
161689568|NCT00464334|583913539|FG006|Overall Study|Lost to Follow-up|1|||
161689569|NCT00464334|583913540|FG007|Overall Study|Lost to Follow-up|0|||
161689570|NCT00464334|583913541|FG008|Overall Study|Lost to Follow-up|0|||
161689571|NCT00464334|583913542|FG009|Overall Study|Lost to Follow-up|0|||
161689572|NCT00464334|583913543|FG010|Overall Study|Lost to Follow-up|2|||
161689573|NCT00464334|583913533|FG000|Overall Study|Progressive Disease|0|||
161689574|NCT00464334|583913534|FG001|Overall Study|Progressive Disease|0|||
161689575|NCT00464334|583913535|FG002|Overall Study|Progressive Disease|0|||
161689576|NCT00464334|583913536|FG003|Overall Study|Progressive Disease|0|||
161689577|NCT00464334|583913537|FG004|Overall Study|Progressive Disease|0|||
161689578|NCT00464334|583913538|FG005|Overall Study|Progressive Disease|1|||
161689579|NCT00464334|583913539|FG006|Overall Study|Progressive Disease|0|||
161689580|NCT00464334|583913540|FG007|Overall Study|Progressive Disease|0|||
161689581|NCT00464334|583913541|FG008|Overall Study|Progressive Disease|1|||
161689582|NCT00464334|583913542|FG009|Overall Study|Progressive Disease|0|||
161689583|NCT00464334|583913543|FG010|Overall Study|Progressive Disease|0|||
161689584|NCT00464334|583913533|FG000|Overall Study|Study Terminated by Sponsor|0|||
161689585|NCT00464334|583913534|FG001|Overall Study|Study Terminated by Sponsor|0|||
161689586|NCT00464334|583913535|FG002|Overall Study|Study Terminated by Sponsor|0|||
161689587|NCT00464334|583913536|FG003|Overall Study|Study Terminated by Sponsor|1|||
161689588|NCT00464334|583913537|FG004|Overall Study|Study Terminated by Sponsor|0|||
161689589|NCT00464334|583913538|FG005|Overall Study|Study Terminated by Sponsor|0|||
161689590|NCT00464334|583913539|FG006|Overall Study|Study Terminated by Sponsor|0|||
161689591|NCT00464334|583913540|FG007|Overall Study|Study Terminated by Sponsor|0|||
161689592|NCT00464334|583913541|FG008|Overall Study|Study Terminated by Sponsor|0|||
161689593|NCT00464334|583913542|FG009|Overall Study|Study Terminated by Sponsor|0|||
161689594|NCT00464334|583913543|FG010|Overall Study|Study Terminated by Sponsor|0|||
161689595|NCT00464334|583913533|FG000|Overall Study|Withdrawal by Subject|1|||
161689596|NCT00464334|583913534|FG001|Overall Study|Withdrawal by Subject|7|||
161689597|NCT00464334|583913535|FG002|Overall Study|Withdrawal by Subject|4|||
161689598|NCT00464334|583913536|FG003|Overall Study|Withdrawal by Subject|2|||
161689599|NCT00464334|583913537|FG004|Overall Study|Withdrawal by Subject|2|||
161689600|NCT00464334|583913538|FG005|Overall Study|Withdrawal by Subject|2|||
161689601|NCT00464334|583913539|FG006|Overall Study|Withdrawal by Subject|2|||
161689602|NCT00464334|583913540|FG007|Overall Study|Withdrawal by Subject|1|||
161689603|NCT00464334|583913541|FG008|Overall Study|Withdrawal by Subject|3|||
161689604|NCT00464334|583913542|FG009|Overall Study|Withdrawal by Subject|0|||
161689605|NCT00464334|583913543|FG010|Overall Study|Withdrawal by Subject|0|||
161689606|NCT01857869|583913544|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
161689607|NCT01857869|583913545|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
161689608|NCT01857869|583913546|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
161689609|NCT01857869|583913547|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
161689610|NCT01857869|583913548|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
161689611|NCT01857869|583913549|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
161689612|NCT01857869|583913550|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
161689613|NCT01857869|583913551|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
161689614|NCT01857869|583913552|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
161689615|NCT01857869|583913553|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
161689616|NCT01857869|583913544|FG000|Primary/Challenge Phase|Pregnancy|1|||
161689617|NCT01857869|583913545|FG001|Primary/Challenge Phase|Pregnancy|0|||
161689618|NCT01857869|583913546|FG002|Primary/Challenge Phase|Pregnancy|0|||
161689619|NCT01857869|583913547|FG003|Primary/Challenge Phase|Pregnancy|0|||
161689620|NCT01857869|583913548|FG004|Primary/Challenge Phase|Pregnancy|0|||
161689621|NCT01857869|583913549|FG005|Primary/Challenge Phase|Pregnancy|0|||
161689622|NCT01857869|583913550|FG006|Primary/Challenge Phase|Pregnancy|0|||
161689623|NCT01857869|583913551|FG007|Primary/Challenge Phase|Pregnancy|0|||
161689624|NCT01857869|583913552|FG008|Primary/Challenge Phase|Pregnancy|0|||
161689625|NCT01857869|583913553|FG009|Primary/Challenge Phase|Pregnancy|0|||
161689626|NCT01857869|583913544|FG000|Primary/Challenge Phase|Protocol Violation|1|||
161689627|NCT01857869|583913545|FG001|Primary/Challenge Phase|Protocol Violation|0|||
161689628|NCT01857869|583913546|FG002|Primary/Challenge Phase|Protocol Violation|0|||
161689629|NCT01857869|583913547|FG003|Primary/Challenge Phase|Protocol Violation|0|||
161689630|NCT01857869|583913548|FG004|Primary/Challenge Phase|Protocol Violation|0|||
161689631|NCT01857869|583913549|FG005|Primary/Challenge Phase|Protocol Violation|0|||
161689632|NCT01857869|583913550|FG006|Primary/Challenge Phase|Protocol Violation|0|||
161689633|NCT01857869|583913551|FG007|Primary/Challenge Phase|Protocol Violation|0|||
161689634|NCT01857869|583913552|FG008|Primary/Challenge Phase|Protocol Violation|0|||
161689635|NCT01857869|583913553|FG009|Primary/Challenge Phase|Protocol Violation|0|||
161689636|NCT01857869|583913544|FG000|Primary/Challenge Phase|Other|1|||
161689637|NCT01857869|583913545|FG001|Primary/Challenge Phase|Other|1|||
161689638|NCT01857869|583913546|FG002|Primary/Challenge Phase|Other|0|||
161689639|NCT01857869|583913547|FG003|Primary/Challenge Phase|Other|0|||
161689640|NCT01857869|583913548|FG004|Primary/Challenge Phase|Other|0|||
161836219|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
161836220|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
161836221|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
161836222|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161651366|NCT01399697|583773893|FG000|Overall Study|Adverse Event|13|||
161651367|NCT01399697|583773894|FG001|Overall Study|Adverse Event|3|||
161651368|NCT01399697|583773895|FG002|Overall Study|Adverse Event|1|||
161651369|NCT01399697|583773893|FG000|Overall Study|Lost to Follow-up|2|||
161651370|NCT01399697|583773894|FG001|Overall Study|Lost to Follow-up|0|||
161651371|NCT01399697|583773895|FG002|Overall Study|Lost to Follow-up|0|||
161651372|NCT01399697|583773893|FG000|Overall Study|Withdrawal by Subject|8|||
161651373|NCT01399697|583773894|FG001|Overall Study|Withdrawal by Subject|0|||
161651374|NCT01399697|583773895|FG002|Overall Study|Withdrawal by Subject|0|||
161651375|NCT01399697|583773893|FG000|Overall Study|Investigator Decisión|1|||
161651376|NCT01399697|583773894|FG001|Overall Study|Investigator Decisión|0|||
161651377|NCT01399697|583773895|FG002|Overall Study|Investigator Decisión|2|||
161651378|NCT01399697|583773893|FG000|Overall Study|Lack of Efficacy|9|||
161651379|NCT01399697|583773894|FG001|Overall Study|Lack of Efficacy|0|||
161651380|NCT01399697|583773895|FG002|Overall Study|Lack of Efficacy|1|||
161651381|NCT01399697|583773893|FG000|Overall Study|Protocol Violation|2|||
161651382|NCT01399697|583773894|FG001|Overall Study|Protocol Violation|0|||
161651383|NCT01399697|583773895|FG002|Overall Study|Protocol Violation|0|||
161651384|NCT01399697|583773893|FG000|Overall Study|Non-Compliant|1|||
161651385|NCT01399697|583773894|FG001|Overall Study|Non-Compliant|0|||
161651386|NCT01399697|583773895|FG002|Overall Study|Non-Compliant|0|||
161651387|NCT01399697|583773893|FG000|Overall Study|Inclusion Error|2|||
161651388|NCT01399697|583773894|FG001|Overall Study|Inclusion Error|0|||
161651389|NCT01399697|583773895|FG002|Overall Study|Inclusion Error|0|||
161651390|NCT01399697|583773893|FG000|Overall Study|Positive result for hepatitis B|1|||
161651391|NCT01399697|583773894|FG001|Overall Study|Positive result for hepatitis B|0|||
161651392|NCT01399697|583773895|FG002|Overall Study|Positive result for hepatitis B|0|||
161651393|NCT01399697|583773893|FG000|Overall Study|Clinical RA remission|1|||
161651394|NCT01399697|583773894|FG001|Overall Study|Clinical RA remission|0|||
161651395|NCT01399697|583773895|FG002|Overall Study|Clinical RA remission|0|||
161651396|NCT01399697|583773893|FG000|Overall Study|Sponsor Decision|1|||
161651397|NCT01399697|583773894|FG001|Overall Study|Sponsor Decision|0|||
161651398|NCT01399697|583773895|FG002|Overall Study|Sponsor Decision|0|||
161651399|NCT01712061|583773897|FG000|Overall Study|Adverse Event|4|||
161651400|NCT01712061|583773898|FG001|Overall Study|Adverse Event|9|||
161651401|NCT01712061|583773899|FG002|Overall Study|Adverse Event|5|||
161651402|NCT01712061|583773897|FG000|Overall Study|Death|0|||
161651403|NCT01712061|583773898|FG001|Overall Study|Death|0|||
161651404|NCT01712061|583773899|FG002|Overall Study|Death|1|||
161651405|NCT01712061|583773897|FG000|Overall Study|Lost to Follow-up|1|||
161651406|NCT01712061|583773898|FG001|Overall Study|Lost to Follow-up|0|||
161651407|NCT01712061|583773899|FG002|Overall Study|Lost to Follow-up|1|||
161651408|NCT01712061|583773897|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
161651409|NCT01712061|583773898|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
161651410|NCT01712061|583773899|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
161651411|NCT01712061|583773897|FG000|Overall Study|Medication Error Without Associated AE|0|||
161651412|NCT01712061|583773898|FG001|Overall Study|Medication Error Without Associated AE|1|||
161651413|NCT01712061|583773899|FG002|Overall Study|Medication Error Without Associated AE|0|||
161651414|NCT01712061|583773897|FG000|Overall Study|Withdrawal by Subject|1|||
161651415|NCT01712061|583773898|FG001|Overall Study|Withdrawal by Subject|7|||
161651416|NCT01712061|583773899|FG002|Overall Study|Withdrawal by Subject|1|||
161651417|NCT01712061|583773897|FG000|Overall Study|Other|0|||
161651418|NCT01712061|583773898|FG001|Overall Study|Other|3|||
161651419|NCT01712061|583773899|FG002|Overall Study|Other|0|||
161651420|NCT00504777|583773904|FG000|Overall Study|Adverse Event|1|||
161651421|NCT04868539|583773908|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
161651422|NCT04868539|583773909|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
161651423|NCT01572740|583773910|FG000|Overall Study|Adverse Event|1|||
161651424|NCT01572740|583773911|FG001|Overall Study|Adverse Event|1|||
161836223|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161836224|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161836225|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
161836226|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
161651425|NCT01572740|583773910|FG000|Overall Study|Withdrawal by Subject|1|||
161651426|NCT01572740|583773911|FG001|Overall Study|Withdrawal by Subject|1|||
161651427|NCT01572740|583773910|FG000|Overall Study|unclassified|4|||
161651428|NCT01572740|583773911|FG001|Overall Study|unclassified|3|||
161651429|NCT01401153|583773912|FG000|First Test Day|Learning disabilities; illness|1|||
161651430|NCT01401153|583773913|FG001|First Test Day|Learning disabilities; illness|10|||
161651431|NCT01401153|583773912|FG000|Second Test Day|illness|0|||
161651432|NCT01401153|583773913|FG001|Second Test Day|illness|5|||
161651433|NCT01677767|583773916|FG000|Overall Study|Adverse Event|1|||
161689641|NCT01857869|583913549|FG005|Primary/Challenge Phase|Other|0|||
161689642|NCT01857869|583913550|FG006|Primary/Challenge Phase|Other|0|||
161689643|NCT01857869|583913551|FG007|Primary/Challenge Phase|Other|0|||
161689644|NCT01857869|583913552|FG008|Primary/Challenge Phase|Other|0|||
161689645|NCT01857869|583913553|FG009|Primary/Challenge Phase|Other|0|||
161689646|NCT01857869|583913544|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689647|NCT01857869|583913545|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689648|NCT01857869|583913546|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689649|NCT01857869|583913547|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
161689650|NCT01857869|583913548|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689651|NCT01857869|583913549|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689652|NCT01857869|583913550|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689653|NCT01857869|583913551|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689654|NCT01857869|583913552|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689655|NCT01857869|583913553|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689656|NCT01857869|583913544|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689657|NCT01857869|583913545|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689658|NCT01857869|583913546|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689659|NCT01857869|583913547|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
161689660|NCT01857869|583913548|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689661|NCT01857869|583913549|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689662|NCT01857869|583913550|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689663|NCT01857869|583913551|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689664|NCT01857869|583913552|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689665|NCT01857869|583913553|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689666|NCT02898259|583913565|FG000|Overall Study|Adverse Event|0|||
161689667|NCT02898259|583913566|FG001|Overall Study|Adverse Event|0|||
161689668|NCT02898259|583913567|FG002|Overall Study|Adverse Event|1|||
161689669|NCT02898259|583913568|FG003|Overall Study|Adverse Event|0|||
161689670|NCT02898259|583913569|FG004|Overall Study|Adverse Event|0|||
161689671|NCT02898259|583913565|FG000|Overall Study|Lack of Efficacy|1|||
161689672|NCT02898259|583913566|FG001|Overall Study|Lack of Efficacy|1|||
161689673|NCT02898259|583913567|FG002|Overall Study|Lack of Efficacy|3|||
161689674|NCT02898259|583913568|FG003|Overall Study|Lack of Efficacy|0|||
161689675|NCT02898259|583913569|FG004|Overall Study|Lack of Efficacy|0|||
161689676|NCT02898259|583913565|FG000|Overall Study|Lost to Follow-up|0|||
161689677|NCT02898259|583913566|FG001|Overall Study|Lost to Follow-up|0|||
161689678|NCT02898259|583913567|FG002|Overall Study|Lost to Follow-up|1|||
161689679|NCT02898259|583913568|FG003|Overall Study|Lost to Follow-up|0|||
161689680|NCT02898259|583913569|FG004|Overall Study|Lost to Follow-up|0|||
161689681|NCT02898259|583913565|FG000|Overall Study|Transformation before study began|0|||
161689682|NCT02898259|583913566|FG001|Overall Study|Transformation before study began|0|||
161689683|NCT02898259|583913567|FG002|Overall Study|Transformation before study began|0|||
161689684|NCT02898259|583913568|FG003|Overall Study|Transformation before study began|1|||
161689685|NCT02898259|583913569|FG004|Overall Study|Transformation before study began|0|||
161689686|NCT02728830|583913583|FG000|Overall Study|Exclusionary Surgery|9|||
161689687|NCT02728830|583913583|FG000|Overall Study|Exclusionary Pathology|6|||
161689688|NCT02728830|583913583|FG000|Overall Study|Physician Decision|3|||
161689689|NCT02728830|583913583|FG000|Overall Study|Withdrawal by Subject|2|||
161689690|NCT02728830|583913583|FG000|Overall Study|Lost to Follow-up|1|||
161689691|NCT02728830|583913583|FG000|Overall Study|Exclusionary Lab Values|1|||
161689692|NCT02728830|583913583|FG000|Overall Study|Contraindicated Illness|1|||
161689693|NCT02728830|583913583|FG000|Overall Study|Language Barrier|1|||
161689694|NCT01087905|583913584|FG000|Overall Study|Lost to Follow-up|24|||
161689695|NCT01087905|583913585|FG001|Overall Study|Lost to Follow-up|28|||
161689696|NCT01087905|583913586|FG002|Overall Study|Lost to Follow-up|18|||
161689697|NCT01087905|583913587|FG003|Overall Study|Lost to Follow-up|31|||
161689698|NCT01087905|583913588|FG004|Overall Study|Lost to Follow-up|27|||
161689699|NCT01087905|583913589|FG005|Overall Study|Lost to Follow-up|25|||
161689700|NCT01087905|583913590|FG006|Overall Study|Lost to Follow-up|20|||
161689701|NCT01087905|583913591|FG007|Overall Study|Lost to Follow-up|24|||
161689702|NCT01087905|583913584|FG000|Overall Study|Withdrawal by Subject|5|||
161689703|NCT01087905|583913585|FG001|Overall Study|Withdrawal by Subject|4|||
161689704|NCT01087905|583913586|FG002|Overall Study|Withdrawal by Subject|4|||
161689705|NCT01087905|583913587|FG003|Overall Study|Withdrawal by Subject|5|||
161689706|NCT01087905|583913588|FG004|Overall Study|Withdrawal by Subject|4|||
161689707|NCT01087905|583913589|FG005|Overall Study|Withdrawal by Subject|3|||
161689708|NCT01087905|583913590|FG006|Overall Study|Withdrawal by Subject|3|||
161689709|NCT01087905|583913591|FG007|Overall Study|Withdrawal by Subject|5|||
161689710|NCT00790907|583913592|FG000|Overall Study|Adverse Event|9|||
161689711|NCT00790907|583913593|FG001|Overall Study|Adverse Event|7|||
161689712|NCT00790907|583913594|FG002|Overall Study|Adverse Event|6|||
161689713|NCT00790907|583913592|FG000|Overall Study|Physician Decision|304|||
161689714|NCT00790907|583913593|FG001|Overall Study|Physician Decision|271|||
161689715|NCT00790907|583913594|FG002|Overall Study|Physician Decision|255|||
161689716|NCT00790907|583913592|FG000|Overall Study|Withdrawal by Subject|1|||
161689717|NCT00790907|583913593|FG001|Overall Study|Withdrawal by Subject|7|||
161689718|NCT00790907|583913594|FG002|Overall Study|Withdrawal by Subject|5|||
161689719|NCT00790907|583913592|FG000|Overall Study|Bleeding Event|11|||
161689720|NCT00790907|583913593|FG001|Overall Study|Bleeding Event|16|||
161689721|NCT00790907|583913594|FG002|Overall Study|Bleeding Event|21|||
161689722|NCT00790907|583913592|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
161689723|NCT00790907|583913593|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
161689724|NCT00790907|583913594|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
161689725|NCT00790907|583913592|FG000|Overall Study|Qualifying Condition Not Present|29|||
161689726|NCT00790907|583913593|FG001|Overall Study|Qualifying Condition Not Present|14|||
161689727|NCT00790907|583913594|FG002|Overall Study|Qualifying Condition Not Present|16|||
161689728|NCT00790907|583913592|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
161689729|NCT00790907|583913593|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
161689730|NCT00790907|583913594|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
161689731|NCT00790907|583913592|FG000|Overall Study|Did Not Receive Study Drug|10|||
161689732|NCT00790907|583913593|FG001|Overall Study|Did Not Receive Study Drug|0|||
161689733|NCT00790907|583913594|FG002|Overall Study|Did Not Receive Study Drug|0|||
161689734|NCT00774345|583913595|FG000|Pre-treatment|Other reasons|2|||
161689735|NCT00774345|583913596|FG001|Pre-treatment|Other reasons|0|||
161689736|NCT00774345|583913595|FG000|Treatment|Adverse Event|61|||
161689737|NCT00774345|583913596|FG001|Treatment|Adverse Event|15|||
161689738|NCT00774345|583913595|FG000|Treatment|Progressive Disease without histologic transformation|51|||
161689739|NCT00774345|583913596|FG001|Treatment|Progressive Disease without histologic transformation|111|||
161689740|NCT00774345|583913595|FG000|Treatment|Progressive Disease with histologic transformation|4|||
161689741|NCT00774345|583913596|FG001|Treatment|Progressive Disease with histologic transformation|2|||
161689742|NCT00774345|583913595|FG000|Treatment|Withdrawal by Subject|5|||
161689743|NCT00774345|583913596|FG001|Treatment|Withdrawal by Subject|2|||
161689744|NCT00774345|583913595|FG000|Treatment|Lost to Follow-up|1|||
161689745|NCT00774345|583913596|FG001|Treatment|Lost to Follow-up|1|||
161689746|NCT00774345|583913595|FG000|Treatment|Death|4|||
161689747|NCT00774345|583913596|FG001|Treatment|Death|0|||
161689748|NCT00774345|583913595|FG000|Treatment|Other Reasons|32|||
161689749|NCT00774345|583913596|FG001|Treatment|Other Reasons|26|||
161689750|NCT03436862|583913597|FG000|Overall Study|Adverse Event|4|||
161689751|NCT03436862|583913597|FG000|Overall Study|Progressive Disease|2|||
161689752|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161689753|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161689754|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161689755|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
161689756|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161689757|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161689758|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161689759|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
161689760|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161689761|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161689762|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161689763|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
161689764|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161689765|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161689766|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161689767|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
161689768|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
161689769|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
161689770|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
161689771|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
161689772|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
161689773|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
161689774|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
161689775|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
161689776|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
161689777|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
161689778|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
161689779|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
161651434|NCT01677767|583773916|FG000|Overall Study|Death|4|||
161651435|NCT01677767|583773916|FG000|Overall Study|Protocol Violation|4|||
161651436|NCT01677767|583773916|FG000|Overall Study|Withdrawal by Subject|10|||
161651437|NCT01677767|583773916|FG000|Overall Study|Non-compliance by the participants|3|||
161651438|NCT00842244|583773917|FG000|Overall Study|Death|3|||
161651439|NCT00842244|583773917|FG000|Overall Study|Withdrawal by Subject|1|||
161651440|NCT00842244|583773917|FG000|Overall Study|Other|17|||
161651441|NCT01068665|583773922|FG000|Overall Study|Adverse Event|5|||
161651442|NCT01068665|583773923|FG001|Overall Study|Adverse Event|4|||
161651443|NCT01068665|583773922|FG000|Overall Study|Lack of Efficacy|0|||
161651444|NCT01068665|583773923|FG001|Overall Study|Lack of Efficacy|2|||
161651445|NCT01068665|583773922|FG000|Overall Study|Protocol Violation|5|||
161651446|NCT01068665|583773923|FG001|Overall Study|Protocol Violation|2|||
161651447|NCT01068665|583773922|FG000|Overall Study|Withdrawal Criteria|3|||
161651448|NCT01068665|583773923|FG001|Overall Study|Withdrawal Criteria|9|||
161651449|NCT01068665|583773922|FG000|Overall Study|Other|17|||
161651450|NCT01068665|583773923|FG001|Overall Study|Other|12|||
161651451|NCT02807272|583773924|FG000|Overall Study|Death|9|||
161651452|NCT02807272|583773925|FG001|Overall Study|Death|5|||
161651453|NCT02807272|583773926|FG002|Overall Study|Death|2|||
161651454|NCT02807272|583773927|FG003|Overall Study|Death|0|||
161651455|NCT02807272|583773928|FG004|Overall Study|Death|1|||
161651456|NCT02807272|583773924|FG000|Overall Study|Lost to Follow-up|1|||
161651457|NCT02807272|583773925|FG001|Overall Study|Lost to Follow-up|0|||
161651458|NCT02807272|583773926|FG002|Overall Study|Lost to Follow-up|0|||
161651459|NCT02807272|583773927|FG003|Overall Study|Lost to Follow-up|0|||
161651460|NCT02807272|583773928|FG004|Overall Study|Lost to Follow-up|0|||
161651461|NCT02807272|583773924|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
161651462|NCT02807272|583773925|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
161651463|NCT02807272|583773926|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
161651464|NCT02807272|583773927|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
161651465|NCT02807272|583773928|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
161651466|NCT02807272|583773924|FG000|Overall Study|Protocol-defined Disease Progression|0|||
161651467|NCT02807272|583773925|FG001|Overall Study|Protocol-defined Disease Progression|1|||
161651468|NCT02807272|583773926|FG002|Overall Study|Protocol-defined Disease Progression|0|||
161651469|NCT02807272|583773927|FG003|Overall Study|Protocol-defined Disease Progression|0|||
161651470|NCT02807272|583773928|FG004|Overall Study|Protocol-defined Disease Progression|1|||
161651471|NCT02807272|583773924|FG000|Overall Study|Study Terminated by Sponsor|1|||
161651472|NCT02807272|583773925|FG001|Overall Study|Study Terminated by Sponsor|0|||
161651473|NCT02807272|583773926|FG002|Overall Study|Study Terminated by Sponsor|0|||
161651474|NCT02807272|583773927|FG003|Overall Study|Study Terminated by Sponsor|1|||
161651475|NCT02807272|583773928|FG004|Overall Study|Study Terminated by Sponsor|0|||
161651476|NCT02807272|583773924|FG000|Overall Study|Other|1|||
161651477|NCT02807272|583773925|FG001|Overall Study|Other|0|||
161651478|NCT02807272|583773926|FG002|Overall Study|Other|0|||
161651479|NCT02807272|583773927|FG003|Overall Study|Other|0|||
161689780|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
161651480|NCT02807272|583773928|FG004|Overall Study|Other|1|||
161651481|NCT01162863|583773932|FG000|Overall Study|Lack of Efficacy|1|||
161651482|NCT01162863|583773933|FG001|Overall Study|Lack of Efficacy|0|||
161689781|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
161651483|NCT01162863|583773934|FG002|Overall Study|Lack of Efficacy|0|||
161651484|NCT01162863|583773932|FG000|Overall Study|Adverse Event|0|||
161651485|NCT01162863|583773933|FG001|Overall Study|Adverse Event|1|||
161651486|NCT01162863|583773934|FG002|Overall Study|Adverse Event|0|||
161689782|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
161651487|NCT00392925|583773935|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
161651488|NCT00392925|583773936|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161651489|NCT00392925|583773937|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161651490|NCT00392925|583773938|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161651491|NCT00392925|583773935|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
161651492|NCT00392925|583773936|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
161651493|NCT00392925|583773937|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
161651494|NCT00392925|583773938|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
161651495|NCT00392925|583773935|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
161651496|NCT00392925|583773936|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
161651497|NCT00392925|583773937|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
161651498|NCT00392925|583773938|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
161651499|NCT00392925|583773935|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
161651500|NCT00392925|583773936|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
161651501|NCT00392925|583773937|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
161651502|NCT00392925|583773938|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
161651503|NCT00392925|583773935|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
161651504|NCT00392925|583773936|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
161651505|NCT00392925|583773937|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
161651506|NCT00392925|583773938|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
161651507|NCT00392925|583773935|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
161651508|NCT00392925|583773936|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
161651509|NCT00392925|583773937|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
161651510|NCT00392925|583773938|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
161651511|NCT00392925|583773935|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
161651512|NCT00392925|583773936|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
161651513|NCT00392925|583773937|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
161651514|NCT00392925|583773938|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
161651515|NCT00392925|583773935|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
161651516|NCT00392925|583773936|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
161651517|NCT00392925|583773937|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
161651518|NCT00392925|583773938|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
161651519|NCT00392925|583773935|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
161651520|NCT00392925|583773936|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
161651521|NCT00392925|583773937|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
161651522|NCT00392925|583773938|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
161651523|NCT03552523|583773939|FG000|Overall Study|Withdrawal by Subject|1|||
161651524|NCT03552523|583773940|FG001|Overall Study|Withdrawal by Subject|1|||
161651525|NCT04145700|583773941|FG000|Overall Study|Withdrawal by Subject|8|||
161651526|NCT04145700|583773942|FG001|Overall Study|Withdrawal by Subject|3|||
161651527|NCT00780559|583773945|FG000|Overall Study|Lost to Follow-up|2|||
161651528|NCT00780559|583773946|FG001|Overall Study|Lost to Follow-up|7|||
161651529|NCT00780559|583773945|FG000|Overall Study|Death|1|||
161651530|NCT00780559|583773946|FG001|Overall Study|Death|0|||
161651531|NCT01840410|583773948|FG000|Overall Study|Physician Decision|1|||
161651532|NCT01840410|583773949|FG001|Overall Study|Physician Decision|2|||
161651533|NCT01840410|583773948|FG000|Overall Study|Pregnancy|1|||
161651534|NCT01840410|583773949|FG001|Overall Study|Pregnancy|0|||
161651535|NCT01840410|583773948|FG000|Overall Study|Protocol deviation|1|||
161651536|NCT01840410|583773949|FG001|Overall Study|Protocol deviation|0|||
161651537|NCT01840410|583773948|FG000|Overall Study|Lost to Follow-up|1|||
161651538|NCT01840410|583773949|FG001|Overall Study|Lost to Follow-up|0|||
161651539|NCT01840410|583773948|FG000|Overall Study|Withdrawal by Subject|2|||
161651540|NCT01840410|583773949|FG001|Overall Study|Withdrawal by Subject|1|||
161651541|NCT01840410|583773948|FG000|Overall Study|Adverse Event|1|||
161651542|NCT01840410|583773949|FG001|Overall Study|Adverse Event|1|||
161651543|NCT00839956|583773950|FG000|Overall Study|Adverse Event|2|||
161651544|NCT00839956|583773950|FG000|Overall Study|Lack of Efficacy|6|||
161651545|NCT00839956|583773950|FG000|Overall Study|Physician Decision|1|||
161651546|NCT00839956|583773950|FG000|Overall Study|Withdrawal by Subject|3|||
161651547|NCT00594880|583773951|FG000|Overall Study|Withdrawal by Subject|1|||
161651548|NCT00594880|583773952|FG001|Overall Study|Withdrawal by Subject|1|||
161651549|NCT00594880|583773951|FG000|Overall Study|Lost to Follow-up|1|||
161651550|NCT00594880|583773952|FG001|Overall Study|Lost to Follow-up|0|||
161651551|NCT02206061|583773953|FG000|Overall Study|Withdrawal by Subject|4|||
161651552|NCT02206061|583773954|FG001|Overall Study|Withdrawal by Subject|7|||
161651553|NCT02206061|583773955|FG002|Overall Study|Withdrawal by Subject|1|||
161651554|NCT02206061|583773953|FG000|Overall Study|Lost to Follow-up|14|||
161651555|NCT02206061|583773954|FG001|Overall Study|Lost to Follow-up|7|||
161651556|NCT02206061|583773955|FG002|Overall Study|Lost to Follow-up|20|||
161651557|NCT00694109|583773956|FG000|Overall Study|Physician Decision|3|||
161651558|NCT00694109|583773956|FG000|Overall Study|Adverse Event|74|||
161651559|NCT00694109|583773956|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
161651560|NCT00694109|583773956|FG000|Overall Study|Lack of Efficacy|2|||
161651561|NCT00694109|583773956|FG000|Overall Study|Withdrawal by Subject|13|||
161651562|NCT00694109|583773956|FG000|Overall Study|Pregnancy|1|||
161651563|NCT00694109|583773956|FG000|Overall Study|Enrolled but not treated|1|||
161651564|NCT00694109|583773956|FG000|Overall Study|Other|2|||
161651565|NCT00694109|583773956|FG000|Overall Study|Consented but no additional treatment|3|||
161651566|NCT04520659|583773959|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
161651567|NCT04520659|583773960|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
161651568|NCT04520659|583773961|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
161651569|NCT04520659|583773962|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
161651570|NCT04485611|583773963|FG000|Prehabilitation|Physician Decision|1|||
161651571|NCT03345576|583773965|FG000|Overall Study|Withdrawal by Subject|2|||
161651572|NCT03345576|583773966|FG001|Overall Study|Withdrawal by Subject|2|||
161651573|NCT03345576|583773965|FG000|Overall Study|Adverse Event|1|||
161651574|NCT03345576|583773966|FG001|Overall Study|Adverse Event|0|||
161651575|NCT05718466|583775904|FG000|Overall Study|Withdrawal by Subject|1|||
161651576|NCT05718466|583775905|FG001|Overall Study|Withdrawal by Subject|2|||
161651577|NCT05718466|583775904|FG000|Overall Study|Death|0|||
161651578|NCT05718466|583775905|FG001|Overall Study|Death|1|||
161651579|NCT01253135|583775908|FG000|Original Protocol|Protocol Amendment|15|||
161651580|NCT01253135|583775908|FG000|Amended Protocol|Non-compliance|1|||
161651581|NCT00833261|583775915|FG000|Overall Study|Withdrawal by Subject|4|||
161651582|NCT01255631|583775919|FG000|Overall Study|poor enrollment, no data analyzed|9|||
161651583|NCT01255631|583775920|FG001|Overall Study|poor enrollment, no data analyzed|6|||
161651584|NCT00264303|583775928|FG000|Overall Study|Adverse Event|4|||
161651585|NCT00264303|583775929|FG001|Overall Study|Adverse Event|3|||
161651586|NCT00264303|583775928|FG000|Overall Study|Lack of Efficacy|10|||
161651587|NCT00264303|583775929|FG001|Overall Study|Lack of Efficacy|13|||
161651588|NCT00264303|583775928|FG000|Overall Study|Lost to Follow-up|3|||
161651589|NCT00264303|583775929|FG001|Overall Study|Lost to Follow-up|3|||
161651590|NCT00264303|583775928|FG000|Overall Study|Withdrawal by Subject|2|||
161651591|NCT00264303|583775929|FG001|Overall Study|Withdrawal by Subject|3|||
161651592|NCT00264303|583775928|FG000|Overall Study|Various reasons listed in study report|6|||
161651593|NCT00264303|583775929|FG001|Overall Study|Various reasons listed in study report|7|||
161651594|NCT02815579|583775930|FG000|Overall Study|Non-payment of loan down-payment|16|||
161651595|NCT02815579|583775931|FG001|Overall Study|Non-payment of loan down-payment|0|||
161651596|NCT02815579|583775930|FG000|Overall Study|Withdrawal by Subject|7|||
161651597|NCT02815579|583775931|FG001|Overall Study|Withdrawal by Subject|1|||
161651598|NCT02815579|583775930|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
161651599|NCT02815579|583775931|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
161651600|NCT02815579|583775930|FG000|Overall Study|Lost to Follow-up|7|||
161651601|NCT02815579|583775931|FG001|Overall Study|Lost to Follow-up|4|||
161651602|NCT02815579|583775930|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
161651603|NCT02815579|583775931|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
161651604|NCT02815579|583775930|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
161651605|NCT02815579|583775931|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
161651606|NCT02815579|583775930|FG000|Overall Study|Death|5|||
161651607|NCT02815579|583775931|FG001|Overall Study|Death|4|||
161651608|NCT02815579|583775930|FG000|Overall Study|Imprisoned|0|||
161651609|NCT02815579|583775931|FG001|Overall Study|Imprisoned|2|||
161651610|NCT02815579|583775930|FG000|Overall Study|Did not meet enrollment criteria|0|||
161651611|NCT02815579|583775931|FG001|Overall Study|Did not meet enrollment criteria|1|||
161651612|NCT02389452|583775932|FG000|Overall Study|Lost to Follow-up|13|||
161651613|NCT02389452|583775932|FG000|Overall Study|Adverse Event|1|||
161651614|NCT02389452|583775932|FG000|Overall Study|Withdrawal by Subject|5|||
161651615|NCT02389452|583775932|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
161651616|NCT02311673|583775933|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
161651617|NCT02311673|583775934|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
161651618|NCT02311673|583775935|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
161689783|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
161836227|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
161651619|NCT02311673|583775936|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
161651620|NCT00414908|583775942|FG000|Overall Study|Protocol Violation|1|||
161651621|NCT00414908|583775943|FG001|Overall Study|Protocol Violation|1|||
161651622|NCT00818168|583775944|FG000|Overall Study|Lack of Efficacy|18|||
161651623|NCT00818168|583775944|FG000|Overall Study|Pregnancy|2|||
161651624|NCT00818168|583775944|FG000|Overall Study|Withdrawal by Subject|16|||
161651625|NCT00818168|583775944|FG000|Overall Study|Lost to Follow-up|7|||
161651626|NCT00818168|583775944|FG000|Overall Study|Adverse Event|19|||
161651627|NCT00818168|583775944|FG000|Overall Study|Reason for Non-completion Not reported|6|||
161651628|NCT00818168|583775944|FG000|Overall Study|Participant Moved|2|||
161651629|NCT01977677|583775945|FG000|Overall Study|Unrelated Adverse Event|0|||
161651630|NCT01977677|583775946|FG001|Overall Study|Unrelated Adverse Event|0|||
161651631|NCT01977677|583775947|FG002|Overall Study|Unrelated Adverse Event|1|||
161651632|NCT00667225|583775948|FG000|Overall Study|Subject had no more lesions to treat.|1|||
161651633|NCT00667225|583775949|FG001|Overall Study|Subject had no more lesions to treat.|0|||
161651634|NCT00667225|583775948|FG000|Overall Study|Lost to Follow-up|0|||
161651635|NCT00667225|583775949|FG001|Overall Study|Lost to Follow-up|1|||
161651636|NCT03563157|583775954|FG000|Overall Study|Progressive Disease|2|||
161651637|NCT02248818|583775955|FG000|Screening|Protocol Violation|0|||
161651638|NCT02248818|583775956|FG001|Screening|Protocol Violation|0|||
161651639|NCT02248818|583775957|FG002|Screening|Protocol Violation|0|||
161651640|NCT02248818|583775958|FG003|Screening|Protocol Violation|0|||
161651641|NCT02248818|583775959|FG004|Screening|Protocol Violation|0|||
161651642|NCT02248818|583775960|FG005|Screening|Protocol Violation|0|||
161651643|NCT02248818|583775961|FG006|Screening|Protocol Violation|0|||
161651644|NCT02248818|583775962|FG007|Screening|Protocol Violation|0|||
161651645|NCT02248818|583775963|FG008|Screening|Protocol Violation|7|||
161651646|NCT02248818|583775955|FG000|Screening|Study fully enrolled|0|||
161651647|NCT02248818|583775956|FG001|Screening|Study fully enrolled|0|||
161651648|NCT02248818|583775957|FG002|Screening|Study fully enrolled|0|||
161651649|NCT02248818|583775958|FG003|Screening|Study fully enrolled|0|||
161651650|NCT02248818|583775959|FG004|Screening|Study fully enrolled|0|||
161651651|NCT02248818|583775960|FG005|Screening|Study fully enrolled|0|||
161651652|NCT02248818|583775961|FG006|Screening|Study fully enrolled|0|||
161651653|NCT02248818|583775962|FG007|Screening|Study fully enrolled|0|||
161651654|NCT02248818|583775963|FG008|Screening|Study fully enrolled|14|||
161651655|NCT02248818|583775955|FG000|Screening|Physician Decision|0|||
161651656|NCT02248818|583775956|FG001|Screening|Physician Decision|0|||
161651657|NCT02248818|583775957|FG002|Screening|Physician Decision|0|||
161651658|NCT02248818|583775958|FG003|Screening|Physician Decision|0|||
161651659|NCT02248818|583775959|FG004|Screening|Physician Decision|0|||
161651660|NCT02248818|583775960|FG005|Screening|Physician Decision|0|||
161651661|NCT02248818|583775961|FG006|Screening|Physician Decision|0|||
161651662|NCT02248818|583775962|FG007|Screening|Physician Decision|0|||
161651663|NCT02248818|583775963|FG008|Screening|Physician Decision|73|||
161651664|NCT02248818|583775955|FG000|Screening|Withdrawal by Subject|0|||
161651665|NCT02248818|583775956|FG001|Screening|Withdrawal by Subject|0|||
161651666|NCT02248818|583775957|FG002|Screening|Withdrawal by Subject|0|||
161651667|NCT02248818|583775958|FG003|Screening|Withdrawal by Subject|0|||
161651668|NCT02248818|583775959|FG004|Screening|Withdrawal by Subject|0|||
161651669|NCT02248818|583775960|FG005|Screening|Withdrawal by Subject|0|||
161651670|NCT02248818|583775961|FG006|Screening|Withdrawal by Subject|0|||
161651671|NCT02248818|583775962|FG007|Screening|Withdrawal by Subject|0|||
161651672|NCT02248818|583775963|FG008|Screening|Withdrawal by Subject|6|||
161651673|NCT02248818|583775955|FG000|Screening|Lost to Follow-up|0|||
161689784|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
161689785|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
161689786|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
161689787|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
161689788|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
161836228|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
161836229|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
161836230|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
161836231|NCT00094458|584442897|FG000|OLE: Open-Label Extension|Adverse Event|0|||
161836232|NCT00094458|584442898|FG001|OLE: Open-Label Extension|Adverse Event|0|||
161836233|NCT00094458|584442899|FG002|OLE: Open-Label Extension|Adverse Event|0|||
161836234|NCT00094458|584442900|FG003|OLE: Open-Label Extension|Adverse Event|0|||
161836235|NCT00094458|584442901|FG004|OLE: Open-Label Extension|Adverse Event|3|||
161836236|NCT00094458|584442902|FG005|OLE: Open-Label Extension|Adverse Event|4|||
161836237|NCT00094458|584442897|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836238|NCT00094458|584442898|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836239|NCT00094458|584442899|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836240|NCT00094458|584442900|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
161836241|NCT00094458|584442901|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
161836242|NCT00094458|584442902|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836243|NCT00094458|584442897|FG000|OLE: Open-Label Extension|Patient decision|0|||
161836244|NCT00094458|584442898|FG001|OLE: Open-Label Extension|Patient decision|0|||
161836245|NCT00094458|584442899|FG002|OLE: Open-Label Extension|Patient decision|0|||
161836246|NCT00094458|584442900|FG003|OLE: Open-Label Extension|Patient decision|0|||
161836247|NCT00094458|584442901|FG004|OLE: Open-Label Extension|Patient decision|1|||
161836248|NCT00094458|584442902|FG005|OLE: Open-Label Extension|Patient decision|0|||
161836249|NCT03247517|584442903|FG000|Overall Study|Adverse Event|0|||
161836250|NCT03247517|584442904|FG001|Overall Study|Adverse Event|4|||
161836251|NCT03247517|584442905|FG002|Overall Study|Adverse Event|2|||
161836252|NCT03247517|584442903|FG000|Overall Study|Lost to Follow-up|2|||
161836253|NCT03247517|584442904|FG001|Overall Study|Lost to Follow-up|6|||
161836254|NCT03247517|584442905|FG002|Overall Study|Lost to Follow-up|4|||
161836255|NCT03247517|584442903|FG000|Overall Study|Consent withdrawn by caregiver|1|||
161836256|NCT03247517|584442904|FG001|Overall Study|Consent withdrawn by caregiver|4|||
161689789|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
161689790|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
161689791|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
161689792|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Other|6|||
161689793|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Other|1|||
161689794|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Other|6|||
161689795|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Other|0|||
161689796|NCT01119248|583913602|FG000|Overall Study|Physician Decision|5|||
161689797|NCT00550680|583913603|FG000|Overall Study|Administrative Reasons|1|||
161689798|NCT00550680|583913603|FG000|Overall Study|Adverse Event|5|||
161689799|NCT00550680|583913603|FG000|Overall Study|Death|3|||
161836257|NCT03247517|584442905|FG002|Overall Study|Consent withdrawn by caregiver|7|||
161836258|NCT03247517|584442903|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
161836259|NCT03247517|584442904|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
161836260|NCT03247517|584442905|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
161836261|NCT03247517|584442903|FG000|Overall Study|Protocol Violation|0|||
161651674|NCT02248818|583775956|FG001|Screening|Lost to Follow-up|0|||
161651675|NCT02248818|583775957|FG002|Screening|Lost to Follow-up|0|||
161651676|NCT02248818|583775958|FG003|Screening|Lost to Follow-up|0|||
161651677|NCT02248818|583775959|FG004|Screening|Lost to Follow-up|0|||
161651678|NCT02248818|583775960|FG005|Screening|Lost to Follow-up|0|||
161651679|NCT02248818|583775961|FG006|Screening|Lost to Follow-up|0|||
161651680|NCT02248818|583775962|FG007|Screening|Lost to Follow-up|0|||
161651681|NCT02248818|583775963|FG008|Screening|Lost to Follow-up|7|||
161651682|NCT02248818|583775955|FG000|Randomised Study|Administrative - randomization error|0|||
161651683|NCT02248818|583775956|FG001|Randomised Study|Administrative - randomization error|0|||
161651684|NCT02248818|583775957|FG002|Randomised Study|Administrative - randomization error|0|||
161651685|NCT02248818|583775958|FG003|Randomised Study|Administrative - randomization error|0|||
161651686|NCT02248818|583775959|FG004|Randomised Study|Administrative - randomization error|0|||
161689800|NCT00550680|583913603|FG000|Overall Study|Early Improvement|1|||
161836262|NCT03247517|584442904|FG001|Overall Study|Protocol Violation|2|||
161836263|NCT03247517|584442905|FG002|Overall Study|Protocol Violation|0|||
161836264|NCT03247517|584442903|FG000|Overall Study|Multiple reasons|3|||
161836265|NCT03247517|584442904|FG001|Overall Study|Multiple reasons|1|||
161836266|NCT03247517|584442905|FG002|Overall Study|Multiple reasons|0|||
161836267|NCT03310411|584442906|FG000|Period 1|Adverse Event|0|||
161836268|NCT03310411|584442907|FG001|Period 1|Adverse Event|0|||
161651687|NCT02248818|583775960|FG005|Randomised Study|Administrative - randomization error|8|||
161651688|NCT02248818|583775961|FG006|Randomised Study|Administrative - randomization error|0|||
161651689|NCT02248818|583775962|FG007|Randomised Study|Administrative - randomization error|0|||
161651690|NCT02248818|583775963|FG008|Randomised Study|Administrative - randomization error|0|||
161651691|NCT04313608|583775966|FG000|Overall Study|Death|12|||
161651692|NCT04313608|583775967|FG001|Overall Study|Death|3|||
161651693|NCT01867333|583775968|FG000|Overall Study|Withdrawal by Subject|1|||
161651694|NCT01867333|583775969|FG001|Overall Study|Withdrawal by Subject|0|||
161651695|NCT01867333|583775968|FG000|Overall Study|Adverse Event|1|||
161651696|NCT01867333|583775969|FG001|Overall Study|Adverse Event|0|||
161651697|NCT01867333|583775968|FG000|Overall Study|Participant choice|1|||
161651698|NCT01867333|583775969|FG001|Overall Study|Participant choice|2|||
161651699|NCT01867333|583775968|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
161651700|NCT01867333|583775969|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
161651701|NCT01867333|583775968|FG000|Overall Study|Death|0|||
161651702|NCT01867333|583775969|FG001|Overall Study|Death|1|||
161651703|NCT01867333|583775968|FG000|Overall Study|Physician Decision|3|||
161651704|NCT01867333|583775969|FG001|Overall Study|Physician Decision|2|||
161651705|NCT01867333|583775968|FG000|Overall Study|Switched to alternative treatment|1|||
161651706|NCT01867333|583775969|FG001|Overall Study|Switched to alternative treatment|0|||
161651707|NCT01145898|583775970|FG000|3-year Treatment|medication change by treating physician|3|||
161651708|NCT01145898|583775971|FG001|3-year Treatment|medication change by treating physician|16|||
161651709|NCT00879775|583775972|FG000|Overall Study|Lost to Follow-up|2|||
161651710|NCT00879775|583775973|FG001|Overall Study|Lost to Follow-up|1|||
161651711|NCT04343976|583775978|FG000|Overall Study|Withdrawal by Subject|0|||
161651712|NCT04343976|583775979|FG001|Overall Study|Withdrawal by Subject|1|||
161651713|NCT02807883|583775980|FG000|Overall Study|Withdrawal by Subject|2|||
161651714|NCT02833077|583775981|FG000|Overall Study|Adverse Event|1|||
161651715|NCT02833077|583775982|FG001|Overall Study|Adverse Event|2|||
161651716|NCT02833077|583775981|FG000|Overall Study|Lost to Follow-up|10|||
161651717|NCT02833077|583775982|FG001|Overall Study|Lost to Follow-up|1|||
161651718|NCT02833077|583775981|FG000|Overall Study|Personal Reasons|6|||
161651719|NCT02833077|583775982|FG001|Overall Study|Personal Reasons|4|||
161651720|NCT02833077|583775981|FG000|Overall Study|Protocol Deviation|0|||
161651721|NCT02833077|583775982|FG001|Overall Study|Protocol Deviation|1|||
161651722|NCT04608773|583775983|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
161651723|NCT04608773|583775984|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
161651724|NCT04608773|583775983|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
161651725|NCT04608773|583775984|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161651726|NCT04608773|583775983|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
161651727|NCT04608773|583775984|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
161651728|NCT04608773|583775983|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
161651729|NCT04608773|583775984|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
161651730|NCT04608773|583775983|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
161651731|NCT04608773|583775984|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
161651732|NCT01077518|583775987|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
161651733|NCT01077518|583775988|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
161651734|NCT01077518|583775989|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
161651735|NCT01077518|583775987|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
161651736|NCT01077518|583775988|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
161651737|NCT01077518|583775989|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
161651738|NCT01077518|583775987|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
161651739|NCT01077518|583775988|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
161651740|NCT01077518|583775989|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
161651741|NCT01077518|583775987|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
161651742|NCT01077518|583775988|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
161651743|NCT01077518|583775989|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
161651744|NCT01077518|583775987|FG000|Optional Ofa Phase|Physician Decision|0|||
161651745|NCT01077518|583775988|FG001|Optional Ofa Phase|Physician Decision|0|||
161651746|NCT01077518|583775989|FG002|Optional Ofa Phase|Physician Decision|1|||
161651747|NCT01077518|583775987|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
161651748|NCT01077518|583775988|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
161689801|NCT00550680|583913603|FG000|Overall Study|Lost to Follow-up|3|||
161689802|NCT00550680|583913603|FG000|Overall Study|Lack of Efficacy|1|||
161836269|NCT03310411|584442908|FG002|Period 1|Adverse Event|0|||
161836270|NCT03310411|584442909|FG003|Period 1|Adverse Event|1|||
161689803|NCT00550680|583913603|FG000|Overall Study|Other|10|||
161689804|NCT00550680|583913603|FG000|Overall Study|Protocol Violation|7|||
161689805|NCT00550680|583913603|FG000|Overall Study|Refused Treatment|19|||
161689806|NCT00550680|583913603|FG000|Overall Study|Screen Failure|6|||
161689807|NCT01967550|583913604|FG000|Overall Study|Withdrawal by Subject|1|||
161689808|NCT01967550|583913605|FG001|Overall Study|Withdrawal by Subject|0|||
161689809|NCT01967550|583913604|FG000|Overall Study|Adverse Event|2|||
161689810|NCT01967550|583913605|FG001|Overall Study|Adverse Event|0|||
161689811|NCT01967550|583913604|FG000|Overall Study|Protocol Violation|2|||
161689812|NCT01967550|583913605|FG001|Overall Study|Protocol Violation|1|||
161689813|NCT01967550|583913604|FG000|Overall Study|Non Compliance|0|||
161689814|NCT01967550|583913605|FG001|Overall Study|Non Compliance|1|||
161689815|NCT00333359|583913610|FG000|Overall Study|Adverse Event|29|||
161689816|NCT00333359|583913611|FG001|Overall Study|Adverse Event|35|||
161689817|NCT00333359|583913610|FG000|Overall Study|Withdrawal by Subject|19|||
161689818|NCT00333359|583913611|FG001|Overall Study|Withdrawal by Subject|37|||
161689819|NCT00333359|583913610|FG000|Overall Study|Physician Decision|2|||
161689820|NCT00333359|583913611|FG001|Overall Study|Physician Decision|2|||
161689821|NCT00333359|583913610|FG000|Overall Study|Protocol Non-compliance|2|||
161689822|NCT00333359|583913611|FG001|Overall Study|Protocol Non-compliance|8|||
161689823|NCT00333359|583913610|FG000|Overall Study|Lost to Follow-up|15|||
161689824|NCT00333359|583913611|FG001|Overall Study|Lost to Follow-up|25|||
161689825|NCT00333359|583913610|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
161689826|NCT00333359|583913611|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
161689827|NCT00333359|583913610|FG000|Overall Study|Treatment Failure|3|||
161689828|NCT00333359|583913611|FG001|Overall Study|Treatment Failure|8|||
161689829|NCT00333359|583913610|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
161689830|NCT00333359|583913611|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
161689831|NCT02867995|583913616|FG000|Overall Study|Withdrawal by Subject|0|||
161689832|NCT02867995|583913617|FG001|Overall Study|Withdrawal by Subject|1|||
161689833|NCT02867995|583913616|FG000|Overall Study|Lost to Follow-up|0|||
161689834|NCT02867995|583913617|FG001|Overall Study|Lost to Follow-up|2|||
161689835|NCT01534533|583913618|FG000|Overall Study|Lost to Follow-up|3|||
161689836|NCT01534533|583913619|FG001|Overall Study|Lost to Follow-up|0|||
161689837|NCT01534533|583913620|FG002|Overall Study|Lost to Follow-up|4|||
161689838|NCT01534533|583913621|FG003|Overall Study|Lost to Follow-up|3|||
161689839|NCT01534533|583913618|FG000|Overall Study|Withdrawal by Subject|5|||
161689840|NCT01534533|583913619|FG001|Overall Study|Withdrawal by Subject|3|||
161689841|NCT01534533|583913620|FG002|Overall Study|Withdrawal by Subject|4|||
161689842|NCT01534533|583913621|FG003|Overall Study|Withdrawal by Subject|1|||
161689843|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
161689844|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
161689845|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
161689846|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
161689847|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
161689848|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
161689849|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
161689850|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
161689851|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
161689852|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
161689853|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
161689854|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
161689855|NCT03315871|583913622|FG000|PROSTVAC + CV301|Progressive disease|0|||
161689856|NCT03315871|583913623|FG001|PROSTVAC + CV301|Progressive disease|0|||
161689857|NCT03315871|583913624|FG002|PROSTVAC + CV301|Progressive disease|1|||
161689858|NCT03315871|583913622|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
161689859|NCT03315871|583913623|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
161689860|NCT03315871|583913624|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
161689861|NCT04099251|583915684|FG000|Pre-Treatment|Other reasons|1|||
161689862|NCT04099251|583915685|FG001|Pre-Treatment|Other reasons|0|||
161689863|NCT04099251|583915684|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
161689864|NCT04099251|583915685|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
161689865|NCT04099251|583915684|FG000|Blinded Treatment Phase|Other reasons|16|||
161689866|NCT04099251|583915685|FG001|Blinded Treatment Phase|Other reasons|7|||
161689867|NCT04099251|583915684|FG000|Blinded Treatment Phase|Disease recurrence|26|||
161689868|NCT04099251|583915685|FG001|Blinded Treatment Phase|Disease recurrence|41|||
161836271|NCT00619112|584442910|FG000|Overall Study|Adverse Event|1|||
161689869|NCT04099251|583915684|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
161836272|NCT00619112|584442911|FG001|Overall Study|Adverse Event|2|||
161836273|NCT00729248|584442912|FG000|Overall Study|Physician Decision|2|||
161836274|NCT03573505|584442913|FG000|Overall Study|Adverse Event|1|||
161689870|NCT04099251|583915685|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
161689871|NCT04099251|583915684|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
161689872|NCT04099251|583915685|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
161689873|NCT04099251|583915684|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
161689874|NCT04099251|583915685|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
161689875|NCT04099251|583915684|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
161689876|NCT04099251|583915685|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
161689877|NCT04099251|583915684|FG000|Blinded Treatment Phase|Death|6|||
161689878|NCT04099251|583915685|FG001|Blinded Treatment Phase|Death|2|||
161689879|NCT04099251|583915684|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
161689880|NCT04099251|583915685|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
161689881|NCT04099251|583915684|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
161689882|NCT04099251|583915685|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
161689883|NCT04099251|583915684|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
161689884|NCT04099251|583915685|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
161689885|NCT04099251|583915684|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
161689886|NCT04099251|583915685|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
161689887|NCT04099251|583915684|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
161689888|NCT04099251|583915685|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
161689889|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
161689890|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
161689891|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
161689892|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
161689893|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
161689894|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
161689895|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
161689896|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
161689897|NCT04311502|583915686|FG000|Overall Study|Death|1|||
161689898|NCT04311502|583915687|FG001|Overall Study|Death|1|||
161689899|NCT04311502|583915688|FG002|Overall Study|Death|1|||
161689900|NCT04311502|583915686|FG000|Overall Study|Lost to Follow-up|2|||
161689901|NCT04311502|583915687|FG001|Overall Study|Lost to Follow-up|3|||
161689902|NCT04311502|583915688|FG002|Overall Study|Lost to Follow-up|0|||
161689903|NCT04311502|583915686|FG000|Overall Study|Participant is in prison|1|||
161689904|NCT04311502|583915687|FG001|Overall Study|Participant is in prison|0|||
161689905|NCT04311502|583915688|FG002|Overall Study|Participant is in prison|0|||
161689906|NCT04311502|583915686|FG000|Overall Study|Participant moved out of country|1|||
161689907|NCT04311502|583915687|FG001|Overall Study|Participant moved out of country|0|||
161689908|NCT04311502|583915688|FG002|Overall Study|Participant moved out of country|0|||
161689909|NCT04311502|583915686|FG000|Overall Study|Withdrawal by Subject|2|||
161689910|NCT04311502|583915687|FG001|Overall Study|Withdrawal by Subject|0|||
161689911|NCT04311502|583915688|FG002|Overall Study|Withdrawal by Subject|0|||
161689912|NCT04311502|583915686|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
161689913|NCT04311502|583915687|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
161689914|NCT04311502|583915688|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
161689915|NCT05032157|583915695|FG000|Overall Study|Adverse Event|12|||
161689916|NCT05032157|583915696|FG001|Overall Study|Adverse Event|7|||
161689917|NCT05032157|583915695|FG000|Overall Study|Pregnancy|0|||
161689918|NCT05032157|583915696|FG001|Overall Study|Pregnancy|2|||
161689919|NCT05032157|583915695|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161689920|NCT05032157|583915696|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
161689921|NCT05032157|583915695|FG000|Overall Study|Protocol Deviation|8|||
161689922|NCT05032157|583915696|FG001|Overall Study|Protocol Deviation|4|||
161689923|NCT05032157|583915695|FG000|Overall Study|Lost to Follow-up|1|||
161689924|NCT05032157|583915696|FG001|Overall Study|Lost to Follow-up|3|||
161689925|NCT05032157|583915695|FG000|Overall Study|Physician Decision|7|||
161689926|NCT05032157|583915696|FG001|Overall Study|Physician Decision|2|||
161689927|NCT05032157|583915695|FG000|Overall Study|Patient Decision|38|||
161689928|NCT05032157|583915696|FG001|Overall Study|Patient Decision|19|||
161689929|NCT03451773|583915697|FG000|Overall Study|Death on study|1|||
161689930|NCT03451773|583915698|FG001|Overall Study|Death on study|5|||
161689931|NCT03451773|583915697|FG000|Overall Study|Death during follow-up period|0|||
161689932|NCT03451773|583915698|FG001|Overall Study|Death during follow-up period|1|||
161689933|NCT02627495|583915699|FG000|Overall Study|Withdrawal by Subject|4|||
161689934|NCT02543528|583915700|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689935|NCT02543528|583915701|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689936|NCT02543528|583915702|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689937|NCT02543528|583915703|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161651749|NCT01077518|583775989|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
161651750|NCT01077518|583775987|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
161651751|NCT01077518|583775988|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
161651752|NCT01077518|583775989|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
161651753|NCT00972322|583775990|FG000|Overall Study|Adverse Event|2|||
161651754|NCT00972322|583775991|FG001|Overall Study|Adverse Event|1|||
161651755|NCT00972322|583775990|FG000|Overall Study|Positive drug screen|0|||
161651756|NCT00972322|583775991|FG001|Overall Study|Positive drug screen|1|||
161651757|NCT00972322|583775990|FG000|Overall Study|Lost to Follow-up|0|||
161651758|NCT00972322|583775991|FG001|Overall Study|Lost to Follow-up|1|||
161651759|NCT00972322|583775990|FG000|Overall Study|Consistently high glucose values|1|||
161651760|NCT00972322|583775991|FG001|Overall Study|Consistently high glucose values|0|||
161651761|NCT04958200|583775992|FG000|Overall Study|Withdrawal by Subject|0|||
161651762|NCT04958200|583775993|FG001|Overall Study|Withdrawal by Subject|2|||
161651763|NCT04958200|583775992|FG000|Overall Study|Lost to Follow-up|3|||
161651764|NCT04958200|583775993|FG001|Overall Study|Lost to Follow-up|2|||
161651765|NCT00316017|583775996|FG000|Overall Study|Protocol Violation|11|||
161651766|NCT00316017|583775997|FG001|Overall Study|Protocol Violation|13|||
161651767|NCT00316017|583775998|FG002|Overall Study|Protocol Violation|19|||
161651768|NCT04157400|583775999|FG000|Overall Study|Withdrawal by Subject|1|||
161651769|NCT04157400|583775999|FG000|Overall Study|Lost to Follow-up|3|||
161651770|NCT00623805|583776001|FG000|Overall Study|Adverse Event|9|||
161651771|NCT00623805|583776002|FG001|Overall Study|Adverse Event|6|||
161651772|NCT00623805|583776001|FG000|Overall Study|Death|2|||
161651773|NCT00623805|583776002|FG001|Overall Study|Death|0|||
161651774|NCT00623805|583776001|FG000|Overall Study|Lack of Efficacy|3|||
161651775|NCT00623805|583776002|FG001|Overall Study|Lack of Efficacy|7|||
161651776|NCT00623805|583776001|FG000|Overall Study|Lost to Follow-up|2|||
161651777|NCT00623805|583776002|FG001|Overall Study|Lost to Follow-up|2|||
161651778|NCT00623805|583776001|FG000|Overall Study|Protocol Violation|1|||
161651779|NCT00623805|583776002|FG001|Overall Study|Protocol Violation|1|||
161651780|NCT00623805|583776001|FG000|Overall Study|Reason not Specified|3|||
161651781|NCT00623805|583776002|FG001|Overall Study|Reason not Specified|6|||
161651782|NCT02671500|583776009|FG000|Overall Study|Lack of Efficacy|12|||
161651783|NCT02671500|583776009|FG000|Overall Study|Lost to Follow-up|2|||
161651784|NCT05235269|583776011|FG000|Overall Study|Adverse Event|1|||
161651785|NCT05235269|583776011|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
161651786|NCT05235269|583776011|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
161651787|NCT03361865|583776012|FG000|Overall Study|Death|17|||
161651788|NCT03361865|583776013|FG001|Overall Study|Death|18|||
161651789|NCT03361865|583776012|FG000|Overall Study|Physician Decision|1|||
161651790|NCT03361865|583776013|FG001|Overall Study|Physician Decision|9|||
161651791|NCT03361865|583776012|FG000|Overall Study|Withdrawal by Subject|1|||
161651792|NCT03361865|583776013|FG001|Overall Study|Withdrawal by Subject|0|||
161651793|NCT03852719|583776015|FG000|Overall Study|Withdrawal of consent|8|||
161651794|NCT03852719|583776016|FG001|Overall Study|Withdrawal of consent|8|||
161651795|NCT03852719|583776017|FG002|Overall Study|Withdrawal of consent|9|||
161651796|NCT03852719|583776015|FG000|Overall Study|Physician Decision|5|||
161651797|NCT03852719|583776016|FG001|Overall Study|Physician Decision|4|||
161651798|NCT03852719|583776017|FG002|Overall Study|Physician Decision|1|||
161651799|NCT03852719|583776015|FG000|Overall Study|Pregnancy|2|||
161651800|NCT03852719|583776016|FG001|Overall Study|Pregnancy|1|||
161651801|NCT03852719|583776017|FG002|Overall Study|Pregnancy|0|||
161651802|NCT03852719|583776015|FG000|Overall Study|Death|1|||
161651803|NCT03852719|583776016|FG001|Overall Study|Death|0|||
161651804|NCT03852719|583776017|FG002|Overall Study|Death|0|||
161651805|NCT03852719|583776015|FG000|Overall Study|Reason not Specified|3|||
161651806|NCT03852719|583776016|FG001|Overall Study|Reason not Specified|3|||
161651807|NCT03852719|583776017|FG002|Overall Study|Reason not Specified|5|||
161651808|NCT03852719|583776015|FG000|Overall Study|Adverse Event|2|||
161651809|NCT03852719|583776016|FG001|Overall Study|Adverse Event|1|||
161651810|NCT03852719|583776017|FG002|Overall Study|Adverse Event|4|||
161651811|NCT03852719|583776015|FG000|Overall Study|Progressive disease|1|||
161651812|NCT03852719|583776016|FG001|Overall Study|Progressive disease|4|||
161651813|NCT03852719|583776017|FG002|Overall Study|Progressive disease|1|||
161651814|NCT03852719|583776015|FG000|Overall Study|Lost to Follow-up|1|||
161651815|NCT03852719|583776016|FG001|Overall Study|Lost to Follow-up|0|||
161651816|NCT03852719|583776017|FG002|Overall Study|Lost to Follow-up|0|||
161651817|NCT03810235|583776018|FG000|Overall Study|Withdrawal by Subject|2|||
161651818|NCT03810235|583776019|FG001|Overall Study|Withdrawal by Subject|0|||
161651819|NCT04201262|583776020|FG000|Primary Treatment Period|Adverse Event|1|||
161651820|NCT04201262|583776021|FG001|Primary Treatment Period|Adverse Event|2|||
161651821|NCT04201262|583776020|FG000|Primary Treatment Period|Physician Decision|1|||
161651822|NCT04201262|583776021|FG001|Primary Treatment Period|Physician Decision|1|||
161651823|NCT04201262|583776020|FG000|Long-term Extension Period|Death|1|||
161689938|NCT02543528|583915704|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
161651824|NCT04201262|583776021|FG001|Long-term Extension Period|Death|0|||
161651825|NCT01647542|583776023|FG000|Overall Study|Major Protocol Deviation|1|||
161651826|NCT01647542|583776024|FG001|Overall Study|Major Protocol Deviation|0|||
161651827|NCT01647542|583776025|FG002|Overall Study|Major Protocol Deviation|0|||
161651828|NCT01647542|583776023|FG000|Overall Study|Adverse Event|4|||
161651829|NCT01647542|583776024|FG001|Overall Study|Adverse Event|5|||
161651830|NCT01647542|583776025|FG002|Overall Study|Adverse Event|4|||
161651831|NCT01647542|583776023|FG000|Overall Study|Lost to Follow-up|0|||
161651832|NCT01647542|583776024|FG001|Overall Study|Lost to Follow-up|2|||
161651833|NCT01647542|583776025|FG002|Overall Study|Lost to Follow-up|2|||
161651834|NCT01647542|583776023|FG000|Overall Study|Withdrawal by Subject|6|||
161651835|NCT01647542|583776024|FG001|Overall Study|Withdrawal by Subject|4|||
161651836|NCT01647542|583776025|FG002|Overall Study|Withdrawal by Subject|0|||
161651837|NCT01647542|583776023|FG000|Overall Study|Study Termination|64|||
161651838|NCT01647542|583776024|FG001|Overall Study|Study Termination|61|||
161651839|NCT01647542|583776025|FG002|Overall Study|Study Termination|65|||
161651840|NCT01647542|583776023|FG000|Overall Study|Lack of Efficacy|1|||
161651841|NCT01647542|583776024|FG001|Overall Study|Lack of Efficacy|1|||
161651842|NCT01647542|583776025|FG002|Overall Study|Lack of Efficacy|0|||
161651843|NCT01647542|583776023|FG000|Overall Study|Death|0|||
161651844|NCT01647542|583776024|FG001|Overall Study|Death|0|||
161651845|NCT01647542|583776025|FG002|Overall Study|Death|1|||
161651846|NCT02819024|583776026|FG000|Overall Study|Withdrawal by Subject|1|||
161651847|NCT05217641|583776030|FG000|Overall Study|Lost to Follow-up|1|||
161651848|NCT05217641|583776031|FG001|Overall Study|Lost to Follow-up|1|||
161651849|NCT05217641|583776032|FG002|Overall Study|Lost to Follow-up|0|||
161651850|NCT05217641|583776033|FG003|Overall Study|Lost to Follow-up|1|||
161651851|NCT05217641|583776034|FG004|Overall Study|Lost to Follow-up|1|||
161651852|NCT05217641|583776035|FG005|Overall Study|Lost to Follow-up|0|||
161651853|NCT05217641|583776030|FG000|Overall Study|Withdrawal by Subject|0|||
161651854|NCT05217641|583776031|FG001|Overall Study|Withdrawal by Subject|0|||
161651855|NCT05217641|583776032|FG002|Overall Study|Withdrawal by Subject|0|||
161651856|NCT05217641|583776033|FG003|Overall Study|Withdrawal by Subject|3|||
161651857|NCT05217641|583776034|FG004|Overall Study|Withdrawal by Subject|1|||
161651858|NCT05217641|583776035|FG005|Overall Study|Withdrawal by Subject|0|||
161651859|NCT05217641|583776030|FG000|Overall Study|Other: participant did not specify reason|0|||
161651860|NCT05217641|583776031|FG001|Overall Study|Other: participant did not specify reason|0|||
161651861|NCT05217641|583776032|FG002|Overall Study|Other: participant did not specify reason|0|||
161651862|NCT05217641|583776033|FG003|Overall Study|Other: participant did not specify reason|0|||
161651863|NCT05217641|583776034|FG004|Overall Study|Other: participant did not specify reason|1|||
161651864|NCT05217641|583776035|FG005|Overall Study|Other: participant did not specify reason|0|||
161651865|NCT05217641|583776030|FG000|Overall Study|Extended Follow up|1|||
161651866|NCT05217641|583776031|FG001|Overall Study|Extended Follow up|1|||
161651867|NCT05217641|583776032|FG002|Overall Study|Extended Follow up|0|||
161651868|NCT05217641|583776033|FG003|Overall Study|Extended Follow up|0|||
161651869|NCT05217641|583776034|FG004|Overall Study|Extended Follow up|1|||
161651870|NCT05217641|583776035|FG005|Overall Study|Extended Follow up|0|||
161651871|NCT03548220|583776037|FG000|Overall Study|Lost to Follow-up|1|||
161651872|NCT03548220|583776038|FG001|Overall Study|Lost to Follow-up|0|||
161651873|NCT03548220|583776039|FG002|Overall Study|Lost to Follow-up|0|||
161651874|NCT03548220|583776040|FG003|Overall Study|Lost to Follow-up|0|||
161651875|NCT02397447|583776041|FG000|Overall Study|Lost to Follow-up|2|||
161651876|NCT02397447|583776042|FG001|Overall Study|Lost to Follow-up|2|||
161651877|NCT02994069|583776045|FG000|Overall Study|Death|7|||
161651878|NCT02994069|583776046|FG001|Overall Study|Death|13|||
161651879|NCT02994069|583776045|FG000|Overall Study|Adverse Event|1|||
161651880|NCT02994069|583776046|FG001|Overall Study|Adverse Event|0|||
161651881|NCT02994069|583776045|FG000|Overall Study|Other|2|||
161651882|NCT02994069|583776046|FG001|Overall Study|Other|0|||
161651883|NCT02994069|583776045|FG000|Overall Study|still on follow up/treatment|5|||
161651884|NCT02994069|583776046|FG001|Overall Study|still on follow up/treatment|6|||
161651885|NCT06926673|583776047|FG000|Overall Study|Lost to Follow-up|0|||
161651886|NCT06926673|583776048|FG001|Overall Study|Lost to Follow-up|0|||
161651887|NCT06926673|583776049|FG002|Overall Study|Lost to Follow-up|0|||
161651888|NCT06926673|583776050|FG003|Overall Study|Lost to Follow-up|1|||
161651889|NCT06926673|583776051|FG004|Overall Study|Lost to Follow-up|0|||
161651890|NCT06926673|583776052|FG005|Overall Study|Lost to Follow-up|0|||
161651891|NCT06926673|583776053|FG006|Overall Study|Lost to Follow-up|0|||
161651892|NCT06926673|583776047|FG000|Overall Study|Physician Decision|0|||
161651893|NCT06926673|583776048|FG001|Overall Study|Physician Decision|0|||
161651894|NCT06926673|583776049|FG002|Overall Study|Physician Decision|0|||
161651895|NCT06926673|583776050|FG003|Overall Study|Physician Decision|0|||
161651896|NCT06926673|583776051|FG004|Overall Study|Physician Decision|0|||
161651897|NCT06926673|583776052|FG005|Overall Study|Physician Decision|0|||
161651898|NCT06926673|583776053|FG006|Overall Study|Physician Decision|1|||
161651899|NCT06926673|583776047|FG000|Overall Study|Withdrawal by Subject|0|||
161651900|NCT06926673|583776048|FG001|Overall Study|Withdrawal by Subject|3|||
161651901|NCT06926673|583776049|FG002|Overall Study|Withdrawal by Subject|2|||
161651902|NCT06926673|583776050|FG003|Overall Study|Withdrawal by Subject|1|||
161651903|NCT06926673|583776051|FG004|Overall Study|Withdrawal by Subject|0|||
161651904|NCT06926673|583776052|FG005|Overall Study|Withdrawal by Subject|2|||
161651905|NCT06926673|583776053|FG006|Overall Study|Withdrawal by Subject|0|||
161651906|NCT01076153|583777297|FG000|Overall Study|Symptoms improved/resolved|10|||
161651907|NCT01076153|583777297|FG000|Overall Study|Adverse Event|1|||
161651908|NCT04165031|583777298|FG000|Overall Study|Adverse Event|1|||
161651909|NCT04165031|583777299|FG001|Overall Study|Adverse Event|1|||
161651910|NCT04165031|583777300|FG002|Overall Study|Adverse Event|0|||
161651911|NCT04165031|583777301|FG003|Overall Study|Adverse Event|0|||
161651912|NCT04165031|583777302|FG004|Overall Study|Adverse Event|0|||
161651913|NCT04165031|583777303|FG005|Overall Study|Adverse Event|0|||
161651914|NCT04165031|583777298|FG000|Overall Study|Withdrawal by Subject|0|||
161651915|NCT04165031|583777299|FG001|Overall Study|Withdrawal by Subject|0|||
161651916|NCT04165031|583777300|FG002|Overall Study|Withdrawal by Subject|1|||
161651917|NCT04165031|583777301|FG003|Overall Study|Withdrawal by Subject|0|||
161651918|NCT04165031|583777302|FG004|Overall Study|Withdrawal by Subject|0|||
161651919|NCT04165031|583777303|FG005|Overall Study|Withdrawal by Subject|0|||
161651920|NCT02187159|583777304|FG000|Overall Study|Protocol Violation|4|||
161651921|NCT02187159|583777305|FG001|Overall Study|Protocol Violation|6|||
161651922|NCT02187159|583777306|FG002|Overall Study|Protocol Violation|3|||
161651923|NCT02187159|583777307|FG003|Overall Study|Protocol Violation|4|||
161651924|NCT02187159|583777304|FG000|Overall Study|Lack of Efficacy|10|||
161651925|NCT02187159|583777305|FG001|Overall Study|Lack of Efficacy|5|||
161651926|NCT02187159|583777306|FG002|Overall Study|Lack of Efficacy|4|||
161651927|NCT02187159|583777307|FG003|Overall Study|Lack of Efficacy|7|||
161651928|NCT02187159|583777304|FG000|Overall Study|Adverse Event|28|||
161651929|NCT02187159|583777305|FG001|Overall Study|Adverse Event|33|||
161651930|NCT02187159|583777306|FG002|Overall Study|Adverse Event|42|||
161651931|NCT02187159|583777307|FG003|Overall Study|Adverse Event|50|||
161651932|NCT02187159|583777304|FG000|Overall Study|Withdrawal by Subject|24|||
161651933|NCT02187159|583777305|FG001|Overall Study|Withdrawal by Subject|28|||
161651934|NCT02187159|583777306|FG002|Overall Study|Withdrawal by Subject|25|||
161651935|NCT02187159|583777307|FG003|Overall Study|Withdrawal by Subject|26|||
161651936|NCT02187159|583777304|FG000|Overall Study|Other|3|||
161651937|NCT02187159|583777305|FG001|Overall Study|Other|7|||
161651938|NCT02187159|583777306|FG002|Overall Study|Other|3|||
161651939|NCT02187159|583777307|FG003|Overall Study|Other|9|||
161651940|NCT01283152|583777308|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
161651941|NCT01283152|583777309|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
161651942|NCT01283152|583777308|FG000|Overall Study|Refused HESA|1|||
161651943|NCT01283152|583777309|FG001|Overall Study|Refused HESA|0|||
161651944|NCT03482466|583777310|FG000|Overall Study|Protocol Violation|2|||
161651945|NCT04833127|583777311|FG000|Overall Study|Lost to Follow-up|1|||
161651946|NCT04833127|583777312|FG001|Overall Study|Lost to Follow-up|1|||
161651947|NCT01736189|583777313|FG000|Overall Study|Violation of registration criteria|41|||
161651948|NCT01736189|583777313|FG000|Overall Study|Protocol Violation|4|||
161651949|NCT01736189|583777313|FG000|Overall Study|Criteria and protocol violations|1|||
161651950|NCT01499303|583777314|FG000|Overall Study|Ongoing|2|||
161651951|NCT01499303|583777315|FG001|Overall Study|Ongoing|1|||
161651952|NCT01499303|583777314|FG000|Overall Study|Withdrawal by Subject|0|||
161651953|NCT01499303|583777315|FG001|Overall Study|Withdrawal by Subject|1|||
161651954|NCT01499303|583777314|FG000|Overall Study|Adverse Event|1|||
161651955|NCT01499303|583777315|FG001|Overall Study|Adverse Event|4|||
161651956|NCT01499303|583777314|FG000|Overall Study|Other|0|||
161651957|NCT01499303|583777315|FG001|Overall Study|Other|1|||
161651958|NCT00461981|583777316|FG000|Overall Study|Lost to Follow-up|9|||
161651959|NCT00461981|583777317|FG001|Overall Study|Lost to Follow-up|6|||
161651960|NCT00461981|583777316|FG000|Overall Study|Withdrawal by Subject|2|||
161651961|NCT00461981|583777317|FG001|Overall Study|Withdrawal by Subject|3|||
161651962|NCT01896557|583777318|FG000|Clopidogrel Alone|Adverse Event|1|||
161651963|NCT01896557|583777319|FG001|Clopidogrel Alone|Adverse Event|0|||
161651964|NCT01896557|583777318|FG000|Clopidogrel + GI Protector|low adherence|1|||
161651965|NCT01896557|583777319|FG001|Clopidogrel + GI Protector|low adherence|1|||
161651966|NCT01896557|583777318|FG000|Clopidogrel + GI Protector|Reading error|1|||
161651967|NCT01896557|583777319|FG001|Clopidogrel + GI Protector|Reading error|3|||
161651968|NCT02383940|583777320|FG000|Overall Study|Adverse Event|1|||
161651969|NCT02383940|583777321|FG001|Overall Study|Adverse Event|0|||
161689939|NCT02543528|583915700|FG000|Adaptation Period|Lens Handling Difficultes|0|||
161689940|NCT02543528|583915701|FG001|Adaptation Period|Lens Handling Difficultes|0|||
161689941|NCT02543528|583915702|FG002|Adaptation Period|Lens Handling Difficultes|0|||
161689942|NCT02543528|583915703|FG003|Adaptation Period|Lens Handling Difficultes|0|||
161689943|NCT02543528|583915704|FG004|Adaptation Period|Lens Handling Difficultes|8|||
161689944|NCT02543528|583915700|FG000|Adaptation Period|Lost to Follow-up|0|||
161689945|NCT02543528|583915701|FG001|Adaptation Period|Lost to Follow-up|0|||
161689946|NCT02543528|583915702|FG002|Adaptation Period|Lost to Follow-up|0|||
161689947|NCT02543528|583915703|FG003|Adaptation Period|Lost to Follow-up|0|||
161689948|NCT02543528|583915704|FG004|Adaptation Period|Lost to Follow-up|14|||
161689949|NCT02543528|583915700|FG000|Adaptation Period|Adverse Event|0|||
161689950|NCT02543528|583915701|FG001|Adaptation Period|Adverse Event|0|||
161689951|NCT02543528|583915702|FG002|Adaptation Period|Adverse Event|0|||
161689952|NCT02543528|583915703|FG003|Adaptation Period|Adverse Event|0|||
161689953|NCT02543528|583915704|FG004|Adaptation Period|Adverse Event|2|||
161689954|NCT02543528|583915700|FG000|Extended Wear Period|Adverse Event|17|||
161689955|NCT02543528|583915701|FG001|Extended Wear Period|Adverse Event|11|||
161689956|NCT02543528|583915702|FG002|Extended Wear Period|Adverse Event|16|||
161689957|NCT02543528|583915703|FG003|Extended Wear Period|Adverse Event|3|||
161689958|NCT02543528|583915704|FG004|Extended Wear Period|Adverse Event|0|||
161689959|NCT02543528|583915700|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
161689960|NCT02543528|583915701|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
161689961|NCT02543528|583915702|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
161689962|NCT02543528|583915703|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
161689963|NCT02543528|583915704|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
161689964|NCT02543528|583915700|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
161689965|NCT02543528|583915701|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689966|NCT02543528|583915702|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689967|NCT02543528|583915703|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689968|NCT02543528|583915704|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689969|NCT02543528|583915700|FG000|Extended Wear Period|Lost to Follow-up|0|||
161689970|NCT02543528|583915701|FG001|Extended Wear Period|Lost to Follow-up|1|||
161689971|NCT02543528|583915702|FG002|Extended Wear Period|Lost to Follow-up|2|||
161689972|NCT02543528|583915703|FG003|Extended Wear Period|Lost to Follow-up|1|||
161689973|NCT02543528|583915704|FG004|Extended Wear Period|Lost to Follow-up|0|||
161689974|NCT02543528|583915700|FG000|Extended Wear Period|Withdrawal by Subject|10|||
161689975|NCT02543528|583915701|FG001|Extended Wear Period|Withdrawal by Subject|9|||
161689976|NCT02543528|583915702|FG002|Extended Wear Period|Withdrawal by Subject|4|||
161689977|NCT02543528|583915703|FG003|Extended Wear Period|Withdrawal by Subject|5|||
161689978|NCT02543528|583915704|FG004|Extended Wear Period|Withdrawal by Subject|0|||
161689979|NCT01339559|583915705|FG000|Overall Study|Adverse Event|92|||
161689980|NCT01339559|583915705|FG000|Overall Study|Death|5|||
161689981|NCT01339559|583915705|FG000|Overall Study|Lack of Efficacy|164|||
161689982|NCT01339559|583915705|FG000|Overall Study|Lost to Follow-up|22|||
161689983|NCT01339559|583915705|FG000|Overall Study|Subject choice|89|||
161689984|NCT01339559|583915705|FG000|Overall Study|Protocol Violation|15|||
161689985|NCT01339559|583915705|FG000|Overall Study|Study closure at site|1|||
161689986|NCT01339559|583915705|FG000|Overall Study|Incarcerated|2|||
161689987|NCT01339559|583915705|FG000|Overall Study|Epilepsy surgery|1|||
161689988|NCT01339559|583915705|FG000|Overall Study|Pregnancy planned|2|||
161689989|NCT01339559|583915705|FG000|Overall Study|Left the country|1|||
161689990|NCT01339559|583915705|FG000|Overall Study|Investigator decision|2|||
161689991|NCT01339559|583915705|FG000|Overall Study|Patient didn't wish to continue|1|||
161689992|NCT01339559|583915705|FG000|Overall Study|PI decision|1|||
161689993|NCT00971945|583915706|FG000|Overall Study|Progressive Disease|3|||
161689994|NCT00971945|583915706|FG000|Overall Study|Change in treatment policy|1|||
161689995|NCT00971945|583915706|FG000|Overall Study|Other reasons|2|||
161689996|NCT00746252|583915710|FG000|Overall Study|weight gain >7.5 %|1|||
161689997|NCT00746252|583915711|FG001|Overall Study|weight gain >7.5 %|2|||
161689998|NCT01049035|583915712|FG000|Overall Study|Serious adverse event|0|||
161689999|NCT01049035|583915713|FG001|Overall Study|Serious adverse event|1|||
161690000|NCT01049035|583915714|FG002|Overall Study|Serious adverse event|1|||
161690001|NCT01049035|583915715|FG003|Overall Study|Serious adverse event|2|||
161690002|NCT01049035|583915716|FG004|Overall Study|Serious adverse event|0|||
161690003|NCT01049035|583915717|FG005|Overall Study|Serious adverse event|0|||
161690004|NCT01049035|583915718|FG006|Overall Study|Serious adverse event|0|||
161690005|NCT01049035|583915712|FG000|Overall Study|Other adverse event (AE)|0|||
161690006|NCT01049035|583915713|FG001|Overall Study|Other adverse event (AE)|0|||
161690007|NCT01049035|583915714|FG002|Overall Study|Other adverse event (AE)|0|||
161690008|NCT01049035|583915715|FG003|Overall Study|Other adverse event (AE)|1|||
161690009|NCT01049035|583915716|FG004|Overall Study|Other adverse event (AE)|0|||
161690010|NCT01049035|583915717|FG005|Overall Study|Other adverse event (AE)|0|||
161690011|NCT01049035|583915718|FG006|Overall Study|Other adverse event (AE)|0|||
161690012|NCT01049035|583915712|FG000|Overall Study|Non-compliance with the protocol|12|||
161690013|NCT01049035|583915713|FG001|Overall Study|Non-compliance with the protocol|6|||
161690014|NCT01049035|583915714|FG002|Overall Study|Non-compliance with the protocol|14|||
161690015|NCT01049035|583915715|FG003|Overall Study|Non-compliance with the protocol|5|||
161690016|NCT01049035|583915716|FG004|Overall Study|Non-compliance with the protocol|3|||
161690017|NCT01049035|583915717|FG005|Overall Study|Non-compliance with the protocol|4|||
161690018|NCT01049035|583915718|FG006|Overall Study|Non-compliance with the protocol|10|||
161690019|NCT01049035|583915712|FG000|Overall Study|Lost to Follow-up|5|||
161690020|NCT01049035|583915713|FG001|Overall Study|Lost to Follow-up|4|||
161690021|NCT01049035|583915714|FG002|Overall Study|Lost to Follow-up|4|||
161690022|NCT01049035|583915715|FG003|Overall Study|Lost to Follow-up|1|||
161690023|NCT01049035|583915716|FG004|Overall Study|Lost to Follow-up|0|||
161690024|NCT01049035|583915717|FG005|Overall Study|Lost to Follow-up|3|||
161690025|NCT01049035|583915718|FG006|Overall Study|Lost to Follow-up|3|||
161690026|NCT01049035|583915712|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
161690027|NCT01049035|583915713|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
161690028|NCT01049035|583915714|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
161690029|NCT01049035|583915715|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
161690030|NCT01049035|583915716|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
161690031|NCT01049035|583915717|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
161690032|NCT01049035|583915718|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
161690033|NCT01137773|583915719|FG000|Overall Study|Death|3|||
161690034|NCT01137773|583915720|FG001|Overall Study|Death|3|||
161690035|NCT01137773|583915719|FG000|Overall Study|Lost to Follow-up|6|||
161690036|NCT01137773|583915720|FG001|Overall Study|Lost to Follow-up|0|||
161690037|NCT03548051|583915722|FG000|Overall Study|Death|1|||
161690038|NCT03548051|583915723|FG001|Overall Study|Death|1|||
161690039|NCT03548051|583915722|FG000|Overall Study|Withdrawal by Subject|1|||
161690040|NCT03548051|583915723|FG001|Overall Study|Withdrawal by Subject|0|||
161690041|NCT00082888|583915724|FG000|Overall Study|Ineligible|1|||
161690042|NCT00082888|583915725|FG001|Overall Study|Ineligible|0|||
161690043|NCT00082888|583915726|FG002|Overall Study|Ineligible|0|||
161690044|NCT00817531|583915728|FG000|Overall Study|Adverse Event|1|||
161690045|NCT00817531|583915728|FG000|Overall Study|Lack of Efficacy|1|||
161690046|NCT00812214|583915729|FG000|Overall Study|Lost to Follow-up|3|||
161690047|NCT00812214|583915730|FG001|Overall Study|Lost to Follow-up|1|||
161690048|NCT03325673|583915733|FG000|Overall Study|Adverse Event|4|||
161690049|NCT03325673|583915734|FG001|Overall Study|Adverse Event|0|||
161690050|NCT02684981|583915735|FG000|Overall Study|Permanently discontinued the treatment|157|||
161690051|NCT02684981|583915736|FG001|Overall Study|Permanently discontinued the treatment|161|||
161690052|NCT02684981|583915737|FG002|Overall Study|Permanently discontinued the treatment|110|||
161690053|NCT02684981|583915735|FG000|Overall Study|Other|83|||
161690054|NCT02684981|583915736|FG001|Overall Study|Other|49|||
161690055|NCT02684981|583915737|FG002|Overall Study|Other|17|||
161690056|NCT00820898|583915740|FG000|Overall Study|Inelgible - wrong primary site|1|||
161690057|NCT00452699|583915743|FG000|Overall Study|Adverse Event|10|||
161690058|NCT00452699|583915744|FG001|Overall Study|Adverse Event|3|||
161690059|NCT00452699|583915743|FG000|Overall Study|Lack of Efficacy|6|||
161690060|NCT00452699|583915744|FG001|Overall Study|Lack of Efficacy|4|||
161690061|NCT00452699|583915743|FG000|Overall Study|Lost to Follow-up|6|||
161690062|NCT00452699|583915744|FG001|Overall Study|Lost to Follow-up|9|||
161690063|NCT00452699|583915743|FG000|Overall Study|Protocol Violation|21|||
161690064|NCT00452699|583915744|FG001|Overall Study|Protocol Violation|25|||
161690065|NCT00452699|583915743|FG000|Overall Study|Withdrawal by Subject|26|||
161690066|NCT00452699|583915744|FG001|Overall Study|Withdrawal by Subject|25|||
161690067|NCT00452699|583915743|FG000|Overall Study|Other|12|||
161690068|NCT00452699|583915744|FG001|Overall Study|Other|7|||
161690069|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Adverse Event|109|||
161690070|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Adverse Event|0|||
161690071|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Adverse Event|0|||
161690072|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
161690073|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
161690074|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
161690075|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Death|1|||
161690076|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Death|0|||
161690077|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Death|0|||
161690078|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
161690079|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
161690080|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
161690081|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161690082|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
161690083|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
161690084|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161690085|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
161690086|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
161690087|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161690088|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
161690089|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
161690090|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
161690091|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
161690092|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
161690093|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
161690094|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
161690095|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
161690096|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161690097|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
161690098|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161690099|NCT03509350|583915755|FG000|Overall Study|Withdrawal by Subject|0|||
161690100|NCT03509350|583915756|FG001|Overall Study|Withdrawal by Subject|2|||
161690101|NCT00763815|583915757|FG000|Overall Study|Adverse Event|14|||
161690102|NCT00763815|583915758|FG001|Overall Study|Adverse Event|29|||
161690103|NCT00763815|583915757|FG000|Overall Study|Lack of Efficacy|10|||
161690104|NCT00763815|583915758|FG001|Overall Study|Lack of Efficacy|11|||
161690105|NCT00763815|583915757|FG000|Overall Study|Poor Compliance to Protocol|6|||
161690106|NCT00763815|583915758|FG001|Overall Study|Poor Compliance to Protocol|6|||
161690107|NCT00763815|583915757|FG000|Overall Study|Lost to Follow-up|2|||
161690108|NCT00763815|583915758|FG001|Overall Study|Lost to Follow-up|4|||
161690109|NCT00763815|583915757|FG000|Overall Study|Early Termination|1|||
161690110|NCT00763815|583915758|FG001|Overall Study|Early Termination|0|||
161690111|NCT00763815|583915757|FG000|Overall Study|Familial and Personal Reasons|9|||
161690112|NCT00763815|583915758|FG001|Overall Study|Familial and Personal Reasons|16|||
161690113|NCT00763815|583915757|FG000|Overall Study|Physician Decision|1|||
161690114|NCT00763815|583915758|FG001|Overall Study|Physician Decision|0|||
161690115|NCT00763815|583915757|FG000|Overall Study|Withdrawal by Subject|7|||
161690116|NCT00763815|583915758|FG001|Overall Study|Withdrawal by Subject|12|||
161690117|NCT00763815|583915757|FG000|Overall Study|Protocol Violation|2|||
161690118|NCT00763815|583915758|FG001|Overall Study|Protocol Violation|5|||
161690119|NCT00763815|583915757|FG000|Overall Study|Sponsor's Decision|0|||
161690120|NCT00763815|583915758|FG001|Overall Study|Sponsor's Decision|1|||
161690121|NCT04951037|583915759|FG000|Overall Study|Lost to Follow-up|16|||
161690122|NCT04951037|583915759|FG000|Overall Study|Withdrawal by Subject|5|||
161690123|NCT04951037|583915759|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
161690124|NCT05630937|583915760|FG000|Overall Study|Study terminated by sponsor|1|||
161690125|NCT05630937|583915761|FG001|Overall Study|Study terminated by sponsor|1|||
161690126|NCT05630937|583915762|FG002|Overall Study|Study terminated by sponsor|8|||
161690127|NCT05630937|583915763|FG003|Overall Study|Study terminated by sponsor|0|||
161690128|NCT05630937|583915760|FG000|Overall Study|Lost to Follow-up|0|||
161690129|NCT05630937|583915761|FG001|Overall Study|Lost to Follow-up|0|||
161690130|NCT05630937|583915762|FG002|Overall Study|Lost to Follow-up|1|||
161690131|NCT05630937|583915763|FG003|Overall Study|Lost to Follow-up|0|||
161690132|NCT05630937|583915760|FG000|Overall Study|Enrolled but not treated|0|||
161690133|NCT05630937|583915761|FG001|Overall Study|Enrolled but not treated|0|||
161690134|NCT05630937|583915762|FG002|Overall Study|Enrolled but not treated|0|||
161690135|NCT05630937|583915763|FG003|Overall Study|Enrolled but not treated|1|||
161690136|NCT03245450|583915764|FG000|Overall Study|Radiological disease progression|3|||
161690137|NCT03245450|583915765|FG001|Overall Study|Radiological disease progression|3|||
161690138|NCT03245450|583915766|FG002|Overall Study|Radiological disease progression|2|||
161690139|NCT03245450|583915767|FG003|Overall Study|Radiological disease progression|2|||
161690140|NCT03245450|583915768|FG004|Overall Study|Radiological disease progression|7|||
161690141|NCT03245450|583915769|FG005|Overall Study|Radiological disease progression|6|||
161690142|NCT03245450|583915770|FG006|Overall Study|Radiological disease progression|6|||
161690143|NCT03245450|583915764|FG000|Overall Study|Clinical disease progression|0|||
161836275|NCT03573505|584442914|FG001|Overall Study|Adverse Event|1|||
161836276|NCT03573505|584442913|FG000|Overall Study|Consent withdrawn|0|||
161836277|NCT03573505|584442914|FG001|Overall Study|Consent withdrawn|1|||
161690144|NCT03245450|583915765|FG001|Overall Study|Clinical disease progression|0|||
161690145|NCT03245450|583915766|FG002|Overall Study|Clinical disease progression|1|||
161690146|NCT03245450|583915767|FG003|Overall Study|Clinical disease progression|0|||
161690147|NCT03245450|583915768|FG004|Overall Study|Clinical disease progression|0|||
161690148|NCT03245450|583915769|FG005|Overall Study|Clinical disease progression|2|||
161690149|NCT03245450|583915770|FG006|Overall Study|Clinical disease progression|0|||
161690150|NCT03245450|583915764|FG000|Overall Study|Other|0|||
161690151|NCT03245450|583915765|FG001|Overall Study|Other|0|||
161690152|NCT03245450|583915766|FG002|Overall Study|Other|0|||
161690153|NCT03245450|583915767|FG003|Overall Study|Other|1|||
161690154|NCT03245450|583915768|FG004|Overall Study|Other|1|||
161836278|NCT03573505|584442913|FG000|Overall Study|Disease progression|0|||
161836279|NCT03573505|584442914|FG001|Overall Study|Disease progression|1|||
161836280|NCT03573505|584442913|FG000|Overall Study|Site Terminated by Sponsor|1|||
161690155|NCT03245450|583915769|FG005|Overall Study|Other|1|||
161690156|NCT03245450|583915770|FG006|Overall Study|Other|1|||
161690157|NCT03245450|583915764|FG000|Overall Study|Withdrawal by Subject|0|||
161690158|NCT03245450|583915765|FG001|Overall Study|Withdrawal by Subject|1|||
161690159|NCT03245450|583915766|FG002|Overall Study|Withdrawal by Subject|0|||
161690160|NCT03245450|583915767|FG003|Overall Study|Withdrawal by Subject|0|||
161690161|NCT03245450|583915768|FG004|Overall Study|Withdrawal by Subject|0|||
161690162|NCT03245450|583915769|FG005|Overall Study|Withdrawal by Subject|0|||
161690163|NCT03245450|583915770|FG006|Overall Study|Withdrawal by Subject|0|||
161690164|NCT03245450|583915764|FG000|Overall Study|Adverse Event|0|||
161690165|NCT03245450|583915765|FG001|Overall Study|Adverse Event|0|||
161690166|NCT03245450|583915766|FG002|Overall Study|Adverse Event|0|||
161690167|NCT03245450|583915767|FG003|Overall Study|Adverse Event|0|||
161690168|NCT03245450|583915768|FG004|Overall Study|Adverse Event|1|||
161690169|NCT03245450|583915769|FG005|Overall Study|Adverse Event|0|||
161690170|NCT03245450|583915770|FG006|Overall Study|Adverse Event|2|||
161690171|NCT02429414|583915771|FG000|Overall Study|Physician Decision|0|||
161690172|NCT02429414|583915772|FG001|Overall Study|Physician Decision|1|||
161690173|NCT01604265|583915777|FG000|Overall Study|Adverse Event|1|||
161690174|NCT01604265|583915778|FG001|Overall Study|Adverse Event|0|||
161690175|NCT01604265|583915777|FG000|Overall Study|Withdrawal by Subject|1|||
161690176|NCT01604265|583915778|FG001|Overall Study|Withdrawal by Subject|0|||
161690177|NCT01903837|583915779|FG000|Part A|Withdrawal by Subject|4|||
161690178|NCT01903837|583915780|FG001|Part A|Withdrawal by Subject|9|||
161690179|NCT01903837|583915781|FG002|Part A|Withdrawal by Subject|8|||
161690180|NCT01903837|583915782|FG003|Part A|Withdrawal by Subject|5|||
161690181|NCT01903837|583915779|FG000|Part A|Adverse Event|3|||
161690182|NCT01903837|583915780|FG001|Part A|Adverse Event|6|||
161690183|NCT01903837|583915781|FG002|Part A|Adverse Event|9|||
161690184|NCT01903837|583915782|FG003|Part A|Adverse Event|6|||
161690185|NCT01903837|583915779|FG000|Part A|Lost to Follow-up|9|||
161690186|NCT01903837|583915780|FG001|Part A|Lost to Follow-up|7|||
161690187|NCT01903837|583915781|FG002|Part A|Lost to Follow-up|7|||
161690188|NCT01903837|583915782|FG003|Part A|Lost to Follow-up|2|||
161690189|NCT01903837|583915779|FG000|Part A|Non-compliance with study drug|1|||
161690190|NCT01903837|583915780|FG001|Part A|Non-compliance with study drug|4|||
161690191|NCT01903837|583915781|FG002|Part A|Non-compliance with study drug|4|||
161690192|NCT01903837|583915782|FG003|Part A|Non-compliance with study drug|0|||
161690193|NCT01903837|583915779|FG000|Part A|Physician Decision|1|||
161690194|NCT01903837|583915780|FG001|Part A|Physician Decision|1|||
161690195|NCT01903837|583915781|FG002|Part A|Physician Decision|0|||
161690196|NCT01903837|583915782|FG003|Part A|Physician Decision|0|||
161690197|NCT01903837|583915779|FG000|Part A|Protocol Violation|1|||
161690198|NCT01903837|583915780|FG001|Part A|Protocol Violation|1|||
161690199|NCT01903837|583915781|FG002|Part A|Protocol Violation|0|||
161690200|NCT01903837|583915782|FG003|Part A|Protocol Violation|0|||
161690201|NCT01903837|583915779|FG000|Part B|Lost to Follow-up|0|||
161690202|NCT01903837|583915780|FG001|Part B|Lost to Follow-up|3|||
161690203|NCT01903837|583915781|FG002|Part B|Lost to Follow-up|3|||
161690204|NCT01903837|583915782|FG003|Part B|Lost to Follow-up|4|||
161690205|NCT01903837|583915779|FG000|Part B|Withdrawal by Subject|1|||
161690206|NCT01903837|583915780|FG001|Part B|Withdrawal by Subject|2|||
161690207|NCT01903837|583915781|FG002|Part B|Withdrawal by Subject|0|||
161690208|NCT01903837|583915782|FG003|Part B|Withdrawal by Subject|3|||
161690209|NCT01903837|583915779|FG000|Part B|Adverse Event|3|||
161690210|NCT01903837|583915780|FG001|Part B|Adverse Event|0|||
161690211|NCT01903837|583915781|FG002|Part B|Adverse Event|2|||
161690212|NCT01903837|583915782|FG003|Part B|Adverse Event|0|||
161690213|NCT01903837|583915779|FG000|Part B|Non-compliance with study drug|2|||
161690214|NCT01903837|583915780|FG001|Part B|Non-compliance with study drug|0|||
161690215|NCT01903837|583915781|FG002|Part B|Non-compliance with study drug|0|||
161690216|NCT01903837|583915782|FG003|Part B|Non-compliance with study drug|1|||
161690217|NCT01903837|583915779|FG000|Part B|Incarceration|2|||
161836281|NCT03573505|584442914|FG001|Overall Study|Site Terminated by Sponsor|1|||
161836282|NCT03573505|584442913|FG000|Overall Study|Study terminated by sponsor|50|||
161836283|NCT03573505|584442914|FG001|Overall Study|Study terminated by sponsor|45|||
161690218|NCT01903837|583915780|FG001|Part B|Incarceration|0|||
161690219|NCT01903837|583915781|FG002|Part B|Incarceration|0|||
161690220|NCT01903837|583915782|FG003|Part B|Incarceration|1|||
161836284|NCT03573505|584442913|FG000|Overall Study|Reason not specified|0|||
161690221|NCT01903837|583915779|FG000|Part B|Physician Decision|1|||
161690222|NCT01903837|583915780|FG001|Part B|Physician Decision|0|||
161690223|NCT01903837|583915781|FG002|Part B|Physician Decision|0|||
161690224|NCT01903837|583915782|FG003|Part B|Physician Decision|2|||
161836285|NCT03573505|584442914|FG001|Overall Study|Reason not specified|1|||
161690225|NCT01903837|583915779|FG000|Part B|Lack of Efficacy|0|||
161690226|NCT01903837|583915780|FG001|Part B|Lack of Efficacy|1|||
161690227|NCT01903837|583915781|FG002|Part B|Lack of Efficacy|0|||
161690228|NCT01903837|583915782|FG003|Part B|Lack of Efficacy|0|||
161690229|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
161690230|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
161690231|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
161690232|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
161690233|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
161690234|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
161690235|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
161690236|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
161690237|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
161690238|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161690239|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
161690240|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
161690241|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
161690242|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
161690243|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
161690244|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
161690245|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
161690246|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
161690247|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
161690248|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
161690249|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
161690250|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
161690251|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
161690252|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
161690253|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
161690254|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
161690255|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
161690256|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
161690257|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
161690258|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
161690259|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
161690260|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
161690261|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
161690262|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
161690263|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
161690264|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
161690265|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
161690266|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
161690267|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
161690268|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
161690269|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161690270|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161690271|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161690272|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
161690273|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
161690274|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
161690275|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
161690276|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
161690277|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
161690278|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
161690279|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
161690280|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
161690281|NCT05098041|583915788|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
161690282|NCT00705939|583915789|FG000|Overall Study|Protocol Violation|0|||
161690283|NCT00705939|583915790|FG001|Overall Study|Protocol Violation|0|||
161690284|NCT00705939|583915791|FG002|Overall Study|Protocol Violation|1|||
161690285|NCT00705939|583915789|FG000|Overall Study|Withdrawal by Subject|0|||
161690286|NCT00705939|583915790|FG001|Overall Study|Withdrawal by Subject|1|||
161690287|NCT00705939|583915791|FG002|Overall Study|Withdrawal by Subject|3|||
161690288|NCT00705939|583915789|FG000|Overall Study|Physician Decision|0|||
161690289|NCT00705939|583915790|FG001|Overall Study|Physician Decision|1|||
161690290|NCT00705939|583915791|FG002|Overall Study|Physician Decision|0|||
161690291|NCT00797732|583915796|FG000|Overall Study|Withdrawal by Subject|3|||
161690292|NCT00797732|583915797|FG001|Overall Study|Withdrawal by Subject|3|||
161690293|NCT00797732|583915798|FG002|Overall Study|Withdrawal by Subject|0|||
161690294|NCT00797732|583915796|FG000|Overall Study|Lost to Follow-up|1|||
161690295|NCT00797732|583915797|FG001|Overall Study|Lost to Follow-up|0|||
161690296|NCT00797732|583915798|FG002|Overall Study|Lost to Follow-up|0|||
161690297|NCT00797732|583915796|FG000|Overall Study|Death|1|||
161690298|NCT00797732|583915797|FG001|Overall Study|Death|0|||
161690299|NCT00797732|583915798|FG002|Overall Study|Death|0|||
161690300|NCT00797732|583915796|FG000|Overall Study|Not meet inclusion criteria|0|||
161690301|NCT00797732|583915797|FG001|Overall Study|Not meet inclusion criteria|0|||
161690302|NCT00797732|583915798|FG002|Overall Study|Not meet inclusion criteria|7|||
161690303|NCT00797732|583915796|FG000|Overall Study|Excluded due to time constraints|0|||
161690304|NCT00797732|583915797|FG001|Overall Study|Excluded due to time constraints|0|||
161690305|NCT00797732|583915798|FG002|Overall Study|Excluded due to time constraints|24|||
161690306|NCT00797732|583915796|FG000|Overall Study|Refused to Participate|0|||
161690307|NCT00797732|583915797|FG001|Overall Study|Refused to Participate|0|||
161690308|NCT00797732|583915798|FG002|Overall Study|Refused to Participate|123|||
161690309|NCT03948178|583915799|FG000|Overall Study|Protocol Violation|1|||
161690310|NCT03948178|583915799|FG000|Overall Study|Lost to Follow-up|2|||
161690311|NCT03948178|583915799|FG000|Overall Study|Withdrawal by Subject|2|||
161690312|NCT03948178|583915799|FG000|Overall Study|Reason not known|2|||
161690313|NCT03948178|583915799|FG000|Overall Study|Personal reason|14|||
161690314|NCT03948178|583915799|FG000|Overall Study|Disease progression|30|||
161690315|NCT03948178|583915799|FG000|Overall Study|Adverse Event|12|||
161690316|NCT03948178|583915799|FG000|Overall Study|Sponsor terminated study|164|||
161690317|NCT01297270|583915800|FG000|Overall Study|Adverse Event|19|||
161690318|NCT01297270|583915801|FG001|Overall Study|Adverse Event|32|||
161690319|NCT01297270|583915802|FG002|Overall Study|Adverse Event|5|||
161690320|NCT01297270|583915800|FG000|Overall Study|Lack of Efficacy|15|||
161690321|NCT01297270|583915801|FG001|Overall Study|Lack of Efficacy|17|||
161690322|NCT01297270|583915802|FG002|Overall Study|Lack of Efficacy|15|||
161690323|NCT01297270|583915800|FG000|Overall Study|Lost to Follow-up|1|||
161690324|NCT01297270|583915801|FG001|Overall Study|Lost to Follow-up|2|||
161690325|NCT01297270|583915802|FG002|Overall Study|Lost to Follow-up|1|||
161690326|NCT01297270|583915800|FG000|Overall Study|Protocol Violation|0|||
161690327|NCT01297270|583915801|FG001|Overall Study|Protocol Violation|2|||
161690328|NCT01297270|583915802|FG002|Overall Study|Protocol Violation|0|||
161690329|NCT01297270|583915800|FG000|Overall Study|Withdrawal by Subject|7|||
161690330|NCT01297270|583915801|FG001|Overall Study|Withdrawal by Subject|15|||
161690331|NCT01297270|583915802|FG002|Overall Study|Withdrawal by Subject|7|||
161690332|NCT01297270|583915800|FG000|Overall Study|Other reason not defined above|3|||
161690333|NCT01297270|583915801|FG001|Overall Study|Other reason not defined above|3|||
161690334|NCT01297270|583915802|FG002|Overall Study|Other reason not defined above|1|||
161690335|NCT01297270|583915800|FG000|Overall Study|Not treated|0|||
161690336|NCT01297270|583915801|FG001|Overall Study|Not treated|1|||
161690337|NCT01297270|583915802|FG002|Overall Study|Not treated|0|||
161690338|NCT02432235|583915805|FG000|Overall Study|Death|1|||
161690339|NCT02432235|583915806|FG001|Overall Study|Death|1|||
161690340|NCT02432235|583915807|FG002|Overall Study|Death|2|||
161690341|NCT02432235|583915808|FG003|Overall Study|Death|2|||
161690342|NCT02432235|583915809|FG004|Overall Study|Death|1|||
161690343|NCT02432235|583915810|FG005|Overall Study|Death|3|||
161690344|NCT02432235|583915811|FG006|Overall Study|Death|11|||
161690345|NCT02432235|583915812|FG007|Overall Study|Death|15|||
161690346|NCT02432235|583915813|FG008|Overall Study|Death|15|||
161690347|NCT02432235|583915814|FG009|Overall Study|Death|3|||
161690348|NCT02432235|583915815|FG010|Overall Study|Death|1|||
161690349|NCT02432235|583915816|FG011|Overall Study|Death|0|||
161690350|NCT02432235|583915805|FG000|Overall Study|Withdrawal by Subject|0|||
161690351|NCT02432235|583915806|FG001|Overall Study|Withdrawal by Subject|1|||
161690352|NCT02432235|583915807|FG002|Overall Study|Withdrawal by Subject|0|||
161690353|NCT02432235|583915808|FG003|Overall Study|Withdrawal by Subject|0|||
161690354|NCT02432235|583915809|FG004|Overall Study|Withdrawal by Subject|0|||
161690355|NCT02432235|583915810|FG005|Overall Study|Withdrawal by Subject|2|||
161690356|NCT02432235|583915811|FG006|Overall Study|Withdrawal by Subject|5|||
161690357|NCT02432235|583915812|FG007|Overall Study|Withdrawal by Subject|3|||
161690358|NCT02432235|583915813|FG008|Overall Study|Withdrawal by Subject|1|||
161690359|NCT02432235|583915814|FG009|Overall Study|Withdrawal by Subject|0|||
161690360|NCT02432235|583915815|FG010|Overall Study|Withdrawal by Subject|0|||
161690361|NCT02432235|583915816|FG011|Overall Study|Withdrawal by Subject|0|||
161690362|NCT02432235|583915805|FG000|Overall Study|Lost to Follow-up|0|||
161690363|NCT02432235|583915806|FG001|Overall Study|Lost to Follow-up|0|||
161690364|NCT02432235|583915807|FG002|Overall Study|Lost to Follow-up|0|||
161690365|NCT02432235|583915808|FG003|Overall Study|Lost to Follow-up|0|||
161690366|NCT02432235|583915809|FG004|Overall Study|Lost to Follow-up|0|||
161690367|NCT02432235|583915810|FG005|Overall Study|Lost to Follow-up|1|||
161690368|NCT02432235|583915811|FG006|Overall Study|Lost to Follow-up|0|||
161690369|NCT02432235|583915812|FG007|Overall Study|Lost to Follow-up|0|||
161690370|NCT02432235|583915813|FG008|Overall Study|Lost to Follow-up|1|||
161690371|NCT02432235|583915814|FG009|Overall Study|Lost to Follow-up|0|||
161690372|NCT02432235|583915815|FG010|Overall Study|Lost to Follow-up|0|||
161690373|NCT02432235|583915816|FG011|Overall Study|Lost to Follow-up|0|||
161690374|NCT02432235|583915805|FG000|Overall Study|Miscellaneous|0|||
161690375|NCT02432235|583915806|FG001|Overall Study|Miscellaneous|0|||
161690376|NCT02432235|583915807|FG002|Overall Study|Miscellaneous|0|||
161690377|NCT02432235|583915808|FG003|Overall Study|Miscellaneous|0|||
161690378|NCT02432235|583915809|FG004|Overall Study|Miscellaneous|1|||
161690379|NCT02432235|583915810|FG005|Overall Study|Miscellaneous|6|||
161690380|NCT02432235|583915811|FG006|Overall Study|Miscellaneous|2|||
161690381|NCT02432235|583915812|FG007|Overall Study|Miscellaneous|2|||
161690382|NCT02432235|583915813|FG008|Overall Study|Miscellaneous|4|||
161690383|NCT02432235|583915814|FG009|Overall Study|Miscellaneous|0|||
161690384|NCT02432235|583915815|FG010|Overall Study|Miscellaneous|0|||
161690385|NCT02432235|583915816|FG011|Overall Study|Miscellaneous|1|||
161690386|NCT00401752|583915817|FG000|Overall Study|Adverse Event|2|||
161690387|NCT00401752|583915818|FG001|Overall Study|Adverse Event|5|||
161690388|NCT00401752|583915817|FG000|Overall Study|Withdrawal by Subject|2|||
161690389|NCT00401752|583915818|FG001|Overall Study|Withdrawal by Subject|6|||
161690390|NCT00401752|583915817|FG000|Overall Study|Lost to Follow-up|1|||
161690391|NCT00401752|583915818|FG001|Overall Study|Lost to Follow-up|4|||
161690392|NCT00401752|583915817|FG000|Overall Study|Development of any exclusion criteria|4|||
161690393|NCT00401752|583915818|FG001|Overall Study|Development of any exclusion criteria|2|||
161690394|NCT00401752|583915817|FG000|Overall Study|Physician Decision|1|||
161690395|NCT00401752|583915818|FG001|Overall Study|Physician Decision|1|||
161690396|NCT01895322|583915819|FG000|Overall Study|Adverse Event|1|||
161690397|NCT01895322|583915819|FG000|Overall Study|Withdrawal by Subject|2|||
161690398|NCT01895322|583915819|FG000|Overall Study|Protocol Violation|10|||
161690399|NCT01347554|583915820|FG000|Overall Study|Lack of Efficacy|7|||
161690400|NCT01347554|583915821|FG001|Overall Study|Lack of Efficacy|11|||
161690401|NCT02873936|583915822|FG000|Overall Study|Withdrew Consent|4|||
161690402|NCT02873936|583915823|FG001|Overall Study|Withdrew Consent|11|||
161690403|NCT02873936|583915824|FG002|Overall Study|Withdrew Consent|20|||
161690404|NCT02873936|583915822|FG000|Overall Study|Investigator's Discretion|3|||
161690405|NCT02873936|583915823|FG001|Overall Study|Investigator's Discretion|5|||
161690406|NCT02873936|583915824|FG002|Overall Study|Investigator's Discretion|4|||
161690407|NCT02873936|583915822|FG000|Overall Study|Adverse Event|3|||
161690408|NCT02873936|583915823|FG001|Overall Study|Adverse Event|5|||
161690409|NCT02873936|583915824|FG002|Overall Study|Adverse Event|3|||
161690410|NCT02873936|583915822|FG000|Overall Study|Protocol Violation|0|||
161690411|NCT02873936|583915823|FG001|Overall Study|Protocol Violation|1|||
161690412|NCT02873936|583915824|FG002|Overall Study|Protocol Violation|3|||
161690413|NCT02873936|583915822|FG000|Overall Study|Lost to Follow-up|1|||
161690414|NCT02873936|583915823|FG001|Overall Study|Lost to Follow-up|1|||
161690415|NCT02873936|583915824|FG002|Overall Study|Lost to Follow-up|1|||
161690416|NCT02873936|583915822|FG000|Overall Study|Non-compliance With Study Drug|1|||
161690417|NCT02873936|583915823|FG001|Overall Study|Non-compliance With Study Drug|0|||
161690418|NCT02873936|583915824|FG002|Overall Study|Non-compliance With Study Drug|1|||
161690419|NCT02873936|583915822|FG000|Overall Study|Randomized but not Dosed|1|||
161690420|NCT02873936|583915823|FG001|Overall Study|Randomized but not Dosed|0|||
161690421|NCT02873936|583915824|FG002|Overall Study|Randomized but not Dosed|0|||
161690422|NCT01505634|583915825|FG000|Overall Study|Withdrawal by Subject|2|||
161690423|NCT01505634|583915826|FG001|Overall Study|Withdrawal by Subject|5|||
161690424|NCT01505634|583915827|FG002|Overall Study|Withdrawal by Subject|1|||
161690425|NCT01505634|583915825|FG000|Overall Study|Physician Decision|1|||
161690426|NCT01505634|583915826|FG001|Overall Study|Physician Decision|1|||
161690427|NCT01505634|583915827|FG002|Overall Study|Physician Decision|0|||
161690428|NCT01505634|583915825|FG000|Overall Study|Adverse Event|1|||
161690429|NCT01505634|583915826|FG001|Overall Study|Adverse Event|0|||
161690430|NCT01505634|583915827|FG002|Overall Study|Adverse Event|0|||
161690431|NCT01505634|583915825|FG000|Overall Study|Insufficient supply of drug at site|1|||
161690432|NCT01505634|583915826|FG001|Overall Study|Insufficient supply of drug at site|0|||
161690433|NCT01505634|583915827|FG002|Overall Study|Insufficient supply of drug at site|0|||
161690434|NCT01505634|583915825|FG000|Overall Study|Protocol Violation|2|||
161690435|NCT01505634|583915826|FG001|Overall Study|Protocol Violation|0|||
161690436|NCT01505634|583915827|FG002|Overall Study|Protocol Violation|0|||
161690437|NCT01505634|583915825|FG000|Overall Study|Lost to Follow-up|1|||
161690438|NCT01505634|583915826|FG001|Overall Study|Lost to Follow-up|4|||
161690439|NCT01505634|583915827|FG002|Overall Study|Lost to Follow-up|4|||
161690440|NCT01505634|583915825|FG000|Overall Study|Death|1|||
161690441|NCT01505634|583915826|FG001|Overall Study|Death|0|||
161836286|NCT03573505|584442913|FG000|Overall Study|Death|0|||
161690442|NCT01505634|583915827|FG002|Overall Study|Death|0|||
161690443|NCT01505634|583915825|FG000|Overall Study|In a conflict zone|0|||
161690444|NCT01505634|583915826|FG001|Overall Study|In a conflict zone|0|||
161690445|NCT01505634|583915827|FG002|Overall Study|In a conflict zone|1|||
161690446|NCT02054897|583915828|FG000|Overall Study|Withdrawal by Subject|2|||
161690447|NCT02054897|583915829|FG001|Overall Study|Withdrawal by Subject|0|||
161690448|NCT02054897|583915830|FG002|Overall Study|Withdrawal by Subject|2|||
161690449|NCT02054897|583915828|FG000|Overall Study|Missing follow-up information|3|||
161690450|NCT02054897|583915829|FG001|Overall Study|Missing follow-up information|5|||
161690451|NCT02054897|583915830|FG002|Overall Study|Missing follow-up information|3|||
161690452|NCT02054897|583915828|FG000|Overall Study|Lost to Follow-up|4|||
161690453|NCT02054897|583915829|FG001|Overall Study|Lost to Follow-up|2|||
161690454|NCT02054897|583915830|FG002|Overall Study|Lost to Follow-up|7|||
161690455|NCT02054897|583915828|FG000|Overall Study|Randomized but not exposed|1|||
161690456|NCT02054897|583915829|FG001|Overall Study|Randomized but not exposed|0|||
161690457|NCT02054897|583915830|FG002|Overall Study|Randomized but not exposed|0|||
161690458|NCT00960843|583915831|FG000|Overall Study|Lost to Follow-up|2|||
161836287|NCT03573505|584442914|FG001|Overall Study|Death|4|||
161836288|NCT00515541|584442915|FG000|Overall Study|Physician Decision|0|||
161836289|NCT00515541|584442916|FG001|Overall Study|Physician Decision|2|||
161836290|NCT00515541|584442917|FG002|Overall Study|Physician Decision|0|||
161836291|NCT00515541|584442918|FG003|Overall Study|Physician Decision|1|||
161836292|NCT00515541|584442915|FG000|Overall Study|No show for appointments|0|||
161836293|NCT00515541|584442916|FG001|Overall Study|No show for appointments|1|||
161836294|NCT00515541|584442917|FG002|Overall Study|No show for appointments|0|||
161836295|NCT00515541|584442918|FG003|Overall Study|No show for appointments|2|||
161836296|NCT00515541|584442915|FG000|Overall Study|Withdrawal by Subject|0|||
161836297|NCT00515541|584442916|FG001|Overall Study|Withdrawal by Subject|2|||
161836298|NCT00515541|584442917|FG002|Overall Study|Withdrawal by Subject|0|||
161836299|NCT00515541|584442918|FG003|Overall Study|Withdrawal by Subject|2|||
161836300|NCT02145026|584442920|FG000|Overall Study|Adverse Event|2|||
161836301|NCT02145026|584442920|FG000|Overall Study|Death|4|||
161836302|NCT02145026|584442920|FG000|Overall Study|Withdrawal by Subject|2|||
161836303|NCT02145026|584442920|FG000|Overall Study|Physician Decision|4|||
161836304|NCT03052322|584442921|FG000|Overall Study|Other un-specified|1|||
161836305|NCT03052322|584442922|FG001|Overall Study|Other un-specified|2|||
161836306|NCT03052322|584442921|FG000|Overall Study|Withdrawal by Subject|10|||
161836307|NCT03052322|584442922|FG001|Overall Study|Withdrawal by Subject|9|||
161836308|NCT03052322|584442921|FG000|Overall Study|Death|0|||
161836309|NCT03052322|584442922|FG001|Overall Study|Death|2|||
161836310|NCT03052322|584442921|FG000|Overall Study|Lack of Efficacy|1|||
161836311|NCT03052322|584442922|FG001|Overall Study|Lack of Efficacy|2|||
161836312|NCT03052322|584442921|FG000|Overall Study|Protocol Violation|1|||
161836313|NCT03052322|584442922|FG001|Overall Study|Protocol Violation|0|||
161836314|NCT03052322|584442921|FG000|Overall Study|Lost to Follow-up|2|||
161836315|NCT03052322|584442922|FG001|Overall Study|Lost to Follow-up|4|||
161836316|NCT03052322|584442921|FG000|Overall Study|Adverse Event|6|||
161836317|NCT03052322|584442922|FG001|Overall Study|Adverse Event|13|||
161836318|NCT05065983|584442923|FG000|Overall Study|Lost to Follow-up|2|||
161836319|NCT00003875|584442926|FG000|Overall Study|Screen Failed|1|||
161836320|NCT01546649|584442927|FG000|Overall Study|Adverse Event|4|||
161836321|NCT01546649|584442928|FG001|Overall Study|Adverse Event|5|||
161836322|NCT01546649|584442927|FG000|Overall Study|Protocol Violation|1|||
161836323|NCT01546649|584442928|FG001|Overall Study|Protocol Violation|0|||
161836324|NCT01546649|584442927|FG000|Overall Study|Lack of Efficacy|1|||
161836325|NCT01546649|584442928|FG001|Overall Study|Lack of Efficacy|0|||
161836326|NCT01546649|584442927|FG000|Overall Study|Recurrence|1|||
161836327|NCT01546649|584442928|FG001|Overall Study|Recurrence|1|||
161836328|NCT01546649|584442927|FG000|Overall Study|Discovery of secondary cancer|0|||
161836329|NCT01546649|584442928|FG001|Overall Study|Discovery of secondary cancer|1|||
161836330|NCT01546649|584442927|FG000|Overall Study|Withdrawal by Subject|1|||
161836331|NCT01546649|584442928|FG001|Overall Study|Withdrawal by Subject|2|||
161836332|NCT00706381|584442931|FG000|Overall Study|Lost to Follow-up|0|||
161836333|NCT00706381|584442932|FG001|Overall Study|Lost to Follow-up|1|||
161690459|NCT00960843|583915832|FG001|Overall Study|Lost to Follow-up|0|||
161690460|NCT00960843|583915831|FG000|Overall Study|Protocol Violation|0|||
161690461|NCT00960843|583915832|FG001|Overall Study|Protocol Violation|4|||
161690462|NCT00960843|583915831|FG000|Overall Study|Repeated needle dislodgment|0|||
161690463|NCT00960843|583915832|FG001|Overall Study|Repeated needle dislodgment|1|||
161690464|NCT00254501|583915833|FG000|Overall Study|Lost to Follow-up|1|||
161836334|NCT00706381|584442933|FG002|Overall Study|Lost to Follow-up|1|||
161836335|NCT00706381|584442934|FG003|Overall Study|Lost to Follow-up|0|||
161836336|NCT05420012|584442935|FG000|Overall Study|Lost to Follow-up|0|||
161836337|NCT05420012|584442936|FG001|Overall Study|Lost to Follow-up|1|||
161836338|NCT00038649|584442940|FG000|Overall Study|Adverse Event|9|||
161836339|NCT03395639|584442941|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
161836340|NCT03395639|584442942|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
161836341|NCT03395639|584442943|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
161690465|NCT00254501|583915834|FG001|Overall Study|Lost to Follow-up|1|||
161690466|NCT00879697|583915836|FG000|Overall Study|Physician Decision|2|||
161690467|NCT00879697|583915837|FG001|Overall Study|Physician Decision|2|||
161690468|NCT01836783|583915840|FG000|Overall Study|Withdrawal by Subject|0|||
161690469|NCT01836783|583915841|FG001|Overall Study|Withdrawal by Subject|2|||
161690470|NCT01100437|583915847|FG000|Titration/Stabilization|Adverse Event|0|||
161690471|NCT01100437|583915848|FG001|Titration/Stabilization|Adverse Event|0|||
161690472|NCT01100437|583915849|FG002|Titration/Stabilization|Adverse Event|4|||
161690473|NCT01100437|583915847|FG000|Titration/Stabilization|Non-compliance|0|||
161690474|NCT01100437|583915848|FG001|Titration/Stabilization|Non-compliance|0|||
161690475|NCT01100437|583915849|FG002|Titration/Stabilization|Non-compliance|1|||
161690476|NCT01100437|583915847|FG000|Titration/Stabilization|Sponsor canceled study|0|||
161690477|NCT01100437|583915848|FG001|Titration/Stabilization|Sponsor canceled study|0|||
161690478|NCT01100437|583915849|FG002|Titration/Stabilization|Sponsor canceled study|1|||
161690479|NCT01100437|583915847|FG000|Maintenance|Withdrawal by Subject|0|||
161690480|NCT01100437|583915848|FG001|Maintenance|Withdrawal by Subject|0|||
161690481|NCT01100437|583915849|FG002|Maintenance|Withdrawal by Subject|1|||
161690482|NCT01100437|583915847|FG000|Maintenance|Sponsor termination of study|0|||
161690483|NCT01100437|583915848|FG001|Maintenance|Sponsor termination of study|0|||
161690484|NCT01100437|583915849|FG002|Maintenance|Sponsor termination of study|1|||
161690485|NCT01014689|583915852|FG000|Overall Study|Lack of Efficacy|0|||
161690486|NCT01014689|583915853|FG001|Overall Study|Lack of Efficacy|1|||
161690487|NCT01014689|583915852|FG000|Overall Study|Adverse Event|3|||
161690488|NCT01014689|583915853|FG001|Overall Study|Adverse Event|0|||
161690489|NCT01014689|583915852|FG000|Overall Study|Withdrawal by Subject|5|||
161690490|NCT01014689|583915853|FG001|Overall Study|Withdrawal by Subject|4|||
161690491|NCT01014689|583915852|FG000|Overall Study|Protocol Violation|1|||
161690492|NCT01014689|583915853|FG001|Overall Study|Protocol Violation|1|||
161690493|NCT01014689|583915852|FG000|Overall Study|Lost to Follow-up|3|||
161690494|NCT01014689|583915853|FG001|Overall Study|Lost to Follow-up|7|||
161690495|NCT01014689|583915852|FG000|Overall Study|Pregnancy|1|||
161690496|NCT01014689|583915853|FG001|Overall Study|Pregnancy|0|||
161690497|NCT04418076|583915855|FG000|Overall Study|Death|1|||
161690498|NCT04418076|583915856|FG001|Overall Study|Death|0|||
161690499|NCT04418076|583915857|FG002|Overall Study|Death|0|||
161690500|NCT04418076|583915858|FG003|Overall Study|Death|0|||
161690501|NCT04418076|583915855|FG000|Overall Study|Lost to Follow-up|2|||
161690502|NCT04418076|583915856|FG001|Overall Study|Lost to Follow-up|5|||
161690503|NCT04418076|583915857|FG002|Overall Study|Lost to Follow-up|1|||
161690504|NCT04418076|583915858|FG003|Overall Study|Lost to Follow-up|2|||
161690505|NCT04418076|583915855|FG000|Overall Study|Withdrawal by Subject|1|||
161690506|NCT04418076|583915856|FG001|Overall Study|Withdrawal by Subject|0|||
161690507|NCT04418076|583915857|FG002|Overall Study|Withdrawal by Subject|1|||
161690508|NCT04418076|583915858|FG003|Overall Study|Withdrawal by Subject|1|||
161690509|NCT04418076|583915855|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
161690510|NCT04418076|583915856|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
161690511|NCT04418076|583915857|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
161690512|NCT04418076|583915858|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
161690513|NCT01452152|583915861|FG000|Overall Study|Study termination by sponsor|5|||
161690514|NCT01452152|583915862|FG001|Overall Study|Study termination by sponsor|0|||
161690515|NCT01452152|583915863|FG002|Overall Study|Study termination by sponsor|4|||
161690516|NCT00328627|583918742|FG000|Overall Study|Hyperglycemic Rescue|41|||
161690517|NCT00328627|583918743|FG001|Overall Study|Hyperglycemic Rescue|18|||
161690518|NCT00328627|583918744|FG002|Overall Study|Hyperglycemic Rescue|16|||
161690519|NCT00328627|583918745|FG003|Overall Study|Hyperglycemic Rescue|13|||
161690520|NCT00328627|583918746|FG004|Overall Study|Hyperglycemic Rescue|6|||
161690521|NCT00328627|583918747|FG005|Overall Study|Hyperglycemic Rescue|5|||
161690522|NCT00328627|583918748|FG006|Overall Study|Hyperglycemic Rescue|19|||
161690523|NCT00328627|583918749|FG007|Overall Study|Hyperglycemic Rescue|6|||
161690524|NCT00328627|583918750|FG008|Overall Study|Hyperglycemic Rescue|6|||
161690525|NCT00328627|583918751|FG009|Overall Study|Hyperglycemic Rescue|11|||
161690526|NCT00328627|583918752|FG010|Overall Study|Hyperglycemic Rescue|3|||
161690527|NCT00328627|583918753|FG011|Overall Study|Hyperglycemic Rescue|2|||
161690528|NCT00328627|583918742|FG000|Overall Study|Adverse Event|3|||
161690529|NCT00328627|583918743|FG001|Overall Study|Adverse Event|1|||
161690530|NCT00328627|583918744|FG002|Overall Study|Adverse Event|2|||
161690531|NCT00328627|583918745|FG003|Overall Study|Adverse Event|3|||
161690532|NCT00328627|583918746|FG004|Overall Study|Adverse Event|1|||
161690533|NCT00328627|583918747|FG005|Overall Study|Adverse Event|2|||
161690534|NCT00328627|583918748|FG006|Overall Study|Adverse Event|1|||
161690535|NCT00328627|583918749|FG007|Overall Study|Adverse Event|2|||
161690536|NCT00328627|583918750|FG008|Overall Study|Adverse Event|0|||
161690537|NCT00328627|583918751|FG009|Overall Study|Adverse Event|7|||
161690538|NCT00328627|583918752|FG010|Overall Study|Adverse Event|5|||
161690539|NCT00328627|583918753|FG011|Overall Study|Adverse Event|4|||
161690540|NCT00328627|583918742|FG000|Overall Study|Protocol Violation|2|||
161690541|NCT00328627|583918743|FG001|Overall Study|Protocol Violation|2|||
161690542|NCT00328627|583918744|FG002|Overall Study|Protocol Violation|2|||
161690543|NCT00328627|583918745|FG003|Overall Study|Protocol Violation|8|||
161690544|NCT00328627|583918746|FG004|Overall Study|Protocol Violation|5|||
161690545|NCT00328627|583918747|FG005|Overall Study|Protocol Violation|5|||
161690546|NCT00328627|583918748|FG006|Overall Study|Protocol Violation|6|||
161690547|NCT00328627|583918749|FG007|Overall Study|Protocol Violation|2|||
161690548|NCT00328627|583918750|FG008|Overall Study|Protocol Violation|1|||
161690549|NCT00328627|583918751|FG009|Overall Study|Protocol Violation|4|||
161690550|NCT00328627|583918752|FG010|Overall Study|Protocol Violation|6|||
161690551|NCT00328627|583918753|FG011|Overall Study|Protocol Violation|2|||
161690552|NCT00328627|583918742|FG000|Overall Study|Lost to Follow-up|4|||
161690553|NCT00328627|583918743|FG001|Overall Study|Lost to Follow-up|2|||
161690554|NCT00328627|583918744|FG002|Overall Study|Lost to Follow-up|2|||
161690555|NCT00328627|583918745|FG003|Overall Study|Lost to Follow-up|4|||
161690556|NCT00328627|583918746|FG004|Overall Study|Lost to Follow-up|0|||
161690557|NCT00328627|583918747|FG005|Overall Study|Lost to Follow-up|2|||
161690558|NCT00328627|583918748|FG006|Overall Study|Lost to Follow-up|3|||
161690559|NCT00328627|583918749|FG007|Overall Study|Lost to Follow-up|0|||
161690560|NCT00328627|583918750|FG008|Overall Study|Lost to Follow-up|3|||
161690561|NCT00328627|583918751|FG009|Overall Study|Lost to Follow-up|2|||
161690562|NCT00328627|583918752|FG010|Overall Study|Lost to Follow-up|0|||
161690563|NCT00328627|583918753|FG011|Overall Study|Lost to Follow-up|1|||
161690564|NCT00328627|583918742|FG000|Overall Study|Withdrawal by Subject|5|||
161690565|NCT00328627|583918743|FG001|Overall Study|Withdrawal by Subject|4|||
161690566|NCT00328627|583918744|FG002|Overall Study|Withdrawal by Subject|5|||
161690567|NCT00328627|583918745|FG003|Overall Study|Withdrawal by Subject|6|||
161690568|NCT00328627|583918746|FG004|Overall Study|Withdrawal by Subject|2|||
161690569|NCT00328627|583918747|FG005|Overall Study|Withdrawal by Subject|5|||
161690570|NCT00328627|583918748|FG006|Overall Study|Withdrawal by Subject|4|||
161690571|NCT00328627|583918749|FG007|Overall Study|Withdrawal by Subject|4|||
161690572|NCT00328627|583918750|FG008|Overall Study|Withdrawal by Subject|4|||
161690573|NCT00328627|583918751|FG009|Overall Study|Withdrawal by Subject|5|||
161690574|NCT00328627|583918752|FG010|Overall Study|Withdrawal by Subject|2|||
161690575|NCT00328627|583918753|FG011|Overall Study|Withdrawal by Subject|7|||
161690576|NCT00328627|583918742|FG000|Overall Study|Pregnancy|0|||
161690577|NCT00328627|583918743|FG001|Overall Study|Pregnancy|1|||
161690578|NCT00328627|583918744|FG002|Overall Study|Pregnancy|0|||
161690579|NCT00328627|583918745|FG003|Overall Study|Pregnancy|0|||
161690580|NCT00328627|583918746|FG004|Overall Study|Pregnancy|0|||
161690581|NCT00328627|583918747|FG005|Overall Study|Pregnancy|0|||
161690582|NCT00328627|583918748|FG006|Overall Study|Pregnancy|0|||
161690583|NCT00328627|583918749|FG007|Overall Study|Pregnancy|0|||
161690584|NCT00328627|583918750|FG008|Overall Study|Pregnancy|0|||
161690585|NCT00328627|583918751|FG009|Overall Study|Pregnancy|0|||
161690586|NCT00328627|583918752|FG010|Overall Study|Pregnancy|0|||
161690587|NCT00328627|583918753|FG011|Overall Study|Pregnancy|0|||
161690588|NCT00328627|583918742|FG000|Overall Study|Physician Decision|4|||
161690589|NCT00328627|583918743|FG001|Overall Study|Physician Decision|3|||
161690590|NCT00328627|583918744|FG002|Overall Study|Physician Decision|1|||
161690591|NCT00328627|583918745|FG003|Overall Study|Physician Decision|2|||
161690592|NCT00328627|583918746|FG004|Overall Study|Physician Decision|1|||
161690593|NCT00328627|583918747|FG005|Overall Study|Physician Decision|1|||
161690594|NCT00328627|583918748|FG006|Overall Study|Physician Decision|1|||
161690595|NCT00328627|583918749|FG007|Overall Study|Physician Decision|0|||
161690596|NCT00328627|583918750|FG008|Overall Study|Physician Decision|3|||
161690597|NCT00328627|583918751|FG009|Overall Study|Physician Decision|2|||
161690598|NCT00328627|583918752|FG010|Overall Study|Physician Decision|1|||
161690599|NCT00328627|583918753|FG011|Overall Study|Physician Decision|0|||
161690600|NCT00328627|583918742|FG000|Overall Study|Other|0|||
161690601|NCT00328627|583918743|FG001|Overall Study|Other|0|||
161690602|NCT00328627|583918744|FG002|Overall Study|Other|0|||
161690603|NCT00328627|583918745|FG003|Overall Study|Other|1|||
161690604|NCT00328627|583918746|FG004|Overall Study|Other|0|||
161690605|NCT00328627|583918747|FG005|Overall Study|Other|0|||
161690606|NCT00328627|583918748|FG006|Overall Study|Other|1|||
161690607|NCT00328627|583918749|FG007|Overall Study|Other|0|||
161690608|NCT00328627|583918750|FG008|Overall Study|Other|0|||
161690609|NCT00328627|583918751|FG009|Overall Study|Other|1|||
161690610|NCT00328627|583918752|FG010|Overall Study|Other|1|||
161690611|NCT00328627|583918753|FG011|Overall Study|Other|0|||
161690612|NCT02049944|583918754|FG000|Overall Study|Protocol Violation|2|||
161690613|NCT03691974|583918757|FG000|Overall Study|Physician Decision|1|||
161690614|NCT03691974|583918758|FG001|Overall Study|Physician Decision|0|||
161690615|NCT03691974|583918757|FG000|Overall Study|Adverse Event|1|||
161690616|NCT03691974|583918758|FG001|Overall Study|Adverse Event|0|||
161690617|NCT03691974|583918757|FG000|Overall Study|Withdrawal by Subject|11|||
161690618|NCT03691974|583918758|FG001|Overall Study|Withdrawal by Subject|9|||
161690619|NCT03691974|583918757|FG000|Overall Study|Protocol Violation|1|||
161690620|NCT03691974|583918758|FG001|Overall Study|Protocol Violation|0|||
161690621|NCT03691974|583918757|FG000|Overall Study|Lost to Follow-up|8|||
161690622|NCT03691974|583918758|FG001|Overall Study|Lost to Follow-up|7|||
161690623|NCT00513409|583918759|FG000|Overall Study|Adverse Event|0|||
161690624|NCT00513409|583918760|FG001|Overall Study|Adverse Event|1|||
161690625|NCT00513409|583918759|FG000|Overall Study|Withdrawal by Subject|0|||
161690626|NCT00513409|583918760|FG001|Overall Study|Withdrawal by Subject|2|||
161690627|NCT00513409|583918759|FG000|Overall Study|Lost to Follow-up|0|||
161690628|NCT00513409|583918760|FG001|Overall Study|Lost to Follow-up|1|||
161690629|NCT00513409|583918759|FG000|Overall Study|Physician Decision|1|||
161690630|NCT00513409|583918760|FG001|Overall Study|Physician Decision|0|||
161690631|NCT00513409|583918759|FG000|Overall Study|Visit 3 not done|1|||
161690632|NCT00513409|583918760|FG001|Overall Study|Visit 3 not done|2|||
161690633|NCT00691483|583918761|FG000|Overall Study|Adverse Event|14|||
161690634|NCT00691483|583918762|FG001|Overall Study|Adverse Event|6|||
161690635|NCT00691483|583918761|FG000|Overall Study|Lost to Follow-up|17|||
161690636|NCT00691483|583918762|FG001|Overall Study|Lost to Follow-up|10|||
161690637|NCT00691483|583918761|FG000|Overall Study|Withdrawal by Subject|24|||
161690638|NCT00691483|583918762|FG001|Overall Study|Withdrawal by Subject|7|||
161690639|NCT00691483|583918761|FG000|Overall Study|Other known cause|6|||
161690640|NCT00691483|583918762|FG001|Overall Study|Other known cause|1|||
161690641|NCT00691483|583918761|FG000|Overall Study|Randomized by not treated|7|||
161690642|NCT00691483|583918762|FG001|Overall Study|Randomized by not treated|1|||
161690643|NCT04623242|583918763|FG000|Overall Study|Withdrawal by Subject|7|||
161690644|NCT04623242|583918764|FG001|Overall Study|Withdrawal by Subject|12|||
161690645|NCT04623242|583918765|FG002|Overall Study|Withdrawal by Subject|5|||
161690646|NCT04623242|583918766|FG003|Overall Study|Withdrawal by Subject|7|||
161690647|NCT04623242|583918767|FG004|Overall Study|Withdrawal by Subject|0|||
161690648|NCT04623242|583918763|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
161690649|NCT04623242|583918764|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
161690650|NCT04623242|583918765|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
161690651|NCT04623242|583918766|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
161690652|NCT04623242|583918767|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
161690653|NCT04623242|583918763|FG000|Overall Study|Subject unblinded to mutation status|0|||
161690654|NCT04623242|583918764|FG001|Overall Study|Subject unblinded to mutation status|0|||
161690655|NCT04623242|583918765|FG002|Overall Study|Subject unblinded to mutation status|0|||
161690656|NCT04623242|583918766|FG003|Overall Study|Subject unblinded to mutation status|13|||
161690657|NCT04623242|583918767|FG004|Overall Study|Subject unblinded to mutation status|0|||
161690658|NCT02921971|583918770|FG000|Overall Study|Adverse Event|1|||
161690659|NCT02921971|583918771|FG001|Overall Study|Adverse Event|2|||
161690660|NCT02921971|583918770|FG000|Overall Study|Lack of Efficacy|3|||
161690661|NCT02921971|583918771|FG001|Overall Study|Lack of Efficacy|1|||
161690662|NCT02921971|583918770|FG000|Overall Study|Other than specified above|2|||
161690663|NCT02921971|583918771|FG001|Overall Study|Other than specified above|1|||
161690664|NCT02105454|583918772|FG000|Overall Study|Withdrawal by Subject|1|||
161690665|NCT00326898|583918773|FG000|Overall Study|Disease progression|52|||
161690666|NCT00326898|583918774|FG001|Overall Study|Disease progression|54|||
161690667|NCT00326898|583918775|FG002|Overall Study|Disease progression|102|||
161690668|NCT00326898|583918773|FG000|Overall Study|Adverse Event|124|||
161690669|NCT00326898|583918774|FG001|Overall Study|Adverse Event|128|||
161690670|NCT00326898|583918775|FG002|Overall Study|Adverse Event|33|||
161690671|NCT00326898|583918773|FG000|Overall Study|Death|2|||
161690672|NCT00326898|583918774|FG001|Overall Study|Death|0|||
161690673|NCT00326898|583918775|FG002|Overall Study|Death|0|||
161690674|NCT00326898|583918773|FG000|Overall Study|Withdrawal by Subject|134|||
161690675|NCT00326898|583918774|FG001|Overall Study|Withdrawal by Subject|128|||
161690676|NCT00326898|583918775|FG002|Overall Study|Withdrawal by Subject|32|||
161690677|NCT00326898|583918773|FG000|Overall Study|Alternative therapy|1|||
161690678|NCT00326898|583918774|FG001|Overall Study|Alternative therapy|0|||
161690679|NCT00326898|583918775|FG002|Overall Study|Alternative therapy|0|||
161690680|NCT00326898|583918773|FG000|Overall Study|Other complicating disease|5|||
161690681|NCT00326898|583918774|FG001|Overall Study|Other complicating disease|5|||
161690682|NCT00326898|583918775|FG002|Overall Study|Other complicating disease|4|||
161690683|NCT00326898|583918773|FG000|Overall Study|Other/Missing/Unknown|33|||
161690684|NCT00326898|583918774|FG001|Overall Study|Other/Missing/Unknown|28|||
161690685|NCT00326898|583918775|FG002|Overall Study|Other/Missing/Unknown|32|||
161690686|NCT03847987|583918776|FG000|Overall Study|Lost to Follow-up|1|||
161690687|NCT03847987|583918777|FG001|Overall Study|Lost to Follow-up|0|||
161690688|NCT03847987|583918776|FG000|Overall Study|Adverse Event|2|||
161690689|NCT03847987|583918777|FG001|Overall Study|Adverse Event|0|||
161690690|NCT02721355|583918780|FG000|Overall Study|Lost to Follow-up|6|||
161690691|NCT02721355|583918781|FG001|Overall Study|Lost to Follow-up|1|||
161690692|NCT00356278|583918782|FG000|Overall Study|Withdrawal by Subject|25|||
161690693|NCT00356278|583918783|FG001|Overall Study|Withdrawal by Subject|15|||
161690694|NCT00356278|583918784|FG002|Overall Study|Withdrawal by Subject|19|||
161690695|NCT00687362|583918791|FG000|Overall Study|Protocol Violation|2|||
161690696|NCT00687362|583918791|FG000|Overall Study|Withdrawal by Subject|1|||
161690697|NCT01268293|583918796|FG000|Overall Study|Disease progression|7|||
161690698|NCT01268293|583918796|FG000|Overall Study|Adverse Event|1|||
161690699|NCT01268293|583918796|FG000|Overall Study|Subject choice|1|||
161690700|NCT02597855|583918797|FG000|Overall Study|Lost to Follow-up|2|||
161690701|NCT02597855|583918798|FG001|Overall Study|Lost to Follow-up|1|||
161690702|NCT01777152|583918800|FG000|Overall Study|Withdrawal by Subject|22|||
161690703|NCT01777152|583918801|FG001|Overall Study|Withdrawal by Subject|16|||
161690704|NCT01777152|583918800|FG000|Overall Study|Lost to Follow-up|3|||
161690705|NCT01777152|583918801|FG001|Overall Study|Lost to Follow-up|5|||
161690706|NCT01777152|583918800|FG000|Overall Study|Death|68|||
161690707|NCT01777152|583918801|FG001|Overall Study|Death|89|||
161690708|NCT01777152|583918800|FG000|Overall Study|Not eligible, no study drug received|1|||
161690709|NCT01777152|583918801|FG001|Overall Study|Not eligible, no study drug received|0|||
161690710|NCT01777152|583918800|FG000|Overall Study|Change of diagnosis|1|||
161690711|NCT01777152|583918801|FG001|Overall Study|Change of diagnosis|0|||
161690712|NCT05882318|583918804|FG000|Overall Study|Withdrawal by Subject|1|||
161690713|NCT05882318|583918805|FG001|Overall Study|Withdrawal by Subject|0|||
161690714|NCT05882318|583918804|FG000|Overall Study|Protocol Violation|0|||
161690715|NCT05882318|583918805|FG001|Overall Study|Protocol Violation|1|||
161690716|NCT03042468|583918806|FG000|Overall Study|Death|0|||
161690717|NCT03042468|583918807|FG001|Overall Study|Death|1|||
161690718|NCT03042468|583918808|FG002|Overall Study|Death|1|||
161690719|NCT03042468|583918809|FG003|Overall Study|Death|0|||
161690720|NCT03042468|583918810|FG004|Overall Study|Death|0|||
161690721|NCT03042468|583918811|FG005|Overall Study|Death|0|||
161690722|NCT03042468|583918806|FG000|Overall Study|Withdrawal by Subject|0|||
161690723|NCT03042468|583918807|FG001|Overall Study|Withdrawal by Subject|0|||
161690724|NCT03042468|583918808|FG002|Overall Study|Withdrawal by Subject|0|||
161690725|NCT03042468|583918809|FG003|Overall Study|Withdrawal by Subject|0|||
161690726|NCT03042468|583918810|FG004|Overall Study|Withdrawal by Subject|0|||
161690727|NCT03042468|583918811|FG005|Overall Study|Withdrawal by Subject|1|||
161690728|NCT03042468|583918806|FG000|Overall Study|Lost to Follow-up|0|||
161690729|NCT03042468|583918807|FG001|Overall Study|Lost to Follow-up|0|||
161690730|NCT03042468|583918808|FG002|Overall Study|Lost to Follow-up|0|||
161690731|NCT03042468|583918809|FG003|Overall Study|Lost to Follow-up|0|||
161690732|NCT03042468|583918810|FG004|Overall Study|Lost to Follow-up|1|||
161690733|NCT03042468|583918811|FG005|Overall Study|Lost to Follow-up|1|||
161690734|NCT01485627|583918812|FG000|Overall Study|Patient withdrew|6|||
161690735|NCT01485627|583918813|FG001|Overall Study|Patient withdrew|5|||
161690736|NCT01485627|583918812|FG000|Overall Study|Patient died|3|||
161690737|NCT01485627|583918813|FG001|Overall Study|Patient died|1|||
161690738|NCT01485627|583918812|FG000|Overall Study|Patient lost to followup|0|||
161690739|NCT01485627|583918813|FG001|Overall Study|Patient lost to followup|1|||
161690740|NCT01485627|583918812|FG000|Overall Study|Caregiver withdrew|3|||
161690741|NCT01485627|583918813|FG001|Overall Study|Caregiver withdrew|3|||
161690742|NCT01485627|583918812|FG000|Overall Study|Caregiver lost to follow up|11|||
161690743|NCT01485627|583918813|FG001|Overall Study|Caregiver lost to follow up|12|||
161690744|NCT01485627|583918812|FG000|Overall Study|Caregiver died|1|||
161690745|NCT01485627|583918813|FG001|Overall Study|Caregiver died|0|||
161690746|NCT01485627|583918812|FG000|Overall Study|caregiver was not bereaved|42|||
161690747|NCT01485627|583918813|FG001|Overall Study|caregiver was not bereaved|35|||
161690748|NCT00267748|583918815|FG000|Non-randomized Period|Progressive disease|10|||
161690749|NCT00267748|583918816|FG001|Non-randomized Period|Progressive disease|0|||
161690750|NCT00267748|583918817|FG002|Non-randomized Period|Progressive disease|0|||
161690751|NCT00267748|583918815|FG000|Non-randomized Period|Adverse Event|8|||
161690752|NCT00267748|583918816|FG001|Non-randomized Period|Adverse Event|0|||
161690753|NCT00267748|583918817|FG002|Non-randomized Period|Adverse Event|0|||
161690754|NCT00267748|583918815|FG000|Non-randomized Period|Death|1|||
161690755|NCT00267748|583918816|FG001|Non-randomized Period|Death|0|||
161690756|NCT00267748|583918817|FG002|Non-randomized Period|Death|0|||
161690757|NCT00267748|583918815|FG000|Non-randomized Period|Participant not willing to participate|1|||
161690758|NCT00267748|583918816|FG001|Non-randomized Period|Participant not willing to participate|0|||
161690759|NCT00267748|583918817|FG002|Non-randomized Period|Participant not willing to participate|0|||
161690760|NCT00267748|583918815|FG000|Non-randomized Period|Other|3|||
161690761|NCT00267748|583918816|FG001|Non-randomized Period|Other|0|||
161690762|NCT00267748|583918817|FG002|Non-randomized Period|Other|0|||
161690763|NCT00267748|583918815|FG000|Randomized Period|Death|0|||
161690764|NCT00267748|583918816|FG001|Randomized Period|Death|2|||
161690765|NCT00267748|583918817|FG002|Randomized Period|Death|3|||
161690766|NCT00267748|583918815|FG000|Randomized Period|Adverse Event|0|||
161690767|NCT00267748|583918816|FG001|Randomized Period|Adverse Event|23|||
161690768|NCT00267748|583918817|FG002|Randomized Period|Adverse Event|25|||
161690769|NCT00267748|583918815|FG000|Randomized Period|Global deterioration of health status|0|||
161690770|NCT00267748|583918816|FG001|Randomized Period|Global deterioration of health status|6|||
161690771|NCT00267748|583918817|FG002|Randomized Period|Global deterioration of health status|7|||
161690772|NCT00267748|583918815|FG000|Randomized Period|Lost to Follow-up|0|||
161690773|NCT00267748|583918816|FG001|Randomized Period|Lost to Follow-up|1|||
161690774|NCT00267748|583918817|FG002|Randomized Period|Lost to Follow-up|0|||
161690775|NCT00267748|583918815|FG000|Randomized Period|Objective progression or relapse|0|||
161690776|NCT00267748|583918816|FG001|Randomized Period|Objective progression or relapse|77|||
161690777|NCT00267748|583918817|FG002|Randomized Period|Objective progression or relapse|86|||
161690778|NCT00267748|583918815|FG000|Randomized Period|Withdrawal by Subject|0|||
161690779|NCT00267748|583918816|FG001|Randomized Period|Withdrawal by Subject|9|||
161690780|NCT00267748|583918817|FG002|Randomized Period|Withdrawal by Subject|2|||
161690781|NCT00267748|583918815|FG000|Randomized Period|Other|0|||
161690782|NCT00267748|583918816|FG001|Randomized Period|Other|9|||
161690783|NCT00267748|583918817|FG002|Randomized Period|Other|6|||
161690784|NCT00267748|583918815|FG000|Randomized Period|randomized but not treated|0|||
161690785|NCT00267748|583918816|FG001|Randomized Period|randomized but not treated|0|||
161690786|NCT00267748|583918817|FG002|Randomized Period|randomized but not treated|3|||
161690787|NCT01665807|583918823|FG000|Overall Study|Withdrawal by Subject|2|||
161690788|NCT01665807|583918824|FG001|Overall Study|Withdrawal by Subject|0|||
161690789|NCT01665807|583918825|FG002|Overall Study|Withdrawal by Subject|1|||
161690790|NCT03603496|583918826|FG000|Overall Study|Death|19|||
161690791|NCT03603496|583918827|FG001|Overall Study|Death|24|||
161690792|NCT03603496|583918826|FG000|Overall Study|Lost to Follow-up|141|||
161690793|NCT03603496|583918827|FG001|Overall Study|Lost to Follow-up|141|||
161690794|NCT03603496|583918826|FG000|Overall Study|Withdrawal by Subject|26|||
161690795|NCT03603496|583918827|FG001|Overall Study|Withdrawal by Subject|20|||
161690796|NCT00004259|583918830|FG000|Overall Study|Protocol Violation|1|||
161690797|NCT00004259|583918831|FG001|Overall Study|Protocol Violation|2|||
161690798|NCT00004259|583918832|FG002|Overall Study|Protocol Violation|0|||
161690799|NCT00004259|583918833|FG003|Overall Study|Protocol Violation|0|||
161690800|NCT00004259|583918830|FG000|Overall Study|Withdrawal by Subject|0|||
161690801|NCT00004259|583918831|FG001|Overall Study|Withdrawal by Subject|2|||
161690802|NCT00004259|583918832|FG002|Overall Study|Withdrawal by Subject|0|||
161690803|NCT00004259|583918833|FG003|Overall Study|Withdrawal by Subject|0|||
161690804|NCT03594227|583918834|FG000|Overall Study|Adverse Event|2|||
161690805|NCT03594227|583918835|FG001|Overall Study|Adverse Event|1|||
161690806|NCT03594227|583918836|FG002|Overall Study|Adverse Event|0|||
161690807|NCT03594227|583918837|FG003|Overall Study|Adverse Event|2|||
161690808|NCT03594227|583918834|FG000|Overall Study|Lost to Follow-up|1|||
161690809|NCT03594227|583918835|FG001|Overall Study|Lost to Follow-up|1|||
161690810|NCT03594227|583918836|FG002|Overall Study|Lost to Follow-up|1|||
161690811|NCT03594227|583918837|FG003|Overall Study|Lost to Follow-up|0|||
161690812|NCT03594227|583918834|FG000|Overall Study|Withdrawal by Subject|1|||
161690813|NCT03594227|583918835|FG001|Overall Study|Withdrawal by Subject|1|||
161690814|NCT03594227|583918836|FG002|Overall Study|Withdrawal by Subject|1|||
161690815|NCT03594227|583918837|FG003|Overall Study|Withdrawal by Subject|1|||
161690816|NCT03594227|583918834|FG000|Overall Study|Pregnancy|0|||
161690817|NCT03594227|583918835|FG001|Overall Study|Pregnancy|1|||
161690818|NCT03594227|583918836|FG002|Overall Study|Pregnancy|0|||
161690819|NCT03594227|583918837|FG003|Overall Study|Pregnancy|0|||
161690820|NCT03594227|583918834|FG000|Overall Study|Sponsor Decision|0|||
161690821|NCT03594227|583918835|FG001|Overall Study|Sponsor Decision|0|||
161690822|NCT03594227|583918836|FG002|Overall Study|Sponsor Decision|0|||
161690823|NCT03594227|583918837|FG003|Overall Study|Sponsor Decision|1|||
161690824|NCT03594227|583918834|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
161690825|NCT03594227|583918835|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
161690826|NCT03594227|583918836|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
161690827|NCT03594227|583918837|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
161690828|NCT01618214|583918843|FG000|Overall Study|Adverse Event|3|||
161690829|NCT01618214|583918844|FG001|Overall Study|Adverse Event|1|||
161690830|NCT01618214|583918843|FG000|Overall Study|Lack of Efficacy|1|||
161690831|NCT01618214|583918844|FG001|Overall Study|Lack of Efficacy|1|||
161690832|NCT01618214|583918843|FG000|Overall Study|Protocol Violation|1|||
161690833|NCT01618214|583918844|FG001|Overall Study|Protocol Violation|4|||
161690834|NCT01618214|583918843|FG000|Overall Study|Withdrawal Criteria|1|||
161690835|NCT01618214|583918844|FG001|Overall Study|Withdrawal Criteria|2|||
161690836|NCT01618214|583918843|FG000|Overall Study|Unclassified|4|||
161690837|NCT01618214|583918844|FG001|Overall Study|Unclassified|5|||
161690838|NCT02937818|583918845|FG000|Overall Study|Participants decision|2|||
161690839|NCT02937818|583918846|FG001|Overall Study|Participants decision|1|||
161690840|NCT02937818|583918847|FG002|Overall Study|Participants decision|1|||
161690841|NCT02937818|583918848|FG003|Overall Study|Participants decision|1|||
161690842|NCT02937818|583918845|FG000|Overall Study|Adverse Event|2|||
161690843|NCT02937818|583918846|FG001|Overall Study|Adverse Event|4|||
161690844|NCT02937818|583918847|FG002|Overall Study|Adverse Event|1|||
161690845|NCT02937818|583918848|FG003|Overall Study|Adverse Event|1|||
161690846|NCT02937818|583918845|FG000|Overall Study|Disease progression|17|||
161690847|NCT02937818|583918846|FG001|Overall Study|Disease progression|15|||
161690848|NCT02937818|583918847|FG002|Overall Study|Disease progression|7|||
161690849|NCT02937818|583918848|FG003|Overall Study|Disease progression|19|||
161690850|NCT02937818|583918845|FG000|Overall Study|Condition under investigation worsened|0|||
161690851|NCT02937818|583918846|FG001|Overall Study|Condition under investigation worsened|0|||
161690852|NCT02937818|583918847|FG002|Overall Study|Condition under investigation worsened|1|||
161690853|NCT02937818|583918848|FG003|Overall Study|Condition under investigation worsened|0|||
161690854|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
161690855|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
161690856|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
161690857|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
161690858|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
161690859|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
161690860|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
161690861|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
161690862|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
161690863|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
161690864|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
161690865|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
161690866|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
161690867|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
161690868|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
161690869|NCT01508702|583918874|FG000|Overall Study|Adverse Event|7|||
161690870|NCT01508702|583918875|FG001|Overall Study|Adverse Event|3|||
161690871|NCT01508702|583918874|FG000|Overall Study|Gout flare|2|||
161690872|NCT01508702|583918875|FG001|Overall Study|Gout flare|0|||
161690873|NCT01508702|583918874|FG000|Overall Study|Protocol Violation|2|||
161690874|NCT01508702|583918875|FG001|Overall Study|Protocol Violation|1|||
161690875|NCT01508702|583918874|FG000|Overall Study|Lost to Follow-up|1|||
161690876|NCT01508702|583918875|FG001|Overall Study|Lost to Follow-up|2|||
161690877|NCT01508702|583918874|FG000|Overall Study|Withdrawal by Subject|11|||
161690878|NCT01508702|583918875|FG001|Overall Study|Withdrawal by Subject|7|||
161690879|NCT04472429|583918876|FG000|Randomized Period|Ongoing|90|||
161690880|NCT04472429|583918877|FG001|Randomized Period|Ongoing|40|||
161690881|NCT04472429|583918878|FG002|Randomized Period|Ongoing|0|||
161690882|NCT04472429|583918876|FG000|Randomized Period|Death|52|||
161690883|NCT04472429|583918877|FG001|Randomized Period|Death|37|||
161690884|NCT04472429|583918878|FG002|Randomized Period|Death|0|||
161690885|NCT04472429|583918876|FG000|Randomized Period|Lost to Follow-up|4|||
161690886|NCT04472429|583918877|FG001|Randomized Period|Lost to Follow-up|0|||
161690887|NCT04472429|583918878|FG002|Randomized Period|Lost to Follow-up|0|||
161690888|NCT04472429|583918876|FG000|Randomized Period|Physician Decision|1|||
161690889|NCT04472429|583918877|FG001|Randomized Period|Physician Decision|2|||
161690890|NCT04472429|583918878|FG002|Randomized Period|Physician Decision|0|||
161690891|NCT04472429|583918876|FG000|Randomized Period|Withdrawal by Subject|6|||
161690892|NCT04472429|583918877|FG001|Randomized Period|Withdrawal by Subject|5|||
161690893|NCT04472429|583918878|FG002|Randomized Period|Withdrawal by Subject|0|||
161690894|NCT04472429|583918876|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
161690895|NCT04472429|583918877|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
161690896|NCT04472429|583918878|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
161690897|NCT04472429|583918876|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
161690898|NCT04472429|583918877|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
161690899|NCT04472429|583918878|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
161690900|NCT04472429|583918876|FG000|Open-label Monotherapy Period|Ongoing|0|||
161690901|NCT04472429|583918877|FG001|Open-label Monotherapy Period|Ongoing|0|||
161690902|NCT04472429|583918878|FG002|Open-label Monotherapy Period|Ongoing|32|||
161690903|NCT04472429|583918876|FG000|Open-label Monotherapy Period|Death|0|||
161690904|NCT04472429|583918877|FG001|Open-label Monotherapy Period|Death|0|||
161690905|NCT04472429|583918878|FG002|Open-label Monotherapy Period|Death|35|||
161690906|NCT04472429|583918876|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
161690907|NCT04472429|583918877|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
161690908|NCT04472429|583918878|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
161690909|NCT01180660|583918879|FG000|Overall Study|Changed to open surgery|1|||
161690910|NCT01180660|583918880|FG001|Overall Study|Changed to open surgery|0|||
161690911|NCT00250835|583918881|FG000|Overall Study|Withdrawal by Subject|1|||
161690912|NCT03461757|583918882|FG000|Overall Study|Adverse Event|1|||
161690913|NCT03461757|583918883|FG001|Overall Study|Adverse Event|0|||
161690914|NCT03461757|583918882|FG000|Overall Study|Lost to Follow-up|13|||
161690915|NCT03461757|583918883|FG001|Overall Study|Lost to Follow-up|7|||
161690916|NCT03461757|583918882|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
161690917|NCT03461757|583918883|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
161690918|NCT03461757|583918882|FG000|Overall Study|Non-compliance with study treatment|0|||
161690919|NCT03461757|583918883|FG001|Overall Study|Non-compliance with study treatment|1|||
161690920|NCT03461757|583918882|FG000|Overall Study|Pregnancy|2|||
161690921|NCT03461757|583918883|FG001|Overall Study|Pregnancy|0|||
161690922|NCT03461757|583918882|FG000|Overall Study|Protocol Violation|1|||
161690923|NCT03461757|583918883|FG001|Overall Study|Protocol Violation|1|||
161690924|NCT03461757|583918882|FG000|Overall Study|Withdrawal by Subject|7|||
161690925|NCT03461757|583918883|FG001|Overall Study|Withdrawal by Subject|7|||
161690926|NCT03461757|583918882|FG000|Overall Study|Other Reasons|1|||
161690927|NCT03461757|583918883|FG001|Overall Study|Other Reasons|4|||
161690928|NCT03861559|583918884|FG000|Overall Study|Adverse Event|0|||
161690929|NCT03861559|583918885|FG001|Overall Study|Adverse Event|2|||
161690930|NCT03861559|583918884|FG000|Overall Study|Treatment failure|0|||
161690931|NCT03861559|583918885|FG001|Overall Study|Treatment failure|2|||
161690932|NCT03861559|583918884|FG000|Overall Study|Noncompliance|1|||
161690933|NCT03861559|583918885|FG001|Overall Study|Noncompliance|1|||
161690934|NCT03861559|583918884|FG000|Overall Study|Did not meet eligibility requirements|1|||
161690935|NCT03861559|583918885|FG001|Overall Study|Did not meet eligibility requirements|0|||
161690936|NCT02500121|583918888|FG000|Overall Study|Lost to Follow-up|0|||
161690937|NCT02500121|583918889|FG001|Overall Study|Lost to Follow-up|1|||
161690938|NCT02500121|583918888|FG000|Overall Study|Withdrawal by Subject|1|||
161690939|NCT02500121|583918889|FG001|Overall Study|Withdrawal by Subject|1|||
161690940|NCT02500121|583918888|FG000|Overall Study|Death|26|||
161690941|NCT02500121|583918889|FG001|Overall Study|Death|24|||
161690942|NCT04942925|583918891|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161690943|NCT04942925|583918892|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161690944|NCT04942925|583918891|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
161690945|NCT04942925|583918892|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
161690946|NCT02124564|583918893|FG000|Treatment Period|Adverse Event|2|||
161690947|NCT02124564|583918893|FG000|Treatment Period|Lack of Efficacy|3|||
161690948|NCT02124564|583918893|FG000|Treatment Period|Withdrawal by Subject|2|||
161690949|NCT04489888|583918894|FG000|Overall Study|Death|75|||
161690950|NCT04489888|583918894|FG000|Overall Study|Sponsor Decision|26|||
161690951|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
161690952|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
161690953|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
161690954|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
161690955|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
161690956|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
161690957|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690958|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690959|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690960|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690961|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
161690962|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
161690963|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
161690964|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
161690965|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
161690966|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
161690967|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
161690968|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
161690969|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161690970|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161690971|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
161690972|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
161690973|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
161690974|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
161690975|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
161690976|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
161690977|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
161690978|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
161690979|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
161690980|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
161690981|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690982|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690983|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690984|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690985|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
161690986|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161690987|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161690988|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161690989|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
161690990|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
161690991|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161690992|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161690993|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161690994|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
161690995|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
161690996|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161690997|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161690998|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161690999|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161691000|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
161691001|NCT00562588|583918908|FG000|Overall Study|Adverse Event|40|||
161691002|NCT00562588|583918909|FG001|Overall Study|Adverse Event|58|||
161691003|NCT00562588|583918908|FG000|Overall Study|Protocol Violation|30|||
161691004|NCT00562588|583918909|FG001|Overall Study|Protocol Violation|26|||
161691005|NCT00562588|583918908|FG000|Overall Study|Lost to Follow-up|12|||
161691006|NCT00562588|583918909|FG001|Overall Study|Lost to Follow-up|4|||
161691007|NCT00562588|583918908|FG000|Overall Study|Withdrawal by Subject|10|||
161691008|NCT00562588|583918909|FG001|Overall Study|Withdrawal by Subject|9|||
161691009|NCT00562588|583918908|FG000|Overall Study|Other|0|||
161691010|NCT00562588|583918909|FG001|Overall Study|Other|2|||
161691011|NCT03368170|583920512|FG000|Overall Study|Adverse Event|2|||
161691012|NCT03368170|583920513|FG001|Overall Study|Adverse Event|1|||
161691013|NCT03257267|583920519|FG000|Overall Study|Adverse Event|17|||
161691014|NCT03257267|583920520|FG001|Overall Study|Adverse Event|7|||
161691015|NCT03257267|583920519|FG000|Overall Study|Death|96|||
161691016|NCT03257267|583920520|FG001|Overall Study|Death|98|||
161691017|NCT03257267|583920519|FG000|Overall Study|Lost to Follow-up|2|||
161691018|NCT03257267|583920520|FG001|Overall Study|Lost to Follow-up|2|||
161691019|NCT03257267|583920519|FG000|Overall Study|Non-compliance with Study Drug|0|||
161691020|NCT03257267|583920520|FG001|Overall Study|Non-compliance with Study Drug|2|||
161691021|NCT03257267|583920519|FG000|Overall Study|Participant Decision|35|||
161691022|NCT03257267|583920520|FG001|Overall Study|Participant Decision|43|||
161691023|NCT03257267|583920519|FG000|Overall Study|Sponsor Decision|1|||
161691024|NCT03257267|583920520|FG001|Overall Study|Sponsor Decision|0|||
161691025|NCT03257267|583920519|FG000|Overall Study|Physician Decision|1|||
161691026|NCT03257267|583920520|FG001|Overall Study|Physician Decision|3|||
161691027|NCT03257267|583920519|FG000|Overall Study|Disease Progression|109|||
161691028|NCT03257267|583920520|FG001|Overall Study|Disease Progression|121|||
161691029|NCT03257267|583920519|FG000|Overall Study|Withdrawal by Subject|8|||
161691030|NCT03257267|583920520|FG001|Overall Study|Withdrawal by Subject|26|||
161691031|NCT03257267|583920519|FG000|Overall Study|Other|0|||
161691032|NCT03257267|583920520|FG001|Overall Study|Other|2|||
161691033|NCT03445000|583920521|FG000|Overall Study|Disease progression|8|||
161691034|NCT03445000|583920521|FG000|Overall Study|Adverse Event|3|||
161691035|NCT03445000|583920521|FG000|Overall Study|Death|2|||
161691036|NCT03445000|583920521|FG000|Overall Study|Physician Decision|1|||
161691037|NCT01982292|583920522|FG000|Overall Study|Adverse Event|2|||
161691038|NCT01982292|583920523|FG001|Overall Study|Adverse Event|0|||
161691039|NCT01982292|583920522|FG000|Overall Study|Death|1|||
161691040|NCT01982292|583920523|FG001|Overall Study|Death|0|||
161691041|NCT01982292|583920522|FG000|Overall Study|Lost to Follow-up|2|||
161691042|NCT01982292|583920523|FG001|Overall Study|Lost to Follow-up|0|||
161691043|NCT01982292|583920522|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
161691044|NCT01982292|583920523|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
161691045|NCT01982292|583920522|FG000|Overall Study|Protocol Deviation|1|||
161691046|NCT01982292|583920523|FG001|Overall Study|Protocol Deviation|0|||
161691047|NCT01982292|583920522|FG000|Overall Study|Patient/Guardian Decision|3|||
161691048|NCT01982292|583920523|FG001|Overall Study|Patient/Guardian Decision|1|||
161691049|NCT01982292|583920522|FG000|Overall Study|Technical Problems|2|||
161691050|NCT01982292|583920523|FG001|Overall Study|Technical Problems|0|||
161691051|NCT03409744|583920524|FG000|Overall Study|Death|2|||
161691052|NCT03409744|583920524|FG000|Overall Study|Physician Decision|5|||
161691053|NCT03409744|583920524|FG000|Overall Study|Pregnancy|1|||
161691054|NCT03409744|583920524|FG000|Overall Study|Lost to Follow-up|1|||
161691055|NCT03409744|583920524|FG000|Overall Study|Protocol Violation|1|||
161691056|NCT04872101|583920525|FG000|Overall Study|Withdrawal by Subject|10|||
161691057|NCT04872101|583920526|FG001|Overall Study|Withdrawal by Subject|16|||
161691058|NCT04872101|583920525|FG000|Overall Study|Lack of Efficacy|6|||
161691059|NCT04872101|583920526|FG001|Overall Study|Lack of Efficacy|14|||
161691060|NCT04872101|583920525|FG000|Overall Study|Adverse Event|1|||
161691061|NCT04872101|583920526|FG001|Overall Study|Adverse Event|6|||
161691062|NCT04872101|583920525|FG000|Overall Study|Lost to Follow-up|2|||
161691063|NCT04872101|583920526|FG001|Overall Study|Lost to Follow-up|1|||
161691064|NCT04872101|583920525|FG000|Overall Study|Pregnancy|2|||
161691065|NCT04872101|583920526|FG001|Overall Study|Pregnancy|0|||
161691066|NCT04872101|583920525|FG000|Overall Study|Prohibited Medication|1|||
161691067|NCT04872101|583920526|FG001|Overall Study|Prohibited Medication|0|||
161691068|NCT04872101|583920525|FG000|Overall Study|Not dosed|1|||
161691069|NCT04872101|583920526|FG001|Overall Study|Not dosed|0|||
161691070|NCT05804877|583920527|FG000|Overall Study|Lost to Follow-up|1|||
161691071|NCT05804877|583920528|FG001|Overall Study|Lost to Follow-up|3|||
161691072|NCT05804877|583920527|FG000|Overall Study|Withdrawal by Subject|1|||
161691073|NCT05804877|583920528|FG001|Overall Study|Withdrawal by Subject|0|||
161691074|NCT05804877|583920527|FG000|Overall Study|Withdrawal by Subject|1|||
161691075|NCT05804877|583920528|FG001|Overall Study|Withdrawal by Subject|0|||
161691076|NCT00879229|583920529|FG000|Overall Study|Study terminated by Sponsor|13|||
161691077|NCT00879229|583920530|FG001|Overall Study|Study terminated by Sponsor|12|||
161691078|NCT00879229|583920529|FG000|Overall Study|Death|4|||
161691079|NCT00879229|583920530|FG001|Overall Study|Death|2|||
161691080|NCT00879229|583920529|FG000|Overall Study|Adverse Event|2|||
161691081|NCT00879229|583920530|FG001|Overall Study|Adverse Event|0|||
161691082|NCT00879229|583920529|FG000|Overall Study|Withdrawal by Subject|1|||
161691083|NCT00879229|583920530|FG001|Overall Study|Withdrawal by Subject|0|||
161691084|NCT00879229|583920529|FG000|Overall Study|Clinical status did not improve|1|||
161691085|NCT00879229|583920530|FG001|Overall Study|Clinical status did not improve|0|||
161691086|NCT00879229|583920529|FG000|Overall Study|Other|1|||
161691087|NCT00879229|583920530|FG001|Overall Study|Other|0|||
161691088|NCT00264004|583920531|FG000|Overall Study|Adverse Event|2|||
161691089|NCT00264004|583920532|FG001|Overall Study|Adverse Event|3|||
161691090|NCT00264004|583920533|FG002|Overall Study|Adverse Event|6|||
161691091|NCT00264004|583920534|FG003|Overall Study|Adverse Event|4|||
161691092|NCT00264004|583920531|FG000|Overall Study|Withdrawal by Subject|0|||
161691093|NCT00264004|583920532|FG001|Overall Study|Withdrawal by Subject|1|||
161691094|NCT00264004|583920533|FG002|Overall Study|Withdrawal by Subject|2|||
161691095|NCT00264004|583920534|FG003|Overall Study|Withdrawal by Subject|2|||
161691096|NCT00264004|583920531|FG000|Overall Study|Other|2|||
161691097|NCT00264004|583920532|FG001|Overall Study|Other|2|||
161691098|NCT00264004|583920533|FG002|Overall Study|Other|0|||
161691099|NCT00264004|583920534|FG003|Overall Study|Other|3|||
161691100|NCT00264004|583920531|FG000|Overall Study|Development study specific disc. crit.|1|||
161691101|NCT00264004|583920532|FG001|Overall Study|Development study specific disc. crit.|0|||
161691102|NCT00264004|583920533|FG002|Overall Study|Development study specific disc. crit.|1|||
161691103|NCT00264004|583920534|FG003|Overall Study|Development study specific disc. crit.|0|||
161691104|NCT00264004|583920531|FG000|Overall Study|Cond. under inv. worsened|9|||
161691105|NCT00264004|583920532|FG001|Overall Study|Cond. under inv. worsened|5|||
161691106|NCT00264004|583920533|FG002|Overall Study|Cond. under inv. worsened|3|||
161691107|NCT00264004|583920534|FG003|Overall Study|Cond. under inv. worsened|4|||
161691108|NCT00264004|583920531|FG000|Overall Study|Not treated|3|||
161691109|NCT00264004|583920532|FG001|Overall Study|Not treated|0|||
161691110|NCT00264004|583920533|FG002|Overall Study|Not treated|2|||
161691111|NCT00264004|583920534|FG003|Overall Study|Not treated|2|||
161691112|NCT02475681|583920535|FG000|Overall Study|Death|16|||
161691113|NCT02475681|583920536|FG001|Overall Study|Death|6|||
161691114|NCT02475681|583920537|FG002|Overall Study|Death|9|||
161691115|NCT02475681|583920535|FG000|Overall Study|Physician Decision|0|||
161691116|NCT02475681|583920536|FG001|Overall Study|Physician Decision|3|||
161691117|NCT02475681|583920537|FG002|Overall Study|Physician Decision|1|||
161691118|NCT02475681|583920535|FG000|Overall Study|Withdrawal by Subject|12|||
161691119|NCT02475681|583920536|FG001|Overall Study|Withdrawal by Subject|6|||
161691120|NCT02475681|583920537|FG002|Overall Study|Withdrawal by Subject|9|||
161691121|NCT02475681|583920535|FG000|Overall Study|Lost to Follow-up|2|||
161691122|NCT02475681|583920536|FG001|Overall Study|Lost to Follow-up|1|||
161691123|NCT02475681|583920537|FG002|Overall Study|Lost to Follow-up|3|||
161691124|NCT02475681|583920535|FG000|Overall Study|Ongoing in Study|0|||
161691125|NCT02475681|583920536|FG001|Overall Study|Ongoing in Study|163|||
161691126|NCT02475681|583920537|FG002|Overall Study|Ongoing in Study|157|||
161691127|NCT02475681|583920535|FG000|Overall Study|Reasons other than above listed|2|||
161691128|NCT02475681|583920536|FG001|Overall Study|Reasons other than above listed|0|||
161691129|NCT02475681|583920537|FG002|Overall Study|Reasons other than above listed|0|||
161691130|NCT00527605|583920544|FG000|Overall Study|Adverse Event|3|||
161691131|NCT00527605|583920545|FG001|Overall Study|Adverse Event|0|||
161691132|NCT00527605|583920544|FG000|Overall Study|Withdrawal by Subject|3|||
161691133|NCT00527605|583920545|FG001|Overall Study|Withdrawal by Subject|7|||
161691134|NCT00527605|583920544|FG000|Overall Study|Lost to Follow-up|6|||
161691135|NCT00527605|583920545|FG001|Overall Study|Lost to Follow-up|2|||
161691136|NCT00527605|583920544|FG000|Overall Study|Protocol Violation|1|||
161691137|NCT00527605|583920545|FG001|Overall Study|Protocol Violation|2|||
161691138|NCT01363986|583920549|FG000|Overall Study|Disease progression|1|||
161691139|NCT01637142|583920550|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
161691140|NCT02605642|583920551|FG000|Overall Study|Other|11|||
161691141|NCT02605642|583920552|FG001|Overall Study|Other|1|||
161691142|NCT02605642|583920551|FG000|Overall Study|Participant non-compliance|2|||
161691143|NCT02605642|583920552|FG001|Overall Study|Participant non-compliance|4|||
161691144|NCT02605642|583920551|FG000|Overall Study|Physician Decision|10|||
161691145|NCT02605642|583920552|FG001|Overall Study|Physician Decision|0|||
161691146|NCT02605642|583920551|FG000|Overall Study|Lost to Follow-up|12|||
161691147|NCT02605642|583920552|FG001|Overall Study|Lost to Follow-up|1|||
161691148|NCT02605642|583920551|FG000|Overall Study|Adverse Event|14|||
161691149|NCT02605642|583920552|FG001|Overall Study|Adverse Event|2|||
161691150|NCT02605642|583920551|FG000|Overall Study|Withdrawal by Subject|23|||
161691151|NCT02605642|583920552|FG001|Overall Study|Withdrawal by Subject|2|||
161691152|NCT02605642|583920551|FG000|Overall Study|Lack of response|24|||
161691153|NCT02605642|583920552|FG001|Overall Study|Lack of response|11|||
161691154|NCT02111564|583920555|FG000|Overall Study|Death|109|||
161691155|NCT02111564|583920556|FG001|Overall Study|Death|120|||
161691156|NCT02111564|583920555|FG000|Overall Study|Lost to Follow-up|2|||
161691157|NCT02111564|583920556|FG001|Overall Study|Lost to Follow-up|3|||
161691158|NCT02111564|583920555|FG000|Overall Study|Withdrawal by Subject|20|||
161691159|NCT02111564|583920556|FG001|Overall Study|Withdrawal by Subject|20|||
161691160|NCT03704194|583920565|FG000|Overall Study|Withdrawal by Subject|0|||
161691161|NCT03704194|583920566|FG001|Overall Study|Withdrawal by Subject|1|||
161691162|NCT00925015|583920567|FG000|Overall Study|Adverse Event|1|||
161691163|NCT00925015|583920568|FG001|Overall Study|Adverse Event|2|||
161691164|NCT00925015|583920569|FG002|Overall Study|Adverse Event|1|||
161691165|NCT00925015|583920567|FG000|Overall Study|Physician Decision|0|||
161691166|NCT00925015|583920568|FG001|Overall Study|Physician Decision|1|||
161691167|NCT00925015|583920569|FG002|Overall Study|Physician Decision|0|||
161836342|NCT03395639|584442941|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
161836343|NCT03395639|584442942|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
161691168|NCT00925015|583920567|FG000|Overall Study|Progressive Disease|7|||
161691169|NCT00925015|583920568|FG001|Overall Study|Progressive Disease|3|||
161691170|NCT00925015|583920569|FG002|Overall Study|Progressive Disease|4|||
161836344|NCT03395639|584442943|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
161691171|NCT00925015|583920567|FG000|Overall Study|Withdrawal by Subject|0|||
161691172|NCT00925015|583920568|FG001|Overall Study|Withdrawal by Subject|0|||
161691173|NCT00925015|583920569|FG002|Overall Study|Withdrawal by Subject|1|||
161651970|NCT02383940|583777320|FG000|Overall Study|Lost to Follow-up|2|||
161651971|NCT02383940|583777321|FG001|Overall Study|Lost to Follow-up|2|||
161651972|NCT02383940|583777320|FG000|Overall Study|Physician Decision|2|||
161651973|NCT02383940|583777321|FG001|Overall Study|Physician Decision|0|||
161651974|NCT02383940|583777320|FG000|Overall Study|Withdrawal by Subject|1|||
161651975|NCT02383940|583777321|FG001|Overall Study|Withdrawal by Subject|1|||
161651976|NCT02383940|583777320|FG000|Overall Study|Randomized but not treated|2|||
161651977|NCT02383940|583777321|FG001|Overall Study|Randomized but not treated|0|||
161651978|NCT02383940|583777320|FG000|Overall Study|Other than specified above|1|||
161651979|NCT02383940|583777321|FG001|Overall Study|Other than specified above|0|||
161651980|NCT01517295|583777322|FG000|Overall Study|Physician Decision|1|||
161651981|NCT01517295|583777323|FG001|Overall Study|Physician Decision|0|||
161651982|NCT00565773|583777324|FG000|Overall Study|Withdrawal by Subject|1|||
161651983|NCT00565773|583777324|FG000|Overall Study|Physician Decision|1|||
161651984|NCT03853551|583777325|FG000|Overall Study|Death|2|||
161651985|NCT03853551|583777325|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
161651986|NCT01923467|583777328|FG000|Overall Study|Lost to Follow-up|62|||
161651987|NCT01923467|583777328|FG000|Overall Study|Subject non-interest|479|||
161651988|NCT01075958|583777329|FG000|Overall Study|Blood sample could not be obtained|44|||
161651989|NCT01240915|583777332|FG000|Overall Study|Adverse Event|0|||
161651990|NCT01240915|583777333|FG001|Overall Study|Adverse Event|0|||
161651991|NCT01240915|583777334|FG002|Overall Study|Adverse Event|0|||
161651992|NCT01240915|583777335|FG003|Overall Study|Adverse Event|1|||
161651993|NCT01240915|583777336|FG004|Overall Study|Adverse Event|0|||
161651994|NCT01240915|583777337|FG005|Overall Study|Adverse Event|2|||
161651995|NCT01240915|583777338|FG006|Overall Study|Adverse Event|0|||
161651996|NCT01240915|583777339|FG007|Overall Study|Adverse Event|0|||
161651997|NCT01240915|583777340|FG008|Overall Study|Adverse Event|1|||
161651998|NCT01240915|583777332|FG000|Overall Study|Lost to Follow-up|0|||
161651999|NCT01240915|583777333|FG001|Overall Study|Lost to Follow-up|0|||
161652000|NCT01240915|583777334|FG002|Overall Study|Lost to Follow-up|0|||
161652001|NCT01240915|583777335|FG003|Overall Study|Lost to Follow-up|0|||
161652002|NCT01240915|583777336|FG004|Overall Study|Lost to Follow-up|1|||
161652003|NCT01240915|583777337|FG005|Overall Study|Lost to Follow-up|1|||
161652004|NCT01240915|583777338|FG006|Overall Study|Lost to Follow-up|0|||
161652005|NCT01240915|583777339|FG007|Overall Study|Lost to Follow-up|1|||
161652006|NCT01240915|583777340|FG008|Overall Study|Lost to Follow-up|1|||
161652007|NCT01240915|583777332|FG000|Overall Study|Withdrawal by Subject|2|||
161652008|NCT01240915|583777333|FG001|Overall Study|Withdrawal by Subject|1|||
161652009|NCT01240915|583777334|FG002|Overall Study|Withdrawal by Subject|0|||
161652010|NCT01240915|583777335|FG003|Overall Study|Withdrawal by Subject|2|||
161652011|NCT01240915|583777336|FG004|Overall Study|Withdrawal by Subject|0|||
161652012|NCT01240915|583777337|FG005|Overall Study|Withdrawal by Subject|4|||
161652013|NCT01240915|583777338|FG006|Overall Study|Withdrawal by Subject|2|||
161652014|NCT01240915|583777339|FG007|Overall Study|Withdrawal by Subject|3|||
161652015|NCT01240915|583777340|FG008|Overall Study|Withdrawal by Subject|3|||
161652016|NCT01240915|583777332|FG000|Overall Study|Other|0|||
161652017|NCT01240915|583777333|FG001|Overall Study|Other|0|||
161652018|NCT01240915|583777334|FG002|Overall Study|Other|0|||
161652019|NCT01240915|583777335|FG003|Overall Study|Other|0|||
161652020|NCT01240915|583777336|FG004|Overall Study|Other|2|||
161652021|NCT01240915|583777337|FG005|Overall Study|Other|0|||
161652022|NCT01240915|583777338|FG006|Overall Study|Other|0|||
161652023|NCT01240915|583777339|FG007|Overall Study|Other|0|||
161652024|NCT01240915|583777340|FG008|Overall Study|Other|0|||
161652025|NCT01240915|583777332|FG000|Overall Study|Insufficient Clinical Response|0|||
161652026|NCT01240915|583777333|FG001|Overall Study|Insufficient Clinical Response|0|||
161652027|NCT01240915|583777334|FG002|Overall Study|Insufficient Clinical Response|0|||
161652028|NCT01240915|583777335|FG003|Overall Study|Insufficient Clinical Response|0|||
161652029|NCT01240915|583777336|FG004|Overall Study|Insufficient Clinical Response|1|||
161652030|NCT01240915|583777337|FG005|Overall Study|Insufficient Clinical Response|3|||
161652031|NCT01240915|583777338|FG006|Overall Study|Insufficient Clinical Response|6|||
161691174|NCT00179309|583920576|FG000|Treatment|Toxicity|2|||
161652032|NCT01240915|583777339|FG007|Overall Study|Insufficient Clinical Response|0|||
161652033|NCT01240915|583777340|FG008|Overall Study|Insufficient Clinical Response|3|||
161652034|NCT02574845|583777344|FG000|Overall Study|Consent withdrawn further participation|0|||
161652035|NCT02574845|583777345|FG001|Overall Study|Consent withdrawn further participation|0|||
161652036|NCT02574845|583777346|FG002|Overall Study|Consent withdrawn further participation|0|||
161652037|NCT02574845|583777347|FG003|Overall Study|Consent withdrawn further participation|0|||
161691175|NCT00179309|583920577|FG001|Treatment|Toxicity|3|||
161691176|NCT00179309|583920576|FG000|Treatment|Withdrawal by Subject|1|||
161691177|NCT00179309|583920577|FG001|Treatment|Withdrawal by Subject|2|||
161691178|NCT00179309|583920576|FG000|Treatment|Allergy|1|||
161691179|NCT00179309|583920577|FG001|Treatment|Allergy|0|||
161691180|NCT04986202|583920578|FG000|Overall Study|Death|10|||
161691181|NCT04986202|583920579|FG001|Overall Study|Death|3|||
161691182|NCT04986202|583920580|FG002|Overall Study|Death|10|||
161691183|NCT04986202|583920578|FG000|Overall Study|Physician Decision|3|||
161691184|NCT04986202|583920579|FG001|Overall Study|Physician Decision|1|||
161691185|NCT04986202|583920580|FG002|Overall Study|Physician Decision|2|||
161691186|NCT04986202|583920578|FG000|Overall Study|Withdrawal by Subject|4|||
161691187|NCT04986202|583920579|FG001|Overall Study|Withdrawal by Subject|2|||
161691188|NCT04986202|583920580|FG002|Overall Study|Withdrawal by Subject|4|||
161691189|NCT05131204|583920581|FG000|Overall Study|Sponsor request|2|||
161691190|NCT05131204|583920582|FG001|Overall Study|Sponsor request|1|||
161691191|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
161691192|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
161691193|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
161691194|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
161691195|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
161691196|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
161691197|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
161691198|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
161691199|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
161691200|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
161691201|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
161691202|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
161691203|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
161691204|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
161691205|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
161691206|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
161691207|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
161691208|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
161691209|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
161691210|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
161691211|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
161691212|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
161691213|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
161691214|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
161691215|NCT03446885|583920587|FG000|Overall Study|Lost to Follow-up|1|||
161691216|NCT03446885|583920588|FG001|Overall Study|Lost to Follow-up|0|||
161691217|NCT03446885|583920587|FG000|Overall Study|Did not complete entire visit|1|||
161691218|NCT03446885|583920588|FG001|Overall Study|Did not complete entire visit|0|||
161691219|NCT03823391|583920592|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
161691220|NCT03823391|583920593|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
161691221|NCT03823391|583920592|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
161691222|NCT03823391|583920593|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
161691223|NCT05030311|583920595|FG000|Overall Study|Technical problems|0|||
161691224|NCT05030311|583920596|FG001|Overall Study|Technical problems|1|||
161691225|NCT05030311|583920595|FG000|Overall Study|Withdrawal by Subject|31|||
161691226|NCT05030311|583920596|FG001|Overall Study|Withdrawal by Subject|17|||
161691227|NCT05030311|583920595|FG000|Overall Study|Adverse Event|13|||
161691228|NCT05030311|583920596|FG001|Overall Study|Adverse Event|5|||
161691229|NCT05030311|583920595|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161691230|NCT05030311|583920596|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161691231|NCT05030311|583920595|FG000|Overall Study|Physician Decision|5|||
161691232|NCT05030311|583920596|FG001|Overall Study|Physician Decision|2|||
161691233|NCT05030311|583920595|FG000|Overall Study|Lost to Follow-up|5|||
161691234|NCT05030311|583920596|FG001|Overall Study|Lost to Follow-up|1|||
161691235|NCT05030311|583920595|FG000|Overall Study|Protocol Violation|4|||
161691236|NCT05030311|583920596|FG001|Overall Study|Protocol Violation|4|||
161691237|NCT01425203|583920597|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
161691238|NCT01425203|583920598|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
161691239|NCT01425203|583920599|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
161691240|NCT01425203|583920597|FG000|Treatment Phase|Failure at futility timepoint|8|||
161691241|NCT01425203|583920598|FG001|Treatment Phase|Failure at futility timepoint|27|||
161691242|NCT01425203|583920599|FG002|Treatment Phase|Failure at futility timepoint|0|||
161691243|NCT01425203|583920597|FG000|Treatment Phase|Other virologic failure criteria|5|||
161691244|NCT01425203|583920598|FG001|Treatment Phase|Other virologic failure criteria|3|||
161691245|NCT01425203|583920599|FG002|Treatment Phase|Other virologic failure criteria|0|||
161691246|NCT01425203|583920597|FG000|Treatment Phase|Unidentified reasons|11|||
161691247|NCT01425203|583920598|FG001|Treatment Phase|Unidentified reasons|5|||
161691248|NCT01425203|583920599|FG002|Treatment Phase|Unidentified reasons|0|||
161691249|NCT01425203|583920597|FG000|Treatment Phase|Did not receive treatment|0|||
161691250|NCT01425203|583920598|FG001|Treatment Phase|Did not receive treatment|1|||
161691251|NCT01425203|583920599|FG002|Treatment Phase|Did not receive treatment|0|||
161691252|NCT01425203|583920597|FG000|Crossover Phase|Failure at futility timepoint|0|||
161691253|NCT01425203|583920598|FG001|Crossover Phase|Failure at futility timepoint|0|||
161691254|NCT01425203|583920599|FG002|Crossover Phase|Failure at futility timepoint|3|||
161691255|NCT01425203|583920597|FG000|Crossover Phase|Other virologic failure criteria|0|||
161691256|NCT01425203|583920598|FG001|Crossover Phase|Other virologic failure criteria|0|||
161691257|NCT01425203|583920599|FG002|Crossover Phase|Other virologic failure criteria|3|||
161691258|NCT00290433|583920602|FG000|Overall Study|Disease Progression|13|||
161691259|NCT00290433|583920602|FG000|Overall Study|Adverse Event|14|||
161691260|NCT00290433|583920602|FG000|Overall Study|Withdrawal by Subject|1|||
161691261|NCT00290433|583920602|FG000|Overall Study|Non-Compliance|1|||
161691262|NCT00290433|583920602|FG000|Overall Study|Congestive Heart Failure|1|||
161691263|NCT00290433|583920602|FG000|Overall Study|Transplant in CR|5|||
161691264|NCT00290433|583920602|FG000|Overall Study|Unrelated Infection/Death|1|||
161691265|NCT02264990|583920607|FG000|Overall Study|Death|255|||
161691266|NCT02264990|583920608|FG001|Overall Study|Death|250|||
161691267|NCT02264990|583920607|FG000|Overall Study|Withdrawal by Subject|4|||
161691268|NCT02264990|583920608|FG001|Overall Study|Withdrawal by Subject|5|||
161691269|NCT02264990|583920607|FG000|Overall Study|Lost to Follow-up|1|||
161691270|NCT02264990|583920608|FG001|Overall Study|Lost to Follow-up|3|||
161691271|NCT02264990|583920607|FG000|Overall Study|Other|0|||
161691272|NCT02264990|583920608|FG001|Overall Study|Other|1|||
161691273|NCT03031301|583920609|FG000|Overall Study|Protocol Violation|4|||
161691274|NCT03031301|583920610|FG001|Overall Study|Protocol Violation|8|||
161691275|NCT03031301|583920609|FG000|Overall Study|Withdrawal by Subject|7|||
161691276|NCT03031301|583920610|FG001|Overall Study|Withdrawal by Subject|4|||
161691277|NCT03031301|583920609|FG000|Overall Study|Lost to Follow-up|4|||
161691278|NCT03031301|583920610|FG001|Overall Study|Lost to Follow-up|12|||
161691279|NCT03031301|583920609|FG000|Overall Study|Noncompliance|1|||
161691280|NCT03031301|583920610|FG001|Overall Study|Noncompliance|3|||
161691281|NCT03031301|583920609|FG000|Overall Study|Technical issue|1|||
161691282|NCT03031301|583920610|FG001|Overall Study|Technical issue|1|||
161691283|NCT03031301|583920609|FG000|Overall Study|Adverse Event|1|||
161691284|NCT03031301|583920610|FG001|Overall Study|Adverse Event|0|||
161691285|NCT02275338|583920612|FG000|Overall Study|Adverse Event|15|||
161691286|NCT02275338|583920612|FG000|Overall Study|Lack of Efficacy|3|||
161691287|NCT02275338|583920612|FG000|Overall Study|Withdrawal by Subject|4|||
161691288|NCT02275338|583920612|FG000|Overall Study|Disease progression (death)|1|||
161691289|NCT02275338|583920612|FG000|Overall Study|Ineligible to start Phase 2|4|||
161691290|NCT02275338|583920612|FG000|Overall Study|Reason not specified|5|||
161691291|NCT02275338|583920612|FG000|Overall Study|Does not meet entry criteria|1|||
161691292|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
161691293|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
161691294|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
161691295|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
161691296|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
161691297|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
161691298|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
161691299|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
161691300|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
161691301|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
161691302|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
161691303|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
161691304|NCT00109707|583920617|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
161691305|NCT00109707|583920618|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
161691306|NCT00109707|583920619|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
161691307|NCT00109707|583920617|FG000|Overall Study|Abnormal laboratory values|1|||
161691308|NCT00109707|583920618|FG001|Overall Study|Abnormal laboratory values|0|||
161691309|NCT00109707|583920619|FG002|Overall Study|Abnormal laboratory values|0|||
161691310|NCT00109707|583920617|FG000|Overall Study|Administrative problems|2|||
161691311|NCT00109707|583920618|FG001|Overall Study|Administrative problems|0|||
161691312|NCT00109707|583920619|FG002|Overall Study|Administrative problems|1|||
161691313|NCT00109707|583920617|FG000|Overall Study|Adverse Event|10|||
161691314|NCT00109707|583920618|FG001|Overall Study|Adverse Event|2|||
161691315|NCT00109707|583920619|FG002|Overall Study|Adverse Event|3|||
161691316|NCT00109707|583920617|FG000|Overall Study|Death|4|||
161691317|NCT00109707|583920618|FG001|Overall Study|Death|0|||
161691318|NCT00109707|583920619|FG002|Overall Study|Death|0|||
161691319|NCT00109707|583920617|FG000|Overall Study|Disease progression|12|||
161691320|NCT00109707|583920618|FG001|Overall Study|Disease progression|4|||
161691321|NCT00109707|583920619|FG002|Overall Study|Disease progression|3|||
161691322|NCT00109707|583920617|FG000|Overall Study|Lost to Follow-up|3|||
161691323|NCT00109707|583920618|FG001|Overall Study|Lost to Follow-up|0|||
161691324|NCT00109707|583920619|FG002|Overall Study|Lost to Follow-up|0|||
161691325|NCT00109707|583920617|FG000|Overall Study|Protocol Violation|1|||
161691326|NCT00109707|583920618|FG001|Overall Study|Protocol Violation|0|||
161691327|NCT00109707|583920619|FG002|Overall Study|Protocol Violation|0|||
161691328|NCT00109707|583920617|FG000|Overall Study|Patient withdrew consent|6|||
161691329|NCT00109707|583920618|FG001|Overall Study|Patient withdrew consent|1|||
161691330|NCT00109707|583920619|FG002|Overall Study|Patient withdrew consent|0|||
161691331|NCT00623428|583920628|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
161691332|NCT00623428|583920629|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
161691333|NCT00623428|583920628|FG000|Treatment Period|Death|0|||
161691334|NCT00623428|583920629|FG001|Treatment Period|Death|1|||
161691335|NCT00623428|583920628|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
161691336|NCT00623428|583920629|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
161691337|NCT00623428|583920628|FG000|Treatment Period|Insufficient therapeutic response|0|||
161691338|NCT00623428|583920629|FG001|Treatment Period|Insufficient therapeutic response|2|||
161691339|NCT00623428|583920628|FG000|Treatment Period|Other|0|||
161691340|NCT00623428|583920629|FG001|Treatment Period|Other|1|||
161691341|NCT00623428|583920628|FG000|Treatment Period|Withdrawal by Subject|0|||
161691342|NCT00623428|583920629|FG001|Treatment Period|Withdrawal by Subject|1|||
161691343|NCT00623428|583920628|FG000|Follow-up Period|Relapse post-treatment|11|||
161691344|NCT00623428|583920629|FG001|Follow-up Period|Relapse post-treatment|3|||
161691345|NCT00623428|583920628|FG000|Follow-up Period|Failure to return|10|||
161691346|NCT00623428|583920629|FG001|Follow-up Period|Failure to return|2|||
161691347|NCT00623428|583920628|FG000|Follow-up Period|Patient withdrew consent|5|||
161691348|NCT00623428|583920629|FG001|Follow-up Period|Patient withdrew consent|4|||
161691349|NCT00623428|583920628|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
161691350|NCT00623428|583920629|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
161691351|NCT00623428|583920628|FG000|Follow-up Period|Did not cooperate|0|||
161691352|NCT00623428|583920629|FG001|Follow-up Period|Did not cooperate|3|||
161691353|NCT00623428|583920628|FG000|Follow-up Period|Reason not specified|1|||
161691354|NCT00623428|583920629|FG001|Follow-up Period|Reason not specified|1|||
161691355|NCT00623428|583920628|FG000|Follow-up Period|Death|0|||
161691356|NCT00623428|583920629|FG001|Follow-up Period|Death|1|||
161691357|NCT01692301|583920630|FG000|Overall Study|Adverse Event|15|||
161691358|NCT01692301|583920631|FG001|Overall Study|Adverse Event|12|||
161691359|NCT01692301|583920630|FG000|Overall Study|Death|1|||
161691360|NCT01692301|583920631|FG001|Overall Study|Death|2|||
161691361|NCT01692301|583920630|FG000|Overall Study|Lack of Efficacy|0|||
161691362|NCT01692301|583920631|FG001|Overall Study|Lack of Efficacy|5|||
161691363|NCT01692301|583920630|FG000|Overall Study|Non-compliance with study treatment|1|||
161691364|NCT01692301|583920631|FG001|Overall Study|Non-compliance with study treatment|2|||
161691365|NCT01692301|583920630|FG000|Overall Study|Protocol deviation|9|||
161691366|NCT01692301|583920631|FG001|Overall Study|Protocol deviation|2|||
161691367|NCT01692301|583920630|FG000|Overall Study|Patient/guardian decision|16|||
161691368|NCT01692301|583920631|FG001|Overall Study|Patient/guardian decision|15|||
161691369|NCT01692301|583920630|FG000|Overall Study|Technical problems|0|||
161691370|NCT01692301|583920631|FG001|Overall Study|Technical problems|1|||
161691371|NCT01692301|583920630|FG000|Overall Study|Physician Decision|2|||
161691372|NCT01692301|583920631|FG001|Overall Study|Physician Decision|2|||
161691373|NCT01692301|583920630|FG000|Overall Study|Lost to Follow-up|1|||
161691374|NCT01692301|583920631|FG001|Overall Study|Lost to Follow-up|1|||
161691375|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
161691376|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
161691377|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
161691378|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
161691379|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
161691380|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
161691381|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
161691382|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
161691383|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
161691384|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
161691385|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
161691386|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
161691387|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
161691388|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
161691389|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
161691390|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
161691391|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
161691392|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
161691393|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
161691394|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
161691395|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
161691396|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
161691397|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
161691398|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
161691399|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
161691400|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
161691401|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
161691402|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
161691403|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
161691404|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
161691405|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
161691406|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
161691407|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
161691408|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
161691409|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
161691410|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
161691411|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
161691412|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
161691413|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
161691414|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161691415|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161691416|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161691417|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
161691418|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
161691419|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
161691420|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
161691421|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
161691422|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
161691423|NCT02228590|583920635|FG000|Overall Study|Withdrawal by Subject|1|||
161691424|NCT02111993|583920636|FG000|Overall Study|Physician Decision|5|||
161691425|NCT02111993|583920637|FG001|Overall Study|Physician Decision|4|||
161691426|NCT00574275|583920638|FG000|Overall Study|Randomized but not treated|2|||
161691427|NCT00574275|583920639|FG001|Overall Study|Randomized but not treated|3|||
161691428|NCT00574275|583920638|FG000|Overall Study|Adverse Event|32|||
161691429|NCT00574275|583920639|FG001|Overall Study|Adverse Event|76|||
161691430|NCT00574275|583920638|FG000|Overall Study|Disease progression|160|||
161691431|NCT00574275|583920639|FG001|Overall Study|Disease progression|146|||
161691432|NCT00574275|583920638|FG000|Overall Study|Lost to Follow-up|2|||
161691433|NCT00574275|583920639|FG001|Overall Study|Lost to Follow-up|1|||
161691434|NCT00574275|583920638|FG000|Overall Study|Study stopped based on DMC decision|62|||
161691435|NCT00574275|583920639|FG001|Overall Study|Study stopped based on DMC decision|23|||
161691436|NCT00574275|583920638|FG000|Overall Study|Withdrawal by Subject|15|||
161691437|NCT00574275|583920639|FG001|Overall Study|Withdrawal by Subject|17|||
161691438|NCT00574275|583920638|FG000|Overall Study|Error calculating tumor measurement|1|||
161691439|NCT00574275|583920639|FG001|Overall Study|Error calculating tumor measurement|0|||
161691440|NCT00574275|583920638|FG000|Overall Study|Physician Decision|1|||
161691441|NCT00574275|583920639|FG001|Overall Study|Physician Decision|1|||
161691442|NCT00574275|583920638|FG000|Overall Study|Protocol Violation|0|||
161691443|NCT00574275|583920639|FG001|Overall Study|Protocol Violation|1|||
161691444|NCT00574275|583920638|FG000|Overall Study|Patient and Investigator decision|0|||
161691445|NCT00574275|583920639|FG001|Overall Study|Patient and Investigator decision|1|||
161691446|NCT00574275|583920638|FG000|Overall Study|Insurance change|0|||
161691447|NCT00574275|583920639|FG001|Overall Study|Insurance change|1|||
161691448|NCT00574275|583920638|FG000|Overall Study|Operation for curative intent|0|||
161691449|NCT00574275|583920639|FG001|Overall Study|Operation for curative intent|1|||
161691450|NCT00889265|583920642|FG000|Overall Study|Adverse Event|1|||
161691451|NCT00889265|583920642|FG000|Overall Study|Lost to Follow-up|5|||
161691452|NCT00889265|583920642|FG000|Overall Study|Protocol Violation|1|||
161691453|NCT03028870|583920643|FG000|Overall Study|Adverse Event|7|||
161691454|NCT03028870|583920644|FG001|Overall Study|Adverse Event|4|||
161691455|NCT03028870|583920645|FG002|Overall Study|Adverse Event|3|||
161691456|NCT03028870|583920646|FG003|Overall Study|Adverse Event|3|||
161691457|NCT03028870|583920643|FG000|Overall Study|Withdrawal by Subject|1|||
161691458|NCT03028870|583920644|FG001|Overall Study|Withdrawal by Subject|1|||
161691459|NCT03028870|583920645|FG002|Overall Study|Withdrawal by Subject|1|||
161691460|NCT03028870|583920646|FG003|Overall Study|Withdrawal by Subject|2|||
161691461|NCT03028870|583920643|FG000|Overall Study|Lost to Follow-up|1|||
161691462|NCT03028870|583920644|FG001|Overall Study|Lost to Follow-up|0|||
161691463|NCT03028870|583920645|FG002|Overall Study|Lost to Follow-up|0|||
161691464|NCT03028870|583920646|FG003|Overall Study|Lost to Follow-up|0|||
161691465|NCT03028870|583920643|FG000|Overall Study|Lack of Efficacy|3|||
161691466|NCT03028870|583920644|FG001|Overall Study|Lack of Efficacy|0|||
161691467|NCT03028870|583920645|FG002|Overall Study|Lack of Efficacy|0|||
161691468|NCT03028870|583920646|FG003|Overall Study|Lack of Efficacy|0|||
161691469|NCT03028870|583920643|FG000|Overall Study|Administrative|5|||
161691470|NCT03028870|583920644|FG001|Overall Study|Administrative|5|||
161691471|NCT03028870|583920645|FG002|Overall Study|Administrative|12|||
161691472|NCT03028870|583920646|FG003|Overall Study|Administrative|4|||
161691473|NCT01967537|583920649|FG000|Overall Study|Withdrawal by Subject|52|||
161691474|NCT01967537|583920649|FG000|Overall Study|Refuse treatment|2|||
161691475|NCT01967537|583920649|FG000|Overall Study|Lost to Follow-up|6|||
161691476|NCT00317109|583920652|FG000|Overall Study|Withdrawal by Subject|2|||
161691477|NCT00317109|583920653|FG001|Overall Study|Withdrawal by Subject|0|||
161691478|NCT00317109|583920652|FG000|Overall Study|Migated/moved from study area|1|||
161691479|NCT00317109|583920653|FG001|Overall Study|Migated/moved from study area|0|||
161652038|NCT02574845|583777348|FG004|Overall Study|Consent withdrawn further participation|1|||
161652039|NCT02574845|583777349|FG005|Overall Study|Consent withdrawn further participation|0|||
161652040|NCT02574845|583777344|FG000|Overall Study|Adverse Event|0|||
161652041|NCT02574845|583777345|FG001|Overall Study|Adverse Event|1|||
161652042|NCT02574845|583777346|FG002|Overall Study|Adverse Event|0|||
161652043|NCT02574845|583777347|FG003|Overall Study|Adverse Event|0|||
161652044|NCT02574845|583777348|FG004|Overall Study|Adverse Event|0|||
161652045|NCT02574845|583777349|FG005|Overall Study|Adverse Event|1|||
161652046|NCT02440425|583777352|FG000|Overall Study|Death likely due to disease progression|1|||
161652047|NCT02440425|583777352|FG000|Overall Study|Withdrawal by Subject|2|||
161652048|NCT02440425|583777352|FG000|Overall Study|Adverse Event|1|||
161652049|NCT02440425|583777352|FG000|Overall Study|Adverse Event/Ineligible|1|||
161652050|NCT03101462|583777353|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
161652051|NCT03101462|583777354|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
161652052|NCT01696045|583777358|FG000|Overall Study|Study drug toxicity|1|||
161652053|NCT01696045|583777359|FG001|Overall Study|Study drug toxicity|5|||
161652054|NCT01696045|583777358|FG000|Overall Study|Disease progression|2|||
161652055|NCT01696045|583777359|FG001|Overall Study|Disease progression|2|||
161652056|NCT01559129|583777360|FG000|Treatment Phase|Adverse Event|0|||
161652057|NCT01559129|583777361|FG001|Treatment Phase|Adverse Event|2|||
161652058|NCT01559129|583777360|FG000|Treatment Phase|Progressive Disease|1|||
161652059|NCT01559129|583777361|FG001|Treatment Phase|Progressive Disease|1|||
161652060|NCT01559129|583777360|FG000|Treatment Phase|Lack of Efficacy|0|||
161652061|NCT01559129|583777361|FG001|Treatment Phase|Lack of Efficacy|1|||
161652062|NCT01559129|583777360|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
161652063|NCT01559129|583777361|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
161652064|NCT01559129|583777360|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
161652065|NCT01559129|583777361|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
161652066|NCT01559129|583777360|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
161652067|NCT01559129|583777361|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
161652068|NCT01559129|583777360|FG000|Open-label Extension Period|Adverse Event|1|||
161652069|NCT01559129|583777361|FG001|Open-label Extension Period|Adverse Event|0|||
161652070|NCT01559129|583777360|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
161652071|NCT01559129|583777361|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
161652072|NCT03525392|583777362|FG000|Overall Study|Adverse Event|1|||
161652073|NCT03525392|583777363|FG001|Overall Study|Adverse Event|0|||
161652074|NCT03525392|583777364|FG002|Overall Study|Adverse Event|2|||
161652075|NCT03525392|583777365|FG003|Overall Study|Adverse Event|0|||
161691480|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
161691481|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
161691482|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
161691483|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
161691484|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
161691485|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
161691486|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
161691487|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
161652076|NCT03525392|583777366|FG004|Overall Study|Adverse Event|0|||
161652077|NCT03525392|583777362|FG000|Overall Study|Progressive disease|0|||
161652078|NCT03525392|583777363|FG001|Overall Study|Progressive disease|1|||
161652079|NCT03525392|583777364|FG002|Overall Study|Progressive disease|1|||
161652080|NCT03525392|583777365|FG003|Overall Study|Progressive disease|3|||
161691488|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
161691489|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
161691490|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
161691491|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
161691492|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
161691493|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
161691494|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
161691495|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
161691496|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
161691497|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
161691498|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
161691499|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
161691500|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
161691501|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
161691502|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
161691503|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
161691504|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
161691505|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
161691506|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
161691507|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
161691508|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
161691509|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
161691510|NCT01344876|583920658|FG000|Overall Study|Adverse Event|0|||
161691511|NCT01344876|583920659|FG001|Overall Study|Adverse Event|0|||
161691512|NCT01344876|583920660|FG002|Overall Study|Adverse Event|0|||
161691513|NCT01344876|583920661|FG003|Overall Study|Adverse Event|0|||
161691514|NCT01344876|583920662|FG004|Overall Study|Adverse Event|1|||
161691515|NCT01344876|583920658|FG000|Overall Study|Withdrawal by Subject|0|||
161691516|NCT01344876|583920659|FG001|Overall Study|Withdrawal by Subject|0|||
161691517|NCT01344876|583920660|FG002|Overall Study|Withdrawal by Subject|1|||
161691518|NCT01344876|583920661|FG003|Overall Study|Withdrawal by Subject|0|||
161691519|NCT01344876|583920662|FG004|Overall Study|Withdrawal by Subject|0|||
161691520|NCT01344876|583920658|FG000|Overall Study|Definite progression of primary disease|1|||
161691521|NCT01344876|583920659|FG001|Overall Study|Definite progression of primary disease|0|||
161691522|NCT01344876|583920660|FG002|Overall Study|Definite progression of primary disease|0|||
161691523|NCT01344876|583920661|FG003|Overall Study|Definite progression of primary disease|3|||
161691524|NCT01344876|583920662|FG004|Overall Study|Definite progression of primary disease|0|||
161691525|NCT05107765|583920663|FG000|Overall Study|Lost to Follow-up|4|||
161691526|NCT05107765|583920664|FG001|Overall Study|Lost to Follow-up|1|||
161691527|NCT05107765|583920663|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
161691528|NCT05107765|583920664|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
161691529|NCT05107765|583920663|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
161691530|NCT05107765|583920664|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
161691531|NCT03047980|583922294|FG000|Overall Study|Adverse Event|1|||
161691532|NCT02164981|583922295|FG000|Started|Withdrawal by Subject|2|||
161691533|NCT02164981|583922296|FG001|Started|Withdrawal by Subject|1|||
161691534|NCT02164981|583922297|FG002|Started|Withdrawal by Subject|0|||
161691535|NCT02164981|583922295|FG000|Started|Protocol Violation|2|||
161691536|NCT02164981|583922296|FG001|Started|Protocol Violation|0|||
161691537|NCT02164981|583922297|FG002|Started|Protocol Violation|0|||
161691538|NCT02164981|583922295|FG000|Started|Adverse Event|1|||
161691539|NCT02164981|583922296|FG001|Started|Adverse Event|2|||
161691540|NCT02164981|583922297|FG002|Started|Adverse Event|0|||
161691541|NCT02164981|583922295|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
161691542|NCT02164981|583922296|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
161691543|NCT02164981|583922297|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
161691544|NCT02164981|583922295|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
161691545|NCT02164981|583922296|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
161691546|NCT02164981|583922297|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
161691547|NCT02164981|583922295|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
161691548|NCT02164981|583922296|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
161691549|NCT02164981|583922297|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
161691550|NCT01761266|583922298|FG000|Overall Study|Death|415|||
161691551|NCT01761266|583922299|FG001|Overall Study|Death|402|||
161691552|NCT01761266|583922298|FG000|Overall Study|Lost to Follow-up|8|||
161691553|NCT01761266|583922299|FG001|Overall Study|Lost to Follow-up|12|||
161691554|NCT01761266|583922298|FG000|Overall Study|Withdrawal by Subject|14|||
161691555|NCT01761266|583922299|FG001|Overall Study|Withdrawal by Subject|10|||
161691556|NCT01761266|583922298|FG000|Overall Study|Sponsor Decision|41|||
161691557|NCT01761266|583922299|FG001|Overall Study|Sponsor Decision|52|||
161691558|NCT01662440|583922300|FG000|Overall Study|Adverse Event|1|||
161691559|NCT01662440|583922301|FG001|Overall Study|Adverse Event|0|||
161691560|NCT01662440|583922302|FG002|Overall Study|Adverse Event|0|||
161691561|NCT01662440|583922303|FG003|Overall Study|Adverse Event|1|||
161691562|NCT01662440|583922300|FG000|Overall Study|Death|0|||
161691563|NCT01662440|583922301|FG001|Overall Study|Death|1|||
161691564|NCT01662440|583922302|FG002|Overall Study|Death|0|||
161691565|NCT01662440|583922303|FG003|Overall Study|Death|0|||
161691566|NCT01662440|583922300|FG000|Overall Study|Lost to Follow-up|2|||
161691567|NCT01662440|583922301|FG001|Overall Study|Lost to Follow-up|2|||
161691568|NCT01662440|583922302|FG002|Overall Study|Lost to Follow-up|4|||
161691569|NCT01662440|583922303|FG003|Overall Study|Lost to Follow-up|1|||
161691570|NCT01662440|583922300|FG000|Overall Study|Subject moved to another country.|0|||
161691571|NCT01662440|583922301|FG001|Overall Study|Subject moved to another country.|1|||
161691572|NCT01662440|583922302|FG002|Overall Study|Subject moved to another country.|0|||
161691573|NCT01662440|583922303|FG003|Overall Study|Subject moved to another country.|0|||
161691574|NCT01662440|583922300|FG000|Overall Study|Protocol Violation|1|||
161691575|NCT01662440|583922301|FG001|Overall Study|Protocol Violation|0|||
161691576|NCT01662440|583922302|FG002|Overall Study|Protocol Violation|0|||
161691577|NCT01662440|583922303|FG003|Overall Study|Protocol Violation|0|||
161691578|NCT01662440|583922300|FG000|Overall Study|Withdrawal by Subject|5|||
161691579|NCT01662440|583922301|FG001|Overall Study|Withdrawal by Subject|2|||
161691580|NCT01662440|583922302|FG002|Overall Study|Withdrawal by Subject|2|||
161691581|NCT01662440|583922303|FG003|Overall Study|Withdrawal by Subject|2|||
161691582|NCT00112905|583922304|FG000|Overall Study|Adverse Event|4|||
161691583|NCT00112905|583922304|FG000|Overall Study|Death|1|||
161691584|NCT00112905|583922304|FG000|Overall Study|Ineligibility|5|||
161691585|NCT00112905|583922304|FG000|Overall Study|Alternative treatment|1|||
161691586|NCT00112905|583922304|FG000|Overall Study|performance status was deteiorating|1|||
161691587|NCT01765673|583922305|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
161691588|NCT02600507|583922306|FG000|Overall Study|Adverse Event|3|||
161691589|NCT02600507|583922307|FG001|Overall Study|Adverse Event|15|||
161691590|NCT02600507|583922308|FG002|Overall Study|Adverse Event|5|||
161691591|NCT02600507|583922306|FG000|Overall Study|Lack of Efficacy|3|||
161691592|NCT02600507|583922307|FG001|Overall Study|Lack of Efficacy|8|||
161691593|NCT02600507|583922308|FG002|Overall Study|Lack of Efficacy|5|||
161691594|NCT02600507|583922306|FG000|Overall Study|Lost to Follow-up|3|||
161691595|NCT02600507|583922307|FG001|Overall Study|Lost to Follow-up|5|||
161691596|NCT02600507|583922308|FG002|Overall Study|Lost to Follow-up|2|||
161691597|NCT02600507|583922306|FG000|Overall Study|Protocol Violation|12|||
161691598|NCT02600507|583922307|FG001|Overall Study|Protocol Violation|4|||
161691599|NCT02600507|583922308|FG002|Overall Study|Protocol Violation|4|||
161691600|NCT02600507|583922306|FG000|Overall Study|Physician Decision|1|||
161691601|NCT02600507|583922307|FG001|Overall Study|Physician Decision|0|||
161691602|NCT02600507|583922308|FG002|Overall Study|Physician Decision|1|||
161691603|NCT02600507|583922306|FG000|Overall Study|Withdrawal by Subject|7|||
161691604|NCT02600507|583922307|FG001|Overall Study|Withdrawal by Subject|11|||
161691605|NCT02600507|583922308|FG002|Overall Study|Withdrawal by Subject|7|||
161652081|NCT03525392|583777366|FG004|Overall Study|Progressive disease|1|||
161652082|NCT00831129|583777369|FG000|Overall Study|Adverse Event|0|||
161652083|NCT00831129|583777370|FG001|Overall Study|Adverse Event|1|||
161652084|NCT00831129|583777369|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
161652085|NCT00831129|583777370|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
161652086|NCT01669577|583777372|FG000|Overall Study|Death|22|||
161652087|NCT01669577|583777372|FG000|Overall Study|Lost to Follow-up|78|||
161652088|NCT01669577|583777372|FG000|Overall Study|Physician Decision|34|||
161652089|NCT04462289|583777375|FG000|Overall Study|Lost to Follow-up|4|||
161652090|NCT04462289|583777376|FG001|Overall Study|Lost to Follow-up|5|||
161652091|NCT04462289|583777375|FG000|Overall Study|Death|0|||
161652092|NCT04462289|583777376|FG001|Overall Study|Death|3|||
161652093|NCT04462289|583777375|FG000|Overall Study|Withdrawal by Subject|1|||
161652094|NCT04462289|583777376|FG001|Overall Study|Withdrawal by Subject|3|||
161652095|NCT00818779|583777377|FG000|Overall Study|Protocol Violation|1|||
161652096|NCT00818779|583777378|FG001|Overall Study|Protocol Violation|0|||
161652097|NCT00818779|583777377|FG000|Overall Study|Lost to Follow-up|1|||
161652098|NCT00818779|583777378|FG001|Overall Study|Lost to Follow-up|0|||
161652099|NCT00818779|583777377|FG000|Overall Study|Adverse Event|4|||
161652100|NCT00818779|583777378|FG001|Overall Study|Adverse Event|1|||
161652101|NCT01518153|583777379|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
161691606|NCT02600507|583922306|FG000|Overall Study|Other|0|||
161691607|NCT02600507|583922307|FG001|Overall Study|Other|1|||
161691608|NCT02600507|583922308|FG002|Overall Study|Other|1|||
161691609|NCT05048719|583922313|FG000|Overall Study|Withdrawal by Subject|2|||
161691610|NCT05048719|583922314|FG001|Overall Study|Withdrawal by Subject|1|||
161652102|NCT01518153|583777380|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
161691611|NCT05048719|583922315|FG002|Overall Study|Withdrawal by Subject|3|||
161691612|NCT05048719|583922316|FG003|Overall Study|Withdrawal by Subject|1|||
161691613|NCT05048719|583922317|FG004|Overall Study|Withdrawal by Subject|0|||
161691614|NCT05048719|583922318|FG005|Overall Study|Withdrawal by Subject|2|||
161691615|NCT05048719|583922319|FG006|Overall Study|Withdrawal by Subject|1|||
161691616|NCT05048719|583922320|FG007|Overall Study|Withdrawal by Subject|1|||
161691617|NCT05048719|583922321|FG008|Overall Study|Withdrawal by Subject|0|||
161691618|NCT05048719|583922313|FG000|Overall Study|Death|1|||
161691619|NCT05048719|583922314|FG001|Overall Study|Death|0|||
161691620|NCT05048719|583922315|FG002|Overall Study|Death|0|||
161691621|NCT05048719|583922316|FG003|Overall Study|Death|0|||
161691622|NCT05048719|583922317|FG004|Overall Study|Death|0|||
161691623|NCT05048719|583922318|FG005|Overall Study|Death|0|||
161691624|NCT05048719|583922319|FG006|Overall Study|Death|0|||
161691625|NCT05048719|583922320|FG007|Overall Study|Death|0|||
161691626|NCT05048719|583922321|FG008|Overall Study|Death|0|||
161691627|NCT05048719|583922313|FG000|Overall Study|Adverse Event|0|||
161691628|NCT05048719|583922314|FG001|Overall Study|Adverse Event|1|||
161691629|NCT05048719|583922315|FG002|Overall Study|Adverse Event|2|||
161691630|NCT05048719|583922316|FG003|Overall Study|Adverse Event|0|||
161691631|NCT05048719|583922317|FG004|Overall Study|Adverse Event|1|||
161691632|NCT05048719|583922318|FG005|Overall Study|Adverse Event|0|||
161691633|NCT05048719|583922319|FG006|Overall Study|Adverse Event|0|||
161691634|NCT05048719|583922320|FG007|Overall Study|Adverse Event|0|||
161691635|NCT05048719|583922321|FG008|Overall Study|Adverse Event|0|||
161691636|NCT05048719|583922313|FG000|Overall Study|Lost to Follow-up|0|||
161691637|NCT05048719|583922314|FG001|Overall Study|Lost to Follow-up|0|||
161691638|NCT05048719|583922315|FG002|Overall Study|Lost to Follow-up|1|||
161691639|NCT05048719|583922316|FG003|Overall Study|Lost to Follow-up|3|||
161691640|NCT05048719|583922317|FG004|Overall Study|Lost to Follow-up|1|||
161691641|NCT05048719|583922318|FG005|Overall Study|Lost to Follow-up|1|||
161691642|NCT05048719|583922319|FG006|Overall Study|Lost to Follow-up|1|||
161691643|NCT05048719|583922320|FG007|Overall Study|Lost to Follow-up|1|||
161691644|NCT05048719|583922321|FG008|Overall Study|Lost to Follow-up|0|||
161691645|NCT05048719|583922313|FG000|Overall Study|Physician Decision|0|||
161691646|NCT05048719|583922314|FG001|Overall Study|Physician Decision|0|||
161691647|NCT05048719|583922315|FG002|Overall Study|Physician Decision|0|||
161691648|NCT05048719|583922316|FG003|Overall Study|Physician Decision|0|||
161691649|NCT05048719|583922317|FG004|Overall Study|Physician Decision|0|||
161691650|NCT05048719|583922318|FG005|Overall Study|Physician Decision|0|||
161691651|NCT05048719|583922319|FG006|Overall Study|Physician Decision|0|||
161691652|NCT05048719|583922320|FG007|Overall Study|Physician Decision|1|||
161691653|NCT05048719|583922321|FG008|Overall Study|Physician Decision|1|||
161691654|NCT05048719|583922313|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
161691655|NCT05048719|583922314|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691656|NCT05048719|583922315|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691657|NCT05048719|583922316|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691658|NCT05048719|583922317|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691659|NCT05048719|583922318|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691660|NCT05048719|583922319|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691661|NCT05048719|583922320|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691662|NCT05048719|583922321|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691663|NCT05048719|583922313|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691664|NCT05048719|583922314|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
161691665|NCT05048719|583922315|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691666|NCT05048719|583922316|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691667|NCT05048719|583922317|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691668|NCT05048719|583922318|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691669|NCT05048719|583922319|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691670|NCT05048719|583922320|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691671|NCT05048719|583922321|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691672|NCT05048719|583922313|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691673|NCT05048719|583922314|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
161691674|NCT05048719|583922315|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691675|NCT05048719|583922316|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691676|NCT05048719|583922317|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691677|NCT05048719|583922318|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691678|NCT05048719|583922319|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161836345|NCT03395639|584442941|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
161691679|NCT05048719|583922320|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691680|NCT05048719|583922321|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691681|NCT05048719|583922313|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161836346|NCT03395639|584442942|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
161691682|NCT05048719|583922314|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691683|NCT05048719|583922315|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691684|NCT05048719|583922316|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
161691685|NCT05048719|583922317|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691686|NCT05048719|583922318|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691687|NCT05048719|583922319|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691688|NCT05048719|583922320|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691689|NCT05048719|583922321|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691690|NCT05048719|583922313|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691691|NCT05048719|583922314|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691692|NCT05048719|583922315|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691693|NCT05048719|583922316|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691694|NCT05048719|583922317|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691695|NCT05048719|583922318|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
161691696|NCT05048719|583922319|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691697|NCT05048719|583922320|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691698|NCT05048719|583922321|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691699|NCT04541004|583922322|FG000|Overall Study|Adverse Event|2|||
161691700|NCT00605085|583922323|FG000|Overall Study|Withdrawal by Subject|8|||
161691701|NCT00605085|583922324|FG001|Overall Study|Withdrawal by Subject|5|||
161691702|NCT00605085|583922323|FG000|Overall Study|Adverse Event|9|||
161691703|NCT00605085|583922324|FG001|Overall Study|Adverse Event|5|||
161691704|NCT00605085|583922323|FG000|Overall Study|Pregnancy|2|||
161691705|NCT00605085|583922324|FG001|Overall Study|Pregnancy|0|||
161691706|NCT00605085|583922323|FG000|Overall Study|Protocol Violation|3|||
161691707|NCT00605085|583922324|FG001|Overall Study|Protocol Violation|2|||
161691708|NCT00605085|583922323|FG000|Overall Study|Lost to Follow-up|10|||
161691709|NCT00605085|583922324|FG001|Overall Study|Lost to Follow-up|5|||
161691710|NCT00605085|583922323|FG000|Overall Study|administrative reasons|18|||
161691711|NCT00605085|583922324|FG001|Overall Study|administrative reasons|8|||
161691712|NCT01262365|583922328|FG000|Overall Study|Lack of Efficacy|35|||
161691713|NCT01262365|583922329|FG001|Overall Study|Lack of Efficacy|30|||
161691714|NCT01262365|583922330|FG002|Overall Study|Lack of Efficacy|47|||
161691715|NCT01262365|583922328|FG000|Overall Study|Protocol Violation|3|||
161691716|NCT01262365|583922329|FG001|Overall Study|Protocol Violation|1|||
161691717|NCT01262365|583922330|FG002|Overall Study|Protocol Violation|1|||
161691718|NCT01262365|583922328|FG000|Overall Study|Lost to Follow-up|3|||
161691719|NCT01262365|583922329|FG001|Overall Study|Lost to Follow-up|7|||
161691720|NCT01262365|583922330|FG002|Overall Study|Lost to Follow-up|6|||
161691721|NCT01262365|583922328|FG000|Overall Study|Withdrawal by Subject|17|||
161691722|NCT01262365|583922329|FG001|Overall Study|Withdrawal by Subject|22|||
161691723|NCT01262365|583922330|FG002|Overall Study|Withdrawal by Subject|22|||
161691724|NCT01262365|583922328|FG000|Overall Study|Death|1|||
161691725|NCT01262365|583922329|FG001|Overall Study|Death|2|||
161691726|NCT01262365|583922330|FG002|Overall Study|Death|1|||
161691727|NCT01262365|583922328|FG000|Overall Study|Adverse Event|26|||
161691728|NCT01262365|583922329|FG001|Overall Study|Adverse Event|16|||
161691729|NCT01262365|583922330|FG002|Overall Study|Adverse Event|11|||
161691730|NCT01262365|583922328|FG000|Overall Study|sponsor decision|1|||
161691731|NCT01262365|583922329|FG001|Overall Study|sponsor decision|1|||
161691732|NCT01262365|583922330|FG002|Overall Study|sponsor decision|0|||
161691733|NCT01262365|583922328|FG000|Overall Study|Randomization error|1|||
161691734|NCT01262365|583922329|FG001|Overall Study|Randomization error|0|||
161691735|NCT01262365|583922330|FG002|Overall Study|Randomization error|2|||
161691736|NCT01262365|583922328|FG000|Overall Study|Non-compliance|1|||
161691737|NCT01262365|583922329|FG001|Overall Study|Non-compliance|0|||
161691738|NCT01262365|583922330|FG002|Overall Study|Non-compliance|2|||
161691739|NCT01262365|583922328|FG000|Overall Study|Suspected pregnancy|1|||
161691740|NCT01262365|583922329|FG001|Overall Study|Suspected pregnancy|0|||
161691741|NCT01262365|583922330|FG002|Overall Study|Suspected pregnancy|0|||
161691742|NCT01262365|583922328|FG000|Overall Study|Patient pregnant|1|||
161691743|NCT01262365|583922329|FG001|Overall Study|Patient pregnant|0|||
161691744|NCT01262365|583922330|FG002|Overall Study|Patient pregnant|1|||
161691745|NCT01262365|583922328|FG000|Overall Study|Toxicity related to study drug|0|||
161691746|NCT01262365|583922329|FG001|Overall Study|Toxicity related to study drug|1|||
161691747|NCT01262365|583922330|FG002|Overall Study|Toxicity related to study drug|0|||
161691748|NCT01262365|583922328|FG000|Overall Study|Cannot tolerate the protocol|0|||
161691749|NCT01262365|583922329|FG001|Overall Study|Cannot tolerate the protocol|1|||
161691750|NCT01262365|583922330|FG002|Overall Study|Cannot tolerate the protocol|0|||
161691751|NCT01262365|583922328|FG000|Overall Study|Patient unavailable|0|||
161691752|NCT01262365|583922329|FG001|Overall Study|Patient unavailable|0|||
161691753|NCT01262365|583922330|FG002|Overall Study|Patient unavailable|1|||
161691754|NCT01592760|583922334|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
161691755|NCT01592760|583922335|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
161691756|NCT01592760|583922336|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
161691757|NCT04312009|583922337|FG000|Overall Study|Withdrawal by Subject|2|||
161691758|NCT04312009|583922338|FG001|Overall Study|Withdrawal by Subject|1|||
161691759|NCT02354703|583922341|FG000|Overall Study|Withdrawal by Subject|1|||
161691760|NCT02354703|583922342|FG001|Overall Study|Withdrawal by Subject|1|||
161691761|NCT02354703|583922343|FG002|Overall Study|Withdrawal by Subject|1|||
161691762|NCT02354703|583922344|FG003|Overall Study|Withdrawal by Subject|1|||
161691763|NCT02354703|583922341|FG000|Overall Study|Lost to Follow-up|2|||
161691764|NCT02354703|583922342|FG001|Overall Study|Lost to Follow-up|7|||
161691765|NCT02354703|583922343|FG002|Overall Study|Lost to Follow-up|9|||
161691766|NCT02354703|583922344|FG003|Overall Study|Lost to Follow-up|2|||
161691767|NCT02354703|583922341|FG000|Overall Study|Adverse Event|0|||
161691768|NCT02354703|583922342|FG001|Overall Study|Adverse Event|0|||
161691769|NCT02354703|583922343|FG002|Overall Study|Adverse Event|1|||
161691770|NCT02354703|583922344|FG003|Overall Study|Adverse Event|0|||
161691771|NCT00699348|583922345|FG000|Overall Study|Death|6|||
161691772|NCT00699348|583922345|FG000|Overall Study|Adverse Event|15|||
161691773|NCT00699348|583922345|FG000|Overall Study|Withdrawal by Subject|11|||
161691774|NCT00699348|583922345|FG000|Overall Study|Protocol Violation|10|||
161691775|NCT00699348|583922345|FG000|Overall Study|Lack of Efficacy|8|||
161691776|NCT00699348|583922345|FG000|Overall Study|Failure to return|1|||
161691777|NCT00699348|583922345|FG000|Overall Study|Blood transfusion|24|||
161691778|NCT00699348|583922345|FG000|Overall Study|Renal transplantation|10|||
161691779|NCT00699348|583922345|FG000|Overall Study|Other|5|||
161691780|NCT00122135|583922346|FG000|Overall Study|Withdrawal by Subject|3|||
161691781|NCT00122135|583922347|FG001|Overall Study|Withdrawal by Subject|0|||
161691782|NCT04681170|583922348|FG000|Stratified Enrolment & run-in|Death|1|||
161691783|NCT04681170|583922349|FG001|Stratified Enrolment & run-in|Death|0|||
161691784|NCT04681170|583922348|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
161691785|NCT04681170|583922349|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
161691786|NCT04681170|583922348|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
161691787|NCT04681170|583922349|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
161691788|NCT04681170|583922348|FG000|Open Label Efficacy Phase|Adverse Event|0|||
161691789|NCT04681170|583922349|FG001|Open Label Efficacy Phase|Adverse Event|2|||
161691790|NCT04681170|583922348|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
161691791|NCT04681170|583922349|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
161691792|NCT04681170|583922348|FG000|Open Label Safety Phase|AEs and none compliance|0|||
161691793|NCT04681170|583922349|FG001|Open Label Safety Phase|AEs and none compliance|1|||
161691794|NCT02468648|583922354|FG000|Overall Study|Death|1|||
161691795|NCT00488982|583922355|FG000|Course 1|Physician Decision|0|||
161691796|NCT00488982|583922356|FG001|Course 1|Physician Decision|2|||
161691797|NCT00488982|583922357|FG002|Course 1|Physician Decision|4|||
161691798|NCT00488982|583922355|FG000|Course 1|Withdrawal by Subject|0|||
161691799|NCT00488982|583922356|FG001|Course 1|Withdrawal by Subject|8|||
161691800|NCT00488982|583922357|FG002|Course 1|Withdrawal by Subject|2|||
161691801|NCT00488982|583922355|FG000|Course 1|nonprotocol therapy|0|||
161691802|NCT00488982|583922356|FG001|Course 1|nonprotocol therapy|2|||
161691803|NCT00488982|583922357|FG002|Course 1|nonprotocol therapy|2|||
161691804|NCT00488982|583922355|FG000|Course 1|Adverse Event|0|||
161691805|NCT00488982|583922356|FG001|Course 1|Adverse Event|0|||
161691806|NCT00488982|583922357|FG002|Course 1|Adverse Event|6|||
161691807|NCT01368835|583922358|FG000|Overall Study|Inclusion criteria/photography quality|22|||
161691808|NCT01368835|583922358|FG000|Overall Study|Lost to Follow-up|11|||
161691809|NCT01678144|583922359|FG000|Stage 1: MAR Classic|Adverse Event|1|||
161691810|NCT02754726|583922360|FG000|Overall Study|Progressive Disease by RECIST|13|||
161691811|NCT02754726|583922360|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
161691812|NCT02754726|583922360|FG000|Overall Study|Clinical Disease Progression|5|||
161691813|NCT02754726|583922360|FG000|Overall Study|Adverse Event|3|||
161691814|NCT02754726|583922360|FG000|Overall Study|Withdrawal by Subject|1|||
161691815|NCT02754726|583922360|FG000|Overall Study|Tolerability|1|||
161691816|NCT03806127|583922369|FG000|Overall Study|Withdrawal by Subject|4|||
161691817|NCT03806127|583922370|FG001|Overall Study|Withdrawal by Subject|5|||
161691818|NCT03806127|583922369|FG000|Overall Study|Protocol Violation|3|||
161691819|NCT03806127|583922370|FG001|Overall Study|Protocol Violation|1|||
161691820|NCT03806127|583922369|FG000|Overall Study|Adverse Event|3|||
161691821|NCT03806127|583922370|FG001|Overall Study|Adverse Event|0|||
161691822|NCT03806127|583922369|FG000|Overall Study|Unable to Complete Procedures|0|||
161691823|NCT03806127|583922370|FG001|Overall Study|Unable to Complete Procedures|1|||
161691824|NCT03806127|583922369|FG000|Overall Study|Pregnancy|0|||
161691825|NCT03806127|583922370|FG001|Overall Study|Pregnancy|1|||
161691826|NCT03806127|583922369|FG000|Overall Study|Lost to Follow-up|5|||
161691827|NCT03806127|583922370|FG001|Overall Study|Lost to Follow-up|1|||
161691828|NCT03806127|583922369|FG000|Overall Study|Physician Decision|1|||
161691829|NCT03806127|583922370|FG001|Overall Study|Physician Decision|1|||
161691830|NCT03806127|583922369|FG000|Overall Study|Could Not Come Due to Covid|1|||
161691831|NCT03806127|583922370|FG001|Overall Study|Could Not Come Due to Covid|0|||
161691832|NCT03806127|583922369|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
161691833|NCT03806127|583922370|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
161691834|NCT03806127|583922369|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
161691835|NCT03806127|583922370|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
161691836|NCT03806127|583922369|FG000|Overall Study|Covid 19 Restrictions|2|||
161691837|NCT03806127|583922370|FG001|Overall Study|Covid 19 Restrictions|0|||
161691838|NCT03806127|583922369|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
161691839|NCT03806127|583922370|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
161691840|NCT03806127|583922369|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
161691841|NCT03806127|583922370|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
161691842|NCT01289015|583922376|FG000|Overall Study|Protocol Violation|12|||
161691843|NCT01289015|583922377|FG001|Overall Study|Protocol Violation|9|||
161691844|NCT01289015|583922376|FG000|Overall Study|Adverse Event|3|||
161691845|NCT01289015|583922377|FG001|Overall Study|Adverse Event|0|||
161691846|NCT01289015|583922376|FG000|Overall Study|Lost to Follow-up|33|||
161691847|NCT01289015|583922377|FG001|Overall Study|Lost to Follow-up|17|||
161691848|NCT01289015|583922376|FG000|Overall Study|Withdrawal by Subject|17|||
161691849|NCT01289015|583922377|FG001|Overall Study|Withdrawal by Subject|8|||
161691850|NCT01289015|583922376|FG000|Overall Study|Disease progression|1|||
161691851|NCT01289015|583922377|FG001|Overall Study|Disease progression|0|||
161691852|NCT01289015|583922376|FG000|Overall Study|Negative baseline culture and others|33|||
161691853|NCT01289015|583922377|FG001|Overall Study|Negative baseline culture and others|20|||
161691854|NCT05980299|583922382|FG000|Overall Study|Death|28|||
161691855|NCT05980299|583922383|FG001|Overall Study|Death|0|||
161691856|NCT05980299|583922382|FG000|Overall Study|Discharged from Nursing Home|9|||
161691857|NCT05980299|583922383|FG001|Overall Study|Discharged from Nursing Home|0|||
161691858|NCT05980299|583922382|FG000|Overall Study|Lost to Follow-up|0|||
161691859|NCT05980299|583922383|FG001|Overall Study|Lost to Follow-up|10|||
161691860|NCT01294800|583922391|FG000|Overall Study|Adverse Event|7|||
161691861|NCT01294800|583922392|FG001|Overall Study|Adverse Event|6|||
161691862|NCT01294800|583922393|FG002|Overall Study|Adverse Event|12|||
161691863|NCT01294800|583922394|FG003|Overall Study|Adverse Event|5|||
161691864|NCT01294800|583922391|FG000|Overall Study|Subject Withdrew Consent|2|||
161691865|NCT01294800|583922392|FG001|Overall Study|Subject Withdrew Consent|2|||
161691866|NCT01294800|583922393|FG002|Overall Study|Subject Withdrew Consent|2|||
161691867|NCT01294800|583922394|FG003|Overall Study|Subject Withdrew Consent|11|||
161691868|NCT01294800|583922391|FG000|Overall Study|Lost to Follow-up|0|||
161691869|NCT01294800|583922392|FG001|Overall Study|Lost to Follow-up|0|||
161691870|NCT01294800|583922393|FG002|Overall Study|Lost to Follow-up|1|||
161691871|NCT01294800|583922394|FG003|Overall Study|Lost to Follow-up|0|||
161691872|NCT01294800|583922391|FG000|Overall Study|Non-compliance With Protocol|0|||
161691873|NCT01294800|583922392|FG001|Overall Study|Non-compliance With Protocol|1|||
161691874|NCT01294800|583922393|FG002|Overall Study|Non-compliance With Protocol|1|||
161691875|NCT01294800|583922394|FG003|Overall Study|Non-compliance With Protocol|0|||
161691876|NCT01294800|583922391|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
161691877|NCT01294800|583922392|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161691878|NCT01294800|583922393|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
161691879|NCT01294800|583922394|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
161691880|NCT01662895|583922395|FG000|Overall Study|Lost to Follow-up|0|||
161691881|NCT01662895|583922396|FG001|Overall Study|Lost to Follow-up|1|||
161691882|NCT05048342|583922397|FG000|Overall Study|Adverse Event|1|||
161691883|NCT05048342|583922397|FG000|Overall Study|Subject decision|2|||
161691884|NCT00493038|583922398|FG000|Treatment|Adverse Event|8|||
161691885|NCT00493038|583922399|FG001|Treatment|Adverse Event|4|||
161691886|NCT00493038|583922398|FG000|Treatment|Lost to Follow-up|5|||
161691887|NCT00493038|583922399|FG001|Treatment|Lost to Follow-up|3|||
161691888|NCT00493038|583922398|FG000|Treatment|Withdrawal by Subject|11|||
161691889|NCT00493038|583922399|FG001|Treatment|Withdrawal by Subject|12|||
161691890|NCT00493038|583922398|FG000|Treatment|Other|0|||
161691891|NCT00493038|583922399|FG001|Treatment|Other|1|||
161691892|NCT00493038|583922398|FG000|Follow-up|Lost to Follow-up|1|||
161691893|NCT00493038|583922399|FG001|Follow-up|Lost to Follow-up|0|||
161691894|NCT01441063|583922400|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
161691895|NCT01441063|583922400|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
161691896|NCT03345472|583922402|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
161691897|NCT03345472|583922402|FG000|Implant to 3 Months|Physician Decision|1|||
161691898|NCT03345472|583922402|FG000|Implant to 3 Months|Adverse Event|1|||
161691899|NCT03345472|583922402|FG000|3 Months to 12 Months|Physician Decision|3|||
161691900|NCT03345472|583922402|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
161652103|NCT01518153|583777381|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
161652104|NCT01518153|583777379|FG000|Stem Cell Transplant|Death|2|||
161652105|NCT01518153|583777380|FG001|Stem Cell Transplant|Death|0|||
161652106|NCT01518153|583777381|FG002|Stem Cell Transplant|Death|0|||
161652107|NCT01518153|583777379|FG000|Stem Cell Transplant|Secondary graft failure|1|||
161652108|NCT01518153|583777380|FG001|Stem Cell Transplant|Secondary graft failure|0|||
161652109|NCT01518153|583777381|FG002|Stem Cell Transplant|Secondary graft failure|0|||
161652110|NCT01518153|583777379|FG000|Stem Cell Transplant|Adverse Event|1|||
161652111|NCT01518153|583777380|FG001|Stem Cell Transplant|Adverse Event|0|||
161652112|NCT01518153|583777381|FG002|Stem Cell Transplant|Adverse Event|0|||
161652113|NCT01518153|583777379|FG000|Donor Lymphocyte Infusion|Death|0|||
161652114|NCT01518153|583777380|FG001|Donor Lymphocyte Infusion|Death|2|||
161652115|NCT01518153|583777381|FG002|Donor Lymphocyte Infusion|Death|1|||
161652116|NCT00132873|583777382|FG000|Overall Study|Adverse Event|3|||
161652117|NCT00132873|583777382|FG000|Overall Study|Lost to Follow-up|1|||
161652118|NCT00132873|583777382|FG000|Overall Study|Lack of Efficacy|1|||
161652119|NCT00132873|583777382|FG000|Overall Study|Withdrawal by Subject|3|||
161652120|NCT00132873|583777382|FG000|Overall Study|Planned Pregnancy|1|||
161652121|NCT04276415|583777383|FG000|Overall Study|Adverse Event|0|||
161652122|NCT04276415|583777384|FG001|Overall Study|Adverse Event|0|||
161652123|NCT04276415|583777385|FG002|Overall Study|Adverse Event|0|||
161652124|NCT04276415|583777386|FG003|Overall Study|Adverse Event|3|||
161652125|NCT04276415|583777387|FG004|Overall Study|Adverse Event|0|||
161652126|NCT04276415|583777388|FG005|Overall Study|Adverse Event|0|||
161652127|NCT04276415|583777383|FG000|Overall Study|Clinical progression|1|||
161652128|NCT04276415|583777384|FG001|Overall Study|Clinical progression|1|||
161652129|NCT04276415|583777385|FG002|Overall Study|Clinical progression|0|||
161652130|NCT04276415|583777386|FG003|Overall Study|Clinical progression|0|||
161652131|NCT04276415|583777387|FG004|Overall Study|Clinical progression|1|||
161652132|NCT04276415|583777388|FG005|Overall Study|Clinical progression|0|||
161652133|NCT04276415|583777383|FG000|Overall Study|Other|0|||
161652134|NCT04276415|583777384|FG001|Overall Study|Other|0|||
161652135|NCT04276415|583777385|FG002|Overall Study|Other|0|||
161652136|NCT04276415|583777386|FG003|Overall Study|Other|1|||
161652137|NCT04276415|583777387|FG004|Overall Study|Other|0|||
161652138|NCT04276415|583777388|FG005|Overall Study|Other|0|||
161652139|NCT04276415|583777383|FG000|Overall Study|Physician Decision|0|||
161652140|NCT04276415|583777384|FG001|Overall Study|Physician Decision|0|||
161652141|NCT04276415|583777385|FG002|Overall Study|Physician Decision|1|||
161652142|NCT04276415|583777386|FG003|Overall Study|Physician Decision|3|||
161652143|NCT04276415|583777387|FG004|Overall Study|Physician Decision|2|||
161652144|NCT04276415|583777388|FG005|Overall Study|Physician Decision|0|||
161652145|NCT04276415|583777383|FG000|Overall Study|Progressive disease|3|||
161652146|NCT04276415|583777384|FG001|Overall Study|Progressive disease|3|||
161652147|NCT04276415|583777385|FG002|Overall Study|Progressive disease|4|||
161652148|NCT04276415|583777386|FG003|Overall Study|Progressive disease|5|||
161652149|NCT04276415|583777387|FG004|Overall Study|Progressive disease|1|||
161652150|NCT04276415|583777388|FG005|Overall Study|Progressive disease|2|||
161652151|NCT04276415|583777383|FG000|Overall Study|Withdrawal by patient|0|||
161652152|NCT04276415|583777384|FG001|Overall Study|Withdrawal by patient|0|||
161652153|NCT04276415|583777385|FG002|Overall Study|Withdrawal by patient|0|||
161652154|NCT04276415|583777386|FG003|Overall Study|Withdrawal by patient|1|||
161652155|NCT04276415|583777387|FG004|Overall Study|Withdrawal by patient|2|||
161652156|NCT04276415|583777388|FG005|Overall Study|Withdrawal by patient|0|||
161652157|NCT03309813|583777389|FG000|Main Randomized Study|Withdrawal by Subject|1|||
161652158|NCT03309813|583777390|FG001|Main Randomized Study|Withdrawal by Subject|0|||
161652159|NCT01327846|583777391|FG000|Core Phase|Subject decision (vital status: missing)|1|||
161652160|NCT01327846|583777392|FG001|Core Phase|Subject decision (vital status: missing)|2|||
161691901|NCT03345472|583922402|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
161652161|NCT01327846|583777393|FG002|Core Phase|Subject decision (vital status: missing)|2|||
161652162|NCT01327846|583777394|FG003|Core Phase|Subject decision (vital status: missing)|1|||
161652163|NCT01327846|583777391|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
161652164|NCT01327846|583777392|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
161652165|NCT01327846|583777393|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
161652166|NCT01327846|583777394|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
161652167|NCT01327846|583777391|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
161652168|NCT01327846|583777392|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
161652169|NCT01327846|583777393|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
161652170|NCT01327846|583777394|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
161652171|NCT01327846|583777391|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
161652172|NCT01327846|583777392|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
161652173|NCT01327846|583777393|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
161652174|NCT01327846|583777394|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
161652175|NCT01327846|583777391|FG000|Core Phase|Lost to Follow-up|3|||
161652176|NCT01327846|583777392|FG001|Core Phase|Lost to Follow-up|3|||
161652177|NCT01327846|583777393|FG002|Core Phase|Lost to Follow-up|4|||
161652178|NCT01327846|583777394|FG003|Core Phase|Lost to Follow-up|5|||
161652179|NCT01327846|583777391|FG000|Extension Phase|Study terminated by sponsor|1073|||
161652180|NCT01327846|583777392|FG001|Extension Phase|Study terminated by sponsor|1124|||
161652181|NCT01327846|583777393|FG002|Extension Phase|Study terminated by sponsor|1067|||
161652182|NCT01327846|583777394|FG003|Extension Phase|Study terminated by sponsor|1660|||
161652183|NCT01327846|583777391|FG000|Extension Phase|Withdrawal by Subject|20|||
161652184|NCT01327846|583777392|FG001|Extension Phase|Withdrawal by Subject|13|||
161652185|NCT01327846|583777393|FG002|Extension Phase|Withdrawal by Subject|19|||
161652186|NCT01327846|583777394|FG003|Extension Phase|Withdrawal by Subject|37|||
161652187|NCT01327846|583777391|FG000|Extension Phase|Lost to Follow-up|4|||
161652188|NCT01327846|583777392|FG001|Extension Phase|Lost to Follow-up|3|||
161652189|NCT01327846|583777393|FG002|Extension Phase|Lost to Follow-up|4|||
161652190|NCT01327846|583777394|FG003|Extension Phase|Lost to Follow-up|7|||
161652191|NCT01327846|583777391|FG000|Extension Phase|Technical Problems|2|||
161652192|NCT01327846|583777392|FG001|Extension Phase|Technical Problems|4|||
161652193|NCT01327846|583777393|FG002|Extension Phase|Technical Problems|2|||
161652194|NCT01327846|583777394|FG003|Extension Phase|Technical Problems|2|||
161652195|NCT04662931|583777397|FG000|Overall Study|Withdrawal by Subject|17|||
161652196|NCT04662931|583777397|FG000|Overall Study|Death|3|||
161652197|NCT04662931|583777397|FG000|Overall Study|Lost to Follow-up|3|||
161652198|NCT04662931|583777397|FG000|Overall Study|Guardian Decision|1|||
161652199|NCT03682185|583777403|FG000|Overall Study|Lost to Follow-up|4|||
161652200|NCT03682185|583777404|FG001|Overall Study|Lost to Follow-up|7|||
161652201|NCT03682185|583777405|FG002|Overall Study|Lost to Follow-up|4|||
161652202|NCT03682185|583777406|FG003|Overall Study|Lost to Follow-up|7|||
161652203|NCT03682185|583777407|FG004|Overall Study|Lost to Follow-up|1|||
161652204|NCT03682185|583777403|FG000|Overall Study|Withdrawal by Subject|7|||
161652205|NCT03682185|583777404|FG001|Overall Study|Withdrawal by Subject|3|||
161652206|NCT03682185|583777405|FG002|Overall Study|Withdrawal by Subject|7|||
161652207|NCT03682185|583777406|FG003|Overall Study|Withdrawal by Subject|3|||
161652208|NCT03682185|583777407|FG004|Overall Study|Withdrawal by Subject|0|||
161652209|NCT01967147|583779239|FG000|Overall Study|Adverse Event|5|||
161652210|NCT01967147|583779240|FG001|Overall Study|Adverse Event|2|||
161652211|NCT01967147|583779239|FG000|Overall Study|Lack of Efficacy|1|||
161652212|NCT01967147|583779240|FG001|Overall Study|Lack of Efficacy|4|||
161652213|NCT01967147|583779239|FG000|Overall Study|Lost to Follow-up|1|||
161652214|NCT01967147|583779240|FG001|Overall Study|Lost to Follow-up|2|||
161652215|NCT01967147|583779239|FG000|Overall Study|Withdrawal by Subject|2|||
161652216|NCT01967147|583779240|FG001|Overall Study|Withdrawal by Subject|4|||
161652217|NCT01967147|583779239|FG000|Overall Study|Non-compliance with Study Drug|0|||
161652218|NCT01967147|583779240|FG001|Overall Study|Non-compliance with Study Drug|3|||
161652219|NCT01967147|583779239|FG000|Overall Study|Other|4|||
161652220|NCT01967147|583779240|FG001|Overall Study|Other|5|||
161652221|NCT03843554|583779241|FG000|Overall Study|Physician Decision|0|||
161652222|NCT03843554|583779242|FG001|Overall Study|Physician Decision|2|||
161652223|NCT00387426|583779244|FG000|Overall Study|Lack of Response|7|||
161652224|NCT00387426|583779244|FG000|Overall Study|Toxicities|4|||
161652225|NCT00387426|583779244|FG000|Overall Study|Disease Progression|3|||
161652226|NCT02218606|583779245|FG000|Overall Study|Adverse Event|1|||
161652227|NCT02218606|583779246|FG001|Overall Study|Adverse Event|1|||
161652228|NCT02218606|583779245|FG000|Overall Study|Death|15|||
161652229|NCT02218606|583779246|FG001|Overall Study|Death|28|||
161652230|NCT02218606|583779245|FG000|Overall Study|Physician Decision|0|||
161652231|NCT02218606|583779246|FG001|Overall Study|Physician Decision|1|||
161652232|NCT02218606|583779245|FG000|Overall Study|Withdrawal by Subject|4|||
161652233|NCT02218606|583779246|FG001|Overall Study|Withdrawal by Subject|0|||
161652234|NCT02218606|583779245|FG000|Overall Study|Noncompliance|1|||
161652235|NCT02218606|583779246|FG001|Overall Study|Noncompliance|0|||
161652236|NCT02218606|583779245|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
161652237|NCT02218606|583779246|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
161652238|NCT02218606|583779245|FG000|Overall Study|Other|2|||
161652239|NCT02218606|583779246|FG001|Overall Study|Other|1|||
161652240|NCT02218606|583779245|FG000|Overall Study|Never started treatment|0|||
161652241|NCT02218606|583779246|FG001|Overall Study|Never started treatment|1|||
161652242|NCT03203473|583779247|FG000|Induction Phase|Never started primary treatment|2|||
161652243|NCT03203473|583779248|FG001|Induction Phase|Never started primary treatment|0|||
161652244|NCT03203473|583779249|FG002|Induction Phase|Never started primary treatment|0|||
161691902|NCT03345472|583922402|FG000|3 Months to 12 Months|Adverse Event|1|||
161691903|NCT03345472|583922402|FG000|3 Months to 12 Months|Death|1|||
161691904|NCT02296242|583922428|FG000|Overall Study|Death|1|||
161691905|NCT02296242|583922429|FG001|Overall Study|Death|1|||
161691906|NCT02296242|583922430|FG002|Overall Study|Death|1|||
161691907|NCT02296242|583922431|FG003|Overall Study|Death|1|||
161691908|NCT02296242|583922432|FG004|Overall Study|Death|1|||
161691909|NCT02296242|583922428|FG000|Overall Study|Withdrawal by Subject|0|||
161691910|NCT02296242|583922429|FG001|Overall Study|Withdrawal by Subject|0|||
161691911|NCT02296242|583922430|FG002|Overall Study|Withdrawal by Subject|1|||
161691912|NCT02296242|583922431|FG003|Overall Study|Withdrawal by Subject|1|||
161691913|NCT02296242|583922432|FG004|Overall Study|Withdrawal by Subject|3|||
161691914|NCT02296242|583922428|FG000|Overall Study|Disease Progression|1|||
161691915|NCT02296242|583922429|FG001|Overall Study|Disease Progression|3|||
161691916|NCT02296242|583922430|FG002|Overall Study|Disease Progression|2|||
161691917|NCT02296242|583922431|FG003|Overall Study|Disease Progression|8|||
161691918|NCT02296242|583922432|FG004|Overall Study|Disease Progression|11|||
161691919|NCT02296242|583922428|FG000|Overall Study|Unacceptable Toxicity|0|||
161691920|NCT02296242|583922429|FG001|Overall Study|Unacceptable Toxicity|0|||
161691921|NCT02296242|583922430|FG002|Overall Study|Unacceptable Toxicity|0|||
161691922|NCT02296242|583922431|FG003|Overall Study|Unacceptable Toxicity|0|||
161691923|NCT02296242|583922432|FG004|Overall Study|Unacceptable Toxicity|1|||
161691924|NCT02296242|583922428|FG000|Overall Study|Patient Condition Changed|0|||
161691925|NCT02296242|583922429|FG001|Overall Study|Patient Condition Changed|0|||
161691926|NCT02296242|583922430|FG002|Overall Study|Patient Condition Changed|2|||
161691927|NCT02296242|583922431|FG003|Overall Study|Patient Condition Changed|0|||
161691928|NCT02296242|583922432|FG004|Overall Study|Patient Condition Changed|1|||
161691929|NCT02296242|583922428|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
161691930|NCT02296242|583922429|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
161691931|NCT02296242|583922430|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
161691932|NCT02296242|583922431|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
161691933|NCT02296242|583922432|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
161691934|NCT02296242|583922428|FG000|Overall Study|Lost to Follow-up|1|||
161691935|NCT02296242|583922429|FG001|Overall Study|Lost to Follow-up|0|||
161691936|NCT02296242|583922430|FG002|Overall Study|Lost to Follow-up|0|||
161691937|NCT02296242|583922431|FG003|Overall Study|Lost to Follow-up|0|||
161691938|NCT02296242|583922432|FG004|Overall Study|Lost to Follow-up|0|||
161691939|NCT02296242|583922428|FG000|Overall Study|Need for Hydroxyurea|2|||
161691940|NCT02296242|583922429|FG001|Overall Study|Need for Hydroxyurea|0|||
161691941|NCT02296242|583922430|FG002|Overall Study|Need for Hydroxyurea|0|||
161691942|NCT02296242|583922431|FG003|Overall Study|Need for Hydroxyurea|0|||
161691943|NCT02296242|583922432|FG004|Overall Study|Need for Hydroxyurea|0|||
161691944|NCT02296242|583922428|FG000|Overall Study|Screened for Other Protocol|0|||
161691945|NCT02296242|583922429|FG001|Overall Study|Screened for Other Protocol|1|||
161691946|NCT02296242|583922430|FG002|Overall Study|Screened for Other Protocol|0|||
161691947|NCT02296242|583922431|FG003|Overall Study|Screened for Other Protocol|0|||
161691948|NCT02296242|583922432|FG004|Overall Study|Screened for Other Protocol|0|||
161691949|NCT02296242|583922428|FG000|Overall Study|Physician Decision|0|||
161691950|NCT02296242|583922429|FG001|Overall Study|Physician Decision|1|||
161691951|NCT02296242|583922430|FG002|Overall Study|Physician Decision|0|||
161691952|NCT02296242|583922431|FG003|Overall Study|Physician Decision|1|||
161691953|NCT02296242|583922432|FG004|Overall Study|Physician Decision|0|||
161691954|NCT02296242|583922428|FG000|Overall Study|Alternative Treatment|0|||
161691955|NCT02296242|583922429|FG001|Overall Study|Alternative Treatment|0|||
161691956|NCT02296242|583922430|FG002|Overall Study|Alternative Treatment|0|||
161691957|NCT02296242|583922431|FG003|Overall Study|Alternative Treatment|1|||
161691958|NCT02296242|583922432|FG004|Overall Study|Alternative Treatment|0|||
161691959|NCT02296242|583922428|FG000|Overall Study|Adverse Event|0|||
161691960|NCT02296242|583922429|FG001|Overall Study|Adverse Event|0|||
161691961|NCT02296242|583922430|FG002|Overall Study|Adverse Event|0|||
161691962|NCT02296242|583922431|FG003|Overall Study|Adverse Event|1|||
161691963|NCT02296242|583922432|FG004|Overall Study|Adverse Event|0|||
161691964|NCT02296242|583922428|FG000|Overall Study|Lack of Efficacy|0|||
161691965|NCT02296242|583922429|FG001|Overall Study|Lack of Efficacy|0|||
161691966|NCT02296242|583922430|FG002|Overall Study|Lack of Efficacy|0|||
161691967|NCT02296242|583922431|FG003|Overall Study|Lack of Efficacy|0|||
161691968|NCT02296242|583922432|FG004|Overall Study|Lack of Efficacy|3|||
161691969|NCT01639833|583922433|FG000|Overall Study|Death|4|||
161691970|NCT01639833|583922434|FG001|Overall Study|Death|2|||
161691971|NCT01639833|583922433|FG000|Overall Study|Withdrawal by Subject|2|||
161691972|NCT01639833|583922434|FG001|Overall Study|Withdrawal by Subject|2|||
161691973|NCT00070941|583922435|FG000|Overall Study|Adverse Event|10|||
161691974|NCT00070941|583922436|FG001|Overall Study|Adverse Event|8|||
161691975|NCT00070941|583922437|FG002|Overall Study|Adverse Event|4|||
161691976|NCT01888640|583922438|FG000|Overall Study|Lost to Follow-up|1|||
161691977|NCT01888640|583922439|FG001|Overall Study|Lost to Follow-up|2|||
161691978|NCT01888640|583922440|FG002|Overall Study|Lost to Follow-up|0|||
161691979|NCT01888640|583922438|FG000|Overall Study|Withdrawal by Subject|15|||
161691980|NCT01888640|583922439|FG001|Overall Study|Withdrawal by Subject|11|||
161691981|NCT01888640|583922440|FG002|Overall Study|Withdrawal by Subject|4|||
161691982|NCT01888640|583922438|FG000|Overall Study|Minimum dose not met|10|||
161691983|NCT01888640|583922439|FG001|Overall Study|Minimum dose not met|16|||
161691984|NCT01888640|583922440|FG002|Overall Study|Minimum dose not met|0|||
161691985|NCT01888640|583922438|FG000|Overall Study|Given wrong unit (placebo)|1|||
161691986|NCT01888640|583922439|FG001|Overall Study|Given wrong unit (placebo)|0|||
161691987|NCT01888640|583922440|FG002|Overall Study|Given wrong unit (placebo)|0|||
161691988|NCT01888640|583922438|FG000|Overall Study|Excluded for prior TENS|0|||
161691989|NCT01888640|583922439|FG001|Overall Study|Excluded for prior TENS|1|||
161691990|NCT01888640|583922440|FG002|Overall Study|Excluded for prior TENS|0|||
161691991|NCT01888640|583922438|FG000|Overall Study|Researcher Termination of Participant|0|||
161691992|NCT01888640|583922439|FG001|Overall Study|Researcher Termination of Participant|1|||
161691993|NCT01888640|583922440|FG002|Overall Study|Researcher Termination of Participant|1|||
161691994|NCT02199080|583922441|FG000|Overall Study|Protocol Violation|12|||
161691995|NCT01277549|583922442|FG000|Overall Study|Failed to meet eligibility criteria|13|||
161691996|NCT01277549|583922443|FG001|Overall Study|Failed to meet eligibility criteria|9|||
161691997|NCT01277549|583922442|FG000|Overall Study|Withdrawal by Subject|1|||
161691998|NCT01277549|583922443|FG001|Overall Study|Withdrawal by Subject|3|||
161691999|NCT01277549|583922442|FG000|Overall Study|Protocol Violation|10|||
161692000|NCT01277549|583922443|FG001|Overall Study|Protocol Violation|1|||
161692001|NCT01277549|583922442|FG000|Overall Study|Physician Decision|2|||
161692002|NCT01277549|583922443|FG001|Overall Study|Physician Decision|1|||
161692003|NCT01568593|583922444|FG000|Overall Study|Lack of Efficacy|4|||
161692004|NCT01568593|583922445|FG001|Overall Study|Lack of Efficacy|1|||
161692005|NCT01568593|583922444|FG000|Overall Study|Adverse Event|3|||
161692006|NCT01568593|583922445|FG001|Overall Study|Adverse Event|2|||
161692007|NCT02109484|583922446|FG000|Overall Study|Lost to Follow-up|0|||
161692008|NCT02109484|583922447|FG001|Overall Study|Lost to Follow-up|0|||
161692009|NCT02109484|583922448|FG002|Overall Study|Lost to Follow-up|0|||
161692010|NCT02109484|583922449|FG003|Overall Study|Lost to Follow-up|1|||
161692011|NCT02109484|583922450|FG004|Overall Study|Lost to Follow-up|1|||
161692012|NCT02109484|583922451|FG005|Overall Study|Lost to Follow-up|0|||
161692013|NCT02109484|583922452|FG006|Overall Study|Lost to Follow-up|1|||
161692014|NCT02109484|583922453|FG007|Overall Study|Lost to Follow-up|0|||
161692015|NCT02109484|583922446|FG000|Overall Study|Withdrawal by Subject|0|||
161692016|NCT02109484|583922447|FG001|Overall Study|Withdrawal by Subject|0|||
161692017|NCT02109484|583922448|FG002|Overall Study|Withdrawal by Subject|0|||
161692018|NCT02109484|583922449|FG003|Overall Study|Withdrawal by Subject|0|||
161692019|NCT02109484|583922450|FG004|Overall Study|Withdrawal by Subject|1|||
161692020|NCT02109484|583922451|FG005|Overall Study|Withdrawal by Subject|1|||
161692021|NCT02109484|583922452|FG006|Overall Study|Withdrawal by Subject|1|||
161692022|NCT02109484|583922453|FG007|Overall Study|Withdrawal by Subject|0|||
161692023|NCT02109484|583922446|FG000|Overall Study|Physician Decision|0|||
161692024|NCT02109484|583922447|FG001|Overall Study|Physician Decision|0|||
161692025|NCT02109484|583922448|FG002|Overall Study|Physician Decision|0|||
161692026|NCT02109484|583922449|FG003|Overall Study|Physician Decision|0|||
161692027|NCT02109484|583922450|FG004|Overall Study|Physician Decision|2|||
161692028|NCT02109484|583922451|FG005|Overall Study|Physician Decision|0|||
161692029|NCT02109484|583922452|FG006|Overall Study|Physician Decision|0|||
161692030|NCT02109484|583922453|FG007|Overall Study|Physician Decision|0|||
161692031|NCT02109484|583922446|FG000|Overall Study|Death|0|||
161692032|NCT02109484|583922447|FG001|Overall Study|Death|0|||
161692033|NCT02109484|583922448|FG002|Overall Study|Death|0|||
161692034|NCT02109484|583922449|FG003|Overall Study|Death|0|||
161692035|NCT02109484|583922450|FG004|Overall Study|Death|0|||
161692036|NCT02109484|583922451|FG005|Overall Study|Death|0|||
161692037|NCT02109484|583922452|FG006|Overall Study|Death|0|||
161692038|NCT02109484|583922453|FG007|Overall Study|Death|2|||
161692039|NCT02109484|583922446|FG000|Overall Study|Moved away from study area|0|||
161692040|NCT02109484|583922447|FG001|Overall Study|Moved away from study area|0|||
161692041|NCT02109484|583922448|FG002|Overall Study|Moved away from study area|0|||
161692042|NCT02109484|583922449|FG003|Overall Study|Moved away from study area|0|||
161692043|NCT02109484|583922450|FG004|Overall Study|Moved away from study area|0|||
161692044|NCT02109484|583922451|FG005|Overall Study|Moved away from study area|0|||
161692045|NCT02109484|583922452|FG006|Overall Study|Moved away from study area|1|||
161692046|NCT02109484|583922453|FG007|Overall Study|Moved away from study area|1|||
161692047|NCT01097863|583922454|FG000|Overall Study|Discomfort|1|||
161692048|NCT01097863|583922455|FG001|Overall Study|Discomfort|0|||
161692049|NCT01097863|583922456|FG002|Overall Study|Discomfort|1|||
161692050|NCT01097863|583922454|FG000|Overall Study|Did not return for final visit|0|||
161692051|NCT01097863|583922455|FG001|Overall Study|Did not return for final visit|0|||
161692052|NCT01097863|583922456|FG002|Overall Study|Did not return for final visit|1|||
161692053|NCT00419380|583922457|FG000|Overall Study|Lack of Efficacy|1|||
161692054|NCT00419380|583922458|FG001|Overall Study|Lack of Efficacy|7|||
161692055|NCT00419380|583922457|FG000|Overall Study|Physician Decision|0|||
161692056|NCT00419380|583922458|FG001|Overall Study|Physician Decision|1|||
161692057|NCT00419380|583922457|FG000|Overall Study|Lost to Follow-up|0|||
161692058|NCT00419380|583922458|FG001|Overall Study|Lost to Follow-up|1|||
161692059|NCT00419380|583922457|FG000|Overall Study|Withdrawal by Subject|0|||
161692060|NCT00419380|583922458|FG001|Overall Study|Withdrawal by Subject|1|||
161692061|NCT00796315|583922459|FG000|Overall Study|Protocol Violation|0|||
161692062|NCT00796315|583922460|FG001|Overall Study|Protocol Violation|1|||
161692063|NCT00796315|583922461|FG002|Overall Study|Protocol Violation|0|||
161692064|NCT03099707|583922462|FG000|Overall Study|Withdrawal by Subject|0|||
161692065|NCT03099707|583922463|FG001|Overall Study|Withdrawal by Subject|3|||
161692066|NCT03099707|583922462|FG000|Overall Study|Lost to Follow-up|0|||
161692067|NCT03099707|583922463|FG001|Overall Study|Lost to Follow-up|1|||
161692068|NCT01294579|583922469|FG000|Overall Study|Disease progression|12|||
161692069|NCT01294579|583922469|FG000|Overall Study|Adverse Event|11|||
161692070|NCT01294579|583922469|FG000|Overall Study|Study closed/terminated|3|||
161692071|NCT01294579|583922469|FG000|Overall Study|Lost to Follow-up|1|||
161692072|NCT01294579|583922469|FG000|Overall Study|Physician Decision|3|||
161692073|NCT01294579|583922469|FG000|Overall Study|Withdrawal by Subject|5|||
161692074|NCT02788747|583922470|FG000|Overall Study|Adverse Event|1|||
161692075|NCT02788747|583922471|FG001|Overall Study|Adverse Event|0|||
161692076|NCT02788747|583922472|FG002|Overall Study|Adverse Event|0|||
161692077|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
161692078|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
161692079|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
161692080|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
161692081|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
161692082|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
161692083|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
161692084|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
161692085|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
161692086|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
161692087|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
161692088|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
161692089|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
161692090|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
161692091|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
161692092|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
161692093|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
161692094|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
161692095|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
161692096|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
161692097|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
161692098|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
161692099|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
161692100|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
161692101|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
161692102|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
161692103|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
161692104|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
161692105|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
161692106|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
161692107|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
161692108|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
161692109|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
161692110|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
161692111|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
161692112|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
161692113|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
161692114|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
161692115|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
161692116|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161692117|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161692118|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
161692119|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
161692120|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
161692121|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
161692122|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161692123|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Adverse Event|1|||
161692124|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Adverse Event|1|||
161692125|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
161692126|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
161692127|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
161692128|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Family reasons|0|||
161692129|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Family reasons|0|||
161692130|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Family reasons|1|||
161692131|NCT00562354|583922476|FG000|Overall Study|Physician Decision|0|||
161692132|NCT00562354|583922477|FG001|Overall Study|Physician Decision|1|||
161692133|NCT00562354|583922476|FG000|Overall Study|Lost to Follow-up|0|||
161692134|NCT00562354|583922477|FG001|Overall Study|Lost to Follow-up|1|||
161692135|NCT03074474|583922483|FG000|Overall Study|Lost to Follow-up|10|||
161692136|NCT03074474|583922483|FG000|Overall Study|Withdrawal by Subject|10|||
161692137|NCT03074474|583922483|FG000|Overall Study|Death|4|||
161692138|NCT03074474|583922483|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
161692139|NCT01430455|583922494|FG000|Overall Study|Withdrawal by Subject|1|||
161692140|NCT01430455|583922494|FG000|Overall Study|Switched to follow-up phase|1|||
161692141|NCT05061719|583922498|FG000|Overall Study|Adverse Event|60|||
161692142|NCT05061719|583922498|FG000|Overall Study|Death|1|||
161692143|NCT05061719|583922498|FG000|Overall Study|Lack of Efficacy|7|||
161692144|NCT05061719|583922498|FG000|Overall Study|Lost to Follow-up|5|||
161692145|NCT05061719|583922498|FG000|Overall Study|Pregnancy|1|||
161692146|NCT05061719|583922498|FG000|Overall Study|Protocol Violation|8|||
161692147|NCT05061719|583922498|FG000|Overall Study|Withdrawal by Subject|41|||
161692148|NCT05061719|583922498|FG000|Overall Study|Site Closure|2|||
161692149|NCT00494091|583924267|FG000|Overall Study|Death|5|||
161692150|NCT00494091|583924268|FG001|Overall Study|Death|54|||
161692151|NCT00494091|583924267|FG000|Overall Study|Lost to Follow-up|0|||
161692152|NCT00494091|583924268|FG001|Overall Study|Lost to Follow-up|4|||
161692153|NCT00494091|583924267|FG000|Overall Study|Other|1|||
161692154|NCT00494091|583924268|FG001|Overall Study|Other|11|||
161692155|NCT00494091|583924267|FG000|Overall Study|Withdrawal by Subject|0|||
161692156|NCT00494091|583924268|FG001|Overall Study|Withdrawal by Subject|7|||
161692157|NCT01652287|583924269|FG000|Overall Study|Withdrawal by Subject|2|||
161692158|NCT01652287|583924270|FG001|Overall Study|Withdrawal by Subject|0|||
161692159|NCT00984204|583924282|FG000|Overall Study|Death|1|||
161692160|NCT00984204|583924282|FG000|Overall Study|Lost to Follow-up|4|||
161692161|NCT00984204|583924282|FG000|Overall Study|Lack of Efficacy|10|||
161692162|NCT04478708|583924286|FG000|Overall Study|Lost to Follow-up|0|||
161692163|NCT04478708|583924287|FG001|Overall Study|Lost to Follow-up|0|||
161692164|NCT04478708|583924288|FG002|Overall Study|Lost to Follow-up|0|||
161692165|NCT04478708|583924289|FG003|Overall Study|Lost to Follow-up|0|||
161692166|NCT04478708|583924290|FG004|Overall Study|Lost to Follow-up|0|||
161692167|NCT04478708|583924291|FG005|Overall Study|Lost to Follow-up|0|||
161692168|NCT04478708|583924292|FG006|Overall Study|Lost to Follow-up|0|||
161692169|NCT04478708|583924293|FG007|Overall Study|Lost to Follow-up|0|||
161692170|NCT04478708|583924294|FG008|Overall Study|Lost to Follow-up|1|||
161692171|NCT04478708|583924295|FG009|Overall Study|Lost to Follow-up|1|||
161692172|NCT04478708|583924296|FG010|Overall Study|Lost to Follow-up|1|||
161692173|NCT04478708|583924297|FG011|Overall Study|Lost to Follow-up|2|||
161692174|NCT04478708|583924298|FG012|Overall Study|Lost to Follow-up|1|||
161692175|NCT04478708|583924299|FG013|Overall Study|Lost to Follow-up|0|||
161692176|NCT04478708|583924300|FG014|Overall Study|Lost to Follow-up|0|||
161692177|NCT04478708|583924301|FG015|Overall Study|Lost to Follow-up|0|||
161692178|NCT04478708|583924302|FG016|Overall Study|Lost to Follow-up|0|||
161692179|NCT04478708|583924286|FG000|Overall Study|Withdrawal of consent from study|0|||
161692180|NCT04478708|583924287|FG001|Overall Study|Withdrawal of consent from study|1|||
161692181|NCT04478708|583924288|FG002|Overall Study|Withdrawal of consent from study|2|||
161692182|NCT04478708|583924289|FG003|Overall Study|Withdrawal of consent from study|0|||
161692183|NCT04478708|583924290|FG004|Overall Study|Withdrawal of consent from study|1|||
161692184|NCT04478708|583924291|FG005|Overall Study|Withdrawal of consent from study|1|||
161692185|NCT04478708|583924292|FG006|Overall Study|Withdrawal of consent from study|1|||
161692186|NCT04478708|583924293|FG007|Overall Study|Withdrawal of consent from study|0|||
161692187|NCT04478708|583924294|FG008|Overall Study|Withdrawal of consent from study|0|||
161692188|NCT04478708|583924295|FG009|Overall Study|Withdrawal of consent from study|0|||
161692189|NCT04478708|583924296|FG010|Overall Study|Withdrawal of consent from study|4|||
161692190|NCT04478708|583924297|FG011|Overall Study|Withdrawal of consent from study|3|||
161692191|NCT04478708|583924298|FG012|Overall Study|Withdrawal of consent from study|0|||
161692192|NCT04478708|583924299|FG013|Overall Study|Withdrawal of consent from study|0|||
161692193|NCT04478708|583924300|FG014|Overall Study|Withdrawal of consent from study|1|||
161692194|NCT04478708|583924301|FG015|Overall Study|Withdrawal of consent from study|0|||
161692195|NCT04478708|583924302|FG016|Overall Study|Withdrawal of consent from study|4|||
161692196|NCT01869114|583924303|FG000|Overall Study|Death|19|||
161692197|NCT01869114|583924304|FG001|Overall Study|Death|18|||
161692198|NCT01869114|583924305|FG002|Overall Study|Death|8|||
161692199|NCT01869114|583924303|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
161692200|NCT01869114|583924304|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
161692201|NCT01869114|583924305|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
161692202|NCT01869114|583924303|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
161692203|NCT01869114|583924304|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
161692204|NCT01869114|583924305|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
161692205|NCT01869114|583924303|FG000|Overall Study|Withdrawal by Subject|0|||
161692206|NCT01869114|583924304|FG001|Overall Study|Withdrawal by Subject|3|||
161692207|NCT01869114|583924305|FG002|Overall Study|Withdrawal by Subject|0|||
161692208|NCT01869114|583924303|FG000|Overall Study|Disease Progression|0|||
161692209|NCT01869114|583924304|FG001|Overall Study|Disease Progression|1|||
161692210|NCT01869114|583924305|FG002|Overall Study|Disease Progression|0|||
161692211|NCT00559507|583924306|FG000|Overall Study|Not treated, patient ineligible|3|||
161692212|NCT01407926|583924307|FG000|Overall Study|Lost to Follow-up|55|||
161692213|NCT02118792|583924308|FG000|Overall Study|Withdrawal by Subject|6|||
161692214|NCT02118792|583924309|FG001|Overall Study|Withdrawal by Subject|3|||
161692215|NCT02118792|583924308|FG000|Overall Study|Lost to Follow-up|4|||
161692216|NCT02118792|583924309|FG001|Overall Study|Lost to Follow-up|4|||
161692217|NCT02118792|583924308|FG000|Overall Study|Adverse Event|5|||
161692218|NCT02118792|583924309|FG001|Overall Study|Adverse Event|4|||
161692219|NCT02118792|583924308|FG000|Overall Study|Withdrawal by parent/guardian|14|||
161692220|NCT02118792|583924309|FG001|Overall Study|Withdrawal by parent/guardian|20|||
161692221|NCT02118792|583924308|FG000|Overall Study|Other|1|||
161692222|NCT02118792|583924309|FG001|Overall Study|Other|6|||
161692223|NCT02118792|583924308|FG000|Overall Study|Randomised but not treated|1|||
161692224|NCT02118792|583924309|FG001|Overall Study|Randomised but not treated|0|||
161692225|NCT01885000|583924310|FG000|Overall Study|Adverse Event|1|||
161692226|NCT01885000|583924311|FG001|Overall Study|Adverse Event|0|||
161692227|NCT01885000|583924310|FG000|Overall Study|Withdrawal by Subject|1|||
161836347|NCT03395639|584442943|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
161836348|NCT03395639|584442941|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
161836349|NCT03395639|584442942|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
161836350|NCT03395639|584442943|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
161836351|NCT03395639|584442941|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
161836352|NCT03395639|584442942|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
161836353|NCT03395639|584442943|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
161836354|NCT00942331|584442944|FG000|Overall Study|Did not start treatment|15|||
161692228|NCT01885000|583924311|FG001|Overall Study|Withdrawal by Subject|1|||
161692229|NCT01885000|583924310|FG000|Overall Study|Protocol Violation|0|||
161692230|NCT01885000|583924311|FG001|Overall Study|Protocol Violation|1|||
161692231|NCT02792842|583924315|FG000|Overall Study|Adverse Event|4|||
161692232|NCT02792842|583924316|FG001|Overall Study|Adverse Event|2|||
161692233|NCT02792842|583924317|FG002|Overall Study|Adverse Event|3|||
161692234|NCT02792842|583924315|FG000|Overall Study|Withdrawal by Subject|0|||
161652245|NCT03203473|583779247|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
161652246|NCT03203473|583779248|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
161652247|NCT03203473|583779249|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
161652248|NCT03203473|583779247|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
161652249|NCT03203473|583779248|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
161652250|NCT03203473|583779249|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
161652251|NCT03203473|583779247|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
161652252|NCT03203473|583779248|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
161652253|NCT03203473|583779249|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
161652254|NCT03203473|583779247|FG000|Arm Allocation Phase|started salvage therapy|0|||
161652255|NCT03203473|583779248|FG001|Arm Allocation Phase|started salvage therapy|5|||
161652256|NCT03203473|583779249|FG002|Arm Allocation Phase|started salvage therapy|0|||
161652257|NCT03203473|583779247|FG000|Arm Allocation Phase|Disease progression|0|||
161652258|NCT03203473|583779248|FG001|Arm Allocation Phase|Disease progression|0|||
161652259|NCT03203473|583779249|FG002|Arm Allocation Phase|Disease progression|37|||
161652260|NCT03203473|583779247|FG000|Arm Allocation Phase|Adverse Event|0|||
161652261|NCT03203473|583779248|FG001|Arm Allocation Phase|Adverse Event|0|||
161652262|NCT03203473|583779249|FG002|Arm Allocation Phase|Adverse Event|11|||
161652263|NCT03203473|583779247|FG000|Arm Allocation Phase|Physician Decision|0|||
161652264|NCT03203473|583779248|FG001|Arm Allocation Phase|Physician Decision|0|||
161652265|NCT03203473|583779249|FG002|Arm Allocation Phase|Physician Decision|3|||
161652266|NCT03203473|583779247|FG000|Arm Allocation Phase|Death|0|||
161652267|NCT03203473|583779248|FG001|Arm Allocation Phase|Death|0|||
161652268|NCT03203473|583779249|FG002|Arm Allocation Phase|Death|1|||
161652269|NCT03203473|583779247|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
161652270|NCT03203473|583779248|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
161652271|NCT03203473|583779249|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
161652272|NCT03203473|583779247|FG000|Arm Allocation Phase|Intercurrent illness|0|||
161652273|NCT03203473|583779248|FG001|Arm Allocation Phase|Intercurrent illness|0|||
161652274|NCT03203473|583779249|FG002|Arm Allocation Phase|Intercurrent illness|1|||
161652275|NCT03203473|583779247|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
161652276|NCT03203473|583779248|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
161652277|NCT03203473|583779249|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
161652278|NCT00890695|583779250|FG000|Overall Study|Protocol Violation|1|||
161652279|NCT00890695|583779251|FG001|Overall Study|Protocol Violation|0|||
161652280|NCT04396366|583779254|FG000|Overall Study|Adverse Event|1|||
161652281|NCT04396366|583779255|FG001|Overall Study|Adverse Event|0|||
161652282|NCT01531673|583779256|FG000|Overall Study|Non-Compliance|0|||
161652283|NCT01531673|583779257|FG001|Overall Study|Non-Compliance|0|||
161652284|NCT01531673|583779258|FG002|Overall Study|Non-Compliance|0|||
161652285|NCT01531673|583779259|FG003|Overall Study|Non-Compliance|0|||
161652286|NCT01531673|583779260|FG004|Overall Study|Non-Compliance|0|||
161652287|NCT01531673|583779261|FG005|Overall Study|Non-Compliance|1|||
161652288|NCT01531673|583779262|FG006|Overall Study|Non-Compliance|0|||
161652289|NCT01531673|583779263|FG007|Overall Study|Non-Compliance|0|||
161652290|NCT01531673|583779264|FG008|Overall Study|Non-Compliance|0|||
161652291|NCT01531673|583779265|FG009|Overall Study|Non-Compliance|0|||
161652292|NCT01531673|583779266|FG010|Overall Study|Non-Compliance|0|||
161652293|NCT01531673|583779267|FG011|Overall Study|Non-Compliance|0|||
161652294|NCT01531673|583779268|FG012|Overall Study|Non-Compliance|0|||
161652295|NCT01531673|583779256|FG000|Overall Study|Adverse Event|0|||
161652296|NCT01531673|583779257|FG001|Overall Study|Adverse Event|1|||
161692235|NCT02792842|583924316|FG001|Overall Study|Withdrawal by Subject|1|||
161652297|NCT01531673|583779258|FG002|Overall Study|Adverse Event|0|||
161652298|NCT01531673|583779259|FG003|Overall Study|Adverse Event|0|||
161652299|NCT01531673|583779260|FG004|Overall Study|Adverse Event|0|||
161652300|NCT01531673|583779261|FG005|Overall Study|Adverse Event|0|||
161652301|NCT01531673|583779262|FG006|Overall Study|Adverse Event|0|||
161692236|NCT02792842|583924317|FG002|Overall Study|Withdrawal by Subject|2|||
161652302|NCT01531673|583779263|FG007|Overall Study|Adverse Event|0|||
161652303|NCT01531673|583779264|FG008|Overall Study|Adverse Event|0|||
161652304|NCT01531673|583779265|FG009|Overall Study|Adverse Event|0|||
161652305|NCT01531673|583779266|FG010|Overall Study|Adverse Event|0|||
161652306|NCT01531673|583779267|FG011|Overall Study|Adverse Event|0|||
161652307|NCT01531673|583779268|FG012|Overall Study|Adverse Event|0|||
161652308|NCT01531673|583779256|FG000|Overall Study|Lost to Follow-up|0|||
161652309|NCT01531673|583779257|FG001|Overall Study|Lost to Follow-up|0|||
161692237|NCT02792842|583924315|FG000|Overall Study|Lost to Follow-up|0|||
161692238|NCT02792842|583924316|FG001|Overall Study|Lost to Follow-up|0|||
161692239|NCT02792842|583924317|FG002|Overall Study|Lost to Follow-up|1|||
161692240|NCT02792842|583924315|FG000|Overall Study|Schedule delay|0|||
161692241|NCT02792842|583924316|FG001|Overall Study|Schedule delay|1|||
161692242|NCT02792842|583924317|FG002|Overall Study|Schedule delay|1|||
161692243|NCT05617911|583924325|FG000|Overall Study|Withdrawal by Subject|1|||
161692244|NCT05617911|583924326|FG001|Overall Study|Withdrawal by Subject|0|||
161692245|NCT03557359|583924327|FG000|Dose 1: 240 mg|Adverse Event|1|||
161692246|NCT03557359|583924328|FG001|Dose 1: 240 mg|Adverse Event|0|||
161692247|NCT03975647|583924329|FG000|Overall Study|Death|71|||
161692248|NCT03975647|583924330|FG001|Overall Study|Death|63|||
161692249|NCT03975647|583924329|FG000|Overall Study|Lost to Follow-up|2|||
161692250|NCT03975647|583924330|FG001|Overall Study|Lost to Follow-up|2|||
161692251|NCT03975647|583924329|FG000|Overall Study|Subject withdrawal of consent|7|||
161692252|NCT03975647|583924330|FG001|Overall Study|Subject withdrawal of consent|11|||
161692253|NCT04868903|583924331|FG000|Overall Study|Adverse Event|0|||
161692254|NCT04868903|583924332|FG001|Overall Study|Adverse Event|0|||
161692255|NCT04868903|583924333|FG002|Overall Study|Adverse Event|0|||
161692256|NCT04868903|583924334|FG003|Overall Study|Adverse Event|1|||
161692257|NCT04868903|583924331|FG000|Overall Study|Withdrawal by Subject|29|||
161692258|NCT04868903|583924332|FG001|Overall Study|Withdrawal by Subject|44|||
161692259|NCT04868903|583924333|FG002|Overall Study|Withdrawal by Subject|17|||
161692260|NCT04868903|583924334|FG003|Overall Study|Withdrawal by Subject|12|||
161692261|NCT04868903|583924331|FG000|Overall Study|Hyperparathyroidism|3|||
161692262|NCT04868903|583924332|FG001|Overall Study|Hyperparathyroidism|5|||
161692263|NCT04868903|583924333|FG002|Overall Study|Hyperparathyroidism|2|||
161692264|NCT04868903|583924334|FG003|Overall Study|Hyperparathyroidism|3|||
161836355|NCT00942331|584442945|FG001|Overall Study|Did not start treatment|22|||
161836356|NCT00995085|584442950|FG000|Overall Study|Withdrawal by Subject|5|||
161836357|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
161836358|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
161836359|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
161836360|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
161836361|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
161836362|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
161836363|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161836364|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
161836365|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161836366|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161836367|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
161836368|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
161836369|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
161836370|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
161836371|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
161836372|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
161836373|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
161836374|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
161836375|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
161836376|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
161836377|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Unclassified|14|||
161836378|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Unclassified|4|||
161836379|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Unclassified|8|||
161836380|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Unclassified|0|||
161836381|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Unclassified|0|||
161836382|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
161836383|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
161836384|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
161836385|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
161836386|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
161836387|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
161836388|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
161692265|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
161692266|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
161692267|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
161692268|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
161692269|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
161836389|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
161836390|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
161836391|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
161692270|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
161836392|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
161652310|NCT01531673|583779258|FG002|Overall Study|Lost to Follow-up|0|||
161652311|NCT01531673|583779259|FG003|Overall Study|Lost to Follow-up|0|||
161652312|NCT01531673|583779260|FG004|Overall Study|Lost to Follow-up|1|||
161652313|NCT01531673|583779261|FG005|Overall Study|Lost to Follow-up|0|||
161652314|NCT01531673|583779262|FG006|Overall Study|Lost to Follow-up|0|||
161652315|NCT01531673|583779263|FG007|Overall Study|Lost to Follow-up|0|||
161692271|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
161692272|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
161692273|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
161692274|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
161692275|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
161692276|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
161692277|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
161692278|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
161692279|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
161692280|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
161692281|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
161692282|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
161692283|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
161692284|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
161692285|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
161692286|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
161692287|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
161692288|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
161692289|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
161692290|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
161692291|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
161692292|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
161692293|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
161692294|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
161692295|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
161692296|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
161692297|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
161692298|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
161692299|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
161692300|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
161692301|NCT03092726|583924338|FG000|Overall Study|Adverse Event|3|||
161692302|NCT03092726|583924339|FG001|Overall Study|Adverse Event|10|||
161692303|NCT03092726|583924338|FG000|Overall Study|Lack of Efficacy|0|||
161692304|NCT03092726|583924339|FG001|Overall Study|Lack of Efficacy|1|||
161692305|NCT03092726|583924338|FG000|Overall Study|Lost to Follow-up|1|||
161692306|NCT03092726|583924339|FG001|Overall Study|Lost to Follow-up|0|||
161692307|NCT03092726|583924338|FG000|Overall Study|Withdrawal by Subject|5|||
161692308|NCT03092726|583924339|FG001|Overall Study|Withdrawal by Subject|3|||
161692309|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
161692310|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
161692311|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
161692312|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
161692313|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
161692314|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
161692315|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
161692316|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
161652316|NCT01531673|583779264|FG008|Overall Study|Lost to Follow-up|0|||
161652317|NCT01531673|583779265|FG009|Overall Study|Lost to Follow-up|0|||
161652318|NCT01531673|583779266|FG010|Overall Study|Lost to Follow-up|0|||
161652319|NCT01531673|583779267|FG011|Overall Study|Lost to Follow-up|0|||
161652320|NCT01531673|583779268|FG012|Overall Study|Lost to Follow-up|0|||
161652321|NCT01531673|583779256|FG000|Overall Study|Other|0|||
161692317|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
161692318|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
161692319|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
161692320|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
161692321|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
161692322|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
161692323|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
161692324|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
161652322|NCT01531673|583779257|FG001|Overall Study|Other|0|||
161652323|NCT01531673|583779258|FG002|Overall Study|Other|0|||
161652324|NCT01531673|583779259|FG003|Overall Study|Other|1|||
161652325|NCT01531673|583779260|FG004|Overall Study|Other|0|||
161652326|NCT01531673|583779261|FG005|Overall Study|Other|0|||
161652327|NCT01531673|583779262|FG006|Overall Study|Other|0|||
161652328|NCT01531673|583779263|FG007|Overall Study|Other|0|||
161652329|NCT01531673|583779264|FG008|Overall Study|Other|0|||
161652330|NCT01531673|583779265|FG009|Overall Study|Other|1|||
161652331|NCT01531673|583779266|FG010|Overall Study|Other|0|||
161652332|NCT01531673|583779267|FG011|Overall Study|Other|0|||
161652333|NCT01531673|583779268|FG012|Overall Study|Other|0|||
161652334|NCT01014208|583779272|FG000|Overall Study|Lost to Follow-up|2|||
161652335|NCT01014208|583779273|FG001|Overall Study|Lost to Follow-up|5|||
161652336|NCT01014208|583779272|FG000|Overall Study|Participant Withdrew Consent|12|||
161652337|NCT01014208|583779273|FG001|Overall Study|Participant Withdrew Consent|12|||
161652338|NCT01014208|583779272|FG000|Overall Study|Did Not Receive Study Drug|2|||
161652339|NCT01014208|583779273|FG001|Overall Study|Did Not Receive Study Drug|0|||
161652340|NCT01014208|583779272|FG000|Overall Study|Study Closed/terminated|78|||
161652341|NCT01014208|583779273|FG001|Overall Study|Study Closed/terminated|83|||
161652342|NCT01008410|583779276|FG000|Overall Study|Adverse Event|13|||
161652343|NCT01008410|583779277|FG001|Overall Study|Adverse Event|7|||
161652344|NCT01008410|583779276|FG000|Overall Study|Withdrawal by Subject|6|||
161652345|NCT01008410|583779277|FG001|Overall Study|Withdrawal by Subject|2|||
161652346|NCT01008410|583779276|FG000|Overall Study|Lost to Follow-up|1|||
161652347|NCT01008410|583779277|FG001|Overall Study|Lost to Follow-up|0|||
161652348|NCT01008410|583779276|FG000|Overall Study|Noncompliance|1|||
161652349|NCT01008410|583779277|FG001|Overall Study|Noncompliance|0|||
161652350|NCT01008410|583779276|FG000|Overall Study|Low Cortisol|2|||
161652351|NCT01008410|583779277|FG001|Overall Study|Low Cortisol|0|||
161652352|NCT01008410|583779276|FG000|Overall Study|Lack of Efficacy|2|||
161652353|NCT01008410|583779277|FG001|Overall Study|Lack of Efficacy|6|||
161652354|NCT01008410|583779276|FG000|Overall Study|Met Exclusion Criterion|0|||
161652355|NCT01008410|583779277|FG001|Overall Study|Met Exclusion Criterion|1|||
161652356|NCT00297427|583779280|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
161652357|NCT00297427|583779281|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
161652358|NCT00297427|583779280|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
161652359|NCT00297427|583779281|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
161652360|NCT00297427|583779280|FG000|Phase 1: Initial Intervention|Death|0|||
161652361|NCT00297427|583779281|FG001|Phase 1: Initial Intervention|Death|1|||
161652362|NCT00297427|583779280|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
161652363|NCT00297427|583779281|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
161652364|NCT00297427|583779280|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
161652365|NCT00297427|583779281|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
161652366|NCT00297427|583779280|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
161652367|NCT00297427|583779281|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
161652368|NCT00297427|583779280|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
161652369|NCT00297427|583779281|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
161652370|NCT00297427|583779280|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
161652371|NCT00297427|583779281|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
161652372|NCT01127893|583779282|FG000|Overall Study|Study Termination by the Sponsor|1|||
161652373|NCT01262677|583779283|FG000|Overall Study|Does not meet entrance criteria|0|||
161652374|NCT01262677|583779284|FG001|Overall Study|Does not meet entrance criteria|2|||
161652375|NCT01262677|583779285|FG002|Overall Study|Does not meet entrance criteria|0|||
161652376|NCT01262677|583779283|FG000|Overall Study|Insufficient clinical response|0|||
161652377|NCT01262677|583779284|FG001|Overall Study|Insufficient clinical response|0|||
161652378|NCT01262677|583779285|FG002|Overall Study|Insufficient clinical response|1|||
161652379|NCT01262677|583779283|FG000|Overall Study|Lost to Follow-up|1|||
161652380|NCT01262677|583779284|FG001|Overall Study|Lost to Follow-up|0|||
161652381|NCT01262677|583779285|FG002|Overall Study|Lost to Follow-up|2|||
161652382|NCT01262677|583779283|FG000|Overall Study|No longer willing to participate|3|||
161652383|NCT01262677|583779284|FG001|Overall Study|No longer willing to participate|3|||
161652384|NCT01262677|583779285|FG002|Overall Study|No longer willing to participate|2|||
161652385|NCT01262677|583779283|FG000|Overall Study|Reason not provided|2|||
161652386|NCT01262677|583779284|FG001|Overall Study|Reason not provided|1|||
161652387|NCT01262677|583779285|FG002|Overall Study|Reason not provided|3|||
161652388|NCT01262677|583779283|FG000|Overall Study|Protocol Violation|0|||
161692325|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
161692326|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
161692327|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
161692328|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
161692329|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
161692330|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
161692331|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
161692332|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
161692333|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
161692334|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
161692335|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
161692336|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
161692337|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
161692338|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
161692339|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
161692340|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
161692341|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
161692342|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
161692343|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
161692344|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
161692345|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Other than specified|0|||
161692346|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Other than specified|5|||
161692347|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Other than specified|2|||
161692348|NCT01926782|583924351|FG000|Overall Study|Participant moved|2|||
161692349|NCT01926782|583924352|FG001|Overall Study|Participant moved|0|||
161692350|NCT01926782|583924353|FG002|Overall Study|Participant moved|1|||
161692351|NCT01926782|583924354|FG003|Overall Study|Participant moved|1|||
161692352|NCT01926782|583924355|FG004|Overall Study|Participant moved|0|||
161692353|NCT01926782|583924356|FG005|Overall Study|Participant moved|3|||
161692354|NCT01926782|583924351|FG000|Overall Study|Physician Decision|0|||
161692355|NCT01926782|583924352|FG001|Overall Study|Physician Decision|2|||
161692356|NCT01926782|583924353|FG002|Overall Study|Physician Decision|1|||
161692357|NCT01926782|583924354|FG003|Overall Study|Physician Decision|1|||
161692358|NCT01926782|583924355|FG004|Overall Study|Physician Decision|0|||
161692359|NCT01926782|583924356|FG005|Overall Study|Physician Decision|0|||
161692360|NCT01926782|583924351|FG000|Overall Study|Other than specified|2|||
161692361|NCT01926782|583924352|FG001|Overall Study|Other than specified|3|||
161692362|NCT01926782|583924353|FG002|Overall Study|Other than specified|5|||
161692363|NCT01926782|583924354|FG003|Overall Study|Other than specified|12|||
161692364|NCT01926782|583924355|FG004|Overall Study|Other than specified|4|||
161692365|NCT01926782|583924356|FG005|Overall Study|Other than specified|11|||
161692366|NCT01926782|583924351|FG000|Overall Study|Adverse Event|13|||
161692367|NCT01926782|583924352|FG001|Overall Study|Adverse Event|4|||
161692368|NCT01926782|583924353|FG002|Overall Study|Adverse Event|17|||
161692369|NCT01926782|583924354|FG003|Overall Study|Adverse Event|4|||
161692370|NCT01926782|583924355|FG004|Overall Study|Adverse Event|3|||
161692371|NCT01926782|583924356|FG005|Overall Study|Adverse Event|14|||
161692372|NCT01926782|583924351|FG000|Overall Study|Poor compliance to protocol|5|||
161692373|NCT01926782|583924352|FG001|Overall Study|Poor compliance to protocol|3|||
161692374|NCT01926782|583924353|FG002|Overall Study|Poor compliance to protocol|8|||
161692375|NCT01926782|583924354|FG003|Overall Study|Poor compliance to protocol|0|||
161692376|NCT01926782|583924355|FG004|Overall Study|Poor compliance to protocol|1|||
161692377|NCT01926782|583924356|FG005|Overall Study|Poor compliance to protocol|6|||
161836393|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
161692378|NCT01926782|583924351|FG000|Overall Study|Randomized and not treated|0|||
161692379|NCT01926782|583924352|FG001|Overall Study|Randomized and not treated|0|||
161692380|NCT01926782|583924353|FG002|Overall Study|Randomized and not treated|0|||
161692381|NCT01926782|583924354|FG003|Overall Study|Randomized and not treated|1|||
161692382|NCT01926782|583924355|FG004|Overall Study|Randomized and not treated|0|||
161692383|NCT01926782|583924356|FG005|Overall Study|Randomized and not treated|0|||
161692384|NCT01926782|583924351|FG000|Overall Study|Withdrawal by Subject|6|||
161692385|NCT01926782|583924352|FG001|Overall Study|Withdrawal by Subject|1|||
161692386|NCT01926782|583924353|FG002|Overall Study|Withdrawal by Subject|8|||
161692387|NCT01926782|583924354|FG003|Overall Study|Withdrawal by Subject|1|||
161692388|NCT01926782|583924355|FG004|Overall Study|Withdrawal by Subject|0|||
161692389|NCT01926782|583924356|FG005|Overall Study|Withdrawal by Subject|5|||
161692390|NCT01926782|583924351|FG000|Overall Study|Related to study drug administration|0|||
161692391|NCT01926782|583924352|FG001|Overall Study|Related to study drug administration|0|||
161692392|NCT01926782|583924353|FG002|Overall Study|Related to study drug administration|0|||
161692393|NCT01926782|583924354|FG003|Overall Study|Related to study drug administration|0|||
161692394|NCT01926782|583924355|FG004|Overall Study|Related to study drug administration|0|||
161692395|NCT01926782|583924356|FG005|Overall Study|Related to study drug administration|2|||
161692396|NCT04607733|583924359|FG000|Overall Study|Lost to Follow-up|1|||
161692397|NCT04607733|583924360|FG001|Overall Study|Lost to Follow-up|0|||
161692398|NCT04607733|583924361|FG002|Overall Study|Lost to Follow-up|0|||
161692399|NCT04607733|583924362|FG003|Overall Study|Lost to Follow-up|1|||
161692400|NCT04607733|583924363|FG004|Overall Study|Lost to Follow-up|1|||
161692401|NCT04607733|583924364|FG005|Overall Study|Lost to Follow-up|0|||
161692402|NCT04607733|583924359|FG000|Overall Study|Withdrawal by Subject|0|||
161692403|NCT04607733|583924360|FG001|Overall Study|Withdrawal by Subject|0|||
161692404|NCT04607733|583924361|FG002|Overall Study|Withdrawal by Subject|0|||
161692405|NCT04607733|583924362|FG003|Overall Study|Withdrawal by Subject|0|||
161692406|NCT04607733|583924363|FG004|Overall Study|Withdrawal by Subject|1|||
161692407|NCT04607733|583924364|FG005|Overall Study|Withdrawal by Subject|0|||
161692408|NCT03504397|583924370|FG000|Overall Study|Progressive Disease|151|||
161692409|NCT03504397|583924371|FG001|Overall Study|Progressive Disease|199|||
161692410|NCT03504397|583924370|FG000|Overall Study|Withdrawal by Subject|29|||
161692411|NCT03504397|583924371|FG001|Overall Study|Withdrawal by Subject|17|||
161692412|NCT03504397|583924370|FG000|Overall Study|Lost to Follow-up|1|||
161692413|NCT03504397|583924371|FG001|Overall Study|Lost to Follow-up|0|||
161692414|NCT03504397|583924370|FG000|Overall Study|Death|14|||
161692415|NCT03504397|583924371|FG001|Overall Study|Death|16|||
161692416|NCT03504397|583924370|FG000|Overall Study|Adverse Event|40|||
161692417|NCT03504397|583924371|FG001|Overall Study|Adverse Event|14|||
161692418|NCT03504397|583924370|FG000|Overall Study|miscellaneous|17|||
161692419|NCT03504397|583924371|FG001|Overall Study|miscellaneous|15|||
161692420|NCT03504397|583924370|FG000|Overall Study|Protocol deviation|1|||
161692421|NCT03504397|583924371|FG001|Overall Study|Protocol deviation|0|||
161692422|NCT03504397|583924370|FG000|Overall Study|Participants who did not take the study drug|4|||
161692423|NCT03504397|583924371|FG001|Overall Study|Participants who did not take the study drug|4|||
161692424|NCT02443883|583924372|FG000|Overall Study|Adverse Event|0|||
161692425|NCT02443883|583924373|FG001|Overall Study|Adverse Event|1|||
161692426|NCT02443883|583924374|FG002|Overall Study|Adverse Event|0|||
161692427|NCT02443883|583924375|FG003|Overall Study|Adverse Event|0|||
161692428|NCT02443883|583924372|FG000|Overall Study|Lost to Follow-up|3|||
161692429|NCT02443883|583924373|FG001|Overall Study|Lost to Follow-up|2|||
161692430|NCT02443883|583924374|FG002|Overall Study|Lost to Follow-up|1|||
161692431|NCT02443883|583924375|FG003|Overall Study|Lost to Follow-up|0|||
161692432|NCT02443883|583924372|FG000|Overall Study|Physician Decision|1|||
161692433|NCT02443883|583924373|FG001|Overall Study|Physician Decision|1|||
161692434|NCT02443883|583924374|FG002|Overall Study|Physician Decision|0|||
161692435|NCT02443883|583924375|FG003|Overall Study|Physician Decision|3|||
161692436|NCT02443883|583924372|FG000|Overall Study|Withdrawal by Subject|1|||
161692437|NCT02443883|583924373|FG001|Overall Study|Withdrawal by Subject|0|||
161692438|NCT02443883|583924374|FG002|Overall Study|Withdrawal by Subject|0|||
161692439|NCT02443883|583924375|FG003|Overall Study|Withdrawal by Subject|2|||
161692440|NCT02443883|583924372|FG000|Overall Study|Randomized, but never treated|1|||
161692441|NCT02443883|583924373|FG001|Overall Study|Randomized, but never treated|0|||
161692442|NCT02443883|583924374|FG002|Overall Study|Randomized, but never treated|0|||
161692443|NCT02443883|583924375|FG003|Overall Study|Randomized, but never treated|0|||
161692444|NCT00999908|583924376|FG000|Treatment Period 1|Subject withdrew consent|2|||
161692445|NCT00999908|583924377|FG001|Treatment Period 1|Subject withdrew consent|0|||
161836394|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
161836395|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
161836396|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
161692446|NCT00999908|583924378|FG002|Treatment Period 1|Subject withdrew consent|0|||
161692447|NCT00999908|583924376|FG000|Treatment Period 2|Protocol Violation|1|||
161692448|NCT00999908|583924377|FG001|Treatment Period 2|Protocol Violation|0|||
161692449|NCT00999908|583924378|FG002|Treatment Period 2|Protocol Violation|0|||
161692450|NCT03167073|583924379|FG000|Overall Study|Stillbirth|1|||
161692451|NCT03167073|583924380|FG001|Overall Study|Stillbirth|0|||
161692452|NCT01079182|583924383|FG000|Overall Study|Lost to Follow-up|1634|||
161692453|NCT01079182|583924383|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
161692454|NCT01079182|583924383|FG000|Overall Study|Lack of Efficacy|514|||
161692455|NCT01079182|583924383|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
161692456|NCT01079182|583924383|FG000|Overall Study|Reasons not Evaluated|271|||
161692457|NCT01026831|583924384|FG000|Overall Study|Adverse Event|4|||
161652389|NCT01262677|583779284|FG001|Overall Study|Protocol Violation|1|||
161652390|NCT01262677|583779285|FG002|Overall Study|Protocol Violation|1|||
161652391|NCT01262677|583779283|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
161652392|NCT01262677|583779284|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
161652393|NCT01262677|583779285|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
161652394|NCT02787044|583779288|FG000|Overall Study|Lost to Follow-up|15|||
161652395|NCT02787044|583779289|FG001|Overall Study|Lost to Follow-up|19|||
161652396|NCT00567567|583779290|FG000|Overall Study|Adverse Event|0|||
161652397|NCT00567567|583779291|FG001|Overall Study|Adverse Event|2|||
161652398|NCT00567567|583779292|FG002|Overall Study|Adverse Event|5|||
161652399|NCT00567567|583779290|FG000|Overall Study|Death|8|||
161652400|NCT00567567|583779291|FG001|Overall Study|Death|1|||
161652401|NCT00567567|583779292|FG002|Overall Study|Death|5|||
161652402|NCT00567567|583779290|FG000|Overall Study|Lack of Efficacy|16|||
161652403|NCT00567567|583779291|FG001|Overall Study|Lack of Efficacy|17|||
161652404|NCT00567567|583779292|FG002|Overall Study|Lack of Efficacy|48|||
161652405|NCT00567567|583779290|FG000|Overall Study|Lost to Follow-up|0|||
161652406|NCT00567567|583779291|FG001|Overall Study|Lost to Follow-up|0|||
161652407|NCT00567567|583779292|FG002|Overall Study|Lost to Follow-up|1|||
161652408|NCT00567567|583779290|FG000|Overall Study|Physician Decision|16|||
161652409|NCT00567567|583779291|FG001|Overall Study|Physician Decision|18|||
161652410|NCT00567567|583779292|FG002|Overall Study|Physician Decision|84|||
161652411|NCT00567567|583779290|FG000|Overall Study|Withdrawal by Subject|0|||
161652412|NCT00567567|583779291|FG001|Overall Study|Withdrawal by Subject|0|||
161652413|NCT00567567|583779292|FG002|Overall Study|Withdrawal by Subject|2|||
161652414|NCT00567567|583779290|FG000|Overall Study|Ineligible|4|||
161652415|NCT00567567|583779291|FG001|Overall Study|Ineligible|0|||
161652416|NCT00567567|583779292|FG002|Overall Study|Ineligible|9|||
161652417|NCT00567567|583779290|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
161652418|NCT00567567|583779291|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
161652419|NCT00567567|583779292|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
161652420|NCT00567567|583779290|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
161652421|NCT00567567|583779291|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
161652422|NCT00567567|583779292|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
161652423|NCT00567567|583779290|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
161652424|NCT00567567|583779291|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
161652425|NCT00567567|583779292|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
161652426|NCT03433677|583779293|FG000|Period 1|Protocol Violation|1|||
161652427|NCT03433677|583779294|FG001|Period 1|Protocol Violation|0|||
161652428|NCT03433677|583779293|FG000|Period 2|Withdrawal by Subject|1|||
161652429|NCT03433677|583779294|FG001|Period 2|Withdrawal by Subject|1|||
161652430|NCT03330405|583779295|FG000|Overall Study|Other|1|||
161652431|NCT03330405|583779296|FG001|Overall Study|Other|3|||
161652432|NCT03330405|583779297|FG002|Overall Study|Other|1|||
161652433|NCT03330405|583779298|FG003|Overall Study|Other|0|||
161652434|NCT03330405|583779299|FG004|Overall Study|Other|2|||
161652435|NCT03330405|583779300|FG005|Overall Study|Other|0|||
161652436|NCT03330405|583779301|FG006|Overall Study|Other|1|||
161652437|NCT03330405|583779302|FG007|Overall Study|Other|0|||
161652438|NCT03330405|583779303|FG008|Overall Study|Other|0|||
161652439|NCT03330405|583779304|FG009|Overall Study|Other|0|||
161652440|NCT03330405|583779305|FG010|Overall Study|Other|0|||
161652441|NCT03330405|583779295|FG000|Overall Study|Progressive disease|8|||
161652442|NCT03330405|583779296|FG001|Overall Study|Progressive disease|27|||
161652443|NCT03330405|583779297|FG002|Overall Study|Progressive disease|4|||
161652444|NCT03330405|583779298|FG003|Overall Study|Progressive disease|18|||
161652445|NCT03330405|583779299|FG004|Overall Study|Progressive disease|16|||
161652446|NCT03330405|583779300|FG005|Overall Study|Progressive disease|14|||
161652447|NCT03330405|583779301|FG006|Overall Study|Progressive disease|7|||
161652448|NCT03330405|583779302|FG007|Overall Study|Progressive disease|29|||
161652449|NCT03330405|583779303|FG008|Overall Study|Progressive disease|9|||
161652450|NCT03330405|583779304|FG009|Overall Study|Progressive disease|11|||
161652451|NCT03330405|583779305|FG010|Overall Study|Progressive disease|5|||
161652452|NCT03330405|583779295|FG000|Overall Study|Withdrawal by Subject|1|||
161652453|NCT03330405|583779296|FG001|Overall Study|Withdrawal by Subject|4|||
161652454|NCT03330405|583779297|FG002|Overall Study|Withdrawal by Subject|0|||
161652455|NCT03330405|583779298|FG003|Overall Study|Withdrawal by Subject|1|||
161652456|NCT03330405|583779299|FG004|Overall Study|Withdrawal by Subject|1|||
161652457|NCT03330405|583779300|FG005|Overall Study|Withdrawal by Subject|1|||
161652458|NCT03330405|583779301|FG006|Overall Study|Withdrawal by Subject|0|||
161692458|NCT01026831|583924385|FG001|Overall Study|Adverse Event|3|||
161692459|NCT01026831|583924384|FG000|Overall Study|Lost to Follow-up|2|||
161692460|NCT01026831|583924385|FG001|Overall Study|Lost to Follow-up|0|||
161692461|NCT01026831|583924384|FG000|Overall Study|Physician Decision|1|||
161692462|NCT01026831|583924385|FG001|Overall Study|Physician Decision|1|||
161692463|NCT01026831|583924384|FG000|Overall Study|Protocol Violation|0|||
161692464|NCT01026831|583924385|FG001|Overall Study|Protocol Violation|2|||
161692465|NCT01026831|583924384|FG000|Overall Study|Withdrawal by Subject|7|||
161692466|NCT01026831|583924385|FG001|Overall Study|Withdrawal by Subject|5|||
161692467|NCT04417894|583924386|FG000|Overall Study|Lost to Follow-up|3|||
161692468|NCT04417894|583924387|FG001|Overall Study|Lost to Follow-up|0|||
161692469|NCT04417894|583924386|FG000|Overall Study|Withdrawal by Subject|7|||
161692470|NCT04417894|583924387|FG001|Overall Study|Withdrawal by Subject|6|||
161692471|NCT04417894|583924386|FG000|Overall Study|Lack of Efficacy|3|||
161692472|NCT04417894|583924387|FG001|Overall Study|Lack of Efficacy|1|||
161692473|NCT00262873|583924388|FG000|Overall Study|Adverse Event|3|||
161692474|NCT00262873|583924388|FG000|Overall Study|Withdrawal by Subject|5|||
161692475|NCT00844753|583924389|FG000|Overall Study|Lack of Efficacy|1|||
161692476|NCT00844753|583924390|FG001|Overall Study|Lack of Efficacy|0|||
161692477|NCT00844753|583924391|FG002|Overall Study|Lack of Efficacy|2|||
161692478|NCT00844753|583924392|FG003|Overall Study|Lack of Efficacy|2|||
161692479|NCT00844753|583924389|FG000|Overall Study|Adverse Event|3|||
161692480|NCT00844753|583924390|FG001|Overall Study|Adverse Event|2|||
161692481|NCT00844753|583924391|FG002|Overall Study|Adverse Event|5|||
161692482|NCT00844753|583924392|FG003|Overall Study|Adverse Event|5|||
161692483|NCT00844753|583924389|FG000|Overall Study|Lost to Follow-up|1|||
161692484|NCT00844753|583924390|FG001|Overall Study|Lost to Follow-up|1|||
161692485|NCT00844753|583924391|FG002|Overall Study|Lost to Follow-up|0|||
161692486|NCT00844753|583924392|FG003|Overall Study|Lost to Follow-up|1|||
161692487|NCT00844753|583924389|FG000|Overall Study|could not swallow medication|2|||
161692488|NCT00844753|583924390|FG001|Overall Study|could not swallow medication|0|||
161692489|NCT00844753|583924391|FG002|Overall Study|could not swallow medication|0|||
161692490|NCT00844753|583924392|FG003|Overall Study|could not swallow medication|0|||
161692491|NCT00844753|583924389|FG000|Overall Study|Withdrawal by Subject|1|||
161692492|NCT00844753|583924390|FG001|Overall Study|Withdrawal by Subject|0|||
161692493|NCT00844753|583924391|FG002|Overall Study|Withdrawal by Subject|0|||
161692494|NCT00844753|583924392|FG003|Overall Study|Withdrawal by Subject|3|||
161692495|NCT00903175|583924394|FG000|Period 1 - First Line|Adverse Event|36|||
161692496|NCT00903175|583924395|FG001|Period 1 - First Line|Adverse Event|50|||
161692497|NCT00903175|583924394|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
161692498|NCT00903175|583924395|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
161692499|NCT00903175|583924394|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
161692500|NCT00903175|583924395|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
161692501|NCT00903175|583924394|FG000|Period 1 - First Line|Protocol Violation|3|||
161692502|NCT00903175|583924395|FG001|Period 1 - First Line|Protocol Violation|3|||
161692503|NCT00903175|583924394|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
161692504|NCT00903175|583924395|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
161692505|NCT00903175|583924394|FG000|Period 1 - First Line|Administrative problems|12|||
161692506|NCT00903175|583924395|FG001|Period 1 - First Line|Administrative problems|13|||
161692507|NCT00903175|583924394|FG000|Period 1 - First Line|Death|17|||
161692508|NCT00903175|583924395|FG001|Period 1 - First Line|Death|10|||
161692509|NCT00903175|583924394|FG000|Period 2 - Second Line|Missing|1|||
161692510|NCT00903175|583924395|FG001|Period 2 - Second Line|Missing|0|||
161692511|NCT00903175|583924394|FG000|Period 2 - Second Line|Adverse Event|16|||
161692512|NCT00903175|583924395|FG001|Period 2 - Second Line|Adverse Event|20|||
161692513|NCT00903175|583924394|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
161692514|NCT00903175|583924395|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
161692515|NCT00903175|583924394|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
161692516|NCT00903175|583924395|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
161692517|NCT00903175|583924394|FG000|Period 2 - Second Line|Administrative problems|19|||
161692518|NCT00903175|583924395|FG001|Period 2 - Second Line|Administrative problems|9|||
161692519|NCT00903175|583924394|FG000|Period 2 - Second Line|Death|5|||
161692520|NCT00903175|583924395|FG001|Period 2 - Second Line|Death|2|||
161692521|NCT00371865|583924400|FG000|Overall Study|Lack of Efficacy|0|||
161692522|NCT00371865|583924401|FG001|Overall Study|Lack of Efficacy|2|||
161692523|NCT00371865|583924400|FG000|Overall Study|Protocol Violation|3|||
161692524|NCT00371865|583924401|FG001|Overall Study|Protocol Violation|2|||
161692525|NCT00371865|583924400|FG000|Overall Study|Withdrawal by Subject|12|||
161692526|NCT00371865|583924401|FG001|Overall Study|Withdrawal by Subject|10|||
161692527|NCT05073458|583924405|FG000|24-week Double-blind Period|Adverse Event|1|||
161692528|NCT05073458|583924406|FG001|24-week Double-blind Period|Adverse Event|0|||
161692529|NCT05073458|583924405|FG000|24-week Double-blind Period|Physician Decision|1|||
161692530|NCT05073458|583924406|FG001|24-week Double-blind Period|Physician Decision|0|||
161692531|NCT05073458|583924405|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
161692532|NCT05073458|583924406|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
161692533|NCT05073458|583924405|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
161692534|NCT05073458|583924406|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
161692535|NCT05073458|583924405|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
161692536|NCT05073458|583924406|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
161692537|NCT05073458|583924405|FG000|24-week Open-label Period|Adverse Event|1|||
161692538|NCT05073458|583924406|FG001|24-week Open-label Period|Adverse Event|2|||
161692539|NCT01627899|583924414|FG000|Overall Study|Study terminated early by sponsor.|5|||
161692540|NCT01425008|583924415|FG000|Dose Escalation Phase|Progressive Disease|2|||
161692541|NCT01425008|583924416|FG001|Dose Escalation Phase|Progressive Disease|3|||
161692542|NCT01425008|583924417|FG002|Dose Escalation Phase|Progressive Disease|2|||
161692543|NCT01425008|583924418|FG003|Dose Escalation Phase|Progressive Disease|3|||
161692544|NCT01425008|583924419|FG004|Dose Escalation Phase|Progressive Disease|5|||
161692545|NCT01425008|583924420|FG005|Dose Escalation Phase|Progressive Disease|4|||
161692546|NCT01425008|583924421|FG006|Dose Escalation Phase|Progressive Disease|0|||
161692547|NCT01425008|583924422|FG007|Dose Escalation Phase|Progressive Disease|2|||
161692548|NCT01425008|583924423|FG008|Dose Escalation Phase|Progressive Disease|6|||
161692549|NCT01425008|583924424|FG009|Dose Escalation Phase|Progressive Disease|2|||
161692550|NCT01425008|583924425|FG010|Dose Escalation Phase|Progressive Disease|0|||
161692551|NCT01425008|583924426|FG011|Dose Escalation Phase|Progressive Disease|0|||
161692552|NCT01425008|583924427|FG012|Dose Escalation Phase|Progressive Disease|0|||
161692553|NCT01425008|583924428|FG013|Dose Escalation Phase|Progressive Disease|0|||
161692554|NCT01425008|583924429|FG014|Dose Escalation Phase|Progressive Disease|0|||
161692555|NCT01425008|583924430|FG015|Dose Escalation Phase|Progressive Disease|0|||
161692556|NCT01425008|583924431|FG016|Dose Escalation Phase|Progressive Disease|0|||
161692557|NCT01425008|583924432|FG017|Dose Escalation Phase|Progressive Disease|0|||
161692558|NCT01425008|583924433|FG018|Dose Escalation Phase|Progressive Disease|0|||
161692559|NCT01425008|583924415|FG000|Dose Escalation Phase|Adverse Event|2|||
161692560|NCT01425008|583924416|FG001|Dose Escalation Phase|Adverse Event|0|||
161692561|NCT01425008|583924417|FG002|Dose Escalation Phase|Adverse Event|0|||
161692562|NCT01425008|583924418|FG003|Dose Escalation Phase|Adverse Event|0|||
161692563|NCT01425008|583924419|FG004|Dose Escalation Phase|Adverse Event|0|||
161692564|NCT01425008|583924420|FG005|Dose Escalation Phase|Adverse Event|2|||
161692565|NCT01425008|583924421|FG006|Dose Escalation Phase|Adverse Event|0|||
161692566|NCT01425008|583924422|FG007|Dose Escalation Phase|Adverse Event|0|||
161692567|NCT01425008|583924423|FG008|Dose Escalation Phase|Adverse Event|2|||
161692568|NCT01425008|583924424|FG009|Dose Escalation Phase|Adverse Event|0|||
161692569|NCT01425008|583924425|FG010|Dose Escalation Phase|Adverse Event|0|||
161692570|NCT01425008|583924426|FG011|Dose Escalation Phase|Adverse Event|0|||
161692571|NCT01425008|583924427|FG012|Dose Escalation Phase|Adverse Event|0|||
161692572|NCT01425008|583924428|FG013|Dose Escalation Phase|Adverse Event|0|||
161692573|NCT01425008|583924429|FG014|Dose Escalation Phase|Adverse Event|0|||
161692574|NCT01425008|583924430|FG015|Dose Escalation Phase|Adverse Event|0|||
161692575|NCT01425008|583924431|FG016|Dose Escalation Phase|Adverse Event|0|||
161692576|NCT01425008|583924432|FG017|Dose Escalation Phase|Adverse Event|0|||
161692577|NCT01425008|583924433|FG018|Dose Escalation Phase|Adverse Event|0|||
161692578|NCT01425008|583924415|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692579|NCT01425008|583924416|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692580|NCT01425008|583924417|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692581|NCT01425008|583924418|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692582|NCT01425008|583924419|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161692583|NCT01425008|583924420|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692584|NCT01425008|583924421|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
161692585|NCT01425008|583924422|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161692586|NCT01425008|583924423|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161692587|NCT01425008|583924424|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692588|NCT01425008|583924425|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692589|NCT01425008|583924426|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692590|NCT01425008|583924427|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692591|NCT01425008|583924428|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692592|NCT01425008|583924429|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692593|NCT01425008|583924430|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692594|NCT01425008|583924431|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692595|NCT01425008|583924432|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692596|NCT01425008|583924433|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692597|NCT01425008|583924415|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161692598|NCT01425008|583924416|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161692599|NCT01425008|583924417|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161692600|NCT01425008|583924418|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161692601|NCT01425008|583924419|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
161692602|NCT01425008|583924420|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
161692603|NCT01425008|583924421|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
161692604|NCT01425008|583924422|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
161692605|NCT01425008|583924423|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
161692606|NCT01425008|583924424|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
161692607|NCT01425008|583924425|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
161692608|NCT01425008|583924426|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
161692609|NCT01425008|583924427|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
161692610|NCT01425008|583924428|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
161692611|NCT01425008|583924429|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
161692612|NCT01425008|583924430|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
161692613|NCT01425008|583924431|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
161692614|NCT01425008|583924432|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
161692615|NCT01425008|583924433|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
161692616|NCT01425008|583924415|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692617|NCT01425008|583924416|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692618|NCT01425008|583924417|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
161692619|NCT01425008|583924418|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692620|NCT01425008|583924419|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692621|NCT01425008|583924420|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692622|NCT01425008|583924421|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692623|NCT01425008|583924422|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692624|NCT01425008|583924423|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
161692625|NCT01425008|583924424|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
161692626|NCT01425008|583924425|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692627|NCT01425008|583924426|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692628|NCT01425008|583924427|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692629|NCT01425008|583924428|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692630|NCT01425008|583924429|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692631|NCT01425008|583924430|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692632|NCT01425008|583924431|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692633|NCT01425008|583924432|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692634|NCT01425008|583924433|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692635|NCT01425008|583924415|FG000|Dose Escalation Phase|Other|0|||
161692636|NCT01425008|583924416|FG001|Dose Escalation Phase|Other|0|||
161692637|NCT01425008|583924417|FG002|Dose Escalation Phase|Other|0|||
161692638|NCT01425008|583924418|FG003|Dose Escalation Phase|Other|0|||
161692639|NCT01425008|583924419|FG004|Dose Escalation Phase|Other|0|||
161692640|NCT01425008|583924420|FG005|Dose Escalation Phase|Other|0|||
161692641|NCT01425008|583924421|FG006|Dose Escalation Phase|Other|0|||
161692642|NCT01425008|583924422|FG007|Dose Escalation Phase|Other|0|||
161692643|NCT01425008|583924423|FG008|Dose Escalation Phase|Other|1|||
161692644|NCT01425008|583924424|FG009|Dose Escalation Phase|Other|0|||
161692645|NCT01425008|583924425|FG010|Dose Escalation Phase|Other|0|||
161692646|NCT01425008|583924426|FG011|Dose Escalation Phase|Other|0|||
161692647|NCT01425008|583924427|FG012|Dose Escalation Phase|Other|0|||
161692648|NCT01425008|583924428|FG013|Dose Escalation Phase|Other|0|||
161692649|NCT01425008|583924429|FG014|Dose Escalation Phase|Other|0|||
161692650|NCT01425008|583924430|FG015|Dose Escalation Phase|Other|0|||
161692651|NCT01425008|583924431|FG016|Dose Escalation Phase|Other|0|||
161692652|NCT01425008|583924432|FG017|Dose Escalation Phase|Other|0|||
161692653|NCT01425008|583924433|FG018|Dose Escalation Phase|Other|0|||
161692654|NCT01425008|583924415|FG000|Dose Expansion Phase|Progressive Disease|0|||
161692655|NCT01425008|583924416|FG001|Dose Expansion Phase|Progressive Disease|0|||
161692656|NCT01425008|583924417|FG002|Dose Expansion Phase|Progressive Disease|0|||
161692657|NCT01425008|583924418|FG003|Dose Expansion Phase|Progressive Disease|0|||
161692658|NCT01425008|583924419|FG004|Dose Expansion Phase|Progressive Disease|0|||
161692659|NCT01425008|583924420|FG005|Dose Expansion Phase|Progressive Disease|0|||
161692660|NCT01425008|583924421|FG006|Dose Expansion Phase|Progressive Disease|0|||
161692661|NCT01425008|583924422|FG007|Dose Expansion Phase|Progressive Disease|0|||
161692662|NCT01425008|583924423|FG008|Dose Expansion Phase|Progressive Disease|0|||
161692663|NCT01425008|583924424|FG009|Dose Expansion Phase|Progressive Disease|0|||
161692664|NCT01425008|583924425|FG010|Dose Expansion Phase|Progressive Disease|10|||
161692665|NCT01425008|583924426|FG011|Dose Expansion Phase|Progressive Disease|4|||
161692666|NCT01425008|583924427|FG012|Dose Expansion Phase|Progressive Disease|12|||
161692667|NCT01425008|583924428|FG013|Dose Expansion Phase|Progressive Disease|1|||
161692668|NCT01425008|583924429|FG014|Dose Expansion Phase|Progressive Disease|5|||
161692669|NCT01425008|583924430|FG015|Dose Expansion Phase|Progressive Disease|8|||
161692670|NCT01425008|583924431|FG016|Dose Expansion Phase|Progressive Disease|9|||
161692671|NCT01425008|583924432|FG017|Dose Expansion Phase|Progressive Disease|2|||
161692672|NCT01425008|583924433|FG018|Dose Expansion Phase|Progressive Disease|10|||
161692673|NCT01425008|583924415|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
161692674|NCT01425008|583924416|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
161692675|NCT01425008|583924417|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
161692676|NCT01425008|583924418|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
161692677|NCT01425008|583924419|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
161692678|NCT01425008|583924420|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
161692679|NCT01425008|583924421|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
161692680|NCT01425008|583924422|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
161692681|NCT01425008|583924423|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
161692682|NCT01425008|583924424|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
161692683|NCT01425008|583924425|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
161692684|NCT01425008|583924426|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
161692685|NCT01425008|583924427|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
161692686|NCT01425008|583924428|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
161692687|NCT01425008|583924429|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
161692688|NCT01425008|583924430|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
161692689|NCT01425008|583924431|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
161692690|NCT01425008|583924432|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
161692691|NCT01425008|583924433|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
161692692|NCT01425008|583924415|FG000|Dose Expansion Phase|Other|0|||
161692693|NCT01425008|583924416|FG001|Dose Expansion Phase|Other|0|||
161692694|NCT01425008|583924417|FG002|Dose Expansion Phase|Other|0|||
161692695|NCT01425008|583924418|FG003|Dose Expansion Phase|Other|0|||
161692696|NCT01425008|583924419|FG004|Dose Expansion Phase|Other|0|||
161692697|NCT01425008|583924420|FG005|Dose Expansion Phase|Other|0|||
161692698|NCT01425008|583924421|FG006|Dose Expansion Phase|Other|0|||
161692699|NCT01425008|583924422|FG007|Dose Expansion Phase|Other|0|||
161692700|NCT01425008|583924423|FG008|Dose Expansion Phase|Other|0|||
161692701|NCT01425008|583924424|FG009|Dose Expansion Phase|Other|0|||
161692702|NCT01425008|583924425|FG010|Dose Expansion Phase|Other|0|||
161692703|NCT01425008|583924426|FG011|Dose Expansion Phase|Other|0|||
161692704|NCT01425008|583924427|FG012|Dose Expansion Phase|Other|1|||
161692705|NCT01425008|583924428|FG013|Dose Expansion Phase|Other|0|||
161692706|NCT01425008|583924429|FG014|Dose Expansion Phase|Other|0|||
161692707|NCT01425008|583924430|FG015|Dose Expansion Phase|Other|0|||
161692708|NCT01425008|583924431|FG016|Dose Expansion Phase|Other|2|||
161692709|NCT01425008|583924432|FG017|Dose Expansion Phase|Other|0|||
161692710|NCT01425008|583924433|FG018|Dose Expansion Phase|Other|4|||
161692711|NCT01425008|583924415|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692712|NCT01425008|583924416|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692713|NCT01425008|583924417|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692714|NCT01425008|583924418|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692715|NCT01425008|583924419|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692716|NCT01425008|583924420|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692717|NCT01425008|583924421|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692718|NCT01425008|583924422|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692719|NCT01425008|583924423|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692720|NCT01425008|583924424|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692721|NCT01425008|583924425|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
161692722|NCT01425008|583924426|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
161692723|NCT01425008|583924427|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692724|NCT01425008|583924428|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692725|NCT01425008|583924429|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692726|NCT01425008|583924430|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
161692727|NCT01425008|583924431|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
161692728|NCT01425008|583924432|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
161652459|NCT03330405|583779302|FG007|Overall Study|Withdrawal by Subject|2|||
161652460|NCT03330405|583779303|FG008|Overall Study|Withdrawal by Subject|2|||
161652461|NCT03330405|583779304|FG009|Overall Study|Withdrawal by Subject|1|||
161652462|NCT03330405|583779305|FG010|Overall Study|Withdrawal by Subject|1|||
161652463|NCT03330405|583779295|FG000|Overall Study|Global deterioration of health status|2|||
161652464|NCT03330405|583779296|FG001|Overall Study|Global deterioration of health status|3|||
161652465|NCT03330405|583779297|FG002|Overall Study|Global deterioration of health status|0|||
161652466|NCT03330405|583779298|FG003|Overall Study|Global deterioration of health status|2|||
161652467|NCT03330405|583779299|FG004|Overall Study|Global deterioration of health status|3|||
161652468|NCT03330405|583779300|FG005|Overall Study|Global deterioration of health status|3|||
161652469|NCT03330405|583779301|FG006|Overall Study|Global deterioration of health status|0|||
161652470|NCT03330405|583779302|FG007|Overall Study|Global deterioration of health status|2|||
161652471|NCT03330405|583779303|FG008|Overall Study|Global deterioration of health status|8|||
161652472|NCT03330405|583779304|FG009|Overall Study|Global deterioration of health status|4|||
161652473|NCT03330405|583779305|FG010|Overall Study|Global deterioration of health status|1|||
161652474|NCT03330405|583779295|FG000|Overall Study|Adverse Event|0|||
161652475|NCT03330405|583779296|FG001|Overall Study|Adverse Event|1|||
161652476|NCT03330405|583779297|FG002|Overall Study|Adverse Event|0|||
161652477|NCT03330405|583779298|FG003|Overall Study|Adverse Event|1|||
161652478|NCT03330405|583779299|FG004|Overall Study|Adverse Event|1|||
161652479|NCT03330405|583779300|FG005|Overall Study|Adverse Event|1|||
161652480|NCT03330405|583779301|FG006|Overall Study|Adverse Event|3|||
161652481|NCT03330405|583779302|FG007|Overall Study|Adverse Event|4|||
161652482|NCT03330405|583779303|FG008|Overall Study|Adverse Event|2|||
161652483|NCT03330405|583779304|FG009|Overall Study|Adverse Event|2|||
161652484|NCT03330405|583779305|FG010|Overall Study|Adverse Event|2|||
161652485|NCT03330405|583779295|FG000|Overall Study|Death|0|||
161652486|NCT03330405|583779296|FG001|Overall Study|Death|4|||
161652487|NCT03330405|583779297|FG002|Overall Study|Death|0|||
161652488|NCT03330405|583779298|FG003|Overall Study|Death|0|||
161652489|NCT03330405|583779299|FG004|Overall Study|Death|0|||
161652490|NCT03330405|583779300|FG005|Overall Study|Death|1|||
161652491|NCT03330405|583779301|FG006|Overall Study|Death|0|||
161652492|NCT03330405|583779302|FG007|Overall Study|Death|2|||
161652493|NCT03330405|583779303|FG008|Overall Study|Death|0|||
161652494|NCT03330405|583779304|FG009|Overall Study|Death|0|||
161652495|NCT03330405|583779305|FG010|Overall Study|Death|0|||
161652496|NCT03330405|583779295|FG000|Overall Study|Physician Decision|0|||
161652497|NCT03330405|583779296|FG001|Overall Study|Physician Decision|0|||
161652498|NCT03330405|583779297|FG002|Overall Study|Physician Decision|0|||
161652499|NCT03330405|583779298|FG003|Overall Study|Physician Decision|0|||
161652500|NCT03330405|583779299|FG004|Overall Study|Physician Decision|0|||
161652501|NCT03330405|583779300|FG005|Overall Study|Physician Decision|0|||
161652502|NCT03330405|583779301|FG006|Overall Study|Physician Decision|0|||
161652503|NCT03330405|583779302|FG007|Overall Study|Physician Decision|1|||
161652504|NCT03330405|583779303|FG008|Overall Study|Physician Decision|0|||
161652505|NCT03330405|583779304|FG009|Overall Study|Physician Decision|0|||
161652506|NCT03330405|583779305|FG010|Overall Study|Physician Decision|0|||
161652507|NCT03889704|583779307|FG000|Overall Study|Study terminated due to pandemic|1|||
161652508|NCT04552899|583779310|FG000|Overall Study|Adverse Event|4|||
161652509|NCT04552899|583779311|FG001|Overall Study|Adverse Event|3|||
161652510|NCT04552899|583779310|FG000|Overall Study|Death|4|||
161652511|NCT04552899|583779311|FG001|Overall Study|Death|4|||
161652512|NCT04552899|583779310|FG000|Overall Study|Lost to Follow-up|8|||
161652513|NCT04552899|583779311|FG001|Overall Study|Lost to Follow-up|13|||
161836397|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
161652514|NCT04552899|583779310|FG000|Overall Study|Lung Transplant|4|||
161652515|NCT04552899|583779311|FG001|Overall Study|Lung Transplant|3|||
161652516|NCT04552899|583779310|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
161652517|NCT04552899|583779311|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
161652518|NCT04552899|583779310|FG000|Overall Study|Physician Decision|3|||
161652519|NCT04552899|583779311|FG001|Overall Study|Physician Decision|4|||
161652520|NCT04552899|583779310|FG000|Overall Study|Study Terminated By Sponsor|237|||
161652521|NCT04552899|583779311|FG001|Overall Study|Study Terminated By Sponsor|239|||
161652522|NCT04552899|583779310|FG000|Overall Study|Withdrawal by Subject|15|||
161652523|NCT04552899|583779311|FG001|Overall Study|Withdrawal by Subject|17|||
161652524|NCT01353859|583779316|FG000|Overall Study|Adverse Event|3|||
161652525|NCT01353859|583779316|FG000|Overall Study|Lack of Efficacy|1|||
161652526|NCT02672852|583779317|FG000|Part A1|Disease Worsening|1|||
161652527|NCT02672852|583779318|FG001|Part A1|Disease Worsening|0|||
161652528|NCT02672852|583779319|FG002|Part A1|Disease Worsening|0|||
161652529|NCT02672852|583779320|FG003|Part A1|Disease Worsening|0|||
161652530|NCT02672852|583779321|FG004|Part A1|Disease Worsening|0|||
161652531|NCT02672852|583779322|FG005|Part A1|Disease Worsening|0|||
161652532|NCT02672852|583779323|FG006|Part A1|Disease Worsening|0|||
161652533|NCT02672852|583779317|FG000|Part A1|Adverse Event|0|||
161652534|NCT02672852|583779318|FG001|Part A1|Adverse Event|1|||
161652535|NCT02672852|583779319|FG002|Part A1|Adverse Event|0|||
161652536|NCT02672852|583779320|FG003|Part A1|Adverse Event|0|||
161652537|NCT02672852|583779321|FG004|Part A1|Adverse Event|0|||
161652538|NCT02672852|583779322|FG005|Part A1|Adverse Event|0|||
161652539|NCT02672852|583779323|FG006|Part A1|Adverse Event|0|||
161652540|NCT02672852|583779317|FG000|Part A1|Lost to Follow-up|1|||
161652541|NCT02672852|583779318|FG001|Part A1|Lost to Follow-up|2|||
161652542|NCT02672852|583779319|FG002|Part A1|Lost to Follow-up|0|||
161652543|NCT02672852|583779320|FG003|Part A1|Lost to Follow-up|0|||
161652544|NCT02672852|583779321|FG004|Part A1|Lost to Follow-up|0|||
161652545|NCT02672852|583779322|FG005|Part A1|Lost to Follow-up|0|||
161652546|NCT02672852|583779323|FG006|Part A1|Lost to Follow-up|0|||
161652547|NCT02672852|583779317|FG000|Part A1|Withdrawal by Subject|1|||
161652548|NCT02672852|583779318|FG001|Part A1|Withdrawal by Subject|1|||
161652549|NCT02672852|583779319|FG002|Part A1|Withdrawal by Subject|0|||
161652550|NCT02672852|583779320|FG003|Part A1|Withdrawal by Subject|0|||
161652551|NCT02672852|583779321|FG004|Part A1|Withdrawal by Subject|0|||
161652552|NCT02672852|583779322|FG005|Part A1|Withdrawal by Subject|0|||
161652553|NCT02672852|583779323|FG006|Part A1|Withdrawal by Subject|0|||
161652554|NCT02672852|583779317|FG000|Part A2|Disease worsening|0|||
161652555|NCT02672852|583779318|FG001|Part A2|Disease worsening|0|||
161652556|NCT02672852|583779319|FG002|Part A2|Disease worsening|1|||
161652557|NCT02672852|583779320|FG003|Part A2|Disease worsening|0|||
161652558|NCT02672852|583779321|FG004|Part A2|Disease worsening|0|||
161652559|NCT02672852|583779322|FG005|Part A2|Disease worsening|0|||
161652560|NCT02672852|583779323|FG006|Part A2|Disease worsening|0|||
161652561|NCT02672852|583779317|FG000|Part A2|Adverse Event|0|||
161652562|NCT02672852|583779318|FG001|Part A2|Adverse Event|0|||
161652563|NCT02672852|583779319|FG002|Part A2|Adverse Event|3|||
161652564|NCT02672852|583779320|FG003|Part A2|Adverse Event|0|||
161652565|NCT02672852|583779321|FG004|Part A2|Adverse Event|0|||
161652566|NCT02672852|583779322|FG005|Part A2|Adverse Event|0|||
161652567|NCT02672852|583779323|FG006|Part A2|Adverse Event|0|||
161652568|NCT02672852|583779317|FG000|Part A2|Lost to Follow-up|0|||
161652569|NCT02672852|583779318|FG001|Part A2|Lost to Follow-up|0|||
161652570|NCT02672852|583779319|FG002|Part A2|Lost to Follow-up|2|||
161652571|NCT02672852|583779320|FG003|Part A2|Lost to Follow-up|0|||
161652572|NCT02672852|583779321|FG004|Part A2|Lost to Follow-up|0|||
161652573|NCT02672852|583779322|FG005|Part A2|Lost to Follow-up|0|||
161652574|NCT02672852|583779323|FG006|Part A2|Lost to Follow-up|0|||
161652575|NCT02672852|583779317|FG000|Part A2|Withdrawal by Subject|0|||
161652576|NCT02672852|583779318|FG001|Part A2|Withdrawal by Subject|0|||
161652577|NCT02672852|583779319|FG002|Part A2|Withdrawal by Subject|1|||
161652578|NCT02672852|583779320|FG003|Part A2|Withdrawal by Subject|0|||
161652579|NCT02672852|583779321|FG004|Part A2|Withdrawal by Subject|0|||
161836398|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
161652580|NCT02672852|583779322|FG005|Part A2|Withdrawal by Subject|0|||
161652581|NCT02672852|583779323|FG006|Part A2|Withdrawal by Subject|0|||
161652582|NCT02672852|583779317|FG000|Part A2|Other|0|||
161652583|NCT02672852|583779318|FG001|Part A2|Other|0|||
161652584|NCT02672852|583779319|FG002|Part A2|Other|3|||
161652585|NCT02672852|583779320|FG003|Part A2|Other|0|||
161652586|NCT02672852|583779321|FG004|Part A2|Other|0|||
161652587|NCT02672852|583779322|FG005|Part A2|Other|0|||
161652588|NCT02672852|583779323|FG006|Part A2|Other|0|||
161652589|NCT02672852|583779317|FG000|Part A2|Not entered in Part B|0|||
161652590|NCT02672852|583779318|FG001|Part A2|Not entered in Part B|0|||
161652591|NCT02672852|583779319|FG002|Part A2|Not entered in Part B|0|||
161652592|NCT02672852|583779320|FG003|Part A2|Not entered in Part B|4|||
161652593|NCT02672852|583779321|FG004|Part A2|Not entered in Part B|0|||
161652594|NCT02672852|583779322|FG005|Part A2|Not entered in Part B|0|||
161652595|NCT02672852|583779323|FG006|Part A2|Not entered in Part B|0|||
161652596|NCT02672852|583779317|FG000|Part B|Disease worsening|0|||
161652597|NCT02672852|583779318|FG001|Part B|Disease worsening|0|||
161652598|NCT02672852|583779319|FG002|Part B|Disease worsening|0|||
161652599|NCT02672852|583779320|FG003|Part B|Disease worsening|0|||
161652600|NCT02672852|583779321|FG004|Part B|Disease worsening|1|||
161652601|NCT02672852|583779322|FG005|Part B|Disease worsening|0|||
161652602|NCT02672852|583779323|FG006|Part B|Disease worsening|1|||
161652603|NCT02672852|583779317|FG000|Part B|Worsening pre-existing condition|0|||
161652604|NCT02672852|583779318|FG001|Part B|Worsening pre-existing condition|0|||
161652605|NCT02672852|583779319|FG002|Part B|Worsening pre-existing condition|0|||
161652606|NCT02672852|583779320|FG003|Part B|Worsening pre-existing condition|0|||
161652607|NCT02672852|583779321|FG004|Part B|Worsening pre-existing condition|0|||
161652608|NCT02672852|583779322|FG005|Part B|Worsening pre-existing condition|1|||
161652609|NCT02672852|583779323|FG006|Part B|Worsening pre-existing condition|0|||
161652610|NCT02672852|583779317|FG000|Part B|Other adverse event|0|||
161652611|NCT02672852|583779318|FG001|Part B|Other adverse event|0|||
161652612|NCT02672852|583779319|FG002|Part B|Other adverse event|0|||
161652613|NCT02672852|583779320|FG003|Part B|Other adverse event|0|||
161652614|NCT02672852|583779321|FG004|Part B|Other adverse event|3|||
161652615|NCT02672852|583779322|FG005|Part B|Other adverse event|5|||
161652616|NCT02672852|583779323|FG006|Part B|Other adverse event|1|||
161652617|NCT02672852|583779317|FG000|Part B|Lost to Follow-up|0|||
161652618|NCT02672852|583779318|FG001|Part B|Lost to Follow-up|0|||
161652619|NCT02672852|583779319|FG002|Part B|Lost to Follow-up|0|||
161652620|NCT02672852|583779320|FG003|Part B|Lost to Follow-up|0|||
161652621|NCT02672852|583779321|FG004|Part B|Lost to Follow-up|3|||
161652622|NCT02672852|583779322|FG005|Part B|Lost to Follow-up|4|||
161652623|NCT02672852|583779323|FG006|Part B|Lost to Follow-up|1|||
161652624|NCT02672852|583779317|FG000|Part B|Withdrawal by Subject|0|||
161652625|NCT02672852|583779318|FG001|Part B|Withdrawal by Subject|0|||
161652626|NCT02672852|583779319|FG002|Part B|Withdrawal by Subject|0|||
161652627|NCT02672852|583779320|FG003|Part B|Withdrawal by Subject|0|||
161652628|NCT02672852|583779321|FG004|Part B|Withdrawal by Subject|5|||
161652629|NCT02672852|583779322|FG005|Part B|Withdrawal by Subject|0|||
161652630|NCT02672852|583779323|FG006|Part B|Withdrawal by Subject|7|||
161652631|NCT02672852|583779317|FG000|Part B|Other|0|||
161652632|NCT02672852|583779318|FG001|Part B|Other|0|||
161652633|NCT02672852|583779319|FG002|Part B|Other|0|||
161652634|NCT02672852|583779320|FG003|Part B|Other|0|||
161652635|NCT02672852|583779321|FG004|Part B|Other|4|||
161652636|NCT02672852|583779322|FG005|Part B|Other|1|||
161652637|NCT02672852|583779323|FG006|Part B|Other|2|||
161652638|NCT01725126|583779326|FG000|Overall Study|Protocol Violation|0|||
161652639|NCT01725126|583779327|FG001|Overall Study|Protocol Violation|1|||
161652640|NCT01725126|583779328|FG002|Overall Study|Protocol Violation|0|||
161652641|NCT01725126|583779329|FG003|Overall Study|Protocol Violation|0|||
161652642|NCT01725126|583779330|FG004|Overall Study|Protocol Violation|0|||
161652643|NCT01725126|583779331|FG005|Overall Study|Protocol Violation|0|||
161652644|NCT01725126|583779326|FG000|Overall Study|Withdrawal by Subject|0|||
161652645|NCT01725126|583779327|FG001|Overall Study|Withdrawal by Subject|0|||
161652646|NCT01725126|583779328|FG002|Overall Study|Withdrawal by Subject|0|||
161652647|NCT01725126|583779329|FG003|Overall Study|Withdrawal by Subject|1|||
161652648|NCT01725126|583779330|FG004|Overall Study|Withdrawal by Subject|0|||
161652649|NCT01725126|583779331|FG005|Overall Study|Withdrawal by Subject|0|||
161652650|NCT00208325|583779332|FG000|Overall Study|Death|18|||
161652651|NCT00208325|583779333|FG001|Overall Study|Death|19|||
161652652|NCT00208325|583779334|FG002|Overall Study|Death|7|||
161652653|NCT00208325|583779335|FG003|Overall Study|Death|5|||
161652654|NCT00208325|583779332|FG000|Overall Study|Withdrawal by Subject|0|||
161652655|NCT00208325|583779333|FG001|Overall Study|Withdrawal by Subject|1|||
161652656|NCT00208325|583779334|FG002|Overall Study|Withdrawal by Subject|0|||
161652657|NCT00208325|583779335|FG003|Overall Study|Withdrawal by Subject|0|||
161652658|NCT00208325|583779332|FG000|Overall Study|Revision|4|||
161652659|NCT00208325|583779333|FG001|Overall Study|Revision|1|||
161652660|NCT00208325|583779334|FG002|Overall Study|Revision|0|||
161652661|NCT00208325|583779335|FG003|Overall Study|Revision|4|||
161652662|NCT00208325|583779332|FG000|Overall Study|Lost to Follow-up|1|||
161652663|NCT00208325|583779333|FG001|Overall Study|Lost to Follow-up|0|||
161652664|NCT00208325|583779334|FG002|Overall Study|Lost to Follow-up|2|||
161652665|NCT00208325|583779335|FG003|Overall Study|Lost to Follow-up|0|||
161652666|NCT00208325|583779332|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
161652667|NCT00208325|583779333|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
161652668|NCT00208325|583779334|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
161652669|NCT00208325|583779335|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
161652670|NCT00208325|583779332|FG000|Overall Study|Does not wish to Continue in Study|5|||
161652671|NCT00208325|583779333|FG001|Overall Study|Does not wish to Continue in Study|8|||
161652672|NCT00208325|583779334|FG002|Overall Study|Does not wish to Continue in Study|3|||
161652673|NCT00208325|583779335|FG003|Overall Study|Does not wish to Continue in Study|2|||
161652674|NCT00208325|583779332|FG000|Overall Study|Other|2|||
161652675|NCT00208325|583779333|FG001|Overall Study|Other|1|||
161652676|NCT00208325|583779334|FG002|Overall Study|Other|1|||
161692729|NCT01425008|583924433|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
161692730|NCT01425008|583924415|FG000|Dose Expansion Phase|Adverse Event|0|||
161692731|NCT01425008|583924416|FG001|Dose Expansion Phase|Adverse Event|0|||
161692732|NCT01425008|583924417|FG002|Dose Expansion Phase|Adverse Event|0|||
161692733|NCT01425008|583924418|FG003|Dose Expansion Phase|Adverse Event|0|||
161692734|NCT01425008|583924419|FG004|Dose Expansion Phase|Adverse Event|0|||
161692735|NCT01425008|583924420|FG005|Dose Expansion Phase|Adverse Event|0|||
161692736|NCT01425008|583924421|FG006|Dose Expansion Phase|Adverse Event|0|||
161692737|NCT01425008|583924422|FG007|Dose Expansion Phase|Adverse Event|0|||
161692738|NCT01425008|583924423|FG008|Dose Expansion Phase|Adverse Event|0|||
161692739|NCT01425008|583924424|FG009|Dose Expansion Phase|Adverse Event|0|||
161692740|NCT01425008|583924425|FG010|Dose Expansion Phase|Adverse Event|2|||
161692741|NCT01425008|583924426|FG011|Dose Expansion Phase|Adverse Event|3|||
161692742|NCT01425008|583924427|FG012|Dose Expansion Phase|Adverse Event|3|||
161652677|NCT00208325|583779335|FG003|Overall Study|Other|0|||
161652678|NCT00208325|583779332|FG000|Overall Study|Mis-Randomized|17|||
161652679|NCT00208325|583779333|FG001|Overall Study|Mis-Randomized|20|||
161652680|NCT00208325|583779334|FG002|Overall Study|Mis-Randomized|0|||
161652681|NCT00208325|583779335|FG003|Overall Study|Mis-Randomized|0|||
161652682|NCT01254747|583779336|FG000|Overall Study|Unacceptable subjective vision|0|||
161652683|NCT01254747|583779337|FG001|Overall Study|Unacceptable subjective vision|0|||
161652684|NCT01254747|583779338|FG002|Overall Study|Unacceptable subjective vision|0|||
161652685|NCT01254747|583779339|FG003|Overall Study|Unacceptable subjective vision|2|||
161652686|NCT01254747|583779336|FG000|Overall Study|Difficult removal handling|0|||
161652687|NCT01254747|583779337|FG001|Overall Study|Difficult removal handling|0|||
161652688|NCT01254747|583779338|FG002|Overall Study|Difficult removal handling|1|||
161652689|NCT01254747|583779339|FG003|Overall Study|Difficult removal handling|0|||
161652690|NCT01254747|583779336|FG000|Overall Study|Symptoms and problems|0|||
161652691|NCT01254747|583779337|FG001|Overall Study|Symptoms and problems|2|||
161652692|NCT01254747|583779338|FG002|Overall Study|Symptoms and problems|1|||
161652693|NCT01254747|583779339|FG003|Overall Study|Symptoms and problems|0|||
161652694|NCT01254747|583779336|FG000|Overall Study|Lost to Follow-up|0|||
161652695|NCT01254747|583779337|FG001|Overall Study|Lost to Follow-up|0|||
161652696|NCT01254747|583779338|FG002|Overall Study|Lost to Follow-up|1|||
161652697|NCT01254747|583779339|FG003|Overall Study|Lost to Follow-up|0|||
161652698|NCT01254747|583779336|FG000|Overall Study|Biomicroscopy|0|||
161652699|NCT01254747|583779337|FG001|Overall Study|Biomicroscopy|0|||
161652700|NCT01254747|583779338|FG002|Overall Study|Biomicroscopy|1|||
161652701|NCT01254747|583779339|FG003|Overall Study|Biomicroscopy|0|||
161652702|NCT01254747|583779336|FG000|Overall Study|Discomfort|0|||
161652703|NCT01254747|583779337|FG001|Overall Study|Discomfort|4|||
161652704|NCT01254747|583779338|FG002|Overall Study|Discomfort|0|||
161652705|NCT01254747|583779339|FG003|Overall Study|Discomfort|0|||
161652706|NCT02406677|583779340|FG000|Overall Study|Death|16|||
161652707|NCT02406677|583779341|FG001|Overall Study|Death|8|||
161652708|NCT02406677|583779340|FG000|Overall Study|Discharged without P2Y12|1|||
161652709|NCT02406677|583779341|FG001|Overall Study|Discharged without P2Y12|3|||
161652710|NCT02406677|583779340|FG000|Overall Study|Discharged on prasugrel|283|||
161652711|NCT02406677|583779341|FG001|Overall Study|Discharged on prasugrel|587|||
161652712|NCT02406677|583779340|FG000|Overall Study|Withdrawal by Subject|1|||
161652713|NCT02406677|583779341|FG001|Overall Study|Withdrawal by Subject|0|||
161652714|NCT04531098|583779346|FG000|Stage I|Adverse Event|0|||
161652715|NCT04531098|583779347|FG001|Stage I|Adverse Event|0|||
161652716|NCT04531098|583779348|FG002|Stage I|Adverse Event|3|||
161652717|NCT04531098|583779346|FG000|Stage I|Protocol Violation|0|||
161652718|NCT04531098|583779347|FG001|Stage I|Protocol Violation|0|||
161652719|NCT04531098|583779348|FG002|Stage I|Protocol Violation|5|||
161652720|NCT04531098|583779346|FG000|Stage I|Withdrawal by Subject|0|||
161652721|NCT04531098|583779347|FG001|Stage I|Withdrawal by Subject|5|||
161652722|NCT04531098|583779348|FG002|Stage I|Withdrawal by Subject|10|||
161652723|NCT04531098|583779346|FG000|Stage II|Adverse Event|1|||
161652724|NCT04531098|583779347|FG001|Stage II|Adverse Event|2|||
161652725|NCT04531098|583779348|FG002|Stage II|Adverse Event|0|||
161652726|NCT04531098|583779346|FG000|Stage II|Protocol Violation|1|||
161652727|NCT04531098|583779347|FG001|Stage II|Protocol Violation|2|||
161652728|NCT04531098|583779348|FG002|Stage II|Protocol Violation|0|||
161692743|NCT01425008|583924428|FG013|Dose Expansion Phase|Adverse Event|0|||
161692744|NCT01425008|583924429|FG014|Dose Expansion Phase|Adverse Event|1|||
161692745|NCT01425008|583924430|FG015|Dose Expansion Phase|Adverse Event|1|||
161652729|NCT04531098|583779346|FG000|Stage II|Withdrawal by Subject|3|||
161652730|NCT04531098|583779347|FG001|Stage II|Withdrawal by Subject|1|||
161652731|NCT04531098|583779348|FG002|Stage II|Withdrawal by Subject|0|||
161652732|NCT04531098|583779346|FG000|Stage II|Moved from study area|8|||
161652733|NCT04531098|583779347|FG001|Stage II|Moved from study area|5|||
161652734|NCT04531098|583779348|FG002|Stage II|Moved from study area|0|||
161652735|NCT02145468|583779349|FG000|Overall Study|Withdrawal by Subject|5|||
161652736|NCT02145468|583779350|FG001|Overall Study|Withdrawal by Subject|8|||
161652737|NCT01803282|583779354|FG000|Overall Study|Progressive Disease|4|||
161652738|NCT01803282|583779355|FG001|Overall Study|Progressive Disease|3|||
161692746|NCT01425008|583924431|FG016|Dose Expansion Phase|Adverse Event|5|||
161692747|NCT01425008|583924432|FG017|Dose Expansion Phase|Adverse Event|0|||
161692748|NCT01425008|583924433|FG018|Dose Expansion Phase|Adverse Event|3|||
161692749|NCT01425008|583924415|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
161692750|NCT01425008|583924416|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
161692751|NCT01425008|583924417|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
161692752|NCT01425008|583924418|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
161692753|NCT01425008|583924419|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
161692754|NCT01425008|583924420|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
161692755|NCT01425008|583924421|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
161692756|NCT01425008|583924422|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
161692757|NCT01425008|583924423|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
161692758|NCT01425008|583924424|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
161692759|NCT01425008|583924425|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
161692760|NCT01425008|583924426|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
161692761|NCT01425008|583924427|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
161692762|NCT01425008|583924428|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
161692763|NCT01425008|583924429|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
161692764|NCT01425008|583924430|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
161692765|NCT01425008|583924431|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
161692766|NCT01425008|583924432|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
161652739|NCT01803282|583779356|FG002|Overall Study|Progressive Disease|6|||
161652740|NCT01803282|583779357|FG003|Overall Study|Progressive Disease|22|||
161652741|NCT01803282|583779358|FG004|Overall Study|Progressive Disease|5|||
161652742|NCT01803282|583779359|FG005|Overall Study|Progressive Disease|8|||
161652743|NCT01803282|583779360|FG006|Overall Study|Progressive Disease|23|||
161652744|NCT01803282|583779361|FG007|Overall Study|Progressive Disease|24|||
161652745|NCT01803282|583779362|FG008|Overall Study|Progressive Disease|3|||
161652746|NCT01803282|583779363|FG009|Overall Study|Progressive Disease|29|||
161652747|NCT01803282|583779364|FG010|Overall Study|Progressive Disease|6|||
161652748|NCT01803282|583779365|FG011|Overall Study|Progressive Disease|11|||
161652749|NCT01803282|583779354|FG000|Overall Study|Death|0|||
161652750|NCT01803282|583779355|FG001|Overall Study|Death|0|||
161652751|NCT01803282|583779356|FG002|Overall Study|Death|0|||
161652752|NCT01803282|583779357|FG003|Overall Study|Death|0|||
161652753|NCT01803282|583779358|FG004|Overall Study|Death|2|||
161652754|NCT01803282|583779359|FG005|Overall Study|Death|1|||
161652755|NCT01803282|583779360|FG006|Overall Study|Death|1|||
161652756|NCT01803282|583779361|FG007|Overall Study|Death|5|||
161652757|NCT01803282|583779362|FG008|Overall Study|Death|1|||
161652758|NCT01803282|583779363|FG009|Overall Study|Death|1|||
161652759|NCT01803282|583779364|FG010|Overall Study|Death|0|||
161652760|NCT01803282|583779365|FG011|Overall Study|Death|0|||
161652761|NCT01803282|583779354|FG000|Overall Study|Withdrew Consent|0|||
161652762|NCT01803282|583779355|FG001|Overall Study|Withdrew Consent|0|||
161652763|NCT01803282|583779356|FG002|Overall Study|Withdrew Consent|0|||
161652764|NCT01803282|583779357|FG003|Overall Study|Withdrew Consent|6|||
161652765|NCT01803282|583779358|FG004|Overall Study|Withdrew Consent|1|||
161652766|NCT01803282|583779359|FG005|Overall Study|Withdrew Consent|0|||
161652767|NCT01803282|583779360|FG006|Overall Study|Withdrew Consent|8|||
161652768|NCT01803282|583779361|FG007|Overall Study|Withdrew Consent|3|||
161652769|NCT01803282|583779362|FG008|Overall Study|Withdrew Consent|1|||
161652770|NCT01803282|583779363|FG009|Overall Study|Withdrew Consent|5|||
161652771|NCT01803282|583779364|FG010|Overall Study|Withdrew Consent|0|||
161652772|NCT01803282|583779365|FG011|Overall Study|Withdrew Consent|1|||
161652773|NCT01803282|583779354|FG000|Overall Study|Investigator's Discretion|0|||
161652774|NCT01803282|583779355|FG001|Overall Study|Investigator's Discretion|0|||
161652775|NCT01803282|583779356|FG002|Overall Study|Investigator's Discretion|0|||
161652776|NCT01803282|583779357|FG003|Overall Study|Investigator's Discretion|7|||
161652777|NCT01803282|583779358|FG004|Overall Study|Investigator's Discretion|2|||
161652778|NCT01803282|583779359|FG005|Overall Study|Investigator's Discretion|1|||
161652779|NCT01803282|583779360|FG006|Overall Study|Investigator's Discretion|7|||
161692767|NCT01425008|583924433|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
161692768|NCT01425008|583924415|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692769|NCT01425008|583924416|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692770|NCT01425008|583924417|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161652780|NCT01803282|583779361|FG007|Overall Study|Investigator's Discretion|10|||
161652781|NCT01803282|583779362|FG008|Overall Study|Investigator's Discretion|6|||
161652782|NCT01803282|583779363|FG009|Overall Study|Investigator's Discretion|7|||
161652783|NCT01803282|583779364|FG010|Overall Study|Investigator's Discretion|1|||
161652784|NCT01803282|583779365|FG011|Overall Study|Investigator's Discretion|0|||
161652785|NCT01803282|583779354|FG000|Overall Study|Adverse Event|0|||
161692771|NCT01425008|583924418|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692772|NCT01425008|583924419|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692773|NCT01425008|583924420|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692774|NCT01425008|583924421|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692775|NCT01425008|583924422|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692776|NCT01425008|583924423|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692777|NCT01425008|583924424|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692778|NCT01425008|583924425|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692779|NCT01425008|583924426|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692780|NCT01425008|583924427|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692781|NCT01425008|583924428|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692782|NCT01425008|583924429|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692783|NCT01425008|583924430|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692784|NCT01425008|583924431|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692785|NCT01425008|583924432|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692786|NCT01425008|583924433|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
161692787|NCT04818593|583924434|FG000|Overall Study|Low Oocyte Yield|8|||
161692788|NCT04818593|583924435|FG001|Overall Study|Low Oocyte Yield|8|||
161692789|NCT04818593|583924434|FG000|Overall Study|Not ICSI Insemination|7|||
161692790|NCT04818593|583924435|FG001|Overall Study|Not ICSI Insemination|7|||
161692791|NCT04818593|583924434|FG000|Overall Study|Poor Sperm Quality|2|||
161692792|NCT04818593|583924435|FG001|Overall Study|Poor Sperm Quality|2|||
161692793|NCT04818593|583924434|FG000|Overall Study|Withdrawal by Subject|2|||
161692794|NCT04818593|583924435|FG001|Overall Study|Withdrawal by Subject|2|||
161692795|NCT04818593|583924434|FG000|Overall Study|Conversion to IUI due to low response|1|||
161692796|NCT04818593|583924435|FG001|Overall Study|Conversion to IUI due to low response|1|||
161692797|NCT04179175|583926168|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
161692798|NCT04179175|583926169|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
161692799|NCT04179175|583926170|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
161692800|NCT04179175|583926171|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
161692801|NCT04179175|583926172|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
161692802|NCT04179175|583926173|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
161692803|NCT04179175|583926168|FG000|Overall Study|Adverse Event|5|||
161692804|NCT04179175|583926169|FG001|Overall Study|Adverse Event|3|||
161692805|NCT04179175|583926170|FG002|Overall Study|Adverse Event|3|||
161692806|NCT04179175|583926171|FG003|Overall Study|Adverse Event|4|||
161692807|NCT04179175|583926172|FG004|Overall Study|Adverse Event|6|||
161692808|NCT04179175|583926173|FG005|Overall Study|Adverse Event|6|||
161692809|NCT04179175|583926168|FG000|Overall Study|Lack of Efficacy|5|||
161692810|NCT04179175|583926169|FG001|Overall Study|Lack of Efficacy|1|||
161692811|NCT04179175|583926170|FG002|Overall Study|Lack of Efficacy|3|||
161692812|NCT04179175|583926171|FG003|Overall Study|Lack of Efficacy|2|||
161692813|NCT04179175|583926172|FG004|Overall Study|Lack of Efficacy|18|||
161692814|NCT04179175|583926173|FG005|Overall Study|Lack of Efficacy|7|||
161692815|NCT04179175|583926168|FG000|Overall Study|Lost to Follow-up|5|||
161692816|NCT04179175|583926169|FG001|Overall Study|Lost to Follow-up|3|||
161692817|NCT04179175|583926170|FG002|Overall Study|Lost to Follow-up|2|||
161692818|NCT04179175|583926171|FG003|Overall Study|Lost to Follow-up|2|||
161692819|NCT04179175|583926172|FG004|Overall Study|Lost to Follow-up|4|||
161692820|NCT04179175|583926173|FG005|Overall Study|Lost to Follow-up|5|||
161692821|NCT04179175|583926168|FG000|Overall Study|Physician Decision|2|||
161692822|NCT04179175|583926169|FG001|Overall Study|Physician Decision|0|||
161692823|NCT04179175|583926170|FG002|Overall Study|Physician Decision|2|||
161692824|NCT04179175|583926171|FG003|Overall Study|Physician Decision|3|||
161692825|NCT04179175|583926172|FG004|Overall Study|Physician Decision|1|||
161692826|NCT04179175|583926173|FG005|Overall Study|Physician Decision|1|||
161692827|NCT04179175|583926168|FG000|Overall Study|Pregnancy|3|||
161692828|NCT04179175|583926169|FG001|Overall Study|Pregnancy|0|||
161692829|NCT04179175|583926170|FG002|Overall Study|Pregnancy|3|||
161692830|NCT04179175|583926171|FG003|Overall Study|Pregnancy|0|||
161692831|NCT04179175|583926172|FG004|Overall Study|Pregnancy|1|||
161692832|NCT04179175|583926173|FG005|Overall Study|Pregnancy|2|||
161692833|NCT04179175|583926168|FG000|Overall Study|Withdrawal by Subject|22|||
161692834|NCT04179175|583926169|FG001|Overall Study|Withdrawal by Subject|10|||
161692835|NCT04179175|583926170|FG002|Overall Study|Withdrawal by Subject|12|||
161692836|NCT04179175|583926171|FG003|Overall Study|Withdrawal by Subject|8|||
161692837|NCT04179175|583926172|FG004|Overall Study|Withdrawal by Subject|23|||
161692838|NCT04179175|583926173|FG005|Overall Study|Withdrawal by Subject|31|||
161692839|NCT04179175|583926168|FG000|Overall Study|Technical problems|0|||
161692840|NCT04179175|583926169|FG001|Overall Study|Technical problems|0|||
161692841|NCT04179175|583926170|FG002|Overall Study|Technical problems|1|||
161692842|NCT04179175|583926171|FG003|Overall Study|Technical problems|1|||
161692843|NCT04179175|583926172|FG004|Overall Study|Technical problems|0|||
161692844|NCT04179175|583926173|FG005|Overall Study|Technical problems|0|||
161692845|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
161692846|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
161692847|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692848|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
161692849|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692850|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692851|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692852|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692853|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692854|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692855|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692856|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692857|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161692858|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692859|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692860|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161692861|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692862|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692863|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692864|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692865|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692866|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692867|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692868|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692869|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Death|15|||
161692870|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Death|6|||
161692871|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Death|6|||
161692872|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Death|8|||
161692873|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Death|0|||
161692874|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Death|0|||
161692875|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Death|0|||
161692876|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Death|0|||
161692877|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Death|0|||
161692878|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Death|0|||
161692879|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Death|0|||
161692880|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Death|0|||
161692881|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
161692882|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
161692883|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
161692884|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
161692885|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
161692886|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
161692887|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
161692888|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
161692889|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
161692890|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
161692891|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
161692892|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
161692893|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692894|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161652786|NCT01803282|583779355|FG001|Overall Study|Adverse Event|0|||
161652787|NCT01803282|583779356|FG002|Overall Study|Adverse Event|0|||
161652788|NCT01803282|583779357|FG003|Overall Study|Adverse Event|0|||
161652789|NCT01803282|583779358|FG004|Overall Study|Adverse Event|0|||
161652790|NCT01803282|583779359|FG005|Overall Study|Adverse Event|0|||
161652791|NCT01803282|583779360|FG006|Overall Study|Adverse Event|1|||
161652792|NCT01803282|583779361|FG007|Overall Study|Adverse Event|2|||
161652793|NCT01803282|583779362|FG008|Overall Study|Adverse Event|0|||
161652794|NCT01803282|583779363|FG009|Overall Study|Adverse Event|1|||
161652795|NCT01803282|583779364|FG010|Overall Study|Adverse Event|0|||
161652796|NCT01803282|583779365|FG011|Overall Study|Adverse Event|3|||
161652797|NCT01803282|583779354|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161692895|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692896|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692897|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692898|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692899|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692900|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
161692901|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692902|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692903|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692904|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692905|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692906|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692907|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692908|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692909|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161692910|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161692911|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
161692912|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
161692913|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692914|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692915|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692916|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692917|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Death|0|||
161692918|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Death|0|||
161692919|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Death|0|||
161692920|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Death|0|||
161692921|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Death|3|||
161692922|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Death|1|||
161692923|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Death|5|||
161692924|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Death|4|||
161692925|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Death|0|||
161692926|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Death|0|||
161692927|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Death|0|||
161692928|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Death|0|||
161692929|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
161692930|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
161692931|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
161692932|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
161692933|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
161692934|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
161692935|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
161692936|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
161692937|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
161692938|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
161692939|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
161692940|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
161692941|NCT03215030|583926178|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
161692942|NCT03215030|583926179|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
161692943|NCT03215030|583926180|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
161692944|NCT03215030|583926181|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
161692945|NCT03215030|583926182|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
161692946|NCT03215030|583926183|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
161692947|NCT03215030|583926184|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
161692948|NCT03215030|583926185|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
161692949|NCT03215030|583926186|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
161692950|NCT03215030|583926187|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
161692951|NCT03215030|583926188|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
161692952|NCT03215030|583926189|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
161692953|NCT03215030|583926178|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692954|NCT03215030|583926179|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692955|NCT03215030|583926180|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692956|NCT03215030|583926181|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692957|NCT03215030|583926182|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692958|NCT03215030|583926183|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692959|NCT03215030|583926184|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692960|NCT03215030|583926185|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692961|NCT03215030|583926186|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
161692962|NCT03215030|583926187|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
161692963|NCT03215030|583926188|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692964|NCT03215030|583926189|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692965|NCT03215030|583926178|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692966|NCT03215030|583926179|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692967|NCT03215030|583926180|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692968|NCT03215030|583926181|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692969|NCT03215030|583926182|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692970|NCT03215030|583926183|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692971|NCT03215030|583926184|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692972|NCT03215030|583926185|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692973|NCT03215030|583926186|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
161692974|NCT03215030|583926187|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
161692975|NCT03215030|583926188|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692976|NCT03215030|583926189|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692977|NCT03215030|583926178|FG000|Part 3: Dose Extension|Death|0|||
161652798|NCT01803282|583779355|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161652799|NCT01803282|583779356|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161652800|NCT01803282|583779357|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161652801|NCT01803282|583779358|FG004|Overall Study|Non-Compliance with Study Drug|0|||
161652802|NCT01803282|583779359|FG005|Overall Study|Non-Compliance with Study Drug|0|||
161692978|NCT03215030|583926179|FG001|Part 3: Dose Extension|Death|0|||
161692979|NCT03215030|583926180|FG002|Part 3: Dose Extension|Death|0|||
161692980|NCT03215030|583926181|FG003|Part 3: Dose Extension|Death|0|||
161692981|NCT03215030|583926182|FG004|Part 3: Dose Extension|Death|0|||
161692982|NCT03215030|583926183|FG005|Part 3: Dose Extension|Death|0|||
161652803|NCT01803282|583779360|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161652804|NCT01803282|583779361|FG007|Overall Study|Non-Compliance with Study Drug|0|||
161652805|NCT01803282|583779362|FG008|Overall Study|Non-Compliance with Study Drug|0|||
161652806|NCT01803282|583779363|FG009|Overall Study|Non-Compliance with Study Drug|0|||
161652807|NCT01803282|583779364|FG010|Overall Study|Non-Compliance with Study Drug|0|||
161652808|NCT01803282|583779365|FG011|Overall Study|Non-Compliance with Study Drug|0|||
161652809|NCT01803282|583779354|FG000|Overall Study|Unknown Reason|0|||
161652810|NCT01803282|583779355|FG001|Overall Study|Unknown Reason|0|||
161652811|NCT01803282|583779356|FG002|Overall Study|Unknown Reason|0|||
161652812|NCT01803282|583779357|FG003|Overall Study|Unknown Reason|0|||
161652813|NCT01803282|583779358|FG004|Overall Study|Unknown Reason|0|||
161652814|NCT01803282|583779359|FG005|Overall Study|Unknown Reason|0|||
161652815|NCT01803282|583779360|FG006|Overall Study|Unknown Reason|0|||
161652816|NCT01803282|583779361|FG007|Overall Study|Unknown Reason|1|||
161652817|NCT01803282|583779362|FG008|Overall Study|Unknown Reason|0|||
161652818|NCT01803282|583779363|FG009|Overall Study|Unknown Reason|0|||
161652819|NCT01803282|583779364|FG010|Overall Study|Unknown Reason|0|||
161652820|NCT01803282|583779365|FG011|Overall Study|Unknown Reason|0|||
161652821|NCT01803282|583779354|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
161652822|NCT01803282|583779355|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
161652823|NCT01803282|583779356|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
161652824|NCT01803282|583779357|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
161652825|NCT01803282|583779358|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
161652826|NCT01803282|583779359|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
161652827|NCT01803282|583779360|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
161652828|NCT01803282|583779361|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
161652829|NCT01803282|583779362|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
161652830|NCT01803282|583779363|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
161652831|NCT01803282|583779364|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
161652832|NCT01803282|583779365|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
161652833|NCT01803282|583779354|FG000|Overall Study|Enrolled but Never Treated|0|||
161652834|NCT01803282|583779355|FG001|Overall Study|Enrolled but Never Treated|0|||
161652835|NCT01803282|583779356|FG002|Overall Study|Enrolled but Never Treated|0|||
161652836|NCT01803282|583779357|FG003|Overall Study|Enrolled but Never Treated|0|||
161652837|NCT01803282|583779358|FG004|Overall Study|Enrolled but Never Treated|1|||
161652838|NCT01803282|583779359|FG005|Overall Study|Enrolled but Never Treated|0|||
161652839|NCT01803282|583779360|FG006|Overall Study|Enrolled but Never Treated|1|||
161652840|NCT01803282|583779361|FG007|Overall Study|Enrolled but Never Treated|1|||
161652841|NCT01803282|583779362|FG008|Overall Study|Enrolled but Never Treated|0|||
161652842|NCT01803282|583779363|FG009|Overall Study|Enrolled but Never Treated|1|||
161692983|NCT03215030|583926184|FG006|Part 3: Dose Extension|Death|0|||
161652843|NCT01803282|583779364|FG010|Overall Study|Enrolled but Never Treated|0|||
161692984|NCT03215030|583926185|FG007|Part 3: Dose Extension|Death|0|||
161692985|NCT03215030|583926186|FG008|Part 3: Dose Extension|Death|19|||
161692986|NCT03215030|583926187|FG009|Part 3: Dose Extension|Death|20|||
161692987|NCT03215030|583926188|FG010|Part 3: Dose Extension|Death|0|||
161692988|NCT03215030|583926189|FG011|Part 3: Dose Extension|Death|0|||
161652844|NCT01803282|583779365|FG011|Overall Study|Enrolled but Never Treated|0|||
161652845|NCT05543707|583779374|FG000|Overall Study|Study drug non-compliance/|5|||
161652846|NCT05543707|583779375|FG001|Overall Study|Study drug non-compliance/|0|||
161692989|NCT03215030|583926178|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
161692990|NCT03215030|583926179|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
161692991|NCT03215030|583926180|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
161692992|NCT03215030|583926181|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
161692993|NCT03215030|583926182|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
161692994|NCT03215030|583926183|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
161692995|NCT03215030|583926184|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
161692996|NCT03215030|583926185|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
161692997|NCT03215030|583926186|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
161692998|NCT03215030|583926187|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
161692999|NCT03215030|583926188|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
161693000|NCT03215030|583926189|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
161693001|NCT03215030|583926178|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693002|NCT03215030|583926179|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693003|NCT03215030|583926180|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693004|NCT03215030|583926181|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693005|NCT03215030|583926182|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693006|NCT03215030|583926183|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693007|NCT03215030|583926184|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693008|NCT03215030|583926185|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693009|NCT03215030|583926186|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693010|NCT03215030|583926187|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693011|NCT03215030|583926188|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
161693012|NCT03215030|583926189|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
161693013|NCT01745146|583926192|FG000|Overall Study|Withdrawal by Subject|1|||
161693014|NCT01745146|583926193|FG001|Overall Study|Withdrawal by Subject|3|||
161693015|NCT01745146|583926192|FG000|Overall Study|Lost to Follow-up|2|||
161693016|NCT01745146|583926193|FG001|Overall Study|Lost to Follow-up|0|||
161693017|NCT04316585|583926194|FG000|Overall Study|Adverse Event|2|||
161693018|NCT04316585|583926195|FG001|Overall Study|Adverse Event|1|||
161693019|NCT04316585|583926194|FG000|Overall Study|Lost to Follow-up|1|||
161693020|NCT04316585|583926195|FG001|Overall Study|Lost to Follow-up|0|||
161693021|NCT04316585|583926194|FG000|Overall Study|Withdrawal by Subject|2|||
161693022|NCT04316585|583926195|FG001|Overall Study|Withdrawal by Subject|3|||
161693023|NCT04316585|583926194|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161693024|NCT04316585|583926195|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
161693025|NCT04316585|583926194|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
161693026|NCT04316585|583926195|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
161693027|NCT00130832|583926196|FG000|Overall Study|Adverse Event|1|||
161693028|NCT00130832|583926197|FG001|Overall Study|Adverse Event|1|||
161693029|NCT00130832|583926196|FG000|Overall Study|Lost to Follow-up|1|||
161693030|NCT00130832|583926197|FG001|Overall Study|Lost to Follow-up|2|||
161693031|NCT00130832|583926196|FG000|Overall Study|Protocol Violation|6|||
161693032|NCT00130832|583926197|FG001|Overall Study|Protocol Violation|8|||
161693033|NCT00130832|583926196|FG000|Overall Study|Withdrawal by Subject|6|||
161693034|NCT00130832|583926197|FG001|Overall Study|Withdrawal by Subject|1|||
161693035|NCT00130832|583926196|FG000|Overall Study|Moved|2|||
161693036|NCT00130832|583926197|FG001|Overall Study|Moved|2|||
161693037|NCT00130832|583926196|FG000|Overall Study|Other|0|||
161693038|NCT00130832|583926197|FG001|Overall Study|Other|3|||
161693039|NCT03269344|583926198|FG000|Overall Study|Protocol Violation|4|||
161693040|NCT03269344|583926199|FG001|Overall Study|Protocol Violation|3|||
161693041|NCT02770326|583926200|FG000|Overall Study|Death|3|||
161693042|NCT02770326|583926200|FG000|Overall Study|Lost to Follow-up|1|||
161693043|NCT04232696|583926204|FG000|Overall Study|Implant attempted but not completed|5|||
161693044|NCT04232696|583926205|FG001|Overall Study|Implant attempted but not completed|2|||
161693045|NCT04232696|583926204|FG000|Overall Study|Not satisfied with therapy outcome|0|||
161693046|NCT04232696|583926205|FG001|Overall Study|Not satisfied with therapy outcome|8|||
161693047|NCT04232696|583926204|FG000|Overall Study|Adverse Event|0|||
161693048|NCT04232696|583926205|FG001|Overall Study|Adverse Event|3|||
161693049|NCT04232696|583926204|FG000|Overall Study|Withdrawal by Subject|0|||
161693050|NCT04232696|583926205|FG001|Overall Study|Withdrawal by Subject|3|||
161693051|NCT04232696|583926204|FG000|Overall Study|Missed Visit|0|||
161693052|NCT04232696|583926205|FG001|Overall Study|Missed Visit|2|||
161693053|NCT04232696|583926204|FG000|Overall Study|Other reason|0|||
161693054|NCT04232696|583926205|FG001|Overall Study|Other reason|1|||
161693055|NCT03118297|583926206|FG000|Overall Study|Lost to Follow-up|0|||
161693056|NCT03118297|583926207|FG001|Overall Study|Lost to Follow-up|2|||
161693057|NCT02363686|583926210|FG000|Overall Study|Withdrawal by Subject|22|||
161693058|NCT02363686|583926210|FG000|Overall Study|incomplete FEES examinations|13|||
161693059|NCT05289830|583926213|FG000|Overall Study|Lost to Follow-up|1|||
161693060|NCT05289830|583926214|FG001|Overall Study|Lost to Follow-up|1|||
161693061|NCT05289830|583926213|FG000|Overall Study|Physician Decision|0|||
161693062|NCT05289830|583926214|FG001|Overall Study|Physician Decision|1|||
161693063|NCT01046825|583926215|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693064|NCT01046825|583926216|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
161693065|NCT01046825|583926217|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693066|NCT01046825|583926218|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693067|NCT01046825|583926219|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693068|NCT01046825|583926215|FG000|Overall Study|Physician Decision|0|||
161693069|NCT01046825|583926216|FG001|Overall Study|Physician Decision|1|||
161693070|NCT01046825|583926217|FG002|Overall Study|Physician Decision|2|||
161693071|NCT01046825|583926218|FG003|Overall Study|Physician Decision|0|||
161693072|NCT01046825|583926219|FG004|Overall Study|Physician Decision|0|||
161693073|NCT01046825|583926215|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693074|NCT01046825|583926216|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693075|NCT01046825|583926217|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
161693076|NCT01046825|583926218|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693077|NCT01046825|583926219|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693078|NCT01046825|583926215|FG000|Overall Study|Found to be ineligible|0|||
161693079|NCT01046825|583926216|FG001|Overall Study|Found to be ineligible|1|||
161693080|NCT01046825|583926217|FG002|Overall Study|Found to be ineligible|0|||
161693081|NCT01046825|583926218|FG003|Overall Study|Found to be ineligible|0|||
161693082|NCT01046825|583926219|FG004|Overall Study|Found to be ineligible|0|||
161693083|NCT01046825|583926215|FG000|Overall Study|Death|0|||
161693084|NCT01046825|583926216|FG001|Overall Study|Death|0|||
161693085|NCT01046825|583926217|FG002|Overall Study|Death|0|||
161693086|NCT01046825|583926218|FG003|Overall Study|Death|1|||
161693087|NCT01046825|583926219|FG004|Overall Study|Death|0|||
161693088|NCT01046825|583926215|FG000|Overall Study|Did not submit biology samples|0|||
161693089|NCT01046825|583926216|FG001|Overall Study|Did not submit biology samples|0|||
161693090|NCT01046825|583926217|FG002|Overall Study|Did not submit biology samples|0|||
161693091|NCT01046825|583926218|FG003|Overall Study|Did not submit biology samples|0|||
161693092|NCT01046825|583926219|FG004|Overall Study|Did not submit biology samples|13|||
161693093|NCT02872311|583926220|FG000|Overall Study|Death|2|||
161693094|NCT02872311|583926221|FG001|Overall Study|Death|0|||
161693095|NCT02872311|583926222|FG002|Overall Study|Death|0|||
161693096|NCT02872311|583926223|FG003|Overall Study|Death|0|||
161693097|NCT02872311|583926224|FG004|Overall Study|Death|0|||
161693098|NCT02872311|583926220|FG000|Overall Study|Lost to Follow-up|2|||
161693099|NCT02872311|583926221|FG001|Overall Study|Lost to Follow-up|0|||
161693100|NCT02872311|583926222|FG002|Overall Study|Lost to Follow-up|0|||
161693101|NCT02872311|583926223|FG003|Overall Study|Lost to Follow-up|0|||
161693102|NCT02872311|583926224|FG004|Overall Study|Lost to Follow-up|0|||
161693103|NCT02872311|583926220|FG000|Overall Study|Protocol Violation|0|||
161693104|NCT02872311|583926221|FG001|Overall Study|Protocol Violation|2|||
161693105|NCT02872311|583926222|FG002|Overall Study|Protocol Violation|1|||
161693106|NCT02872311|583926223|FG003|Overall Study|Protocol Violation|0|||
161693107|NCT02872311|583926224|FG004|Overall Study|Protocol Violation|0|||
161693108|NCT01121393|583926228|FG000|Overall Study|Progressive disease|201|||
161693109|NCT01121393|583926229|FG001|Overall Study|Progressive disease|20|||
161693110|NCT01121393|583926228|FG000|Overall Study|Other Adverse events|24|||
161693111|NCT01121393|583926229|FG001|Overall Study|Other Adverse events|45|||
161693112|NCT01121393|583926228|FG000|Overall Study|Non-compliant with protocol|0|||
161693113|NCT01121393|583926229|FG001|Overall Study|Non-compliant with protocol|3|||
161693114|NCT01121393|583926228|FG000|Overall Study|Lost to Follow-up|1|||
161693115|NCT01121393|583926229|FG001|Overall Study|Lost to Follow-up|0|||
161693116|NCT01121393|583926228|FG000|Overall Study|Refused cont. medication|7|||
161693117|NCT01121393|583926229|FG001|Overall Study|Refused cont. medication|7|||
161693118|NCT01121393|583926228|FG000|Overall Study|Not treated|3|||
161693119|NCT01121393|583926229|FG001|Overall Study|Not treated|9|||
161836399|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
161836400|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
161836401|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
161836402|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
161836403|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
161836404|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
161836405|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
161836406|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
161836407|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161693120|NCT01121393|583926228|FG000|Overall Study|Other than listed|6|||
161693121|NCT01121393|583926229|FG001|Overall Study|Other than listed|0|||
161693122|NCT00577993|583926235|FG000|Overall Study|Adverse Event|1|||
161693123|NCT00577993|583926236|FG001|Overall Study|Adverse Event|0|||
161693124|NCT00577993|583926237|FG002|Overall Study|Adverse Event|0|||
161693125|NCT00577993|583926235|FG000|Overall Study|Death|0|||
161693126|NCT00577993|583926236|FG001|Overall Study|Death|1|||
161693127|NCT00577993|583926237|FG002|Overall Study|Death|1|||
161693128|NCT00577993|583926235|FG000|Overall Study|Lack of Efficacy|0|||
161693129|NCT00577993|583926236|FG001|Overall Study|Lack of Efficacy|1|||
161693130|NCT00577993|583926237|FG002|Overall Study|Lack of Efficacy|0|||
161693131|NCT00577993|583926235|FG000|Overall Study|Protocol Violation|2|||
161693132|NCT00577993|583926236|FG001|Overall Study|Protocol Violation|3|||
161693133|NCT00577993|583926237|FG002|Overall Study|Protocol Violation|0|||
161693134|NCT00577993|583926235|FG000|Overall Study|Withdrawal by Subject|1|||
161693135|NCT00577993|583926236|FG001|Overall Study|Withdrawal by Subject|0|||
161693136|NCT00577993|583926237|FG002|Overall Study|Withdrawal by Subject|2|||
161693137|NCT00577993|583926235|FG000|Overall Study|Conversion|2|||
161693138|NCT00577993|583926236|FG001|Overall Study|Conversion|5|||
161693139|NCT00577993|583926237|FG002|Overall Study|Conversion|0|||
161693140|NCT00577993|583926235|FG000|Overall Study|Uninsured|1|||
161693141|NCT00577993|583926236|FG001|Overall Study|Uninsured|0|||
161693142|NCT00577993|583926237|FG002|Overall Study|Uninsured|0|||
161693143|NCT02217566|583926238|FG000|Overall Study|Lost to Follow-up|2|||
161693144|NCT02217566|583926238|FG000|Overall Study|Death|3|||
161693145|NCT02217566|583926238|FG000|Overall Study|Early study termination|6|||
161693146|NCT02064387|583926243|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693147|NCT02064387|583926244|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693148|NCT02064387|583926245|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693149|NCT02064387|583926246|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693150|NCT02064387|583926247|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693151|NCT02064387|583926248|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693152|NCT02064387|583926249|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693153|NCT02064387|583926250|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
161693154|NCT02064387|583926251|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693155|NCT02064387|583926252|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
161693156|NCT02064387|583926253|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693157|NCT02064387|583926254|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693158|NCT02064387|583926243|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693159|NCT02064387|583926244|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693160|NCT02064387|583926245|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693161|NCT02064387|583926246|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693162|NCT02064387|583926247|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693163|NCT02064387|583926248|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693164|NCT02064387|583926249|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693165|NCT02064387|583926250|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
161693166|NCT02064387|583926251|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161652847|NCT05543707|583779374|FG000|Overall Study|Withdrawal by Subject|1|||
161652848|NCT05543707|583779375|FG001|Overall Study|Withdrawal by Subject|1|||
161652849|NCT05543707|583779374|FG000|Overall Study|Adverse Event|1|||
161652850|NCT05543707|583779375|FG001|Overall Study|Adverse Event|0|||
161652851|NCT05543707|583779374|FG000|Overall Study|concurrent illness|0|||
161652852|NCT05543707|583779375|FG001|Overall Study|concurrent illness|1|||
161652853|NCT05543707|583779374|FG000|Overall Study|Pregnancy|1|||
161652854|NCT05543707|583779375|FG001|Overall Study|Pregnancy|1|||
161652855|NCT05511038|583779376|FG000|Overall|Withdrawal by Subject|5|||
161652856|NCT05511038|583779377|FG001|Overall|Withdrawal by Subject|3|||
161652857|NCT05511038|583779376|FG000|Overall|Screen Failure|20|||
161652858|NCT05511038|583779377|FG001|Overall|Screen Failure|1|||
161652859|NCT05511038|583779376|FG000|Overall|Physician Decision|3|||
161652860|NCT05511038|583779377|FG001|Overall|Physician Decision|0|||
161652861|NCT05511038|583779376|FG000|Overall|Lost to Follow-up|3|||
161652862|NCT05511038|583779377|FG001|Overall|Lost to Follow-up|0|||
161652863|NCT05511038|583779376|FG000|Overall|Death|1|||
161652864|NCT05511038|583779377|FG001|Overall|Death|0|||
161652865|NCT05511038|583779376|FG000|Screening|Withdrawal by Subject|1|||
161652866|NCT05511038|583779377|FG001|Screening|Withdrawal by Subject|0|||
161652867|NCT05511038|583779376|FG000|Screening|Lost to Follow Up (1 participant)|1|||
161652868|NCT05511038|583779377|FG001|Screening|Lost to Follow Up (1 participant)|0|||
161652869|NCT05511038|583779376|FG000|Screening|Screen Failure|3|||
161652870|NCT05511038|583779377|FG001|Screening|Screen Failure|0|||
161652871|NCT05511038|583779376|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
161652872|NCT05511038|583779377|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
161652873|NCT05511038|583779376|FG000|Treatment|Withdrawal by Subject|5|||
161652874|NCT05511038|583779377|FG001|Treatment|Withdrawal by Subject|3|||
161652875|NCT05511038|583779376|FG000|Treatment|Physician Decision|4|||
161693167|NCT02064387|583926252|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693168|NCT02064387|583926253|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693169|NCT02064387|583926254|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693170|NCT02064387|583926243|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693171|NCT02064387|583926244|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161652876|NCT05511038|583779377|FG001|Treatment|Physician Decision|0|||
161652877|NCT05511038|583779376|FG000|Treatment|Lost to Follow-up|2|||
161652878|NCT05511038|583779377|FG001|Treatment|Lost to Follow-up|0|||
161652879|NCT05511038|583779376|FG000|Treatment|Death|1|||
161652880|NCT05511038|583779377|FG001|Treatment|Death|0|||
161693172|NCT02064387|583926245|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693173|NCT02064387|583926246|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693174|NCT02064387|583926247|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693175|NCT02064387|583926248|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693176|NCT02064387|583926249|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693177|NCT02064387|583926250|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693178|NCT02064387|583926251|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
161693179|NCT02064387|583926252|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693180|NCT02064387|583926253|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693181|NCT02064387|583926254|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693182|NCT02064387|583926243|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
161693183|NCT02064387|583926244|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
161693184|NCT02064387|583926245|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
161693185|NCT02064387|583926246|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
161693186|NCT02064387|583926247|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
161693187|NCT02064387|583926248|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
161693188|NCT02064387|583926249|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
161693189|NCT02064387|583926250|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
161693190|NCT02064387|583926251|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
161693191|NCT02064387|583926252|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
161693192|NCT02064387|583926253|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
161693193|NCT02064387|583926254|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
161693194|NCT02064387|583926243|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693195|NCT02064387|583926244|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693196|NCT02064387|583926245|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693197|NCT02064387|583926246|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693198|NCT02064387|583926247|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693199|NCT02064387|583926248|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693200|NCT02064387|583926249|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693201|NCT02064387|583926250|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693202|NCT02064387|583926251|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693203|NCT02064387|583926252|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693204|NCT02064387|583926253|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
161693205|NCT02064387|583926254|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693206|NCT02436876|583926258|FG000|Overall Study|Lost to Follow-up|0|||
161693207|NCT02436876|583926259|FG001|Overall Study|Lost to Follow-up|1|||
161693208|NCT02436876|583926260|FG002|Overall Study|Lost to Follow-up|1|||
161693209|NCT02436876|583926261|FG003|Overall Study|Lost to Follow-up|1|||
161693210|NCT02436876|583926258|FG000|Overall Study|Withdrawal by Subject|1|||
161693211|NCT02436876|583926259|FG001|Overall Study|Withdrawal by Subject|0|||
161693212|NCT02436876|583926260|FG002|Overall Study|Withdrawal by Subject|0|||
161693213|NCT02436876|583926261|FG003|Overall Study|Withdrawal by Subject|1|||
161693214|NCT02436876|583926258|FG000|Overall Study|Physician Decision|0|||
161693215|NCT02436876|583926259|FG001|Overall Study|Physician Decision|2|||
161693216|NCT02436876|583926260|FG002|Overall Study|Physician Decision|1|||
161693217|NCT02436876|583926261|FG003|Overall Study|Physician Decision|0|||
161693218|NCT02436876|583926258|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
161693219|NCT02436876|583926259|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
161693220|NCT02436876|583926260|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
161693221|NCT02436876|583926261|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
161693222|NCT00075504|583926262|FG000|Overall Study|Withdrawal by Subject|9|||
161693223|NCT00075504|583926263|FG001|Overall Study|Withdrawal by Subject|7|||
161693224|NCT01290692|583926264|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
161693225|NCT02780648|583926265|FG000|Overall Study|Disease Progression|1|||
161693226|NCT02780648|583926266|FG001|Overall Study|Disease Progression|0|||
161693227|NCT03127384|583926278|FG000|Overall Study|Lost to Follow-up|4|||
161693228|NCT03127384|583926278|FG000|Overall Study|Subject request|2|||
161693229|NCT00689871|583926279|FG000|Overall Study|Lost to Follow-up|123|||
161693230|NCT00689871|583926280|FG001|Overall Study|Lost to Follow-up|13|||
161693231|NCT00689871|583926281|FG002|Overall Study|Lost to Follow-up|37|||
161693232|NCT00689871|583926282|FG003|Overall Study|Lost to Follow-up|1|||
161693233|NCT00689871|583926279|FG000|Overall Study|Explanted of All Study Devices|36|||
161693234|NCT00689871|583926280|FG001|Overall Study|Explanted of All Study Devices|25|||
161693235|NCT00689871|583926281|FG002|Overall Study|Explanted of All Study Devices|29|||
161693236|NCT00689871|583926282|FG003|Overall Study|Explanted of All Study Devices|3|||
161693237|NCT00689871|583926279|FG000|Overall Study|Withdrawal by Subject|13|||
161693238|NCT00689871|583926280|FG001|Overall Study|Withdrawal by Subject|3|||
161693239|NCT00689871|583926281|FG002|Overall Study|Withdrawal by Subject|4|||
161693240|NCT00689871|583926282|FG003|Overall Study|Withdrawal by Subject|1|||
161693241|NCT00689871|583926279|FG000|Overall Study|Death|1|||
161693242|NCT00689871|583926280|FG001|Overall Study|Death|10|||
161693243|NCT00689871|583926281|FG002|Overall Study|Death|2|||
161693244|NCT00689871|583926282|FG003|Overall Study|Death|2|||
161693245|NCT00689871|583926279|FG000|Overall Study|Physician Decision|2|||
161693246|NCT00689871|583926280|FG001|Overall Study|Physician Decision|1|||
161693247|NCT00689871|583926281|FG002|Overall Study|Physician Decision|1|||
161693248|NCT00689871|583926282|FG003|Overall Study|Physician Decision|0|||
161693249|NCT02703311|583926283|FG000|Overall Study|Death|5|||
161693250|NCT02703311|583926283|FG000|Overall Study|Withdrawal by Subject|3|||
161693251|NCT00343889|583926291|FG000|Overall Study|Lost to Follow-up|2|||
161693252|NCT00343889|583926292|FG001|Overall Study|Lost to Follow-up|0|||
161693253|NCT00343889|583926291|FG000|Overall Study|Withdrawal by Subject|0|||
161693254|NCT00343889|583926292|FG001|Overall Study|Withdrawal by Subject|1|||
161693255|NCT00343889|583926291|FG000|Overall Study|Protocol Violation|1|||
161693256|NCT00343889|583926292|FG001|Overall Study|Protocol Violation|0|||
161693257|NCT00088374|583926295|FG000|Overall Study|patient did not receive any 17AAG|1|||
161693258|NCT00088374|583926295|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
161693259|NCT01110200|583926296|FG000|Overall Study|Adverse Event|28|||
161693260|NCT01110200|583926297|FG001|Overall Study|Adverse Event|28|||
161693261|NCT01110200|583926296|FG000|Overall Study|Withdrawal by Subject|25|||
161693262|NCT01110200|583926297|FG001|Overall Study|Withdrawal by Subject|32|||
161693263|NCT01110200|583926296|FG000|Overall Study|Lack of Efficacy|16|||
161693264|NCT01110200|583926297|FG001|Overall Study|Lack of Efficacy|25|||
161693265|NCT01110200|583926296|FG000|Overall Study|Protocol Violation|14|||
161693266|NCT01110200|583926297|FG001|Overall Study|Protocol Violation|12|||
161693267|NCT01110200|583926296|FG000|Overall Study|Physician Decision|13|||
161693268|NCT01110200|583926297|FG001|Overall Study|Physician Decision|17|||
161693269|NCT01110200|583926296|FG000|Overall Study|Lost to Follow-up|10|||
161693270|NCT01110200|583926297|FG001|Overall Study|Lost to Follow-up|7|||
161693271|NCT05913232|583926301|FG000|Overall Study|Adverse Event|0|||
161693272|NCT05913232|583926302|FG001|Overall Study|Adverse Event|2|||
161693273|NCT05913232|583926303|FG002|Overall Study|Adverse Event|1|||
161693274|NCT05913232|583926304|FG003|Overall Study|Adverse Event|1|||
161693275|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693276|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
161693277|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
161693278|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693279|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693280|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
161693281|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693282|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693283|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693284|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693285|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693286|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693287|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693288|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693289|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693290|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693291|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693292|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693293|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693294|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
161693295|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693296|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
161693297|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693298|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693299|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
161836408|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
161836409|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161836410|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
161836411|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161836412|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161836413|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
161693300|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693301|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693302|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693303|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693304|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693305|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693306|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693307|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693308|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693309|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693310|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693311|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
161693312|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693313|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
161693314|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693315|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693316|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
161693317|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693318|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693319|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693320|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693321|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693322|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693323|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693324|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693325|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693326|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693327|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693328|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693329|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Other|0|||
161693330|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Other|0|||
161693331|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Other|0|||
161693332|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Other|1|||
161693333|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Other|0|||
161693334|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Other|0|||
161693335|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Other|0|||
161693336|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Other|0|||
161693337|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Other|0|||
161693338|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Other|0|||
161693339|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Other|0|||
161693340|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Other|0|||
161693341|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Other|0|||
161693342|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Other|0|||
161693343|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Other|0|||
161693344|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Other|0|||
161693345|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Other|0|||
161693346|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Other|0|||
161693347|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693348|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693349|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693350|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693351|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693352|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693353|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693354|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693355|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693356|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693357|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
161693358|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693359|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693360|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693361|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693362|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693363|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693364|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693365|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693366|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161836414|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
161693367|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693368|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693369|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693370|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693371|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693372|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693373|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
161693374|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693375|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693376|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693377|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693378|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693379|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693380|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693381|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693382|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693383|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693384|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693385|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693386|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693387|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693388|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693389|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693390|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693391|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693392|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693393|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693394|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
161693395|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693396|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693397|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693398|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693399|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693400|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693401|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693402|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693403|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693404|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693405|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693406|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693407|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
161693408|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
161693409|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693410|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
161693411|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
161693412|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
161693413|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693414|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693415|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693416|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693417|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693418|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693419|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693420|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693421|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693422|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693423|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693424|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693425|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693426|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693427|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693428|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693429|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693430|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693431|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
161693432|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
161693433|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
161693434|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
161693435|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
161693436|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
161693437|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693438|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693439|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693440|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693441|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693442|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693443|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693444|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693445|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693446|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693447|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693448|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693449|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693450|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693451|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693452|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693453|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693454|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
161693455|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693456|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693457|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693458|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693459|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693460|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693461|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693462|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693463|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693464|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693465|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693466|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693467|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
161652881|NCT05511038|583779376|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
161652882|NCT05511038|583779377|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
161652883|NCT05511038|583779376|FG000|Treatment|Refuse by subject|1|||
161652884|NCT05511038|583779377|FG001|Treatment|Refuse by subject|0|||
161652885|NCT05511038|583779376|FG000|Treatment|Subject did not go to the site for visit|1|||
161652886|NCT05511038|583779377|FG001|Treatment|Subject did not go to the site for visit|0|||
161652887|NCT02108964|583779378|FG000|Overall Study|Progressive disease|15|||
161652888|NCT02108964|583779379|FG001|Overall Study|Progressive disease|31|||
161652889|NCT02108964|583779380|FG002|Overall Study|Progressive disease|54|||
161652890|NCT02108964|583779381|FG003|Overall Study|Progressive disease|7|||
161652891|NCT02108964|583779382|FG004|Overall Study|Progressive disease|20|||
161652892|NCT02108964|583779383|FG005|Overall Study|Progressive disease|4|||
161652893|NCT02108964|583779384|FG006|Overall Study|Progressive disease|6|||
161652894|NCT02108964|583779385|FG007|Overall Study|Progressive disease|33|||
161652895|NCT02108964|583779378|FG000|Overall Study|Physician Decision|1|||
161652896|NCT02108964|583779379|FG001|Overall Study|Physician Decision|5|||
161693468|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693469|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
161693470|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
161693471|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
161693472|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
161693473|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693474|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693475|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693476|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693477|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693478|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693479|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693480|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693481|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693482|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693483|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693484|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693485|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693486|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693487|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
161693488|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
161693489|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693490|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
161652897|NCT02108964|583779380|FG002|Overall Study|Physician Decision|7|||
161652898|NCT02108964|583779381|FG003|Overall Study|Physician Decision|1|||
161652899|NCT02108964|583779382|FG004|Overall Study|Physician Decision|2|||
161652900|NCT02108964|583779383|FG005|Overall Study|Physician Decision|1|||
161652901|NCT02108964|583779384|FG006|Overall Study|Physician Decision|1|||
161652902|NCT02108964|583779385|FG007|Overall Study|Physician Decision|3|||
161652903|NCT02108964|583779378|FG000|Overall Study|Adverse Event|0|||
161652904|NCT02108964|583779379|FG001|Overall Study|Adverse Event|0|||
161652905|NCT02108964|583779380|FG002|Overall Study|Adverse Event|4|||
161652906|NCT02108964|583779381|FG003|Overall Study|Adverse Event|0|||
161652907|NCT02108964|583779382|FG004|Overall Study|Adverse Event|1|||
161652908|NCT02108964|583779383|FG005|Overall Study|Adverse Event|0|||
161652909|NCT02108964|583779384|FG006|Overall Study|Adverse Event|3|||
161652910|NCT02108964|583779385|FG007|Overall Study|Adverse Event|2|||
161652911|NCT02108964|583779378|FG000|Overall Study|Death|1|||
161652912|NCT02108964|583779379|FG001|Overall Study|Death|1|||
161652913|NCT02108964|583779380|FG002|Overall Study|Death|4|||
161652914|NCT02108964|583779381|FG003|Overall Study|Death|0|||
161652915|NCT02108964|583779382|FG004|Overall Study|Death|3|||
161652916|NCT02108964|583779383|FG005|Overall Study|Death|0|||
161652917|NCT02108964|583779384|FG006|Overall Study|Death|0|||
161652918|NCT02108964|583779385|FG007|Overall Study|Death|2|||
161652919|NCT02108964|583779378|FG000|Overall Study|Subject/Guardian decision|0|||
161652920|NCT02108964|583779379|FG001|Overall Study|Subject/Guardian decision|1|||
161652921|NCT02108964|583779380|FG002|Overall Study|Subject/Guardian decision|4|||
161652922|NCT02108964|583779381|FG003|Overall Study|Subject/Guardian decision|0|||
161652923|NCT02108964|583779382|FG004|Overall Study|Subject/Guardian decision|2|||
161652924|NCT02108964|583779383|FG005|Overall Study|Subject/Guardian decision|0|||
161652925|NCT02108964|583779384|FG006|Overall Study|Subject/Guardian decision|1|||
161652926|NCT02108964|583779385|FG007|Overall Study|Subject/Guardian decision|2|||
161652927|NCT02108964|583779378|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652928|NCT02108964|583779379|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652929|NCT02108964|583779380|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652930|NCT02108964|583779381|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652931|NCT02108964|583779382|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652932|NCT02108964|583779383|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652933|NCT02108964|583779384|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161652934|NCT02108964|583779385|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
161652935|NCT00798434|583779388|FG000|Double-Blind|Adverse Event|22|||
161652936|NCT00798434|583779389|FG001|Double-Blind|Adverse Event|46|||
161652937|NCT00798434|583779388|FG000|Double-Blind|Death|0|||
161652938|NCT00798434|583779389|FG001|Double-Blind|Death|1|||
161652939|NCT00798434|583779388|FG000|Double-Blind|Lost to Follow-up|1|||
161652940|NCT00798434|583779389|FG001|Double-Blind|Lost to Follow-up|0|||
161652941|NCT00798434|583779388|FG000|Double-Blind|Lack of Efficacy|8|||
161693491|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Death|0|||
161693492|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Death|0|||
161693493|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Death|0|||
161693494|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Death|0|||
161693495|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Death|0|||
161693496|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Death|0|||
161693497|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Death|0|||
161693498|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Death|0|||
161693499|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Death|0|||
161693500|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Death|0|||
161693501|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Death|0|||
161693502|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Death|0|||
161693503|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Death|0|||
161693504|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Death|0|||
161693505|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Death|1|||
161693506|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Death|0|||
161693507|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Death|0|||
161693508|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Death|1|||
161693509|NCT04428476|583926325|FG000|Overall Study|Withdrawal by Subject|1|||
161693510|NCT04428476|583926325|FG000|Overall Study|Still on treatment|12|||
161693511|NCT02043548|583926327|FG000|Overall Study|Lack of Efficacy|1|||
161693512|NCT02043548|583926328|FG001|Overall Study|Lack of Efficacy|0|||
161693513|NCT02043548|583926327|FG000|Overall Study|Adverse Event|0|||
161693514|NCT02043548|583926328|FG001|Overall Study|Adverse Event|1|||
161693515|NCT02289950|583926330|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
161693516|NCT02289950|583926331|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
161693517|NCT02289950|583926330|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
161693518|NCT02289950|583926331|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
161693519|NCT02289950|583926330|FG000|Overall Study|Lost to Follow-up|1|||
161693520|NCT02289950|583926331|FG001|Overall Study|Lost to Follow-up|0|||
161693521|NCT02289950|583926330|FG000|Overall Study|Physician Decision|9|||
161693522|NCT02289950|583926331|FG001|Overall Study|Physician Decision|3|||
161693523|NCT02289950|583926330|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
161693524|NCT02289950|583926331|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
161693525|NCT02289950|583926330|FG000|Overall Study|Withdrawal by Subject|1|||
161693526|NCT02289950|583926331|FG001|Overall Study|Withdrawal by Subject|3|||
161693527|NCT02289950|583926330|FG000|Overall Study|Test article held for greater than 28 days|0|||
161693528|NCT02289950|583926331|FG001|Overall Study|Test article held for greater than 28 days|1|||
161693529|NCT02289950|583926330|FG000|Overall Study|Adverse Event|11|||
161693530|NCT02289950|583926331|FG001|Overall Study|Adverse Event|3|||
161693531|NCT02289950|583926330|FG000|Overall Study|Death|1|||
161693532|NCT02289950|583926331|FG001|Overall Study|Death|1|||
161693533|NCT02289950|583926330|FG000|Overall Study|Other|5|||
161693534|NCT02289950|583926331|FG001|Overall Study|Other|2|||
161693535|NCT02289950|583926330|FG000|Overall Study|Not Treated|2|||
161693536|NCT02289950|583926331|FG001|Overall Study|Not Treated|1|||
161693537|NCT00264238|583926332|FG000|Overall Study|Protocol Violation|1|||
161693538|NCT03359759|583926333|FG000|Overall Study|Death|3|||
161693539|NCT03359759|583926333|FG000|Overall Study|Lost to Follow-up|2|||
161693540|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
161693541|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
161693542|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
161693543|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
161693544|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
161693545|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
161693546|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
161693547|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
161693548|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
161693549|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
161693550|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
161693551|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
161693552|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
161693553|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
161693554|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
161693555|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
161693556|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
161693557|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
161693558|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
161693559|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
161693560|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
161693561|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
161693562|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
161693563|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
161693564|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
161693565|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
161693566|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
161693567|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
161693568|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
161693569|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
161693570|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
161693571|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
161693572|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
161693573|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
161836415|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161836416|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161836417|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
161836418|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
161693574|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
161693575|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
161693576|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
161693577|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
161693578|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
161836419|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161836420|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161836421|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161836422|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
161836423|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
161836424|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
161836425|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
161836426|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
161836427|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
161836428|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
161836429|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
161836430|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
161836431|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
161836432|NCT01194973|584442959|FG000|Screening Period|Screen Failure|3|||
161836433|NCT01194973|584442959|FG000|26 Week Treatment Period|Adverse Event|1|||
161836434|NCT01194973|584442959|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
161836435|NCT01194973|584442959|FG000|26 Week Treatment Period|Pregnancy|1|||
161836436|NCT01338987|584442962|FG000|Overall Study|enrolled on new protocol|0|||
161836437|NCT01338987|584442963|FG001|Overall Study|enrolled on new protocol|0|||
161836438|NCT01338987|584442964|FG002|Overall Study|enrolled on new protocol|1|||
161836439|NCT01338987|584442965|FG003|Overall Study|enrolled on new protocol|0|||
161836440|NCT01338987|584442966|FG004|Overall Study|enrolled on new protocol|0|||
161836441|NCT01338987|584442962|FG000|Overall Study|Disease progression on study|2|||
161836442|NCT01338987|584442963|FG001|Overall Study|Disease progression on study|1|||
161836443|NCT01338987|584442964|FG002|Overall Study|Disease progression on study|1|||
161836444|NCT01338987|584442965|FG003|Overall Study|Disease progression on study|0|||
161836445|NCT01338987|584442966|FG004|Overall Study|Disease progression on study|0|||
161836446|NCT00058214|584442967|FG000|Overall Study|Adverse Event|1|||
161836447|NCT03856593|584442970|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
161836448|NCT03856593|584442971|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
161836449|NCT03407118|584442972|FG000|Period 2|Withdrawal by Subject|1|||
161836450|NCT03407118|584442973|FG001|Period 2|Withdrawal by Subject|0|||
161836451|NCT01347866|584442990|FG000|Overall Study|Death|0|||
161836452|NCT01347866|584442991|FG001|Overall Study|Death|0|||
161836453|NCT01347866|584442992|FG002|Overall Study|Death|0|||
161836454|NCT01347866|584442993|FG003|Overall Study|Death|1|||
161836455|NCT01347866|584442994|FG004|Overall Study|Death|2|||
161836456|NCT01347866|584442995|FG005|Overall Study|Death|2|||
161836457|NCT01347866|584442996|FG006|Overall Study|Death|1|||
161836458|NCT01347866|584442997|FG007|Overall Study|Death|0|||
161836459|NCT01347866|584442998|FG008|Overall Study|Death|4|||
161693579|NCT00661271|583927896|FG000|Overall Study|Lost to Follow-up|28|||
161693580|NCT00661271|583927897|FG001|Overall Study|Lost to Follow-up|25|||
161693581|NCT00953758|583927898|FG000|Overall Study|Death|2|||
161693582|NCT00953758|583927899|FG001|Overall Study|Death|0|||
161693583|NCT00953758|583927900|FG002|Overall Study|Death|1|||
161693584|NCT00953758|583927901|FG003|Overall Study|Death|1|||
161693585|NCT00953758|583927902|FG004|Overall Study|Death|1|||
161693586|NCT00953758|583927903|FG005|Overall Study|Death|1|||
161693587|NCT00953758|583927904|FG006|Overall Study|Death|1|||
161693588|NCT00953758|583927905|FG007|Overall Study|Death|3|||
161693589|NCT00953758|583927906|FG008|Overall Study|Death|1|||
161693590|NCT00953758|583927907|FG009|Overall Study|Death|0|||
161693591|NCT00953758|583927898|FG000|Overall Study|Participant refused further follow-up|0|||
161693592|NCT00953758|583927899|FG001|Overall Study|Participant refused further follow-up|0|||
161693593|NCT00953758|583927900|FG002|Overall Study|Participant refused further follow-up|1|||
161693594|NCT00953758|583927901|FG003|Overall Study|Participant refused further follow-up|0|||
161693595|NCT00953758|583927902|FG004|Overall Study|Participant refused further follow-up|3|||
161693596|NCT00953758|583927903|FG005|Overall Study|Participant refused further follow-up|0|||
161693597|NCT00953758|583927904|FG006|Overall Study|Participant refused further follow-up|0|||
161693598|NCT00953758|583927905|FG007|Overall Study|Participant refused further follow-up|0|||
161693599|NCT00953758|583927906|FG008|Overall Study|Participant refused further follow-up|1|||
161693600|NCT00953758|583927907|FG009|Overall Study|Participant refused further follow-up|0|||
161693601|NCT00953758|583927898|FG000|Overall Study|Lost to Follow-up|0|||
161693602|NCT00953758|583927899|FG001|Overall Study|Lost to Follow-up|0|||
161693603|NCT00953758|583927900|FG002|Overall Study|Lost to Follow-up|0|||
161693604|NCT00953758|583927901|FG003|Overall Study|Lost to Follow-up|1|||
161693605|NCT00953758|583927902|FG004|Overall Study|Lost to Follow-up|0|||
161693606|NCT00953758|583927903|FG005|Overall Study|Lost to Follow-up|0|||
161693607|NCT00953758|583927904|FG006|Overall Study|Lost to Follow-up|0|||
161693608|NCT00953758|583927905|FG007|Overall Study|Lost to Follow-up|1|||
161693609|NCT00953758|583927906|FG008|Overall Study|Lost to Follow-up|0|||
161693610|NCT00953758|583927907|FG009|Overall Study|Lost to Follow-up|1|||
161693611|NCT00953758|583927898|FG000|Overall Study|Physician Decision|0|||
161693612|NCT00953758|583927899|FG001|Overall Study|Physician Decision|0|||
161693613|NCT00953758|583927900|FG002|Overall Study|Physician Decision|0|||
161693614|NCT00953758|583927901|FG003|Overall Study|Physician Decision|0|||
161693615|NCT00953758|583927902|FG004|Overall Study|Physician Decision|1|||
161693616|NCT00953758|583927903|FG005|Overall Study|Physician Decision|0|||
161693617|NCT00953758|583927904|FG006|Overall Study|Physician Decision|0|||
161693618|NCT00953758|583927905|FG007|Overall Study|Physician Decision|0|||
161693619|NCT00953758|583927906|FG008|Overall Study|Physician Decision|0|||
161693620|NCT00953758|583927907|FG009|Overall Study|Physician Decision|0|||
161693621|NCT00953758|583927898|FG000|Overall Study|Disease progression|0|||
161693622|NCT00953758|583927899|FG001|Overall Study|Disease progression|0|||
161693623|NCT00953758|583927900|FG002|Overall Study|Disease progression|0|||
161693624|NCT00953758|583927901|FG003|Overall Study|Disease progression|0|||
161693625|NCT00953758|583927902|FG004|Overall Study|Disease progression|1|||
161693626|NCT00953758|583927903|FG005|Overall Study|Disease progression|0|||
161693627|NCT00953758|583927904|FG006|Overall Study|Disease progression|0|||
161693628|NCT00953758|583927905|FG007|Overall Study|Disease progression|0|||
161693629|NCT00953758|583927906|FG008|Overall Study|Disease progression|0|||
161693630|NCT00953758|583927907|FG009|Overall Study|Disease progression|0|||
161693631|NCT00953758|583927898|FG000|Overall Study|Participant went for transplant|0|||
161693632|NCT00953758|583927899|FG001|Overall Study|Participant went for transplant|0|||
161693633|NCT00953758|583927900|FG002|Overall Study|Participant went for transplant|0|||
161693634|NCT00953758|583927901|FG003|Overall Study|Participant went for transplant|0|||
161693635|NCT00953758|583927902|FG004|Overall Study|Participant went for transplant|0|||
161693636|NCT00953758|583927903|FG005|Overall Study|Participant went for transplant|0|||
161693637|NCT00953758|583927904|FG006|Overall Study|Participant went for transplant|0|||
161693638|NCT00953758|583927905|FG007|Overall Study|Participant went for transplant|0|||
161693639|NCT00953758|583927906|FG008|Overall Study|Participant went for transplant|1|||
161693640|NCT00953758|583927907|FG009|Overall Study|Participant went for transplant|0|||
161693641|NCT00293579|583927909|FG000|Overall Study|Withdrawal by Subject|1|||
161693642|NCT01276236|583927910|FG000|Overall Study|Lack of Efficacy|2|||
161836460|NCT01347866|584442999|FG009|Overall Study|Death|1|||
161693643|NCT01276236|583927910|FG000|Overall Study|Withdrawal by Subject|4|||
161693644|NCT02799069|583927911|FG000|Overall Study|Adverse Event|0|||
161693645|NCT02799069|583927912|FG001|Overall Study|Adverse Event|2|||
161693646|NCT02799069|583927913|FG002|Overall Study|Adverse Event|2|||
161693647|NCT02799069|583927911|FG000|Overall Study|Lack of Efficacy|2|||
161693648|NCT02799069|583927912|FG001|Overall Study|Lack of Efficacy|0|||
161693649|NCT02799069|583927913|FG002|Overall Study|Lack of Efficacy|0|||
161693650|NCT02799069|583927911|FG000|Overall Study|Lost to Follow-up|1|||
161693651|NCT02799069|583927912|FG001|Overall Study|Lost to Follow-up|1|||
161693652|NCT02799069|583927913|FG002|Overall Study|Lost to Follow-up|0|||
161693653|NCT02799069|583927911|FG000|Overall Study|Withdrawal by Subject|4|||
161693654|NCT02799069|583927912|FG001|Overall Study|Withdrawal by Subject|4|||
161693655|NCT02799069|583927913|FG002|Overall Study|Withdrawal by Subject|3|||
161693656|NCT02799069|583927911|FG000|Overall Study|Protocol Violation|1|||
161693657|NCT02799069|583927912|FG001|Overall Study|Protocol Violation|0|||
161693658|NCT02799069|583927913|FG002|Overall Study|Protocol Violation|2|||
161693659|NCT03215771|583927914|FG000|Overall Study|Withdrawal by Subject|2|||
161693660|NCT03215771|583927914|FG000|Overall Study|Physician Decision|1|||
161693661|NCT00137111|583927923|FG000|Total Therapy|Death|35|||
161693662|NCT00137111|583927924|FG001|Total Therapy|Death|0|||
161693663|NCT00137111|583927925|FG002|Total Therapy|Death|0|||
161693664|NCT00137111|583927926|FG003|Total Therapy|Death|0|||
161693665|NCT00137111|583927923|FG000|Total Therapy|Non Compliance|5|||
161693666|NCT00137111|583927924|FG001|Total Therapy|Non Compliance|0|||
161693667|NCT00137111|583927925|FG002|Total Therapy|Non Compliance|0|||
161693668|NCT00137111|583927926|FG003|Total Therapy|Non Compliance|0|||
161693669|NCT00852995|583927927|FG000|Overall Study|Adverse Event|1|||
161693670|NCT00852995|583927928|FG001|Overall Study|Adverse Event|0|||
161693671|NCT00852995|583927929|FG002|Overall Study|Adverse Event|4|||
161693672|NCT00852995|583927930|FG003|Overall Study|Adverse Event|0|||
161693673|NCT00852995|583927931|FG004|Overall Study|Adverse Event|0|||
161693674|NCT00852995|583927927|FG000|Overall Study|Lost to Follow-up|0|||
161693675|NCT00852995|583927928|FG001|Overall Study|Lost to Follow-up|1|||
161693676|NCT00852995|583927929|FG002|Overall Study|Lost to Follow-up|1|||
161693677|NCT00852995|583927930|FG003|Overall Study|Lost to Follow-up|0|||
161693678|NCT00852995|583927931|FG004|Overall Study|Lost to Follow-up|0|||
161693679|NCT00852995|583927927|FG000|Overall Study|Withdrawal by Subject|4|||
161693680|NCT00852995|583927928|FG001|Overall Study|Withdrawal by Subject|0|||
161693681|NCT00852995|583927929|FG002|Overall Study|Withdrawal by Subject|0|||
161693682|NCT00852995|583927930|FG003|Overall Study|Withdrawal by Subject|1|||
161693683|NCT00852995|583927931|FG004|Overall Study|Withdrawal by Subject|2|||
161693684|NCT00852995|583927927|FG000|Overall Study|Non-Compliance|0|||
161693685|NCT00852995|583927928|FG001|Overall Study|Non-Compliance|0|||
161693686|NCT00852995|583927929|FG002|Overall Study|Non-Compliance|0|||
161693687|NCT00852995|583927930|FG003|Overall Study|Non-Compliance|2|||
161693688|NCT00852995|583927931|FG004|Overall Study|Non-Compliance|0|||
161693689|NCT00852995|583927927|FG000|Overall Study|Progressive Disease|1|||
161693690|NCT00852995|583927928|FG001|Overall Study|Progressive Disease|0|||
161693691|NCT00852995|583927929|FG002|Overall Study|Progressive Disease|0|||
161693692|NCT00852995|583927930|FG003|Overall Study|Progressive Disease|2|||
161693693|NCT00852995|583927931|FG004|Overall Study|Progressive Disease|1|||
161693694|NCT00852995|583927927|FG000|Overall Study|Physician Decision|1|||
161693695|NCT00852995|583927928|FG001|Overall Study|Physician Decision|0|||
161693696|NCT00852995|583927929|FG002|Overall Study|Physician Decision|0|||
161693697|NCT00852995|583927930|FG003|Overall Study|Physician Decision|0|||
161693698|NCT00852995|583927931|FG004|Overall Study|Physician Decision|0|||
161693699|NCT00852995|583927927|FG000|Overall Study|Protocol Violation|0|||
161693700|NCT00852995|583927928|FG001|Overall Study|Protocol Violation|0|||
161693701|NCT00852995|583927929|FG002|Overall Study|Protocol Violation|0|||
161693702|NCT00852995|583927930|FG003|Overall Study|Protocol Violation|0|||
161693703|NCT00852995|583927931|FG004|Overall Study|Protocol Violation|1|||
161693704|NCT00852995|583927927|FG000|Overall Study|Moved Out of Area|1|||
161693705|NCT00852995|583927928|FG001|Overall Study|Moved Out of Area|0|||
161693706|NCT00852995|583927929|FG002|Overall Study|Moved Out of Area|0|||
161693707|NCT00852995|583927930|FG003|Overall Study|Moved Out of Area|0|||
161693708|NCT00852995|583927931|FG004|Overall Study|Moved Out of Area|0|||
161693709|NCT00626093|583927934|FG000|Overall Study|Lost to Follow-up|5|||
161693710|NCT00626093|583927934|FG000|Overall Study|Death|1|||
161693711|NCT00626093|583927934|FG000|Overall Study|Physician Decision|4|||
161693712|NCT00626093|583927934|FG000|Overall Study|Withdrawal by Subject|6|||
161693713|NCT00626093|583927934|FG000|Overall Study|Protocol Violation|1|||
161693714|NCT00626093|583927934|FG000|Overall Study|One of the required devices not implante|6|||
161693715|NCT00511355|583927935|FG000|Overall Study|Adverse Event|4|||
161693716|NCT00511355|583927936|FG001|Overall Study|Adverse Event|4|||
161693717|NCT00511355|583927935|FG000|Overall Study|Pregnancy Wish|1|||
161693718|NCT00511355|583927936|FG001|Overall Study|Pregnancy Wish|0|||
161693719|NCT00511355|583927935|FG000|Overall Study|Lost to Follow-up|2|||
161693720|NCT00511355|583927936|FG001|Overall Study|Lost to Follow-up|1|||
161693721|NCT00511355|583927935|FG000|Overall Study|Other Reason|0|||
161693722|NCT00511355|583927936|FG001|Overall Study|Other Reason|1|||
161693723|NCT00511355|583927935|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
161693724|NCT00511355|583927936|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
161693725|NCT00511355|583927935|FG000|Overall Study|Withdrawal of informed consent|0|||
161693726|NCT00511355|583927936|FG001|Overall Study|Withdrawal of informed consent|1|||
161693727|NCT00511355|583927935|FG000|Overall Study|Other reason pre-treatment|0|||
161693728|NCT00511355|583927936|FG001|Overall Study|Other reason pre-treatment|1|||
161693729|NCT01632566|583927938|FG000|Overall Study|Withdrawal by Subject|0|||
161693730|NCT01632566|583927939|FG001|Overall Study|Withdrawal by Subject|1|||
161693731|NCT01632566|583927940|FG002|Overall Study|Withdrawal by Subject|0|||
161693732|NCT01632566|583927941|FG003|Overall Study|Withdrawal by Subject|0|||
161693733|NCT01632566|583927942|FG004|Overall Study|Withdrawal by Subject|0|||
161652942|NCT00798434|583779389|FG001|Double-Blind|Lack of Efficacy|12|||
161652943|NCT00798434|583779388|FG000|Double-Blind|Withdrawal by Subject|17|||
161652944|NCT00798434|583779389|FG001|Double-Blind|Withdrawal by Subject|14|||
161652945|NCT00798434|583779388|FG000|Double-Blind|Protocol Violation|1|||
161652946|NCT00798434|583779389|FG001|Double-Blind|Protocol Violation|4|||
161652947|NCT00798434|583779388|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
161652948|NCT00798434|583779389|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
161652949|NCT00798434|583779388|FG000|Double-Blind|Other|1|||
161652950|NCT00798434|583779389|FG001|Double-Blind|Other|0|||
161652951|NCT00798434|583779388|FG000|Double-Blind|Not Treated|3|||
161652952|NCT00798434|583779389|FG001|Double-Blind|Not Treated|6|||
161652953|NCT00798434|583779388|FG000|Open-Label|Adverse Event|33|||
161652954|NCT00798434|583779389|FG001|Open-Label|Adverse Event|11|||
161652955|NCT00798434|583779388|FG000|Open-Label|Lack of Efficacy|5|||
161652956|NCT00798434|583779389|FG001|Open-Label|Lack of Efficacy|11|||
161652957|NCT00798434|583779388|FG000|Open-Label|Withdrawal by Subject|2|||
161652958|NCT00798434|583779389|FG001|Open-Label|Withdrawal by Subject|7|||
161652959|NCT00798434|583779388|FG000|Open-Label|Protocol Violation|1|||
161652960|NCT00798434|583779389|FG001|Open-Label|Protocol Violation|0|||
161652961|NCT00798434|583779388|FG000|Open-Label|Other|1|||
161652962|NCT00798434|583779389|FG001|Open-Label|Other|2|||
161652963|NCT00798434|583779388|FG000|Open-Label|Not Treated|0|||
161652964|NCT00798434|583779389|FG001|Open-Label|Not Treated|1|||
161652965|NCT01217437|583779393|FG000|Overall Study|Adverse Event|0|||
161652966|NCT01217437|583779394|FG001|Overall Study|Adverse Event|8|||
161652967|NCT01217437|583779393|FG000|Overall Study|Death|5|||
161652968|NCT01217437|583779394|FG001|Overall Study|Death|0|||
161652969|NCT01217437|583779393|FG000|Overall Study|Lack of Efficacy|29|||
161652970|NCT01217437|583779394|FG001|Overall Study|Lack of Efficacy|25|||
161652971|NCT01217437|583779393|FG000|Overall Study|Physician Decision|8|||
161652972|NCT01217437|583779394|FG001|Overall Study|Physician Decision|5|||
161652973|NCT01217437|583779393|FG000|Overall Study|Withdrawal by Subject|0|||
161652974|NCT01217437|583779394|FG001|Overall Study|Withdrawal by Subject|2|||
161652975|NCT01217437|583779393|FG000|Overall Study|Ineligible|1|||
161652976|NCT01217437|583779394|FG001|Overall Study|Ineligible|1|||
161652977|NCT04908631|583779395|FG000|Overall Study|Lost to Follow-up|1|||
161652978|NCT04908631|583779395|FG000|Overall Study|Physician Decision|1|||
161652979|NCT04908631|583779395|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
161652980|NCT03578887|583779400|FG000|Overall Study|Withdrawal by Subject|7|||
161652981|NCT03578887|583779401|FG001|Overall Study|Withdrawal by Subject|2|||
161652982|NCT03578887|583779402|FG002|Overall Study|Withdrawal by Subject|1|||
161652983|NCT03578887|583779400|FG000|Overall Study|Lost to Follow-up|13|||
161652984|NCT03578887|583779401|FG001|Overall Study|Lost to Follow-up|1|||
161652985|NCT03578887|583779402|FG002|Overall Study|Lost to Follow-up|4|||
161652986|NCT03578887|583779400|FG000|Overall Study|Physician Decision|0|||
161652987|NCT03578887|583779401|FG001|Overall Study|Physician Decision|1|||
161652988|NCT03578887|583779402|FG002|Overall Study|Physician Decision|1|||
161652989|NCT00095498|583780999|FG000|Overall Study|Physician Decision|9|||
161652990|NCT00095498|583781000|FG001|Overall Study|Physician Decision|10|||
161652991|NCT00095498|583781001|FG002|Overall Study|Physician Decision|8|||
161652992|NCT00095498|583780999|FG000|Overall Study|Adverse Event|1|||
161652993|NCT00095498|583781000|FG001|Overall Study|Adverse Event|0|||
161652994|NCT00095498|583781001|FG002|Overall Study|Adverse Event|1|||
161652995|NCT00095498|583780999|FG000|Overall Study|Withdrawal by Subject|15|||
161652996|NCT00095498|583781000|FG001|Overall Study|Withdrawal by Subject|16|||
161652997|NCT00095498|583781001|FG002|Overall Study|Withdrawal by Subject|15|||
161652998|NCT00095498|583780999|FG000|Overall Study|Disease progression|0|||
161652999|NCT00095498|583781000|FG001|Overall Study|Disease progression|1|||
161653000|NCT00095498|583781001|FG002|Overall Study|Disease progression|1|||
161653001|NCT00095498|583780999|FG000|Overall Study|Ineligibility determined|3|||
161653002|NCT00095498|583781000|FG001|Overall Study|Ineligibility determined|0|||
161653003|NCT00095498|583781001|FG002|Overall Study|Ineligibility determined|2|||
161653004|NCT00095498|583780999|FG000|Overall Study|Lost to Follow-up|1|||
161653005|NCT00095498|583781000|FG001|Overall Study|Lost to Follow-up|1|||
161653006|NCT00095498|583781001|FG002|Overall Study|Lost to Follow-up|2|||
161653007|NCT00095498|583780999|FG000|Overall Study|Noncompliance|1|||
161653008|NCT00095498|583781000|FG001|Overall Study|Noncompliance|0|||
161653009|NCT00095498|583781001|FG002|Overall Study|Noncompliance|1|||
161653010|NCT00095498|583780999|FG000|Overall Study|Other|6|||
161653011|NCT00095498|583781000|FG001|Overall Study|Other|7|||
161653012|NCT00095498|583781001|FG002|Overall Study|Other|6|||
161653013|NCT00095498|583780999|FG000|Overall Study|Protocol Violation|0|||
161653014|NCT00095498|583781000|FG001|Overall Study|Protocol Violation|0|||
161653015|NCT00095498|583781001|FG002|Overall Study|Protocol Violation|1|||
161653016|NCT00095498|583780999|FG000|Overall Study|Requirement for alternative therapy|1|||
161653017|NCT00095498|583781000|FG001|Overall Study|Requirement for alternative therapy|0|||
161653018|NCT00095498|583781001|FG002|Overall Study|Requirement for alternative therapy|2|||
161653019|NCT05020327|583781003|FG000|Overall Study|Physician Decision|3|||
161653020|NCT05020327|583781004|FG001|Overall Study|Physician Decision|0|||
161653021|NCT05020327|583781005|FG002|Overall Study|Physician Decision|0|||
161693734|NCT01632566|583927938|FG000|Overall Study|Sponsor Decision|0|||
161693735|NCT01632566|583927939|FG001|Overall Study|Sponsor Decision|2|||
161693736|NCT01632566|583927940|FG002|Overall Study|Sponsor Decision|9|||
161693737|NCT01632566|583927941|FG003|Overall Study|Sponsor Decision|2|||
161693738|NCT01632566|583927942|FG004|Overall Study|Sponsor Decision|2|||
161693739|NCT00454805|583927943|FG000|Overall Study|Withdrawal by Subject|9|||
161693740|NCT00454805|583927944|FG001|Overall Study|Withdrawal by Subject|2|||
161693741|NCT00454805|583927943|FG000|Overall Study|Death|0|||
161693742|NCT00454805|583927944|FG001|Overall Study|Death|2|||
161693743|NCT00454805|583927943|FG000|Overall Study|Disease progression|16|||
161693744|NCT00454805|583927944|FG001|Overall Study|Disease progression|19|||
161693745|NCT00454805|583927943|FG000|Overall Study|In order to begin radiotherapy|1|||
161693746|NCT00454805|583927944|FG001|Overall Study|In order to begin radiotherapy|0|||
161693747|NCT00217087|583927945|FG000|Overall Study|decided to have esophagectomy|1|||
161693748|NCT00217087|583927946|FG001|Overall Study|decided to have esophagectomy|2|||
161693749|NCT00217087|583927945|FG000|Overall Study|completed less than 12 months return|10|||
161693750|NCT00217087|583927946|FG001|Overall Study|completed less than 12 months return|18|||
161653022|NCT05020327|583781003|FG000|Overall Study|Withdrawal by Subject|1|||
161653023|NCT05020327|583781004|FG001|Overall Study|Withdrawal by Subject|1|||
161653024|NCT05020327|583781005|FG002|Overall Study|Withdrawal by Subject|0|||
161653025|NCT05020327|583781003|FG000|Overall Study|personal/cultural, ineligible|12|||
161653026|NCT05020327|583781004|FG001|Overall Study|personal/cultural, ineligible|0|||
161653027|NCT05020327|583781005|FG002|Overall Study|personal/cultural, ineligible|0|||
161653028|NCT03002220|583781007|FG000|Overall Study|Lack of Efficacy|2|||
161653029|NCT03002220|583781007|FG000|Overall Study|Withdrawal by Subject|3|||
161653030|NCT03002220|583781007|FG000|Overall Study|Adverse Event|2|||
161653031|NCT03002220|583781007|FG000|Overall Study|Disease progression|13|||
161653032|NCT03002220|583781007|FG000|Overall Study|Physician Decision|1|||
161653033|NCT01015560|583781008|FG000|Overall Study|Adverse Event|1|||
161653034|NCT01015560|583781008|FG000|Overall Study|Not protocol specified|1|||
161653035|NCT01015560|583781008|FG000|Overall Study|Withdrawal by Subject|1|||
161653036|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
161653037|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
161653038|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
161653039|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
161653040|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
161653041|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
161653042|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
161653043|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161653044|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161653045|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161653046|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161653047|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161653048|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Death|1|||
161653049|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Death|2|||
161653050|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Death|2|||
161653051|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Death|0|||
161653052|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Death|0|||
161653053|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Death|0|||
161653054|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161693751|NCT03892746|583927949|FG000|Overall Study|Withdrawal by Subject|2|||
161693752|NCT03892746|583927950|FG001|Overall Study|Withdrawal by Subject|1|||
161693753|NCT03892746|583927949|FG000|Overall Study|Lost to Follow-up|2|||
161693754|NCT03892746|583927950|FG001|Overall Study|Lost to Follow-up|0|||
161693755|NCT03977467|583927951|FG000|Overall Study|Disease Progression|1|||
161693756|NCT03977467|583927952|FG001|Overall Study|Disease Progression|1|||
161693757|NCT03977467|583927953|FG002|Overall Study|Disease Progression|30|||
161693758|NCT03977467|583927954|FG003|Overall Study|Disease Progression|0|||
161693759|NCT03977467|583927951|FG000|Overall Study|Adverse Event|0|||
161693760|NCT03977467|583927952|FG001|Overall Study|Adverse Event|1|||
161693761|NCT03977467|583927953|FG002|Overall Study|Adverse Event|0|||
161693762|NCT03977467|583927954|FG003|Overall Study|Adverse Event|0|||
161693763|NCT03977467|583927951|FG000|Overall Study|Death|0|||
161693764|NCT03977467|583927952|FG001|Overall Study|Death|0|||
161693765|NCT03977467|583927953|FG002|Overall Study|Death|3|||
161693766|NCT03977467|583927954|FG003|Overall Study|Death|0|||
161693767|NCT03977467|583927951|FG000|Overall Study|Lack of Efficacy|0|||
161693768|NCT03977467|583927952|FG001|Overall Study|Lack of Efficacy|0|||
161693769|NCT03977467|583927953|FG002|Overall Study|Lack of Efficacy|1|||
161693770|NCT03977467|583927954|FG003|Overall Study|Lack of Efficacy|0|||
161693771|NCT03977467|583927951|FG000|Overall Study|Withdrawal by Subject|2|||
161693772|NCT03977467|583927952|FG001|Overall Study|Withdrawal by Subject|1|||
161693773|NCT03977467|583927953|FG002|Overall Study|Withdrawal by Subject|4|||
161693774|NCT03977467|583927954|FG003|Overall Study|Withdrawal by Subject|0|||
161693775|NCT03977467|583927951|FG000|Overall Study|Study Terminated|1|||
161693776|NCT03977467|583927952|FG001|Overall Study|Study Terminated|0|||
161693777|NCT03977467|583927953|FG002|Overall Study|Study Terminated|0|||
161693778|NCT03977467|583927954|FG003|Overall Study|Study Terminated|1|||
161693779|NCT01328951|583927955|FG000|Overall Study|Disease Progression|17|||
161693780|NCT01328951|583927956|FG001|Overall Study|Disease Progression|14|||
161693781|NCT01328951|583927955|FG000|Overall Study|Adverse Event|2|||
161693782|NCT01328951|583927956|FG001|Overall Study|Adverse Event|0|||
161693783|NCT01328951|583927955|FG000|Overall Study|Death|243|||
161693784|NCT01328951|583927956|FG001|Overall Study|Death|258|||
161693785|NCT01328951|583927955|FG000|Overall Study|Lost to Follow-up|6|||
161693786|NCT01328951|583927956|FG001|Overall Study|Lost to Follow-up|7|||
161693787|NCT01328951|583927955|FG000|Overall Study|Withdrawal by Subject|6|||
161693788|NCT01328951|583927956|FG001|Overall Study|Withdrawal by Subject|6|||
161693789|NCT01328951|583927955|FG000|Overall Study|Study Closed by the Sponsor|36|||
161693790|NCT01328951|583927956|FG001|Overall Study|Study Closed by the Sponsor|31|||
161693791|NCT01328951|583927955|FG000|Overall Study|Other|11|||
161693792|NCT01328951|583927956|FG001|Overall Study|Other|6|||
161693793|NCT04042103|583927962|FG000|Overall Study|Lost to Follow-up|1|||
161693794|NCT04042103|583927962|FG000|Overall Study|Withdrawal by Subject|1|||
161693795|NCT04209855|583927963|FG000|Overall Study|Death|161|||
161693796|NCT04209855|583927964|FG001|Overall Study|Death|177|||
161693797|NCT04209855|583927963|FG000|Overall Study|PI Discretion|1|||
161693798|NCT04209855|583927964|FG001|Overall Study|PI Discretion|1|||
161693799|NCT04209855|583927963|FG000|Overall Study|Lost to Follow-up|5|||
161693800|NCT04209855|583927964|FG001|Overall Study|Lost to Follow-up|2|||
161693801|NCT04209855|583927963|FG000|Overall Study|Withdrew consent|10|||
161693802|NCT04209855|583927964|FG001|Overall Study|Withdrew consent|24|||
161693803|NCT04209855|583927963|FG000|Overall Study|Sponsor decision|44|||
161693804|NCT04209855|583927964|FG001|Overall Study|Sponsor decision|18|||
161693805|NCT04209855|583927963|FG000|Overall Study|Other than specified|6|||
161693806|NCT04209855|583927964|FG001|Overall Study|Other than specified|4|||
161693807|NCT04518462|583927965|FG000|Overall Study|Withdrawal by Subject|0|||
161693808|NCT04518462|583927966|FG001|Overall Study|Withdrawal by Subject|0|||
161693809|NCT04518462|583927967|FG002|Overall Study|Withdrawal by Subject|1|||
161693810|NCT04518462|583927965|FG000|Overall Study|Physician Decision|1|||
161693811|NCT04518462|583927966|FG001|Overall Study|Physician Decision|1|||
161693812|NCT04518462|583927967|FG002|Overall Study|Physician Decision|0|||
161693813|NCT01003210|583927968|FG000|Overall Study|Lost to Follow-up|1|||
161693814|NCT01003210|583927969|FG001|Overall Study|Lost to Follow-up|3|||
161693815|NCT00271817|583927970|FG000|Part 1|Adverse Event|68|||
161693816|NCT00271817|583927971|FG001|Part 1|Adverse Event|25|||
161693817|NCT00271817|583927972|FG002|Part 1|Adverse Event|156|||
161693818|NCT00271817|583927970|FG000|Part 1|Lost to Follow-up|6|||
161693819|NCT00271817|583927971|FG001|Part 1|Lost to Follow-up|8|||
161693820|NCT00271817|583927972|FG002|Part 1|Lost to Follow-up|24|||
161693821|NCT00271817|583927970|FG000|Part 1|Protocol Violation|5|||
161693822|NCT00271817|583927971|FG001|Part 1|Protocol Violation|4|||
161693823|NCT00271817|583927972|FG002|Part 1|Protocol Violation|7|||
161693824|NCT00271817|583927970|FG000|Part 1|Patient Moved|3|||
161693825|NCT00271817|583927971|FG001|Part 1|Patient Moved|1|||
161693826|NCT00271817|583927972|FG002|Part 1|Patient Moved|5|||
161693827|NCT00271817|583927970|FG000|Part 1|Withdrawal by Subject|23|||
161693828|NCT00271817|583927971|FG001|Part 1|Withdrawal by Subject|17|||
161693829|NCT00271817|583927972|FG002|Part 1|Withdrawal by Subject|45|||
161693830|NCT00271817|583927970|FG000|Part 1|LDL < 50 mg/dL|1|||
161693831|NCT00271817|583927971|FG001|Part 1|LDL < 50 mg/dL|4|||
161693832|NCT00271817|583927972|FG002|Part 1|LDL < 50 mg/dL|48|||
161693833|NCT00271817|583927970|FG000|Part 2|Adverse Event|0|||
161693834|NCT00271817|583927971|FG001|Part 2|Adverse Event|17|||
161693835|NCT00271817|583927972|FG002|Part 2|Adverse Event|33|||
161693836|NCT00271817|583927970|FG000|Part 2|Lack of Efficacy|0|||
161693837|NCT00271817|583927971|FG001|Part 2|Lack of Efficacy|1|||
161693838|NCT00271817|583927972|FG002|Part 2|Lack of Efficacy|6|||
161693839|NCT00271817|583927970|FG000|Part 2|Lost to Follow-up|0|||
161693840|NCT00271817|583927971|FG001|Part 2|Lost to Follow-up|6|||
161693841|NCT00271817|583927972|FG002|Part 2|Lost to Follow-up|18|||
161693842|NCT00271817|583927970|FG000|Part 2|Protocol Violation|0|||
161693843|NCT00271817|583927971|FG001|Part 2|Protocol Violation|3|||
161693844|NCT00271817|583927972|FG002|Part 2|Protocol Violation|5|||
161693845|NCT00271817|583927970|FG000|Part 2|Patient Moved|0|||
161693846|NCT00271817|583927971|FG001|Part 2|Patient Moved|0|||
161693847|NCT00271817|583927972|FG002|Part 2|Patient Moved|5|||
161836461|NCT01347866|584443000|FG010|Overall Study|Death|3|||
161836462|NCT01347866|584443001|FG011|Overall Study|Death|1|||
161836463|NCT01347866|584443002|FG012|Overall Study|Death|2|||
161836464|NCT01347866|584443003|FG013|Overall Study|Death|0|||
161836465|NCT01347866|584443004|FG014|Overall Study|Death|0|||
161693848|NCT00271817|583927970|FG000|Part 2|Withdrawal by Subject|0|||
161693849|NCT00271817|583927971|FG001|Part 2|Withdrawal by Subject|2|||
161693850|NCT00271817|583927972|FG002|Part 2|Withdrawal by Subject|13|||
161693851|NCT00271817|583927970|FG000|Part 2|LDL < 50 mg/dL|0|||
161836466|NCT01347866|584443005|FG015|Overall Study|Death|1|||
161836467|NCT01347866|584443006|FG016|Overall Study|Death|0|||
161836468|NCT01347866|584442990|FG000|Overall Study|Lost to Follow-up|0|||
161836469|NCT01347866|584442991|FG001|Overall Study|Lost to Follow-up|0|||
161836470|NCT01347866|584442992|FG002|Overall Study|Lost to Follow-up|0|||
161836471|NCT01347866|584442993|FG003|Overall Study|Lost to Follow-up|0|||
161836472|NCT01347866|584442994|FG004|Overall Study|Lost to Follow-up|0|||
161836473|NCT01347866|584442995|FG005|Overall Study|Lost to Follow-up|0|||
161836474|NCT01347866|584442996|FG006|Overall Study|Lost to Follow-up|0|||
161836475|NCT01347866|584442997|FG007|Overall Study|Lost to Follow-up|1|||
161836476|NCT01347866|584442998|FG008|Overall Study|Lost to Follow-up|1|||
161836477|NCT01347866|584442999|FG009|Overall Study|Lost to Follow-up|0|||
161836478|NCT01347866|584443000|FG010|Overall Study|Lost to Follow-up|0|||
161836479|NCT01347866|584443001|FG011|Overall Study|Lost to Follow-up|0|||
161836480|NCT01347866|584443002|FG012|Overall Study|Lost to Follow-up|0|||
161836481|NCT01347866|584443003|FG013|Overall Study|Lost to Follow-up|0|||
161836482|NCT01347866|584443004|FG014|Overall Study|Lost to Follow-up|0|||
161836483|NCT01347866|584443005|FG015|Overall Study|Lost to Follow-up|0|||
161836484|NCT01347866|584443006|FG016|Overall Study|Lost to Follow-up|0|||
161836485|NCT01347866|584442990|FG000|Overall Study|Other|3|||
161836486|NCT01347866|584442991|FG001|Overall Study|Other|1|||
161836487|NCT01347866|584442992|FG002|Overall Study|Other|1|||
161836488|NCT01347866|584442993|FG003|Overall Study|Other|4|||
161836489|NCT01347866|584442994|FG004|Overall Study|Other|5|||
161836490|NCT01347866|584442995|FG005|Overall Study|Other|0|||
161836491|NCT01347866|584442996|FG006|Overall Study|Other|5|||
161836492|NCT01347866|584442997|FG007|Overall Study|Other|3|||
161693852|NCT00271817|583927971|FG001|Part 2|LDL < 50 mg/dL|3|||
161693853|NCT00271817|583927972|FG002|Part 2|LDL < 50 mg/dL|4|||
161693854|NCT01471782|583927976|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
161693855|NCT01471782|583927977|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
161836493|NCT01347866|584442998|FG008|Overall Study|Other|22|||
161836494|NCT01347866|584442999|FG009|Overall Study|Other|5|||
161836495|NCT01347866|584443000|FG010|Overall Study|Other|0|||
161836496|NCT01347866|584443001|FG011|Overall Study|Other|3|||
161653055|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
161653056|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
161653057|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161653058|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161653059|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161653060|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
161653061|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161653062|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161653063|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161653064|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161693856|NCT01471782|583927978|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
161693857|NCT01471782|583927979|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
161693858|NCT01471782|583927980|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
161836497|NCT01347866|584443002|FG012|Overall Study|Other|4|||
161836498|NCT01347866|584443003|FG013|Overall Study|Other|4|||
161836499|NCT01347866|584443004|FG014|Overall Study|Other|2|||
161693859|NCT01471782|583927981|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
161693860|NCT01471782|583927976|FG000|Overall Study|Lack of Efficacy|1|||
161836500|NCT01347866|584443005|FG015|Overall Study|Other|3|||
161836501|NCT01347866|584443006|FG016|Overall Study|Other|0|||
161836502|NCT01347866|584442990|FG000|Overall Study|Subject refused further follow-up|2|||
161836503|NCT01347866|584442991|FG001|Overall Study|Subject refused further follow-up|0|||
161693861|NCT01471782|583927977|FG001|Overall Study|Lack of Efficacy|2|||
161693862|NCT01471782|583927978|FG002|Overall Study|Lack of Efficacy|1|||
161693863|NCT01471782|583927979|FG003|Overall Study|Lack of Efficacy|1|||
161693864|NCT01471782|583927980|FG004|Overall Study|Lack of Efficacy|5|||
161693865|NCT01471782|583927981|FG005|Overall Study|Lack of Efficacy|18|||
161693866|NCT01471782|583927976|FG000|Overall Study|Adverse Event|1|||
161693867|NCT01471782|583927977|FG001|Overall Study|Adverse Event|1|||
161693868|NCT01471782|583927978|FG002|Overall Study|Adverse Event|2|||
161693869|NCT01471782|583927979|FG003|Overall Study|Adverse Event|2|||
161693870|NCT01471782|583927980|FG004|Overall Study|Adverse Event|3|||
161693871|NCT01471782|583927981|FG005|Overall Study|Adverse Event|1|||
161693872|NCT01471782|583927976|FG000|Overall Study|Other|0|||
161693873|NCT01471782|583927977|FG001|Overall Study|Other|0|||
161693874|NCT01471782|583927978|FG002|Overall Study|Other|1|||
161693875|NCT01471782|583927979|FG003|Overall Study|Other|1|||
161693876|NCT01471782|583927980|FG004|Overall Study|Other|6|||
161693877|NCT01471782|583927981|FG005|Overall Study|Other|5|||
161693878|NCT01471782|583927976|FG000|Overall Study|Change of Chemotherapy|1|||
161693879|NCT01471782|583927977|FG001|Overall Study|Change of Chemotherapy|1|||
161693880|NCT01471782|583927978|FG002|Overall Study|Change of Chemotherapy|0|||
161693881|NCT01471782|583927979|FG003|Overall Study|Change of Chemotherapy|0|||
161693882|NCT01471782|583927980|FG004|Overall Study|Change of Chemotherapy|1|||
161693883|NCT01471782|583927981|FG005|Overall Study|Change of Chemotherapy|4|||
161693884|NCT01471782|583927976|FG000|Overall Study|Disease Relapse|0|||
161693885|NCT01471782|583927977|FG001|Overall Study|Disease Relapse|0|||
161693886|NCT01471782|583927978|FG002|Overall Study|Disease Relapse|0|||
161693887|NCT01471782|583927979|FG003|Overall Study|Disease Relapse|1|||
161693888|NCT01471782|583927980|FG004|Overall Study|Disease Relapse|2|||
161693889|NCT01471782|583927981|FG005|Overall Study|Disease Relapse|1|||
161693890|NCT01471782|583927976|FG000|Overall Study|Physician Decision|0|||
161693891|NCT01471782|583927977|FG001|Overall Study|Physician Decision|0|||
161693892|NCT01471782|583927978|FG002|Overall Study|Physician Decision|0|||
161693893|NCT01471782|583927979|FG003|Overall Study|Physician Decision|0|||
161693894|NCT01471782|583927980|FG004|Overall Study|Physician Decision|3|||
161693895|NCT01471782|583927981|FG005|Overall Study|Physician Decision|8|||
161693896|NCT01471782|583927976|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161693897|NCT01471782|583927977|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161693898|NCT01471782|583927978|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161693899|NCT01471782|583927979|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161693900|NCT01471782|583927980|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
161693901|NCT01471782|583927981|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161693902|NCT01471782|583927976|FG000|Overall Study|Death|0|||
161693903|NCT01471782|583927977|FG001|Overall Study|Death|0|||
161693904|NCT01471782|583927978|FG002|Overall Study|Death|0|||
161693905|NCT01471782|583927979|FG003|Overall Study|Death|0|||
161693906|NCT01471782|583927980|FG004|Overall Study|Death|0|||
161693907|NCT01471782|583927981|FG005|Overall Study|Death|1|||
161693908|NCT00936208|583927982|FG000|Overall Study|Protocol Violation|37|||
161693909|NCT00936208|583927983|FG001|Overall Study|Protocol Violation|22|||
161693910|NCT04428424|583927984|FG000|Overall Study|Does not meet entrance criteria|132|||
161693911|NCT04428424|583927984|FG000|Overall Study|Lost to Follow-up|115|||
161693912|NCT01411085|583927985|FG000|Overall Study|Physician Decision|1|||
161693913|NCT01411085|583927985|FG000|Overall Study|Protocol Violation|1|||
161693914|NCT01411085|583927985|FG000|Overall Study|Adverse Event|1|||
161693915|NCT01564862|583927986|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
161693916|NCT01564862|583927987|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
161693917|NCT01564862|583927988|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161693918|NCT01564862|583927986|FG000|Overall Study|Major Protocol Deviation|3|||
161693919|NCT01564862|583927987|FG001|Overall Study|Major Protocol Deviation|3|||
161693920|NCT01564862|583927988|FG002|Overall Study|Major Protocol Deviation|4|||
161693921|NCT01564862|583927986|FG000|Overall Study|Lost to Follow-up|10|||
161693922|NCT01564862|583927987|FG001|Overall Study|Lost to Follow-up|8|||
161693923|NCT01564862|583927988|FG002|Overall Study|Lost to Follow-up|6|||
161693924|NCT01564862|583927986|FG000|Overall Study|Voluntary Withdrawal|9|||
161693925|NCT01564862|583927987|FG001|Overall Study|Voluntary Withdrawal|6|||
161693926|NCT01564862|583927988|FG002|Overall Study|Voluntary Withdrawal|8|||
161693927|NCT01564862|583927986|FG000|Overall Study|Lack of Efficacy|1|||
161693928|NCT01564862|583927987|FG001|Overall Study|Lack of Efficacy|5|||
161693929|NCT01564862|583927988|FG002|Overall Study|Lack of Efficacy|6|||
161693930|NCT01564862|583927986|FG000|Overall Study|Other reason(s)|1|||
161693931|NCT01564862|583927987|FG001|Overall Study|Other reason(s)|0|||
161693932|NCT01564862|583927988|FG002|Overall Study|Other reason(s)|0|||
161693933|NCT03809611|583927989|FG000|Overall Study|Withdrawal by Subject|1|||
161693934|NCT03809611|583927990|FG001|Overall Study|Withdrawal by Subject|1|||
161693935|NCT02193074|583927993|FG000|Overall Study|Withdrawal by Subject|1|||
161693936|NCT02193074|583927994|FG001|Overall Study|Withdrawal by Subject|2|||
161693937|NCT02193074|583927993|FG000|Overall Study|Adverse Event|16|||
161693938|NCT02193074|583927994|FG001|Overall Study|Adverse Event|13|||
161693939|NCT03124563|583927996|FG000|Overall Study|Lost to Follow-up|1|||
161693940|NCT03124563|583927997|FG001|Overall Study|Lost to Follow-up|1|||
161693941|NCT03124563|583927996|FG000|Overall Study|Withdrawal by Subject|1|||
161693942|NCT03124563|583927997|FG001|Overall Study|Withdrawal by Subject|1|||
161693943|NCT04745689|583927998|FG000|Overall Study|Death|9|||
161693944|NCT04745689|583927999|FG001|Overall Study|Death|6|||
161693945|NCT04745689|583927998|FG000|Overall Study|Lost to Follow-up|1|||
161693946|NCT04745689|583927999|FG001|Overall Study|Lost to Follow-up|0|||
161693947|NCT04745689|583927998|FG000|Overall Study|Withdrawal by Subject|2|||
161693948|NCT04745689|583927999|FG001|Overall Study|Withdrawal by Subject|0|||
161693949|NCT04745689|583927998|FG000|Overall Study|Study terminated by sponsor|10|||
161693950|NCT04745689|583927999|FG001|Overall Study|Study terminated by sponsor|3|||
161693951|NCT02396589|583928002|FG000|Intervention|Lost to Follow-up|1|||
161693952|NCT02396589|583928003|FG001|Intervention|Lost to Follow-up|0|||
161693953|NCT02396589|583928002|FG000|6 Month Follow-up|change in health status|0|||
161693954|NCT02396589|583928003|FG001|6 Month Follow-up|change in health status|1|||
161693955|NCT02396589|583928002|FG000|9 Month Follow-up|Death|0|||
161693956|NCT02396589|583928003|FG001|9 Month Follow-up|Death|1|||
161693957|NCT02396589|583928002|FG000|12 Month Follow up|Lost to Follow-up|0|||
161693958|NCT02396589|583928003|FG001|12 Month Follow up|Lost to Follow-up|2|||
161693959|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693960|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693961|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693962|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
161693963|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693964|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693965|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693966|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693967|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693968|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693969|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693970|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693971|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693972|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693973|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
161693974|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693975|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693976|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693977|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693978|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693979|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693980|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693981|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
161693982|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
161693983|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
161693984|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
161693985|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693986|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693987|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693988|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693989|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693990|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693991|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693992|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693993|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693994|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
161693995|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
161693996|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693997|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693998|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693999|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694000|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694001|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694002|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694003|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694004|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161694005|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161694006|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161694007|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694008|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694009|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694010|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694011|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694012|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694013|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694014|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694015|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694016|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694017|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694018|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
161694019|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
161694020|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694021|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694022|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694023|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
161694024|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694025|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694026|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694027|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694028|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694029|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694030|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694031|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694032|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161694033|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161694034|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161694035|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694036|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694037|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694038|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694039|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694040|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
161694041|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
161694042|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694043|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
161694044|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
161694045|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
161694046|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
161694047|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694048|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694049|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694050|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694051|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161694052|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
161694053|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
161694054|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
161694055|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161694056|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
161694057|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161694058|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694059|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694060|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694061|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694062|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694063|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694064|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694065|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
161694066|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694067|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694068|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694069|NCT05593016|583929770|FG000|Overall Study|Death|1|||
161694070|NCT05593016|583929771|FG001|Overall Study|Death|1|||
161694071|NCT05593016|583929772|FG002|Overall Study|Death|1|||
161694072|NCT05593016|583929773|FG003|Overall Study|Death|0|||
161694073|NCT05593016|583929774|FG004|Overall Study|Death|0|||
161694074|NCT05593016|583929770|FG000|Overall Study|Lost to Follow-up|1|||
161694075|NCT05593016|583929771|FG001|Overall Study|Lost to Follow-up|1|||
161694076|NCT05593016|583929772|FG002|Overall Study|Lost to Follow-up|1|||
161694077|NCT05593016|583929773|FG003|Overall Study|Lost to Follow-up|2|||
161694078|NCT05593016|583929774|FG004|Overall Study|Lost to Follow-up|0|||
161694079|NCT05416138|583929775|FG000|Overall Study|Withdrawal by Subject|2|||
161694080|NCT05416138|583929776|FG001|Overall Study|Withdrawal by Subject|1|||
161694081|NCT04705051|583929777|FG000|Overall Study|Enrolled but not treated|1|||
161694082|NCT04705051|583929777|FG000|Overall Study|Study terminated by sponsor|23|||
161694083|NCT03686397|583929778|FG000|Overall Study|Lack of Efficacy|3|||
161694084|NCT03686397|583929779|FG001|Overall Study|Lack of Efficacy|5|||
161694085|NCT03686397|583929778|FG000|Overall Study|Adverse Event|0|||
161694086|NCT03686397|583929779|FG001|Overall Study|Adverse Event|1|||
161694087|NCT03686397|583929778|FG000|Overall Study|Protocol Violation|0|||
161694088|NCT03686397|583929779|FG001|Overall Study|Protocol Violation|1|||
161694089|NCT03686397|583929778|FG000|Overall Study|Withdrawal by Subject|0|||
161694090|NCT03686397|583929779|FG001|Overall Study|Withdrawal by Subject|1|||
161694091|NCT03686397|583929778|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
161694092|NCT03686397|583929779|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
161694093|NCT03160560|583929780|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
161694094|NCT03160560|583929781|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161694095|NCT03160560|583929782|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161694096|NCT03160560|583929783|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694097|NCT03160560|583929780|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161694098|NCT03160560|583929781|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694099|NCT03160560|583929782|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694100|NCT03160560|583929783|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694101|NCT02814565|583929791|FG000|Overall Study|Lack of Efficacy|0|||
161694102|NCT02814565|583929792|FG001|Overall Study|Lack of Efficacy|1|||
161694103|NCT02814565|583929791|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
161694104|NCT02814565|583929792|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
161694105|NCT05587296|583929795|FG000|Overall Study|Adverse Event|15|||
161694106|NCT05587296|583929796|FG001|Overall Study|Adverse Event|7|||
161694107|NCT05587296|583929795|FG000|Overall Study|Lack of Efficacy|2|||
161694108|NCT05587296|583929796|FG001|Overall Study|Lack of Efficacy|0|||
161694109|NCT05587296|583929795|FG000|Overall Study|Lost to Follow-up|1|||
161694110|NCT05587296|583929796|FG001|Overall Study|Lost to Follow-up|0|||
161694111|NCT05587296|583929795|FG000|Overall Study|Withdrawal by Subject|14|||
161694112|NCT05587296|583929796|FG001|Overall Study|Withdrawal by Subject|4|||
161694113|NCT05587296|583929795|FG000|Overall Study|miscellaneous|3|||
161694114|NCT05587296|583929796|FG001|Overall Study|miscellaneous|6|||
161694115|NCT05587296|583929795|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
161694116|NCT05587296|583929796|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
161694117|NCT02847624|583929799|FG000|Overall Study|Lost to Follow-up|28|||
161694118|NCT02847624|583929799|FG000|Overall Study|Protocol Violation|98|||
161694119|NCT02847624|583929799|FG000|Overall Study|Case report failures|4|||
161694120|NCT04735653|583929800|FG000|Overall Study|Lost to Follow-up|17|||
161694121|NCT04735653|583929801|FG001|Overall Study|Lost to Follow-up|7|||
161694122|NCT04735653|583929800|FG000|Overall Study|Withdrawal by Subject|8|||
161694123|NCT04735653|583929801|FG001|Overall Study|Withdrawal by Subject|2|||
161694124|NCT04735653|583929800|FG000|Overall Study|Death|0|||
161694125|NCT04735653|583929801|FG001|Overall Study|Death|2|||
161694126|NCT04735653|583929800|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
161694127|NCT04735653|583929801|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
161694128|NCT00608985|583929816|FG000|Overall Study|Adverse Event|2|||
161694129|NCT00608985|583929817|FG001|Overall Study|Adverse Event|7|||
161694130|NCT00608985|583929818|FG002|Overall Study|Adverse Event|4|||
161694131|NCT00608985|583929819|FG003|Overall Study|Adverse Event|6|||
161694132|NCT00608985|583929816|FG000|Overall Study|Administrative/Other|7|||
161694133|NCT00608985|583929817|FG001|Overall Study|Administrative/Other|4|||
161694134|NCT00608985|583929818|FG002|Overall Study|Administrative/Other|1|||
161694135|NCT00608985|583929819|FG003|Overall Study|Administrative/Other|2|||
161694136|NCT00608985|583929816|FG000|Overall Study|Withdrawal of Consent|5|||
161694137|NCT00608985|583929817|FG001|Overall Study|Withdrawal of Consent|1|||
161694138|NCT00608985|583929818|FG002|Overall Study|Withdrawal of Consent|1|||
161694139|NCT00608985|583929819|FG003|Overall Study|Withdrawal of Consent|1|||
161694140|NCT00608985|583929816|FG000|Overall Study|Lost to Follow-up|2|||
161694141|NCT00608985|583929817|FG001|Overall Study|Lost to Follow-up|1|||
161694142|NCT00608985|583929818|FG002|Overall Study|Lost to Follow-up|0|||
161694143|NCT00608985|583929819|FG003|Overall Study|Lost to Follow-up|0|||
161653065|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161653066|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
161653067|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161653068|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161653069|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161653070|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161653071|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161653072|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
161653073|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161653074|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161653075|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161653076|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161653077|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161653078|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161653079|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
161653080|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161653081|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161653082|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161694144|NCT03870555|583929820|FG000|Period 3 (2 Days)|Adverse Event|1|||
161694145|NCT03870555|583929821|FG001|Period 3 (2 Days)|Adverse Event|0|||
161694146|NCT03870555|583929822|FG002|Period 3 (2 Days)|Adverse Event|0|||
161694147|NCT03847610|583929823|FG000|Overall Study|Withdrawal by Subject|1|||
161694148|NCT02004873|583929824|FG000|Overall Study|Implant unsuccessful|6|||
161694149|NCT02004873|583929824|FG000|Overall Study|Awaiting 6-month visit|390|||
161694150|NCT02004873|583929824|FG000|Overall Study|Missed 6-month visit|4|||
161694151|NCT02004873|583929824|FG000|Overall Study|Death|23|||
161694152|NCT02004873|583929824|FG000|Overall Study|Withdrawal by Subject|1|||
161694153|NCT00044512|583929826|FG000|Follow Up|Lost to Follow-up|2|||
161694154|NCT03440814|583929831|FG000|Overall Study|Adverse Event|2|||
161694155|NCT03440814|583929832|FG001|Overall Study|Adverse Event|1|||
161694156|NCT03440814|583929831|FG000|Overall Study|Lost to Follow-up|2|||
161694157|NCT03440814|583929832|FG001|Overall Study|Lost to Follow-up|0|||
161694158|NCT03440814|583929831|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
161694159|NCT03440814|583929832|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
161694160|NCT01437397|583929833|FG000|Overall Study|Lost to Follow-up|9|||
161694161|NCT01437397|583929834|FG001|Overall Study|Lost to Follow-up|4|||
161694162|NCT01437397|583929835|FG002|Overall Study|Lost to Follow-up|2|||
161694163|NCT01437397|583929836|FG003|Overall Study|Lost to Follow-up|4|||
161694164|NCT01437397|583929837|FG004|Overall Study|Lost to Follow-up|5|||
161694165|NCT01437397|583929833|FG000|Overall Study|Withdrawal by Subject|11|||
161694166|NCT01437397|583929834|FG001|Overall Study|Withdrawal by Subject|12|||
161694167|NCT01437397|583929835|FG002|Overall Study|Withdrawal by Subject|24|||
161694168|NCT01437397|583929836|FG003|Overall Study|Withdrawal by Subject|11|||
161694169|NCT01437397|583929837|FG004|Overall Study|Withdrawal by Subject|22|||
161694170|NCT01437397|583929833|FG000|Overall Study|Protocol Violation|10|||
161694171|NCT01437397|583929834|FG001|Overall Study|Protocol Violation|12|||
161694172|NCT01437397|583929835|FG002|Overall Study|Protocol Violation|13|||
161694173|NCT01437397|583929836|FG003|Overall Study|Protocol Violation|21|||
161694174|NCT01437397|583929837|FG004|Overall Study|Protocol Violation|19|||
161694175|NCT01437397|583929833|FG000|Overall Study|Lack of Efficacy|5|||
161694176|NCT01437397|583929834|FG001|Overall Study|Lack of Efficacy|4|||
161694177|NCT01437397|583929835|FG002|Overall Study|Lack of Efficacy|8|||
161694178|NCT01437397|583929836|FG003|Overall Study|Lack of Efficacy|10|||
161694179|NCT01437397|583929837|FG004|Overall Study|Lack of Efficacy|20|||
161694180|NCT01437397|583929833|FG000|Overall Study|Adverse Event|21|||
161694181|NCT01437397|583929834|FG001|Overall Study|Adverse Event|22|||
161694182|NCT01437397|583929835|FG002|Overall Study|Adverse Event|16|||
161694183|NCT01437397|583929836|FG003|Overall Study|Adverse Event|14|||
161694184|NCT01437397|583929837|FG004|Overall Study|Adverse Event|21|||
161694185|NCT01437397|583929833|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
161694186|NCT01437397|583929834|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
161694187|NCT01437397|583929835|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
161694188|NCT01437397|583929836|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
161694189|NCT01437397|583929837|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
161694190|NCT00866307|583929839|FG000|Induction|Adverse Event|5|||
161694191|NCT00866307|583929840|FG001|Induction|Adverse Event|0|||
161694192|NCT00866307|583929841|FG002|Induction|Adverse Event|0|||
161694193|NCT00866307|583929839|FG000|Induction|Death|2|||
161694194|NCT00866307|583929840|FG001|Induction|Death|0|||
161694195|NCT00866307|583929841|FG002|Induction|Death|0|||
161694196|NCT00866307|583929839|FG000|Induction|Physician Decision|5|||
161694197|NCT00866307|583929840|FG001|Induction|Physician Decision|0|||
161694198|NCT00866307|583929841|FG002|Induction|Physician Decision|0|||
161694199|NCT00866307|583929839|FG000|Induction|Progressive Disease|1|||
161694200|NCT00866307|583929840|FG001|Induction|Progressive Disease|0|||
161694201|NCT00866307|583929841|FG002|Induction|Progressive Disease|0|||
161694202|NCT00866307|583929839|FG000|Induction|Identification of Patients with Day 29 M|3|||
161694203|NCT00866307|583929840|FG001|Induction|Identification of Patients with Day 29 M|0|||
161694204|NCT00866307|583929841|FG002|Induction|Identification of Patients with Day 29 M|0|||
161694205|NCT00866307|583929839|FG000|Induction|Inadequate cytognetic samples th|1|||
161694206|NCT00866307|583929840|FG001|Induction|Inadequate cytognetic samples th|0|||
161694207|NCT00866307|583929841|FG002|Induction|Inadequate cytognetic samples th|0|||
161694208|NCT00866307|583929839|FG000|Induction|Improper post-induction consent|2|||
161694209|NCT00866307|583929840|FG001|Induction|Improper post-induction consent|0|||
161694210|NCT00866307|583929841|FG002|Induction|Improper post-induction consent|0|||
161694211|NCT00866307|583929839|FG000|Induction|Study was closed at the time|1|||
161694212|NCT00866307|583929840|FG001|Induction|Study was closed at the time|0|||
161694213|NCT00866307|583929841|FG002|Induction|Study was closed at the time|0|||
161694214|NCT00866307|583929839|FG000|Consolidation/Maintenance|Adverse Event|0|||
161694215|NCT00866307|583929840|FG001|Consolidation/Maintenance|Adverse Event|0|||
161694216|NCT00866307|583929841|FG002|Consolidation/Maintenance|Adverse Event|8|||
161694217|NCT00866307|583929839|FG000|Consolidation/Maintenance|Death|0|||
161694218|NCT00866307|583929840|FG001|Consolidation/Maintenance|Death|0|||
161694219|NCT00866307|583929841|FG002|Consolidation/Maintenance|Death|1|||
161694220|NCT00866307|583929839|FG000|Consolidation/Maintenance|Physician Decision|0|||
161694221|NCT00866307|583929840|FG001|Consolidation/Maintenance|Physician Decision|3|||
161694222|NCT00866307|583929841|FG002|Consolidation/Maintenance|Physician Decision|2|||
161694223|NCT00866307|583929839|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
161694224|NCT00866307|583929840|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
161694225|NCT00866307|583929841|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
161694226|NCT00866307|583929839|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
161694227|NCT00866307|583929840|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
161694228|NCT00866307|583929841|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
161694229|NCT00866307|583929839|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
161694230|NCT00866307|583929840|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
161694231|NCT00866307|583929841|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
161694232|NCT00866307|583929839|FG000|Consolidation/Maintenance|Therapy error|0|||
161694233|NCT00866307|583929840|FG001|Consolidation/Maintenance|Therapy error|1|||
161694234|NCT00866307|583929841|FG002|Consolidation/Maintenance|Therapy error|0|||
161694235|NCT00866307|583929839|FG000|Consolidation/Maintenance|Non-compliance|0|||
161694236|NCT00866307|583929840|FG001|Consolidation/Maintenance|Non-compliance|0|||
161694237|NCT00866307|583929841|FG002|Consolidation/Maintenance|Non-compliance|1|||
161694238|NCT00866307|583929839|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
161694239|NCT00866307|583929840|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
161694240|NCT00866307|583929841|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
161694241|NCT02573155|583929844|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
161694242|NCT02573155|583929845|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
161694243|NCT02573155|583929844|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
161694244|NCT02573155|583929845|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
161694245|NCT02573155|583929844|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
161694246|NCT02573155|583929845|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
161694247|NCT02573155|583929844|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
161694248|NCT02573155|583929845|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
161694249|NCT02573155|583929844|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
161694250|NCT02573155|583929845|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
161694251|NCT02573155|583929844|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
161694252|NCT02573155|583929845|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
161694253|NCT02573155|583929844|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
161694254|NCT02573155|583929845|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
161694255|NCT02573155|583929844|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
161694256|NCT02573155|583929845|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
161694257|NCT01681433|583929846|FG000|Overall Study|Lack of Efficacy|23|||
161694258|NCT01681433|583929847|FG001|Overall Study|Lack of Efficacy|23|||
161694259|NCT01681433|583929846|FG000|Overall Study|Withdrawal by Subject|5|||
161694260|NCT01681433|583929847|FG001|Overall Study|Withdrawal by Subject|5|||
161694261|NCT01681433|583929846|FG000|Overall Study|Protocol Violation|2|||
161694262|NCT01681433|583929847|FG001|Overall Study|Protocol Violation|0|||
161694263|NCT01681433|583929846|FG000|Overall Study|Adverse Event|2|||
161694264|NCT01681433|583929847|FG001|Overall Study|Adverse Event|4|||
161694265|NCT01681433|583929846|FG000|Overall Study|Lost to Follow-up|0|||
161694266|NCT01681433|583929847|FG001|Overall Study|Lost to Follow-up|1|||
161694267|NCT00903929|583929848|FG000|Overall Study|Withdrawal by Subject|0|||
161694268|NCT00903929|583929849|FG001|Overall Study|Withdrawal by Subject|0|||
161694269|NCT00903929|583929850|FG002|Overall Study|Withdrawal by Subject|1|||
161694270|NCT00903929|583929851|FG003|Overall Study|Withdrawal by Subject|2|||
161694271|NCT00903929|583929848|FG000|Overall Study|Adverse Event|0|||
161694272|NCT00903929|583929849|FG001|Overall Study|Adverse Event|0|||
161836504|NCT01347866|584442992|FG002|Overall Study|Subject refused further follow-up|0|||
161836505|NCT01347866|584442993|FG003|Overall Study|Subject refused further follow-up|2|||
161836506|NCT01347866|584442994|FG004|Overall Study|Subject refused further follow-up|0|||
161836507|NCT01347866|584442995|FG005|Overall Study|Subject refused further follow-up|1|||
161836508|NCT01347866|584442996|FG006|Overall Study|Subject refused further follow-up|0|||
161836509|NCT01347866|584442997|FG007|Overall Study|Subject refused further follow-up|0|||
161836510|NCT01347866|584442998|FG008|Overall Study|Subject refused further follow-up|4|||
161836511|NCT01347866|584442999|FG009|Overall Study|Subject refused further follow-up|1|||
161836512|NCT01347866|584443000|FG010|Overall Study|Subject refused further follow-up|0|||
161836513|NCT01347866|584443001|FG011|Overall Study|Subject refused further follow-up|0|||
161694273|NCT00903929|583929850|FG002|Overall Study|Adverse Event|0|||
161694274|NCT00903929|583929851|FG003|Overall Study|Adverse Event|1|||
161694275|NCT02508194|583929855|FG000|Overall Study|Death|5|||
161694276|NCT02508194|583929856|FG001|Overall Study|Death|3|||
161836514|NCT01347866|584443002|FG012|Overall Study|Subject refused further follow-up|1|||
161694277|NCT02508194|583929855|FG000|Overall Study|Lost to Follow-up|25|||
161694278|NCT02508194|583929856|FG001|Overall Study|Lost to Follow-up|18|||
161694279|NCT02508194|583929855|FG000|Overall Study|Withdrawal by Subject|20|||
161694280|NCT02508194|583929856|FG001|Overall Study|Withdrawal by Subject|18|||
161694281|NCT02508194|583929855|FG000|Overall Study|Error in Randomization|1|||
161694282|NCT02508194|583929856|FG001|Overall Study|Error in Randomization|3|||
161694283|NCT02508194|583929855|FG000|Overall Study|Principal Investigator Decision|1|||
161694284|NCT02508194|583929856|FG001|Overall Study|Principal Investigator Decision|2|||
161694285|NCT03208231|583929859|FG000|Overall Study|Death|1|||
161694286|NCT03208231|583929860|FG001|Overall Study|Death|2|||
161694287|NCT03208231|583929859|FG000|Overall Study|Moved and unable to get to clinic|1|||
161694288|NCT03208231|583929860|FG001|Overall Study|Moved and unable to get to clinic|0|||
161694289|NCT03208231|583929859|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
161694290|NCT03208231|583929860|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
161694291|NCT03205995|583929861|FG000|Overall Study|Adverse Event|1|||
161694292|NCT03205995|583929861|FG000|Overall Study|Death|1|||
161694293|NCT03205995|583929861|FG000|Overall Study|Physician Decision|2|||
161694294|NCT03205995|583929861|FG000|Overall Study|Protocol Violation|2|||
161694295|NCT04947800|583929864|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
161694296|NCT04947800|583929865|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
161653083|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161653084|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
161653085|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
161653086|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
161653087|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
161653088|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
161653089|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
161653090|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161653091|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161653092|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
161653093|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161653094|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161653095|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161653096|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Site closure|0|||
161653097|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Site closure|0|||
161653098|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Site closure|1|||
161653099|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Site closure|0|||
161653100|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Site closure|0|||
161653101|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Site closure|0|||
161653102|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
161653103|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
161653104|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
161653105|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
161653106|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
161653107|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
161653108|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
161653109|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
161653110|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
161653111|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
161653112|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
161653113|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
161653114|NCT03439254|583781011|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
161653115|NCT03439254|583781012|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
161653116|NCT03439254|583781013|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
161653117|NCT03439254|583781014|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
161653118|NCT03439254|583781015|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
161653119|NCT03439254|583781016|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
161653120|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
161653121|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
161653122|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
161653123|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
161653124|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
161694297|NCT04947800|583929866|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
161694298|NCT02158091|583929867|FG000|Overall Study|DLT|2|||
161694299|NCT02158091|583929868|FG001|Overall Study|DLT|1|||
161694300|NCT02158091|583929869|FG002|Overall Study|DLT|0|||
161694301|NCT01318109|583929870|FG000|Overall Study|Adverse Event|0|||
161694302|NCT01318109|583929871|FG001|Overall Study|Adverse Event|2|||
161694303|NCT01318109|583929872|FG002|Overall Study|Adverse Event|0|||
161694304|NCT01318109|583929870|FG000|Overall Study|Withdrawal by Subject|1|||
161694305|NCT01318109|583929871|FG001|Overall Study|Withdrawal by Subject|0|||
161694306|NCT01318109|583929872|FG002|Overall Study|Withdrawal by Subject|0|||
161694307|NCT01318109|583929870|FG000|Overall Study|Schedule Conflict|0|||
161694308|NCT01318109|583929871|FG001|Overall Study|Schedule Conflict|1|||
161694309|NCT01318109|583929872|FG002|Overall Study|Schedule Conflict|0|||
161694310|NCT01358864|583929887|FG000|Overall Study|Adverse Event|0|||
161694311|NCT01358864|583929888|FG001|Overall Study|Adverse Event|6|||
161694312|NCT01358864|583929889|FG002|Overall Study|Adverse Event|9|||
161694313|NCT01358864|583929890|FG003|Overall Study|Adverse Event|0|||
161694314|NCT01358864|583929891|FG004|Overall Study|Adverse Event|4|||
161694315|NCT01358864|583929892|FG005|Overall Study|Adverse Event|8|||
161694316|NCT01358864|583929893|FG006|Overall Study|Adverse Event|12|||
161694317|NCT01358864|583929894|FG007|Overall Study|Adverse Event|7|||
161694318|NCT01358864|583929887|FG000|Overall Study|Lack of Efficacy|26|||
161694319|NCT01358864|583929888|FG001|Overall Study|Lack of Efficacy|3|||
161694320|NCT01358864|583929889|FG002|Overall Study|Lack of Efficacy|4|||
161694321|NCT01358864|583929890|FG003|Overall Study|Lack of Efficacy|19|||
161694322|NCT01358864|583929891|FG004|Overall Study|Lack of Efficacy|7|||
161653125|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
161653126|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161653127|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161653128|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161653129|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
161653130|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161653131|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
161653132|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161653133|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161653134|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161653135|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161653136|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161653137|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
161653138|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161653139|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161653140|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161653141|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161653142|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
161653143|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161653144|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161653145|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161653146|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161653147|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161653148|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
161653149|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161653150|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161653151|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161653152|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161653153|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161653154|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161653155|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
161653156|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161653157|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161653158|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161653159|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
161694323|NCT01358864|583929892|FG005|Overall Study|Lack of Efficacy|4|||
161694324|NCT01358864|583929893|FG006|Overall Study|Lack of Efficacy|49|||
161694325|NCT01358864|583929894|FG007|Overall Study|Lack of Efficacy|44|||
161694326|NCT01358864|583929887|FG000|Overall Study|Lost to Follow-up|0|||
161694327|NCT01358864|583929888|FG001|Overall Study|Lost to Follow-up|0|||
161694328|NCT01358864|583929889|FG002|Overall Study|Lost to Follow-up|1|||
161694329|NCT01358864|583929890|FG003|Overall Study|Lost to Follow-up|0|||
161694330|NCT01358864|583929891|FG004|Overall Study|Lost to Follow-up|0|||
161694331|NCT01358864|583929892|FG005|Overall Study|Lost to Follow-up|0|||
161694332|NCT01358864|583929893|FG006|Overall Study|Lost to Follow-up|0|||
161836515|NCT01347866|584443003|FG013|Overall Study|Subject refused further follow-up|3|||
161836516|NCT01347866|584443004|FG014|Overall Study|Subject refused further follow-up|1|||
161836517|NCT01347866|584443005|FG015|Overall Study|Subject refused further follow-up|0|||
161836518|NCT01347866|584443006|FG016|Overall Study|Subject refused further follow-up|2|||
161836519|NCT02939014|584443007|FG000|Overall Study|Lost to Follow-up|1|||
161694333|NCT01358864|583929894|FG007|Overall Study|Lost to Follow-up|1|||
161694334|NCT01358864|583929887|FG000|Overall Study|Withdrawal by Subject|3|||
161694335|NCT01358864|583929888|FG001|Overall Study|Withdrawal by Subject|4|||
161694336|NCT01358864|583929889|FG002|Overall Study|Withdrawal by Subject|2|||
161694337|NCT01358864|583929890|FG003|Overall Study|Withdrawal by Subject|0|||
161694338|NCT01358864|583929891|FG004|Overall Study|Withdrawal by Subject|0|||
161694339|NCT01358864|583929892|FG005|Overall Study|Withdrawal by Subject|1|||
161694340|NCT01358864|583929893|FG006|Overall Study|Withdrawal by Subject|1|||
161694341|NCT01358864|583929894|FG007|Overall Study|Withdrawal by Subject|3|||
161694342|NCT01358864|583929887|FG000|Overall Study|Other reason not defined above|2|||
161694343|NCT01358864|583929888|FG001|Overall Study|Other reason not defined above|0|||
161694344|NCT01358864|583929889|FG002|Overall Study|Other reason not defined above|0|||
161694345|NCT01358864|583929890|FG003|Overall Study|Other reason not defined above|0|||
161694346|NCT01358864|583929891|FG004|Overall Study|Other reason not defined above|0|||
161694347|NCT01358864|583929892|FG005|Overall Study|Other reason not defined above|0|||
161694348|NCT01358864|583929893|FG006|Overall Study|Other reason not defined above|2|||
161694349|NCT01358864|583929894|FG007|Overall Study|Other reason not defined above|0|||
161694350|NCT01358864|583929887|FG000|Overall Study|Not treated|0|||
161694351|NCT01358864|583929888|FG001|Overall Study|Not treated|0|||
161694352|NCT01358864|583929889|FG002|Overall Study|Not treated|0|||
161694353|NCT01358864|583929890|FG003|Overall Study|Not treated|0|||
161694354|NCT01358864|583929891|FG004|Overall Study|Not treated|0|||
161694355|NCT01358864|583929892|FG005|Overall Study|Not treated|0|||
161694356|NCT01358864|583929893|FG006|Overall Study|Not treated|1|||
161694357|NCT01358864|583929894|FG007|Overall Study|Not treated|0|||
161694358|NCT00861744|583929900|FG000|Overall Study|Adverse Event|0|||
161694359|NCT00861744|583929901|FG001|Overall Study|Adverse Event|0|||
161694360|NCT00861744|583929902|FG002|Overall Study|Adverse Event|0|||
161694361|NCT00861744|583929903|FG003|Overall Study|Adverse Event|1|||
161694362|NCT00861744|583929900|FG000|Overall Study|Lost to Follow-up|7|||
161694363|NCT00861744|583929901|FG001|Overall Study|Lost to Follow-up|19|||
161694364|NCT00861744|583929902|FG002|Overall Study|Lost to Follow-up|17|||
161694365|NCT00861744|583929903|FG003|Overall Study|Lost to Follow-up|12|||
161694366|NCT00861744|583929900|FG000|Overall Study|Withdrawal by Subject|10|||
161694367|NCT00861744|583929901|FG001|Overall Study|Withdrawal by Subject|6|||
161694368|NCT00861744|583929902|FG002|Overall Study|Withdrawal by Subject|6|||
161694369|NCT00861744|583929903|FG003|Overall Study|Withdrawal by Subject|19|||
161694370|NCT00861744|583929900|FG000|Overall Study|Protocol Violation|0|||
161694371|NCT00861744|583929901|FG001|Overall Study|Protocol Violation|1|||
161694372|NCT00861744|583929902|FG002|Overall Study|Protocol Violation|0|||
161694373|NCT00861744|583929903|FG003|Overall Study|Protocol Violation|0|||
161694374|NCT00861744|583929900|FG000|Overall Study|Migration from study area|0|||
161694375|NCT00861744|583929901|FG001|Overall Study|Migration from study area|3|||
161694376|NCT00861744|583929902|FG002|Overall Study|Migration from study area|1|||
161694377|NCT00861744|583929903|FG003|Overall Study|Migration from study area|0|||
161694378|NCT00861744|583929900|FG000|Overall Study|Blood draws|0|||
161694379|NCT00861744|583929901|FG001|Overall Study|Blood draws|0|||
161694380|NCT00861744|583929902|FG002|Overall Study|Blood draws|0|||
161694381|NCT00861744|583929903|FG003|Overall Study|Blood draws|1|||
161694382|NCT05568888|583929904|FG000|Overall Study|Physician Decision|1|||
161694383|NCT05568888|583929905|FG001|Overall Study|Physician Decision|0|||
161694384|NCT05568888|583929904|FG000|Overall Study|Protocol Deviation|2|||
161694385|NCT05568888|583929905|FG001|Overall Study|Protocol Deviation|1|||
161694386|NCT05568888|583929904|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
161694387|NCT05568888|583929905|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
161694388|NCT05568888|583929904|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
161694389|NCT05568888|583929905|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
161694390|NCT05568888|583929904|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
161694391|NCT05568888|583929905|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
161694392|NCT05036083|583929913|FG000|Overall Study|Physician Decision|1|||
161694393|NCT05036083|583929913|FG000|Overall Study|Withdrawal by Subject|1|||
161694394|NCT05036083|583929913|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
161694395|NCT05036083|583929913|FG000|Overall Study|IV not sustainable|1|||
161694396|NCT02028455|583929916|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694397|NCT02028455|583929917|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694398|NCT02028455|583929918|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694399|NCT02028455|583929919|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161836520|NCT02939014|584443008|FG001|Overall Study|Lost to Follow-up|0|||
161836521|NCT02939014|584443007|FG000|Overall Study|Death|4|||
161694400|NCT02028455|583929920|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694401|NCT02028455|583929921|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694402|NCT02028455|583929922|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
161694403|NCT02028455|583929923|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
161694404|NCT02028455|583929916|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
161694405|NCT02028455|583929917|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
161694406|NCT02028455|583929918|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
161694407|NCT02028455|583929919|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
161694408|NCT02028455|583929920|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
161694409|NCT02028455|583929921|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
161694410|NCT02028455|583929922|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
161694411|NCT02028455|583929923|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
161694412|NCT02028455|583929916|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694413|NCT02028455|583929917|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694414|NCT02028455|583929918|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694415|NCT02028455|583929919|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694416|NCT02028455|583929920|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694417|NCT02028455|583929921|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
161694418|NCT02028455|583929922|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694419|NCT02028455|583929923|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
161694420|NCT02028455|583929916|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694421|NCT02028455|583929917|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694422|NCT02028455|583929918|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
161694423|NCT02028455|583929919|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
161694424|NCT02028455|583929920|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694425|NCT02028455|583929921|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694426|NCT02028455|583929922|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
161694427|NCT02028455|583929923|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
161694428|NCT07099521|583929924|FG000|Overall Study|Incompeleted stimulus program|1|||
161694429|NCT07099521|583929925|FG001|Overall Study|Incompeleted stimulus program|0|||
161694430|NCT07099521|583929924|FG000|Overall Study|Non-social anxiety symtpoms|0|||
161694431|NCT07099521|583929925|FG001|Overall Study|Non-social anxiety symtpoms|1|||
161694432|NCT07099521|583929924|FG000|Overall Study|Extreme values|2|||
161694433|NCT07099521|583929925|FG001|Overall Study|Extreme values|4|||
161694434|NCT00482014|583932317|FG000|Overall Study|Withdrawal by Subject|1|||
161694435|NCT00482014|583932318|FG001|Overall Study|Withdrawal by Subject|2|||
161694436|NCT00482014|583932319|FG002|Overall Study|Withdrawal by Subject|3|||
161694437|NCT00482014|583932320|FG003|Overall Study|Withdrawal by Subject|4|||
161694438|NCT00482014|583932317|FG000|Overall Study|Adverse Event|3|||
161694439|NCT00482014|583932318|FG001|Overall Study|Adverse Event|0|||
161694440|NCT00482014|583932319|FG002|Overall Study|Adverse Event|2|||
161694441|NCT00482014|583932320|FG003|Overall Study|Adverse Event|8|||
161694442|NCT00482014|583932317|FG000|Overall Study|Death|1|||
161694443|NCT00482014|583932318|FG001|Overall Study|Death|2|||
161694444|NCT00482014|583932319|FG002|Overall Study|Death|1|||
161694445|NCT00482014|583932320|FG003|Overall Study|Death|4|||
161694446|NCT00482014|583932317|FG000|Overall Study|Lack of Efficacy|1|||
161694447|NCT00482014|583932318|FG001|Overall Study|Lack of Efficacy|0|||
161694448|NCT00482014|583932319|FG002|Overall Study|Lack of Efficacy|4|||
161694449|NCT00482014|583932320|FG003|Overall Study|Lack of Efficacy|6|||
161694450|NCT00482014|583932317|FG000|Overall Study|Sponsor Decision|1|||
161694451|NCT00482014|583932318|FG001|Overall Study|Sponsor Decision|2|||
161694452|NCT00482014|583932319|FG002|Overall Study|Sponsor Decision|1|||
161694453|NCT00482014|583932320|FG003|Overall Study|Sponsor Decision|1|||
161694454|NCT00542997|583932323|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
161694455|NCT00542997|583932323|FG000|Wash in / Wash Out Period|Adverse Event|3|||
161694456|NCT00542997|583932323|FG000|Efficacy Period|Adverse Event|3|||
161694457|NCT01284114|583932326|FG000|Overall Study|viral infection|1|||
161694458|NCT01284114|583932326|FG000|Overall Study|From the results of ALLTITUDE study|1|||
161694459|NCT01284114|583932326|FG000|Overall Study|Symptomatic hypotension|1|||
161694460|NCT01284114|583932326|FG000|Overall Study|dizziness|1|||
161694461|NCT00598975|583932327|FG000|Overall Study|Adverse Event|1|||
161694462|NCT00598975|583932328|FG001|Overall Study|Adverse Event|1|||
161694463|NCT00598975|583932327|FG000|Overall Study|Brain metastases|1|||
161694464|NCT00598975|583932328|FG001|Overall Study|Brain metastases|0|||
161694465|NCT00598975|583932327|FG000|Overall Study|Withdrawal by Subject|1|||
161694466|NCT00598975|583932328|FG001|Overall Study|Withdrawal by Subject|1|||
161694467|NCT00598975|583932327|FG000|Overall Study|Withdrawal of consent|0|||
161694468|NCT00598975|583932328|FG001|Overall Study|Withdrawal of consent|1|||
161694469|NCT00598975|583932327|FG000|Overall Study|Disease progression|8|||
161694470|NCT00598975|583932328|FG001|Overall Study|Disease progression|3|||
161694471|NCT00598975|583932327|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
161694472|NCT00598975|583932328|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
161694473|NCT04137887|583932329|FG000|Overall Study|Death|102|||
161694474|NCT04137887|583932330|FG001|Overall Study|Death|92|||
161694475|NCT04137887|583932329|FG000|Overall Study|Withdrawal by Subject|2|||
161694476|NCT04137887|583932330|FG001|Overall Study|Withdrawal by Subject|3|||
161694477|NCT04137887|583932329|FG000|Overall Study|Randomized but not treated|0|||
161694478|NCT04137887|583932330|FG001|Overall Study|Randomized but not treated|1|||
161694479|NCT01790503|583932331|FG000|Overall Study|Adverse Event|1|||
161694480|NCT01790503|583932332|FG001|Overall Study|Adverse Event|0|||
161694481|NCT01790503|583932333|FG002|Overall Study|Adverse Event|0|||
161694482|NCT01790503|583932334|FG003|Overall Study|Adverse Event|0|||
161694483|NCT01790503|583932335|FG004|Overall Study|Adverse Event|0|||
161694484|NCT01790503|583932336|FG005|Overall Study|Adverse Event|2|||
161694485|NCT01790503|583932337|FG006|Overall Study|Adverse Event|0|||
161694486|NCT01790503|583932338|FG007|Overall Study|Adverse Event|0|||
161694487|NCT01790503|583932339|FG008|Overall Study|Adverse Event|2|||
161694488|NCT01790503|583932340|FG009|Overall Study|Adverse Event|4|||
161694489|NCT01790503|583932341|FG010|Overall Study|Adverse Event|7|||
161694490|NCT01790503|583932331|FG000|Overall Study|Withdrawal by Subject|0|||
161694491|NCT01790503|583932332|FG001|Overall Study|Withdrawal by Subject|0|||
161694492|NCT01790503|583932333|FG002|Overall Study|Withdrawal by Subject|1|||
161694493|NCT01790503|583932334|FG003|Overall Study|Withdrawal by Subject|1|||
161694494|NCT01790503|583932335|FG004|Overall Study|Withdrawal by Subject|1|||
161694495|NCT01790503|583932336|FG005|Overall Study|Withdrawal by Subject|2|||
161694496|NCT01790503|583932337|FG006|Overall Study|Withdrawal by Subject|1|||
161694497|NCT01790503|583932338|FG007|Overall Study|Withdrawal by Subject|0|||
161694498|NCT01790503|583932339|FG008|Overall Study|Withdrawal by Subject|0|||
161694499|NCT01790503|583932340|FG009|Overall Study|Withdrawal by Subject|0|||
161694500|NCT01790503|583932341|FG010|Overall Study|Withdrawal by Subject|1|||
161694501|NCT01790503|583932331|FG000|Overall Study|Disease progression|2|||
161694502|NCT01790503|583932332|FG001|Overall Study|Disease progression|1|||
161694503|NCT01790503|583932333|FG002|Overall Study|Disease progression|0|||
161694504|NCT01790503|583932334|FG003|Overall Study|Disease progression|1|||
161694505|NCT01790503|583932335|FG004|Overall Study|Disease progression|2|||
161694506|NCT01790503|583932336|FG005|Overall Study|Disease progression|1|||
161694507|NCT01790503|583932337|FG006|Overall Study|Disease progression|0|||
161694508|NCT01790503|583932338|FG007|Overall Study|Disease progression|1|||
161694509|NCT01790503|583932339|FG008|Overall Study|Disease progression|0|||
161694510|NCT01790503|583932340|FG009|Overall Study|Disease progression|17|||
161694511|NCT01790503|583932341|FG010|Overall Study|Disease progression|7|||
161694512|NCT01790503|583932331|FG000|Overall Study|Protocol Violation|0|||
161694513|NCT01790503|583932332|FG001|Overall Study|Protocol Violation|0|||
161694514|NCT01790503|583932333|FG002|Overall Study|Protocol Violation|0|||
161694515|NCT01790503|583932334|FG003|Overall Study|Protocol Violation|0|||
161694516|NCT01790503|583932335|FG004|Overall Study|Protocol Violation|0|||
161694517|NCT01790503|583932336|FG005|Overall Study|Protocol Violation|0|||
161694518|NCT01790503|583932337|FG006|Overall Study|Protocol Violation|0|||
161694519|NCT01790503|583932338|FG007|Overall Study|Protocol Violation|0|||
161694520|NCT01790503|583932339|FG008|Overall Study|Protocol Violation|0|||
161694521|NCT01790503|583932340|FG009|Overall Study|Protocol Violation|1|||
161694522|NCT01790503|583932341|FG010|Overall Study|Protocol Violation|0|||
161694523|NCT01790503|583932331|FG000|Overall Study|Physician Decision|0|||
161694524|NCT01790503|583932332|FG001|Overall Study|Physician Decision|0|||
161694525|NCT01790503|583932333|FG002|Overall Study|Physician Decision|0|||
161694526|NCT01790503|583932334|FG003|Overall Study|Physician Decision|0|||
161694527|NCT01790503|583932335|FG004|Overall Study|Physician Decision|0|||
161694528|NCT01790503|583932336|FG005|Overall Study|Physician Decision|0|||
161694529|NCT01790503|583932337|FG006|Overall Study|Physician Decision|0|||
161694530|NCT01790503|583932338|FG007|Overall Study|Physician Decision|0|||
161694531|NCT01790503|583932339|FG008|Overall Study|Physician Decision|0|||
161836522|NCT02939014|584443008|FG001|Overall Study|Death|3|||
161836523|NCT02143583|584443011|FG000|Overall Study|Withdrawal by Subject|1|||
161836524|NCT02143583|584443012|FG001|Overall Study|Withdrawal by Subject|0|||
161694532|NCT01790503|583932340|FG009|Overall Study|Physician Decision|1|||
161694533|NCT01790503|583932341|FG010|Overall Study|Physician Decision|1|||
161694534|NCT01790503|583932331|FG000|Overall Study|Death|0|||
161694535|NCT01790503|583932332|FG001|Overall Study|Death|0|||
161694536|NCT01790503|583932333|FG002|Overall Study|Death|0|||
161694537|NCT01790503|583932334|FG003|Overall Study|Death|0|||
161694538|NCT01790503|583932335|FG004|Overall Study|Death|0|||
161694539|NCT01790503|583932336|FG005|Overall Study|Death|0|||
161694540|NCT01790503|583932337|FG006|Overall Study|Death|0|||
161694541|NCT01790503|583932338|FG007|Overall Study|Death|0|||
161694542|NCT01790503|583932339|FG008|Overall Study|Death|0|||
161694543|NCT01790503|583932340|FG009|Overall Study|Death|1|||
161694544|NCT01790503|583932341|FG010|Overall Study|Death|0|||
161694545|NCT01790503|583932331|FG000|Overall Study|Non Compliance|0|||
161694546|NCT01790503|583932332|FG001|Overall Study|Non Compliance|0|||
161694547|NCT01790503|583932333|FG002|Overall Study|Non Compliance|0|||
161694548|NCT01790503|583932334|FG003|Overall Study|Non Compliance|0|||
161694549|NCT01790503|583932335|FG004|Overall Study|Non Compliance|1|||
161694550|NCT01790503|583932336|FG005|Overall Study|Non Compliance|0|||
161694551|NCT01790503|583932337|FG006|Overall Study|Non Compliance|0|||
161694552|NCT01790503|583932338|FG007|Overall Study|Non Compliance|0|||
161694553|NCT01790503|583932339|FG008|Overall Study|Non Compliance|0|||
161694554|NCT01790503|583932340|FG009|Overall Study|Non Compliance|0|||
161694555|NCT01790503|583932341|FG010|Overall Study|Non Compliance|0|||
161694556|NCT01790503|583932331|FG000|Overall Study|Other|0|||
161694557|NCT01790503|583932332|FG001|Overall Study|Other|0|||
161694558|NCT01790503|583932333|FG002|Overall Study|Other|0|||
161694559|NCT01790503|583932334|FG003|Overall Study|Other|0|||
161694560|NCT01790503|583932335|FG004|Overall Study|Other|1|||
161694561|NCT01790503|583932336|FG005|Overall Study|Other|0|||
161694562|NCT01790503|583932337|FG006|Overall Study|Other|0|||
161694563|NCT01790503|583932338|FG007|Overall Study|Other|0|||
161694564|NCT01790503|583932339|FG008|Overall Study|Other|1|||
161694565|NCT01790503|583932340|FG009|Overall Study|Other|2|||
161694566|NCT01790503|583932341|FG010|Overall Study|Other|0|||
161694567|NCT04183335|583932342|FG000|Overall Study|Adverse Event|1|||
161694568|NCT04183335|583932343|FG001|Overall Study|Adverse Event|0|||
161694569|NCT04183335|583932342|FG000|Overall Study|Withdrawal by Subject|12|||
161694570|NCT04183335|583932343|FG001|Overall Study|Withdrawal by Subject|3|||
161694571|NCT00049673|583932344|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
161694572|NCT00049673|583932345|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
161694573|NCT01535729|583932346|FG000|Overall Study|Withdrawal by Subject|2|||
161694574|NCT01535729|583932346|FG000|Overall Study|Disease progression|230|||
161694575|NCT01535729|583932346|FG000|Overall Study|Discontinued treatment|25|||
161694576|NCT01535729|583932346|FG000|Overall Study|Lost to Follow-up|8|||
161694577|NCT01535729|583932346|FG000|Overall Study|Death|52|||
161694578|NCT01535729|583932346|FG000|Overall Study|Other|19|||
161694579|NCT01535729|583932346|FG000|Overall Study|Did not sign informed consent|1|||
161694580|NCT01535729|583932346|FG000|Overall Study|No previous chemotherapy|33|||
161694581|NCT01535729|583932346|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
161694582|NCT01535729|583932346|FG000|Overall Study|Protocol Violation|11|||
161694583|NCT01535729|583932346|FG000|Overall Study|Screening failure|1|||
161694584|NCT01535729|583932346|FG000|Overall Study|Not treated|9|||
161694585|NCT01535729|583932346|FG000|Overall Study|No participant record available|5|||
161694586|NCT03733392|583932349|FG000|Overall Study|Withdrawal by Subject|11|||
161694587|NCT03733392|583932350|FG001|Overall Study|Withdrawal by Subject|1|||
161694588|NCT03733392|583932349|FG000|Overall Study|Death|1|||
161694589|NCT03733392|583932350|FG001|Overall Study|Death|0|||
161694590|NCT03733392|583932349|FG000|Overall Study|Lost to Follow-up|5|||
161694591|NCT03733392|583932350|FG001|Overall Study|Lost to Follow-up|0|||
161694592|NCT03733392|583932349|FG000|Overall Study|Protocol Violation|0|||
161694593|NCT03733392|583932350|FG001|Overall Study|Protocol Violation|1|||
161694594|NCT03733392|583932349|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
161694595|NCT03733392|583932350|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
161694596|NCT03733392|583932349|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
161694597|NCT03733392|583932350|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
161694598|NCT03733392|583932349|FG000|Overall Study|Patient Non-Compliance|2|||
161694599|NCT03733392|583932350|FG001|Overall Study|Patient Non-Compliance|1|||
161694600|NCT03733392|583932349|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
161694601|NCT03733392|583932350|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
161694602|NCT03733392|583932349|FG000|Overall Study|Withdrawal prior to procedure|5|||
161694603|NCT03733392|583932350|FG001|Overall Study|Withdrawal prior to procedure|2|||
161694604|NCT02740478|583932351|FG000|Overall Study|Withdrawal by Subject|1|||
161694605|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Other|24|||
161694606|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Other|6|||
161694607|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
161836525|NCT02143583|584443013|FG002|Overall Study|Withdrawal by Subject|1|||
161694608|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
161694609|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
161694610|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
161694611|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
161694612|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
161694613|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
161694614|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
161694615|NCT01934140|583932358|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
161694616|NCT01934140|583932359|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
161694617|NCT01934140|583932358|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
161694618|NCT01934140|583932359|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
161694619|NCT01934140|583932358|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
161694620|NCT01934140|583932359|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
161694621|NCT01461044|583932363|FG000|Overall Study|Death|58|||
161694622|NCT01461044|583932364|FG001|Overall Study|Death|35|||
161694623|NCT01461044|583932363|FG000|Overall Study|Lost to Follow-up|12|||
161694624|NCT01461044|583932364|FG001|Overall Study|Lost to Follow-up|5|||
161694625|NCT00618748|583932365|FG000|Overall Study|Adverse Event|4|||
161694626|NCT00618748|583932366|FG001|Overall Study|Adverse Event|3|||
161694627|NCT00618748|583932367|FG002|Overall Study|Adverse Event|8|||
161694628|NCT00618748|583932365|FG000|Overall Study|Physician Decision|3|||
161694629|NCT00618748|583932366|FG001|Overall Study|Physician Decision|1|||
161694630|NCT00618748|583932367|FG002|Overall Study|Physician Decision|1|||
161694631|NCT00618748|583932365|FG000|Overall Study|Withdrawal by Subject|4|||
161694632|NCT00618748|583932366|FG001|Overall Study|Withdrawal by Subject|1|||
161694633|NCT00618748|583932367|FG002|Overall Study|Withdrawal by Subject|5|||
161694634|NCT00200850|583932368|FG000|Overall Study|relocation|1|||
161694635|NCT00200850|583932369|FG001|Overall Study|relocation|0|||
161694636|NCT00200850|583932370|FG002|Overall Study|relocation|1|||
161694637|NCT00200850|583932368|FG000|Overall Study|too busy|1|||
161694638|NCT00200850|583932369|FG001|Overall Study|too busy|0|||
161694639|NCT00200850|583932370|FG002|Overall Study|too busy|0|||
161694640|NCT00200850|583932368|FG000|Overall Study|Pregnancy|0|||
161694641|NCT00200850|583932369|FG001|Overall Study|Pregnancy|0|||
161694642|NCT00200850|583932370|FG002|Overall Study|Pregnancy|1|||
161694643|NCT00200850|583932368|FG000|Overall Study|Poor adherence|0|||
161694644|NCT00200850|583932369|FG001|Overall Study|Poor adherence|0|||
161694645|NCT00200850|583932370|FG002|Overall Study|Poor adherence|1|||
161694646|NCT00200850|583932368|FG000|Overall Study|optic neuritis|0|||
161694647|NCT00200850|583932369|FG001|Overall Study|optic neuritis|0|||
161694648|NCT00200850|583932370|FG002|Overall Study|optic neuritis|1|||
161694649|NCT00200850|583932368|FG000|Overall Study|Adverse Event|1|||
161694650|NCT00200850|583932369|FG001|Overall Study|Adverse Event|1|||
161694651|NCT00200850|583932370|FG002|Overall Study|Adverse Event|2|||
161694652|NCT02889796|583932373|FG000|Overall Study|Withdrew Consent|18|||
161694653|NCT02889796|583932374|FG001|Overall Study|Withdrew Consent|29|||
161694654|NCT02889796|583932375|FG002|Overall Study|Withdrew Consent|20|||
161694655|NCT02889796|583932376|FG003|Overall Study|Withdrew Consent|1|||
161694656|NCT02889796|583932377|FG004|Overall Study|Withdrew Consent|2|||
161694657|NCT02889796|583932378|FG005|Overall Study|Withdrew Consent|35|||
161694658|NCT02889796|583932373|FG000|Overall Study|Investigator's Discretion|10|||
161694659|NCT02889796|583932374|FG001|Overall Study|Investigator's Discretion|9|||
161694660|NCT02889796|583932375|FG002|Overall Study|Investigator's Discretion|10|||
161694661|NCT02889796|583932376|FG003|Overall Study|Investigator's Discretion|3|||
161694662|NCT02889796|583932377|FG004|Overall Study|Investigator's Discretion|0|||
161694663|NCT02889796|583932378|FG005|Overall Study|Investigator's Discretion|15|||
161694664|NCT02889796|583932373|FG000|Overall Study|Adverse Event|17|||
161694665|NCT02889796|583932374|FG001|Overall Study|Adverse Event|8|||
161694666|NCT02889796|583932375|FG002|Overall Study|Adverse Event|8|||
161694667|NCT02889796|583932376|FG003|Overall Study|Adverse Event|4|||
161694668|NCT02889796|583932377|FG004|Overall Study|Adverse Event|1|||
161694669|NCT02889796|583932378|FG005|Overall Study|Adverse Event|7|||
161694670|NCT02889796|583932373|FG000|Overall Study|Lost to Follow-up|5|||
161694671|NCT02889796|583932374|FG001|Overall Study|Lost to Follow-up|7|||
161694672|NCT02889796|583932375|FG002|Overall Study|Lost to Follow-up|2|||
161694673|NCT02889796|583932376|FG003|Overall Study|Lost to Follow-up|0|||
161694674|NCT02889796|583932377|FG004|Overall Study|Lost to Follow-up|2|||
161694675|NCT02889796|583932378|FG005|Overall Study|Lost to Follow-up|6|||
161694676|NCT02889796|583932373|FG000|Overall Study|Protocol Violation|0|||
161694677|NCT02889796|583932374|FG001|Overall Study|Protocol Violation|1|||
161836526|NCT02143583|584443011|FG000|Overall Study|husband illness|0|||
161694678|NCT02889796|583932375|FG002|Overall Study|Protocol Violation|3|||
161694679|NCT02889796|583932376|FG003|Overall Study|Protocol Violation|0|||
161694680|NCT02889796|583932377|FG004|Overall Study|Protocol Violation|0|||
161694681|NCT02889796|583932378|FG005|Overall Study|Protocol Violation|4|||
161694682|NCT02889796|583932373|FG000|Overall Study|Non-compliance With Study Drug|0|||
161694683|NCT02889796|583932374|FG001|Overall Study|Non-compliance With Study Drug|2|||
161694684|NCT02889796|583932375|FG002|Overall Study|Non-compliance With Study Drug|0|||
161694685|NCT02889796|583932376|FG003|Overall Study|Non-compliance With Study Drug|0|||
161694686|NCT02889796|583932377|FG004|Overall Study|Non-compliance With Study Drug|1|||
161694687|NCT02889796|583932378|FG005|Overall Study|Non-compliance With Study Drug|2|||
161694688|NCT02889796|583932373|FG000|Overall Study|Death|1|||
161694689|NCT02889796|583932374|FG001|Overall Study|Death|1|||
161694690|NCT02889796|583932375|FG002|Overall Study|Death|0|||
161694691|NCT02889796|583932376|FG003|Overall Study|Death|1|||
161694692|NCT02889796|583932377|FG004|Overall Study|Death|0|||
161694693|NCT02889796|583932378|FG005|Overall Study|Death|1|||
161694694|NCT02889796|583932373|FG000|Overall Study|Pregnancy|0|||
161694695|NCT02889796|583932374|FG001|Overall Study|Pregnancy|1|||
161694696|NCT02889796|583932375|FG002|Overall Study|Pregnancy|1|||
161694697|NCT02889796|583932376|FG003|Overall Study|Pregnancy|0|||
161694698|NCT02889796|583932377|FG004|Overall Study|Pregnancy|0|||
161694699|NCT02889796|583932378|FG005|Overall Study|Pregnancy|0|||
161694700|NCT02889796|583932373|FG000|Overall Study|Randomized but not Dosed|2|||
161694701|NCT02889796|583932374|FG001|Overall Study|Randomized but not Dosed|0|||
161694702|NCT02889796|583932375|FG002|Overall Study|Randomized but not Dosed|0|||
161694703|NCT02889796|583932376|FG003|Overall Study|Randomized but not Dosed|0|||
161694704|NCT02889796|583932377|FG004|Overall Study|Randomized but not Dosed|0|||
161694705|NCT02889796|583932378|FG005|Overall Study|Randomized but not Dosed|2|||
161694706|NCT04294459|583932379|FG000|Overall Study|Adverse Event|0|||
161694707|NCT04294459|583932380|FG001|Overall Study|Adverse Event|1|||
161694708|NCT02787863|583932381|FG000|Overall Study|Death|1|||
161694709|NCT02787863|583932382|FG001|Overall Study|Death|0|||
161694710|NCT02787863|583932383|FG002|Overall Study|Death|1|||
161694711|NCT02787863|583932384|FG003|Overall Study|Death|0|||
161694712|NCT02787863|583932385|FG004|Overall Study|Death|0|||
161694713|NCT02787863|583932386|FG005|Overall Study|Death|0|||
161694714|NCT02787863|583932387|FG006|Overall Study|Death|0|||
161694715|NCT02787863|583932388|FG007|Overall Study|Death|0|||
161694716|NCT02787863|583932381|FG000|Overall Study|Withdrawal by Subject|0|||
161694717|NCT02787863|583932382|FG001|Overall Study|Withdrawal by Subject|1|||
161694718|NCT02787863|583932383|FG002|Overall Study|Withdrawal by Subject|1|||
161694719|NCT02787863|583932384|FG003|Overall Study|Withdrawal by Subject|0|||
161694720|NCT02787863|583932385|FG004|Overall Study|Withdrawal by Subject|0|||
161694721|NCT02787863|583932386|FG005|Overall Study|Withdrawal by Subject|0|||
161694722|NCT02787863|583932387|FG006|Overall Study|Withdrawal by Subject|0|||
161694723|NCT02787863|583932388|FG007|Overall Study|Withdrawal by Subject|0|||
161694724|NCT01414257|583932389|FG000|Overall Study|No Visit After First Day of Treatment|12|||
161694725|NCT01414257|583932389|FG000|Overall Study|Protocol Violation|10|||
161694726|NCT02421887|583932390|FG000|Overall Study|Lost to Follow-up|5|||
161694727|NCT02421887|583932391|FG001|Overall Study|Lost to Follow-up|0|||
161694728|NCT02421887|583932390|FG000|Overall Study|Withdrawal by Subject|8|||
161694729|NCT02421887|583932391|FG001|Overall Study|Withdrawal by Subject|5|||
161694730|NCT02421887|583932390|FG000|Overall Study|Physician Decision|2|||
161694731|NCT02421887|583932391|FG001|Overall Study|Physician Decision|4|||
161694732|NCT02421887|583932390|FG000|Overall Study|Adverse Event|2|||
161694733|NCT02421887|583932391|FG001|Overall Study|Adverse Event|0|||
161694734|NCT02479802|583932392|FG000|Overall Study|Lost to Follow-up|1|||
161694735|NCT02479802|583932392|FG000|Overall Study|Adverse Event|1|||
161694736|NCT01882907|583932393|FG000|Overall Study|Adverse Event|3|||
161694737|NCT01882907|583932394|FG001|Overall Study|Adverse Event|1|||
161694738|NCT01882907|583932393|FG000|Overall Study|Lack of Efficacy|0|||
161694739|NCT01882907|583932394|FG001|Overall Study|Lack of Efficacy|3|||
161694740|NCT01882907|583932393|FG000|Overall Study|Lost to Follow-up|1|||
161694741|NCT01882907|583932394|FG001|Overall Study|Lost to Follow-up|4|||
161694742|NCT01882907|583932393|FG000|Overall Study|Protocol Violation|10|||
161694743|NCT01882907|583932394|FG001|Overall Study|Protocol Violation|14|||
161694744|NCT01882907|583932393|FG000|Overall Study|Withdrawal by Subject|0|||
161694745|NCT01882907|583932394|FG001|Overall Study|Withdrawal by Subject|6|||
161694746|NCT01978093|583932395|FG000|Overall Study|Death|1|||
161694747|NCT01978093|583932396|FG001|Overall Study|Death|0|||
161694748|NCT01978093|583932395|FG000|Overall Study|Adverse Event|0|||
161694749|NCT01978093|583932396|FG001|Overall Study|Adverse Event|5|||
161694750|NCT01978093|583932395|FG000|Overall Study|Protocol Violation|8|||
161694751|NCT01978093|583932396|FG001|Overall Study|Protocol Violation|2|||
161694752|NCT01978093|583932395|FG000|Overall Study|Withdrawal by Subject|29|||
161694753|NCT01978093|583932396|FG001|Overall Study|Withdrawal by Subject|25|||
161694754|NCT01978093|583932395|FG000|Overall Study|Lost to Follow-up|11|||
161694755|NCT01978093|583932396|FG001|Overall Study|Lost to Follow-up|15|||
161694756|NCT01978093|583932395|FG000|Overall Study|Migrated/moved from study area|11|||
161694757|NCT01978093|583932396|FG001|Overall Study|Migrated/moved from study area|13|||
161836527|NCT02143583|584443012|FG001|Overall Study|husband illness|0|||
161694758|NCT01978093|583932395|FG000|Overall Study|Loss of kaiser coverage|4|||
161694759|NCT01978093|583932396|FG001|Overall Study|Loss of kaiser coverage|10|||
161694760|NCT01978093|583932395|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
161694761|NCT01978093|583932396|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
161694762|NCT01978093|583932395|FG000|Overall Study|Mother lost custody of child|0|||
161694763|NCT01978093|583932396|FG001|Overall Study|Mother lost custody of child|1|||
161836528|NCT02143583|584443013|FG002|Overall Study|husband illness|1|||
161836529|NCT02333487|584443014|FG000|Overall Study|Adverse Event|0|||
161694764|NCT01978093|583932395|FG000|Overall Study|Child was in care of grandmother|0|||
161694765|NCT01978093|583932396|FG001|Overall Study|Child was in care of grandmother|1|||
161694766|NCT01978093|583932395|FG000|Overall Study|N/A for vaccine administration|0|||
161694767|NCT01978093|583932396|FG001|Overall Study|N/A for vaccine administration|1|||
161694768|NCT03124784|583932401|FG000|Overall Study|Adverse Event|1|||
161836530|NCT02333487|584443015|FG001|Overall Study|Adverse Event|2|||
161694769|NCT03124784|583932401|FG000|Overall Study|Computer/Equip Malfunction|1|||
161694770|NCT05702515|583932402|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
161694771|NCT02162732|583932403|FG000|Overall Study|Biopsy not performed.|18|||
161694772|NCT01784965|583932404|FG000|Overall Study|Withdrawal by Subject|6|||
161694773|NCT01784965|583932405|FG001|Overall Study|Withdrawal by Subject|3|||
161694774|NCT01784965|583932404|FG000|Overall Study|Adverse Event|0|||
161694775|NCT01784965|583932405|FG001|Overall Study|Adverse Event|8|||
161694776|NCT03757988|583932406|FG000|Overall Study|Withdrawal by Subject|1|||
161694777|NCT02450487|583932407|FG000|Overall Study|Lost to Follow-up|3|||
161694778|NCT04269395|583932408|FG000|Overall Study|Lost to Follow-up|1|||
161694779|NCT04269395|583932409|FG001|Overall Study|Lost to Follow-up|0|||
161694780|NCT04269395|583932408|FG000|Overall Study|Study terminated by Sponsor|13|||
161694781|NCT04269395|583932409|FG001|Overall Study|Study terminated by Sponsor|10|||
161694782|NCT04161495|583932410|FG000|Overall Study|Withdrawal by Subject|3|||
161694783|NCT04161495|583932411|FG001|Overall Study|Withdrawal by Subject|0|||
161694784|NCT04161495|583932410|FG000|Overall Study|Protocol Violation|1|||
161694785|NCT04161495|583932411|FG001|Overall Study|Protocol Violation|0|||
161694786|NCT04161495|583932410|FG000|Overall Study|Prohibited concomitant medication|3|||
161694787|NCT04161495|583932411|FG001|Overall Study|Prohibited concomitant medication|0|||
161694788|NCT04161495|583932410|FG000|Overall Study|Adverse Event|1|||
161694789|NCT04161495|583932411|FG001|Overall Study|Adverse Event|0|||
161694790|NCT04161495|583932410|FG000|Overall Study|Other - Unspecified|1|||
161694791|NCT04161495|583932411|FG001|Overall Study|Other - Unspecified|0|||
161694792|NCT04161495|583932410|FG000|Overall Study|Death|0|||
161694793|NCT04161495|583932411|FG001|Overall Study|Death|1|||
161694794|NCT00252057|583932414|FG000|Overall Study|Withdrawal by Subject|2|||
161694795|NCT00252057|583932415|FG001|Overall Study|Withdrawal by Subject|5|||
161694796|NCT00252057|583932414|FG000|Overall Study|Death|1|||
161694797|NCT00252057|583932415|FG001|Overall Study|Death|2|||
161694798|NCT00252057|583932414|FG000|Overall Study|Participant previously enrolled|0|||
161694799|NCT00252057|583932415|FG001|Overall Study|Participant previously enrolled|1|||
161694800|NCT02926209|583932416|FG000|Study Cohort|Poor Bowel Preparation|1|||
161694801|NCT02926209|583932417|FG001|Study Cohort|Poor Bowel Preparation|0|||
161694802|NCT01340209|583932418|FG000|Overall Study|Adverse Event|1|||
161694803|NCT01340209|583932419|FG001|Overall Study|Adverse Event|1|||
161694804|NCT01340209|583932420|FG002|Overall Study|Adverse Event|2|||
161694805|NCT01340209|583932418|FG000|Overall Study|Protocol Violation|1|||
161694806|NCT01340209|583932419|FG001|Overall Study|Protocol Violation|2|||
161694807|NCT01340209|583932420|FG002|Overall Study|Protocol Violation|1|||
161694808|NCT01340209|583932418|FG000|Overall Study|Withdrawal by Subject|0|||
161694809|NCT01340209|583932419|FG001|Overall Study|Withdrawal by Subject|0|||
161694810|NCT01340209|583932420|FG002|Overall Study|Withdrawal by Subject|1|||
161694811|NCT01340209|583932418|FG000|Overall Study|Other reason not defined above|3|||
161694812|NCT01340209|583932419|FG001|Overall Study|Other reason not defined above|5|||
161694813|NCT01340209|583932420|FG002|Overall Study|Other reason not defined above|4|||
161694814|NCT00429858|583932421|FG000|Overall Study|Withdrawal by Subject|1|||
161694815|NCT00429858|583932421|FG000|Overall Study|Study Termination|1|||
161694816|NCT01587079|583932422|FG000|Overall Study|Protocol-specified criteria|9|||
161694817|NCT01587079|583932422|FG000|Overall Study|Protocol Violation|5|||
161694818|NCT01587079|583932422|FG000|Overall Study|Lost to Follow-up|2|||
161694819|NCT01587079|583932422|FG000|Overall Study|Physician Decision|2|||
161694820|NCT01587079|583932422|FG000|Overall Study|Withdrawal by Subject|7|||
161694821|NCT01587079|583932422|FG000|Overall Study|Adverse Event|14|||
161694822|NCT01764633|583932423|FG000|Overall Study|Withdrawal by Subject|105|||
161694823|NCT01764633|583932424|FG001|Overall Study|Withdrawal by Subject|88|||
161694824|NCT01764633|583932423|FG000|Overall Study|Lost to Follow-up|13|||
161694825|NCT01764633|583932424|FG001|Overall Study|Lost to Follow-up|5|||
161694826|NCT02268058|583932425|FG000|Overall Study|Protocol Violation|1|||
161694827|NCT02268058|583932426|FG001|Overall Study|Protocol Violation|0|||
161694828|NCT02268058|583932427|FG002|Overall Study|Protocol Violation|0|||
161694829|NCT02268058|583932428|FG003|Overall Study|Protocol Violation|0|||
161694830|NCT04142983|583932433|FG000|Overall Study|Lost to Follow-up|73|||
161694831|NCT04142983|583932433|FG000|Overall Study|Withdrawal by Subject|10|||
161694832|NCT04142983|583932433|FG000|Overall Study|Physician Decision|1|||
161694833|NCT04142983|583932433|FG000|Overall Study|Adverse Event|1|||
161694834|NCT04142983|583932433|FG000|Overall Study|No longer eligible|4|||
161694835|NCT04142983|583932433|FG000|Overall Study|Screen Failure|10|||
161694836|NCT04781816|583932434|FG000|Overall Study|Adverse Event|0|||
161694837|NCT04781816|583932435|FG001|Overall Study|Adverse Event|1|||
161694838|NCT04781816|583932434|FG000|Overall Study|Withdrawal by Subject|1|||
161694839|NCT04781816|583932435|FG001|Overall Study|Withdrawal by Subject|1|||
161694840|NCT04781816|583932434|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
161694841|NCT04781816|583932435|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
161694842|NCT01789970|583932436|FG000|Open-label Titration Period|Adverse Event|68|||
161694843|NCT01789970|583932437|FG001|Open-label Titration Period|Adverse Event|0|||
161694844|NCT01789970|583932438|FG002|Open-label Titration Period|Adverse Event|0|||
161694845|NCT01789970|583932436|FG000|Open-label Titration Period|Lack of Efficacy|31|||
161694846|NCT01789970|583932437|FG001|Open-label Titration Period|Lack of Efficacy|0|||
161694847|NCT01789970|583932438|FG002|Open-label Titration Period|Lack of Efficacy|0|||
161694848|NCT01789970|583932436|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
161694849|NCT01789970|583932437|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
161694850|NCT01789970|583932438|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
161694851|NCT01789970|583932436|FG000|Open-label Titration Period|Protocol Violation|18|||
161694852|NCT01789970|583932437|FG001|Open-label Titration Period|Protocol Violation|0|||
161694853|NCT01789970|583932438|FG002|Open-label Titration Period|Protocol Violation|0|||
161694854|NCT01789970|583932436|FG000|Open-label Titration Period|Lost to Follow-up|5|||
161694855|NCT01789970|583932437|FG001|Open-label Titration Period|Lost to Follow-up|0|||
161694856|NCT01789970|583932438|FG002|Open-label Titration Period|Lost to Follow-up|0|||
161694857|NCT01789970|583932436|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
161694858|NCT01789970|583932437|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
161694859|NCT01789970|583932438|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
161694860|NCT01789970|583932436|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
161694861|NCT01789970|583932437|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
161694862|NCT01789970|583932438|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
161694863|NCT01789970|583932436|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
161694864|NCT01789970|583932437|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
161694865|NCT01789970|583932438|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
161694866|NCT01789970|583932436|FG000|Open-label Titration Period|Pregnancy|2|||
161694867|NCT01789970|583932437|FG001|Open-label Titration Period|Pregnancy|0|||
161694868|NCT01789970|583932438|FG002|Open-label Titration Period|Pregnancy|0|||
161694869|NCT01789970|583932436|FG000|Open-label Titration Period|Other|76|||
161694870|NCT01789970|583932437|FG001|Open-label Titration Period|Other|0|||
161694871|NCT01789970|583932438|FG002|Open-label Titration Period|Other|0|||
161694872|NCT01789970|583932436|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
161694873|NCT01789970|583932437|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
161694874|NCT01789970|583932438|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
161694875|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
161694876|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
161694877|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
161694878|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161694879|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
161694880|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
161694881|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161694882|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
161694883|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
161694884|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161694885|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
161694886|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
161694887|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
161694888|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
161694889|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
161694890|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
161694891|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
161694892|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
161694893|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161694894|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161694895|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
161694896|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
161694897|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
161694898|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
161694899|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
161694900|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
161694901|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
161694902|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
161694903|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
161694904|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
161694905|NCT04372927|583932443|FG000|Overall Study|Death|1|||
161694906|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
161694907|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
161694908|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
161694909|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
161694910|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
161694911|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
161694912|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Screen failure|39|||
161694913|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Screen failure|0|||
161694914|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Screen failure|0|||
161694915|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
161694916|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
161694917|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
161694918|NCT01847885|583932447|FG000|Randomization|Protocol Violation|0|||
161694919|NCT01847885|583932448|FG001|Randomization|Protocol Violation|1|||
161694920|NCT01847885|583932449|FG002|Randomization|Protocol Violation|0|||
161694921|NCT01847885|583932447|FG000|Randomization|Withdrawal by Subject|0|||
161694922|NCT01847885|583932448|FG001|Randomization|Withdrawal by Subject|0|||
161694923|NCT01847885|583932449|FG002|Randomization|Withdrawal by Subject|2|||
161694924|NCT01847885|583932447|FG000|Randomization|Screen Failure|0|||
161694925|NCT01847885|583932448|FG001|Randomization|Screen Failure|3|||
161694926|NCT01847885|583932449|FG002|Randomization|Screen Failure|0|||
161694927|NCT03033745|583932452|FG000|Overall Study|Protocol Violation|0|||
161694928|NCT03033745|583932453|FG001|Overall Study|Protocol Violation|0|||
161694929|NCT03033745|583932454|FG002|Overall Study|Protocol Violation|1|||
161694930|NCT03033745|583932452|FG000|Overall Study|Adverse Event|1|||
161694931|NCT03033745|583932453|FG001|Overall Study|Adverse Event|0|||
161694932|NCT03033745|583932454|FG002|Overall Study|Adverse Event|1|||
161694933|NCT03033745|583932452|FG000|Overall Study|Withdrawal by Subject|0|||
161694934|NCT03033745|583932453|FG001|Overall Study|Withdrawal by Subject|1|||
161694935|NCT03033745|583932454|FG002|Overall Study|Withdrawal by Subject|0|||
161694936|NCT01999582|583932456|FG000|Overall Study|Withdrawal by Subject|0|||
161694937|NCT01999582|583932457|FG001|Overall Study|Withdrawal by Subject|0|||
161694938|NCT01999582|583932458|FG002|Overall Study|Withdrawal by Subject|0|||
161694939|NCT01999582|583932459|FG003|Overall Study|Withdrawal by Subject|1|||
161694940|NCT01999582|583932460|FG004|Overall Study|Withdrawal by Subject|0|||
161694941|NCT01999582|583932461|FG005|Overall Study|Withdrawal by Subject|0|||
161694942|NCT01999582|583932456|FG000|Overall Study|Adverse Event|0|||
161694943|NCT01999582|583932457|FG001|Overall Study|Adverse Event|0|||
161694944|NCT01999582|583932458|FG002|Overall Study|Adverse Event|3|||
161694945|NCT01999582|583932459|FG003|Overall Study|Adverse Event|0|||
161694946|NCT01999582|583932460|FG004|Overall Study|Adverse Event|1|||
161694947|NCT01999582|583932461|FG005|Overall Study|Adverse Event|0|||
161694948|NCT01999582|583932456|FG000|Overall Study|Other Reasons|1|||
161694949|NCT01999582|583932457|FG001|Overall Study|Other Reasons|0|||
161694950|NCT01999582|583932458|FG002|Overall Study|Other Reasons|3|||
161694951|NCT01999582|583932459|FG003|Overall Study|Other Reasons|1|||
161694952|NCT01999582|583932460|FG004|Overall Study|Other Reasons|1|||
161694953|NCT01999582|583932461|FG005|Overall Study|Other Reasons|2|||
161694954|NCT01999582|583932456|FG000|Overall Study|Protocol Violation|1|||
161694955|NCT01999582|583932457|FG001|Overall Study|Protocol Violation|0|||
161694956|NCT01999582|583932458|FG002|Overall Study|Protocol Violation|0|||
161694957|NCT01999582|583932459|FG003|Overall Study|Protocol Violation|0|||
161694958|NCT01999582|583932460|FG004|Overall Study|Protocol Violation|0|||
161694959|NCT01999582|583932461|FG005|Overall Study|Protocol Violation|1|||
161694960|NCT01999582|583932456|FG000|Overall Study|Lack of Efficacy|1|||
161694961|NCT01999582|583932457|FG001|Overall Study|Lack of Efficacy|3|||
161694962|NCT01999582|583932458|FG002|Overall Study|Lack of Efficacy|0|||
161694963|NCT01999582|583932459|FG003|Overall Study|Lack of Efficacy|1|||
161694964|NCT01999582|583932460|FG004|Overall Study|Lack of Efficacy|0|||
161694965|NCT01999582|583932461|FG005|Overall Study|Lack of Efficacy|0|||
161694966|NCT03728309|583932466|FG000|Overall Study|Randomized but not Treated|0|||
161694967|NCT03728309|583932467|FG001|Overall Study|Randomized but not Treated|1|||
161694968|NCT03728309|583932466|FG000|Overall Study|Adverse Event|0|||
161836531|NCT02333487|584443016|FG002|Overall Study|Adverse Event|0|||
161836532|NCT03303625|584444929|FG000|Overall Study|Withdrawal by Subject|2|||
161836533|NCT03303625|584444930|FG001|Overall Study|Withdrawal by Subject|0|||
161836534|NCT03303625|584444931|FG002|Overall Study|Withdrawal by Subject|0|||
161836535|NCT03303625|584444932|FG003|Overall Study|Withdrawal by Subject|0|||
161836536|NCT02858492|584444935|FG000|Overall Study|Withdrawal by Subject|0|||
161836537|NCT02858492|584444936|FG001|Overall Study|Withdrawal by Subject|1|||
161836538|NCT02858492|584444937|FG002|Overall Study|Withdrawal by Subject|0|||
161694969|NCT03728309|583932467|FG001|Overall Study|Adverse Event|1|||
161694970|NCT03728309|583932466|FG000|Overall Study|Withdrawal by Subject|2|||
161694971|NCT03728309|583932467|FG001|Overall Study|Withdrawal by Subject|8|||
161694972|NCT03728309|583932466|FG000|Overall Study|Lost to Follow-up|9|||
161694973|NCT03728309|583932467|FG001|Overall Study|Lost to Follow-up|10|||
161694974|NCT03728309|583932466|FG000|Overall Study|Protocol Deviation|0|||
161694975|NCT03728309|583932467|FG001|Overall Study|Protocol Deviation|1|||
161694976|NCT03728309|583932466|FG000|Overall Study|Due to COVID|1|||
161694977|NCT03728309|583932467|FG001|Overall Study|Due to COVID|3|||
161836539|NCT02858492|584444938|FG003|Overall Study|Withdrawal by Subject|1|||
161694978|NCT00927095|583932470|FG000|Overall Study|Adverse Event|3|||
161694979|NCT00927095|583932471|FG001|Overall Study|Adverse Event|1|||
161694980|NCT00927095|583932472|FG002|Overall Study|Adverse Event|0|||
161694981|NCT00927095|583932470|FG000|Overall Study|Withdrawal by Subject|2|||
161694982|NCT00927095|583932471|FG001|Overall Study|Withdrawal by Subject|1|||
161694983|NCT00927095|583932472|FG002|Overall Study|Withdrawal by Subject|1|||
161694984|NCT00927095|583932470|FG000|Overall Study|Physician Decision|1|||
161694985|NCT00927095|583932471|FG001|Overall Study|Physician Decision|2|||
161694986|NCT00927095|583932472|FG002|Overall Study|Physician Decision|1|||
161694987|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
161694988|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
161694989|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
161694990|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
161694991|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161694992|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161694993|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
161694994|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694995|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
161694996|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694997|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694998|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694999|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
161695000|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
161695001|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
161695002|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
161695003|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
161695004|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
161695005|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
161695006|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
161695007|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695008|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695009|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695010|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695011|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
161695012|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695013|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695014|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695015|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695016|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695017|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695018|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
161695019|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695020|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695021|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695022|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695023|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
161695024|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161695025|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
161695026|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
161695027|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161695028|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161695029|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
161695030|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
161695031|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
161695032|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
161695033|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
161695034|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
161695035|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
161695036|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
161695037|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
161695038|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
161695039|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
161695040|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
161695041|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Death|1|||
161695042|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Death|0|||
161695043|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Death|0|||
161695044|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Death|0|||
161695045|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Death|0|||
161695046|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Death|0|||
161695047|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
161695048|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695049|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695050|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695051|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695052|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695053|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
161695054|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
161695055|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695056|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695057|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695058|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695059|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
161695060|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695061|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695062|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695063|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695064|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695065|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
161695066|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
161695067|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
161695068|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
161695069|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
161695070|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
161695071|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
161695072|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
161695073|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
161695074|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
161695075|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
161695076|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
161695077|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
161695078|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
161695079|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
161695080|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
161836540|NCT02858492|584444935|FG000|Overall Study|Adverse Event|0|||
161695081|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
161695082|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
161695083|NCT00706030|583932485|FG000|Overall Study|Disease Progression|4|||
161695084|NCT00706030|583932486|FG001|Overall Study|Disease Progression|6|||
161695085|NCT00706030|583932487|FG002|Overall Study|Disease Progression|46|||
161695086|NCT00706030|583932488|FG003|Overall Study|Disease Progression|12|||
161695087|NCT00706030|583932485|FG000|Overall Study|Adverse Event|1|||
161695088|NCT00706030|583932486|FG001|Overall Study|Adverse Event|0|||
161695089|NCT00706030|583932487|FG002|Overall Study|Adverse Event|4|||
161695090|NCT00706030|583932488|FG003|Overall Study|Adverse Event|2|||
161695091|NCT00706030|583932485|FG000|Overall Study|Withdrawal by Subject|1|||
161695092|NCT00706030|583932486|FG001|Overall Study|Withdrawal by Subject|0|||
161695093|NCT00706030|583932487|FG002|Overall Study|Withdrawal by Subject|2|||
161695094|NCT00706030|583932488|FG003|Overall Study|Withdrawal by Subject|0|||
161695095|NCT00706030|583932485|FG000|Overall Study|Physician Decision|0|||
161695096|NCT00706030|583932486|FG001|Overall Study|Physician Decision|0|||
161695097|NCT00706030|583932487|FG002|Overall Study|Physician Decision|2|||
161695098|NCT00706030|583932488|FG003|Overall Study|Physician Decision|0|||
161695099|NCT00706030|583932485|FG000|Overall Study|Not recorded|0|||
161695100|NCT00706030|583932486|FG001|Overall Study|Not recorded|0|||
161695101|NCT00706030|583932487|FG002|Overall Study|Not recorded|2|||
161695102|NCT00706030|583932488|FG003|Overall Study|Not recorded|0|||
161695103|NCT00706030|583932485|FG000|Overall Study|Protocol Violation|0|||
161695104|NCT00706030|583932486|FG001|Overall Study|Protocol Violation|0|||
161695105|NCT00706030|583932487|FG002|Overall Study|Protocol Violation|1|||
161695106|NCT00706030|583932488|FG003|Overall Study|Protocol Violation|1|||
161695107|NCT00706030|583932485|FG000|Overall Study|Failed to return|0|||
161695108|NCT00706030|583932486|FG001|Overall Study|Failed to return|0|||
161695109|NCT00706030|583932487|FG002|Overall Study|Failed to return|1|||
161695110|NCT00706030|583932488|FG003|Overall Study|Failed to return|0|||
161695111|NCT00706030|583932485|FG000|Overall Study|Symptomatic Deterioration|0|||
161695112|NCT00706030|583932486|FG001|Overall Study|Symptomatic Deterioration|0|||
161695113|NCT00706030|583932487|FG002|Overall Study|Symptomatic Deterioration|1|||
161695114|NCT00706030|583932488|FG003|Overall Study|Symptomatic Deterioration|0|||
161695115|NCT00706030|583932485|FG000|Overall Study|No treatment received|0|||
161695116|NCT00706030|583932486|FG001|Overall Study|No treatment received|0|||
161695117|NCT00706030|583932487|FG002|Overall Study|No treatment received|0|||
161695118|NCT00706030|583932488|FG003|Overall Study|No treatment received|1|||
161695119|NCT00706030|583932485|FG000|Overall Study|Death|0|||
161695120|NCT00706030|583932486|FG001|Overall Study|Death|0|||
161695121|NCT00706030|583932487|FG002|Overall Study|Death|1|||
161695122|NCT00706030|583932488|FG003|Overall Study|Death|0|||
161695123|NCT05779072|583932489|FG000|Overall Study|Lost to Follow-up|0|||
161695124|NCT05779072|583932490|FG001|Overall Study|Lost to Follow-up|1|||
161695125|NCT05779072|583932489|FG000|Overall Study|Withdrawal by Subject|1|||
161695126|NCT05779072|583932490|FG001|Overall Study|Withdrawal by Subject|5|||
161695127|NCT01445769|583932491|FG000|Overall Study|Consent Withdrawn|2|||
161695128|NCT01445769|583932491|FG000|Overall Study|Disease Progression|1|||
161695129|NCT01445769|583932491|FG000|Overall Study|Lost to Follow-up|5|||
161695130|NCT05130463|583932494|FG000|Overall Study|Unspecified reasons|2|||
161695131|NCT05130463|583932494|FG000|Overall Study|off-label indication dose|435|||
161695132|NCT03652662|583932498|FG000|Overall Study|Withdrawal by Subject|2|||
161695133|NCT03652662|583932499|FG001|Overall Study|Withdrawal by Subject|1|||
161695134|NCT03652662|583932498|FG000|Overall Study|Lost to Follow-up|1|||
161695135|NCT03652662|583932499|FG001|Overall Study|Lost to Follow-up|0|||
161695136|NCT00487539|583932500|FG000|Overall Study|Adverse Event|3|||
161695137|NCT00487539|583932501|FG001|Overall Study|Adverse Event|2|||
161695138|NCT00487539|583932502|FG002|Overall Study|Adverse Event|1|||
161695139|NCT00487539|583932503|FG003|Overall Study|Adverse Event|1|||
161695140|NCT00487539|583932500|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161695141|NCT00487539|583932501|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161695142|NCT00487539|583932502|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161695143|NCT00487539|583932503|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
161695144|NCT00487539|583932500|FG000|Overall Study|Other|3|||
161695145|NCT00487539|583932501|FG001|Overall Study|Other|1|||
161695146|NCT00487539|583932502|FG002|Overall Study|Other|2|||
161695147|NCT00487539|583932503|FG003|Overall Study|Other|2|||
161695148|NCT02695628|583932504|FG000|Overall Study|Withdrawal by Subject|1|||
161695149|NCT02751502|583932505|FG000|Overall Study|Lack of funding|4|||
161695150|NCT02678390|583932506|FG000|AE (1 Day)|Withdrawal by Subject|0|||
161695151|NCT02678390|583932507|FG001|AE (1 Day)|Withdrawal by Subject|1|||
161695152|NCT03499028|583932508|FG000|Overall Study|Lost to Follow-up|12|||
161695153|NCT03499028|583932509|FG001|Overall Study|Lost to Follow-up|9|||
161695154|NCT03499028|583932508|FG000|Overall Study|Withdrawal by Subject|5|||
161695155|NCT03499028|583932509|FG001|Overall Study|Withdrawal by Subject|8|||
161695156|NCT03499028|583932508|FG000|Overall Study|Unplanned SNF discharge|5|||
161695157|NCT03499028|583932509|FG001|Overall Study|Unplanned SNF discharge|8|||
161695158|NCT02925156|583932510|FG000|Overall Study|Lost to Follow-up|27|||
161695159|NCT02925156|583932511|FG001|Overall Study|Lost to Follow-up|53|||
161695160|NCT02925156|583932512|FG002|Overall Study|Lost to Follow-up|51|||
161695161|NCT02925156|583932513|FG003|Overall Study|Lost to Follow-up|59|||
161695162|NCT02925156|583932514|FG004|Overall Study|Lost to Follow-up|89|||
161695163|NCT02925156|583932515|FG005|Overall Study|Lost to Follow-up|107|||
161695164|NCT02925156|583932516|FG006|Overall Study|Lost to Follow-up|34|||
161695165|NCT02925156|583932517|FG007|Overall Study|Lost to Follow-up|36|||
161695166|NCT02925156|583932518|FG008|Overall Study|Lost to Follow-up|73|||
161695167|NCT02925156|583932519|FG009|Overall Study|Lost to Follow-up|34|||
161695168|NCT01844895|583932520|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
161695169|NCT01844895|583932520|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
161695170|NCT01844895|583932520|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
161695171|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
161695172|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
161695173|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
161695174|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
161695175|NCT04982250|583932521|FG000|Overall Study|Lost to Follow-up|0|||
161695176|NCT04982250|583932522|FG001|Overall Study|Lost to Follow-up|26|||
161695177|NCT04982250|583932523|FG002|Overall Study|Lost to Follow-up|0|||
161695178|NCT04982250|583932524|FG003|Overall Study|Lost to Follow-up|0|||
161695179|NCT04982250|583932525|FG004|Overall Study|Lost to Follow-up|72|||
161695180|NCT04982250|583932526|FG005|Overall Study|Lost to Follow-up|69|||
161695181|NCT04982250|583932521|FG000|Overall Study|Not Eligible to Enroll|0|||
161695182|NCT04982250|583932522|FG001|Overall Study|Not Eligible to Enroll|0|||
161695183|NCT04982250|583932523|FG002|Overall Study|Not Eligible to Enroll|0|||
161695184|NCT04982250|583932524|FG003|Overall Study|Not Eligible to Enroll|0|||
161695185|NCT04982250|583932525|FG004|Overall Study|Not Eligible to Enroll|10|||
161695186|NCT04982250|583932526|FG005|Overall Study|Not Eligible to Enroll|7|||
161695187|NCT01844986|583932529|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
161695188|NCT01844986|583932530|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
161695189|NCT01844986|583932529|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
161695190|NCT01844986|583932530|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
161695191|NCT01844986|583932529|FG000|Overall Study (Global Cohort)|Death|55|||
161695192|NCT01844986|583932530|FG001|Overall Study (Global Cohort)|Death|26|||
161695193|NCT01844986|583932529|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
161695194|NCT01844986|583932530|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
161695195|NCT01844986|583932529|FG000|Overall Study (China Cohort)|Death|10|||
161695196|NCT01844986|583932530|FG001|Overall Study (China Cohort)|Death|6|||
161695197|NCT02392429|583933642|FG000|Screening|Screen failure|15|||
161695198|NCT02392429|583933642|FG000|Enrolled Participants|Ineligible due to disease|3|||
161695199|NCT02392429|583933642|FG000|Enrolled Participants|Withdrawal by Subject|4|||
161695200|NCT02392429|583933642|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
161695201|NCT02392429|583933642|FG000|Evaluable|Death|5|||
161695202|NCT02392429|583933642|FG000|Evaluable|Withdrawal by Subject|1|||
161695203|NCT02392429|583933642|FG000|Evaluable|Adverse Event|1|||
161695204|NCT02392429|583933642|FG000|Evaluable|remission bone marrow biopsy|3|||
161695205|NCT01178138|583933645|FG000|Overall Study|Lost to Follow-up|8|||
161695206|NCT01178138|583933645|FG000|Overall Study|Withdrawal by Subject|7|||
161695207|NCT01178138|583933645|FG000|Overall Study|Physician Decision|8|||
161695208|NCT00403260|583933646|FG000|Overall Study|Adverse Event|5|||
161695209|NCT00403260|583933647|FG001|Overall Study|Adverse Event|4|||
161695210|NCT00403260|583933646|FG000|Overall Study|Withdrawal by Subject|5|||
161695211|NCT00403260|583933647|FG001|Overall Study|Withdrawal by Subject|6|||
161695212|NCT00403260|583933646|FG000|Overall Study|Lost to Follow-up|49|||
161695213|NCT00403260|583933647|FG001|Overall Study|Lost to Follow-up|25|||
161695214|NCT00403260|583933646|FG000|Overall Study|Re-appearance of P. falciparum|34|||
161695215|NCT00403260|583933647|FG001|Overall Study|Re-appearance of P. falciparum|25|||
161695216|NCT00403260|583933646|FG000|Overall Study|P. vivax infection|26|||
161695217|NCT00403260|583933647|FG001|Overall Study|P. vivax infection|4|||
161695218|NCT00403260|583933646|FG000|Overall Study|Mixed infection with P. vivax|2|||
161695219|NCT00403260|583933647|FG001|Overall Study|Mixed infection with P. vivax|0|||
161695220|NCT00403260|583933646|FG000|Overall Study|Mixed infection with P. falciparum|1|||
161695221|NCT00403260|583933647|FG001|Overall Study|Mixed infection with P. falciparum|0|||
161695222|NCT00403260|583933646|FG000|Overall Study|P. vivax infection at screening|1|||
161695223|NCT00403260|583933647|FG001|Overall Study|P. vivax infection at screening|0|||
161695224|NCT00403260|583933646|FG000|Overall Study|P. ovale infection|1|||
161695225|NCT00403260|583933647|FG001|Overall Study|P. ovale infection|0|||
161695226|NCT00403260|583933646|FG000|Overall Study|Gametocyte re-appearance|1|||
161695227|NCT00403260|583933647|FG001|Overall Study|Gametocyte re-appearance|1|||
161695228|NCT00403260|583933646|FG000|Overall Study|Withdrawn from study accidentally|0|||
161695229|NCT00403260|583933647|FG001|Overall Study|Withdrawn from study accidentally|1|||
161695230|NCT01241708|583933648|FG000|Overall Study|Withdrawal by Subject|6|||
161695231|NCT01241708|583933648|FG000|Overall Study|Screen Failure|6|||
161695232|NCT01241708|583933648|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
161695233|NCT01241708|583933648|FG000|Overall Study|Lost to Follow-up|5|||
161695234|NCT02322710|583933656|FG000|Overall Study|No efficacy assessment post-baseline|0|||
161695235|NCT02322710|583933657|FG001|Overall Study|No efficacy assessment post-baseline|1|||
161695236|NCT02322710|583933656|FG000|Overall Study|Protocol Violation|20|||
161695237|NCT02322710|583933657|FG001|Overall Study|Protocol Violation|25|||
161695238|NCT04161131|583933658|FG000|Overall Study|Ineligible|2|||
161695239|NCT04161131|583933658|FG000|Overall Study|Lost to Follow-up|4|||
161695240|NCT05064059|583933659|FG000|Overall Study|Death|199|||
161695241|NCT05064059|583933660|FG001|Overall Study|Death|196|||
161695242|NCT05064059|583933659|FG000|Overall Study|Physician Decision|4|||
161695243|NCT05064059|583933660|FG001|Overall Study|Physician Decision|2|||
161695244|NCT05064059|583933659|FG000|Overall Study|Sponsor Decision|14|||
161695245|NCT05064059|583933660|FG001|Overall Study|Sponsor Decision|11|||
161695246|NCT05064059|583933659|FG000|Overall Study|Withdrawal by Subject|4|||
161695247|NCT05064059|583933660|FG001|Overall Study|Withdrawal by Subject|11|||
161695248|NCT02615990|583933661|FG000|Overall Study|study terminated|1|||
161695249|NCT02615990|583933662|FG001|Overall Study|study terminated|1|||
161695250|NCT00808444|583933665|FG000|Overall Study|Withdrawal by Subject|1|||
161695251|NCT00808444|583933666|FG001|Overall Study|Withdrawal by Subject|0|||
161695252|NCT00808444|583933665|FG000|Overall Study|Lost to Follow-up|0|||
161695253|NCT00808444|583933666|FG001|Overall Study|Lost to Follow-up|1|||
161695254|NCT04401267|583933667|FG000|Overall Study|Death|0|||
161695255|NCT04401267|583933668|FG001|Overall Study|Death|1|||
161695256|NCT04401267|583933667|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
161695257|NCT04401267|583933668|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
161695258|NCT04401267|583933667|FG000|Overall Study|Found to be Ineligible|1|||
161695259|NCT04401267|583933668|FG001|Overall Study|Found to be Ineligible|0|||
161695260|NCT01449708|583933678|FG000|Overall Study|Protocol Violation|0|||
161695261|NCT01449708|583933679|FG001|Overall Study|Protocol Violation|1|||
161695262|NCT01449708|583933678|FG000|Overall Study|surgical complication|1|||
161695263|NCT01449708|583933679|FG001|Overall Study|surgical complication|2|||
161695264|NCT01449708|583933678|FG000|Overall Study|respiratory failure|1|||
161695265|NCT01449708|583933679|FG001|Overall Study|respiratory failure|0|||
161695266|NCT01239160|583933685|FG000|Overall Study|Lost to Follow-up|3|||
161695267|NCT01239160|583933686|FG001|Overall Study|Lost to Follow-up|5|||
161695268|NCT01239160|583933687|FG002|Overall Study|Lost to Follow-up|0|||
161695269|NCT01239160|583933685|FG000|Overall Study|Withdrawal by Subject|17|||
161695270|NCT01239160|583933686|FG001|Overall Study|Withdrawal by Subject|6|||
161695271|NCT01239160|583933687|FG002|Overall Study|Withdrawal by Subject|2|||
161695272|NCT01239160|583933685|FG000|Overall Study|Physician Decision|5|||
161695273|NCT01239160|583933686|FG001|Overall Study|Physician Decision|7|||
161695274|NCT01239160|583933687|FG002|Overall Study|Physician Decision|2|||
161695275|NCT01239160|583933685|FG000|Overall Study|Early Termination Due to Study Closure|0|||
161695276|NCT01239160|583933686|FG001|Overall Study|Early Termination Due to Study Closure|1|||
161695277|NCT01239160|583933687|FG002|Overall Study|Early Termination Due to Study Closure|6|||
161695278|NCT00643994|583933688|FG000|Overall Study|Death|24|||
161695279|NCT00643994|583933688|FG000|Overall Study|Lost to Follow-up|72|||
161695280|NCT04016311|583933692|FG000|Overall Study|Withdrawal by Subject|1|||
161695281|NCT04016311|583933693|FG001|Overall Study|Withdrawal by Subject|0|||
161695282|NCT02706730|583933697|FG000|Overall Study|Adverse Event|3|||
161695283|NCT02706730|583933697|FG000|Overall Study|Lack of Efficacy|5|||
161695284|NCT02706730|583933697|FG000|Overall Study|Withdrawal by Subject|11|||
161695285|NCT02706730|583933697|FG000|Overall Study|Study Terminated by Sponsor|11|||
161695286|NCT02706730|583933697|FG000|Overall Study|Subject chose not to receive injection|3|||
161695287|NCT02499029|583933698|FG000|Overall Study|Lost to Follow-up|2|||
161695288|NCT02499029|583933699|FG001|Overall Study|Lost to Follow-up|2|||
161695289|NCT02499029|583933698|FG000|Overall Study|Physician Decision|2|||
161695290|NCT02499029|583933699|FG001|Overall Study|Physician Decision|1|||
161695291|NCT02499029|583933698|FG000|Overall Study|Death|1|||
161695292|NCT02499029|583933699|FG001|Overall Study|Death|0|||
161695293|NCT00094055|583933700|FG000|Overall Study|Adverse Event|11|||
161695294|NCT00094055|583933700|FG000|Overall Study|Death|4|||
161695295|NCT00094055|583933700|FG000|Overall Study|Lack of Efficacy|17|||
161695296|NCT00094055|583933700|FG000|Overall Study|Lost to Follow-up|2|||
161695297|NCT00094055|583933700|FG000|Overall Study|progressive disease|2|||
161695298|NCT00094055|583933700|FG000|Overall Study|clinical progression|1|||
161695299|NCT00094055|583933700|FG000|Overall Study|roll-over to another study|14|||
161695300|NCT00094055|583933700|FG000|Overall Study|Withdrawal by Subject|9|||
161695301|NCT00756938|583933701|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
161695302|NCT00756938|583933702|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
161695303|NCT00756938|583933703|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
161695304|NCT00756938|583933704|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
161695305|NCT00756938|583933701|FG000|12-week Base Study|Protocol Violation|0|||
161695306|NCT00756938|583933702|FG001|12-week Base Study|Protocol Violation|0|||
161695307|NCT00756938|583933703|FG002|12-week Base Study|Protocol Violation|1|||
161695308|NCT00756938|583933704|FG003|12-week Base Study|Protocol Violation|0|||
161695309|NCT00756938|583933701|FG000|12-week Base Study|Lost to Follow-up|1|||
161695310|NCT00756938|583933702|FG001|12-week Base Study|Lost to Follow-up|0|||
161695311|NCT00756938|583933703|FG002|12-week Base Study|Lost to Follow-up|0|||
161695312|NCT00756938|583933704|FG003|12-week Base Study|Lost to Follow-up|0|||
161695313|NCT00756938|583933701|FG000|Optional Extension|Lack of Efficacy|0|||
161695314|NCT00756938|583933702|FG001|Optional Extension|Lack of Efficacy|0|||
161695315|NCT00756938|583933703|FG002|Optional Extension|Lack of Efficacy|0|||
161695316|NCT00756938|583933704|FG003|Optional Extension|Lack of Efficacy|1|||
161695317|NCT00756938|583933701|FG000|Optional Extension|End of Study|0|||
161695318|NCT00756938|583933702|FG001|Optional Extension|End of Study|0|||
161695319|NCT00756938|583933703|FG002|Optional Extension|End of Study|0|||
161695320|NCT00756938|583933704|FG003|Optional Extension|End of Study|11|||
161695321|NCT00756938|583933701|FG000|Optional Extension|Protocol-specific criteria met|0|||
161695322|NCT00756938|583933702|FG001|Optional Extension|Protocol-specific criteria met|0|||
161695323|NCT00756938|583933703|FG002|Optional Extension|Protocol-specific criteria met|0|||
161695324|NCT00756938|583933704|FG003|Optional Extension|Protocol-specific criteria met|9|||
161695325|NCT00756938|583933701|FG000|Optional Extension|Physician Decision|0|||
161695326|NCT00756938|583933702|FG001|Optional Extension|Physician Decision|0|||
161695327|NCT00756938|583933703|FG002|Optional Extension|Physician Decision|0|||
161695328|NCT00756938|583933704|FG003|Optional Extension|Physician Decision|3|||
161695329|NCT00756938|583933701|FG000|Optional Extension|Lost to Follow-up|0|||
161695330|NCT00756938|583933702|FG001|Optional Extension|Lost to Follow-up|0|||
161695331|NCT00756938|583933703|FG002|Optional Extension|Lost to Follow-up|0|||
161695332|NCT00756938|583933704|FG003|Optional Extension|Lost to Follow-up|1|||
161695333|NCT00756938|583933701|FG000|Optional Extension|Protocol Violation|0|||
161695334|NCT00756938|583933702|FG001|Optional Extension|Protocol Violation|0|||
161695335|NCT00756938|583933703|FG002|Optional Extension|Protocol Violation|0|||
161695336|NCT00756938|583933704|FG003|Optional Extension|Protocol Violation|1|||
161695337|NCT00756938|583933701|FG000|Optional Extension|Withdrawal by Subject|0|||
161695338|NCT00756938|583933702|FG001|Optional Extension|Withdrawal by Subject|0|||
161695339|NCT00756938|583933703|FG002|Optional Extension|Withdrawal by Subject|0|||
161695340|NCT00756938|583933704|FG003|Optional Extension|Withdrawal by Subject|10|||
161695341|NCT00756938|583933701|FG000|Optional Extension|Adverse Event|0|||
161695342|NCT00756938|583933702|FG001|Optional Extension|Adverse Event|0|||
161695343|NCT00756938|583933703|FG002|Optional Extension|Adverse Event|0|||
161695344|NCT00756938|583933704|FG003|Optional Extension|Adverse Event|1|||
161695345|NCT04823949|583933705|FG000|Overall Study|Withdrawal by Subject|0|||
161695346|NCT04823949|583933706|FG001|Overall Study|Withdrawal by Subject|4|||
161695347|NCT04823949|583933705|FG000|Overall Study|Physician Decision|0|||
161695348|NCT04823949|583933706|FG001|Overall Study|Physician Decision|1|||
161695349|NCT00441545|583933707|FG000|First Intervention|Adverse Event|6|||
161695350|NCT00441545|583933708|FG001|First Intervention|Adverse Event|5|||
161695351|NCT00441545|583933707|FG000|First Intervention|Protocol Violation|2|||
161695352|NCT00441545|583933708|FG001|First Intervention|Protocol Violation|2|||
161695353|NCT00441545|583933707|FG000|First Intervention|Withdrawal by Subject|3|||
161695354|NCT00441545|583933708|FG001|First Intervention|Withdrawal by Subject|3|||
161695355|NCT00441545|583933707|FG000|First Intervention|Kidney transplant|1|||
161695356|NCT00441545|583933708|FG001|First Intervention|Kidney transplant|1|||
161695357|NCT00441545|583933707|FG000|First Intervention|Lack of Efficacy|2|||
161695358|NCT00441545|583933708|FG001|First Intervention|Lack of Efficacy|0|||
161695359|NCT00441545|583933707|FG000|First Intervention|Subject exceeded safety criteria|0|||
161695360|NCT00441545|583933708|FG001|First Intervention|Subject exceeded safety criteria|1|||
161695361|NCT00441545|583933707|FG000|First Intervention|Subject met an exclusionary criteria|1|||
161695362|NCT00441545|583933708|FG001|First Intervention|Subject met an exclusionary criteria|0|||
161695363|NCT00441545|583933707|FG000|First Intervention|Extended hospitalization|1|||
161695364|NCT00441545|583933708|FG001|First Intervention|Extended hospitalization|0|||
161695365|NCT00441545|583933707|FG000|First Intervention|Site error|1|||
161695366|NCT00441545|583933708|FG001|First Intervention|Site error|0|||
161695367|NCT00441545|583933707|FG000|First Intervention|Sponsor's request|1|||
161695368|NCT00441545|583933708|FG001|First Intervention|Sponsor's request|0|||
161695369|NCT00441545|583933707|FG000|Second Intervention|Adverse Event|5|||
161695370|NCT00441545|583933708|FG001|Second Intervention|Adverse Event|2|||
161695371|NCT00441545|583933707|FG000|Second Intervention|Protocol Violation|4|||
161695372|NCT00441545|583933708|FG001|Second Intervention|Protocol Violation|1|||
161695373|NCT00441545|583933707|FG000|Second Intervention|Withdrawal by Subject|1|||
161695374|NCT00441545|583933708|FG001|Second Intervention|Withdrawal by Subject|1|||
161695375|NCT00441545|583933707|FG000|Second Intervention|Kidney Transplant|1|||
161695376|NCT00441545|583933708|FG001|Second Intervention|Kidney Transplant|1|||
161695377|NCT00441545|583933707|FG000|Second Intervention|Lack of Efficacy|0|||
161695378|NCT00441545|583933708|FG001|Second Intervention|Lack of Efficacy|1|||
161695379|NCT00441545|583933707|FG000|Second Intervention|Subject exceeded safety criteria|1|||
161695380|NCT00441545|583933708|FG001|Second Intervention|Subject exceeded safety criteria|0|||
161695381|NCT00441545|583933707|FG000|Second Intervention|Subject moved|0|||
161695382|NCT00441545|583933708|FG001|Second Intervention|Subject moved|1|||
161695383|NCT00411554|583933711|FG000|Overall Study|Adverse Event|2|||
161695384|NCT00411554|583933712|FG001|Overall Study|Adverse Event|4|||
161695385|NCT00411554|583933711|FG000|Overall Study|Lack of Efficacy|2|||
161695386|NCT00411554|583933712|FG001|Overall Study|Lack of Efficacy|5|||
161695387|NCT00411554|583933711|FG000|Overall Study|Withdrawal by Subject|3|||
161695388|NCT00411554|583933712|FG001|Overall Study|Withdrawal by Subject|0|||
161695389|NCT00411554|583933711|FG000|Overall Study|Patient Moved|1|||
161695390|NCT00411554|583933712|FG001|Overall Study|Patient Moved|0|||
161695391|NCT00939692|583933715|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
161695392|NCT00939692|583933716|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
161695393|NCT00939692|583933715|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
161695394|NCT00939692|583933716|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
161695395|NCT00143455|583933717|FG000|Cohort 1|Adverse Event|8|||
161695396|NCT00143455|583933718|FG001|Cohort 1|Adverse Event|4|||
161695397|NCT00143455|583933719|FG002|Cohort 1|Adverse Event|0|||
161695398|NCT00143455|583933720|FG003|Cohort 1|Adverse Event|0|||
161695399|NCT00143455|583933717|FG000|Cohort 1|Death|5|||
161695400|NCT00143455|583933718|FG001|Cohort 1|Death|2|||
161695401|NCT00143455|583933719|FG002|Cohort 1|Death|0|||
161695402|NCT00143455|583933720|FG003|Cohort 1|Death|0|||
161695403|NCT00143455|583933717|FG000|Cohort 1|Progressive Disease|0|||
161695404|NCT00143455|583933718|FG001|Cohort 1|Progressive Disease|6|||
161695405|NCT00143455|583933719|FG002|Cohort 1|Progressive Disease|0|||
161695406|NCT00143455|583933720|FG003|Cohort 1|Progressive Disease|0|||
161695407|NCT00143455|583933717|FG000|Cohort 1|Withdrawal by Subject|1|||
161695408|NCT00143455|583933718|FG001|Cohort 1|Withdrawal by Subject|4|||
161695409|NCT00143455|583933719|FG002|Cohort 1|Withdrawal by Subject|0|||
161695410|NCT00143455|583933720|FG003|Cohort 1|Withdrawal by Subject|0|||
161695411|NCT00143455|583933717|FG000|Cohort 1|Randomized But Not Treated|0|||
161695412|NCT00143455|583933718|FG001|Cohort 1|Randomized But Not Treated|1|||
161695413|NCT00143455|583933719|FG002|Cohort 1|Randomized But Not Treated|0|||
161695414|NCT00143455|583933720|FG003|Cohort 1|Randomized But Not Treated|0|||
161695415|NCT00143455|583933717|FG000|Cohort 2|Adverse Event|0|||
161695416|NCT00143455|583933718|FG001|Cohort 2|Adverse Event|0|||
161695417|NCT00143455|583933719|FG002|Cohort 2|Adverse Event|42|||
161695418|NCT00143455|583933720|FG003|Cohort 2|Adverse Event|30|||
161695419|NCT00143455|583933717|FG000|Cohort 2|No Longer Required Study Treatment|0|||
161695420|NCT00143455|583933718|FG001|Cohort 2|No Longer Required Study Treatment|0|||
161695421|NCT00143455|583933719|FG002|Cohort 2|No Longer Required Study Treatment|1|||
161695422|NCT00143455|583933720|FG003|Cohort 2|No Longer Required Study Treatment|0|||
161695423|NCT00143455|583933717|FG000|Cohort 2|Protocol Violation|0|||
161695424|NCT00143455|583933718|FG001|Cohort 2|Protocol Violation|0|||
161695425|NCT00143455|583933719|FG002|Cohort 2|Protocol Violation|1|||
161695426|NCT00143455|583933720|FG003|Cohort 2|Protocol Violation|1|||
161695427|NCT00143455|583933717|FG000|Cohort 2|Lost to Follow-up|0|||
161695428|NCT00143455|583933718|FG001|Cohort 2|Lost to Follow-up|0|||
161695429|NCT00143455|583933719|FG002|Cohort 2|Lost to Follow-up|1|||
161695430|NCT00143455|583933720|FG003|Cohort 2|Lost to Follow-up|4|||
161695431|NCT00143455|583933717|FG000|Cohort 2|Death|0|||
161695432|NCT00143455|583933718|FG001|Cohort 2|Death|0|||
161695433|NCT00143455|583933719|FG002|Cohort 2|Death|20|||
161695434|NCT00143455|583933720|FG003|Cohort 2|Death|12|||
161695435|NCT00143455|583933717|FG000|Cohort 2|Progressive Disease|0|||
161695436|NCT00143455|583933718|FG001|Cohort 2|Progressive Disease|0|||
161695437|NCT00143455|583933719|FG002|Cohort 2|Progressive Disease|20|||
161695438|NCT00143455|583933720|FG003|Cohort 2|Progressive Disease|27|||
161695439|NCT00143455|583933717|FG000|Cohort 2|Withdrawal by Subject|0|||
161695440|NCT00143455|583933718|FG001|Cohort 2|Withdrawal by Subject|0|||
161695441|NCT00143455|583933719|FG002|Cohort 2|Withdrawal by Subject|13|||
161695442|NCT00143455|583933720|FG003|Cohort 2|Withdrawal by Subject|12|||
161695443|NCT00143455|583933717|FG000|Cohort 2|Other|0|||
161836541|NCT02858492|584444936|FG001|Overall Study|Adverse Event|0|||
161695444|NCT00143455|583933718|FG001|Cohort 2|Other|0|||
161695445|NCT00143455|583933719|FG002|Cohort 2|Other|7|||
161695446|NCT00143455|583933720|FG003|Cohort 2|Other|6|||
161695447|NCT00143455|583933717|FG000|Cohort 2|Randomized But Not Treated|0|||
161695448|NCT00143455|583933718|FG001|Cohort 2|Randomized But Not Treated|0|||
161695449|NCT00143455|583933719|FG002|Cohort 2|Randomized But Not Treated|1|||
161695450|NCT00143455|583933720|FG003|Cohort 2|Randomized But Not Treated|1|||
161695451|NCT00720109|583933735|FG000|Induction Period|Did not meet eligibility criteria|3|||
161695452|NCT00720109|583933736|FG001|Induction Period|Did not meet eligibility criteria|0|||
161695453|NCT00720109|583933737|FG002|Induction Period|Did not meet eligibility criteria|0|||
161695454|NCT00720109|583933735|FG000|Induction Period|Bone Marrow Transplant|2|||
161695455|NCT00720109|583933736|FG001|Induction Period|Bone Marrow Transplant|0|||
161695456|NCT00720109|583933737|FG002|Induction Period|Bone Marrow Transplant|0|||
161695457|NCT00720109|583933735|FG000|Induction Period|Physician Decision|1|||
161695458|NCT00720109|583933736|FG001|Induction Period|Physician Decision|0|||
161695459|NCT00720109|583933737|FG002|Induction Period|Physician Decision|0|||
161695460|NCT00720109|583933735|FG000|Risk Stratification Period|Adverse Event|0|||
161836542|NCT02858492|584444937|FG002|Overall Study|Adverse Event|0|||
161836543|NCT02858492|584444938|FG003|Overall Study|Adverse Event|3|||
161695461|NCT00720109|583933736|FG001|Risk Stratification Period|Adverse Event|1|||
161695462|NCT00720109|583933737|FG002|Risk Stratification Period|Adverse Event|0|||
161695463|NCT00720109|583933735|FG000|Risk Stratification Period|Physician Decision|0|||
161695464|NCT00720109|583933736|FG001|Risk Stratification Period|Physician Decision|2|||
161695465|NCT00720109|583933737|FG002|Risk Stratification Period|Physician Decision|1|||
161695466|NCT00720109|583933735|FG000|Risk Stratification Period|Bone marrow transplant|0|||
161695467|NCT00720109|583933736|FG001|Risk Stratification Period|Bone marrow transplant|9|||
161695468|NCT00720109|583933737|FG002|Risk Stratification Period|Bone marrow transplant|7|||
161695469|NCT00720109|583933735|FG000|Risk Stratification Period|Disease progression or relapse|0|||
161836544|NCT02858492|584444935|FG000|Overall Study|Lack of Efficacy|0|||
161695470|NCT00720109|583933736|FG001|Risk Stratification Period|Disease progression or relapse|2|||
161695471|NCT00720109|583933737|FG002|Risk Stratification Period|Disease progression or relapse|0|||
161695472|NCT00720109|583933735|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
161695473|NCT00720109|583933736|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
161695474|NCT00720109|583933737|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
161695475|NCT02665286|583933738|FG000|Overall Study|Lost to Follow-up|3|||
161695476|NCT02665286|583933739|FG001|Overall Study|Lost to Follow-up|2|||
161695477|NCT02665286|583933740|FG002|Overall Study|Lost to Follow-up|1|||
161695478|NCT04153188|583933754|FG000|Overall Study|Lost to Follow-up|1|||
161695479|NCT04153188|583933755|FG001|Overall Study|Lost to Follow-up|1|||
161695480|NCT04153188|583933754|FG000|Overall Study|Withdrawal by Subject|2|||
161695481|NCT04153188|583933755|FG001|Overall Study|Withdrawal by Subject|0|||
161695482|NCT04153188|583933754|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
161695483|NCT04153188|583933755|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
161695484|NCT01489527|583933756|FG000|Overall Study|Pregnancy|9|||
161695485|NCT01489527|583933757|FG001|Overall Study|Pregnancy|14|||
161695486|NCT01489527|583933756|FG000|Overall Study|Participant moved|6|||
161695487|NCT01489527|583933757|FG001|Overall Study|Participant moved|7|||
161695488|NCT01489527|583933756|FG000|Overall Study|Withdrawal by Subject|0|||
161695489|NCT01489527|583933757|FG001|Overall Study|Withdrawal by Subject|4|||
161695490|NCT01489527|583933756|FG000|Overall Study|Lost to Follow-up|5|||
161695491|NCT01489527|583933757|FG001|Overall Study|Lost to Follow-up|1|||
161695492|NCT01489527|583933756|FG000|Overall Study|Procedures|1|||
161695493|NCT01489527|583933757|FG001|Overall Study|Procedures|0|||
161695494|NCT01489527|583933756|FG000|Overall Study|Not compliant|1|||
161695495|NCT01489527|583933757|FG001|Overall Study|Not compliant|0|||
161695496|NCT04899232|583933758|FG000|Screening Period|Physician Decision|1|||
161695497|NCT04899232|583933759|FG001|Screening Period|Physician Decision|0|||
161695498|NCT04899232|583933760|FG002|Screening Period|Physician Decision|0|||
161695499|NCT04899232|583933758|FG000|Screening Period|Withdrawal by Subject|1|||
161695500|NCT04899232|583933759|FG001|Screening Period|Withdrawal by Subject|0|||
161695501|NCT04899232|583933760|FG002|Screening Period|Withdrawal by Subject|0|||
161695502|NCT04899232|583933758|FG000|Screening Period|Participant discharged before receiving intervention|3|||
161695503|NCT04899232|583933759|FG001|Screening Period|Participant discharged before receiving intervention|0|||
161695504|NCT04899232|583933760|FG002|Screening Period|Participant discharged before receiving intervention|0|||
161695505|NCT00700271|583933761|FG000|Overall Study|Adverse Event|4|||
161695506|NCT00700271|583933762|FG001|Overall Study|Adverse Event|6|||
161695507|NCT00700271|583933761|FG000|Overall Study|Protocol Violation|1|||
161695508|NCT00700271|583933762|FG001|Overall Study|Protocol Violation|0|||
161695509|NCT00700271|583933761|FG000|Overall Study|Administrative Reasons|1|||
161695510|NCT00700271|583933762|FG001|Overall Study|Administrative Reasons|0|||
161695511|NCT00700271|583933761|FG000|Overall Study|Withdrawal by Subject|6|||
161695512|NCT00700271|583933762|FG001|Overall Study|Withdrawal by Subject|4|||
161695513|NCT00700271|583933761|FG000|Overall Study|Lost to Follow-up|2|||
161695514|NCT00700271|583933762|FG001|Overall Study|Lost to Follow-up|2|||
161695515|NCT02926950|583933763|FG000|Overall Study|Adverse Event|4|||
161695516|NCT02926950|583933764|FG001|Overall Study|Adverse Event|6|||
161695517|NCT02926950|583933763|FG000|Overall Study|At the participant's own request|21|||
161695518|NCT02926950|583933764|FG001|Overall Study|At the participant's own request|25|||
161695519|NCT02926950|583933763|FG000|Overall Study|Reason not Specified|17|||
161695520|NCT02926950|583933764|FG001|Overall Study|Reason not Specified|9|||
161695521|NCT02926950|583933763|FG000|Overall Study|Lost to Follow-up|7|||
161695522|NCT02926950|583933764|FG001|Overall Study|Lost to Follow-up|8|||
161695523|NCT02553460|583933765|FG000|Overall Study|Death|3|||
161695524|NCT02553460|583933765|FG000|Overall Study|Withdrawal by Subject|1|||
161695525|NCT02553460|583933765|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
161695526|NCT02553460|583933765|FG000|Overall Study|Relapse or Transplant|14|||
161695527|NCT02553460|583933765|FG000|Overall Study|No response to treatment|2|||
161695528|NCT02553460|583933765|FG000|Overall Study|CAR T cells|2|||
161695529|NCT03505021|583933766|FG000|Overall Study|Protocol Violation|1|||
161695530|NCT03505021|583933767|FG001|Overall Study|Protocol Violation|0|||
161695531|NCT03505021|583933766|FG000|Overall Study|Death|9|||
161695532|NCT03505021|583933767|FG001|Overall Study|Death|8|||
161695533|NCT03505021|583933766|FG000|Overall Study|Consent withdrawn by subject|6|||
161695534|NCT03505021|583933767|FG001|Overall Study|Consent withdrawn by subject|1|||
161695535|NCT03505021|583933766|FG000|Overall Study|Lost to Follow-up|5|||
161695536|NCT03505021|583933767|FG001|Overall Study|Lost to Follow-up|3|||
161695537|NCT03505021|583933766|FG000|Overall Study|Adverse Event|26|||
161695538|NCT03505021|583933767|FG001|Overall Study|Adverse Event|9|||
161695539|NCT03505021|583933766|FG000|Overall Study|Disease progression|33|||
161695540|NCT03505021|583933767|FG001|Overall Study|Disease progression|17|||
161695541|NCT03505021|583933766|FG000|Overall Study|Other|11|||
161695542|NCT03505021|583933767|FG001|Overall Study|Other|5|||
161695543|NCT03505021|583933766|FG000|Overall Study|Personal reason|21|||
161695544|NCT03505021|583933767|FG001|Overall Study|Personal reason|12|||
161695545|NCT03087955|583935853|FG000|Overall Study|Death|4|||
161695546|NCT03087955|583935854|FG001|Overall Study|Death|0|||
161695547|NCT03087955|583935853|FG000|Overall Study|Lack of Efficacy|2|||
161695548|NCT03087955|583935854|FG001|Overall Study|Lack of Efficacy|0|||
161695549|NCT03087955|583935853|FG000|Overall Study|Lost to Follow-up|1|||
161695550|NCT03087955|583935854|FG001|Overall Study|Lost to Follow-up|0|||
161695551|NCT03266016|583935861|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
161695552|NCT03266016|583935862|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161695553|NCT03266016|583935863|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161695554|NCT03266016|583935864|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161695555|NCT03266016|583935861|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
161695556|NCT03266016|583935862|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
161695557|NCT03266016|583935863|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
161695558|NCT03266016|583935864|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
161695559|NCT05280756|583935865|FG000|Overall Study|Lost to Follow-up|1|||
161695560|NCT05280756|583935866|FG001|Overall Study|Lost to Follow-up|1|||
161695561|NCT00768898|583935867|FG000|Overall Study|Unrelated injury|1|||
161695562|NCT00768898|583935867|FG000|Overall Study|Headache|1|||
161695563|NCT01777763|583935880|FG000|Overall Study|Adverse Event|2|||
161695564|NCT01777763|583935881|FG001|Overall Study|Adverse Event|32|||
161695565|NCT01777763|583935880|FG000|Overall Study|Protocol Violation|1|||
161695566|NCT01777763|583935881|FG001|Overall Study|Protocol Violation|7|||
161695567|NCT01777763|583935880|FG000|Overall Study|Withdrawal by Subject|0|||
161695568|NCT01777763|583935881|FG001|Overall Study|Withdrawal by Subject|2|||
161695569|NCT01777763|583935880|FG000|Overall Study|Treatment Failure|1|||
161695570|NCT01777763|583935881|FG001|Overall Study|Treatment Failure|6|||
161695571|NCT02968810|583935885|FG000|Overall Study|Lost to Follow-up|1|||
161695572|NCT02968810|583935886|FG001|Overall Study|Lost to Follow-up|0|||
161695573|NCT02968810|583935885|FG000|Overall Study|Physician Decision|1|||
161695574|NCT02968810|583935886|FG001|Overall Study|Physician Decision|0|||
161695575|NCT02968810|583935885|FG000|Overall Study|Withdrawal by Subject|1|||
161695576|NCT02968810|583935886|FG001|Overall Study|Withdrawal by Subject|3|||
161695577|NCT02968810|583935885|FG000|Overall Study|Disease Progression|0|||
161695578|NCT02968810|583935886|FG001|Overall Study|Disease Progression|1|||
161695579|NCT02787850|583935888|FG000|Overall Study|Withdrawal by Subject|0|||
161695580|NCT02787850|583935889|FG001|Overall Study|Withdrawal by Subject|1|||
161695581|NCT03718143|583935890|FG000|Overall Study|Death|1|||
161695582|NCT03718143|583935891|FG001|Overall Study|Death|0|||
161695583|NCT03718143|583935892|FG002|Overall Study|Death|0|||
161695584|NCT03718143|583935890|FG000|Overall Study|Progression of Disease|1|||
161695585|NCT03718143|583935891|FG001|Overall Study|Progression of Disease|0|||
161695586|NCT03718143|583935892|FG002|Overall Study|Progression of Disease|0|||
161695587|NCT03718143|583935890|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161695588|NCT03718143|583935891|FG001|Overall Study|Withdrawal of Informed Consent|2|||
161695589|NCT03718143|583935892|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161695590|NCT03905863|583935893|FG000|Overall Study|Adverse Event|2|||
161695591|NCT03905863|583935894|FG001|Overall Study|Adverse Event|4|||
161695592|NCT03905863|583935893|FG000|Overall Study|Withdrawal by Subject|2|||
161695593|NCT03905863|583935894|FG001|Overall Study|Withdrawal by Subject|2|||
161695594|NCT03905863|583935893|FG000|Overall Study|Physician Decision|0|||
161695595|NCT03905863|583935894|FG001|Overall Study|Physician Decision|3|||
161695596|NCT03905863|583935893|FG000|Overall Study|Lost to Follow-up|1|||
161695597|NCT03905863|583935894|FG001|Overall Study|Lost to Follow-up|0|||
161695598|NCT03905863|583935893|FG000|Overall Study|Protocol Violation|0|||
161695599|NCT03905863|583935894|FG001|Overall Study|Protocol Violation|2|||
161695600|NCT03905863|583935893|FG000|Overall Study|Death|0|||
161695601|NCT03905863|583935894|FG001|Overall Study|Death|1|||
161695602|NCT02944448|583935898|FG000|Overall Study|Adverse Event|37|||
161695603|NCT02944448|583935899|FG001|Overall Study|Adverse Event|6|||
161695604|NCT02944448|583935898|FG000|Overall Study|Lack of Efficacy|8|||
161695605|NCT02944448|583935899|FG001|Overall Study|Lack of Efficacy|5|||
161695606|NCT02944448|583935898|FG000|Overall Study|Lost to Follow-up|3|||
161695607|NCT02944448|583935899|FG001|Overall Study|Lost to Follow-up|1|||
161695608|NCT02944448|583935898|FG000|Overall Study|Protocol Violation|25|||
161695609|NCT02944448|583935899|FG001|Overall Study|Protocol Violation|7|||
161695610|NCT02944448|583935898|FG000|Overall Study|Withdrawal by Subject|14|||
161695611|NCT02944448|583935899|FG001|Overall Study|Withdrawal by Subject|4|||
161695612|NCT02944448|583935898|FG000|Overall Study|Sponsor did not supply drug in time|0|||
161695613|NCT02944448|583935899|FG001|Overall Study|Sponsor did not supply drug in time|1|||
161695614|NCT02944448|583935898|FG000|Overall Study|Noncompliant with dosing|1|||
161695615|NCT02944448|583935899|FG001|Overall Study|Noncompliant with dosing|0|||
161695616|NCT02944448|583935898|FG000|Overall Study|Abnormal laboratory values|1|||
161695617|NCT02944448|583935899|FG001|Overall Study|Abnormal laboratory values|0|||
161695618|NCT01191697|583935902|FG000|Overall Study|Death|1|||
161695619|NCT01191697|583935902|FG000|Overall Study|Physician Decision|2|||
161695620|NCT01191697|583935902|FG000|Overall Study|Pursue chemoradiation|2|||
161836545|NCT02858492|584444936|FG001|Overall Study|Lack of Efficacy|0|||
161836546|NCT02858492|584444937|FG002|Overall Study|Lack of Efficacy|0|||
161653160|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161653161|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161653162|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161653163|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161653164|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161653165|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
161653166|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
161653167|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161653168|NCT03439254|583781011|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
161653169|NCT03439254|583781012|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
161653170|NCT03439254|583781013|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
161653171|NCT03439254|583781014|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
161653172|NCT03439254|583781015|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
161653173|NCT03439254|583781016|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
161653174|NCT00128102|583781019|FG000|Overall Study|Site Discontinued|3|||
161653175|NCT00128102|583781020|FG001|Overall Study|Site Discontinued|6|||
161653176|NCT00128102|583781019|FG000|Overall Study|Other|0|||
161653177|NCT00128102|583781020|FG001|Overall Study|Other|1|||
161653178|NCT00128102|583781019|FG000|Overall Study|Progressive Disease|255|||
161653179|NCT00128102|583781020|FG001|Overall Study|Progressive Disease|285|||
161653180|NCT00128102|583781019|FG000|Overall Study|Adverse Event|34|||
161653181|NCT00128102|583781020|FG001|Overall Study|Adverse Event|11|||
161653182|NCT00128102|583781019|FG000|Overall Study|Death|12|||
161653183|NCT00128102|583781020|FG001|Overall Study|Death|13|||
161653184|NCT00128102|583781019|FG000|Overall Study|Physician Decision|3|||
161653185|NCT00128102|583781020|FG001|Overall Study|Physician Decision|3|||
161653186|NCT00128102|583781019|FG000|Overall Study|Withdrawal by Subject|19|||
161653187|NCT00128102|583781020|FG001|Overall Study|Withdrawal by Subject|11|||
161653188|NCT00128102|583781019|FG000|Overall Study|Protocol Violation|2|||
161653189|NCT00128102|583781020|FG001|Overall Study|Protocol Violation|2|||
161653190|NCT00568178|583781021|FG000|Double Blind Base Study|Adverse Event|0|||
161653191|NCT00568178|583781022|FG001|Double Blind Base Study|Adverse Event|2|||
161653192|NCT00568178|583781023|FG002|Double Blind Base Study|Adverse Event|1|||
161653193|NCT00568178|583781024|FG003|Double Blind Base Study|Adverse Event|2|||
161653194|NCT00568178|583781025|FG004|Double Blind Base Study|Adverse Event|0|||
161653195|NCT00568178|583781026|FG005|Double Blind Base Study|Adverse Event|0|||
161653196|NCT00568178|583781021|FG000|Double Blind Base Study|Lost to Follow-up|1|||
161653197|NCT00568178|583781022|FG001|Double Blind Base Study|Lost to Follow-up|0|||
161653198|NCT00568178|583781023|FG002|Double Blind Base Study|Lost to Follow-up|0|||
161653199|NCT00568178|583781024|FG003|Double Blind Base Study|Lost to Follow-up|1|||
161653200|NCT00568178|583781025|FG004|Double Blind Base Study|Lost to Follow-up|0|||
161653201|NCT00568178|583781026|FG005|Double Blind Base Study|Lost to Follow-up|0|||
161653202|NCT00568178|583781021|FG000|Double Blind Base Study|Physician Decision|1|||
161653203|NCT00568178|583781022|FG001|Double Blind Base Study|Physician Decision|1|||
161653204|NCT00568178|583781023|FG002|Double Blind Base Study|Physician Decision|0|||
161653205|NCT00568178|583781024|FG003|Double Blind Base Study|Physician Decision|1|||
161653206|NCT00568178|583781025|FG004|Double Blind Base Study|Physician Decision|0|||
161653207|NCT00568178|583781026|FG005|Double Blind Base Study|Physician Decision|0|||
161653208|NCT00568178|583781021|FG000|Double Blind Base Study|Protocol Violation|3|||
161653209|NCT00568178|583781022|FG001|Double Blind Base Study|Protocol Violation|2|||
161653210|NCT00568178|583781023|FG002|Double Blind Base Study|Protocol Violation|0|||
161653211|NCT00568178|583781024|FG003|Double Blind Base Study|Protocol Violation|0|||
161653212|NCT00568178|583781025|FG004|Double Blind Base Study|Protocol Violation|0|||
161653213|NCT00568178|583781026|FG005|Double Blind Base Study|Protocol Violation|0|||
161653214|NCT00568178|583781021|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
161653215|NCT00568178|583781022|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
161653216|NCT00568178|583781023|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
161695621|NCT01191697|583935902|FG000|Overall Study|Break from chemotherapy|2|||
161695622|NCT01191697|583935902|FG000|Overall Study|Withdrawal by Subject|1|||
161695623|NCT01191697|583935902|FG000|Overall Study|Surveillance|1|||
161695624|NCT01191697|583935902|FG000|Overall Study|Adverse Event|2|||
161695625|NCT01191697|583935902|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
161695626|NCT01191697|583935902|FG000|Overall Study|Not completed but analyzed|25|||
161695627|NCT01396005|583935903|FG000|Overall Study|Withdrawal by Subject|0|||
161695628|NCT01396005|583935904|FG001|Overall Study|Withdrawal by Subject|1|||
161695629|NCT01396005|583935903|FG000|Overall Study|Non-compliance with protocol|0|||
161695630|NCT01396005|583935904|FG001|Overall Study|Non-compliance with protocol|1|||
161695631|NCT02397473|583935907|FG000|Treatment Phase|Adverse Event|1|||
161695632|NCT02397473|583935908|FG001|Treatment Phase|Adverse Event|2|||
161695633|NCT02397473|583935907|FG000|Treatment Phase|Lack of Efficacy|8|||
161695634|NCT02397473|583935908|FG001|Treatment Phase|Lack of Efficacy|1|||
161695635|NCT02397473|583935907|FG000|Treatment Phase|Lost to Follow-up|1|||
161695636|NCT02397473|583935908|FG001|Treatment Phase|Lost to Follow-up|0|||
161695637|NCT02397473|583935907|FG000|Treatment Phase|Withdrawal by Subject|2|||
161695638|NCT02397473|583935908|FG001|Treatment Phase|Withdrawal by Subject|1|||
161695639|NCT02397473|583935907|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
161695640|NCT02397473|583935908|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
161695641|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
161695642|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
161695643|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
161695644|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161695645|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
161695646|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
161695647|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161695648|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161695649|NCT01467492|583935909|FG000|Overall Study|Withdrawal by Subject|6|||
161695650|NCT01467492|583935910|FG001|Overall Study|Withdrawal by Subject|4|||
161695651|NCT01467492|583935909|FG000|Overall Study|Study Terminated by Sponsor|6|||
161695652|NCT01467492|583935910|FG001|Overall Study|Study Terminated by Sponsor|4|||
161695653|NCT01467492|583935909|FG000|Overall Study|Adverse Event|4|||
161695654|NCT01467492|583935910|FG001|Overall Study|Adverse Event|3|||
161695655|NCT01467492|583935909|FG000|Overall Study|Lost to Follow-up|3|||
161695656|NCT01467492|583935910|FG001|Overall Study|Lost to Follow-up|2|||
161695657|NCT01467492|583935909|FG000|Overall Study|Undefined|2|||
161695658|NCT01467492|583935910|FG001|Overall Study|Undefined|0|||
161695659|NCT01467492|583935909|FG000|Overall Study|Enrolled But Not Treated|1|||
161695660|NCT01467492|583935910|FG001|Overall Study|Enrolled But Not Treated|0|||
161695661|NCT00491179|583935911|FG000|Overall Study|Adverse Event|5|||
161695662|NCT00491179|583935912|FG001|Overall Study|Adverse Event|1|||
161695663|NCT00491179|583935911|FG000|Overall Study|Withdrawal by Subject|2|||
161695664|NCT00491179|583935912|FG001|Overall Study|Withdrawal by Subject|1|||
161695665|NCT02009878|583935914|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
161695666|NCT02009878|583935915|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161695667|NCT02009878|583935916|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
161695668|NCT01790048|583935917|FG000|Overall Study|Incorrect Age|9|||
161695669|NCT01790048|583935918|FG001|Overall Study|Incorrect Age|14|||
161695670|NCT01790048|583935917|FG000|Overall Study|data entry error|0|||
161695671|NCT01790048|583935918|FG001|Overall Study|data entry error|1|||
161695672|NCT01790048|583935917|FG000|Overall Study|Other|0|||
161695673|NCT01790048|583935918|FG001|Overall Study|Other|2|||
161695674|NCT01790048|583935917|FG000|Overall Study|SAM at Enrollment|2|||
161695675|NCT01790048|583935918|FG001|Overall Study|SAM at Enrollment|0|||
161695676|NCT01790048|583935917|FG000|Overall Study|Measurement error|1|||
161695677|NCT01790048|583935918|FG001|Overall Study|Measurement error|0|||
161695678|NCT01491178|583935919|FG000|Overall Study|Adverse Event|1016|||
161695679|NCT01491178|583935919|FG000|Overall Study|Improvement of NVAF|210|||
161695680|NCT01491178|583935919|FG000|Overall Study|To conduct invasive treatment|59|||
161695681|NCT01491178|583935919|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
161695682|NCT01491178|583935919|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
161695683|NCT01491178|583935919|FG000|Overall Study|To take a contraindication|20|||
161695684|NCT01491178|583935919|FG000|Overall Study|Other than specified above|657|||
161695685|NCT01604512|583935922|FG000|Overall Study|Withdrawal by Subject|3|||
161695686|NCT01604512|583935922|FG000|Overall Study|Not treated|4|||
161695687|NCT01415752|583935925|FG000|Induction (Step 1)|Ineligible|4|||
161695688|NCT01415752|583935926|FG001|Induction (Step 1)|Ineligible|3|||
161695689|NCT01415752|583935927|FG002|Induction (Step 1)|Ineligible|4|||
161695690|NCT01415752|583935928|FG003|Induction (Step 1)|Ineligible|4|||
161695691|NCT01415752|583935925|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
161695692|NCT01415752|583935926|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
161695693|NCT01415752|583935927|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
161695694|NCT01415752|583935928|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
161695695|NCT01415752|583935925|FG000|Maintenance (Step 2)|Adverse Event|3|||
161695696|NCT01415752|583935926|FG001|Maintenance (Step 2)|Adverse Event|4|||
161695697|NCT01415752|583935927|FG002|Maintenance (Step 2)|Adverse Event|9|||
161695698|NCT01415752|583935928|FG003|Maintenance (Step 2)|Adverse Event|6|||
161695699|NCT01415752|583935925|FG000|Maintenance (Step 2)|Death|1|||
161695700|NCT01415752|583935926|FG001|Maintenance (Step 2)|Death|1|||
161695701|NCT01415752|583935927|FG002|Maintenance (Step 2)|Death|2|||
161695702|NCT01415752|583935928|FG003|Maintenance (Step 2)|Death|0|||
161695703|NCT01415752|583935925|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
161695704|NCT01415752|583935926|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
161695705|NCT01415752|583935927|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
161695706|NCT01415752|583935928|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
161695707|NCT01415752|583935925|FG000|Maintenance (Step 2)|Alternative therapy|0|||
161695708|NCT01415752|583935926|FG001|Maintenance (Step 2)|Alternative therapy|1|||
161695709|NCT01415752|583935927|FG002|Maintenance (Step 2)|Alternative therapy|0|||
161695710|NCT01415752|583935928|FG003|Maintenance (Step 2)|Alternative therapy|0|||
161695711|NCT01415752|583935925|FG000|Maintenance (Step 2)|Other reasons|3|||
161695712|NCT01415752|583935926|FG001|Maintenance (Step 2)|Other reasons|6|||
161695713|NCT01415752|583935927|FG002|Maintenance (Step 2)|Other reasons|4|||
161695714|NCT01415752|583935928|FG003|Maintenance (Step 2)|Other reasons|6|||
161695715|NCT01415752|583935925|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
161695716|NCT01415752|583935926|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
161695717|NCT01415752|583935927|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
161695718|NCT01415752|583935928|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
161695719|NCT01415752|583935925|FG000|Maintenance (Step 2)|ineligible|1|||
161695720|NCT01415752|583935926|FG001|Maintenance (Step 2)|ineligible|1|||
161695721|NCT01415752|583935927|FG002|Maintenance (Step 2)|ineligible|1|||
161695722|NCT01415752|583935928|FG003|Maintenance (Step 2)|ineligible|0|||
161695723|NCT01415752|583935925|FG000|Maintenance (Step 2)|Missing|4|||
161695724|NCT01415752|583935926|FG001|Maintenance (Step 2)|Missing|1|||
161695725|NCT01415752|583935927|FG002|Maintenance (Step 2)|Missing|4|||
161695726|NCT01415752|583935928|FG003|Maintenance (Step 2)|Missing|3|||
161695727|NCT03083886|583935929|FG000|Overall Study|Withdrawal by Subject|51|||
161695728|NCT03083886|583935930|FG001|Overall Study|Withdrawal by Subject|73|||
161695729|NCT03083886|583935931|FG002|Overall Study|Withdrawal by Subject|104|||
161695730|NCT03083886|583935929|FG000|Overall Study|Missing Baseline data|43|||
161695731|NCT03083886|583935930|FG001|Overall Study|Missing Baseline data|42|||
161695732|NCT03083886|583935931|FG002|Overall Study|Missing Baseline data|31|||
161695733|NCT03083886|583935929|FG000|Overall Study|Investigator terminated|1|||
161695734|NCT03083886|583935930|FG001|Overall Study|Investigator terminated|6|||
161695735|NCT03083886|583935931|FG002|Overall Study|Investigator terminated|3|||
161695736|NCT01391507|583935932|FG000|Overall Study|Death|0|||
161695737|NCT01391507|583935933|FG001|Overall Study|Death|0|||
161695738|NCT01391507|583935934|FG002|Overall Study|Death|0|||
161695739|NCT01391507|583935935|FG003|Overall Study|Death|1|||
161695740|NCT01391507|583935932|FG000|Overall Study|Adverse Event|1|||
161695741|NCT01391507|583935933|FG001|Overall Study|Adverse Event|1|||
161695742|NCT01391507|583935934|FG002|Overall Study|Adverse Event|2|||
161695743|NCT01391507|583935935|FG003|Overall Study|Adverse Event|2|||
161695744|NCT01391507|583935932|FG000|Overall Study|Withdrawal by Subject|1|||
161695745|NCT01391507|583935933|FG001|Overall Study|Withdrawal by Subject|2|||
161695746|NCT01391507|583935934|FG002|Overall Study|Withdrawal by Subject|1|||
161695747|NCT01391507|583935935|FG003|Overall Study|Withdrawal by Subject|1|||
161695748|NCT01391507|583935932|FG000|Overall Study|Lack of Efficacy|0|||
161695749|NCT01391507|583935933|FG001|Overall Study|Lack of Efficacy|0|||
161695750|NCT01391507|583935934|FG002|Overall Study|Lack of Efficacy|0|||
161695751|NCT01391507|583935935|FG003|Overall Study|Lack of Efficacy|1|||
161695752|NCT01391507|583935932|FG000|Overall Study|Protocol Violation|2|||
161695753|NCT01391507|583935933|FG001|Overall Study|Protocol Violation|1|||
161695754|NCT01391507|583935934|FG002|Overall Study|Protocol Violation|1|||
161695755|NCT01391507|583935935|FG003|Overall Study|Protocol Violation|2|||
161695756|NCT01453855|583935936|FG000|Overall Study|Adverse Event|3|||
161695757|NCT01453855|583935937|FG001|Overall Study|Adverse Event|4|||
161695758|NCT01453855|583935936|FG000|Overall Study|Lost to Follow-up|2|||
161695759|NCT01453855|583935937|FG001|Overall Study|Lost to Follow-up|1|||
161695760|NCT01453855|583935936|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
161836547|NCT02858492|584444938|FG003|Overall Study|Lack of Efficacy|1|||
161695761|NCT01453855|583935937|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
161695762|NCT01453855|583935936|FG000|Overall Study|Noncompliance|1|||
161695763|NCT01453855|583935937|FG001|Overall Study|Noncompliance|0|||
161695764|NCT01453855|583935936|FG000|Overall Study|Inadequate Control of IOP|1|||
161695765|NCT01453855|583935937|FG001|Overall Study|Inadequate Control of IOP|5|||
161695766|NCT01453855|583935936|FG000|Overall Study|Other|0|||
161695767|NCT01453855|583935937|FG001|Overall Study|Other|1|||
161695768|NCT03529773|583935940|FG000|Overall Study|Adverse Event|0|||
161695769|NCT03529773|583935941|FG001|Overall Study|Adverse Event|0|||
161695770|NCT03529773|583935942|FG002|Overall Study|Adverse Event|0|||
161695771|NCT03529773|583935943|FG003|Overall Study|Adverse Event|0|||
161695772|NCT03529773|583935944|FG004|Overall Study|Adverse Event|0|||
161695773|NCT03529773|583935945|FG005|Overall Study|Adverse Event|0|||
161695774|NCT03529773|583935946|FG006|Overall Study|Adverse Event|0|||
161695775|NCT03529773|583935947|FG007|Overall Study|Adverse Event|0|||
161695776|NCT03529773|583935948|FG008|Overall Study|Adverse Event|0|||
161695777|NCT03529773|583935949|FG009|Overall Study|Adverse Event|0|||
161695778|NCT03529773|583935950|FG010|Overall Study|Adverse Event|0|||
161695779|NCT03529773|583935951|FG011|Overall Study|Adverse Event|0|||
161695780|NCT03529773|583935952|FG012|Overall Study|Adverse Event|0|||
161695781|NCT03529773|583935953|FG013|Overall Study|Adverse Event|0|||
161695782|NCT03529773|583935954|FG014|Overall Study|Adverse Event|0|||
161695783|NCT03529773|583935955|FG015|Overall Study|Adverse Event|0|||
161695784|NCT03529773|583935956|FG016|Overall Study|Adverse Event|0|||
161695785|NCT03529773|583935957|FG017|Overall Study|Adverse Event|0|||
161695786|NCT03529773|583935958|FG018|Overall Study|Adverse Event|0|||
161695787|NCT03529773|583935959|FG019|Overall Study|Adverse Event|0|||
161695788|NCT03529773|583935960|FG020|Overall Study|Adverse Event|0|||
161695789|NCT03529773|583935961|FG021|Overall Study|Adverse Event|0|||
161695790|NCT03529773|583935962|FG022|Overall Study|Adverse Event|0|||
161695791|NCT03529773|583935963|FG023|Overall Study|Adverse Event|0|||
161695792|NCT03529773|583935964|FG024|Overall Study|Adverse Event|0|||
161695793|NCT03529773|583935965|FG025|Overall Study|Adverse Event|0|||
161695794|NCT03529773|583935966|FG026|Overall Study|Adverse Event|0|||
161695795|NCT03529773|583935967|FG027|Overall Study|Adverse Event|0|||
161695796|NCT03529773|583935968|FG028|Overall Study|Adverse Event|0|||
161695797|NCT03529773|583935969|FG029|Overall Study|Adverse Event|0|||
161695798|NCT03529773|583935970|FG030|Overall Study|Adverse Event|1|||
161695799|NCT03529773|583935971|FG031|Overall Study|Adverse Event|0|||
161695800|NCT03529773|583935972|FG032|Overall Study|Adverse Event|0|||
161695801|NCT03529773|583935973|FG033|Overall Study|Adverse Event|0|||
161695802|NCT03529773|583935974|FG034|Overall Study|Adverse Event|0|||
161695803|NCT03529773|583935975|FG035|Overall Study|Adverse Event|1|||
161695804|NCT03529773|583935976|FG036|Overall Study|Adverse Event|0|||
161695805|NCT03529773|583935977|FG037|Overall Study|Adverse Event|0|||
161695806|NCT03529773|583935978|FG038|Overall Study|Adverse Event|1|||
161695807|NCT03529773|583935979|FG039|Overall Study|Adverse Event|1|||
161695808|NCT03529773|583935940|FG000|Overall Study|Death|0|||
161695809|NCT03529773|583935941|FG001|Overall Study|Death|0|||
161695810|NCT03529773|583935942|FG002|Overall Study|Death|0|||
161695811|NCT03529773|583935943|FG003|Overall Study|Death|0|||
161695812|NCT03529773|583935944|FG004|Overall Study|Death|0|||
161695813|NCT03529773|583935945|FG005|Overall Study|Death|0|||
161695814|NCT03529773|583935946|FG006|Overall Study|Death|0|||
161695815|NCT03529773|583935947|FG007|Overall Study|Death|0|||
161695816|NCT03529773|583935948|FG008|Overall Study|Death|0|||
161695817|NCT03529773|583935949|FG009|Overall Study|Death|0|||
161695818|NCT03529773|583935950|FG010|Overall Study|Death|0|||
161695819|NCT03529773|583935951|FG011|Overall Study|Death|0|||
161695820|NCT03529773|583935952|FG012|Overall Study|Death|1|||
161695821|NCT03529773|583935953|FG013|Overall Study|Death|0|||
161695822|NCT03529773|583935954|FG014|Overall Study|Death|0|||
161695823|NCT03529773|583935955|FG015|Overall Study|Death|0|||
161695824|NCT03529773|583935956|FG016|Overall Study|Death|0|||
161695825|NCT03529773|583935957|FG017|Overall Study|Death|0|||
161695826|NCT03529773|583935958|FG018|Overall Study|Death|0|||
161695827|NCT03529773|583935959|FG019|Overall Study|Death|1|||
161695828|NCT03529773|583935960|FG020|Overall Study|Death|0|||
161695829|NCT03529773|583935961|FG021|Overall Study|Death|0|||
161695830|NCT03529773|583935962|FG022|Overall Study|Death|1|||
161695831|NCT03529773|583935963|FG023|Overall Study|Death|0|||
161695832|NCT03529773|583935964|FG024|Overall Study|Death|0|||
161695833|NCT03529773|583935965|FG025|Overall Study|Death|0|||
161695834|NCT03529773|583935966|FG026|Overall Study|Death|0|||
161695835|NCT03529773|583935967|FG027|Overall Study|Death|0|||
161695836|NCT03529773|583935968|FG028|Overall Study|Death|0|||
161695837|NCT03529773|583935969|FG029|Overall Study|Death|0|||
161836548|NCT02858492|584444935|FG000|Overall Study|Protocol defined stopping criteria|0|||
161836549|NCT02858492|584444936|FG001|Overall Study|Protocol defined stopping criteria|0|||
161836550|NCT02858492|584444937|FG002|Overall Study|Protocol defined stopping criteria|0|||
161695838|NCT03529773|583935970|FG030|Overall Study|Death|0|||
161695839|NCT03529773|583935971|FG031|Overall Study|Death|0|||
161695840|NCT03529773|583935972|FG032|Overall Study|Death|0|||
161695841|NCT03529773|583935973|FG033|Overall Study|Death|1|||
161695842|NCT03529773|583935974|FG034|Overall Study|Death|1|||
161695843|NCT03529773|583935975|FG035|Overall Study|Death|0|||
161695844|NCT03529773|583935976|FG036|Overall Study|Death|1|||
161695845|NCT03529773|583935977|FG037|Overall Study|Death|0|||
161695846|NCT03529773|583935978|FG038|Overall Study|Death|0|||
161695847|NCT03529773|583935979|FG039|Overall Study|Death|0|||
161695848|NCT03529773|583935940|FG000|Overall Study|Lost to Follow-up|0|||
161695849|NCT03529773|583935941|FG001|Overall Study|Lost to Follow-up|0|||
161695850|NCT03529773|583935942|FG002|Overall Study|Lost to Follow-up|1|||
161695851|NCT03529773|583935943|FG003|Overall Study|Lost to Follow-up|0|||
161695852|NCT03529773|583935944|FG004|Overall Study|Lost to Follow-up|1|||
161695853|NCT03529773|583935945|FG005|Overall Study|Lost to Follow-up|1|||
161695854|NCT03529773|583935946|FG006|Overall Study|Lost to Follow-up|0|||
161695855|NCT03529773|583935947|FG007|Overall Study|Lost to Follow-up|0|||
161695856|NCT03529773|583935948|FG008|Overall Study|Lost to Follow-up|0|||
161695857|NCT03529773|583935949|FG009|Overall Study|Lost to Follow-up|0|||
161695858|NCT03529773|583935950|FG010|Overall Study|Lost to Follow-up|0|||
161836551|NCT02858492|584444938|FG003|Overall Study|Protocol defined stopping criteria|1|||
161836552|NCT02944383|584444939|FG000|Overall Study|Lost to Follow-up|0|||
161836553|NCT02944383|584444940|FG001|Overall Study|Lost to Follow-up|0|||
161836554|NCT02944383|584444941|FG002|Overall Study|Lost to Follow-up|1|||
161836555|NCT02944383|584444939|FG000|Overall Study|Withdrawal by Subject|1|||
161695859|NCT03529773|583935951|FG011|Overall Study|Lost to Follow-up|0|||
161695860|NCT03529773|583935952|FG012|Overall Study|Lost to Follow-up|0|||
161695861|NCT03529773|583935953|FG013|Overall Study|Lost to Follow-up|1|||
161695862|NCT03529773|583935954|FG014|Overall Study|Lost to Follow-up|4|||
161695863|NCT03529773|583935955|FG015|Overall Study|Lost to Follow-up|1|||
161695864|NCT03529773|583935956|FG016|Overall Study|Lost to Follow-up|1|||
161695865|NCT03529773|583935957|FG017|Overall Study|Lost to Follow-up|0|||
161695866|NCT03529773|583935958|FG018|Overall Study|Lost to Follow-up|1|||
161695867|NCT03529773|583935959|FG019|Overall Study|Lost to Follow-up|1|||
161695868|NCT03529773|583935960|FG020|Overall Study|Lost to Follow-up|2|||
161695869|NCT03529773|583935961|FG021|Overall Study|Lost to Follow-up|4|||
161695870|NCT03529773|583935962|FG022|Overall Study|Lost to Follow-up|3|||
161695871|NCT03529773|583935963|FG023|Overall Study|Lost to Follow-up|4|||
161695872|NCT03529773|583935964|FG024|Overall Study|Lost to Follow-up|3|||
161695873|NCT03529773|583935965|FG025|Overall Study|Lost to Follow-up|5|||
161695874|NCT03529773|583935966|FG026|Overall Study|Lost to Follow-up|5|||
161695875|NCT03529773|583935967|FG027|Overall Study|Lost to Follow-up|0|||
161695876|NCT03529773|583935968|FG028|Overall Study|Lost to Follow-up|0|||
161695877|NCT03529773|583935969|FG029|Overall Study|Lost to Follow-up|0|||
161695878|NCT03529773|583935970|FG030|Overall Study|Lost to Follow-up|1|||
161695879|NCT03529773|583935971|FG031|Overall Study|Lost to Follow-up|0|||
161695880|NCT03529773|583935972|FG032|Overall Study|Lost to Follow-up|0|||
161695881|NCT03529773|583935973|FG033|Overall Study|Lost to Follow-up|1|||
161695882|NCT03529773|583935974|FG034|Overall Study|Lost to Follow-up|1|||
161695883|NCT03529773|583935975|FG035|Overall Study|Lost to Follow-up|0|||
161695884|NCT03529773|583935976|FG036|Overall Study|Lost to Follow-up|0|||
161695885|NCT03529773|583935977|FG037|Overall Study|Lost to Follow-up|3|||
161695886|NCT03529773|583935978|FG038|Overall Study|Lost to Follow-up|1|||
161695887|NCT03529773|583935979|FG039|Overall Study|Lost to Follow-up|1|||
161695888|NCT03529773|583935940|FG000|Overall Study|No longer meets eligibility criteria|0|||
161695889|NCT03529773|583935941|FG001|Overall Study|No longer meets eligibility criteria|0|||
161695890|NCT03529773|583935942|FG002|Overall Study|No longer meets eligibility criteria|0|||
161695891|NCT03529773|583935943|FG003|Overall Study|No longer meets eligibility criteria|0|||
161695892|NCT03529773|583935944|FG004|Overall Study|No longer meets eligibility criteria|0|||
161695893|NCT03529773|583935945|FG005|Overall Study|No longer meets eligibility criteria|0|||
161695894|NCT03529773|583935946|FG006|Overall Study|No longer meets eligibility criteria|0|||
161695895|NCT03529773|583935947|FG007|Overall Study|No longer meets eligibility criteria|0|||
161695896|NCT03529773|583935948|FG008|Overall Study|No longer meets eligibility criteria|0|||
161695897|NCT03529773|583935949|FG009|Overall Study|No longer meets eligibility criteria|0|||
161695898|NCT03529773|583935950|FG010|Overall Study|No longer meets eligibility criteria|0|||
161695899|NCT03529773|583935951|FG011|Overall Study|No longer meets eligibility criteria|0|||
161695900|NCT03529773|583935952|FG012|Overall Study|No longer meets eligibility criteria|0|||
161695901|NCT03529773|583935953|FG013|Overall Study|No longer meets eligibility criteria|0|||
161695902|NCT03529773|583935954|FG014|Overall Study|No longer meets eligibility criteria|0|||
161695903|NCT03529773|583935955|FG015|Overall Study|No longer meets eligibility criteria|0|||
161695904|NCT03529773|583935956|FG016|Overall Study|No longer meets eligibility criteria|0|||
161695905|NCT03529773|583935957|FG017|Overall Study|No longer meets eligibility criteria|0|||
161695906|NCT03529773|583935958|FG018|Overall Study|No longer meets eligibility criteria|0|||
161695907|NCT03529773|583935959|FG019|Overall Study|No longer meets eligibility criteria|0|||
161695908|NCT03529773|583935960|FG020|Overall Study|No longer meets eligibility criteria|0|||
161695909|NCT03529773|583935961|FG021|Overall Study|No longer meets eligibility criteria|0|||
161695910|NCT03529773|583935962|FG022|Overall Study|No longer meets eligibility criteria|1|||
161836556|NCT02944383|584444940|FG001|Overall Study|Withdrawal by Subject|0|||
161695911|NCT03529773|583935963|FG023|Overall Study|No longer meets eligibility criteria|0|||
161695912|NCT03529773|583935964|FG024|Overall Study|No longer meets eligibility criteria|0|||
161695913|NCT03529773|583935965|FG025|Overall Study|No longer meets eligibility criteria|0|||
161695914|NCT03529773|583935966|FG026|Overall Study|No longer meets eligibility criteria|0|||
161695915|NCT03529773|583935967|FG027|Overall Study|No longer meets eligibility criteria|0|||
161695916|NCT03529773|583935968|FG028|Overall Study|No longer meets eligibility criteria|0|||
161695917|NCT03529773|583935969|FG029|Overall Study|No longer meets eligibility criteria|0|||
161695918|NCT03529773|583935970|FG030|Overall Study|No longer meets eligibility criteria|0|||
161695919|NCT03529773|583935971|FG031|Overall Study|No longer meets eligibility criteria|0|||
161836557|NCT02944383|584444941|FG002|Overall Study|Withdrawal by Subject|0|||
161695920|NCT03529773|583935972|FG032|Overall Study|No longer meets eligibility criteria|0|||
161695921|NCT03529773|583935973|FG033|Overall Study|No longer meets eligibility criteria|0|||
161695922|NCT03529773|583935974|FG034|Overall Study|No longer meets eligibility criteria|0|||
161695923|NCT03529773|583935975|FG035|Overall Study|No longer meets eligibility criteria|0|||
161695924|NCT03529773|583935976|FG036|Overall Study|No longer meets eligibility criteria|0|||
161695925|NCT03529773|583935977|FG037|Overall Study|No longer meets eligibility criteria|0|||
161695926|NCT03529773|583935978|FG038|Overall Study|No longer meets eligibility criteria|1|||
161695927|NCT03529773|583935979|FG039|Overall Study|No longer meets eligibility criteria|0|||
161695928|NCT03529773|583935940|FG000|Overall Study|Other|0|||
161695929|NCT03529773|583935941|FG001|Overall Study|Other|0|||
161695930|NCT03529773|583935942|FG002|Overall Study|Other|0|||
161695931|NCT03529773|583935943|FG003|Overall Study|Other|0|||
161695932|NCT03529773|583935944|FG004|Overall Study|Other|0|||
161695933|NCT03529773|583935945|FG005|Overall Study|Other|0|||
161695934|NCT03529773|583935946|FG006|Overall Study|Other|0|||
161695935|NCT03529773|583935947|FG007|Overall Study|Other|0|||
161695936|NCT03529773|583935948|FG008|Overall Study|Other|0|||
161695937|NCT03529773|583935949|FG009|Overall Study|Other|0|||
161695938|NCT03529773|583935950|FG010|Overall Study|Other|0|||
161695939|NCT03529773|583935951|FG011|Overall Study|Other|0|||
161695940|NCT03529773|583935952|FG012|Overall Study|Other|1|||
161695941|NCT03529773|583935953|FG013|Overall Study|Other|0|||
161695942|NCT03529773|583935954|FG014|Overall Study|Other|2|||
161695943|NCT03529773|583935955|FG015|Overall Study|Other|0|||
161695944|NCT03529773|583935956|FG016|Overall Study|Other|0|||
161695945|NCT03529773|583935957|FG017|Overall Study|Other|3|||
161695946|NCT03529773|583935958|FG018|Overall Study|Other|0|||
161695947|NCT03529773|583935959|FG019|Overall Study|Other|0|||
161695948|NCT03529773|583935960|FG020|Overall Study|Other|1|||
161695949|NCT03529773|583935961|FG021|Overall Study|Other|0|||
161695950|NCT03529773|583935962|FG022|Overall Study|Other|1|||
161695951|NCT03529773|583935963|FG023|Overall Study|Other|0|||
161695952|NCT03529773|583935964|FG024|Overall Study|Other|3|||
161695953|NCT03529773|583935965|FG025|Overall Study|Other|2|||
161695954|NCT03529773|583935966|FG026|Overall Study|Other|2|||
161695955|NCT03529773|583935967|FG027|Overall Study|Other|0|||
161695956|NCT03529773|583935968|FG028|Overall Study|Other|0|||
161695957|NCT03529773|583935969|FG029|Overall Study|Other|0|||
161695958|NCT03529773|583935970|FG030|Overall Study|Other|0|||
161695959|NCT03529773|583935971|FG031|Overall Study|Other|0|||
161695960|NCT03529773|583935972|FG032|Overall Study|Other|0|||
161695961|NCT03529773|583935973|FG033|Overall Study|Other|0|||
161695962|NCT03529773|583935974|FG034|Overall Study|Other|1|||
161695963|NCT03529773|583935975|FG035|Overall Study|Other|1|||
161695964|NCT03529773|583935976|FG036|Overall Study|Other|0|||
161695965|NCT03529773|583935977|FG037|Overall Study|Other|0|||
161695966|NCT03529773|583935978|FG038|Overall Study|Other|0|||
161695967|NCT03529773|583935979|FG039|Overall Study|Other|0|||
161695968|NCT03529773|583935940|FG000|Overall Study|Physician Decision|0|||
161695969|NCT03529773|583935941|FG001|Overall Study|Physician Decision|0|||
161695970|NCT03529773|583935942|FG002|Overall Study|Physician Decision|0|||
161695971|NCT03529773|583935943|FG003|Overall Study|Physician Decision|0|||
161695972|NCT03529773|583935944|FG004|Overall Study|Physician Decision|0|||
161695973|NCT03529773|583935945|FG005|Overall Study|Physician Decision|0|||
161695974|NCT03529773|583935946|FG006|Overall Study|Physician Decision|0|||
161695975|NCT03529773|583935947|FG007|Overall Study|Physician Decision|0|||
161695976|NCT03529773|583935948|FG008|Overall Study|Physician Decision|0|||
161695977|NCT03529773|583935949|FG009|Overall Study|Physician Decision|0|||
161695978|NCT03529773|583935950|FG010|Overall Study|Physician Decision|0|||
161695979|NCT03529773|583935951|FG011|Overall Study|Physician Decision|0|||
161695980|NCT03529773|583935952|FG012|Overall Study|Physician Decision|0|||
161695981|NCT03529773|583935953|FG013|Overall Study|Physician Decision|0|||
161695982|NCT03529773|583935954|FG014|Overall Study|Physician Decision|0|||
161695983|NCT03529773|583935955|FG015|Overall Study|Physician Decision|0|||
161695984|NCT03529773|583935956|FG016|Overall Study|Physician Decision|0|||
161695985|NCT03529773|583935957|FG017|Overall Study|Physician Decision|0|||
161695986|NCT03529773|583935958|FG018|Overall Study|Physician Decision|0|||
161695987|NCT03529773|583935959|FG019|Overall Study|Physician Decision|1|||
161695988|NCT03529773|583935960|FG020|Overall Study|Physician Decision|1|||
161695989|NCT03529773|583935961|FG021|Overall Study|Physician Decision|0|||
161695990|NCT03529773|583935962|FG022|Overall Study|Physician Decision|0|||
161695991|NCT03529773|583935963|FG023|Overall Study|Physician Decision|0|||
161695992|NCT03529773|583935964|FG024|Overall Study|Physician Decision|0|||
161695993|NCT03529773|583935965|FG025|Overall Study|Physician Decision|0|||
161695994|NCT03529773|583935966|FG026|Overall Study|Physician Decision|0|||
161695995|NCT03529773|583935967|FG027|Overall Study|Physician Decision|0|||
161695996|NCT03529773|583935968|FG028|Overall Study|Physician Decision|0|||
161695997|NCT03529773|583935969|FG029|Overall Study|Physician Decision|0|||
161695998|NCT03529773|583935970|FG030|Overall Study|Physician Decision|0|||
161695999|NCT03529773|583935971|FG031|Overall Study|Physician Decision|0|||
161696000|NCT03529773|583935972|FG032|Overall Study|Physician Decision|0|||
161696001|NCT03529773|583935973|FG033|Overall Study|Physician Decision|0|||
161696002|NCT03529773|583935974|FG034|Overall Study|Physician Decision|0|||
161696003|NCT03529773|583935975|FG035|Overall Study|Physician Decision|0|||
161696004|NCT03529773|583935976|FG036|Overall Study|Physician Decision|0|||
161696005|NCT03529773|583935977|FG037|Overall Study|Physician Decision|0|||
161696006|NCT03529773|583935978|FG038|Overall Study|Physician Decision|0|||
161696007|NCT03529773|583935979|FG039|Overall Study|Physician Decision|0|||
161696008|NCT03529773|583935940|FG000|Overall Study|Protocol Violation|0|||
161696009|NCT03529773|583935941|FG001|Overall Study|Protocol Violation|0|||
161696010|NCT03529773|583935942|FG002|Overall Study|Protocol Violation|0|||
161696011|NCT03529773|583935943|FG003|Overall Study|Protocol Violation|0|||
161696012|NCT03529773|583935944|FG004|Overall Study|Protocol Violation|0|||
161696013|NCT03529773|583935945|FG005|Overall Study|Protocol Violation|0|||
161696014|NCT03529773|583935946|FG006|Overall Study|Protocol Violation|0|||
161696015|NCT03529773|583935947|FG007|Overall Study|Protocol Violation|0|||
161696016|NCT03529773|583935948|FG008|Overall Study|Protocol Violation|0|||
161696017|NCT03529773|583935949|FG009|Overall Study|Protocol Violation|0|||
161696018|NCT03529773|583935950|FG010|Overall Study|Protocol Violation|0|||
161696019|NCT03529773|583935951|FG011|Overall Study|Protocol Violation|0|||
161696020|NCT03529773|583935952|FG012|Overall Study|Protocol Violation|0|||
161696021|NCT03529773|583935953|FG013|Overall Study|Protocol Violation|0|||
161696022|NCT03529773|583935954|FG014|Overall Study|Protocol Violation|0|||
161696023|NCT03529773|583935955|FG015|Overall Study|Protocol Violation|0|||
161836558|NCT01995266|584444942|FG000|Overall Study|Death|1|||
161836559|NCT01995266|584444942|FG000|Overall Study|Lack of Efficacy|6|||
161836560|NCT01995266|584444942|FG000|Overall Study|Adverse Event|2|||
161836561|NCT02588950|584444945|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
161836562|NCT02588950|584444946|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
161836563|NCT02588950|584444947|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
161653217|NCT00568178|583781024|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
161653218|NCT00568178|583781025|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
161653219|NCT00568178|583781026|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
161653220|NCT00568178|583781021|FG000|Double Blind Base Study|Progressive Disease|0|||
161653221|NCT00568178|583781022|FG001|Double Blind Base Study|Progressive Disease|0|||
161653222|NCT00568178|583781023|FG002|Double Blind Base Study|Progressive Disease|0|||
161653223|NCT00568178|583781024|FG003|Double Blind Base Study|Progressive Disease|1|||
161653224|NCT00568178|583781025|FG004|Double Blind Base Study|Progressive Disease|0|||
161653225|NCT00568178|583781026|FG005|Double Blind Base Study|Progressive Disease|0|||
161653226|NCT00568178|583781021|FG000|Open Label Extension|Adverse Event|0|||
161653227|NCT00568178|583781022|FG001|Open Label Extension|Adverse Event|0|||
161653228|NCT00568178|583781023|FG002|Open Label Extension|Adverse Event|0|||
161653229|NCT00568178|583781024|FG003|Open Label Extension|Adverse Event|0|||
161653230|NCT00568178|583781025|FG004|Open Label Extension|Adverse Event|11|||
161653231|NCT00568178|583781026|FG005|Open Label Extension|Adverse Event|8|||
161653232|NCT00568178|583781021|FG000|Open Label Extension|Protocol Violation|0|||
161653233|NCT00568178|583781022|FG001|Open Label Extension|Protocol Violation|0|||
161653234|NCT00568178|583781023|FG002|Open Label Extension|Protocol Violation|0|||
161653235|NCT00568178|583781024|FG003|Open Label Extension|Protocol Violation|0|||
161653236|NCT00568178|583781025|FG004|Open Label Extension|Protocol Violation|1|||
161653237|NCT00568178|583781026|FG005|Open Label Extension|Protocol Violation|0|||
161653238|NCT00568178|583781021|FG000|Open Label Extension|Lost to Follow-up|0|||
161653239|NCT00568178|583781022|FG001|Open Label Extension|Lost to Follow-up|0|||
161696024|NCT03529773|583935956|FG016|Overall Study|Protocol Violation|0|||
161696025|NCT03529773|583935957|FG017|Overall Study|Protocol Violation|0|||
161696026|NCT03529773|583935958|FG018|Overall Study|Protocol Violation|0|||
161696027|NCT03529773|583935959|FG019|Overall Study|Protocol Violation|0|||
161696028|NCT03529773|583935960|FG020|Overall Study|Protocol Violation|0|||
161696029|NCT03529773|583935961|FG021|Overall Study|Protocol Violation|0|||
161696030|NCT03529773|583935962|FG022|Overall Study|Protocol Violation|0|||
161696031|NCT03529773|583935963|FG023|Overall Study|Protocol Violation|0|||
161696032|NCT03529773|583935964|FG024|Overall Study|Protocol Violation|0|||
161696033|NCT03529773|583935965|FG025|Overall Study|Protocol Violation|0|||
161696034|NCT03529773|583935966|FG026|Overall Study|Protocol Violation|0|||
161696035|NCT03529773|583935967|FG027|Overall Study|Protocol Violation|0|||
161696036|NCT03529773|583935968|FG028|Overall Study|Protocol Violation|0|||
161696037|NCT03529773|583935969|FG029|Overall Study|Protocol Violation|0|||
161696038|NCT03529773|583935970|FG030|Overall Study|Protocol Violation|1|||
161696039|NCT03529773|583935971|FG031|Overall Study|Protocol Violation|0|||
161696040|NCT03529773|583935972|FG032|Overall Study|Protocol Violation|0|||
161696041|NCT03529773|583935973|FG033|Overall Study|Protocol Violation|0|||
161696042|NCT03529773|583935974|FG034|Overall Study|Protocol Violation|0|||
161696043|NCT03529773|583935975|FG035|Overall Study|Protocol Violation|0|||
161696044|NCT03529773|583935976|FG036|Overall Study|Protocol Violation|0|||
161696045|NCT03529773|583935977|FG037|Overall Study|Protocol Violation|0|||
161696046|NCT03529773|583935978|FG038|Overall Study|Protocol Violation|0|||
161696047|NCT03529773|583935979|FG039|Overall Study|Protocol Violation|0|||
161696048|NCT03529773|583935940|FG000|Overall Study|Withdrawal by Subject|0|||
161696049|NCT03529773|583935941|FG001|Overall Study|Withdrawal by Subject|0|||
161696050|NCT03529773|583935942|FG002|Overall Study|Withdrawal by Subject|0|||
161696051|NCT03529773|583935943|FG003|Overall Study|Withdrawal by Subject|0|||
161696052|NCT03529773|583935944|FG004|Overall Study|Withdrawal by Subject|0|||
161696053|NCT03529773|583935945|FG005|Overall Study|Withdrawal by Subject|0|||
161696054|NCT03529773|583935946|FG006|Overall Study|Withdrawal by Subject|0|||
161696055|NCT03529773|583935947|FG007|Overall Study|Withdrawal by Subject|1|||
161696056|NCT03529773|583935948|FG008|Overall Study|Withdrawal by Subject|0|||
161696057|NCT03529773|583935949|FG009|Overall Study|Withdrawal by Subject|1|||
161696058|NCT03529773|583935950|FG010|Overall Study|Withdrawal by Subject|1|||
161696059|NCT03529773|583935951|FG011|Overall Study|Withdrawal by Subject|0|||
161696060|NCT03529773|583935952|FG012|Overall Study|Withdrawal by Subject|0|||
161696061|NCT03529773|583935953|FG013|Overall Study|Withdrawal by Subject|0|||
161696062|NCT03529773|583935954|FG014|Overall Study|Withdrawal by Subject|0|||
161696063|NCT03529773|583935955|FG015|Overall Study|Withdrawal by Subject|3|||
161696064|NCT03529773|583935956|FG016|Overall Study|Withdrawal by Subject|0|||
161696065|NCT03529773|583935957|FG017|Overall Study|Withdrawal by Subject|2|||
161696066|NCT03529773|583935958|FG018|Overall Study|Withdrawal by Subject|3|||
161696067|NCT03529773|583935959|FG019|Overall Study|Withdrawal by Subject|1|||
161696068|NCT03529773|583935960|FG020|Overall Study|Withdrawal by Subject|3|||
161696069|NCT03529773|583935961|FG021|Overall Study|Withdrawal by Subject|1|||
161696070|NCT03529773|583935962|FG022|Overall Study|Withdrawal by Subject|1|||
161696071|NCT03529773|583935963|FG023|Overall Study|Withdrawal by Subject|2|||
161696072|NCT03529773|583935964|FG024|Overall Study|Withdrawal by Subject|2|||
161696073|NCT03529773|583935965|FG025|Overall Study|Withdrawal by Subject|4|||
161696074|NCT03529773|583935966|FG026|Overall Study|Withdrawal by Subject|2|||
161696075|NCT03529773|583935967|FG027|Overall Study|Withdrawal by Subject|1|||
161696076|NCT03529773|583935968|FG028|Overall Study|Withdrawal by Subject|1|||
161696077|NCT03529773|583935969|FG029|Overall Study|Withdrawal by Subject|0|||
161696078|NCT03529773|583935970|FG030|Overall Study|Withdrawal by Subject|0|||
161696079|NCT03529773|583935971|FG031|Overall Study|Withdrawal by Subject|0|||
161696080|NCT03529773|583935972|FG032|Overall Study|Withdrawal by Subject|0|||
161696081|NCT03529773|583935973|FG033|Overall Study|Withdrawal by Subject|0|||
161696082|NCT03529773|583935974|FG034|Overall Study|Withdrawal by Subject|1|||
161696083|NCT03529773|583935975|FG035|Overall Study|Withdrawal by Subject|2|||
161696084|NCT03529773|583935976|FG036|Overall Study|Withdrawal by Subject|0|||
161696085|NCT03529773|583935977|FG037|Overall Study|Withdrawal by Subject|2|||
161696086|NCT03529773|583935978|FG038|Overall Study|Withdrawal by Subject|1|||
161696087|NCT03529773|583935979|FG039|Overall Study|Withdrawal by Subject|1|||
161696088|NCT03529773|583935940|FG000|Overall Study|Screen Failure|0|||
161696089|NCT03529773|583935941|FG001|Overall Study|Screen Failure|0|||
161696090|NCT03529773|583935942|FG002|Overall Study|Screen Failure|0|||
161696091|NCT03529773|583935943|FG003|Overall Study|Screen Failure|0|||
161696092|NCT03529773|583935944|FG004|Overall Study|Screen Failure|0|||
161696093|NCT03529773|583935945|FG005|Overall Study|Screen Failure|0|||
161696094|NCT03529773|583935946|FG006|Overall Study|Screen Failure|0|||
161696095|NCT03529773|583935947|FG007|Overall Study|Screen Failure|0|||
161696096|NCT03529773|583935948|FG008|Overall Study|Screen Failure|0|||
161696097|NCT03529773|583935949|FG009|Overall Study|Screen Failure|0|||
161696098|NCT03529773|583935950|FG010|Overall Study|Screen Failure|0|||
161696099|NCT03529773|583935951|FG011|Overall Study|Screen Failure|0|||
161696100|NCT03529773|583935952|FG012|Overall Study|Screen Failure|0|||
161696101|NCT03529773|583935953|FG013|Overall Study|Screen Failure|0|||
161696102|NCT03529773|583935954|FG014|Overall Study|Screen Failure|0|||
161696103|NCT03529773|583935955|FG015|Overall Study|Screen Failure|0|||
161696104|NCT03529773|583935956|FG016|Overall Study|Screen Failure|0|||
161696105|NCT03529773|583935957|FG017|Overall Study|Screen Failure|0|||
161696106|NCT03529773|583935958|FG018|Overall Study|Screen Failure|0|||
161696107|NCT03529773|583935959|FG019|Overall Study|Screen Failure|0|||
161696108|NCT03529773|583935960|FG020|Overall Study|Screen Failure|0|||
161696109|NCT03529773|583935961|FG021|Overall Study|Screen Failure|0|||
161696110|NCT03529773|583935962|FG022|Overall Study|Screen Failure|0|||
161696111|NCT03529773|583935963|FG023|Overall Study|Screen Failure|0|||
161696112|NCT03529773|583935964|FG024|Overall Study|Screen Failure|0|||
161696113|NCT03529773|583935965|FG025|Overall Study|Screen Failure|0|||
161696114|NCT03529773|583935966|FG026|Overall Study|Screen Failure|0|||
161696115|NCT03529773|583935967|FG027|Overall Study|Screen Failure|0|||
161696116|NCT03529773|583935968|FG028|Overall Study|Screen Failure|0|||
161696117|NCT03529773|583935969|FG029|Overall Study|Screen Failure|0|||
161696118|NCT03529773|583935970|FG030|Overall Study|Screen Failure|0|||
161696119|NCT03529773|583935971|FG031|Overall Study|Screen Failure|0|||
161696120|NCT03529773|583935972|FG032|Overall Study|Screen Failure|0|||
161696121|NCT03529773|583935973|FG033|Overall Study|Screen Failure|0|||
161696122|NCT03529773|583935974|FG034|Overall Study|Screen Failure|0|||
161696123|NCT03529773|583935975|FG035|Overall Study|Screen Failure|0|||
161696124|NCT03529773|583935976|FG036|Overall Study|Screen Failure|1|||
161696125|NCT03529773|583935977|FG037|Overall Study|Screen Failure|1|||
161696126|NCT03529773|583935978|FG038|Overall Study|Screen Failure|0|||
161696127|NCT03529773|583935979|FG039|Overall Study|Screen Failure|1|||
161696128|NCT03529773|583935940|FG000|Overall Study|Randomized but not vaccinated|0|||
161696129|NCT03529773|583935941|FG001|Overall Study|Randomized but not vaccinated|0|||
161696130|NCT03529773|583935942|FG002|Overall Study|Randomized but not vaccinated|0|||
161696131|NCT03529773|583935943|FG003|Overall Study|Randomized but not vaccinated|0|||
161696132|NCT03529773|583935944|FG004|Overall Study|Randomized but not vaccinated|0|||
161696133|NCT03529773|583935945|FG005|Overall Study|Randomized but not vaccinated|0|||
161696134|NCT03529773|583935946|FG006|Overall Study|Randomized but not vaccinated|0|||
161696135|NCT03529773|583935947|FG007|Overall Study|Randomized but not vaccinated|0|||
161696136|NCT03529773|583935948|FG008|Overall Study|Randomized but not vaccinated|0|||
161696137|NCT03529773|583935949|FG009|Overall Study|Randomized but not vaccinated|0|||
161696138|NCT03529773|583935950|FG010|Overall Study|Randomized but not vaccinated|0|||
161696139|NCT03529773|583935951|FG011|Overall Study|Randomized but not vaccinated|0|||
161696140|NCT03529773|583935952|FG012|Overall Study|Randomized but not vaccinated|0|||
161696141|NCT03529773|583935953|FG013|Overall Study|Randomized but not vaccinated|0|||
161696142|NCT03529773|583935954|FG014|Overall Study|Randomized but not vaccinated|0|||
161696143|NCT03529773|583935955|FG015|Overall Study|Randomized but not vaccinated|0|||
161696144|NCT03529773|583935956|FG016|Overall Study|Randomized but not vaccinated|0|||
161696145|NCT03529773|583935957|FG017|Overall Study|Randomized but not vaccinated|1|||
161696146|NCT03529773|583935958|FG018|Overall Study|Randomized but not vaccinated|0|||
161696147|NCT03529773|583935959|FG019|Overall Study|Randomized but not vaccinated|0|||
161696148|NCT03529773|583935960|FG020|Overall Study|Randomized but not vaccinated|0|||
161696149|NCT03529773|583935961|FG021|Overall Study|Randomized but not vaccinated|0|||
161696150|NCT03529773|583935962|FG022|Overall Study|Randomized but not vaccinated|0|||
161696151|NCT03529773|583935963|FG023|Overall Study|Randomized but not vaccinated|0|||
161696152|NCT03529773|583935964|FG024|Overall Study|Randomized but not vaccinated|0|||
161696153|NCT03529773|583935965|FG025|Overall Study|Randomized but not vaccinated|0|||
161696154|NCT03529773|583935966|FG026|Overall Study|Randomized but not vaccinated|0|||
161696155|NCT03529773|583935967|FG027|Overall Study|Randomized but not vaccinated|1|||
161696156|NCT03529773|583935968|FG028|Overall Study|Randomized but not vaccinated|0|||
161696157|NCT03529773|583935969|FG029|Overall Study|Randomized but not vaccinated|0|||
161696158|NCT03529773|583935970|FG030|Overall Study|Randomized but not vaccinated|0|||
161696159|NCT03529773|583935971|FG031|Overall Study|Randomized but not vaccinated|0|||
161696160|NCT03529773|583935972|FG032|Overall Study|Randomized but not vaccinated|0|||
161696161|NCT03529773|583935973|FG033|Overall Study|Randomized but not vaccinated|0|||
161696162|NCT03529773|583935974|FG034|Overall Study|Randomized but not vaccinated|0|||
161696163|NCT03529773|583935975|FG035|Overall Study|Randomized but not vaccinated|0|||
161696164|NCT03529773|583935976|FG036|Overall Study|Randomized but not vaccinated|0|||
161696165|NCT03529773|583935977|FG037|Overall Study|Randomized but not vaccinated|0|||
161696166|NCT03529773|583935978|FG038|Overall Study|Randomized but not vaccinated|0|||
161696167|NCT03529773|583935979|FG039|Overall Study|Randomized but not vaccinated|0|||
161696168|NCT01496066|583935981|FG000|Overall Study|Lost to Follow-up|8|||
161696169|NCT01496066|583935982|FG001|Overall Study|Lost to Follow-up|5|||
161696170|NCT01496066|583935981|FG000|Overall Study|Explant|3|||
161696171|NCT01496066|583935982|FG001|Overall Study|Explant|0|||
161696172|NCT01496066|583935981|FG000|Overall Study|Death|1|||
161696173|NCT01496066|583935982|FG001|Overall Study|Death|4|||
161696174|NCT00253630|583935983|FG000|Overall Study|ineligible|2|||
161696175|NCT03237065|583935984|FG000|Overall Study|Adverse Event|0|||
161696176|NCT03237065|583935985|FG001|Overall Study|Adverse Event|2|||
161696177|NCT03237065|583935984|FG000|Overall Study|Protocol Violation|0|||
161696178|NCT03237065|583935985|FG001|Overall Study|Protocol Violation|1|||
161696179|NCT03237065|583935984|FG000|Overall Study|Withdrawal by Subject|3|||
161696180|NCT03237065|583935985|FG001|Overall Study|Withdrawal by Subject|0|||
161696181|NCT03237065|583935984|FG000|Overall Study|Lost to Follow-up|1|||
161696182|NCT03237065|583935985|FG001|Overall Study|Lost to Follow-up|0|||
161836564|NCT02588950|584444948|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
161696183|NCT03237065|583935984|FG000|Overall Study|Unable to obtain venous access|0|||
161696184|NCT03237065|583935985|FG001|Overall Study|Unable to obtain venous access|1|||
161836565|NCT02588950|584444945|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
161836566|NCT02588950|584444946|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
161696185|NCT00209339|583935986|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
161696186|NCT00209339|583935986|FG000|At 12 Months Follow-up|Death|1|||
161696187|NCT00209339|583935986|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
161696188|NCT00209339|583935986|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
161696189|NCT00209339|583935986|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
161696190|NCT00209339|583935986|FG000|At 24 Months Follow-up|Death|1|||
161696191|NCT00209339|583935986|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
161696192|NCT00209339|583935986|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
161696193|NCT00209339|583935986|FG000|At 4 Years Follow-up|Death|1|||
161696194|NCT00209339|583935986|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
161696195|NCT00209339|583935986|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
161696196|NCT00209339|583935986|FG000|At 5 Years Follow-up|Death|1|||
161696197|NCT02062658|583935988|FG000|Overall Study|Withdrawal by Subject|1|||
161696198|NCT02062658|583935988|FG000|Overall Study|Lack of Efficacy|1|||
161696199|NCT02475655|583935989|FG000|Overall Study|Lost to Follow-up|0|||
161696200|NCT02475655|583935990|FG001|Overall Study|Lost to Follow-up|1|||
161696201|NCT00257010|583935993|FG000|Overall Study|Lack of Efficacy|11|||
161696202|NCT00257010|583935993|FG000|Overall Study|Lost to Follow-up|53|||
161696203|NCT00257010|583935993|FG000|Overall Study|Withdrawal by Subject|34|||
161696204|NCT00257010|583935993|FG000|Overall Study|Adverse Event|10|||
161696205|NCT00257010|583935993|FG000|Overall Study|various|11|||
161696206|NCT00257010|583935993|FG000|Overall Study|no headache reported|9|||
161696207|NCT02574637|583935994|FG000|Double-blind Period|Adverse Event|1|||
161696208|NCT02574637|583935995|FG001|Double-blind Period|Adverse Event|0|||
161696209|NCT02574637|583935996|FG002|Double-blind Period|Adverse Event|0|||
161696210|NCT02574637|583935997|FG003|Double-blind Period|Adverse Event|0|||
161696211|NCT02574637|583935998|FG004|Double-blind Period|Adverse Event|0|||
161696212|NCT02574637|583935999|FG005|Double-blind Period|Adverse Event|0|||
161696213|NCT02574637|583936000|FG006|Double-blind Period|Adverse Event|0|||
161696214|NCT02574637|583936001|FG007|Double-blind Period|Adverse Event|0|||
161696215|NCT02574637|583936002|FG008|Double-blind Period|Adverse Event|0|||
161696216|NCT02574637|583936003|FG009|Double-blind Period|Adverse Event|0|||
161696217|NCT02574637|583935994|FG000|Double-blind Period|Lack of Efficacy|0|||
161696218|NCT02574637|583935995|FG001|Double-blind Period|Lack of Efficacy|0|||
161696219|NCT02574637|583935996|FG002|Double-blind Period|Lack of Efficacy|2|||
161696220|NCT02574637|583935997|FG003|Double-blind Period|Lack of Efficacy|0|||
161696221|NCT02574637|583935998|FG004|Double-blind Period|Lack of Efficacy|0|||
161696222|NCT02574637|583935999|FG005|Double-blind Period|Lack of Efficacy|0|||
161696223|NCT02574637|583936000|FG006|Double-blind Period|Lack of Efficacy|0|||
161696224|NCT02574637|583936001|FG007|Double-blind Period|Lack of Efficacy|0|||
161696225|NCT02574637|583936002|FG008|Double-blind Period|Lack of Efficacy|0|||
161696226|NCT02574637|583936003|FG009|Double-blind Period|Lack of Efficacy|0|||
161696227|NCT02574637|583935994|FG000|Double-blind Period|Protocol Deviation|1|||
161696228|NCT02574637|583935995|FG001|Double-blind Period|Protocol Deviation|0|||
161696229|NCT02574637|583935996|FG002|Double-blind Period|Protocol Deviation|0|||
161696230|NCT02574637|583935997|FG003|Double-blind Period|Protocol Deviation|0|||
161696231|NCT02574637|583935998|FG004|Double-blind Period|Protocol Deviation|0|||
161696232|NCT02574637|583935999|FG005|Double-blind Period|Protocol Deviation|0|||
161696233|NCT02574637|583936000|FG006|Double-blind Period|Protocol Deviation|0|||
161696234|NCT02574637|583936001|FG007|Double-blind Period|Protocol Deviation|0|||
161696235|NCT02574637|583936002|FG008|Double-blind Period|Protocol Deviation|0|||
161696236|NCT02574637|583936003|FG009|Double-blind Period|Protocol Deviation|0|||
161696237|NCT02574637|583935994|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
161696238|NCT02574637|583935995|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
161696239|NCT02574637|583935996|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
161696240|NCT02574637|583935997|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
161696241|NCT02574637|583935998|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
161653240|NCT00568178|583781023|FG002|Open Label Extension|Lost to Follow-up|0|||
161653241|NCT00568178|583781024|FG003|Open Label Extension|Lost to Follow-up|0|||
161653242|NCT00568178|583781025|FG004|Open Label Extension|Lost to Follow-up|6|||
161653243|NCT00568178|583781026|FG005|Open Label Extension|Lost to Follow-up|11|||
161653244|NCT00568178|583781021|FG000|Open Label Extension|Physician Decision|0|||
161653245|NCT00568178|583781022|FG001|Open Label Extension|Physician Decision|0|||
161653246|NCT00568178|583781023|FG002|Open Label Extension|Physician Decision|0|||
161653247|NCT00568178|583781024|FG003|Open Label Extension|Physician Decision|0|||
161653248|NCT00568178|583781025|FG004|Open Label Extension|Physician Decision|9|||
161653249|NCT00568178|583781026|FG005|Open Label Extension|Physician Decision|8|||
161653250|NCT00568178|583781021|FG000|Open Label Extension|Pregnancy|0|||
161653251|NCT00568178|583781022|FG001|Open Label Extension|Pregnancy|0|||
161653252|NCT00568178|583781023|FG002|Open Label Extension|Pregnancy|0|||
161696242|NCT02574637|583935999|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
161696243|NCT02574637|583936000|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
161696244|NCT02574637|583936001|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
161696245|NCT02574637|583936002|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
161696246|NCT02574637|583936003|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
161696247|NCT02574637|583935994|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
161696248|NCT02574637|583935995|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
161696249|NCT02574637|583935996|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
161696250|NCT02574637|583935997|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
161696251|NCT02574637|583935998|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
161696252|NCT02574637|583935999|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
161696253|NCT02574637|583936000|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
161696254|NCT02574637|583936001|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
161696255|NCT02574637|583936002|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
161696256|NCT02574637|583936003|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
161696257|NCT02574637|583935994|FG000|Double-blind Period|Reason Not Specified|0|||
161696258|NCT02574637|583935995|FG001|Double-blind Period|Reason Not Specified|0|||
161696259|NCT02574637|583935996|FG002|Double-blind Period|Reason Not Specified|0|||
161696260|NCT02574637|583935997|FG003|Double-blind Period|Reason Not Specified|1|||
161696261|NCT02574637|583935998|FG004|Double-blind Period|Reason Not Specified|0|||
161696262|NCT02574637|583935999|FG005|Double-blind Period|Reason Not Specified|0|||
161696263|NCT02574637|583936000|FG006|Double-blind Period|Reason Not Specified|0|||
161696264|NCT02574637|583936001|FG007|Double-blind Period|Reason Not Specified|0|||
161696265|NCT02574637|583936002|FG008|Double-blind Period|Reason Not Specified|0|||
161696266|NCT02574637|583936003|FG009|Double-blind Period|Reason Not Specified|0|||
161696267|NCT02574637|583935994|FG000|Open-label (OL) Period|Adverse Event|0|||
161696268|NCT02574637|583935995|FG001|Open-label (OL) Period|Adverse Event|0|||
161696269|NCT02574637|583935996|FG002|Open-label (OL) Period|Adverse Event|0|||
161696270|NCT02574637|583935997|FG003|Open-label (OL) Period|Adverse Event|0|||
161696271|NCT02574637|583935998|FG004|Open-label (OL) Period|Adverse Event|0|||
161696272|NCT02574637|583935999|FG005|Open-label (OL) Period|Adverse Event|0|||
161696273|NCT02574637|583936000|FG006|Open-label (OL) Period|Adverse Event|0|||
161696274|NCT02574637|583936001|FG007|Open-label (OL) Period|Adverse Event|0|||
161696275|NCT02574637|583936002|FG008|Open-label (OL) Period|Adverse Event|1|||
161696276|NCT02574637|583936003|FG009|Open-label (OL) Period|Adverse Event|0|||
161696277|NCT02574637|583935994|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
161696278|NCT02574637|583935995|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
161696279|NCT02574637|583935996|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
161696280|NCT02574637|583935997|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
161696281|NCT02574637|583935998|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
161696282|NCT02574637|583935999|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
161696283|NCT02574637|583936000|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
161696284|NCT02574637|583936001|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
161696285|NCT02574637|583936002|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
161696286|NCT02574637|583936003|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
161696287|NCT02574637|583935994|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696288|NCT02574637|583935995|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696289|NCT02574637|583935996|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696290|NCT02574637|583935997|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696291|NCT02574637|583935998|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696292|NCT02574637|583935999|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161696293|NCT02574637|583936000|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
161696294|NCT02574637|583936001|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161696295|NCT02574637|583936002|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161696296|NCT02574637|583936003|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696297|NCT00662792|583936004|FG000|Period 1|Personal Reasons|0|||
161696298|NCT00662792|583936005|FG001|Period 1|Personal Reasons|0|||
161696299|NCT00662792|583936006|FG002|Period 1|Personal Reasons|1|||
161696300|NCT00662792|583936007|FG003|Period 1|Personal Reasons|0|||
161696301|NCT00662792|583936004|FG000|Period 1|Refused continuing medication|0|||
161696302|NCT00662792|583936005|FG001|Period 1|Refused continuing medication|1|||
161696303|NCT00662792|583936006|FG002|Period 1|Refused continuing medication|1|||
161696304|NCT00662792|583936007|FG003|Period 1|Refused continuing medication|0|||
161696305|NCT00662792|583936004|FG000|Period 1|Lost to Follow-up|1|||
161696306|NCT00662792|583936005|FG001|Period 1|Lost to Follow-up|0|||
161696307|NCT00662792|583936006|FG002|Period 1|Lost to Follow-up|0|||
161696308|NCT00662792|583936007|FG003|Period 1|Lost to Follow-up|0|||
161696309|NCT00662792|583936004|FG000|Period 1|Other adverse event (AE)|0|||
161696310|NCT00662792|583936005|FG001|Period 1|Other adverse event (AE)|2|||
161696311|NCT00662792|583936006|FG002|Period 1|Other adverse event (AE)|0|||
161696312|NCT00662792|583936007|FG003|Period 1|Other adverse event (AE)|0|||
161696313|NCT00662792|583936004|FG000|Period 1|Worsening of disease under study (AE)|1|||
161696314|NCT00662792|583936005|FG001|Period 1|Worsening of disease under study (AE)|3|||
161696315|NCT00662792|583936006|FG002|Period 1|Worsening of disease under study (AE)|2|||
161696316|NCT00662792|583936007|FG003|Period 1|Worsening of disease under study (AE)|0|||
161696317|NCT00662792|583936004|FG000|Period 1|Not treated|0|||
161696318|NCT00662792|583936005|FG001|Period 1|Not treated|1|||
161696319|NCT00662792|583936006|FG002|Period 1|Not treated|0|||
161696320|NCT00662792|583936007|FG003|Period 1|Not treated|0|||
161696321|NCT00662792|583936004|FG000|Period 2|Worsening of disease under study|1|||
161696322|NCT00662792|583936005|FG001|Period 2|Worsening of disease under study|0|||
161696323|NCT00662792|583936006|FG002|Period 2|Worsening of disease under study|0|||
161696324|NCT00662792|583936007|FG003|Period 2|Worsening of disease under study|3|||
161696325|NCT00662792|583936004|FG000|Period 3|Refused continuing medication|1|||
161696326|NCT00662792|583936005|FG001|Period 3|Refused continuing medication|0|||
161696327|NCT00662792|583936006|FG002|Period 3|Refused continuing medication|1|||
161696328|NCT00662792|583936007|FG003|Period 3|Refused continuing medication|0|||
161696329|NCT00662792|583936004|FG000|Period 3|Other adverse event (AE)|0|||
161696330|NCT00662792|583936005|FG001|Period 3|Other adverse event (AE)|0|||
161696331|NCT00662792|583936006|FG002|Period 3|Other adverse event (AE)|1|||
161696332|NCT00662792|583936007|FG003|Period 3|Other adverse event (AE)|1|||
161696333|NCT00662792|583936004|FG000|Period 4|Refused continuing medication|0|||
161696334|NCT00662792|583936005|FG001|Period 4|Refused continuing medication|1|||
161696335|NCT00662792|583936006|FG002|Period 4|Refused continuing medication|0|||
161696336|NCT00662792|583936007|FG003|Period 4|Refused continuing medication|0|||
161696337|NCT00662792|583936004|FG000|Period 4|Other adverse event (AE)|1|||
161696338|NCT00662792|583936005|FG001|Period 4|Other adverse event (AE)|0|||
161696339|NCT00662792|583936006|FG002|Period 4|Other adverse event (AE)|0|||
161696340|NCT00662792|583936007|FG003|Period 4|Other adverse event (AE)|0|||
161696341|NCT00662792|583936004|FG000|Period 4|Worsening of disease under study (AE)|0|||
161696342|NCT00662792|583936005|FG001|Period 4|Worsening of disease under study (AE)|0|||
161696343|NCT00662792|583936006|FG002|Period 4|Worsening of disease under study (AE)|0|||
161696344|NCT00662792|583936007|FG003|Period 4|Worsening of disease under study (AE)|1|||
161696345|NCT04029519|583936008|FG000|Overall Study|Protocol Violation|1|||
161696346|NCT04029519|583936008|FG000|Overall Study|Withdrawal by Subject|3|||
161696347|NCT04029519|583936008|FG000|Overall Study|Lost to Follow-up|1|||
161696348|NCT02347176|583936015|FG000|Overall Study|Lost to Follow-up|2|||
161696349|NCT02347176|583936016|FG001|Overall Study|Lost to Follow-up|3|||
161696350|NCT02347176|583936017|FG002|Overall Study|Lost to Follow-up|1|||
161696351|NCT02347176|583936018|FG003|Overall Study|Lost to Follow-up|1|||
161696352|NCT02347176|583936015|FG000|Overall Study|Withdrawal by Subject|9|||
161696353|NCT02347176|583936016|FG001|Overall Study|Withdrawal by Subject|5|||
161696354|NCT02347176|583936017|FG002|Overall Study|Withdrawal by Subject|5|||
161696355|NCT02347176|583936018|FG003|Overall Study|Withdrawal by Subject|3|||
161696356|NCT02347176|583936015|FG000|Overall Study|Other|1|||
161696357|NCT02347176|583936016|FG001|Overall Study|Other|2|||
161696358|NCT02347176|583936017|FG002|Overall Study|Other|2|||
161696359|NCT02347176|583936018|FG003|Overall Study|Other|0|||
161696360|NCT00699907|583936027|FG000|Overall Study|Withdrawal by Subject|2|||
161696361|NCT00699907|583936028|FG001|Overall Study|Withdrawal by Subject|1|||
161696362|NCT00699907|583936029|FG002|Overall Study|Withdrawal by Subject|0|||
161696363|NCT00699907|583936027|FG000|Overall Study|No usable sample|0|||
161696364|NCT00699907|583936028|FG001|Overall Study|No usable sample|9|||
161836567|NCT02588950|584444947|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
161696365|NCT00699907|583936029|FG002|Overall Study|No usable sample|8|||
161696366|NCT01081795|583936030|FG000|Overall Study|Adverse Event|18|||
161696367|NCT01081795|583936031|FG001|Overall Study|Adverse Event|23|||
161696368|NCT01081795|583936032|FG002|Overall Study|Adverse Event|6|||
161696369|NCT01081795|583936030|FG000|Overall Study|Lack of Efficacy|7|||
161696370|NCT01081795|583936031|FG001|Overall Study|Lack of Efficacy|5|||
161696371|NCT01081795|583936032|FG002|Overall Study|Lack of Efficacy|19|||
161696372|NCT01081795|583936030|FG000|Overall Study|Subject's schedule|1|||
161696373|NCT01081795|583936031|FG001|Overall Study|Subject's schedule|1|||
161696374|NCT01081795|583936032|FG002|Overall Study|Subject's schedule|2|||
161696375|NCT01081795|583936030|FG000|Overall Study|Revocation of informed consent|2|||
161696376|NCT01081795|583936031|FG001|Overall Study|Revocation of informed consent|0|||
161696377|NCT01081795|583936032|FG002|Overall Study|Revocation of informed consent|0|||
161696378|NCT01081795|583936030|FG000|Overall Study|Ineligible for participation|1|||
161696379|NCT01081795|583936031|FG001|Overall Study|Ineligible for participation|0|||
161696380|NCT01081795|583936032|FG002|Overall Study|Ineligible for participation|0|||
161696381|NCT01081795|583936030|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
161696382|NCT01081795|583936031|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
161696383|NCT01081795|583936032|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
161696384|NCT01081795|583936030|FG000|Overall Study|Using drug with restricted days of use|2|||
161696385|NCT01081795|583936031|FG001|Overall Study|Using drug with restricted days of use|3|||
161696386|NCT01081795|583936032|FG002|Overall Study|Using drug with restricted days of use|2|||
161696387|NCT01081795|583936030|FG000|Overall Study|Other|1|||
161696388|NCT01081795|583936031|FG001|Overall Study|Other|2|||
161696389|NCT01081795|583936032|FG002|Overall Study|Other|0|||
161696390|NCT02462473|583936033|FG000|Overall Study|Death|1|||
161696391|NCT02462473|583936033|FG000|Overall Study|Other|3|||
161696392|NCT01536860|583936035|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
161696393|NCT01536860|583936036|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
161696394|NCT01536860|583936037|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
161696395|NCT01164722|583936038|FG000|Overall Study|Adverse Event|0|||
161696396|NCT01164722|583936039|FG001|Overall Study|Adverse Event|1|||
161696397|NCT01164722|583936038|FG000|Overall Study|Withdrawal by Subject|3|||
161696398|NCT01164722|583936039|FG001|Overall Study|Withdrawal by Subject|4|||
161696399|NCT01164722|583936038|FG000|Overall Study|Lost to Follow-up|3|||
161696400|NCT01164722|583936039|FG001|Overall Study|Lost to Follow-up|6|||
161696401|NCT01164722|583936038|FG000|Overall Study|met protocol criteria for non-treatment|11|||
161696402|NCT01164722|583936039|FG001|Overall Study|met protocol criteria for non-treatment|1|||
161696403|NCT01164722|583936038|FG000|Overall Study|enrolled on other study, concomitant med|1|||
161696404|NCT01164722|583936039|FG001|Overall Study|enrolled on other study, concomitant med|3|||
161696405|NCT03889639|583936041|FG000|Overall Study|Withdrawal by Subject|0|||
161696406|NCT03889639|583936042|FG001|Overall Study|Withdrawal by Subject|0|||
161696407|NCT03889639|583936043|FG002|Overall Study|Withdrawal by Subject|0|||
161696408|NCT03889639|583936044|FG003|Overall Study|Withdrawal by Subject|0|||
161696409|NCT03889639|583936045|FG004|Overall Study|Withdrawal by Subject|0|||
161696410|NCT03889639|583936046|FG005|Overall Study|Withdrawal by Subject|0|||
161696411|NCT03889639|583936047|FG006|Overall Study|Withdrawal by Subject|0|||
161696412|NCT03889639|583936048|FG007|Overall Study|Withdrawal by Subject|1|||
161696413|NCT01707693|583936049|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
161696414|NCT01707693|583936050|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
161696415|NCT01707693|583936049|FG000|Overall Study Allocation|Protocol Violation|4|||
161696416|NCT01707693|583936050|FG001|Overall Study Allocation|Protocol Violation|3|||
161696417|NCT01707693|583936049|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
161696418|NCT01707693|583936050|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
161696419|NCT01707693|583936049|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
161696420|NCT01707693|583936050|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
161696421|NCT02556255|583936052|FG000|Overall Study|Lost to Follow-up|4|||
161696422|NCT00993031|583936053|FG000|Overall Study|Death|0|||
161696423|NCT00993031|583936054|FG001|Overall Study|Death|1|||
161696424|NCT00993031|583936053|FG000|Overall Study|Physician Decision|0|||
161696425|NCT00993031|583936054|FG001|Overall Study|Physician Decision|2|||
161696426|NCT00993031|583936053|FG000|Overall Study|Withdrawal by Subject|3|||
161696427|NCT00993031|583936054|FG001|Overall Study|Withdrawal by Subject|3|||
161696428|NCT00993031|583936053|FG000|Overall Study|Lost to Follow-up|19|||
161696429|NCT00993031|583936054|FG001|Overall Study|Lost to Follow-up|13|||
161696430|NCT03115151|583936055|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
161696431|NCT03115151|583936056|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
161696432|NCT03115151|583936055|FG000|Overall Study|Epidural catheter removal|1|||
161696433|NCT03115151|583936056|FG001|Overall Study|Epidural catheter removal|0|||
161696434|NCT03115151|583936055|FG000|Overall Study|Withdrawal by Subject|0|||
161696435|NCT03115151|583936056|FG001|Overall Study|Withdrawal by Subject|1|||
161696436|NCT03115151|583936055|FG000|Overall Study|Intervention not received according to the protocol.|1|||
161696437|NCT03115151|583936056|FG001|Overall Study|Intervention not received according to the protocol.|1|||
161696438|NCT03115151|583936055|FG000|Overall Study|Physician Decision|1|||
161696439|NCT03115151|583936056|FG001|Overall Study|Physician Decision|0|||
161696440|NCT03115151|583936055|FG000|Overall Study|Randomization not applied|1|||
161696441|NCT03115151|583936056|FG001|Overall Study|Randomization not applied|1|||
161696442|NCT01834729|583936062|FG000|Overall Study|Did not return bowel diaries|0|||
161696443|NCT01834729|583936063|FG001|Overall Study|Did not return bowel diaries|0|||
161696444|NCT01834729|583936064|FG002|Overall Study|Did not return bowel diaries|3|||
161696445|NCT01834729|583936065|FG003|Overall Study|Did not return bowel diaries|0|||
161696446|NCT01834729|583936062|FG000|Overall Study|Withdrawal by Subject|1|||
161696447|NCT01834729|583936063|FG001|Overall Study|Withdrawal by Subject|1|||
161696448|NCT01834729|583936064|FG002|Overall Study|Withdrawal by Subject|0|||
161696449|NCT01834729|583936065|FG003|Overall Study|Withdrawal by Subject|0|||
161696450|NCT01834729|583936062|FG000|Overall Study|Adverse Event|0|||
161696451|NCT01834729|583936063|FG001|Overall Study|Adverse Event|0|||
161696452|NCT01834729|583936064|FG002|Overall Study|Adverse Event|0|||
161696453|NCT01834729|583936065|FG003|Overall Study|Adverse Event|2|||
161696454|NCT01543087|583936066|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
161696455|NCT01543087|583936067|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
161696456|NCT01543087|583936068|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
161696457|NCT01543087|583936069|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
161696458|NCT01543087|583936070|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
161696459|NCT01543087|583936071|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
161696460|NCT01543087|583936066|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
161696461|NCT01543087|583936067|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161696462|NCT01543087|583936068|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
161696463|NCT01543087|583936069|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
161696464|NCT01543087|583936070|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161696465|NCT01543087|583936071|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161696466|NCT01543087|583936066|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
161696467|NCT01543087|583936067|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
161696468|NCT01543087|583936068|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
161696469|NCT01543087|583936069|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
161696470|NCT01543087|583936070|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
161696471|NCT01543087|583936071|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
161696472|NCT01543087|583936066|FG000|Stage 1 (48 Months)|Other than specified|5|||
161696473|NCT01543087|583936067|FG001|Stage 1 (48 Months)|Other than specified|0|||
161696474|NCT01543087|583936068|FG002|Stage 1 (48 Months)|Other than specified|9|||
161696475|NCT01543087|583936069|FG003|Stage 1 (48 Months)|Other than specified|0|||
161696476|NCT01543087|583936070|FG004|Stage 1 (48 Months)|Other than specified|0|||
161696477|NCT01543087|583936071|FG005|Stage 1 (48 Months)|Other than specified|0|||
161696478|NCT01543087|583936066|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
161696479|NCT01543087|583936067|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
161696480|NCT01543087|583936068|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
161696481|NCT01543087|583936069|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
161696482|NCT01543087|583936070|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
161696483|NCT01543087|583936071|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
161696484|NCT01543087|583936066|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696485|NCT01543087|583936067|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
161696486|NCT01543087|583936068|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696487|NCT01543087|583936069|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696488|NCT01543087|583936070|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
161696489|NCT01543087|583936071|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696490|NCT01543087|583936066|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696491|NCT01543087|583936067|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696492|NCT01543087|583936068|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
161696493|NCT01543087|583936069|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696494|NCT01543087|583936070|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696495|NCT01543087|583936071|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696496|NCT02682901|583936072|FG000|Overall Study|Adverse Event|10|||
161696497|NCT02682901|583936073|FG001|Overall Study|Adverse Event|3|||
161696498|NCT02682901|583936072|FG000|Overall Study|Lack of Efficacy|0|||
161696499|NCT02682901|583936073|FG001|Overall Study|Lack of Efficacy|1|||
161696500|NCT03713944|583936074|FG000|Study Treatment|Patient non-compliance|1|||
161696501|NCT03713944|583936074|FG000|Study Treatment|Alternative Cancer Therapy|3|||
161696502|NCT03713944|583936074|FG000|Study Treatment|Disease Progression|18|||
161696503|NCT03713944|583936074|FG000|Study Treatment|AE/Side Effects/Complications|2|||
161696504|NCT03713944|583936074|FG000|Study Treatment|Death|2|||
161696505|NCT03713944|583936074|FG000|Study Treatment|Withdrawal by Subject|1|||
161696506|NCT03713944|583936074|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
161696507|NCT03713944|583936074|FG000|Study Treatment|Symptomatic Deterioration|2|||
161696508|NCT03713944|583936074|FG000|Follow up|Withdrawal by Subject|2|||
161696509|NCT03713944|583936074|FG000|Follow up|Death|11|||
161696510|NCT03713944|583936074|FG000|Follow up|Study Terminated|3|||
161696511|NCT04484285|583937808|FG000|Overall Study|Unable to operate stimulator|3|||
161696512|NCT04484285|583937809|FG001|Overall Study|Unable to operate stimulator|0|||
161696513|NCT01072344|583937810|FG000|Overall Study|Relasped-reached end point|7|||
161696514|NCT01072344|583937811|FG001|Overall Study|Relasped-reached end point|12|||
161696515|NCT01072344|583937810|FG000|Overall Study|Protocol Violation|1|||
161696516|NCT01072344|583937811|FG001|Overall Study|Protocol Violation|2|||
161696517|NCT01072344|583937810|FG000|Overall Study|Lost to Follow-up|3|||
161696518|NCT01072344|583937811|FG001|Overall Study|Lost to Follow-up|4|||
161696519|NCT00804687|583937812|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
161836568|NCT02588950|584444948|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
161696520|NCT00804687|583937813|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
161696521|NCT00804687|583937814|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
161696522|NCT00804687|583937815|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
161696523|NCT00804687|583937816|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
161696524|NCT00804687|583937817|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
161696525|NCT00804687|583937812|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696526|NCT00804687|583937813|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696527|NCT00804687|583937814|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696528|NCT00804687|583937815|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696529|NCT00804687|583937816|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
161696530|NCT00804687|583937817|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696531|NCT00804687|583937812|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696532|NCT00804687|583937813|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696533|NCT00804687|583937814|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
161696534|NCT00804687|583937815|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696535|NCT00804687|583937816|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696536|NCT00804687|583937817|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696537|NCT00804687|583937812|FG000|Period 5: Treatment Period|Positive drug test|1|||
161696538|NCT00804687|583937813|FG001|Period 5: Treatment Period|Positive drug test|0|||
161696539|NCT00804687|583937814|FG002|Period 5: Treatment Period|Positive drug test|0|||
161696540|NCT00804687|583937815|FG003|Period 5: Treatment Period|Positive drug test|0|||
161696541|NCT00804687|583937816|FG004|Period 5: Treatment Period|Positive drug test|0|||
161696542|NCT00804687|583937817|FG005|Period 5: Treatment Period|Positive drug test|0|||
161696543|NCT00716976|583937820|FG000|Overall Study|Adverse Event|2|||
161696544|NCT00716976|583937821|FG001|Overall Study|Adverse Event|0|||
161696545|NCT00716976|583937820|FG000|Overall Study|Death|1|||
161696546|NCT00716976|583937821|FG001|Overall Study|Death|0|||
161696547|NCT00716976|583937820|FG000|Overall Study|Physician Decision|2|||
161696548|NCT00716976|583937821|FG001|Overall Study|Physician Decision|2|||
161696549|NCT00716976|583937820|FG000|Overall Study|Withdrawal by Subject|5|||
161696550|NCT00716976|583937821|FG001|Overall Study|Withdrawal by Subject|1|||
161696551|NCT00716976|583937820|FG000|Overall Study|Premature discontinuation cisplatin|5|||
161696552|NCT00716976|583937821|FG001|Overall Study|Premature discontinuation cisplatin|4|||
161696553|NCT00716976|583937820|FG000|Overall Study|Radiation during protocol|1|||
161696554|NCT00716976|583937821|FG001|Overall Study|Radiation during protocol|0|||
161696555|NCT00716976|583937820|FG000|Overall Study|Ineligibles|4|||
161696556|NCT00716976|583937821|FG001|Overall Study|Ineligibles|2|||
161696557|NCT00805740|583937823|FG000|Overall Study|Death|7|||
161696558|NCT00805740|583937824|FG001|Overall Study|Death|4|||
161696559|NCT00805740|583937823|FG000|Overall Study|Withdrawal by Subject|1|||
161696560|NCT00805740|583937824|FG001|Overall Study|Withdrawal by Subject|0|||
161696561|NCT00805740|583937823|FG000|Overall Study|Lost to Follow-up|1|||
161696562|NCT00805740|583937824|FG001|Overall Study|Lost to Follow-up|0|||
161696563|NCT00805740|583937823|FG000|Overall Study|Randomized, but not treated|2|||
161696564|NCT00805740|583937824|FG001|Overall Study|Randomized, but not treated|0|||
161696565|NCT05227690|583937832|FG000|Overall Study|Adverse Event|5|||
161696566|NCT05227690|583937833|FG001|Overall Study|Adverse Event|6|||
161696567|NCT05227690|583937834|FG002|Overall Study|Adverse Event|10|||
161696568|NCT05227690|583937832|FG000|Overall Study|Lack of Efficacy|2|||
161696569|NCT05227690|583937833|FG001|Overall Study|Lack of Efficacy|4|||
161696570|NCT05227690|583937834|FG002|Overall Study|Lack of Efficacy|1|||
161696571|NCT05227690|583937832|FG000|Overall Study|Physician Decision|6|||
161696572|NCT05227690|583937833|FG001|Overall Study|Physician Decision|0|||
161696573|NCT05227690|583937834|FG002|Overall Study|Physician Decision|4|||
161696574|NCT05227690|583937832|FG000|Overall Study|Withdrawal of consent|28|||
161696575|NCT05227690|583937833|FG001|Overall Study|Withdrawal of consent|27|||
161696576|NCT05227690|583937834|FG002|Overall Study|Withdrawal of consent|21|||
161696577|NCT05227690|583937832|FG000|Overall Study|Other, not specified|2|||
161696578|NCT05227690|583937833|FG001|Overall Study|Other, not specified|2|||
161696579|NCT05227690|583937834|FG002|Overall Study|Other, not specified|1|||
161696580|NCT00975156|583937835|FG000|Overall Study|Protocol Violation|0|||
161696581|NCT00975156|583937836|FG001|Overall Study|Protocol Violation|1|||
161696582|NCT01534676|583937842|FG000|Overall Study|Study closed due to poor enrollment|2|||
161696583|NCT01534676|583937843|FG001|Overall Study|Study closed due to poor enrollment|1|||
161696584|NCT02634580|583937844|FG000|Double-blind Treatment Period|Subject Request|1|||
161696585|NCT02634580|583937845|FG001|Double-blind Treatment Period|Subject Request|0|||
161696586|NCT02634580|583937846|FG002|Double-blind Treatment Period|Subject Request|1|||
161696587|NCT02634580|583937847|FG003|Double-blind Treatment Period|Subject Request|1|||
161696588|NCT02634580|583937844|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161696589|NCT02634580|583937845|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
161696590|NCT02634580|583937846|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161696591|NCT02634580|583937847|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
161696592|NCT02908880|583937849|FG000|Overall Study|Lost to Follow-up|4|||
161696593|NCT02908880|583937849|FG000|Overall Study|Explantation of the device|1|||
161696594|NCT02908880|583937849|FG000|Overall Study|Withdrawal by Subject|17|||
161696595|NCT02908880|583937849|FG000|Overall Study|Death|5|||
161696596|NCT00424827|583937854|FG000|Overall Study|Adverse Event|1|||
161696597|NCT05689047|583937857|FG000|Overall Study|Lost to Follow-up|0|||
161696598|NCT05689047|583937858|FG001|Overall Study|Lost to Follow-up|1|||
161696599|NCT05689047|583937857|FG000|Overall Study|Protocol Deviation|1|||
161696600|NCT05689047|583937858|FG001|Overall Study|Protocol Deviation|0|||
161696601|NCT03132636|583937859|FG000|Overall Study|Adverse Event|1|||
161696602|NCT03132636|583937860|FG001|Overall Study|Adverse Event|2|||
161696603|NCT03132636|583937859|FG000|Overall Study|Death|4|||
161696604|NCT03132636|583937860|FG001|Overall Study|Death|7|||
161696605|NCT03132636|583937859|FG000|Overall Study|Lost to Follow-up|3|||
161696606|NCT03132636|583937860|FG001|Overall Study|Lost to Follow-up|2|||
161696607|NCT03132636|583937859|FG000|Overall Study|Non compliance with protocol by participant|1|||
161696608|NCT03132636|583937860|FG001|Overall Study|Non compliance with protocol by participant|1|||
161696609|NCT03132636|583937859|FG000|Overall Study|Subject decision|1|||
161696610|NCT03132636|583937860|FG001|Overall Study|Subject decision|9|||
161696611|NCT03132636|583937859|FG000|Overall Study|Sponsor decision|0|||
161696612|NCT03132636|583937860|FG001|Overall Study|Sponsor decision|1|||
161696613|NCT03132636|583937859|FG000|Overall Study|Physician Decision|1|||
161696614|NCT03132636|583937860|FG001|Overall Study|Physician Decision|0|||
161696615|NCT03132636|583937859|FG000|Overall Study|Progressive disease|33|||
161696616|NCT03132636|583937860|FG001|Overall Study|Progressive disease|36|||
161696617|NCT03132636|583937859|FG000|Overall Study|Withdrawal of consent|2|||
161696618|NCT03132636|583937860|FG001|Overall Study|Withdrawal of consent|5|||
161696619|NCT03132636|583937859|FG000|Overall Study|Did not re-consent|1|||
161696620|NCT03132636|583937860|FG001|Overall Study|Did not re-consent|0|||
161696621|NCT03132636|583937859|FG000|Overall Study|Lost insurance coverage|1|||
161696622|NCT03132636|583937860|FG001|Overall Study|Lost insurance coverage|0|||
161696623|NCT03132636|583937859|FG000|Overall Study|Related to radiological outcomes|0|||
161696624|NCT03132636|583937860|FG001|Overall Study|Related to radiological outcomes|1|||
161696625|NCT03132636|583937859|FG000|Overall Study|Unable to come to site for continued visits|0|||
161696626|NCT03132636|583937860|FG001|Overall Study|Unable to come to site for continued visits|1|||
161696627|NCT03286842|583937861|FG000|Overall Study|Patients rolled over to another study|80|||
161696628|NCT01285908|583937867|FG000|Baseline Measurement|unable to insert catheter|1|||
161696629|NCT01285908|583937868|FG001|Baseline Measurement|unable to insert catheter|0|||
161696630|NCT01285908|583937869|FG002|Baseline Measurement|unable to insert catheter|0|||
161696631|NCT01285908|583937867|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
161696632|NCT01285908|583937868|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
161696633|NCT01285908|583937869|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
161696634|NCT01285908|583937867|FG000|Baseline Measurement|unable to tolerate procedure|1|||
161696635|NCT01285908|583937868|FG001|Baseline Measurement|unable to tolerate procedure|0|||
161696636|NCT01285908|583937869|FG002|Baseline Measurement|unable to tolerate procedure|0|||
161696637|NCT01562548|583937870|FG000|Overall Study|Lost to Follow-up|0|||
161836569|NCT00652028|584444951|FG000|Overall Study|Adverse Event|1|||
161696638|NCT01562548|583937871|FG001|Overall Study|Lost to Follow-up|0|||
161696639|NCT01562548|583937872|FG002|Overall Study|Lost to Follow-up|1|||
161696640|NCT01562548|583937873|FG003|Overall Study|Lost to Follow-up|0|||
161696641|NCT03655756|583937874|FG000|Overall Study|Death|1|||
161696642|NCT02161211|583937877|FG000|Overall Study|Lost to Follow-up|21|||
161696643|NCT02161211|583937878|FG001|Overall Study|Lost to Follow-up|27|||
161696644|NCT02161211|583937879|FG002|Overall Study|Lost to Follow-up|21|||
161836570|NCT00652028|584444952|FG001|Overall Study|Adverse Event|0|||
161696645|NCT02161211|583937877|FG000|Overall Study|Dropped|12|||
161696646|NCT02161211|583937878|FG001|Overall Study|Dropped|5|||
161696647|NCT02161211|583937879|FG002|Overall Study|Dropped|9|||
161696648|NCT01703858|583937880|FG000|Overall Study|Withdrawal by Subject|0|||
161696649|NCT01703858|583937881|FG001|Overall Study|Withdrawal by Subject|1|||
161696650|NCT01703858|583937882|FG002|Overall Study|Withdrawal by Subject|0|||
161696651|NCT03403192|583937883|FG000|Overall Study|Lost to Follow-up|1|||
161696652|NCT03403192|583937884|FG001|Overall Study|Lost to Follow-up|2|||
161696653|NCT03403192|583937885|FG002|Overall Study|Lost to Follow-up|0|||
161696654|NCT03403192|583937886|FG003|Overall Study|Lost to Follow-up|0|||
161696655|NCT03403192|583937883|FG000|Overall Study|Unable to respond|0|||
161696656|NCT03403192|583937884|FG001|Overall Study|Unable to respond|1|||
161696657|NCT03403192|583937885|FG002|Overall Study|Unable to respond|0|||
161696658|NCT03403192|583937886|FG003|Overall Study|Unable to respond|0|||
161696659|NCT03403192|583937883|FG000|Overall Study|Incomplete|3|||
161696660|NCT03403192|583937884|FG001|Overall Study|Incomplete|1|||
161696661|NCT03403192|583937885|FG002|Overall Study|Incomplete|3|||
161696662|NCT03403192|583937886|FG003|Overall Study|Incomplete|6|||
161696663|NCT04673786|583937889|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
161696664|NCT04673786|583937890|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
161696665|NCT04673786|583937891|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
161696666|NCT04673786|583937889|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
161696667|NCT04673786|583937890|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
161696668|NCT04673786|583937891|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
161696669|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
161696670|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
161696671|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
161696672|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
161696673|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
161696674|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
161696675|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
161696676|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
161696677|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
161696678|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
161696679|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
161696680|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
161696681|NCT01325428|583937892|FG000|Part A|Progressive disease according to RECIST|9|||
161696682|NCT01325428|583937892|FG000|Part A|Clinical signs, symptoms of progression|2|||
161696683|NCT01325428|583937892|FG000|Part A|Other adverse event|1|||
161696684|NCT01325428|583937892|FG000|Part A|Refused continue taking trial medication|2|||
161696685|NCT01325428|583937892|FG000|Part A|Other reason not defined above|2|||
161696686|NCT01325428|583937892|FG000|Part B|Refused continue taking trial medication|2|||
161696687|NCT01325428|583937892|FG000|Part B|Other reason not defined above|1|||
161696688|NCT04849780|583937893|FG000|Period 1|Covid-19 Related|1|||
161696689|NCT04849780|583937894|FG001|Period 1|Covid-19 Related|0|||
161696690|NCT04849780|583937893|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
161696691|NCT04849780|583937894|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
161696692|NCT04849780|583937893|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
161696693|NCT04849780|583937894|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
161696694|NCT00725075|583937895|FG000|Overall Study|Use of Excluded Medication|0|||
161696695|NCT00725075|583937896|FG001|Overall Study|Use of Excluded Medication|1|||
161696696|NCT00725075|583937897|FG002|Overall Study|Use of Excluded Medication|0|||
161696697|NCT00725075|583937895|FG000|Overall Study|Protocol Violation|0|||
161696698|NCT00725075|583937896|FG001|Overall Study|Protocol Violation|0|||
161696699|NCT00725075|583937897|FG002|Overall Study|Protocol Violation|1|||
161696700|NCT00725075|583937895|FG000|Overall Study|Lost to Follow-up|1|||
161696701|NCT00725075|583937896|FG001|Overall Study|Lost to Follow-up|0|||
161696702|NCT00725075|583937897|FG002|Overall Study|Lost to Follow-up|0|||
161696703|NCT00725075|583937895|FG000|Overall Study|Withdrawal by Subject|4|||
161696704|NCT00725075|583937896|FG001|Overall Study|Withdrawal by Subject|5|||
161696705|NCT00725075|583937897|FG002|Overall Study|Withdrawal by Subject|4|||
161696706|NCT00725075|583937895|FG000|Overall Study|Adverse Event|2|||
161696707|NCT00725075|583937896|FG001|Overall Study|Adverse Event|1|||
161696708|NCT00725075|583937897|FG002|Overall Study|Adverse Event|1|||
161696709|NCT00725075|583937895|FG000|Overall Study|Worsening of Disease|2|||
161696710|NCT00725075|583937896|FG001|Overall Study|Worsening of Disease|1|||
161696711|NCT00725075|583937897|FG002|Overall Study|Worsening of Disease|2|||
161696712|NCT00725075|583937895|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
161696713|NCT00725075|583937896|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161696714|NCT00725075|583937897|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
161696715|NCT00725075|583937895|FG000|Overall Study|Other|1|||
161696716|NCT00725075|583937896|FG001|Overall Study|Other|0|||
161696717|NCT00725075|583937897|FG002|Overall Study|Other|0|||
161696718|NCT01298492|583937898|FG000|Overall Study|Death|2|||
161696719|NCT01298492|583937898|FG000|Overall Study|Insufficient Clinical Response|22|||
161696720|NCT01298492|583937898|FG000|Overall Study|Lost to Follow-up|12|||
161696721|NCT01298492|583937898|FG000|Overall Study|Withdrawal by Subject|47|||
161696722|NCT01298492|583937898|FG000|Overall Study|Other (Unspecified)|7|||
161696723|NCT01298492|583937898|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
161696724|NCT01298492|583937898|FG000|Overall Study|Protocol Violation|2|||
161696725|NCT01298492|583937898|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
161696726|NCT01298492|583937898|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
161696727|NCT02340663|583937899|FG000|Overall Study|Lost to Follow-up|1|||
161696728|NCT02340663|583937900|FG001|Overall Study|Lost to Follow-up|0|||
161696729|NCT02340663|583937899|FG000|Overall Study|Protocol Violation|1|||
161696730|NCT02340663|583937900|FG001|Overall Study|Protocol Violation|0|||
161696731|NCT02340663|583937899|FG000|Overall Study|Withdrawal by Subject|3|||
161696732|NCT02340663|583937900|FG001|Overall Study|Withdrawal by Subject|1|||
161696733|NCT02902120|583937902|FG000|Overall Study|Lack of Efficacy|1|||
161696734|NCT01353703|583937903|FG000|Overall Study|Migrated/moved from study area|1|||
161696735|NCT01353703|583937904|FG001|Overall Study|Migrated/moved from study area|0|||
161696736|NCT03298022|583937905|FG000|Overall Study|Lack of Efficacy|4|||
161696737|NCT03298022|583937905|FG000|Overall Study|Withdrawal by Subject|7|||
161696738|NCT03298022|583937905|FG000|Overall Study|Adverse Event|1|||
161696739|NCT03298022|583937905|FG000|Overall Study|disease relapse|1|||
161696740|NCT03694925|583937906|FG000|Overall Study|Inadequate laboratory testing|0|||
161696741|NCT03694925|583937907|FG001|Overall Study|Inadequate laboratory testing|3|||
161696742|NCT03694925|583937908|FG002|Overall Study|Inadequate laboratory testing|0|||
161696743|NCT01422239|583937909|FG000|Overall Study|Lost to Follow-up|4|||
161696744|NCT01422239|583937910|FG001|Overall Study|Lost to Follow-up|3|||
161696745|NCT03033875|583937914|FG000|Overall Study|Withdrawal by Subject|5|||
161696746|NCT03033875|583937915|FG001|Overall Study|Withdrawal by Subject|9|||
161696747|NCT03033875|583937916|FG002|Overall Study|Withdrawal by Subject|4|||
161696748|NCT03033875|583937914|FG000|Overall Study|Other|14|||
161696749|NCT03033875|583937915|FG001|Overall Study|Other|15|||
161696750|NCT03033875|583937916|FG002|Overall Study|Other|8|||
161696751|NCT03595553|583937920|FG000|Overall Study|Withdrawal by Subject|20|||
161696752|NCT03595553|583937921|FG001|Overall Study|Withdrawal by Subject|8|||
161696753|NCT03595553|583937920|FG000|Overall Study|Physician Decision|3|||
161696754|NCT03595553|583937921|FG001|Overall Study|Physician Decision|2|||
161696755|NCT03595553|583937920|FG000|Overall Study|Adverse Event|2|||
161696756|NCT03595553|583937921|FG001|Overall Study|Adverse Event|5|||
161696757|NCT03595553|583937920|FG000|Overall Study|Death|24|||
161696758|NCT03595553|583937921|FG001|Overall Study|Death|22|||
161696759|NCT03595553|583937920|FG000|Overall Study|Lost to Follow-up|6|||
161696760|NCT03595553|583937921|FG001|Overall Study|Lost to Follow-up|7|||
161696761|NCT03595553|583937920|FG000|Overall Study|Other as indicated in CSR|3|||
161696762|NCT03595553|583937921|FG001|Overall Study|Other as indicated in CSR|3|||
161696763|NCT03595553|583937920|FG000|Overall Study|Sponsor Decision|0|||
161696764|NCT03595553|583937921|FG001|Overall Study|Sponsor Decision|1|||
161696765|NCT03467958|583937922|FG000|Overall Study|Adverse Event|20|||
161696766|NCT03467958|583937923|FG001|Overall Study|Adverse Event|32|||
161696767|NCT03467958|583937924|FG002|Overall Study|Adverse Event|5|||
161696768|NCT03467958|583937925|FG003|Overall Study|Adverse Event|3|||
161696769|NCT03467958|583937926|FG004|Overall Study|Adverse Event|3|||
161696770|NCT03467958|583937927|FG005|Overall Study|Adverse Event|3|||
161696771|NCT03467958|583937928|FG006|Overall Study|Adverse Event|6|||
161696772|NCT03467958|583937929|FG007|Overall Study|Adverse Event|5|||
161696773|NCT03467958|583937930|FG008|Overall Study|Adverse Event|0|||
161696774|NCT03467958|583937922|FG000|Overall Study|Lack of Efficacy|59|||
161696775|NCT03467958|583937923|FG001|Overall Study|Lack of Efficacy|120|||
161696776|NCT03467958|583937924|FG002|Overall Study|Lack of Efficacy|6|||
161696777|NCT03467958|583937925|FG003|Overall Study|Lack of Efficacy|9|||
161696778|NCT03467958|583937926|FG004|Overall Study|Lack of Efficacy|8|||
161696779|NCT03467958|583937927|FG005|Overall Study|Lack of Efficacy|9|||
161696780|NCT03467958|583937928|FG006|Overall Study|Lack of Efficacy|11|||
161696781|NCT03467958|583937929|FG007|Overall Study|Lack of Efficacy|9|||
161696782|NCT03467958|583937930|FG008|Overall Study|Lack of Efficacy|3|||
161696783|NCT03467958|583937922|FG000|Overall Study|Lost to Follow-up|1|||
161696784|NCT03467958|583937923|FG001|Overall Study|Lost to Follow-up|2|||
161836571|NCT00652028|584444953|FG002|Overall Study|Adverse Event|0|||
161696785|NCT03467958|583937924|FG002|Overall Study|Lost to Follow-up|1|||
161696786|NCT03467958|583937925|FG003|Overall Study|Lost to Follow-up|0|||
161696787|NCT03467958|583937926|FG004|Overall Study|Lost to Follow-up|4|||
161696788|NCT03467958|583937927|FG005|Overall Study|Lost to Follow-up|0|||
161696789|NCT03467958|583937928|FG006|Overall Study|Lost to Follow-up|0|||
161696790|NCT03467958|583937929|FG007|Overall Study|Lost to Follow-up|0|||
161696791|NCT03467958|583937930|FG008|Overall Study|Lost to Follow-up|0|||
161696792|NCT03467958|583937922|FG000|Overall Study|Other reasons|8|||
161696793|NCT03467958|583937923|FG001|Overall Study|Other reasons|14|||
161696794|NCT03467958|583937924|FG002|Overall Study|Other reasons|2|||
161696795|NCT03467958|583937925|FG003|Overall Study|Other reasons|1|||
161696796|NCT03467958|583937926|FG004|Overall Study|Other reasons|4|||
161696797|NCT03467958|583937927|FG005|Overall Study|Other reasons|0|||
161696798|NCT03467958|583937928|FG006|Overall Study|Other reasons|1|||
161696799|NCT03467958|583937929|FG007|Overall Study|Other reasons|0|||
161696800|NCT03467958|583937930|FG008|Overall Study|Other reasons|1|||
161696801|NCT03467958|583937922|FG000|Overall Study|Pregnancy|1|||
161696802|NCT03467958|583937923|FG001|Overall Study|Pregnancy|0|||
161696803|NCT03467958|583937924|FG002|Overall Study|Pregnancy|0|||
161696804|NCT03467958|583937925|FG003|Overall Study|Pregnancy|0|||
161696805|NCT03467958|583937926|FG004|Overall Study|Pregnancy|0|||
161696806|NCT03467958|583937927|FG005|Overall Study|Pregnancy|1|||
161653253|NCT00568178|583781024|FG003|Open Label Extension|Pregnancy|0|||
161653254|NCT00568178|583781025|FG004|Open Label Extension|Pregnancy|0|||
161653255|NCT00568178|583781026|FG005|Open Label Extension|Pregnancy|1|||
161653256|NCT00568178|583781021|FG000|Open Label Extension|Progressive Disease|0|||
161653257|NCT00568178|583781022|FG001|Open Label Extension|Progressive Disease|0|||
161653258|NCT00568178|583781023|FG002|Open Label Extension|Progressive Disease|0|||
161653259|NCT00568178|583781024|FG003|Open Label Extension|Progressive Disease|0|||
161653260|NCT00568178|583781025|FG004|Open Label Extension|Progressive Disease|3|||
161653261|NCT00568178|583781026|FG005|Open Label Extension|Progressive Disease|1|||
161653262|NCT00568178|583781021|FG000|Open Label Extension|Termination of Trial|0|||
161653263|NCT00568178|583781022|FG001|Open Label Extension|Termination of Trial|0|||
161653264|NCT00568178|583781023|FG002|Open Label Extension|Termination of Trial|0|||
161653265|NCT00568178|583781024|FG003|Open Label Extension|Termination of Trial|0|||
161653266|NCT00568178|583781025|FG004|Open Label Extension|Termination of Trial|45|||
161653267|NCT00568178|583781026|FG005|Open Label Extension|Termination of Trial|47|||
161653268|NCT00568178|583781021|FG000|Open Label Extension|Withdrawal by Subject|0|||
161653269|NCT00568178|583781022|FG001|Open Label Extension|Withdrawal by Subject|0|||
161653270|NCT00568178|583781023|FG002|Open Label Extension|Withdrawal by Subject|0|||
161653271|NCT00568178|583781024|FG003|Open Label Extension|Withdrawal by Subject|0|||
161653272|NCT00568178|583781025|FG004|Open Label Extension|Withdrawal by Subject|4|||
161653273|NCT00568178|583781026|FG005|Open Label Extension|Withdrawal by Subject|4|||
161653274|NCT01332630|583781027|FG000|Overall Study|Withdrawal by Subject|3|||
161653275|NCT04476251|583781030|FG000|Overall Study|Not treated|1|||
161653276|NCT01008553|583781031|FG000|Period 1 (Titration Period)|Physician Decision|2|||
161653277|NCT01008553|583781032|FG001|Period 1 (Titration Period)|Physician Decision|0|||
161653278|NCT01008553|583781033|FG002|Period 1 (Titration Period)|Physician Decision|0|||
161653279|NCT01008553|583781031|FG000|Period 1 (Titration Period)|Adverse Event|33|||
161653280|NCT01008553|583781032|FG001|Period 1 (Titration Period)|Adverse Event|0|||
161653281|NCT01008553|583781033|FG002|Period 1 (Titration Period)|Adverse Event|0|||
161653282|NCT01008553|583781031|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
161653283|NCT01008553|583781032|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161653284|NCT01008553|583781033|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161653285|NCT01008553|583781031|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
161653286|NCT01008553|583781032|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
161653287|NCT01008553|583781033|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
161653288|NCT01008553|583781031|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
161653289|NCT01008553|583781032|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161653290|NCT01008553|583781033|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161653291|NCT01008553|583781031|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
161653292|NCT01008553|583781032|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
161653293|NCT01008553|583781033|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
161653294|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
161653295|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
161653296|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
161653297|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
161653298|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
161653299|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
161653300|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
161653301|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
161653302|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
161653303|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
161653304|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
161653305|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
161653306|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
161653307|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
161653308|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
161653309|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
161653310|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
161653311|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
161696807|NCT03467958|583937928|FG006|Overall Study|Pregnancy|0|||
161696808|NCT03467958|583937929|FG007|Overall Study|Pregnancy|0|||
161696809|NCT03467958|583937930|FG008|Overall Study|Pregnancy|0|||
161696810|NCT03467958|583937922|FG000|Overall Study|Study terminated by sponsor|65|||
161696811|NCT03467958|583937923|FG001|Overall Study|Study terminated by sponsor|117|||
161696812|NCT03467958|583937924|FG002|Overall Study|Study terminated by sponsor|45|||
161696813|NCT03467958|583937925|FG003|Overall Study|Study terminated by sponsor|64|||
161696814|NCT03467958|583937926|FG004|Overall Study|Study terminated by sponsor|66|||
161696815|NCT03467958|583937927|FG005|Overall Study|Study terminated by sponsor|17|||
161696816|NCT03467958|583937928|FG006|Overall Study|Study terminated by sponsor|11|||
161696817|NCT03467958|583937929|FG007|Overall Study|Study terminated by sponsor|5|||
161696818|NCT03467958|583937930|FG008|Overall Study|Study terminated by sponsor|5|||
161696819|NCT03467958|583937922|FG000|Overall Study|Withdrawal by Subject|25|||
161696820|NCT03467958|583937923|FG001|Overall Study|Withdrawal by Subject|44|||
161696821|NCT03467958|583937924|FG002|Overall Study|Withdrawal by Subject|7|||
161696822|NCT03467958|583937925|FG003|Overall Study|Withdrawal by Subject|8|||
161696823|NCT03467958|583937926|FG004|Overall Study|Withdrawal by Subject|6|||
161696824|NCT03467958|583937927|FG005|Overall Study|Withdrawal by Subject|8|||
161696825|NCT03467958|583937928|FG006|Overall Study|Withdrawal by Subject|4|||
161696826|NCT03467958|583937929|FG007|Overall Study|Withdrawal by Subject|1|||
161696827|NCT03467958|583937930|FG008|Overall Study|Withdrawal by Subject|4|||
161696828|NCT02286947|583937931|FG000|Overall Study|Withdrawal by Subject|2|||
161696829|NCT00730639|583937932|FG000|Overall Study|Adverse Event|3|||
161696830|NCT00730639|583937933|FG001|Overall Study|Adverse Event|0|||
161696831|NCT00730639|583937934|FG002|Overall Study|Adverse Event|9|||
161696832|NCT00730639|583937935|FG003|Overall Study|Adverse Event|8|||
161696833|NCT00730639|583937936|FG004|Overall Study|Adverse Event|23|||
161696834|NCT00730639|583937932|FG000|Overall Study|Complete Response|0|||
161696835|NCT00730639|583937933|FG001|Overall Study|Complete Response|0|||
161696836|NCT00730639|583937934|FG002|Overall Study|Complete Response|2|||
161696837|NCT00730639|583937935|FG003|Overall Study|Complete Response|2|||
161696838|NCT00730639|583937936|FG004|Overall Study|Complete Response|1|||
161696839|NCT00730639|583937932|FG000|Overall Study|Completed Maximum Cycles|0|||
161696840|NCT00730639|583937933|FG001|Overall Study|Completed Maximum Cycles|0|||
161696841|NCT00730639|583937934|FG002|Overall Study|Completed Maximum Cycles|11|||
161696842|NCT00730639|583937935|FG003|Overall Study|Completed Maximum Cycles|3|||
161696843|NCT00730639|583937936|FG004|Overall Study|Completed Maximum Cycles|6|||
161696844|NCT00730639|583937932|FG000|Overall Study|Death|0|||
161696845|NCT00730639|583937933|FG001|Overall Study|Death|0|||
161696846|NCT00730639|583937934|FG002|Overall Study|Death|0|||
161696847|NCT00730639|583937935|FG003|Overall Study|Death|0|||
161696848|NCT00730639|583937936|FG004|Overall Study|Death|2|||
161696849|NCT00730639|583937932|FG000|Overall Study|Disease Progression|12|||
161696850|NCT00730639|583937933|FG001|Overall Study|Disease Progression|13|||
161696851|NCT00730639|583937934|FG002|Overall Study|Disease Progression|48|||
161696852|NCT00730639|583937935|FG003|Overall Study|Disease Progression|32|||
161696853|NCT00730639|583937936|FG004|Overall Study|Disease Progression|88|||
161696854|NCT00730639|583937932|FG000|Overall Study|non-specified|0|||
161696855|NCT00730639|583937933|FG001|Overall Study|non-specified|0|||
161696856|NCT00730639|583937934|FG002|Overall Study|non-specified|4|||
161836572|NCT00652028|584444954|FG003|Overall Study|Adverse Event|0|||
161836573|NCT00652028|584444951|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
161836574|NCT00652028|584444952|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
161836575|NCT00652028|584444953|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
161836576|NCT00652028|584444954|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
161836577|NCT00652028|584444951|FG000|Overall Study|Physician Decision|0|||
161836578|NCT00652028|584444952|FG001|Overall Study|Physician Decision|0|||
161836579|NCT00652028|584444953|FG002|Overall Study|Physician Decision|1|||
161836580|NCT00652028|584444954|FG003|Overall Study|Physician Decision|0|||
161836581|NCT02072824|584444955|FG000|Overall Study|Insufficient clinical response|1|||
161836582|NCT02072824|584444956|FG001|Overall Study|Insufficient clinical response|0|||
161696857|NCT00730639|583937935|FG003|Overall Study|non-specified|2|||
161696858|NCT00730639|583937936|FG004|Overall Study|non-specified|3|||
161696859|NCT00730639|583937932|FG000|Overall Study|Protocol Violation|0|||
161696860|NCT00730639|583937933|FG001|Overall Study|Protocol Violation|0|||
161836583|NCT02072824|584444957|FG002|Overall Study|Insufficient clinical response|1|||
161696861|NCT00730639|583937934|FG002|Overall Study|Protocol Violation|1|||
161696862|NCT00730639|583937935|FG003|Overall Study|Protocol Violation|0|||
161696863|NCT00730639|583937936|FG004|Overall Study|Protocol Violation|0|||
161696864|NCT00730639|583937932|FG000|Overall Study|Withdrawal by Subject|0|||
161696865|NCT00730639|583937933|FG001|Overall Study|Withdrawal by Subject|0|||
161696866|NCT00730639|583937934|FG002|Overall Study|Withdrawal by Subject|6|||
161696867|NCT00730639|583937935|FG003|Overall Study|Withdrawal by Subject|3|||
161696868|NCT00730639|583937936|FG004|Overall Study|Withdrawal by Subject|4|||
161696869|NCT00730639|583937932|FG000|Overall Study|Treatment on-going|2|||
161696870|NCT00730639|583937933|FG001|Overall Study|Treatment on-going|5|||
161696871|NCT00730639|583937934|FG002|Overall Study|Treatment on-going|5|||
161696872|NCT00730639|583937935|FG003|Overall Study|Treatment on-going|4|||
161696873|NCT00730639|583937936|FG004|Overall Study|Treatment on-going|4|||
161836584|NCT02072824|584444955|FG000|Overall Study|No longer willing to participate|1|||
161696874|NCT00516737|583937942|FG000|Overall Study|Lost to Follow-up|2|||
161696875|NCT00516737|583937943|FG001|Overall Study|Lost to Follow-up|0|||
161696876|NCT00516737|583937942|FG000|Overall Study|Physician Decision|0|||
161696877|NCT00516737|583937943|FG001|Overall Study|Physician Decision|1|||
161696878|NCT00516737|583937942|FG000|Overall Study|Withdrawal by Subject|0|||
161696879|NCT00516737|583937943|FG001|Overall Study|Withdrawal by Subject|1|||
161696880|NCT00516737|583937942|FG000|Overall Study|Lack of Qualifying Event|9|||
161696881|NCT00516737|583937943|FG001|Overall Study|Lack of Qualifying Event|6|||
161696882|NCT00848354|583937944|FG000|Phase 1|Adverse Event|5|||
161696883|NCT00848354|583937945|FG001|Phase 1|Adverse Event|4|||
161696884|NCT00848354|583937944|FG000|Phase 1|Discontinuation of study by sponsor|2|||
161696885|NCT00848354|583937945|FG001|Phase 1|Discontinuation of study by sponsor|1|||
161696886|NCT00848354|583937944|FG000|Phase 1|Failed to return|0|||
161696887|NCT00848354|583937945|FG001|Phase 1|Failed to return|1|||
161696888|NCT00848354|583937944|FG000|Phase 1|Lost to Follow-up|1|||
161696889|NCT00848354|583937945|FG001|Phase 1|Lost to Follow-up|1|||
161696890|NCT00848354|583937944|FG000|Phase 1|Unspecified Reason|1|||
161696891|NCT00848354|583937945|FG001|Phase 1|Unspecified Reason|1|||
161696892|NCT00848354|583937944|FG000|Phase 1|Protocol Violation|1|||
161696893|NCT00848354|583937945|FG001|Phase 1|Protocol Violation|1|||
161696894|NCT00848354|583937944|FG000|Phase 1|Withdrawal by Subject|2|||
161696895|NCT00848354|583937945|FG001|Phase 1|Withdrawal by Subject|4|||
161696896|NCT00848354|583937944|FG000|Phase 1|Lack of Efficacy|0|||
161696897|NCT00848354|583937945|FG001|Phase 1|Lack of Efficacy|1|||
161696898|NCT00848354|583937944|FG000|Phase 2 Year 1|Adverse Event|7|||
161696899|NCT00848354|583937945|FG001|Phase 2 Year 1|Adverse Event|2|||
161696900|NCT00848354|583937944|FG000|Phase 2 Year 1|Death|1|||
161696901|NCT00848354|583937945|FG001|Phase 2 Year 1|Death|0|||
161696902|NCT00848354|583937944|FG000|Phase 2 Year 1|Failed to Return|1|||
161696903|NCT00848354|583937945|FG001|Phase 2 Year 1|Failed to Return|1|||
161696904|NCT00848354|583937944|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
161696905|NCT00848354|583937945|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
161696906|NCT00848354|583937944|FG000|Phase 2 Year 1|Unspecified Reason|3|||
161696907|NCT00848354|583937945|FG001|Phase 2 Year 1|Unspecified Reason|0|||
161696908|NCT00848354|583937944|FG000|Phase 2 Year 1|Protocol Violation|4|||
161696909|NCT00848354|583937945|FG001|Phase 2 Year 1|Protocol Violation|1|||
161696910|NCT00848354|583937944|FG000|Phase 2 Year 1|Subject Request|1|||
161696911|NCT00848354|583937945|FG001|Phase 2 Year 1|Subject Request|2|||
161696912|NCT00848354|583937944|FG000|Phase 2 Year 2|Adverse Event|12|||
161696913|NCT00848354|583937945|FG001|Phase 2 Year 2|Adverse Event|2|||
161696914|NCT00848354|583937944|FG000|Phase 2 Year 2|Death|2|||
161696915|NCT00848354|583937945|FG001|Phase 2 Year 2|Death|0|||
161696916|NCT00848354|583937944|FG000|Phase 2 Year 2|Failed to return|3|||
161696917|NCT00848354|583937945|FG001|Phase 2 Year 2|Failed to return|0|||
161696918|NCT00848354|583937944|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
161696919|NCT00848354|583937945|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
161696920|NCT00848354|583937944|FG000|Phase 2 Year 2|Unspecified Reason|1|||
161696921|NCT00848354|583937945|FG001|Phase 2 Year 2|Unspecified Reason|0|||
161696922|NCT00848354|583937944|FG000|Phase 2 Year 2|Protocol Violation|1|||
161696923|NCT00848354|583937945|FG001|Phase 2 Year 2|Protocol Violation|1|||
161696924|NCT00848354|583937944|FG000|Phase 2 Year 2|Subject Request|1|||
161696925|NCT00848354|583937945|FG001|Phase 2 Year 2|Subject Request|1|||
161696926|NCT00848354|583937944|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
161696927|NCT00848354|583937945|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
161696928|NCT00512798|583937946|FG000|Overall Study|Death|0|||
161696929|NCT00512798|583937947|FG001|Overall Study|Death|3|||
161696930|NCT00512798|583937946|FG000|Overall Study|Adverse Event|2|||
161696931|NCT00512798|583937947|FG001|Overall Study|Adverse Event|4|||
161696932|NCT00512798|583937946|FG000|Overall Study|Progression of disease|14|||
161696933|NCT00512798|583937947|FG001|Overall Study|Progression of disease|20|||
161696934|NCT00512798|583937946|FG000|Overall Study|Withdrawal by Subject|3|||
161696935|NCT00512798|583937947|FG001|Overall Study|Withdrawal by Subject|0|||
161696936|NCT00915343|583937948|FG000|Part B - Open Label Period|Treatment switch|0|||
161696937|NCT00915343|583937949|FG001|Part B - Open Label Period|Treatment switch|0|||
161696938|NCT00915343|583937950|FG002|Part B - Open Label Period|Treatment switch|1|||
161696939|NCT00915343|583937948|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
161696940|NCT00915343|583937949|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
161696941|NCT00915343|583937950|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
161696942|NCT03551743|583937951|FG000|Overall Study|Adverse Event|1|||
161696943|NCT03551743|583937952|FG001|Overall Study|Adverse Event|0|||
161696944|NCT03551743|583937953|FG002|Overall Study|Adverse Event|0|||
161696945|NCT03551743|583937954|FG003|Overall Study|Adverse Event|0|||
161696946|NCT03551743|583937951|FG000|Overall Study|Withdrawal by Subject|1|||
161696947|NCT03551743|583937952|FG001|Overall Study|Withdrawal by Subject|0|||
161696948|NCT03551743|583937953|FG002|Overall Study|Withdrawal by Subject|0|||
161696949|NCT03551743|583937954|FG003|Overall Study|Withdrawal by Subject|0|||
161696950|NCT02317562|583937955|FG000|Overall Study|Physician Decision|1|||
161696951|NCT02317562|583937955|FG000|Overall Study|early termination of the study|8|||
161696952|NCT02317562|583937955|FG000|Overall Study|Lack of Efficacy|4|||
161696953|NCT02317562|583937955|FG000|Overall Study|Withdrawal by Subject|1|||
161696954|NCT00911989|583937956|FG000|Overall Study|Adverse Event|1|||
161696955|NCT03434977|583937957|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
161696956|NCT03434977|583937958|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
161696957|NCT01314716|583937959|FG000|Double-Blind Phase|Randomized but not treated|1|||
161696958|NCT01314716|583937960|FG001|Double-Blind Phase|Randomized but not treated|1|||
161696959|NCT01314716|583937959|FG000|Double-Blind Phase|Adverse Event|10|||
161696960|NCT01314716|583937960|FG001|Double-Blind Phase|Adverse Event|4|||
161696961|NCT01314716|583937959|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
161696962|NCT01314716|583937960|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161696963|NCT01314716|583937959|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161696964|NCT01314716|583937960|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161696965|NCT01314716|583937959|FG000|Double-Blind Phase|Sponsor request|1|||
161696966|NCT01314716|583937960|FG001|Double-Blind Phase|Sponsor request|2|||
161696967|NCT01314716|583937959|FG000|Double-Blind Phase|Physician Decision|0|||
161696968|NCT01314716|583937960|FG001|Double-Blind Phase|Physician Decision|1|||
161696969|NCT01314716|583937959|FG000|Open-Label Phase|Adverse Event|4|||
161696970|NCT01314716|583937960|FG001|Open-Label Phase|Adverse Event|6|||
161696971|NCT01314716|583937959|FG000|Open-Label Phase|Withdrawal by Subject|1|||
161696972|NCT01314716|583937960|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161696973|NCT01314716|583937959|FG000|Open-Label Phase|Physician Decision|5|||
161696974|NCT01314716|583937960|FG001|Open-Label Phase|Physician Decision|4|||
161696975|NCT01928381|583937963|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
161696976|NCT01928381|583937964|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696977|NCT01928381|583937965|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696978|NCT01928381|583937966|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696979|NCT01928381|583937967|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696980|NCT01928381|583937968|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696981|NCT01928381|583937969|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696982|NCT01928381|583937963|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
161696983|NCT01928381|583937964|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
161696984|NCT01928381|583937965|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
161696985|NCT01928381|583937966|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
161696986|NCT01928381|583937967|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
161696987|NCT01928381|583937968|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
161696988|NCT01928381|583937969|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
161696989|NCT01928381|583937963|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
161696990|NCT01928381|583937964|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696991|NCT01928381|583937965|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696992|NCT01928381|583937966|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696993|NCT01928381|583937967|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696994|NCT01928381|583937968|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696995|NCT01928381|583937969|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696996|NCT01928381|583937963|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
161696997|NCT01928381|583937964|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
161696998|NCT01928381|583937965|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
161696999|NCT01928381|583937966|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
161697000|NCT01928381|583937967|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
161697001|NCT01928381|583937968|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
161697002|NCT01928381|583937969|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
161697003|NCT01928381|583937963|FG000|Part 1 - Pain Training|Protocol Violation|1|||
161697004|NCT01928381|583937964|FG001|Part 1 - Pain Training|Protocol Violation|0|||
161697005|NCT01928381|583937965|FG002|Part 1 - Pain Training|Protocol Violation|0|||
161697006|NCT01928381|583937966|FG003|Part 1 - Pain Training|Protocol Violation|0|||
161697007|NCT01928381|583937967|FG004|Part 1 - Pain Training|Protocol Violation|0|||
161697008|NCT01928381|583937968|FG005|Part 1 - Pain Training|Protocol Violation|0|||
161697009|NCT01928381|583937969|FG006|Part 1 - Pain Training|Protocol Violation|0|||
161697010|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
161697011|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697012|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697013|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697014|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697015|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697016|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697017|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
161697018|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161836585|NCT02072824|584444956|FG001|Overall Study|No longer willing to participate|0|||
161697019|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697020|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161653312|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161653313|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161653314|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
161653315|NCT01008553|583781031|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
161653316|NCT01008553|583781032|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
161653317|NCT01008553|583781033|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
161653318|NCT00574873|583781036|FG000|Overall Study|Withdrawal by Subject|18|||
161653319|NCT00574873|583781037|FG001|Overall Study|Withdrawal by Subject|19|||
161653320|NCT00574873|583781036|FG000|Overall Study|Investigator request|18|||
161653321|NCT00574873|583781037|FG001|Overall Study|Investigator request|8|||
161653322|NCT00574873|583781036|FG000|Overall Study|Death|15|||
161653323|NCT00574873|583781037|FG001|Overall Study|Death|14|||
161653324|NCT00574873|583781036|FG000|Overall Study|Lost to Follow-up|14|||
161653325|NCT00574873|583781037|FG001|Overall Study|Lost to Follow-up|5|||
161653326|NCT00574873|583781036|FG000|Overall Study|Other|40|||
161653327|NCT00574873|583781037|FG001|Overall Study|Other|4|||
161653328|NCT00574873|583781036|FG000|Overall Study|Discontinuation of study by sponsor|5|||
161653329|NCT00574873|583781037|FG001|Overall Study|Discontinuation of study by sponsor|199|||
161653330|NCT00574873|583781036|FG000|Overall Study|Blank, site closed per local regulations|2|||
161653331|NCT00574873|583781037|FG001|Overall Study|Blank, site closed per local regulations|2|||
161653332|NCT00574873|583781036|FG000|Overall Study|Extension Study|126|||
161653333|NCT00574873|583781037|FG001|Overall Study|Extension Study|0|||
161653334|NCT00581555|583781038|FG000|Overall Study|Adverse Event|4|||
161653335|NCT00581555|583781039|FG001|Overall Study|Adverse Event|3|||
161653336|NCT00581555|583781038|FG000|Overall Study|Physician Decision|3|||
161653337|NCT00581555|583781039|FG001|Overall Study|Physician Decision|2|||
161653338|NCT00581555|583781038|FG000|Overall Study|Withdrawal by Subject|18|||
161653339|NCT00581555|583781039|FG001|Overall Study|Withdrawal by Subject|9|||
161653340|NCT00581555|583781038|FG000|Overall Study|Lost to Follow-up|2|||
161653341|NCT00581555|583781039|FG001|Overall Study|Lost to Follow-up|2|||
161653342|NCT00581555|583781038|FG000|Overall Study|Other reasons|16|||
161653343|NCT00581555|583781039|FG001|Overall Study|Other reasons|4|||
161653344|NCT01638429|583781040|FG000|Overall Study|Withdrawal by Subject|1|||
161653345|NCT02591953|583781041|FG000|Overall Study|Lost to Follow-up|6|||
161653346|NCT02591953|583781042|FG001|Overall Study|Lost to Follow-up|6|||
161653347|NCT02060370|583781043|FG000|Overall Study|Physician Decision|1|||
161653348|NCT00731133|583781044|FG000|Overall Study|Withdrawal by Subject|10|||
161653349|NCT00943852|583781045|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653350|NCT00943852|583781046|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653351|NCT00943852|583781047|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653352|NCT00943852|583781048|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
161653353|NCT00943852|583781049|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653354|NCT00943852|583781050|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653355|NCT00943852|583781051|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653356|NCT00943852|583781052|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653357|NCT00943852|583781053|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653358|NCT00943852|583781054|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161653359|NCT00943852|583781045|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653360|NCT00943852|583781046|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653361|NCT00943852|583781047|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653362|NCT00943852|583781048|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653363|NCT00943852|583781049|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653364|NCT00943852|583781050|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
161653365|NCT00943852|583781051|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653366|NCT00943852|583781052|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653367|NCT00943852|583781053|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653368|NCT00943852|583781054|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161653369|NCT00943852|583781045|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653370|NCT00943852|583781046|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653371|NCT00943852|583781047|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653372|NCT00943852|583781048|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653373|NCT00943852|583781049|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653374|NCT00943852|583781050|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161697021|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697022|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697023|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697024|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
161697025|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697026|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697027|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697028|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697029|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697030|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697031|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
161697032|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697033|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697034|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697035|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697036|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697037|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697038|NCT01928381|583937963|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697039|NCT01928381|583937964|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697040|NCT01928381|583937965|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
161697041|NCT01928381|583937966|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697042|NCT01928381|583937967|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697043|NCT01928381|583937968|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697044|NCT01928381|583937969|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697045|NCT01928381|583937963|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697046|NCT01928381|583937964|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697047|NCT01928381|583937965|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
161697048|NCT01928381|583937966|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697049|NCT01928381|583937967|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697050|NCT01928381|583937968|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697051|NCT01928381|583937969|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697052|NCT01928381|583937963|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697053|NCT01928381|583937964|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697054|NCT01928381|583937965|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697055|NCT01928381|583937966|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697056|NCT01928381|583937967|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697057|NCT01928381|583937968|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
161697058|NCT01928381|583937969|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
161697059|NCT01928381|583937963|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
161697060|NCT01928381|583937964|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
161697061|NCT01928381|583937965|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
161697062|NCT01928381|583937966|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
161697063|NCT01928381|583937967|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
161697064|NCT01928381|583937968|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
161697065|NCT01928381|583937969|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
161697066|NCT01928381|583937963|FG000|Washout First Intervention|Protocol Violation|0|||
161697067|NCT01928381|583937964|FG001|Washout First Intervention|Protocol Violation|0|||
161697068|NCT01928381|583937965|FG002|Washout First Intervention|Protocol Violation|0|||
161697069|NCT01928381|583937966|FG003|Washout First Intervention|Protocol Violation|0|||
161697070|NCT01928381|583937967|FG004|Washout First Intervention|Protocol Violation|1|||
161697071|NCT01928381|583937968|FG005|Washout First Intervention|Protocol Violation|0|||
161697072|NCT01928381|583937969|FG006|Washout First Intervention|Protocol Violation|0|||
161697073|NCT01928381|583937963|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697074|NCT01928381|583937964|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
161697075|NCT01928381|583937965|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697076|NCT01928381|583937966|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
161836586|NCT02072824|584444957|FG002|Overall Study|No longer willing to participate|1|||
161836587|NCT02072824|584444955|FG000|Overall Study|Medication error|0|||
161836588|NCT02072824|584444956|FG001|Overall Study|Medication error|1|||
161836589|NCT02072824|584444957|FG002|Overall Study|Medication error|0|||
161836590|NCT02072824|584444955|FG000|Overall Study|Adverse Event|0|||
161836591|NCT02072824|584444956|FG001|Overall Study|Adverse Event|0|||
161836592|NCT02072824|584444957|FG002|Overall Study|Adverse Event|1|||
161836593|NCT01859130|584444958|FG000|Overall Study|Death|4|||
161836594|NCT01859130|584444958|FG000|Overall Study|Lost to Follow-up|16|||
161836595|NCT01859130|584444958|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
161836596|NCT01859130|584444958|FG000|Overall Study|Physician Decision|6|||
161836597|NCT01859130|584444958|FG000|Overall Study|Withdrawal by Subject|17|||
161697077|NCT01928381|583937967|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697078|NCT01928381|583937968|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697079|NCT01928381|583937969|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697080|NCT01928381|583937963|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697081|NCT01928381|583937964|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697082|NCT01928381|583937965|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
161697083|NCT01928381|583937966|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697084|NCT01928381|583937967|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697085|NCT01928381|583937968|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697086|NCT01928381|583937969|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697087|NCT02406781|583937970|FG000|Overall Study|Protocol Violation|2|||
161697088|NCT02406781|583937971|FG001|Overall Study|Protocol Violation|2|||
161697089|NCT02406781|583937972|FG002|Overall Study|Protocol Violation|2|||
161697090|NCT02406781|583937973|FG003|Overall Study|Protocol Violation|2|||
161697091|NCT02406781|583937974|FG004|Overall Study|Protocol Violation|1|||
161697092|NCT02406781|583937975|FG005|Overall Study|Protocol Violation|5|||
161697093|NCT02406781|583937976|FG006|Overall Study|Protocol Violation|3|||
161697094|NCT06272370|583940068|FG000|Overall Study|Lost to Follow-up|0|||
161697095|NCT06272370|583940069|FG001|Overall Study|Lost to Follow-up|3|||
161697096|NCT06272370|583940070|FG002|Overall Study|Lost to Follow-up|1|||
161697097|NCT06272370|583940071|FG003|Overall Study|Lost to Follow-up|1|||
161697098|NCT02527707|583940073|FG000|Overall Study|Adverse Event|1|||
161697099|NCT02527707|583940073|FG000|Overall Study|Adverse Event|1|||
161697100|NCT00930059|583940074|FG000|Overall Study|Death|1|||
161697101|NCT00930059|583940075|FG001|Overall Study|Death|0|||
161697102|NCT00930059|583940074|FG000|Overall Study|Did not meet entrance criteria|1|||
161697103|NCT00930059|583940075|FG001|Overall Study|Did not meet entrance criteria|1|||
161697104|NCT00930059|583940074|FG000|Overall Study|Withdrawal by Subject|3|||
161697105|NCT00930059|583940075|FG001|Overall Study|Withdrawal by Subject|4|||
161697106|NCT00930059|583940074|FG000|Overall Study|Other|1|||
161697107|NCT00930059|583940075|FG001|Overall Study|Other|0|||
161697108|NCT00930059|583940074|FG000|Overall Study|1 site terminated by sponsor|1|||
161697109|NCT00930059|583940075|FG001|Overall Study|1 site terminated by sponsor|1|||
161697110|NCT00930059|583940074|FG000|Overall Study|Adverse Event|1|||
161697111|NCT00930059|583940075|FG001|Overall Study|Adverse Event|6|||
161697112|NCT01299766|583940076|FG000|Overall Study|Death|5|||
161697113|NCT01299766|583940077|FG001|Overall Study|Death|4|||
161697114|NCT01299766|583940076|FG000|Overall Study|Withdrawal by Subject|29|||
161697115|NCT01299766|583940077|FG001|Overall Study|Withdrawal by Subject|19|||
161697116|NCT04002310|583940078|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697117|NCT04002310|583940079|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697118|NCT04002310|583940080|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697119|NCT04002310|583940081|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697120|NCT04002310|583940082|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
161697121|NCT00352534|583940083|FG000|Initial Staging|Ineligible|8|||
161697122|NCT00352534|583940084|FG001|Initial Staging|Ineligible|9|||
161697123|NCT00352534|583940085|FG002|Initial Staging|Ineligible|0|||
161697124|NCT00352534|583940086|FG003|Initial Staging|Ineligible|0|||
161697125|NCT00352534|583940087|FG004|Initial Staging|Ineligible|0|||
161697126|NCT00352534|583940088|FG005|Initial Staging|Ineligible|0|||
161697127|NCT00352534|583940089|FG006|Initial Staging|Ineligible|0|||
161697128|NCT00352534|583940083|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
161697129|NCT00352534|583940084|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
161697130|NCT00352534|583940085|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
161697131|NCT00352534|583940086|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
161697132|NCT00352534|583940087|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
161697133|NCT00352534|583940088|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
161697134|NCT00352534|583940089|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
161697135|NCT00352534|583940083|FG000|Final Risk Group Assignment|Physician Decision|0|||
161697136|NCT00352534|583940084|FG001|Final Risk Group Assignment|Physician Decision|0|||
161697137|NCT00352534|583940085|FG002|Final Risk Group Assignment|Physician Decision|0|||
161697138|NCT00352534|583940086|FG003|Final Risk Group Assignment|Physician Decision|0|||
161697139|NCT00352534|583940087|FG004|Final Risk Group Assignment|Physician Decision|0|||
161697140|NCT00352534|583940088|FG005|Final Risk Group Assignment|Physician Decision|8|||
161697141|NCT00352534|583940089|FG006|Final Risk Group Assignment|Physician Decision|0|||
161697142|NCT00352534|583940083|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697143|NCT00352534|583940084|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697144|NCT00352534|583940085|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697145|NCT00352534|583940086|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697146|NCT00352534|583940087|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697147|NCT00352534|583940088|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
161697148|NCT00352534|583940089|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697149|NCT00352534|583940083|FG000|Final Risk Group Assignment|Ineligible|0|||
161697150|NCT00352534|583940084|FG001|Final Risk Group Assignment|Ineligible|0|||
161697151|NCT00352534|583940085|FG002|Final Risk Group Assignment|Ineligible|3|||
161697152|NCT00352534|583940086|FG003|Final Risk Group Assignment|Ineligible|1|||
161697153|NCT00352534|583940087|FG004|Final Risk Group Assignment|Ineligible|0|||
161697154|NCT00352534|583940088|FG005|Final Risk Group Assignment|Ineligible|13|||
161697155|NCT00352534|583940089|FG006|Final Risk Group Assignment|Ineligible|0|||
161697156|NCT00352534|583940083|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697157|NCT00352534|583940084|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697158|NCT00352534|583940085|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697159|NCT00352534|583940086|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697160|NCT00352534|583940087|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697161|NCT00352534|583940088|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697162|NCT00352534|583940089|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
161697163|NCT00352534|583940083|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697164|NCT00352534|583940084|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697165|NCT00352534|583940085|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697166|NCT00352534|583940086|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697167|NCT00352534|583940087|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697168|NCT00352534|583940088|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697169|NCT00352534|583940089|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
161697170|NCT00352534|583940083|FG000|Final Risk Group Assignment|Death|0|||
161697171|NCT00352534|583940084|FG001|Final Risk Group Assignment|Death|0|||
161697172|NCT00352534|583940085|FG002|Final Risk Group Assignment|Death|0|||
161697173|NCT00352534|583940086|FG003|Final Risk Group Assignment|Death|0|||
161697174|NCT00352534|583940087|FG004|Final Risk Group Assignment|Death|0|||
161697175|NCT00352534|583940088|FG005|Final Risk Group Assignment|Death|2|||
161697176|NCT00352534|583940089|FG006|Final Risk Group Assignment|Death|0|||
161697177|NCT02090855|583940090|FG000|Overall Study|no evaluable Standard of Truth results|2|||
161697178|NCT00544869|583940094|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
161697179|NCT00544869|583940095|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
161697180|NCT00544869|583940096|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
161697181|NCT00544869|583940094|FG000|Overall Study|Adverse Event|6|||
161697182|NCT00544869|583940095|FG001|Overall Study|Adverse Event|1|||
161697183|NCT00544869|583940096|FG002|Overall Study|Adverse Event|0|||
161697184|NCT00544869|583940094|FG000|Overall Study|Lack of Efficacy|1|||
161697185|NCT00544869|583940095|FG001|Overall Study|Lack of Efficacy|1|||
161697186|NCT00544869|583940096|FG002|Overall Study|Lack of Efficacy|0|||
161697187|NCT00544869|583940094|FG000|Overall Study|Physician Decision|2|||
161697188|NCT00544869|583940095|FG001|Overall Study|Physician Decision|0|||
161697189|NCT00544869|583940096|FG002|Overall Study|Physician Decision|0|||
161697190|NCT00619502|583940097|FG000|Overall Study|Lost to Follow-up|8|||
161697191|NCT00619502|583940098|FG001|Overall Study|Lost to Follow-up|10|||
161697192|NCT01354028|583940099|FG000|Overall Study|Physician Decision|0|||
161697193|NCT01354028|583940100|FG001|Overall Study|Physician Decision|2|||
161697194|NCT01354028|583940099|FG000|Overall Study|Discharged before study start|2|||
161697195|NCT01354028|583940100|FG001|Overall Study|Discharged before study start|2|||
161697196|NCT01354028|583940099|FG000|Overall Study|No quiet alert state|0|||
161697197|NCT01354028|583940100|FG001|Overall Study|No quiet alert state|1|||
161697198|NCT03968419|583940103|FG000|Treatment Period|Adverse Event|0|||
161697199|NCT03968419|583940104|FG001|Treatment Period|Adverse Event|0|||
161697200|NCT03968419|583940105|FG002|Treatment Period|Adverse Event|1|||
161697201|NCT03968419|583940103|FG000|Safety Follow-up Period|Death|3|||
161697202|NCT03968419|583940104|FG001|Safety Follow-up Period|Death|2|||
161697203|NCT03968419|583940105|FG002|Safety Follow-up Period|Death|1|||
161697204|NCT03968419|583940103|FG000|Safety Follow-up Period|Subject Decision|2|||
161697205|NCT03968419|583940104|FG001|Safety Follow-up Period|Subject Decision|1|||
161697206|NCT03968419|583940105|FG002|Safety Follow-up Period|Subject Decision|0|||
161697207|NCT00935883|583940106|FG000|Treatment Period|Physician Decision|1|||
161697208|NCT00935883|583940107|FG001|Treatment Period|Physician Decision|0|||
161697209|NCT00935883|583940106|FG000|Treatment Period|Withdrawal by Subject|0|||
161697210|NCT00935883|583940107|FG001|Treatment Period|Withdrawal by Subject|2|||
161697211|NCT01641939|583940110|FG000|Overall Study|Death|90|||
161697212|NCT01641939|583940111|FG001|Overall Study|Death|187|||
161697213|NCT01641939|583940112|FG002|Overall Study|Death|61|||
161697214|NCT01641939|583940110|FG000|Overall Study|Lost to Follow-up|3|||
161697215|NCT01641939|583940111|FG001|Overall Study|Lost to Follow-up|2|||
161697216|NCT01641939|583940112|FG002|Overall Study|Lost to Follow-up|1|||
161697217|NCT01641939|583940110|FG000|Overall Study|Withdrawal by Subject|14|||
161697218|NCT01641939|583940111|FG001|Overall Study|Withdrawal by Subject|11|||
161697219|NCT01641939|583940112|FG002|Overall Study|Withdrawal by Subject|5|||
161697220|NCT01641939|583940110|FG000|Overall Study|Study Terminated by Sponsor|10|||
161697221|NCT01641939|583940111|FG001|Overall Study|Study Terminated by Sponsor|28|||
161697222|NCT01641939|583940112|FG002|Overall Study|Study Terminated by Sponsor|3|||
161697223|NCT02894840|583940113|FG000|Overall Study|Lost to Follow-up|1|||
161697224|NCT02894840|583940114|FG001|Overall Study|Lost to Follow-up|0|||
161697225|NCT02894840|583940115|FG002|Overall Study|Lost to Follow-up|3|||
161697226|NCT02894840|583940116|FG003|Overall Study|Lost to Follow-up|0|||
161697227|NCT05499559|583940121|FG000|Overall Study|Lost to Follow-up|467|||
161697228|NCT02971202|583940128|FG000|Overall Study|Pregnancy|1|||
161697229|NCT02971202|583940129|FG001|Overall Study|Pregnancy|0|||
161697230|NCT02971202|583940130|FG002|Overall Study|Pregnancy|0|||
161697231|NCT02971202|583940128|FG000|Overall Study|screen fail after consent|1|||
161697232|NCT02971202|583940129|FG001|Overall Study|screen fail after consent|0|||
161697233|NCT02971202|583940130|FG002|Overall Study|screen fail after consent|1|||
161697234|NCT04033367|583940131|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
161697235|NCT04033367|583940132|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
161697236|NCT04033367|583940131|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
161697237|NCT04033367|583940132|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
161697238|NCT04033367|583940131|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
161697239|NCT04033367|583940132|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
161697240|NCT04033367|583940131|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
161697241|NCT04033367|583940132|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
161697242|NCT02723201|583940133|FG000|Second Intervention Period|Protocol Violation|1|||
161697243|NCT02723201|583940134|FG001|Second Intervention Period|Protocol Violation|0|||
161697244|NCT02723201|583940135|FG002|Second Intervention Period|Protocol Violation|0|||
161697245|NCT02723201|583940133|FG000|Second Intervention Period|Adverse Event|1|||
161697246|NCT02723201|583940134|FG001|Second Intervention Period|Adverse Event|0|||
161697247|NCT02723201|583940135|FG002|Second Intervention Period|Adverse Event|0|||
161697248|NCT03472560|583940136|FG000|Overall Study|Subject transfer to continuation protocol|0|||
161697249|NCT03472560|583940137|FG001|Overall Study|Subject transfer to continuation protocol|1|||
161697250|NCT03472560|583940136|FG000|Overall Study|Withdrawal by Subject|4|||
161697251|NCT03472560|583940137|FG001|Overall Study|Withdrawal by Subject|0|||
161697252|NCT03472560|583940136|FG000|Overall Study|Progressive disease|24|||
161697253|NCT03472560|583940137|FG001|Overall Study|Progressive disease|8|||
161697254|NCT03472560|583940136|FG000|Overall Study|Physician Decision|1|||
161697255|NCT03472560|583940137|FG001|Overall Study|Physician Decision|0|||
161697256|NCT03472560|583940136|FG000|Overall Study|Death|7|||
161697257|NCT03472560|583940137|FG001|Overall Study|Death|4|||
161697258|NCT03472560|583940136|FG000|Overall Study|Adverse Event|5|||
161697259|NCT03472560|583940137|FG001|Overall Study|Adverse Event|3|||
161697260|NCT03472560|583940136|FG000|Overall Study|Global deterioration of health status|0|||
161697261|NCT03472560|583940137|FG001|Overall Study|Global deterioration of health status|4|||
161697262|NCT01946178|583940138|FG000|Overall Study|Pregnancy|1|||
161836598|NCT01859130|584444958|FG000|Overall Study|Adverse Event|11|||
161836599|NCT00127036|584444962|FG000|Overall Study|Insufficient Data for Analysis|6|||
161836600|NCT00127036|584444963|FG001|Overall Study|Insufficient Data for Analysis|11|||
161836601|NCT00127036|584444962|FG000|Overall Study|Screen Failure|2|||
161836602|NCT00127036|584444963|FG001|Overall Study|Screen Failure|0|||
161836603|NCT03921151|584444966|FG000|Overall Study|Withdrawal by Subject|11|||
161836604|NCT03921151|584444967|FG001|Overall Study|Withdrawal by Subject|16|||
161836605|NCT03001219|584444975|FG000|Proof of Concept|Study Termination by Sponsor|0|||
161697263|NCT01946178|583940138|FG000|Overall Study|Lost to Follow-up|1|||
161836606|NCT03001219|584444976|FG001|Proof of Concept|Study Termination by Sponsor|1|||
161697264|NCT05425563|583940143|FG000|Overall Study|Withdrawal by Subject|17|||
161697265|NCT01001702|583940144|FG000|Overall Study|Lost to Follow-up|7|||
161697266|NCT01001702|583940144|FG000|Overall Study|Adverse Event|7|||
161697267|NCT01001702|583940144|FG000|Overall Study|Sponsor Discontinued Study|4|||
161697268|NCT01001702|583940144|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
161697269|NCT01001702|583940144|FG000|Overall Study|Investigator withdrew Subject|10|||
161697270|NCT01001702|583940144|FG000|Overall Study|Withdrawal by Subject|19|||
161697271|NCT01001702|583940144|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
161697272|NCT00584233|583940147|FG000|Overall Study|Withdrawal by Subject|5|||
161697273|NCT00584233|583940147|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
161697274|NCT02494596|583940148|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161653375|NCT00943852|583781051|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
161653376|NCT00943852|583781052|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653377|NCT00943852|583781053|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653378|NCT00943852|583781054|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161653379|NCT00943852|583781045|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653380|NCT00943852|583781046|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653381|NCT00943852|583781047|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653382|NCT00943852|583781048|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653383|NCT00943852|583781049|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653384|NCT00943852|583781050|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653385|NCT00943852|583781051|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653386|NCT00943852|583781052|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
161653387|NCT00943852|583781053|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653388|NCT00943852|583781054|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161653389|NCT00943852|583781045|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161653390|NCT00943852|583781046|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161653391|NCT00943852|583781047|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161653392|NCT00943852|583781048|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161653393|NCT00943852|583781049|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161653394|NCT00943852|583781050|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161653395|NCT00943852|583781051|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161653396|NCT00943852|583781052|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161653397|NCT00943852|583781053|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161653398|NCT00943852|583781054|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161653399|NCT02530970|583781076|FG000|Overall Study|Adverse Event|8|||
161653400|NCT02530970|583781076|FG000|Overall Study|Lost to Follow-up|88|||
161653401|NCT02530970|583781076|FG000|Overall Study|Physician Decision|5|||
161653402|NCT02530970|583781076|FG000|Overall Study|Withdrawal by Subject|14|||
161653403|NCT02530970|583781076|FG000|Overall Study|Death|6|||
161653404|NCT02530970|583781076|FG000|Overall Study|Hospitalization|1|||
161653405|NCT02530970|583781076|FG000|Overall Study|Insurance|2|||
161653406|NCT02530970|583781076|FG000|Overall Study|Explant|2|||
161653407|NCT02530970|583781076|FG000|Overall Study|Change in Provider|5|||
161653408|NCT02530970|583781076|FG000|Overall Study|Relocation|3|||
161653409|NCT02636725|583781078|FG000|Overall Study|Adverse Event|1|||
161653410|NCT00743431|583781087|FG000|Overall Study|Toxicity|6|||
161653411|NCT00743431|583781087|FG000|Overall Study|Tumor progression|56|||
161653412|NCT00743431|583781087|FG000|Overall Study|Withdrawal by Subject|13|||
161653413|NCT00743431|583781087|FG000|Overall Study|Death|9|||
161653414|NCT00743431|583781087|FG000|Overall Study|Reason for discontinuation not specified|29|||
161653415|NCT00743431|583781087|FG000|Overall Study|No documentation available|13|||
161653416|NCT03291288|583781088|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
161653417|NCT03291288|583781089|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
161653418|NCT03291288|583781088|FG000|Drug-drug Interaction Phase|Disease progression|1|||
161653419|NCT03291288|583781089|FG001|Drug-drug Interaction Phase|Disease progression|0|||
161653420|NCT03291288|583781088|FG000|Drug-drug Interaction Phase|Other|3|||
161653421|NCT03291288|583781089|FG001|Drug-drug Interaction Phase|Other|0|||
161653422|NCT03291288|583781088|FG000|Pexidartinib Only|Ongoing|0|||
161653423|NCT03291288|583781089|FG001|Pexidartinib Only|Ongoing|2|||
161653424|NCT04978493|583781090|FG000|Overall Study|No reason available|0|||
161653425|NCT04978493|583781091|FG001|Overall Study|No reason available|1|||
161653426|NCT04978493|583781090|FG000|Overall Study|Adverse Event|1|||
161653427|NCT04978493|583781091|FG001|Overall Study|Adverse Event|0|||
161653428|NCT01896726|583781092|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
161653429|NCT01896726|583781092|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
161653430|NCT01128114|583781093|FG000|Overall Study|Treatment Withdrawn|6|||
161653431|NCT01128114|583781093|FG000|Overall Study|Screening Failed|2|||
161836607|NCT03001219|584444975|FG000|Proof of Concept|Withdrawal by Subject|0|||
161836608|NCT03001219|584444976|FG001|Proof of Concept|Withdrawal by Subject|4|||
161836609|NCT03001219|584444975|FG000|Proof of Concept|Protocol Deviation|0|||
161836610|NCT03001219|584444976|FG001|Proof of Concept|Protocol Deviation|1|||
161653432|NCT02336451|583781094|FG000|Overall Study|Adverse Event|1|||
161653433|NCT02336451|583781095|FG001|Overall Study|Adverse Event|2|||
161653434|NCT02336451|583781096|FG002|Overall Study|Adverse Event|0|||
161653435|NCT02336451|583781097|FG003|Overall Study|Adverse Event|6|||
161653436|NCT02336451|583781098|FG004|Overall Study|Adverse Event|4|||
161653437|NCT02336451|583781094|FG000|Overall Study|Death|6|||
161653438|NCT02336451|583781095|FG001|Overall Study|Death|2|||
161653439|NCT02336451|583781096|FG002|Overall Study|Death|3|||
161653440|NCT02336451|583781097|FG003|Overall Study|Death|6|||
161653441|NCT02336451|583781098|FG004|Overall Study|Death|6|||
161653442|NCT02336451|583781094|FG000|Overall Study|Physician Decision|9|||
161653443|NCT02336451|583781095|FG001|Overall Study|Physician Decision|6|||
161653444|NCT02336451|583781096|FG002|Overall Study|Physician Decision|7|||
161653445|NCT02336451|583781097|FG003|Overall Study|Physician Decision|16|||
161653446|NCT02336451|583781098|FG004|Overall Study|Physician Decision|3|||
161653447|NCT02336451|583781094|FG000|Overall Study|Progressive disease|23|||
161653448|NCT02336451|583781095|FG001|Overall Study|Progressive disease|26|||
161653449|NCT02336451|583781096|FG002|Overall Study|Progressive disease|2|||
161653450|NCT02336451|583781097|FG003|Overall Study|Progressive disease|14|||
161653451|NCT02336451|583781098|FG004|Overall Study|Progressive disease|4|||
161653452|NCT02336451|583781094|FG000|Overall Study|Protocol Violation|1|||
161653453|NCT02336451|583781095|FG001|Overall Study|Protocol Violation|0|||
161653454|NCT02336451|583781096|FG002|Overall Study|Protocol Violation|0|||
161653455|NCT02336451|583781097|FG003|Overall Study|Protocol Violation|0|||
161653456|NCT02336451|583781098|FG004|Overall Study|Protocol Violation|0|||
161653457|NCT02336451|583781094|FG000|Overall Study|Patient/guardian decision|2|||
161653458|NCT02336451|583781095|FG001|Overall Study|Patient/guardian decision|4|||
161653459|NCT02336451|583781096|FG002|Overall Study|Patient/guardian decision|0|||
161653460|NCT02336451|583781097|FG003|Overall Study|Patient/guardian decision|2|||
161653461|NCT02336451|583781098|FG004|Overall Study|Patient/guardian decision|1|||
161653462|NCT06655558|583781101|FG000|Overall Study|Protocol Violation|1|||
161653463|NCT04998812|583781107|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
161653464|NCT04998812|583781108|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
161653465|NCT04998812|583781107|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
161653466|NCT04998812|583781108|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
161653467|NCT04998812|583781107|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
161653468|NCT04998812|583781108|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
161653469|NCT04998812|583781107|FG000|Vaccination Period|Ongoing in study|23|||
161653470|NCT04998812|583781108|FG001|Vaccination Period|Ongoing in study|23|||
161653471|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
161653472|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
161653473|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
161653474|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
161653475|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
161653476|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
161653477|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
161653478|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
161653479|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
161653480|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
161653481|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
161653482|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
161653483|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161653484|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
161653485|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161653486|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161653487|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161653488|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161653489|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161653490|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
161653491|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161653492|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161653493|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161653494|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161653495|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161653496|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161653497|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
161836611|NCT03001219|584444975|FG000|Proof of Concept|Adverse Event|1|||
161836612|NCT03001219|584444976|FG001|Proof of Concept|Adverse Event|1|||
161697275|NCT02494596|583940149|FG001|Overall Study|Insufficient Therapeutic Response|3|||
161697276|NCT02494596|583940150|FG002|Overall Study|Insufficient Therapeutic Response|1|||
161697277|NCT02494596|583940148|FG000|Overall Study|Adverse Event|0|||
161697278|NCT02494596|583940149|FG001|Overall Study|Adverse Event|1|||
161697279|NCT02494596|583940150|FG002|Overall Study|Adverse Event|0|||
161697280|NCT02494596|583940148|FG000|Overall Study|Refused Treatment|0|||
161697281|NCT02494596|583940149|FG001|Overall Study|Refused Treatment|1|||
161697282|NCT02494596|583940150|FG002|Overall Study|Refused Treatment|0|||
161697283|NCT02222714|583940151|FG000|Overall Study|Death|0|||
161697284|NCT02222714|583940152|FG001|Overall Study|Death|2|||
161697285|NCT02222714|583940153|FG002|Overall Study|Death|3|||
161697286|NCT02222714|583940154|FG003|Overall Study|Death|4|||
161697287|NCT02222714|583940155|FG004|Overall Study|Death|6|||
161697288|NCT02222714|583940151|FG000|Overall Study|Withdrawal by Subject|0|||
161697289|NCT02222714|583940152|FG001|Overall Study|Withdrawal by Subject|0|||
161697290|NCT02222714|583940153|FG002|Overall Study|Withdrawal by Subject|1|||
161697291|NCT02222714|583940154|FG003|Overall Study|Withdrawal by Subject|0|||
161697292|NCT02222714|583940155|FG004|Overall Study|Withdrawal by Subject|1|||
161697293|NCT00159432|583940156|FG000|Overall Study|Adverse Event|1|||
161697294|NCT00159432|583940156|FG000|Overall Study|Death|1|||
161697295|NCT00159432|583940156|FG000|Overall Study|Lack of Efficacy|8|||
161697296|NCT04537208|583940157|FG000|Overall Study|Adverse Event|0|||
161697297|NCT04537208|583940158|FG001|Overall Study|Adverse Event|0|||
161697298|NCT04537208|583940159|FG002|Overall Study|Adverse Event|0|||
161697299|NCT04537208|583940160|FG003|Overall Study|Adverse Event|0|||
161697300|NCT04537208|583940161|FG004|Overall Study|Adverse Event|0|||
161697301|NCT04537208|583940162|FG005|Overall Study|Adverse Event|0|||
161697302|NCT04537208|583940163|FG006|Overall Study|Adverse Event|0|||
161697303|NCT04537208|583940164|FG007|Overall Study|Adverse Event|0|||
161697304|NCT04537208|583940165|FG008|Overall Study|Adverse Event|1|||
161697305|NCT04537208|583940166|FG009|Overall Study|Adverse Event|0|||
161697306|NCT04537208|583940167|FG010|Overall Study|Adverse Event|0|||
161697307|NCT04537208|583940157|FG000|Overall Study|Protocol deviation|0|||
161697308|NCT04537208|583940158|FG001|Overall Study|Protocol deviation|0|||
161697309|NCT04537208|583940159|FG002|Overall Study|Protocol deviation|2|||
161697310|NCT04537208|583940160|FG003|Overall Study|Protocol deviation|0|||
161697311|NCT04537208|583940161|FG004|Overall Study|Protocol deviation|0|||
161697312|NCT04537208|583940162|FG005|Overall Study|Protocol deviation|2|||
161697313|NCT04537208|583940163|FG006|Overall Study|Protocol deviation|4|||
161697314|NCT04537208|583940164|FG007|Overall Study|Protocol deviation|0|||
161697315|NCT04537208|583940165|FG008|Overall Study|Protocol deviation|1|||
161697316|NCT04537208|583940166|FG009|Overall Study|Protocol deviation|0|||
161697317|NCT04537208|583940167|FG010|Overall Study|Protocol deviation|2|||
161697318|NCT04537208|583940157|FG000|Overall Study|Withdrawal by Subject|4|||
161697319|NCT04537208|583940158|FG001|Overall Study|Withdrawal by Subject|2|||
161697320|NCT04537208|583940159|FG002|Overall Study|Withdrawal by Subject|1|||
161697321|NCT04537208|583940160|FG003|Overall Study|Withdrawal by Subject|3|||
161697322|NCT04537208|583940161|FG004|Overall Study|Withdrawal by Subject|5|||
161697323|NCT04537208|583940162|FG005|Overall Study|Withdrawal by Subject|1|||
161697324|NCT04537208|583940163|FG006|Overall Study|Withdrawal by Subject|6|||
161697325|NCT04537208|583940164|FG007|Overall Study|Withdrawal by Subject|1|||
161697326|NCT04537208|583940165|FG008|Overall Study|Withdrawal by Subject|7|||
161697327|NCT04537208|583940166|FG009|Overall Study|Withdrawal by Subject|2|||
161697328|NCT04537208|583940167|FG010|Overall Study|Withdrawal by Subject|4|||
161697329|NCT04537208|583940157|FG000|Overall Study|Lost to Follow-up|4|||
161697330|NCT04537208|583940158|FG001|Overall Study|Lost to Follow-up|1|||
161697331|NCT04537208|583940159|FG002|Overall Study|Lost to Follow-up|3|||
161697332|NCT04537208|583940160|FG003|Overall Study|Lost to Follow-up|4|||
161697333|NCT04537208|583940161|FG004|Overall Study|Lost to Follow-up|3|||
161697334|NCT04537208|583940162|FG005|Overall Study|Lost to Follow-up|2|||
161697335|NCT04537208|583940163|FG006|Overall Study|Lost to Follow-up|3|||
161697336|NCT04537208|583940164|FG007|Overall Study|Lost to Follow-up|2|||
161697337|NCT04537208|583940165|FG008|Overall Study|Lost to Follow-up|7|||
161697338|NCT04537208|583940166|FG009|Overall Study|Lost to Follow-up|2|||
161697339|NCT04537208|583940167|FG010|Overall Study|Lost to Follow-up|2|||
161697340|NCT03178487|583940168|FG000|Period 1|Adverse Event|1|||
161697341|NCT03178487|583940169|FG001|Period 1|Adverse Event|2|||
161697342|NCT03178487|583940168|FG000|Period 1|Withdrawal by Subject|2|||
161697343|NCT03178487|583940169|FG001|Period 1|Withdrawal by Subject|1|||
161697344|NCT03178487|583940168|FG000|Period 1|Lost to Follow-up|1|||
161697345|NCT03178487|583940169|FG001|Period 1|Lost to Follow-up|0|||
161697346|NCT03178487|583940168|FG000|Period 1|Other|0|||
161697347|NCT03178487|583940169|FG001|Period 1|Other|1|||
161697348|NCT03178487|583940168|FG000|Period 2|Adverse Event|4|||
161697349|NCT03178487|583940169|FG001|Period 2|Adverse Event|4|||
161697350|NCT03178487|583940168|FG000|Period 2|Withdrawal by Subject|6|||
161697351|NCT03178487|583940169|FG001|Period 2|Withdrawal by Subject|6|||
161697352|NCT03178487|583940168|FG000|Period 2|Lost to Follow-up|2|||
161697353|NCT03178487|583940169|FG001|Period 2|Lost to Follow-up|2|||
161697354|NCT03178487|583940168|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
161697355|NCT03178487|583940169|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
161697356|NCT03178487|583940168|FG000|Period 2|Other|8|||
161697357|NCT03178487|583940169|FG001|Period 2|Other|7|||
161697358|NCT00704964|583940173|FG000|Overall Study|Not completed on time|328|||
161697359|NCT02161562|583940174|FG000|Overall Study|Withdrawal by Subject|5|||
161697360|NCT02161562|583940175|FG001|Overall Study|Withdrawal by Subject|8|||
161697361|NCT02161562|583940174|FG000|Overall Study|Protocol Violation|9|||
161697362|NCT02161562|583940175|FG001|Overall Study|Protocol Violation|4|||
161697363|NCT02161562|583940174|FG000|Overall Study|Pregnancy|1|||
161697364|NCT02161562|583940175|FG001|Overall Study|Pregnancy|2|||
161697365|NCT02161562|583940174|FG000|Overall Study|Lost to Follow-up|3|||
161697366|NCT02161562|583940175|FG001|Overall Study|Lost to Follow-up|1|||
161697367|NCT02161562|583940174|FG000|Overall Study|Lack of Efficacy|4|||
161697368|NCT02161562|583940175|FG001|Overall Study|Lack of Efficacy|1|||
161697369|NCT02161562|583940174|FG000|Overall Study|Adverse Event|1|||
161697370|NCT02161562|583940175|FG001|Overall Study|Adverse Event|1|||
161697371|NCT02161562|583940174|FG000|Overall Study|Participant moved back to home country|1|||
161697372|NCT02161562|583940175|FG001|Overall Study|Participant moved back to home country|0|||
161697373|NCT02161562|583940174|FG000|Overall Study|Withdrew due to being out of the country|1|||
161697374|NCT02161562|583940175|FG001|Overall Study|Withdrew due to being out of the country|0|||
161697375|NCT02161562|583940174|FG000|Overall Study|Participant moved out of province|1|||
161697376|NCT02161562|583940175|FG001|Overall Study|Participant moved out of province|0|||
161697377|NCT00197054|583940182|FG000|Overall Study|Withdrawal by Subject|9|||
161697378|NCT00197054|583940183|FG001|Overall Study|Withdrawal by Subject|3|||
161697379|NCT00197054|583940184|FG002|Overall Study|Withdrawal by Subject|3|||
161697380|NCT00197054|583940182|FG000|Overall Study|Moved from area|7|||
161697381|NCT00197054|583940183|FG001|Overall Study|Moved from area|14|||
161697382|NCT00197054|583940184|FG002|Overall Study|Moved from area|9|||
161697383|NCT00197054|583940182|FG000|Overall Study|Lost to Follow-up|1|||
161697384|NCT00197054|583940183|FG001|Overall Study|Lost to Follow-up|4|||
161697385|NCT00197054|583940184|FG002|Overall Study|Lost to Follow-up|0|||
161697386|NCT01163786|583940185|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
161697387|NCT01163786|583940185|FG000|Treatment With Bortezomib|Adverse Event|2|||
161697388|NCT01163786|583940185|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
161697389|NCT02167945|583940190|FG000|Overall Study|Adverse Event|16|||
161697390|NCT02167945|583940190|FG000|Overall Study|Withdrew Consent|42|||
161697391|NCT02167945|583940190|FG000|Overall Study|Lost to Follow-up|122|||
161697392|NCT02167945|583940190|FG000|Overall Study|COVID-19 logistical restrictions|6|||
161697393|NCT02167945|583940190|FG000|Overall Study|Other, not specified|63|||
161697394|NCT00132730|583940191|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
161697395|NCT00132730|583940192|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
161697396|NCT00132730|583940193|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
161697397|NCT00132730|583940194|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
161697398|NCT00132730|583940195|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
161697399|NCT00132730|583940196|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
161697400|NCT00132730|583940191|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
161697401|NCT00132730|583940192|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
161697402|NCT00132730|583940193|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697403|NCT00132730|583940194|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697404|NCT00132730|583940195|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697405|NCT00132730|583940196|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697406|NCT00132730|583940191|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
161697407|NCT00132730|583940192|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
161697408|NCT00132730|583940193|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
161697409|NCT00132730|583940194|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
161697410|NCT00132730|583940195|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
161697411|NCT00132730|583940196|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
161697412|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697413|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697414|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
161697415|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
161697416|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697417|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697418|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161697419|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161697420|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
161697421|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
161697422|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161697423|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161653498|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161653499|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161653500|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161653501|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161653502|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
161653503|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
161653504|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161653505|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161653506|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161653507|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
161653508|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
161653509|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
161653510|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
161653511|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
161653512|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
161653513|NCT03524092|583781114|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
161653514|NCT03524092|583781115|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
161653515|NCT03524092|583781116|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
161653516|NCT03524092|583781117|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
161653517|NCT03524092|583781118|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
161653518|NCT03524092|583781119|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
161653519|NCT03524092|583781114|FG000|Loss of Response Rescue Period|Adverse Event|0|||
161653520|NCT03524092|583781115|FG001|Loss of Response Rescue Period|Adverse Event|0|||
161653521|NCT03524092|583781116|FG002|Loss of Response Rescue Period|Adverse Event|0|||
161653522|NCT03524092|583781117|FG003|Loss of Response Rescue Period|Adverse Event|2|||
161653523|NCT03524092|583781118|FG004|Loss of Response Rescue Period|Adverse Event|0|||
161653524|NCT03524092|583781119|FG005|Loss of Response Rescue Period|Adverse Event|0|||
161653525|NCT03524092|583781114|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
161653526|NCT03524092|583781115|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
161653527|NCT03524092|583781116|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
161653528|NCT03524092|583781117|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
161653529|NCT03524092|583781118|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
161653530|NCT03524092|583781119|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
161653531|NCT03524092|583781114|FG000|Loss of Response Rescue Period|Pregnancy|0|||
161653532|NCT03524092|583781115|FG001|Loss of Response Rescue Period|Pregnancy|0|||
161653533|NCT03524092|583781116|FG002|Loss of Response Rescue Period|Pregnancy|0|||
161653534|NCT03524092|583781117|FG003|Loss of Response Rescue Period|Pregnancy|1|||
161653535|NCT03524092|583781118|FG004|Loss of Response Rescue Period|Pregnancy|0|||
161653536|NCT03524092|583781119|FG005|Loss of Response Rescue Period|Pregnancy|0|||
161653537|NCT03524092|583781114|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161653538|NCT03524092|583781115|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161653539|NCT03524092|583781116|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161653540|NCT03524092|583781117|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
161653541|NCT03524092|583781118|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161653542|NCT03524092|583781119|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161653543|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161653544|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161653545|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161653546|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161653547|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
161653548|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161653549|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161653550|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161653551|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161653552|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161653553|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
161653554|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161653555|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161653556|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161653557|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161697424|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161653558|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161653559|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
161653560|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161653561|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161653562|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161653563|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161653564|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161653565|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
161653566|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161653567|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161653568|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161653569|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161653570|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161653571|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
161653572|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161653573|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161653574|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161653575|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161653576|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161653577|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
161653578|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161653579|NCT03524092|583781114|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161653580|NCT03524092|583781115|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161653581|NCT03524092|583781116|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161653582|NCT03524092|583781117|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161653583|NCT03524092|583781118|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
161653584|NCT03524092|583781119|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161653585|NCT03524092|583781114|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161653586|NCT03524092|583781115|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161653587|NCT03524092|583781116|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161653588|NCT03524092|583781117|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161653589|NCT03524092|583781118|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161653590|NCT03524092|583781119|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
161653591|NCT03524092|583781114|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161653592|NCT03524092|583781115|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161653593|NCT03524092|583781116|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161653594|NCT03524092|583781117|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161653595|NCT03524092|583781118|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161653596|NCT03524092|583781119|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
161653597|NCT03524092|583781114|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161653598|NCT03524092|583781115|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161653599|NCT03524092|583781116|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161653600|NCT03524092|583781117|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161653601|NCT03524092|583781118|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161653602|NCT03524092|583781119|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
161653603|NCT03524092|583781114|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161653604|NCT03524092|583781115|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161653605|NCT03524092|583781116|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161653606|NCT03524092|583781117|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161653607|NCT03524092|583781118|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161697425|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161697426|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161697427|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
161697428|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161697429|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161653608|NCT03524092|583781119|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
161653609|NCT04303780|583781120|FG000|Overall Study|Death|104|||
161653610|NCT04303780|583781121|FG001|Overall Study|Death|85|||
161653611|NCT04303780|583781120|FG000|Overall Study|Lost to Follow-up|5|||
161653612|NCT04303780|583781121|FG001|Overall Study|Lost to Follow-up|2|||
161653613|NCT04303780|583781120|FG000|Overall Study|Withdrawal by Subject|12|||
161653614|NCT04303780|583781121|FG001|Overall Study|Withdrawal by Subject|39|||
161653615|NCT04303780|583781120|FG000|Overall Study|Ongoing in study|50|||
161653616|NCT04303780|583781121|FG001|Overall Study|Ongoing in study|45|||
161653617|NCT03826030|583781122|FG000|Overall Study|Withdrawal by Subject|2|||
161653618|NCT03826030|583781123|FG001|Overall Study|Withdrawal by Subject|0|||
161653619|NCT03826030|583781124|FG002|Overall Study|Withdrawal by Subject|1|||
161653620|NCT03826030|583781122|FG000|Overall Study|Lost to Follow-up|1|||
161653621|NCT03826030|583781123|FG001|Overall Study|Lost to Follow-up|1|||
161653622|NCT03826030|583781124|FG002|Overall Study|Lost to Follow-up|1|||
161653623|NCT03826030|583781122|FG000|Overall Study|Too busy to return for visits|1|||
161653624|NCT03826030|583781123|FG001|Overall Study|Too busy to return for visits|0|||
161653625|NCT03826030|583781124|FG002|Overall Study|Too busy to return for visits|0|||
161653626|NCT04893460|583781125|FG000|Overall Study|Lost to Follow-up|18|||
161653627|NCT01099215|583782674|FG000|Overall Study|Withdrawal by Subject|1|||
161653628|NCT01099215|583782675|FG001|Overall Study|Withdrawal by Subject|0|||
161653629|NCT01099215|583782674|FG000|Overall Study|Adverse Event|0|||
161653630|NCT01099215|583782675|FG001|Overall Study|Adverse Event|1|||
161653631|NCT01901432|583782678|FG000|Overall Study|Adverse Event|0|||
161653632|NCT01901432|583782679|FG001|Overall Study|Adverse Event|1|||
161653633|NCT01901432|583782680|FG002|Overall Study|Adverse Event|1|||
161653634|NCT01901432|583782681|FG003|Overall Study|Adverse Event|0|||
161653635|NCT01901432|583782682|FG004|Overall Study|Adverse Event|1|||
161653636|NCT01901432|583782678|FG000|Overall Study|Withdrawal by Subject|0|||
161653637|NCT01901432|583782679|FG001|Overall Study|Withdrawal by Subject|0|||
161653638|NCT01901432|583782680|FG002|Overall Study|Withdrawal by Subject|1|||
161653639|NCT01901432|583782681|FG003|Overall Study|Withdrawal by Subject|0|||
161653640|NCT01901432|583782682|FG004|Overall Study|Withdrawal by Subject|5|||
161653641|NCT01901432|583782678|FG000|Overall Study|Physician Decision|0|||
161653642|NCT01901432|583782679|FG001|Overall Study|Physician Decision|0|||
161653643|NCT01901432|583782680|FG002|Overall Study|Physician Decision|0|||
161653644|NCT01901432|583782681|FG003|Overall Study|Physician Decision|0|||
161653645|NCT01901432|583782682|FG004|Overall Study|Physician Decision|2|||
161653646|NCT01901432|583782678|FG000|Overall Study|Patient decision to stop study drug|0|||
161653647|NCT01901432|583782679|FG001|Overall Study|Patient decision to stop study drug|0|||
161653648|NCT01901432|583782680|FG002|Overall Study|Patient decision to stop study drug|0|||
161653649|NCT01901432|583782681|FG003|Overall Study|Patient decision to stop study drug|0|||
161653650|NCT01901432|583782682|FG004|Overall Study|Patient decision to stop study drug|1|||
161653651|NCT01077271|583782688|FG000|Overall Study|Parental desire|8|||
161653652|NCT01077271|583782688|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
161653653|NCT01077271|583782688|FG000|Overall Study|Noncompliance|2|||
161653654|NCT01077271|583782688|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
161697430|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697431|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697432|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
161697433|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
161697434|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697435|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697436|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697437|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697438|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697439|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697440|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
161697441|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
161697442|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697443|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697444|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697445|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697446|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
161697447|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697448|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697449|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697450|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697451|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697452|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
161836613|NCT03001219|584444975|FG000|Proof of Concept|Physician Decision|1|||
161836614|NCT03001219|584444976|FG001|Proof of Concept|Physician Decision|0|||
161836615|NCT03001219|584444975|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
161836616|NCT03001219|584444976|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
161836617|NCT03001219|584444975|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
161836618|NCT03001219|584444976|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
161653655|NCT01077271|583782688|FG000|Overall Study|Changed doctors|2|||
161653656|NCT01077271|583782688|FG000|Overall Study|Parents thought too many injections|2|||
161653657|NCT01077271|583782688|FG000|Overall Study|End of RSV season nearly reached|1|||
161653658|NCT01077271|583782688|FG000|Overall Study|Mother unconvinced of the necessity|1|||
161653659|NCT00215137|583782689|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
161653660|NCT00215137|583782690|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
161653661|NCT00215137|583782691|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
161653662|NCT00215137|583782689|FG000|Randomization Period|Lost to Follow-up|0|||
161653663|NCT00215137|583782690|FG001|Randomization Period|Lost to Follow-up|1|||
161653664|NCT00215137|583782691|FG002|Randomization Period|Lost to Follow-up|0|||
161653665|NCT00215137|583782689|FG000|Randomization Period|Withdrawal by Subject|0|||
161653666|NCT00215137|583782690|FG001|Randomization Period|Withdrawal by Subject|1|||
161653667|NCT00215137|583782691|FG002|Randomization Period|Withdrawal by Subject|0|||
161653668|NCT03333876|583782692|FG000|Screening Period|Screen Failure|4|||
161653669|NCT03333876|583782692|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
161653670|NCT03333876|583782692|FG000|Mandibular Advancement|Adverse Event|2|||
161653671|NCT03333876|583782692|FG000|Mandibular Advancement|Product Damage|2|||
161653672|NCT00166712|583782694|FG000|Overall Study|Death|0|||
161653673|NCT00166712|583782695|FG001|Overall Study|Death|1|||
161653674|NCT00166712|583782694|FG000|Overall Study|Adverse Event|1|||
161653675|NCT00166712|583782695|FG001|Overall Study|Adverse Event|0|||
161653676|NCT00166712|583782694|FG000|Overall Study|Withdrawal by Subject|1|||
161653677|NCT00166712|583782695|FG001|Overall Study|Withdrawal by Subject|2|||
161653678|NCT00166712|583782694|FG000|Overall Study|Physician Decision|0|||
161653679|NCT00166712|583782695|FG001|Overall Study|Physician Decision|2|||
161653680|NCT04684394|583782696|FG000|Overall Study|Death|1|||
161653681|NCT04684394|583782697|FG001|Overall Study|Death|2|||
161653682|NCT04684394|583782696|FG000|Overall Study|Lost to Follow-up|1|||
161653683|NCT04684394|583782697|FG001|Overall Study|Lost to Follow-up|0|||
161653684|NCT04684394|583782696|FG000|Overall Study|Withdrawal by Subject|2|||
161653685|NCT04684394|583782697|FG001|Overall Study|Withdrawal by Subject|0|||
161653686|NCT04684394|583782696|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
161653687|NCT04684394|583782697|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
161653688|NCT03986944|583782698|FG000|Overall Study|Adverse Event|1|||
161653689|NCT03986944|583782699|FG001|Overall Study|Adverse Event|2|||
161653690|NCT03986944|583782700|FG002|Overall Study|Adverse Event|3|||
161653691|NCT03986944|583782698|FG000|Overall Study|Protocol Violation|0|||
161653692|NCT03986944|583782699|FG001|Overall Study|Protocol Violation|1|||
161697453|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697454|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697455|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697456|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697457|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697458|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
161697459|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697460|NCT00132730|583940191|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697461|NCT00132730|583940192|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697462|NCT00132730|583940193|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697463|NCT00132730|583940194|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697464|NCT00132730|583940195|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
161697465|NCT00132730|583940196|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
161697466|NCT03021642|583940199|FG000|Washout Period (21 Days)|Adverse Event|1|||
161697467|NCT03021642|583940200|FG001|Washout Period (21 Days)|Adverse Event|1|||
161697468|NCT01192347|583940201|FG000|Overall Study|Death|3|||
161697469|NCT01192347|583940201|FG000|Overall Study|Lost to Follow-up|3|||
161697470|NCT01192347|583940201|FG000|Overall Study|Withdrawal by Subject|1|||
161697471|NCT01192347|583940201|FG000|Overall Study|Adverse Event|1|||
161697472|NCT01192347|583940201|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
161697473|NCT01192347|583940201|FG000|Overall Study|Patient seen in different hospital|1|||
161697474|NCT01192347|583940201|FG000|Overall Study|Patient not visiting hospital regularly|1|||
161697475|NCT01192347|583940201|FG000|Overall Study|Patient did not show up for visits|1|||
161697476|NCT02623335|583940202|FG000|Overall Study|Death|8|||
161697477|NCT02623335|583940203|FG001|Overall Study|Death|7|||
161697478|NCT02623335|583940202|FG000|Overall Study|Lost to Follow-up|15|||
161697479|NCT02623335|583940203|FG001|Overall Study|Lost to Follow-up|23|||
161697480|NCT02623335|583940202|FG000|Overall Study|Withdrawal by Subject|2|||
161697481|NCT02623335|583940203|FG001|Overall Study|Withdrawal by Subject|5|||
161697482|NCT02623335|583940202|FG000|Overall Study|Protocol Violation|2|||
161697483|NCT02623335|583940203|FG001|Overall Study|Protocol Violation|1|||
161697484|NCT00090545|583940204|FG000|Overall Study|Disease progression on study|21|||
161697485|NCT00090545|583940205|FG001|Overall Study|Disease progression on study|17|||
161697486|NCT00090545|583940204|FG000|Overall Study|Refused further treatment|1|||
161697487|NCT00090545|583940205|FG001|Overall Study|Refused further treatment|4|||
161697488|NCT00090545|583940204|FG000|Overall Study|Death|0|||
161697489|NCT00090545|583940205|FG001|Overall Study|Death|1|||
161697490|NCT00090545|583940204|FG000|Overall Study|Adverse Event|0|||
161697491|NCT00090545|583940205|FG001|Overall Study|Adverse Event|2|||
161697492|NCT02474082|583940206|FG000|Overall Study|Adverse Event|2|||
161697493|NCT02474082|583940207|FG001|Overall Study|Adverse Event|32|||
161697494|NCT02474082|583940206|FG000|Overall Study|Withdrawal of informed consent|1|||
161697495|NCT02474082|583940207|FG001|Overall Study|Withdrawal of informed consent|11|||
161697496|NCT02474082|583940206|FG000|Overall Study|Lost to Follow-up|2|||
161697497|NCT02474082|583940207|FG001|Overall Study|Lost to Follow-up|2|||
161697498|NCT02474082|583940206|FG000|Overall Study|Dose tapering not achieved|0|||
161697499|NCT02474082|583940207|FG001|Overall Study|Dose tapering not achieved|4|||
161697500|NCT02474082|583940206|FG000|Overall Study|Participant/guardian decision|1|||
161697501|NCT02474082|583940207|FG001|Overall Study|Participant/guardian decision|2|||
161697502|NCT02474082|583940206|FG000|Overall Study|Non-compliance with study treatment|0|||
161697503|NCT02474082|583940207|FG001|Overall Study|Non-compliance with study treatment|2|||
161697504|NCT02474082|583940206|FG000|Overall Study|Protocol deviation|0|||
161697505|NCT02474082|583940207|FG001|Overall Study|Protocol deviation|1|||
161697506|NCT04317274|583940210|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
161697507|NCT04317274|583940211|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
161697508|NCT04317274|583940212|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
161697509|NCT04317274|583940213|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
161697510|NCT00430508|583940214|FG000|Overall Study|Adverse Event|2|||
161697511|NCT00430508|583940215|FG001|Overall Study|Adverse Event|3|||
161697512|NCT00430508|583940216|FG002|Overall Study|Adverse Event|5|||
161653693|NCT03986944|583782700|FG002|Overall Study|Protocol Violation|1|||
161653694|NCT03986944|583782698|FG000|Overall Study|Withdrawal by Subject|3|||
161653695|NCT03986944|583782699|FG001|Overall Study|Withdrawal by Subject|5|||
161653696|NCT03986944|583782700|FG002|Overall Study|Withdrawal by Subject|5|||
161653697|NCT03986944|583782698|FG000|Overall Study|Study termination|10|||
161653698|NCT03986944|583782699|FG001|Overall Study|Study termination|10|||
161653699|NCT03986944|583782700|FG002|Overall Study|Study termination|10|||
161653700|NCT03986944|583782698|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
161653701|NCT03986944|583782699|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
161653702|NCT03986944|583782700|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
161653703|NCT03986944|583782698|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
161653704|NCT03986944|583782699|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
161653705|NCT03986944|583782700|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
161653706|NCT05816330|583782707|FG000|Overall Study|Withdrawal by Subject|4|||
161653707|NCT05816330|583782708|FG001|Overall Study|Withdrawal by Subject|1|||
161653708|NCT00201643|583782709|FG000|Overall Study|Withdrawal by Subject|5|||
161653709|NCT00201643|583782710|FG001|Overall Study|Withdrawal by Subject|4|||
161653710|NCT03446781|583782711|FG000|Overall Study|Lost to Follow-up|11|||
161653711|NCT03446781|583782712|FG001|Overall Study|Lost to Follow-up|5|||
161653712|NCT03446781|583782711|FG000|Overall Study|Withdrawal by Subject|9|||
161653713|NCT03446781|583782712|FG001|Overall Study|Withdrawal by Subject|7|||
161653714|NCT03446781|583782711|FG000|Overall Study|Adverse Event|8|||
161653715|NCT03446781|583782712|FG001|Overall Study|Adverse Event|2|||
161653716|NCT03446781|583782711|FG000|Overall Study|Protocol Violation|0|||
161653717|NCT03446781|583782712|FG001|Overall Study|Protocol Violation|3|||
161653718|NCT02898077|583782719|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
161653719|NCT02898077|583782720|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
161653720|NCT02898077|583782719|FG000|Overall Study|Lost to Follow-up|4|||
161653721|NCT02898077|583782720|FG001|Overall Study|Lost to Follow-up|3|||
161653722|NCT02898077|583782719|FG000|Overall Study|Physician Decision|0|||
161653723|NCT02898077|583782720|FG001|Overall Study|Physician Decision|2|||
161653724|NCT02898077|583782719|FG000|Overall Study|Sponsor Decision|32|||
161653725|NCT02898077|583782720|FG001|Overall Study|Sponsor Decision|13|||
161653726|NCT02898077|583782719|FG000|Overall Study|Withdrawal by Subject|6|||
161697513|NCT00430508|583940217|FG003|Overall Study|Adverse Event|3|||
161697514|NCT00430508|583940214|FG000|Overall Study|Withdrawal by Subject|0|||
161697515|NCT00430508|583940215|FG001|Overall Study|Withdrawal by Subject|1|||
161697516|NCT00430508|583940216|FG002|Overall Study|Withdrawal by Subject|1|||
161697517|NCT00430508|583940217|FG003|Overall Study|Withdrawal by Subject|1|||
161697518|NCT00430508|583940214|FG000|Overall Study|responder at visit 4|0|||
161697519|NCT00430508|583940215|FG001|Overall Study|responder at visit 4|0|||
161697520|NCT00430508|583940216|FG002|Overall Study|responder at visit 4|2|||
161697521|NCT00430508|583940217|FG003|Overall Study|responder at visit 4|0|||
161697522|NCT00430508|583940214|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
161697523|NCT00430508|583940215|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
161697524|NCT00430508|583940216|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
161697525|NCT00430508|583940217|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
161697526|NCT00430508|583940214|FG000|Overall Study|Other|1|||
161697527|NCT00430508|583940215|FG001|Overall Study|Other|1|||
161697528|NCT00430508|583940216|FG002|Overall Study|Other|3|||
161697529|NCT00430508|583940217|FG003|Overall Study|Other|0|||
161697530|NCT02971670|583940224|FG000|Overall Study|Withdrawal by Subject|4|||
161697531|NCT02971670|583940225|FG001|Overall Study|Withdrawal by Subject|1|||
161697532|NCT02971670|583940226|FG002|Overall Study|Withdrawal by Subject|1|||
161697533|NCT02971670|583940227|FG003|Overall Study|Withdrawal by Subject|2|||
161697534|NCT00288080|583940228|FG000|Overall Study|Withdrawal by Subject|1|||
161697535|NCT00288080|583940229|FG001|Overall Study|Withdrawal by Subject|3|||
161697536|NCT00288080|583940228|FG000|Overall Study|Protocol Violation|25|||
161697537|NCT00288080|583940229|FG001|Overall Study|Protocol Violation|20|||
161697538|NCT00379795|583940230|FG000|Overall Study|Death|31|||
161697539|NCT00379795|583940231|FG001|Overall Study|Death|8|||
161697540|NCT00379795|583940232|FG002|Overall Study|Death|6|||
161697541|NCT00379795|583940233|FG003|Overall Study|Death|4|||
161697542|NCT00379795|583940234|FG004|Overall Study|Death|7|||
161697543|NCT00379795|583940230|FG000|Overall Study|Adverse Event|17|||
161697544|NCT00379795|583940231|FG001|Overall Study|Adverse Event|3|||
161697545|NCT00379795|583940232|FG002|Overall Study|Adverse Event|3|||
161697546|NCT00379795|583940233|FG003|Overall Study|Adverse Event|1|||
161697547|NCT00379795|583940234|FG004|Overall Study|Adverse Event|4|||
161697548|NCT00379795|583940230|FG000|Overall Study|Lost to Follow-up|8|||
161697549|NCT00379795|583940231|FG001|Overall Study|Lost to Follow-up|1|||
161697550|NCT00379795|583940232|FG002|Overall Study|Lost to Follow-up|2|||
161697551|NCT00379795|583940233|FG003|Overall Study|Lost to Follow-up|1|||
161697552|NCT00379795|583940234|FG004|Overall Study|Lost to Follow-up|4|||
161697553|NCT00379795|583940230|FG000|Overall Study|Physician Decision|25|||
161697554|NCT00379795|583940231|FG001|Overall Study|Physician Decision|0|||
161697555|NCT00379795|583940232|FG002|Overall Study|Physician Decision|2|||
161697556|NCT00379795|583940233|FG003|Overall Study|Physician Decision|2|||
161697557|NCT00379795|583940234|FG004|Overall Study|Physician Decision|2|||
161697558|NCT00379795|583940230|FG000|Overall Study|Withdrawal by Subject|94|||
161697559|NCT00379795|583940231|FG001|Overall Study|Withdrawal by Subject|11|||
161697560|NCT00379795|583940232|FG002|Overall Study|Withdrawal by Subject|19|||
161697561|NCT00379795|583940233|FG003|Overall Study|Withdrawal by Subject|7|||
161697562|NCT00379795|583940234|FG004|Overall Study|Withdrawal by Subject|14|||
161697563|NCT00379795|583940230|FG000|Overall Study|Subject non-compliance|7|||
161697564|NCT00379795|583940231|FG001|Overall Study|Subject non-compliance|2|||
161697565|NCT00379795|583940232|FG002|Overall Study|Subject non-compliance|0|||
161697566|NCT00379795|583940233|FG003|Overall Study|Subject non-compliance|0|||
161697567|NCT00379795|583940234|FG004|Overall Study|Subject non-compliance|1|||
161836619|NCT03001219|584444975|FG000|Extension Period Analysis|Physician Decision|0|||
161836620|NCT03001219|584444976|FG001|Extension Period Analysis|Physician Decision|1|||
161836621|NCT03001219|584444975|FG000|Extension Period Analysis|Adverse Event|1|||
161697568|NCT00379795|583940230|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
161697569|NCT00379795|583940231|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161697570|NCT00379795|583940232|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161697571|NCT00379795|583940233|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
161697572|NCT00379795|583940234|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161836622|NCT03001219|584444976|FG001|Extension Period Analysis|Adverse Event|1|||
161836623|NCT03001219|584444975|FG000|Extension Period Analysis|Protocol Deviation|0|||
161697573|NCT00379795|583940230|FG000|Overall Study|Subjects condition mandated intervention|34|||
161697574|NCT00379795|583940231|FG001|Overall Study|Subjects condition mandated intervention|9|||
161697575|NCT00379795|583940232|FG002|Overall Study|Subjects condition mandated intervention|7|||
161697576|NCT00379795|583940233|FG003|Overall Study|Subjects condition mandated intervention|5|||
161697577|NCT00379795|583940234|FG004|Overall Study|Subjects condition mandated intervention|7|||
161697578|NCT00379795|583940230|FG000|Overall Study|Sponsor's decision|257|||
161697579|NCT00379795|583940231|FG001|Overall Study|Sponsor's decision|17|||
161697580|NCT00379795|583940232|FG002|Overall Study|Sponsor's decision|54|||
161697581|NCT00379795|583940233|FG003|Overall Study|Sponsor's decision|47|||
161697582|NCT00379795|583940234|FG004|Overall Study|Sponsor's decision|10|||
161697583|NCT01687712|583940235|FG000|Cycle 1|Not Biochemically Pregnant|386|||
161697584|NCT01687712|583940236|FG001|Cycle 1|Not Biochemically Pregnant|348|||
161697585|NCT01687712|583940235|FG000|Cycle 1|Early Pregnancy Loss|43|||
161697586|NCT01687712|583940236|FG001|Cycle 1|Early Pregnancy Loss|60|||
161697587|NCT01687712|583940235|FG000|Cycle 1|Ectopic Pregnancy|5|||
161697588|NCT01687712|583940236|FG001|Cycle 1|Ectopic Pregnancy|5|||
161697589|NCT01687712|583940235|FG000|Cycle 1|Heterotropic Pregnancy|1|||
161697590|NCT01687712|583940236|FG001|Cycle 1|Heterotropic Pregnancy|0|||
161697591|NCT01687712|583940235|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
161697592|NCT01687712|583940236|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
161697593|NCT01687712|583940235|FG000|Cycle 1|Abortion|3|||
161697594|NCT01687712|583940236|FG001|Cycle 1|Abortion|0|||
161697595|NCT01687712|583940235|FG000|Cycle 1|Intrauterine Fetal Death|0|||
161697596|NCT01687712|583940236|FG001|Cycle 1|Intrauterine Fetal Death|1|||
161697597|NCT01687712|583940235|FG000|Cycle 1|Lost to Follow-up|1|||
161697598|NCT01687712|583940236|FG001|Cycle 1|Lost to Follow-up|1|||
161697599|NCT01687712|583940235|FG000|Cycle 2|Not Biochemically Pregnant|74|||
161697600|NCT01687712|583940236|FG001|Cycle 2|Not Biochemically Pregnant|77|||
161697601|NCT01687712|583940235|FG000|Cycle 2|Early Pregnancy Loss|18|||
161697602|NCT01687712|583940236|FG001|Cycle 2|Early Pregnancy Loss|16|||
161697603|NCT01687712|583940235|FG000|Cycle 2|Ectopic Pregnancy|0|||
161697604|NCT01687712|583940236|FG001|Cycle 2|Ectopic Pregnancy|1|||
161697605|NCT01687712|583940235|FG000|Cycle 2|Still Birth|1|||
161697606|NCT01687712|583940236|FG001|Cycle 2|Still Birth|0|||
161697607|NCT01687712|583940235|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
161697608|NCT01687712|583940236|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
161697609|NCT01687712|583940235|FG000|Cycle 3|Not Biochemically Pregnant|21|||
161697610|NCT01687712|583940236|FG001|Cycle 3|Not Biochemically Pregnant|22|||
161697611|NCT01687712|583940235|FG000|Cycle 3|Early Pregnancy Loss|1|||
161697612|NCT01687712|583940236|FG001|Cycle 3|Early Pregnancy Loss|2|||
161697613|NCT01687712|583940235|FG000|Cycle 3|Ectopic Pregnancy|1|||
161697614|NCT01687712|583940236|FG001|Cycle 3|Ectopic Pregnancy|0|||
161697615|NCT01687712|583940235|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
161697616|NCT01687712|583940236|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
161697617|NCT03064841|583940237|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
161697618|NCT03064841|583940237|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
161697619|NCT03064841|583940237|FG000|Overall Study|Screen failure|2|||
161697620|NCT01145066|583940238|FG000|Overall Study|To resume NSAIDs|2|||
161697621|NCT01145066|583940239|FG001|Overall Study|To resume NSAIDs|2|||
161697622|NCT01145066|583940240|FG002|Overall Study|To resume NSAIDs|1|||
161697623|NCT01145066|583940238|FG000|Overall Study|Non-related surgery|0|||
161697624|NCT01145066|583940239|FG001|Overall Study|Non-related surgery|0|||
161697625|NCT01145066|583940240|FG002|Overall Study|Non-related surgery|1|||
161697626|NCT01145066|583940238|FG000|Overall Study|Withdrawal by Subject|0|||
161697627|NCT01145066|583940239|FG001|Overall Study|Withdrawal by Subject|0|||
161697628|NCT01145066|583940240|FG002|Overall Study|Withdrawal by Subject|2|||
161697629|NCT01145066|583940238|FG000|Overall Study|To start new med|1|||
161697630|NCT01145066|583940239|FG001|Overall Study|To start new med|0|||
161697631|NCT01145066|583940240|FG002|Overall Study|To start new med|0|||
161697632|NCT01145066|583940238|FG000|Overall Study|problems swallowing capsule|1|||
161697633|NCT01145066|583940239|FG001|Overall Study|problems swallowing capsule|0|||
161697634|NCT01145066|583940240|FG002|Overall Study|problems swallowing capsule|0|||
161697635|NCT01145066|583940238|FG000|Overall Study|Abdominal discomfort|0|||
161697636|NCT01145066|583940239|FG001|Overall Study|Abdominal discomfort|1|||
161697637|NCT01145066|583940240|FG002|Overall Study|Abdominal discomfort|0|||
161697638|NCT01145066|583940238|FG000|Overall Study|Low platelet count|0|||
161697639|NCT01145066|583940239|FG001|Overall Study|Low platelet count|1|||
161697640|NCT01145066|583940240|FG002|Overall Study|Low platelet count|0|||
161697641|NCT03920670|583940241|FG000|Overall Study|Protocol Violation|2|||
161697642|NCT03920670|583940242|FG001|Overall Study|Protocol Violation|2|||
161697643|NCT03920670|583940241|FG000|Overall Study|Adverse Event|1|||
161697644|NCT03920670|583940242|FG001|Overall Study|Adverse Event|0|||
161697645|NCT01250379|583940249|FG000|Overall Study|Death|141|||
161697646|NCT01250379|583940250|FG001|Overall Study|Death|148|||
161697647|NCT01250379|583940249|FG000|Overall Study|Withdrawal by Subject|32|||
161697648|NCT01250379|583940250|FG001|Overall Study|Withdrawal by Subject|20|||
161697649|NCT01250379|583940249|FG000|Overall Study|Physician Decision|11|||
161697650|NCT01250379|583940250|FG001|Overall Study|Physician Decision|3|||
161697651|NCT01250379|583940249|FG000|Overall Study|Protocol Violation|2|||
161697652|NCT01250379|583940250|FG001|Overall Study|Protocol Violation|8|||
161697653|NCT01250379|583940249|FG000|Overall Study|Lost to Follow-up|9|||
161697654|NCT01250379|583940250|FG001|Overall Study|Lost to Follow-up|6|||
161697655|NCT01250379|583940249|FG000|Overall Study|Adverse Event|5|||
161697656|NCT01250379|583940250|FG001|Overall Study|Adverse Event|4|||
161697657|NCT01250379|583940249|FG000|Overall Study|Other|0|||
161697658|NCT01250379|583940250|FG001|Overall Study|Other|4|||
161697659|NCT01250379|583940249|FG000|Overall Study|Participant noncompliance|2|||
161697660|NCT01250379|583940250|FG001|Overall Study|Participant noncompliance|0|||
161697661|NCT01984268|583940251|FG000|Overall Study|Study Terminated|15|||
161697662|NCT01227902|583941877|FG000|Overall Study|Adverse Event|12|||
161697663|NCT01227902|583941878|FG001|Overall Study|Adverse Event|8|||
161697664|NCT01227902|583941879|FG002|Overall Study|Adverse Event|11|||
161697665|NCT01227902|583941880|FG003|Overall Study|Adverse Event|4|||
161697666|NCT01227902|583941877|FG000|Overall Study|Lack of Efficacy|1|||
161697667|NCT01227902|583941878|FG001|Overall Study|Lack of Efficacy|2|||
161697668|NCT01227902|583941879|FG002|Overall Study|Lack of Efficacy|2|||
161697669|NCT01227902|583941880|FG003|Overall Study|Lack of Efficacy|1|||
161697670|NCT01227902|583941877|FG000|Overall Study|Protocol Violation|1|||
161697671|NCT01227902|583941878|FG001|Overall Study|Protocol Violation|0|||
161697672|NCT01227902|583941879|FG002|Overall Study|Protocol Violation|0|||
161697673|NCT01227902|583941880|FG003|Overall Study|Protocol Violation|0|||
161697674|NCT01227902|583941877|FG000|Overall Study|Lost to Follow-up|0|||
161697675|NCT01227902|583941878|FG001|Overall Study|Lost to Follow-up|0|||
161697676|NCT01227902|583941879|FG002|Overall Study|Lost to Follow-up|1|||
161697677|NCT01227902|583941880|FG003|Overall Study|Lost to Follow-up|2|||
161697678|NCT01227902|583941877|FG000|Overall Study|Physician Decision|0|||
161697679|NCT01227902|583941878|FG001|Overall Study|Physician Decision|1|||
161697680|NCT01227902|583941879|FG002|Overall Study|Physician Decision|1|||
161697681|NCT01227902|583941880|FG003|Overall Study|Physician Decision|0|||
161697682|NCT01227902|583941877|FG000|Overall Study|Withdrawal by Subject|4|||
161697683|NCT01227902|583941878|FG001|Overall Study|Withdrawal by Subject|2|||
161697684|NCT01227902|583941879|FG002|Overall Study|Withdrawal by Subject|4|||
161697685|NCT01227902|583941880|FG003|Overall Study|Withdrawal by Subject|3|||
161697686|NCT02363478|583941885|FG000|Overall Study|Lost to Follow-up|4|||
161697687|NCT02363478|583941885|FG000|Overall Study|Adverse Event|4|||
161697688|NCT01916980|583941889|FG000|Overall Study|Adverse Event|4|||
161697689|NCT01916980|583941890|FG001|Overall Study|Adverse Event|2|||
161697690|NCT01916980|583941889|FG000|Overall Study|Lack of Efficacy|2|||
161697691|NCT01916980|583941890|FG001|Overall Study|Lack of Efficacy|2|||
161697692|NCT01916980|583941889|FG000|Overall Study|Withdrawal by Subject|1|||
161697693|NCT01916980|583941890|FG001|Overall Study|Withdrawal by Subject|0|||
161697694|NCT00546364|583941891|FG000|Overall Study|Disease progression|5|||
161697695|NCT00546364|583941892|FG001|Overall Study|Disease progression|11|||
161697696|NCT00546364|583941893|FG002|Overall Study|Disease progression|8|||
161697697|NCT00546364|583941891|FG000|Overall Study|Completed and off treatment|1|||
161697698|NCT00546364|583941892|FG001|Overall Study|Completed and off treatment|0|||
161697699|NCT00546364|583941893|FG002|Overall Study|Completed and off treatment|2|||
161697700|NCT00546364|583941891|FG000|Overall Study|Administrative reason by sponsor|1|||
161697701|NCT00546364|583941892|FG001|Overall Study|Administrative reason by sponsor|0|||
161697702|NCT00546364|583941893|FG002|Overall Study|Administrative reason by sponsor|0|||
161697703|NCT00546364|583941891|FG000|Overall Study|Poor compliance/noncompliance|0|||
161697704|NCT00546364|583941892|FG001|Overall Study|Poor compliance/noncompliance|0|||
161697705|NCT00546364|583941893|FG002|Overall Study|Poor compliance/noncompliance|1|||
161697706|NCT00546364|583941891|FG000|Overall Study|No longer meets study criteria|1|||
161697707|NCT00546364|583941892|FG001|Overall Study|No longer meets study criteria|1|||
161697708|NCT00546364|583941893|FG002|Overall Study|No longer meets study criteria|0|||
161697709|NCT00546364|583941891|FG000|Overall Study|Withdrawal by Subject|5|||
161697710|NCT00546364|583941892|FG001|Overall Study|Withdrawal by Subject|6|||
161697711|NCT00546364|583941893|FG002|Overall Study|Withdrawal by Subject|3|||
161697712|NCT00546364|583941891|FG000|Overall Study|Prior taxotere|1|||
161836624|NCT03001219|584444976|FG001|Extension Period Analysis|Protocol Deviation|1|||
161697713|NCT00546364|583941892|FG001|Overall Study|Prior taxotere|0|||
161697714|NCT00546364|583941893|FG002|Overall Study|Prior taxotere|0|||
161697715|NCT00546364|583941891|FG000|Overall Study|Mixed response|1|||
161836625|NCT03001219|584444975|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
161697716|NCT00546364|583941892|FG001|Overall Study|Mixed response|0|||
161697717|NCT00546364|583941893|FG002|Overall Study|Mixed response|0|||
161697718|NCT00546364|583941891|FG000|Overall Study|Palliative treatment|1|||
161697719|NCT00546364|583941892|FG001|Overall Study|Palliative treatment|0|||
161697720|NCT00546364|583941893|FG002|Overall Study|Palliative treatment|1|||
161697721|NCT00546364|583941891|FG000|Overall Study|Target lesions resected|1|||
161697722|NCT00546364|583941892|FG001|Overall Study|Target lesions resected|0|||
161697723|NCT00546364|583941893|FG002|Overall Study|Target lesions resected|0|||
161697724|NCT00546364|583941891|FG000|Overall Study|Physician Decision|0|||
161697725|NCT00546364|583941892|FG001|Overall Study|Physician Decision|0|||
161697726|NCT00546364|583941893|FG002|Overall Study|Physician Decision|1|||
161697727|NCT00546364|583941891|FG000|Overall Study|Sponsor decision|0|||
161697728|NCT00546364|583941892|FG001|Overall Study|Sponsor decision|0|||
161697729|NCT00546364|583941893|FG002|Overall Study|Sponsor decision|1|||
161697730|NCT03064763|583941894|FG000|Overall Study|Lost to Follow-up|1|||
161697731|NCT03064763|583941894|FG000|Overall Study|Death|8|||
161697732|NCT02415712|583941895|FG000|Overall Study|Protocol Violation|16|||
161697733|NCT01537211|583941897|FG000|Overall Study|Lost to Follow-up|0|||
161697734|NCT01537211|583941898|FG001|Overall Study|Lost to Follow-up|1|||
161697735|NCT02624492|583941916|FG000|Overall Study|Adverse Event|2|||
161697736|NCT02624492|583941917|FG001|Overall Study|Adverse Event|2|||
161697737|NCT02624492|583941918|FG002|Overall Study|Adverse Event|2|||
161697738|NCT02624492|583941916|FG000|Overall Study|Progressive disease|0|||
161697739|NCT02624492|583941917|FG001|Overall Study|Progressive disease|2|||
161697740|NCT02624492|583941918|FG002|Overall Study|Progressive disease|3|||
161697741|NCT00343512|583941919|FG000|Overall Study|Withdrawal by Subject|2|||
161697742|NCT00323557|583941920|FG000|Overall Study|Physician Decision|1|||
161697743|NCT00323557|583941921|FG001|Overall Study|Physician Decision|0|||
161697744|NCT00684515|583941922|FG000|Overall Study|Adverse Event|3|||
161697745|NCT00684515|583941923|FG001|Overall Study|Adverse Event|3|||
161697746|NCT00684515|583941924|FG002|Overall Study|Adverse Event|1|||
161697747|NCT00684515|583941922|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
161697748|NCT00684515|583941923|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
161697749|NCT00684515|583941924|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
161697750|NCT00763321|583941925|FG000|Open-label Period|Adverse Event|24|||
161836626|NCT03001219|584444976|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
161836627|NCT01797835|584444977|FG000|Overall Study|Lost to Follow-up|31|||
161836628|NCT01797835|584444978|FG001|Overall Study|Lost to Follow-up|27|||
161697751|NCT00763321|583941926|FG001|Open-label Period|Adverse Event|0|||
161697752|NCT00763321|583941927|FG002|Open-label Period|Adverse Event|0|||
161697753|NCT00763321|583941925|FG000|Open-label Period|Lost to Follow-up|14|||
161697754|NCT00763321|583941926|FG001|Open-label Period|Lost to Follow-up|0|||
161697755|NCT00763321|583941927|FG002|Open-label Period|Lost to Follow-up|0|||
161697756|NCT00763321|583941925|FG000|Open-label Period|Withdrawal by Subject|7|||
161697757|NCT00763321|583941926|FG001|Open-label Period|Withdrawal by Subject|0|||
161836629|NCT01403064|584444979|FG000|Overall Study|Death|0|||
161836630|NCT01403064|584444980|FG001|Overall Study|Death|0|||
161697758|NCT00763321|583941927|FG002|Open-label Period|Withdrawal by Subject|0|||
161697759|NCT00763321|583941925|FG000|Open-label Period|Subject noncompliant|7|||
161697760|NCT00763321|583941926|FG001|Open-label Period|Subject noncompliant|0|||
161697761|NCT00763321|583941927|FG002|Open-label Period|Subject noncompliant|0|||
161697762|NCT00763321|583941925|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
161697763|NCT00763321|583941926|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
161697764|NCT00763321|583941927|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
161697765|NCT00763321|583941925|FG000|Open-label Period|Lack of Efficacy|2|||
161697766|NCT00763321|583941926|FG001|Open-label Period|Lack of Efficacy|0|||
161697767|NCT00763321|583941927|FG002|Open-label Period|Lack of Efficacy|0|||
161697768|NCT00763321|583941925|FG000|Open-label Period|Other|4|||
161697769|NCT00763321|583941926|FG001|Open-label Period|Other|0|||
161697770|NCT00763321|583941927|FG002|Open-label Period|Other|0|||
161697771|NCT00763321|583941925|FG000|Double-blind Period|Lack of Efficacy|0|||
161697772|NCT00763321|583941926|FG001|Double-blind Period|Lack of Efficacy|9|||
161697773|NCT00763321|583941927|FG002|Double-blind Period|Lack of Efficacy|17|||
161697774|NCT00763321|583941925|FG000|Double-blind Period|Adverse Event|0|||
161697775|NCT00763321|583941926|FG001|Double-blind Period|Adverse Event|4|||
161697776|NCT00763321|583941927|FG002|Double-blind Period|Adverse Event|4|||
161697777|NCT00763321|583941925|FG000|Double-blind Period|Lost to Follow-up|0|||
161697778|NCT00763321|583941926|FG001|Double-blind Period|Lost to Follow-up|4|||
161697779|NCT00763321|583941927|FG002|Double-blind Period|Lost to Follow-up|2|||
161697780|NCT00763321|583941925|FG000|Double-blind Period|Withdrawal by Subject|0|||
161697781|NCT00763321|583941926|FG001|Double-blind Period|Withdrawal by Subject|2|||
161697782|NCT00763321|583941927|FG002|Double-blind Period|Withdrawal by Subject|3|||
161697783|NCT00763321|583941925|FG000|Double-blind Period|Other|0|||
161697784|NCT00763321|583941926|FG001|Double-blind Period|Other|2|||
161836631|NCT01403064|584444981|FG002|Overall Study|Death|1|||
161697785|NCT00763321|583941927|FG002|Double-blind Period|Other|3|||
161697786|NCT02793232|583941928|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697787|NCT02793232|583941929|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697788|NCT02793232|583941930|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697789|NCT02793232|583941931|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697790|NCT02793232|583941932|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
161697791|NCT02793232|583941933|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697792|NCT02793232|583941934|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
161697793|NCT02793232|583941935|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697794|NCT02793232|583941936|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697795|NCT02387580|583941939|FG000|Overall Study|Withdrawal by Subject|0|||
161697796|NCT02387580|583941940|FG001|Overall Study|Withdrawal by Subject|0|||
161697797|NCT02387580|583941941|FG002|Overall Study|Withdrawal by Subject|0|||
161697798|NCT02387580|583941942|FG003|Overall Study|Withdrawal by Subject|1|||
161697799|NCT02387580|583941943|FG004|Overall Study|Withdrawal by Subject|0|||
161697800|NCT02387580|583941944|FG005|Overall Study|Withdrawal by Subject|0|||
161697801|NCT00087646|583941945|FG000|Overall Study|Adverse Event|37|||
161697802|NCT00087646|583941946|FG001|Overall Study|Adverse Event|6|||
161697803|NCT00087646|583941947|FG002|Overall Study|Adverse Event|18|||
161697804|NCT00087646|583941948|FG003|Overall Study|Adverse Event|20|||
161697805|NCT00087646|583941945|FG000|Overall Study|Death|0|||
161836632|NCT01403064|584444982|FG003|Overall Study|Death|1|||
161836633|NCT01403064|584444979|FG000|Overall Study|Withdrawal by Subject|0|||
161836634|NCT01403064|584444980|FG001|Overall Study|Withdrawal by Subject|0|||
161836635|NCT01403064|584444981|FG002|Overall Study|Withdrawal by Subject|1|||
161836636|NCT01403064|584444982|FG003|Overall Study|Withdrawal by Subject|1|||
161836637|NCT01403064|584444979|FG000|Overall Study|Other|1|||
161836638|NCT01403064|584444980|FG001|Overall Study|Other|0|||
161836639|NCT01403064|584444981|FG002|Overall Study|Other|2|||
161836640|NCT01403064|584444982|FG003|Overall Study|Other|1|||
161836641|NCT00973765|584444983|FG000|Overall Study|Lost to Follow-up|8|||
161836642|NCT00973765|584444984|FG001|Overall Study|Lost to Follow-up|14|||
161836643|NCT02669940|584444985|FG000|Overall Study|Failure to return|0|||
161836644|NCT02669940|584444986|FG001|Overall Study|Failure to return|3|||
161836645|NCT02669940|584444985|FG000|Overall Study|Insufficient follow-up data|1|||
161836646|NCT02669940|584444986|FG001|Overall Study|Insufficient follow-up data|0|||
161836647|NCT01892657|584444987|FG000|Overall Study|Withdrawal by Subject|6|||
161836648|NCT01892657|584444987|FG000|Overall Study|Protocol Violation|12|||
161836649|NCT00986180|584444988|FG000|Overall Study|Adverse Event|21|||
161836650|NCT00986180|584444989|FG001|Overall Study|Adverse Event|23|||
161836651|NCT00986180|584444988|FG000|Overall Study|Lack of Efficacy|4|||
161836652|NCT00986180|584444989|FG001|Overall Study|Lack of Efficacy|3|||
161836653|NCT00986180|584444988|FG000|Overall Study|Lost to Follow-up|5|||
161836654|NCT00986180|584444989|FG001|Overall Study|Lost to Follow-up|7|||
161836655|NCT00986180|584444988|FG000|Overall Study|Physician Decision|1|||
161836656|NCT00986180|584444989|FG001|Overall Study|Physician Decision|3|||
161836657|NCT00986180|584444988|FG000|Overall Study|Protocol Violation|2|||
161836658|NCT00986180|584444989|FG001|Overall Study|Protocol Violation|0|||
161836659|NCT00986180|584444988|FG000|Overall Study|Withdrawal by Subject|1|||
161836660|NCT00986180|584444989|FG001|Overall Study|Withdrawal by Subject|9|||
161836661|NCT00986180|584444988|FG000|Overall Study|Miscellanies|10|||
161836662|NCT00986180|584444989|FG001|Overall Study|Miscellanies|11|||
161836663|NCT01070771|584444992|FG000|Overall Study|Adverse Event|2|||
161836664|NCT01070771|584444992|FG000|Overall Study|Protocol Violation|1|||
161836665|NCT03835325|584444993|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
161836666|NCT03835325|584444993|FG000|Overall Study|Selection failure|1|||
161836667|NCT01370213|584444996|FG000|Overall Study|Early Death|1|||
161836668|NCT01370213|584444997|FG001|Overall Study|Early Death|0|||
161836669|NCT01370213|584444998|FG002|Overall Study|Early Death|0|||
161697806|NCT00087646|583941946|FG001|Overall Study|Death|1|||
161697807|NCT00087646|583941947|FG002|Overall Study|Death|0|||
161697808|NCT00087646|583941948|FG003|Overall Study|Death|0|||
161697809|NCT00087646|583941945|FG000|Overall Study|Withdrawal by Subject|6|||
161697810|NCT00087646|583941946|FG001|Overall Study|Withdrawal by Subject|1|||
161697811|NCT00087646|583941947|FG002|Overall Study|Withdrawal by Subject|2|||
161697812|NCT00087646|583941948|FG003|Overall Study|Withdrawal by Subject|2|||
161836670|NCT01370213|584444996|FG000|Overall Study|Not evaluable|0|||
161836671|NCT01370213|584444997|FG001|Overall Study|Not evaluable|2|||
161836672|NCT01370213|584444998|FG002|Overall Study|Not evaluable|0|||
161836673|NCT00567476|584445004|FG000|Overall Study|Adverse Event|2|||
161836674|NCT00567476|584445005|FG001|Overall Study|Adverse Event|0|||
161836675|NCT00567476|584445004|FG000|Overall Study|Pregnancy|1|||
161836676|NCT00567476|584445005|FG001|Overall Study|Pregnancy|0|||
161836677|NCT00567476|584445004|FG000|Overall Study|Protocol Violation|4|||
161836678|NCT00567476|584445005|FG001|Overall Study|Protocol Violation|1|||
161836679|NCT00567476|584445004|FG000|Overall Study|Lost to Follow-up|0|||
161836680|NCT00567476|584445005|FG001|Overall Study|Lost to Follow-up|1|||
161836681|NCT00567476|584445004|FG000|Overall Study|Administrative issues|1|||
161697813|NCT00087646|583941945|FG000|Overall Study|Insufficient therapeutic response|64|||
161697814|NCT00087646|583941946|FG001|Overall Study|Insufficient therapeutic response|24|||
161697815|NCT00087646|583941947|FG002|Overall Study|Insufficient therapeutic response|38|||
161697816|NCT00087646|583941948|FG003|Overall Study|Insufficient therapeutic response|51|||
161697817|NCT00087646|583941945|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
161697818|NCT00087646|583941946|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
161697819|NCT00087646|583941947|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
161697820|NCT00087646|583941948|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
161697821|NCT00087646|583941945|FG000|Overall Study|Failure to Return|5|||
161697822|NCT00087646|583941946|FG001|Overall Study|Failure to Return|2|||
161697823|NCT00087646|583941947|FG002|Overall Study|Failure to Return|2|||
161697824|NCT00087646|583941948|FG003|Overall Study|Failure to Return|3|||
161697825|NCT00087646|583941945|FG000|Overall Study|Administrative/Other|6|||
161697826|NCT00087646|583941946|FG001|Overall Study|Administrative/Other|1|||
161697827|NCT00087646|583941947|FG002|Overall Study|Administrative/Other|1|||
161697828|NCT00087646|583941948|FG003|Overall Study|Administrative/Other|2|||
161697829|NCT00087646|583941945|FG000|Overall Study|Other Protocol Violation|3|||
161697830|NCT00087646|583941946|FG001|Overall Study|Other Protocol Violation|1|||
161697831|NCT00087646|583941947|FG002|Overall Study|Other Protocol Violation|0|||
161697832|NCT00087646|583941948|FG003|Overall Study|Other Protocol Violation|0|||
161697833|NCT00087646|583941945|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161697834|NCT00087646|583941946|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161697835|NCT00087646|583941947|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161697836|NCT00087646|583941948|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
161697837|NCT02301403|583941962|FG000|Overall Study|Withdrawal by Subject|28|||
161697838|NCT02301403|583941963|FG001|Overall Study|Withdrawal by Subject|41|||
161697839|NCT01060059|583941964|FG000|Overall Study|Adverse Event|1|||
161697840|NCT01060059|583941965|FG001|Overall Study|Adverse Event|1|||
161697841|NCT01060059|583941964|FG000|Overall Study|Death|2|||
161697842|NCT01060059|583941965|FG001|Overall Study|Death|3|||
161697843|NCT01060059|583941964|FG000|Overall Study|Lost to Follow-up|18|||
161697844|NCT01060059|583941965|FG001|Overall Study|Lost to Follow-up|34|||
161697845|NCT01060059|583941964|FG000|Overall Study|entry criteria not met|4|||
161697846|NCT01060059|583941965|FG001|Overall Study|entry criteria not met|3|||
161697847|NCT01060059|583941964|FG000|Overall Study|Withdrawal by Subject|35|||
161697848|NCT01060059|583941965|FG001|Overall Study|Withdrawal by Subject|23|||
161697849|NCT01060059|583941964|FG000|Overall Study|lack of glycemic control|2|||
161697850|NCT01060059|583941965|FG001|Overall Study|lack of glycemic control|1|||
161697851|NCT01060059|583941964|FG000|Overall Study|lack of compliance|5|||
161697852|NCT01060059|583941965|FG001|Overall Study|lack of compliance|2|||
161697853|NCT02302963|583941968|FG000|Overall Study|Withdrawal by Subject|2|||
161697854|NCT02302963|583941969|FG001|Overall Study|Withdrawal by Subject|1|||
161697855|NCT02302963|583941968|FG000|Overall Study|Steroid injection|0|||
161697856|NCT02302963|583941969|FG001|Overall Study|Steroid injection|1|||
161697857|NCT02302963|583941968|FG000|Overall Study|Physician Decision|1|||
161697858|NCT02302963|583941969|FG001|Overall Study|Physician Decision|0|||
161697859|NCT01816243|583941970|FG000|Overall Study|Adverse Event|6|||
161697860|NCT01816243|583941970|FG000|Overall Study|Lost to Follow-up|1|||
161697861|NCT01816243|583941970|FG000|Overall Study|Lack of Efficacy|1|||
161697862|NCT01816243|583941970|FG000|Overall Study|Not eligible for the study|1|||
161697863|NCT01816243|583941970|FG000|Overall Study|Amputation|3|||
161697864|NCT01920711|583941971|FG000|Overall Study|Death|347|||
161697865|NCT01920711|583941972|FG001|Overall Study|Death|356|||
161697866|NCT01920711|583941971|FG000|Overall Study|Lost to Follow-up|13|||
161697867|NCT01920711|583941972|FG001|Overall Study|Lost to Follow-up|14|||
161697868|NCT01920711|583941971|FG000|Overall Study|Withdrawal by Subject|4|||
161697869|NCT01920711|583941972|FG001|Overall Study|Withdrawal by Subject|3|||
161697870|NCT03891901|583941973|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
161697871|NCT03891901|583941974|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697872|NCT03891901|583941975|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697873|NCT03891901|583941976|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697874|NCT03891901|583941977|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697875|NCT03891901|583941978|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697876|NCT03891901|583941979|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697877|NCT03891901|583941980|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697878|NCT03891901|583941981|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697879|NCT03891901|583941973|FG000|Overall Study|Adverse Event|2|||
161697880|NCT03891901|583941974|FG001|Overall Study|Adverse Event|2|||
161697881|NCT03891901|583941975|FG002|Overall Study|Adverse Event|0|||
161697882|NCT03891901|583941976|FG003|Overall Study|Adverse Event|0|||
161697883|NCT03891901|583941977|FG004|Overall Study|Adverse Event|0|||
161697884|NCT03891901|583941978|FG005|Overall Study|Adverse Event|0|||
161697885|NCT03891901|583941979|FG006|Overall Study|Adverse Event|0|||
161697886|NCT03891901|583941980|FG007|Overall Study|Adverse Event|0|||
161697887|NCT03891901|583941981|FG008|Overall Study|Adverse Event|0|||
161697888|NCT03891901|583941973|FG000|Overall Study|Poor venous access|1|||
161697889|NCT03891901|583941974|FG001|Overall Study|Poor venous access|0|||
161697890|NCT03891901|583941975|FG002|Overall Study|Poor venous access|0|||
161697891|NCT03891901|583941976|FG003|Overall Study|Poor venous access|0|||
161697892|NCT03891901|583941977|FG004|Overall Study|Poor venous access|0|||
161697893|NCT03891901|583941978|FG005|Overall Study|Poor venous access|0|||
161697894|NCT03891901|583941979|FG006|Overall Study|Poor venous access|0|||
161697895|NCT03891901|583941980|FG007|Overall Study|Poor venous access|0|||
161697896|NCT03891901|583941981|FG008|Overall Study|Poor venous access|0|||
161697897|NCT03891901|583941973|FG000|Overall Study|Withdrawal by Subject|0|||
161697898|NCT03891901|583941974|FG001|Overall Study|Withdrawal by Subject|2|||
161697899|NCT03891901|583941975|FG002|Overall Study|Withdrawal by Subject|0|||
161697900|NCT03891901|583941976|FG003|Overall Study|Withdrawal by Subject|0|||
161697901|NCT03891901|583941977|FG004|Overall Study|Withdrawal by Subject|0|||
161697902|NCT03891901|583941978|FG005|Overall Study|Withdrawal by Subject|0|||
161697903|NCT03891901|583941979|FG006|Overall Study|Withdrawal by Subject|0|||
161697904|NCT03891901|583941980|FG007|Overall Study|Withdrawal by Subject|0|||
161697905|NCT03891901|583941981|FG008|Overall Study|Withdrawal by Subject|0|||
161697906|NCT00573794|583941982|FG000|Overall Study|Adverse Event|81|||
161697907|NCT00573794|583941982|FG000|Overall Study|Withdrew Consent|90|||
161697908|NCT00573794|583941982|FG000|Overall Study|Lost to Follow-up|13|||
161697909|NCT00573794|583941982|FG000|Overall Study|Protocol Violation|6|||
161697910|NCT00573794|583941982|FG000|Overall Study|Lack of Efficacy|94|||
161697911|NCT00573794|583941982|FG000|Overall Study|Other|46|||
161697912|NCT04556617|583941993|FG000|Overall Study|progressive disease|0|||
161697913|NCT04556617|583941994|FG001|Overall Study|progressive disease|2|||
161836682|NCT00567476|584445005|FG001|Overall Study|Administrative issues|0|||
161836683|NCT00567476|584445004|FG000|Overall Study|Medical Decision|0|||
161836684|NCT00567476|584445005|FG001|Overall Study|Medical Decision|1|||
161836685|NCT00567476|584445004|FG000|Overall Study|Non-adherence to protocol|0|||
161836686|NCT00567476|584445005|FG001|Overall Study|Non-adherence to protocol|1|||
161836687|NCT02595008|584445006|FG000|Overall Study|Enrolled In Error|1|||
161836688|NCT02595008|584445007|FG001|Overall Study|Enrolled In Error|0|||
161836689|NCT02999477|584445008|FG000|Overall Study|found ineligible after first dose|0|||
161836690|NCT02999477|584445009|FG001|Overall Study|found ineligible after first dose|1|||
161836691|NCT02999477|584445008|FG000|Overall Study|Withdrawal by Subject|1|||
161836692|NCT02999477|584445009|FG001|Overall Study|Withdrawal by Subject|1|||
161836693|NCT01846273|584445012|FG000|Overall Study|Adverse Event|9|||
161836694|NCT01846273|584445013|FG001|Overall Study|Adverse Event|7|||
161836695|NCT01846273|584445014|FG002|Overall Study|Adverse Event|0|||
161836696|NCT01846273|584445012|FG000|Overall Study|Subject withdrew consent|5|||
161836697|NCT01846273|584445013|FG001|Overall Study|Subject withdrew consent|8|||
161836698|NCT01846273|584445014|FG002|Overall Study|Subject withdrew consent|0|||
161836699|NCT01846273|584445012|FG000|Overall Study|Lost to Follow-up|2|||
161836700|NCT01846273|584445013|FG001|Overall Study|Lost to Follow-up|1|||
161836701|NCT01846273|584445014|FG002|Overall Study|Lost to Follow-up|0|||
161836702|NCT01846273|584445012|FG000|Overall Study|Administrative problems|1|||
161836703|NCT01846273|584445013|FG001|Overall Study|Administrative problems|0|||
161836704|NCT01846273|584445014|FG002|Overall Study|Administrative problems|0|||
161836705|NCT01846273|584445012|FG000|Overall Study|Death|2|||
161836706|NCT01846273|584445013|FG001|Overall Study|Death|1|||
161836707|NCT01846273|584445014|FG002|Overall Study|Death|0|||
161697914|NCT04556617|583941995|FG002|Overall Study|progressive disease|2|||
161697915|NCT04556617|583941996|FG003|Overall Study|progressive disease|1|||
161697916|NCT04556617|583941997|FG004|Overall Study|progressive disease|1|||
161697917|NCT04556617|583941993|FG000|Overall Study|Physician Decision|0|||
161836708|NCT01846273|584445012|FG000|Overall Study|Disease Progression|0|||
161836709|NCT01846273|584445013|FG001|Overall Study|Disease Progression|4|||
161836710|NCT01846273|584445014|FG002|Overall Study|Disease Progression|0|||
161836711|NCT01846273|584445012|FG000|Overall Study|Protocol Deviation|2|||
161836712|NCT01846273|584445013|FG001|Overall Study|Protocol Deviation|3|||
161836713|NCT01846273|584445014|FG002|Overall Study|Protocol Deviation|0|||
161836714|NCT01846273|584445012|FG000|Overall Study|Physician Decision|1|||
161836715|NCT01846273|584445013|FG001|Overall Study|Physician Decision|2|||
161697918|NCT04556617|583941994|FG001|Overall Study|Physician Decision|0|||
161697919|NCT04556617|583941995|FG002|Overall Study|Physician Decision|2|||
161697920|NCT04556617|583941996|FG003|Overall Study|Physician Decision|0|||
161697921|NCT04556617|583941997|FG004|Overall Study|Physician Decision|0|||
161697922|NCT04556617|583941993|FG000|Overall Study|Adverse Event|0|||
161697923|NCT04556617|583941994|FG001|Overall Study|Adverse Event|0|||
161697924|NCT04556617|583941995|FG002|Overall Study|Adverse Event|2|||
161697925|NCT04556617|583941996|FG003|Overall Study|Adverse Event|3|||
161697926|NCT04556617|583941997|FG004|Overall Study|Adverse Event|0|||
161697927|NCT04556617|583941993|FG000|Overall Study|Withdrawal by Subject|0|||
161697928|NCT04556617|583941994|FG001|Overall Study|Withdrawal by Subject|2|||
161697929|NCT04556617|583941995|FG002|Overall Study|Withdrawal by Subject|1|||
161697930|NCT04556617|583941996|FG003|Overall Study|Withdrawal by Subject|1|||
161697931|NCT04556617|583941997|FG004|Overall Study|Withdrawal by Subject|0|||
161697932|NCT04556617|583941993|FG000|Overall Study|PSA increase|0|||
161697933|NCT04556617|583941994|FG001|Overall Study|PSA increase|1|||
161697934|NCT04556617|583941995|FG002|Overall Study|PSA increase|0|||
161697935|NCT04556617|583941996|FG003|Overall Study|PSA increase|0|||
161697936|NCT04556617|583941997|FG004|Overall Study|PSA increase|0|||
161697937|NCT04556617|583941993|FG000|Overall Study|Sponsor study termination|1|||
161697938|NCT04556617|583941994|FG001|Overall Study|Sponsor study termination|0|||
161697939|NCT04556617|583941995|FG002|Overall Study|Sponsor study termination|0|||
161697940|NCT04556617|583941996|FG003|Overall Study|Sponsor study termination|0|||
161697941|NCT04556617|583941997|FG004|Overall Study|Sponsor study termination|0|||
161697942|NCT04949841|583941998|FG000|Overall Study|Adverse Event|7|||
161697943|NCT04949841|583941998|FG000|Overall Study|Death|1|||
161697944|NCT04949841|583941998|FG000|Overall Study|Withdrawal by Subject|52|||
161697945|NCT04949841|583941998|FG000|Overall Study|Pregnancy|4|||
161697946|NCT04949841|583941998|FG000|Overall Study|Lost to Follow-up|9|||
161697947|NCT04949841|583941998|FG000|Overall Study|Lack of Efficacy|55|||
161697948|NCT04949841|583941998|FG000|Overall Study|Various reasons|9|||
161697949|NCT04820309|583941999|FG000|Overall Study|Adverse Event|96|||
161697950|NCT04820309|583941999|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
161697951|NCT04820309|583941999|FG000|Overall Study|Consent Withdrawn|93|||
161697952|NCT04820309|583941999|FG000|Overall Study|failure to adhere to protocol|32|||
161697953|NCT04820309|583941999|FG000|Overall Study|alcohol or drug use|6|||
161697954|NCT04820309|583941999|FG000|Overall Study|Lost to Follow-up|46|||
161697955|NCT04820309|583941999|FG000|Overall Study|Death|2|||
161697956|NCT04820309|583941999|FG000|Overall Study|Pregnancy|1|||
161697957|NCT04820309|583941999|FG000|Overall Study|Other reasons|12|||
161697958|NCT04202679|583942006|FG000|Overall Study|Adverse Event|2|||
161697959|NCT04202679|583942007|FG001|Overall Study|Adverse Event|0|||
161697960|NCT04202679|583942006|FG000|Overall Study|Poor compliance to protocol|1|||
161697961|NCT04202679|583942007|FG001|Overall Study|Poor compliance to protocol|0|||
161697962|NCT04202679|583942006|FG000|Overall Study|Withdrawal by Subject|23|||
161697963|NCT04202679|583942007|FG001|Overall Study|Withdrawal by Subject|6|||
161697964|NCT05902364|583942008|FG000|Overall Study|Adverse Event|1|||
161697965|NCT05902364|583942009|FG001|Overall Study|Adverse Event|0|||
161697966|NCT02270242|583942010|FG000|Overall Study|Withdrawal by Subject|18|||
161697967|NCT02270242|583942011|FG001|Overall Study|Withdrawal by Subject|25|||
161697968|NCT02270242|583942010|FG000|Overall Study|Lost to Follow-up|41|||
161697969|NCT02270242|583942011|FG001|Overall Study|Lost to Follow-up|27|||
161697970|NCT02270242|583942010|FG000|Overall Study|Physician Decision|0|||
161697971|NCT02270242|583942011|FG001|Overall Study|Physician Decision|1|||
161697972|NCT03864653|583942012|FG000|Overall Study|Withdrawal by Subject|1|||
161697973|NCT02531646|583942013|FG000|Overall Study|equip. image processing issue|5|||
161697974|NCT02531646|583942014|FG001|Overall Study|equip. image processing issue|1|||
161697975|NCT02531646|583942015|FG002|Overall Study|equip. image processing issue|0|||
161697976|NCT00429585|583942016|FG000|Overall Study|Death|1|||
161697977|NCT00429585|583942017|FG001|Overall Study|Death|0|||
161697978|NCT00429585|583942016|FG000|Overall Study|Lost to Follow-up|27|||
161697979|NCT00429585|583942017|FG001|Overall Study|Lost to Follow-up|20|||
161697980|NCT00429585|583942016|FG000|Overall Study|Physician Decision|2|||
161697981|NCT00429585|583942017|FG001|Overall Study|Physician Decision|0|||
161697982|NCT01582308|583942018|FG000|Period 1|Withdrawal by Subject|0|||
161697983|NCT01582308|583942019|FG001|Period 1|Withdrawal by Subject|0|||
161697984|NCT01582308|583942020|FG002|Period 1|Withdrawal by Subject|0|||
161697985|NCT01582308|583942021|FG003|Period 1|Withdrawal by Subject|0|||
161697986|NCT01582308|583942022|FG004|Period 1|Withdrawal by Subject|0|||
161697987|NCT01582308|583942023|FG005|Period 1|Withdrawal by Subject|0|||
161697988|NCT01582308|583942024|FG006|Period 1|Withdrawal by Subject|1|||
161697989|NCT01582308|583942025|FG007|Period 1|Withdrawal by Subject|0|||
161697990|NCT01582308|583942026|FG008|Period 1|Withdrawal by Subject|0|||
161697991|NCT01582308|583942027|FG009|Period 1|Withdrawal by Subject|0|||
161697992|NCT01582308|583942018|FG000|10-day Washout Following Period 1|Physician Decision|0|||
161697993|NCT01582308|583942019|FG001|10-day Washout Following Period 1|Physician Decision|0|||
161697994|NCT01582308|583942020|FG002|10-day Washout Following Period 1|Physician Decision|0|||
161697995|NCT01582308|583942021|FG003|10-day Washout Following Period 1|Physician Decision|0|||
161697996|NCT01582308|583942022|FG004|10-day Washout Following Period 1|Physician Decision|1|||
161697997|NCT01582308|583942023|FG005|10-day Washout Following Period 1|Physician Decision|0|||
161697998|NCT01582308|583942024|FG006|10-day Washout Following Period 1|Physician Decision|0|||
161697999|NCT01582308|583942025|FG007|10-day Washout Following Period 1|Physician Decision|0|||
161698000|NCT01582308|583942026|FG008|10-day Washout Following Period 1|Physician Decision|0|||
161698001|NCT01582308|583942027|FG009|10-day Washout Following Period 1|Physician Decision|0|||
161698002|NCT01582308|583942018|FG000|Period 4|Physician Decision|1|||
161698003|NCT01582308|583942019|FG001|Period 4|Physician Decision|0|||
161698004|NCT01582308|583942020|FG002|Period 4|Physician Decision|0|||
161698005|NCT01582308|583942021|FG003|Period 4|Physician Decision|0|||
161698006|NCT01582308|583942022|FG004|Period 4|Physician Decision|0|||
161698007|NCT01582308|583942023|FG005|Period 4|Physician Decision|1|||
161698008|NCT01582308|583942024|FG006|Period 4|Physician Decision|0|||
161698009|NCT01582308|583942025|FG007|Period 4|Physician Decision|0|||
161698010|NCT01582308|583942026|FG008|Period 4|Physician Decision|0|||
161698011|NCT01582308|583942027|FG009|Period 4|Physician Decision|1|||
161698012|NCT00772668|583942030|FG000|Overall Study|Physician Decision|3|||
161698013|NCT01182428|583942031|FG000|Overall Study|Physician Decision|1|||
161698014|NCT01182428|583942032|FG001|Overall Study|Physician Decision|0|||
161698015|NCT01182428|583942031|FG000|Overall Study|Lost to Follow-up|9|||
161698016|NCT01182428|583942032|FG001|Overall Study|Lost to Follow-up|1|||
161698017|NCT01182428|583942031|FG000|Overall Study|Withdrawal by Subject|1|||
161698018|NCT01182428|583942032|FG001|Overall Study|Withdrawal by Subject|0|||
161698019|NCT03631706|583942034|FG000|Overall Study|Randomized, not treated|1|||
161698020|NCT03631706|583942035|FG001|Overall Study|Randomized, not treated|0|||
161698021|NCT00684957|583942039|FG000|Overall Study|Withdrawal by Subject|1|||
161698022|NCT00684957|583942040|FG001|Overall Study|Withdrawal by Subject|1|||
161698023|NCT00684957|583942039|FG000|Overall Study|Lost to Follow-up|1|||
161698024|NCT00684957|583942040|FG001|Overall Study|Lost to Follow-up|0|||
161698025|NCT04341948|583942041|FG000|Overall Study|Adverse Event|0|||
161698026|NCT04341948|583942042|FG001|Overall Study|Adverse Event|1|||
161698027|NCT04341948|583942041|FG000|Overall Study|Lost to Follow-up|6|||
161698028|NCT04341948|583942042|FG001|Overall Study|Lost to Follow-up|1|||
161698029|NCT04341948|583942041|FG000|Overall Study|Physician Decision|1|||
161698030|NCT04341948|583942042|FG001|Overall Study|Physician Decision|2|||
161698031|NCT04341948|583942041|FG000|Overall Study|Withdrawal by Participant|6|||
161698032|NCT04341948|583942042|FG001|Overall Study|Withdrawal by Participant|3|||
161698033|NCT04341948|583942041|FG000|Overall Study|Lack of compliance by Participant|1|||
161698034|NCT04341948|583942042|FG001|Overall Study|Lack of compliance by Participant|0|||
161698035|NCT03406897|583942043|FG000|Overall Study|Lost to Follow-up|1|||
161698036|NCT03406897|583942044|FG001|Overall Study|Lost to Follow-up|2|||
161698037|NCT03406897|583942043|FG000|Overall Study|Withdrawal by Subject|4|||
161698038|NCT03406897|583942044|FG001|Overall Study|Withdrawal by Subject|4|||
161698039|NCT03406897|583942043|FG000|Overall Study|Physician Decision|0|||
161698040|NCT03406897|583942044|FG001|Overall Study|Physician Decision|1|||
161698041|NCT02554929|583944094|FG000|Overall Study|Lost to Follow-up|4|||
161698042|NCT02554929|583944095|FG001|Overall Study|Lost to Follow-up|4|||
161698043|NCT02554929|583944094|FG000|Overall Study|Withdrawal by Subject|2|||
161698044|NCT02554929|583944095|FG001|Overall Study|Withdrawal by Subject|8|||
161698045|NCT00388947|583944097|FG000|Overall Study|Protocol Violation|47|||
161698046|NCT04187092|583944098|FG000|Overall Study|Lost to Follow-up|1|||
161698047|NCT04187092|583944099|FG001|Overall Study|Lost to Follow-up|1|||
161698048|NCT04187092|583944098|FG000|Overall Study|Withdrawal by Subject|1|||
161698049|NCT04187092|583944099|FG001|Overall Study|Withdrawal by Subject|1|||
161698050|NCT04187092|583944098|FG000|Overall Study|Adverse Event|0|||
161698051|NCT04187092|583944099|FG001|Overall Study|Adverse Event|1|||
161698052|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
161698053|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
161698054|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
161698055|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
161698056|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
161698057|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
161698058|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
161698059|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
161698060|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
161698061|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
161698062|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
161698063|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
161698064|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
161698065|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
161698066|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
161698067|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
161698068|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
161698069|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
161698070|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
161698071|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
161698072|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
161698073|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
161698074|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
161698075|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
161698076|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
161698077|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
161698078|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
161698079|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
161698080|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
161698081|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
161698082|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
161698083|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
161698084|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
161698085|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
161698086|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
161698087|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
161698088|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
161698089|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
161698090|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
161698091|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
161698092|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
161698093|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
161698094|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
161836716|NCT01846273|584445014|FG002|Overall Study|Physician Decision|0|||
161836717|NCT00891839|584445015|FG000|Overall Study|Adverse Event|2|||
161836718|NCT00891839|584445015|FG000|Overall Study|Withdrawal by Subject|2|||
161836719|NCT00891839|584445015|FG000|Overall Study|Disease progression|3|||
161836720|NCT00851643|584445016|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
161836721|NCT00851643|584445017|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836722|NCT00851643|584445018|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836723|NCT00851643|584445019|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836724|NCT00851643|584445020|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836725|NCT00851643|584445021|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836726|NCT00851643|584445016|FG000|Base Study (Up to 12 Months)|Other|0|||
161836727|NCT00851643|584445017|FG001|Base Study (Up to 12 Months)|Other|0|||
161836728|NCT00851643|584445018|FG002|Base Study (Up to 12 Months)|Other|0|||
161836729|NCT00851643|584445019|FG003|Base Study (Up to 12 Months)|Other|0|||
161836730|NCT00851643|584445020|FG004|Base Study (Up to 12 Months)|Other|0|||
161836731|NCT00851643|584445021|FG005|Base Study (Up to 12 Months)|Other|1|||
161836732|NCT00851643|584445016|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
161836733|NCT00851643|584445017|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
161836734|NCT00851643|584445018|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
161836735|NCT00851643|584445019|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
161653727|NCT02898077|583782720|FG001|Overall Study|Withdrawal by Subject|3|||
161653728|NCT02898077|583782719|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
161653729|NCT02898077|583782720|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
161653730|NCT02898077|583782719|FG000|Overall Study|Ended extension period|3|||
161653731|NCT02898077|583782720|FG001|Overall Study|Ended extension period|0|||
161653732|NCT02040584|583782721|FG000|Overall Study|Adverse Event|13|||
161653733|NCT02040584|583782722|FG001|Overall Study|Adverse Event|6|||
161653734|NCT02040584|583782721|FG000|Overall Study|Protocol Violation|9|||
161653735|NCT02040584|583782722|FG001|Overall Study|Protocol Violation|11|||
161653736|NCT02040584|583782721|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161653737|NCT02040584|583782722|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161653738|NCT02040584|583782721|FG000|Overall Study|Death|6|||
161653739|NCT02040584|583782722|FG001|Overall Study|Death|3|||
161653740|NCT02040584|583782721|FG000|Overall Study|Transplant rejection/retransplant|0|||
161698095|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
161698096|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
161698097|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
161698098|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
161698099|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
161698100|NCT05162066|583944106|FG000|Overall Study|Adverse Event|1|||
161698101|NCT05162066|583944107|FG001|Overall Study|Adverse Event|0|||
161698102|NCT05162066|583944108|FG002|Overall Study|Adverse Event|0|||
161698103|NCT05162066|583944106|FG000|Overall Study|Perceived lack of efficacy|1|||
161698104|NCT05162066|583944107|FG001|Overall Study|Perceived lack of efficacy|0|||
161698105|NCT05162066|583944108|FG002|Overall Study|Perceived lack of efficacy|0|||
161698106|NCT01220414|583944109|FG000|Overall Study|Withdrawal by Subject|1|||
161698107|NCT01220414|583944110|FG001|Overall Study|Withdrawal by Subject|0|||
161698108|NCT01220414|583944111|FG002|Overall Study|Withdrawal by Subject|0|||
161698109|NCT01220414|583944112|FG003|Overall Study|Withdrawal by Subject|1|||
161698110|NCT00669617|583944115|FG000|Period 1|Withdrawal by Subject|0|||
161698111|NCT00669617|583944116|FG001|Period 1|Withdrawal by Subject|0|||
161698112|NCT00669617|583944117|FG002|Period 1|Withdrawal by Subject|1|||
161698113|NCT00669617|583944118|FG003|Period 1|Withdrawal by Subject|0|||
161698114|NCT00669617|583944119|FG004|Period 1|Withdrawal by Subject|0|||
161698115|NCT00669617|583944115|FG000|Period 1|Protocol Deviation|0|||
161698116|NCT00669617|583944116|FG001|Period 1|Protocol Deviation|0|||
161698117|NCT00669617|583944117|FG002|Period 1|Protocol Deviation|0|||
161698118|NCT00669617|583944118|FG003|Period 1|Protocol Deviation|0|||
161698119|NCT00669617|583944119|FG004|Period 1|Protocol Deviation|1|||
161698120|NCT00669617|583944115|FG000|Period 3|Lost to Follow-up|1|||
161698121|NCT00669617|583944116|FG001|Period 3|Lost to Follow-up|0|||
161698122|NCT00669617|583944117|FG002|Period 3|Lost to Follow-up|0|||
161698123|NCT00669617|583944118|FG003|Period 3|Lost to Follow-up|0|||
161698124|NCT00669617|583944119|FG004|Period 3|Lost to Follow-up|0|||
161698125|NCT00623831|583944120|FG000|Overall Study|Withdrawal by Subject|1|||
161698126|NCT00623831|583944121|FG001|Overall Study|Withdrawal by Subject|0|||
161698127|NCT00623831|583944120|FG000|Overall Study|Progressive Disease|0|||
161698128|NCT00623831|583944121|FG001|Overall Study|Progressive Disease|1|||
161698129|NCT01276821|583944122|FG000|Overall Study|Protocol Violation|0|||
161698130|NCT01276821|583944123|FG001|Overall Study|Protocol Violation|1|||
161698131|NCT01748071|583944124|FG000|Overall Study|Adverse Event|2|||
161698132|NCT01748071|583944125|FG001|Overall Study|Adverse Event|2|||
161698133|NCT01748071|583944126|FG002|Overall Study|Adverse Event|0|||
161698134|NCT03068325|583944127|FG000|Overall Study|Lost to Follow-up|5|||
161698135|NCT00066690|583944130|FG000|Overall Study|Adverse Event|145|||
161698136|NCT00066690|583944131|FG001|Overall Study|Adverse Event|58|||
161698137|NCT00066690|583944132|FG002|Overall Study|Adverse Event|126|||
161698138|NCT00066690|583944130|FG000|Overall Study|Death|3|||
161698139|NCT00066690|583944131|FG001|Overall Study|Death|0|||
161698140|NCT00066690|583944132|FG002|Overall Study|Death|2|||
161698141|NCT00066690|583944130|FG000|Overall Study|Lack of Efficacy|114|||
161698142|NCT00066690|583944131|FG001|Overall Study|Lack of Efficacy|110|||
161698143|NCT00066690|583944132|FG002|Overall Study|Lack of Efficacy|76|||
161698144|NCT00066690|583944130|FG000|Overall Study|Lost to Follow-up|40|||
161698145|NCT00066690|583944131|FG001|Overall Study|Lost to Follow-up|21|||
161698146|NCT00066690|583944132|FG002|Overall Study|Lost to Follow-up|29|||
161698147|NCT00066690|583944130|FG000|Overall Study|Withdrawal by Subject|50|||
161698148|NCT00066690|583944131|FG001|Overall Study|Withdrawal by Subject|55|||
161698149|NCT00066690|583944132|FG002|Overall Study|Withdrawal by Subject|49|||
161698150|NCT00066690|583944130|FG000|Overall Study|Treatment Ongoing|246|||
161698151|NCT00066690|583944131|FG001|Overall Study|Treatment Ongoing|278|||
161698152|NCT00066690|583944132|FG002|Overall Study|Treatment Ongoing|282|||
161698153|NCT00223496|583944133|FG000|Overall Study|screen failure|9|||
161698154|NCT00223496|583944133|FG000|Overall Study|Lost to Follow-up|4|||
161698155|NCT00223496|583944133|FG000|Overall Study|Lack of Efficacy|6|||
161698156|NCT00223496|583944133|FG000|Overall Study|Withdrawal by Subject|1|||
161698157|NCT00223496|583944133|FG000|Overall Study|Physician Decision|2|||
161698158|NCT02939131|583944136|FG000|Overall Study|Unable to get to clinic|6|||
161698159|NCT02939131|583944137|FG001|Overall Study|Unable to get to clinic|4|||
161698160|NCT02939131|583944136|FG000|Overall Study|Lost to Follow-up|2|||
161698161|NCT02939131|583944137|FG001|Overall Study|Lost to Follow-up|4|||
161698162|NCT02939131|583944136|FG000|Overall Study|severe debilitation|1|||
161698163|NCT02939131|583944137|FG001|Overall Study|severe debilitation|0|||
161698164|NCT02939131|583944136|FG000|Overall Study|Other|0|||
161698165|NCT02939131|583944137|FG001|Overall Study|Other|1|||
161698166|NCT02939131|583944136|FG000|Overall Study|not willing to adhere to protocol|2|||
161698167|NCT02939131|583944137|FG001|Overall Study|not willing to adhere to protocol|0|||
161698168|NCT03569202|583944141|FG000|Part 3|Physician Decision|1|||
161698169|NCT03569202|583944142|FG001|Part 3|Physician Decision|0|||
161698170|NCT03569202|583944141|FG000|Part 3|Other|1|||
161698171|NCT03569202|583944142|FG001|Part 3|Other|1|||
161698172|NCT00420511|583944143|FG000|Overall Study|Adverse Event|1|||
161698173|NCT00420511|583944144|FG001|Overall Study|Adverse Event|1|||
161698174|NCT00420511|583944143|FG000|Overall Study|Lost to Follow-up|1|||
161698175|NCT00420511|583944144|FG001|Overall Study|Lost to Follow-up|0|||
161836736|NCT00851643|584445020|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
161836737|NCT00851643|584445021|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
161836738|NCT00851643|584445016|FG000|Extension Study (Up to 36 Months)|Moved|0|||
161836739|NCT00851643|584445017|FG001|Extension Study (Up to 36 Months)|Moved|2|||
161836740|NCT00851643|584445018|FG002|Extension Study (Up to 36 Months)|Moved|1|||
161836741|NCT00851643|584445019|FG003|Extension Study (Up to 36 Months)|Moved|1|||
161836742|NCT00851643|584445020|FG004|Extension Study (Up to 36 Months)|Moved|0|||
161836743|NCT00851643|584445021|FG005|Extension Study (Up to 36 Months)|Moved|1|||
161836744|NCT00359788|584445022|FG000|Overall Study|Adverse Event|11|||
161836745|NCT00359788|584445023|FG001|Overall Study|Adverse Event|10|||
161836746|NCT00359788|584445022|FG000|Overall Study|Lack of Efficacy|1|||
161836747|NCT00359788|584445023|FG001|Overall Study|Lack of Efficacy|2|||
161836748|NCT00359788|584445022|FG000|Overall Study|Lost to Follow-up|3|||
161836749|NCT00359788|584445023|FG001|Overall Study|Lost to Follow-up|2|||
161836750|NCT00359788|584445022|FG000|Overall Study|Withdrawal by Subject|4|||
161836751|NCT00359788|584445023|FG001|Overall Study|Withdrawal by Subject|1|||
161836752|NCT00359788|584445022|FG000|Overall Study|Protocol Violation|4|||
161836753|NCT00359788|584445023|FG001|Overall Study|Protocol Violation|2|||
161836754|NCT01641133|584445024|FG000|Overall Study|Protocol Violation|0|||
161836755|NCT01641133|584445025|FG001|Overall Study|Protocol Violation|1|||
161836756|NCT01641133|584445026|FG002|Overall Study|Protocol Violation|1|||
161836757|NCT01641133|584445024|FG000|Overall Study|Migrated/moved from study area|5|||
161836758|NCT01641133|584445025|FG001|Overall Study|Migrated/moved from study area|3|||
161836759|NCT01641133|584445026|FG002|Overall Study|Migrated/moved from study area|1|||
161836760|NCT01641133|584445024|FG000|Overall Study|Adverse Event|0|||
161836761|NCT01641133|584445025|FG001|Overall Study|Adverse Event|0|||
161836762|NCT01641133|584445026|FG002|Overall Study|Adverse Event|1|||
161836763|NCT01641133|584445024|FG000|Overall Study|Withdrawal by Subject|5|||
161836764|NCT01641133|584445025|FG001|Overall Study|Withdrawal by Subject|3|||
161836765|NCT01641133|584445026|FG002|Overall Study|Withdrawal by Subject|3|||
161836766|NCT01641133|584445024|FG000|Overall Study|Lost to Follow-up|0|||
161653741|NCT02040584|583782722|FG001|Overall Study|Transplant rejection/retransplant|1|||
161653742|NCT02040584|583782721|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
161653743|NCT02040584|583782722|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
161653744|NCT00996476|583782723|FG000|Overall Study|Withdrawal by Subject|1|||
161653745|NCT00996476|583782724|FG001|Overall Study|Withdrawal by Subject|2|||
161653746|NCT00996476|583782725|FG002|Overall Study|Withdrawal by Subject|1|||
161653747|NCT00996476|583782726|FG003|Overall Study|Withdrawal by Subject|0|||
161653748|NCT00996476|583782727|FG004|Overall Study|Withdrawal by Subject|1|||
161653749|NCT00996476|583782723|FG000|Overall Study|Adverse Event|0|||
161653750|NCT00996476|583782724|FG001|Overall Study|Adverse Event|1|||
161653751|NCT00996476|583782725|FG002|Overall Study|Adverse Event|0|||
161653752|NCT00996476|583782726|FG003|Overall Study|Adverse Event|0|||
161653753|NCT00996476|583782727|FG004|Overall Study|Adverse Event|1|||
161653754|NCT01940939|583782728|FG000|Overall Study|Withdrawal by Subject|2|||
161653755|NCT01940939|583782729|FG001|Overall Study|Withdrawal by Subject|8|||
161653756|NCT01470001|583782730|FG000|Overall Study|Lost to Follow-up|1|||
161653757|NCT01470001|583782731|FG001|Overall Study|Lost to Follow-up|1|||
161653758|NCT01470001|583782730|FG000|Overall Study|Physician Decision|2|||
161653759|NCT01470001|583782731|FG001|Overall Study|Physician Decision|0|||
161653760|NCT01470001|583782730|FG000|Overall Study|Withdrawal by Subject|2|||
161653761|NCT01470001|583782731|FG001|Overall Study|Withdrawal by Subject|1|||
161653762|NCT04939701|583782735|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
161653763|NCT04939701|583782736|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
161653764|NCT04939701|583782737|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
161653765|NCT04939701|583782735|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
161653766|NCT04939701|583782736|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
161653767|NCT04939701|583782737|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
161653768|NCT04939701|583782735|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
161653769|NCT04939701|583782736|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
161653770|NCT04939701|583782737|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
161653771|NCT04939701|583782735|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
161698176|NCT02450578|583944145|FG000|Overall Study|ECG abnormality so not treated|1|||
161836767|NCT01641133|584445025|FG001|Overall Study|Lost to Follow-up|2|||
161653772|NCT04939701|583782736|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
161653773|NCT04939701|583782737|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
161653774|NCT04939701|583782735|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
161836768|NCT01641133|584445026|FG002|Overall Study|Lost to Follow-up|2|||
161836769|NCT02220725|584445027|FG000|Overall Study|Lost to Follow-up|0|||
161836770|NCT02220725|584445028|FG001|Overall Study|Lost to Follow-up|0|||
161836771|NCT02220725|584445029|FG002|Overall Study|Lost to Follow-up|0|||
161836772|NCT02220725|584445030|FG003|Overall Study|Lost to Follow-up|1|||
161698177|NCT02450578|583944146|FG001|Overall Study|ECG abnormality so not treated|0|||
161698178|NCT02450578|583944147|FG002|Overall Study|ECG abnormality so not treated|0|||
161698179|NCT02450578|583944148|FG003|Overall Study|ECG abnormality so not treated|0|||
161698180|NCT04428411|583944151|FG000|Overall Study|Lost to Follow-up|114|||
161698181|NCT00634569|583944152|FG000|Overall Study|Withdrawal by Subject|0|||
161698182|NCT00634569|583944153|FG001|Overall Study|Withdrawal by Subject|4|||
161698183|NCT00634569|583944152|FG000|Overall Study|Physician Decision|0|||
161698184|NCT00634569|583944153|FG001|Overall Study|Physician Decision|1|||
161698185|NCT02918019|583944154|FG000|Overall Study|Death|0|||
161698186|NCT02918019|583944155|FG001|Overall Study|Death|0|||
161698187|NCT02918019|583944156|FG002|Overall Study|Death|1|||
161698188|NCT02918019|583944157|FG003|Overall Study|Death|0|||
161698189|NCT02918019|583944154|FG000|Overall Study|Lost to Follow-up|1|||
161698190|NCT02918019|583944155|FG001|Overall Study|Lost to Follow-up|1|||
161698191|NCT02918019|583944156|FG002|Overall Study|Lost to Follow-up|0|||
161698192|NCT02918019|583944157|FG003|Overall Study|Lost to Follow-up|1|||
161698193|NCT02918019|583944154|FG000|Overall Study|Principal investigator request|0|||
161698194|NCT02918019|583944155|FG001|Overall Study|Principal investigator request|0|||
161698195|NCT02918019|583944156|FG002|Overall Study|Principal investigator request|0|||
161698196|NCT02918019|583944157|FG003|Overall Study|Principal investigator request|1|||
161698197|NCT02918019|583944154|FG000|Overall Study|Physician Decision|1|||
161698198|NCT02918019|583944155|FG001|Overall Study|Physician Decision|3|||
161698199|NCT02918019|583944156|FG002|Overall Study|Physician Decision|2|||
161698200|NCT02918019|583944157|FG003|Overall Study|Physician Decision|0|||
161698201|NCT02918019|583944154|FG000|Overall Study|Protocol deviation|1|||
161698202|NCT02918019|583944155|FG001|Overall Study|Protocol deviation|1|||
161698203|NCT02918019|583944156|FG002|Overall Study|Protocol deviation|0|||
161698204|NCT02918019|583944157|FG003|Overall Study|Protocol deviation|2|||
161698205|NCT02918019|583944154|FG000|Overall Study|Withdrawal by Subject|3|||
161698206|NCT02918019|583944155|FG001|Overall Study|Withdrawal by Subject|4|||
161698207|NCT02918019|583944156|FG002|Overall Study|Withdrawal by Subject|6|||
161698208|NCT02918019|583944157|FG003|Overall Study|Withdrawal by Subject|4|||
161698209|NCT02918019|583944154|FG000|Overall Study|Adverse Event|0|||
161698210|NCT02918019|583944155|FG001|Overall Study|Adverse Event|1|||
161698211|NCT02918019|583944156|FG002|Overall Study|Adverse Event|0|||
161698212|NCT02918019|583944157|FG003|Overall Study|Adverse Event|1|||
161698213|NCT01212185|583944159|FG000|Overall Study|Protocol Violation|2|||
161698214|NCT01212185|583944160|FG001|Overall Study|Protocol Violation|1|||
161698215|NCT01699087|583944161|FG000|Overall Study|Lost to Follow-up|7|||
161698216|NCT01699087|583944161|FG000|Overall Study|Screen failure (prior to treatment)|15|||
161698217|NCT01699087|583944161|FG000|Overall Study|Unable to make future visits|2|||
161698218|NCT03370770|583944162|FG000|Overall Study|Patient was followed in another hospital center|1|||
161698219|NCT03370770|583944162|FG000|Overall Study|Progressive Disease|98|||
161698220|NCT03370770|583944162|FG000|Overall Study|Adverse Event|2|||
161698221|NCT03370770|583944162|FG000|Overall Study|Death|5|||
161698222|NCT00094757|583944166|FG000|Overall Study|Adverse Event|11|||
161698223|NCT00094757|583944167|FG001|Overall Study|Adverse Event|9|||
161698224|NCT00094757|583944168|FG002|Overall Study|Adverse Event|6|||
161698225|NCT00094757|583944166|FG000|Overall Study|Lack of Efficacy|11|||
161698226|NCT00094757|583944167|FG001|Overall Study|Lack of Efficacy|15|||
161698227|NCT00094757|583944168|FG002|Overall Study|Lack of Efficacy|8|||
161698228|NCT00094757|583944166|FG000|Overall Study|Lost to Follow-up|3|||
161698229|NCT00094757|583944167|FG001|Overall Study|Lost to Follow-up|5|||
161698230|NCT00094757|583944168|FG002|Overall Study|Lost to Follow-up|6|||
161698231|NCT00094757|583944166|FG000|Overall Study|Patient Moved|2|||
161698232|NCT00094757|583944167|FG001|Overall Study|Patient Moved|1|||
161698233|NCT00094757|583944168|FG002|Overall Study|Patient Moved|1|||
161698234|NCT00094757|583944166|FG000|Overall Study|Protocol Violation|8|||
161698235|NCT00094757|583944167|FG001|Overall Study|Protocol Violation|5|||
161698236|NCT00094757|583944168|FG002|Overall Study|Protocol Violation|3|||
161698237|NCT00094757|583944166|FG000|Overall Study|Withdrawal by Subject|14|||
161698238|NCT00094757|583944167|FG001|Overall Study|Withdrawal by Subject|21|||
161698239|NCT00094757|583944168|FG002|Overall Study|Withdrawal by Subject|5|||
161698240|NCT00094757|583944166|FG000|Overall Study|Other|3|||
161698241|NCT00094757|583944167|FG001|Overall Study|Other|3|||
161698242|NCT00094757|583944168|FG002|Overall Study|Other|1|||
161698243|NCT00094757|583944166|FG000|Overall Study|Protocol specified discontinuation|1|||
161698244|NCT00094757|583944167|FG001|Overall Study|Protocol specified discontinuation|3|||
161698245|NCT00094757|583944168|FG002|Overall Study|Protocol specified discontinuation|0|||
161698246|NCT01463098|583944170|FG000|Part A (11 Days)|Participant Choice|2|||
161698247|NCT01463098|583944171|FG001|Part A (11 Days)|Participant Choice|0|||
161698248|NCT01463098|583944172|FG002|Part A (11 Days)|Participant Choice|0|||
161698249|NCT01463098|583944173|FG003|Part A (11 Days)|Participant Choice|0|||
161698250|NCT01463098|583944174|FG004|Part A (11 Days)|Participant Choice|0|||
161698251|NCT01463098|583944175|FG005|Part A (11 Days)|Participant Choice|0|||
161698252|NCT01463098|583944176|FG006|Part A (11 Days)|Participant Choice|0|||
161698253|NCT01463098|583944177|FG007|Part A (11 Days)|Participant Choice|0|||
161698254|NCT01463098|583944178|FG008|Part A (11 Days)|Participant Choice|1|||
161698255|NCT01463098|583944179|FG009|Part A (11 Days)|Participant Choice|0|||
161698256|NCT01463098|583944180|FG010|Part A (11 Days)|Participant Choice|0|||
161698257|NCT01463098|583944181|FG011|Part A (11 Days)|Participant Choice|0|||
161698258|NCT01463098|583944182|FG012|Part A (11 Days)|Participant Choice|0|||
161698259|NCT01463098|583944183|FG013|Part A (11 Days)|Participant Choice|0|||
161698260|NCT01463098|583944170|FG000|Part A (11 Days)|Lost to Follow-up|0|||
161698261|NCT01463098|583944171|FG001|Part A (11 Days)|Lost to Follow-up|0|||
161698262|NCT01463098|583944172|FG002|Part A (11 Days)|Lost to Follow-up|0|||
161698263|NCT01463098|583944173|FG003|Part A (11 Days)|Lost to Follow-up|0|||
161698264|NCT01463098|583944174|FG004|Part A (11 Days)|Lost to Follow-up|1|||
161698265|NCT01463098|583944175|FG005|Part A (11 Days)|Lost to Follow-up|0|||
161698266|NCT01463098|583944176|FG006|Part A (11 Days)|Lost to Follow-up|0|||
161698267|NCT01463098|583944177|FG007|Part A (11 Days)|Lost to Follow-up|0|||
161698268|NCT01463098|583944178|FG008|Part A (11 Days)|Lost to Follow-up|0|||
161698269|NCT01463098|583944179|FG009|Part A (11 Days)|Lost to Follow-up|0|||
161698270|NCT01463098|583944180|FG010|Part A (11 Days)|Lost to Follow-up|0|||
161698271|NCT01463098|583944181|FG011|Part A (11 Days)|Lost to Follow-up|0|||
161698272|NCT01463098|583944182|FG012|Part A (11 Days)|Lost to Follow-up|0|||
161698273|NCT01463098|583944183|FG013|Part A (11 Days)|Lost to Follow-up|0|||
161698274|NCT01463098|583944170|FG000|Part B (11 Days)|Participant Choice|0|||
161698275|NCT01463098|583944171|FG001|Part B (11 Days)|Participant Choice|0|||
161698276|NCT01463098|583944172|FG002|Part B (11 Days)|Participant Choice|0|||
161698277|NCT01463098|583944173|FG003|Part B (11 Days)|Participant Choice|0|||
161698278|NCT01463098|583944174|FG004|Part B (11 Days)|Participant Choice|0|||
161698279|NCT01463098|583944175|FG005|Part B (11 Days)|Participant Choice|0|||
161698280|NCT01463098|583944176|FG006|Part B (11 Days)|Participant Choice|0|||
161698281|NCT01463098|583944177|FG007|Part B (11 Days)|Participant Choice|0|||
161698282|NCT01463098|583944178|FG008|Part B (11 Days)|Participant Choice|0|||
161698283|NCT01463098|583944179|FG009|Part B (11 Days)|Participant Choice|0|||
161698284|NCT01463098|583944180|FG010|Part B (11 Days)|Participant Choice|0|||
161698285|NCT01463098|583944181|FG011|Part B (11 Days)|Participant Choice|1|||
161698286|NCT01463098|583944182|FG012|Part B (11 Days)|Participant Choice|0|||
161698287|NCT01463098|583944183|FG013|Part B (11 Days)|Participant Choice|0|||
161698288|NCT00395967|583944184|FG000|Treatment Period|Failed Mobilization|1|||
161698289|NCT00395967|583944184|FG000|Follow-up Period|Death|1|||
161698290|NCT00395967|583944184|FG000|Follow-up Period|Lost to Follow-up|1|||
161698291|NCT01262976|583944185|FG000|Up to Month 2|Serious Adverse Event|0|||
161698292|NCT01262976|583944186|FG001|Up to Month 2|Serious Adverse Event|0|||
161698293|NCT01262976|583944187|FG002|Up to Month 2|Serious Adverse Event|1|||
161698294|NCT01262976|583944188|FG003|Up to Month 2|Serious Adverse Event|0|||
161698295|NCT01262976|583944189|FG004|Up to Month 2|Serious Adverse Event|0|||
161698296|NCT01262976|583944190|FG005|Up to Month 2|Serious Adverse Event|0|||
161698297|NCT01262976|583944185|FG000|Up to Month 2|Withdrawal by Subject|1|||
161698298|NCT01262976|583944186|FG001|Up to Month 2|Withdrawal by Subject|0|||
161698299|NCT01262976|583944187|FG002|Up to Month 2|Withdrawal by Subject|0|||
161698300|NCT01262976|583944188|FG003|Up to Month 2|Withdrawal by Subject|0|||
161698301|NCT01262976|583944189|FG004|Up to Month 2|Withdrawal by Subject|0|||
161698302|NCT01262976|583944190|FG005|Up to Month 2|Withdrawal by Subject|0|||
161698303|NCT01262976|583944185|FG000|Up to Month 2|Migrated/moved from study area|0|||
161698304|NCT01262976|583944186|FG001|Up to Month 2|Migrated/moved from study area|1|||
161698305|NCT01262976|583944187|FG002|Up to Month 2|Migrated/moved from study area|0|||
161698306|NCT01262976|583944188|FG003|Up to Month 2|Migrated/moved from study area|0|||
161698307|NCT01262976|583944189|FG004|Up to Month 2|Migrated/moved from study area|1|||
161698308|NCT01262976|583944190|FG005|Up to Month 2|Migrated/moved from study area|1|||
161698309|NCT01262976|583944185|FG000|Up to Month 2|Lost to Follow-up|1|||
161698310|NCT01262976|583944186|FG001|Up to Month 2|Lost to Follow-up|0|||
161698311|NCT01262976|583944187|FG002|Up to Month 2|Lost to Follow-up|0|||
161698312|NCT01262976|583944188|FG003|Up to Month 2|Lost to Follow-up|1|||
161698313|NCT01262976|583944189|FG004|Up to Month 2|Lost to Follow-up|1|||
161698314|NCT01262976|583944190|FG005|Up to Month 2|Lost to Follow-up|1|||
161698315|NCT01262976|583944185|FG000|Up to Month 2|Other|1|||
161698316|NCT01262976|583944186|FG001|Up to Month 2|Other|0|||
161698317|NCT01262976|583944187|FG002|Up to Month 2|Other|0|||
161698318|NCT01262976|583944188|FG003|Up to Month 2|Other|1|||
161698319|NCT01262976|583944189|FG004|Up to Month 2|Other|0|||
161698320|NCT01262976|583944190|FG005|Up to Month 2|Other|2|||
161698321|NCT01262976|583944185|FG000|Up to Month 7|Serious Adverse Event|0|||
161698322|NCT01262976|583944186|FG001|Up to Month 7|Serious Adverse Event|0|||
161698323|NCT01262976|583944187|FG002|Up to Month 7|Serious Adverse Event|2|||
161698324|NCT01262976|583944188|FG003|Up to Month 7|Serious Adverse Event|0|||
161698325|NCT01262976|583944189|FG004|Up to Month 7|Serious Adverse Event|0|||
161698326|NCT01262976|583944190|FG005|Up to Month 7|Serious Adverse Event|0|||
161698327|NCT01262976|583944185|FG000|Up to Month 7|Withdrawal by Subject|1|||
161698328|NCT01262976|583944186|FG001|Up to Month 7|Withdrawal by Subject|0|||
161698329|NCT01262976|583944187|FG002|Up to Month 7|Withdrawal by Subject|0|||
161698330|NCT01262976|583944188|FG003|Up to Month 7|Withdrawal by Subject|0|||
161698331|NCT01262976|583944189|FG004|Up to Month 7|Withdrawal by Subject|0|||
161698332|NCT01262976|583944190|FG005|Up to Month 7|Withdrawal by Subject|0|||
161698333|NCT01262976|583944185|FG000|Up to Month 7|Migrated/moved from study area|0|||
161698334|NCT01262976|583944186|FG001|Up to Month 7|Migrated/moved from study area|0|||
161698335|NCT01262976|583944187|FG002|Up to Month 7|Migrated/moved from study area|1|||
161698336|NCT01262976|583944188|FG003|Up to Month 7|Migrated/moved from study area|3|||
161698337|NCT01262976|583944189|FG004|Up to Month 7|Migrated/moved from study area|1|||
161698338|NCT01262976|583944190|FG005|Up to Month 7|Migrated/moved from study area|1|||
161698339|NCT01262976|583944185|FG000|Up to Month 7|Lost to Follow-up|1|||
161698340|NCT01262976|583944186|FG001|Up to Month 7|Lost to Follow-up|0|||
161698341|NCT01262976|583944187|FG002|Up to Month 7|Lost to Follow-up|1|||
161698342|NCT01262976|583944188|FG003|Up to Month 7|Lost to Follow-up|3|||
161698343|NCT01262976|583944189|FG004|Up to Month 7|Lost to Follow-up|1|||
161698344|NCT01262976|583944190|FG005|Up to Month 7|Lost to Follow-up|3|||
161698345|NCT01262976|583944185|FG000|Up to Month 7|Other|3|||
161698346|NCT01262976|583944186|FG001|Up to Month 7|Other|0|||
161698347|NCT01262976|583944187|FG002|Up to Month 7|Other|2|||
161698348|NCT01262976|583944188|FG003|Up to Month 7|Other|0|||
161698349|NCT01262976|583944189|FG004|Up to Month 7|Other|0|||
161698350|NCT01262976|583944190|FG005|Up to Month 7|Other|0|||
161698351|NCT01262976|583944185|FG000|Up to Year 1|Serious Adverse Event|0|||
161698352|NCT01262976|583944186|FG001|Up to Year 1|Serious Adverse Event|0|||
161698353|NCT01262976|583944187|FG002|Up to Year 1|Serious Adverse Event|2|||
161698354|NCT01262976|583944188|FG003|Up to Year 1|Serious Adverse Event|0|||
161698355|NCT01262976|583944189|FG004|Up to Year 1|Serious Adverse Event|0|||
161698356|NCT01262976|583944190|FG005|Up to Year 1|Serious Adverse Event|0|||
161698357|NCT01262976|583944185|FG000|Up to Year 1|Withdrawal by Subject|1|||
161698358|NCT01262976|583944186|FG001|Up to Year 1|Withdrawal by Subject|0|||
161698359|NCT01262976|583944187|FG002|Up to Year 1|Withdrawal by Subject|0|||
161698360|NCT01262976|583944188|FG003|Up to Year 1|Withdrawal by Subject|0|||
161698361|NCT01262976|583944189|FG004|Up to Year 1|Withdrawal by Subject|0|||
161698362|NCT01262976|583944190|FG005|Up to Year 1|Withdrawal by Subject|0|||
161698363|NCT01262976|583944185|FG000|Up to Year 1|Migrated/moved from study area|1|||
161698364|NCT01262976|583944186|FG001|Up to Year 1|Migrated/moved from study area|0|||
161698365|NCT01262976|583944187|FG002|Up to Year 1|Migrated/moved from study area|0|||
161698366|NCT01262976|583944188|FG003|Up to Year 1|Migrated/moved from study area|3|||
161698367|NCT01262976|583944189|FG004|Up to Year 1|Migrated/moved from study area|3|||
161698368|NCT01262976|583944190|FG005|Up to Year 1|Migrated/moved from study area|2|||
161698369|NCT01262976|583944185|FG000|Up to Year 1|Lost to Follow-up|4|||
161698370|NCT01262976|583944186|FG001|Up to Year 1|Lost to Follow-up|0|||
161698371|NCT01262976|583944187|FG002|Up to Year 1|Lost to Follow-up|0|||
161698372|NCT01262976|583944188|FG003|Up to Year 1|Lost to Follow-up|1|||
161698373|NCT01262976|583944189|FG004|Up to Year 1|Lost to Follow-up|6|||
161698374|NCT01262976|583944190|FG005|Up to Year 1|Lost to Follow-up|5|||
161698375|NCT01262976|583944185|FG000|Up to Year 1|Other|3|||
161698376|NCT01262976|583944186|FG001|Up to Year 1|Other|1|||
161698377|NCT01262976|583944187|FG002|Up to Year 1|Other|0|||
161698378|NCT01262976|583944188|FG003|Up to Year 1|Other|0|||
161698379|NCT01262976|583944189|FG004|Up to Year 1|Other|2|||
161698380|NCT01262976|583944190|FG005|Up to Year 1|Other|1|||
161698381|NCT01262976|583944185|FG000|Up to Year 1|Subjects with unknown completion status|0|||
161698382|NCT01262976|583944186|FG001|Up to Year 1|Subjects with unknown completion status|0|||
161698383|NCT01262976|583944187|FG002|Up to Year 1|Subjects with unknown completion status|1|||
161698384|NCT01262976|583944188|FG003|Up to Year 1|Subjects with unknown completion status|0|||
161698385|NCT01262976|583944189|FG004|Up to Year 1|Subjects with unknown completion status|0|||
161698386|NCT01262976|583944190|FG005|Up to Year 1|Subjects with unknown completion status|1|||
161698387|NCT01262976|583944185|FG000|Up to Year 2|Serious Adverse Event|0|||
161698388|NCT01262976|583944186|FG001|Up to Year 2|Serious Adverse Event|0|||
161698389|NCT01262976|583944187|FG002|Up to Year 2|Serious Adverse Event|2|||
161698390|NCT01262976|583944188|FG003|Up to Year 2|Serious Adverse Event|0|||
161698391|NCT01262976|583944189|FG004|Up to Year 2|Serious Adverse Event|0|||
161698392|NCT01262976|583944190|FG005|Up to Year 2|Serious Adverse Event|0|||
161698393|NCT01262976|583944185|FG000|Up to Year 2|Withdrawal by Subject|1|||
161698394|NCT01262976|583944186|FG001|Up to Year 2|Withdrawal by Subject|0|||
161698395|NCT01262976|583944187|FG002|Up to Year 2|Withdrawal by Subject|0|||
161698396|NCT01262976|583944188|FG003|Up to Year 2|Withdrawal by Subject|0|||
161698397|NCT01262976|583944189|FG004|Up to Year 2|Withdrawal by Subject|0|||
161698398|NCT01262976|583944190|FG005|Up to Year 2|Withdrawal by Subject|0|||
161698399|NCT01262976|583944185|FG000|Up to Year 2|Migrated/moved from study area|0|||
161698400|NCT01262976|583944186|FG001|Up to Year 2|Migrated/moved from study area|0|||
161698401|NCT01262976|583944187|FG002|Up to Year 2|Migrated/moved from study area|0|||
161698402|NCT01262976|583944188|FG003|Up to Year 2|Migrated/moved from study area|2|||
161698403|NCT01262976|583944189|FG004|Up to Year 2|Migrated/moved from study area|1|||
161698404|NCT01262976|583944190|FG005|Up to Year 2|Migrated/moved from study area|2|||
161698405|NCT01262976|583944185|FG000|Up to Year 2|Lost to Follow-up|1|||
161698406|NCT01262976|583944186|FG001|Up to Year 2|Lost to Follow-up|1|||
161698407|NCT01262976|583944187|FG002|Up to Year 2|Lost to Follow-up|2|||
161698408|NCT01262976|583944188|FG003|Up to Year 2|Lost to Follow-up|2|||
161698409|NCT01262976|583944189|FG004|Up to Year 2|Lost to Follow-up|3|||
161698410|NCT01262976|583944190|FG005|Up to Year 2|Lost to Follow-up|3|||
161698411|NCT01262976|583944185|FG000|Up to Year 2|Subjects with unknown completion status|0|||
161698412|NCT01262976|583944186|FG001|Up to Year 2|Subjects with unknown completion status|0|||
161698413|NCT01262976|583944187|FG002|Up to Year 2|Subjects with unknown completion status|1|||
161698414|NCT01262976|583944188|FG003|Up to Year 2|Subjects with unknown completion status|0|||
161698415|NCT01262976|583944189|FG004|Up to Year 2|Subjects with unknown completion status|0|||
161698416|NCT01262976|583944190|FG005|Up to Year 2|Subjects with unknown completion status|0|||
161698417|NCT01262976|583944185|FG000|Up to Year 2|Other|3|||
161698418|NCT01262976|583944186|FG001|Up to Year 2|Other|0|||
161698419|NCT01262976|583944187|FG002|Up to Year 2|Other|0|||
161698420|NCT01262976|583944188|FG003|Up to Year 2|Other|0|||
161698421|NCT01262976|583944189|FG004|Up to Year 2|Other|0|||
161698422|NCT01262976|583944190|FG005|Up to Year 2|Other|0|||
161698423|NCT01262976|583944185|FG000|Up to Year 3|Serious Adverse Event|0|||
161698424|NCT01262976|583944186|FG001|Up to Year 3|Serious Adverse Event|0|||
161698425|NCT01262976|583944187|FG002|Up to Year 3|Serious Adverse Event|2|||
161698426|NCT01262976|583944188|FG003|Up to Year 3|Serious Adverse Event|0|||
161698427|NCT01262976|583944189|FG004|Up to Year 3|Serious Adverse Event|0|||
161698428|NCT01262976|583944190|FG005|Up to Year 3|Serious Adverse Event|0|||
161698429|NCT01262976|583944185|FG000|Up to Year 3|Withdrawal by Subject|1|||
161698430|NCT01262976|583944186|FG001|Up to Year 3|Withdrawal by Subject|0|||
161698431|NCT01262976|583944187|FG002|Up to Year 3|Withdrawal by Subject|0|||
161698432|NCT01262976|583944188|FG003|Up to Year 3|Withdrawal by Subject|0|||
161698433|NCT01262976|583944189|FG004|Up to Year 3|Withdrawal by Subject|0|||
161698434|NCT01262976|583944190|FG005|Up to Year 3|Withdrawal by Subject|0|||
161698435|NCT01262976|583944185|FG000|Up to Year 3|Migrated/moved from study area|0|||
161698436|NCT01262976|583944186|FG001|Up to Year 3|Migrated/moved from study area|0|||
161698437|NCT01262976|583944187|FG002|Up to Year 3|Migrated/moved from study area|0|||
161698438|NCT01262976|583944188|FG003|Up to Year 3|Migrated/moved from study area|2|||
161698439|NCT01262976|583944189|FG004|Up to Year 3|Migrated/moved from study area|1|||
161698440|NCT01262976|583944190|FG005|Up to Year 3|Migrated/moved from study area|1|||
161698441|NCT01262976|583944185|FG000|Up to Year 3|Lost to Follow-up|2|||
161698442|NCT01262976|583944186|FG001|Up to Year 3|Lost to Follow-up|2|||
161698443|NCT01262976|583944187|FG002|Up to Year 3|Lost to Follow-up|4|||
161698444|NCT01262976|583944188|FG003|Up to Year 3|Lost to Follow-up|3|||
161698445|NCT01262976|583944189|FG004|Up to Year 3|Lost to Follow-up|1|||
161698446|NCT01262976|583944190|FG005|Up to Year 3|Lost to Follow-up|3|||
161698447|NCT01262976|583944185|FG000|Up to Year 3|Subjects with unknown completion status|0|||
161698448|NCT01262976|583944186|FG001|Up to Year 3|Subjects with unknown completion status|0|||
161698449|NCT01262976|583944187|FG002|Up to Year 3|Subjects with unknown completion status|1|||
161698450|NCT01262976|583944188|FG003|Up to Year 3|Subjects with unknown completion status|0|||
161698451|NCT01262976|583944189|FG004|Up to Year 3|Subjects with unknown completion status|0|||
161698452|NCT01262976|583944190|FG005|Up to Year 3|Subjects with unknown completion status|0|||
161698453|NCT01262976|583944185|FG000|Up to Year 3|Other|3|||
161698454|NCT01262976|583944186|FG001|Up to Year 3|Other|0|||
161698455|NCT01262976|583944187|FG002|Up to Year 3|Other|0|||
161698456|NCT01262976|583944188|FG003|Up to Year 3|Other|0|||
161698457|NCT01262976|583944189|FG004|Up to Year 3|Other|0|||
161698458|NCT01262976|583944190|FG005|Up to Year 3|Other|0|||
161698459|NCT01528787|583944191|FG000|Overall Study|Withdrawal by Subject|0|||
161698460|NCT01528787|583944192|FG001|Overall Study|Withdrawal by Subject|0|||
161698461|NCT01528787|583944193|FG002|Overall Study|Withdrawal by Subject|0|||
161698462|NCT01528787|583944194|FG003|Overall Study|Withdrawal by Subject|1|||
161698463|NCT01528787|583944191|FG000|Overall Study|Family Emergency|0|||
161698464|NCT01528787|583944192|FG001|Overall Study|Family Emergency|0|||
161698465|NCT01528787|583944193|FG002|Overall Study|Family Emergency|1|||
161698466|NCT01528787|583944194|FG003|Overall Study|Family Emergency|0|||
161698467|NCT03433781|583944202|FG000|Overall Study|Progression of Disease|1|||
161698468|NCT03433781|583944203|FG001|Overall Study|Progression of Disease|0|||
161698469|NCT03433781|583944204|FG002|Overall Study|Progression of Disease|0|||
161698470|NCT03433781|583944202|FG000|Overall Study|Physician Decision|0|||
161698471|NCT03433781|583944203|FG001|Overall Study|Physician Decision|1|||
161698472|NCT03433781|583944204|FG002|Overall Study|Physician Decision|0|||
161698473|NCT02400255|583944205|FG000|Overall Study|Relapse|4|||
161698474|NCT02400255|583944206|FG001|Overall Study|Relapse|1|||
161698475|NCT02400255|583944207|FG002|Overall Study|Relapse|1|||
161698476|NCT02400255|583944208|FG003|Overall Study|Relapse|2|||
161698477|NCT02400255|583944205|FG000|Overall Study|Adverse Event|6|||
161698478|NCT02400255|583944206|FG001|Overall Study|Adverse Event|3|||
161698479|NCT02400255|583944207|FG002|Overall Study|Adverse Event|0|||
161698480|NCT02400255|583944208|FG003|Overall Study|Adverse Event|0|||
161698481|NCT02400255|583944205|FG000|Overall Study|Physician Decision|6|||
161698482|NCT02400255|583944206|FG001|Overall Study|Physician Decision|0|||
161698483|NCT02400255|583944207|FG002|Overall Study|Physician Decision|0|||
161698484|NCT02400255|583944208|FG003|Overall Study|Physician Decision|0|||
161698485|NCT02400255|583944205|FG000|Overall Study|Loss of insurance|1|||
161698486|NCT02400255|583944206|FG001|Overall Study|Loss of insurance|0|||
161698487|NCT02400255|583944207|FG002|Overall Study|Loss of insurance|0|||
161698488|NCT02400255|583944208|FG003|Overall Study|Loss of insurance|0|||
161698489|NCT02568046|583944209|FG000|Overall Study|Adverse Event|0|||
161698490|NCT02568046|583944210|FG001|Overall Study|Adverse Event|1|||
161698491|NCT02568046|583944209|FG000|Overall Study|Death|2|||
161698492|NCT02568046|583944210|FG001|Overall Study|Death|0|||
161698493|NCT02568046|583944209|FG000|Overall Study|Progressive Disease|1|||
161698494|NCT02568046|583944210|FG001|Overall Study|Progressive Disease|0|||
161698495|NCT02568046|583944209|FG000|Overall Study|Withdrawal by Subject|2|||
161698496|NCT02568046|583944210|FG001|Overall Study|Withdrawal by Subject|1|||
161836773|NCT02220725|584445027|FG000|Overall Study|Withdrawal by Subject|0|||
161836774|NCT02220725|584445028|FG001|Overall Study|Withdrawal by Subject|0|||
161836775|NCT02220725|584445029|FG002|Overall Study|Withdrawal by Subject|0|||
161698497|NCT02568046|583944209|FG000|Overall Study|Other Events|0|||
161698498|NCT02568046|583944210|FG001|Overall Study|Other Events|1|||
161698499|NCT02809833|583944211|FG000|Overall Study|Death|3|||
161836776|NCT02220725|584445030|FG003|Overall Study|Withdrawal by Subject|1|||
161836777|NCT03351231|584445031|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
161836778|NCT03351231|584445031|FG000|Combination Therapy Period|Disease progression|2|||
161698500|NCT02809833|583944211|FG000|Overall Study|Intolerance|54|||
161698501|NCT02809833|583944211|FG000|Overall Study|Lack of Efficacy|89|||
161698502|NCT02809833|583944211|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
161698503|NCT02809833|583944211|FG000|Overall Study|Noncompliance|1|||
161698504|NCT02809833|583944211|FG000|Overall Study|Withdrawal by Subject|34|||
161698505|NCT02809833|583944211|FG000|Overall Study|Lost to Follow-up|35|||
161698506|NCT02809833|583944211|FG000|Overall Study|Adverse Event (AE)|24|||
161698507|NCT02809833|583944211|FG000|Overall Study|Other|5|||
161698508|NCT02809833|583944211|FG000|Overall Study|Missing Information|52|||
161698509|NCT00408694|583944212|FG000|Overall Study|Ineligible|1|||
161698510|NCT00408694|583944212|FG000|Overall Study|No protocol treatment|1|||
161698511|NCT00523991|583944215|FG000|Overall Study|Adverse Event|6|||
161698512|NCT00523991|583944216|FG001|Overall Study|Adverse Event|5|||
161698513|NCT00523991|583944215|FG000|Overall Study|Protocol Violation|1|||
161698514|NCT00523991|583944216|FG001|Overall Study|Protocol Violation|4|||
161698515|NCT00523991|583944215|FG000|Overall Study|Lost to Follow-up|4|||
161698516|NCT00523991|583944216|FG001|Overall Study|Lost to Follow-up|1|||
161698517|NCT00523991|583944215|FG000|Overall Study|Withdrawal by Subject|7|||
161698518|NCT00523991|583944216|FG001|Overall Study|Withdrawal by Subject|17|||
161698519|NCT00523991|583944215|FG000|Overall Study|Other reason (not specified)|3|||
161698520|NCT00523991|583944216|FG001|Overall Study|Other reason (not specified)|0|||
161698521|NCT00193063|583944217|FG000|Overall Study|Lack of Efficacy|3|||
161698522|NCT00193063|583944217|FG000|Overall Study|Adverse Event|1|||
161698523|NCT03261531|583944219|FG000|Overall Study|Withdrawal by Subject|4|||
161698524|NCT00744874|583944221|FG000|Overall Study|Lost to Follow-up|1|||
161698525|NCT00744874|583944221|FG000|Overall Study|Withdrawal by Subject|1|||
161698526|NCT00744874|583944221|FG000|Overall Study|Study Device not available at procedure|1|||
161698527|NCT00744874|583944221|FG000|Overall Study|Unable to accomodate schedule|1|||
161698528|NCT01127165|583944224|FG000|Overall Study|Adverse Event|2|||
161698529|NCT01127165|583944225|FG001|Overall Study|Adverse Event|2|||
161698530|NCT01127165|583944224|FG000|Overall Study|Lack of Efficacy|10|||
161698531|NCT01127165|583944225|FG001|Overall Study|Lack of Efficacy|8|||
161698532|NCT01127165|583944224|FG000|Overall Study|Lost to Follow-up|3|||
161698533|NCT01127165|583944225|FG001|Overall Study|Lost to Follow-up|5|||
161698534|NCT01127165|583944224|FG000|Overall Study|Withdrawal by Subject|1|||
161698535|NCT01127165|583944225|FG001|Overall Study|Withdrawal by Subject|3|||
161698536|NCT01127165|583944224|FG000|Overall Study|Protocol Violation|0|||
161698537|NCT01127165|583944225|FG001|Overall Study|Protocol Violation|1|||
161698538|NCT02435849|583944226|FG000|Overall Study|Death|23|||
161698539|NCT02435849|583944227|FG001|Overall Study|Death|0|||
161698540|NCT02435849|583944226|FG000|Overall Study|Lack of Efficacy|10|||
161698541|NCT02435849|583944227|FG001|Overall Study|Lack of Efficacy|0|||
161698542|NCT02435849|583944226|FG000|Overall Study|New therapy for study indication|8|||
161698543|NCT02435849|583944227|FG001|Overall Study|New therapy for study indication|0|||
161698544|NCT02435849|583944226|FG000|Overall Study|Subject/guardian decision|5|||
161698545|NCT02435849|583944227|FG001|Overall Study|Subject/guardian decision|1|||
161698546|NCT02435849|583944226|FG000|Overall Study|Lost to Follow-up|1|||
161698547|NCT02435849|583944227|FG001|Overall Study|Lost to Follow-up|0|||
161698548|NCT02435849|583944226|FG000|Overall Study|Physician Decision|1|||
161698549|NCT02435849|583944227|FG001|Overall Study|Physician Decision|0|||
161698550|NCT03175549|583944228|FG000|Overall Study|Lost to Follow-up|2|||
161698551|NCT03175549|583944229|FG001|Overall Study|Lost to Follow-up|2|||
161698552|NCT03175549|583944228|FG000|Overall Study|Medication non-compliance|2|||
161698553|NCT03175549|583944229|FG001|Overall Study|Medication non-compliance|2|||
161698554|NCT02486757|583944230|FG000|Overall Study|Lost to Follow-up|1|||
161698555|NCT01064167|583944231|FG000|Overall Study|Protocol Violation|14|||
161698556|NCT01064167|583944232|FG001|Overall Study|Protocol Violation|15|||
161698557|NCT03984305|583944234|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
161698558|NCT03984305|583944235|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
161836779|NCT03351231|584445031|FG000|Combination Therapy Period|Study drug toxicity|1|||
161836780|NCT03351231|584445031|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
161836781|NCT03351231|584445031|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
161698559|NCT03984305|583944234|FG000|Overall Study|Withdrawal by Subject|3|||
161698560|NCT03984305|583944235|FG001|Overall Study|Withdrawal by Subject|3|||
161836782|NCT03351231|584445031|FG000|Safety Follow-Up Period|Other reason|2|||
161698561|NCT03984305|583944234|FG000|Overall Study|Lost to Follow-up|1|||
161698562|NCT03984305|583944235|FG001|Overall Study|Lost to Follow-up|0|||
161698563|NCT02883244|583944236|FG000|Overall Study|Lost to Follow-up|0|||
161698564|NCT02883244|583944237|FG001|Overall Study|Lost to Follow-up|1|||
161698565|NCT03979274|583944245|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161698566|NCT03979274|583944246|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161698567|NCT01614093|583944249|FG000|Overall Study|Withdrawal by Subject|1|||
161698568|NCT00603915|583944250|FG000|Overall Study|Physician Decision|1|||
161698569|NCT01724528|583944256|FG000|Overall Study|Death|3|||
161698570|NCT01724528|583944257|FG001|Overall Study|Death|0|||
161698571|NCT01724528|583944256|FG000|Overall Study|Withdrawal by Subject|0|||
161698572|NCT01724528|583944257|FG001|Overall Study|Withdrawal by Subject|2|||
161698573|NCT01724528|583944256|FG000|Overall Study|Protocol Violation|0|||
161698574|NCT01724528|583944257|FG001|Overall Study|Protocol Violation|1|||
161698575|NCT01724528|583944256|FG000|Overall Study|Patient refused to attend last visit|1|||
161698576|NCT01724528|583944257|FG001|Overall Study|Patient refused to attend last visit|0|||
161698577|NCT02183519|583944261|FG000|Overall Study|computer error|3|||
161698578|NCT02183519|583944262|FG001|Overall Study|computer error|0|||
161698579|NCT02183519|583944261|FG000|Overall Study|Did not respond to cough inducter|0|||
161698580|NCT02183519|583944262|FG001|Overall Study|Did not respond to cough inducter|3|||
161698581|NCT05574062|583944265|FG000|Pre Run-In|Screening failure|3|||
161698582|NCT05574062|583944266|FG001|Pre Run-In|Screening failure|0|||
161698583|NCT05574062|583944267|FG002|Pre Run-In|Screening failure|0|||
161698584|NCT05574062|583944268|FG003|Pre Run-In|Screening failure|0|||
161698585|NCT05574062|583944269|FG004|Pre Run-In|Screening failure|0|||
161698586|NCT05574062|583944265|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
161698587|NCT05574062|583944266|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
161698588|NCT05574062|583944267|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
161698589|NCT05574062|583944268|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
161698590|NCT05574062|583944269|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
161698591|NCT05574062|583944265|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
161698592|NCT05574062|583944266|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
161698593|NCT05574062|583944267|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
161698594|NCT05574062|583944268|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
161698595|NCT05574062|583944269|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
161698596|NCT05574062|583944265|FG000|Continuation Phase Period 1|Physician Decision|1|||
161698597|NCT05574062|583944266|FG001|Continuation Phase Period 1|Physician Decision|0|||
161698598|NCT05574062|583944267|FG002|Continuation Phase Period 1|Physician Decision|0|||
161698599|NCT05574062|583944268|FG003|Continuation Phase Period 1|Physician Decision|0|||
161698600|NCT05574062|583944269|FG004|Continuation Phase Period 1|Physician Decision|0|||
161698601|NCT05574062|583944265|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
161698602|NCT05574062|583944266|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698603|NCT05574062|583944267|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698604|NCT05574062|583944268|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698605|NCT05574062|583944269|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698606|NCT05574062|583944265|FG000|Continuation Phase Period 1|Adverse Event|1|||
161698607|NCT05574062|583944266|FG001|Continuation Phase Period 1|Adverse Event|0|||
161698608|NCT05574062|583944267|FG002|Continuation Phase Period 1|Adverse Event|0|||
161698609|NCT05574062|583944268|FG003|Continuation Phase Period 1|Adverse Event|0|||
161698610|NCT05574062|583944269|FG004|Continuation Phase Period 1|Adverse Event|0|||
161698611|NCT05574062|583944265|FG000|Continuation Phase Period 1|Death|1|||
161698612|NCT05574062|583944266|FG001|Continuation Phase Period 1|Death|0|||
161698613|NCT05574062|583944267|FG002|Continuation Phase Period 1|Death|0|||
161698614|NCT05574062|583944268|FG003|Continuation Phase Period 1|Death|0|||
161698615|NCT05574062|583944269|FG004|Continuation Phase Period 1|Death|0|||
161698616|NCT05574062|583944265|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698617|NCT05574062|583944266|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698618|NCT05574062|583944267|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698619|NCT05574062|583944268|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
161698620|NCT05574062|583944269|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698621|NCT00700180|583945748|FG000|Overall Study|Death|99|||
161698622|NCT00700180|583945749|FG001|Overall Study|Death|114|||
161698623|NCT00700180|583945748|FG000|Overall Study|Alive on treatment|5|||
161698624|NCT00700180|583945749|FG001|Overall Study|Alive on treatment|3|||
161698625|NCT00700180|583945748|FG000|Overall Study|Alive in follow-up|46|||
161698626|NCT00700180|583945749|FG001|Overall Study|Alive in follow-up|27|||
161698627|NCT00700180|583945748|FG000|Overall Study|Lost to Follow-up|4|||
161698628|NCT00700180|583945749|FG001|Overall Study|Lost to Follow-up|5|||
161698629|NCT03588741|583945750|FG000|Overall Study|Withdrawal by Subject|1|||
161698630|NCT01445535|583945751|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161698631|NCT01445535|583945752|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161698632|NCT01445535|583945753|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161698633|NCT01445535|583945754|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
161698634|NCT01445535|583945751|FG000|Overall Study|Disease progression|1|||
161698635|NCT01445535|583945752|FG001|Overall Study|Disease progression|0|||
161698636|NCT01445535|583945753|FG002|Overall Study|Disease progression|1|||
161698637|NCT01445535|583945754|FG003|Overall Study|Disease progression|0|||
161698638|NCT01445535|583945751|FG000|Overall Study|PI discretion|0|||
161698639|NCT01445535|583945752|FG001|Overall Study|PI discretion|0|||
161698640|NCT01445535|583945753|FG002|Overall Study|PI discretion|0|||
161698641|NCT01445535|583945754|FG003|Overall Study|PI discretion|1|||
161698642|NCT01668654|583945759|FG000|Overall Study|Study Closed/Terminated|3|||
161698643|NCT01668654|583945759|FG000|Overall Study|Withdrawal by Subject|1|||
161698644|NCT00454779|583945760|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
161698645|NCT00454779|583945761|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
161698646|NCT00454779|583945760|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
161698647|NCT00454779|583945761|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
161698648|NCT00454779|583945760|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
161698649|NCT00454779|583945761|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
161698650|NCT00454779|583945760|FG000|First-line Treatment Phase|Protocol Violation|0|||
161698651|NCT00454779|583945761|FG001|First-line Treatment Phase|Protocol Violation|1|||
161698652|NCT00454779|583945760|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
161698653|NCT00454779|583945761|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
161698654|NCT00454779|583945760|FG000|First-line Treatment Phase|Ongoing|1|||
161698655|NCT00454779|583945761|FG001|First-line Treatment Phase|Ongoing|0|||
161698656|NCT00454779|583945760|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
161698657|NCT00454779|583945761|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
161698658|NCT00454779|583945760|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
161698659|NCT00454779|583945761|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
161698660|NCT00454779|583945760|FG000|Second-line Treatment Phase|Ongoing|0|||
161698661|NCT00454779|583945761|FG001|Second-line Treatment Phase|Ongoing|1|||
161698662|NCT01337973|583945763|FG000|Overall Study|Lost to Follow-up|2|||
161698663|NCT01337973|583945764|FG001|Overall Study|Lost to Follow-up|4|||
161698664|NCT01337973|583945765|FG002|Overall Study|Lost to Follow-up|3|||
161698665|NCT01337973|583945763|FG000|Overall Study|Death|1|||
161698666|NCT01337973|583945764|FG001|Overall Study|Death|2|||
161698667|NCT01337973|583945765|FG002|Overall Study|Death|1|||
161698668|NCT01337973|583945763|FG000|Overall Study|Withdrawal by Subject|10|||
161698669|NCT01337973|583945764|FG001|Overall Study|Withdrawal by Subject|8|||
161698670|NCT01337973|583945765|FG002|Overall Study|Withdrawal by Subject|4|||
161698671|NCT01337973|583945763|FG000|Overall Study|missing data on primary outcome|3|||
161698672|NCT01337973|583945764|FG001|Overall Study|missing data on primary outcome|1|||
161698673|NCT01337973|583945765|FG002|Overall Study|missing data on primary outcome|3|||
161698674|NCT03634800|583945766|FG000|Overall Study|Adverse Event|1|||
161698675|NCT03634800|583945766|FG000|Overall Study|Disease Progression|4|||
161698676|NCT03634800|583945766|FG000|Overall Study|Withdrawal by Subject|1|||
161698677|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
161698678|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
161698679|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
161698680|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
161698681|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
161698682|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
161698683|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
161698684|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
161698685|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
161698686|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
161698687|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
161698688|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
161698689|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161698690|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161698691|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161698692|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
161698693|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
161698694|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
161698695|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
161698696|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
161698697|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
161698698|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
161698699|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
161698700|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
161698701|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Death|2|||
161698702|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Death|1|||
161698703|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Death|2|||
161698704|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Graft loss|0|||
161698705|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Graft loss|2|||
161698706|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Graft loss|0|||
161698707|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
161698708|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
161698709|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
161698710|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Missing|2|||
161698711|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Missing|0|||
161698712|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Missing|0|||
161698713|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
161698714|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
161698715|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
161698716|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
161698717|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
161698718|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
161698719|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Death|8|||
161698720|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Death|5|||
161698721|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Death|4|||
161698722|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Other|2|||
161698723|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Other|0|||
161698724|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Other|0|||
161698725|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Missing|2|||
161698726|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Missing|0|||
161698727|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Missing|0|||
161698728|NCT03555266|583945770|FG000|Overall Study|Protocol Violation|6|||
161698729|NCT03555266|583945771|FG001|Overall Study|Protocol Violation|4|||
161698730|NCT00797823|583945772|FG000|First Period (Initial Randomization)|Physician Decision|1|||
161698731|NCT00797823|583945773|FG001|First Period (Initial Randomization)|Physician Decision|0|||
161698732|NCT00797823|583945774|FG002|First Period (Initial Randomization)|Physician Decision|0|||
161698733|NCT01700192|583945775|FG000|Overall Study|Adverse Event|73|||
161698734|NCT01700192|583945776|FG001|Overall Study|Adverse Event|18|||
161698735|NCT01700192|583945775|FG000|Overall Study|Lack of Efficacy|1|||
161698736|NCT01700192|583945776|FG001|Overall Study|Lack of Efficacy|0|||
161698737|NCT01700192|583945775|FG000|Overall Study|Lost to Follow-up|42|||
161698738|NCT01700192|583945776|FG001|Overall Study|Lost to Follow-up|29|||
161698739|NCT01700192|583945775|FG000|Overall Study|Noncompliance with study drug|0|||
161698740|NCT01700192|583945776|FG001|Overall Study|Noncompliance with study drug|5|||
161698741|NCT01700192|583945775|FG000|Overall Study|Physician Decision|2|||
161698742|NCT01700192|583945776|FG001|Overall Study|Physician Decision|3|||
161698743|NCT01700192|583945775|FG000|Overall Study|Pregnancy|1|||
161698744|NCT01700192|583945776|FG001|Overall Study|Pregnancy|4|||
161698745|NCT01700192|583945775|FG000|Overall Study|Progressive disease|1|||
161698746|NCT01700192|583945776|FG001|Overall Study|Progressive disease|0|||
161698747|NCT01700192|583945775|FG000|Overall Study|Protocol Violation|3|||
161698748|NCT01700192|583945776|FG001|Overall Study|Protocol Violation|4|||
161698749|NCT01700192|583945775|FG000|Overall Study|Technical problems|0|||
161698750|NCT01700192|583945776|FG001|Overall Study|Technical problems|1|||
161698751|NCT01700192|583945775|FG000|Overall Study|Withdrawal by Subject|56|||
161698752|NCT01700192|583945776|FG001|Overall Study|Withdrawal by Subject|64|||
161698753|NCT01700192|583945775|FG000|Overall Study|Never received study drug|1|||
161698754|NCT01700192|583945776|FG001|Overall Study|Never received study drug|0|||
161698755|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
161698756|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698757|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698758|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698759|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698760|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
161698761|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
161698762|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
161698763|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
161698764|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
161698765|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
161698766|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698767|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698768|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698769|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698770|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
161698771|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161836783|NCT00103402|584445034|FG000|Overall Study|Adverse Event|3|||
161836784|NCT00103402|584445035|FG001|Overall Study|Adverse Event|4|||
161836785|NCT00103402|584445034|FG000|Overall Study|Lost to Follow-up|8|||
161836786|NCT00103402|584445035|FG001|Overall Study|Lost to Follow-up|7|||
161836787|NCT00103402|584445034|FG000|Overall Study|Dissatisfied/No longer interested|6|||
161836788|NCT00103402|584445035|FG001|Overall Study|Dissatisfied/No longer interested|6|||
161698772|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161698773|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161698774|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161698775|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
161698776|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
161698777|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
161698778|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
161836789|NCT00103402|584445034|FG000|Overall Study|Personal constraints/Other|5|||
161698779|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
161698780|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
161836790|NCT00103402|584445035|FG001|Overall Study|Personal constraints/Other|0|||
161836791|NCT01673698|584445036|FG000|Overall Study|Lost to Follow-up|51|||
161836792|NCT01673698|584445037|FG001|Overall Study|Lost to Follow-up|13|||
161698781|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698782|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698783|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698784|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698785|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
161698786|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
161698787|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
161698788|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
161698789|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
161698790|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161698791|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
161698792|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
161698793|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
161698794|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
161698795|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161698796|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
161698797|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
161698798|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
161698799|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
161698800|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
161698801|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161698802|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
161698803|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
161698804|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161698805|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161698806|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
161698807|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161698808|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
161698809|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
161698810|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161698811|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161698812|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161698813|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161698814|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161698815|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161698816|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161698817|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
161698818|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161836793|NCT01297322|584445038|FG000|Overall Study|Lost to Follow-up|1|||
161653775|NCT04939701|583782736|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
161653776|NCT04939701|583782737|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
161653777|NCT04939701|583782735|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
161653778|NCT04939701|583782736|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
161653779|NCT04939701|583782737|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
161653780|NCT04939701|583782735|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
161653781|NCT04939701|583782736|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
161653782|NCT04939701|583782737|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
161653783|NCT01283516|583782742|FG000|Overall Study|Adverse Event|0|||
161653784|NCT01283516|583782743|FG001|Overall Study|Adverse Event|0|||
161653785|NCT01283516|583782744|FG002|Overall Study|Adverse Event|0|||
161653786|NCT01283516|583782745|FG003|Overall Study|Adverse Event|0|||
161653787|NCT01283516|583782746|FG004|Overall Study|Adverse Event|0|||
161653788|NCT01283516|583782747|FG005|Overall Study|Adverse Event|0|||
161653789|NCT01283516|583782748|FG006|Overall Study|Adverse Event|2|||
161653790|NCT01283516|583782749|FG007|Overall Study|Adverse Event|0|||
161653791|NCT01283516|583782750|FG008|Overall Study|Adverse Event|28|||
161653792|NCT01283516|583782742|FG000|Overall Study|Death|0|||
161653793|NCT01283516|583782743|FG001|Overall Study|Death|0|||
161653794|NCT01283516|583782744|FG002|Overall Study|Death|0|||
161653795|NCT01283516|583782745|FG003|Overall Study|Death|0|||
161653796|NCT01283516|583782746|FG004|Overall Study|Death|0|||
161653797|NCT01283516|583782747|FG005|Overall Study|Death|1|||
161653798|NCT01283516|583782748|FG006|Overall Study|Death|0|||
161653799|NCT01283516|583782749|FG007|Overall Study|Death|1|||
161653800|NCT01283516|583782750|FG008|Overall Study|Death|12|||
161653801|NCT01283516|583782742|FG000|Overall Study|Disease Progression|2|||
161653802|NCT01283516|583782743|FG001|Overall Study|Disease Progression|2|||
161653803|NCT01283516|583782744|FG002|Overall Study|Disease Progression|3|||
161653804|NCT01283516|583782745|FG003|Overall Study|Disease Progression|3|||
161653805|NCT01283516|583782746|FG004|Overall Study|Disease Progression|13|||
161653806|NCT01283516|583782747|FG005|Overall Study|Disease Progression|8|||
161653807|NCT01283516|583782748|FG006|Overall Study|Disease Progression|6|||
161653808|NCT01283516|583782749|FG007|Overall Study|Disease Progression|3|||
161653809|NCT01283516|583782750|FG008|Overall Study|Disease Progression|139|||
161653810|NCT01283516|583782742|FG000|Overall Study|Withdrawal by Subject|0|||
161653811|NCT01283516|583782743|FG001|Overall Study|Withdrawal by Subject|0|||
161653812|NCT01283516|583782744|FG002|Overall Study|Withdrawal by Subject|0|||
161653813|NCT01283516|583782745|FG003|Overall Study|Withdrawal by Subject|0|||
161653814|NCT01283516|583782746|FG004|Overall Study|Withdrawal by Subject|1|||
161653815|NCT01283516|583782747|FG005|Overall Study|Withdrawal by Subject|0|||
161653816|NCT01283516|583782748|FG006|Overall Study|Withdrawal by Subject|1|||
161653817|NCT01283516|583782749|FG007|Overall Study|Withdrawal by Subject|0|||
161653818|NCT01283516|583782750|FG008|Overall Study|Withdrawal by Subject|36|||
161836794|NCT01297322|584445039|FG001|Overall Study|Lost to Follow-up|0|||
161653819|NCT01283516|583782742|FG000|Overall Study|Administrative problems|0|||
161653820|NCT01283516|583782743|FG001|Overall Study|Administrative problems|0|||
161653821|NCT01283516|583782744|FG002|Overall Study|Administrative problems|0|||
161653822|NCT01283516|583782745|FG003|Overall Study|Administrative problems|0|||
161653823|NCT01283516|583782746|FG004|Overall Study|Administrative problems|0|||
161653824|NCT01283516|583782747|FG005|Overall Study|Administrative problems|1|||
161653825|NCT01283516|583782748|FG006|Overall Study|Administrative problems|1|||
161653826|NCT01283516|583782749|FG007|Overall Study|Administrative problems|1|||
161653827|NCT01283516|583782750|FG008|Overall Study|Administrative problems|39|||
161653828|NCT01283516|583782742|FG000|Overall Study|Lost to Follow-up|0|||
161653829|NCT01283516|583782743|FG001|Overall Study|Lost to Follow-up|0|||
161653830|NCT01283516|583782744|FG002|Overall Study|Lost to Follow-up|0|||
161653831|NCT01283516|583782745|FG003|Overall Study|Lost to Follow-up|0|||
161653832|NCT01283516|583782746|FG004|Overall Study|Lost to Follow-up|0|||
161653833|NCT01283516|583782747|FG005|Overall Study|Lost to Follow-up|0|||
161653834|NCT01283516|583782748|FG006|Overall Study|Lost to Follow-up|0|||
161653835|NCT01283516|583782749|FG007|Overall Study|Lost to Follow-up|0|||
161653836|NCT01283516|583782750|FG008|Overall Study|Lost to Follow-up|1|||
161653837|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
161653838|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
161653839|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
161653840|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
161653841|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
161653842|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
161653843|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
161653844|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
161653845|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
161653846|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
161653847|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Adverse Event|0|||
161653848|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Adverse Event|0|||
161653849|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Adverse Event|3|||
161653850|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Adverse Event|2|||
161653851|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Adverse Event|13|||
161653852|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
161653853|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
161653854|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
161653855|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
161653856|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
161653857|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Patient's wish|0|||
161653858|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Patient's wish|0|||
161653859|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Patient's wish|19|||
161653860|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Patient's wish|9|||
161653861|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Patient's wish|20|||
161653862|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
161653863|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
161653864|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
161653865|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
161653866|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
161653867|NCT00444275|583782753|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
161653868|NCT00444275|583782754|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
161653869|NCT00444275|583782755|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
161653870|NCT00444275|583782756|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
161653871|NCT00444275|583782757|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
161653872|NCT04187326|583782758|FG000|Overall Study|Lost to Follow-up|2|||
161698819|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
161698820|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
161698821|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
161698822|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
161698823|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
161698824|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
161698825|NCT00352105|583945787|FG000|Overall Study|Death|5|||
161698826|NCT00352105|583945787|FG000|Overall Study|Withdrawal by Subject|5|||
161698827|NCT00352105|583945787|FG000|Overall Study|Lack of Efficacy|9|||
161698828|NCT00352105|583945787|FG000|Overall Study|Adverse Event|19|||
161698829|NCT00352105|583945787|FG000|Overall Study|Protocol Violation|2|||
161698830|NCT02979431|583945790|FG000|Overall Study|Parent/guardian withdrew consent|2|||
161698831|NCT02979431|583945791|FG001|Overall Study|Parent/guardian withdrew consent|1|||
161698832|NCT02979431|583945792|FG002|Overall Study|Parent/guardian withdrew consent|1|||
161698833|NCT02979431|583945793|FG003|Overall Study|Parent/guardian withdrew consent|1|||
161698834|NCT02979431|583945790|FG000|Overall Study|Randomized but received no study drug|1|||
161698835|NCT02979431|583945791|FG001|Overall Study|Randomized but received no study drug|1|||
161698836|NCT02979431|583945792|FG002|Overall Study|Randomized but received no study drug|0|||
161698837|NCT02979431|583945793|FG003|Overall Study|Randomized but received no study drug|0|||
161698838|NCT02979431|583945790|FG000|Overall Study|Adverse Event|0|||
161698839|NCT02979431|583945791|FG001|Overall Study|Adverse Event|0|||
161698840|NCT02979431|583945792|FG002|Overall Study|Adverse Event|1|||
161698841|NCT02979431|583945793|FG003|Overall Study|Adverse Event|0|||
161698842|NCT02979431|583945790|FG000|Overall Study|Subject left country after Day14|1|||
161698843|NCT02979431|583945791|FG001|Overall Study|Subject left country after Day14|0|||
161698844|NCT02979431|583945792|FG002|Overall Study|Subject left country after Day14|0|||
161698845|NCT02979431|583945793|FG003|Overall Study|Subject left country after Day14|0|||
161698846|NCT01656434|583945794|FG000|Overall Study|Adverse Event|199|||
161698847|NCT01656434|583945795|FG001|Overall Study|Adverse Event|63|||
161698848|NCT01656434|583945794|FG000|Overall Study|Enrollment terminated at trial site|2|||
161698849|NCT01656434|583945795|FG001|Overall Study|Enrollment terminated at trial site|0|||
161698850|NCT01656434|583945794|FG000|Overall Study|Lost to Follow-up|309|||
161836795|NCT01297322|584445038|FG000|Overall Study|Withdrawal by Subject|0|||
161836796|NCT01297322|584445039|FG001|Overall Study|Withdrawal by Subject|1|||
161653873|NCT04187326|583782759|FG001|Overall Study|Lost to Follow-up|1|||
161653874|NCT04187326|583782758|FG000|Overall Study|Computer error- task was only partially completed.|0|||
161653875|NCT04187326|583782759|FG001|Overall Study|Computer error- task was only partially completed.|1|||
161653876|NCT02387970|583782760|FG000|Overall Study|Did not complete 1-year follow up|1|||
161653877|NCT02387970|583782761|FG001|Overall Study|Did not complete 1-year follow up|2|||
161653878|NCT02628028|583782762|FG000|Dosing Period|Withdrawal by Subject|0|||
161653879|NCT02628028|583782763|FG001|Dosing Period|Withdrawal by Subject|0|||
161653880|NCT02628028|583782764|FG002|Dosing Period|Withdrawal by Subject|1|||
161653881|NCT02628028|583782765|FG003|Dosing Period|Withdrawal by Subject|0|||
161653882|NCT02628028|583782766|FG004|Dosing Period|Withdrawal by Subject|2|||
161653883|NCT02628028|583782767|FG005|Dosing Period|Withdrawal by Subject|4|||
161653884|NCT02628028|583782768|FG006|Dosing Period|Withdrawal by Subject|1|||
161653885|NCT02628028|583782769|FG007|Dosing Period|Withdrawal by Subject|1|||
161653886|NCT02628028|583782762|FG000|Dosing Period|Adverse Event|0|||
161653887|NCT02628028|583782763|FG001|Dosing Period|Adverse Event|0|||
161653888|NCT02628028|583782764|FG002|Dosing Period|Adverse Event|0|||
161653889|NCT02628028|583782765|FG003|Dosing Period|Adverse Event|0|||
161653890|NCT02628028|583782766|FG004|Dosing Period|Adverse Event|2|||
161653891|NCT02628028|583782767|FG005|Dosing Period|Adverse Event|1|||
161653892|NCT02628028|583782768|FG006|Dosing Period|Adverse Event|3|||
161653893|NCT02628028|583782769|FG007|Dosing Period|Adverse Event|2|||
161653894|NCT02628028|583782762|FG000|Dosing Period|Death|0|||
161653895|NCT02628028|583782763|FG001|Dosing Period|Death|0|||
161653896|NCT02628028|583782764|FG002|Dosing Period|Death|0|||
161653897|NCT02628028|583782765|FG003|Dosing Period|Death|0|||
161653898|NCT02628028|583782766|FG004|Dosing Period|Death|0|||
161653899|NCT02628028|583782767|FG005|Dosing Period|Death|0|||
161653900|NCT02628028|583782768|FG006|Dosing Period|Death|0|||
161653901|NCT02628028|583782769|FG007|Dosing Period|Death|1|||
161653902|NCT02628028|583782762|FG000|Dosing Period|Lack of Efficacy|0|||
161653903|NCT02628028|583782763|FG001|Dosing Period|Lack of Efficacy|0|||
161653904|NCT02628028|583782764|FG002|Dosing Period|Lack of Efficacy|0|||
161653905|NCT02628028|583782765|FG003|Dosing Period|Lack of Efficacy|0|||
161653906|NCT02628028|583782766|FG004|Dosing Period|Lack of Efficacy|3|||
161653907|NCT02628028|583782767|FG005|Dosing Period|Lack of Efficacy|0|||
161653908|NCT02628028|583782768|FG006|Dosing Period|Lack of Efficacy|1|||
161653909|NCT02628028|583782769|FG007|Dosing Period|Lack of Efficacy|0|||
161653910|NCT02628028|583782762|FG000|Dosing Period|Study Terminated by Sponsor|0|||
161653911|NCT02628028|583782763|FG001|Dosing Period|Study Terminated by Sponsor|0|||
161653912|NCT02628028|583782764|FG002|Dosing Period|Study Terminated by Sponsor|0|||
161698851|NCT01656434|583945795|FG001|Overall Study|Lost to Follow-up|76|||
161653913|NCT02628028|583782765|FG003|Dosing Period|Study Terminated by Sponsor|0|||
161698852|NCT01656434|583945794|FG000|Overall Study|Site discontinued study participation|24|||
161698853|NCT01656434|583945795|FG001|Overall Study|Site discontinued study participation|9|||
161698854|NCT01656434|583945794|FG000|Overall Study|Screen failure|2|||
161698855|NCT01656434|583945795|FG001|Overall Study|Screen failure|0|||
161698856|NCT01656434|583945794|FG000|Overall Study|Protocol Violation|7|||
161698857|NCT01656434|583945795|FG001|Overall Study|Protocol Violation|0|||
161698858|NCT01656434|583945794|FG000|Overall Study|Pregnancy wish|18|||
161698859|NCT01656434|583945795|FG001|Overall Study|Pregnancy wish|6|||
161698860|NCT01656434|583945794|FG000|Overall Study|Pregnancy|45|||
161698861|NCT01656434|583945795|FG001|Overall Study|Pregnancy|10|||
161698862|NCT01656434|583945794|FG000|Overall Study|Physician Decision|7|||
161698863|NCT01656434|583945795|FG001|Overall Study|Physician Decision|2|||
161698864|NCT01656434|583945794|FG000|Overall Study|Non-compliance with study drug|48|||
161698865|NCT01656434|583945795|FG001|Overall Study|Non-compliance with study drug|9|||
161698866|NCT01656434|583945794|FG000|Overall Study|Study terminated by sponsor|1501|||
161698867|NCT01656434|583945795|FG001|Overall Study|Study terminated by sponsor|348|||
161698868|NCT01656434|583945794|FG000|Overall Study|Participant discontinued; drug related|13|||
161698869|NCT01656434|583945795|FG001|Overall Study|Participant discontinued; drug related|4|||
161698870|NCT01656434|583945794|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
161698871|NCT01656434|583945795|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
161698872|NCT01656434|583945794|FG000|Overall Study|Non-compliance with protocol|39|||
161698873|NCT01656434|583945795|FG001|Overall Study|Non-compliance with protocol|15|||
161698874|NCT01656434|583945794|FG000|Overall Study|Participant moved|40|||
161698875|NCT01656434|583945795|FG001|Overall Study|Participant moved|12|||
161698876|NCT01656434|583945794|FG000|Overall Study|Participant withdrew consent|28|||
161698877|NCT01656434|583945795|FG001|Overall Study|Participant withdrew consent|9|||
161698878|NCT01656434|583945794|FG000|Overall Study|Withdrawal by Subject|64|||
161698879|NCT01656434|583945795|FG001|Overall Study|Withdrawal by Subject|7|||
161698880|NCT01235962|583945796|FG000|Overall Study|Withdrawal by Subject|20|||
161698881|NCT01235962|583945797|FG001|Overall Study|Withdrawal by Subject|19|||
161698882|NCT01235962|583945798|FG002|Overall Study|Withdrawal by Subject|62|||
161698883|NCT01235962|583945799|FG003|Overall Study|Withdrawal by Subject|49|||
161698884|NCT01235962|583945796|FG000|Overall Study|Lost to Follow-up|21|||
161698885|NCT01235962|583945797|FG001|Overall Study|Lost to Follow-up|16|||
161698886|NCT01235962|583945798|FG002|Overall Study|Lost to Follow-up|47|||
161698887|NCT01235962|583945799|FG003|Overall Study|Lost to Follow-up|32|||
161698888|NCT01235962|583945796|FG000|Overall Study|Physician Decision|5|||
161698889|NCT01235962|583945797|FG001|Overall Study|Physician Decision|0|||
161698890|NCT01235962|583945798|FG002|Overall Study|Physician Decision|9|||
161698891|NCT01235962|583945799|FG003|Overall Study|Physician Decision|5|||
161698892|NCT01580397|583945800|FG000|Overall Study|Lack of Efficacy|14|||
161698893|NCT02435914|583945801|FG000|Overall Study|Ocular Adverse Event|1|||
161698894|NCT02435914|583945802|FG001|Overall Study|Ocular Adverse Event|0|||
161698895|NCT02435914|583945803|FG002|Overall Study|Ocular Adverse Event|0|||
161698896|NCT02435914|583945804|FG003|Overall Study|Ocular Adverse Event|0|||
161698897|NCT02435914|583945801|FG000|Overall Study|Withdrawal by Subject|0|||
161698898|NCT02435914|583945802|FG001|Overall Study|Withdrawal by Subject|1|||
161698899|NCT02435914|583945803|FG002|Overall Study|Withdrawal by Subject|0|||
161698900|NCT02435914|583945804|FG003|Overall Study|Withdrawal by Subject|0|||
161698901|NCT02435914|583945801|FG000|Overall Study|Other Miscellaneous Reason|0|||
161698902|NCT02435914|583945802|FG001|Overall Study|Other Miscellaneous Reason|0|||
161698903|NCT02435914|583945803|FG002|Overall Study|Other Miscellaneous Reason|1|||
161698904|NCT02435914|583945804|FG003|Overall Study|Other Miscellaneous Reason|0|||
161698905|NCT01727258|583945805|FG000|Overall Study|Adverse Event|0|||
161836797|NCT01297322|584445038|FG000|Overall Study|Protocol Violation|0|||
161836798|NCT01297322|584445039|FG001|Overall Study|Protocol Violation|3|||
161698906|NCT01727258|583945806|FG001|Overall Study|Adverse Event|2|||
161698907|NCT01727258|583945807|FG002|Overall Study|Adverse Event|0|||
161698908|NCT01727258|583945805|FG000|Overall Study|Noncompliance with Study Drug|0|||
161698909|NCT01727258|583945806|FG001|Overall Study|Noncompliance with Study Drug|0|||
161698910|NCT01727258|583945807|FG002|Overall Study|Noncompliance with Study Drug|1|||
161698911|NCT01727258|583945805|FG000|Overall Study|Withdrawal by Subject|1|||
161698912|NCT01727258|583945806|FG001|Overall Study|Withdrawal by Subject|1|||
161698913|NCT01727258|583945807|FG002|Overall Study|Withdrawal by Subject|0|||
161698914|NCT01727258|583945805|FG000|Overall Study|Lost to Follow-up|1|||
161698915|NCT01727258|583945806|FG001|Overall Study|Lost to Follow-up|0|||
161698916|NCT01727258|583945807|FG002|Overall Study|Lost to Follow-up|0|||
161836799|NCT01111019|584445040|FG000|Overall Study|Withdrew Prematurely|2|||
161698917|NCT01405053|583945813|FG000|Overall Study|Adverse Event|3|||
161698918|NCT01405053|583945814|FG001|Overall Study|Adverse Event|0|||
161698919|NCT01405053|583945813|FG000|Overall Study|Lost to Follow-up|0|||
161698920|NCT01405053|583945814|FG001|Overall Study|Lost to Follow-up|1|||
161698921|NCT01405053|583945813|FG000|Overall Study|Participant choice|2|||
161698922|NCT01405053|583945814|FG001|Overall Study|Participant choice|1|||
161698923|NCT01405053|583945813|FG000|Overall Study|Inadequate therapeutic effect|2|||
161698924|NCT01405053|583945814|FG001|Overall Study|Inadequate therapeutic effect|1|||
161698925|NCT01405053|583945813|FG000|Overall Study|Withdrawal by Subject|3|||
161698926|NCT01405053|583945814|FG001|Overall Study|Withdrawal by Subject|4|||
161698927|NCT01405053|583945813|FG000|Overall Study|Other|0|||
161698928|NCT01405053|583945814|FG001|Overall Study|Other|1|||
161698929|NCT00130286|583945817|FG000|Overall Study|Withdrawal by Subject|0|||
161698930|NCT00130286|583945818|FG001|Overall Study|Withdrawal by Subject|1|||
161698931|NCT00130286|583945819|FG002|Overall Study|Withdrawal by Subject|2|||
161698932|NCT00130286|583945820|FG003|Overall Study|Withdrawal by Subject|2|||
161698933|NCT00130286|583945817|FG000|Overall Study|Adverse Event|0|||
161698934|NCT00130286|583945818|FG001|Overall Study|Adverse Event|0|||
161698935|NCT00130286|583945819|FG002|Overall Study|Adverse Event|2|||
161698936|NCT00130286|583945820|FG003|Overall Study|Adverse Event|0|||
161698937|NCT00130286|583945817|FG000|Overall Study|Missing lab specimens|0|||
161698938|NCT00130286|583945818|FG001|Overall Study|Missing lab specimens|2|||
161698939|NCT00130286|583945819|FG002|Overall Study|Missing lab specimens|0|||
161698940|NCT00130286|583945820|FG003|Overall Study|Missing lab specimens|0|||
161698941|NCT01818726|583945826|FG000|Overall Study|Administrative reasons|5|||
161698942|NCT01818726|583945827|FG001|Overall Study|Administrative reasons|1|||
161698943|NCT01818726|583945826|FG000|Overall Study|Withdrawal by Subject|0|||
161698944|NCT01818726|583945827|FG001|Overall Study|Withdrawal by Subject|1|||
161698945|NCT01818726|583945826|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
161698946|NCT01818726|583945827|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
161698947|NCT00357500|583945828|FG000|Overall Study|Adverse Event|3|||
161698948|NCT00357500|583945828|FG000|Overall Study|Withdrawal by Subject|5|||
161698949|NCT00357500|583945828|FG000|Overall Study|Progressive Disease|65|||
161698950|NCT00357500|583945828|FG000|Overall Study|Not Started Protocol Therapy|4|||
161698951|NCT00993928|583945829|FG000|Overall Study|Withdrawal by Subject|4|||
161698952|NCT00993928|583945830|FG001|Overall Study|Withdrawal by Subject|7|||
161698953|NCT00993928|583945829|FG000|Overall Study|ineligible|1|||
161698954|NCT00993928|583945830|FG001|Overall Study|ineligible|0|||
161698955|NCT02319044|583945832|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
161698956|NCT02319044|583945833|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
161698957|NCT02319044|583945834|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
161698958|NCT02319044|583945832|FG000|Overall Study|Withdrawal by Subject|3|||
161698959|NCT02319044|583945833|FG001|Overall Study|Withdrawal by Subject|3|||
161698960|NCT02319044|583945834|FG002|Overall Study|Withdrawal by Subject|6|||
161698961|NCT02319044|583945832|FG000|Overall Study|Condition under investigation worsened|100|||
161698962|NCT02319044|583945833|FG001|Overall Study|Condition under investigation worsened|50|||
161698963|NCT02319044|583945834|FG002|Overall Study|Condition under investigation worsened|46|||
161698964|NCT02319044|583945832|FG000|Overall Study|Adverse Event|17|||
161698965|NCT02319044|583945833|FG001|Overall Study|Adverse Event|2|||
161698966|NCT02319044|583945834|FG002|Overall Study|Adverse Event|8|||
161698967|NCT02319044|583945832|FG000|Overall Study|Study specific discontinuation criteria|2|||
161698968|NCT02319044|583945833|FG001|Overall Study|Study specific discontinuation criteria|2|||
161698969|NCT02319044|583945834|FG002|Overall Study|Study specific discontinuation criteria|1|||
161698970|NCT02319044|583945832|FG000|Overall Study|Not treated|0|||
161698971|NCT02319044|583945833|FG001|Overall Study|Not treated|2|||
161698972|NCT02319044|583945834|FG002|Overall Study|Not treated|2|||
161698973|NCT02154087|583945842|FG000|Overall Study|Study Termination|1|||
161698974|NCT03687502|583945846|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
161698975|NCT03687502|583945846|FG000|Overall Study|Lumason not available|1|||
161698976|NCT00486278|583945848|FG000|Overall Study|Adverse Event|5|||
161698977|NCT00486278|583945848|FG000|Overall Study|Withdrawal by Subject|2|||
161836800|NCT01111019|584445040|FG000|Overall Study|Other|1|||
161836801|NCT01583218|584445041|FG000|Overall Study|Withdrawal by Subject|43|||
161698978|NCT00486278|583945848|FG000|Overall Study|Physician Decision|2|||
161698979|NCT05702736|583945855|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
161698980|NCT05702736|583945856|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
161698981|NCT05702736|583945855|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
161698982|NCT05702736|583945856|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
161698983|NCT03110900|583945871|FG000|Overall Study|Sponsor withdrew|1|||
161698984|NCT03110900|583945872|FG001|Overall Study|Sponsor withdrew|1|||
161698985|NCT02321436|583945873|FG000|Overall Study|Withdrawal by Subject|1|||
161698986|NCT02321436|583945874|FG001|Overall Study|Withdrawal by Subject|0|||
161698987|NCT02321436|583945873|FG000|Overall Study|Lost to Follow-up|0|||
161698988|NCT02321436|583945874|FG001|Overall Study|Lost to Follow-up|1|||
161836802|NCT01583218|584445042|FG001|Overall Study|Withdrawal by Subject|29|||
161698989|NCT00644787|583945875|FG000|Period 1: Titration Phase|Adverse Event|11|||
161698990|NCT00644787|583945876|FG001|Period 1: Titration Phase|Adverse Event|0|||
161698991|NCT00644787|583945877|FG002|Period 1: Titration Phase|Adverse Event|0|||
161698992|NCT00644787|583945875|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
161698993|NCT00644787|583945876|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
161698994|NCT00644787|583945877|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
161698995|NCT00644787|583945875|FG000|Period 1: Titration Phase|Physician Decision|1|||
161698996|NCT00644787|583945876|FG001|Period 1: Titration Phase|Physician Decision|0|||
161698997|NCT00644787|583945877|FG002|Period 1: Titration Phase|Physician Decision|0|||
161698998|NCT00644787|583945875|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
161698999|NCT00644787|583945876|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
161699000|NCT00644787|583945877|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
161699001|NCT00644787|583945875|FG000|Period 1: Titration Phase|Worsening of complications|1|||
161699002|NCT00644787|583945876|FG001|Period 1: Titration Phase|Worsening of complications|0|||
161699003|NCT00644787|583945877|FG002|Period 1: Titration Phase|Worsening of complications|0|||
161699004|NCT00644787|583945875|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
161699005|NCT00644787|583945876|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
161653914|NCT02628028|583782766|FG004|Dosing Period|Study Terminated by Sponsor|7|||
161653915|NCT02628028|583782767|FG005|Dosing Period|Study Terminated by Sponsor|6|||
161653916|NCT02628028|583782768|FG006|Dosing Period|Study Terminated by Sponsor|7|||
161653917|NCT02628028|583782769|FG007|Dosing Period|Study Terminated by Sponsor|7|||
161653918|NCT02628028|583782762|FG000|Dosing Period|Physician Decision|0|||
161653919|NCT02628028|583782763|FG001|Dosing Period|Physician Decision|0|||
161653920|NCT02628028|583782764|FG002|Dosing Period|Physician Decision|0|||
161653921|NCT02628028|583782765|FG003|Dosing Period|Physician Decision|0|||
161653922|NCT02628028|583782766|FG004|Dosing Period|Physician Decision|0|||
161653923|NCT02628028|583782767|FG005|Dosing Period|Physician Decision|1|||
161653924|NCT02628028|583782768|FG006|Dosing Period|Physician Decision|0|||
161653925|NCT02628028|583782769|FG007|Dosing Period|Physician Decision|0|||
161653926|NCT02628028|583782762|FG000|Dosing Period|Site Terminated by Sponsor|0|||
161653927|NCT02628028|583782763|FG001|Dosing Period|Site Terminated by Sponsor|0|||
161653928|NCT02628028|583782764|FG002|Dosing Period|Site Terminated by Sponsor|0|||
161653929|NCT02628028|583782765|FG003|Dosing Period|Site Terminated by Sponsor|0|||
161653930|NCT02628028|583782766|FG004|Dosing Period|Site Terminated by Sponsor|0|||
161653931|NCT02628028|583782767|FG005|Dosing Period|Site Terminated by Sponsor|1|||
161653932|NCT02628028|583782768|FG006|Dosing Period|Site Terminated by Sponsor|1|||
161653933|NCT02628028|583782769|FG007|Dosing Period|Site Terminated by Sponsor|0|||
161653934|NCT02628028|583782762|FG000|Dosing Period|Lost to Follow-up|0|||
161653935|NCT02628028|583782763|FG001|Dosing Period|Lost to Follow-up|0|||
161653936|NCT02628028|583782764|FG002|Dosing Period|Lost to Follow-up|0|||
161653937|NCT02628028|583782765|FG003|Dosing Period|Lost to Follow-up|0|||
161653938|NCT02628028|583782766|FG004|Dosing Period|Lost to Follow-up|0|||
161653939|NCT02628028|583782767|FG005|Dosing Period|Lost to Follow-up|0|||
161653940|NCT02628028|583782768|FG006|Dosing Period|Lost to Follow-up|1|||
161653941|NCT02628028|583782769|FG007|Dosing Period|Lost to Follow-up|0|||
161653942|NCT02628028|583782762|FG000|Dosing Period|Other|0|||
161653943|NCT02628028|583782763|FG001|Dosing Period|Other|0|||
161653944|NCT02628028|583782764|FG002|Dosing Period|Other|0|||
161653945|NCT02628028|583782765|FG003|Dosing Period|Other|0|||
161653946|NCT02628028|583782766|FG004|Dosing Period|Other|2|||
161653947|NCT02628028|583782767|FG005|Dosing Period|Other|1|||
161653948|NCT02628028|583782768|FG006|Dosing Period|Other|2|||
161653949|NCT02628028|583782769|FG007|Dosing Period|Other|4|||
161653950|NCT02628028|583782762|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
161653951|NCT02628028|583782763|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
161653952|NCT02628028|583782764|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
161653953|NCT02628028|583782765|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
161653954|NCT02628028|583782766|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
161653955|NCT02628028|583782767|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
161653956|NCT02628028|583782768|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
161653957|NCT02628028|583782769|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
161653958|NCT02628028|583782762|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161653959|NCT02628028|583782763|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161653960|NCT02628028|583782764|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161653961|NCT02628028|583782765|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161653962|NCT02628028|583782766|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161653963|NCT02628028|583782767|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
161653964|NCT02628028|583782768|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161653965|NCT02628028|583782769|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
161653966|NCT02628028|583782762|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161653967|NCT02628028|583782763|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161653968|NCT02628028|583782764|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161653969|NCT02628028|583782765|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161653970|NCT02628028|583782766|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161699006|NCT00644787|583945877|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
161699007|NCT00644787|583945875|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
161699008|NCT00644787|583945876|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
161699009|NCT00644787|583945877|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
161699010|NCT00644787|583945875|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
161699011|NCT00644787|583945876|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
161699012|NCT00644787|583945877|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
161699013|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
161699014|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
161699015|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
161699016|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
161699017|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
161699018|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
161699019|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
161699020|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
161699021|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
161699022|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
161699023|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
161699024|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
161699025|NCT03355300|583945878|FG000|Overall Study|Physician Decision|0|||
161699026|NCT03355300|583945879|FG001|Overall Study|Physician Decision|1|||
161699027|NCT03355300|583945878|FG000|Overall Study|Lack of Efficacy|2|||
161699028|NCT03355300|583945879|FG001|Overall Study|Lack of Efficacy|1|||
161699029|NCT03355300|583945878|FG000|Overall Study|Other reason|1|||
161699030|NCT03355300|583945879|FG001|Overall Study|Other reason|0|||
161699031|NCT00546052|583945880|FG000|Overall Study|Adverse Event|47|||
161699032|NCT00546052|583945880|FG000|Overall Study|Lost to Follow-up|144|||
161699033|NCT00546052|583945880|FG000|Overall Study|Protocol Violation|9|||
161699034|NCT00546052|583945880|FG000|Overall Study|Withdrawal by Subject|20|||
161699035|NCT00546052|583945880|FG000|Overall Study|Non Compliance|7|||
161699036|NCT03048422|583945883|FG000|Overall Study|Death|1|||
161699037|NCT03048422|583945884|FG001|Overall Study|Death|0|||
161699038|NCT03048422|583945885|FG002|Overall Study|Death|0|||
161699039|NCT03048422|583945883|FG000|Overall Study|Lost to Follow-up|5|||
161699040|NCT03048422|583945884|FG001|Overall Study|Lost to Follow-up|0|||
161699041|NCT03048422|583945885|FG002|Overall Study|Lost to Follow-up|1|||
161699042|NCT03048422|583945883|FG000|Overall Study|Withdrawal by Subject|5|||
161699043|NCT03048422|583945884|FG001|Overall Study|Withdrawal by Subject|7|||
161699044|NCT03048422|583945885|FG002|Overall Study|Withdrawal by Subject|4|||
161699045|NCT03048422|583945883|FG000|Overall Study|Moved|3|||
161699046|NCT03048422|583945884|FG001|Overall Study|Moved|2|||
161699047|NCT03048422|583945885|FG002|Overall Study|Moved|2|||
161699048|NCT03048422|583945883|FG000|Overall Study|Noncompliant with Study Requirements|2|||
161699049|NCT03048422|583945884|FG001|Overall Study|Noncompliant with Study Requirements|1|||
161699050|NCT03048422|583945885|FG002|Overall Study|Noncompliant with Study Requirements|2|||
161699051|NCT03048422|583945883|FG000|Overall Study|Not Able to Get to Clinic|1|||
161699052|NCT03048422|583945884|FG001|Overall Study|Not Able to Get to Clinic|0|||
161699053|NCT03048422|583945885|FG002|Overall Study|Not Able to Get to Clinic|0|||
161699054|NCT02482129|583945889|FG000|Overall Study|Adverse Event-prior to treatment|0|||
161699055|NCT02482129|583945890|FG001|Overall Study|Adverse Event-prior to treatment|1|||
161699056|NCT02482129|583945889|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
161699057|NCT02482129|583945890|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
161699058|NCT02482129|583945889|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
161699059|NCT02482129|583945890|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
161699060|NCT02482129|583945889|FG000|Overall Study|Criteria not met-prior to treatment|1|||
161699061|NCT02482129|583945890|FG001|Overall Study|Criteria not met-prior to treatment|0|||
161699062|NCT02482129|583945889|FG000|Overall Study|Adverse Event|1|||
161699063|NCT02482129|583945890|FG001|Overall Study|Adverse Event|0|||
161699064|NCT02482129|583945889|FG000|Overall Study|Withdrawal by Subject|2|||
161699065|NCT02482129|583945890|FG001|Overall Study|Withdrawal by Subject|0|||
161699066|NCT02482129|583945889|FG000|Overall Study|Criteria not met|1|||
161699067|NCT02482129|583945890|FG001|Overall Study|Criteria not met|0|||
161699068|NCT01031446|583945892|FG000|Overall Study|Disease Progression|38|||
161699069|NCT01031446|583945892|FG000|Overall Study|Adverse Event|9|||
161699070|NCT01031446|583945892|FG000|Overall Study|Physician Decision|4|||
161699071|NCT01031446|583945892|FG000|Overall Study|Withdrawal by Subject|3|||
161699072|NCT01031446|583945892|FG000|Overall Study|Still on treatment|1|||
161699073|NCT01877083|583945895|FG000|Treatment Phase|Disease Progression|10|||
161699074|NCT01877083|583945895|FG000|Treatment Phase|Clinical Progression|1|||
161699075|NCT01877083|583945895|FG000|Treatment Phase|Adverse Event|6|||
161699076|NCT01877083|583945895|FG000|Treatment Phase|Withdrawal by Subject|2|||
161699077|NCT01877083|583945895|FG000|Treatment Phase|Lost to Follow-up|1|||
161699078|NCT01877083|583945895|FG000|Extension Phase|Disease Progression|3|||
161699079|NCT01877083|583945895|FG000|Extension Phase|Adverse Event|2|||
161699080|NCT03344003|583945902|FG000|Overall Study|Switched to alternative treatment|1|||
161699081|NCT03344003|583945903|FG001|Overall Study|Switched to alternative treatment|0|||
161699082|NCT03344003|583945902|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
161699083|NCT03344003|583945903|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
161699084|NCT01602341|583946936|FG000|Overall Study|Adverse Event|0|||
161699085|NCT01602341|583946937|FG001|Overall Study|Adverse Event|1|||
161699086|NCT02324270|583946939|FG000|Overall Study|Withdrawal by Subject|0|||
161699087|NCT02324270|583946940|FG001|Overall Study|Withdrawal by Subject|1|||
161699088|NCT02324270|583946941|FG002|Overall Study|Withdrawal by Subject|0|||
161699089|NCT02324270|583946939|FG000|Overall Study|Lost to Follow-up|4|||
161699090|NCT02324270|583946940|FG001|Overall Study|Lost to Follow-up|3|||
161699091|NCT02324270|583946941|FG002|Overall Study|Lost to Follow-up|4|||
161699092|NCT02324270|583946939|FG000|Overall Study|Protocol Violation|0|||
161699093|NCT02324270|583946940|FG001|Overall Study|Protocol Violation|1|||
161699094|NCT02324270|583946941|FG002|Overall Study|Protocol Violation|1|||
161699095|NCT02324270|583946939|FG000|Overall Study|Non Compliance with Study Drug|1|||
161699096|NCT02324270|583946940|FG001|Overall Study|Non Compliance with Study Drug|2|||
161699097|NCT02324270|583946941|FG002|Overall Study|Non Compliance with Study Drug|0|||
161699098|NCT03521791|583946942|FG000|Overall Study|Protocol Violation|7|||
161699099|NCT03521791|583946943|FG001|Overall Study|Protocol Violation|17|||
161699100|NCT00680836|583946944|FG000|Overall Study|Withdrawal by Subject|3|||
161699101|NCT00680836|583946945|FG001|Overall Study|Withdrawal by Subject|0|||
161699102|NCT00680836|583946944|FG000|Overall Study|Lost to Follow-up|3|||
161699103|NCT00680836|583946945|FG001|Overall Study|Lost to Follow-up|1|||
161699104|NCT00680836|583946944|FG000|Overall Study|Physician Decision|2|||
161699105|NCT00680836|583946945|FG001|Overall Study|Physician Decision|1|||
161699106|NCT03786432|583946946|FG000|Overall Study|Screen Failure after consent|1|||
161699107|NCT03786432|583946946|FG000|Overall Study|Lost to Follow-up|4|||
161699108|NCT03786432|583946946|FG000|Overall Study|did not complete 12 month CT scan|1|||
161699109|NCT03038308|583946947|FG000|Overall Study|Surgical resection|1|||
161699110|NCT03038308|583946947|FG000|Overall Study|Withdrawal by Subject|2|||
161699111|NCT03038308|583946947|FG000|Overall Study|Lost to Follow-up|1|||
161699112|NCT01475734|583946951|FG000|Overall Study|Withdrawal by Subject|1|||
161699113|NCT01475734|583946952|FG001|Overall Study|Withdrawal by Subject|0|||
161699114|NCT01475734|583946951|FG000|Overall Study|Protocol Violation|1|||
161699115|NCT01475734|583946952|FG001|Overall Study|Protocol Violation|0|||
161699116|NCT01475734|583946951|FG000|Overall Study|Physician Decision|0|||
161699117|NCT01475734|583946952|FG001|Overall Study|Physician Decision|1|||
161699118|NCT00771472|583946953|FG000|Overall Study|Physician Decision|2|||
161699119|NCT00771472|583946954|FG001|Overall Study|Physician Decision|3|||
161699120|NCT00771472|583946953|FG000|Overall Study|Progressive Disease|3|||
161699121|NCT00771472|583946954|FG001|Overall Study|Progressive Disease|1|||
161699122|NCT00771472|583946953|FG000|Overall Study|Protocol Violation|1|||
161699123|NCT00771472|583946954|FG001|Overall Study|Protocol Violation|0|||
161699124|NCT00880750|583946960|FG000|First Intervention|Adverse Event|1|||
161699125|NCT00880750|583946961|FG001|First Intervention|Adverse Event|0|||
161699126|NCT00880750|583946960|FG000|First Intervention|Unable to collect urine|4|||
161699127|NCT00880750|583946961|FG001|First Intervention|Unable to collect urine|0|||
161699128|NCT00880750|583946960|FG000|First Intervention|Non-compliance with meals|0|||
161699129|NCT00880750|583946961|FG001|First Intervention|Non-compliance with meals|1|||
161699130|NCT00880750|583946960|FG000|First Intervention|Withdrawal by Subject|2|||
161699131|NCT00880750|583946961|FG001|First Intervention|Withdrawal by Subject|0|||
161699132|NCT00880750|583946960|FG000|First Intervention|Lost to Follow-up|2|||
161699133|NCT00880750|583946961|FG001|First Intervention|Lost to Follow-up|0|||
161699134|NCT00880750|583946960|FG000|Second Intervention|Withdrawal by Subject|2|||
161699135|NCT00880750|583946961|FG001|Second Intervention|Withdrawal by Subject|2|||
161699136|NCT00880750|583946960|FG000|Second Intervention|Protocol Violation|1|||
161699137|NCT00880750|583946961|FG001|Second Intervention|Protocol Violation|0|||
161699138|NCT00880750|583946960|FG000|Second Intervention|Unable to collect urine|1|||
161699139|NCT00880750|583946961|FG001|Second Intervention|Unable to collect urine|0|||
161699140|NCT00667576|583946962|FG000|Overall Study|Withdrawal by Subject|1|||
161836803|NCT01583218|584445041|FG000|Overall Study|Death|206|||
161836804|NCT01583218|584445042|FG001|Overall Study|Death|211|||
161836805|NCT01583218|584445041|FG000|Overall Study|Lost to Follow-up|11|||
161699141|NCT00667576|583946963|FG001|Overall Study|Withdrawal by Subject|0|||
161699142|NCT00667576|583946964|FG002|Overall Study|Withdrawal by Subject|1|||
161836806|NCT01583218|584445042|FG001|Overall Study|Lost to Follow-up|17|||
161699143|NCT00667576|583946965|FG003|Overall Study|Withdrawal by Subject|1|||
161699144|NCT00667576|583946966|FG004|Overall Study|Withdrawal by Subject|1|||
161699145|NCT00667576|583946962|FG000|Overall Study|Adverse Event|1|||
161699146|NCT00667576|583946963|FG001|Overall Study|Adverse Event|1|||
161699147|NCT00667576|583946964|FG002|Overall Study|Adverse Event|0|||
161699148|NCT00667576|583946965|FG003|Overall Study|Adverse Event|0|||
161699149|NCT00667576|583946966|FG004|Overall Study|Adverse Event|0|||
161699150|NCT00667576|583946962|FG000|Overall Study|Lost to Follow-up|0|||
161699151|NCT00667576|583946963|FG001|Overall Study|Lost to Follow-up|0|||
161699152|NCT00667576|583946964|FG002|Overall Study|Lost to Follow-up|1|||
161699153|NCT00667576|583946965|FG003|Overall Study|Lost to Follow-up|0|||
161699154|NCT00667576|583946966|FG004|Overall Study|Lost to Follow-up|0|||
161699155|NCT00667576|583946962|FG000|Overall Study|Protocol Violation|0|||
161699156|NCT00667576|583946963|FG001|Overall Study|Protocol Violation|0|||
161699157|NCT00667576|583946964|FG002|Overall Study|Protocol Violation|0|||
161699158|NCT00667576|583946965|FG003|Overall Study|Protocol Violation|1|||
161699159|NCT00667576|583946966|FG004|Overall Study|Protocol Violation|0|||
161699160|NCT00667576|583946962|FG000|Overall Study|Physician Decision|0|||
161699161|NCT00667576|583946963|FG001|Overall Study|Physician Decision|0|||
161699162|NCT00667576|583946964|FG002|Overall Study|Physician Decision|0|||
161699163|NCT00667576|583946965|FG003|Overall Study|Physician Decision|1|||
161699164|NCT00667576|583946966|FG004|Overall Study|Physician Decision|0|||
161699165|NCT00667576|583946962|FG000|Overall Study|Missed Visit|0|||
161699166|NCT00667576|583946963|FG001|Overall Study|Missed Visit|0|||
161699167|NCT00667576|583946964|FG002|Overall Study|Missed Visit|0|||
161699168|NCT00667576|583946965|FG003|Overall Study|Missed Visit|1|||
161699169|NCT00667576|583946966|FG004|Overall Study|Missed Visit|0|||
161699170|NCT03988907|583946967|FG000|Overall Study|Unable to complete visit|0|||
161699171|NCT03988907|583946968|FG001|Overall Study|Unable to complete visit|1|||
161699172|NCT03523351|583946971|FG000|Overall Study|Death|13|||
161699173|NCT03523351|583946972|FG001|Overall Study|Death|11|||
161699174|NCT03523351|583946971|FG000|Overall Study|Lost to Follow-up|2|||
161699175|NCT03523351|583946972|FG001|Overall Study|Lost to Follow-up|3|||
161699176|NCT03523351|583946971|FG000|Overall Study|Withdrawal by Subject|4|||
161699177|NCT03523351|583946972|FG001|Overall Study|Withdrawal by Subject|0|||
161699178|NCT03523351|583946971|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
161699179|NCT03523351|583946972|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
161699180|NCT03609619|583946977|FG000|Overall Study|Adverse Event|1|||
161699181|NCT03609619|583946978|FG001|Overall Study|Adverse Event|0|||
161699182|NCT03609619|583946977|FG000|Overall Study|Lack of Efficacy|1|||
161699183|NCT03609619|583946978|FG001|Overall Study|Lack of Efficacy|2|||
161699184|NCT03609619|583946977|FG000|Overall Study|Protocol Violation|5|||
161699185|NCT03609619|583946978|FG001|Overall Study|Protocol Violation|0|||
161699186|NCT03609619|583946977|FG000|Overall Study|Withdrawal by Subject|2|||
161699187|NCT03609619|583946978|FG001|Overall Study|Withdrawal by Subject|3|||
161699188|NCT03609619|583946977|FG000|Overall Study|Lost to Follow-up|1|||
161699189|NCT03609619|583946978|FG001|Overall Study|Lost to Follow-up|1|||
161699190|NCT00568555|583946979|FG000|Overall Study|Withdrawal by Subject|1|||
161699191|NCT00568555|583946980|FG001|Overall Study|Withdrawal by Subject|1|||
161699192|NCT01231555|583946981|FG000|Overall Study|Study terminated|8|||
161699193|NCT01231555|583946982|FG001|Overall Study|Study terminated|5|||
161699194|NCT01231555|583946983|FG002|Overall Study|Study terminated|8|||
161699195|NCT01231555|583946981|FG000|Overall Study|Withdrawal by Subject|0|||
161699196|NCT01231555|583946982|FG001|Overall Study|Withdrawal by Subject|2|||
161699197|NCT01231555|583946983|FG002|Overall Study|Withdrawal by Subject|0|||
161699198|NCT00688909|583946984|FG000|Overall Study|Adverse Event|28|||
161699199|NCT00688909|583946984|FG000|Overall Study|Patient withdrew consent|2|||
161699200|NCT00688909|583946984|FG000|Overall Study|Administrative problems|1|||
161699201|NCT00688909|583946984|FG000|Overall Study|Protocol Violation|2|||
161699202|NCT02817087|583946988|FG000|Overall Study|Withdrawal by Subject|2|||
161699203|NCT02817087|583946989|FG001|Overall Study|Withdrawal by Subject|0|||
161699204|NCT06098729|583946992|FG000|Overall Study|Withdrawal by Subject|1|||
161699205|NCT01890421|583946993|FG000|Overall Study|Adverse Event|1|||
161699206|NCT01890421|583946993|FG000|Overall Study|Other reason|10|||
161699207|NCT04871711|583946994|FG000|Overall Study|Withdrawal by Subject|11|||
161699208|NCT04871711|583946995|FG001|Overall Study|Withdrawal by Subject|5|||
161699209|NCT04871711|583946994|FG000|Overall Study|Lack of Efficacy|5|||
161699210|NCT04871711|583946995|FG001|Overall Study|Lack of Efficacy|7|||
161699211|NCT04871711|583946994|FG000|Overall Study|Adverse Event|2|||
161699212|NCT04871711|583946995|FG001|Overall Study|Adverse Event|6|||
161699213|NCT04871711|583946994|FG000|Overall Study|Various reasons|2|||
161699214|NCT04871711|583946995|FG001|Overall Study|Various reasons|1|||
161699215|NCT04871711|583946994|FG000|Overall Study|Lost to Follow-up|0|||
161699216|NCT04871711|583946995|FG001|Overall Study|Lost to Follow-up|2|||
161699217|NCT01665144|583946996|FG000|Core Part|Withdrawal by Subject|96|||
161699218|NCT01665144|583946997|FG001|Core Part|Withdrawal by Subject|77|||
161699219|NCT01665144|583946998|FG002|Core Part|Withdrawal by Subject|0|||
161699220|NCT01665144|583946996|FG000|Core Part|Adverse Event|45|||
161699221|NCT01665144|583946997|FG001|Core Part|Adverse Event|18|||
161699222|NCT01665144|583946998|FG002|Core Part|Adverse Event|0|||
161699223|NCT01665144|583946996|FG000|Core Part|Lack of Efficacy|16|||
161699224|NCT01665144|583946997|FG001|Core Part|Lack of Efficacy|11|||
161699225|NCT01665144|583946998|FG002|Core Part|Lack of Efficacy|0|||
161699226|NCT01665144|583946996|FG000|Core Part|Lost to Follow-up|9|||
161699227|NCT01665144|583946997|FG001|Core Part|Lost to Follow-up|8|||
161699228|NCT01665144|583946998|FG002|Core Part|Lost to Follow-up|0|||
161699229|NCT01665144|583946996|FG000|Core Part|Physician Decision|13|||
161699230|NCT01665144|583946997|FG001|Core Part|Physician Decision|1|||
161699231|NCT01665144|583946998|FG002|Core Part|Physician Decision|0|||
161699232|NCT01665144|583946996|FG000|Core Part|Progressive disease|8|||
161699233|NCT01665144|583946997|FG001|Core Part|Progressive disease|4|||
161699234|NCT01665144|583946998|FG002|Core Part|Progressive disease|0|||
161699235|NCT01665144|583946996|FG000|Core Part|Non-compliance with study treatment|5|||
161699236|NCT01665144|583946997|FG001|Core Part|Non-compliance with study treatment|0|||
161699237|NCT01665144|583946998|FG002|Core Part|Non-compliance with study treatment|0|||
161699238|NCT01665144|583946996|FG000|Core Part|Death|3|||
161699239|NCT01665144|583946997|FG001|Core Part|Death|1|||
161699240|NCT01665144|583946998|FG002|Core Part|Death|0|||
161699241|NCT01665144|583946996|FG000|Core Part|Protocol deviation|3|||
161699242|NCT01665144|583946997|FG001|Core Part|Protocol deviation|1|||
161699243|NCT01665144|583946998|FG002|Core Part|Protocol deviation|0|||
161699244|NCT01665144|583946996|FG000|Core Part|New therapy for study indication|2|||
161699245|NCT01665144|583946997|FG001|Core Part|New therapy for study indication|1|||
161699246|NCT01665144|583946998|FG002|Core Part|New therapy for study indication|0|||
161699247|NCT01665144|583946996|FG000|Core Part|Technical problems|2|||
161699248|NCT01665144|583946997|FG001|Core Part|Technical problems|0|||
161699249|NCT01665144|583946998|FG002|Core Part|Technical problems|0|||
161699250|NCT01665144|583946996|FG000|Extension Part|Patient/guardian decision|180|||
161699251|NCT01665144|583946997|FG001|Extension Part|Patient/guardian decision|0|||
161699252|NCT01665144|583946998|FG002|Extension Part|Patient/guardian decision|98|||
161699253|NCT01665144|583946996|FG000|Extension Part|Adverse Event|104|||
161699254|NCT01665144|583946997|FG001|Extension Part|Adverse Event|0|||
161699255|NCT01665144|583946998|FG002|Extension Part|Adverse Event|59|||
161699256|NCT01665144|583946996|FG000|Extension Part|Study closed early|42|||
161699257|NCT01665144|583946997|FG001|Extension Part|Study closed early|0|||
161699258|NCT01665144|583946998|FG002|Extension Part|Study closed early|19|||
161699259|NCT01665144|583946996|FG000|Extension Part|Progressive disease|36|||
161699260|NCT01665144|583946997|FG001|Extension Part|Progressive disease|0|||
161699261|NCT01665144|583946998|FG002|Extension Part|Progressive disease|14|||
161699262|NCT01665144|583946996|FG000|Extension Part|Lack of Efficacy|37|||
161699263|NCT01665144|583946997|FG001|Extension Part|Lack of Efficacy|0|||
161699264|NCT01665144|583946998|FG002|Extension Part|Lack of Efficacy|12|||
161699265|NCT01665144|583946996|FG000|Extension Part|Physician Decision|29|||
161699266|NCT01665144|583946997|FG001|Extension Part|Physician Decision|0|||
161699267|NCT01665144|583946998|FG002|Extension Part|Physician Decision|13|||
161699268|NCT01665144|583946996|FG000|Extension Part|Technical problems|20|||
161699269|NCT01665144|583946997|FG001|Extension Part|Technical problems|0|||
161699270|NCT01665144|583946998|FG002|Extension Part|Technical problems|8|||
161699271|NCT01665144|583946996|FG000|Extension Part|Death|20|||
161699272|NCT01665144|583946997|FG001|Extension Part|Death|0|||
161699273|NCT01665144|583946998|FG002|Extension Part|Death|4|||
161699274|NCT01665144|583946996|FG000|Extension Part|Missing|12|||
161699275|NCT01665144|583946997|FG001|Extension Part|Missing|0|||
161699276|NCT01665144|583946998|FG002|Extension Part|Missing|6|||
161699277|NCT01665144|583946996|FG000|Extension Part|Lost to Follow-up|9|||
161699278|NCT01665144|583946997|FG001|Extension Part|Lost to Follow-up|0|||
161699279|NCT01665144|583946998|FG002|Extension Part|Lost to Follow-up|5|||
161699280|NCT01665144|583946996|FG000|Extension Part|New therapy for study indication|3|||
161699281|NCT01665144|583946997|FG001|Extension Part|New therapy for study indication|0|||
161699282|NCT01665144|583946998|FG002|Extension Part|New therapy for study indication|2|||
161699283|NCT01665144|583946996|FG000|Extension Part|Protocol deviation|3|||
161699284|NCT01665144|583946997|FG001|Extension Part|Protocol deviation|0|||
161699285|NCT01665144|583946998|FG002|Extension Part|Protocol deviation|0|||
161699286|NCT01972074|583947006|FG000|Overall Study|Adverse Event|4|||
161836807|NCT01583218|584445041|FG000|Overall Study|Adverse event or serious adverse event|3|||
161836808|NCT01583218|584445042|FG001|Overall Study|Adverse event or serious adverse event|3|||
161699287|NCT01972074|583947007|FG001|Overall Study|Adverse Event|1|||
161699288|NCT01972074|583947008|FG002|Overall Study|Adverse Event|0|||
161836809|NCT01583218|584445041|FG000|Overall Study|Patient /Family decision|3|||
161836810|NCT01583218|584445042|FG001|Overall Study|Patient /Family decision|0|||
161699289|NCT01972074|583947006|FG000|Overall Study|Lack of Efficacy|1|||
161699290|NCT01972074|583947007|FG001|Overall Study|Lack of Efficacy|1|||
161699291|NCT01972074|583947008|FG002|Overall Study|Lack of Efficacy|0|||
161699292|NCT01972074|583947006|FG000|Overall Study|Lost to Follow-up|0|||
161699293|NCT01972074|583947007|FG001|Overall Study|Lost to Follow-up|1|||
161699294|NCT01972074|583947008|FG002|Overall Study|Lost to Follow-up|1|||
161699295|NCT01972074|583947006|FG000|Overall Study|Withdrawal by Subject|1|||
161699296|NCT01972074|583947007|FG001|Overall Study|Withdrawal by Subject|1|||
161699297|NCT01972074|583947008|FG002|Overall Study|Withdrawal by Subject|1|||
161699298|NCT01972074|583947006|FG000|Overall Study|Scanner Unavailable|0|||
161699299|NCT01972074|583947007|FG001|Overall Study|Scanner Unavailable|0|||
161699300|NCT01972074|583947008|FG002|Overall Study|Scanner Unavailable|1|||
161699301|NCT02026063|583947011|FG000|Overall Study|Physician Decision|0|||
161699302|NCT02026063|583947012|FG001|Overall Study|Physician Decision|10|||
161699303|NCT02026063|583947011|FG000|Overall Study|Noncompliance with Study Drug|1|||
161699304|NCT02026063|583947012|FG001|Overall Study|Noncompliance with Study Drug|1|||
161699305|NCT02026063|583947011|FG000|Overall Study|Withdrawal of Consent|1|||
161699306|NCT02026063|583947012|FG001|Overall Study|Withdrawal of Consent|6|||
161699307|NCT02026063|583947011|FG000|Overall Study|Adverse Event|5|||
161699308|NCT02026063|583947012|FG001|Overall Study|Adverse Event|20|||
161699309|NCT02026063|583947011|FG000|Overall Study|Lack of Efficacy|0|||
161699310|NCT02026063|583947012|FG001|Overall Study|Lack of Efficacy|4|||
161699311|NCT02026063|583947011|FG000|Overall Study|Lost to Follow-up|0|||
161699312|NCT02026063|583947012|FG001|Overall Study|Lost to Follow-up|1|||
161699313|NCT02026063|583947011|FG000|Overall Study|Reason not Specified|2|||
161699314|NCT02026063|583947012|FG001|Overall Study|Reason not Specified|7|||
161699315|NCT01777581|583947013|FG000|Overall Study|Lost to Follow-up|1|||
161699316|NCT01777581|583947014|FG001|Overall Study|Lost to Follow-up|1|||
161699317|NCT01777581|583947013|FG000|Overall Study|Adverse Event|2|||
161699318|NCT01777581|583947014|FG001|Overall Study|Adverse Event|0|||
161699319|NCT01777581|583947013|FG000|Overall Study|Lack of Efficacy|0|||
161699320|NCT01777581|583947014|FG001|Overall Study|Lack of Efficacy|1|||
161699321|NCT02887521|583947017|FG000|Overall Study|Withdrawal by Subject|0|||
161699322|NCT02887521|583947018|FG001|Overall Study|Withdrawal by Subject|3|||
161699323|NCT00695565|583947019|FG000|Overall Study|Lost to Follow-up|4|||
161699324|NCT00695565|583947020|FG001|Overall Study|Lost to Follow-up|4|||
161699325|NCT00695565|583947019|FG000|Overall Study|Adverse Event|3|||
161699326|NCT00695565|583947020|FG001|Overall Study|Adverse Event|1|||
161699327|NCT00695565|583947019|FG000|Overall Study|Protocol Violation|3|||
161699328|NCT00695565|583947020|FG001|Overall Study|Protocol Violation|1|||
161699329|NCT00695565|583947019|FG000|Overall Study|Withdrawal by Subject|1|||
161699330|NCT00695565|583947020|FG001|Overall Study|Withdrawal by Subject|1|||
161699331|NCT00695565|583947019|FG000|Overall Study|Lack of Efficacy|1|||
161699332|NCT00695565|583947020|FG001|Overall Study|Lack of Efficacy|1|||
161699333|NCT00695565|583947019|FG000|Overall Study|Subject did not follow instructions|1|||
161699334|NCT00695565|583947020|FG001|Overall Study|Subject did not follow instructions|1|||
161699335|NCT02937350|583947021|FG000|Overall Study|Withdrawal by Subject|0|||
161699336|NCT02937350|583947022|FG001|Overall Study|Withdrawal by Subject|1|||
161699337|NCT02937350|583947023|FG002|Overall Study|Withdrawal by Subject|0|||
161699338|NCT01462266|583947024|FG000|Overall Study|Adverse Event|7|||
161699339|NCT01462266|583947025|FG001|Overall Study|Adverse Event|6|||
161699340|NCT01462266|583947024|FG000|Overall Study|Death|2|||
161699341|NCT01462266|583947025|FG001|Overall Study|Death|1|||
161699342|NCT01462266|583947024|FG000|Overall Study|Lack of Efficacy|0|||
161699343|NCT01462266|583947025|FG001|Overall Study|Lack of Efficacy|2|||
161699344|NCT01462266|583947024|FG000|Overall Study|Lost to Follow-up|4|||
161699345|NCT01462266|583947025|FG001|Overall Study|Lost to Follow-up|3|||
161699346|NCT01462266|583947024|FG000|Overall Study|Non-compliance with study drug|3|||
161699347|NCT01462266|583947025|FG001|Overall Study|Non-compliance with study drug|0|||
161699348|NCT01462266|583947024|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
161699349|NCT01462266|583947025|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
161699350|NCT01462266|583947024|FG000|Overall Study|Physician Decision|2|||
161699351|NCT01462266|583947025|FG001|Overall Study|Physician Decision|5|||
161699352|NCT01462266|583947024|FG000|Overall Study|Protocol Violation|1|||
161699353|NCT01462266|583947025|FG001|Overall Study|Protocol Violation|3|||
161699354|NCT01462266|583947024|FG000|Overall Study|Withdrawal by Subject|7|||
161836811|NCT01583218|584445041|FG000|Overall Study|Cannot contact patient directly|1|||
161836812|NCT01583218|584445042|FG001|Overall Study|Cannot contact patient directly|2|||
161836813|NCT01583218|584445041|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
161836814|NCT01583218|584445042|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
161836815|NCT01583218|584445041|FG000|Overall Study|Patient did not wish to attend visits|0|||
161836816|NCT01583218|584445042|FG001|Overall Study|Patient did not wish to attend visits|1|||
161836817|NCT01583218|584445041|FG000|Overall Study|Patient randomized but not dosed|17|||
161836818|NCT01583218|584445042|FG001|Overall Study|Patient randomized but not dosed|16|||
161699355|NCT01462266|583947025|FG001|Overall Study|Withdrawal by Subject|2|||
161699356|NCT01462266|583947024|FG000|Overall Study|Screen failure|1|||
161699357|NCT01462266|583947025|FG001|Overall Study|Screen failure|1|||
161699358|NCT01106846|583947026|FG000|Overall Study|Change in surgical procedure|0|||
161699359|NCT01106846|583947027|FG001|Overall Study|Change in surgical procedure|1|||
161699360|NCT04811716|583947029|FG000|Overall Study|Withdrawal by Subject|2|||
161699361|NCT04811716|583947030|FG001|Overall Study|Withdrawal by Subject|0|||
161699362|NCT02320487|583947031|FG000|Overall Study|Reason not Specified|1|||
161699363|NCT02320487|583947031|FG000|Overall Study|Physician Decision|5|||
161699364|NCT02320487|583947031|FG000|Overall Study|Withdrawal by Subject|1|||
161699365|NCT02320487|583947031|FG000|Overall Study|Death|3|||
161699366|NCT02320487|583947031|FG000|Overall Study|Adverse Event|11|||
161699367|NCT05900115|583948461|FG000|Overall Study|Lost to Follow-up|129|||
161699368|NCT05900115|583948462|FG001|Overall Study|Lost to Follow-up|98|||
161699369|NCT02152345|583948463|FG000|Overall Study|Case Cancellations|2|||
161699370|NCT02152345|583948464|FG001|Overall Study|Case Cancellations|4|||
161699371|NCT02152345|583948463|FG000|Overall Study|Withdrawal by Subject|2|||
161699372|NCT02152345|583948464|FG001|Overall Study|Withdrawal by Subject|1|||
161699373|NCT00483327|583948468|FG000|Overall Study|Adverse Event|1|||
161699374|NCT00483327|583948468|FG000|Overall Study|Withdrawal by Subject|3|||
161699375|NCT00483327|583948468|FG000|Overall Study|Lost to Follow-up|4|||
161699376|NCT00483327|583948468|FG000|Overall Study|Patient Non Compliance|2|||
161699377|NCT01390389|583948469|FG000|Overall Study|Withdrawal by Subject|2|||
161699378|NCT01390389|583948470|FG001|Overall Study|Withdrawal by Subject|0|||
161699379|NCT01390389|583948469|FG000|Overall Study|Screen Fail|2|||
161699380|NCT01390389|583948470|FG001|Overall Study|Screen Fail|1|||
161699381|NCT03593915|583948471|FG000|Overall Study|Adverse Event|0|||
161699382|NCT03593915|583948472|FG001|Overall Study|Adverse Event|0|||
161699383|NCT03593915|583948473|FG002|Overall Study|Adverse Event|0|||
161699384|NCT03593915|583948474|FG003|Overall Study|Adverse Event|1|||
161699385|NCT03593915|583948475|FG004|Overall Study|Adverse Event|0|||
161699386|NCT03593915|583948476|FG005|Overall Study|Adverse Event|0|||
161699387|NCT03593915|583948471|FG000|Overall Study|Physician Decision|0|||
161699388|NCT03593915|583948472|FG001|Overall Study|Physician Decision|0|||
161699389|NCT03593915|583948473|FG002|Overall Study|Physician Decision|0|||
161699390|NCT03593915|583948474|FG003|Overall Study|Physician Decision|0|||
161699391|NCT03593915|583948475|FG004|Overall Study|Physician Decision|0|||
161699392|NCT03593915|583948476|FG005|Overall Study|Physician Decision|1|||
161699393|NCT01583179|583948477|FG000|Overall Study|Screen failure|1|||
161699394|NCT01583179|583948478|FG001|Overall Study|Screen failure|2|||
161699395|NCT01246206|583948479|FG000|Overall Study|Patient did not receive study regiments.|1|||
161699396|NCT02002975|583948480|FG000|Overall Study|Case Report Forms Uncollected|135|||
161699397|NCT02002975|583948480|FG000|Overall Study|Protocol Deviation|437|||
161699398|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
161699399|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
161699400|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
161699401|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
161699402|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
161699403|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
161699404|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
161699405|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
161699406|NCT02472847|583948483|FG000|Overall Study|Withdrawal by Subject|1|||
161699407|NCT02472847|583948484|FG001|Overall Study|Withdrawal by Subject|5|||
161699408|NCT04656990|583948485|FG000|Baseline|pandemic|20|||
161699409|NCT04656990|583948486|FG001|Baseline|pandemic|24|||
161699410|NCT04656990|583948485|FG000|Follow Up Period|Lost to Follow-up|61|||
161699411|NCT04656990|583948486|FG001|Follow Up Period|Lost to Follow-up|73|||
161699412|NCT03244059|583948487|FG000|Specific Aim 1|Physician Decision|1|||
161699413|NCT03244059|583948488|FG001|Specific Aim 1|Physician Decision|0|||
161699414|NCT03244059|583948487|FG000|Specific Aim 2|Physician Decision|1|||
161699415|NCT03244059|583948488|FG001|Specific Aim 2|Physician Decision|0|||
161699416|NCT01613326|583948489|FG000|Overall Study|Adverse Event|7|||
161699417|NCT01613326|583948490|FG001|Overall Study|Adverse Event|5|||
161699418|NCT01613326|583948489|FG000|Overall Study|Withdrawal by Subject|3|||
161699419|NCT01613326|583948490|FG001|Overall Study|Withdrawal by Subject|4|||
161699420|NCT01613326|583948489|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161699421|NCT01613326|583948490|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161699422|NCT01613326|583948489|FG000|Overall Study|inability to use device|1|||
161699423|NCT01613326|583948490|FG001|Overall Study|inability to use device|0|||
161699424|NCT01613326|583948489|FG000|Overall Study|Lack of Efficacy|0|||
161699425|NCT01613326|583948490|FG001|Overall Study|Lack of Efficacy|1|||
161699426|NCT01613326|583948489|FG000|Overall Study|Lost to Follow-up|0|||
161699427|NCT01613326|583948490|FG001|Overall Study|Lost to Follow-up|1|||
161699428|NCT01613326|583948489|FG000|Overall Study|Administrative|0|||
161699429|NCT01613326|583948490|FG001|Overall Study|Administrative|2|||
161699430|NCT01613326|583948489|FG000|Overall Study|Protocol Violation|0|||
161699431|NCT01613326|583948490|FG001|Overall Study|Protocol Violation|1|||
161699432|NCT01940484|583948491|FG000|Overall Study|Withdrawal by Subject|3|||
161699433|NCT01940484|583948491|FG000|Overall Study|Underwent transplantation|4|||
161699434|NCT01940484|583948491|FG000|Overall Study|Death|2|||
161699435|NCT01940484|583948491|FG000|Overall Study|Adverse Event|1|||
161699436|NCT01705691|583948493|FG000|Overall Study|Death|1|||
161699437|NCT01705691|583948494|FG001|Overall Study|Death|2|||
161699438|NCT01705691|583948493|FG000|Overall Study|Withdrawal by Subject|1|||
161699439|NCT01705691|583948494|FG001|Overall Study|Withdrawal by Subject|2|||
161699440|NCT01705691|583948493|FG000|Overall Study|Lost to Follow-up|1|||
161699441|NCT01705691|583948494|FG001|Overall Study|Lost to Follow-up|1|||
161699442|NCT01705691|583948493|FG000|Overall Study|Other|0|||
161699443|NCT01705691|583948494|FG001|Overall Study|Other|1|||
161699444|NCT02658448|583948495|FG000|Overall Study|Lost to Follow-up|1|||
161699445|NCT03106779|583948496|FG000|Overall Study|Lack of Efficacy|33|||
161699446|NCT03106779|583948497|FG001|Overall Study|Lack of Efficacy|24|||
161699447|NCT03106779|583948496|FG000|Overall Study|Adverse Event|8|||
161699448|NCT03106779|583948497|FG001|Overall Study|Adverse Event|16|||
161699449|NCT03106779|583948496|FG000|Overall Study|Physician Decision|10|||
161699450|NCT03106779|583948497|FG001|Overall Study|Physician Decision|6|||
161699451|NCT03106779|583948496|FG000|Overall Study|Patient/guardian decision|4|||
161699452|NCT03106779|583948497|FG001|Overall Study|Patient/guardian decision|3|||
161699453|NCT03106779|583948496|FG000|Overall Study|Progressive disease|1|||
161699454|NCT03106779|583948497|FG001|Overall Study|Progressive disease|3|||
161699455|NCT03106779|583948496|FG000|Overall Study|Lost to Follow-up|1|||
161699456|NCT03106779|583948497|FG001|Overall Study|Lost to Follow-up|2|||
161699457|NCT03106779|583948496|FG000|Overall Study|Death|1|||
161699458|NCT03106779|583948497|FG001|Overall Study|Death|0|||
161699459|NCT03106779|583948496|FG000|Overall Study|Protocol Violation|1|||
161699460|NCT03106779|583948497|FG001|Overall Study|Protocol Violation|0|||
161699461|NCT03106779|583948496|FG000|Overall Study|Not treated|1|||
161699462|NCT03106779|583948497|FG001|Overall Study|Not treated|0|||
161836819|NCT01583218|584445041|FG000|Overall Study|Patient was assessed via phone in person|1|||
161836820|NCT01583218|584445042|FG001|Overall Study|Patient was assessed via phone in person|0|||
161699463|NCT04233229|583948498|FG000|Overall Study|Withdrawal by Subject|0|||
161699464|NCT04233229|583948499|FG001|Overall Study|Withdrawal by Subject|1|||
161699465|NCT04233229|583948498|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
161699466|NCT04233229|583948499|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
161699467|NCT04233229|583948498|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
161699468|NCT04233229|583948499|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
161699469|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
161699470|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
161699471|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
161699472|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
161699473|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
161699474|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
161699475|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
161699476|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
161699477|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
161699478|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
161699479|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
161699480|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
161699481|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
161699482|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
161699483|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
161699484|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
161699485|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
161699486|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
161699487|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
161699488|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
161699489|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
161699490|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
161699491|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
161699492|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
161699493|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
161699494|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
161699495|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
161699496|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
161699497|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
161699498|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
161699499|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
161699500|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
161699501|NCT04652804|583948502|FG000|Overall Study|Ineligible post randomization|1|||
161699502|NCT04652804|583948503|FG001|Overall Study|Ineligible post randomization|0|||
161699503|NCT04652804|583948504|FG002|Overall Study|Ineligible post randomization|1|||
161699504|NCT04652804|583948505|FG003|Overall Study|Ineligible post randomization|0|||
161699505|NCT04652804|583948506|FG004|Overall Study|Ineligible post randomization|1|||
161699506|NCT04652804|583948507|FG005|Overall Study|Ineligible post randomization|1|||
161699507|NCT04652804|583948502|FG000|Overall Study|Missing SVR lab results|2|||
161699508|NCT04652804|583948503|FG001|Overall Study|Missing SVR lab results|0|||
161699509|NCT04652804|583948504|FG002|Overall Study|Missing SVR lab results|0|||
161699510|NCT04652804|583948505|FG003|Overall Study|Missing SVR lab results|0|||
161699511|NCT04652804|583948506|FG004|Overall Study|Missing SVR lab results|0|||
161699512|NCT04652804|583948507|FG005|Overall Study|Missing SVR lab results|0|||
161699513|NCT00584194|583948508|FG000|Overall Study|Other|135|||
161699514|NCT04093531|583948509|FG000|Overall Study|failed screening|4|||
161699515|NCT03222349|583948510|FG000|Overall Study|Treatment B not done|5|||
161699516|NCT03222349|583948511|FG001|Overall Study|Treatment B not done|0|||
161699517|NCT03222349|583948510|FG000|Overall Study|Lost to Follow-up|1|||
161699518|NCT03222349|583948511|FG001|Overall Study|Lost to Follow-up|2|||
161699519|NCT03222349|583948510|FG000|Overall Study|Withdrawal by Subject|1|||
161699520|NCT03222349|583948511|FG001|Overall Study|Withdrawal by Subject|0|||
161699521|NCT03222349|583948510|FG000|Overall Study|Treatment A not done|0|||
161699522|NCT03222349|583948511|FG001|Overall Study|Treatment A not done|5|||
161699523|NCT03222349|583948510|FG000|Overall Study|Study terminated by sponsor|1|||
161699524|NCT03222349|583948511|FG001|Overall Study|Study terminated by sponsor|0|||
161699525|NCT03665285|583948512|FG000|Overall Study|Started New Anticancer Treatment|1|||
161699526|NCT03665285|583948513|FG001|Overall Study|Started New Anticancer Treatment|1|||
161699527|NCT03665285|583948514|FG002|Overall Study|Started New Anticancer Treatment|2|||
161699528|NCT03665285|583948515|FG003|Overall Study|Started New Anticancer Treatment|4|||
161699529|NCT03665285|583948516|FG004|Overall Study|Started New Anticancer Treatment|1|||
161699530|NCT03665285|583948517|FG005|Overall Study|Started New Anticancer Treatment|1|||
161699531|NCT03665285|583948518|FG006|Overall Study|Started New Anticancer Treatment|2|||
161699532|NCT03665285|583948519|FG007|Overall Study|Started New Anticancer Treatment|15|||
161699533|NCT03665285|583948520|FG008|Overall Study|Started New Anticancer Treatment|1|||
161699534|NCT03665285|583948512|FG000|Overall Study|Disease Progression|0|||
161699535|NCT03665285|583948513|FG001|Overall Study|Disease Progression|0|||
161699536|NCT03665285|583948514|FG002|Overall Study|Disease Progression|3|||
161699537|NCT03665285|583948515|FG003|Overall Study|Disease Progression|1|||
161699538|NCT03665285|583948516|FG004|Overall Study|Disease Progression|0|||
161699539|NCT03665285|583948517|FG005|Overall Study|Disease Progression|0|||
161699540|NCT03665285|583948518|FG006|Overall Study|Disease Progression|0|||
161699541|NCT03665285|583948519|FG007|Overall Study|Disease Progression|7|||
161699542|NCT03665285|583948520|FG008|Overall Study|Disease Progression|1|||
161699543|NCT03665285|583948512|FG000|Overall Study|Hospice|0|||
161699544|NCT03665285|583948513|FG001|Overall Study|Hospice|0|||
161699545|NCT03665285|583948514|FG002|Overall Study|Hospice|0|||
161699546|NCT03665285|583948515|FG003|Overall Study|Hospice|0|||
161699547|NCT03665285|583948516|FG004|Overall Study|Hospice|0|||
161699548|NCT03665285|583948517|FG005|Overall Study|Hospice|0|||
161699549|NCT03665285|583948518|FG006|Overall Study|Hospice|0|||
161699550|NCT03665285|583948519|FG007|Overall Study|Hospice|2|||
161699551|NCT03665285|583948520|FG008|Overall Study|Hospice|0|||
161699552|NCT03665285|583948512|FG000|Overall Study|Withdrawal by Subject|0|||
161699553|NCT03665285|583948513|FG001|Overall Study|Withdrawal by Subject|0|||
161699554|NCT03665285|583948514|FG002|Overall Study|Withdrawal by Subject|0|||
161699555|NCT03665285|583948515|FG003|Overall Study|Withdrawal by Subject|0|||
161699556|NCT03665285|583948516|FG004|Overall Study|Withdrawal by Subject|1|||
161699557|NCT03665285|583948517|FG005|Overall Study|Withdrawal by Subject|0|||
161699558|NCT03665285|583948518|FG006|Overall Study|Withdrawal by Subject|0|||
161699559|NCT03665285|583948519|FG007|Overall Study|Withdrawal by Subject|2|||
161699560|NCT03665285|583948520|FG008|Overall Study|Withdrawal by Subject|0|||
161699561|NCT03665285|583948512|FG000|Overall Study|Physician Decision|0|||
161699562|NCT03665285|583948513|FG001|Overall Study|Physician Decision|0|||
161699563|NCT03665285|583948514|FG002|Overall Study|Physician Decision|0|||
161699564|NCT03665285|583948515|FG003|Overall Study|Physician Decision|0|||
161699565|NCT03665285|583948516|FG004|Overall Study|Physician Decision|0|||
161699566|NCT03665285|583948517|FG005|Overall Study|Physician Decision|0|||
161699567|NCT03665285|583948518|FG006|Overall Study|Physician Decision|0|||
161699568|NCT03665285|583948519|FG007|Overall Study|Physician Decision|2|||
161699569|NCT03665285|583948520|FG008|Overall Study|Physician Decision|0|||
161699570|NCT03543410|583948521|FG000|Overall Study|Adverse Event|10|||
161699571|NCT03543410|583948522|FG001|Overall Study|Adverse Event|8|||
161699572|NCT03543410|583948523|FG002|Overall Study|Adverse Event|2|||
161699573|NCT03543410|583948521|FG000|Overall Study|Lack of Efficacy|0|||
161699574|NCT03543410|583948522|FG001|Overall Study|Lack of Efficacy|1|||
161699575|NCT03543410|583948523|FG002|Overall Study|Lack of Efficacy|0|||
161699576|NCT03543410|583948521|FG000|Overall Study|Lost to Follow-up|0|||
161699577|NCT03543410|583948522|FG001|Overall Study|Lost to Follow-up|1|||
161699578|NCT03543410|583948523|FG002|Overall Study|Lost to Follow-up|0|||
161699579|NCT03543410|583948521|FG000|Overall Study|Withdrawal by Subject|5|||
161699580|NCT03543410|583948522|FG001|Overall Study|Withdrawal by Subject|2|||
161699581|NCT03543410|583948523|FG002|Overall Study|Withdrawal by Subject|8|||
161699582|NCT03543410|583948521|FG000|Overall Study|Protocol Violation|0|||
161699583|NCT03543410|583948522|FG001|Overall Study|Protocol Violation|1|||
161699584|NCT03543410|583948523|FG002|Overall Study|Protocol Violation|0|||
161699585|NCT03543410|583948521|FG000|Overall Study|Due to COVID-19|4|||
161699586|NCT03543410|583948522|FG001|Overall Study|Due to COVID-19|0|||
161699587|NCT03543410|583948523|FG002|Overall Study|Due to COVID-19|2|||
161699588|NCT03543410|583948521|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
161699589|NCT03543410|583948522|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
161699590|NCT03543410|583948523|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
161699591|NCT03543410|583948521|FG000|Overall Study|Not Due to COVID-19|2|||
161699592|NCT03543410|583948522|FG001|Overall Study|Not Due to COVID-19|0|||
161699593|NCT03543410|583948523|FG002|Overall Study|Not Due to COVID-19|1|||
161699594|NCT01318122|583948524|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161699595|NCT01318122|583948525|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161699596|NCT01318122|583948526|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
161699597|NCT01318122|583948527|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161699598|NCT01318122|583948524|FG000|Enrolled - Long-Term Extension Study|Other|1|||
161699599|NCT01318122|583948525|FG001|Enrolled - Long-Term Extension Study|Other|0|||
161699600|NCT01318122|583948526|FG002|Enrolled - Long-Term Extension Study|Other|0|||
161699601|NCT01318122|583948527|FG003|Enrolled - Long-Term Extension Study|Other|0|||
161699602|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
161699603|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
161699604|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
161699605|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
161699606|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
161699607|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161699608|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161699609|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161699610|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161699611|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
161699612|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161699613|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161699614|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161699615|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161699616|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
161699617|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161699618|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
161699619|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
161699620|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
161699621|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Death|28|||
161699622|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Death|0|||
161699623|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Death|0|||
161699624|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
161699625|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
161699626|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
161699627|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
161699628|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
161699629|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
161699630|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
161699631|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
161699632|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
161699633|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
161699634|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
161699635|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
161699636|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
161699637|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
161699638|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
161699639|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Other|11|||
161699640|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Other|0|||
161699641|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Other|0|||
161699642|NCT00820755|583948528|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
161699643|NCT00820755|583948529|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
161699644|NCT00820755|583948530|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
161699645|NCT01486199|583948531|FG000|Two Year Period Between Study Days|Physician Decision|1|||
161699646|NCT01486199|583948532|FG001|Two Year Period Between Study Days|Physician Decision|0|||
161699647|NCT03604445|583948536|FG000|Overall Study|Death|0|||
161699648|NCT03604445|583948537|FG001|Overall Study|Death|0|||
161699649|NCT03604445|583948538|FG002|Overall Study|Death|0|||
161699650|NCT03604445|583948539|FG003|Overall Study|Death|0|||
161699651|NCT03604445|583948540|FG004|Overall Study|Death|0|||
161699652|NCT03604445|583948541|FG005|Overall Study|Death|0|||
161699653|NCT03604445|583948542|FG006|Overall Study|Death|0|||
161699654|NCT03604445|583948543|FG007|Overall Study|Death|0|||
161699655|NCT03604445|583948544|FG008|Overall Study|Death|1|||
161699656|NCT03604445|583948536|FG000|Overall Study|Withdrawal by Subject|0|||
161836821|NCT01583218|584445041|FG000|Overall Study|Patient deemed ineligible after random|2|||
161836822|NCT01583218|584445042|FG001|Overall Study|Patient deemed ineligible after random|0|||
161836823|NCT01583218|584445041|FG000|Overall Study|Patient was early terminated from study|0|||
161836824|NCT01583218|584445042|FG001|Overall Study|Patient was early terminated from study|1|||
161699657|NCT03604445|583948537|FG001|Overall Study|Withdrawal by Subject|0|||
161699658|NCT03604445|583948538|FG002|Overall Study|Withdrawal by Subject|0|||
161699659|NCT03604445|583948539|FG003|Overall Study|Withdrawal by Subject|0|||
161699660|NCT03604445|583948540|FG004|Overall Study|Withdrawal by Subject|0|||
161699661|NCT03604445|583948541|FG005|Overall Study|Withdrawal by Subject|0|||
161699662|NCT03604445|583948542|FG006|Overall Study|Withdrawal by Subject|1|||
161699663|NCT03604445|583948543|FG007|Overall Study|Withdrawal by Subject|0|||
161699664|NCT03604445|583948544|FG008|Overall Study|Withdrawal by Subject|0|||
161699665|NCT03604445|583948536|FG000|Overall Study|Missing visit|0|||
161699666|NCT03604445|583948537|FG001|Overall Study|Missing visit|0|||
161699667|NCT03604445|583948538|FG002|Overall Study|Missing visit|0|||
161699668|NCT03604445|583948539|FG003|Overall Study|Missing visit|0|||
161699669|NCT03604445|583948540|FG004|Overall Study|Missing visit|0|||
161699670|NCT03604445|583948541|FG005|Overall Study|Missing visit|1|||
161699671|NCT03604445|583948542|FG006|Overall Study|Missing visit|0|||
161699672|NCT03604445|583948543|FG007|Overall Study|Missing visit|1|||
161699673|NCT03604445|583948544|FG008|Overall Study|Missing visit|0|||
161699674|NCT03604445|583948536|FG000|Overall Study|Adverse Event|0|||
161699675|NCT03604445|583948537|FG001|Overall Study|Adverse Event|0|||
161699676|NCT03604445|583948538|FG002|Overall Study|Adverse Event|0|||
161699677|NCT03604445|583948539|FG003|Overall Study|Adverse Event|1|||
161699678|NCT03604445|583948540|FG004|Overall Study|Adverse Event|0|||
161699679|NCT03604445|583948541|FG005|Overall Study|Adverse Event|0|||
161699680|NCT03604445|583948542|FG006|Overall Study|Adverse Event|0|||
161699681|NCT03604445|583948543|FG007|Overall Study|Adverse Event|0|||
161699682|NCT03604445|583948544|FG008|Overall Study|Adverse Event|1|||
161699683|NCT02154425|583948545|FG000|Screening Period|Adverse Event|1|||
161699684|NCT00480857|583948548|FG000|Overall Study|Lack of Efficacy|2|||
161699685|NCT00611247|583948551|FG000|Overall Study|Death|1|||
161699686|NCT00611247|583948552|FG001|Overall Study|Death|5|||
161699687|NCT00611247|583948551|FG000|Overall Study|Lack of Efficacy|1|||
161699688|NCT00611247|583948552|FG001|Overall Study|Lack of Efficacy|16|||
161699689|NCT02551159|583948553|FG000|Overall Study|Death|352|||
161699690|NCT02551159|583948554|FG001|Overall Study|Death|174|||
161699691|NCT02551159|583948555|FG002|Overall Study|Death|161|||
161699692|NCT02551159|583948553|FG000|Overall Study|Withdrawal by Subject|8|||
161699693|NCT02551159|583948554|FG001|Overall Study|Withdrawal by Subject|5|||
161699694|NCT02551159|583948555|FG002|Overall Study|Withdrawal by Subject|16|||
161699695|NCT02551159|583948553|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
161699696|NCT02551159|583948554|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
161699697|NCT02551159|583948555|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
161699698|NCT00243659|583948556|FG000|Overall Study|Withdrawal by Subject|1|||
161699699|NCT00243659|583948557|FG001|Overall Study|Withdrawal by Subject|1|||
161699700|NCT00243659|583948556|FG000|Overall Study|Protocol Violation|1|||
161699701|NCT00243659|583948557|FG001|Overall Study|Protocol Violation|2|||
161699702|NCT00268242|583948563|FG000|Overall Study|Death|1|||
161699703|NCT02175680|583948565|FG000|Overall Study|non-compliance|1|||
161699704|NCT02175680|583948565|FG000|Overall Study|other non-medical reason|1|||
161699705|NCT01913483|583948566|FG000|Overall Study|Withdrawal by Subject|1|||
161699706|NCT01913483|583948567|FG001|Overall Study|Withdrawal by Subject|2|||
161699707|NCT01913483|583948566|FG000|Overall Study|Lost to Follow-up|6|||
161699708|NCT01913483|583948567|FG001|Overall Study|Lost to Follow-up|3|||
161699709|NCT01913483|583948566|FG000|Overall Study|Death|14|||
161699710|NCT01913483|583948567|FG001|Overall Study|Death|17|||
161699711|NCT03969888|583948568|FG000|Overall Study|Never Received Study Drug|0|||
161699712|NCT03969888|583948569|FG001|Overall Study|Never Received Study Drug|0|||
161699713|NCT03969888|583948570|FG002|Overall Study|Never Received Study Drug|1|||
161699714|NCT03969888|583948571|FG003|Overall Study|Never Received Study Drug|0|||
161699715|NCT03969888|583948572|FG004|Overall Study|Never Received Study Drug|0|||
161699716|NCT03969888|583948573|FG005|Overall Study|Never Received Study Drug|0|||
161699717|NCT03969888|583948574|FG006|Overall Study|Never Received Study Drug|1|||
161699718|NCT03969888|583948575|FG007|Overall Study|Never Received Study Drug|0|||
161699719|NCT03969888|583948568|FG000|Overall Study|Reason Not Specified|0|||
161699720|NCT03969888|583948569|FG001|Overall Study|Reason Not Specified|0|||
161699721|NCT03969888|583948570|FG002|Overall Study|Reason Not Specified|0|||
161699722|NCT03969888|583948571|FG003|Overall Study|Reason Not Specified|0|||
161699723|NCT03969888|583948572|FG004|Overall Study|Reason Not Specified|0|||
161699724|NCT03969888|583948573|FG005|Overall Study|Reason Not Specified|0|||
161699725|NCT03969888|583948574|FG006|Overall Study|Reason Not Specified|0|||
161699726|NCT03969888|583948575|FG007|Overall Study|Reason Not Specified|1|||
161699727|NCT00464178|583948580|FG000|Overall Study|Protocol Violation|1|||
161699728|NCT00464178|583948580|FG000|Overall Study|Withdrawal by Subject|1|||
161699729|NCT04506294|583948583|FG000|Overall Study|Lost to Follow-up|70|||
161699730|NCT04506294|583948584|FG001|Overall Study|Lost to Follow-up|20|||
161699731|NCT04506294|583948583|FG000|Overall Study|Withdrawal by Subject|16|||
161699732|NCT04506294|583948584|FG001|Overall Study|Withdrawal by Subject|2|||
161699733|NCT01469000|583948586|FG000|Overall Study|Withdrawal by Subject|16|||
161699734|NCT01469000|583948587|FG001|Overall Study|Withdrawal by Subject|3|||
161699735|NCT01469000|583948586|FG000|Overall Study|Sponsor Decision|4|||
161699736|NCT01469000|583948587|FG001|Overall Study|Sponsor Decision|1|||
161699737|NCT00769119|583948590|FG000|Overall Study|Voluntary discontinuation|0|||
161699738|NCT00769119|583948591|FG001|Overall Study|Voluntary discontinuation|2|||
161699739|NCT00769119|583948590|FG000|Overall Study|Adverse Event|1|||
161699740|NCT00769119|583948591|FG001|Overall Study|Adverse Event|1|||
161699741|NCT00769119|583948590|FG000|Overall Study|Disallowed medication|1|||
161699742|NCT00769119|583948591|FG001|Overall Study|Disallowed medication|0|||
161699743|NCT01116544|583948594|FG000|Overall Study|Protocol Violation|1|||
161699744|NCT01116544|583948595|FG001|Overall Study|Protocol Violation|0|||
161699745|NCT01116544|583948594|FG000|Overall Study|Withdrawal by Subject|1|||
161699746|NCT01116544|583948595|FG001|Overall Study|Withdrawal by Subject|1|||
161699747|NCT05168267|583948596|FG000|Overall Study|Withdrawal by Subject|2|||
161699748|NCT05168267|583948597|FG001|Overall Study|Withdrawal by Subject|1|||
161699749|NCT05168267|583948596|FG000|Overall Study|Withdrawn by Therapist|1|||
161699750|NCT05168267|583948597|FG001|Overall Study|Withdrawn by Therapist|1|||
161699751|NCT05168267|583948596|FG000|Overall Study|Left Facility|1|||
161699752|NCT05168267|583948597|FG001|Overall Study|Left Facility|0|||
161699753|NCT02419508|583948598|FG000|Overall Study|Adverse Event|9|||
161699754|NCT02419508|583948599|FG001|Overall Study|Adverse Event|3|||
161699755|NCT02419508|583948598|FG000|Overall Study|Withdrawal by Subject|1|||
161699756|NCT02419508|583948599|FG001|Overall Study|Withdrawal by Subject|0|||
161699757|NCT02419508|583948598|FG000|Overall Study|Other - Reason not specified|0|||
161699758|NCT02419508|583948599|FG001|Overall Study|Other - Reason not specified|1|||
161699759|NCT01738971|583948602|FG000|Overall Study|Lost to Follow-up|19|||
161699760|NCT01738971|583948603|FG001|Overall Study|Lost to Follow-up|30|||
161699761|NCT01738971|583948604|FG002|Overall Study|Lost to Follow-up|17|||
161699762|NCT04698629|583948616|FG000|Overall Study|Adverse Event|1|||
161699763|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
161699764|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
161699765|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
161699766|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
161699767|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
161699768|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
161699769|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
161699770|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
161699771|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
161699772|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
161699773|NCT00670007|583950975|FG000|Overall Study|Drug abuse|1|||
161699774|NCT00670007|583950975|FG000|Overall Study|Lung transplant|1|||
161699775|NCT00670007|583950975|FG000|Overall Study|Travel/Vacation|1|||
161699776|NCT00670007|583950975|FG000|Overall Study|Adverse event, serious fatal|1|||
161699777|NCT00670007|583950975|FG000|Overall Study|Adverse Event|1|||
161699778|NCT00670007|583950975|FG000|Overall Study|Withdrawal by Subject|4|||
161699779|NCT00618722|583950976|FG000|Overall Study|Refusal of Treatment|0|||
161699780|NCT00618722|583950977|FG001|Overall Study|Refusal of Treatment|0|||
161699781|NCT00618722|583950978|FG002|Overall Study|Refusal of Treatment|1|||
161699782|NCT00618722|583950979|FG003|Overall Study|Refusal of Treatment|0|||
161699783|NCT00618722|583950976|FG000|Overall Study|Patient Request|1|||
161699784|NCT00618722|583950977|FG001|Overall Study|Patient Request|1|||
161699785|NCT00618722|583950978|FG002|Overall Study|Patient Request|1|||
161699786|NCT00618722|583950979|FG003|Overall Study|Patient Request|1|||
161699787|NCT00618722|583950976|FG000|Overall Study|Inability to Complete Study Procedure|0|||
161699788|NCT00618722|583950977|FG001|Overall Study|Inability to Complete Study Procedure|1|||
161699789|NCT00618722|583950978|FG002|Overall Study|Inability to Complete Study Procedure|0|||
161699790|NCT00618722|583950979|FG003|Overall Study|Inability to Complete Study Procedure|0|||
161699791|NCT00618722|583950976|FG000|Overall Study|Lost to Follow-up|2|||
161699792|NCT00618722|583950977|FG001|Overall Study|Lost to Follow-up|0|||
161699793|NCT00618722|583950978|FG002|Overall Study|Lost to Follow-up|0|||
161699794|NCT00618722|583950979|FG003|Overall Study|Lost to Follow-up|2|||
161699795|NCT00618722|583950976|FG000|Overall Study|Miscellaneous Reasons|0|||
161836825|NCT01583218|584445041|FG000|Overall Study|Patient was randomized due to mistake|1|||
161836826|NCT01583218|584445042|FG001|Overall Study|Patient was randomized due to mistake|0|||
161699796|NCT00618722|583950977|FG001|Overall Study|Miscellaneous Reasons|0|||
161699797|NCT00618722|583950978|FG002|Overall Study|Miscellaneous Reasons|1|||
161699798|NCT00618722|583950979|FG003|Overall Study|Miscellaneous Reasons|1|||
161699799|NCT00925600|583950980|FG000|Overall Study|Withdrawal by Subject|16|||
161699800|NCT00925600|583950981|FG001|Overall Study|Withdrawal by Subject|14|||
161699801|NCT00925600|583950980|FG000|Overall Study|Death|4|||
161699802|NCT00925600|583950981|FG001|Overall Study|Death|3|||
161699803|NCT00925600|583950980|FG000|Overall Study|Lost to Follow-up|2|||
161699804|NCT00925600|583950981|FG001|Overall Study|Lost to Follow-up|2|||
161699805|NCT00925600|583950980|FG000|Overall Study|Disease Progression|1|||
161699806|NCT00925600|583950981|FG001|Overall Study|Disease Progression|3|||
161699807|NCT00925600|583950980|FG000|Overall Study|Administrative Decision|1|||
161699808|NCT00925600|583950981|FG001|Overall Study|Administrative Decision|1|||
161699809|NCT00925600|583950980|FG000|Overall Study|Noncompliance|2|||
161699810|NCT00925600|583950981|FG001|Overall Study|Noncompliance|0|||
161699811|NCT00925600|583950980|FG000|Overall Study|Ineligibility Determined|2|||
161699812|NCT00925600|583950981|FG001|Overall Study|Ineligibility Determined|0|||
161699813|NCT00925600|583950980|FG000|Overall Study|Protocol Deviation|0|||
161699814|NCT00925600|583950981|FG001|Overall Study|Protocol Deviation|1|||
161699815|NCT00925600|583950980|FG000|Overall Study|Requirement for Alternative Therapy|0|||
161699816|NCT00925600|583950981|FG001|Overall Study|Requirement for Alternative Therapy|1|||
161699817|NCT00925600|583950980|FG000|Overall Study|Other|3|||
161699818|NCT00925600|583950981|FG001|Overall Study|Other|1|||
161699819|NCT00925600|583950980|FG000|Overall Study|Adverse Event|1|||
161699820|NCT00925600|583950981|FG001|Overall Study|Adverse Event|2|||
161699821|NCT00127127|583950986|FG000|Overall Study|Adverse Event|0|||
161699822|NCT00127127|583950987|FG001|Overall Study|Adverse Event|2|||
161699823|NCT00127127|583950988|FG002|Overall Study|Adverse Event|0|||
161699824|NCT00127127|583950989|FG003|Overall Study|Adverse Event|1|||
161699825|NCT00127127|583950986|FG000|Overall Study|Lack of Efficacy|1|||
161699826|NCT00127127|583950987|FG001|Overall Study|Lack of Efficacy|3|||
161699827|NCT00127127|583950988|FG002|Overall Study|Lack of Efficacy|0|||
161699828|NCT00127127|583950989|FG003|Overall Study|Lack of Efficacy|2|||
161699829|NCT00200057|583950990|FG000|Overall Study|Lack of Efficacy|3|||
161699830|NCT00200057|583950990|FG000|Overall Study|Exited due to terminal illness of PI|2|||
161699831|NCT00200057|583950990|FG000|Overall Study|Withdrawal by Subject|1|||
161699832|NCT00200057|583950990|FG000|Overall Study|Change in medical condition|1|||
161699833|NCT00200057|583950990|FG000|Overall Study|Infection|1|||
161699834|NCT00200057|583950990|FG000|Overall Study|Death|1|||
161699835|NCT01059448|583950992|FG000|Overall Study|Adverse Event|1|||
161699836|NCT01059448|583950993|FG001|Overall Study|Adverse Event|3|||
161699837|NCT01059448|583950994|FG002|Overall Study|Adverse Event|0|||
161699838|NCT01059448|583950995|FG003|Overall Study|Adverse Event|1|||
161699839|NCT01059448|583950992|FG000|Overall Study|Withdrawal by Subject|2|||
161699840|NCT01059448|583950993|FG001|Overall Study|Withdrawal by Subject|0|||
161699841|NCT01059448|583950994|FG002|Overall Study|Withdrawal by Subject|2|||
161699842|NCT01059448|583950995|FG003|Overall Study|Withdrawal by Subject|4|||
161699843|NCT01059448|583950992|FG000|Overall Study|Disease Progression|2|||
161699844|NCT01059448|583950993|FG001|Overall Study|Disease Progression|1|||
161699845|NCT01059448|583950994|FG002|Overall Study|Disease Progression|4|||
161699846|NCT01059448|583950995|FG003|Overall Study|Disease Progression|2|||
161699847|NCT01059448|583950992|FG000|Overall Study|Administrative Decision|43|||
161699848|NCT01059448|583950993|FG001|Overall Study|Administrative Decision|49|||
161699849|NCT01059448|583950994|FG002|Overall Study|Administrative Decision|45|||
161699850|NCT01059448|583950995|FG003|Overall Study|Administrative Decision|46|||
161699851|NCT01059448|583950992|FG000|Overall Study|Lost to Follow-up|0|||
161699852|NCT01059448|583950993|FG001|Overall Study|Lost to Follow-up|0|||
161699853|NCT01059448|583950994|FG002|Overall Study|Lost to Follow-up|2|||
161699854|NCT01059448|583950995|FG003|Overall Study|Lost to Follow-up|0|||
161699855|NCT01059448|583950992|FG000|Overall Study|Death|0|||
161699856|NCT01059448|583950993|FG001|Overall Study|Death|1|||
161699857|NCT01059448|583950994|FG002|Overall Study|Death|0|||
161699858|NCT01059448|583950995|FG003|Overall Study|Death|0|||
161699859|NCT01059448|583950992|FG000|Overall Study|Other|1|||
161699860|NCT01059448|583950993|FG001|Overall Study|Other|1|||
161836827|NCT01583218|584445041|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
161836828|NCT01583218|584445042|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
161836829|NCT01583218|584445041|FG000|Overall Study|Withdraw of consent on day of random|1|||
161836830|NCT01583218|584445042|FG001|Overall Study|Withdraw of consent on day of random|0|||
161836831|NCT02013375|584445045|FG000|Overall Study|Did not engraft|1|||
161836832|NCT02013375|584445045|FG000|Overall Study|Did not engraft|1|||
161836833|NCT00712985|584445046|FG000|Overall Study|1 withdrew prior to start of drug|1|||
161836834|NCT00712985|584445046|FG000|Overall Study|1 patient moved out of state|1|||
161836835|NCT00712985|584445046|FG000|Overall Study|Lack of Efficacy|3|||
161836836|NCT02674061|584445047|FG000|Overall Study|Death|229|||
161836837|NCT02674061|584445048|FG001|Overall Study|Death|77|||
161836838|NCT02674061|584445047|FG000|Overall Study|Lost to Follow-up|3|||
161836839|NCT02674061|584445048|FG001|Overall Study|Lost to Follow-up|3|||
161699861|NCT01059448|583950994|FG002|Overall Study|Other|0|||
161699862|NCT01059448|583950995|FG003|Overall Study|Other|1|||
161699863|NCT00778830|583950996|FG000|Overall Study|Ongoing at data cut-off|0|||
161699864|NCT00778830|583950997|FG001|Overall Study|Ongoing at data cut-off|1|||
161699865|NCT05512949|583950998|FG000|Overall Study|Lost to Follow-up|4|||
161699866|NCT05512949|583950999|FG001|Overall Study|Lost to Follow-up|6|||
161699867|NCT05512949|583951000|FG002|Overall Study|Lost to Follow-up|2|||
161699868|NCT05512949|583950998|FG000|Overall Study|Protocol Violation|0|||
161699869|NCT05512949|583950999|FG001|Overall Study|Protocol Violation|0|||
161699870|NCT05512949|583951000|FG002|Overall Study|Protocol Violation|1|||
161699871|NCT05512949|583950998|FG000|Overall Study|Withdrawal by Subject|1|||
161699872|NCT05512949|583950999|FG001|Overall Study|Withdrawal by Subject|1|||
161699873|NCT05512949|583951000|FG002|Overall Study|Withdrawal by Subject|2|||
161699874|NCT05512949|583950998|FG000|Overall Study|Completion status unknown|1|||
161699875|NCT05512949|583950999|FG001|Overall Study|Completion status unknown|3|||
161699876|NCT05512949|583951000|FG002|Overall Study|Completion status unknown|0|||
161699877|NCT01891643|583951001|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161699878|NCT01891643|583951002|FG001|Overall Study|Adverse event unrelated to study drug|5|||
161699879|NCT01891643|583951001|FG000|Overall Study|Disease Progression|4|||
161699880|NCT01891643|583951002|FG001|Overall Study|Disease Progression|3|||
161699881|NCT01891643|583951001|FG000|Overall Study|Study Drug Toxicity|3|||
161699882|NCT01891643|583951002|FG001|Overall Study|Study Drug Toxicity|0|||
161699883|NCT01891643|583951001|FG000|Overall Study|Maximum Clinical Benefit|0|||
161699884|NCT01891643|583951002|FG001|Overall Study|Maximum Clinical Benefit|1|||
161699885|NCT01891643|583951001|FG000|Overall Study|Poor/Non-compliance|0|||
161699886|NCT01891643|583951002|FG001|Overall Study|Poor/Non-compliance|1|||
161699887|NCT01891643|583951001|FG000|Overall Study|Participant request to discontinue|1|||
161699888|NCT01891643|583951002|FG001|Overall Study|Participant request to discontinue|0|||
161699889|NCT04047797|583951005|FG000|Overall Study|Progressive Disease|1|||
161699890|NCT01430442|583951006|FG000|Overall Study|Subject Withdrew Consent|3|||
161699891|NCT01430442|583951007|FG001|Overall Study|Subject Withdrew Consent|0|||
161699892|NCT01430442|583951008|FG002|Overall Study|Subject Withdrew Consent|1|||
161699893|NCT01430442|583951009|FG003|Overall Study|Subject Withdrew Consent|0|||
161699894|NCT01430442|583951010|FG004|Overall Study|Subject Withdrew Consent|2|||
161699895|NCT01430442|583951011|FG005|Overall Study|Subject Withdrew Consent|1|||
161699896|NCT01430442|583951012|FG006|Overall Study|Subject Withdrew Consent|5|||
161699897|NCT01430442|583951013|FG007|Overall Study|Subject Withdrew Consent|2|||
161699898|NCT01430442|583951006|FG000|Overall Study|Lost to Follow-up|2|||
161699899|NCT01430442|583951007|FG001|Overall Study|Lost to Follow-up|0|||
161699900|NCT01430442|583951008|FG002|Overall Study|Lost to Follow-up|1|||
161699901|NCT01430442|583951009|FG003|Overall Study|Lost to Follow-up|2|||
161699902|NCT01430442|583951010|FG004|Overall Study|Lost to Follow-up|2|||
161699903|NCT01430442|583951011|FG005|Overall Study|Lost to Follow-up|1|||
161699904|NCT01430442|583951012|FG006|Overall Study|Lost to Follow-up|5|||
161699905|NCT01430442|583951013|FG007|Overall Study|Lost to Follow-up|1|||
161699906|NCT01430442|583951006|FG000|Overall Study|Pregnancy|1|||
161699907|NCT01430442|583951007|FG001|Overall Study|Pregnancy|0|||
161699908|NCT01430442|583951008|FG002|Overall Study|Pregnancy|0|||
161699909|NCT01430442|583951009|FG003|Overall Study|Pregnancy|0|||
161699910|NCT01430442|583951010|FG004|Overall Study|Pregnancy|0|||
161699911|NCT01430442|583951011|FG005|Overall Study|Pregnancy|1|||
161699912|NCT01430442|583951012|FG006|Overall Study|Pregnancy|0|||
161699913|NCT01430442|583951013|FG007|Overall Study|Pregnancy|0|||
161699914|NCT01430442|583951006|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
161699915|NCT01430442|583951007|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
161699916|NCT01430442|583951008|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
161699917|NCT01430442|583951009|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
161699918|NCT01430442|583951010|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
161699919|NCT01430442|583951011|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
161699920|NCT01430442|583951012|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
161699921|NCT01430442|583951013|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
161699922|NCT00772629|583951015|FG000|Overall Study|Subject was not vaccinated|1|||
161699923|NCT00772629|583951016|FG001|Overall Study|Subject was not vaccinated|0|||
161836840|NCT02674061|584445047|FG000|Overall Study|Withdrawal by Subject|9|||
161836841|NCT02674061|584445048|FG001|Overall Study|Withdrawal by Subject|1|||
161836842|NCT02674061|584445047|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
161836843|NCT02674061|584445048|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
161836844|NCT03334721|584445051|FG000|Overall Study|Withdrawal by Subject|1|||
161836845|NCT03334721|584445052|FG001|Overall Study|Withdrawal by Subject|0|||
161836846|NCT03334721|584445051|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
161699924|NCT00947531|583951025|FG000|Overall Study|Withdrawal by Subject|10|||
161699925|NCT00947531|583951026|FG001|Overall Study|Withdrawal by Subject|7|||
161699926|NCT00947531|583951025|FG000|Overall Study|Administrative Reason|0|||
161699927|NCT00947531|583951026|FG001|Overall Study|Administrative Reason|1|||
161699928|NCT00947531|583951025|FG000|Overall Study|Adverse Event|2|||
161699929|NCT00947531|583951026|FG001|Overall Study|Adverse Event|2|||
161699930|NCT00947531|583951025|FG000|Overall Study|Lack of Efficacy|1|||
161699931|NCT00947531|583951026|FG001|Overall Study|Lack of Efficacy|0|||
161699932|NCT00947531|583951025|FG000|Overall Study|Other|1|||
161836847|NCT03334721|584445052|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
161699933|NCT00947531|583951026|FG001|Overall Study|Other|1|||
161699934|NCT02327260|583951027|FG000|Overall Study|Lost to Follow-up|2|||
161699935|NCT02327260|583951028|FG001|Overall Study|Lost to Follow-up|3|||
161699936|NCT02327260|583951029|FG002|Overall Study|Lost to Follow-up|2|||
161699937|NCT02327260|583951027|FG000|Overall Study|invalid phone number|1|||
161699938|NCT02327260|583951028|FG001|Overall Study|invalid phone number|1|||
161699939|NCT02327260|583951029|FG002|Overall Study|invalid phone number|0|||
161699940|NCT02327260|583951027|FG000|Overall Study|non-adherence to protocol|2|||
161699941|NCT02327260|583951028|FG001|Overall Study|non-adherence to protocol|0|||
161699942|NCT02327260|583951029|FG002|Overall Study|non-adherence to protocol|0|||
161699943|NCT02327260|583951027|FG000|Overall Study|cognitive concerns|1|||
161699944|NCT02327260|583951028|FG001|Overall Study|cognitive concerns|0|||
161699945|NCT02327260|583951029|FG002|Overall Study|cognitive concerns|0|||
161699946|NCT03502330|583951030|FG000|Overall Study|Adverse Event|2|||
161699947|NCT03502330|583951031|FG001|Overall Study|Adverse Event|1|||
161699948|NCT03502330|583951032|FG002|Overall Study|Adverse Event|0|||
161699949|NCT03502330|583951033|FG003|Overall Study|Adverse Event|0|||
161699950|NCT03502330|583951034|FG004|Overall Study|Adverse Event|1|||
161699951|NCT03502330|583951035|FG005|Overall Study|Adverse Event|0|||
161699952|NCT03502330|583951036|FG006|Overall Study|Adverse Event|1|||
161699953|NCT03502330|583951037|FG007|Overall Study|Adverse Event|1|||
161699954|NCT03502330|583951038|FG008|Overall Study|Adverse Event|0|||
161699955|NCT03502330|583951030|FG000|Overall Study|Lack of Efficacy|1|||
161699956|NCT03502330|583951031|FG001|Overall Study|Lack of Efficacy|5|||
161699957|NCT03502330|583951032|FG002|Overall Study|Lack of Efficacy|3|||
161699958|NCT03502330|583951033|FG003|Overall Study|Lack of Efficacy|5|||
161699959|NCT03502330|583951034|FG004|Overall Study|Lack of Efficacy|1|||
161699960|NCT03502330|583951035|FG005|Overall Study|Lack of Efficacy|5|||
161699961|NCT03502330|583951036|FG006|Overall Study|Lack of Efficacy|5|||
161699962|NCT03502330|583951037|FG007|Overall Study|Lack of Efficacy|6|||
161699963|NCT03502330|583951038|FG008|Overall Study|Lack of Efficacy|0|||
161699964|NCT03502330|583951030|FG000|Overall Study|Physician Decision|0|||
161699965|NCT03502330|583951031|FG001|Overall Study|Physician Decision|0|||
161699966|NCT03502330|583951032|FG002|Overall Study|Physician Decision|0|||
161699967|NCT03502330|583951033|FG003|Overall Study|Physician Decision|0|||
161699968|NCT03502330|583951034|FG004|Overall Study|Physician Decision|1|||
161699969|NCT03502330|583951035|FG005|Overall Study|Physician Decision|0|||
161699970|NCT03502330|583951036|FG006|Overall Study|Physician Decision|0|||
161699971|NCT03502330|583951037|FG007|Overall Study|Physician Decision|0|||
161699972|NCT03502330|583951038|FG008|Overall Study|Physician Decision|0|||
161699973|NCT03502330|583951030|FG000|Overall Study|Withdrawal by Subject|0|||
161699974|NCT03502330|583951031|FG001|Overall Study|Withdrawal by Subject|0|||
161699975|NCT03502330|583951032|FG002|Overall Study|Withdrawal by Subject|0|||
161699976|NCT03502330|583951033|FG003|Overall Study|Withdrawal by Subject|0|||
161699977|NCT03502330|583951034|FG004|Overall Study|Withdrawal by Subject|0|||
161699978|NCT03502330|583951035|FG005|Overall Study|Withdrawal by Subject|1|||
161699979|NCT03502330|583951036|FG006|Overall Study|Withdrawal by Subject|0|||
161699980|NCT03502330|583951037|FG007|Overall Study|Withdrawal by Subject|1|||
161699981|NCT03502330|583951038|FG008|Overall Study|Withdrawal by Subject|0|||
161699982|NCT03502330|583951030|FG000|Overall Study|Death|0|||
161699983|NCT03502330|583951031|FG001|Overall Study|Death|0|||
161699984|NCT03502330|583951032|FG002|Overall Study|Death|0|||
161699985|NCT03502330|583951033|FG003|Overall Study|Death|0|||
161699986|NCT03502330|583951034|FG004|Overall Study|Death|0|||
161699987|NCT03502330|583951035|FG005|Overall Study|Death|0|||
161699988|NCT03502330|583951036|FG006|Overall Study|Death|2|||
161699989|NCT03502330|583951037|FG007|Overall Study|Death|0|||
161699990|NCT03502330|583951038|FG008|Overall Study|Death|0|||
161699991|NCT02804763|583951039|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
161699992|NCT02804763|583951040|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161699993|NCT02804763|583951041|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161699994|NCT02804763|583951042|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161699995|NCT02804763|583951039|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
161699996|NCT02804763|583951040|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
161699997|NCT02804763|583951041|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
161699998|NCT02804763|583951042|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
161699999|NCT02804763|583951039|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161700000|NCT02804763|583951040|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
161700001|NCT02804763|583951041|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161700002|NCT02804763|583951042|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161700003|NCT02804763|583951039|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
161700004|NCT02804763|583951040|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
161700005|NCT02804763|583951041|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
161700006|NCT02804763|583951042|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
161700007|NCT02804763|583951039|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
161700008|NCT02804763|583951040|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
161700009|NCT02804763|583951041|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
161700010|NCT02804763|583951042|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
161836848|NCT01663727|584445054|FG000|Overall Study|Death|161|||
161700011|NCT02804763|583951039|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161700012|NCT02804763|583951040|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
161700013|NCT02804763|583951041|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161700014|NCT02804763|583951042|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161700015|NCT05499520|583951043|FG000|Overall Study|Lost to Follow-up|0|||
161700016|NCT05499520|583951044|FG001|Overall Study|Lost to Follow-up|0|||
161700017|NCT05499520|583951045|FG002|Overall Study|Lost to Follow-up|38|||
161700018|NCT05499520|583951046|FG003|Overall Study|Lost to Follow-up|41|||
161700019|NCT05499520|583951047|FG004|Overall Study|Lost to Follow-up|46|||
161700020|NCT05499520|583951048|FG005|Overall Study|Lost to Follow-up|0|||
161700021|NCT05499520|583951049|FG006|Overall Study|Lost to Follow-up|31|||
161836849|NCT01663727|584445055|FG001|Overall Study|Death|155|||
161836850|NCT01663727|584445054|FG000|Overall Study|Lost to Follow-up|10|||
161836851|NCT01663727|584445055|FG001|Overall Study|Lost to Follow-up|8|||
161836852|NCT01663727|584445054|FG000|Overall Study|Withdrawal by Subject|18|||
161836853|NCT01663727|584445055|FG001|Overall Study|Withdrawal by Subject|25|||
161836854|NCT01663727|584445054|FG000|Overall Study|Study Terminated|51|||
161836855|NCT01663727|584445055|FG001|Overall Study|Study Terminated|50|||
161836856|NCT01663727|584445054|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
161836857|NCT01663727|584445055|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
161836858|NCT01663727|584445054|FG000|Overall Study|Withdrawal prior to dosing.|1|||
161836859|NCT01663727|584445055|FG001|Overall Study|Withdrawal prior to dosing.|0|||
161836860|NCT01902628|584445056|FG000|Overall Study|Withdrawal of participant's consent|7|||
161836861|NCT01902628|584445056|FG000|Overall Study|Adverse Event|41|||
161836862|NCT01902628|584445056|FG000|Overall Study|Lost to Follow-up|35|||
161836863|NCT01232491|584445057|FG000|Overall Study|Adverse Event|13|||
161836864|NCT01232491|584445058|FG001|Overall Study|Adverse Event|8|||
161836865|NCT01232491|584445057|FG000|Overall Study|Lack of Efficacy|1|||
161836866|NCT01232491|584445058|FG001|Overall Study|Lack of Efficacy|5|||
161836867|NCT01232491|584445057|FG000|Overall Study|Protocol Violation|13|||
161836868|NCT01232491|584445058|FG001|Overall Study|Protocol Violation|11|||
161836869|NCT01232491|584445057|FG000|Overall Study|Withdrawal Criteria|12|||
161836870|NCT01232491|584445058|FG001|Overall Study|Withdrawal Criteria|21|||
161836871|NCT01232491|584445057|FG000|Overall Study|Other|21|||
161836872|NCT01232491|584445058|FG001|Overall Study|Other|18|||
161836873|NCT02932228|584445059|FG000|Overall Study|Death|8|||
161836874|NCT02932228|584445060|FG001|Overall Study|Death|23|||
161836875|NCT02932228|584445059|FG000|Overall Study|not eligible upon chart review|2|||
161836876|NCT02932228|584445060|FG001|Overall Study|not eligible upon chart review|5|||
161700022|NCT05499520|583951050|FG007|Overall Study|Lost to Follow-up|45|||
161700023|NCT05499520|583951051|FG008|Overall Study|Lost to Follow-up|42|||
161700024|NCT05499520|583951052|FG009|Overall Study|Lost to Follow-up|0|||
161700025|NCT05499520|583951053|FG010|Overall Study|Lost to Follow-up|0|||
161700026|NCT05499520|583951054|FG011|Overall Study|Lost to Follow-up|37|||
161700027|NCT05499520|583951055|FG012|Overall Study|Lost to Follow-up|53|||
161700028|NCT05499520|583951056|FG013|Overall Study|Lost to Follow-up|49|||
161700029|NCT05499520|583951057|FG014|Overall Study|Lost to Follow-up|0|||
161700030|NCT05499520|583951058|FG015|Overall Study|Lost to Follow-up|36|||
161700031|NCT05499520|583951059|FG016|Overall Study|Lost to Follow-up|58|||
161700032|NCT05499520|583951060|FG017|Overall Study|Lost to Follow-up|53|||
161700033|NCT00605267|583951061|FG000|Overall Study|Adverse Event|0|||
161700034|NCT00605267|583951062|FG001|Overall Study|Adverse Event|1|||
161700035|NCT00605267|583951061|FG000|Overall Study|Lack of Efficacy|1|||
161700036|NCT00605267|583951062|FG001|Overall Study|Lack of Efficacy|5|||
161700037|NCT00605267|583951061|FG000|Overall Study|Withdrawal by Subject|2|||
161700038|NCT00605267|583951062|FG001|Overall Study|Withdrawal by Subject|3|||
161700039|NCT00793793|583951063|FG000|Overall Study|Adverse Event|0|||
161700040|NCT00793793|583951064|FG001|Overall Study|Adverse Event|0|||
161700041|NCT00793793|583951065|FG002|Overall Study|Adverse Event|1|||
161700042|NCT00793793|583951066|FG003|Overall Study|Adverse Event|1|||
161700043|NCT00793793|583951067|FG004|Overall Study|Adverse Event|0|||
161700044|NCT00793793|583951068|FG005|Overall Study|Adverse Event|1|||
161700045|NCT00793793|583951069|FG006|Overall Study|Adverse Event|2|||
161700046|NCT00793793|583951070|FG007|Overall Study|Adverse Event|0|||
161700047|NCT00793793|583951071|FG008|Overall Study|Adverse Event|0|||
161700048|NCT00793793|583951072|FG009|Overall Study|Adverse Event|0|||
161700049|NCT00793793|583951073|FG010|Overall Study|Adverse Event|0|||
161700050|NCT00793793|583951074|FG011|Overall Study|Adverse Event|2|||
161700051|NCT00793793|583951063|FG000|Overall Study|Protocol Violation|0|||
161700052|NCT00793793|583951064|FG001|Overall Study|Protocol Violation|0|||
161700053|NCT00793793|583951065|FG002|Overall Study|Protocol Violation|0|||
161700054|NCT00793793|583951066|FG003|Overall Study|Protocol Violation|1|||
161700055|NCT00793793|583951067|FG004|Overall Study|Protocol Violation|0|||
161700056|NCT00793793|583951068|FG005|Overall Study|Protocol Violation|0|||
161700057|NCT00793793|583951069|FG006|Overall Study|Protocol Violation|0|||
161700058|NCT00793793|583951070|FG007|Overall Study|Protocol Violation|0|||
161700059|NCT00793793|583951071|FG008|Overall Study|Protocol Violation|0|||
161700060|NCT00793793|583951072|FG009|Overall Study|Protocol Violation|0|||
161700061|NCT00793793|583951073|FG010|Overall Study|Protocol Violation|0|||
161700062|NCT00793793|583951074|FG011|Overall Study|Protocol Violation|0|||
161700063|NCT00793793|583951063|FG000|Overall Study|Lost to Follow-up|0|||
161700064|NCT00793793|583951064|FG001|Overall Study|Lost to Follow-up|0|||
161700065|NCT00793793|583951065|FG002|Overall Study|Lost to Follow-up|1|||
161700066|NCT00793793|583951066|FG003|Overall Study|Lost to Follow-up|0|||
161700067|NCT00793793|583951067|FG004|Overall Study|Lost to Follow-up|0|||
161700068|NCT00793793|583951068|FG005|Overall Study|Lost to Follow-up|0|||
161700069|NCT00793793|583951069|FG006|Overall Study|Lost to Follow-up|0|||
161700070|NCT00793793|583951070|FG007|Overall Study|Lost to Follow-up|0|||
161836877|NCT04062448|584446475|FG000|Overall Study|Lost to Follow-up|1|||
161836878|NCT04062448|584446475|FG000|Overall Study|Withdrawal by Subject|2|||
161836879|NCT04385277|584446476|FG000|Overall Study|Physician Decision|2|||
161836880|NCT04385277|584446476|FG000|Overall Study|Ineligible|1|||
161836881|NCT04385277|584446476|FG000|Overall Study|Patient/Parent Refusal|2|||
161836882|NCT04905290|584446477|FG000|Overall Study|Adverse Event|4|||
161700071|NCT00793793|583951071|FG008|Overall Study|Lost to Follow-up|1|||
161700072|NCT00793793|583951072|FG009|Overall Study|Lost to Follow-up|3|||
161700073|NCT00793793|583951073|FG010|Overall Study|Lost to Follow-up|1|||
161700074|NCT00793793|583951074|FG011|Overall Study|Lost to Follow-up|0|||
161700075|NCT00793793|583951063|FG000|Overall Study|Withdrawal by Subject|0|||
161700076|NCT00793793|583951064|FG001|Overall Study|Withdrawal by Subject|0|||
161700077|NCT00793793|583951065|FG002|Overall Study|Withdrawal by Subject|0|||
161700078|NCT00793793|583951066|FG003|Overall Study|Withdrawal by Subject|0|||
161700079|NCT00793793|583951067|FG004|Overall Study|Withdrawal by Subject|1|||
161700080|NCT00793793|583951068|FG005|Overall Study|Withdrawal by Subject|0|||
161700081|NCT00793793|583951069|FG006|Overall Study|Withdrawal by Subject|0|||
161700082|NCT00793793|583951070|FG007|Overall Study|Withdrawal by Subject|0|||
161700083|NCT00793793|583951071|FG008|Overall Study|Withdrawal by Subject|1|||
161700084|NCT00793793|583951072|FG009|Overall Study|Withdrawal by Subject|0|||
161700085|NCT00793793|583951073|FG010|Overall Study|Withdrawal by Subject|0|||
161700086|NCT00793793|583951074|FG011|Overall Study|Withdrawal by Subject|0|||
161700087|NCT00793793|583951063|FG000|Overall Study|reason not specified|0|||
161700088|NCT00793793|583951064|FG001|Overall Study|reason not specified|1|||
161700089|NCT00793793|583951065|FG002|Overall Study|reason not specified|0|||
161700090|NCT00793793|583951066|FG003|Overall Study|reason not specified|1|||
161700091|NCT00793793|583951067|FG004|Overall Study|reason not specified|1|||
161700092|NCT00793793|583951068|FG005|Overall Study|reason not specified|1|||
161700093|NCT00793793|583951069|FG006|Overall Study|reason not specified|2|||
161700094|NCT00793793|583951070|FG007|Overall Study|reason not specified|0|||
161836883|NCT04905290|584446477|FG000|Overall Study|Death|2|||
161836884|NCT04905290|584446477|FG000|Overall Study|Withdrawal by Subject|4|||
161700095|NCT00793793|583951071|FG008|Overall Study|reason not specified|7|||
161700096|NCT00793793|583951072|FG009|Overall Study|reason not specified|6|||
161700097|NCT00793793|583951073|FG010|Overall Study|reason not specified|2|||
161700098|NCT00793793|583951074|FG011|Overall Study|reason not specified|4|||
161700099|NCT00840827|583951075|FG000|Overall Study|Adverse Event|1|||
161700100|NCT00840827|583951075|FG000|Overall Study|Lack of Efficacy|4|||
161700101|NCT00840827|583951075|FG000|Overall Study|Physician Decision|1|||
161700102|NCT01505894|583951077|FG000|Overall Study|Adverse Event|1|||
161700103|NCT01505894|583951078|FG001|Overall Study|Adverse Event|0|||
161700104|NCT01505894|583951079|FG002|Overall Study|Adverse Event|0|||
161700105|NCT01505894|583951080|FG003|Overall Study|Adverse Event|0|||
161700106|NCT01505894|583951081|FG004|Overall Study|Adverse Event|0|||
161700107|NCT01505894|583951082|FG005|Overall Study|Adverse Event|0|||
161700108|NCT01505894|583951083|FG006|Overall Study|Adverse Event|0|||
161700109|NCT01505894|583951084|FG007|Overall Study|Adverse Event|0|||
161700110|NCT01505894|583951085|FG008|Overall Study|Adverse Event|0|||
161700111|NCT01505894|583951077|FG000|Overall Study|Other than specified|0|||
161700112|NCT01505894|583951078|FG001|Overall Study|Other than specified|0|||
161700113|NCT01505894|583951079|FG002|Overall Study|Other than specified|0|||
161700114|NCT01505894|583951080|FG003|Overall Study|Other than specified|0|||
161700115|NCT01505894|583951081|FG004|Overall Study|Other than specified|1|||
161700116|NCT01505894|583951082|FG005|Overall Study|Other than specified|0|||
161700117|NCT01505894|583951083|FG006|Overall Study|Other than specified|0|||
161700118|NCT01505894|583951084|FG007|Overall Study|Other than specified|0|||
161700119|NCT01505894|583951085|FG008|Overall Study|Other than specified|0|||
161700120|NCT04088409|583951087|FG000|Part A|Withdrawal by Subject|2|||
161700121|NCT04088409|583951088|FG001|Part A|Withdrawal by Subject|1|||
161700122|NCT04088409|583951087|FG000|Part A|Did Not Meet Randomization Criteria|2|||
161700123|NCT04088409|583951088|FG001|Part A|Did Not Meet Randomization Criteria|0|||
161700124|NCT04088409|583951087|FG000|Part A|Lack of Efficacy|9|||
161700125|NCT04088409|583951088|FG001|Part A|Lack of Efficacy|0|||
161700126|NCT04088409|583951087|FG000|Part A|Lost to Follow-up|1|||
161700127|NCT04088409|583951088|FG001|Part A|Lost to Follow-up|0|||
161700128|NCT04088409|583951087|FG000|Part A|Adverse Event|1|||
161700129|NCT04088409|583951088|FG001|Part A|Adverse Event|0|||
161700130|NCT04088409|583951087|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
161700131|NCT04088409|583951088|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
161700132|NCT04088409|583951087|FG000|Part B|Ongoing Treatment|10|||
161700133|NCT04088409|583951088|FG001|Part B|Ongoing Treatment|0|||
161700134|NCT00648167|583951089|FG000|Overall Study|Adverse Event|6|||
161700135|NCT00648167|583951089|FG000|Overall Study|unable to swallow tablets|1|||
161700136|NCT00927368|583951090|FG000|Overall Study|enrollment in another study|1|||
161700137|NCT00927368|583951091|FG001|Overall Study|enrollment in another study|1|||
161700138|NCT00927368|583951092|FG002|Overall Study|enrollment in another study|2|||
161700139|NCT00927368|583951090|FG000|Overall Study|Lost to Follow-up|4|||
161700140|NCT00927368|583951091|FG001|Overall Study|Lost to Follow-up|0|||
161700141|NCT00927368|583951092|FG002|Overall Study|Lost to Follow-up|0|||
161700142|NCT00927368|583951090|FG000|Overall Study|equipment failure|1|||
161700143|NCT00927368|583951091|FG001|Overall Study|equipment failure|0|||
161700144|NCT00927368|583951092|FG002|Overall Study|equipment failure|0|||
161700145|NCT00927368|583951090|FG000|Overall Study|ineligible post randomization|0|||
161700146|NCT00927368|583951091|FG001|Overall Study|ineligible post randomization|3|||
161700147|NCT00927368|583951092|FG002|Overall Study|ineligible post randomization|1|||
161700148|NCT00927368|583951090|FG000|Overall Study|cancellation of surgery|0|||
161700149|NCT00927368|583951091|FG001|Overall Study|cancellation of surgery|1|||
161700150|NCT00927368|583951092|FG002|Overall Study|cancellation of surgery|2|||
161700151|NCT00191451|583951093|FG000|Overall Study|Withdrawal by Subject|2|||
161700152|NCT00191451|583951094|FG001|Overall Study|Withdrawal by Subject|3|||
161700153|NCT00191451|583951095|FG002|Overall Study|Withdrawal by Subject|5|||
161700154|NCT00191451|583951093|FG000|Overall Study|Physician Decision|2|||
161700155|NCT00191451|583951094|FG001|Overall Study|Physician Decision|9|||
161700156|NCT00191451|583951095|FG002|Overall Study|Physician Decision|6|||
161700157|NCT00191451|583951093|FG000|Overall Study|Sponsor Decision|1|||
161700158|NCT00191451|583951094|FG001|Overall Study|Sponsor Decision|0|||
161700159|NCT00191451|583951095|FG002|Overall Study|Sponsor Decision|0|||
161700160|NCT00191451|583951093|FG000|Overall Study|Ineligible|0|||
161700161|NCT00191451|583951094|FG001|Overall Study|Ineligible|1|||
161700162|NCT00191451|583951095|FG002|Overall Study|Ineligible|0|||
161700163|NCT00191451|583951093|FG000|Overall Study|Reason Not Specified|2|||
161700164|NCT00191451|583951094|FG001|Overall Study|Reason Not Specified|1|||
161700165|NCT00191451|583951095|FG002|Overall Study|Reason Not Specified|3|||
161700166|NCT00272987|583951103|FG000|Overall Study|Adverse Event|1|||
161700167|NCT00272987|583951104|FG001|Overall Study|Adverse Event|0|||
161700168|NCT00272987|583951105|FG002|Overall Study|Adverse Event|0|||
161700169|NCT00272987|583951103|FG000|Overall Study|Lost to Follow-up|3|||
161836885|NCT04905290|584446477|FG000|Overall Study|Physician Decision|2|||
161836886|NCT04905290|584446477|FG000|Overall Study|Lost to Follow-up|2|||
161836887|NCT04905290|584446477|FG000|Overall Study|Screen Failure|2|||
161836888|NCT04905290|584446477|FG000|Overall Study|Unsuccessful Procedure|2|||
161700170|NCT00272987|583951104|FG001|Overall Study|Lost to Follow-up|1|||
161700171|NCT00272987|583951105|FG002|Overall Study|Lost to Follow-up|1|||
161700172|NCT00272987|583951103|FG000|Overall Study|Withdrawal by Subject|1|||
161700173|NCT00272987|583951104|FG001|Overall Study|Withdrawal by Subject|0|||
161700174|NCT00272987|583951105|FG002|Overall Study|Withdrawal by Subject|3|||
161700175|NCT00272987|583951103|FG000|Overall Study|Sponsor Terminated study|0|||
161700176|NCT00272987|583951104|FG001|Overall Study|Sponsor Terminated study|1|||
161700177|NCT00272987|583951105|FG002|Overall Study|Sponsor Terminated study|1|||
161700178|NCT00272987|583951103|FG000|Overall Study|Disease progression|1|||
161700179|NCT00272987|583951104|FG001|Overall Study|Disease progression|1|||
161700180|NCT00272987|583951105|FG002|Overall Study|Disease progression|2|||
161700181|NCT00272987|583951103|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
161700182|NCT00272987|583951104|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
161700183|NCT00272987|583951105|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
161700184|NCT00272987|583951103|FG000|Overall Study|Death|1|||
161700185|NCT00272987|583951104|FG001|Overall Study|Death|0|||
161700186|NCT00272987|583951105|FG002|Overall Study|Death|0|||
161700187|NCT00331409|583951106|FG000|Overall Study|Lack of Efficacy|4|||
161700188|NCT01482910|583951107|FG000|Overall Study|Adverse Event|6|||
161700189|NCT01482910|583951108|FG001|Overall Study|Adverse Event|5|||
161700190|NCT01482910|583951107|FG000|Overall Study|Lost to Follow-up|0|||
161700191|NCT01482910|583951108|FG001|Overall Study|Lost to Follow-up|1|||
161700192|NCT01482910|583951107|FG000|Overall Study|Protocol Violation|1|||
161700193|NCT01482910|583951108|FG001|Overall Study|Protocol Violation|1|||
161700194|NCT01482910|583951107|FG000|Overall Study|Withdrawal by Subject|7|||
161700195|NCT01482910|583951108|FG001|Overall Study|Withdrawal by Subject|2|||
161700196|NCT01482910|583951107|FG000|Overall Study|Death|1|||
161700197|NCT01482910|583951108|FG001|Overall Study|Death|0|||
161700198|NCT02614079|583951112|FG000|Overall Study|Withdrawal by Subject|1|||
161700199|NCT03739528|583951115|FG000|Overall Study|Not treated|8|||
161700200|NCT03739528|583951116|FG001|Overall Study|Not treated|12|||
161700201|NCT03739528|583951115|FG000|Overall Study|Treatment and study discontinued|6|||
161700202|NCT03739528|583951116|FG001|Overall Study|Treatment and study discontinued|2|||
161700203|NCT03739528|583951115|FG000|Overall Study|Treatment discontinued + study completed|1|||
161700204|NCT03739528|583951116|FG001|Overall Study|Treatment discontinued + study completed|3|||
161700205|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Adverse Event|11|||
161700206|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Adverse Event|15|||
161700207|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
161700208|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
161700209|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
161700210|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
161700211|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
161700212|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
161700213|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161700214|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161700215|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
161700216|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
161700217|NCT05655377|583951119|FG000|Overall Study|Withdrawal by Subject|2|||
161700218|NCT04451330|583951120|FG000|Overall Study|Adverse Event|1|||
161700219|NCT04451330|583951121|FG001|Overall Study|Adverse Event|2|||
161700220|NCT04451330|583951120|FG000|Overall Study|Lost to Follow-up|5|||
161700221|NCT04451330|583951121|FG001|Overall Study|Lost to Follow-up|0|||
161700222|NCT04451330|583951120|FG000|Overall Study|Withdrawal by Subject|3|||
161700223|NCT04451330|583951121|FG001|Overall Study|Withdrawal by Subject|1|||
161700224|NCT04451330|583951120|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161700225|NCT04451330|583951121|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161700226|NCT04451330|583951120|FG000|Overall Study|Other than specified|0|||
161700227|NCT04451330|583951121|FG001|Overall Study|Other than specified|1|||
161700228|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
161700229|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
161700230|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
161700231|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
161700232|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
161700233|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
161836889|NCT01045421|584446481|FG000|Phase 1|Progressive Disease|0|||
161700234|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
161700235|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
161700236|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
161700237|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
161700238|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
161700239|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
161700240|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
161700241|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
161700242|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
161700243|NCT05099640|583951122|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
161700244|NCT05099640|583951123|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
161700245|NCT05099640|583951124|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
161700246|NCT00179959|583951125|FG000|Overall Study|Lost to Follow-up|3|||
161700247|NCT00179959|583951126|FG001|Overall Study|Lost to Follow-up|1|||
161700248|NCT00179959|583951125|FG000|Overall Study|Withdrawal by Subject|3|||
161700249|NCT00179959|583951126|FG001|Overall Study|Withdrawal by Subject|2|||
161700250|NCT01552681|583951131|FG000|Overall Study|Withdrawal by Subject|4|||
161700251|NCT01552681|583951132|FG001|Overall Study|Withdrawal by Subject|0|||
161700252|NCT01552681|583951131|FG000|Overall Study|Physician Decision|1|||
161700253|NCT01552681|583951132|FG001|Overall Study|Physician Decision|0|||
161700254|NCT01552681|583951131|FG000|Overall Study|Subject moved away|0|||
161700255|NCT01552681|583951132|FG001|Overall Study|Subject moved away|1|||
161700256|NCT03075163|583951133|FG000|Overall Study|not eligible for treatment limb|138|||
161700257|NCT03075163|583951134|FG001|Overall Study|not eligible for treatment limb|138|||
161700258|NCT00236080|583951135|FG000|Overall Study|Adverse Event|0|||
161700259|NCT00236080|583951136|FG001|Overall Study|Adverse Event|0|||
161700260|NCT00236080|583951137|FG002|Overall Study|Adverse Event|3|||
161700261|NCT00236080|583951138|FG003|Overall Study|Adverse Event|1|||
161700262|NCT00236080|583951139|FG004|Overall Study|Adverse Event|0|||
161700263|NCT00236080|583951135|FG000|Overall Study|Lost to Follow-up|0|||
161700264|NCT00236080|583951136|FG001|Overall Study|Lost to Follow-up|1|||
161700265|NCT00236080|583951137|FG002|Overall Study|Lost to Follow-up|0|||
161700266|NCT00236080|583951138|FG003|Overall Study|Lost to Follow-up|0|||
161700267|NCT00236080|583951139|FG004|Overall Study|Lost to Follow-up|0|||
161700268|NCT00236080|583951135|FG000|Overall Study|Physician Decision|1|||
161700269|NCT00236080|583951136|FG001|Overall Study|Physician Decision|0|||
161700270|NCT00236080|583951137|FG002|Overall Study|Physician Decision|1|||
161700271|NCT00236080|583951138|FG003|Overall Study|Physician Decision|1|||
161700272|NCT00236080|583951139|FG004|Overall Study|Physician Decision|1|||
161700273|NCT00236080|583951135|FG000|Overall Study|Withdrawal by Subject|1|||
161700274|NCT00236080|583951136|FG001|Overall Study|Withdrawal by Subject|0|||
161700275|NCT00236080|583951137|FG002|Overall Study|Withdrawal by Subject|0|||
161700276|NCT00236080|583951138|FG003|Overall Study|Withdrawal by Subject|0|||
161700277|NCT00236080|583951139|FG004|Overall Study|Withdrawal by Subject|0|||
161700278|NCT00236080|583951135|FG000|Overall Study|Miscellaneous|0|||
161700279|NCT00236080|583951136|FG001|Overall Study|Miscellaneous|0|||
161700280|NCT00236080|583951137|FG002|Overall Study|Miscellaneous|1|||
161700281|NCT00236080|583951138|FG003|Overall Study|Miscellaneous|0|||
161700282|NCT00236080|583951139|FG004|Overall Study|Miscellaneous|0|||
161700283|NCT01214044|583951140|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
161700284|NCT01214044|583951140|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
161700285|NCT01214044|583951140|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
161700286|NCT01214044|583951140|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
161700287|NCT01214044|583951140|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
161700288|NCT01214044|583951140|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
161700289|NCT04698525|583951141|FG000|Overall Study|Lost to Follow-up|1|||
161700290|NCT04698525|583951142|FG001|Overall Study|Lost to Follow-up|2|||
161700291|NCT04698525|583951141|FG000|Overall Study|Three suffered of Covid-19|2|||
161700292|NCT04698525|583951142|FG001|Overall Study|Three suffered of Covid-19|1|||
161700293|NCT01961544|583951143|FG000|Overall Study|Protocol Violation|1|||
161700294|NCT01961544|583951143|FG000|Overall Study|Withdrawal by Subject|7|||
161700295|NCT01961544|583951143|FG000|Overall Study|Adverse Event|1|||
161700296|NCT01961544|583951143|FG000|Overall Study|Physician Decision|2|||
161700297|NCT01961544|583951143|FG000|Overall Study|Poor Tolerance|1|||
161700298|NCT01961544|583951143|FG000|Overall Study|Aggravation of Steral Pain|1|||
161700299|NCT03157531|583951146|FG000|Overall Study|Death|2|||
161700300|NCT03157531|583951146|FG000|Overall Study|Lost to Follow-up|4|||
161700301|NCT02211261|583951154|FG000|Overall Study|Withdrawal by Subject|0|||
161700302|NCT02211261|583951155|FG001|Overall Study|Withdrawal by Subject|0|||
161700303|NCT02211261|583951156|FG002|Overall Study|Withdrawal by Subject|1|||
161700304|NCT02211261|583951157|FG003|Overall Study|Withdrawal by Subject|0|||
161700305|NCT02211261|583951158|FG004|Overall Study|Withdrawal by Subject|2|||
161700306|NCT02211261|583951159|FG005|Overall Study|Withdrawal by Subject|0|||
161700307|NCT02211261|583951160|FG006|Overall Study|Withdrawal by Subject|0|||
161700308|NCT02211261|583951161|FG007|Overall Study|Withdrawal by Subject|0|||
161700309|NCT02211261|583951162|FG008|Overall Study|Withdrawal by Subject|0|||
161700310|NCT02211261|583951163|FG009|Overall Study|Withdrawal by Subject|0|||
161700311|NCT02211261|583951164|FG010|Overall Study|Withdrawal by Subject|0|||
161700312|NCT02211261|583951154|FG000|Overall Study|Other|0|||
161700313|NCT02211261|583951155|FG001|Overall Study|Other|0|||
161700314|NCT02211261|583951156|FG002|Overall Study|Other|0|||
161700315|NCT02211261|583951157|FG003|Overall Study|Other|0|||
161700316|NCT02211261|583951158|FG004|Overall Study|Other|0|||
161700317|NCT02211261|583951159|FG005|Overall Study|Other|1|||
161700318|NCT02211261|583951160|FG006|Overall Study|Other|0|||
161700319|NCT02211261|583951161|FG007|Overall Study|Other|0|||
161700320|NCT02211261|583951162|FG008|Overall Study|Other|0|||
161700321|NCT02211261|583951163|FG009|Overall Study|Other|2|||
161700322|NCT02211261|583951164|FG010|Overall Study|Other|0|||
161700323|NCT02211261|583951154|FG000|Overall Study|Lost to Follow-up|0|||
161700324|NCT02211261|583951155|FG001|Overall Study|Lost to Follow-up|0|||
161700325|NCT02211261|583951156|FG002|Overall Study|Lost to Follow-up|0|||
161700326|NCT02211261|583951157|FG003|Overall Study|Lost to Follow-up|0|||
161700327|NCT02211261|583951158|FG004|Overall Study|Lost to Follow-up|0|||
161700328|NCT02211261|583951159|FG005|Overall Study|Lost to Follow-up|0|||
161700329|NCT02211261|583951160|FG006|Overall Study|Lost to Follow-up|0|||
161700330|NCT02211261|583951161|FG007|Overall Study|Lost to Follow-up|1|||
161700331|NCT02211261|583951162|FG008|Overall Study|Lost to Follow-up|0|||
161700332|NCT02211261|583951163|FG009|Overall Study|Lost to Follow-up|0|||
161700333|NCT02211261|583951164|FG010|Overall Study|Lost to Follow-up|0|||
161700334|NCT01573910|583951165|FG000|Overall Study|Adverse Event|4|||
161700335|NCT01573910|583951166|FG001|Overall Study|Adverse Event|4|||
161700336|NCT01573910|583951165|FG000|Overall Study|Lost to Follow-up|2|||
161700337|NCT01573910|583951166|FG001|Overall Study|Lost to Follow-up|1|||
161700338|NCT01573910|583951165|FG000|Overall Study|Withdrawal by Subject|0|||
161700339|NCT01573910|583951166|FG001|Overall Study|Withdrawal by Subject|1|||
161700340|NCT01573910|583951165|FG000|Overall Study|Protocol Violation|3|||
161700341|NCT01573910|583951166|FG001|Overall Study|Protocol Violation|0|||
161700342|NCT01573910|583951165|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
161700343|NCT01573910|583951166|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
161700344|NCT02251912|583951167|FG000|Overall Study|Withdrawal by Subject|2|||
161700345|NCT02251912|583951168|FG001|Overall Study|Withdrawal by Subject|3|||
161700346|NCT02251912|583951167|FG000|Overall Study|Adverse Event|0|||
161700347|NCT02251912|583951168|FG001|Overall Study|Adverse Event|2|||
161700348|NCT04062214|583951170|FG000|Week 12|Death|1|||
161700349|NCT04062214|583951171|FG001|Week 12|Death|1|||
161700350|NCT04062214|583951170|FG000|Week 12|Withdrawal by Subject|14|||
161700351|NCT04062214|583951171|FG001|Week 12|Withdrawal by Subject|13|||
161700352|NCT04062214|583951170|FG000|Week 12|Lost to Follow-up|55|||
161700353|NCT04062214|583951171|FG001|Week 12|Lost to Follow-up|68|||
161700354|NCT04062214|583951170|FG000|Week 12|Intermittent missing|31|||
161700355|NCT04062214|583951171|FG001|Week 12|Intermittent missing|29|||
161700356|NCT04062214|583951170|FG000|Week 36|Withdrawal by Subject|4|||
161700357|NCT04062214|583951171|FG001|Week 36|Withdrawal by Subject|5|||
161700358|NCT04062214|583951170|FG000|Week 36|Lost to Follow-up|50|||
161700359|NCT04062214|583951171|FG001|Week 36|Lost to Follow-up|46|||
161700360|NCT04062214|583951170|FG000|Week 36|Death|0|||
161700361|NCT04062214|583951171|FG001|Week 36|Death|1|||
161700362|NCT06228586|583951178|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
161700363|NCT06228586|583951179|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
161700364|NCT00865020|583951190|FG000|Overall Study|Withdrawal by Subject|22|||
161700365|NCT00865020|583951191|FG001|Overall Study|Withdrawal by Subject|16|||
161700366|NCT00865020|583951190|FG000|Overall Study|Adverse Event|9|||
161700367|NCT00865020|583951191|FG001|Overall Study|Adverse Event|14|||
161700368|NCT00865020|583951190|FG000|Overall Study|Abnormal test procedure result(s)|6|||
161700369|NCT00865020|583951191|FG001|Overall Study|Abnormal test procedure result(s)|8|||
161700370|NCT00865020|583951190|FG000|Overall Study|Lost to Follow-up|6|||
161700371|NCT00865020|583951191|FG001|Overall Study|Lost to Follow-up|4|||
161700372|NCT00865020|583951190|FG000|Overall Study|Protocol deviation|4|||
161700373|NCT00865020|583951191|FG001|Overall Study|Protocol deviation|1|||
161836890|NCT01045421|584446482|FG001|Phase 1|Progressive Disease|0|||
161836891|NCT01045421|584446483|FG002|Phase 1|Progressive Disease|0|||
161836892|NCT01045421|584446484|FG003|Phase 1|Progressive Disease|0|||
161700374|NCT00865020|583951190|FG000|Overall Study|Administrative problems|0|||
161700375|NCT00865020|583951191|FG001|Overall Study|Administrative problems|2|||
161700376|NCT00865020|583951190|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161700377|NCT00865020|583951191|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161700378|NCT00865020|583951190|FG000|Overall Study|Death|0|||
161700379|NCT00865020|583951191|FG001|Overall Study|Death|1|||
161700380|NCT00865020|583951190|FG000|Overall Study|Randomized but discontinued|2|||
161700381|NCT00865020|583951191|FG001|Overall Study|Randomized but discontinued|4|||
161700382|NCT00132041|583953421|FG000|Baseline|Ineligible|6|||
161700383|NCT00132041|583953421|FG000|3 Months Post Ablation|Transplant|1|||
161836893|NCT01045421|584446485|FG004|Phase 1|Progressive Disease|1|||
161653971|NCT02628028|583782767|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
161653972|NCT02628028|583782768|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
161653973|NCT02628028|583782769|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
161653974|NCT02628028|583782762|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161653975|NCT02628028|583782763|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161653976|NCT02628028|583782764|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161653977|NCT02628028|583782765|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161653978|NCT02628028|583782766|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161653979|NCT02628028|583782767|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
161653980|NCT02628028|583782768|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
161653981|NCT02628028|583782769|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
161653982|NCT02628028|583782762|FG000|Long-term Extension (LTE) Period|Other|0|||
161653983|NCT02628028|583782763|FG001|Long-term Extension (LTE) Period|Other|0|||
161653984|NCT02628028|583782764|FG002|Long-term Extension (LTE) Period|Other|0|||
161653985|NCT02628028|583782765|FG003|Long-term Extension (LTE) Period|Other|0|||
161653986|NCT02628028|583782766|FG004|Long-term Extension (LTE) Period|Other|0|||
161653987|NCT02628028|583782767|FG005|Long-term Extension (LTE) Period|Other|3|||
161653988|NCT02628028|583782768|FG006|Long-term Extension (LTE) Period|Other|4|||
161653989|NCT02628028|583782769|FG007|Long-term Extension (LTE) Period|Other|3|||
161653990|NCT00586612|583782770|FG000|Primary Phase|Protocol Violation|1|||
161653991|NCT00586612|583782771|FG001|Primary Phase|Protocol Violation|0|||
161653992|NCT00586612|583782770|FG000|Primary Phase|Lost to Follow-up|0|||
161653993|NCT00586612|583782771|FG001|Primary Phase|Lost to Follow-up|1|||
161653994|NCT00586612|583782770|FG000|Primary Phase|Withdrawal by Subject|0|||
161653995|NCT00586612|583782771|FG001|Primary Phase|Withdrawal by Subject|2|||
161653996|NCT00586612|583782770|FG000|Booster Phase|Lost to Follow-up|3|||
161653997|NCT00586612|583782771|FG001|Booster Phase|Lost to Follow-up|1|||
161653998|NCT01743989|583782772|FG000|Treatment Phase|Unstable MR4.0|0|||
161653999|NCT01743989|583782773|FG001|Treatment Phase|Unstable MR4.0|6|||
161654000|NCT01743989|583782774|FG002|Treatment Phase|Unstable MR4.0|263|||
161654001|NCT01743989|583782772|FG000|Treatment Phase|Adverse Event|0|||
161654002|NCT01743989|583782773|FG001|Treatment Phase|Adverse Event|4|||
161654003|NCT01743989|583782774|FG002|Treatment Phase|Adverse Event|67|||
161654004|NCT01743989|583782772|FG000|Treatment Phase|Withdrawal by Subject|1|||
161654005|NCT01743989|583782773|FG001|Treatment Phase|Withdrawal by Subject|3|||
161654006|NCT01743989|583782774|FG002|Treatment Phase|Withdrawal by Subject|28|||
161654007|NCT01743989|583782772|FG000|Treatment Phase|Death|0|||
161654008|NCT01743989|583782773|FG001|Treatment Phase|Death|1|||
161700384|NCT00132041|583953421|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
161700385|NCT00132041|583953421|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
161700386|NCT00132041|583953421|FG000|6 Months Post Ablation|Death|2|||
161700387|NCT00132041|583953421|FG000|6 Months Post Ablation|Transplant|6|||
161700388|NCT00132041|583953421|FG000|9 Months Post Ablation|Death|1|||
161700389|NCT00132041|583953421|FG000|9 Months Post Ablation|Transplant|1|||
161700390|NCT00132041|583953421|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
161700391|NCT00132041|583953421|FG000|12 Months Post Ablation|Death|1|||
161700392|NCT00132041|583953421|FG000|12 Months Post Ablation|Transplant|1|||
161700393|NCT00132041|583953421|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
161700394|NCT00132041|583953421|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
161700395|NCT00132041|583953421|FG000|15 Months Post Ablation|Death|1|||
161700396|NCT00132041|583953421|FG000|15 Months Post Ablation|Transplant|5|||
161700397|NCT00132041|583953421|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
161700398|NCT00132041|583953421|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
161700399|NCT00132041|583953421|FG000|18 Months Post Ablation|Transplant|1|||
161700400|NCT00132041|583953421|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
161700401|NCT00132041|583953421|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
161700402|NCT01171820|583953423|FG000|Overall Study|Death|3|||
161700403|NCT01171820|583953424|FG001|Overall Study|Death|3|||
161700404|NCT01171820|583953423|FG000|Overall Study|Lost to Follow-up|0|||
161700405|NCT01171820|583953424|FG001|Overall Study|Lost to Follow-up|1|||
161700406|NCT01171820|583953423|FG000|Overall Study|Withdrawal by Subject|2|||
161700407|NCT01171820|583953424|FG001|Overall Study|Withdrawal by Subject|0|||
161700408|NCT01171820|583953423|FG000|Overall Study|Physician Decision|0|||
161700409|NCT01171820|583953424|FG001|Overall Study|Physician Decision|1|||
161700410|NCT01171820|583953423|FG000|Overall Study|1-Year Missed Visit|1|||
161700411|NCT01171820|583953424|FG001|Overall Study|1-Year Missed Visit|1|||
161700412|NCT03969875|583953425|FG000|Overall Study|did not receive allocated intervention|3|||
161700413|NCT03969875|583953426|FG001|Overall Study|did not receive allocated intervention|3|||
161700414|NCT03969875|583953427|FG002|Overall Study|did not receive allocated intervention|4|||
161700415|NCT03969875|583953425|FG000|Overall Study|Protocol Violation|4|||
161700416|NCT03969875|583953426|FG001|Overall Study|Protocol Violation|2|||
161700417|NCT03969875|583953427|FG002|Overall Study|Protocol Violation|2|||
161700418|NCT00167245|583953428|FG000|Overall Study|Lost to Follow-up|20|||
161700419|NCT00167245|583953429|FG001|Overall Study|Lost to Follow-up|31|||
161700420|NCT00167245|583953428|FG000|Overall Study|Withdrawal by Subject|5|||
161700421|NCT00167245|583953429|FG001|Overall Study|Withdrawal by Subject|8|||
161700422|NCT00167245|583953428|FG000|Overall Study|Incarcerated|3|||
161700423|NCT00167245|583953429|FG001|Overall Study|Incarcerated|2|||
161700424|NCT00167245|583953428|FG000|Overall Study|Drowsy|1|||
161700425|NCT00167245|583953429|FG001|Overall Study|Drowsy|0|||
161700426|NCT01871090|583953430|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
161700427|NCT01871090|583953431|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
161700428|NCT01871090|583953430|FG000|Overall Study|Interrogation not completed correctly|1|||
161700429|NCT01871090|583953431|FG001|Overall Study|Interrogation not completed correctly|0|||
161700430|NCT01871090|583953430|FG000|Overall Study|Subject Non-Compliance|0|||
161700431|NCT01871090|583953431|FG001|Overall Study|Subject Non-Compliance|1|||
161700432|NCT02911688|583953435|FG000|Washout|Lost to Follow-up|1|||
161700433|NCT02911688|583953436|FG001|Washout|Lost to Follow-up|1|||
161700434|NCT02911688|583953435|FG000|Washout|Withdrawal by Subject|0|||
161700435|NCT02911688|583953436|FG001|Washout|Withdrawal by Subject|1|||
161700436|NCT01307033|583953439|FG000|8-week Double-blind Period|Adverse Event|2|||
161700437|NCT01307033|583953440|FG001|8-week Double-blind Period|Adverse Event|0|||
161700438|NCT01307033|583953441|FG002|8-week Double-blind Period|Adverse Event|0|||
161700439|NCT01307033|583953442|FG003|8-week Double-blind Period|Adverse Event|0|||
161700440|NCT01307033|583953439|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
161700441|NCT01307033|583953440|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
161700442|NCT01307033|583953441|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
161700443|NCT01307033|583953442|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
161700444|NCT01307033|583953439|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
161836894|NCT01045421|584446486|FG005|Phase 1|Progressive Disease|0|||
161700445|NCT01307033|583953440|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
161700446|NCT01307033|583953441|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
161700447|NCT01307033|583953442|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
161836895|NCT01045421|584446487|FG006|Phase 1|Progressive Disease|0|||
161700448|NCT01307033|583953439|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161836896|NCT01045421|584446488|FG007|Phase 1|Progressive Disease|0|||
161700449|NCT01307033|583953440|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
161700450|NCT01307033|583953441|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161836897|NCT01045421|584446489|FG008|Phase 1|Progressive Disease|0|||
161700451|NCT01307033|583953442|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161700452|NCT01307033|583953439|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
161700453|NCT01307033|583953440|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
161700454|NCT01307033|583953441|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
161700455|NCT01307033|583953442|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
161700456|NCT01307033|583953439|FG000|44-week Open-label Extension|Adverse Event|0|||
161700457|NCT01307033|583953440|FG001|44-week Open-label Extension|Adverse Event|0|||
161700458|NCT01307033|583953441|FG002|44-week Open-label Extension|Adverse Event|2|||
161700459|NCT01307033|583953442|FG003|44-week Open-label Extension|Adverse Event|1|||
161700460|NCT01307033|583953439|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
161700461|NCT01307033|583953440|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
161700462|NCT01307033|583953441|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
161700463|NCT01307033|583953442|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
161700464|NCT01307033|583953439|FG000|44-week Open-label Extension|Physician Decision|0|||
161700465|NCT01307033|583953440|FG001|44-week Open-label Extension|Physician Decision|0|||
161700466|NCT01307033|583953441|FG002|44-week Open-label Extension|Physician Decision|1|||
161700467|NCT01307033|583953442|FG003|44-week Open-label Extension|Physician Decision|0|||
161700468|NCT01307033|583953439|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161700469|NCT01307033|583953440|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161700470|NCT01307033|583953441|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161700471|NCT01307033|583953442|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
161700472|NCT01307033|583953439|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
161836898|NCT01045421|584446490|FG009|Phase 1|Progressive Disease|0|||
161836899|NCT01045421|584446491|FG010|Phase 1|Progressive Disease|0|||
161836900|NCT01045421|584446481|FG000|Phase 1|Withdrawal by Subject|0|||
161654009|NCT01743989|583782774|FG002|Treatment Phase|Death|3|||
161654010|NCT01743989|583782772|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
161654011|NCT01743989|583782773|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
161654012|NCT01743989|583782774|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
161654013|NCT01743989|583782772|FG000|Treatment Phase|Protocol deviation|0|||
161654014|NCT01743989|583782773|FG001|Treatment Phase|Protocol deviation|0|||
161654015|NCT01743989|583782774|FG002|Treatment Phase|Protocol deviation|3|||
161654016|NCT01743989|583782772|FG000|Treatment Phase|Pregnancy|0|||
161654017|NCT01743989|583782773|FG001|Treatment Phase|Pregnancy|0|||
161654018|NCT01743989|583782774|FG002|Treatment Phase|Pregnancy|2|||
161654019|NCT01743989|583782772|FG000|Treatment Phase|Lost to Follow-up|0|||
161654020|NCT01743989|583782773|FG001|Treatment Phase|Lost to Follow-up|0|||
161654021|NCT01743989|583782774|FG002|Treatment Phase|Lost to Follow-up|2|||
161654022|NCT01743989|583782772|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
161654023|NCT01743989|583782773|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
161654024|NCT01743989|583782774|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
161654025|NCT01743989|583782772|FG000|Treatment Phase|Administrative problems|0|||
161654026|NCT01743989|583782773|FG001|Treatment Phase|Administrative problems|0|||
161654027|NCT01743989|583782774|FG002|Treatment Phase|Administrative problems|1|||
161654028|NCT01743989|583782772|FG000|Treatment Phase|New cancer (CML) therapy|0|||
161654029|NCT01743989|583782773|FG001|Treatment Phase|New cancer (CML) therapy|1|||
161654030|NCT01743989|583782774|FG002|Treatment Phase|New cancer (CML) therapy|0|||
161654031|NCT01743989|583782772|FG000|Treatment Phase|Physician Decision|0|||
161654032|NCT01743989|583782773|FG001|Treatment Phase|Physician Decision|0|||
161654033|NCT01743989|583782774|FG002|Treatment Phase|Physician Decision|3|||
161654034|NCT01743989|583782772|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
161654035|NCT01743989|583782773|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
161654036|NCT01743989|583782774|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
161654037|NCT01743989|583782772|FG000|Treatment Phase|Not randomized by mistake|0|||
161654038|NCT01743989|583782773|FG001|Treatment Phase|Not randomized by mistake|0|||
161654039|NCT01743989|583782774|FG002|Treatment Phase|Not randomized by mistake|1|||
161654040|NCT01743989|583782772|FG000|Treatment Phase|Included by mistake|0|||
161654041|NCT01743989|583782773|FG001|Treatment Phase|Included by mistake|0|||
161654042|NCT01743989|583782774|FG002|Treatment Phase|Included by mistake|1|||
161654043|NCT01743989|583782772|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
161654044|NCT01743989|583782773|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
161654045|NCT01743989|583782774|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
161654046|NCT01743989|583782772|FG000|TFR Phase|Adverse Event|0|||
161654047|NCT01743989|583782773|FG001|TFR Phase|Adverse Event|1|||
161654048|NCT01743989|583782774|FG002|TFR Phase|Adverse Event|0|||
161654049|NCT01743989|583782772|FG000|TFR Phase|Lost to Follow-up|0|||
161654050|NCT01743989|583782773|FG001|TFR Phase|Lost to Follow-up|2|||
161654051|NCT01743989|583782774|FG002|TFR Phase|Lost to Follow-up|0|||
161654052|NCT01743989|583782772|FG000|TFR Phase|Physician Decision|0|||
161654053|NCT01743989|583782773|FG001|TFR Phase|Physician Decision|1|||
161654054|NCT01743989|583782774|FG002|TFR Phase|Physician Decision|0|||
161836901|NCT01045421|584446482|FG001|Phase 1|Withdrawal by Subject|0|||
161654055|NCT01743989|583782772|FG000|TFR Phase|Logistical problems|0|||
161654056|NCT01743989|583782773|FG001|TFR Phase|Logistical problems|2|||
161654057|NCT01743989|583782774|FG002|TFR Phase|Logistical problems|0|||
161654058|NCT01743989|583782772|FG000|TFR Phase|Protocol deviation|0|||
161654059|NCT01743989|583782773|FG001|TFR Phase|Protocol deviation|1|||
161654060|NCT01743989|583782774|FG002|TFR Phase|Protocol deviation|0|||
161654061|NCT01743989|583782772|FG000|TFR Phase|Withdrawal by Subject|0|||
161654062|NCT01743989|583782773|FG001|TFR Phase|Withdrawal by Subject|2|||
161654063|NCT01743989|583782774|FG002|TFR Phase|Withdrawal by Subject|0|||
161654064|NCT01743989|583782772|FG000|Re-treatment Phase|Adverse Event|8|||
161654065|NCT01743989|583782773|FG001|Re-treatment Phase|Adverse Event|4|||
161654066|NCT01743989|583782774|FG002|Re-treatment Phase|Adverse Event|0|||
161654067|NCT01743989|583782772|FG000|Re-treatment Phase|Death|1|||
161654068|NCT01743989|583782773|FG001|Re-treatment Phase|Death|1|||
161654069|NCT01743989|583782774|FG002|Re-treatment Phase|Death|0|||
161654070|NCT01743989|583782772|FG000|Re-treatment Phase|Administrative problems|1|||
161654071|NCT01743989|583782773|FG001|Re-treatment Phase|Administrative problems|1|||
161654072|NCT01743989|583782774|FG002|Re-treatment Phase|Administrative problems|0|||
161654073|NCT01743989|583782772|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
161654074|NCT01743989|583782773|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
161654075|NCT01743989|583782774|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
161654076|NCT01743989|583782772|FG000|Re-treatment Phase|Unstable MR|1|||
161654077|NCT01743989|583782773|FG001|Re-treatment Phase|Unstable MR|0|||
161654078|NCT01743989|583782774|FG002|Re-treatment Phase|Unstable MR|0|||
161654079|NCT01743989|583782772|FG000|Re-treatment Phase|Physician Decision|0|||
161654080|NCT01743989|583782773|FG001|Re-treatment Phase|Physician Decision|1|||
161654081|NCT01743989|583782774|FG002|Re-treatment Phase|Physician Decision|0|||
161654082|NCT01743989|583782772|FG000|Re-treatment Phase|Lost to Follow-up|0|||
161654083|NCT01743989|583782773|FG001|Re-treatment Phase|Lost to Follow-up|1|||
161654084|NCT01743989|583782774|FG002|Re-treatment Phase|Lost to Follow-up|0|||
161654085|NCT02235311|583782777|FG000|Overall Study|Lost to Follow-up|0|||
161654086|NCT02235311|583782778|FG001|Overall Study|Lost to Follow-up|1|||
161654087|NCT02235311|583782777|FG000|Overall Study|Protocol Violation|0|||
161654088|NCT02235311|583782778|FG001|Overall Study|Protocol Violation|1|||
161654089|NCT04655027|583782779|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
161654090|NCT04655027|583782780|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
161654091|NCT00658788|583782781|FG000|Overall Study|Adverse Event|11|||
161654092|NCT00658788|583782781|FG000|Overall Study|Withdrawal by Subject|13|||
161654093|NCT00658788|583782781|FG000|Overall Study|Lost to Follow-up|18|||
161654094|NCT00658788|583782781|FG000|Overall Study|Treatment Discontinuation|32|||
161654095|NCT00653523|583782782|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
161654096|NCT00653523|583782782|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
161654097|NCT00653523|583782782|FG000|Overall Study|Adverse Event|7|||
161654098|NCT00653523|583782782|FG000|Overall Study|Withdrawal by Subject|6|||
161654099|NCT00653523|583782782|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
161654100|NCT00653523|583782782|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
161654101|NCT00186888|583782785|FG000|Overall Study|Toxicity|0|||
161654102|NCT00186888|583782786|FG001|Overall Study|Toxicity|1|||
161654103|NCT00186888|583782787|FG002|Overall Study|Toxicity|0|||
161654104|NCT00186888|583782785|FG000|Overall Study|Relapse or progression of disease|4|||
161654105|NCT00186888|583782786|FG001|Overall Study|Relapse or progression of disease|2|||
161654106|NCT00186888|583782787|FG002|Overall Study|Relapse or progression of disease|0|||
161654107|NCT03006848|583782788|FG000|Overall Study|Adverse Event|1|||
161654108|NCT03006848|583782788|FG000|Overall Study|Physician Decision|1|||
161654109|NCT03006848|583782788|FG000|Overall Study|Lack of Efficacy|16|||
161654110|NCT05543187|583782789|FG000|Overall Study|Ongoing|3|||
161654111|NCT05543187|583782790|FG001|Overall Study|Ongoing|2|||
161654112|NCT04777864|583782791|FG000|Overall Study|Lost to Follow-up|8|||
161654113|NCT04777864|583782792|FG001|Overall Study|Lost to Follow-up|19|||
161654114|NCT03086655|583782793|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
161654115|NCT03086655|583782794|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
161654116|NCT03086655|583782793|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
161654117|NCT03086655|583782794|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
161654118|NCT03086655|583782793|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
161654119|NCT03086655|583782794|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
161654120|NCT03086655|583782793|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
161654121|NCT03086655|583782794|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
161654122|NCT03086655|583782793|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
161654123|NCT03086655|583782794|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
161654124|NCT03086655|583782793|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
161654125|NCT03086655|583782794|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
161654126|NCT03086655|583782793|FG000|12 Month Follow-up = Final Assessment|Death|0|||
161654127|NCT03086655|583782794|FG001|12 Month Follow-up = Final Assessment|Death|1|||
161700473|NCT01307033|583953440|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
161700474|NCT01307033|583953441|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
161700475|NCT01307033|583953442|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
161700476|NCT01307033|583953439|FG000|44-week Open-label Extension|Death|0|||
161700477|NCT01307033|583953440|FG001|44-week Open-label Extension|Death|0|||
161700478|NCT01307033|583953441|FG002|44-week Open-label Extension|Death|0|||
161700479|NCT01307033|583953442|FG003|44-week Open-label Extension|Death|1|||
161700480|NCT01773421|583953444|FG000|Treatment Phase|Other|0|||
161700481|NCT01773421|583953445|FG001|Treatment Phase|Other|0|||
161700482|NCT01773421|583953446|FG002|Treatment Phase|Other|2|||
161700483|NCT01773421|583953447|FG003|Treatment Phase|Other|0|||
161700484|NCT01773421|583953448|FG004|Treatment Phase|Other|0|||
161700485|NCT01773421|583953449|FG005|Treatment Phase|Other|0|||
161700486|NCT01773421|583953450|FG006|Treatment Phase|Other|0|||
161700487|NCT01773421|583953444|FG000|Treatment Phase|Adverse Event|0|||
161700488|NCT01773421|583953445|FG001|Treatment Phase|Adverse Event|0|||
161700489|NCT01773421|583953446|FG002|Treatment Phase|Adverse Event|3|||
161700490|NCT01773421|583953447|FG003|Treatment Phase|Adverse Event|1|||
161700491|NCT01773421|583953448|FG004|Treatment Phase|Adverse Event|0|||
161700492|NCT01773421|583953449|FG005|Treatment Phase|Adverse Event|0|||
161700493|NCT01773421|583953450|FG006|Treatment Phase|Adverse Event|0|||
161700494|NCT01773421|583953444|FG000|Treatment Phase|Withdrawal by Subject|0|||
161700495|NCT01773421|583953445|FG001|Treatment Phase|Withdrawal by Subject|0|||
161700496|NCT01773421|583953446|FG002|Treatment Phase|Withdrawal by Subject|1|||
161700497|NCT01773421|583953447|FG003|Treatment Phase|Withdrawal by Subject|1|||
161700498|NCT01773421|583953448|FG004|Treatment Phase|Withdrawal by Subject|0|||
161700499|NCT01773421|583953449|FG005|Treatment Phase|Withdrawal by Subject|0|||
161700500|NCT01773421|583953450|FG006|Treatment Phase|Withdrawal by Subject|0|||
161700501|NCT01773421|583953444|FG000|Extension Phase|Other|0|||
161700502|NCT01773421|583953445|FG001|Extension Phase|Other|0|||
161700503|NCT01773421|583953446|FG002|Extension Phase|Other|0|||
161700504|NCT01773421|583953447|FG003|Extension Phase|Other|0|||
161700505|NCT01773421|583953448|FG004|Extension Phase|Other|1|||
161700506|NCT01773421|583953449|FG005|Extension Phase|Other|2|||
161700507|NCT01773421|583953450|FG006|Extension Phase|Other|0|||
161700508|NCT01773421|583953444|FG000|Extension Phase|Adverse Event|0|||
161700509|NCT01773421|583953445|FG001|Extension Phase|Adverse Event|0|||
161700510|NCT01773421|583953446|FG002|Extension Phase|Adverse Event|0|||
161700511|NCT01773421|583953447|FG003|Extension Phase|Adverse Event|0|||
161700512|NCT01773421|583953448|FG004|Extension Phase|Adverse Event|2|||
161700513|NCT01773421|583953449|FG005|Extension Phase|Adverse Event|0|||
161700514|NCT01773421|583953450|FG006|Extension Phase|Adverse Event|0|||
161700515|NCT01400932|583953458|FG000|Overall Study|Adverse Event|10|||
161700516|NCT01400932|583953459|FG001|Overall Study|Adverse Event|5|||
161700517|NCT01400932|583953458|FG000|Overall Study|Lack of Efficacy|0|||
161700518|NCT01400932|583953459|FG001|Overall Study|Lack of Efficacy|3|||
161700519|NCT01400932|583953458|FG000|Overall Study|Withdrawal by Subject|2|||
161700520|NCT01400932|583953459|FG001|Overall Study|Withdrawal by Subject|6|||
161700521|NCT01400932|583953458|FG000|Overall Study|Lost to Follow-up|1|||
161700522|NCT01400932|583953459|FG001|Overall Study|Lost to Follow-up|0|||
161700523|NCT01400932|583953458|FG000|Overall Study|Protocol Deviation|0|||
161700524|NCT01400932|583953459|FG001|Overall Study|Protocol Deviation|1|||
161700525|NCT01400932|583953458|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161700526|NCT01400932|583953459|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161700527|NCT00860158|583953460|FG000|Overall Study|Study Terminated|1|||
161700528|NCT00282243|583953463|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
161700529|NCT00282243|583953463|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
161700530|NCT00282243|583953463|FG000|Extension Treatment Period|Adverse Event|15|||
161700531|NCT00282243|583953463|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
161700532|NCT00282243|583953463|FG000|Extension Treatment Period|Non-compliance|2|||
161700533|NCT00282243|583953463|FG000|Extension Treatment Period|Physician Decision|1|||
161700534|NCT00270894|583953464|FG000|Overall Study|Adverse Event|1|||
161700535|NCT00270894|583953464|FG000|Overall Study|Withdrawal by Subject|1|||
161700536|NCT01070329|583953465|FG000|Overall Study|Adverse Event|13|||
161700537|NCT01070329|583953466|FG001|Overall Study|Adverse Event|10|||
161700538|NCT01070329|583953465|FG000|Overall Study|Lost to Follow-up|22|||
161700539|NCT01070329|583953466|FG001|Overall Study|Lost to Follow-up|12|||
161700540|NCT01070329|583953465|FG000|Overall Study|Withdrawal by Subject|9|||
161700541|NCT01070329|583953466|FG001|Overall Study|Withdrawal by Subject|11|||
161700542|NCT01070329|583953465|FG000|Overall Study|Protocol Violation|3|||
161700543|NCT01070329|583953466|FG001|Overall Study|Protocol Violation|8|||
161700544|NCT01070329|583953465|FG000|Overall Study|Lack of Efficacy|2|||
161700545|NCT01070329|583953466|FG001|Overall Study|Lack of Efficacy|6|||
161700546|NCT01070329|583953465|FG000|Overall Study|Physician Decision|2|||
161700547|NCT01070329|583953466|FG001|Overall Study|Physician Decision|1|||
161700548|NCT01070329|583953465|FG000|Overall Study|Entry Criteria Not Met|1|||
161700549|NCT01070329|583953466|FG001|Overall Study|Entry Criteria Not Met|0|||
161700550|NCT01070329|583953465|FG000|Overall Study|Sponsor Decision|0|||
161700551|NCT01070329|583953466|FG001|Overall Study|Sponsor Decision|1|||
161700552|NCT02863848|583953467|FG000|Overall Study|Lost to Follow-up|1|||
161700553|NCT02863848|583953468|FG001|Overall Study|Lost to Follow-up|1|||
161700554|NCT02863848|583953467|FG000|Overall Study|Protocol Violation|1|||
161700555|NCT02863848|583953468|FG001|Overall Study|Protocol Violation|2|||
161836902|NCT01045421|584446483|FG002|Phase 1|Withdrawal by Subject|0|||
161700556|NCT03980938|583953472|FG000|Treatment Period 1|Study Terminated|1|||
161700557|NCT03980938|583953473|FG001|Treatment Period 1|Study Terminated|1|||
161700558|NCT03980938|583953472|FG000|Treatment Period 2|Study Terminated|2|||
161700559|NCT03980938|583953473|FG001|Treatment Period 2|Study Terminated|2|||
161700560|NCT03706365|583953475|FG000|Overall Study|Lost to Follow-up|7|||
161700561|NCT03706365|583953476|FG001|Overall Study|Lost to Follow-up|0|||
161700562|NCT03706365|583953475|FG000|Overall Study|Withdrawal by Subject|17|||
161700563|NCT03706365|583953476|FG001|Overall Study|Withdrawal by Subject|15|||
161700564|NCT03706365|583953475|FG000|Overall Study|On Study Treatment|51|||
161836903|NCT01045421|584446484|FG003|Phase 1|Withdrawal by Subject|1|||
161700565|NCT03706365|583953476|FG001|Overall Study|On Study Treatment|51|||
161700566|NCT00883493|583953477|FG000|Overall Study|Adverse Event|11|||
161700567|NCT00883493|583953478|FG001|Overall Study|Adverse Event|12|||
161700568|NCT00883493|583953477|FG000|Overall Study|Lack of Efficacy|4|||
161700569|NCT00883493|583953478|FG001|Overall Study|Lack of Efficacy|3|||
161700570|NCT00883493|583953477|FG000|Overall Study|Lost to Follow-up|7|||
161700571|NCT00883493|583953478|FG001|Overall Study|Lost to Follow-up|6|||
161700572|NCT00883493|583953477|FG000|Overall Study|Withdrawal by Subject|11|||
161700573|NCT00883493|583953478|FG001|Overall Study|Withdrawal by Subject|20|||
161700574|NCT00883493|583953477|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
161700575|NCT00883493|583953478|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
161700576|NCT00883493|583953477|FG000|Overall Study|Study specific disc. criteria|2|||
161700577|NCT00883493|583953478|FG001|Overall Study|Study specific disc. criteria|0|||
161700578|NCT00883493|583953477|FG000|Overall Study|Other|5|||
161700579|NCT00883493|583953478|FG001|Overall Study|Other|3|||
161700580|NCT04557384|583953479|FG000|Overall Study|Study Terminated by Sponsor|1|||
161700581|NCT04557384|583953479|FG000|Overall Study|Death|1|||
161700582|NCT00168831|583953484|FG000|Overall Study|Adverse Event|36|||
161700583|NCT00168831|583953485|FG001|Overall Study|Adverse Event|47|||
161700584|NCT00168831|583953486|FG002|Overall Study|Adverse Event|74|||
161700585|NCT00168831|583953484|FG000|Overall Study|Lost to Follow-up|5|||
161700586|NCT00168831|583953485|FG001|Overall Study|Lost to Follow-up|6|||
161700587|NCT00168831|583953486|FG002|Overall Study|Lost to Follow-up|4|||
161700588|NCT00168831|583953484|FG000|Overall Study|Withdrawal by Subject|7|||
161700589|NCT00168831|583953485|FG001|Overall Study|Withdrawal by Subject|14|||
161700590|NCT00168831|583953486|FG002|Overall Study|Withdrawal by Subject|19|||
161700591|NCT00168831|583953484|FG000|Overall Study|Protocol Violation|6|||
161700592|NCT00168831|583953485|FG001|Overall Study|Protocol Violation|11|||
161700593|NCT00168831|583953486|FG002|Overall Study|Protocol Violation|11|||
161700594|NCT00168831|583953484|FG000|Overall Study|Other|6|||
161700595|NCT00168831|583953485|FG001|Overall Study|Other|3|||
161700596|NCT00168831|583953486|FG002|Overall Study|Other|6|||
161700597|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
161700598|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
161700599|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
161700600|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161700601|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161700602|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161700603|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
161700604|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161700605|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
161700606|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161700607|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
161700608|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
161700609|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161700610|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
161700611|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161700612|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
161700613|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161700614|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161700615|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161700616|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161836904|NCT01045421|584446485|FG004|Phase 1|Withdrawal by Subject|0|||
161700617|NCT01622569|583953487|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161700618|NCT01622569|583953488|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
161700619|NCT01622569|583953489|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161700620|NCT01622569|583953490|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161700621|NCT01622569|583953487|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161700622|NCT01622569|583953488|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161700623|NCT01622569|583953489|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
161700624|NCT01622569|583953490|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161700625|NCT01622569|583953487|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161700626|NCT01622569|583953488|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161700627|NCT01622569|583953489|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161700628|NCT01622569|583953490|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
161700629|NCT04173741|583953492|FG000|Overall Study|IVC measurement cannot be done|1|||
161700630|NCT04173741|583953493|FG001|Overall Study|IVC measurement cannot be done|1|||
161700631|NCT02522767|583953494|FG000|Double-blind|Withdrawal by Subject|8|||
161700632|NCT02522767|583953495|FG001|Double-blind|Withdrawal by Subject|11|||
161700633|NCT02522767|583953494|FG000|Double-blind|Lost to Follow-up|1|||
161700634|NCT02522767|583953495|FG001|Double-blind|Lost to Follow-up|0|||
161700635|NCT02522767|583953494|FG000|Double-blind|Adverse Event|1|||
161700636|NCT02522767|583953495|FG001|Double-blind|Adverse Event|10|||
161700637|NCT02522767|583953494|FG000|Double-blind|Protocol Violation|0|||
161700638|NCT02522767|583953495|FG001|Double-blind|Protocol Violation|1|||
161700639|NCT02522767|583953494|FG000|Double-blind|Lack of Efficacy|0|||
161700640|NCT02522767|583953495|FG001|Double-blind|Lack of Efficacy|2|||
161700641|NCT02522767|583953494|FG000|Double-blind|Protocol Deviation|1|||
161700642|NCT02522767|583953495|FG001|Double-blind|Protocol Deviation|0|||
161700643|NCT02522767|583953494|FG000|Open-label|Withdrawal by Subject|2|||
161700644|NCT02522767|583953495|FG001|Open-label|Withdrawal by Subject|3|||
161700645|NCT02522767|583953494|FG000|Open-label|Lost to Follow-up|0|||
161700646|NCT02522767|583953495|FG001|Open-label|Lost to Follow-up|1|||
161700647|NCT02522767|583953494|FG000|Open-label|Adverse Event|2|||
161700648|NCT02522767|583953495|FG001|Open-label|Adverse Event|1|||
161700649|NCT02522767|583953494|FG000|Open-label|Lack of Efficacy|1|||
161700650|NCT02522767|583953495|FG001|Open-label|Lack of Efficacy|1|||
161700651|NCT02522767|583953494|FG000|Open-label|Protocol Violation|0|||
161700652|NCT02522767|583953495|FG001|Open-label|Protocol Violation|1|||
161700653|NCT00254566|583953497|FG000|Overall Study|Death|1|||
161700654|NCT00254566|583953498|FG001|Overall Study|Death|0|||
161700655|NCT00254566|583953497|FG000|Overall Study|Adverse Event|5|||
161700656|NCT00254566|583953498|FG001|Overall Study|Adverse Event|4|||
161700657|NCT00254566|583953497|FG000|Overall Study|Lack of Efficacy|12|||
161700658|NCT00254566|583953498|FG001|Overall Study|Lack of Efficacy|9|||
161700659|NCT00254566|583953497|FG000|Overall Study|Other|1|||
161700660|NCT00254566|583953498|FG001|Overall Study|Other|5|||
161700661|NCT00254566|583953497|FG000|Overall Study|Withdrawal by Subject|5|||
161700662|NCT00254566|583953498|FG001|Overall Study|Withdrawal by Subject|6|||
161700663|NCT00254566|583953497|FG000|Overall Study|Lost to Follow-up|7|||
161700664|NCT00254566|583953498|FG001|Overall Study|Lost to Follow-up|2|||
161700665|NCT00059202|583953500|FG000|Overall Study|Withdrawal by Subject|5|||
161700666|NCT00059202|583953501|FG001|Overall Study|Withdrawal by Subject|9|||
161700667|NCT00059202|583953500|FG000|Overall Study|Protocol Violation|1|||
161700668|NCT00059202|583953501|FG001|Overall Study|Protocol Violation|3|||
161700669|NCT00059202|583953500|FG000|Overall Study|drug toxicity|0|||
161700670|NCT00059202|583953501|FG001|Overall Study|drug toxicity|3|||
161700671|NCT00548548|583953504|FG000|Overall Study|Death|345|||
161700672|NCT00548548|583953505|FG001|Overall Study|Death|348|||
161700673|NCT00548548|583953504|FG000|Overall Study|Lost to Follow-up|17|||
161700674|NCT00548548|583953505|FG001|Overall Study|Lost to Follow-up|18|||
161700675|NCT00841763|583953506|FG000|Overall Study|Withdrawal by Subject|60|||
161700676|NCT00841763|583953507|FG001|Overall Study|Withdrawal by Subject|17|||
161700677|NCT00841763|583953508|FG002|Overall Study|Withdrawal by Subject|4|||
161700678|NCT00841763|583953509|FG003|Overall Study|Withdrawal by Subject|1|||
161700679|NCT00841763|583953506|FG000|Overall Study|Adverse Event|9|||
161700680|NCT00841763|583953507|FG001|Overall Study|Adverse Event|10|||
161700681|NCT00841763|583953508|FG002|Overall Study|Adverse Event|3|||
161700682|NCT00841763|583953509|FG003|Overall Study|Adverse Event|2|||
161700683|NCT00841763|583953506|FG000|Overall Study|Lost to Follow-up|63|||
161700684|NCT00841763|583953507|FG001|Overall Study|Lost to Follow-up|25|||
161700685|NCT00841763|583953508|FG002|Overall Study|Lost to Follow-up|0|||
161700686|NCT00841763|583953509|FG003|Overall Study|Lost to Follow-up|0|||
161700687|NCT00841763|583953506|FG000|Overall Study|Protocol Violation|20|||
161700688|NCT00841763|583953507|FG001|Overall Study|Protocol Violation|3|||
161700689|NCT00841763|583953508|FG002|Overall Study|Protocol Violation|1|||
161700690|NCT00841763|583953509|FG003|Overall Study|Protocol Violation|0|||
161700691|NCT00841763|583953506|FG000|Overall Study|Administrative Reasons|3|||
161700692|NCT00841763|583953507|FG001|Overall Study|Administrative Reasons|1|||
161700693|NCT00841763|583953508|FG002|Overall Study|Administrative Reasons|0|||
161700694|NCT00841763|583953509|FG003|Overall Study|Administrative Reasons|0|||
161700695|NCT00841763|583953506|FG000|Overall Study|Unable to Classify|7|||
161700696|NCT00841763|583953507|FG001|Overall Study|Unable to Classify|1|||
161700697|NCT00841763|583953508|FG002|Overall Study|Unable to Classify|0|||
161700698|NCT00841763|583953509|FG003|Overall Study|Unable to Classify|0|||
161700699|NCT00400400|583953510|FG000|Overall Study|Adverse Event|9|||
161700700|NCT00400400|583953511|FG001|Overall Study|Adverse Event|8|||
161700701|NCT00400400|583953510|FG000|Overall Study|Protocol Violation|2|||
161700702|NCT00400400|583953511|FG001|Overall Study|Protocol Violation|0|||
161700703|NCT00400400|583953510|FG000|Overall Study|Withdrawal by Subject|1|||
161700704|NCT00400400|583953511|FG001|Overall Study|Withdrawal by Subject|3|||
161700705|NCT00400400|583953510|FG000|Overall Study|Administrative Problem|1|||
161700706|NCT00400400|583953511|FG001|Overall Study|Administrative Problem|0|||
161700707|NCT00400400|583953510|FG000|Overall Study|Lost to Follow-up|0|||
161700708|NCT00400400|583953511|FG001|Overall Study|Lost to Follow-up|1|||
161700709|NCT00400400|583953510|FG000|Overall Study|Did not receive study drug|1|||
161700710|NCT00400400|583953511|FG001|Overall Study|Did not receive study drug|3|||
161700711|NCT01688050|583953512|FG000|Overall Study|Death|7|||
161700712|NCT01688050|583953512|FG000|Overall Study|Conversion to open repair|1|||
161700713|NCT01688050|583953512|FG000|Overall Study|Lost to Follow-up|13|||
161700714|NCT01688050|583953512|FG000|Overall Study|Withdrawal by Subject|10|||
161700715|NCT01848145|583953513|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
161700716|NCT01848145|583953513|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
161700717|NCT01848145|583953513|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
161700718|NCT01848145|583953513|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
161700719|NCT01848145|583953513|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
161700720|NCT01848145|583953513|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
161700721|NCT01848145|583953513|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
161700722|NCT04426695|583953520|FG000|Overall Study|Death|2|||
161700723|NCT04426695|583953521|FG001|Overall Study|Death|0|||
161700724|NCT04426695|583953522|FG002|Overall Study|Death|1|||
161700725|NCT04426695|583953523|FG003|Overall Study|Death|27|||
161700726|NCT04426695|583953524|FG004|Overall Study|Death|25|||
161700727|NCT04426695|583953525|FG005|Overall Study|Death|21|||
161700728|NCT04426695|583953526|FG006|Overall Study|Death|42|||
161700729|NCT04426695|583953527|FG007|Overall Study|Death|23|||
161700730|NCT04426695|583953528|FG008|Overall Study|Death|37|||
161700731|NCT04426695|583953529|FG009|Overall Study|Death|14|||
161700732|NCT04426695|583953530|FG010|Overall Study|Death|8|||
161700733|NCT04426695|583953531|FG011|Overall Study|Death|7|||
161700734|NCT04426695|583953532|FG012|Overall Study|Death|13|||
161700735|NCT04426695|583953533|FG013|Overall Study|Death|25|||
161700736|NCT04426695|583953534|FG014|Overall Study|Death|19|||
161700737|NCT04426695|583953535|FG015|Overall Study|Death|7|||
161700738|NCT04426695|583953536|FG016|Overall Study|Death|8|||
161700739|NCT04426695|583953537|FG017|Overall Study|Death|4|||
161700740|NCT04426695|583953520|FG000|Overall Study|Lost to Follow-up|2|||
161700741|NCT04426695|583953521|FG001|Overall Study|Lost to Follow-up|4|||
161700742|NCT04426695|583953522|FG002|Overall Study|Lost to Follow-up|1|||
161700743|NCT04426695|583953523|FG003|Overall Study|Lost to Follow-up|19|||
161700744|NCT04426695|583953524|FG004|Overall Study|Lost to Follow-up|10|||
161700745|NCT04426695|583953525|FG005|Overall Study|Lost to Follow-up|14|||
161700746|NCT04426695|583953526|FG006|Overall Study|Lost to Follow-up|5|||
161700747|NCT04426695|583953527|FG007|Overall Study|Lost to Follow-up|14|||
161700748|NCT04426695|583953528|FG008|Overall Study|Lost to Follow-up|10|||
161700749|NCT04426695|583953529|FG009|Overall Study|Lost to Follow-up|11|||
161700750|NCT04426695|583953530|FG010|Overall Study|Lost to Follow-up|12|||
161700751|NCT04426695|583953531|FG011|Overall Study|Lost to Follow-up|6|||
161700752|NCT04426695|583953532|FG012|Overall Study|Lost to Follow-up|2|||
161700753|NCT04426695|583953533|FG013|Overall Study|Lost to Follow-up|2|||
161700754|NCT04426695|583953534|FG014|Overall Study|Lost to Follow-up|2|||
161836905|NCT01045421|584446486|FG005|Phase 1|Withdrawal by Subject|0|||
161700755|NCT04426695|583953535|FG015|Overall Study|Lost to Follow-up|0|||
161700756|NCT04426695|583953536|FG016|Overall Study|Lost to Follow-up|0|||
161700757|NCT04426695|583953537|FG017|Overall Study|Lost to Follow-up|0|||
161700758|NCT04426695|583953520|FG000|Overall Study|Participant Decision|1|||
161700759|NCT04426695|583953521|FG001|Overall Study|Participant Decision|2|||
161700760|NCT04426695|583953522|FG002|Overall Study|Participant Decision|2|||
161700761|NCT04426695|583953523|FG003|Overall Study|Participant Decision|12|||
161700762|NCT04426695|583953524|FG004|Overall Study|Participant Decision|18|||
161836906|NCT01045421|584446487|FG006|Phase 1|Withdrawal by Subject|0|||
161836907|NCT01045421|584446488|FG007|Phase 1|Withdrawal by Subject|0|||
161700763|NCT04426695|583953525|FG005|Overall Study|Participant Decision|22|||
161700764|NCT04426695|583953526|FG006|Overall Study|Participant Decision|13|||
161700765|NCT04426695|583953527|FG007|Overall Study|Participant Decision|13|||
161700766|NCT04426695|583953528|FG008|Overall Study|Participant Decision|10|||
161700767|NCT04426695|583953529|FG009|Overall Study|Participant Decision|15|||
161700768|NCT04426695|583953530|FG010|Overall Study|Participant Decision|16|||
161700769|NCT04426695|583953531|FG011|Overall Study|Participant Decision|17|||
161700770|NCT04426695|583953532|FG012|Overall Study|Participant Decision|2|||
161700771|NCT04426695|583953533|FG013|Overall Study|Participant Decision|1|||
161700772|NCT04426695|583953534|FG014|Overall Study|Participant Decision|2|||
161700773|NCT04426695|583953535|FG015|Overall Study|Participant Decision|0|||
161700774|NCT04426695|583953536|FG016|Overall Study|Participant Decision|0|||
161700775|NCT04426695|583953537|FG017|Overall Study|Participant Decision|0|||
161700776|NCT04426695|583953520|FG000|Overall Study|Adverse Event|0|||
161700777|NCT04426695|583953521|FG001|Overall Study|Adverse Event|0|||
161700778|NCT04426695|583953522|FG002|Overall Study|Adverse Event|0|||
161700779|NCT04426695|583953523|FG003|Overall Study|Adverse Event|0|||
161700780|NCT04426695|583953524|FG004|Overall Study|Adverse Event|0|||
161700781|NCT04426695|583953525|FG005|Overall Study|Adverse Event|0|||
161700782|NCT04426695|583953526|FG006|Overall Study|Adverse Event|0|||
161700783|NCT04426695|583953527|FG007|Overall Study|Adverse Event|1|||
161700784|NCT04426695|583953528|FG008|Overall Study|Adverse Event|0|||
161700785|NCT04426695|583953529|FG009|Overall Study|Adverse Event|0|||
161700786|NCT04426695|583953530|FG010|Overall Study|Adverse Event|1|||
161700787|NCT04426695|583953531|FG011|Overall Study|Adverse Event|1|||
161700788|NCT04426695|583953532|FG012|Overall Study|Adverse Event|0|||
161700789|NCT04426695|583953533|FG013|Overall Study|Adverse Event|0|||
161700790|NCT04426695|583953534|FG014|Overall Study|Adverse Event|0|||
161700791|NCT04426695|583953535|FG015|Overall Study|Adverse Event|0|||
161700792|NCT04426695|583953536|FG016|Overall Study|Adverse Event|0|||
161700793|NCT04426695|583953537|FG017|Overall Study|Adverse Event|0|||
161700794|NCT04426695|583953520|FG000|Overall Study|Sponsor Request|0|||
161700795|NCT04426695|583953521|FG001|Overall Study|Sponsor Request|0|||
161700796|NCT04426695|583953522|FG002|Overall Study|Sponsor Request|0|||
161700797|NCT04426695|583953523|FG003|Overall Study|Sponsor Request|0|||
161700798|NCT04426695|583953524|FG004|Overall Study|Sponsor Request|0|||
161700799|NCT04426695|583953525|FG005|Overall Study|Sponsor Request|0|||
161700800|NCT04426695|583953526|FG006|Overall Study|Sponsor Request|1|||
161700801|NCT04426695|583953527|FG007|Overall Study|Sponsor Request|0|||
161700802|NCT04426695|583953528|FG008|Overall Study|Sponsor Request|0|||
161700803|NCT04426695|583953529|FG009|Overall Study|Sponsor Request|0|||
161700804|NCT04426695|583953530|FG010|Overall Study|Sponsor Request|0|||
161700805|NCT04426695|583953531|FG011|Overall Study|Sponsor Request|0|||
161700806|NCT04426695|583953532|FG012|Overall Study|Sponsor Request|0|||
161700807|NCT04426695|583953533|FG013|Overall Study|Sponsor Request|0|||
161700808|NCT04426695|583953534|FG014|Overall Study|Sponsor Request|0|||
161700809|NCT04426695|583953535|FG015|Overall Study|Sponsor Request|0|||
161700810|NCT04426695|583953536|FG016|Overall Study|Sponsor Request|0|||
161700811|NCT04426695|583953537|FG017|Overall Study|Sponsor Request|0|||
161700812|NCT04426695|583953520|FG000|Overall Study|Physician Decision|0|||
161700813|NCT04426695|583953521|FG001|Overall Study|Physician Decision|0|||
161700814|NCT04426695|583953522|FG002|Overall Study|Physician Decision|0|||
161700815|NCT04426695|583953523|FG003|Overall Study|Physician Decision|0|||
161700816|NCT04426695|583953524|FG004|Overall Study|Physician Decision|0|||
161700817|NCT04426695|583953525|FG005|Overall Study|Physician Decision|0|||
161700818|NCT04426695|583953526|FG006|Overall Study|Physician Decision|0|||
161700819|NCT04426695|583953527|FG007|Overall Study|Physician Decision|0|||
161700820|NCT04426695|583953528|FG008|Overall Study|Physician Decision|0|||
161700821|NCT04426695|583953529|FG009|Overall Study|Physician Decision|1|||
161700822|NCT04426695|583953530|FG010|Overall Study|Physician Decision|0|||
161700823|NCT04426695|583953531|FG011|Overall Study|Physician Decision|0|||
161700824|NCT04426695|583953532|FG012|Overall Study|Physician Decision|1|||
161700825|NCT04426695|583953533|FG013|Overall Study|Physician Decision|0|||
161700826|NCT04426695|583953534|FG014|Overall Study|Physician Decision|0|||
161700827|NCT04426695|583953535|FG015|Overall Study|Physician Decision|0|||
161700828|NCT04426695|583953536|FG016|Overall Study|Physician Decision|0|||
161700829|NCT04426695|583953537|FG017|Overall Study|Physician Decision|0|||
161700830|NCT04426695|583953520|FG000|Overall Study|Randomized but Never Treated|3|||
161700831|NCT04426695|583953521|FG001|Overall Study|Randomized but Never Treated|1|||
161700832|NCT04426695|583953522|FG002|Overall Study|Randomized but Never Treated|0|||
161700833|NCT04426695|583953523|FG003|Overall Study|Randomized but Never Treated|4|||
161700834|NCT04426695|583953524|FG004|Overall Study|Randomized but Never Treated|5|||
161700835|NCT04426695|583953525|FG005|Overall Study|Randomized but Never Treated|5|||
161700836|NCT04426695|583953526|FG006|Overall Study|Randomized but Never Treated|4|||
161700837|NCT04426695|583953527|FG007|Overall Study|Randomized but Never Treated|6|||
161700838|NCT04426695|583953528|FG008|Overall Study|Randomized but Never Treated|6|||
161700839|NCT04426695|583953529|FG009|Overall Study|Randomized but Never Treated|3|||
161700840|NCT04426695|583953530|FG010|Overall Study|Randomized but Never Treated|3|||
161700841|NCT04426695|583953531|FG011|Overall Study|Randomized but Never Treated|6|||
161700842|NCT04426695|583953532|FG012|Overall Study|Randomized but Never Treated|1|||
161836908|NCT01045421|584446489|FG008|Phase 1|Withdrawal by Subject|0|||
161836909|NCT01045421|584446490|FG009|Phase 1|Withdrawal by Subject|0|||
161700843|NCT04426695|583953533|FG013|Overall Study|Randomized but Never Treated|2|||
161700844|NCT04426695|583953534|FG014|Overall Study|Randomized but Never Treated|0|||
161700845|NCT04426695|583953535|FG015|Overall Study|Randomized but Never Treated|0|||
161700846|NCT04426695|583953536|FG016|Overall Study|Randomized but Never Treated|0|||
161700847|NCT04426695|583953537|FG017|Overall Study|Randomized but Never Treated|0|||
161700848|NCT04303000|583953538|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
161700849|NCT04303000|583953539|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
161700850|NCT04303000|583953540|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
161700851|NCT03118947|583953543|FG000|Overall Study|Adverse Event|7|||
161700852|NCT03118947|583953543|FG000|Overall Study|Death|3|||
161700853|NCT03118947|583953543|FG000|Overall Study|Lack of Efficacy|4|||
161700854|NCT03118947|583953543|FG000|Overall Study|Non-compliance with study drug|1|||
161700855|NCT03118947|583953543|FG000|Overall Study|Protocol Violation|2|||
161700856|NCT03118947|583953543|FG000|Overall Study|Withdrawal by Subject|3|||
161700857|NCT03118947|583953543|FG000|Overall Study|Withdrawal by caregiver|3|||
161700858|NCT03118947|583953543|FG000|Overall Study|Change in patient's living situation|4|||
161700859|NCT03118947|583953543|FG000|Overall Study|Lost to Follow-up|2|||
161700860|NCT02769624|583953544|FG000|Overall Study|Lost to Follow-up|0|||
161700861|NCT02769624|583953545|FG001|Overall Study|Lost to Follow-up|1|||
161700862|NCT01987908|583953554|FG000|Placebo Lead-in Period|Adverse Event|2|||
161700863|NCT01987908|583953555|FG001|Placebo Lead-in Period|Adverse Event|0|||
161700864|NCT01987908|583953556|FG002|Placebo Lead-in Period|Adverse Event|0|||
161700865|NCT01987908|583953554|FG000|Placebo Lead-in Period|Physician Decision|2|||
161700866|NCT01987908|583953555|FG001|Placebo Lead-in Period|Physician Decision|0|||
161700867|NCT01987908|583953556|FG002|Placebo Lead-in Period|Physician Decision|0|||
161700868|NCT01987908|583953554|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
161836910|NCT01045421|584446491|FG010|Phase 1|Withdrawal by Subject|0|||
161836911|NCT01045421|584446481|FG000|Phase 2|Progressive Disease|0|||
161700869|NCT01987908|583953555|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
161700870|NCT01987908|583953556|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
161700871|NCT01987908|583953554|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
161700872|NCT01987908|583953555|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
161700873|NCT01987908|583953556|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
161700874|NCT01987908|583953554|FG000|Treatment Period|Adverse Event|0|||
161700875|NCT01987908|583953555|FG001|Treatment Period|Adverse Event|1|||
161700876|NCT01987908|583953556|FG002|Treatment Period|Adverse Event|1|||
161700877|NCT01987908|583953554|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
161700878|NCT01987908|583953555|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
161700879|NCT01987908|583953556|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
161700880|NCT01987908|583953554|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
161700881|NCT01987908|583953555|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
161700882|NCT01987908|583953556|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
161700883|NCT01869348|583953557|FG000|Overall Study|Withdrawal by Subject|1|||
161700884|NCT01869348|583953558|FG001|Overall Study|Withdrawal by Subject|1|||
161700885|NCT02789657|583953560|FG000|Overall Study|Withdrawal by Subject|2|||
161700886|NCT02789657|583953561|FG001|Overall Study|Withdrawal by Subject|0|||
161700887|NCT02789657|583953562|FG002|Overall Study|Withdrawal by Subject|0|||
161700888|NCT02789657|583953563|FG003|Overall Study|Withdrawal by Subject|0|||
161700889|NCT01728779|583953564|FG000|Overall Study|Withdrawal by Subject|1|||
161700890|NCT00448708|583953565|FG000|Overall Study|Death|21|||
161700891|NCT00448708|583953566|FG001|Overall Study|Death|17|||
161700892|NCT00448708|583953565|FG000|Overall Study|Withdrawal by Subject|8|||
161700893|NCT00448708|583953566|FG001|Overall Study|Withdrawal by Subject|4|||
161700894|NCT00448708|583953565|FG000|Overall Study|Lost to Follow-up|6|||
161836912|NCT01045421|584446482|FG001|Phase 2|Progressive Disease|0|||
161836913|NCT01045421|584446483|FG002|Phase 2|Progressive Disease|0|||
161836914|NCT01045421|584446484|FG003|Phase 2|Progressive Disease|0|||
161700895|NCT00448708|583953566|FG001|Overall Study|Lost to Follow-up|8|||
161700896|NCT00448708|583953565|FG000|Overall Study|not listed|0|||
161700897|NCT00448708|583953566|FG001|Overall Study|not listed|2|||
161836915|NCT01045421|584446485|FG004|Phase 2|Progressive Disease|0|||
161836916|NCT01045421|584446486|FG005|Phase 2|Progressive Disease|0|||
161836917|NCT01045421|584446487|FG006|Phase 2|Progressive Disease|0|||
161836918|NCT01045421|584446488|FG007|Phase 2|Progressive Disease|1|||
161836919|NCT01045421|584446489|FG008|Phase 2|Progressive Disease|1|||
161836920|NCT01045421|584446490|FG009|Phase 2|Progressive Disease|1|||
161836921|NCT01045421|584446491|FG010|Phase 2|Progressive Disease|1|||
161836922|NCT01045421|584446481|FG000|Phase 2|Death|0|||
161836923|NCT01045421|584446482|FG001|Phase 2|Death|0|||
161836924|NCT01045421|584446483|FG002|Phase 2|Death|0|||
161836925|NCT01045421|584446484|FG003|Phase 2|Death|0|||
161836926|NCT01045421|584446485|FG004|Phase 2|Death|0|||
161836927|NCT01045421|584446486|FG005|Phase 2|Death|0|||
161836928|NCT01045421|584446487|FG006|Phase 2|Death|0|||
161836929|NCT01045421|584446488|FG007|Phase 2|Death|1|||
161836930|NCT01045421|584446489|FG008|Phase 2|Death|1|||
161836931|NCT01045421|584446490|FG009|Phase 2|Death|2|||
161836932|NCT01045421|584446491|FG010|Phase 2|Death|0|||
161836933|NCT01045421|584446481|FG000|Phase 2|Other|0|||
161836934|NCT01045421|584446482|FG001|Phase 2|Other|0|||
161836935|NCT01045421|584446483|FG002|Phase 2|Other|0|||
161836936|NCT01045421|584446484|FG003|Phase 2|Other|0|||
161836937|NCT01045421|584446485|FG004|Phase 2|Other|0|||
161836938|NCT01045421|584446486|FG005|Phase 2|Other|0|||
161836939|NCT01045421|584446487|FG006|Phase 2|Other|0|||
161836940|NCT01045421|584446488|FG007|Phase 2|Other|3|||
161836941|NCT01045421|584446489|FG008|Phase 2|Other|0|||
161836942|NCT01045421|584446490|FG009|Phase 2|Other|0|||
161836943|NCT01045421|584446491|FG010|Phase 2|Other|1|||
161836944|NCT03340064|584446492|FG000|First Period|Adverse Event, non-fatal|2|||
161836945|NCT03340064|584446493|FG001|First Period|Adverse Event, non-fatal|0|||
161836946|NCT03340064|584446492|FG000|First Period|Lack of Efficacy|3|||
161836947|NCT03340064|584446493|FG001|First Period|Lack of Efficacy|0|||
161836948|NCT03340064|584446492|FG000|Second Period|Adverse Event, non-fatal|1|||
161836949|NCT03340064|584446493|FG001|Second Period|Adverse Event, non-fatal|1|||
161836950|NCT03340064|584446492|FG000|Second Period|Lack of Efficacy|11|||
161836951|NCT03340064|584446493|FG001|Second Period|Lack of Efficacy|0|||
161836952|NCT03340064|584446492|FG000|Second Period|Physician Decision|3|||
161700898|NCT01925209|583953567|FG000|Treatment Epoch|Physician Decision|1|||
161700899|NCT01925209|583953568|FG001|Treatment Epoch|Physician Decision|0|||
161700900|NCT01925209|583953569|FG002|Treatment Epoch|Physician Decision|0|||
161700901|NCT01925209|583953570|FG003|Treatment Epoch|Physician Decision|0|||
161836953|NCT03340064|584446493|FG001|Second Period|Physician Decision|0|||
161836954|NCT03340064|584446492|FG000|Second Period|Withdrawal by Subject|2|||
161836955|NCT03340064|584446493|FG001|Second Period|Withdrawal by Subject|1|||
161836956|NCT03340064|584446492|FG000|Second Period|Approved Drug Available For Indication|1|||
161836957|NCT03340064|584446493|FG001|Second Period|Approved Drug Available For Indication|0|||
161836958|NCT03340064|584446492|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
161836959|NCT03340064|584446493|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
161836960|NCT00856973|584446494|FG000|Overall Study|Adverse Event|5|||
161836961|NCT00856973|584446495|FG001|Overall Study|Adverse Event|5|||
161836962|NCT00856973|584446496|FG002|Overall Study|Adverse Event|3|||
161836963|NCT00856973|584446494|FG000|Overall Study|Lost to Follow-up|6|||
161836964|NCT00856973|584446495|FG001|Overall Study|Lost to Follow-up|3|||
161836965|NCT00856973|584446496|FG002|Overall Study|Lost to Follow-up|5|||
161836966|NCT00856973|584446494|FG000|Overall Study|Physician Decision|0|||
161836967|NCT00856973|584446495|FG001|Overall Study|Physician Decision|3|||
161836968|NCT00856973|584446496|FG002|Overall Study|Physician Decision|1|||
161836969|NCT00856973|584446494|FG000|Overall Study|Protocol Violation|1|||
161836970|NCT00856973|584446495|FG001|Overall Study|Protocol Violation|2|||
161836971|NCT00856973|584446496|FG002|Overall Study|Protocol Violation|1|||
161836972|NCT00856973|584446494|FG000|Overall Study|Withdrawal by Subject|13|||
161836973|NCT00856973|584446495|FG001|Overall Study|Withdrawal by Subject|16|||
161836974|NCT00856973|584446496|FG002|Overall Study|Withdrawal by Subject|15|||
161836975|NCT00856973|584446494|FG000|Overall Study|Other|11|||
161836976|NCT00856973|584446495|FG001|Overall Study|Other|12|||
161836977|NCT00856973|584446496|FG002|Overall Study|Other|13|||
161836978|NCT03955471|584446497|FG000|Overall Study|Death|22|||
161836979|NCT03955471|584446497|FG000|Overall Study|Lost to Follow-up|1|||
161836980|NCT03955471|584446497|FG000|Overall Study|Withdrawal by Subject|6|||
161836981|NCT03955471|584446497|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
161836982|NCT01030341|584446498|FG000|Overall Study|Withdrawal by Subject|1|||
161836983|NCT01030341|584446498|FG000|Overall Study|Lost to Follow-up|2|||
161836984|NCT01884311|584446499|FG000|Overall Study|Withdrawal by Subject|3|||
161836985|NCT01884311|584446499|FG000|Overall Study|withdrew consent due to AEs|1|||
161836986|NCT01884311|584446499|FG000|Overall Study|Precautionary measure|1|||
161836987|NCT03853148|584446501|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
161836988|NCT03853148|584446502|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
161836989|NCT03853148|584446503|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
161836990|NCT03853148|584446504|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
161836991|NCT00090610|584446505|FG000|Overall Study|Withdrawal by Subject|1|||
161836992|NCT00090610|584446506|FG001|Overall Study|Withdrawal by Subject|1|||
161836993|NCT03623386|584446509|FG000|Overall Study|Protocol Violation|3|||
161836994|NCT03623386|584446510|FG001|Overall Study|Protocol Violation|2|||
161836995|NCT03623386|584446511|FG002|Overall Study|Protocol Violation|0|||
161836996|NCT03623386|584446509|FG000|Overall Study|Physician Decision|1|||
161836997|NCT03623386|584446510|FG001|Overall Study|Physician Decision|1|||
161836998|NCT03623386|584446511|FG002|Overall Study|Physician Decision|0|||
161836999|NCT03623386|584446509|FG000|Overall Study|Lost to Follow-up|0|||
161837000|NCT03623386|584446510|FG001|Overall Study|Lost to Follow-up|2|||
161837001|NCT03623386|584446511|FG002|Overall Study|Lost to Follow-up|0|||
161837002|NCT03623386|584446509|FG000|Overall Study|COVID-19|0|||
161837003|NCT03623386|584446510|FG001|Overall Study|COVID-19|1|||
161837004|NCT03623386|584446511|FG002|Overall Study|COVID-19|0|||
161837005|NCT00599521|584446514|FG000|Overall Study|Lack of Efficacy|4|||
161837006|NCT00599521|584446515|FG001|Overall Study|Lack of Efficacy|8|||
161837007|NCT00599521|584446514|FG000|Overall Study|Adverse Event|4|||
161837008|NCT00599521|584446515|FG001|Overall Study|Adverse Event|1|||
161837009|NCT00599521|584446514|FG000|Overall Study|Withdrawal by Subject|28|||
161837010|NCT00599521|584446515|FG001|Overall Study|Withdrawal by Subject|34|||
161837011|NCT00599521|584446514|FG000|Overall Study|Protocol Violation|1|||
161837012|NCT00599521|584446515|FG001|Overall Study|Protocol Violation|1|||
161837013|NCT00599521|584446514|FG000|Overall Study|Lost to Follow-up|23|||
161837014|NCT00599521|584446515|FG001|Overall Study|Lost to Follow-up|23|||
161837015|NCT00599521|584446514|FG000|Overall Study|Pregnancy|0|||
161837016|NCT00599521|584446515|FG001|Overall Study|Pregnancy|2|||
161700902|NCT01925209|583953567|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
161700903|NCT01925209|583953568|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
161700904|NCT01925209|583953569|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
161700905|NCT01925209|583953570|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
161700906|NCT01925209|583953567|FG000|Treatment Epoch|Death|1|||
161700907|NCT01925209|583953568|FG001|Treatment Epoch|Death|0|||
161700908|NCT01925209|583953569|FG002|Treatment Epoch|Death|0|||
161700909|NCT01925209|583953570|FG003|Treatment Epoch|Death|0|||
161700910|NCT01925209|583953567|FG000|Treatment Epoch|Protocol deviation|0|||
161700911|NCT01925209|583953568|FG001|Treatment Epoch|Protocol deviation|0|||
161700912|NCT01925209|583953569|FG002|Treatment Epoch|Protocol deviation|1|||
161700913|NCT01925209|583953570|FG003|Treatment Epoch|Protocol deviation|1|||
161700914|NCT01925209|583953567|FG000|Treatment Epoch|Withdrawal by Subject|4|||
161700915|NCT01925209|583953568|FG001|Treatment Epoch|Withdrawal by Subject|3|||
161700916|NCT01925209|583953569|FG002|Treatment Epoch|Withdrawal by Subject|3|||
161700917|NCT01925209|583953570|FG003|Treatment Epoch|Withdrawal by Subject|2|||
161700918|NCT01925209|583953567|FG000|Treatment Epoch|Adverse Event|3|||
161700919|NCT01925209|583953568|FG001|Treatment Epoch|Adverse Event|5|||
161700920|NCT01925209|583953569|FG002|Treatment Epoch|Adverse Event|3|||
161700921|NCT01925209|583953570|FG003|Treatment Epoch|Adverse Event|1|||
161700922|NCT01925209|583953567|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
161700923|NCT01925209|583953568|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
161700924|NCT01925209|583953569|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
161700925|NCT01925209|583953570|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
161700926|NCT01925209|583953567|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
161700927|NCT01925209|583953568|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
161700928|NCT01925209|583953569|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
161700929|NCT01925209|583953570|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
161700930|NCT01925209|583953567|FG000|Follow-up|Adverse Event|1|||
161700931|NCT01925209|583953568|FG001|Follow-up|Adverse Event|4|||
161700932|NCT01925209|583953569|FG002|Follow-up|Adverse Event|0|||
161700933|NCT01925209|583953570|FG003|Follow-up|Adverse Event|1|||
161700934|NCT01925209|583953567|FG000|Follow-up|Physician Decision|0|||
161700935|NCT01925209|583953568|FG001|Follow-up|Physician Decision|0|||
161700936|NCT01925209|583953569|FG002|Follow-up|Physician Decision|1|||
161700937|NCT01925209|583953570|FG003|Follow-up|Physician Decision|0|||
161700938|NCT01925209|583953567|FG000|Follow-up|Non-compliance with study treatment|0|||
161700939|NCT01925209|583953568|FG001|Follow-up|Non-compliance with study treatment|0|||
161700940|NCT01925209|583953569|FG002|Follow-up|Non-compliance with study treatment|0|||
161700941|NCT01925209|583953570|FG003|Follow-up|Non-compliance with study treatment|1|||
161700942|NCT01925209|583953567|FG000|Follow-up|Withdrawal by Subject|0|||
161700943|NCT01925209|583953568|FG001|Follow-up|Withdrawal by Subject|2|||
161700944|NCT01925209|583953569|FG002|Follow-up|Withdrawal by Subject|0|||
161700945|NCT01925209|583953570|FG003|Follow-up|Withdrawal by Subject|2|||
161700946|NCT01299727|583953571|FG000|Overall Study|Withdrawal by Subject|1|||
161700947|NCT01299727|583953572|FG001|Overall Study|Withdrawal by Subject|0|||
161700948|NCT01299727|583953573|FG002|Overall Study|Withdrawal by Subject|0|||
161700949|NCT01299727|583953571|FG000|Overall Study|Adverse Event|0|||
161700950|NCT01299727|583953572|FG001|Overall Study|Adverse Event|0|||
161700951|NCT01299727|583953573|FG002|Overall Study|Adverse Event|1|||
161700952|NCT01299727|583953571|FG000|Overall Study|Completed the Treatment Period|3|||
161700953|NCT01299727|583953572|FG001|Overall Study|Completed the Treatment Period|4|||
161700954|NCT01299727|583953573|FG002|Overall Study|Completed the Treatment Period|3|||
161700955|NCT03882424|583953575|FG000|Overall Study|Lost to Follow-up|3|||
161700956|NCT03882424|583953576|FG001|Overall Study|Lost to Follow-up|0|||
161700957|NCT03882424|583953577|FG002|Overall Study|Lost to Follow-up|0|||
161700958|NCT03882424|583953575|FG000|Overall Study|schedule conflict|1|||
161700959|NCT03882424|583953576|FG001|Overall Study|schedule conflict|0|||
161700960|NCT03882424|583953577|FG002|Overall Study|schedule conflict|0|||
161700961|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Adverse Event|21|||
161700962|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Adverse Event|6|||
161700963|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
161700964|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
161700965|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
161700966|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
161700967|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
161700968|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
161700969|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Physician Decision|0|||
161700970|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Physician Decision|3|||
161700971|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
161700972|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
161700973|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
161700974|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
161700975|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Subject Decision|26|||
161700976|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Subject Decision|28|||
161700977|NCT00510276|583953587|FG000|Extension Open-Label Phase|Adverse Event|9|||
161700978|NCT00510276|583953588|FG001|Extension Open-Label Phase|Adverse Event|18|||
161700979|NCT00510276|583953587|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
161700980|NCT00510276|583953588|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
161700981|NCT00510276|583953587|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
161700982|NCT00510276|583953588|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
161700983|NCT00510276|583953587|FG000|Extension Open-Label Phase|Physician Decision|2|||
161700984|NCT00510276|583953588|FG001|Extension Open-Label Phase|Physician Decision|3|||
161700985|NCT00510276|583953587|FG000|Extension Open-Label Phase|Protocol Violation|0|||
161700986|NCT00510276|583953588|FG001|Extension Open-Label Phase|Protocol Violation|1|||
161700987|NCT00510276|583953587|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
161700988|NCT00510276|583953588|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
161700989|NCT00510276|583953587|FG000|Extension Open-Label Phase|Subject Decision|7|||
161700990|NCT00510276|583953588|FG001|Extension Open-Label Phase|Subject Decision|9|||
161700991|NCT00441792|583953589|FG000|Overall Study|Lost to Follow-up|0|||
161700992|NCT00441792|583953590|FG001|Overall Study|Lost to Follow-up|2|||
161700993|NCT01731678|583953591|FG000|Overall Study|Withdrawal by Subject|3|||
161700994|NCT01731678|583953591|FG000|Overall Study|Did not meet inclusion criteria|1|||
161700995|NCT01731678|583953591|FG000|Overall Study|RMT too high, making TMS difficult|3|||
161700996|NCT00888355|583953594|FG000|Overall Study|Adverse Event|10|||
161700997|NCT00888355|583953595|FG001|Overall Study|Adverse Event|0|||
161700998|NCT00888355|583953596|FG002|Overall Study|Adverse Event|3|||
161700999|NCT00888355|583953597|FG003|Overall Study|Adverse Event|3|||
161701000|NCT00888355|583953594|FG000|Overall Study|Lack of Efficacy|9|||
161701001|NCT00888355|583953595|FG001|Overall Study|Lack of Efficacy|2|||
161701002|NCT00888355|583953596|FG002|Overall Study|Lack of Efficacy|5|||
161701003|NCT00888355|583953597|FG003|Overall Study|Lack of Efficacy|2|||
161701004|NCT00888355|583953594|FG000|Overall Study|Lost to Follow-up|0|||
161701005|NCT00888355|583953595|FG001|Overall Study|Lost to Follow-up|2|||
161701006|NCT00888355|583953596|FG002|Overall Study|Lost to Follow-up|2|||
161701007|NCT00888355|583953597|FG003|Overall Study|Lost to Follow-up|0|||
161701008|NCT00888355|583953594|FG000|Overall Study|Protocol Violation|3|||
161701009|NCT00888355|583953595|FG001|Overall Study|Protocol Violation|2|||
161701010|NCT00888355|583953596|FG002|Overall Study|Protocol Violation|1|||
161701011|NCT00888355|583953597|FG003|Overall Study|Protocol Violation|2|||
161701012|NCT00888355|583953594|FG000|Overall Study|Withdrawal by Subject|0|||
161701013|NCT00888355|583953595|FG001|Overall Study|Withdrawal by Subject|3|||
161701014|NCT00888355|583953596|FG002|Overall Study|Withdrawal by Subject|1|||
161701015|NCT00888355|583953597|FG003|Overall Study|Withdrawal by Subject|3|||
161701016|NCT04025632|583955512|FG000|Overall Study|Adverse Event|1|||
161701017|NCT04025632|583955513|FG001|Overall Study|Adverse Event|1|||
161701018|NCT04025632|583955512|FG000|Overall Study|Withdrawal by Subject|1|||
161701019|NCT04025632|583955513|FG001|Overall Study|Withdrawal by Subject|1|||
161701020|NCT04025632|583955512|FG000|Overall Study|Study Terminated by Sponsor|10|||
161701021|NCT04025632|583955513|FG001|Overall Study|Study Terminated by Sponsor|9|||
161701022|NCT04025632|583955512|FG000|Overall Study|Physician Decision|3|||
161701023|NCT04025632|583955513|FG001|Overall Study|Physician Decision|1|||
161701024|NCT00376961|583955514|FG000|Initial Registration|Adverse Event|1|||
161701025|NCT00376961|583955515|FG001|Initial Registration|Adverse Event|0|||
161701026|NCT00376961|583955514|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
161701027|NCT00376961|583955515|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161701028|NCT00376961|583955514|FG000|Initial Registration|Progression/relapse|1|||
161701029|NCT00376961|583955515|FG001|Initial Registration|Progression/relapse|0|||
161701030|NCT00376961|583955514|FG000|Initial Registration|Ineligible|3|||
161701031|NCT00376961|583955515|FG001|Initial Registration|Ineligible|0|||
161701032|NCT00376961|583955514|FG000|Maintenance|Adverse Event|0|||
161701033|NCT00376961|583955515|FG001|Maintenance|Adverse Event|1|||
161701034|NCT00376961|583955514|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
161701035|NCT00376961|583955515|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
161701036|NCT00376961|583955514|FG000|Maintenance|Progression/relapse|0|||
161701037|NCT00376961|583955515|FG001|Maintenance|Progression/relapse|18|||
161701038|NCT00376961|583955514|FG000|Maintenance|Ineligible|0|||
161701039|NCT00376961|583955515|FG001|Maintenance|Ineligible|3|||
161701040|NCT02591615|583955522|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161701041|NCT02591615|583955523|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161701042|NCT02591615|583955524|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
161701043|NCT02591615|583955525|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161701044|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161701045|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
161701046|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161701047|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161701048|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
161701049|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
161701050|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
161701051|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
161654128|NCT00384397|583782795|FG000|Overall Study|Adverse Event|0|||
161654129|NCT00384397|583782796|FG001|Overall Study|Adverse Event|1|||
161654130|NCT00384397|583782797|FG002|Overall Study|Adverse Event|2|||
161654131|NCT00384397|583782795|FG000|Overall Study|Protocol Violation|7|||
161654132|NCT00384397|583782796|FG001|Overall Study|Protocol Violation|15|||
161654133|NCT00384397|583782797|FG002|Overall Study|Protocol Violation|13|||
161654134|NCT00384397|583782795|FG000|Overall Study|Lost to Follow-up|11|||
161654135|NCT00384397|583782796|FG001|Overall Study|Lost to Follow-up|13|||
161654136|NCT00384397|583782797|FG002|Overall Study|Lost to Follow-up|3|||
161654137|NCT00384397|583782795|FG000|Overall Study|Withdrawal by Subject|14|||
161654138|NCT00384397|583782796|FG001|Overall Study|Withdrawal by Subject|17|||
161654139|NCT00384397|583782797|FG002|Overall Study|Withdrawal by Subject|15|||
161654140|NCT04531982|583782798|FG000|Overall Study|Withdrawal by Subject|10|||
161654141|NCT04531982|583782799|FG001|Overall Study|Withdrawal by Subject|11|||
161654142|NCT04531982|583782798|FG000|Overall Study|Adverse Event|6|||
161654143|NCT04531982|583782799|FG001|Overall Study|Adverse Event|14|||
161654144|NCT04531982|583782798|FG000|Overall Study|Protocol Violation|6|||
161654145|NCT04531982|583782799|FG001|Overall Study|Protocol Violation|9|||
161654146|NCT04531982|583782798|FG000|Overall Study|Non-compliance with study drug|3|||
161654147|NCT04531982|583782799|FG001|Overall Study|Non-compliance with study drug|2|||
161654148|NCT04531982|583782798|FG000|Overall Study|Use of prohibited medication|2|||
161654149|NCT04531982|583782799|FG001|Overall Study|Use of prohibited medication|0|||
161654150|NCT04531982|583782798|FG000|Overall Study|Lost to Follow-up|0|||
161654151|NCT04531982|583782799|FG001|Overall Study|Lost to Follow-up|1|||
161654152|NCT04531982|583782798|FG000|Overall Study|Geopolitical conflict|2|||
161654153|NCT04531982|583782799|FG001|Overall Study|Geopolitical conflict|0|||
161654154|NCT04531982|583782798|FG000|Overall Study|Lack of Efficacy|3|||
161654155|NCT04531982|583782799|FG001|Overall Study|Lack of Efficacy|1|||
161654156|NCT06748729|583782801|FG000|Overall Study|Withdrawal by Subject|1|||
161654157|NCT01732822|583784862|FG000|Overall Study|Withdrawal by Subject|123|||
161654158|NCT01732822|583784863|FG001|Overall Study|Withdrawal by Subject|113|||
161654159|NCT02314780|583784864|FG000|Overall Study|organizational reasons|0|||
161654160|NCT02314780|583784865|FG001|Overall Study|organizational reasons|2|||
161654161|NCT02314780|583784866|FG002|Overall Study|organizational reasons|0|||
161654162|NCT02314780|583784864|FG000|Overall Study|Adverse Event|0|||
161654163|NCT02314780|583784865|FG001|Overall Study|Adverse Event|1|||
161654164|NCT02314780|583784866|FG002|Overall Study|Adverse Event|0|||
161654165|NCT00379288|583784867|FG000|Overall Study|Adverse Event|5|||
161654166|NCT00379288|583784868|FG001|Overall Study|Adverse Event|6|||
161654167|NCT00379288|583784869|FG002|Overall Study|Adverse Event|2|||
161654168|NCT00379288|583784870|FG003|Overall Study|Adverse Event|0|||
161654169|NCT00379288|583784867|FG000|Overall Study|Treatment Failure|0|||
161654170|NCT00379288|583784868|FG001|Overall Study|Treatment Failure|1|||
161654171|NCT00379288|583784869|FG002|Overall Study|Treatment Failure|0|||
161654172|NCT00379288|583784870|FG003|Overall Study|Treatment Failure|1|||
161654173|NCT00379288|583784867|FG000|Overall Study|Lost to Follow-up|3|||
161654174|NCT00379288|583784868|FG001|Overall Study|Lost to Follow-up|3|||
161654175|NCT00379288|583784869|FG002|Overall Study|Lost to Follow-up|2|||
161654176|NCT00379288|583784870|FG003|Overall Study|Lost to Follow-up|0|||
161654177|NCT00379288|583784867|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
161654178|NCT00379288|583784868|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
161654179|NCT00379288|583784869|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
161654180|NCT00379288|583784870|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
161654181|NCT00379288|583784867|FG000|Overall Study|Subject withdrew-related to study drug|1|||
161654182|NCT00379288|583784868|FG001|Overall Study|Subject withdrew-related to study drug|0|||
161654183|NCT00379288|583784869|FG002|Overall Study|Subject withdrew-related to study drug|0|||
161654184|NCT00379288|583784870|FG003|Overall Study|Subject withdrew-related to study drug|1|||
161654185|NCT00379288|583784867|FG000|Overall Study|Noncompliance with protocol|8|||
161654186|NCT00379288|583784868|FG001|Overall Study|Noncompliance with protocol|6|||
161654187|NCT00379288|583784869|FG002|Overall Study|Noncompliance with protocol|2|||
161654188|NCT00379288|583784870|FG003|Overall Study|Noncompliance with protocol|1|||
161654189|NCT00379288|583784867|FG000|Overall Study|Did not meet protocol eligibility|0|||
161654190|NCT00379288|583784868|FG001|Overall Study|Did not meet protocol eligibility|1|||
161654191|NCT00379288|583784869|FG002|Overall Study|Did not meet protocol eligibility|0|||
161654192|NCT00379288|583784870|FG003|Overall Study|Did not meet protocol eligibility|2|||
161654193|NCT00379288|583784867|FG000|Overall Study|Administrative|2|||
161654194|NCT00379288|583784868|FG001|Overall Study|Administrative|2|||
161654195|NCT00379288|583784869|FG002|Overall Study|Administrative|0|||
161654196|NCT00379288|583784870|FG003|Overall Study|Administrative|1|||
161654197|NCT00095056|583784873|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
161701052|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
161654198|NCT00095056|583784874|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
161654199|NCT00095056|583784873|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
161654200|NCT00095056|583784874|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
161654201|NCT00095056|583784873|FG000|Phase A (Weeks 0-12)|Death|1|||
161654202|NCT00095056|583784874|FG001|Phase A (Weeks 0-12)|Death|0|||
161654203|NCT00095056|583784873|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
161654204|NCT00095056|583784874|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
161654205|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
161654206|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
161654207|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
161654208|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
161654209|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
161654210|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
161654211|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
161654212|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
161654213|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Death|3|||
161654214|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Death|1|||
161654215|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
161654216|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
161654217|NCT00095056|583784873|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
161654218|NCT00095056|583784874|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
161654219|NCT02735577|583784878|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
161654220|NCT02735577|583784878|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
161654221|NCT00833833|583784879|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161654222|NCT00833833|583784880|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161654223|NCT00833833|583784881|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
161654224|NCT00833833|583784882|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
161654225|NCT00833833|583784883|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161654226|NCT00833833|583784884|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161654227|NCT00833833|583784879|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
161654228|NCT00833833|583784880|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
161654229|NCT00833833|583784881|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
161654230|NCT00833833|583784882|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
161654231|NCT00833833|583784883|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
161654232|NCT00833833|583784884|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
161654233|NCT00833833|583784879|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
161654234|NCT00833833|583784880|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
161654235|NCT00833833|583784881|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
161654236|NCT00833833|583784882|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
161654237|NCT00833833|583784883|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
161654238|NCT00833833|583784884|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
161654239|NCT00833833|583784879|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
161654240|NCT00833833|583784880|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
161654241|NCT00833833|583784881|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
161654242|NCT00833833|583784882|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
161654243|NCT00833833|583784883|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
161654244|NCT00833833|583784884|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
161654245|NCT00833833|583784879|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
161654246|NCT00833833|583784880|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654247|NCT00833833|583784881|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
161654248|NCT00833833|583784882|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654249|NCT00833833|583784883|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654250|NCT00833833|583784884|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654251|NCT00833833|583784879|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
161654252|NCT00833833|583784880|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
161654253|NCT00833833|583784881|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
161654254|NCT00833833|583784882|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
161654255|NCT00833833|583784883|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
161654256|NCT00833833|583784884|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
161654257|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161654258|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161654259|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161654260|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161654261|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
161654262|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
161654263|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161654264|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161654265|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161701053|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
161701054|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
161701055|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
161701056|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
161701057|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
161701058|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
161701059|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
161701060|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161701061|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
161701062|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161701063|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161701064|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
161701065|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
161701066|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
161701067|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
161701068|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
161701069|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161701070|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161701071|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161701072|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
161701073|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
161701074|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
161701075|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
161701076|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
161701077|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
161701078|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
161701079|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
161701080|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
161701081|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
161701082|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
161701083|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
161701084|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161701085|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161701086|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
161701087|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161701088|NCT02591615|583955522|FG000|Maintenance MK-3475|Adverse Event|0|||
161701089|NCT02591615|583955523|FG001|Maintenance MK-3475|Adverse Event|3|||
161701090|NCT02591615|583955524|FG002|Maintenance MK-3475|Adverse Event|1|||
161701091|NCT02591615|583955525|FG003|Maintenance MK-3475|Adverse Event|2|||
161701092|NCT02591615|583955522|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
161701093|NCT02591615|583955523|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
161701094|NCT02591615|583955524|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
161701095|NCT02591615|583955525|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
161701096|NCT02591615|583955522|FG000|Maintenance MK-3475|Death|0|||
161701097|NCT02591615|583955523|FG001|Maintenance MK-3475|Death|1|||
161701098|NCT02591615|583955524|FG002|Maintenance MK-3475|Death|1|||
161701099|NCT02591615|583955525|FG003|Maintenance MK-3475|Death|0|||
161701100|NCT02591615|583955522|FG000|Maintenance MK-3475|Physician discretion|0|||
161701101|NCT02591615|583955523|FG001|Maintenance MK-3475|Physician discretion|0|||
161701102|NCT02591615|583955524|FG002|Maintenance MK-3475|Physician discretion|1|||
161701103|NCT02591615|583955525|FG003|Maintenance MK-3475|Physician discretion|0|||
161701104|NCT02591615|583955522|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
161701105|NCT02591615|583955523|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
161701106|NCT02591615|583955524|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
161701107|NCT02591615|583955525|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
161701108|NCT02591615|583955522|FG000|Maintenance MK-3475|In active treatment|2|||
161701109|NCT02591615|583955523|FG001|Maintenance MK-3475|In active treatment|0|||
161701110|NCT02591615|583955524|FG002|Maintenance MK-3475|In active treatment|0|||
161701111|NCT02591615|583955525|FG003|Maintenance MK-3475|In active treatment|1|||
161701112|NCT01793792|583955526|FG000|Overall Study|Death|5|||
161701113|NCT01793792|583955526|FG000|Overall Study|Lost to Follow-up|5|||
161701114|NCT01793792|583955526|FG000|Overall Study|Withdrawal by Subject|1|||
161701115|NCT01793792|583955526|FG000|Overall Study|Device Not Implanted|1|||
161701116|NCT00851903|583955529|FG000|Overall Study|Withdrawal by Subject|2|||
161701117|NCT00686127|583955532|FG000|Overall Study|Withdrawal by Subject|14|||
161837017|NCT05855616|584446516|FG000|Overall Study|Lost to Follow-up|1|||
161837018|NCT05855616|584446517|FG001|Overall Study|Lost to Follow-up|2|||
161837019|NCT01388166|584446518|FG000|Overall Study|Adverse Event|16|||
161837020|NCT01388166|584446518|FG000|Overall Study|Lost to Follow-up|30|||
161701118|NCT00686127|583955533|FG001|Overall Study|Withdrawal by Subject|6|||
161701119|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
161701120|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
161701121|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
161701122|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
161701123|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
161701124|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
161837021|NCT01388166|584446518|FG000|Overall Study|Others than specified above|13|||
161837022|NCT02751359|584446524|FG000|Overall Study|Lost to Follow-up|1|||
161701125|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
161701126|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
161701127|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161701128|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161701129|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161701130|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
161701131|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
161701132|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161701133|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161701134|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
161701135|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
161701136|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
161701137|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161701138|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161701139|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
161701140|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701141|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701142|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701143|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701144|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
161701145|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
161701146|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
161701147|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
161701148|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
161701149|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Other|0|||
161701150|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Other|0|||
161701151|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Other|1|||
161701152|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Other|0|||
161701153|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Other|0|||
161701154|NCT05195528|583955539|FG000|Extension Period|PTE or AE or SAE|0|||
161701155|NCT05195528|583955540|FG001|Extension Period|PTE or AE or SAE|4|||
161701156|NCT05195528|583955541|FG002|Extension Period|PTE or AE or SAE|5|||
161701157|NCT05195528|583955542|FG003|Extension Period|PTE or AE or SAE|4|||
161701158|NCT05195528|583955543|FG004|Extension Period|PTE or AE or SAE|4|||
161701159|NCT05195528|583955539|FG000|Extension Period|Protocol Violation|0|||
161701160|NCT05195528|583955540|FG001|Extension Period|Protocol Violation|2|||
161701161|NCT05195528|583955541|FG002|Extension Period|Protocol Violation|1|||
161701162|NCT05195528|583955542|FG003|Extension Period|Protocol Violation|0|||
161701163|NCT05195528|583955543|FG004|Extension Period|Protocol Violation|1|||
161701164|NCT05195528|583955539|FG000|Extension Period|Lost to Follow-up|0|||
161701165|NCT05195528|583955540|FG001|Extension Period|Lost to Follow-up|6|||
161701166|NCT05195528|583955541|FG002|Extension Period|Lost to Follow-up|13|||
161701167|NCT05195528|583955542|FG003|Extension Period|Lost to Follow-up|3|||
161701168|NCT05195528|583955543|FG004|Extension Period|Lost to Follow-up|7|||
161701169|NCT05195528|583955539|FG000|Extension Period|Withdrawal by Subject|0|||
161701170|NCT05195528|583955540|FG001|Extension Period|Withdrawal by Subject|12|||
161701171|NCT05195528|583955541|FG002|Extension Period|Withdrawal by Subject|9|||
161701172|NCT05195528|583955542|FG003|Extension Period|Withdrawal by Subject|6|||
161701173|NCT05195528|583955543|FG004|Extension Period|Withdrawal by Subject|5|||
161701174|NCT05195528|583955539|FG000|Extension Period|Lack of Efficacy|0|||
161701175|NCT05195528|583955540|FG001|Extension Period|Lack of Efficacy|3|||
161701176|NCT05195528|583955541|FG002|Extension Period|Lack of Efficacy|0|||
161701177|NCT05195528|583955542|FG003|Extension Period|Lack of Efficacy|0|||
161701178|NCT05195528|583955543|FG004|Extension Period|Lack of Efficacy|2|||
161701179|NCT05195528|583955539|FG000|Extension Period|Not Treated|0|||
161701180|NCT05195528|583955540|FG001|Extension Period|Not Treated|0|||
161701181|NCT05195528|583955541|FG002|Extension Period|Not Treated|2|||
161701182|NCT05195528|583955542|FG003|Extension Period|Not Treated|3|||
161837023|NCT01196078|584446525|FG000|Overall Study|Withdrawal by Subject|3|||
161837024|NCT01196078|584446526|FG001|Overall Study|Withdrawal by Subject|5|||
161837025|NCT01196078|584446525|FG000|Overall Study|Adverse Event|4|||
161837026|NCT01196078|584446526|FG001|Overall Study|Adverse Event|4|||
161837027|NCT01196078|584446525|FG000|Overall Study|Protocol Violation|2|||
161701183|NCT05195528|583955543|FG004|Extension Period|Not Treated|0|||
161701184|NCT05195528|583955539|FG000|Extension Period|Other|0|||
161701185|NCT05195528|583955540|FG001|Extension Period|Other|1|||
161701186|NCT05195528|583955541|FG002|Extension Period|Other|1|||
161701187|NCT05195528|583955542|FG003|Extension Period|Other|0|||
161837028|NCT01196078|584446526|FG001|Overall Study|Protocol Violation|1|||
161837029|NCT01196078|584446525|FG000|Overall Study|Lack of Efficacy|17|||
161701188|NCT05195528|583955543|FG004|Extension Period|Other|0|||
161701189|NCT01552902|583955544|FG000|Overall Study|Adverse Event|1|||
161701190|NCT01552902|583955545|FG001|Overall Study|Adverse Event|15|||
161701191|NCT01552902|583955546|FG002|Overall Study|Adverse Event|14|||
161701192|NCT01552902|583955544|FG000|Overall Study|Protocol Violation|3|||
161701193|NCT01552902|583955545|FG001|Overall Study|Protocol Violation|3|||
161701194|NCT01552902|583955546|FG002|Overall Study|Protocol Violation|3|||
161701195|NCT01552902|583955544|FG000|Overall Study|Lack of Efficacy|4|||
161701196|NCT01552902|583955545|FG001|Overall Study|Lack of Efficacy|3|||
161701197|NCT01552902|583955546|FG002|Overall Study|Lack of Efficacy|1|||
161701198|NCT01552902|583955544|FG000|Overall Study|Withdrawal by Subject|1|||
161701199|NCT01552902|583955545|FG001|Overall Study|Withdrawal by Subject|9|||
161701200|NCT01552902|583955546|FG002|Overall Study|Withdrawal by Subject|6|||
161701201|NCT01552902|583955544|FG000|Overall Study|Lost to Follow-up|1|||
161701202|NCT01552902|583955545|FG001|Overall Study|Lost to Follow-up|3|||
161701203|NCT01552902|583955546|FG002|Overall Study|Lost to Follow-up|6|||
161701204|NCT01552902|583955544|FG000|Overall Study|Other|3|||
161701205|NCT01552902|583955545|FG001|Overall Study|Other|4|||
161701206|NCT01552902|583955546|FG002|Overall Study|Other|3|||
161837030|NCT01196078|584446526|FG001|Overall Study|Lack of Efficacy|23|||
161837031|NCT01196078|584446525|FG000|Overall Study|Lost to Follow-up|1|||
161654266|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161654267|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
161654268|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
161654269|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
161654270|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
161654271|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
161654272|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
161654273|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
161654274|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
161654275|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654276|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654277|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654278|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161654279|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
161654280|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
161654281|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161654282|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161654283|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161654284|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161654285|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
161654286|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
161654287|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
161654288|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
161654289|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
161654290|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
161654291|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
161654292|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
161654293|NCT00833833|583784879|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161654294|NCT00833833|583784880|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161654295|NCT00833833|583784881|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161654296|NCT00833833|583784882|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161654297|NCT00833833|583784883|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161654298|NCT00833833|583784884|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
161654299|NCT02040259|583784885|FG000|Overall Study|Death|280|||
161654300|NCT02040259|583784885|FG000|Overall Study|Lost to Follow-up|76|||
161654301|NCT02040259|583784885|FG000|Overall Study|Assessment not completed|3|||
161654302|NCT02040259|583784885|FG000|Overall Study|Withdrawal by Subject|4|||
161654303|NCT00316602|583784895|FG000|Overall Study|Withdrawal by Subject|3|||
161654304|NCT00316602|583784896|FG001|Overall Study|Withdrawal by Subject|2|||
161654305|NCT00316602|583784895|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
161654306|NCT00316602|583784896|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
161654307|NCT00316602|583784895|FG000|Overall Study|Adverse Event|1|||
161654308|NCT00316602|583784896|FG001|Overall Study|Adverse Event|0|||
161654309|NCT00316602|583784895|FG000|Overall Study|Other|3|||
161654310|NCT00316602|583784896|FG001|Overall Study|Other|6|||
161654311|NCT01142232|583784897|FG000|Overall Study|Adverse Event|1|||
161701207|NCT02487108|583955547|FG000|Overall Study|Adverse Event|1|||
161701208|NCT02487108|583955548|FG001|Overall Study|Adverse Event|6|||
161701209|NCT02487108|583955549|FG002|Overall Study|Adverse Event|12|||
161701210|NCT02487108|583955550|FG003|Overall Study|Adverse Event|6|||
161701211|NCT02487108|583955547|FG000|Overall Study|Withdrawal by Subject|8|||
161701212|NCT02487108|583955548|FG001|Overall Study|Withdrawal by Subject|5|||
161701213|NCT02487108|583955549|FG002|Overall Study|Withdrawal by Subject|5|||
161701214|NCT02487108|583955550|FG003|Overall Study|Withdrawal by Subject|0|||
161701215|NCT02487108|583955547|FG000|Overall Study|Non-compliance to study medication|3|||
161701216|NCT02487108|583955548|FG001|Overall Study|Non-compliance to study medication|2|||
161701217|NCT02487108|583955549|FG002|Overall Study|Non-compliance to study medication|5|||
161701218|NCT02487108|583955550|FG003|Overall Study|Non-compliance to study medication|4|||
161701219|NCT02487108|583955547|FG000|Overall Study|Protocol Violation|1|||
161701220|NCT02487108|583955548|FG001|Overall Study|Protocol Violation|1|||
161701221|NCT02487108|583955549|FG002|Overall Study|Protocol Violation|2|||
161701222|NCT02487108|583955550|FG003|Overall Study|Protocol Violation|0|||
161701223|NCT02487108|583955547|FG000|Overall Study|Non-compliance to study procedures|0|||
161701224|NCT02487108|583955548|FG001|Overall Study|Non-compliance to study procedures|0|||
161701225|NCT02487108|583955549|FG002|Overall Study|Non-compliance to study procedures|0|||
161701226|NCT02487108|583955550|FG003|Overall Study|Non-compliance to study procedures|1|||
161701227|NCT02487108|583955547|FG000|Overall Study|Other than specified|3|||
161701228|NCT02487108|583955548|FG001|Overall Study|Other than specified|2|||
161701229|NCT02487108|583955549|FG002|Overall Study|Other than specified|2|||
161701230|NCT02487108|583955550|FG003|Overall Study|Other than specified|0|||
161701231|NCT00469612|583955551|FG000|Overall Study|Study terminated before data collected|2|||
161701232|NCT00469612|583955552|FG001|Overall Study|Study terminated before data collected|0|||
161701233|NCT02720757|583955553|FG000|Overall Study|Other reason|5|||
161701234|NCT02720757|583955553|FG000|Overall Study|Loss of contact|4|||
161701235|NCT02720757|583955553|FG000|Overall Study|Informed consent withdrawal|1|||
161701236|NCT02720757|583955553|FG000|Overall Study|Patients wish to withdraw|2|||
161701237|NCT02720757|583955553|FG000|Overall Study|Missing|3|||
161701238|NCT02720757|583955553|FG000|Overall Study|General exclusion|3|||
161701239|NCT02357420|583955554|FG000|Overall Study|Adverse Event|3|||
161701240|NCT02357420|583955555|FG001|Overall Study|Adverse Event|3|||
161701241|NCT02357420|583955556|FG002|Overall Study|Adverse Event|8|||
161701242|NCT02357420|583955557|FG003|Overall Study|Adverse Event|9|||
161701243|NCT02357420|583955554|FG000|Overall Study|Investigator Decision|1|||
161701244|NCT02357420|583955555|FG001|Overall Study|Investigator Decision|0|||
161701245|NCT02357420|583955556|FG002|Overall Study|Investigator Decision|0|||
161837032|NCT01196078|584446526|FG001|Overall Study|Lost to Follow-up|0|||
161701246|NCT02357420|583955557|FG003|Overall Study|Investigator Decision|0|||
161701247|NCT02357420|583955554|FG000|Overall Study|Prohibited Medication|1|||
161701248|NCT02357420|583955555|FG001|Overall Study|Prohibited Medication|1|||
161701249|NCT02357420|583955556|FG002|Overall Study|Prohibited Medication|0|||
161701250|NCT02357420|583955557|FG003|Overall Study|Prohibited Medication|0|||
161701251|NCT02357420|583955554|FG000|Overall Study|Protocol Non-compliance|0|||
161701252|NCT02357420|583955555|FG001|Overall Study|Protocol Non-compliance|0|||
161701253|NCT02357420|583955556|FG002|Overall Study|Protocol Non-compliance|0|||
161701254|NCT02357420|583955557|FG003|Overall Study|Protocol Non-compliance|1|||
161701255|NCT02357420|583955554|FG000|Overall Study|Withdrawn Consent|4|||
161701256|NCT02357420|583955555|FG001|Overall Study|Withdrawn Consent|8|||
161701257|NCT02357420|583955556|FG002|Overall Study|Withdrawn Consent|6|||
161701258|NCT02357420|583955557|FG003|Overall Study|Withdrawn Consent|6|||
161701259|NCT02357420|583955554|FG000|Overall Study|Lost to Follow-up|3|||
161701260|NCT02357420|583955555|FG001|Overall Study|Lost to Follow-up|0|||
161701261|NCT02357420|583955556|FG002|Overall Study|Lost to Follow-up|2|||
161701262|NCT02357420|583955557|FG003|Overall Study|Lost to Follow-up|3|||
161701263|NCT00214461|583955558|FG000|Overall Study|Adverse Event|0|||
161701264|NCT00214461|583955559|FG001|Overall Study|Adverse Event|0|||
161701265|NCT00214461|583955560|FG002|Overall Study|Adverse Event|1|||
161701266|NCT00214461|583955561|FG003|Overall Study|Adverse Event|1|||
161701267|NCT00214461|583955558|FG000|Overall Study|Withdrawal by Subject|0|||
161701268|NCT00214461|583955559|FG001|Overall Study|Withdrawal by Subject|0|||
161701269|NCT00214461|583955560|FG002|Overall Study|Withdrawal by Subject|1|||
161701270|NCT00214461|583955561|FG003|Overall Study|Withdrawal by Subject|0|||
161701271|NCT00364689|583955562|FG000|Overall Study|Lost to Follow-up|1|||
161701272|NCT00234039|583955565|FG000|Overall Study|Adverse Event|2|||
161701273|NCT00234039|583955565|FG000|Overall Study|Progression/relapse|34|||
161701274|NCT00234039|583955565|FG000|Overall Study|Other - Not Protocol Specified|3|||
161701275|NCT00234039|583955565|FG000|Overall Study|Ineligible|9|||
161701276|NCT00234039|583955565|FG000|Overall Study|No Protocol Treatment Received|2|||
161701277|NCT01808612|583955566|FG000|Treatment Period|Adverse Event|8|||
161701278|NCT01808612|583955567|FG001|Treatment Period|Adverse Event|4|||
161701279|NCT01808612|583955568|FG002|Treatment Period|Adverse Event|3|||
161701280|NCT01808612|583955566|FG000|Treatment Period|Lost to Follow-up|2|||
161701281|NCT01808612|583955567|FG001|Treatment Period|Lost to Follow-up|2|||
161701282|NCT01808612|583955568|FG002|Treatment Period|Lost to Follow-up|1|||
161701283|NCT01808612|583955566|FG000|Treatment Period|Protocol Violation|1|||
161701284|NCT01808612|583955567|FG001|Treatment Period|Protocol Violation|0|||
161701285|NCT01808612|583955568|FG002|Treatment Period|Protocol Violation|0|||
161701286|NCT01808612|583955566|FG000|Treatment Period|Withdrawal by Subject|1|||
161701287|NCT01808612|583955567|FG001|Treatment Period|Withdrawal by Subject|0|||
161701288|NCT01808612|583955568|FG002|Treatment Period|Withdrawal by Subject|4|||
161701289|NCT01808612|583955566|FG000|Treatment Period|Physician Decision|1|||
161701290|NCT01808612|583955567|FG001|Treatment Period|Physician Decision|0|||
161701291|NCT01808612|583955568|FG002|Treatment Period|Physician Decision|4|||
161701292|NCT01808612|583955566|FG000|Treatment Period|Sponsor Decision|1|||
161701293|NCT01808612|583955567|FG001|Treatment Period|Sponsor Decision|0|||
161701294|NCT01808612|583955568|FG002|Treatment Period|Sponsor Decision|0|||
161701295|NCT01808612|583955566|FG000|Treatment Period|Lack of Efficacy|1|||
161701296|NCT01808612|583955567|FG001|Treatment Period|Lack of Efficacy|1|||
161701297|NCT01808612|583955568|FG002|Treatment Period|Lack of Efficacy|2|||
161701298|NCT01808612|583955566|FG000|Discontinuation Period|Adverse Event|1|||
161701299|NCT01808612|583955567|FG001|Discontinuation Period|Adverse Event|0|||
161701300|NCT01808612|583955568|FG002|Discontinuation Period|Adverse Event|0|||
161701301|NCT01808612|583955566|FG000|Discontinuation Period|Physician Decision|1|||
161701302|NCT01808612|583955567|FG001|Discontinuation Period|Physician Decision|0|||
161701303|NCT01808612|583955568|FG002|Discontinuation Period|Physician Decision|0|||
161701304|NCT01808612|583955566|FG000|Discontinuation Period|Lost to Follow-up|0|||
161701305|NCT01808612|583955567|FG001|Discontinuation Period|Lost to Follow-up|1|||
161701306|NCT01808612|583955568|FG002|Discontinuation Period|Lost to Follow-up|0|||
161701307|NCT03683394|583955569|FG000|Overall Study|Withdrawal by Subject|4|||
161701308|NCT03683394|583955570|FG001|Overall Study|Withdrawal by Subject|8|||
161701309|NCT03683394|583955569|FG000|Overall Study|Lost to Follow-up|7|||
161701310|NCT03683394|583955570|FG001|Overall Study|Lost to Follow-up|0|||
161701311|NCT03683394|583955569|FG000|Overall Study|Death|3|||
161701312|NCT03683394|583955570|FG001|Overall Study|Death|1|||
161701313|NCT02239263|583955573|FG000|Overall Study|Protocol Violation|6|||
161701314|NCT01109940|583955577|FG000|Overall Study|Administrative problems|2|||
161701315|NCT01109940|583955578|FG001|Overall Study|Administrative problems|0|||
161701316|NCT01109940|583955579|FG002|Overall Study|Administrative problems|0|||
161701317|NCT01109940|583955580|FG003|Overall Study|Administrative problems|0|||
161701318|NCT01109940|583955577|FG000|Overall Study|Serious Adverse Event|2|||
161701319|NCT01109940|583955578|FG001|Overall Study|Serious Adverse Event|1|||
161701320|NCT01109940|583955579|FG002|Overall Study|Serious Adverse Event|0|||
161701321|NCT01109940|583955580|FG003|Overall Study|Serious Adverse Event|0|||
161701322|NCT01109940|583955577|FG000|Overall Study|Lost to Follow-up|1|||
161701323|NCT01109940|583955578|FG001|Overall Study|Lost to Follow-up|0|||
161701324|NCT01109940|583955579|FG002|Overall Study|Lost to Follow-up|0|||
161701325|NCT01109940|583955580|FG003|Overall Study|Lost to Follow-up|0|||
161701326|NCT01109940|583955577|FG000|Overall Study|Patient withdrew consent|1|||
161701327|NCT01109940|583955578|FG001|Overall Study|Patient withdrew consent|1|||
161701328|NCT01109940|583955579|FG002|Overall Study|Patient withdrew consent|0|||
161654312|NCT01142232|583784898|FG001|Overall Study|Adverse Event|2|||
161654313|NCT01142232|583784899|FG002|Overall Study|Adverse Event|1|||
161654314|NCT01142232|583784900|FG003|Overall Study|Adverse Event|0|||
161654315|NCT01142232|583784901|FG004|Overall Study|Adverse Event|4|||
161654316|NCT01142232|583784897|FG000|Overall Study|Death|0|||
161654317|NCT01142232|583784898|FG001|Overall Study|Death|0|||
161654318|NCT01142232|583784899|FG002|Overall Study|Death|0|||
161654319|NCT01142232|583784900|FG003|Overall Study|Death|0|||
161654320|NCT01142232|583784901|FG004|Overall Study|Death|1|||
161654321|NCT01142232|583784897|FG000|Overall Study|Disease Progression|2|||
161654322|NCT01142232|583784898|FG001|Overall Study|Disease Progression|0|||
161654323|NCT01142232|583784899|FG002|Overall Study|Disease Progression|1|||
161654324|NCT01142232|583784900|FG003|Overall Study|Disease Progression|2|||
161654325|NCT01142232|583784901|FG004|Overall Study|Disease Progression|12|||
161654326|NCT01142232|583784897|FG000|Overall Study|Withdrawal by Subject|0|||
161654327|NCT01142232|583784898|FG001|Overall Study|Withdrawal by Subject|0|||
161654328|NCT01142232|583784899|FG002|Overall Study|Withdrawal by Subject|0|||
161654329|NCT01142232|583784900|FG003|Overall Study|Withdrawal by Subject|1|||
161654330|NCT01142232|583784901|FG004|Overall Study|Withdrawal by Subject|3|||
161654331|NCT01142232|583784897|FG000|Overall Study|Physician Decision|0|||
161654332|NCT01142232|583784898|FG001|Overall Study|Physician Decision|1|||
161654333|NCT01142232|583784899|FG002|Overall Study|Physician Decision|0|||
161654334|NCT01142232|583784900|FG003|Overall Study|Physician Decision|2|||
161654335|NCT01142232|583784901|FG004|Overall Study|Physician Decision|10|||
161654336|NCT01142232|583784897|FG000|Overall Study|Alternative Therapy|0|||
161654337|NCT01142232|583784898|FG001|Overall Study|Alternative Therapy|1|||
161654338|NCT01142232|583784899|FG002|Overall Study|Alternative Therapy|1|||
161654339|NCT01142232|583784900|FG003|Overall Study|Alternative Therapy|0|||
161654340|NCT01142232|583784901|FG004|Overall Study|Alternative Therapy|1|||
161654341|NCT01142232|583784897|FG000|Overall Study|Off Trt for other complicating disease|0|||
161654342|NCT01142232|583784898|FG001|Overall Study|Off Trt for other complicating disease|0|||
161654343|NCT01142232|583784899|FG002|Overall Study|Off Trt for other complicating disease|0|||
161654344|NCT01142232|583784900|FG003|Overall Study|Off Trt for other complicating disease|0|||
161654345|NCT01142232|583784901|FG004|Overall Study|Off Trt for other complicating disease|1|||
161654346|NCT01142232|583784897|FG000|Overall Study|Noncompliance|0|||
161654347|NCT01142232|583784898|FG001|Overall Study|Noncompliance|0|||
161654348|NCT01142232|583784899|FG002|Overall Study|Noncompliance|0|||
161654349|NCT01142232|583784900|FG003|Overall Study|Noncompliance|0|||
161654350|NCT01142232|583784901|FG004|Overall Study|Noncompliance|2|||
161654351|NCT00626990|583784902|FG000|Overall Study|Lack of Efficacy|6|||
161654352|NCT00626990|583784903|FG001|Overall Study|Lack of Efficacy|7|||
161654353|NCT00626990|583784904|FG002|Overall Study|Lack of Efficacy|49|||
161654354|NCT00626990|583784905|FG003|Overall Study|Lack of Efficacy|40|||
161654355|NCT00626990|583784902|FG000|Overall Study|Adverse Event|1|||
161654356|NCT00626990|583784903|FG001|Overall Study|Adverse Event|7|||
161654357|NCT00626990|583784904|FG002|Overall Study|Adverse Event|14|||
161654358|NCT00626990|583784905|FG003|Overall Study|Adverse Event|28|||
161654359|NCT00626990|583784902|FG000|Overall Study|Death|0|||
161654360|NCT00626990|583784903|FG001|Overall Study|Death|1|||
161654361|NCT00626990|583784904|FG002|Overall Study|Death|0|||
161654362|NCT00626990|583784905|FG003|Overall Study|Death|0|||
161654363|NCT00626990|583784902|FG000|Overall Study|Withdrawal by Subject|3|||
161654364|NCT00626990|583784903|FG001|Overall Study|Withdrawal by Subject|1|||
161654365|NCT00626990|583784904|FG002|Overall Study|Withdrawal by Subject|5|||
161654366|NCT00626990|583784905|FG003|Overall Study|Withdrawal by Subject|11|||
161701329|NCT01109940|583955580|FG003|Overall Study|Patient withdrew consent|0|||
161701330|NCT01109940|583955577|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161701331|NCT01109940|583955578|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161701332|NCT01109940|583955579|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161701333|NCT01109940|583955580|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161701334|NCT03653390|583955581|FG000|Overall Study|Lost to Follow-up|12|||
161701335|NCT03653390|583955582|FG001|Overall Study|Lost to Follow-up|8|||
161701336|NCT03653390|583955583|FG002|Overall Study|Lost to Follow-up|7|||
161701337|NCT03653390|583955581|FG000|Overall Study|Withdrawal by Subject|6|||
161701338|NCT03653390|583955582|FG001|Overall Study|Withdrawal by Subject|1|||
161701339|NCT03653390|583955583|FG002|Overall Study|Withdrawal by Subject|1|||
161654367|NCT00626990|583784902|FG000|Overall Study|Protocol Violation|0|||
161654368|NCT00626990|583784903|FG001|Overall Study|Protocol Violation|1|||
161654369|NCT00626990|583784904|FG002|Overall Study|Protocol Violation|1|||
161654370|NCT00626990|583784905|FG003|Overall Study|Protocol Violation|0|||
161654371|NCT00626990|583784902|FG000|Overall Study|Various different reasons/missing|4|||
161654372|NCT00626990|583784903|FG001|Overall Study|Various different reasons/missing|8|||
161654373|NCT00626990|583784904|FG002|Overall Study|Various different reasons/missing|8|||
161654374|NCT00626990|583784905|FG003|Overall Study|Various different reasons/missing|16|||
161654375|NCT01802567|583784908|FG000|Overall Study|Withdrawal by Subject|2|||
161654376|NCT01802567|583784908|FG000|Overall Study|Physician Decision|1|||
161654377|NCT01802567|583784908|FG000|Overall Study|Lack of Efficacy|7|||
161654378|NCT01802567|583784908|FG000|Overall Study|Consented but did not start therapy|7|||
161654379|NCT01802567|583784908|FG000|Overall Study|Protocol Violation|1|||
161654380|NCT01895101|583784909|FG000|Overall Study|OPCAB procedure|1|||
161654381|NCT01895101|583784910|FG001|Overall Study|OPCAB procedure|1|||
161654382|NCT01895101|583784911|FG002|Overall Study|OPCAB procedure|3|||
161654383|NCT01895101|583784909|FG000|Overall Study|Withdrawal by Subject|0|||
161654384|NCT01895101|583784910|FG001|Overall Study|Withdrawal by Subject|1|||
161654385|NCT01895101|583784911|FG002|Overall Study|Withdrawal by Subject|2|||
161654386|NCT01895101|583784909|FG000|Overall Study|another study, enrolled in other study|0|||
161654387|NCT01895101|583784910|FG001|Overall Study|another study, enrolled in other study|1|||
161654388|NCT01895101|583784911|FG002|Overall Study|another study, enrolled in other study|0|||
161654389|NCT01895101|583784909|FG000|Overall Study|Death|0|||
161654390|NCT01895101|583784910|FG001|Overall Study|Death|1|||
161654391|NCT01895101|583784911|FG002|Overall Study|Death|0|||
161654392|NCT01895101|583784909|FG000|Overall Study|coagulation disorder|0|||
161654393|NCT01895101|583784910|FG001|Overall Study|coagulation disorder|1|||
161654394|NCT01895101|583784911|FG002|Overall Study|coagulation disorder|0|||
161654395|NCT03268603|583784912|FG000|Overall Study|Withdrawal by Subject|6|||
161654396|NCT03268603|583784912|FG000|Overall Study|Physician Decision|1|||
161654397|NCT03268603|583784912|FG000|Overall Study|Withdrawn due to disease progression|2|||
161654398|NCT02182947|583784913|FG000|Overall Study|Withdrawal by Subject|7|||
161654399|NCT02182947|583784913|FG000|Overall Study|Lost to Follow-up|3|||
161654400|NCT02182947|583784913|FG000|Overall Study|Failed screening activities|8|||
161654401|NCT03248882|583784914|FG000|Overall Study|Adverse Event|3|||
161654402|NCT03248882|583784915|FG001|Overall Study|Adverse Event|3|||
161654403|NCT03248882|583784916|FG002|Overall Study|Adverse Event|2|||
161654404|NCT03248882|583784917|FG003|Overall Study|Adverse Event|6|||
161654405|NCT03248882|583784918|FG004|Overall Study|Adverse Event|9|||
161654406|NCT03248882|583784914|FG000|Overall Study|Lost to Follow-up|0|||
161654407|NCT03248882|583784915|FG001|Overall Study|Lost to Follow-up|0|||
161654408|NCT03248882|583784916|FG002|Overall Study|Lost to Follow-up|0|||
161654409|NCT03248882|583784917|FG003|Overall Study|Lost to Follow-up|0|||
161654410|NCT03248882|583784918|FG004|Overall Study|Lost to Follow-up|1|||
161654411|NCT03248882|583784914|FG000|Overall Study|Protocol Violation|2|||
161654412|NCT03248882|583784915|FG001|Overall Study|Protocol Violation|0|||
161654413|NCT03248882|583784916|FG002|Overall Study|Protocol Violation|2|||
161654414|NCT03248882|583784917|FG003|Overall Study|Protocol Violation|0|||
161654415|NCT03248882|583784918|FG004|Overall Study|Protocol Violation|1|||
161654416|NCT03248882|583784914|FG000|Overall Study|Withdrawal by Subject|2|||
161654417|NCT03248882|583784915|FG001|Overall Study|Withdrawal by Subject|2|||
161654418|NCT03248882|583784916|FG002|Overall Study|Withdrawal by Subject|3|||
161654419|NCT03248882|583784917|FG003|Overall Study|Withdrawal by Subject|4|||
161654420|NCT03248882|583784918|FG004|Overall Study|Withdrawal by Subject|2|||
161654421|NCT02236988|583784919|FG000|Overall Study|Lost to Follow-up|0|||
161654422|NCT02236988|583784920|FG001|Overall Study|Lost to Follow-up|0|||
161654423|NCT02236988|583784921|FG002|Overall Study|Lost to Follow-up|0|||
161654424|NCT02236988|583784922|FG003|Overall Study|Lost to Follow-up|1|||
161654425|NCT02236988|583784919|FG000|Overall Study|Unable to Comply with Study Visits|0|||
161654426|NCT02236988|583784920|FG001|Overall Study|Unable to Comply with Study Visits|0|||
161654427|NCT02236988|583784921|FG002|Overall Study|Unable to Comply with Study Visits|0|||
161654428|NCT02236988|583784922|FG003|Overall Study|Unable to Comply with Study Visits|2|||
161654429|NCT04308590|583784923|FG000|Overall Study|Adverse Event|12|||
161654430|NCT04308590|583784924|FG001|Overall Study|Adverse Event|2|||
161654431|NCT04308590|583784923|FG000|Overall Study|Withdrawal by Subject|10|||
161701340|NCT03653390|583955581|FG000|Overall Study|Death|1|||
161654432|NCT04308590|583784924|FG001|Overall Study|Withdrawal by Subject|4|||
161654433|NCT04308590|583784923|FG000|Overall Study|Death|1|||
161654434|NCT04308590|583784924|FG001|Overall Study|Death|0|||
161654435|NCT04308590|583784923|FG000|Overall Study|Lost to Follow-up|1|||
161654436|NCT04308590|583784924|FG001|Overall Study|Lost to Follow-up|1|||
161654437|NCT04308590|583784923|FG000|Overall Study|Physician Decision|1|||
161654438|NCT04308590|583784924|FG001|Overall Study|Physician Decision|0|||
161654439|NCT04308590|583784923|FG000|Overall Study|Subject does not want to continue with Pi|0|||
161654440|NCT04308590|583784924|FG001|Overall Study|Subject does not want to continue with Pi|1|||
161654441|NCT01156376|583784926|FG000|Overall Study|Adverse Event|1|||
161654442|NCT01156376|583784927|FG001|Overall Study|Adverse Event|0|||
161654443|NCT01156376|583784928|FG002|Overall Study|Adverse Event|1|||
161654444|NCT01156376|583784926|FG000|Overall Study|Withdrawal by Subject|0|||
161654445|NCT01156376|583784927|FG001|Overall Study|Withdrawal by Subject|0|||
161654446|NCT01156376|583784928|FG002|Overall Study|Withdrawal by Subject|3|||
161654447|NCT01493427|583784929|FG000|Overall Study|Adverse Event|10|||
161654448|NCT01493427|583784929|FG000|Overall Study|Personal Reasons|4|||
161654449|NCT01493427|583784929|FG000|Overall Study|Lost to Follow-up|2|||
161654450|NCT01493427|583784929|FG000|Overall Study|Inability to Follow Instructions|2|||
161654451|NCT01493427|583784929|FG000|Overall Study|Other|2|||
161654452|NCT05775991|583784930|FG000|Overall Study|Withdrawal by Subject|0|||
161654453|NCT05775991|583784931|FG001|Overall Study|Withdrawal by Subject|0|||
161654454|NCT05775991|583784932|FG002|Overall Study|Withdrawal by Subject|2|||
161654455|NCT00939822|583784939|FG000|Overall Study|Lost to Follow-up|1|||
161654456|NCT00939822|583784940|FG001|Overall Study|Lost to Follow-up|0|||
161654457|NCT00939822|583784939|FG000|Overall Study|withdrew from study due to busy schedule|1|||
161654458|NCT00939822|583784940|FG001|Overall Study|withdrew from study due to busy schedule|1|||
161654459|NCT00939822|583784939|FG000|Overall Study|Mental health issues|0|||
161654460|NCT00939822|583784940|FG001|Overall Study|Mental health issues|2|||
161654461|NCT01072630|583784941|FG000|Overall Study|Adverse Event|11|||
161654462|NCT01072630|583784942|FG001|Overall Study|Adverse Event|19|||
161654463|NCT01072630|583784943|FG002|Overall Study|Adverse Event|2|||
161654464|NCT01072630|583784941|FG000|Overall Study|Lack of Efficacy|10|||
161654465|NCT01072630|583784942|FG001|Overall Study|Lack of Efficacy|10|||
161654466|NCT01072630|583784943|FG002|Overall Study|Lack of Efficacy|1|||
161654467|NCT01072630|583784941|FG000|Overall Study|Withdrawal by Subject|8|||
161654468|NCT01072630|583784942|FG001|Overall Study|Withdrawal by Subject|7|||
161654469|NCT01072630|583784943|FG002|Overall Study|Withdrawal by Subject|2|||
161654470|NCT01072630|583784941|FG000|Overall Study|Protocol Violation|10|||
161654471|NCT01072630|583784942|FG001|Overall Study|Protocol Violation|8|||
161654472|NCT01072630|583784943|FG002|Overall Study|Protocol Violation|4|||
161654473|NCT01072630|583784941|FG000|Overall Study|Lost to Follow-up|11|||
161654474|NCT01072630|583784942|FG001|Overall Study|Lost to Follow-up|11|||
161654475|NCT01072630|583784943|FG002|Overall Study|Lost to Follow-up|1|||
161654476|NCT01072630|583784941|FG000|Overall Study|Noncompliance with study medication|1|||
161654477|NCT01072630|583784942|FG001|Overall Study|Noncompliance with study medication|1|||
161654478|NCT01072630|583784943|FG002|Overall Study|Noncompliance with study medication|1|||
161654479|NCT01072630|583784941|FG000|Overall Study|Noncompliance with study procedures|1|||
161654480|NCT01072630|583784942|FG001|Overall Study|Noncompliance with study procedures|2|||
161654481|NCT01072630|583784943|FG002|Overall Study|Noncompliance with study procedures|1|||
161654482|NCT01072630|583784941|FG000|Overall Study|Other|3|||
161654483|NCT01072630|583784942|FG001|Overall Study|Other|2|||
161654484|NCT01072630|583784943|FG002|Overall Study|Other|1|||
161654485|NCT05032872|583784944|FG000|Overall Study|Adverse Event|1|||
161701341|NCT03653390|583955582|FG001|Overall Study|Death|0|||
161654486|NCT05032872|583784945|FG001|Overall Study|Adverse Event|0|||
161654487|NCT05032872|583784944|FG000|Overall Study|Lost to Follow-up|2|||
161654488|NCT05032872|583784945|FG001|Overall Study|Lost to Follow-up|4|||
161654489|NCT05032872|583784944|FG000|Overall Study|Withdrawal by Subject|4|||
161654490|NCT05032872|583784945|FG001|Overall Study|Withdrawal by Subject|3|||
161654491|NCT00338962|583784946|FG000|Overall Study|Lost to Follow-up|3|||
161654492|NCT00338962|583784947|FG001|Overall Study|Lost to Follow-up|3|||
161654493|NCT00338962|583784948|FG002|Overall Study|Lost to Follow-up|2|||
161701342|NCT03653390|583955583|FG002|Overall Study|Death|0|||
161701343|NCT03653390|583955581|FG000|Overall Study|Paper Survey Lost|1|||
161701344|NCT03653390|583955582|FG001|Overall Study|Paper Survey Lost|0|||
161701345|NCT03653390|583955583|FG002|Overall Study|Paper Survey Lost|0|||
161701346|NCT00849667|583955587|FG000|Overall Study|Withdrawal by Subject|16|||
161701347|NCT00849667|583955588|FG001|Overall Study|Withdrawal by Subject|33|||
161701348|NCT00849667|583955589|FG002|Overall Study|Withdrawal by Subject|35|||
161701349|NCT00849667|583955587|FG000|Overall Study|Lost to Follow-up|8|||
161701350|NCT00849667|583955588|FG001|Overall Study|Lost to Follow-up|8|||
161701351|NCT00849667|583955589|FG002|Overall Study|Lost to Follow-up|8|||
161701352|NCT00849667|583955587|FG000|Overall Study|Adverse Event|1|||
161701353|NCT00849667|583955588|FG001|Overall Study|Adverse Event|2|||
161837033|NCT01196078|584446525|FG000|Overall Study|Death|6|||
161837034|NCT01196078|584446526|FG001|Overall Study|Death|4|||
161837035|NCT02667288|584446527|FG000|Overall Study|Protocol Violation|5|||
161837036|NCT02667288|584446527|FG000|Overall Study|Lost to Follow-up|3|||
161837037|NCT02667288|584446527|FG000|Overall Study|Withdrawal by Subject|5|||
161837038|NCT02400671|584446528|FG000|Overall Study|Death|5|||
161837039|NCT02400671|584446529|FG001|Overall Study|Death|3|||
161654494|NCT00338962|583784949|FG003|Overall Study|Lost to Follow-up|3|||
161654495|NCT00338962|583784946|FG000|Overall Study|Withdrawal by Subject|1|||
161654496|NCT00338962|583784947|FG001|Overall Study|Withdrawal by Subject|0|||
161654497|NCT00338962|583784948|FG002|Overall Study|Withdrawal by Subject|0|||
161654498|NCT00338962|583784949|FG003|Overall Study|Withdrawal by Subject|0|||
161654499|NCT00338962|583784946|FG000|Overall Study|No Transportation|2|||
161654500|NCT00338962|583784947|FG001|Overall Study|No Transportation|0|||
161654501|NCT00338962|583784948|FG002|Overall Study|No Transportation|0|||
161654502|NCT00338962|583784949|FG003|Overall Study|No Transportation|0|||
161654503|NCT00338962|583784946|FG000|Overall Study|Time Constraint|2|||
161654504|NCT00338962|583784947|FG001|Overall Study|Time Constraint|0|||
161654505|NCT00338962|583784948|FG002|Overall Study|Time Constraint|0|||
161654506|NCT00338962|583784949|FG003|Overall Study|Time Constraint|0|||
161654507|NCT00338962|583784946|FG000|Overall Study|Moved|0|||
161654508|NCT00338962|583784947|FG001|Overall Study|Moved|1|||
161654509|NCT00338962|583784948|FG002|Overall Study|Moved|0|||
161654510|NCT00338962|583784949|FG003|Overall Study|Moved|0|||
161654511|NCT00338962|583784946|FG000|Overall Study|Adverse Event|0|||
161654512|NCT00338962|583784947|FG001|Overall Study|Adverse Event|0|||
161654513|NCT00338962|583784948|FG002|Overall Study|Adverse Event|2|||
161654514|NCT00338962|583784949|FG003|Overall Study|Adverse Event|0|||
161654515|NCT00338962|583784946|FG000|Overall Study|Poor Compliance|0|||
161654516|NCT00338962|583784947|FG001|Overall Study|Poor Compliance|0|||
161654517|NCT00338962|583784948|FG002|Overall Study|Poor Compliance|2|||
161654518|NCT00338962|583784949|FG003|Overall Study|Poor Compliance|0|||
161654519|NCT03733314|583784950|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
161654520|NCT03733314|583784951|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
161654521|NCT03733314|583784950|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
161654522|NCT03733314|583784951|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
161654523|NCT03733314|583784950|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
161654524|NCT03733314|583784951|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
161654525|NCT03733314|583784950|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
161654526|NCT03733314|583784951|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
161654527|NCT03733314|583784950|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
161654528|NCT03733314|583784951|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
161654529|NCT03733314|583784950|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
161654530|NCT03733314|583784951|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
161654531|NCT01598662|583784952|FG000|Overall Study|Lost to Follow-up|10|||
161654532|NCT01598662|583784953|FG001|Overall Study|Lost to Follow-up|17|||
161654533|NCT01598662|583784952|FG000|Overall Study|Physician Decision|1|||
161654534|NCT01598662|583784953|FG001|Overall Study|Physician Decision|2|||
161654535|NCT01598662|583784952|FG000|Overall Study|IUD expelled before month 6|0|||
161654536|NCT01598662|583784953|FG001|Overall Study|IUD expelled before month 6|2|||
161654537|NCT00910039|583784954|FG000|Overall Study|Physician Decision|1|||
161654538|NCT04155047|583784959|FG000|Overall Study|Adverse Event|1|||
161654539|NCT04155047|583784960|FG001|Overall Study|Adverse Event|0|||
161654540|NCT04155047|583784959|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
161654541|NCT04155047|583784960|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
161654542|NCT04514510|583784961|FG000|Overall Study|Lost to Follow-up|0|||
161701354|NCT00849667|583955589|FG002|Overall Study|Adverse Event|0|||
161837040|NCT02400671|584446530|FG002|Overall Study|Death|4|||
161837041|NCT02400671|584446528|FG000|Overall Study|Lost to Follow-up|20|||
161837042|NCT02400671|584446529|FG001|Overall Study|Lost to Follow-up|27|||
161701355|NCT00849667|583955587|FG000|Overall Study|Other|18|||
161837043|NCT02400671|584446530|FG002|Overall Study|Lost to Follow-up|24|||
161701356|NCT00849667|583955588|FG001|Overall Study|Other|19|||
161701357|NCT00849667|583955589|FG002|Overall Study|Other|18|||
161701358|NCT00849667|583955587|FG000|Overall Study|Progressive disease|119|||
161701359|NCT00849667|583955588|FG001|Overall Study|Progressive disease|100|||
161701360|NCT00849667|583955589|FG002|Overall Study|Progressive disease|112|||
161701361|NCT00849667|583955587|FG000|Overall Study|Sponsor decision|208|||
161701362|NCT00849667|583955588|FG001|Overall Study|Sponsor decision|204|||
161701363|NCT00849667|583955589|FG002|Overall Study|Sponsor decision|190|||
161701364|NCT00849667|583955587|FG000|Overall Study|Investigator discretion|0|||
161701365|NCT00849667|583955588|FG001|Overall Study|Investigator discretion|0|||
161701366|NCT00849667|583955589|FG002|Overall Study|Investigator discretion|1|||
161701367|NCT00189462|583955590|FG000|Overall Study|Lack of Efficacy|5|||
161701368|NCT00189462|583955591|FG001|Overall Study|Lack of Efficacy|1|||
161701369|NCT00189462|583955590|FG000|Overall Study|Lost to Follow-up|18|||
161701370|NCT00189462|583955591|FG001|Overall Study|Lost to Follow-up|20|||
161701371|NCT00553462|583955594|FG000|Overall Study|Adverse Event|4|||
161701372|NCT00553462|583955594|FG000|Overall Study|Progression|4|||
161701373|NCT00553462|583955594|FG000|Overall Study|Withdrawal by Subject|5|||
161701374|NCT00553462|583955594|FG000|Overall Study|Physician Decision|1|||
161701375|NCT01262625|583955595|FG000|Overall Study|Administrative Error|1|||
161701376|NCT01262625|583955596|FG001|Overall Study|Administrative Error|1|||
161701377|NCT01262625|583955595|FG000|Overall Study|Site Closed|1|||
161701378|NCT01262625|583955596|FG001|Overall Study|Site Closed|0|||
161701379|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
161701380|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
161701381|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Death|1|||
161701382|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Death|0|||
161701383|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
161701384|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
161701385|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
161701386|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
161701387|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
161701388|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
161701389|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|other reasons|2|||
161701390|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|other reasons|3|||
161701391|NCT00110994|583955597|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
161701392|NCT00110994|583955598|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
161701393|NCT00110994|583955597|FG000|Active Follow-up|Other reasons|0|||
161701394|NCT00110994|583955598|FG001|Active Follow-up|Other reasons|2|||
161701395|NCT00110994|583955597|FG000|Long Term Follow-up|Death|19|||
161701396|NCT00110994|583955598|FG001|Long Term Follow-up|Death|17|||
161701397|NCT04398732|583955599|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
161701398|NCT02772757|583955602|FG000|Overall Study|Withdrawal by Subject|1|||
161701399|NCT02772757|583955603|FG001|Overall Study|Withdrawal by Subject|0|||
161701400|NCT02772757|583955604|FG002|Overall Study|Withdrawal by Subject|1|||
161701401|NCT02772757|583955602|FG000|Overall Study|Protocol Violation|0|||
161701402|NCT02772757|583955603|FG001|Overall Study|Protocol Violation|0|||
161701403|NCT02772757|583955604|FG002|Overall Study|Protocol Violation|1|||
161701404|NCT02772757|583955602|FG000|Overall Study|Physician Decision|0|||
161701405|NCT02772757|583955603|FG001|Overall Study|Physician Decision|3|||
161701406|NCT02772757|583955604|FG002|Overall Study|Physician Decision|3|||
161701407|NCT00354601|583955611|FG000|Overall Study|Protocol Violation|1|||
161701408|NCT00354601|583955611|FG000|Overall Study|progression|1|||
161701409|NCT02532855|583955614|FG000|Overall Study|Lost to Follow-up|4|||
161701410|NCT02532855|583955615|FG001|Overall Study|Lost to Follow-up|3|||
161701411|NCT02532855|583955614|FG000|Overall Study|Withdrawal by Subject|4|||
161701412|NCT02532855|583955615|FG001|Overall Study|Withdrawal by Subject|8|||
161701413|NCT00666926|583955616|FG000|Overall Study|Adverse Event|0|||
161701414|NCT00666926|583955617|FG001|Overall Study|Adverse Event|0|||
161701415|NCT00666926|583955618|FG002|Overall Study|Adverse Event|0|||
161701416|NCT00666926|583955619|FG003|Overall Study|Adverse Event|0|||
161701417|NCT00666926|583955620|FG004|Overall Study|Adverse Event|0|||
161701418|NCT00666926|583955621|FG005|Overall Study|Adverse Event|0|||
161701419|NCT00666926|583955622|FG006|Overall Study|Adverse Event|0|||
161701420|NCT00666926|583955623|FG007|Overall Study|Adverse Event|0|||
161701421|NCT00666926|583955624|FG008|Overall Study|Adverse Event|0|||
161701422|NCT00666926|583955625|FG009|Overall Study|Adverse Event|2|||
161701423|NCT00666926|583955626|FG010|Overall Study|Adverse Event|2|||
161701424|NCT00666926|583955627|FG011|Overall Study|Adverse Event|2|||
161701425|NCT00666926|583955628|FG012|Overall Study|Adverse Event|0|||
161701426|NCT00666926|583955629|FG013|Overall Study|Adverse Event|1|||
161701427|NCT00666926|583955630|FG014|Overall Study|Adverse Event|0|||
161701428|NCT00666926|583955631|FG015|Overall Study|Adverse Event|0|||
161701429|NCT00666926|583955616|FG000|Overall Study|Laboratory abnormality|0|||
161701430|NCT00666926|583955617|FG001|Overall Study|Laboratory abnormality|0|||
161701431|NCT00666926|583955618|FG002|Overall Study|Laboratory abnormality|0|||
161701432|NCT00666926|583955619|FG003|Overall Study|Laboratory abnormality|0|||
161701433|NCT00666926|583955620|FG004|Overall Study|Laboratory abnormality|0|||
161654543|NCT04514510|583784962|FG001|Overall Study|Lost to Follow-up|1|||
161654544|NCT04514510|583784961|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
161654545|NCT04514510|583784962|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
161654546|NCT00821587|583784963|FG000|Overall Study|Physician Decision|0|||
161654547|NCT00821587|583784964|FG001|Overall Study|Physician Decision|1|||
161654548|NCT02781090|583784967|FG000|3-Month Follow-Up|Missed Visit|20|||
161654549|NCT02781090|583784968|FG001|3-Month Follow-Up|Missed Visit|20|||
161654550|NCT02781090|583784967|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
161654551|NCT02781090|583784968|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
161654552|NCT02781090|583784967|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
161654553|NCT02781090|583784968|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
161654554|NCT02781090|583784967|FG000|3-Month Follow-Up|Death|1|||
161654555|NCT02781090|583784968|FG001|3-Month Follow-Up|Death|0|||
161654556|NCT02781090|583784967|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
161654557|NCT02781090|583784968|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
161654558|NCT02781090|583784967|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
161654559|NCT02781090|583784968|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
161654560|NCT02781090|583784967|FG000|6-Month Follow-Up|Death|0|||
161654561|NCT02781090|583784968|FG001|6-Month Follow-Up|Death|1|||
161654562|NCT00643617|583784969|FG000|Overall Study|Death|6|||
161654563|NCT00643617|583784970|FG001|Overall Study|Death|9|||
161654564|NCT00643617|583784969|FG000|Overall Study|Lost to Follow-up|42|||
161654565|NCT00643617|583784970|FG001|Overall Study|Lost to Follow-up|51|||
161654566|NCT02075073|583784971|FG000|Overall Study|Withdrawal by Subject|0|||
161654567|NCT02075073|583784972|FG001|Overall Study|Withdrawal by Subject|1|||
161654568|NCT02075073|583784973|FG002|Overall Study|Withdrawal by Subject|0|||
161654569|NCT01208103|583784980|FG000|Overall Study|Adverse Event|1|||
161654570|NCT01208103|583784980|FG000|Overall Study|Withdrawal by Subject|1|||
161654571|NCT02683785|583784983|FG000|Overall Study|Withdrawal by Subject|1|||
161654572|NCT02683785|583784984|FG001|Overall Study|Withdrawal by Subject|1|||
161654573|NCT02683785|583784983|FG000|Overall Study|Lost to Follow-up|0|||
161654574|NCT02683785|583784984|FG001|Overall Study|Lost to Follow-up|1|||
161654575|NCT02683785|583784983|FG000|Overall Study|Adverse Event|0|||
161654576|NCT02683785|583784984|FG001|Overall Study|Adverse Event|2|||
161654577|NCT00416195|583784985|FG000|Overall Study|Adverse Event|1|||
161654578|NCT00416195|583784986|FG001|Overall Study|Adverse Event|2|||
161654579|NCT00416195|583784985|FG000|Overall Study|Protocol Violation|1|||
161654580|NCT00416195|583784986|FG001|Overall Study|Protocol Violation|1|||
161701434|NCT00666926|583955621|FG005|Overall Study|Laboratory abnormality|0|||
161654581|NCT00416195|583784985|FG000|Overall Study|Other|0|||
161654582|NCT00416195|583784986|FG001|Overall Study|Other|1|||
161654583|NCT01305408|583784991|FG000|Overall Study|Adverse Event|10|||
161654584|NCT01305408|583784992|FG001|Overall Study|Adverse Event|7|||
161654585|NCT01305408|583784991|FG000|Overall Study|Lack of Efficacy|3|||
161654586|NCT01305408|583784992|FG001|Overall Study|Lack of Efficacy|4|||
161654587|NCT01305408|583784991|FG000|Overall Study|Withdrawal by Subject|9|||
161654588|NCT01305408|583784992|FG001|Overall Study|Withdrawal by Subject|9|||
161654589|NCT01305408|583784991|FG000|Overall Study|Protocol Violation|4|||
161701435|NCT00666926|583955622|FG006|Overall Study|Laboratory abnormality|0|||
161701436|NCT00666926|583955623|FG007|Overall Study|Laboratory abnormality|0|||
161701437|NCT00666926|583955624|FG008|Overall Study|Laboratory abnormality|0|||
161701438|NCT00666926|583955625|FG009|Overall Study|Laboratory abnormality|0|||
161701439|NCT00666926|583955626|FG010|Overall Study|Laboratory abnormality|1|||
161701440|NCT00666926|583955627|FG011|Overall Study|Laboratory abnormality|0|||
161701441|NCT00666926|583955628|FG012|Overall Study|Laboratory abnormality|0|||
161701442|NCT00666926|583955629|FG013|Overall Study|Laboratory abnormality|0|||
161701443|NCT00666926|583955630|FG014|Overall Study|Laboratory abnormality|0|||
161701444|NCT00666926|583955631|FG015|Overall Study|Laboratory abnormality|1|||
161701445|NCT00666926|583955616|FG000|Overall Study|Lack of Efficacy|0|||
161701446|NCT00666926|583955617|FG001|Overall Study|Lack of Efficacy|0|||
161701447|NCT00666926|583955618|FG002|Overall Study|Lack of Efficacy|0|||
161701448|NCT00666926|583955619|FG003|Overall Study|Lack of Efficacy|0|||
161701449|NCT00666926|583955620|FG004|Overall Study|Lack of Efficacy|0|||
161701450|NCT00666926|583955621|FG005|Overall Study|Lack of Efficacy|1|||
161701451|NCT00666926|583955622|FG006|Overall Study|Lack of Efficacy|0|||
161701452|NCT00666926|583955623|FG007|Overall Study|Lack of Efficacy|0|||
161701453|NCT00666926|583955624|FG008|Overall Study|Lack of Efficacy|0|||
161701454|NCT00666926|583955625|FG009|Overall Study|Lack of Efficacy|0|||
161701455|NCT00666926|583955626|FG010|Overall Study|Lack of Efficacy|0|||
161701456|NCT00666926|583955627|FG011|Overall Study|Lack of Efficacy|1|||
161701457|NCT00666926|583955628|FG012|Overall Study|Lack of Efficacy|0|||
161701458|NCT00666926|583955629|FG013|Overall Study|Lack of Efficacy|0|||
161701459|NCT00666926|583955630|FG014|Overall Study|Lack of Efficacy|0|||
161701460|NCT00666926|583955631|FG015|Overall Study|Lack of Efficacy|0|||
161701461|NCT00666926|583955616|FG000|Overall Study|Lost to Follow-up|0|||
161701462|NCT00666926|583955617|FG001|Overall Study|Lost to Follow-up|0|||
161701463|NCT00666926|583955618|FG002|Overall Study|Lost to Follow-up|0|||
161701464|NCT00666926|583955619|FG003|Overall Study|Lost to Follow-up|1|||
161701465|NCT00666926|583955620|FG004|Overall Study|Lost to Follow-up|0|||
161701466|NCT00666926|583955621|FG005|Overall Study|Lost to Follow-up|0|||
161701467|NCT00666926|583955622|FG006|Overall Study|Lost to Follow-up|0|||
161837044|NCT02400671|584446528|FG000|Overall Study|Withdrawal by Subject|2|||
161837045|NCT02400671|584446529|FG001|Overall Study|Withdrawal by Subject|2|||
161837046|NCT02400671|584446530|FG002|Overall Study|Withdrawal by Subject|0|||
161654590|NCT01305408|583784992|FG001|Overall Study|Protocol Violation|6|||
161654591|NCT01305408|583784991|FG000|Overall Study|Lost to Follow-up|5|||
161654592|NCT01305408|583784992|FG001|Overall Study|Lost to Follow-up|3|||
161654593|NCT01305408|583784991|FG000|Overall Study|Noncompliance with study medication|0|||
161654594|NCT01305408|583784992|FG001|Overall Study|Noncompliance with study medication|1|||
161654595|NCT01305408|583784991|FG000|Overall Study|Noncompliance with study procedures|0|||
161654596|NCT01305408|583784992|FG001|Overall Study|Noncompliance with study procedures|1|||
161654597|NCT01305408|583784991|FG000|Overall Study|Other|1|||
161654598|NCT01305408|583784992|FG001|Overall Study|Other|0|||
161654599|NCT02770612|583784993|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
161654600|NCT02233803|583784994|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
161654601|NCT02233803|583784995|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
161654602|NCT02233803|583784994|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
161654603|NCT02233803|583784995|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
161654604|NCT02233803|583784994|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
161654605|NCT02233803|583784995|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
161654606|NCT02233803|583784994|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
161654607|NCT02233803|583784995|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
161654608|NCT02233803|583784994|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
161654609|NCT02233803|583784995|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
161654610|NCT02233803|583784994|FG000|Washout Period (4-Wks)|Physician Decision|1|||
161654611|NCT02233803|583784995|FG001|Washout Period (4-Wks)|Physician Decision|0|||
161654612|NCT02233803|583784994|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
161654613|NCT02233803|583784995|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
161654614|NCT02233803|583784994|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
161654615|NCT02233803|583784995|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
161654616|NCT02233803|583784994|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
161654617|NCT02233803|583784995|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
161654618|NCT03846453|583784996|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
161654619|NCT03846453|583784997|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
161654620|NCT03846453|583784998|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
161654621|NCT03846453|583784996|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
161654622|NCT03846453|583784997|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
161654623|NCT03846453|583784998|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
161654624|NCT03846453|583784996|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
161654625|NCT03846453|583784997|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
161654626|NCT03846453|583784998|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
161701468|NCT00666926|583955623|FG007|Overall Study|Lost to Follow-up|0|||
161701469|NCT00666926|583955624|FG008|Overall Study|Lost to Follow-up|0|||
161701470|NCT00666926|583955625|FG009|Overall Study|Lost to Follow-up|0|||
161701471|NCT00666926|583955626|FG010|Overall Study|Lost to Follow-up|0|||
161701472|NCT00666926|583955627|FG011|Overall Study|Lost to Follow-up|0|||
161701473|NCT00666926|583955628|FG012|Overall Study|Lost to Follow-up|0|||
161701474|NCT00666926|583955629|FG013|Overall Study|Lost to Follow-up|0|||
161701475|NCT00666926|583955630|FG014|Overall Study|Lost to Follow-up|0|||
161701476|NCT00666926|583955631|FG015|Overall Study|Lost to Follow-up|0|||
161701477|NCT00666926|583955616|FG000|Overall Study|Other|2|||
161701478|NCT00666926|583955617|FG001|Overall Study|Other|4|||
161701479|NCT00666926|583955618|FG002|Overall Study|Other|3|||
161701480|NCT00666926|583955619|FG003|Overall Study|Other|3|||
161701481|NCT00666926|583955620|FG004|Overall Study|Other|3|||
161701482|NCT00666926|583955621|FG005|Overall Study|Other|3|||
161701483|NCT00666926|583955622|FG006|Overall Study|Other|4|||
161701484|NCT00666926|583955623|FG007|Overall Study|Other|0|||
161701485|NCT00666926|583955624|FG008|Overall Study|Other|3|||
161701486|NCT00666926|583955625|FG009|Overall Study|Other|5|||
161701487|NCT00666926|583955626|FG010|Overall Study|Other|3|||
161701488|NCT00666926|583955627|FG011|Overall Study|Other|26|||
161701489|NCT00666926|583955628|FG012|Overall Study|Other|3|||
161701490|NCT00666926|583955629|FG013|Overall Study|Other|2|||
161701491|NCT00666926|583955630|FG014|Overall Study|Other|4|||
161701492|NCT00666926|583955631|FG015|Overall Study|Other|4|||
161701493|NCT00666926|583955616|FG000|Overall Study|Withdrawal by Subject|0|||
161701494|NCT00666926|583955617|FG001|Overall Study|Withdrawal by Subject|0|||
161701495|NCT00666926|583955618|FG002|Overall Study|Withdrawal by Subject|0|||
161701496|NCT00666926|583955619|FG003|Overall Study|Withdrawal by Subject|0|||
161701497|NCT00666926|583955620|FG004|Overall Study|Withdrawal by Subject|0|||
161701498|NCT00666926|583955621|FG005|Overall Study|Withdrawal by Subject|0|||
161701499|NCT00666926|583955622|FG006|Overall Study|Withdrawal by Subject|0|||
161701500|NCT00666926|583955623|FG007|Overall Study|Withdrawal by Subject|1|||
161701501|NCT00666926|583955624|FG008|Overall Study|Withdrawal by Subject|0|||
161701502|NCT00666926|583955625|FG009|Overall Study|Withdrawal by Subject|3|||
161701503|NCT00666926|583955626|FG010|Overall Study|Withdrawal by Subject|0|||
161701504|NCT00666926|583955627|FG011|Overall Study|Withdrawal by Subject|3|||
161701505|NCT00666926|583955628|FG012|Overall Study|Withdrawal by Subject|0|||
161837047|NCT01429051|584446531|FG000|Titration Phase|Death|1|||
161701506|NCT00666926|583955629|FG013|Overall Study|Withdrawal by Subject|1|||
161701507|NCT00666926|583955630|FG014|Overall Study|Withdrawal by Subject|3|||
161701508|NCT00666926|583955631|FG015|Overall Study|Withdrawal by Subject|3|||
161701509|NCT00666926|583955616|FG000|Overall Study|Death|0|||
161701510|NCT00666926|583955617|FG001|Overall Study|Death|0|||
161701511|NCT00666926|583955618|FG002|Overall Study|Death|0|||
161701512|NCT00666926|583955619|FG003|Overall Study|Death|0|||
161701513|NCT00666926|583955620|FG004|Overall Study|Death|0|||
161701514|NCT00666926|583955621|FG005|Overall Study|Death|0|||
161701515|NCT00666926|583955622|FG006|Overall Study|Death|0|||
161701516|NCT00666926|583955623|FG007|Overall Study|Death|0|||
161701517|NCT00666926|583955624|FG008|Overall Study|Death|0|||
161701518|NCT00666926|583955625|FG009|Overall Study|Death|0|||
161701519|NCT00666926|583955626|FG010|Overall Study|Death|0|||
161701520|NCT00666926|583955627|FG011|Overall Study|Death|1|||
161701521|NCT00666926|583955628|FG012|Overall Study|Death|0|||
161701522|NCT00666926|583955629|FG013|Overall Study|Death|0|||
161701523|NCT00666926|583955630|FG014|Overall Study|Death|0|||
161701524|NCT00666926|583955631|FG015|Overall Study|Death|0|||
161701525|NCT01960855|583955632|FG000|Overall Study|Subject noncompliant|1|||
161701526|NCT01960855|583955633|FG001|Overall Study|Subject noncompliant|0|||
161701527|NCT01960855|583955634|FG002|Overall Study|Subject noncompliant|0|||
161701528|NCT01960855|583955635|FG003|Overall Study|Subject noncompliant|0|||
161701529|NCT01960855|583955636|FG004|Overall Study|Subject noncompliant|0|||
161701530|NCT01960855|583955632|FG000|Overall Study|Adverse Event|2|||
161701531|NCT01960855|583955633|FG001|Overall Study|Adverse Event|0|||
161701532|NCT01960855|583955634|FG002|Overall Study|Adverse Event|6|||
161701533|NCT01960855|583955635|FG003|Overall Study|Adverse Event|2|||
161701534|NCT01960855|583955636|FG004|Overall Study|Adverse Event|2|||
161701535|NCT01960855|583955632|FG000|Overall Study|Lack of Efficacy|1|||
161701536|NCT01960855|583955633|FG001|Overall Study|Lack of Efficacy|1|||
161701537|NCT01960855|583955634|FG002|Overall Study|Lack of Efficacy|0|||
161701538|NCT01960855|583955635|FG003|Overall Study|Lack of Efficacy|0|||
161701539|NCT01960855|583955636|FG004|Overall Study|Lack of Efficacy|0|||
161701540|NCT01960855|583955632|FG000|Overall Study|Other|2|||
161701541|NCT01960855|583955633|FG001|Overall Study|Other|1|||
161701542|NCT01960855|583955634|FG002|Overall Study|Other|1|||
161701543|NCT01960855|583955635|FG003|Overall Study|Other|1|||
161701544|NCT01960855|583955636|FG004|Overall Study|Other|0|||
161701545|NCT01960855|583955632|FG000|Overall Study|Consent withdrawn by subject|3|||
161701546|NCT01960855|583955633|FG001|Overall Study|Consent withdrawn by subject|1|||
161701547|NCT01960855|583955634|FG002|Overall Study|Consent withdrawn by subject|2|||
161837048|NCT01429051|584446531|FG000|Titration Phase|Withdrawal by Subject|7|||
161701548|NCT01960855|583955635|FG003|Overall Study|Consent withdrawn by subject|1|||
161701549|NCT01960855|583955636|FG004|Overall Study|Consent withdrawn by subject|1|||
161701550|NCT01960855|583955632|FG000|Overall Study|Lost to Follow-up|2|||
161701551|NCT01960855|583955633|FG001|Overall Study|Lost to Follow-up|1|||
161701552|NCT01960855|583955634|FG002|Overall Study|Lost to Follow-up|0|||
161701553|NCT01960855|583955635|FG003|Overall Study|Lost to Follow-up|0|||
161701554|NCT01960855|583955636|FG004|Overall Study|Lost to Follow-up|2|||
161701555|NCT02471716|583955638|FG000|Overall Study|Withdrawal by Subject|0|||
161701556|NCT02471716|583955639|FG001|Overall Study|Withdrawal by Subject|1|||
161701557|NCT02471716|583955640|FG002|Overall Study|Withdrawal by Subject|0|||
161701558|NCT02471716|583955641|FG003|Overall Study|Withdrawal by Subject|2|||
161701559|NCT02471716|583955642|FG004|Overall Study|Withdrawal by Subject|5|||
161701560|NCT02471716|583955638|FG000|Overall Study|Study Terminiated by sponsor|0|||
161701561|NCT02471716|583955639|FG001|Overall Study|Study Terminiated by sponsor|0|||
161701562|NCT02471716|583955640|FG002|Overall Study|Study Terminiated by sponsor|0|||
161701563|NCT02471716|583955641|FG003|Overall Study|Study Terminiated by sponsor|1|||
161701564|NCT02471716|583955642|FG004|Overall Study|Study Terminiated by sponsor|0|||
161701565|NCT02471716|583955638|FG000|Overall Study|Lost to Follow-up|0|||
161701566|NCT02471716|583955639|FG001|Overall Study|Lost to Follow-up|0|||
161837049|NCT01429051|584446531|FG000|Titration Phase|Physician Decision|1|||
161701567|NCT02471716|583955640|FG002|Overall Study|Lost to Follow-up|0|||
161701568|NCT02471716|583955641|FG003|Overall Study|Lost to Follow-up|3|||
161701569|NCT02471716|583955642|FG004|Overall Study|Lost to Follow-up|2|||
161701570|NCT02471716|583955638|FG000|Overall Study|Death|0|||
161701571|NCT02471716|583955639|FG001|Overall Study|Death|0|||
161701572|NCT02471716|583955640|FG002|Overall Study|Death|0|||
161701573|NCT02471716|583955641|FG003|Overall Study|Death|1|||
161701574|NCT02471716|583955642|FG004|Overall Study|Death|0|||
161701575|NCT02471716|583955638|FG000|Overall Study|Other|0|||
161701576|NCT02471716|583955639|FG001|Overall Study|Other|0|||
161701577|NCT02471716|583955640|FG002|Overall Study|Other|0|||
161701578|NCT02471716|583955641|FG003|Overall Study|Other|8|||
161701579|NCT02471716|583955642|FG004|Overall Study|Other|9|||
161701580|NCT00330187|583955655|FG000|Overall Study|Lost to Follow-up|12|||
161701581|NCT00330187|583955656|FG001|Overall Study|Lost to Follow-up|13|||
161701582|NCT00330187|583955657|FG002|Overall Study|Lost to Follow-up|14|||
161701583|NCT00330187|583955658|FG003|Overall Study|Lost to Follow-up|10|||
161701584|NCT00330187|583955655|FG000|Overall Study|Withdrawal by Subject|8|||
161701585|NCT00330187|583955656|FG001|Overall Study|Withdrawal by Subject|5|||
161701586|NCT00330187|583955657|FG002|Overall Study|Withdrawal by Subject|4|||
161701587|NCT00330187|583955658|FG003|Overall Study|Withdrawal by Subject|4|||
161701588|NCT01162421|583955664|FG000|Overall Study|Did not receive study drug|2|||
161701589|NCT01162421|583955665|FG001|Overall Study|Did not receive study drug|1|||
161701590|NCT01162421|583955664|FG000|Overall Study|Adverse Event|2|||
161701591|NCT01162421|583955665|FG001|Overall Study|Adverse Event|5|||
161701592|NCT01162421|583955664|FG000|Overall Study|Lost to Follow-up|0|||
161701593|NCT01162421|583955665|FG001|Overall Study|Lost to Follow-up|2|||
161701594|NCT01162421|583955664|FG000|Overall Study|Lack of Efficacy|2|||
161701595|NCT01162421|583955665|FG001|Overall Study|Lack of Efficacy|2|||
161701596|NCT01162421|583955664|FG000|Overall Study|Other|2|||
161701597|NCT01162421|583955665|FG001|Overall Study|Other|3|||
161701598|NCT01133171|583955669|FG000|Overall Study|Withdrawal by Subject|1|||
161701599|NCT01133171|583955670|FG001|Overall Study|Withdrawal by Subject|2|||
161701600|NCT01133171|583955671|FG002|Overall Study|Withdrawal by Subject|0|||
161701601|NCT02526550|583955672|FG000|Overall Study|Lost to Follow-up|1|||
161701602|NCT03434379|583955676|FG000|Global Period|Lost to Follow-up|3|||
161701603|NCT03434379|583955677|FG001|Global Period|Lost to Follow-up|6|||
161701604|NCT03434379|583955678|FG002|Global Period|Lost to Follow-up|0|||
161701605|NCT03434379|583955679|FG003|Global Period|Lost to Follow-up|0|||
161701606|NCT03434379|583955676|FG000|Global Period|Death|115|||
161701607|NCT03434379|583955677|FG001|Global Period|Death|228|||
161701608|NCT03434379|583955678|FG002|Global Period|Death|0|||
161701609|NCT03434379|583955679|FG003|Global Period|Death|0|||
161701610|NCT03434379|583955676|FG000|Global Period|Withdrawal by Subject|20|||
161701611|NCT03434379|583955677|FG001|Global Period|Withdrawal by Subject|21|||
161701612|NCT03434379|583955678|FG002|Global Period|Withdrawal by Subject|0|||
161701613|NCT03434379|583955679|FG003|Global Period|Withdrawal by Subject|0|||
161701614|NCT03434379|583955676|FG000|Global Period|Reason Unspecified|0|||
161701615|NCT03434379|583955677|FG001|Global Period|Reason Unspecified|1|||
161701616|NCT03434379|583955678|FG002|Global Period|Reason Unspecified|0|||
161701617|NCT03434379|583955679|FG003|Global Period|Reason Unspecified|0|||
161701618|NCT03434379|583955676|FG000|Global Period|Study Ended by Sponsor|26|||
161701619|NCT03434379|583955677|FG001|Global Period|Study Ended by Sponsor|80|||
161701620|NCT03434379|583955678|FG002|Global Period|Study Ended by Sponsor|0|||
161701621|NCT03434379|583955679|FG003|Global Period|Study Ended by Sponsor|0|||
161837050|NCT01429051|584446531|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
161837051|NCT01429051|584446531|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
161701622|NCT03434379|583955676|FG000|Global Period|Physician Decision|1|||
161701623|NCT03434379|583955677|FG001|Global Period|Physician Decision|0|||
161701624|NCT03434379|583955678|FG002|Global Period|Physician Decision|0|||
161701625|NCT03434379|583955679|FG003|Global Period|Physician Decision|0|||
161701626|NCT03434379|583955676|FG000|China Extension Period|Lost to Follow-up|0|||
161701627|NCT03434379|583955677|FG001|China Extension Period|Lost to Follow-up|0|||
161701628|NCT03434379|583955678|FG002|China Extension Period|Lost to Follow-up|2|||
161701629|NCT03434379|583955679|FG003|China Extension Period|Lost to Follow-up|3|||
161701630|NCT03434379|583955676|FG000|China Extension Period|Death|0|||
161701631|NCT03434379|583955677|FG001|China Extension Period|Death|0|||
161701632|NCT03434379|583955678|FG002|China Extension Period|Death|46|||
161701633|NCT03434379|583955679|FG003|China Extension Period|Death|88|||
161701634|NCT03434379|583955676|FG000|China Extension Period|Withdrawal by Subject|0|||
161701635|NCT03434379|583955677|FG001|China Extension Period|Withdrawal by Subject|0|||
161701636|NCT03434379|583955678|FG002|China Extension Period|Withdrawal by Subject|8|||
161701637|NCT03434379|583955679|FG003|China Extension Period|Withdrawal by Subject|6|||
161701638|NCT03434379|583955676|FG000|China Extension Period|Study Ended by Sponsor|0|||
161701639|NCT03434379|583955677|FG001|China Extension Period|Study Ended by Sponsor|0|||
161701640|NCT03434379|583955678|FG002|China Extension Period|Study Ended by Sponsor|5|||
161701641|NCT03434379|583955679|FG003|China Extension Period|Study Ended by Sponsor|36|||
161701642|NCT00686647|583955683|FG000|Overall Study|Lost to Follow-up|1|||
161701643|NCT00686647|583955683|FG000|Overall Study|Death|1|||
161701644|NCT00578643|583955684|FG000|Overall Study|Death|1|||
161701645|NCT00578643|583955684|FG000|Overall Study|Lost to Follow-up|1|||
161701646|NCT01725750|583955685|FG000|Overall Study|Adverse Event|1|||
161701647|NCT01725750|583955686|FG001|Overall Study|Adverse Event|0|||
161701648|NCT01725750|583955685|FG000|Overall Study|Lost to Follow-up|1|||
161701649|NCT01725750|583955686|FG001|Overall Study|Lost to Follow-up|1|||
161701650|NCT01725750|583955685|FG000|Overall Study|Withdrawal by Subject|0|||
161701651|NCT01725750|583955686|FG001|Overall Study|Withdrawal by Subject|9|||
161701652|NCT03179436|583955689|FG000|Overall Study|Withdrawal by Subject|1|||
161701653|NCT03179436|583955690|FG001|Overall Study|Withdrawal by Subject|0|||
161701654|NCT03179436|583955691|FG002|Overall Study|Withdrawal by Subject|0|||
161701655|NCT03179436|583955692|FG003|Overall Study|Withdrawal by Subject|4|||
161701656|NCT03179436|583955693|FG004|Overall Study|Withdrawal by Subject|2|||
161701657|NCT03179436|583955694|FG005|Overall Study|Withdrawal by Subject|2|||
161701658|NCT03179436|583955695|FG006|Overall Study|Withdrawal by Subject|5|||
161701659|NCT03179436|583955696|FG007|Overall Study|Withdrawal by Subject|0|||
161701660|NCT03179436|583955697|FG008|Overall Study|Withdrawal by Subject|3|||
161701661|NCT03179436|583955698|FG009|Overall Study|Withdrawal by Subject|0|||
161837052|NCT01429051|584446531|FG000|Efficacy Phase|Adverse Event|1|||
161837053|NCT01429051|584446531|FG000|Efficacy Phase|Death|1|||
161837054|NCT01429051|584446531|FG000|Tolerability Phase|Death|5|||
161837055|NCT01429051|584446531|FG000|Tolerability Phase|Adverse Event|2|||
161837056|NCT01429051|584446531|FG000|Tolerability Phase|Withdrawal by Subject|5|||
161837057|NCT01429051|584446531|FG000|Tolerability Phase|Physician Decision|1|||
161837058|NCT01429051|584446531|FG000|Tolerability Phase|Other|2|||
161701662|NCT03179436|583955699|FG010|Overall Study|Withdrawal by Subject|0|||
161701663|NCT03179436|583955700|FG011|Overall Study|Withdrawal by Subject|0|||
161701664|NCT03179436|583955689|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161701665|NCT03179436|583955690|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161701666|NCT03179436|583955691|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161701667|NCT03179436|583955692|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161701668|NCT03179436|583955693|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161701669|NCT03179436|583955694|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161701670|NCT03179436|583955695|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161701671|NCT03179436|583955696|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
161701672|NCT03179436|583955697|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
161701673|NCT03179436|583955698|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
161701674|NCT03179436|583955699|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
161701675|NCT03179436|583955700|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
161701676|NCT03179436|583955689|FG000|Overall Study|Sponsor Decision|0|||
161701677|NCT03179436|583955690|FG001|Overall Study|Sponsor Decision|0|||
161701678|NCT03179436|583955691|FG002|Overall Study|Sponsor Decision|1|||
161701679|NCT03179436|583955692|FG003|Overall Study|Sponsor Decision|3|||
161701680|NCT03179436|583955693|FG004|Overall Study|Sponsor Decision|9|||
161701681|NCT03179436|583955694|FG005|Overall Study|Sponsor Decision|7|||
161701682|NCT03179436|583955695|FG006|Overall Study|Sponsor Decision|2|||
161701683|NCT03179436|583955696|FG007|Overall Study|Sponsor Decision|4|||
161701684|NCT03179436|583955697|FG008|Overall Study|Sponsor Decision|23|||
161701685|NCT03179436|583955698|FG009|Overall Study|Sponsor Decision|6|||
161701686|NCT03179436|583955699|FG010|Overall Study|Sponsor Decision|7|||
161701687|NCT03179436|583955700|FG011|Overall Study|Sponsor Decision|5|||
161701688|NCT03179436|583955689|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701689|NCT03179436|583955690|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
161701690|NCT03179436|583955691|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701691|NCT03179436|583955692|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701692|NCT03179436|583955693|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701693|NCT03179436|583955694|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
161701694|NCT03179436|583955695|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701695|NCT03179436|583955696|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701696|NCT03179436|583955697|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701697|NCT03179436|583955698|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701698|NCT03179436|583955699|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701699|NCT03179436|583955700|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701700|NCT03179436|583955689|FG000|Overall Study|Lost to Follow-up|1|||
161701701|NCT03179436|583955690|FG001|Overall Study|Lost to Follow-up|0|||
161701702|NCT03179436|583955691|FG002|Overall Study|Lost to Follow-up|0|||
161701703|NCT03179436|583955692|FG003|Overall Study|Lost to Follow-up|1|||
161701704|NCT03179436|583955693|FG004|Overall Study|Lost to Follow-up|0|||
161701705|NCT03179436|583955694|FG005|Overall Study|Lost to Follow-up|1|||
161701706|NCT03179436|583955695|FG006|Overall Study|Lost to Follow-up|0|||
161701707|NCT03179436|583955696|FG007|Overall Study|Lost to Follow-up|0|||
161701708|NCT03179436|583955697|FG008|Overall Study|Lost to Follow-up|1|||
161701709|NCT03179436|583955698|FG009|Overall Study|Lost to Follow-up|1|||
161701710|NCT03179436|583955699|FG010|Overall Study|Lost to Follow-up|0|||
161701711|NCT03179436|583955700|FG011|Overall Study|Lost to Follow-up|0|||
161701712|NCT03179436|583955689|FG000|Overall Study|Death|12|||
161701713|NCT03179436|583955690|FG001|Overall Study|Death|17|||
161701714|NCT03179436|583955691|FG002|Overall Study|Death|7|||
161701715|NCT03179436|583955692|FG003|Overall Study|Death|32|||
161701716|NCT03179436|583955693|FG004|Overall Study|Death|29|||
161701717|NCT03179436|583955694|FG005|Overall Study|Death|30|||
161701718|NCT03179436|583955695|FG006|Overall Study|Death|33|||
161701719|NCT03179436|583955696|FG007|Overall Study|Death|9|||
161701720|NCT03179436|583955697|FG008|Overall Study|Death|84|||
161701721|NCT03179436|583955698|FG009|Overall Study|Death|33|||
161701722|NCT03179436|583955699|FG010|Overall Study|Death|22|||
161701723|NCT03179436|583955700|FG011|Overall Study|Death|15|||
161701724|NCT02474329|583955701|FG000|Overall Study|Withdraw or did not contribute data.|13|||
161701725|NCT01634555|583955702|FG000|Overall Study|Adverse Event|3|||
161701726|NCT01634555|583955702|FG000|Overall Study|Physician Decision|1|||
161701727|NCT01506882|583955703|FG000|Overall Study|Lack of Efficacy|4|||
161701728|NCT01506882|583955704|FG001|Overall Study|Lack of Efficacy|3|||
161701729|NCT01506882|583955703|FG000|Overall Study|Lost to Follow-up|1|||
161701730|NCT01506882|583955704|FG001|Overall Study|Lost to Follow-up|0|||
161701731|NCT01506882|583955703|FG000|Overall Study|Withdrawal by Subject|9|||
161701732|NCT01506882|583955704|FG001|Overall Study|Withdrawal by Subject|3|||
161701733|NCT01506882|583955703|FG000|Overall Study|SAE, non-fatal|2|||
161701734|NCT01506882|583955704|FG001|Overall Study|SAE, non-fatal|0|||
161701735|NCT01506882|583955703|FG000|Overall Study|AE, non-serious non-fatal|3|||
161701736|NCT01506882|583955704|FG001|Overall Study|AE, non-serious non-fatal|1|||
161701737|NCT01506882|583955703|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161701738|NCT01506882|583955704|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161701739|NCT01506882|583955703|FG000|Overall Study|Other Reason|2|||
161701740|NCT01506882|583955704|FG001|Overall Study|Other Reason|0|||
161701741|NCT03617705|583957308|FG000|Overall Study|Withdrawal by Subject|2|||
161701742|NCT03617705|583957308|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
161701743|NCT03617705|583957308|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
161701744|NCT03502187|583957309|FG000|Overall Study|Withdrawal by Subject|4|||
161701745|NCT03502187|583957310|FG001|Overall Study|Withdrawal by Subject|3|||
161837059|NCT00857792|584446533|FG000|Overall Study|inadequate image quality for analysis|12|||
161837060|NCT03733210|584446535|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
161837061|NCT03733210|584446536|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
161701746|NCT03502187|583957311|FG002|Overall Study|Withdrawal by Subject|3|||
161701747|NCT03502187|583957309|FG000|Overall Study|Lost to Follow-up|5|||
161701748|NCT03502187|583957310|FG001|Overall Study|Lost to Follow-up|4|||
161701749|NCT03502187|583957311|FG002|Overall Study|Lost to Follow-up|5|||
161701750|NCT06118385|583957312|FG000|Overall Study|Protocol Violation|0|||
161701751|NCT06118385|583957313|FG001|Overall Study|Protocol Violation|0|||
161701752|NCT06118385|583957314|FG002|Overall Study|Protocol Violation|0|||
161701753|NCT06118385|583957315|FG003|Overall Study|Protocol Violation|0|||
161701754|NCT06118385|583957316|FG004|Overall Study|Protocol Violation|0|||
161701755|NCT06118385|583957317|FG005|Overall Study|Protocol Violation|0|||
161654627|NCT03846453|583784996|FG000|Placebo Run-in (14 Days)|Other|2|||
161701756|NCT06118385|583957318|FG006|Overall Study|Protocol Violation|0|||
161701757|NCT06118385|583957319|FG007|Overall Study|Protocol Violation|0|||
161701758|NCT06118385|583957320|FG008|Overall Study|Protocol Violation|1|||
161701759|NCT06118385|583957321|FG009|Overall Study|Protocol Violation|0|||
161701760|NCT06118385|583957322|FG010|Overall Study|Protocol Violation|0|||
161701761|NCT06118385|583957323|FG011|Overall Study|Protocol Violation|0|||
161701762|NCT06118385|583957312|FG000|Overall Study|Out-of-range blood tests|0|||
161701763|NCT06118385|583957313|FG001|Overall Study|Out-of-range blood tests|0|||
161654628|NCT03846453|583784997|FG001|Placebo Run-in (14 Days)|Other|0|||
161654629|NCT03846453|583784998|FG002|Placebo Run-in (14 Days)|Other|0|||
161654630|NCT03846453|583784996|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
161654631|NCT03846453|583784997|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
161654632|NCT03846453|583784998|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
161654633|NCT03846453|583784996|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
161654634|NCT03846453|583784997|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
161654635|NCT03846453|583784998|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
161654636|NCT03846453|583784996|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
161654637|NCT03846453|583784997|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
161654638|NCT03846453|583784998|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
161654639|NCT03846453|583784996|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
161654640|NCT03846453|583784997|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
161654641|NCT03846453|583784998|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
161654642|NCT03846453|583784996|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
161654643|NCT03846453|583784997|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
161654644|NCT03846453|583784998|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
161654645|NCT00468143|583784999|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
161654646|NCT00468143|583785000|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
161654647|NCT00468143|583784999|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
161654648|NCT00468143|583785000|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
161654649|NCT01606670|583785003|FG000|Overall Study|Adverse Event|6|||
161654650|NCT01606670|583785003|FG000|Overall Study|Lack of Efficacy|2|||
161654651|NCT01606670|583785003|FG000|Overall Study|Lost to Follow-up|3|||
161654652|NCT01606670|583785003|FG000|Overall Study|Withdrawal by Subject|3|||
161654653|NCT01606670|583785003|FG000|Overall Study|Other Reason|2|||
161654654|NCT00886795|583785008|FG000|Overall Study|Lack of Efficacy|1|||
161654655|NCT01877239|583785011|FG000|Overall Study|Adverse Event|4|||
161654656|NCT01877239|583785011|FG000|Overall Study|Disease Remission|1|||
161654657|NCT01877239|583785011|FG000|Overall Study|Withdrawal by Subject|4|||
161654658|NCT01877239|583785011|FG000|Overall Study|Other|2|||
161654659|NCT01877239|583785011|FG000|Overall Study|Lack of Efficacy|4|||
161654660|NCT01877239|583785011|FG000|Overall Study|Data not available|35|||
161654661|NCT01989169|583785014|FG000|Period 2|Adverse Event|0|||
161654662|NCT01989169|583785015|FG001|Period 2|Adverse Event|1|||
161654663|NCT01114880|583785016|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
161654664|NCT01114880|583785017|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
161654665|NCT01114880|583785016|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
161654666|NCT01114880|583785017|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
161654667|NCT01114880|583785016|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
161654668|NCT01114880|583785017|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
161654669|NCT01114880|583785016|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
161654670|NCT01114880|583785017|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
161654671|NCT01114880|583785016|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
161654672|NCT01114880|583785017|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
161654673|NCT01114880|583785016|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
161654674|NCT01114880|583785017|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
161654675|NCT04531904|583785019|FG000|Overall Study|Lost to Follow-up|1|||
161654676|NCT04531904|583785019|FG000|Overall Study|Death|14|||
161654677|NCT00283244|583785020|FG000|Overall Study|Adverse Event|0|||
161654678|NCT00283244|583785021|FG001|Overall Study|Adverse Event|8|||
161654679|NCT00283244|583785022|FG002|Overall Study|Adverse Event|11|||
161654680|NCT00283244|583785020|FG000|Overall Study|Death|4|||
161654681|NCT00283244|583785021|FG001|Overall Study|Death|3|||
161654682|NCT00283244|583785022|FG002|Overall Study|Death|2|||
161654683|NCT00283244|583785020|FG000|Overall Study|Lack of Efficacy|8|||
161654684|NCT00283244|583785021|FG001|Overall Study|Lack of Efficacy|32|||
161654685|NCT00283244|583785022|FG002|Overall Study|Lack of Efficacy|26|||
161654686|NCT00283244|583785020|FG000|Overall Study|Withdrawal by Subject|1|||
161654687|NCT00283244|583785021|FG001|Overall Study|Withdrawal by Subject|2|||
161654688|NCT00283244|583785022|FG002|Overall Study|Withdrawal by Subject|2|||
161701764|NCT06118385|583957314|FG002|Overall Study|Out-of-range blood tests|0|||
161701765|NCT06118385|583957315|FG003|Overall Study|Out-of-range blood tests|0|||
161654689|NCT00283244|583785020|FG000|Overall Study|Physician Decision|0|||
161701766|NCT06118385|583957316|FG004|Overall Study|Out-of-range blood tests|0|||
161701767|NCT06118385|583957317|FG005|Overall Study|Out-of-range blood tests|0|||
161701768|NCT06118385|583957318|FG006|Overall Study|Out-of-range blood tests|0|||
161701769|NCT06118385|583957319|FG007|Overall Study|Out-of-range blood tests|0|||
161701770|NCT06118385|583957320|FG008|Overall Study|Out-of-range blood tests|1|||
161701771|NCT06118385|583957321|FG009|Overall Study|Out-of-range blood tests|0|||
161701772|NCT06118385|583957322|FG010|Overall Study|Out-of-range blood tests|0|||
161701773|NCT06118385|583957323|FG011|Overall Study|Out-of-range blood tests|0|||
161701774|NCT01554579|583957324|FG000|Overall Study|Adverse Event|6|||
161701775|NCT01554579|583957325|FG001|Overall Study|Adverse Event|25|||
161701776|NCT01554579|583957324|FG000|Overall Study|Lack of Efficacy|2|||
161701777|NCT01554579|583957325|FG001|Overall Study|Lack of Efficacy|1|||
161701778|NCT01554579|583957324|FG000|Overall Study|Withdrawal by Subject|2|||
161701779|NCT01554579|583957325|FG001|Overall Study|Withdrawal by Subject|1|||
161701780|NCT03072160|583957326|FG000|Overall Study|Adverse Event|3|||
161701781|NCT03072160|583957327|FG001|Overall Study|Adverse Event|1|||
161701782|NCT03072160|583957326|FG000|Overall Study|Refused further treatment|6|||
161701783|NCT03072160|583957327|FG001|Overall Study|Refused further treatment|1|||
161701784|NCT03072160|583957326|FG000|Overall Study|Physician Decision|1|||
161701785|NCT03072160|583957327|FG001|Overall Study|Physician Decision|0|||
161701786|NCT03072160|583957326|FG000|Overall Study|Disease progression on study|1|||
161701787|NCT03072160|583957327|FG001|Overall Study|Disease progression on study|1|||
161701788|NCT03072160|583957326|FG000|Overall Study|No contact|0|||
161701789|NCT03072160|583957327|FG001|Overall Study|No contact|1|||
161701790|NCT01046695|583957328|FG000|Overall Study|Subject had a pacemaker|0|||
161701791|NCT01046695|583957329|FG001|Overall Study|Subject had a pacemaker|1|||
161701792|NCT01046695|583957328|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
161701793|NCT01046695|583957329|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
161701794|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Death|3|||
161701795|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Death|4|||
161701796|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
161701797|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
161701798|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
161701799|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
161701800|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
161701801|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
161701802|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
161701803|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
161701804|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Death|1|||
161701805|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Death|3|||
161701806|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
161701807|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
161701808|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
161701809|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
161701810|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
161701811|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
161701812|NCT01500057|583957332|FG000|Overall Study|Lost to Follow-up|6|||
161701813|NCT01500057|583957333|FG001|Overall Study|Lost to Follow-up|4|||
161701814|NCT03213366|583957335|FG000|Overall Study|Lost to Follow-up|9|||
161701815|NCT03213366|583957336|FG001|Overall Study|Lost to Follow-up|4|||
161701816|NCT02058147|583957337|FG000|Overall Study|Randomized but not treated|0|||
161701817|NCT02058147|583957338|FG001|Overall Study|Randomized but not treated|0|||
161701818|NCT02058147|583957339|FG002|Overall Study|Randomized but not treated|1|||
161701819|NCT02058147|583957337|FG000|Overall Study|Adverse Event|12|||
161701820|NCT02058147|583957338|FG001|Overall Study|Adverse Event|9|||
161701821|NCT02058147|583957339|FG002|Overall Study|Adverse Event|21|||
161701822|NCT02058147|583957337|FG000|Overall Study|Lack of Efficacy|1|||
161837062|NCT03760250|584446537|FG000|Overall Study|Withdrawal by Subject|1|||
161837063|NCT03760250|584446537|FG000|Overall Study|Physician Decision|1|||
161701823|NCT02058147|583957338|FG001|Overall Study|Lack of Efficacy|0|||
161837064|NCT04421586|584446538|FG000|Overall Study|Death|0|||
161837065|NCT04421586|584446539|FG001|Overall Study|Death|1|||
161701824|NCT02058147|583957339|FG002|Overall Study|Lack of Efficacy|3|||
161701825|NCT02058147|583957337|FG000|Overall Study|Poor compliance to protocol|8|||
161701826|NCT02058147|583957338|FG001|Overall Study|Poor compliance to protocol|9|||
161701827|NCT02058147|583957339|FG002|Overall Study|Poor compliance to protocol|4|||
161701828|NCT02058147|583957337|FG000|Overall Study|Other than specified|8|||
161701829|NCT02058147|583957338|FG001|Overall Study|Other than specified|9|||
161701830|NCT02058147|583957339|FG002|Overall Study|Other than specified|0|||
161654690|NCT00283244|583785021|FG001|Overall Study|Physician Decision|0|||
161654691|NCT00283244|583785022|FG002|Overall Study|Physician Decision|1|||
161654692|NCT00283244|583785020|FG000|Overall Study|Medical illness (other complicating dz)|4|||
161654693|NCT00283244|583785021|FG001|Overall Study|Medical illness (other complicating dz)|3|||
161654694|NCT00283244|583785022|FG002|Overall Study|Medical illness (other complicating dz)|6|||
161654695|NCT00283244|583785020|FG000|Overall Study|Clinical deterioration|1|||
161654696|NCT00283244|583785021|FG001|Overall Study|Clinical deterioration|3|||
161654697|NCT00283244|583785022|FG002|Overall Study|Clinical deterioration|3|||
161654698|NCT02738853|583785025|FG000|Enrollment|Inclusion/Exclusion not met|21|||
161654699|NCT02738853|583785025|FG000|Enrollment|Withdrawal by Subject|3|||
161654700|NCT02738853|583785025|FG000|Enrollment|Subject treated with commercially available device|6|||
161654701|NCT02738853|583785025|FG000|Enrollment|Study Enrollment Closed|3|||
161654702|NCT02738853|583785025|FG000|Procedure|Death|1|||
161654703|NCT02738853|583785025|FG000|1 Month|Death|2|||
161654704|NCT02738853|583785025|FG000|6 Month|Death|4|||
161654705|NCT02738853|583785025|FG000|6 Month|Withdrawal by Subject|2|||
161654706|NCT02738853|583785025|FG000|1 Year|Death|6|||
161654707|NCT02738853|583785025|FG000|1 Year|Withdrawal by Subject|1|||
161654708|NCT02738853|583785025|FG000|2 Year|Death|2|||
161654709|NCT02738853|583785025|FG000|2 Year|Lost to Follow-up|1|||
161654710|NCT02738853|583785025|FG000|3 Year|Death|2|||
161654711|NCT02738853|583785025|FG000|3 Year|Withdrawal by Subject|1|||
161654712|NCT02738853|583785025|FG000|4 Year|Death|9|||
161654713|NCT02738853|583785025|FG000|5 Year|Lost to Follow-up|4|||
161654714|NCT03519997|583785026|FG000|Overall Study|Adverse Event|4|||
161654715|NCT03519997|583785026|FG000|Overall Study|Withdrawal by Subject|2|||
161654716|NCT03519997|583785026|FG000|Overall Study|Protocol Violation|1|||
161654717|NCT03361605|583785027|FG000|Overall Study|Analyzable data not available|3|||
161654718|NCT03520712|583785028|FG000|Overall Study|Early termination of the study by Sponsor|2|||
161654719|NCT04372121|583785029|FG000|Overall Study|Lost to Follow-up|0|||
161654720|NCT04372121|583785030|FG001|Overall Study|Lost to Follow-up|0|||
161654721|NCT04372121|583785031|FG002|Overall Study|Lost to Follow-up|0|||
161654722|NCT04372121|583785032|FG003|Overall Study|Lost to Follow-up|1|||
161654723|NCT04372121|583785029|FG000|Overall Study|Protocol Violation|0|||
161654724|NCT04372121|583785030|FG001|Overall Study|Protocol Violation|0|||
161654725|NCT04372121|583785031|FG002|Overall Study|Protocol Violation|1|||
161654726|NCT04372121|583785032|FG003|Overall Study|Protocol Violation|0|||
161654727|NCT04372121|583785029|FG000|Overall Study|Withdrawal by Subject|3|||
161654728|NCT04372121|583785030|FG001|Overall Study|Withdrawal by Subject|1|||
161654729|NCT04372121|583785031|FG002|Overall Study|Withdrawal by Subject|0|||
161654730|NCT04372121|583785032|FG003|Overall Study|Withdrawal by Subject|0|||
161654731|NCT04372121|583785029|FG000|Overall Study|Study termination|6|||
161654732|NCT04372121|583785030|FG001|Overall Study|Study termination|5|||
161654733|NCT04372121|583785031|FG002|Overall Study|Study termination|1|||
161654734|NCT04372121|583785032|FG003|Overall Study|Study termination|1|||
161654735|NCT04372121|583785029|FG000|Overall Study|Hysterectomy planned|1|||
161654736|NCT04372121|583785030|FG001|Overall Study|Hysterectomy planned|0|||
161654737|NCT04372121|583785031|FG002|Overall Study|Hysterectomy planned|0|||
161654738|NCT04372121|583785032|FG003|Overall Study|Hysterectomy planned|0|||
161654739|NCT02344290|583785036|FG000|Overall Study|Withdrawal by Subject|315|||
161654740|NCT02344290|583785037|FG001|Overall Study|Withdrawal by Subject|324|||
161654741|NCT02344290|583785036|FG000|Overall Study|Lost to Follow-up|258|||
161654742|NCT02344290|583785037|FG001|Overall Study|Lost to Follow-up|249|||
161654743|NCT02344290|583785036|FG000|Overall Study|Unable to get to clinic|69|||
161654744|NCT02344290|583785037|FG001|Overall Study|Unable to get to clinic|60|||
161654745|NCT02344290|583785036|FG000|Overall Study|Physician Decision|25|||
161654746|NCT02344290|583785037|FG001|Overall Study|Physician Decision|25|||
161654747|NCT02344290|583785036|FG000|Overall Study|Site Closure|15|||
161654748|NCT02344290|583785037|FG001|Overall Study|Site Closure|19|||
161654749|NCT02344290|583785036|FG000|Overall Study|Other|5|||
161654750|NCT02344290|583785037|FG001|Overall Study|Other|3|||
161654751|NCT00591370|583786510|FG000|Overall Study|Not Treated|2|||
161654752|NCT01183260|583786511|FG000|Overall Study|Intraop screen failure|2|||
161654753|NCT01183260|583786512|FG001|Overall Study|Intraop screen failure|0|||
161654754|NCT01183260|583786511|FG000|Overall Study|Withdrawal by Subject|1|||
161654755|NCT01183260|583786512|FG001|Overall Study|Withdrawal by Subject|1|||
161654756|NCT01183260|583786511|FG000|Overall Study|Revised within 30 days|0|||
161654757|NCT01183260|583786512|FG001|Overall Study|Revised within 30 days|1|||
161654758|NCT01183260|583786511|FG000|Overall Study|Death|1|||
161654759|NCT01183260|583786512|FG001|Overall Study|Death|0|||
161701831|NCT01014585|583957342|FG000|Overall Study|Adverse Event|0|||
161701832|NCT01014585|583957343|FG001|Overall Study|Adverse Event|2|||
161701833|NCT01014585|583957344|FG002|Overall Study|Adverse Event|0|||
161701834|NCT01014585|583957345|FG003|Overall Study|Adverse Event|3|||
161701835|NCT01014585|583957342|FG000|Overall Study|Withdrawal by Subject|2|||
161701836|NCT01014585|583957343|FG001|Overall Study|Withdrawal by Subject|0|||
161701837|NCT01014585|583957344|FG002|Overall Study|Withdrawal by Subject|1|||
161701838|NCT01014585|583957345|FG003|Overall Study|Withdrawal by Subject|3|||
161701839|NCT01014585|583957342|FG000|Overall Study|Lost to Follow-up|0|||
161701840|NCT01014585|583957343|FG001|Overall Study|Lost to Follow-up|0|||
161701841|NCT01014585|583957344|FG002|Overall Study|Lost to Follow-up|0|||
161701842|NCT01014585|583957345|FG003|Overall Study|Lost to Follow-up|2|||
161701843|NCT01014585|583957342|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
161701844|NCT01014585|583957343|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
161701845|NCT01014585|583957344|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
161701846|NCT01014585|583957345|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
161701847|NCT04178772|583957349|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
161701848|NCT04178772|583957349|FG000|Overall Study|study terminated early due to COVID-19|7|||
161701849|NCT00773279|583957350|FG000|Period 1|Adverse Event|2|||
161701850|NCT00773279|583957351|FG001|Period 1|Adverse Event|1|||
161701851|NCT00773279|583957350|FG000|Period 1|Lack of Efficacy|0|||
161701852|NCT00773279|583957351|FG001|Period 1|Lack of Efficacy|2|||
161701853|NCT00773279|583957350|FG000|Period 1|Unclassified|5|||
161701854|NCT00773279|583957351|FG001|Period 1|Unclassified|1|||
161701855|NCT00773279|583957350|FG000|Period 2|Adverse Event|0|||
161701856|NCT00773279|583957351|FG001|Period 2|Adverse Event|1|||
161701857|NCT00773279|583957350|FG000|Period 2|Lack of Efficacy|1|||
161701858|NCT00773279|583957351|FG001|Period 2|Lack of Efficacy|0|||
161701859|NCT00773279|583957350|FG000|Period 2|Protocol Violation|0|||
161701860|NCT00773279|583957351|FG001|Period 2|Protocol Violation|3|||
161701861|NCT00773279|583957350|FG000|Period 2|Unclassified|2|||
161701862|NCT00773279|583957351|FG001|Period 2|Unclassified|2|||
161701863|NCT01737931|583957355|FG000|Overall Study|Withdrawal by Subject|0|||
161701864|NCT01737931|583957356|FG001|Overall Study|Withdrawal by Subject|1|||
161701865|NCT01737931|583957357|FG002|Overall Study|Withdrawal by Subject|1|||
161701866|NCT01737931|583957355|FG000|Overall Study|Physician Decision|0|||
161701867|NCT01737931|583957356|FG001|Overall Study|Physician Decision|1|||
161701868|NCT01737931|583957357|FG002|Overall Study|Physician Decision|0|||
161701869|NCT04897867|583957358|FG000|Overall Study|Withdrawal of Consent|1|||
161701870|NCT04897867|583957358|FG000|Overall Study|Pregnancy|1|||
161701871|NCT04897867|583957358|FG000|Overall Study|Lost to Follow-up|7|||
161701872|NCT04897867|583957358|FG000|Overall Study|Reason not Specified|2|||
161701873|NCT01838044|583957359|FG000|Overall Study|Adverse Event|4|||
161701874|NCT01838044|583957360|FG001|Overall Study|Adverse Event|6|||
161701875|NCT01838044|583957359|FG000|Overall Study|Protocol Violation|3|||
161701876|NCT01838044|583957360|FG001|Overall Study|Protocol Violation|3|||
161701877|NCT01838044|583957359|FG000|Overall Study|Withdrawal by Subject|0|||
161701878|NCT01838044|583957360|FG001|Overall Study|Withdrawal by Subject|2|||
161701879|NCT01838044|583957359|FG000|Overall Study|Insufficient clinical response|1|||
161701880|NCT01838044|583957360|FG001|Overall Study|Insufficient clinical response|2|||
161701881|NCT01838044|583957359|FG000|Overall Study|Medication error without associated AE|0|||
161701882|NCT01838044|583957360|FG001|Overall Study|Medication error without associated AE|1|||
161701883|NCT01838044|583957359|FG000|Overall Study|Lost to Follow-up|0|||
161701884|NCT01838044|583957360|FG001|Overall Study|Lost to Follow-up|2|||
161701885|NCT01481896|583957361|FG000|Overall Study|Lost to Follow-up|12|||
161701886|NCT00364182|583957367|FG000|First Intervention|Secondary prophylaxis|1|||
161701887|NCT00364182|583957368|FG001|First Intervention|Secondary prophylaxis|0|||
161701888|NCT00364182|583957369|FG002|First Intervention|Secondary prophylaxis|0|||
161701889|NCT00364182|583957367|FG000|First Intervention|Withdrawal by Subject|2|||
161701890|NCT00364182|583957368|FG001|First Intervention|Withdrawal by Subject|0|||
161701891|NCT00364182|583957369|FG002|First Intervention|Withdrawal by Subject|0|||
161701892|NCT00364182|583957367|FG000|Second Intervention|non-compliance|0|||
161701893|NCT00364182|583957368|FG001|Second Intervention|non-compliance|1|||
161701894|NCT00364182|583957369|FG002|Second Intervention|non-compliance|1|||
161701895|NCT00364182|583957367|FG000|Second Intervention|Protocol Violation|0|||
161701896|NCT00364182|583957368|FG001|Second Intervention|Protocol Violation|1|||
161701897|NCT00364182|583957369|FG002|Second Intervention|Protocol Violation|0|||
161701898|NCT00364182|583957367|FG000|Second Intervention|Adverse Event|0|||
161701899|NCT00364182|583957368|FG001|Second Intervention|Adverse Event|0|||
161701900|NCT00364182|583957369|FG002|Second Intervention|Adverse Event|1|||
161701901|NCT00364182|583957367|FG000|Third Intervention|non-compliance|0|||
161701902|NCT00364182|583957368|FG001|Third Intervention|non-compliance|1|||
161701903|NCT00364182|583957369|FG002|Third Intervention|non-compliance|0|||
161701904|NCT00364182|583957367|FG000|Third Intervention|Lost to Follow-up|0|||
161701905|NCT00364182|583957368|FG001|Third Intervention|Lost to Follow-up|0|||
161701906|NCT00364182|583957369|FG002|Third Intervention|Lost to Follow-up|1|||
161701907|NCT03336502|583957371|FG000|Overall Study|Physician Decision|0|||
161701908|NCT03336502|583957372|FG001|Overall Study|Physician Decision|1|||
161701909|NCT03336502|583957371|FG000|Overall Study|Prohibited Drugs|1|||
161701910|NCT03336502|583957372|FG001|Overall Study|Prohibited Drugs|1|||
161701911|NCT03336502|583957371|FG000|Overall Study|Death|1|||
161701912|NCT03336502|583957372|FG001|Overall Study|Death|2|||
161701913|NCT03336502|583957371|FG000|Overall Study|Adverse Event|2|||
161701914|NCT03336502|583957372|FG001|Overall Study|Adverse Event|5|||
161701915|NCT02601573|583957373|FG000|Overall Study|Lost to Follow-up|0|||
161701916|NCT02601573|583957374|FG001|Overall Study|Lost to Follow-up|3|||
161701917|NCT02601573|583957375|FG002|Overall Study|Lost to Follow-up|1|||
161701918|NCT02601573|583957376|FG003|Overall Study|Lost to Follow-up|0|||
161701919|NCT02601573|583957377|FG004|Overall Study|Lost to Follow-up|2|||
161701920|NCT02601573|583957373|FG000|Overall Study|Withdrawal by Subject|0|||
161701921|NCT02601573|583957374|FG001|Overall Study|Withdrawal by Subject|1|||
161701922|NCT02601573|583957375|FG002|Overall Study|Withdrawal by Subject|0|||
161701923|NCT02601573|583957376|FG003|Overall Study|Withdrawal by Subject|1|||
161701924|NCT02601573|583957377|FG004|Overall Study|Withdrawal by Subject|0|||
161701925|NCT01850615|583957378|FG000|Overall Study|Protocol Violation|4|||
161701926|NCT01850615|583957379|FG001|Overall Study|Protocol Violation|1|||
161701927|NCT01850615|583957378|FG000|Overall Study|Adverse Event|2|||
161701928|NCT01850615|583957379|FG001|Overall Study|Adverse Event|1|||
161701929|NCT01850615|583957378|FG000|Overall Study|Withdrawal by Subject|3|||
161701930|NCT01850615|583957379|FG001|Overall Study|Withdrawal by Subject|1|||
161701931|NCT01850615|583957378|FG000|Overall Study|Lost to Follow-up|0|||
161701932|NCT01850615|583957379|FG001|Overall Study|Lost to Follow-up|1|||
161701933|NCT01850615|583957378|FG000|Overall Study|Unclassified|0|||
161701934|NCT01850615|583957379|FG001|Overall Study|Unclassified|1|||
161701935|NCT00706628|583957380|FG000|Overall Study|Other Adverse Event|16|||
161701936|NCT00706628|583957381|FG001|Overall Study|Other Adverse Event|5|||
161701937|NCT00706628|583957382|FG002|Overall Study|Other Adverse Event|5|||
161701938|NCT00706628|583957383|FG003|Overall Study|Other Adverse Event|2|||
161701939|NCT00706628|583957380|FG000|Overall Study|Non compliant with protocol|0|||
161701940|NCT00706628|583957381|FG001|Overall Study|Non compliant with protocol|1|||
161701941|NCT00706628|583957382|FG002|Overall Study|Non compliant with protocol|0|||
161701942|NCT00706628|583957383|FG003|Overall Study|Non compliant with protocol|0|||
161701943|NCT00706628|583957380|FG000|Overall Study|Consent withdrawn|6|||
161701944|NCT00706628|583957381|FG001|Overall Study|Consent withdrawn|1|||
161701945|NCT00706628|583957382|FG002|Overall Study|Consent withdrawn|3|||
161701946|NCT00706628|583957383|FG003|Overall Study|Consent withdrawn|0|||
161701947|NCT00706628|583957380|FG000|Overall Study|Progressive disease|20|||
161701948|NCT00706628|583957381|FG001|Overall Study|Progressive disease|13|||
161701949|NCT00706628|583957382|FG002|Overall Study|Progressive disease|8|||
161701950|NCT00706628|583957383|FG003|Overall Study|Progressive disease|1|||
161701951|NCT00706628|583957380|FG000|Overall Study|Other than those stated above|4|||
161701952|NCT00706628|583957381|FG001|Overall Study|Other than those stated above|0|||
161701953|NCT00706628|583957382|FG002|Overall Study|Other than those stated above|0|||
161701954|NCT00706628|583957383|FG003|Overall Study|Other than those stated above|0|||
161701955|NCT00706628|583957380|FG000|Overall Study|Not treated|1|||
161701956|NCT00706628|583957381|FG001|Overall Study|Not treated|1|||
161701957|NCT00706628|583957382|FG002|Overall Study|Not treated|0|||
161701958|NCT00706628|583957383|FG003|Overall Study|Not treated|0|||
161701959|NCT02921425|583957384|FG000|Overall Study|Protocol Violation|9|||
161701960|NCT01227967|583957385|FG000|Overall Study|Protocol Violation|3|||
161701961|NCT01227967|583957386|FG001|Overall Study|Protocol Violation|1|||
161701962|NCT01227967|583957385|FG000|Overall Study|Death|0|||
161701963|NCT01227967|583957386|FG001|Overall Study|Death|1|||
161701964|NCT01227967|583957385|FG000|Overall Study|Lost to Follow-up|8|||
161701965|NCT01227967|583957386|FG001|Overall Study|Lost to Follow-up|3|||
161701966|NCT01227967|583957385|FG000|Overall Study|Withdrawal by Subject|4|||
161654760|NCT01202903|583786514|FG000|Overall Study|Administrative Probelms|1|||
161654761|NCT01202903|583786515|FG001|Overall Study|Administrative Probelms|4|||
161654762|NCT01202903|583786514|FG000|Overall Study|Protocol Violation|0|||
161654763|NCT01202903|583786515|FG001|Overall Study|Protocol Violation|1|||
161654764|NCT01202903|583786514|FG000|Overall Study|Death|1|||
161654765|NCT01202903|583786515|FG001|Overall Study|Death|0|||
161654766|NCT01202903|583786514|FG000|Overall Study|Lost to Follow-up|1|||
161654767|NCT01202903|583786515|FG001|Overall Study|Lost to Follow-up|1|||
161654768|NCT01202903|583786514|FG000|Overall Study|Lack of Efficacy|1|||
161654769|NCT01202903|583786515|FG001|Overall Study|Lack of Efficacy|3|||
161654770|NCT01202903|583786514|FG000|Overall Study|Adverse Event|3|||
161654771|NCT01202903|583786515|FG001|Overall Study|Adverse Event|3|||
161654772|NCT01202903|583786514|FG000|Overall Study|Withdrawal by Subject|4|||
161654773|NCT01202903|583786515|FG001|Overall Study|Withdrawal by Subject|4|||
161654774|NCT01302080|583786516|FG000|Overall Study|Withdrew Consent|92|||
161654775|NCT01302080|583786517|FG001|Overall Study|Withdrew Consent|39|||
161654776|NCT01302080|583786516|FG000|Overall Study|Patient/Family Moved|28|||
161654777|NCT01302080|583786517|FG001|Overall Study|Patient/Family Moved|3|||
161654778|NCT01302080|583786516|FG000|Overall Study|Lost to Follow-up|192|||
161654779|NCT01302080|583786517|FG001|Overall Study|Lost to Follow-up|93|||
161654780|NCT01302080|583786516|FG000|Overall Study|Death|1|||
161654781|NCT01302080|583786517|FG001|Overall Study|Death|0|||
161654782|NCT01302080|583786516|FG000|Overall Study|Other|52|||
161654783|NCT01302080|583786517|FG001|Overall Study|Other|8|||
161654784|NCT01302080|583786516|FG000|Overall Study|Reason Missing For Discontinuation|1|||
161654785|NCT01302080|583786517|FG001|Overall Study|Reason Missing For Discontinuation|0|||
161654786|NCT00837694|583786518|FG000|Overall Study|Lost to Follow-up|2|||
161654787|NCT00837694|583786519|FG001|Overall Study|Lost to Follow-up|0|||
161654788|NCT00837694|583786520|FG002|Overall Study|Lost to Follow-up|2|||
161654789|NCT00837694|583786521|FG003|Overall Study|Lost to Follow-up|1|||
161654790|NCT00837694|583786522|FG004|Overall Study|Lost to Follow-up|1|||
161654791|NCT00837694|583786523|FG005|Overall Study|Lost to Follow-up|1|||
161654792|NCT00306670|583786524|FG000|Overall Study|patients recruited; Genentech, the st|0|||
161654793|NCT00306670|583786525|FG001|Overall Study|patients recruited; Genentech, the st|2|||
161654794|NCT00503139|583786526|FG000|Overall Study|Case Report Forms were not collected|4|||
161654795|NCT00503139|583786526|FG000|Overall Study|Protocol Violation|4|||
161654796|NCT00091169|583786530|FG000|Overall Study|Disease progression|3|||
161654797|NCT00091169|583786531|FG001|Overall Study|Disease progression|1|||
161654798|NCT00091169|583786530|FG000|Overall Study|Adverse Event|11|||
161654799|NCT00091169|583786531|FG001|Overall Study|Adverse Event|17|||
161654800|NCT00091169|583786530|FG000|Overall Study|Death|4|||
161654801|NCT00091169|583786531|FG001|Overall Study|Death|1|||
161654802|NCT00091169|583786530|FG000|Overall Study|Withdrawal by Subject|10|||
161654803|NCT00091169|583786531|FG001|Overall Study|Withdrawal by Subject|13|||
161654804|NCT00091169|583786530|FG000|Overall Study|Other|3|||
161654805|NCT00091169|583786531|FG001|Overall Study|Other|4|||
161654806|NCT00091169|583786530|FG000|Overall Study|Not start protocol therapy|26|||
161654807|NCT00091169|583786531|FG001|Overall Study|Not start protocol therapy|17|||
161654808|NCT04138576|583786536|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
161654809|NCT04410523|583786540|FG000|Overall Study|Study terminated by sponsor|1|||
161654810|NCT04410523|583786541|FG001|Overall Study|Study terminated by sponsor|3|||
161654811|NCT04410523|583786542|FG002|Overall Study|Study terminated by sponsor|2|||
161654812|NCT04410523|583786543|FG003|Overall Study|Study terminated by sponsor|6|||
161654813|NCT04410523|583786544|FG004|Overall Study|Study terminated by sponsor|3|||
161654814|NCT04410523|583786545|FG005|Overall Study|Study terminated by sponsor|4|||
161654815|NCT04410523|583786540|FG000|Overall Study|Adverse Event|1|||
161654816|NCT04410523|583786541|FG001|Overall Study|Adverse Event|0|||
161654817|NCT04410523|583786542|FG002|Overall Study|Adverse Event|0|||
161654818|NCT04410523|583786543|FG003|Overall Study|Adverse Event|0|||
161654819|NCT04410523|583786544|FG004|Overall Study|Adverse Event|0|||
161654820|NCT04410523|583786545|FG005|Overall Study|Adverse Event|2|||
161654821|NCT04410523|583786540|FG000|Overall Study|Lost to Follow-up|0|||
161654822|NCT04410523|583786541|FG001|Overall Study|Lost to Follow-up|1|||
161654823|NCT04410523|583786542|FG002|Overall Study|Lost to Follow-up|0|||
161654824|NCT04410523|583786543|FG003|Overall Study|Lost to Follow-up|0|||
161654825|NCT04410523|583786544|FG004|Overall Study|Lost to Follow-up|0|||
161654826|NCT04410523|583786545|FG005|Overall Study|Lost to Follow-up|0|||
161654827|NCT04410523|583786540|FG000|Overall Study|Physician Decision|0|||
161654828|NCT04410523|583786541|FG001|Overall Study|Physician Decision|1|||
161654829|NCT04410523|583786542|FG002|Overall Study|Physician Decision|0|||
161654830|NCT04410523|583786543|FG003|Overall Study|Physician Decision|0|||
161654831|NCT04410523|583786544|FG004|Overall Study|Physician Decision|0|||
161654832|NCT04410523|583786545|FG005|Overall Study|Physician Decision|0|||
161654833|NCT04410523|583786540|FG000|Overall Study|Pregnancy|0|||
161654834|NCT04410523|583786541|FG001|Overall Study|Pregnancy|0|||
161654835|NCT04410523|583786542|FG002|Overall Study|Pregnancy|0|||
161654836|NCT04410523|583786543|FG003|Overall Study|Pregnancy|0|||
161837066|NCT04421586|584446538|FG000|Overall Study|Lost to Follow-up|2|||
161837067|NCT04421586|584446539|FG001|Overall Study|Lost to Follow-up|2|||
161837068|NCT04421586|584446538|FG000|Overall Study|Withdrawn by PI|1|||
161837069|NCT04421586|584446539|FG001|Overall Study|Withdrawn by PI|0|||
161837070|NCT04421586|584446538|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
161837071|NCT04421586|584446539|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
161837072|NCT02963441|584446540|FG000|Overall Study|Protocol violation or withdrawn|8|||
161837073|NCT02963441|584446540|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
161837074|NCT02963441|584446540|FG000|Overall Study|IDx-DR insufficient quality|33|||
161837075|NCT04920916|584446541|FG000|Phase IIa 60 Day Study|Death|2|||
161837076|NCT04920916|584446542|FG001|Phase IIa 60 Day Study|Death|5|||
161837077|NCT04920916|584446541|FG000|1 Year Follow up (Phone Call)|Death|1|||
161654837|NCT04410523|583786544|FG004|Overall Study|Pregnancy|0|||
161654838|NCT04410523|583786545|FG005|Overall Study|Pregnancy|1|||
161654839|NCT04410523|583786540|FG000|Overall Study|Protocol deviation|0|||
161654840|NCT04410523|583786541|FG001|Overall Study|Protocol deviation|0|||
161654841|NCT04410523|583786542|FG002|Overall Study|Protocol deviation|0|||
161654842|NCT04410523|583786543|FG003|Overall Study|Protocol deviation|0|||
161654843|NCT04410523|583786544|FG004|Overall Study|Protocol deviation|0|||
161654844|NCT04410523|583786545|FG005|Overall Study|Protocol deviation|2|||
161654845|NCT04410523|583786540|FG000|Overall Study|Subject decision|2|||
161654846|NCT04410523|583786541|FG001|Overall Study|Subject decision|0|||
161654847|NCT04410523|583786542|FG002|Overall Study|Subject decision|0|||
161654848|NCT04410523|583786543|FG003|Overall Study|Subject decision|1|||
161654849|NCT04410523|583786544|FG004|Overall Study|Subject decision|0|||
161654850|NCT04410523|583786545|FG005|Overall Study|Subject decision|1|||
161654851|NCT00490490|583786546|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
161654852|NCT00490490|583786546|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
161654853|NCT00772330|583786547|FG000|Overall Study|Lost to Follow-up|3|||
161654854|NCT00734591|583786548|FG000|Screening for Prospective Period|Site did not participate|1604|||
161654855|NCT00734591|583786549|FG001|Screening for Prospective Period|Site did not participate|1488|||
161654856|NCT00734591|583786548|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
161654857|NCT00734591|583786549|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
161654858|NCT00734591|583786548|FG000|Prospective Period|Withdrawal by Subject|11|||
161654859|NCT00734591|583786549|FG001|Prospective Period|Withdrawal by Subject|9|||
161654860|NCT00734591|583786548|FG000|Prospective Period|Lost to Follow-up|37|||
161654861|NCT00734591|583786549|FG001|Prospective Period|Lost to Follow-up|33|||
161654862|NCT00734591|583786548|FG000|Prospective Period|Study Terminated|1|||
161654863|NCT00734591|583786549|FG001|Prospective Period|Study Terminated|0|||
161654864|NCT00734591|583786548|FG000|Prospective Period|Other|2|||
161654865|NCT00734591|583786549|FG001|Prospective Period|Other|2|||
161654866|NCT01656200|583786552|FG000|Overall Study|Withdrawal by Subject|1|||
161654867|NCT01461811|583786553|FG000|Overall Study|Adverse Event|2|||
161654868|NCT01461811|583786554|FG001|Overall Study|Adverse Event|1|||
161654869|NCT01461811|583786553|FG000|Overall Study|Subject decision unrelated to an AE|1|||
161654870|NCT01461811|583786554|FG001|Overall Study|Subject decision unrelated to an AE|1|||
161654871|NCT01461811|583786553|FG000|Overall Study|Noncompliance|1|||
161654872|NCT01461811|583786554|FG001|Overall Study|Noncompliance|1|||
161654873|NCT03015129|583786555|FG000|Overall Study|Death|2|||
161654874|NCT03015129|583786556|FG001|Overall Study|Death|2|||
161654875|NCT03015129|583786555|FG000|Overall Study|Lost to Follow-up|0|||
161654876|NCT03015129|583786556|FG001|Overall Study|Lost to Follow-up|1|||
161654877|NCT03015129|583786555|FG000|Overall Study|Progression of disease|38|||
161654878|NCT03015129|583786556|FG001|Overall Study|Progression of disease|33|||
161654879|NCT03015129|583786555|FG000|Overall Study|Adverse Event|0|||
161654880|NCT03015129|583786556|FG001|Overall Study|Adverse Event|4|||
161654881|NCT03192475|583786563|FG000|Overall Study|Death|0|||
161654882|NCT03192475|583786564|FG001|Overall Study|Death|1|||
161654883|NCT03192475|583786563|FG000|Overall Study|Lost to Follow-up|13|||
161654884|NCT03192475|583786564|FG001|Overall Study|Lost to Follow-up|8|||
161654885|NCT00798590|583786565|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
161654886|NCT00798590|583786566|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
161654887|NCT03653208|583786571|FG000|Overall Study|Withdrawal by Subject|0|||
161654888|NCT03653208|583786572|FG001|Overall Study|Withdrawal by Subject|0|||
161654889|NCT03653208|583786573|FG002|Overall Study|Withdrawal by Subject|0|||
161654890|NCT03653208|583786574|FG003|Overall Study|Withdrawal by Subject|0|||
161654891|NCT03653208|583786575|FG004|Overall Study|Withdrawal by Subject|1|||
161654892|NCT03653208|583786576|FG005|Overall Study|Withdrawal by Subject|0|||
161654893|NCT03653208|583786577|FG006|Overall Study|Withdrawal by Subject|0|||
161654894|NCT03653208|583786578|FG007|Overall Study|Withdrawal by Subject|1|||
161654895|NCT03653208|583786579|FG008|Overall Study|Withdrawal by Subject|1|||
161654896|NCT00368927|583786580|FG000|Overall Study|Lost to Follow-up|2|||
161654897|NCT00368927|583786581|FG001|Overall Study|Lost to Follow-up|0|||
161654898|NCT00368927|583786580|FG000|Overall Study|Adverse Event|1|||
161654899|NCT00368927|583786581|FG001|Overall Study|Adverse Event|1|||
161654900|NCT00368927|583786580|FG000|Overall Study|Withdrawal by Subject|1|||
161701967|NCT01227967|583957386|FG001|Overall Study|Withdrawal by Subject|3|||
161701968|NCT01227967|583957385|FG000|Overall Study|Physician Decision|0|||
161701969|NCT01227967|583957386|FG001|Overall Study|Physician Decision|1|||
161701970|NCT01227967|583957385|FG000|Overall Study|Never Started Treatment|0|||
161701971|NCT01227967|583957386|FG001|Overall Study|Never Started Treatment|4|||
161701972|NCT01227967|583957385|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
161701973|NCT01227967|583957386|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
161701974|NCT03403400|583957387|FG000|Overall Study|Lost to Follow-up|1|||
161701975|NCT03403400|583957388|FG001|Overall Study|Lost to Follow-up|0|||
161701976|NCT03403400|583957389|FG002|Overall Study|Lost to Follow-up|1|||
161701977|NCT03403400|583957387|FG000|Overall Study|Hospitalization|1|||
161701978|NCT03403400|583957388|FG001|Overall Study|Hospitalization|0|||
161701979|NCT03403400|583957389|FG002|Overall Study|Hospitalization|0|||
161701980|NCT03403400|583957387|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
161701981|NCT03403400|583957388|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
161701982|NCT03403400|583957389|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
161701983|NCT01107444|583957393|FG000|Overall Study|Withdrawal by Subject|8|||
161701984|NCT01107444|583957394|FG001|Overall Study|Withdrawal by Subject|12|||
161701985|NCT01107444|583957393|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
161701986|NCT01107444|583957394|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
161701987|NCT00737529|583957395|FG000|Overall Study|Disease Progression|95|||
161701988|NCT00737529|583957395|FG000|Overall Study|Adverse Event|24|||
161701989|NCT00737529|583957395|FG000|Overall Study|Withdrawal by Subject|5|||
161701990|NCT00737529|583957395|FG000|Overall Study|Death|4|||
161701991|NCT00737529|583957395|FG000|Overall Study|Protocol Violation|1|||
161701992|NCT00737529|583957395|FG000|Overall Study|Other|4|||
161701993|NCT01948830|583957396|FG000|Overall Study|Physician Decision|1|||
161701994|NCT01948830|583957397|FG001|Overall Study|Physician Decision|3|||
161701995|NCT01948830|583957396|FG000|Overall Study|Protocol deviation|1|||
161701996|NCT01948830|583957397|FG001|Overall Study|Protocol deviation|2|||
161701997|NCT01948830|583957396|FG000|Overall Study|Lost to Follow-up|5|||
161701998|NCT01948830|583957397|FG001|Overall Study|Lost to Follow-up|4|||
161701999|NCT01948830|583957396|FG000|Overall Study|Withdrawal by Subject|14|||
161702000|NCT01948830|583957397|FG001|Overall Study|Withdrawal by Subject|17|||
161702001|NCT01948830|583957396|FG000|Overall Study|Adverse Event|9|||
161702002|NCT01948830|583957397|FG001|Overall Study|Adverse Event|2|||
161702003|NCT01948830|583957396|FG000|Overall Study|Death|3|||
161702004|NCT01948830|583957397|FG001|Overall Study|Death|4|||
161702005|NCT01145560|583957398|FG000|Overall Study|Withdrawal by Subject|2|||
161702006|NCT01145560|583957399|FG001|Overall Study|Withdrawal by Subject|1|||
161702007|NCT01145560|583957400|FG002|Overall Study|Withdrawal by Subject|0|||
161702008|NCT01145560|583957398|FG000|Overall Study|Lost to Follow-up|1|||
161702009|NCT01145560|583957399|FG001|Overall Study|Lost to Follow-up|1|||
161702010|NCT01145560|583957400|FG002|Overall Study|Lost to Follow-up|1|||
161702011|NCT01145560|583957398|FG000|Overall Study|No study drug by 24h after organ failure|1|||
161702012|NCT01145560|583957399|FG001|Overall Study|No study drug by 24h after organ failure|0|||
161702013|NCT01145560|583957400|FG002|Overall Study|No study drug by 24h after organ failure|0|||
161702014|NCT01145560|583957398|FG000|Overall Study|Accidental unblinding of study treatment|0|||
161702015|NCT01145560|583957399|FG001|Overall Study|Accidental unblinding of study treatment|1|||
161702016|NCT01145560|583957400|FG002|Overall Study|Accidental unblinding of study treatment|0|||
161702017|NCT01145560|583957398|FG000|Overall Study|False insurance information|0|||
161702018|NCT01145560|583957399|FG001|Overall Study|False insurance information|1|||
161702019|NCT01145560|583957400|FG002|Overall Study|False insurance information|0|||
161702020|NCT01145560|583957398|FG000|Overall Study|Withdrawal of therapy|0|||
161702021|NCT01145560|583957399|FG001|Overall Study|Withdrawal of therapy|0|||
161702022|NCT01145560|583957400|FG002|Overall Study|Withdrawal of therapy|1|||
161702023|NCT00712348|583957401|FG000|Overall Study|Withdrawal by Subject|1|||
161702024|NCT03310970|583957405|FG000|Overall Study|Withdrawal by Subject|0|||
161702025|NCT03310970|583957406|FG001|Overall Study|Withdrawal by Subject|1|||
161702026|NCT00091832|583957409|FG000|Overall Study|Physician Decision|1|||
161702027|NCT00091832|583957410|FG001|Overall Study|Physician Decision|0|||
161702028|NCT00091832|583957411|FG002|Overall Study|Physician Decision|0|||
161702029|NCT00091832|583957412|FG003|Overall Study|Physician Decision|0|||
161702030|NCT00091832|583957413|FG004|Overall Study|Physician Decision|0|||
161702031|NCT00091832|583957414|FG005|Overall Study|Physician Decision|0|||
161702032|NCT00091832|583957409|FG000|Overall Study|Adverse Event|0|||
161702033|NCT00091832|583957410|FG001|Overall Study|Adverse Event|0|||
161702034|NCT00091832|583957411|FG002|Overall Study|Adverse Event|0|||
161702035|NCT00091832|583957412|FG003|Overall Study|Adverse Event|1|||
161702036|NCT00091832|583957413|FG004|Overall Study|Adverse Event|3|||
161702037|NCT00091832|583957414|FG005|Overall Study|Adverse Event|0|||
161702038|NCT00091832|583957409|FG000|Overall Study|Withdrawal by Subject|4|||
161702039|NCT00091832|583957410|FG001|Overall Study|Withdrawal by Subject|5|||
161702040|NCT00091832|583957411|FG002|Overall Study|Withdrawal by Subject|0|||
161702041|NCT00091832|583957412|FG003|Overall Study|Withdrawal by Subject|1|||
161702042|NCT00091832|583957413|FG004|Overall Study|Withdrawal by Subject|3|||
161702043|NCT00091832|583957414|FG005|Overall Study|Withdrawal by Subject|1|||
161702044|NCT00091832|583957409|FG000|Overall Study|Death|6|||
161702045|NCT00091832|583957410|FG001|Overall Study|Death|4|||
161702046|NCT00091832|583957411|FG002|Overall Study|Death|5|||
161702047|NCT00091832|583957412|FG003|Overall Study|Death|8|||
161702048|NCT00091832|583957413|FG004|Overall Study|Death|5|||
161702049|NCT00091832|583957414|FG005|Overall Study|Death|6|||
161702050|NCT00091832|583957409|FG000|Overall Study|Disease Progression|2|||
161702051|NCT00091832|583957410|FG001|Overall Study|Disease Progression|0|||
161702052|NCT00091832|583957411|FG002|Overall Study|Disease Progression|0|||
161702053|NCT00091832|583957412|FG003|Overall Study|Disease Progression|1|||
161702054|NCT00091832|583957413|FG004|Overall Study|Disease Progression|1|||
161702055|NCT00091832|583957414|FG005|Overall Study|Disease Progression|2|||
161702056|NCT00091832|583957409|FG000|Overall Study|Ineligibility Determined|0|||
161702057|NCT00091832|583957410|FG001|Overall Study|Ineligibility Determined|0|||
161702058|NCT00091832|583957411|FG002|Overall Study|Ineligibility Determined|1|||
161702059|NCT00091832|583957412|FG003|Overall Study|Ineligibility Determined|0|||
161702060|NCT00091832|583957413|FG004|Overall Study|Ineligibility Determined|1|||
161702061|NCT00091832|583957414|FG005|Overall Study|Ineligibility Determined|0|||
161702062|NCT00091832|583957409|FG000|Overall Study|Lost to Follow-up|1|||
161702063|NCT00091832|583957410|FG001|Overall Study|Lost to Follow-up|0|||
161702064|NCT00091832|583957411|FG002|Overall Study|Lost to Follow-up|3|||
161702065|NCT00091832|583957412|FG003|Overall Study|Lost to Follow-up|3|||
161702066|NCT00091832|583957413|FG004|Overall Study|Lost to Follow-up|2|||
161702067|NCT00091832|583957414|FG005|Overall Study|Lost to Follow-up|1|||
161702068|NCT00091832|583957409|FG000|Overall Study|Noncompliance|0|||
161702069|NCT00091832|583957410|FG001|Overall Study|Noncompliance|1|||
161702070|NCT00091832|583957411|FG002|Overall Study|Noncompliance|0|||
161702071|NCT00091832|583957412|FG003|Overall Study|Noncompliance|0|||
161702072|NCT00091832|583957413|FG004|Overall Study|Noncompliance|0|||
161702073|NCT00091832|583957414|FG005|Overall Study|Noncompliance|0|||
161702074|NCT00091832|583957409|FG000|Overall Study|Other|0|||
161702075|NCT00091832|583957410|FG001|Overall Study|Other|1|||
161702076|NCT00091832|583957411|FG002|Overall Study|Other|2|||
161702077|NCT00091832|583957412|FG003|Overall Study|Other|0|||
161702078|NCT00091832|583957413|FG004|Overall Study|Other|0|||
161702079|NCT00091832|583957414|FG005|Overall Study|Other|0|||
161702080|NCT00091832|583957409|FG000|Overall Study|Protocol Violation|0|||
161702081|NCT00091832|583957410|FG001|Overall Study|Protocol Violation|0|||
161702082|NCT00091832|583957411|FG002|Overall Study|Protocol Violation|1|||
161702083|NCT00091832|583957412|FG003|Overall Study|Protocol Violation|0|||
161702084|NCT00091832|583957413|FG004|Overall Study|Protocol Violation|0|||
161702085|NCT00091832|583957414|FG005|Overall Study|Protocol Violation|1|||
161702086|NCT01446419|583957417|FG000|Overall Study|Death|1|||
161702087|NCT01446419|583957418|FG001|Overall Study|Death|0|||
161702088|NCT01446419|583957417|FG000|Overall Study|Withdrawal by Subject|1|||
161702089|NCT01446419|583957418|FG001|Overall Study|Withdrawal by Subject|1|||
161702090|NCT01446419|583957417|FG000|Overall Study|Terminated per protocol|3|||
161702091|NCT01446419|583957418|FG001|Overall Study|Terminated per protocol|0|||
161702092|NCT01557166|583957419|FG000|Overall Study|Adverse Event|20|||
161702093|NCT01557166|583957420|FG001|Overall Study|Adverse Event|6|||
161702094|NCT01557166|583957419|FG000|Overall Study|Lack of Efficacy|2|||
161702095|NCT01557166|583957420|FG001|Overall Study|Lack of Efficacy|1|||
161702096|NCT01557166|583957419|FG000|Overall Study|Protocol Violation|8|||
161702097|NCT01557166|583957420|FG001|Overall Study|Protocol Violation|5|||
161702098|NCT01557166|583957419|FG000|Overall Study|Withdrawn consent|12|||
161702099|NCT01557166|583957420|FG001|Overall Study|Withdrawn consent|20|||
161702100|NCT01557166|583957419|FG000|Overall Study|Target dose not tolerated|1|||
161702101|NCT01557166|583957420|FG001|Overall Study|Target dose not tolerated|0|||
161702102|NCT01557166|583957419|FG000|Overall Study|Psychiatric disorder|1|||
161702103|NCT01557166|583957420|FG001|Overall Study|Psychiatric disorder|0|||
161702104|NCT01557166|583957419|FG000|Overall Study|Unclassified|2|||
161702105|NCT01557166|583957420|FG001|Overall Study|Unclassified|5|||
161702106|NCT00946309|583957421|FG000|Overall Study|Protocol Violation|1|||
161702107|NCT00946309|583957422|FG001|Overall Study|Protocol Violation|0|||
161702108|NCT00946309|583957421|FG000|Overall Study|Lost to Follow-up|0|||
161702109|NCT00946309|583957422|FG001|Overall Study|Lost to Follow-up|1|||
161837078|NCT04920916|584446542|FG001|1 Year Follow up (Phone Call)|Death|3|||
161837079|NCT04920916|584446541|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
161837080|NCT04920916|584446542|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
161837081|NCT02011113|584446543|FG000|Overall Study|Adverse Event|4|||
161837082|NCT02011113|584446543|FG000|Overall Study|Disease Progression (DP)|16|||
161837083|NCT02011113|584446543|FG000|Overall Study|Death|1|||
161837084|NCT02011113|584446543|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
161837085|NCT02011113|584446543|FG000|Overall Study|Investigator's judgement- DP|3|||
161702110|NCT00946309|583957421|FG000|Overall Study|Procedure cancelled/discontinued|0|||
161702111|NCT00946309|583957422|FG001|Overall Study|Procedure cancelled/discontinued|3|||
161702112|NCT01465659|583957423|FG000|Completed 1 Cycle of Treatment|Death|0|||
161702113|NCT01465659|583957424|FG001|Completed 1 Cycle of Treatment|Death|1|||
161837086|NCT02011113|584446543|FG000|Overall Study|Study terminated by sponsor|11|||
161837087|NCT04688931|584446546|FG000|Overall Study|Adverse Event|4|||
161837088|NCT04688931|584446547|FG001|Overall Study|Adverse Event|1|||
161837089|NCT04688931|584446546|FG000|Overall Study|Withdrawal by Subject|5|||
161837090|NCT04688931|584446547|FG001|Overall Study|Withdrawal by Subject|16|||
161837091|NCT04688931|584446546|FG000|Overall Study|Physician Decision|3|||
161837092|NCT04688931|584446547|FG001|Overall Study|Physician Decision|5|||
161837093|NCT04688931|584446546|FG000|Overall Study|Noncompliance|0|||
161837094|NCT04688931|584446547|FG001|Overall Study|Noncompliance|1|||
161837095|NCT04688931|584446546|FG000|Overall Study|Lost to Follow-up|1|||
161702114|NCT01465659|583957425|FG002|Completed 1 Cycle of Treatment|Death|0|||
161702115|NCT01465659|583957426|FG003|Completed 1 Cycle of Treatment|Death|0|||
161702116|NCT01465659|583957423|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
161702117|NCT01465659|583957424|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
161702118|NCT01465659|583957425|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
161702119|NCT01465659|583957426|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
161702120|NCT01465659|583957423|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161702121|NCT01465659|583957424|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
161702122|NCT01465659|583957425|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161702123|NCT01465659|583957426|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161702124|NCT01465659|583957423|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
161702125|NCT01465659|583957424|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
161702126|NCT01465659|583957425|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
161702127|NCT01465659|583957426|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
161702128|NCT01465659|583957423|FG000|Completed Follow for 1 Year|Death|6|||
161702129|NCT01465659|583957424|FG001|Completed Follow for 1 Year|Death|3|||
161702130|NCT01465659|583957425|FG002|Completed Follow for 1 Year|Death|2|||
161702131|NCT01465659|583957426|FG003|Completed Follow for 1 Year|Death|4|||
161702132|NCT02411747|583957429|FG000|Overall Study|Withdrawal by Subject|1|||
161702133|NCT02411747|583957430|FG001|Overall Study|Withdrawal by Subject|0|||
161702134|NCT02411747|583957429|FG000|Overall Study|Protocol Violation|2|||
161702135|NCT02411747|583957430|FG001|Overall Study|Protocol Violation|4|||
161702136|NCT02149810|583957431|FG000|Overall Study|Physician Decision|1|||
161702137|NCT02149810|583957432|FG001|Overall Study|Physician Decision|2|||
161702138|NCT02149810|583957431|FG000|Overall Study|Lost to Follow-up|2|||
161702139|NCT02149810|583957432|FG001|Overall Study|Lost to Follow-up|1|||
161702140|NCT02149810|583957431|FG000|Overall Study|Withdrawal by Subject|5|||
161702141|NCT02149810|583957432|FG001|Overall Study|Withdrawal by Subject|1|||
161702142|NCT00428597|583957433|FG000|Overall Study|Randomized but not treated|3|||
161702143|NCT00428597|583957434|FG001|Overall Study|Randomized but not treated|3|||
161702144|NCT00428597|583957433|FG000|Overall Study|Objective Progression or Relapse|19|||
161837096|NCT04688931|584446547|FG001|Overall Study|Lost to Follow-up|3|||
161837097|NCT04688931|584446546|FG000|Overall Study|Randomization Error|3|||
161837098|NCT04688931|584446547|FG001|Overall Study|Randomization Error|0|||
161837099|NCT04688931|584446546|FG000|Overall Study|Not Eligible|1|||
161837100|NCT04688931|584446547|FG001|Overall Study|Not Eligible|3|||
161837101|NCT04688931|584446546|FG000|Overall Study|Disease Progression|0|||
161837102|NCT04688931|584446547|FG001|Overall Study|Disease Progression|2|||
161837103|NCT04688931|584446546|FG000|Overall Study|Sponsor Requirement|1|||
161837104|NCT04688931|584446547|FG001|Overall Study|Sponsor Requirement|1|||
161837105|NCT04688931|584446546|FG000|Overall Study|Other Reason|1|||
161837106|NCT04688931|584446547|FG001|Overall Study|Other Reason|2|||
161837107|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Adverse Event|9|||
161837108|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Adverse Event|4|||
161837109|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Adverse Event|5|||
161837110|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Adverse Event|9|||
161837111|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Adverse Event|8|||
161702145|NCT00428597|583957434|FG001|Overall Study|Objective Progression or Relapse|47|||
161702146|NCT00428597|583957433|FG000|Overall Study|Study Terminated by Sponsor|41|||
161702147|NCT00428597|583957434|FG001|Overall Study|Study Terminated by Sponsor|16|||
161837112|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Adverse Event|0|||
161702148|NCT00428597|583957433|FG000|Overall Study|Adverse Event|15|||
161702149|NCT00428597|583957434|FG001|Overall Study|Adverse Event|7|||
161702150|NCT00428597|583957433|FG000|Overall Study|Global Deterioration of Health Status|1|||
161702151|NCT00428597|583957434|FG001|Overall Study|Global Deterioration of Health Status|5|||
161702152|NCT00428597|583957433|FG000|Overall Study|Protocol Violation|2|||
161702153|NCT00428597|583957434|FG001|Overall Study|Protocol Violation|1|||
161702154|NCT00428597|583957433|FG000|Overall Study|Withdrawal by Subject|2|||
161702155|NCT00428597|583957434|FG001|Overall Study|Withdrawal by Subject|1|||
161702156|NCT00428597|583957433|FG000|Overall Study|Other|1|||
161702157|NCT00428597|583957434|FG001|Overall Study|Other|1|||
161702158|NCT00428597|583957433|FG000|Overall Study|Lost to Follow-up|0|||
161702159|NCT00428597|583957434|FG001|Overall Study|Lost to Follow-up|1|||
161702160|NCT00428597|583957433|FG000|Overall Study|Pregnancy|1|||
161702161|NCT00428597|583957434|FG001|Overall Study|Pregnancy|0|||
161702162|NCT00428597|583957433|FG000|Overall Study|Death|1|||
161702163|NCT00428597|583957434|FG001|Overall Study|Death|3|||
161702164|NCT00675597|583957435|FG000|Overall Study|Withdrawal by Subject|3|||
161702165|NCT00560755|583957437|FG000|Overall Study|Protocol Violation|15|||
161702166|NCT00560755|583957437|FG000|Overall Study|Withdrawal by Subject|26|||
161702167|NCT00560755|583957437|FG000|Overall Study|Lost to Follow-up|9|||
161702168|NCT00560755|583957437|FG000|Overall Study|Adverse Event|8|||
161702169|NCT00560755|583957437|FG000|Overall Study|Physician Decision|2|||
161702170|NCT03828487|583957442|FG000|Overall Study|Physician Decision|1|||
161702171|NCT05032950|583957444|FG000|Overall Study|Adverse Event|0|||
161702172|NCT05032950|583957445|FG001|Overall Study|Adverse Event|0|||
161702173|NCT05032950|583957446|FG002|Overall Study|Adverse Event|1|||
161702174|NCT05032950|583957447|FG003|Overall Study|Adverse Event|1|||
161702175|NCT05032950|583957448|FG004|Overall Study|Adverse Event|0|||
161702176|NCT05032950|583957449|FG005|Overall Study|Adverse Event|0|||
161702177|NCT01356589|583957452|FG000|Overall Study|Enrolled, but not treated|3|||
161702178|NCT01356589|583957452|FG000|Overall Study|Dose data not recorded|2|||
161702179|NCT02447848|583957453|FG000|Overall Study|Patient discharged|3|||
161702180|NCT02447848|583957453|FG000|Overall Study|Lack of Efficacy|4|||
161702181|NCT02447848|583957453|FG000|Overall Study|Withdrawal by Subject|4|||
161702182|NCT02307370|583957454|FG000|Overall Study|Death|5|||
161702183|NCT02307370|583957454|FG000|Overall Study|Lost to Follow-up|1|||
161702184|NCT02307370|583957454|FG000|Overall Study|Withdrawal by Subject|1|||
161702185|NCT02307370|583957454|FG000|Overall Study|Declined Addendum ICF|6|||
161702186|NCT02307370|583957454|FG000|Overall Study|No response during telephone contact|5|||
161702187|NCT02307370|583957454|FG000|Overall Study|Protocol Violation|1|||
161702188|NCT03219164|583959196|FG000|Overall Study|Study Terminated by Sponsor|16|||
161702189|NCT03219164|583959197|FG001|Overall Study|Study Terminated by Sponsor|12|||
161702190|NCT03219164|583959196|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
161702191|NCT03219164|583959197|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
161702192|NCT03219164|583959196|FG000|Overall Study|Lost to Follow-up|1|||
161702193|NCT03219164|583959197|FG001|Overall Study|Lost to Follow-up|1|||
161702194|NCT03219164|583959196|FG000|Overall Study|Adverse Event|1|||
161702195|NCT03219164|583959197|FG001|Overall Study|Adverse Event|0|||
161702196|NCT03219164|583959196|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161702197|NCT03219164|583959197|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161702198|NCT03219164|583959196|FG000|Overall Study|Protocol Violation|0|||
161702199|NCT03219164|583959197|FG001|Overall Study|Protocol Violation|1|||
161702200|NCT03219164|583959196|FG000|Overall Study|Withdrew Assent|1|||
161702201|NCT03219164|583959197|FG001|Overall Study|Withdrew Assent|0|||
161702202|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
161702203|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
161702204|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
161702205|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702206|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702207|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702208|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702209|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702210|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
161702211|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
161702212|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
161702213|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702214|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702215|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702216|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702217|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702218|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
161702219|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
161702220|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
161702221|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702222|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702223|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702224|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702225|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702226|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
161702227|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
161702228|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161702229|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702230|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702231|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702232|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702233|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702234|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
161702235|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
161702236|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
161702237|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702238|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702239|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702240|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702241|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702242|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
161702243|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
161702244|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702245|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702246|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702247|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702248|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702249|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702250|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
161702251|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
161702252|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
161702253|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702254|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702255|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702256|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702257|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702258|NCT01097629|583959208|FG000|DB RO Phase|Withdrawal by Subject|0|||
161702259|NCT01097629|583959209|FG001|DB RO Phase|Withdrawal by Subject|0|||
161702260|NCT01097629|583959210|FG002|DB RO Phase|Withdrawal by Subject|0|||
161702261|NCT01097629|583959211|FG003|DB RO Phase|Withdrawal by Subject|0|||
161702262|NCT01097629|583959212|FG004|DB RO Phase|Withdrawal by Subject|0|||
161702263|NCT01097629|583959213|FG005|DB RO Phase|Withdrawal by Subject|0|||
161702264|NCT01097629|583959214|FG006|DB RO Phase|Withdrawal by Subject|0|||
161702265|NCT01097629|583959215|FG007|DB RO Phase|Withdrawal by Subject|1|||
161702266|NCT01097629|583959208|FG000|DB RO Phase|Protocol Violation|0|||
161702267|NCT01097629|583959209|FG001|DB RO Phase|Protocol Violation|0|||
161702268|NCT01097629|583959210|FG002|DB RO Phase|Protocol Violation|0|||
161702269|NCT01097629|583959211|FG003|DB RO Phase|Protocol Violation|1|||
161702270|NCT01097629|583959212|FG004|DB RO Phase|Protocol Violation|0|||
161702271|NCT01097629|583959213|FG005|DB RO Phase|Protocol Violation|1|||
161702272|NCT01097629|583959214|FG006|DB RO Phase|Protocol Violation|1|||
161702273|NCT01097629|583959215|FG007|DB RO Phase|Protocol Violation|0|||
161702274|NCT01097629|583959208|FG000|DB RO Phase|Lost to Follow-up|0|||
161702275|NCT01097629|583959209|FG001|DB RO Phase|Lost to Follow-up|0|||
161702276|NCT01097629|583959210|FG002|DB RO Phase|Lost to Follow-up|0|||
161702277|NCT01097629|583959211|FG003|DB RO Phase|Lost to Follow-up|0|||
161702278|NCT01097629|583959212|FG004|DB RO Phase|Lost to Follow-up|0|||
161702279|NCT01097629|583959213|FG005|DB RO Phase|Lost to Follow-up|0|||
161702280|NCT01097629|583959214|FG006|DB RO Phase|Lost to Follow-up|2|||
161702281|NCT01097629|583959215|FG007|DB RO Phase|Lost to Follow-up|0|||
161702282|NCT00956943|583959216|FG000|Overall Study|Lost to Follow-up|9|||
161702283|NCT00956943|583959217|FG001|Overall Study|Lost to Follow-up|10|||
161702284|NCT02613208|583959218|FG000|Overall Study|Withdrawal by Subject|1|||
161702285|NCT02613208|583959218|FG000|Overall Study|Change of address|2|||
161702286|NCT02613208|583959218|FG000|Overall Study|Physician Decision|2|||
161702287|NCT02613208|583959218|FG000|Overall Study|Lost to Follow-up|5|||
161702288|NCT02613208|583959218|FG000|Overall Study|Death|37|||
161702289|NCT02663895|583959219|FG000|Overall Study|Adverse Event|3|||
161837113|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Adverse Event|0|||
161702290|NCT02663895|583959219|FG000|Overall Study|Physician Decision|2|||
161702291|NCT02663895|583959219|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
161702292|NCT02663895|583959219|FG000|Overall Study|Withdrawal by Subject|1|||
161702293|NCT00809328|583959220|FG000|Overall Study|Lack of Efficacy|18|||
161702294|NCT00809328|583959220|FG000|Overall Study|Adverse Event|6|||
161702295|NCT00809328|583959220|FG000|Overall Study|Protocol Violation|3|||
161702296|NCT00809328|583959220|FG000|Overall Study|Withdrawal by Subject|2|||
161702297|NCT00008385|583959223|FG000|Overall Study|Off treatment reasons not reported|79|||
161702298|NCT00008385|583959224|FG001|Overall Study|Off treatment reasons not reported|70|||
161702299|NCT00008385|583959223|FG000|Overall Study|Progressive disease|52|||
161702300|NCT00008385|583959224|FG001|Overall Study|Progressive disease|117|||
161702301|NCT00008385|583959223|FG000|Overall Study|Adverse Event|8|||
161702302|NCT00008385|583959224|FG001|Overall Study|Adverse Event|20|||
161702303|NCT00008385|583959223|FG000|Overall Study|Death|12|||
161702304|NCT00008385|583959224|FG001|Overall Study|Death|18|||
161702305|NCT00008385|583959223|FG000|Overall Study|Withdrawal by Subject|67|||
161702306|NCT00008385|583959224|FG001|Overall Study|Withdrawal by Subject|157|||
161702307|NCT00008385|583959223|FG000|Overall Study|Start non-protocol therapy|3|||
161702308|NCT00008385|583959224|FG001|Overall Study|Start non-protocol therapy|1|||
161702309|NCT00008385|583959223|FG000|Overall Study|Other complicating disease|17|||
161702310|NCT00008385|583959224|FG001|Overall Study|Other complicating disease|30|||
161702311|NCT00008385|583959223|FG000|Overall Study|Maximum dose reached|0|||
161702312|NCT00008385|583959224|FG001|Overall Study|Maximum dose reached|2|||
161702313|NCT00008385|583959223|FG000|Overall Study|Other|105|||
161702314|NCT00008385|583959224|FG001|Overall Study|Other|212|||
161702315|NCT00008385|583959223|FG000|Overall Study|Not start protocol therapy|44|||
161702316|NCT00008385|583959224|FG001|Overall Study|Not start protocol therapy|175|||
161702317|NCT05148884|583959225|FG000|Overall Study|Withdrawal by Subject|3|||
161702318|NCT05148884|583959226|FG001|Overall Study|Withdrawal by Subject|0|||
161702319|NCT05148884|583959225|FG000|Overall Study|Deep brain stimulation operation|0|||
161702320|NCT05148884|583959226|FG001|Overall Study|Deep brain stimulation operation|1|||
161702321|NCT01341457|583959229|FG000|Overall Study|Adverse Event|2|||
161702322|NCT01341457|583959230|FG001|Overall Study|Adverse Event|0|||
161702323|NCT00317044|583959231|FG000|Overall Study|Protocol Violation|28|||
161702324|NCT00317044|583959232|FG001|Overall Study|Protocol Violation|22|||
161702325|NCT00317044|583959233|FG002|Overall Study|Protocol Violation|20|||
161702326|NCT00317044|583959231|FG000|Overall Study|Adverse Event|4|||
161702327|NCT00317044|583959232|FG001|Overall Study|Adverse Event|7|||
161702328|NCT00317044|583959233|FG002|Overall Study|Adverse Event|4|||
161702329|NCT00317044|583959231|FG000|Overall Study|Withdrawal by Subject|10|||
161702330|NCT00317044|583959232|FG001|Overall Study|Withdrawal by Subject|7|||
161702331|NCT00317044|583959233|FG002|Overall Study|Withdrawal by Subject|12|||
161702332|NCT00317044|583959231|FG000|Overall Study|Lost to Follow-up|0|||
161702333|NCT00317044|583959232|FG001|Overall Study|Lost to Follow-up|2|||
161702334|NCT00317044|583959233|FG002|Overall Study|Lost to Follow-up|3|||
161702335|NCT00317044|583959231|FG000|Overall Study|Multiple Reasons|6|||
161702336|NCT00317044|583959232|FG001|Overall Study|Multiple Reasons|2|||
161702337|NCT00317044|583959233|FG002|Overall Study|Multiple Reasons|6|||
161702338|NCT04317690|583959236|FG000|Overall Study|did not have complete information for primary outcome|0|||
161702339|NCT04317690|583959237|FG001|Overall Study|did not have complete information for primary outcome|4|||
161702340|NCT04317690|583959238|FG002|Overall Study|did not have complete information for primary outcome|0|||
161702341|NCT04317690|583959239|FG003|Overall Study|did not have complete information for primary outcome|2|||
161702342|NCT04317690|583959240|FG004|Overall Study|did not have complete information for primary outcome|0|||
161702343|NCT02318095|583959241|FG000|Overall Study|Adverse Event|1|||
161702344|NCT01717638|583959242|FG000|Overall Study|Lost to Follow-up|0|||
161702345|NCT01717638|583959243|FG001|Overall Study|Lost to Follow-up|0|||
161702346|NCT01717638|583959244|FG002|Overall Study|Lost to Follow-up|0|||
161702347|NCT01717638|583959245|FG003|Overall Study|Lost to Follow-up|0|||
161702348|NCT01717638|583959246|FG004|Overall Study|Lost to Follow-up|0|||
161702349|NCT01717638|583959247|FG005|Overall Study|Lost to Follow-up|1|||
161702350|NCT01717638|583959248|FG006|Overall Study|Lost to Follow-up|0|||
161702351|NCT01717638|583959249|FG007|Overall Study|Lost to Follow-up|0|||
161702352|NCT01717638|583959250|FG008|Overall Study|Lost to Follow-up|0|||
161702353|NCT01717638|583959251|FG009|Overall Study|Lost to Follow-up|0|||
161702354|NCT01717638|583959252|FG010|Overall Study|Lost to Follow-up|0|||
161702355|NCT01717638|583959253|FG011|Overall Study|Lost to Follow-up|0|||
161702356|NCT01717638|583959254|FG012|Overall Study|Lost to Follow-up|0|||
161702357|NCT01717638|583959242|FG000|Overall Study|Father in hospital|0|||
161702358|NCT01717638|583959243|FG001|Overall Study|Father in hospital|0|||
161702359|NCT01717638|583959244|FG002|Overall Study|Father in hospital|0|||
161702360|NCT01717638|583959245|FG003|Overall Study|Father in hospital|0|||
161702361|NCT01717638|583959246|FG004|Overall Study|Father in hospital|0|||
161702362|NCT01717638|583959247|FG005|Overall Study|Father in hospital|0|||
161702363|NCT01717638|583959248|FG006|Overall Study|Father in hospital|0|||
161702364|NCT01717638|583959249|FG007|Overall Study|Father in hospital|0|||
161702365|NCT01717638|583959250|FG008|Overall Study|Father in hospital|0|||
161702366|NCT01717638|583959251|FG009|Overall Study|Father in hospital|0|||
161702367|NCT01717638|583959252|FG010|Overall Study|Father in hospital|0|||
161702368|NCT01717638|583959253|FG011|Overall Study|Father in hospital|0|||
161702369|NCT01717638|583959254|FG012|Overall Study|Father in hospital|1|||
161702370|NCT01717638|583959242|FG000|Overall Study|Withdrawal by Subject|0|||
161702371|NCT01717638|583959243|FG001|Overall Study|Withdrawal by Subject|1|||
161702372|NCT01717638|583959244|FG002|Overall Study|Withdrawal by Subject|1|||
161702373|NCT01717638|583959245|FG003|Overall Study|Withdrawal by Subject|0|||
161702374|NCT01717638|583959246|FG004|Overall Study|Withdrawal by Subject|1|||
161702375|NCT01717638|583959247|FG005|Overall Study|Withdrawal by Subject|0|||
161702376|NCT01717638|583959248|FG006|Overall Study|Withdrawal by Subject|2|||
161702377|NCT01717638|583959249|FG007|Overall Study|Withdrawal by Subject|1|||
161702378|NCT01717638|583959250|FG008|Overall Study|Withdrawal by Subject|2|||
161702379|NCT01717638|583959251|FG009|Overall Study|Withdrawal by Subject|1|||
161702380|NCT01717638|583959252|FG010|Overall Study|Withdrawal by Subject|0|||
161702381|NCT01717638|583959253|FG011|Overall Study|Withdrawal by Subject|0|||
161702382|NCT01717638|583959254|FG012|Overall Study|Withdrawal by Subject|18|||
161702383|NCT00600171|583959258|FG000|Overall Study|Adverse Event|0|||
161702384|NCT00600171|583959259|FG001|Overall Study|Adverse Event|1|||
161702385|NCT00600171|583959260|FG002|Overall Study|Adverse Event|0|||
161702386|NCT00600171|583959261|FG003|Overall Study|Adverse Event|0|||
161702387|NCT00600171|583959262|FG004|Overall Study|Adverse Event|1|||
161702388|NCT00600171|583959263|FG005|Overall Study|Adverse Event|0|||
161702389|NCT00600171|583959258|FG000|Overall Study|Lack of Efficacy|9|||
161702390|NCT00600171|583959259|FG001|Overall Study|Lack of Efficacy|12|||
161702391|NCT00600171|583959260|FG002|Overall Study|Lack of Efficacy|3|||
161702392|NCT00600171|583959261|FG003|Overall Study|Lack of Efficacy|5|||
161702393|NCT00600171|583959262|FG004|Overall Study|Lack of Efficacy|4|||
161702394|NCT00600171|583959263|FG005|Overall Study|Lack of Efficacy|0|||
161702395|NCT00600171|583959258|FG000|Overall Study|Protocol Violation|1|||
161702396|NCT00600171|583959259|FG001|Overall Study|Protocol Violation|2|||
161702397|NCT00600171|583959260|FG002|Overall Study|Protocol Violation|0|||
161702398|NCT00600171|583959261|FG003|Overall Study|Protocol Violation|1|||
161702399|NCT00600171|583959262|FG004|Overall Study|Protocol Violation|0|||
161702400|NCT00600171|583959263|FG005|Overall Study|Protocol Violation|0|||
161702401|NCT00600171|583959258|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
161702402|NCT00600171|583959259|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161702403|NCT00600171|583959260|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
161702404|NCT00600171|583959261|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
161702405|NCT00600171|583959262|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161702406|NCT00600171|583959263|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161702407|NCT00600171|583959258|FG000|Overall Study|Withdrawal by Subject|3|||
161702408|NCT00600171|583959259|FG001|Overall Study|Withdrawal by Subject|0|||
161702409|NCT00600171|583959260|FG002|Overall Study|Withdrawal by Subject|0|||
161702410|NCT00600171|583959261|FG003|Overall Study|Withdrawal by Subject|1|||
161702411|NCT00600171|583959262|FG004|Overall Study|Withdrawal by Subject|1|||
161702412|NCT00600171|583959263|FG005|Overall Study|Withdrawal by Subject|1|||
161702413|NCT00600171|583959258|FG000|Overall Study|Physician Decision|0|||
161702414|NCT00600171|583959259|FG001|Overall Study|Physician Decision|1|||
161702415|NCT00600171|583959260|FG002|Overall Study|Physician Decision|0|||
161702416|NCT00600171|583959261|FG003|Overall Study|Physician Decision|1|||
161702417|NCT00600171|583959262|FG004|Overall Study|Physician Decision|0|||
161702418|NCT00600171|583959263|FG005|Overall Study|Physician Decision|2|||
161702419|NCT00600171|583959258|FG000|Overall Study|Lost to Follow-up|0|||
161702420|NCT00600171|583959259|FG001|Overall Study|Lost to Follow-up|0|||
161702421|NCT00600171|583959260|FG002|Overall Study|Lost to Follow-up|0|||
161702422|NCT00600171|583959261|FG003|Overall Study|Lost to Follow-up|1|||
161702423|NCT00600171|583959262|FG004|Overall Study|Lost to Follow-up|0|||
161702424|NCT00600171|583959263|FG005|Overall Study|Lost to Follow-up|0|||
161702425|NCT02367521|583959264|FG000|Overall Study|severe headache after intervention|2|||
161702426|NCT02367521|583959265|FG001|Overall Study|severe headache after intervention|0|||
161702427|NCT02367521|583959264|FG000|Overall Study|unable to find transportation|2|||
161837114|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
161702428|NCT02367521|583959265|FG001|Overall Study|unable to find transportation|0|||
161702429|NCT00542191|583959269|FG000|Overall Study|Death|3|||
161702430|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702431|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161702432|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702433|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702434|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702435|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
161702436|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161702437|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161702438|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161702439|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
161702440|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702441|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702442|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702443|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702444|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702445|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702446|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702447|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702448|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702449|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
161702450|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702451|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702452|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702453|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702454|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702455|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161702456|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
161702457|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702458|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702459|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702460|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
161702461|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
161702462|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
161702463|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
161702464|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
161702465|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702466|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
161702467|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
161702468|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
161702469|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702470|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
161702471|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702472|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
161702473|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702474|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702475|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702476|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702477|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161702478|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702479|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702480|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
161702481|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
161702482|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
161702483|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
161702484|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
161702485|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702486|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
161702487|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702488|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702489|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702490|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
161702491|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702492|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
161702493|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702494|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702495|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702496|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702497|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702498|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702499|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702500|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702501|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161702502|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
161702503|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161702504|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702505|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
161702506|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
161702507|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
161702508|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
161702509|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
161702510|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161702511|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
161702512|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
161702513|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161702514|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161702515|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
161702516|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702517|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702518|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702519|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702520|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702521|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702522|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702523|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702524|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
161702525|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702526|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702527|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702528|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702529|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
161702530|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702531|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702532|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702533|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702534|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
161702535|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702536|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702537|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702538|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702539|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
161702540|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702541|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702542|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702543|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702544|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
161702545|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702546|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161702547|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702548|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702549|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702550|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
161702551|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
161702552|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
161702553|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
161702554|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
161702555|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702556|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702557|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702558|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
161702559|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702560|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702561|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702562|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702563|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702564|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702565|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
161702566|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
161702567|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
161702568|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
161702569|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
161702570|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702571|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
161702572|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
161702573|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702574|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702575|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702576|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702577|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702578|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702579|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
161702580|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702581|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
161702582|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702583|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702584|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702585|NCT03822884|583959275|FG000|Overall Study|Withdrawal by Subject|0|||
161702586|NCT03822884|583959276|FG001|Overall Study|Withdrawal by Subject|0|||
161702587|NCT03822884|583959277|FG002|Overall Study|Withdrawal by Subject|0|||
161702588|NCT03822884|583959278|FG003|Overall Study|Withdrawal by Subject|0|||
161702589|NCT03822884|583959279|FG004|Overall Study|Withdrawal by Subject|1|||
161702590|NCT03822884|583959280|FG005|Overall Study|Withdrawal by Subject|0|||
161702591|NCT00434967|583959283|FG000|Overall Study|Adverse Event|2|||
161702592|NCT00434967|583959284|FG001|Overall Study|Adverse Event|4|||
161702593|NCT00434967|583959285|FG002|Overall Study|Adverse Event|3|||
161702594|NCT00434967|583959286|FG003|Overall Study|Adverse Event|3|||
161702595|NCT00434967|583959283|FG000|Overall Study|Lost to Follow-up|0|||
161702596|NCT00434967|583959284|FG001|Overall Study|Lost to Follow-up|0|||
161702597|NCT00434967|583959285|FG002|Overall Study|Lost to Follow-up|1|||
161702598|NCT00434967|583959286|FG003|Overall Study|Lost to Follow-up|0|||
161702599|NCT00434967|583959283|FG000|Overall Study|Withdrawal by Subject|2|||
161702600|NCT00434967|583959284|FG001|Overall Study|Withdrawal by Subject|2|||
161702601|NCT00434967|583959285|FG002|Overall Study|Withdrawal by Subject|4|||
161702602|NCT00434967|583959286|FG003|Overall Study|Withdrawal by Subject|6|||
161702603|NCT00434967|583959283|FG000|Overall Study|Randomized in error|0|||
161702604|NCT00434967|583959284|FG001|Overall Study|Randomized in error|0|||
161702605|NCT00434967|583959285|FG002|Overall Study|Randomized in error|0|||
161702606|NCT00434967|583959286|FG003|Overall Study|Randomized in error|1|||
161702607|NCT00434967|583959283|FG000|Overall Study|Protocol Violation|0|||
161702608|NCT00434967|583959284|FG001|Overall Study|Protocol Violation|1|||
161702609|NCT00434967|583959285|FG002|Overall Study|Protocol Violation|0|||
161702610|NCT00434967|583959286|FG003|Overall Study|Protocol Violation|1|||
161702611|NCT00434967|583959283|FG000|Overall Study|Physician Decision|1|||
161702612|NCT00434967|583959284|FG001|Overall Study|Physician Decision|1|||
161702613|NCT00434967|583959285|FG002|Overall Study|Physician Decision|1|||
161702614|NCT00434967|583959286|FG003|Overall Study|Physician Decision|0|||
161702615|NCT00434967|583959283|FG000|Overall Study|Patient Disposition Challenges|2|||
161702616|NCT00434967|583959284|FG001|Overall Study|Patient Disposition Challenges|0|||
161702617|NCT00434967|583959285|FG002|Overall Study|Patient Disposition Challenges|0|||
161702618|NCT00434967|583959286|FG003|Overall Study|Patient Disposition Challenges|3|||
161702619|NCT00110019|583959292|FG000|Overall Study|Lack of Efficacy|253|||
161702620|NCT00110019|583959293|FG001|Overall Study|Lack of Efficacy|285|||
161702621|NCT00110019|583959292|FG000|Overall Study|Adverse Event|61|||
161702622|NCT00110019|583959293|FG001|Overall Study|Adverse Event|40|||
161702623|NCT00110019|583959292|FG000|Overall Study|Death|13|||
161702624|NCT00110019|583959293|FG001|Overall Study|Death|15|||
161702625|NCT00110019|583959292|FG000|Overall Study|Withdrawal by Subject|21|||
161837115|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
161702626|NCT00110019|583959293|FG001|Overall Study|Withdrawal by Subject|9|||
161702627|NCT00110019|583959292|FG000|Overall Study|alternative therapy|5|||
161702628|NCT00110019|583959293|FG001|Overall Study|alternative therapy|1|||
161702629|NCT00110019|583959292|FG000|Overall Study|complicating disease|1|||
161702630|NCT00110019|583959293|FG001|Overall Study|complicating disease|1|||
161702631|NCT00110019|583959292|FG000|Overall Study|symptom deterioration|13|||
161702632|NCT00110019|583959293|FG001|Overall Study|symptom deterioration|16|||
161702633|NCT00110019|583959292|FG000|Overall Study|Not start protocol therapy|17|||
161702634|NCT00110019|583959293|FG001|Overall Study|Not start protocol therapy|16|||
161702635|NCT00110019|583959292|FG000|Overall Study|other reasons|22|||
161702636|NCT00110019|583959293|FG001|Overall Study|other reasons|30|||
161702637|NCT04276207|583959294|FG000|Period 1|Withdrawal by Subject|0|||
161702638|NCT04276207|583959295|FG001|Period 1|Withdrawal by Subject|1|||
161702639|NCT01256177|583959296|FG000|Overall Study|Withdrawal by Subject|23|||
161702640|NCT01256177|583959297|FG001|Overall Study|Withdrawal by Subject|22|||
161702641|NCT01256177|583959296|FG000|Overall Study|Lost to Follow-up|2|||
161702642|NCT01256177|583959297|FG001|Overall Study|Lost to Follow-up|2|||
161702643|NCT01256177|583959296|FG000|Overall Study|Adverse Event|8|||
161702644|NCT01256177|583959297|FG001|Overall Study|Adverse Event|9|||
161702645|NCT01256177|583959296|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161702646|NCT01256177|583959297|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161702647|NCT01256177|583959296|FG000|Overall Study|Condition under Investigation Worsened|1|||
161702648|NCT01256177|583959297|FG001|Overall Study|Condition under Investigation Worsened|0|||
161702649|NCT01256177|583959296|FG000|Overall Study|Lack of Efficacy|11|||
161702650|NCT01256177|583959297|FG001|Overall Study|Lack of Efficacy|2|||
161702651|NCT01256177|583959296|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
161702652|NCT01256177|583959297|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
161702653|NCT01596257|583959299|FG000|Overall Study|Inadequate Collection|23|||
161702654|NCT01596257|583959300|FG001|Overall Study|Inadequate Collection|19|||
161702655|NCT00531960|583959301|FG000|Overall Study|Adverse Event|5|||
161702656|NCT00531960|583959302|FG001|Overall Study|Adverse Event|4|||
161702657|NCT00531960|583959301|FG000|Overall Study|Death|3|||
161702658|NCT00531960|583959302|FG001|Overall Study|Death|2|||
161702659|NCT00531960|583959301|FG000|Overall Study|Lack of Efficacy|42|||
161702660|NCT00531960|583959302|FG001|Overall Study|Lack of Efficacy|41|||
161702661|NCT00531960|583959301|FG000|Overall Study|Violation of Selection Criteria|2|||
161702662|NCT00531960|583959302|FG001|Overall Study|Violation of Selection Criteria|0|||
161702663|NCT00531960|583959301|FG000|Overall Study|Refused Treatment|5|||
161702664|NCT00531960|583959302|FG001|Overall Study|Refused Treatment|6|||
161702665|NCT00531960|583959301|FG000|Overall Study|Other|4|||
161702666|NCT00531960|583959302|FG001|Overall Study|Other|10|||
161702667|NCT02318784|583959305|FG000|Overall Study|Adverse Event|13|||
161702668|NCT02318784|583959305|FG000|Overall Study|Death|2|||
161702669|NCT02318784|583959305|FG000|Overall Study|Progressive Disease|37|||
161702670|NCT02318784|583959305|FG000|Overall Study|Withdrawal by Subject|10|||
161702671|NCT03603652|583959309|FG000|Overall Study|Death|2|||
161702672|NCT01879410|583959317|FG000|Overall Study|Adverse Event|9|||
161702673|NCT01879410|583959318|FG001|Overall Study|Adverse Event|14|||
161702674|NCT01879410|583959317|FG000|Overall Study|Lack of Efficacy|4|||
161702675|NCT01879410|583959318|FG001|Overall Study|Lack of Efficacy|6|||
161702676|NCT01879410|583959317|FG000|Overall Study|Protocol Violation|1|||
161702677|NCT01879410|583959318|FG001|Overall Study|Protocol Violation|7|||
161702678|NCT01879410|583959317|FG000|Overall Study|Lost to Follow-up|2|||
161702679|NCT01879410|583959318|FG001|Overall Study|Lost to Follow-up|1|||
161702680|NCT01879410|583959317|FG000|Overall Study|Withdrawal by Subject|7|||
161702681|NCT01879410|583959318|FG001|Overall Study|Withdrawal by Subject|8|||
161702682|NCT01879410|583959317|FG000|Overall Study|Randomised in Error|1|||
161702683|NCT01879410|583959318|FG001|Overall Study|Randomised in Error|2|||
161702684|NCT00238264|583959319|FG000|Overall Study|Death|7|||
161702685|NCT00238264|583959319|FG000|Overall Study|Lost to Follow-up|18|||
161702686|NCT00238264|583959319|FG000|Overall Study|Withdrawal by Subject|4|||
161702687|NCT00238264|583959319|FG000|Overall Study|Ineligible|7|||
161702688|NCT00508391|583959320|FG000|First Treatment|Withdrawal by Subject|6|||
161702689|NCT00508391|583959321|FG001|First Treatment|Withdrawal by Subject|3|||
161702690|NCT00508391|583959320|FG000|Second Treatment|Withdrawal by Subject|2|||
161702691|NCT00508391|583959321|FG001|Second Treatment|Withdrawal by Subject|0|||
161837116|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
161837117|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
161702692|NCT00880256|583959322|FG000|Overall Study|Lost to Follow-up|28|||
161702693|NCT02041962|583959326|FG000|Overall Study|Lost Aetna Coverage|43|||
161702694|NCT02041962|583959327|FG001|Overall Study|Lost Aetna Coverage|40|||
161702695|NCT02041962|583959326|FG000|Overall Study|Death|1|||
161702696|NCT02041962|583959327|FG001|Overall Study|Death|1|||
161702697|NCT02041962|583959326|FG000|Overall Study|Lost to Follow-up|37|||
161702698|NCT02041962|583959327|FG001|Overall Study|Lost to Follow-up|32|||
161702699|NCT02041962|583959326|FG000|Overall Study|Withdrawal by Subject|0|||
161702700|NCT02041962|583959327|FG001|Overall Study|Withdrawal by Subject|11|||
161702701|NCT01686568|583959328|FG000|Main Study|Withdrawal by Subject|1|||
161702702|NCT01686568|583959329|FG001|Main Study|Withdrawal by Subject|3|||
161702703|NCT01686568|583959328|FG000|Main Study|Noncompliance with protocol|0|||
161702704|NCT01686568|583959329|FG001|Main Study|Noncompliance with protocol|1|||
161702705|NCT01686568|583959328|FG000|Main Study|Liver enzymes above range of exclusion|1|||
161702706|NCT01686568|583959329|FG001|Main Study|Liver enzymes above range of exclusion|0|||
161702707|NCT01686568|583959328|FG000|Sub-Study|Not consented for sub-study|2|||
161702708|NCT01686568|583959329|FG001|Sub-Study|Not consented for sub-study|2|||
161702709|NCT00974220|583959330|FG000|Treatment Period 1|Adverse Event|2|||
161702710|NCT00974220|583959331|FG001|Treatment Period 1|Adverse Event|1|||
161702711|NCT00974220|583959330|FG000|Treatment Period 1|noncompliant subjects|0|||
161702712|NCT00974220|583959331|FG001|Treatment Period 1|noncompliant subjects|1|||
161702713|NCT02959814|583959350|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
161702714|NCT02959814|583959350|FG000|Overall Study|Excluded based on anatomical criteria|2|||
161702715|NCT02959814|583959350|FG000|Overall Study|Protocol Violation|7|||
161702716|NCT02959814|583959350|FG000|Overall Study|FFR not measured|2|||
161702717|NCT02959814|583959350|FG000|Overall Study|In-procedure QFR not computed|6|||
161702718|NCT02959814|583959350|FG000|Overall Study|Excluded by FFR core-lab|24|||
161702719|NCT04343651|583959354|FG000|Overall Study|Physician Decision|2|||
161702720|NCT04343651|583959355|FG001|Overall Study|Physician Decision|1|||
161702721|NCT04343651|583959354|FG000|Overall Study|Lost to Follow-up|2|||
161702722|NCT04343651|583959355|FG001|Overall Study|Lost to Follow-up|1|||
161702723|NCT04343651|583959354|FG000|Overall Study|Protocol Violation|4|||
161702724|NCT04343651|583959355|FG001|Overall Study|Protocol Violation|6|||
161702725|NCT04343651|583959354|FG000|Overall Study|Missing|3|||
161702726|NCT04343651|583959355|FG001|Overall Study|Missing|9|||
161702727|NCT04343651|583959354|FG000|Overall Study|Withdrawal by Subject|0|||
161702728|NCT04343651|583959355|FG001|Overall Study|Withdrawal by Subject|4|||
161702729|NCT04343651|583959354|FG000|Overall Study|Death|0|||
161702730|NCT04343651|583959355|FG001|Overall Study|Death|1|||
161702731|NCT04343651|583959354|FG000|Overall Study|Did not start treatment|1|||
161702732|NCT04343651|583959355|FG001|Overall Study|Did not start treatment|1|||
161702733|NCT04343651|583959354|FG000|Overall Study|Patient did not complete visits 3-6|0|||
161702734|NCT04343651|583959355|FG001|Overall Study|Patient did not complete visits 3-6|1|||
161702735|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
161702736|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
161702737|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
161702738|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702739|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702740|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702741|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702742|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702743|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702744|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
161702745|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
161702746|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
161702747|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702748|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702749|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702750|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702751|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702752|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702753|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161702754|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161702755|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702756|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702757|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702758|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702759|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702760|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702761|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702762|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
161702763|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
161702764|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
161702765|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702766|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702767|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702768|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702769|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702770|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161837118|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
161702771|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
161702772|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
161702773|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702774|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702775|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702776|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702777|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702778|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702779|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702780|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702781|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702782|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
161702783|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702784|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702785|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702786|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702787|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702788|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702789|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702790|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
161702791|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702792|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702793|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702794|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702795|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702796|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702797|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702798|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702799|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161837119|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
161837120|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
161837121|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Death|1|||
161837122|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Death|1|||
161837123|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Death|1|||
161837124|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Death|1|||
161837125|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Death|0|||
161837126|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Death|0|||
161837127|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Death|0|||
161837128|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
161837129|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161837130|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161837131|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161837132|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
161837133|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
161837134|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
161837135|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837136|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161702800|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702801|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702802|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702803|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702804|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702805|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
161702806|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702807|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702808|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702809|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
161702810|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702811|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702812|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702813|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702814|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702815|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702816|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
161702817|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161702818|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
161837137|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
161837138|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161702819|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
161702820|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
161702821|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161702822|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
161702823|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
161702824|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161702825|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702826|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
161702827|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
161702828|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702829|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
161702830|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702831|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702832|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702833|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702834|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702835|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702836|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
161702837|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702838|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
161702839|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
161702840|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702841|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702842|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702843|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
161702844|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
161702845|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702846|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702847|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
161702848|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702849|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702850|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
161702851|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
161702852|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
161702853|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161702854|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
161702855|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
161702856|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
161702857|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
161702858|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161702859|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
161702860|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161702861|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702862|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702863|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161837139|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837140|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837141|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837142|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
161837143|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
161837144|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
161837145|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
161837146|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
161837147|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
161837148|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
161837149|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Other|2|||
161837150|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Other|9|||
161837151|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Other|9|||
161837152|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Other|3|||
161837153|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Other|2|||
161837154|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Other|0|||
161837155|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Other|0|||
161837156|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
161837157|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
161837158|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
161837159|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
161837160|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
161702864|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702865|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161702866|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702867|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702868|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161702869|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161702870|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
161702871|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
161702872|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
161702873|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
161702874|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
161702875|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
161702876|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
161702877|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
161702878|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
161702879|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702880|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702881|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702882|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702883|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
161702884|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702885|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
161702886|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702887|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702888|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702889|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702890|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702891|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702892|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702893|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702894|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702895|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702896|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702897|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161702898|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
161702899|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161702900|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
161702901|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161702902|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161702903|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
161702904|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161702905|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161702906|NCT01292057|583959370|FG000|Overall Study|Protocol Violation|1|||
161702907|NCT01292057|583959371|FG001|Overall Study|Protocol Violation|1|||
161702908|NCT01292057|583959370|FG000|Overall Study|Lost to Follow-up|1|||
161702909|NCT01292057|583959371|FG001|Overall Study|Lost to Follow-up|1|||
161702910|NCT03658889|583961479|FG000|Overall Study|Protocol Violation|2|||
161702911|NCT03658889|583961480|FG001|Overall Study|Protocol Violation|0|||
161702912|NCT04188197|583961481|FG000|Overall Study|Lost to Follow-up|4|||
161702913|NCT04188197|583961482|FG001|Overall Study|Lost to Follow-up|1|||
161702914|NCT04188197|583961481|FG000|Overall Study|Withdrawal by Subject|1|||
161702915|NCT04188197|583961482|FG001|Overall Study|Withdrawal by Subject|1|||
161702916|NCT04188197|583961481|FG000|Overall Study|Pregnancy|0|||
161702917|NCT04188197|583961482|FG001|Overall Study|Pregnancy|1|||
161702918|NCT01524991|583961485|FG000|Overall Study|Adverse Event|12|||
161702919|NCT01524991|583961485|FG000|Overall Study|Death|1|||
161702920|NCT01524991|583961485|FG000|Overall Study|Disease ProgressionDu|17|||
161702921|NCT01524991|583961485|FG000|Overall Study|Other complicating disease|1|||
161702922|NCT01524991|583961485|FG000|Overall Study|Withdrawal by Subject|2|||
161702923|NCT01524991|583961485|FG000|Overall Study|Symptomatic Deterioration|1|||
161702924|NCT04574999|583961486|FG000|Overall Study|Adverse Event|1|||
161702925|NCT04574999|583961487|FG001|Overall Study|Adverse Event|0|||
161702926|NCT04574999|583961486|FG000|Overall Study|Lack of Efficacy|2|||
161702927|NCT04574999|583961487|FG001|Overall Study|Lack of Efficacy|3|||
161702928|NCT04574999|583961486|FG000|Overall Study|Protocol Violation|1|||
161702929|NCT04574999|583961487|FG001|Overall Study|Protocol Violation|0|||
161702930|NCT04574999|583961486|FG000|Overall Study|Withdrawal by Subject|2|||
161702931|NCT04574999|583961487|FG001|Overall Study|Withdrawal by Subject|2|||
161702932|NCT04574999|583961486|FG000|Overall Study|Lost to Follow-up|1|||
161702933|NCT04574999|583961487|FG001|Overall Study|Lost to Follow-up|0|||
161702934|NCT04574999|583961486|FG000|Overall Study|Personal problems|1|||
161702935|NCT04574999|583961487|FG001|Overall Study|Personal problems|0|||
161702936|NCT04574999|583961486|FG000|Overall Study|Previous planned surgery|1|||
161702937|NCT04574999|583961487|FG001|Overall Study|Previous planned surgery|0|||
161702938|NCT00206726|583961489|FG000|Overall Study|Delayed recovery of blood counts|1|||
161702939|NCT00206726|583961489|FG000|Overall Study|Progressive disease or relapsed disease|18|||
161702940|NCT00206726|583961489|FG000|Overall Study|Placed on new protocol|1|||
161702941|NCT00206726|583961489|FG000|Overall Study|Bone marrow transplant|1|||
161702942|NCT00206726|583961489|FG000|Overall Study|Adverse Event|17|||
161702943|NCT00206726|583961489|FG000|Overall Study|Death|4|||
161702944|NCT00206726|583961489|FG000|Overall Study|Protocol Violation|1|||
161702945|NCT00206726|583961489|FG000|Overall Study|Withdrawal by Subject|8|||
161702946|NCT00365989|583961490|FG000|Overall Study|Withdrawal by Subject|1|||
161702947|NCT00365989|583961490|FG000|Overall Study|Non-compliance|1|||
161702948|NCT00832819|583961493|FG000|Overall Study|Adverse Event|0|||
161702949|NCT00832819|583961494|FG001|Overall Study|Adverse Event|1|||
161702950|NCT00832819|583961495|FG002|Overall Study|Adverse Event|0|||
161702951|NCT00832819|583961493|FG000|Overall Study|Protocol Violation|0|||
161702952|NCT00832819|583961494|FG001|Overall Study|Protocol Violation|0|||
161702953|NCT00832819|583961495|FG002|Overall Study|Protocol Violation|1|||
161702954|NCT01719757|583961496|FG000|Overall Study|Adverse Event|38|||
161702955|NCT01719757|583961496|FG000|Overall Study|Withdrawal by Subject|15|||
161702956|NCT01719757|583961496|FG000|Overall Study|Lost to Follow-up|20|||
161702957|NCT01719757|583961496|FG000|Overall Study|Protocol Violation|1|||
161702958|NCT01719757|583961496|FG000|Overall Study|well controlled pain|27|||
161702959|NCT02626338|583961497|FG000|Overall Study|Lack of Efficacy|3|||
161702960|NCT02626338|583961498|FG001|Overall Study|Lack of Efficacy|2|||
161702961|NCT02626338|583961499|FG002|Overall Study|Lack of Efficacy|0|||
161702962|NCT03312218|583961505|FG000|Overall Study|Never signed in to access the app|54|||
161702963|NCT03312218|583961506|FG001|Overall Study|Never signed in to access the app|58|||
161702964|NCT01901224|583961507|FG000|Overall Study|study was not funded and terminated|2|||
161702965|NCT06441877|583961508|FG000|Overall Study|Withdrawal by Subject|0|||
161702966|NCT06441877|583961509|FG001|Overall Study|Withdrawal by Subject|2|||
161702967|NCT06441877|583961510|FG002|Overall Study|Withdrawal by Subject|0|||
161702968|NCT06441877|583961511|FG003|Overall Study|Withdrawal by Subject|0|||
161702969|NCT05742984|583961512|FG000|Overall Study|Adverse Event|0|||
161702970|NCT05742984|583961513|FG001|Overall Study|Adverse Event|0|||
161702971|NCT05742984|583961514|FG002|Overall Study|Adverse Event|1|||
161702972|NCT05742984|583961515|FG003|Overall Study|Adverse Event|0|||
161702973|NCT05742984|583961516|FG004|Overall Study|Adverse Event|1|||
161702974|NCT05742984|583961517|FG005|Overall Study|Adverse Event|1|||
161702975|NCT05742984|583961512|FG000|Overall Study|Withdrawal by Subject|0|||
161702976|NCT05742984|583961513|FG001|Overall Study|Withdrawal by Subject|1|||
161702977|NCT05742984|583961514|FG002|Overall Study|Withdrawal by Subject|0|||
161702978|NCT05742984|583961515|FG003|Overall Study|Withdrawal by Subject|0|||
161702979|NCT05742984|583961516|FG004|Overall Study|Withdrawal by Subject|0|||
161702980|NCT05742984|583961517|FG005|Overall Study|Withdrawal by Subject|2|||
161702981|NCT02162862|583961518|FG000|Overall Study|Lost to Follow-up|0|||
161702982|NCT02162862|583961519|FG001|Overall Study|Lost to Follow-up|11|||
161702983|NCT02162862|583961520|FG002|Overall Study|Lost to Follow-up|0|||
161702984|NCT02162862|583961518|FG000|Overall Study|Subject did not feel the med was needed|0|||
161702985|NCT02162862|583961519|FG001|Overall Study|Subject did not feel the med was needed|0|||
161702986|NCT02162862|583961520|FG002|Overall Study|Subject did not feel the med was needed|4|||
161702987|NCT03116113|583961521|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702988|NCT03116113|583961522|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161837161|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
161837162|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
161837163|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
161837164|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
161837165|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
161702989|NCT03116113|583961523|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702990|NCT03116113|583961524|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702991|NCT03116113|583961525|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702992|NCT03116113|583961526|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702993|NCT03116113|583961527|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702994|NCT03116113|583961528|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
161702995|NCT03116113|583961529|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
161702996|NCT02159807|583961530|FG000|Overall Study|Adverse Event|0|||
161702997|NCT02159807|583961531|FG001|Overall Study|Adverse Event|0|||
161702998|NCT02159807|583961532|FG002|Overall Study|Adverse Event|1|||
161702999|NCT02159807|583961530|FG000|Overall Study|No CSF|1|||
161703000|NCT02159807|583961531|FG001|Overall Study|No CSF|1|||
161703001|NCT02159807|583961532|FG002|Overall Study|No CSF|1|||
161703002|NCT02159807|583961530|FG000|Overall Study|elevated blood pressure|0|||
161703003|NCT02159807|583961531|FG001|Overall Study|elevated blood pressure|0|||
161703004|NCT02159807|583961532|FG002|Overall Study|elevated blood pressure|1|||
161703005|NCT00950170|583961533|FG000|Overall Study|Parent/Legal Guardian Request|1|||
161703006|NCT00950170|583961533|FG000|Overall Study|Adverse Event|2|||
161703007|NCT00950170|583961533|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161703008|NCT01254669|583961536|FG000|Overall Study|Withdrawal by Subject|0|||
161703009|NCT01254669|583961537|FG001|Overall Study|Withdrawal by Subject|1|||
161703010|NCT01254669|583961536|FG000|Overall Study|time constraint|2|||
161703011|NCT01254669|583961537|FG001|Overall Study|time constraint|2|||
161703012|NCT01254669|583961536|FG000|Overall Study|called to clinic during intervention|1|||
161703013|NCT01254669|583961537|FG001|Overall Study|called to clinic during intervention|1|||
161703014|NCT00103012|583961538|FG000|Overall Study|Withdrawal by Subject|2|||
161703015|NCT00103012|583961539|FG001|Overall Study|Withdrawal by Subject|1|||
161703016|NCT00103012|583961540|FG002|Overall Study|Withdrawal by Subject|2|||
161703017|NCT00103012|583961538|FG000|Overall Study|Pregnancy|1|||
161703018|NCT00103012|583961539|FG001|Overall Study|Pregnancy|0|||
161703019|NCT00103012|583961540|FG002|Overall Study|Pregnancy|0|||
161703020|NCT00103012|583961538|FG000|Overall Study|Adverse Event|0|||
161703021|NCT00103012|583961539|FG001|Overall Study|Adverse Event|0|||
161703022|NCT00103012|583961540|FG002|Overall Study|Adverse Event|1|||
161703023|NCT00103012|583961538|FG000|Overall Study|Subject non-compliant with medications|0|||
161703024|NCT00103012|583961539|FG001|Overall Study|Subject non-compliant with medications|0|||
161703025|NCT00103012|583961540|FG002|Overall Study|Subject non-compliant with medications|1|||
161703026|NCT00393718|583961547|FG000|Overall Study|Adverse Event|20|||
161703027|NCT00393718|583961548|FG001|Overall Study|Adverse Event|8|||
161703028|NCT00393718|583961547|FG000|Overall Study|Protocol Violation|1|||
161703029|NCT00393718|583961548|FG001|Overall Study|Protocol Violation|2|||
161703030|NCT00393718|583961547|FG000|Overall Study|Lack of Efficacy|10|||
161703031|NCT00393718|583961548|FG001|Overall Study|Lack of Efficacy|9|||
161703032|NCT00393718|583961547|FG000|Overall Study|Hypoglycaemia|3|||
161703033|NCT00393718|583961548|FG001|Overall Study|Hypoglycaemia|2|||
161703034|NCT00393718|583961547|FG000|Overall Study|Subject decision|5|||
161703035|NCT00393718|583961548|FG001|Overall Study|Subject decision|0|||
161703036|NCT00393718|583961547|FG000|Overall Study|Withdrawal of consent|2|||
161703037|NCT00393718|583961548|FG001|Overall Study|Withdrawal of consent|1|||
161703038|NCT00393718|583961547|FG000|Overall Study|Missed measurement|1|||
161703039|NCT00393718|583961548|FG001|Overall Study|Missed measurement|0|||
161703040|NCT00393718|583961547|FG000|Overall Study|Move|1|||
161703041|NCT00393718|583961548|FG001|Overall Study|Move|0|||
161703042|NCT01084551|583961553|FG000|Overall Study|Adverse Event|2|||
161703043|NCT01084551|583961554|FG001|Overall Study|Adverse Event|9|||
161703044|NCT01084551|583961555|FG002|Overall Study|Adverse Event|4|||
161703045|NCT01084551|583961553|FG000|Overall Study|Lack of Efficacy|2|||
161703046|NCT01084551|583961554|FG001|Overall Study|Lack of Efficacy|0|||
161703047|NCT01084551|583961555|FG002|Overall Study|Lack of Efficacy|1|||
161703048|NCT01084551|583961553|FG000|Overall Study|Withdrawal by Subject|2|||
161703049|NCT01084551|583961554|FG001|Overall Study|Withdrawal by Subject|1|||
161703050|NCT01084551|583961555|FG002|Overall Study|Withdrawal by Subject|0|||
161703051|NCT01084551|583961553|FG000|Overall Study|Protocol Violation|2|||
161703052|NCT01084551|583961554|FG001|Overall Study|Protocol Violation|4|||
161703053|NCT01084551|583961555|FG002|Overall Study|Protocol Violation|0|||
161703054|NCT01084551|583961553|FG000|Overall Study|Lost to Follow-up|0|||
161703055|NCT01084551|583961554|FG001|Overall Study|Lost to Follow-up|0|||
161703056|NCT01084551|583961555|FG002|Overall Study|Lost to Follow-up|3|||
161703057|NCT01084551|583961553|FG000|Overall Study|Physician Decision|1|||
161703058|NCT01084551|583961554|FG001|Overall Study|Physician Decision|0|||
161703059|NCT01084551|583961555|FG002|Overall Study|Physician Decision|0|||
161703060|NCT03902080|583961556|FG000|Overall Study|Adverse Event|17|||
161703061|NCT03902080|583961557|FG001|Overall Study|Adverse Event|15|||
161703062|NCT03902080|583961556|FG000|Overall Study|Withdrawal by Subject|28|||
161837166|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
161837167|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
161703063|NCT03902080|583961557|FG001|Overall Study|Withdrawal by Subject|35|||
161703064|NCT03902080|583961556|FG000|Overall Study|Lost to Follow-up|6|||
161837168|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
161703065|NCT03902080|583961557|FG001|Overall Study|Lost to Follow-up|7|||
161703066|NCT03902080|583961556|FG000|Overall Study|Other|3|||
161703067|NCT03902080|583961557|FG001|Overall Study|Other|5|||
161703068|NCT03902080|583961556|FG000|Overall Study|Non compliance|4|||
161703069|NCT03902080|583961557|FG001|Overall Study|Non compliance|3|||
161703070|NCT03902080|583961556|FG000|Overall Study|Physician Decision|5|||
161703071|NCT03902080|583961557|FG001|Overall Study|Physician Decision|1|||
161703072|NCT03902080|583961556|FG000|Overall Study|Protocol Violation|3|||
161703073|NCT03902080|583961557|FG001|Overall Study|Protocol Violation|3|||
161703074|NCT03902080|583961556|FG000|Overall Study|Lack of Efficacy|1|||
161703075|NCT03902080|583961557|FG001|Overall Study|Lack of Efficacy|3|||
161703076|NCT03902080|583961556|FG000|Overall Study|Withdrawn prior to dosing|0|||
161703077|NCT03902080|583961557|FG001|Overall Study|Withdrawn prior to dosing|1|||
161703078|NCT01703000|583961558|FG000|Overall Study|Death|1|||
161703079|NCT01279057|583961559|FG000|Overall Study|Adverse Event|1|||
161703080|NCT01279057|583961560|FG001|Overall Study|Adverse Event|0|||
161703081|NCT01279057|583961561|FG002|Overall Study|Adverse Event|1|||
161703082|NCT01279057|583961559|FG000|Overall Study|Insufficient therapeutic response|0|||
161703083|NCT01279057|583961560|FG001|Overall Study|Insufficient therapeutic response|0|||
161703084|NCT01279057|583961561|FG002|Overall Study|Insufficient therapeutic response|1|||
161703085|NCT01279057|583961559|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161703086|NCT01279057|583961560|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
161703087|NCT01279057|583961561|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161703088|NCT01279057|583961559|FG000|Overall Study|Withdrew consent|2|||
161703089|NCT01279057|583961560|FG001|Overall Study|Withdrew consent|0|||
161703090|NCT01279057|583961561|FG002|Overall Study|Withdrew consent|1|||
161703091|NCT01279057|583961559|FG000|Overall Study|Pregnancy|0|||
161703092|NCT01279057|583961560|FG001|Overall Study|Pregnancy|1|||
161703093|NCT01279057|583961561|FG002|Overall Study|Pregnancy|0|||
161703094|NCT01279057|583961559|FG000|Overall Study|Other|3|||
161703095|NCT01279057|583961560|FG001|Overall Study|Other|3|||
161703096|NCT01279057|583961561|FG002|Overall Study|Other|0|||
161703097|NCT01427309|583961562|FG000|Overall Study|Lost to Follow-up|130|||
161703098|NCT01427309|583961563|FG001|Overall Study|Lost to Follow-up|145|||
161703099|NCT01427309|583961564|FG002|Overall Study|Lost to Follow-up|122|||
161703100|NCT01427309|583961565|FG003|Overall Study|Lost to Follow-up|135|||
161703101|NCT01427309|583961562|FG000|Overall Study|Protocol Violation|42|||
161703102|NCT01427309|583961563|FG001|Overall Study|Protocol Violation|69|||
161703103|NCT01427309|583961564|FG002|Overall Study|Protocol Violation|125|||
161703104|NCT01427309|583961565|FG003|Overall Study|Protocol Violation|124|||
161703105|NCT01427309|583961562|FG000|Overall Study|Adverse Event|0|||
161703106|NCT01427309|583961563|FG001|Overall Study|Adverse Event|0|||
161703107|NCT01427309|583961564|FG002|Overall Study|Adverse Event|3|||
161703108|NCT01427309|583961565|FG003|Overall Study|Adverse Event|1|||
161703109|NCT01427309|583961562|FG000|Overall Study|Serious adverse event|52|||
161703110|NCT01427309|583961563|FG001|Overall Study|Serious adverse event|45|||
161703111|NCT01427309|583961564|FG002|Overall Study|Serious adverse event|50|||
161703112|NCT01427309|583961565|FG003|Overall Study|Serious adverse event|61|||
161703113|NCT01427309|583961562|FG000|Overall Study|Withdrawal by Subject|148|||
161703114|NCT01427309|583961563|FG001|Overall Study|Withdrawal by Subject|148|||
161703115|NCT01427309|583961564|FG002|Overall Study|Withdrawal by Subject|61|||
161703116|NCT01427309|583961565|FG003|Overall Study|Withdrawal by Subject|55|||
161703117|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
161703118|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
161703119|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
161703120|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
161703121|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
161703122|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
161703123|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
161703124|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
161703125|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
161703126|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
161703127|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
161703128|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
161703129|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
161703130|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
161703131|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
161703132|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
161703133|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
161703134|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
161703135|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
161703136|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
161703137|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
161703138|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
161703139|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
161703140|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
161703141|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
161703142|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
161703143|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
161703144|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
161703145|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161703146|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
161703147|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
161654901|NCT00368927|583786581|FG001|Overall Study|Withdrawal by Subject|2|||
161654902|NCT00368927|583786580|FG000|Overall Study|Physician Decision|1|||
161654903|NCT00368927|583786581|FG001|Overall Study|Physician Decision|0|||
161654904|NCT01204710|583786582|FG000|Randomization Treatment|Lost to Follow-up|1|||
161654905|NCT01204710|583786583|FG001|Randomization Treatment|Lost to Follow-up|0|||
161654906|NCT01204710|583786582|FG000|Randomization Treatment|Withdrawal by Subject|6|||
161654907|NCT01204710|583786583|FG001|Randomization Treatment|Withdrawal by Subject|5|||
161654908|NCT01204710|583786582|FG000|Randomization Treatment|Physician Decision|3|||
161654909|NCT01204710|583786583|FG001|Randomization Treatment|Physician Decision|2|||
161654910|NCT01204710|583786582|FG000|Randomization Treatment|Entry criteria not met|0|||
161654911|NCT01204710|583786583|FG001|Randomization Treatment|Entry criteria not met|1|||
161654912|NCT01204710|583786582|FG000|Randomization Treatment|Adverse Event|4|||
161654913|NCT01204710|583786583|FG001|Randomization Treatment|Adverse Event|2|||
161654914|NCT01204710|583786582|FG000|Randomization Treatment|Sponsor Decision|0|||
161654915|NCT01204710|583786583|FG001|Randomization Treatment|Sponsor Decision|1|||
161654916|NCT01204710|583786582|FG000|Randomization Treatment|Worsening of General condition|0|||
161654917|NCT01204710|583786583|FG001|Randomization Treatment|Worsening of General condition|1|||
161654918|NCT01204710|583786582|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
161654919|NCT01204710|583786583|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
161654920|NCT01204710|583786582|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
161654921|NCT01204710|583786583|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
161654922|NCT01204710|583786582|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
161654923|NCT01204710|583786583|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
161654924|NCT01204710|583786582|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
161654925|NCT01204710|583786583|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
161654926|NCT03898167|583786584|FG000|Overall Study|Terminated phone call early|7|||
161654927|NCT03898167|583786585|FG001|Overall Study|Terminated phone call early|0|||
161654928|NCT03898167|583786586|FG002|Overall Study|Terminated phone call early|0|||
161654929|NCT03898167|583786584|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
161654930|NCT03898167|583786585|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
161654931|NCT03898167|583786586|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
161654932|NCT00151281|583786587|FG000|Overall Study|Not evaluable|3|||
161654933|NCT02906007|583786590|FG000|Overall Study|Physician Decision|0|||
161654934|NCT02906007|583786591|FG001|Overall Study|Physician Decision|0|||
161654935|NCT02906007|583786592|FG002|Overall Study|Physician Decision|1|||
161654936|NCT02906007|583786590|FG000|Overall Study|Died|1|||
161654937|NCT02906007|583786591|FG001|Overall Study|Died|0|||
161654938|NCT02906007|583786592|FG002|Overall Study|Died|0|||
161654939|NCT04696653|583786593|FG000|Overall Study|left organization|18|||
161654940|NCT04696653|583786593|FG000|Overall Study|Lost to Follow-up|3|||
161654941|NCT04047862|583786600|FG000|Overall Study|Death|0|||
161654942|NCT04047862|583786601|FG001|Overall Study|Death|0|||
161654943|NCT04047862|583786602|FG002|Overall Study|Death|4|||
161654944|NCT04047862|583786603|FG003|Overall Study|Death|7|||
161654945|NCT04047862|583786604|FG004|Overall Study|Death|2|||
161703148|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
161703149|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
161703150|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
161703151|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161703152|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
161703153|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161703154|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
161703155|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
161703156|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
161703157|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
161703158|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
161703159|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
161703160|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
161703161|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
161703162|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
161703163|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161703164|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161703165|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
161703166|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
161703167|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
161703168|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
161703169|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
161703170|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
161703171|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
161703172|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
161703173|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
161703174|NCT02913313|583961571|FG000|Overall Study|DISEASE PROGRESSION|1|||
161703175|NCT02913313|583961572|FG001|Overall Study|DISEASE PROGRESSION|2|||
161703176|NCT02913313|583961573|FG002|Overall Study|DISEASE PROGRESSION|2|||
161703177|NCT02913313|583961574|FG003|Overall Study|DISEASE PROGRESSION|4|||
161703178|NCT02913313|583961575|FG004|Overall Study|DISEASE PROGRESSION|6|||
161703179|NCT02913313|583961576|FG005|Overall Study|DISEASE PROGRESSION|4|||
161703180|NCT02913313|583961577|FG006|Overall Study|DISEASE PROGRESSION|19|||
161703181|NCT02913313|583961578|FG007|Overall Study|DISEASE PROGRESSION|3|||
161703182|NCT02913313|583961579|FG008|Overall Study|DISEASE PROGRESSION|4|||
161703183|NCT02913313|583961580|FG009|Overall Study|DISEASE PROGRESSION|4|||
161703184|NCT02913313|583961581|FG010|Overall Study|DISEASE PROGRESSION|11|||
161703185|NCT02913313|583961582|FG011|Overall Study|DISEASE PROGRESSION|5|||
161703186|NCT02913313|583961583|FG012|Overall Study|DISEASE PROGRESSION|14|||
161703187|NCT02913313|583961584|FG013|Overall Study|DISEASE PROGRESSION|3|||
161703188|NCT02913313|583961571|FG000|Overall Study|Not Reported|0|||
161703189|NCT02913313|583961572|FG001|Overall Study|Not Reported|0|||
161703190|NCT02913313|583961573|FG002|Overall Study|Not Reported|0|||
161703191|NCT02913313|583961574|FG003|Overall Study|Not Reported|0|||
161703192|NCT02913313|583961575|FG004|Overall Study|Not Reported|1|||
161703193|NCT02913313|583961576|FG005|Overall Study|Not Reported|0|||
161703194|NCT02913313|583961577|FG006|Overall Study|Not Reported|0|||
161703195|NCT02913313|583961578|FG007|Overall Study|Not Reported|0|||
161703196|NCT02913313|583961579|FG008|Overall Study|Not Reported|0|||
161703197|NCT02913313|583961580|FG009|Overall Study|Not Reported|0|||
161703198|NCT02913313|583961581|FG010|Overall Study|Not Reported|4|||
161703199|NCT02913313|583961582|FG011|Overall Study|Not Reported|0|||
161703200|NCT02913313|583961583|FG012|Overall Study|Not Reported|0|||
161703201|NCT02913313|583961584|FG013|Overall Study|Not Reported|0|||
161703202|NCT02913313|583961571|FG000|Overall Study|Other reasons|0|||
161703203|NCT02913313|583961572|FG001|Overall Study|Other reasons|0|||
161703204|NCT02913313|583961573|FG002|Overall Study|Other reasons|0|||
161703205|NCT02913313|583961574|FG003|Overall Study|Other reasons|0|||
161703206|NCT02913313|583961575|FG004|Overall Study|Other reasons|1|||
161703207|NCT02913313|583961576|FG005|Overall Study|Other reasons|0|||
161703208|NCT02913313|583961577|FG006|Overall Study|Other reasons|0|||
161703209|NCT02913313|583961578|FG007|Overall Study|Other reasons|0|||
161703210|NCT02913313|583961579|FG008|Overall Study|Other reasons|0|||
161703211|NCT02913313|583961580|FG009|Overall Study|Other reasons|0|||
161703212|NCT02913313|583961581|FG010|Overall Study|Other reasons|1|||
161703213|NCT02913313|583961582|FG011|Overall Study|Other reasons|0|||
161703214|NCT02913313|583961583|FG012|Overall Study|Other reasons|0|||
161703215|NCT02913313|583961584|FG013|Overall Study|Other reasons|0|||
161703216|NCT02913313|583961571|FG000|Overall Study|Withdrawal by Subject|0|||
161703217|NCT02913313|583961572|FG001|Overall Study|Withdrawal by Subject|0|||
161703218|NCT02913313|583961573|FG002|Overall Study|Withdrawal by Subject|1|||
161703219|NCT02913313|583961574|FG003|Overall Study|Withdrawal by Subject|0|||
161703220|NCT02913313|583961575|FG004|Overall Study|Withdrawal by Subject|0|||
161703221|NCT02913313|583961576|FG005|Overall Study|Withdrawal by Subject|0|||
161703222|NCT02913313|583961577|FG006|Overall Study|Withdrawal by Subject|1|||
161703223|NCT02913313|583961578|FG007|Overall Study|Withdrawal by Subject|1|||
161703224|NCT02913313|583961579|FG008|Overall Study|Withdrawal by Subject|0|||
161703225|NCT02913313|583961580|FG009|Overall Study|Withdrawal by Subject|0|||
161703226|NCT02913313|583961581|FG010|Overall Study|Withdrawal by Subject|1|||
161703227|NCT02913313|583961582|FG011|Overall Study|Withdrawal by Subject|0|||
161703228|NCT02913313|583961583|FG012|Overall Study|Withdrawal by Subject|0|||
161703229|NCT02913313|583961584|FG013|Overall Study|Withdrawal by Subject|0|||
161703230|NCT02913313|583961571|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703231|NCT02913313|583961572|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703232|NCT02913313|583961573|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703233|NCT02913313|583961574|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703234|NCT02913313|583961575|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703235|NCT02913313|583961576|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703236|NCT02913313|583961577|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703237|NCT02913313|583961578|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703238|NCT02913313|583961579|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703239|NCT02913313|583961580|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703240|NCT02913313|583961581|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161703241|NCT02913313|583961582|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703242|NCT02913313|583961583|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161703243|NCT02913313|583961584|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161703244|NCT02913313|583961571|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
161703245|NCT02913313|583961572|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
161703246|NCT02913313|583961573|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
161703247|NCT02913313|583961574|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
161703248|NCT02913313|583961575|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
161703249|NCT02913313|583961576|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
161703250|NCT02913313|583961577|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
161703251|NCT02913313|583961578|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
161703252|NCT02913313|583961579|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
161703253|NCT02913313|583961580|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
161703254|NCT02913313|583961581|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
161703255|NCT02913313|583961582|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
161703256|NCT02913313|583961583|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
161703257|NCT02913313|583961584|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
161703258|NCT01061008|583961585|FG000|Overall Study|Badiocephalic fistula failed|3|||
161703259|NCT01061008|583961586|FG001|Overall Study|Badiocephalic fistula failed|2|||
161703260|NCT01061008|583961585|FG000|Overall Study|Death|1|||
161703261|NCT01061008|583961586|FG001|Overall Study|Death|0|||
161703262|NCT01061008|583961585|FG000|Overall Study|Withdrawal by Subject|1|||
161703263|NCT01061008|583961586|FG001|Overall Study|Withdrawal by Subject|3|||
161703264|NCT01061008|583961585|FG000|Overall Study|Unable to exercise following surgery|1|||
161703265|NCT01061008|583961586|FG001|Overall Study|Unable to exercise following surgery|0|||
161703266|NCT01061008|583961585|FG000|Overall Study|Adverse Event|0|||
161703267|NCT01061008|583961586|FG001|Overall Study|Adverse Event|1|||
161703268|NCT02024971|583961589|FG000|Overall Study|Data Not Available|30|||
161703269|NCT02024971|583961589|FG000|Overall Study|Lost to Follow-up|6|||
161703270|NCT02908100|583961590|FG000|Overall Study|Adverse Event|7|||
161703271|NCT02908100|583961591|FG001|Overall Study|Adverse Event|6|||
161703272|NCT02908100|583961592|FG002|Overall Study|Adverse Event|9|||
161703273|NCT02908100|583961590|FG000|Overall Study|Death|2|||
161703274|NCT02908100|583961591|FG001|Overall Study|Death|0|||
161703275|NCT02908100|583961592|FG002|Overall Study|Death|0|||
161703276|NCT02908100|583961590|FG000|Overall Study|Lack of Efficacy|2|||
161703277|NCT02908100|583961591|FG001|Overall Study|Lack of Efficacy|3|||
161703278|NCT02908100|583961592|FG002|Overall Study|Lack of Efficacy|3|||
161703279|NCT02908100|583961590|FG000|Overall Study|Lost to Follow-up|0|||
161703280|NCT02908100|583961591|FG001|Overall Study|Lost to Follow-up|1|||
161703281|NCT02908100|583961592|FG002|Overall Study|Lost to Follow-up|2|||
161703282|NCT02908100|583961590|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161703283|NCT02908100|583961591|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161703284|NCT02908100|583961592|FG002|Overall Study|Non-Compliance With Study Drug|2|||
161703285|NCT02908100|583961590|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
161703286|NCT02908100|583961591|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
161703287|NCT02908100|583961592|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
161703288|NCT02908100|583961590|FG000|Overall Study|Physician Decision|0|||
161703289|NCT02908100|583961591|FG001|Overall Study|Physician Decision|1|||
161703290|NCT02908100|583961592|FG002|Overall Study|Physician Decision|0|||
161703291|NCT02908100|583961590|FG000|Overall Study|Pregnancy|1|||
161703292|NCT02908100|583961591|FG001|Overall Study|Pregnancy|2|||
161703293|NCT02908100|583961592|FG002|Overall Study|Pregnancy|0|||
161703294|NCT02908100|583961590|FG000|Overall Study|Withdrawal by Subject|8|||
161703295|NCT02908100|583961591|FG001|Overall Study|Withdrawal by Subject|7|||
161703296|NCT02908100|583961592|FG002|Overall Study|Withdrawal by Subject|5|||
161703297|NCT02908100|583961590|FG000|Overall Study|Randomised in Error|1|||
161703298|NCT02908100|583961591|FG001|Overall Study|Randomised in Error|0|||
161703299|NCT02908100|583961592|FG002|Overall Study|Randomised in Error|0|||
161703300|NCT05254418|583961593|FG000|Overall Study|Adverse Event|2|||
161703313|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
161703314|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
161703315|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
161703316|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
161703317|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
161703318|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
161703319|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
161703320|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
161703321|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
161703322|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
161703323|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
161703324|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
161703325|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
161703326|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
161703327|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
161703328|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
161703329|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161703330|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161703331|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
161703332|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161703333|NCT02631538|583961597|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
161703334|NCT02631538|583961598|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
161703335|NCT02631538|583961599|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
161703336|NCT02631538|583961600|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
161703337|NCT00440726|583961601|FG000|Phase 1|Dose-Limiting Toxicity|0|||
161703338|NCT00440726|583961602|FG001|Phase 1|Dose-Limiting Toxicity|1|||
161703339|NCT00440726|583961603|FG002|Phase 1|Dose-Limiting Toxicity|0|||
161703340|NCT00440726|583961601|FG000|Phase 1|Physician Decision|1|||
161703341|NCT00440726|583961602|FG001|Phase 1|Physician Decision|0|||
161703342|NCT00440726|583961603|FG002|Phase 1|Physician Decision|0|||
161837169|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
161837170|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161703343|NCT00440726|583961601|FG000|Phase 2|Death|0|||
161703344|NCT00440726|583961602|FG001|Phase 2|Death|0|||
161703345|NCT00440726|583961603|FG002|Phase 2|Death|1|||
161703346|NCT00440726|583961601|FG000|Phase 2|Adverse Event|0|||
161703347|NCT00440726|583961602|FG001|Phase 2|Adverse Event|0|||
161703348|NCT00440726|583961603|FG002|Phase 2|Adverse Event|1|||
161703349|NCT04067518|583961604|FG000|Overall Study|Adverse Event|1|||
161703350|NCT04067518|583961605|FG001|Overall Study|Adverse Event|3|||
161703351|NCT04067518|583961604|FG000|Overall Study|Screen failures|0|||
161703352|NCT04067518|583961605|FG001|Overall Study|Screen failures|1|||
161703353|NCT04067518|583961604|FG000|Overall Study|Enrolled but not treated|0|||
161837171|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161703354|NCT04067518|583961605|FG001|Overall Study|Enrolled but not treated|1|||
161703355|NCT03624946|583961609|FG000|Overall Study|Lost to Follow-up|0|||
161703356|NCT03624946|583961610|FG001|Overall Study|Lost to Follow-up|1|||
161703357|NCT00862251|583961614|FG000|Overall Study|Adverse Event|8|||
161703358|NCT00862251|583961615|FG001|Overall Study|Adverse Event|3|||
161703359|NCT00862251|583961616|FG002|Overall Study|Adverse Event|1|||
161703360|NCT00862251|583961614|FG000|Overall Study|Lost to Follow-up|0|||
161703361|NCT00862251|583961615|FG001|Overall Study|Lost to Follow-up|0|||
161703362|NCT00862251|583961616|FG002|Overall Study|Lost to Follow-up|1|||
161703363|NCT00862251|583961614|FG000|Overall Study|Protocol Violation|2|||
161703364|NCT00862251|583961615|FG001|Overall Study|Protocol Violation|0|||
161703365|NCT00862251|583961616|FG002|Overall Study|Protocol Violation|1|||
161703366|NCT00862251|583961614|FG000|Overall Study|Withdrawal by Subject|9|||
161703367|NCT00862251|583961615|FG001|Overall Study|Withdrawal by Subject|2|||
161703368|NCT00862251|583961616|FG002|Overall Study|Withdrawal by Subject|6|||
161703369|NCT02796755|583961617|FG000|Overall Study|Adverse Event|2|||
161703370|NCT02796755|583961618|FG001|Overall Study|Adverse Event|0|||
161703371|NCT00675025|583961619|FG000|Overall Study|Study Terminated by Sponsor|38|||
161703372|NCT00675025|583961620|FG001|Overall Study|Study Terminated by Sponsor|42|||
161703373|NCT00675025|583961619|FG000|Overall Study|Adverse Event|6|||
161703374|NCT00675025|583961620|FG001|Overall Study|Adverse Event|11|||
161703375|NCT00675025|583961619|FG000|Overall Study|Lost to Follow-up|6|||
161703376|NCT00675025|583961620|FG001|Overall Study|Lost to Follow-up|4|||
161703377|NCT00675025|583961619|FG000|Overall Study|Withdrawal by Subject|4|||
161703378|NCT00675025|583961620|FG001|Overall Study|Withdrawal by Subject|6|||
161703379|NCT00944034|583961622|FG000|Overall Study|Inappropriate enrollment|0|||
161703380|NCT00944034|583961623|FG001|Overall Study|Inappropriate enrollment|1|||
161703381|NCT00944034|583961624|FG002|Overall Study|Inappropriate enrollment|0|||
161703382|NCT00944034|583961625|FG003|Overall Study|Inappropriate enrollment|1|||
161703383|NCT00944034|583961626|FG004|Overall Study|Inappropriate enrollment|2|||
161703384|NCT00944034|583961627|FG005|Overall Study|Inappropriate enrollment|1|||
161703385|NCT00944034|583961628|FG006|Overall Study|Inappropriate enrollment|0|||
161703386|NCT00944034|583961629|FG007|Overall Study|Inappropriate enrollment|0|||
161703387|NCT00944034|583961630|FG008|Overall Study|Inappropriate enrollment|1|||
161703388|NCT00944034|583961631|FG009|Overall Study|Inappropriate enrollment|1|||
161703389|NCT00944034|583961632|FG010|Overall Study|Inappropriate enrollment|0|||
161703390|NCT00944034|583961633|FG011|Overall Study|Inappropriate enrollment|0|||
161703391|NCT00944034|583961622|FG000|Overall Study|Withdrawal by Subject|3|||
161703392|NCT00944034|583961623|FG001|Overall Study|Withdrawal by Subject|2|||
161703393|NCT00944034|583961624|FG002|Overall Study|Withdrawal by Subject|6|||
161703394|NCT00944034|583961625|FG003|Overall Study|Withdrawal by Subject|2|||
161703395|NCT00944034|583961626|FG004|Overall Study|Withdrawal by Subject|5|||
161703396|NCT00944034|583961627|FG005|Overall Study|Withdrawal by Subject|8|||
161703397|NCT00944034|583961628|FG006|Overall Study|Withdrawal by Subject|2|||
161703398|NCT00944034|583961629|FG007|Overall Study|Withdrawal by Subject|2|||
161703399|NCT00944034|583961630|FG008|Overall Study|Withdrawal by Subject|3|||
161703400|NCT00944034|583961631|FG009|Overall Study|Withdrawal by Subject|4|||
161703401|NCT00944034|583961632|FG010|Overall Study|Withdrawal by Subject|0|||
161703402|NCT00944034|583961633|FG011|Overall Study|Withdrawal by Subject|4|||
161703403|NCT00944034|583961622|FG000|Overall Study|Lost to Follow-up|0|||
161703404|NCT00944034|583961623|FG001|Overall Study|Lost to Follow-up|4|||
161703405|NCT00944034|583961624|FG002|Overall Study|Lost to Follow-up|2|||
161703406|NCT00944034|583961625|FG003|Overall Study|Lost to Follow-up|0|||
161703407|NCT00944034|583961626|FG004|Overall Study|Lost to Follow-up|5|||
161703408|NCT00944034|583961627|FG005|Overall Study|Lost to Follow-up|7|||
161703409|NCT00944034|583961628|FG006|Overall Study|Lost to Follow-up|0|||
161703410|NCT00944034|583961629|FG007|Overall Study|Lost to Follow-up|1|||
161703411|NCT00944034|583961630|FG008|Overall Study|Lost to Follow-up|5|||
161703412|NCT00944034|583961631|FG009|Overall Study|Lost to Follow-up|1|||
161703413|NCT00944034|583961632|FG010|Overall Study|Lost to Follow-up|1|||
161703414|NCT00944034|583961633|FG011|Overall Study|Lost to Follow-up|0|||
161703415|NCT00944034|583961622|FG000|Overall Study|Death|0|||
161703416|NCT00944034|583961623|FG001|Overall Study|Death|0|||
161703417|NCT00944034|583961624|FG002|Overall Study|Death|1|||
161703418|NCT00944034|583961625|FG003|Overall Study|Death|0|||
161703419|NCT00944034|583961626|FG004|Overall Study|Death|0|||
161703420|NCT00944034|583961627|FG005|Overall Study|Death|0|||
161703421|NCT00944034|583961628|FG006|Overall Study|Death|0|||
161703422|NCT00944034|583961629|FG007|Overall Study|Death|0|||
161703423|NCT00944034|583961630|FG008|Overall Study|Death|0|||
161703424|NCT00944034|583961631|FG009|Overall Study|Death|0|||
161703425|NCT00944034|583961632|FG010|Overall Study|Death|0|||
161703426|NCT00944034|583961633|FG011|Overall Study|Death|0|||
161703427|NCT00944034|583961622|FG000|Overall Study|Protocol Violation|2|||
161703428|NCT00944034|583961623|FG001|Overall Study|Protocol Violation|0|||
161703429|NCT00944034|583961624|FG002|Overall Study|Protocol Violation|0|||
161703430|NCT00944034|583961625|FG003|Overall Study|Protocol Violation|1|||
161703431|NCT00944034|583961626|FG004|Overall Study|Protocol Violation|2|||
161703432|NCT00944034|583961627|FG005|Overall Study|Protocol Violation|3|||
161703433|NCT00944034|583961628|FG006|Overall Study|Protocol Violation|0|||
161703434|NCT00944034|583961629|FG007|Overall Study|Protocol Violation|1|||
161703435|NCT00944034|583961630|FG008|Overall Study|Protocol Violation|1|||
161703436|NCT00944034|583961631|FG009|Overall Study|Protocol Violation|4|||
161703437|NCT00944034|583961632|FG010|Overall Study|Protocol Violation|0|||
161703438|NCT00944034|583961633|FG011|Overall Study|Protocol Violation|0|||
161703439|NCT00944034|583961622|FG000|Overall Study|Unable to classify|0|||
161703440|NCT00944034|583961623|FG001|Overall Study|Unable to classify|0|||
161703441|NCT00944034|583961624|FG002|Overall Study|Unable to classify|0|||
161703442|NCT00944034|583961625|FG003|Overall Study|Unable to classify|0|||
161703443|NCT00944034|583961626|FG004|Overall Study|Unable to classify|0|||
161703444|NCT00944034|583961627|FG005|Overall Study|Unable to classify|1|||
161703445|NCT00944034|583961628|FG006|Overall Study|Unable to classify|1|||
161703446|NCT00944034|583961629|FG007|Overall Study|Unable to classify|1|||
161703447|NCT00944034|583961630|FG008|Overall Study|Unable to classify|0|||
161703448|NCT00944034|583961631|FG009|Overall Study|Unable to classify|0|||
161703449|NCT00944034|583961632|FG010|Overall Study|Unable to classify|0|||
161703450|NCT00944034|583961633|FG011|Overall Study|Unable to classify|0|||
161703451|NCT00944034|583961622|FG000|Overall Study|Administrative reason|0|||
161703452|NCT00944034|583961623|FG001|Overall Study|Administrative reason|0|||
161703453|NCT00944034|583961624|FG002|Overall Study|Administrative reason|0|||
161703454|NCT00944034|583961625|FG003|Overall Study|Administrative reason|0|||
161703455|NCT00944034|583961626|FG004|Overall Study|Administrative reason|0|||
161703456|NCT00944034|583961627|FG005|Overall Study|Administrative reason|0|||
161703457|NCT00944034|583961628|FG006|Overall Study|Administrative reason|1|||
161703458|NCT00944034|583961629|FG007|Overall Study|Administrative reason|0|||
161703459|NCT00944034|583961630|FG008|Overall Study|Administrative reason|0|||
161703460|NCT00944034|583961631|FG009|Overall Study|Administrative reason|0|||
161703461|NCT00944034|583961632|FG010|Overall Study|Administrative reason|0|||
161703462|NCT00944034|583961633|FG011|Overall Study|Administrative reason|0|||
161703463|NCT04258579|583961634|FG000|Overall Study|Withdrawal by Subject|7|||
161703464|NCT04258579|583961634|FG000|Overall Study|Lost to Follow-up|3|||
161703465|NCT04258579|583961634|FG000|Overall Study|Protocol Violation|2|||
161703466|NCT04258579|583961634|FG000|Overall Study|Adverse Event|1|||
161703467|NCT04007159|583961635|FG000|Induction Phase|(missed study visits)|16|||
161703468|NCT04007159|583961635|FG000|Induction Phase|Withdrawal by Subject|4|||
161703469|NCT04007159|583961635|FG000|Induction Phase|Adverse Event|2|||
161703470|NCT04007159|583961635|FG000|Challenge Phase|missed study visits|3|||
161703471|NCT00331006|583961637|FG000|Screening Phase|Withdrawal by Subject|1|||
161703472|NCT00331006|583961637|FG000|Screening Phase|enrollment halted|1|||
161703473|NCT00331006|583961637|FG000|Screening Phase|Lost to Follow-up|1|||
161703474|NCT00331006|583961637|FG000|Screening Phase|Ineligible for treatment phase|4|||
161703475|NCT00331006|583961637|FG000|Treatment Phase|Withdrawal by Subject|1|||
161703476|NCT00331006|583961637|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
161703477|NCT00331006|583961637|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
161703478|NCT03804684|583961638|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
161703479|NCT03804684|583961639|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
161703480|NCT01950819|583961640|FG000|Overall Study|Graft Loss|35|||
161703481|NCT01950819|583961641|FG001|Overall Study|Graft Loss|30|||
161703482|NCT01950819|583961640|FG000|Overall Study|Death|29|||
161703483|NCT01950819|583961641|FG001|Overall Study|Death|34|||
161703484|NCT01950819|583961640|FG000|Overall Study|Subject / Gardian decision|54|||
161703485|NCT01950819|583961641|FG001|Overall Study|Subject / Gardian decision|51|||
161703486|NCT01950819|583961640|FG000|Overall Study|technical problems|2|||
161703487|NCT01950819|583961641|FG001|Overall Study|technical problems|0|||
161703488|NCT01950819|583961640|FG000|Overall Study|Pregnancy|0|||
161703489|NCT01950819|583961641|FG001|Overall Study|Pregnancy|2|||
161703490|NCT01950819|583961640|FG000|Overall Study|Lost to Follow-up|9|||
161703491|NCT01950819|583961641|FG001|Overall Study|Lost to Follow-up|17|||
161703492|NCT03183128|583961642|FG000|Overall Study|Adverse Event|1|||
161703493|NCT03183128|583961643|FG001|Overall Study|Adverse Event|2|||
161703494|NCT03183128|583961642|FG000|Overall Study|Withdrawal by Subject|1|||
161703495|NCT03183128|583961643|FG001|Overall Study|Withdrawal by Subject|8|||
161703496|NCT03183128|583961642|FG000|Overall Study|Protocol Violation|2|||
161703497|NCT03183128|583961643|FG001|Overall Study|Protocol Violation|0|||
161703498|NCT03183128|583961642|FG000|Overall Study|Lack of Efficacy|4|||
161703499|NCT03183128|583961643|FG001|Overall Study|Lack of Efficacy|27|||
161837172|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161837173|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161837174|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161703500|NCT03183128|583961642|FG000|Overall Study|Lost to Follow-up|1|||
161703501|NCT03183128|583961643|FG001|Overall Study|Lost to Follow-up|0|||
161837175|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161703502|NCT03183128|583961642|FG000|Overall Study|Death|2|||
161703503|NCT03183128|583961643|FG001|Overall Study|Death|0|||
161703504|NCT03183128|583961642|FG000|Overall Study|Physician Decision|1|||
161703505|NCT03183128|583961643|FG001|Overall Study|Physician Decision|0|||
161703506|NCT01413958|583961644|FG000|Overall Study|Lost to Follow-up|0|||
161703507|NCT01413958|583961645|FG001|Overall Study|Lost to Follow-up|1|||
161703508|NCT02908516|583961648|FG000|Overall Study|Study Terminated|3|||
161703509|NCT02908516|583961649|FG001|Overall Study|Study Terminated|3|||
161703510|NCT01225562|583961650|FG000|Overall Study|Withdrawal by Subject|52|||
161703511|NCT01225562|583961651|FG001|Overall Study|Withdrawal by Subject|50|||
161703512|NCT01225562|583961652|FG002|Overall Study|Withdrawal by Subject|52|||
161703513|NCT01225562|583961650|FG000|Overall Study|Lost to Follow-up|3|||
161703514|NCT01225562|583961651|FG001|Overall Study|Lost to Follow-up|6|||
161703515|NCT01225562|583961652|FG002|Overall Study|Lost to Follow-up|1|||
161703516|NCT02928952|583961653|FG000|Overall Study|Lost to Follow-up|5|||
161703517|NCT02928952|583961654|FG001|Overall Study|Lost to Follow-up|5|||
161703518|NCT02928952|583961653|FG000|Overall Study|Withdrawal by Subject|5|||
161703519|NCT02928952|583961654|FG001|Overall Study|Withdrawal by Subject|1|||
161703520|NCT02928952|583961653|FG000|Overall Study|Physician Decision|0|||
161703521|NCT02928952|583961654|FG001|Overall Study|Physician Decision|1|||
161703522|NCT02266433|583961655|FG000|Overall Study|Lost to Follow-up|54|||
161703523|NCT02266433|583961656|FG001|Overall Study|Lost to Follow-up|46|||
161703524|NCT02266433|583961655|FG000|Overall Study|Withdrawal by Subject|5|||
161703525|NCT02266433|583961656|FG001|Overall Study|Withdrawal by Subject|7|||
161703526|NCT01375764|583961658|FG000|Overall Study|Lost to Follow-up|0|||
161703527|NCT01375764|583961659|FG001|Overall Study|Lost to Follow-up|1|||
161703528|NCT01375764|583961660|FG002|Overall Study|Lost to Follow-up|0|||
161703529|NCT01375764|583961661|FG003|Overall Study|Lost to Follow-up|0|||
161703530|NCT01375764|583961662|FG004|Overall Study|Lost to Follow-up|0|||
161703531|NCT01375764|583961658|FG000|Overall Study|Withdrawal by Subject|2|||
161703532|NCT01375764|583961659|FG001|Overall Study|Withdrawal by Subject|0|||
161703533|NCT01375764|583961660|FG002|Overall Study|Withdrawal by Subject|0|||
161703534|NCT01375764|583961661|FG003|Overall Study|Withdrawal by Subject|0|||
161703535|NCT01375764|583961662|FG004|Overall Study|Withdrawal by Subject|1|||
161703536|NCT01375764|583961658|FG000|Overall Study|Other|0|||
161703537|NCT01375764|583961659|FG001|Overall Study|Other|0|||
161703538|NCT01375764|583961660|FG002|Overall Study|Other|0|||
161703539|NCT01375764|583961661|FG003|Overall Study|Other|1|||
161703540|NCT01375764|583961662|FG004|Overall Study|Other|0|||
161703541|NCT02445586|583961665|FG000|Overall Study|Death|14|||
161703542|NCT02445586|583961665|FG000|Overall Study|Withdrawal by Subject|13|||
161703543|NCT02445586|583961665|FG000|Overall Study|Disease Progression|10|||
161703544|NCT02445586|583961665|FG000|Overall Study|Protocol Violation|1|||
161703545|NCT02445586|583961665|FG000|Overall Study|Medical Condition|1|||
161703546|NCT01194440|583961666|FG000|Baseline (First Dose)|Reason not specified|4|||
161703547|NCT01194440|583961666|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
161703548|NCT01194440|583961666|FG000|Baseline (First Dose)|Change in therapy|1|||
161703549|NCT01194440|583961666|FG000|Baseline (First Dose)|Adverse Event|1|||
161703550|NCT01194440|583961666|FG000|6-months (2nd Dose)|Change in therapy|4|||
161703551|NCT02732951|583963676|FG000|Overall Study|Other than listed|1|||
161703552|NCT02732951|583963677|FG001|Overall Study|Other than listed|0|||
161703553|NCT02732951|583963676|FG000|Overall Study|Lost to Follow-up|0|||
161703554|NCT02732951|583963677|FG001|Overall Study|Lost to Follow-up|1|||
161703555|NCT02732951|583963676|FG000|Overall Study|Adverse Event|4|||
161703556|NCT02732951|583963677|FG001|Overall Study|Adverse Event|4|||
161703557|NCT02732951|583963676|FG000|Overall Study|Protocol Violation|0|||
161703558|NCT02732951|583963677|FG001|Overall Study|Protocol Violation|1|||
161703559|NCT01974817|583963678|FG000|Overall Study|Death|4|||
161703560|NCT01974817|583963678|FG000|Overall Study|Lost to Follow-up|2|||
161703561|NCT01974817|583963678|FG000|Overall Study|Protocol Violation|2|||
161703562|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703563|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703564|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
161703565|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703566|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703567|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703568|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703569|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
161703570|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703571|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703572|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703573|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703574|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
161703575|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
161703576|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
161703577|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
161703578|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
161703579|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
161703580|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
161703581|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703582|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703583|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703584|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703585|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703586|NCT05047523|583963683|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703587|NCT05047523|583963684|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703588|NCT05047523|583963685|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703589|NCT05047523|583963686|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703590|NCT05047523|583963687|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
161703591|NCT05047523|583963688|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
161703592|NCT05047523|583963683|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
161703593|NCT05047523|583963684|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
161703594|NCT05047523|583963685|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
161703595|NCT05047523|583963686|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
161703596|NCT05047523|583963687|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
161703597|NCT05047523|583963688|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
161703598|NCT01805180|583963691|FG000|Lead-in Donor Phase|screen failure|1|||
161703599|NCT01805180|583963692|FG001|Lead-in Donor Phase|screen failure|0|||
161703600|NCT01805180|583963693|FG002|Lead-in Donor Phase|screen failure|0|||
161703601|NCT04684420|583963698|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161703602|NCT04684420|583963699|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161703603|NCT04684420|583963700|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
161703604|NCT04684420|583963701|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161703605|NCT04684420|583963698|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
161703606|NCT04684420|583963699|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
161703607|NCT04684420|583963700|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
161703608|NCT04684420|583963701|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
161703609|NCT00463476|583963702|FG000|Overall Study|Withdrawal by Subject|1|||
161703610|NCT00463476|583963703|FG001|Overall Study|Withdrawal by Subject|2|||
161703611|NCT00463476|583963702|FG000|Overall Study|Lost to Follow-up|1|||
161703612|NCT00463476|583963703|FG001|Overall Study|Lost to Follow-up|1|||
161703613|NCT00928070|583963708|FG000|Overall Study|Lost to Follow-up|1|||
161703614|NCT00928070|583963709|FG001|Overall Study|Lost to Follow-up|2|||
161703615|NCT00928070|583963708|FG000|Overall Study|Withdrawal by Subject|10|||
161703616|NCT00928070|583963709|FG001|Overall Study|Withdrawal by Subject|3|||
161703617|NCT00928070|583963708|FG000|Overall Study|Adverse Event|14|||
161703618|NCT00928070|583963709|FG001|Overall Study|Adverse Event|26|||
161703619|NCT00928070|583963708|FG000|Overall Study|Lack of Efficacy|9|||
161703620|NCT00928070|583963709|FG001|Overall Study|Lack of Efficacy|5|||
161703621|NCT00928070|583963708|FG000|Overall Study|Did not meet entrance criteria|16|||
161703622|NCT00928070|583963709|FG001|Overall Study|Did not meet entrance criteria|9|||
161703623|NCT00928070|583963708|FG000|Overall Study|Protocol Violation|6|||
161703624|NCT00928070|583963709|FG001|Overall Study|Protocol Violation|5|||
161703625|NCT00928070|583963708|FG000|Overall Study|Randomized but not treated|2|||
161703626|NCT00928070|583963709|FG001|Overall Study|Randomized but not treated|2|||
161703627|NCT00928070|583963708|FG000|Overall Study|Other|5|||
161703628|NCT00928070|583963709|FG001|Overall Study|Other|5|||
161703629|NCT02690194|583963714|FG000|Overall Study|Withdrawal by Subject|1|||
161703630|NCT02690194|583963715|FG001|Overall Study|Withdrawal by Subject|4|||
161703631|NCT02690194|583963716|FG002|Overall Study|Withdrawal by Subject|0|||
161703632|NCT00624520|583963717|FG000|Overall Study|Withdrawal by Subject|12|||
161703633|NCT00624520|583963718|FG001|Overall Study|Withdrawal by Subject|7|||
161703634|NCT00624520|583963717|FG000|Overall Study|Death|0|||
161703635|NCT00624520|583963718|FG001|Overall Study|Death|1|||
161703636|NCT01570244|583963722|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
161703637|NCT03486392|583963723|FG000|Overall Study|Lost to Follow-up|0|||
161703638|NCT03486392|583963724|FG001|Overall Study|Lost to Follow-up|0|||
161703639|NCT03486392|583963725|FG002|Overall Study|Lost to Follow-up|8|||
161703640|NCT03486392|583963726|FG003|Overall Study|Lost to Follow-up|5|||
161703641|NCT03486392|583963727|FG004|Overall Study|Lost to Follow-up|2|||
161703642|NCT03486392|583963723|FG000|Overall Study|Withdrawal by Subject|3|||
161703643|NCT03486392|583963724|FG001|Overall Study|Withdrawal by Subject|0|||
161703644|NCT03486392|583963725|FG002|Overall Study|Withdrawal by Subject|6|||
161703645|NCT03486392|583963726|FG003|Overall Study|Withdrawal by Subject|4|||
161703646|NCT03486392|583963727|FG004|Overall Study|Withdrawal by Subject|1|||
161703647|NCT03486392|583963723|FG000|Overall Study|Death|0|||
161703648|NCT03486392|583963724|FG001|Overall Study|Death|0|||
161703649|NCT03486392|583963725|FG002|Overall Study|Death|0|||
161703650|NCT03486392|583963726|FG003|Overall Study|Death|0|||
161703651|NCT03486392|583963727|FG004|Overall Study|Death|1|||
161703652|NCT02347631|583963728|FG000|First Intervention (2 Months)|Adverse Event|1|||
161703653|NCT02347631|583963729|FG001|First Intervention (2 Months)|Adverse Event|1|||
161703654|NCT02347631|583963728|FG000|First Intervention (2 Months)|Pregnancy|1|||
161703655|NCT02347631|583963729|FG001|First Intervention (2 Months)|Pregnancy|0|||
161703656|NCT02347631|583963728|FG000|First Intervention (2 Months)|Moved out of area|0|||
161703657|NCT02347631|583963729|FG001|First Intervention (2 Months)|Moved out of area|2|||
161703658|NCT02347631|583963728|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
161703659|NCT02347631|583963729|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
161703660|NCT02347631|583963728|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
161703661|NCT02347631|583963729|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
161703662|NCT02347631|583963728|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
161703663|NCT02347631|583963729|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
161703664|NCT02347631|583963728|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
161703665|NCT02347631|583963729|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
161703666|NCT02347631|583963728|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
161703667|NCT02347631|583963729|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
161703668|NCT02304926|583963730|FG000|Overall Study|Lost to Follow-up|2|||
161703669|NCT02304926|583963731|FG001|Overall Study|Lost to Follow-up|1|||
161703670|NCT02076165|583963733|FG000|Overall Study|Lost to Follow-up|7|||
161703671|NCT02076165|583963734|FG001|Overall Study|Lost to Follow-up|5|||
161703672|NCT02076165|583963733|FG000|Overall Study|Refused follow-up assessment|1|||
161703673|NCT02076165|583963734|FG001|Overall Study|Refused follow-up assessment|1|||
161703674|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
161703675|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161703676|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161703677|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161703678|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
161703679|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161703680|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161703681|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161703682|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
161703683|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161703684|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161703685|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161703686|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
161703687|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161703688|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161703689|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161703690|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
161703691|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161703692|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161703693|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161703694|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
161703695|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161703696|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161703697|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161703698|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
161703699|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
161703700|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
161703701|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
161703702|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Adverse Event|0|||
161703703|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Adverse Event|6|||
161703704|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Adverse Event|0|||
161703705|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Adverse Event|0|||
161703706|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161703707|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
161703708|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
161703709|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161703710|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161703711|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
161703712|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
161703713|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161703714|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
161703715|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
161703716|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
161703717|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
161703718|NCT01360645|583963739|FG000|Phase A+|Lost to Follow-up|0|||
161703719|NCT01360645|583963740|FG001|Phase A+|Lost to Follow-up|0|||
161703720|NCT01360645|583963741|FG002|Phase A+|Lost to Follow-up|0|||
161703721|NCT01360645|583963742|FG003|Phase A+|Lost to Follow-up|7|||
161703722|NCT01360645|583963739|FG000|Phase A+|Adverse Event|0|||
161703723|NCT01360645|583963740|FG001|Phase A+|Adverse Event|0|||
161703724|NCT01360645|583963741|FG002|Phase A+|Adverse Event|0|||
161703725|NCT01360645|583963742|FG003|Phase A+|Adverse Event|2|||
161703726|NCT01360645|583963739|FG000|Phase A+|Met Withdrawal Criteria|0|||
161703727|NCT01360645|583963740|FG001|Phase A+|Met Withdrawal Criteria|0|||
161703728|NCT01360645|583963741|FG002|Phase A+|Met Withdrawal Criteria|0|||
161703729|NCT01360645|583963742|FG003|Phase A+|Met Withdrawal Criteria|4|||
161703730|NCT01360645|583963739|FG000|Phase A+|Physician Decision|0|||
161703731|NCT01360645|583963740|FG001|Phase A+|Physician Decision|0|||
161703732|NCT01360645|583963741|FG002|Phase A+|Physician Decision|0|||
161703733|NCT01360645|583963742|FG003|Phase A+|Physician Decision|2|||
161703734|NCT01360645|583963739|FG000|Phase A+|Withdrawal by Subject|0|||
161703735|NCT01360645|583963740|FG001|Phase A+|Withdrawal by Subject|0|||
161703736|NCT01360645|583963741|FG002|Phase A+|Withdrawal by Subject|0|||
161703737|NCT01360645|583963742|FG003|Phase A+|Withdrawal by Subject|5|||
161703738|NCT01360645|583963739|FG000|Phase A+|Protocol Deviation|0|||
161703739|NCT01360645|583963740|FG001|Phase A+|Protocol Deviation|0|||
161703740|NCT01360645|583963741|FG002|Phase A+|Protocol Deviation|0|||
161703741|NCT01360645|583963742|FG003|Phase A+|Protocol Deviation|4|||
161703742|NCT00713219|583963743|FG000|Overall Study|Death|1|||
161703743|NCT00713219|583963743|FG000|Overall Study|Protocol Violation|1|||
161703744|NCT02978222|583963744|FG000|Overall Study|Withdrawal by Subject|2|||
161703745|NCT02978222|583963745|FG001|Overall Study|Withdrawal by Subject|2|||
161703746|NCT02978222|583963744|FG000|Overall Study|Physician Decision|2|||
161703747|NCT02978222|583963745|FG001|Overall Study|Physician Decision|0|||
161703748|NCT02978222|583963744|FG000|Overall Study|Adverse Event|0|||
161703749|NCT02978222|583963745|FG001|Overall Study|Adverse Event|1|||
161703750|NCT02978222|583963744|FG000|Overall Study|Death|1|||
161703751|NCT02978222|583963745|FG001|Overall Study|Death|0|||
161703752|NCT02978222|583963744|FG000|Overall Study|Disease Progression|32|||
161703753|NCT02978222|583963745|FG001|Overall Study|Disease Progression|32|||
161703754|NCT02978222|583963744|FG000|Overall Study|Early Study Termination|24|||
161703755|NCT02978222|583963745|FG001|Overall Study|Early Study Termination|21|||
161703756|NCT03258814|583963746|FG000|Overall Study|Early Termination|4|||
161703757|NCT03258814|583963747|FG001|Overall Study|Early Termination|3|||
161703758|NCT03258814|583963748|FG002|Overall Study|Early Termination|10|||
161703759|NCT00348140|583963753|FG000|Overall Study|Adverse Event|46|||
161703760|NCT00348140|583963754|FG001|Overall Study|Adverse Event|49|||
161703761|NCT00348140|583963755|FG002|Overall Study|Adverse Event|78|||
161703762|NCT00348140|583963753|FG000|Overall Study|Lost to Follow-up|4|||
161703763|NCT00348140|583963754|FG001|Overall Study|Lost to Follow-up|4|||
161703764|NCT00348140|583963755|FG002|Overall Study|Lost to Follow-up|4|||
161703765|NCT00348140|583963753|FG000|Overall Study|Protocol Violation|12|||
161703766|NCT00348140|583963754|FG001|Overall Study|Protocol Violation|13|||
161703767|NCT00348140|583963755|FG002|Overall Study|Protocol Violation|14|||
161703768|NCT00348140|583963753|FG000|Overall Study|Withdrawal by Subject|32|||
161703769|NCT00348140|583963754|FG001|Overall Study|Withdrawal by Subject|40|||
161703770|NCT00348140|583963755|FG002|Overall Study|Withdrawal by Subject|40|||
161703771|NCT00348140|583963753|FG000|Overall Study|Non-compliance|8|||
161703772|NCT00348140|583963754|FG001|Overall Study|Non-compliance|13|||
161703773|NCT00348140|583963755|FG002|Overall Study|Non-compliance|5|||
161703774|NCT00348140|583963753|FG000|Overall Study|Participant at risk due to study drug|2|||
161703775|NCT00348140|583963754|FG001|Overall Study|Participant at risk due to study drug|0|||
161703776|NCT00348140|583963755|FG002|Overall Study|Participant at risk due to study drug|0|||
161703777|NCT00348140|583963753|FG000|Overall Study|Conditional medication increased dose|1|||
161703778|NCT00348140|583963754|FG001|Overall Study|Conditional medication increased dose|0|||
161837176|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161703779|NCT00348140|583963755|FG002|Overall Study|Conditional medication increased dose|0|||
161703780|NCT00348140|583963753|FG000|Overall Study|Caregiver related|4|||
161703781|NCT00348140|583963754|FG001|Overall Study|Caregiver related|7|||
161703782|NCT00348140|583963755|FG002|Overall Study|Caregiver related|3|||
161703783|NCT00348140|583963753|FG000|Overall Study|Participant hospitalised|3|||
161703784|NCT00348140|583963754|FG001|Overall Study|Participant hospitalised|0|||
161703785|NCT00348140|583963755|FG002|Overall Study|Participant hospitalised|0|||
161703786|NCT00348140|583963753|FG000|Overall Study|Efficacy related|1|||
161703787|NCT00348140|583963754|FG001|Overall Study|Efficacy related|1|||
161703788|NCT00348140|583963755|FG002|Overall Study|Efficacy related|0|||
161703789|NCT00348140|583963753|FG000|Overall Study|Administration related|3|||
161703790|NCT00348140|583963754|FG001|Overall Study|Administration related|1|||
161703791|NCT00348140|583963755|FG002|Overall Study|Administration related|1|||
161703792|NCT00348140|583963753|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
161703793|NCT00348140|583963754|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
161703794|NCT00348140|583963755|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
161703795|NCT00348140|583963753|FG000|Overall Study|Participant unwell|1|||
161703796|NCT00348140|583963754|FG001|Overall Study|Participant unwell|0|||
161703797|NCT00348140|583963755|FG002|Overall Study|Participant unwell|0|||
161703798|NCT00348140|583963753|FG000|Overall Study|Screen failure|1|||
161703799|NCT00348140|583963754|FG001|Overall Study|Screen failure|0|||
161703800|NCT00348140|583963755|FG002|Overall Study|Screen failure|0|||
161703801|NCT00348140|583963753|FG000|Overall Study|Investigator decided to discontinue|4|||
161703802|NCT00348140|583963754|FG001|Overall Study|Investigator decided to discontinue|1|||
161703803|NCT00348140|583963755|FG002|Overall Study|Investigator decided to discontinue|4|||
161837177|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Death|0|||
161837178|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Death|0|||
161837179|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Death|0|||
161837180|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Death|0|||
161837181|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Death|0|||
161837182|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Death|0|||
161837183|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Death|1|||
161837184|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837185|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161837186|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161837187|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161837188|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837189|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837190|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837191|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Other|1|||
161837192|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Other|0|||
161837193|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Other|0|||
161837194|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Other|1|||
161837195|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Other|0|||
161837196|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Other|1|||
161837197|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Other|2|||
161837198|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837199|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837200|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
161837201|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837202|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837203|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837204|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
161654946|NCT04047862|583786605|FG005|Overall Study|Death|4|||
161654947|NCT04047862|583786606|FG006|Overall Study|Death|3|||
161654948|NCT04047862|583786607|FG007|Overall Study|Death|24|||
161654949|NCT04047862|583786608|FG008|Overall Study|Death|24|||
161654950|NCT04047862|583786609|FG009|Overall Study|Death|22|||
161654951|NCT04047862|583786610|FG010|Overall Study|Death|35|||
161654952|NCT04047862|583786611|FG011|Overall Study|Death|18|||
161654953|NCT04047862|583786612|FG012|Overall Study|Death|14|||
161654954|NCT04047862|583786613|FG013|Overall Study|Death|6|||
161654955|NCT04047862|583786614|FG014|Overall Study|Death|19|||
161654956|NCT04047862|583786615|FG015|Overall Study|Death|42|||
161654957|NCT04047862|583786616|FG016|Overall Study|Death|9|||
161654958|NCT04047862|583786617|FG017|Overall Study|Death|8|||
161654959|NCT04047862|583786618|FG018|Overall Study|Death|10|||
161654960|NCT04047862|583786600|FG000|Overall Study|Withdrawal by Subject|0|||
161654961|NCT04047862|583786601|FG001|Overall Study|Withdrawal by Subject|0|||
161654962|NCT04047862|583786602|FG002|Overall Study|Withdrawal by Subject|0|||
161654963|NCT04047862|583786603|FG003|Overall Study|Withdrawal by Subject|5|||
161654964|NCT04047862|583786604|FG004|Overall Study|Withdrawal by Subject|2|||
161654965|NCT04047862|583786605|FG005|Overall Study|Withdrawal by Subject|0|||
161654966|NCT04047862|583786606|FG006|Overall Study|Withdrawal by Subject|1|||
161654967|NCT04047862|583786607|FG007|Overall Study|Withdrawal by Subject|0|||
161654968|NCT04047862|583786608|FG008|Overall Study|Withdrawal by Subject|4|||
161654969|NCT04047862|583786609|FG009|Overall Study|Withdrawal by Subject|4|||
161654970|NCT04047862|583786610|FG010|Overall Study|Withdrawal by Subject|4|||
161654971|NCT04047862|583786611|FG011|Overall Study|Withdrawal by Subject|2|||
161654972|NCT04047862|583786612|FG012|Overall Study|Withdrawal by Subject|3|||
161703804|NCT00348140|583963753|FG000|Overall Study|Decided to discontinue on their own|1|||
161837205|NCT01765582|584446565|FG000|Overall Study|Other|3|||
161837206|NCT01765582|584446566|FG001|Overall Study|Other|6|||
161837207|NCT01765582|584446567|FG002|Overall Study|Other|9|||
161654973|NCT04047862|583786613|FG013|Overall Study|Withdrawal by Subject|0|||
161654974|NCT04047862|583786614|FG014|Overall Study|Withdrawal by Subject|9|||
161654975|NCT04047862|583786615|FG015|Overall Study|Withdrawal by Subject|5|||
161654976|NCT04047862|583786616|FG016|Overall Study|Withdrawal by Subject|1|||
161654977|NCT04047862|583786617|FG017|Overall Study|Withdrawal by Subject|3|||
161654978|NCT04047862|583786618|FG018|Overall Study|Withdrawal by Subject|1|||
161654979|NCT04047862|583786600|FG000|Overall Study|Lost to Follow-up|0|||
161654980|NCT04047862|583786601|FG001|Overall Study|Lost to Follow-up|0|||
161654981|NCT04047862|583786602|FG002|Overall Study|Lost to Follow-up|1|||
161654982|NCT04047862|583786603|FG003|Overall Study|Lost to Follow-up|0|||
161654983|NCT04047862|583786604|FG004|Overall Study|Lost to Follow-up|0|||
161654984|NCT04047862|583786605|FG005|Overall Study|Lost to Follow-up|0|||
161654985|NCT04047862|583786606|FG006|Overall Study|Lost to Follow-up|0|||
161654986|NCT04047862|583786607|FG007|Overall Study|Lost to Follow-up|1|||
161654987|NCT04047862|583786608|FG008|Overall Study|Lost to Follow-up|0|||
161654988|NCT04047862|583786609|FG009|Overall Study|Lost to Follow-up|1|||
161654989|NCT04047862|583786610|FG010|Overall Study|Lost to Follow-up|0|||
161654990|NCT04047862|583786611|FG011|Overall Study|Lost to Follow-up|3|||
161654991|NCT04047862|583786612|FG012|Overall Study|Lost to Follow-up|0|||
161654992|NCT04047862|583786613|FG013|Overall Study|Lost to Follow-up|0|||
161654993|NCT04047862|583786614|FG014|Overall Study|Lost to Follow-up|2|||
161654994|NCT04047862|583786615|FG015|Overall Study|Lost to Follow-up|2|||
161654995|NCT04047862|583786616|FG016|Overall Study|Lost to Follow-up|1|||
161654996|NCT04047862|583786617|FG017|Overall Study|Lost to Follow-up|0|||
161654997|NCT04047862|583786618|FG018|Overall Study|Lost to Follow-up|0|||
161654998|NCT04047862|583786600|FG000|Overall Study|Physician Decision|0|||
161654999|NCT04047862|583786601|FG001|Overall Study|Physician Decision|0|||
161655000|NCT04047862|583786602|FG002|Overall Study|Physician Decision|0|||
161655001|NCT04047862|583786603|FG003|Overall Study|Physician Decision|1|||
161655002|NCT04047862|583786604|FG004|Overall Study|Physician Decision|0|||
161655003|NCT04047862|583786605|FG005|Overall Study|Physician Decision|0|||
161655004|NCT04047862|583786606|FG006|Overall Study|Physician Decision|0|||
161655005|NCT04047862|583786607|FG007|Overall Study|Physician Decision|0|||
161655006|NCT04047862|583786608|FG008|Overall Study|Physician Decision|0|||
161655007|NCT04047862|583786609|FG009|Overall Study|Physician Decision|0|||
161655008|NCT04047862|583786610|FG010|Overall Study|Physician Decision|0|||
161655009|NCT04047862|583786611|FG011|Overall Study|Physician Decision|0|||
161655010|NCT04047862|583786612|FG012|Overall Study|Physician Decision|0|||
161837208|NCT01765582|584446565|FG000|Overall Study|Lost to Follow-up|2|||
161655011|NCT04047862|583786613|FG013|Overall Study|Physician Decision|0|||
161655012|NCT04047862|583786614|FG014|Overall Study|Physician Decision|1|||
161655013|NCT04047862|583786615|FG015|Overall Study|Physician Decision|0|||
161655014|NCT04047862|583786616|FG016|Overall Study|Physician Decision|1|||
161655015|NCT04047862|583786617|FG017|Overall Study|Physician Decision|0|||
161655016|NCT04047862|583786618|FG018|Overall Study|Physician Decision|0|||
161655017|NCT04047862|583786600|FG000|Overall Study|Completed all Assessments|1|||
161655018|NCT04047862|583786601|FG001|Overall Study|Completed all Assessments|3|||
161655019|NCT04047862|583786602|FG002|Overall Study|Completed all Assessments|1|||
161655020|NCT04047862|583786603|FG003|Overall Study|Completed all Assessments|3|||
161655021|NCT04047862|583786604|FG004|Overall Study|Completed all Assessments|2|||
161655022|NCT04047862|583786605|FG005|Overall Study|Completed all Assessments|5|||
161655023|NCT04047862|583786606|FG006|Overall Study|Completed all Assessments|7|||
161655024|NCT04047862|583786607|FG007|Overall Study|Completed all Assessments|0|||
161655025|NCT04047862|583786608|FG008|Overall Study|Completed all Assessments|0|||
161655026|NCT04047862|583786609|FG009|Overall Study|Completed all Assessments|0|||
161655027|NCT04047862|583786610|FG010|Overall Study|Completed all Assessments|0|||
161655028|NCT04047862|583786611|FG011|Overall Study|Completed all Assessments|0|||
161655029|NCT04047862|583786612|FG012|Overall Study|Completed all Assessments|0|||
161655030|NCT04047862|583786613|FG013|Overall Study|Completed all Assessments|0|||
161655031|NCT04047862|583786614|FG014|Overall Study|Completed all Assessments|0|||
161655032|NCT04047862|583786615|FG015|Overall Study|Completed all Assessments|0|||
161655033|NCT04047862|583786616|FG016|Overall Study|Completed all Assessments|0|||
161655034|NCT04047862|583786617|FG017|Overall Study|Completed all Assessments|0|||
161655035|NCT04047862|583786618|FG018|Overall Study|Completed all Assessments|0|||
161655036|NCT04047862|583786600|FG000|Overall Study|Sponsor Decision|0|||
161655037|NCT04047862|583786601|FG001|Overall Study|Sponsor Decision|0|||
161655038|NCT04047862|583786602|FG002|Overall Study|Sponsor Decision|0|||
161655039|NCT04047862|583786603|FG003|Overall Study|Sponsor Decision|0|||
161703805|NCT00348140|583963754|FG001|Overall Study|Decided to discontinue on their own|4|||
161703806|NCT00348140|583963755|FG002|Overall Study|Decided to discontinue on their own|1|||
161703807|NCT00348140|583963753|FG000|Overall Study|Use of prohibited drug|1|||
161703808|NCT00348140|583963754|FG001|Overall Study|Use of prohibited drug|0|||
161703809|NCT00348140|583963755|FG002|Overall Study|Use of prohibited drug|2|||
161703810|NCT00348140|583963753|FG000|Overall Study|Disease progression|1|||
161703811|NCT00348140|583963754|FG001|Overall Study|Disease progression|2|||
161703812|NCT00348140|583963755|FG002|Overall Study|Disease progression|5|||
161703813|NCT00348140|583963753|FG000|Overall Study|Increased risk of cardiac infarction|0|||
161703814|NCT00348140|583963754|FG001|Overall Study|Increased risk of cardiac infarction|1|||
161703815|NCT00348140|583963755|FG002|Overall Study|Increased risk of cardiac infarction|0|||
161703816|NCT00348140|583963753|FG000|Overall Study|Serious adverse event|0|||
161703817|NCT00348140|583963754|FG001|Overall Study|Serious adverse event|1|||
161703818|NCT00348140|583963755|FG002|Overall Study|Serious adverse event|0|||
161703819|NCT00348140|583963753|FG000|Overall Study|Abnormal ECG|0|||
161703820|NCT00348140|583963754|FG001|Overall Study|Abnormal ECG|1|||
161703821|NCT00348140|583963755|FG002|Overall Study|Abnormal ECG|3|||
161703822|NCT00348140|583963753|FG000|Overall Study|Participant died|0|||
161703823|NCT00348140|583963754|FG001|Overall Study|Participant died|1|||
161703824|NCT00348140|583963755|FG002|Overall Study|Participant died|0|||
161703825|NCT00348140|583963753|FG000|Overall Study|Exclusion criteria met|0|||
161703826|NCT00348140|583963754|FG001|Overall Study|Exclusion criteria met|0|||
161703827|NCT00348140|583963755|FG002|Overall Study|Exclusion criteria met|1|||
161703828|NCT00348140|583963753|FG000|Overall Study|Memory declined|0|||
161703829|NCT00348140|583963754|FG001|Overall Study|Memory declined|0|||
161703830|NCT00348140|583963755|FG002|Overall Study|Memory declined|1|||
161703831|NCT00868790|583963756|FG000|Period 1|Adverse Event|1|||
161703832|NCT00868790|583963757|FG001|Period 1|Adverse Event|0|||
161703833|NCT00868790|583963758|FG002|Period 1|Adverse Event|0|||
161703834|NCT00868790|583963759|FG003|Period 1|Adverse Event|0|||
161703835|NCT00868790|583963760|FG004|Period 1|Adverse Event|0|||
161703836|NCT00868790|583963761|FG005|Period 1|Adverse Event|0|||
161703837|NCT00868790|583963762|FG006|Period 1|Adverse Event|0|||
161703838|NCT00868790|583963763|FG007|Period 1|Adverse Event|3|||
161703839|NCT00868790|583963764|FG008|Period 1|Adverse Event|1|||
161703840|NCT00868790|583963765|FG009|Period 1|Adverse Event|0|||
161703841|NCT00868790|583963766|FG010|Period 1|Adverse Event|0|||
161703842|NCT00868790|583963767|FG011|Period 1|Adverse Event|0|||
161703843|NCT00868790|583963768|FG012|Period 1|Adverse Event|0|||
161703844|NCT00868790|583963769|FG013|Period 1|Adverse Event|1|||
161703845|NCT00868790|583963756|FG000|Period 1|Protocol Violation|1|||
161703846|NCT00868790|583963757|FG001|Period 1|Protocol Violation|0|||
161703847|NCT00868790|583963758|FG002|Period 1|Protocol Violation|0|||
161703848|NCT00868790|583963759|FG003|Period 1|Protocol Violation|0|||
161703849|NCT00868790|583963760|FG004|Period 1|Protocol Violation|0|||
161703850|NCT00868790|583963761|FG005|Period 1|Protocol Violation|0|||
161703851|NCT00868790|583963762|FG006|Period 1|Protocol Violation|0|||
161703852|NCT00868790|583963763|FG007|Period 1|Protocol Violation|0|||
161703853|NCT00868790|583963764|FG008|Period 1|Protocol Violation|0|||
161703854|NCT00868790|583963765|FG009|Period 1|Protocol Violation|0|||
161703855|NCT00868790|583963766|FG010|Period 1|Protocol Violation|0|||
161703856|NCT00868790|583963767|FG011|Period 1|Protocol Violation|0|||
161703857|NCT00868790|583963768|FG012|Period 1|Protocol Violation|0|||
161703858|NCT00868790|583963769|FG013|Period 1|Protocol Violation|0|||
161703859|NCT00868790|583963756|FG000|Period 1|Withdrawal by Subject|0|||
161703860|NCT00868790|583963757|FG001|Period 1|Withdrawal by Subject|1|||
161703861|NCT00868790|583963758|FG002|Period 1|Withdrawal by Subject|0|||
161703862|NCT00868790|583963759|FG003|Period 1|Withdrawal by Subject|0|||
161703863|NCT00868790|583963760|FG004|Period 1|Withdrawal by Subject|0|||
161703864|NCT00868790|583963761|FG005|Period 1|Withdrawal by Subject|0|||
161703865|NCT00868790|583963762|FG006|Period 1|Withdrawal by Subject|0|||
161703866|NCT00868790|583963763|FG007|Period 1|Withdrawal by Subject|0|||
161703867|NCT00868790|583963764|FG008|Period 1|Withdrawal by Subject|0|||
161703868|NCT00868790|583963765|FG009|Period 1|Withdrawal by Subject|0|||
161703869|NCT00868790|583963766|FG010|Period 1|Withdrawal by Subject|0|||
161703870|NCT00868790|583963767|FG011|Period 1|Withdrawal by Subject|0|||
161703871|NCT00868790|583963768|FG012|Period 1|Withdrawal by Subject|0|||
161703872|NCT00868790|583963769|FG013|Period 1|Withdrawal by Subject|1|||
161703873|NCT00868790|583963756|FG000|Period 1|Abnormal Triglycerides|0|||
161703874|NCT00868790|583963757|FG001|Period 1|Abnormal Triglycerides|0|||
161703875|NCT00868790|583963758|FG002|Period 1|Abnormal Triglycerides|0|||
161703876|NCT00868790|583963759|FG003|Period 1|Abnormal Triglycerides|0|||
161703877|NCT00868790|583963760|FG004|Period 1|Abnormal Triglycerides|1|||
161703878|NCT00868790|583963761|FG005|Period 1|Abnormal Triglycerides|0|||
161703879|NCT00868790|583963762|FG006|Period 1|Abnormal Triglycerides|0|||
161703880|NCT00868790|583963763|FG007|Period 1|Abnormal Triglycerides|0|||
161703881|NCT00868790|583963764|FG008|Period 1|Abnormal Triglycerides|0|||
161703882|NCT00868790|583963765|FG009|Period 1|Abnormal Triglycerides|0|||
161703883|NCT00868790|583963766|FG010|Period 1|Abnormal Triglycerides|0|||
161703884|NCT00868790|583963767|FG011|Period 1|Abnormal Triglycerides|0|||
161703885|NCT00868790|583963768|FG012|Period 1|Abnormal Triglycerides|0|||
161703886|NCT00868790|583963769|FG013|Period 1|Abnormal Triglycerides|0|||
161703887|NCT00868790|583963756|FG000|Period 1|Lost to Follow-up|0|||
161703888|NCT00868790|583963757|FG001|Period 1|Lost to Follow-up|0|||
161703889|NCT00868790|583963758|FG002|Period 1|Lost to Follow-up|0|||
161703890|NCT00868790|583963759|FG003|Period 1|Lost to Follow-up|0|||
161703891|NCT00868790|583963760|FG004|Period 1|Lost to Follow-up|0|||
161703892|NCT00868790|583963761|FG005|Period 1|Lost to Follow-up|1|||
161703893|NCT00868790|583963762|FG006|Period 1|Lost to Follow-up|0|||
161703894|NCT00868790|583963763|FG007|Period 1|Lost to Follow-up|0|||
161703895|NCT00868790|583963764|FG008|Period 1|Lost to Follow-up|0|||
161703896|NCT00868790|583963765|FG009|Period 1|Lost to Follow-up|0|||
161703897|NCT00868790|583963766|FG010|Period 1|Lost to Follow-up|0|||
161703898|NCT00868790|583963767|FG011|Period 1|Lost to Follow-up|0|||
161703899|NCT00868790|583963768|FG012|Period 1|Lost to Follow-up|0|||
161703900|NCT00868790|583963769|FG013|Period 1|Lost to Follow-up|0|||
161703901|NCT00868790|583963756|FG000|Period 2|Adverse Event|0|||
161703902|NCT00868790|583963757|FG001|Period 2|Adverse Event|0|||
161703903|NCT00868790|583963758|FG002|Period 2|Adverse Event|0|||
161703904|NCT00868790|583963759|FG003|Period 2|Adverse Event|0|||
161703905|NCT00868790|583963760|FG004|Period 2|Adverse Event|0|||
161703906|NCT00868790|583963761|FG005|Period 2|Adverse Event|0|||
161703907|NCT00868790|583963762|FG006|Period 2|Adverse Event|0|||
161703908|NCT00868790|583963763|FG007|Period 2|Adverse Event|0|||
161703909|NCT00868790|583963764|FG008|Period 2|Adverse Event|1|||
161703910|NCT00868790|583963765|FG009|Period 2|Adverse Event|0|||
161703911|NCT00868790|583963766|FG010|Period 2|Adverse Event|0|||
161703912|NCT00868790|583963767|FG011|Period 2|Adverse Event|0|||
161703913|NCT00868790|583963768|FG012|Period 2|Adverse Event|0|||
161703914|NCT00868790|583963769|FG013|Period 2|Adverse Event|0|||
161703915|NCT00868790|583963756|FG000|Period 2|Lost to Follow-up|0|||
161703916|NCT00868790|583963757|FG001|Period 2|Lost to Follow-up|1|||
161703917|NCT00868790|583963758|FG002|Period 2|Lost to Follow-up|0|||
161703918|NCT00868790|583963759|FG003|Period 2|Lost to Follow-up|0|||
161703919|NCT00868790|583963760|FG004|Period 2|Lost to Follow-up|0|||
161703920|NCT00868790|583963761|FG005|Period 2|Lost to Follow-up|1|||
161703921|NCT00868790|583963762|FG006|Period 2|Lost to Follow-up|0|||
161703922|NCT00868790|583963763|FG007|Period 2|Lost to Follow-up|0|||
161703923|NCT00868790|583963764|FG008|Period 2|Lost to Follow-up|0|||
161703924|NCT00868790|583963765|FG009|Period 2|Lost to Follow-up|0|||
161703925|NCT00868790|583963766|FG010|Period 2|Lost to Follow-up|0|||
161703926|NCT00868790|583963767|FG011|Period 2|Lost to Follow-up|0|||
161703927|NCT00868790|583963768|FG012|Period 2|Lost to Follow-up|0|||
161703928|NCT00868790|583963769|FG013|Period 2|Lost to Follow-up|0|||
161703929|NCT00868790|583963756|FG000|Period 2|Withdrawal by Subject|0|||
161703930|NCT00868790|583963757|FG001|Period 2|Withdrawal by Subject|0|||
161703931|NCT00868790|583963758|FG002|Period 2|Withdrawal by Subject|0|||
161703932|NCT00868790|583963759|FG003|Period 2|Withdrawal by Subject|0|||
161703933|NCT00868790|583963760|FG004|Period 2|Withdrawal by Subject|0|||
161703934|NCT00868790|583963761|FG005|Period 2|Withdrawal by Subject|0|||
161703935|NCT00868790|583963762|FG006|Period 2|Withdrawal by Subject|0|||
161703936|NCT00868790|583963763|FG007|Period 2|Withdrawal by Subject|0|||
161703937|NCT00868790|583963764|FG008|Period 2|Withdrawal by Subject|1|||
161703938|NCT00868790|583963765|FG009|Period 2|Withdrawal by Subject|0|||
161703939|NCT00868790|583963766|FG010|Period 2|Withdrawal by Subject|0|||
161703940|NCT00868790|583963767|FG011|Period 2|Withdrawal by Subject|0|||
161703941|NCT00868790|583963768|FG012|Period 2|Withdrawal by Subject|0|||
161703942|NCT00868790|583963769|FG013|Period 2|Withdrawal by Subject|1|||
161703943|NCT00868790|583963756|FG000|Period 3|Adverse Event|0|||
161703944|NCT00868790|583963757|FG001|Period 3|Adverse Event|0|||
161703945|NCT00868790|583963758|FG002|Period 3|Adverse Event|0|||
161703946|NCT00868790|583963759|FG003|Period 3|Adverse Event|0|||
161703947|NCT00868790|583963760|FG004|Period 3|Adverse Event|0|||
161703948|NCT00868790|583963761|FG005|Period 3|Adverse Event|0|||
161703949|NCT00868790|583963762|FG006|Period 3|Adverse Event|0|||
161703950|NCT00868790|583963763|FG007|Period 3|Adverse Event|0|||
161703951|NCT00868790|583963764|FG008|Period 3|Adverse Event|0|||
161703952|NCT00868790|583963765|FG009|Period 3|Adverse Event|1|||
161703953|NCT00868790|583963766|FG010|Period 3|Adverse Event|0|||
161703954|NCT00868790|583963767|FG011|Period 3|Adverse Event|0|||
161703955|NCT00868790|583963768|FG012|Period 3|Adverse Event|0|||
161703956|NCT00868790|583963769|FG013|Period 3|Adverse Event|0|||
161703957|NCT00868790|583963756|FG000|Period 3|Protocol Violation|0|||
161703958|NCT00868790|583963757|FG001|Period 3|Protocol Violation|0|||
161703959|NCT00868790|583963758|FG002|Period 3|Protocol Violation|0|||
161703960|NCT00868790|583963759|FG003|Period 3|Protocol Violation|0|||
161703961|NCT00868790|583963760|FG004|Period 3|Protocol Violation|0|||
161703962|NCT00868790|583963761|FG005|Period 3|Protocol Violation|0|||
161703963|NCT00868790|583963762|FG006|Period 3|Protocol Violation|0|||
161703964|NCT00868790|583963763|FG007|Period 3|Protocol Violation|0|||
161703965|NCT00868790|583963764|FG008|Period 3|Protocol Violation|0|||
161703966|NCT00868790|583963765|FG009|Period 3|Protocol Violation|0|||
161703967|NCT00868790|583963766|FG010|Period 3|Protocol Violation|1|||
161703968|NCT00868790|583963767|FG011|Period 3|Protocol Violation|0|||
161703969|NCT00868790|583963768|FG012|Period 3|Protocol Violation|0|||
161703970|NCT00868790|583963769|FG013|Period 3|Protocol Violation|0|||
161703971|NCT00868790|583963756|FG000|Period 3|Study Terminated by Sponsor|0|||
161703972|NCT00868790|583963757|FG001|Period 3|Study Terminated by Sponsor|0|||
161703973|NCT00868790|583963758|FG002|Period 3|Study Terminated by Sponsor|0|||
161703974|NCT00868790|583963759|FG003|Period 3|Study Terminated by Sponsor|1|||
161703975|NCT00868790|583963760|FG004|Period 3|Study Terminated by Sponsor|0|||
161703976|NCT00868790|583963761|FG005|Period 3|Study Terminated by Sponsor|0|||
161703977|NCT00868790|583963762|FG006|Period 3|Study Terminated by Sponsor|0|||
161703978|NCT00868790|583963763|FG007|Period 3|Study Terminated by Sponsor|0|||
161703979|NCT00868790|583963764|FG008|Period 3|Study Terminated by Sponsor|0|||
161703980|NCT00868790|583963765|FG009|Period 3|Study Terminated by Sponsor|0|||
161703981|NCT00868790|583963766|FG010|Period 3|Study Terminated by Sponsor|0|||
161703982|NCT00868790|583963767|FG011|Period 3|Study Terminated by Sponsor|0|||
161703983|NCT00868790|583963768|FG012|Period 3|Study Terminated by Sponsor|0|||
161703984|NCT00868790|583963769|FG013|Period 3|Study Terminated by Sponsor|0|||
161703985|NCT00868790|583963756|FG000|Period 4|Adverse Event|0|||
161703986|NCT00868790|583963757|FG001|Period 4|Adverse Event|0|||
161703987|NCT00868790|583963758|FG002|Period 4|Adverse Event|0|||
161703988|NCT00868790|583963759|FG003|Period 4|Adverse Event|0|||
161703989|NCT00868790|583963760|FG004|Period 4|Adverse Event|0|||
161703990|NCT00868790|583963761|FG005|Period 4|Adverse Event|0|||
161703991|NCT00868790|583963762|FG006|Period 4|Adverse Event|0|||
161703992|NCT00868790|583963763|FG007|Period 4|Adverse Event|1|||
161703993|NCT00868790|583963764|FG008|Period 4|Adverse Event|0|||
161703994|NCT00868790|583963765|FG009|Period 4|Adverse Event|0|||
161703995|NCT00868790|583963766|FG010|Period 4|Adverse Event|1|||
161703996|NCT00868790|583963767|FG011|Period 4|Adverse Event|0|||
161703997|NCT00868790|583963768|FG012|Period 4|Adverse Event|1|||
161703998|NCT00868790|583963769|FG013|Period 4|Adverse Event|0|||
161703999|NCT00868790|583963756|FG000|Period 4|Lost to Follow-up|0|||
161704000|NCT00868790|583963757|FG001|Period 4|Lost to Follow-up|0|||
161704001|NCT00868790|583963758|FG002|Period 4|Lost to Follow-up|0|||
161704002|NCT00868790|583963759|FG003|Period 4|Lost to Follow-up|0|||
161704003|NCT00868790|583963760|FG004|Period 4|Lost to Follow-up|0|||
161704004|NCT00868790|583963761|FG005|Period 4|Lost to Follow-up|0|||
161704005|NCT00868790|583963762|FG006|Period 4|Lost to Follow-up|0|||
161704006|NCT00868790|583963763|FG007|Period 4|Lost to Follow-up|1|||
161704007|NCT00868790|583963764|FG008|Period 4|Lost to Follow-up|0|||
161704008|NCT00868790|583963765|FG009|Period 4|Lost to Follow-up|0|||
161704009|NCT00868790|583963766|FG010|Period 4|Lost to Follow-up|0|||
161704010|NCT00868790|583963767|FG011|Period 4|Lost to Follow-up|0|||
161704011|NCT00868790|583963768|FG012|Period 4|Lost to Follow-up|0|||
161704012|NCT00868790|583963769|FG013|Period 4|Lost to Follow-up|0|||
161704013|NCT00868790|583963756|FG000|Period 4|Study Terminated by Sponsor|2|||
161704014|NCT00868790|583963757|FG001|Period 4|Study Terminated by Sponsor|0|||
161704015|NCT00868790|583963758|FG002|Period 4|Study Terminated by Sponsor|0|||
161704016|NCT00868790|583963759|FG003|Period 4|Study Terminated by Sponsor|0|||
161704017|NCT00868790|583963760|FG004|Period 4|Study Terminated by Sponsor|0|||
161704018|NCT00868790|583963761|FG005|Period 4|Study Terminated by Sponsor|0|||
161704019|NCT00868790|583963762|FG006|Period 4|Study Terminated by Sponsor|0|||
161704020|NCT00868790|583963763|FG007|Period 4|Study Terminated by Sponsor|1|||
161704021|NCT00868790|583963764|FG008|Period 4|Study Terminated by Sponsor|2|||
161704022|NCT00868790|583963765|FG009|Period 4|Study Terminated by Sponsor|0|||
161704023|NCT00868790|583963766|FG010|Period 4|Study Terminated by Sponsor|2|||
161704024|NCT00868790|583963767|FG011|Period 4|Study Terminated by Sponsor|1|||
161704025|NCT00868790|583963768|FG012|Period 4|Study Terminated by Sponsor|0|||
161704026|NCT00868790|583963769|FG013|Period 4|Study Terminated by Sponsor|1|||
161704027|NCT00868790|583963756|FG000|Period 4|Abnormal ALT/AST|0|||
161704028|NCT00868790|583963757|FG001|Period 4|Abnormal ALT/AST|0|||
161704029|NCT00868790|583963758|FG002|Period 4|Abnormal ALT/AST|1|||
161704030|NCT00868790|583963759|FG003|Period 4|Abnormal ALT/AST|0|||
161704031|NCT00868790|583963760|FG004|Period 4|Abnormal ALT/AST|0|||
161704032|NCT00868790|583963761|FG005|Period 4|Abnormal ALT/AST|0|||
161704033|NCT00868790|583963762|FG006|Period 4|Abnormal ALT/AST|0|||
161704034|NCT00868790|583963763|FG007|Period 4|Abnormal ALT/AST|0|||
161704035|NCT00868790|583963764|FG008|Period 4|Abnormal ALT/AST|0|||
161704036|NCT00868790|583963765|FG009|Period 4|Abnormal ALT/AST|0|||
161704037|NCT00868790|583963766|FG010|Period 4|Abnormal ALT/AST|0|||
161704038|NCT00868790|583963767|FG011|Period 4|Abnormal ALT/AST|0|||
161655040|NCT04047862|583786604|FG004|Overall Study|Sponsor Decision|0|||
161655041|NCT04047862|583786605|FG005|Overall Study|Sponsor Decision|0|||
161655042|NCT04047862|583786606|FG006|Overall Study|Sponsor Decision|0|||
161655043|NCT04047862|583786607|FG007|Overall Study|Sponsor Decision|13|||
161655044|NCT04047862|583786608|FG008|Overall Study|Sponsor Decision|10|||
161655045|NCT04047862|583786609|FG009|Overall Study|Sponsor Decision|18|||
161655046|NCT04047862|583786610|FG010|Overall Study|Sponsor Decision|3|||
161655047|NCT04047862|583786611|FG011|Overall Study|Sponsor Decision|3|||
161655048|NCT04047862|583786612|FG012|Overall Study|Sponsor Decision|4|||
161655049|NCT04047862|583786613|FG013|Overall Study|Sponsor Decision|0|||
161655050|NCT04047862|583786614|FG014|Overall Study|Sponsor Decision|7|||
161655051|NCT04047862|583786615|FG015|Overall Study|Sponsor Decision|8|||
161655052|NCT04047862|583786616|FG016|Overall Study|Sponsor Decision|9|||
161655053|NCT04047862|583786617|FG017|Overall Study|Sponsor Decision|7|||
161655054|NCT04047862|583786618|FG018|Overall Study|Sponsor Decision|8|||
161655055|NCT04047862|583786600|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655056|NCT04047862|583786601|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655057|NCT04047862|583786602|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655058|NCT04047862|583786603|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655059|NCT04047862|583786604|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655060|NCT04047862|583786605|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655061|NCT04047862|583786606|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655062|NCT04047862|583786607|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
161655063|NCT04047862|583786608|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
161655064|NCT04047862|583786609|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655065|NCT04047862|583786610|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
161655066|NCT04047862|583786611|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655067|NCT04047862|583786612|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655068|NCT04047862|583786613|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161655069|NCT04047862|583786614|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
161655070|NCT04047862|583786615|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
161655071|NCT04047862|583786616|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
161655072|NCT04047862|583786617|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
161655073|NCT04047862|583786618|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
161655074|NCT04047862|583786600|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655075|NCT04047862|583786601|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655076|NCT04047862|583786602|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655077|NCT04047862|583786603|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161704039|NCT00868790|583963768|FG012|Period 4|Abnormal ALT/AST|0|||
161704040|NCT00868790|583963769|FG013|Period 4|Abnormal ALT/AST|0|||
161704041|NCT00868790|583963756|FG000|Post-study|Withdrawal by Subject|0|||
161704042|NCT00868790|583963757|FG001|Post-study|Withdrawal by Subject|0|||
161704043|NCT00868790|583963758|FG002|Post-study|Withdrawal by Subject|0|||
161704044|NCT00868790|583963759|FG003|Post-study|Withdrawal by Subject|0|||
161704045|NCT00868790|583963760|FG004|Post-study|Withdrawal by Subject|1|||
161704046|NCT00868790|583963761|FG005|Post-study|Withdrawal by Subject|0|||
161704047|NCT00868790|583963762|FG006|Post-study|Withdrawal by Subject|0|||
161704048|NCT00868790|583963763|FG007|Post-study|Withdrawal by Subject|0|||
161704049|NCT00868790|583963764|FG008|Post-study|Withdrawal by Subject|0|||
161704050|NCT00868790|583963765|FG009|Post-study|Withdrawal by Subject|0|||
161704051|NCT00868790|583963766|FG010|Post-study|Withdrawal by Subject|0|||
161704052|NCT00868790|583963767|FG011|Post-study|Withdrawal by Subject|0|||
161704053|NCT00868790|583963768|FG012|Post-study|Withdrawal by Subject|0|||
161704054|NCT00868790|583963769|FG013|Post-study|Withdrawal by Subject|0|||
161704055|NCT00868790|583963756|FG000|Post-study|Excluded Medication|0|||
161704056|NCT00868790|583963757|FG001|Post-study|Excluded Medication|0|||
161704057|NCT00868790|583963758|FG002|Post-study|Excluded Medication|0|||
161704058|NCT00868790|583963759|FG003|Post-study|Excluded Medication|0|||
161704059|NCT00868790|583963760|FG004|Post-study|Excluded Medication|0|||
161704060|NCT00868790|583963761|FG005|Post-study|Excluded Medication|0|||
161704061|NCT00868790|583963762|FG006|Post-study|Excluded Medication|0|||
161704062|NCT00868790|583963763|FG007|Post-study|Excluded Medication|2|||
161704063|NCT00868790|583963764|FG008|Post-study|Excluded Medication|0|||
161704064|NCT00868790|583963765|FG009|Post-study|Excluded Medication|1|||
161704065|NCT00868790|583963766|FG010|Post-study|Excluded Medication|0|||
161704066|NCT00868790|583963767|FG011|Post-study|Excluded Medication|0|||
161704067|NCT00868790|583963768|FG012|Post-study|Excluded Medication|0|||
161704068|NCT00868790|583963769|FG013|Post-study|Excluded Medication|0|||
161704069|NCT02909153|583963774|FG000|Overall Study|Withdrawal by Subject|0|||
161704070|NCT02909153|583963775|FG001|Overall Study|Withdrawal by Subject|1|||
161704071|NCT02909153|583963776|FG002|Overall Study|Withdrawal by Subject|0|||
161704072|NCT02909153|583963777|FG003|Overall Study|Withdrawal by Subject|0|||
161704073|NCT02909153|583963778|FG004|Overall Study|Withdrawal by Subject|0|||
161704074|NCT01273064|583963779|FG000|Overall Study|Adverse Event|5|||
161704075|NCT01273064|583963780|FG001|Overall Study|Adverse Event|1|||
161704076|NCT01273064|583963781|FG002|Overall Study|Adverse Event|3|||
161704077|NCT01273064|583963782|FG003|Overall Study|Adverse Event|2|||
161704078|NCT01273064|583963783|FG004|Overall Study|Adverse Event|1|||
161704079|NCT01273064|583963779|FG000|Overall Study|Withdrawal by Subject|4|||
161704080|NCT01273064|583963780|FG001|Overall Study|Withdrawal by Subject|2|||
161704081|NCT01273064|583963781|FG002|Overall Study|Withdrawal by Subject|2|||
161704082|NCT01273064|583963782|FG003|Overall Study|Withdrawal by Subject|2|||
161704083|NCT01273064|583963783|FG004|Overall Study|Withdrawal by Subject|0|||
161704084|NCT01273064|583963779|FG000|Overall Study|Study Termination|13|||
161704085|NCT01273064|583963780|FG001|Overall Study|Study Termination|27|||
161704086|NCT01273064|583963781|FG002|Overall Study|Study Termination|26|||
161704087|NCT01273064|583963782|FG003|Overall Study|Study Termination|16|||
161704088|NCT01273064|583963783|FG004|Overall Study|Study Termination|8|||
161704089|NCT01273064|583963779|FG000|Overall Study|Lost to Follow-up|1|||
161704090|NCT01273064|583963780|FG001|Overall Study|Lost to Follow-up|0|||
161704091|NCT01273064|583963781|FG002|Overall Study|Lost to Follow-up|0|||
161704092|NCT01273064|583963782|FG003|Overall Study|Lost to Follow-up|0|||
161704093|NCT01273064|583963783|FG004|Overall Study|Lost to Follow-up|0|||
161704094|NCT01273064|583963779|FG000|Overall Study|Physician Decision|0|||
161704095|NCT01273064|583963780|FG001|Overall Study|Physician Decision|0|||
161704096|NCT01273064|583963781|FG002|Overall Study|Physician Decision|0|||
161704097|NCT01273064|583963782|FG003|Overall Study|Physician Decision|0|||
161704098|NCT01273064|583963783|FG004|Overall Study|Physician Decision|1|||
161704099|NCT04666038|583963784|FG000|Overall Study|Progressive Disease|2|||
161704100|NCT04666038|583963785|FG001|Overall Study|Progressive Disease|0|||
161704101|NCT04666038|583963784|FG000|Overall Study|Death|38|||
161704102|NCT04666038|583963785|FG001|Overall Study|Death|32|||
161704103|NCT04666038|583963784|FG000|Overall Study|Withdrawal by Subject|10|||
161704104|NCT04666038|583963785|FG001|Overall Study|Withdrawal by Subject|19|||
161704105|NCT04666038|583963784|FG000|Overall Study|Lost to Follow-up|0|||
161704106|NCT04666038|583963785|FG001|Overall Study|Lost to Follow-up|2|||
161704107|NCT04666038|583963784|FG000|Overall Study|On Study Treatment|46|||
161704108|NCT04666038|583963785|FG001|Overall Study|On Study Treatment|5|||
161704109|NCT04666038|583963784|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
161704110|NCT04666038|583963785|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
161704111|NCT02867761|583963791|FG000|Overall Study|Participant withdrawn by investigator|0|||
161704112|NCT02867761|583963792|FG001|Overall Study|Participant withdrawn by investigator|1|||
161704113|NCT02867761|583963791|FG000|Overall Study|Lost to Follow-up|25|||
161704114|NCT02867761|583963792|FG001|Overall Study|Lost to Follow-up|18|||
161704115|NCT02867761|583963791|FG000|Overall Study|Unable to complete protocol|3|||
161704116|NCT02867761|583963792|FG001|Overall Study|Unable to complete protocol|7|||
161704117|NCT03595280|583963793|FG000|Overall Study|Lost to Follow-up|6|||
161704118|NCT03595280|583963794|FG001|Overall Study|Lost to Follow-up|9|||
161704119|NCT03595280|583963795|FG002|Overall Study|Lost to Follow-up|15|||
161704120|NCT01512264|583963796|FG000|Overall Study|Lost to Follow-up|0|||
161704121|NCT01512264|583963797|FG001|Overall Study|Lost to Follow-up|0|||
161704122|NCT01512264|583963798|FG002|Overall Study|Lost to Follow-up|0|||
161704123|NCT01512264|583963799|FG003|Overall Study|Lost to Follow-up|1|||
161704124|NCT01931059|583963800|FG000|Day 1|Pregnancy|0|||
161704125|NCT01931059|583963801|FG001|Day 1|Pregnancy|1|||
161704126|NCT01931059|583963800|FG000|Day3|Lost to Follow-up|1|||
161704127|NCT01931059|583963801|FG001|Day3|Lost to Follow-up|0|||
161704128|NCT02675075|583963811|FG000|Overall Study|Lost to Follow-up|3|||
161704129|NCT02675075|583963812|FG001|Overall Study|Lost to Follow-up|0|||
161704130|NCT02292212|583963813|FG000|ViE Phase|Withdrawal by Subject|1|||
161704131|NCT02292212|583963813|FG000|ViE Phase|Protocol Violation|2|||
161704132|NCT04957290|583963814|FG000|Overall Study|Progressive disease|3|||
161704133|NCT04957290|583963815|FG001|Overall Study|Progressive disease|3|||
161704134|NCT04957290|583963816|FG002|Overall Study|Progressive disease|2|||
161704135|NCT04957290|583963817|FG003|Overall Study|Progressive disease|0|||
161704136|NCT04957290|583963818|FG004|Overall Study|Progressive disease|0|||
161704137|NCT04957290|583963819|FG005|Overall Study|Progressive disease|0|||
161704138|NCT04957290|583963814|FG000|Overall Study|Withdrawal by Subject|1|||
161704139|NCT04957290|583963815|FG001|Overall Study|Withdrawal by Subject|0|||
161704140|NCT04957290|583963816|FG002|Overall Study|Withdrawal by Subject|1|||
161704141|NCT04957290|583963817|FG003|Overall Study|Withdrawal by Subject|0|||
161704142|NCT04957290|583963818|FG004|Overall Study|Withdrawal by Subject|0|||
161704143|NCT04957290|583963819|FG005|Overall Study|Withdrawal by Subject|0|||
161704144|NCT04957290|583963814|FG000|Overall Study|Death|0|||
161704145|NCT04957290|583963815|FG001|Overall Study|Death|2|||
161704146|NCT04957290|583963816|FG002|Overall Study|Death|1|||
161704147|NCT04957290|583963817|FG003|Overall Study|Death|0|||
161704148|NCT04957290|583963818|FG004|Overall Study|Death|0|||
161704149|NCT04957290|583963819|FG005|Overall Study|Death|0|||
161704150|NCT04957290|583963814|FG000|Overall Study|non compliance with study drug|0|||
161704151|NCT04957290|583963815|FG001|Overall Study|non compliance with study drug|1|||
161704152|NCT04957290|583963816|FG002|Overall Study|non compliance with study drug|0|||
161704153|NCT04957290|583963817|FG003|Overall Study|non compliance with study drug|0|||
161704154|NCT04957290|583963818|FG004|Overall Study|non compliance with study drug|0|||
161704155|NCT04957290|583963819|FG005|Overall Study|non compliance with study drug|0|||
161704156|NCT04957290|583963814|FG000|Overall Study|none specified.|0|||
161704157|NCT04957290|583963815|FG001|Overall Study|none specified.|1|||
161704158|NCT04957290|583963816|FG002|Overall Study|none specified.|2|||
161704159|NCT04957290|583963817|FG003|Overall Study|none specified.|0|||
161704160|NCT04957290|583963818|FG004|Overall Study|none specified.|0|||
161704161|NCT04957290|583963819|FG005|Overall Study|none specified.|0|||
161704162|NCT04957290|583963814|FG000|Overall Study|unacceptable toxicity|0|||
161704163|NCT04957290|583963815|FG001|Overall Study|unacceptable toxicity|0|||
161704164|NCT04957290|583963816|FG002|Overall Study|unacceptable toxicity|1|||
161704165|NCT04957290|583963817|FG003|Overall Study|unacceptable toxicity|0|||
161704166|NCT04957290|583963818|FG004|Overall Study|unacceptable toxicity|0|||
161704167|NCT04957290|583963819|FG005|Overall Study|unacceptable toxicity|0|||
161704168|NCT04957290|583963814|FG000|Overall Study|Adverse Event|0|||
161704169|NCT04957290|583963815|FG001|Overall Study|Adverse Event|0|||
161704170|NCT04957290|583963816|FG002|Overall Study|Adverse Event|1|||
161837209|NCT01765582|584446566|FG001|Overall Study|Lost to Follow-up|2|||
161704171|NCT04957290|583963817|FG003|Overall Study|Adverse Event|0|||
161704172|NCT04957290|583963818|FG004|Overall Study|Adverse Event|0|||
161704173|NCT04957290|583963819|FG005|Overall Study|Adverse Event|0|||
161704174|NCT04957290|583963814|FG000|Overall Study|study terminated by sponsor|0|||
161704175|NCT04957290|583963815|FG001|Overall Study|study terminated by sponsor|0|||
161704176|NCT04957290|583963816|FG002|Overall Study|study terminated by sponsor|2|||
161704177|NCT04957290|583963817|FG003|Overall Study|study terminated by sponsor|0|||
161704178|NCT04957290|583963818|FG004|Overall Study|study terminated by sponsor|0|||
161704179|NCT04957290|583963819|FG005|Overall Study|study terminated by sponsor|0|||
161704180|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704181|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704182|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704183|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
161704184|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704185|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
161704186|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704187|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704188|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704189|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704190|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704191|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704192|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704193|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704194|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704195|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704196|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704197|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704198|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704199|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704200|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704201|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704202|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704203|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704204|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
161704205|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704206|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
161704207|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704208|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704209|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704210|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704211|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704212|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704213|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704214|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704215|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704216|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704217|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704218|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704219|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704220|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704221|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704222|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704223|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704224|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704225|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704226|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704227|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
161704228|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704229|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
161704230|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
161704231|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
161704232|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704233|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704234|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704235|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704236|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704237|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704238|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704239|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704240|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704241|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704242|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704243|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704244|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704245|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704246|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704247|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704248|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704249|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704250|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704251|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
161704252|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704253|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
161704254|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704255|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704256|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704257|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704258|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704259|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704260|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704261|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704262|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704263|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161837210|NCT01765582|584446567|FG002|Overall Study|Lost to Follow-up|1|||
161837211|NCT01765582|584446565|FG000|Overall Study|Death|31|||
161837212|NCT01765582|584446566|FG001|Overall Study|Death|36|||
161837213|NCT01765582|584446567|FG002|Overall Study|Death|33|||
161837214|NCT01765582|584446565|FG000|Overall Study|Sponsor Decision|46|||
161837215|NCT01765582|584446566|FG001|Overall Study|Sponsor Decision|42|||
161837216|NCT01765582|584446567|FG002|Overall Study|Sponsor Decision|42|||
161837217|NCT01765582|584446565|FG000|Overall Study|Withdrawal of Consent|11|||
161837218|NCT01765582|584446566|FG001|Overall Study|Withdrawal of Consent|6|||
161837219|NCT01765582|584446567|FG002|Overall Study|Withdrawal of Consent|10|||
161837220|NCT03251963|584446570|FG000|Overall Study|inappropriate Xa level timing|6|||
161837221|NCT03251963|584446571|FG001|Overall Study|inappropriate Xa level timing|3|||
161837222|NCT03251963|584446570|FG000|Overall Study|no peak Xa level drawn|2|||
161837223|NCT03251963|584446571|FG001|Overall Study|no peak Xa level drawn|0|||
161837224|NCT03251963|584446570|FG000|Overall Study|bled prior to Xa level|1|||
161837225|NCT03251963|584446571|FG001|Overall Study|bled prior to Xa level|2|||
161837226|NCT00714493|584446579|FG000|Overall Study|Adverse Event|11|||
161837227|NCT00714493|584446579|FG000|Overall Study|Death|3|||
161837228|NCT00714493|584446579|FG000|Overall Study|Lack of Efficacy|10|||
161837229|NCT00714493|584446579|FG000|Overall Study|Lost to Follow-up|3|||
161655078|NCT04047862|583786604|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655079|NCT04047862|583786605|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655080|NCT04047862|583786606|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655081|NCT04047862|583786607|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655082|NCT04047862|583786608|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655083|NCT04047862|583786609|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655084|NCT04047862|583786610|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161704264|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704265|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704266|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704267|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704268|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704269|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704270|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704271|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704272|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
161704273|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704274|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704275|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
161704276|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704277|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704278|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704279|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704280|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704281|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704282|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704283|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704284|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704285|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704286|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704287|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704288|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704289|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704290|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704291|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704292|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704293|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704294|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704295|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704296|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704297|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
161704298|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704299|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704300|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704301|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704302|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704303|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704304|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704305|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704306|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704307|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704308|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704309|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704310|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704311|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704312|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704313|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704314|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704315|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704316|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704317|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704318|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704319|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704320|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
161704321|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704322|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704323|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704324|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704325|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704326|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704327|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704328|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704329|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704330|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704331|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704332|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704333|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704334|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704335|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704336|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704337|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704338|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704339|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704340|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704341|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704342|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704343|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704344|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
161704345|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704346|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704347|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704348|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704349|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704350|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161837230|NCT00714493|584446579|FG000|Overall Study|Protocol Violation|12|||
161655085|NCT04047862|583786611|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655086|NCT04047862|583786612|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655087|NCT04047862|583786613|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655088|NCT04047862|583786614|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655089|NCT04047862|583786615|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
161655090|NCT04047862|583786616|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655091|NCT04047862|583786617|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161655092|NCT04047862|583786618|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
161655093|NCT04047862|583786600|FG000|Overall Study|Other|0|||
161655094|NCT04047862|583786601|FG001|Overall Study|Other|0|||
161655095|NCT04047862|583786602|FG002|Overall Study|Other|0|||
161655096|NCT04047862|583786603|FG003|Overall Study|Other|0|||
161655097|NCT04047862|583786604|FG004|Overall Study|Other|0|||
161655098|NCT04047862|583786605|FG005|Overall Study|Other|0|||
161655099|NCT04047862|583786606|FG006|Overall Study|Other|0|||
161655100|NCT04047862|583786607|FG007|Overall Study|Other|0|||
161655101|NCT04047862|583786608|FG008|Overall Study|Other|0|||
161655102|NCT04047862|583786609|FG009|Overall Study|Other|0|||
161655103|NCT04047862|583786610|FG010|Overall Study|Other|0|||
161655104|NCT04047862|583786611|FG011|Overall Study|Other|0|||
161655105|NCT04047862|583786612|FG012|Overall Study|Other|0|||
161655106|NCT04047862|583786613|FG013|Overall Study|Other|0|||
161655107|NCT04047862|583786614|FG014|Overall Study|Other|2|||
161655108|NCT04047862|583786615|FG015|Overall Study|Other|1|||
161655109|NCT04047862|583786616|FG016|Overall Study|Other|1|||
161655110|NCT04047862|583786617|FG017|Overall Study|Other|1|||
161655111|NCT04047862|583786618|FG018|Overall Study|Other|0|||
161655112|NCT04349631|583786623|FG000|Overall Study|Lost to Follow-up|3|||
161655113|NCT04349631|583786623|FG000|Overall Study|Withdrawal by Subject|7|||
161655114|NCT00640133|583788816|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
161655115|NCT00640133|583788817|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
161655116|NCT00640133|583788816|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
161655117|NCT00640133|583788817|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
161655118|NCT00640133|583788816|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
161655119|NCT00640133|583788817|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
161655120|NCT01994837|583788819|FG000|Overall Study|Progressive disease per protocol|23|||
161655121|NCT01994837|583788819|FG000|Overall Study|Adv event related to progressive disease|3|||
161655122|NCT01994837|583788819|FG000|Overall Study|Fatal progressive disease|2|||
161655123|NCT01994837|583788819|FG000|Overall Study|Adverse event not related to progression|1|||
161655124|NCT01994837|583788819|FG000|Overall Study|Chose palliative care|1|||
161655125|NCT01994837|583788819|FG000|Overall Study|Proceeded to transplant|1|||
161655126|NCT01994837|583788819|FG000|Overall Study|Removed from study due to no response|1|||
161655127|NCT03900416|583788821|FG000|Six Week Follow-up|Lost to Follow-up|1|||
161655128|NCT03900416|583788822|FG001|Six Week Follow-up|Lost to Follow-up|0|||
161655129|NCT03900416|583788821|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
161655130|NCT03900416|583788822|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
161655131|NCT03900416|583788821|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
161655132|NCT03900416|583788822|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
161655133|NCT03900416|583788821|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
161655134|NCT03900416|583788822|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
161655135|NCT03900416|583788821|FG000|Twelve Week Follow-up|Adverse Event|1|||
161655136|NCT03900416|583788822|FG001|Twelve Week Follow-up|Adverse Event|1|||
161655137|NCT03900416|583788821|FG000|Six Month Follow-up|Lost to Follow-up|4|||
161655138|NCT03900416|583788822|FG001|Six Month Follow-up|Lost to Follow-up|3|||
161655139|NCT03900416|583788821|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
161655140|NCT03900416|583788822|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
161655141|NCT03207451|583788825|FG000|Overall Study|scheduling conflict|1|||
161655142|NCT03207451|583788826|FG001|Overall Study|scheduling conflict|0|||
161655143|NCT03207451|583788827|FG002|Overall Study|scheduling conflict|2|||
161655144|NCT03207451|583788828|FG003|Overall Study|scheduling conflict|2|||
161655145|NCT03207451|583788825|FG000|Overall Study|Adverse Event|0|||
161655146|NCT03207451|583788826|FG001|Overall Study|Adverse Event|0|||
161704351|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704352|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704353|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704354|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704355|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704356|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704357|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704358|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704359|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704360|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704361|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704362|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704363|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704364|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704365|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161704366|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704367|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161704368|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161704369|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704370|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704371|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704372|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704373|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704374|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704375|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704376|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704377|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704378|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704379|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704380|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704381|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704382|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704383|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704384|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704385|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704386|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704387|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704388|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704389|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704390|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704391|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704392|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704393|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704394|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704395|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
161704396|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704397|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704398|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704399|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704400|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704401|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704402|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704403|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704404|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704405|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704406|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704407|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704408|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704409|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704410|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161837231|NCT00714493|584446579|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
161837232|NCT00714493|584446579|FG000|Overall Study|OTHER|2|||
161704411|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704412|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704413|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704414|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704415|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704416|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704417|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704418|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704419|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704420|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704421|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704422|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
161704423|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704424|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704425|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704426|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704427|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704428|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704429|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704430|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704431|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704432|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704433|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704434|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704435|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704436|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704437|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704438|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704439|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704440|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704441|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704442|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704443|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
161704444|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704445|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
161704446|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704447|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704448|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704449|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704450|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704451|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704452|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704453|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704454|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704455|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704456|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704457|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704458|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704459|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704460|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704461|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704462|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704463|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704464|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704465|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704466|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704467|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704468|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
161704469|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
161704470|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704471|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704472|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704473|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704474|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704475|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704476|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704477|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704478|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704479|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
161704480|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
161704481|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
161704482|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
161704483|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
161704484|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
161704485|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
161704486|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
161704487|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
161704488|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
161704489|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
161704490|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
161704491|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
161704492|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
161704493|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
161704494|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
161704495|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
161704496|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
161704497|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
161704498|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
161704499|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
161704500|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
161704501|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
161704502|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704503|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704504|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704505|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704506|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704507|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704508|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704509|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704510|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704511|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704512|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704513|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704514|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704515|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704516|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704517|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
161704518|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
161704519|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704520|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704521|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704522|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704523|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704524|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704525|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704526|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704527|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704528|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704529|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704530|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704531|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704532|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704533|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704534|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704535|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704536|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704537|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704538|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704539|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704540|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
161704541|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
161704542|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
161704543|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704544|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704545|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704546|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704547|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704548|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704549|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704550|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704551|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704552|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704553|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704554|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704555|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704556|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704557|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704558|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704559|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704560|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704561|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704562|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704563|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704564|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
161704565|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704566|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704567|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704568|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704569|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704570|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704571|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
161704572|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
161704573|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
161704574|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
161704575|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
161704576|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
161704577|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
161704578|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
161704579|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
161704580|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
161704581|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
161704582|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
161704583|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
161704584|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
161704585|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
161704586|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
161704587|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
161704588|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
161704589|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
161704590|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
161704591|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
161837233|NCT00354341|584446582|FG000|Overall Study|Adverse Event|1|||
161704592|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
161704593|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
161704594|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704595|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704596|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704597|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704598|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704599|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704600|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704601|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704602|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704603|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704604|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704605|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704606|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704607|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704608|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704609|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704610|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
161704611|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704612|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704613|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704614|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704615|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704616|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704617|NCT00896532|583963820|FG000|Months 48-72: Follow-on Phase|Death|0|||
161704618|NCT00896532|583963821|FG001|Months 48-72: Follow-on Phase|Death|0|||
161704619|NCT00896532|583963822|FG002|Months 48-72: Follow-on Phase|Death|0|||
161704620|NCT00896532|583963823|FG003|Months 48-72: Follow-on Phase|Death|0|||
161704621|NCT00896532|583963824|FG004|Months 48-72: Follow-on Phase|Death|0|||
161704622|NCT00896532|583963825|FG005|Months 48-72: Follow-on Phase|Death|0|||
161704623|NCT00896532|583963826|FG006|Months 48-72: Follow-on Phase|Death|0|||
161704624|NCT00896532|583963827|FG007|Months 48-72: Follow-on Phase|Death|0|||
161704625|NCT00896532|583963828|FG008|Months 48-72: Follow-on Phase|Death|0|||
161704626|NCT00896532|583963829|FG009|Months 48-72: Follow-on Phase|Death|0|||
161704627|NCT00896532|583963830|FG010|Months 48-72: Follow-on Phase|Death|0|||
161704628|NCT00896532|583963831|FG011|Months 48-72: Follow-on Phase|Death|0|||
161704629|NCT00896532|583963832|FG012|Months 48-72: Follow-on Phase|Death|0|||
161704630|NCT00896532|583963833|FG013|Months 48-72: Follow-on Phase|Death|0|||
161704631|NCT00896532|583963834|FG014|Months 48-72: Follow-on Phase|Death|0|||
161704632|NCT00896532|583963835|FG015|Months 48-72: Follow-on Phase|Death|0|||
161704633|NCT00896532|583963836|FG016|Months 48-72: Follow-on Phase|Death|0|||
161704634|NCT00896532|583963837|FG017|Months 48-72: Follow-on Phase|Death|0|||
161704635|NCT00896532|583963838|FG018|Months 48-72: Follow-on Phase|Death|1|||
161704636|NCT00896532|583963839|FG019|Months 48-72: Follow-on Phase|Death|0|||
161704637|NCT00896532|583963840|FG020|Months 48-72: Follow-on Phase|Death|0|||
161704638|NCT00896532|583963841|FG021|Months 48-72: Follow-on Phase|Death|0|||
161704639|NCT00896532|583963842|FG022|Months 48-72: Follow-on Phase|Death|0|||
161704640|NCT00896532|583963820|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704641|NCT00896532|583963821|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704642|NCT00896532|583963822|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704643|NCT00896532|583963823|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704644|NCT00896532|583963824|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704645|NCT00896532|583963825|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704646|NCT00896532|583963826|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704647|NCT00896532|583963827|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704648|NCT00896532|583963828|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704649|NCT00896532|583963829|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704650|NCT00896532|583963830|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704651|NCT00896532|583963831|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704652|NCT00896532|583963832|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704653|NCT00896532|583963833|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704654|NCT00896532|583963834|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704655|NCT00896532|583963835|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704656|NCT00896532|583963836|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704657|NCT00896532|583963837|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704658|NCT00896532|583963838|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704659|NCT00896532|583963839|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704660|NCT00896532|583963840|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704661|NCT00896532|583963841|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
161704662|NCT00896532|583963842|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704663|NCT00896532|583963820|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704664|NCT00896532|583963821|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161655147|NCT03207451|583788827|FG002|Overall Study|Adverse Event|0|||
161655148|NCT03207451|583788828|FG003|Overall Study|Adverse Event|1|||
161655149|NCT03896152|583788829|FG000|Overall Study|Patient/guardian decision|1|||
161655150|NCT03896152|583788830|FG001|Overall Study|Patient/guardian decision|1|||
161655151|NCT03896152|583788829|FG000|Overall Study|Adverse Event|0|||
161655152|NCT03896152|583788830|FG001|Overall Study|Adverse Event|1|||
161655153|NCT03896152|583788829|FG000|Overall Study|Physician Decision|1|||
161655154|NCT03896152|583788830|FG001|Overall Study|Physician Decision|0|||
161655155|NCT03896152|583788829|FG000|Overall Study|Technical problems|1|||
161655156|NCT03896152|583788830|FG001|Overall Study|Technical problems|0|||
161655157|NCT00436852|583788831|FG000|Overall Study|Death|23|||
161655158|NCT00436852|583788832|FG001|Overall Study|Death|34|||
161655159|NCT00436852|583788831|FG000|Overall Study|Lack of Efficacy|9|||
161655160|NCT00436852|583788832|FG001|Overall Study|Lack of Efficacy|7|||
161655161|NCT00436852|583788831|FG000|Overall Study|Withdrawal by Subject|2|||
161655162|NCT00436852|583788832|FG001|Overall Study|Withdrawal by Subject|4|||
161655163|NCT00436852|583788831|FG000|Overall Study|Ineligible|1|||
161655164|NCT00436852|583788832|FG001|Overall Study|Ineligible|0|||
161655165|NCT00370682|583788833|FG000|Overall Study|Moved from area|0|||
161655166|NCT00370682|583788834|FG001|Overall Study|Moved from area|2|||
161655167|NCT00370682|583788835|FG002|Overall Study|Moved from area|0|||
161655168|NCT00370682|583788833|FG000|Overall Study|Lost to Follow-up|0|||
161655169|NCT00370682|583788834|FG001|Overall Study|Lost to Follow-up|1|||
161704665|NCT00896532|583963822|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161655170|NCT00370682|583788835|FG002|Overall Study|Lost to Follow-up|1|||
161655171|NCT03167359|583788836|FG000|Overall Study|Physician Decision|1|||
161704666|NCT00896532|583963823|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704667|NCT00896532|583963824|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704668|NCT00896532|583963825|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704669|NCT00896532|583963826|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704670|NCT00896532|583963827|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704671|NCT00896532|583963828|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704672|NCT00896532|583963829|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704673|NCT00896532|583963830|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704674|NCT00896532|583963831|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704675|NCT00896532|583963832|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704676|NCT00896532|583963833|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704677|NCT00896532|583963834|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704678|NCT00896532|583963835|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704679|NCT00896532|583963836|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704680|NCT00896532|583963837|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704681|NCT00896532|583963838|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704682|NCT00896532|583963839|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704683|NCT00896532|583963840|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704684|NCT00896532|583963841|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
161704685|NCT00896532|583963842|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704686|NCT01176916|583963843|FG000|Overall Study|Adverse Event|61|||
161704687|NCT01176916|583963843|FG000|Overall Study|Death|1|||
161704688|NCT01176916|583963843|FG000|Overall Study|Lost to Follow-up|15|||
161704689|NCT01176916|583963843|FG000|Overall Study|Objective progression or relapse|17|||
161704690|NCT01176916|583963843|FG000|Overall Study|Protocol Violation|24|||
161704691|NCT01176916|583963843|FG000|Overall Study|Withdrawal by Subject|37|||
161704692|NCT01176916|583963843|FG000|Overall Study|Other|6|||
161704693|NCT01176916|583963843|FG000|Overall Study|Withdrawal prior to Treatment|6|||
161704694|NCT03158220|583963846|FG000|Overall Study|Screen Failure|0|||
161704695|NCT03158220|583963847|FG001|Overall Study|Screen Failure|1|||
161704696|NCT03158220|583963846|FG000|Overall Study|Withdrawal by Subject|8|||
161704697|NCT03158220|583963847|FG001|Overall Study|Withdrawal by Subject|9|||
161704698|NCT03158220|583963846|FG000|Overall Study|Status unknown|0|||
161704699|NCT03158220|583963847|FG001|Overall Study|Status unknown|1|||
161704700|NCT03158220|583963846|FG000|Overall Study|Lost to Follow-up|8|||
161704701|NCT03158220|583963847|FG001|Overall Study|Lost to Follow-up|5|||
161704702|NCT03158220|583963846|FG000|Overall Study|Physician Decision|1|||
161704703|NCT03158220|583963847|FG001|Overall Study|Physician Decision|0|||
161704704|NCT01961115|583963860|FG000|Overall Study|Disease Progression|1|||
161704705|NCT01961115|583963861|FG001|Overall Study|Disease Progression|0|||
161704706|NCT01961115|583963862|FG002|Overall Study|Disease Progression|3|||
161704707|NCT01961115|583963860|FG000|Overall Study|Adverse Event|1|||
161704708|NCT01961115|583963861|FG001|Overall Study|Adverse Event|0|||
161704709|NCT01961115|583963862|FG002|Overall Study|Adverse Event|1|||
161704710|NCT03887130|583963866|FG000|Overall Study|Progressive disease|23|||
161704711|NCT03887130|583963867|FG001|Overall Study|Progressive disease|14|||
161704712|NCT03887130|583963868|FG002|Overall Study|Progressive disease|7|||
161704713|NCT03887130|583963866|FG000|Overall Study|Protocol Violation|3|||
161704714|NCT03887130|583963867|FG001|Overall Study|Protocol Violation|1|||
161704715|NCT03887130|583963868|FG002|Overall Study|Protocol Violation|2|||
161704716|NCT03887130|583963866|FG000|Overall Study|Drug related toxicity|7|||
161704717|NCT03887130|583963867|FG001|Overall Study|Drug related toxicity|7|||
161704718|NCT03887130|583963868|FG002|Overall Study|Drug related toxicity|13|||
161704719|NCT03887130|583963866|FG000|Overall Study|Non drug related toxicity|3|||
161704720|NCT03887130|583963867|FG001|Overall Study|Non drug related toxicity|0|||
161704721|NCT03887130|583963868|FG002|Overall Study|Non drug related toxicity|0|||
161704722|NCT03887130|583963866|FG000|Overall Study|Death|2|||
161704723|NCT03887130|583963867|FG001|Overall Study|Death|2|||
161704724|NCT03887130|583963868|FG002|Overall Study|Death|1|||
161704725|NCT03887130|583963866|FG000|Overall Study|Withdrawal by Subject|7|||
161704726|NCT03887130|583963867|FG001|Overall Study|Withdrawal by Subject|6|||
161704727|NCT03887130|583963868|FG002|Overall Study|Withdrawal by Subject|11|||
161704728|NCT03887130|583963866|FG000|Overall Study|other reason|6|||
161704729|NCT03887130|583963867|FG001|Overall Study|other reason|20|||
161704730|NCT03887130|583963868|FG002|Overall Study|other reason|17|||
161704731|NCT01439945|583963869|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161704732|NCT01439945|583963870|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161704733|NCT01439945|583963871|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161704734|NCT01439945|583963872|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161704735|NCT01439945|583963869|FG000|Double-Blind Treatment Phase|Ineligible|1|||
161704736|NCT01439945|583963870|FG001|Double-Blind Treatment Phase|Ineligible|2|||
161704737|NCT01439945|583963871|FG002|Double-Blind Treatment Phase|Ineligible|0|||
161704738|NCT01439945|583963872|FG003|Double-Blind Treatment Phase|Ineligible|1|||
161704739|NCT04082663|583963873|FG000|Overall Study|Adverse Event|6|||
161704740|NCT04082663|583963873|FG000|Overall Study|Lost to Follow-up|1|||
161704741|NCT00705263|583963876|FG000|Overall Study|Withdrawal by Subject|2|||
161704742|NCT01752023|583963877|FG000|Overall Study|Physician Decision|2|||
161704743|NCT01752023|583963878|FG001|Overall Study|Physician Decision|1|||
161704744|NCT02542072|583963879|FG000|First Intervention (1 Month)|Adverse Event|1|||
161704745|NCT02542072|583963880|FG001|First Intervention (1 Month)|Adverse Event|1|||
161704746|NCT02542072|583963879|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
161704747|NCT02542072|583963880|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
161704748|NCT02542072|583963879|FG000|First Intervention (1 Month)|Lens discomfort|1|||
161704749|NCT02542072|583963880|FG001|First Intervention (1 Month)|Lens discomfort|2|||
161704750|NCT02542072|583963879|FG000|First Intervention (1 Month)|Protocol Violation|1|||
161704751|NCT02542072|583963880|FG001|First Intervention (1 Month)|Protocol Violation|0|||
161704752|NCT02542072|583963879|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
161704753|NCT02542072|583963880|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
161704754|NCT02542072|583963879|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
161704755|NCT02542072|583963880|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
161704756|NCT02899156|583963881|FG000|Overall Study|Death|1|||
161704757|NCT02899156|583963882|FG001|Overall Study|Death|0|||
161704758|NCT02899156|583963881|FG000|Overall Study|Physician Decision|0|||
161704759|NCT02899156|583963882|FG001|Overall Study|Physician Decision|1|||
161704760|NCT00654498|583963883|FG000|Overall Study|Not Treated|1|||
161704761|NCT00654498|583963884|FG001|Overall Study|Not Treated|0|||
161704762|NCT00654498|583963883|FG000|Overall Study|Adverse Event|6|||
161704763|NCT00654498|583963884|FG001|Overall Study|Adverse Event|1|||
161704764|NCT00654498|583963883|FG000|Overall Study|Protocol Violation|1|||
161704765|NCT00654498|583963884|FG001|Overall Study|Protocol Violation|1|||
161704766|NCT00654498|583963883|FG000|Overall Study|Lost to Follow-up|1|||
161704767|NCT00654498|583963884|FG001|Overall Study|Lost to Follow-up|5|||
161704768|NCT00654498|583963883|FG000|Overall Study|Withdrawal by Subject|1|||
161704769|NCT00654498|583963884|FG001|Overall Study|Withdrawal by Subject|0|||
161704770|NCT00654498|583963883|FG000|Overall Study|Other reason not defined above|4|||
161704771|NCT00654498|583963884|FG001|Overall Study|Other reason not defined above|5|||
161704772|NCT01990261|583963886|FG000|Overall Study|Death Before Treatment Start|2|||
161704773|NCT01990261|583963886|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
161704774|NCT01990261|583963886|FG000|Overall Study|Death From other Causes|1|||
161704775|NCT01990261|583963886|FG000|Overall Study|Disease Progression (PD)|8|||
161704776|NCT01990261|583963886|FG000|Overall Study|PD Before Treatment Start|1|||
161704777|NCT01990261|583963886|FG000|Overall Study|Dossier not Approved|1|||
161704778|NCT01990261|583963886|FG000|Overall Study|Lost to Follow-up|2|||
161704779|NCT01078805|583963889|FG000|Overall Study|Clinically significant abnormal lab|5|||
161704780|NCT01078805|583963889|FG000|Overall Study|Death|134|||
161704781|NCT01078805|583963889|FG000|Overall Study|Lost to Follow-up|676|||
161704782|NCT01078805|583963889|FG000|Overall Study|Physician Decision|169|||
161704783|NCT01078805|583963889|FG000|Overall Study|Serious adverse event|26|||
161704784|NCT01078805|583963889|FG000|Overall Study|Sponsor decision|46|||
161704785|NCT01078805|583963889|FG000|Overall Study|Withdrawal by Subject|739|||
161704786|NCT01078805|583963889|FG000|Overall Study|Other|173|||
161704787|NCT01078805|583963889|FG000|Overall Study|Didn't take study drug|82|||
161704788|NCT01609842|583963890|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
161704789|NCT01609842|583963891|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
161837234|NCT00354341|584446583|FG001|Overall Study|Adverse Event|0|||
161837235|NCT00354341|584446582|FG000|Overall Study|Death|0|||
161704790|NCT04722991|583963892|FG000|Overall Study|Adverse Event|12|||
161704791|NCT04722991|583963893|FG001|Overall Study|Adverse Event|4|||
161704792|NCT04722991|583963892|FG000|Overall Study|Death|2|||
161704793|NCT04722991|583963893|FG001|Overall Study|Death|0|||
161704794|NCT04722991|583963892|FG000|Overall Study|Lost to Follow-up|1|||
161704795|NCT04722991|583963893|FG001|Overall Study|Lost to Follow-up|1|||
161704796|NCT04722991|583963892|FG000|Overall Study|Withdrawal cirterion met|2|||
161704797|NCT04722991|583963893|FG001|Overall Study|Withdrawal cirterion met|2|||
161704798|NCT04722991|583963892|FG000|Overall Study|Other|1|||
161704799|NCT04722991|583963893|FG001|Overall Study|Other|0|||
161704800|NCT04722991|583963892|FG000|Overall Study|Non-compliance|0|||
161655172|NCT03167359|583788836|FG000|Overall Study|Lost to Follow-up|1|||
161655173|NCT03339583|583788837|FG000|First Intervention (14 Days)|Adverse Event|1|||
161655174|NCT03339583|583788838|FG001|First Intervention (14 Days)|Adverse Event|0|||
161655175|NCT03339583|583788837|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
161655176|NCT03339583|583788838|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
161655177|NCT03339583|583788837|FG000|Second Intervention (14 Days)|Adverse Event|0|||
161655178|NCT03339583|583788838|FG001|Second Intervention (14 Days)|Adverse Event|1|||
161655179|NCT03339583|583788837|FG000|Follow-up (14 Days)|Physician Decision|6|||
161655180|NCT03339583|583788838|FG001|Follow-up (14 Days)|Physician Decision|3|||
161655181|NCT02141620|583788839|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
161655182|NCT02141620|583788840|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
161655183|NCT03651622|583788841|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
161655184|NCT03651622|583788842|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
161655185|NCT03651622|583788843|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
161655186|NCT03651622|583788841|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
161655187|NCT03651622|583788842|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
161655188|NCT03651622|583788843|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
161655189|NCT03651622|583788841|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
161655190|NCT03651622|583788842|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
161655191|NCT03651622|583788843|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
161655192|NCT03651622|583788841|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
161655193|NCT03651622|583788842|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
161655194|NCT03651622|583788843|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
161655195|NCT03651622|583788841|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
161655196|NCT03651622|583788842|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
161655197|NCT03651622|583788843|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
161655198|NCT01519089|583788844|FG000|Overall Study|Adverse Event|4|||
161655199|NCT01519089|583788845|FG001|Overall Study|Adverse Event|4|||
161655200|NCT01519089|583788844|FG000|Overall Study|Lack of Efficacy|0|||
161655201|NCT01519089|583788845|FG001|Overall Study|Lack of Efficacy|2|||
161655202|NCT01519089|583788844|FG000|Overall Study|Lost to Follow-up|1|||
161655203|NCT01519089|583788845|FG001|Overall Study|Lost to Follow-up|0|||
161655204|NCT01519089|583788844|FG000|Overall Study|Withdrawal by Subject|0|||
161655205|NCT01519089|583788845|FG001|Overall Study|Withdrawal by Subject|2|||
161655206|NCT01519089|583788844|FG000|Overall Study|Other|2|||
161655207|NCT01519089|583788845|FG001|Overall Study|Other|6|||
161655208|NCT01519089|583788844|FG000|Overall Study|Not received study drug|0|||
161655209|NCT01519089|583788845|FG001|Overall Study|Not received study drug|1|||
161655210|NCT00307684|583788846|FG000|Open Label Phase|Lack of Efficacy|0|||
161655211|NCT00307684|583788847|FG001|Open Label Phase|Lack of Efficacy|0|||
161655212|NCT00307684|583788848|FG002|Open Label Phase|Lack of Efficacy|3|||
161655213|NCT00307684|583788846|FG000|Open Label Phase|Adverse Event|0|||
161655214|NCT00307684|583788847|FG001|Open Label Phase|Adverse Event|0|||
161655215|NCT00307684|583788848|FG002|Open Label Phase|Adverse Event|16|||
161655216|NCT00307684|583788846|FG000|Open Label Phase|Withdrawal by Subject|0|||
161655217|NCT00307684|583788847|FG001|Open Label Phase|Withdrawal by Subject|0|||
161655218|NCT00307684|583788848|FG002|Open Label Phase|Withdrawal by Subject|15|||
161655219|NCT00307684|583788846|FG000|Open Label Phase|Lost to Follow-up|0|||
161655220|NCT00307684|583788847|FG001|Open Label Phase|Lost to Follow-up|0|||
161655221|NCT00307684|583788848|FG002|Open Label Phase|Lost to Follow-up|11|||
161655222|NCT00307684|583788846|FG000|Open Label Phase|non compliance|0|||
161655223|NCT00307684|583788847|FG001|Open Label Phase|non compliance|0|||
161655224|NCT00307684|583788848|FG002|Open Label Phase|non compliance|5|||
161655225|NCT00307684|583788846|FG000|Open Label Phase|other|0|||
161655226|NCT00307684|583788847|FG001|Open Label Phase|other|0|||
161655227|NCT00307684|583788848|FG002|Open Label Phase|other|6|||
161655228|NCT00307684|583788846|FG000|Double Blind Phase|Lack of Efficacy|2|||
161655229|NCT00307684|583788847|FG001|Double Blind Phase|Lack of Efficacy|5|||
161655230|NCT00307684|583788848|FG002|Double Blind Phase|Lack of Efficacy|0|||
161655231|NCT00224887|583788849|FG000|Overall Study|Pregnancy|6|||
161655232|NCT00224887|583788850|FG001|Overall Study|Pregnancy|6|||
161655233|NCT00730275|583788851|FG000|Overall Study|Withdrawal by Subject|0|||
161655234|NCT00730275|583788852|FG001|Overall Study|Withdrawal by Subject|0|||
161655235|NCT00730275|583788853|FG002|Overall Study|Withdrawal by Subject|0|||
161655236|NCT00730275|583788854|FG003|Overall Study|Withdrawal by Subject|1|||
161655237|NCT00356408|583788855|FG000|Overall Study|Adverse Event|9|||
161655238|NCT00356408|583788855|FG000|Overall Study|Lack of Efficacy|36|||
161655239|NCT00356408|583788855|FG000|Overall Study|Lost to Follow-up|2|||
161655240|NCT00356408|583788855|FG000|Overall Study|Withdrawal by Subject|6|||
161655241|NCT00356408|583788855|FG000|Overall Study|Other: Principal investigator discretion|3|||
161655242|NCT00356408|583788855|FG000|Overall Study|Other: Sponsor request|1|||
161655243|NCT00356408|583788855|FG000|Overall Study|Other: Azathioprine stopped|1|||
161655244|NCT00356408|583788855|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
161655245|NCT00356408|583788855|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
161655246|NCT05487586|583788860|FG000|Overall Study|Death|22|||
161655247|NCT05487586|583788860|FG000|Overall Study|Physician Decision|1|||
161655248|NCT05487586|583788860|FG000|Overall Study|Transfer to another hospital|4|||
161655249|NCT05487586|583788860|FG000|Overall Study|Other|1|||
161655250|NCT03921723|583788861|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
161655251|NCT03921723|583788861|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
161655252|NCT03046121|583788863|FG000|Overall Study|Death|32|||
161655253|NCT03046121|583788864|FG001|Overall Study|Death|60|||
161655254|NCT03046121|583788863|FG000|Overall Study|Withdrawal by Subject|14|||
161655255|NCT03046121|583788864|FG001|Overall Study|Withdrawal by Subject|12|||
161655256|NCT03214640|583788865|FG000|Overall Study|Protocol Violation|1|||
161655257|NCT03214640|583788866|FG001|Overall Study|Protocol Violation|2|||
161655258|NCT03214640|583788867|FG002|Overall Study|Protocol Violation|1|||
161655259|NCT03214640|583788868|FG003|Overall Study|Protocol Violation|4|||
161655260|NCT00406692|583788876|FG000|Overall Study|Withdrawal by Subject|4|||
161655261|NCT00406692|583788876|FG000|Overall Study|Physician Decision|1|||
161655262|NCT00406692|583788876|FG000|Overall Study|Adverse Event|1|||
161655263|NCT00406692|583788876|FG000|Overall Study|Lack of Efficacy|1|||
161655264|NCT04488770|583788877|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655265|NCT04488770|583788878|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655266|NCT04488770|583788879|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655267|NCT04488770|583788880|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
161655268|NCT04488770|583788881|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655269|NCT04488770|583788882|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655270|NCT04488770|583788883|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655271|NCT04488770|583788884|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655272|NCT04488770|583788885|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655273|NCT04488770|583788886|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655274|NCT04488770|583788887|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655275|NCT04488770|583788888|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655276|NCT04488770|583788889|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161655277|NCT04488770|583788877|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
161655278|NCT04488770|583788878|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655279|NCT04488770|583788879|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655280|NCT04488770|583788880|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655281|NCT04488770|583788881|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655282|NCT04488770|583788882|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655283|NCT04488770|583788883|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161704801|NCT04722991|583963893|FG001|Overall Study|Non-compliance|1|||
161704802|NCT04722991|583963892|FG000|Overall Study|Withdrawal by Subject|0|||
161704803|NCT04722991|583963893|FG001|Overall Study|Withdrawal by Subject|1|||
161704804|NCT03186989|583963894|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704805|NCT03186989|583963895|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704806|NCT03186989|583963896|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161704807|NCT03186989|583963897|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161704808|NCT03186989|583963898|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161704809|NCT03186989|583963899|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704810|NCT03186989|583963900|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704811|NCT03186989|583963901|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704812|NCT03186989|583963902|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704813|NCT03186989|583963903|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704814|NCT03186989|583963904|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704815|NCT03186989|583963894|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704816|NCT03186989|583963895|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704817|NCT03186989|583963896|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704818|NCT03186989|583963897|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704819|NCT03186989|583963898|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704820|NCT03186989|583963899|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
161704821|NCT03186989|583963900|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704822|NCT03186989|583963901|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704823|NCT03186989|583963902|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704824|NCT03186989|583963903|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161837236|NCT00354341|584446583|FG001|Overall Study|Death|2|||
161837237|NCT00354341|584446582|FG000|Overall Study|Refused treatment|1|||
161837238|NCT00354341|584446583|FG001|Overall Study|Refused treatment|2|||
161837239|NCT00354341|584446582|FG000|Overall Study|Failure to return|0|||
161837240|NCT00354341|584446583|FG001|Overall Study|Failure to return|1|||
161837241|NCT00354341|584446582|FG000|Overall Study|Other|1|||
161837242|NCT00354341|584446583|FG001|Overall Study|Other|2|||
161837243|NCT00251719|584446584|FG000|Overall Study|Adverse Event|14|||
161837244|NCT00251719|584446585|FG001|Overall Study|Adverse Event|8|||
161837245|NCT00251719|584446586|FG002|Overall Study|Adverse Event|7|||
161837246|NCT00251719|584446584|FG000|Overall Study|Protocol Violation|1|||
161837247|NCT00251719|584446585|FG001|Overall Study|Protocol Violation|1|||
161837248|NCT00251719|584446586|FG002|Overall Study|Protocol Violation|1|||
161837249|NCT00251719|584446584|FG000|Overall Study|Lost to Follow-up|5|||
161837250|NCT00251719|584446585|FG001|Overall Study|Lost to Follow-up|11|||
161837251|NCT00251719|584446586|FG002|Overall Study|Lost to Follow-up|8|||
161837252|NCT00251719|584446584|FG000|Overall Study|Withdrawal by Subject|14|||
161837253|NCT00251719|584446585|FG001|Overall Study|Withdrawal by Subject|12|||
161837254|NCT00251719|584446586|FG002|Overall Study|Withdrawal by Subject|11|||
161837255|NCT00251719|584446584|FG000|Overall Study|Lack of Efficacy|2|||
161837256|NCT00251719|584446585|FG001|Overall Study|Lack of Efficacy|1|||
161837257|NCT00251719|584446586|FG002|Overall Study|Lack of Efficacy|0|||
161837258|NCT00251719|584446584|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
161837259|NCT00251719|584446585|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
161837260|NCT00251719|584446586|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
161837261|NCT00251719|584446584|FG000|Overall Study|Investigator decision|1|||
161837262|NCT00251719|584446585|FG001|Overall Study|Investigator decision|1|||
161837263|NCT00251719|584446586|FG002|Overall Study|Investigator decision|0|||
161837264|NCT00251719|584446584|FG000|Overall Study|Noncompliance|2|||
161837265|NCT00251719|584446585|FG001|Overall Study|Noncompliance|3|||
161837266|NCT00251719|584446586|FG002|Overall Study|Noncompliance|1|||
161837267|NCT00251719|584446584|FG000|Overall Study|Barrett's esophagus|2|||
161837268|NCT00251719|584446585|FG001|Overall Study|Barrett's esophagus|2|||
161837269|NCT00251719|584446586|FG002|Overall Study|Barrett's esophagus|0|||
161837270|NCT01449279|584446587|FG000|Overall Study|Lack of Efficacy|5|||
161837271|NCT01449279|584446587|FG000|Overall Study|Toxicity|2|||
161837272|NCT01732874|584446589|FG000|Overall Study|Withdrawal by Subject|5|||
161837273|NCT01732874|584446590|FG001|Overall Study|Withdrawal by Subject|1|||
161837274|NCT01732874|584446589|FG000|Overall Study|Death of Infant|3|||
161837275|NCT01732874|584446590|FG001|Overall Study|Death of Infant|2|||
161837276|NCT02792959|584446591|FG000|Overall Study|Protocol Violation|1|||
161837277|NCT01249365|584446592|FG000|Overall Study|Lost to Follow-up|1|||
161837278|NCT03579966|584446593|FG000|Overall Study|Adverse Event|6|||
161837279|NCT03579966|584446593|FG000|Overall Study|Lost to Follow-up|4|||
161837280|NCT03579966|584446593|FG000|Overall Study|Physician Decision|10|||
161837281|NCT03579966|584446593|FG000|Overall Study|Pregnancy|1|||
161837282|NCT03579966|584446593|FG000|Overall Study|Withdrawal by Subject|16|||
161837283|NCT03579966|584446593|FG000|Overall Study|Study terminated by Sponsor|22|||
161837284|NCT03579966|584446593|FG000|Overall Study|Protocol Violation|1|||
161704825|NCT03186989|583963904|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704826|NCT03186989|583963894|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704827|NCT03186989|583963895|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704828|NCT03186989|583963896|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704829|NCT03186989|583963897|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704830|NCT03186989|583963898|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704831|NCT03186989|583963899|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704832|NCT03186989|583963900|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
161704833|NCT03186989|583963901|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704834|NCT03186989|583963902|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704835|NCT03186989|583963903|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704836|NCT03186989|583963904|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704837|NCT03186989|583963894|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704838|NCT03186989|583963895|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704839|NCT03186989|583963896|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704840|NCT03186989|583963897|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704841|NCT03186989|583963898|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704842|NCT03186989|583963899|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161704843|NCT03186989|583963900|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161704844|NCT03186989|583963901|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704845|NCT03186989|583963902|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161704846|NCT03186989|583963903|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704847|NCT03186989|583963904|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704848|NCT02246621|583963908|FG000|Overall Study|Withdrawal by Subject|28|||
161704849|NCT02246621|583963909|FG001|Overall Study|Withdrawal by Subject|16|||
161704850|NCT02246621|583963908|FG000|Overall Study|Lost to Follow-up|1|||
161704851|NCT02246621|583963909|FG001|Overall Study|Lost to Follow-up|0|||
161704852|NCT02246621|583963908|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
161704853|NCT02246621|583963909|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
161704854|NCT00821678|583963910|FG000|Overall Study|Withdrawal by Subject|8|||
161704855|NCT00821678|583963911|FG001|Overall Study|Withdrawal by Subject|0|||
161704856|NCT00821678|583963910|FG000|Overall Study|Lost to Follow-up|13|||
161704857|NCT00821678|583963911|FG001|Overall Study|Lost to Follow-up|12|||
161704858|NCT00821678|583963910|FG000|Overall Study|Death|0|||
161704859|NCT00821678|583963911|FG001|Overall Study|Death|2|||
161704860|NCT03641560|583963917|FG000|Overall Study|Withdrawal by Subject|6|||
161704861|NCT03641560|583963917|FG000|Overall Study|Progressive disease|40|||
161704862|NCT03641560|583963917|FG000|Overall Study|Death|6|||
161704863|NCT04439279|583965836|FG000|Overall Study|Adverse Event|7|||
161837285|NCT02408068|584446594|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837286|NCT02408068|584446595|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837287|NCT02408068|584446596|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
161704864|NCT04439279|583965836|FG000|Overall Study|Death|4|||
161704865|NCT04439279|583965836|FG000|Overall Study|Disease progression|17|||
161704866|NCT04439279|583965836|FG000|Overall Study|Complicating disease|3|||
161704867|NCT04439279|583965836|FG000|Overall Study|Withdrawal by Subject|2|||
161704868|NCT04439279|583965836|FG000|Overall Study|Ineligible|1|||
161704869|NCT04439279|583965836|FG000|Overall Study|Treatment still ongoing|1|||
161704870|NCT02689492|583965837|FG000|Overall Study|Lost to Follow-up|61|||
161704871|NCT02689492|583965837|FG000|Overall Study|Withdrawal by Subject|11|||
161704872|NCT02689492|583965837|FG000|Overall Study|Death|9|||
161704873|NCT02689492|583965837|FG000|Overall Study|Physician Decision|2|||
161837288|NCT02408068|584446597|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837289|NCT02408068|584446598|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837290|NCT02408068|584446599|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837291|NCT03484117|584446600|FG000|Overall Study|Lost to Follow-up|1|||
161837292|NCT03484117|584446601|FG001|Overall Study|Lost to Follow-up|3|||
161837293|NCT03484117|584446600|FG000|Overall Study|Declined participation in exit assess|1|||
161704874|NCT02689492|583965837|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
161704875|NCT02689492|583965837|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
161704876|NCT02689492|583965837|FG000|Overall Study|Other than listed|1|||
161704877|NCT01750918|583965838|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
161704878|NCT01750918|583965839|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
161704879|NCT01750918|583965840|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
161704880|NCT01750918|583965841|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
161704881|NCT01750918|583965842|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
161837294|NCT03484117|584446601|FG001|Overall Study|Declined participation in exit assess|1|||
161704882|NCT01750918|583965843|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
161704883|NCT01750918|583965844|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
161704884|NCT01750918|583965845|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
161704885|NCT01750918|583965838|FG000|Overall Study|Lost to Follow-up|0|||
161704886|NCT01750918|583965839|FG001|Overall Study|Lost to Follow-up|0|||
161704887|NCT01750918|583965840|FG002|Overall Study|Lost to Follow-up|2|||
161704888|NCT01750918|583965841|FG003|Overall Study|Lost to Follow-up|2|||
161704889|NCT01750918|583965842|FG004|Overall Study|Lost to Follow-up|0|||
161704890|NCT01750918|583965843|FG005|Overall Study|Lost to Follow-up|0|||
161704891|NCT01750918|583965844|FG006|Overall Study|Lost to Follow-up|0|||
161704892|NCT01750918|583965845|FG007|Overall Study|Lost to Follow-up|1|||
161704893|NCT01750918|583965838|FG000|Overall Study|Withdrawal by Subject|0|||
161704894|NCT01750918|583965839|FG001|Overall Study|Withdrawal by Subject|0|||
161704895|NCT01750918|583965840|FG002|Overall Study|Withdrawal by Subject|1|||
161704896|NCT01750918|583965841|FG003|Overall Study|Withdrawal by Subject|2|||
161704897|NCT01750918|583965842|FG004|Overall Study|Withdrawal by Subject|1|||
161704898|NCT01750918|583965843|FG005|Overall Study|Withdrawal by Subject|1|||
161704899|NCT01750918|583965844|FG006|Overall Study|Withdrawal by Subject|2|||
161704900|NCT01750918|583965845|FG007|Overall Study|Withdrawal by Subject|2|||
161704901|NCT02031679|583965848|FG000|Overall Study|Protocol Violation|0|||
161704902|NCT02031679|583965849|FG001|Overall Study|Protocol Violation|1|||
161837295|NCT03551496|584446605|FG000|Overall Study|Death|11|||
161837296|NCT03551496|584446606|FG001|Overall Study|Death|7|||
161837297|NCT03551496|584446605|FG000|Overall Study|Withdrawal by Subject|4|||
161837298|NCT03551496|584446606|FG001|Overall Study|Withdrawal by Subject|3|||
161837299|NCT03551496|584446605|FG000|Overall Study|Other Reasons|1|||
161837300|NCT03551496|584446606|FG001|Overall Study|Other Reasons|0|||
161837301|NCT02303041|584446609|FG000|Overall Study|Adverse Event|1|||
161837302|NCT02303041|584446610|FG001|Overall Study|Adverse Event|2|||
161837303|NCT00886288|584446611|FG000|Overall Study|no respect of the 12 weeks period|657|||
161837304|NCT00886288|584446612|FG001|Overall Study|no respect of the 12 weeks period|227|||
161837305|NCT00886288|584446611|FG000|Overall Study|Lost to Follow-up|86|||
161837306|NCT00886288|584446612|FG001|Overall Study|Lost to Follow-up|0|||
161837307|NCT04319718|584448506|FG000|Overall Study|Adverse Event|0|||
161837308|NCT04319718|584448507|FG001|Overall Study|Adverse Event|2|||
161837309|NCT04319718|584448506|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
161837310|NCT04319718|584448507|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
161837311|NCT02221037|584448508|FG000|Overall Study|Physician Decision|0|||
161837312|NCT02221037|584448509|FG001|Overall Study|Physician Decision|0|||
161837313|NCT02221037|584448510|FG002|Overall Study|Physician Decision|1|||
161837314|NCT02221037|584448511|FG003|Overall Study|Physician Decision|0|||
161837315|NCT01293539|584448514|FG000|Overall Study|Physician Decision|1|||
161837316|NCT00609518|584448516|FG000|Overall Study|Death from Study Disease|32|||
161837317|NCT00609518|584448517|FG001|Overall Study|Death from Study Disease|32|||
161837318|NCT00609518|584448516|FG000|Overall Study|Withdrawal by Subject|5|||
161837319|NCT00609518|584448517|FG001|Overall Study|Withdrawal by Subject|3|||
161837320|NCT00609518|584448516|FG000|Overall Study|Lost to Follow-up|3|||
161837321|NCT00609518|584448517|FG001|Overall Study|Lost to Follow-up|0|||
161837322|NCT00609518|584448516|FG000|Overall Study|Physician Decision|1|||
161837323|NCT00609518|584448517|FG001|Overall Study|Physician Decision|3|||
161837324|NCT00609518|584448516|FG000|Overall Study|Death from Adverse Event|2|||
161837325|NCT00609518|584448517|FG001|Overall Study|Death from Adverse Event|2|||
161837326|NCT04032158|584448518|FG000|Overall Study|Study Termination|2|||
161837327|NCT04032158|584448519|FG001|Overall Study|Study Termination|1|||
161837328|NCT00059787|584448520|FG000|Overall Study|Adverse Event|13|||
161837329|NCT00059787|584448520|FG000|Overall Study|disease progression|2|||
161837330|NCT00059787|584448520|FG000|Overall Study|ineligible|1|||
161837331|NCT00059787|584448520|FG000|Overall Study|Other|4|||
161837332|NCT01248013|584448523|FG000|Overall Study|Withdrawal by Subject|14|||
161837333|NCT04325204|584448526|FG000|Overall Study|Death|0|||
161837334|NCT04325204|584448527|FG001|Overall Study|Death|1|||
161837335|NCT04325204|584448526|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
161837336|NCT04325204|584448527|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
161837337|NCT04325204|584448526|FG000|Overall Study|Lost to Follow-up|8|||
161837338|NCT04325204|584448527|FG001|Overall Study|Lost to Follow-up|8|||
161704903|NCT02031679|583965848|FG000|Overall Study|Lack of Efficacy|0|||
161704904|NCT02031679|583965849|FG001|Overall Study|Lack of Efficacy|1|||
161704905|NCT02338843|583965853|FG000|Overall Study|Adverse Event|2|||
161837339|NCT04325204|584448526|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
161837340|NCT04325204|584448527|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
161704906|NCT02338843|583965854|FG001|Overall Study|Adverse Event|1|||
161704907|NCT02338843|583965853|FG000|Overall Study|Death|40|||
161704908|NCT02338843|583965854|FG001|Overall Study|Death|53|||
161704909|NCT02338843|583965853|FG000|Overall Study|Physician Decision|1|||
161704910|NCT02338843|583965854|FG001|Overall Study|Physician Decision|0|||
161704911|NCT02338843|583965853|FG000|Overall Study|Withdrawal by Subject|0|||
161704912|NCT02338843|583965854|FG001|Overall Study|Withdrawal by Subject|2|||
161704913|NCT02338843|583965853|FG000|Overall Study|Subject Recovered|0|||
161704914|NCT02338843|583965854|FG001|Overall Study|Subject Recovered|2|||
161704915|NCT02338843|583965853|FG000|Overall Study|Discontinued prior to randomizat|1|||
161704916|NCT02338843|583965854|FG001|Overall Study|Discontinued prior to randomizat|0|||
161704917|NCT00110305|583965855|FG000|Overall Study|Adverse Event|46|||
161704918|NCT00110305|583965856|FG001|Overall Study|Adverse Event|13|||
161704919|NCT00110305|583965855|FG000|Overall Study|Sponsors Decision|1|||
161704920|NCT00110305|583965856|FG001|Overall Study|Sponsors Decision|0|||
161704921|NCT00110305|583965855|FG000|Overall Study|Subject Non-Compliant|9|||
161704922|NCT00110305|583965856|FG001|Overall Study|Subject Non-Compliant|2|||
161704923|NCT00110305|583965855|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161704924|NCT00110305|583965856|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
161704925|NCT00110305|583965855|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
161704926|NCT00110305|583965856|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
161704927|NCT00110305|583965855|FG000|Overall Study|Protocol Violation|0|||
161704928|NCT00110305|583965856|FG001|Overall Study|Protocol Violation|1|||
161704929|NCT00110305|583965855|FG000|Overall Study|Withdrawal by Subject|7|||
161704930|NCT00110305|583965856|FG001|Overall Study|Withdrawal by Subject|7|||
161704931|NCT00110305|583965855|FG000|Overall Study|Lost to Follow-up|20|||
161704932|NCT00110305|583965856|FG001|Overall Study|Lost to Follow-up|3|||
161704933|NCT00110305|583965855|FG000|Overall Study|Other|8|||
161704934|NCT00110305|583965856|FG001|Overall Study|Other|2|||
161704935|NCT00224016|583965860|FG000|Titration Period|Withdrawal by Subject|0|||
161704936|NCT00224016|583965861|FG001|Titration Period|Withdrawal by Subject|1|||
161704937|NCT00224016|583965860|FG000|Titration Period|Lost to Follow-up|1|||
161704938|NCT00224016|583965861|FG001|Titration Period|Lost to Follow-up|0|||
161704939|NCT00224016|583965860|FG000|Maintenance Period|Withdrawal by Subject|2|||
161704940|NCT00224016|583965861|FG001|Maintenance Period|Withdrawal by Subject|0|||
161704941|NCT00224016|583965860|FG000|Maintenance Period|Lost to Follow-up|0|||
161704942|NCT00224016|583965861|FG001|Maintenance Period|Lost to Follow-up|1|||
161704943|NCT01609933|583965862|FG000|Overall Study|Adverse Event|1|||
161704944|NCT01609933|583965862|FG000|Overall Study|Withdrawal by Subject|3|||
161704945|NCT01252966|583965863|FG000|Overall Study|Lost to Follow-up|16|||
161704946|NCT01252966|583965864|FG001|Overall Study|Lost to Follow-up|10|||
161704947|NCT01252966|583965863|FG000|Overall Study|Withdrawal by Subject|7|||
161704948|NCT01252966|583965864|FG001|Overall Study|Withdrawal by Subject|3|||
161704949|NCT00522392|583965888|FG000|Overall Study|Disease progression|0|||
161704950|NCT00522392|583965889|FG001|Overall Study|Disease progression|3|||
161704951|NCT00522392|583965888|FG000|Overall Study|Adverse Event|7|||
161704952|NCT00522392|583965889|FG001|Overall Study|Adverse Event|7|||
161704953|NCT00522392|583965888|FG000|Overall Study|Withdrawal by Subject|1|||
161704954|NCT00522392|583965889|FG001|Overall Study|Withdrawal by Subject|1|||
161704955|NCT00522392|583965888|FG000|Overall Study|Physician Decision|0|||
161837341|NCT00841906|584448528|FG000|Overall Study|Withdrawal by Subject|2|||
161837342|NCT00841906|584448529|FG001|Overall Study|Withdrawal by Subject|0|||
161837343|NCT04710979|584448532|FG000|Overall Study|Lost to Follow-up|2|||
161837344|NCT04710979|584448533|FG001|Overall Study|Lost to Follow-up|4|||
161837345|NCT04710979|584448532|FG000|Overall Study|Withdrawal by Subject|1|||
161837346|NCT04710979|584448533|FG001|Overall Study|Withdrawal by Subject|0|||
161837347|NCT04397445|584448541|FG000|Overall Study|Withdrawal by Subject|1|||
161837348|NCT04397445|584448542|FG001|Overall Study|Withdrawal by Subject|0|||
161837349|NCT04397445|584448543|FG002|Overall Study|Withdrawal by Subject|0|||
161837350|NCT04397445|584448544|FG003|Overall Study|Withdrawal by Subject|0|||
161837351|NCT00891371|584448545|FG000|Pre-assignment|Inclusion/exclusion|5|||
161837352|NCT00891371|584448545|FG000|Pre-assignment|Consent withdrawal|1|||
161837353|NCT00891371|584448545|FG000|Treatment|Lack of Efficacy|5|||
161837354|NCT00891371|584448545|FG000|Treatment|Adverse Event|2|||
161837355|NCT00891371|584448545|FG000|Treatment|Death|1|||
161837356|NCT00891371|584448545|FG000|Treatment|Lost to Follow-up|1|||
161837357|NCT00307034|584448546|FG000|Overall Study|Adverse Event|1|||
161837358|NCT00307034|584448547|FG001|Overall Study|Adverse Event|2|||
161704956|NCT00522392|583965889|FG001|Overall Study|Physician Decision|1|||
161704957|NCT00522392|583965888|FG000|Overall Study|Non-compliance|0|||
161704958|NCT00522392|583965889|FG001|Overall Study|Non-compliance|1|||
161704959|NCT00430755|583965892|FG000|Overall Study|Withdrawal by Subject|53|||
161704960|NCT01154101|583965893|FG000|Overall Study|Adverse Event|0|||
161704961|NCT01154101|583965894|FG001|Overall Study|Adverse Event|2|||
161837359|NCT00307034|584448546|FG000|Overall Study|Withdrawal by Subject|1|||
161837360|NCT00307034|584448547|FG001|Overall Study|Withdrawal by Subject|2|||
161837361|NCT00307034|584448546|FG000|Overall Study|Lost to Follow-up|0|||
161704962|NCT01154101|583965895|FG002|Overall Study|Adverse Event|1|||
161704963|NCT01154101|583965896|FG003|Overall Study|Adverse Event|1|||
161704964|NCT01154101|583965897|FG004|Overall Study|Adverse Event|0|||
161837362|NCT00307034|584448547|FG001|Overall Study|Lost to Follow-up|3|||
161837363|NCT02034058|584448556|FG000|Overall Study|Death|3|||
161704965|NCT01154101|583965893|FG000|Overall Study|Lost to Follow-up|0|||
161704966|NCT01154101|583965894|FG001|Overall Study|Lost to Follow-up|1|||
161704967|NCT01154101|583965895|FG002|Overall Study|Lost to Follow-up|0|||
161704968|NCT01154101|583965896|FG003|Overall Study|Lost to Follow-up|1|||
161704969|NCT01154101|583965897|FG004|Overall Study|Lost to Follow-up|0|||
161704970|NCT01154101|583965893|FG000|Overall Study|Withdrawal by Subject|0|||
161704971|NCT01154101|583965894|FG001|Overall Study|Withdrawal by Subject|1|||
161704972|NCT01154101|583965895|FG002|Overall Study|Withdrawal by Subject|2|||
161704973|NCT01154101|583965896|FG003|Overall Study|Withdrawal by Subject|0|||
161704974|NCT01154101|583965897|FG004|Overall Study|Withdrawal by Subject|1|||
161704975|NCT05019131|583965898|FG000|Overall Study|Lost to Follow-up|0|||
161704976|NCT05019131|583965899|FG001|Overall Study|Lost to Follow-up|3|||
161704977|NCT03575104|583965900|FG000|Overall Study|Adverse Event|4|||
161704978|NCT03575104|583965901|FG001|Overall Study|Adverse Event|3|||
161704979|NCT03575104|583965902|FG002|Overall Study|Adverse Event|4|||
161704980|NCT03575104|583965900|FG000|Overall Study|Withdrawal by Subject|13|||
161704981|NCT03575104|583965901|FG001|Overall Study|Withdrawal by Subject|16|||
161704982|NCT03575104|583965902|FG002|Overall Study|Withdrawal by Subject|11|||
161704983|NCT03575104|583965900|FG000|Overall Study|Other reasons|6|||
161704984|NCT03575104|583965901|FG001|Overall Study|Other reasons|8|||
161704985|NCT03575104|583965902|FG002|Overall Study|Other reasons|6|||
161704986|NCT03575104|583965900|FG000|Overall Study|Lost to Follow-up|1|||
161704987|NCT03575104|583965901|FG001|Overall Study|Lost to Follow-up|2|||
161704988|NCT03575104|583965902|FG002|Overall Study|Lost to Follow-up|1|||
161704989|NCT02360098|583965903|FG000|Overall Study|Physician Decision|7|||
161704990|NCT01919307|583965906|FG000|Overall Study|Withdrawal by Subject|9|||
161704991|NCT05052723|583965908|FG000|Overall Study|Death|19|||
161704992|NCT02771522|583965911|FG000|Overall Study|Lost to Follow-up|3|||
161704993|NCT02771522|583965911|FG000|Overall Study|Withdrawal by Subject|2|||
161704994|NCT02771522|583965911|FG000|Overall Study|No white spot lesions|3|||
161704995|NCT00556426|583965917|FG000|Overall Study|Withdrawal by Subject|3|||
161704996|NCT00556426|583965917|FG000|Overall Study|Death|6|||
161704997|NCT03049449|583965918|FG000|Overall Study|Did not receive treatment.|0|||
161704998|NCT03049449|583965919|FG001|Overall Study|Did not receive treatment.|0|||
161704999|NCT03049449|583965920|FG002|Overall Study|Did not receive treatment.|0|||
161705000|NCT03049449|583965921|FG003|Overall Study|Did not receive treatment.|0|||
161705001|NCT03049449|583965922|FG004|Overall Study|Did not receive treatment.|0|||
161705002|NCT03049449|583965923|FG005|Overall Study|Did not receive treatment.|0|||
161705003|NCT03049449|583965924|FG006|Overall Study|Did not receive treatment.|0|||
161705004|NCT03049449|583965925|FG007|Overall Study|Did not receive treatment.|0|||
161705005|NCT03049449|583965926|FG008|Overall Study|Did not receive treatment.|1|||
161705006|NCT03049449|583965927|FG009|Overall Study|Did not receive treatment.|0|||
161705007|NCT03049449|583965918|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
161705008|NCT03049449|583965919|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
161705009|NCT03049449|583965920|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
161705010|NCT03049449|583965921|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
161705011|NCT03049449|583965922|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
161705012|NCT03049449|583965923|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
161705013|NCT03049449|583965924|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
161705014|NCT03049449|583965925|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
161705015|NCT03049449|583965926|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
161705016|NCT03049449|583965927|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
161705017|NCT03049449|583965918|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705018|NCT03049449|583965919|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705019|NCT03049449|583965920|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705020|NCT03049449|583965921|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705021|NCT03049449|583965922|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705022|NCT03049449|583965923|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705023|NCT03049449|583965924|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705024|NCT03049449|583965925|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
161705025|NCT03049449|583965926|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705026|NCT03049449|583965927|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
161705027|NCT02054702|583965933|FG000|Overall Study|Lost to Follow-up|3|||
161705028|NCT02054702|583965934|FG001|Overall Study|Lost to Follow-up|5|||
161705029|NCT02054702|583965933|FG000|Overall Study|Adverse Event|3|||
161705030|NCT02054702|583965934|FG001|Overall Study|Adverse Event|1|||
161705031|NCT02054702|583965933|FG000|Overall Study|Met Withdrawal Criteria|4|||
161705032|NCT02054702|583965934|FG001|Overall Study|Met Withdrawal Criteria|1|||
161705033|NCT02054702|583965933|FG000|Overall Study|Physician Decision|0|||
161705034|NCT02054702|583965934|FG001|Overall Study|Physician Decision|1|||
161705035|NCT02054702|583965933|FG000|Overall Study|Withdrawal by Subject|14|||
161705036|NCT02054702|583965934|FG001|Overall Study|Withdrawal by Subject|4|||
161705037|NCT01262898|583965941|FG000|Overall Study|Protocol Violation|1|||
161705038|NCT01262898|583965942|FG001|Overall Study|Protocol Violation|1|||
161705039|NCT01262898|583965943|FG002|Overall Study|Protocol Violation|0|||
161705040|NCT01262898|583965944|FG003|Overall Study|Protocol Violation|0|||
161705041|NCT01262898|583965941|FG000|Overall Study|Lost to Follow-up|1|||
161705042|NCT01262898|583965942|FG001|Overall Study|Lost to Follow-up|0|||
161705043|NCT01262898|583965943|FG002|Overall Study|Lost to Follow-up|0|||
161705044|NCT01262898|583965944|FG003|Overall Study|Lost to Follow-up|0|||
161705045|NCT01262898|583965941|FG000|Overall Study|Withdrawal by Subject|1|||
161705046|NCT01262898|583965942|FG001|Overall Study|Withdrawal by Subject|1|||
161705047|NCT01262898|583965943|FG002|Overall Study|Withdrawal by Subject|0|||
161705048|NCT01262898|583965944|FG003|Overall Study|Withdrawal by Subject|0|||
161705049|NCT02388295|583965950|FG000|Dose Escalation Week 1|Adverse Event|1|||
161705050|NCT02388295|583965951|FG001|Dose Escalation Week 1|Adverse Event|2|||
161705051|NCT02388295|583965952|FG002|Dose Escalation Week 1|Adverse Event|1|||
161705052|NCT02388295|583965950|FG000|Dose Escalation Week 1|Determined not eligible|1|||
161705053|NCT02388295|583965951|FG001|Dose Escalation Week 1|Determined not eligible|1|||
161705054|NCT02388295|583965952|FG002|Dose Escalation Week 1|Determined not eligible|1|||
161705055|NCT02388295|583965950|FG000|Dose Escalation Week 2|Protocol Violation|0|||
161705056|NCT02388295|583965951|FG001|Dose Escalation Week 2|Protocol Violation|1|||
161705057|NCT02388295|583965952|FG002|Dose Escalation Week 2|Protocol Violation|0|||
161705058|NCT02388295|583965950|FG000|Dose Escalation Week 2|Determined not eligible|1|||
161705059|NCT02388295|583965951|FG001|Dose Escalation Week 2|Determined not eligible|1|||
161705060|NCT02388295|583965952|FG002|Dose Escalation Week 2|Determined not eligible|1|||
161705061|NCT02388295|583965950|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
161705062|NCT02388295|583965951|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
161705063|NCT02388295|583965952|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
161705064|NCT01551693|583965954|FG000|Overall Study|Disease Progression|1|||
161705065|NCT01551693|583965955|FG001|Overall Study|Disease Progression|0|||
161705066|NCT01551693|583965954|FG000|Overall Study|Adverse Event|0|||
161705067|NCT01551693|583965955|FG001|Overall Study|Adverse Event|1|||
161705068|NCT01551693|583965954|FG000|Overall Study|Withdrawal by Subject|0|||
161705069|NCT01551693|583965955|FG001|Overall Study|Withdrawal by Subject|1|||
161705070|NCT02429856|583965956|FG000|Overall Study|Death|12|||
161705071|NCT02429856|583965957|FG001|Overall Study|Death|13|||
161705072|NCT02429856|583965956|FG000|Overall Study|Lost to Follow-up|6|||
161705073|NCT02429856|583965957|FG001|Overall Study|Lost to Follow-up|5|||
161705074|NCT02429856|583965956|FG000|Overall Study|Withdrawal by Subject|1|||
161705075|NCT02429856|583965957|FG001|Overall Study|Withdrawal by Subject|1|||
161705076|NCT04134494|583965961|FG000|Overall Study|Lost to Follow-up|2|||
161705077|NCT00781365|583965962|FG000|Overall Study|Withdrawal by Subject|13|||
161705078|NCT00781365|583965963|FG001|Overall Study|Withdrawal by Subject|8|||
161705079|NCT00781365|583965962|FG000|Overall Study|Did Not Attend Visit|20|||
161705080|NCT00781365|583965963|FG001|Overall Study|Did Not Attend Visit|28|||
161705081|NCT00781365|583965962|FG000|Overall Study|Language barrier|1|||
161705082|NCT00781365|583965963|FG001|Overall Study|Language barrier|0|||
161705083|NCT01900002|583965964|FG000|Overall Study|Withdrawal by Subject|2|||
161705084|NCT01900002|583965964|FG000|Overall Study|ineligible for Y-90|4|||
161705085|NCT01662648|583965965|FG000|Overall Study|Death|1|||
161705086|NCT01662648|583965966|FG001|Overall Study|Death|3|||
161705087|NCT01662648|583965965|FG000|Overall Study|Adverse Event|40|||
161705088|NCT01662648|583965966|FG001|Overall Study|Adverse Event|37|||
161705089|NCT01662648|583965965|FG000|Overall Study|Lack of Efficacy|17|||
161705090|NCT01662648|583965966|FG001|Overall Study|Lack of Efficacy|16|||
161705091|NCT01662648|583965965|FG000|Overall Study|Participant ineligible to continue trial|1|||
161705092|NCT01662648|583965966|FG001|Overall Study|Participant ineligible to continue trial|1|||
161705093|NCT01662648|583965965|FG000|Overall Study|Lost to Follow-up|24|||
161705094|NCT01662648|583965966|FG001|Overall Study|Lost to Follow-up|36|||
161705095|NCT01662648|583965965|FG000|Overall Study|Withdrawal by Subject|36|||
161705096|NCT01662648|583965966|FG001|Overall Study|Withdrawal by Subject|53|||
161705097|NCT01662648|583965965|FG000|Overall Study|Participant non-compliant|16|||
161705098|NCT01662648|583965966|FG001|Overall Study|Participant non-compliant|20|||
161705099|NCT01662648|583965965|FG000|Overall Study|Other|8|||
161705100|NCT01662648|583965966|FG001|Overall Study|Other|11|||
161705101|NCT01662648|583965965|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
161705102|NCT01662648|583965966|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
161705103|NCT01662648|583965965|FG000|Overall Study|LOE and other reason unspecified|1|||
161705104|NCT01662648|583965966|FG001|Overall Study|LOE and other reason unspecified|0|||
161705105|NCT01662648|583965965|FG000|Overall Study|LOE and Participant non-compliant|0|||
161705106|NCT01662648|583965966|FG001|Overall Study|LOE and Participant non-compliant|1|||
161705107|NCT03040024|583965968|FG000|Overall Study|Adverse Event|0|||
161705108|NCT03040024|583965969|FG001|Overall Study|Adverse Event|1|||
161705109|NCT03040024|583965970|FG002|Overall Study|Adverse Event|0|||
161705110|NCT03040024|583965968|FG000|Overall Study|Death|0|||
161705111|NCT03040024|583965969|FG001|Overall Study|Death|1|||
161705112|NCT03040024|583965970|FG002|Overall Study|Death|0|||
161705113|NCT03040024|583965968|FG000|Overall Study|Physician Decision|0|||
161705114|NCT03040024|583965969|FG001|Overall Study|Physician Decision|0|||
161705115|NCT03040024|583965970|FG002|Overall Study|Physician Decision|1|||
161705116|NCT02658812|583965971|FG000|Overall Study|Disease Progression|7|||
161705117|NCT02658812|583965971|FG000|Overall Study|Unrelated to study treatment|1|||
161705118|NCT02658812|583965971|FG000|Overall Study|Adverse Event|1|||
161705119|NCT00854828|583965974|FG000|Overall Study|Death|1|||
161705120|NCT00854828|583965975|FG001|Overall Study|Death|0|||
161705121|NCT00854828|583965976|FG002|Overall Study|Death|0|||
161705122|NCT00854828|583965977|FG003|Overall Study|Death|0|||
161705123|NCT00854828|583965974|FG000|Overall Study|Withdrawal by Subject|1|||
161705124|NCT00854828|583965975|FG001|Overall Study|Withdrawal by Subject|1|||
161705125|NCT00854828|583965976|FG002|Overall Study|Withdrawal by Subject|0|||
161705126|NCT00854828|583965977|FG003|Overall Study|Withdrawal by Subject|9|||
161705127|NCT00854828|583965974|FG000|Overall Study|Missed 24mo visit|1|||
161705128|NCT00854828|583965975|FG001|Overall Study|Missed 24mo visit|1|||
161705129|NCT00854828|583965976|FG002|Overall Study|Missed 24mo visit|8|||
161705130|NCT00854828|583965977|FG003|Overall Study|Missed 24mo visit|8|||
161837364|NCT00616941|584448557|FG000|Overall Study|Progressive Disease|1|||
161837365|NCT00616941|584448558|FG001|Overall Study|Progressive Disease|2|||
161837366|NCT00616941|584448559|FG002|Overall Study|Progressive Disease|1|||
161837367|NCT00616941|584448557|FG000|Overall Study|Adverse Event|0|||
161837368|NCT00616941|584448558|FG001|Overall Study|Adverse Event|1|||
161837369|NCT00616941|584448559|FG002|Overall Study|Adverse Event|1|||
161837370|NCT00616941|584448557|FG000|Overall Study|Subject Non-compliance|0|||
161837371|NCT00616941|584448558|FG001|Overall Study|Subject Non-compliance|0|||
161837372|NCT00616941|584448559|FG002|Overall Study|Subject Non-compliance|1|||
161837373|NCT00616941|584448557|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
161837374|NCT00616941|584448558|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
161837375|NCT00616941|584448559|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
161837376|NCT00616941|584448557|FG000|Overall Study|Vaccination Suspended|0|||
161837377|NCT00616941|584448558|FG001|Overall Study|Vaccination Suspended|0|||
161837378|NCT00616941|584448559|FG002|Overall Study|Vaccination Suspended|3|||
161837379|NCT00076804|584448570|FG000|Overall Study|Death|9|||
161837380|NCT00076804|584448571|FG001|Overall Study|Death|20|||
161837381|NCT00076804|584448570|FG000|Overall Study|Lost to Follow-up|9|||
161705131|NCT01282229|583965978|FG000|Overall Study|Protocol Violation|2|||
161705132|NCT03686969|583965979|FG000|Overall Study|Study terminated|1|||
161705133|NCT03686969|583965980|FG001|Overall Study|Study terminated|0|||
161705134|NCT00848120|583965981|FG000|Overall Study|Adverse Event|1|||
161705135|NCT01988090|583965985|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
161705136|NCT01988090|583965986|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
161705137|NCT01988090|583965985|FG000|Start Treament After Randomization|Protocol Violation|0|||
161705138|NCT01988090|583965986|FG001|Start Treament After Randomization|Protocol Violation|1|||
161705139|NCT01988090|583965985|FG000|Complete Study After Start|Withdrawal by Subject|2|||
161705140|NCT01988090|583965986|FG001|Complete Study After Start|Withdrawal by Subject|0|||
161705141|NCT01988090|583965985|FG000|Complete Study After Start|Protocol Violation|1|||
161705142|NCT01988090|583965986|FG001|Complete Study After Start|Protocol Violation|1|||
161705143|NCT00927563|583965990|FG000|Overall Study|Lost to Follow-up|1|||
161705144|NCT00927563|583965990|FG000|Overall Study|Withdrawal by Subject|1|||
161705145|NCT02497001|583965991|FG000|Overall Study|Lost to Follow-up|10|||
161705146|NCT02497001|583965992|FG001|Overall Study|Lost to Follow-up|2|||
161705147|NCT02497001|583965993|FG002|Overall Study|Lost to Follow-up|0|||
161837382|NCT00076804|584448571|FG001|Overall Study|Lost to Follow-up|9|||
161837383|NCT00076804|584448570|FG000|Overall Study|Withdrawal by Subject|10|||
161837384|NCT00076804|584448571|FG001|Overall Study|Withdrawal by Subject|8|||
161837385|NCT00076804|584448570|FG000|Overall Study|Early study Closure|32|||
161837386|NCT00076804|584448571|FG001|Overall Study|Early study Closure|32|||
161837387|NCT03709823|584448572|FG000|Overall Study|Adverse Event|0|||
161705148|NCT02497001|583965994|FG003|Overall Study|Lost to Follow-up|2|||
161705149|NCT02497001|583965991|FG000|Overall Study|Adverse Event|28|||
161837388|NCT03709823|584448573|FG001|Overall Study|Adverse Event|0|||
161837389|NCT03709823|584448574|FG002|Overall Study|Adverse Event|1|||
161837390|NCT03709823|584448575|FG003|Overall Study|Adverse Event|0|||
161837391|NCT03709823|584448576|FG004|Overall Study|Adverse Event|0|||
161705150|NCT02497001|583965992|FG001|Overall Study|Adverse Event|30|||
161705151|NCT02497001|583965993|FG002|Overall Study|Adverse Event|11|||
161705152|NCT02497001|583965994|FG003|Overall Study|Adverse Event|11|||
161705153|NCT02497001|583965991|FG000|Overall Study|Withdrawal by Subject|14|||
161705154|NCT02497001|583965992|FG001|Overall Study|Withdrawal by Subject|37|||
161705155|NCT02497001|583965993|FG002|Overall Study|Withdrawal by Subject|19|||
161705156|NCT02497001|583965994|FG003|Overall Study|Withdrawal by Subject|15|||
161705157|NCT02497001|583965991|FG000|Overall Study|Physician Decision|5|||
161705158|NCT02497001|583965992|FG001|Overall Study|Physician Decision|11|||
161705159|NCT02497001|583965993|FG002|Overall Study|Physician Decision|5|||
161705160|NCT02497001|583965994|FG003|Overall Study|Physician Decision|1|||
161705161|NCT02497001|583965991|FG000|Overall Study|subjects that were not treated|1|||
161705162|NCT02497001|583965992|FG001|Overall Study|subjects that were not treated|2|||
161705163|NCT02497001|583965993|FG002|Overall Study|subjects that were not treated|2|||
161705164|NCT02497001|583965994|FG003|Overall Study|subjects that were not treated|1|||
161705165|NCT02497001|583965991|FG000|Overall Study|Major Protocol Deviation|3|||
161705166|NCT02497001|583965992|FG001|Overall Study|Major Protocol Deviation|4|||
161705167|NCT02497001|583965993|FG002|Overall Study|Major Protocol Deviation|4|||
161705168|NCT02497001|583965994|FG003|Overall Study|Major Protocol Deviation|4|||
161705169|NCT02497001|583965991|FG000|Overall Study|Lack of Efficacy|10|||
161705170|NCT02497001|583965992|FG001|Overall Study|Lack of Efficacy|16|||
161705171|NCT02497001|583965993|FG002|Overall Study|Lack of Efficacy|6|||
161837392|NCT03709823|584448577|FG005|Overall Study|Adverse Event|0|||
161837393|NCT03709823|584448572|FG000|Overall Study|Lost to Follow-up|2|||
161837394|NCT03709823|584448573|FG001|Overall Study|Lost to Follow-up|2|||
161837395|NCT03709823|584448574|FG002|Overall Study|Lost to Follow-up|2|||
161837396|NCT03709823|584448575|FG003|Overall Study|Lost to Follow-up|1|||
161837397|NCT03709823|584448576|FG004|Overall Study|Lost to Follow-up|1|||
161837398|NCT03709823|584448577|FG005|Overall Study|Lost to Follow-up|0|||
161837399|NCT03709823|584448572|FG000|Overall Study|Withdrawal by Subject|1|||
161837400|NCT03709823|584448573|FG001|Overall Study|Withdrawal by Subject|3|||
161837401|NCT03709823|584448574|FG002|Overall Study|Withdrawal by Subject|0|||
161837402|NCT03709823|584448575|FG003|Overall Study|Withdrawal by Subject|0|||
161837403|NCT03709823|584448576|FG004|Overall Study|Withdrawal by Subject|0|||
161837404|NCT03709823|584448577|FG005|Overall Study|Withdrawal by Subject|0|||
161837405|NCT03709823|584448572|FG000|Overall Study|Other, Not Specified|0|||
161837406|NCT03709823|584448573|FG001|Overall Study|Other, Not Specified|0|||
161837407|NCT03709823|584448574|FG002|Overall Study|Other, Not Specified|0|||
161837408|NCT03709823|584448575|FG003|Overall Study|Other, Not Specified|1|||
161837409|NCT03709823|584448576|FG004|Overall Study|Other, Not Specified|0|||
161837410|NCT03709823|584448577|FG005|Overall Study|Other, Not Specified|0|||
161837411|NCT00688376|584448578|FG000|Double-Blind Phase|Adverse Event|4|||
161837412|NCT00688376|584448579|FG001|Double-Blind Phase|Adverse Event|4|||
161837413|NCT00688376|584448578|FG000|Double-Blind Phase|Protocol Violation|1|||
161837414|NCT00688376|584448579|FG001|Double-Blind Phase|Protocol Violation|2|||
161837415|NCT00688376|584448578|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
161837416|NCT00688376|584448579|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
161837417|NCT00688376|584448578|FG000|Double-Blind Phase|Not treated|0|||
161837418|NCT00688376|584448579|FG001|Double-Blind Phase|Not treated|1|||
161837419|NCT00688376|584448578|FG000|Blinded Extension Phase|Adverse Event|3|||
161837420|NCT00688376|584448579|FG001|Blinded Extension Phase|Adverse Event|4|||
161837421|NCT00688376|584448578|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
161837422|NCT00688376|584448579|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
161837423|NCT00688376|584448578|FG000|Blinded Extension Phase|Physician Decision|1|||
161837424|NCT00688376|584448579|FG001|Blinded Extension Phase|Physician Decision|0|||
161837425|NCT00688376|584448578|FG000|Blinded Extension Phase|Other|1|||
161837426|NCT00688376|584448579|FG001|Blinded Extension Phase|Other|0|||
161837427|NCT00557076|584448580|FG000|Overall Study|Unblinding|0|||
161837428|NCT00557076|584448581|FG001|Overall Study|Unblinding|1|||
161837429|NCT00846521|584448582|FG000|Overall Study|Withdrawal by Subject|5|||
161837430|NCT00846521|584448582|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
161837431|NCT00846521|584448582|FG000|Overall Study|Protocol Violation|1|||
161837432|NCT03201250|584448584|FG000|Overall Study|screen failures|3|||
161837433|NCT03201250|584448585|FG001|Overall Study|screen failures|0|||
161837434|NCT03201250|584448586|FG002|Overall Study|screen failures|0|||
161705172|NCT02497001|583965994|FG003|Overall Study|Lack of Efficacy|6|||
161705173|NCT02497001|583965991|FG000|Overall Study|Protocol Violation|3|||
161837435|NCT02575911|584448589|FG000|Overall Study|Lost to Follow-up|1|||
161837436|NCT02335983|584448590|FG000|Overall Study|Sponsor Decision|0|||
161837437|NCT02335983|584448591|FG001|Overall Study|Sponsor Decision|0|||
161837438|NCT02335983|584448592|FG002|Overall Study|Sponsor Decision|1|||
161837439|NCT02335983|584448593|FG003|Overall Study|Sponsor Decision|1|||
161837440|NCT02335983|584448594|FG004|Overall Study|Sponsor Decision|0|||
161837441|NCT02335983|584448595|FG005|Overall Study|Sponsor Decision|1|||
161837442|NCT02335983|584448590|FG000|Overall Study|Withdrawal by Subject|3|||
161837443|NCT02335983|584448591|FG001|Overall Study|Withdrawal by Subject|2|||
161705174|NCT02497001|583965992|FG001|Overall Study|Protocol Violation|1|||
161705175|NCT02497001|583965993|FG002|Overall Study|Protocol Violation|3|||
161705176|NCT02497001|583965994|FG003|Overall Study|Protocol Violation|1|||
161705177|NCT05501119|583965995|FG000|Overall Study|Withdrawal by Subject|2|||
161837444|NCT02335983|584448592|FG002|Overall Study|Withdrawal by Subject|2|||
161837445|NCT02335983|584448593|FG003|Overall Study|Withdrawal by Subject|1|||
161837446|NCT02335983|584448594|FG004|Overall Study|Withdrawal by Subject|3|||
161837447|NCT02335983|584448595|FG005|Overall Study|Withdrawal by Subject|9|||
161837448|NCT02335983|584448590|FG000|Overall Study|Death|0|||
161837449|NCT02335983|584448591|FG001|Overall Study|Death|0|||
161837450|NCT02335983|584448592|FG002|Overall Study|Death|2|||
161837451|NCT02335983|584448593|FG003|Overall Study|Death|0|||
161837452|NCT02335983|584448594|FG004|Overall Study|Death|0|||
161837453|NCT02335983|584448595|FG005|Overall Study|Death|0|||
161837454|NCT02335983|584448590|FG000|Overall Study|Lost to Follow-up|0|||
161837455|NCT02335983|584448591|FG001|Overall Study|Lost to Follow-up|0|||
161837456|NCT02335983|584448592|FG002|Overall Study|Lost to Follow-up|0|||
161837457|NCT02335983|584448593|FG003|Overall Study|Lost to Follow-up|0|||
161837458|NCT02335983|584448594|FG004|Overall Study|Lost to Follow-up|0|||
161837459|NCT02335983|584448595|FG005|Overall Study|Lost to Follow-up|1|||
161837460|NCT02335983|584448590|FG000|Overall Study|Protocol Specified Criteria|5|||
161837461|NCT02335983|584448591|FG001|Overall Study|Protocol Specified Criteria|7|||
161837462|NCT02335983|584448592|FG002|Overall Study|Protocol Specified Criteria|27|||
161837463|NCT02335983|584448593|FG003|Overall Study|Protocol Specified Criteria|7|||
161837464|NCT02335983|584448594|FG004|Overall Study|Protocol Specified Criteria|5|||
161837465|NCT02335983|584448595|FG005|Overall Study|Protocol Specified Criteria|21|||
161837466|NCT00629265|584448600|FG000|Overall Study|Lost to Follow-up|4|||
161837467|NCT00629265|584448601|FG001|Overall Study|Lost to Follow-up|5|||
161837468|NCT00629265|584448600|FG000|Overall Study|Withdrawal by Subject|11|||
161837469|NCT00629265|584448601|FG001|Overall Study|Withdrawal by Subject|8|||
161837470|NCT00629265|584448600|FG000|Overall Study|Death|1|||
161837471|NCT00629265|584448601|FG001|Overall Study|Death|0|||
161837472|NCT00629265|584448600|FG000|Overall Study|Adverse Event|2|||
161837473|NCT00629265|584448601|FG001|Overall Study|Adverse Event|0|||
161837474|NCT00629265|584448600|FG000|Overall Study|HNC Recurrence|4|||
161837475|NCT00629265|584448601|FG001|Overall Study|HNC Recurrence|0|||
161837476|NCT00629265|584448600|FG000|Overall Study|Other CA Requiring Treatment|1|||
161837477|NCT00629265|584448601|FG001|Overall Study|Other CA Requiring Treatment|3|||
161837478|NCT00629265|584448600|FG000|Overall Study|Needed Esophageal Dilation|4|||
161837479|NCT00629265|584448601|FG001|Overall Study|Needed Esophageal Dilation|1|||
161837480|NCT00629265|584448600|FG000|Overall Study|Unrelated Medical Complications|3|||
161837481|NCT00629265|584448601|FG001|Overall Study|Unrelated Medical Complications|1|||
161837482|NCT00629265|584448600|FG000|Overall Study|Unknown Reason|2|||
161837483|NCT00629265|584448601|FG001|Overall Study|Unknown Reason|2|||
161837484|NCT04465630|584448602|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
161837485|NCT04465630|584448602|FG000|Overall Study|Screen failure|8|||
161705178|NCT05501119|583965995|FG000|Overall Study|Lost to Follow-up|5|||
161705179|NCT02440581|583966001|FG000|Overall Study|Death|0|||
161705180|NCT02440581|583966002|FG001|Overall Study|Death|0|||
161705181|NCT02440581|583966003|FG002|Overall Study|Death|7|||
161705182|NCT02440581|583966004|FG003|Overall Study|Death|5|||
161705183|NCT02440581|583966001|FG000|Overall Study|Transplanted|1|||
161705184|NCT02440581|583966002|FG001|Overall Study|Transplanted|0|||
161705185|NCT02440581|583966003|FG002|Overall Study|Transplanted|3|||
161705186|NCT02440581|583966004|FG003|Overall Study|Transplanted|2|||
161705187|NCT02440581|583966001|FG000|Overall Study|Withdrawal by Subject|4|||
161705188|NCT02440581|583966002|FG001|Overall Study|Withdrawal by Subject|11|||
161705189|NCT02440581|583966003|FG002|Overall Study|Withdrawal by Subject|3|||
161705190|NCT02440581|583966004|FG003|Overall Study|Withdrawal by Subject|7|||
161705191|NCT01468987|583966005|FG000|Overall Study|Adverse Event|12|||
161705192|NCT01468987|583966006|FG001|Overall Study|Adverse Event|9|||
161705193|NCT01468987|583966005|FG000|Overall Study|Death|4|||
161705194|NCT01468987|583966006|FG001|Overall Study|Death|1|||
161705195|NCT01468987|583966005|FG000|Overall Study|Lost to Follow-up|10|||
161705196|NCT01468987|583966006|FG001|Overall Study|Lost to Follow-up|5|||
161705197|NCT01468987|583966005|FG000|Overall Study|Protocol Violation|8|||
161837486|NCT04465630|584448602|FG000|Overall Study|Baseline failure|16|||
161837487|NCT01732484|584448606|FG000|Overall Study|Death|7|||
161837488|NCT01732484|584448606|FG000|Overall Study|Lost to Follow-up|14|||
161837489|NCT01732484|584448606|FG000|Overall Study|chronical illness|5|||
161705198|NCT01468987|583966006|FG001|Overall Study|Protocol Violation|2|||
161705199|NCT01468987|583966005|FG000|Overall Study|Withdrawal by Subject|28|||
161705200|NCT01468987|583966006|FG001|Overall Study|Withdrawal by Subject|28|||
161705201|NCT01468987|583966005|FG000|Overall Study|Physician Decision|8|||
161837490|NCT00289874|584448607|FG000|Overall Study|Adverse Event|1|||
161837491|NCT00289874|584448608|FG001|Overall Study|Adverse Event|5|||
161837492|NCT00289874|584448607|FG000|Overall Study|Lost to Follow-up|1|||
161705202|NCT01468987|583966006|FG001|Overall Study|Physician Decision|15|||
161705203|NCT01468987|583966005|FG000|Overall Study|Sponsor Decision|1|||
161705204|NCT01468987|583966006|FG001|Overall Study|Sponsor Decision|0|||
161705205|NCT00787787|583966007|FG000|Overall Study|Lack of Efficacy|4|||
161837493|NCT00289874|584448608|FG001|Overall Study|Lost to Follow-up|1|||
161837494|NCT00289874|584448607|FG000|Overall Study|Protocol Violation|3|||
161705206|NCT00787787|583966007|FG000|Overall Study|Adverse Event|3|||
161705207|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Death|6|||
161705208|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Death|2|||
161705209|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
161705210|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
161705211|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
161705212|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
161705213|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
161705214|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
161705215|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
161705216|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
161705217|NCT00484315|583966009|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
161837495|NCT00289874|584448608|FG001|Overall Study|Protocol Violation|2|||
161837496|NCT00289874|584448607|FG000|Overall Study|Did not meet eligibility|1|||
161837497|NCT00289874|584448608|FG001|Overall Study|Did not meet eligibility|0|||
161837498|NCT01087489|584448609|FG000|Overall Study|enrolled in another VA study|0|||
161837499|NCT01087489|584448610|FG001|Overall Study|enrolled in another VA study|1|||
161837500|NCT01087489|584448609|FG000|Overall Study|Death|0|||
161837501|NCT01087489|584448610|FG001|Overall Study|Death|1|||
161837502|NCT01087489|584448609|FG000|Overall Study|unable to survey by telephone|0|||
161837503|NCT01087489|584448610|FG001|Overall Study|unable to survey by telephone|1|||
161837504|NCT05070546|584448618|FG000|Overall Study|Death|0|||
161837505|NCT05070546|584448619|FG001|Overall Study|Death|0|||
161837506|NCT05070546|584448620|FG002|Overall Study|Death|0|||
161837507|NCT05070546|584448621|FG003|Overall Study|Death|0|||
161837508|NCT05070546|584448622|FG004|Overall Study|Death|0|||
161837509|NCT05070546|584448623|FG005|Overall Study|Death|1|||
161837510|NCT05070546|584448618|FG000|Overall Study|Lost to Follow-up|8|||
161837511|NCT05070546|584448619|FG001|Overall Study|Lost to Follow-up|2|||
161837512|NCT05070546|584448620|FG002|Overall Study|Lost to Follow-up|7|||
161837513|NCT05070546|584448621|FG003|Overall Study|Lost to Follow-up|1|||
161655284|NCT04488770|583788884|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655285|NCT04488770|583788885|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655286|NCT04488770|583788886|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655287|NCT04488770|583788887|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655288|NCT04488770|583788888|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655289|NCT04488770|583788889|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161655290|NCT04488770|583788877|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655291|NCT04488770|583788878|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655292|NCT04488770|583788879|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655293|NCT04488770|583788880|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655294|NCT04488770|583788881|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655295|NCT04488770|583788882|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
161655296|NCT04488770|583788883|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
161655297|NCT04488770|583788884|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655298|NCT04488770|583788885|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655299|NCT04488770|583788886|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655300|NCT04488770|583788887|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655301|NCT04488770|583788888|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655302|NCT04488770|583788889|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161655303|NCT04488770|583788877|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655304|NCT04488770|583788878|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655305|NCT04488770|583788879|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655306|NCT04488770|583788880|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161705218|NCT00484315|583966010|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
161705219|NCT00484315|583966009|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
161837514|NCT05070546|584448622|FG004|Overall Study|Lost to Follow-up|2|||
161837515|NCT05070546|584448623|FG005|Overall Study|Lost to Follow-up|0|||
161837516|NCT05070546|584448618|FG000|Overall Study|Withdrawal by Subject|1|||
161837517|NCT05070546|584448619|FG001|Overall Study|Withdrawal by Subject|1|||
161837518|NCT05070546|584448620|FG002|Overall Study|Withdrawal by Subject|3|||
161837519|NCT05070546|584448621|FG003|Overall Study|Withdrawal by Subject|0|||
161837520|NCT05070546|584448622|FG004|Overall Study|Withdrawal by Subject|0|||
161837521|NCT05070546|584448623|FG005|Overall Study|Withdrawal by Subject|0|||
161837522|NCT05070546|584448618|FG000|Overall Study|Other|0|||
161837523|NCT05070546|584448619|FG001|Overall Study|Other|0|||
161837524|NCT05070546|584448620|FG002|Overall Study|Other|0|||
161837525|NCT05070546|584448621|FG003|Overall Study|Other|0|||
161837526|NCT05070546|584448622|FG004|Overall Study|Other|3|||
161837527|NCT05070546|584448623|FG005|Overall Study|Other|0|||
161837528|NCT05070546|584448618|FG000|Overall Study|Randomized but not vaccinated|1|||
161837529|NCT05070546|584448619|FG001|Overall Study|Randomized but not vaccinated|0|||
161837530|NCT05070546|584448620|FG002|Overall Study|Randomized but not vaccinated|1|||
161837531|NCT05070546|584448621|FG003|Overall Study|Randomized but not vaccinated|1|||
161837532|NCT05070546|584448622|FG004|Overall Study|Randomized but not vaccinated|3|||
161837533|NCT05070546|584448623|FG005|Overall Study|Randomized but not vaccinated|0|||
161837534|NCT02643355|584448624|FG000|Overall Study|Withdrawal by Subject|1|||
161837535|NCT02643355|584448625|FG001|Overall Study|Withdrawal by Subject|3|||
161837536|NCT02643355|584448624|FG000|Overall Study|Protocol Violation|0|||
161837537|NCT02643355|584448625|FG001|Overall Study|Protocol Violation|2|||
161837538|NCT01615263|584448637|FG000|Overall Study|Post-randomization exclusion|0|||
161837539|NCT01615263|584448638|FG001|Overall Study|Post-randomization exclusion|2|||
161837540|NCT00988065|584448643|FG000|Overall Study|Adverse Event|4|||
161837541|NCT00988065|584448644|FG001|Overall Study|Adverse Event|10|||
161837542|NCT00988065|584448645|FG002|Overall Study|Adverse Event|2|||
161837543|NCT00988065|584448643|FG000|Overall Study|Lost to Follow-up|1|||
161837544|NCT00988065|584448644|FG001|Overall Study|Lost to Follow-up|2|||
161837545|NCT00988065|584448645|FG002|Overall Study|Lost to Follow-up|2|||
161837546|NCT00988065|584448643|FG000|Overall Study|Subject withdrew consent|3|||
161837547|NCT00988065|584448644|FG001|Overall Study|Subject withdrew consent|5|||
161837548|NCT00988065|584448645|FG002|Overall Study|Subject withdrew consent|2|||
161837549|NCT00988065|584448643|FG000|Overall Study|Noncompliance with protocol|5|||
161837550|NCT00988065|584448644|FG001|Overall Study|Noncompliance with protocol|6|||
161837551|NCT00988065|584448645|FG002|Overall Study|Noncompliance with protocol|9|||
161837552|NCT03096847|584448651|FG000|Overall Study|Other|2|||
161837553|NCT03096847|584448652|FG001|Overall Study|Other|1|||
161837554|NCT03096847|584448653|FG002|Overall Study|Other|2|||
161837555|NCT03096847|584448651|FG000|Overall Study|Lost to Follow-up|1|||
161837556|NCT03096847|584448652|FG001|Overall Study|Lost to Follow-up|0|||
161837557|NCT03096847|584448653|FG002|Overall Study|Lost to Follow-up|1|||
161705220|NCT00484315|583966010|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
161705221|NCT00943683|583966011|FG000|Overall Study|Adverse Event|3|||
161705222|NCT00943683|583966012|FG001|Overall Study|Adverse Event|3|||
161705223|NCT00943683|583966011|FG000|Overall Study|Lost to Follow-up|1|||
161705224|NCT00943683|583966012|FG001|Overall Study|Lost to Follow-up|1|||
161705225|NCT00943683|583966011|FG000|Overall Study|Protocol Violation|1|||
161705226|NCT00943683|583966012|FG001|Overall Study|Protocol Violation|2|||
161705227|NCT00943683|583966011|FG000|Overall Study|Withdrawal by Subject|1|||
161705228|NCT00943683|583966012|FG001|Overall Study|Withdrawal by Subject|0|||
161705229|NCT00943683|583966011|FG000|Overall Study|Patient Moved|1|||
161705230|NCT00943683|583966012|FG001|Overall Study|Patient Moved|0|||
161705231|NCT01245673|583966013|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
161705232|NCT01445678|583966025|FG000|Overall Study|Adverse Event|12|||
161705233|NCT01445678|583966026|FG001|Overall Study|Adverse Event|8|||
161705234|NCT01445678|583966025|FG000|Overall Study|Lack of Efficacy|0|||
161705235|NCT01445678|583966026|FG001|Overall Study|Lack of Efficacy|2|||
161705236|NCT01445678|583966025|FG000|Overall Study|Lost to Follow-up|8|||
161705237|NCT01445678|583966026|FG001|Overall Study|Lost to Follow-up|5|||
161705238|NCT01445678|583966025|FG000|Overall Study|Protocol Violation|1|||
161705239|NCT01445678|583966026|FG001|Overall Study|Protocol Violation|1|||
161705240|NCT01445678|583966025|FG000|Overall Study|Withdrawal by Subject|9|||
161705241|NCT01445678|583966026|FG001|Overall Study|Withdrawal by Subject|5|||
161705242|NCT01459614|583966029|FG000|Overall Study|Adverse Event|1|||
161837558|NCT03096847|584448651|FG000|Overall Study|Death|6|||
161705243|NCT01459614|583966030|FG001|Overall Study|Adverse Event|0|||
161705244|NCT01565980|583966031|FG000|Overall Study|Death|1|||
161837559|NCT03096847|584448652|FG001|Overall Study|Death|0|||
161705245|NCT01565980|583966032|FG001|Overall Study|Death|0|||
161837560|NCT03096847|584448653|FG002|Overall Study|Death|2|||
161837561|NCT03096847|584448651|FG000|Overall Study|Protocol Violation|3|||
161837562|NCT03096847|584448652|FG001|Overall Study|Protocol Violation|0|||
161705246|NCT01565980|583966031|FG000|Overall Study|Lost to Follow-up|1|||
161705247|NCT01565980|583966032|FG001|Overall Study|Lost to Follow-up|0|||
161705248|NCT01565980|583966031|FG000|Overall Study|health complications|1|||
161705249|NCT01565980|583966032|FG001|Overall Study|health complications|1|||
161837563|NCT03096847|584448653|FG002|Overall Study|Protocol Violation|6|||
161837564|NCT03096847|584448651|FG000|Overall Study|Physician Decision|12|||
161837565|NCT03096847|584448652|FG001|Overall Study|Physician Decision|2|||
161837566|NCT03096847|584448653|FG002|Overall Study|Physician Decision|8|||
161837567|NCT03096847|584448651|FG000|Overall Study|Withdrawal by Subject|24|||
161655307|NCT04488770|583788881|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
161655308|NCT04488770|583788882|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655309|NCT04488770|583788883|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655310|NCT04488770|583788884|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655311|NCT04488770|583788885|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655312|NCT04488770|583788886|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655313|NCT04488770|583788887|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161705250|NCT01565980|583966031|FG000|Overall Study|stopped medical treatment|1|||
161705251|NCT01565980|583966032|FG001|Overall Study|stopped medical treatment|0|||
161705252|NCT01565980|583966031|FG000|Overall Study|Withdrawal by Subject|0|||
161705253|NCT01565980|583966032|FG001|Overall Study|Withdrawal by Subject|3|||
161705254|NCT02078219|583966035|FG000|Overall Study|Other|2|||
161705255|NCT02078219|583966036|FG001|Overall Study|Other|2|||
161705256|NCT02078219|583966037|FG002|Overall Study|Other|3|||
161705257|NCT02078219|583966038|FG003|Overall Study|Other|0|||
161705258|NCT02078219|583966039|FG004|Overall Study|Other|1|||
161705259|NCT02078219|583966035|FG000|Overall Study|Withdrawal by Subject|0|||
161705260|NCT02078219|583966036|FG001|Overall Study|Withdrawal by Subject|1|||
161705261|NCT02078219|583966037|FG002|Overall Study|Withdrawal by Subject|0|||
161705262|NCT02078219|583966038|FG003|Overall Study|Withdrawal by Subject|1|||
161705263|NCT02078219|583966039|FG004|Overall Study|Withdrawal by Subject|1|||
161705264|NCT02078219|583966035|FG000|Overall Study|Protocol Violation|0|||
161705265|NCT02078219|583966036|FG001|Overall Study|Protocol Violation|0|||
161705266|NCT02078219|583966037|FG002|Overall Study|Protocol Violation|0|||
161705267|NCT02078219|583966038|FG003|Overall Study|Protocol Violation|1|||
161705268|NCT02078219|583966039|FG004|Overall Study|Protocol Violation|0|||
161705269|NCT02078219|583966035|FG000|Overall Study|Death|0|||
161705270|NCT02078219|583966036|FG001|Overall Study|Death|0|||
161705271|NCT02078219|583966037|FG002|Overall Study|Death|0|||
161705272|NCT02078219|583966038|FG003|Overall Study|Death|1|||
161705273|NCT02078219|583966039|FG004|Overall Study|Death|0|||
161705274|NCT02078219|583966035|FG000|Overall Study|Adverse Event|1|||
161705275|NCT02078219|583966036|FG001|Overall Study|Adverse Event|1|||
161705276|NCT02078219|583966037|FG002|Overall Study|Adverse Event|3|||
161705277|NCT02078219|583966038|FG003|Overall Study|Adverse Event|1|||
161705278|NCT02078219|583966039|FG004|Overall Study|Adverse Event|0|||
161705279|NCT00891202|583966040|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
161705280|NCT00891202|583966041|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161705281|NCT00891202|583966042|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161705282|NCT00891202|583966043|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161705283|NCT00891202|583966040|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161705284|NCT00891202|583966041|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161705285|NCT00891202|583966042|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
161705286|NCT00891202|583966043|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161705287|NCT00891202|583966040|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161705288|NCT00891202|583966041|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161705289|NCT00891202|583966042|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
161705290|NCT00891202|583966043|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161705291|NCT00891202|583966040|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
161705292|NCT00891202|583966041|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
161705293|NCT00891202|583966042|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
161705294|NCT00891202|583966043|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
161705295|NCT00398112|583967806|FG000|Overall Study|Adverse Event|4|||
161705296|NCT00398112|583967806|FG000|Overall Study|Disease progression|9|||
161705297|NCT00398112|583967806|FG000|Overall Study|Alternative treatment|1|||
161705298|NCT00398112|583967806|FG000|Overall Study|Withdrawal by Subject|3|||
161705299|NCT00398112|583967806|FG000|Overall Study|Death|1|||
161705300|NCT00582556|583967807|FG000|Overall Study|Withdrawal by Subject|0|||
161705301|NCT00582556|583967808|FG001|Overall Study|Withdrawal by Subject|1|||
161705302|NCT00582556|583967809|FG002|Overall Study|Withdrawal by Subject|1|||
161705303|NCT00582556|583967807|FG000|Overall Study|Physician Decision|0|||
161705304|NCT00582556|583967808|FG001|Overall Study|Physician Decision|0|||
161705305|NCT00582556|583967809|FG002|Overall Study|Physician Decision|1|||
161705306|NCT01993888|583967810|FG000|Overall Study|Death|1|||
161705307|NCT01993888|583967811|FG001|Overall Study|Death|1|||
161705308|NCT01993888|583967810|FG000|Overall Study|Lost to Follow-up|1|||
161705309|NCT01993888|583967811|FG001|Overall Study|Lost to Follow-up|1|||
161705310|NCT01993888|583967810|FG000|Overall Study|Withdrawal by Subject|0|||
161705311|NCT01993888|583967811|FG001|Overall Study|Withdrawal by Subject|1|||
161705312|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161837568|NCT03096847|584448652|FG001|Overall Study|Withdrawal by Subject|1|||
161837569|NCT03096847|584448653|FG002|Overall Study|Withdrawal by Subject|12|||
161705313|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705314|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705315|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705316|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
161705317|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705318|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705319|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705320|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705321|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705322|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
161655314|NCT04488770|583788888|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655315|NCT04488770|583788889|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161655316|NCT03547739|583788890|FG000|Overall Study|Death|0|||
161655317|NCT03547739|583788891|FG001|Overall Study|Death|1|||
161655318|NCT03547739|583788892|FG002|Overall Study|Death|5|||
161655319|NCT03547739|583788890|FG000|Overall Study|Adverse Event|24|||
161655320|NCT03547739|583788891|FG001|Overall Study|Adverse Event|11|||
161655321|NCT03547739|583788892|FG002|Overall Study|Adverse Event|13|||
161655322|NCT03547739|583788890|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
161655323|NCT03547739|583788891|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
161655324|NCT03547739|583788892|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
161655325|NCT03547739|583788890|FG000|Overall Study|Lost to Follow-up|80|||
161655326|NCT03547739|583788891|FG001|Overall Study|Lost to Follow-up|84|||
161655327|NCT03547739|583788892|FG002|Overall Study|Lost to Follow-up|116|||
161655328|NCT01696955|583788893|FG000|Main Study|Protocol Violation|1|||
161655329|NCT01696955|583788894|FG001|Main Study|Protocol Violation|0|||
161655330|NCT01696955|583788893|FG000|Main Study|Withdrawal by Subject|1|||
161655331|NCT01696955|583788894|FG001|Main Study|Withdrawal by Subject|1|||
161655332|NCT01641159|583788895|FG000|Overall Study|Lost to Follow-up|2|||
161655333|NCT01641159|583788896|FG001|Overall Study|Lost to Follow-up|1|||
161655334|NCT01641159|583788895|FG000|Overall Study|Withdrawal by Subject|0|||
161655335|NCT01641159|583788896|FG001|Overall Study|Withdrawal by Subject|1|||
161655336|NCT03980808|583788897|FG000|Overall Study|Lost to Follow-up|2|||
161655337|NCT03980808|583788898|FG001|Overall Study|Lost to Follow-up|2|||
161655338|NCT05330676|583788899|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
161655339|NCT05330676|583788900|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
161655340|NCT00436605|583788901|FG000|Overall Study|Protocol Violation|3|||
161655341|NCT00573859|583788906|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
161655342|NCT00573859|583788906|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
161655343|NCT02416453|583788907|FG000|Overall Study|Adverse Event|0|||
161655344|NCT02416453|583788908|FG001|Overall Study|Adverse Event|0|||
161655345|NCT02416453|583788909|FG002|Overall Study|Adverse Event|0|||
161655346|NCT02416453|583788910|FG003|Overall Study|Adverse Event|2|||
161655347|NCT02416453|583788911|FG004|Overall Study|Adverse Event|0|||
161655348|NCT02416453|583788912|FG005|Overall Study|Adverse Event|1|||
161655349|NCT02416453|583788913|FG006|Overall Study|Adverse Event|0|||
161655350|NCT02416453|583788914|FG007|Overall Study|Adverse Event|0|||
161655351|NCT02416453|583788915|FG008|Overall Study|Adverse Event|0|||
161655352|NCT02416453|583788916|FG009|Overall Study|Adverse Event|0|||
161655353|NCT02416453|583788917|FG010|Overall Study|Adverse Event|0|||
161655354|NCT02416453|583788907|FG000|Overall Study|Lost to Follow-up|1|||
161655355|NCT02416453|583788908|FG001|Overall Study|Lost to Follow-up|3|||
161655356|NCT02416453|583788909|FG002|Overall Study|Lost to Follow-up|0|||
161655357|NCT02416453|583788910|FG003|Overall Study|Lost to Follow-up|8|||
161655358|NCT02416453|583788911|FG004|Overall Study|Lost to Follow-up|0|||
161655359|NCT02416453|583788912|FG005|Overall Study|Lost to Follow-up|5|||
161655360|NCT02416453|583788913|FG006|Overall Study|Lost to Follow-up|1|||
161655361|NCT02416453|583788914|FG007|Overall Study|Lost to Follow-up|3|||
161655362|NCT02416453|583788915|FG008|Overall Study|Lost to Follow-up|1|||
161655363|NCT02416453|583788916|FG009|Overall Study|Lost to Follow-up|0|||
161655364|NCT02416453|583788917|FG010|Overall Study|Lost to Follow-up|0|||
161655365|NCT02416453|583788907|FG000|Overall Study|Physician Decision|0|||
161655366|NCT02416453|583788908|FG001|Overall Study|Physician Decision|0|||
161655367|NCT02416453|583788909|FG002|Overall Study|Physician Decision|0|||
161655368|NCT02416453|583788910|FG003|Overall Study|Physician Decision|0|||
161655369|NCT02416453|583788911|FG004|Overall Study|Physician Decision|0|||
161655370|NCT02416453|583788912|FG005|Overall Study|Physician Decision|1|||
161655371|NCT02416453|583788913|FG006|Overall Study|Physician Decision|1|||
161655372|NCT02416453|583788914|FG007|Overall Study|Physician Decision|1|||
161655373|NCT02416453|583788915|FG008|Overall Study|Physician Decision|0|||
161655374|NCT02416453|583788916|FG009|Overall Study|Physician Decision|0|||
161655375|NCT02416453|583788917|FG010|Overall Study|Physician Decision|0|||
161655376|NCT02416453|583788907|FG000|Overall Study|Withdrawal by Subject|2|||
161655377|NCT02416453|583788908|FG001|Overall Study|Withdrawal by Subject|0|||
161655378|NCT02416453|583788909|FG002|Overall Study|Withdrawal by Subject|0|||
161655379|NCT02416453|583788910|FG003|Overall Study|Withdrawal by Subject|5|||
161655380|NCT02416453|583788911|FG004|Overall Study|Withdrawal by Subject|1|||
161655381|NCT02416453|583788912|FG005|Overall Study|Withdrawal by Subject|8|||
161655382|NCT02416453|583788913|FG006|Overall Study|Withdrawal by Subject|0|||
161655383|NCT02416453|583788914|FG007|Overall Study|Withdrawal by Subject|8|||
161655384|NCT02416453|583788915|FG008|Overall Study|Withdrawal by Subject|4|||
161655385|NCT02416453|583788916|FG009|Overall Study|Withdrawal by Subject|0|||
161655386|NCT02416453|583788917|FG010|Overall Study|Withdrawal by Subject|0|||
161655387|NCT02416453|583788907|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655388|NCT02416453|583788908|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161705323|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705324|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705325|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705326|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705327|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
161705328|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
161705329|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705330|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705331|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705332|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705333|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
161705334|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
161705335|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705336|NCT03124459|583967812|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705337|NCT03124459|583967813|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705338|NCT03124459|583967814|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705339|NCT03124459|583967815|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705340|NCT03124459|583967816|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705341|NCT03124459|583967817|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
161705342|NCT03124459|583967812|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705343|NCT03124459|583967813|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705344|NCT03124459|583967814|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705345|NCT03124459|583967815|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705346|NCT03124459|583967816|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705347|NCT03124459|583967817|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
161705348|NCT03932812|583967818|FG000|Overall Study|Lost to Follow-up|12|||
161705349|NCT03932812|583967819|FG001|Overall Study|Lost to Follow-up|14|||
161705350|NCT03932812|583967818|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
161705351|NCT03932812|583967819|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
161705352|NCT03293654|583967820|FG000|Overall Study|Lost to Follow-up|0|||
161705353|NCT03293654|583967821|FG001|Overall Study|Lost to Follow-up|1|||
161705354|NCT03293654|583967822|FG002|Overall Study|Lost to Follow-up|0|||
161705355|NCT01355289|583967825|FG000|Core Study|Adverse Event, Non-Fatal|1|||
161705356|NCT01355289|583967826|FG001|Core Study|Adverse Event, Non-Fatal|0|||
161705357|NCT01355289|583967827|FG002|Core Study|Adverse Event, Non-Fatal|0|||
161705358|NCT01355289|583967828|FG003|Core Study|Adverse Event, Non-Fatal|0|||
161705359|NCT01355289|583967829|FG004|Core Study|Adverse Event, Non-Fatal|0|||
161705360|NCT01355289|583967825|FG000|Core Study|Inadequate Therapeutic Effect|0|||
161705361|NCT01355289|583967826|FG001|Core Study|Inadequate Therapeutic Effect|0|||
161705362|NCT01355289|583967827|FG002|Core Study|Inadequate Therapeutic Effect|0|||
161705363|NCT01355289|583967828|FG003|Core Study|Inadequate Therapeutic Effect|1|||
161705364|NCT01355289|583967829|FG004|Core Study|Inadequate Therapeutic Effect|0|||
161705365|NCT01355289|583967825|FG000|Core Study|Other|0|||
161705366|NCT01355289|583967826|FG001|Core Study|Other|0|||
161705367|NCT01355289|583967827|FG002|Core Study|Other|0|||
161705368|NCT01355289|583967828|FG003|Core Study|Other|1|||
161705369|NCT01355289|583967829|FG004|Core Study|Other|0|||
161705370|NCT01355289|583967825|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705371|NCT01355289|583967826|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705372|NCT01355289|583967827|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705373|NCT01355289|583967828|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705374|NCT01355289|583967829|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
161705375|NCT01355289|583967825|FG000|Open Label Extension|Lost to Follow-up|0|||
161705376|NCT01355289|583967826|FG001|Open Label Extension|Lost to Follow-up|0|||
161705377|NCT01355289|583967827|FG002|Open Label Extension|Lost to Follow-up|0|||
161705378|NCT01355289|583967828|FG003|Open Label Extension|Lost to Follow-up|0|||
161705379|NCT01355289|583967829|FG004|Open Label Extension|Lost to Follow-up|1|||
161705380|NCT01355289|583967825|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705381|NCT01355289|583967826|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705382|NCT01355289|583967827|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705383|NCT01355289|583967828|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705384|NCT01355289|583967829|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
161705385|NCT01355289|583967825|FG000|Open Label Extension|Other|0|||
161705386|NCT01355289|583967826|FG001|Open Label Extension|Other|0|||
161705387|NCT01355289|583967827|FG002|Open Label Extension|Other|0|||
161705388|NCT01355289|583967828|FG003|Open Label Extension|Other|0|||
161705389|NCT01355289|583967829|FG004|Open Label Extension|Other|3|||
161705390|NCT00802360|583967832|FG000|Overall Study|Stimulation failure|4|||
161705391|NCT00802360|583967833|FG001|Overall Study|Stimulation failure|0|||
161705392|NCT00802360|583967834|FG002|Overall Study|Stimulation failure|3|||
161705393|NCT00802360|583967835|FG003|Overall Study|Stimulation failure|3|||
161705394|NCT00802360|583967832|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
161705395|NCT00802360|583967833|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
161705396|NCT00802360|583967834|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
161705397|NCT00802360|583967835|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
161705398|NCT00802360|583967832|FG000|Overall Study|Cycle cancelled|0|||
161705399|NCT00802360|583967833|FG001|Overall Study|Cycle cancelled|1|||
161705400|NCT00802360|583967834|FG002|Overall Study|Cycle cancelled|1|||
161705401|NCT00802360|583967835|FG003|Overall Study|Cycle cancelled|1|||
161705402|NCT00802360|583967832|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161705403|NCT00802360|583967833|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161705404|NCT00802360|583967834|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161705405|NCT00802360|583967835|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
161705406|NCT00802360|583967832|FG000|Overall Study|No positive serum pregnancy|17|||
161705407|NCT00802360|583967833|FG001|Overall Study|No positive serum pregnancy|20|||
161705408|NCT00802360|583967834|FG002|Overall Study|No positive serum pregnancy|14|||
161705409|NCT00802360|583967835|FG003|Overall Study|No positive serum pregnancy|10|||
161705410|NCT00802360|583967832|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161705411|NCT00802360|583967833|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161705412|NCT00802360|583967834|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161705413|NCT00802360|583967835|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161705414|NCT00802360|583967832|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
161837570|NCT03096847|584448651|FG000|Overall Study|Adverse Event|72|||
161837571|NCT03096847|584448652|FG001|Overall Study|Adverse Event|6|||
161837572|NCT03096847|584448653|FG002|Overall Study|Adverse Event|28|||
161837573|NCT03096847|584448651|FG000|Overall Study|Progressive disease|97|||
161837574|NCT03096847|584448652|FG001|Overall Study|Progressive disease|10|||
161837575|NCT03096847|584448653|FG002|Overall Study|Progressive disease|78|||
161837576|NCT03096847|584448651|FG000|Overall Study|Non-compliance with study medication|1|||
161837577|NCT03096847|584448652|FG001|Overall Study|Non-compliance with study medication|0|||
161837578|NCT03096847|584448653|FG002|Overall Study|Non-compliance with study medication|0|||
161837579|NCT03096847|584448651|FG000|Overall Study|New therapy for study indication|1|||
161705415|NCT00802360|583967833|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
161705416|NCT00802360|583967834|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
161705417|NCT00802360|583967835|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
161705418|NCT00802360|583967832|FG000|Overall Study|Other|2|||
161705419|NCT00802360|583967833|FG001|Overall Study|Other|3|||
161705420|NCT00802360|583967834|FG002|Overall Study|Other|6|||
161705421|NCT00802360|583967835|FG003|Overall Study|Other|3|||
161705422|NCT03838484|583967846|FG000|Overall Study|Lost to Follow-up|0|||
161705423|NCT03838484|583967847|FG001|Overall Study|Lost to Follow-up|1|||
161705424|NCT03838484|583967848|FG002|Overall Study|Lost to Follow-up|0|||
161705425|NCT03838484|583967849|FG003|Overall Study|Lost to Follow-up|0|||
161705426|NCT01614964|583967850|FG000|Overall Study|Withdrawal by Subject|2|||
161705427|NCT01614964|583967851|FG001|Overall Study|Withdrawal by Subject|0|||
161705428|NCT01614964|583967850|FG000|Overall Study|Lost to Follow-up|3|||
161705429|NCT01614964|583967851|FG001|Overall Study|Lost to Follow-up|0|||
161705430|NCT00860470|583967860|FG000|Overall Study|Death|6|||
161705431|NCT00860470|583967861|FG001|Overall Study|Death|10|||
161705432|NCT00860470|583967860|FG000|Overall Study|Moved away|8|||
161705433|NCT00860470|583967861|FG001|Overall Study|Moved away|10|||
161705434|NCT00860470|583967860|FG000|Overall Study|Lost to Follow-up|34|||
161705435|NCT00860470|583967861|FG001|Overall Study|Lost to Follow-up|39|||
161705436|NCT01032629|583967863|FG000|Overall Study|Closed Site|21|||
161705437|NCT01032629|583967864|FG001|Overall Study|Closed Site|18|||
161705438|NCT01032629|583967865|FG002|Overall Study|Closed Site|16|||
161705439|NCT01032629|583967863|FG000|Overall Study|Withdrawal by Subject|50|||
161837580|NCT03096847|584448652|FG001|Overall Study|New therapy for study indication|0|||
161705440|NCT01032629|583967864|FG001|Overall Study|Withdrawal by Subject|36|||
161705441|NCT01032629|583967865|FG002|Overall Study|Withdrawal by Subject|35|||
161705442|NCT01032629|583967863|FG000|Overall Study|Lost to Follow-up|74|||
161705443|NCT01032629|583967864|FG001|Overall Study|Lost to Follow-up|47|||
161837581|NCT03096847|584448653|FG002|Overall Study|New therapy for study indication|1|||
161837582|NCT00359632|584448657|FG000|Overall Study|Death|2|||
161837583|NCT00359632|584448658|FG001|Overall Study|Death|0|||
161705444|NCT01032629|583967865|FG002|Overall Study|Lost to Follow-up|37|||
161705445|NCT03371355|583967868|FG000|Overall Study|Investigator judgment|0|||
161705446|NCT03371355|583967869|FG001|Overall Study|Investigator judgment|0|||
161705447|NCT03371355|583967870|FG002|Overall Study|Investigator judgment|1|||
161705448|NCT03371355|583967871|FG003|Overall Study|Investigator judgment|1|||
161705449|NCT03371355|583967868|FG000|Overall Study|Voluntary withdrawal|1|||
161705450|NCT03371355|583967869|FG001|Overall Study|Voluntary withdrawal|0|||
161705451|NCT03371355|583967870|FG002|Overall Study|Voluntary withdrawal|1|||
161705452|NCT03371355|583967871|FG003|Overall Study|Voluntary withdrawal|2|||
161705453|NCT03371355|583967868|FG000|Overall Study|Adverse Event|0|||
161705454|NCT03371355|583967869|FG001|Overall Study|Adverse Event|1|||
161705455|NCT03371355|583967870|FG002|Overall Study|Adverse Event|2|||
161705456|NCT03371355|583967871|FG003|Overall Study|Adverse Event|3|||
161705457|NCT03371355|583967868|FG000|Overall Study|Reason not Specified|0|||
161705458|NCT03371355|583967869|FG001|Overall Study|Reason not Specified|1|||
161705459|NCT03371355|583967870|FG002|Overall Study|Reason not Specified|0|||
161705460|NCT03371355|583967871|FG003|Overall Study|Reason not Specified|1|||
161705461|NCT00619957|583967875|FG000|Month 24 Double-Blind|Adverse Event|9|||
161705462|NCT00619957|583967876|FG001|Month 24 Double-Blind|Adverse Event|7|||
161705463|NCT00619957|583967875|FG000|Month 24 Double-Blind|Protocol Violation|1|||
161705464|NCT00619957|583967876|FG001|Month 24 Double-Blind|Protocol Violation|0|||
161705465|NCT00619957|583967875|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
161705466|NCT00619957|583967876|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
161705467|NCT00619957|583967875|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
161705468|NCT00619957|583967876|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
161705469|NCT00619957|583967875|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
161705470|NCT00619957|583967876|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
161705471|NCT00619957|583967875|FG000|Month 48 Open-Label|Adverse Event|4|||
161705472|NCT00619957|583967876|FG001|Month 48 Open-Label|Adverse Event|4|||
161705473|NCT00619957|583967875|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
161705474|NCT00619957|583967876|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
161705475|NCT00619957|583967875|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
161705476|NCT00619957|583967876|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
161705477|NCT00723957|583967877|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161705478|NCT00723957|583967878|FG001|Overall Study|Adverse event unrelated to study drug|4|||
161705479|NCT00723957|583967877|FG000|Overall Study|Death|3|||
161705480|NCT00723957|583967878|FG001|Overall Study|Death|4|||
161705481|NCT00723957|583967877|FG000|Overall Study|Disease progression|27|||
161705482|NCT00723957|583967878|FG001|Overall Study|Disease progression|25|||
161705483|NCT00723957|583967877|FG000|Overall Study|Maximum clinical benefit|4|||
161705484|NCT00723957|583967878|FG001|Overall Study|Maximum clinical benefit|5|||
161705485|NCT00723957|583967877|FG000|Overall Study|Investigator decision|1|||
161705486|NCT00723957|583967878|FG001|Overall Study|Investigator decision|1|||
161705487|NCT00723957|583967877|FG000|Overall Study|Study drug toxicity|4|||
161705488|NCT00723957|583967878|FG001|Overall Study|Study drug toxicity|6|||
161705489|NCT00723957|583967877|FG000|Overall Study|Withdrawal by Subject|7|||
161705490|NCT00723957|583967878|FG001|Overall Study|Withdrawal by Subject|5|||
161705491|NCT00723957|583967877|FG000|Overall Study|Reason not analyzed|1|||
161705492|NCT00723957|583967878|FG001|Overall Study|Reason not analyzed|0|||
161705493|NCT00723957|583967877|FG000|Overall Study|Never received treatment|3|||
161705494|NCT00723957|583967878|FG001|Overall Study|Never received treatment|3|||
161705495|NCT01763164|583967880|FG000|Treatment Phase|Participant/Guardian decision|26|||
161705496|NCT01763164|583967881|FG001|Treatment Phase|Participant/Guardian decision|14|||
161705497|NCT01763164|583967880|FG000|Treatment Phase|Protocol Violation|1|||
161705498|NCT01763164|583967881|FG001|Treatment Phase|Protocol Violation|1|||
161705499|NCT01763164|583967880|FG000|Treatment Phase|Progressive Disease|142|||
161705500|NCT01763164|583967881|FG001|Treatment Phase|Progressive Disease|76|||
161705501|NCT01763164|583967880|FG000|Treatment Phase|Physician Decision|24|||
161705502|NCT01763164|583967881|FG001|Treatment Phase|Physician Decision|13|||
161705503|NCT01763164|583967880|FG000|Treatment Phase|Death|10|||
161705504|NCT01763164|583967881|FG001|Treatment Phase|Death|1|||
161705505|NCT01763164|583967880|FG000|Treatment Phase|Adverse Event|66|||
161705506|NCT01763164|583967881|FG001|Treatment Phase|Adverse Event|8|||
161705507|NCT01763164|583967880|FG000|Treatment Phase|Randomized but not Treated|0|||
161705508|NCT01763164|583967881|FG001|Treatment Phase|Randomized but not Treated|19|||
161705509|NCT01763164|583967880|FG000|Treatment Phase|Other|0|||
161705510|NCT01763164|583967881|FG001|Treatment Phase|Other|1|||
161705511|NCT01763164|583967880|FG000|Follow up Phase|New therapy for study indication|12|||
161705512|NCT01763164|583967881|FG001|Follow up Phase|New therapy for study indication|3|||
161705513|NCT01763164|583967880|FG000|Follow up Phase|Death|21|||
161705514|NCT01763164|583967881|FG001|Follow up Phase|Death|4|||
161705515|NCT01763164|583967880|FG000|Follow up Phase|Subject/guardian decision|9|||
161705516|NCT01763164|583967881|FG001|Follow up Phase|Subject/guardian decision|2|||
161705517|NCT01763164|583967880|FG000|Follow up Phase|Progressive disease|127|||
161705518|NCT01763164|583967881|FG001|Follow up Phase|Progressive disease|62|||
161837584|NCT00359632|584448657|FG000|Overall Study|Adverse Event|1|||
161705519|NCT01763164|583967880|FG000|Follow up Phase|Physician Decision|10|||
161705520|NCT01763164|583967881|FG001|Follow up Phase|Physician Decision|3|||
161705521|NCT01763164|583967880|FG000|Follow up Phase|Lost to Follow-up|1|||
161705522|NCT01763164|583967881|FG001|Follow up Phase|Lost to Follow-up|0|||
161705523|NCT01763164|583967880|FG000|Follow up Phase|Adverse Event|17|||
161705524|NCT01763164|583967881|FG001|Follow up Phase|Adverse Event|1|||
161705525|NCT01264939|583967882|FG000|Overall Study|Adverse Event|1|||
161705526|NCT01264939|583967883|FG001|Overall Study|Adverse Event|3|||
161705527|NCT01264939|583967882|FG000|Overall Study|Lost to Follow-up|0|||
161705528|NCT01264939|583967883|FG001|Overall Study|Lost to Follow-up|3|||
161705529|NCT01264939|583967882|FG000|Overall Study|Physician Decision|1|||
161705530|NCT01264939|583967883|FG001|Overall Study|Physician Decision|1|||
161705531|NCT01264939|583967882|FG000|Overall Study|Patient/Guardian Decision|8|||
161705532|NCT01264939|583967883|FG001|Overall Study|Patient/Guardian Decision|10|||
161705533|NCT01264939|583967882|FG000|Overall Study|Disease Progression|8|||
161705534|NCT01264939|583967883|FG001|Overall Study|Disease Progression|11|||
161705535|NCT04964258|583967884|FG000|Overall Study|Lost to Follow-up|1|||
161705536|NCT04964258|583967885|FG001|Overall Study|Lost to Follow-up|0|||
161705537|NCT04964258|583967886|FG002|Overall Study|Lost to Follow-up|0|||
161705538|NCT04964258|583967887|FG003|Overall Study|Lost to Follow-up|0|||
161705539|NCT04964258|583967888|FG004|Overall Study|Lost to Follow-up|0|||
161705540|NCT04964258|583967889|FG005|Overall Study|Lost to Follow-up|1|||
161705541|NCT04964258|583967890|FG006|Overall Study|Lost to Follow-up|0|||
161705542|NCT04964258|583967891|FG007|Overall Study|Lost to Follow-up|0|||
161705543|NCT04964258|583967892|FG008|Overall Study|Lost to Follow-up|0|||
161705544|NCT04964258|583967893|FG009|Overall Study|Lost to Follow-up|0|||
161705545|NCT04964258|583967894|FG010|Overall Study|Lost to Follow-up|0|||
161705546|NCT02965378|583967895|FG000|Overall Study|Progression|16|||
161705547|NCT02965378|583967896|FG001|Overall Study|Progression|4|||
161705548|NCT02965378|583967895|FG000|Overall Study|Adverse Event|5|||
161705549|NCT02965378|583967896|FG001|Overall Study|Adverse Event|2|||
161705550|NCT02965378|583967895|FG000|Overall Study|Death|2|||
161705551|NCT02965378|583967896|FG001|Overall Study|Death|0|||
161705552|NCT02965378|583967895|FG000|Overall Study|Refusal|2|||
161705553|NCT02965378|583967896|FG001|Overall Study|Refusal|1|||
161705554|NCT02965378|583967895|FG000|Overall Study|Not protocol specified|0|||
161705555|NCT02965378|583967896|FG001|Overall Study|Not protocol specified|2|||
161705556|NCT01384292|583967899|FG000|Part B|Severe non-compliance to protocol|1|||
161705557|NCT01384292|583967900|FG001|Part B|Severe non-compliance to protocol|0|||
161705558|NCT01384292|583967901|FG002|Part B|Severe non-compliance to protocol|0|||
161705559|NCT01171612|583967903|FG000|Overall Study|Lost to Follow-up|51|||
161705560|NCT04525703|583967904|FG000|Overall Study|Lost to Follow-up|6|||
161705561|NCT04525703|583967905|FG001|Overall Study|Lost to Follow-up|15|||
161705562|NCT04525703|583967906|FG002|Overall Study|Lost to Follow-up|8|||
161705563|NCT01285349|583967907|FG000|Overall Study|Lost to Follow-up|27|||
161705564|NCT01285349|583967908|FG001|Overall Study|Lost to Follow-up|20|||
161705565|NCT01285349|583967909|FG002|Overall Study|Lost to Follow-up|27|||
161705566|NCT00565617|583967910|FG000|Overall Study|Withdrawal by Subject|1|||
161705567|NCT01526148|583967916|FG000|Overall Study|Adverse Event|6|||
161705568|NCT01526148|583967917|FG001|Overall Study|Adverse Event|5|||
161705569|NCT01526148|583967916|FG000|Overall Study|Lost to Follow-up|3|||
161705570|NCT01526148|583967917|FG001|Overall Study|Lost to Follow-up|6|||
161705571|NCT01526148|583967916|FG000|Overall Study|Withdrawal by Subject|2|||
161705572|NCT01526148|583967917|FG001|Overall Study|Withdrawal by Subject|0|||
161705573|NCT01526148|583967916|FG000|Overall Study|Unstable Medical Condition|1|||
161705574|NCT01526148|583967917|FG001|Overall Study|Unstable Medical Condition|0|||
161705575|NCT01526148|583967916|FG000|Overall Study|Unable to discontinue concomitant med|1|||
161705576|NCT01526148|583967917|FG001|Overall Study|Unable to discontinue concomitant med|0|||
161705577|NCT01526148|583967916|FG000|Overall Study|Moved out of state|1|||
161705578|NCT01526148|583967917|FG001|Overall Study|Moved out of state|0|||
161705579|NCT01526148|583967916|FG000|Overall Study|Incarcerated|0|||
161705580|NCT01526148|583967917|FG001|Overall Study|Incarcerated|2|||
161705581|NCT01173653|583967918|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
161705582|NCT01173653|583967919|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
161705583|NCT00996203|583967922|FG000|Overall Study|Adverse Event|3|||
161705584|NCT00996203|583967922|FG000|Overall Study|Lost to Follow-up|1|||
161705585|NCT00996203|583967922|FG000|Overall Study|Lack of Efficacy|1|||
161705586|NCT00996203|583967922|FG000|Overall Study|Protocol Violation|2|||
161705587|NCT01671280|583967923|FG000|Overall Study|Withdrawal by Subject|2|||
161705588|NCT01959165|583967924|FG000|Overall Study|Adverse Event|0|||
161705589|NCT01959165|583967925|FG001|Overall Study|Adverse Event|0|||
161705590|NCT01959165|583967926|FG002|Overall Study|Adverse Event|0|||
161705591|NCT01959165|583967927|FG003|Overall Study|Adverse Event|1|||
161705592|NCT01959165|583967924|FG000|Overall Study|Lack of Efficacy|1|||
161705593|NCT01959165|583967925|FG001|Overall Study|Lack of Efficacy|0|||
161705594|NCT01959165|583967926|FG002|Overall Study|Lack of Efficacy|0|||
161705595|NCT01959165|583967927|FG003|Overall Study|Lack of Efficacy|0|||
161705596|NCT01959165|583967924|FG000|Overall Study|overdose|0|||
161705597|NCT01959165|583967925|FG001|Overall Study|overdose|0|||
161705598|NCT01959165|583967926|FG002|Overall Study|overdose|0|||
161705599|NCT01959165|583967927|FG003|Overall Study|overdose|1|||
161705600|NCT01959165|583967924|FG000|Overall Study|Welfare recipient|0|||
161705601|NCT01959165|583967925|FG001|Overall Study|Welfare recipient|1|||
161705602|NCT01959165|583967926|FG002|Overall Study|Welfare recipient|0|||
161705603|NCT01959165|583967927|FG003|Overall Study|Welfare recipient|0|||
161705604|NCT03529409|583967937|FG000|Randomized|Lost to Follow-up|0|||
161705605|NCT03529409|583967938|FG001|Randomized|Lost to Follow-up|0|||
161705606|NCT03529409|583967939|FG002|Randomized|Lost to Follow-up|4|||
161705607|NCT03529409|583967937|FG000|Randomized|Excluded|0|||
161705608|NCT03529409|583967938|FG001|Randomized|Excluded|0|||
161705609|NCT03529409|583967939|FG002|Randomized|Excluded|1|||
161705610|NCT03529409|583967937|FG000|Post-treatment Assessment|Death|1|||
161705611|NCT03529409|583967938|FG001|Post-treatment Assessment|Death|0|||
161705612|NCT03529409|583967939|FG002|Post-treatment Assessment|Death|0|||
161705613|NCT03529409|583967937|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
161705614|NCT03529409|583967938|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
161705615|NCT03529409|583967939|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
161705616|NCT03529409|583967937|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
161705617|NCT03529409|583967938|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
161705618|NCT03529409|583967939|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
161705619|NCT03529409|583967937|FG000|Follow-up Assessment|Death|1|||
161705620|NCT03529409|583967938|FG001|Follow-up Assessment|Death|0|||
161705621|NCT03529409|583967939|FG002|Follow-up Assessment|Death|0|||
161705622|NCT03529409|583967937|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
161705623|NCT03529409|583967938|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
161705624|NCT03529409|583967939|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
161705625|NCT01497262|583967940|FG000|Overall Study|Abnormal Lab Values|4|||
161705626|NCT01497262|583967940|FG000|Overall Study|Abnormal Test Procedure Result|1|||
161705627|NCT01497262|583967940|FG000|Overall Study|Physician Decision|1|||
161705628|NCT01497262|583967940|FG000|Overall Study|Withdrawal by Subject|2|||
161705629|NCT01497262|583967940|FG000|Overall Study|Adverse Event|2|||
161705630|NCT01497262|583967940|FG000|Overall Study|Protocol Violation|1|||
161705631|NCT03898063|583967943|FG000|Overall Study|Withdrawal by Subject|10|||
161705632|NCT03898063|583967944|FG001|Overall Study|Withdrawal by Subject|8|||
161705633|NCT03430986|583967947|FG000|24-week Control Period|Adverse Event|1|||
161705634|NCT03430986|583967948|FG001|24-week Control Period|Adverse Event|0|||
161705635|NCT03430986|583967947|FG000|24-week Control Period|Lost to Follow-up|2|||
161705636|NCT03430986|583967948|FG001|24-week Control Period|Lost to Follow-up|2|||
161705637|NCT03430986|583967947|FG000|24-week Control Period|Withdrawal by Participant|5|||
161705638|NCT03430986|583967948|FG001|24-week Control Period|Withdrawal by Participant|0|||
161705639|NCT03430986|583967947|FG000|24-week Control Period|Protocol Deviation|0|||
161705640|NCT03430986|583967948|FG001|24-week Control Period|Protocol Deviation|2|||
161705641|NCT03430986|583967947|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
161705642|NCT03430986|583967948|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
161705643|NCT03430986|583967947|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
161705644|NCT03430986|583967948|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
161705645|NCT01889602|583967951|FG000|First Intervention|Adverse Event|1|||
161705646|NCT01889602|583967952|FG001|First Intervention|Adverse Event|1|||
161837585|NCT00359632|584448658|FG001|Overall Study|Adverse Event|0|||
161837586|NCT00359632|584448657|FG000|Overall Study|Non-compliance with visit schedule|1|||
161837587|NCT00359632|584448658|FG001|Overall Study|Non-compliance with visit schedule|0|||
161837588|NCT03978091|584448659|FG000|Overall Study|Lost to Follow-up|0|||
161837589|NCT03978091|584448660|FG001|Overall Study|Lost to Follow-up|0|||
161837590|NCT03978091|584448661|FG002|Overall Study|Lost to Follow-up|1|||
161837591|NCT03978091|584448662|FG003|Overall Study|Lost to Follow-up|0|||
161837592|NCT03978091|584448663|FG004|Overall Study|Lost to Follow-up|0|||
161837593|NCT03978091|584448664|FG005|Overall Study|Lost to Follow-up|0|||
161837594|NCT03978091|584448659|FG000|Overall Study|Withdrawal by Subject|0|||
161837595|NCT03978091|584448660|FG001|Overall Study|Withdrawal by Subject|0|||
161837596|NCT03978091|584448661|FG002|Overall Study|Withdrawal by Subject|0|||
161837597|NCT03978091|584448662|FG003|Overall Study|Withdrawal by Subject|1|||
161837598|NCT03978091|584448663|FG004|Overall Study|Withdrawal by Subject|1|||
161837599|NCT03978091|584448664|FG005|Overall Study|Withdrawal by Subject|0|||
161837600|NCT04700280|584448668|FG000|Overall Study|Adverse Event|4|||
161837601|NCT04700280|584448669|FG001|Overall Study|Adverse Event|0|||
161837602|NCT04700280|584448668|FG000|Overall Study|Lack of Efficacy|1|||
161837603|NCT04700280|584448669|FG001|Overall Study|Lack of Efficacy|0|||
161837604|NCT04700280|584448668|FG000|Overall Study|Study terminated by sponsor|5|||
161837605|NCT04700280|584448669|FG001|Overall Study|Study terminated by sponsor|3|||
161837606|NCT04700280|584448668|FG000|Overall Study|Other than specified|1|||
161837607|NCT04700280|584448669|FG001|Overall Study|Other than specified|0|||
161837608|NCT02093221|584448670|FG000|Overall Study|Adverse Event|1|||
161837609|NCT02093221|584448671|FG001|Overall Study|Adverse Event|0|||
161837610|NCT02093221|584448672|FG002|Overall Study|Adverse Event|0|||
161837611|NCT02093221|584448673|FG003|Overall Study|Adverse Event|0|||
161837612|NCT02093221|584448674|FG004|Overall Study|Adverse Event|0|||
161705647|NCT01889602|583967953|FG002|First Intervention|Adverse Event|1|||
161705648|NCT01889602|583967951|FG000|First Intervention|Protocol Violation|0|||
161705649|NCT01889602|583967952|FG001|First Intervention|Protocol Violation|1|||
161705650|NCT01889602|583967953|FG002|First Intervention|Protocol Violation|1|||
161705651|NCT01889602|583967951|FG000|First Intervention|Study ending|0|||
161705652|NCT01889602|583967952|FG001|First Intervention|Study ending|1|||
161705653|NCT01889602|583967953|FG002|First Intervention|Study ending|0|||
161705654|NCT01889602|583967951|FG000|Second Intervention|Adverse Event|0|||
161705655|NCT01889602|583967952|FG001|Second Intervention|Adverse Event|0|||
161705656|NCT01889602|583967953|FG002|Second Intervention|Adverse Event|1|||
161705657|NCT01889602|583967951|FG000|Second Intervention|Study ending|1|||
161705658|NCT01889602|583967952|FG001|Second Intervention|Study ending|0|||
161705659|NCT01889602|583967953|FG002|Second Intervention|Study ending|0|||
161705660|NCT01889602|583967951|FG000|Second Intervention|Withdrawal by Subject|0|||
161705661|NCT01889602|583967952|FG001|Second Intervention|Withdrawal by Subject|0|||
161705662|NCT01889602|583967953|FG002|Second Intervention|Withdrawal by Subject|1|||
161705663|NCT01889602|583967951|FG000|Third Intervention|Protocol Violation|1|||
161705664|NCT01889602|583967952|FG001|Third Intervention|Protocol Violation|0|||
161705665|NCT01889602|583967953|FG002|Third Intervention|Protocol Violation|0|||
161705666|NCT01889602|583967951|FG000|Third Intervention|Withdrawal by Subject|2|||
161705667|NCT01889602|583967952|FG001|Third Intervention|Withdrawal by Subject|2|||
161705668|NCT01889602|583967953|FG002|Third Intervention|Withdrawal by Subject|0|||
161705669|NCT00961961|583967954|FG000|Phase I|Withdrawal by Subject|7|||
161705670|NCT00961961|583967955|FG001|Phase I|Withdrawal by Subject|0|||
161705671|NCT00961961|583967956|FG002|Phase I|Withdrawal by Subject|0|||
161705672|NCT00961961|583967957|FG003|Phase I|Withdrawal by Subject|0|||
161705673|NCT00961961|583967954|FG000|Phase I|Lost to Follow-up|10|||
161705674|NCT00961961|583967955|FG001|Phase I|Lost to Follow-up|0|||
161705675|NCT00961961|583967956|FG002|Phase I|Lost to Follow-up|0|||
161705676|NCT00961961|583967957|FG003|Phase I|Lost to Follow-up|0|||
161705677|NCT00961961|583967954|FG000|Phase I|Lack of Efficacy|94|||
161705678|NCT00961961|583967955|FG001|Phase I|Lack of Efficacy|0|||
161705679|NCT00961961|583967956|FG002|Phase I|Lack of Efficacy|0|||
161705680|NCT00961961|583967957|FG003|Phase I|Lack of Efficacy|0|||
161705681|NCT00961961|583967954|FG000|Phase I|Adverse Event|7|||
161705682|NCT00961961|583967955|FG001|Phase I|Adverse Event|0|||
161705683|NCT00961961|583967956|FG002|Phase I|Adverse Event|0|||
161705684|NCT00961961|583967957|FG003|Phase I|Adverse Event|0|||
161705685|NCT00961961|583967954|FG000|Phase I|Physician Decision|8|||
161705686|NCT00961961|583967955|FG001|Phase I|Physician Decision|0|||
161705687|NCT00961961|583967956|FG002|Phase I|Physician Decision|0|||
161705688|NCT00961961|583967957|FG003|Phase I|Physician Decision|0|||
161705689|NCT00961961|583967954|FG000|Phase II|Lost to Follow-up|0|||
161705690|NCT00961961|583967955|FG001|Phase II|Lost to Follow-up|0|||
161705691|NCT00961961|583967956|FG002|Phase II|Lost to Follow-up|10|||
161705692|NCT00961961|583967957|FG003|Phase II|Lost to Follow-up|7|||
161705693|NCT00961961|583967954|FG000|Phase II|Adverse Event|0|||
161705694|NCT00961961|583967955|FG001|Phase II|Adverse Event|0|||
161705695|NCT00961961|583967956|FG002|Phase II|Adverse Event|0|||
161705696|NCT00961961|583967957|FG003|Phase II|Adverse Event|1|||
161705697|NCT00961961|583967954|FG000|Phase II|Physician Decision|0|||
161705698|NCT00961961|583967955|FG001|Phase II|Physician Decision|0|||
161705699|NCT00961961|583967956|FG002|Phase II|Physician Decision|1|||
161705700|NCT00961961|583967957|FG003|Phase II|Physician Decision|0|||
161705701|NCT00961961|583967954|FG000|Phase II|Withdrawal by Subject|0|||
161705702|NCT00961961|583967955|FG001|Phase II|Withdrawal by Subject|0|||
161705703|NCT00961961|583967956|FG002|Phase II|Withdrawal by Subject|1|||
161705704|NCT00961961|583967957|FG003|Phase II|Withdrawal by Subject|0|||
161705705|NCT01412957|583967958|FG000|Overall Study|Withdrawal by Subject|6|||
161837613|NCT02093221|584448670|FG000|Overall Study|Withdrawal by Subject|1|||
161837614|NCT02093221|584448671|FG001|Overall Study|Withdrawal by Subject|1|||
161837615|NCT02093221|584448672|FG002|Overall Study|Withdrawal by Subject|4|||
161837616|NCT02093221|584448673|FG003|Overall Study|Withdrawal by Subject|1|||
161837617|NCT02093221|584448674|FG004|Overall Study|Withdrawal by Subject|1|||
161837618|NCT02093221|584448670|FG000|Overall Study|Lost to Follow-up|2|||
161837619|NCT02093221|584448671|FG001|Overall Study|Lost to Follow-up|0|||
161837620|NCT02093221|584448672|FG002|Overall Study|Lost to Follow-up|1|||
161705706|NCT01412957|583967959|FG001|Overall Study|Withdrawal by Subject|22|||
161705707|NCT01412957|583967958|FG000|Overall Study|Lost to Follow-up|7|||
161705708|NCT01412957|583967959|FG001|Overall Study|Lost to Follow-up|2|||
161837621|NCT02093221|584448673|FG003|Overall Study|Lost to Follow-up|1|||
161705709|NCT01412957|583967958|FG000|Overall Study|Death|136|||
161837622|NCT02093221|584448674|FG004|Overall Study|Lost to Follow-up|0|||
161837623|NCT02093221|584448670|FG000|Overall Study|Death|0|||
161705710|NCT01412957|583967959|FG001|Overall Study|Death|133|||
161705711|NCT01870739|583967965|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
161705712|NCT01870739|583967966|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
161705713|NCT01870739|583967965|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
161837624|NCT02093221|584448671|FG001|Overall Study|Death|1|||
161837625|NCT02093221|584448672|FG002|Overall Study|Death|0|||
161705714|NCT01870739|583967966|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
161705715|NCT01870739|583967965|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
161705716|NCT01870739|583967966|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
161705717|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
161705718|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
161705719|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
161705720|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
161705721|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
161705722|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
161705723|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
161705724|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
161705725|NCT02425098|583967968|FG000|Overall Study|Lost to Follow-up|7|||
161705726|NCT02425098|583967969|FG001|Overall Study|Lost to Follow-up|7|||
161705727|NCT02425098|583967968|FG000|Overall Study|Withdrawal by Subject|4|||
161705728|NCT02425098|583967969|FG001|Overall Study|Withdrawal by Subject|8|||
161705729|NCT02425098|583967968|FG000|Overall Study|Pregnancy|2|||
161705730|NCT02425098|583967969|FG001|Overall Study|Pregnancy|0|||
161705731|NCT02425098|583967968|FG000|Overall Study|Reason not Specified|0|||
161705732|NCT02425098|583967969|FG001|Overall Study|Reason not Specified|1|||
161705733|NCT01926626|583967979|FG000|Overall Study|Withdrawal by Subject|15|||
161705734|NCT01926626|583967979|FG000|Overall Study|Lost to Follow-up|7|||
161705735|NCT03283085|583967980|FG000|Overall Study|Adverse Event|18|||
161705736|NCT03283085|583967981|FG001|Overall Study|Adverse Event|3|||
161705737|NCT03283085|583967982|FG002|Overall Study|Adverse Event|13|||
161705738|NCT03283085|583967983|FG003|Overall Study|Adverse Event|0|||
161705739|NCT03283085|583967984|FG004|Overall Study|Adverse Event|0|||
161705740|NCT03283085|583967985|FG005|Overall Study|Adverse Event|5|||
161705741|NCT03283085|583967980|FG000|Overall Study|Death|0|||
161705742|NCT03283085|583967981|FG001|Overall Study|Death|0|||
161705743|NCT03283085|583967982|FG002|Overall Study|Death|3|||
161705744|NCT03283085|583967983|FG003|Overall Study|Death|1|||
161705745|NCT03283085|583967984|FG004|Overall Study|Death|0|||
161705746|NCT03283085|583967985|FG005|Overall Study|Death|0|||
161705747|NCT03283085|583967980|FG000|Overall Study|Withdrawal by Subject|42|||
161705748|NCT03283085|583967981|FG001|Overall Study|Withdrawal by Subject|21|||
161705749|NCT03283085|583967982|FG002|Overall Study|Withdrawal by Subject|66|||
161705750|NCT03283085|583967983|FG003|Overall Study|Withdrawal by Subject|3|||
161705751|NCT03283085|583967984|FG004|Overall Study|Withdrawal by Subject|3|||
161705752|NCT03283085|583967985|FG005|Overall Study|Withdrawal by Subject|5|||
161705753|NCT03283085|583967980|FG000|Overall Study|Physician Decision|14|||
161705754|NCT03283085|583967981|FG001|Overall Study|Physician Decision|8|||
161705755|NCT03283085|583967982|FG002|Overall Study|Physician Decision|19|||
161705756|NCT03283085|583967983|FG003|Overall Study|Physician Decision|0|||
161705757|NCT03283085|583967984|FG004|Overall Study|Physician Decision|0|||
161705758|NCT03283085|583967985|FG005|Overall Study|Physician Decision|2|||
161705759|NCT03283085|583967980|FG000|Overall Study|Site Terminated by Sponsor|1|||
161705760|NCT03283085|583967981|FG001|Overall Study|Site Terminated by Sponsor|0|||
161705761|NCT03283085|583967982|FG002|Overall Study|Site Terminated by Sponsor|3|||
161705762|NCT03283085|583967983|FG003|Overall Study|Site Terminated by Sponsor|0|||
161705763|NCT03283085|583967984|FG004|Overall Study|Site Terminated by Sponsor|0|||
161705764|NCT03283085|583967985|FG005|Overall Study|Site Terminated by Sponsor|0|||
161705765|NCT03283085|583967980|FG000|Overall Study|Lost to Follow-up|2|||
161705766|NCT03283085|583967981|FG001|Overall Study|Lost to Follow-up|0|||
161705767|NCT03283085|583967982|FG002|Overall Study|Lost to Follow-up|2|||
161705768|NCT03283085|583967983|FG003|Overall Study|Lost to Follow-up|0|||
161705769|NCT03283085|583967984|FG004|Overall Study|Lost to Follow-up|0|||
161705770|NCT03283085|583967985|FG005|Overall Study|Lost to Follow-up|1|||
161705771|NCT03283085|583967980|FG000|Overall Study|Pregnancy|0|||
161705772|NCT03283085|583967981|FG001|Overall Study|Pregnancy|0|||
161705773|NCT03283085|583967982|FG002|Overall Study|Pregnancy|1|||
161705774|NCT03283085|583967983|FG003|Overall Study|Pregnancy|0|||
161705775|NCT03283085|583967984|FG004|Overall Study|Pregnancy|0|||
161705776|NCT03283085|583967985|FG005|Overall Study|Pregnancy|0|||
161705777|NCT03283085|583967980|FG000|Overall Study|Lack of Efficacy|12|||
161705778|NCT03283085|583967981|FG001|Overall Study|Lack of Efficacy|6|||
161705779|NCT03283085|583967982|FG002|Overall Study|Lack of Efficacy|24|||
161705780|NCT03283085|583967983|FG003|Overall Study|Lack of Efficacy|1|||
161705781|NCT03283085|583967984|FG004|Overall Study|Lack of Efficacy|1|||
161705782|NCT03283085|583967985|FG005|Overall Study|Lack of Efficacy|0|||
161705783|NCT03283085|583967980|FG000|Overall Study|Reason not Specified|0|||
161705784|NCT03283085|583967981|FG001|Overall Study|Reason not Specified|4|||
161705785|NCT03283085|583967982|FG002|Overall Study|Reason not Specified|8|||
161705786|NCT03283085|583967983|FG003|Overall Study|Reason not Specified|0|||
161705787|NCT03283085|583967984|FG004|Overall Study|Reason not Specified|0|||
161705788|NCT03283085|583967985|FG005|Overall Study|Reason not Specified|1|||
161705789|NCT03636906|583967986|FG000|Overall Study|Adverse Event|0|||
161705790|NCT03636906|583967987|FG001|Overall Study|Adverse Event|0|||
161705791|NCT03636906|583967988|FG002|Overall Study|Adverse Event|1|||
161705792|NCT03636906|583967986|FG000|Overall Study|Lost to Follow-up|1|||
161705793|NCT03636906|583967987|FG001|Overall Study|Lost to Follow-up|0|||
161705794|NCT03636906|583967988|FG002|Overall Study|Lost to Follow-up|0|||
161705795|NCT03636906|583967986|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
161705796|NCT03636906|583967987|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
161705797|NCT03636906|583967988|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
161705798|NCT03636906|583967986|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161705799|NCT03636906|583967987|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161705800|NCT03636906|583967988|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
161705801|NCT03636906|583967986|FG000|Overall Study|Other|0|||
161705802|NCT03636906|583967987|FG001|Overall Study|Other|0|||
161705803|NCT03636906|583967988|FG002|Overall Study|Other|1|||
161705804|NCT02292771|583967994|FG000|Overall Study|Withdrawal by Subject|2|||
161705805|NCT02292771|583967995|FG001|Overall Study|Withdrawal by Subject|1|||
161705806|NCT02292771|583967994|FG000|Overall Study|Lost to Follow-up|2|||
161705807|NCT02292771|583967995|FG001|Overall Study|Lost to Follow-up|1|||
161705808|NCT04280081|583967997|FG000|Overall Study|Adverse Event|4|||
161705809|NCT04280081|583967997|FG000|Overall Study|Death|2|||
161705810|NCT04280081|583967997|FG000|Overall Study|Progressive Disease|6|||
161705811|NCT01468311|583967998|FG000|Overall Study|mobilization failure|1|||
161705812|NCT01468311|583967998|FG000|Overall Study|Withdrawal by Subject|1|||
161705813|NCT06001307|583969203|FG000|Overall Study|Lost to Follow-up|1|||
161705814|NCT06001307|583969204|FG001|Overall Study|Lost to Follow-up|2|||
161705815|NCT03532100|583969207|FG000|Overall Study|Intervention malfunction|1|||
161705816|NCT03896581|583969208|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
161705817|NCT03896581|583969209|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
161705818|NCT03896581|583969208|FG000|Overall Study|Withdrawal by Subject|4|||
161705819|NCT03896581|583969209|FG001|Overall Study|Withdrawal by Subject|1|||
161705820|NCT03896581|583969208|FG000|Overall Study|Lost to Follow-up|1|||
161705821|NCT03896581|583969209|FG001|Overall Study|Lost to Follow-up|0|||
161705822|NCT03896581|583969208|FG000|Overall Study|Lack of Efficacy|2|||
161705823|NCT03896581|583969209|FG001|Overall Study|Lack of Efficacy|1|||
161705824|NCT03896581|583969208|FG000|Overall Study|Adverse event, non-fatal|0|||
161705825|NCT03896581|583969209|FG001|Overall Study|Adverse event, non-fatal|2|||
161705826|NCT00162773|583969216|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
161705827|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
161705828|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
161705829|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161705830|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161705831|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161705832|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
161705833|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
161705834|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161705835|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161705836|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161837626|NCT02093221|584448673|FG003|Overall Study|Death|0|||
161837627|NCT02093221|584448674|FG004|Overall Study|Death|0|||
161837628|NCT02093221|584448670|FG000|Overall Study|Protocol Violation|0|||
161837629|NCT02093221|584448671|FG001|Overall Study|Protocol Violation|1|||
161837630|NCT02093221|584448672|FG002|Overall Study|Protocol Violation|0|||
161837631|NCT02093221|584448673|FG003|Overall Study|Protocol Violation|0|||
161837632|NCT02093221|584448674|FG004|Overall Study|Protocol Violation|0|||
161837633|NCT02093221|584448670|FG000|Overall Study|Study termination|6|||
161837634|NCT02093221|584448671|FG001|Overall Study|Study termination|5|||
161837635|NCT02093221|584448672|FG002|Overall Study|Study termination|4|||
161837636|NCT02093221|584448673|FG003|Overall Study|Study termination|6|||
161837637|NCT02093221|584448674|FG004|Overall Study|Study termination|7|||
161837638|NCT00725621|584448675|FG000|Overall Study|Adverse Event|25|||
161837639|NCT00725621|584448675|FG000|Overall Study|Lack of Efficacy|46|||
161837640|NCT00725621|584448675|FG000|Overall Study|Withdrawal by Subject|57|||
161837641|NCT00725621|584448675|FG000|Overall Study|Physician Decision|19|||
161837642|NCT00725621|584448675|FG000|Overall Study|Lost to Follow-up|52|||
161705837|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
161705838|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161705839|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161705840|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161705841|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161837643|NCT00725621|584448675|FG000|Overall Study|Non-compliance|8|||
161837644|NCT00725621|584448675|FG000|Overall Study|Continued treatment by other physician|6|||
161837645|NCT00725621|584448675|FG000|Overall Study|Switched to other study|1|||
161705842|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705843|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
161705844|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705845|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705846|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705847|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
161705848|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
161705849|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161705850|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161705851|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161705852|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
161705853|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
161705854|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161705855|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161705856|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161705857|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
161705858|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
161705859|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161705860|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161705861|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161705862|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161705863|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161705864|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
161705865|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161705866|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
161705867|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161705868|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161705869|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
161705870|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161705871|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
161705872|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
161705873|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
161705874|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
161705875|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
161705876|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
161705877|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
161705878|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
161705879|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
161705880|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
161705881|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
161705882|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
161705883|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
161705884|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
161705885|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
161705886|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
161705887|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161705888|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161705889|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161705890|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
161705891|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
161705892|NCT04854499|583969234|FG000|Overall Study|Study Terminated by Sponsor|5|||
161705893|NCT04854499|583969235|FG001|Overall Study|Study Terminated by Sponsor|27|||
161705894|NCT04854499|583969236|FG002|Overall Study|Study Terminated by Sponsor|28|||
161705895|NCT04854499|583969237|FG003|Overall Study|Study Terminated by Sponsor|19|||
161705896|NCT04854499|583969238|FG004|Overall Study|Study Terminated by Sponsor|1|||
161705897|NCT04854499|583969239|FG005|Overall Study|Study Terminated by Sponsor|10|||
161705898|NCT04854499|583969234|FG000|Overall Study|Death|1|||
161705899|NCT04854499|583969235|FG001|Overall Study|Death|23|||
161705900|NCT04854499|583969236|FG002|Overall Study|Death|21|||
161705901|NCT04854499|583969237|FG003|Overall Study|Death|7|||
161705902|NCT04854499|583969238|FG004|Overall Study|Death|6|||
161705903|NCT04854499|583969239|FG005|Overall Study|Death|24|||
161705904|NCT04854499|583969234|FG000|Overall Study|Investigator's Discretion|0|||
161705905|NCT04854499|583969235|FG001|Overall Study|Investigator's Discretion|1|||
161705906|NCT04854499|583969236|FG002|Overall Study|Investigator's Discretion|3|||
161705907|NCT04854499|583969237|FG003|Overall Study|Investigator's Discretion|4|||
161705908|NCT04854499|583969238|FG004|Overall Study|Investigator's Discretion|1|||
161705909|NCT04854499|583969239|FG005|Overall Study|Investigator's Discretion|5|||
161705910|NCT04854499|583969234|FG000|Overall Study|Withdrew Consent|0|||
161705911|NCT04854499|583969235|FG001|Overall Study|Withdrew Consent|1|||
161705912|NCT04854499|583969236|FG002|Overall Study|Withdrew Consent|2|||
161705913|NCT04854499|583969237|FG003|Overall Study|Withdrew Consent|2|||
161705914|NCT04854499|583969238|FG004|Overall Study|Withdrew Consent|0|||
161705915|NCT04854499|583969239|FG005|Overall Study|Withdrew Consent|1|||
161705916|NCT04854499|583969234|FG000|Overall Study|Lost to Follow-up|0|||
161705917|NCT04854499|583969235|FG001|Overall Study|Lost to Follow-up|0|||
161705918|NCT04854499|583969236|FG002|Overall Study|Lost to Follow-up|0|||
161705919|NCT04854499|583969237|FG003|Overall Study|Lost to Follow-up|0|||
161705920|NCT04854499|583969238|FG004|Overall Study|Lost to Follow-up|0|||
161705921|NCT04854499|583969239|FG005|Overall Study|Lost to Follow-up|1|||
161705922|NCT05415449|583969240|FG000|Overall Study|Lost to Follow-up|2|||
161705923|NCT05415449|583969240|FG000|Overall Study|Withdrawal by Subject|4|||
161705924|NCT02185521|583969243|FG000|Overall Study|Withdrawal by Subject|1|||
161705925|NCT02185521|583969243|FG000|Overall Study|Protocol Violation|1|||
161705926|NCT01028352|583969247|FG000|Overall Study|Ineligible due to baseline average pain|5|||
161705927|NCT01028352|583969247|FG000|Overall Study|Withdrawal by Subject|1|||
161705928|NCT01903876|583969248|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
161705929|NCT01903876|583969249|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
161837646|NCT00725621|584448675|FG000|Overall Study|Switched to other drug|1|||
161837647|NCT00725621|584448675|FG000|Overall Study|Prepared for elective surgery|1|||
161655389|NCT02416453|583788909|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
161655390|NCT02416453|583788910|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655391|NCT02416453|583788911|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655392|NCT02416453|583788912|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655393|NCT02416453|583788913|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655394|NCT02416453|583788914|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655395|NCT02416453|583788915|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655396|NCT02416453|583788916|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655397|NCT02416453|583788917|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161655398|NCT02416453|583788907|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655399|NCT02416453|583788908|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655400|NCT02416453|583788909|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655401|NCT02416453|583788910|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655402|NCT02416453|583788911|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655403|NCT02416453|583788912|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
161655404|NCT02416453|583788913|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655405|NCT02416453|583788914|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655406|NCT02416453|583788915|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655407|NCT02416453|583788916|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655408|NCT02416453|583788917|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161655409|NCT01152814|583788918|FG000|Overall Study|Lost to Follow-up|2|||
161655410|NCT02729831|583788920|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
161705930|NCT01903876|583969248|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
161705931|NCT01903876|583969249|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
161705932|NCT00826748|583969260|FG000|Overall Study|Withdrawal by Subject|0|||
161705933|NCT00826748|583969261|FG001|Overall Study|Withdrawal by Subject|0|||
161705934|NCT00826748|583969262|FG002|Overall Study|Withdrawal by Subject|2|||
161705935|NCT00826748|583969260|FG000|Overall Study|Physician Decision|0|||
161705936|NCT00826748|583969261|FG001|Overall Study|Physician Decision|0|||
161705937|NCT00826748|583969262|FG002|Overall Study|Physician Decision|1|||
161705938|NCT00826748|583969260|FG000|Overall Study|Samples Did Not pass QC|0|||
161705939|NCT00826748|583969261|FG001|Overall Study|Samples Did Not pass QC|0|||
161705940|NCT00826748|583969262|FG002|Overall Study|Samples Did Not pass QC|1|||
161705941|NCT02300129|583969264|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161705942|NCT02300129|583969265|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
161705943|NCT02300129|583969266|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161705944|NCT02300129|583969267|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161705945|NCT02300129|583969264|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161705946|NCT02300129|583969265|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161705947|NCT02300129|583969266|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161705948|NCT02300129|583969267|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
161705949|NCT02300129|583969264|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
161705950|NCT02300129|583969265|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161705951|NCT02300129|583969266|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161705952|NCT02300129|583969267|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161705953|NCT01887912|583969268|FG000|Overall Study|Serious adverse event|400|||
161705954|NCT01887912|583969269|FG001|Overall Study|Serious adverse event|198|||
161705955|NCT01887912|583969268|FG000|Overall Study|Other Adverse Event|34|||
161705956|NCT01887912|583969269|FG001|Overall Study|Other Adverse Event|15|||
161705957|NCT01887912|583969268|FG000|Overall Study|Protocol Violation|67|||
161705958|NCT01887912|583969269|FG001|Overall Study|Protocol Violation|37|||
161705959|NCT01887912|583969268|FG000|Overall Study|Lost to Follow-up|163|||
161705960|NCT01887912|583969269|FG001|Overall Study|Lost to Follow-up|74|||
161705961|NCT01887912|583969268|FG000|Overall Study|Withdrawal by Subject|606|||
161705962|NCT01887912|583969269|FG001|Overall Study|Withdrawal by Subject|349|||
161705963|NCT01887912|583969268|FG000|Overall Study|Other|122|||
161705964|NCT01887912|583969269|FG001|Overall Study|Other|58|||
161705965|NCT04462536|583969270|FG000|Overall Study|Withdrawal by Subject|3|||
161705966|NCT04462536|583969271|FG001|Overall Study|Withdrawal by Subject|9|||
161705967|NCT04462536|583969270|FG000|Overall Study|Lost to Follow-up|2|||
161705968|NCT04462536|583969271|FG001|Overall Study|Lost to Follow-up|4|||
161705969|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
161705970|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
161705971|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
161705972|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
161705973|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
161705974|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
161705975|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
161705976|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
161705977|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
161705978|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
161705979|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
161705980|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
161705981|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
161705982|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
161705983|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
161705984|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
161705985|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
161705986|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
161705987|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
161705988|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
161705989|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
161705990|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
161705991|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
161705992|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
161705993|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
161705994|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
161705995|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
161705996|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
161705997|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
161705998|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
161705999|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
161706000|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
161706001|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
161706002|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
161706003|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
161706004|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
161706005|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
161706006|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
161706007|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
161706008|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
161706009|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
161706010|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
161706011|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
161706012|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
161706013|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
161706014|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
161706015|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
161706016|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
161706017|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
161706018|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
161706019|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
161706020|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
161706021|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
161706022|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
161706023|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
161706024|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
161706025|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
161706026|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
161706027|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
161706028|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
161706029|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
161706030|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
161706031|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
161706032|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
161706033|NCT00450580|583969276|FG000|Overall Study|Adverse Event|5|||
161706034|NCT00450580|583969277|FG001|Overall Study|Adverse Event|7|||
161706035|NCT00450580|583969276|FG000|Overall Study|Lost to Follow-up|4|||
161706036|NCT00450580|583969277|FG001|Overall Study|Lost to Follow-up|5|||
161706037|NCT00450580|583969276|FG000|Overall Study|Withdrawal by Subject|2|||
161706038|NCT00450580|583969277|FG001|Overall Study|Withdrawal by Subject|2|||
161706039|NCT00450580|583969276|FG000|Overall Study|Protocol Violation|1|||
161706040|NCT00450580|583969277|FG001|Overall Study|Protocol Violation|1|||
161706041|NCT00450580|583969276|FG000|Overall Study|Protocol-defined virologic failure|1|||
161706042|NCT00450580|583969277|FG001|Overall Study|Protocol-defined virologic failure|0|||
161706043|NCT00450580|583969276|FG000|Overall Study|Could not comply with scheduled visits|1|||
161706044|NCT00450580|583969277|FG001|Overall Study|Could not comply with scheduled visits|0|||
161706045|NCT00450580|583969276|FG000|Overall Study|Patient went to Brazil|1|||
161706046|NCT00450580|583969277|FG001|Overall Study|Patient went to Brazil|0|||
161706047|NCT00450580|583969276|FG000|Overall Study|Patient could not swallow Norvir|1|||
161706048|NCT00450580|583969277|FG001|Overall Study|Patient could not swallow Norvir|0|||
161706049|NCT00450580|583969276|FG000|Overall Study|Withdrawal due to pregnancy|0|||
161706050|NCT00450580|583969277|FG001|Overall Study|Withdrawal due to pregnancy|1|||
161706051|NCT00332709|583969286|FG000|Overall Study|Adverse Event|11|||
161706052|NCT00332709|583969287|FG001|Overall Study|Adverse Event|14|||
161706053|NCT00332709|583969286|FG000|Overall Study|Withdrawal by Subject|2|||
161706054|NCT00332709|583969287|FG001|Overall Study|Withdrawal by Subject|3|||
161706055|NCT00332709|583969286|FG000|Overall Study|Lost to Follow-up|2|||
161706056|NCT00332709|583969287|FG001|Overall Study|Lost to Follow-up|0|||
161706057|NCT00332709|583969286|FG000|Overall Study|Administrative Problems|0|||
161706058|NCT00332709|583969287|FG001|Overall Study|Administrative Problems|3|||
161706059|NCT00332709|583969286|FG000|Overall Study|Abnormal test procedure result|1|||
161706060|NCT00332709|583969287|FG001|Overall Study|Abnormal test procedure result|0|||
161706061|NCT00988247|583969288|FG000|Overall Study|Adverse Event|17|||
161706062|NCT00988247|583969289|FG001|Overall Study|Adverse Event|3|||
161706063|NCT00988247|583969288|FG000|Overall Study|Withdrawal by Subject|44|||
161706064|NCT00988247|583969289|FG001|Overall Study|Withdrawal by Subject|13|||
161706065|NCT00988247|583969288|FG000|Overall Study|Pregnancy|1|||
161706066|NCT00988247|583969289|FG001|Overall Study|Pregnancy|2|||
161706067|NCT00988247|583969288|FG000|Overall Study|Lost to Follow-up|11|||
161706068|NCT00988247|583969289|FG001|Overall Study|Lost to Follow-up|2|||
161706069|NCT00988247|583969288|FG000|Overall Study|Protocol Violation|4|||
161706070|NCT00988247|583969289|FG001|Overall Study|Protocol Violation|5|||
161706071|NCT00988247|583969288|FG000|Overall Study|Sponsor requested withdrawal|3|||
161706072|NCT00988247|583969289|FG001|Overall Study|Sponsor requested withdrawal|1|||
161706073|NCT00988247|583969288|FG000|Overall Study|Other|3|||
161706074|NCT00988247|583969289|FG001|Overall Study|Other|0|||
161706075|NCT01409928|583969290|FG000|Overall Study|Physician Decision|12|||
161706076|NCT02661594|583969291|FG000|Overall Study|Protocol Violation|1|||
161706077|NCT02661594|583969292|FG001|Overall Study|Protocol Violation|0|||
161706078|NCT02661594|583969293|FG002|Overall Study|Protocol Violation|1|||
161706079|NCT02661594|583969294|FG003|Overall Study|Protocol Violation|0|||
161706080|NCT01169779|583969297|FG000|Overall Study|Adverse Event|3|||
161706081|NCT01169779|583969298|FG001|Overall Study|Adverse Event|11|||
161706082|NCT01169779|583969297|FG000|Overall Study|Lack of Efficacy|1|||
161706083|NCT01169779|583969298|FG001|Overall Study|Lack of Efficacy|0|||
161706084|NCT01169779|583969297|FG000|Overall Study|Protocol Violation|1|||
161706085|NCT01169779|583969298|FG001|Overall Study|Protocol Violation|1|||
161706086|NCT01169779|583969297|FG000|Overall Study|Withdrawal by Subject|3|||
161706087|NCT01169779|583969298|FG001|Overall Study|Withdrawal by Subject|2|||
161706088|NCT01169779|583969297|FG000|Overall Study|Familial and personal reasons|3|||
161706089|NCT01169779|583969298|FG001|Overall Study|Familial and personal reasons|3|||
161706090|NCT00432237|583969301|FG000|Overall Study|Adverse Event|0|||
161706091|NCT00432237|583969302|FG001|Overall Study|Adverse Event|0|||
161706092|NCT00432237|583969303|FG002|Overall Study|Adverse Event|0|||
161706093|NCT00432237|583969304|FG003|Overall Study|Adverse Event|1|||
161706094|NCT00432237|583969301|FG000|Overall Study|Lack of Efficacy|0|||
161706095|NCT00432237|583969302|FG001|Overall Study|Lack of Efficacy|0|||
161706096|NCT00432237|583969303|FG002|Overall Study|Lack of Efficacy|0|||
161706097|NCT00432237|583969304|FG003|Overall Study|Lack of Efficacy|1|||
161706098|NCT00432237|583969301|FG000|Overall Study|Lost to Follow-up|10|||
161706099|NCT00432237|583969302|FG001|Overall Study|Lost to Follow-up|10|||
161706100|NCT00432237|583969303|FG002|Overall Study|Lost to Follow-up|18|||
161706101|NCT00432237|583969304|FG003|Overall Study|Lost to Follow-up|18|||
161706102|NCT00432237|583969301|FG000|Overall Study|Physician Decision|1|||
161706103|NCT00432237|583969302|FG001|Overall Study|Physician Decision|3|||
161706104|NCT00432237|583969303|FG002|Overall Study|Physician Decision|2|||
161706105|NCT00432237|583969304|FG003|Overall Study|Physician Decision|1|||
161706106|NCT00432237|583969301|FG000|Overall Study|Pregnancy|0|||
161706107|NCT00432237|583969302|FG001|Overall Study|Pregnancy|1|||
161706108|NCT00432237|583969303|FG002|Overall Study|Pregnancy|0|||
161706109|NCT00432237|583969304|FG003|Overall Study|Pregnancy|0|||
161706110|NCT00432237|583969301|FG000|Overall Study|Protocol Violation|13|||
161706111|NCT00432237|583969302|FG001|Overall Study|Protocol Violation|10|||
161706112|NCT00432237|583969303|FG002|Overall Study|Protocol Violation|11|||
161706113|NCT00432237|583969304|FG003|Overall Study|Protocol Violation|8|||
161706114|NCT00432237|583969301|FG000|Overall Study|Withdrawal by Subject|5|||
161706115|NCT00432237|583969302|FG001|Overall Study|Withdrawal by Subject|6|||
161706116|NCT00432237|583969303|FG002|Overall Study|Withdrawal by Subject|9|||
161706117|NCT00432237|583969304|FG003|Overall Study|Withdrawal by Subject|11|||
161706118|NCT00432237|583969301|FG000|Overall Study|Lack of Qualifying Event|38|||
161706119|NCT00432237|583969302|FG001|Overall Study|Lack of Qualifying Event|71|||
161706120|NCT00432237|583969303|FG002|Overall Study|Lack of Qualifying Event|69|||
161706121|NCT00432237|583969304|FG003|Overall Study|Lack of Qualifying Event|84|||
161706122|NCT01354132|583969305|FG000|Randomization|Physician Decision|1|||
161706123|NCT01354132|583969306|FG001|Randomization|Physician Decision|0|||
161706124|NCT01354132|583969305|FG000|Randomization|Withdrawal by Subject|0|||
161706125|NCT01354132|583969306|FG001|Randomization|Withdrawal by Subject|1|||
161706126|NCT01354132|583969305|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
161706127|NCT01354132|583969306|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
161706128|NCT01354132|583969305|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
161706129|NCT01354132|583969306|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
161706130|NCT01354132|583969305|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
161706131|NCT01354132|583969306|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
161706132|NCT00191854|583969309|FG000|Overall Study|Death|26|||
161706133|NCT00191854|583969310|FG001|Overall Study|Death|23|||
161706134|NCT00191854|583969311|FG002|Overall Study|Death|29|||
161706135|NCT00191854|583969309|FG000|Overall Study|Lost to Follow-up|7|||
161706136|NCT00191854|583969310|FG001|Overall Study|Lost to Follow-up|5|||
161706137|NCT00191854|583969311|FG002|Overall Study|Lost to Follow-up|5|||
161706138|NCT00191854|583969309|FG000|Overall Study|Withdrawal by Subject|4|||
161706139|NCT00191854|583969310|FG001|Overall Study|Withdrawal by Subject|2|||
161706140|NCT00191854|583969311|FG002|Overall Study|Withdrawal by Subject|3|||
161706141|NCT00191854|583969309|FG000|Overall Study|Sponsor Decision|0|||
161706142|NCT00191854|583969310|FG001|Overall Study|Sponsor Decision|0|||
161706143|NCT00191854|583969311|FG002|Overall Study|Sponsor Decision|1|||
161706144|NCT00191854|583969309|FG000|Overall Study|Screen Failure|0|||
161706145|NCT00191854|583969310|FG001|Overall Study|Screen Failure|0|||
161706146|NCT00191854|583969311|FG002|Overall Study|Screen Failure|1|||
161706147|NCT01933932|583969314|FG000|Overall Study|Death|173|||
161706148|NCT01933932|583969315|FG001|Overall Study|Death|163|||
161706149|NCT01933932|583969314|FG000|Overall Study|Withdrawal by Subject|11|||
161706150|NCT01933932|583969315|FG001|Overall Study|Withdrawal by Subject|14|||
161706151|NCT01933932|583969314|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161706152|NCT01933932|583969315|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161706153|NCT00763009|583969319|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
161706154|NCT02013544|583969320|FG000|Overall Study|Adverse Event|5|||
161706155|NCT02013544|583969321|FG001|Overall Study|Adverse Event|5|||
161706156|NCT02013544|583969320|FG000|Overall Study|Lost to Follow-up|2|||
161706157|NCT02013544|583969321|FG001|Overall Study|Lost to Follow-up|3|||
161706158|NCT02013544|583969320|FG000|Overall Study|Withdrawal by Subject|2|||
161706159|NCT02013544|583969321|FG001|Overall Study|Withdrawal by Subject|8|||
161706160|NCT02013544|583969320|FG000|Overall Study|Physician Decision|0|||
161706161|NCT02013544|583969321|FG001|Overall Study|Physician Decision|1|||
161706162|NCT02013544|583969320|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
161706163|NCT02013544|583969321|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
161706164|NCT01295125|583969322|FG000|Overall Study|Study stopped prematurely|9|||
161706165|NCT00891735|583969323|FG000|Overall Study|Adverse Event|2|||
161706166|NCT00891735|583969324|FG001|Overall Study|Adverse Event|0|||
161706167|NCT00891735|583969325|FG002|Overall Study|Adverse Event|2|||
161706168|NCT00891735|583969326|FG003|Overall Study|Adverse Event|0|||
161706169|NCT00891735|583969323|FG000|Overall Study|Death|8|||
161706170|NCT00891735|583969324|FG001|Overall Study|Death|5|||
161706171|NCT00891735|583969325|FG002|Overall Study|Death|4|||
161706172|NCT00891735|583969326|FG003|Overall Study|Death|5|||
161706173|NCT00891735|583969323|FG000|Overall Study|Lost to Follow-up|2|||
161706174|NCT00891735|583969324|FG001|Overall Study|Lost to Follow-up|2|||
161706175|NCT00891735|583969325|FG002|Overall Study|Lost to Follow-up|2|||
161706176|NCT00891735|583969326|FG003|Overall Study|Lost to Follow-up|2|||
161706177|NCT00891735|583969323|FG000|Overall Study|Physician's decision to withdraw patient|1|||
161706178|NCT00891735|583969324|FG001|Overall Study|Physician's decision to withdraw patient|0|||
161706179|NCT00891735|583969325|FG002|Overall Study|Physician's decision to withdraw patient|0|||
161706180|NCT00891735|583969326|FG003|Overall Study|Physician's decision to withdraw patient|0|||
161706181|NCT00891735|583969323|FG000|Overall Study|Patient's decision to withdraw|4|||
161706182|NCT00891735|583969324|FG001|Overall Study|Patient's decision to withdraw|9|||
161706183|NCT00891735|583969325|FG002|Overall Study|Patient's decision to withdraw|4|||
161706184|NCT00891735|583969326|FG003|Overall Study|Patient's decision to withdraw|8|||
161706185|NCT00888238|583969332|FG000|Washout Period After Period 2|Adverse Event|0|||
161706186|NCT00888238|583969333|FG001|Washout Period After Period 2|Adverse Event|0|||
161706187|NCT00888238|583969334|FG002|Washout Period After Period 2|Adverse Event|1|||
161706188|NCT03480802|583971504|FG000|Overall Study|Lost to Follow-up|5|||
161706189|NCT03480802|583971505|FG001|Overall Study|Lost to Follow-up|1|||
161706190|NCT03480802|583971504|FG000|Overall Study|Withdrawal by Subject|2|||
161706191|NCT03480802|583971505|FG001|Overall Study|Withdrawal by Subject|1|||
161706192|NCT03480802|583971504|FG000|Overall Study|Relocated|0|||
161706193|NCT03480802|583971505|FG001|Overall Study|Relocated|1|||
161706194|NCT02601950|583971510|FG000|Overall Study|Participant enrolled in rollover study|0|||
161706195|NCT02601950|583971511|FG001|Overall Study|Participant enrolled in rollover study|0|||
161706196|NCT02601950|583971512|FG002|Overall Study|Participant enrolled in rollover study|1|||
161706197|NCT02601950|583971513|FG003|Overall Study|Participant enrolled in rollover study|0|||
161706198|NCT02601950|583971514|FG004|Overall Study|Participant enrolled in rollover study|1|||
161706199|NCT02601950|583971515|FG005|Overall Study|Participant enrolled in rollover study|1|||
161706200|NCT02601950|583971516|FG006|Overall Study|Participant enrolled in rollover study|1|||
161706201|NCT02601950|583971517|FG007|Overall Study|Participant enrolled in rollover study|0|||
161706202|NCT02601950|583971510|FG000|Overall Study|Disease progression - radiological|21|||
161706203|NCT02601950|583971511|FG001|Overall Study|Disease progression - radiological|26|||
161706204|NCT02601950|583971512|FG002|Overall Study|Disease progression - radiological|22|||
161706205|NCT02601950|583971513|FG003|Overall Study|Disease progression - radiological|11|||
161706206|NCT02601950|583971514|FG004|Overall Study|Disease progression - radiological|46|||
161706207|NCT02601950|583971515|FG005|Overall Study|Disease progression - radiological|52|||
161706208|NCT02601950|583971516|FG006|Overall Study|Disease progression - radiological|7|||
161706209|NCT02601950|583971517|FG007|Overall Study|Disease progression - radiological|5|||
161706210|NCT02601950|583971510|FG000|Overall Study|Disease progression - clinical|3|||
161706211|NCT02601950|583971511|FG001|Overall Study|Disease progression - clinical|5|||
161706212|NCT02601950|583971512|FG002|Overall Study|Disease progression - clinical|4|||
161706213|NCT02601950|583971513|FG003|Overall Study|Disease progression - clinical|2|||
161706214|NCT02601950|583971514|FG004|Overall Study|Disease progression - clinical|6|||
161706215|NCT02601950|583971515|FG005|Overall Study|Disease progression - clinical|6|||
161706216|NCT02601950|583971516|FG006|Overall Study|Disease progression - clinical|5|||
161706217|NCT02601950|583971517|FG007|Overall Study|Disease progression - clinical|1|||
161706218|NCT02601950|583971510|FG000|Overall Study|Death|6|||
161706219|NCT02601950|583971511|FG001|Overall Study|Death|0|||
161706220|NCT02601950|583971512|FG002|Overall Study|Death|3|||
161706221|NCT02601950|583971513|FG003|Overall Study|Death|1|||
161706222|NCT02601950|583971514|FG004|Overall Study|Death|4|||
161706223|NCT02601950|583971515|FG005|Overall Study|Death|1|||
161706224|NCT02601950|583971516|FG006|Overall Study|Death|0|||
161706225|NCT02601950|583971517|FG007|Overall Study|Death|0|||
161706226|NCT02601950|583971510|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706227|NCT02601950|583971511|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706228|NCT02601950|583971512|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706229|NCT02601950|583971513|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706230|NCT02601950|583971514|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706231|NCT02601950|583971515|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
161706232|NCT02601950|583971516|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706233|NCT02601950|583971517|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706234|NCT02601950|583971510|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
161706235|NCT02601950|583971511|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
161706236|NCT02601950|583971512|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
161706237|NCT02601950|583971513|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
161706238|NCT02601950|583971514|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
161706239|NCT02601950|583971515|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
161706240|NCT02601950|583971516|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
161706241|NCT02601950|583971517|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
161706242|NCT02601950|583971510|FG000|Overall Study|Non-compliance|0|||
161706243|NCT02601950|583971511|FG001|Overall Study|Non-compliance|1|||
161706244|NCT02601950|583971512|FG002|Overall Study|Non-compliance|0|||
161706245|NCT02601950|583971513|FG003|Overall Study|Non-compliance|0|||
161706246|NCT02601950|583971514|FG004|Overall Study|Non-compliance|0|||
161706247|NCT02601950|583971515|FG005|Overall Study|Non-compliance|1|||
161706248|NCT02601950|583971516|FG006|Overall Study|Non-compliance|1|||
161706249|NCT02601950|583971517|FG007|Overall Study|Non-compliance|0|||
161706250|NCT02601950|583971510|FG000|Overall Study|Participant refused further study treatment|0|||
161706251|NCT02601950|583971511|FG001|Overall Study|Participant refused further study treatment|1|||
161706252|NCT02601950|583971512|FG002|Overall Study|Participant refused further study treatment|1|||
161706253|NCT02601950|583971513|FG003|Overall Study|Participant refused further study treatment|0|||
161706254|NCT02601950|583971514|FG004|Overall Study|Participant refused further study treatment|2|||
161706255|NCT02601950|583971515|FG005|Overall Study|Participant refused further study treatment|2|||
161706256|NCT02601950|583971516|FG006|Overall Study|Participant refused further study treatment|2|||
161706257|NCT02601950|583971517|FG007|Overall Study|Participant refused further study treatment|1|||
161706258|NCT02601950|583971510|FG000|Overall Study|Investigator discretion|1|||
161706259|NCT02601950|583971511|FG001|Overall Study|Investigator discretion|0|||
161706260|NCT02601950|583971512|FG002|Overall Study|Investigator discretion|1|||
161706261|NCT02601950|583971513|FG003|Overall Study|Investigator discretion|0|||
161706262|NCT02601950|583971514|FG004|Overall Study|Investigator discretion|1|||
161706263|NCT02601950|583971515|FG005|Overall Study|Investigator discretion|1|||
161706264|NCT02601950|583971516|FG006|Overall Study|Investigator discretion|1|||
161706265|NCT02601950|583971517|FG007|Overall Study|Investigator discretion|0|||
161706266|NCT02601950|583971510|FG000|Overall Study|Other|0|||
161706267|NCT02601950|583971511|FG001|Overall Study|Other|0|||
161706268|NCT02601950|583971512|FG002|Overall Study|Other|0|||
161706269|NCT02601950|583971513|FG003|Overall Study|Other|0|||
161706270|NCT02601950|583971514|FG004|Overall Study|Other|2|||
161706271|NCT02601950|583971515|FG005|Overall Study|Other|2|||
161706272|NCT02601950|583971516|FG006|Overall Study|Other|1|||
161706273|NCT02601950|583971517|FG007|Overall Study|Other|0|||
161706274|NCT02157883|583971518|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
161706275|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
161706276|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
161706277|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
161706278|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
161706279|NCT01701258|583971519|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
161706280|NCT01701258|583971520|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
161706281|NCT01701258|583971521|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
161706282|NCT01701258|583971522|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
161706283|NCT01701258|583971523|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
161706284|NCT01701258|583971524|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
161706285|NCT01701258|583971525|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
161706286|NCT01701258|583971526|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
161706287|NCT01701258|583971527|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
161706288|NCT01701258|583971528|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
161706289|NCT01701258|583971529|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
161706290|NCT01701258|583971530|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
161706291|NCT01701258|583971531|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
161706292|NCT01701258|583971519|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
161706293|NCT01701258|583971520|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
161706294|NCT01701258|583971521|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
161706295|NCT01701258|583971522|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
161706296|NCT01701258|583971523|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
161706297|NCT01701258|583971524|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
161706298|NCT01701258|583971525|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
161706299|NCT01701258|583971526|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
161706300|NCT01701258|583971527|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
161706301|NCT01701258|583971528|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
161706302|NCT01701258|583971529|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
161706303|NCT01701258|583971530|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
161706304|NCT01701258|583971531|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
161706305|NCT01701258|583971519|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
161706306|NCT01701258|583971520|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
161706307|NCT01701258|583971521|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
161706308|NCT01701258|583971522|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
161706309|NCT01701258|583971523|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
161706310|NCT01701258|583971524|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
161706311|NCT01701258|583971525|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
161706312|NCT01701258|583971526|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
161706313|NCT01701258|583971527|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
161706314|NCT01701258|583971528|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
161706315|NCT01701258|583971529|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
161706316|NCT01701258|583971530|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
161706317|NCT01701258|583971531|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
161706318|NCT01701258|583971519|FG000|Assessment and Scheduling|Investigator Terminated|2|||
161706319|NCT01701258|583971520|FG001|Assessment and Scheduling|Investigator Terminated|0|||
161706320|NCT01701258|583971521|FG002|Assessment and Scheduling|Investigator Terminated|0|||
161706321|NCT01701258|583971522|FG003|Assessment and Scheduling|Investigator Terminated|0|||
161706322|NCT01701258|583971523|FG004|Assessment and Scheduling|Investigator Terminated|0|||
161706323|NCT01701258|583971524|FG005|Assessment and Scheduling|Investigator Terminated|0|||
161706324|NCT01701258|583971525|FG006|Assessment and Scheduling|Investigator Terminated|0|||
161706325|NCT01701258|583971526|FG007|Assessment and Scheduling|Investigator Terminated|0|||
161706326|NCT01701258|583971527|FG008|Assessment and Scheduling|Investigator Terminated|0|||
161706327|NCT01701258|583971528|FG009|Assessment and Scheduling|Investigator Terminated|0|||
161706328|NCT01701258|583971529|FG010|Assessment and Scheduling|Investigator Terminated|0|||
161706329|NCT01701258|583971530|FG011|Assessment and Scheduling|Investigator Terminated|0|||
161706330|NCT01701258|583971531|FG012|Assessment and Scheduling|Investigator Terminated|0|||
161706331|NCT01323478|583971532|FG000|Overall Study|Adverse Event|7|||
161706332|NCT01323478|583971532|FG000|Overall Study|Lack of Efficacy|4|||
161706333|NCT01323478|583971532|FG000|Overall Study|Non-compliance With Study Product|3|||
161706334|NCT01323478|583971532|FG000|Overall Study|Protocol Violation|1|||
161706335|NCT01323478|583971532|FG000|Overall Study|Withdrawal of Consent|1|||
161706336|NCT01323478|583971532|FG000|Overall Study|Administrative or Other Reasons|8|||
161706337|NCT00934102|583971536|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
161706338|NCT00934102|583971537|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
161706339|NCT00934102|583971538|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
161706340|NCT00792298|583971539|FG000|Treatment Period 1|Adverse Event|0|||
161706341|NCT00792298|583971540|FG001|Treatment Period 1|Adverse Event|1|||
161706342|NCT00792298|583971541|FG002|Treatment Period 1|Adverse Event|0|||
161706343|NCT00792298|583971542|FG003|Treatment Period 1|Adverse Event|1|||
161706344|NCT00792298|583971543|FG004|Treatment Period 1|Adverse Event|0|||
161706345|NCT00792298|583971544|FG005|Treatment Period 1|Adverse Event|1|||
161706346|NCT00792298|583971545|FG006|Treatment Period 1|Adverse Event|1|||
161706347|NCT00792298|583971546|FG007|Treatment Period 1|Adverse Event|0|||
161706348|NCT00792298|583971539|FG000|Treatment Period 1|Lack of Efficacy|0|||
161706349|NCT00792298|583971540|FG001|Treatment Period 1|Lack of Efficacy|0|||
161706350|NCT00792298|583971541|FG002|Treatment Period 1|Lack of Efficacy|1|||
161706351|NCT00792298|583971542|FG003|Treatment Period 1|Lack of Efficacy|0|||
161706352|NCT00792298|583971543|FG004|Treatment Period 1|Lack of Efficacy|0|||
161706353|NCT00792298|583971544|FG005|Treatment Period 1|Lack of Efficacy|0|||
161706354|NCT00792298|583971545|FG006|Treatment Period 1|Lack of Efficacy|0|||
161706355|NCT00792298|583971546|FG007|Treatment Period 1|Lack of Efficacy|0|||
161706356|NCT00792298|583971539|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161706357|NCT00792298|583971540|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161655411|NCT02729831|583788921|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
161655412|NCT02729831|583788922|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
161655413|NCT02729831|583788923|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
161655414|NCT02729831|583788920|FG000|1 Week Post-visit|Lost to Follow-up|43|||
161655415|NCT02729831|583788921|FG001|1 Week Post-visit|Lost to Follow-up|40|||
161655416|NCT02729831|583788922|FG002|1 Week Post-visit|Lost to Follow-up|38|||
161655417|NCT02729831|583788923|FG003|1 Week Post-visit|Lost to Follow-up|36|||
161655418|NCT02729831|583788920|FG000|6 Month Follow-up|Lost to Follow-up|54|||
161655419|NCT02729831|583788921|FG001|6 Month Follow-up|Lost to Follow-up|51|||
161655420|NCT02729831|583788922|FG002|6 Month Follow-up|Lost to Follow-up|48|||
161655421|NCT02729831|583788923|FG003|6 Month Follow-up|Lost to Follow-up|42|||
161655422|NCT02729831|583788920|FG000|6 Month Follow-up|Death|1|||
161655423|NCT02729831|583788921|FG001|6 Month Follow-up|Death|3|||
161655424|NCT02729831|583788922|FG002|6 Month Follow-up|Death|0|||
161655425|NCT02729831|583788923|FG003|6 Month Follow-up|Death|1|||
161655426|NCT00864253|583788924|FG000|Overall Study|Adverse Event|56|||
161655427|NCT00864253|583788925|FG001|Overall Study|Adverse Event|11|||
161655428|NCT00864253|583788924|FG000|Overall Study|Unrelated Adverse Event|3|||
161655429|NCT00864253|583788925|FG001|Overall Study|Unrelated Adverse Event|1|||
161655430|NCT00864253|583788924|FG000|Overall Study|Physician Decision|11|||
161655431|NCT00864253|583788925|FG001|Overall Study|Physician Decision|15|||
161655432|NCT00864253|583788924|FG000|Overall Study|Protocol Violation|0|||
161655433|NCT00864253|583788925|FG001|Overall Study|Protocol Violation|2|||
161655434|NCT00864253|583788924|FG000|Overall Study|Lost to Follow-up|1|||
161655435|NCT00864253|583788925|FG001|Overall Study|Lost to Follow-up|1|||
161655436|NCT00864253|583788924|FG000|Overall Study|Withdrawal by Subject|18|||
161655437|NCT00864253|583788925|FG001|Overall Study|Withdrawal by Subject|18|||
161655438|NCT00864253|583788924|FG000|Overall Study|Death|1|||
161655439|NCT00864253|583788925|FG001|Overall Study|Death|0|||
161655440|NCT00864253|583788924|FG000|Overall Study|Ongoing|2|||
161655441|NCT00864253|583788925|FG001|Overall Study|Ongoing|3|||
161655442|NCT00864253|583788924|FG000|Overall Study|Untreated|7|||
161655443|NCT00864253|583788925|FG001|Overall Study|Untreated|7|||
161655444|NCT01111240|583788926|FG000|Overall Study|Adverse Event|190|||
161655445|NCT01111240|583788926|FG000|Overall Study|Lack of Efficacy|545|||
161655446|NCT01111240|583788926|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
161655447|NCT01111240|583788926|FG000|Overall Study|Other|312|||
161655448|NCT01747551|583788927|FG000|Overall Study|Progressive Disease|24|||
161655449|NCT01747551|583788928|FG001|Overall Study|Progressive Disease|17|||
161655450|NCT01747551|583788927|FG000|Overall Study|Death|3|||
161655451|NCT01747551|583788928|FG001|Overall Study|Death|1|||
161655452|NCT01747551|583788927|FG000|Overall Study|Adverse Event|7|||
161655453|NCT01747551|583788928|FG001|Overall Study|Adverse Event|1|||
161655454|NCT01747551|583788927|FG000|Overall Study|Prolonged Treatment Delay|2|||
161655455|NCT01747551|583788928|FG001|Overall Study|Prolonged Treatment Delay|0|||
161655456|NCT01747551|583788927|FG000|Overall Study|Withdrawal by Subject|3|||
161655457|NCT01747551|583788928|FG001|Overall Study|Withdrawal by Subject|1|||
161655458|NCT01747551|583788927|FG000|Overall Study|Physician Decision|2|||
161655459|NCT01747551|583788928|FG001|Overall Study|Physician Decision|1|||
161655460|NCT01747551|583788927|FG000|Overall Study|Other|2|||
161655461|NCT01747551|583788928|FG001|Overall Study|Other|0|||
161655462|NCT01609062|583788929|FG000|Extension Phase|Terminated by Sponsor|14|||
161655463|NCT01609062|583788930|FG001|Extension Phase|Terminated by Sponsor|9|||
161655464|NCT01609062|583788929|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
161655465|NCT01609062|583788930|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
161655466|NCT01609062|583788929|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
161655467|NCT01609062|583788930|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
161655468|NCT00680992|583788931|FG000|Overall Study|Complete Resection (as per protocol)|25|||
161655469|NCT00680992|583788932|FG001|Overall Study|Complete Resection (as per protocol)|121|||
161655470|NCT00680992|583788933|FG002|Overall Study|Complete Resection (as per protocol)|0|||
161655471|NCT00680992|583788931|FG000|Overall Study|Administrative Decision|83|||
161655472|NCT00680992|583788932|FG001|Overall Study|Administrative Decision|42|||
161655473|NCT00680992|583788933|FG002|Overall Study|Administrative Decision|5|||
161655474|NCT00680992|583788931|FG000|Overall Study|End of Trial|32|||
161655475|NCT00680992|583788932|FG001|Overall Study|End of Trial|12|||
161655476|NCT00680992|583788933|FG002|Overall Study|End of Trial|3|||
161655477|NCT00680992|583788931|FG000|Overall Study|Withdrawal by Subject|33|||
161655478|NCT00680992|583788932|FG001|Overall Study|Withdrawal by Subject|11|||
161655479|NCT00680992|583788933|FG002|Overall Study|Withdrawal by Subject|1|||
161655480|NCT00680992|583788931|FG000|Overall Study|Adverse Event|21|||
161655481|NCT00680992|583788932|FG001|Overall Study|Adverse Event|19|||
161655482|NCT00680992|583788933|FG002|Overall Study|Adverse Event|1|||
161655483|NCT00680992|583788931|FG000|Overall Study|Other|19|||
161655484|NCT00680992|583788932|FG001|Overall Study|Other|14|||
161655485|NCT00680992|583788933|FG002|Overall Study|Other|1|||
161655486|NCT00680992|583788931|FG000|Overall Study|Disease Progression|21|||
161655487|NCT00680992|583788932|FG001|Overall Study|Disease Progression|9|||
161655488|NCT00680992|583788933|FG002|Overall Study|Disease Progression|0|||
161706358|NCT00792298|583971541|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161706359|NCT00792298|583971542|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161706360|NCT00792298|583971543|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161706361|NCT00792298|583971544|FG005|Treatment Period 1|Withdrawal by Subject|2|||
161706362|NCT00792298|583971545|FG006|Treatment Period 1|Withdrawal by Subject|1|||
161706363|NCT00792298|583971546|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161706364|NCT00792298|583971539|FG000|Treatment Period 1|Lost to Follow-up|0|||
161706365|NCT00792298|583971540|FG001|Treatment Period 1|Lost to Follow-up|0|||
161706366|NCT00792298|583971541|FG002|Treatment Period 1|Lost to Follow-up|0|||
161706367|NCT00792298|583971542|FG003|Treatment Period 1|Lost to Follow-up|0|||
161706368|NCT00792298|583971543|FG004|Treatment Period 1|Lost to Follow-up|0|||
161706369|NCT00792298|583971544|FG005|Treatment Period 1|Lost to Follow-up|0|||
161706370|NCT00792298|583971545|FG006|Treatment Period 1|Lost to Follow-up|1|||
161706371|NCT00792298|583971546|FG007|Treatment Period 1|Lost to Follow-up|0|||
161706372|NCT00792298|583971539|FG000|Treatment Period 1|Physician Decision|0|||
161706373|NCT00792298|583971540|FG001|Treatment Period 1|Physician Decision|0|||
161706374|NCT00792298|583971541|FG002|Treatment Period 1|Physician Decision|0|||
161706375|NCT00792298|583971542|FG003|Treatment Period 1|Physician Decision|1|||
161706376|NCT00792298|583971543|FG004|Treatment Period 1|Physician Decision|0|||
161706377|NCT00792298|583971544|FG005|Treatment Period 1|Physician Decision|0|||
161706378|NCT00792298|583971545|FG006|Treatment Period 1|Physician Decision|1|||
161706379|NCT00792298|583971546|FG007|Treatment Period 1|Physician Decision|0|||
161706380|NCT00792298|583971539|FG000|Treatment Period 1|Protocol Violation|0|||
161706381|NCT00792298|583971540|FG001|Treatment Period 1|Protocol Violation|0|||
161706382|NCT00792298|583971541|FG002|Treatment Period 1|Protocol Violation|0|||
161706383|NCT00792298|583971542|FG003|Treatment Period 1|Protocol Violation|0|||
161706384|NCT00792298|583971543|FG004|Treatment Period 1|Protocol Violation|0|||
161706385|NCT00792298|583971544|FG005|Treatment Period 1|Protocol Violation|0|||
161706386|NCT00792298|583971545|FG006|Treatment Period 1|Protocol Violation|0|||
161706387|NCT00792298|583971546|FG007|Treatment Period 1|Protocol Violation|1|||
161706388|NCT00792298|583971539|FG000|Washout|Adverse Event|0|||
161706389|NCT00792298|583971540|FG001|Washout|Adverse Event|0|||
161706390|NCT00792298|583971541|FG002|Washout|Adverse Event|0|||
161706391|NCT00792298|583971542|FG003|Washout|Adverse Event|0|||
161706392|NCT00792298|583971543|FG004|Washout|Adverse Event|0|||
161706393|NCT00792298|583971544|FG005|Washout|Adverse Event|1|||
161837648|NCT00725621|584448675|FG000|Overall Study|Reason not specified|55|||
161837649|NCT01189500|584448676|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
161837650|NCT01189500|584448676|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
161837651|NCT00062751|584448677|FG000|Overall Study|Disease progression|24|||
161837652|NCT00062751|584448678|FG001|Overall Study|Disease progression|17|||
161837653|NCT00062751|584448679|FG002|Overall Study|Disease progression|24|||
161837654|NCT00062751|584448680|FG003|Overall Study|Disease progression|2|||
161837655|NCT00062751|584448681|FG004|Overall Study|Disease progression|2|||
161706394|NCT00792298|583971545|FG006|Washout|Adverse Event|0|||
161706395|NCT00792298|583971546|FG007|Washout|Adverse Event|0|||
161706396|NCT00792298|583971539|FG000|Washout|Withdrawal by Subject|0|||
161706397|NCT00792298|583971540|FG001|Washout|Withdrawal by Subject|0|||
161706398|NCT00792298|583971541|FG002|Washout|Withdrawal by Subject|1|||
161706399|NCT00792298|583971542|FG003|Washout|Withdrawal by Subject|0|||
161706400|NCT00792298|583971543|FG004|Washout|Withdrawal by Subject|0|||
161706401|NCT00792298|583971544|FG005|Washout|Withdrawal by Subject|1|||
161837656|NCT00062751|584448677|FG000|Overall Study|Adverse Event|4|||
161706402|NCT00792298|583971545|FG006|Washout|Withdrawal by Subject|0|||
161706403|NCT00792298|583971546|FG007|Washout|Withdrawal by Subject|0|||
161706404|NCT00792298|583971539|FG000|Treatment Period 2|Lack of Efficacy|0|||
161706405|NCT00792298|583971540|FG001|Treatment Period 2|Lack of Efficacy|0|||
161706406|NCT00792298|583971541|FG002|Treatment Period 2|Lack of Efficacy|0|||
161706407|NCT00792298|583971542|FG003|Treatment Period 2|Lack of Efficacy|0|||
161706408|NCT00792298|583971543|FG004|Treatment Period 2|Lack of Efficacy|1|||
161706409|NCT00792298|583971544|FG005|Treatment Period 2|Lack of Efficacy|0|||
161837657|NCT00062751|584448678|FG001|Overall Study|Adverse Event|7|||
161706410|NCT00792298|583971545|FG006|Treatment Period 2|Lack of Efficacy|0|||
161706411|NCT00792298|583971546|FG007|Treatment Period 2|Lack of Efficacy|0|||
161706412|NCT00792298|583971539|FG000|Treatment Period 2|Physician Decision|0|||
161706413|NCT00792298|583971540|FG001|Treatment Period 2|Physician Decision|0|||
161706414|NCT00792298|583971541|FG002|Treatment Period 2|Physician Decision|0|||
161706415|NCT00792298|583971542|FG003|Treatment Period 2|Physician Decision|0|||
161706416|NCT00792298|583971543|FG004|Treatment Period 2|Physician Decision|0|||
161706417|NCT00792298|583971544|FG005|Treatment Period 2|Physician Decision|0|||
161706418|NCT00792298|583971545|FG006|Treatment Period 2|Physician Decision|1|||
161706419|NCT00792298|583971546|FG007|Treatment Period 2|Physician Decision|0|||
161706420|NCT00792298|583971539|FG000|Treatment Period 2|Pregnancy|0|||
161706421|NCT00792298|583971540|FG001|Treatment Period 2|Pregnancy|0|||
161706422|NCT00792298|583971541|FG002|Treatment Period 2|Pregnancy|1|||
161706423|NCT00792298|583971542|FG003|Treatment Period 2|Pregnancy|0|||
161706424|NCT00792298|583971543|FG004|Treatment Period 2|Pregnancy|0|||
161706425|NCT00792298|583971544|FG005|Treatment Period 2|Pregnancy|0|||
161706426|NCT00792298|583971545|FG006|Treatment Period 2|Pregnancy|0|||
161706427|NCT00792298|583971546|FG007|Treatment Period 2|Pregnancy|0|||
161706428|NCT00792298|583971539|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161706429|NCT00792298|583971540|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161706430|NCT00792298|583971541|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161706431|NCT00792298|583971542|FG003|Treatment Period 2|Withdrawal by Subject|2|||
161706432|NCT00792298|583971543|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161706433|NCT00792298|583971544|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161706434|NCT00792298|583971545|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161706435|NCT00792298|583971546|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161706436|NCT00486603|583971548|FG000|Overall Study|Withdrawal by Subject|1|||
161706437|NCT00486603|583971549|FG001|Overall Study|Withdrawal by Subject|0|||
161706438|NCT00486603|583971550|FG002|Overall Study|Withdrawal by Subject|0|||
161706439|NCT00486603|583971551|FG003|Overall Study|Withdrawal by Subject|0|||
161706440|NCT00486603|583971552|FG004|Overall Study|Withdrawal by Subject|0|||
161706441|NCT00486603|583971548|FG000|Overall Study|Physician Decision|0|||
161706442|NCT00486603|583971549|FG001|Overall Study|Physician Decision|1|||
161706443|NCT00486603|583971550|FG002|Overall Study|Physician Decision|0|||
161706444|NCT00486603|583971551|FG003|Overall Study|Physician Decision|0|||
161706445|NCT00486603|583971552|FG004|Overall Study|Physician Decision|0|||
161706446|NCT02649634|583971553|FG000|Overall Study|Withdrawal by Subject|3|||
161706447|NCT02649634|583971554|FG001|Overall Study|Withdrawal by Subject|5|||
161706448|NCT02649634|583971553|FG000|Overall Study|Lost to Follow-up|0|||
161706449|NCT02649634|583971554|FG001|Overall Study|Lost to Follow-up|1|||
161655489|NCT00680992|583788931|FG000|Overall Study|Lost to Follow-up|12|||
161655490|NCT00680992|583788932|FG001|Overall Study|Lost to Follow-up|14|||
161655491|NCT00680992|583788933|FG002|Overall Study|Lost to Follow-up|0|||
161655492|NCT00680992|583788931|FG000|Overall Study|Noncompliance|4|||
161655493|NCT00680992|583788932|FG001|Overall Study|Noncompliance|6|||
161655494|NCT00680992|583788933|FG002|Overall Study|Noncompliance|0|||
161655495|NCT00680992|583788931|FG000|Overall Study|Requirement for Alternative Therapy|8|||
161655496|NCT00680992|583788932|FG001|Overall Study|Requirement for Alternative Therapy|2|||
161655497|NCT00680992|583788933|FG002|Overall Study|Requirement for Alternative Therapy|0|||
161655498|NCT00680992|583788931|FG000|Overall Study|Pregnancy|5|||
161655499|NCT00680992|583788932|FG001|Overall Study|Pregnancy|0|||
161655500|NCT00680992|583788933|FG002|Overall Study|Pregnancy|1|||
161655501|NCT00680992|583788931|FG000|Overall Study|Death|5|||
161655502|NCT00680992|583788932|FG001|Overall Study|Death|1|||
161655503|NCT00680992|583788933|FG002|Overall Study|Death|0|||
161655504|NCT00680992|583788931|FG000|Overall Study|Ineligibility Determined|0|||
161655505|NCT00680992|583788932|FG001|Overall Study|Ineligibility Determined|1|||
161655506|NCT00680992|583788933|FG002|Overall Study|Ineligibility Determined|0|||
161655507|NCT03842358|583788938|FG000|Overall Study|Poor DOT probe contact with breast|2|||
161655508|NCT03842358|583788938|FG000|Overall Study|DOT system problem|1|||
161655509|NCT03842358|583788938|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
161655510|NCT03842358|583788938|FG000|Overall Study|No biopsy after physician review|4|||
161655511|NCT03842358|583788938|FG000|Overall Study|Patient withdrew|2|||
161655512|NCT05384938|583788939|FG000|Overall Study|Withdrawal by Subject|8|||
161655513|NCT05384938|583788939|FG000|Overall Study|Lost to Follow-up|6|||
161655514|NCT05384938|583788939|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
161655515|NCT02626455|583788940|FG000|Overall Study|Other|1|||
161655516|NCT02626455|583788941|FG001|Overall Study|Other|1|||
161655517|NCT02626455|583788942|FG002|Overall Study|Other|0|||
161655518|NCT02626455|583788943|FG003|Overall Study|Other|0|||
161655519|NCT02626455|583788944|FG004|Overall Study|Other|0|||
161655520|NCT02626455|583788945|FG005|Overall Study|Other|17|||
161837658|NCT00062751|584448679|FG002|Overall Study|Adverse Event|2|||
161655521|NCT02626455|583788946|FG006|Overall Study|Other|23|||
161655522|NCT02626455|583788940|FG000|Overall Study|Withdrawal by Subject|1|||
161655523|NCT02626455|583788941|FG001|Overall Study|Withdrawal by Subject|0|||
161655524|NCT02626455|583788942|FG002|Overall Study|Withdrawal by Subject|0|||
161655525|NCT02626455|583788943|FG003|Overall Study|Withdrawal by Subject|0|||
161837659|NCT00062751|584448680|FG003|Overall Study|Adverse Event|2|||
161837660|NCT00062751|584448681|FG004|Overall Study|Adverse Event|2|||
161837661|NCT00062751|584448677|FG000|Overall Study|Other|2|||
161837662|NCT00062751|584448678|FG001|Overall Study|Other|3|||
161837663|NCT00062751|584448679|FG002|Overall Study|Other|1|||
161837664|NCT00062751|584448680|FG003|Overall Study|Other|0|||
161837665|NCT00062751|584448681|FG004|Overall Study|Other|1|||
161837666|NCT00062751|584448677|FG000|Overall Study|Withdrawal by Subject|1|||
161837667|NCT00062751|584448678|FG001|Overall Study|Withdrawal by Subject|2|||
161655526|NCT02626455|583788944|FG004|Overall Study|Withdrawal by Subject|0|||
161655527|NCT02626455|583788945|FG005|Overall Study|Withdrawal by Subject|10|||
161655528|NCT02626455|583788946|FG006|Overall Study|Withdrawal by Subject|6|||
161655529|NCT02626455|583788940|FG000|Overall Study|Physician Decision|0|||
161655530|NCT02626455|583788941|FG001|Overall Study|Physician Decision|2|||
161655531|NCT02626455|583788942|FG002|Overall Study|Physician Decision|2|||
161655532|NCT02626455|583788943|FG003|Overall Study|Physician Decision|2|||
161655533|NCT02626455|583788944|FG004|Overall Study|Physician Decision|1|||
161655534|NCT02626455|583788945|FG005|Overall Study|Physician Decision|10|||
161655535|NCT02626455|583788946|FG006|Overall Study|Physician Decision|3|||
161655536|NCT02626455|583788940|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161655537|NCT02626455|583788941|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161655538|NCT02626455|583788942|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161655539|NCT02626455|583788943|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161655540|NCT02626455|583788944|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161655541|NCT02626455|583788945|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161655542|NCT02626455|583788946|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
161655543|NCT02626455|583788940|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161655544|NCT02626455|583788941|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161655545|NCT02626455|583788942|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161655546|NCT02626455|583788943|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161655547|NCT02626455|583788944|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161655548|NCT02626455|583788945|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161655549|NCT02626455|583788946|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
161655550|NCT02626455|583788940|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161655551|NCT02626455|583788941|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161655552|NCT02626455|583788942|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161655553|NCT02626455|583788943|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161655554|NCT02626455|583788944|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161655555|NCT02626455|583788945|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
161655556|NCT02626455|583788946|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
161655557|NCT02626455|583788940|FG000|Overall Study|Patient decision|0|||
161655558|NCT02626455|583788941|FG001|Overall Study|Patient decision|1|||
161655559|NCT02626455|583788942|FG002|Overall Study|Patient decision|0|||
161655560|NCT02626455|583788943|FG003|Overall Study|Patient decision|0|||
161655561|NCT02626455|583788944|FG004|Overall Study|Patient decision|1|||
161655562|NCT02626455|583788945|FG005|Overall Study|Patient decision|36|||
161655563|NCT02626455|583788946|FG006|Overall Study|Patient decision|22|||
161655564|NCT02626455|583788940|FG000|Overall Study|Protocol Violation|0|||
161655565|NCT02626455|583788941|FG001|Overall Study|Protocol Violation|0|||
161655566|NCT02626455|583788942|FG002|Overall Study|Protocol Violation|0|||
161655567|NCT02626455|583788943|FG003|Overall Study|Protocol Violation|0|||
161655568|NCT02626455|583788944|FG004|Overall Study|Protocol Violation|0|||
161655569|NCT02626455|583788945|FG005|Overall Study|Protocol Violation|0|||
161655570|NCT02626455|583788946|FG006|Overall Study|Protocol Violation|1|||
161655571|NCT02626455|583788940|FG000|Overall Study|Progressive disease - radiological progression|0|||
161655572|NCT02626455|583788941|FG001|Overall Study|Progressive disease - radiological progression|0|||
161655573|NCT02626455|583788942|FG002|Overall Study|Progressive disease - radiological progression|0|||
161655574|NCT02626455|583788943|FG003|Overall Study|Progressive disease - radiological progression|0|||
161655575|NCT02626455|583788944|FG004|Overall Study|Progressive disease - radiological progression|0|||
161655576|NCT02626455|583788945|FG005|Overall Study|Progressive disease - radiological progression|11|||
161655577|NCT02626455|583788946|FG006|Overall Study|Progressive disease - radiological progression|22|||
161655578|NCT02626455|583788940|FG000|Overall Study|Progressive disease - clinical progression|0|||
161655579|NCT02626455|583788941|FG001|Overall Study|Progressive disease - clinical progression|0|||
161655580|NCT02626455|583788942|FG002|Overall Study|Progressive disease - clinical progression|0|||
161655581|NCT02626455|583788943|FG003|Overall Study|Progressive disease - clinical progression|0|||
161655582|NCT02626455|583788944|FG004|Overall Study|Progressive disease - clinical progression|0|||
161655583|NCT02626455|583788945|FG005|Overall Study|Progressive disease - clinical progression|1|||
161655584|NCT02626455|583788946|FG006|Overall Study|Progressive disease - clinical progression|2|||
161837668|NCT00062751|584448679|FG002|Overall Study|Withdrawal by Subject|2|||
161837669|NCT00062751|584448680|FG003|Overall Study|Withdrawal by Subject|1|||
161837670|NCT00062751|584448681|FG004|Overall Study|Withdrawal by Subject|0|||
161837671|NCT00062751|584448677|FG000|Overall Study|Symptomatic deterioration|1|||
161655585|NCT02626455|583788940|FG000|Overall Study|Lost to Follow-up|0|||
161655586|NCT02626455|583788941|FG001|Overall Study|Lost to Follow-up|0|||
161655587|NCT02626455|583788942|FG002|Overall Study|Lost to Follow-up|0|||
161655588|NCT02626455|583788943|FG003|Overall Study|Lost to Follow-up|0|||
161655589|NCT02626455|583788944|FG004|Overall Study|Lost to Follow-up|0|||
161655590|NCT02626455|583788945|FG005|Overall Study|Lost to Follow-up|1|||
161655591|NCT02626455|583788946|FG006|Overall Study|Lost to Follow-up|0|||
161655592|NCT02626455|583788940|FG000|Overall Study|AE not associated with clinical disease progression|1|||
161655593|NCT02626455|583788941|FG001|Overall Study|AE not associated with clinical disease progression|1|||
161655594|NCT02626455|583788942|FG002|Overall Study|AE not associated with clinical disease progression|0|||
161655595|NCT02626455|583788943|FG003|Overall Study|AE not associated with clinical disease progression|2|||
161655596|NCT02626455|583788944|FG004|Overall Study|AE not associated with clinical disease progression|1|||
161655597|NCT02626455|583788945|FG005|Overall Study|AE not associated with clinical disease progression|65|||
161655598|NCT02626455|583788946|FG006|Overall Study|AE not associated with clinical disease progression|21|||
161655599|NCT02626455|583788940|FG000|Overall Study|AE associated with clinical disease progression|0|||
161655600|NCT02626455|583788941|FG001|Overall Study|AE associated with clinical disease progression|0|||
161655601|NCT02626455|583788942|FG002|Overall Study|AE associated with clinical disease progression|0|||
161655602|NCT02626455|583788943|FG003|Overall Study|AE associated with clinical disease progression|0|||
161655603|NCT02626455|583788944|FG004|Overall Study|AE associated with clinical disease progression|0|||
161655604|NCT02626455|583788945|FG005|Overall Study|AE associated with clinical disease progression|1|||
161655605|NCT02626455|583788946|FG006|Overall Study|AE associated with clinical disease progression|2|||
161655606|NCT02626455|583788940|FG000|Overall Study|Study intervention never administered|0|||
161655607|NCT02626455|583788941|FG001|Overall Study|Study intervention never administered|0|||
161655608|NCT02626455|583788942|FG002|Overall Study|Study intervention never administered|0|||
161655609|NCT02626455|583788943|FG003|Overall Study|Study intervention never administered|0|||
161655610|NCT02626455|583788944|FG004|Overall Study|Study intervention never administered|0|||
161655611|NCT02626455|583788945|FG005|Overall Study|Study intervention never administered|1|||
161655612|NCT02626455|583788946|FG006|Overall Study|Study intervention never administered|3|||
161655613|NCT05148962|583788947|FG000|Overall Study|Withdrawal by Subject|1|||
161655614|NCT05148962|583788948|FG001|Overall Study|Withdrawal by Subject|1|||
161655615|NCT05148962|583788949|FG002|Overall Study|Withdrawal by Subject|0|||
161655616|NCT05148962|583788950|FG003|Overall Study|Withdrawal by Subject|1|||
161655617|NCT05148962|583788951|FG004|Overall Study|Withdrawal by Subject|0|||
161655618|NCT05148962|583788947|FG000|Overall Study|Participant was early terminated per protocol|0|||
161655619|NCT05148962|583788948|FG001|Overall Study|Participant was early terminated per protocol|0|||
161655620|NCT05148962|583788949|FG002|Overall Study|Participant was early terminated per protocol|3|||
161655621|NCT05148962|583788950|FG003|Overall Study|Participant was early terminated per protocol|5|||
161655622|NCT05148962|583788951|FG004|Overall Study|Participant was early terminated per protocol|2|||
161655623|NCT05148962|583788947|FG000|Overall Study|Miscellaneous|0|||
161655624|NCT05148962|583788948|FG001|Overall Study|Miscellaneous|0|||
161655625|NCT05148962|583788949|FG002|Overall Study|Miscellaneous|0|||
161655626|NCT05148962|583788950|FG003|Overall Study|Miscellaneous|1|||
161655627|NCT05148962|583788951|FG004|Overall Study|Miscellaneous|0|||
161655628|NCT06665919|583788952|FG000|Overall Study|Withdrawal by Subject|4|||
161655629|NCT06665919|583788953|FG001|Overall Study|Withdrawal by Subject|4|||
161655630|NCT06665919|583788954|FG002|Overall Study|Withdrawal by Subject|4|||
161655631|NCT06665919|583788952|FG000|Overall Study|Non-compliance to Treatment|4|||
161655632|NCT06665919|583788953|FG001|Overall Study|Non-compliance to Treatment|1|||
161655633|NCT06665919|583788954|FG002|Overall Study|Non-compliance to Treatment|6|||
161655634|NCT06665919|583788952|FG000|Overall Study|Lost to Follow-up|3|||
161655635|NCT06665919|583788953|FG001|Overall Study|Lost to Follow-up|0|||
161655636|NCT06665919|583788954|FG002|Overall Study|Lost to Follow-up|2|||
161655637|NCT06665919|583788952|FG000|Overall Study|Physician Decision|4|||
161655638|NCT06665919|583788953|FG001|Overall Study|Physician Decision|0|||
161655639|NCT06665919|583788954|FG002|Overall Study|Physician Decision|1|||
161655640|NCT01200290|583788956|FG000|Treatment Period|Adverse Event|1|||
161655641|NCT01200290|583788956|FG000|Post-Treatment Follow-Up Period|Death|2|||
161655642|NCT01525238|583788957|FG000|Overall Study|Withdrawal by Subject|1|||
161655643|NCT01525238|583788958|FG001|Overall Study|Withdrawal by Subject|0|||
161655644|NCT01525238|583788959|FG002|Overall Study|Withdrawal by Subject|0|||
161655645|NCT00607724|583788960|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
161655646|NCT00607724|583788961|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
161655647|NCT00607724|583788962|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
161655648|NCT00607724|583788963|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161655649|NCT00607724|583788964|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161655650|NCT00607724|583788965|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161706450|NCT01670994|583971556|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
161706451|NCT01670994|583971557|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
161706452|NCT01670994|583971556|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
161706453|NCT01670994|583971557|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
161706454|NCT01670994|583971556|FG000|Overall Study|Patient experienced DLT|0|||
161706455|NCT01670994|583971557|FG001|Overall Study|Patient experienced DLT|1|||
161706456|NCT02706938|583971562|FG000|First Period, 6 Weeks|Adverse Event|8|||
161706457|NCT02706938|583971563|FG001|First Period, 6 Weeks|Adverse Event|0|||
161706458|NCT02706938|583971562|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
161706459|NCT02706938|583971563|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
161706460|NCT02706938|583971562|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
161706461|NCT02706938|583971563|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
161706462|NCT02706938|583971562|FG000|Second Period, 6 Weeks|Adverse Event|0|||
161706463|NCT02706938|583971563|FG001|Second Period, 6 Weeks|Adverse Event|7|||
161706464|NCT02706938|583971562|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
161706465|NCT02706938|583971563|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
161706466|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161706467|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161706468|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161706469|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161706470|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161706471|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161706472|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706473|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706474|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706475|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
161706476|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
161706477|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706478|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706479|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
161706480|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706481|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706482|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706483|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706484|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
161706485|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
161706486|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
161706487|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
161706488|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
161706489|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
161706490|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Other causes|0|||
161706491|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Other causes|0|||
161706492|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Other causes|0|||
161706493|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Other causes|1|||
161706494|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Other causes|2|||
161706495|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Other causes|2|||
161706496|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
161706497|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
161837672|NCT00062751|584448678|FG001|Overall Study|Symptomatic deterioration|1|||
161837673|NCT00062751|584448679|FG002|Overall Study|Symptomatic deterioration|0|||
161837674|NCT00062751|584448680|FG003|Overall Study|Symptomatic deterioration|0|||
161837675|NCT00062751|584448681|FG004|Overall Study|Symptomatic deterioration|1|||
161837676|NCT00062751|584448677|FG000|Overall Study|Death|1|||
161837677|NCT00062751|584448678|FG001|Overall Study|Death|0|||
161837678|NCT00062751|584448679|FG002|Overall Study|Death|1|||
161837679|NCT00062751|584448680|FG003|Overall Study|Death|0|||
161837680|NCT00062751|584448681|FG004|Overall Study|Death|0|||
161837681|NCT03097588|584448688|FG000|Overall Study|Adverse Event|1|||
161837682|NCT01144364|584448689|FG000|Induction Phase|Disease progression|14|||
161837683|NCT01144364|584448690|FG001|Induction Phase|Disease progression|0|||
161837684|NCT01144364|584448691|FG002|Induction Phase|Disease progression|0|||
161706498|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
161706499|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
161706500|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
161706501|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
161706502|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706503|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
161837685|NCT01144364|584448689|FG000|Induction Phase|Adverse Event|9|||
161837686|NCT01144364|584448690|FG001|Induction Phase|Adverse Event|0|||
161706504|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706505|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706506|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706507|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706508|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706509|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706510|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706511|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706512|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706513|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
161706514|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
161706515|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
161706516|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
161706517|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
161706518|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
161706519|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
161706520|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161706521|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161706522|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
161706523|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
161706524|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161706525|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
161706526|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Other causes|0|||
161706527|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Other causes|0|||
161706528|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Other causes|0|||
161706529|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Other causes|1|||
161706530|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Other causes|3|||
161706531|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Other causes|5|||
161706532|NCT00813995|583971572|FG000|Overall Study|Clinical adverse event|9|||
161706533|NCT00813995|583971573|FG001|Overall Study|Clinical adverse event|3|||
161706534|NCT00813995|583971572|FG000|Overall Study|Laboratory adverse event|0|||
161706535|NCT00813995|583971573|FG001|Overall Study|Laboratory adverse event|2|||
161706536|NCT00813995|583971572|FG000|Overall Study|Lack of Efficacy|1|||
161706537|NCT00813995|583971573|FG001|Overall Study|Lack of Efficacy|0|||
161706538|NCT00813995|583971572|FG000|Overall Study|Lost to Follow-up|4|||
161706539|NCT00813995|583971573|FG001|Overall Study|Lost to Follow-up|2|||
161706540|NCT00813995|583971572|FG000|Overall Study|Other reason|2|||
161706541|NCT00813995|583971573|FG001|Overall Study|Other reason|2|||
161706542|NCT00813995|583971572|FG000|Overall Study|Protocol Violation|3|||
161706543|NCT00813995|583971573|FG001|Overall Study|Protocol Violation|2|||
161706544|NCT00813995|583971572|FG000|Overall Study|Subject moved|4|||
161706545|NCT00813995|583971573|FG001|Overall Study|Subject moved|0|||
161706546|NCT00813995|583971572|FG000|Overall Study|Withdrawal by Subject|0|||
161706547|NCT00813995|583971573|FG001|Overall Study|Withdrawal by Subject|5|||
161706548|NCT02507349|583971574|FG000|Overall Study|Death|12|||
161706549|NCT02507349|583971575|FG001|Overall Study|Death|16|||
161706550|NCT02507349|583971574|FG000|Overall Study|Withdrawal by Subject|1|||
161706551|NCT02507349|583971575|FG001|Overall Study|Withdrawal by Subject|1|||
161706552|NCT02507349|583971574|FG000|Overall Study|Lost to Follow-up|174|||
161706553|NCT02507349|583971575|FG001|Overall Study|Lost to Follow-up|144|||
161706554|NCT02700984|583971576|FG000|Overall Study|Death|2|||
161706555|NCT02700984|583971577|FG001|Overall Study|Death|1|||
161706556|NCT02700984|583971576|FG000|Overall Study|Lost to Follow-up|2|||
161706557|NCT02700984|583971577|FG001|Overall Study|Lost to Follow-up|1|||
161706558|NCT02700984|583971576|FG000|Overall Study|Physician Decision|0|||
161706559|NCT02700984|583971577|FG001|Overall Study|Physician Decision|1|||
161706560|NCT02700984|583971576|FG000|Overall Study|Withdrawal by Subject|8|||
161706561|NCT02700984|583971577|FG001|Overall Study|Withdrawal by Subject|9|||
161706562|NCT02700984|583971576|FG000|Overall Study|Reason not specified|3|||
161706563|NCT02700984|583971577|FG001|Overall Study|Reason not specified|2|||
161706564|NCT02868892|583971578|FG000|Overall Study|Investigator left site and no follow-up|6|||
161706565|NCT01360996|583971586|FG000|Overall Study|Withdrawal by Subject|4|||
161837687|NCT01144364|584448691|FG002|Induction Phase|Adverse Event|0|||
161706566|NCT01360996|583971587|FG001|Overall Study|Withdrawal by Subject|3|||
161706567|NCT01360996|583971588|FG002|Overall Study|Withdrawal by Subject|2|||
161706568|NCT01360996|583971586|FG000|Overall Study|Noncompliant|2|||
161706569|NCT01360996|583971587|FG001|Overall Study|Noncompliant|0|||
161706570|NCT01360996|583971588|FG002|Overall Study|Noncompliant|0|||
161706571|NCT03377634|583971589|FG000|Study Period|Adverse Event|1|||
161706572|NCT03377634|583971590|FG001|Study Period|Adverse Event|0|||
161706573|NCT03377634|583971589|FG000|Study Period|Withdrawal by Subject|1|||
161706574|NCT03377634|583971590|FG001|Study Period|Withdrawal by Subject|0|||
161706575|NCT01454076|583971591|FG000|Overall Study|Other|2|||
161706576|NCT01454076|583971592|FG001|Overall Study|Other|0|||
161837688|NCT01144364|584448689|FG000|Induction Phase|Death|1|||
161706577|NCT01454076|583971593|FG002|Overall Study|Other|0|||
161837689|NCT01144364|584448690|FG001|Induction Phase|Death|0|||
161837690|NCT01144364|584448691|FG002|Induction Phase|Death|0|||
161837691|NCT01144364|584448689|FG000|Induction Phase|Withdrawal by Subject|1|||
161837692|NCT01144364|584448690|FG001|Induction Phase|Withdrawal by Subject|0|||
161837693|NCT01144364|584448691|FG002|Induction Phase|Withdrawal by Subject|0|||
161837694|NCT01144364|584448689|FG000|Induction Phase|Lost to Follow-up|2|||
161837695|NCT01144364|584448690|FG001|Induction Phase|Lost to Follow-up|0|||
161655651|NCT00607724|583788966|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161655652|NCT00607724|583788960|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
161655653|NCT00607724|583788961|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
161655654|NCT00607724|583788962|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
161655655|NCT00607724|583788963|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
161655656|NCT00607724|583788964|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
161655657|NCT00607724|583788965|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
161655658|NCT00607724|583788966|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
161655659|NCT00607724|583788960|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
161655660|NCT00607724|583788961|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
161655661|NCT00607724|583788962|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
161655662|NCT00607724|583788963|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
161655663|NCT00607724|583788964|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
161655664|NCT00607724|583788965|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
161655665|NCT00607724|583788966|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
161655666|NCT00607724|583788960|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
161655667|NCT00607724|583788961|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
161655668|NCT00607724|583788962|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
161655669|NCT00607724|583788963|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
161655670|NCT00607724|583788964|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
161655671|NCT00607724|583788965|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
161655672|NCT00607724|583788966|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
161655673|NCT00607724|583788960|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161655674|NCT00607724|583788961|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161655675|NCT00607724|583788962|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161655676|NCT00607724|583788963|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
161655677|NCT00607724|583788964|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161655678|NCT00607724|583788965|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161655679|NCT00607724|583788966|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161655680|NCT00775463|583790492|FG000|Overall Study|Withdrawal by Subject|0|||
161655681|NCT00775463|583790493|FG001|Overall Study|Withdrawal by Subject|1|||
161655682|NCT00775463|583790492|FG000|Overall Study|Adverse Event|7|||
161655683|NCT00775463|583790493|FG001|Overall Study|Adverse Event|9|||
161655684|NCT00775463|583790492|FG000|Overall Study|Protocol Violation|2|||
161655685|NCT00775463|583790493|FG001|Overall Study|Protocol Violation|2|||
161655686|NCT00775463|583790492|FG000|Overall Study|Lost to Follow-up|1|||
161655687|NCT00775463|583790493|FG001|Overall Study|Lost to Follow-up|0|||
161655688|NCT00775463|583790492|FG000|Overall Study|Lack of Efficacy|1|||
161655689|NCT00775463|583790493|FG001|Overall Study|Lack of Efficacy|1|||
161655690|NCT01789567|583790494|FG000|Overall Study|Death|6|||
161655691|NCT04032613|583790495|FG000|Overall Study|Did not complete post-program assessment|5|||
161655692|NCT04032613|583790496|FG001|Overall Study|Did not complete post-program assessment|2|||
161655693|NCT01659853|583790497|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
161655694|NCT01659853|583790498|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
161655695|NCT01659853|583790497|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
161655696|NCT01659853|583790498|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
161655697|NCT01744392|583790502|FG000|Overall Study|Physician Decision|1|||
161655698|NCT00299494|583790503|FG000|Overall Study|Withdrawal by Subject|0|||
161655699|NCT00299494|583790504|FG001|Overall Study|Withdrawal by Subject|0|||
161655700|NCT00299494|583790505|FG002|Overall Study|Withdrawal by Subject|0|||
161655701|NCT00299494|583790506|FG003|Overall Study|Withdrawal by Subject|3|||
161655702|NCT00299494|583790507|FG004|Overall Study|Withdrawal by Subject|1|||
161655703|NCT00299494|583790508|FG005|Overall Study|Withdrawal by Subject|4|||
161655704|NCT00299494|583790503|FG000|Overall Study|Physician Decision|0|||
161655705|NCT00299494|583790504|FG001|Overall Study|Physician Decision|0|||
161655706|NCT00299494|583790505|FG002|Overall Study|Physician Decision|0|||
161706578|NCT01454076|583971594|FG003|Overall Study|Other|1|||
161706579|NCT01454076|583971595|FG004|Overall Study|Other|2|||
161706580|NCT01454076|583971591|FG000|Overall Study|Withdrawal by Subject|3|||
161706581|NCT01454076|583971592|FG001|Overall Study|Withdrawal by Subject|4|||
161706582|NCT01454076|583971593|FG002|Overall Study|Withdrawal by Subject|2|||
161706583|NCT01454076|583971594|FG003|Overall Study|Withdrawal by Subject|1|||
161706584|NCT01454076|583971595|FG004|Overall Study|Withdrawal by Subject|2|||
161706585|NCT01454076|583971591|FG000|Overall Study|Adverse Event|8|||
161706586|NCT01454076|583971592|FG001|Overall Study|Adverse Event|2|||
161706587|NCT01454076|583971593|FG002|Overall Study|Adverse Event|7|||
161706588|NCT01454076|583971594|FG003|Overall Study|Adverse Event|0|||
161706589|NCT01454076|583971595|FG004|Overall Study|Adverse Event|2|||
161706590|NCT00291551|583971598|FG000|Overall Study|Death|7|||
161706591|NCT00291551|583971598|FG000|Overall Study|Withdrawal by Subject|6|||
161706592|NCT02452762|583971599|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
161706593|NCT02452762|583971600|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
161706594|NCT02452762|583971599|FG000|Overall Study|Withdrawal by Subject|1|||
161706595|NCT02452762|583971600|FG001|Overall Study|Withdrawal by Subject|0|||
161706596|NCT00584870|583971601|FG000|Overall Study|Adverse Event|4|||
161706597|NCT00584870|583971602|FG001|Overall Study|Adverse Event|3|||
161706598|NCT00584870|583971603|FG002|Overall Study|Adverse Event|2|||
161706599|NCT00584870|583971601|FG000|Overall Study|Lost to Follow-up|4|||
161706600|NCT00584870|583971602|FG001|Overall Study|Lost to Follow-up|1|||
161706601|NCT00584870|583971603|FG002|Overall Study|Lost to Follow-up|1|||
161706602|NCT00584870|583971601|FG000|Overall Study|Lack of Efficacy|7|||
161706603|NCT00584870|583971602|FG001|Overall Study|Lack of Efficacy|14|||
161706604|NCT00584870|583971603|FG002|Overall Study|Lack of Efficacy|8|||
161706605|NCT00584870|583971601|FG000|Overall Study|Withdrawal by Subject|10|||
161706606|NCT00584870|583971602|FG001|Overall Study|Withdrawal by Subject|5|||
161706607|NCT00584870|583971603|FG002|Overall Study|Withdrawal by Subject|3|||
161706608|NCT00584870|583971601|FG000|Overall Study|Protocol Violation|1|||
161706609|NCT00584870|583971602|FG001|Overall Study|Protocol Violation|1|||
161706610|NCT00584870|583971603|FG002|Overall Study|Protocol Violation|2|||
161706611|NCT00584870|583971601|FG000|Overall Study|Did not met entrance criteria|1|||
161706612|NCT00584870|583971602|FG001|Overall Study|Did not met entrance criteria|0|||
161706613|NCT00584870|583971603|FG002|Overall Study|Did not met entrance criteria|0|||
161706614|NCT00584870|583971601|FG000|Overall Study|Other|2|||
161706615|NCT00584870|583971602|FG001|Overall Study|Other|0|||
161706616|NCT00584870|583971603|FG002|Overall Study|Other|0|||
161706617|NCT00584870|583971601|FG000|Overall Study|Randomized but not treated|0|||
161706618|NCT00584870|583971602|FG001|Overall Study|Randomized but not treated|1|||
161706619|NCT00584870|583971603|FG002|Overall Study|Randomized but not treated|2|||
161706620|NCT00631137|583971604|FG000|Overall Study|Withdrawal by Subject|1|||
161706621|NCT00631137|583971605|FG001|Overall Study|Withdrawal by Subject|0|||
161706622|NCT03682120|583971606|FG000|Overall Study|Lost to Follow-up|11|||
161706623|NCT03682120|583971607|FG001|Overall Study|Lost to Follow-up|4|||
161706624|NCT03682120|583971608|FG002|Overall Study|Lost to Follow-up|5|||
161706625|NCT03682120|583971609|FG003|Overall Study|Lost to Follow-up|2|||
161706626|NCT03682120|583971606|FG000|Overall Study|Physician Decision|1|||
161706627|NCT03682120|583971607|FG001|Overall Study|Physician Decision|0|||
161706628|NCT03682120|583971608|FG002|Overall Study|Physician Decision|0|||
161706629|NCT03682120|583971609|FG003|Overall Study|Physician Decision|0|||
161706630|NCT03682120|583971606|FG000|Overall Study|Withdrawal by Subject|1|||
161706631|NCT03682120|583971607|FG001|Overall Study|Withdrawal by Subject|2|||
161706632|NCT03682120|583971608|FG002|Overall Study|Withdrawal by Subject|3|||
161706633|NCT03682120|583971609|FG003|Overall Study|Withdrawal by Subject|0|||
161706634|NCT03682120|583971606|FG000|Overall Study|Death|0|||
161706635|NCT03682120|583971607|FG001|Overall Study|Death|1|||
161706636|NCT03682120|583971608|FG002|Overall Study|Death|0|||
161706637|NCT03682120|583971609|FG003|Overall Study|Death|0|||
161706638|NCT03682120|583971606|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
161706639|NCT03682120|583971607|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
161706640|NCT03682120|583971608|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
161706641|NCT03682120|583971609|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
161706642|NCT01015833|583971610|FG000|Overall Study|Death|1|||
161706643|NCT01015833|583971611|FG001|Overall Study|Death|0|||
161706644|NCT01015833|583971610|FG000|Overall Study|Withdrawal by Subject|3|||
161706645|NCT01015833|583971611|FG001|Overall Study|Withdrawal by Subject|2|||
161706646|NCT01015833|583971610|FG000|Overall Study|Adverse Event|0|||
161706647|NCT01015833|583971611|FG001|Overall Study|Adverse Event|1|||
161706648|NCT01015833|583971610|FG000|Overall Study|Physician Decision|2|||
161706649|NCT01015833|583971611|FG001|Overall Study|Physician Decision|0|||
161706650|NCT01015833|583971610|FG000|Overall Study|Symptomatic deterioration|0|||
161706651|NCT01015833|583971611|FG001|Overall Study|Symptomatic deterioration|1|||
161706652|NCT01015833|583971610|FG000|Overall Study|Other|5|||
161706653|NCT01015833|583971611|FG001|Overall Study|Other|1|||
161706654|NCT01015833|583971610|FG000|Overall Study|Motor Vehicle Accidents|1|||
161706655|NCT01015833|583971611|FG001|Overall Study|Motor Vehicle Accidents|0|||
161706656|NCT01015833|583971610|FG000|Overall Study|Did not start treatment|1|||
161706657|NCT01015833|583971611|FG001|Overall Study|Did not start treatment|0|||
161706658|NCT02040142|583971612|FG000|Overall Study|Lost to Follow-up|5|||
161706659|NCT02040142|583971612|FG000|Overall Study|Death|17|||
161706660|NCT02040142|583971612|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
161706661|NCT04439331|583971616|FG000|Overall Study|Never Start Protocol Therapy|2|||
161706662|NCT04439331|583971616|FG000|Overall Study|Ineligible|2|||
161706663|NCT04439331|583971616|FG000|Overall Study|Mutation Status Not Confirmed|1|||
161706664|NCT04439331|583971616|FG000|Overall Study|Adverse Event|1|||
161706665|NCT04439331|583971616|FG000|Overall Study|Death|1|||
161706666|NCT04439331|583971616|FG000|Overall Study|Disease Progression|20|||
161706667|NCT04439331|583971616|FG000|Overall Study|Withdrawal by Subject|6|||
161706668|NCT04439331|583971616|FG000|Overall Study|Physician Decision|1|||
161706669|NCT04439331|583971616|FG000|Overall Study|Other Complicating Disease|1|||
161706670|NCT03726268|583971618|FG000|Overall Study|Physician Decision|2|||
161706671|NCT03726268|583971619|FG001|Overall Study|Physician Decision|8|||
161706672|NCT03726268|583971620|FG002|Overall Study|Physician Decision|6|||
161706673|NCT03726268|583971621|FG003|Overall Study|Physician Decision|3|||
161706674|NCT03726268|583971618|FG000|Overall Study|Withdrawal by Subject|11|||
161706675|NCT03726268|583971619|FG001|Overall Study|Withdrawal by Subject|5|||
161706676|NCT03726268|583971620|FG002|Overall Study|Withdrawal by Subject|9|||
161706677|NCT03726268|583971621|FG003|Overall Study|Withdrawal by Subject|8|||
161706678|NCT04370509|583971623|FG000|Overall Study|Adverse Event|1|||
161706679|NCT04370509|583971624|FG001|Overall Study|Adverse Event|0|||
161706680|NCT04370509|583971623|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
161706681|NCT04370509|583971624|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
161706682|NCT04743856|583971625|FG000|Overall Study|Lost to Follow-up|6|||
161706683|NCT04743856|583971626|FG001|Overall Study|Lost to Follow-up|7|||
161706684|NCT04743856|583971625|FG000|Overall Study|Withdrawal by Subject|1|||
161706685|NCT04743856|583971626|FG001|Overall Study|Withdrawal by Subject|0|||
161706686|NCT04696861|583971627|FG000|Overall Study|Death|1|||
161706687|NCT04696861|583971628|FG001|Overall Study|Death|0|||
161706688|NCT04696861|583971627|FG000|Overall Study|Lost to Follow-up|3|||
161706689|NCT04696861|583971628|FG001|Overall Study|Lost to Follow-up|0|||
161706690|NCT04439188|583971629|FG000|Overall Study|Ineligible|3|||
161706691|NCT04439188|583971629|FG000|Overall Study|Adverse Event|4|||
161706692|NCT04439188|583971629|FG000|Overall Study|Death|1|||
161706693|NCT04439188|583971629|FG000|Overall Study|Disease Progression|25|||
161706694|NCT04439188|583971629|FG000|Overall Study|Withdrawal by Subject|2|||
161706695|NCT00413959|583971630|FG000|Overall Study|Pt had only one cycle.|1|||
161706696|NCT01813890|583971633|FG000|Overall Study|Adverse Event|0|||
161706697|NCT01813890|583971634|FG001|Overall Study|Adverse Event|3|||
161706698|NCT01813890|583971635|FG002|Overall Study|Adverse Event|4|||
161706699|NCT01813890|583971633|FG000|Overall Study|Lack of Efficacy|9|||
161706700|NCT01813890|583971634|FG001|Overall Study|Lack of Efficacy|1|||
161706701|NCT01813890|583971635|FG002|Overall Study|Lack of Efficacy|2|||
161706702|NCT04482647|583971636|FG000|Overall Study|Time constraints|2|||
161706703|NCT04482647|583971636|FG000|Overall Study|Health issues|1|||
161706704|NCT04482647|583971636|FG000|Overall Study|Death in the family|1|||
161706705|NCT04482647|583971636|FG000|Overall Study|Disliked the intervention|1|||
161706706|NCT04482647|583971636|FG000|Overall Study|No reasons specified|7|||
161706707|NCT03952559|583971637|FG000|Double Blind Treatment Period|Adverse Event|0|||
161706708|NCT03952559|583971638|FG001|Double Blind Treatment Period|Adverse Event|2|||
161706709|NCT03952559|583971639|FG002|Double Blind Treatment Period|Adverse Event|1|||
161706710|NCT03952559|583971640|FG003|Double Blind Treatment Period|Adverse Event|0|||
161706711|NCT03952559|583971641|FG004|Double Blind Treatment Period|Adverse Event|1|||
161706712|NCT03952559|583971637|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
161706713|NCT03952559|583971638|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
161706714|NCT03952559|583971639|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
161706715|NCT03952559|583971640|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
161706716|NCT03952559|583971641|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161706717|NCT03952559|583971637|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161706718|NCT03952559|583971638|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
161706719|NCT03952559|583971639|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
161706720|NCT03952559|583971640|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
161706721|NCT03952559|583971641|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161706722|NCT03952559|583971637|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
161706723|NCT03952559|583971638|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
161706724|NCT03952559|583971639|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
161706725|NCT03952559|583971640|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
161706726|NCT03952559|583971641|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
161706727|NCT03538743|583971642|FG000|Overall Study|Adverse Event|0|||
161706728|NCT03538743|583971643|FG001|Overall Study|Adverse Event|0|||
161706729|NCT03538743|583971644|FG002|Overall Study|Adverse Event|1|||
161706730|NCT03538743|583971645|FG003|Overall Study|Adverse Event|1|||
161706731|NCT03538743|583971646|FG004|Overall Study|Adverse Event|0|||
161706732|NCT03538743|583971647|FG005|Overall Study|Adverse Event|0|||
161706733|NCT03538743|583971648|FG006|Overall Study|Adverse Event|0|||
161706734|NCT03538743|583971649|FG007|Overall Study|Adverse Event|0|||
161706735|NCT03538743|583971650|FG008|Overall Study|Adverse Event|0|||
161706736|NCT03538743|583971642|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
161706737|NCT03538743|583971643|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
161706738|NCT03538743|583971644|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
161706739|NCT03538743|583971645|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
161706740|NCT03538743|583971646|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
161706741|NCT03538743|583971647|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
161706742|NCT03538743|583971648|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
161706743|NCT03538743|583971649|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
161706744|NCT03538743|583971650|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
161706745|NCT03538743|583971642|FG000|Overall Study|Withdrawal by Subject|0|||
161706746|NCT03538743|583971643|FG001|Overall Study|Withdrawal by Subject|0|||
161706747|NCT03538743|583971644|FG002|Overall Study|Withdrawal by Subject|0|||
161706748|NCT03538743|583971645|FG003|Overall Study|Withdrawal by Subject|1|||
161706749|NCT03538743|583971646|FG004|Overall Study|Withdrawal by Subject|0|||
161706750|NCT03538743|583971647|FG005|Overall Study|Withdrawal by Subject|0|||
161706751|NCT03538743|583971648|FG006|Overall Study|Withdrawal by Subject|0|||
161706752|NCT03538743|583971649|FG007|Overall Study|Withdrawal by Subject|0|||
161706753|NCT03538743|583971650|FG008|Overall Study|Withdrawal by Subject|0|||
161706754|NCT00630331|583971654|FG000|Overall Study|Death|2|||
161706755|NCT00630331|583971655|FG001|Overall Study|Death|1|||
161706756|NCT00630331|583971656|FG002|Overall Study|Death|1|||
161706757|NCT00630331|583971654|FG000|Overall Study|Adverse Event|1|||
161706758|NCT00630331|583971655|FG001|Overall Study|Adverse Event|0|||
161706759|NCT00630331|583971656|FG002|Overall Study|Adverse Event|0|||
161706760|NCT00630331|583971654|FG000|Overall Study|Withdrawal by Subject|12|||
161706761|NCT00630331|583971655|FG001|Overall Study|Withdrawal by Subject|7|||
161706762|NCT00630331|583971656|FG002|Overall Study|Withdrawal by Subject|5|||
161706763|NCT00630331|583971654|FG000|Overall Study|Lost to Follow-up|175|||
161706764|NCT00630331|583971655|FG001|Overall Study|Lost to Follow-up|143|||
161706765|NCT00630331|583971656|FG002|Overall Study|Lost to Follow-up|170|||
161706766|NCT00630331|583971654|FG000|Overall Study|Inappropriate enrollment|3|||
161706767|NCT00630331|583971655|FG001|Overall Study|Inappropriate enrollment|6|||
161706768|NCT00630331|583971656|FG002|Overall Study|Inappropriate enrollment|3|||
161706769|NCT00630331|583971654|FG000|Overall Study|Unable to classify|9|||
161706770|NCT00630331|583971655|FG001|Overall Study|Unable to classify|4|||
161706771|NCT00630331|583971656|FG002|Overall Study|Unable to classify|3|||
161706772|NCT00630331|583971654|FG000|Overall Study|Protocol Violation|4|||
161706773|NCT00630331|583971655|FG001|Overall Study|Protocol Violation|5|||
161706774|NCT00630331|583971656|FG002|Overall Study|Protocol Violation|6|||
161706775|NCT01929135|583971664|FG000|Overall Study|Lost to Follow-up|1|||
161706776|NCT01929135|583971665|FG001|Overall Study|Lost to Follow-up|1|||
161706777|NCT03136107|583971668|FG000|Overall Study|Other (Not specified)|1|||
161706778|NCT01955707|583971669|FG000|Overall Study|Adverse Event|1|||
161706779|NCT01955707|583971670|FG001|Overall Study|Adverse Event|2|||
161706780|NCT01955707|583971669|FG000|Overall Study|Lost to Follow-up|2|||
161706781|NCT01955707|583971670|FG001|Overall Study|Lost to Follow-up|1|||
161706782|NCT01955707|583971669|FG000|Overall Study|Withdrawal by Subject|0|||
161706783|NCT01955707|583971670|FG001|Overall Study|Withdrawal by Subject|3|||
161706784|NCT01955707|583971669|FG000|Overall Study|Death|13|||
161706785|NCT01955707|583971670|FG001|Overall Study|Death|14|||
161706786|NCT01955707|583971669|FG000|Overall Study|Other|4|||
161706787|NCT01955707|583971670|FG001|Overall Study|Other|2|||
161706788|NCT01817790|583971675|FG000|Overall Study|Adverse Event|0|||
161706789|NCT01817790|583971676|FG001|Overall Study|Adverse Event|2|||
161706790|NCT01817790|583971675|FG000|Overall Study|Lost to Follow-up|0|||
161706791|NCT01817790|583971676|FG001|Overall Study|Lost to Follow-up|1|||
161706792|NCT01817790|583971675|FG000|Overall Study|Protocol Violation|2|||
161706793|NCT01817790|583971676|FG001|Overall Study|Protocol Violation|1|||
161706794|NCT01817790|583971675|FG000|Overall Study|Withdrawal by Subject|1|||
161706795|NCT01817790|583971676|FG001|Overall Study|Withdrawal by Subject|3|||
161706796|NCT01817790|583971675|FG000|Overall Study|Other: Could not attend appointment|1|||
161706797|NCT01817790|583971676|FG001|Overall Study|Other: Could not attend appointment|1|||
161706798|NCT01671345|583971677|FG000|Overall Study|Lost to Follow-up|10|||
161706799|NCT01671345|583971678|FG001|Overall Study|Lost to Follow-up|6|||
161706800|NCT01671345|583971677|FG000|Overall Study|visit with non-participating physician|3|||
161706801|NCT01671345|583971678|FG001|Overall Study|visit with non-participating physician|3|||
161706802|NCT02847598|583971681|FG000|Overall Study|Adverse Event|0|||
161706803|NCT02847598|583971682|FG001|Overall Study|Adverse Event|0|||
161706804|NCT02847598|583971683|FG002|Overall Study|Adverse Event|0|||
161706805|NCT02847598|583971684|FG003|Overall Study|Adverse Event|0|||
161706806|NCT02847598|583971685|FG004|Overall Study|Adverse Event|0|||
161706807|NCT02847598|583971686|FG005|Overall Study|Adverse Event|0|||
161706808|NCT02847598|583971687|FG006|Overall Study|Adverse Event|0|||
161706809|NCT02847598|583971688|FG007|Overall Study|Adverse Event|1|||
161706810|NCT02847598|583971681|FG000|Overall Study|Consent withdrawn|2|||
161706811|NCT02847598|583971682|FG001|Overall Study|Consent withdrawn|0|||
161706812|NCT02847598|583971683|FG002|Overall Study|Consent withdrawn|0|||
161706813|NCT02847598|583971684|FG003|Overall Study|Consent withdrawn|4|||
161706814|NCT02847598|583971685|FG004|Overall Study|Consent withdrawn|3|||
161706815|NCT02847598|583971686|FG005|Overall Study|Consent withdrawn|2|||
161706816|NCT02847598|583971687|FG006|Overall Study|Consent withdrawn|1|||
161706817|NCT02847598|583971688|FG007|Overall Study|Consent withdrawn|3|||
161706818|NCT02847598|583971681|FG000|Overall Study|Death|3|||
161706819|NCT02847598|583971682|FG001|Overall Study|Death|0|||
161706820|NCT02847598|583971683|FG002|Overall Study|Death|0|||
161706821|NCT02847598|583971684|FG003|Overall Study|Death|0|||
161706822|NCT02847598|583971685|FG004|Overall Study|Death|0|||
161706823|NCT02847598|583971686|FG005|Overall Study|Death|0|||
161706824|NCT02847598|583971687|FG006|Overall Study|Death|0|||
161706825|NCT02847598|583971688|FG007|Overall Study|Death|0|||
161706826|NCT02847598|583971681|FG000|Overall Study|Lost to Follow-up|0|||
161706827|NCT02847598|583971682|FG001|Overall Study|Lost to Follow-up|0|||
161706828|NCT02847598|583971683|FG002|Overall Study|Lost to Follow-up|0|||
161706829|NCT02847598|583971684|FG003|Overall Study|Lost to Follow-up|0|||
161706830|NCT02847598|583971685|FG004|Overall Study|Lost to Follow-up|0|||
161706831|NCT02847598|583971686|FG005|Overall Study|Lost to Follow-up|1|||
161706832|NCT02847598|583971687|FG006|Overall Study|Lost to Follow-up|1|||
161706833|NCT02847598|583971688|FG007|Overall Study|Lost to Follow-up|0|||
161706834|NCT03690869|583971689|FG000|Overall Study|Adverse Event|0|||
161706835|NCT03690869|583971690|FG001|Overall Study|Adverse Event|0|||
161706836|NCT03690869|583971691|FG002|Overall Study|Adverse Event|0|||
161706837|NCT03690869|583971692|FG003|Overall Study|Adverse Event|1|||
161706838|NCT03690869|583971693|FG004|Overall Study|Adverse Event|0|||
161706839|NCT03690869|583971694|FG005|Overall Study|Adverse Event|0|||
161706840|NCT03690869|583971695|FG006|Overall Study|Adverse Event|0|||
161706841|NCT03690869|583971696|FG007|Overall Study|Adverse Event|1|||
161706842|NCT03690869|583971697|FG008|Overall Study|Adverse Event|0|||
161706843|NCT03690869|583971698|FG009|Overall Study|Adverse Event|1|||
161706844|NCT03690869|583971689|FG000|Overall Study|Death|1|||
161706845|NCT03690869|583971690|FG001|Overall Study|Death|1|||
161706846|NCT03690869|583971691|FG002|Overall Study|Death|1|||
161706847|NCT03690869|583971692|FG003|Overall Study|Death|4|||
161706848|NCT03690869|583971693|FG004|Overall Study|Death|2|||
161706849|NCT03690869|583971694|FG005|Overall Study|Death|5|||
161706850|NCT03690869|583971695|FG006|Overall Study|Death|3|||
161706851|NCT03690869|583971696|FG007|Overall Study|Death|2|||
161706852|NCT03690869|583971697|FG008|Overall Study|Death|0|||
161706853|NCT03690869|583971698|FG009|Overall Study|Death|3|||
161706854|NCT03690869|583971689|FG000|Overall Study|Lost to Follow-up|0|||
161706855|NCT03690869|583971690|FG001|Overall Study|Lost to Follow-up|0|||
161706856|NCT03690869|583971691|FG002|Overall Study|Lost to Follow-up|1|||
161837696|NCT01144364|584448691|FG002|Induction Phase|Lost to Follow-up|0|||
161706857|NCT03690869|583971692|FG003|Overall Study|Lost to Follow-up|0|||
161706858|NCT03690869|583971693|FG004|Overall Study|Lost to Follow-up|0|||
161706859|NCT03690869|583971694|FG005|Overall Study|Lost to Follow-up|0|||
161837697|NCT01144364|584448689|FG000|Induction Phase|Physician Decision|1|||
161837698|NCT01144364|584448690|FG001|Induction Phase|Physician Decision|0|||
161706860|NCT03690869|583971695|FG006|Overall Study|Lost to Follow-up|0|||
161706861|NCT03690869|583971696|FG007|Overall Study|Lost to Follow-up|0|||
161706862|NCT03690869|583971697|FG008|Overall Study|Lost to Follow-up|0|||
161837699|NCT01144364|584448691|FG002|Induction Phase|Physician Decision|0|||
161706863|NCT03690869|583971698|FG009|Overall Study|Lost to Follow-up|0|||
161706864|NCT03690869|583971689|FG000|Overall Study|Other Treatment|1|||
161706865|NCT03690869|583971690|FG001|Overall Study|Other Treatment|1|||
161706866|NCT03690869|583971691|FG002|Overall Study|Other Treatment|1|||
161706867|NCT03690869|583971692|FG003|Overall Study|Other Treatment|2|||
161706868|NCT03690869|583971693|FG004|Overall Study|Other Treatment|3|||
161706869|NCT03690869|583971694|FG005|Overall Study|Other Treatment|1|||
161706870|NCT03690869|583971695|FG006|Overall Study|Other Treatment|2|||
161706871|NCT03690869|583971696|FG007|Overall Study|Other Treatment|7|||
161706872|NCT03690869|583971697|FG008|Overall Study|Other Treatment|0|||
161706873|NCT03690869|583971698|FG009|Overall Study|Other Treatment|3|||
161706874|NCT03690869|583971689|FG000|Overall Study|Physician Decision|0|||
161706875|NCT03690869|583971690|FG001|Overall Study|Physician Decision|1|||
161706876|NCT03690869|583971691|FG002|Overall Study|Physician Decision|0|||
161706877|NCT03690869|583971692|FG003|Overall Study|Physician Decision|0|||
161706878|NCT03690869|583971693|FG004|Overall Study|Physician Decision|0|||
161706879|NCT03690869|583971694|FG005|Overall Study|Physician Decision|0|||
161706880|NCT03690869|583971695|FG006|Overall Study|Physician Decision|0|||
161706881|NCT03690869|583971696|FG007|Overall Study|Physician Decision|0|||
161706882|NCT03690869|583971697|FG008|Overall Study|Physician Decision|0|||
161706883|NCT03690869|583971698|FG009|Overall Study|Physician Decision|0|||
161706884|NCT03690869|583971689|FG000|Overall Study|Progressive Disease|1|||
161706885|NCT03690869|583971690|FG001|Overall Study|Progressive Disease|2|||
161706886|NCT03690869|583971691|FG002|Overall Study|Progressive Disease|0|||
161706887|NCT03690869|583971692|FG003|Overall Study|Progressive Disease|1|||
161706888|NCT03690869|583971693|FG004|Overall Study|Progressive Disease|0|||
161706889|NCT03690869|583971694|FG005|Overall Study|Progressive Disease|0|||
161706890|NCT03690869|583971695|FG006|Overall Study|Progressive Disease|0|||
161706891|NCT03690869|583971696|FG007|Overall Study|Progressive Disease|0|||
161706892|NCT03690869|583971697|FG008|Overall Study|Progressive Disease|1|||
161706893|NCT03690869|583971698|FG009|Overall Study|Progressive Disease|1|||
161706894|NCT03690869|583971689|FG000|Overall Study|Subject Decision|0|||
161706895|NCT03690869|583971690|FG001|Overall Study|Subject Decision|0|||
161706896|NCT03690869|583971691|FG002|Overall Study|Subject Decision|0|||
161706897|NCT03690869|583971692|FG003|Overall Study|Subject Decision|1|||
161706898|NCT03690869|583971693|FG004|Overall Study|Subject Decision|0|||
161706899|NCT03690869|583971694|FG005|Overall Study|Subject Decision|0|||
161706900|NCT03690869|583971695|FG006|Overall Study|Subject Decision|0|||
161706901|NCT03690869|583971696|FG007|Overall Study|Subject Decision|1|||
161706902|NCT03690869|583971697|FG008|Overall Study|Subject Decision|0|||
161706903|NCT03690869|583971698|FG009|Overall Study|Subject Decision|0|||
161706904|NCT00960076|583973362|FG000|Overall Study|Adverse Event|1|||
161706905|NCT00960076|583973363|FG001|Overall Study|Adverse Event|7|||
161706906|NCT00960076|583973362|FG000|Overall Study|No longer met study criteria|1|||
161706907|NCT00960076|583973363|FG001|Overall Study|No longer met study criteria|5|||
161706908|NCT00960076|583973362|FG000|Overall Study|Withdrawal by Subject|1|||
161706909|NCT00960076|583973363|FG001|Overall Study|Withdrawal by Subject|2|||
161706910|NCT00960076|583973362|FG000|Overall Study|Lost to Follow-up|3|||
161706911|NCT00960076|583973363|FG001|Overall Study|Lost to Follow-up|3|||
161706912|NCT00960076|583973362|FG000|Overall Study|Severe non-compliance to protocol|1|||
161706913|NCT00960076|583973363|FG001|Overall Study|Severe non-compliance to protocol|2|||
161706914|NCT00960076|583973362|FG000|Overall Study|Hyperglycemia|1|||
161706915|NCT00960076|583973363|FG001|Overall Study|Hyperglycemia|5|||
161706916|NCT00960076|583973362|FG000|Overall Study|Did not attend the termination visit|0|||
161706917|NCT00960076|583973363|FG001|Overall Study|Did not attend the termination visit|1|||
161706918|NCT02029976|583973364|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
161706919|NCT02029976|583973365|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
161706920|NCT02029976|583973364|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
161706921|NCT02029976|583973365|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
161706922|NCT02029976|583973364|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
161706923|NCT02029976|583973365|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
161706924|NCT02029976|583973364|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
161706925|NCT02029976|583973365|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
161706926|NCT03263806|583973366|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
161706927|NCT03263806|583973367|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
161706928|NCT03263806|583973366|FG000|Overall Study|Withdrawal by Subject|0|||
161706929|NCT03263806|583973367|FG001|Overall Study|Withdrawal by Subject|1|||
161706930|NCT03263806|583973366|FG000|Overall Study|Study Termination|5|||
161706931|NCT03263806|583973367|FG001|Overall Study|Study Termination|6|||
161706932|NCT04840667|583973368|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
161706933|NCT01445171|583973369|FG000|Overall Study|Lost to Follow-up|11|||
161706934|NCT01445171|583973369|FG000|Overall Study|Withdrawal by Subject|16|||
161706935|NCT01445171|583973369|FG000|Overall Study|Death|51|||
161706936|NCT01445171|583973369|FG000|Overall Study|Subjects declined to return for followup|9|||
161706937|NCT01445171|583973369|FG000|Overall Study|Consented but did not receive device|8|||
161706938|NCT00023322|583973370|FG000|Overall Study|Lost to Follow-up|1|||
161706939|NCT05194345|583973373|FG000|Overall Study|Withdrawal by Subject|6|||
161706940|NCT05194345|583973374|FG001|Overall Study|Withdrawal by Subject|4|||
161706941|NCT05194345|583973375|FG002|Overall Study|Withdrawal by Subject|0|||
161706942|NCT05194345|583973373|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
161706943|NCT05194345|583973374|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
161706944|NCT05194345|583973375|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
161706945|NCT02612909|583973376|FG000|Phase 2|Withdrawal by Subject|2|||
161706946|NCT02612909|583973377|FG001|Phase 2|Withdrawal by Subject|5|||
161706947|NCT02612909|583973378|FG002|Phase 2|Withdrawal by Subject|0|||
161706948|NCT02612909|583973379|FG003|Phase 2|Withdrawal by Subject|0|||
161706949|NCT02612909|583973380|FG004|Phase 2|Withdrawal by Subject|0|||
161706950|NCT02612909|583973376|FG000|Phase 2|Pregnancy|0|||
161706951|NCT02612909|583973377|FG001|Phase 2|Pregnancy|0|||
161706952|NCT02612909|583973378|FG002|Phase 2|Pregnancy|1|||
161706953|NCT02612909|583973379|FG003|Phase 2|Pregnancy|0|||
161706954|NCT02612909|583973380|FG004|Phase 2|Pregnancy|0|||
161706955|NCT02612909|583973376|FG000|Phase 3|Withdrawal by Subject|0|||
161706956|NCT02612909|583973377|FG001|Phase 3|Withdrawal by Subject|0|||
161706957|NCT02612909|583973378|FG002|Phase 3|Withdrawal by Subject|0|||
161706958|NCT02612909|583973379|FG003|Phase 3|Withdrawal by Subject|1|||
161706959|NCT02612909|583973380|FG004|Phase 3|Withdrawal by Subject|0|||
161706960|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161706961|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
161706962|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161706963|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161706964|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161706965|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
161706966|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161706967|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161706968|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
161706969|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706970|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706971|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706972|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161706973|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
161706974|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161706975|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161706976|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
161706977|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
161706978|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
161706979|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
161706980|NCT05067127|583973385|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161706981|NCT05067127|583973386|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161706982|NCT05067127|583973387|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161706983|NCT05067127|583973388|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
161706984|NCT05067127|583973385|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706985|NCT05067127|583973386|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706986|NCT05067127|583973387|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
161706987|NCT05067127|583973388|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
161706988|NCT03615222|583973390|FG000|Overall Study|Ineligible|26|||
161706989|NCT03615222|583973390|FG000|Overall Study|Withdrawal by Subject|7|||
161706990|NCT03615222|583973390|FG000|Overall Study|Death|1|||
161706991|NCT04572633|583973391|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
161706992|NCT03155997|583973394|FG000|Overall Study|Withdrawal by Subject|119|||
161706993|NCT03155997|583973395|FG001|Overall Study|Withdrawal by Subject|134|||
161706994|NCT03155997|583973394|FG000|Overall Study|Lost to Follow-up|12|||
161706995|NCT03155997|583973395|FG001|Overall Study|Lost to Follow-up|13|||
161706996|NCT03155997|583973394|FG000|Overall Study|Missing disposition data|0|||
161706997|NCT03155997|583973395|FG001|Overall Study|Missing disposition data|1|||
161706998|NCT03155997|583973394|FG000|Overall Study|On study treatment|2027|||
161706999|NCT03155997|583973395|FG001|Overall Study|On study treatment|2074|||
161707000|NCT03304522|583973398|FG000|Overall Study|Adverse Event|0|||
161707001|NCT03304522|583973399|FG001|Overall Study|Adverse Event|4|||
161707002|NCT03304522|583973398|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161707003|NCT03304522|583973399|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161707004|NCT03304522|583973398|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
161707005|NCT03304522|583973399|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
161707006|NCT03304522|583973398|FG000|Overall Study|Other|0|||
161707007|NCT03304522|583973399|FG001|Overall Study|Other|1|||
161707008|NCT03367871|583973402|FG000|Overall Study|Lost to Follow-up|1|||
161707009|NCT01111604|583973404|FG000|Overall Study|Lost to Follow-up|0|||
161707010|NCT01111604|583973405|FG001|Overall Study|Lost to Follow-up|0|||
161707011|NCT01111604|583973406|FG002|Overall Study|Lost to Follow-up|1|||
161707012|NCT01111604|583973404|FG000|Overall Study|Withdrew Consent|3|||
161707013|NCT01111604|583973405|FG001|Overall Study|Withdrew Consent|0|||
161707014|NCT01111604|583973406|FG002|Overall Study|Withdrew Consent|2|||
161707015|NCT01111604|583973404|FG000|Overall Study|Withdrawal by Subject|2|||
161707016|NCT01111604|583973405|FG001|Overall Study|Withdrawal by Subject|0|||
161707017|NCT01111604|583973406|FG002|Overall Study|Withdrawal by Subject|0|||
161707018|NCT01111604|583973404|FG000|Overall Study|Death|1|||
161707019|NCT01111604|583973405|FG001|Overall Study|Death|0|||
161707020|NCT01111604|583973406|FG002|Overall Study|Death|0|||
161707021|NCT01111604|583973404|FG000|Overall Study|Met Exclusion Criteria|2|||
161707022|NCT01111604|583973405|FG001|Overall Study|Met Exclusion Criteria|0|||
161707023|NCT01111604|583973406|FG002|Overall Study|Met Exclusion Criteria|0|||
161707024|NCT00885365|583973409|FG000|4 Weeks ON Treatment|Adverse Event|2|||
161707025|NCT00885365|583973410|FG001|4 Weeks ON Treatment|Adverse Event|4|||
161707026|NCT00885365|583973409|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
161707027|NCT00885365|583973410|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
161707028|NCT00885365|583973409|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
161707029|NCT00885365|583973410|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
161707030|NCT01824979|583973411|FG000|Overall Study|Withdrawal by Subject|5|||
161707031|NCT01824979|583973412|FG001|Overall Study|Withdrawal by Subject|0|||
161707032|NCT01824979|583973411|FG000|Overall Study|Physician Decision|2|||
161707033|NCT01824979|583973412|FG001|Overall Study|Physician Decision|0|||
161707034|NCT01824979|583973411|FG000|Overall Study|Protocol Violation|6|||
161707035|NCT01824979|583973412|FG001|Overall Study|Protocol Violation|13|||
161707036|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
161707037|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
161707038|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
161707039|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707040|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707041|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707042|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707043|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707044|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
161707045|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
161707046|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
161707047|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707048|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707049|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707050|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707051|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707052|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707053|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707054|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161707055|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707056|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707057|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707058|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707059|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707060|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707061|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
161707062|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
161707063|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707064|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707065|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707066|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707067|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707068|NCT01651780|583973423|FG000|Overall Study|Physician decision: No 30-day visit|2|||
161707069|NCT01651780|583973424|FG001|Overall Study|Physician decision: No 30-day visit|1|||
161707070|NCT01651780|583973423|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
161707071|NCT01651780|583973424|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
161707072|NCT01651780|583973423|FG000|Overall Study|Withdrawal by Subject|2|||
161707073|NCT01651780|583973424|FG001|Overall Study|Withdrawal by Subject|0|||
161707074|NCT01651780|583973423|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
161707075|NCT01651780|583973424|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161707076|NCT01651780|583973423|FG000|Overall Study|Lost to Follow-up|1|||
161707077|NCT01651780|583973424|FG001|Overall Study|Lost to Follow-up|2|||
161707078|NCT01651780|583973423|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
161707079|NCT01651780|583973424|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
161707080|NCT00054132|583973425|FG000|Overall Study|Not Treated|1|||
161707081|NCT02949830|583973426|FG000|Overall Study|Adverse Event|1|||
161707082|NCT02949830|583973426|FG000|Overall Study|Withdrawal by Subject|1|||
161707083|NCT01290887|583973427|FG000|Overall Study|Adverse Event|6|||
161707084|NCT01290887|583973428|FG001|Overall Study|Adverse Event|11|||
161707085|NCT01290887|583973427|FG000|Overall Study|Lack of Efficacy|4|||
161707086|NCT01290887|583973428|FG001|Overall Study|Lack of Efficacy|5|||
161707087|NCT01290887|583973427|FG000|Overall Study|Withdrawal by Subject|26|||
161707088|NCT01290887|583973428|FG001|Overall Study|Withdrawal by Subject|32|||
161707089|NCT01290887|583973427|FG000|Overall Study|Protocol Violation|2|||
161707090|NCT01290887|583973428|FG001|Overall Study|Protocol Violation|1|||
161707091|NCT01290887|583973427|FG000|Overall Study|Lost to Follow-up|4|||
161707092|NCT01290887|583973428|FG001|Overall Study|Lost to Follow-up|4|||
161707093|NCT01290887|583973427|FG000|Overall Study|Non-compliance to study procedures|0|||
161707094|NCT01290887|583973428|FG001|Overall Study|Non-compliance to study procedures|1|||
161707095|NCT01290887|583973427|FG000|Overall Study|Non-compliance to study medications|1|||
161707096|NCT01290887|583973428|FG001|Overall Study|Non-compliance to study medications|0|||
161707097|NCT01290887|583973427|FG000|Overall Study|Sponsor closure of study|420|||
161707098|NCT01290887|583973428|FG001|Overall Study|Sponsor closure of study|476|||
161707099|NCT01290887|583973427|FG000|Overall Study|Other|3|||
161707100|NCT01290887|583973428|FG001|Overall Study|Other|6|||
161707101|NCT01628926|583973429|FG000|Overall Study|Adverse Event|13|||
161707102|NCT01628926|583973430|FG001|Overall Study|Adverse Event|11|||
161707103|NCT01628926|583973431|FG002|Overall Study|Adverse Event|9|||
161707104|NCT01628926|583973429|FG000|Overall Study|Lack of Efficacy|2|||
161707105|NCT01628926|583973430|FG001|Overall Study|Lack of Efficacy|1|||
161707106|NCT01628926|583973431|FG002|Overall Study|Lack of Efficacy|5|||
161707107|NCT01628926|583973429|FG000|Overall Study|Withdrawal by Subject|6|||
161707108|NCT01628926|583973430|FG001|Overall Study|Withdrawal by Subject|4|||
161707109|NCT01628926|583973431|FG002|Overall Study|Withdrawal by Subject|2|||
161707110|NCT01628926|583973429|FG000|Overall Study|Protocol Violation|0|||
161707111|NCT01628926|583973430|FG001|Overall Study|Protocol Violation|1|||
161707112|NCT01628926|583973431|FG002|Overall Study|Protocol Violation|0|||
161707113|NCT01628926|583973429|FG000|Overall Study|Discontinuation criteria|3|||
161707114|NCT01628926|583973430|FG001|Overall Study|Discontinuation criteria|4|||
161707115|NCT01628926|583973431|FG002|Overall Study|Discontinuation criteria|0|||
161707116|NCT01628926|583973429|FG000|Overall Study|Physician Decision|2|||
161707117|NCT01628926|583973430|FG001|Overall Study|Physician Decision|2|||
161707118|NCT01628926|583973431|FG002|Overall Study|Physician Decision|1|||
161707119|NCT03029832|583973432|FG000|Overall Study|Safety Follow-Up Completed|2|||
161707120|NCT03029832|583973433|FG001|Overall Study|Safety Follow-Up Completed|0|||
161707121|NCT03029832|583973432|FG000|Overall Study|Death due to Disease Progression|1|||
161707122|NCT03029832|583973433|FG001|Overall Study|Death due to Disease Progression|0|||
161707123|NCT03029832|583973432|FG000|Overall Study|Study Terminated By Sponsor|1|||
161707124|NCT03029832|583973433|FG001|Overall Study|Study Terminated By Sponsor|1|||
161707125|NCT04373460|583973434|FG000|Overall Study|Did not receive tranfusion|18|||
161707126|NCT04373460|583973435|FG001|Overall Study|Did not receive tranfusion|26|||
161707127|NCT01412229|583973436|FG000|Overall Study|Physician Decision|1|||
161707128|NCT00454207|583973437|FG000|Overall Study|Adverse Event|3|||
161707129|NCT00454207|583973438|FG001|Overall Study|Adverse Event|1|||
161707130|NCT00454207|583973437|FG000|Overall Study|Lack of Efficacy|1|||
161707131|NCT00454207|583973438|FG001|Overall Study|Lack of Efficacy|0|||
161707132|NCT00454207|583973437|FG000|Overall Study|Protocol Violation|0|||
161707133|NCT00454207|583973438|FG001|Overall Study|Protocol Violation|1|||
161707134|NCT01672957|583973439|FG000|Overall Study|Protocol Violation|48|||
161707135|NCT01672957|583973439|FG000|Overall Study|Death|2|||
161837700|NCT01144364|584448689|FG000|Induction Phase|Stable disease|2|||
161837701|NCT01144364|584448690|FG001|Induction Phase|Stable disease|0|||
161837702|NCT01144364|584448691|FG002|Induction Phase|Stable disease|0|||
161837703|NCT01144364|584448689|FG000|Induction Phase|Secondary neoplasia|1|||
161707136|NCT01672957|583973439|FG000|Overall Study|ICF Signed After Transplantation|5|||
161707137|NCT01795547|583973444|FG000|Overall Study|Adverse Event|16|||
161707138|NCT01795547|583973445|FG001|Overall Study|Adverse Event|27|||
161707139|NCT01795547|583973444|FG000|Overall Study|Lack of Efficacy|8|||
161837704|NCT01144364|584448690|FG001|Induction Phase|Secondary neoplasia|0|||
161655707|NCT00299494|583790506|FG003|Overall Study|Physician Decision|0|||
161655708|NCT00299494|583790507|FG004|Overall Study|Physician Decision|1|||
161655709|NCT00299494|583790508|FG005|Overall Study|Physician Decision|0|||
161655710|NCT00299494|583790503|FG000|Overall Study|Death|3|||
161655711|NCT00299494|583790504|FG001|Overall Study|Death|1|||
161655712|NCT00299494|583790505|FG002|Overall Study|Death|4|||
161655713|NCT00299494|583790506|FG003|Overall Study|Death|6|||
161655714|NCT00299494|583790507|FG004|Overall Study|Death|18|||
161655715|NCT00299494|583790508|FG005|Overall Study|Death|19|||
161655716|NCT00299494|583790503|FG000|Overall Study|Lost to Follow-up|0|||
161655717|NCT00299494|583790504|FG001|Overall Study|Lost to Follow-up|0|||
161655718|NCT00299494|583790505|FG002|Overall Study|Lost to Follow-up|0|||
161655719|NCT00299494|583790506|FG003|Overall Study|Lost to Follow-up|0|||
161655720|NCT00299494|583790507|FG004|Overall Study|Lost to Follow-up|3|||
161655721|NCT00299494|583790508|FG005|Overall Study|Lost to Follow-up|1|||
161655722|NCT00299494|583790503|FG000|Overall Study|Other - Unspecified|0|||
161655723|NCT00299494|583790504|FG001|Overall Study|Other - Unspecified|0|||
161655724|NCT00299494|583790505|FG002|Overall Study|Other - Unspecified|0|||
161655725|NCT00299494|583790506|FG003|Overall Study|Other - Unspecified|0|||
161655726|NCT00299494|583790507|FG004|Overall Study|Other - Unspecified|3|||
161655727|NCT00299494|583790508|FG005|Overall Study|Other - Unspecified|1|||
161655728|NCT00299494|583790503|FG000|Overall Study|Other - site closure|0|||
161655729|NCT00299494|583790504|FG001|Overall Study|Other - site closure|0|||
161655730|NCT00299494|583790505|FG002|Overall Study|Other - site closure|0|||
161655731|NCT00299494|583790506|FG003|Overall Study|Other - site closure|1|||
161655732|NCT00299494|583790507|FG004|Overall Study|Other - site closure|1|||
161655733|NCT00299494|583790508|FG005|Overall Study|Other - site closure|1|||
161655734|NCT01417104|583790512|FG000|Overall Study|Withdrawal by Subject|5|||
161655735|NCT01417104|583790513|FG001|Overall Study|Withdrawal by Subject|1|||
161655736|NCT01417104|583790512|FG000|Overall Study|Failure to make contact|0|||
161655737|NCT01417104|583790513|FG001|Overall Study|Failure to make contact|1|||
161655738|NCT01417104|583790512|FG000|Overall Study|Adverse Event|1|||
161655739|NCT01417104|583790513|FG001|Overall Study|Adverse Event|0|||
161655740|NCT01365481|583790519|FG000|Overall Study|Adverse Event|6|||
161655741|NCT01365481|583790520|FG001|Overall Study|Adverse Event|9|||
161655742|NCT01365481|583790521|FG002|Overall Study|Adverse Event|0|||
161655743|NCT01365481|583790522|FG003|Overall Study|Adverse Event|2|||
161655744|NCT01365481|583790519|FG000|Overall Study|Withdrawal by Subject|0|||
161655745|NCT01365481|583790520|FG001|Overall Study|Withdrawal by Subject|2|||
161655746|NCT01365481|583790521|FG002|Overall Study|Withdrawal by Subject|1|||
161655747|NCT01365481|583790522|FG003|Overall Study|Withdrawal by Subject|1|||
161655748|NCT01365481|583790519|FG000|Overall Study|Lost to Follow-up|1|||
161655749|NCT01365481|583790520|FG001|Overall Study|Lost to Follow-up|1|||
161655750|NCT01365481|583790521|FG002|Overall Study|Lost to Follow-up|2|||
161655751|NCT01365481|583790522|FG003|Overall Study|Lost to Follow-up|3|||
161655752|NCT01365481|583790519|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161655753|NCT01365481|583790520|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161655754|NCT01365481|583790521|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161655755|NCT01365481|583790522|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161655756|NCT01365481|583790519|FG000|Overall Study|Administrative problems|0|||
161655757|NCT01365481|583790520|FG001|Overall Study|Administrative problems|1|||
161655758|NCT01365481|583790521|FG002|Overall Study|Administrative problems|0|||
161655759|NCT01365481|583790522|FG003|Overall Study|Administrative problems|0|||
161655760|NCT01365481|583790519|FG000|Overall Study|Protocol deviation|0|||
161655761|NCT01365481|583790520|FG001|Overall Study|Protocol deviation|1|||
161655762|NCT01365481|583790521|FG002|Overall Study|Protocol deviation|0|||
161655763|NCT01365481|583790522|FG003|Overall Study|Protocol deviation|1|||
161655764|NCT01365481|583790519|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161655765|NCT01365481|583790520|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161655766|NCT01365481|583790521|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161655767|NCT01365481|583790522|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161655768|NCT00757627|583790523|FG000|Overall Study|Adverse Event|15|||
161655769|NCT00757627|583790523|FG000|Overall Study|Lack of Efficacy|10|||
161655770|NCT00757627|583790523|FG000|Overall Study|Lost to Follow-up|28|||
161655771|NCT00757627|583790523|FG000|Overall Study|Withdrawal by Subject|27|||
161655772|NCT00757627|583790523|FG000|Overall Study|Other|1|||
161655773|NCT00635661|583790528|FG000|Overall Study|Withdrawal by Subject|4|||
161655774|NCT00403767|583790534|FG000|Overall Study|Adverse Event|993|||
161707140|NCT01795547|583973445|FG001|Overall Study|Lack of Efficacy|3|||
161707141|NCT01795547|583973444|FG000|Overall Study|Protocol Violation|6|||
161707142|NCT01795547|583973445|FG001|Overall Study|Protocol Violation|4|||
161707143|NCT01795547|583973444|FG000|Overall Study|Lost to Follow-up|2|||
161707144|NCT01795547|583973445|FG001|Overall Study|Lost to Follow-up|5|||
161707145|NCT01795547|583973444|FG000|Overall Study|Withdrawal of consent|7|||
161707146|NCT01795547|583973445|FG001|Overall Study|Withdrawal of consent|12|||
161707147|NCT01795547|583973444|FG000|Overall Study|Not Treated|4|||
161707148|NCT01795547|583973445|FG001|Overall Study|Not Treated|10|||
161707149|NCT01795547|583973444|FG000|Overall Study|Non-compliance with IMP|1|||
161707150|NCT01795547|583973445|FG001|Overall Study|Non-compliance with IMP|1|||
161707151|NCT01795547|583973444|FG000|Overall Study|Others|4|||
161707152|NCT01795547|583973445|FG001|Overall Study|Others|1|||
161707153|NCT01795547|583973444|FG000|Overall Study|Not stated|0|||
161707154|NCT01795547|583973445|FG001|Overall Study|Not stated|1|||
161707155|NCT00642642|583973447|FG000|Treatment & Follow Up|Adverse Event|2|||
161707156|NCT00642642|583973447|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
161707157|NCT00642642|583973447|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
161707158|NCT02116621|583973448|FG000|Baseline|Withdrawal by Subject|0|||
161707159|NCT02116621|583973449|FG001|Baseline|Withdrawal by Subject|4|||
161707160|NCT02116621|583973448|FG000|Three Month Follow-up|Death|1|||
161707161|NCT02116621|583973449|FG001|Three Month Follow-up|Death|1|||
161707162|NCT02116621|583973448|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
161707163|NCT02116621|583973449|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
161707164|NCT02116621|583973448|FG000|Three Month Follow-up|Lost to Follow-up|0|||
161707165|NCT02116621|583973449|FG001|Three Month Follow-up|Lost to Follow-up|1|||
161707166|NCT02116621|583973448|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
161707167|NCT02116621|583973449|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
161707168|NCT02116621|583973448|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
161707169|NCT02116621|583973449|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
161707170|NCT02116621|583973448|FG000|Six Month Follow-up|Lost to Follow-up|2|||
161707171|NCT02116621|583973449|FG001|Six Month Follow-up|Lost to Follow-up|1|||
161707172|NCT02116621|583973448|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
161707173|NCT02116621|583973449|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
161707174|NCT02116621|583973448|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
161707175|NCT02116621|583973449|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
161707176|NCT02116621|583973448|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
161707177|NCT02116621|583973449|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
161707178|NCT02116621|583973448|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
161707179|NCT02116621|583973449|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
161707180|NCT02116621|583973448|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
161707181|NCT02116621|583973449|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
161707182|NCT00151892|583973450|FG000|Overall Study|Lack of Efficacy|50|||
161707183|NCT00151892|583973451|FG001|Overall Study|Lack of Efficacy|57|||
161707184|NCT00151892|583973450|FG000|Overall Study|Patient request|10|||
161707185|NCT00151892|583973451|FG001|Overall Study|Patient request|7|||
161707186|NCT00151892|583973450|FG000|Overall Study|Lost to Follow-up|5|||
161707187|NCT00151892|583973451|FG001|Overall Study|Lost to Follow-up|10|||
161837705|NCT01144364|584448691|FG002|Induction Phase|Secondary neoplasia|0|||
161707188|NCT00151892|583973450|FG000|Overall Study|Adverse Event|6|||
161837706|NCT01144364|584448689|FG000|Induction Phase|Protocol Violation|1|||
161655775|NCT00403767|583790535|FG001|Overall Study|Adverse Event|919|||
161655776|NCT00403767|583790534|FG000|Overall Study|Non-compliant with study medication|134|||
161707189|NCT00151892|583973451|FG001|Overall Study|Adverse Event|3|||
161707190|NCT00151892|583973450|FG000|Overall Study|Protocol Violation|3|||
161707191|NCT00151892|583973451|FG001|Overall Study|Protocol Violation|3|||
161707192|NCT00151892|583973450|FG000|Overall Study|Non-compliance|0|||
161707193|NCT00151892|583973451|FG001|Overall Study|Non-compliance|1|||
161707194|NCT00151892|583973450|FG000|Overall Study|Pregnancy|0|||
161707195|NCT00151892|583973451|FG001|Overall Study|Pregnancy|1|||
161707196|NCT00151892|583973450|FG000|Overall Study|Did not return for a visit|1|||
161707197|NCT00151892|583973451|FG001|Overall Study|Did not return for a visit|0|||
161707198|NCT00151892|583973450|FG000|Overall Study|Used prohibited corticosteroids|1|||
161707199|NCT00151892|583973451|FG001|Overall Study|Used prohibited corticosteroids|0|||
161707200|NCT00151892|583973450|FG000|Overall Study|Lack of study medication at center|0|||
161707201|NCT00151892|583973451|FG001|Overall Study|Lack of study medication at center|1|||
161707202|NCT04223609|583973454|FG000|Overall Study|Adverse Event|0|||
161707203|NCT04223609|583973455|FG001|Overall Study|Adverse Event|1|||
161707204|NCT04223609|583973454|FG000|Overall Study|Missed last visit|0|||
161707205|NCT04223609|583973455|FG001|Overall Study|Missed last visit|1|||
161707206|NCT03437447|583973456|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161707207|NCT03437447|583973457|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161707208|NCT03437447|583973458|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161707209|NCT03440944|583973461|FG000|Overall Study|Physician Decision|1|||
161707210|NCT03440944|583973462|FG001|Overall Study|Physician Decision|0|||
161707211|NCT03440944|583973461|FG000|Overall Study|No Acceptable Vasculature|0|||
161707212|NCT03440944|583973462|FG001|Overall Study|No Acceptable Vasculature|1|||
161707213|NCT00591734|583973463|FG000|Overall Study|Lack of Efficacy|35|||
161707214|NCT00591734|583973463|FG000|Overall Study|Adverse Event|5|||
161707215|NCT00591734|583973463|FG000|Overall Study|Physician Decision|5|||
161707216|NCT00591734|583973463|FG000|Overall Study|Intercurrent Illness|8|||
161707217|NCT04672083|583973464|FG000|Overall Study|Lost to Follow-up|1|||
161707218|NCT04672083|583973465|FG001|Overall Study|Lost to Follow-up|0|||
161707219|NCT04672083|583973466|FG002|Overall Study|Lost to Follow-up|0|||
161707220|NCT04672083|583973467|FG003|Overall Study|Lost to Follow-up|0|||
161707221|NCT04672083|583973468|FG004|Overall Study|Lost to Follow-up|0|||
161707222|NCT01551745|583973469|FG000|Overall Study|Withdrawal by Subject|1|||
161707223|NCT01551745|583973469|FG000|Overall Study|Disease Progression|2|||
161707224|NCT01661790|583973470|FG000|Overall Study|Lost to Follow-up|0|||
161707225|NCT01661790|583973471|FG001|Overall Study|Lost to Follow-up|2|||
161707226|NCT02764541|583973472|FG000|Overall Study|Withdrawal by Subject|0|||
161707227|NCT02764541|583973473|FG001|Overall Study|Withdrawal by Subject|0|||
161707228|NCT02764541|583973474|FG002|Overall Study|Withdrawal by Subject|0|||
161707229|NCT02764541|583973475|FG003|Overall Study|Withdrawal by Subject|0|||
161707230|NCT02764541|583973476|FG004|Overall Study|Withdrawal by Subject|1|||
161707231|NCT02764541|583973477|FG005|Overall Study|Withdrawal by Subject|1|||
161707232|NCT02764541|583973478|FG006|Overall Study|Withdrawal by Subject|0|||
161707233|NCT02764541|583973479|FG007|Overall Study|Withdrawal by Subject|1|||
161707234|NCT02764541|583973472|FG000|Overall Study|Adverse Event|1|||
161707235|NCT02764541|583973473|FG001|Overall Study|Adverse Event|0|||
161707236|NCT02764541|583973474|FG002|Overall Study|Adverse Event|0|||
161707237|NCT02764541|583973475|FG003|Overall Study|Adverse Event|0|||
161707238|NCT02764541|583973476|FG004|Overall Study|Adverse Event|0|||
161707239|NCT02764541|583973477|FG005|Overall Study|Adverse Event|0|||
161707240|NCT02764541|583973478|FG006|Overall Study|Adverse Event|1|||
161707241|NCT02764541|583973479|FG007|Overall Study|Adverse Event|0|||
161707242|NCT02764541|583973472|FG000|Overall Study|Metastasis|1|||
161707243|NCT02764541|583973473|FG001|Overall Study|Metastasis|0|||
161707244|NCT02764541|583973474|FG002|Overall Study|Metastasis|0|||
161707245|NCT02764541|583973475|FG003|Overall Study|Metastasis|0|||
161707246|NCT02764541|583973476|FG004|Overall Study|Metastasis|0|||
161707247|NCT02764541|583973477|FG005|Overall Study|Metastasis|0|||
161707248|NCT02764541|583973478|FG006|Overall Study|Metastasis|0|||
161707249|NCT02764541|583973479|FG007|Overall Study|Metastasis|0|||
161707250|NCT02764541|583973472|FG000|Overall Study|Disease progression|1|||
161707251|NCT02764541|583973473|FG001|Overall Study|Disease progression|1|||
161707252|NCT02764541|583973474|FG002|Overall Study|Disease progression|0|||
161707253|NCT02764541|583973475|FG003|Overall Study|Disease progression|0|||
161707254|NCT02764541|583973476|FG004|Overall Study|Disease progression|0|||
161707255|NCT02764541|583973477|FG005|Overall Study|Disease progression|0|||
161707256|NCT02764541|583973478|FG006|Overall Study|Disease progression|0|||
161707257|NCT02764541|583973479|FG007|Overall Study|Disease progression|1|||
161707258|NCT02764541|583973472|FG000|Overall Study|Protocol Violation|0|||
161707259|NCT02764541|583973473|FG001|Overall Study|Protocol Violation|0|||
161707260|NCT02764541|583973474|FG002|Overall Study|Protocol Violation|0|||
161707261|NCT02764541|583973475|FG003|Overall Study|Protocol Violation|1|||
161707262|NCT02764541|583973476|FG004|Overall Study|Protocol Violation|0|||
161707263|NCT02764541|583973477|FG005|Overall Study|Protocol Violation|1|||
161707264|NCT02764541|583973478|FG006|Overall Study|Protocol Violation|0|||
161707265|NCT02764541|583973479|FG007|Overall Study|Protocol Violation|0|||
161707266|NCT02764541|583973472|FG000|Overall Study|Physician Decision|0|||
161707267|NCT02764541|583973473|FG001|Overall Study|Physician Decision|0|||
161707268|NCT02764541|583973474|FG002|Overall Study|Physician Decision|0|||
161707269|NCT02764541|583973475|FG003|Overall Study|Physician Decision|1|||
161707270|NCT02764541|583973476|FG004|Overall Study|Physician Decision|0|||
161707271|NCT02764541|583973477|FG005|Overall Study|Physician Decision|0|||
161707272|NCT02764541|583973478|FG006|Overall Study|Physician Decision|0|||
161707273|NCT02764541|583973479|FG007|Overall Study|Physician Decision|1|||
161707274|NCT02764541|583973472|FG000|Overall Study|Three Cycles completed before surgery|0|||
161707275|NCT02764541|583973473|FG001|Overall Study|Three Cycles completed before surgery|0|||
161707276|NCT02764541|583973474|FG002|Overall Study|Three Cycles completed before surgery|0|||
161707277|NCT02764541|583973475|FG003|Overall Study|Three Cycles completed before surgery|1|||
161707278|NCT02764541|583973476|FG004|Overall Study|Three Cycles completed before surgery|0|||
161707279|NCT02764541|583973477|FG005|Overall Study|Three Cycles completed before surgery|0|||
161707280|NCT02764541|583973478|FG006|Overall Study|Three Cycles completed before surgery|0|||
161707281|NCT02764541|583973479|FG007|Overall Study|Three Cycles completed before surgery|0|||
161707282|NCT02764541|583973472|FG000|Overall Study|Patient Compliance|0|||
161707283|NCT02764541|583973473|FG001|Overall Study|Patient Compliance|0|||
161707284|NCT02764541|583973474|FG002|Overall Study|Patient Compliance|1|||
161707285|NCT02764541|583973475|FG003|Overall Study|Patient Compliance|0|||
161707286|NCT02764541|583973476|FG004|Overall Study|Patient Compliance|0|||
161707287|NCT02764541|583973477|FG005|Overall Study|Patient Compliance|0|||
161707288|NCT02764541|583973478|FG006|Overall Study|Patient Compliance|0|||
161707289|NCT02764541|583973479|FG007|Overall Study|Patient Compliance|0|||
161707290|NCT02764541|583973472|FG000|Overall Study|Death|0|||
161707291|NCT02764541|583973473|FG001|Overall Study|Death|0|||
161707292|NCT02764541|583973474|FG002|Overall Study|Death|0|||
161707293|NCT02764541|583973475|FG003|Overall Study|Death|0|||
161707294|NCT02764541|583973476|FG004|Overall Study|Death|0|||
161707295|NCT02764541|583973477|FG005|Overall Study|Death|0|||
161707296|NCT02764541|583973478|FG006|Overall Study|Death|1|||
161707297|NCT02764541|583973479|FG007|Overall Study|Death|0|||
161707298|NCT02764541|583973472|FG000|Overall Study|Insurance reasons|0|||
161707299|NCT02764541|583973473|FG001|Overall Study|Insurance reasons|0|||
161707300|NCT02764541|583973474|FG002|Overall Study|Insurance reasons|0|||
161707301|NCT02764541|583973475|FG003|Overall Study|Insurance reasons|0|||
161707302|NCT02764541|583973476|FG004|Overall Study|Insurance reasons|0|||
161707303|NCT02764541|583973477|FG005|Overall Study|Insurance reasons|0|||
161707304|NCT02764541|583973478|FG006|Overall Study|Insurance reasons|1|||
161707305|NCT02764541|583973479|FG007|Overall Study|Insurance reasons|0|||
161707306|NCT02048904|583973482|FG000|Overall Study|Withdrawal by Subject|7|||
161707307|NCT02048904|583973482|FG000|Overall Study|Physician Decision|70|||
161707308|NCT00749190|583973485|FG000|Overall Study|Adverse Event|0|||
161707309|NCT00749190|583973486|FG001|Overall Study|Adverse Event|2|||
161707310|NCT00749190|583973487|FG002|Overall Study|Adverse Event|0|||
161707311|NCT00749190|583973488|FG003|Overall Study|Adverse Event|4|||
161707312|NCT00749190|583973489|FG004|Overall Study|Adverse Event|0|||
161707313|NCT00749190|583973490|FG005|Overall Study|Adverse Event|3|||
161707314|NCT00749190|583973491|FG006|Overall Study|Adverse Event|0|||
161707315|NCT00749190|583973485|FG000|Overall Study|Lack of Efficacy|3|||
161707316|NCT00749190|583973486|FG001|Overall Study|Lack of Efficacy|1|||
161707317|NCT00749190|583973487|FG002|Overall Study|Lack of Efficacy|1|||
161707318|NCT00749190|583973488|FG003|Overall Study|Lack of Efficacy|0|||
161707319|NCT00749190|583973489|FG004|Overall Study|Lack of Efficacy|0|||
161707320|NCT00749190|583973490|FG005|Overall Study|Lack of Efficacy|1|||
161707321|NCT00749190|583973491|FG006|Overall Study|Lack of Efficacy|0|||
161707322|NCT00749190|583973485|FG000|Overall Study|Withdrawal by Subject|2|||
161707323|NCT00749190|583973486|FG001|Overall Study|Withdrawal by Subject|1|||
161707324|NCT00749190|583973487|FG002|Overall Study|Withdrawal by Subject|0|||
161707325|NCT00749190|583973488|FG003|Overall Study|Withdrawal by Subject|0|||
161707326|NCT00749190|583973489|FG004|Overall Study|Withdrawal by Subject|0|||
161707327|NCT00749190|583973490|FG005|Overall Study|Withdrawal by Subject|1|||
161707328|NCT00749190|583973491|FG006|Overall Study|Withdrawal by Subject|0|||
161707329|NCT00749190|583973485|FG000|Overall Study|Protocol Violation|0|||
161707330|NCT00749190|583973486|FG001|Overall Study|Protocol Violation|1|||
161707331|NCT00749190|583973487|FG002|Overall Study|Protocol Violation|0|||
161707332|NCT00749190|583973488|FG003|Overall Study|Protocol Violation|0|||
161707333|NCT00749190|583973489|FG004|Overall Study|Protocol Violation|0|||
161707334|NCT00749190|583973490|FG005|Overall Study|Protocol Violation|0|||
161707335|NCT00749190|583973491|FG006|Overall Study|Protocol Violation|1|||
161707336|NCT00749190|583973485|FG000|Overall Study|Other reason not defined above|0|||
161837707|NCT01144364|584448690|FG001|Induction Phase|Protocol Violation|0|||
161837708|NCT01144364|584448691|FG002|Induction Phase|Protocol Violation|0|||
161707337|NCT00749190|583973486|FG001|Overall Study|Other reason not defined above|0|||
161707338|NCT00749190|583973487|FG002|Overall Study|Other reason not defined above|0|||
161707339|NCT00749190|583973488|FG003|Overall Study|Other reason not defined above|1|||
161707340|NCT00749190|583973489|FG004|Overall Study|Other reason not defined above|0|||
161707341|NCT00749190|583973490|FG005|Overall Study|Other reason not defined above|0|||
161707342|NCT00749190|583973491|FG006|Overall Study|Other reason not defined above|0|||
161707343|NCT04752384|583973493|FG000|Overall Study|Withdrawal by Subject|1|||
161707344|NCT04752384|583973493|FG000|Overall Study|Death|1|||
161707345|NCT00490542|583973497|FG000|Overall Study|Lost to Follow-up|3|||
161707346|NCT00490542|583973498|FG001|Overall Study|Lost to Follow-up|0|||
161707347|NCT00490542|583973497|FG000|Overall Study|Adverse Event|3|||
161707348|NCT00490542|583973498|FG001|Overall Study|Adverse Event|3|||
161707349|NCT00490542|583973497|FG000|Overall Study|Lack of Efficacy|1|||
161707350|NCT00490542|583973498|FG001|Overall Study|Lack of Efficacy|1|||
161707351|NCT02875223|583973499|FG000|Overall Study|Other reasons|0|||
161707352|NCT02875223|583973500|FG001|Overall Study|Other reasons|0|||
161707353|NCT02875223|583973501|FG002|Overall Study|Other reasons|1|||
161707354|NCT02875223|583973502|FG003|Overall Study|Other reasons|0|||
161707355|NCT02875223|583973503|FG004|Overall Study|Other reasons|1|||
161707356|NCT02875223|583973504|FG005|Overall Study|Other reasons|2|||
161707357|NCT02875223|583973505|FG006|Overall Study|Other reasons|0|||
161707358|NCT02875223|583973506|FG007|Overall Study|Other reasons|2|||
161707359|NCT02875223|583973507|FG008|Overall Study|Other reasons|0|||
161707360|NCT02875223|583973508|FG009|Overall Study|Other reasons|0|||
161707361|NCT02875223|583973509|FG010|Overall Study|Other reasons|0|||
161707362|NCT02875223|583973510|FG011|Overall Study|Other reasons|0|||
161707363|NCT02875223|583973511|FG012|Overall Study|Other reasons|0|||
161707364|NCT02875223|583973499|FG000|Overall Study|Withdrawal by Subject|0|||
161707365|NCT02875223|583973500|FG001|Overall Study|Withdrawal by Subject|0|||
161707366|NCT02875223|583973501|FG002|Overall Study|Withdrawal by Subject|0|||
161707367|NCT02875223|583973502|FG003|Overall Study|Withdrawal by Subject|0|||
161707368|NCT02875223|583973503|FG004|Overall Study|Withdrawal by Subject|1|||
161707369|NCT02875223|583973504|FG005|Overall Study|Withdrawal by Subject|1|||
161707370|NCT02875223|583973505|FG006|Overall Study|Withdrawal by Subject|0|||
161707371|NCT02875223|583973506|FG007|Overall Study|Withdrawal by Subject|0|||
161707372|NCT02875223|583973507|FG008|Overall Study|Withdrawal by Subject|1|||
161707373|NCT02875223|583973508|FG009|Overall Study|Withdrawal by Subject|0|||
161707374|NCT02875223|583973509|FG010|Overall Study|Withdrawal by Subject|0|||
161707375|NCT02875223|583973510|FG011|Overall Study|Withdrawal by Subject|0|||
161707376|NCT02875223|583973511|FG012|Overall Study|Withdrawal by Subject|0|||
161707377|NCT02875223|583973499|FG000|Overall Study|Progressive disease|0|||
161707378|NCT02875223|583973500|FG001|Overall Study|Progressive disease|0|||
161837709|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
161837710|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
161707379|NCT02875223|583973501|FG002|Overall Study|Progressive disease|1|||
161707380|NCT02875223|583973502|FG003|Overall Study|Progressive disease|0|||
161837711|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
161707381|NCT02875223|583973503|FG004|Overall Study|Progressive disease|0|||
161707382|NCT02875223|583973504|FG005|Overall Study|Progressive disease|0|||
161707383|NCT02875223|583973505|FG006|Overall Study|Progressive disease|0|||
161707384|NCT02875223|583973506|FG007|Overall Study|Progressive disease|0|||
161707385|NCT02875223|583973507|FG008|Overall Study|Progressive disease|0|||
161707386|NCT02875223|583973508|FG009|Overall Study|Progressive disease|12|||
161707387|NCT02875223|583973509|FG010|Overall Study|Progressive disease|2|||
161707388|NCT02875223|583973510|FG011|Overall Study|Progressive disease|3|||
161707389|NCT02875223|583973511|FG012|Overall Study|Progressive disease|6|||
161707390|NCT02875223|583973499|FG000|Overall Study|Death|4|||
161707391|NCT02875223|583973500|FG001|Overall Study|Death|4|||
161707392|NCT02875223|583973501|FG002|Overall Study|Death|3|||
161707393|NCT02875223|583973502|FG003|Overall Study|Death|4|||
161707394|NCT02875223|583973503|FG004|Overall Study|Death|2|||
161707395|NCT02875223|583973504|FG005|Overall Study|Death|3|||
161707396|NCT02875223|583973505|FG006|Overall Study|Death|5|||
161707397|NCT02875223|583973506|FG007|Overall Study|Death|7|||
161707398|NCT02875223|583973507|FG008|Overall Study|Death|3|||
161707399|NCT02875223|583973508|FG009|Overall Study|Death|2|||
161707400|NCT02875223|583973509|FG010|Overall Study|Death|0|||
161707401|NCT02875223|583973510|FG011|Overall Study|Death|0|||
161707402|NCT02875223|583973511|FG012|Overall Study|Death|0|||
161707403|NCT02875223|583973499|FG000|Overall Study|Lost to Follow-up|0|||
161707404|NCT02875223|583973500|FG001|Overall Study|Lost to Follow-up|1|||
161707405|NCT02875223|583973501|FG002|Overall Study|Lost to Follow-up|1|||
161707406|NCT02875223|583973502|FG003|Overall Study|Lost to Follow-up|0|||
161707407|NCT02875223|583973503|FG004|Overall Study|Lost to Follow-up|1|||
161707408|NCT02875223|583973504|FG005|Overall Study|Lost to Follow-up|0|||
161707409|NCT02875223|583973505|FG006|Overall Study|Lost to Follow-up|1|||
161707410|NCT02875223|583973506|FG007|Overall Study|Lost to Follow-up|1|||
161707411|NCT02875223|583973507|FG008|Overall Study|Lost to Follow-up|0|||
161707412|NCT02875223|583973508|FG009|Overall Study|Lost to Follow-up|0|||
161707413|NCT02875223|583973509|FG010|Overall Study|Lost to Follow-up|0|||
161707414|NCT02875223|583973510|FG011|Overall Study|Lost to Follow-up|0|||
161707415|NCT02875223|583973511|FG012|Overall Study|Lost to Follow-up|0|||
161707416|NCT01986062|583973514|FG000|Overall Study|Lost to Follow-up|1|||
161707417|NCT01986062|583973515|FG001|Overall Study|Lost to Follow-up|0|||
161707418|NCT01986062|583973514|FG000|Overall Study|Withdrawal by Subject|0|||
161707419|NCT01986062|583973515|FG001|Overall Study|Withdrawal by Subject|1|||
161707420|NCT01827384|583973516|FG000|Overall Study|Switched to alternative treatment|0|||
161707421|NCT01827384|583973517|FG001|Overall Study|Switched to alternative treatment|0|||
161707422|NCT01827384|583973518|FG002|Overall Study|Switched to alternative treatment|0|||
161707423|NCT01827384|583973519|FG003|Overall Study|Switched to alternative treatment|0|||
161707424|NCT01827384|583973520|FG004|Overall Study|Switched to alternative treatment|0|||
161707425|NCT01827384|583973521|FG005|Overall Study|Switched to alternative treatment|0|||
161707426|NCT01827384|583973522|FG006|Overall Study|Switched to alternative treatment|0|||
161707427|NCT01827384|583973523|FG007|Overall Study|Switched to alternative treatment|0|||
161707428|NCT01827384|583973524|FG008|Overall Study|Switched to alternative treatment|0|||
161707429|NCT01827384|583973525|FG009|Overall Study|Switched to alternative treatment|0|||
161707430|NCT01827384|583973526|FG010|Overall Study|Switched to alternative treatment|0|||
161707431|NCT01827384|583973527|FG011|Overall Study|Switched to alternative treatment|0|||
161707432|NCT01827384|583973528|FG012|Overall Study|Switched to alternative treatment|0|||
161707433|NCT01827384|583973529|FG013|Overall Study|Switched to alternative treatment|2|||
161707434|NCT01827384|583973516|FG000|Overall Study|Disease progression before treatment|0|||
161707435|NCT01827384|583973517|FG001|Overall Study|Disease progression before treatment|0|||
161707436|NCT01827384|583973518|FG002|Overall Study|Disease progression before treatment|0|||
161707437|NCT01827384|583973519|FG003|Overall Study|Disease progression before treatment|0|||
161707438|NCT01827384|583973520|FG004|Overall Study|Disease progression before treatment|0|||
161707439|NCT01827384|583973521|FG005|Overall Study|Disease progression before treatment|0|||
161707440|NCT01827384|583973522|FG006|Overall Study|Disease progression before treatment|0|||
161707441|NCT01827384|583973523|FG007|Overall Study|Disease progression before treatment|0|||
161707442|NCT01827384|583973524|FG008|Overall Study|Disease progression before treatment|0|||
161707443|NCT01827384|583973525|FG009|Overall Study|Disease progression before treatment|0|||
161707444|NCT01827384|583973526|FG010|Overall Study|Disease progression before treatment|0|||
161707445|NCT01827384|583973527|FG011|Overall Study|Disease progression before treatment|0|||
161707446|NCT01827384|583973528|FG012|Overall Study|Disease progression before treatment|0|||
161707447|NCT01827384|583973529|FG013|Overall Study|Disease progression before treatment|4|||
161707448|NCT01827384|583973516|FG000|Overall Study|Ineligible|0|||
161707449|NCT01827384|583973517|FG001|Overall Study|Ineligible|0|||
161707450|NCT01827384|583973518|FG002|Overall Study|Ineligible|0|||
161707451|NCT01827384|583973519|FG003|Overall Study|Ineligible|0|||
161707452|NCT01827384|583973520|FG004|Overall Study|Ineligible|0|||
161707453|NCT01827384|583973521|FG005|Overall Study|Ineligible|0|||
161707454|NCT01827384|583973522|FG006|Overall Study|Ineligible|0|||
161707455|NCT01827384|583973523|FG007|Overall Study|Ineligible|0|||
161707456|NCT01827384|583973524|FG008|Overall Study|Ineligible|0|||
161707457|NCT01827384|583973525|FG009|Overall Study|Ineligible|0|||
161707458|NCT01827384|583973526|FG010|Overall Study|Ineligible|0|||
161707459|NCT01827384|583973527|FG011|Overall Study|Ineligible|0|||
161707460|NCT01827384|583973528|FG012|Overall Study|Ineligible|0|||
161707461|NCT01827384|583973529|FG013|Overall Study|Ineligible|19|||
161707462|NCT01827384|583973516|FG000|Overall Study|Participant died before treatment|0|||
161707463|NCT01827384|583973517|FG001|Overall Study|Participant died before treatment|0|||
161707464|NCT01827384|583973518|FG002|Overall Study|Participant died before treatment|0|||
161707465|NCT01827384|583973519|FG003|Overall Study|Participant died before treatment|0|||
161707466|NCT01827384|583973520|FG004|Overall Study|Participant died before treatment|0|||
161707467|NCT01827384|583973521|FG005|Overall Study|Participant died before treatment|0|||
161707468|NCT01827384|583973522|FG006|Overall Study|Participant died before treatment|0|||
161707469|NCT01827384|583973523|FG007|Overall Study|Participant died before treatment|0|||
161707470|NCT01827384|583973524|FG008|Overall Study|Participant died before treatment|0|||
161707471|NCT01827384|583973525|FG009|Overall Study|Participant died before treatment|0|||
161707472|NCT01827384|583973526|FG010|Overall Study|Participant died before treatment|0|||
161707473|NCT01827384|583973527|FG011|Overall Study|Participant died before treatment|0|||
161707474|NCT01827384|583973528|FG012|Overall Study|Participant died before treatment|0|||
161707475|NCT01827384|583973529|FG013|Overall Study|Participant died before treatment|5|||
161707476|NCT01827384|583973516|FG000|Overall Study|Insufficient tumor cells|0|||
161707477|NCT01827384|583973517|FG001|Overall Study|Insufficient tumor cells|0|||
161707478|NCT01827384|583973518|FG002|Overall Study|Insufficient tumor cells|0|||
161707479|NCT01827384|583973519|FG003|Overall Study|Insufficient tumor cells|0|||
161707480|NCT01827384|583973520|FG004|Overall Study|Insufficient tumor cells|0|||
161707481|NCT01827384|583973521|FG005|Overall Study|Insufficient tumor cells|0|||
161707482|NCT01827384|583973522|FG006|Overall Study|Insufficient tumor cells|0|||
161707483|NCT01827384|583973523|FG007|Overall Study|Insufficient tumor cells|0|||
161707484|NCT01827384|583973524|FG008|Overall Study|Insufficient tumor cells|0|||
161707485|NCT01827384|583973525|FG009|Overall Study|Insufficient tumor cells|0|||
161707486|NCT01827384|583973526|FG010|Overall Study|Insufficient tumor cells|0|||
161707487|NCT01827384|583973527|FG011|Overall Study|Insufficient tumor cells|0|||
161707488|NCT01827384|583973528|FG012|Overall Study|Insufficient tumor cells|0|||
161707489|NCT01827384|583973529|FG013|Overall Study|Insufficient tumor cells|13|||
161707490|NCT01827384|583973516|FG000|Overall Study|No actionable mutation|0|||
161707491|NCT01827384|583973517|FG001|Overall Study|No actionable mutation|0|||
161707492|NCT01827384|583973518|FG002|Overall Study|No actionable mutation|0|||
161707493|NCT01827384|583973519|FG003|Overall Study|No actionable mutation|0|||
161707494|NCT01827384|583973520|FG004|Overall Study|No actionable mutation|0|||
161707495|NCT01827384|583973521|FG005|Overall Study|No actionable mutation|0|||
161707496|NCT01827384|583973522|FG006|Overall Study|No actionable mutation|0|||
161707497|NCT01827384|583973523|FG007|Overall Study|No actionable mutation|0|||
161707498|NCT01827384|583973524|FG008|Overall Study|No actionable mutation|0|||
161707499|NCT01827384|583973525|FG009|Overall Study|No actionable mutation|0|||
161707500|NCT01827384|583973526|FG010|Overall Study|No actionable mutation|0|||
161707501|NCT01827384|583973527|FG011|Overall Study|No actionable mutation|0|||
161707502|NCT01827384|583973528|FG012|Overall Study|No actionable mutation|0|||
161707503|NCT01827384|583973529|FG013|Overall Study|No actionable mutation|73|||
161707504|NCT01827384|583973516|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161707505|NCT01827384|583973517|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
161707506|NCT01827384|583973518|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
161707507|NCT01827384|583973519|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
161707508|NCT01827384|583973520|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
161707509|NCT01827384|583973521|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
161707510|NCT01827384|583973522|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
161707511|NCT01827384|583973523|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
161707512|NCT01827384|583973524|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
161707513|NCT01827384|583973525|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
161707514|NCT01827384|583973526|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
161707515|NCT01827384|583973527|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
161707516|NCT01827384|583973528|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
161707517|NCT01827384|583973529|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
161707518|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
161837712|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
161707519|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
161707520|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
161707521|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161707522|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161707523|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161707524|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
161707525|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
161707526|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
161707527|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161707528|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161707529|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161707530|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
161707531|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
161707532|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
161707533|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161707534|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161707535|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161707536|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
161707537|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707538|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707539|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707540|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707541|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707542|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
161707543|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
161707544|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
161707545|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161707546|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161707547|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161707548|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
161707549|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
161707550|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
161707551|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161707552|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161707553|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161707554|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
161707555|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
161707556|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
161707557|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
161707558|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
161707559|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
161707560|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
161707561|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
161707562|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
161707563|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161707564|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161707565|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161707566|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
161707567|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
161707568|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
161707569|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161707570|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161707571|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161707572|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707573|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707574|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707575|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
161707576|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
161707577|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707578|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161707579|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161707580|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161707581|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
161707582|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
161707583|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
161707584|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161707585|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161707586|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161707587|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
161707588|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
161707589|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
161707590|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
161707591|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
161707592|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
161707593|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
161707594|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
161707595|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
161707596|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161707597|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161707598|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161707599|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
161707600|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
161707601|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
161707602|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Death|0|||
161707603|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Death|0|||
161707604|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Death|0|||
161707605|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Death|2|||
161707606|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Death|0|||
161707607|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Death|0|||
161707608|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
161707609|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
161707610|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
161707611|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
161707612|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
161707613|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
161707614|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707615|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707616|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707617|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707618|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
161707619|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
161707620|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161707621|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161707622|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161707623|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
161707624|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
161707625|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
161707626|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707627|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707628|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707629|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707630|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
161707631|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707632|NCT01552057|583975092|FG000|Overall Study|Adverse Event|14|||
161707633|NCT01552057|583975093|FG001|Overall Study|Adverse Event|15|||
161707634|NCT01552057|583975092|FG000|Overall Study|Lack of Efficacy|8|||
161707635|NCT01552057|583975093|FG001|Overall Study|Lack of Efficacy|23|||
161707636|NCT01552057|583975092|FG000|Overall Study|Withdrawal by Subject|5|||
161707637|NCT01552057|583975093|FG001|Overall Study|Withdrawal by Subject|8|||
161707638|NCT01552057|583975092|FG000|Overall Study|Entry Criteria Not Met|2|||
161707639|NCT01552057|583975093|FG001|Overall Study|Entry Criteria Not Met|2|||
161707640|NCT01552057|583975092|FG000|Overall Study|Physician Decision|1|||
161707641|NCT01552057|583975093|FG001|Overall Study|Physician Decision|0|||
161707642|NCT00476086|583975094|FG000|Overall Study|Alternative therapy|1|||
161707643|NCT00476086|583975094|FG000|Overall Study|Progressive Disease|4|||
161707644|NCT02900092|583975095|FG000|Overall Study|Adverse Event|1|||
161707645|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
161707646|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
161707647|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
161707648|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161707649|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161707650|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161707651|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
161707652|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707653|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707654|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707655|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707656|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707657|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
161707658|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707659|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707660|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707661|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707662|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707663|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
161707664|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
161707665|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
161707666|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161707667|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161707668|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161707669|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707670|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
161707671|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707672|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707673|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707674|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707675|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707676|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
161707677|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707678|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707679|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707680|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707681|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707682|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707683|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707684|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
161707685|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707686|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707687|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161707688|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161707689|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161707690|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
161707691|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
161707692|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
161707693|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161707694|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161707695|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161707696|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
161707697|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
161707698|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
161707699|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161837713|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
161837714|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
161837715|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Death|0|||
161837716|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Death|2|||
161837717|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Death|0|||
161837718|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
161707700|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161707701|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161707702|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
161707703|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
161837719|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
161707704|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161707705|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161707706|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161707707|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161707708|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
161707709|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
161707710|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
161707711|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707712|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707713|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707714|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
161707715|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707716|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707717|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707718|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707719|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707720|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
161707721|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707722|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707723|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707724|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707725|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707726|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707727|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707728|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
161707729|NCT01389245|583975102|FG000|Overall Study|Protocol Violation|10|||
161707730|NCT01389245|583975102|FG000|Overall Study|Lost to Follow-up|3|||
161707731|NCT01389245|583975102|FG000|Overall Study|Withdrawal by Subject|2|||
161707732|NCT05540652|583975103|FG000|Overall Study|Withdrawal by Subject|1|||
161707733|NCT05424276|583975104|FG000|Overall Study|Adverse Event|1|||
161707734|NCT05424276|583975105|FG001|Overall Study|Adverse Event|0|||
161707735|NCT05424276|583975106|FG002|Overall Study|Adverse Event|0|||
161707736|NCT05424276|583975107|FG003|Overall Study|Adverse Event|2|||
161707737|NCT05424276|583975104|FG000|Overall Study|Withdrawal by Subject|0|||
161707738|NCT05424276|583975105|FG001|Overall Study|Withdrawal by Subject|0|||
161707739|NCT05424276|583975106|FG002|Overall Study|Withdrawal by Subject|2|||
161707740|NCT05424276|583975107|FG003|Overall Study|Withdrawal by Subject|0|||
161707741|NCT05424276|583975104|FG000|Overall Study|Protocol Violation|0|||
161707742|NCT05424276|583975105|FG001|Overall Study|Protocol Violation|1|||
161707743|NCT05424276|583975106|FG002|Overall Study|Protocol Violation|0|||
161707744|NCT05424276|583975107|FG003|Overall Study|Protocol Violation|0|||
161707745|NCT05424276|583975104|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161707746|NCT05424276|583975105|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
161707747|NCT05424276|583975106|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161707748|NCT05424276|583975107|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161707749|NCT05113940|583975108|FG000|Part A (18 Days)|Adverse Event|0|||
161707750|NCT05113940|583975109|FG001|Part A (18 Days)|Adverse Event|0|||
161707751|NCT05113940|583975110|FG002|Part A (18 Days)|Adverse Event|1|||
161707752|NCT05113940|583975111|FG003|Part A (18 Days)|Adverse Event|1|||
161707753|NCT05113940|583975112|FG004|Part A (18 Days)|Adverse Event|1|||
161707754|NCT05113940|583975113|FG005|Part A (18 Days)|Adverse Event|0|||
161707755|NCT05113940|583975114|FG006|Part A (18 Days)|Adverse Event|0|||
161707756|NCT05113940|583975115|FG007|Part A (18 Days)|Adverse Event|0|||
161707757|NCT05113940|583975116|FG008|Part A (18 Days)|Adverse Event|0|||
161707758|NCT05113940|583975117|FG009|Part A (18 Days)|Adverse Event|0|||
161707759|NCT05113940|583975118|FG010|Part A (18 Days)|Adverse Event|0|||
161707760|NCT05113940|583975119|FG011|Part A (18 Days)|Adverse Event|2|||
161707761|NCT05113940|583975120|FG012|Part A (18 Days)|Adverse Event|0|||
161707762|NCT05113940|583975121|FG013|Part A (18 Days)|Adverse Event|0|||
161707763|NCT05113940|583975122|FG014|Part A (18 Days)|Adverse Event|0|||
161707764|NCT05113940|583975108|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707765|NCT05113940|583975109|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707766|NCT05113940|583975110|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707767|NCT05113940|583975111|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707768|NCT05113940|583975112|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707769|NCT05113940|583975113|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707770|NCT05113940|583975114|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707771|NCT05113940|583975115|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707772|NCT05113940|583975116|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707773|NCT05113940|583975117|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707774|NCT05113940|583975118|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707775|NCT05113940|583975119|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707776|NCT05113940|583975120|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707777|NCT05113940|583975121|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707778|NCT05113940|583975122|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
161707779|NCT04454489|583975123|FG000|Overall Study|Disease progression|12|||
161707780|NCT04454489|583975123|FG000|Overall Study|Death|4|||
161707781|NCT04454489|583975123|FG000|Overall Study|Adverse Event|1|||
161707782|NCT04454489|583975123|FG000|Overall Study|Physician Decision|1|||
161707783|NCT01756274|583975129|FG000|Overall Study|Protocol Violation|2|||
161707784|NCT01756274|583975129|FG000|Overall Study|Laboratory error|1|||
161707785|NCT03514914|583975130|FG000|Overall Study|Death|3|||
161707786|NCT03514914|583975131|FG001|Overall Study|Death|3|||
161707787|NCT03514914|583975130|FG000|Overall Study|Lost to Follow-up|117|||
161707788|NCT03514914|583975131|FG001|Overall Study|Lost to Follow-up|89|||
161707789|NCT03926143|583975137|FG000|Overall Study|Physician Decision|3|||
161707790|NCT03926143|583975137|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
161707791|NCT03926143|583975137|FG000|Overall Study|Adverse Event|2|||
161707792|NCT03926143|583975137|FG000|Overall Study|Progressive disease|3|||
161707793|NCT01071070|583975144|FG000|Overall Study|Adverse Event|0|||
161707794|NCT01071070|583975145|FG001|Overall Study|Adverse Event|3|||
161707795|NCT01071070|583975144|FG000|Overall Study|Withdrawal by Subject|1|||
161707796|NCT01071070|583975145|FG001|Overall Study|Withdrawal by Subject|0|||
161707797|NCT01071070|583975144|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
161707798|NCT01071070|583975145|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
161707799|NCT01071070|583975144|FG000|Overall Study|Hypercalcemia|1|||
161707800|NCT01071070|583975145|FG001|Overall Study|Hypercalcemia|0|||
161707801|NCT00473876|583975151|FG000|Overall Study|Lost to Follow-up|3|||
161707802|NCT00473876|583975152|FG001|Overall Study|Lost to Follow-up|1|||
161707803|NCT02393209|583975155|FG000|Overall Study|Study Terminated by Sponsor|1|||
161707804|NCT02393209|583975156|FG001|Overall Study|Study Terminated by Sponsor|1|||
161707805|NCT02393209|583975157|FG002|Overall Study|Study Terminated by Sponsor|0|||
161707806|NCT02393209|583975158|FG003|Overall Study|Study Terminated by Sponsor|0|||
161707807|NCT02393209|583975155|FG000|Overall Study|Withdrawal by Patient|1|||
161707808|NCT02393209|583975156|FG001|Overall Study|Withdrawal by Patient|0|||
161707809|NCT02393209|583975157|FG002|Overall Study|Withdrawal by Patient|0|||
161707810|NCT02393209|583975158|FG003|Overall Study|Withdrawal by Patient|0|||
161707811|NCT02393209|583975155|FG000|Overall Study|Death|2|||
161707812|NCT02393209|583975156|FG001|Overall Study|Death|2|||
161707813|NCT02393209|583975157|FG002|Overall Study|Death|0|||
161707814|NCT02393209|583975158|FG003|Overall Study|Death|0|||
161707815|NCT02393209|583975155|FG000|Overall Study|Death due to Disease Progression|2|||
161707816|NCT02393209|583975156|FG001|Overall Study|Death due to Disease Progression|2|||
161707817|NCT02393209|583975157|FG002|Overall Study|Death due to Disease Progression|0|||
161707818|NCT02393209|583975158|FG003|Overall Study|Death due to Disease Progression|0|||
161707819|NCT02393209|583975155|FG000|Overall Study|Death from Legionella Infection|0|||
161707820|NCT02393209|583975156|FG001|Overall Study|Death from Legionella Infection|1|||
161707821|NCT02393209|583975157|FG002|Overall Study|Death from Legionella Infection|0|||
161707822|NCT02393209|583975158|FG003|Overall Study|Death from Legionella Infection|0|||
161707823|NCT02393209|583975155|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
161707824|NCT02393209|583975156|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
161707825|NCT02393209|583975157|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
161707826|NCT02393209|583975158|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
161707827|NCT02393209|583975155|FG000|Overall Study|Lost to Follow-up|0|||
161707828|NCT02393209|583975156|FG001|Overall Study|Lost to Follow-up|1|||
161707829|NCT02393209|583975157|FG002|Overall Study|Lost to Follow-up|0|||
161707830|NCT02393209|583975158|FG003|Overall Study|Lost to Follow-up|0|||
161707831|NCT00727402|583975159|FG000|Overall Study|Physician Decision|116|||
161707832|NCT00755079|583975160|FG000|Overall Study|Lost to Follow-up|1|||
161707833|NCT00755079|583975161|FG001|Overall Study|Lost to Follow-up|3|||
161707834|NCT00755079|583975160|FG000|Overall Study|Adverse Event|0|||
161707835|NCT00755079|583975161|FG001|Overall Study|Adverse Event|1|||
161707836|NCT00755079|583975160|FG000|Overall Study|Withdrawal by Subject|0|||
161707837|NCT00755079|583975161|FG001|Overall Study|Withdrawal by Subject|2|||
161707838|NCT03545282|583975162|FG000|Overall Study|Lost to Follow-up|15|||
161707839|NCT03545282|583975163|FG001|Overall Study|Lost to Follow-up|10|||
161707840|NCT03545282|583975162|FG000|Overall Study|Withdrawal by Subject|2|||
161707841|NCT03545282|583975163|FG001|Overall Study|Withdrawal by Subject|2|||
161707842|NCT03751111|583975164|FG000|Overall Study|Lack of Efficacy|9|||
161707843|NCT03751111|583975165|FG001|Overall Study|Lack of Efficacy|30|||
161707844|NCT03751111|583975164|FG000|Overall Study|Adverse Event|3|||
161707845|NCT03751111|583975165|FG001|Overall Study|Adverse Event|2|||
161707846|NCT02582671|583975166|FG000|Overall Study|Failure to return|1|||
161707847|NCT02582671|583975166|FG000|Overall Study|Other, not specified|1|||
161707848|NCT01287104|583975171|FG000|Overall Study|Patient developed progressive disease|1|||
161707849|NCT01287104|583975172|FG001|Overall Study|Patient developed progressive disease|1|||
161707850|NCT01287104|583975173|FG002|Overall Study|Patient developed progressive disease|3|||
161707851|NCT01287104|583975174|FG003|Overall Study|Patient developed progressive disease|2|||
161707852|NCT01287104|583975171|FG000|Overall Study|Donor anaphylaxis|0|||
161707853|NCT01287104|583975172|FG001|Overall Study|Donor anaphylaxis|1|||
161707854|NCT01287104|583975173|FG002|Overall Study|Donor anaphylaxis|0|||
161707855|NCT01287104|583975174|FG003|Overall Study|Donor anaphylaxis|1|||
161707856|NCT01287104|583975171|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
161707857|NCT01287104|583975172|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
161707858|NCT01287104|583975173|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
161707859|NCT01287104|583975174|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
161707860|NCT01287104|583975171|FG000|Overall Study|Low donor chimerism|0|||
161707861|NCT01287104|583975172|FG001|Overall Study|Low donor chimerism|1|||
161707862|NCT01287104|583975173|FG002|Overall Study|Low donor chimerism|0|||
161707863|NCT01287104|583975174|FG003|Overall Study|Low donor chimerism|0|||
161707864|NCT01287104|583975171|FG000|Overall Study|NK cells did not meet release criteria|0|||
161707865|NCT01287104|583975172|FG001|Overall Study|NK cells did not meet release criteria|1|||
161707866|NCT01287104|583975173|FG002|Overall Study|NK cells did not meet release criteria|0|||
161707867|NCT01287104|583975174|FG003|Overall Study|NK cells did not meet release criteria|0|||
161707868|NCT00998738|583975177|FG000|Overall Study|Uknown|1|||
161707869|NCT03498521|583975178|FG000|Overall Study|Death|227|||
161707870|NCT03498521|583975179|FG001|Overall Study|Death|79|||
161707871|NCT03498521|583975180|FG002|Overall Study|Death|84|||
161707872|NCT03498521|583975178|FG000|Overall Study|Exclusion criteria|1|||
161707873|NCT03498521|583975179|FG001|Overall Study|Exclusion criteria|0|||
161707874|NCT03498521|583975180|FG002|Overall Study|Exclusion criteria|0|||
161707875|NCT03498521|583975178|FG000|Overall Study|Lost to Follow-up|4|||
161707876|NCT03498521|583975179|FG001|Overall Study|Lost to Follow-up|3|||
161707877|NCT03498521|583975180|FG002|Overall Study|Lost to Follow-up|3|||
161707878|NCT03498521|583975178|FG000|Overall Study|No profile due to technical failure|1|||
161707879|NCT03498521|583975179|FG001|Overall Study|No profile due to technical failure|0|||
161707880|NCT03498521|583975180|FG002|Overall Study|No profile due to technical failure|0|||
161707881|NCT03498521|583975178|FG000|Overall Study|Physician Decision|3|||
161707882|NCT03498521|583975179|FG001|Overall Study|Physician Decision|1|||
161707883|NCT03498521|583975180|FG002|Overall Study|Physician Decision|0|||
161707884|NCT03498521|583975178|FG000|Overall Study|Withdrawal by Subject|11|||
161707885|NCT03498521|583975179|FG001|Overall Study|Withdrawal by Subject|6|||
161707886|NCT03498521|583975180|FG002|Overall Study|Withdrawal by Subject|2|||
161707887|NCT03498521|583975178|FG000|Overall Study|Study terminated by sponsor|79|||
161707888|NCT03498521|583975179|FG001|Overall Study|Study terminated by sponsor|21|||
161707889|NCT03498521|583975180|FG002|Overall Study|Study terminated by sponsor|4|||
161707890|NCT02848833|583975189|FG000|Overall Study|subject who are duplicated|1|||
161707891|NCT02848833|583975189|FG000|Overall Study|have not taken the study drug|11|||
161707892|NCT02848833|583975189|FG000|Overall Study|follow-up failure|6|||
161707893|NCT02848833|583975189|FG000|Overall Study|Protocol Violation|119|||
161707894|NCT04980391|583975190|FG000|Overall Study|Death|0|||
161707895|NCT04980391|583975191|FG001|Overall Study|Death|0|||
161707896|NCT04980391|583975192|FG002|Overall Study|Death|1|||
161707897|NCT04980391|583975193|FG003|Overall Study|Death|1|||
161707898|NCT04980391|583975190|FG000|Overall Study|Lost to Follow-up|3|||
161707899|NCT04980391|583975191|FG001|Overall Study|Lost to Follow-up|3|||
161707900|NCT04980391|583975192|FG002|Overall Study|Lost to Follow-up|2|||
161707901|NCT04980391|583975193|FG003|Overall Study|Lost to Follow-up|3|||
161707902|NCT04980391|583975190|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
161707903|NCT04980391|583975191|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161707904|NCT04980391|583975192|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161707905|NCT04980391|583975193|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161707906|NCT04980391|583975190|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161707907|NCT04980391|583975191|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161707908|NCT04980391|583975192|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161707909|NCT04980391|583975193|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161707910|NCT04980391|583975190|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161707911|NCT04980391|583975191|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161707912|NCT04980391|583975192|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
161707913|NCT04980391|583975193|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161707914|NCT04167345|583975194|FG000|Overall Study|Other|1|||
161707915|NCT04167345|583975195|FG001|Overall Study|Other|1|||
161707916|NCT04167345|583975196|FG002|Overall Study|Other|0|||
161707917|NCT04167345|583975197|FG003|Overall Study|Other|0|||
161707918|NCT04167345|583975198|FG004|Overall Study|Other|0|||
161837720|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
161707919|NCT04375761|583977287|FG000|Overall Study|Death|1|||
161707920|NCT04375761|583977288|FG001|Overall Study|Death|2|||
161707921|NCT04375761|583977287|FG000|Overall Study|Lost to Follow-up|203|||
161707922|NCT04375761|583977288|FG001|Overall Study|Lost to Follow-up|380|||
161707923|NCT04375761|583977287|FG000|Overall Study|Withdrawal by Subject|47|||
161707924|NCT04375761|583977288|FG001|Overall Study|Withdrawal by Subject|98|||
161707925|NCT04375761|583977287|FG000|Overall Study|Noncompliance with study procedure|121|||
161707926|NCT04375761|583977288|FG001|Overall Study|Noncompliance with study procedure|251|||
161707927|NCT04375761|583977287|FG000|Overall Study|Reimbursement not enough|1|||
161707928|NCT04375761|583977288|FG001|Overall Study|Reimbursement not enough|2|||
161707929|NCT04375761|583977287|FG000|Overall Study|Unforeseen family circumstances|1|||
161707930|NCT04375761|583977288|FG001|Overall Study|Unforeseen family circumstances|3|||
161707931|NCT04375761|583977287|FG000|Overall Study|Test too painful|1|||
161707932|NCT04375761|583977288|FG001|Overall Study|Test too painful|1|||
161707933|NCT04375761|583977287|FG000|Overall Study|Moved|0|||
161707934|NCT04375761|583977288|FG001|Overall Study|Moved|2|||
161707935|NCT04375761|583977287|FG000|Overall Study|Nonresponsive|0|||
161707936|NCT04375761|583977288|FG001|Overall Study|Nonresponsive|5|||
161707937|NCT03797001|583977289|FG000|Overall Study|Withdrawn due to COVID19|4|||
161707938|NCT03797001|583977290|FG001|Overall Study|Withdrawn due to COVID19|0|||
161707939|NCT03797001|583977289|FG000|Overall Study|Withdrawal by Subject|7|||
161707940|NCT03797001|583977290|FG001|Overall Study|Withdrawal by Subject|6|||
161707941|NCT03797001|583977289|FG000|Overall Study|Adverse Event|0|||
161707942|NCT03797001|583977290|FG001|Overall Study|Adverse Event|1|||
161707943|NCT00500266|583977302|FG000|Overall Study|Death|3|||
161707944|NCT00500266|583977302|FG000|Overall Study|Lost to Follow-up|3|||
161707945|NCT00500266|583977302|FG000|Overall Study|Withdrawal by Subject|3|||
161707946|NCT00500266|583977302|FG000|Overall Study|Assigned, not treated|4|||
161707947|NCT02251743|583977303|FG000|Overall Study|Withdrawal by Subject|1|||
161707948|NCT02251743|583977304|FG001|Overall Study|Withdrawal by Subject|1|||
161707949|NCT00824564|583977305|FG000|Overall Study|Lost to Follow-up|5|||
161707950|NCT00824564|583977306|FG001|Overall Study|Lost to Follow-up|7|||
161707951|NCT00824564|583977305|FG000|Overall Study|Withdrawal by Subject|1|||
161707952|NCT00824564|583977306|FG001|Overall Study|Withdrawal by Subject|1|||
161707953|NCT00824564|583977305|FG000|Overall Study|Other|1|||
161707954|NCT00824564|583977306|FG001|Overall Study|Other|2|||
161707955|NCT00824564|583977305|FG000|Overall Study|Randomized, but not treated|1|||
161707956|NCT00824564|583977306|FG001|Overall Study|Randomized, but not treated|0|||
161707957|NCT01725165|583977308|FG000|Overall Study|Death|11|||
161707958|NCT01725165|583977309|FG001|Overall Study|Death|18|||
161707959|NCT00442598|583977313|FG000|Overall Study|Adverse Event|1|||
161707960|NCT00442598|583977314|FG001|Overall Study|Adverse Event|0|||
161707961|NCT00442598|583977315|FG002|Overall Study|Adverse Event|0|||
161707962|NCT00442598|583977313|FG000|Overall Study|Tumor progression|3|||
161707963|NCT00442598|583977314|FG001|Overall Study|Tumor progression|4|||
161707964|NCT00442598|583977315|FG002|Overall Study|Tumor progression|0|||
161707965|NCT00442598|583977313|FG000|Overall Study|Clinical deterioration|1|||
161707966|NCT00442598|583977314|FG001|Overall Study|Clinical deterioration|2|||
161707967|NCT00442598|583977315|FG002|Overall Study|Clinical deterioration|0|||
161707968|NCT00442598|583977313|FG000|Overall Study|CA125 progression|0|||
161707969|NCT00442598|583977314|FG001|Overall Study|CA125 progression|1|||
161707970|NCT00442598|583977315|FG002|Overall Study|CA125 progression|0|||
161707971|NCT00442598|583977313|FG000|Overall Study|Reduced creatinine clearance|1|||
161707972|NCT00442598|583977314|FG001|Overall Study|Reduced creatinine clearance|0|||
161707973|NCT00442598|583977315|FG002|Overall Study|Reduced creatinine clearance|0|||
161707974|NCT00442598|583977313|FG000|Overall Study|Death|0|||
161707975|NCT00442598|583977314|FG001|Overall Study|Death|1|||
161707976|NCT00442598|583977315|FG002|Overall Study|Death|0|||
161707977|NCT02886702|583977316|FG000|Overall Study|Other|4|||
161707978|NCT02886702|583977317|FG001|Overall Study|Other|3|||
161707979|NCT02886702|583977318|FG002|Overall Study|Other|9|||
161707980|NCT02886702|583977316|FG000|Overall Study|Withdrawal by Subject|24|||
161707981|NCT02886702|583977317|FG001|Overall Study|Withdrawal by Subject|18|||
161707982|NCT02886702|583977318|FG002|Overall Study|Withdrawal by Subject|22|||
161707983|NCT02886702|583977316|FG000|Overall Study|Significant Worsening of Condition|0|||
161707984|NCT02886702|583977317|FG001|Overall Study|Significant Worsening of Condition|1|||
161707985|NCT02886702|583977318|FG002|Overall Study|Significant Worsening of Condition|0|||
161707986|NCT02886702|583977316|FG000|Overall Study|Protocol Violation|2|||
161707987|NCT02886702|583977317|FG001|Overall Study|Protocol Violation|2|||
161707988|NCT02886702|583977318|FG002|Overall Study|Protocol Violation|1|||
161707989|NCT02886702|583977316|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161707990|NCT02886702|583977317|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161707991|NCT02886702|583977318|FG002|Overall Study|Non-Compliance With Study Drug|4|||
161707992|NCT02886702|583977316|FG000|Overall Study|Lost to Follow-up|11|||
161707993|NCT02886702|583977317|FG001|Overall Study|Lost to Follow-up|13|||
161707994|NCT02886702|583977318|FG002|Overall Study|Lost to Follow-up|8|||
161707995|NCT02886702|583977316|FG000|Overall Study|Lack of Efficacy|3|||
161707996|NCT02886702|583977317|FG001|Overall Study|Lack of Efficacy|4|||
161707997|NCT02886702|583977318|FG002|Overall Study|Lack of Efficacy|5|||
161707998|NCT02886702|583977316|FG000|Overall Study|Adverse Event|4|||
161707999|NCT02886702|583977317|FG001|Overall Study|Adverse Event|9|||
161708000|NCT02886702|583977318|FG002|Overall Study|Adverse Event|3|||
161708001|NCT02886702|583977316|FG000|Overall Study|Administrative Reasons|0|||
161708002|NCT02886702|583977317|FG001|Overall Study|Administrative Reasons|0|||
161708003|NCT02886702|583977318|FG002|Overall Study|Administrative Reasons|1|||
161708004|NCT01147926|583977326|FG000|Overall Study|Subject Withdrew Consent|9|||
161708005|NCT01147926|583977327|FG001|Overall Study|Subject Withdrew Consent|10|||
161708006|NCT01147926|583977326|FG000|Overall Study|Adverse Event|7|||
161708007|NCT01147926|583977327|FG001|Overall Study|Adverse Event|6|||
161708008|NCT01147926|583977326|FG000|Overall Study|Subject Non-Compliant|5|||
161708009|NCT01147926|583977327|FG001|Overall Study|Subject Non-Compliant|4|||
161708010|NCT01147926|583977326|FG000|Overall Study|Principal investigator left hospital|1|||
161708011|NCT01147926|583977327|FG001|Overall Study|Principal investigator left hospital|3|||
161708012|NCT01147926|583977326|FG000|Overall Study|Selection criteria not met|3|||
161708013|NCT01147926|583977327|FG001|Overall Study|Selection criteria not met|1|||
161708014|NCT01147926|583977326|FG000|Overall Study|Lost to Follow-up|0|||
161708015|NCT01147926|583977327|FG001|Overall Study|Lost to Follow-up|2|||
161708016|NCT01147926|583977326|FG000|Overall Study|Sponsor's Decision|0|||
161708017|NCT01147926|583977327|FG001|Overall Study|Sponsor's Decision|1|||
161708018|NCT01147926|583977326|FG000|Overall Study|Lack of Efficacy|1|||
161708019|NCT01147926|583977327|FG001|Overall Study|Lack of Efficacy|0|||
161708020|NCT01147926|583977326|FG000|Overall Study|Too busy, no time for study|1|||
161708021|NCT01147926|583977327|FG001|Overall Study|Too busy, no time for study|0|||
161708022|NCT01147926|583977326|FG000|Overall Study|Went on holiday|0|||
161708023|NCT01147926|583977327|FG001|Overall Study|Went on holiday|1|||
161708024|NCT01147926|583977326|FG000|Overall Study|Colonoscopy result|0|||
161708025|NCT01147926|583977327|FG001|Overall Study|Colonoscopy result|1|||
161708026|NCT01085682|583977328|FG000|Overall Study|Withdrawal by Subject|25|||
161708027|NCT01085682|583977329|FG001|Overall Study|Withdrawal by Subject|25|||
161708028|NCT02561156|583977332|FG000|Part 2|Adverse Event|0|||
161708029|NCT02561156|583977333|FG001|Part 2|Adverse Event|0|||
161708030|NCT02561156|583977334|FG002|Part 2|Adverse Event|0|||
161708031|NCT02561156|583977335|FG003|Part 2|Adverse Event|0|||
161708032|NCT02561156|583977336|FG004|Part 2|Adverse Event|0|||
161708033|NCT02561156|583977337|FG005|Part 2|Adverse Event|0|||
161708034|NCT02561156|583977338|FG006|Part 2|Adverse Event|0|||
161708035|NCT02561156|583977339|FG007|Part 2|Adverse Event|0|||
161708036|NCT02561156|583977340|FG008|Part 2|Adverse Event|0|||
161708037|NCT02561156|583977341|FG009|Part 2|Adverse Event|0|||
161708038|NCT02561156|583977342|FG010|Part 2|Adverse Event|0|||
161708039|NCT02561156|583977343|FG011|Part 2|Adverse Event|1|||
161708040|NCT02561156|583977344|FG012|Part 2|Adverse Event|0|||
161708041|NCT02207907|583977345|FG000|Overall Study|Lost to Follow-up|3|||
161708042|NCT02207907|583977346|FG001|Overall Study|Lost to Follow-up|1|||
161708043|NCT02207907|583977345|FG000|Overall Study|Withdrawal by Subject|5|||
161708044|NCT02207907|583977346|FG001|Overall Study|Withdrawal by Subject|6|||
161708045|NCT02207907|583977345|FG000|Overall Study|Did not meet study criteria|3|||
161708046|NCT02207907|583977346|FG001|Overall Study|Did not meet study criteria|0|||
161708047|NCT02207907|583977345|FG000|Overall Study|Pregnancy|0|||
161708048|NCT02207907|583977346|FG001|Overall Study|Pregnancy|1|||
161708049|NCT00158184|583977347|FG000|Overall Study|personal issues|3|||
161708050|NCT00158184|583977348|FG001|Overall Study|personal issues|1|||
161708051|NCT00158184|583977347|FG000|Overall Study|failed for follow unit/study rules|2|||
161708052|NCT00158184|583977348|FG001|Overall Study|failed for follow unit/study rules|0|||
161708053|NCT00158184|583977347|FG000|Overall Study|Adverse Event|1|||
161708054|NCT00158184|583977348|FG001|Overall Study|Adverse Event|1|||
161708055|NCT01025635|583977352|FG000|Overall Study|Withdrawal by Subject|6|||
161708056|NCT01025635|583977353|FG001|Overall Study|Withdrawal by Subject|7|||
161708057|NCT01025635|583977352|FG000|Overall Study|Protocol Violation|4|||
161708058|NCT01025635|583977353|FG001|Overall Study|Protocol Violation|2|||
161708059|NCT01025635|583977352|FG000|Overall Study|Lack of Efficacy|0|||
161708060|NCT01025635|583977353|FG001|Overall Study|Lack of Efficacy|1|||
161708061|NCT01025635|583977352|FG000|Overall Study|Lost to Follow-up|9|||
161708062|NCT01025635|583977353|FG001|Overall Study|Lost to Follow-up|13|||
161708063|NCT01025635|583977352|FG000|Overall Study|Reason not known|4|||
161708064|NCT01025635|583977353|FG001|Overall Study|Reason not known|2|||
161708065|NCT00929240|583977354|FG000|Initial Treatment Phase|Adverse Event|31|||
161708066|NCT00929240|583977355|FG001|Initial Treatment Phase|Adverse Event|0|||
161708067|NCT00929240|583977356|FG002|Initial Treatment Phase|Adverse Event|0|||
161708068|NCT00929240|583977354|FG000|Initial Treatment Phase|Disease progression|41|||
161708069|NCT00929240|583977355|FG001|Initial Treatment Phase|Disease progression|0|||
161708070|NCT00929240|583977356|FG002|Initial Treatment Phase|Disease progression|0|||
161708071|NCT00929240|583977354|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
161708072|NCT00929240|583977355|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
161708073|NCT00929240|583977356|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
161708074|NCT00929240|583977354|FG000|Initial Treatment Phase|Protocol Violation|5|||
161708075|NCT00929240|583977355|FG001|Initial Treatment Phase|Protocol Violation|0|||
161708076|NCT00929240|583977356|FG002|Initial Treatment Phase|Protocol Violation|0|||
161708077|NCT00929240|583977354|FG000|Initial Treatment Phase|Death|2|||
161708078|NCT00929240|583977355|FG001|Initial Treatment Phase|Death|0|||
161708079|NCT00929240|583977356|FG002|Initial Treatment Phase|Death|0|||
161708080|NCT00929240|583977354|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
161708081|NCT00929240|583977355|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
161708082|NCT00929240|583977356|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
161708083|NCT00929240|583977354|FG000|Initial Treatment Phase|Physician Decision|4|||
161708084|NCT00929240|583977355|FG001|Initial Treatment Phase|Physician Decision|0|||
161708085|NCT00929240|583977356|FG002|Initial Treatment Phase|Physician Decision|0|||
161708086|NCT00929240|583977354|FG000|Maintenance Phase|Disease progression|0|||
161708087|NCT00929240|583977355|FG001|Maintenance Phase|Disease progression|73|||
161708088|NCT00929240|583977356|FG002|Maintenance Phase|Disease progression|60|||
161708089|NCT00929240|583977354|FG000|Maintenance Phase|Adverse Event|0|||
161708090|NCT00929240|583977355|FG001|Maintenance Phase|Adverse Event|9|||
161708091|NCT00929240|583977356|FG002|Maintenance Phase|Adverse Event|12|||
161708092|NCT00929240|583977354|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161708093|NCT00929240|583977355|FG001|Maintenance Phase|Withdrawal by Subject|2|||
161708094|NCT00929240|583977356|FG002|Maintenance Phase|Withdrawal by Subject|6|||
161708095|NCT00929240|583977354|FG000|Maintenance Phase|Protocol Violation|0|||
161708096|NCT00929240|583977355|FG001|Maintenance Phase|Protocol Violation|1|||
161708097|NCT00929240|583977356|FG002|Maintenance Phase|Protocol Violation|0|||
161708098|NCT00929240|583977354|FG000|Maintenance Phase|Health authority/Study termination|0|||
161708099|NCT00929240|583977355|FG001|Maintenance Phase|Health authority/Study termination|1|||
161708100|NCT00929240|583977356|FG002|Maintenance Phase|Health authority/Study termination|2|||
161708101|NCT00929240|583977354|FG000|Maintenance Phase|Physician Decision|0|||
161708102|NCT00929240|583977355|FG001|Maintenance Phase|Physician Decision|2|||
161708103|NCT00929240|583977356|FG002|Maintenance Phase|Physician Decision|1|||
161708104|NCT00929240|583977354|FG000|Maintenance Phase|Change of treatment|0|||
161708105|NCT00929240|583977355|FG001|Maintenance Phase|Change of treatment|4|||
161708106|NCT00929240|583977356|FG002|Maintenance Phase|Change of treatment|0|||
161708107|NCT00929240|583977354|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
161708108|NCT00929240|583977355|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
161708109|NCT00929240|583977356|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
161708110|NCT00929240|583977354|FG000|Maintenance Phase|Participant not treated|0|||
161708111|NCT00929240|583977355|FG001|Maintenance Phase|Participant not treated|2|||
161708112|NCT00929240|583977356|FG002|Maintenance Phase|Participant not treated|0|||
161708113|NCT01276288|583977359|FG000|Overall Study|Adverse Event|1|||
161708114|NCT01276288|583977360|FG001|Overall Study|Adverse Event|1|||
161708115|NCT01276288|583977361|FG002|Overall Study|Adverse Event|0|||
161708116|NCT01276288|583977362|FG003|Overall Study|Adverse Event|0|||
161708117|NCT01276288|583977359|FG000|Overall Study|not treated|1|||
161708118|NCT01276288|583977360|FG001|Overall Study|not treated|0|||
161708119|NCT01276288|583977361|FG002|Overall Study|not treated|0|||
161708120|NCT01276288|583977362|FG003|Overall Study|not treated|0|||
161708121|NCT00629083|583977369|FG000|Overall Study|Adverse Event|0|||
161708122|NCT00629083|583977370|FG001|Overall Study|Adverse Event|2|||
161708123|NCT00629083|583977369|FG000|Overall Study|Lack of Efficacy|3|||
161708124|NCT00629083|583977370|FG001|Overall Study|Lack of Efficacy|1|||
161708125|NCT00629083|583977369|FG000|Overall Study|Withdrawal by Subject|10|||
161708126|NCT00629083|583977370|FG001|Overall Study|Withdrawal by Subject|2|||
161708127|NCT00629083|583977369|FG000|Overall Study|Lost to Follow-up|12|||
161708128|NCT00629083|583977370|FG001|Overall Study|Lost to Follow-up|8|||
161708129|NCT00629083|583977369|FG000|Overall Study|Moved out of country/state|2|||
161708130|NCT00629083|583977370|FG001|Overall Study|Moved out of country/state|1|||
161708131|NCT00629083|583977369|FG000|Overall Study|Refused to return for 12 month visit|1|||
161708132|NCT00629083|583977370|FG001|Overall Study|Refused to return for 12 month visit|0|||
161708133|NCT01478958|583977371|FG000|Overall Study|Withdrawal by Subject|1|||
161708134|NCT01478958|583977372|FG001|Overall Study|Withdrawal by Subject|1|||
161708135|NCT01478958|583977373|FG002|Overall Study|Withdrawal by Subject|1|||
161708136|NCT01478958|583977371|FG000|Overall Study|Weight loss|1|||
161708137|NCT01478958|583977372|FG001|Overall Study|Weight loss|0|||
161708138|NCT01478958|583977373|FG002|Overall Study|Weight loss|0|||
161708139|NCT01478958|583977371|FG000|Overall Study|Re-located|0|||
161708140|NCT01478958|583977372|FG001|Overall Study|Re-located|1|||
161708141|NCT01478958|583977373|FG002|Overall Study|Re-located|0|||
161708142|NCT01478958|583977371|FG000|Overall Study|Unable to comply|0|||
161708143|NCT01478958|583977372|FG001|Overall Study|Unable to comply|0|||
161708144|NCT01478958|583977373|FG002|Overall Study|Unable to comply|2|||
161708145|NCT01193686|583977374|FG000|Overall Study|Withdrawal by Subject|4|||
161708146|NCT01193686|583977375|FG001|Overall Study|Withdrawal by Subject|1|||
161708147|NCT01193686|583977374|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
161708148|NCT01193686|583977375|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
161708149|NCT03401749|583977376|FG000|Overall Study|Lost to Follow-up|20|||
161708150|NCT03401749|583977377|FG001|Overall Study|Lost to Follow-up|16|||
161708151|NCT03401749|583977378|FG002|Overall Study|Lost to Follow-up|26|||
161708152|NCT01147809|583977381|FG000|Phase I (168 Days)|Adverse Event|0|||
161708153|NCT01147809|583977382|FG001|Phase I (168 Days)|Adverse Event|0|||
161708154|NCT01147809|583977383|FG002|Phase I (168 Days)|Adverse Event|0|||
161708155|NCT01147809|583977384|FG003|Phase I (168 Days)|Adverse Event|1|||
161708156|NCT01147809|583977385|FG004|Phase I (168 Days)|Adverse Event|0|||
161708157|NCT01147809|583977386|FG005|Phase I (168 Days)|Adverse Event|0|||
161708158|NCT01147809|583977381|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
161708159|NCT01147809|583977382|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
161708160|NCT01147809|583977383|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
161708161|NCT01147809|583977384|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
161708162|NCT01147809|583977385|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
161708163|NCT01147809|583977386|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
161708164|NCT01147809|583977381|FG000|Phase I (168 Days)|Physician Decision|0|||
161708165|NCT01147809|583977382|FG001|Phase I (168 Days)|Physician Decision|1|||
161708166|NCT01147809|583977383|FG002|Phase I (168 Days)|Physician Decision|2|||
161708167|NCT01147809|583977384|FG003|Phase I (168 Days)|Physician Decision|0|||
161708168|NCT01147809|583977385|FG004|Phase I (168 Days)|Physician Decision|0|||
161708169|NCT01147809|583977386|FG005|Phase I (168 Days)|Physician Decision|0|||
161708170|NCT01147809|583977381|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
161708171|NCT01147809|583977382|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
161708172|NCT01147809|583977383|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
161708173|NCT01147809|583977384|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
161708174|NCT01147809|583977385|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
161708175|NCT01147809|583977386|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
161708176|NCT01147809|583977381|FG000|Phase II (168 Days)|Adverse Event|0|||
161708177|NCT01147809|583977382|FG001|Phase II (168 Days)|Adverse Event|0|||
161708178|NCT01147809|583977383|FG002|Phase II (168 Days)|Adverse Event|0|||
161708179|NCT01147809|583977384|FG003|Phase II (168 Days)|Adverse Event|0|||
161708180|NCT01147809|583977385|FG004|Phase II (168 Days)|Adverse Event|3|||
161708181|NCT01147809|583977386|FG005|Phase II (168 Days)|Adverse Event|6|||
161708182|NCT01147809|583977381|FG000|Phase II (168 Days)|Protocol Violation|0|||
161708183|NCT01147809|583977382|FG001|Phase II (168 Days)|Protocol Violation|0|||
161708184|NCT01147809|583977383|FG002|Phase II (168 Days)|Protocol Violation|0|||
161708185|NCT01147809|583977384|FG003|Phase II (168 Days)|Protocol Violation|0|||
161708186|NCT01147809|583977385|FG004|Phase II (168 Days)|Protocol Violation|0|||
161708187|NCT01147809|583977386|FG005|Phase II (168 Days)|Protocol Violation|1|||
161708188|NCT01147809|583977381|FG000|Phase II (168 Days)|Physician Decision|0|||
161708189|NCT01147809|583977382|FG001|Phase II (168 Days)|Physician Decision|0|||
161708190|NCT01147809|583977383|FG002|Phase II (168 Days)|Physician Decision|0|||
161708191|NCT01147809|583977384|FG003|Phase II (168 Days)|Physician Decision|0|||
161708192|NCT01147809|583977385|FG004|Phase II (168 Days)|Physician Decision|5|||
161708193|NCT01147809|583977386|FG005|Phase II (168 Days)|Physician Decision|11|||
161708194|NCT01147809|583977381|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
161708195|NCT01147809|583977382|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
161708196|NCT01147809|583977383|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
161708197|NCT01147809|583977384|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
161708198|NCT01147809|583977385|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
161708199|NCT01147809|583977386|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
161708200|NCT01147809|583977381|FG000|Phase II (168 Days)|Ongoing|0|||
161708201|NCT01147809|583977382|FG001|Phase II (168 Days)|Ongoing|0|||
161708202|NCT01147809|583977383|FG002|Phase II (168 Days)|Ongoing|0|||
161708203|NCT01147809|583977384|FG003|Phase II (168 Days)|Ongoing|0|||
161708204|NCT01147809|583977385|FG004|Phase II (168 Days)|Ongoing|1|||
161708205|NCT01147809|583977386|FG005|Phase II (168 Days)|Ongoing|0|||
161708206|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161708207|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161708208|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
161708209|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708210|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708211|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708212|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708213|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708214|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708215|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
161708216|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161708217|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
161708218|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708219|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708220|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708221|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708222|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708223|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708224|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
161708225|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
161708226|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
161708227|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708228|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708229|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708230|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708231|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708232|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708233|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708234|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708235|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
161708236|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708237|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708238|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708239|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708240|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708241|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708242|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
161708243|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161708244|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
161708245|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708246|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708247|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708248|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708249|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708250|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708251|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161708252|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708253|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708254|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708255|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708256|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708257|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708258|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708259|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708260|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
161708261|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
161708262|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708263|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708264|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708265|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708266|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708267|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708268|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708269|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708270|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
161708271|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
161708272|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708273|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708274|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708275|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708276|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708277|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161837721|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
161837722|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
161708278|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708279|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
161708280|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161708281|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161708282|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161708283|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708284|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708285|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708286|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708287|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708288|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
161708289|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
161708290|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
161708291|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
161708292|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708293|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708294|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708295|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708296|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708297|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708298|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708299|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708300|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708301|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
161708302|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708303|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708304|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708305|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708306|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
161708307|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
161708308|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708309|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708310|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
161708311|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
161708312|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708313|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708314|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708315|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708316|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708317|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
161708318|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708319|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708320|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708321|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708322|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708323|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
161708324|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
161708325|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
161708326|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
161708327|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
161708328|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
161708329|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
161708330|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
161708331|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
161708332|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708333|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708334|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161837723|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
161837724|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
161837725|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
161837726|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
161837727|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
161837728|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
161837729|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
161837730|NCT04932941|584448692|FG000|Overall Study|Lost to Follow-up|3|||
161708335|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708336|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708337|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
161708338|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708339|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708340|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708341|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708342|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
161708343|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
161708344|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708345|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708346|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708347|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708348|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
161708349|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
161708350|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708351|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
161708352|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
161708353|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708354|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708355|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708356|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708357|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
161708358|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
161708359|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708360|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708361|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
161708362|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708363|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708364|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708365|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708366|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708367|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708368|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708369|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
161708370|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
161708371|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708372|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708373|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708374|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708375|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
161708376|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
161708377|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708378|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161708379|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708380|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708381|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708382|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708383|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708384|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161708385|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161708386|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708387|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
161708388|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161708389|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708390|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708391|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161837731|NCT04932941|584448693|FG001|Overall Study|Lost to Follow-up|1|||
161837732|NCT04932941|584448692|FG000|Overall Study|Withdrawal by Subject|7|||
161837733|NCT04932941|584448693|FG001|Overall Study|Withdrawal by Subject|4|||
161837734|NCT04932941|584448692|FG000|Overall Study|Other|4|||
161837735|NCT04932941|584448693|FG001|Overall Study|Other|2|||
161837736|NCT03510182|584448696|FG000|Overall Study|Withdrawal by Subject|2|||
161837737|NCT00375492|584448697|FG000|Overall Study|Adverse Event|4|||
161837738|NCT00375492|584448698|FG001|Overall Study|Adverse Event|5|||
161837739|NCT00375492|584448697|FG000|Overall Study|Entry Criteria Not Met|0|||
161837740|NCT00375492|584448698|FG001|Overall Study|Entry Criteria Not Met|1|||
161837741|NCT00375492|584448697|FG000|Overall Study|Loss of Glucose Control|0|||
161708392|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708393|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
161708394|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
161708395|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708396|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161708397|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
161708398|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708399|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708400|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708401|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708402|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
161708403|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161708404|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708405|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
161708406|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
161708407|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708408|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708409|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708410|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708411|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708412|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708413|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708414|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
161708415|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
161708416|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708417|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708418|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708419|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708420|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
161708421|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
161708422|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708423|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
161708424|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
161708425|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708426|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708427|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708428|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708429|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161708430|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161708431|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708432|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161708433|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708434|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708435|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708436|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708437|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708438|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161708439|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708440|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708441|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
161708442|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708443|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708444|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708445|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708446|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708447|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708448|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708449|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708450|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161708451|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708452|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708453|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708454|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708455|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708456|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708457|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161708458|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708459|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
161708460|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161708461|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708462|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708463|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708464|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708465|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
161708466|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161708467|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708468|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708469|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
161708470|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708471|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708472|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708473|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708474|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708475|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708476|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708477|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708478|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708479|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708480|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708481|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708482|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708483|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
161708484|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708485|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708486|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161708487|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161708488|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708489|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708490|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708491|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708492|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708493|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161708494|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708495|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
161708496|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
161708497|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708498|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708499|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708500|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708501|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708502|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708503|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708504|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
161708505|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
161708506|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708507|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708508|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708509|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708510|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708511|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161708512|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708513|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
161708514|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708515|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708516|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708517|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708518|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708519|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708520|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708521|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708522|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708523|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
161708524|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708525|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708526|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708527|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708528|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
161708529|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
161708530|NCT01499290|583977398|FG000|Overall Study|Withdrawal by Subject|22|||
161708531|NCT01499290|583977399|FG001|Overall Study|Withdrawal by Subject|15|||
161708532|NCT01499290|583977398|FG000|Overall Study|Not specified in study report|11|||
161708533|NCT01499290|583977399|FG001|Overall Study|Not specified in study report|5|||
161708534|NCT01499290|583977398|FG000|Overall Study|Condition improved/subject recovered|1|||
161708535|NCT01499290|583977399|FG001|Overall Study|Condition improved/subject recovered|0|||
161708536|NCT01499290|583977398|FG000|Overall Study|Lack of Efficacy|7|||
161708537|NCT01499290|583977399|FG001|Overall Study|Lack of Efficacy|8|||
161708538|NCT01499290|583977398|FG000|Overall Study|Adverse Event|14|||
161708539|NCT01499290|583977399|FG001|Overall Study|Adverse Event|7|||
161708540|NCT03406962|583977400|FG000|Overall Study|Death|2|||
161708541|NCT03406962|583977400|FG000|Overall Study|Adverse Event|1|||
161708542|NCT03853694|583977401|FG000|Overall Study|Protocol Violation|3|||
161708543|NCT03853694|583977402|FG001|Overall Study|Protocol Violation|5|||
161708544|NCT03853694|583977403|FG002|Overall Study|Protocol Violation|3|||
161708545|NCT03853694|583977401|FG000|Overall Study|Delivered early|0|||
161708546|NCT03853694|583977402|FG001|Overall Study|Delivered early|1|||
161708547|NCT03853694|583977403|FG002|Overall Study|Delivered early|0|||
161708548|NCT03853694|583977401|FG000|Overall Study|not suitable to proceed|0|||
161708549|NCT03853694|583977402|FG001|Overall Study|not suitable to proceed|1|||
161708550|NCT03853694|583977403|FG002|Overall Study|not suitable to proceed|0|||
161708551|NCT03853694|583977401|FG000|Overall Study|difficult surgery|0|||
161708552|NCT03853694|583977402|FG001|Overall Study|difficult surgery|0|||
161708553|NCT03853694|583977403|FG002|Overall Study|difficult surgery|1|||
161708554|NCT03853694|583977401|FG000|Overall Study|Lost to Follow-up|0|||
161708555|NCT03853694|583977402|FG001|Overall Study|Lost to Follow-up|1|||
161708556|NCT03853694|583977403|FG002|Overall Study|Lost to Follow-up|0|||
161708557|NCT03853694|583977401|FG000|Overall Study|Withdrawal by Subject|0|||
161708558|NCT03853694|583977402|FG001|Overall Study|Withdrawal by Subject|1|||
161708559|NCT03853694|583977403|FG002|Overall Study|Withdrawal by Subject|0|||
161708560|NCT02209766|583977404|FG000|Overall Study|Withdrawal by Subject|0|||
161708561|NCT02209766|583977405|FG001|Overall Study|Withdrawal by Subject|0|||
161708562|NCT02209766|583977406|FG002|Overall Study|Withdrawal by Subject|0|||
161708563|NCT02209766|583977407|FG003|Overall Study|Withdrawal by Subject|1|||
161708564|NCT02209766|583977408|FG004|Overall Study|Withdrawal by Subject|0|||
161708565|NCT00805207|583977409|FG000|Overall Study|Protocol Violation|0|||
161708566|NCT00805207|583977410|FG001|Overall Study|Protocol Violation|0|||
161708567|NCT00805207|583977411|FG002|Overall Study|Protocol Violation|1|||
161708568|NCT00805207|583977412|FG003|Overall Study|Protocol Violation|0|||
161708569|NCT00805207|583977413|FG004|Overall Study|Protocol Violation|0|||
161708570|NCT00805207|583977414|FG005|Overall Study|Protocol Violation|0|||
161708571|NCT00805207|583977415|FG006|Overall Study|Protocol Violation|0|||
161708572|NCT00805207|583977416|FG007|Overall Study|Protocol Violation|0|||
161708573|NCT00805207|583977417|FG008|Overall Study|Protocol Violation|0|||
161708574|NCT00805207|583977409|FG000|Overall Study|Physician Decision|0|||
161708575|NCT00805207|583977410|FG001|Overall Study|Physician Decision|1|||
161708576|NCT00805207|583977411|FG002|Overall Study|Physician Decision|0|||
161708577|NCT00805207|583977412|FG003|Overall Study|Physician Decision|0|||
161708578|NCT00805207|583977413|FG004|Overall Study|Physician Decision|0|||
161708579|NCT00805207|583977414|FG005|Overall Study|Physician Decision|1|||
161708580|NCT00805207|583977415|FG006|Overall Study|Physician Decision|0|||
161708581|NCT00805207|583977416|FG007|Overall Study|Physician Decision|0|||
161708582|NCT00805207|583977417|FG008|Overall Study|Physician Decision|0|||
161708583|NCT00805207|583977409|FG000|Overall Study|Withdrawal by Subject|0|||
161708584|NCT00805207|583977410|FG001|Overall Study|Withdrawal by Subject|1|||
161708585|NCT00805207|583977411|FG002|Overall Study|Withdrawal by Subject|0|||
161708586|NCT00805207|583977412|FG003|Overall Study|Withdrawal by Subject|0|||
161708587|NCT00805207|583977413|FG004|Overall Study|Withdrawal by Subject|1|||
161708588|NCT00805207|583977414|FG005|Overall Study|Withdrawal by Subject|2|||
161708589|NCT00805207|583977415|FG006|Overall Study|Withdrawal by Subject|0|||
161708590|NCT00805207|583977416|FG007|Overall Study|Withdrawal by Subject|0|||
161708591|NCT00805207|583977417|FG008|Overall Study|Withdrawal by Subject|0|||
161708592|NCT00064701|583977418|FG000|One Year Post-transplant|Did not receive study drug|7|||
161708593|NCT00064701|583977419|FG001|One Year Post-transplant|Did not receive study drug|12|||
161708594|NCT00064701|583977420|FG002|One Year Post-transplant|Did not receive study drug|11|||
161708595|NCT00064701|583977418|FG000|One Year Post-transplant|Adverse Event|23|||
161708596|NCT00064701|583977419|FG001|One Year Post-transplant|Adverse Event|19|||
161708597|NCT00064701|583977420|FG002|One Year Post-transplant|Adverse Event|37|||
161708598|NCT00064701|583977418|FG000|One Year Post-transplant|Rejection|0|||
161708599|NCT00064701|583977419|FG001|One Year Post-transplant|Rejection|1|||
161708600|NCT00064701|583977420|FG002|One Year Post-transplant|Rejection|16|||
161708601|NCT00064701|583977418|FG000|One Year Post-transplant|Non-compliance|4|||
161708602|NCT00064701|583977419|FG001|One Year Post-transplant|Non-compliance|2|||
161708603|NCT00064701|583977420|FG002|One Year Post-transplant|Non-compliance|5|||
161708604|NCT00064701|583977418|FG000|One Year Post-transplant|Graft Failure|3|||
161708605|NCT00064701|583977419|FG001|One Year Post-transplant|Graft Failure|2|||
161708606|NCT00064701|583977420|FG002|One Year Post-transplant|Graft Failure|1|||
161708607|NCT00064701|583977418|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
161708608|NCT00064701|583977419|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
161708609|NCT00064701|583977420|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
161708610|NCT00064701|583977418|FG000|One Year Post-transplant|Lost to Follow-up|1|||
161708611|NCT00064701|583977419|FG001|One Year Post-transplant|Lost to Follow-up|0|||
161708612|NCT00064701|583977420|FG002|One Year Post-transplant|Lost to Follow-up|0|||
161708613|NCT00064701|583977418|FG000|One Year Post-transplant|Converted to rapamycin|1|||
161708614|NCT00064701|583977419|FG001|One Year Post-transplant|Converted to rapamycin|0|||
161708615|NCT00064701|583977420|FG002|One Year Post-transplant|Converted to rapamycin|0|||
161708616|NCT00064701|583977418|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
161708617|NCT00064701|583977419|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
161708618|NCT00064701|583977420|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
161708619|NCT00064701|583977418|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
161708620|NCT00064701|583977419|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
161708621|NCT00064701|583977420|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
161708622|NCT00064701|583977418|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
161708623|NCT00064701|583977419|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
161708624|NCT00064701|583977420|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
161708625|NCT00064701|583977418|FG000|One Year Post-transplant|Poor absorption|0|||
161708626|NCT00064701|583977419|FG001|One Year Post-transplant|Poor absorption|1|||
161708627|NCT00064701|583977420|FG002|One Year Post-transplant|Poor absorption|0|||
161708628|NCT00064701|583977418|FG000|One Year Post-transplant|Pancreas transplant|0|||
161708629|NCT00064701|583977419|FG001|One Year Post-transplant|Pancreas transplant|0|||
161708630|NCT00064701|583977420|FG002|One Year Post-transplant|Pancreas transplant|1|||
161708631|NCT00064701|583977418|FG000|Clinical Continuation Phase|Adverse Event|12|||
161708632|NCT00064701|583977419|FG001|Clinical Continuation Phase|Adverse Event|21|||
161708633|NCT00064701|583977420|FG002|Clinical Continuation Phase|Adverse Event|14|||
161708634|NCT00064701|583977418|FG000|Clinical Continuation Phase|Non-compliance|8|||
161708635|NCT00064701|583977419|FG001|Clinical Continuation Phase|Non-compliance|6|||
161708636|NCT00064701|583977420|FG002|Clinical Continuation Phase|Non-compliance|7|||
161708637|NCT00064701|583977418|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
161708638|NCT00064701|583977419|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
161708639|NCT00064701|583977420|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
161708640|NCT00064701|583977418|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
161708641|NCT00064701|583977419|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
161708642|NCT00064701|583977420|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
161708643|NCT00064701|583977418|FG000|Clinical Continuation Phase|Graft Failure|5|||
161708644|NCT00064701|583977419|FG001|Clinical Continuation Phase|Graft Failure|5|||
161708645|NCT00064701|583977420|FG002|Clinical Continuation Phase|Graft Failure|2|||
161708646|NCT00064701|583977418|FG000|Clinical Continuation Phase|Rejection|1|||
161708647|NCT00064701|583977419|FG001|Clinical Continuation Phase|Rejection|2|||
161708648|NCT00064701|583977420|FG002|Clinical Continuation Phase|Rejection|2|||
161708649|NCT00064701|583977418|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
161708650|NCT00064701|583977419|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
161708651|NCT00064701|583977420|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
161708652|NCT00064701|583977418|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
161708653|NCT00064701|583977419|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
161708654|NCT00064701|583977420|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
161708655|NCT00064701|583977418|FG000|Clinical Continuation Phase|Physician Decision|1|||
161708656|NCT00064701|583977419|FG001|Clinical Continuation Phase|Physician Decision|3|||
161708657|NCT00064701|583977420|FG002|Clinical Continuation Phase|Physician Decision|0|||
161708658|NCT00064701|583977418|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
161708659|NCT00064701|583977419|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
161708660|NCT00064701|583977420|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
161708661|NCT00064701|583977418|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
161708662|NCT00064701|583977419|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
161708663|NCT00064701|583977420|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
161708664|NCT00064701|583977418|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
161708665|NCT00064701|583977419|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
161708666|NCT00064701|583977420|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
161708667|NCT00064701|583977418|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
161708668|NCT00064701|583977419|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
161708669|NCT00064701|583977420|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
161708670|NCT00064701|583977418|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
161708671|NCT00064701|583977419|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
161708672|NCT00064701|583977420|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
161708673|NCT00064701|583977418|FG000|Clinical Continuation Phase|Patient opted out|0|||
161708674|NCT00064701|583977419|FG001|Clinical Continuation Phase|Patient opted out|0|||
161708675|NCT00064701|583977420|FG002|Clinical Continuation Phase|Patient opted out|1|||
161708676|NCT01818297|583977421|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
161708677|NCT01818297|583977422|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
161708678|NCT01818297|583977421|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
161708679|NCT01818297|583977422|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
161708680|NCT01818297|583977421|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
161708681|NCT01818297|583977422|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
161708682|NCT03308188|583977423|FG000|Overall Study|Withdrawal by Subject|0|||
161708683|NCT03308188|583977424|FG001|Overall Study|Withdrawal by Subject|3|||
161708684|NCT03308188|583977423|FG000|Overall Study|Death|0|||
161708685|NCT03308188|583977424|FG001|Overall Study|Death|1|||
161708686|NCT01791855|583977425|FG000|Overall Study|Adverse Event|0|||
161708687|NCT01791855|583977426|FG001|Overall Study|Adverse Event|0|||
161708688|NCT01791855|583977427|FG002|Overall Study|Adverse Event|0|||
161708689|NCT01791855|583977428|FG003|Overall Study|Adverse Event|1|||
161708690|NCT01791855|583977425|FG000|Overall Study|Randomized, not treated|0|||
161708691|NCT01791855|583977426|FG001|Overall Study|Randomized, not treated|1|||
161708692|NCT01791855|583977427|FG002|Overall Study|Randomized, not treated|0|||
161708693|NCT01791855|583977428|FG003|Overall Study|Randomized, not treated|0|||
161708694|NCT00481065|583977429|FG000|Overall Study|Adverse event or death|1|||
161708695|NCT00481065|583977430|FG001|Overall Study|Adverse event or death|1|||
161708696|NCT00481065|583977431|FG002|Overall Study|Adverse event or death|3|||
161708697|NCT00481065|583977432|FG003|Overall Study|Adverse event or death|0|||
161708698|NCT00481065|583977433|FG004|Overall Study|Adverse event or death|2|||
161708699|NCT00481065|583977434|FG005|Overall Study|Adverse event or death|0|||
161708700|NCT00481065|583977435|FG006|Overall Study|Adverse event or death|1|||
161708701|NCT00481065|583977436|FG007|Overall Study|Adverse event or death|1|||
161708702|NCT00481065|583977429|FG000|Overall Study|Withdrawal by Subject|11|||
161708703|NCT00481065|583977430|FG001|Overall Study|Withdrawal by Subject|12|||
161708704|NCT00481065|583977431|FG002|Overall Study|Withdrawal by Subject|7|||
161708705|NCT00481065|583977432|FG003|Overall Study|Withdrawal by Subject|11|||
161708706|NCT00481065|583977433|FG004|Overall Study|Withdrawal by Subject|13|||
161708707|NCT00481065|583977434|FG005|Overall Study|Withdrawal by Subject|12|||
161708708|NCT00481065|583977435|FG006|Overall Study|Withdrawal by Subject|9|||
161708709|NCT00481065|583977436|FG007|Overall Study|Withdrawal by Subject|10|||
161708710|NCT00481065|583977429|FG000|Overall Study|Lost to Follow-up|4|||
161708711|NCT00481065|583977430|FG001|Overall Study|Lost to Follow-up|2|||
161708712|NCT00481065|583977431|FG002|Overall Study|Lost to Follow-up|4|||
161708713|NCT00481065|583977432|FG003|Overall Study|Lost to Follow-up|3|||
161708714|NCT00481065|583977433|FG004|Overall Study|Lost to Follow-up|3|||
161708715|NCT00481065|583977434|FG005|Overall Study|Lost to Follow-up|3|||
161708716|NCT00481065|583977435|FG006|Overall Study|Lost to Follow-up|2|||
161708717|NCT00481065|583977436|FG007|Overall Study|Lost to Follow-up|5|||
161708718|NCT00481065|583977429|FG000|Overall Study|Inappropriate enrollment|4|||
161708719|NCT00481065|583977430|FG001|Overall Study|Inappropriate enrollment|0|||
161708720|NCT00481065|583977431|FG002|Overall Study|Inappropriate enrollment|2|||
161708721|NCT00481065|583977432|FG003|Overall Study|Inappropriate enrollment|0|||
161708722|NCT00481065|583977433|FG004|Overall Study|Inappropriate enrollment|2|||
161708723|NCT00481065|583977434|FG005|Overall Study|Inappropriate enrollment|1|||
161708724|NCT00481065|583977435|FG006|Overall Study|Inappropriate enrollment|0|||
161708725|NCT00481065|583977436|FG007|Overall Study|Inappropriate enrollment|1|||
161708726|NCT00481065|583977429|FG000|Overall Study|Administrative reason|0|||
161708727|NCT00481065|583977430|FG001|Overall Study|Administrative reason|0|||
161708728|NCT00481065|583977431|FG002|Overall Study|Administrative reason|0|||
161708729|NCT00481065|583977432|FG003|Overall Study|Administrative reason|0|||
161708730|NCT00481065|583977433|FG004|Overall Study|Administrative reason|0|||
161708731|NCT00481065|583977434|FG005|Overall Study|Administrative reason|2|||
161708732|NCT00481065|583977435|FG006|Overall Study|Administrative reason|1|||
161708733|NCT00481065|583977436|FG007|Overall Study|Administrative reason|0|||
161708734|NCT00481065|583977429|FG000|Overall Study|Protocol Violation|2|||
161708735|NCT00481065|583977430|FG001|Overall Study|Protocol Violation|1|||
161708736|NCT00481065|583977431|FG002|Overall Study|Protocol Violation|1|||
161837742|NCT00375492|584448698|FG001|Overall Study|Loss of Glucose Control|1|||
161708737|NCT00481065|583977432|FG003|Overall Study|Protocol Violation|1|||
161708738|NCT00481065|583977433|FG004|Overall Study|Protocol Violation|2|||
161708739|NCT00481065|583977434|FG005|Overall Study|Protocol Violation|6|||
161708740|NCT00481065|583977435|FG006|Overall Study|Protocol Violation|3|||
161708741|NCT00481065|583977436|FG007|Overall Study|Protocol Violation|2|||
161708742|NCT00481065|583977429|FG000|Overall Study|Unable to classify|0|||
161708743|NCT00481065|583977430|FG001|Overall Study|Unable to classify|1|||
161708744|NCT00481065|583977431|FG002|Overall Study|Unable to classify|2|||
161708745|NCT00481065|583977432|FG003|Overall Study|Unable to classify|0|||
161708746|NCT00481065|583977433|FG004|Overall Study|Unable to classify|1|||
161708747|NCT00481065|583977434|FG005|Overall Study|Unable to classify|0|||
161708748|NCT00481065|583977435|FG006|Overall Study|Unable to classify|0|||
161708749|NCT00481065|583977436|FG007|Overall Study|Unable to classify|0|||
161837743|NCT00375492|584448697|FG000|Overall Study|Lost to Follow-up|10|||
161837744|NCT00375492|584448698|FG001|Overall Study|Lost to Follow-up|5|||
161837745|NCT00375492|584448697|FG000|Overall Study|Physician Decision|0|||
161837746|NCT00375492|584448698|FG001|Overall Study|Physician Decision|4|||
161837747|NCT00375492|584448697|FG000|Overall Study|Protocol Violation|6|||
161837748|NCT00375492|584448698|FG001|Overall Study|Protocol Violation|3|||
161837749|NCT00375492|584448697|FG000|Overall Study|Sponsor Decision|0|||
161837750|NCT00375492|584448698|FG001|Overall Study|Sponsor Decision|1|||
161837751|NCT00375492|584448697|FG000|Overall Study|Withdrawal by Subject|6|||
161837752|NCT00375492|584448698|FG001|Overall Study|Withdrawal by Subject|6|||
161837753|NCT03295318|584450181|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
161837754|NCT03295318|584450182|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
161837755|NCT03295318|584450183|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
161837756|NCT03295318|584450181|FG000|Overall Study|Death|1|||
161837757|NCT03295318|584450182|FG001|Overall Study|Death|1|||
161837758|NCT03295318|584450183|FG002|Overall Study|Death|1|||
161837759|NCT03295318|584450181|FG000|Overall Study|Protocol Violation|4|||
161837760|NCT03295318|584450182|FG001|Overall Study|Protocol Violation|3|||
161837761|NCT03295318|584450183|FG002|Overall Study|Protocol Violation|3|||
161837762|NCT03295318|584450181|FG000|Overall Study|Withdrawal by Subject|0|||
161837763|NCT03295318|584450182|FG001|Overall Study|Withdrawal by Subject|0|||
161837764|NCT03295318|584450183|FG002|Overall Study|Withdrawal by Subject|1|||
161837765|NCT03295318|584450181|FG000|Overall Study|Subject discontinued due to travel|0|||
161837766|NCT03295318|584450182|FG001|Overall Study|Subject discontinued due to travel|1|||
161837767|NCT03295318|584450183|FG002|Overall Study|Subject discontinued due to travel|0|||
161837768|NCT03747601|584450184|FG000|Overall Study|COVID halt to visits|4|||
161837769|NCT02307266|584450187|FG000|Overall Study|Adverse Event|3|||
161837770|NCT02307266|584450188|FG001|Overall Study|Adverse Event|1|||
161837771|NCT02307266|584450189|FG002|Overall Study|Adverse Event|5|||
161837772|NCT02307266|584450187|FG000|Overall Study|Withdrawal by Subject|2|||
161837773|NCT02307266|584450188|FG001|Overall Study|Withdrawal by Subject|0|||
161837774|NCT02307266|584450189|FG002|Overall Study|Withdrawal by Subject|1|||
161837775|NCT02307266|584450187|FG000|Overall Study|Lost to Follow-up|3|||
161837776|NCT02307266|584450188|FG001|Overall Study|Lost to Follow-up|0|||
161837777|NCT02307266|584450189|FG002|Overall Study|Lost to Follow-up|0|||
161837778|NCT00793780|584450190|FG000|Overall Study|Withdrawal by Subject|2|||
161837779|NCT00793780|584450191|FG001|Overall Study|Withdrawal by Subject|1|||
161837780|NCT00573157|584450192|FG000|Overall Study|Adverse Event|3|||
161837781|NCT00573157|584450193|FG001|Overall Study|Adverse Event|1|||
161837782|NCT00573157|584450192|FG000|Overall Study|Other|1|||
161837783|NCT00573157|584450193|FG001|Overall Study|Other|1|||
161837784|NCT01032018|584450194|FG000|Overall Study|Lost to Follow-up|6|||
161837785|NCT01032018|584450195|FG001|Overall Study|Lost to Follow-up|5|||
161837786|NCT01032018|584450194|FG000|Overall Study|Death|0|||
161837787|NCT01032018|584450195|FG001|Overall Study|Death|1|||
161837788|NCT00858143|584450197|FG000|Overall Study|Adverse Event|16|||
161837789|NCT00858143|584450197|FG000|Overall Study|Lack of Efficacy|4|||
161837790|NCT00858143|584450197|FG000|Overall Study|Death|7|||
161837791|NCT00858143|584450197|FG000|Overall Study|Other|23|||
161837792|NCT02621034|584450201|FG000|Overall Study|Lost to Follow-up|3|||
161837793|NCT02621034|584450202|FG001|Overall Study|Lost to Follow-up|2|||
161837794|NCT02621034|584450203|FG002|Overall Study|Lost to Follow-up|5|||
161837795|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
161708750|NCT01709331|583977437|FG000|Overall Study|Adverse Event|1|||
161708751|NCT04439344|583977438|FG000|Overall Study|Never started threapy|3|||
161708752|NCT04439344|583977438|FG000|Overall Study|Ineligible|3|||
161708753|NCT04439344|583977438|FG000|Overall Study|Adverse Event|13|||
161708754|NCT04439344|583977438|FG000|Overall Study|Death|2|||
161837796|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
161837797|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
161837798|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
161837799|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
161837800|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
161837801|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
161837802|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
161708755|NCT04439344|583977438|FG000|Overall Study|Disease progression|29|||
161708756|NCT04439344|583977438|FG000|Overall Study|Withdrawal by Subject|2|||
161708757|NCT04439344|583977438|FG000|Overall Study|Alternative therapy|1|||
161708758|NCT00772447|583977439|FG000|Overall Study|Withdrawal by Subject|9|||
161708759|NCT00772447|583977440|FG001|Overall Study|Withdrawal by Subject|5|||
161708760|NCT00772447|583977439|FG000|Overall Study|Physician Decision|4|||
161708761|NCT00772447|583977440|FG001|Overall Study|Physician Decision|8|||
161708762|NCT00772447|583977439|FG000|Overall Study|Lost to Follow-up|2|||
161708763|NCT00772447|583977440|FG001|Overall Study|Lost to Follow-up|4|||
161708764|NCT00772447|583977439|FG000|Overall Study|incorrect enrolment|3|||
161708765|NCT00772447|583977440|FG001|Overall Study|incorrect enrolment|4|||
161708766|NCT00772447|583977439|FG000|Overall Study|Protocol Violation|0|||
161708767|NCT00772447|583977440|FG001|Overall Study|Protocol Violation|1|||
161708768|NCT00772447|583977439|FG000|Overall Study|all others|2|||
161708769|NCT00772447|583977440|FG001|Overall Study|all others|2|||
161708770|NCT03770403|583977446|FG000|Overall Study|Adverse Event|8|||
161708771|NCT03770403|583977446|FG000|Overall Study|Death|5|||
161708772|NCT03770403|583977446|FG000|Overall Study|Physician Decision|1|||
161708773|NCT03770403|583977446|FG000|Overall Study|Sponsor decision|1|||
161708774|NCT03770403|583977446|FG000|Overall Study|Study terminated by Sponsor|1|||
161708775|NCT03770403|583977446|FG000|Overall Study|Withdrawal by Subject|13|||
161708776|NCT03770403|583977446|FG000|Overall Study|Other|88|||
161708777|NCT03896295|583977447|FG000|Overall Study|Adverse Event|0|||
161708778|NCT03896295|583977448|FG001|Overall Study|Adverse Event|1|||
161708779|NCT03896295|583977447|FG000|Overall Study|COVID-19|7|||
161708780|NCT03896295|583977448|FG001|Overall Study|COVID-19|29|||
161708781|NCT01957137|583977449|FG000|Randomized Portion|Adverse Event|1|||
161708782|NCT01957137|583977449|FG000|Randomized Portion|Withdrawal by Subject|1|||
161708783|NCT00552110|583977450|FG000|Overall Study|Serious or Life-Threatening AE|0|||
161708784|NCT00552110|583977451|FG001|Overall Study|Serious or Life-Threatening AE|0|||
161708785|NCT00552110|583977452|FG002|Overall Study|Serious or Life-Threatening AE|1|||
161708786|NCT00552110|583977453|FG003|Overall Study|Serious or Life-Threatening AE|0|||
161708787|NCT00552110|583977454|FG004|Overall Study|Serious or Life-Threatening AE|0|||
161708788|NCT00552110|583977450|FG000|Overall Study|Lack of Efficacy|1|||
161708789|NCT00552110|583977451|FG001|Overall Study|Lack of Efficacy|0|||
161708790|NCT00552110|583977452|FG002|Overall Study|Lack of Efficacy|0|||
161708791|NCT00552110|583977453|FG003|Overall Study|Lack of Efficacy|1|||
161708792|NCT00552110|583977454|FG004|Overall Study|Lack of Efficacy|4|||
161708793|NCT00552110|583977450|FG000|Overall Study|Withdrawal by Subject|0|||
161708794|NCT00552110|583977451|FG001|Overall Study|Withdrawal by Subject|2|||
161708795|NCT00552110|583977452|FG002|Overall Study|Withdrawal by Subject|0|||
161708796|NCT00552110|583977453|FG003|Overall Study|Withdrawal by Subject|3|||
161708797|NCT00552110|583977454|FG004|Overall Study|Withdrawal by Subject|2|||
161708798|NCT00552110|583977450|FG000|Overall Study|Lost to Follow-up|0|||
161708799|NCT00552110|583977451|FG001|Overall Study|Lost to Follow-up|0|||
161708800|NCT00552110|583977452|FG002|Overall Study|Lost to Follow-up|0|||
161708801|NCT00552110|583977453|FG003|Overall Study|Lost to Follow-up|1|||
161708802|NCT00552110|583977454|FG004|Overall Study|Lost to Follow-up|1|||
161708803|NCT00552110|583977450|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
161708804|NCT00552110|583977451|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
161708805|NCT00552110|583977452|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
161708806|NCT00552110|583977453|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
161708807|NCT00552110|583977454|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
161708808|NCT00552110|583977450|FG000|Overall Study|Withdrawn per Sponsor|0|||
161708809|NCT00552110|583977451|FG001|Overall Study|Withdrawn per Sponsor|1|||
161708810|NCT00552110|583977452|FG002|Overall Study|Withdrawn per Sponsor|0|||
161708811|NCT00552110|583977453|FG003|Overall Study|Withdrawn per Sponsor|0|||
161708812|NCT00552110|583977454|FG004|Overall Study|Withdrawn per Sponsor|1|||
161708813|NCT00552110|583977450|FG000|Overall Study|Use of Prohibited Medication|1|||
161708814|NCT00552110|583977451|FG001|Overall Study|Use of Prohibited Medication|1|||
161708815|NCT00552110|583977452|FG002|Overall Study|Use of Prohibited Medication|0|||
161708816|NCT00552110|583977453|FG003|Overall Study|Use of Prohibited Medication|0|||
161708817|NCT00552110|583977454|FG004|Overall Study|Use of Prohibited Medication|0|||
161708818|NCT00552110|583977450|FG000|Overall Study|Delay of Study due to Relabeling|0|||
161708819|NCT00552110|583977451|FG001|Overall Study|Delay of Study due to Relabeling|0|||
161708820|NCT00552110|583977452|FG002|Overall Study|Delay of Study due to Relabeling|0|||
161708821|NCT00552110|583977453|FG003|Overall Study|Delay of Study due to Relabeling|1|||
161708822|NCT00552110|583977454|FG004|Overall Study|Delay of Study due to Relabeling|0|||
161708823|NCT00552110|583977450|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708824|NCT00552110|583977451|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708825|NCT00552110|583977452|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708826|NCT00552110|583977453|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
161708827|NCT00552110|583977454|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708828|NCT00552110|583977450|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
161708829|NCT00552110|583977451|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
161708830|NCT00552110|583977452|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
161708831|NCT00552110|583977453|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
161708832|NCT00552110|583977454|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
161708833|NCT00700804|583977467|FG000|Overall Study|Withdrawal by Subject|1|||
161708834|NCT00700804|583977468|FG001|Overall Study|Withdrawal by Subject|2|||
161708835|NCT00700804|583977467|FG000|Overall Study|Protocol Violation|1|||
161708836|NCT00700804|583977468|FG001|Overall Study|Protocol Violation|1|||
161708837|NCT00700804|583977467|FG000|Overall Study|Loose Stools|1|||
161708838|NCT00700804|583977468|FG001|Overall Study|Loose Stools|1|||
161708839|NCT02901431|583977469|FG000|PK Part|Adverse Event|0|||
161708840|NCT02901431|583977470|FG001|PK Part|Adverse Event|1|||
161708841|NCT02901431|583977471|FG002|PK Part|Adverse Event|0|||
161708842|NCT02901431|583977472|FG003|PK Part|Adverse Event|0|||
161708843|NCT02901431|583977473|FG004|PK Part|Adverse Event|0|||
161708844|NCT02901431|583977474|FG005|PK Part|Adverse Event|0|||
161708845|NCT02901431|583977475|FG006|PK Part|Adverse Event|0|||
161708846|NCT02901431|583977476|FG007|PK Part|Adverse Event|0|||
161708847|NCT02901431|583977477|FG008|PK Part|Adverse Event|0|||
161708848|NCT02901431|583977478|FG009|PK Part|Adverse Event|0|||
161708849|NCT02901431|583977479|FG010|PK Part|Adverse Event|0|||
161708850|NCT02901431|583977480|FG011|PK Part|Adverse Event|0|||
161708851|NCT02901431|583977481|FG012|PK Part|Adverse Event|0|||
161708852|NCT02901431|583977469|FG000|PK Part|Lost to Follow-up|0|||
161708853|NCT02901431|583977470|FG001|PK Part|Lost to Follow-up|0|||
161708854|NCT02901431|583977471|FG002|PK Part|Lost to Follow-up|1|||
161708855|NCT02901431|583977472|FG003|PK Part|Lost to Follow-up|0|||
161708856|NCT02901431|583977473|FG004|PK Part|Lost to Follow-up|0|||
161708857|NCT02901431|583977474|FG005|PK Part|Lost to Follow-up|0|||
161708858|NCT02901431|583977475|FG006|PK Part|Lost to Follow-up|0|||
161708859|NCT02901431|583977476|FG007|PK Part|Lost to Follow-up|0|||
161708860|NCT02901431|583977477|FG008|PK Part|Lost to Follow-up|0|||
161708861|NCT02901431|583977478|FG009|PK Part|Lost to Follow-up|0|||
161708862|NCT02901431|583977479|FG010|PK Part|Lost to Follow-up|0|||
161708863|NCT02901431|583977480|FG011|PK Part|Lost to Follow-up|0|||
161708864|NCT02901431|583977481|FG012|PK Part|Lost to Follow-up|0|||
161708865|NCT02901431|583977469|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
161708866|NCT02901431|583977470|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708867|NCT02901431|583977471|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708868|NCT02901431|583977472|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161837803|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Various|0|||
161837804|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Various|9|||
161837805|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Adverse Event|23|||
161708869|NCT02901431|583977473|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708870|NCT02901431|583977474|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708871|NCT02901431|583977475|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708872|NCT02901431|583977476|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708873|NCT02901431|583977477|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708874|NCT02901431|583977478|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708875|NCT02901431|583977479|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708876|NCT02901431|583977480|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708877|NCT02901431|583977481|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708878|NCT02901431|583977469|FG000|PK Part|Pending dose confirmation|0|||
161708879|NCT02901431|583977470|FG001|PK Part|Pending dose confirmation|1|||
161708880|NCT02901431|583977471|FG002|PK Part|Pending dose confirmation|0|||
161708881|NCT02901431|583977472|FG003|PK Part|Pending dose confirmation|0|||
161708882|NCT02901431|583977473|FG004|PK Part|Pending dose confirmation|0|||
161708883|NCT02901431|583977474|FG005|PK Part|Pending dose confirmation|0|||
161708884|NCT02901431|583977475|FG006|PK Part|Pending dose confirmation|0|||
161708885|NCT02901431|583977476|FG007|PK Part|Pending dose confirmation|0|||
161708886|NCT02901431|583977477|FG008|PK Part|Pending dose confirmation|0|||
161708887|NCT02901431|583977478|FG009|PK Part|Pending dose confirmation|0|||
161708888|NCT02901431|583977479|FG010|PK Part|Pending dose confirmation|0|||
161708889|NCT02901431|583977480|FG011|PK Part|Pending dose confirmation|0|||
161708890|NCT02901431|583977481|FG012|PK Part|Pending dose confirmation|0|||
161708891|NCT02901431|583977469|FG000|PK Part|8 weeks of treatment ran out|2|||
161708892|NCT02901431|583977470|FG001|PK Part|8 weeks of treatment ran out|0|||
161708893|NCT02901431|583977471|FG002|PK Part|8 weeks of treatment ran out|0|||
161708894|NCT02901431|583977472|FG003|PK Part|8 weeks of treatment ran out|0|||
161708895|NCT02901431|583977473|FG004|PK Part|8 weeks of treatment ran out|0|||
161708896|NCT02901431|583977474|FG005|PK Part|8 weeks of treatment ran out|0|||
161708897|NCT02901431|583977475|FG006|PK Part|8 weeks of treatment ran out|0|||
161708898|NCT02901431|583977476|FG007|PK Part|8 weeks of treatment ran out|0|||
161708899|NCT02901431|583977477|FG008|PK Part|8 weeks of treatment ran out|0|||
161708900|NCT02901431|583977478|FG009|PK Part|8 weeks of treatment ran out|0|||
161708901|NCT02901431|583977479|FG010|PK Part|8 weeks of treatment ran out|0|||
161708902|NCT02901431|583977480|FG011|PK Part|8 weeks of treatment ran out|0|||
161708903|NCT02901431|583977481|FG012|PK Part|8 weeks of treatment ran out|0|||
161708904|NCT02901431|583977469|FG000|PK Part|Stopped treatment after 8 weeks|1|||
161708905|NCT02901431|583977470|FG001|PK Part|Stopped treatment after 8 weeks|0|||
161708906|NCT02901431|583977471|FG002|PK Part|Stopped treatment after 8 weeks|1|||
161708907|NCT02901431|583977472|FG003|PK Part|Stopped treatment after 8 weeks|0|||
161708908|NCT02901431|583977473|FG004|PK Part|Stopped treatment after 8 weeks|0|||
161708909|NCT02901431|583977474|FG005|PK Part|Stopped treatment after 8 weeks|0|||
161708910|NCT02901431|583977475|FG006|PK Part|Stopped treatment after 8 weeks|0|||
161708911|NCT02901431|583977476|FG007|PK Part|Stopped treatment after 8 weeks|0|||
161708912|NCT02901431|583977477|FG008|PK Part|Stopped treatment after 8 weeks|0|||
161708913|NCT02901431|583977478|FG009|PK Part|Stopped treatment after 8 weeks|0|||
161708914|NCT02901431|583977479|FG010|PK Part|Stopped treatment after 8 weeks|0|||
161708915|NCT02901431|583977480|FG011|PK Part|Stopped treatment after 8 weeks|0|||
161708916|NCT02901431|583977481|FG012|PK Part|Stopped treatment after 8 weeks|0|||
161708917|NCT02901431|583977469|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
161708918|NCT02901431|583977470|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708919|NCT02901431|583977471|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
161708920|NCT02901431|583977472|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708921|NCT02901431|583977473|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708922|NCT02901431|583977474|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708923|NCT02901431|583977475|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708924|NCT02901431|583977476|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708925|NCT02901431|583977477|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708926|NCT02901431|583977478|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708927|NCT02901431|583977479|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708928|NCT02901431|583977480|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708929|NCT02901431|583977481|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708930|NCT02901431|583977469|FG000|PK Part|Discontinued per Sponsor|0|||
161708931|NCT02901431|583977470|FG001|PK Part|Discontinued per Sponsor|3|||
161708932|NCT02901431|583977471|FG002|PK Part|Discontinued per Sponsor|0|||
161708933|NCT02901431|583977472|FG003|PK Part|Discontinued per Sponsor|0|||
161708934|NCT02901431|583977473|FG004|PK Part|Discontinued per Sponsor|0|||
161708935|NCT02901431|583977474|FG005|PK Part|Discontinued per Sponsor|0|||
161708936|NCT02901431|583977475|FG006|PK Part|Discontinued per Sponsor|0|||
161708937|NCT02901431|583977476|FG007|PK Part|Discontinued per Sponsor|0|||
161708938|NCT02901431|583977477|FG008|PK Part|Discontinued per Sponsor|0|||
161708939|NCT02901431|583977478|FG009|PK Part|Discontinued per Sponsor|0|||
161708940|NCT02901431|583977479|FG010|PK Part|Discontinued per Sponsor|0|||
161708941|NCT02901431|583977480|FG011|PK Part|Discontinued per Sponsor|0|||
161708942|NCT02901431|583977481|FG012|PK Part|Discontinued per Sponsor|0|||
161708943|NCT02901431|583977469|FG000|PK Part|Withdrawal by Subject|1|||
161708944|NCT02901431|583977470|FG001|PK Part|Withdrawal by Subject|1|||
161708945|NCT02901431|583977471|FG002|PK Part|Withdrawal by Subject|3|||
161708946|NCT02901431|583977472|FG003|PK Part|Withdrawal by Subject|0|||
161708947|NCT02901431|583977473|FG004|PK Part|Withdrawal by Subject|0|||
161708948|NCT02901431|583977474|FG005|PK Part|Withdrawal by Subject|0|||
161708949|NCT02901431|583977475|FG006|PK Part|Withdrawal by Subject|0|||
161708950|NCT02901431|583977476|FG007|PK Part|Withdrawal by Subject|0|||
161708951|NCT02901431|583977477|FG008|PK Part|Withdrawal by Subject|0|||
161708952|NCT02901431|583977478|FG009|PK Part|Withdrawal by Subject|0|||
161708953|NCT02901431|583977479|FG010|PK Part|Withdrawal by Subject|0|||
161708954|NCT02901431|583977480|FG011|PK Part|Withdrawal by Subject|0|||
161708955|NCT02901431|583977481|FG012|PK Part|Withdrawal by Subject|0|||
161708956|NCT02901431|583977469|FG000|Main Treatment Part|Adverse Event|0|||
161708957|NCT02901431|583977470|FG001|Main Treatment Part|Adverse Event|0|||
161708958|NCT02901431|583977471|FG002|Main Treatment Part|Adverse Event|0|||
161708959|NCT02901431|583977472|FG003|Main Treatment Part|Adverse Event|3|||
161708960|NCT02901431|583977473|FG004|Main Treatment Part|Adverse Event|3|||
161708961|NCT02901431|583977474|FG005|Main Treatment Part|Adverse Event|4|||
161708962|NCT02901431|583977475|FG006|Main Treatment Part|Adverse Event|1|||
161708963|NCT02901431|583977476|FG007|Main Treatment Part|Adverse Event|0|||
161708964|NCT02901431|583977477|FG008|Main Treatment Part|Adverse Event|0|||
161708965|NCT02901431|583977478|FG009|Main Treatment Part|Adverse Event|0|||
161708966|NCT02901431|583977479|FG010|Main Treatment Part|Adverse Event|0|||
161708967|NCT02901431|583977480|FG011|Main Treatment Part|Adverse Event|0|||
161708968|NCT02901431|583977481|FG012|Main Treatment Part|Adverse Event|0|||
161708969|NCT02901431|583977469|FG000|Main Treatment Part|Lack of Efficacy|0|||
161708970|NCT02901431|583977470|FG001|Main Treatment Part|Lack of Efficacy|0|||
161708971|NCT02901431|583977471|FG002|Main Treatment Part|Lack of Efficacy|0|||
161708972|NCT02901431|583977472|FG003|Main Treatment Part|Lack of Efficacy|1|||
161708973|NCT02901431|583977473|FG004|Main Treatment Part|Lack of Efficacy|0|||
161708974|NCT02901431|583977474|FG005|Main Treatment Part|Lack of Efficacy|0|||
161708975|NCT02901431|583977475|FG006|Main Treatment Part|Lack of Efficacy|0|||
161708976|NCT02901431|583977476|FG007|Main Treatment Part|Lack of Efficacy|0|||
161708977|NCT02901431|583977477|FG008|Main Treatment Part|Lack of Efficacy|0|||
161708978|NCT02901431|583977478|FG009|Main Treatment Part|Lack of Efficacy|0|||
161708979|NCT02901431|583977479|FG010|Main Treatment Part|Lack of Efficacy|0|||
161708980|NCT02901431|583977480|FG011|Main Treatment Part|Lack of Efficacy|0|||
161708981|NCT02901431|583977481|FG012|Main Treatment Part|Lack of Efficacy|0|||
161708982|NCT02901431|583977469|FG000|Main Treatment Part|Lost to Follow-up|0|||
161708983|NCT02901431|583977470|FG001|Main Treatment Part|Lost to Follow-up|0|||
161708984|NCT02901431|583977471|FG002|Main Treatment Part|Lost to Follow-up|0|||
161708985|NCT02901431|583977472|FG003|Main Treatment Part|Lost to Follow-up|3|||
161708986|NCT02901431|583977473|FG004|Main Treatment Part|Lost to Follow-up|1|||
161708987|NCT02901431|583977474|FG005|Main Treatment Part|Lost to Follow-up|2|||
161708988|NCT02901431|583977475|FG006|Main Treatment Part|Lost to Follow-up|3|||
161708989|NCT02901431|583977476|FG007|Main Treatment Part|Lost to Follow-up|0|||
161708990|NCT02901431|583977477|FG008|Main Treatment Part|Lost to Follow-up|0|||
161708991|NCT02901431|583977478|FG009|Main Treatment Part|Lost to Follow-up|0|||
161708992|NCT02901431|583977479|FG010|Main Treatment Part|Lost to Follow-up|0|||
161708993|NCT02901431|583977480|FG011|Main Treatment Part|Lost to Follow-up|0|||
161708994|NCT02901431|583977481|FG012|Main Treatment Part|Lost to Follow-up|0|||
161708995|NCT02901431|583977469|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
161708996|NCT02901431|583977470|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
161708997|NCT02901431|583977471|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
161708998|NCT02901431|583977472|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
161708999|NCT02901431|583977473|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
161709000|NCT02901431|583977474|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
161709001|NCT02901431|583977475|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
161709002|NCT02901431|583977476|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
161709003|NCT02901431|583977477|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
161709004|NCT02901431|583977478|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
161709005|NCT02901431|583977479|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
161709006|NCT02901431|583977480|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
161709007|NCT02901431|583977481|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
161709008|NCT02901431|583977469|FG000|Main Treatment Part|Physician Decision|0|||
161709009|NCT02901431|583977470|FG001|Main Treatment Part|Physician Decision|0|||
161709010|NCT02901431|583977471|FG002|Main Treatment Part|Physician Decision|0|||
161709011|NCT02901431|583977472|FG003|Main Treatment Part|Physician Decision|1|||
161709012|NCT02901431|583977473|FG004|Main Treatment Part|Physician Decision|0|||
161709013|NCT02901431|583977474|FG005|Main Treatment Part|Physician Decision|0|||
161709014|NCT02901431|583977475|FG006|Main Treatment Part|Physician Decision|1|||
161709015|NCT02901431|583977476|FG007|Main Treatment Part|Physician Decision|0|||
161709016|NCT02901431|583977477|FG008|Main Treatment Part|Physician Decision|0|||
161709017|NCT02901431|583977478|FG009|Main Treatment Part|Physician Decision|0|||
161709018|NCT02901431|583977479|FG010|Main Treatment Part|Physician Decision|0|||
161709019|NCT02901431|583977480|FG011|Main Treatment Part|Physician Decision|0|||
161709020|NCT02901431|583977481|FG012|Main Treatment Part|Physician Decision|0|||
161709021|NCT02901431|583977469|FG000|Main Treatment Part|Withdrawal by Subject|0|||
161709022|NCT02901431|583977470|FG001|Main Treatment Part|Withdrawal by Subject|0|||
161709023|NCT02901431|583977471|FG002|Main Treatment Part|Withdrawal by Subject|0|||
161709024|NCT02901431|583977472|FG003|Main Treatment Part|Withdrawal by Subject|18|||
161709025|NCT02901431|583977473|FG004|Main Treatment Part|Withdrawal by Subject|3|||
161709026|NCT02901431|583977474|FG005|Main Treatment Part|Withdrawal by Subject|5|||
161709027|NCT02901431|583977475|FG006|Main Treatment Part|Withdrawal by Subject|6|||
161709028|NCT02901431|583977476|FG007|Main Treatment Part|Withdrawal by Subject|0|||
161709029|NCT02901431|583977477|FG008|Main Treatment Part|Withdrawal by Subject|0|||
161709030|NCT02901431|583977478|FG009|Main Treatment Part|Withdrawal by Subject|0|||
161709031|NCT02901431|583977479|FG010|Main Treatment Part|Withdrawal by Subject|0|||
161709032|NCT02901431|583977480|FG011|Main Treatment Part|Withdrawal by Subject|0|||
161709033|NCT02901431|583977481|FG012|Main Treatment Part|Withdrawal by Subject|0|||
161709034|NCT02901431|583977469|FG000|Open Label Part|Adverse Event|0|||
161709035|NCT02901431|583977470|FG001|Open Label Part|Adverse Event|0|||
161709036|NCT02901431|583977471|FG002|Open Label Part|Adverse Event|0|||
161709037|NCT02901431|583977472|FG003|Open Label Part|Adverse Event|0|||
161709038|NCT02901431|583977473|FG004|Open Label Part|Adverse Event|0|||
161709039|NCT02901431|583977474|FG005|Open Label Part|Adverse Event|0|||
161709040|NCT02901431|583977475|FG006|Open Label Part|Adverse Event|0|||
161709041|NCT02901431|583977476|FG007|Open Label Part|Adverse Event|0|||
161709042|NCT02901431|583977477|FG008|Open Label Part|Adverse Event|4|||
161709043|NCT02901431|583977478|FG009|Open Label Part|Adverse Event|4|||
161709044|NCT02901431|583977479|FG010|Open Label Part|Adverse Event|0|||
161709045|NCT02901431|583977480|FG011|Open Label Part|Adverse Event|4|||
161709046|NCT02901431|583977481|FG012|Open Label Part|Adverse Event|1|||
161709047|NCT02901431|583977469|FG000|Open Label Part|Lost to Follow-up|0|||
161709048|NCT02901431|583977470|FG001|Open Label Part|Lost to Follow-up|0|||
161709049|NCT02901431|583977471|FG002|Open Label Part|Lost to Follow-up|0|||
161709050|NCT02901431|583977472|FG003|Open Label Part|Lost to Follow-up|0|||
161709051|NCT02901431|583977473|FG004|Open Label Part|Lost to Follow-up|0|||
161709052|NCT02901431|583977474|FG005|Open Label Part|Lost to Follow-up|0|||
161709053|NCT02901431|583977475|FG006|Open Label Part|Lost to Follow-up|0|||
161709054|NCT02901431|583977476|FG007|Open Label Part|Lost to Follow-up|0|||
161709055|NCT02901431|583977477|FG008|Open Label Part|Lost to Follow-up|2|||
161709056|NCT02901431|583977478|FG009|Open Label Part|Lost to Follow-up|2|||
161709057|NCT02901431|583977479|FG010|Open Label Part|Lost to Follow-up|1|||
161709058|NCT02901431|583977480|FG011|Open Label Part|Lost to Follow-up|1|||
161709059|NCT02901431|583977481|FG012|Open Label Part|Lost to Follow-up|1|||
161709060|NCT02901431|583977469|FG000|Open Label Part|Physician Decision|0|||
161709061|NCT02901431|583977470|FG001|Open Label Part|Physician Decision|0|||
161709062|NCT02901431|583977471|FG002|Open Label Part|Physician Decision|0|||
161709063|NCT02901431|583977472|FG003|Open Label Part|Physician Decision|0|||
161709064|NCT02901431|583977473|FG004|Open Label Part|Physician Decision|0|||
161709065|NCT02901431|583977474|FG005|Open Label Part|Physician Decision|0|||
161709066|NCT02901431|583977475|FG006|Open Label Part|Physician Decision|0|||
161709067|NCT02901431|583977476|FG007|Open Label Part|Physician Decision|0|||
161709068|NCT02901431|583977477|FG008|Open Label Part|Physician Decision|1|||
161709069|NCT02901431|583977478|FG009|Open Label Part|Physician Decision|1|||
161709070|NCT02901431|583977479|FG010|Open Label Part|Physician Decision|0|||
161709071|NCT02901431|583977480|FG011|Open Label Part|Physician Decision|0|||
161709072|NCT02901431|583977481|FG012|Open Label Part|Physician Decision|0|||
161709073|NCT02901431|583977469|FG000|Open Label Part|Study Terminated By Sponsor|0|||
161709074|NCT02901431|583977470|FG001|Open Label Part|Study Terminated By Sponsor|0|||
161709075|NCT02901431|583977471|FG002|Open Label Part|Study Terminated By Sponsor|0|||
161709076|NCT02901431|583977472|FG003|Open Label Part|Study Terminated By Sponsor|0|||
161709077|NCT02901431|583977473|FG004|Open Label Part|Study Terminated By Sponsor|0|||
161709078|NCT02901431|583977474|FG005|Open Label Part|Study Terminated By Sponsor|0|||
161709079|NCT02901431|583977475|FG006|Open Label Part|Study Terminated By Sponsor|0|||
161709080|NCT02901431|583977476|FG007|Open Label Part|Study Terminated By Sponsor|0|||
161709081|NCT02901431|583977477|FG008|Open Label Part|Study Terminated By Sponsor|35|||
161709082|NCT02901431|583977478|FG009|Open Label Part|Study Terminated By Sponsor|12|||
161709083|NCT02901431|583977479|FG010|Open Label Part|Study Terminated By Sponsor|21|||
161709084|NCT02901431|583977480|FG011|Open Label Part|Study Terminated By Sponsor|31|||
161709085|NCT02901431|583977481|FG012|Open Label Part|Study Terminated By Sponsor|0|||
161709086|NCT02901431|583977469|FG000|Open Label Part|Withdrawal by Subject|0|||
161709087|NCT02901431|583977470|FG001|Open Label Part|Withdrawal by Subject|0|||
161709088|NCT02901431|583977471|FG002|Open Label Part|Withdrawal by Subject|0|||
161709089|NCT02901431|583977472|FG003|Open Label Part|Withdrawal by Subject|0|||
161709090|NCT02901431|583977473|FG004|Open Label Part|Withdrawal by Subject|0|||
161709091|NCT02901431|583977474|FG005|Open Label Part|Withdrawal by Subject|0|||
161709092|NCT02901431|583977475|FG006|Open Label Part|Withdrawal by Subject|0|||
161709093|NCT02901431|583977476|FG007|Open Label Part|Withdrawal by Subject|0|||
161709094|NCT02901431|583977477|FG008|Open Label Part|Withdrawal by Subject|6|||
161709095|NCT02901431|583977478|FG009|Open Label Part|Withdrawal by Subject|5|||
161709096|NCT02901431|583977479|FG010|Open Label Part|Withdrawal by Subject|7|||
161709097|NCT02901431|583977480|FG011|Open Label Part|Withdrawal by Subject|3|||
161709098|NCT02901431|583977481|FG012|Open Label Part|Withdrawal by Subject|1|||
161709099|NCT02500537|583977482|FG000|Overall Study|Death|2|||
161709100|NCT02500537|583977483|FG001|Overall Study|Death|0|||
161709101|NCT02500537|583977482|FG000|Overall Study|Lost to Follow-up|0|||
161709102|NCT02500537|583977483|FG001|Overall Study|Lost to Follow-up|1|||
161709103|NCT02500537|583977482|FG000|Overall Study|Withdrawal by Subject|1|||
161709104|NCT02500537|583977483|FG001|Overall Study|Withdrawal by Subject|0|||
161709105|NCT03832387|583977486|FG000|Overall Study|Protocol Violation|2|||
161709106|NCT03832387|583977487|FG001|Overall Study|Protocol Violation|6|||
161709107|NCT03832387|583977486|FG000|Overall Study|EXCLUSION CRITERIA|3|||
161709108|NCT03832387|583977487|FG001|Overall Study|EXCLUSION CRITERIA|1|||
161709109|NCT00355121|583977488|FG000|Overall Study|Did not receive study vaccine|1|||
161709110|NCT00355121|583977489|FG001|Overall Study|Did not receive study vaccine|0|||
161709111|NCT00355121|583977490|FG002|Overall Study|Did not receive study vaccine|1|||
161709112|NCT00355121|583977488|FG000|Overall Study|Adverse Event|0|||
161709113|NCT00355121|583977489|FG001|Overall Study|Adverse Event|1|||
161709114|NCT00355121|583977490|FG002|Overall Study|Adverse Event|0|||
161709115|NCT00355121|583977488|FG000|Overall Study|Protocol Violation|7|||
161709116|NCT00355121|583977489|FG001|Overall Study|Protocol Violation|9|||
161709117|NCT00355121|583977490|FG002|Overall Study|Protocol Violation|1|||
161709118|NCT00355121|583977488|FG000|Overall Study|Lost to Follow-up|4|||
161709119|NCT00355121|583977489|FG001|Overall Study|Lost to Follow-up|7|||
161709120|NCT00355121|583977490|FG002|Overall Study|Lost to Follow-up|1|||
161709121|NCT00355121|583977488|FG000|Overall Study|Withdrawal by Subject|9|||
161709122|NCT00355121|583977489|FG001|Overall Study|Withdrawal by Subject|10|||
161709123|NCT00355121|583977490|FG002|Overall Study|Withdrawal by Subject|2|||
161709124|NCT00355121|583977488|FG000|Overall Study|Serious adverse events|0|||
161709125|NCT00355121|583977489|FG001|Overall Study|Serious adverse events|2|||
161709126|NCT00355121|583977490|FG002|Overall Study|Serious adverse events|0|||
161709127|NCT00784758|583977491|FG000|Overall Study|Withdrawal by Subject|3|||
161709128|NCT00784758|583977492|FG001|Overall Study|Withdrawal by Subject|0|||
161709129|NCT00784758|583977491|FG000|Overall Study|Adverse Event|1|||
161709130|NCT00784758|583977492|FG001|Overall Study|Adverse Event|0|||
161709131|NCT05775289|583977493|FG000|Overall Study|Study Ongoing|20|||
161709132|NCT05775289|583977494|FG001|Overall Study|Study Ongoing|53|||
161709133|NCT05775289|583977495|FG002|Overall Study|Study Ongoing|15|||
161709134|NCT05775289|583977496|FG003|Overall Study|Study Ongoing|55|||
161709135|NCT05775289|583977493|FG000|Overall Study|Death|4|||
161709136|NCT05775289|583977494|FG001|Overall Study|Death|11|||
161709137|NCT05775289|583977495|FG002|Overall Study|Death|8|||
161709138|NCT05775289|583977496|FG003|Overall Study|Death|12|||
161709139|NCT05775289|583977493|FG000|Overall Study|Lost to Follow-up|0|||
161709140|NCT05775289|583977494|FG001|Overall Study|Lost to Follow-up|1|||
161709141|NCT05775289|583977495|FG002|Overall Study|Lost to Follow-up|0|||
161709142|NCT05775289|583977496|FG003|Overall Study|Lost to Follow-up|0|||
161709143|NCT05775289|583977493|FG000|Overall Study|Progressive Disease|0|||
161709144|NCT05775289|583977494|FG001|Overall Study|Progressive Disease|0|||
161709145|NCT05775289|583977495|FG002|Overall Study|Progressive Disease|1|||
161709146|NCT05775289|583977496|FG003|Overall Study|Progressive Disease|0|||
161709147|NCT05775289|583977493|FG000|Overall Study|Withdrawal by Subject|1|||
161709148|NCT05775289|583977494|FG001|Overall Study|Withdrawal by Subject|1|||
161709149|NCT05775289|583977495|FG002|Overall Study|Withdrawal by Subject|0|||
161709150|NCT05775289|583977496|FG003|Overall Study|Withdrawal by Subject|0|||
161709151|NCT02330419|583977501|FG000|Overall Study|Lost to Follow-up|3|||
161709152|NCT02330419|583977502|FG001|Overall Study|Lost to Follow-up|7|||
161709153|NCT00215150|583980123|FG000|Open Label Phase|Lost to Follow-up|7|||
161709154|NCT00215150|583980123|FG000|Open Label Phase|Withdrawal by Subject|1|||
161709155|NCT00215150|583980123|FG000|Open Label Phase|Did not complete a post base visit|13|||
161709156|NCT00215150|583980123|FG000|Open Label Phase|Did not meet randomization criteria|9|||
161709157|NCT00215150|583980123|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
161709158|NCT00215150|583980123|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
161709159|NCT00215150|583980123|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
161709160|NCT02091440|583980127|FG000|Overall Study|Death|2|||
161709161|NCT00278629|583980134|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
161709162|NCT03323749|583980135|FG000|Double-blind Period|Lost to Follow-up|4|||
161709163|NCT03323749|583980136|FG001|Double-blind Period|Lost to Follow-up|5|||
161709164|NCT03323749|583980135|FG000|Double-blind Period|Adverse Event|3|||
161709165|NCT03323749|583980136|FG001|Double-blind Period|Adverse Event|1|||
161709166|NCT03323749|583980135|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
161709167|NCT03323749|583980136|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
161709168|NCT03323749|583980135|FG000|Open-Label Period|Adverse Event|3|||
161709169|NCT03323749|583980136|FG001|Open-Label Period|Adverse Event|10|||
161709170|NCT03323749|583980135|FG000|Open-Label Period|Withdrawal by Subject|7|||
161709171|NCT03323749|583980136|FG001|Open-Label Period|Withdrawal by Subject|5|||
161709172|NCT01821963|583980137|FG000|Overall Study|Adverse Event|1|||
161709173|NCT00783289|583980138|FG000|Overall Study|Protocol Violation|0|||
161709174|NCT00783289|583980139|FG001|Overall Study|Protocol Violation|1|||
161709175|NCT00783289|583980140|FG002|Overall Study|Protocol Violation|0|||
161709176|NCT00783289|583980141|FG003|Overall Study|Protocol Violation|0|||
161709177|NCT00506389|583980142|FG000|In-treatment Period|Other|3|||
161709178|NCT00506389|583980143|FG001|In-treatment Period|Other|3|||
161709179|NCT00506389|583980144|FG002|In-treatment Period|Other|4|||
161709180|NCT00506389|583980142|FG000|In-treatment Period|Lost to Follow-up|0|||
161709181|NCT00506389|583980143|FG001|In-treatment Period|Lost to Follow-up|0|||
161709182|NCT00506389|583980144|FG002|In-treatment Period|Lost to Follow-up|1|||
161709183|NCT00506389|583980142|FG000|In-treatment Period|Lack of compliance|1|||
161709184|NCT00506389|583980143|FG001|In-treatment Period|Lack of compliance|0|||
161709185|NCT00506389|583980144|FG002|In-treatment Period|Lack of compliance|0|||
161709186|NCT00506389|583980142|FG000|In-treatment Period|Reasons not related to trial|4|||
161709187|NCT00506389|583980143|FG001|In-treatment Period|Reasons not related to trial|1|||
161709188|NCT00506389|583980144|FG002|In-treatment Period|Reasons not related to trial|0|||
161709189|NCT00506389|583980142|FG000|In-treatment Period|Withdrawal by Subject|3|||
161709190|NCT00506389|583980143|FG001|In-treatment Period|Withdrawal by Subject|3|||
161709191|NCT00506389|583980144|FG002|In-treatment Period|Withdrawal by Subject|4|||
161709192|NCT00506389|583980142|FG000|In-treatment Period|Lack of Efficacy|0|||
161709193|NCT00506389|583980143|FG001|In-treatment Period|Lack of Efficacy|2|||
161709194|NCT00506389|583980144|FG002|In-treatment Period|Lack of Efficacy|0|||
161709195|NCT00506389|583980142|FG000|In-treatment Period|Adverse Event|11|||
161709196|NCT00506389|583980143|FG001|In-treatment Period|Adverse Event|5|||
161709197|NCT00506389|583980144|FG002|In-treatment Period|Adverse Event|2|||
161709198|NCT00506389|583980142|FG000|In-treatment Period|Randomized but not treated|4|||
161709199|NCT00506389|583980143|FG001|In-treatment Period|Randomized but not treated|1|||
161709200|NCT00506389|583980144|FG002|In-treatment Period|Randomized but not treated|1|||
161709201|NCT05224258|583980146|FG000|Overall Study|Withdrawal by Subject|1|||
161709202|NCT05224258|583980147|FG001|Overall Study|Withdrawal by Subject|1|||
161709203|NCT05224258|583980146|FG000|Overall Study|Physician Decision|1|||
161709204|NCT05224258|583980147|FG001|Overall Study|Physician Decision|1|||
161709205|NCT05224258|583980146|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161709206|NCT05224258|583980147|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161709207|NCT05224258|583980146|FG000|Overall Study|Study Product No Longer in Use|1|||
161709208|NCT05224258|583980147|FG001|Overall Study|Study Product No Longer in Use|0|||
161709209|NCT05224258|583980146|FG000|Overall Study|Adverse Event|0|||
161709210|NCT05224258|583980147|FG001|Overall Study|Adverse Event|1|||
161709211|NCT05224258|583980146|FG000|Overall Study|Protocol Deviation|0|||
161709212|NCT05224258|583980147|FG001|Overall Study|Protocol Deviation|1|||
161709213|NCT03095703|583980149|FG000|Overall Study|Withdrawal by Subject|1|||
161709214|NCT03539432|583980150|FG000|Overall Study|Lost to Follow-up|0|||
161709215|NCT03539432|583980151|FG001|Overall Study|Lost to Follow-up|1|||
161709216|NCT01381094|583980152|FG000|Overall Study|Adverse Event|1|||
161709217|NCT01381094|583980153|FG001|Overall Study|Adverse Event|2|||
161709218|NCT01381094|583980154|FG002|Overall Study|Adverse Event|0|||
161709219|NCT01381094|583980155|FG003|Overall Study|Adverse Event|1|||
161709220|NCT01381094|583980156|FG004|Overall Study|Adverse Event|0|||
161709221|NCT01381094|583980152|FG000|Overall Study|Lost to Follow-up|0|||
161709222|NCT01381094|583980153|FG001|Overall Study|Lost to Follow-up|0|||
161709223|NCT01381094|583980154|FG002|Overall Study|Lost to Follow-up|0|||
161709224|NCT01381094|583980155|FG003|Overall Study|Lost to Follow-up|0|||
161709225|NCT01381094|583980156|FG004|Overall Study|Lost to Follow-up|1|||
161709226|NCT01381094|583980152|FG000|Overall Study|Withdrawal of informed consent|0|||
161709227|NCT01381094|583980153|FG001|Overall Study|Withdrawal of informed consent|1|||
161709228|NCT01381094|583980154|FG002|Overall Study|Withdrawal of informed consent|0|||
161709229|NCT01381094|583980155|FG003|Overall Study|Withdrawal of informed consent|0|||
161709230|NCT01381094|583980156|FG004|Overall Study|Withdrawal of informed consent|0|||
161709231|NCT01381094|583980152|FG000|Overall Study|Participant given Aranesp injection|1|||
161709232|NCT01381094|583980153|FG001|Overall Study|Participant given Aranesp injection|0|||
161709233|NCT01381094|583980154|FG002|Overall Study|Participant given Aranesp injection|0|||
161709234|NCT01381094|583980155|FG003|Overall Study|Participant given Aranesp injection|0|||
161709235|NCT01381094|583980156|FG004|Overall Study|Participant given Aranesp injection|0|||
161709236|NCT02443402|583980159|FG000|Overall Study|Withdrawal by Subject|3|||
161709237|NCT02443402|583980160|FG001|Overall Study|Withdrawal by Subject|1|||
161709238|NCT02443402|583980159|FG000|Overall Study|Screen Failure|1|||
161709239|NCT02443402|583980160|FG001|Overall Study|Screen Failure|2|||
161709240|NCT01934504|583980162|FG000|Overall Study|Protocol Deviation|0|||
161709241|NCT01934504|583980163|FG001|Overall Study|Protocol Deviation|0|||
161709242|NCT01934504|583980164|FG002|Overall Study|Protocol Deviation|0|||
161709243|NCT01934504|583980165|FG003|Overall Study|Protocol Deviation|2|||
161709244|NCT01934504|583980162|FG000|Overall Study|Study Terminated by Sponsor|1|||
161709245|NCT01934504|583980163|FG001|Overall Study|Study Terminated by Sponsor|0|||
161709246|NCT01934504|583980164|FG002|Overall Study|Study Terminated by Sponsor|5|||
161709247|NCT01934504|583980165|FG003|Overall Study|Study Terminated by Sponsor|5|||
161709248|NCT02665689|583980166|FG000|Overall Study|Adverse Event|1|||
161709249|NCT02665689|583980167|FG001|Overall Study|Adverse Event|0|||
161709250|NCT02665689|583980166|FG000|Overall Study|Trial termination|1|||
161709251|NCT02665689|583980167|FG001|Overall Study|Trial termination|1|||
161709252|NCT02665689|583980166|FG000|Overall Study|Lost to Follow-up|0|||
161709253|NCT02665689|583980167|FG001|Overall Study|Lost to Follow-up|1|||
161709254|NCT00996840|583980174|FG000|Overall Study|Adverse Event|0|||
161709255|NCT00996840|583980175|FG001|Overall Study|Adverse Event|1|||
161709256|NCT00996840|583980176|FG002|Overall Study|Adverse Event|0|||
161709257|NCT00996840|583980177|FG003|Overall Study|Adverse Event|0|||
161709258|NCT00996840|583980178|FG004|Overall Study|Adverse Event|0|||
161709259|NCT00996840|583980174|FG000|Overall Study|Physician Decision|0|||
161709260|NCT00996840|583980175|FG001|Overall Study|Physician Decision|0|||
161709261|NCT00996840|583980176|FG002|Overall Study|Physician Decision|1|||
161709262|NCT00996840|583980177|FG003|Overall Study|Physician Decision|1|||
161709263|NCT00996840|583980178|FG004|Overall Study|Physician Decision|2|||
161709264|NCT00996840|583980174|FG000|Overall Study|Withdrawal by Subject|1|||
161709265|NCT00996840|583980175|FG001|Overall Study|Withdrawal by Subject|1|||
161709266|NCT00996840|583980176|FG002|Overall Study|Withdrawal by Subject|0|||
161709267|NCT00996840|583980177|FG003|Overall Study|Withdrawal by Subject|0|||
161709268|NCT00996840|583980178|FG004|Overall Study|Withdrawal by Subject|0|||
161709269|NCT02292849|583980179|FG000|Overall Study|Lost to Follow-up|0|||
161709270|NCT02292849|583980180|FG001|Overall Study|Lost to Follow-up|2|||
161709271|NCT02292849|583980181|FG002|Overall Study|Lost to Follow-up|2|||
161709272|NCT02292849|583980179|FG000|Overall Study|Physician Decision|4|||
161709273|NCT02292849|583980180|FG001|Overall Study|Physician Decision|0|||
161709274|NCT02292849|583980181|FG002|Overall Study|Physician Decision|0|||
161709275|NCT01562028|583980183|FG000|Overall Study|Withdrawal by Subject|1|||
161709276|NCT01562028|583980184|FG001|Overall Study|Withdrawal by Subject|1|||
161709277|NCT01562028|583980183|FG000|Overall Study|Lost to Follow-up|2|||
161709278|NCT01562028|583980184|FG001|Overall Study|Lost to Follow-up|1|||
161709279|NCT04938648|583980185|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
161709280|NCT04938648|583980186|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
161709281|NCT04938648|583980185|FG000|Overall Study|Patient too ill|0|||
161709282|NCT04938648|583980186|FG001|Overall Study|Patient too ill|1|||
161709283|NCT04938648|583980185|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
161709284|NCT04938648|583980186|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
161709285|NCT04938648|583980185|FG000|Overall Study|Patient did not have memory problems|1|||
161709286|NCT04938648|583980186|FG001|Overall Study|Patient did not have memory problems|1|||
161709287|NCT04938648|583980185|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
161709288|NCT04938648|583980186|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
161709289|NCT04938648|583980185|FG000|Overall Study|Care partner could not be reached|0|||
161709290|NCT04938648|583980186|FG001|Overall Study|Care partner could not be reached|1|||
161709291|NCT04938648|583980185|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
161709292|NCT04938648|583980186|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
161709293|NCT04938648|583980185|FG000|Overall Study|Withdrawal by Subject|2|||
161709294|NCT04938648|583980186|FG001|Overall Study|Withdrawal by Subject|1|||
161709295|NCT05127486|583980187|FG000|Overall Study|Adverse Event|2|||
161709296|NCT05127486|583980188|FG001|Overall Study|Adverse Event|4|||
161709297|NCT05127486|583980187|FG000|Overall Study|Lack of Efficacy|1|||
161709298|NCT05127486|583980188|FG001|Overall Study|Lack of Efficacy|0|||
161709299|NCT05127486|583980187|FG000|Overall Study|Pregnancy|0|||
161709300|NCT05127486|583980188|FG001|Overall Study|Pregnancy|1|||
161709301|NCT05127486|583980187|FG000|Overall Study|Physician Decision|4|||
161709302|NCT05127486|583980188|FG001|Overall Study|Physician Decision|1|||
161709303|NCT05127486|583980187|FG000|Overall Study|Withdrawal by Subject|14|||
161709304|NCT05127486|583980188|FG001|Overall Study|Withdrawal by Subject|13|||
161709305|NCT05127486|583980187|FG000|Overall Study|Lost to Follow-up|5|||
161709306|NCT05127486|583980188|FG001|Overall Study|Lost to Follow-up|8|||
161709307|NCT00775021|583980189|FG000|First Intervention|Lost to Follow-up|1|||
161709308|NCT00775021|583980190|FG001|First Intervention|Lost to Follow-up|0|||
161709309|NCT00775021|583980189|FG000|Second Intervention|Adverse Event|0|||
161709310|NCT00775021|583980190|FG001|Second Intervention|Adverse Event|1|||
161709311|NCT01287754|583980191|FG000|Overall Study|Death|2|||
161709312|NCT01287754|583980192|FG001|Overall Study|Death|12|||
161709313|NCT01287754|583980191|FG000|Overall Study|Lost to Follow-up|1|||
161709314|NCT01287754|583980192|FG001|Overall Study|Lost to Follow-up|6|||
161709315|NCT01287754|583980191|FG000|Overall Study|Protocol Violation|0|||
161709316|NCT01287754|583980192|FG001|Overall Study|Protocol Violation|3|||
161709317|NCT04439266|583980203|FG000|Overall Study|Ineligible|1|||
161709318|NCT04439266|583980203|FG000|Overall Study|Adverse Event|1|||
161709319|NCT04439266|583980203|FG000|Overall Study|Death|1|||
161709320|NCT04439266|583980203|FG000|Overall Study|Disease progression|1|||
161709321|NCT04439266|583980203|FG000|Overall Study|Still on treatment|1|||
161709322|NCT05027802|583980205|FG000|Overall Study|Adverse Event|2|||
161709323|NCT05027802|583980205|FG000|Overall Study|Withdrawal by Subject|18|||
161709324|NCT05027802|583980205|FG000|Overall Study|Death|2|||
161709325|NCT05027802|583980205|FG000|Overall Study|Other|1|||
161709326|NCT00001337|583980212|FG000|Overall Study|Switched to alternate treatment|2|||
161709327|NCT00001337|583980213|FG001|Overall Study|Switched to alternate treatment|2|||
161709328|NCT00001337|583980214|FG002|Overall Study|Switched to alternate treatment|0|||
161709329|NCT00001337|583980212|FG000|Overall Study|Refused further treatment|2|||
161709330|NCT00001337|583980213|FG001|Overall Study|Refused further treatment|1|||
161709331|NCT00001337|583980214|FG002|Overall Study|Refused further treatment|0|||
161709332|NCT00001337|583980212|FG000|Overall Study|Began other Tx|1|||
161709333|NCT00001337|583980213|FG001|Overall Study|Began other Tx|0|||
161709334|NCT00001337|583980214|FG002|Overall Study|Began other Tx|0|||
161709335|NCT00001337|583980212|FG000|Overall Study|Physician Decision|3|||
161709336|NCT00001337|583980213|FG001|Overall Study|Physician Decision|1|||
161709337|NCT00001337|583980214|FG002|Overall Study|Physician Decision|0|||
161709338|NCT00001337|583980212|FG000|Overall Study|Doesn't have NHL|0|||
161709339|NCT00001337|583980213|FG001|Overall Study|Doesn't have NHL|1|||
161709340|NCT00001337|583980214|FG002|Overall Study|Doesn't have NHL|0|||
161709341|NCT00001337|583980212|FG000|Overall Study|Non protocol tx needed|3|||
161709342|NCT00001337|583980213|FG001|Overall Study|Non protocol tx needed|1|||
161709343|NCT00001337|583980214|FG002|Overall Study|Non protocol tx needed|0|||
161709344|NCT00001337|583980212|FG000|Overall Study|Protocol change|1|||
161709345|NCT00001337|583980213|FG001|Overall Study|Protocol change|0|||
161709346|NCT00001337|583980214|FG002|Overall Study|Protocol change|0|||
161709347|NCT00001337|583980212|FG000|Overall Study|2nd primary disease|0|||
161709348|NCT00001337|583980213|FG001|Overall Study|2nd primary disease|0|||
161709349|NCT00001337|583980214|FG002|Overall Study|2nd primary disease|1|||
161709350|NCT00001337|583980212|FG000|Overall Study|Death during follow up period|9|||
161709351|NCT00001337|583980213|FG001|Overall Study|Death during follow up period|4|||
161709352|NCT00001337|583980214|FG002|Overall Study|Death during follow up period|0|||
161709353|NCT00001337|583980212|FG000|Overall Study|Death on study|19|||
161709354|NCT00001337|583980213|FG001|Overall Study|Death on study|9|||
161709355|NCT00001337|583980214|FG002|Overall Study|Death on study|0|||
161709356|NCT00001337|583980212|FG000|Overall Study|Disease progression during follow-up period|3|||
161709357|NCT00001337|583980213|FG001|Overall Study|Disease progression during follow-up period|1|||
161709358|NCT00001337|583980214|FG002|Overall Study|Disease progression during follow-up period|0|||
161709359|NCT00001337|583980212|FG000|Overall Study|Disease progression on study|33|||
161709360|NCT00001337|583980213|FG001|Overall Study|Disease progression on study|41|||
161709361|NCT00001337|583980214|FG002|Overall Study|Disease progression on study|0|||
161709362|NCT00001337|583980212|FG000|Overall Study|Lost to further follow-up|10|||
161709363|NCT00001337|583980213|FG001|Overall Study|Lost to further follow-up|6|||
161709364|NCT00001337|583980214|FG002|Overall Study|Lost to further follow-up|0|||
161709365|NCT00001337|583980212|FG000|Overall Study|2nd malignancy|1|||
161709366|NCT00001337|583980213|FG001|Overall Study|2nd malignancy|0|||
161709367|NCT00001337|583980214|FG002|Overall Study|2nd malignancy|0|||
161709368|NCT00001337|583980212|FG000|Overall Study|Treatment for second lymphoma|0|||
161709369|NCT00001337|583980213|FG001|Overall Study|Treatment for second lymphoma|1|||
161709370|NCT00001337|583980214|FG002|Overall Study|Treatment for second lymphoma|0|||
161709371|NCT00001337|583980212|FG000|Overall Study|Transfer to transplant|0|||
161709372|NCT00001337|583980213|FG001|Overall Study|Transfer to transplant|1|||
161709373|NCT00001337|583980214|FG002|Overall Study|Transfer to transplant|0|||
161709374|NCT06161012|583980215|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161709375|NCT06161012|583980216|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161709376|NCT00408005|583980221|FG000|Induction|Adverse Event|19|||
161709377|NCT00408005|583980222|FG001|Induction|Adverse Event|3|||
161709378|NCT00408005|583980223|FG002|Induction|Adverse Event|0|||
161709379|NCT00408005|583980224|FG003|Induction|Adverse Event|0|||
161709380|NCT00408005|583980225|FG004|Induction|Adverse Event|0|||
161709381|NCT00408005|583980226|FG005|Induction|Adverse Event|0|||
161709382|NCT00408005|583980227|FG006|Induction|Adverse Event|0|||
161709383|NCT00408005|583980228|FG007|Induction|Adverse Event|0|||
161709384|NCT00408005|583980221|FG000|Induction|Death|6|||
161709385|NCT00408005|583980222|FG001|Induction|Death|0|||
161709386|NCT00408005|583980223|FG002|Induction|Death|0|||
161709387|NCT00408005|583980224|FG003|Induction|Death|0|||
161709388|NCT00408005|583980225|FG004|Induction|Death|0|||
161709389|NCT00408005|583980226|FG005|Induction|Death|0|||
161709390|NCT00408005|583980227|FG006|Induction|Death|0|||
161709391|NCT00408005|583980228|FG007|Induction|Death|0|||
161709392|NCT00408005|583980221|FG000|Induction|Physician Decision|83|||
161709393|NCT00408005|583980222|FG001|Induction|Physician Decision|9|||
161709394|NCT00408005|583980223|FG002|Induction|Physician Decision|0|||
161709395|NCT00408005|583980224|FG003|Induction|Physician Decision|0|||
161709396|NCT00408005|583980225|FG004|Induction|Physician Decision|0|||
161709397|NCT00408005|583980226|FG005|Induction|Physician Decision|0|||
161709398|NCT00408005|583980227|FG006|Induction|Physician Decision|0|||
161709399|NCT00408005|583980228|FG007|Induction|Physician Decision|0|||
161709400|NCT00408005|583980221|FG000|Induction|Withdrawal by Subject|2|||
161709401|NCT00408005|583980222|FG001|Induction|Withdrawal by Subject|4|||
161709402|NCT00408005|583980223|FG002|Induction|Withdrawal by Subject|0|||
161709403|NCT00408005|583980224|FG003|Induction|Withdrawal by Subject|0|||
161709404|NCT00408005|583980225|FG004|Induction|Withdrawal by Subject|0|||
161709405|NCT00408005|583980226|FG005|Induction|Withdrawal by Subject|0|||
161709406|NCT00408005|583980227|FG006|Induction|Withdrawal by Subject|0|||
161709407|NCT00408005|583980228|FG007|Induction|Withdrawal by Subject|0|||
161709408|NCT00408005|583980221|FG000|Induction|Ineligible|33|||
161709409|NCT00408005|583980222|FG001|Induction|Ineligible|14|||
161709410|NCT00408005|583980223|FG002|Induction|Ineligible|0|||
161709411|NCT00408005|583980224|FG003|Induction|Ineligible|0|||
161709412|NCT00408005|583980225|FG004|Induction|Ineligible|0|||
161709413|NCT00408005|583980226|FG005|Induction|Ineligible|0|||
161709414|NCT00408005|583980227|FG006|Induction|Ineligible|0|||
161709415|NCT00408005|583980228|FG007|Induction|Ineligible|0|||
161709416|NCT00408005|583980221|FG000|Induction|Refusal of Further Protocol Therapy|225|||
161709417|NCT00408005|583980222|FG001|Induction|Refusal of Further Protocol Therapy|44|||
161709418|NCT00408005|583980223|FG002|Induction|Refusal of Further Protocol Therapy|0|||
161709419|NCT00408005|583980224|FG003|Induction|Refusal of Further Protocol Therapy|0|||
161709420|NCT00408005|583980225|FG004|Induction|Refusal of Further Protocol Therapy|0|||
161709421|NCT00408005|583980226|FG005|Induction|Refusal of Further Protocol Therapy|0|||
161709422|NCT00408005|583980227|FG006|Induction|Refusal of Further Protocol Therapy|0|||
161709423|NCT00408005|583980228|FG007|Induction|Refusal of Further Protocol Therapy|0|||
161709424|NCT00408005|583980221|FG000|Induction|Entered another COG therapeutic protocol|4|||
161709425|NCT00408005|583980222|FG001|Induction|Entered another COG therapeutic protocol|0|||
161709426|NCT00408005|583980223|FG002|Induction|Entered another COG therapeutic protocol|0|||
161709427|NCT00408005|583980224|FG003|Induction|Entered another COG therapeutic protocol|0|||
161709428|NCT00408005|583980225|FG004|Induction|Entered another COG therapeutic protocol|0|||
161709429|NCT00408005|583980226|FG005|Induction|Entered another COG therapeutic protocol|0|||
161709430|NCT00408005|583980227|FG006|Induction|Entered another COG therapeutic protocol|0|||
161709431|NCT00408005|583980228|FG007|Induction|Entered another COG therapeutic protocol|0|||
161709432|NCT00408005|583980221|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
161709433|NCT00408005|583980222|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
161709434|NCT00408005|583980223|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
161709435|NCT00408005|583980224|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
161709436|NCT00408005|583980225|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
161709437|NCT00408005|583980226|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
161709438|NCT00408005|583980227|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
161709439|NCT00408005|583980228|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
161709440|NCT00408005|583980221|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
161709441|NCT00408005|583980222|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
161709442|NCT00408005|583980223|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
161709443|NCT00408005|583980224|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
161709444|NCT00408005|583980225|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
161709445|NCT00408005|583980226|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
161709446|NCT00408005|583980227|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
161709447|NCT00408005|583980228|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
161709448|NCT00408005|583980221|FG000|Induction|Progressive Disease|0|||
161709449|NCT00408005|583980222|FG001|Induction|Progressive Disease|1|||
161709450|NCT00408005|583980223|FG002|Induction|Progressive Disease|0|||
161709451|NCT00408005|583980224|FG003|Induction|Progressive Disease|0|||
161709452|NCT00408005|583980225|FG004|Induction|Progressive Disease|0|||
161709453|NCT00408005|583980226|FG005|Induction|Progressive Disease|0|||
161709454|NCT00408005|583980227|FG006|Induction|Progressive Disease|0|||
161709455|NCT00408005|583980228|FG007|Induction|Progressive Disease|0|||
161709456|NCT00408005|583980221|FG000|Induction|Inevaluable|18|||
161709457|NCT00408005|583980222|FG001|Induction|Inevaluable|14|||
161709458|NCT00408005|583980223|FG002|Induction|Inevaluable|0|||
161709459|NCT00408005|583980224|FG003|Induction|Inevaluable|0|||
161709460|NCT00408005|583980225|FG004|Induction|Inevaluable|0|||
161709461|NCT00408005|583980226|FG005|Induction|Inevaluable|0|||
161709462|NCT00408005|583980227|FG006|Induction|Inevaluable|0|||
161709463|NCT00408005|583980228|FG007|Induction|Inevaluable|0|||
161709464|NCT00408005|583980221|FG000|Induction|Failed to Complete Randomization|3|||
161709465|NCT00408005|583980222|FG001|Induction|Failed to Complete Randomization|2|||
161709466|NCT00408005|583980223|FG002|Induction|Failed to Complete Randomization|0|||
161709467|NCT00408005|583980224|FG003|Induction|Failed to Complete Randomization|0|||
161709468|NCT00408005|583980225|FG004|Induction|Failed to Complete Randomization|0|||
161709469|NCT00408005|583980226|FG005|Induction|Failed to Complete Randomization|0|||
161709470|NCT00408005|583980227|FG006|Induction|Failed to Complete Randomization|0|||
161709471|NCT00408005|583980228|FG007|Induction|Failed to Complete Randomization|0|||
161709472|NCT00408005|583980221|FG000|Induction|Protocol Deviation|3|||
161709473|NCT00408005|583980222|FG001|Induction|Protocol Deviation|1|||
161709474|NCT00408005|583980223|FG002|Induction|Protocol Deviation|0|||
161709475|NCT00408005|583980224|FG003|Induction|Protocol Deviation|0|||
161709476|NCT00408005|583980225|FG004|Induction|Protocol Deviation|0|||
161709477|NCT00408005|583980226|FG005|Induction|Protocol Deviation|0|||
161709478|NCT00408005|583980227|FG006|Induction|Protocol Deviation|0|||
161709479|NCT00408005|583980228|FG007|Induction|Protocol Deviation|0|||
161709480|NCT00408005|583980221|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
161709481|NCT00408005|583980222|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709482|NCT00408005|583980223|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709483|NCT00408005|583980224|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709484|NCT00408005|583980225|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709485|NCT00408005|583980226|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709486|NCT00408005|583980227|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709487|NCT00408005|583980228|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709488|NCT00408005|583980221|FG000|Induction|Recurrent leukemia|1|||
161709489|NCT00408005|583980222|FG001|Induction|Recurrent leukemia|0|||
161709490|NCT00408005|583980223|FG002|Induction|Recurrent leukemia|0|||
161709491|NCT00408005|583980224|FG003|Induction|Recurrent leukemia|0|||
161709492|NCT00408005|583980225|FG004|Induction|Recurrent leukemia|0|||
161709493|NCT00408005|583980226|FG005|Induction|Recurrent leukemia|0|||
161709494|NCT00408005|583980227|FG006|Induction|Recurrent leukemia|0|||
161709495|NCT00408005|583980228|FG007|Induction|Recurrent leukemia|0|||
161709496|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161709497|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161709498|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
161837806|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Adverse Event|0|||
161837807|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Death|2|||
161837808|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Death|0|||
161837809|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
161709499|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
161709500|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
161709501|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
161709502|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
161709503|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161709504|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
161837810|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
161837811|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
161837812|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
161709505|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
161709506|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
161709507|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
161837813|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Various|3|||
161709508|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
161709509|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
161709510|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
161709511|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
161709512|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709513|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709514|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
161709515|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709516|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
161709517|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709518|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709519|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709520|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161709521|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161709522|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
161709523|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
161709524|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
161709525|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
161709526|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
161709527|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
161709528|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709529|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709530|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
161709531|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
161709532|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709533|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
161709534|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709535|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709536|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
161709537|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
161709538|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
161709539|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
161709540|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
161709541|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
161709542|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
161709543|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
161709544|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709545|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709546|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709547|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709548|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
161709549|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709550|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709551|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709552|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709553|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709554|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
161709555|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161709556|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161709557|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709558|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161709559|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709560|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709561|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709562|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709563|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709564|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
161709565|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709566|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
161709567|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
161709568|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709569|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709570|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709571|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709572|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709573|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
161709574|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709575|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709576|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709577|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709578|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
161709579|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
161709580|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
161709581|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
161709582|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709583|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709584|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709585|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709586|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709587|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709588|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
161709589|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
161709590|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161837814|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Various|0|||
161837815|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
161709591|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709592|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161709593|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161709594|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
161709595|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
161709596|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
161709597|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
161709598|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
161709599|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161709600|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709601|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709602|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
161709603|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161709604|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161709605|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161709606|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709607|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709608|NCT05817045|583980229|FG000|Overall Study|Protocol Violation|0|||
161709609|NCT05817045|583980230|FG001|Overall Study|Protocol Violation|3|||
161709610|NCT05817045|583980229|FG000|Overall Study|Withdrawal by Subject|10|||
161709611|NCT05817045|583980230|FG001|Overall Study|Withdrawal by Subject|7|||
161709612|NCT05817045|583980229|FG000|Overall Study|Physician Decision|3|||
161709613|NCT05817045|583980230|FG001|Overall Study|Physician Decision|0|||
161709614|NCT05817045|583980229|FG000|Overall Study|Lost to Follow-up|0|||
161709615|NCT05817045|583980230|FG001|Overall Study|Lost to Follow-up|1|||
161709616|NCT05817045|583980229|FG000|Overall Study|Device Deficiency|1|||
161709617|NCT05817045|583980230|FG001|Overall Study|Device Deficiency|0|||
161709618|NCT05817045|583980229|FG000|Overall Study|System Error|1|||
161709619|NCT05817045|583980230|FG001|Overall Study|System Error|0|||
161709620|NCT01506141|583980231|FG000|Overall Study|Adverse Event|0|||
161709621|NCT01506141|583980232|FG001|Overall Study|Adverse Event|2|||
161709622|NCT01506141|583980231|FG000|Overall Study|Participation Terminated by Investigator|1|||
161709623|NCT01506141|583980232|FG001|Overall Study|Participation Terminated by Investigator|1|||
161709624|NCT01506141|583980231|FG000|Overall Study|Site Terminated by Sponsor|2|||
161709625|NCT01506141|583980232|FG001|Overall Study|Site Terminated by Sponsor|0|||
161709626|NCT01506141|583980231|FG000|Overall Study|Reason Not Specified|4|||
161709627|NCT01506141|583980232|FG001|Overall Study|Reason Not Specified|2|||
161709628|NCT04889209|583980233|FG000|All Cohorts Except 15E|Adverse Event|0|||
161709629|NCT04889209|583980234|FG001|All Cohorts Except 15E|Adverse Event|0|||
161709630|NCT04889209|583980235|FG002|All Cohorts Except 15E|Adverse Event|0|||
161709631|NCT04889209|583980236|FG003|All Cohorts Except 15E|Adverse Event|0|||
161709632|NCT04889209|583980237|FG004|All Cohorts Except 15E|Adverse Event|0|||
161709633|NCT04889209|583980238|FG005|All Cohorts Except 15E|Adverse Event|0|||
161709634|NCT04889209|583980239|FG006|All Cohorts Except 15E|Adverse Event|1|||
161709635|NCT04889209|583980240|FG007|All Cohorts Except 15E|Adverse Event|0|||
161709636|NCT04889209|583980241|FG008|All Cohorts Except 15E|Adverse Event|0|||
161709637|NCT04889209|583980242|FG009|All Cohorts Except 15E|Adverse Event|0|||
161709638|NCT04889209|583980243|FG010|All Cohorts Except 15E|Adverse Event|0|||
161709639|NCT04889209|583980244|FG011|All Cohorts Except 15E|Adverse Event|0|||
161709640|NCT04889209|583980245|FG012|All Cohorts Except 15E|Adverse Event|0|||
161709641|NCT04889209|583980246|FG013|All Cohorts Except 15E|Adverse Event|0|||
161709642|NCT04889209|583980247|FG014|All Cohorts Except 15E|Adverse Event|0|||
161709643|NCT04889209|583980248|FG015|All Cohorts Except 15E|Adverse Event|0|||
161709644|NCT04889209|583980249|FG016|All Cohorts Except 15E|Adverse Event|0|||
161709645|NCT04889209|583980250|FG017|All Cohorts Except 15E|Adverse Event|0|||
161709646|NCT04889209|583980233|FG000|All Cohorts Except 15E|Death|0|||
161709647|NCT04889209|583980234|FG001|All Cohorts Except 15E|Death|1|||
161709648|NCT04889209|583980235|FG002|All Cohorts Except 15E|Death|0|||
161709649|NCT04889209|583980236|FG003|All Cohorts Except 15E|Death|0|||
161709650|NCT04889209|583980237|FG004|All Cohorts Except 15E|Death|0|||
161709651|NCT04889209|583980238|FG005|All Cohorts Except 15E|Death|0|||
161709652|NCT04889209|583980239|FG006|All Cohorts Except 15E|Death|0|||
161837816|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
161709653|NCT04889209|583980240|FG007|All Cohorts Except 15E|Death|0|||
161709654|NCT04889209|583980241|FG008|All Cohorts Except 15E|Death|0|||
161709655|NCT04889209|583980242|FG009|All Cohorts Except 15E|Death|0|||
161709656|NCT04889209|583980243|FG010|All Cohorts Except 15E|Death|0|||
161709657|NCT04889209|583980244|FG011|All Cohorts Except 15E|Death|0|||
161709658|NCT04889209|583980245|FG012|All Cohorts Except 15E|Death|0|||
161709659|NCT04889209|583980246|FG013|All Cohorts Except 15E|Death|0|||
161709660|NCT04889209|583980247|FG014|All Cohorts Except 15E|Death|0|||
161709661|NCT04889209|583980248|FG015|All Cohorts Except 15E|Death|0|||
161709662|NCT04889209|583980249|FG016|All Cohorts Except 15E|Death|0|||
161709663|NCT04889209|583980250|FG017|All Cohorts Except 15E|Death|0|||
161709664|NCT04889209|583980233|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
161709665|NCT04889209|583980234|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
161709666|NCT04889209|583980235|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
161709667|NCT04889209|583980236|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
161709668|NCT04889209|583980237|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
161709669|NCT04889209|583980238|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
161709670|NCT04889209|583980239|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
161709671|NCT04889209|583980240|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
161709672|NCT04889209|583980241|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
161709673|NCT04889209|583980242|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
161709674|NCT04889209|583980243|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
161709675|NCT04889209|583980244|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
161709676|NCT04889209|583980245|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
161709677|NCT04889209|583980246|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
161709678|NCT04889209|583980247|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
161709679|NCT04889209|583980248|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
161709680|NCT04889209|583980249|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
161709681|NCT04889209|583980250|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
161709682|NCT04889209|583980233|FG000|All Cohorts Except 15E|Physician Decision|0|||
161709683|NCT04889209|583980234|FG001|All Cohorts Except 15E|Physician Decision|0|||
161709684|NCT04889209|583980235|FG002|All Cohorts Except 15E|Physician Decision|0|||
161709685|NCT04889209|583980236|FG003|All Cohorts Except 15E|Physician Decision|0|||
161709686|NCT04889209|583980237|FG004|All Cohorts Except 15E|Physician Decision|1|||
161709687|NCT04889209|583980238|FG005|All Cohorts Except 15E|Physician Decision|0|||
161709688|NCT04889209|583980239|FG006|All Cohorts Except 15E|Physician Decision|0|||
161709689|NCT04889209|583980240|FG007|All Cohorts Except 15E|Physician Decision|1|||
161837817|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
161837818|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
161709690|NCT04889209|583980241|FG008|All Cohorts Except 15E|Physician Decision|0|||
161709691|NCT04889209|583980242|FG009|All Cohorts Except 15E|Physician Decision|1|||
161709692|NCT04889209|583980243|FG010|All Cohorts Except 15E|Physician Decision|0|||
161709693|NCT04889209|583980244|FG011|All Cohorts Except 15E|Physician Decision|1|||
161709694|NCT04889209|583980245|FG012|All Cohorts Except 15E|Physician Decision|1|||
161709695|NCT04889209|583980246|FG013|All Cohorts Except 15E|Physician Decision|0|||
161709696|NCT04889209|583980247|FG014|All Cohorts Except 15E|Physician Decision|0|||
161709697|NCT04889209|583980248|FG015|All Cohorts Except 15E|Physician Decision|0|||
161709698|NCT04889209|583980249|FG016|All Cohorts Except 15E|Physician Decision|0|||
161709699|NCT04889209|583980250|FG017|All Cohorts Except 15E|Physician Decision|0|||
161709700|NCT04889209|583980233|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709701|NCT04889209|583980234|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709702|NCT04889209|583980235|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
161709703|NCT04889209|583980236|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
161709704|NCT04889209|583980237|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
161709705|NCT04889209|583980238|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
161837819|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
161837820|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
161837821|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
161837822|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
161837823|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
161709706|NCT04889209|583980239|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709707|NCT04889209|583980240|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709708|NCT04889209|583980241|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709709|NCT04889209|583980242|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709710|NCT04889209|583980243|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709711|NCT04889209|583980244|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709712|NCT04889209|583980245|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709713|NCT04889209|583980246|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
161709714|NCT04889209|583980247|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
161709715|NCT04889209|583980248|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709716|NCT04889209|583980249|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709717|NCT04889209|583980250|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
161709718|NCT04889209|583980233|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
161709719|NCT04889209|583980234|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
161709720|NCT04889209|583980235|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709721|NCT04889209|583980236|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709722|NCT04889209|583980237|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709723|NCT04889209|583980238|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709724|NCT04889209|583980239|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709725|NCT04889209|583980240|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709726|NCT04889209|583980241|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709727|NCT04889209|583980242|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709728|NCT04889209|583980243|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709729|NCT04889209|583980244|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709730|NCT04889209|583980245|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709731|NCT04889209|583980246|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709732|NCT04889209|583980247|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709733|NCT04889209|583980248|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709734|NCT04889209|583980249|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709735|NCT04889209|583980250|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709736|NCT04889209|583980233|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709737|NCT04889209|583980234|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709738|NCT04889209|583980235|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709739|NCT04889209|583980236|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
161709740|NCT04889209|583980237|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709741|NCT04889209|583980238|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709742|NCT04889209|583980239|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709743|NCT04889209|583980240|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709744|NCT04889209|583980241|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709745|NCT04889209|583980242|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709746|NCT04889209|583980243|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709747|NCT04889209|583980244|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709748|NCT04889209|583980245|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709749|NCT04889209|583980246|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709750|NCT04889209|583980247|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709751|NCT04889209|583980248|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709752|NCT04889209|583980249|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709753|NCT04889209|583980250|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709754|NCT04889209|583980233|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709755|NCT04889209|583980234|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709756|NCT04889209|583980235|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709757|NCT04889209|583980236|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709758|NCT04889209|583980237|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709759|NCT04889209|583980238|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709760|NCT04889209|583980239|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709761|NCT04889209|583980240|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709762|NCT04889209|583980241|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709763|NCT04889209|583980242|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709764|NCT04889209|583980243|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709765|NCT04889209|583980244|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709766|NCT04889209|583980245|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709767|NCT04889209|583980246|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709768|NCT04889209|583980247|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709769|NCT04889209|583980248|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709770|NCT04889209|583980249|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709771|NCT04889209|583980250|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709772|NCT04889209|583980233|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709773|NCT04889209|583980234|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709774|NCT04889209|583980235|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709775|NCT04889209|583980236|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709776|NCT04889209|583980237|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709777|NCT04889209|583980238|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709778|NCT04889209|583980239|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709779|NCT04889209|583980240|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709780|NCT04889209|583980241|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709781|NCT04889209|583980242|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709782|NCT04889209|583980243|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709783|NCT04889209|583980244|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709784|NCT04889209|583980245|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709785|NCT04889209|583980246|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709786|NCT04889209|583980247|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709787|NCT04889209|583980248|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709788|NCT04889209|583980249|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709789|NCT04889209|583980250|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
161709790|NCT04889209|583980233|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709791|NCT04889209|583980234|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709792|NCT04889209|583980235|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709793|NCT04889209|583980236|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709794|NCT04889209|583980237|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709795|NCT04889209|583980238|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709796|NCT04889209|583980239|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709797|NCT04889209|583980240|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709798|NCT04889209|583980241|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709799|NCT04889209|583980242|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709800|NCT04889209|583980243|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709801|NCT04889209|583980244|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709802|NCT04889209|583980245|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709803|NCT04889209|583980246|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709804|NCT04889209|583980247|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709805|NCT04889209|583980248|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709806|NCT04889209|583980249|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709807|NCT04889209|583980250|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
161709808|NCT04889209|583980233|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709809|NCT04889209|583980234|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709810|NCT04889209|583980235|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709811|NCT04889209|583980236|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709812|NCT04889209|583980237|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709813|NCT04889209|583980238|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709814|NCT04889209|583980239|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709815|NCT04889209|583980240|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709816|NCT04889209|583980241|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709817|NCT04889209|583980242|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709818|NCT04889209|583980243|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709819|NCT04889209|583980244|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709820|NCT04889209|583980245|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709821|NCT04889209|583980246|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709822|NCT04889209|583980247|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
161709823|NCT04889209|583980248|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709824|NCT04889209|583980249|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709825|NCT04889209|583980250|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709826|NCT04607408|583980251|FG000|Overall Study|Lost to Follow-up|0|||
161709827|NCT04607408|583980252|FG001|Overall Study|Lost to Follow-up|0|||
161709828|NCT04607408|583980253|FG002|Overall Study|Lost to Follow-up|0|||
161709829|NCT04607408|583980254|FG003|Overall Study|Lost to Follow-up|1|||
161709830|NCT04607408|583980255|FG004|Overall Study|Lost to Follow-up|0|||
161709831|NCT04607408|583980251|FG000|Overall Study|Withdrawal by Subject|0|||
161709832|NCT04607408|583980252|FG001|Overall Study|Withdrawal by Subject|1|||
161709833|NCT04607408|583980253|FG002|Overall Study|Withdrawal by Subject|0|||
161709834|NCT04607408|583980254|FG003|Overall Study|Withdrawal by Subject|1|||
161837824|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
161837825|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
161709835|NCT04607408|583980255|FG004|Overall Study|Withdrawal by Subject|0|||
161709836|NCT03619213|583980262|FG000|Overall Study|Lost to Follow-up|2|||
161709837|NCT03619213|583980263|FG001|Overall Study|Lost to Follow-up|1|||
161709838|NCT03619213|583980262|FG000|Overall Study|Withdrawal by Subject|8|||
161709839|NCT03619213|583980263|FG001|Overall Study|Withdrawal by Subject|10|||
161709840|NCT00382967|583980264|FG000|Overall Study|Protocol Violation|1|||
161709841|NCT00382967|583980265|FG001|Overall Study|Protocol Violation|1|||
161709842|NCT00501228|583980267|FG000|Overall Study|Withdrawal by Subject|1|||
161709843|NCT00461175|583980268|FG000|Overall Study|Protocol Violation|522|||
161709844|NCT00461175|583980269|FG001|Overall Study|Protocol Violation|365|||
161709845|NCT00316264|583980271|FG000|Overall Study|Lost to Follow-up|0|||
161709846|NCT00316264|583980272|FG001|Overall Study|Lost to Follow-up|1|||
161709847|NCT00316264|583980273|FG002|Overall Study|Lost to Follow-up|0|||
161709848|NCT00316264|583980271|FG000|Overall Study|Withdrawal of Consent|3|||
161709849|NCT00316264|583980272|FG001|Overall Study|Withdrawal of Consent|5|||
161709850|NCT00316264|583980273|FG002|Overall Study|Withdrawal of Consent|6|||
161709851|NCT00316264|583980271|FG000|Overall Study|Death|2|||
161709852|NCT00316264|583980272|FG001|Overall Study|Death|0|||
161709853|NCT00316264|583980273|FG002|Overall Study|Death|0|||
161709854|NCT00316264|583980271|FG000|Overall Study|Other|1|||
161709855|NCT00316264|583980272|FG001|Overall Study|Other|1|||
161709856|NCT00316264|583980273|FG002|Overall Study|Other|0|||
161709857|NCT02209506|583980276|FG000|Overall Study|Withdrawal by Subject|0|||
161709858|NCT02209506|583980277|FG001|Overall Study|Withdrawal by Subject|0|||
161709859|NCT02209506|583980278|FG002|Overall Study|Withdrawal by Subject|0|||
161709860|NCT02209506|583980279|FG003|Overall Study|Withdrawal by Subject|0|||
161709861|NCT02209506|583980280|FG004|Overall Study|Withdrawal by Subject|1|||
161709862|NCT01587989|583980281|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
161709863|NCT01587989|583980282|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
161709864|NCT01587989|583980283|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
161709865|NCT01587989|583980281|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
161709866|NCT01587989|583980282|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
161709867|NCT01587989|583980283|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
161709868|NCT01587989|583980281|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
161709869|NCT01587989|583980282|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
161709870|NCT01587989|583980283|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
161709871|NCT01587989|583980281|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
161709872|NCT01587989|583980282|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
161709873|NCT01587989|583980283|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
161709874|NCT01587989|583980281|FG000|Randomized Study Treatment|Screening failure|0|||
161709875|NCT01587989|583980282|FG001|Randomized Study Treatment|Screening failure|1|||
161709876|NCT01587989|583980283|FG002|Randomized Study Treatment|Screening failure|0|||
161709877|NCT01587989|583980281|FG000|Randomized Study Treatment|Physician Decision|0|||
161709878|NCT01587989|583980282|FG001|Randomized Study Treatment|Physician Decision|0|||
161709879|NCT01587989|583980283|FG002|Randomized Study Treatment|Physician Decision|1|||
161709880|NCT03313050|583980284|FG000|Stage 2: 12 Months|Adverse Event|0|||
161709881|NCT03313050|583980285|FG001|Stage 2: 12 Months|Adverse Event|0|||
161709882|NCT03313050|583980286|FG002|Stage 2: 12 Months|Adverse Event|0|||
161709883|NCT03313050|583980287|FG003|Stage 2: 12 Months|Adverse Event|1|||
161709884|NCT03313050|583980284|FG000|Stage 2: 12 Months|Death|0|||
161709885|NCT03313050|583980285|FG001|Stage 2: 12 Months|Death|0|||
161709886|NCT03313050|583980286|FG002|Stage 2: 12 Months|Death|3|||
161709887|NCT03313050|583980287|FG003|Stage 2: 12 Months|Death|0|||
161709888|NCT03313050|583980284|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
161709889|NCT03313050|583980285|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
161709890|NCT03313050|583980286|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
161709891|NCT03313050|583980287|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
161709892|NCT03313050|583980284|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161709893|NCT03313050|583980285|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161709894|NCT03313050|583980286|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161709895|NCT03313050|583980287|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
161709896|NCT03313050|583980284|FG000|Stage 2: 12 Months|Protocol deviation|0|||
161709897|NCT03313050|583980285|FG001|Stage 2: 12 Months|Protocol deviation|0|||
161709898|NCT03313050|583980286|FG002|Stage 2: 12 Months|Protocol deviation|7|||
161709899|NCT03313050|583980287|FG003|Stage 2: 12 Months|Protocol deviation|7|||
161709900|NCT03313050|583980284|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
161709901|NCT03313050|583980285|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
161709902|NCT03313050|583980286|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
161709903|NCT03313050|583980287|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
161709904|NCT03313050|583980284|FG000|Stage 2: 12 Months|Other|0|||
161709905|NCT03313050|583980285|FG001|Stage 2: 12 Months|Other|0|||
161709906|NCT03313050|583980286|FG002|Stage 2: 12 Months|Other|0|||
161709907|NCT03313050|583980287|FG003|Stage 2: 12 Months|Other|1|||
161709908|NCT04211337|583980288|FG000|Overall Study|On Treatment|175|||
161709909|NCT04211337|583980289|FG001|Overall Study|On Treatment|40|||
161709910|NCT04211337|583980288|FG000|Overall Study|Withdrawal by Subject|0|||
161709911|NCT04211337|583980289|FG001|Overall Study|Withdrawal by Subject|2|||
161709912|NCT01291017|583980290|FG000|Overall Study|Lost to Follow-up|2|||
161709913|NCT01291017|583980290|FG000|Overall Study|Withdrawal by Subject|3|||
161709914|NCT05630846|583982306|FG000|Overall Study|Death|1|||
161709915|NCT05630846|583982307|FG001|Overall Study|Death|0|||
161709916|NCT05630846|583982308|FG002|Overall Study|Death|0|||
161709917|NCT05630846|583982309|FG003|Overall Study|Death|0|||
161709918|NCT05630846|583982306|FG000|Overall Study|Withdrawal by Subject|3|||
161709919|NCT05630846|583982307|FG001|Overall Study|Withdrawal by Subject|3|||
161709920|NCT05630846|583982308|FG002|Overall Study|Withdrawal by Subject|4|||
161709921|NCT05630846|583982309|FG003|Overall Study|Withdrawal by Subject|1|||
161709922|NCT05630846|583982306|FG000|Overall Study|Lost to Follow-up|6|||
161709923|NCT05630846|583982307|FG001|Overall Study|Lost to Follow-up|5|||
161709924|NCT05630846|583982308|FG002|Overall Study|Lost to Follow-up|2|||
161709925|NCT05630846|583982309|FG003|Overall Study|Lost to Follow-up|5|||
161709926|NCT05630846|583982306|FG000|Overall Study|Other|1|||
161709927|NCT05630846|583982307|FG001|Overall Study|Other|0|||
161709928|NCT05630846|583982308|FG002|Overall Study|Other|0|||
161709929|NCT05630846|583982309|FG003|Overall Study|Other|0|||
161709930|NCT01431287|583982310|FG000|Overall Study|not treated|0|||
161709931|NCT01431287|583982311|FG001|Overall Study|not treated|0|||
161709932|NCT01431287|583982312|FG002|Overall Study|not treated|1|||
161709933|NCT01431287|583982313|FG003|Overall Study|not treated|0|||
161709934|NCT01431287|583982314|FG004|Overall Study|not treated|0|||
161709935|NCT01431287|583982310|FG000|Overall Study|Adverse Event|59|||
161709936|NCT01431287|583982311|FG001|Overall Study|Adverse Event|57|||
161709937|NCT01431287|583982312|FG002|Overall Study|Adverse Event|53|||
161709938|NCT01431287|583982313|FG003|Overall Study|Adverse Event|33|||
161709939|NCT01431287|583982314|FG004|Overall Study|Adverse Event|41|||
161709940|NCT01431287|583982310|FG000|Overall Study|Non compliant with protocol|6|||
161709941|NCT01431287|583982311|FG001|Overall Study|Non compliant with protocol|6|||
161709942|NCT01431287|583982312|FG002|Overall Study|Non compliant with protocol|5|||
161709943|NCT01431287|583982313|FG003|Overall Study|Non compliant with protocol|6|||
161709944|NCT01431287|583982314|FG004|Overall Study|Non compliant with protocol|5|||
161709945|NCT01431287|583982310|FG000|Overall Study|Lost to Follow-up|0|||
161709946|NCT01431287|583982311|FG001|Overall Study|Lost to Follow-up|3|||
161709947|NCT01431287|583982312|FG002|Overall Study|Lost to Follow-up|2|||
161709948|NCT01431287|583982313|FG003|Overall Study|Lost to Follow-up|3|||
161709949|NCT01431287|583982314|FG004|Overall Study|Lost to Follow-up|1|||
161709950|NCT01431287|583982310|FG000|Overall Study|Consent withdrawn not due to AE|29|||
161709951|NCT01431287|583982311|FG001|Overall Study|Consent withdrawn not due to AE|30|||
161709952|NCT01431287|583982312|FG002|Overall Study|Consent withdrawn not due to AE|34|||
161709953|NCT01431287|583982313|FG003|Overall Study|Consent withdrawn not due to AE|19|||
161709954|NCT01431287|583982314|FG004|Overall Study|Consent withdrawn not due to AE|29|||
161709955|NCT01431287|583982310|FG000|Overall Study|not stated above|4|||
161709956|NCT01431287|583982311|FG001|Overall Study|not stated above|2|||
161709957|NCT01431287|583982312|FG002|Overall Study|not stated above|2|||
161709958|NCT01431287|583982313|FG003|Overall Study|not stated above|2|||
161709959|NCT01431287|583982314|FG004|Overall Study|not stated above|1|||
161709960|NCT03019549|583982315|FG000|Washout|DId not meet genotype criteria|11|||
161709961|NCT03019549|583982315|FG000|Period 2|Adverse Event|2|||
161709962|NCT03019549|583982315|FG000|Period 2|Physician Decision|2|||
161709963|NCT03019549|583982315|FG000|Period 2|Withdrawal by Subject|1|||
161709964|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
161709965|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
161709966|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
161709967|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
161709968|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
161709969|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
161709970|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
161709971|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
161709972|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
161709973|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
161709974|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
161709975|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
161709976|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
161709977|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
161709978|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
161709979|NCT04030195|583982319|FG000|Overall Study|Withdrawal by Subject|2|||
161709980|NCT04030195|583982320|FG001|Overall Study|Withdrawal by Subject|0|||
161709981|NCT04030195|583982321|FG002|Overall Study|Withdrawal by Subject|0|||
161709982|NCT01056107|583982323|FG000|Overall Study|Withdrawal by Subject|0|||
161709983|NCT01056107|583982324|FG001|Overall Study|Withdrawal by Subject|1|||
161709984|NCT01056107|583982325|FG002|Overall Study|Withdrawal by Subject|3|||
161709985|NCT01056107|583982326|FG003|Overall Study|Withdrawal by Subject|0|||
161709986|NCT00603239|583982336|FG000|Overall Study|Adverse Event|4|||
161709987|NCT00603239|583982337|FG001|Overall Study|Adverse Event|1|||
161709988|NCT00603239|583982336|FG000|Overall Study|Entry criteria not met|0|||
161709989|NCT00603239|583982337|FG001|Overall Study|Entry criteria not met|1|||
161709990|NCT00603239|583982336|FG000|Overall Study|Loss of glucose control|3|||
161709991|NCT00603239|583982337|FG001|Overall Study|Loss of glucose control|0|||
161709992|NCT00603239|583982336|FG000|Overall Study|Lost to Follow-up|2|||
161709993|NCT00603239|583982337|FG001|Overall Study|Lost to Follow-up|1|||
161709994|NCT00603239|583982336|FG000|Overall Study|Physician Decision|2|||
161709995|NCT00603239|583982337|FG001|Overall Study|Physician Decision|0|||
161709996|NCT00603239|583982336|FG000|Overall Study|Protocol Violation|2|||
161709997|NCT00603239|583982337|FG001|Overall Study|Protocol Violation|0|||
161709998|NCT00603239|583982336|FG000|Overall Study|Subject decision|2|||
161709999|NCT00603239|583982337|FG001|Overall Study|Subject decision|1|||
161710000|NCT02210780|583982338|FG000|Overall Study|Adverse Event|0|||
161710001|NCT02210780|583982339|FG001|Overall Study|Adverse Event|5|||
161710002|NCT02210780|583982338|FG000|Overall Study|Lost to Follow-up|2|||
161710003|NCT02210780|583982339|FG001|Overall Study|Lost to Follow-up|1|||
161710004|NCT02210780|583982338|FG000|Overall Study|Withdrawal by Subject|1|||
161710005|NCT02210780|583982339|FG001|Overall Study|Withdrawal by Subject|1|||
161710006|NCT02210780|583982338|FG000|Overall Study|Physician Decision|1|||
161710007|NCT02210780|583982339|FG001|Overall Study|Physician Decision|0|||
161710008|NCT02210780|583982338|FG000|Overall Study|Protocol Violation|1|||
161710009|NCT02210780|583982339|FG001|Overall Study|Protocol Violation|0|||
161710010|NCT02210780|583982338|FG000|Overall Study|Other than specified above|0|||
161710011|NCT02210780|583982339|FG001|Overall Study|Other than specified above|1|||
161710012|NCT00097539|583982340|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
161710013|NCT00097539|583982341|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
161710014|NCT00097539|583982342|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
161710015|NCT00097539|583982343|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
161710016|NCT00097539|583982344|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
161710017|NCT00097539|583982345|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
161710018|NCT00097539|583982346|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
161710019|NCT00097539|583982340|FG000|Overall Study|Withdrawal by Subject|925|||
161710020|NCT00097539|583982341|FG001|Overall Study|Withdrawal by Subject|323|||
161710021|NCT00097539|583982342|FG002|Overall Study|Withdrawal by Subject|346|||
161710022|NCT00097539|583982343|FG003|Overall Study|Withdrawal by Subject|217|||
161710023|NCT00097539|583982344|FG004|Overall Study|Withdrawal by Subject|68|||
161710024|NCT00097539|583982345|FG005|Overall Study|Withdrawal by Subject|229|||
161710025|NCT00097539|583982346|FG006|Overall Study|Withdrawal by Subject|3|||
161710026|NCT00097539|583982340|FG000|Overall Study|Participant Non-compliant|2140|||
161710027|NCT00097539|583982341|FG001|Overall Study|Participant Non-compliant|567|||
161710028|NCT00097539|583982342|FG002|Overall Study|Participant Non-compliant|1067|||
161710029|NCT00097539|583982343|FG003|Overall Study|Participant Non-compliant|353|||
161710030|NCT00097539|583982344|FG004|Overall Study|Participant Non-compliant|136|||
161710031|NCT00097539|583982345|FG005|Overall Study|Participant Non-compliant|543|||
161710032|NCT00097539|583982346|FG006|Overall Study|Participant Non-compliant|18|||
161710033|NCT00097539|583982340|FG000|Overall Study|Lack of Efficacy|249|||
161710034|NCT00097539|583982341|FG001|Overall Study|Lack of Efficacy|122|||
161710035|NCT00097539|583982342|FG002|Overall Study|Lack of Efficacy|202|||
161710036|NCT00097539|583982343|FG003|Overall Study|Lack of Efficacy|105|||
161655777|NCT00403767|583790535|FG001|Overall Study|Non-compliant with study medication|164|||
161655778|NCT00403767|583790534|FG000|Overall Study|Consent withdrawn|671|||
161655779|NCT00403767|583790535|FG001|Overall Study|Consent withdrawn|673|||
161655780|NCT00403767|583790534|FG000|Overall Study|Investigator dec./not protocol-related|191|||
161655781|NCT00403767|583790535|FG001|Overall Study|Investigator dec./not protocol-related|178|||
161655782|NCT00403767|583790534|FG000|Overall Study|Lost to Follow-up|6|||
161655783|NCT00403767|583790535|FG001|Overall Study|Lost to Follow-up|8|||
161655784|NCT00403767|583790534|FG000|Overall Study|Protocol Violation|142|||
161655785|NCT00403767|583790535|FG001|Overall Study|Protocol Violation|124|||
161655786|NCT00403767|583790534|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
161655787|NCT00403767|583790535|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
161655788|NCT00403767|583790534|FG000|Overall Study|Study terminated by sponsor|82|||
161655789|NCT00403767|583790535|FG001|Overall Study|Study terminated by sponsor|69|||
161655790|NCT00403767|583790534|FG000|Overall Study|Missing/incomplete data|1|||
161655791|NCT00403767|583790535|FG001|Overall Study|Missing/incomplete data|1|||
161655792|NCT02755818|583790536|FG000|Overall Study|Withdrawal by Subject|0|||
161655793|NCT02755818|583790537|FG001|Overall Study|Withdrawal by Subject|0|||
161655794|NCT02755818|583790538|FG002|Overall Study|Withdrawal by Subject|0|||
161655795|NCT02755818|583790539|FG003|Overall Study|Withdrawal by Subject|2|||
161655796|NCT02755818|583790536|FG000|Overall Study|withdrawal by PI|0|||
161655797|NCT02755818|583790537|FG001|Overall Study|withdrawal by PI|0|||
161655798|NCT02755818|583790538|FG002|Overall Study|withdrawal by PI|1|||
161655799|NCT02755818|583790539|FG003|Overall Study|withdrawal by PI|1|||
161655800|NCT03014011|583790540|FG000|First Intervention|Withdrawal by Subject|1|||
161655801|NCT03014011|583790541|FG001|First Intervention|Withdrawal by Subject|0|||
161655802|NCT03014011|583790540|FG000|Washout|Withdrawal by Subject|1|||
161655803|NCT03014011|583790541|FG001|Washout|Withdrawal by Subject|0|||
161655804|NCT03223662|583790552|FG000|Overall Study|Physician Decision|1|||
161655805|NCT03223662|583790552|FG000|Overall Study|Study closure|1|||
161655806|NCT01280357|583790553|FG000|Overall Study|Excluded no internal monitoring|14|||
161655807|NCT01280357|583790553|FG000|Overall Study|IInsufficient data/No data supplied|12|||
161655808|NCT03284203|583790554|FG000|Overall Study|Lost to Follow-up|3|||
161655809|NCT02229851|583790555|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
161655810|NCT02229851|583790556|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
161655811|NCT02229851|583790557|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
161655812|NCT02229851|583790558|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
161655813|NCT02229851|583790559|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
161655814|NCT02229851|583790560|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
161655815|NCT02229851|583790561|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
161655816|NCT02229851|583790555|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161655817|NCT02229851|583790556|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
161655818|NCT02229851|583790557|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161655819|NCT02229851|583790558|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161655820|NCT02229851|583790559|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161655821|NCT02229851|583790560|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161655822|NCT02229851|583790561|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161655823|NCT02229851|583790555|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
161655824|NCT02229851|583790556|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
161655825|NCT02229851|583790557|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
161655826|NCT02229851|583790558|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161655827|NCT02229851|583790559|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161655828|NCT02229851|583790560|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161655829|NCT02229851|583790561|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161655830|NCT02229851|583790555|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161655831|NCT02229851|583790556|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161655832|NCT02229851|583790557|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
161655833|NCT02229851|583790558|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161710037|NCT00097539|583982344|FG004|Overall Study|Lack of Efficacy|45|||
161655834|NCT02229851|583790559|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161655835|NCT02229851|583790560|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161655836|NCT02229851|583790561|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161655837|NCT02229851|583790555|FG000|Main Phase (Double-blind Phase)|Death|1|||
161710038|NCT00097539|583982345|FG005|Overall Study|Lack of Efficacy|228|||
161655838|NCT02229851|583790556|FG001|Main Phase (Double-blind Phase)|Death|1|||
161655839|NCT02229851|583790557|FG002|Main Phase (Double-blind Phase)|Death|0|||
161655840|NCT02229851|583790558|FG003|Main Phase (Double-blind Phase)|Death|0|||
161655841|NCT02229851|583790559|FG004|Main Phase (Double-blind Phase)|Death|0|||
161655842|NCT02229851|583790560|FG005|Main Phase (Double-blind Phase)|Death|0|||
161710039|NCT00097539|583982346|FG006|Overall Study|Lack of Efficacy|5|||
161655843|NCT02229851|583790561|FG006|Main Phase (Double-blind Phase)|Death|0|||
161655844|NCT02229851|583790555|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161655845|NCT02229851|583790556|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161655846|NCT02229851|583790557|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161655847|NCT02229851|583790558|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161655848|NCT02229851|583790559|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
161655849|NCT02229851|583790560|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
161655850|NCT02229851|583790561|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
161655851|NCT02229851|583790555|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
161655852|NCT02229851|583790556|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
161655853|NCT02229851|583790557|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
161655854|NCT02229851|583790558|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
161655855|NCT02229851|583790559|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
161655856|NCT02229851|583790560|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
161655857|NCT02229851|583790561|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
161655858|NCT02229851|583790555|FG000|Extension Phase (Open-label Phase)|Death|0|||
161655859|NCT02229851|583790556|FG001|Extension Phase (Open-label Phase)|Death|0|||
161655860|NCT02229851|583790557|FG002|Extension Phase (Open-label Phase)|Death|0|||
161655861|NCT02229851|583790558|FG003|Extension Phase (Open-label Phase)|Death|1|||
161655862|NCT02229851|583790559|FG004|Extension Phase (Open-label Phase)|Death|0|||
161655863|NCT02229851|583790560|FG005|Extension Phase (Open-label Phase)|Death|1|||
161655864|NCT02229851|583790561|FG006|Extension Phase (Open-label Phase)|Death|1|||
161655865|NCT00528931|583790562|FG000|Overall Study|Lost to Follow-up|1|||
161655866|NCT00992225|583790565|FG000|Overall Study|Entry Criteria Not Met|8|||
161655867|NCT00992225|583790565|FG000|Overall Study|Adverse Event|2|||
161655868|NCT03122223|583790566|FG000|Overall Study|Withdrawal by Subject|2|||
161655869|NCT03122223|583790567|FG001|Overall Study|Withdrawal by Subject|2|||
161655870|NCT03122223|583790568|FG002|Overall Study|Withdrawal by Subject|1|||
161655871|NCT03122223|583790569|FG003|Overall Study|Withdrawal by Subject|0|||
161655872|NCT03122223|583790566|FG000|Overall Study|Lost to Follow-up|0|||
161837826|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
161837827|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
161837828|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
161655873|NCT03122223|583790567|FG001|Overall Study|Lost to Follow-up|2|||
161655874|NCT03122223|583790568|FG002|Overall Study|Lost to Follow-up|2|||
161655875|NCT03122223|583790569|FG003|Overall Study|Lost to Follow-up|0|||
161655876|NCT03122223|583790566|FG000|Overall Study|Participant unable to adhere|1|||
161655877|NCT03122223|583790567|FG001|Overall Study|Participant unable to adhere|1|||
161655878|NCT03122223|583790568|FG002|Overall Study|Participant unable to adhere|1|||
161655879|NCT03122223|583790569|FG003|Overall Study|Participant unable to adhere|0|||
161655880|NCT03466073|583790570|FG000|Overall Study|Death|1|||
161655881|NCT03466073|583790571|FG001|Overall Study|Death|0|||
161655882|NCT03466073|583790572|FG002|Overall Study|Death|0|||
161655883|NCT03466073|583790573|FG003|Overall Study|Death|0|||
161655884|NCT03466073|583790574|FG004|Overall Study|Death|0|||
161655885|NCT03466073|583790575|FG005|Overall Study|Death|1|||
161655886|NCT03682302|583790576|FG000|Overall Study|Lost to Follow-up|1|||
161655887|NCT03682302|583790577|FG001|Overall Study|Lost to Follow-up|2|||
161655888|NCT03682302|583790578|FG002|Overall Study|Lost to Follow-up|0|||
161655889|NCT03682302|583790579|FG003|Overall Study|Lost to Follow-up|1|||
161655890|NCT03682302|583790576|FG000|Overall Study|Study drug was not administered|0|||
161655891|NCT03682302|583790577|FG001|Overall Study|Study drug was not administered|0|||
161655892|NCT03682302|583790578|FG002|Overall Study|Study drug was not administered|1|||
161655893|NCT03682302|583790579|FG003|Overall Study|Study drug was not administered|1|||
161655894|NCT01489891|583790582|FG000|Overall Study|Endoscopy failure|1|||
161655895|NCT01489891|583790583|FG001|Overall Study|Endoscopy failure|0|||
161655896|NCT00532493|583790584|FG000|Overall Study|Death|1|||
161655897|NCT00532493|583790585|FG001|Overall Study|Death|1|||
161655898|NCT00532493|583790584|FG000|Overall Study|Lost to Follow-up|10|||
161655899|NCT00532493|583790585|FG001|Overall Study|Lost to Follow-up|7|||
161655900|NCT00532493|583790584|FG000|Overall Study|Withdrawal by Subject|7|||
161655901|NCT00532493|583790585|FG001|Overall Study|Withdrawal by Subject|9|||
161655902|NCT00532493|583790584|FG000|Overall Study|Physician Decision|1|||
161655903|NCT00532493|583790585|FG001|Overall Study|Physician Decision|6|||
161655904|NCT00532493|583790584|FG000|Overall Study|Adverse Event|6|||
161655905|NCT00532493|583790585|FG001|Overall Study|Adverse Event|5|||
161655906|NCT00532493|583790584|FG000|Overall Study|Protocol Deviation|1|||
161655907|NCT00532493|583790585|FG001|Overall Study|Protocol Deviation|0|||
161655908|NCT00532493|583790584|FG000|Overall Study|Subject Moved Away|3|||
161655909|NCT00532493|583790585|FG001|Overall Study|Subject Moved Away|1|||
161655910|NCT00532493|583790584|FG000|Overall Study|Contraindicative Medication|1|||
161655911|NCT00532493|583790585|FG001|Overall Study|Contraindicative Medication|0|||
161655912|NCT02045875|583790589|FG000|Overall Study|Lost to Follow-up|3|||
161655913|NCT02045875|583790590|FG001|Overall Study|Lost to Follow-up|0|||
161655914|NCT02045875|583790589|FG000|Overall Study|Withdrawal by Subject|4|||
161655915|NCT02045875|583790590|FG001|Overall Study|Withdrawal by Subject|3|||
161655916|NCT03459443|583790593|FG000|Overall Study|Lack of Efficacy|3|||
161655917|NCT03459443|583790593|FG000|Overall Study|Adverse Event|1|||
161655918|NCT03459443|583790593|FG000|Overall Study|Sponsor's decision to close the study|18|||
161655919|NCT02153073|583790594|FG000|Overall Study|Case Report Forms Uncollected|230|||
161655920|NCT02153073|583790594|FG000|Overall Study|Protocol Deviation|68|||
161655921|NCT03189745|583790595|FG000|Overall Study|Conflict in work schedule of participant|1|||
161655922|NCT03189745|583790596|FG001|Overall Study|Conflict in work schedule of participant|1|||
161655923|NCT03702231|583790597|FG000|Overall Study|Withdrawal by Subject|1|||
161655924|NCT03702231|583790598|FG001|Overall Study|Withdrawal by Subject|0|||
161655925|NCT03702231|583790599|FG002|Overall Study|Withdrawal by Subject|0|||
161655926|NCT03702231|583790597|FG000|Overall Study|Protocol Violation|0|||
161655927|NCT03702231|583790598|FG001|Overall Study|Protocol Violation|0|||
161655928|NCT03702231|583790599|FG002|Overall Study|Protocol Violation|1|||
161655929|NCT03702231|583790597|FG000|Overall Study|Change in CLL Treatment|0|||
161655930|NCT03702231|583790598|FG001|Overall Study|Change in CLL Treatment|0|||
161655931|NCT03702231|583790599|FG002|Overall Study|Change in CLL Treatment|1|||
161655932|NCT03702231|583790597|FG000|Overall Study|COVID Pandemic|1|||
161655933|NCT03702231|583790598|FG001|Overall Study|COVID Pandemic|4|||
161655934|NCT03702231|583790599|FG002|Overall Study|COVID Pandemic|1|||
161655935|NCT03702231|583790597|FG000|Overall Study|Non-compliance|0|||
161655936|NCT03702231|583790598|FG001|Overall Study|Non-compliance|0|||
161655937|NCT03702231|583790599|FG002|Overall Study|Non-compliance|1|||
161655938|NCT01276379|583790600|FG000|Overall Study|Screening failure|40|||
161655939|NCT01278173|583790601|FG000|Overall Study|Lack of Efficacy|13|||
161655940|NCT01278173|583790601|FG000|Overall Study|Adverse Event|8|||
161655941|NCT01278173|583790601|FG000|Overall Study|Administrative or other reason|4|||
161655942|NCT01278173|583790601|FG000|Overall Study|Protocol Violation|1|||
161655943|NCT01278173|583790601|FG000|Overall Study|Withdrawal by Subject|1|||
161655944|NCT04445987|583790604|FG000|Overall Study|Adverse Event|0|||
161655945|NCT04445987|583790605|FG001|Overall Study|Adverse Event|0|||
161655946|NCT04445987|583790606|FG002|Overall Study|Adverse Event|1|||
161655947|NCT04445987|583790607|FG003|Overall Study|Adverse Event|0|||
161655948|NCT04445987|583790608|FG004|Overall Study|Adverse Event|4|||
161655949|NCT04445987|583790609|FG005|Overall Study|Adverse Event|0|||
161655950|NCT04445987|583790604|FG000|Overall Study|Lost to Follow-up|4|||
161655951|NCT04445987|583790605|FG001|Overall Study|Lost to Follow-up|3|||
161655952|NCT04445987|583790606|FG002|Overall Study|Lost to Follow-up|1|||
161655953|NCT04445987|583790607|FG003|Overall Study|Lost to Follow-up|1|||
161655954|NCT04445987|583790608|FG004|Overall Study|Lost to Follow-up|29|||
161655955|NCT04445987|583790609|FG005|Overall Study|Lost to Follow-up|0|||
161837829|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Various|4|||
161655956|NCT04445987|583790604|FG000|Overall Study|Physician Decision|0|||
161655957|NCT04445987|583790605|FG001|Overall Study|Physician Decision|0|||
161655958|NCT04445987|583790606|FG002|Overall Study|Physician Decision|0|||
161655959|NCT04445987|583790607|FG003|Overall Study|Physician Decision|0|||
161655960|NCT04445987|583790608|FG004|Overall Study|Physician Decision|1|||
161655961|NCT04445987|583790609|FG005|Overall Study|Physician Decision|0|||
161655962|NCT04445987|583790604|FG000|Overall Study|Protocol Violation|1|||
161655963|NCT04445987|583790605|FG001|Overall Study|Protocol Violation|0|||
161655964|NCT04445987|583790606|FG002|Overall Study|Protocol Violation|0|||
161655965|NCT04445987|583790607|FG003|Overall Study|Protocol Violation|0|||
161655966|NCT04445987|583790608|FG004|Overall Study|Protocol Violation|2|||
161655967|NCT04445987|583790609|FG005|Overall Study|Protocol Violation|0|||
161655968|NCT04445987|583790604|FG000|Overall Study|Withdrawal by Subject|4|||
161655969|NCT04445987|583790605|FG001|Overall Study|Withdrawal by Subject|0|||
161655970|NCT04445987|583790606|FG002|Overall Study|Withdrawal by Subject|1|||
161655971|NCT04445987|583790607|FG003|Overall Study|Withdrawal by Subject|0|||
161655972|NCT04445987|583790608|FG004|Overall Study|Withdrawal by Subject|18|||
161655973|NCT04445987|583790609|FG005|Overall Study|Withdrawal by Subject|1|||
161655974|NCT04445987|583790604|FG000|Overall Study|Other reason|0|||
161655975|NCT04445987|583790605|FG001|Overall Study|Other reason|0|||
161655976|NCT04445987|583790606|FG002|Overall Study|Other reason|1|||
161655977|NCT04445987|583790607|FG003|Overall Study|Other reason|0|||
161655978|NCT04445987|583790608|FG004|Overall Study|Other reason|2|||
161655979|NCT04445987|583790609|FG005|Overall Study|Other reason|0|||
161655980|NCT01133418|583790610|FG000|Overall Study|Lost to Follow-up|5|||
161655981|NCT01133418|583790611|FG001|Overall Study|Lost to Follow-up|6|||
161655982|NCT04150068|583790617|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
161655983|NCT04150068|583790618|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
161655984|NCT04150068|583790619|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
161655985|NCT04150068|583790617|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
161655986|NCT04150068|583790618|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
161655987|NCT04150068|583790619|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
161655988|NCT05316701|583790620|FG000|Overall Study|Adverse Event|0|||
161655989|NCT05316701|583790621|FG001|Overall Study|Adverse Event|1|||
161655990|NCT05316701|583790620|FG000|Overall Study|Death|3|||
161655991|NCT05316701|583790621|FG001|Overall Study|Death|9|||
161655992|NCT05316701|583790620|FG000|Overall Study|Lost to Follow-up|1|||
161655993|NCT05316701|583790621|FG001|Overall Study|Lost to Follow-up|0|||
161655994|NCT05316701|583790620|FG000|Overall Study|Physician Decision|1|||
161655995|NCT05316701|583790621|FG001|Overall Study|Physician Decision|4|||
161655996|NCT05316701|583790620|FG000|Overall Study|Withdrawal by Subject|3|||
161655997|NCT05316701|583790621|FG001|Overall Study|Withdrawal by Subject|5|||
161655998|NCT05316701|583790620|FG000|Overall Study|Progression/Relapse|14|||
161655999|NCT05316701|583790621|FG001|Overall Study|Progression/Relapse|9|||
161656000|NCT05316701|583790620|FG000|Overall Study|Received Standard of Care|1|||
161656001|NCT05316701|583790621|FG001|Overall Study|Received Standard of Care|0|||
161656002|NCT05316701|583790620|FG000|Overall Study|Ongoing|70|||
161656003|NCT05316701|583790621|FG001|Overall Study|Ongoing|64|||
161656004|NCT01946529|583790622|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
161656005|NCT01946529|583790623|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
161656006|NCT01946529|583790624|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
161656007|NCT01946529|583790622|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
161656008|NCT01946529|583790623|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
161656009|NCT01946529|583790624|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
161656010|NCT04679935|583790625|FG000|Overall Study|Death|0|||
161656011|NCT04679935|583790626|FG001|Overall Study|Death|1|||
161656012|NCT02980731|583791730|FG000|Overall Study|Death|63|||
161656013|NCT02980731|583791730|FG000|Overall Study|Withdrawal by Subject|6|||
161656014|NCT02980731|583791730|FG000|Overall Study|Lost to Follow-up|5|||
161656015|NCT02980731|583791730|FG000|Overall Study|Study terminated by Sponsor|4|||
161656016|NCT02980731|583791730|FG000|Overall Study|Completed survival follow-up period|65|||
161656017|NCT02980731|583791730|FG000|Overall Study|COVID-19 infection|1|||
161656018|NCT02980731|583791730|FG000|Overall Study|Other, not specified|66|||
161656019|NCT03037931|583791731|FG000|Overall Study|Death|354|||
161656020|NCT03037931|583791732|FG001|Overall Study|Death|367|||
161656021|NCT03037931|583791731|FG000|Overall Study|Lost to Follow-up|7|||
161656022|NCT03037931|583791732|FG001|Overall Study|Lost to Follow-up|4|||
161837830|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Various|0|||
161656023|NCT03037931|583791731|FG000|Overall Study|Withdrawal by Subject|48|||
161656024|NCT03037931|583791732|FG001|Overall Study|Withdrawal by Subject|41|||
161656025|NCT02075476|583791733|FG000|Overall Study|Death|2|||
161837831|NCT01959035|584450214|FG000|Overall Study|Adverse Event|5|||
161656026|NCT02075476|583791734|FG001|Overall Study|Death|2|||
161656027|NCT02075476|583791733|FG000|Overall Study|Lost to Follow-up|1|||
161656028|NCT02075476|583791734|FG001|Overall Study|Lost to Follow-up|3|||
161656029|NCT01850446|583791735|FG000|Overall Study|Lack of Efficacy|1|||
161656030|NCT01850446|583791736|FG001|Overall Study|Lack of Efficacy|0|||
161656031|NCT01850446|583791735|FG000|Overall Study|Withdrawal by Subject|4|||
161656032|NCT01850446|583791736|FG001|Overall Study|Withdrawal by Subject|0|||
161656033|NCT01850446|583791735|FG000|Overall Study|Protocol Violation|0|||
161656034|NCT01850446|583791736|FG001|Overall Study|Protocol Violation|2|||
161656035|NCT00591721|583791737|FG000|Overall Study|Withdrawal by Subject|10|||
161656036|NCT00591721|583791738|FG001|Overall Study|Withdrawal by Subject|10|||
161656037|NCT00591721|583791737|FG000|Overall Study|Lost to Follow-up|1|||
161656038|NCT00591721|583791738|FG001|Overall Study|Lost to Follow-up|4|||
161656039|NCT00591721|583791737|FG000|Overall Study|Intervention not received|10|||
161656040|NCT00591721|583791738|FG001|Overall Study|Intervention not received|8|||
161656041|NCT03527550|583791745|FG000|Overall Study|Lost to Follow-up|4|||
161656042|NCT03527550|583791746|FG001|Overall Study|Lost to Follow-up|2|||
161656043|NCT03527550|583791745|FG000|Overall Study|Withdrawal by Subject|4|||
161656044|NCT03527550|583791746|FG001|Overall Study|Withdrawal by Subject|1|||
161656045|NCT03527550|583791745|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
161656046|NCT03527550|583791746|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
161656047|NCT03053518|583791748|FG000|Overall Study|Withdrawal by Subject|3|||
161656048|NCT03053518|583791748|FG000|Overall Study|Lost to Follow-up|2|||
161656049|NCT03053518|583791748|FG000|Overall Study|Ineligible|5|||
161656050|NCT02683876|583791749|FG000|Overall Study|samples damaged during shipping|2|||
161656051|NCT02683876|583791750|FG001|Overall Study|samples damaged during shipping|0|||
161656052|NCT01232738|583791751|FG000|Overall Study|Death|3|||
161656053|NCT01232738|583791751|FG000|Overall Study|Physician Decision|2|||
161656054|NCT01232738|583791751|FG000|Overall Study|Lost to Follow-up|1|||
161656055|NCT01232738|583791751|FG000|Overall Study|Withdrawal by Subject|2|||
161656056|NCT01232738|583791751|FG000|Overall Study|Adverse Event|5|||
161656057|NCT00859222|583791756|FG000|Overall Study|Adverse Event|2|||
161656058|NCT00859222|583791757|FG001|Overall Study|Adverse Event|3|||
161656059|NCT00859222|583791758|FG002|Overall Study|Adverse Event|6|||
161656060|NCT00859222|583791759|FG003|Overall Study|Adverse Event|24|||
161656061|NCT00859222|583791760|FG004|Overall Study|Adverse Event|15|||
161656062|NCT00859222|583791756|FG000|Overall Study|DLT|1|||
161656063|NCT00859222|583791757|FG001|Overall Study|DLT|0|||
161656064|NCT00859222|583791758|FG002|Overall Study|DLT|0|||
161656065|NCT00859222|583791759|FG003|Overall Study|DLT|0|||
161656066|NCT00859222|583791760|FG004|Overall Study|DLT|0|||
161656067|NCT00488475|583791761|FG000|Overall Study|Other|1754|||
161656068|NCT00400725|583791772|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
161656069|NCT00400725|583791773|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
161656070|NCT00400725|583791774|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
161656071|NCT00400725|583791772|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
161656072|NCT00400725|583791773|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
161656073|NCT00400725|583791774|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
161656074|NCT00400725|583791772|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
161656075|NCT00400725|583791773|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
161656076|NCT00400725|583791774|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
161656077|NCT00400725|583791772|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
161656078|NCT00400725|583791773|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
161656079|NCT00400725|583791774|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
161656080|NCT00400725|583791772|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
161656081|NCT00400725|583791773|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
161656082|NCT00400725|583791774|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
161656083|NCT00400725|583791772|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
161656084|NCT00400725|583791773|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
161656085|NCT00400725|583791774|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
161656086|NCT00400725|583791772|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
161656087|NCT00400725|583791773|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
161656088|NCT00400725|583791774|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
161656089|NCT00400725|583791772|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
161656090|NCT00400725|583791773|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
161656091|NCT00400725|583791774|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
161656092|NCT00400725|583791772|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
161656093|NCT00400725|583791773|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
161656094|NCT00400725|583791774|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
161656095|NCT02797080|583791778|FG000|Overall Study|Lost to Follow-up|1|||
161656096|NCT02797080|583791778|FG000|Overall Study|Withdrawal by Subject|1|||
161656097|NCT00744757|583791781|FG000|Overall Study|Objective disease progression|7|||
161656098|NCT00744757|583791781|FG000|Overall Study|Physician Decision|5|||
161656099|NCT00744757|583791781|FG000|Overall Study|Withdrawal by Subject|1|||
161656100|NCT00744757|583791781|FG000|Overall Study|Death|6|||
161656101|NCT00744757|583791781|FG000|Overall Study|Adverse Event|2|||
161710040|NCT00097539|583982340|FG000|Overall Study|Adverse Event|78|||
161656102|NCT01712659|583791782|FG000|Dose Escalation|Physician Decision|0|||
161656103|NCT01712659|583791783|FG001|Dose Escalation|Physician Decision|1|||
161656104|NCT01712659|583791784|FG002|Dose Escalation|Physician Decision|0|||
161656105|NCT01712659|583791785|FG003|Dose Escalation|Physician Decision|0|||
161656106|NCT01712659|583791786|FG004|Dose Escalation|Physician Decision|0|||
161656107|NCT01712659|583791782|FG000|Dose Escalation|Unable to take study drug|0|||
161656108|NCT01712659|583791783|FG001|Dose Escalation|Unable to take study drug|1|||
161656109|NCT01712659|583791784|FG002|Dose Escalation|Unable to take study drug|0|||
161656110|NCT01712659|583791785|FG003|Dose Escalation|Unable to take study drug|0|||
161656111|NCT01712659|583791786|FG004|Dose Escalation|Unable to take study drug|0|||
161656112|NCT01712659|583791782|FG000|Dose Expansion|Early disease progression|1|||
161656113|NCT01712659|583791783|FG001|Dose Expansion|Early disease progression|0|||
161656114|NCT01712659|583791784|FG002|Dose Expansion|Early disease progression|0|||
161656115|NCT01712659|583791785|FG003|Dose Expansion|Early disease progression|0|||
161656116|NCT01712659|583791786|FG004|Dose Expansion|Early disease progression|0|||
161656117|NCT01712659|583791782|FG000|Dose Expansion|Physician Decision|1|||
161656118|NCT01712659|583791783|FG001|Dose Expansion|Physician Decision|0|||
161656119|NCT01712659|583791784|FG002|Dose Expansion|Physician Decision|0|||
161656120|NCT01712659|583791785|FG003|Dose Expansion|Physician Decision|0|||
161656121|NCT01712659|583791786|FG004|Dose Expansion|Physician Decision|0|||
161656122|NCT00548262|583791787|FG000|Overall Study|Death|21|||
161656123|NCT00548262|583791787|FG000|Overall Study|Adverse Event|2|||
161656124|NCT00548262|583791787|FG000|Overall Study|Lack of Efficacy|4|||
161656125|NCT00548262|583791787|FG000|Overall Study|Lost to Follow-up|1|||
161656126|NCT00548262|583791787|FG000|Overall Study|Other|3|||
161656127|NCT00548262|583791787|FG000|Overall Study|Withdrawal by Subject|1|||
161656128|NCT02285153|583791788|FG000|Overall Study|Adverse Event|1|||
161656129|NCT02285153|583791789|FG001|Overall Study|Adverse Event|0|||
161656130|NCT00948766|583791790|FG000|Core Study|Adverse Event|73|||
161656131|NCT00948766|583791791|FG001|Core Study|Adverse Event|51|||
161656132|NCT00948766|583791790|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
161656133|NCT00948766|583791791|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
161656134|NCT00948766|583791790|FG000|Core Study|Patient Withdrew Consent|27|||
161656135|NCT00948766|583791791|FG001|Core Study|Patient Withdrew Consent|46|||
161656136|NCT00948766|583791790|FG000|Core Study|Lost to Follow-up|3|||
161656137|NCT00948766|583791791|FG001|Core Study|Lost to Follow-up|2|||
161656138|NCT00948766|583791790|FG000|Core Study|Administrative Problems|2|||
161656139|NCT00948766|583791791|FG001|Core Study|Administrative Problems|2|||
161656140|NCT00948766|583791790|FG000|Core Study|Death|1|||
161656141|NCT00948766|583791791|FG001|Core Study|Death|1|||
161656142|NCT00948766|583791790|FG000|Core Study|Protocol Deviation|8|||
161656143|NCT00948766|583791791|FG001|Core Study|Protocol Deviation|10|||
161656144|NCT00948766|583791790|FG000|Extension Study|Adverse Event|43|||
161656145|NCT00948766|583791791|FG001|Extension Study|Adverse Event|0|||
161656146|NCT00948766|583791790|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
161656147|NCT00948766|583791791|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
161656148|NCT00948766|583791790|FG000|Extension Study|Study Drug No Longer Required|1|||
161656149|NCT00948766|583791791|FG001|Extension Study|Study Drug No Longer Required|0|||
161656150|NCT00948766|583791790|FG000|Extension Study|Patient Withdrew Consent|32|||
161656151|NCT00948766|583791791|FG001|Extension Study|Patient Withdrew Consent|0|||
161656152|NCT00948766|583791790|FG000|Extension Study|Lost to Follow-up|8|||
161656153|NCT00948766|583791791|FG001|Extension Study|Lost to Follow-up|0|||
161656154|NCT00948766|583791790|FG000|Extension Study|Administrative Problems|1|||
161656155|NCT00948766|583791791|FG001|Extension Study|Administrative Problems|0|||
161656156|NCT00948766|583791790|FG000|Extension Study|Death|4|||
161656157|NCT00948766|583791791|FG001|Extension Study|Death|0|||
161656158|NCT01769326|583791795|FG000|Overall Study|Lost to Follow-up|1|||
161656159|NCT01769326|583791796|FG001|Overall Study|Lost to Follow-up|2|||
161656160|NCT01769326|583791797|FG002|Overall Study|Lost to Follow-up|0|||
161656161|NCT01769326|583791798|FG003|Overall Study|Lost to Follow-up|0|||
161656162|NCT01769326|583791795|FG000|Overall Study|unrelated injry|1|||
161656163|NCT01769326|583791796|FG001|Overall Study|unrelated injry|1|||
161656164|NCT01769326|583791797|FG002|Overall Study|unrelated injry|0|||
161656165|NCT01769326|583791798|FG003|Overall Study|unrelated injry|0|||
161656166|NCT01769326|583791795|FG000|Overall Study|got a job|0|||
161656167|NCT01769326|583791796|FG001|Overall Study|got a job|1|||
161656168|NCT01769326|583791797|FG002|Overall Study|got a job|0|||
161656169|NCT01769326|583791798|FG003|Overall Study|got a job|0|||
161656170|NCT01769326|583791795|FG000|Overall Study|Got sick and could not complete study|0|||
161656171|NCT01769326|583791796|FG001|Overall Study|Got sick and could not complete study|0|||
161656172|NCT01769326|583791797|FG002|Overall Study|Got sick and could not complete study|1|||
161656173|NCT01769326|583791798|FG003|Overall Study|Got sick and could not complete study|0|||
161656174|NCT01036438|583791799|FG000|Overall Study|Adverse Event|7|||
161656175|NCT01036438|583791800|FG001|Overall Study|Adverse Event|8|||
161656176|NCT01036438|583791799|FG000|Overall Study|Death|0|||
161656177|NCT01036438|583791800|FG001|Overall Study|Death|1|||
161656178|NCT01036438|583791799|FG000|Overall Study|No effect of study treatment|3|||
161656179|NCT01036438|583791800|FG001|Overall Study|No effect of study treatment|1|||
161656180|NCT00888927|583791801|FG000|Overall Study|Adverse Event|0|||
161656181|NCT00888927|583791802|FG001|Overall Study|Adverse Event|0|||
161656182|NCT00888927|583791803|FG002|Overall Study|Adverse Event|0|||
161656183|NCT00888927|583791804|FG003|Overall Study|Adverse Event|1|||
161656184|NCT00888927|583791801|FG000|Overall Study|Withdrawal of consent|0|||
161656185|NCT00888927|583791802|FG001|Overall Study|Withdrawal of consent|0|||
161656186|NCT00888927|583791803|FG002|Overall Study|Withdrawal of consent|0|||
161656187|NCT00888927|583791804|FG003|Overall Study|Withdrawal of consent|1|||
161656188|NCT02270515|583791805|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
161656189|NCT02270515|583791805|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
161656190|NCT02270515|583791805|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
161656191|NCT02270515|583791805|FG000|Intervention Period 1: 0-6 Months|Death|7|||
161656192|NCT02270515|583791805|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
161656193|NCT02270515|583791805|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
161656194|NCT02270515|583791805|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
161656195|NCT02270515|583791805|FG000|Intervention Period 2: 6-12 Months|Death|5|||
161656196|NCT02270515|583791805|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
161656197|NCT02270515|583791805|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
161656198|NCT02270515|583791805|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
161656199|NCT02270515|583791805|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
161656200|NCT02270515|583791805|FG000|Intervention Period 3: 12-18 Months|Death|3|||
161656201|NCT02270515|583791805|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
161656202|NCT01607476|583791807|FG000|Overall Study|Withdrawal by Subject|1|||
161656203|NCT01607476|583791808|FG001|Overall Study|Withdrawal by Subject|0|||
161656204|NCT01607476|583791809|FG002|Overall Study|Withdrawal by Subject|1|||
161656205|NCT01607476|583791807|FG000|Overall Study|Lost to Follow-up|0|||
161656206|NCT01607476|583791808|FG001|Overall Study|Lost to Follow-up|0|||
161656207|NCT01607476|583791809|FG002|Overall Study|Lost to Follow-up|2|||
161656208|NCT02091206|583791810|FG000|Treatment Period|Adverse Event|0|||
161656209|NCT02091206|583791811|FG001|Treatment Period|Adverse Event|1|||
161656210|NCT02091206|583791812|FG002|Treatment Period|Adverse Event|0|||
161656211|NCT02091206|583791813|FG003|Treatment Period|Adverse Event|0|||
161656212|NCT02091206|583791810|FG000|Treatment Period|Met withdrawal criteria|0|||
161656213|NCT02091206|583791811|FG001|Treatment Period|Met withdrawal criteria|0|||
161656214|NCT02091206|583791812|FG002|Treatment Period|Met withdrawal criteria|1|||
161656215|NCT02091206|583791813|FG003|Treatment Period|Met withdrawal criteria|0|||
161656216|NCT02091206|583791810|FG000|Taper Period|Participant refused study drug|1|||
161656217|NCT02091206|583791811|FG001|Taper Period|Participant refused study drug|0|||
161656218|NCT02091206|583791812|FG002|Taper Period|Participant refused study drug|0|||
161656219|NCT02091206|583791813|FG003|Taper Period|Participant refused study drug|1|||
161656220|NCT02091206|583791810|FG000|Taper Period|Lost to Follow-up|0|||
161656221|NCT02091206|583791811|FG001|Taper Period|Lost to Follow-up|0|||
161656222|NCT02091206|583791812|FG002|Taper Period|Lost to Follow-up|0|||
161656223|NCT02091206|583791813|FG003|Taper Period|Lost to Follow-up|1|||
161656224|NCT03772587|583791819|FG000|Overall Study|COVID-19|0|||
161656225|NCT03772587|583791820|FG001|Overall Study|COVID-19|0|||
161656226|NCT03772587|583791821|FG002|Overall Study|COVID-19|1|||
161656227|NCT03772587|583791822|FG003|Overall Study|COVID-19|1|||
161656228|NCT03772587|583791823|FG004|Overall Study|COVID-19|0|||
161656229|NCT03772587|583791819|FG000|Overall Study|Withdrawal by Subject|1|||
161656230|NCT03772587|583791820|FG001|Overall Study|Withdrawal by Subject|0|||
161656231|NCT03772587|583791821|FG002|Overall Study|Withdrawal by Subject|0|||
161656232|NCT03772587|583791822|FG003|Overall Study|Withdrawal by Subject|0|||
161656233|NCT03772587|583791823|FG004|Overall Study|Withdrawal by Subject|0|||
161656234|NCT02297139|583791824|FG000|Overall Study|Disease progression|0|||
161656235|NCT02297139|583791825|FG001|Overall Study|Disease progression|1|||
161656236|NCT02297139|583791824|FG000|Overall Study|Study drug toxicity|0|||
161656237|NCT02297139|583791825|FG001|Overall Study|Study drug toxicity|4|||
161656238|NCT02297139|583791824|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161656239|NCT02297139|583791825|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161656240|NCT02297139|583791824|FG000|Overall Study|Maximum clinical benefit|1|||
161656241|NCT02297139|583791825|FG001|Overall Study|Maximum clinical benefit|0|||
161656242|NCT02297139|583791824|FG000|Overall Study|Administrative reason by sponsor|0|||
161656243|NCT02297139|583791825|FG001|Overall Study|Administrative reason by sponsor|2|||
161656244|NCT02297139|583791824|FG000|Overall Study|Other reasons|0|||
161656245|NCT02297139|583791825|FG001|Overall Study|Other reasons|8|||
161656246|NCT05051462|583791831|FG000|Overall Study|Lost to Follow-up|1|||
161656247|NCT05051462|583791832|FG001|Overall Study|Lost to Follow-up|8|||
161656248|NCT05051462|583791831|FG000|Overall Study|Withdrawal by Subject|1|||
161656249|NCT05051462|583791832|FG001|Overall Study|Withdrawal by Subject|0|||
161656250|NCT05051462|583791831|FG000|Overall Study|Protocol Violation|0|||
161656251|NCT05051462|583791832|FG001|Overall Study|Protocol Violation|2|||
161656252|NCT02425904|583791833|FG000|Overall Study|Lost to Follow-up|1|||
161656253|NCT02425904|583791834|FG001|Overall Study|Lost to Follow-up|0|||
161656254|NCT02425904|583791833|FG000|Overall Study|Withdrawal by Subject|2|||
161656255|NCT02425904|583791834|FG001|Overall Study|Withdrawal by Subject|0|||
161656256|NCT02425904|583791833|FG000|Overall Study|Death|0|||
161656257|NCT02425904|583791834|FG001|Overall Study|Death|3|||
161656258|NCT05260021|583791835|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
161656259|NCT05260021|583791836|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
161656260|NCT05260021|583791837|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
161656261|NCT05260021|583791835|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
161656262|NCT05260021|583791836|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
161656263|NCT05260021|583791837|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
161656264|NCT05260021|583791835|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
161656265|NCT05260021|583791836|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
161656266|NCT05260021|583791837|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
161656267|NCT05260021|583791835|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
161656268|NCT05260021|583791836|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
161656269|NCT05260021|583791837|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
161656270|NCT05260021|583791835|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
161656271|NCT05260021|583791836|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
161656272|NCT05260021|583791837|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
161656273|NCT05597787|583791838|FG000|Overall Study|Withdrawal by Subject|0|||
161656274|NCT05597787|583791839|FG001|Overall Study|Withdrawal by Subject|0|||
161656275|NCT05597787|583791840|FG002|Overall Study|Withdrawal by Subject|1|||
161656276|NCT01144377|583791842|FG000|52 Week Treatment Period|Adverse Event|0|||
161656277|NCT01144377|583791843|FG001|52 Week Treatment Period|Adverse Event|0|||
161656278|NCT01144377|583791844|FG002|52 Week Treatment Period|Adverse Event|3|||
161656279|NCT01144377|583791845|FG003|52 Week Treatment Period|Adverse Event|2|||
161656280|NCT01144377|583791846|FG004|52 Week Treatment Period|Adverse Event|1|||
161656281|NCT01144377|583791842|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
161656282|NCT01144377|583791843|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
161656283|NCT01144377|583791844|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
161656284|NCT01144377|583791845|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
161656285|NCT01144377|583791846|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
161656286|NCT01144377|583791842|FG000|52 Week Treatment Period|Protocol Violation|0|||
161656287|NCT01144377|583791843|FG001|52 Week Treatment Period|Protocol Violation|0|||
161656288|NCT01144377|583791844|FG002|52 Week Treatment Period|Protocol Violation|0|||
161656289|NCT01144377|583791845|FG003|52 Week Treatment Period|Protocol Violation|0|||
161656290|NCT01144377|583791846|FG004|52 Week Treatment Period|Protocol Violation|1|||
161656291|NCT01144377|583791842|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
161656292|NCT01144377|583791843|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
161656293|NCT01144377|583791844|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
161656294|NCT01144377|583791845|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
161656295|NCT01144377|583791846|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
161656296|NCT01144377|583791842|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
161656297|NCT01144377|583791843|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
161656298|NCT01144377|583791844|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
161656299|NCT01144377|583791845|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
161656300|NCT01144377|583791846|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
161656301|NCT01144377|583791842|FG000|52 Week Treatment Period|Sponsor Decision|0|||
161656302|NCT01144377|583791843|FG001|52 Week Treatment Period|Sponsor Decision|0|||
161656303|NCT01144377|583791844|FG002|52 Week Treatment Period|Sponsor Decision|0|||
161656304|NCT01144377|583791845|FG003|52 Week Treatment Period|Sponsor Decision|0|||
161656305|NCT01144377|583791846|FG004|52 Week Treatment Period|Sponsor Decision|1|||
161656306|NCT01144377|583791842|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
161656307|NCT01144377|583791843|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
161656308|NCT01144377|583791844|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
161656309|NCT01144377|583791845|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
161710041|NCT00097539|583982341|FG001|Overall Study|Adverse Event|133|||
161656310|NCT01144377|583791846|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
161656311|NCT01144377|583791842|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161656312|NCT01144377|583791843|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161656313|NCT01144377|583791844|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161656314|NCT01144377|583791845|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161710042|NCT00097539|583982342|FG002|Overall Study|Adverse Event|37|||
161656315|NCT01144377|583791846|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
161656316|NCT01144377|583791842|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
161656317|NCT01144377|583791843|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161656318|NCT01144377|583791844|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161656319|NCT01144377|583791845|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161656320|NCT01144377|583791846|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161656321|NCT01241604|583791847|FG000|Screening Period|Screen Failure|3|||
161656322|NCT01241604|583791848|FG001|Screening Period|Screen Failure|0|||
161656323|NCT01241604|583791849|FG002|Screening Period|Screen Failure|0|||
161656324|NCT01214642|583791850|FG000|Overall Study|Progressive Disease|3|||
161656325|NCT01214642|583791851|FG001|Overall Study|Progressive Disease|2|||
161656326|NCT01214642|583791852|FG002|Overall Study|Progressive Disease|3|||
161656327|NCT01214642|583791853|FG003|Overall Study|Progressive Disease|5|||
161656328|NCT01214642|583791854|FG004|Overall Study|Progressive Disease|5|||
161656329|NCT01214642|583791855|FG005|Overall Study|Progressive Disease|3|||
161656330|NCT01214642|583791856|FG006|Overall Study|Progressive Disease|5|||
161656331|NCT01214642|583791857|FG007|Overall Study|Progressive Disease|3|||
161656332|NCT01214642|583791858|FG008|Overall Study|Progressive Disease|10|||
161656333|NCT01214642|583791859|FG009|Overall Study|Progressive Disease|2|||
161656334|NCT01214642|583791860|FG010|Overall Study|Progressive Disease|1|||
161656335|NCT01214642|583791861|FG011|Overall Study|Progressive Disease|4|||
161656336|NCT01214642|583791850|FG000|Overall Study|Adverse Event|0|||
161656337|NCT01214642|583791851|FG001|Overall Study|Adverse Event|1|||
161656338|NCT01214642|583791852|FG002|Overall Study|Adverse Event|0|||
161656339|NCT01214642|583791853|FG003|Overall Study|Adverse Event|0|||
161656340|NCT01214642|583791854|FG004|Overall Study|Adverse Event|0|||
161656341|NCT01214642|583791855|FG005|Overall Study|Adverse Event|0|||
161656342|NCT01214642|583791856|FG006|Overall Study|Adverse Event|1|||
161656343|NCT01214642|583791857|FG007|Overall Study|Adverse Event|0|||
161656344|NCT01214642|583791858|FG008|Overall Study|Adverse Event|0|||
161656345|NCT01214642|583791859|FG009|Overall Study|Adverse Event|1|||
161656346|NCT01214642|583791860|FG010|Overall Study|Adverse Event|1|||
161656347|NCT01214642|583791861|FG011|Overall Study|Adverse Event|0|||
161656348|NCT01214642|583791850|FG000|Overall Study|Death|0|||
161656349|NCT01214642|583791851|FG001|Overall Study|Death|0|||
161656350|NCT01214642|583791852|FG002|Overall Study|Death|1|||
161656351|NCT01214642|583791853|FG003|Overall Study|Death|0|||
161656352|NCT01214642|583791854|FG004|Overall Study|Death|0|||
161656353|NCT01214642|583791855|FG005|Overall Study|Death|0|||
161656354|NCT01214642|583791856|FG006|Overall Study|Death|0|||
161656355|NCT01214642|583791857|FG007|Overall Study|Death|0|||
161656356|NCT01214642|583791858|FG008|Overall Study|Death|0|||
161656357|NCT01214642|583791859|FG009|Overall Study|Death|0|||
161656358|NCT01214642|583791860|FG010|Overall Study|Death|1|||
161837832|NCT01959035|584450214|FG000|Overall Study|Withdrawal by Subject|4|||
161837833|NCT01959035|584450214|FG000|Overall Study|Lost to Follow-up|1|||
161837834|NCT01959035|584450214|FG000|Overall Study|Other (no primary reason given)|1|||
161837835|NCT03254602|584450215|FG000|Overall Study|Lost to Follow-up|4|||
161837836|NCT01691820|584450218|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
161837837|NCT01691820|584450219|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
161837838|NCT01691820|584450218|FG000|Overall Study|Migrated/moved from study area|7|||
161837839|NCT01691820|584450219|FG001|Overall Study|Migrated/moved from study area|4|||
161837840|NCT01691820|584450218|FG000|Overall Study|Lost to Follow-up|6|||
161837841|NCT01691820|584450219|FG001|Overall Study|Lost to Follow-up|17|||
161837842|NCT01691820|584450218|FG000|Overall Study|Other (unspecified)|4|||
161837843|NCT01691820|584450219|FG001|Overall Study|Other (unspecified)|1|||
161837844|NCT01968694|584450220|FG000|Washout (1 Month)|Lost to Follow-up|0|||
161837845|NCT01968694|584450221|FG001|Washout (1 Month)|Lost to Follow-up|1|||
161837846|NCT02836496|584450222|FG000|Overall Study|Adverse Event|2|||
161837847|NCT02836496|584450223|FG001|Overall Study|Adverse Event|1|||
161837848|NCT02836496|584450222|FG000|Overall Study|Withdrawal by Subject|0|||
161837849|NCT02836496|584450223|FG001|Overall Study|Withdrawal by Subject|1|||
161837850|NCT01400919|584450224|FG000|Overall Study|Withdrawal by Subject|4|||
161837851|NCT01400919|584450224|FG000|Overall Study|Lost to Follow-up|2|||
161656359|NCT01214642|583791861|FG011|Overall Study|Death|0|||
161656360|NCT01214642|583791850|FG000|Overall Study|Withdrawal by Subject|0|||
161656361|NCT01214642|583791851|FG001|Overall Study|Withdrawal by Subject|0|||
161656362|NCT01214642|583791852|FG002|Overall Study|Withdrawal by Subject|1|||
161656363|NCT01214642|583791853|FG003|Overall Study|Withdrawal by Subject|0|||
161656364|NCT01214642|583791854|FG004|Overall Study|Withdrawal by Subject|0|||
161656365|NCT01214642|583791855|FG005|Overall Study|Withdrawal by Subject|0|||
161656366|NCT01214642|583791856|FG006|Overall Study|Withdrawal by Subject|0|||
161656367|NCT01214642|583791857|FG007|Overall Study|Withdrawal by Subject|0|||
161656368|NCT01214642|583791858|FG008|Overall Study|Withdrawal by Subject|3|||
161656369|NCT01214642|583791859|FG009|Overall Study|Withdrawal by Subject|1|||
161656370|NCT01214642|583791860|FG010|Overall Study|Withdrawal by Subject|1|||
161837852|NCT01400919|584450224|FG000|Overall Study|Missed visit|2|||
161837853|NCT01246011|584450225|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
161656371|NCT01214642|583791861|FG011|Overall Study|Withdrawal by Subject|0|||
161656372|NCT01214642|583791850|FG000|Overall Study|Physician Decision|0|||
161656373|NCT01214642|583791851|FG001|Overall Study|Physician Decision|0|||
161656374|NCT01214642|583791852|FG002|Overall Study|Physician Decision|1|||
161656375|NCT01214642|583791853|FG003|Overall Study|Physician Decision|1|||
161656376|NCT01214642|583791854|FG004|Overall Study|Physician Decision|1|||
161656377|NCT01214642|583791855|FG005|Overall Study|Physician Decision|0|||
161656378|NCT01214642|583791856|FG006|Overall Study|Physician Decision|0|||
161656379|NCT01214642|583791857|FG007|Overall Study|Physician Decision|0|||
161656380|NCT01214642|583791858|FG008|Overall Study|Physician Decision|0|||
161656381|NCT01214642|583791859|FG009|Overall Study|Physician Decision|0|||
161656382|NCT01214642|583791860|FG010|Overall Study|Physician Decision|0|||
161656383|NCT01214642|583791861|FG011|Overall Study|Physician Decision|2|||
161656384|NCT01593787|583791862|FG000|Overall Study|Adverse Event|1|||
161656385|NCT01593787|583791863|FG001|Overall Study|Adverse Event|0|||
161656386|NCT01593787|583791864|FG002|Overall Study|Adverse Event|0|||
161656387|NCT02914275|583793696|FG000|Overall Study|Lost to Follow-up|84|||
161656388|NCT02914275|583793697|FG001|Overall Study|Lost to Follow-up|29|||
161656389|NCT02914275|583793696|FG000|Overall Study|Withdrawal by Subject|26|||
161656390|NCT02914275|583793697|FG001|Overall Study|Withdrawal by Subject|10|||
161656391|NCT02914275|583793696|FG000|Overall Study|Protocol Violation|1|||
161656392|NCT02914275|583793697|FG001|Overall Study|Protocol Violation|1|||
161656393|NCT02914275|583793696|FG000|Overall Study|Physician Decision|3|||
161656394|NCT02914275|583793697|FG001|Overall Study|Physician Decision|1|||
161656395|NCT02914275|583793696|FG000|Overall Study|Other|4|||
161656396|NCT02914275|583793697|FG001|Overall Study|Other|1|||
161656397|NCT02914275|583793696|FG000|Overall Study|Excluded due to invalid informed consent|3|||
161656398|NCT02914275|583793697|FG001|Overall Study|Excluded due to invalid informed consent|0|||
161656399|NCT02731690|583793698|FG000|Overall Study|Adverse Event|1|||
161656400|NCT02731690|583793698|FG000|Overall Study|Withdrawal by Subject|3|||
161656401|NCT02731690|583793698|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
161656402|NCT00872989|583793699|FG000|Overall Study|Adverse Event|7|||
161656403|NCT00872989|583793700|FG001|Overall Study|Adverse Event|15|||
161656404|NCT00872989|583793699|FG000|Overall Study|Withdrawal by Subject|8|||
161656405|NCT00872989|583793700|FG001|Overall Study|Withdrawal by Subject|5|||
161656406|NCT00872989|583793699|FG000|Overall Study|Progression/relapse|47|||
161656407|NCT00872989|583793700|FG001|Overall Study|Progression/relapse|35|||
161656408|NCT00872989|583793699|FG000|Overall Study|Not protocol specified|3|||
161656409|NCT00872989|583793700|FG001|Overall Study|Not protocol specified|8|||
161656410|NCT02407990|583793701|FG000|Overall Study|Death|2|||
161656411|NCT02407990|583793702|FG001|Overall Study|Death|22|||
161656412|NCT02407990|583793703|FG002|Overall Study|Death|23|||
161656413|NCT02407990|583793704|FG003|Overall Study|Death|7|||
161656414|NCT02407990|583793705|FG004|Overall Study|Death|17|||
161656415|NCT02407990|583793706|FG005|Overall Study|Death|16|||
161656416|NCT02407990|583793707|FG006|Overall Study|Death|10|||
161656417|NCT02407990|583793708|FG007|Overall Study|Death|248|||
161656418|NCT02407990|583793701|FG000|Overall Study|Lost to Follow-up|0|||
161656419|NCT02407990|583793702|FG001|Overall Study|Lost to Follow-up|1|||
161656420|NCT02407990|583793703|FG002|Overall Study|Lost to Follow-up|0|||
161656421|NCT02407990|583793704|FG003|Overall Study|Lost to Follow-up|0|||
161656422|NCT02407990|583793705|FG004|Overall Study|Lost to Follow-up|0|||
161656423|NCT02407990|583793706|FG005|Overall Study|Lost to Follow-up|0|||
161656424|NCT02407990|583793707|FG006|Overall Study|Lost to Follow-up|0|||
161656425|NCT02407990|583793708|FG007|Overall Study|Lost to Follow-up|17|||
161656426|NCT02407990|583793701|FG000|Overall Study|Progressive Disease|0|||
161656427|NCT02407990|583793702|FG001|Overall Study|Progressive Disease|0|||
161656428|NCT02407990|583793703|FG002|Overall Study|Progressive Disease|0|||
161656429|NCT02407990|583793704|FG003|Overall Study|Progressive Disease|0|||
161656430|NCT02407990|583793705|FG004|Overall Study|Progressive Disease|0|||
161656431|NCT02407990|583793706|FG005|Overall Study|Progressive Disease|0|||
161656432|NCT02407990|583793707|FG006|Overall Study|Progressive Disease|0|||
161656433|NCT02407990|583793708|FG007|Overall Study|Progressive Disease|1|||
161656434|NCT02407990|583793701|FG000|Overall Study|Withdrawal by Subject|0|||
161656435|NCT02407990|583793702|FG001|Overall Study|Withdrawal by Subject|0|||
161656436|NCT02407990|583793703|FG002|Overall Study|Withdrawal by Subject|0|||
161656437|NCT02407990|583793704|FG003|Overall Study|Withdrawal by Subject|0|||
161656438|NCT02407990|583793705|FG004|Overall Study|Withdrawal by Subject|1|||
161656439|NCT02407990|583793706|FG005|Overall Study|Withdrawal by Subject|0|||
161656440|NCT02407990|583793707|FG006|Overall Study|Withdrawal by Subject|0|||
161656441|NCT02407990|583793708|FG007|Overall Study|Withdrawal by Subject|30|||
161656442|NCT02407990|583793701|FG000|Overall Study|Study Terminated by Sponsor|1|||
161656443|NCT02407990|583793702|FG001|Overall Study|Study Terminated by Sponsor|3|||
161656444|NCT02407990|583793703|FG002|Overall Study|Study Terminated by Sponsor|3|||
161656445|NCT02407990|583793704|FG003|Overall Study|Study Terminated by Sponsor|0|||
161656446|NCT02407990|583793705|FG004|Overall Study|Study Terminated by Sponsor|3|||
161656447|NCT02407990|583793706|FG005|Overall Study|Study Terminated by Sponsor|4|||
161656448|NCT02407990|583793707|FG006|Overall Study|Study Terminated by Sponsor|3|||
161656449|NCT02407990|583793708|FG007|Overall Study|Study Terminated by Sponsor|37|||
161656450|NCT02407990|583793701|FG000|Overall Study|Logistics|0|||
161656451|NCT02407990|583793702|FG001|Overall Study|Logistics|0|||
161656452|NCT02407990|583793703|FG002|Overall Study|Logistics|0|||
161656453|NCT02407990|583793704|FG003|Overall Study|Logistics|0|||
161656454|NCT02407990|583793705|FG004|Overall Study|Logistics|0|||
161656455|NCT02407990|583793706|FG005|Overall Study|Logistics|0|||
161656456|NCT02407990|583793707|FG006|Overall Study|Logistics|0|||
161656457|NCT02407990|583793708|FG007|Overall Study|Logistics|1|||
161656458|NCT02407990|583793701|FG000|Overall Study|Rolled into long-term extension study|0|||
161656459|NCT02407990|583793702|FG001|Overall Study|Rolled into long-term extension study|0|||
161656460|NCT02407990|583793703|FG002|Overall Study|Rolled into long-term extension study|0|||
161656461|NCT02407990|583793704|FG003|Overall Study|Rolled into long-term extension study|0|||
161656462|NCT02407990|583793705|FG004|Overall Study|Rolled into long-term extension study|0|||
161656463|NCT02407990|583793706|FG005|Overall Study|Rolled into long-term extension study|0|||
161656464|NCT02407990|583793707|FG006|Overall Study|Rolled into long-term extension study|0|||
161656465|NCT02407990|583793708|FG007|Overall Study|Rolled into long-term extension study|1|||
161656466|NCT00923260|583793709|FG000|Overall Study|Lost to Follow-up|1|||
161656467|NCT00923260|583793710|FG001|Overall Study|Lost to Follow-up|1|||
161656468|NCT01238900|583793715|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
161656469|NCT01238900|583793715|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
161656470|NCT03241927|583793716|FG000|Overall Study|study terminated|1|||
161656471|NCT03241927|583793717|FG001|Overall Study|study terminated|0|||
161656472|NCT03573583|583793718|FG000|Overall Study|Lost to Follow-up|1|||
161656473|NCT03573583|583793719|FG001|Overall Study|Lost to Follow-up|0|||
161656474|NCT03573583|583793718|FG000|Overall Study|Withdrawal by Subject|1|||
161656475|NCT03573583|583793719|FG001|Overall Study|Withdrawal by Subject|1|||
161656476|NCT01198756|583793720|FG000|Overall Study|Adverse Event|0|||
161656477|NCT01198756|583793721|FG001|Overall Study|Adverse Event|0|||
161656478|NCT01198756|583793722|FG002|Overall Study|Adverse Event|0|||
161656479|NCT01198756|583793723|FG003|Overall Study|Adverse Event|1|||
161656480|NCT01198756|583793720|FG000|Overall Study|Protocol Violation|0|||
161656481|NCT01198756|583793721|FG001|Overall Study|Protocol Violation|0|||
161656482|NCT01198756|583793722|FG002|Overall Study|Protocol Violation|0|||
161656483|NCT01198756|583793723|FG003|Overall Study|Protocol Violation|2|||
161656484|NCT01198756|583793720|FG000|Overall Study|Withdrawal by Subject|9|||
161656485|NCT01198756|583793721|FG001|Overall Study|Withdrawal by Subject|4|||
161656486|NCT01198756|583793722|FG002|Overall Study|Withdrawal by Subject|7|||
161656487|NCT01198756|583793723|FG003|Overall Study|Withdrawal by Subject|5|||
161656488|NCT01198756|583793720|FG000|Overall Study|Lost to Follow-up|29|||
161656489|NCT01198756|583793721|FG001|Overall Study|Lost to Follow-up|36|||
161656490|NCT01198756|583793722|FG002|Overall Study|Lost to Follow-up|23|||
161656491|NCT01198756|583793723|FG003|Overall Study|Lost to Follow-up|18|||
161656492|NCT02915302|583793726|FG000|Overall Study|Adverse Event|3|||
161656493|NCT02915302|583793727|FG001|Overall Study|Adverse Event|0|||
161656494|NCT02915302|583793726|FG000|Overall Study|Protocol Violation|20|||
161656495|NCT02915302|583793727|FG001|Overall Study|Protocol Violation|27|||
161656496|NCT02915302|583793726|FG000|Overall Study|Lost to Follow-up|19|||
161656497|NCT02915302|583793727|FG001|Overall Study|Lost to Follow-up|22|||
161656498|NCT02915302|583793726|FG000|Overall Study|Withdrawal by Subject|22|||
161656499|NCT02915302|583793727|FG001|Overall Study|Withdrawal by Subject|29|||
161656500|NCT02915302|583793726|FG000|Overall Study|Other|1|||
161656501|NCT02915302|583793727|FG001|Overall Study|Other|0|||
161656502|NCT04343872|583793730|FG000|Overall Study|Lost to Follow-up|6|||
161656503|NCT04343872|583793731|FG001|Overall Study|Lost to Follow-up|3|||
161656504|NCT02134977|583793732|FG000|Overall Study|Protocol Deviation|102|||
161656505|NCT01119105|583793733|FG000|Overall Study|Withdrawal by Subject|1|||
161656506|NCT01119105|583793734|FG001|Overall Study|Withdrawal by Subject|1|||
161656507|NCT01119105|583793735|FG002|Overall Study|Withdrawal by Subject|1|||
161656508|NCT01119105|583793733|FG000|Overall Study|Lost to Follow-up|0|||
161656509|NCT01119105|583793734|FG001|Overall Study|Lost to Follow-up|2|||
161656510|NCT01119105|583793735|FG002|Overall Study|Lost to Follow-up|5|||
161656511|NCT01119105|583793733|FG000|Overall Study|Adverse Event|1|||
161656512|NCT01119105|583793734|FG001|Overall Study|Adverse Event|0|||
161656513|NCT01119105|583793735|FG002|Overall Study|Adverse Event|1|||
161656514|NCT01119105|583793733|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
161656515|NCT01119105|583793734|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
161656516|NCT01119105|583793735|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
161656517|NCT01119105|583793733|FG000|Overall Study|Other|1|||
161656518|NCT01119105|583793734|FG001|Overall Study|Other|1|||
161656519|NCT01119105|583793735|FG002|Overall Study|Other|0|||
161656520|NCT01639495|583793736|FG000|Overall Study|Lost to Follow-up|6|||
161656521|NCT01639495|583793736|FG000|Overall Study|Consented but didn't have study catheter|4|||
161656522|NCT01639495|583793736|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
161656523|NCT01639495|583793736|FG000|Overall Study|No radiofrequency energy applied|2|||
161656524|NCT03507777|583793737|FG000|Overall Study|Lost to Follow-up|5|||
161656525|NCT03507777|583793738|FG001|Overall Study|Lost to Follow-up|7|||
161656526|NCT03507777|583793737|FG000|Overall Study|Withdrawal by Subject|6|||
161656527|NCT03507777|583793738|FG001|Overall Study|Withdrawal by Subject|11|||
161656528|NCT03507777|583793737|FG000|Overall Study|Death|30|||
161656529|NCT03507777|583793738|FG001|Overall Study|Death|44|||
161656530|NCT03507777|583793737|FG000|Overall Study|Other Reasons|3|||
161656531|NCT03507777|583793738|FG001|Overall Study|Other Reasons|8|||
161656532|NCT02366468|583793740|FG000|Overall Study|Adverse Event|2|||
161656533|NCT02366468|583793741|FG001|Overall Study|Adverse Event|0|||
161656534|NCT02366468|583793740|FG000|Overall Study|Withdrawal by Subject|1|||
161656535|NCT02366468|583793741|FG001|Overall Study|Withdrawal by Subject|5|||
161656536|NCT02366468|583793740|FG000|Overall Study|Lost to Follow-up|2|||
161656537|NCT02366468|583793741|FG001|Overall Study|Lost to Follow-up|0|||
161656538|NCT02366468|583793740|FG000|Overall Study|Death|1|||
161656539|NCT02366468|583793741|FG001|Overall Study|Death|2|||
161656540|NCT02366468|583793740|FG000|Overall Study|Other|0|||
161656541|NCT02366468|583793741|FG001|Overall Study|Other|2|||
161656542|NCT00446043|583793742|FG000|Overall Study|Adverse Event|9|||
161656543|NCT00446043|583793742|FG000|Overall Study|Withdrawal by Subject|70|||
161656544|NCT00446043|583793742|FG000|Overall Study|Protocol Violation|2|||
161656545|NCT00446043|583793742|FG000|Overall Study|Lost to Follow-up|42|||
161656546|NCT00446043|583793742|FG000|Overall Study|Pregnancy|2|||
161656547|NCT05540717|583793745|FG000|Overall Study|Lost to Follow-up|2|||
161656548|NCT05540717|583793746|FG001|Overall Study|Lost to Follow-up|5|||
161656549|NCT05540717|583793745|FG000|Overall Study|Withdrawal by Subject|6|||
161656550|NCT05540717|583793746|FG001|Overall Study|Withdrawal by Subject|6|||
161656551|NCT05540717|583793745|FG000|Overall Study|Sponsor request|1|||
161656552|NCT05540717|583793746|FG001|Overall Study|Sponsor request|0|||
161656553|NCT05540717|583793745|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
161710043|NCT00097539|583982343|FG003|Overall Study|Adverse Event|27|||
161656554|NCT05540717|583793746|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
161656555|NCT05540717|583793745|FG000|Overall Study|Other|0|||
161656556|NCT05540717|583793746|FG001|Overall Study|Other|1|||
161656557|NCT01144052|583793747|FG000|Overall Study|Withdrawal by Subject|1|||
161656558|NCT01144052|583793748|FG001|Overall Study|Withdrawal by Subject|1|||
161656559|NCT03836716|583793752|FG000|Overall Study|Adverse Event|3|||
161656560|NCT03836716|583793752|FG000|Overall Study|Death|22|||
161656561|NCT03836716|583793752|FG000|Overall Study|Withdrawal by Subject|8|||
161656562|NCT03836716|583793752|FG000|Overall Study|Study terminated by sponsor|87|||
161656563|NCT01879722|583793753|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161656564|NCT01879722|583793754|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161656565|NCT01879722|583793755|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161656566|NCT01879722|583793756|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161656567|NCT01879722|583793757|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
161656568|NCT01879722|583793758|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
161656569|NCT01879722|583793759|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
161656570|NCT01879722|583793760|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
161656571|NCT01879722|583793761|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
161656572|NCT01879722|583793762|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
161656573|NCT01879722|583793753|FG000|Overall Study|Voluntary Withdrawal|0|||
161656574|NCT01879722|583793754|FG001|Overall Study|Voluntary Withdrawal|0|||
161656575|NCT01879722|583793755|FG002|Overall Study|Voluntary Withdrawal|0|||
161656576|NCT01879722|583793756|FG003|Overall Study|Voluntary Withdrawal|0|||
161656577|NCT01879722|583793757|FG004|Overall Study|Voluntary Withdrawal|0|||
161656578|NCT01879722|583793758|FG005|Overall Study|Voluntary Withdrawal|0|||
161656579|NCT01879722|583793759|FG006|Overall Study|Voluntary Withdrawal|0|||
161656580|NCT01879722|583793760|FG007|Overall Study|Voluntary Withdrawal|0|||
161656581|NCT01879722|583793761|FG008|Overall Study|Voluntary Withdrawal|1|||
161656582|NCT01879722|583793762|FG009|Overall Study|Voluntary Withdrawal|0|||
161656583|NCT01983254|583793763|FG000|Overall Study|Death|6|||
161656584|NCT01983254|583793764|FG001|Overall Study|Death|6|||
161656585|NCT01983254|583793763|FG000|Overall Study|Lost to Follow-up|17|||
161656586|NCT01983254|583793764|FG001|Overall Study|Lost to Follow-up|16|||
161656587|NCT01983254|583793763|FG000|Overall Study|too ill|11|||
161656588|NCT01983254|583793764|FG001|Overall Study|too ill|8|||
161656589|NCT00037830|583793765|FG000|Overall Study|Adverse Event|2|||
161656590|NCT00037830|583793766|FG001|Overall Study|Adverse Event|0|||
161656591|NCT00037830|583793767|FG002|Overall Study|Adverse Event|0|||
161656592|NCT00037830|583793765|FG000|Overall Study|Withdrawal by Subject|4|||
161656593|NCT00037830|583793766|FG001|Overall Study|Withdrawal by Subject|5|||
161656594|NCT00037830|583793767|FG002|Overall Study|Withdrawal by Subject|1|||
161656595|NCT00037830|583793765|FG000|Overall Study|Protocol Violation|2|||
161656596|NCT00037830|583793766|FG001|Overall Study|Protocol Violation|2|||
161656597|NCT00037830|583793767|FG002|Overall Study|Protocol Violation|0|||
161656598|NCT00037830|583793765|FG000|Overall Study|Unrelated Medical Problem|2|||
161656599|NCT00037830|583793766|FG001|Overall Study|Unrelated Medical Problem|0|||
161656600|NCT00037830|583793767|FG002|Overall Study|Unrelated Medical Problem|0|||
161656601|NCT00127205|583793768|FG000|Overall Study|Adverse Event|228|||
161656602|NCT00127205|583793769|FG001|Overall Study|Adverse Event|387|||
161656603|NCT00127205|583793770|FG002|Overall Study|Adverse Event|273|||
161656604|NCT00127205|583793768|FG000|Overall Study|Death|8|||
161656605|NCT00127205|583793769|FG001|Overall Study|Death|6|||
161656606|NCT00127205|583793770|FG002|Overall Study|Death|5|||
161656607|NCT00127205|583793768|FG000|Overall Study|Withdrawal by Subject|318|||
161656608|NCT00127205|583793769|FG001|Overall Study|Withdrawal by Subject|310|||
161656609|NCT00127205|583793770|FG002|Overall Study|Withdrawal by Subject|172|||
161656610|NCT00127205|583793768|FG000|Overall Study|Other-non protocol specified|142|||
161656611|NCT00127205|583793769|FG001|Overall Study|Other-non protocol specified|129|||
161656612|NCT00127205|583793770|FG002|Overall Study|Other-non protocol specified|77|||
161656613|NCT00127205|583793768|FG000|Overall Study|Data not reported|6|||
161656614|NCT00127205|583793769|FG001|Overall Study|Data not reported|10|||
161656615|NCT00127205|583793770|FG002|Overall Study|Data not reported|1|||
161656616|NCT00127205|583793768|FG000|Overall Study|Progression|127|||
161656617|NCT00127205|583793769|FG001|Overall Study|Progression|131|||
161656618|NCT00127205|583793770|FG002|Overall Study|Progression|84|||
161656619|NCT01327495|583793771|FG000|Overall Study|Adverse Event|2|||
161656620|NCT01327495|583793772|FG001|Overall Study|Adverse Event|1|||
161656621|NCT01327495|583793773|FG002|Overall Study|Adverse Event|1|||
161656622|NCT01327495|583793774|FG003|Overall Study|Adverse Event|0|||
161656623|NCT01327495|583793775|FG004|Overall Study|Adverse Event|0|||
161656624|NCT01327495|583793776|FG005|Overall Study|Adverse Event|2|||
161656625|NCT01327495|583793771|FG000|Overall Study|Withdrawal by Subject|0|||
161656626|NCT01327495|583793772|FG001|Overall Study|Withdrawal by Subject|1|||
161656627|NCT01327495|583793773|FG002|Overall Study|Withdrawal by Subject|1|||
161656628|NCT01327495|583793774|FG003|Overall Study|Withdrawal by Subject|0|||
161656629|NCT01327495|583793775|FG004|Overall Study|Withdrawal by Subject|1|||
161656630|NCT01327495|583793776|FG005|Overall Study|Withdrawal by Subject|0|||
161710044|NCT00097539|583982344|FG004|Overall Study|Adverse Event|30|||
161710045|NCT00097539|583982345|FG005|Overall Study|Adverse Event|59|||
161710046|NCT00097539|583982346|FG006|Overall Study|Adverse Event|1|||
161710047|NCT00097539|583982340|FG000|Overall Study|Death|2|||
161710048|NCT00097539|583982341|FG001|Overall Study|Death|7|||
161710049|NCT00097539|583982342|FG002|Overall Study|Death|0|||
161710050|NCT00097539|583982343|FG003|Overall Study|Death|0|||
161710051|NCT00097539|583982344|FG004|Overall Study|Death|1|||
161710052|NCT00097539|583982345|FG005|Overall Study|Death|3|||
161710053|NCT00097539|583982346|FG006|Overall Study|Death|0|||
161710054|NCT00097539|583982340|FG000|Overall Study|Reasons Other Than Above|3602|||
161710055|NCT00097539|583982341|FG001|Overall Study|Reasons Other Than Above|1382|||
161710056|NCT00097539|583982342|FG002|Overall Study|Reasons Other Than Above|1757|||
161710057|NCT00097539|583982343|FG003|Overall Study|Reasons Other Than Above|692|||
161710058|NCT00097539|583982344|FG004|Overall Study|Reasons Other Than Above|361|||
161710059|NCT00097539|583982345|FG005|Overall Study|Reasons Other Than Above|1244|||
161710060|NCT00097539|583982346|FG006|Overall Study|Reasons Other Than Above|34|||
161710061|NCT00097539|583982340|FG000|Overall Study|Reason not Specified|111|||
161710062|NCT00097539|583982341|FG001|Overall Study|Reason not Specified|49|||
161710063|NCT00097539|583982342|FG002|Overall Study|Reason not Specified|53|||
161710064|NCT00097539|583982343|FG003|Overall Study|Reason not Specified|21|||
161710065|NCT00097539|583982344|FG004|Overall Study|Reason not Specified|11|||
161710066|NCT00097539|583982345|FG005|Overall Study|Reason not Specified|40|||
161710067|NCT00097539|583982346|FG006|Overall Study|Reason not Specified|2|||
161710068|NCT00364793|583982347|FG000|Overall Study|Adverse Event|2|||
161710069|NCT00364793|583982348|FG001|Overall Study|Adverse Event|0|||
161710070|NCT00364793|583982349|FG002|Overall Study|Adverse Event|0|||
161710071|NCT00364793|583982350|FG003|Overall Study|Adverse Event|0|||
161656631|NCT01327495|583793771|FG000|Overall Study|Physician Decision|0|||
161656632|NCT01327495|583793772|FG001|Overall Study|Physician Decision|0|||
161656633|NCT01327495|583793773|FG002|Overall Study|Physician Decision|0|||
161656634|NCT01327495|583793774|FG003|Overall Study|Physician Decision|0|||
161656635|NCT01327495|583793775|FG004|Overall Study|Physician Decision|2|||
161656636|NCT01327495|583793776|FG005|Overall Study|Physician Decision|0|||
161656637|NCT03377699|583793780|FG000|Overall Study|Withdrawal by Subject|2|||
161656638|NCT03377699|583793781|FG001|Overall Study|Withdrawal by Subject|9|||
161656639|NCT03377699|583793780|FG000|Overall Study|Lost to Follow-up|1|||
161656640|NCT03377699|583793781|FG001|Overall Study|Lost to Follow-up|1|||
161656641|NCT03377699|583793780|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
161656642|NCT03377699|583793781|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
161656643|NCT03377699|583793780|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
161656644|NCT03377699|583793781|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
161656645|NCT03377699|583793780|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
161656646|NCT03377699|583793781|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
161656647|NCT03377699|583793780|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
161656648|NCT03377699|583793781|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
161656649|NCT02580305|583793782|FG000|Overall Study|Adverse Event|15|||
161656650|NCT02580305|583793783|FG001|Overall Study|Adverse Event|19|||
161656651|NCT02580305|583793784|FG002|Overall Study|Adverse Event|10|||
161656652|NCT02580305|583793782|FG000|Overall Study|Lack of Efficacy|5|||
161656653|NCT02580305|583793783|FG001|Overall Study|Lack of Efficacy|0|||
161656654|NCT02580305|583793784|FG002|Overall Study|Lack of Efficacy|2|||
161656655|NCT02580305|583793782|FG000|Overall Study|Protocol Violation|4|||
161656656|NCT02580305|583793783|FG001|Overall Study|Protocol Violation|9|||
161656657|NCT02580305|583793784|FG002|Overall Study|Protocol Violation|6|||
161656658|NCT02580305|583793782|FG000|Overall Study|Lost to Follow-up|4|||
161656659|NCT02580305|583793783|FG001|Overall Study|Lost to Follow-up|4|||
161656660|NCT02580305|583793784|FG002|Overall Study|Lost to Follow-up|2|||
161710072|NCT00364793|583982347|FG000|Overall Study|Death|1|||
161710073|NCT00364793|583982348|FG001|Overall Study|Death|0|||
161710074|NCT00364793|583982349|FG002|Overall Study|Death|1|||
161710075|NCT00364793|583982350|FG003|Overall Study|Death|0|||
161710076|NCT00364793|583982347|FG000|Overall Study|Lack of Efficacy|3|||
161710077|NCT00364793|583982348|FG001|Overall Study|Lack of Efficacy|3|||
161710078|NCT00364793|583982349|FG002|Overall Study|Lack of Efficacy|1|||
161710079|NCT00364793|583982350|FG003|Overall Study|Lack of Efficacy|1|||
161710080|NCT00364793|583982347|FG000|Overall Study|Lost to Follow-up|1|||
161710081|NCT00364793|583982348|FG001|Overall Study|Lost to Follow-up|0|||
161656661|NCT02580305|583793782|FG000|Overall Study|Withdrawal by Subject|11|||
161656662|NCT02580305|583793783|FG001|Overall Study|Withdrawal by Subject|9|||
161656663|NCT02580305|583793784|FG002|Overall Study|Withdrawal by Subject|7|||
161656664|NCT02580305|583793782|FG000|Overall Study|Randomized in error and never treated|4|||
161656665|NCT02580305|583793783|FG001|Overall Study|Randomized in error and never treated|8|||
161656666|NCT02580305|583793784|FG002|Overall Study|Randomized in error and never treated|5|||
161656667|NCT03582943|583793785|FG000|Allocated to Groups|Withdrawal by Subject|1|||
161656668|NCT03582943|583793786|FG001|Allocated to Groups|Withdrawal by Subject|1|||
161656669|NCT03582943|583793785|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
161656670|NCT03582943|583793786|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
161656671|NCT03582943|583793785|FG000|Analyzed|Protocol Violation|4|||
161656672|NCT03582943|583793786|FG001|Analyzed|Protocol Violation|1|||
161656673|NCT01631227|583793789|FG000|Overall Study|withdrawn consent|27|||
161656674|NCT01631227|583793790|FG001|Overall Study|withdrawn consent|21|||
161656675|NCT01631227|583793789|FG000|Overall Study|Adverse Event|1|||
161656676|NCT01631227|583793790|FG001|Overall Study|Adverse Event|0|||
161656677|NCT01631227|583793789|FG000|Overall Study|administrative|2|||
161656678|NCT01631227|583793790|FG001|Overall Study|administrative|1|||
161656679|NCT01153321|583793791|FG000|Overall Study|Development of study withdrawal criteria|0|||
161656680|NCT01153321|583793792|FG001|Overall Study|Development of study withdrawal criteria|1|||
161656681|NCT01153321|583793791|FG000|Overall Study|Withdrawal by Subject|0|||
161656682|NCT01153321|583793792|FG001|Overall Study|Withdrawal by Subject|1|||
161656683|NCT01153321|583793791|FG000|Overall Study|Adverse Event|1|||
161656684|NCT01153321|583793792|FG001|Overall Study|Adverse Event|1|||
161656685|NCT01177800|583793794|FG000|Overall Study|Adverse Event|9|||
161656686|NCT01177800|583793795|FG001|Overall Study|Adverse Event|3|||
161656687|NCT01177800|583793794|FG000|Overall Study|Protocol Violation|0|||
161656688|NCT01177800|583793795|FG001|Overall Study|Protocol Violation|1|||
161656689|NCT01177800|583793794|FG000|Overall Study|Physician Decision|1|||
161656690|NCT01177800|583793795|FG001|Overall Study|Physician Decision|0|||
161656691|NCT01177800|583793794|FG000|Overall Study|Withdrawal of informed consent|0|||
161656692|NCT01177800|583793795|FG001|Overall Study|Withdrawal of informed consent|1|||
161656693|NCT05560243|583793799|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
161656694|NCT05870228|583793801|FG000|Overall Study|Lost to Follow-up|2|||
161656695|NCT05870228|583793802|FG001|Overall Study|Lost to Follow-up|0|||
161656696|NCT05870228|583793801|FG000|Overall Study|Withdrawal by Subject|1|||
161656697|NCT05870228|583793802|FG001|Overall Study|Withdrawal by Subject|0|||
161656698|NCT03231800|583793804|FG000|Overall Study|Lost to Follow-up|0|||
161656699|NCT03231800|583793805|FG001|Overall Study|Lost to Follow-up|2|||
161656700|NCT03231800|583793804|FG000|Overall Study|Protocol Violation|1|||
161656701|NCT03231800|583793805|FG001|Overall Study|Protocol Violation|1|||
161656702|NCT03231800|583793804|FG000|Overall Study|reason not provided|2|||
161656703|NCT03231800|583793805|FG001|Overall Study|reason not provided|0|||
161656704|NCT03500159|583793810|FG000|Overall Study|Study Terminated|2|||
161656705|NCT03500159|583793811|FG001|Overall Study|Study Terminated|1|||
161656706|NCT04075994|583793814|FG000|Overall Study|Withdrawal by Subject|8|||
161656707|NCT04075994|583793815|FG001|Overall Study|Withdrawal by Subject|9|||
161656708|NCT04075994|583793814|FG000|Overall Study|Adverse Event|2|||
161656709|NCT04075994|583793815|FG001|Overall Study|Adverse Event|2|||
161656710|NCT04075994|583793814|FG000|Overall Study|Investigator withdrew|3|||
161656711|NCT04075994|583793815|FG001|Overall Study|Investigator withdrew|1|||
161656712|NCT00252577|583793821|FG000|Overall Study|Lost to Follow-up|20|||
161656713|NCT00560066|583793822|FG000|Overall Study|Death|2|||
161656714|NCT00560066|583793823|FG001|Overall Study|Death|1|||
161656715|NCT00560066|583793822|FG000|Overall Study|Withdrawal by Subject|0|||
161656716|NCT00560066|583793823|FG001|Overall Study|Withdrawal by Subject|3|||
161656717|NCT00560066|583793822|FG000|Overall Study|Lost to Follow-up|4|||
161656718|NCT00560066|583793823|FG001|Overall Study|Lost to Follow-up|10|||
161656719|NCT00560066|583793822|FG000|Overall Study|Protocol Violation|0|||
161656720|NCT00560066|583793823|FG001|Overall Study|Protocol Violation|1|||
161656721|NCT00560066|583793822|FG000|Overall Study|Administrative reason|0|||
161656722|NCT00560066|583793823|FG001|Overall Study|Administrative reason|5|||
161656723|NCT00560066|583793822|FG000|Overall Study|Missing primary reason|0|||
161656724|NCT00560066|583793823|FG001|Overall Study|Missing primary reason|2|||
161656725|NCT04035499|583793824|FG000|Overall Study|Death|2|||
161656726|NCT04035499|583793824|FG000|Overall Study|Withdrawal by Subject|1|||
161656727|NCT00951015|583793825|FG000|Randomization Phase 96 Week|Adverse Event|1|||
161656728|NCT00951015|583793826|FG001|Randomization Phase 96 Week|Adverse Event|1|||
161656729|NCT00951015|583793827|FG002|Randomization Phase 96 Week|Adverse Event|2|||
161656730|NCT00951015|583793828|FG003|Randomization Phase 96 Week|Adverse Event|5|||
161656731|NCT00951015|583793829|FG004|Randomization Phase 96 Week|Adverse Event|0|||
161656732|NCT00951015|583793825|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
161656733|NCT00951015|583793826|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
161656734|NCT00951015|583793827|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
161656735|NCT00951015|583793828|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
161656736|NCT00951015|583793829|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
161656737|NCT00951015|583793825|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
161656738|NCT00951015|583793826|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
161656739|NCT00951015|583793827|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
161656740|NCT00951015|583793828|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
161656741|NCT00951015|583793829|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
161656742|NCT00951015|583793825|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161656743|NCT00951015|583793826|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161656744|NCT00951015|583793827|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161656745|NCT00951015|583793828|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
161656746|NCT00951015|583793829|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161656747|NCT00951015|583793825|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
161656748|NCT00951015|583793826|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
161656749|NCT00951015|583793827|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
161656750|NCT00951015|583793828|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
161656751|NCT00951015|583793829|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
161656752|NCT00951015|583793825|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
161656753|NCT00951015|583793826|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
161656754|NCT00951015|583793827|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
161656755|NCT00951015|583793828|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
161656756|NCT00951015|583793829|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
161656757|NCT00951015|583793825|FG000|Open-label Phase|Adverse Event|0|||
161656758|NCT00951015|583793826|FG001|Open-label Phase|Adverse Event|0|||
161656759|NCT00951015|583793827|FG002|Open-label Phase|Adverse Event|0|||
161656760|NCT00951015|583793828|FG003|Open-label Phase|Adverse Event|0|||
161656761|NCT00951015|583793829|FG004|Open-label Phase|Adverse Event|3|||
161656762|NCT00951015|583793825|FG000|Open-label Phase|Lack of Efficacy|0|||
161656763|NCT00951015|583793826|FG001|Open-label Phase|Lack of Efficacy|0|||
161656764|NCT00951015|583793827|FG002|Open-label Phase|Lack of Efficacy|0|||
161656765|NCT00951015|583793828|FG003|Open-label Phase|Lack of Efficacy|0|||
161656766|NCT00951015|583793829|FG004|Open-label Phase|Lack of Efficacy|1|||
161656767|NCT00951015|583793825|FG000|Open-label Phase|Protocol Violation|0|||
161656768|NCT00951015|583793826|FG001|Open-label Phase|Protocol Violation|0|||
161656769|NCT00951015|583793827|FG002|Open-label Phase|Protocol Violation|0|||
161656770|NCT00951015|583793828|FG003|Open-label Phase|Protocol Violation|0|||
161656771|NCT00951015|583793829|FG004|Open-label Phase|Protocol Violation|12|||
161656772|NCT00951015|583793825|FG000|Open-label Phase|Lost to Follow-up|0|||
161656773|NCT00951015|583793826|FG001|Open-label Phase|Lost to Follow-up|0|||
161656774|NCT00951015|583793827|FG002|Open-label Phase|Lost to Follow-up|0|||
161656775|NCT00951015|583793828|FG003|Open-label Phase|Lost to Follow-up|0|||
161656776|NCT00951015|583793829|FG004|Open-label Phase|Lost to Follow-up|12|||
161656777|NCT00951015|583793825|FG000|Open-label Phase|Withdrawal by Subject|0|||
161656778|NCT00951015|583793826|FG001|Open-label Phase|Withdrawal by Subject|0|||
161656779|NCT00951015|583793827|FG002|Open-label Phase|Withdrawal by Subject|0|||
161656780|NCT00951015|583793828|FG003|Open-label Phase|Withdrawal by Subject|0|||
161656781|NCT00951015|583793829|FG004|Open-label Phase|Withdrawal by Subject|14|||
161656782|NCT00951015|583793825|FG000|Open-label Phase|Physician Decision|0|||
161656783|NCT00951015|583793826|FG001|Open-label Phase|Physician Decision|0|||
161656784|NCT00951015|583793827|FG002|Open-label Phase|Physician Decision|0|||
161656785|NCT00951015|583793828|FG003|Open-label Phase|Physician Decision|0|||
161656786|NCT00951015|583793829|FG004|Open-label Phase|Physician Decision|8|||
161656787|NCT01416389|583793830|FG000|Overall Study|Lost to Follow-up|1|||
161656788|NCT01416389|583793831|FG001|Overall Study|Lost to Follow-up|0|||
161656789|NCT01416389|583793830|FG000|Overall Study|Started New Therapy|2|||
161656790|NCT01416389|583793831|FG001|Overall Study|Started New Therapy|0|||
161656791|NCT00958841|583793832|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161656792|NCT00958841|583793832|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161656793|NCT00958841|583793832|FG000|Overall Study|Administrative problems|1|||
161656794|NCT00958841|583793832|FG000|Overall Study|Adverse Event|8|||
161656795|NCT00958841|583793832|FG000|Overall Study|New cancer therapy|5|||
161656796|NCT00958841|583793832|FG000|Overall Study|Withdrawal by Subject|1|||
161656797|NCT00958841|583793832|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
161656798|NCT00958841|583793832|FG000|Overall Study|Completed M6/did not enter extension|27|||
161656799|NCT00958841|583793832|FG000|Overall Study|Discontinued prior to M*|28|||
161656800|NCT02535091|583793839|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
161656801|NCT02535091|583793840|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
161656802|NCT02535091|583793841|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
161656803|NCT02535091|583793839|FG000|Overall Study|Withdrawal by Subject|14|||
161656804|NCT02535091|583793840|FG001|Overall Study|Withdrawal by Subject|5|||
161656805|NCT02535091|583793841|FG002|Overall Study|Withdrawal by Subject|121|||
161656806|NCT02535091|583793839|FG000|Overall Study|Adverse Event|9|||
161656807|NCT02535091|583793840|FG001|Overall Study|Adverse Event|4|||
161656808|NCT02535091|583793841|FG002|Overall Study|Adverse Event|170|||
161656809|NCT02535091|583793839|FG000|Overall Study|Other|4|||
161656810|NCT02535091|583793840|FG001|Overall Study|Other|3|||
161656811|NCT02535091|583793841|FG002|Overall Study|Other|81|||
161656812|NCT02535091|583793839|FG000|Overall Study|Lost to Follow-up|0|||
161656813|NCT02535091|583793840|FG001|Overall Study|Lost to Follow-up|1|||
161656814|NCT02535091|583793841|FG002|Overall Study|Lost to Follow-up|19|||
161656815|NCT02535091|583793839|FG000|Overall Study|Protocol Violation|0|||
161656816|NCT02535091|583793840|FG001|Overall Study|Protocol Violation|1|||
161656817|NCT02535091|583793841|FG002|Overall Study|Protocol Violation|11|||
161656818|NCT02535091|583793839|FG000|Overall Study|Pregnancy|0|||
161656819|NCT02535091|583793840|FG001|Overall Study|Pregnancy|0|||
161656820|NCT02535091|583793841|FG002|Overall Study|Pregnancy|7|||
161656821|NCT01259089|583793846|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161656822|NCT01259089|583793847|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161656823|NCT01259089|583793848|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161656824|NCT01259089|583793849|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161656825|NCT01259089|583793850|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161656826|NCT01259089|583793851|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
161656827|NCT01259089|583793846|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
161656828|NCT01259089|583793847|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
161656829|NCT01259089|583793848|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
161656830|NCT01259089|583793849|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
161656831|NCT01259089|583793850|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
161656832|NCT01259089|583793851|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
161656833|NCT01259089|583793846|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161656834|NCT01259089|583793847|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161656835|NCT01259089|583793848|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161656836|NCT01259089|583793849|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161656837|NCT01259089|583793850|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161656838|NCT01259089|583793851|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
161656839|NCT01259089|583793846|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
161656840|NCT01259089|583793847|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
161656841|NCT01259089|583793848|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
161656842|NCT01259089|583793849|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
161656843|NCT01259089|583793850|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
161656844|NCT01259089|583793851|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
161656845|NCT01259089|583793846|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
161656846|NCT01259089|583793847|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
161656847|NCT01259089|583793848|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
161656848|NCT01259089|583793849|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
161656849|NCT01259089|583793850|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
161656850|NCT01259089|583793851|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
161656851|NCT01259089|583793846|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
161656852|NCT01259089|583793847|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161656853|NCT01259089|583793848|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161656854|NCT01259089|583793849|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161656855|NCT01259089|583793850|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161710082|NCT00364793|583982349|FG002|Overall Study|Lost to Follow-up|2|||
161656856|NCT01259089|583793851|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161656857|NCT01259089|583793846|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
161656858|NCT01259089|583793847|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
161656859|NCT01259089|583793848|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
161656860|NCT01259089|583793849|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
161656861|NCT01259089|583793850|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
161656862|NCT01259089|583793851|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
161656863|NCT01259089|583793846|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
161656864|NCT01259089|583793847|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
161656865|NCT01259089|583793848|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
161656866|NCT01259089|583793849|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
161656867|NCT01259089|583793850|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
161656868|NCT01259089|583793851|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
161656869|NCT01259089|583793846|FG000|Survival Follow up for Two Years|Death|3|||
161656870|NCT01259089|583793847|FG001|Survival Follow up for Two Years|Death|2|||
161656871|NCT01259089|583793848|FG002|Survival Follow up for Two Years|Death|2|||
161656872|NCT01259089|583793849|FG003|Survival Follow up for Two Years|Death|3|||
161656873|NCT01259089|583793850|FG004|Survival Follow up for Two Years|Death|6|||
161656874|NCT01259089|583793851|FG005|Survival Follow up for Two Years|Death|13|||
161656875|NCT01259089|583793846|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
161656876|NCT01259089|583793847|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
161656877|NCT01259089|583793848|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
161656878|NCT01259089|583793849|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
161656879|NCT01259089|583793850|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
161656880|NCT01259089|583793851|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
161656881|NCT01259089|583793846|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161656882|NCT01259089|583793847|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161656883|NCT01259089|583793848|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161656884|NCT01259089|583793849|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161656885|NCT01259089|583793850|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161656886|NCT01259089|583793851|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
161656887|NCT00688870|583793852|FG000|Infant Series|Parent or legal guardian request|4|||
161656888|NCT00688870|583793853|FG001|Infant Series|Parent or legal guardian request|0|||
161656889|NCT01151410|583793854|FG000|Overall Study|Withdrawal by Subject|3|||
161656890|NCT01151410|583793855|FG001|Overall Study|Withdrawal by Subject|5|||
161656891|NCT01151410|583793854|FG000|Overall Study|Lost to Follow-up|3|||
161656892|NCT01151410|583793855|FG001|Overall Study|Lost to Follow-up|4|||
161656893|NCT01151410|583793854|FG000|Overall Study|Adverse Event|1|||
161656894|NCT01151410|583793855|FG001|Overall Study|Adverse Event|2|||
161656895|NCT01151410|583793854|FG000|Overall Study|Protocol deviation|2|||
161656896|NCT01151410|583793855|FG001|Overall Study|Protocol deviation|1|||
161656897|NCT01151410|583793854|FG000|Overall Study|Administrative problems|1|||
161656898|NCT01151410|583793855|FG001|Overall Study|Administrative problems|1|||
161656899|NCT01151410|583793854|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161656900|NCT01151410|583793855|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161656901|NCT01151410|583793854|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161656902|NCT01151410|583793855|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161656903|NCT01253018|583793856|FG000|Overall Study|Lost to Follow-up|1|||
161656904|NCT01253018|583793857|FG001|Overall Study|Lost to Follow-up|1|||
161656905|NCT01253018|583793856|FG000|Overall Study|Robot Repair Issues|2|||
161656906|NCT01253018|583793857|FG001|Overall Study|Robot Repair Issues|0|||
161656907|NCT01253018|583793856|FG000|Overall Study|Withdrawal by Subject|1|||
161656908|NCT01253018|583793857|FG001|Overall Study|Withdrawal by Subject|1|||
161656909|NCT00969709|583795701|FG000|Overall Study|Adverse Event|3|||
161656910|NCT00969709|583795702|FG001|Overall Study|Adverse Event|13|||
161656911|NCT00969709|583795703|FG002|Overall Study|Adverse Event|26|||
161656912|NCT00969709|583795704|FG003|Overall Study|Adverse Event|12|||
161656913|NCT00969709|583795701|FG000|Overall Study|Lack of Efficacy|7|||
161656914|NCT00969709|583795702|FG001|Overall Study|Lack of Efficacy|4|||
161656915|NCT00969709|583795703|FG002|Overall Study|Lack of Efficacy|1|||
161656916|NCT00969709|583795704|FG003|Overall Study|Lack of Efficacy|3|||
161656917|NCT00969709|583795701|FG000|Overall Study|Protocol Violation|9|||
161656918|NCT00969709|583795702|FG001|Overall Study|Protocol Violation|5|||
161656919|NCT00969709|583795703|FG002|Overall Study|Protocol Violation|9|||
161656920|NCT00969709|583795704|FG003|Overall Study|Protocol Violation|10|||
161656921|NCT00969709|583795701|FG000|Overall Study|Withdrawal by Subject|9|||
161656922|NCT00969709|583795702|FG001|Overall Study|Withdrawal by Subject|12|||
161656923|NCT00969709|583795703|FG002|Overall Study|Withdrawal by Subject|11|||
161656924|NCT00969709|583795704|FG003|Overall Study|Withdrawal by Subject|23|||
161656925|NCT00969709|583795701|FG000|Overall Study|Lost to Follow-up|10|||
161656926|NCT00969709|583795702|FG001|Overall Study|Lost to Follow-up|14|||
161656927|NCT00969709|583795703|FG002|Overall Study|Lost to Follow-up|8|||
161656928|NCT00969709|583795704|FG003|Overall Study|Lost to Follow-up|15|||
161656929|NCT00969709|583795701|FG000|Overall Study|Other reasons|0|||
161656930|NCT00969709|583795702|FG001|Overall Study|Other reasons|0|||
161656931|NCT00969709|583795703|FG002|Overall Study|Other reasons|3|||
161656932|NCT00969709|583795704|FG003|Overall Study|Other reasons|0|||
161656933|NCT02516332|583795705|FG000|Overall Study|Withdrawal by Subject|2|||
161656934|NCT02516332|583795706|FG001|Overall Study|Withdrawal by Subject|1|||
161656935|NCT02516332|583795707|FG002|Overall Study|Withdrawal by Subject|2|||
161656936|NCT03695237|583795708|FG000|Overall Study|Withdrawal by Subject|1|||
161656937|NCT03695237|583795709|FG001|Overall Study|Withdrawal by Subject|3|||
161656938|NCT03695237|583795708|FG000|Overall Study|Lost to Follow-up|1|||
161656939|NCT03695237|583795709|FG001|Overall Study|Lost to Follow-up|2|||
161656940|NCT03695237|583795708|FG000|Overall Study|Other, Not Specified|8|||
161656941|NCT03695237|583795709|FG001|Overall Study|Other, Not Specified|2|||
161656942|NCT00055601|583795710|FG000|Overall Study|Protocol Violation|1|||
161656943|NCT00055601|583795711|FG001|Overall Study|Protocol Violation|1|||
161656944|NCT00055601|583795710|FG000|Overall Study|No protocol treatment received|1|||
161656945|NCT00055601|583795711|FG001|Overall Study|No protocol treatment received|1|||
161656946|NCT02217332|583795712|FG000|Overall Study|Adverse Event|3|||
161656947|NCT02217332|583795712|FG000|Overall Study|Dose interruption >1 month|1|||
161656948|NCT02217332|583795712|FG000|Overall Study|Protocol Violation (eligibility)|1|||
161656949|NCT02217332|583795712|FG000|Overall Study|Withdrawal by Subject|1|||
161656950|NCT02217332|583795712|FG000|Overall Study|Lost to Follow-up|1|||
161656951|NCT03828747|583795721|FG000|Double-Blind Treatment Period|Adverse Event|6|||
161656952|NCT03828747|583795722|FG001|Double-Blind Treatment Period|Adverse Event|6|||
161656953|NCT03828747|583795721|FG000|Double-Blind Treatment Period|Death|1|||
161656954|NCT03828747|583795722|FG001|Double-Blind Treatment Period|Death|1|||
161656955|NCT03828747|583795721|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161656956|NCT03828747|583795722|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161656957|NCT03828747|583795721|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
161656958|NCT03828747|583795722|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
161656959|NCT03828747|583795721|FG000|Double-Blind Treatment Period|Physician Decision|1|||
161656960|NCT03828747|583795722|FG001|Double-Blind Treatment Period|Physician Decision|4|||
161656961|NCT03828747|583795721|FG000|Double-Blind Treatment Period|Various reasons|5|||
161656962|NCT03828747|583795722|FG001|Double-Blind Treatment Period|Various reasons|3|||
161656963|NCT03828747|583795721|FG000|Open-Label Extension|Adverse Event|9|||
161656964|NCT03828747|583795722|FG001|Open-Label Extension|Adverse Event|7|||
161656965|NCT03828747|583795721|FG000|Open-Label Extension|Death|0|||
161656966|NCT03828747|583795722|FG001|Open-Label Extension|Death|2|||
161656967|NCT03828747|583795721|FG000|Open-Label Extension|Lost to Follow-up|4|||
161656968|NCT03828747|583795722|FG001|Open-Label Extension|Lost to Follow-up|0|||
161656969|NCT03828747|583795721|FG000|Open-Label Extension|Withdrawal by Subject|31|||
161656970|NCT03828747|583795722|FG001|Open-Label Extension|Withdrawal by Subject|30|||
161656971|NCT03828747|583795721|FG000|Open-Label Extension|Various reasons|4|||
161656972|NCT03828747|583795722|FG001|Open-Label Extension|Various reasons|4|||
161837854|NCT01246011|584450226|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
161837855|NCT01246011|584450227|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
161656973|NCT03828747|583795721|FG000|Open-Label Extension|Physician Decision|6|||
161656974|NCT03828747|583795722|FG001|Open-Label Extension|Physician Decision|2|||
161837856|NCT01246011|584450225|FG000|Overall Study|Withdrawal by Subject|0|||
161656975|NCT01658150|583795723|FG000|Overall Study|Withdrawal by Subject|1|||
161656976|NCT04187989|583795724|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
161656977|NCT04187989|583795725|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
161656978|NCT04187989|583795724|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
161656979|NCT04187989|583795725|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
161656980|NCT03646656|583795726|FG000|Overall Study|Lost to Follow-up|1|||
161656981|NCT03646656|583795727|FG001|Overall Study|Lost to Follow-up|0|||
161656982|NCT03646656|583795726|FG000|Overall Study|Withdrawal by Subject|2|||
161656983|NCT03646656|583795727|FG001|Overall Study|Withdrawal by Subject|0|||
161656984|NCT02245737|583795728|FG000|Overall Study|Adverse Event|23|||
161656985|NCT02245737|583795729|FG001|Overall Study|Adverse Event|26|||
161656986|NCT02245737|583795730|FG002|Overall Study|Adverse Event|33|||
161656987|NCT02245737|583795728|FG000|Overall Study|Condition Worsened|9|||
161656988|NCT02245737|583795729|FG001|Overall Study|Condition Worsened|10|||
161656989|NCT02245737|583795730|FG002|Overall Study|Condition Worsened|9|||
161656990|NCT02245737|583795728|FG000|Overall Study|Death|2|||
161656991|NCT02245737|583795729|FG001|Overall Study|Death|4|||
161656992|NCT02245737|583795730|FG002|Overall Study|Death|4|||
161656993|NCT02245737|583795728|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
161656994|NCT02245737|583795729|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
161656995|NCT02245737|583795730|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
161656996|NCT02245737|583795728|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
161656997|NCT02245737|583795729|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
161656998|NCT02245737|583795730|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
161656999|NCT02245737|583795728|FG000|Overall Study|Lost to Follow-up|2|||
161657000|NCT02245737|583795729|FG001|Overall Study|Lost to Follow-up|5|||
161657001|NCT02245737|583795730|FG002|Overall Study|Lost to Follow-up|4|||
161657002|NCT02245737|583795728|FG000|Overall Study|Other-determined by Investigator|9|||
161657003|NCT02245737|583795729|FG001|Overall Study|Other-determined by Investigator|10|||
161657004|NCT02245737|583795730|FG002|Overall Study|Other-determined by Investigator|10|||
161657005|NCT02245737|583795728|FG000|Overall Study|Physician Decision|6|||
161657006|NCT02245737|583795729|FG001|Overall Study|Physician Decision|3|||
161657007|NCT02245737|583795730|FG002|Overall Study|Physician Decision|6|||
161657008|NCT02245737|583795728|FG000|Overall Study|Protocol Violation|3|||
161657009|NCT02245737|583795729|FG001|Overall Study|Protocol Violation|2|||
161657010|NCT02245737|583795730|FG002|Overall Study|Protocol Violation|3|||
161657011|NCT02245737|583795728|FG000|Overall Study|Withdrawal by Subject|40|||
161657012|NCT02245737|583795729|FG001|Overall Study|Withdrawal by Subject|41|||
161657013|NCT02245737|583795730|FG002|Overall Study|Withdrawal by Subject|44|||
161657014|NCT02245737|583795728|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
161657015|NCT02245737|583795729|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
161657016|NCT02245737|583795730|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
161657017|NCT02245737|583795728|FG000|Overall Study|Sponsor Decision|445|||
161657018|NCT02245737|583795729|FG001|Overall Study|Sponsor Decision|430|||
161657019|NCT02245737|583795730|FG002|Overall Study|Sponsor Decision|432|||
161657020|NCT01699503|583795734|FG000|Overall Study|Death|31|||
161657021|NCT01699503|583795735|FG001|Overall Study|Death|40|||
161657022|NCT01699503|583795734|FG000|Overall Study|Withdrawal by Subject|65|||
161657023|NCT01699503|583795735|FG001|Overall Study|Withdrawal by Subject|57|||
161657024|NCT01699503|583795734|FG000|Overall Study|Lost to Follow-up|121|||
161657025|NCT01699503|583795735|FG001|Overall Study|Lost to Follow-up|117|||
161657026|NCT01699503|583795734|FG000|Overall Study|Excluded due to quality|783|||
161657027|NCT01699503|583795735|FG001|Overall Study|Excluded due to quality|791|||
161657028|NCT01639560|583795736|FG000|Overall Study|Withdrawal by Subject|9|||
161657029|NCT01639560|583795737|FG001|Overall Study|Withdrawal by Subject|14|||
161657030|NCT01639560|583795736|FG000|Overall Study|Lack of Efficacy|1|||
161657031|NCT01639560|583795737|FG001|Overall Study|Lack of Efficacy|2|||
161657032|NCT01639560|583795736|FG000|Overall Study|Lost to Follow-up|9|||
161657033|NCT01639560|583795737|FG001|Overall Study|Lost to Follow-up|11|||
161657034|NCT01639560|583795736|FG000|Overall Study|Adverse Event|0|||
161657035|NCT01639560|583795737|FG001|Overall Study|Adverse Event|2|||
161657036|NCT00774930|583795739|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
161657037|NCT00774930|583795740|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
161657038|NCT00774930|583795739|FG000|DB Phase|Adverse Event|1|||
161710083|NCT00364793|583982350|FG003|Overall Study|Lost to Follow-up|0|||
161710084|NCT00364793|583982347|FG000|Overall Study|Poor or non-compliance|1|||
161710085|NCT00364793|583982348|FG001|Overall Study|Poor or non-compliance|1|||
161657039|NCT00774930|583795740|FG001|DB Phase|Adverse Event|2|||
161657040|NCT00774930|583795739|FG000|DB Phase|Subject Decision|1|||
161657041|NCT00774930|583795740|FG001|DB Phase|Subject Decision|5|||
161657042|NCT00774930|583795739|FG000|DB Phase|Sponsor Decision|0|||
161657043|NCT00774930|583795740|FG001|DB Phase|Sponsor Decision|1|||
161710086|NCT00364793|583982349|FG002|Overall Study|Poor or non-compliance|0|||
161657044|NCT00774930|583795739|FG000|DB Phase|Disease Progression|1|||
161657045|NCT00774930|583795740|FG001|DB Phase|Disease Progression|1|||
161657046|NCT00774930|583795739|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
161657047|NCT00774930|583795740|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
161657048|NCT00774930|583795739|FG000|IOL Phase|Adverse Event|1|||
161657049|NCT00774930|583795740|FG001|IOL Phase|Adverse Event|1|||
161657050|NCT00774930|583795739|FG000|IOL Phase|Subject Decision|4|||
161657051|NCT00774930|583795740|FG001|IOL Phase|Subject Decision|3|||
161657052|NCT00774930|583795739|FG000|IOL Phase|Physician Decision|3|||
161657053|NCT00774930|583795740|FG001|IOL Phase|Physician Decision|2|||
161657054|NCT00774930|583795739|FG000|IOL Phase|Sponsor Decision|1|||
161657055|NCT00774930|583795740|FG001|IOL Phase|Sponsor Decision|0|||
161657056|NCT00774930|583795739|FG000|IOL Phase|Disease Progression|2|||
161657057|NCT00774930|583795740|FG001|IOL Phase|Disease Progression|1|||
161657058|NCT00774930|583795739|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
161657059|NCT00774930|583795740|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
161657060|NCT00774930|583795739|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
161657061|NCT00774930|583795740|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
161657062|NCT00774930|583795739|FG000|IOL Phase|Other|1|||
161657063|NCT00774930|583795740|FG001|IOL Phase|Other|0|||
161657064|NCT00774930|583795739|FG000|IOL Phase|Brain radiation|0|||
161657065|NCT00774930|583795740|FG001|IOL Phase|Brain radiation|1|||
161657066|NCT00774930|583795739|FG000|LTOLE Phase|Adverse Event|7|||
161657067|NCT00774930|583795740|FG001|LTOLE Phase|Adverse Event|3|||
161657068|NCT00774930|583795739|FG000|LTOLE Phase|Subject decision|0|||
161657069|NCT00774930|583795740|FG001|LTOLE Phase|Subject decision|5|||
161657070|NCT00774930|583795739|FG000|LTOLE Phase|Physician Decision|4|||
161657071|NCT00774930|583795740|FG001|LTOLE Phase|Physician Decision|1|||
161657072|NCT00774930|583795739|FG000|LTOLE Phase|Sponsor decision|2|||
161657073|NCT00774930|583795740|FG001|LTOLE Phase|Sponsor decision|1|||
161657074|NCT00774930|583795739|FG000|LTOLE Phase|Disease Progression|2|||
161657075|NCT00774930|583795740|FG001|LTOLE Phase|Disease Progression|5|||
161657076|NCT00774930|583795739|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
161657077|NCT00774930|583795740|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
161657078|NCT00774930|583795739|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
161657079|NCT00774930|583795740|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
161657080|NCT00766363|583795745|FG000|Overall Study|Withdrawal by Subject|1|||
161657081|NCT00766363|583795746|FG001|Overall Study|Withdrawal by Subject|0|||
161657082|NCT00766363|583795747|FG002|Overall Study|Withdrawal by Subject|0|||
161657083|NCT00766363|583795748|FG003|Overall Study|Withdrawal by Subject|0|||
161657084|NCT00766363|583795745|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
161657085|NCT00766363|583795746|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
161657086|NCT00766363|583795747|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
161657087|NCT00766363|583795748|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
161657088|NCT03020576|583795749|FG000|Overall Study|Withdrawal by Subject|1|||
161657089|NCT03020576|583795750|FG001|Overall Study|Withdrawal by Subject|2|||
161657090|NCT03292432|583795751|FG000|Overall Study|Lost to Follow-up|11|||
161657091|NCT03292432|583795752|FG001|Overall Study|Lost to Follow-up|8|||
161657092|NCT03292432|583795751|FG000|Overall Study|Death|2|||
161657093|NCT03292432|583795752|FG001|Overall Study|Death|1|||
161657094|NCT03292432|583795751|FG000|Overall Study|Withdrawal by Subject|1|||
161657095|NCT03292432|583795752|FG001|Overall Study|Withdrawal by Subject|2|||
161657096|NCT03292432|583795751|FG000|Overall Study|Site closed before any data collected|1|||
161657097|NCT03292432|583795752|FG001|Overall Study|Site closed before any data collected|0|||
161657098|NCT00911937|583795753|FG000|Overall Study|Death|1|||
161657099|NCT00911937|583795754|FG001|Overall Study|Death|0|||
161657100|NCT00911937|583795753|FG000|Overall Study|Lost to Follow-up|8|||
161657101|NCT00911937|583795754|FG001|Overall Study|Lost to Follow-up|5|||
161657102|NCT00911937|583795753|FG000|Overall Study|Withdrawal by Subject|10|||
161657103|NCT00911937|583795754|FG001|Overall Study|Withdrawal by Subject|7|||
161657104|NCT00911937|583795753|FG000|Overall Study|Withdrawn due to pregnancy|1|||
161657105|NCT00911937|583795754|FG001|Overall Study|Withdrawn due to pregnancy|0|||
161657106|NCT00911937|583795753|FG000|Overall Study|Adverse Event|11|||
161657107|NCT00911937|583795754|FG001|Overall Study|Adverse Event|25|||
161657108|NCT00911937|583795753|FG000|Overall Study|Lack of Efficacy|11|||
161657109|NCT00911937|583795754|FG001|Overall Study|Lack of Efficacy|6|||
161657110|NCT00911937|583795753|FG000|Overall Study|Did not meet inclusion criteria|9|||
161657111|NCT00911937|583795754|FG001|Overall Study|Did not meet inclusion criteria|11|||
161657112|NCT00911937|583795753|FG000|Overall Study|Protocol Violation|14|||
161657113|NCT00911937|583795754|FG001|Overall Study|Protocol Violation|23|||
161657114|NCT00911937|583795753|FG000|Overall Study|Randomized but not treated|13|||
161657115|NCT00911937|583795754|FG001|Overall Study|Randomized but not treated|13|||
161657116|NCT00911937|583795753|FG000|Overall Study|Other|9|||
161657117|NCT00911937|583795754|FG001|Overall Study|Other|5|||
161657118|NCT01498679|583795755|FG000|Overall Study|Adverse Event|1|||
161657119|NCT01498679|583795756|FG001|Overall Study|Adverse Event|4|||
161657120|NCT01498679|583795755|FG000|Overall Study|Lack of Efficacy|72|||
161657121|NCT01498679|583795756|FG001|Overall Study|Lack of Efficacy|12|||
161657122|NCT01498679|583795755|FG000|Overall Study|Protocol Violation|4|||
161657123|NCT01498679|583795756|FG001|Overall Study|Protocol Violation|0|||
161657124|NCT01498679|583795755|FG000|Overall Study|Physician Decision|0|||
161657125|NCT01498679|583795756|FG001|Overall Study|Physician Decision|2|||
161657126|NCT01498679|583795755|FG000|Overall Study|Withdrawal by Subject|12|||
161657127|NCT01498679|583795756|FG001|Overall Study|Withdrawal by Subject|4|||
161657128|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
161657129|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161657130|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161657131|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161657132|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161657133|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
161657134|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161657135|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161657136|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161657137|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161657138|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
161657139|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161657140|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161657141|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161657142|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161657143|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
161657144|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161657145|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161657146|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161657147|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161657148|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
161657149|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161657150|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161657151|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161657152|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161657153|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
161657154|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161657155|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161657156|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161657157|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161657158|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
161657159|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161657160|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161657161|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161657162|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161657163|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
161657164|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161657165|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161657166|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161657167|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161657168|NCT00700427|583795757|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
161657169|NCT00700427|583795758|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161657170|NCT00700427|583795759|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161657171|NCT00700427|583795760|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161657172|NCT00700427|583795761|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161657173|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161657174|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
161657175|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161710087|NCT00364793|583982350|FG003|Overall Study|Poor or non-compliance|1|||
161710088|NCT00364793|583982347|FG000|Overall Study|No longer meets criteria|0|||
161710089|NCT00364793|583982348|FG001|Overall Study|No longer meets criteria|0|||
161710090|NCT00364793|583982349|FG002|Overall Study|No longer meets criteria|0|||
161837857|NCT01246011|584450226|FG001|Overall Study|Withdrawal by Subject|0|||
161837858|NCT01246011|584450227|FG002|Overall Study|Withdrawal by Subject|1|||
161657176|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161657177|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161837859|NCT04392583|584450228|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
161657178|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161657179|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
161657180|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161657181|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161657182|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161657183|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161657184|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
161657185|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161657186|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161657187|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161657188|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161657189|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
161657190|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161657191|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161657192|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161657193|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161657194|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
161657195|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161657196|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161657197|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161657198|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161657199|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
161657200|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161657201|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161657202|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161657203|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161837860|NCT01340768|584450229|FG000|Overall Study|Lost to Follow-up|10|||
161837861|NCT01340768|584450230|FG001|Overall Study|Lost to Follow-up|4|||
161710091|NCT00364793|583982350|FG003|Overall Study|No longer meets criteria|1|||
161710092|NCT00364793|583982347|FG000|Overall Study|Withdrawal by Subject|0|||
161710093|NCT00364793|583982348|FG001|Overall Study|Withdrawal by Subject|1|||
161710094|NCT00364793|583982349|FG002|Overall Study|Withdrawal by Subject|0|||
161710095|NCT00364793|583982350|FG003|Overall Study|Withdrawal by Subject|0|||
161710096|NCT00363415|583982354|FG000|Overall Study|Progressive Disease|196|||
161710097|NCT00363415|583982355|FG001|Overall Study|Progressive Disease|107|||
161710098|NCT00363415|583982354|FG000|Overall Study|Sponsor Decision|67|||
161710099|NCT00363415|583982355|FG001|Overall Study|Sponsor Decision|31|||
161710100|NCT00363415|583982354|FG000|Overall Study|Death|32|||
161710101|NCT00363415|583982355|FG001|Overall Study|Death|29|||
161657204|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
161657205|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161657206|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161657207|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161657208|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161657209|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
161657210|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161657211|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161657212|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161657213|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161657214|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
161657215|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161657216|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161657217|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161657218|NCT00700427|583795757|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161657219|NCT00700427|583795758|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
161657220|NCT00700427|583795759|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161657221|NCT00700427|583795760|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161657222|NCT00700427|583795761|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161657223|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
161657224|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
161657225|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
161657226|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
161657227|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
161657228|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
161657229|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
161657230|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
161657231|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
161657232|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
161657233|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
161657234|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
161657235|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
161657236|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
161657237|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
161657238|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
161657239|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
161657240|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
161657241|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
161657242|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
161657243|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
161657244|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
161657245|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
161657246|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
161657247|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
161657248|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161657249|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161710102|NCT00363415|583982354|FG000|Overall Study|Adverse Event|24|||
161710103|NCT00363415|583982355|FG001|Overall Study|Adverse Event|15|||
161710104|NCT00363415|583982354|FG000|Overall Study|Physician Decision|18|||
161657250|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161657251|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
161657252|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161657253|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161657254|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161657255|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161657256|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
161657257|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161657258|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
161657259|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
161657260|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
161657261|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
161657262|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
161657263|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161657264|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161657265|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
161657266|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161657267|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161657268|NCT00700427|583795757|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
161657269|NCT00700427|583795758|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
161657270|NCT00700427|583795759|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
161657271|NCT00700427|583795760|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
161657272|NCT00700427|583795761|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
161657273|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161657274|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161657275|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161657276|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161657277|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
161657278|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
161657279|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
161657280|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
161657281|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
161657282|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
161657283|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161657284|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161657285|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161657286|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161657287|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
161657288|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161657289|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161657290|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161657291|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161657292|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
161657293|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161657294|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161657295|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161657296|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161657297|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
161657298|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161657299|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161657300|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161657301|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161657302|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
161657303|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161710105|NCT00363415|583982355|FG001|Overall Study|Physician Decision|35|||
161657304|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161657305|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161657306|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161657307|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
161657308|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161657309|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161657310|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161657311|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161657312|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
161657313|NCT00700427|583795757|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161657314|NCT00700427|583795758|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161657315|NCT00700427|583795759|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161657316|NCT00700427|583795760|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161657317|NCT00700427|583795761|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
161657318|NCT00424385|583795764|FG000|Cohort 0|Withdrawal by Subject|5|||
161657319|NCT00424385|583795764|FG000|Cohort 0|Physician Decision|1|||
161657320|NCT00424385|583795764|FG000|Cohort 1|Withdrawal by Subject|1|||
161657321|NCT02057523|583795767|FG000|Overall Study|Withdrawal by Subject|1|||
161657322|NCT02057523|583795767|FG000|Overall Study|Lack of Efficacy|1|||
161657323|NCT02071290|583795768|FG000|Overall Study|Death|1|||
161657324|NCT02071290|583795769|FG001|Overall Study|Death|0|||
161657325|NCT02071290|583795768|FG000|Overall Study|Withdrawal by Subject|0|||
161657326|NCT02071290|583795769|FG001|Overall Study|Withdrawal by Subject|1|||
161657327|NCT02071290|583795768|FG000|Overall Study|Protocol Violation|3|||
161657328|NCT02071290|583795769|FG001|Overall Study|Protocol Violation|5|||
161657329|NCT02071290|583795768|FG000|Overall Study|Physician Decision|0|||
161657330|NCT02071290|583795769|FG001|Overall Study|Physician Decision|1|||
161657331|NCT00964886|583795774|FG000|Overall Study|Lost to Follow-up|2|||
161657332|NCT00964886|583795775|FG001|Overall Study|Lost to Follow-up|2|||
161657333|NCT00964886|583795776|FG002|Overall Study|Lost to Follow-up|6|||
161657334|NCT00964886|583795777|FG003|Overall Study|Lost to Follow-up|4|||
161657335|NCT00964886|583795774|FG000|Overall Study|Withdrawal by Subject|6|||
161657336|NCT00964886|583795775|FG001|Overall Study|Withdrawal by Subject|2|||
161657337|NCT00964886|583795776|FG002|Overall Study|Withdrawal by Subject|5|||
161657338|NCT00964886|583795777|FG003|Overall Study|Withdrawal by Subject|3|||
161657339|NCT00964886|583795774|FG000|Overall Study|Adverse Event|3|||
161657340|NCT00964886|583795775|FG001|Overall Study|Adverse Event|1|||
161657341|NCT00964886|583795776|FG002|Overall Study|Adverse Event|5|||
161657342|NCT00964886|583795777|FG003|Overall Study|Adverse Event|2|||
161657343|NCT00964886|583795774|FG000|Overall Study|Protocol Violation|0|||
161657344|NCT00964886|583795775|FG001|Overall Study|Protocol Violation|2|||
161657345|NCT00964886|583795776|FG002|Overall Study|Protocol Violation|0|||
161657346|NCT00964886|583795777|FG003|Overall Study|Protocol Violation|0|||
161657347|NCT01941719|583795779|FG000|Overall Study|Lost to Follow-up|20|||
161657348|NCT01941719|583795780|FG001|Overall Study|Lost to Follow-up|19|||
161657349|NCT03819634|583795782|FG000|Overall Study|Physician Decision|2|||
161657350|NCT01125514|583795784|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
161657351|NCT01125514|583795784|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
161657352|NCT01125514|583795784|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
161657353|NCT01125514|583795784|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
161657354|NCT01125514|583795784|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
161657355|NCT01125514|583795784|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
161657356|NCT00858364|583795785|FG000|Overall Study|Administrative Decision|3|||
161657357|NCT00858364|583795786|FG001|Overall Study|Administrative Decision|2|||
161657358|NCT00858364|583795785|FG000|Overall Study|Adverse Event|5|||
161657359|NCT00858364|583795786|FG001|Overall Study|Adverse Event|2|||
161657360|NCT00858364|583795785|FG000|Overall Study|Withdrawal by Subject|44|||
161657361|NCT00858364|583795786|FG001|Overall Study|Withdrawal by Subject|118|||
161657362|NCT00858364|583795785|FG000|Overall Study|Ineligibility Determined|1|||
161657363|NCT00858364|583795786|FG001|Overall Study|Ineligibility Determined|10|||
161657364|NCT00858364|583795785|FG000|Overall Study|Lost to Follow-up|24|||
161657365|NCT00858364|583795786|FG001|Overall Study|Lost to Follow-up|54|||
161657366|NCT00858364|583795785|FG000|Overall Study|Noncompliance|3|||
161657367|NCT00858364|583795786|FG001|Overall Study|Noncompliance|4|||
161657368|NCT00858364|583795785|FG000|Overall Study|Protocol Deviation|0|||
161657369|NCT00858364|583795786|FG001|Overall Study|Protocol Deviation|2|||
161657370|NCT00858364|583795785|FG000|Overall Study|Other|9|||
161657371|NCT00858364|583795786|FG001|Overall Study|Other|17|||
161657372|NCT00858364|583795785|FG000|Overall Study|Missing|1|||
161657373|NCT00858364|583795786|FG001|Overall Study|Missing|1|||
161657374|NCT00858364|583795785|FG000|Overall Study|Still on-study|114|||
161657375|NCT00858364|583795786|FG001|Overall Study|Still on-study|247|||
161657376|NCT01655693|583795790|FG000|Overall Study|Progression of Disease|92|||
161657377|NCT01655693|583795791|FG001|Overall Study|Progression of Disease|76|||
161657378|NCT01655693|583795792|FG002|Overall Study|Progression of Disease|58|||
161657379|NCT01655693|583795790|FG000|Overall Study|Death|8|||
161657380|NCT01655693|583795791|FG001|Overall Study|Death|9|||
161657381|NCT01655693|583795792|FG002|Overall Study|Death|12|||
161657382|NCT01655693|583795790|FG000|Overall Study|Serious Adverse Event|3|||
161657383|NCT01655693|583795791|FG001|Overall Study|Serious Adverse Event|15|||
161657384|NCT01655693|583795792|FG002|Overall Study|Serious Adverse Event|11|||
161657385|NCT01655693|583795790|FG000|Overall Study|Withdrawal by Subject|3|||
161657386|NCT01655693|583795791|FG001|Overall Study|Withdrawal by Subject|2|||
161657387|NCT01655693|583795792|FG002|Overall Study|Withdrawal by Subject|20|||
161657388|NCT01655693|583795790|FG000|Overall Study|Adverse Event|3|||
161657389|NCT01655693|583795791|FG001|Overall Study|Adverse Event|11|||
161657390|NCT01655693|583795792|FG002|Overall Study|Adverse Event|3|||
161657391|NCT01655693|583795790|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
161657392|NCT01655693|583795791|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
161657393|NCT01655693|583795792|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
161657394|NCT01655693|583795790|FG000|Overall Study|Non-Compliance|0|||
161657395|NCT01655693|583795791|FG001|Overall Study|Non-Compliance|0|||
161657396|NCT01655693|583795792|FG002|Overall Study|Non-Compliance|7|||
161657397|NCT01655693|583795790|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
161657398|NCT01655693|583795791|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
161657399|NCT01655693|583795792|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
161657400|NCT01655693|583795790|FG000|Overall Study|Protocol Violation|1|||
161657401|NCT01655693|583795791|FG001|Overall Study|Protocol Violation|0|||
161657402|NCT01655693|583795792|FG002|Overall Study|Protocol Violation|3|||
161657403|NCT01655693|583795790|FG000|Overall Study|Lost to Follow-up|1|||
161657404|NCT01655693|583795791|FG001|Overall Study|Lost to Follow-up|0|||
161657405|NCT01655693|583795792|FG002|Overall Study|Lost to Follow-up|1|||
161657406|NCT01655693|583795790|FG000|Overall Study|Screening Failure|1|||
161657407|NCT01655693|583795791|FG001|Overall Study|Screening Failure|0|||
161657408|NCT01655693|583795792|FG002|Overall Study|Screening Failure|0|||
161657409|NCT01655693|583795790|FG000|Overall Study|Other|8|||
161657410|NCT01655693|583795791|FG001|Overall Study|Other|6|||
161657411|NCT01655693|583795792|FG002|Overall Study|Other|15|||
161657412|NCT00929110|583795795|FG000|Overall Study|Adverse Event|40|||
161657413|NCT00929110|583795796|FG001|Overall Study|Adverse Event|29|||
161657414|NCT00929110|583795797|FG002|Overall Study|Adverse Event|18|||
161657415|NCT00929110|583795795|FG000|Overall Study|Subject withdrew consent|40|||
161710106|NCT00363415|583982354|FG000|Overall Study|Entry Criteria Not Met|11|||
161710107|NCT00363415|583982355|FG001|Overall Study|Entry Criteria Not Met|10|||
161710108|NCT00363415|583982354|FG000|Overall Study|Withdrawal by Subject|9|||
161710109|NCT00363415|583982355|FG001|Overall Study|Withdrawal by Subject|15|||
161710110|NCT00363415|583982354|FG000|Overall Study|Lost to Follow-up|3|||
161710111|NCT00363415|583982355|FG001|Overall Study|Lost to Follow-up|3|||
161710112|NCT00363415|583982354|FG000|Overall Study|Protocol Violation|1|||
161710113|NCT00363415|583982355|FG001|Overall Study|Protocol Violation|4|||
161710114|NCT02688647|583982364|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
161657416|NCT00929110|583795796|FG001|Overall Study|Subject withdrew consent|23|||
161657417|NCT00929110|583795797|FG002|Overall Study|Subject withdrew consent|26|||
161657418|NCT00929110|583795795|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
161657419|NCT00929110|583795796|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
161710115|NCT02688647|583982365|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
161657420|NCT00929110|583795797|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
161657421|NCT00929110|583795795|FG000|Overall Study|Lost to Follow-up|7|||
161710116|NCT02688647|583982364|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
161710117|NCT02688647|583982365|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
161710118|NCT02688647|583982364|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
161710119|NCT02688647|583982365|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
161710120|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
161710121|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
161710122|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
161837862|NCT01340768|584450229|FG000|Overall Study|Withdrawal by Subject|5|||
161657422|NCT00929110|583795796|FG001|Overall Study|Lost to Follow-up|7|||
161657423|NCT00929110|583795797|FG002|Overall Study|Lost to Follow-up|3|||
161657424|NCT00929110|583795795|FG000|Overall Study|Protocol deviation|5|||
161657425|NCT00929110|583795796|FG001|Overall Study|Protocol deviation|2|||
161657426|NCT00929110|583795797|FG002|Overall Study|Protocol deviation|4|||
161657427|NCT00929110|583795795|FG000|Overall Study|Administrative problems|4|||
161657428|NCT00929110|583795796|FG001|Overall Study|Administrative problems|1|||
161657429|NCT00929110|583795797|FG002|Overall Study|Administrative problems|2|||
161657430|NCT00929110|583795795|FG000|Overall Study|Death|2|||
161657431|NCT00929110|583795796|FG001|Overall Study|Death|2|||
161657432|NCT00929110|583795797|FG002|Overall Study|Death|2|||
161657433|NCT00929110|583795795|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161657434|NCT00929110|583795796|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161657435|NCT00929110|583795797|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161657436|NCT00929110|583795795|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161657437|NCT00929110|583795796|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161657438|NCT00929110|583795797|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161657439|NCT00929110|583795795|FG000|Overall Study|Patient inability to use the device|0|||
161657440|NCT00929110|583795796|FG001|Overall Study|Patient inability to use the device|1|||
161657441|NCT00929110|583795797|FG002|Overall Study|Patient inability to use the device|0|||
161657442|NCT01163292|583795801|FG000|Overall Study|Lack of Efficacy|9|||
161657443|NCT01163292|583795802|FG001|Overall Study|Lack of Efficacy|0|||
161657444|NCT01163292|583795801|FG000|Overall Study|Adverse Event|6|||
161657445|NCT01163292|583795802|FG001|Overall Study|Adverse Event|0|||
161657446|NCT01163292|583795801|FG000|Overall Study|Initiation of biological therapy|0|||
161657447|NCT01163292|583795802|FG001|Overall Study|Initiation of biological therapy|15|||
161657448|NCT01163292|583795801|FG000|Overall Study|Sufficient response to adalimumab|8|||
161657449|NCT01163292|583795802|FG001|Overall Study|Sufficient response to adalimumab|0|||
161657450|NCT01163292|583795801|FG000|Overall Study|Refusal to receive adalimumab|7|||
161657451|NCT01163292|583795802|FG001|Overall Study|Refusal to receive adalimumab|0|||
161657452|NCT01163292|583795801|FG000|Overall Study|Economic reasons|6|||
161657453|NCT01163292|583795802|FG001|Overall Study|Economic reasons|0|||
161657454|NCT01163292|583795801|FG000|Overall Study|No further visits|5|||
161657455|NCT01163292|583795802|FG001|Overall Study|No further visits|7|||
161657456|NCT02643472|583795806|FG000|Overall Study|Death|2|||
161657457|NCT02643472|583795807|FG001|Overall Study|Death|5|||
161657458|NCT02643472|583795806|FG000|Overall Study|Withdrawal by Subject|3|||
161657459|NCT02643472|583795807|FG001|Overall Study|Withdrawal by Subject|2|||
161657460|NCT02643472|583795806|FG000|Overall Study|Protocol Violation|0|||
161657461|NCT02643472|583795807|FG001|Overall Study|Protocol Violation|1|||
161657462|NCT02643472|583795806|FG000|Overall Study|Lost to Follow-up|22|||
161657463|NCT02643472|583795807|FG001|Overall Study|Lost to Follow-up|26|||
161657464|NCT01258595|583795808|FG000|Overall Study|Lost to Follow-up|1|||
161657465|NCT01258595|583795809|FG001|Overall Study|Lost to Follow-up|0|||
161657466|NCT01258595|583795808|FG000|Overall Study|Withdrawal by Subject|0|||
161657467|NCT01258595|583795809|FG001|Overall Study|Withdrawal by Subject|1|||
161657468|NCT01215188|583795810|FG000|Overall Study|Lost to Follow-up|22|||
161657469|NCT01215188|583795811|FG001|Overall Study|Lost to Follow-up|22|||
161657470|NCT01215188|583795812|FG002|Overall Study|Lost to Follow-up|16|||
161657471|NCT01215188|583795810|FG000|Overall Study|Adverse Event|1|||
161657472|NCT01215188|583795811|FG001|Overall Study|Adverse Event|1|||
161657473|NCT01215188|583795812|FG002|Overall Study|Adverse Event|3|||
161657474|NCT01215188|583795810|FG000|Overall Study|Physician Decision|2|||
161657475|NCT01215188|583795811|FG001|Overall Study|Physician Decision|1|||
161657476|NCT01215188|583795812|FG002|Overall Study|Physician Decision|0|||
161657477|NCT01215188|583795810|FG000|Overall Study|Lack of Efficacy|0|||
161657478|NCT01215188|583795811|FG001|Overall Study|Lack of Efficacy|0|||
161657479|NCT01215188|583795812|FG002|Overall Study|Lack of Efficacy|1|||
161657480|NCT01215188|583795810|FG000|Overall Study|Protocol Violation|1|||
161657481|NCT01215188|583795811|FG001|Overall Study|Protocol Violation|1|||
161657482|NCT01215188|583795812|FG002|Overall Study|Protocol Violation|1|||
161657483|NCT01215188|583795810|FG000|Overall Study|Withdrawal by Subject|32|||
161657484|NCT01215188|583795811|FG001|Overall Study|Withdrawal by Subject|34|||
161657485|NCT01215188|583795812|FG002|Overall Study|Withdrawal by Subject|31|||
161657486|NCT02310100|583795813|FG000|Overall Study|Physician Decision|3|||
161657487|NCT02310100|583795813|FG000|Overall Study|Withdrawal by Subject|10|||
161657488|NCT02310100|583795813|FG000|Overall Study|Enrollment closure|1|||
161657489|NCT02310100|583795813|FG000|Overall Study|Unapproved ablation operator|1|||
161657490|NCT02310100|583795813|FG000|Overall Study|Visit compliance|1|||
161657491|NCT02310100|583795813|FG000|Overall Study|Lost to Follow-up|2|||
161657492|NCT01820585|583795820|FG000|Overall Study|Adverse Event|9|||
161657493|NCT01820585|583795821|FG001|Overall Study|Adverse Event|13|||
161657494|NCT01820585|583795822|FG002|Overall Study|Adverse Event|23|||
161657495|NCT01820585|583795823|FG003|Overall Study|Adverse Event|34|||
161657496|NCT01820585|583795820|FG000|Overall Study|Lack of Efficacy|9|||
161657497|NCT01820585|583795821|FG001|Overall Study|Lack of Efficacy|7|||
161657498|NCT01820585|583795822|FG002|Overall Study|Lack of Efficacy|5|||
161657499|NCT01820585|583795823|FG003|Overall Study|Lack of Efficacy|1|||
161657500|NCT01820585|583795820|FG000|Overall Study|Withdrawal by Subject|3|||
161657501|NCT01820585|583795821|FG001|Overall Study|Withdrawal by Subject|7|||
161657502|NCT01820585|583795822|FG002|Overall Study|Withdrawal by Subject|3|||
161657503|NCT01820585|583795823|FG003|Overall Study|Withdrawal by Subject|8|||
161657504|NCT01820585|583795820|FG000|Overall Study|Lost to Follow-up|3|||
161657505|NCT01820585|583795821|FG001|Overall Study|Lost to Follow-up|3|||
161657506|NCT01820585|583795822|FG002|Overall Study|Lost to Follow-up|0|||
161657507|NCT01820585|583795823|FG003|Overall Study|Lost to Follow-up|3|||
161657508|NCT01820585|583795820|FG000|Overall Study|Protocol Violation|3|||
161657509|NCT01820585|583795821|FG001|Overall Study|Protocol Violation|1|||
161657510|NCT01820585|583795822|FG002|Overall Study|Protocol Violation|1|||
161657511|NCT01820585|583795823|FG003|Overall Study|Protocol Violation|1|||
161657512|NCT01820585|583795820|FG000|Overall Study|Subject non-compliance|0|||
161657513|NCT01820585|583795821|FG001|Overall Study|Subject non-compliance|0|||
161657514|NCT01820585|583795822|FG002|Overall Study|Subject non-compliance|1|||
161657515|NCT01820585|583795823|FG003|Overall Study|Subject non-compliance|2|||
161657516|NCT01820585|583795820|FG000|Overall Study|at sponsor request|0|||
161657517|NCT01820585|583795821|FG001|Overall Study|at sponsor request|0|||
161657518|NCT01820585|583795822|FG002|Overall Study|at sponsor request|1|||
161657519|NCT01820585|583795823|FG003|Overall Study|at sponsor request|0|||
161657520|NCT01820585|583795820|FG000|Overall Study|Pregnancy|0|||
161657521|NCT01820585|583795821|FG001|Overall Study|Pregnancy|1|||
161657522|NCT01820585|583795822|FG002|Overall Study|Pregnancy|0|||
161657523|NCT01820585|583795823|FG003|Overall Study|Pregnancy|0|||
161657524|NCT03592745|583795826|FG000|Overall Study|Adverse Event|0|||
161657525|NCT03592745|583795827|FG001|Overall Study|Adverse Event|2|||
161657526|NCT03592745|583795826|FG000|Overall Study|Lost to Follow-up|2|||
161657527|NCT03592745|583795827|FG001|Overall Study|Lost to Follow-up|0|||
161657528|NCT03592745|583795826|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
161657529|NCT03592745|583795827|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
161657530|NCT00293059|583795828|FG000|Overall Study|Adverse Event|12|||
161657531|NCT00293059|583795829|FG001|Overall Study|Adverse Event|4|||
161657532|NCT00293059|583795828|FG000|Overall Study|Lack of Efficacy|2|||
161657533|NCT00293059|583795829|FG001|Overall Study|Lack of Efficacy|0|||
161657534|NCT00293059|583795828|FG000|Overall Study|Lost to Follow-up|2|||
161657535|NCT00293059|583795829|FG001|Overall Study|Lost to Follow-up|3|||
161657536|NCT00293059|583795828|FG000|Overall Study|Pregnancy|1|||
161657537|NCT00293059|583795829|FG001|Overall Study|Pregnancy|1|||
161657538|NCT00293059|583795828|FG000|Overall Study|Protocol Violation|2|||
161657539|NCT00293059|583795829|FG001|Overall Study|Protocol Violation|0|||
161657540|NCT00293059|583795828|FG000|Overall Study|Withdrawal by Subject|11|||
161657541|NCT00293059|583795829|FG001|Overall Study|Withdrawal by Subject|5|||
161657542|NCT00293059|583795828|FG000|Overall Study|Participant moved out of state|1|||
161657543|NCT00293059|583795829|FG001|Overall Study|Participant moved out of state|0|||
161657544|NCT00293059|583795828|FG000|Overall Study|Participant stopped study drug|1|||
161657545|NCT00293059|583795829|FG001|Overall Study|Participant stopped study drug|0|||
161657546|NCT00293059|583795828|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
161657547|NCT00293059|583795829|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
161657548|NCT00293059|583795828|FG000|Overall Study|missing|3|||
161657549|NCT00293059|583795829|FG001|Overall Study|missing|5|||
161657550|NCT04362189|583795833|FG000|Overall Study|Lost to Follow-up|0|||
161657551|NCT04362189|583795834|FG001|Overall Study|Lost to Follow-up|1|||
161657552|NCT04362189|583795833|FG000|Overall Study|Withdrawal by Subject|1|||
161657553|NCT04362189|583795834|FG001|Overall Study|Withdrawal by Subject|0|||
161657554|NCT04362189|583795833|FG000|Overall Study|FDA Clinical Hold|7|||
161657555|NCT04362189|583795834|FG001|Overall Study|FDA Clinical Hold|2|||
161657556|NCT04362189|583795833|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
161657557|NCT04362189|583795834|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
161657558|NCT04362189|583795833|FG000|Overall Study|Adverse Event|0|||
161657559|NCT04362189|583795834|FG001|Overall Study|Adverse Event|2|||
161657560|NCT04362189|583795833|FG000|Overall Study|Death|4|||
161657561|NCT04362189|583795834|FG001|Overall Study|Death|1|||
161657562|NCT02111681|583795835|FG000|Overall Study|Death|5|||
161657563|NCT02111681|583795835|FG000|Overall Study|Lack of Efficacy|2|||
161657564|NCT02111681|583795835|FG000|Overall Study|Progression of disease|4|||
161657565|NCT03981861|583795836|FG000|Overall Study|Withdrawal by Subject|3|||
161657566|NCT01227577|583797754|FG000|Overall Study|Protocol deviation|3|||
161657567|NCT01227577|583797754|FG000|Overall Study|Death|3|||
161657568|NCT01227577|583797754|FG000|Overall Study|Administrative problems|2|||
161657569|NCT01227577|583797754|FG000|Overall Study|Lost to Follow-up|1|||
161657570|NCT01227577|583797754|FG000|Overall Study|Withdrawal by Subject|4|||
161657571|NCT01227577|583797754|FG000|Overall Study|Lack of Efficacy|5|||
161657572|NCT01227577|583797754|FG000|Overall Study|Adverse Event|17|||
161657573|NCT03809429|583797755|FG000|Overall Study|Withdrawal by Subject|7|||
161657574|NCT03809429|583797756|FG001|Overall Study|Withdrawal by Subject|3|||
161657575|NCT03809429|583797755|FG000|Overall Study|Adverse Event|6|||
161657576|NCT03809429|583797756|FG001|Overall Study|Adverse Event|9|||
161657577|NCT03809429|583797755|FG000|Overall Study|COVID-19|3|||
161657578|NCT03809429|583797756|FG001|Overall Study|COVID-19|1|||
161657579|NCT03809429|583797755|FG000|Overall Study|Participant was discontinued by investigator|12|||
161657580|NCT03809429|583797756|FG001|Overall Study|Participant was discontinued by investigator|7|||
161657581|NCT00836745|583797757|FG000|Overall Study|Death|2|||
161657582|NCT00836745|583797757|FG000|Overall Study|Lost to Follow-up|10|||
161657583|NCT00836745|583797757|FG000|Overall Study|Adverse Event|3|||
161657584|NCT00836745|583797757|FG000|Overall Study|Objective progression or relapse|4|||
161657585|NCT00836745|583797757|FG000|Overall Study|Other|2|||
161657586|NCT01239043|583797760|FG000|Overall Study|Protocol Violation|2|||
161657587|NCT01239043|583797761|FG001|Overall Study|Protocol Violation|1|||
161657588|NCT02929329|583797764|FG000|Overall Study|Withdrawal by Subject|24|||
161657589|NCT02929329|583797765|FG001|Overall Study|Withdrawal by Subject|21|||
161657590|NCT02929329|583797764|FG000|Overall Study|Lost to Follow-up|26|||
161657591|NCT02929329|583797765|FG001|Overall Study|Lost to Follow-up|20|||
161657592|NCT02929329|583797764|FG000|Overall Study|Death|1054|||
161657593|NCT02929329|583797765|FG001|Overall Study|Death|1051|||
161657594|NCT02121301|583797766|FG000|Overall Study|Protocol Violation|1|||
161657595|NCT02121301|583797767|FG001|Overall Study|Protocol Violation|4|||
161657596|NCT02121301|583797768|FG002|Overall Study|Protocol Violation|1|||
161657597|NCT00434213|583797774|FG000|Overall Study|Adverse Event|12|||
161657598|NCT00434213|583797774|FG000|Overall Study|Lack of Efficacy|9|||
161657599|NCT00434213|583797774|FG000|Overall Study|Lost to Follow-up|14|||
161657600|NCT00434213|583797774|FG000|Overall Study|Withdrawal by Subject|7|||
161657601|NCT00434213|583797774|FG000|Overall Study|Protocol Violation|3|||
161657602|NCT00434213|583797774|FG000|Overall Study|Unable to comply with study visit window|2|||
161657603|NCT00434213|583797774|FG000|Overall Study|Application site reaction|1|||
161657604|NCT00434213|583797774|FG000|Overall Study|Non-compliant to study schedule|1|||
161657605|NCT01871805|583797785|FG000|Phase I|Death|7|||
161657606|NCT01871805|583797786|FG001|Phase I|Death|4|||
161657607|NCT01871805|583797787|FG002|Phase I|Death|6|||
161657608|NCT01871805|583797788|FG003|Phase I|Death|2|||
161657609|NCT01871805|583797789|FG004|Phase I|Death|9|||
161657610|NCT01871805|583797790|FG005|Phase I|Death|0|||
161657611|NCT01871805|583797785|FG000|Phase I|Alive in Survival Follow-up|0|||
161657612|NCT01871805|583797786|FG001|Phase I|Alive in Survival Follow-up|2|||
161657613|NCT01871805|583797787|FG002|Phase I|Alive in Survival Follow-up|4|||
161657614|NCT01871805|583797788|FG003|Phase I|Alive in Survival Follow-up|5|||
161657615|NCT01871805|583797789|FG004|Phase I|Alive in Survival Follow-up|4|||
161657616|NCT01871805|583797790|FG005|Phase I|Alive in Survival Follow-up|0|||
161657617|NCT01871805|583797785|FG000|Phase I|Lost to Follow-up|0|||
161657618|NCT01871805|583797786|FG001|Phase I|Lost to Follow-up|1|||
161657619|NCT01871805|583797787|FG002|Phase I|Lost to Follow-up|3|||
161657620|NCT01871805|583797788|FG003|Phase I|Lost to Follow-up|0|||
161710123|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
161710124|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
161710125|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
161710126|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
161710127|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
161710128|NCT02542267|583982366|FG000|Overall Study|Withdrawal by Subject|10|||
161710129|NCT02542267|583982366|FG000|Overall Study|Physician Decision|6|||
161710130|NCT02542267|583982366|FG000|Overall Study|Lost to Follow-up|4|||
161710131|NCT02542267|583982366|FG000|Overall Study|Death|13|||
161710132|NCT02542267|583982366|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
161710133|NCT02542267|583982366|FG000|Overall Study|Other|9|||
161710134|NCT03093402|583982367|FG000|Overall Study|Lost to Follow-up|1|||
161710135|NCT03093402|583982368|FG001|Overall Study|Lost to Follow-up|0|||
161710136|NCT03093402|583982369|FG002|Overall Study|Lost to Follow-up|0|||
161657621|NCT01871805|583797789|FG004|Phase I|Lost to Follow-up|0|||
161657622|NCT01871805|583797790|FG005|Phase I|Lost to Follow-up|0|||
161657623|NCT01871805|583797785|FG000|Phase II|Death|0|||
161657624|NCT01871805|583797786|FG001|Phase II|Death|0|||
161657625|NCT01871805|583797787|FG002|Phase II|Death|0|||
161657626|NCT01871805|583797788|FG003|Phase II|Death|0|||
161657627|NCT01871805|583797789|FG004|Phase II|Death|0|||
161657628|NCT01871805|583797790|FG005|Phase II|Death|45|||
161657629|NCT01871805|583797785|FG000|Phase II|Alive in Survival Follow-up|0|||
161657630|NCT01871805|583797786|FG001|Phase II|Alive in Survival Follow-up|0|||
161710137|NCT03093402|583982370|FG003|Overall Study|Lost to Follow-up|0|||
161710138|NCT03093402|583982367|FG000|Overall Study|Withdrawal by Subject|3|||
161710139|NCT03093402|583982368|FG001|Overall Study|Withdrawal by Subject|3|||
161710140|NCT03093402|583982369|FG002|Overall Study|Withdrawal by Subject|0|||
161657631|NCT01871805|583797787|FG002|Phase II|Alive in Survival Follow-up|0|||
161657632|NCT01871805|583797788|FG003|Phase II|Alive in Survival Follow-up|0|||
161657633|NCT01871805|583797789|FG004|Phase II|Alive in Survival Follow-up|0|||
161657634|NCT01871805|583797790|FG005|Phase II|Alive in Survival Follow-up|29|||
161657635|NCT01871805|583797785|FG000|Phase II|Lost to Follow-up|0|||
161657636|NCT01871805|583797786|FG001|Phase II|Lost to Follow-up|0|||
161657637|NCT01871805|583797787|FG002|Phase II|Lost to Follow-up|0|||
161657638|NCT01871805|583797788|FG003|Phase II|Lost to Follow-up|0|||
161657639|NCT01871805|583797789|FG004|Phase II|Lost to Follow-up|0|||
161657640|NCT01871805|583797790|FG005|Phase II|Lost to Follow-up|13|||
161657641|NCT00941070|583797795|FG000|Overall Study|Patient non-compliant|1|||
161657642|NCT03174431|583797796|FG000|Overall Study|Withdrawal by Subject|14|||
161657643|NCT03174431|583797797|FG001|Overall Study|Withdrawal by Subject|11|||
161657644|NCT03174431|583797796|FG000|Overall Study|alternative treatment|2|||
161657645|NCT03174431|583797797|FG001|Overall Study|alternative treatment|0|||
161657646|NCT03174431|583797796|FG000|Overall Study|Lost to Follow-up|1|||
161657647|NCT03174431|583797797|FG001|Overall Study|Lost to Follow-up|5|||
161657648|NCT03484273|583797802|FG000|Overall Study|Equipment Malfunction|1|||
161657649|NCT03484273|583797802|FG000|Overall Study|Data excluded from analysis|1|||
161657650|NCT00468104|583797808|FG000|First Intervention|Protocol Violation|2|||
161657651|NCT00468104|583797809|FG001|First Intervention|Protocol Violation|1|||
161657652|NCT00468104|583797808|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
161657653|NCT00468104|583797809|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
161657654|NCT00468104|583797808|FG000|First Intervention|died within 3 weeks|1|||
161657655|NCT00468104|583797809|FG001|First Intervention|died within 3 weeks|0|||
161657656|NCT00468104|583797808|FG000|First Intervention|malposition/blocked chest tube tube|2|||
161657657|NCT00468104|583797809|FG001|First Intervention|malposition/blocked chest tube tube|0|||
161657658|NCT00468104|583797808|FG000|First Intervention|large lung mass with minimal effusion|1|||
161657659|NCT00468104|583797809|FG001|First Intervention|large lung mass with minimal effusion|0|||
161657660|NCT00468104|583797808|FG000|First Intervention|associated prolonged pneumothorax|1|||
161657661|NCT00468104|583797809|FG001|First Intervention|associated prolonged pneumothorax|0|||
161657662|NCT00468104|583797808|FG000|First Intervention|trapped lung|1|||
161657663|NCT00468104|583797809|FG001|First Intervention|trapped lung|0|||
161657664|NCT00468104|583797808|FG000|Second Intervention|Withdrawal by Subject|5|||
161657665|NCT00468104|583797809|FG001|Second Intervention|Withdrawal by Subject|2|||
161657666|NCT00468104|583797808|FG000|Second Intervention|discarded for malposition of chest tube|0|||
161657667|NCT00468104|583797809|FG001|Second Intervention|discarded for malposition of chest tube|2|||
161657668|NCT01263665|583797810|FG000|Overall Study|Withdrew Consent|1|||
161657669|NCT01263665|583797810|FG000|Overall Study|Lost to Follow-up|3|||
161657670|NCT01263665|583797810|FG000|Overall Study|Death|2|||
161657671|NCT01263665|583797810|FG000|Overall Study|Amputation above the ankle|1|||
161657672|NCT01263665|583797810|FG000|Overall Study|Surgical Bypass|2|||
161657673|NCT02706899|583797815|FG000|Overall Study|Withdrawal by Subject|1|||
161657674|NCT02706899|583797816|FG001|Overall Study|Withdrawal by Subject|0|||
161657675|NCT02706899|583797815|FG000|Overall Study|Death|8|||
161657676|NCT02706899|583797816|FG001|Overall Study|Death|0|||
161657677|NCT02706899|583797815|FG000|Overall Study|Study Termination by Sponsor|4|||
161657678|NCT02706899|583797816|FG001|Overall Study|Study Termination by Sponsor|6|||
161657679|NCT00324675|583797817|FG000|Overall Study|Adverse Event|1|||
161657680|NCT00324675|583797818|FG001|Overall Study|Adverse Event|0|||
161657681|NCT00381615|583797819|FG000|Overall Study|Withdrawal by Subject|1|||
161657682|NCT00381615|583797820|FG001|Overall Study|Withdrawal by Subject|3|||
161657683|NCT00381615|583797821|FG002|Overall Study|Withdrawal by Subject|0|||
161657684|NCT00381615|583797822|FG003|Overall Study|Withdrawal by Subject|1|||
161657685|NCT00381615|583797819|FG000|Overall Study|Lost to Follow-up|3|||
161657686|NCT00381615|583797820|FG001|Overall Study|Lost to Follow-up|2|||
161657687|NCT00381615|583797821|FG002|Overall Study|Lost to Follow-up|0|||
161657688|NCT00381615|583797822|FG003|Overall Study|Lost to Follow-up|1|||
161657689|NCT00381615|583797819|FG000|Overall Study|Protocol Violation|0|||
161657690|NCT00381615|583797820|FG001|Overall Study|Protocol Violation|0|||
161657691|NCT00381615|583797821|FG002|Overall Study|Protocol Violation|1|||
161657692|NCT00381615|583797822|FG003|Overall Study|Protocol Violation|0|||
161657693|NCT01012414|583797824|FG000|Overall Study|Withdrawal by Subject|2|||
161710141|NCT03093402|583982370|FG003|Overall Study|Withdrawal by Subject|1|||
161710142|NCT03093402|583982367|FG000|Overall Study|Withdrew prior to dosing|2|||
161657694|NCT01012414|583797824|FG000|Overall Study|Lost to Follow-up|1|||
161657695|NCT01012414|583797824|FG000|Overall Study|Trial was stopped before completed|7|||
161657696|NCT02601300|583797825|FG000|Induction Phase|Lack of Efficacy|2|||
161657697|NCT02601300|583797825|FG000|Induction Phase|Protocol Violation|1|||
161657698|NCT02601300|583797825|FG000|Extension Phase|Withdrawal by Subject|3|||
161657699|NCT02601300|583797825|FG000|Extension Phase|Adverse Event|4|||
161657700|NCT02601300|583797825|FG000|Extension Phase|Lack of Efficacy|10|||
161657701|NCT00291642|583797830|FG000|Overall Study|Adverse Event|1|||
161657702|NCT00291642|583797831|FG001|Overall Study|Adverse Event|0|||
161657703|NCT00291642|583797832|FG002|Overall Study|Adverse Event|1|||
161657704|NCT00291642|583797833|FG003|Overall Study|Adverse Event|0|||
161657705|NCT00291642|583797834|FG004|Overall Study|Adverse Event|1|||
161657706|NCT00291642|583797830|FG000|Overall Study|Patient missed visit|0|||
161657707|NCT00291642|583797831|FG001|Overall Study|Patient missed visit|0|||
161657708|NCT00291642|583797832|FG002|Overall Study|Patient missed visit|1|||
161657709|NCT00291642|583797833|FG003|Overall Study|Patient missed visit|0|||
161657710|NCT00291642|583797834|FG004|Overall Study|Patient missed visit|0|||
161657711|NCT00291642|583797830|FG000|Overall Study|Intake of prohibited medication|1|||
161657712|NCT00291642|583797831|FG001|Overall Study|Intake of prohibited medication|0|||
161657713|NCT00291642|583797832|FG002|Overall Study|Intake of prohibited medication|0|||
161657714|NCT00291642|583797833|FG003|Overall Study|Intake of prohibited medication|0|||
161657715|NCT00291642|583797834|FG004|Overall Study|Intake of prohibited medication|0|||
161657716|NCT02544451|583797838|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
161657717|NCT02544451|583797839|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
161657718|NCT02544451|583797840|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
161657719|NCT02544451|583797841|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
161657720|NCT02544451|583797838|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
161657721|NCT02544451|583797839|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
161657722|NCT02544451|583797840|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
161657723|NCT02544451|583797841|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
161657724|NCT02544451|583797838|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
161657725|NCT02544451|583797839|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
161657726|NCT02544451|583797840|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
161657727|NCT02544451|583797841|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
161657728|NCT02544451|583797838|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
161657729|NCT02544451|583797839|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
161657730|NCT02544451|583797840|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
161657731|NCT02544451|583797841|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
161657732|NCT02544451|583797838|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
161657733|NCT02544451|583797839|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
161657734|NCT02544451|583797840|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
161657735|NCT02544451|583797841|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
161657736|NCT02544451|583797838|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
161657737|NCT02544451|583797839|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
161657738|NCT02544451|583797840|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
161657739|NCT02544451|583797841|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
161657740|NCT03001076|583797845|FG000|Overall Study|Withdrawal by patient|2|||
161657741|NCT03001076|583797846|FG001|Overall Study|Withdrawal by patient|0|||
161657742|NCT03001076|583797845|FG000|Overall Study|Other|1|||
161657743|NCT03001076|583797846|FG001|Overall Study|Other|0|||
161657744|NCT03001076|583797845|FG000|Overall Study|Adverse Event|3|||
161657745|NCT03001076|583797846|FG001|Overall Study|Adverse Event|3|||
161657746|NCT03001076|583797845|FG000|Overall Study|Sponsor decision|1|||
161657747|NCT03001076|583797846|FG001|Overall Study|Sponsor decision|0|||
161657748|NCT03001076|583797845|FG000|Overall Study|Lost to Follow-up|0|||
161657749|NCT03001076|583797846|FG001|Overall Study|Lost to Follow-up|2|||
161657750|NCT04602221|583797848|FG000|Overall Study|Discontinuation of trial treatment|0|||
161657751|NCT04602221|583797849|FG001|Overall Study|Discontinuation of trial treatment|0|||
161657752|NCT04602221|583797850|FG002|Overall Study|Discontinuation of trial treatment|1|||
161657753|NCT04602221|583797851|FG003|Overall Study|Discontinuation of trial treatment|0|||
161657754|NCT04602221|583797852|FG004|Overall Study|Discontinuation of trial treatment|0|||
161657755|NCT04602221|583797853|FG005|Overall Study|Discontinuation of trial treatment|0|||
161657756|NCT04602221|583797854|FG006|Overall Study|Discontinuation of trial treatment|0|||
161657757|NCT04602221|583797855|FG007|Overall Study|Discontinuation of trial treatment|0|||
161657758|NCT04602221|583797856|FG008|Overall Study|Discontinuation of trial treatment|0|||
161657759|NCT04602221|583797857|FG009|Overall Study|Discontinuation of trial treatment|0|||
161657760|NCT04602221|583797858|FG010|Overall Study|Discontinuation of trial treatment|0|||
161657761|NCT04602221|583797859|FG011|Overall Study|Discontinuation of trial treatment|0|||
161657762|NCT04602221|583797860|FG012|Overall Study|Discontinuation of trial treatment|0|||
161657763|NCT04602221|583797861|FG013|Overall Study|Discontinuation of trial treatment|0|||
161657764|NCT04602221|583797862|FG014|Overall Study|Discontinuation of trial treatment|0|||
161657765|NCT04602221|583797863|FG015|Overall Study|Discontinuation of trial treatment|0|||
161657766|NCT04602221|583797864|FG016|Overall Study|Discontinuation of trial treatment|0|||
161657767|NCT04602221|583797865|FG017|Overall Study|Discontinuation of trial treatment|0|||
161657768|NCT04602221|583797848|FG000|Overall Study|Other than listed|0|||
161657769|NCT04602221|583797849|FG001|Overall Study|Other than listed|0|||
161657770|NCT04602221|583797850|FG002|Overall Study|Other than listed|0|||
161657771|NCT04602221|583797851|FG003|Overall Study|Other than listed|0|||
161657772|NCT04602221|583797852|FG004|Overall Study|Other than listed|0|||
161657773|NCT04602221|583797853|FG005|Overall Study|Other than listed|0|||
161657774|NCT04602221|583797854|FG006|Overall Study|Other than listed|0|||
161657775|NCT04602221|583797855|FG007|Overall Study|Other than listed|0|||
161657776|NCT04602221|583797856|FG008|Overall Study|Other than listed|0|||
161657777|NCT04602221|583797857|FG009|Overall Study|Other than listed|0|||
161657778|NCT04602221|583797858|FG010|Overall Study|Other than listed|0|||
161657779|NCT04602221|583797859|FG011|Overall Study|Other than listed|0|||
161657780|NCT04602221|583797860|FG012|Overall Study|Other than listed|0|||
161657781|NCT04602221|583797861|FG013|Overall Study|Other than listed|0|||
161657782|NCT04602221|583797862|FG014|Overall Study|Other than listed|0|||
161657783|NCT04602221|583797863|FG015|Overall Study|Other than listed|1|||
161657784|NCT04602221|583797864|FG016|Overall Study|Other than listed|0|||
161657785|NCT04602221|583797865|FG017|Overall Study|Other than listed|1|||
161657786|NCT04602221|583797848|FG000|Overall Study|Withdrawal by Subject|0|||
161657787|NCT04602221|583797849|FG001|Overall Study|Withdrawal by Subject|0|||
161657788|NCT04602221|583797850|FG002|Overall Study|Withdrawal by Subject|0|||
161657789|NCT04602221|583797851|FG003|Overall Study|Withdrawal by Subject|0|||
161657790|NCT04602221|583797852|FG004|Overall Study|Withdrawal by Subject|0|||
161657791|NCT04602221|583797853|FG005|Overall Study|Withdrawal by Subject|0|||
161657792|NCT04602221|583797854|FG006|Overall Study|Withdrawal by Subject|0|||
161657793|NCT04602221|583797855|FG007|Overall Study|Withdrawal by Subject|0|||
161657794|NCT04602221|583797856|FG008|Overall Study|Withdrawal by Subject|0|||
161657795|NCT04602221|583797857|FG009|Overall Study|Withdrawal by Subject|0|||
161710143|NCT03093402|583982368|FG001|Overall Study|Withdrew prior to dosing|1|||
161657796|NCT04602221|583797858|FG010|Overall Study|Withdrawal by Subject|0|||
161657797|NCT04602221|583797859|FG011|Overall Study|Withdrawal by Subject|0|||
161657798|NCT04602221|583797860|FG012|Overall Study|Withdrawal by Subject|1|||
161657799|NCT04602221|583797861|FG013|Overall Study|Withdrawal by Subject|0|||
161657800|NCT04602221|583797862|FG014|Overall Study|Withdrawal by Subject|0|||
161657801|NCT04602221|583797863|FG015|Overall Study|Withdrawal by Subject|0|||
161657802|NCT04602221|583797864|FG016|Overall Study|Withdrawal by Subject|0|||
161657803|NCT04602221|583797865|FG017|Overall Study|Withdrawal by Subject|0|||
161657804|NCT04602221|583797848|FG000|Overall Study|Lost to Follow-up|0|||
161657805|NCT04602221|583797849|FG001|Overall Study|Lost to Follow-up|0|||
161657806|NCT04602221|583797850|FG002|Overall Study|Lost to Follow-up|0|||
161657807|NCT04602221|583797851|FG003|Overall Study|Lost to Follow-up|0|||
161657808|NCT04602221|583797852|FG004|Overall Study|Lost to Follow-up|0|||
161657809|NCT04602221|583797853|FG005|Overall Study|Lost to Follow-up|1|||
161657810|NCT04602221|583797854|FG006|Overall Study|Lost to Follow-up|0|||
161657811|NCT04602221|583797855|FG007|Overall Study|Lost to Follow-up|0|||
161657812|NCT04602221|583797856|FG008|Overall Study|Lost to Follow-up|0|||
161657813|NCT04602221|583797857|FG009|Overall Study|Lost to Follow-up|0|||
161657814|NCT04602221|583797858|FG010|Overall Study|Lost to Follow-up|0|||
161657815|NCT04602221|583797859|FG011|Overall Study|Lost to Follow-up|0|||
161657816|NCT04602221|583797860|FG012|Overall Study|Lost to Follow-up|0|||
161710144|NCT03093402|583982369|FG002|Overall Study|Withdrew prior to dosing|2|||
161710145|NCT03093402|583982370|FG003|Overall Study|Withdrew prior to dosing|3|||
161710146|NCT03093402|583982367|FG000|Overall Study|Ineligible for study|1|||
161710147|NCT03093402|583982368|FG001|Overall Study|Ineligible for study|0|||
161710148|NCT03093402|583982369|FG002|Overall Study|Ineligible for study|0|||
161710149|NCT03093402|583982370|FG003|Overall Study|Ineligible for study|0|||
161710150|NCT03093402|583982367|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
161657817|NCT04602221|583797861|FG013|Overall Study|Lost to Follow-up|0|||
161657818|NCT04602221|583797862|FG014|Overall Study|Lost to Follow-up|0|||
161657819|NCT04602221|583797863|FG015|Overall Study|Lost to Follow-up|0|||
161657820|NCT04602221|583797864|FG016|Overall Study|Lost to Follow-up|0|||
161657821|NCT04602221|583797865|FG017|Overall Study|Lost to Follow-up|0|||
161657822|NCT00844532|583797866|FG000|Overall Study|Death|16|||
161710151|NCT03093402|583982368|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
161710152|NCT03093402|583982369|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
161710153|NCT03093402|583982370|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
161710154|NCT01147497|583982375|FG000|Overall Study|failed insertion|2|||
161710155|NCT01147497|583982376|FG001|Overall Study|failed insertion|0|||
161710156|NCT02731742|583982377|FG000|Overall Study|Death|1|||
161710157|NCT02731742|583982378|FG001|Overall Study|Death|2|||
161710158|NCT02731742|583982379|FG002|Overall Study|Death|5|||
161710159|NCT02731742|583982380|FG003|Overall Study|Death|0|||
161710160|NCT02731742|583982377|FG000|Overall Study|Physician Decision|0|||
161710161|NCT02731742|583982378|FG001|Overall Study|Physician Decision|0|||
161657823|NCT00844532|583797866|FG000|Overall Study|Withdrawal by Subject|16|||
161657824|NCT00844532|583797866|FG000|Overall Study|Lost to Follow-up|7|||
161657825|NCT02576587|583797867|FG000|Baseline|Equipment failure|0|||
161657826|NCT02576587|583797868|FG001|Baseline|Equipment failure|1|||
161657827|NCT02576587|583797867|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
161657828|NCT02576587|583797868|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
161657829|NCT02576587|583797867|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
161657830|NCT02576587|583797868|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
161657831|NCT02576587|583797867|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
161657832|NCT02576587|583797868|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
161657833|NCT01080716|583797869|FG000|Part 1|Physician Decision|1|||
161657834|NCT01080716|583797870|FG001|Part 1|Physician Decision|0|||
161657835|NCT01080716|583797871|FG002|Part 1|Physician Decision|0|||
161657836|NCT01080716|583797872|FG003|Part 1|Physician Decision|0|||
161657837|NCT01056718|583797873|FG000|Overall Study|Withdrawal by Subject|2|||
161657838|NCT01056718|583797873|FG000|Overall Study|Ischemia on baseline stress test|1|||
161657839|NCT03590366|583797874|FG000|Overall Study|Adverse Event|0|||
161657840|NCT03590366|583797875|FG001|Overall Study|Adverse Event|3|||
161657841|NCT03590366|583797874|FG000|Overall Study|Lost to Follow-up|3|||
161657842|NCT03590366|583797875|FG001|Overall Study|Lost to Follow-up|3|||
161657843|NCT03590366|583797874|FG000|Overall Study|Withdrawal by Subject|0|||
161657844|NCT03590366|583797875|FG001|Overall Study|Withdrawal by Subject|2|||
161657845|NCT00738894|583797876|FG000|Overall Study|Lost to Follow-up|23|||
161657846|NCT00738894|583797877|FG001|Overall Study|Lost to Follow-up|13|||
161657847|NCT00738894|583797876|FG000|Overall Study|Withdrawal by Subject|10|||
161657848|NCT00738894|583797877|FG001|Overall Study|Withdrawal by Subject|15|||
161657849|NCT00738894|583797876|FG000|Overall Study|Physician Decision|4|||
161657850|NCT00738894|583797877|FG001|Overall Study|Physician Decision|5|||
161657851|NCT00738894|583797876|FG000|Overall Study|Death|2|||
161657852|NCT00738894|583797877|FG001|Overall Study|Death|0|||
161657853|NCT05017103|583797878|FG000|Overall Study|Death|2|||
161657854|NCT02656329|583797879|FG000|Overall Study|Lost to Follow-up|2|||
161657855|NCT02656329|583797880|FG001|Overall Study|Lost to Follow-up|3|||
161657856|NCT02656329|583797879|FG000|Overall Study|Withdrawal by Subject|7|||
161657857|NCT02656329|583797880|FG001|Overall Study|Withdrawal by Subject|6|||
161657858|NCT02656329|583797879|FG000|Overall Study|Study termination by Sponsor|150|||
161657859|NCT02656329|583797880|FG001|Overall Study|Study termination by Sponsor|142|||
161657860|NCT02656329|583797879|FG000|Overall Study|Other than specified above|5|||
161657861|NCT02656329|583797880|FG001|Overall Study|Other than specified above|6|||
161657862|NCT01081665|583797882|FG000|Overall Study|Death|41|||
161657863|NCT01081665|583797882|FG000|Overall Study|Lost to Follow-up|18|||
161657864|NCT01081665|583797882|FG000|Overall Study|Withdrawal by Subject|17|||
161657865|NCT01081665|583797882|FG000|Overall Study|Change of dialysis unit|10|||
161657866|NCT01081665|583797882|FG000|Overall Study|Regulation of iPTH|5|||
161657867|NCT01081665|583797882|FG000|Overall Study|Change in renal replacement therapy|2|||
161657868|NCT01081665|583797882|FG000|Overall Study|Adverse Event|1|||
161657869|NCT01081665|583797882|FG000|Overall Study|Lack of Efficacy|1|||
161657870|NCT02546921|583797895|FG000|Overall Study|Adverse Event|0|||
161657871|NCT02546921|583797896|FG001|Overall Study|Adverse Event|5|||
161657872|NCT02546921|583797897|FG002|Overall Study|Adverse Event|2|||
161657873|NCT02546921|583797898|FG003|Overall Study|Adverse Event|0|||
161657874|NCT02546921|583797899|FG004|Overall Study|Adverse Event|0|||
161657875|NCT02546921|583797900|FG005|Overall Study|Adverse Event|0|||
161657876|NCT02546921|583797901|FG006|Overall Study|Adverse Event|0|||
161657877|NCT02546921|583797895|FG000|Overall Study|Evidence of Disease Progression|1|||
161657878|NCT02546921|583797896|FG001|Overall Study|Evidence of Disease Progression|0|||
161710162|NCT02731742|583982379|FG002|Overall Study|Physician Decision|0|||
161657879|NCT02546921|583797897|FG002|Overall Study|Evidence of Disease Progression|0|||
161657880|NCT02546921|583797898|FG003|Overall Study|Evidence of Disease Progression|0|||
161657881|NCT02546921|583797899|FG004|Overall Study|Evidence of Disease Progression|1|||
161710163|NCT02731742|583982380|FG003|Overall Study|Physician Decision|1|||
161657882|NCT02546921|583797900|FG005|Overall Study|Evidence of Disease Progression|0|||
161710164|NCT02731742|583982377|FG000|Overall Study|Study Terminated by Sponsor|2|||
161837863|NCT01340768|584450230|FG001|Overall Study|Withdrawal by Subject|1|||
161837864|NCT01340768|584450229|FG000|Overall Study|Other|2|||
161837865|NCT01340768|584450230|FG001|Overall Study|Other|0|||
161837866|NCT03052959|584450235|FG000|Overall Study|Lost to Follow-up|4|||
161837867|NCT03052959|584450236|FG001|Overall Study|Lost to Follow-up|5|||
161837868|NCT02397408|584450237|FG000|Overall Study|Physician Decision|4|||
161837869|NCT02397408|584450237|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
161837870|NCT01683838|584450238|FG000|Overall Study|Adverse Event|12|||
161837871|NCT01683838|584450239|FG001|Overall Study|Adverse Event|2|||
161837872|NCT01683838|584450238|FG000|Overall Study|Protocol Violation|3|||
161837873|NCT01683838|584450239|FG001|Overall Study|Protocol Violation|1|||
161837874|NCT01683838|584450238|FG000|Overall Study|Withdrawal by Subject|6|||
161657883|NCT02546921|583797901|FG006|Overall Study|Evidence of Disease Progression|0|||
161657884|NCT02546921|583797895|FG000|Overall Study|Patient Choice|0|||
161657885|NCT02546921|583797896|FG001|Overall Study|Patient Choice|1|||
161657886|NCT02546921|583797897|FG002|Overall Study|Patient Choice|0|||
161657887|NCT02546921|583797898|FG003|Overall Study|Patient Choice|0|||
161657888|NCT02546921|583797899|FG004|Overall Study|Patient Choice|0|||
161657889|NCT02546921|583797900|FG005|Overall Study|Patient Choice|1|||
161657890|NCT02546921|583797901|FG006|Overall Study|Patient Choice|0|||
161657891|NCT01413503|583797902|FG000|Overall Study|Lost to Follow-up|1|||
161657892|NCT01373151|583797903|FG000|Period 1|Lack of Efficacy|3|||
161657893|NCT01373151|583797904|FG001|Period 1|Lack of Efficacy|0|||
161657894|NCT01373151|583797905|FG002|Period 1|Lack of Efficacy|0|||
161657895|NCT01373151|583797906|FG003|Period 1|Lack of Efficacy|0|||
161657896|NCT01373151|583797907|FG004|Period 1|Lack of Efficacy|1|||
161657897|NCT01373151|583797908|FG005|Period 1|Lack of Efficacy|0|||
161657898|NCT01373151|583797909|FG006|Period 1|Lack of Efficacy|0|||
161657899|NCT01373151|583797903|FG000|Period 1|Adverse Event|0|||
161657900|NCT01373151|583797904|FG001|Period 1|Adverse Event|0|||
161657901|NCT01373151|583797905|FG002|Period 1|Adverse Event|1|||
161657902|NCT01373151|583797906|FG003|Period 1|Adverse Event|0|||
161657903|NCT01373151|583797907|FG004|Period 1|Adverse Event|4|||
161657904|NCT01373151|583797908|FG005|Period 1|Adverse Event|3|||
161657905|NCT01373151|583797909|FG006|Period 1|Adverse Event|0|||
161657906|NCT01373151|583797903|FG000|Period 1|Withdrawal by Subject|2|||
161657907|NCT01373151|583797904|FG001|Period 1|Withdrawal by Subject|0|||
161657908|NCT01373151|583797905|FG002|Period 1|Withdrawal by Subject|3|||
161657909|NCT01373151|583797906|FG003|Period 1|Withdrawal by Subject|1|||
161657910|NCT01373151|583797907|FG004|Period 1|Withdrawal by Subject|0|||
161657911|NCT01373151|583797908|FG005|Period 1|Withdrawal by Subject|1|||
161657912|NCT01373151|583797909|FG006|Period 1|Withdrawal by Subject|0|||
161657913|NCT01373151|583797903|FG000|Period 2|Lack of Efficacy|9|||
161657914|NCT01373151|583797904|FG001|Period 2|Lack of Efficacy|0|||
161657915|NCT01373151|583797905|FG002|Period 2|Lack of Efficacy|0|||
161657916|NCT01373151|583797906|FG003|Period 2|Lack of Efficacy|1|||
161657917|NCT01373151|583797907|FG004|Period 2|Lack of Efficacy|2|||
161657918|NCT01373151|583797908|FG005|Period 2|Lack of Efficacy|0|||
161657919|NCT01373151|583797909|FG006|Period 2|Lack of Efficacy|3|||
161657920|NCT01373151|583797903|FG000|Period 2|Adverse Event|0|||
161657921|NCT01373151|583797904|FG001|Period 2|Adverse Event|0|||
161657922|NCT01373151|583797905|FG002|Period 2|Adverse Event|3|||
161657923|NCT01373151|583797906|FG003|Period 2|Adverse Event|3|||
161657924|NCT01373151|583797907|FG004|Period 2|Adverse Event|0|||
161657925|NCT01373151|583797908|FG005|Period 2|Adverse Event|0|||
161657926|NCT01373151|583797909|FG006|Period 2|Adverse Event|1|||
161657927|NCT01373151|583797903|FG000|Period 2|subject request to discontinue|0|||
161837875|NCT01683838|584450239|FG001|Overall Study|Withdrawal by Subject|5|||
161837876|NCT01683838|584450238|FG000|Overall Study|Lost to Follow-up|1|||
161837877|NCT01683838|584450239|FG001|Overall Study|Lost to Follow-up|1|||
161837878|NCT01683838|584450238|FG000|Overall Study|Other|4|||
161837879|NCT01683838|584450239|FG001|Overall Study|Other|3|||
161837880|NCT01646138|584450240|FG000|Overall Study|Lost to Follow-up|0|||
161837881|NCT01646138|584450241|FG001|Overall Study|Lost to Follow-up|0|||
161837882|NCT01646138|584450242|FG002|Overall Study|Lost to Follow-up|0|||
161837883|NCT01646138|584450243|FG003|Overall Study|Lost to Follow-up|0|||
161837884|NCT01646138|584450244|FG004|Overall Study|Lost to Follow-up|2|||
161657928|NCT01373151|583797904|FG001|Period 2|subject request to discontinue|1|||
161657929|NCT01373151|583797905|FG002|Period 2|subject request to discontinue|0|||
161657930|NCT01373151|583797906|FG003|Period 2|subject request to discontinue|0|||
161657931|NCT01373151|583797907|FG004|Period 2|subject request to discontinue|0|||
161837885|NCT04049617|584450245|FG000|Overall Study|Adverse Event|0|||
161657932|NCT01373151|583797908|FG005|Period 2|subject request to discontinue|0|||
161657933|NCT01373151|583797909|FG006|Period 2|subject request to discontinue|0|||
161657934|NCT01373151|583797903|FG000|Period 2|Withdrawal by Subject|0|||
161657935|NCT01373151|583797904|FG001|Period 2|Withdrawal by Subject|0|||
161657936|NCT01373151|583797905|FG002|Period 2|Withdrawal by Subject|0|||
161657937|NCT01373151|583797906|FG003|Period 2|Withdrawal by Subject|1|||
161657938|NCT01373151|583797907|FG004|Period 2|Withdrawal by Subject|0|||
161837886|NCT04049617|584450246|FG001|Overall Study|Adverse Event|0|||
161837887|NCT04049617|584450247|FG002|Overall Study|Adverse Event|0|||
161657939|NCT01373151|583797908|FG005|Period 2|Withdrawal by Subject|0|||
161657940|NCT01373151|583797909|FG006|Period 2|Withdrawal by Subject|0|||
161657941|NCT01373151|583797903|FG000|Period 2|Other|0|||
161657942|NCT01373151|583797904|FG001|Period 2|Other|0|||
161657943|NCT01373151|583797905|FG002|Period 2|Other|1|||
161657944|NCT01373151|583797906|FG003|Period 2|Other|0|||
161657945|NCT01373151|583797907|FG004|Period 2|Other|0|||
161657946|NCT01373151|583797908|FG005|Period 2|Other|0|||
161657947|NCT01373151|583797909|FG006|Period 2|Other|1|||
161657948|NCT03026075|583797913|FG000|Overall Study|Physician Decision|1|||
161657949|NCT03381339|583797914|FG000|Overall Study|Protocol Violation|4|||
161657950|NCT03381339|583797915|FG001|Overall Study|Protocol Violation|3|||
161657951|NCT03381339|583797914|FG000|Overall Study|Lost to Follow-up|0|||
161657952|NCT03381339|583797915|FG001|Overall Study|Lost to Follow-up|1|||
161657953|NCT02001064|583797917|FG000|Overall Study|Withdrawal by Subject|2|||
161657954|NCT02001064|583797918|FG001|Overall Study|Withdrawal by Subject|1|||
161657955|NCT00545753|583797919|FG000|Overall Study|Withdrawal by Subject|0|||
161657956|NCT00545753|583797920|FG001|Overall Study|Withdrawal by Subject|1|||
161657957|NCT00545753|583797921|FG002|Overall Study|Withdrawal by Subject|10|||
161657958|NCT00545753|583797919|FG000|Overall Study|Lost to Follow-up|13|||
161657959|NCT00545753|583797920|FG001|Overall Study|Lost to Follow-up|3|||
161657960|NCT00545753|583797921|FG002|Overall Study|Lost to Follow-up|12|||
161710165|NCT02731742|583982378|FG001|Overall Study|Study Terminated by Sponsor|1|||
161710166|NCT02731742|583982379|FG002|Overall Study|Study Terminated by Sponsor|1|||
161710167|NCT02731742|583982380|FG003|Overall Study|Study Terminated by Sponsor|1|||
161710168|NCT04026568|583982381|FG000|Overall Study|study terminated|0|||
161710169|NCT04026568|583982382|FG001|Overall Study|study terminated|1|||
161710170|NCT01974323|583982383|FG000|Overall Study|Other Reasons|25|||
161657961|NCT00545753|583797919|FG000|Overall Study|Protocol Violation|3|||
161657962|NCT00545753|583797920|FG001|Overall Study|Protocol Violation|1|||
161657963|NCT00545753|583797921|FG002|Overall Study|Protocol Violation|4|||
161657964|NCT01011153|583797922|FG000|Overall Study|Less than 78 cases completed|8|||
161657965|NCT01011153|583797923|FG001|Overall Study|Less than 78 cases completed|11|||
161657966|NCT01011153|583797924|FG002|Overall Study|Less than 78 cases completed|9|||
161657967|NCT03014479|583797929|FG000|Overall Study|Adverse Event|0|||
161657968|NCT03014479|583797930|FG001|Overall Study|Adverse Event|1|||
161657969|NCT03014479|583797929|FG000|Overall Study|Voluntary Withdrawal|0|||
161657970|NCT03014479|583797930|FG001|Overall Study|Voluntary Withdrawal|2|||
161657971|NCT03014479|583797929|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
161657972|NCT03014479|583797930|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
161657973|NCT01081132|583797936|FG000|Overall Study|Lack of Efficacy|25|||
161657974|NCT01081132|583797937|FG001|Overall Study|Lack of Efficacy|9|||
161657975|NCT01081132|583797936|FG000|Overall Study|Withdrawal by Subject|13|||
161657976|NCT01081132|583797937|FG001|Overall Study|Withdrawal by Subject|16|||
161657977|NCT01081132|583797936|FG000|Overall Study|Lost to Follow-up|4|||
161657978|NCT01081132|583797937|FG001|Overall Study|Lost to Follow-up|11|||
161657979|NCT01081132|583797936|FG000|Overall Study|Adverse Event|3|||
161657980|NCT01081132|583797937|FG001|Overall Study|Adverse Event|9|||
161657981|NCT01081132|583797936|FG000|Overall Study|Non Compliance|4|||
161657982|NCT01081132|583797937|FG001|Overall Study|Non Compliance|2|||
161657983|NCT01081132|583797936|FG000|Overall Study|Lack Of Compliance|0|||
161657984|NCT01081132|583797937|FG001|Overall Study|Lack Of Compliance|1|||
161657985|NCT01081132|583797936|FG000|Overall Study|Missed Visits|1|||
161657986|NCT01081132|583797937|FG001|Overall Study|Missed Visits|1|||
161657987|NCT01081132|583797936|FG000|Overall Study|Stopped Taking Meds|2|||
161657988|NCT01081132|583797937|FG001|Overall Study|Stopped Taking Meds|0|||
161657989|NCT01081132|583797936|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
161657990|NCT01081132|583797937|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
161657991|NCT01081132|583797936|FG000|Overall Study|Declined Taper Phase|0|||
161657992|NCT01081132|583797937|FG001|Overall Study|Declined Taper Phase|1|||
161657993|NCT01081132|583797936|FG000|Overall Study|Protocol Violation|3|||
161657994|NCT01081132|583797937|FG001|Overall Study|Protocol Violation|1|||
161657995|NCT02101385|583797938|FG000|Study Treatment|Disease Progression|9|||
161657996|NCT02101385|583797939|FG001|Study Treatment|Disease Progression|3|||
161657997|NCT02101385|583797938|FG000|Study Treatment|Alternative therapy|0|||
161657998|NCT02101385|583797939|FG001|Study Treatment|Alternative therapy|1|||
161657999|NCT02101385|583797938|FG000|Study Treatment|No treatment, per protocol criteria|0|||
161658000|NCT02101385|583797939|FG001|Study Treatment|No treatment, per protocol criteria|4|||
161710171|NCT01974323|583982384|FG001|Overall Study|Other Reasons|28|||
161837888|NCT04049617|584450248|FG003|Overall Study|Adverse Event|1|||
161658001|NCT02101385|583797938|FG000|Study Treatment|Patient Non compliance|0|||
161658002|NCT02101385|583797939|FG001|Study Treatment|Patient Non compliance|2|||
161658003|NCT02101385|583797938|FG000|Study Treatment|Withdrawal by Subject|5|||
161658004|NCT02101385|583797939|FG001|Study Treatment|Withdrawal by Subject|2|||
161658005|NCT02101385|583797938|FG000|Study Treatment|screen failure|1|||
161710172|NCT01974323|583982383|FG000|Overall Study|Protocol Violation|2|||
161658006|NCT02101385|583797939|FG001|Study Treatment|screen failure|0|||
161658007|NCT02101385|583797938|FG000|Study Treatment|AE/Side Effects/Complications|8|||
161658008|NCT02101385|583797939|FG001|Study Treatment|AE/Side Effects/Complications|0|||
161658009|NCT02101385|583797938|FG000|Study Treatment|Lost to Follow-up|1|||
161658010|NCT02101385|583797939|FG001|Study Treatment|Lost to Follow-up|0|||
161658011|NCT02101385|583797938|FG000|Study Treatment|Disease Progression before treatment|1|||
161658012|NCT02101385|583797939|FG001|Study Treatment|Disease Progression before treatment|0|||
161658013|NCT02101385|583797938|FG000|Study Treatment|Death|1|||
161658014|NCT02101385|583797939|FG001|Study Treatment|Death|0|||
161658015|NCT02101385|583797938|FG000|Follow up|Lost to Follow-up|4|||
161658016|NCT02101385|583797939|FG001|Follow up|Lost to Follow-up|9|||
161658017|NCT02101385|583797938|FG000|Follow up|Refused to follow up|5|||
161658018|NCT02101385|583797939|FG001|Follow up|Refused to follow up|4|||
161658019|NCT02101385|583797938|FG000|Follow up|Death|21|||
161658020|NCT02101385|583797939|FG001|Follow up|Death|39|||
161658021|NCT02101385|583797938|FG000|Follow up|study completed|33|||
161658022|NCT02101385|583797939|FG001|Follow up|study completed|52|||
161658023|NCT02101385|583797938|FG000|Follow up|screen failure|2|||
161658024|NCT02101385|583797939|FG001|Follow up|screen failure|0|||
161658025|NCT02101385|583797938|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
161658026|NCT02101385|583797939|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
161658027|NCT02101385|583797938|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
161658028|NCT02101385|583797939|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
161658029|NCT02101385|583797938|FG000|Follow up|Withdrawal by Subject|2|||
161658030|NCT02101385|583797939|FG001|Follow up|Withdrawal by Subject|2|||
161658031|NCT02101385|583797938|FG000|Follow up|PI requested closure of site|0|||
161658032|NCT02101385|583797939|FG001|Follow up|PI requested closure of site|5|||
161658033|NCT03973931|583797946|FG000|Overall Study|Lost to Follow-up|47|||
161658034|NCT03973931|583797947|FG001|Overall Study|Lost to Follow-up|63|||
161658035|NCT03973931|583797948|FG002|Overall Study|Lost to Follow-up|51|||
161658036|NCT03973931|583797949|FG003|Overall Study|Lost to Follow-up|54|||
161658037|NCT03973931|583797946|FG000|Overall Study|opted out|6|||
161658038|NCT03973931|583797947|FG001|Overall Study|opted out|5|||
161658039|NCT03973931|583797948|FG002|Overall Study|opted out|5|||
161658040|NCT03973931|583797949|FG003|Overall Study|opted out|1|||
161658041|NCT03541174|583799144|FG000|Part 1 Double-Blind|Adverse Event|6|||
161658042|NCT03541174|583799145|FG001|Part 1 Double-Blind|Adverse Event|5|||
161658043|NCT03541174|583799146|FG002|Part 1 Double-Blind|Adverse Event|2|||
161658044|NCT03541174|583799147|FG003|Part 1 Double-Blind|Adverse Event|0|||
161658045|NCT03541174|583799148|FG004|Part 1 Double-Blind|Adverse Event|0|||
161658046|NCT03541174|583799149|FG005|Part 1 Double-Blind|Adverse Event|0|||
161658047|NCT03541174|583799144|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
161658048|NCT03541174|583799145|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
161658049|NCT03541174|583799146|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
161658050|NCT03541174|583799147|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
161658051|NCT03541174|583799148|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
161658052|NCT03541174|583799149|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
161658053|NCT03541174|583799144|FG000|Part 1 Double-Blind|Other reasons|3|||
161658054|NCT03541174|583799145|FG001|Part 1 Double-Blind|Other reasons|2|||
161658055|NCT03541174|583799146|FG002|Part 1 Double-Blind|Other reasons|3|||
161658056|NCT03541174|583799147|FG003|Part 1 Double-Blind|Other reasons|0|||
161658057|NCT03541174|583799148|FG004|Part 1 Double-Blind|Other reasons|0|||
161658058|NCT03541174|583799149|FG005|Part 1 Double-Blind|Other reasons|0|||
161658059|NCT03541174|583799144|FG000|Part 2 Single-Blind|Adverse Event|0|||
161658060|NCT03541174|583799145|FG001|Part 2 Single-Blind|Adverse Event|0|||
161658061|NCT03541174|583799146|FG002|Part 2 Single-Blind|Adverse Event|0|||
161658062|NCT03541174|583799147|FG003|Part 2 Single-Blind|Adverse Event|25|||
161658063|NCT03541174|583799148|FG004|Part 2 Single-Blind|Adverse Event|0|||
161658064|NCT03541174|583799149|FG005|Part 2 Single-Blind|Adverse Event|0|||
161658065|NCT03541174|583799144|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
161658066|NCT03541174|583799145|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
161658067|NCT03541174|583799146|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
161658068|NCT03541174|583799147|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
161658069|NCT03541174|583799148|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
161658070|NCT03541174|583799149|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
161658071|NCT03541174|583799144|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
161658072|NCT03541174|583799145|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
161658073|NCT03541174|583799146|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
161658074|NCT03541174|583799147|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
161658075|NCT03541174|583799148|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
161658076|NCT03541174|583799149|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
161658077|NCT03541174|583799144|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
161658078|NCT03541174|583799145|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
161658079|NCT03541174|583799146|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
161658080|NCT03541174|583799147|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
161658081|NCT03541174|583799148|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
161658082|NCT03541174|583799149|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
161658083|NCT03541174|583799144|FG000|Part 2 Single-Blind|Death|0|||
161658084|NCT03541174|583799145|FG001|Part 2 Single-Blind|Death|0|||
161658085|NCT03541174|583799146|FG002|Part 2 Single-Blind|Death|0|||
161658086|NCT03541174|583799147|FG003|Part 2 Single-Blind|Death|5|||
161658087|NCT03541174|583799148|FG004|Part 2 Single-Blind|Death|0|||
161658088|NCT03541174|583799149|FG005|Part 2 Single-Blind|Death|0|||
161658089|NCT03541174|583799144|FG000|Part 2 Single-Blind|Pregnancy|0|||
161658090|NCT03541174|583799145|FG001|Part 2 Single-Blind|Pregnancy|0|||
161658091|NCT03541174|583799146|FG002|Part 2 Single-Blind|Pregnancy|0|||
161658092|NCT03541174|583799147|FG003|Part 2 Single-Blind|Pregnancy|1|||
161658093|NCT03541174|583799148|FG004|Part 2 Single-Blind|Pregnancy|0|||
161658094|NCT03541174|583799149|FG005|Part 2 Single-Blind|Pregnancy|0|||
161658095|NCT03541174|583799144|FG000|Part 2 Single-Blind|Other reasons|0|||
161658096|NCT03541174|583799145|FG001|Part 2 Single-Blind|Other reasons|0|||
161658097|NCT03541174|583799146|FG002|Part 2 Single-Blind|Other reasons|0|||
161658098|NCT03541174|583799147|FG003|Part 2 Single-Blind|Other reasons|32|||
161658099|NCT03541174|583799148|FG004|Part 2 Single-Blind|Other reasons|0|||
161658100|NCT03541174|583799149|FG005|Part 2 Single-Blind|Other reasons|0|||
161658101|NCT03541174|583799144|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161658102|NCT03541174|583799145|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161658103|NCT03541174|583799146|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161658104|NCT03541174|583799147|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161658105|NCT03541174|583799148|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
161658106|NCT03541174|583799149|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
161658107|NCT03541174|583799144|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161658108|NCT03541174|583799145|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161658109|NCT03541174|583799146|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161658110|NCT03541174|583799147|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161658111|NCT03541174|583799148|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
161658112|NCT03541174|583799149|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
161658113|NCT03541174|583799144|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161658114|NCT03541174|583799145|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161658115|NCT03541174|583799146|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161658116|NCT03541174|583799147|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161658117|NCT03541174|583799148|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161658118|NCT03541174|583799149|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
161658119|NCT03541174|583799144|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161658120|NCT03541174|583799145|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161658121|NCT03541174|583799146|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161658122|NCT03541174|583799147|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161658123|NCT03541174|583799148|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
161658124|NCT03541174|583799149|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
161658125|NCT03541174|583799144|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161658126|NCT03541174|583799145|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161658127|NCT03541174|583799146|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161658128|NCT03541174|583799147|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161658129|NCT03541174|583799148|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
161658130|NCT03541174|583799149|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161658131|NCT00605215|583799150|FG000|Overall Study|Death|0|||
161658132|NCT00605215|583799151|FG001|Overall Study|Death|0|||
161658133|NCT00605215|583799152|FG002|Overall Study|Death|1|||
161658134|NCT00605215|583799150|FG000|Overall Study|Adverse Event|19|||
161658135|NCT00605215|583799151|FG001|Overall Study|Adverse Event|21|||
161658136|NCT00605215|583799152|FG002|Overall Study|Adverse Event|26|||
161658137|NCT00605215|583799150|FG000|Overall Study|Refusal to sign the re-consent form|8|||
161658138|NCT00605215|583799151|FG001|Overall Study|Refusal to sign the re-consent form|3|||
161658139|NCT00605215|583799152|FG002|Overall Study|Refusal to sign the re-consent form|3|||
161837889|NCT04049617|584450249|FG004|Overall Study|Adverse Event|0|||
161658140|NCT00605215|583799150|FG000|Overall Study|Withdrawal by Subject|39|||
161658141|NCT00605215|583799151|FG001|Overall Study|Withdrawal by Subject|37|||
161658142|NCT00605215|583799152|FG002|Overall Study|Withdrawal by Subject|27|||
161658143|NCT00605215|583799150|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
161837890|NCT04049617|584450250|FG005|Overall Study|Adverse Event|0|||
161658144|NCT00605215|583799151|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
161658145|NCT00605215|583799152|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
161658146|NCT00605215|583799150|FG000|Overall Study|Protocol Violation|3|||
161658147|NCT00605215|583799151|FG001|Overall Study|Protocol Violation|4|||
161658148|NCT00605215|583799152|FG002|Overall Study|Protocol Violation|1|||
161658149|NCT00605215|583799150|FG000|Overall Study|Pregnancy|8|||
161658150|NCT00605215|583799151|FG001|Overall Study|Pregnancy|5|||
161658151|NCT00605215|583799152|FG002|Overall Study|Pregnancy|4|||
161658152|NCT00605215|583799150|FG000|Overall Study|Lost to Follow-up|8|||
161658153|NCT00605215|583799151|FG001|Overall Study|Lost to Follow-up|5|||
161658154|NCT00605215|583799152|FG002|Overall Study|Lost to Follow-up|2|||
161658155|NCT00605215|583799150|FG000|Overall Study|Other than specified|0|||
161658156|NCT00605215|583799151|FG001|Overall Study|Other than specified|2|||
161658157|NCT00605215|583799152|FG002|Overall Study|Other than specified|1|||
161658158|NCT00275262|583799159|FG000|Overall Study|Adverse Event|2|||
161658159|NCT00275262|583799160|FG001|Overall Study|Adverse Event|0|||
161658160|NCT00275262|583799159|FG000|Overall Study|Disease progression|2|||
161658161|NCT00275262|583799160|FG001|Overall Study|Disease progression|5|||
161658162|NCT00275262|583799159|FG000|Overall Study|Lost to Follow-up|0|||
161658163|NCT00275262|583799160|FG001|Overall Study|Lost to Follow-up|2|||
161658164|NCT00275262|583799159|FG000|Overall Study|Protocol Violation|0|||
161658165|NCT00275262|583799160|FG001|Overall Study|Protocol Violation|2|||
161658166|NCT00275262|583799159|FG000|Overall Study|Death|1|||
161658167|NCT00275262|583799160|FG001|Overall Study|Death|0|||
161658168|NCT00275262|583799159|FG000|Overall Study|Started Chemotherapy|1|||
161658169|NCT00275262|583799160|FG001|Overall Study|Started Chemotherapy|0|||
161658170|NCT04058366|583799163|FG000|Overall Study|Adverse Event|14|||
161658171|NCT04058366|583799163|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
161658172|NCT04058366|583799163|FG000|Overall Study|Commercial drug is available for participants|6|||
161658173|NCT04058366|583799163|FG000|Overall Study|Death|1|||
161658174|NCT04058366|583799163|FG000|Overall Study|Other non-compliance|2|||
161658175|NCT04058366|583799163|FG000|Overall Study|Other|6|||
161658176|NCT02738203|583799164|FG000|Overall Study|Failed IUD Insertion|2|||
161658177|NCT02738203|583799165|FG001|Overall Study|Failed IUD Insertion|2|||
161658178|NCT02738203|583799164|FG000|Overall Study|Protocol Violation|0|||
161658179|NCT02738203|583799165|FG001|Overall Study|Protocol Violation|1|||
161658180|NCT05087979|583799166|FG000|Overall Study|Converted to general anesthesia|1|||
161658181|NCT05087979|583799167|FG001|Overall Study|Converted to general anesthesia|0|||
161658182|NCT00194987|583799168|FG000|Overall Study|Withdrawal by Subject|0|||
161658183|NCT00194987|583799169|FG001|Overall Study|Withdrawal by Subject|3|||
161658184|NCT01664598|583799170|FG000|Overall Study|Sponsor Decision|1|||
161658185|NCT01664598|583799170|FG000|Overall Study|Withdrawal of Informed Consent|4|||
161658186|NCT01664598|583799170|FG000|Overall Study|Adverse Event|1|||
161658187|NCT04988867|583799177|FG000|Overall Study|Study terminated by Sponsor|12|||
161658188|NCT04988867|583799177|FG000|Overall Study|Adverse Event|2|||
161658189|NCT04988867|583799177|FG000|Overall Study|Study drug noncompliance|1|||
161658190|NCT01097707|583799178|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161658191|NCT01097707|583799179|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161658192|NCT01097707|583799180|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161658193|NCT01097707|583799181|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161658194|NCT01097707|583799182|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161658195|NCT01097707|583799178|FG000|Overall Study|Adverse Event|4|||
161837891|NCT04049617|584450245|FG000|Overall Study|Death|0|||
161658196|NCT01097707|583799179|FG001|Overall Study|Adverse Event|2|||
161658197|NCT01097707|583799180|FG002|Overall Study|Adverse Event|3|||
161658198|NCT01097707|583799181|FG003|Overall Study|Adverse Event|1|||
161658199|NCT01097707|583799182|FG004|Overall Study|Adverse Event|3|||
161658200|NCT01097707|583799178|FG000|Overall Study|Entry Criteria Not Met|2|||
161658201|NCT01097707|583799179|FG001|Overall Study|Entry Criteria Not Met|1|||
161658202|NCT01097707|583799180|FG002|Overall Study|Entry Criteria Not Met|1|||
161710173|NCT01974323|583982384|FG001|Overall Study|Protocol Violation|2|||
161658203|NCT01097707|583799181|FG003|Overall Study|Entry Criteria Not Met|0|||
161658204|NCT01097707|583799182|FG004|Overall Study|Entry Criteria Not Met|1|||
161658205|NCT01097707|583799178|FG000|Overall Study|Lack of Efficacy|1|||
161658206|NCT01097707|583799179|FG001|Overall Study|Lack of Efficacy|0|||
161658207|NCT01097707|583799180|FG002|Overall Study|Lack of Efficacy|0|||
161658208|NCT01097707|583799181|FG003|Overall Study|Lack of Efficacy|1|||
161658209|NCT01097707|583799182|FG004|Overall Study|Lack of Efficacy|0|||
161658210|NCT01097707|583799178|FG000|Overall Study|Lost to Follow-up|1|||
161658211|NCT01097707|583799179|FG001|Overall Study|Lost to Follow-up|1|||
161658212|NCT01097707|583799180|FG002|Overall Study|Lost to Follow-up|2|||
161658213|NCT01097707|583799181|FG003|Overall Study|Lost to Follow-up|0|||
161658214|NCT01097707|583799182|FG004|Overall Study|Lost to Follow-up|3|||
161658215|NCT01097707|583799178|FG000|Overall Study|Protocol Violation|2|||
161658216|NCT01097707|583799179|FG001|Overall Study|Protocol Violation|2|||
161658217|NCT01097707|583799180|FG002|Overall Study|Protocol Violation|3|||
161658218|NCT01097707|583799181|FG003|Overall Study|Protocol Violation|2|||
161658219|NCT01097707|583799182|FG004|Overall Study|Protocol Violation|2|||
161658220|NCT01097707|583799178|FG000|Overall Study|Sponsor Decision|31|||
161658221|NCT01097707|583799179|FG001|Overall Study|Sponsor Decision|31|||
161658222|NCT01097707|583799180|FG002|Overall Study|Sponsor Decision|34|||
161658223|NCT01097707|583799181|FG003|Overall Study|Sponsor Decision|35|||
161658224|NCT01097707|583799182|FG004|Overall Study|Sponsor Decision|36|||
161658225|NCT01097707|583799178|FG000|Overall Study|Withdrawal by Subject|3|||
161658226|NCT01097707|583799179|FG001|Overall Study|Withdrawal by Subject|6|||
161658227|NCT01097707|583799180|FG002|Overall Study|Withdrawal by Subject|1|||
161658228|NCT01097707|583799181|FG003|Overall Study|Withdrawal by Subject|4|||
161658229|NCT01097707|583799182|FG004|Overall Study|Withdrawal by Subject|3|||
161658230|NCT01097707|583799178|FG000|Overall Study|Reason unknown|0|||
161658231|NCT01097707|583799179|FG001|Overall Study|Reason unknown|0|||
161658232|NCT01097707|583799180|FG002|Overall Study|Reason unknown|0|||
161658233|NCT01097707|583799181|FG003|Overall Study|Reason unknown|0|||
161658234|NCT01097707|583799182|FG004|Overall Study|Reason unknown|1|||
161658235|NCT04811131|583799187|FG000|Overall Study|Adverse Event|0|||
161658236|NCT04811131|583799188|FG001|Overall Study|Adverse Event|0|||
161658237|NCT04811131|583799189|FG002|Overall Study|Adverse Event|1|||
161658238|NCT04811131|583799190|FG003|Overall Study|Adverse Event|0|||
161658239|NCT04811131|583799187|FG000|Overall Study|Lack of Efficacy|0|||
161658240|NCT04811131|583799188|FG001|Overall Study|Lack of Efficacy|0|||
161658241|NCT04811131|583799189|FG002|Overall Study|Lack of Efficacy|0|||
161658242|NCT04811131|583799190|FG003|Overall Study|Lack of Efficacy|1|||
161658243|NCT04811131|583799187|FG000|Overall Study|Lost to Follow-up|0|||
161658244|NCT04811131|583799188|FG001|Overall Study|Lost to Follow-up|1|||
161658245|NCT04811131|583799189|FG002|Overall Study|Lost to Follow-up|0|||
161658246|NCT04811131|583799190|FG003|Overall Study|Lost to Follow-up|0|||
161658247|NCT04811131|583799187|FG000|Overall Study|Sponsor request|31|||
161837892|NCT04049617|584450246|FG001|Overall Study|Death|0|||
161837893|NCT04049617|584450247|FG002|Overall Study|Death|0|||
161837894|NCT04049617|584450248|FG003|Overall Study|Death|0|||
161837895|NCT04049617|584450249|FG004|Overall Study|Death|0|||
161837896|NCT04049617|584450250|FG005|Overall Study|Death|1|||
161837897|NCT04049617|584450245|FG000|Overall Study|Lost to Follow-up|0|||
161837898|NCT04049617|584450246|FG001|Overall Study|Lost to Follow-up|0|||
161837899|NCT04049617|584450247|FG002|Overall Study|Lost to Follow-up|0|||
161837900|NCT04049617|584450248|FG003|Overall Study|Lost to Follow-up|1|||
161837901|NCT04049617|584450249|FG004|Overall Study|Lost to Follow-up|0|||
161837902|NCT04049617|584450250|FG005|Overall Study|Lost to Follow-up|0|||
161837903|NCT04049617|584450245|FG000|Overall Study|Withdrew consent|0|||
161837904|NCT04049617|584450246|FG001|Overall Study|Withdrew consent|0|||
161837905|NCT04049617|584450247|FG002|Overall Study|Withdrew consent|1|||
161837906|NCT04049617|584450248|FG003|Overall Study|Withdrew consent|0|||
161658248|NCT04811131|583799188|FG001|Overall Study|Sponsor request|35|||
161658249|NCT04811131|583799189|FG002|Overall Study|Sponsor request|27|||
161658250|NCT04811131|583799190|FG003|Overall Study|Sponsor request|10|||
161837907|NCT04049617|584450249|FG004|Overall Study|Withdrew consent|0|||
161837908|NCT04049617|584450250|FG005|Overall Study|Withdrew consent|0|||
161837909|NCT01524679|584450251|FG000|Overall Study|Lost to Follow-up|1|||
161658251|NCT04811131|583799187|FG000|Overall Study|Withdrawal by Subject|3|||
161658252|NCT04811131|583799188|FG001|Overall Study|Withdrawal by Subject|1|||
161658253|NCT04811131|583799189|FG002|Overall Study|Withdrawal by Subject|3|||
161658254|NCT04811131|583799190|FG003|Overall Study|Withdrawal by Subject|1|||
161837910|NCT01524679|584450252|FG001|Overall Study|Lost to Follow-up|4|||
161837911|NCT01524679|584450251|FG000|Overall Study|Withdrawal by Subject|4|||
161837912|NCT01524679|584450252|FG001|Overall Study|Withdrawal by Subject|4|||
161658255|NCT01127763|583799193|FG000|Overall Study|Adverse Event|2|||
161658256|NCT01127763|583799193|FG000|Overall Study|Withdrawal by Subject|1|||
161658257|NCT01127763|583799193|FG000|Overall Study|Physician Decision|2|||
161658258|NCT03181789|583799195|FG000|Overall Study|Withdrawal by Subject|0|||
161658259|NCT03181789|583799196|FG001|Overall Study|Withdrawal by Subject|1|||
161837913|NCT01524679|584450251|FG000|Overall Study|Adverse Event|9|||
161837914|NCT01524679|584450252|FG001|Overall Study|Adverse Event|0|||
161658260|NCT03181789|583799197|FG002|Overall Study|Withdrawal by Subject|1|||
161658261|NCT03181789|583799198|FG003|Overall Study|Withdrawal by Subject|0|||
161658262|NCT03181789|583799195|FG000|Overall Study|Lost to Follow-up|7|||
161658263|NCT03181789|583799196|FG001|Overall Study|Lost to Follow-up|1|||
161658264|NCT03181789|583799197|FG002|Overall Study|Lost to Follow-up|0|||
161658265|NCT03181789|583799198|FG003|Overall Study|Lost to Follow-up|0|||
161658266|NCT03181789|583799195|FG000|Overall Study|Participant unable to adhere to visit|0|||
161658267|NCT03181789|583799196|FG001|Overall Study|Participant unable to adhere to visit|1|||
161658268|NCT03181789|583799197|FG002|Overall Study|Participant unable to adhere to visit|0|||
161658269|NCT03181789|583799198|FG003|Overall Study|Participant unable to adhere to visit|0|||
161658270|NCT01131182|583799199|FG000|Overall Study|Withdrawal by Subject|1|||
161658271|NCT01131182|583799200|FG001|Overall Study|Withdrawal by Subject|1|||
161658272|NCT01131182|583799199|FG000|Overall Study|Lost to Follow-up|14|||
161658273|NCT01131182|583799200|FG001|Overall Study|Lost to Follow-up|15|||
161658274|NCT01131182|583799199|FG000|Overall Study|Other Reason|1|||
161658275|NCT01131182|583799200|FG001|Overall Study|Other Reason|0|||
161658276|NCT00735475|583799201|FG000|Overall Study|Adverse Event|0|||
161658277|NCT00735475|583799202|FG001|Overall Study|Adverse Event|1|||
161658278|NCT00735475|583799201|FG000|Overall Study|Death|1|||
161658279|NCT00735475|583799202|FG001|Overall Study|Death|1|||
161658280|NCT00735475|583799201|FG000|Overall Study|Lost to Follow-up|3|||
161658281|NCT00735475|583799202|FG001|Overall Study|Lost to Follow-up|3|||
161658282|NCT00735475|583799201|FG000|Overall Study|Physician Decision|0|||
161837915|NCT01524679|584450251|FG000|Overall Study|Protocol Violation|1|||
161837916|NCT01524679|584450252|FG001|Overall Study|Protocol Violation|0|||
161658283|NCT00735475|583799202|FG001|Overall Study|Physician Decision|1|||
161658284|NCT00735475|583799201|FG000|Overall Study|Withdrawal by Subject|4|||
161658285|NCT00735475|583799202|FG001|Overall Study|Withdrawal by Subject|5|||
161658286|NCT05086276|583799203|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
161658287|NCT05086276|583799204|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
161658288|NCT00777088|583799205|FG000|Overall Study|PED Treatment not attempted|1|||
161658289|NCT00633880|583799206|FG000|Open Label Titration|Lack of Efficacy|1|||
161658290|NCT00633880|583799207|FG001|Open Label Titration|Lack of Efficacy|0|||
161658291|NCT00633880|583799208|FG002|Open Label Titration|Lack of Efficacy|0|||
161658292|NCT00633880|583799206|FG000|Open Label Titration|Adverse Event|13|||
161658293|NCT00633880|583799207|FG001|Open Label Titration|Adverse Event|0|||
161658294|NCT00633880|583799208|FG002|Open Label Titration|Adverse Event|0|||
161837917|NCT01524679|584450251|FG000|Overall Study|Lack of Efficacy|2|||
161837918|NCT01524679|584450252|FG001|Overall Study|Lack of Efficacy|0|||
161837919|NCT01524679|584450251|FG000|Overall Study|e.g.wish for children, relocation|6|||
161837920|NCT01524679|584450252|FG001|Overall Study|e.g.wish for children, relocation|1|||
161837921|NCT00801099|584450253|FG000|Overall Study|Lost to Follow-up|101|||
161837922|NCT01780987|584450254|FG000|Overall Study|Adverse Event|0|||
161837923|NCT01780987|584450255|FG001|Overall Study|Adverse Event|4|||
161658295|NCT00633880|583799206|FG000|Open Label Titration|Treatment Failure|55|||
161658296|NCT00633880|583799207|FG001|Open Label Titration|Treatment Failure|0|||
161658297|NCT00633880|583799208|FG002|Open Label Titration|Treatment Failure|0|||
161658298|NCT00633880|583799206|FG000|Open Label Titration|Protocol Violation|6|||
161658299|NCT00633880|583799207|FG001|Open Label Titration|Protocol Violation|0|||
161658300|NCT00633880|583799208|FG002|Open Label Titration|Protocol Violation|0|||
161658301|NCT00633880|583799206|FG000|Open Label Titration|Physician Decision|1|||
161658302|NCT00633880|583799207|FG001|Open Label Titration|Physician Decision|0|||
161658303|NCT00633880|583799208|FG002|Open Label Titration|Physician Decision|0|||
161658304|NCT00633880|583799206|FG000|Open Label Titration|Withdrawal by Subject|4|||
161658305|NCT00633880|583799207|FG001|Open Label Titration|Withdrawal by Subject|0|||
161658306|NCT00633880|583799208|FG002|Open Label Titration|Withdrawal by Subject|0|||
161658307|NCT03117998|583799211|FG000|Overall Study|Adverse Event|1|||
161658308|NCT03117998|583799212|FG001|Overall Study|Adverse Event|0|||
161658309|NCT03117998|583799213|FG002|Overall Study|Adverse Event|0|||
161658310|NCT03117998|583799214|FG003|Overall Study|Adverse Event|0|||
161658311|NCT03117998|583799215|FG004|Overall Study|Adverse Event|0|||
161658312|NCT03117998|583799216|FG005|Overall Study|Adverse Event|0|||
161658313|NCT03117998|583799211|FG000|Overall Study|Withdrawal by Subject|0|||
161658314|NCT03117998|583799212|FG001|Overall Study|Withdrawal by Subject|0|||
161658315|NCT03117998|583799213|FG002|Overall Study|Withdrawal by Subject|2|||
161658316|NCT03117998|583799214|FG003|Overall Study|Withdrawal by Subject|3|||
161658317|NCT03117998|583799215|FG004|Overall Study|Withdrawal by Subject|3|||
161658318|NCT03117998|583799216|FG005|Overall Study|Withdrawal by Subject|0|||
161658319|NCT03117998|583799211|FG000|Overall Study|Physician Decision|0|||
161658320|NCT03117998|583799212|FG001|Overall Study|Physician Decision|1|||
161658321|NCT03117998|583799213|FG002|Overall Study|Physician Decision|1|||
161658322|NCT03117998|583799214|FG003|Overall Study|Physician Decision|0|||
161658323|NCT03117998|583799215|FG004|Overall Study|Physician Decision|0|||
161658324|NCT03117998|583799216|FG005|Overall Study|Physician Decision|0|||
161658325|NCT03117998|583799211|FG000|Overall Study|Lost to Follow-up|0|||
161658326|NCT03117998|583799212|FG001|Overall Study|Lost to Follow-up|0|||
161658327|NCT03117998|583799213|FG002|Overall Study|Lost to Follow-up|0|||
161658328|NCT03117998|583799214|FG003|Overall Study|Lost to Follow-up|1|||
161658329|NCT03117998|583799215|FG004|Overall Study|Lost to Follow-up|4|||
161658330|NCT03117998|583799216|FG005|Overall Study|Lost to Follow-up|0|||
161658331|NCT03117998|583799211|FG000|Overall Study|Subject noncompliance|0|||
161658332|NCT03117998|583799212|FG001|Overall Study|Subject noncompliance|0|||
161658333|NCT03117998|583799213|FG002|Overall Study|Subject noncompliance|1|||
161658334|NCT03117998|583799214|FG003|Overall Study|Subject noncompliance|0|||
161658335|NCT03117998|583799215|FG004|Overall Study|Subject noncompliance|0|||
161658336|NCT03117998|583799216|FG005|Overall Study|Subject noncompliance|2|||
161658337|NCT03117998|583799211|FG000|Overall Study|Protocol Violation|0|||
161658338|NCT03117998|583799212|FG001|Overall Study|Protocol Violation|0|||
161658339|NCT03117998|583799213|FG002|Overall Study|Protocol Violation|0|||
161658340|NCT03117998|583799214|FG003|Overall Study|Protocol Violation|0|||
161658341|NCT03117998|583799215|FG004|Overall Study|Protocol Violation|0|||
161658342|NCT03117998|583799216|FG005|Overall Study|Protocol Violation|1|||
161658343|NCT04927247|583799217|FG000|Overall Study|Other|2|||
161837924|NCT01780987|584450254|FG000|Overall Study|Withdrawal by Subject|2|||
161837925|NCT01780987|584450255|FG001|Overall Study|Withdrawal by Subject|0|||
161837926|NCT01780987|584450254|FG000|Overall Study|Request of Changing Hospital|0|||
161837927|NCT01780987|584450255|FG001|Overall Study|Request of Changing Hospital|1|||
161658344|NCT04927247|583799218|FG001|Overall Study|Other|1|||
161658345|NCT04927247|583799217|FG000|Overall Study|Physician Decision|0|||
161658346|NCT04927247|583799218|FG001|Overall Study|Physician Decision|1|||
161658347|NCT04927247|583799217|FG000|Overall Study|Adverse Event|1|||
161658348|NCT04927247|583799218|FG001|Overall Study|Adverse Event|0|||
161658349|NCT01468181|583799223|FG000|Overall Study|Adverse Event|8|||
161658350|NCT01468181|583799224|FG001|Overall Study|Adverse Event|1|||
161658351|NCT01468181|583799225|FG002|Overall Study|Adverse Event|6|||
161658352|NCT01468181|583799226|FG003|Overall Study|Adverse Event|2|||
161658353|NCT01468181|583799227|FG004|Overall Study|Adverse Event|2|||
161837928|NCT01780987|584450254|FG000|Overall Study|Changing Residence|1|||
161837929|NCT01780987|584450255|FG001|Overall Study|Changing Residence|0|||
161658354|NCT01468181|583799223|FG000|Overall Study|Protocol Violation|2|||
161837930|NCT01780987|584450254|FG000|Overall Study|Not Receiving any Study Medication|0|||
161658355|NCT01468181|583799224|FG001|Overall Study|Protocol Violation|0|||
161658356|NCT01468181|583799225|FG002|Overall Study|Protocol Violation|1|||
161658357|NCT01468181|583799226|FG003|Overall Study|Protocol Violation|0|||
161658358|NCT01468181|583799227|FG004|Overall Study|Protocol Violation|1|||
161658359|NCT01468181|583799223|FG000|Overall Study|Physician Decision|0|||
161658360|NCT01468181|583799224|FG001|Overall Study|Physician Decision|0|||
161658361|NCT01468181|583799225|FG002|Overall Study|Physician Decision|0|||
161658362|NCT01468181|583799226|FG003|Overall Study|Physician Decision|1|||
161658363|NCT01468181|583799227|FG004|Overall Study|Physician Decision|1|||
161658364|NCT01468181|583799223|FG000|Overall Study|Lost to Follow-up|0|||
161658365|NCT01468181|583799224|FG001|Overall Study|Lost to Follow-up|0|||
161658366|NCT01468181|583799225|FG002|Overall Study|Lost to Follow-up|1|||
161658367|NCT01468181|583799226|FG003|Overall Study|Lost to Follow-up|0|||
161658368|NCT01468181|583799227|FG004|Overall Study|Lost to Follow-up|1|||
161658369|NCT01468181|583799223|FG000|Overall Study|Withdrawal by Subject|0|||
161658370|NCT01468181|583799224|FG001|Overall Study|Withdrawal by Subject|1|||
161658371|NCT01468181|583799225|FG002|Overall Study|Withdrawal by Subject|0|||
161658372|NCT01468181|583799226|FG003|Overall Study|Withdrawal by Subject|0|||
161658373|NCT01468181|583799227|FG004|Overall Study|Withdrawal by Subject|0|||
161658374|NCT00513305|583799228|FG000|Overall Study|Adverse Event|6|||
161658375|NCT00513305|583799229|FG001|Overall Study|Adverse Event|2|||
161710174|NCT01974323|583982383|FG000|Overall Study|Personal Reasons|15|||
161710175|NCT01974323|583982384|FG001|Overall Study|Personal Reasons|19|||
161710176|NCT01974323|583982383|FG000|Overall Study|Lost to Follow-up|45|||
161658376|NCT00513305|583799228|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
161658377|NCT00513305|583799229|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
161658378|NCT00513305|583799228|FG000|Overall Study|Lack of Efficacy|8|||
161658379|NCT00513305|583799229|FG001|Overall Study|Lack of Efficacy|13|||
161658380|NCT00513305|583799228|FG000|Overall Study|Withdrawal by Subject|1|||
161710177|NCT01974323|583982384|FG001|Overall Study|Lost to Follow-up|40|||
161658381|NCT00513305|583799229|FG001|Overall Study|Withdrawal by Subject|2|||
161658382|NCT00513305|583799228|FG000|Overall Study|Disease progression|8|||
161658383|NCT00513305|583799229|FG001|Overall Study|Disease progression|5|||
161658384|NCT00513305|583799228|FG000|Overall Study|Eligible for stem cell transplant|1|||
161658385|NCT00513305|583799229|FG001|Overall Study|Eligible for stem cell transplant|0|||
161658386|NCT00513305|583799228|FG000|Overall Study|Hematologic counts did not recover|1|||
161658387|NCT00513305|583799229|FG001|Overall Study|Hematologic counts did not recover|0|||
161658388|NCT00513305|583799228|FG000|Overall Study|Physician Decision|1|||
161658389|NCT00513305|583799229|FG001|Overall Study|Physician Decision|0|||
161658390|NCT00513305|583799228|FG000|Overall Study|Persistent hypocellularity|0|||
161658391|NCT00513305|583799229|FG001|Overall Study|Persistent hypocellularity|1|||
161658392|NCT00513305|583799228|FG000|Overall Study|Sponsor Decision|0|||
161658393|NCT00513305|583799229|FG001|Overall Study|Sponsor Decision|2|||
161658394|NCT01262027|583799231|FG000|Overall Study|Adverse Event|1|||
161658395|NCT01262027|583799231|FG000|Overall Study|Withdrawal by Subject|3|||
161658396|NCT01262027|583799231|FG000|Overall Study|Protocol Violation|1|||
161658397|NCT02489968|583799235|FG000|Open-label Treatment Period|Adverse Event|14|||
161658398|NCT02489968|583799236|FG001|Open-label Treatment Period|Adverse Event|7|||
161658399|NCT02489968|583799237|FG002|Open-label Treatment Period|Adverse Event|0|||
161658400|NCT02489968|583799238|FG003|Open-label Treatment Period|Adverse Event|0|||
161658401|NCT02489968|583799239|FG004|Open-label Treatment Period|Adverse Event|0|||
161658402|NCT02489968|583799240|FG005|Open-label Treatment Period|Adverse Event|0|||
161658403|NCT02489968|583799235|FG000|Open-label Treatment Period|Protocol Violation|2|||
161658404|NCT02489968|583799236|FG001|Open-label Treatment Period|Protocol Violation|2|||
161658405|NCT02489968|583799237|FG002|Open-label Treatment Period|Protocol Violation|0|||
161658406|NCT02489968|583799238|FG003|Open-label Treatment Period|Protocol Violation|0|||
161658407|NCT02489968|583799239|FG004|Open-label Treatment Period|Protocol Violation|0|||
161658408|NCT02489968|583799240|FG005|Open-label Treatment Period|Protocol Violation|0|||
161658409|NCT02489968|583799235|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161658410|NCT02489968|583799236|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
161658411|NCT02489968|583799237|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161658412|NCT02489968|583799238|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161658413|NCT02489968|583799239|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
161658414|NCT02489968|583799240|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
161658415|NCT02489968|583799235|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
161658416|NCT02489968|583799236|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
161658417|NCT02489968|583799237|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161658418|NCT02489968|583799238|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
161658419|NCT02489968|583799239|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
161658420|NCT02489968|583799240|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
161658421|NCT02489968|583799235|FG000|Open-label Treatment Period|Other than specified above|204|||
161658422|NCT02489968|583799236|FG001|Open-label Treatment Period|Other than specified above|189|||
161658423|NCT02489968|583799237|FG002|Open-label Treatment Period|Other than specified above|0|||
161658424|NCT02489968|583799238|FG003|Open-label Treatment Period|Other than specified above|0|||
161658425|NCT02489968|583799239|FG004|Open-label Treatment Period|Other than specified above|0|||
161658426|NCT02489968|583799240|FG005|Open-label Treatment Period|Other than specified above|0|||
161658427|NCT02489968|583799235|FG000|Double-blind Treatment Period|Adverse Event|0|||
161658428|NCT02489968|583799236|FG001|Double-blind Treatment Period|Adverse Event|0|||
161658429|NCT02489968|583799237|FG002|Double-blind Treatment Period|Adverse Event|2|||
161658430|NCT02489968|583799238|FG003|Double-blind Treatment Period|Adverse Event|6|||
161658431|NCT02489968|583799239|FG004|Double-blind Treatment Period|Adverse Event|4|||
161658432|NCT02489968|583799240|FG005|Double-blind Treatment Period|Adverse Event|5|||
161658433|NCT02489968|583799235|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161658434|NCT02489968|583799236|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161658435|NCT02489968|583799237|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161658436|NCT02489968|583799238|FG003|Double-blind Treatment Period|Protocol Violation|0|||
161658437|NCT02489968|583799239|FG004|Double-blind Treatment Period|Protocol Violation|1|||
161658438|NCT02489968|583799240|FG005|Double-blind Treatment Period|Protocol Violation|1|||
161658439|NCT02489968|583799235|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161658440|NCT02489968|583799236|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161658441|NCT02489968|583799237|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161658442|NCT02489968|583799238|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
161658443|NCT02489968|583799239|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
161658444|NCT02489968|583799240|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
161658445|NCT02489968|583799235|FG000|Double-blind Treatment Period|Other than specified above|0|||
161658446|NCT02489968|583799236|FG001|Double-blind Treatment Period|Other than specified above|0|||
161658447|NCT02489968|583799237|FG002|Double-blind Treatment Period|Other than specified above|0|||
161658448|NCT02489968|583799238|FG003|Double-blind Treatment Period|Other than specified above|0|||
161658449|NCT02489968|583799239|FG004|Double-blind Treatment Period|Other than specified above|1|||
161658450|NCT02489968|583799240|FG005|Double-blind Treatment Period|Other than specified above|0|||
161658451|NCT03738423|583799241|FG000|Overall Study|Withdrawal by Subject|9|||
161658452|NCT03738423|583799242|FG001|Overall Study|Withdrawal by Subject|12|||
161658453|NCT03738423|583799243|FG002|Overall Study|Withdrawal by Subject|9|||
161658454|NCT03738423|583799244|FG003|Overall Study|Withdrawal by Subject|12|||
161658455|NCT03738423|583799245|FG004|Overall Study|Withdrawal by Subject|10|||
161658456|NCT03738423|583799241|FG000|Overall Study|Lack of Efficacy|3|||
161658457|NCT03738423|583799242|FG001|Overall Study|Lack of Efficacy|1|||
161658458|NCT03738423|583799243|FG002|Overall Study|Lack of Efficacy|1|||
161658459|NCT03738423|583799244|FG003|Overall Study|Lack of Efficacy|1|||
161658460|NCT03738423|583799245|FG004|Overall Study|Lack of Efficacy|2|||
161658461|NCT03738423|583799241|FG000|Overall Study|Lost to Follow-up|1|||
161658462|NCT03738423|583799242|FG001|Overall Study|Lost to Follow-up|0|||
161710178|NCT01974323|583982383|FG000|Overall Study|Pregnancy|2|||
161710179|NCT01974323|583982384|FG001|Overall Study|Pregnancy|1|||
161710180|NCT01974323|583982383|FG000|Overall Study|Lack of Efficacy|1|||
161658463|NCT03738423|583799243|FG002|Overall Study|Lost to Follow-up|1|||
161710181|NCT01974323|583982384|FG001|Overall Study|Lack of Efficacy|1|||
161710182|NCT01974323|583982383|FG000|Overall Study|Adverse Event|2|||
161658464|NCT03738423|583799244|FG003|Overall Study|Lost to Follow-up|1|||
161710183|NCT01974323|583982384|FG001|Overall Study|Adverse Event|2|||
161658465|NCT03738423|583799245|FG004|Overall Study|Lost to Follow-up|0|||
161658466|NCT03738423|583799241|FG000|Overall Study|Protocol Violation|1|||
161658467|NCT03738423|583799242|FG001|Overall Study|Protocol Violation|0|||
161658468|NCT03738423|583799243|FG002|Overall Study|Protocol Violation|0|||
161658469|NCT03738423|583799244|FG003|Overall Study|Protocol Violation|0|||
161658470|NCT03738423|583799245|FG004|Overall Study|Protocol Violation|1|||
161658471|NCT03738423|583799241|FG000|Overall Study|Physician Decision|0|||
161658472|NCT03738423|583799242|FG001|Overall Study|Physician Decision|0|||
161658473|NCT03738423|583799243|FG002|Overall Study|Physician Decision|1|||
161658474|NCT03738423|583799244|FG003|Overall Study|Physician Decision|0|||
161658475|NCT03738423|583799245|FG004|Overall Study|Physician Decision|1|||
161658476|NCT03738423|583799241|FG000|Overall Study|Death|0|||
161658477|NCT03738423|583799242|FG001|Overall Study|Death|0|||
161658478|NCT03738423|583799243|FG002|Overall Study|Death|0|||
161658479|NCT03738423|583799244|FG003|Overall Study|Death|0|||
161658480|NCT03738423|583799245|FG004|Overall Study|Death|1|||
161658481|NCT03738423|583799241|FG000|Overall Study|Randomized but never treated|0|||
161658482|NCT03738423|583799242|FG001|Overall Study|Randomized but never treated|0|||
161658483|NCT03738423|583799243|FG002|Overall Study|Randomized but never treated|1|||
161658484|NCT03738423|583799244|FG003|Overall Study|Randomized but never treated|1|||
161658485|NCT03738423|583799245|FG004|Overall Study|Randomized but never treated|0|||
161658486|NCT01865747|583799251|FG000|Overall Study (ITT)|Adverse Event|32|||
161658487|NCT01865747|583799252|FG001|Overall Study (ITT)|Adverse Event|31|||
161658488|NCT01865747|583799251|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
161658489|NCT01865747|583799252|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
161658490|NCT01865747|583799251|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
161658491|NCT01865747|583799252|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
161658492|NCT01865747|583799251|FG000|Overall Study (ITT)|Protocol Violation|1|||
161658493|NCT01865747|583799252|FG001|Overall Study (ITT)|Protocol Violation|1|||
161658494|NCT01865747|583799251|FG000|Overall Study (ITT)|Physician Decision|5|||
161658495|NCT01865747|583799252|FG001|Overall Study (ITT)|Physician Decision|2|||
161658496|NCT01865747|583799251|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
161658497|NCT01865747|583799252|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
161658498|NCT01865747|583799251|FG000|Overall Study (ITT)|Sponsor Decision|0|||
161658499|NCT01865747|583799252|FG001|Overall Study (ITT)|Sponsor Decision|1|||
161658500|NCT01865747|583799251|FG000|Overall Study (ITT)|Progressive Disease|122|||
161658501|NCT01865747|583799252|FG001|Overall Study (ITT)|Progressive Disease|158|||
161658502|NCT01865747|583799251|FG000|Overall Study (ITT)|Reason Not Provided|0|||
161658503|NCT01865747|583799252|FG001|Overall Study (ITT)|Reason Not Provided|1|||
161658504|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
161658505|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
161658506|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
161658507|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
161658508|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
161658509|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
161658510|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
161658511|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
161658512|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
161658513|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
161658514|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
161658515|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
161658516|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
161658517|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
161658518|NCT01865747|583799251|FG000|Primary Intent to Treat (PITT)|Other|0|||
161658519|NCT01865747|583799252|FG001|Primary Intent to Treat (PITT)|Other|1|||
161658520|NCT02592876|583799253|FG000|Overall Study|Withdrawal by Subject|3|||
161658521|NCT02592876|583799254|FG001|Overall Study|Withdrawal by Subject|3|||
161658522|NCT02592876|583799253|FG000|Overall Study|Study Termination by Sponsor|32|||
161658523|NCT02592876|583799254|FG001|Overall Study|Study Termination by Sponsor|27|||
161658524|NCT02592876|583799253|FG000|Overall Study|Lost to Follow-up|0|||
161658525|NCT02592876|583799254|FG001|Overall Study|Lost to Follow-up|1|||
161658526|NCT02592876|583799253|FG000|Overall Study|Death|6|||
161658527|NCT02592876|583799254|FG001|Overall Study|Death|9|||
161658528|NCT00867308|583799255|FG000|Overall Study|Death|1|||
161658529|NCT00867308|583799256|FG001|Overall Study|Death|0|||
161658530|NCT00867308|583799255|FG000|Overall Study|Adverse Event|1|||
161658531|NCT00867308|583799256|FG001|Overall Study|Adverse Event|4|||
161658532|NCT00867308|583799255|FG000|Overall Study|Lack of Efficacy|6|||
161658533|NCT00867308|583799256|FG001|Overall Study|Lack of Efficacy|12|||
161658534|NCT00867308|583799255|FG000|Overall Study|Withdrawal by Subject|1|||
161658535|NCT00867308|583799256|FG001|Overall Study|Withdrawal by Subject|2|||
161658536|NCT00611975|583799259|FG000|Overall Study|Withdrawal by Subject|3|||
161658537|NCT00611975|583799260|FG001|Overall Study|Withdrawal by Subject|7|||
161658538|NCT00611975|583799259|FG000|Overall Study|Pregnancy|2|||
161658539|NCT00611975|583799260|FG001|Overall Study|Pregnancy|1|||
161658540|NCT04625413|583799261|FG000|Overall Study|Hospice|2|||
161837931|NCT01780987|584450255|FG001|Overall Study|Not Receiving any Study Medication|1|||
161837932|NCT03321630|584450256|FG000|Overall Study|Adverse Event|1|||
161837933|NCT03321630|584450256|FG000|Overall Study|Investigator Discretion|2|||
161837934|NCT03321630|584450256|FG000|Overall Study|Withdrawal by Subject|1|||
161837935|NCT00140426|584450257|FG000|Overall Study|Withdrawal by Subject|0|||
161837936|NCT00140426|584450258|FG001|Overall Study|Withdrawal by Subject|3|||
161837937|NCT04168190|584450259|FG000|Overall Study|Lost to Follow-up|0|||
161837938|NCT04168190|584450260|FG001|Overall Study|Lost to Follow-up|1|||
161837939|NCT04168190|584450261|FG002|Overall Study|Lost to Follow-up|0|||
161837940|NCT04168190|584450262|FG003|Overall Study|Lost to Follow-up|7|||
161837941|NCT04168190|584450263|FG004|Overall Study|Lost to Follow-up|5|||
161837942|NCT04168190|584450259|FG000|Overall Study|Withdrawal by Subject|1|||
161837943|NCT04168190|584450260|FG001|Overall Study|Withdrawal by Subject|0|||
161837944|NCT04168190|584450261|FG002|Overall Study|Withdrawal by Subject|0|||
161837945|NCT04168190|584450262|FG003|Overall Study|Withdrawal by Subject|2|||
161837946|NCT04168190|584450263|FG004|Overall Study|Withdrawal by Subject|4|||
161837947|NCT04168190|584450259|FG000|Overall Study|Death|0|||
161837948|NCT04168190|584450260|FG001|Overall Study|Death|0|||
161837949|NCT04168190|584450261|FG002|Overall Study|Death|0|||
161837950|NCT04168190|584450262|FG003|Overall Study|Death|1|||
161837951|NCT04168190|584450263|FG004|Overall Study|Death|0|||
161837952|NCT02325518|584450264|FG000|Overall Study|Adverse Event|4|||
161837953|NCT02325518|584450265|FG001|Overall Study|Adverse Event|1|||
161837954|NCT02325518|584450264|FG000|Overall Study|Physician Decision|0|||
161837955|NCT02325518|584450265|FG001|Overall Study|Physician Decision|1|||
161837956|NCT02325518|584450264|FG000|Overall Study|Withdrawal by Subject|0|||
161837957|NCT02325518|584450265|FG001|Overall Study|Withdrawal by Subject|1|||
161837958|NCT04765384|584450266|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
161837959|NCT04765384|584450267|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
161837960|NCT04765384|584450268|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
161837961|NCT04765384|584450269|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
161837962|NCT04765384|584450270|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
161837963|NCT04765384|584450271|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
161837964|NCT04765384|584450266|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
161710184|NCT00331760|583982385|FG000|Overall Study|Ineligible / no protocol treatment|15|||
161710185|NCT00331760|583982386|FG001|Overall Study|Ineligible / no protocol treatment|8|||
161710186|NCT00833092|583982387|FG000|Overall Study|Withdrawal by Subject|2|||
161710187|NCT00833092|583982388|FG001|Overall Study|Withdrawal by Subject|3|||
161710188|NCT00833092|583982387|FG000|Overall Study|Protocol Violation|2|||
161710189|NCT00833092|583982388|FG001|Overall Study|Protocol Violation|1|||
161710190|NCT00833092|583982387|FG000|Overall Study|Diarrhea|0|||
161710191|NCT00833092|583982388|FG001|Overall Study|Diarrhea|2|||
161710192|NCT00833092|583982387|FG000|Overall Study|constipation|0|||
161710193|NCT00833092|583982388|FG001|Overall Study|constipation|1|||
161710194|NCT00619229|583982391|FG000|Overall Study|Withdrawal by Subject|1|||
161710195|NCT00619229|583982392|FG001|Overall Study|Withdrawal by Subject|1|||
161710196|NCT00619229|583982391|FG000|Overall Study|Lost to Follow-up|1|||
161710197|NCT00619229|583982392|FG001|Overall Study|Lost to Follow-up|0|||
161710198|NCT00619229|583982391|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
161710199|NCT00619229|583982392|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
161710200|NCT00619229|583982391|FG000|Overall Study|Investigator planned Cataract Operation|1|||
161837965|NCT04765384|584450267|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
161837966|NCT04765384|584450268|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
161837967|NCT04765384|584450269|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
161837968|NCT04765384|584450270|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
161837969|NCT04765384|584450271|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
161837970|NCT04765384|584450266|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837971|NCT04765384|584450267|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837972|NCT04765384|584450268|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161710201|NCT00619229|583982392|FG001|Overall Study|Investigator planned Cataract Operation|0|||
161710202|NCT03417440|583982393|FG000|Overall Study|Lost to Follow-up|0|||
161710203|NCT03417440|583982394|FG001|Overall Study|Lost to Follow-up|1|||
161710204|NCT03417440|583982395|FG002|Overall Study|Lost to Follow-up|0|||
161710205|NCT03417440|583982396|FG003|Overall Study|Lost to Follow-up|0|||
161710206|NCT03417440|583982397|FG004|Overall Study|Lost to Follow-up|1|||
161710207|NCT03417440|583982398|FG005|Overall Study|Lost to Follow-up|0|||
161710208|NCT03417440|583982399|FG006|Overall Study|Lost to Follow-up|0|||
161710209|NCT03417440|583982400|FG007|Overall Study|Lost to Follow-up|0|||
161710210|NCT03417440|583982393|FG000|Overall Study|Withdrawal by Subject|2|||
161710211|NCT03417440|583982394|FG001|Overall Study|Withdrawal by Subject|0|||
161710212|NCT03417440|583982395|FG002|Overall Study|Withdrawal by Subject|2|||
161710213|NCT03417440|583982396|FG003|Overall Study|Withdrawal by Subject|1|||
161710214|NCT03417440|583982397|FG004|Overall Study|Withdrawal by Subject|1|||
161710215|NCT03417440|583982398|FG005|Overall Study|Withdrawal by Subject|0|||
161710216|NCT03417440|583982399|FG006|Overall Study|Withdrawal by Subject|0|||
161710217|NCT03417440|583982400|FG007|Overall Study|Withdrawal by Subject|1|||
161710218|NCT02786901|583982401|FG000|Overall Study|Adverse Event|1|||
161710219|NCT02786901|583982402|FG001|Overall Study|Adverse Event|1|||
161710220|NCT02786901|583982403|FG002|Overall Study|Adverse Event|2|||
161710221|NCT02786901|583982401|FG000|Overall Study|Physician Decision|1|||
161710222|NCT02786901|583982402|FG001|Overall Study|Physician Decision|0|||
161710223|NCT02786901|583982403|FG002|Overall Study|Physician Decision|0|||
161710224|NCT02786901|583982401|FG000|Overall Study|Rescue Therapy Use|71|||
161710225|NCT02786901|583982402|FG001|Overall Study|Rescue Therapy Use|49|||
161710226|NCT02786901|583982403|FG002|Overall Study|Rescue Therapy Use|33|||
161658541|NCT04625413|583799261|FG000|Overall Study|Distress|1|||
161658542|NCT04625413|583799261|FG000|Overall Study|Not feeling well|1|||
161658543|NCT01982448|583799265|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
161658544|NCT01982448|583799266|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
161658545|NCT01982448|583799265|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
161658546|NCT01982448|583799266|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
161658547|NCT01982448|583799265|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
161658548|NCT01982448|583799266|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
161837973|NCT04765384|584450269|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837974|NCT04765384|584450270|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837975|NCT04765384|584450271|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
161837976|NCT04765384|584450266|FG000|Post-natal: Neonates and Infants|Death|0|||
161837977|NCT04765384|584450267|FG001|Post-natal: Neonates and Infants|Death|0|||
161837978|NCT04765384|584450268|FG002|Post-natal: Neonates and Infants|Death|0|||
161837979|NCT04765384|584450269|FG003|Post-natal: Neonates and Infants|Death|1|||
161837980|NCT04765384|584450270|FG004|Post-natal: Neonates and Infants|Death|0|||
161837981|NCT04765384|584450271|FG005|Post-natal: Neonates and Infants|Death|0|||
161837982|NCT04765384|584450266|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837983|NCT04765384|584450267|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837984|NCT04765384|584450268|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837985|NCT04765384|584450269|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837986|NCT04765384|584450270|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837987|NCT04765384|584450271|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
161837988|NCT03246126|584450272|FG000|Overall Study|Withdrawal by Subject|0|||
161837989|NCT03246126|584450273|FG001|Overall Study|Withdrawal by Subject|1|||
161837990|NCT01006135|584450276|FG000|Overall Study|Adverse Event|22|||
161837991|NCT01006135|584450276|FG000|Overall Study|Protocol Violation|14|||
161837992|NCT01006135|584450276|FG000|Overall Study|Lost to Follow-up|32|||
161837993|NCT01006135|584450276|FG000|Overall Study|Other|72|||
161837994|NCT05297578|584450277|FG000|Overall Study|Lost to Follow-up|1|||
161837995|NCT05297578|584450278|FG001|Overall Study|Lost to Follow-up|1|||
161837996|NCT05297578|584450279|FG002|Overall Study|Lost to Follow-up|2|||
161837997|NCT05297578|584450280|FG003|Overall Study|Lost to Follow-up|1|||
161837998|NCT05297578|584450277|FG000|Overall Study|Death|0|||
161837999|NCT05297578|584450278|FG001|Overall Study|Death|1|||
161838000|NCT05297578|584450279|FG002|Overall Study|Death|0|||
161658549|NCT01982448|583799265|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
161658550|NCT01982448|583799266|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
161658551|NCT00432666|583800668|FG000|Main Period|Adverse Event|1|||
161658552|NCT00432666|583800669|FG001|Main Period|Adverse Event|1|||
161658553|NCT00432666|583800668|FG000|Main Period|Consent Withdrawn|1|||
161658554|NCT00432666|583800669|FG001|Main Period|Consent Withdrawn|0|||
161658555|NCT00432666|583800668|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
161658556|NCT00432666|583800669|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
161658557|NCT00432666|583800668|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
161658558|NCT00432666|583800669|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
161658559|NCT00432666|583800668|FG000|Open-Label Extension Period|Adverse Event|5|||
161658560|NCT00432666|583800669|FG001|Open-Label Extension Period|Adverse Event|0|||
161658561|NCT00432666|583800668|FG000|Open-Label Extension Period|Consent withdrawn|10|||
161658562|NCT00432666|583800669|FG001|Open-Label Extension Period|Consent withdrawn|0|||
161658563|NCT00432666|583800668|FG000|Open-Label Extension Period|Physician Decision|3|||
161658564|NCT00432666|583800669|FG001|Open-Label Extension Period|Physician Decision|0|||
161658565|NCT00978627|583800670|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
161658566|NCT00978627|583800671|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
161710227|NCT02786901|583982401|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
161710228|NCT02786901|583982402|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
161710229|NCT02786901|583982403|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
161710230|NCT02786901|583982401|FG000|Overall Study|Disallowed medication|1|||
161710231|NCT02786901|583982402|FG001|Overall Study|Disallowed medication|1|||
161710232|NCT02786901|583982403|FG002|Overall Study|Disallowed medication|0|||
161710233|NCT02786901|583982401|FG000|Overall Study|Randomized in error|2|||
161710234|NCT02786901|583982402|FG001|Overall Study|Randomized in error|0|||
161710235|NCT02786901|583982403|FG002|Overall Study|Randomized in error|1|||
161710236|NCT00607048|583982404|FG000|Overall Study|Adverse Event|0|||
161710237|NCT00607048|583982405|FG001|Overall Study|Adverse Event|1|||
161710238|NCT00607048|583982406|FG002|Overall Study|Adverse Event|0|||
161710239|NCT00607048|583982407|FG003|Overall Study|Adverse Event|0|||
161710240|NCT00607048|583982408|FG004|Overall Study|Adverse Event|4|||
161710241|NCT00607048|583982409|FG005|Overall Study|Adverse Event|0|||
161710242|NCT00607048|583982404|FG000|Overall Study|Global deterioration of health|1|||
161710243|NCT00607048|583982405|FG001|Overall Study|Global deterioration of health|0|||
161710244|NCT00607048|583982406|FG002|Overall Study|Global deterioration of health|0|||
161710245|NCT00607048|583982407|FG003|Overall Study|Global deterioration of health|0|||
161710246|NCT00607048|583982408|FG004|Overall Study|Global deterioration of health|0|||
161710247|NCT00607048|583982409|FG005|Overall Study|Global deterioration of health|0|||
161710248|NCT00607048|583982404|FG000|Overall Study|Objective disease progression - relapse|1|||
161710249|NCT00607048|583982405|FG001|Overall Study|Objective disease progression - relapse|2|||
161838001|NCT05297578|584450280|FG003|Overall Study|Death|0|||
161838002|NCT05297578|584450277|FG000|Overall Study|Withdrawal by Subject|0|||
161838003|NCT05297578|584450278|FG001|Overall Study|Withdrawal by Subject|0|||
161658567|NCT00978627|583800670|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
161658568|NCT00978627|583800671|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
161658569|NCT00978627|583800670|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
161658570|NCT00978627|583800671|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
161658571|NCT00978627|583800670|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
161658572|NCT00978627|583800671|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
161658573|NCT00978627|583800670|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
161658574|NCT00978627|583800671|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
161658575|NCT00978627|583800670|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
161658576|NCT00978627|583800671|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
161658577|NCT00978627|583800670|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
161658578|NCT00978627|583800671|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
161658579|NCT00978627|583800670|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
161658580|NCT00978627|583800671|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
161658581|NCT00978627|583800670|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
161658582|NCT00978627|583800671|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
161658583|NCT01506453|583800672|FG000|Overall Study|Withdrawal prior to treatment|0|||
161658584|NCT01506453|583800673|FG001|Overall Study|Withdrawal prior to treatment|2|||
161658585|NCT00603304|583800684|FG000|Overall Study|Lost to Follow-up|5|||
161658586|NCT00603304|583800685|FG001|Overall Study|Lost to Follow-up|7|||
161658587|NCT00603304|583800684|FG000|Overall Study|Withdrawal by Subject|8|||
161658588|NCT00603304|583800685|FG001|Overall Study|Withdrawal by Subject|5|||
161658589|NCT00603304|583800684|FG000|Overall Study|Protocol Violation|1|||
161658590|NCT00603304|583800685|FG001|Overall Study|Protocol Violation|0|||
161658591|NCT00603304|583800684|FG000|Overall Study|Adverse Event|4|||
161710250|NCT00607048|583982406|FG002|Overall Study|Objective disease progression - relapse|4|||
161710251|NCT00607048|583982407|FG003|Overall Study|Objective disease progression - relapse|2|||
161710252|NCT00607048|583982408|FG004|Overall Study|Objective disease progression - relapse|2|||
161710253|NCT00607048|583982409|FG005|Overall Study|Objective disease progression - relapse|2|||
161658592|NCT00603304|583800685|FG001|Overall Study|Adverse Event|2|||
161658593|NCT00603304|583800684|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
161658594|NCT00603304|583800685|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
161658595|NCT00603304|583800684|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
161658596|NCT00603304|583800685|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
161658597|NCT00603304|583800684|FG000|Overall Study|Exclusionary Medication|2|||
161658598|NCT00603304|583800685|FG001|Overall Study|Exclusionary Medication|3|||
161658599|NCT00603304|583800684|FG000|Overall Study|Non-Compliant|0|||
161658600|NCT00603304|583800685|FG001|Overall Study|Non-Compliant|1|||
161658601|NCT00603304|583800684|FG000|Overall Study|Moved Away|0|||
161658602|NCT00603304|583800685|FG001|Overall Study|Moved Away|2|||
161658603|NCT00603304|583800684|FG000|Overall Study|Other|2|||
161658604|NCT00603304|583800685|FG001|Overall Study|Other|0|||
161658605|NCT00603304|583800684|FG000|Overall Study|Patient Decision|2|||
161658606|NCT00603304|583800685|FG001|Overall Study|Patient Decision|0|||
161658607|NCT01076192|583800686|FG000|Overall Study|Other|197|||
161658608|NCT01290315|583800687|FG000|Overall Study|Adverse Event|0|||
161658609|NCT01290315|583800688|FG001|Overall Study|Adverse Event|0|||
161658610|NCT01290315|583800689|FG002|Overall Study|Adverse Event|0|||
161658611|NCT01290315|583800690|FG003|Overall Study|Adverse Event|3|||
161658612|NCT01290315|583800687|FG000|Overall Study|Selection criteria/compliance|2|||
161658613|NCT01290315|583800688|FG001|Overall Study|Selection criteria/compliance|1|||
161658614|NCT01290315|583800689|FG002|Overall Study|Selection criteria/compliance|0|||
161658615|NCT01290315|583800690|FG003|Overall Study|Selection criteria/compliance|2|||
161658616|NCT01290315|583800687|FG000|Overall Study|Lost to Follow-up|0|||
161658617|NCT01290315|583800688|FG001|Overall Study|Lost to Follow-up|1|||
161658618|NCT01290315|583800689|FG002|Overall Study|Lost to Follow-up|0|||
161658619|NCT01290315|583800690|FG003|Overall Study|Lost to Follow-up|0|||
161658620|NCT01290315|583800687|FG000|Overall Study|Withdrawal by Subject|1|||
161658621|NCT01290315|583800688|FG001|Overall Study|Withdrawal by Subject|1|||
161658622|NCT01290315|583800689|FG002|Overall Study|Withdrawal by Subject|0|||
161658623|NCT01290315|583800690|FG003|Overall Study|Withdrawal by Subject|0|||
161658624|NCT03725085|583800691|FG000|Overall Study|Lost to Follow-up|2|||
161658625|NCT00705679|583800692|FG000|Overall Study|Adverse Event|1|||
161658626|NCT00705679|583800693|FG001|Overall Study|Adverse Event|1|||
161658627|NCT00705679|583800694|FG002|Overall Study|Adverse Event|0|||
161658628|NCT00705679|583800695|FG003|Overall Study|Adverse Event|0|||
161658629|NCT00705679|583800696|FG004|Overall Study|Adverse Event|0|||
161658630|NCT00705679|583800692|FG000|Overall Study|Death|0|||
161658631|NCT00705679|583800693|FG001|Overall Study|Death|0|||
161658632|NCT00705679|583800694|FG002|Overall Study|Death|3|||
161658633|NCT00705679|583800695|FG003|Overall Study|Death|2|||
161658634|NCT00705679|583800696|FG004|Overall Study|Death|1|||
161658635|NCT00705679|583800692|FG000|Overall Study|Lost to Follow-up|32|||
161658636|NCT00705679|583800693|FG001|Overall Study|Lost to Follow-up|60|||
161658637|NCT00705679|583800694|FG002|Overall Study|Lost to Follow-up|44|||
161658638|NCT00705679|583800695|FG003|Overall Study|Lost to Follow-up|30|||
161658639|NCT00705679|583800696|FG004|Overall Study|Lost to Follow-up|35|||
161658640|NCT00705679|583800692|FG000|Overall Study|Physician Decision|0|||
161658641|NCT00705679|583800693|FG001|Overall Study|Physician Decision|1|||
161658642|NCT00705679|583800694|FG002|Overall Study|Physician Decision|0|||
161658643|NCT00705679|583800695|FG003|Overall Study|Physician Decision|1|||
161658644|NCT00705679|583800696|FG004|Overall Study|Physician Decision|0|||
161658645|NCT00705679|583800692|FG000|Overall Study|Withdrawal by Subject|32|||
161658646|NCT00705679|583800693|FG001|Overall Study|Withdrawal by Subject|77|||
161658647|NCT00705679|583800694|FG002|Overall Study|Withdrawal by Subject|68|||
161658648|NCT00705679|583800695|FG003|Overall Study|Withdrawal by Subject|47|||
161658649|NCT00705679|583800696|FG004|Overall Study|Withdrawal by Subject|33|||
161658650|NCT03527173|583800697|FG000|Overall Study|Lost to Follow-up|4|||
161658651|NCT03527173|583800698|FG001|Overall Study|Lost to Follow-up|2|||
161658652|NCT03527173|583800697|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
161658653|NCT03527173|583800698|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
161658654|NCT03527173|583800697|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161658655|NCT03527173|583800698|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
161658656|NCT03527173|583800697|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161658657|NCT03527173|583800698|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161658658|NCT02704754|583800699|FG000|Overall Study|Lost to Follow-up|1|||
161658659|NCT02704754|583800700|FG001|Overall Study|Lost to Follow-up|1|||
161658660|NCT02704754|583800699|FG000|Overall Study|Lack of Efficacy|1|||
161658661|NCT02704754|583800700|FG001|Overall Study|Lack of Efficacy|0|||
161658662|NCT02704754|583800699|FG000|Overall Study|Withdrawal by Subject|1|||
161658663|NCT02704754|583800700|FG001|Overall Study|Withdrawal by Subject|0|||
161658664|NCT00423943|583800703|FG000|Overall Study|Withdrawal by Subject|3|||
161658665|NCT00423943|583800704|FG001|Overall Study|Withdrawal by Subject|1|||
161658666|NCT03730480|583800705|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
161658667|NCT01248780|583800706|FG000|Overall Study|Lack of Efficacy|2|||
161658668|NCT01248780|583800707|FG001|Overall Study|Lack of Efficacy|0|||
161658669|NCT01248780|583800706|FG000|Overall Study|Lost to Follow-up|0|||
161658670|NCT01248780|583800707|FG001|Overall Study|Lost to Follow-up|1|||
161658671|NCT01248780|583800706|FG000|Overall Study|Death|0|||
161658672|NCT01248780|583800707|FG001|Overall Study|Death|1|||
161658673|NCT01248780|583800706|FG000|Overall Study|Adverse Event|2|||
161658674|NCT01248780|583800707|FG001|Overall Study|Adverse Event|7|||
161658675|NCT01248780|583800706|FG000|Overall Study|Protocol Violation|1|||
161658676|NCT01248780|583800707|FG001|Overall Study|Protocol Violation|1|||
161658677|NCT01248780|583800706|FG000|Overall Study|Withdrawal by Subject|4|||
161658678|NCT01248780|583800707|FG001|Overall Study|Withdrawal by Subject|4|||
161658679|NCT01248780|583800706|FG000|Overall Study|Not treated|0|||
161658680|NCT01248780|583800707|FG001|Overall Study|Not treated|1|||
161658681|NCT00107120|583800711|FG000|Overall Study|Adverse Event|4|||
161658682|NCT00107120|583800712|FG001|Overall Study|Adverse Event|1|||
161658683|NCT00107120|583800711|FG000|Overall Study|Lack of Efficacy|5|||
161658684|NCT00107120|583800712|FG001|Overall Study|Lack of Efficacy|5|||
161658685|NCT00107120|583800711|FG000|Overall Study|Protocol Violation|3|||
161658686|NCT00107120|583800712|FG001|Overall Study|Protocol Violation|0|||
161658687|NCT00107120|583800711|FG000|Overall Study|Withdrawal by Subject|8|||
161658688|NCT00107120|583800712|FG001|Overall Study|Withdrawal by Subject|9|||
161658689|NCT00107120|583800711|FG000|Overall Study|Lost to Follow-up|8|||
161658690|NCT00107120|583800712|FG001|Overall Study|Lost to Follow-up|6|||
161658691|NCT00107120|583800711|FG000|Overall Study|Pregnancy|0|||
161658692|NCT00107120|583800712|FG001|Overall Study|Pregnancy|1|||
161658693|NCT00107120|583800711|FG000|Overall Study|moving away from site|1|||
161658694|NCT00107120|583800712|FG001|Overall Study|moving away from site|1|||
161658695|NCT00107120|583800711|FG000|Overall Study|death of parent|0|||
161658696|NCT00107120|583800712|FG001|Overall Study|death of parent|1|||
161658697|NCT04214600|583800715|FG000|Overall Study|Lost to Follow-up|9|||
161658698|NCT04214600|583800716|FG001|Overall Study|Lost to Follow-up|14|||
161658699|NCT00896051|583800717|FG000|Overall Study|Adverse Event|2|||
161658700|NCT00896051|583800718|FG001|Overall Study|Adverse Event|1|||
161658701|NCT00896051|583800717|FG000|Overall Study|Lost to Follow-up|3|||
161658702|NCT00896051|583800718|FG001|Overall Study|Lost to Follow-up|2|||
161658703|NCT00896051|583800717|FG000|Overall Study|Withdrawal by Subject|3|||
161658704|NCT00896051|583800718|FG001|Overall Study|Withdrawal by Subject|2|||
161658705|NCT00896051|583800717|FG000|Overall Study|Subject noncompliant|1|||
161658706|NCT00896051|583800718|FG001|Overall Study|Subject noncompliant|3|||
161658707|NCT00896051|583800717|FG000|Overall Study|Other|1|||
161658708|NCT00896051|583800718|FG001|Overall Study|Other|1|||
161658709|NCT02935452|583800719|FG000|Overall Study|work and life commintment|3|||
161658710|NCT02935452|583800720|FG001|Overall Study|work and life commintment|1|||
161658711|NCT01635920|583800721|FG000|Overall Study|Adverse Event|1|||
161658712|NCT01635920|583800722|FG001|Overall Study|Adverse Event|0|||
161658713|NCT01635920|583800721|FG000|Overall Study|Lost to Follow-up|0|||
161658714|NCT01635920|583800722|FG001|Overall Study|Lost to Follow-up|1|||
161658715|NCT01635920|583800721|FG000|Overall Study|Subject decision|2|||
161658716|NCT01635920|583800722|FG001|Overall Study|Subject decision|0|||
161658717|NCT01813929|583800724|FG000|Overall Study|Withdrawal by Subject|0|||
161658718|NCT01813929|583800725|FG001|Overall Study|Withdrawal by Subject|1|||
161658719|NCT00007345|583800726|FG000|Overall Study|Refused further treatment|0|||
161710254|NCT00607048|583982404|FG000|Overall Study|Withdrawal by Subject|0|||
161710255|NCT00607048|583982405|FG001|Overall Study|Withdrawal by Subject|0|||
161710256|NCT00607048|583982406|FG002|Overall Study|Withdrawal by Subject|0|||
161710257|NCT00607048|583982407|FG003|Overall Study|Withdrawal by Subject|1|||
161710258|NCT00607048|583982408|FG004|Overall Study|Withdrawal by Subject|0|||
161710259|NCT00607048|583982409|FG005|Overall Study|Withdrawal by Subject|2|||
161710260|NCT00607048|583982404|FG000|Overall Study|Other|1|||
161658720|NCT00007345|583800727|FG001|Overall Study|Refused further treatment|7|||
161710261|NCT00607048|583982405|FG001|Overall Study|Other|1|||
161710262|NCT00607048|583982406|FG002|Overall Study|Other|0|||
161710263|NCT00607048|583982407|FG003|Overall Study|Other|0|||
161710264|NCT00607048|583982408|FG004|Overall Study|Other|0|||
161710265|NCT00607048|583982409|FG005|Overall Study|Other|1|||
161710266|NCT00355264|583982410|FG000|Extension (Variable Duration)|Adverse Event|1|||
161710267|NCT00355264|583982410|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
161710268|NCT00466505|583982411|FG000|Overall Study|disease progression|13|||
161710269|NCT00466505|583982411|FG000|Overall Study|Adverse Event|4|||
161710270|NCT00699192|583982412|FG000|Overall Study|Missing|1|||
161710271|NCT00699192|583982413|FG001|Overall Study|Missing|1|||
161710272|NCT00699192|583982414|FG002|Overall Study|Missing|1|||
161658721|NCT00007345|583800726|FG000|Overall Study|Switched to alternative treatment|0|||
161710273|NCT00699192|583982412|FG000|Overall Study|Adverse Event|9|||
161710274|NCT00699192|583982413|FG001|Overall Study|Adverse Event|4|||
161710275|NCT00699192|583982414|FG002|Overall Study|Adverse Event|3|||
161710276|NCT00699192|583982412|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161658722|NCT00007345|583800727|FG001|Overall Study|Switched to alternative treatment|3|||
161658723|NCT00007345|583800726|FG000|Overall Study|Intercurrent illness|1|||
161658724|NCT00007345|583800727|FG001|Overall Study|Intercurrent illness|0|||
161658725|NCT00007345|583800726|FG000|Overall Study|Death on study|1|||
161658726|NCT00007345|583800727|FG001|Overall Study|Death on study|1|||
161658727|NCT04433585|583800728|FG000|Overall Study|Withdrawal by Subject|15|||
161658728|NCT04433585|583800729|FG001|Overall Study|Withdrawal by Subject|3|||
161658729|NCT04433585|583800730|FG002|Overall Study|Withdrawal by Subject|15|||
161658730|NCT04433585|583800731|FG003|Overall Study|Withdrawal by Subject|6|||
161658731|NCT04433585|583800728|FG000|Overall Study|Adverse Event|10|||
161658732|NCT04433585|583800729|FG001|Overall Study|Adverse Event|4|||
161658733|NCT04433585|583800730|FG002|Overall Study|Adverse Event|1|||
161658734|NCT04433585|583800731|FG003|Overall Study|Adverse Event|0|||
161658735|NCT04433585|583800728|FG000|Overall Study|Due to the conflict in Ukraine|2|||
161658736|NCT04433585|583800729|FG001|Overall Study|Due to the conflict in Ukraine|1|||
161658737|NCT04433585|583800730|FG002|Overall Study|Due to the conflict in Ukraine|1|||
161658738|NCT04433585|583800731|FG003|Overall Study|Due to the conflict in Ukraine|2|||
161658739|NCT04433585|583800728|FG000|Overall Study|Physician Decision|1|||
161658740|NCT04433585|583800729|FG001|Overall Study|Physician Decision|2|||
161658741|NCT04433585|583800730|FG002|Overall Study|Physician Decision|0|||
161658742|NCT04433585|583800731|FG003|Overall Study|Physician Decision|0|||
161658743|NCT04433585|583800728|FG000|Overall Study|Lost to Follow-up|1|||
161658744|NCT04433585|583800729|FG001|Overall Study|Lost to Follow-up|1|||
161658745|NCT04433585|583800730|FG002|Overall Study|Lost to Follow-up|1|||
161658746|NCT04433585|583800731|FG003|Overall Study|Lost to Follow-up|0|||
161658747|NCT04433585|583800728|FG000|Overall Study|Lack of Efficacy|0|||
161658748|NCT04433585|583800729|FG001|Overall Study|Lack of Efficacy|1|||
161658749|NCT04433585|583800730|FG002|Overall Study|Lack of Efficacy|1|||
161658750|NCT04433585|583800731|FG003|Overall Study|Lack of Efficacy|1|||
161658751|NCT04433585|583800728|FG000|Overall Study|Death|0|||
161658752|NCT04433585|583800729|FG001|Overall Study|Death|1|||
161658753|NCT04433585|583800730|FG002|Overall Study|Death|0|||
161658754|NCT04433585|583800731|FG003|Overall Study|Death|0|||
161658755|NCT03212989|583800746|FG000|Overall Study|Physician Decision|8|||
161658756|NCT03775434|583800747|FG000|Overall Study|Adverse Event|2|||
161658757|NCT03775434|583800747|FG000|Overall Study|Withdrawal by Subject|1|||
161658758|NCT03047395|583800748|FG000|Overall Study|Adverse Event|142|||
161658759|NCT03047395|583800748|FG000|Overall Study|Withdrawal by Subject|155|||
161658760|NCT03047395|583800748|FG000|Overall Study|Lost to Follow-up|144|||
161658761|NCT03047395|583800748|FG000|Overall Study|COVID-19 Infection|2|||
161658762|NCT03047395|583800748|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
161658763|NCT03047395|583800748|FG000|Overall Study|Other, Not Specified|117|||
161658764|NCT00620282|583800756|FG000|Overall Study|Adverse Event|0|||
161658765|NCT00620282|583800757|FG001|Overall Study|Adverse Event|1|||
161658766|NCT00620282|583800758|FG002|Overall Study|Adverse Event|0|||
161658767|NCT00620282|583800756|FG000|Overall Study|Arterial line unable to be placed|0|||
161658768|NCT00620282|583800757|FG001|Overall Study|Arterial line unable to be placed|0|||
161658769|NCT00620282|583800758|FG002|Overall Study|Arterial line unable to be placed|1|||
161658770|NCT00620282|583800756|FG000|Overall Study|Withdrawal by Subject|0|||
161658771|NCT00620282|583800757|FG001|Overall Study|Withdrawal by Subject|1|||
161658772|NCT00620282|583800758|FG002|Overall Study|Withdrawal by Subject|0|||
161658773|NCT02217475|583800759|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
161658774|NCT02217475|583800760|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
161658775|NCT02217475|583800761|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
161658776|NCT02217475|583800759|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
161658777|NCT02217475|583800760|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
161658778|NCT02217475|583800761|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
161658779|NCT02217475|583800759|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
161658780|NCT02217475|583800760|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
161658781|NCT02217475|583800761|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
161658782|NCT02217475|583800759|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
161658783|NCT02217475|583800760|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
161658784|NCT02217475|583800761|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
161658785|NCT02217475|583800759|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
161658786|NCT02217475|583800760|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
161658787|NCT02217475|583800761|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
161658788|NCT02217475|583800759|FG000|Discontinued After Period 1|Adverse Event|1|||
161658789|NCT02217475|583800760|FG001|Discontinued After Period 1|Adverse Event|2|||
161658790|NCT02217475|583800761|FG002|Discontinued After Period 1|Adverse Event|0|||
161658791|NCT02217475|583800759|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
161658792|NCT02217475|583800760|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
161658793|NCT02217475|583800761|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
161658794|NCT02217475|583800759|FG000|Discontinued After Period 1|Physician Decision|0|||
161658795|NCT02217475|583800760|FG001|Discontinued After Period 1|Physician Decision|0|||
161658796|NCT02217475|583800761|FG002|Discontinued After Period 1|Physician Decision|1|||
161658797|NCT02217475|583800759|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
161658798|NCT02217475|583800760|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
161658799|NCT02217475|583800761|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
161658800|NCT02217475|583800759|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
161658801|NCT02217475|583800760|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
161658802|NCT02217475|583800761|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
161658803|NCT02217475|583800759|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
161658804|NCT02217475|583800760|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
161658805|NCT02217475|583800761|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
161658806|NCT02217475|583800759|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
161658807|NCT02217475|583800760|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
161658808|NCT02217475|583800761|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
161658809|NCT02217475|583800759|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
161658810|NCT02217475|583800760|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
161658811|NCT02217475|583800761|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
161658812|NCT04738292|583800766|FG000|Overall Study|Death|1|||
161658813|NCT02442336|583800767|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
161658814|NCT02442336|583800767|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
161658815|NCT02442336|583800767|FG000|Overall Study|Lost to Follow-up|11|||
161658816|NCT01237587|583800768|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
161658817|NCT01237587|583800769|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
161658818|NCT01237587|583800768|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
161658819|NCT01237587|583800769|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
161658820|NCT01237587|583800768|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
161658821|NCT01237587|583800769|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
161658822|NCT01237587|583800768|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
161658823|NCT01237587|583800769|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
161658824|NCT01237587|583800768|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
161658825|NCT01237587|583800769|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
161658826|NCT01237587|583800768|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
161658827|NCT01237587|583800769|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
161658828|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
161658829|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
161710277|NCT00699192|583982413|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161710278|NCT00699192|583982414|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161710279|NCT00699192|583982412|FG000|Overall Study|Lack of Efficacy|0|||
161710280|NCT00699192|583982413|FG001|Overall Study|Lack of Efficacy|0|||
161710281|NCT00699192|583982414|FG002|Overall Study|Lack of Efficacy|1|||
161710282|NCT00699192|583982412|FG000|Overall Study|Withdrawal by Subject|3|||
161710283|NCT00699192|583982413|FG001|Overall Study|Withdrawal by Subject|2|||
161710284|NCT00699192|583982414|FG002|Overall Study|Withdrawal by Subject|4|||
161710285|NCT00699192|583982412|FG000|Overall Study|Administrative problems|1|||
161710286|NCT00699192|583982413|FG001|Overall Study|Administrative problems|3|||
161710287|NCT00699192|583982414|FG002|Overall Study|Administrative problems|1|||
161710288|NCT00699192|583982412|FG000|Overall Study|Protocol Violation|2|||
161710289|NCT00699192|583982413|FG001|Overall Study|Protocol Violation|2|||
161710290|NCT00699192|583982414|FG002|Overall Study|Protocol Violation|0|||
161710291|NCT01773473|583982415|FG000|Overall Study|Adverse Event|3|||
161710292|NCT01773473|583982416|FG001|Overall Study|Adverse Event|2|||
161710293|NCT01773473|583982415|FG000|Overall Study|Protocol Violation|0|||
161710294|NCT01773473|583982416|FG001|Overall Study|Protocol Violation|4|||
161710295|NCT01773473|583982415|FG000|Overall Study|Physician Decision|3|||
161710296|NCT01773473|583982416|FG001|Overall Study|Physician Decision|5|||
161710297|NCT01773473|583982415|FG000|Overall Study|Sponsor Decision|2|||
161710298|NCT01773473|583982416|FG001|Overall Study|Sponsor Decision|0|||
161710299|NCT01773473|583982415|FG000|Overall Study|Lack of Efficacy|0|||
161710300|NCT01773473|583982416|FG001|Overall Study|Lack of Efficacy|1|||
161710301|NCT01773473|583982415|FG000|Overall Study|Non-Compliance with study drug|1|||
161710302|NCT01773473|583982416|FG001|Overall Study|Non-Compliance with study drug|4|||
161710303|NCT01773473|583982415|FG000|Overall Study|Withdrawal by Subject|5|||
161710304|NCT01773473|583982416|FG001|Overall Study|Withdrawal by Subject|3|||
161710305|NCT01773473|583982415|FG000|Overall Study|Lost to Follow-up|2|||
161710306|NCT01773473|583982416|FG001|Overall Study|Lost to Follow-up|0|||
161710307|NCT00826514|583982417|FG000|Overall Study|Adverse Event|1|||
161710308|NCT00826514|583982418|FG001|Overall Study|Adverse Event|1|||
161710309|NCT00826514|583982417|FG000|Overall Study|Lack of Efficacy|0|||
161710310|NCT00826514|583982418|FG001|Overall Study|Lack of Efficacy|1|||
161710311|NCT00826514|583982417|FG000|Overall Study|Withdrawal by Subject|2|||
161710312|NCT00826514|583982418|FG001|Overall Study|Withdrawal by Subject|3|||
161710313|NCT01451645|583982419|FG000|Overall Study|Protocol Violation|1|||
161710314|NCT01451645|583982420|FG001|Overall Study|Protocol Violation|0|||
161710315|NCT01451645|583982419|FG000|Overall Study|Adverse Event|0|||
161710316|NCT01451645|583982420|FG001|Overall Study|Adverse Event|3|||
161710317|NCT01451645|583982419|FG000|Overall Study|Withdrawal by Subject|4|||
161710318|NCT01451645|583982420|FG001|Overall Study|Withdrawal by Subject|2|||
161710319|NCT01451645|583982419|FG000|Overall Study|Lost to Follow-up|4|||
161710320|NCT01451645|583982420|FG001|Overall Study|Lost to Follow-up|3|||
161710321|NCT03663166|583982423|FG000|Overall Study|Withdrawal by Subject|1|||
161710322|NCT02620020|583982429|FG000|Overall Study|Adverse Event|8|||
161710323|NCT02620020|583982430|FG001|Overall Study|Adverse Event|4|||
161710324|NCT02620020|583982431|FG002|Overall Study|Adverse Event|3|||
161710325|NCT02620020|583982432|FG003|Overall Study|Adverse Event|5|||
161710326|NCT02620020|583982429|FG000|Overall Study|Lost to Follow-up|4|||
161710327|NCT02620020|583982430|FG001|Overall Study|Lost to Follow-up|8|||
161710328|NCT02620020|583982431|FG002|Overall Study|Lost to Follow-up|1|||
161710329|NCT02620020|583982432|FG003|Overall Study|Lost to Follow-up|4|||
161710330|NCT02620020|583982429|FG000|Overall Study|Physician Decision|7|||
161710331|NCT02620020|583982430|FG001|Overall Study|Physician Decision|4|||
161710332|NCT02620020|583982431|FG002|Overall Study|Physician Decision|3|||
161710333|NCT02620020|583982432|FG003|Overall Study|Physician Decision|4|||
161710334|NCT02620020|583982429|FG000|Overall Study|Protocol Violation|5|||
161710335|NCT02620020|583982430|FG001|Overall Study|Protocol Violation|2|||
161710336|NCT02620020|583982431|FG002|Overall Study|Protocol Violation|1|||
161710337|NCT02620020|583982432|FG003|Overall Study|Protocol Violation|1|||
161710338|NCT02620020|583982429|FG000|Overall Study|Withdrawal by Subject|20|||
161710339|NCT02620020|583982430|FG001|Overall Study|Withdrawal by Subject|16|||
161710340|NCT02620020|583982431|FG002|Overall Study|Withdrawal by Subject|17|||
161710341|NCT02620020|583982432|FG003|Overall Study|Withdrawal by Subject|12|||
161710342|NCT02620020|583982429|FG000|Overall Study|Death|0|||
161710343|NCT02620020|583982430|FG001|Overall Study|Death|1|||
161710344|NCT02620020|583982431|FG002|Overall Study|Death|0|||
161710345|NCT02620020|583982432|FG003|Overall Study|Death|0|||
161710346|NCT00098787|583982434|FG000|Overall Study|Never started treatment|3|||
161710347|NCT00098787|583982435|FG001|Overall Study|Never started treatment|2|||
161710348|NCT00098787|583982436|FG002|Overall Study|Never started treatment|1|||
161710349|NCT00098787|583982434|FG000|Overall Study|Ineligible|9|||
161710350|NCT00098787|583982435|FG001|Overall Study|Ineligible|7|||
161710351|NCT00098787|583982436|FG002|Overall Study|Ineligible|3|||
161710352|NCT00098787|583982434|FG000|Overall Study|Disease progression|28|||
161710353|NCT00098787|583982435|FG001|Overall Study|Disease progression|17|||
161710354|NCT00098787|583982436|FG002|Overall Study|Disease progression|23|||
161710355|NCT00098787|583982434|FG000|Overall Study|Adverse Event|8|||
161710356|NCT00098787|583982435|FG001|Overall Study|Adverse Event|17|||
161710357|NCT00098787|583982436|FG002|Overall Study|Adverse Event|8|||
161710358|NCT00098787|583982434|FG000|Overall Study|Death|6|||
161710359|NCT00098787|583982435|FG001|Overall Study|Death|1|||
161710360|NCT00098787|583982436|FG002|Overall Study|Death|0|||
161710361|NCT00098787|583982434|FG000|Overall Study|Withdrawal by Subject|4|||
161710362|NCT00098787|583982435|FG001|Overall Study|Withdrawal by Subject|12|||
161710363|NCT00098787|583982436|FG002|Overall Study|Withdrawal by Subject|6|||
161710364|NCT00098787|583982434|FG000|Overall Study|Alternative therapy|8|||
161710365|NCT00098787|583982435|FG001|Overall Study|Alternative therapy|13|||
161710366|NCT00098787|583982436|FG002|Overall Study|Alternative therapy|13|||
161710367|NCT00098787|583982434|FG000|Overall Study|Other|7|||
161710368|NCT00098787|583982435|FG001|Overall Study|Other|6|||
161710369|NCT00098787|583982436|FG002|Overall Study|Other|9|||
161710370|NCT02203149|583982437|FG000|Part 1|Adverse Event|0|||
161710371|NCT02203149|583982438|FG001|Part 1|Adverse Event|1|||
161710372|NCT02203149|583982439|FG002|Part 1|Adverse Event|0|||
161710373|NCT02203149|583982440|FG003|Part 1|Adverse Event|0|||
161710374|NCT02203149|583982441|FG004|Part 1|Adverse Event|0|||
161710375|NCT02203149|583982437|FG000|Part 2|Death|0|||
161710376|NCT02203149|583982438|FG001|Part 2|Death|0|||
161710377|NCT02203149|583982439|FG002|Part 2|Death|1|||
161710378|NCT02203149|583982440|FG003|Part 2|Death|1|||
161710379|NCT02203149|583982441|FG004|Part 2|Death|0|||
161710380|NCT02203149|583982437|FG000|Part 2|Withdrawal by Subject|0|||
161710381|NCT02203149|583982438|FG001|Part 2|Withdrawal by Subject|0|||
161710382|NCT02203149|583982439|FG002|Part 2|Withdrawal by Subject|0|||
161710383|NCT02203149|583982440|FG003|Part 2|Withdrawal by Subject|1|||
161710384|NCT02203149|583982441|FG004|Part 2|Withdrawal by Subject|0|||
161710385|NCT02203149|583982437|FG000|Part 2|Adverse Event|0|||
161710386|NCT02203149|583982438|FG001|Part 2|Adverse Event|0|||
161710387|NCT02203149|583982439|FG002|Part 2|Adverse Event|0|||
161710388|NCT02203149|583982440|FG003|Part 2|Adverse Event|1|||
161710389|NCT02203149|583982441|FG004|Part 2|Adverse Event|1|||
161710390|NCT00684814|583982442|FG000|Washout Period of 7 Days|Adverse Event|1|||
161710391|NCT00684814|583982443|FG001|Washout Period of 7 Days|Adverse Event|2|||
161710392|NCT00684814|583982442|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161710393|NCT00684814|583982443|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
161710394|NCT00684814|583982442|FG000|Second Intervention|Adverse Event|1|||
161710395|NCT00684814|583982443|FG001|Second Intervention|Adverse Event|0|||
161710396|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
161710397|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
161710398|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
161710399|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
161710400|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
161710401|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
161658830|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
161658831|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
161658832|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
161658833|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
161658834|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
161658835|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
161658836|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
161658837|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
161658838|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
161658839|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
161658840|NCT01237587|583800768|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
161658841|NCT01237587|583800769|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
161658842|NCT01237587|583800768|FG000|Taper Phase|Adverse Event|0|||
161658843|NCT01237587|583800769|FG001|Taper Phase|Adverse Event|2|||
161658844|NCT01237587|583800768|FG000|Taper Phase|Protocol Violation|2|||
161658845|NCT01237587|583800769|FG001|Taper Phase|Protocol Violation|0|||
161658846|NCT01237587|583800768|FG000|Taper Phase|Lack of Efficacy|2|||
161658847|NCT01237587|583800769|FG001|Taper Phase|Lack of Efficacy|5|||
161658848|NCT01237587|583800768|FG000|Taper Phase|Parent/Guardian Decision|0|||
161658849|NCT01237587|583800769|FG001|Taper Phase|Parent/Guardian Decision|2|||
161658850|NCT01237587|583800768|FG000|Taper Phase|Sponsor Decision|1|||
161658851|NCT01237587|583800769|FG001|Taper Phase|Sponsor Decision|0|||
161658852|NCT01237587|583800768|FG000|Taper Phase|Withdrawal by Subject|0|||
161658853|NCT01237587|583800769|FG001|Taper Phase|Withdrawal by Subject|1|||
161658854|NCT01011387|583800770|FG000|Overall Study|Withdrawal by Subject|3|||
161658855|NCT01011387|583800770|FG000|Overall Study|Adverse Event|2|||
161658856|NCT01011387|583800770|FG000|Overall Study|Protocol Violation|1|||
161658857|NCT01139580|583800771|FG000|Overall Study|Adverse Event|5|||
161658858|NCT01139580|583800772|FG001|Overall Study|Adverse Event|4|||
161658859|NCT01139580|583800771|FG000|Overall Study|Lost to Follow-up|9|||
161658860|NCT01139580|583800772|FG001|Overall Study|Lost to Follow-up|1|||
161658861|NCT01139580|583800771|FG000|Overall Study|Lack of Efficacy|0|||
161658862|NCT01139580|583800772|FG001|Overall Study|Lack of Efficacy|2|||
161710402|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
161710403|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
161710404|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
161658863|NCT01139580|583800771|FG000|Overall Study|Withdrawal by Subject|6|||
161710405|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
161710406|NCT02537678|583982444|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
161710407|NCT02537678|583982445|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
161658864|NCT01139580|583800772|FG001|Overall Study|Withdrawal by Subject|9|||
161710408|NCT02537678|583982444|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
161710409|NCT02537678|583982445|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
161710410|NCT04348851|583982446|FG000|Post-Test 1|Withdrawal by Subject|0|||
161710411|NCT04348851|583982447|FG001|Post-Test 1|Withdrawal by Subject|1|||
161710412|NCT04348851|583982448|FG002|Post-Test 1|Withdrawal by Subject|0|||
161710413|NCT04348851|583982449|FG003|Post-Test 1|Withdrawal by Subject|0|||
161710414|NCT04348851|583982446|FG000|Post-Test 1|Lost to Follow-up|0|||
161710415|NCT04348851|583982447|FG001|Post-Test 1|Lost to Follow-up|1|||
161658865|NCT01139580|583800771|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
161658866|NCT01139580|583800772|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
161658867|NCT01139580|583800771|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
161658868|NCT01139580|583800772|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
161658869|NCT01139580|583800771|FG000|Overall Study|Misrandomized|1|||
161658870|NCT01139580|583800772|FG001|Overall Study|Misrandomized|0|||
161658871|NCT01139580|583800771|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
161658872|NCT01139580|583800772|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
161658873|NCT01139580|583800771|FG000|Overall Study|Participant Randomization in Error|0|||
161658874|NCT01139580|583800772|FG001|Overall Study|Participant Randomization in Error|1|||
161658875|NCT01285609|583800773|FG000|Randomized|Progressive Disease|41|||
161658876|NCT01285609|583800774|FG001|Randomized|Progressive Disease|61|||
161658877|NCT01285609|583800773|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
161658878|NCT01285609|583800774|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
161658879|NCT01285609|583800773|FG000|Randomized|Study Drug Toxicity|13|||
161658880|NCT01285609|583800774|FG001|Randomized|Study Drug Toxicity|14|||
161658881|NCT01285609|583800773|FG000|Randomized|Death|5|||
161658882|NCT01285609|583800774|FG001|Randomized|Death|7|||
161658883|NCT01285609|583800773|FG000|Randomized|Withdrawal by Subject|8|||
161658884|NCT01285609|583800774|FG001|Randomized|Withdrawal by Subject|11|||
161658885|NCT01285609|583800773|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
161658886|NCT01285609|583800774|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
161658887|NCT01285609|583800773|FG000|Randomized|Undisclosed Reasons|1|||
161658888|NCT01285609|583800774|FG001|Randomized|Undisclosed Reasons|0|||
161658889|NCT01285609|583800773|FG000|Randomized|Randomized but not Treated|4|||
161658890|NCT01285609|583800774|FG001|Randomized|Randomized but not Treated|4|||
161658891|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
161658892|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
161658893|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
161658894|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
161658895|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
161658896|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
161658897|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
161658898|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
161658899|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Death|11|||
161658900|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Death|3|||
161658901|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
161658902|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
161658903|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Not Reported|0|||
161658904|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Not Reported|2|||
161658905|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
161658906|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
161658907|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
161658908|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
161658909|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
161658910|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
161710416|NCT04348851|583982448|FG002|Post-Test 1|Lost to Follow-up|0|||
161710417|NCT04348851|583982449|FG003|Post-Test 1|Lost to Follow-up|0|||
161710418|NCT04348851|583982446|FG000|Post-Test 2|Stroke survivor death|0|||
161710419|NCT04348851|583982447|FG001|Post-Test 2|Stroke survivor death|1|||
161710420|NCT04348851|583982448|FG002|Post-Test 2|Stroke survivor death|0|||
161710421|NCT04348851|583982449|FG003|Post-Test 2|Stroke survivor death|1|||
161710422|NCT00195650|583982450|FG000|Overall Study|Adverse Event|194|||
161710423|NCT00195650|583982450|FG000|Overall Study|Lack of Efficacy|99|||
161710424|NCT00195650|583982450|FG000|Overall Study|Withdrawal by Subject|67|||
161710425|NCT00195650|583982450|FG000|Overall Study|Lost to Follow-up|44|||
161710426|NCT00195650|583982450|FG000|Overall Study|Death|23|||
161710427|NCT00195650|583982450|FG000|Overall Study|Protocol Violation|15|||
161710428|NCT00195650|583982450|FG000|Overall Study|Administrative reasons|83|||
161710429|NCT00432809|583982451|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
161710430|NCT00432809|583982452|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
161710431|NCT00432809|583982453|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
161710432|NCT00432809|583982451|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
161710433|NCT00432809|583982452|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
161710434|NCT00432809|583982453|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
161710435|NCT00655928|583982455|FG000|Overall Study|Withdrawal by Subject|2|||
161710436|NCT00655928|583982456|FG001|Overall Study|Withdrawal by Subject|1|||
161710437|NCT00655928|583982455|FG000|Overall Study|Physician Decision|1|||
161710438|NCT00655928|583982456|FG001|Overall Study|Physician Decision|1|||
161710439|NCT00275561|583982460|FG000|Overall Study|Withdrawal by Subject|0|||
161710440|NCT00275561|583982461|FG001|Overall Study|Withdrawal by Subject|1|||
161710441|NCT00275561|583982460|FG000|Overall Study|Travel|1|||
161710442|NCT00275561|583982461|FG001|Overall Study|Travel|1|||
161710443|NCT00275561|583982460|FG000|Overall Study|Scheduling|1|||
161710444|NCT00275561|583982461|FG001|Overall Study|Scheduling|2|||
161710445|NCT00275561|583982460|FG000|Overall Study|Family Issues|0|||
161710446|NCT00275561|583982461|FG001|Overall Study|Family Issues|2|||
161710447|NCT01769105|583982462|FG000|First Intervention|Protocol Violation|2|||
161710448|NCT01769105|583982463|FG001|First Intervention|Protocol Violation|2|||
161710449|NCT01769105|583982462|FG000|Cross-over|Lost to Follow-up|5|||
161710450|NCT01769105|583982463|FG001|Cross-over|Lost to Follow-up|0|||
161710451|NCT02109029|583984067|FG000|Part B|Adverse Event|0|||
161710452|NCT02109029|583984068|FG001|Part B|Adverse Event|0|||
161710453|NCT02109029|583984069|FG002|Part B|Adverse Event|0|||
161710454|NCT02109029|583984070|FG003|Part B|Adverse Event|0|||
161710455|NCT02109029|583984071|FG004|Part B|Adverse Event|1|||
161710456|NCT02109029|583984072|FG005|Part B|Adverse Event|1|||
161710457|NCT03195894|583984073|FG000|Overall Study|"An example is Started other treatment."|4|||
161710458|NCT03195894|583984074|FG001|Overall Study|"An example is Started other treatment."|5|||
161710459|NCT03195894|583984073|FG000|Overall Study|Withdrawal by Subject|15|||
161710460|NCT03195894|583984074|FG001|Overall Study|Withdrawal by Subject|4|||
161710461|NCT03195894|583984073|FG000|Overall Study|Lost to Follow-up|14|||
161710462|NCT03195894|583984074|FG001|Overall Study|Lost to Follow-up|19|||
161710463|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Adverse Event|18|||
161710464|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Adverse Event|2|||
161710465|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Death|3|||
161710466|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Death|0|||
161710467|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
161710468|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
161710469|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
161710470|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
161710471|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
161710472|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
161710473|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Death|1|||
161710474|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Death|1|||
161710475|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
161710476|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
161710477|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
161710478|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
161710479|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
161710480|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
161710481|NCT00496366|583984083|FG000|Overall Study|Death|1|||
161710482|NCT00260208|583984084|FG000|Overall Study|Subject withdrew consent|11|||
161710483|NCT00260208|583984085|FG001|Overall Study|Subject withdrew consent|7|||
161710484|NCT00260208|583984084|FG000|Overall Study|Lost to Follow-up|6|||
161710485|NCT00260208|583984085|FG001|Overall Study|Lost to Follow-up|1|||
161710486|NCT00260208|583984084|FG000|Overall Study|Death|12|||
161710487|NCT00260208|583984085|FG001|Overall Study|Death|10|||
161710488|NCT00260208|583984084|FG000|Overall Study|Missing|18|||
161710489|NCT00260208|583984085|FG001|Overall Study|Missing|16|||
161710490|NCT00768222|583984086|FG000|Overall Study|Lost to Follow-up|1|||
161710491|NCT00768222|583984087|FG001|Overall Study|Lost to Follow-up|1|||
161710492|NCT00768222|583984086|FG000|Overall Study|Withdrawal by Subject|3|||
161710493|NCT00768222|583984087|FG001|Overall Study|Withdrawal by Subject|1|||
161710494|NCT00768222|583984086|FG000|Overall Study|Protocol Violation|0|||
161710495|NCT00768222|583984087|FG001|Overall Study|Protocol Violation|2|||
161658911|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
161658912|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
161658913|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
161658914|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
161658915|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
161658916|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
161658917|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
161658918|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
161658919|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
161658920|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
161658921|NCT01285609|583800773|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
161658922|NCT01285609|583800774|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
161658923|NCT01285609|583800773|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
161658924|NCT01285609|583800774|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
161658925|NCT01142115|583800775|FG000|First Intervention|Lack of Efficacy|1|||
161658926|NCT01142115|583800776|FG001|First Intervention|Lack of Efficacy|1|||
161658927|NCT01142115|583800775|FG000|First Intervention|Adverse Event|1|||
161658928|NCT01142115|583800776|FG001|First Intervention|Adverse Event|0|||
161658929|NCT00320528|583800779|FG000|Study Period II|Adverse Event|3|||
161658930|NCT00320528|583800780|FG001|Study Period II|Adverse Event|4|||
161658931|NCT00320528|583800781|FG002|Study Period II|Adverse Event|8|||
161658932|NCT00320528|583800779|FG000|Study Period II|Parent/Caregiver Decision|8|||
161658933|NCT00320528|583800780|FG001|Study Period II|Parent/Caregiver Decision|3|||
161658934|NCT00320528|583800781|FG002|Study Period II|Parent/Caregiver Decision|11|||
161658935|NCT00320528|583800779|FG000|Study Period II|Withdrawal by Subject|0|||
161658936|NCT00320528|583800780|FG001|Study Period II|Withdrawal by Subject|1|||
161658937|NCT00320528|583800781|FG002|Study Period II|Withdrawal by Subject|1|||
161658938|NCT00320528|583800779|FG000|Study Period II|Entry Criteria Exclusion|0|||
161658939|NCT00320528|583800780|FG001|Study Period II|Entry Criteria Exclusion|2|||
161658940|NCT00320528|583800781|FG002|Study Period II|Entry Criteria Exclusion|2|||
161658941|NCT00320528|583800779|FG000|Study Period III|Adverse Event|1|||
161658942|NCT00320528|583800780|FG001|Study Period III|Adverse Event|0|||
161658943|NCT00320528|583800781|FG002|Study Period III|Adverse Event|0|||
161658944|NCT00320528|583800779|FG000|Study Period III|Lost to Follow-up|1|||
161658945|NCT00320528|583800780|FG001|Study Period III|Lost to Follow-up|0|||
161658946|NCT00320528|583800781|FG002|Study Period III|Lost to Follow-up|0|||
161658947|NCT00320528|583800779|FG000|Study Period III|Withdrawal by Subject|1|||
161658948|NCT00320528|583800780|FG001|Study Period III|Withdrawal by Subject|1|||
161658949|NCT00320528|583800781|FG002|Study Period III|Withdrawal by Subject|2|||
161658950|NCT00320528|583800779|FG000|Study Period III|Lack of Efficacy|2|||
161658951|NCT00320528|583800780|FG001|Study Period III|Lack of Efficacy|0|||
161658952|NCT00320528|583800781|FG002|Study Period III|Lack of Efficacy|0|||
161658953|NCT00320528|583800779|FG000|Study Period III|Parent/Caregiver Decision|14|||
161658954|NCT00320528|583800780|FG001|Study Period III|Parent/Caregiver Decision|3|||
161658955|NCT00320528|583800781|FG002|Study Period III|Parent/Caregiver Decision|11|||
161658956|NCT00320528|583800779|FG000|Study Period III|Protocol Violation|0|||
161658957|NCT00320528|583800780|FG001|Study Period III|Protocol Violation|1|||
161658958|NCT00320528|583800781|FG002|Study Period III|Protocol Violation|0|||
161658959|NCT00320528|583800779|FG000|Study Period III|Physician Decision|0|||
161658960|NCT00320528|583800780|FG001|Study Period III|Physician Decision|1|||
161658961|NCT00320528|583800781|FG002|Study Period III|Physician Decision|2|||
161710496|NCT03263091|583984089|FG000|OL Component|Withdrawal by Subject|1|||
161710497|NCT03263091|583984090|FG001|OL Component|Withdrawal by Subject|1|||
161710498|NCT03263091|583984091|FG002|OL Component|Withdrawal by Subject|0|||
161710499|NCT03263091|583984092|FG003|OL Component|Withdrawal by Subject|0|||
161710500|NCT03263091|583984093|FG004|OL Component|Withdrawal by Subject|0|||
161710501|NCT03263091|583984094|FG005|OL Component|Withdrawal by Subject|0|||
161710502|NCT03263091|583984089|FG000|OL Component|Physician Decision|0|||
161710503|NCT03263091|583984090|FG001|OL Component|Physician Decision|1|||
161710504|NCT03263091|583984091|FG002|OL Component|Physician Decision|2|||
161710505|NCT03263091|583984092|FG003|OL Component|Physician Decision|0|||
161710506|NCT03263091|583984093|FG004|OL Component|Physician Decision|0|||
161710507|NCT03263091|583984094|FG005|OL Component|Physician Decision|0|||
161710508|NCT03263091|583984089|FG000|OL Component|Death|1|||
161710509|NCT03263091|583984090|FG001|OL Component|Death|0|||
161710510|NCT03263091|583984091|FG002|OL Component|Death|0|||
161710511|NCT03263091|583984092|FG003|OL Component|Death|0|||
161710512|NCT03263091|583984093|FG004|OL Component|Death|0|||
161710513|NCT03263091|583984094|FG005|OL Component|Death|0|||
161710514|NCT03263091|583984089|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
161710515|NCT03263091|583984090|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
161710516|NCT03263091|583984091|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
161710517|NCT03263091|583984092|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
161710518|NCT03263091|583984093|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
161710519|NCT03263091|583984094|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
161710520|NCT03263091|583984089|FG000|OL High-EPO Component|Physician Decision|0|||
161658962|NCT00320528|583800779|FG000|Study Period III|Sponsor Decision|0|||
161658963|NCT00320528|583800780|FG001|Study Period III|Sponsor Decision|0|||
161658964|NCT00320528|583800781|FG002|Study Period III|Sponsor Decision|1|||
161658965|NCT00320528|583800779|FG000|Study Period III|Atomoxetine Commercially Available|68|||
161658966|NCT00320528|583800780|FG001|Study Period III|Atomoxetine Commercially Available|25|||
161658967|NCT00320528|583800781|FG002|Study Period III|Atomoxetine Commercially Available|90|||
161658968|NCT04828837|583800782|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
161658969|NCT04828837|583800783|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
161658970|NCT04828837|583800782|FG000|Overall Study|Lost to Follow-up|2|||
161658971|NCT04828837|583800783|FG001|Overall Study|Lost to Follow-up|6|||
161658972|NCT04828837|583800782|FG000|Overall Study|Lack of Efficacy|1|||
161658973|NCT04828837|583800783|FG001|Overall Study|Lack of Efficacy|0|||
161658974|NCT04828837|583800782|FG000|Overall Study|Admitted due to pneumothorax.|1|||
161658975|NCT04828837|583800783|FG001|Overall Study|Admitted due to pneumothorax.|0|||
161658976|NCT04828837|583800782|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
161658977|NCT04828837|583800783|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
161658978|NCT01397422|583800784|FG000|Overall Study|Adverse Event|0|||
161658979|NCT01397422|583800785|FG001|Overall Study|Adverse Event|3|||
161658980|NCT01397422|583800786|FG002|Overall Study|Adverse Event|3|||
161658981|NCT01397422|583800787|FG003|Overall Study|Adverse Event|8|||
161658982|NCT01397422|583800784|FG000|Overall Study|Withdrawal by Subject|1|||
161658983|NCT01397422|583800785|FG001|Overall Study|Withdrawal by Subject|0|||
161658984|NCT01397422|583800786|FG002|Overall Study|Withdrawal by Subject|0|||
161658985|NCT01397422|583800787|FG003|Overall Study|Withdrawal by Subject|0|||
161658986|NCT01397422|583800784|FG000|Overall Study|Increased bradykinesia related to PD|1|||
161658987|NCT01397422|583800785|FG001|Overall Study|Increased bradykinesia related to PD|0|||
161658988|NCT01397422|583800786|FG002|Overall Study|Increased bradykinesia related to PD|0|||
161658989|NCT01397422|583800787|FG003|Overall Study|Increased bradykinesia related to PD|0|||
161658990|NCT03762200|583800800|FG000|Overall Study|Death|2|||
161658991|NCT05618912|583800801|FG000|Overall Study|Lost to Follow-up|14|||
161658992|NCT05618912|583800802|FG001|Overall Study|Lost to Follow-up|19|||
161658993|NCT02594163|583802588|FG000|Treatment Period|Progressive disease|2|||
161658994|NCT02594163|583802589|FG001|Treatment Period|Progressive disease|3|||
161658995|NCT02594163|583802588|FG000|Treatment Period|Adverse Event|1|||
161658996|NCT02594163|583802589|FG001|Treatment Period|Adverse Event|5|||
161658997|NCT02594163|583802588|FG000|Treatment Period|Physician Decision|1|||
161658998|NCT02594163|583802589|FG001|Treatment Period|Physician Decision|3|||
161658999|NCT02594163|583802588|FG000|Treatment Period|Study termination by sponsor|2|||
161659000|NCT02594163|583802589|FG001|Treatment Period|Study termination by sponsor|1|||
161659001|NCT02594163|583802588|FG000|Treatment Period|Other, Non-AE|1|||
161659002|NCT02594163|583802589|FG001|Treatment Period|Other, Non-AE|0|||
161659003|NCT02594163|583802588|FG000|Follow-up Period|Withdrawal by Subject|0|||
161659004|NCT02594163|583802589|FG001|Follow-up Period|Withdrawal by Subject|1|||
161659005|NCT02594163|583802588|FG000|Follow-up Period|Study Termination by Sponsor|6|||
161710521|NCT03263091|583984090|FG001|OL High-EPO Component|Physician Decision|0|||
161710522|NCT03263091|583984091|FG002|OL High-EPO Component|Physician Decision|0|||
161710523|NCT03263091|583984092|FG003|OL High-EPO Component|Physician Decision|1|||
161710524|NCT03263091|583984093|FG004|OL High-EPO Component|Physician Decision|0|||
161710525|NCT03263091|583984094|FG005|OL High-EPO Component|Physician Decision|0|||
161710526|NCT03263091|583984089|FG000|OL High-EPO Component|Death|0|||
161710527|NCT03263091|583984090|FG001|OL High-EPO Component|Death|0|||
161710528|NCT03263091|583984091|FG002|OL High-EPO Component|Death|0|||
161710529|NCT03263091|583984092|FG003|OL High-EPO Component|Death|3|||
161710530|NCT03263091|583984093|FG004|OL High-EPO Component|Death|0|||
161710531|NCT03263091|583984094|FG005|OL High-EPO Component|Death|0|||
161710532|NCT03263091|583984089|FG000|DB Component|Withdrawal by Subject|0|||
161710533|NCT03263091|583984090|FG001|DB Component|Withdrawal by Subject|0|||
161710534|NCT03263091|583984091|FG002|DB Component|Withdrawal by Subject|0|||
161710535|NCT03263091|583984092|FG003|DB Component|Withdrawal by Subject|0|||
161710536|NCT03263091|583984093|FG004|DB Component|Withdrawal by Subject|22|||
161710537|NCT03263091|583984094|FG005|DB Component|Withdrawal by Subject|8|||
161710538|NCT03263091|583984089|FG000|DB Component|Physician Decision|0|||
161710539|NCT03263091|583984090|FG001|DB Component|Physician Decision|0|||
161710540|NCT03263091|583984091|FG002|DB Component|Physician Decision|0|||
161710541|NCT03263091|583984092|FG003|DB Component|Physician Decision|0|||
161710542|NCT03263091|583984093|FG004|DB Component|Physician Decision|3|||
161710543|NCT03263091|583984094|FG005|DB Component|Physician Decision|1|||
161710544|NCT03263091|583984089|FG000|DB Component|Adverse Event|0|||
161710545|NCT03263091|583984090|FG001|DB Component|Adverse Event|0|||
161710546|NCT03263091|583984091|FG002|DB Component|Adverse Event|0|||
161710547|NCT03263091|583984092|FG003|DB Component|Adverse Event|0|||
161710548|NCT03263091|583984093|FG004|DB Component|Adverse Event|2|||
161710549|NCT03263091|583984094|FG005|DB Component|Adverse Event|1|||
161710550|NCT03263091|583984089|FG000|DB Component|Lost to Follow-up|0|||
161710551|NCT03263091|583984090|FG001|DB Component|Lost to Follow-up|0|||
161710552|NCT03263091|583984091|FG002|DB Component|Lost to Follow-up|0|||
161710553|NCT03263091|583984092|FG003|DB Component|Lost to Follow-up|0|||
161710554|NCT03263091|583984093|FG004|DB Component|Lost to Follow-up|2|||
161710555|NCT03263091|583984094|FG005|DB Component|Lost to Follow-up|1|||
161710556|NCT03263091|583984089|FG000|DB Component|Death|0|||
161710557|NCT03263091|583984090|FG001|DB Component|Death|0|||
161710558|NCT03263091|583984091|FG002|DB Component|Death|0|||
161710559|NCT03263091|583984092|FG003|DB Component|Death|0|||
161710560|NCT03263091|583984093|FG004|DB Component|Death|7|||
161710561|NCT03263091|583984094|FG005|DB Component|Death|4|||
161710562|NCT03263091|583984089|FG000|DB Component|Other than specified|0|||
161710563|NCT03263091|583984090|FG001|DB Component|Other than specified|0|||
161710564|NCT03263091|583984091|FG002|DB Component|Other than specified|0|||
161710565|NCT03263091|583984092|FG003|DB Component|Other than specified|0|||
161710566|NCT03263091|583984093|FG004|DB Component|Other than specified|8|||
161710567|NCT03263091|583984094|FG005|DB Component|Other than specified|6|||
161710568|NCT00265941|583984104|FG000|Overall Study|Protocol Violation|22|||
161710569|NCT00265941|583984105|FG001|Overall Study|Protocol Violation|25|||
161710570|NCT00265941|583984104|FG000|Overall Study|Lost to Follow-up|1|||
161710571|NCT00265941|583984105|FG001|Overall Study|Lost to Follow-up|1|||
161710572|NCT01217606|583984112|FG000|Initial Treatment Phase|Other Reasons|0|||
161710573|NCT01217606|583984113|FG001|Initial Treatment Phase|Other Reasons|2|||
161710574|NCT01217606|583984112|FG000|Initial Treatment Phase|Protocol Violation|3|||
161710575|NCT01217606|583984113|FG001|Initial Treatment Phase|Protocol Violation|2|||
161710576|NCT01217606|583984112|FG000|Initial Treatment Phase|Personal Reasons|0|||
161710577|NCT01217606|583984113|FG001|Initial Treatment Phase|Personal Reasons|2|||
161710578|NCT01217606|583984112|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
161710579|NCT01217606|583984113|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
161710580|NCT01217606|583984112|FG000|Initial Treatment Phase|Adverse Event|10|||
161710581|NCT01217606|583984113|FG001|Initial Treatment Phase|Adverse Event|6|||
161710582|NCT01217606|583984112|FG000|9-Month Masked Extension|Adverse Event|3|||
161710583|NCT01217606|583984113|FG001|9-Month Masked Extension|Adverse Event|6|||
161710584|NCT01217606|583984112|FG000|9-Month Masked Extension|Other Reasons|4|||
161710585|NCT01217606|583984113|FG001|9-Month Masked Extension|Other Reasons|4|||
161710586|NCT01217606|583984112|FG000|9-Month Masked Extension|Personal Reasons|2|||
161710587|NCT01217606|583984113|FG001|9-Month Masked Extension|Personal Reasons|1|||
161710588|NCT01217606|583984112|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
161659006|NCT02594163|583802589|FG001|Follow-up Period|Study Termination by Sponsor|4|||
161659007|NCT02594163|583802588|FG000|Follow-up Period|Lost to Follow-up|1|||
161659008|NCT02594163|583802589|FG001|Follow-up Period|Lost to Follow-up|0|||
161659009|NCT02594163|583802588|FG000|Follow-up Period|Death|2|||
161659010|NCT02594163|583802589|FG001|Follow-up Period|Death|5|||
161659011|NCT02594163|583802588|FG000|Follow-up Period|Adverse Event|0|||
161659012|NCT02594163|583802589|FG001|Follow-up Period|Adverse Event|1|||
161659013|NCT02594163|583802588|FG000|Follow-up Period|Progressive Disease|2|||
161659014|NCT02594163|583802589|FG001|Follow-up Period|Progressive Disease|0|||
161659015|NCT02594163|583802588|FG000|Follow-up Period|Physician Decision|0|||
161659016|NCT02594163|583802589|FG001|Follow-up Period|Physician Decision|1|||
161659017|NCT01342341|583802590|FG000|Overall Study|Lost to Follow-up|4|||
161659018|NCT01342341|583802591|FG001|Overall Study|Lost to Follow-up|4|||
161659019|NCT01022268|583802594|FG000|Overall Study|Withdrawal by Subject|1|||
161659020|NCT01022268|583802595|FG001|Overall Study|Withdrawal by Subject|0|||
161659021|NCT01022268|583802594|FG000|Overall Study|Withdrawal by Subject|1|||
161659022|NCT01022268|583802595|FG001|Overall Study|Withdrawal by Subject|0|||
161659023|NCT01034176|583802596|FG000|Overall Study|Physician Decision|2|||
161659024|NCT01034176|583802597|FG001|Overall Study|Physician Decision|0|||
161659025|NCT01034176|583802596|FG000|Overall Study|Withdrawal by Subject|0|||
161659026|NCT01034176|583802597|FG001|Overall Study|Withdrawal by Subject|1|||
161659027|NCT01034176|583802596|FG000|Overall Study|Lost to Follow-up|0|||
161659028|NCT01034176|583802597|FG001|Overall Study|Lost to Follow-up|1|||
161659029|NCT00266227|583802600|FG000|Initial Treatment|Adverse Event|0|||
161659030|NCT00266227|583802601|FG001|Initial Treatment|Adverse Event|0|||
161659031|NCT00266227|583802602|FG002|Initial Treatment|Adverse Event|13|||
161659032|NCT00266227|583802600|FG000|Initial Treatment|Lost to Follow-up|0|||
161659033|NCT00266227|583802601|FG001|Initial Treatment|Lost to Follow-up|0|||
161659034|NCT00266227|583802602|FG002|Initial Treatment|Lost to Follow-up|6|||
161659035|NCT00266227|583802600|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
161710589|NCT01217606|583984113|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
161710590|NCT01217606|583984112|FG000|9-Month Masked Extension|Pregnancy|1|||
161659036|NCT00266227|583802601|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
161659037|NCT00266227|583802602|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
161659038|NCT00266227|583802600|FG000|Initial Treatment|Physician decision to withdraw|0|||
161659039|NCT00266227|583802601|FG001|Initial Treatment|Physician decision to withdraw|0|||
161659040|NCT00266227|583802602|FG002|Initial Treatment|Physician decision to withdraw|12|||
161659041|NCT00266227|583802600|FG000|Initial Treatment|Pregnancy|0|||
161659042|NCT00266227|583802601|FG001|Initial Treatment|Pregnancy|0|||
161659043|NCT00266227|583802602|FG002|Initial Treatment|Pregnancy|1|||
161659044|NCT00266227|583802600|FG000|Retreatment: Up to Week 48|Death|1|||
161659045|NCT00266227|583802601|FG001|Retreatment: Up to Week 48|Death|0|||
161659046|NCT00266227|583802602|FG002|Retreatment: Up to Week 48|Death|0|||
161659047|NCT00266227|583802600|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
161659048|NCT00266227|583802601|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
161659049|NCT00266227|583802602|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
161659050|NCT00266227|583802600|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
161659051|NCT00266227|583802601|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
161659052|NCT00266227|583802602|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
161659053|NCT00266227|583802600|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
161659054|NCT00266227|583802601|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
161659055|NCT00266227|583802602|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
161659056|NCT00266227|583802600|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
161659057|NCT00266227|583802601|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
161659058|NCT00266227|583802602|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
161659059|NCT00266227|583802600|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
161659060|NCT00266227|583802601|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
161659061|NCT00266227|583802602|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
161659062|NCT00266227|583802600|FG000|Retreatment: Week 48 to Week 72|Death|1|||
161659063|NCT00266227|583802601|FG001|Retreatment: Week 48 to Week 72|Death|1|||
161659064|NCT00266227|583802602|FG002|Retreatment: Week 48 to Week 72|Death|0|||
161659065|NCT00266227|583802600|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
161659066|NCT00266227|583802601|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
161659067|NCT00266227|583802602|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
161659068|NCT00266227|583802600|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
161659069|NCT00266227|583802601|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
161659070|NCT00266227|583802602|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
161659071|NCT00266227|583802600|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
161659072|NCT00266227|583802601|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
161710591|NCT01217606|583984113|FG001|9-Month Masked Extension|Pregnancy|0|||
161710592|NCT01217606|583984112|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
161710593|NCT01217606|583984113|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
161710594|NCT02432807|583984120|FG000|Overall Study|Adverse Event|0|||
161710595|NCT02432807|583984121|FG001|Overall Study|Adverse Event|2|||
161710596|NCT02432807|583984120|FG000|Overall Study|Lost to Follow-up|1|||
161710597|NCT02432807|583984121|FG001|Overall Study|Lost to Follow-up|0|||
161710598|NCT02432807|583984120|FG000|Overall Study|Withdrawal by Subject|1|||
161710599|NCT02432807|583984121|FG001|Overall Study|Withdrawal by Subject|1|||
161710600|NCT02432807|583984120|FG000|Overall Study|Other|1|||
161710601|NCT02432807|583984121|FG001|Overall Study|Other|1|||
161710602|NCT03976401|583984122|FG000|Overall Study|Adverse Event|2|||
161710603|NCT03976401|583984123|FG001|Overall Study|Adverse Event|0|||
161659073|NCT00266227|583802602|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
161659074|NCT00266227|583802600|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
161710604|NCT03976401|583984124|FG002|Overall Study|Adverse Event|4|||
161710605|NCT03976401|583984125|FG003|Overall Study|Adverse Event|1|||
161710606|NCT03976401|583984126|FG004|Overall Study|Adverse Event|1|||
161710607|NCT03976401|583984127|FG005|Overall Study|Adverse Event|0|||
161710608|NCT03976401|583984122|FG000|Overall Study|Withdrawal by Subject|0|||
161659075|NCT00266227|583802601|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
161659076|NCT00266227|583802602|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
161710609|NCT03976401|583984123|FG001|Overall Study|Withdrawal by Subject|1|||
161710610|NCT03976401|583984124|FG002|Overall Study|Withdrawal by Subject|0|||
161710611|NCT03976401|583984125|FG003|Overall Study|Withdrawal by Subject|0|||
161710612|NCT03976401|583984126|FG004|Overall Study|Withdrawal by Subject|0|||
161710613|NCT03976401|583984127|FG005|Overall Study|Withdrawal by Subject|1|||
161710614|NCT03976401|583984122|FG000|Overall Study|Physician Decision|0|||
161710615|NCT03976401|583984123|FG001|Overall Study|Physician Decision|0|||
161710616|NCT03976401|583984124|FG002|Overall Study|Physician Decision|1|||
161710617|NCT03976401|583984125|FG003|Overall Study|Physician Decision|0|||
161710618|NCT03976401|583984126|FG004|Overall Study|Physician Decision|0|||
161710619|NCT03976401|583984127|FG005|Overall Study|Physician Decision|0|||
161710620|NCT03976401|583984122|FG000|Overall Study|Lost to Follow-up|1|||
161710621|NCT03976401|583984123|FG001|Overall Study|Lost to Follow-up|2|||
161710622|NCT03976401|583984124|FG002|Overall Study|Lost to Follow-up|0|||
161710623|NCT03976401|583984125|FG003|Overall Study|Lost to Follow-up|0|||
161710624|NCT03976401|583984126|FG004|Overall Study|Lost to Follow-up|0|||
161710625|NCT03976401|583984127|FG005|Overall Study|Lost to Follow-up|0|||
161710626|NCT03976401|583984122|FG000|Overall Study|Protocol Violation|0|||
161710627|NCT03976401|583984123|FG001|Overall Study|Protocol Violation|1|||
161710628|NCT03976401|583984124|FG002|Overall Study|Protocol Violation|0|||
161710629|NCT03976401|583984125|FG003|Overall Study|Protocol Violation|0|||
161710630|NCT03976401|583984126|FG004|Overall Study|Protocol Violation|0|||
161659077|NCT02680002|583802604|FG000|Overall Study|Lost to Follow-up|5|||
161659078|NCT02680002|583802605|FG001|Overall Study|Lost to Follow-up|1|||
161659079|NCT02680002|583802606|FG002|Overall Study|Lost to Follow-up|4|||
161659080|NCT02680002|583802607|FG003|Overall Study|Lost to Follow-up|2|||
161659081|NCT02680002|583802608|FG004|Overall Study|Lost to Follow-up|0|||
161659082|NCT02680002|583802609|FG005|Overall Study|Lost to Follow-up|2|||
161659083|NCT02680002|583802604|FG000|Overall Study|Physician Decision|5|||
161659084|NCT02680002|583802605|FG001|Overall Study|Physician Decision|1|||
161659085|NCT02680002|583802606|FG002|Overall Study|Physician Decision|1|||
161659086|NCT02680002|583802607|FG003|Overall Study|Physician Decision|1|||
161659087|NCT02680002|583802608|FG004|Overall Study|Physician Decision|1|||
161659088|NCT02680002|583802609|FG005|Overall Study|Physician Decision|1|||
161659089|NCT02680002|583802604|FG000|Overall Study|Protocol Violation|1|||
161659090|NCT02680002|583802605|FG001|Overall Study|Protocol Violation|0|||
161659091|NCT02680002|583802606|FG002|Overall Study|Protocol Violation|1|||
161659092|NCT02680002|583802607|FG003|Overall Study|Protocol Violation|0|||
161659093|NCT02680002|583802608|FG004|Overall Study|Protocol Violation|1|||
161710631|NCT03976401|583984127|FG005|Overall Study|Protocol Violation|0|||
161710632|NCT03976401|583984122|FG000|Overall Study|Withdrew Consent|0|||
161710633|NCT03976401|583984123|FG001|Overall Study|Withdrew Consent|0|||
161710634|NCT03976401|583984124|FG002|Overall Study|Withdrew Consent|0|||
161710635|NCT03976401|583984125|FG003|Overall Study|Withdrew Consent|1|||
161710636|NCT03976401|583984126|FG004|Overall Study|Withdrew Consent|0|||
161710637|NCT03976401|583984127|FG005|Overall Study|Withdrew Consent|0|||
161710638|NCT04125680|583984129|FG000|Overall Study|Lost to Follow-up|15|||
161710639|NCT02966314|583984132|FG000|Overall Study|Lost to Follow-up|1|||
161710640|NCT02966314|583984133|FG001|Overall Study|Lost to Follow-up|0|||
161710641|NCT00391976|583984134|FG000|Overall Study|Adverse Event|0|||
161710642|NCT00391976|583984135|FG001|Overall Study|Adverse Event|0|||
161710643|NCT00391976|583984136|FG002|Overall Study|Adverse Event|1|||
161710644|NCT00391976|583984134|FG000|Overall Study|Withdrawal of consent|0|||
161710645|NCT00391976|583984135|FG001|Overall Study|Withdrawal of consent|1|||
161710646|NCT00391976|583984136|FG002|Overall Study|Withdrawal of consent|1|||
161710647|NCT00391976|583984134|FG000|Overall Study|Lost to Follow-up|1|||
161710648|NCT00391976|583984135|FG001|Overall Study|Lost to Follow-up|2|||
161710649|NCT00391976|583984136|FG002|Overall Study|Lost to Follow-up|0|||
161710650|NCT00391976|583984134|FG000|Overall Study|Inappropriate enrollment|1|||
161710651|NCT00391976|583984135|FG001|Overall Study|Inappropriate enrollment|1|||
161710652|NCT00391976|583984136|FG002|Overall Study|Inappropriate enrollment|0|||
161710653|NCT00391976|583984134|FG000|Overall Study|Protocol deviation/violation|4|||
161710654|NCT00391976|583984135|FG001|Overall Study|Protocol deviation/violation|2|||
161710655|NCT00391976|583984136|FG002|Overall Study|Protocol deviation/violation|1|||
161710656|NCT00391976|583984134|FG000|Overall Study|Recurrence/no eradication of infection|21|||
161710657|NCT00391976|583984135|FG001|Overall Study|Recurrence/no eradication of infection|19|||
161710658|NCT00391976|583984136|FG002|Overall Study|Recurrence/no eradication of infection|0|||
161710659|NCT00391976|583984134|FG000|Overall Study|Unable to classify|0|||
161659094|NCT02680002|583802609|FG005|Overall Study|Protocol Violation|2|||
161659095|NCT02680002|583802604|FG000|Overall Study|Withdrawal by Subject|0|||
161659096|NCT02680002|583802605|FG001|Overall Study|Withdrawal by Subject|0|||
161659097|NCT02680002|583802606|FG002|Overall Study|Withdrawal by Subject|1|||
161659098|NCT02680002|583802607|FG003|Overall Study|Withdrawal by Subject|0|||
161659099|NCT02680002|583802608|FG004|Overall Study|Withdrawal by Subject|2|||
161659100|NCT02680002|583802609|FG005|Overall Study|Withdrawal by Subject|2|||
161659101|NCT02680002|583802604|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
161659102|NCT02680002|583802605|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
161659103|NCT02680002|583802606|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
161659104|NCT02680002|583802607|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
161659105|NCT02680002|583802608|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
161659106|NCT02680002|583802609|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
161659107|NCT02680002|583802604|FG000|Overall Study|Other|0|||
161659108|NCT02680002|583802605|FG001|Overall Study|Other|1|||
161659109|NCT02680002|583802606|FG002|Overall Study|Other|0|||
161659110|NCT02680002|583802607|FG003|Overall Study|Other|0|||
161659111|NCT02680002|583802608|FG004|Overall Study|Other|1|||
161659112|NCT02680002|583802609|FG005|Overall Study|Other|0|||
161659113|NCT02680002|583802604|FG000|Overall Study|Adverse Event|0|||
161659114|NCT02680002|583802605|FG001|Overall Study|Adverse Event|0|||
161659115|NCT02680002|583802606|FG002|Overall Study|Adverse Event|0|||
161659116|NCT02680002|583802607|FG003|Overall Study|Adverse Event|0|||
161659117|NCT02680002|583802608|FG004|Overall Study|Adverse Event|1|||
161659118|NCT02680002|583802609|FG005|Overall Study|Adverse Event|2|||
161659119|NCT04097301|583802612|FG000|Overall Study|Death|1|||
161659120|NCT04097301|583802612|FG000|Overall Study|Withdrawal by Subject|1|||
161659121|NCT04097301|583802612|FG000|Overall Study|Screening Failure|5|||
161659122|NCT01403610|583802616|FG000|Overall Study|Withdrawal by Subject|2|||
161659123|NCT01403610|583802617|FG001|Overall Study|Withdrawal by Subject|0|||
161659124|NCT01403610|583802618|FG002|Overall Study|Withdrawal by Subject|0|||
161659125|NCT01403610|583802619|FG003|Overall Study|Withdrawal by Subject|0|||
161659126|NCT01403610|583802616|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
161659127|NCT01403610|583802617|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
161659128|NCT01403610|583802618|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
161659129|NCT01403610|583802619|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
161659130|NCT00901186|583802620|FG000|Overall Study|Lack of Efficacy|0|||
161659131|NCT00901186|583802621|FG001|Overall Study|Lack of Efficacy|1|||
161659132|NCT00901186|583802620|FG000|Overall Study|Abnormal laboratory values|0|||
161659133|NCT00901186|583802621|FG001|Overall Study|Abnormal laboratory values|1|||
161659134|NCT00901186|583802620|FG000|Overall Study|Lost to Follow-up|2|||
161659135|NCT00901186|583802621|FG001|Overall Study|Lost to Follow-up|0|||
161659136|NCT00901186|583802620|FG000|Overall Study|Adverse Event|2|||
161659137|NCT00901186|583802621|FG001|Overall Study|Adverse Event|4|||
161659138|NCT00901186|583802620|FG000|Overall Study|Administration problems|0|||
161659139|NCT00901186|583802621|FG001|Overall Study|Administration problems|1|||
161659140|NCT00901186|583802620|FG000|Overall Study|Protocol deviations|5|||
161659141|NCT00901186|583802621|FG001|Overall Study|Protocol deviations|4|||
161659142|NCT02383056|583802622|FG000|Overall Study|Adverse Event|1|||
161659143|NCT02383056|583802623|FG001|Overall Study|Adverse Event|0|||
161659144|NCT02383056|583802622|FG000|Overall Study|Lost to Follow-up|0|||
161659145|NCT02383056|583802623|FG001|Overall Study|Lost to Follow-up|2|||
161659146|NCT01775475|583802624|FG000|Overall Study|Death|3|||
161659147|NCT01775475|583802625|FG001|Overall Study|Death|3|||
161659148|NCT02074553|583802629|FG000|Intervention Period 1|Family Emergency|0|||
161659149|NCT02074553|583802630|FG001|Intervention Period 1|Family Emergency|0|||
161659150|NCT02074553|583802631|FG002|Intervention Period 1|Family Emergency|0|||
161659151|NCT02074553|583802632|FG003|Intervention Period 1|Family Emergency|1|||
161659152|NCT02074553|583802633|FG004|Intervention Period 1|Family Emergency|0|||
161659153|NCT02074553|583802634|FG005|Intervention Period 1|Family Emergency|0|||
161659154|NCT02074553|583802635|FG006|Intervention Period 1|Family Emergency|0|||
161659155|NCT02074553|583802636|FG007|Intervention Period 1|Family Emergency|0|||
161659156|NCT02074553|583802629|FG000|Washout Period 1|Adverse Event|1|||
161710660|NCT00391976|583984135|FG001|Overall Study|Unable to classify|0|||
161659157|NCT02074553|583802630|FG001|Washout Period 1|Adverse Event|0|||
161659158|NCT02074553|583802631|FG002|Washout Period 1|Adverse Event|0|||
161659159|NCT02074553|583802632|FG003|Washout Period 1|Adverse Event|0|||
161659160|NCT02074553|583802633|FG004|Washout Period 1|Adverse Event|0|||
161659161|NCT02074553|583802634|FG005|Washout Period 1|Adverse Event|0|||
161659162|NCT02074553|583802635|FG006|Washout Period 1|Adverse Event|0|||
161659163|NCT02074553|583802636|FG007|Washout Period 1|Adverse Event|0|||
161659164|NCT02074553|583802629|FG000|Washout Period 1|Physician Decision|0|||
161659165|NCT02074553|583802630|FG001|Washout Period 1|Physician Decision|0|||
161659166|NCT02074553|583802631|FG002|Washout Period 1|Physician Decision|0|||
161659167|NCT02074553|583802632|FG003|Washout Period 1|Physician Decision|1|||
161659168|NCT02074553|583802633|FG004|Washout Period 1|Physician Decision|0|||
161659169|NCT02074553|583802634|FG005|Washout Period 1|Physician Decision|0|||
161659170|NCT02074553|583802635|FG006|Washout Period 1|Physician Decision|0|||
161659171|NCT02074553|583802636|FG007|Washout Period 1|Physician Decision|0|||
161659172|NCT02074553|583802629|FG000|Washout Period 1|Other|0|||
161659173|NCT02074553|583802630|FG001|Washout Period 1|Other|0|||
161659174|NCT02074553|583802631|FG002|Washout Period 1|Other|0|||
161659175|NCT02074553|583802632|FG003|Washout Period 1|Other|0|||
161659176|NCT02074553|583802633|FG004|Washout Period 1|Other|0|||
161659177|NCT02074553|583802634|FG005|Washout Period 1|Other|1|||
161659178|NCT02074553|583802635|FG006|Washout Period 1|Other|0|||
161659179|NCT02074553|583802636|FG007|Washout Period 1|Other|0|||
161659180|NCT02074553|583802629|FG000|Washout Period 2|Adverse Event|0|||
161659181|NCT02074553|583802630|FG001|Washout Period 2|Adverse Event|0|||
161659182|NCT02074553|583802631|FG002|Washout Period 2|Adverse Event|0|||
161659183|NCT02074553|583802632|FG003|Washout Period 2|Adverse Event|0|||
161659184|NCT02074553|583802633|FG004|Washout Period 2|Adverse Event|0|||
161659185|NCT02074553|583802634|FG005|Washout Period 2|Adverse Event|0|||
161659186|NCT02074553|583802635|FG006|Washout Period 2|Adverse Event|1|||
161659187|NCT02074553|583802636|FG007|Washout Period 2|Adverse Event|0|||
161659188|NCT02074553|583802629|FG000|Washout Period 2|Physician Decision|0|||
161659189|NCT02074553|583802630|FG001|Washout Period 2|Physician Decision|0|||
161659190|NCT02074553|583802631|FG002|Washout Period 2|Physician Decision|0|||
161659191|NCT02074553|583802632|FG003|Washout Period 2|Physician Decision|0|||
161659192|NCT02074553|583802633|FG004|Washout Period 2|Physician Decision|0|||
161659193|NCT02074553|583802634|FG005|Washout Period 2|Physician Decision|1|||
161659194|NCT02074553|583802635|FG006|Washout Period 2|Physician Decision|0|||
161659195|NCT02074553|583802636|FG007|Washout Period 2|Physician Decision|0|||
161659196|NCT02074553|583802629|FG000|Washout Period 2|Lost to Follow-up|0|||
161659197|NCT02074553|583802630|FG001|Washout Period 2|Lost to Follow-up|0|||
161659198|NCT02074553|583802631|FG002|Washout Period 2|Lost to Follow-up|1|||
161659199|NCT02074553|583802632|FG003|Washout Period 2|Lost to Follow-up|0|||
161659200|NCT02074553|583802633|FG004|Washout Period 2|Lost to Follow-up|0|||
161659201|NCT02074553|583802634|FG005|Washout Period 2|Lost to Follow-up|0|||
161659202|NCT02074553|583802635|FG006|Washout Period 2|Lost to Follow-up|0|||
161659203|NCT02074553|583802636|FG007|Washout Period 2|Lost to Follow-up|0|||
161659204|NCT02074553|583802629|FG000|Washout Period 3|Physician Decision|0|||
161659205|NCT02074553|583802630|FG001|Washout Period 3|Physician Decision|0|||
161659206|NCT02074553|583802631|FG002|Washout Period 3|Physician Decision|0|||
161659207|NCT02074553|583802632|FG003|Washout Period 3|Physician Decision|0|||
161659208|NCT02074553|583802633|FG004|Washout Period 3|Physician Decision|0|||
161659209|NCT02074553|583802634|FG005|Washout Period 3|Physician Decision|0|||
161659210|NCT02074553|583802635|FG006|Washout Period 3|Physician Decision|0|||
161659211|NCT02074553|583802636|FG007|Washout Period 3|Physician Decision|1|||
161659212|NCT02342743|583802637|FG000|Baseline Period|Withdrawal by Subject|3|||
161659213|NCT02342743|583802637|FG000|Baseline Period|Lost to Follow-up|2|||
161659214|NCT02342743|583802637|FG000|Baseline Period|Change in prophylactic medication|3|||
161659215|NCT02342743|583802637|FG000|Baseline Period|Screening failure regarding baseline|7|||
161659216|NCT02342743|583802637|FG000|Treatment Period|Withdrawal by Subject|2|||
161659217|NCT02342743|583802637|FG000|Treatment Period|Lost to Follow-up|8|||
161659218|NCT02342743|583802637|FG000|Treatment Period|Change in prophylactic medication|1|||
161659219|NCT00686725|583802638|FG000|Overall Study|Adverse Event|1|||
161659220|NCT00686725|583802639|FG001|Overall Study|Adverse Event|1|||
161659221|NCT00686725|583802638|FG000|Overall Study|Progressive Disease|17|||
161659222|NCT00686725|583802639|FG001|Overall Study|Progressive Disease|23|||
161659223|NCT00686725|583802638|FG000|Overall Study|Lost to Follow-up|7|||
161659224|NCT00686725|583802639|FG001|Overall Study|Lost to Follow-up|5|||
161659225|NCT00686725|583802638|FG000|Overall Study|Death|6|||
161659226|NCT00686725|583802639|FG001|Overall Study|Death|3|||
161659227|NCT00686725|583802638|FG000|Overall Study|Withdrawal by Subject|13|||
161659228|NCT00686725|583802639|FG001|Overall Study|Withdrawal by Subject|4|||
161659229|NCT00686725|583802638|FG000|Overall Study|Protocol Violation|1|||
161659230|NCT00686725|583802639|FG001|Overall Study|Protocol Violation|3|||
161659231|NCT00686725|583802638|FG000|Overall Study|Other|1|||
161659232|NCT00686725|583802639|FG001|Overall Study|Other|3|||
161659233|NCT03602066|583802640|FG000|Overall Study|Withdrawal by Subject|2|||
161659234|NCT03602066|583802641|FG001|Overall Study|Withdrawal by Subject|0|||
161659235|NCT03602066|583802640|FG000|Overall Study|Physician Decision|1|||
161659236|NCT03602066|583802641|FG001|Overall Study|Physician Decision|0|||
161659237|NCT00092495|583802642|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
161659238|NCT00092495|583802643|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
161659239|NCT00092495|583802644|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161659240|NCT00092495|583802645|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
161659241|NCT00092495|583802646|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161659242|NCT00092495|583802642|FG000|Base Study Vaccination Period|Extended|0|||
161659243|NCT00092495|583802643|FG001|Base Study Vaccination Period|Extended|0|||
161659244|NCT00092495|583802644|FG002|Base Study Vaccination Period|Extended|0|||
161659245|NCT00092495|583802645|FG003|Base Study Vaccination Period|Extended|1|||
161659246|NCT00092495|583802646|FG004|Base Study Vaccination Period|Extended|0|||
161659247|NCT00092495|583802642|FG000|Base Study Vaccination Period|*Clinical AE|1|||
161659248|NCT00092495|583802643|FG001|Base Study Vaccination Period|*Clinical AE|0|||
161659249|NCT00092495|583802644|FG002|Base Study Vaccination Period|*Clinical AE|1|||
161659250|NCT00092495|583802645|FG003|Base Study Vaccination Period|*Clinical AE|2|||
161659251|NCT00092495|583802646|FG004|Base Study Vaccination Period|*Clinical AE|0|||
161659252|NCT00092495|583802642|FG000|Base Study Vaccination Period|*Other reasons|1|||
161659253|NCT00092495|583802643|FG001|Base Study Vaccination Period|*Other reasons|0|||
161659254|NCT00092495|583802644|FG002|Base Study Vaccination Period|*Other reasons|0|||
161659255|NCT00092495|583802645|FG003|Base Study Vaccination Period|*Other reasons|1|||
161659256|NCT00092495|583802646|FG004|Base Study Vaccination Period|*Other reasons|0|||
161659257|NCT00092495|583802642|FG000|Base Study Vaccination Period|*Pregnancy|0|||
161659258|NCT00092495|583802643|FG001|Base Study Vaccination Period|*Pregnancy|2|||
161659259|NCT00092495|583802644|FG002|Base Study Vaccination Period|*Pregnancy|5|||
161659260|NCT00092495|583802645|FG003|Base Study Vaccination Period|*Pregnancy|7|||
161659261|NCT00092495|583802646|FG004|Base Study Vaccination Period|*Pregnancy|0|||
161659262|NCT00092495|583802642|FG000|Base Study Vaccination Period|Adverse Event|1|||
161659263|NCT00092495|583802643|FG001|Base Study Vaccination Period|Adverse Event|0|||
161659264|NCT00092495|583802644|FG002|Base Study Vaccination Period|Adverse Event|0|||
161659265|NCT00092495|583802645|FG003|Base Study Vaccination Period|Adverse Event|3|||
161659266|NCT00092495|583802646|FG004|Base Study Vaccination Period|Adverse Event|0|||
161659267|NCT00092495|583802642|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
161659268|NCT00092495|583802643|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
161659269|NCT00092495|583802644|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
161659270|NCT00092495|583802645|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
161659271|NCT00092495|583802646|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161659272|NCT00092495|583802642|FG000|Base Study Vaccination Period|Moved|3|||
161659273|NCT00092495|583802643|FG001|Base Study Vaccination Period|Moved|1|||
161659274|NCT00092495|583802644|FG002|Base Study Vaccination Period|Moved|2|||
161659275|NCT00092495|583802645|FG003|Base Study Vaccination Period|Moved|2|||
161710661|NCT00391976|583984136|FG002|Overall Study|Unable to classify|1|||
161659276|NCT00092495|583802646|FG004|Base Study Vaccination Period|Moved|0|||
161659277|NCT00092495|583802642|FG000|Base Study Vaccination Period|Other|1|||
161659278|NCT00092495|583802643|FG001|Base Study Vaccination Period|Other|1|||
161659279|NCT00092495|583802644|FG002|Base Study Vaccination Period|Other|0|||
161659280|NCT00092495|583802645|FG003|Base Study Vaccination Period|Other|2|||
161659281|NCT00092495|583802646|FG004|Base Study Vaccination Period|Other|0|||
161659282|NCT00092495|583802642|FG000|Base Study Vaccination Period|Pregnancy|2|||
161659283|NCT00092495|583802643|FG001|Base Study Vaccination Period|Pregnancy|0|||
161659284|NCT00092495|583802644|FG002|Base Study Vaccination Period|Pregnancy|0|||
161659285|NCT00092495|583802645|FG003|Base Study Vaccination Period|Pregnancy|0|||
161659286|NCT00092495|583802646|FG004|Base Study Vaccination Period|Pregnancy|0|||
161659287|NCT00092495|583802642|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
161659288|NCT00092495|583802643|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
161659289|NCT00092495|583802644|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
161659290|NCT00092495|583802645|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
161659291|NCT00092495|583802646|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
161659292|NCT00092495|583802642|FG000|Base Study Vaccination Period|Protocol Violation|1|||
161659293|NCT00092495|583802643|FG001|Base Study Vaccination Period|Protocol Violation|0|||
161659294|NCT00092495|583802644|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161659295|NCT00092495|583802645|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161659296|NCT00092495|583802646|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161659297|NCT00092495|583802642|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
161659298|NCT00092495|583802643|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
161659299|NCT00092495|583802644|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
161659300|NCT00092495|583802645|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
161659301|NCT00092495|583802646|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161659302|NCT00092495|583802642|FG000|Base Study Follow-up Period|Extended|0|||
161659303|NCT00092495|583802643|FG001|Base Study Follow-up Period|Extended|0|||
161659304|NCT00092495|583802644|FG002|Base Study Follow-up Period|Extended|1|||
161659305|NCT00092495|583802645|FG003|Base Study Follow-up Period|Extended|2|||
161659306|NCT00092495|583802646|FG004|Base Study Follow-up Period|Extended|0|||
161659307|NCT00092495|583802642|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
161659308|NCT00092495|583802643|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
161659309|NCT00092495|583802644|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
161659310|NCT00092495|583802645|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
161659311|NCT00092495|583802646|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161659312|NCT00092495|583802642|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
161659313|NCT00092495|583802643|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
161659314|NCT00092495|583802644|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161659315|NCT00092495|583802645|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161659316|NCT00092495|583802646|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161659317|NCT00938470|583802647|FG000|Overall Study|Disease Progression|3|||
161659318|NCT00938470|583802648|FG001|Overall Study|Disease Progression|0|||
161659319|NCT00938470|583802647|FG000|Overall Study|Alternate Treatment|1|||
161659320|NCT00938470|583802648|FG001|Overall Study|Alternate Treatment|0|||
161659321|NCT00938470|583802647|FG000|Overall Study|Death|3|||
161659322|NCT00938470|583802648|FG001|Overall Study|Death|2|||
161659323|NCT00938470|583802647|FG000|Overall Study|Other Reason|0|||
161659324|NCT00938470|583802648|FG001|Overall Study|Other Reason|1|||
161659325|NCT01552603|583802649|FG000|Overall Study|Physician Decision|1|||
161659326|NCT00618618|583802650|FG000|Overall Study|Patient Request|0|||
161659327|NCT00618618|583802651|FG001|Overall Study|Patient Request|0|||
161659328|NCT00618618|583802652|FG002|Overall Study|Patient Request|2|||
161659329|NCT00618618|583802653|FG003|Overall Study|Patient Request|0|||
161659330|NCT00618618|583802650|FG000|Overall Study|Inability to Complete Study Procedures|0|||
161659331|NCT00618618|583802651|FG001|Overall Study|Inability to Complete Study Procedures|1|||
161659332|NCT00618618|583802652|FG002|Overall Study|Inability to Complete Study Procedures|0|||
161659333|NCT00618618|583802653|FG003|Overall Study|Inability to Complete Study Procedures|0|||
161659334|NCT00618618|583802650|FG000|Overall Study|Lost to Follow-up|3|||
161659335|NCT00618618|583802651|FG001|Overall Study|Lost to Follow-up|0|||
161659336|NCT00618618|583802652|FG002|Overall Study|Lost to Follow-up|0|||
161659337|NCT00618618|583802653|FG003|Overall Study|Lost to Follow-up|1|||
161659338|NCT00618618|583802650|FG000|Overall Study|Non-compliance|1|||
161659339|NCT00618618|583802651|FG001|Overall Study|Non-compliance|1|||
161659340|NCT00618618|583802652|FG002|Overall Study|Non-compliance|0|||
161659341|NCT00618618|583802653|FG003|Overall Study|Non-compliance|0|||
161659342|NCT00618618|583802650|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
161659343|NCT00618618|583802651|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
161659344|NCT00618618|583802652|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
161659345|NCT00618618|583802653|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
161659346|NCT00618618|583802650|FG000|Overall Study|Death|0|||
161659347|NCT00618618|583802651|FG001|Overall Study|Death|1|||
161659348|NCT00618618|583802652|FG002|Overall Study|Death|0|||
161659349|NCT00618618|583802653|FG003|Overall Study|Death|0|||
161659350|NCT01236365|583802657|FG000|Overall Study|Lost to Follow-up|0|||
161659351|NCT01236365|583802658|FG001|Overall Study|Lost to Follow-up|2|||
161659352|NCT01236365|583802657|FG000|Overall Study|Moved Out of State|1|||
161659353|NCT01236365|583802658|FG001|Overall Study|Moved Out of State|0|||
161659354|NCT01236365|583802657|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
161659355|NCT01236365|583802658|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
161659356|NCT00006011|583802664|FG000|Overall Study|Disease progression|13|||
161659357|NCT00006011|583802665|FG001|Overall Study|Disease progression|6|||
161659358|NCT00006011|583802666|FG002|Overall Study|Disease progression|26|||
161659359|NCT00006011|583802664|FG000|Overall Study|Refused further treatment|15|||
161659360|NCT00006011|583802665|FG001|Overall Study|Refused further treatment|13|||
161659361|NCT00006011|583802666|FG002|Overall Study|Refused further treatment|26|||
161659362|NCT00006011|583802664|FG000|Overall Study|Adverse Event|15|||
161659363|NCT00006011|583802665|FG001|Overall Study|Adverse Event|39|||
161659364|NCT00006011|583802666|FG002|Overall Study|Adverse Event|5|||
161659365|NCT00006011|583802664|FG000|Overall Study|Death|0|||
161659366|NCT00006011|583802665|FG001|Overall Study|Death|1|||
161659367|NCT00006011|583802666|FG002|Overall Study|Death|2|||
161659368|NCT00006011|583802664|FG000|Overall Study|Other|4|||
161659369|NCT00006011|583802665|FG001|Overall Study|Other|2|||
161659370|NCT00006011|583802666|FG002|Overall Study|Other|5|||
161659371|NCT00006011|583802664|FG000|Overall Study|Ineligible|18|||
161659372|NCT00006011|583802665|FG001|Overall Study|Ineligible|16|||
161659373|NCT00006011|583802666|FG002|Overall Study|Ineligible|9|||
161659374|NCT01236534|583802672|FG000|Overall Study|Adverse Event|3|||
161659375|NCT01236534|583802673|FG001|Overall Study|Adverse Event|0|||
161659376|NCT01844687|583802676|FG000|Visit 1|Protocol Violation|3|||
161659377|NCT01844687|583802676|FG000|Visit 1|Lost to Follow-up|5|||
161659378|NCT01844687|583802676|FG000|Visit 2|Withdrawal by Subject|1|||
161659379|NCT01844687|583802676|FG000|Visit 2|Protocol Violation|1|||
161659380|NCT01844687|583802676|FG000|Visit 3|Lost to Follow-up|1|||
161659381|NCT01844687|583802676|FG000|Visit 3|Withdrawal by Subject|3|||
161659382|NCT01844687|583802676|FG000|Visit 3|child care problems|1|||
161659383|NCT01844687|583802676|FG000|Visit 4|Pregnancy|1|||
161659384|NCT01844687|583802676|FG000|Visit 4|Lost to Follow-up|1|||
161659385|NCT01844687|583802676|FG000|Visit 4|Withdrawal by Subject|2|||
161659386|NCT00158860|583802691|FG000|Overall Study|Adverse Event|3|||
161659387|NCT00158860|583802692|FG001|Overall Study|Adverse Event|6|||
161659388|NCT00158860|583802691|FG000|Overall Study|Lost to Follow-up|11|||
161659389|NCT00158860|583802692|FG001|Overall Study|Lost to Follow-up|17|||
161659390|NCT00158860|583802691|FG000|Overall Study|Protocol Violation|8|||
161659391|NCT00158860|583802692|FG001|Overall Study|Protocol Violation|23|||
161659392|NCT00158860|583802691|FG000|Overall Study|Withdrawal by Subject|7|||
161659393|NCT00158860|583802692|FG001|Overall Study|Withdrawal by Subject|17|||
161659394|NCT00158860|583802691|FG000|Overall Study|MOVING OUT OF STATE|1|||
161659395|NCT00158860|583802692|FG001|Overall Study|MOVING OUT OF STATE|0|||
161659396|NCT00158860|583802691|FG000|Overall Study|Pregnancy|3|||
161659397|NCT00158860|583802692|FG001|Overall Study|Pregnancy|3|||
161659398|NCT00158860|583802691|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
161659399|NCT00158860|583802692|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
161659400|NCT00158860|583802691|FG000|Overall Study|SPONSOR REQUEST|0|||
161659401|NCT00158860|583802692|FG001|Overall Study|SPONSOR REQUEST|1|||
161659402|NCT00158860|583802691|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
161659403|NCT00158860|583802692|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
161659404|NCT00158860|583802691|FG000|Overall Study|Closed per sponsor|0|||
161659405|NCT00158860|583802692|FG001|Overall Study|Closed per sponsor|1|||
161659406|NCT04638920|583802693|FG000|Overall Study|Withdrawal by Subject|5|||
161659407|NCT01801735|583802694|FG000|Overall Study|Adverse Event|79|||
161659408|NCT01801735|583802694|FG000|Overall Study|Lack of Efficacy|28|||
161659409|NCT01801735|583802694|FG000|Overall Study|Withdrawal by Subject|27|||
161659410|NCT01801735|583802694|FG000|Overall Study|Protocol Violation|25|||
161659411|NCT01801735|583802694|FG000|Overall Study|Lost to Follow-up|15|||
161659412|NCT01801735|583802694|FG000|Overall Study|Non-compliance with Trial Drug|13|||
161659413|NCT01801735|583802694|FG000|Overall Study|Physician Decision|3|||
161659414|NCT01801735|583802694|FG000|Overall Study|Death|1|||
161659415|NCT01801735|583802694|FG000|Overall Study|Other, including site closure|19|||
161659416|NCT01435616|583802695|FG000|Overall Study|Adverse Event|39|||
161659417|NCT01435616|583802696|FG001|Overall Study|Adverse Event|21|||
161659418|NCT01435616|583802695|FG000|Overall Study|Death|7|||
161659419|NCT01435616|583802696|FG001|Overall Study|Death|2|||
161659420|NCT01435616|583802695|FG000|Overall Study|Lost to Follow-up|22|||
161659421|NCT01435616|583802696|FG001|Overall Study|Lost to Follow-up|13|||
161659422|NCT01435616|583802695|FG000|Overall Study|Protocol Violation|16|||
161659423|NCT01435616|583802696|FG001|Overall Study|Protocol Violation|13|||
161659424|NCT01435616|583802695|FG000|Overall Study|Withdrawal by Subject|66|||
161659425|NCT01435616|583802696|FG001|Overall Study|Withdrawal by Subject|24|||
161659426|NCT01435616|583802695|FG000|Overall Study|Physician Decision|20|||
161659427|NCT01435616|583802696|FG001|Overall Study|Physician Decision|7|||
161659428|NCT01435616|583802695|FG000|Overall Study|Sponsor Decision|1|||
161659429|NCT01435616|583802696|FG001|Overall Study|Sponsor Decision|0|||
161659430|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|Death|1|||
161659431|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|Death|1|||
161659432|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
161659433|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
161659434|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
161659435|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
161659436|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
161659437|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
161659438|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
161659439|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
161659440|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
161659441|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
161659442|NCT00371683|583802698|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
161659443|NCT00371683|583802699|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
161659444|NCT00371683|583802698|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
161659445|NCT00371683|583802699|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
161659446|NCT00371683|583802698|FG000|Follow-Up Period - Randomized Patients|Death|0|||
161659447|NCT00371683|583802699|FG001|Follow-Up Period - Randomized Patients|Death|2|||
161659448|NCT00371683|583802698|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
161659449|NCT00371683|583802699|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
161659450|NCT00371683|583802698|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
161659451|NCT00371683|583802699|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
161659452|NCT03208036|583802701|FG000|Baseline Assessment|Withdrawal by Subject|1|||
161659453|NCT03208036|583802702|FG001|Baseline Assessment|Withdrawal by Subject|1|||
161659454|NCT03208036|583802701|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
161659455|NCT03208036|583802702|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
161659456|NCT03208036|583802701|FG000|Intervention|Withdrawal by Subject|3|||
161659457|NCT03208036|583802702|FG001|Intervention|Withdrawal by Subject|2|||
161659458|NCT03208036|583802701|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
161659459|NCT03208036|583802702|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
161659460|NCT00700778|583802703|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
161659461|NCT00350103|583802707|FG000|Overall Study|Adverse Event|12|||
161659462|NCT00350103|583802708|FG001|Overall Study|Adverse Event|29|||
161659463|NCT00350103|583802709|FG002|Overall Study|Adverse Event|17|||
161659464|NCT00350103|583802707|FG000|Overall Study|Lack of Efficacy|5|||
161659465|NCT00350103|583802708|FG001|Overall Study|Lack of Efficacy|1|||
161659466|NCT00350103|583802709|FG002|Overall Study|Lack of Efficacy|3|||
161659467|NCT00350103|583802707|FG000|Overall Study|Withdrawal by Subject|6|||
161659468|NCT00350103|583802708|FG001|Overall Study|Withdrawal by Subject|6|||
161659469|NCT00350103|583802709|FG002|Overall Study|Withdrawal by Subject|8|||
161659470|NCT00350103|583802707|FG000|Overall Study|Protocol Violation|0|||
161659471|NCT00350103|583802708|FG001|Overall Study|Protocol Violation|0|||
161659472|NCT00350103|583802709|FG002|Overall Study|Protocol Violation|1|||
161659473|NCT00350103|583802707|FG000|Overall Study|Unsatisfactory Compliance|2|||
161659474|NCT00350103|583802708|FG001|Overall Study|Unsatisfactory Compliance|2|||
161659475|NCT00350103|583802709|FG002|Overall Study|Unsatisfactory Compliance|1|||
161659476|NCT00350103|583802707|FG000|Overall Study|Investigator´s decision|1|||
161659477|NCT00350103|583802708|FG001|Overall Study|Investigator´s decision|1|||
161659478|NCT00350103|583802709|FG002|Overall Study|Investigator´s decision|0|||
161659479|NCT00350103|583802707|FG000|Overall Study|Exclusion criteria met|0|||
161659480|NCT00350103|583802708|FG001|Overall Study|Exclusion criteria met|0|||
161659481|NCT00350103|583802709|FG002|Overall Study|Exclusion criteria met|1|||
161659482|NCT00350103|583802707|FG000|Overall Study|Patient relocated|0|||
161659483|NCT00350103|583802708|FG001|Overall Study|Patient relocated|0|||
161659484|NCT00350103|583802709|FG002|Overall Study|Patient relocated|1|||
161659485|NCT00350103|583802707|FG000|Overall Study|Need for prohibited medication|1|||
161659486|NCT00350103|583802708|FG001|Overall Study|Need for prohibited medication|0|||
161659487|NCT00350103|583802709|FG002|Overall Study|Need for prohibited medication|0|||
161659488|NCT00350103|583802707|FG000|Overall Study|Personal reasons|0|||
161659489|NCT00350103|583802708|FG001|Overall Study|Personal reasons|0|||
161659490|NCT00350103|583802709|FG002|Overall Study|Personal reasons|1|||
161659491|NCT00350103|583802707|FG000|Overall Study|Patient stopped feeling pain|1|||
161659492|NCT00350103|583802708|FG001|Overall Study|Patient stopped feeling pain|0|||
161659493|NCT00350103|583802709|FG002|Overall Study|Patient stopped feeling pain|0|||
161659494|NCT00350103|583802707|FG000|Overall Study|PR greater than 250ms|0|||
161659495|NCT00350103|583802708|FG001|Overall Study|PR greater than 250ms|0|||
161659496|NCT00350103|583802709|FG002|Overall Study|PR greater than 250ms|1|||
161659497|NCT00350103|583802707|FG000|Overall Study|Wrong calculation of QT interval|0|||
161659498|NCT00350103|583802708|FG001|Overall Study|Wrong calculation of QT interval|0|||
161659499|NCT00350103|583802709|FG002|Overall Study|Wrong calculation of QT interval|1|||
161659500|NCT00350103|583802707|FG000|Overall Study|Sponsor mistake|1|||
161659501|NCT00350103|583802708|FG001|Overall Study|Sponsor mistake|0|||
161659502|NCT00350103|583802709|FG002|Overall Study|Sponsor mistake|0|||
161659503|NCT00350103|583802707|FG000|Overall Study|Randomization mistake|0|||
161659504|NCT00350103|583802708|FG001|Overall Study|Randomization mistake|1|||
161659505|NCT00350103|583802709|FG002|Overall Study|Randomization mistake|1|||
161659506|NCT00350103|583802707|FG000|Overall Study|Sponsor´s decision|0|||
161659507|NCT00350103|583802708|FG001|Overall Study|Sponsor´s decision|1|||
161659508|NCT00350103|583802709|FG002|Overall Study|Sponsor´s decision|0|||
161659509|NCT00350103|583802707|FG000|Overall Study|Lost, Reason unknown|1|||
161659510|NCT00350103|583802708|FG001|Overall Study|Lost, Reason unknown|1|||
161659511|NCT00350103|583802709|FG002|Overall Study|Lost, Reason unknown|0|||
161659512|NCT01879553|583802710|FG000|Overall Study|Withdrawal by Subject|1|||
161659513|NCT01879553|583802711|FG001|Overall Study|Withdrawal by Subject|0|||
161659514|NCT02559895|583802712|FG000|Overall Study|Adverse Event|3|||
161659515|NCT02559895|583802713|FG001|Overall Study|Adverse Event|3|||
161659516|NCT02559895|583802714|FG002|Overall Study|Adverse Event|2|||
161659517|NCT02559895|583802715|FG003|Overall Study|Adverse Event|1|||
161659518|NCT02559895|583802712|FG000|Overall Study|Lack of Efficacy|2|||
161659519|NCT02559895|583802713|FG001|Overall Study|Lack of Efficacy|3|||
161659520|NCT02559895|583802714|FG002|Overall Study|Lack of Efficacy|2|||
161659521|NCT02559895|583802715|FG003|Overall Study|Lack of Efficacy|8|||
161659522|NCT02559895|583802712|FG000|Overall Study|Lost to Follow-up|22|||
161659523|NCT02559895|583802713|FG001|Overall Study|Lost to Follow-up|16|||
161659524|NCT02559895|583802714|FG002|Overall Study|Lost to Follow-up|12|||
161659525|NCT02559895|583802715|FG003|Overall Study|Lost to Follow-up|17|||
161659526|NCT02559895|583802712|FG000|Overall Study|Physician Decision|1|||
161659527|NCT02559895|583802713|FG001|Overall Study|Physician Decision|1|||
161659528|NCT02559895|583802714|FG002|Overall Study|Physician Decision|3|||
161659529|NCT02559895|583802715|FG003|Overall Study|Physician Decision|0|||
161659530|NCT02559895|583802712|FG000|Overall Study|Withdrawal by Subject|16|||
161659531|NCT02559895|583802713|FG001|Overall Study|Withdrawal by Subject|9|||
161659532|NCT02559895|583802714|FG002|Overall Study|Withdrawal by Subject|20|||
161659533|NCT02559895|583802715|FG003|Overall Study|Withdrawal by Subject|9|||
161659534|NCT02559895|583802712|FG000|Overall Study|Study Burden|10|||
161659535|NCT02559895|583802713|FG001|Overall Study|Study Burden|16|||
161659536|NCT02559895|583802714|FG002|Overall Study|Study Burden|12|||
161659537|NCT02559895|583802715|FG003|Overall Study|Study Burden|22|||
161659538|NCT02559895|583802712|FG000|Overall Study|Other|1|||
161659539|NCT02559895|583802713|FG001|Overall Study|Other|5|||
161659540|NCT02559895|583802714|FG002|Overall Study|Other|3|||
161659541|NCT02559895|583802715|FG003|Overall Study|Other|3|||
161659542|NCT04540887|583802716|FG000|Overall Study|Withdrawal by Subject|2|||
161659543|NCT00760474|583802717|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
161659544|NCT00760474|583802718|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
161659545|NCT00760474|583802717|FG000|Placebo Washout Period|Other|0|||
161659546|NCT00760474|583802718|FG001|Placebo Washout Period|Other|1|||
161659547|NCT00760474|583802717|FG000|Period 2 (P2)|Lost to Follow-up|1|||
161659548|NCT00760474|583802718|FG001|Period 2 (P2)|Lost to Follow-up|0|||
161659549|NCT00760474|583802717|FG000|Period 2 (P2)|Adverse Event|0|||
161659550|NCT00760474|583802718|FG001|Period 2 (P2)|Adverse Event|1|||
161659551|NCT04664400|583802719|FG000|Overall Study|Withdrawal by Subject|2|||
161659552|NCT01394978|583802726|FG000|Overall Study|Withdrawal by Subject|2|||
161659553|NCT01394978|583802727|FG001|Overall Study|Withdrawal by Subject|4|||
161659554|NCT01394978|583802726|FG000|Overall Study|Lost to Follow-up|13|||
161659555|NCT01394978|583802727|FG001|Overall Study|Lost to Follow-up|20|||
161659556|NCT01394978|583802726|FG000|Overall Study|Death|6|||
161659557|NCT01394978|583802727|FG001|Overall Study|Death|7|||
161659558|NCT02217501|583802728|FG000|Overall Study|Death|3|||
161659559|NCT02217501|583802729|FG001|Overall Study|Death|4|||
161659560|NCT02019667|583802730|FG000|First Intervention (6 Months)|Adverse Event|0|||
161659561|NCT02019667|583802731|FG001|First Intervention (6 Months)|Adverse Event|1|||
161659562|NCT02019667|583802730|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
161659563|NCT02019667|583802731|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
161659564|NCT02019667|583802730|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
161659565|NCT02019667|583802731|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
161659566|NCT05038163|583802740|FG000|Stage 1|Did not complete survey|374|||
161659567|NCT05038163|583802741|FG001|Stage 1|Did not complete survey|0|||
161659568|NCT05038163|583802742|FG002|Stage 1|Did not complete survey|0|||
161659569|NCT05038163|583802743|FG003|Stage 1|Did not complete survey|0|||
161659570|NCT05038163|583802744|FG004|Stage 1|Did not complete survey|0|||
161659571|NCT05038163|583802745|FG005|Stage 1|Did not complete survey|0|||
161659572|NCT05038163|583802740|FG000|Stage 2|Did not complete Stage 2 survey|0|||
161659573|NCT05038163|583802741|FG001|Stage 2|Did not complete Stage 2 survey|29|||
161659574|NCT05038163|583802742|FG002|Stage 2|Did not complete Stage 2 survey|30|||
161659575|NCT05038163|583802743|FG003|Stage 2|Did not complete Stage 2 survey|24|||
161710662|NCT00391976|583984134|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
161659576|NCT05038163|583802744|FG004|Stage 2|Did not complete Stage 2 survey|21|||
161659577|NCT05038163|583802745|FG005|Stage 2|Did not complete Stage 2 survey|100|||
161659578|NCT05453201|583802747|FG000|Overall Study|Withdrawal by Subject|1|||
161659579|NCT03562975|583802748|FG000|Overall Study|Death|1|||
161659580|NCT03562975|583802748|FG000|Overall Study|Lost to Follow-up|1|||
161659581|NCT03562975|583802748|FG000|Overall Study|Withdrawal by Subject|1|||
161659582|NCT01934790|583802749|FG000|Treatment|Adverse Event|3|||
161659583|NCT01934790|583802749|FG000|Treatment|Clinical progression|6|||
161659584|NCT01934790|583802749|FG000|Treatment|Radiological progression|4|||
161659585|NCT01934790|583802749|FG000|Treatment|Withdrawal by Subject|2|||
161659586|NCT01934790|583802749|FG000|Treatment|Study drug never administered|1|||
161659587|NCT01934790|583802749|FG000|Active Follow up|Death|20|||
161659588|NCT01934790|583802749|FG000|Active Follow up|Physician Decision|2|||
161659589|NCT01934790|583802749|FG000|Active Follow up|Progressive disease|1|||
161710663|NCT00391976|583984135|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
161710664|NCT00391976|583984136|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
161710665|NCT00049127|583984137|FG000|Overall Study|Withdrawal by Subject|0|||
161710666|NCT00049127|583984138|FG001|Overall Study|Withdrawal by Subject|0|||
161659590|NCT01934790|583802749|FG000|Active Follow up|Other reason|1|||
161659591|NCT00552929|583802752|FG000|Overall Study|Lost to Follow-up|0|||
161659592|NCT00552929|583802753|FG001|Overall Study|Lost to Follow-up|0|||
161659593|NCT00552929|583802754|FG002|Overall Study|Lost to Follow-up|0|||
161659594|NCT00552929|583802755|FG003|Overall Study|Lost to Follow-up|0|||
161659595|NCT00552929|583802756|FG004|Overall Study|Lost to Follow-up|0|||
161659596|NCT00552929|583802757|FG005|Overall Study|Lost to Follow-up|0|||
161659597|NCT00552929|583802758|FG006|Overall Study|Lost to Follow-up|0|||
161659598|NCT00552929|583802759|FG007|Overall Study|Lost to Follow-up|0|||
161659599|NCT00552929|583802760|FG008|Overall Study|Lost to Follow-up|1|||
161659600|NCT00552929|583802761|FG009|Overall Study|Lost to Follow-up|0|||
161659601|NCT00552929|583802752|FG000|Overall Study|Not Eligible|0|||
161659602|NCT00552929|583802753|FG001|Overall Study|Not Eligible|0|||
161659603|NCT00552929|583802754|FG002|Overall Study|Not Eligible|0|||
161659604|NCT00552929|583802755|FG003|Overall Study|Not Eligible|0|||
161659605|NCT00552929|583802756|FG004|Overall Study|Not Eligible|0|||
161659606|NCT00552929|583802757|FG005|Overall Study|Not Eligible|1|||
161659607|NCT00552929|583802758|FG006|Overall Study|Not Eligible|0|||
161659608|NCT00552929|583802759|FG007|Overall Study|Not Eligible|0|||
161659609|NCT00552929|583802760|FG008|Overall Study|Not Eligible|0|||
161659610|NCT00552929|583802761|FG009|Overall Study|Not Eligible|0|||
161659611|NCT01758900|583802764|FG000|Overall Study|difficulty for further intubation|7|||
161659612|NCT01758900|583802765|FG001|Overall Study|difficulty for further intubation|8|||
161659613|NCT04577001|583802766|FG000|Overall Study|Subject became ineligible|0|||
161659614|NCT04577001|583802767|FG001|Overall Study|Subject became ineligible|1|||
161659615|NCT00734097|583804818|FG000|Screening|Protocol Violation|12|||
161659616|NCT00734097|583804818|FG000|Screening|Withdrawal by Subject|5|||
161659617|NCT00734097|583804818|FG000|Screening|Lost to Follow-up|2|||
161659618|NCT00734097|583804818|FG000|Screening|Unconfirmed pregnancy|1|||
161659619|NCT00734097|583804818|FG000|Open Label|Lost to Follow-up|7|||
161659620|NCT00734097|583804818|FG000|Open Label|Withdrawal by Subject|5|||
161659621|NCT00734097|583804818|FG000|Open Label|Protocol Violation|4|||
161659622|NCT02233543|583804821|FG000|Period 1|Withdrawal by Subject|1|||
161659623|NCT02233543|583804822|FG001|Period 1|Withdrawal by Subject|0|||
161659624|NCT02233543|583804821|FG000|Period 1|Participants required other treatment.|2|||
161659625|NCT02233543|583804822|FG001|Period 1|Participants required other treatment.|3|||
161659626|NCT02233543|583804821|FG000|Period 2|Adverse Event|1|||
161659627|NCT02233543|583804822|FG001|Period 2|Adverse Event|0|||
161659628|NCT02233543|583804821|FG000|Period 2|Participant required other treatment.|0|||
161659629|NCT02233543|583804822|FG001|Period 2|Participant required other treatment.|1|||
161659630|NCT02233543|583804821|FG000|Period 2|COPD exacerbation|1|||
161659631|NCT02233543|583804822|FG001|Period 2|COPD exacerbation|0|||
161659632|NCT01302067|583804823|FG000|Overall Study|Death|0|||
161659633|NCT01302067|583804824|FG001|Overall Study|Death|0|||
161659634|NCT01302067|583804825|FG002|Overall Study|Death|1|||
161659635|NCT01302067|583804823|FG000|Overall Study|Physician Decision|9|||
161659636|NCT01302067|583804824|FG001|Overall Study|Physician Decision|5|||
161659637|NCT01302067|583804825|FG002|Overall Study|Physician Decision|14|||
161659638|NCT01302067|583804823|FG000|Overall Study|Lack of Efficacy|8|||
161659639|NCT01302067|583804824|FG001|Overall Study|Lack of Efficacy|4|||
161659640|NCT01302067|583804825|FG002|Overall Study|Lack of Efficacy|2|||
161659641|NCT01302067|583804823|FG000|Overall Study|Lost to Follow-up|9|||
161659642|NCT01302067|583804824|FG001|Overall Study|Lost to Follow-up|4|||
161659643|NCT01302067|583804825|FG002|Overall Study|Lost to Follow-up|15|||
161659644|NCT01302067|583804823|FG000|Overall Study|Withdrawal by Subject|13|||
161659645|NCT01302067|583804824|FG001|Overall Study|Withdrawal by Subject|6|||
161710667|NCT00049127|583984139|FG002|Overall Study|Withdrawal by Subject|1|||
161710668|NCT00049127|583984140|FG003|Overall Study|Withdrawal by Subject|0|||
161710669|NCT00049127|583984141|FG004|Overall Study|Withdrawal by Subject|0|||
161710670|NCT02582515|583984144|FG000|Overall Study|Withdrawal by Subject|0|||
161710671|NCT02582515|583984145|FG001|Overall Study|Withdrawal by Subject|1|||
161710672|NCT02725788|583984148|FG000|Overall Study|Lost to Follow-up|1|||
161710673|NCT02725788|583984149|FG001|Overall Study|Lost to Follow-up|1|||
161710674|NCT02725788|583984148|FG000|Overall Study|Protocol Violation|0|||
161710675|NCT02725788|583984149|FG001|Overall Study|Protocol Violation|1|||
161710676|NCT04927312|583984150|FG000|Overall Study|Adverse Event|1|||
161710677|NCT04927312|583984150|FG000|Overall Study|Death|1|||
161710678|NCT04927312|583984150|FG000|Overall Study|Withdrawal by Subject|1|||
161710679|NCT04927312|583984150|FG000|Overall Study|Other|1|||
161659646|NCT01302067|583804825|FG002|Overall Study|Withdrawal by Subject|10|||
161659647|NCT01302067|583804823|FG000|Overall Study|Other|1|||
161659648|NCT01302067|583804824|FG001|Overall Study|Other|1|||
161659649|NCT01302067|583804825|FG002|Overall Study|Other|3|||
161710680|NCT04919564|583984156|FG000|Overall Study|Lost to Follow-up|1|||
161710681|NCT04919564|583984157|FG001|Overall Study|Lost to Follow-up|0|||
161659650|NCT01302067|583804823|FG000|Overall Study|Protocol Violation|11|||
161659651|NCT01302067|583804824|FG001|Overall Study|Protocol Violation|0|||
161659652|NCT01302067|583804825|FG002|Overall Study|Protocol Violation|8|||
161659653|NCT01302067|583804823|FG000|Overall Study|Adverse Event|27|||
161659654|NCT01302067|583804824|FG001|Overall Study|Adverse Event|14|||
161659655|NCT01302067|583804825|FG002|Overall Study|Adverse Event|45|||
161659656|NCT02924428|583804826|FG000|Overall Study|Adverse Event|1|||
161659657|NCT02924428|583804827|FG001|Overall Study|Adverse Event|0|||
161659658|NCT02924428|583804826|FG000|Overall Study|Physician Decision|1|||
161659659|NCT02924428|583804827|FG001|Overall Study|Physician Decision|0|||
161659660|NCT02924428|583804826|FG000|Overall Study|Lost to Follow-up|2|||
161659661|NCT02924428|583804827|FG001|Overall Study|Lost to Follow-up|4|||
161659662|NCT02924428|583804826|FG000|Overall Study|Pregnancy|0|||
161659663|NCT02924428|583804827|FG001|Overall Study|Pregnancy|1|||
161659664|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
161659665|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
161659666|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
161659667|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
161659668|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
161659669|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
161659670|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
161659671|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
161659672|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
161659673|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
161659674|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
161659675|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
161659676|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
161659677|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
161659678|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
161659679|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
161659680|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
161659681|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
161659682|NCT02480153|583804828|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
161710682|NCT04919564|583984156|FG000|Overall Study|Physician Decision|1|||
161710683|NCT04919564|583984157|FG001|Overall Study|Physician Decision|1|||
161710684|NCT05292755|583984161|FG000|Overall Study|Lost to Follow-up|5|||
161710685|NCT05292755|583984162|FG001|Overall Study|Lost to Follow-up|9|||
161710686|NCT04052139|583984163|FG000|Overall Study|Lost to Follow-up|2|||
161710687|NCT04052139|583984164|FG001|Overall Study|Lost to Follow-up|0|||
161710688|NCT04052139|583984165|FG002|Overall Study|Lost to Follow-up|0|||
161710689|NCT04052139|583984163|FG000|Overall Study|Withdrawal by Subject|1|||
161710690|NCT04052139|583984164|FG001|Overall Study|Withdrawal by Subject|0|||
161710691|NCT04052139|583984165|FG002|Overall Study|Withdrawal by Subject|0|||
161710692|NCT00707577|583984166|FG000|Overall Study|Withdrawal by Subject|3|||
161710693|NCT00707577|583984167|FG001|Overall Study|Withdrawal by Subject|2|||
161710694|NCT00707577|583984166|FG000|Overall Study|Lost to Follow-up|34|||
161710695|NCT00707577|583984167|FG001|Overall Study|Lost to Follow-up|25|||
161710696|NCT00707577|583984166|FG000|Overall Study|Left employment|13|||
161710697|NCT00707577|583984167|FG001|Overall Study|Left employment|10|||
161710698|NCT00707577|583984166|FG000|Overall Study|Pregnancy|4|||
161710699|NCT00707577|583984167|FG001|Overall Study|Pregnancy|1|||
161659683|NCT02480153|583804829|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
161659684|NCT02480153|583804830|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
161659685|NCT02480153|583804828|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
161659686|NCT02480153|583804829|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
161659687|NCT02480153|583804830|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
161659688|NCT02480153|583804828|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
161659689|NCT02480153|583804829|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
161659690|NCT02480153|583804830|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
161659691|NCT02480153|583804828|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
161659692|NCT02480153|583804829|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
161659693|NCT02480153|583804830|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
161659694|NCT02480153|583804828|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
161659695|NCT02480153|583804829|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
161659696|NCT02480153|583804830|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
161659697|NCT02480153|583804828|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
161659698|NCT02480153|583804829|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
161659699|NCT02480153|583804830|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
161659700|NCT02480153|583804828|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
161659701|NCT02480153|583804829|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
161659702|NCT02480153|583804830|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
161659703|NCT02480153|583804828|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
161659704|NCT02480153|583804829|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
161659705|NCT02480153|583804830|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
161659706|NCT02480153|583804828|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
161659707|NCT02480153|583804829|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
161659708|NCT02480153|583804830|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
161659709|NCT02480153|583804828|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
161659710|NCT02480153|583804829|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
161659711|NCT02480153|583804830|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
161659712|NCT02480153|583804828|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
161659713|NCT02480153|583804829|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
161659714|NCT02480153|583804830|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
161659715|NCT02480153|583804828|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
161659716|NCT02480153|583804829|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
161659717|NCT02480153|583804830|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
161659718|NCT03241225|583804834|FG000|Overall Study|Lost to Follow-up|2|||
161659719|NCT03241225|583804835|FG001|Overall Study|Lost to Follow-up|1|||
161659720|NCT03241225|583804834|FG000|Overall Study|Protocol Violation|4|||
161659721|NCT03241225|583804835|FG001|Overall Study|Protocol Violation|1|||
161659722|NCT03241225|583804834|FG000|Overall Study|Withdrawal by Subject|1|||
161659723|NCT03241225|583804835|FG001|Overall Study|Withdrawal by Subject|0|||
161659724|NCT00852540|583804836|FG000|Overall Study|Adverse Event|10|||
161659725|NCT00852540|583804837|FG001|Overall Study|Adverse Event|3|||
161659726|NCT00852540|583804836|FG000|Overall Study|Lack of Efficacy|15|||
161659727|NCT00852540|583804837|FG001|Overall Study|Lack of Efficacy|3|||
161659728|NCT00852540|583804836|FG000|Overall Study|Protocol Violation|1|||
161659729|NCT00852540|583804837|FG001|Overall Study|Protocol Violation|2|||
161659730|NCT00852540|583804836|FG000|Overall Study|Lost to Follow-up|2|||
161659731|NCT00852540|583804837|FG001|Overall Study|Lost to Follow-up|3|||
161659732|NCT00852540|583804836|FG000|Overall Study|Investigator Discretion|2|||
161659733|NCT00852540|583804837|FG001|Overall Study|Investigator Discretion|3|||
161659734|NCT00852540|583804836|FG000|Overall Study|Withdrawal by Subject|3|||
161659735|NCT00852540|583804837|FG001|Overall Study|Withdrawal by Subject|1|||
161659736|NCT00852540|583804836|FG000|Overall Study|Did Not Receive Study Drug|3|||
161659737|NCT00852540|583804837|FG001|Overall Study|Did Not Receive Study Drug|3|||
161659738|NCT04875676|583804847|FG000|Overall Study|Lost to Follow-up|1|||
161659739|NCT04875676|583804848|FG001|Overall Study|Lost to Follow-up|0|||
161659740|NCT04875676|583804849|FG002|Overall Study|Lost to Follow-up|0|||
161659741|NCT03064035|583804850|FG000|Overall Study|Did not receive allocated intervention|4|||
161659742|NCT03064035|583804851|FG001|Overall Study|Did not receive allocated intervention|2|||
161659743|NCT03064035|583804850|FG000|Overall Study|Lost to Follow-up|1|||
161659744|NCT03064035|583804851|FG001|Overall Study|Lost to Follow-up|1|||
161659745|NCT03103763|583804854|FG000|Overall Study|Death|15|||
161659746|NCT03103763|583804855|FG001|Overall Study|Death|5|||
161659747|NCT03103763|583804856|FG002|Overall Study|Death|5|||
161659748|NCT03103763|583804854|FG000|Overall Study|Withdrawal by Subject|0|||
161659749|NCT03103763|583804855|FG001|Overall Study|Withdrawal by Subject|3|||
161659750|NCT03103763|583804856|FG002|Overall Study|Withdrawal by Subject|2|||
161659751|NCT02336178|583804857|FG000|Overall Study|Lost to Follow-up|1|||
161659752|NCT02336178|583804857|FG000|Overall Study|Protocol Violation|1|||
161710700|NCT00190775|583984168|FG000|Overall Study|Adverse Event|57|||
161710701|NCT00190775|583984169|FG001|Overall Study|Adverse Event|22|||
161710702|NCT00190775|583984168|FG000|Overall Study|Satisfactory Response|1|||
161710703|NCT00190775|583984169|FG001|Overall Study|Satisfactory Response|0|||
161659753|NCT02336178|583804857|FG000|Overall Study|Withdrawal by Subject|1|||
161659754|NCT02336178|583804857|FG000|Overall Study|Other|1|||
161659755|NCT03245151|583804858|FG000|Overall Study|Withdrawal by Subject|2|||
161659756|NCT03245151|583804859|FG001|Overall Study|Withdrawal by Subject|0|||
161659757|NCT03245151|583804860|FG002|Overall Study|Withdrawal by Subject|0|||
161659758|NCT03245151|583804861|FG003|Overall Study|Withdrawal by Subject|2|||
161659759|NCT03245151|583804862|FG004|Overall Study|Withdrawal by Subject|1|||
161659760|NCT03245151|583804858|FG000|Overall Study|Death|3|||
161659761|NCT03245151|583804859|FG001|Overall Study|Death|14|||
161659762|NCT03245151|583804860|FG002|Overall Study|Death|9|||
161659763|NCT03245151|583804861|FG003|Overall Study|Death|16|||
161659764|NCT03245151|583804862|FG004|Overall Study|Death|7|||
161659765|NCT03245151|583804858|FG000|Overall Study|Sponsor's decision|0|||
161659766|NCT03245151|583804859|FG001|Overall Study|Sponsor's decision|1|||
161659767|NCT03245151|583804860|FG002|Overall Study|Sponsor's decision|0|||
161659768|NCT03245151|583804861|FG003|Overall Study|Sponsor's decision|0|||
161659769|NCT03245151|583804862|FG004|Overall Study|Sponsor's decision|0|||
161659770|NCT01970345|583804863|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
161659771|NCT01970345|583804864|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
161659772|NCT01970345|583804863|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
161659773|NCT01970345|583804864|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
161659774|NCT01346475|583804865|FG000|First Intervention|Lost to Follow-up|4|||
161659775|NCT01346475|583804866|FG001|First Intervention|Lost to Follow-up|3|||
161659776|NCT00621777|583804867|FG000|Open Phase|Adverse Event|20|||
161659777|NCT00621777|583804868|FG001|Open Phase|Adverse Event|0|||
161659778|NCT00621777|583804867|FG000|Open Phase|Did not abstain during open phase|56|||
161659779|NCT00621777|583804868|FG001|Open Phase|Did not abstain during open phase|0|||
161659780|NCT00621777|583804867|FG000|Open Phase|Withdrawal by Subject|17|||
161659781|NCT00621777|583804868|FG001|Open Phase|Withdrawal by Subject|0|||
161659782|NCT00621777|583804867|FG000|Open Phase|administrative|13|||
161659783|NCT00621777|583804868|FG001|Open Phase|administrative|0|||
161659784|NCT00621777|583804867|FG000|Open Phase|Lost to Follow-up|10|||
161659785|NCT00621777|583804868|FG001|Open Phase|Lost to Follow-up|0|||
161659786|NCT00621777|583804867|FG000|Randomized Phase|Adverse Event|3|||
161659787|NCT00621777|583804868|FG001|Randomized Phase|Adverse Event|3|||
161659788|NCT00621777|583804867|FG000|Randomized Phase|Lost to Follow-up|3|||
161659789|NCT00621777|583804868|FG001|Randomized Phase|Lost to Follow-up|3|||
161659790|NCT00621777|583804867|FG000|Randomized Phase|Withdrawal by Subject|1|||
161659791|NCT00621777|583804868|FG001|Randomized Phase|Withdrawal by Subject|9|||
161659792|NCT00621777|583804867|FG000|Randomized Phase|administrative|0|||
161659793|NCT00621777|583804868|FG001|Randomized Phase|administrative|3|||
161659794|NCT00621777|583804867|FG000|Randomized Phase|Death|0|||
161659795|NCT00621777|583804868|FG001|Randomized Phase|Death|1|||
161659796|NCT00558259|583804869|FG000|Overall Study|Adverse Event|50|||
161659797|NCT00558259|583804870|FG001|Overall Study|Adverse Event|81|||
161659798|NCT00558259|583804869|FG000|Overall Study|Protocol Violation|9|||
161659799|NCT00558259|583804870|FG001|Overall Study|Protocol Violation|5|||
161659800|NCT00558259|583804869|FG000|Overall Study|Withdrawal by Subject|12|||
161659801|NCT00558259|583804870|FG001|Overall Study|Withdrawal by Subject|13|||
161659802|NCT00700258|583804877|FG000|Overall Study|Premature discontinuation of documentation|136|||
161659803|NCT00700258|583804877|FG000|Overall Study|Type of study end not documented|1|||
161659804|NCT00700258|583804877|FG000|Overall Study|Lost to Follow-up|81|||
161659805|NCT00700258|583804877|FG000|Overall Study|Premature discontinuation of therapy|1013|||
161659806|NCT00473265|583804878|FG000|Overall Study|Unrelated adverse event|5|||
161659807|NCT00473265|583804878|FG000|Overall Study|Off treatment early|15|||
161659808|NCT02663518|583804881|FG000|Part 1: Phase 1a Escalation|Death|0|||
161659809|NCT02663518|583804882|FG001|Part 1: Phase 1a Escalation|Death|0|||
161659810|NCT02663518|583804883|FG002|Part 1: Phase 1a Escalation|Death|1|||
161659811|NCT02663518|583804884|FG003|Part 1: Phase 1a Escalation|Death|0|||
161659812|NCT02663518|583804885|FG004|Part 1: Phase 1a Escalation|Death|0|||
161659813|NCT02663518|583804886|FG005|Part 1: Phase 1a Escalation|Death|0|||
161659814|NCT02663518|583804887|FG006|Part 1: Phase 1a Escalation|Death|0|||
161659815|NCT02663518|583804888|FG007|Part 1: Phase 1a Escalation|Death|0|||
161659816|NCT02663518|583804889|FG008|Part 1: Phase 1a Escalation|Death|0|||
161659817|NCT02663518|583804890|FG009|Part 1: Phase 1a Escalation|Death|0|||
161659818|NCT02663518|583804891|FG010|Part 1: Phase 1a Escalation|Death|0|||
161659819|NCT02663518|583804892|FG011|Part 1: Phase 1a Escalation|Death|0|||
161659820|NCT02663518|583804893|FG012|Part 1: Phase 1a Escalation|Death|0|||
161659821|NCT02663518|583804894|FG013|Part 1: Phase 1a Escalation|Death|0|||
161659822|NCT02663518|583804881|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659823|NCT02663518|583804882|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659824|NCT02663518|583804883|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
161659825|NCT02663518|583804884|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659826|NCT02663518|583804885|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659827|NCT02663518|583804886|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659828|NCT02663518|583804887|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659829|NCT02663518|583804888|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659830|NCT02663518|583804889|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659831|NCT02663518|583804890|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659832|NCT02663518|583804891|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659833|NCT02663518|583804892|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659834|NCT02663518|583804893|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659835|NCT02663518|583804894|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161659836|NCT02663518|583804881|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
161659837|NCT02663518|583804882|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
161659838|NCT02663518|583804883|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
161659839|NCT02663518|583804884|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
161659840|NCT02663518|583804885|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659841|NCT02663518|583804886|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659842|NCT02663518|583804887|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659843|NCT02663518|583804888|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659844|NCT02663518|583804889|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659845|NCT02663518|583804890|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659846|NCT02663518|583804891|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659847|NCT02663518|583804892|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659848|NCT02663518|583804893|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659849|NCT02663518|583804894|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161659850|NCT02663518|583804881|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
161659851|NCT02663518|583804882|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659852|NCT02663518|583804883|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
161659853|NCT02663518|583804884|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
161659854|NCT02663518|583804885|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659855|NCT02663518|583804886|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659856|NCT02663518|583804887|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659857|NCT02663518|583804888|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659858|NCT02663518|583804889|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659859|NCT02663518|583804890|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659860|NCT02663518|583804891|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659861|NCT02663518|583804892|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659862|NCT02663518|583804893|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659863|NCT02663518|583804894|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161659864|NCT02663518|583804881|FG000|Part 1: Phase 1a Escalation|Other|0|||
161659865|NCT02663518|583804882|FG001|Part 1: Phase 1a Escalation|Other|0|||
161659866|NCT02663518|583804883|FG002|Part 1: Phase 1a Escalation|Other|2|||
161659867|NCT02663518|583804884|FG003|Part 1: Phase 1a Escalation|Other|0|||
161659868|NCT02663518|583804885|FG004|Part 1: Phase 1a Escalation|Other|0|||
161659869|NCT02663518|583804886|FG005|Part 1: Phase 1a Escalation|Other|0|||
161659870|NCT02663518|583804887|FG006|Part 1: Phase 1a Escalation|Other|0|||
161659871|NCT02663518|583804888|FG007|Part 1: Phase 1a Escalation|Other|0|||
161659872|NCT02663518|583804889|FG008|Part 1: Phase 1a Escalation|Other|0|||
161659873|NCT02663518|583804890|FG009|Part 1: Phase 1a Escalation|Other|0|||
161659874|NCT02663518|583804891|FG010|Part 1: Phase 1a Escalation|Other|0|||
161659875|NCT02663518|583804892|FG011|Part 1: Phase 1a Escalation|Other|0|||
161659876|NCT02663518|583804893|FG012|Part 1: Phase 1a Escalation|Other|0|||
161659877|NCT02663518|583804894|FG013|Part 1: Phase 1a Escalation|Other|0|||
161659878|NCT02663518|583804881|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659879|NCT02663518|583804882|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659880|NCT02663518|583804883|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659881|NCT02663518|583804884|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659882|NCT02663518|583804885|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
161659883|NCT02663518|583804886|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659884|NCT02663518|583804887|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
161659885|NCT02663518|583804888|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
161659886|NCT02663518|583804889|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659887|NCT02663518|583804890|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659888|NCT02663518|583804891|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659889|NCT02663518|583804892|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659890|NCT02663518|583804893|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659891|NCT02663518|583804894|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
161659892|NCT02663518|583804881|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659893|NCT02663518|583804882|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659894|NCT02663518|583804883|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659895|NCT02663518|583804884|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659896|NCT02663518|583804885|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
161659897|NCT02663518|583804886|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659898|NCT02663518|583804887|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
161659899|NCT02663518|583804888|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
161659900|NCT02663518|583804889|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659901|NCT02663518|583804890|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659902|NCT02663518|583804891|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659903|NCT02663518|583804892|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659904|NCT02663518|583804893|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659905|NCT02663518|583804894|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161659906|NCT02663518|583804881|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659907|NCT02663518|583804882|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659908|NCT02663518|583804883|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659909|NCT02663518|583804884|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659910|NCT02663518|583804885|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
161659911|NCT02663518|583804886|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659912|NCT02663518|583804887|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659913|NCT02663518|583804888|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659914|NCT02663518|583804889|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659915|NCT02663518|583804890|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659916|NCT02663518|583804891|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659917|NCT02663518|583804892|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659918|NCT02663518|583804893|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659919|NCT02663518|583804894|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161659920|NCT02663518|583804881|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659921|NCT02663518|583804882|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659922|NCT02663518|583804883|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659923|NCT02663518|583804884|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659924|NCT02663518|583804885|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
161659925|NCT02663518|583804886|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
161659926|NCT02663518|583804887|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
161659927|NCT02663518|583804888|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
161659928|NCT02663518|583804889|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659929|NCT02663518|583804890|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659930|NCT02663518|583804891|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659931|NCT02663518|583804892|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659932|NCT02663518|583804893|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659933|NCT02663518|583804894|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161659934|NCT02663518|583804881|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659935|NCT02663518|583804882|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659936|NCT02663518|583804883|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659937|NCT02663518|583804884|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659938|NCT02663518|583804885|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
161659939|NCT02663518|583804886|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659940|NCT02663518|583804887|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
161659941|NCT02663518|583804888|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659942|NCT02663518|583804889|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659943|NCT02663518|583804890|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659944|NCT02663518|583804891|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659945|NCT02663518|583804892|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659946|NCT02663518|583804893|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659947|NCT02663518|583804894|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
161659948|NCT02663518|583804881|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659949|NCT02663518|583804882|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659950|NCT02663518|583804883|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659951|NCT02663518|583804884|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659952|NCT02663518|583804885|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659953|NCT02663518|583804886|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659954|NCT02663518|583804887|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
161659955|NCT02663518|583804888|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659956|NCT02663518|583804889|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659957|NCT02663518|583804890|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659958|NCT02663518|583804891|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659959|NCT02663518|583804892|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659960|NCT02663518|583804893|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659961|NCT02663518|583804894|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161659962|NCT02663518|583804881|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
161659963|NCT02663518|583804882|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
161659964|NCT02663518|583804883|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
161659965|NCT02663518|583804884|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
161659966|NCT02663518|583804885|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
161659967|NCT02663518|583804886|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
161659968|NCT02663518|583804887|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
161659969|NCT02663518|583804888|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
161659970|NCT02663518|583804889|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
161659971|NCT02663518|583804890|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
161659972|NCT02663518|583804891|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
161659973|NCT02663518|583804892|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
161659974|NCT02663518|583804893|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
161659975|NCT02663518|583804894|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
161659976|NCT02663518|583804881|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659977|NCT02663518|583804882|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659978|NCT02663518|583804883|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659979|NCT02663518|583804884|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659980|NCT02663518|583804885|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659981|NCT02663518|583804886|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659982|NCT02663518|583804887|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659983|NCT02663518|583804888|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659984|NCT02663518|583804889|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659985|NCT02663518|583804890|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659986|NCT02663518|583804891|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659987|NCT02663518|583804892|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659988|NCT02663518|583804893|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
161659989|NCT02663518|583804894|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161659990|NCT02663518|583804881|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659991|NCT02663518|583804882|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659992|NCT02663518|583804883|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659993|NCT02663518|583804884|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659994|NCT02663518|583804885|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659995|NCT02663518|583804886|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659996|NCT02663518|583804887|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659997|NCT02663518|583804888|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659998|NCT02663518|583804889|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161659999|NCT02663518|583804890|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161660000|NCT02663518|583804891|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161660001|NCT02663518|583804892|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
161710704|NCT00190775|583984168|FG000|Overall Study|Lack of Efficacy|28|||
161710705|NCT00190775|583984169|FG001|Overall Study|Lack of Efficacy|32|||
161710706|NCT00190775|583984168|FG000|Overall Study|Lost to Follow-up|31|||
161710707|NCT00190775|583984169|FG001|Overall Study|Lost to Follow-up|23|||
161710708|NCT00190775|583984168|FG000|Overall Study|Participant Moved|0|||
161710709|NCT00190775|583984169|FG001|Overall Study|Participant Moved|1|||
161710710|NCT00190775|583984168|FG000|Overall Study|Withdrawal by Subject|24|||
161710711|NCT00190775|583984169|FG001|Overall Study|Withdrawal by Subject|13|||
161710712|NCT00190775|583984168|FG000|Overall Study|Sponsor Decision|1|||
161710713|NCT00190775|583984169|FG001|Overall Study|Sponsor Decision|0|||
161710714|NCT00190775|583984168|FG000|Overall Study|Physician Decision|3|||
161710715|NCT00190775|583984169|FG001|Overall Study|Physician Decision|0|||
161710716|NCT00190775|583984168|FG000|Overall Study|Noncompliance|3|||
161660002|NCT02663518|583804893|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161660003|NCT02663518|583804894|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161660004|NCT02663518|583804881|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660005|NCT02663518|583804882|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660006|NCT02663518|583804883|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660007|NCT02663518|583804884|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660008|NCT02663518|583804885|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660009|NCT02663518|583804886|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660010|NCT02663518|583804887|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660011|NCT02663518|583804888|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660012|NCT02663518|583804889|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660013|NCT02663518|583804890|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
161660014|NCT02663518|583804891|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161660015|NCT02663518|583804892|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
161660016|NCT02663518|583804893|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
161660017|NCT02663518|583804894|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
161660018|NCT02663518|583804881|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
161660019|NCT02663518|583804882|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
161660020|NCT02663518|583804883|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
161660021|NCT02663518|583804884|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
161660022|NCT02663518|583804885|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
161660023|NCT02663518|583804886|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
161660024|NCT02663518|583804887|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
161660025|NCT02663518|583804888|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
161660026|NCT02663518|583804889|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
161660027|NCT02663518|583804890|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
161660028|NCT02663518|583804891|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
161660029|NCT02663518|583804892|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
161660030|NCT02663518|583804893|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
161660031|NCT02663518|583804894|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
161660032|NCT02663518|583804881|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660033|NCT02663518|583804882|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660034|NCT02663518|583804883|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660035|NCT02663518|583804884|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660036|NCT02663518|583804885|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660037|NCT02663518|583804886|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660038|NCT02663518|583804887|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660039|NCT02663518|583804888|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660040|NCT02663518|583804889|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660041|NCT02663518|583804890|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660042|NCT02663518|583804891|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660043|NCT02663518|583804892|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660044|NCT02663518|583804893|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
161660045|NCT02663518|583804894|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161660046|NCT01004848|583804895|FG000|Overall Study|Lost to Follow-up|55|||
161660047|NCT01004848|583804896|FG001|Overall Study|Lost to Follow-up|45|||
161660048|NCT03215810|583804897|FG000|Overall Study|Still responding to nivolumab|1|||
161660049|NCT03215810|583804897|FG000|Overall Study|Insufficient TIL growth|1|||
161660050|NCT03215810|583804897|FG000|Overall Study|Decline in performance status|1|||
161660051|NCT03215810|583804897|FG000|Overall Study|Withdrawal by Subject|1|||
161660052|NCT01157676|583804901|FG000|Randomization|Death|1|||
161660053|NCT01157676|583804902|FG001|Randomization|Death|1|||
161660054|NCT01157676|583804901|FG000|Randomization|unresectable|2|||
161660055|NCT01157676|583804902|FG001|Randomization|unresectable|3|||
161660056|NCT01157676|583804901|FG000|Randomization|Withdrawal by Subject|17|||
161660057|NCT01157676|583804902|FG001|Randomization|Withdrawal by Subject|13|||
161660058|NCT01157676|583804901|FG000|Randomization|Physician Decision|1|||
161660059|NCT01157676|583804902|FG001|Randomization|Physician Decision|0|||
161660060|NCT01157676|583804901|FG000|Surgery|underwent open cystectomy|0|||
161660061|NCT01157676|583804902|FG001|Surgery|underwent open cystectomy|4|||
161660062|NCT01157676|583804901|FG000|Surgery|converted to open procedure|0|||
161660063|NCT01157676|583804902|FG001|Surgery|converted to open procedure|5|||
161660064|NCT01157676|583804901|FG000|Surgery|underwent robotic cystectomy|1|||
161660065|NCT01157676|583804902|FG001|Surgery|underwent robotic cystectomy|0|||
161660066|NCT00682890|583804903|FG000|Overall Study|Lost to Follow-up|1|||
161660067|NCT00682890|583804904|FG001|Overall Study|Lost to Follow-up|1|||
161660068|NCT00682890|583804903|FG000|Overall Study|subject moved away|0|||
161660069|NCT00682890|583804904|FG001|Overall Study|subject moved away|1|||
161660070|NCT00682890|583804903|FG000|Overall Study|heavy menstrual bleeding|1|||
161660071|NCT00682890|583804904|FG001|Overall Study|heavy menstrual bleeding|0|||
161660072|NCT00141219|583804907|FG000|Overall Study|Protocol violations|5|||
161660073|NCT00141219|583804908|FG001|Overall Study|Protocol violations|4|||
161660074|NCT00141219|583804907|FG000|Overall Study|Adverse Event|8|||
161660075|NCT00141219|583804908|FG001|Overall Study|Adverse Event|6|||
161660076|NCT00141219|583804907|FG000|Overall Study|Lack of Efficacy|5|||
161660077|NCT00141219|583804908|FG001|Overall Study|Lack of Efficacy|4|||
161660078|NCT00141219|583804907|FG000|Overall Study|Withdrawal by Subject|6|||
161660079|NCT00141219|583804908|FG001|Overall Study|Withdrawal by Subject|2|||
161660080|NCT01577745|583804909|FG000|Overall Study|Withdrawal by Subject|0|||
161660081|NCT01577745|583804910|FG001|Overall Study|Withdrawal by Subject|1|||
161710717|NCT00190775|583984169|FG001|Overall Study|Noncompliance|5|||
161660082|NCT01577745|583804911|FG002|Overall Study|Withdrawal by Subject|0|||
161660083|NCT01577745|583804912|FG003|Overall Study|Withdrawal by Subject|3|||
161660084|NCT01577745|583804913|FG004|Overall Study|Withdrawal by Subject|2|||
161660085|NCT01577745|583804914|FG005|Overall Study|Withdrawal by Subject|0|||
161660086|NCT01577745|583804909|FG000|Overall Study|Death|3|||
161660087|NCT01577745|583804910|FG001|Overall Study|Death|2|||
161660088|NCT01577745|583804911|FG002|Overall Study|Death|2|||
161660089|NCT01577745|583804912|FG003|Overall Study|Death|1|||
161660090|NCT01577745|583804913|FG004|Overall Study|Death|1|||
161660091|NCT01577745|583804914|FG005|Overall Study|Death|3|||
161660092|NCT01577745|583804909|FG000|Overall Study|Physician Decision|0|||
161660093|NCT01577745|583804910|FG001|Overall Study|Physician Decision|0|||
161660094|NCT01577745|583804911|FG002|Overall Study|Physician Decision|0|||
161660095|NCT01577745|583804912|FG003|Overall Study|Physician Decision|1|||
161660096|NCT01577745|583804913|FG004|Overall Study|Physician Decision|1|||
161660097|NCT01577745|583804914|FG005|Overall Study|Physician Decision|0|||
161660098|NCT01577745|583804909|FG000|Overall Study|Lost to Follow-up|0|||
161660099|NCT01577745|583804910|FG001|Overall Study|Lost to Follow-up|0|||
161660100|NCT01577745|583804911|FG002|Overall Study|Lost to Follow-up|0|||
161660101|NCT01577745|583804912|FG003|Overall Study|Lost to Follow-up|0|||
161660102|NCT01577745|583804913|FG004|Overall Study|Lost to Follow-up|0|||
161660103|NCT01577745|583804914|FG005|Overall Study|Lost to Follow-up|1|||
161660104|NCT01577745|583804909|FG000|Overall Study|Alternative Therapy|0|||
161660105|NCT01577745|583804910|FG001|Overall Study|Alternative Therapy|0|||
161660106|NCT01577745|583804911|FG002|Overall Study|Alternative Therapy|0|||
161660107|NCT01577745|583804912|FG003|Overall Study|Alternative Therapy|1|||
161660108|NCT01577745|583804913|FG004|Overall Study|Alternative Therapy|1|||
161660109|NCT01577745|583804914|FG005|Overall Study|Alternative Therapy|0|||
161660110|NCT02971761|583804916|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
161660111|NCT02624791|583804917|FG000|Overall Study|Withdrawal by Subject|2|||
161660112|NCT02624791|583804918|FG001|Overall Study|Withdrawal by Subject|0|||
161660113|NCT02624791|583804919|FG002|Overall Study|Withdrawal by Subject|0|||
161660114|NCT02624791|583804920|FG003|Overall Study|Withdrawal by Subject|0|||
161660115|NCT02624791|583804921|FG004|Overall Study|Withdrawal by Subject|0|||
161660116|NCT02624791|583804922|FG005|Overall Study|Withdrawal by Subject|0|||
161660117|NCT01146782|583804926|FG000|Screening Cohort|Screen Failure|187|||
161660118|NCT01146782|583804926|FG000|Screening Cohort|Lost to Follow-up|4|||
161660119|NCT01146782|583804926|FG000|Screening Cohort|Physician Decision|1|||
161660120|NCT01146782|583804926|FG000|Screening Cohort|Withdrawal by Subject|29|||
161660121|NCT01146782|583804926|FG000|Safety Cohort|Screen Failure|61|||
161660122|NCT01146782|583804926|FG000|Safety Cohort|Withdrawal by Subject|4|||
161660123|NCT01146782|583804926|FG000|Safety Cohort|Control AHI <5|4|||
161660124|NCT01146782|583804926|FG000|Safety Cohort|TST <4 hrs|14|||
161660125|NCT01146782|583804926|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
161660126|NCT01146782|583804926|FG000|Primary Endpoint Cohort|Physician Decision|1|||
161660127|NCT01605916|583804927|FG000|Overall Study|Adverse Event|1|||
161660128|NCT01605916|583804928|FG001|Overall Study|Adverse Event|0|||
161660129|NCT01605916|583804929|FG002|Overall Study|Adverse Event|0|||
161660130|NCT01605916|583804930|FG003|Overall Study|Adverse Event|1|||
161660131|NCT01605916|583804931|FG004|Overall Study|Adverse Event|0|||
161660132|NCT01605916|583804927|FG000|Overall Study|Lack of Efficacy|2|||
161660133|NCT01605916|583804928|FG001|Overall Study|Lack of Efficacy|3|||
161660134|NCT01605916|583804929|FG002|Overall Study|Lack of Efficacy|3|||
161660135|NCT01605916|583804930|FG003|Overall Study|Lack of Efficacy|5|||
161660136|NCT01605916|583804931|FG004|Overall Study|Lack of Efficacy|4|||
161660137|NCT01605916|583804927|FG000|Overall Study|Withdrawal by Subject|1|||
161660138|NCT01605916|583804928|FG001|Overall Study|Withdrawal by Subject|1|||
161660139|NCT01605916|583804929|FG002|Overall Study|Withdrawal by Subject|0|||
161660140|NCT01605916|583804930|FG003|Overall Study|Withdrawal by Subject|0|||
161660141|NCT01605916|583804931|FG004|Overall Study|Withdrawal by Subject|2|||
161660142|NCT02842151|583804934|FG000|Overall Study|Adverse Event|1|||
161660143|NCT02842151|583804934|FG000|Overall Study|Subject moved too far away|1|||
161660144|NCT00438672|583804935|FG000|Overall Study|Lost to Follow-up|7|||
161660145|NCT00438672|583804936|FG001|Overall Study|Lost to Follow-up|9|||
161710718|NCT00190775|583984168|FG000|Overall Study|Protocol Violation|0|||
161660146|NCT03965351|583804939|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161660147|NCT03965351|583804940|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161660148|NCT03965351|583804939|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
161660149|NCT03965351|583804940|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
161660150|NCT02432196|583804943|FG000|Overall Study|Exit - did not receive study device|1|||
161660151|NCT02432196|583804943|FG000|Overall Study|Death|2|||
161660152|NCT02432196|583804943|FG000|Overall Study|Reoperation|3|||
161660153|NCT01942785|583804947|FG000|Overall Study|Adverse Event|2|||
161660154|NCT01942785|583804947|FG000|Overall Study|Withdrawal by Subject|1|||
161660155|NCT01942785|583804947|FG000|Overall Study|Protocol Violation|1|||
161660156|NCT01905150|583804951|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
161660157|NCT01905150|583804952|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
161660158|NCT01147536|583804953|FG000|Overall Study|Administrative study close|2|||
161660159|NCT01147536|583804953|FG000|Overall Study|Death|1|||
161660160|NCT00935818|583804954|FG000|Overall Study|Withdrawal by Subject|45|||
161660161|NCT00935818|583804955|FG001|Overall Study|Withdrawal by Subject|50|||
161660162|NCT00935818|583804954|FG000|Overall Study|Lost to Follow-up|40|||
161660163|NCT00935818|583804955|FG001|Overall Study|Lost to Follow-up|42|||
161660164|NCT00935818|583804954|FG000|Overall Study|Adverse Event|6|||
161660165|NCT00935818|583804955|FG001|Overall Study|Adverse Event|7|||
161660166|NCT00935818|583804954|FG000|Overall Study|Physician Decision|0|||
161660167|NCT00935818|583804955|FG001|Overall Study|Physician Decision|1|||
161660168|NCT02631577|583804956|FG000|Overall Study|Death|1|||
161660169|NCT02631577|583804957|FG001|Overall Study|Death|7|||
161710719|NCT00190775|583984169|FG001|Overall Study|Protocol Violation|1|||
161710720|NCT00190775|583984168|FG000|Overall Study|Exclusion Criteria Met|1|||
161710721|NCT00190775|583984169|FG001|Overall Study|Exclusion Criteria Met|3|||
161710722|NCT01794780|583984170|FG000|Overall Study|Adverse Event|0|||
161710723|NCT01794780|583984171|FG001|Overall Study|Adverse Event|1|||
161660170|NCT02631577|583804956|FG000|Overall Study|Withdrawal by Subject|0|||
161660171|NCT02631577|583804957|FG001|Overall Study|Withdrawal by Subject|3|||
161660172|NCT00604825|583804960|FG000|Overall Study|Adverse Event|2|||
161660173|NCT00604825|583804961|FG001|Overall Study|Adverse Event|6|||
161660174|NCT00604825|583804962|FG002|Overall Study|Adverse Event|7|||
161660175|NCT00604825|583804963|FG003|Overall Study|Adverse Event|4|||
161660176|NCT00604825|583804960|FG000|Overall Study|Lost to Follow-up|0|||
161660177|NCT00604825|583804961|FG001|Overall Study|Lost to Follow-up|3|||
161660178|NCT00604825|583804962|FG002|Overall Study|Lost to Follow-up|1|||
161660179|NCT00604825|583804963|FG003|Overall Study|Lost to Follow-up|0|||
161660180|NCT00604825|583804960|FG000|Overall Study|Protocol Violation|0|||
161660181|NCT00604825|583804961|FG001|Overall Study|Protocol Violation|1|||
161660182|NCT00604825|583804962|FG002|Overall Study|Protocol Violation|0|||
161660183|NCT00604825|583804963|FG003|Overall Study|Protocol Violation|0|||
161660184|NCT00604825|583804960|FG000|Overall Study|Withdrawal by Subject|4|||
161660185|NCT00604825|583804961|FG001|Overall Study|Withdrawal by Subject|3|||
161660186|NCT00604825|583804962|FG002|Overall Study|Withdrawal by Subject|5|||
161660187|NCT00604825|583804963|FG003|Overall Study|Withdrawal by Subject|5|||
161660188|NCT00604825|583804960|FG000|Overall Study|Lack of Efficacy|3|||
161660189|NCT00604825|583804961|FG001|Overall Study|Lack of Efficacy|2|||
161660190|NCT00604825|583804962|FG002|Overall Study|Lack of Efficacy|1|||
161660191|NCT00604825|583804963|FG003|Overall Study|Lack of Efficacy|0|||
161660192|NCT00604825|583804960|FG000|Overall Study|Did not meet eligibility criteria|0|||
161660193|NCT00604825|583804961|FG001|Overall Study|Did not meet eligibility criteria|0|||
161660194|NCT00604825|583804962|FG002|Overall Study|Did not meet eligibility criteria|2|||
161660195|NCT00604825|583804963|FG003|Overall Study|Did not meet eligibility criteria|0|||
161660196|NCT00604825|583804960|FG000|Overall Study|Physician Decision|0|||
161710724|NCT01794780|583984172|FG002|Overall Study|Adverse Event|2|||
161710725|NCT01794780|583984173|FG003|Overall Study|Adverse Event|0|||
161660197|NCT00604825|583804961|FG001|Overall Study|Physician Decision|0|||
161660198|NCT00604825|583804962|FG002|Overall Study|Physician Decision|0|||
161660199|NCT00604825|583804963|FG003|Overall Study|Physician Decision|1|||
161660200|NCT00604825|583804960|FG000|Overall Study|Exclusion criterion met|0|||
161660201|NCT00604825|583804961|FG001|Overall Study|Exclusion criterion met|0|||
161660202|NCT00604825|583804962|FG002|Overall Study|Exclusion criterion met|0|||
161660203|NCT00604825|583804963|FG003|Overall Study|Exclusion criterion met|1|||
161660204|NCT03465904|583804964|FG000|Overall Study|Withdrawal by Subject|9|||
161660205|NCT03465904|583804965|FG001|Overall Study|Withdrawal by Subject|5|||
161660206|NCT03465904|583804964|FG000|Overall Study|Lost to Follow-up|11|||
161660207|NCT03465904|583804965|FG001|Overall Study|Lost to Follow-up|9|||
161660208|NCT03465904|583804964|FG000|Overall Study|Protocol Violation|20|||
161660209|NCT03465904|583804965|FG001|Overall Study|Protocol Violation|15|||
161660210|NCT05593445|583804966|FG000|12-Week DBVC Period|Adverse Event|1|||
161660211|NCT05593445|583804967|FG001|12-Week DBVC Period|Adverse Event|0|||
161660212|NCT05593445|583804968|FG002|12-Week DBVC Period|Adverse Event|0|||
161660213|NCT05593445|583804969|FG003|12-Week DBVC Period|Adverse Event|0|||
161660214|NCT05593445|583804966|FG000|12-Week DBVC Period|Physician Decision|0|||
161710726|NCT01794780|583984174|FG004|Overall Study|Adverse Event|0|||
161660215|NCT05593445|583804967|FG001|12-Week DBVC Period|Physician Decision|1|||
161660216|NCT05593445|583804968|FG002|12-Week DBVC Period|Physician Decision|0|||
161660217|NCT05593445|583804969|FG003|12-Week DBVC Period|Physician Decision|0|||
161660218|NCT05593445|583804966|FG000|12-Week DBVC Period|Protocol Violation|0|||
161660219|NCT05593445|583804967|FG001|12-Week DBVC Period|Protocol Violation|1|||
161660220|NCT05593445|583804968|FG002|12-Week DBVC Period|Protocol Violation|0|||
161660221|NCT05593445|583804969|FG003|12-Week DBVC Period|Protocol Violation|0|||
161660222|NCT05593445|583804966|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
161710727|NCT01794780|583984175|FG005|Overall Study|Adverse Event|0|||
161710728|NCT01794780|583984176|FG006|Overall Study|Adverse Event|0|||
161710729|NCT01794780|583984177|FG007|Overall Study|Adverse Event|0|||
161710730|NCT01794780|583984170|FG000|Overall Study|Death|0|||
161710731|NCT01794780|583984171|FG001|Overall Study|Death|2|||
161710732|NCT01794780|583984172|FG002|Overall Study|Death|14|||
161710733|NCT01794780|583984173|FG003|Overall Study|Death|1|||
161710734|NCT01794780|583984174|FG004|Overall Study|Death|0|||
161710735|NCT01794780|583984175|FG005|Overall Study|Death|9|||
161710736|NCT01794780|583984176|FG006|Overall Study|Death|4|||
161710737|NCT01794780|583984177|FG007|Overall Study|Death|0|||
161710738|NCT01794780|583984170|FG000|Overall Study|Lost to Follow-up|10|||
161710739|NCT01794780|583984171|FG001|Overall Study|Lost to Follow-up|64|||
161710740|NCT01794780|583984172|FG002|Overall Study|Lost to Follow-up|165|||
161710741|NCT01794780|583984173|FG003|Overall Study|Lost to Follow-up|53|||
161710742|NCT01794780|583984174|FG004|Overall Study|Lost to Follow-up|2|||
161710743|NCT01794780|583984175|FG005|Overall Study|Lost to Follow-up|99|||
161710744|NCT01794780|583984176|FG006|Overall Study|Lost to Follow-up|30|||
161710745|NCT01794780|583984177|FG007|Overall Study|Lost to Follow-up|5|||
161710746|NCT01794780|583984170|FG000|Overall Study|Withdrew informed consent|7|||
161660223|NCT05593445|583804967|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
161660224|NCT05593445|583804968|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
161660225|NCT05593445|583804969|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
161660226|NCT05593445|583804966|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
161660227|NCT05593445|583804967|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
161660228|NCT05593445|583804968|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
161660229|NCT05593445|583804969|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
161660230|NCT05593445|583804966|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
161660231|NCT05593445|583804967|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
161660232|NCT05593445|583804968|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
161660233|NCT05593445|583804969|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
161660234|NCT05593445|583804966|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
161660235|NCT05593445|583804967|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
161660236|NCT05593445|583804968|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
161660237|NCT05593445|583804969|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
161660238|NCT05593445|583804966|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161660239|NCT05593445|583804967|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161660240|NCT05593445|583804968|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
161660241|NCT05593445|583804969|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161660242|NCT03694275|583806775|FG000|Overall Study|Adverse Event|0|||
161660243|NCT03694275|583806776|FG001|Overall Study|Adverse Event|1|||
161710747|NCT01794780|583984171|FG001|Overall Study|Withdrew informed consent|17|||
161710748|NCT01794780|583984172|FG002|Overall Study|Withdrew informed consent|36|||
161660244|NCT03694275|583806775|FG000|Overall Study|Reason not Specified|0|||
161660245|NCT03694275|583806776|FG001|Overall Study|Reason not Specified|1|||
161660246|NCT00910689|583806778|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
161660247|NCT00910689|583806779|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
161660248|NCT00910689|583806780|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
161660249|NCT00910689|583806781|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
161660250|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
161660251|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
161660252|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
161660253|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
161660254|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
161710749|NCT01794780|583984173|FG003|Overall Study|Withdrew informed consent|9|||
161710750|NCT01794780|583984174|FG004|Overall Study|Withdrew informed consent|0|||
161710751|NCT01794780|583984175|FG005|Overall Study|Withdrew informed consent|48|||
161710752|NCT01794780|583984176|FG006|Overall Study|Withdrew informed consent|4|||
161710753|NCT01794780|583984177|FG007|Overall Study|Withdrew informed consent|3|||
161710754|NCT01794780|583984170|FG000|Overall Study|Other|0|||
161710755|NCT01794780|583984171|FG001|Overall Study|Other|12|||
161710756|NCT01794780|583984172|FG002|Overall Study|Other|25|||
161710757|NCT01794780|583984173|FG003|Overall Study|Other|20|||
161710758|NCT01794780|583984174|FG004|Overall Study|Other|1|||
161710759|NCT01794780|583984175|FG005|Overall Study|Other|24|||
161660255|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
161660256|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
161660257|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
161660258|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
161660259|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
161660260|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
161660261|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
161660262|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
161660263|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
161660264|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
161660265|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
161660266|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
161660267|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
161660268|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
161660269|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
161660270|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
161660271|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
161660272|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
161660273|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
161660274|NCT00910689|583806778|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
161660275|NCT00910689|583806779|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
161660276|NCT00910689|583806780|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
161660277|NCT00910689|583806781|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
161660278|NCT00910689|583806778|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
161660279|NCT00910689|583806779|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
161660280|NCT00910689|583806780|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
161660281|NCT00910689|583806781|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
161660282|NCT00910689|583806778|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
161660283|NCT00910689|583806779|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
161660284|NCT00910689|583806780|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
161660285|NCT00910689|583806781|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
161660286|NCT00910689|583806778|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
161660287|NCT00910689|583806779|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
161660288|NCT00910689|583806780|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
161660289|NCT00910689|583806781|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
161660290|NCT00910689|583806778|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
161660291|NCT00910689|583806779|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
161660292|NCT00910689|583806780|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
161660293|NCT00910689|583806781|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
161660294|NCT00910689|583806778|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
161660295|NCT00910689|583806779|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
161660296|NCT00910689|583806780|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
161660297|NCT00910689|583806781|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
161660298|NCT00910689|583806778|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
161660299|NCT00910689|583806779|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
161660300|NCT00910689|583806780|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
161660301|NCT00910689|583806781|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
161660302|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
161660303|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
161660304|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
161660305|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
161660306|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
161660307|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
161660308|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
161660309|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
161660310|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
161660311|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
161660312|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
161660313|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
161660314|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
161660315|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
161660316|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
161660317|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
161660318|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
161660319|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
161660320|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
161660321|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
161660322|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
161660323|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
161660324|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
161660325|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
161660326|NCT00910689|583806778|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
161660327|NCT00910689|583806779|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
161660328|NCT00910689|583806780|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
161660329|NCT00910689|583806781|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
161660330|NCT01290029|583806784|FG000|Overall Study|Other|2|||
161660331|NCT00616902|583806787|FG000|Overall Study|Termination of study|6|||
161660332|NCT00616902|583806788|FG001|Overall Study|Termination of study|6|||
161660333|NCT01877837|583806789|FG000|Overall Study|Lost to Follow-up|1|||
161660334|NCT01877837|583806789|FG000|Overall Study|Ineligible|4|||
161660335|NCT00645801|583806790|FG000|Overall Study|unclear if patient took all the medication.|1|||
161660336|NCT00645801|583806791|FG001|Overall Study|unclear if patient took all the medication.|0|||
161710760|NCT01794780|583984176|FG006|Overall Study|Other|4|||
161710761|NCT01794780|583984177|FG007|Overall Study|Other|1|||
161710762|NCT00519077|583984178|FG000|Overall Study|Death|6|||
161710763|NCT00519077|583984178|FG000|Overall Study|Other|2|||
161710764|NCT02286102|583984180|FG000|Overall Study|Screen Failure|1|||
161710765|NCT02286102|583984181|FG001|Overall Study|Screen Failure|1|||
161710766|NCT01967225|583984182|FG000|Overall Study|Adverse Event|3|||
161710767|NCT01967225|583984183|FG001|Overall Study|Adverse Event|1|||
161660337|NCT00645801|583806790|FG000|Overall Study|Lost to Follow-up|19|||
161660338|NCT00645801|583806791|FG001|Overall Study|Lost to Follow-up|15|||
161660339|NCT00759915|583806792|FG000|Overall Study|Withdrawal by Subject|1|||
161660340|NCT00759915|583806793|FG001|Overall Study|Withdrawal by Subject|0|||
161660341|NCT00759915|583806792|FG000|Overall Study|Adverse Event|0|||
161660342|NCT00759915|583806793|FG001|Overall Study|Adverse Event|1|||
161660343|NCT00932113|583806796|FG000|Overall Study|Lost to Follow-up|1|||
161660344|NCT00932113|583806797|FG001|Overall Study|Lost to Follow-up|0|||
161660345|NCT01773291|583806798|FG000|Overall Study|Protocol Violation|1|||
161660346|NCT01773291|583806799|FG001|Overall Study|Protocol Violation|0|||
161660347|NCT01773291|583806800|FG002|Overall Study|Protocol Violation|0|||
161660348|NCT01773291|583806798|FG000|Overall Study|Withdrawal by Subject|0|||
161660349|NCT01773291|583806799|FG001|Overall Study|Withdrawal by Subject|0|||
161660350|NCT01773291|583806800|FG002|Overall Study|Withdrawal by Subject|1|||
161660351|NCT00203476|583806801|FG000|Overall Study|Lost to Follow-up|1|||
161660352|NCT00203476|583806802|FG001|Overall Study|Lost to Follow-up|0|||
161660353|NCT00203476|583806803|FG002|Overall Study|Lost to Follow-up|0|||
161660354|NCT00203476|583806801|FG000|Overall Study|Withdrawal by Subject|0|||
161660355|NCT00203476|583806802|FG001|Overall Study|Withdrawal by Subject|1|||
161660356|NCT00203476|583806803|FG002|Overall Study|Withdrawal by Subject|0|||
161660357|NCT03310268|583806804|FG000|Overall Study|(Not specified)|1|||
161660358|NCT03310268|583806805|FG001|Overall Study|(Not specified)|5|||
161660359|NCT03310268|583806806|FG002|Overall Study|(Not specified)|0|||
161660360|NCT04797650|583806807|FG000|Overall Study|Reason Not Specified|5|||
161660361|NCT04797650|583806808|FG001|Overall Study|Reason Not Specified|12|||
161660362|NCT04797650|583806809|FG002|Overall Study|Reason Not Specified|5|||
161660363|NCT04797650|583806807|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
161660364|NCT04797650|583806808|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
161660365|NCT04797650|583806809|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
161660366|NCT04797650|583806807|FG000|Overall Study|Lack of Efficacy|1|||
161660367|NCT04797650|583806808|FG001|Overall Study|Lack of Efficacy|0|||
161660368|NCT04797650|583806809|FG002|Overall Study|Lack of Efficacy|1|||
161660369|NCT04797650|583806807|FG000|Overall Study|Non-compliance with Study Drug|0|||
161660370|NCT04797650|583806808|FG001|Overall Study|Non-compliance with Study Drug|0|||
161660371|NCT04797650|583806809|FG002|Overall Study|Non-compliance with Study Drug|2|||
161660372|NCT04797650|583806807|FG000|Overall Study|Lost to Follow-up|4|||
161660373|NCT04797650|583806808|FG001|Overall Study|Lost to Follow-up|6|||
161660374|NCT04797650|583806809|FG002|Overall Study|Lost to Follow-up|1|||
161660375|NCT04772898|583806812|FG000|Overall Study|Withdrawal by Subject|0|||
161660376|NCT04772898|583806813|FG001|Overall Study|Withdrawal by Subject|1|||
161660377|NCT00309959|583806815|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
161660378|NCT02937454|583806816|FG000|Overall Study|Adverse Event|0|||
161660379|NCT02937454|583806817|FG001|Overall Study|Adverse Event|1|||
161660380|NCT02937454|583806816|FG000|Overall Study|Death|98|||
161660381|NCT02937454|583806817|FG001|Overall Study|Death|95|||
161660382|NCT02937454|583806816|FG000|Overall Study|Lost to Follow-up|1|||
161660383|NCT02937454|583806817|FG001|Overall Study|Lost to Follow-up|1|||
161710768|NCT01967225|583984182|FG000|Overall Study|Withdrawal by Subject|2|||
161660384|NCT02937454|583806816|FG000|Overall Study|Physician Decision|0|||
161660385|NCT02937454|583806817|FG001|Overall Study|Physician Decision|1|||
161660386|NCT02937454|583806816|FG000|Overall Study|Protocol Violation|6|||
161660387|NCT02937454|583806817|FG001|Overall Study|Protocol Violation|10|||
161660388|NCT02937454|583806816|FG000|Overall Study|Withdrawal by Subject|27|||
161660389|NCT02937454|583806817|FG001|Overall Study|Withdrawal by Subject|15|||
161660390|NCT02937454|583806816|FG000|Overall Study|Other|8|||
161660391|NCT02937454|583806817|FG001|Overall Study|Other|5|||
161660392|NCT01253304|583806818|FG000|Overall Study|Adverse Event|0|||
161660393|NCT01253304|583806819|FG001|Overall Study|Adverse Event|0|||
161660394|NCT01253304|583806820|FG002|Overall Study|Adverse Event|0|||
161660395|NCT01253304|583806821|FG003|Overall Study|Adverse Event|1|||
161660396|NCT01888900|583806829|FG000|Overall Study|failed treatment|0|||
161660397|NCT01888900|583806830|FG001|Overall Study|failed treatment|2|||
161660398|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
161660399|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161660400|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161660401|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161660402|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161660403|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161660404|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
161660405|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161660406|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161660407|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161660408|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161660409|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161660410|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
161660411|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161660412|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161660413|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161660414|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161660415|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161660416|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
161660417|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161660418|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161660419|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161660420|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161660421|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161660422|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
161660423|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161660424|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161660425|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161660426|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161660427|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161660428|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
161660429|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161660430|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161660431|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161660432|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161660433|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161660434|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
161660435|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161660436|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161660437|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161660438|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161660439|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161660440|NCT01160289|583806831|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
161660441|NCT01160289|583806832|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161660442|NCT01160289|583806833|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161660443|NCT01160289|583806834|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161660444|NCT01160289|583806835|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161660445|NCT01160289|583806836|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161660446|NCT01160289|583806831|FG000|Post-Randomization Period|Adverse Event|0|||
161660447|NCT01160289|583806832|FG001|Post-Randomization Period|Adverse Event|4|||
161660448|NCT01160289|583806833|FG002|Post-Randomization Period|Adverse Event|4|||
161660449|NCT01160289|583806834|FG003|Post-Randomization Period|Adverse Event|2|||
161660450|NCT01160289|583806835|FG004|Post-Randomization Period|Adverse Event|0|||
161660451|NCT01160289|583806836|FG005|Post-Randomization Period|Adverse Event|0|||
161660452|NCT01160289|583806831|FG000|Post-Randomization Period|Death|0|||
161660453|NCT01160289|583806832|FG001|Post-Randomization Period|Death|0|||
161660454|NCT01160289|583806833|FG002|Post-Randomization Period|Death|0|||
161660455|NCT01160289|583806834|FG003|Post-Randomization Period|Death|1|||
161660456|NCT01160289|583806835|FG004|Post-Randomization Period|Death|0|||
161660457|NCT01160289|583806836|FG005|Post-Randomization Period|Death|0|||
161660458|NCT01160289|583806831|FG000|Post-Randomization Period|Lack of Efficacy|0|||
161660459|NCT01160289|583806832|FG001|Post-Randomization Period|Lack of Efficacy|1|||
161660460|NCT01160289|583806833|FG002|Post-Randomization Period|Lack of Efficacy|0|||
161660461|NCT01160289|583806834|FG003|Post-Randomization Period|Lack of Efficacy|3|||
161660462|NCT01160289|583806835|FG004|Post-Randomization Period|Lack of Efficacy|0|||
161660463|NCT01160289|583806836|FG005|Post-Randomization Period|Lack of Efficacy|0|||
161660464|NCT01160289|583806831|FG000|Post-Randomization Period|Lost to Follow-up|0|||
161660465|NCT01160289|583806832|FG001|Post-Randomization Period|Lost to Follow-up|3|||
161660466|NCT01160289|583806833|FG002|Post-Randomization Period|Lost to Follow-up|2|||
161660467|NCT01160289|583806834|FG003|Post-Randomization Period|Lost to Follow-up|5|||
161660468|NCT01160289|583806835|FG004|Post-Randomization Period|Lost to Follow-up|3|||
161660469|NCT01160289|583806836|FG005|Post-Randomization Period|Lost to Follow-up|4|||
161660470|NCT01160289|583806831|FG000|Post-Randomization Period|Physician Decision|0|||
161660471|NCT01160289|583806832|FG001|Post-Randomization Period|Physician Decision|0|||
161660472|NCT01160289|583806833|FG002|Post-Randomization Period|Physician Decision|1|||
161660473|NCT01160289|583806834|FG003|Post-Randomization Period|Physician Decision|0|||
161660474|NCT01160289|583806835|FG004|Post-Randomization Period|Physician Decision|0|||
161660475|NCT01160289|583806836|FG005|Post-Randomization Period|Physician Decision|0|||
161660476|NCT01160289|583806831|FG000|Post-Randomization Period|Protocol Violation|0|||
161660477|NCT01160289|583806832|FG001|Post-Randomization Period|Protocol Violation|4|||
161660478|NCT01160289|583806833|FG002|Post-Randomization Period|Protocol Violation|2|||
161660479|NCT01160289|583806834|FG003|Post-Randomization Period|Protocol Violation|0|||
161660480|NCT01160289|583806835|FG004|Post-Randomization Period|Protocol Violation|1|||
161660481|NCT01160289|583806836|FG005|Post-Randomization Period|Protocol Violation|3|||
161660482|NCT01160289|583806831|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
161660483|NCT01160289|583806832|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
161660484|NCT01160289|583806833|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
161660485|NCT01160289|583806834|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
161660486|NCT01160289|583806835|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
161660487|NCT01160289|583806836|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
161660488|NCT01160289|583806831|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
161660489|NCT01160289|583806832|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
161660490|NCT01160289|583806833|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
161660491|NCT01160289|583806834|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
161660492|NCT01160289|583806835|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
161660493|NCT01160289|583806836|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
161660494|NCT01160289|583806831|FG000|Post-Randomization Period|Sponsor Decision|0|||
161660495|NCT01160289|583806832|FG001|Post-Randomization Period|Sponsor Decision|1|||
161660496|NCT01160289|583806833|FG002|Post-Randomization Period|Sponsor Decision|0|||
161660497|NCT01160289|583806834|FG003|Post-Randomization Period|Sponsor Decision|0|||
161660498|NCT01160289|583806835|FG004|Post-Randomization Period|Sponsor Decision|0|||
161660499|NCT01160289|583806836|FG005|Post-Randomization Period|Sponsor Decision|0|||
161660500|NCT01156792|583806841|FG000|Overall Study|Adverse Event|1|||
161660501|NCT01156792|583806841|FG000|Overall Study|Lack of Efficacy|36|||
161660502|NCT01156792|583806841|FG000|Overall Study|Protocol Violation|6|||
161660503|NCT01156792|583806841|FG000|Overall Study|Lost to Follow-up|3|||
161710769|NCT01967225|583984183|FG001|Overall Study|Withdrawal by Subject|1|||
161710770|NCT01967225|583984182|FG000|Overall Study|Lack of Efficacy|1|||
161710771|NCT01967225|583984183|FG001|Overall Study|Lack of Efficacy|1|||
161710772|NCT01967225|583984182|FG000|Overall Study|Switching to other therapy|2|||
161710773|NCT01967225|583984183|FG001|Overall Study|Switching to other therapy|0|||
161710774|NCT01967225|583984182|FG000|Overall Study|Protocol driven decision point|1|||
161710775|NCT01967225|583984183|FG001|Overall Study|Protocol driven decision point|0|||
161710776|NCT01967225|583984182|FG000|Overall Study|Logistical difficulties|1|||
161710777|NCT01967225|583984183|FG001|Overall Study|Logistical difficulties|0|||
161710778|NCT01967225|583984182|FG000|Overall Study|Protocol Violation|2|||
161710779|NCT01967225|583984183|FG001|Overall Study|Protocol Violation|0|||
161660504|NCT01156792|583806841|FG000|Overall Study|Physician Decision|3|||
161710780|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
161660505|NCT01156792|583806841|FG000|Overall Study|Withdrawal by Subject|9|||
161660506|NCT01156792|583806841|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
161660507|NCT00768079|583806842|FG000|Overall Study|Lost to Follow-up|2|||
161660508|NCT00768079|583806843|FG001|Overall Study|Lost to Follow-up|0|||
161660509|NCT00768079|583806844|FG002|Overall Study|Lost to Follow-up|4|||
161660510|NCT00768079|583806842|FG000|Overall Study|Participant incarcerated|0|||
161660511|NCT00768079|583806843|FG001|Overall Study|Participant incarcerated|1|||
161660512|NCT00768079|583806844|FG002|Overall Study|Participant incarcerated|0|||
161660513|NCT03271021|583806845|FG000|Overall Study|Adverse Event|3|||
161660514|NCT03271021|583806846|FG001|Overall Study|Adverse Event|2|||
161660515|NCT03271021|583806845|FG000|Overall Study|Withdrawal by Subject|36|||
161660516|NCT03271021|583806846|FG001|Overall Study|Withdrawal by Subject|53|||
161660517|NCT03271021|583806845|FG000|Overall Study|Lost to Follow-up|34|||
161660518|NCT03271021|583806846|FG001|Overall Study|Lost to Follow-up|39|||
161660519|NCT03271021|583806845|FG000|Overall Study|Protocol Violation|6|||
161660520|NCT03271021|583806846|FG001|Overall Study|Protocol Violation|4|||
161660521|NCT03271021|583806845|FG000|Overall Study|Abnormal Lab Results|1|||
161660522|NCT03271021|583806846|FG001|Overall Study|Abnormal Lab Results|0|||
161660523|NCT03271021|583806845|FG000|Overall Study|Miscellaneous|9|||
161660524|NCT03271021|583806846|FG001|Overall Study|Miscellaneous|8|||
161660525|NCT01474434|583806847|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
161660526|NCT01474434|583806848|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
161660527|NCT01474434|583806849|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
161660528|NCT01474434|583806850|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
161660529|NCT01474434|583806847|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
161660530|NCT01474434|583806848|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
161660531|NCT01474434|583806849|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
161660532|NCT01474434|583806850|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
161660533|NCT01474434|583806847|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
161660534|NCT01474434|583806848|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
161660535|NCT01474434|583806849|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
161660536|NCT01474434|583806850|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
161660537|NCT00993668|583806853|FG000|Single-Blind Period|Adverse Event|1|||
161660538|NCT00993668|583806854|FG001|Single-Blind Period|Adverse Event|1|||
161660539|NCT00993668|583806853|FG000|Single-Blind Period|Lack of Efficacy|0|||
161660540|NCT00993668|583806854|FG001|Single-Blind Period|Lack of Efficacy|1|||
161660541|NCT00993668|583806853|FG000|Single-Blind Period|Lost to Follow-up|3|||
161660542|NCT00993668|583806854|FG001|Single-Blind Period|Lost to Follow-up|1|||
161660543|NCT00993668|583806853|FG000|Open-Label Period|Adverse Event|9|||
161660544|NCT00993668|583806854|FG001|Open-Label Period|Adverse Event|8|||
161660545|NCT00993668|583806853|FG000|Open-Label Period|Lack of Efficacy|4|||
161660546|NCT00993668|583806854|FG001|Open-Label Period|Lack of Efficacy|3|||
161660547|NCT00993668|583806853|FG000|Open-Label Period|Withdrawal by Subject|4|||
161660548|NCT00993668|583806854|FG001|Open-Label Period|Withdrawal by Subject|3|||
161660549|NCT00993668|583806853|FG000|Open-Label Period|Lost to Follow-up|6|||
161660550|NCT00993668|583806854|FG001|Open-Label Period|Lost to Follow-up|1|||
161660551|NCT02207569|583806855|FG000|1-Month|Death|6|||
161660552|NCT02207569|583806855|FG000|1-Month|Withdrawal by Subject|2|||
161660553|NCT02207569|583806855|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
161660554|NCT02207569|583806855|FG000|6-Month|Death|8|||
161710781|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
161710782|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
161710783|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
161710784|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
161710785|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
161710786|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
161660555|NCT02207569|583806855|FG000|6-Month|Withdrawal by Subject|2|||
161660556|NCT02207569|583806855|FG000|12-Month|Death|14|||
161660557|NCT02207569|583806855|FG000|12-Month|Withdrawal by Subject|2|||
161660558|NCT02207569|583806855|FG000|24-Month|Death|23|||
161660559|NCT02207569|583806855|FG000|24-Month|Withdrawal by Subject|3|||
161660560|NCT02207569|583806855|FG000|36-Month|Death|23|||
161660561|NCT02207569|583806855|FG000|36-Month|Withdrawal by Subject|4|||
161660562|NCT02207569|583806855|FG000|48-Month|Death|25|||
161660563|NCT02207569|583806855|FG000|48-Month|Withdrawal by Subject|2|||
161660564|NCT02207569|583806855|FG000|48-Month|Lost to Follow-up|4|||
161660565|NCT02207569|583806855|FG000|60-Month|Death|1|||
161660566|NCT02207569|583806855|FG000|60-Month|Lost to Follow-up|1|||
161660567|NCT02207569|583806855|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
161660568|NCT02207569|583806855|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
161660569|NCT02585232|583806858|FG000|Overall Study|Lost to Follow-up|8|||
161660570|NCT02585232|583806859|FG001|Overall Study|Lost to Follow-up|8|||
161660571|NCT02585232|583806858|FG000|Overall Study|Withdrawal by Subject|4|||
161660572|NCT02585232|583806859|FG001|Overall Study|Withdrawal by Subject|8|||
161660573|NCT02313233|583806863|FG000|Overall Study|Withdrawal by Subject|1|||
161660574|NCT02313233|583806864|FG001|Overall Study|Withdrawal by Subject|2|||
161660575|NCT02313233|583806863|FG000|Overall Study|Administrative reason|1|||
161660576|NCT02313233|583806864|FG001|Overall Study|Administrative reason|1|||
161660577|NCT02095951|583806865|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
161660578|NCT02095951|583806866|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
161660579|NCT03618823|583806867|FG000|Overall Study|Lost to Follow-up|63|||
161660580|NCT03618823|583806868|FG001|Overall Study|Lost to Follow-up|61|||
161660581|NCT05383508|583806869|FG000|Overall Study|Withdrawal by Subject|1|||
161660582|NCT05383508|583806870|FG001|Overall Study|Withdrawal by Subject|0|||
161660583|NCT05383508|583806871|FG002|Overall Study|Withdrawal by Subject|1|||
161660584|NCT05383508|583806872|FG003|Overall Study|Withdrawal by Subject|1|||
161660585|NCT05383508|583806873|FG004|Overall Study|Withdrawal by Subject|2|||
161660586|NCT05383508|583806874|FG005|Overall Study|Withdrawal by Subject|0|||
161660587|NCT01621568|583806876|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
161660588|NCT01621568|583806877|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
161660589|NCT01621568|583806876|FG000|Week 5-6 No Treatment|Death|1|||
161660590|NCT01621568|583806877|FG001|Week 5-6 No Treatment|Death|0|||
161660591|NCT01859988|583806878|FG000|Overall Study|Withdrawal by Subject|6|||
161660592|NCT01859988|583806879|FG001|Overall Study|Withdrawal by Subject|3|||
161660593|NCT01859988|583806880|FG002|Overall Study|Withdrawal by Subject|4|||
161660594|NCT01859988|583806881|FG003|Overall Study|Withdrawal by Subject|3|||
161660595|NCT01859988|583806882|FG004|Overall Study|Withdrawal by Subject|2|||
161660596|NCT01859988|583806883|FG005|Overall Study|Withdrawal by Subject|2|||
161660597|NCT01859988|583806878|FG000|Overall Study|Lack of Efficacy|1|||
161660598|NCT01859988|583806879|FG001|Overall Study|Lack of Efficacy|1|||
161660599|NCT01859988|583806880|FG002|Overall Study|Lack of Efficacy|5|||
161660600|NCT01859988|583806881|FG003|Overall Study|Lack of Efficacy|0|||
161660601|NCT01859988|583806882|FG004|Overall Study|Lack of Efficacy|7|||
161660602|NCT01859988|583806883|FG005|Overall Study|Lack of Efficacy|9|||
161660603|NCT01859988|583806878|FG000|Overall Study|Physician Decision|1|||
161660604|NCT01859988|583806879|FG001|Overall Study|Physician Decision|3|||
161660605|NCT01859988|583806880|FG002|Overall Study|Physician Decision|1|||
161660606|NCT01859988|583806881|FG003|Overall Study|Physician Decision|3|||
161660607|NCT01859988|583806882|FG004|Overall Study|Physician Decision|4|||
161660608|NCT01859988|583806883|FG005|Overall Study|Physician Decision|1|||
161660609|NCT01859988|583806878|FG000|Overall Study|Adverse Event|2|||
161660610|NCT01859988|583806879|FG001|Overall Study|Adverse Event|1|||
161660611|NCT01859988|583806880|FG002|Overall Study|Adverse Event|3|||
161660612|NCT01859988|583806881|FG003|Overall Study|Adverse Event|1|||
161660613|NCT01859988|583806882|FG004|Overall Study|Adverse Event|2|||
161710787|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
161710788|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
161710789|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
161710790|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
161710791|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
161710792|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
161710793|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
161710794|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
161710795|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
161710796|NCT01658514|583984187|FG000|Overall Study|Protocol Violation|1|||
161710797|NCT01658514|583984188|FG001|Overall Study|Protocol Violation|0|||
161710798|NCT01658514|583984189|FG002|Overall Study|Protocol Violation|2|||
161710799|NCT00144170|583984191|FG000|Overall Study|Adverse Event|84|||
161710800|NCT00144170|583984192|FG001|Overall Study|Adverse Event|41|||
161710801|NCT00144170|583984191|FG000|Overall Study|Protocol Violation|23|||
161710802|NCT00144170|583984192|FG001|Overall Study|Protocol Violation|16|||
161710803|NCT00144170|583984191|FG000|Overall Study|Lost to Follow-up|5|||
161710804|NCT00144170|583984192|FG001|Overall Study|Lost to Follow-up|10|||
161710805|NCT00144170|583984191|FG000|Overall Study|Withdrawal by Subject|29|||
161710806|NCT00144170|583984192|FG001|Overall Study|Withdrawal by Subject|13|||
161710807|NCT00144170|583984191|FG000|Overall Study|Other reason not defined above|211|||
161710808|NCT00144170|583984192|FG001|Overall Study|Other reason not defined above|316|||
161710809|NCT00981526|583984193|FG000|Overall Study|Withdrawal by Subject|0|||
161710810|NCT00981526|583984194|FG001|Overall Study|Withdrawal by Subject|2|||
161710811|NCT00981526|583984193|FG000|Overall Study|Physician Decision|4|||
161710812|NCT00981526|583984194|FG001|Overall Study|Physician Decision|4|||
161710813|NCT00332202|583984195|FG000|Overall Study|Adverse Event|72|||
161710814|NCT00332202|583984196|FG001|Overall Study|Adverse Event|28|||
161710815|NCT00332202|583984195|FG000|Overall Study|Lost to Follow-up|2|||
161710816|NCT00332202|583984196|FG001|Overall Study|Lost to Follow-up|1|||
161710817|NCT00332202|583984195|FG000|Overall Study|Physician Decision|6|||
161710818|NCT00332202|583984196|FG001|Overall Study|Physician Decision|8|||
161710819|NCT00332202|583984195|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
161710820|NCT00332202|583984196|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
161710821|NCT00332202|583984195|FG000|Overall Study|Protocol Violation|7|||
161710822|NCT00332202|583984196|FG001|Overall Study|Protocol Violation|2|||
161710823|NCT00332202|583984195|FG000|Overall Study|Sponsor Decision|1|||
161710824|NCT00332202|583984196|FG001|Overall Study|Sponsor Decision|2|||
161710825|NCT00332202|583984195|FG000|Overall Study|Withdrawal by Subject|36|||
161710826|NCT00332202|583984196|FG001|Overall Study|Withdrawal by Subject|17|||
161710827|NCT00332202|583984195|FG000|Overall Study|Progressive Disease|106|||
161710828|NCT00332202|583984196|FG001|Overall Study|Progressive Disease|60|||
161710829|NCT00332202|583984195|FG000|Overall Study|Death|5|||
161710830|NCT00332202|583984196|FG001|Overall Study|Death|2|||
161710831|NCT00957853|583984197|FG000|Overall Study|Withdrawal by Subject|1|||
161710832|NCT00957853|583984198|FG001|Overall Study|Withdrawal by Subject|0|||
161710833|NCT00957853|583984199|FG002|Overall Study|Withdrawal by Subject|0|||
161710834|NCT02370121|583984200|FG000|Overall Study|Lost to Follow-up|1|||
161710835|NCT02370121|583984201|FG001|Overall Study|Lost to Follow-up|1|||
161710836|NCT02654002|583984208|FG000|Overall Study|Adverse Event|0|||
161710837|NCT02654002|583984209|FG001|Overall Study|Adverse Event|0|||
161710838|NCT02654002|583984210|FG002|Overall Study|Adverse Event|0|||
161710839|NCT02654002|583984211|FG003|Overall Study|Adverse Event|0|||
161660614|NCT01859988|583806883|FG005|Overall Study|Adverse Event|2|||
161660615|NCT01859988|583806878|FG000|Overall Study|Lost to Follow-up|1|||
161660616|NCT01859988|583806879|FG001|Overall Study|Lost to Follow-up|2|||
161660617|NCT01859988|583806880|FG002|Overall Study|Lost to Follow-up|3|||
161660618|NCT01859988|583806881|FG003|Overall Study|Lost to Follow-up|0|||
161660619|NCT01859988|583806882|FG004|Overall Study|Lost to Follow-up|3|||
161660620|NCT01859988|583806883|FG005|Overall Study|Lost to Follow-up|2|||
161660621|NCT01859988|583806878|FG000|Overall Study|Protocol Violation|0|||
161660622|NCT01859988|583806879|FG001|Overall Study|Protocol Violation|0|||
161660623|NCT01859988|583806880|FG002|Overall Study|Protocol Violation|1|||
161660624|NCT01859988|583806881|FG003|Overall Study|Protocol Violation|0|||
161710840|NCT02654002|583984212|FG004|Overall Study|Adverse Event|0|||
161710841|NCT02654002|583984213|FG005|Overall Study|Adverse Event|0|||
161710842|NCT02654002|583984214|FG006|Overall Study|Adverse Event|1|||
161710843|NCT02654002|583984215|FG007|Overall Study|Adverse Event|0|||
161710844|NCT02654002|583984216|FG008|Overall Study|Adverse Event|0|||
161710845|NCT02654002|583984208|FG000|Overall Study|Withdrew Consent|0|||
161710846|NCT02654002|583984209|FG001|Overall Study|Withdrew Consent|0|||
161660625|NCT01859988|583806882|FG004|Overall Study|Protocol Violation|0|||
161660626|NCT01859988|583806883|FG005|Overall Study|Protocol Violation|0|||
161660627|NCT01859988|583806878|FG000|Overall Study|Other than specified above|0|||
161660628|NCT01859988|583806879|FG001|Overall Study|Other than specified above|2|||
161660629|NCT01859988|583806880|FG002|Overall Study|Other than specified above|11|||
161660630|NCT01859988|583806881|FG003|Overall Study|Other than specified above|3|||
161660631|NCT01859988|583806882|FG004|Overall Study|Other than specified above|5|||
161660632|NCT01859988|583806883|FG005|Overall Study|Other than specified above|3|||
161660633|NCT02930226|583806884|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
161660634|NCT02930226|583806885|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
161660635|NCT02930226|583806886|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
161660636|NCT02930226|583806887|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
161660637|NCT02930226|583806888|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
161660638|NCT02930226|583806889|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
161660639|NCT00652327|583806890|FG000|Overall Study|Adverse Event|0|||
161660640|NCT00652327|583806891|FG001|Overall Study|Adverse Event|2|||
161660641|NCT00652327|583806890|FG000|Overall Study|Lost to Follow-up|0|||
161660642|NCT00652327|583806891|FG001|Overall Study|Lost to Follow-up|3|||
161660643|NCT00564889|583806893|FG000|Overall Study|Death|7|||
161660644|NCT00564889|583806893|FG000|Overall Study|Adverse Event|12|||
161660645|NCT00564889|583806893|FG000|Overall Study|Alternative treatment|3|||
161660646|NCT00564889|583806893|FG000|Overall Study|Disease progression|3|||
161660647|NCT00564889|583806893|FG000|Overall Study|Other, not specified|4|||
161710847|NCT02654002|583984210|FG002|Overall Study|Withdrew Consent|0|||
161710848|NCT02654002|583984211|FG003|Overall Study|Withdrew Consent|0|||
161710849|NCT02654002|583984212|FG004|Overall Study|Withdrew Consent|0|||
161710850|NCT02654002|583984213|FG005|Overall Study|Withdrew Consent|1|||
161710851|NCT02654002|583984214|FG006|Overall Study|Withdrew Consent|0|||
161710852|NCT02654002|583984215|FG007|Overall Study|Withdrew Consent|1|||
161710853|NCT02654002|583984216|FG008|Overall Study|Withdrew Consent|0|||
161710854|NCT05262764|583984217|FG000|Overall Study|Case report form not collected|9|||
161710855|NCT05262764|583984217|FG000|Overall Study|No patient visits after entry|23|||
161710856|NCT05262764|583984217|FG000|Overall Study|Registration rule not followed|2|||
161710857|NCT05262764|583984217|FG000|Overall Study|Patient of non-chronic heart failure|1|||
161710858|NCT01392183|583984218|FG000|First Drug Administration|Adverse Event|3|||
161710859|NCT01392183|583984219|FG001|First Drug Administration|Adverse Event|2|||
161710860|NCT01392183|583984218|FG000|First Drug Administration|Death|1|||
161710861|NCT01392183|583984219|FG001|First Drug Administration|Death|0|||
161710862|NCT01392183|583984218|FG000|First Drug Administration|Withdrawal by Subject|10|||
161710863|NCT01392183|583984219|FG001|First Drug Administration|Withdrawal by Subject|17|||
161710864|NCT00963807|583984222|FG000|Overall Study|Physician Decision|2|||
161710865|NCT00963807|583984222|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
161710866|NCT00963807|583984222|FG000|Overall Study|Disease progression|15|||
161660648|NCT00635427|583806894|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161710867|NCT00684177|583984225|FG000|Overall Study|Adverse Event|4|||
161710868|NCT00684177|583984226|FG001|Overall Study|Adverse Event|3|||
161710869|NCT00684177|583984225|FG000|Overall Study|Lack of Efficacy|10|||
161710870|NCT00684177|583984226|FG001|Overall Study|Lack of Efficacy|15|||
161710871|NCT00684177|583984225|FG000|Overall Study|Protocol Violation|1|||
161710872|NCT00684177|583984226|FG001|Overall Study|Protocol Violation|0|||
161710873|NCT00684177|583984225|FG000|Overall Study|Lost to Follow-up|2|||
161660649|NCT00635427|583806895|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161660650|NCT00635427|583806896|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
161660651|NCT00635427|583806897|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161660652|NCT00635427|583806898|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161660653|NCT00635427|583806894|FG000|Overall Study|Death|0|||
161660654|NCT00635427|583806895|FG001|Overall Study|Death|0|||
161660655|NCT00635427|583806896|FG002|Overall Study|Death|0|||
161660656|NCT00635427|583806897|FG003|Overall Study|Death|1|||
161660657|NCT00635427|583806898|FG004|Overall Study|Death|0|||
161660658|NCT00635427|583806894|FG000|Overall Study|Termination Of Study By Sponsor|12|||
161660659|NCT00635427|583806895|FG001|Overall Study|Termination Of Study By Sponsor|6|||
161660660|NCT00635427|583806896|FG002|Overall Study|Termination Of Study By Sponsor|10|||
161660661|NCT00635427|583806897|FG003|Overall Study|Termination Of Study By Sponsor|6|||
161660662|NCT00635427|583806898|FG004|Overall Study|Termination Of Study By Sponsor|6|||
161660663|NCT00635427|583806894|FG000|Overall Study|Withdrawal Of Consent|0|||
161660664|NCT00635427|583806895|FG001|Overall Study|Withdrawal Of Consent|0|||
161660665|NCT00635427|583806896|FG002|Overall Study|Withdrawal Of Consent|0|||
161660666|NCT00635427|583806897|FG003|Overall Study|Withdrawal Of Consent|2|||
161660667|NCT00635427|583806898|FG004|Overall Study|Withdrawal Of Consent|2|||
161660668|NCT01506609|583806907|FG000|Overall Study|Adverse Event Related to Progression|0|||
161660669|NCT01506609|583806908|FG001|Overall Study|Adverse Event Related to Progression|0|||
161660670|NCT01506609|583806909|FG002|Overall Study|Adverse Event Related to Progression|0|||
161660671|NCT01506609|583806910|FG003|Overall Study|Adverse Event Related to Progression|3|||
161660672|NCT01506609|583806911|FG004|Overall Study|Adverse Event Related to Progression|7|||
161660673|NCT01506609|583806912|FG005|Overall Study|Adverse Event Related to Progression|3|||
161660674|NCT01506609|583806907|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
161660675|NCT01506609|583806908|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
161660676|NCT01506609|583806909|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
161660677|NCT01506609|583806910|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
161660678|NCT01506609|583806911|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
161660679|NCT01506609|583806912|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
161660680|NCT01506609|583806907|FG000|Overall Study|Withdrawal by Subject|0|||
161660681|NCT01506609|583806908|FG001|Overall Study|Withdrawal by Subject|0|||
161660682|NCT01506609|583806909|FG002|Overall Study|Withdrawal by Subject|0|||
161660683|NCT01506609|583806910|FG003|Overall Study|Withdrawal by Subject|9|||
161660684|NCT01506609|583806911|FG004|Overall Study|Withdrawal by Subject|7|||
161660685|NCT01506609|583806912|FG005|Overall Study|Withdrawal by Subject|7|||
161660686|NCT01506609|583806907|FG000|Overall Study|Lost to Follow-up|0|||
161660687|NCT01506609|583806908|FG001|Overall Study|Lost to Follow-up|0|||
161660688|NCT01506609|583806909|FG002|Overall Study|Lost to Follow-up|0|||
161660689|NCT01506609|583806910|FG003|Overall Study|Lost to Follow-up|1|||
161660690|NCT01506609|583806911|FG004|Overall Study|Lost to Follow-up|2|||
161660691|NCT01506609|583806912|FG005|Overall Study|Lost to Follow-up|0|||
161660692|NCT01506609|583806907|FG000|Overall Study|Sponsor Discontinued Study|0|||
161660693|NCT01506609|583806908|FG001|Overall Study|Sponsor Discontinued Study|0|||
161660694|NCT01506609|583806909|FG002|Overall Study|Sponsor Discontinued Study|0|||
161660695|NCT01506609|583806910|FG003|Overall Study|Sponsor Discontinued Study|2|||
161660696|NCT01506609|583806911|FG004|Overall Study|Sponsor Discontinued Study|2|||
161660697|NCT01506609|583806912|FG005|Overall Study|Sponsor Discontinued Study|0|||
161660698|NCT01506609|583806907|FG000|Overall Study|Progressive Disease per Protocol|1|||
161660699|NCT01506609|583806908|FG001|Overall Study|Progressive Disease per Protocol|0|||
161660700|NCT01506609|583806909|FG002|Overall Study|Progressive Disease per Protocol|0|||
161660701|NCT01506609|583806910|FG003|Overall Study|Progressive Disease per Protocol|64|||
161660702|NCT01506609|583806911|FG004|Overall Study|Progressive Disease per Protocol|57|||
161660703|NCT01506609|583806912|FG005|Overall Study|Progressive Disease per Protocol|74|||
161660704|NCT01506609|583806907|FG000|Overall Study|Other, Not Specified|0|||
161660705|NCT01506609|583806908|FG001|Overall Study|Other, Not Specified|0|||
161660706|NCT01506609|583806909|FG002|Overall Study|Other, Not Specified|0|||
161660707|NCT01506609|583806910|FG003|Overall Study|Other, Not Specified|10|||
161660708|NCT01506609|583806911|FG004|Overall Study|Other, Not Specified|7|||
161660709|NCT01506609|583806912|FG005|Overall Study|Other, Not Specified|3|||
161660710|NCT01506609|583806907|FG000|Overall Study|Missing / Unknown Reason|1|||
161660711|NCT01506609|583806908|FG001|Overall Study|Missing / Unknown Reason|0|||
161660712|NCT01506609|583806909|FG002|Overall Study|Missing / Unknown Reason|1|||
161660713|NCT01506609|583806910|FG003|Overall Study|Missing / Unknown Reason|4|||
161660714|NCT01506609|583806911|FG004|Overall Study|Missing / Unknown Reason|4|||
161660715|NCT01506609|583806912|FG005|Overall Study|Missing / Unknown Reason|2|||
161660716|NCT00577473|583806917|FG000|Overall Study|Protocol Violation|1|||
161660717|NCT00577473|583806918|FG001|Overall Study|Protocol Violation|4|||
161660718|NCT00577473|583806917|FG000|Overall Study|Adverse Event|8|||
161660719|NCT00577473|583806918|FG001|Overall Study|Adverse Event|5|||
161660720|NCT00577473|583806917|FG000|Overall Study|Withdrawal by Subject|2|||
161660721|NCT00577473|583806918|FG001|Overall Study|Withdrawal by Subject|6|||
161660722|NCT00577473|583806917|FG000|Overall Study|Physician Decision|2|||
161660723|NCT00577473|583806918|FG001|Overall Study|Physician Decision|2|||
161660724|NCT00577473|583806917|FG000|Overall Study|Lack of Efficacy|8|||
161660725|NCT00577473|583806918|FG001|Overall Study|Lack of Efficacy|7|||
161660726|NCT02595073|583806921|FG000|Overall Study|Progressive Disease|0|||
161660727|NCT02595073|583806922|FG001|Overall Study|Progressive Disease|1|||
161660728|NCT02595073|583806921|FG000|Overall Study|Protocol Violation|2|||
161660729|NCT02595073|583806922|FG001|Overall Study|Protocol Violation|0|||
161660730|NCT01990560|583806925|FG000|Overall Study|Withdrawal by Subject|1|||
161660731|NCT01324440|583806926|FG000|Overall Study|Subject moved|0|||
161660732|NCT01324440|583806927|FG001|Overall Study|Subject moved|1|||
161660733|NCT02884908|583806933|FG000|Overall Study|Lost to Follow-up|13|||
161660734|NCT02884908|583806934|FG001|Overall Study|Lost to Follow-up|18|||
161660735|NCT01293487|583806938|FG000|Overall Study|Lost to Follow-up|0|||
161660736|NCT01293487|583806939|FG001|Overall Study|Lost to Follow-up|0|||
161660737|NCT01293487|583806940|FG002|Overall Study|Lost to Follow-up|0|||
161660738|NCT01293487|583806941|FG003|Overall Study|Lost to Follow-up|1|||
161660739|NCT01293487|583806942|FG004|Overall Study|Lost to Follow-up|0|||
161660740|NCT01293487|583806943|FG005|Overall Study|Lost to Follow-up|0|||
161660741|NCT01293487|583806944|FG006|Overall Study|Lost to Follow-up|0|||
161660742|NCT01293487|583806945|FG007|Overall Study|Lost to Follow-up|0|||
161660743|NCT01293487|583806938|FG000|Overall Study|Withdrawal by Subject|0|||
161660744|NCT01293487|583806939|FG001|Overall Study|Withdrawal by Subject|0|||
161660745|NCT01293487|583806940|FG002|Overall Study|Withdrawal by Subject|0|||
161660746|NCT01293487|583806941|FG003|Overall Study|Withdrawal by Subject|0|||
161660747|NCT01293487|583806942|FG004|Overall Study|Withdrawal by Subject|0|||
161660748|NCT01293487|583806943|FG005|Overall Study|Withdrawal by Subject|0|||
161660749|NCT01293487|583806944|FG006|Overall Study|Withdrawal by Subject|0|||
161660750|NCT01293487|583806945|FG007|Overall Study|Withdrawal by Subject|2|||
161660751|NCT04860297|583806946|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
161660752|NCT04860297|583806947|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
161660753|NCT04860297|583806948|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
161660754|NCT04860297|583806949|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
161660755|NCT04860297|583806950|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
161660756|NCT04860297|583806951|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
161660757|NCT04860297|583806952|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
161660758|NCT04860297|583806953|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
161660759|NCT04860297|583806946|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
161660760|NCT04860297|583806947|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
161660761|NCT04860297|583806948|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
161660762|NCT04860297|583806949|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
161660763|NCT04860297|583806950|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
161660764|NCT04860297|583806951|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
161660765|NCT04860297|583806952|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
161660766|NCT04860297|583806953|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
161660767|NCT04860297|583806946|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
161660768|NCT04860297|583806947|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
161660769|NCT04860297|583806948|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
161660770|NCT04860297|583806949|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
161660771|NCT04860297|583806950|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
161660772|NCT04860297|583806951|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
161660773|NCT04860297|583806952|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
161660774|NCT04860297|583806953|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
161660775|NCT04860297|583806946|FG000|Part B (Booster Dose)|Other Than Specified|0|||
161660776|NCT04860297|583806947|FG001|Part B (Booster Dose)|Other Than Specified|0|||
161660777|NCT04860297|583806948|FG002|Part B (Booster Dose)|Other Than Specified|0|||
161660778|NCT04860297|583806949|FG003|Part B (Booster Dose)|Other Than Specified|0|||
161660779|NCT04860297|583806950|FG004|Part B (Booster Dose)|Other Than Specified|0|||
161660780|NCT04860297|583806951|FG005|Part B (Booster Dose)|Other Than Specified|1|||
161660781|NCT04860297|583806952|FG006|Part B (Booster Dose)|Other Than Specified|1|||
161660782|NCT04860297|583806953|FG007|Part B (Booster Dose)|Other Than Specified|0|||
161660783|NCT04860297|583806946|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
161660784|NCT04860297|583806947|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
161660785|NCT04860297|583806948|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
161660786|NCT04860297|583806949|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
161660787|NCT04860297|583806950|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
161660788|NCT04860297|583806951|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
161660789|NCT04860297|583806952|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
161660790|NCT04860297|583806953|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
161660791|NCT04860297|583806946|FG000|Part B (Booster Dose)|Death|0|||
161660792|NCT04860297|583806947|FG001|Part B (Booster Dose)|Death|0|||
161660793|NCT04860297|583806948|FG002|Part B (Booster Dose)|Death|0|||
161660794|NCT04860297|583806949|FG003|Part B (Booster Dose)|Death|0|||
161660795|NCT04860297|583806950|FG004|Part B (Booster Dose)|Death|1|||
161660796|NCT04860297|583806951|FG005|Part B (Booster Dose)|Death|2|||
161660797|NCT04860297|583806952|FG006|Part B (Booster Dose)|Death|1|||
161660798|NCT04860297|583806953|FG007|Part B (Booster Dose)|Death|0|||
161660799|NCT04860297|583806946|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
161660800|NCT04860297|583806947|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
161660801|NCT04860297|583806948|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
161660802|NCT04860297|583806949|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
161660803|NCT04860297|583806950|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
161660804|NCT04860297|583806951|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
161660805|NCT04860297|583806952|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
161660806|NCT04860297|583806953|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
161660807|NCT00468559|583806957|FG000|Open-label Treatment Phase|Adverse Event|5|||
161660808|NCT00468559|583806958|FG001|Open-label Treatment Phase|Adverse Event|0|||
161660809|NCT00468559|583806959|FG002|Open-label Treatment Phase|Adverse Event|0|||
161660810|NCT00468559|583806957|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
161660811|NCT00468559|583806958|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
161660812|NCT00468559|583806959|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
161660813|NCT00468559|583806957|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
161660814|NCT00468559|583806958|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161660815|NCT00468559|583806959|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
161660816|NCT00468559|583806957|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
161660817|NCT00468559|583806958|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
161660818|NCT00468559|583806959|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
161660819|NCT00468559|583806957|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
161660820|NCT00468559|583806958|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
161660821|NCT00468559|583806959|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
161660822|NCT00862719|583806960|FG000|Overall Study|Disease Progression|5|||
161660823|NCT00862719|583806961|FG001|Overall Study|Disease Progression|0|||
161660824|NCT00862719|583806962|FG002|Overall Study|Disease Progression|1|||
161660825|NCT00862719|583806963|FG003|Overall Study|Disease Progression|0|||
161660826|NCT00862719|583806960|FG000|Overall Study|Death|5|||
161660827|NCT00862719|583806961|FG001|Overall Study|Death|6|||
161660828|NCT00862719|583806962|FG002|Overall Study|Death|1|||
161660829|NCT00862719|583806963|FG003|Overall Study|Death|1|||
161660830|NCT00862719|583806960|FG000|Overall Study|Engraftment failure|0|||
161660831|NCT00862719|583806961|FG001|Overall Study|Engraftment failure|0|||
161660832|NCT00862719|583806962|FG002|Overall Study|Engraftment failure|1|||
161660833|NCT00862719|583806963|FG003|Overall Study|Engraftment failure|0|||
161660834|NCT00862719|583806960|FG000|Overall Study|Veno-Occlusive Disease|0|||
161660835|NCT00862719|583806961|FG001|Overall Study|Veno-Occlusive Disease|0|||
161660836|NCT00862719|583806962|FG002|Overall Study|Veno-Occlusive Disease|1|||
161660837|NCT00862719|583806963|FG003|Overall Study|Veno-Occlusive Disease|0|||
161660838|NCT01153958|583806964|FG000|Overall Study|Study Terminated|36|||
161660839|NCT01153958|583806965|FG001|Overall Study|Study Terminated|32|||
161660840|NCT00925353|583806966|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
161660841|NCT03647488|583808657|FG000|Overall Study|Progressive disease|10|||
161660842|NCT03647488|583808658|FG001|Overall Study|Progressive disease|0|||
161660843|NCT03647488|583808659|FG002|Overall Study|Progressive disease|0|||
161660844|NCT03647488|583808657|FG000|Overall Study|Adverse Event|5|||
161660845|NCT03647488|583808658|FG001|Overall Study|Adverse Event|0|||
161660846|NCT03647488|583808659|FG002|Overall Study|Adverse Event|0|||
161660847|NCT03647488|583808657|FG000|Overall Study|Clinical progression|2|||
161660848|NCT03647488|583808658|FG001|Overall Study|Clinical progression|0|||
161660849|NCT03647488|583808659|FG002|Overall Study|Clinical progression|0|||
161660850|NCT03647488|583808657|FG000|Overall Study|Participant refused to take investigational product|1|||
161660851|NCT03647488|583808658|FG001|Overall Study|Participant refused to take investigational product|0|||
161660852|NCT03647488|583808659|FG002|Overall Study|Participant refused to take investigational product|0|||
161660853|NCT00812331|583808660|FG000|Overall Study|Adverse Event|1|||
161660854|NCT00812331|583808661|FG001|Overall Study|Adverse Event|0|||
161660855|NCT00812331|583808662|FG002|Overall Study|Adverse Event|0|||
161660856|NCT00812331|583808663|FG003|Overall Study|Adverse Event|0|||
161660857|NCT00812331|583808664|FG004|Overall Study|Adverse Event|0|||
161660858|NCT02502799|583808665|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
161660859|NCT02502799|583808666|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
161660860|NCT02502799|583808667|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
161660861|NCT02502799|583808668|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
161660862|NCT02502799|583808665|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
161660863|NCT02502799|583808666|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
161660864|NCT02502799|583808667|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
161660865|NCT02502799|583808668|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
161660866|NCT02502799|583808665|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
161660867|NCT02502799|583808666|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
161660868|NCT02502799|583808667|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
161660869|NCT02502799|583808668|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
161660870|NCT02502799|583808665|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
161660871|NCT02502799|583808666|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
161660872|NCT02502799|583808667|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
161660873|NCT02502799|583808668|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
161660874|NCT02502799|583808665|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
161660875|NCT02502799|583808666|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
161660876|NCT02502799|583808667|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
161660877|NCT02502799|583808668|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
161660878|NCT00153062|583808678|FG000|Overall Study|Death|360|||
161660879|NCT00153062|583808679|FG001|Overall Study|Death|352|||
161660880|NCT00153062|583808680|FG002|Overall Study|Death|369|||
161660881|NCT00153062|583808681|FG003|Overall Study|Death|365|||
161660882|NCT00153062|583808678|FG000|Overall Study|Withdrawal by Subject|14|||
161660883|NCT00153062|583808679|FG001|Overall Study|Withdrawal by Subject|30|||
161660884|NCT00153062|583808680|FG002|Overall Study|Withdrawal by Subject|27|||
161660885|NCT00153062|583808681|FG003|Overall Study|Withdrawal by Subject|28|||
161660886|NCT00153062|583808678|FG000|Overall Study|Lost to Follow-up|12|||
161660887|NCT00153062|583808679|FG001|Overall Study|Lost to Follow-up|20|||
161660888|NCT00153062|583808680|FG002|Overall Study|Lost to Follow-up|15|||
161660889|NCT00153062|583808681|FG003|Overall Study|Lost to Follow-up|16|||
161660890|NCT00153062|583808678|FG000|Overall Study|Adverse Event|0|||
161660891|NCT00153062|583808679|FG001|Overall Study|Adverse Event|1|||
161660892|NCT00153062|583808680|FG002|Overall Study|Adverse Event|1|||
161660893|NCT00153062|583808681|FG003|Overall Study|Adverse Event|0|||
161660894|NCT00153062|583808678|FG000|Overall Study|Protocol Violation|0|||
161660895|NCT00153062|583808679|FG001|Overall Study|Protocol Violation|2|||
161660896|NCT00153062|583808680|FG002|Overall Study|Protocol Violation|1|||
161660897|NCT00153062|583808681|FG003|Overall Study|Protocol Violation|1|||
161660898|NCT00153062|583808678|FG000|Overall Study|No disposition data available|1|||
161660899|NCT00153062|583808679|FG001|Overall Study|No disposition data available|1|||
161660900|NCT00153062|583808680|FG002|Overall Study|No disposition data available|1|||
161660901|NCT00153062|583808681|FG003|Overall Study|No disposition data available|1|||
161660902|NCT00153062|583808678|FG000|Overall Study|Other|0|||
161660903|NCT00153062|583808679|FG001|Overall Study|Other|0|||
161660904|NCT00153062|583808680|FG002|Overall Study|Other|1|||
161660905|NCT00153062|583808681|FG003|Overall Study|Other|0|||
161660906|NCT02359877|583808682|FG000|Overall Study|Withdrawal by Subject|1|||
161660907|NCT02359877|583808683|FG001|Overall Study|Withdrawal by Subject|0|||
161660908|NCT02359877|583808684|FG002|Overall Study|Withdrawal by Subject|0|||
161660909|NCT02359877|583808685|FG003|Overall Study|Withdrawal by Subject|2|||
161660910|NCT02359877|583808682|FG000|Overall Study|Adverse Event|0|||
161660911|NCT02359877|583808683|FG001|Overall Study|Adverse Event|0|||
161660912|NCT02359877|583808684|FG002|Overall Study|Adverse Event|0|||
161660913|NCT02359877|583808685|FG003|Overall Study|Adverse Event|1|||
161660914|NCT01589237|583808698|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
161660915|NCT01589237|583808699|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
161660916|NCT01589237|583808700|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
161660917|NCT01589237|583808701|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
161660918|NCT01589237|583808698|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
161660919|NCT01589237|583808699|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
161660920|NCT01589237|583808700|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
161660921|NCT01589237|583808701|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
161660922|NCT01589237|583808698|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
161660923|NCT01589237|583808699|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
161660924|NCT01589237|583808700|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
161660925|NCT01589237|583808701|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
161660926|NCT01589237|583808698|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
161710874|NCT00684177|583984226|FG001|Overall Study|Lost to Follow-up|1|||
161660927|NCT01589237|583808699|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
161660928|NCT01589237|583808700|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
161660929|NCT01589237|583808701|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
161660930|NCT00117845|583808702|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
161660931|NCT00189488|583808703|FG000|Overall Study|Ineligibility determined|1|||
161660932|NCT00189488|583808704|FG001|Overall Study|Ineligibility determined|0|||
161660933|NCT00189488|583808703|FG000|Overall Study|Protocol deviation|2|||
161660934|NCT00189488|583808704|FG001|Overall Study|Protocol deviation|1|||
161660935|NCT00189488|583808703|FG000|Overall Study|Adverse Event|2|||
161660936|NCT00189488|583808704|FG001|Overall Study|Adverse Event|1|||
161660937|NCT00189488|583808703|FG000|Overall Study|Withdrawal by Subject|2|||
161660938|NCT00189488|583808704|FG001|Overall Study|Withdrawal by Subject|6|||
161660939|NCT00189488|583808703|FG000|Overall Study|Disease progression|2|||
161660940|NCT00189488|583808704|FG001|Overall Study|Disease progression|4|||
161660941|NCT00189488|583808703|FG000|Overall Study|Administrative Decision|0|||
161660942|NCT00189488|583808704|FG001|Overall Study|Administrative Decision|2|||
161660943|NCT00189488|583808703|FG000|Overall Study|Death|5|||
161660944|NCT00189488|583808704|FG001|Overall Study|Death|8|||
161660945|NCT00189488|583808703|FG000|Overall Study|Other|1|||
161660946|NCT00189488|583808704|FG001|Overall Study|Other|0|||
161660947|NCT02349425|583808705|FG000|Period 1|Adverse Event|1|||
161660948|NCT02349425|583808706|FG001|Period 1|Adverse Event|1|||
161660949|NCT02349425|583808707|FG002|Period 1|Adverse Event|0|||
161660950|NCT02349425|583808708|FG003|Period 1|Adverse Event|0|||
161660951|NCT02349425|583808705|FG000|Period 2|Adverse Event|0|||
161660952|NCT02349425|583808706|FG001|Period 2|Adverse Event|1|||
161660953|NCT02349425|583808707|FG002|Period 2|Adverse Event|1|||
161660954|NCT02349425|583808708|FG003|Period 2|Adverse Event|0|||
161660955|NCT03207009|583808709|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
161660956|NCT01491672|583808710|FG000|Overall Study|Lost to Follow-up|0|||
161660957|NCT01491672|583808711|FG001|Overall Study|Lost to Follow-up|4|||
161660958|NCT01491672|583808712|FG002|Overall Study|Lost to Follow-up|1|||
161660959|NCT01491672|583808710|FG000|Overall Study|Withdrawal by Subject|6|||
161660960|NCT01491672|583808711|FG001|Overall Study|Withdrawal by Subject|7|||
161660961|NCT01491672|583808712|FG002|Overall Study|Withdrawal by Subject|0|||
161660962|NCT01491672|583808710|FG000|Overall Study|Adverse Event|8|||
161660963|NCT01491672|583808711|FG001|Overall Study|Adverse Event|10|||
161660964|NCT01491672|583808712|FG002|Overall Study|Adverse Event|4|||
161660965|NCT01491672|583808710|FG000|Overall Study|Disease progression|42|||
161660966|NCT01491672|583808711|FG001|Overall Study|Disease progression|34|||
161660967|NCT01491672|583808712|FG002|Overall Study|Disease progression|6|||
161660968|NCT01491672|583808710|FG000|Overall Study|Protocol deviation|0|||
161660969|NCT01491672|583808711|FG001|Overall Study|Protocol deviation|1|||
161660970|NCT01491672|583808712|FG002|Overall Study|Protocol deviation|0|||
161660971|NCT01491672|583808710|FG000|Overall Study|Death|0|||
161660972|NCT01491672|583808711|FG001|Overall Study|Death|4|||
161660973|NCT01491672|583808712|FG002|Overall Study|Death|0|||
161660974|NCT01143038|583808713|FG000|Overall Study|Withdrawal by Subject|4|||
161660975|NCT01143038|583808713|FG000|Overall Study|Requirement for alternative therapy|5|||
161660976|NCT01143038|583808713|FG000|Overall Study|Adverse Event|3|||
161660977|NCT01143038|583808713|FG000|Overall Study|Lost to Follow-up|2|||
161660978|NCT01143038|583808713|FG000|Overall Study|Protocol Deviation|1|||
161660979|NCT01143038|583808713|FG000|Overall Study|Death|1|||
161660980|NCT00657020|583808716|FG000|PERIOD 1|Adverse Event|0|||
161660981|NCT00657020|583808717|FG001|PERIOD 1|Adverse Event|1|||
161660982|NCT01183234|583808718|FG000|First Intervention|Adverse Event|1|||
161660983|NCT01183234|583808719|FG001|First Intervention|Adverse Event|0|||
161660984|NCT02029846|583808722|FG000|Overall Study|n=1 each arm|1|||
161660985|NCT02029846|583808723|FG001|Overall Study|n=1 each arm|1|||
161660986|NCT02966301|583808724|FG000|Overall Study|Death|2|||
161660987|NCT02966301|583808724|FG000|Overall Study|Withdrawal by Subject|1|||
161660988|NCT00822172|583808728|FG000|Overall Study|Adverse Event|10|||
161660989|NCT00822172|583808729|FG001|Overall Study|Adverse Event|12|||
161660990|NCT00822172|583808728|FG000|Overall Study|Death|1|||
161660991|NCT00822172|583808729|FG001|Overall Study|Death|0|||
161660992|NCT00822172|583808728|FG000|Overall Study|Lost to Follow-up|3|||
161660993|NCT00822172|583808729|FG001|Overall Study|Lost to Follow-up|1|||
161660994|NCT00822172|583808728|FG000|Overall Study|Withdrawal by Subject|1|||
161660995|NCT00822172|583808729|FG001|Overall Study|Withdrawal by Subject|4|||
161660996|NCT00822172|583808728|FG000|Overall Study|site closed|0|||
161660997|NCT00822172|583808729|FG001|Overall Study|site closed|1|||
161660998|NCT00822172|583808728|FG000|Overall Study|Other|0|||
161660999|NCT00822172|583808729|FG001|Overall Study|Other|1|||
161661000|NCT00370331|583808730|FG000|Overall Study|Adverse Event|4|||
161661001|NCT00370331|583808731|FG001|Overall Study|Adverse Event|13|||
161661002|NCT00370331|583808730|FG000|Overall Study|Withdrawal by Subject|2|||
161661003|NCT00370331|583808731|FG001|Overall Study|Withdrawal by Subject|4|||
161661004|NCT00370331|583808730|FG000|Overall Study|Lost to Follow-up|0|||
161661005|NCT00370331|583808731|FG001|Overall Study|Lost to Follow-up|3|||
161661006|NCT00370331|583808730|FG000|Overall Study|Lack of Efficacy|0|||
161661007|NCT00370331|583808731|FG001|Overall Study|Lack of Efficacy|1|||
161661008|NCT00370331|583808730|FG000|Overall Study|Non-compliance|0|||
161661009|NCT00370331|583808731|FG001|Overall Study|Non-compliance|1|||
161661010|NCT00370331|583808730|FG000|Overall Study|Protocol Violation|1|||
161661011|NCT00370331|583808731|FG001|Overall Study|Protocol Violation|1|||
161661012|NCT02947087|583808733|FG000|Overall Study|Withdrawal by Subject|3|||
161661013|NCT02947087|583808734|FG001|Overall Study|Withdrawal by Subject|2|||
161661014|NCT02224690|583808739|FG000|Overall Study|Adverse Event|8|||
161661015|NCT02224690|583808740|FG001|Overall Study|Adverse Event|1|||
161661016|NCT02224690|583808739|FG000|Overall Study|Met Withdrawal Criteria|4|||
161661017|NCT02224690|583808740|FG001|Overall Study|Met Withdrawal Criteria|0|||
161661018|NCT02224690|583808739|FG000|Overall Study|Use of G-tube|1|||
161661019|NCT02224690|583808740|FG001|Overall Study|Use of G-tube|0|||
161661020|NCT02224690|583808739|FG000|Overall Study|Did not meet eligibility criteria|1|||
161661021|NCT02224690|583808740|FG001|Overall Study|Did not meet eligibility criteria|0|||
161661022|NCT05753670|583808741|FG000|Overall Study|Withdrawal by Subject|6|||
161661023|NCT05753670|583808742|FG001|Overall Study|Withdrawal by Subject|8|||
161661024|NCT05753670|583808741|FG000|Overall Study|Protocol Violation|3|||
161661025|NCT05753670|583808742|FG001|Overall Study|Protocol Violation|1|||
161661026|NCT02325557|583808743|FG000|Overall Study|Progressive disease|1|||
161661027|NCT02325557|583808744|FG001|Overall Study|Progressive disease|0|||
161661028|NCT02325557|583808745|FG002|Overall Study|Progressive disease|0|||
161661029|NCT02325557|583808746|FG003|Overall Study|Progressive disease|0|||
161661030|NCT02325557|583808743|FG000|Overall Study|Withdrawal by Subject|4|||
161661031|NCT02325557|583808744|FG001|Overall Study|Withdrawal by Subject|0|||
161661032|NCT02325557|583808745|FG002|Overall Study|Withdrawal by Subject|0|||
161661033|NCT02325557|583808746|FG003|Overall Study|Withdrawal by Subject|15|||
161661034|NCT02325557|583808743|FG000|Overall Study|Death|5|||
161661035|NCT02325557|583808744|FG001|Overall Study|Death|1|||
161661036|NCT02325557|583808745|FG002|Overall Study|Death|1|||
161661037|NCT02325557|583808746|FG003|Overall Study|Death|16|||
161661038|NCT02325557|583808743|FG000|Overall Study|Lost to Follow-up|0|||
161661039|NCT02325557|583808744|FG001|Overall Study|Lost to Follow-up|0|||
161661040|NCT02325557|583808745|FG002|Overall Study|Lost to Follow-up|1|||
161661041|NCT02325557|583808746|FG003|Overall Study|Lost to Follow-up|1|||
161661042|NCT02325557|583808743|FG000|Overall Study|Other|0|||
161661043|NCT02325557|583808744|FG001|Overall Study|Other|0|||
161661044|NCT02325557|583808745|FG002|Overall Study|Other|0|||
161661045|NCT02325557|583808746|FG003|Overall Study|Other|5|||
161661046|NCT02703259|583808747|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
161661047|NCT02703259|583808748|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
161661048|NCT02703259|583808747|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
161661049|NCT02703259|583808748|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
161661050|NCT02703259|583808747|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
161661051|NCT02703259|583808748|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
161661052|NCT01993927|583808750|FG000|Overall Study|Case Report Forms Uncollected|18|||
161661053|NCT01993927|583808750|FG000|Overall Study|Protocol Violation|11|||
161661054|NCT00895154|583808751|FG000|Overall Study|Lost to Follow-up|1|||
161661055|NCT00895154|583808752|FG001|Overall Study|Lost to Follow-up|1|||
161661056|NCT00895154|583808751|FG000|Overall Study|Withdrawal by Subject|0|||
161661057|NCT00895154|583808752|FG001|Overall Study|Withdrawal by Subject|1|||
161661058|NCT02414932|583808753|FG000|Overall Study|Withdrawal by Subject|2|||
161710875|NCT00684177|583984225|FG000|Overall Study|Physician Decision|2|||
161710876|NCT00684177|583984226|FG001|Overall Study|Physician Decision|0|||
161710877|NCT00684177|583984225|FG000|Overall Study|Withdrawal by Subject|1|||
161661059|NCT02414932|583808754|FG001|Overall Study|Withdrawal by Subject|3|||
161661060|NCT02414932|583808753|FG000|Overall Study|Adverse Event|1|||
161661061|NCT02414932|583808754|FG001|Overall Study|Adverse Event|0|||
161661062|NCT00470366|583808755|FG000|Overall Study|Adverse Event|3|||
161661063|NCT00470366|583808755|FG000|Overall Study|Poor compliance|1|||
161661064|NCT00540046|583808756|FG000|Overall Study|Lost to Follow-up|33|||
161661065|NCT00540046|583808757|FG001|Overall Study|Lost to Follow-up|23|||
161661066|NCT01021215|583808765|FG000|Overall Study|Lost to Follow-up|3|||
161661067|NCT01021215|583808766|FG001|Overall Study|Lost to Follow-up|0|||
161661068|NCT00185965|583808769|FG000|Overall Study|Adverse Event|0|||
161661069|NCT00185965|583808770|FG001|Overall Study|Adverse Event|1|||
161661070|NCT01103362|583808771|FG000|Overall Study|study terminated|596|||
161661071|NCT02533531|583808772|FG000|Overall Study|Device did not turn on|1|||
161661072|NCT03814187|583808773|FG000|Overall Study|Sponsor's Administrative Decision|0|||
161661073|NCT03814187|583808774|FG001|Overall Study|Sponsor's Administrative Decision|0|||
161661074|NCT03814187|583808775|FG002|Overall Study|Sponsor's Administrative Decision|272|||
161661075|NCT03814187|583808773|FG000|Overall Study|Death|80|||
161661076|NCT03814187|583808774|FG001|Overall Study|Death|81|||
161661077|NCT03814187|583808775|FG002|Overall Study|Death|4|||
161661078|NCT03814187|583808773|FG000|Overall Study|Withdrew Consent|77|||
161661079|NCT03814187|583808774|FG001|Overall Study|Withdrew Consent|78|||
161661080|NCT03814187|583808775|FG002|Overall Study|Withdrew Consent|2|||
161661081|NCT03814187|583808773|FG000|Overall Study|Lost to Follow-up|47|||
161661082|NCT03814187|583808774|FG001|Overall Study|Lost to Follow-up|52|||
161661083|NCT03814187|583808775|FG002|Overall Study|Lost to Follow-up|1|||
161661084|NCT03814187|583808773|FG000|Overall Study|Adverse Event|22|||
161661085|NCT03814187|583808774|FG001|Overall Study|Adverse Event|23|||
161661086|NCT03814187|583808775|FG002|Overall Study|Adverse Event|0|||
161661087|NCT03814187|583808773|FG000|Overall Study|Physician Decision|7|||
161661088|NCT03814187|583808774|FG001|Overall Study|Physician Decision|4|||
161661089|NCT03814187|583808775|FG002|Overall Study|Physician Decision|2|||
161661090|NCT03814187|583808773|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
161661091|NCT03814187|583808774|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
161661092|NCT03814187|583808775|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
161661093|NCT03814187|583808773|FG000|Overall Study|Other reasons|34|||
161661094|NCT03814187|583808774|FG001|Overall Study|Other reasons|40|||
161661095|NCT03814187|583808775|FG002|Overall Study|Other reasons|2|||
161710878|NCT00684177|583984226|FG001|Overall Study|Withdrawal by Subject|2|||
161710879|NCT00684177|583984225|FG000|Overall Study|Other|1|||
161710880|NCT00684177|583984226|FG001|Overall Study|Other|2|||
161710881|NCT00075881|583985741|FG000|Overall Study|Lack of Efficacy|18|||
161710882|NCT00075881|583985741|FG000|Overall Study|Adverse Event|7|||
161710883|NCT00075881|583985741|FG000|Overall Study|Death|1|||
161710884|NCT00075881|583985741|FG000|Overall Study|Withdrawal by Subject|2|||
161710885|NCT00075881|583985741|FG000|Overall Study|Protocol Violation|4|||
161710886|NCT00075881|583985741|FG000|Overall Study|other complicating disease|3|||
161710887|NCT00075881|583985741|FG000|Overall Study|other|4|||
161710888|NCT00075881|583985741|FG000|Overall Study|missing data|2|||
161710889|NCT00075881|583985741|FG000|Overall Study|Ineligible|1|||
161710890|NCT00075881|583985741|FG000|Overall Study|never start protocol therapy|1|||
161710891|NCT02224664|583985742|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
161710892|NCT02224664|583985743|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710893|NCT02224664|583985744|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710894|NCT02224664|583985745|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710895|NCT02224664|583985746|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710896|NCT02224664|583985742|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
161710897|NCT02224664|583985743|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
161710898|NCT02224664|583985744|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
161710899|NCT02224664|583985745|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
161710900|NCT02224664|583985746|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
161710901|NCT02224664|583985742|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161661096|NCT00513604|583808776|FG000|Overall Study|Not treated|2|||
161661097|NCT00513604|583808777|FG001|Overall Study|Not treated|0|||
161661098|NCT00513604|583808778|FG002|Overall Study|Not treated|1|||
161661099|NCT00513604|583808779|FG003|Overall Study|Not treated|0|||
161661100|NCT00513604|583808780|FG004|Overall Study|Not treated|0|||
161661101|NCT00513604|583808776|FG000|Overall Study|Death during treatment|0|||
161661102|NCT00513604|583808777|FG001|Overall Study|Death during treatment|3|||
161661103|NCT00513604|583808778|FG002|Overall Study|Death during treatment|2|||
161661104|NCT00513604|583808779|FG003|Overall Study|Death during treatment|0|||
161661105|NCT00513604|583808780|FG004|Overall Study|Death during treatment|0|||
161661106|NCT01014533|583808781|FG000|Overall Study|Protocol Violation|3|||
161661107|NCT01014533|583808782|FG001|Overall Study|Protocol Violation|2|||
161661108|NCT01014533|583808781|FG000|Overall Study|Withdrawal by Subject|2|||
161661109|NCT01014533|583808782|FG001|Overall Study|Withdrawal by Subject|0|||
161661110|NCT01014533|583808781|FG000|Overall Study|unable to come to appointment|0|||
161661111|NCT01014533|583808782|FG001|Overall Study|unable to come to appointment|3|||
161661112|NCT00412061|583808784|FG000|Double Blind Phase|Disease Progression|101|||
161661113|NCT00412061|583808785|FG001|Double Blind Phase|Disease Progression|154|||
161661114|NCT00412061|583808784|FG000|Double Blind Phase|Adverse Event|61|||
161661115|NCT00412061|583808785|FG001|Double Blind Phase|Adverse Event|16|||
161661116|NCT00412061|583808784|FG000|Double Blind Phase|Final Primary Analysis|26|||
161661117|NCT00412061|583808785|FG001|Double Blind Phase|Final Primary Analysis|14|||
161661118|NCT00412061|583808784|FG000|Double Blind Phase|Withdrawal by Subject|18|||
161661119|NCT00412061|583808785|FG001|Double Blind Phase|Withdrawal by Subject|20|||
161661120|NCT00412061|583808784|FG000|Double Blind Phase|Death|6|||
161661121|NCT00412061|583808785|FG001|Double Blind Phase|Death|3|||
161661122|NCT00412061|583808784|FG000|Double Blind Phase|Protocol Violation|3|||
161661123|NCT00412061|583808785|FG001|Double Blind Phase|Protocol Violation|4|||
161661124|NCT00412061|583808784|FG000|Double Blind Phase|New Cander Therapy|1|||
161661125|NCT00412061|583808785|FG001|Double Blind Phase|New Cander Therapy|1|||
161661126|NCT00412061|583808784|FG000|Double Blind Phase|Lost to Follow-up|0|||
161661127|NCT00412061|583808785|FG001|Double Blind Phase|Lost to Follow-up|1|||
161661128|NCT00412061|583808784|FG000|Open Label Phase|Disease Progression|0|||
161661129|NCT00412061|583808785|FG001|Open Label Phase|Disease Progression|86|||
161661130|NCT00412061|583808784|FG000|Open Label Phase|Adverse Event|0|||
161661131|NCT00412061|583808785|FG001|Open Label Phase|Adverse Event|46|||
161661132|NCT00412061|583808784|FG000|Open Label Phase|Withdrawal by Subject|0|||
161661133|NCT00412061|583808785|FG001|Open Label Phase|Withdrawal by Subject|15|||
161661134|NCT00412061|583808784|FG000|Open Label Phase|Administrative Problems|0|||
161661135|NCT00412061|583808785|FG001|Open Label Phase|Administrative Problems|13|||
161661136|NCT00412061|583808784|FG000|Open Label Phase|Death|0|||
161661137|NCT00412061|583808785|FG001|Open Label Phase|Death|7|||
161661138|NCT00412061|583808784|FG000|Open Label Phase|Lost to Follow-up|0|||
161661139|NCT00412061|583808785|FG001|Open Label Phase|Lost to Follow-up|2|||
161661140|NCT00412061|583808784|FG000|Open Label Phase|New Cancer Therapy|0|||
161661141|NCT00412061|583808785|FG001|Open Label Phase|New Cancer Therapy|1|||
161661142|NCT02689518|583808786|FG000|Overall Study|Withdrawal by Subject|3|||
161661143|NCT01688830|583808791|FG000|Overall Study|Lost to Follow-up|0|||
161661144|NCT01688830|583808792|FG001|Overall Study|Lost to Follow-up|0|||
161661145|NCT01688830|583808793|FG002|Overall Study|Lost to Follow-up|0|||
161661146|NCT01688830|583808794|FG003|Overall Study|Lost to Follow-up|0|||
161661147|NCT01688830|583808795|FG004|Overall Study|Lost to Follow-up|0|||
161661148|NCT01688830|583808796|FG005|Overall Study|Lost to Follow-up|0|||
161661149|NCT01688830|583808797|FG006|Overall Study|Lost to Follow-up|0|||
161661150|NCT01688830|583808798|FG007|Overall Study|Lost to Follow-up|0|||
161661151|NCT01688830|583808799|FG008|Overall Study|Lost to Follow-up|0|||
161661152|NCT01688830|583808800|FG009|Overall Study|Lost to Follow-up|0|||
161661153|NCT01688830|583808801|FG010|Overall Study|Lost to Follow-up|1|||
161661154|NCT01688830|583808802|FG011|Overall Study|Lost to Follow-up|0|||
161661155|NCT01688830|583808803|FG012|Overall Study|Lost to Follow-up|0|||
161661156|NCT01688830|583808804|FG013|Overall Study|Lost to Follow-up|0|||
161661157|NCT01688830|583808805|FG014|Overall Study|Lost to Follow-up|0|||
161661158|NCT01688830|583808806|FG015|Overall Study|Lost to Follow-up|0|||
161661159|NCT01688830|583808807|FG016|Overall Study|Lost to Follow-up|0|||
161661160|NCT01688830|583808808|FG017|Overall Study|Lost to Follow-up|0|||
161661161|NCT01688830|583808809|FG018|Overall Study|Lost to Follow-up|0|||
161661162|NCT01688830|583808810|FG019|Overall Study|Lost to Follow-up|0|||
161661163|NCT01688830|583808811|FG020|Overall Study|Lost to Follow-up|0|||
161661164|NCT04822597|583808812|FG000|Overall Study|Withdrawal by Subject|0|||
161661165|NCT04822597|583808813|FG001|Overall Study|Withdrawal by Subject|1|||
161661166|NCT04822597|583808814|FG002|Overall Study|Withdrawal by Subject|1|||
161661167|NCT04822597|583808815|FG003|Overall Study|Withdrawal by Subject|0|||
161661168|NCT04822597|583808812|FG000|Overall Study|Physician Decision|0|||
161710902|NCT02224664|583985743|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161710903|NCT02224664|583985744|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161710904|NCT02224664|583985745|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
161710905|NCT02224664|583985746|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
161710906|NCT00828464|583985756|FG000|Overall Study|Withdrawal by Subject|1|||
161661169|NCT04822597|583808813|FG001|Overall Study|Physician Decision|0|||
161661170|NCT04822597|583808814|FG002|Overall Study|Physician Decision|1|||
161661171|NCT04822597|583808815|FG003|Overall Study|Physician Decision|1|||
161661172|NCT04822597|583808812|FG000|Overall Study|Subject withdrawn after enrollment|0|||
161710907|NCT00474240|583985757|FG000|Overall Study|Withdrawal by Subject|1|||
161710908|NCT00474240|583985758|FG001|Overall Study|Withdrawal by Subject|1|||
161710909|NCT00474240|583985759|FG002|Overall Study|Withdrawal by Subject|0|||
161710910|NCT00474240|583985760|FG003|Overall Study|Withdrawal by Subject|2|||
161710911|NCT00474240|583985761|FG004|Overall Study|Withdrawal by Subject|3|||
161710912|NCT00474240|583985762|FG005|Overall Study|Withdrawal by Subject|1|||
161710913|NCT00474240|583985757|FG000|Overall Study|Adverse Event|0|||
161710914|NCT00474240|583985758|FG001|Overall Study|Adverse Event|0|||
161710915|NCT00474240|583985759|FG002|Overall Study|Adverse Event|9|||
161710916|NCT00474240|583985760|FG003|Overall Study|Adverse Event|14|||
161710917|NCT00474240|583985761|FG004|Overall Study|Adverse Event|5|||
161710918|NCT00474240|583985762|FG005|Overall Study|Adverse Event|16|||
161710919|NCT00474240|583985757|FG000|Overall Study|Removed due to lab value|0|||
161710920|NCT00474240|583985758|FG001|Overall Study|Removed due to lab value|0|||
161710921|NCT00474240|583985759|FG002|Overall Study|Removed due to lab value|0|||
161661173|NCT04822597|583808813|FG001|Overall Study|Subject withdrawn after enrollment|1|||
161661174|NCT04822597|583808814|FG002|Overall Study|Subject withdrawn after enrollment|0|||
161661175|NCT04822597|583808815|FG003|Overall Study|Subject withdrawn after enrollment|1|||
161661176|NCT04822597|583808812|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
161661177|NCT04822597|583808813|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
161661178|NCT04822597|583808814|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
161661179|NCT04822597|583808815|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
161661180|NCT02859324|583808816|FG000|Overall Study|Death|4|||
161661181|NCT02859324|583808817|FG001|Overall Study|Death|6|||
161661182|NCT02859324|583808818|FG002|Overall Study|Death|5|||
161661183|NCT02859324|583808816|FG000|Overall Study|Other reasons|3|||
161661184|NCT02859324|583808817|FG001|Overall Study|Other reasons|3|||
161661185|NCT02859324|583808818|FG002|Overall Study|Other reasons|0|||
161661186|NCT02665338|583808820|FG000|Overall Study|Withdrawal by Subject|0|||
161661187|NCT02665338|583808821|FG001|Overall Study|Withdrawal by Subject|1|||
161661188|NCT00998335|583808822|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
161661189|NCT00998335|583808823|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
161710922|NCT00474240|583985760|FG003|Overall Study|Removed due to lab value|0|||
161710923|NCT00474240|583985761|FG004|Overall Study|Removed due to lab value|0|||
161710924|NCT00474240|583985762|FG005|Overall Study|Removed due to lab value|1|||
161710925|NCT02197377|583985763|FG000|Overall Study|Insertion Failure|0|||
161710926|NCT02197377|583985764|FG001|Overall Study|Insertion Failure|3|||
161710927|NCT00502840|583985765|FG000|Overall Study|Adverse Event|5|||
161710928|NCT00502840|583985765|FG000|Overall Study|Additional or changed therapy|48|||
161710929|NCT00502840|583985765|FG000|Overall Study|Lack of Efficacy|11|||
161661190|NCT01305200|583808824|FG000|Overall Study|Physician Decision|4|||
161710930|NCT00502840|583985765|FG000|Overall Study|Protocol Violation|4|||
161710931|NCT00502840|583985765|FG000|Overall Study|Withdrawal by Subject|5|||
161710932|NCT00502840|583985765|FG000|Overall Study|Lost to Follow-up|6|||
161710933|NCT00502840|583985765|FG000|Overall Study|Administrative problems|1|||
161710934|NCT00502840|583985765|FG000|Overall Study|Other|20|||
161710935|NCT00809133|583985766|FG000|Overall Study|Progressive disease|2|||
161710936|NCT00809133|583985767|FG001|Overall Study|Progressive disease|5|||
161710937|NCT00809133|583985768|FG002|Overall Study|Progressive disease|5|||
161710938|NCT00809133|583985769|FG003|Overall Study|Progressive disease|3|||
161710939|NCT00809133|583985770|FG004|Overall Study|Progressive disease|4|||
161710940|NCT00809133|583985771|FG005|Overall Study|Progressive disease|1|||
161710941|NCT00809133|583985772|FG006|Overall Study|Progressive disease|3|||
161710942|NCT00809133|583985773|FG007|Overall Study|Progressive disease|3|||
161710943|NCT00809133|583985774|FG008|Overall Study|Progressive disease|3|||
161710944|NCT00809133|583985775|FG009|Overall Study|Progressive disease|9|||
161710945|NCT00809133|583985776|FG010|Overall Study|Progressive disease|5|||
161710946|NCT00809133|583985777|FG011|Overall Study|Progressive disease|7|||
161710947|NCT00809133|583985778|FG012|Overall Study|Progressive disease|5|||
161710948|NCT00809133|583985779|FG013|Overall Study|Progressive disease|4|||
161710949|NCT00809133|583985766|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710950|NCT00809133|583985767|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710951|NCT00809133|583985768|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710952|NCT00809133|583985769|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710953|NCT00809133|583985770|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161661191|NCT01305200|583808825|FG001|Overall Study|Physician Decision|6|||
161710954|NCT00809133|583985771|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161710955|NCT00809133|583985772|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161710956|NCT00809133|583985773|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161710957|NCT00809133|583985774|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710958|NCT00809133|583985775|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710959|NCT00809133|583985776|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710960|NCT00809133|583985777|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710961|NCT00809133|583985778|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161661192|NCT01305200|583808826|FG002|Overall Study|Physician Decision|1|||
161661193|NCT01305200|583808824|FG000|Overall Study|Withdrawal by Subject|24|||
161710962|NCT00809133|583985779|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161710963|NCT00809133|583985766|FG000|Overall Study|Other adverse event|1|||
161661194|NCT01305200|583808825|FG001|Overall Study|Withdrawal by Subject|21|||
161661195|NCT01305200|583808826|FG002|Overall Study|Withdrawal by Subject|1|||
161661196|NCT01305200|583808824|FG000|Overall Study|Ineligible|1|||
161661197|NCT01305200|583808825|FG001|Overall Study|Ineligible|2|||
161661198|NCT01305200|583808826|FG002|Overall Study|Ineligible|1|||
161661199|NCT01305200|583808824|FG000|Overall Study|Death|0|||
161661200|NCT01305200|583808825|FG001|Overall Study|Death|2|||
161661201|NCT01305200|583808826|FG002|Overall Study|Death|0|||
161661202|NCT05559476|583808827|FG000|Overall Study|Adverse Event|2|||
161661203|NCT05559476|583808828|FG001|Overall Study|Adverse Event|0|||
161661204|NCT05559476|583808827|FG000|Overall Study|Lost to Follow-up|13|||
161661205|NCT05559476|583808828|FG001|Overall Study|Lost to Follow-up|12|||
161661206|NCT05559476|583808827|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
161661207|NCT05559476|583808828|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
161661208|NCT05559476|583808827|FG000|Overall Study|Other|0|||
161661209|NCT05559476|583808828|FG001|Overall Study|Other|2|||
161661210|NCT05110690|583808829|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
161661211|NCT05110690|583808829|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
161661212|NCT05110690|583808829|FG000|Completion of Intervention|Lost to Follow-up|1|||
161661213|NCT05110690|583808829|FG000|Completion of Intervention|Death|1|||
161661214|NCT05110690|583808829|FG000|Completion of Intervention|Withdrawal by Subject|2|||
161661215|NCT01190514|583811069|FG000|First Intervention (Period 1)|Adverse Event|1|||
161661216|NCT01190514|583811070|FG001|First Intervention (Period 1)|Adverse Event|0|||
161661217|NCT01190514|583811071|FG002|First Intervention (Period 1)|Adverse Event|0|||
161661218|NCT01190514|583811072|FG003|First Intervention (Period 1)|Adverse Event|0|||
161661219|NCT01190514|583811069|FG000|Third Intervention (Period 3)|Adverse Event|1|||
161661220|NCT01190514|583811070|FG001|Third Intervention (Period 3)|Adverse Event|0|||
161661221|NCT01190514|583811071|FG002|Third Intervention (Period 3)|Adverse Event|0|||
161661222|NCT01190514|583811072|FG003|Third Intervention (Period 3)|Adverse Event|0|||
161661223|NCT00512317|583811073|FG000|Overall Study|Insufficient clinical response|36|||
161661224|NCT00512317|583811073|FG000|Overall Study|Withdrawal by Subject|23|||
161661225|NCT00512317|583811073|FG000|Overall Study|Sponsor closure of study|21|||
161661226|NCT00512317|583811073|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
161661227|NCT00512317|583811073|FG000|Overall Study|Adverse Event|13|||
161661228|NCT00512317|583811073|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
161661229|NCT00512317|583811073|FG000|Overall Study|Lost to Follow-up|2|||
161661230|NCT00512317|583811073|FG000|Overall Study|Other|2|||
161661231|NCT00706433|583811077|FG000|Overall Study|Lost to Follow-up|3|||
161661232|NCT00706433|583811078|FG001|Overall Study|Lost to Follow-up|1|||
161661233|NCT00706433|583811079|FG002|Overall Study|Lost to Follow-up|6|||
161661234|NCT00706433|583811080|FG003|Overall Study|Lost to Follow-up|0|||
161661235|NCT00706433|583811077|FG000|Overall Study|Withdrawal by Subject|1|||
161661236|NCT00706433|583811078|FG001|Overall Study|Withdrawal by Subject|2|||
161661237|NCT00706433|583811079|FG002|Overall Study|Withdrawal by Subject|3|||
161661238|NCT00706433|583811080|FG003|Overall Study|Withdrawal by Subject|1|||
161661239|NCT00706433|583811077|FG000|Overall Study|Adverse Event|0|||
161661240|NCT00706433|583811078|FG001|Overall Study|Adverse Event|0|||
161661241|NCT00706433|583811079|FG002|Overall Study|Adverse Event|1|||
161661242|NCT00706433|583811080|FG003|Overall Study|Adverse Event|0|||
161661243|NCT00706433|583811077|FG000|Overall Study|Protocol Violation|1|||
161661244|NCT00706433|583811078|FG001|Overall Study|Protocol Violation|0|||
161661245|NCT00706433|583811079|FG002|Overall Study|Protocol Violation|0|||
161661246|NCT00706433|583811080|FG003|Overall Study|Protocol Violation|0|||
161661247|NCT00706433|583811077|FG000|Overall Study|new job|0|||
161661248|NCT00706433|583811078|FG001|Overall Study|new job|0|||
161661249|NCT00706433|583811079|FG002|Overall Study|new job|0|||
161661250|NCT00706433|583811080|FG003|Overall Study|new job|1|||
161661251|NCT04101318|583811082|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
161661252|NCT04101318|583811083|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
161661253|NCT04101318|583811082|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
161661254|NCT04101318|583811083|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
161661255|NCT04101318|583811082|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
161661256|NCT04101318|583811083|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
161661257|NCT00717067|583811084|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161661258|NCT00717067|583811085|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161661259|NCT00717067|583811086|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
161661260|NCT00717067|583811087|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161661261|NCT00717067|583811088|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161661262|NCT02090959|583811089|FG000|Overall Study|Withdrawal by Subject|10|||
161661263|NCT02090959|583811089|FG000|Overall Study|Adverse Event|1|||
161661264|NCT02090959|583811089|FG000|Overall Study|Investigator decision|2|||
161661265|NCT02090959|583811089|FG000|Overall Study|Study termination|6|||
161661266|NCT02090959|583811089|FG000|Overall Study|Enrolled but not treated|1|||
161661267|NCT02090959|583811089|FG000|Overall Study|Transfer for compassionate use medicine|4|||
161661268|NCT02090959|583811089|FG000|Overall Study|Move to medical need program|3|||
161661269|NCT02090959|583811089|FG000|Overall Study|Entered in to other study|34|||
161661270|NCT02090959|583811089|FG000|Overall Study|Switched to commercial supply|88|||
161661271|NCT02090959|583811089|FG000|Overall Study|Other than specified|2|||
161661272|NCT00522873|583811090|FG000|Overall Study|Adverse Event|41|||
161661273|NCT00522873|583811091|FG001|Overall Study|Adverse Event|26|||
161661274|NCT00522873|583811090|FG000|Overall Study|Withdrawal by Subject|20|||
161661275|NCT00522873|583811091|FG001|Overall Study|Withdrawal by Subject|9|||
161661276|NCT00522873|583811090|FG000|Overall Study|Protocol Violation|14|||
161661277|NCT00522873|583811091|FG001|Overall Study|Protocol Violation|4|||
161661278|NCT00522873|583811090|FG000|Overall Study|Lost to Follow-up|11|||
161661279|NCT00522873|583811091|FG001|Overall Study|Lost to Follow-up|3|||
161661280|NCT00522873|583811090|FG000|Overall Study|Personal Reasons|8|||
161661281|NCT00522873|583811091|FG001|Overall Study|Personal Reasons|1|||
161661282|NCT00522873|583811090|FG000|Overall Study|Medication Errors|1|||
161661283|NCT00522873|583811091|FG001|Overall Study|Medication Errors|1|||
161661284|NCT00522873|583811090|FG000|Overall Study|Never Received Medication|1|||
161661285|NCT00522873|583811091|FG001|Overall Study|Never Received Medication|0|||
161661286|NCT00545051|583811093|FG000|Overall Study|Adverse Event|7|||
161661287|NCT00545051|583811094|FG001|Overall Study|Adverse Event|3|||
161661288|NCT00545051|583811093|FG000|Overall Study|Death|1|||
161661289|NCT00545051|583811094|FG001|Overall Study|Death|0|||
161661290|NCT00545051|583811093|FG000|Overall Study|Violation of inclusion/exclusion|0|||
161661291|NCT00545051|583811094|FG001|Overall Study|Violation of inclusion/exclusion|2|||
161661292|NCT00545051|583811093|FG000|Overall Study|Protocol Violation|1|||
161661293|NCT00545051|583811094|FG001|Overall Study|Protocol Violation|0|||
161661294|NCT00545051|583811093|FG000|Overall Study|Withdrawal by Subject|0|||
161661295|NCT00545051|583811094|FG001|Overall Study|Withdrawal by Subject|1|||
161661296|NCT00545051|583811093|FG000|Overall Study|Administrative reasons|0|||
161661297|NCT00545051|583811094|FG001|Overall Study|Administrative reasons|1|||
161661298|NCT01375114|583811095|FG000|Overall Study|Lost to Follow-up|1|||
161661299|NCT01375114|583811096|FG001|Overall Study|Lost to Follow-up|0|||
161661300|NCT01375114|583811097|FG002|Overall Study|Lost to Follow-up|1|||
161661301|NCT01375114|583811095|FG000|Overall Study|Disease Progression|3|||
161661302|NCT01375114|583811096|FG001|Overall Study|Disease Progression|2|||
161661303|NCT01375114|583811097|FG002|Overall Study|Disease Progression|2|||
161661304|NCT01375114|583811095|FG000|Overall Study|Patient Changed Mind|0|||
161661305|NCT01375114|583811096|FG001|Overall Study|Patient Changed Mind|0|||
161661306|NCT01375114|583811097|FG002|Overall Study|Patient Changed Mind|2|||
161661307|NCT01375114|583811095|FG000|Overall Study|Pruritus|0|||
161661308|NCT01375114|583811096|FG001|Overall Study|Pruritus|0|||
161661309|NCT01375114|583811097|FG002|Overall Study|Pruritus|1|||
161661310|NCT01375114|583811095|FG000|Overall Study|Restlessness|0|||
161661311|NCT01375114|583811096|FG001|Overall Study|Restlessness|0|||
161661312|NCT01375114|583811097|FG002|Overall Study|Restlessness|1|||
161661313|NCT01375114|583811095|FG000|Overall Study|Diarrhea|0|||
161661314|NCT01375114|583811096|FG001|Overall Study|Diarrhea|0|||
161661315|NCT01375114|583811097|FG002|Overall Study|Diarrhea|1|||
161661316|NCT01375114|583811095|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
161661317|NCT01375114|583811096|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
161661318|NCT01375114|583811097|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
161661319|NCT01375114|583811095|FG000|Overall Study|Nausea|0|||
161661320|NCT01375114|583811096|FG001|Overall Study|Nausea|1|||
161661321|NCT01375114|583811097|FG002|Overall Study|Nausea|0|||
161661322|NCT01375114|583811095|FG000|Overall Study|Increased AST/ALT|0|||
161661323|NCT01375114|583811096|FG001|Overall Study|Increased AST/ALT|1|||
161661324|NCT01375114|583811097|FG002|Overall Study|Increased AST/ALT|0|||
161661325|NCT01375114|583811095|FG000|Overall Study|Vaginal Hemorrhage|0|||
161661326|NCT01375114|583811096|FG001|Overall Study|Vaginal Hemorrhage|1|||
161661327|NCT01375114|583811097|FG002|Overall Study|Vaginal Hemorrhage|0|||
161661328|NCT01375114|583811095|FG000|Overall Study|Family problem|0|||
161661329|NCT01375114|583811096|FG001|Overall Study|Family problem|1|||
161661330|NCT01375114|583811097|FG002|Overall Study|Family problem|0|||
161661331|NCT01375114|583811095|FG000|Overall Study|Protocol Violation|2|||
161661332|NCT01375114|583811096|FG001|Overall Study|Protocol Violation|0|||
161661333|NCT01375114|583811097|FG002|Overall Study|Protocol Violation|0|||
161661334|NCT04745026|583811098|FG000|Overall Study|Physician Decision|1|||
161661335|NCT04745026|583811099|FG001|Overall Study|Physician Decision|0|||
161661336|NCT04745026|583811098|FG000|Overall Study|Adverse Event|2|||
161661337|NCT04745026|583811099|FG001|Overall Study|Adverse Event|2|||
161661338|NCT04745026|583811098|FG000|Overall Study|Protocol Violation|1|||
161661339|NCT04745026|583811099|FG001|Overall Study|Protocol Violation|3|||
161661340|NCT04745026|583811098|FG000|Overall Study|Lost to Follow-up|4|||
161661341|NCT04745026|583811099|FG001|Overall Study|Lost to Follow-up|3|||
161661342|NCT04745026|583811098|FG000|Overall Study|Withdrawal by Subject|5|||
161661343|NCT04745026|583811099|FG001|Overall Study|Withdrawal by Subject|5|||
161661344|NCT01656733|583811100|FG000|Overall Study|No permission to collect birth outcomes|0|||
161661345|NCT01656733|583811101|FG001|Overall Study|No permission to collect birth outcomes|1|||
161661346|NCT01656733|583811100|FG000|Overall Study|Delivery at another hospital|0|||
161661347|NCT01656733|583811101|FG001|Overall Study|Delivery at another hospital|2|||
161661348|NCT01656733|583811100|FG000|Overall Study|Spontaneous abortion|0|||
161661349|NCT01656733|583811101|FG001|Overall Study|Spontaneous abortion|1|||
161661350|NCT01415531|583811102|FG000|Overall Study|Adverse Event|7|||
161661351|NCT01415531|583811103|FG001|Overall Study|Adverse Event|10|||
161661352|NCT01415531|583811102|FG000|Overall Study|Lack of Efficacy|3|||
161661353|NCT01415531|583811103|FG001|Overall Study|Lack of Efficacy|2|||
161661354|NCT01415531|583811102|FG000|Overall Study|Protocol Violation|0|||
161661355|NCT01415531|583811103|FG001|Overall Study|Protocol Violation|1|||
161661356|NCT01415531|583811102|FG000|Overall Study|Withdrawal by Subject|5|||
161661357|NCT01415531|583811103|FG001|Overall Study|Withdrawal by Subject|4|||
161661358|NCT01415531|583811102|FG000|Overall Study|Lost to Follow-up|6|||
161661359|NCT01415531|583811103|FG001|Overall Study|Lost to Follow-up|14|||
161661360|NCT01415531|583811102|FG000|Overall Study|Lack of Compliance|1|||
161661361|NCT01415531|583811103|FG001|Overall Study|Lack of Compliance|4|||
161661362|NCT01415531|583811102|FG000|Overall Study|Other Reasons|3|||
161661363|NCT01415531|583811103|FG001|Overall Study|Other Reasons|2|||
161661364|NCT00122460|583811104|FG000|Overall Study|investigational study phase ongoing|7|||
161661365|NCT00122460|583811105|FG001|Overall Study|investigational study phase ongoing|1|||
161661366|NCT01236339|583811106|FG000|Overall Study|Termination of study by sponsor|11|||
161661367|NCT01236339|583811107|FG001|Overall Study|Termination of study by sponsor|13|||
161661368|NCT02084056|583811108|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161661369|NCT02084056|583811109|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161661370|NCT02084056|583811110|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161661371|NCT02084056|583811111|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161661372|NCT02084056|583811108|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
161661373|NCT02084056|583811109|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161661374|NCT02084056|583811110|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161661375|NCT02084056|583811111|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161661376|NCT00938860|583811114|FG000|Overall Study|Adverse Event|2|||
161661377|NCT00938860|583811115|FG001|Overall Study|Adverse Event|1|||
161661378|NCT00938860|583811114|FG000|Overall Study|Abnormal laboratory values|2|||
161661379|NCT00938860|583811115|FG001|Overall Study|Abnormal laboratory values|2|||
161661380|NCT00938860|583811114|FG000|Overall Study|Withdrawal by Subject|11|||
161661381|NCT00938860|583811115|FG001|Overall Study|Withdrawal by Subject|8|||
161661382|NCT00938860|583811114|FG000|Overall Study|Lost to Follow-up|4|||
161661383|NCT00938860|583811115|FG001|Overall Study|Lost to Follow-up|4|||
161661384|NCT00938860|583811114|FG000|Overall Study|Administration problems|2|||
161661385|NCT00938860|583811115|FG001|Overall Study|Administration problems|0|||
161661386|NCT00938860|583811114|FG000|Overall Study|Death|1|||
161661387|NCT00938860|583811115|FG001|Overall Study|Death|1|||
161661388|NCT00938860|583811114|FG000|Overall Study|Protocol Violation|3|||
161661389|NCT00938860|583811115|FG001|Overall Study|Protocol Violation|1|||
161661390|NCT01605019|583811116|FG000|Overall Study|pt did not meet transplant endpoint|3|||
161661391|NCT01605019|583811117|FG001|Overall Study|pt did not meet transplant endpoint|0|||
161661392|NCT04223830|583811121|FG000|Overall Study|Lost to Follow-up|9|||
161661393|NCT04223830|583811121|FG000|Overall Study|Adverse Event|1|||
161661394|NCT00324116|583811122|FG000|Overall Study|Adverse Event|5|||
161661395|NCT00324116|583811122|FG000|Overall Study|Lack of Efficacy|17|||
161661396|NCT00324116|583811122|FG000|Overall Study|Withdrawal by Subject|5|||
161661397|NCT00324116|583811122|FG000|Overall Study|Other|5|||
161710964|NCT00809133|583985767|FG001|Overall Study|Other adverse event|1|||
161710965|NCT00809133|583985768|FG002|Overall Study|Other adverse event|1|||
161710966|NCT00809133|583985769|FG003|Overall Study|Other adverse event|0|||
161710967|NCT00809133|583985770|FG004|Overall Study|Other adverse event|0|||
161710968|NCT00809133|583985771|FG005|Overall Study|Other adverse event|3|||
161710969|NCT00809133|583985772|FG006|Overall Study|Other adverse event|2|||
161710970|NCT00809133|583985773|FG007|Overall Study|Other adverse event|4|||
161710971|NCT00809133|583985774|FG008|Overall Study|Other adverse event|0|||
161710972|NCT00809133|583985775|FG009|Overall Study|Other adverse event|0|||
161710973|NCT00809133|583985776|FG010|Overall Study|Other adverse event|1|||
161710974|NCT00809133|583985777|FG011|Overall Study|Other adverse event|1|||
161710975|NCT00809133|583985778|FG012|Overall Study|Other adverse event|0|||
161710976|NCT00809133|583985779|FG013|Overall Study|Other adverse event|1|||
161710977|NCT00809133|583985766|FG000|Overall Study|Lost to Follow-up|0|||
161710978|NCT00809133|583985767|FG001|Overall Study|Lost to Follow-up|0|||
161710979|NCT00809133|583985768|FG002|Overall Study|Lost to Follow-up|0|||
161710980|NCT00809133|583985769|FG003|Overall Study|Lost to Follow-up|0|||
161710981|NCT00809133|583985770|FG004|Overall Study|Lost to Follow-up|0|||
161710982|NCT00809133|583985771|FG005|Overall Study|Lost to Follow-up|1|||
161710983|NCT00809133|583985772|FG006|Overall Study|Lost to Follow-up|0|||
161710984|NCT00809133|583985773|FG007|Overall Study|Lost to Follow-up|0|||
161710985|NCT00809133|583985774|FG008|Overall Study|Lost to Follow-up|0|||
161710986|NCT00809133|583985775|FG009|Overall Study|Lost to Follow-up|0|||
161710987|NCT00809133|583985776|FG010|Overall Study|Lost to Follow-up|0|||
161710988|NCT00809133|583985777|FG011|Overall Study|Lost to Follow-up|0|||
161710989|NCT00809133|583985778|FG012|Overall Study|Lost to Follow-up|0|||
161710990|NCT00809133|583985779|FG013|Overall Study|Lost to Follow-up|0|||
161710991|NCT00809133|583985766|FG000|Overall Study|Consent withdrawn|0|||
161710992|NCT00809133|583985767|FG001|Overall Study|Consent withdrawn|0|||
161710993|NCT00809133|583985768|FG002|Overall Study|Consent withdrawn|0|||
161710994|NCT00809133|583985769|FG003|Overall Study|Consent withdrawn|0|||
161710995|NCT00809133|583985770|FG004|Overall Study|Consent withdrawn|1|||
161710996|NCT00809133|583985771|FG005|Overall Study|Consent withdrawn|0|||
161710997|NCT00809133|583985772|FG006|Overall Study|Consent withdrawn|0|||
161710998|NCT00809133|583985773|FG007|Overall Study|Consent withdrawn|0|||
161710999|NCT00809133|583985774|FG008|Overall Study|Consent withdrawn|0|||
161711000|NCT00809133|583985775|FG009|Overall Study|Consent withdrawn|0|||
161711001|NCT00809133|583985776|FG010|Overall Study|Consent withdrawn|0|||
161711002|NCT00809133|583985777|FG011|Overall Study|Consent withdrawn|0|||
161711003|NCT00809133|583985778|FG012|Overall Study|Consent withdrawn|0|||
161711004|NCT00809133|583985779|FG013|Overall Study|Consent withdrawn|0|||
161711005|NCT00809133|583985766|FG000|Overall Study|Other not mentioned above|0|||
161711006|NCT00809133|583985767|FG001|Overall Study|Other not mentioned above|1|||
161711007|NCT00809133|583985768|FG002|Overall Study|Other not mentioned above|0|||
161711008|NCT00809133|583985769|FG003|Overall Study|Other not mentioned above|0|||
161711009|NCT00809133|583985770|FG004|Overall Study|Other not mentioned above|0|||
161711010|NCT00809133|583985771|FG005|Overall Study|Other not mentioned above|1|||
161711011|NCT00809133|583985772|FG006|Overall Study|Other not mentioned above|0|||
161711012|NCT00809133|583985773|FG007|Overall Study|Other not mentioned above|0|||
161711013|NCT00809133|583985774|FG008|Overall Study|Other not mentioned above|0|||
161711014|NCT00809133|583985775|FG009|Overall Study|Other not mentioned above|0|||
161711015|NCT00809133|583985776|FG010|Overall Study|Other not mentioned above|0|||
161711016|NCT00809133|583985777|FG011|Overall Study|Other not mentioned above|0|||
161711017|NCT00809133|583985778|FG012|Overall Study|Other not mentioned above|0|||
161711018|NCT00809133|583985779|FG013|Overall Study|Other not mentioned above|0|||
161711019|NCT03093155|583985781|FG000|Overall Study|Not Eligible|1|||
161711020|NCT03093155|583985782|FG001|Overall Study|Not Eligible|0|||
161711021|NCT03093155|583985781|FG000|Overall Study|Withdrawal by Subject|0|||
161711022|NCT03093155|583985782|FG001|Overall Study|Withdrawal by Subject|1|||
161711023|NCT01700829|583985783|FG000|Overall Study|Withdrawal by Subject|1|||
161711024|NCT01700829|583985784|FG001|Overall Study|Withdrawal by Subject|1|||
161711025|NCT01075178|583985785|FG000|Subject Matching|eligible but not matched|130|||
161711026|NCT01075178|583985786|FG001|Subject Matching|eligible but not matched|403|||
161711027|NCT01075178|583985785|FG000|Subject Chart Review|died before chart review period|0|||
161711028|NCT01075178|583985786|FG001|Subject Chart Review|died before chart review period|2|||
161711029|NCT01075178|583985785|FG000|Subject Chart Review|no data collected due to site closure|3|||
161711030|NCT01075178|583985786|FG001|Subject Chart Review|no data collected due to site closure|4|||
161711031|NCT01075178|583985785|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
161711032|NCT01075178|583985786|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
161711033|NCT02983604|583985787|FG000|Overall Study|Enrolled but not Treated|0|||
161711034|NCT02983604|583985788|FG001|Overall Study|Enrolled but not Treated|0|||
161711035|NCT02983604|583985789|FG002|Overall Study|Enrolled but not Treated|1|||
161711036|NCT02983604|583985790|FG003|Overall Study|Enrolled but not Treated|0|||
161711037|NCT04336163|583985792|FG000|Overall Study|Lost to Follow-up|55|||
161711038|NCT04336163|583985793|FG001|Overall Study|Lost to Follow-up|0|||
161711039|NCT01241786|583985794|FG000|Overall Study|Lack of Efficacy|5|||
161711040|NCT03182738|583985805|FG000|Overall Study|Lost to Follow-up|9|||
161711041|NCT03182738|583985806|FG001|Overall Study|Lost to Follow-up|3|||
161711042|NCT03182738|583985805|FG000|Overall Study|Pregnancy|0|||
161711043|NCT03182738|583985806|FG001|Overall Study|Pregnancy|1|||
161711044|NCT03182738|583985805|FG000|Overall Study|Withdrawal by Subject|0|||
161711045|NCT03182738|583985806|FG001|Overall Study|Withdrawal by Subject|1|||
161711046|NCT02886715|583985809|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161711047|NCT02886715|583985810|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161711048|NCT02886715|583985811|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161711049|NCT02886715|583985809|FG000|Overall Study|Adverse Event|4|||
161711050|NCT02886715|583985810|FG001|Overall Study|Adverse Event|2|||
161711051|NCT02886715|583985811|FG002|Overall Study|Adverse Event|0|||
161711052|NCT02886715|583985809|FG000|Overall Study|Lack of Efficacy|0|||
161711053|NCT02886715|583985810|FG001|Overall Study|Lack of Efficacy|2|||
161711054|NCT02886715|583985811|FG002|Overall Study|Lack of Efficacy|1|||
161711055|NCT02886715|583985809|FG000|Overall Study|Lost to Follow-up|29|||
161711056|NCT02886715|583985810|FG001|Overall Study|Lost to Follow-up|26|||
161711057|NCT02886715|583985811|FG002|Overall Study|Lost to Follow-up|10|||
161711058|NCT02886715|583985809|FG000|Overall Study|Pregnancy|1|||
161711059|NCT02886715|583985810|FG001|Overall Study|Pregnancy|1|||
161711060|NCT02886715|583985811|FG002|Overall Study|Pregnancy|1|||
161711061|NCT02886715|583985809|FG000|Overall Study|Protocol Violation|3|||
161711062|NCT02886715|583985810|FG001|Overall Study|Protocol Violation|2|||
161711063|NCT02886715|583985811|FG002|Overall Study|Protocol Violation|1|||
161711064|NCT02886715|583985809|FG000|Overall Study|Withdrawal by Subject|20|||
161711065|NCT02886715|583985810|FG001|Overall Study|Withdrawal by Subject|18|||
161711066|NCT02886715|583985811|FG002|Overall Study|Withdrawal by Subject|5|||
161711067|NCT02886715|583985809|FG000|Overall Study|missing|7|||
161711068|NCT02886715|583985810|FG001|Overall Study|missing|2|||
161711069|NCT02886715|583985811|FG002|Overall Study|missing|2|||
161711070|NCT00503399|583985812|FG000|Overall Study|Death|2|||
161711071|NCT00503399|583985813|FG001|Overall Study|Death|1|||
161711072|NCT00503399|583985812|FG000|Overall Study|Protocol Violation|1|||
161711073|NCT00503399|583985813|FG001|Overall Study|Protocol Violation|0|||
161711074|NCT00503399|583985812|FG000|Overall Study|Withdrawal by Subject|4|||
161711075|NCT00503399|583985813|FG001|Overall Study|Withdrawal by Subject|2|||
161711076|NCT00503399|583985812|FG000|Overall Study|Adverse Event|0|||
161711077|NCT00503399|583985813|FG001|Overall Study|Adverse Event|3|||
161711078|NCT00503399|583985812|FG000|Overall Study|Lost to Follow-up|0|||
161711079|NCT00503399|583985813|FG001|Overall Study|Lost to Follow-up|2|||
161711080|NCT01676961|583985814|FG000|Overall Study|Death|3|||
161711081|NCT01676961|583985814|FG000|Overall Study|Lost to Follow-up|1|||
161711082|NCT01676961|583985814|FG000|Overall Study|Withdrawal by Subject|1|||
161711083|NCT01128387|583985815|FG000|Overall Study|Physician Decision|0|||
161711084|NCT01128387|583985816|FG001|Overall Study|Physician Decision|1|||
161711085|NCT02499952|583985817|FG000|Overall Study|Lost to Follow-up|1|||
161711086|NCT02499952|583985817|FG000|Overall Study|Death|9|||
161711087|NCT02120417|583985818|FG000|Overall Study|Death|5|||
161711088|NCT02120417|583985819|FG001|Overall Study|Death|1|||
161711089|NCT02120417|583985818|FG000|Overall Study|Adverse Event|3|||
161711090|NCT02120417|583985819|FG001|Overall Study|Adverse Event|9|||
161711091|NCT02120417|583985818|FG000|Overall Study|Participant decision|4|||
161711092|NCT02120417|583985819|FG001|Overall Study|Participant decision|4|||
161711093|NCT02120417|583985818|FG000|Overall Study|Disease progression|41|||
161711094|NCT02120417|583985819|FG001|Overall Study|Disease progression|45|||
161711095|NCT02120417|583985818|FG000|Overall Study|Noncompliance with study treatment|0|||
161711096|NCT02120417|583985819|FG001|Overall Study|Noncompliance with study treatment|2|||
161711097|NCT02120417|583985818|FG000|Overall Study|Physician Decision|2|||
161711098|NCT02120417|583985819|FG001|Overall Study|Physician Decision|3|||
161711099|NCT02120417|583985818|FG000|Overall Study|Other unspecified|5|||
161711100|NCT02120417|583985819|FG001|Overall Study|Other unspecified|4|||
161711101|NCT00927485|583985820|FG000|Overall Study|Adverse Event|4|||
161711102|NCT00927485|583985821|FG001|Overall Study|Adverse Event|2|||
161711103|NCT00927485|583985820|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
161711104|NCT00927485|583985821|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
161711105|NCT01440101|583985822|FG000|Overall Study|Adverse Event|2|||
161363816|NCT02544763|582720031|FG000|Overall Study|Withdrawn by parent/guardian|1|||
161661398|NCT01806623|583811123|FG000|Overall Study|Withdrawal by Subject|1|||
161661399|NCT01806623|583811123|FG000|Overall Study|Adverse Event|1|||
161711106|NCT01440101|583985823|FG001|Overall Study|Adverse Event|0|||
161711107|NCT01440101|583985824|FG002|Overall Study|Adverse Event|0|||
161711108|NCT01440101|583985822|FG000|Overall Study|Withdrawal by Subject|0|||
161711109|NCT01440101|583985823|FG001|Overall Study|Withdrawal by Subject|3|||
161711110|NCT01440101|583985824|FG002|Overall Study|Withdrawal by Subject|1|||
161711111|NCT01440101|583985822|FG000|Overall Study|Other|0|||
161711112|NCT01440101|583985823|FG001|Overall Study|Other|1|||
161711113|NCT01440101|583985824|FG002|Overall Study|Other|0|||
161711114|NCT02305563|583985828|FG000|Treatment Period|Disease progression|0|||
161711115|NCT02305563|583985829|FG001|Treatment Period|Disease progression|0|||
161711116|NCT02305563|583985830|FG002|Treatment Period|Disease progression|15|||
161711117|NCT02305563|583985831|FG003|Treatment Period|Disease progression|6|||
161711118|NCT02305563|583985832|FG004|Treatment Period|Disease progression|6|||
161711119|NCT02305563|583985828|FG000|Treatment Period|Study drug toxicity|0|||
161711120|NCT02305563|583985829|FG001|Treatment Period|Study drug toxicity|0|||
161711121|NCT02305563|583985830|FG002|Treatment Period|Study drug toxicity|0|||
161711122|NCT02305563|583985831|FG003|Treatment Period|Study drug toxicity|1|||
161711123|NCT02305563|583985832|FG004|Treatment Period|Study drug toxicity|2|||
161711124|NCT02305563|583985828|FG000|Treatment Period|Death|0|||
161711125|NCT02305563|583985829|FG001|Treatment Period|Death|0|||
161711126|NCT02305563|583985830|FG002|Treatment Period|Death|1|||
161711127|NCT02305563|583985831|FG003|Treatment Period|Death|2|||
161711128|NCT02305563|583985832|FG004|Treatment Period|Death|1|||
161711129|NCT02305563|583985828|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
161711130|NCT02305563|583985829|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
161711131|NCT02305563|583985830|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
161711132|NCT02305563|583985831|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
161661400|NCT01806623|583811123|FG000|Overall Study|Did not meet the inclusion criteria|56|||
161661401|NCT01451827|583811124|FG000|Overall Study|Adverse Event|2|||
161661402|NCT01451827|583811125|FG001|Overall Study|Adverse Event|0|||
161661403|NCT01451827|583811126|FG002|Overall Study|Adverse Event|1|||
161661404|NCT01451827|583811127|FG003|Overall Study|Adverse Event|1|||
161661405|NCT01451827|583811124|FG000|Overall Study|Protocol deviation|1|||
161661406|NCT01451827|583811125|FG001|Overall Study|Protocol deviation|0|||
161661407|NCT01451827|583811126|FG002|Overall Study|Protocol deviation|0|||
161661408|NCT01451827|583811127|FG003|Overall Study|Protocol deviation|0|||
161661409|NCT01451827|583811124|FG000|Overall Study|Lost to Follow-up|0|||
161661410|NCT01451827|583811125|FG001|Overall Study|Lost to Follow-up|3|||
161661411|NCT01451827|583811126|FG002|Overall Study|Lost to Follow-up|0|||
161661412|NCT01451827|583811127|FG003|Overall Study|Lost to Follow-up|2|||
161661413|NCT01451827|583811124|FG000|Overall Study|Participant met withdrawal criteria|0|||
161661414|NCT01451827|583811125|FG001|Overall Study|Participant met withdrawal criteria|2|||
161661415|NCT01451827|583811126|FG002|Overall Study|Participant met withdrawal criteria|0|||
161711133|NCT02305563|583985832|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
161711134|NCT02305563|583985828|FG000|Treatment Period|Participant request to stop therapy|0|||
161711135|NCT02305563|583985829|FG001|Treatment Period|Participant request to stop therapy|2|||
161711136|NCT02305563|583985830|FG002|Treatment Period|Participant request to stop therapy|0|||
161711137|NCT02305563|583985831|FG003|Treatment Period|Participant request to stop therapy|1|||
161661416|NCT01451827|583811127|FG003|Overall Study|Participant met withdrawal criteria|0|||
161661417|NCT01451827|583811124|FG000|Overall Study|Withdrawal by Subject|0|||
161661418|NCT01451827|583811125|FG001|Overall Study|Withdrawal by Subject|0|||
161661419|NCT01451827|583811126|FG002|Overall Study|Withdrawal by Subject|1|||
161661420|NCT01451827|583811127|FG003|Overall Study|Withdrawal by Subject|1|||
161661421|NCT01964924|583811128|FG000|Trametinib Monotherapy|Progression|19|||
161661422|NCT01964924|583811129|FG001|Trametinib Monotherapy|Progression|0|||
161661423|NCT01528345|583811130|FG000|Overall Study|Adverse Event|10|||
161661424|NCT01528345|583811131|FG001|Overall Study|Adverse Event|1|||
161661425|NCT01528345|583811130|FG000|Overall Study|Death|1|||
161661426|NCT01528345|583811131|FG001|Overall Study|Death|1|||
161661427|NCT01528345|583811130|FG000|Overall Study|Non-compliance with study treatment|1|||
161661428|NCT01528345|583811131|FG001|Overall Study|Non-compliance with study treatment|0|||
161661429|NCT01528345|583811130|FG000|Overall Study|Progressive Disease|26|||
161661430|NCT01528345|583811131|FG001|Overall Study|Progressive Disease|40|||
161661431|NCT01528345|583811130|FG000|Overall Study|Study Terminated by Sponsor|4|||
161661432|NCT01528345|583811131|FG001|Overall Study|Study Terminated by Sponsor|8|||
161661433|NCT01528345|583811130|FG000|Overall Study|Subject/Guardian Decision|5|||
161661434|NCT01528345|583811131|FG001|Overall Study|Subject/Guardian Decision|0|||
161661435|NCT01034163|583811132|FG000|Overall Study|Treatment completed as per protocol|8|||
161661436|NCT01034163|583811133|FG001|Overall Study|Treatment completed as per protocol|7|||
161661437|NCT01034163|583811132|FG000|Overall Study|Withdrawal by Subject|8|||
161661438|NCT01034163|583811133|FG001|Overall Study|Withdrawal by Subject|2|||
161661439|NCT01034163|583811132|FG000|Overall Study|Protocol deviation|1|||
161661440|NCT01034163|583811133|FG001|Overall Study|Protocol deviation|0|||
161661441|NCT01034163|583811132|FG000|Overall Study|Disease progression|3|||
161661442|NCT01034163|583811133|FG001|Overall Study|Disease progression|4|||
161661443|NCT01034163|583811132|FG000|Overall Study|Adverse Event|6|||
161661444|NCT01034163|583811133|FG001|Overall Study|Adverse Event|0|||
161661445|NCT01034163|583811132|FG000|Overall Study|Administrative problems|0|||
161661446|NCT01034163|583811133|FG001|Overall Study|Administrative problems|1|||
161661447|NCT01034163|583811132|FG000|Overall Study|Abnormal laboratory value|1|||
161661448|NCT01034163|583811133|FG001|Overall Study|Abnormal laboratory value|0|||
161661449|NCT00528645|583811134|FG000|Overall Study|Adverse Event|3|||
161661450|NCT01642251|583811135|FG000|Overall Study|Progressive disease|0|||
161661451|NCT01642251|583811136|FG001|Overall Study|Progressive disease|0|||
161661452|NCT01642251|583811137|FG002|Overall Study|Progressive disease|3|||
161661453|NCT01642251|583811138|FG003|Overall Study|Progressive disease|3|||
161661454|NCT01642251|583811135|FG000|Overall Study|Adverse Event|0|||
161661455|NCT01642251|583811136|FG001|Overall Study|Adverse Event|0|||
161661456|NCT01642251|583811137|FG002|Overall Study|Adverse Event|5|||
161661457|NCT01642251|583811138|FG003|Overall Study|Adverse Event|4|||
161661458|NCT01642251|583811135|FG000|Overall Study|Death|0|||
161661459|NCT01642251|583811136|FG001|Overall Study|Death|0|||
161661460|NCT01642251|583811137|FG002|Overall Study|Death|1|||
161661461|NCT01642251|583811138|FG003|Overall Study|Death|3|||
161661462|NCT01642251|583811135|FG000|Overall Study|Withdrawal by Subject|0|||
161661463|NCT01642251|583811136|FG001|Overall Study|Withdrawal by Subject|0|||
161661464|NCT01642251|583811137|FG002|Overall Study|Withdrawal by Subject|1|||
161661465|NCT01642251|583811138|FG003|Overall Study|Withdrawal by Subject|3|||
161661466|NCT01642251|583811135|FG000|Overall Study|Alternative therapy|0|||
161661467|NCT01642251|583811136|FG001|Overall Study|Alternative therapy|0|||
161661468|NCT01642251|583811137|FG002|Overall Study|Alternative therapy|0|||
161661469|NCT01642251|583811138|FG003|Overall Study|Alternative therapy|2|||
161661470|NCT01642251|583811135|FG000|Overall Study|Other complicating disease|0|||
161661471|NCT01642251|583811136|FG001|Overall Study|Other complicating disease|0|||
161661472|NCT01642251|583811137|FG002|Overall Study|Other complicating disease|1|||
161661473|NCT01642251|583811138|FG003|Overall Study|Other complicating disease|0|||
161661474|NCT01642251|583811135|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
161661475|NCT01642251|583811136|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
161661476|NCT01642251|583811137|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
161661477|NCT01642251|583811138|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
161661478|NCT00998790|583811139|FG000|Overall Study|Withdrawal by Subject|21|||
161661479|NCT00287690|583811142|FG000|Overall Study|Protocol Violation|20|||
161661480|NCT00287690|583811143|FG001|Overall Study|Protocol Violation|26|||
161661481|NCT02047903|583811144|FG000|Overall Study|Adverse Event|14|||
161661482|NCT02047903|583811144|FG000|Overall Study|Serious adverse event|10|||
161661483|NCT02047903|583811144|FG000|Overall Study|Withdrawal by Subject|16|||
161661484|NCT02047903|583811144|FG000|Overall Study|Lost to Follow-up|4|||
161661485|NCT02047903|583811144|FG000|Overall Study|Reason not listed|6|||
161661486|NCT02047903|583811144|FG000|Overall Study|Not Treated|9|||
161661487|NCT01942590|583811148|FG000|Overall Study|Withdrawal by Subject|0|||
161661488|NCT01942590|583811149|FG001|Overall Study|Withdrawal by Subject|1|||
161661489|NCT01942590|583811148|FG000|Overall Study|Adverse Event|1|||
161661490|NCT01942590|583811149|FG001|Overall Study|Adverse Event|0|||
161661491|NCT02433340|583811150|FG000|Overall Study|Adverse Event|0|||
161661492|NCT02433340|583811151|FG001|Overall Study|Adverse Event|0|||
161661493|NCT02433340|583811152|FG002|Overall Study|Adverse Event|1|||
161661494|NCT02433340|583811153|FG003|Overall Study|Adverse Event|0|||
161661495|NCT02433340|583811150|FG000|Overall Study|Withdrawal by Subject|1|||
161661496|NCT02433340|583811151|FG001|Overall Study|Withdrawal by Subject|0|||
161661497|NCT02433340|583811152|FG002|Overall Study|Withdrawal by Subject|1|||
161661498|NCT02433340|583811153|FG003|Overall Study|Withdrawal by Subject|2|||
161711138|NCT02305563|583985832|FG004|Treatment Period|Participant request to stop therapy|0|||
161711139|NCT02305563|583985828|FG000|Treatment Period|Participant withdrew consent|0|||
161711140|NCT02305563|583985829|FG001|Treatment Period|Participant withdrew consent|0|||
161711141|NCT02305563|583985830|FG002|Treatment Period|Participant withdrew consent|1|||
161711142|NCT02305563|583985831|FG003|Treatment Period|Participant withdrew consent|1|||
161711143|NCT02305563|583985832|FG004|Treatment Period|Participant withdrew consent|1|||
161711144|NCT02305563|583985828|FG000|Treatment Period|Maximum clinical benefit|0|||
161711145|NCT02305563|583985829|FG001|Treatment Period|Maximum clinical benefit|0|||
161711146|NCT02305563|583985830|FG002|Treatment Period|Maximum clinical benefit|0|||
161711147|NCT02305563|583985831|FG003|Treatment Period|Maximum clinical benefit|0|||
161711148|NCT02305563|583985832|FG004|Treatment Period|Maximum clinical benefit|1|||
161711149|NCT02305563|583985828|FG000|Treatment Period|Poor/non-compliance|0|||
161711150|NCT02305563|583985829|FG001|Treatment Period|Poor/non-compliance|0|||
161711151|NCT02305563|583985830|FG002|Treatment Period|Poor/non-compliance|0|||
161711152|NCT02305563|583985831|FG003|Treatment Period|Poor/non-compliance|0|||
161711153|NCT02305563|583985832|FG004|Treatment Period|Poor/non-compliance|1|||
161661499|NCT02433340|583811150|FG000|Overall Study|Lost to Follow-up|0|||
161661500|NCT02433340|583811151|FG001|Overall Study|Lost to Follow-up|1|||
161711154|NCT02305563|583985828|FG000|Treatment Period|Administrative reason by Sponsor|0|||
161711155|NCT02305563|583985829|FG001|Treatment Period|Administrative reason by Sponsor|0|||
161661501|NCT02433340|583811152|FG002|Overall Study|Lost to Follow-up|0|||
161661502|NCT02433340|583811153|FG003|Overall Study|Lost to Follow-up|0|||
161661503|NCT02433340|583811150|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
161661504|NCT02433340|583811151|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
161661505|NCT02433340|583811152|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
161661506|NCT02433340|583811153|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
161661507|NCT02433340|583811150|FG000|Overall Study|Other|0|||
161711156|NCT02305563|583985830|FG002|Treatment Period|Administrative reason by Sponsor|0|||
161711157|NCT02305563|583985831|FG003|Treatment Period|Administrative reason by Sponsor|0|||
161711158|NCT02305563|583985832|FG004|Treatment Period|Administrative reason by Sponsor|1|||
161711159|NCT02305563|583985828|FG000|Treatment Period|other reason|2|||
161711160|NCT02305563|583985829|FG001|Treatment Period|other reason|0|||
161661508|NCT02433340|583811151|FG001|Overall Study|Other|1|||
161661509|NCT02433340|583811152|FG002|Overall Study|Other|0|||
161661510|NCT02433340|583811153|FG003|Overall Study|Other|0|||
161711161|NCT02305563|583985830|FG002|Treatment Period|other reason|2|||
161711162|NCT02305563|583985831|FG003|Treatment Period|other reason|2|||
161711163|NCT02305563|583985832|FG004|Treatment Period|other reason|1|||
161711164|NCT02305563|583985828|FG000|Treatment Period|Randomized but not treated|0|||
161711165|NCT02305563|583985829|FG001|Treatment Period|Randomized but not treated|0|||
161711166|NCT02305563|583985830|FG002|Treatment Period|Randomized but not treated|0|||
161711167|NCT02305563|583985831|FG003|Treatment Period|Randomized but not treated|0|||
161711168|NCT02305563|583985832|FG004|Treatment Period|Randomized but not treated|2|||
161711169|NCT02305563|583985828|FG000|Treatment Period|added ULO, then disease progression|0|||
161711170|NCT02305563|583985829|FG001|Treatment Period|added ULO, then disease progression|0|||
161711171|NCT02305563|583985830|FG002|Treatment Period|added ULO, then disease progression|0|||
161711172|NCT02305563|583985831|FG003|Treatment Period|added ULO, then disease progression|0|||
161711173|NCT02305563|583985832|FG004|Treatment Period|added ULO, then disease progression|4|||
161711174|NCT02305563|583985828|FG000|Treatment Period|added ULO; then other reason|0|||
161711175|NCT02305563|583985829|FG001|Treatment Period|added ULO; then other reason|0|||
161711176|NCT02305563|583985830|FG002|Treatment Period|added ULO; then other reason|0|||
161711177|NCT02305563|583985831|FG003|Treatment Period|added ULO; then other reason|0|||
161711178|NCT02305563|583985832|FG004|Treatment Period|added ULO; then other reason|1|||
161711179|NCT02305563|583985828|FG000|Treatment Period|added ULO, then request to stop|0|||
161711180|NCT02305563|583985829|FG001|Treatment Period|added ULO, then request to stop|0|||
161711181|NCT02305563|583985830|FG002|Treatment Period|added ULO, then request to stop|0|||
161711182|NCT02305563|583985831|FG003|Treatment Period|added ULO, then request to stop|0|||
161711183|NCT02305563|583985832|FG004|Treatment Period|added ULO, then request to stop|1|||
161711184|NCT02305563|583985828|FG000|Follow-up Period|Death|0|||
161711185|NCT02305563|583985829|FG001|Follow-up Period|Death|0|||
161711186|NCT02305563|583985830|FG002|Follow-up Period|Death|5|||
161711187|NCT02305563|583985831|FG003|Follow-up Period|Death|4|||
161711188|NCT02305563|583985832|FG004|Follow-up Period|Death|7|||
161711189|NCT02305563|583985828|FG000|Follow-up Period|Participant withdrew consent|0|||
161711190|NCT02305563|583985829|FG001|Follow-up Period|Participant withdrew consent|0|||
161711191|NCT02305563|583985830|FG002|Follow-up Period|Participant withdrew consent|2|||
161711192|NCT02305563|583985831|FG003|Follow-up Period|Participant withdrew consent|1|||
161711193|NCT02305563|583985832|FG004|Follow-up Period|Participant withdrew consent|0|||
161711194|NCT02305563|583985828|FG000|Follow-up Period|other reason|0|||
161711195|NCT02305563|583985829|FG001|Follow-up Period|other reason|0|||
161711196|NCT02305563|583985830|FG002|Follow-up Period|other reason|0|||
161711197|NCT02305563|583985831|FG003|Follow-up Period|other reason|0|||
161711198|NCT02305563|583985832|FG004|Follow-up Period|other reason|1|||
161711199|NCT02305563|583985828|FG000|Follow-up Period|Followup no longer required per protocol|3|||
161711200|NCT02305563|583985829|FG001|Follow-up Period|Followup no longer required per protocol|3|||
161711201|NCT02305563|583985830|FG002|Follow-up Period|Followup no longer required per protocol|4|||
161711202|NCT02305563|583985831|FG003|Follow-up Period|Followup no longer required per protocol|1|||
161711203|NCT02305563|583985832|FG004|Follow-up Period|Followup no longer required per protocol|4|||
161711204|NCT01275222|583985839|FG000|Phase l by Treatment|Adverse Event|1|||
161711205|NCT01275222|583985840|FG001|Phase l by Treatment|Adverse Event|4|||
161711206|NCT01275222|583985841|FG002|Phase l by Treatment|Adverse Event|2|||
161711207|NCT01275222|583985842|FG003|Phase l by Treatment|Adverse Event|3|||
161711208|NCT01275222|583985843|FG004|Phase l by Treatment|Adverse Event|0|||
161711209|NCT01275222|583985844|FG005|Phase l by Treatment|Adverse Event|0|||
161711210|NCT01275222|583985839|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711211|NCT01275222|583985840|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711212|NCT01275222|583985841|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
161711213|NCT01275222|583985842|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711214|NCT01275222|583985843|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711215|NCT01275222|583985844|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711216|NCT01275222|583985839|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711217|NCT01275222|583985840|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711218|NCT01275222|583985841|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711219|NCT01275222|583985842|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
161711220|NCT01275222|583985843|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711221|NCT01275222|583985844|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711222|NCT01275222|583985839|FG000|Phase l by Treatment|Disease progression|12|||
161711223|NCT01275222|583985840|FG001|Phase l by Treatment|Disease progression|8|||
161711224|NCT01275222|583985841|FG002|Phase l by Treatment|Disease progression|2|||
161711225|NCT01275222|583985842|FG003|Phase l by Treatment|Disease progression|5|||
161711226|NCT01275222|583985843|FG004|Phase l by Treatment|Disease progression|0|||
161711227|NCT01275222|583985844|FG005|Phase l by Treatment|Disease progression|0|||
161711228|NCT01275222|583985839|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
161711229|NCT01275222|583985840|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
161711230|NCT01275222|583985841|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
161711231|NCT01275222|583985842|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
161711232|NCT01275222|583985843|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
161711233|NCT01275222|583985844|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
161711234|NCT01275222|583985839|FG000|Phase l by Treatment|Death|0|||
161711235|NCT01275222|583985840|FG001|Phase l by Treatment|Death|1|||
161711236|NCT01275222|583985841|FG002|Phase l by Treatment|Death|0|||
161711237|NCT01275222|583985842|FG003|Phase l by Treatment|Death|1|||
161711238|NCT01275222|583985843|FG004|Phase l by Treatment|Death|0|||
161711239|NCT01275222|583985844|FG005|Phase l by Treatment|Death|0|||
161711240|NCT01275222|583985839|FG000|Phase ll by Stratum|Adverse Event|0|||
161711241|NCT01275222|583985840|FG001|Phase ll by Stratum|Adverse Event|0|||
161711242|NCT01275222|583985841|FG002|Phase ll by Stratum|Adverse Event|0|||
161711243|NCT01275222|583985842|FG003|Phase ll by Stratum|Adverse Event|0|||
161711244|NCT01275222|583985843|FG004|Phase ll by Stratum|Adverse Event|2|||
161711245|NCT01275222|583985844|FG005|Phase ll by Stratum|Adverse Event|10|||
161711246|NCT01275222|583985839|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
161711247|NCT01275222|583985840|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
161711248|NCT01275222|583985841|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
161711249|NCT01275222|583985842|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
161711250|NCT01275222|583985843|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
161711251|NCT01275222|583985844|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
161711252|NCT01275222|583985839|FG000|Phase ll by Stratum|Disease progression|0|||
161711253|NCT01275222|583985840|FG001|Phase ll by Stratum|Disease progression|0|||
161711254|NCT01275222|583985841|FG002|Phase ll by Stratum|Disease progression|0|||
161711255|NCT01275222|583985842|FG003|Phase ll by Stratum|Disease progression|0|||
161711256|NCT01275222|583985843|FG004|Phase ll by Stratum|Disease progression|23|||
161711257|NCT01275222|583985844|FG005|Phase ll by Stratum|Disease progression|31|||
161711258|NCT01275222|583985839|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
161711259|NCT01275222|583985840|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
161711260|NCT01275222|583985841|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
161711261|NCT01275222|583985842|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
161711262|NCT01275222|583985843|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
161711263|NCT01275222|583985844|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
161711264|NCT01275222|583985839|FG000|Phase ll by Stratum|Death|0|||
161711265|NCT01275222|583985840|FG001|Phase ll by Stratum|Death|0|||
161711266|NCT01275222|583985841|FG002|Phase ll by Stratum|Death|0|||
161711267|NCT01275222|583985842|FG003|Phase ll by Stratum|Death|0|||
161711268|NCT01275222|583985843|FG004|Phase ll by Stratum|Death|1|||
161711269|NCT01275222|583985844|FG005|Phase ll by Stratum|Death|1|||
161711270|NCT05202808|583985845|FG000|Overall Study|Lost to Follow-up|3|||
161711271|NCT05202808|583985846|FG001|Overall Study|Lost to Follow-up|1|||
161711272|NCT02495948|583985849|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
161711273|NCT02495948|583985850|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
161711274|NCT02495948|583985849|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
161711275|NCT02495948|583985850|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
161711276|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
161711277|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711278|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711279|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711280|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711281|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
161711282|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161711283|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
161711284|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
161711285|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161711286|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161711287|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
161711288|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
161711289|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
161711290|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161711291|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161711292|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161711293|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
161711294|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
161711295|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
161711296|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
161711297|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
161711298|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
161711299|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
161711300|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
161711301|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
161711302|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
161711303|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
161711304|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
161711305|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
161711306|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
161711307|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
161711308|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
161711309|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
161711310|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
161711311|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
161711312|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
161711313|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
161711314|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
161711315|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
161711316|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
161711317|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
161711318|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711319|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711320|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711321|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
161711322|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711323|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711324|NCT02722044|583985859|FG000|Overall Study|Adverse Event|2|||
161711325|NCT02722044|583985859|FG000|Overall Study|Physician Decision|1|||
161711326|NCT02722044|583985859|FG000|Overall Study|Withdrawal by Subject|1|||
161711327|NCT02722044|583985859|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
161711328|NCT04885257|583985863|FG000|Overall Study|Withdrawal by Subject|1|||
161711329|NCT04885257|583985864|FG001|Overall Study|Withdrawal by Subject|0|||
161711330|NCT00818259|583985865|FG000|Part I|Withdrawal by Subject|1|||
161711331|NCT00818259|583985866|FG001|Part I|Withdrawal by Subject|0|||
161711332|NCT00818259|583985867|FG002|Part I|Withdrawal by Subject|0|||
161711333|NCT00818259|583985868|FG003|Part I|Withdrawal by Subject|0|||
161711334|NCT00818259|583985869|FG004|Part I|Withdrawal by Subject|0|||
161711335|NCT00818259|583985870|FG005|Part I|Withdrawal by Subject|0|||
161711336|NCT00818259|583985871|FG006|Part I|Withdrawal by Subject|0|||
161711337|NCT00818259|583985872|FG007|Part I|Withdrawal by Subject|0|||
161711338|NCT00818259|583985873|FG008|Part I|Withdrawal by Subject|0|||
161711339|NCT00818259|583985865|FG000|Part II|Physician Decision|0|||
161711340|NCT00818259|583985866|FG001|Part II|Physician Decision|0|||
161711341|NCT00818259|583985867|FG002|Part II|Physician Decision|1|||
161711342|NCT00818259|583985868|FG003|Part II|Physician Decision|0|||
161711343|NCT00818259|583985869|FG004|Part II|Physician Decision|0|||
161711344|NCT00818259|583985870|FG005|Part II|Physician Decision|0|||
161711345|NCT00818259|583985871|FG006|Part II|Physician Decision|0|||
161711346|NCT00818259|583985872|FG007|Part II|Physician Decision|0|||
161711347|NCT00818259|583985873|FG008|Part II|Physician Decision|0|||
161711348|NCT00818259|583985865|FG000|Part II|Lack of Efficacy|0|||
161711349|NCT00818259|583985866|FG001|Part II|Lack of Efficacy|0|||
161711350|NCT00818259|583985867|FG002|Part II|Lack of Efficacy|0|||
161711351|NCT00818259|583985868|FG003|Part II|Lack of Efficacy|1|||
161711352|NCT00818259|583985869|FG004|Part II|Lack of Efficacy|0|||
161711353|NCT00818259|583985870|FG005|Part II|Lack of Efficacy|0|||
161711354|NCT00818259|583985871|FG006|Part II|Lack of Efficacy|0|||
161711355|NCT00818259|583985872|FG007|Part II|Lack of Efficacy|0|||
161711356|NCT00818259|583985873|FG008|Part II|Lack of Efficacy|0|||
161711357|NCT00818259|583985865|FG000|Part II|Not Treated|0|||
161711358|NCT00818259|583985866|FG001|Part II|Not Treated|0|||
161711359|NCT00818259|583985867|FG002|Part II|Not Treated|0|||
161711360|NCT00818259|583985868|FG003|Part II|Not Treated|1|||
161711361|NCT00818259|583985869|FG004|Part II|Not Treated|0|||
161711362|NCT00818259|583985870|FG005|Part II|Not Treated|0|||
161711363|NCT00818259|583985871|FG006|Part II|Not Treated|0|||
161711364|NCT00818259|583985872|FG007|Part II|Not Treated|0|||
161711365|NCT00818259|583985873|FG008|Part II|Not Treated|0|||
161711366|NCT00818259|583985865|FG000|Part IV|Physician Decision|0|||
161661511|NCT01226095|583811154|FG000|Overall Study|Poor compliance|1|||
161661512|NCT00911768|583811165|FG000|Overall Study|Protocol Violation|5|||
161661513|NCT00911768|583811166|FG001|Overall Study|Protocol Violation|4|||
161661514|NCT00911768|583811165|FG000|Overall Study|Withdrawal by Subject|1|||
161661515|NCT00911768|583811166|FG001|Overall Study|Withdrawal by Subject|0|||
161661516|NCT03406078|583811168|FG000|Overall Study|Death|1|||
161661517|NCT03406078|583811169|FG001|Overall Study|Death|0|||
161661518|NCT03406078|583811168|FG000|Overall Study|Lost to Follow-up|0|||
161661519|NCT03406078|583811169|FG001|Overall Study|Lost to Follow-up|1|||
161661520|NCT03406078|583811168|FG000|Overall Study|Withdrawal by Subject|5|||
161711367|NCT00818259|583985866|FG001|Part IV|Physician Decision|0|||
161711368|NCT00818259|583985867|FG002|Part IV|Physician Decision|0|||
161711369|NCT00818259|583985868|FG003|Part IV|Physician Decision|0|||
161711370|NCT00818259|583985869|FG004|Part IV|Physician Decision|0|||
161711371|NCT00818259|583985870|FG005|Part IV|Physician Decision|1|||
161711372|NCT00818259|583985871|FG006|Part IV|Physician Decision|0|||
161711373|NCT00818259|583985872|FG007|Part IV|Physician Decision|0|||
161711374|NCT00818259|583985873|FG008|Part IV|Physician Decision|0|||
161711375|NCT00818259|583985865|FG000|Part V|Adverse Event|0|||
161711376|NCT00818259|583985866|FG001|Part V|Adverse Event|0|||
161711377|NCT00818259|583985867|FG002|Part V|Adverse Event|0|||
161711378|NCT00818259|583985868|FG003|Part V|Adverse Event|0|||
161711379|NCT00818259|583985869|FG004|Part V|Adverse Event|0|||
161711380|NCT00818259|583985870|FG005|Part V|Adverse Event|0|||
161711381|NCT00818259|583985871|FG006|Part V|Adverse Event|0|||
161711382|NCT00818259|583985872|FG007|Part V|Adverse Event|1|||
161711383|NCT00818259|583985873|FG008|Part V|Adverse Event|0|||
161711384|NCT04640766|583985874|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
161711385|NCT00609622|583985875|FG000|Overall Study|Adverse Event|14|||
161711386|NCT00609622|583985876|FG001|Overall Study|Adverse Event|10|||
161711387|NCT00609622|583985875|FG000|Overall Study|Withdrawal by Subject|4|||
161711388|NCT00609622|583985876|FG001|Overall Study|Withdrawal by Subject|20|||
161711389|NCT00609622|583985875|FG000|Overall Study|Death|1|||
161711390|NCT00609622|583985876|FG001|Overall Study|Death|4|||
161711391|NCT00609622|583985875|FG000|Overall Study|Protocol Violation|1|||
161711392|NCT00609622|583985876|FG001|Overall Study|Protocol Violation|1|||
161711393|NCT00609622|583985875|FG000|Overall Study|Objective progression or relapse|47|||
161711394|NCT00609622|583985876|FG001|Overall Study|Objective progression or relapse|41|||
161711395|NCT00609622|583985875|FG000|Overall Study|Study terminated by sponsor|16|||
161711396|NCT00609622|583985876|FG001|Overall Study|Study terminated by sponsor|3|||
161711397|NCT00609622|583985875|FG000|Overall Study|Other|7|||
161711398|NCT00609622|583985876|FG001|Overall Study|Other|14|||
161711399|NCT00609622|583985875|FG000|Overall Study|Global deterioration of health status|6|||
161711400|NCT00609622|583985876|FG001|Overall Study|Global deterioration of health status|2|||
161711401|NCT01237951|583985877|FG000|Overall Study|Death|1|||
161711402|NCT01708057|583985880|FG000|Overall Study|Withdrawal due to study termination.|1|||
161711403|NCT01708057|583985881|FG001|Overall Study|Withdrawal due to study termination.|1|||
161711404|NCT01708057|583985882|FG002|Overall Study|Withdrawal due to study termination.|1|||
161711405|NCT02970929|583985887|FG000|Overall Study|Adverse Event|18|||
161711406|NCT02970929|583985887|FG000|Overall Study|Lack of Efficacy|8|||
161711407|NCT02970929|583985887|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
161711408|NCT02970929|583985887|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
161711409|NCT02970929|583985887|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
161711410|NCT02970929|583985887|FG000|Overall Study|LOST TO FOLLOWUP|6|||
161711411|NCT02970929|583985887|FG000|Overall Study|MOVED OUT OF STATE|1|||
161711412|NCT02970929|583985887|FG000|Overall Study|Withdrawal by Subject|16|||
161711413|NCT00666562|583985890|FG000|Overall Study|Withdrawal by Subject|0|||
161711414|NCT00666562|583985891|FG001|Overall Study|Withdrawal by Subject|1|||
161711415|NCT00666562|583985892|FG002|Overall Study|Withdrawal by Subject|0|||
161711416|NCT00666562|583985890|FG000|Overall Study|Concomitant Medication|0|||
161711417|NCT00666562|583985891|FG001|Overall Study|Concomitant Medication|1|||
161711418|NCT00666562|583985892|FG002|Overall Study|Concomitant Medication|0|||
161711419|NCT01024244|583987428|FG000|Overall Study|Adverse Event|1|||
161711420|NCT01024244|583987429|FG001|Overall Study|Adverse Event|2|||
161711421|NCT01024244|583987430|FG002|Overall Study|Adverse Event|0|||
161711422|NCT01024244|583987431|FG003|Overall Study|Adverse Event|1|||
161711423|NCT01024244|583987432|FG004|Overall Study|Adverse Event|2|||
161711424|NCT01024244|583987428|FG000|Overall Study|Entry Criteria Not Met|0|||
161711425|NCT01024244|583987429|FG001|Overall Study|Entry Criteria Not Met|1|||
161711426|NCT01024244|583987430|FG002|Overall Study|Entry Criteria Not Met|0|||
161711427|NCT01024244|583987431|FG003|Overall Study|Entry Criteria Not Met|0|||
161711428|NCT01024244|583987432|FG004|Overall Study|Entry Criteria Not Met|0|||
161711429|NCT01024244|583987428|FG000|Overall Study|Lack of Efficacy|1|||
161711430|NCT01024244|583987429|FG001|Overall Study|Lack of Efficacy|0|||
161711431|NCT01024244|583987430|FG002|Overall Study|Lack of Efficacy|0|||
161711432|NCT01024244|583987431|FG003|Overall Study|Lack of Efficacy|0|||
161711433|NCT01024244|583987432|FG004|Overall Study|Lack of Efficacy|0|||
161711434|NCT01024244|583987428|FG000|Overall Study|Protocol Violation|1|||
161711435|NCT01024244|583987429|FG001|Overall Study|Protocol Violation|0|||
161711436|NCT01024244|583987430|FG002|Overall Study|Protocol Violation|0|||
161661521|NCT03406078|583811169|FG001|Overall Study|Withdrawal by Subject|2|||
161661522|NCT03616977|583811173|FG000|Period 1|Physician Decision|0|||
161661523|NCT03616977|583811174|FG001|Period 1|Physician Decision|1|||
161661524|NCT03616977|583811173|FG000|Period 3|Adverse Event|1|||
161661525|NCT03616977|583811174|FG001|Period 3|Adverse Event|1|||
161661526|NCT00591851|583811175|FG000|Overall Study|Withdrawal by Subject|3|||
161661527|NCT00591851|583811175|FG000|Overall Study|Adverse Event|2|||
161661528|NCT00591851|583811175|FG000|Overall Study|Progressive Disease|1|||
161661529|NCT00515853|583811176|FG000|Overall Study|Lost to Follow-up|9|||
161661530|NCT00515853|583811177|FG001|Overall Study|Lost to Follow-up|13|||
161661531|NCT00515853|583811176|FG000|Overall Study|Withdrawal by Subject|6|||
161661532|NCT00515853|583811177|FG001|Overall Study|Withdrawal by Subject|4|||
161661533|NCT00943111|583811182|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
161661534|NCT00943111|583811183|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
161661535|NCT00943111|583811184|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
161661536|NCT00943111|583811182|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
161661537|NCT00943111|583811183|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
161661538|NCT00943111|583811184|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
161661539|NCT00943111|583811182|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
161661540|NCT00943111|583811183|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
161661541|NCT00943111|583811184|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
161661542|NCT00943111|583811182|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
161661543|NCT00943111|583811183|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
161661544|NCT00943111|583811184|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
161661545|NCT00943111|583811182|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
161661546|NCT00943111|583811183|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
161661547|NCT00943111|583811184|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
161661548|NCT00943111|583811182|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
161661549|NCT00943111|583811183|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
161661550|NCT00943111|583811184|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
161661551|NCT00943111|583811182|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
161661552|NCT00943111|583811183|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
161661553|NCT00943111|583811184|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
161661554|NCT00943111|583811182|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
161661555|NCT00943111|583811183|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
161661556|NCT00943111|583811184|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
161661557|NCT03798691|583811185|FG000|Overall Study|Lost to Follow-up|2|||
161661558|NCT03798691|583811186|FG001|Overall Study|Lost to Follow-up|2|||
161661559|NCT00953407|583813308|FG000|Overall Study|Failed inclusion criteria|1|||
161661560|NCT00953407|583813309|FG001|Overall Study|Failed inclusion criteria|1|||
161661561|NCT00953407|583813310|FG002|Overall Study|Failed inclusion criteria|1|||
161661562|NCT00953407|583813311|FG003|Overall Study|Failed inclusion criteria|1|||
161661563|NCT00953407|583813312|FG004|Overall Study|Failed inclusion criteria|1|||
161661564|NCT00953407|583813308|FG000|Overall Study|Lost to Follow-up|0|||
161661565|NCT00953407|583813309|FG001|Overall Study|Lost to Follow-up|0|||
161661566|NCT00953407|583813310|FG002|Overall Study|Lost to Follow-up|0|||
161661567|NCT00953407|583813311|FG003|Overall Study|Lost to Follow-up|1|||
161661568|NCT00953407|583813312|FG004|Overall Study|Lost to Follow-up|0|||
161661569|NCT02502097|583813313|FG000|Period 1|Adverse Event|0|||
161661570|NCT02502097|583813314|FG001|Period 1|Adverse Event|0|||
161661571|NCT02502097|583813315|FG002|Period 1|Adverse Event|1|||
161661572|NCT02502097|583813316|FG003|Period 1|Adverse Event|0|||
161661573|NCT02502097|583813313|FG000|Wash Out Period|Adverse Event|0|||
161661574|NCT02502097|583813314|FG001|Wash Out Period|Adverse Event|1|||
161661575|NCT02502097|583813315|FG002|Wash Out Period|Adverse Event|1|||
161661576|NCT02502097|583813316|FG003|Wash Out Period|Adverse Event|1|||
161661577|NCT02502097|583813313|FG000|Period 2|Adverse Event|0|||
161661578|NCT02502097|583813314|FG001|Period 2|Adverse Event|0|||
161661579|NCT02502097|583813315|FG002|Period 2|Adverse Event|1|||
161661580|NCT02502097|583813316|FG003|Period 2|Adverse Event|0|||
161661581|NCT02186223|583813317|FG000|Overall Study|Not eligible for device placement|6|||
161661582|NCT02186223|583813317|FG000|Overall Study|Unable to obtain femoral access|3|||
161661583|NCT02186223|583813317|FG000|Overall Study|Death|3|||
161661584|NCT02186223|583813317|FG000|Overall Study|Device in place less than 48 hours|9|||
161661585|NCT01111474|583813318|FG000|Overall Study|Lost to Follow-up|12|||
161661586|NCT00618982|583813319|FG000|Overall Study|Adverse Event|23|||
161661587|NCT00618982|583813319|FG000|Overall Study|Withdrawal by Subject|1|||
161661588|NCT00618982|583813319|FG000|Overall Study|Protocol Violation|1|||
161661589|NCT00618982|583813319|FG000|Overall Study|ongoing, still treated with study med.|25|||
161661590|NCT00642772|583813321|FG000|Overall Study|Lost to Follow-up|3|||
161661591|NCT00642772|583813321|FG000|Overall Study|Withdrawal by Subject|7|||
161661592|NCT05398237|583813326|FG000|Overall Study|Withdrawal by Subject|1|||
161661593|NCT01312857|583813329|FG000|Overall Study|Adverse Event|1|||
161661594|NCT01312857|583813330|FG001|Overall Study|Adverse Event|1|||
161661595|NCT01312857|583813329|FG000|Overall Study|Lost to Follow-up|2|||
161661596|NCT01312857|583813330|FG001|Overall Study|Lost to Follow-up|0|||
161661597|NCT01312857|583813329|FG000|Overall Study|Physician Decision|3|||
161661598|NCT01312857|583813330|FG001|Overall Study|Physician Decision|0|||
161661599|NCT01312857|583813329|FG000|Overall Study|Withdrawal by Subject|2|||
161661600|NCT01312857|583813330|FG001|Overall Study|Withdrawal by Subject|0|||
161711437|NCT01024244|583987431|FG003|Overall Study|Protocol Violation|0|||
161711438|NCT01024244|583987432|FG004|Overall Study|Protocol Violation|2|||
161711439|NCT01024244|583987428|FG000|Overall Study|Sponsor Decision|14|||
161711440|NCT01024244|583987429|FG001|Overall Study|Sponsor Decision|7|||
161711441|NCT01024244|583987430|FG002|Overall Study|Sponsor Decision|14|||
161711442|NCT01024244|583987431|FG003|Overall Study|Sponsor Decision|12|||
161711443|NCT01024244|583987432|FG004|Overall Study|Sponsor Decision|10|||
161711444|NCT01024244|583987428|FG000|Overall Study|Withdrawal by Subject|0|||
161711445|NCT01024244|583987429|FG001|Overall Study|Withdrawal by Subject|1|||
161711446|NCT01024244|583987430|FG002|Overall Study|Withdrawal by Subject|0|||
161711447|NCT01024244|583987431|FG003|Overall Study|Withdrawal by Subject|0|||
161711448|NCT01024244|583987432|FG004|Overall Study|Withdrawal by Subject|0|||
161711449|NCT03874234|583987437|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711450|NCT03874234|583987438|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711451|NCT03874234|583987439|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711452|NCT03874234|583987440|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
161711453|NCT03874234|583987441|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711454|NCT03874234|583987442|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711455|NCT03874234|583987443|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711456|NCT03874234|583987444|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711457|NCT03874234|583987445|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711458|NCT03874234|583987446|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711459|NCT03874234|583987447|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711460|NCT03874234|583987448|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711461|NCT03874234|583987449|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711462|NCT03874234|583987437|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
161711463|NCT03874234|583987438|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711464|NCT03874234|583987439|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711465|NCT03874234|583987440|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711466|NCT03874234|583987441|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711467|NCT03874234|583987442|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711468|NCT03874234|583987443|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711469|NCT03874234|583987444|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711470|NCT03874234|583987445|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711471|NCT03874234|583987446|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711472|NCT03874234|583987447|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711473|NCT03874234|583987448|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711474|NCT03874234|583987449|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711475|NCT03874234|583987437|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711476|NCT03874234|583987438|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711477|NCT03874234|583987439|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711478|NCT03874234|583987440|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
161711479|NCT03874234|583987441|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711480|NCT03874234|583987442|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711481|NCT03874234|583987443|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711482|NCT03874234|583987444|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711483|NCT03874234|583987445|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711484|NCT03874234|583987446|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711485|NCT03874234|583987447|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711486|NCT03874234|583987448|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711487|NCT03874234|583987449|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711488|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711489|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711490|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711491|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711492|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
161711493|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711494|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711495|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711496|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711497|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711498|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711499|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711500|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711501|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711502|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711503|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711504|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711505|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711506|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711507|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711508|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
161711509|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711510|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711511|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711512|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711513|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711514|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711515|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711516|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711517|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711518|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
161711519|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
161711520|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711521|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711522|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711523|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711524|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711525|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711526|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711527|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711528|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711529|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711530|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711531|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711532|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711533|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
161711534|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711535|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711536|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711537|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711538|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711539|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711540|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711541|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711542|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711543|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711544|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
161711545|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711546|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711547|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711548|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711549|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711550|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711551|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711552|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711553|NCT01896232|583987455|FG000|Overall Study|Death|6|||
161711554|NCT01896232|583987456|FG001|Overall Study|Death|10|||
161711555|NCT01896232|583987455|FG000|Overall Study|Withdrawal by Subject|32|||
161711556|NCT01896232|583987456|FG001|Overall Study|Withdrawal by Subject|31|||
161711557|NCT01896232|583987455|FG000|Overall Study|Sponsor Decision|2|||
161711558|NCT01896232|583987456|FG001|Overall Study|Sponsor Decision|0|||
161711559|NCT01896232|583987455|FG000|Overall Study|Lost to Follow-up|9|||
161711560|NCT01896232|583987456|FG001|Overall Study|Lost to Follow-up|12|||
161711561|NCT00686205|583987457|FG000|Overall Study|Protocol Violation|127|||
161711562|NCT00686205|583987458|FG001|Overall Study|Protocol Violation|0|||
161711563|NCT00686205|583987457|FG000|Overall Study|Withdrawal by Subject|2|||
161711564|NCT00686205|583987458|FG001|Overall Study|Withdrawal by Subject|0|||
161711565|NCT00686205|583987457|FG000|Overall Study|Specimen handling procedure altered|5878|||
161711566|NCT00686205|583987458|FG001|Overall Study|Specimen handling procedure altered|0|||
161711567|NCT00686205|583987457|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
161711568|NCT00686205|583987458|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
161711569|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
161711570|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
161711571|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
161711572|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
161711573|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
161711574|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
161711575|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
161711576|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
161711577|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
161711578|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
161711579|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
161711580|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
161711581|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
161711582|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
161711583|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
161711584|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
161711585|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
161711586|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
161711587|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
161711588|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
161711589|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
161711590|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
161711591|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
161711592|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
161711593|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
161711594|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
161711595|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
161711596|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
161711597|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
161711598|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
161711599|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
161711600|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
161711601|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
161711602|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
161711603|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
161711604|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
161711605|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
161711606|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
161711607|NCT03168867|583987473|FG000|Overall Study|Withdrawal by Subject|1|||
161711608|NCT03168867|583987474|FG001|Overall Study|Withdrawal by Subject|5|||
161711609|NCT03812510|583987475|FG000|Overall Study|Lost to Follow-up|39|||
161711610|NCT03812510|583987475|FG000|Overall Study|Withdrawal by Subject|42|||
161711611|NCT03812510|583987475|FG000|Overall Study|Physician Decision|2|||
161711612|NCT03812510|583987475|FG000|Overall Study|Study Terminated by Sponsor|9|||
161711613|NCT03812510|583987475|FG000|Overall Study|Did Not Start Study Medication|55|||
161711614|NCT03812510|583987475|FG000|Overall Study|Adverse Event|5|||
161711615|NCT01535235|583987476|FG000|Overall Study|Adverse Event|1|||
161711616|NCT01535235|583987477|FG001|Overall Study|Adverse Event|0|||
161711617|NCT00858832|583987478|FG000|Overall Study|became ineligible: delivered vaginally|1|||
161711618|NCT00858832|583987479|FG001|Overall Study|became ineligible: delivered vaginally|0|||
161711619|NCT00858832|583987478|FG000|Overall Study|Adverse Event|0|||
161711620|NCT00858832|583987479|FG001|Overall Study|Adverse Event|1|||
161711621|NCT03075839|583987487|FG000|Overall Study|Lost to Follow-up|4|||
161711622|NCT05421754|583987492|FG000|Overall Study|Technical issue with sensor|1|||
161711623|NCT04433117|583987493|FG000|Overall Study|Withdrawal by Subject|1|||
161711624|NCT04433117|583987494|FG001|Overall Study|Withdrawal by Subject|0|||
161711625|NCT01051739|583987495|FG000|Overall Study|Death|3|||
161711626|NCT01051739|583987496|FG001|Overall Study|Death|3|||
161711627|NCT01051739|583987495|FG000|Overall Study|Withdrawal by Subject|25|||
161711628|NCT01051739|583987496|FG001|Overall Study|Withdrawal by Subject|10|||
161711629|NCT00824421|583987497|FG000|Overall Study|Adverse Event|6|||
161711630|NCT00824421|583987498|FG001|Overall Study|Adverse Event|6|||
161711631|NCT00824421|583987499|FG002|Overall Study|Adverse Event|6|||
161711632|NCT00824421|583987497|FG000|Overall Study|Death|0|||
161711633|NCT00824421|583987498|FG001|Overall Study|Death|1|||
161711634|NCT00824421|583987499|FG002|Overall Study|Death|0|||
161711635|NCT00824421|583987497|FG000|Overall Study|Lack of Efficacy|5|||
161711636|NCT00824421|583987498|FG001|Overall Study|Lack of Efficacy|7|||
161711637|NCT00824421|583987499|FG002|Overall Study|Lack of Efficacy|4|||
161711638|NCT00824421|583987497|FG000|Overall Study|Lost to Follow-up|2|||
161711639|NCT00824421|583987498|FG001|Overall Study|Lost to Follow-up|3|||
161711640|NCT00824421|583987499|FG002|Overall Study|Lost to Follow-up|0|||
161711641|NCT00824421|583987497|FG000|Overall Study|Pregnancy|1|||
161711642|NCT00824421|583987498|FG001|Overall Study|Pregnancy|0|||
161711643|NCT00824421|583987499|FG002|Overall Study|Pregnancy|1|||
161711644|NCT00824421|583987497|FG000|Overall Study|Withdrawal by Subject|2|||
161711645|NCT00824421|583987498|FG001|Overall Study|Withdrawal by Subject|3|||
161711646|NCT00824421|583987499|FG002|Overall Study|Withdrawal by Subject|3|||
161711647|NCT00824421|583987497|FG000|Overall Study|Randomized but not Treated|1|||
161711648|NCT00824421|583987498|FG001|Overall Study|Randomized but not Treated|1|||
161711649|NCT00824421|583987499|FG002|Overall Study|Randomized but not Treated|0|||
161711650|NCT00824421|583987497|FG000|Overall Study|Other|0|||
161711651|NCT00824421|583987498|FG001|Overall Study|Other|1|||
161711652|NCT00824421|583987499|FG002|Overall Study|Other|0|||
161711653|NCT05089708|583987501|FG000|Overall Study|Lost to Follow-up|9|||
161711654|NCT05089708|583987502|FG001|Overall Study|Lost to Follow-up|7|||
161711655|NCT05089708|583987501|FG000|Overall Study|Withdrawal by Subject|3|||
161711656|NCT05089708|583987502|FG001|Overall Study|Withdrawal by Subject|1|||
161711657|NCT05089708|583987501|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
161711658|NCT05089708|583987502|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
161711659|NCT05089708|583987501|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
161711660|NCT05089708|583987502|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
161711661|NCT00659438|583987503|FG000|Overall Study|Withdrawal by Subject|2|||
161711662|NCT00659438|583987504|FG001|Overall Study|Withdrawal by Subject|2|||
161711663|NCT00659438|583987503|FG000|Overall Study|Death|11|||
161711664|NCT00659438|583987504|FG001|Overall Study|Death|6|||
161711665|NCT00659438|583987503|FG000|Overall Study|Lost to Follow-up|1|||
161711666|NCT00659438|583987504|FG001|Overall Study|Lost to Follow-up|0|||
161711667|NCT00201851|583987505|FG000|Overall Study|Lost to Follow-up|2|||
161711668|NCT00201851|583987506|FG001|Overall Study|Lost to Follow-up|1|||
161711669|NCT00201851|583987507|FG002|Overall Study|Lost to Follow-up|0|||
161711670|NCT00201851|583987505|FG000|Overall Study|Ineligible post enrollment|6|||
161711671|NCT00201851|583987506|FG001|Overall Study|Ineligible post enrollment|1|||
161711672|NCT00201851|583987507|FG002|Overall Study|Ineligible post enrollment|1|||
161711673|NCT02469246|583987508|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
161711674|NCT02469246|583987509|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
161711675|NCT02469246|583987508|FG000|Double-Blind Phase|Adverse Event|12|||
161711676|NCT02469246|583987509|FG001|Double-Blind Phase|Adverse Event|9|||
161711677|NCT02469246|583987508|FG000|Double-Blind Phase|Death|2|||
161711678|NCT02469246|583987509|FG001|Double-Blind Phase|Death|0|||
161711679|NCT02469246|583987508|FG000|Double-Blind Phase|Lack of Efficacy|2|||
161711680|NCT02469246|583987509|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161711681|NCT02469246|583987508|FG000|Double-Blind Phase|Investigator's Discretion|8|||
161711682|NCT02469246|583987509|FG001|Double-Blind Phase|Investigator's Discretion|8|||
161711683|NCT02469246|583987508|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161711684|NCT02469246|583987509|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161711685|NCT02469246|583987508|FG000|Double-Blind Phase|Protocol Violation|1|||
161711686|NCT02469246|583987509|FG001|Double-Blind Phase|Protocol Violation|1|||
161711687|NCT02469246|583987508|FG000|Double-Blind Phase|Withdrew Consent|25|||
161711688|NCT02469246|583987509|FG001|Double-Blind Phase|Withdrew Consent|25|||
161711689|NCT02469246|583987508|FG000|Double-Blind Phase|Lost to Follow-up|9|||
161711690|NCT02469246|583987509|FG001|Double-Blind Phase|Lost to Follow-up|5|||
161711691|NCT02690701|583987513|FG000|Treatment Period 1|Adverse Event|2|||
161711692|NCT02690701|583987514|FG001|Treatment Period 1|Adverse Event|2|||
161711693|NCT02690701|583987513|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161711694|NCT02690701|583987514|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161711695|NCT02690701|583987513|FG000|Treatment Period 2|Adverse Event|2|||
161711696|NCT02690701|583987514|FG001|Treatment Period 2|Adverse Event|0|||
161711697|NCT02690701|583987513|FG000|Treatment Period 2|Lack of Efficacy|1|||
161711698|NCT02690701|583987514|FG001|Treatment Period 2|Lack of Efficacy|0|||
161711699|NCT02690701|583987513|FG000|Treatment Period 2|Lost to Follow-up|0|||
161711700|NCT02690701|583987514|FG001|Treatment Period 2|Lost to Follow-up|2|||
161711701|NCT02690701|583987513|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161711702|NCT02690701|583987514|FG001|Treatment Period 2|Withdrawal by Subject|2|||
161711703|NCT02690701|583987513|FG000|Treatment Period 2|Protocol Violation|0|||
161711704|NCT02690701|583987514|FG001|Treatment Period 2|Protocol Violation|1|||
161711705|NCT00404092|583987518|FG000|Overall Study|Death|1|||
161711706|NCT00404092|583987519|FG001|Overall Study|Death|0|||
161661601|NCT01248065|583813335|FG000|Overall Study|Lost to Follow-up|3|||
161661602|NCT01248065|583813336|FG001|Overall Study|Lost to Follow-up|5|||
161661603|NCT01248065|583813335|FG000|Overall Study|Withdrawal by Subject|14|||
161661604|NCT01248065|583813336|FG001|Overall Study|Withdrawal by Subject|11|||
161661605|NCT01248065|583813335|FG000|Overall Study|Adverse Event|3|||
161661606|NCT01248065|583813336|FG001|Overall Study|Adverse Event|0|||
161661607|NCT01248065|583813335|FG000|Overall Study|Third treatment failure event|3|||
161661608|NCT01248065|583813336|FG001|Overall Study|Third treatment failure event|1|||
161661609|NCT01248065|583813335|FG000|Overall Study|Other|3|||
161661610|NCT01248065|583813336|FG001|Overall Study|Other|5|||
161661611|NCT02781844|583813342|FG000|Treatment Period 1|Adverse Event|0|||
161661612|NCT02781844|583813343|FG001|Treatment Period 1|Adverse Event|0|||
161661613|NCT02781844|583813344|FG002|Treatment Period 1|Adverse Event|0|||
161661614|NCT02781844|583813345|FG003|Treatment Period 1|Adverse Event|0|||
161661615|NCT02781844|583813346|FG004|Treatment Period 1|Adverse Event|0|||
161661616|NCT02781844|583813347|FG005|Treatment Period 1|Adverse Event|1|||
161661617|NCT02781844|583813348|FG006|Treatment Period 1|Adverse Event|0|||
161661618|NCT02781844|583813349|FG007|Treatment Period 1|Adverse Event|0|||
161661619|NCT04256629|583813352|FG000|Overall Study|Adverse Event|0|||
161661620|NCT04256629|583813353|FG001|Overall Study|Adverse Event|0|||
161661621|NCT04256629|583813354|FG002|Overall Study|Adverse Event|0|||
161661622|NCT04256629|583813355|FG003|Overall Study|Adverse Event|0|||
161661623|NCT04256629|583813356|FG004|Overall Study|Adverse Event|0|||
161661624|NCT04256629|583813357|FG005|Overall Study|Adverse Event|1|||
161661625|NCT04256629|583813352|FG000|Overall Study|Protocol Violation|0|||
161661626|NCT04256629|583813353|FG001|Overall Study|Protocol Violation|1|||
161661627|NCT04256629|583813354|FG002|Overall Study|Protocol Violation|0|||
161661628|NCT04256629|583813355|FG003|Overall Study|Protocol Violation|0|||
161661629|NCT04256629|583813356|FG004|Overall Study|Protocol Violation|0|||
161661630|NCT04256629|583813357|FG005|Overall Study|Protocol Violation|0|||
161661631|NCT00321373|583813358|FG000|Overall Study|Adverse Event|0|||
161661632|NCT00321373|583813359|FG001|Overall Study|Adverse Event|0|||
161661633|NCT00321373|583813360|FG002|Overall Study|Adverse Event|1|||
161661634|NCT00321373|583813358|FG000|Overall Study|Lost to Follow-up|1|||
161661635|NCT00321373|583813359|FG001|Overall Study|Lost to Follow-up|0|||
161661636|NCT00321373|583813360|FG002|Overall Study|Lost to Follow-up|1|||
161661637|NCT00321373|583813358|FG000|Overall Study|Withdrawal by Subject|1|||
161661638|NCT00321373|583813359|FG001|Overall Study|Withdrawal by Subject|0|||
161661639|NCT00321373|583813360|FG002|Overall Study|Withdrawal by Subject|0|||
161661640|NCT00321373|583813358|FG000|Overall Study|Other|0|||
161661641|NCT00321373|583813359|FG001|Overall Study|Other|0|||
161661642|NCT00321373|583813360|FG002|Overall Study|Other|1|||
161661643|NCT01774487|583813361|FG000|Overall Study|Did not tolerate taste|4|||
161661644|NCT01774487|583813362|FG001|Overall Study|Did not tolerate taste|4|||
161661645|NCT01383499|583813363|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
161661646|NCT01383499|583813364|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161661647|NCT01383499|583813365|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161661648|NCT01383499|583813366|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161661649|NCT00477334|583813371|FG000|Overall Study|Discontinued prior to taking study drug|106|||
161661650|NCT00477334|583813372|FG001|Overall Study|Discontinued prior to taking study drug|53|||
161661651|NCT00477334|583813371|FG000|Overall Study|Adverse Event|1|||
161661652|NCT00477334|583813372|FG001|Overall Study|Adverse Event|2|||
161661653|NCT00477334|583813371|FG000|Overall Study|Withdrawal by Subject|2|||
161661654|NCT00477334|583813372|FG001|Overall Study|Withdrawal by Subject|1|||
161661655|NCT00477334|583813371|FG000|Overall Study|Lost to Follow-up|15|||
161661656|NCT00477334|583813372|FG001|Overall Study|Lost to Follow-up|4|||
161661657|NCT00477334|583813371|FG000|Overall Study|Administrative Problems|39|||
161661658|NCT00477334|583813372|FG001|Overall Study|Administrative Problems|15|||
161661659|NCT00477334|583813371|FG000|Overall Study|Protocol Violation|7|||
161661660|NCT00477334|583813372|FG001|Overall Study|Protocol Violation|1|||
161661661|NCT02572882|583813373|FG000|Overall Study|Withdrawal by Subject|1|||
161661662|NCT02572882|583813373|FG000|Overall Study|Participant received kidney transplant|1|||
161661663|NCT04275089|583813374|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
161661664|NCT01079663|583813377|FG000|Overall Study|Adverse Event|0|||
161661665|NCT01079663|583813378|FG001|Overall Study|Adverse Event|2|||
161661666|NCT01079663|583813377|FG000|Overall Study|Protocol Violation|0|||
161661667|NCT01079663|583813378|FG001|Overall Study|Protocol Violation|2|||
161661668|NCT03606668|583813382|FG000|Overall Study|Screen Failure|1|||
161661669|NCT03606668|583813382|FG000|Overall Study|Lost to Follow-up|1|||
161661670|NCT02354508|583813383|FG000|Period 1: Core Phase|Adverse Event|1|||
161661671|NCT02354508|583813384|FG001|Period 1: Core Phase|Adverse Event|1|||
161661672|NCT02354508|583813385|FG002|Period 1: Core Phase|Adverse Event|2|||
161661673|NCT02354508|583813383|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
161661674|NCT02354508|583813384|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
161661675|NCT02354508|583813385|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
161661676|NCT02354508|583813383|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
161661677|NCT02354508|583813384|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
161711707|NCT00404092|583987520|FG002|Overall Study|Death|0|||
161711708|NCT00404092|583987521|FG003|Overall Study|Death|0|||
161711709|NCT00404092|583987518|FG000|Overall Study|Adverse Event|0|||
161711710|NCT00404092|583987519|FG001|Overall Study|Adverse Event|0|||
161711711|NCT00404092|583987520|FG002|Overall Study|Adverse Event|1|||
161711712|NCT00404092|583987521|FG003|Overall Study|Adverse Event|0|||
161711713|NCT02344576|583987525|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
161711714|NCT02344576|583987526|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
161711715|NCT02344576|583987527|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
161711716|NCT02344576|583987528|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
161711717|NCT02344576|583987525|FG000|1-Month Follow-Up|Death|13|||
161711718|NCT02344576|583987526|FG001|1-Month Follow-Up|Death|8|||
161711719|NCT02344576|583987527|FG002|1-Month Follow-Up|Death|0|||
161711720|NCT02344576|583987528|FG003|1-Month Follow-Up|Death|0|||
161711721|NCT02344576|583987525|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
161711722|NCT02344576|583987526|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
161711723|NCT02344576|583987527|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
161711724|NCT02344576|583987528|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
161711725|NCT02344576|583987525|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
161711726|NCT02344576|583987526|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
161711727|NCT02344576|583987527|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
161711728|NCT02344576|583987528|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
161711729|NCT02344576|583987525|FG000|6-Month Follow-Up|Death|14|||
161711730|NCT02344576|583987526|FG001|6-Month Follow-Up|Death|14|||
161711731|NCT02344576|583987527|FG002|6-Month Follow-Up|Death|0|||
161711732|NCT02344576|583987528|FG003|6-Month Follow-Up|Death|0|||
161711733|NCT02344576|583987525|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
161711734|NCT02344576|583987526|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
161711735|NCT02344576|583987527|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
161711736|NCT02344576|583987528|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
161711737|NCT02344576|583987525|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
161711738|NCT02344576|583987526|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
161711739|NCT02344576|583987527|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
161711740|NCT02344576|583987528|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
161711741|NCT04325503|583987530|FG000|Overall Study|Withdrawal by Subject|1|||
161711742|NCT04325503|583987530|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
161711743|NCT02337387|583987531|FG000|Overall Study|Adverse Event|0|||
161711744|NCT02337387|583987532|FG001|Overall Study|Adverse Event|1|||
161711745|NCT02337387|583987533|FG002|Overall Study|Adverse Event|0|||
161711746|NCT02337387|583987534|FG003|Overall Study|Adverse Event|0|||
161711747|NCT02337387|583987531|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
161711748|NCT02337387|583987532|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
161711749|NCT02337387|583987533|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
161711750|NCT02337387|583987534|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
161711751|NCT01243268|583987535|FG000|Overall Study|Lost to Follow-up|4|||
161711752|NCT01243268|583987535|FG000|Overall Study|Protocol Violation|51|||
161711753|NCT01243268|583987535|FG000|Overall Study|Deviation with contract date|7|||
161711754|NCT01243268|583987535|FG000|Overall Study|Duplicate subject|2|||
161711755|NCT00702143|583987536|FG000|Overall Study|Lost to Follow-up|0|||
161711756|NCT00702143|583987537|FG001|Overall Study|Lost to Follow-up|0|||
161711757|NCT00702143|583987538|FG002|Overall Study|Lost to Follow-up|1|||
161711758|NCT03871491|583987541|FG000|Overall Study|Withdrawal by Subject|14|||
161711759|NCT03871491|583987542|FG001|Overall Study|Withdrawal by Subject|14|||
161711760|NCT03871491|583987543|FG002|Overall Study|Withdrawal by Subject|14|||
161711761|NCT03871491|583987544|FG003|Overall Study|Withdrawal by Subject|14|||
161711762|NCT03871491|583987541|FG000|Overall Study|Physician Decision|0|||
161711763|NCT03871491|583987542|FG001|Overall Study|Physician Decision|0|||
161711764|NCT03871491|583987543|FG002|Overall Study|Physician Decision|1|||
161711765|NCT03871491|583987544|FG003|Overall Study|Physician Decision|1|||
161711766|NCT03871491|583987541|FG000|Overall Study|Lost to Follow-up|50|||
161711767|NCT03871491|583987542|FG001|Overall Study|Lost to Follow-up|15|||
161711768|NCT03871491|583987543|FG002|Overall Study|Lost to Follow-up|36|||
161711769|NCT03871491|583987544|FG003|Overall Study|Lost to Follow-up|11|||
161711770|NCT04996797|583987545|FG000|Overall Study|Adverse Event|0|||
161711771|NCT04996797|583987546|FG001|Overall Study|Adverse Event|2|||
161711772|NCT04996797|583987547|FG002|Overall Study|Adverse Event|0|||
161711773|NCT04996797|583987548|FG003|Overall Study|Adverse Event|1|||
161711774|NCT04996797|583987545|FG000|Overall Study|Lack of Efficacy|0|||
161711775|NCT04996797|583987546|FG001|Overall Study|Lack of Efficacy|2|||
161711776|NCT04996797|583987547|FG002|Overall Study|Lack of Efficacy|0|||
161711777|NCT04996797|583987548|FG003|Overall Study|Lack of Efficacy|0|||
161711778|NCT04996797|583987545|FG000|Overall Study|Prohibited Medication|0|||
161711779|NCT04996797|583987546|FG001|Overall Study|Prohibited Medication|1|||
161711780|NCT04996797|583987547|FG002|Overall Study|Prohibited Medication|0|||
161711781|NCT04996797|583987548|FG003|Overall Study|Prohibited Medication|0|||
161711782|NCT04996797|583987545|FG000|Overall Study|Ongoing|68|||
161711783|NCT04996797|583987546|FG001|Overall Study|Ongoing|60|||
161711784|NCT04996797|583987547|FG002|Overall Study|Ongoing|22|||
161661678|NCT02354508|583813385|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
161661679|NCT02354508|583813383|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
161661680|NCT02354508|583813384|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
161661681|NCT02354508|583813385|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
161661682|NCT02354508|583813383|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
161661683|NCT02354508|583813384|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
161661684|NCT02354508|583813385|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
161661685|NCT02354508|583813383|FG000|Period 2: Extension Phase|Physician Decision|5|||
161661686|NCT02354508|583813384|FG001|Period 2: Extension Phase|Physician Decision|0|||
161661687|NCT02354508|583813385|FG002|Period 2: Extension Phase|Physician Decision|1|||
161661688|NCT02354508|583813383|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
161661689|NCT02354508|583813384|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
161661690|NCT02354508|583813385|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
161661691|NCT02354508|583813383|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
161661692|NCT02354508|583813384|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
161661693|NCT02354508|583813385|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
161661694|NCT02354508|583813383|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
161661695|NCT02354508|583813384|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
161661696|NCT02354508|583813385|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
161661697|NCT01014143|583813387|FG000|Second Intervention|Lost to Follow-up|2|||
161661698|NCT01014143|583813388|FG001|Second Intervention|Lost to Follow-up|0|||
161661699|NCT01014143|583813389|FG002|Second Intervention|Lost to Follow-up|0|||
161711785|NCT04996797|583987548|FG003|Overall Study|Ongoing|20|||
161711786|NCT04996797|583987545|FG000|Overall Study|Withdrawal by Subject|0|||
161711787|NCT04996797|583987546|FG001|Overall Study|Withdrawal by Subject|2|||
161711788|NCT04996797|583987547|FG002|Overall Study|Withdrawal by Subject|0|||
161711789|NCT04996797|583987548|FG003|Overall Study|Withdrawal by Subject|0|||
161711790|NCT02793544|583987549|FG000|Overall Study|Death|10|||
161711791|NCT02793544|583987550|FG001|Overall Study|Death|8|||
161711792|NCT02793544|583987549|FG000|Overall Study|Lost to Follow-up|2|||
161711793|NCT02793544|583987550|FG001|Overall Study|Lost to Follow-up|0|||
161711794|NCT02793544|583987549|FG000|Overall Study|Withdrawal by Subject|1|||
161711795|NCT02793544|583987550|FG001|Overall Study|Withdrawal by Subject|0|||
161711796|NCT04091217|583987553|FG000|Overall Study|Lost to Follow-up|2|||
161711797|NCT01822561|583987554|FG000|Overall Study|Withdrawal by Subject|2|||
161711798|NCT02747004|583987555|FG000|Overall Study|Withdrawal by Subject|8|||
161711799|NCT02747004|583987556|FG001|Overall Study|Withdrawal by Subject|5|||
161711800|NCT02747004|583987557|FG002|Overall Study|Withdrawal by Subject|4|||
161711801|NCT02747004|583987555|FG000|Overall Study|Lost to Follow-up|1|||
161661700|NCT04447846|583813390|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
161661701|NCT00461032|583813391|FG000|Overall Study|Adverse Event|5|||
161661702|NCT00461032|583813392|FG001|Overall Study|Adverse Event|6|||
161661703|NCT00461032|583813391|FG000|Overall Study|Lack of Efficacy|5|||
161661704|NCT00461032|583813392|FG001|Overall Study|Lack of Efficacy|1|||
161661705|NCT00461032|583813391|FG000|Overall Study|Lost to Follow-up|7|||
161661706|NCT00461032|583813392|FG001|Overall Study|Lost to Follow-up|12|||
161661707|NCT00461032|583813391|FG000|Overall Study|Protocol Violation|4|||
161661708|NCT00461032|583813392|FG001|Overall Study|Protocol Violation|4|||
161661709|NCT00461032|583813391|FG000|Overall Study|Withdrawal by Subject|7|||
161711802|NCT02747004|583987556|FG001|Overall Study|Lost to Follow-up|2|||
161711803|NCT02747004|583987557|FG002|Overall Study|Lost to Follow-up|2|||
161711804|NCT02747004|583987555|FG000|Overall Study|on study treatment/follow-up|48|||
161711805|NCT02747004|583987556|FG001|Overall Study|on study treatment/follow-up|42|||
161661710|NCT00461032|583813392|FG001|Overall Study|Withdrawal by Subject|15|||
161661711|NCT00461032|583813391|FG000|Overall Study|Patient Moved or Relocated|2|||
161711806|NCT02747004|583987557|FG002|Overall Study|on study treatment/follow-up|41|||
161711807|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
161711808|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
161711809|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161711810|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161711811|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161711812|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
161711813|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
161711814|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161711815|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161711816|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161711817|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
161711818|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711819|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711820|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711821|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711822|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
161711823|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711824|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711825|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161661712|NCT00461032|583813392|FG001|Overall Study|Patient Moved or Relocated|1|||
161661713|NCT00461032|583813391|FG000|Overall Study|Other|7|||
161661714|NCT00461032|583813392|FG001|Overall Study|Other|5|||
161661715|NCT00297232|583813395|FG000|Overall Study|Lack of Efficacy|7|||
161661716|NCT00297232|583813395|FG000|Overall Study|Lost to Follow-up|10|||
161661717|NCT00297232|583813395|FG000|Overall Study|Adverse Event|63|||
161661718|NCT00297232|583813395|FG000|Overall Study|Voluntary Withdrawal|120|||
161661719|NCT00297232|583813395|FG000|Overall Study|Subject was Noncompliant|9|||
161661720|NCT00297232|583813395|FG000|Overall Study|Death|9|||
161711826|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711827|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Death|0|||
161661721|NCT00297232|583813395|FG000|Overall Study|Anti-natalizumab Positive|8|||
161661722|NCT00297232|583813395|FG000|Overall Study|Switched to Commercial Tysabri|22|||
161661723|NCT00297232|583813395|FG000|Overall Study|Disease Progression|8|||
161661724|NCT00297232|583813395|FG000|Overall Study|Fear of PML|10|||
161711828|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Death|1|||
161711829|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Death|0|||
161711830|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Death|0|||
161661725|NCT00297232|583813395|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
161661726|NCT00297232|583813395|FG000|Overall Study|Miscellaneous|5|||
161661727|NCT00297232|583813395|FG000|Overall Study|Sponsor Decision|34|||
161661728|NCT00297232|583813395|FG000|Overall Study|Subject Relocated|7|||
161711831|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Death|0|||
161711832|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711833|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
161711834|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711835|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711836|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711837|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
161711838|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711839|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711840|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711841|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711842|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
161711843|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711844|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711845|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711846|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711847|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Other|1|||
161711848|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Other|2|||
161711849|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Other|0|||
161711850|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Other|0|||
161711851|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Other|0|||
161711852|NCT05087030|583987558|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711853|NCT05087030|583987559|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711854|NCT05087030|583987560|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711855|NCT05087030|583987561|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711856|NCT05087030|583987562|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
161711857|NCT01444300|583987563|FG000|Overall Study|Adverse Event|4|||
161711858|NCT01444300|583987564|FG001|Overall Study|Adverse Event|0|||
161711859|NCT01523873|583987570|FG000|Overall Study|Protocol Violation|422|||
161711860|NCT00942409|583989001|FG000|Overall Study|Lack of Efficacy|1|||
161711861|NCT00942409|583989001|FG000|Overall Study|study drug unavailable|2|||
161711862|NCT01697215|583989002|FG000|Overall Study|Physician Decision|5|||
161711863|NCT01697215|583989002|FG000|Overall Study|Malfunction|9|||
161711864|NCT01697215|583989002|FG000|Overall Study|CXR not available|9|||
161711865|NCT01929083|583989003|FG000|Intervention 1|Lost to Follow-up|2|||
161711866|NCT01929083|583989004|FG001|Intervention 1|Lost to Follow-up|0|||
161711867|NCT01929083|583989003|FG000|Intervention 1|Nonadherent to study medications|1|||
161711868|NCT01929083|583989004|FG001|Intervention 1|Nonadherent to study medications|0|||
161711869|NCT01929083|583989003|FG000|Intervention 2|Adverse Event|0|||
161711870|NCT01929083|583989004|FG001|Intervention 2|Adverse Event|1|||
161711871|NCT02599402|583989005|FG000|Overall Study|Disease progression|153|||
161711872|NCT02599402|583989005|FG000|Overall Study|Study drug toxicity|201|||
161711873|NCT02599402|583989005|FG000|Overall Study|Death|26|||
161711874|NCT02599402|583989005|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
161711875|NCT02599402|583989005|FG000|Overall Study|Participant request to discontinue study treatment|13|||
161711876|NCT02599402|583989005|FG000|Overall Study|Participant withdrew consent|5|||
161711877|NCT02599402|583989005|FG000|Overall Study|Lost to Follow-up|1|||
161711878|NCT02599402|583989005|FG000|Overall Study|Maximum Clinical Benefit|7|||
161711879|NCT02599402|583989005|FG000|Overall Study|Poor/non-compliance|1|||
161711880|NCT02599402|583989005|FG000|Overall Study|Pregnancy|1|||
161711881|NCT02599402|583989005|FG000|Overall Study|Participant no longer met study criteria|7|||
161661729|NCT00297232|583813395|FG000|Overall Study|Subject Withdrew Consent|37|||
161661730|NCT00297232|583813395|FG000|Overall Study|Persistently Positive Antibodies|11|||
161661731|NCT00297232|583813395|FG000|Overall Study|Investigator Withdrew From Program|19|||
161661732|NCT00297232|583813395|FG000|Overall Study|Did Not Enroll to Week 264|34|||
161661733|NCT00297232|583813395|FG000|Overall Study|Did Not Enroll to Week 480|17|||
161661734|NCT00297232|583813395|FG000|Overall Study|No data available after Week 264|161|||
161661735|NCT00297232|583813395|FG000|Overall Study|Other|1|||
161661736|NCT03536143|583813398|FG000|Overall Study|Early termination, Sponsor decision|1|||
161661737|NCT01878214|583813399|FG000|Overall Study|Withdrawal by Subject|18|||
161661738|NCT01878214|583813400|FG001|Overall Study|Withdrawal by Subject|7|||
161661739|NCT01878214|583813399|FG000|Overall Study|Death|0|||
161661740|NCT01878214|583813400|FG001|Overall Study|Death|1|||
161661741|NCT01878214|583813399|FG000|Overall Study|Lost to Follow-up|35|||
161661742|NCT01878214|583813400|FG001|Overall Study|Lost to Follow-up|36|||
161661743|NCT00495586|583813401|FG000|Overall Study|Withdrawal by Subject|4|||
161661744|NCT00495586|583813402|FG001|Overall Study|Withdrawal by Subject|4|||
161661745|NCT02647866|583813403|FG000|Overall Study|Adverse Event|0|||
161661746|NCT02647866|583813404|FG001|Overall Study|Adverse Event|0|||
161661747|NCT02647866|583813405|FG002|Overall Study|Adverse Event|2|||
161661748|NCT02647866|583813406|FG003|Overall Study|Adverse Event|2|||
161661749|NCT02647866|583813407|FG004|Overall Study|Adverse Event|1|||
161661750|NCT02647866|583813403|FG000|Overall Study|Disease Worsening|3|||
161661751|NCT02647866|583813404|FG001|Overall Study|Disease Worsening|1|||
161661752|NCT02647866|583813405|FG002|Overall Study|Disease Worsening|0|||
161661753|NCT02647866|583813406|FG003|Overall Study|Disease Worsening|0|||
161661754|NCT02647866|583813407|FG004|Overall Study|Disease Worsening|1|||
161661755|NCT02647866|583813403|FG000|Overall Study|Withdrawal by Subject|1|||
161661756|NCT02647866|583813404|FG001|Overall Study|Withdrawal by Subject|1|||
161661757|NCT02647866|583813405|FG002|Overall Study|Withdrawal by Subject|2|||
161661758|NCT02647866|583813406|FG003|Overall Study|Withdrawal by Subject|4|||
161711882|NCT02599402|583989005|FG000|Overall Study|Other Reasons|95|||
161711883|NCT02945657|583989006|FG000|Overall Study|Adverse Event|1|||
161711884|NCT02945657|583989006|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161711885|NCT00087438|583989011|FG000|Overall Study|Ineligible / No protocol treatment|4|||
161661759|NCT02647866|583813407|FG004|Overall Study|Withdrawal by Subject|4|||
161661760|NCT02647866|583813403|FG000|Overall Study|Physician Decision|0|||
161661761|NCT02647866|583813404|FG001|Overall Study|Physician Decision|1|||
161661762|NCT02647866|583813405|FG002|Overall Study|Physician Decision|1|||
161661763|NCT02647866|583813406|FG003|Overall Study|Physician Decision|0|||
161661764|NCT02647866|583813407|FG004|Overall Study|Physician Decision|2|||
161661765|NCT02647866|583813403|FG000|Overall Study|Death|0|||
161661766|NCT02647866|583813404|FG001|Overall Study|Death|1|||
161661767|NCT02647866|583813405|FG002|Overall Study|Death|0|||
161661768|NCT02647866|583813406|FG003|Overall Study|Death|0|||
161661769|NCT02647866|583813407|FG004|Overall Study|Death|0|||
161661770|NCT02647866|583813403|FG000|Overall Study|Subject moved to different country|1|||
161661771|NCT02647866|583813404|FG001|Overall Study|Subject moved to different country|0|||
161661772|NCT02647866|583813405|FG002|Overall Study|Subject moved to different country|0|||
161661773|NCT02647866|583813406|FG003|Overall Study|Subject moved to different country|0|||
161661774|NCT02647866|583813407|FG004|Overall Study|Subject moved to different country|0|||
161661775|NCT03406260|583813408|FG000|Period 1|Adverse Event|0|||
161661776|NCT03406260|583813409|FG001|Period 1|Adverse Event|0|||
161661777|NCT03406260|583813410|FG002|Period 1|Adverse Event|0|||
161661778|NCT03406260|583813411|FG003|Period 1|Adverse Event|0|||
161661779|NCT03406260|583813412|FG004|Period 1|Adverse Event|1|||
161661780|NCT03406260|583813413|FG005|Period 1|Adverse Event|0|||
161661781|NCT02527343|583813417|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
161661782|NCT02527343|583813418|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161661783|NCT02527343|583813419|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161661784|NCT02527343|583813420|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161661785|NCT02527343|583813421|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161661786|NCT02527343|583813422|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161661787|NCT02527343|583813417|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
161661788|NCT02527343|583813418|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161661789|NCT02527343|583813419|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161661790|NCT02527343|583813420|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161661791|NCT02527343|583813421|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161661792|NCT02527343|583813422|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161661793|NCT02527343|583813417|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161661794|NCT02527343|583813418|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
161661795|NCT02527343|583813419|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161661796|NCT02527343|583813420|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161661797|NCT02527343|583813421|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161661798|NCT02527343|583813422|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161661799|NCT02527343|583813417|FG000|RT Period: Weeks 1 to 52|Other|4|||
161661800|NCT02527343|583813418|FG001|RT Period: Weeks 1 to 52|Other|3|||
161661801|NCT02527343|583813419|FG002|RT Period: Weeks 1 to 52|Other|0|||
161661802|NCT02527343|583813420|FG003|RT Period: Weeks 1 to 52|Other|0|||
161661803|NCT02527343|583813421|FG004|RT Period: Weeks 1 to 52|Other|0|||
161661804|NCT02527343|583813422|FG005|RT Period: Weeks 1 to 52|Other|0|||
161661805|NCT02527343|583813417|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161661806|NCT02527343|583813418|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161661807|NCT02527343|583813419|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
161661808|NCT02527343|583813420|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161661809|NCT02527343|583813421|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161661810|NCT02527343|583813422|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161661811|NCT02527343|583813417|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161661812|NCT02527343|583813418|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161661813|NCT02527343|583813419|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161661814|NCT02527343|583813420|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
161661815|NCT02527343|583813421|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161661816|NCT02527343|583813422|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161661817|NCT02527343|583813417|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161661818|NCT02527343|583813418|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161661819|NCT02527343|583813419|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161661820|NCT02527343|583813420|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161661821|NCT02527343|583813421|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
161661822|NCT02527343|583813422|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161661823|NCT02527343|583813417|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161661824|NCT02527343|583813418|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161661825|NCT02527343|583813419|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161661826|NCT02527343|583813420|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161661827|NCT02527343|583813421|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
161661828|NCT02527343|583813422|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
161661829|NCT02527343|583813417|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161661830|NCT02527343|583813418|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161661831|NCT02527343|583813419|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161711886|NCT00283387|583989012|FG000|First Intervention|Subject non-compliant|1|||
161711887|NCT00283387|583989013|FG001|First Intervention|Subject non-compliant|1|||
161711888|NCT00283387|583989012|FG000|First Intervention|Withdrawal by Subject|0|||
161711889|NCT00283387|583989013|FG001|First Intervention|Withdrawal by Subject|1|||
161711890|NCT05340504|583989014|FG000|Overall Study|Withdrawal by Subject|1|||
161711891|NCT05340504|583989015|FG001|Overall Study|Withdrawal by Subject|0|||
161711892|NCT03068715|583989019|FG000|Overall Study|No longer met inclusion criteria|1|||
161711893|NCT03068715|583989020|FG001|Overall Study|No longer met inclusion criteria|0|||
161711894|NCT00728416|583989021|FG000|Overall Study|Adverse Event|1|||
161711895|NCT00728416|583989022|FG001|Overall Study|Adverse Event|1|||
161711896|NCT00728416|583989021|FG000|Overall Study|Treatment Failure|0|||
161711897|NCT00728416|583989022|FG001|Overall Study|Treatment Failure|1|||
161711898|NCT00728416|583989021|FG000|Overall Study|Withdrawal by Subject|1|||
161711899|NCT00728416|583989022|FG001|Overall Study|Withdrawal by Subject|0|||
161711900|NCT00117312|583989023|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
161711901|NCT00117312|583989024|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
161711902|NCT00117312|583989025|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
161711903|NCT00117312|583989026|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
161711904|NCT00117312|583989023|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
161711905|NCT00117312|583989024|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
161711906|NCT00117312|583989025|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
161711907|NCT00117312|583989026|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
161711908|NCT00117312|583989023|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
161711909|NCT00117312|583989024|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
161711910|NCT00117312|583989025|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
161711911|NCT00117312|583989026|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
161711912|NCT00117312|583989023|FG000|Overall Study|Other|0|||
161711913|NCT00117312|583989024|FG001|Overall Study|Other|1|||
161711914|NCT00117312|583989025|FG002|Overall Study|Other|3|||
161711915|NCT00117312|583989026|FG003|Overall Study|Other|1|||
161711916|NCT00117312|583989023|FG000|Overall Study|Patient choice|0|||
161711917|NCT00117312|583989024|FG001|Overall Study|Patient choice|0|||
161711918|NCT00117312|583989025|FG002|Overall Study|Patient choice|2|||
161711919|NCT00117312|583989026|FG003|Overall Study|Patient choice|1|||
161711920|NCT00117312|583989023|FG000|Overall Study|Adverse Event|0|||
161711921|NCT00117312|583989024|FG001|Overall Study|Adverse Event|2|||
161711922|NCT00117312|583989025|FG002|Overall Study|Adverse Event|0|||
161711923|NCT00117312|583989026|FG003|Overall Study|Adverse Event|0|||
161711924|NCT00117312|583989023|FG000|Overall Study|Protocol Violation|0|||
161711925|NCT00117312|583989024|FG001|Overall Study|Protocol Violation|1|||
161711926|NCT00117312|583989025|FG002|Overall Study|Protocol Violation|3|||
161711927|NCT00117312|583989026|FG003|Overall Study|Protocol Violation|0|||
161711928|NCT00117312|583989023|FG000|Overall Study|PSA decrease <=50%|0|||
161711929|NCT00117312|583989024|FG001|Overall Study|PSA decrease <=50%|2|||
161711930|NCT00117312|583989025|FG002|Overall Study|PSA decrease <=50%|2|||
161711931|NCT00117312|583989026|FG003|Overall Study|PSA decrease <=50%|4|||
161711932|NCT00117312|583989023|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
161711933|NCT00117312|583989024|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
161711934|NCT00117312|583989025|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
161711935|NCT00117312|583989026|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
161711936|NCT00117312|583989023|FG000|Overall Study|Hepatic abnormality|0|||
161711937|NCT00117312|583989024|FG001|Overall Study|Hepatic abnormality|1|||
161711938|NCT00117312|583989025|FG002|Overall Study|Hepatic abnormality|0|||
161711939|NCT00117312|583989026|FG003|Overall Study|Hepatic abnormality|1|||
161711940|NCT00117312|583989023|FG000|Overall Study|Withdrawal by Subject|0|||
161711941|NCT00117312|583989024|FG001|Overall Study|Withdrawal by Subject|2|||
161711942|NCT00117312|583989025|FG002|Overall Study|Withdrawal by Subject|0|||
161711943|NCT00117312|583989026|FG003|Overall Study|Withdrawal by Subject|0|||
161711944|NCT01120626|583989027|FG000|Overall Study|Withdrawal by Subject|1|||
161711945|NCT01120626|583989028|FG001|Overall Study|Withdrawal by Subject|0|||
161711946|NCT00509106|583989030|FG000|Overall Study|Adverse Event|3|||
161711947|NCT00509106|583989031|FG001|Overall Study|Adverse Event|2|||
161711948|NCT00509106|583989030|FG000|Overall Study|Noncompliance|0|||
161711949|NCT00509106|583989031|FG001|Overall Study|Noncompliance|1|||
161711950|NCT00509106|583989030|FG000|Overall Study|At the request of sponsor/investigator|1|||
161711951|NCT00509106|583989031|FG001|Overall Study|At the request of sponsor/investigator|2|||
161711952|NCT00509106|583989030|FG000|Overall Study|Withdrew consent|4|||
161711953|NCT00509106|583989031|FG001|Overall Study|Withdrew consent|8|||
161711954|NCT00509106|583989030|FG000|Overall Study|Lost to Follow-up|16|||
161711955|NCT00509106|583989031|FG001|Overall Study|Lost to Follow-up|10|||
161711956|NCT00509106|583989030|FG000|Overall Study|Other|1|||
161711957|NCT00509106|583989031|FG001|Overall Study|Other|0|||
161711958|NCT00509106|583989030|FG000|Overall Study|Death|6|||
161711959|NCT00509106|583989031|FG001|Overall Study|Death|6|||
161711960|NCT03527043|583989034|FG000|Overall Study|Withdrawal by Subject|1|||
161711961|NCT03527043|583989035|FG001|Overall Study|Withdrawal by Subject|0|||
161711962|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
161711963|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
161711964|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
161711965|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
161711966|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
161711967|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
161711968|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Personal issues|2|||
161711969|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Personal issues|0|||
161711970|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Personal issues|0|||
161711971|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Too busy|7|||
161711972|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Too busy|1|||
161711973|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Too busy|0|||
161711974|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Pain|2|||
161711975|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Pain|0|||
161711976|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Pain|0|||
161711977|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Moved|1|||
161711978|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Moved|0|||
161711979|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Moved|0|||
161711980|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Family illness|1|||
161711981|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Family illness|0|||
161711982|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Family illness|0|||
161711983|NCT00594399|583989037|FG000|Rerandomization Arm 1 Only|Death|2|||
161711984|NCT00594399|583989038|FG001|Rerandomization Arm 1 Only|Death|1|||
161711985|NCT00594399|583989039|FG002|Rerandomization Arm 1 Only|Death|0|||
161711986|NCT00594399|583989037|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
161711987|NCT00594399|583989038|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
161711988|NCT00594399|583989039|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
161711989|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
161711990|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
161711991|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
161711992|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
161711993|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
161711994|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
161711995|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
161711996|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
161711997|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
161711998|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
161711999|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
161712000|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
161712001|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
161712002|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
161712003|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
161712004|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
161712005|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
161712006|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
161712007|NCT00922935|583989042|FG000|Overall Study|Protocol Violation|0|||
161712008|NCT00922935|583989043|FG001|Overall Study|Protocol Violation|3|||
161712009|NCT00922935|583989044|FG002|Overall Study|Protocol Violation|0|||
161712010|NCT00922935|583989042|FG000|Overall Study|Physician Decision|1|||
161712011|NCT00922935|583989043|FG001|Overall Study|Physician Decision|1|||
161712012|NCT00922935|583989044|FG002|Overall Study|Physician Decision|0|||
161712013|NCT00922935|583989042|FG000|Overall Study|Lost to Follow-up|0|||
161712014|NCT00922935|583989043|FG001|Overall Study|Lost to Follow-up|1|||
161712015|NCT00922935|583989044|FG002|Overall Study|Lost to Follow-up|0|||
161712016|NCT01491945|583989045|FG000|Overall Study|Death|30|||
161712017|NCT01491945|583989045|FG000|Overall Study|Withdrwan/LTF|16|||
161712018|NCT01491945|583989045|FG000|Overall Study|Conversion|4|||
161712019|NCT01491945|583989045|FG000|Overall Study|Missed Visit|1|||
161712020|NCT02201940|583989046|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
161712021|NCT02201940|583989047|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
161712022|NCT02201940|583989046|FG000|Overall Study|Lack of Efficacy|2|||
161712023|NCT02201940|583989047|FG001|Overall Study|Lack of Efficacy|113|||
161712024|NCT02201940|583989046|FG000|Overall Study|Lost to Follow-up|5|||
161712025|NCT02201940|583989047|FG001|Overall Study|Lost to Follow-up|0|||
161712026|NCT02201940|583989046|FG000|Overall Study|Withdrew Consent|2|||
161712027|NCT02201940|583989047|FG001|Overall Study|Withdrew Consent|1|||
161712028|NCT02201940|583989046|FG000|Overall Study|Investigator's Discretion|1|||
161712029|NCT02201940|583989047|FG001|Overall Study|Investigator's Discretion|1|||
161712030|NCT02201940|583989046|FG000|Overall Study|Death|1|||
161712031|NCT02201940|583989047|FG001|Overall Study|Death|0|||
161712032|NCT02201940|583989046|FG000|Overall Study|Adverse Event|0|||
161712033|NCT02201940|583989047|FG001|Overall Study|Adverse Event|1|||
161712034|NCT00074958|583989049|FG000|Overall Study|Adverse Event|1|||
161712035|NCT02700451|583989053|FG000|Overall Study|Protocol Violation|2|||
161712036|NCT02700451|583989054|FG001|Overall Study|Protocol Violation|2|||
161712037|NCT02700451|583989055|FG002|Overall Study|Protocol Violation|3|||
161712038|NCT02700451|583989053|FG000|Overall Study|Discontinued intervention|14|||
161712039|NCT02700451|583989054|FG001|Overall Study|Discontinued intervention|15|||
161712040|NCT02700451|583989055|FG002|Overall Study|Discontinued intervention|14|||
161712041|NCT01511445|583989056|FG000|Overall Study|Lost to Follow-up|3|||
161712042|NCT01511445|583989057|FG001|Overall Study|Lost to Follow-up|1|||
161712043|NCT01511445|583989056|FG000|Overall Study|Protocol Violation|1|||
161712044|NCT01511445|583989057|FG001|Overall Study|Protocol Violation|3|||
161712045|NCT01511445|583989056|FG000|Overall Study|Protocol Violation|1|||
161712046|NCT01511445|583989057|FG001|Overall Study|Protocol Violation|0|||
161712047|NCT00709202|583989058|FG000|Overall Study|Withdrawal by Subject|6|||
161712048|NCT00709202|583989059|FG001|Overall Study|Withdrawal by Subject|6|||
161712049|NCT03133767|583989060|FG000|Overall Study|Lost to Follow-up|38|||
161712050|NCT03133767|583989061|FG001|Overall Study|Lost to Follow-up|24|||
161712051|NCT03133767|583989060|FG000|Overall Study|Protocol Violation|0|||
161712052|NCT03133767|583989061|FG001|Overall Study|Protocol Violation|1|||
161712053|NCT01856114|583989075|FG000|Overall Study|Withdrawal by Subject|1|||
161712054|NCT01856114|583989076|FG001|Overall Study|Withdrawal by Subject|0|||
161712055|NCT01856114|583989075|FG000|Overall Study|Adverse Event|1|||
161712056|NCT01856114|583989076|FG001|Overall Study|Adverse Event|0|||
161712057|NCT02853760|583989077|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
161712058|NCT02853760|583989078|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
161712059|NCT02853760|583989079|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
161712060|NCT02853760|583989080|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
161712061|NCT02853760|583989081|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
161712062|NCT02853760|583989082|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
161712063|NCT01642212|583989083|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
161712064|NCT01642212|583989084|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712065|NCT01642212|583989085|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712066|NCT01642212|583989086|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161661832|NCT02527343|583813420|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161661833|NCT02527343|583813421|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
161661834|NCT02527343|583813422|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
161661835|NCT02527343|583813417|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
161661836|NCT02527343|583813418|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
161661837|NCT02527343|583813419|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
161661838|NCT02527343|583813420|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
161661839|NCT02527343|583813421|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
161661840|NCT02527343|583813422|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
161661841|NCT02527343|583813417|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
161661842|NCT02527343|583813418|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
161661843|NCT02527343|583813419|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
161661844|NCT02527343|583813420|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
161661845|NCT02527343|583813421|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
161661846|NCT02527343|583813422|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
161661847|NCT02527343|583813417|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161661848|NCT02527343|583813418|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161661849|NCT02527343|583813419|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161661850|NCT02527343|583813420|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161661851|NCT02527343|583813421|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
161661852|NCT02527343|583813422|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161661853|NCT02527343|583813417|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
161661854|NCT02527343|583813418|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
161661855|NCT02527343|583813419|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
161661856|NCT02527343|583813420|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
161661857|NCT02527343|583813421|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
161661858|NCT02527343|583813422|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
161661859|NCT01029652|583813423|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
161661860|NCT01029652|583813424|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
161661861|NCT01029652|583813423|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
161661862|NCT01029652|583813424|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
161661863|NCT01029652|583813423|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
161661864|NCT01029652|583813424|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
161661865|NCT01029652|583813423|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
161661866|NCT01029652|583813424|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
161661867|NCT01029652|583813423|FG000|Core Study (0-12 Weeks)|Death|0|||
161661868|NCT01029652|583813424|FG001|Core Study (0-12 Weeks)|Death|1|||
161661869|NCT01029652|583813423|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
161661870|NCT01029652|583813424|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
161661871|NCT01029652|583813423|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
161661872|NCT01029652|583813424|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
161661873|NCT01029652|583813423|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
161661874|NCT01029652|583813424|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
161661875|NCT01029652|583813423|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
161661876|NCT01029652|583813424|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
161661877|NCT01029652|583813423|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
161661878|NCT01029652|583813424|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
161661879|NCT01029652|583813423|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
161661880|NCT01029652|583813424|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
161661881|NCT01029652|583813423|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
161661882|NCT01029652|583813424|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
161661883|NCT05767021|583813425|FG000|Overall Study|Adverse Event|2|||
161661884|NCT05767021|583813425|FG000|Overall Study|Protocol Deviation|1|||
161661885|NCT05767021|583813425|FG000|Overall Study|Withdrawal by Subject|1|||
161661886|NCT05767021|583813425|FG000|Overall Study|Physician Decision|1|||
161661887|NCT05767021|583813425|FG000|Overall Study|Lack of Efficacy|11|||
161661888|NCT05767021|583813425|FG000|Overall Study|Assigned Treatment by Mistake|1|||
161661889|NCT00523640|583813430|FG000|Overall Study|Death|1|||
161661890|NCT06377488|583813431|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
161661891|NCT06377488|583813431|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
161661892|NCT06377488|583813431|FG000|Overall Study|Protocol Violation|1|||
161661893|NCT06377488|583813431|FG000|Overall Study|Lost to Follow-up|1|||
161661894|NCT06377488|583813431|FG000|Overall Study|Incorrect Lens Dispensed|2|||
161661895|NCT02399254|583813434|FG000|Overall Study|Physician Decision|2|||
161661896|NCT02334423|583813435|FG000|Overall Study|Protocol Violation|10|||
161661897|NCT02334423|583813436|FG001|Overall Study|Protocol Violation|3|||
161661898|NCT01076647|583813439|FG000|Overall Study|Adverse Event|4|||
161661899|NCT01076647|583813440|FG001|Overall Study|Adverse Event|1|||
161661900|NCT01076647|583813439|FG000|Overall Study|Lack of Efficacy|0|||
161661901|NCT01076647|583813440|FG001|Overall Study|Lack of Efficacy|1|||
161661902|NCT01076647|583813439|FG000|Overall Study|Protocol Violation|7|||
161661903|NCT01076647|583813440|FG001|Overall Study|Protocol Violation|9|||
161712067|NCT01642212|583989087|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712068|NCT01642212|583989083|FG000|Double-blind Treatment|Other|0|||
161712069|NCT01642212|583989084|FG001|Double-blind Treatment|Other|2|||
161712070|NCT01642212|583989085|FG002|Double-blind Treatment|Other|1|||
161712071|NCT01642212|583989086|FG003|Double-blind Treatment|Other|0|||
161712072|NCT01642212|583989087|FG004|Double-blind Treatment|Other|0|||
161712073|NCT01642212|583989083|FG000|Double-blind Treatment|Non-compliance|0|||
161712074|NCT01642212|583989084|FG001|Double-blind Treatment|Non-compliance|1|||
161712075|NCT01642212|583989085|FG002|Double-blind Treatment|Non-compliance|0|||
161712076|NCT01642212|583989086|FG003|Double-blind Treatment|Non-compliance|0|||
161712077|NCT01642212|583989087|FG004|Double-blind Treatment|Non-compliance|0|||
161712078|NCT01642212|583989083|FG000|Double-blind Treatment|Adverse Event|0|||
161712079|NCT01642212|583989084|FG001|Double-blind Treatment|Adverse Event|0|||
161712080|NCT01642212|583989085|FG002|Double-blind Treatment|Adverse Event|1|||
161712081|NCT01642212|583989086|FG003|Double-blind Treatment|Adverse Event|0|||
161712082|NCT01642212|583989087|FG004|Double-blind Treatment|Adverse Event|0|||
161712083|NCT01642212|583989083|FG000|Open-label Extension|Adverse Event|0|||
161712084|NCT01642212|583989084|FG001|Open-label Extension|Adverse Event|0|||
161712085|NCT01642212|583989085|FG002|Open-label Extension|Adverse Event|0|||
161712086|NCT01642212|583989086|FG003|Open-label Extension|Adverse Event|3|||
161712087|NCT01642212|583989087|FG004|Open-label Extension|Adverse Event|0|||
161712088|NCT01642212|583989083|FG000|Open-label Extension|Sponsor Decision|0|||
161712089|NCT01642212|583989084|FG001|Open-label Extension|Sponsor Decision|0|||
161712090|NCT01642212|583989085|FG002|Open-label Extension|Sponsor Decision|0|||
161712091|NCT01642212|583989086|FG003|Open-label Extension|Sponsor Decision|7|||
161712092|NCT01642212|583989087|FG004|Open-label Extension|Sponsor Decision|4|||
161712093|NCT01642212|583989083|FG000|Open-label Extension|Consent Withdrawn|0|||
161712094|NCT01642212|583989084|FG001|Open-label Extension|Consent Withdrawn|0|||
161712095|NCT01642212|583989085|FG002|Open-label Extension|Consent Withdrawn|0|||
161712096|NCT01642212|583989086|FG003|Open-label Extension|Consent Withdrawn|0|||
161712097|NCT01642212|583989087|FG004|Open-label Extension|Consent Withdrawn|2|||
161712098|NCT01642212|583989083|FG000|Open-label Extension|Lost to Follow-up|0|||
161712099|NCT01642212|583989084|FG001|Open-label Extension|Lost to Follow-up|0|||
161712100|NCT01642212|583989085|FG002|Open-label Extension|Lost to Follow-up|0|||
161712101|NCT01642212|583989086|FG003|Open-label Extension|Lost to Follow-up|0|||
161712102|NCT01642212|583989087|FG004|Open-label Extension|Lost to Follow-up|1|||
161712103|NCT01642212|583989083|FG000|Open-label Extension|Other|0|||
161712104|NCT01642212|583989084|FG001|Open-label Extension|Other|0|||
161712105|NCT01642212|583989085|FG002|Open-label Extension|Other|0|||
161712106|NCT01642212|583989086|FG003|Open-label Extension|Other|0|||
161712107|NCT01642212|583989087|FG004|Open-label Extension|Other|1|||
161712108|NCT01624142|583989089|FG000|Overall Study|Withdrawal by Subject|14|||
161712109|NCT01624142|583989090|FG001|Overall Study|Withdrawal by Subject|4|||
161712110|NCT01624142|583989089|FG000|Overall Study|Death|3|||
161712111|NCT01624142|583989090|FG001|Overall Study|Death|6|||
161712112|NCT01624142|583989089|FG000|Overall Study|Study Closure|12|||
161712113|NCT01624142|583989090|FG001|Overall Study|Study Closure|6|||
161712114|NCT01624142|583989089|FG000|Overall Study|Lost to Follow-up|2|||
161712115|NCT01624142|583989090|FG001|Overall Study|Lost to Follow-up|0|||
161712116|NCT01624142|583989089|FG000|Overall Study|Other|1|||
161712117|NCT01624142|583989090|FG001|Overall Study|Other|0|||
161712118|NCT00667277|583989091|FG000|Overall Study|Withdrawal by Subject|2|||
161712119|NCT04826900|583989092|FG000|Overall Study|Family factor|1|||
161712120|NCT04826900|583989093|FG001|Overall Study|Family factor|1|||
161712121|NCT02597062|583989095|FG000|Overall Study|Ineligible|1|||
161712122|NCT03372941|583989096|FG000|Overall Study|Lost to Follow-up|2|||
161712123|NCT03372941|583989097|FG001|Overall Study|Lost to Follow-up|4|||
161712124|NCT00741819|583989098|FG000|Overall Study|Adverse Event|3|||
161712125|NCT00741819|583989098|FG000|Overall Study|Withdrawal by Subject|3|||
161712126|NCT00741819|583989098|FG000|Overall Study|Death|1|||
161712127|NCT00741819|583989098|FG000|Overall Study|Disease progression|1|||
161712128|NCT00686543|583989101|FG000|Overall Study|Adverse Event|9|||
161712129|NCT00686543|583989102|FG001|Overall Study|Adverse Event|1|||
161712130|NCT00686543|583989103|FG002|Overall Study|Adverse Event|3|||
161712131|NCT00686543|583989104|FG003|Overall Study|Adverse Event|2|||
161712132|NCT00686543|583989101|FG000|Overall Study|Withdrawal by Subject|2|||
161712133|NCT00686543|583989102|FG001|Overall Study|Withdrawal by Subject|0|||
161712134|NCT00686543|583989103|FG002|Overall Study|Withdrawal by Subject|0|||
161712135|NCT00686543|583989104|FG003|Overall Study|Withdrawal by Subject|0|||
161712136|NCT00686543|583989101|FG000|Overall Study|Protocol Violation|3|||
161712137|NCT00686543|583989102|FG001|Overall Study|Protocol Violation|0|||
161712138|NCT00686543|583989103|FG002|Overall Study|Protocol Violation|2|||
161712139|NCT00686543|583989104|FG003|Overall Study|Protocol Violation|1|||
161712140|NCT01053429|583989105|FG000|Overall Study|Adverse Event|64|||
161712141|NCT01053429|583989105|FG000|Overall Study|Other|309|||
161712142|NCT00752986|583989106|FG000|Overall Study|Withdrawal by Subject|2|||
161712143|NCT00752986|583989107|FG001|Overall Study|Withdrawal by Subject|1|||
161712144|NCT00752986|583989108|FG002|Overall Study|Withdrawal by Subject|2|||
161661904|NCT01076647|583813439|FG000|Overall Study|Withdrawal criteria|2|||
161661905|NCT01076647|583813440|FG001|Overall Study|Withdrawal criteria|2|||
161661906|NCT01076647|583813439|FG000|Overall Study|Unclassified|12|||
161661907|NCT01076647|583813440|FG001|Overall Study|Unclassified|12|||
161661908|NCT04426851|583813445|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
161661909|NCT04426851|583813446|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
161661910|NCT04426851|583813445|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
161661911|NCT04426851|583813446|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
161661912|NCT02292927|583813447|FG000|Overall Study|Protocol Violation|13|||
161661913|NCT02292927|583813448|FG001|Overall Study|Protocol Violation|7|||
161661914|NCT02962960|583813451|FG000|Overall Study|Withdrawal by Subject|1|||
161661915|NCT02962960|583813452|FG001|Overall Study|Withdrawal by Subject|1|||
161661916|NCT02962960|583813453|FG002|Overall Study|Withdrawal by Subject|0|||
161661917|NCT02962960|583813451|FG000|Overall Study|Adverse Event|1|||
161661918|NCT02962960|583813452|FG001|Overall Study|Adverse Event|1|||
161661919|NCT02962960|583813453|FG002|Overall Study|Adverse Event|0|||
161661920|NCT02962960|583813451|FG000|Overall Study|Protocol Violation|1|||
161661921|NCT02962960|583813452|FG001|Overall Study|Protocol Violation|0|||
161661922|NCT02962960|583813453|FG002|Overall Study|Protocol Violation|0|||
161661923|NCT02054741|583813454|FG000|Overall Study|Protocol Violation|13|||
161661924|NCT02054741|583813455|FG001|Overall Study|Protocol Violation|2|||
161661925|NCT02054741|583813454|FG000|Overall Study|Withdrawal by Subject|10|||
161661926|NCT02054741|583813455|FG001|Overall Study|Withdrawal by Subject|5|||
161661927|NCT02054741|583813454|FG000|Overall Study|Death|94|||
161661928|NCT02054741|583813455|FG001|Overall Study|Death|90|||
161661929|NCT02054741|583813454|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
161661930|NCT02054741|583813455|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
161661931|NCT00394082|583813456|FG000|Overall Study|Unacceptable toxicity|15|||
161661932|NCT00394082|583813456|FG000|Overall Study|Adverse Event|4|||
161661933|NCT00394082|583813456|FG000|Overall Study|Physician Decision|4|||
161661934|NCT00394082|583813456|FG000|Overall Study|Withdrawal by Subject|2|||
161661935|NCT00394082|583813456|FG000|Overall Study|Other|1|||
161661936|NCT02344004|583813458|FG000|Overall Study|Adverse Event|11|||
161661937|NCT02344004|583813459|FG001|Overall Study|Adverse Event|1|||
161661938|NCT02344004|583813458|FG000|Overall Study|Death|9|||
161661939|NCT02344004|583813459|FG001|Overall Study|Death|7|||
161661940|NCT02344004|583813458|FG000|Overall Study|Physician Decision|4|||
161661941|NCT02344004|583813459|FG001|Overall Study|Physician Decision|1|||
161661942|NCT02344004|583813458|FG000|Overall Study|Withdrawal by Subject|22|||
161661943|NCT02344004|583813459|FG001|Overall Study|Withdrawal by Subject|5|||
161661944|NCT02344004|583813458|FG000|Overall Study|Rescue Medication|2|||
161661945|NCT02344004|583813459|FG001|Overall Study|Rescue Medication|0|||
161661946|NCT02344004|583813458|FG000|Overall Study|Other Not Specified|12|||
161661947|NCT02344004|583813459|FG001|Overall Study|Other Not Specified|0|||
161661948|NCT02344004|583813458|FG000|Overall Study|Protocol Violation|1|||
161661949|NCT02344004|583813459|FG001|Overall Study|Protocol Violation|0|||
161661950|NCT01768117|583813460|FG000|Overall Study|Lost to Follow-up|1|||
161661951|NCT01768117|583813460|FG000|Overall Study|Withdrawal by Subject|2|||
161661952|NCT01768117|583813460|FG000|Overall Study|Protocol Violation|3|||
161712145|NCT00752986|583989106|FG000|Overall Study|Protocol Violation|3|||
161712146|NCT00752986|583989107|FG001|Overall Study|Protocol Violation|0|||
161712147|NCT00752986|583989108|FG002|Overall Study|Protocol Violation|0|||
161712148|NCT01697345|583989109|FG000|Overall Study|Withdrawal by Subject|1|||
161712149|NCT00924703|583989110|FG000|Overall Study|Withdrawal by Subject|11|||
161712150|NCT00924703|583989110|FG000|Overall Study|Physician Decision|5|||
161712151|NCT00924703|583989110|FG000|Overall Study|Lost to Follow-up|3|||
161712152|NCT00924703|583989110|FG000|Overall Study|Adverse Event|2|||
161712153|NCT00924703|583989110|FG000|Overall Study|Withdrawal by Sponsor|1|||
161712154|NCT04906707|583989111|FG000|Overall Study|Withdrawal by Subject|2|||
161712155|NCT04906707|583989112|FG001|Overall Study|Withdrawal by Subject|0|||
161712156|NCT04906707|583989111|FG000|Overall Study|Withdrawal due to PI decision|1|||
161712157|NCT04906707|583989112|FG001|Overall Study|Withdrawal due to PI decision|0|||
161712158|NCT04906707|583989111|FG000|Overall Study|Lost to Follow-up|0|||
161712159|NCT04906707|583989112|FG001|Overall Study|Lost to Follow-up|1|||
161712160|NCT01976806|583989113|FG000|Overall Study|Lost to Follow-up|1|||
161712161|NCT01976806|583989114|FG001|Overall Study|Lost to Follow-up|4|||
161712162|NCT01976806|583989113|FG000|Overall Study|Adverse Event|1|||
161712163|NCT01976806|583989114|FG001|Overall Study|Adverse Event|1|||
161712164|NCT01976806|583989113|FG000|Overall Study|Withdrawal by Subject|1|||
161712165|NCT01976806|583989114|FG001|Overall Study|Withdrawal by Subject|1|||
161712166|NCT03929250|583989117|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
161712167|NCT03929250|583989118|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
161712168|NCT04429022|583989121|FG000|Overall Study|Protocol Violation|18|||
161712169|NCT04429022|583989122|FG001|Overall Study|Protocol Violation|1|||
161712170|NCT00045032|583989127|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
161712171|NCT00045032|583989128|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
161712172|NCT00045032|583989129|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
161712173|NCT00045032|583989127|FG000|Overall Study|Death|22|||
161712174|NCT00045032|583989128|FG001|Overall Study|Death|24|||
161712175|NCT00045032|583989129|FG002|Overall Study|Death|17|||
161712176|NCT00045032|583989127|FG000|Overall Study|Insufficient Therapeutic Response|542|||
161712177|NCT00045032|583989128|FG001|Overall Study|Insufficient Therapeutic Response|437|||
161712178|NCT00045032|583989129|FG002|Overall Study|Insufficient Therapeutic Response|445|||
161712179|NCT00045032|583989127|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
161712180|NCT00045032|583989128|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
161712181|NCT00045032|583989129|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
161712182|NCT00045032|583989127|FG000|Overall Study|Other Protocol Violation|2|||
161712183|NCT00045032|583989128|FG001|Overall Study|Other Protocol Violation|0|||
161712184|NCT00045032|583989129|FG002|Overall Study|Other Protocol Violation|1|||
161712185|NCT00045032|583989127|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
161712186|NCT00045032|583989128|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
161712187|NCT00045032|583989129|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
161712188|NCT00045032|583989127|FG000|Overall Study|Failure to Return|57|||
161712189|NCT00045032|583989128|FG001|Overall Study|Failure to Return|62|||
161712190|NCT00045032|583989129|FG002|Overall Study|Failure to Return|61|||
161712191|NCT00045032|583989127|FG000|Overall Study|Other|93|||
161712192|NCT00045032|583989128|FG001|Overall Study|Other|84|||
161712193|NCT00045032|583989129|FG002|Overall Study|Other|105|||
161712194|NCT02582658|583989130|FG000|Overall Study|Failure to Return|10|||
161712195|NCT02582658|583989130|FG000|Overall Study|Insufficient Virological Response|2|||
161712196|NCT02582658|583989130|FG000|Overall Study|Withdrawn Consent|1|||
161712197|NCT02582658|583989130|FG000|Overall Study|Death|1|||
161712198|NCT02582658|583989130|FG000|Overall Study|Not further specified|11|||
161712199|NCT02581995|583989131|FG000|Overall Study|Unspecified other|3|||
161712200|NCT02581995|583989131|FG000|Overall Study|Adverse Event|6|||
161712201|NCT02581995|583989131|FG000|Overall Study|Lost to Follow-up|5|||
161712202|NCT02581995|583989131|FG000|Overall Study|Withdrawal by participant|12|||
161712203|NCT02581995|583989131|FG000|Overall Study|Physician Decision|1|||
161712204|NCT02581995|583989131|FG000|Overall Study|Death|4|||
161712205|NCT04909463|583991181|FG000|Overall Study|Withdrawal by Subject|0|||
161712206|NCT04909463|583991182|FG001|Overall Study|Withdrawal by Subject|1|||
161712207|NCT04909463|583991183|FG002|Overall Study|Withdrawal by Subject|0|||
161712208|NCT04909463|583991184|FG003|Overall Study|Withdrawal by Subject|0|||
161712209|NCT04909463|583991181|FG000|Overall Study|Lost to Follow-up|2|||
161712210|NCT04909463|583991182|FG001|Overall Study|Lost to Follow-up|1|||
161712211|NCT04909463|583991183|FG002|Overall Study|Lost to Follow-up|1|||
161712212|NCT04909463|583991184|FG003|Overall Study|Lost to Follow-up|0|||
161712213|NCT04364854|583991185|FG000|Overall Study|Withdrawal by Subject|1|||
161712214|NCT04364854|583991186|FG001|Overall Study|Withdrawal by Subject|0|||
161712215|NCT04364854|583991187|FG002|Overall Study|Withdrawal by Subject|1|||
161712216|NCT04364854|583991188|FG003|Overall Study|Withdrawal by Subject|3|||
161712217|NCT04364854|583991185|FG000|Overall Study|Death|1|||
161712218|NCT04364854|583991186|FG001|Overall Study|Death|0|||
161712219|NCT04364854|583991187|FG002|Overall Study|Death|0|||
161712220|NCT04364854|583991188|FG003|Overall Study|Death|0|||
161712221|NCT04364854|583991185|FG000|Overall Study|Lost to Follow-up|0|||
161712222|NCT04364854|583991186|FG001|Overall Study|Lost to Follow-up|0|||
161712223|NCT04364854|583991187|FG002|Overall Study|Lost to Follow-up|0|||
161712224|NCT04364854|583991188|FG003|Overall Study|Lost to Follow-up|1|||
161712225|NCT03528681|583991193|FG000|Open-Label Phase|Physician Decision|2|||
161712226|NCT03528681|583991194|FG001|Open-Label Phase|Physician Decision|0|||
161712227|NCT03528681|583991195|FG002|Open-Label Phase|Physician Decision|0|||
161712228|NCT03528681|583991196|FG003|Open-Label Phase|Physician Decision|0|||
161712229|NCT03528681|583991193|FG000|Open-Label Phase|Withdrawal by Subject|8|||
161712230|NCT03528681|583991194|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161712231|NCT03528681|583991195|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161712232|NCT03528681|583991196|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161712233|NCT03528681|583991193|FG000|Open-Label Phase|(Not collected)|4|||
161712234|NCT03528681|583991194|FG001|Open-Label Phase|(Not collected)|0|||
161712235|NCT03528681|583991195|FG002|Open-Label Phase|(Not collected)|0|||
161712236|NCT03528681|583991196|FG003|Open-Label Phase|(Not collected)|0|||
161712237|NCT03528681|583991193|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
161712238|NCT03528681|583991194|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
161712239|NCT03528681|583991195|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
161712240|NCT03528681|583991196|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
161712241|NCT03528681|583991193|FG000|Randomized Treatment Phase|Physician Decision|0|||
161712242|NCT03528681|583991194|FG001|Randomized Treatment Phase|Physician Decision|5|||
161712243|NCT03528681|583991195|FG002|Randomized Treatment Phase|Physician Decision|1|||
161712244|NCT03528681|583991196|FG003|Randomized Treatment Phase|Physician Decision|2|||
161712245|NCT03528681|583991193|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
161712246|NCT03528681|583991194|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
161712247|NCT03528681|583991195|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
161712248|NCT03528681|583991196|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
161712249|NCT03528681|583991193|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
161712250|NCT03528681|583991194|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
161712251|NCT03528681|583991195|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
161712252|NCT03528681|583991196|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
161712253|NCT03528681|583991193|FG000|Randomized Treatment Phase|(Not collected)|0|||
161712254|NCT03528681|583991194|FG001|Randomized Treatment Phase|(Not collected)|4|||
161712255|NCT03528681|583991195|FG002|Randomized Treatment Phase|(Not collected)|6|||
161712256|NCT03528681|583991196|FG003|Randomized Treatment Phase|(Not collected)|5|||
161712257|NCT01614457|583991203|FG000|Overall Study|Non-Compliance|1|||
161712258|NCT01614457|583991204|FG001|Overall Study|Non-Compliance|0|||
161712259|NCT01614457|583991203|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
161712260|NCT01614457|583991204|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
161712261|NCT03518840|583991207|FG000|Overall Study|Lost to Follow-up|6|||
161712262|NCT00374556|583991212|FG000|Overall Study|Lost to Follow-up|1|||
161712263|NCT00374556|583991213|FG001|Overall Study|Lost to Follow-up|0|||
161712264|NCT00374556|583991212|FG000|Overall Study|Removed at baseline due to medical cond|0|||
161712265|NCT00374556|583991213|FG001|Overall Study|Removed at baseline due to medical cond|1|||
161712266|NCT00473694|583991214|FG000|Overall Study|Adverse Event|0|||
161712267|NCT00473694|583991215|FG001|Overall Study|Adverse Event|1|||
161712268|NCT00473694|583991216|FG002|Overall Study|Adverse Event|0|||
161712269|NCT00473694|583991217|FG003|Overall Study|Adverse Event|0|||
161712270|NCT00473694|583991214|FG000|Overall Study|Participants did not receive treatment|11|||
161712271|NCT00473694|583991215|FG001|Overall Study|Participants did not receive treatment|3|||
161712272|NCT00473694|583991216|FG002|Overall Study|Participants did not receive treatment|5|||
161712273|NCT00473694|583991217|FG003|Overall Study|Participants did not receive treatment|6|||
161712274|NCT00473694|583991214|FG000|Overall Study|Lost to Follow-up|0|||
161712275|NCT00473694|583991215|FG001|Overall Study|Lost to Follow-up|0|||
161712276|NCT00473694|583991216|FG002|Overall Study|Lost to Follow-up|0|||
161712277|NCT00473694|583991217|FG003|Overall Study|Lost to Follow-up|1|||
161712278|NCT02468193|583991218|FG000|Overall Study|Adverse Event|4|||
161712279|NCT02468193|583991218|FG000|Overall Study|Subject/ Guardian decision|2|||
161712280|NCT00742781|583991219|FG000|Overall Study|Withdrawal by Subject|3|||
161712281|NCT01416181|583991220|FG000|Part 1|Other|10|||
161712282|NCT01416181|583991221|FG001|Part 1|Other|24|||
161712283|NCT01416181|583991220|FG000|Part 1|Death|0|||
161712284|NCT01416181|583991221|FG001|Part 1|Death|1|||
161712285|NCT01416181|583991220|FG000|Part 1|Investigator Decision|7|||
161712286|NCT01416181|583991221|FG001|Part 1|Investigator Decision|6|||
161712287|NCT01416181|583991220|FG000|Part 1|Withdrawal by Subject|74|||
161712288|NCT01416181|583991221|FG001|Part 1|Withdrawal by Subject|48|||
161712289|NCT01416181|583991220|FG000|Part 1|Lack of Efficacy|16|||
161712290|NCT01416181|583991221|FG001|Part 1|Lack of Efficacy|8|||
161712291|NCT01416181|583991220|FG000|Part 1|Lost to Follow-up|1|||
161712292|NCT01416181|583991221|FG001|Part 1|Lost to Follow-up|1|||
161712293|NCT01416181|583991220|FG000|Part 1|Adverse Event|15|||
161712294|NCT01416181|583991221|FG001|Part 1|Adverse Event|18|||
161712295|NCT01416181|583991220|FG000|Part 1|Ongoing in Follow-Up|14|||
161712296|NCT01416181|583991221|FG001|Part 1|Ongoing in Follow-Up|8|||
161712297|NCT01416181|583991220|FG000|Part 2|Adverse Event|11|||
161712298|NCT01416181|583991221|FG001|Part 2|Adverse Event|4|||
161712299|NCT01416181|583991220|FG000|Part 2|Other|234|||
161712300|NCT01416181|583991221|FG001|Part 2|Other|267|||
161712301|NCT01416181|583991220|FG000|Part 2|Investigator Decision|6|||
161712302|NCT01416181|583991221|FG001|Part 2|Investigator Decision|7|||
161712303|NCT01416181|583991220|FG000|Part 2|Withdrawal by Subject|14|||
161712304|NCT01416181|583991221|FG001|Part 2|Withdrawal by Subject|5|||
161712305|NCT01416181|583991220|FG000|Part 2|Lack of Efficacy|4|||
161712306|NCT01416181|583991221|FG001|Part 2|Lack of Efficacy|1|||
161712307|NCT01416181|583991220|FG000|Part 2|Lost to Follow-up|2|||
161712308|NCT01416181|583991221|FG001|Part 2|Lost to Follow-up|2|||
161712309|NCT03816995|583991224|FG000|Overall Study|Withdrawal by Subject|3|||
161712310|NCT03816995|583991225|FG001|Overall Study|Withdrawal by Subject|1|||
161712311|NCT03816995|583991224|FG000|Overall Study|Cancelled Surgery|8|||
161712312|NCT03816995|583991225|FG001|Overall Study|Cancelled Surgery|12|||
161712313|NCT03816995|583991224|FG000|Overall Study|No wound protector used|11|||
161712314|NCT03816995|583991225|FG001|Overall Study|No wound protector used|17|||
161712315|NCT03816995|583991224|FG000|Overall Study|Protocol Violation|2|||
161712316|NCT03816995|583991225|FG001|Overall Study|Protocol Violation|3|||
161712317|NCT00486902|583991226|FG000|Overall Study|Withdrawal by Subject|1|||
161712318|NCT00486902|583991227|FG001|Overall Study|Withdrawal by Subject|2|||
161712319|NCT00486902|583991226|FG000|Overall Study|decision for postpartum tubal ligation|3|||
161712320|NCT00486902|583991227|FG001|Overall Study|decision for postpartum tubal ligation|1|||
161712321|NCT00486902|583991226|FG000|Overall Study|spinal anesthetic protocal violation|1|||
161712322|NCT00486902|583991227|FG001|Overall Study|spinal anesthetic protocal violation|1|||
161712323|NCT00486902|583991226|FG000|Overall Study|Did not meet inclusion criteria|1|||
161712324|NCT00486902|583991227|FG001|Overall Study|Did not meet inclusion criteria|0|||
161712325|NCT00486902|583991226|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
161712326|NCT00486902|583991227|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
161712327|NCT00541307|583991228|FG000|Overall Study|Death|5|||
161712328|NCT00541307|583991228|FG000|Overall Study|Physician Decision|3|||
161712329|NCT00541307|583991228|FG000|Overall Study|Withdrawal by Subject|6|||
161712330|NCT00541307|583991228|FG000|Overall Study|Lost to Follow-up|4|||
161712331|NCT00541307|583991228|FG000|Overall Study|Subject returned early (outside window)|1|||
161712332|NCT00541307|583991228|FG000|Overall Study|Surgical Bypass|5|||
161712333|NCT04178590|583991229|FG000|Overall Study|Pregnancy|1|||
161712334|NCT04178590|583991229|FG000|Overall Study|Lost to Follow-up|1|||
161712335|NCT04723537|583991230|FG000|Overall Study|Withdrawal by Subject|3|||
161712336|NCT04723537|583991231|FG001|Overall Study|Withdrawal by Subject|0|||
161712337|NCT04723537|583991232|FG002|Overall Study|Withdrawal by Subject|0|||
161712338|NCT04723537|583991230|FG000|Overall Study|Physician Decision|0|||
161712339|NCT04723537|583991231|FG001|Overall Study|Physician Decision|0|||
161712340|NCT04723537|583991232|FG002|Overall Study|Physician Decision|1|||
161712341|NCT04723537|583991230|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161712342|NCT04723537|583991231|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161712343|NCT04723537|583991232|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161712344|NCT01845025|583991233|FG000|Overall Study|Adverse Event|6|||
161712345|NCT01845025|583991234|FG001|Overall Study|Adverse Event|3|||
161712346|NCT01845025|583991233|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161712347|NCT01845025|583991234|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161712348|NCT01845025|583991233|FG000|Overall Study|Withdrawal by Subject|48|||
161712349|NCT01845025|583991234|FG001|Overall Study|Withdrawal by Subject|44|||
161712350|NCT01845025|583991233|FG000|Overall Study|Lost to Follow-up|13|||
161712351|NCT01845025|583991234|FG001|Overall Study|Lost to Follow-up|13|||
161712352|NCT01845025|583991233|FG000|Overall Study|Administrative problems|8|||
161712353|NCT01845025|583991234|FG001|Overall Study|Administrative problems|8|||
161712354|NCT01845025|583991233|FG000|Overall Study|Death|2|||
161712355|NCT01845025|583991234|FG001|Overall Study|Death|0|||
161712356|NCT01845025|583991233|FG000|Overall Study|Protocol deviation|3|||
161712357|NCT01845025|583991234|FG001|Overall Study|Protocol deviation|6|||
161712358|NCT01845025|583991233|FG000|Overall Study|Missing|1|||
161712359|NCT01845025|583991234|FG001|Overall Study|Missing|1|||
161712360|NCT01485614|583991241|FG000|Randomization|Not Treated|1|||
161712361|NCT01485614|583991242|FG001|Randomization|Not Treated|0|||
161712362|NCT01485614|583991243|FG002|Randomization|Not Treated|0|||
161712363|NCT01485614|583991244|FG003|Randomization|Not Treated|0|||
161712364|NCT01485614|583991241|FG000|Weeks 0-20|Lost to Follow-up|2|||
161712365|NCT01485614|583991242|FG001|Weeks 0-20|Lost to Follow-up|0|||
161712366|NCT01485614|583991243|FG002|Weeks 0-20|Lost to Follow-up|0|||
161712367|NCT01485614|583991244|FG003|Weeks 0-20|Lost to Follow-up|0|||
161661953|NCT01945060|583813461|FG000|Overall Study|Lost to follow up|1|||
161712368|NCT01485614|583991241|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
161712369|NCT01485614|583991242|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
161712370|NCT01485614|583991243|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
161712371|NCT01485614|583991244|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
161712372|NCT01485614|583991241|FG000|Weeks 0-20|Withdrawal by Subject|3|||
161712373|NCT01485614|583991242|FG001|Weeks 0-20|Withdrawal by Subject|2|||
161712374|NCT01485614|583991243|FG002|Weeks 0-20|Withdrawal by Subject|1|||
161712375|NCT01485614|583991244|FG003|Weeks 0-20|Withdrawal by Subject|0|||
161712376|NCT01485614|583991241|FG000|Weeks 20-54|Lost to Follow-up|4|||
161712377|NCT01485614|583991242|FG001|Weeks 20-54|Lost to Follow-up|3|||
161712378|NCT01485614|583991243|FG002|Weeks 20-54|Lost to Follow-up|1|||
161712379|NCT01485614|583991244|FG003|Weeks 20-54|Lost to Follow-up|0|||
161712380|NCT01485614|583991241|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
161712381|NCT01485614|583991242|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
161712382|NCT01485614|583991243|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
161712383|NCT01485614|583991244|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
161712384|NCT01485614|583991241|FG000|Weeks 20-54|Withdrawal by Subject|5|||
161712385|NCT01485614|583991242|FG001|Weeks 20-54|Withdrawal by Subject|3|||
161712386|NCT01485614|583991243|FG002|Weeks 20-54|Withdrawal by Subject|0|||
161712387|NCT01485614|583991244|FG003|Weeks 20-54|Withdrawal by Subject|0|||
161712388|NCT00733902|583991245|FG000|Overall Study|Death|0|||
161712389|NCT00733902|583991246|FG001|Overall Study|Death|0|||
161712390|NCT00733902|583991247|FG002|Overall Study|Death|0|||
161712391|NCT00733902|583991248|FG003|Overall Study|Death|1|||
161712392|NCT00733902|583991245|FG000|Overall Study|Adverse Event|3|||
161712393|NCT00733902|583991246|FG001|Overall Study|Adverse Event|4|||
161712394|NCT00733902|583991247|FG002|Overall Study|Adverse Event|7|||
161712395|NCT00733902|583991248|FG003|Overall Study|Adverse Event|11|||
161712396|NCT00733902|583991245|FG000|Overall Study|Lack of Efficacy|56|||
161712397|NCT00733902|583991246|FG001|Overall Study|Lack of Efficacy|21|||
161712398|NCT00733902|583991247|FG002|Overall Study|Lack of Efficacy|34|||
161712399|NCT00733902|583991248|FG003|Overall Study|Lack of Efficacy|23|||
161712400|NCT00733902|583991245|FG000|Overall Study|Protocol Violation|4|||
161712401|NCT00733902|583991246|FG001|Overall Study|Protocol Violation|6|||
161712402|NCT00733902|583991247|FG002|Overall Study|Protocol Violation|3|||
161712403|NCT00733902|583991248|FG003|Overall Study|Protocol Violation|3|||
161712404|NCT00733902|583991245|FG000|Overall Study|Withdrawal by Subject|10|||
161712405|NCT00733902|583991246|FG001|Overall Study|Withdrawal by Subject|5|||
161712406|NCT00733902|583991247|FG002|Overall Study|Withdrawal by Subject|4|||
161712407|NCT00733902|583991248|FG003|Overall Study|Withdrawal by Subject|16|||
161712408|NCT00733902|583991245|FG000|Overall Study|Entered extension study|89|||
161712409|NCT00733902|583991246|FG001|Overall Study|Entered extension study|124|||
161661954|NCT01945060|583813462|FG001|Overall Study|Lost to follow up|0|||
161661955|NCT01945060|583813461|FG000|Overall Study|Distress related to IV access|0|||
161661956|NCT01945060|583813462|FG001|Overall Study|Distress related to IV access|1|||
161661957|NCT00138671|583813463|FG000|Overall Study|Death|0|||
161661958|NCT00138671|583813464|FG001|Overall Study|Death|3|||
161661959|NCT00138671|583813463|FG000|Overall Study|Adverse Event|6|||
161661960|NCT00138671|583813464|FG001|Overall Study|Adverse Event|3|||
161661961|NCT00138671|583813463|FG000|Overall Study|Lost to Follow-up|1|||
161661962|NCT00138671|583813464|FG001|Overall Study|Lost to Follow-up|2|||
161661963|NCT00138671|583813463|FG000|Overall Study|Withdrawal by Subject|3|||
161661964|NCT00138671|583813464|FG001|Overall Study|Withdrawal by Subject|5|||
161661965|NCT00138671|583813463|FG000|Overall Study|Other|3|||
161661966|NCT00138671|583813464|FG001|Overall Study|Other|3|||
161661967|NCT01488487|583813465|FG000|Overall Study|Adverse Event|6|||
161661968|NCT01488487|583813465|FG000|Overall Study|Death|1|||
161661969|NCT01488487|583813465|FG000|Overall Study|Withdrawal by Subject|2|||
161661970|NCT00395460|583813468|FG000|Overall Study|Withdrawal by Subject|1|||
161661971|NCT00395460|583813469|FG001|Overall Study|Withdrawal by Subject|0|||
161661972|NCT01737827|583813475|FG000|Overall Study|Adverse Event|3|||
161661973|NCT01737827|583813476|FG001|Overall Study|Adverse Event|6|||
161661974|NCT01737827|583813477|FG002|Overall Study|Adverse Event|0|||
161661975|NCT01737827|583813475|FG000|Overall Study|Lost to Follow-up|0|||
161661976|NCT01737827|583813476|FG001|Overall Study|Lost to Follow-up|1|||
161661977|NCT01737827|583813477|FG002|Overall Study|Lost to Follow-up|0|||
161661978|NCT01737827|583813475|FG000|Overall Study|Physician Decision|0|||
161661979|NCT01737827|583813476|FG001|Overall Study|Physician Decision|2|||
161661980|NCT01737827|583813477|FG002|Overall Study|Physician Decision|0|||
161712410|NCT00733902|583991247|FG002|Overall Study|Entered extension study|111|||
161712411|NCT00733902|583991248|FG003|Overall Study|Entered extension study|109|||
161712412|NCT00733902|583991245|FG000|Overall Study|Randomized but not treated|2|||
161712413|NCT00733902|583991246|FG001|Overall Study|Randomized but not treated|2|||
161712414|NCT00733902|583991247|FG002|Overall Study|Randomized but not treated|2|||
161712415|NCT00733902|583991248|FG003|Overall Study|Randomized but not treated|1|||
161661981|NCT01737827|583813475|FG000|Overall Study|Progressive Disease|5|||
161712416|NCT01503021|583991253|FG000|Overall Study|Adverse Event|7|||
161712417|NCT01503021|583991254|FG001|Overall Study|Adverse Event|6|||
161712418|NCT01503021|583991253|FG000|Overall Study|Death|0|||
161712419|NCT01503021|583991254|FG001|Overall Study|Death|2|||
161712420|NCT01503021|583991253|FG000|Overall Study|Lost to Follow-up|2|||
161712421|NCT01503021|583991254|FG001|Overall Study|Lost to Follow-up|0|||
161712422|NCT01503021|583991253|FG000|Overall Study|Physician Decision|3|||
161712423|NCT01503021|583991254|FG001|Overall Study|Physician Decision|0|||
161712424|NCT01503021|583991253|FG000|Overall Study|Protocol Violation|1|||
161712425|NCT01503021|583991254|FG001|Overall Study|Protocol Violation|3|||
161712426|NCT01503021|583991253|FG000|Overall Study|Withdrawal by Subject|9|||
161712427|NCT01503021|583991254|FG001|Overall Study|Withdrawal by Subject|8|||
161712428|NCT01503021|583991253|FG000|Overall Study|Moved, received transplant, etc.|5|||
161712429|NCT01503021|583991254|FG001|Overall Study|Moved, received transplant, etc.|7|||
161712430|NCT03941548|583991255|FG000|Overall Study|Adverse Event|0|||
161712431|NCT03941548|583991256|FG001|Overall Study|Adverse Event|1|||
161712432|NCT03941548|583991255|FG000|Overall Study|Lost to Follow-up|0|||
161712433|NCT03941548|583991256|FG001|Overall Study|Lost to Follow-up|1|||
161712434|NCT03941548|583991255|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
161712435|NCT03941548|583991256|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
161712436|NCT01242111|583991258|FG000|Overall Study|Adverse Event|1|||
161712437|NCT01242111|583991258|FG000|Overall Study|Withdrawal by Subject|1|||
161712438|NCT01242111|583991258|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
161712439|NCT00870688|583991259|FG000|Overall Study|Lost to Follow-up|2|||
161712440|NCT00870688|583991259|FG000|Overall Study|Death, Unrelated|1|||
161712441|NCT00870688|583991259|FG000|Overall Study|Granules in the Stools|1|||
161712442|NCT02015819|583991260|FG000|Overall Study|Rickham catheter was misaligned|0|||
161712443|NCT02015819|583991261|FG001|Overall Study|Rickham catheter was misaligned|0|||
161712444|NCT02015819|583991262|FG002|Overall Study|Rickham catheter was misaligned|0|||
161712445|NCT02015819|583991263|FG003|Overall Study|Rickham catheter was misaligned|1|||
161712446|NCT01486264|583991270|FG000|Overall Study|Death|1|||
161712447|NCT01486264|583991271|FG001|Overall Study|Death|1|||
161712448|NCT01486264|583991270|FG000|Overall Study|Adverse Event|3|||
161712449|NCT01486264|583991271|FG001|Overall Study|Adverse Event|3|||
161712450|NCT01486264|583991270|FG000|Overall Study|Lack of Efficacy|6|||
161712451|NCT01486264|583991271|FG001|Overall Study|Lack of Efficacy|10|||
161712452|NCT01486264|583991270|FG000|Overall Study|Withdrawal by Subject|7|||
161712453|NCT01486264|583991271|FG001|Overall Study|Withdrawal by Subject|18|||
161712454|NCT01486264|583991270|FG000|Overall Study|Physician Decision|1|||
161712455|NCT01486264|583991271|FG001|Overall Study|Physician Decision|1|||
161712456|NCT01486264|583991270|FG000|Overall Study|Protocol Violation|3|||
161712457|NCT01486264|583991271|FG001|Overall Study|Protocol Violation|0|||
161712458|NCT01486264|583991270|FG000|Overall Study|Lost to Follow-up|3|||
161712459|NCT01486264|583991271|FG001|Overall Study|Lost to Follow-up|2|||
161712460|NCT01486264|583991270|FG000|Overall Study|Other|5|||
161712461|NCT01486264|583991271|FG001|Overall Study|Other|11|||
161712462|NCT01486264|583991270|FG000|Overall Study|Not treated|0|||
161712463|NCT01486264|583991271|FG001|Overall Study|Not treated|1|||
161712464|NCT03584009|583991272|FG000|Overall Study|Death|25|||
161712465|NCT03584009|583991273|FG001|Overall Study|Death|18|||
161712466|NCT03584009|583991272|FG000|Overall Study|Lost to Follow-up|0|||
161712467|NCT03584009|583991273|FG001|Overall Study|Lost to Follow-up|1|||
161712468|NCT03584009|583991272|FG000|Overall Study|Physician Decision|1|||
161712469|NCT03584009|583991273|FG001|Overall Study|Physician Decision|1|||
161712470|NCT03584009|583991272|FG000|Overall Study|Study Terminated by Sponsor|22|||
161712471|NCT03584009|583991273|FG001|Overall Study|Study Terminated by Sponsor|30|||
161712472|NCT03584009|583991272|FG000|Overall Study|Withdrawal by Subject|3|||
161712473|NCT03584009|583991273|FG001|Overall Study|Withdrawal by Subject|2|||
161712474|NCT04112914|583991274|FG000|Overall Study|Lost to Follow-up|13|||
161712475|NCT04112914|583991275|FG001|Overall Study|Lost to Follow-up|9|||
161712476|NCT04112914|583991274|FG000|Overall Study|Withdrawal by Subject|1|||
161712477|NCT04112914|583991275|FG001|Overall Study|Withdrawal by Subject|0|||
161712478|NCT00768560|583991276|FG000|Intervention Set 1|Adverse Event|0|||
161712479|NCT00768560|583991277|FG001|Intervention Set 1|Adverse Event|1|||
161712480|NCT00768560|583991278|FG002|Intervention Set 1|Adverse Event|0|||
161712481|NCT00768560|583991279|FG003|Intervention Set 1|Adverse Event|0|||
161712482|NCT00768560|583991280|FG004|Intervention Set 1|Adverse Event|0|||
161712483|NCT00768560|583991281|FG005|Intervention Set 1|Adverse Event|0|||
161712484|NCT02635204|583991282|FG000|Overall Study|Adverse Event|1|||
161712485|NCT02635204|583991283|FG001|Overall Study|Adverse Event|0|||
161712486|NCT02635204|583991282|FG000|Overall Study|Lost to Follow-up|1|||
161712487|NCT02635204|583991283|FG001|Overall Study|Lost to Follow-up|1|||
161712488|NCT01772134|583991289|FG000|Overall Study|Adverse Event|6|||
161712489|NCT01772134|583991290|FG001|Overall Study|Adverse Event|5|||
161712490|NCT01772134|583991291|FG002|Overall Study|Adverse Event|10|||
161712491|NCT01772134|583991289|FG000|Overall Study|Withdrew Consent|3|||
161712492|NCT01772134|583991290|FG001|Overall Study|Withdrew Consent|1|||
161712493|NCT01772134|583991291|FG002|Overall Study|Withdrew Consent|5|||
161712494|NCT01772134|583991289|FG000|Overall Study|Lost to Follow-up|2|||
161712495|NCT01772134|583991290|FG001|Overall Study|Lost to Follow-up|0|||
161712496|NCT01772134|583991291|FG002|Overall Study|Lost to Follow-up|0|||
161712497|NCT01772134|583991289|FG000|Overall Study|Protocol Deviation|4|||
161712498|NCT01772134|583991290|FG001|Overall Study|Protocol Deviation|3|||
161712499|NCT01772134|583991291|FG002|Overall Study|Protocol Deviation|3|||
161712500|NCT01772134|583991289|FG000|Overall Study|Lack of Efficacy|11|||
161712501|NCT01772134|583991290|FG001|Overall Study|Lack of Efficacy|5|||
161712502|NCT01772134|583991291|FG002|Overall Study|Lack of Efficacy|3|||
161712503|NCT01772134|583991289|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
161712504|NCT01772134|583991290|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161712505|NCT01772134|583991291|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
161712506|NCT01772134|583991289|FG000|Overall Study|Randomized Study Medication Not Received|2|||
161712507|NCT01772134|583991290|FG001|Overall Study|Randomized Study Medication Not Received|0|||
161712508|NCT01772134|583991291|FG002|Overall Study|Randomized Study Medication Not Received|1|||
161712509|NCT02500550|583991292|FG000|Overall Study|Death|7|||
161712510|NCT03293680|583991297|FG000|Overall Study|Death|1|||
161712511|NCT03293680|583991297|FG000|Overall Study|Did not meet inclusion criteria|8|||
161712512|NCT00636818|583991298|FG000|Overall Study|Adverse Event|1|||
161712513|NCT00636818|583991298|FG000|Overall Study|Lost to Follow-up|2|||
161712514|NCT00636818|583991298|FG000|Overall Study|Entry Criteria Exclusion|3|||
161712515|NCT00636818|583991298|FG000|Overall Study|Protocol Violation|1|||
161712516|NCT00636818|583991298|FG000|Overall Study|Withdrawal by Subject|4|||
161712517|NCT02604264|583991299|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
161712518|NCT02604264|583991300|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
161712519|NCT03192904|583991302|FG000|Overall Study|Physician Decision|3|||
161712520|NCT03192904|583991303|FG001|Overall Study|Physician Decision|1|||
161712521|NCT03192904|583991302|FG000|Overall Study|Lost to Follow-up|0|||
161712522|NCT03192904|583991303|FG001|Overall Study|Lost to Follow-up|1|||
161712523|NCT03301857|583991310|FG000|Overall Study|Death|0|||
161712524|NCT03301857|583991311|FG001|Overall Study|Death|2|||
161712525|NCT03301857|583991310|FG000|Overall Study|Lost to Follow-up|4|||
161712526|NCT03301857|583991311|FG001|Overall Study|Lost to Follow-up|2|||
161712527|NCT03301857|583991310|FG000|Overall Study|Decision by Sponsor|6|||
161712528|NCT03301857|583991311|FG001|Overall Study|Decision by Sponsor|0|||
161712529|NCT03301857|583991310|FG000|Overall Study|Withdrawal by Subject|12|||
161712530|NCT03301857|583991311|FG001|Overall Study|Withdrawal by Subject|4|||
161712531|NCT01126580|583991316|FG000|Overall Study|Adverse Event|14|||
161712532|NCT01126580|583991317|FG001|Overall Study|Adverse Event|8|||
161712533|NCT01126580|583991318|FG002|Overall Study|Adverse Event|12|||
161712534|NCT01126580|583991316|FG000|Overall Study|Withdrawal by Subject|11|||
161712535|NCT01126580|583991317|FG001|Overall Study|Withdrawal by Subject|19|||
161712536|NCT01126580|583991318|FG002|Overall Study|Withdrawal by Subject|14|||
161712537|NCT01126580|583991316|FG000|Overall Study|Sponsor Decision|5|||
161712538|NCT01126580|583991317|FG001|Overall Study|Sponsor Decision|4|||
161712539|NCT01126580|583991318|FG002|Overall Study|Sponsor Decision|7|||
161712540|NCT01126580|583991316|FG000|Overall Study|Physician Decision|1|||
161712541|NCT01126580|583991317|FG001|Overall Study|Physician Decision|1|||
161661982|NCT01737827|583813476|FG001|Overall Study|Progressive Disease|16|||
161661983|NCT01737827|583813477|FG002|Overall Study|Progressive Disease|2|||
161661984|NCT01737827|583813475|FG000|Overall Study|Study Terminated by Sponsor|0|||
161661985|NCT01737827|583813476|FG001|Overall Study|Study Terminated by Sponsor|1|||
161661986|NCT01737827|583813477|FG002|Overall Study|Study Terminated by Sponsor|0|||
161661987|NCT01737827|583813475|FG000|Overall Study|Subject/Guardian Decision|0|||
161661988|NCT01737827|583813476|FG001|Overall Study|Subject/Guardian Decision|2|||
161661989|NCT01737827|583813477|FG002|Overall Study|Subject/Guardian Decision|0|||
161661990|NCT00296400|583813478|FG000|Overall Study|Adverse Event|7|||
161661991|NCT00296400|583813479|FG001|Overall Study|Adverse Event|7|||
161661992|NCT00296400|583813480|FG002|Overall Study|Adverse Event|7|||
161661993|NCT00296400|583813478|FG000|Overall Study|Withdrawal by Subject|5|||
161661994|NCT00296400|583813479|FG001|Overall Study|Withdrawal by Subject|6|||
161661995|NCT00296400|583813480|FG002|Overall Study|Withdrawal by Subject|2|||
161661996|NCT00296400|583813478|FG000|Overall Study|Incorrect enrollment|2|||
161712542|NCT01126580|583991318|FG002|Overall Study|Physician Decision|2|||
161712543|NCT01126580|583991316|FG000|Overall Study|Entry Criteria Not Met|1|||
161712544|NCT01126580|583991317|FG001|Overall Study|Entry Criteria Not Met|1|||
161712545|NCT01126580|583991318|FG002|Overall Study|Entry Criteria Not Met|2|||
161712546|NCT01126580|583991316|FG000|Overall Study|Lack of Efficacy|2|||
161712547|NCT01126580|583991317|FG001|Overall Study|Lack of Efficacy|3|||
161661997|NCT00296400|583813479|FG001|Overall Study|Incorrect enrollment|0|||
161712548|NCT01126580|583991318|FG002|Overall Study|Lack of Efficacy|4|||
161712549|NCT01126580|583991316|FG000|Overall Study|Protocol Violation|0|||
161712550|NCT01126580|583991317|FG001|Overall Study|Protocol Violation|1|||
161661998|NCT00296400|583813480|FG002|Overall Study|Incorrect enrollment|0|||
161661999|NCT00296400|583813478|FG000|Overall Study|Protocol Violation|1|||
161712551|NCT01126580|583991318|FG002|Overall Study|Protocol Violation|2|||
161712552|NCT01126580|583991316|FG000|Overall Study|Lost to Follow-up|15|||
161712553|NCT01126580|583991317|FG001|Overall Study|Lost to Follow-up|13|||
161712554|NCT01126580|583991318|FG002|Overall Study|Lost to Follow-up|9|||
161712555|NCT01126580|583991316|FG000|Overall Study|Treatment Non-compliance|0|||
161712556|NCT01126580|583991317|FG001|Overall Study|Treatment Non-compliance|2|||
161712557|NCT01126580|583991318|FG002|Overall Study|Treatment Non-compliance|3|||
161712558|NCT01731002|583991328|FG000|Overall Study|Adverse Event|0|||
161712559|NCT01731002|583991329|FG001|Overall Study|Adverse Event|2|||
161712560|NCT01731002|583991330|FG002|Overall Study|Adverse Event|2|||
161712561|NCT01731002|583991328|FG000|Overall Study|Non-Compliant|0|||
161712562|NCT01731002|583991329|FG001|Overall Study|Non-Compliant|1|||
161712563|NCT01731002|583991330|FG002|Overall Study|Non-Compliant|0|||
161712564|NCT01731002|583991328|FG000|Overall Study|Lost to Follow-up|1|||
161712565|NCT01731002|583991329|FG001|Overall Study|Lost to Follow-up|0|||
161712566|NCT01731002|583991330|FG002|Overall Study|Lost to Follow-up|0|||
161712567|NCT01731002|583991328|FG000|Overall Study|Test Agent Discontinuation|0|||
161712568|NCT01731002|583991329|FG001|Overall Study|Test Agent Discontinuation|1|||
161712569|NCT01731002|583991330|FG002|Overall Study|Test Agent Discontinuation|0|||
161712570|NCT01731002|583991328|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
161712571|NCT01731002|583991329|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
161712572|NCT01731002|583991330|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
161712573|NCT01731002|583991328|FG000|Overall Study|Elevated IOP|1|||
161712574|NCT01731002|583991329|FG001|Overall Study|Elevated IOP|0|||
161712575|NCT01731002|583991330|FG002|Overall Study|Elevated IOP|0|||
161712576|NCT01731002|583991328|FG000|Overall Study|Inappropriate use of study medications|0|||
161712577|NCT01731002|583991329|FG001|Overall Study|Inappropriate use of study medications|0|||
161712578|NCT01731002|583991330|FG002|Overall Study|Inappropriate use of study medications|1|||
161712579|NCT02382133|583991333|FG000|Overall Study|Death|22|||
161712580|NCT02382133|583991333|FG000|Overall Study|transfer out of ICU|4|||
161712581|NCT02382133|583991333|FG000|Overall Study|Physician Decision|2|||
161712582|NCT02382133|583991333|FG000|Overall Study|arterial catheter loss|4|||
161712583|NCT02382133|583991333|FG000|Overall Study|pressure injury both sites|1|||
161712584|NCT04321343|583991335|FG000|Overall Study|Adverse Event|0|||
161712585|NCT04321343|583991336|FG001|Overall Study|Adverse Event|0|||
161712586|NCT04321343|583991337|FG002|Overall Study|Adverse Event|1|||
161712587|NCT04321343|583991338|FG003|Overall Study|Adverse Event|0|||
161712588|NCT04321343|583991335|FG000|Overall Study|Death|0|||
161712589|NCT04321343|583991336|FG001|Overall Study|Death|0|||
161712590|NCT04321343|583991337|FG002|Overall Study|Death|0|||
161712591|NCT04321343|583991338|FG003|Overall Study|Death|1|||
161712592|NCT04321343|583991335|FG000|Overall Study|Pregnancy|1|||
161712593|NCT04321343|583991336|FG001|Overall Study|Pregnancy|0|||
161712594|NCT04321343|583991337|FG002|Overall Study|Pregnancy|0|||
161712595|NCT04321343|583991338|FG003|Overall Study|Pregnancy|0|||
161712596|NCT04321343|583991335|FG000|Overall Study|Protocol Violation|1|||
161712597|NCT04321343|583991336|FG001|Overall Study|Protocol Violation|1|||
161712598|NCT04321343|583991337|FG002|Overall Study|Protocol Violation|1|||
161712599|NCT04321343|583991338|FG003|Overall Study|Protocol Violation|1|||
161712600|NCT04321343|583991335|FG000|Overall Study|Withdrawal by Subject|0|||
161712601|NCT04321343|583991336|FG001|Overall Study|Withdrawal by Subject|6|||
161712602|NCT04321343|583991337|FG002|Overall Study|Withdrawal by Subject|0|||
161712603|NCT04321343|583991338|FG003|Overall Study|Withdrawal by Subject|2|||
161712604|NCT04321343|583991335|FG000|Overall Study|Lost to Follow-up|2|||
161712605|NCT04321343|583991336|FG001|Overall Study|Lost to Follow-up|2|||
161712606|NCT04321343|583991337|FG002|Overall Study|Lost to Follow-up|1|||
161712607|NCT04321343|583991338|FG003|Overall Study|Lost to Follow-up|3|||
161712608|NCT03430310|583991339|FG000|Overall Study|Protocol Violation|2|||
161712609|NCT03430310|583991340|FG001|Overall Study|Protocol Violation|0|||
161712610|NCT03430310|583991339|FG000|Overall Study|Withdrawal by Subject|3|||
161712611|NCT03430310|583991340|FG001|Overall Study|Withdrawal by Subject|2|||
161712612|NCT03430310|583991339|FG000|Overall Study|COVID shutdown March 2020|0|||
161712613|NCT03430310|583991340|FG001|Overall Study|COVID shutdown March 2020|1|||
161712614|NCT03972488|583991341|FG000|Overall Study|Progressive disease|42|||
161712615|NCT03972488|583991342|FG001|Overall Study|Progressive disease|44|||
161712616|NCT03972488|583991341|FG000|Overall Study|Physician Decision|13|||
161712617|NCT03972488|583991342|FG001|Overall Study|Physician Decision|7|||
161712618|NCT03972488|583991341|FG000|Overall Study|Adverse Event|8|||
161712619|NCT03972488|583991342|FG001|Overall Study|Adverse Event|1|||
161712620|NCT03972488|583991341|FG000|Overall Study|Death|4|||
161712621|NCT03972488|583991342|FG001|Overall Study|Death|4|||
161712622|NCT03972488|583991341|FG000|Overall Study|Withdrawal by Subject|3|||
161712623|NCT03972488|583991342|FG001|Overall Study|Withdrawal by Subject|4|||
161712624|NCT03972488|583991341|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
161712625|NCT03972488|583991342|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
161712626|NCT03277196|583991343|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
161712627|NCT03277196|583991343|FG000|Overall Study|Lost to Follow-up|3|||
161712628|NCT03277196|583991343|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161712629|NCT03277196|583991343|FG000|Overall Study|Other|2|||
161712630|NCT06119191|583991344|FG000|Overall Study|Adverse Event|0|||
161712631|NCT06119191|583991345|FG001|Overall Study|Adverse Event|1|||
161712632|NCT06119191|583991344|FG000|Overall Study|Protocol Violation|1|||
161712633|NCT06119191|583991345|FG001|Overall Study|Protocol Violation|0|||
161712634|NCT01084252|583993761|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712635|NCT01084252|583993762|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712636|NCT01084252|583993763|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712637|NCT01084252|583993764|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712638|NCT01084252|583993765|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712639|NCT01084252|583993766|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712640|NCT01084252|583993767|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712641|NCT01084252|583993768|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712642|NCT01084252|583993769|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712643|NCT01084252|583993770|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712644|NCT01084252|583993771|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712645|NCT01084252|583993772|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712646|NCT01084252|583993773|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
161712647|NCT01084252|583993774|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712648|NCT00853632|583993775|FG000|Overall Study|Death|88|||
161712649|NCT00853632|583993775|FG000|Overall Study|Withdrawal by Subject|45|||
161712650|NCT00853632|583993775|FG000|Overall Study|Lost to Follow-up|30|||
161712651|NCT00853632|583993775|FG000|Overall Study|Reoperation/Explant|17|||
161712652|NCT00853632|583993775|FG000|Overall Study|Exit with other reason|22|||
161712653|NCT04493619|583993776|FG000|Overall Study|Death|4|||
161712654|NCT04493619|583993777|FG001|Overall Study|Death|3|||
161712655|NCT04493619|583993778|FG002|Overall Study|Death|3|||
161712656|NCT04493619|583993779|FG003|Overall Study|Death|4|||
161712657|NCT04493619|583993776|FG000|Overall Study|Study discontinued early|10|||
161712658|NCT04493619|583993777|FG001|Overall Study|Study discontinued early|0|||
161662000|NCT00296400|583813479|FG001|Overall Study|Protocol Violation|1|||
161662001|NCT00296400|583813480|FG002|Overall Study|Protocol Violation|1|||
161662002|NCT00296400|583813478|FG000|Overall Study|Lost to Follow-up|1|||
161662003|NCT00296400|583813479|FG001|Overall Study|Lost to Follow-up|1|||
161662004|NCT00296400|583813480|FG002|Overall Study|Lost to Follow-up|2|||
161662005|NCT00296400|583813478|FG000|Overall Study|Study specific discontinuation criteria|0|||
161662006|NCT00296400|583813479|FG001|Overall Study|Study specific discontinuation criteria|0|||
161662007|NCT00296400|583813480|FG002|Overall Study|Study specific discontinuation criteria|1|||
161662008|NCT00296400|583813478|FG000|Overall Study|Visit 10 was performed earlier|0|||
161662009|NCT00296400|583813479|FG001|Overall Study|Visit 10 was performed earlier|1|||
161662010|NCT00296400|583813480|FG002|Overall Study|Visit 10 was performed earlier|0|||
161662011|NCT00296400|583813478|FG000|Overall Study|Pregnancy|1|||
161662012|NCT00296400|583813479|FG001|Overall Study|Pregnancy|2|||
161662013|NCT00296400|583813480|FG002|Overall Study|Pregnancy|0|||
161662014|NCT03538301|583813482|FG000|Overall Study|Adverse Event|1|||
161662015|NCT03538301|583813483|FG001|Overall Study|Adverse Event|4|||
161662016|NCT03538301|583813484|FG002|Overall Study|Adverse Event|4|||
161662017|NCT03538301|583813482|FG000|Overall Study|Death|1|||
161662018|NCT03538301|583813483|FG001|Overall Study|Death|1|||
161662019|NCT03538301|583813484|FG002|Overall Study|Death|0|||
161662020|NCT03538301|583813482|FG000|Overall Study|Physician Decision|0|||
161662021|NCT03538301|583813483|FG001|Overall Study|Physician Decision|1|||
161662022|NCT03538301|583813484|FG002|Overall Study|Physician Decision|0|||
161662023|NCT03538301|583813482|FG000|Overall Study|Protocol Violation|0|||
161662024|NCT03538301|583813483|FG001|Overall Study|Protocol Violation|0|||
161662025|NCT03538301|583813484|FG002|Overall Study|Protocol Violation|1|||
161662026|NCT03538301|583813482|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
161662027|NCT03538301|583813483|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
161662028|NCT03538301|583813484|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
161662029|NCT01586910|583815489|FG000|Overall Study|Death|4|||
161662030|NCT01586910|583815490|FG001|Overall Study|Death|4|||
161662031|NCT01586910|583815489|FG000|Overall Study|Withdrawal by Subject|6|||
161662032|NCT01586910|583815490|FG001|Overall Study|Withdrawal by Subject|43|||
161662033|NCT01586910|583815489|FG000|Overall Study|Physician withdrew Subject|5|||
161662034|NCT01586910|583815490|FG001|Overall Study|Physician withdrew Subject|24|||
161662035|NCT00252733|583815491|FG000|Overall Study|Withdrawal by Subject|73|||
161662036|NCT00252733|583815492|FG001|Overall Study|Withdrawal by Subject|67|||
161662037|NCT00252733|583815491|FG000|Overall Study|Death|7|||
161662038|NCT00252733|583815492|FG001|Overall Study|Death|5|||
161662039|NCT00252733|583815491|FG000|Overall Study|Lost to Follow-up|12|||
161662040|NCT00252733|583815492|FG001|Overall Study|Lost to Follow-up|6|||
161662041|NCT00252733|583815491|FG000|Overall Study|Multiple Reasons|14|||
161662042|NCT00252733|583815492|FG001|Overall Study|Multiple Reasons|14|||
161662043|NCT04289051|583815493|FG000|Overall Study|Lost to Follow-up|0|||
161662044|NCT04289051|583815494|FG001|Overall Study|Lost to Follow-up|0|||
161662045|NCT04289051|583815495|FG002|Overall Study|Lost to Follow-up|2|||
161662046|NCT00156819|583815498|FG000|Overall Study|Lost to Follow-up|1|||
161662047|NCT00156819|583815499|FG001|Overall Study|Lost to Follow-up|1|||
161662048|NCT00156819|583815500|FG002|Overall Study|Lost to Follow-up|3|||
161662049|NCT01689337|583815501|FG000|Overall Study|Study Discontinuation|1|||
161662050|NCT03038438|583815505|FG000|Overall Study|Death|3|||
161662051|NCT03038438|583815505|FG000|Overall Study|Lost to Follow-up|8|||
161712659|NCT04493619|583993778|FG002|Overall Study|Study discontinued early|4|||
161662052|NCT03038438|583815505|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
161662053|NCT03038438|583815505|FG000|Overall Study|Withdrawal by Subject|5|||
161662054|NCT03038438|583815505|FG000|Overall Study|No 36-Month Follow-Up|18|||
161662055|NCT01174160|583815506|FG000|Overall Study|Adverse Event|1|||
161662056|NCT01174160|583815507|FG001|Overall Study|Adverse Event|0|||
161662057|NCT01174160|583815506|FG000|Overall Study|Lost to Follow-up|1|||
161662058|NCT01174160|583815507|FG001|Overall Study|Lost to Follow-up|0|||
161662059|NCT01174160|583815506|FG000|Overall Study|Physician Decision|1|||
161662060|NCT01174160|583815507|FG001|Overall Study|Physician Decision|0|||
161662061|NCT01174160|583815506|FG000|Overall Study|Protocol Violation|4|||
161712660|NCT04493619|583993779|FG003|Overall Study|Study discontinued early|8|||
161662062|NCT01174160|583815507|FG001|Overall Study|Protocol Violation|6|||
161712661|NCT04493619|583993776|FG000|Overall Study|Lost to Follow-up|0|||
161712662|NCT04493619|583993777|FG001|Overall Study|Lost to Follow-up|0|||
161712663|NCT04493619|583993778|FG002|Overall Study|Lost to Follow-up|0|||
161712664|NCT04493619|583993779|FG003|Overall Study|Lost to Follow-up|1|||
161712665|NCT02017444|583993786|FG000|Overall Study|Physician Decision|1|||
161712666|NCT02017444|583993787|FG001|Overall Study|Physician Decision|0|||
161712667|NCT02017444|583993786|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
161712668|NCT02017444|583993787|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
161712669|NCT02342171|583993790|FG000|Overall Study|Death|4|||
161712670|NCT02342171|583993791|FG001|Overall Study|Death|87|||
161712671|NCT02342171|583993790|FG000|Overall Study|Received favipiravir|10|||
161712672|NCT02342171|583993791|FG001|Overall Study|Received favipiravir|0|||
161712673|NCT02342171|583993790|FG000|Overall Study|Missing cycle treshold value|1|||
161712674|NCT02342171|583993791|FG001|Overall Study|Missing cycle treshold value|0|||
161712675|NCT02342171|583993790|FG000|Overall Study|Unknown outcome|0|||
161712676|NCT02342171|583993791|FG001|Overall Study|Unknown outcome|1|||
161712677|NCT02342171|583993790|FG000|Overall Study|Missing age data|0|||
161712678|NCT02342171|583993791|FG001|Overall Study|Missing age data|1|||
161712679|NCT00875420|583993792|FG000|Overall Study|Adverse Event|0|||
161712680|NCT00875420|583993793|FG001|Overall Study|Adverse Event|1|||
161712681|NCT00875420|583993794|FG002|Overall Study|Adverse Event|1|||
161712682|NCT00875420|583993795|FG003|Overall Study|Adverse Event|0|||
161712683|NCT00875420|583993796|FG004|Overall Study|Adverse Event|0|||
161712684|NCT00875420|583993792|FG000|Overall Study|Inability to complete study procedures|1|||
161712685|NCT00875420|583993793|FG001|Overall Study|Inability to complete study procedures|0|||
161712686|NCT00875420|583993794|FG002|Overall Study|Inability to complete study procedures|1|||
161712687|NCT00875420|583993795|FG003|Overall Study|Inability to complete study procedures|1|||
161712688|NCT00875420|583993796|FG004|Overall Study|Inability to complete study procedures|1|||
161712689|NCT00875420|583993792|FG000|Overall Study|Lost to Follow-up|1|||
161712690|NCT00875420|583993793|FG001|Overall Study|Lost to Follow-up|0|||
161712691|NCT00875420|583993794|FG002|Overall Study|Lost to Follow-up|0|||
161712692|NCT00875420|583993795|FG003|Overall Study|Lost to Follow-up|0|||
161712693|NCT00875420|583993796|FG004|Overall Study|Lost to Follow-up|0|||
161712694|NCT00875420|583993792|FG000|Overall Study|Personal reason|0|||
161712695|NCT00875420|583993793|FG001|Overall Study|Personal reason|0|||
161712696|NCT00875420|583993794|FG002|Overall Study|Personal reason|0|||
161712697|NCT00875420|583993795|FG003|Overall Study|Personal reason|0|||
161662063|NCT01174160|583815506|FG000|Overall Study|Withdrawal by Subject|1|||
161662064|NCT01174160|583815507|FG001|Overall Study|Withdrawal by Subject|0|||
161662065|NCT02038543|583815510|FG000|Overall Study|Screen Failure|0|||
161662066|NCT02038543|583815511|FG001|Overall Study|Screen Failure|0|||
161662067|NCT02038543|583815512|FG002|Overall Study|Screen Failure|0|||
161662068|NCT02038543|583815513|FG003|Overall Study|Screen Failure|1|||
161662069|NCT02038543|583815510|FG000|Overall Study|Withdrawal by Subject|0|||
161662070|NCT02038543|583815511|FG001|Overall Study|Withdrawal by Subject|0|||
161662071|NCT02038543|583815512|FG002|Overall Study|Withdrawal by Subject|0|||
161662072|NCT02038543|583815513|FG003|Overall Study|Withdrawal by Subject|1|||
161662073|NCT00093808|583815514|FG000|Overall Study|Cancel participation before receiving tx|1|||
161662074|NCT00093808|583815514|FG000|Overall Study|Protocol Violation|1|||
161662075|NCT00871780|583815515|FG000|Overall Study|Enrolled But Not Treated|6|||
161662076|NCT00871780|583815515|FG000|Overall Study|Withdrawal by Subject|9|||
161712698|NCT00875420|583993796|FG004|Overall Study|Personal reason|1|||
161712699|NCT00875420|583993792|FG000|Overall Study|Prohibited medication|0|||
161712700|NCT00875420|583993793|FG001|Overall Study|Prohibited medication|0|||
161712701|NCT00875420|583993794|FG002|Overall Study|Prohibited medication|0|||
161712702|NCT00875420|583993795|FG003|Overall Study|Prohibited medication|1|||
161712703|NCT00875420|583993796|FG004|Overall Study|Prohibited medication|0|||
161712704|NCT00875420|583993792|FG000|Overall Study|Sponsor decision|0|||
161712705|NCT00875420|583993793|FG001|Overall Study|Sponsor decision|1|||
161712706|NCT00875420|583993794|FG002|Overall Study|Sponsor decision|0|||
161712707|NCT00875420|583993795|FG003|Overall Study|Sponsor decision|0|||
161712708|NCT00875420|583993796|FG004|Overall Study|Sponsor decision|0|||
161712709|NCT00875420|583993792|FG000|Overall Study|Withdrawal by Subject|0|||
161712710|NCT00875420|583993793|FG001|Overall Study|Withdrawal by Subject|0|||
161712711|NCT00875420|583993794|FG002|Overall Study|Withdrawal by Subject|1|||
161712712|NCT00875420|583993795|FG003|Overall Study|Withdrawal by Subject|0|||
161712713|NCT00875420|583993796|FG004|Overall Study|Withdrawal by Subject|0|||
161712714|NCT00914628|583993797|FG000|Overall Study|Death|35|||
161712715|NCT00914628|583993798|FG001|Overall Study|Death|17|||
161712716|NCT00914628|583993797|FG000|Overall Study|Medical decision|4|||
161712717|NCT00914628|583993798|FG001|Overall Study|Medical decision|0|||
161712718|NCT00914628|583993797|FG000|Overall Study|Protocol Violation|1|||
161712719|NCT00914628|583993798|FG001|Overall Study|Protocol Violation|0|||
161712720|NCT00914628|583993797|FG000|Overall Study|Lack of Efficacy|1|||
161712721|NCT00914628|583993798|FG001|Overall Study|Lack of Efficacy|0|||
161712722|NCT00914628|583993797|FG000|Overall Study|non-randomized|1|||
161712723|NCT00914628|583993798|FG001|Overall Study|non-randomized|0|||
161712724|NCT00914628|583993797|FG000|Overall Study|Relapse|1|||
161712725|NCT00914628|583993798|FG001|Overall Study|Relapse|2|||
161712726|NCT00914628|583993797|FG000|Overall Study|Study terminated by Sponsor|14|||
161712727|NCT00914628|583993798|FG001|Overall Study|Study terminated by Sponsor|8|||
161712728|NCT00914628|583993797|FG000|Overall Study|Patients who did not receive a single dose|7|||
161712729|NCT00914628|583993798|FG001|Overall Study|Patients who did not receive a single dose|1|||
161712730|NCT01756157|583993799|FG000|First Intervention Period|Withdrawal by Subject|1|||
161712731|NCT01756157|583993800|FG001|First Intervention Period|Withdrawal by Subject|0|||
161712732|NCT01756157|583993799|FG000|First Intervention Period|Lost to Follow-up|0|||
161712733|NCT01756157|583993800|FG001|First Intervention Period|Lost to Follow-up|2|||
161712734|NCT02799381|583993803|FG000|Overall Study|Withdrew consent|3|||
161712735|NCT02799381|583993804|FG001|Overall Study|Withdrew consent|2|||
161712736|NCT02799381|583993803|FG000|Overall Study|Adverse Event|0|||
161712737|NCT02799381|583993804|FG001|Overall Study|Adverse Event|1|||
161712738|NCT02799381|583993803|FG000|Overall Study|Participant did not take any study drug|1|||
161712739|NCT02799381|583993804|FG001|Overall Study|Participant did not take any study drug|0|||
161712740|NCT02698410|583993807|FG000|Overall Study|Adverse Event|2|||
161712741|NCT02698410|583993807|FG000|Overall Study|Withdrawal by Subject|1|||
161712742|NCT02698410|583993807|FG000|Overall Study|Other|1|||
161712743|NCT03952130|583993808|FG000|Overall Study|Adverse Event|0|||
161712744|NCT03952130|583993809|FG001|Overall Study|Adverse Event|1|||
161712745|NCT03952130|583993808|FG000|Overall Study|Lost to Follow-up|1|||
161712746|NCT03952130|583993809|FG001|Overall Study|Lost to Follow-up|0|||
161712747|NCT03952130|583993808|FG000|Overall Study|Withdrawal by Subject|1|||
161712748|NCT03952130|583993809|FG001|Overall Study|Withdrawal by Subject|5|||
161712749|NCT01713348|583993810|FG000|Overall Study|Withdrawal by Subject|3|||
161712750|NCT01713348|583993811|FG001|Overall Study|Withdrawal by Subject|2|||
161712751|NCT01713348|583993812|FG002|Overall Study|Withdrawal by Subject|2|||
161712752|NCT01713348|583993813|FG003|Overall Study|Withdrawal by Subject|0|||
161712753|NCT01713348|583993810|FG000|Overall Study|Lost to Follow-up|1|||
161712754|NCT01713348|583993811|FG001|Overall Study|Lost to Follow-up|0|||
161712755|NCT01713348|583993812|FG002|Overall Study|Lost to Follow-up|0|||
161712756|NCT01713348|583993813|FG003|Overall Study|Lost to Follow-up|0|||
161712757|NCT02638012|583993814|FG000|Overall Study|Lost to Follow-up|1|||
161712758|NCT00621023|583993815|FG000|Overall Study|Death|5|||
161712759|NCT00621023|583993815|FG000|Overall Study|Follow up discontinued|1|||
161712760|NCT03199911|583993822|FG000|Overall Study|Lost to Follow-up|5|||
161712761|NCT03199911|583993823|FG001|Overall Study|Lost to Follow-up|5|||
161712762|NCT03199911|583993822|FG000|Overall Study|Did not proceed with surgery|2|||
161712763|NCT03199911|583993823|FG001|Overall Study|Did not proceed with surgery|1|||
161712764|NCT04331899|583993824|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
161712765|NCT04331899|583993825|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
161712766|NCT01062399|583993828|FG000|Overall Study|Protocol Violation|0|||
161712767|NCT01062399|583993829|FG001|Overall Study|Protocol Violation|1|||
161712768|NCT01062399|583993830|FG002|Overall Study|Protocol Violation|0|||
161712769|NCT01062399|583993831|FG003|Overall Study|Protocol Violation|6|||
161712770|NCT01062399|583993832|FG004|Overall Study|Protocol Violation|4|||
161712771|NCT02424539|583993833|FG000|Overall Study|Adverse Event|0|||
161712772|NCT02424539|583993834|FG001|Overall Study|Adverse Event|0|||
161712773|NCT02424539|583993835|FG002|Overall Study|Adverse Event|1|||
161712774|NCT02424539|583993833|FG000|Overall Study|Physician Decision|0|||
161712775|NCT02424539|583993834|FG001|Overall Study|Physician Decision|0|||
161712776|NCT02424539|583993835|FG002|Overall Study|Physician Decision|1|||
161712777|NCT02424539|583993833|FG000|Overall Study|Withdrawal by Subject|3|||
161712778|NCT02424539|583993834|FG001|Overall Study|Withdrawal by Subject|1|||
161712779|NCT02424539|583993835|FG002|Overall Study|Withdrawal by Subject|0|||
161712780|NCT02424539|583993833|FG000|Overall Study|Other: Reached stopping criteria|11|||
161712781|NCT02424539|583993834|FG001|Overall Study|Other: Reached stopping criteria|7|||
161712782|NCT02424539|583993835|FG002|Overall Study|Other: Reached stopping criteria|6|||
161712783|NCT00813748|583993836|FG000|Skin Test Substudy|Physician Decision|0|||
161712784|NCT00813748|583993837|FG001|Skin Test Substudy|Physician Decision|1|||
161712785|NCT01829048|583993838|FG000|Overall Study|Withdrawal by Subject|0|||
161712786|NCT01829048|583993839|FG001|Overall Study|Withdrawal by Subject|0|||
161712787|NCT01829048|583993840|FG002|Overall Study|Withdrawal by Subject|0|||
161712788|NCT01829048|583993841|FG003|Overall Study|Withdrawal by Subject|2|||
161712789|NCT01829048|583993842|FG004|Overall Study|Withdrawal by Subject|0|||
161712790|NCT00500071|583993850|FG000|Screening and Washout Phase|Protocol Violation|1|||
161712791|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
161712792|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
161712793|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
161712794|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
161712795|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
161712796|NCT00500071|583993850|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
161712797|NCT00389207|583993851|FG000|Overall Study|Adverse Event|26|||
161712798|NCT00389207|583993852|FG001|Overall Study|Adverse Event|32|||
161712799|NCT00389207|583993853|FG002|Overall Study|Adverse Event|10|||
161712800|NCT00389207|583993851|FG000|Overall Study|Protocol Violation|3|||
161712801|NCT00389207|583993852|FG001|Overall Study|Protocol Violation|1|||
161712802|NCT00389207|583993853|FG002|Overall Study|Protocol Violation|4|||
161712803|NCT00389207|583993851|FG000|Overall Study|Lost to Follow-up|12|||
161712804|NCT00389207|583993852|FG001|Overall Study|Lost to Follow-up|9|||
161712805|NCT00389207|583993853|FG002|Overall Study|Lost to Follow-up|7|||
161712806|NCT00389207|583993851|FG000|Overall Study|Withdrawal by Subject|5|||
161712807|NCT00389207|583993852|FG001|Overall Study|Withdrawal by Subject|7|||
161712808|NCT00389207|583993853|FG002|Overall Study|Withdrawal by Subject|11|||
161712809|NCT00389207|583993851|FG000|Overall Study|Other|17|||
161712810|NCT00389207|583993852|FG001|Overall Study|Other|23|||
161712811|NCT00389207|583993853|FG002|Overall Study|Other|9|||
161712812|NCT00424398|583993857|FG000|Overall Study|Withdrawal by Subject|2|||
161712813|NCT00424398|583993858|FG001|Overall Study|Withdrawal by Subject|1|||
161712814|NCT00424398|583993859|FG002|Overall Study|Withdrawal by Subject|0|||
161712815|NCT00424398|583993857|FG000|Overall Study|Subject met exclusion criteria|1|||
161712816|NCT00424398|583993858|FG001|Overall Study|Subject met exclusion criteria|0|||
161712817|NCT00424398|583993859|FG002|Overall Study|Subject met exclusion criteria|0|||
161712818|NCT01023789|583993860|FG000|3 - Year Visit|Death|29|||
161712819|NCT01023789|583993860|FG000|3 - Year Visit|Withdrawal of consent|1|||
161712820|NCT01023789|583993860|FG000|3 - Year Visit|Lost to Follow-up|13|||
161662077|NCT00871780|583815515|FG000|Overall Study|Adverse Event|6|||
161662078|NCT00871780|583815515|FG000|Overall Study|Voluntary Discontinuation|4|||
161662079|NCT00871780|583815515|FG000|Overall Study|Death|1|||
161662080|NCT00871780|583815515|FG000|Overall Study|Physician Decision|1|||
161662081|NCT03545503|583815516|FG000|Overall Study|Protocol Violation|14|||
161662082|NCT03545503|583815517|FG001|Overall Study|Protocol Violation|16|||
161662083|NCT04494256|583815518|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
161662084|NCT04494256|583815519|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
161662085|NCT04494256|583815520|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
161662086|NCT04494256|583815521|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
161662087|NCT04494256|583815522|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
161662088|NCT04494256|583815523|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
161662089|NCT04494256|583815524|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
161712821|NCT02115308|583993871|FG000|Overall Study|Safety Screening|2|||
161712822|NCT02115308|583993872|FG001|Overall Study|Safety Screening|2|||
161712823|NCT01309737|583993873|FG000|Week 0 to 16|Death|1|||
161712824|NCT01309737|583993874|FG001|Week 0 to 16|Death|0|||
161712825|NCT01309737|583993875|FG002|Week 0 to 16|Death|1|||
161712826|NCT01309737|583993876|FG003|Week 0 to 16|Death|0|||
161712827|NCT01309737|583993877|FG004|Week 0 to 16|Death|0|||
161712828|NCT01309737|583993873|FG000|Week 0 to 16|Adverse Event|11|||
161712829|NCT01309737|583993874|FG001|Week 0 to 16|Adverse Event|10|||
161712830|NCT01309737|583993875|FG002|Week 0 to 16|Adverse Event|5|||
161712831|NCT01309737|583993876|FG003|Week 0 to 16|Adverse Event|0|||
161712832|NCT01309737|583993877|FG004|Week 0 to 16|Adverse Event|0|||
161712833|NCT01309737|583993873|FG000|Week 0 to 16|Lack of Efficacy|15|||
161712834|NCT01309737|583993874|FG001|Week 0 to 16|Lack of Efficacy|2|||
161712835|NCT01309737|583993875|FG002|Week 0 to 16|Lack of Efficacy|24|||
161712836|NCT01309737|583993876|FG003|Week 0 to 16|Lack of Efficacy|0|||
161712837|NCT01309737|583993877|FG004|Week 0 to 16|Lack of Efficacy|0|||
161712838|NCT01309737|583993873|FG000|Week 0 to 16|Lost to Follow-up|7|||
161712839|NCT01309737|583993874|FG001|Week 0 to 16|Lost to Follow-up|8|||
161712840|NCT01309737|583993875|FG002|Week 0 to 16|Lost to Follow-up|3|||
161712841|NCT01309737|583993876|FG003|Week 0 to 16|Lost to Follow-up|0|||
161712842|NCT01309737|583993877|FG004|Week 0 to 16|Lost to Follow-up|0|||
161712843|NCT01309737|583993873|FG000|Week 0 to 16|Withdrawal by Subject|7|||
161712844|NCT01309737|583993874|FG001|Week 0 to 16|Withdrawal by Subject|6|||
161712845|NCT01309737|583993875|FG002|Week 0 to 16|Withdrawal by Subject|7|||
161712846|NCT01309737|583993876|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161712847|NCT01309737|583993877|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161712848|NCT01309737|583993873|FG000|Week 0 to 16|Other|10|||
161712849|NCT01309737|583993874|FG001|Week 0 to 16|Other|14|||
161712850|NCT01309737|583993875|FG002|Week 0 to 16|Other|4|||
161712851|NCT01309737|583993876|FG003|Week 0 to 16|Other|0|||
161712852|NCT01309737|583993877|FG004|Week 0 to 16|Other|0|||
161712853|NCT01309737|583993873|FG000|Week 0 to 16|Randomized, but not treated|1|||
161712854|NCT01309737|583993874|FG001|Week 0 to 16|Randomized, but not treated|0|||
161712855|NCT01309737|583993875|FG002|Week 0 to 16|Randomized, but not treated|0|||
161712856|NCT01309737|583993876|FG003|Week 0 to 16|Randomized, but not treated|0|||
161712857|NCT01309737|583993877|FG004|Week 0 to 16|Randomized, but not treated|0|||
161712858|NCT01309737|583993873|FG000|Week 16 to 52|Death|0|||
161712859|NCT01309737|583993874|FG001|Week 16 to 52|Death|0|||
161712860|NCT01309737|583993875|FG002|Week 16 to 52|Death|0|||
161712861|NCT01309737|583993876|FG003|Week 16 to 52|Death|0|||
161712862|NCT01309737|583993877|FG004|Week 16 to 52|Death|1|||
161712863|NCT01309737|583993873|FG000|Week 16 to 52|Adverse Event|7|||
161712864|NCT01309737|583993874|FG001|Week 16 to 52|Adverse Event|7|||
161712865|NCT01309737|583993875|FG002|Week 16 to 52|Adverse Event|0|||
161712866|NCT01309737|583993876|FG003|Week 16 to 52|Adverse Event|6|||
161712867|NCT01309737|583993877|FG004|Week 16 to 52|Adverse Event|5|||
161712868|NCT01309737|583993873|FG000|Week 16 to 52|Lack of Efficacy|107|||
161712869|NCT01309737|583993874|FG001|Week 16 to 52|Lack of Efficacy|76|||
161712870|NCT01309737|583993875|FG002|Week 16 to 52|Lack of Efficacy|0|||
161712871|NCT01309737|583993876|FG003|Week 16 to 52|Lack of Efficacy|25|||
161712872|NCT01309737|583993877|FG004|Week 16 to 52|Lack of Efficacy|21|||
161712873|NCT01309737|583993873|FG000|Week 16 to 52|Lost to Follow-up|4|||
161712874|NCT01309737|583993874|FG001|Week 16 to 52|Lost to Follow-up|2|||
161712875|NCT01309737|583993875|FG002|Week 16 to 52|Lost to Follow-up|0|||
161712876|NCT01309737|583993876|FG003|Week 16 to 52|Lost to Follow-up|1|||
161712877|NCT01309737|583993877|FG004|Week 16 to 52|Lost to Follow-up|4|||
161712878|NCT01309737|583993873|FG000|Week 16 to 52|Withdrawal by Subject|5|||
161712879|NCT01309737|583993874|FG001|Week 16 to 52|Withdrawal by Subject|6|||
161712880|NCT01309737|583993875|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161712881|NCT01309737|583993876|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161712882|NCT01309737|583993877|FG004|Week 16 to 52|Withdrawal by Subject|2|||
161712883|NCT01309737|583993873|FG000|Week 16 to 52|Other|10|||
161712884|NCT01309737|583993874|FG001|Week 16 to 52|Other|12|||
161712885|NCT01309737|583993875|FG002|Week 16 to 52|Other|0|||
161712886|NCT01309737|583993876|FG003|Week 16 to 52|Other|2|||
161712887|NCT01309737|583993877|FG004|Week 16 to 52|Other|0|||
161712888|NCT01442181|583993879|FG000|Overall Study|patient refused surgery|1|||
161712889|NCT01442181|583993880|FG001|Overall Study|patient refused surgery|0|||
161712890|NCT01442181|583993879|FG000|Overall Study|no insurance for surgery|1|||
161712891|NCT01442181|583993880|FG001|Overall Study|no insurance for surgery|0|||
161712892|NCT01442181|583993879|FG000|Overall Study|low ejection factor|0|||
161712893|NCT01442181|583993880|FG001|Overall Study|low ejection factor|1|||
161712894|NCT01442181|583993879|FG000|Overall Study|Lost to Follow-up|1|||
161712895|NCT01442181|583993880|FG001|Overall Study|Lost to Follow-up|1|||
161712896|NCT01442181|583993879|FG000|Overall Study|patient in an additional study|1|||
161712897|NCT01442181|583993880|FG001|Overall Study|patient in an additional study|0|||
161712898|NCT01442181|583993879|FG000|Overall Study|atrial fibrillation not noted|0|||
161712899|NCT01442181|583993880|FG001|Overall Study|atrial fibrillation not noted|1|||
161712900|NCT00749203|583993881|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
161712901|NCT00749203|583993882|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
161712902|NCT00749203|583993881|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
161712903|NCT00749203|583993882|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
161712904|NCT00749203|583993881|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
161712905|NCT00749203|583993882|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
161712906|NCT00749203|583993881|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
161712907|NCT00749203|583993882|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
161712908|NCT00749203|583993881|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
161712909|NCT00749203|583993882|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
161712910|NCT00749203|583993881|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
161712911|NCT00749203|583993882|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
161712912|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712913|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712914|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712915|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712916|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161712917|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712918|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712919|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161712920|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161712921|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712922|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712923|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712924|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712925|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712926|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712927|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712928|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712929|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712930|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712931|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712932|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712933|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
161712934|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712935|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712936|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712937|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712938|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712939|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712940|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712941|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712942|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712943|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712944|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712945|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712946|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712947|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712948|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712949|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712950|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712951|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712952|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712953|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712954|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712955|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712956|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
161712957|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712958|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712959|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712960|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712961|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712962|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712963|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712964|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712965|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712966|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712967|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712968|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712969|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
161712970|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
161712971|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712972|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712973|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712974|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712975|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712976|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712977|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712978|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712979|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712980|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712981|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712982|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712983|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712984|NCT04233424|583993901|FG000|Overall Study|Death|15|||
161712985|NCT04233424|583993902|FG001|Overall Study|Death|16|||
161712986|NCT04233424|583993901|FG000|Overall Study|Withdrawal by Subject|2|||
161712987|NCT04233424|583993902|FG001|Overall Study|Withdrawal by Subject|8|||
161712988|NCT04233424|583993901|FG000|Overall Study|Physician Decision|1|||
161712989|NCT04233424|583993902|FG001|Overall Study|Physician Decision|3|||
161712990|NCT04233424|583993901|FG000|Overall Study|Protocol Violation|3|||
161712991|NCT04233424|583993902|FG001|Overall Study|Protocol Violation|1|||
161712992|NCT04233424|583993901|FG000|Overall Study|Lost to Follow-up|1|||
161712993|NCT04233424|583993902|FG001|Overall Study|Lost to Follow-up|3|||
161712994|NCT04233424|583993901|FG000|Overall Study|subject refuse to visit site|2|||
161712995|NCT04233424|583993902|FG001|Overall Study|subject refuse to visit site|0|||
161712996|NCT02698189|583993903|FG000|Overall Study|Physician Decision|3|||
161712997|NCT02698189|583993904|FG001|Overall Study|Physician Decision|0|||
161712998|NCT02698189|583993903|FG000|Overall Study|Progressive disease|0|||
161712999|NCT02698189|583993904|FG001|Overall Study|Progressive disease|5|||
161713000|NCT02698189|583993903|FG000|Overall Study|Study terminated by sponsor|0|||
161713001|NCT02698189|583993904|FG001|Overall Study|Study terminated by sponsor|1|||
161713002|NCT02240706|583993905|FG000|Overall Study|Lack of Efficacy|2|||
161713003|NCT02240706|583993906|FG001|Overall Study|Lack of Efficacy|2|||
161713004|NCT02240706|583993907|FG002|Overall Study|Lack of Efficacy|2|||
161713005|NCT02240706|583993908|FG003|Overall Study|Lack of Efficacy|2|||
161713006|NCT02240706|583993909|FG004|Overall Study|Lack of Efficacy|5|||
161713007|NCT02240706|583993910|FG005|Overall Study|Lack of Efficacy|0|||
161713008|NCT02240706|583993911|FG006|Overall Study|Lack of Efficacy|0|||
161713009|NCT02240706|583993905|FG000|Overall Study|Adverse Event|1|||
161713010|NCT02240706|583993906|FG001|Overall Study|Adverse Event|0|||
161713011|NCT02240706|583993907|FG002|Overall Study|Adverse Event|1|||
161713012|NCT02240706|583993908|FG003|Overall Study|Adverse Event|0|||
161713013|NCT02240706|583993909|FG004|Overall Study|Adverse Event|2|||
161713014|NCT02240706|583993910|FG005|Overall Study|Adverse Event|0|||
161713015|NCT02240706|583993911|FG006|Overall Study|Adverse Event|0|||
161713016|NCT02240706|583993905|FG000|Overall Study|Progressive disease|0|||
161713017|NCT02240706|583993906|FG001|Overall Study|Progressive disease|0|||
161713018|NCT02240706|583993907|FG002|Overall Study|Progressive disease|0|||
161713019|NCT02240706|583993908|FG003|Overall Study|Progressive disease|0|||
161713020|NCT02240706|583993909|FG004|Overall Study|Progressive disease|1|||
161713021|NCT02240706|583993910|FG005|Overall Study|Progressive disease|0|||
161713022|NCT02240706|583993911|FG006|Overall Study|Progressive disease|0|||
161713023|NCT02240706|583993905|FG000|Overall Study|Dose limiting toxicity|0|||
161713024|NCT02240706|583993906|FG001|Overall Study|Dose limiting toxicity|0|||
161713025|NCT02240706|583993907|FG002|Overall Study|Dose limiting toxicity|0|||
161713026|NCT02240706|583993908|FG003|Overall Study|Dose limiting toxicity|0|||
161713027|NCT02240706|583993909|FG004|Overall Study|Dose limiting toxicity|1|||
161713028|NCT02240706|583993910|FG005|Overall Study|Dose limiting toxicity|0|||
161713029|NCT02240706|583993911|FG006|Overall Study|Dose limiting toxicity|0|||
161713030|NCT02240706|583993905|FG000|Overall Study|Refused to continue taking medication|0|||
161713031|NCT02240706|583993906|FG001|Overall Study|Refused to continue taking medication|1|||
161713032|NCT02240706|583993907|FG002|Overall Study|Refused to continue taking medication|3|||
161713033|NCT02240706|583993908|FG003|Overall Study|Refused to continue taking medication|1|||
161713034|NCT02240706|583993909|FG004|Overall Study|Refused to continue taking medication|2|||
161713035|NCT02240706|583993910|FG005|Overall Study|Refused to continue taking medication|0|||
161713036|NCT02240706|583993911|FG006|Overall Study|Refused to continue taking medication|0|||
161713037|NCT02240706|583993905|FG000|Overall Study|Insurance billing concerns|0|||
161713038|NCT02240706|583993906|FG001|Overall Study|Insurance billing concerns|0|||
161713039|NCT02240706|583993907|FG002|Overall Study|Insurance billing concerns|0|||
161713040|NCT02240706|583993908|FG003|Overall Study|Insurance billing concerns|1|||
161713041|NCT02240706|583993909|FG004|Overall Study|Insurance billing concerns|0|||
161713042|NCT02240706|583993910|FG005|Overall Study|Insurance billing concerns|0|||
161713043|NCT02240706|583993911|FG006|Overall Study|Insurance billing concerns|0|||
161713044|NCT00855439|583993916|FG000|Overall Study|Withdrawal by Subject|2|||
161713045|NCT00855439|583993917|FG001|Overall Study|Withdrawal by Subject|0|||
161713046|NCT00855439|583993916|FG000|Overall Study|Pregnancy|1|||
161713047|NCT00855439|583993917|FG001|Overall Study|Pregnancy|0|||
161713048|NCT05502289|583993918|FG000|Period 1|Out Of Window|1|||
161713049|NCT05502289|583993919|FG001|Period 1|Out Of Window|0|||
161713050|NCT02333227|583993929|FG000|Overall Study|Lost to Follow-up|137|||
161713051|NCT02333227|583993930|FG001|Overall Study|Lost to Follow-up|106|||
161713052|NCT02333227|583993929|FG000|Overall Study|Pregnancy Interrupted|42|||
161713053|NCT02333227|583993930|FG001|Overall Study|Pregnancy Interrupted|89|||
161713054|NCT02333227|583993929|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
161713055|NCT02333227|583993930|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
161713056|NCT01564784|583993931|FG000|Overall Study|Other|1|||
161713057|NCT01564784|583993932|FG001|Overall Study|Other|0|||
161713058|NCT01564784|583993931|FG000|Overall Study|Subject refused further follow-up|1|||
161713059|NCT01564784|583993932|FG001|Overall Study|Subject refused further follow-up|6|||
161713060|NCT01564784|583993931|FG000|Overall Study|Lost to Follow-up|1|||
161713061|NCT01564784|583993932|FG001|Overall Study|Lost to Follow-up|1|||
161713062|NCT01564784|583993931|FG000|Overall Study|Death|131|||
161713063|NCT01564784|583993932|FG001|Overall Study|Death|126|||
161713064|NCT01076179|583993933|FG000|Overall Study|Withdrawal by Subject|1|||
161713065|NCT03459040|583993934|FG000|Overall Study|Death|8|||
161713066|NCT03459040|583993934|FG000|Overall Study|Withdrawal by Subject|1|||
161713067|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
161713068|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
161713069|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
161713070|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
161713071|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
161713072|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
161713073|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713074|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713075|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713076|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713077|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Death|0|||
161713078|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Death|0|||
161713079|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Death|0|||
161713080|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Death|0|||
161713081|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Death|0|||
161713082|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Death|1|||
161713083|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Death|0|||
161713084|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Death|0|||
161713085|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Death|0|||
161713086|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Death|0|||
161713087|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
161713088|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
161713089|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
161713090|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
161713091|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
161713092|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
161713093|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713094|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713095|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713096|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713097|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
161713098|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
161713099|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
161713100|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713101|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
161713102|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
161713103|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713104|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713105|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713106|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713107|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Other|6|||
161713108|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Other|12|||
161713109|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Other|10|||
161713110|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Other|11|||
161713111|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Other|14|||
161713112|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Other|34|||
161713113|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Other|0|||
161713114|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Other|0|||
161713115|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Other|0|||
161713116|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Other|0|||
161713117|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713118|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713119|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713120|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713121|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713122|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713123|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
161713124|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
161713125|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
161713126|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713127|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
161713128|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
161713129|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
161713130|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
161713131|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
161713132|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
161713133|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
161713134|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
161713135|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
161713136|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
161713137|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713138|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713139|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713140|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713141|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713142|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713143|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
161713144|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
161713145|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
161713146|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
161713147|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713148|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713149|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713150|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713151|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713152|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713153|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
161713154|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713155|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
161713156|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713157|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713158|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713159|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713160|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713161|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713162|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713163|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
161713164|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
161713165|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
161713166|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713167|NCT05300087|583993945|FG000|Overall Study|Withdrawal by Subject|0|||
161713168|NCT05300087|583993946|FG001|Overall Study|Withdrawal by Subject|1|||
161713169|NCT03248128|583993947|FG000|Overall Study|Lost to Follow-up|1|||
161713170|NCT03248128|583993948|FG001|Overall Study|Lost to Follow-up|0|||
161713171|NCT03248128|583993947|FG000|Overall Study|Withdrawal by Subject|16|||
161713172|NCT03248128|583993948|FG001|Overall Study|Withdrawal by Subject|14|||
161713173|NCT03248128|583993947|FG000|Overall Study|Site Closed|4|||
161713174|NCT03248128|583993948|FG001|Overall Study|Site Closed|3|||
161713175|NCT03248128|583993947|FG000|Overall Study|Randomized, but did not receive treatment|1|||
161713176|NCT03248128|583993948|FG001|Overall Study|Randomized, but did not receive treatment|3|||
161713177|NCT01914679|583993949|FG000|Overall Study|Lack of Efficacy|1|||
161713178|NCT01914679|583993949|FG000|Overall Study|Sponsor terminated study|4|||
161713179|NCT00256295|583993950|FG000|Overall Study|Withdrawal by Subject|3|||
161713180|NCT00256295|583993950|FG000|Overall Study|Death|1|||
161713181|NCT00947349|583993951|FG000|Triple Treatment Combination Period|Adverse Event|0|||
161713182|NCT00947349|583993952|FG001|Triple Treatment Combination Period|Adverse Event|1|||
161713183|NCT00947349|583993953|FG002|Triple Treatment Combination Period|Adverse Event|0|||
161713184|NCT00947349|583993954|FG003|Triple Treatment Combination Period|Adverse Event|0|||
161713185|NCT00947349|583993951|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
161713186|NCT00947349|583993952|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
161713187|NCT00947349|583993953|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
161713188|NCT00947349|583993954|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
161713189|NCT00947349|583993951|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
161713190|NCT00947349|583993952|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
161713191|NCT00947349|583993953|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
161713192|NCT00947349|583993954|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
161713193|NCT00947349|583993951|FG000|Overall Study Standard of Care|Other|0|||
161713194|NCT00947349|583993952|FG001|Overall Study Standard of Care|Other|0|||
161713195|NCT00947349|583993953|FG002|Overall Study Standard of Care|Other|0|||
161713196|NCT00947349|583993954|FG003|Overall Study Standard of Care|Other|1|||
161713197|NCT00538681|583993955|FG000|Overall Study|Progressive Disease|7|||
161713198|NCT00538681|583993956|FG001|Overall Study|Progressive Disease|0|||
161713199|NCT00538681|583993957|FG002|Overall Study|Progressive Disease|1|||
161713200|NCT00538681|583993958|FG003|Overall Study|Progressive Disease|0|||
161713201|NCT00538681|583993955|FG000|Overall Study|Sponsor Decision|1|||
161713202|NCT00538681|583993956|FG001|Overall Study|Sponsor Decision|3|||
161713203|NCT00538681|583993957|FG002|Overall Study|Sponsor Decision|8|||
161713204|NCT00538681|583993958|FG003|Overall Study|Sponsor Decision|9|||
161713205|NCT00538681|583993955|FG000|Overall Study|Adverse Event|1|||
161713206|NCT00538681|583993956|FG001|Overall Study|Adverse Event|1|||
161713207|NCT00538681|583993957|FG002|Overall Study|Adverse Event|1|||
161713208|NCT00538681|583993958|FG003|Overall Study|Adverse Event|0|||
161713209|NCT00538681|583993955|FG000|Overall Study|Death|0|||
161713210|NCT00538681|583993956|FG001|Overall Study|Death|0|||
161713211|NCT00538681|583993957|FG002|Overall Study|Death|1|||
161713212|NCT00538681|583993958|FG003|Overall Study|Death|1|||
161713213|NCT00538681|583993955|FG000|Overall Study|Investigator Decision|0|||
161713214|NCT00538681|583993956|FG001|Overall Study|Investigator Decision|0|||
161713215|NCT00538681|583993957|FG002|Overall Study|Investigator Decision|0|||
161713216|NCT00538681|583993958|FG003|Overall Study|Investigator Decision|1|||
161713217|NCT05369806|583993959|FG000|Overall Study|Lost to Follow-up|1|||
161713218|NCT00628355|583993960|FG000|Overall Study|Withdrawal by Subject|1|||
161713219|NCT00628355|583993961|FG001|Overall Study|Withdrawal by Subject|1|||
161713220|NCT01446809|583993963|FG000|Overall Study|Adverse Event|0|||
161713221|NCT01446809|583993964|FG001|Overall Study|Adverse Event|0|||
161713222|NCT01446809|583993965|FG002|Overall Study|Adverse Event|1|||
161713223|NCT01446809|583993963|FG000|Overall Study|Failure to complete study procedures|0|||
161713224|NCT01446809|583993964|FG001|Overall Study|Failure to complete study procedures|0|||
161713225|NCT01446809|583993965|FG002|Overall Study|Failure to complete study procedures|1|||
161713226|NCT01331161|583993966|FG000|Overall Study|Physician Decision|1|||
161713227|NCT01331161|583993967|FG001|Overall Study|Physician Decision|0|||
161713228|NCT01331161|583993966|FG000|Overall Study|Lost to Follow-up|0|||
161713229|NCT01331161|583993967|FG001|Overall Study|Lost to Follow-up|1|||
161713230|NCT01331161|583993966|FG000|Overall Study|Pregnancy|0|||
161713231|NCT01331161|583993967|FG001|Overall Study|Pregnancy|1|||
161713232|NCT02770807|583993969|FG000|Overall Study|Adverse Event|3|||
161713233|NCT02770807|583993970|FG001|Overall Study|Adverse Event|3|||
161713234|NCT02770807|583993971|FG002|Overall Study|Adverse Event|1|||
161713235|NCT02770807|583993969|FG000|Overall Study|Withdrawal by Subject|7|||
161713236|NCT02770807|583993970|FG001|Overall Study|Withdrawal by Subject|3|||
161713237|NCT02770807|583993971|FG002|Overall Study|Withdrawal by Subject|4|||
161713238|NCT02770807|583993969|FG000|Overall Study|Other|0|||
161713239|NCT02770807|583993970|FG001|Overall Study|Other|1|||
161713240|NCT02770807|583993971|FG002|Overall Study|Other|0|||
161662090|NCT04494256|583815518|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161662091|NCT04494256|583815519|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161662092|NCT04494256|583815520|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161662093|NCT04494256|583815521|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161662094|NCT04494256|583815522|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
161662095|NCT04494256|583815523|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161662096|NCT04494256|583815524|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161662097|NCT04494256|583815518|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
161662098|NCT04494256|583815519|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
161662099|NCT04494256|583815520|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
161662100|NCT04494256|583815521|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
161662101|NCT04494256|583815522|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
161662102|NCT04494256|583815523|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
161662103|NCT04494256|583815524|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
161662104|NCT04494256|583815518|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662105|NCT04494256|583815519|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662106|NCT04494256|583815520|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662107|NCT04494256|583815521|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
161662108|NCT04494256|583815522|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
161713241|NCT02770807|583993969|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
161713242|NCT02770807|583993970|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
161713243|NCT02770807|583993971|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
161713244|NCT02770807|583993969|FG000|Overall Study|Physician Decision|0|||
161713245|NCT02770807|583993970|FG001|Overall Study|Physician Decision|0|||
161713246|NCT02770807|583993971|FG002|Overall Study|Physician Decision|1|||
161713247|NCT05738486|583996232|FG000|Overall Study|Continuing Study|194|||
161713248|NCT05738486|583996233|FG001|Overall Study|Continuing Study|196|||
161713249|NCT05738486|583996234|FG002|Overall Study|Continuing Study|193|||
161713250|NCT05738486|583996235|FG003|Overall Study|Continuing Study|191|||
161713251|NCT05738486|583996232|FG000|Overall Study|Withdrawal by Subject|8|||
161713252|NCT05738486|583996233|FG001|Overall Study|Withdrawal by Subject|5|||
161713253|NCT05738486|583996234|FG002|Overall Study|Withdrawal by Subject|7|||
161713254|NCT05738486|583996235|FG003|Overall Study|Withdrawal by Subject|13|||
161713255|NCT05738486|583996232|FG000|Overall Study|Adverse Event|4|||
161713256|NCT05738486|583996233|FG001|Overall Study|Adverse Event|6|||
161713257|NCT05738486|583996234|FG002|Overall Study|Adverse Event|4|||
161713258|NCT05738486|583996235|FG003|Overall Study|Adverse Event|5|||
161713259|NCT05738486|583996232|FG000|Overall Study|Physician Decision|0|||
161713260|NCT05738486|583996233|FG001|Overall Study|Physician Decision|2|||
161713261|NCT05738486|583996234|FG002|Overall Study|Physician Decision|4|||
161713262|NCT05738486|583996235|FG003|Overall Study|Physician Decision|1|||
161713263|NCT05738486|583996232|FG000|Overall Study|Lost to Follow-up|1|||
161713264|NCT05738486|583996233|FG001|Overall Study|Lost to Follow-up|1|||
161713265|NCT05738486|583996234|FG002|Overall Study|Lost to Follow-up|2|||
161713266|NCT05738486|583996235|FG003|Overall Study|Lost to Follow-up|1|||
161713267|NCT05738486|583996232|FG000|Overall Study|Participant was Non-ambulatory|0|||
161713268|NCT05738486|583996233|FG001|Overall Study|Participant was Non-ambulatory|0|||
161713269|NCT05738486|583996234|FG002|Overall Study|Participant was Non-ambulatory|1|||
161713270|NCT05738486|583996235|FG003|Overall Study|Participant was Non-ambulatory|0|||
161713271|NCT05738486|583996232|FG000|Overall Study|Participant had Poor Venous Access|0|||
161713272|NCT05738486|583996233|FG001|Overall Study|Participant had Poor Venous Access|0|||
161713273|NCT05738486|583996234|FG002|Overall Study|Participant had Poor Venous Access|0|||
161713274|NCT05738486|583996235|FG003|Overall Study|Participant had Poor Venous Access|1|||
161713275|NCT05738486|583996232|FG000|Overall Study|Assigned Treatment by Mistake|0|||
161713276|NCT05738486|583996233|FG001|Overall Study|Assigned Treatment by Mistake|0|||
161713277|NCT05738486|583996234|FG002|Overall Study|Assigned Treatment by Mistake|0|||
161713278|NCT05738486|583996235|FG003|Overall Study|Assigned Treatment by Mistake|1|||
161713279|NCT05738486|583996232|FG000|Overall Study|Death|0|||
161713280|NCT05738486|583996233|FG001|Overall Study|Death|0|||
161713281|NCT05738486|583996234|FG002|Overall Study|Death|1|||
161713282|NCT05738486|583996235|FG003|Overall Study|Death|0|||
161713283|NCT05738486|583996232|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
161713284|NCT05738486|583996233|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161713285|NCT05738486|583996234|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161713286|NCT05738486|583996235|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161713287|NCT00886821|583996236|FG000|Stage 2|Adverse Event|0|||
161713288|NCT00886821|583996237|FG001|Stage 2|Adverse Event|0|||
161713289|NCT00886821|583996238|FG002|Stage 2|Adverse Event|0|||
161713290|NCT00886821|583996239|FG003|Stage 2|Adverse Event|0|||
161713291|NCT00886821|583996240|FG004|Stage 2|Adverse Event|0|||
161713292|NCT00886821|583996241|FG005|Stage 2|Adverse Event|0|||
161713293|NCT00886821|583996242|FG006|Stage 2|Adverse Event|0|||
161713294|NCT00886821|583996243|FG007|Stage 2|Adverse Event|0|||
161713295|NCT00886821|583996244|FG008|Stage 2|Adverse Event|0|||
161713296|NCT00886821|583996245|FG009|Stage 2|Adverse Event|0|||
161713297|NCT00886821|583996246|FG010|Stage 2|Adverse Event|0|||
161713298|NCT00886821|583996247|FG011|Stage 2|Adverse Event|1|||
161713299|NCT00886821|583996248|FG012|Stage 2|Adverse Event|3|||
161713300|NCT00886821|583996249|FG013|Stage 2|Adverse Event|0|||
161713301|NCT00886821|583996236|FG000|Stage 2|Lost to Follow-up|0|||
161713302|NCT00886821|583996237|FG001|Stage 2|Lost to Follow-up|0|||
161662109|NCT04494256|583815523|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662110|NCT04494256|583815524|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662111|NCT04494256|583815518|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161662112|NCT04494256|583815519|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
161662113|NCT04494256|583815520|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161662114|NCT04494256|583815521|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161662115|NCT04494256|583815522|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161662116|NCT04494256|583815523|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
161662117|NCT04494256|583815524|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
161662118|NCT04494256|583815518|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
161662119|NCT04494256|583815519|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
161662120|NCT04494256|583815520|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
161662121|NCT04494256|583815521|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
161662122|NCT04494256|583815522|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
161662123|NCT04494256|583815523|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
161662124|NCT04494256|583815524|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
161662125|NCT04494256|583815518|FG000|Part 2: Open Label Period|Death|0|||
161662126|NCT04494256|583815519|FG001|Part 2: Open Label Period|Death|0|||
161662127|NCT04494256|583815520|FG002|Part 2: Open Label Period|Death|0|||
161662128|NCT04494256|583815521|FG003|Part 2: Open Label Period|Death|0|||
161662129|NCT04494256|583815522|FG004|Part 2: Open Label Period|Death|0|||
161662130|NCT04494256|583815523|FG005|Part 2: Open Label Period|Death|4|||
161662131|NCT04494256|583815524|FG006|Part 2: Open Label Period|Death|2|||
161713303|NCT00886821|583996238|FG002|Stage 2|Lost to Follow-up|0|||
161713304|NCT00886821|583996239|FG003|Stage 2|Lost to Follow-up|0|||
161713305|NCT00886821|583996240|FG004|Stage 2|Lost to Follow-up|0|||
161713306|NCT00886821|583996241|FG005|Stage 2|Lost to Follow-up|0|||
161713307|NCT00886821|583996242|FG006|Stage 2|Lost to Follow-up|0|||
161713308|NCT00886821|583996243|FG007|Stage 2|Lost to Follow-up|0|||
161713309|NCT00886821|583996244|FG008|Stage 2|Lost to Follow-up|0|||
161713310|NCT00886821|583996245|FG009|Stage 2|Lost to Follow-up|0|||
161713311|NCT00886821|583996246|FG010|Stage 2|Lost to Follow-up|0|||
161713312|NCT00886821|583996247|FG011|Stage 2|Lost to Follow-up|0|||
161713313|NCT00886821|583996248|FG012|Stage 2|Lost to Follow-up|2|||
161713314|NCT00886821|583996249|FG013|Stage 2|Lost to Follow-up|1|||
161713315|NCT03716726|583996250|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
161713316|NCT03716726|583996251|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
161713317|NCT03716726|583996250|FG000|12 Months Followup|Lost to Follow-up|10|||
161713318|NCT03716726|583996251|FG001|12 Months Followup|Lost to Follow-up|17|||
161713319|NCT02579603|583996252|FG000|Overall Study|Not treated|1|||
161713320|NCT02579603|583996253|FG001|Overall Study|Not treated|0|||
161713321|NCT02579603|583996252|FG000|Overall Study|Adverse Event|2|||
161713322|NCT02579603|583996253|FG001|Overall Study|Adverse Event|2|||
161713323|NCT02579603|583996252|FG000|Overall Study|Other than stated|1|||
161713324|NCT02579603|583996253|FG001|Overall Study|Other than stated|0|||
161713325|NCT00469079|583996254|FG000|Overall Study|Lack of Efficacy|3|||
161713326|NCT00469079|583996255|FG001|Overall Study|Lack of Efficacy|8|||
161713327|NCT00469079|583996256|FG002|Overall Study|Lack of Efficacy|5|||
161713328|NCT00469079|583996254|FG000|Overall Study|Adverse Event|1|||
161713329|NCT00469079|583996255|FG001|Overall Study|Adverse Event|3|||
161713330|NCT00469079|583996256|FG002|Overall Study|Adverse Event|2|||
161662132|NCT04494256|583815518|FG000|Part 2: Open Label Period|Adverse Event|0|||
161662133|NCT04494256|583815519|FG001|Part 2: Open Label Period|Adverse Event|0|||
161662134|NCT04494256|583815520|FG002|Part 2: Open Label Period|Adverse Event|0|||
161662135|NCT04494256|583815521|FG003|Part 2: Open Label Period|Adverse Event|0|||
161662136|NCT04494256|583815522|FG004|Part 2: Open Label Period|Adverse Event|0|||
161662137|NCT04494256|583815523|FG005|Part 2: Open Label Period|Adverse Event|0|||
161662138|NCT04494256|583815524|FG006|Part 2: Open Label Period|Adverse Event|2|||
161713331|NCT00469079|583996254|FG000|Overall Study|Lost to Follow-up|4|||
161713332|NCT00469079|583996255|FG001|Overall Study|Lost to Follow-up|8|||
161713333|NCT00469079|583996256|FG002|Overall Study|Lost to Follow-up|10|||
161662139|NCT04494256|583815518|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161713334|NCT00469079|583996254|FG000|Overall Study|Withdrawal by Subject|1|||
161713335|NCT00469079|583996255|FG001|Overall Study|Withdrawal by Subject|2|||
161713336|NCT00469079|583996256|FG002|Overall Study|Withdrawal by Subject|2|||
161713337|NCT00469079|583996254|FG000|Overall Study|Ineligible|0|||
161713338|NCT00469079|583996255|FG001|Overall Study|Ineligible|1|||
161713339|NCT00469079|583996256|FG002|Overall Study|Ineligible|0|||
161713340|NCT00942162|583996257|FG000|Overall Study|Death|45|||
161713341|NCT00942162|583996258|FG001|Overall Study|Death|35|||
161713342|NCT00942162|583996259|FG002|Overall Study|Death|0|||
161713343|NCT00942162|583996257|FG000|Overall Study|Withdrawal by Subject|7|||
161713344|NCT00942162|583996258|FG001|Overall Study|Withdrawal by Subject|2|||
161713345|NCT00942162|583996259|FG002|Overall Study|Withdrawal by Subject|0|||
161713346|NCT00942162|583996257|FG000|Overall Study|Lost to Follow-up|4|||
161713347|NCT00942162|583996258|FG001|Overall Study|Lost to Follow-up|0|||
161713348|NCT00942162|583996259|FG002|Overall Study|Lost to Follow-up|0|||
161713349|NCT00942162|583996257|FG000|Overall Study|Other|14|||
161713350|NCT00942162|583996258|FG001|Overall Study|Other|13|||
161713351|NCT00942162|583996259|FG002|Overall Study|Other|2|||
161713352|NCT01126619|583996260|FG000|Overall Study|Not eligible for the study|2|||
161713353|NCT01126619|583996260|FG000|Overall Study|Investigator decision|4|||
161713354|NCT01126619|583996260|FG000|Overall Study|Serious adverse event|1|||
161713355|NCT01126619|583996260|FG000|Overall Study|Withdrawal by Subject|9|||
161713356|NCT01126619|583996260|FG000|Overall Study|Non-compliance|1|||
161713357|NCT04876391|583996261|FG000|Overall Study|Withdrawal by Subject|1|||
161713358|NCT04876391|583996262|FG001|Overall Study|Withdrawal by Subject|10|||
161713359|NCT04876391|583996261|FG000|Overall Study|Lost to Follow-up|2|||
161713360|NCT04876391|583996262|FG001|Overall Study|Lost to Follow-up|4|||
161713361|NCT04876391|583996261|FG000|Overall Study|Lack of Efficacy|0|||
161713362|NCT04876391|583996262|FG001|Overall Study|Lack of Efficacy|2|||
161713363|NCT04876391|583996261|FG000|Overall Study|Adverse Event|3|||
161713364|NCT04876391|583996262|FG001|Overall Study|Adverse Event|1|||
161713365|NCT04876391|583996261|FG000|Overall Study|Patient non-compliance|0|||
161713366|NCT04876391|583996262|FG001|Overall Study|Patient non-compliance|1|||
161713367|NCT04876391|583996261|FG000|Overall Study|Personal reasons|0|||
161713368|NCT04876391|583996262|FG001|Overall Study|Personal reasons|1|||
161713369|NCT04876391|583996261|FG000|Overall Study|Withdrawn as per protocol|2|||
161713370|NCT04876391|583996262|FG001|Overall Study|Withdrawn as per protocol|2|||
161713371|NCT00811252|583996265|FG000|Overall Study|Adverse Event|6|||
161713372|NCT00811252|583996266|FG001|Overall Study|Adverse Event|10|||
161713373|NCT00811252|583996267|FG002|Overall Study|Adverse Event|15|||
161713374|NCT00811252|583996265|FG000|Overall Study|Lack of Efficacy|7|||
161713375|NCT00811252|583996266|FG001|Overall Study|Lack of Efficacy|2|||
161713376|NCT00811252|583996267|FG002|Overall Study|Lack of Efficacy|0|||
161713377|NCT00811252|583996265|FG000|Overall Study|Protocol Violation|3|||
161713378|NCT00811252|583996266|FG001|Overall Study|Protocol Violation|3|||
161713379|NCT00811252|583996267|FG002|Overall Study|Protocol Violation|2|||
161713380|NCT00811252|583996265|FG000|Overall Study|Withdrawal of Consent|1|||
161713381|NCT00811252|583996266|FG001|Overall Study|Withdrawal of Consent|2|||
161713382|NCT00811252|583996267|FG002|Overall Study|Withdrawal of Consent|2|||
161713383|NCT00811252|583996265|FG000|Overall Study|Lost to Follow-up|0|||
161713384|NCT00811252|583996266|FG001|Overall Study|Lost to Follow-up|0|||
161713385|NCT00811252|583996267|FG002|Overall Study|Lost to Follow-up|2|||
161713386|NCT00811252|583996265|FG000|Overall Study|Administrative or Other Reasons|0|||
161713387|NCT00811252|583996266|FG001|Overall Study|Administrative or Other Reasons|3|||
161713388|NCT00811252|583996267|FG002|Overall Study|Administrative or Other Reasons|2|||
161713389|NCT01931865|583996271|FG000|Overall Study|Lost to Follow-up|2|||
161713390|NCT01931865|583996271|FG000|Overall Study|Withdrawal by Subject|2|||
161713391|NCT01121406|583996272|FG000|Overall Study|Progressive disease RECIST|44|||
161713392|NCT01121406|583996273|FG001|Overall Study|Progressive disease RECIST|28|||
161713393|NCT01121406|583996272|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
161713394|NCT01121406|583996273|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
161713395|NCT01121406|583996272|FG000|Overall Study|Other AE|3|||
161713396|NCT01121406|583996273|FG001|Overall Study|Other AE|10|||
161713397|NCT01121406|583996272|FG000|Overall Study|Non-compliant with protocol|0|||
161713398|NCT01121406|583996273|FG001|Overall Study|Non-compliant with protocol|2|||
161713399|NCT01121406|583996272|FG000|Overall Study|Lost to Follow-up|0|||
161713400|NCT01121406|583996273|FG001|Overall Study|Lost to Follow-up|1|||
161713401|NCT01121406|583996272|FG000|Overall Study|Refused continuation of study med.|1|||
161713402|NCT01121406|583996273|FG001|Overall Study|Refused continuation of study med.|2|||
161713403|NCT01121406|583996272|FG000|Overall Study|Reason other than specified above|2|||
161713404|NCT01121406|583996273|FG001|Overall Study|Reason other than specified above|6|||
161713405|NCT01121406|583996272|FG000|Overall Study|Not treated|1|||
161713406|NCT01121406|583996273|FG001|Overall Study|Not treated|0|||
161713407|NCT00504257|583996274|FG000|Overall Study|Withdrawal by Subject|2|||
161713408|NCT00504257|583996274|FG000|Overall Study|ineligible histology|2|||
161713409|NCT00892437|583996275|FG000|Randomized Phase|Randomized but not treated|6|||
161713410|NCT00892437|583996276|FG001|Randomized Phase|Randomized but not treated|0|||
161713411|NCT00892437|583996275|FG000|Randomized Phase|Adverse Event|2|||
161713412|NCT00892437|583996276|FG001|Randomized Phase|Adverse Event|2|||
161713413|NCT00892437|583996275|FG000|Randomized Phase|Lost to Follow-up|1|||
161713414|NCT00892437|583996276|FG001|Randomized Phase|Lost to Follow-up|3|||
161713415|NCT00892437|583996275|FG000|Randomized Phase|Investigator's Discretion|1|||
161713416|NCT00892437|583996276|FG001|Randomized Phase|Investigator's Discretion|0|||
161713417|NCT00892437|583996275|FG000|Randomized Phase|Withdrew Consent|1|||
161713418|NCT00892437|583996276|FG001|Randomized Phase|Withdrew Consent|0|||
161713419|NCT00892437|583996275|FG000|Open-Label Extension Phase|Adverse Event|4|||
161713420|NCT00892437|583996276|FG001|Open-Label Extension Phase|Adverse Event|2|||
161713421|NCT00892437|583996275|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
161713422|NCT00892437|583996276|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
161713423|NCT00892437|583996275|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
161713424|NCT00892437|583996276|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161713425|NCT00892437|583996275|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
161713426|NCT00892437|583996276|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161713427|NCT00892437|583996275|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
161713428|NCT00892437|583996276|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
161713429|NCT03185130|583996277|FG000|Overall Study|Withdrawal by Subject|0|||
161713430|NCT03185130|583996278|FG001|Overall Study|Withdrawal by Subject|2|||
161713431|NCT02286960|583996279|FG000|Overall Study|Lost to Follow-up|3|||
161713432|NCT02286960|583996280|FG001|Overall Study|Lost to Follow-up|3|||
161713433|NCT02750410|583996282|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161713434|NCT02750410|583996283|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161713435|NCT02750410|583996282|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161713436|NCT02750410|583996283|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161713437|NCT02750410|583996282|FG000|Open-Label Extension Period|Adverse Event|5|||
161713438|NCT02750410|583996283|FG001|Open-Label Extension Period|Adverse Event|3|||
161713439|NCT02750410|583996282|FG000|Open-Label Extension Period|Protocol Violation|0|||
161713440|NCT02750410|583996283|FG001|Open-Label Extension Period|Protocol Violation|1|||
161713441|NCT02750410|583996282|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
161713442|NCT02750410|583996283|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
161713443|NCT02504541|583996284|FG000|Overall Study|Adverse Event|4|||
161713444|NCT02504541|583996284|FG000|Overall Study|Withdrawal by Subject|4|||
161713445|NCT02504541|583996284|FG000|Overall Study|Lost to Follow-up|1|||
161713446|NCT02504541|583996284|FG000|Overall Study|Met Stopping Criteria|1|||
161713447|NCT02504541|583996284|FG000|Overall Study|Protocol Violation|2|||
161713448|NCT02504541|583996284|FG000|Overall Study|Termination by Sponsor|1|||
161713449|NCT02504541|583996284|FG000|Overall Study|Other|2|||
161713450|NCT02504541|583996284|FG000|Overall Study|Multiple|5|||
161713451|NCT03215277|583996296|FG000|Overall Study|Adverse Event|2|||
161713452|NCT03215277|583996297|FG001|Overall Study|Adverse Event|3|||
161713453|NCT03215277|583996296|FG000|Overall Study|Death|1|||
161713454|NCT03215277|583996297|FG001|Overall Study|Death|0|||
161713455|NCT03215277|583996296|FG000|Overall Study|Lost to Follow-up|0|||
161713456|NCT03215277|583996297|FG001|Overall Study|Lost to Follow-up|1|||
161713457|NCT03215277|583996296|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
161713458|NCT03215277|583996297|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
161713459|NCT03596164|583996298|FG000|Overall Study|Adverse Event|0|||
161713460|NCT03596164|583996299|FG001|Overall Study|Adverse Event|1|||
161713461|NCT03596164|583996298|FG000|Overall Study|Death|1|||
161713462|NCT03596164|583996299|FG001|Overall Study|Death|0|||
161713463|NCT03427073|583996300|FG000|Overall Study|Disease Progression|1|||
161713464|NCT03427073|583996301|FG001|Overall Study|Disease Progression|1|||
161713465|NCT03427073|583996302|FG002|Overall Study|Disease Progression|1|||
161713466|NCT03427073|583996303|FG003|Overall Study|Disease Progression|3|||
161713467|NCT03427073|583996304|FG004|Overall Study|Disease Progression|3|||
161713468|NCT03427073|583996305|FG005|Overall Study|Disease Progression|4|||
161713469|NCT03427073|583996306|FG006|Overall Study|Disease Progression|2|||
161713470|NCT03427073|583996307|FG007|Overall Study|Disease Progression|3|||
161713471|NCT03427073|583996300|FG000|Overall Study|Physician Decision|0|||
161713472|NCT03427073|583996301|FG001|Overall Study|Physician Decision|0|||
161713473|NCT03427073|583996302|FG002|Overall Study|Physician Decision|0|||
161713474|NCT03427073|583996303|FG003|Overall Study|Physician Decision|0|||
161713475|NCT03427073|583996304|FG004|Overall Study|Physician Decision|0|||
161713476|NCT03427073|583996305|FG005|Overall Study|Physician Decision|0|||
161713477|NCT03427073|583996306|FG006|Overall Study|Physician Decision|1|||
161713478|NCT03427073|583996307|FG007|Overall Study|Physician Decision|1|||
161713479|NCT02835495|583996310|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
161713480|NCT02835495|583996311|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
161713481|NCT02835495|583996310|FG000|Overall Study|Declined in-person follow-up visit|4|||
161713482|NCT02835495|583996311|FG001|Overall Study|Declined in-person follow-up visit|2|||
161713483|NCT02580058|583996313|FG000|Overall Study|Adverse Event|16|||
161713484|NCT02580058|583996314|FG001|Overall Study|Adverse Event|30|||
161713485|NCT02580058|583996315|FG002|Overall Study|Adverse Event|20|||
161713486|NCT02580058|583996313|FG000|Overall Study|Death|4|||
161713487|NCT02580058|583996314|FG001|Overall Study|Death|4|||
161713488|NCT02580058|583996315|FG002|Overall Study|Death|5|||
161713489|NCT02580058|583996313|FG000|Overall Study|Physician Decision|1|||
161713490|NCT02580058|583996314|FG001|Overall Study|Physician Decision|3|||
161713491|NCT02580058|583996315|FG002|Overall Study|Physician Decision|11|||
161713492|NCT02580058|583996313|FG000|Overall Study|Other|5|||
161713493|NCT02580058|583996314|FG001|Overall Study|Other|1|||
161713494|NCT02580058|583996315|FG002|Overall Study|Other|3|||
161713495|NCT02580058|583996313|FG000|Overall Study|Withdrawal by Subject|4|||
161713496|NCT02580058|583996314|FG001|Overall Study|Withdrawal by Subject|7|||
161713497|NCT02580058|583996315|FG002|Overall Study|Withdrawal by Subject|31|||
161713498|NCT02580058|583996313|FG000|Overall Study|Global Deterioration of Health Status|19|||
161713499|NCT02580058|583996314|FG001|Overall Study|Global Deterioration of Health Status|18|||
161713500|NCT02580058|583996315|FG002|Overall Study|Global Deterioration of Health Status|24|||
161713501|NCT02580058|583996313|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
161713502|NCT02580058|583996314|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161713503|NCT02580058|583996315|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
161713504|NCT02580058|583996313|FG000|Overall Study|Progressive Disease|137|||
161713505|NCT02580058|583996314|FG001|Overall Study|Progressive Disease|125|||
161713506|NCT02580058|583996315|FG002|Overall Study|Progressive Disease|94|||
161713507|NCT02580058|583996313|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161713508|NCT02580058|583996314|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161713509|NCT02580058|583996315|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161713510|NCT04283461|583996316|FG000|Overall Study|Enrolled in separate trial|0|||
161713511|NCT04283461|583996317|FG001|Overall Study|Enrolled in separate trial|0|||
161713512|NCT04283461|583996318|FG002|Overall Study|Enrolled in separate trial|8|||
161713513|NCT04283461|583996319|FG003|Overall Study|Enrolled in separate trial|13|||
161713514|NCT04283461|583996320|FG004|Overall Study|Enrolled in separate trial|12|||
161713515|NCT04283461|583996321|FG005|Overall Study|Enrolled in separate trial|0|||
161713516|NCT04283461|583996322|FG006|Overall Study|Enrolled in separate trial|0|||
161713517|NCT04283461|583996323|FG007|Overall Study|Enrolled in separate trial|8|||
161713518|NCT04283461|583996324|FG008|Overall Study|Enrolled in separate trial|0|||
161713519|NCT04283461|583996325|FG009|Overall Study|Enrolled in separate trial|0|||
161713520|NCT04283461|583996326|FG010|Overall Study|Enrolled in separate trial|0|||
161713521|NCT04283461|583996327|FG011|Overall Study|Enrolled in separate trial|7|||
161713522|NCT04283461|583996328|FG012|Overall Study|Enrolled in separate trial|0|||
161713523|NCT05490771|583996329|FG000|Overall Study|Disease progression|18|||
161713524|NCT05490771|583996329|FG000|Overall Study|Adverse Event|3|||
161713525|NCT05490771|583996329|FG000|Overall Study|Other complicating disease|1|||
161713526|NCT05490771|583996329|FG000|Overall Study|Withdrawal by Subject|3|||
161713527|NCT05490771|583996329|FG000|Overall Study|Physician Decision|1|||
161713528|NCT05490771|583996329|FG000|Overall Study|Still on treatment|2|||
161713529|NCT05490771|583996329|FG000|Overall Study|Never start protocol therapy|5|||
161713530|NCT05490771|583996329|FG000|Overall Study|Ineligible|2|||
161713531|NCT00246259|583996333|FG000|Overall Study|Other|3|||
161713532|NCT00246259|583996334|FG001|Overall Study|Other|3|||
161713533|NCT00246259|583996333|FG000|Overall Study|Not stable by Week 18|2|||
161713534|NCT00246259|583996334|FG001|Overall Study|Not stable by Week 18|1|||
161713535|NCT00246259|583996333|FG000|Overall Study|Participant non-compliant|4|||
161713536|NCT00246259|583996334|FG001|Overall Study|Participant non-compliant|9|||
161713537|NCT00246259|583996333|FG000|Overall Study|Lack of Efficacy|2|||
161713538|NCT00246259|583996334|FG001|Overall Study|Lack of Efficacy|2|||
161713539|NCT00246259|583996333|FG000|Overall Study|Investigator withdrew participant|2|||
161713540|NCT00246259|583996334|FG001|Overall Study|Investigator withdrew participant|0|||
161713541|NCT00246259|583996333|FG000|Overall Study|Adverse Event|5|||
161713542|NCT00246259|583996334|FG001|Overall Study|Adverse Event|0|||
161713543|NCT00246259|583996333|FG000|Overall Study|Lost to Follow-up|3|||
161713544|NCT00246259|583996334|FG001|Overall Study|Lost to Follow-up|4|||
161713545|NCT00246259|583996333|FG000|Overall Study|Withdrawal by Subject|5|||
161713546|NCT00246259|583996334|FG001|Overall Study|Withdrawal by Subject|1|||
161713547|NCT00246259|583996333|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
161713548|NCT00246259|583996334|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
161713549|NCT02272790|583996335|FG000|Overall Study|Physician Decision|0|||
161713550|NCT02272790|583996336|FG001|Overall Study|Physician Decision|1|||
161713551|NCT02272790|583996337|FG002|Overall Study|Physician Decision|0|||
161713552|NCT02272790|583996338|FG003|Overall Study|Physician Decision|0|||
161713553|NCT02272790|583996339|FG004|Overall Study|Physician Decision|0|||
161713554|NCT02272790|583996340|FG005|Overall Study|Physician Decision|0|||
161713555|NCT04375878|583996341|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
161713556|NCT04375878|583996342|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
161713557|NCT04375878|583996343|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713558|NCT04375878|583996344|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713559|NCT04375878|583996345|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713560|NCT04375878|583996346|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713561|NCT04375878|583996341|FG000|Crossover First and Second Interventions|Adverse Event|0|||
161713562|NCT04375878|583996342|FG001|Crossover First and Second Interventions|Adverse Event|0|||
161713563|NCT04375878|583996343|FG002|Crossover First and Second Interventions|Adverse Event|1|||
161713564|NCT04375878|583996344|FG003|Crossover First and Second Interventions|Adverse Event|0|||
161713565|NCT04375878|583996345|FG004|Crossover First and Second Interventions|Adverse Event|0|||
161713566|NCT04375878|583996346|FG005|Crossover First and Second Interventions|Adverse Event|0|||
161713567|NCT04375878|583996341|FG000|Extension Phase|Withdrawal by Subject|0|||
161713568|NCT04375878|583996342|FG001|Extension Phase|Withdrawal by Subject|0|||
161713569|NCT04375878|583996343|FG002|Extension Phase|Withdrawal by Subject|0|||
161713570|NCT04375878|583996344|FG003|Extension Phase|Withdrawal by Subject|0|||
161713571|NCT04375878|583996345|FG004|Extension Phase|Withdrawal by Subject|1|||
161713572|NCT04375878|583996346|FG005|Extension Phase|Withdrawal by Subject|0|||
161713573|NCT03022461|583996347|FG000|Overall Study|Death|3|||
161713574|NCT01982630|583996348|FG000|Overall Study|Adverse Event|2|||
161713575|NCT01982630|583996349|FG001|Overall Study|Adverse Event|0|||
161713576|NCT01982630|583996350|FG002|Overall Study|Adverse Event|1|||
161713577|NCT01982630|583996351|FG003|Overall Study|Adverse Event|0|||
161713578|NCT01982630|583996352|FG004|Overall Study|Adverse Event|1|||
161713579|NCT01982630|583996353|FG005|Overall Study|Adverse Event|2|||
161713580|NCT01982630|583996354|FG006|Overall Study|Adverse Event|1|||
161713581|NCT01982630|583996355|FG007|Overall Study|Adverse Event|0|||
161713582|NCT01982630|583996348|FG000|Overall Study|Physician Decision|1|||
161713583|NCT01982630|583996349|FG001|Overall Study|Physician Decision|0|||
161713584|NCT01982630|583996350|FG002|Overall Study|Physician Decision|2|||
161713585|NCT01982630|583996351|FG003|Overall Study|Physician Decision|1|||
161713586|NCT01982630|583996352|FG004|Overall Study|Physician Decision|2|||
161713587|NCT01982630|583996353|FG005|Overall Study|Physician Decision|0|||
161713588|NCT01982630|583996354|FG006|Overall Study|Physician Decision|0|||
161713589|NCT01982630|583996355|FG007|Overall Study|Physician Decision|0|||
161713590|NCT01982630|583996348|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713591|NCT01982630|583996349|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713592|NCT01982630|583996350|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
161713593|NCT01982630|583996351|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713594|NCT01982630|583996352|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713595|NCT01982630|583996353|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713596|NCT01982630|583996354|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713597|NCT01982630|583996355|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713598|NCT01982630|583996348|FG000|Overall Study|Withdrawal by Subject|0|||
161713599|NCT01982630|583996349|FG001|Overall Study|Withdrawal by Subject|0|||
161713600|NCT01982630|583996350|FG002|Overall Study|Withdrawal by Subject|0|||
161713601|NCT01982630|583996351|FG003|Overall Study|Withdrawal by Subject|0|||
161713602|NCT01982630|583996352|FG004|Overall Study|Withdrawal by Subject|0|||
161713603|NCT01982630|583996353|FG005|Overall Study|Withdrawal by Subject|1|||
161713604|NCT01982630|583996354|FG006|Overall Study|Withdrawal by Subject|0|||
161713605|NCT01982630|583996355|FG007|Overall Study|Withdrawal by Subject|0|||
161713606|NCT00986349|583996356|FG000|Overall Study|Unsuccessful implant procedure|3|||
161713607|NCT00986349|583996356|FG000|Overall Study|Adverse Event|2|||
161713608|NCT00986349|583996356|FG000|Overall Study|Physician Decision|1|||
161713609|NCT00986349|583996356|FG000|Overall Study|device migration|1|||
161713610|NCT02299934|583996357|FG000|Overall Study|Termination of study|13|||
161713611|NCT00561353|583996358|FG000|Overall Study|Subject reached a virologic endpoint|2|||
161713612|NCT00561353|583996359|FG001|Overall Study|Subject reached a virologic endpoint|1|||
161713613|NCT00561353|583996360|FG002|Overall Study|Subject reached a virologic endpoint|1|||
161713614|NCT00561353|583996361|FG003|Overall Study|Subject reached a virologic endpoint|4|||
161713615|NCT00561353|583996362|FG004|Overall Study|Subject reached a virologic endpoint|1|||
161713616|NCT00561353|583996363|FG005|Overall Study|Subject reached a virologic endpoint|3|||
161713617|NCT00561353|583996364|FG006|Overall Study|Subject reached a virologic endpoint|4|||
161713618|NCT00561353|583996365|FG007|Overall Study|Subject reached a virologic endpoint|4|||
161713619|NCT00561353|583996366|FG008|Overall Study|Subject reached a virologic endpoint|5|||
161713620|NCT00561353|583996367|FG009|Overall Study|Subject reached a virologic endpoint|0|||
161713621|NCT00561353|583996358|FG000|Overall Study|Subject ineligible to continue the trial|0|||
161713622|NCT00561353|583996359|FG001|Overall Study|Subject ineligible to continue the trial|0|||
161713623|NCT00561353|583996360|FG002|Overall Study|Subject ineligible to continue the trial|0|||
161713624|NCT00561353|583996361|FG003|Overall Study|Subject ineligible to continue the trial|0|||
161713625|NCT00561353|583996362|FG004|Overall Study|Subject ineligible to continue the trial|0|||
161713626|NCT00561353|583996363|FG005|Overall Study|Subject ineligible to continue the trial|1|||
161713627|NCT00561353|583996364|FG006|Overall Study|Subject ineligible to continue the trial|1|||
161713628|NCT00561353|583996365|FG007|Overall Study|Subject ineligible to continue the trial|0|||
161713629|NCT00561353|583996366|FG008|Overall Study|Subject ineligible to continue the trial|2|||
161713630|NCT00561353|583996367|FG009|Overall Study|Subject ineligible to continue the trial|1|||
161713631|NCT00561353|583996358|FG000|Overall Study|Other|1|||
161713632|NCT00561353|583996359|FG001|Overall Study|Other|0|||
161713633|NCT00561353|583996360|FG002|Overall Study|Other|1|||
161713634|NCT00561353|583996361|FG003|Overall Study|Other|0|||
161713635|NCT00561353|583996362|FG004|Overall Study|Other|0|||
161713636|NCT00561353|583996363|FG005|Overall Study|Other|2|||
161713637|NCT00561353|583996364|FG006|Overall Study|Other|0|||
161713638|NCT00561353|583996365|FG007|Overall Study|Other|0|||
161713639|NCT00561353|583996366|FG008|Overall Study|Other|0|||
161713640|NCT00561353|583996367|FG009|Overall Study|Other|0|||
161713641|NCT00561353|583996358|FG000|Overall Study|Adverse Event|0|||
161713642|NCT00561353|583996359|FG001|Overall Study|Adverse Event|0|||
161713643|NCT00561353|583996360|FG002|Overall Study|Adverse Event|0|||
161713644|NCT00561353|583996361|FG003|Overall Study|Adverse Event|2|||
161713645|NCT00561353|583996362|FG004|Overall Study|Adverse Event|0|||
161713646|NCT00561353|583996363|FG005|Overall Study|Adverse Event|0|||
161713647|NCT00561353|583996364|FG006|Overall Study|Adverse Event|1|||
161713648|NCT00561353|583996365|FG007|Overall Study|Adverse Event|0|||
161713649|NCT00561353|583996366|FG008|Overall Study|Adverse Event|0|||
161713650|NCT00561353|583996367|FG009|Overall Study|Adverse Event|1|||
161713651|NCT00561353|583996358|FG000|Overall Study|Lost to Follow-up|2|||
161713652|NCT00561353|583996359|FG001|Overall Study|Lost to Follow-up|0|||
161713653|NCT00561353|583996360|FG002|Overall Study|Lost to Follow-up|1|||
161713654|NCT00561353|583996361|FG003|Overall Study|Lost to Follow-up|0|||
161713655|NCT00561353|583996362|FG004|Overall Study|Lost to Follow-up|0|||
161713656|NCT00561353|583996363|FG005|Overall Study|Lost to Follow-up|0|||
161713657|NCT00561353|583996364|FG006|Overall Study|Lost to Follow-up|0|||
161713658|NCT00561353|583996365|FG007|Overall Study|Lost to Follow-up|0|||
161713659|NCT00561353|583996366|FG008|Overall Study|Lost to Follow-up|0|||
161713660|NCT00561353|583996367|FG009|Overall Study|Lost to Follow-up|0|||
161713661|NCT00561353|583996358|FG000|Overall Study|Withdrawal by Subject|0|||
161713662|NCT00561353|583996359|FG001|Overall Study|Withdrawal by Subject|2|||
161713663|NCT00561353|583996360|FG002|Overall Study|Withdrawal by Subject|0|||
161713664|NCT00561353|583996361|FG003|Overall Study|Withdrawal by Subject|0|||
161713665|NCT00561353|583996362|FG004|Overall Study|Withdrawal by Subject|0|||
161713666|NCT00561353|583996363|FG005|Overall Study|Withdrawal by Subject|0|||
161713667|NCT00561353|583996364|FG006|Overall Study|Withdrawal by Subject|0|||
161713668|NCT00561353|583996365|FG007|Overall Study|Withdrawal by Subject|0|||
161713669|NCT00561353|583996366|FG008|Overall Study|Withdrawal by Subject|0|||
161713670|NCT00561353|583996367|FG009|Overall Study|Withdrawal by Subject|0|||
161713671|NCT01273818|583996368|FG000|Overall Study|Physician Decision|13|||
161713672|NCT01273818|583996369|FG001|Overall Study|Physician Decision|2|||
161713673|NCT01273818|583996370|FG002|Overall Study|Physician Decision|9|||
161713674|NCT03815175|583996371|FG000|Overall Study|Subject Lost to Follow-up|6|||
161713675|NCT03815175|583996371|FG000|Overall Study|Subject Withdrew Consent|48|||
161713676|NCT03815175|583996371|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
161713677|NCT03815175|583996371|FG000|Overall Study|Death|86|||
161713678|NCT03815175|583996371|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
161713679|NCT03815175|583996371|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
161713680|NCT03815175|583996371|FG000|Overall Study|Other Status Change Reason|1|||
161713681|NCT03815175|583996371|FG000|Overall Study|Missed Visit|12|||
161713682|NCT03577990|583996372|FG000|Overall Study|Lost to Follow-up|4|||
161713683|NCT03577990|583996373|FG001|Overall Study|Lost to Follow-up|6|||
161713684|NCT03577990|583996372|FG000|Overall Study|Withdrawal by Subject|4|||
161713685|NCT03577990|583996373|FG001|Overall Study|Withdrawal by Subject|7|||
161713686|NCT03934684|583996378|FG000|Overall Study|Participants continuing in study|11|||
161713687|NCT03934684|583996379|FG001|Overall Study|Participants continuing in study|4|||
161713688|NCT03934684|583996378|FG000|Overall Study|Discontinuation of carfilzomib|20|||
161713689|NCT03934684|583996379|FG001|Overall Study|Discontinuation of carfilzomib|30|||
161713690|NCT03934684|583996378|FG000|Overall Study|Death|2|||
161713691|NCT03934684|583996379|FG001|Overall Study|Death|2|||
161713692|NCT03934684|583996378|FG000|Overall Study|Lost to Follow-up|2|||
161713693|NCT03934684|583996379|FG001|Overall Study|Lost to Follow-up|5|||
161713694|NCT03934684|583996378|FG000|Overall Study|Withdrawal by Subject|7|||
161713695|NCT03934684|583996379|FG001|Overall Study|Withdrawal by Subject|8|||
161713696|NCT01073943|583996380|FG000|Overall Study|Withdrawal by Subject|8|||
161713697|NCT01073943|583996381|FG001|Overall Study|Withdrawal by Subject|2|||
161713698|NCT01073943|583996380|FG000|Overall Study|Protocol Violation|2|||
161713699|NCT01073943|583996381|FG001|Overall Study|Protocol Violation|1|||
161713700|NCT01073943|583996380|FG000|Overall Study|Adverse Event|1|||
161713701|NCT01073943|583996381|FG001|Overall Study|Adverse Event|1|||
161713702|NCT01073943|583996380|FG000|Overall Study|Lost to Follow-up|0|||
161713703|NCT01073943|583996381|FG001|Overall Study|Lost to Follow-up|2|||
161713704|NCT01073943|583996380|FG000|Overall Study|Power outage; colonoscopy not done|1|||
161713705|NCT01073943|583996381|FG001|Overall Study|Power outage; colonoscopy not done|0|||
161713706|NCT01073943|583996380|FG000|Overall Study|Subject forgot|0|||
161713707|NCT01073943|583996381|FG001|Overall Study|Subject forgot|1|||
161713708|NCT01073943|583996380|FG000|Overall Study|Unable to return for follow-up|0|||
161713709|NCT01073943|583996381|FG001|Overall Study|Unable to return for follow-up|1|||
161713710|NCT01073943|583996380|FG000|Overall Study|Could not tolerate prep|1|||
161713711|NCT01073943|583996381|FG001|Overall Study|Could not tolerate prep|0|||
161713712|NCT00761215|583996382|FG000|Overall Study|Randomized but didn't receive drug|1|||
161713713|NCT00761215|583996383|FG001|Overall Study|Randomized but didn't receive drug|1|||
161713714|NCT00761215|583996384|FG002|Overall Study|Randomized but didn't receive drug|2|||
161713715|NCT00761215|583996382|FG000|Overall Study|Lost to Follow-up|6|||
161713716|NCT00761215|583996383|FG001|Overall Study|Lost to Follow-up|3|||
161713717|NCT00761215|583996384|FG002|Overall Study|Lost to Follow-up|6|||
161713718|NCT00761215|583996382|FG000|Overall Study|Withdrawal by Subject|1|||
161713719|NCT00761215|583996383|FG001|Overall Study|Withdrawal by Subject|0|||
161713720|NCT00761215|583996384|FG002|Overall Study|Withdrawal by Subject|0|||
161713721|NCT00761215|583996382|FG000|Overall Study|Bacteremia|1|||
161713722|NCT00761215|583996383|FG001|Overall Study|Bacteremia|0|||
161713723|NCT00761215|583996384|FG002|Overall Study|Bacteremia|0|||
161713724|NCT05662332|583996385|FG000|Overall Study|Death|3|||
161713725|NCT05662332|583996386|FG001|Overall Study|Death|3|||
161713726|NCT05662332|583996385|FG000|Overall Study|Lost to Follow-up|3|||
161713727|NCT05662332|583996386|FG001|Overall Study|Lost to Follow-up|8|||
161713728|NCT05662332|583996385|FG000|Overall Study|Physician Decision|1|||
161713729|NCT05662332|583996386|FG001|Overall Study|Physician Decision|2|||
161713730|NCT05662332|583996385|FG000|Overall Study|Protocol Deviation|2|||
161713731|NCT05662332|583996386|FG001|Overall Study|Protocol Deviation|1|||
161713732|NCT05662332|583996385|FG000|Overall Study|Withdrawal by Subject|14|||
161713733|NCT05662332|583996386|FG001|Overall Study|Withdrawal by Subject|14|||
161713734|NCT05662332|583996385|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161713735|NCT05662332|583996386|FG001|Overall Study|Assigned Treatment by Mistake|7|||
161713736|NCT05662332|583996385|FG000|Overall Study|Non-compliance with study drug|4|||
161713737|NCT05662332|583996386|FG001|Overall Study|Non-compliance with study drug|1|||
161713738|NCT05662332|583996385|FG000|Overall Study|Due to Bariatric surgery|1|||
161713739|NCT05662332|583996386|FG001|Overall Study|Due to Bariatric surgery|0|||
161713740|NCT05662332|583996385|FG000|Overall Study|Subject Moving out of State|0|||
161713741|NCT05662332|583996386|FG001|Overall Study|Subject Moving out of State|1|||
161713742|NCT05662332|583996385|FG000|Overall Study|Subject Missed the Schedule|1|||
161713743|NCT05662332|583996386|FG001|Overall Study|Subject Missed the Schedule|0|||
161713744|NCT05662332|583996385|FG000|Overall Study|The Patient Moved to Another City|1|||
161713745|NCT05662332|583996386|FG001|Overall Study|The Patient Moved to Another City|0|||
161713746|NCT01097044|583996396|FG000|Overall Study|Withdrawal by Subject|4|||
161713747|NCT01097044|583996397|FG001|Overall Study|Withdrawal by Subject|4|||
161713748|NCT01097044|583996396|FG000|Overall Study|Lost to Follow-up|1|||
161713749|NCT01097044|583996397|FG001|Overall Study|Lost to Follow-up|0|||
161713750|NCT01097044|583996396|FG000|Overall Study|Withdrawal by Sponsor|0|||
161713751|NCT01097044|583996397|FG001|Overall Study|Withdrawal by Sponsor|1|||
161713752|NCT02452359|583996399|FG000|Overall Study|Adverse Event|1|||
161713753|NCT02452359|583996399|FG000|Overall Study|Lost to Follow-up|15|||
161713754|NCT02452359|583996399|FG000|Overall Study|Pregnancy|1|||
161713755|NCT02452359|583996399|FG000|Overall Study|Withdrawal by Subject|4|||
161713756|NCT03414359|583996400|FG000|Overall Study|Lack of Efficacy|1|||
161713757|NCT03414359|583996401|FG001|Overall Study|Lack of Efficacy|1|||
161713758|NCT03414359|583996400|FG000|Overall Study|Protocol Violation|0|||
161713759|NCT03414359|583996401|FG001|Overall Study|Protocol Violation|1|||
161713760|NCT04865731|583996402|FG000|Overall Study|Physician Decision|2|||
161713761|NCT04865731|583996403|FG001|Overall Study|Physician Decision|1|||
161713762|NCT04865731|583996402|FG000|Overall Study|Adverse Event|1|||
161713763|NCT04865731|583996403|FG001|Overall Study|Adverse Event|0|||
161713764|NCT04865731|583996402|FG000|Overall Study|Withdrawal by Subject|0|||
161713765|NCT04865731|583996403|FG001|Overall Study|Withdrawal by Subject|1|||
161713766|NCT00222105|583996406|FG000|Overall Study|Removed due to wrong diagnosis|1|||
161713767|NCT00222105|583996406|FG000|Overall Study|Withdrawal by Subject|1|||
161713768|NCT00222105|583996406|FG000|Overall Study|Adverse Event|8|||
161713769|NCT00222105|583996406|FG000|Overall Study|Treatment delays|2|||
161713770|NCT00222105|583996406|FG000|Overall Study|Death|2|||
161713771|NCT03395210|583998185|FG000|Overall Study|Other|0|||
161713772|NCT03395210|583998186|FG001|Overall Study|Other|0|||
161713773|NCT03395210|583998187|FG002|Overall Study|Other|0|||
161713774|NCT03395210|583998188|FG003|Overall Study|Other|0|||
161713775|NCT03395210|583998189|FG004|Overall Study|Other|1|||
161713776|NCT03395210|583998185|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713777|NCT03395210|583998186|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713778|NCT03395210|583998187|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713779|NCT03395210|583998188|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713780|NCT03395210|583998189|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
161713781|NCT03395210|583998185|FG000|Overall Study|Adverse Event|1|||
161713782|NCT03395210|583998186|FG001|Overall Study|Adverse Event|0|||
161713783|NCT03395210|583998187|FG002|Overall Study|Adverse Event|2|||
161713784|NCT03395210|583998188|FG003|Overall Study|Adverse Event|4|||
161713785|NCT03395210|583998189|FG004|Overall Study|Adverse Event|3|||
161713786|NCT03395210|583998185|FG000|Overall Study|Need of Rescue Medication|1|||
161713787|NCT03395210|583998186|FG001|Overall Study|Need of Rescue Medication|0|||
161713788|NCT03395210|583998187|FG002|Overall Study|Need of Rescue Medication|1|||
161713789|NCT03395210|583998188|FG003|Overall Study|Need of Rescue Medication|4|||
161713790|NCT03395210|583998189|FG004|Overall Study|Need of Rescue Medication|0|||
161713791|NCT03395210|583998185|FG000|Overall Study|Lack of Response|0|||
161838004|NCT05297578|584450279|FG002|Overall Study|Withdrawal by Subject|1|||
161713792|NCT03395210|583998186|FG001|Overall Study|Lack of Response|0|||
161713793|NCT03395210|583998187|FG002|Overall Study|Lack of Response|0|||
161713794|NCT03395210|583998188|FG003|Overall Study|Lack of Response|5|||
161838005|NCT05297578|584450280|FG003|Overall Study|Withdrawal by Subject|0|||
161838006|NCT03127644|584450281|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161713795|NCT03395210|583998189|FG004|Overall Study|Lack of Response|5|||
161713796|NCT03395210|583998185|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
161713797|NCT03395210|583998186|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161713798|NCT03395210|583998187|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161713799|NCT03395210|583998188|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161713800|NCT03395210|583998189|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
161713801|NCT03395210|583998185|FG000|Overall Study|Participant Decision|1|||
161713802|NCT03395210|583998186|FG001|Overall Study|Participant Decision|1|||
161713803|NCT03395210|583998187|FG002|Overall Study|Participant Decision|0|||
161713804|NCT03395210|583998188|FG003|Overall Study|Participant Decision|4|||
161713805|NCT03395210|583998189|FG004|Overall Study|Participant Decision|0|||
161713806|NCT03395210|583998185|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
161713807|NCT03395210|583998186|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
161713808|NCT03395210|583998187|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
161713809|NCT03395210|583998188|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
161713810|NCT03395210|583998189|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
161713811|NCT01006356|583998193|FG000|Overall Study|Adverse Event|6|||
161713812|NCT01006356|583998193|FG000|Overall Study|Physician Decision|1|||
161713813|NCT01006356|583998193|FG000|Overall Study|Paticipants did not cooperate|6|||
161713814|NCT01006356|583998193|FG000|Overall Study|Withdrawal by Subject|1|||
161713815|NCT01006356|583998193|FG000|Overall Study|Choice by participants|2|||
161713816|NCT01006356|583998193|FG000|Overall Study|Protocol Violation|3|||
161713817|NCT01006356|583998193|FG000|Overall Study|Other|23|||
161713818|NCT02981472|583998195|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
161713819|NCT02981472|583998196|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
161713820|NCT02981472|583998195|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161713821|NCT02981472|583998196|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161713822|NCT02981472|583998195|FG000|Treatment Period|Adverse Event|6|||
161713823|NCT02981472|583998196|FG001|Treatment Period|Adverse Event|1|||
161713824|NCT02981472|583998195|FG000|Treatment Period|Participant withdrew consent|1|||
161713825|NCT02981472|583998196|FG001|Treatment Period|Participant withdrew consent|0|||
161713826|NCT02981472|583998195|FG000|Treatment Period|Lost to Follow-up|0|||
161713827|NCT02981472|583998196|FG001|Treatment Period|Lost to Follow-up|1|||
161713828|NCT03368859|583998199|FG000|Overall Study|Withdrew Consent|5|||
161713829|NCT03368859|583998200|FG001|Overall Study|Withdrew Consent|4|||
161713830|NCT03368859|583998199|FG000|Overall Study|Death|12|||
161713831|NCT03368859|583998200|FG001|Overall Study|Death|6|||
161713832|NCT03368859|583998199|FG000|Overall Study|Study terminated by Sponsor|18|||
161713833|NCT03368859|583998200|FG001|Overall Study|Study terminated by Sponsor|23|||
161713834|NCT03368859|583998199|FG000|Overall Study|Other|1|||
161713835|NCT03368859|583998200|FG001|Overall Study|Other|1|||
161713836|NCT02559505|583998206|FG000|Overall Study|Lost to Follow-up|23|||
161713837|NCT02559505|583998207|FG001|Overall Study|Lost to Follow-up|20|||
161713838|NCT02559505|583998206|FG000|Overall Study|Withdrawal by Subject|4|||
161713839|NCT02559505|583998207|FG001|Overall Study|Withdrawal by Subject|2|||
161713840|NCT03523585|583998208|FG000|Overall Study|Progressive Disease|174|||
161713841|NCT03523585|583998209|FG001|Overall Study|Progressive Disease|64|||
161713842|NCT03523585|583998210|FG002|Overall Study|Progressive Disease|77|||
161713843|NCT03523585|583998208|FG000|Overall Study|Adverse Event|74|||
161713844|NCT03523585|583998209|FG001|Overall Study|Adverse Event|5|||
161713845|NCT03523585|583998210|FG002|Overall Study|Adverse Event|9|||
161713846|NCT03523585|583998208|FG000|Overall Study|Withdrawal by Subject|30|||
161713847|NCT03523585|583998209|FG001|Overall Study|Withdrawal by Subject|11|||
161713848|NCT03523585|583998210|FG002|Overall Study|Withdrawal by Subject|6|||
161713849|NCT03523585|583998208|FG000|Overall Study|Clinical Progression|23|||
161713850|NCT03523585|583998209|FG001|Overall Study|Clinical Progression|5|||
161713851|NCT03523585|583998210|FG002|Overall Study|Clinical Progression|10|||
161713852|NCT03523585|583998208|FG000|Overall Study|Death|4|||
161662140|NCT04494256|583815519|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161662141|NCT04494256|583815520|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161662142|NCT04494256|583815521|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161713853|NCT03523585|583998209|FG001|Overall Study|Death|0|||
161713854|NCT03523585|583998210|FG002|Overall Study|Death|1|||
161713855|NCT03523585|583998208|FG000|Overall Study|Physician Decision|2|||
161713856|NCT03523585|583998209|FG001|Overall Study|Physician Decision|1|||
161713857|NCT03523585|583998210|FG002|Overall Study|Physician Decision|0|||
161662143|NCT04494256|583815522|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161662144|NCT04494256|583815523|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
161662145|NCT04494256|583815524|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
161662146|NCT04494256|583815518|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161662147|NCT04494256|583815519|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161662148|NCT04494256|583815520|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161662149|NCT04494256|583815521|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161662150|NCT04494256|583815522|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161662151|NCT04494256|583815523|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161662152|NCT04494256|583815524|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
161662153|NCT04494256|583815518|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161662154|NCT04494256|583815519|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161662155|NCT04494256|583815520|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161662156|NCT04494256|583815521|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161662157|NCT04494256|583815522|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161662158|NCT04494256|583815523|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
161662159|NCT04494256|583815524|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
161662160|NCT04494256|583815518|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662161|NCT04494256|583815519|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662162|NCT04494256|583815520|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662163|NCT04494256|583815521|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662164|NCT04494256|583815522|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161662165|NCT04494256|583815523|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
161662166|NCT04494256|583815524|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
161662167|NCT04494256|583815518|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161662168|NCT04494256|583815519|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161662169|NCT04494256|583815520|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161662170|NCT04494256|583815521|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161662171|NCT04494256|583815522|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161662172|NCT04494256|583815523|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
161662173|NCT04494256|583815524|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
161662174|NCT00262951|583815525|FG000|Overall Study|Progressive disease/relapse|3|||
161662175|NCT00262951|583815525|FG000|Overall Study|Adverse Event|7|||
161662176|NCT00262951|583815525|FG000|Overall Study|Death|1|||
161662177|NCT00262951|583815525|FG000|Overall Study|Withdrawal by Subject|1|||
161662178|NCT00262951|583815525|FG000|Overall Study|Alternative treatment|3|||
161662179|NCT00262951|583815525|FG000|Overall Study|Off treatment for other disease|1|||
161662180|NCT02483585|583815526|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
161662181|NCT02483585|583815527|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
161662182|NCT02483585|583815526|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
161662183|NCT02483585|583815527|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
161662184|NCT02483585|583815526|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
161662185|NCT02483585|583815527|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
161662186|NCT02483585|583815526|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
161662187|NCT02483585|583815527|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
161662188|NCT02483585|583815526|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
161662189|NCT02483585|583815527|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
161662190|NCT02483585|583815526|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
161662191|NCT02483585|583815527|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
161662192|NCT02483585|583815526|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
161662193|NCT02483585|583815527|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
161662194|NCT00825916|583815531|FG000|Overall Study|Lost to Follow-up|4|||
161713858|NCT03523585|583998208|FG000|Overall Study|Lost to Follow-up|1|||
161662195|NCT00825916|583815532|FG001|Overall Study|Lost to Follow-up|2|||
161713859|NCT03523585|583998209|FG001|Overall Study|Lost to Follow-up|0|||
161662196|NCT00825916|583815533|FG002|Overall Study|Lost to Follow-up|1|||
161662197|NCT01778023|583815534|FG000|Overall Study|Withdrawal by Subject|0|||
161662198|NCT01778023|583815535|FG001|Overall Study|Withdrawal by Subject|3|||
161662199|NCT01098097|583815536|FG000|Overall Study|Adverse Event|17|||
161662200|NCT01098097|583815536|FG000|Overall Study|Lost to Follow-up|18|||
161662201|NCT01098097|583815536|FG000|Overall Study|Status unknown|16|||
161662202|NCT01098097|583815536|FG000|Overall Study|No reason reported|31|||
161662203|NCT01502631|583815539|FG000|Overall Study|Adverse Event|5|||
161662204|NCT01502631|583815540|FG001|Overall Study|Adverse Event|8|||
161662205|NCT01502631|583815539|FG000|Overall Study|Lost to Follow-up|2|||
161662206|NCT01502631|583815540|FG001|Overall Study|Lost to Follow-up|2|||
161662207|NCT01502631|583815539|FG000|Overall Study|Participant withdrew consent|2|||
161662208|NCT01502631|583815540|FG001|Overall Study|Participant withdrew consent|4|||
161662209|NCT01502631|583815539|FG000|Overall Study|Participant non-compliant|1|||
161662210|NCT01502631|583815540|FG001|Overall Study|Participant non-compliant|0|||
161662211|NCT01502631|583815539|FG000|Overall Study|Investigator's decision|0|||
161662212|NCT01502631|583815540|FG001|Overall Study|Investigator's decision|1|||
161662213|NCT01502631|583815539|FG000|Overall Study|Other|10|||
161662214|NCT01502631|583815540|FG001|Overall Study|Other|5|||
161662215|NCT01000636|583815543|FG000|Overall Study|Withdrawal by Subject|1|||
161662216|NCT01000636|583815543|FG000|Overall Study|Adverse Event|1|||
161662217|NCT02319525|583815544|FG000|Overall Study|Withdrawal by Subject|2|||
161662218|NCT02319525|583815545|FG001|Overall Study|Withdrawal by Subject|1|||
161662219|NCT00577577|583815549|FG000|Overall Study|Adverse Event|3|||
161662220|NCT00577577|583815550|FG001|Overall Study|Adverse Event|2|||
161662221|NCT00577577|583815549|FG000|Overall Study|Lost to Follow-up|1|||
161662222|NCT00577577|583815550|FG001|Overall Study|Lost to Follow-up|0|||
161662223|NCT00577577|583815549|FG000|Overall Study|Protocol Violation|0|||
161662224|NCT00577577|583815550|FG001|Overall Study|Protocol Violation|3|||
161662225|NCT00577577|583815549|FG000|Overall Study|Transportation|1|||
161662226|NCT00577577|583815550|FG001|Overall Study|Transportation|0|||
161662227|NCT02424734|583815551|FG000|Overall Study|Treatment stopped to be discharged home|2|||
161662228|NCT02424734|583815552|FG001|Overall Study|Treatment stopped to be discharged home|2|||
161662229|NCT02424734|583815553|FG002|Overall Study|Treatment stopped to be discharged home|0|||
161662230|NCT01445301|583815554|FG000|Overall Study|Adverse Event|15|||
161662231|NCT01445301|583815555|FG001|Overall Study|Adverse Event|25|||
161662232|NCT01445301|583815556|FG002|Overall Study|Adverse Event|4|||
161662233|NCT01445301|583815554|FG000|Overall Study|Lack of Efficacy|0|||
161662234|NCT01445301|583815555|FG001|Overall Study|Lack of Efficacy|1|||
161662235|NCT01445301|583815556|FG002|Overall Study|Lack of Efficacy|0|||
161662236|NCT01445301|583815554|FG000|Overall Study|Protocol Violation|1|||
161662237|NCT01445301|583815555|FG001|Overall Study|Protocol Violation|0|||
161662238|NCT01445301|583815556|FG002|Overall Study|Protocol Violation|0|||
161662239|NCT01445301|583815554|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
161662240|NCT01445301|583815555|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
161662241|NCT01445301|583815556|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
161662242|NCT01445301|583815554|FG000|Overall Study|Physician Decision|0|||
161662243|NCT01445301|583815555|FG001|Overall Study|Physician Decision|2|||
161662244|NCT01445301|583815556|FG002|Overall Study|Physician Decision|0|||
161662245|NCT01445301|583815554|FG000|Overall Study|Withdrawal by Subject|5|||
161662246|NCT01445301|583815555|FG001|Overall Study|Withdrawal by Subject|6|||
161662247|NCT01445301|583815556|FG002|Overall Study|Withdrawal by Subject|4|||
161662248|NCT02729753|583815561|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
161662249|NCT02729753|583815562|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
161662250|NCT00190749|583815563|FG000|Overall Study|Lost to Follow-up|8|||
161662251|NCT00190749|583815564|FG001|Overall Study|Lost to Follow-up|11|||
161662252|NCT00190749|583815563|FG000|Overall Study|Withdrawal by Subject|10|||
161662253|NCT00190749|583815564|FG001|Overall Study|Withdrawal by Subject|6|||
161662254|NCT00190749|583815563|FG000|Overall Study|Protocol Violation|5|||
161662255|NCT00190749|583815564|FG001|Overall Study|Protocol Violation|4|||
161662256|NCT00190749|583815563|FG000|Overall Study|Adverse Event|0|||
161662257|NCT00190749|583815564|FG001|Overall Study|Adverse Event|5|||
161662258|NCT00190749|583815563|FG000|Overall Study|Lack of Efficacy|2|||
161662259|NCT00190749|583815564|FG001|Overall Study|Lack of Efficacy|3|||
161662260|NCT00190749|583815563|FG000|Overall Study|Reason Not Specified|0|||
161662261|NCT00190749|583815564|FG001|Overall Study|Reason Not Specified|2|||
161662262|NCT00190749|583815563|FG000|Overall Study|Sponsor Decision|1|||
161662263|NCT00190749|583815564|FG001|Overall Study|Sponsor Decision|0|||
161662264|NCT01090427|583815565|FG000|After Controlled Period|Death|0|||
161662265|NCT01090427|583815566|FG001|After Controlled Period|Death|0|||
161662266|NCT01090427|583815567|FG002|After Controlled Period|Death|0|||
161662267|NCT01090427|583815568|FG003|After Controlled Period|Death|0|||
161662268|NCT01090427|583815569|FG004|After Controlled Period|Death|0|||
161662269|NCT01090427|583815570|FG005|After Controlled Period|Death|1|||
161662270|NCT01090427|583815571|FG006|After Controlled Period|Death|0|||
161662271|NCT01090427|583815565|FG000|After Controlled Period|Lack of Efficacy|0|||
161662272|NCT01090427|583815566|FG001|After Controlled Period|Lack of Efficacy|0|||
161662273|NCT01090427|583815567|FG002|After Controlled Period|Lack of Efficacy|0|||
161662274|NCT01090427|583815568|FG003|After Controlled Period|Lack of Efficacy|0|||
161662275|NCT01090427|583815569|FG004|After Controlled Period|Lack of Efficacy|0|||
161662276|NCT01090427|583815570|FG005|After Controlled Period|Lack of Efficacy|3|||
161662277|NCT01090427|583815571|FG006|After Controlled Period|Lack of Efficacy|2|||
161662278|NCT01090427|583815565|FG000|After Controlled Period|Adverse Event|0|||
161662279|NCT01090427|583815566|FG001|After Controlled Period|Adverse Event|0|||
161662280|NCT01090427|583815567|FG002|After Controlled Period|Adverse Event|0|||
161662281|NCT01090427|583815568|FG003|After Controlled Period|Adverse Event|2|||
161662282|NCT01090427|583815569|FG004|After Controlled Period|Adverse Event|0|||
161662283|NCT01090427|583815570|FG005|After Controlled Period|Adverse Event|1|||
161662284|NCT01090427|583815571|FG006|After Controlled Period|Adverse Event|0|||
161662285|NCT01154010|583815572|FG000|Overall Study|Lost to Follow-up|0|||
161662286|NCT01154010|583815573|FG001|Overall Study|Lost to Follow-up|1|||
161662287|NCT00439231|583815574|FG000|Overall Study|Lack of Efficacy|28|||
161662288|NCT02413333|583815580|FG000|Period 1|Adverse Event|1|||
161662289|NCT02413333|583815581|FG001|Period 1|Adverse Event|0|||
161662290|NCT02413333|583815580|FG000|Period 1|Reason Not Specified|0|||
161662291|NCT02413333|583815581|FG001|Period 1|Reason Not Specified|1|||
161662292|NCT02413333|583815580|FG000|Period 2|Protocol Deviation|1|||
161662293|NCT02413333|583815581|FG001|Period 2|Protocol Deviation|0|||
161662294|NCT01465347|583815582|FG000|Overall Study|Withdrawal by Subject|1|||
161662295|NCT01465347|583815583|FG001|Overall Study|Withdrawal by Subject|1|||
161662296|NCT01465347|583815582|FG000|Overall Study|Physician Decision|0|||
161662297|NCT01465347|583815583|FG001|Overall Study|Physician Decision|1|||
161662298|NCT01465347|583815582|FG000|Overall Study|Admitted to hospice|0|||
161662299|NCT01465347|583815583|FG001|Overall Study|Admitted to hospice|1|||
161662300|NCT00906945|583815584|FG000|Overall Study|Found to be not eligible|0|||
161662301|NCT00906945|583815585|FG001|Overall Study|Found to be not eligible|0|||
161662302|NCT00906945|583815586|FG002|Overall Study|Found to be not eligible|0|||
161662303|NCT00906945|583815587|FG003|Overall Study|Found to be not eligible|1|||
161662304|NCT00906945|583815588|FG004|Overall Study|Found to be not eligible|1|||
161662305|NCT00906945|583815589|FG005|Overall Study|Found to be not eligible|1|||
161662306|NCT00906945|583815584|FG000|Overall Study|Physician Decision|0|||
161662307|NCT00906945|583815585|FG001|Overall Study|Physician Decision|0|||
161662308|NCT00906945|583815586|FG002|Overall Study|Physician Decision|0|||
161662309|NCT00906945|583815587|FG003|Overall Study|Physician Decision|0|||
161662310|NCT00906945|583815588|FG004|Overall Study|Physician Decision|0|||
161662311|NCT00906945|583815589|FG005|Overall Study|Physician Decision|1|||
161662312|NCT02996474|583815591|FG000|Overall Study|Physician Decision|5|||
161662313|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
161662314|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
161662315|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
161662316|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
161662317|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
161662318|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
161662319|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
161662320|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
161662321|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
161662322|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
161662323|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
161662324|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
161662325|NCT04493502|583815592|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
161662326|NCT04493502|583815593|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
161662327|NCT04493502|583815592|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
161662328|NCT04493502|583815593|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
161662329|NCT04493502|583815592|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
161662330|NCT04493502|583815593|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
161662331|NCT04493502|583815592|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
161662332|NCT04493502|583815593|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
161662333|NCT04493502|583815592|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
161662334|NCT04493502|583815593|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
161662335|NCT04493502|583815592|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
161662336|NCT04493502|583815593|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
161662337|NCT04493502|583815592|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
161662338|NCT04493502|583815593|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
161662339|NCT01210664|583815594|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
161662340|NCT01210664|583815595|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
161662341|NCT01210664|583815596|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
161662342|NCT01210664|583815597|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
161662343|NCT01210664|583815594|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161662344|NCT01210664|583815595|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161662345|NCT01210664|583815596|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
161662346|NCT01210664|583815597|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161662347|NCT01210664|583815594|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161662348|NCT01210664|583815595|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161662349|NCT01210664|583815596|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161662350|NCT01210664|583815597|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
161662351|NCT01853644|583815598|FG000|Registration and Treatment Start|Did not start treatment|1|||
161662352|NCT01853644|583815598|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
161662353|NCT01853644|583815598|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
161662354|NCT01853644|583815598|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
161662355|NCT01853644|583815598|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
161662356|NCT01853644|583815598|FG000|Continued Treatment After First Response|Adverse Event|2|||
161662357|NCT01853644|583815598|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
161662358|NCT02891837|583815599|FG000|Overall Study|Lost to Follow-up|2|||
161662359|NCT02891837|583815600|FG001|Overall Study|Lost to Follow-up|0|||
161662360|NCT02891837|583815599|FG000|Overall Study|Withdrawal by Subject|1|||
161662361|NCT02891837|583815600|FG001|Overall Study|Withdrawal by Subject|0|||
161662362|NCT00709852|583815601|FG000|Period 1|Adverse Event|2|||
161662363|NCT00709852|583815602|FG001|Period 1|Adverse Event|0|||
161662364|NCT00709852|583815601|FG000|Period 1|Withdrawal by Subject|4|||
161662365|NCT00709852|583815602|FG001|Period 1|Withdrawal by Subject|2|||
161662366|NCT00709852|583815601|FG000|Period 1|Protocol Violation|1|||
161662367|NCT00709852|583815602|FG001|Period 1|Protocol Violation|0|||
161662368|NCT00709852|583815601|FG000|Period 1|Defective scanner|0|||
161662369|NCT00709852|583815602|FG001|Period 1|Defective scanner|1|||
161662370|NCT00709852|583815601|FG000|Period 1|Lost to Follow-up|1|||
161662371|NCT00709852|583815602|FG001|Period 1|Lost to Follow-up|0|||
161662372|NCT00709852|583815601|FG000|Period 2|Protocol Violation|4|||
161662373|NCT00709852|583815602|FG001|Period 2|Protocol Violation|1|||
161662374|NCT00709852|583815601|FG000|Period 2|Adverse Event|1|||
161662375|NCT00709852|583815602|FG001|Period 2|Adverse Event|1|||
161662376|NCT00709852|583815601|FG000|Period 2|Lost to Follow-up|1|||
161662377|NCT00709852|583815602|FG001|Period 2|Lost to Follow-up|0|||
161662378|NCT00709852|583815601|FG000|Period 2|No 72-hour follow-up|3|||
161662379|NCT00709852|583815602|FG001|Period 2|No 72-hour follow-up|0|||
161662380|NCT01048671|583815603|FG000|Overall Study|Protocol Violation|0|||
161662381|NCT01048671|583815604|FG001|Overall Study|Protocol Violation|1|||
161662382|NCT01048671|583815605|FG002|Overall Study|Protocol Violation|1|||
161662383|NCT01178385|583815610|FG000|Overall Study|Withdrawal by Subject|2|||
161662384|NCT01178385|583815611|FG001|Overall Study|Withdrawal by Subject|0|||
161662385|NCT00985946|583815612|FG000|Overall Study|Lost to Follow-up|6|||
161662386|NCT00985946|583815612|FG000|Overall Study|Withdrawal by Subject|1|||
161662387|NCT00928018|583815617|FG000|Overall Study|Withdrawal by Subject|1|||
161662388|NCT00928018|583815618|FG001|Overall Study|Withdrawal by Subject|0|||
161662389|NCT02008877|583815619|FG000|Overall Study|Inevaluable|0|||
161662390|NCT02008877|583815620|FG001|Overall Study|Inevaluable|1|||
161662391|NCT02008877|583815621|FG002|Overall Study|Inevaluable|0|||
161662392|NCT00847808|583815622|FG000|Overall Study|Adverse Event|7|||
161662393|NCT00847808|583815622|FG000|Overall Study|Protocol Violation|1|||
161662394|NCT00847808|583815622|FG000|Overall Study|Lost to Follow-up|1|||
161662395|NCT00847808|583815622|FG000|Overall Study|Withdrawal by Subject|4|||
161662396|NCT00847808|583815622|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
161713860|NCT03523585|583998210|FG002|Overall Study|Lost to Follow-up|0|||
161713861|NCT03523585|583998208|FG000|Overall Study|Miscellaneous|1|||
161713862|NCT03523585|583998209|FG001|Overall Study|Miscellaneous|0|||
161713863|NCT03523585|583998210|FG002|Overall Study|Miscellaneous|0|||
161713864|NCT03523585|583998208|FG000|Overall Study|Protocol Deviation|1|||
161713865|NCT03523585|583998209|FG001|Overall Study|Protocol Deviation|0|||
161713866|NCT03523585|583998210|FG002|Overall Study|Protocol Deviation|1|||
161713867|NCT03523585|583998208|FG000|Overall Study|Randomized But Not Treated|2|||
161713868|NCT03523585|583998209|FG001|Overall Study|Randomized But Not Treated|4|||
161713869|NCT03523585|583998210|FG002|Overall Study|Randomized But Not Treated|3|||
161713870|NCT02874794|583998213|FG000|Overall Study|Physician Decision|3|||
161713871|NCT02874794|583998214|FG001|Overall Study|Physician Decision|2|||
161713872|NCT02874794|583998213|FG000|Overall Study|Withdrawal by Subject|2|||
161713873|NCT02874794|583998214|FG001|Overall Study|Withdrawal by Subject|8|||
161713874|NCT02874794|583998213|FG000|Overall Study|Death|2|||
161713875|NCT02874794|583998214|FG001|Overall Study|Death|1|||
161713876|NCT01473004|583998215|FG000|Overall Study|Incomplete Lobar Treatment|1|||
161713877|NCT01473004|583998216|FG001|Overall Study|Incomplete Lobar Treatment|0|||
161713878|NCT00698516|583998217|FG000|Overall Study|Study Termination|2|||
161713879|NCT00698516|583998217|FG000|Overall Study|Withdrawal by Subject|3|||
161713880|NCT05882890|583998218|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
161713881|NCT01584024|583998227|FG000|Overall Study|Lost to Follow-up|10|||
161713882|NCT01584024|583998227|FG000|Overall Study|Withdrawal by Subject|3|||
161713883|NCT00613314|583998228|FG000|Overall Study|Adverse Event|5|||
161713884|NCT00613314|583998228|FG000|Overall Study|Protocol Violation|14|||
161713885|NCT00613314|583998228|FG000|Overall Study|Lost to Follow-up|46|||
161713886|NCT00613314|583998228|FG000|Overall Study|Other reason not defined above|90|||
161713887|NCT00719810|583998234|FG000|Overall Study|Adverse Event|0|||
161713888|NCT00719810|583998235|FG001|Overall Study|Adverse Event|2|||
161713889|NCT00719810|583998236|FG002|Overall Study|Adverse Event|3|||
161713890|NCT00719810|583998234|FG000|Overall Study|Lost to Follow-up|2|||
161713891|NCT00719810|583998235|FG001|Overall Study|Lost to Follow-up|0|||
161713892|NCT00719810|583998236|FG002|Overall Study|Lost to Follow-up|3|||
161713893|NCT00719810|583998234|FG000|Overall Study|Physician Decision|0|||
161713894|NCT00719810|583998235|FG001|Overall Study|Physician Decision|1|||
161713895|NCT00719810|583998236|FG002|Overall Study|Physician Decision|0|||
161662397|NCT00847808|583815622|FG000|Overall Study|Participant Took Excluded Medication|1|||
161662398|NCT05000931|583815632|FG000|Overall Study|Lost to Follow-up|1|||
161662399|NCT05326815|583815633|FG000|Overall Study|Withdrawal by Subject|3|||
161662400|NCT05326815|583815633|FG000|Overall Study|Did not complete required labs|6|||
161662401|NCT05326815|583815633|FG000|Overall Study|Screen fail- abnormal labs|5|||
161662402|NCT00979134|583815634|FG000|Overall Study|Disease progression|18|||
161662403|NCT00979134|583815635|FG001|Overall Study|Disease progression|2|||
161713896|NCT00719810|583998234|FG000|Overall Study|Withdrawal by Subject|1|||
161713897|NCT00719810|583998235|FG001|Overall Study|Withdrawal by Subject|1|||
161713898|NCT00719810|583998236|FG002|Overall Study|Withdrawal by Subject|2|||
161713899|NCT04893265|583998259|FG000|Overall Study|Withdrawal by Subject|2|||
161713900|NCT04893265|583998260|FG001|Overall Study|Withdrawal by Subject|5|||
161713901|NCT04893265|583998259|FG000|Overall Study|Lost to Follow-up|0|||
161713902|NCT04893265|583998260|FG001|Overall Study|Lost to Follow-up|4|||
161713903|NCT02465034|583998261|FG000|Overall Study|Withdrawal by Subject|1|||
161713904|NCT02465034|583998262|FG001|Overall Study|Withdrawal by Subject|1|||
161713905|NCT02465034|583998261|FG000|Overall Study|Screen fail|2|||
161713906|NCT02465034|583998262|FG001|Overall Study|Screen fail|0|||
161713907|NCT02465034|583998261|FG000|Overall Study|Could not be scheduled for study visit|0|||
161713908|NCT02465034|583998262|FG001|Overall Study|Could not be scheduled for study visit|5|||
161713909|NCT03090191|583998263|FG000|Overall Study|Adverse Event|90|||
161713910|NCT03090191|583998264|FG001|Overall Study|Adverse Event|72|||
161713911|NCT03090191|583998263|FG000|Overall Study|Death|365|||
161713912|NCT03090191|583998264|FG001|Overall Study|Death|358|||
161713913|NCT03090191|583998263|FG000|Overall Study|Lost to Follow-up|382|||
161713914|NCT03090191|583998264|FG001|Overall Study|Lost to Follow-up|394|||
161713915|NCT03090191|583998263|FG000|Overall Study|Physician Decision|77|||
161713916|NCT03090191|583998264|FG001|Overall Study|Physician Decision|66|||
161713917|NCT03090191|583998263|FG000|Overall Study|Protocol Violation|43|||
161713918|NCT03090191|583998264|FG001|Overall Study|Protocol Violation|52|||
161713919|NCT03090191|583998263|FG000|Overall Study|Withdrawal by Subject|2160|||
161713920|NCT03090191|583998264|FG001|Overall Study|Withdrawal by Subject|2133|||
161713921|NCT03090191|583998263|FG000|Overall Study|Site terminated|7|||
161713922|NCT03090191|583998264|FG001|Overall Study|Site terminated|8|||
161713923|NCT03090191|583998263|FG000|Overall Study|Other|66|||
161713924|NCT03090191|583998264|FG001|Overall Study|Other|60|||
161713925|NCT03090191|583998263|FG000|Overall Study|Withdrawn before any study vaccination|43|||
161713926|NCT03090191|583998264|FG001|Overall Study|Withdrawn before any study vaccination|52|||
161713927|NCT04419506|583998267|FG000|Overall Study|Adverse Event|0|||
161713928|NCT04419506|583998268|FG001|Overall Study|Adverse Event|10|||
161713929|NCT04419506|583998269|FG002|Overall Study|Adverse Event|0|||
161713930|NCT04419506|583998270|FG003|Overall Study|Adverse Event|3|||
161713931|NCT04419506|583998267|FG000|Overall Study|Withdrawal by Subject|0|||
161713932|NCT04419506|583998268|FG001|Overall Study|Withdrawal by Subject|0|||
161713933|NCT04419506|583998269|FG002|Overall Study|Withdrawal by Subject|0|||
161713934|NCT04419506|583998270|FG003|Overall Study|Withdrawal by Subject|1|||
161713935|NCT04419506|583998267|FG000|Overall Study|poor-compliance|0|||
161713936|NCT04419506|583998268|FG001|Overall Study|poor-compliance|0|||
161713937|NCT04419506|583998269|FG002|Overall Study|poor-compliance|0|||
161713938|NCT04419506|583998270|FG003|Overall Study|poor-compliance|1|||
161713939|NCT04329949|583998271|FG000|Overall Study|Death|36|||
161713940|NCT04329949|583998271|FG000|Overall Study|Withdrawal by Subject|4|||
161713941|NCT04329949|583998271|FG000|Overall Study|Termination of study by sponsor|3|||
161713942|NCT04645797|583998272|FG000|Overall Study|Disease Progression|3|||
161838007|NCT03127644|584450282|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161662404|NCT00979134|583815636|FG002|Overall Study|Disease progression|5|||
161662405|NCT00979134|583815634|FG000|Overall Study|Adverse Event|0|||
161662406|NCT00979134|583815635|FG001|Overall Study|Adverse Event|0|||
161662407|NCT00979134|583815636|FG002|Overall Study|Adverse Event|2|||
161662408|NCT00979134|583815634|FG000|Overall Study|Withdrawal by Subject|1|||
161662409|NCT00979134|583815635|FG001|Overall Study|Withdrawal by Subject|1|||
161662410|NCT00979134|583815636|FG002|Overall Study|Withdrawal by Subject|2|||
161662411|NCT00979134|583815634|FG000|Overall Study|Lost to Follow-up|2|||
161662412|NCT00979134|583815635|FG001|Overall Study|Lost to Follow-up|2|||
161662413|NCT00979134|583815636|FG002|Overall Study|Lost to Follow-up|0|||
161662414|NCT00979134|583815634|FG000|Overall Study|Death|4|||
161662415|NCT00979134|583815635|FG001|Overall Study|Death|0|||
161662416|NCT00979134|583815636|FG002|Overall Study|Death|26|||
161662417|NCT00979134|583815634|FG000|Overall Study|Other|8|||
161662418|NCT00979134|583815635|FG001|Overall Study|Other|1|||
161662419|NCT00979134|583815636|FG002|Overall Study|Other|5|||
161662420|NCT05172050|583815637|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
161662421|NCT05172050|583815638|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
161662422|NCT05172050|583815639|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
161662423|NCT05172050|583815637|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
161662424|NCT05172050|583815638|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
161662425|NCT05172050|583815639|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
161662426|NCT05172050|583815637|FG000|Overall Study|Other|2|||
161662427|NCT05172050|583815638|FG001|Overall Study|Other|2|||
161662428|NCT05172050|583815639|FG002|Overall Study|Other|1|||
161662429|NCT04617275|583815644|FG000|Treatment Period|Adverse Event|1|||
161662430|NCT04617275|583815645|FG001|Treatment Period|Adverse Event|6|||
161662431|NCT04617275|583815646|FG002|Treatment Period|Adverse Event|4|||
161662432|NCT04617275|583815647|FG003|Treatment Period|Adverse Event|6|||
161662433|NCT04617275|583815648|FG004|Treatment Period|Adverse Event|7|||
161662434|NCT04617275|583815649|FG005|Treatment Period|Adverse Event|8|||
161662435|NCT04617275|583815650|FG006|Treatment Period|Adverse Event|0|||
161662436|NCT04617275|583815651|FG007|Treatment Period|Adverse Event|12|||
161662437|NCT04617275|583815644|FG000|Treatment Period|Lost to Follow-up|0|||
161662438|NCT04617275|583815645|FG001|Treatment Period|Lost to Follow-up|0|||
161713943|NCT04645797|583998273|FG001|Overall Study|Disease Progression|3|||
161713944|NCT04645797|583998274|FG002|Overall Study|Disease Progression|1|||
161713945|NCT04645797|583998275|FG003|Overall Study|Disease Progression|0|||
161713946|NCT04645797|583998276|FG004|Overall Study|Disease Progression|0|||
161713947|NCT04645797|583998277|FG005|Overall Study|Disease Progression|0|||
161713948|NCT04645797|583998278|FG006|Overall Study|Disease Progression|0|||
161713949|NCT04645797|583998272|FG000|Overall Study|Death|3|||
161713950|NCT04645797|583998273|FG001|Overall Study|Death|1|||
161713951|NCT04645797|583998274|FG002|Overall Study|Death|0|||
161662439|NCT04617275|583815646|FG002|Treatment Period|Lost to Follow-up|2|||
161662440|NCT04617275|583815647|FG003|Treatment Period|Lost to Follow-up|0|||
161662441|NCT04617275|583815648|FG004|Treatment Period|Lost to Follow-up|0|||
161662442|NCT04617275|583815649|FG005|Treatment Period|Lost to Follow-up|3|||
161662443|NCT04617275|583815650|FG006|Treatment Period|Lost to Follow-up|0|||
161662444|NCT04617275|583815651|FG007|Treatment Period|Lost to Follow-up|2|||
161662445|NCT04617275|583815644|FG000|Treatment Period|No longer meets eligibility criteria|0|||
161662446|NCT04617275|583815645|FG001|Treatment Period|No longer meets eligibility criteria|0|||
161662447|NCT04617275|583815646|FG002|Treatment Period|No longer meets eligibility criteria|0|||
161662448|NCT04617275|583815647|FG003|Treatment Period|No longer meets eligibility criteria|1|||
161662449|NCT04617275|583815648|FG004|Treatment Period|No longer meets eligibility criteria|0|||
161662450|NCT04617275|583815649|FG005|Treatment Period|No longer meets eligibility criteria|0|||
161662451|NCT04617275|583815650|FG006|Treatment Period|No longer meets eligibility criteria|0|||
161662452|NCT04617275|583815651|FG007|Treatment Period|No longer meets eligibility criteria|0|||
161662453|NCT04617275|583815644|FG000|Treatment Period|Other|0|||
161662454|NCT04617275|583815645|FG001|Treatment Period|Other|1|||
161662455|NCT04617275|583815646|FG002|Treatment Period|Other|0|||
161662456|NCT04617275|583815647|FG003|Treatment Period|Other|0|||
161662457|NCT04617275|583815648|FG004|Treatment Period|Other|0|||
161662458|NCT04617275|583815649|FG005|Treatment Period|Other|0|||
161662459|NCT04617275|583815650|FG006|Treatment Period|Other|0|||
161662460|NCT04617275|583815651|FG007|Treatment Period|Other|0|||
161662461|NCT04617275|583815644|FG000|Treatment Period|Withdrawal by Subject|2|||
161662462|NCT04617275|583815645|FG001|Treatment Period|Withdrawal by Subject|0|||
161662463|NCT04617275|583815646|FG002|Treatment Period|Withdrawal by Subject|0|||
161662464|NCT04617275|583815647|FG003|Treatment Period|Withdrawal by Subject|2|||
161662465|NCT04617275|583815648|FG004|Treatment Period|Withdrawal by Subject|2|||
161662466|NCT04617275|583815649|FG005|Treatment Period|Withdrawal by Subject|0|||
161662467|NCT04617275|583815650|FG006|Treatment Period|Withdrawal by Subject|1|||
161662468|NCT04617275|583815651|FG007|Treatment Period|Withdrawal by Subject|2|||
161662469|NCT04617275|583815644|FG000|Follow-up Period|Adverse Event|1|||
161662470|NCT04617275|583815645|FG001|Follow-up Period|Adverse Event|1|||
161662471|NCT04617275|583815646|FG002|Follow-up Period|Adverse Event|2|||
161662472|NCT04617275|583815647|FG003|Follow-up Period|Adverse Event|3|||
161662473|NCT04617275|583815648|FG004|Follow-up Period|Adverse Event|4|||
161662474|NCT04617275|583815649|FG005|Follow-up Period|Adverse Event|3|||
161662475|NCT04617275|583815650|FG006|Follow-up Period|Adverse Event|0|||
161662476|NCT04617275|583815651|FG007|Follow-up Period|Adverse Event|3|||
161662477|NCT04617275|583815644|FG000|Follow-up Period|Lost to Follow-up|0|||
161662478|NCT04617275|583815645|FG001|Follow-up Period|Lost to Follow-up|1|||
161662479|NCT04617275|583815646|FG002|Follow-up Period|Lost to Follow-up|2|||
161662480|NCT04617275|583815647|FG003|Follow-up Period|Lost to Follow-up|0|||
161662481|NCT04617275|583815648|FG004|Follow-up Period|Lost to Follow-up|0|||
161662482|NCT04617275|583815649|FG005|Follow-up Period|Lost to Follow-up|4|||
161662483|NCT04617275|583815650|FG006|Follow-up Period|Lost to Follow-up|0|||
161662484|NCT04617275|583815651|FG007|Follow-up Period|Lost to Follow-up|3|||
161662485|NCT04617275|583815644|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
161662486|NCT04617275|583815645|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
161662487|NCT04617275|583815646|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
161662488|NCT04617275|583815647|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
161662489|NCT04617275|583815648|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
161662490|NCT04617275|583815649|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
161662491|NCT04617275|583815650|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
161662492|NCT04617275|583815651|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
161662493|NCT04617275|583815644|FG000|Follow-up Period|Other|0|||
161662494|NCT04617275|583815645|FG001|Follow-up Period|Other|1|||
161662495|NCT04617275|583815646|FG002|Follow-up Period|Other|0|||
161662496|NCT04617275|583815647|FG003|Follow-up Period|Other|0|||
161662497|NCT04617275|583815648|FG004|Follow-up Period|Other|0|||
161662498|NCT04617275|583815649|FG005|Follow-up Period|Other|0|||
161662499|NCT04617275|583815650|FG006|Follow-up Period|Other|0|||
161662500|NCT04617275|583815651|FG007|Follow-up Period|Other|0|||
161662501|NCT04617275|583815644|FG000|Follow-up Period|Withdrawal by Subject|2|||
161662502|NCT04617275|583815645|FG001|Follow-up Period|Withdrawal by Subject|0|||
161662503|NCT04617275|583815646|FG002|Follow-up Period|Withdrawal by Subject|0|||
161662504|NCT04617275|583815647|FG003|Follow-up Period|Withdrawal by Subject|2|||
161662505|NCT04617275|583815648|FG004|Follow-up Period|Withdrawal by Subject|2|||
161662506|NCT04617275|583815649|FG005|Follow-up Period|Withdrawal by Subject|0|||
161662507|NCT04617275|583815650|FG006|Follow-up Period|Withdrawal by Subject|1|||
161662508|NCT04617275|583815651|FG007|Follow-up Period|Withdrawal by Subject|2|||
161662509|NCT04227704|583815652|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
161713952|NCT04645797|583998275|FG003|Overall Study|Death|0|||
161713953|NCT04645797|583998276|FG004|Overall Study|Death|0|||
161713954|NCT04645797|583998277|FG005|Overall Study|Death|0|||
161713955|NCT04645797|583998278|FG006|Overall Study|Death|0|||
161713956|NCT00345605|583998283|FG000|Arm 1|Adverse Event|0|||
161713957|NCT00345605|583998284|FG001|Arm 1|Adverse Event|1|||
161713958|NCT00345605|583998283|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
161713959|NCT00345605|583998284|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
161713960|NCT01324830|583998285|FG000|Overall Study|Progressive Disease|3|||
161713961|NCT01324830|583998286|FG001|Overall Study|Progressive Disease|2|||
161713962|NCT01324830|583998287|FG002|Overall Study|Progressive Disease|3|||
161713963|NCT01324830|583998288|FG003|Overall Study|Progressive Disease|3|||
161713964|NCT01324830|583998289|FG004|Overall Study|Progressive Disease|6|||
161713965|NCT01324830|583998290|FG005|Overall Study|Progressive Disease|6|||
161713966|NCT01324830|583998291|FG006|Overall Study|Progressive Disease|3|||
161713967|NCT01324830|583998292|FG007|Overall Study|Progressive Disease|3|||
161713968|NCT01324830|583998293|FG008|Overall Study|Progressive Disease|3|||
161713969|NCT01324830|583998294|FG009|Overall Study|Progressive Disease|6|||
161713970|NCT01324830|583998295|FG010|Overall Study|Progressive Disease|2|||
161713971|NCT01324830|583998296|FG011|Overall Study|Progressive Disease|1|||
161713972|NCT01324830|583998297|FG012|Overall Study|Progressive Disease|1|||
161713973|NCT01324830|583998298|FG013|Overall Study|Progressive Disease|1|||
161713974|NCT01324830|583998299|FG014|Overall Study|Progressive Disease|1|||
161713975|NCT01324830|583998300|FG015|Overall Study|Progressive Disease|3|||
161713976|NCT01324830|583998301|FG016|Overall Study|Progressive Disease|2|||
161713977|NCT01324830|583998302|FG017|Overall Study|Progressive Disease|3|||
161713978|NCT01324830|583998303|FG018|Overall Study|Progressive Disease|4|||
161713979|NCT01324830|583998285|FG000|Overall Study|Dose limiting toxicity|0|||
161713980|NCT01324830|583998286|FG001|Overall Study|Dose limiting toxicity|0|||
161713981|NCT01324830|583998287|FG002|Overall Study|Dose limiting toxicity|0|||
161713982|NCT01324830|583998288|FG003|Overall Study|Dose limiting toxicity|0|||
161713983|NCT01324830|583998289|FG004|Overall Study|Dose limiting toxicity|1|||
161713984|NCT01324830|583998290|FG005|Overall Study|Dose limiting toxicity|0|||
161713985|NCT01324830|583998291|FG006|Overall Study|Dose limiting toxicity|0|||
161713986|NCT01324830|583998292|FG007|Overall Study|Dose limiting toxicity|0|||
161713987|NCT01324830|583998293|FG008|Overall Study|Dose limiting toxicity|0|||
161713988|NCT01324830|583998294|FG009|Overall Study|Dose limiting toxicity|0|||
161713989|NCT01324830|583998295|FG010|Overall Study|Dose limiting toxicity|0|||
161713990|NCT01324830|583998296|FG011|Overall Study|Dose limiting toxicity|0|||
161713991|NCT01324830|583998297|FG012|Overall Study|Dose limiting toxicity|0|||
161713992|NCT01324830|583998298|FG013|Overall Study|Dose limiting toxicity|0|||
161713993|NCT01324830|583998299|FG014|Overall Study|Dose limiting toxicity|0|||
161713994|NCT01324830|583998300|FG015|Overall Study|Dose limiting toxicity|0|||
161713995|NCT01324830|583998301|FG016|Overall Study|Dose limiting toxicity|1|||
161713996|NCT01324830|583998302|FG017|Overall Study|Dose limiting toxicity|1|||
161713997|NCT01324830|583998303|FG018|Overall Study|Dose limiting toxicity|1|||
161713998|NCT01324830|583998285|FG000|Overall Study|Reason not mentioned above|0|||
161713999|NCT01324830|583998286|FG001|Overall Study|Reason not mentioned above|0|||
161714000|NCT01324830|583998287|FG002|Overall Study|Reason not mentioned above|0|||
161714001|NCT01324830|583998288|FG003|Overall Study|Reason not mentioned above|0|||
161714002|NCT01324830|583998289|FG004|Overall Study|Reason not mentioned above|0|||
161714003|NCT01324830|583998290|FG005|Overall Study|Reason not mentioned above|0|||
161714004|NCT01324830|583998291|FG006|Overall Study|Reason not mentioned above|0|||
161714005|NCT01324830|583998292|FG007|Overall Study|Reason not mentioned above|0|||
161714006|NCT01324830|583998293|FG008|Overall Study|Reason not mentioned above|0|||
161714007|NCT01324830|583998294|FG009|Overall Study|Reason not mentioned above|0|||
161714008|NCT01324830|583998295|FG010|Overall Study|Reason not mentioned above|0|||
161714009|NCT01324830|583998296|FG011|Overall Study|Reason not mentioned above|0|||
161714010|NCT01324830|583998297|FG012|Overall Study|Reason not mentioned above|0|||
161714011|NCT01324830|583998298|FG013|Overall Study|Reason not mentioned above|0|||
161714012|NCT01324830|583998299|FG014|Overall Study|Reason not mentioned above|0|||
161714013|NCT01324830|583998300|FG015|Overall Study|Reason not mentioned above|0|||
161714014|NCT01324830|583998301|FG016|Overall Study|Reason not mentioned above|0|||
161714015|NCT01324830|583998302|FG017|Overall Study|Reason not mentioned above|1|||
161714016|NCT01324830|583998303|FG018|Overall Study|Reason not mentioned above|0|||
161714017|NCT01324830|583998285|FG000|Overall Study|Adverse Event, serious fatal|0|||
161838008|NCT03127644|584450283|FG002|Overall Study|Study-specific withdrawal criteria|2|||
161714018|NCT01324830|583998286|FG001|Overall Study|Adverse Event, serious fatal|1|||
161714019|NCT01324830|583998287|FG002|Overall Study|Adverse Event, serious fatal|0|||
161714020|NCT01324830|583998288|FG003|Overall Study|Adverse Event, serious fatal|0|||
161714021|NCT01324830|583998289|FG004|Overall Study|Adverse Event, serious fatal|0|||
161714022|NCT01324830|583998290|FG005|Overall Study|Adverse Event, serious fatal|0|||
161714023|NCT01324830|583998291|FG006|Overall Study|Adverse Event, serious fatal|0|||
161714024|NCT01324830|583998292|FG007|Overall Study|Adverse Event, serious fatal|0|||
161714025|NCT01324830|583998293|FG008|Overall Study|Adverse Event, serious fatal|0|||
161714026|NCT01324830|583998294|FG009|Overall Study|Adverse Event, serious fatal|0|||
161714027|NCT01324830|583998295|FG010|Overall Study|Adverse Event, serious fatal|0|||
161714028|NCT01324830|583998296|FG011|Overall Study|Adverse Event, serious fatal|0|||
161714029|NCT01324830|583998297|FG012|Overall Study|Adverse Event, serious fatal|0|||
161714030|NCT01324830|583998298|FG013|Overall Study|Adverse Event, serious fatal|0|||
161714031|NCT01324830|583998299|FG014|Overall Study|Adverse Event, serious fatal|0|||
161714032|NCT01324830|583998300|FG015|Overall Study|Adverse Event, serious fatal|0|||
161714033|NCT01324830|583998301|FG016|Overall Study|Adverse Event, serious fatal|0|||
161714034|NCT01324830|583998302|FG017|Overall Study|Adverse Event, serious fatal|0|||
161714035|NCT01324830|583998303|FG018|Overall Study|Adverse Event, serious fatal|0|||
161714036|NCT01324830|583998285|FG000|Overall Study|Adverse Event, non-fatal|0|||
161714037|NCT01324830|583998286|FG001|Overall Study|Adverse Event, non-fatal|0|||
161714038|NCT01324830|583998287|FG002|Overall Study|Adverse Event, non-fatal|0|||
161714039|NCT01324830|583998288|FG003|Overall Study|Adverse Event, non-fatal|0|||
161714040|NCT01324830|583998289|FG004|Overall Study|Adverse Event, non-fatal|0|||
161714041|NCT01324830|583998290|FG005|Overall Study|Adverse Event, non-fatal|0|||
161714042|NCT01324830|583998291|FG006|Overall Study|Adverse Event, non-fatal|0|||
161714043|NCT01324830|583998292|FG007|Overall Study|Adverse Event, non-fatal|0|||
161714044|NCT01324830|583998293|FG008|Overall Study|Adverse Event, non-fatal|2|||
161714045|NCT01324830|583998294|FG009|Overall Study|Adverse Event, non-fatal|0|||
161714046|NCT01324830|583998295|FG010|Overall Study|Adverse Event, non-fatal|1|||
161714047|NCT01324830|583998296|FG011|Overall Study|Adverse Event, non-fatal|0|||
161714048|NCT01324830|583998297|FG012|Overall Study|Adverse Event, non-fatal|0|||
161714049|NCT01324830|583998298|FG013|Overall Study|Adverse Event, non-fatal|0|||
161714050|NCT01324830|583998299|FG014|Overall Study|Adverse Event, non-fatal|0|||
161714051|NCT01324830|583998300|FG015|Overall Study|Adverse Event, non-fatal|0|||
161714052|NCT01324830|583998301|FG016|Overall Study|Adverse Event, non-fatal|0|||
161714053|NCT01324830|583998302|FG017|Overall Study|Adverse Event, non-fatal|1|||
161714054|NCT01324830|583998303|FG018|Overall Study|Adverse Event, non-fatal|0|||
161714055|NCT01324830|583998285|FG000|Overall Study|Withdrawal by Subject|0|||
161714056|NCT01324830|583998286|FG001|Overall Study|Withdrawal by Subject|0|||
161714057|NCT01324830|583998287|FG002|Overall Study|Withdrawal by Subject|0|||
161714058|NCT01324830|583998288|FG003|Overall Study|Withdrawal by Subject|0|||
161714059|NCT01324830|583998289|FG004|Overall Study|Withdrawal by Subject|0|||
161714060|NCT01324830|583998290|FG005|Overall Study|Withdrawal by Subject|1|||
161714061|NCT01324830|583998291|FG006|Overall Study|Withdrawal by Subject|0|||
161714062|NCT01324830|583998292|FG007|Overall Study|Withdrawal by Subject|0|||
161714063|NCT01324830|583998293|FG008|Overall Study|Withdrawal by Subject|0|||
161714064|NCT01324830|583998294|FG009|Overall Study|Withdrawal by Subject|0|||
161714065|NCT01324830|583998295|FG010|Overall Study|Withdrawal by Subject|1|||
161714066|NCT01324830|583998296|FG011|Overall Study|Withdrawal by Subject|0|||
161714067|NCT01324830|583998297|FG012|Overall Study|Withdrawal by Subject|0|||
161714068|NCT01324830|583998298|FG013|Overall Study|Withdrawal by Subject|0|||
161714069|NCT01324830|583998299|FG014|Overall Study|Withdrawal by Subject|0|||
161714070|NCT01324830|583998300|FG015|Overall Study|Withdrawal by Subject|0|||
161714071|NCT01324830|583998301|FG016|Overall Study|Withdrawal by Subject|0|||
161714072|NCT01324830|583998302|FG017|Overall Study|Withdrawal by Subject|0|||
161838009|NCT02032706|584450286|FG000|Overall Study|Did not qualify|5|||
161714073|NCT01324830|583998303|FG018|Overall Study|Withdrawal by Subject|1|||
161714074|NCT01973283|583998304|FG000|Overall Study|Lost to Follow-up|4|||
161714075|NCT00817414|583998305|FG000|Overall Study|Adverse Event|1|||
161714076|NCT00817414|583998306|FG001|Overall Study|Adverse Event|1|||
161714077|NCT00817414|583998307|FG002|Overall Study|Adverse Event|1|||
161714078|NCT00817414|583998308|FG003|Overall Study|Adverse Event|0|||
161714079|NCT00817414|583998309|FG004|Overall Study|Adverse Event|0|||
161714080|NCT00817414|583998305|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
161714081|NCT00817414|583998306|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
161714082|NCT00817414|583998307|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
161714083|NCT00817414|583998308|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
161714084|NCT00817414|583998309|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
161714085|NCT00817414|583998305|FG000|Overall Study|Withdrawal by Subject|1|||
161714086|NCT00817414|583998306|FG001|Overall Study|Withdrawal by Subject|1|||
161714087|NCT00817414|583998307|FG002|Overall Study|Withdrawal by Subject|0|||
161714088|NCT00817414|583998308|FG003|Overall Study|Withdrawal by Subject|0|||
161714089|NCT00817414|583998309|FG004|Overall Study|Withdrawal by Subject|0|||
161714090|NCT00817414|583998305|FG000|Overall Study|Lost to Follow-up|0|||
161714091|NCT00817414|583998306|FG001|Overall Study|Lost to Follow-up|0|||
161714092|NCT00817414|583998307|FG002|Overall Study|Lost to Follow-up|1|||
161714093|NCT00817414|583998308|FG003|Overall Study|Lost to Follow-up|1|||
161714094|NCT00817414|583998309|FG004|Overall Study|Lost to Follow-up|1|||
161714095|NCT00817414|583998305|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714096|NCT00817414|583998306|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714097|NCT00817414|583998307|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714098|NCT00817414|583998308|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
161714099|NCT00817414|583998309|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714100|NCT00817414|583998305|FG000|Overall Study|Protocol Violation|0|||
161714101|NCT00817414|583998306|FG001|Overall Study|Protocol Violation|0|||
161714102|NCT00817414|583998307|FG002|Overall Study|Protocol Violation|0|||
161714103|NCT00817414|583998308|FG003|Overall Study|Protocol Violation|0|||
161714104|NCT00817414|583998309|FG004|Overall Study|Protocol Violation|1|||
161714105|NCT03717922|583998316|FG000|Overall Study|Lost to Follow-up|2|||
161714106|NCT03717922|583998317|FG001|Overall Study|Lost to Follow-up|2|||
161714107|NCT03126227|583998320|FG000|Overall Study|Adverse Event|43|||
161714108|NCT03126227|583998321|FG001|Overall Study|Adverse Event|4|||
161714109|NCT03126227|583998320|FG000|Overall Study|Death|0|||
161714110|NCT03126227|583998321|FG001|Overall Study|Death|1|||
161714111|NCT03126227|583998320|FG000|Overall Study|Lost to Follow-up|0|||
161714112|NCT03126227|583998321|FG001|Overall Study|Lost to Follow-up|1|||
161714113|NCT03126227|583998320|FG000|Overall Study|Physician Decision|2|||
161714114|NCT03126227|583998321|FG001|Overall Study|Physician Decision|0|||
161714115|NCT03126227|583998320|FG000|Overall Study|Protocol Violation|1|||
161714116|NCT03126227|583998321|FG001|Overall Study|Protocol Violation|0|||
161714117|NCT03126227|583998320|FG000|Overall Study|Withdrawal by Subject|19|||
161714118|NCT03126227|583998321|FG001|Overall Study|Withdrawal by Subject|3|||
161714119|NCT03126227|583998320|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
161714120|NCT03126227|583998321|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
161714121|NCT03126227|583998320|FG000|Overall Study|Lack of dosing compliance|2|||
161714122|NCT03126227|583998321|FG001|Overall Study|Lack of dosing compliance|0|||
161714123|NCT03126227|583998320|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
161714124|NCT03126227|583998321|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
161714125|NCT03126227|583998320|FG000|Overall Study|Scheduling conflict|1|||
161714126|NCT03126227|583998321|FG001|Overall Study|Scheduling conflict|0|||
161714127|NCT02586805|583998327|FG000|Overall Study|Withdrawal by Subject|3|||
161714128|NCT02586805|583998328|FG001|Overall Study|Withdrawal by Subject|1|||
161714129|NCT02586805|583998329|FG002|Overall Study|Withdrawal by Subject|1|||
161714130|NCT02586805|583998330|FG003|Overall Study|Withdrawal by Subject|2|||
161714131|NCT02586805|583998327|FG000|Overall Study|Adverse Event|2|||
161714132|NCT02586805|583998328|FG001|Overall Study|Adverse Event|0|||
161714133|NCT02586805|583998329|FG002|Overall Study|Adverse Event|1|||
161714134|NCT02586805|583998330|FG003|Overall Study|Adverse Event|0|||
161714135|NCT02586805|583998327|FG000|Overall Study|Lost to Follow-up|0|||
161714136|NCT02586805|583998328|FG001|Overall Study|Lost to Follow-up|0|||
161714137|NCT02586805|583998329|FG002|Overall Study|Lost to Follow-up|1|||
161714138|NCT02586805|583998330|FG003|Overall Study|Lost to Follow-up|0|||
161714139|NCT02586805|583998327|FG000|Overall Study|Physician Decision|1|||
161714140|NCT02586805|583998328|FG001|Overall Study|Physician Decision|0|||
161714141|NCT02586805|583998329|FG002|Overall Study|Physician Decision|0|||
161714142|NCT02586805|583998330|FG003|Overall Study|Physician Decision|0|||
161714143|NCT01859403|583998331|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
161714144|NCT01859403|583998332|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
161714145|NCT01859403|583998331|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
161714146|NCT01859403|583998332|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
161714147|NCT01859403|583998331|FG000|Primary Endpoint Measure|Physician Decision|0|||
161714148|NCT01859403|583998332|FG001|Primary Endpoint Measure|Physician Decision|1|||
161714149|NCT01859403|583998331|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
161714150|NCT01859403|583998332|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
161714151|NCT01157117|583998333|FG000|Overall Study|Dosing Symptoms|0|||
161714152|NCT01157117|583998334|FG001|Overall Study|Dosing Symptoms|4|||
161714153|NCT01157117|583998335|FG002|Overall Study|Dosing Symptoms|0|||
161714154|NCT01157117|583998333|FG000|Overall Study|Withdrawal by Subject|4|||
161714155|NCT01157117|583998334|FG001|Overall Study|Withdrawal by Subject|1|||
161714156|NCT01157117|583998335|FG002|Overall Study|Withdrawal by Subject|1|||
161714157|NCT01157117|583998333|FG000|Overall Study|Lack of Efficacy|1|||
161714158|NCT01157117|583998334|FG001|Overall Study|Lack of Efficacy|1|||
161714159|NCT01157117|583998335|FG002|Overall Study|Lack of Efficacy|0|||
161714160|NCT01157117|583998333|FG000|Overall Study|Lost to Follow-up|0|||
161714161|NCT01157117|583998334|FG001|Overall Study|Lost to Follow-up|0|||
161714162|NCT01157117|583998335|FG002|Overall Study|Lost to Follow-up|1|||
161714163|NCT01157117|583998333|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
161714164|NCT01157117|583998334|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
161714165|NCT01157117|583998335|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
161714166|NCT01531725|583998337|FG000|Overall Study|Protocol Violation|5|||
161714167|NCT02317510|583998338|FG000|Overall Study|Adverse Event|0|||
161714168|NCT02317510|583998339|FG001|Overall Study|Adverse Event|1|||
161714169|NCT00472303|583998340|FG000|Titration Phase|Adverse Event|22|||
161714170|NCT00472303|583998341|FG001|Titration Phase|Adverse Event|12|||
161714171|NCT00472303|583998342|FG002|Titration Phase|Adverse Event|0|||
161714172|NCT00472303|583998340|FG000|Titration Phase|Death|4|||
161714173|NCT00472303|583998341|FG001|Titration Phase|Death|2|||
161714174|NCT00472303|583998342|FG002|Titration Phase|Death|0|||
161714175|NCT00472303|583998340|FG000|Titration Phase|Lack of Efficacy|10|||
161714176|NCT00472303|583998341|FG001|Titration Phase|Lack of Efficacy|0|||
161714177|NCT00472303|583998342|FG002|Titration Phase|Lack of Efficacy|0|||
161714178|NCT00472303|583998340|FG000|Titration Phase|Withdrawal by Subject|16|||
161714179|NCT00472303|583998341|FG001|Titration Phase|Withdrawal by Subject|13|||
161714180|NCT00472303|583998342|FG002|Titration Phase|Withdrawal by Subject|0|||
161714181|NCT00472303|583998340|FG000|Titration Phase|Trial Medication non-compliant|4|||
161714182|NCT00472303|583998341|FG001|Titration Phase|Trial Medication non-compliant|1|||
161714183|NCT00472303|583998342|FG002|Titration Phase|Trial Medication non-compliant|0|||
161714184|NCT00472303|583998340|FG000|Titration Phase|Other|3|||
161714185|NCT00472303|583998341|FG001|Titration Phase|Other|1|||
161714186|NCT00472303|583998342|FG002|Titration Phase|Other|0|||
161714187|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
161714188|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
161714189|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
161714190|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
161714191|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
161714192|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
161714193|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
161714194|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
161714195|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
161714196|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
161714197|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
161714198|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
161714199|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Other|5|||
161714200|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Other|0|||
161714201|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Other|0|||
161714202|NCT00472303|583998340|FG000|Maintenance Phase|Adverse Event|5|||
161714203|NCT00472303|583998341|FG001|Maintenance Phase|Adverse Event|6|||
161714204|NCT00472303|583998342|FG002|Maintenance Phase|Adverse Event|6|||
161714205|NCT00472303|583998340|FG000|Maintenance Phase|Death|3|||
161714206|NCT00472303|583998341|FG001|Maintenance Phase|Death|0|||
161714207|NCT00472303|583998342|FG002|Maintenance Phase|Death|2|||
161714208|NCT00472303|583998340|FG000|Maintenance Phase|Lack of Efficacy|2|||
161714209|NCT00472303|583998341|FG001|Maintenance Phase|Lack of Efficacy|2|||
161714210|NCT00472303|583998342|FG002|Maintenance Phase|Lack of Efficacy|4|||
161662510|NCT04227704|583815653|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
161662511|NCT04227704|583815654|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
161662512|NCT04227704|583815652|FG000|Overall Study|due to C/S being cancelled|1|||
161662513|NCT04227704|583815653|FG001|Overall Study|due to C/S being cancelled|0|||
161662514|NCT04227704|583815654|FG002|Overall Study|due to C/S being cancelled|0|||
161662515|NCT00729378|583817878|FG000|Baseline|Did not complete study measurements|72|||
161662516|NCT00729378|583817879|FG001|Baseline|Did not complete study measurements|33|||
161662517|NCT00729378|583817878|FG000|Baseline|Withdrawal by Subject|66|||
161662518|NCT00729378|583817879|FG001|Baseline|Withdrawal by Subject|59|||
161662519|NCT00729378|583817878|FG000|12-months|Lost to Follow-up|100|||
161662520|NCT00729378|583817879|FG001|12-months|Lost to Follow-up|65|||
161662521|NCT00729378|583817878|FG000|24-months|Lost to Follow-up|72|||
161662522|NCT00729378|583817879|FG001|24-months|Lost to Follow-up|51|||
161662523|NCT00729378|583817878|FG000|36-months|Lost to Follow-up|15|||
161662524|NCT00729378|583817879|FG001|36-months|Lost to Follow-up|6|||
161662525|NCT00484289|583817887|FG000|Long Term Phase|Adverse Event|1|||
161662526|NCT00484289|583817888|FG001|Long Term Phase|Adverse Event|17|||
161662527|NCT00484289|583817889|FG002|Long Term Phase|Adverse Event|5|||
161662528|NCT00484289|583817887|FG000|Long Term Phase|Withdrawal by Subject|0|||
161662529|NCT00484289|583817888|FG001|Long Term Phase|Withdrawal by Subject|7|||
161662530|NCT00484289|583817889|FG002|Long Term Phase|Withdrawal by Subject|6|||
161662531|NCT00484289|583817887|FG000|Long Term Phase|Inadequate response|2|||
161662532|NCT00484289|583817888|FG001|Long Term Phase|Inadequate response|7|||
161662533|NCT00484289|583817889|FG002|Long Term Phase|Inadequate response|4|||
161662534|NCT00484289|583817887|FG000|Long Term Phase|Other Reason|0|||
161662535|NCT00484289|583817888|FG001|Long Term Phase|Other Reason|5|||
161662536|NCT00484289|583817889|FG002|Long Term Phase|Other Reason|1|||
161662537|NCT00484289|583817887|FG000|Post Marketing Phase|Adverse Event|0|||
161662538|NCT00484289|583817888|FG001|Post Marketing Phase|Adverse Event|1|||
161662539|NCT00484289|583817889|FG002|Post Marketing Phase|Adverse Event|0|||
161662540|NCT00690443|583817890|FG000|Overall Study|Adverse Event|1|||
161662541|NCT00690443|583817891|FG001|Overall Study|Adverse Event|2|||
161662542|NCT02874924|583817894|FG000|Overall Study|Adverse Event|2|||
161662543|NCT02874924|583817895|FG001|Overall Study|Adverse Event|0|||
161662544|NCT02874924|583817896|FG002|Overall Study|Adverse Event|0|||
161662545|NCT02874924|583817894|FG000|Overall Study|Withdrawal by Subject|1|||
161662546|NCT02874924|583817895|FG001|Overall Study|Withdrawal by Subject|0|||
161662547|NCT02874924|583817896|FG002|Overall Study|Withdrawal by Subject|0|||
161662548|NCT02808143|583817897|FG000|Maintenance Phase|Disease recurrence|1|||
161662549|NCT02808143|583817898|FG001|Maintenance Phase|Disease recurrence|3|||
161662550|NCT02808143|583817897|FG000|Maintenance Phase|Disease progression|1|||
161662551|NCT02808143|583817898|FG001|Maintenance Phase|Disease progression|2|||
161662552|NCT02808143|583817897|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
161662553|NCT02808143|583817898|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
161662554|NCT02808143|583817897|FG000|Survival Follow-Up|Disease recurrence|0|||
161662555|NCT02808143|583817898|FG001|Survival Follow-Up|Disease recurrence|2|||
161662556|NCT02808143|583817897|FG000|Survival Follow-Up|Adverse Event|0|||
161662557|NCT02808143|583817898|FG001|Survival Follow-Up|Adverse Event|1|||
161662558|NCT02808143|583817897|FG000|Survival Follow-Up|Death|1|||
161662559|NCT02808143|583817898|FG001|Survival Follow-Up|Death|0|||
161662560|NCT01874431|583817899|FG000|Overall Study|Physician Decision|0|||
161662561|NCT01874431|583817900|FG001|Overall Study|Physician Decision|0|||
161662562|NCT01874431|583817901|FG002|Overall Study|Physician Decision|1|||
161662563|NCT01874431|583817902|FG003|Overall Study|Physician Decision|0|||
161662564|NCT01874431|583817903|FG004|Overall Study|Physician Decision|0|||
161662565|NCT01874431|583817904|FG005|Overall Study|Physician Decision|0|||
161662566|NCT01874431|583817905|FG006|Overall Study|Physician Decision|0|||
161662567|NCT01874431|583817906|FG007|Overall Study|Physician Decision|0|||
161662568|NCT01874431|583817899|FG000|Overall Study|Adverse Event|5|||
161662569|NCT01874431|583817900|FG001|Overall Study|Adverse Event|4|||
161662570|NCT01874431|583817901|FG002|Overall Study|Adverse Event|6|||
161662571|NCT01874431|583817902|FG003|Overall Study|Adverse Event|5|||
161662572|NCT01874431|583817903|FG004|Overall Study|Adverse Event|2|||
161662573|NCT01874431|583817904|FG005|Overall Study|Adverse Event|8|||
161662574|NCT01874431|583817905|FG006|Overall Study|Adverse Event|2|||
161662575|NCT01874431|583817906|FG007|Overall Study|Adverse Event|3|||
161662576|NCT01874431|583817899|FG000|Overall Study|Protocol Violation|1|||
161662577|NCT01874431|583817900|FG001|Overall Study|Protocol Violation|1|||
161662578|NCT01874431|583817901|FG002|Overall Study|Protocol Violation|1|||
161662579|NCT01874431|583817902|FG003|Overall Study|Protocol Violation|0|||
161662580|NCT01874431|583817903|FG004|Overall Study|Protocol Violation|3|||
161662581|NCT01874431|583817904|FG005|Overall Study|Protocol Violation|2|||
161662582|NCT01874431|583817905|FG006|Overall Study|Protocol Violation|1|||
161662583|NCT01874431|583817906|FG007|Overall Study|Protocol Violation|1|||
161662584|NCT01874431|583817899|FG000|Overall Study|Non-compliance|0|||
161662585|NCT01874431|583817900|FG001|Overall Study|Non-compliance|0|||
161662586|NCT01874431|583817901|FG002|Overall Study|Non-compliance|0|||
161662587|NCT01874431|583817902|FG003|Overall Study|Non-compliance|0|||
161662588|NCT01874431|583817903|FG004|Overall Study|Non-compliance|1|||
161662589|NCT01874431|583817904|FG005|Overall Study|Non-compliance|0|||
161662590|NCT01874431|583817905|FG006|Overall Study|Non-compliance|1|||
161662591|NCT01874431|583817906|FG007|Overall Study|Non-compliance|0|||
161662592|NCT01874431|583817899|FG000|Overall Study|Logistical difficulties|0|||
161662593|NCT01874431|583817900|FG001|Overall Study|Logistical difficulties|0|||
161662594|NCT01874431|583817901|FG002|Overall Study|Logistical difficulties|0|||
161662595|NCT01874431|583817902|FG003|Overall Study|Logistical difficulties|0|||
161662596|NCT01874431|583817903|FG004|Overall Study|Logistical difficulties|0|||
161662597|NCT01874431|583817904|FG005|Overall Study|Logistical difficulties|0|||
161662598|NCT01874431|583817905|FG006|Overall Study|Logistical difficulties|1|||
161662599|NCT01874431|583817906|FG007|Overall Study|Logistical difficulties|0|||
161662600|NCT01874431|583817899|FG000|Overall Study|Withdrawal by Subject|0|||
161662601|NCT01874431|583817900|FG001|Overall Study|Withdrawal by Subject|0|||
161662602|NCT01874431|583817901|FG002|Overall Study|Withdrawal by Subject|1|||
161662603|NCT01874431|583817902|FG003|Overall Study|Withdrawal by Subject|2|||
161662604|NCT01874431|583817903|FG004|Overall Study|Withdrawal by Subject|1|||
161662605|NCT01874431|583817904|FG005|Overall Study|Withdrawal by Subject|1|||
161662606|NCT01874431|583817905|FG006|Overall Study|Withdrawal by Subject|3|||
161662607|NCT01874431|583817906|FG007|Overall Study|Withdrawal by Subject|0|||
161662608|NCT01874431|583817899|FG000|Overall Study|Sponsor decision|0|||
161662609|NCT01874431|583817900|FG001|Overall Study|Sponsor decision|0|||
161662610|NCT01874431|583817901|FG002|Overall Study|Sponsor decision|0|||
161662611|NCT01874431|583817902|FG003|Overall Study|Sponsor decision|0|||
161662612|NCT01874431|583817903|FG004|Overall Study|Sponsor decision|1|||
161662613|NCT01874431|583817904|FG005|Overall Study|Sponsor decision|0|||
161662614|NCT01874431|583817905|FG006|Overall Study|Sponsor decision|0|||
161662615|NCT01874431|583817906|FG007|Overall Study|Sponsor decision|0|||
161662616|NCT01874431|583817899|FG000|Overall Study|Lost to Follow-up|0|||
161662617|NCT01874431|583817900|FG001|Overall Study|Lost to Follow-up|0|||
161662618|NCT01874431|583817901|FG002|Overall Study|Lost to Follow-up|1|||
161662619|NCT01874431|583817902|FG003|Overall Study|Lost to Follow-up|0|||
161662620|NCT01874431|583817903|FG004|Overall Study|Lost to Follow-up|0|||
161662621|NCT01874431|583817904|FG005|Overall Study|Lost to Follow-up|0|||
161662622|NCT01874431|583817905|FG006|Overall Study|Lost to Follow-up|0|||
161662623|NCT01874431|583817906|FG007|Overall Study|Lost to Follow-up|0|||
161662624|NCT03718533|583817908|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
161662625|NCT03718533|583817908|FG000|Overall Study|Protocol deviation|1|||
161662626|NCT03718533|583817908|FG000|Overall Study|Disease progression|1|||
161662627|NCT03718533|583817908|FG000|Overall Study|Relapse|1|||
161662628|NCT03718533|583817908|FG000|Overall Study|Physician Decision|2|||
161662629|NCT03718533|583817908|FG000|Overall Study|Physician Decision and Adverse Event|1|||
161662630|NCT02257567|583817909|FG000|Overall Study|Adverse Event|0|||
161662631|NCT02257567|583817910|FG001|Overall Study|Adverse Event|0|||
161662632|NCT02257567|583817911|FG002|Overall Study|Adverse Event|0|||
161662633|NCT02257567|583817912|FG003|Overall Study|Adverse Event|1|||
161662634|NCT02257567|583817913|FG004|Overall Study|Adverse Event|1|||
161662635|NCT02257567|583817914|FG005|Overall Study|Adverse Event|0|||
161662636|NCT02257567|583817915|FG006|Overall Study|Adverse Event|0|||
161662637|NCT02257567|583817916|FG007|Overall Study|Adverse Event|0|||
161662638|NCT02257567|583817917|FG008|Overall Study|Adverse Event|1|||
161662639|NCT02257567|583817918|FG009|Overall Study|Adverse Event|0|||
161662640|NCT02257567|583817919|FG010|Overall Study|Adverse Event|0|||
161662641|NCT02257567|583817909|FG000|Overall Study|Death|2|||
161662642|NCT02257567|583817910|FG001|Overall Study|Death|2|||
161662643|NCT02257567|583817911|FG002|Overall Study|Death|2|||
161662644|NCT02257567|583817912|FG003|Overall Study|Death|4|||
161662645|NCT02257567|583817913|FG004|Overall Study|Death|15|||
161662646|NCT02257567|583817914|FG005|Overall Study|Death|11|||
161662647|NCT02257567|583817915|FG006|Overall Study|Death|26|||
161662648|NCT02257567|583817916|FG007|Overall Study|Death|30|||
161662649|NCT02257567|583817917|FG008|Overall Study|Death|2|||
161662650|NCT02257567|583817918|FG009|Overall Study|Death|18|||
161662651|NCT02257567|583817919|FG010|Overall Study|Death|65|||
161662652|NCT02257567|583817909|FG000|Overall Study|Lost to Follow-up|0|||
161662653|NCT02257567|583817910|FG001|Overall Study|Lost to Follow-up|0|||
161714211|NCT00472303|583998340|FG000|Maintenance Phase|Withdrawal by Subject|6|||
161662654|NCT02257567|583817911|FG002|Overall Study|Lost to Follow-up|0|||
161662655|NCT02257567|583817912|FG003|Overall Study|Lost to Follow-up|0|||
161662656|NCT02257567|583817913|FG004|Overall Study|Lost to Follow-up|2|||
161662657|NCT02257567|583817914|FG005|Overall Study|Lost to Follow-up|2|||
161662658|NCT02257567|583817915|FG006|Overall Study|Lost to Follow-up|0|||
161662659|NCT02257567|583817916|FG007|Overall Study|Lost to Follow-up|0|||
161662660|NCT02257567|583817917|FG008|Overall Study|Lost to Follow-up|0|||
161662661|NCT02257567|583817918|FG009|Overall Study|Lost to Follow-up|1|||
161662662|NCT02257567|583817919|FG010|Overall Study|Lost to Follow-up|1|||
161662663|NCT02257567|583817909|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662664|NCT02257567|583817910|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662665|NCT02257567|583817911|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662666|NCT02257567|583817912|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662667|NCT02257567|583817913|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
161662668|NCT02257567|583817914|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662669|NCT02257567|583817915|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
161662670|NCT02257567|583817916|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662671|NCT02257567|583817917|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662672|NCT02257567|583817918|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662673|NCT02257567|583817919|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161662674|NCT02257567|583817909|FG000|Overall Study|Physician Decision|0|||
161662675|NCT02257567|583817910|FG001|Overall Study|Physician Decision|0|||
161662676|NCT02257567|583817911|FG002|Overall Study|Physician Decision|0|||
161662677|NCT02257567|583817912|FG003|Overall Study|Physician Decision|0|||
161662678|NCT02257567|583817913|FG004|Overall Study|Physician Decision|0|||
161662679|NCT02257567|583817914|FG005|Overall Study|Physician Decision|0|||
161662680|NCT02257567|583817915|FG006|Overall Study|Physician Decision|0|||
161662681|NCT02257567|583817916|FG007|Overall Study|Physician Decision|2|||
161662682|NCT02257567|583817917|FG008|Overall Study|Physician Decision|0|||
161662683|NCT02257567|583817918|FG009|Overall Study|Physician Decision|1|||
161662684|NCT02257567|583817919|FG010|Overall Study|Physician Decision|0|||
161662685|NCT02257567|583817909|FG000|Overall Study|Withdrawal by Subject|0|||
161662686|NCT02257567|583817910|FG001|Overall Study|Withdrawal by Subject|0|||
161662687|NCT02257567|583817911|FG002|Overall Study|Withdrawal by Subject|2|||
161662688|NCT02257567|583817912|FG003|Overall Study|Withdrawal by Subject|0|||
161662689|NCT02257567|583817913|FG004|Overall Study|Withdrawal by Subject|0|||
161662690|NCT02257567|583817914|FG005|Overall Study|Withdrawal by Subject|6|||
161662691|NCT02257567|583817915|FG006|Overall Study|Withdrawal by Subject|6|||
161662692|NCT02257567|583817916|FG007|Overall Study|Withdrawal by Subject|6|||
161662693|NCT02257567|583817917|FG008|Overall Study|Withdrawal by Subject|1|||
161662694|NCT02257567|583817918|FG009|Overall Study|Withdrawal by Subject|1|||
161662695|NCT02257567|583817919|FG010|Overall Study|Withdrawal by Subject|10|||
161662696|NCT00946101|583817920|FG000|Overall Study|Lost to Follow-up|2|||
161662697|NCT00946101|583817921|FG001|Overall Study|Lost to Follow-up|1|||
161662698|NCT00946101|583817920|FG000|Overall Study|Withdrawal of consent|2|||
161662699|NCT00946101|583817921|FG001|Overall Study|Withdrawal of consent|0|||
161662700|NCT00946101|583817920|FG000|Overall Study|Physician Decision|0|||
161662701|NCT00946101|583817921|FG001|Overall Study|Physician Decision|1|||
161662702|NCT01590017|583817922|FG000|Overall Study|Adverse Event|1|||
161662703|NCT01590017|583817922|FG000|Overall Study|Withdrawal by Subject|1|||
161662704|NCT01590017|583817922|FG000|Overall Study|Lack of Efficacy|1|||
161662705|NCT01590017|583817922|FG000|Overall Study|Physician Decision|1|||
161662706|NCT03625895|583817923|FG000|Overall Study|Protocol Violation|585|||
161662707|NCT03256851|583817924|FG000|Overall Study|Withdrawal by Subject|1|||
161662708|NCT03256851|583817925|FG001|Overall Study|Withdrawal by Subject|0|||
161662709|NCT02081417|583817928|FG000|Overall Study|Lost to Follow-up|26|||
161662710|NCT02081417|583817929|FG001|Overall Study|Lost to Follow-up|23|||
161662711|NCT02081417|583817928|FG000|Overall Study|Moved Away|1|||
161662712|NCT02081417|583817929|FG001|Overall Study|Moved Away|2|||
161662713|NCT02081417|583817928|FG000|Overall Study|Incarcerated|2|||
161662714|NCT02081417|583817929|FG001|Overall Study|Incarcerated|2|||
161662715|NCT02081417|583817928|FG000|Overall Study|Death|4|||
161662716|NCT02081417|583817929|FG001|Overall Study|Death|3|||
161662717|NCT02081417|583817928|FG000|Overall Study|Withdrawal by Subject|4|||
161662718|NCT02081417|583817929|FG001|Overall Study|Withdrawal by Subject|0|||
161662719|NCT02081417|583817928|FG000|Overall Study|Admitted to Residential Treatment|2|||
161714212|NCT00472303|583998341|FG001|Maintenance Phase|Withdrawal by Subject|7|||
161714213|NCT00472303|583998342|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161714214|NCT00472303|583998340|FG000|Maintenance Phase|Trial medication non-compliant|0|||
161714215|NCT00472303|583998341|FG001|Maintenance Phase|Trial medication non-compliant|0|||
161714216|NCT00472303|583998342|FG002|Maintenance Phase|Trial medication non-compliant|1|||
161714217|NCT00472303|583998340|FG000|Maintenance Phase|Resolution of pain|0|||
161714218|NCT00472303|583998341|FG001|Maintenance Phase|Resolution of pain|0|||
161714219|NCT00472303|583998342|FG002|Maintenance Phase|Resolution of pain|1|||
161714220|NCT00472303|583998340|FG000|Maintenance Phase|Other|1|||
161714221|NCT00472303|583998341|FG001|Maintenance Phase|Other|1|||
161714222|NCT00472303|583998342|FG002|Maintenance Phase|Other|0|||
161714223|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
161714224|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
161714225|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
161714226|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161714227|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
161714228|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
161714229|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
161714230|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161714231|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
161662720|NCT02081417|583817929|FG001|Overall Study|Admitted to Residential Treatment|0|||
161662721|NCT02081417|583817928|FG000|Overall Study|Did not start treatment|17|||
161662722|NCT02081417|583817929|FG001|Overall Study|Did not start treatment|21|||
161662723|NCT01065844|583817930|FG000|Overall Study|Adverse Event|5|||
161662724|NCT00752557|583817935|FG000|Overall Study|Withdrawal by Subject|4|||
161662725|NCT00752557|583817936|FG001|Overall Study|Withdrawal by Subject|3|||
161662726|NCT00752557|583817937|FG002|Overall Study|Withdrawal by Subject|3|||
161662727|NCT00752557|583817935|FG000|Overall Study|Unspecified resaons|0|||
161662728|NCT00752557|583817936|FG001|Overall Study|Unspecified resaons|2|||
161662729|NCT00752557|583817937|FG002|Overall Study|Unspecified resaons|2|||
161662730|NCT00752557|583817935|FG000|Overall Study|Lost to Follow-up|1|||
161662731|NCT00752557|583817936|FG001|Overall Study|Lost to Follow-up|0|||
161662732|NCT00752557|583817937|FG002|Overall Study|Lost to Follow-up|1|||
161662733|NCT02150343|583817938|FG000|Overall Study|Adverse Event|2|||
161662734|NCT02150343|583817939|FG001|Overall Study|Adverse Event|0|||
161662735|NCT02150343|583817940|FG002|Overall Study|Adverse Event|1|||
161662736|NCT02150343|583817941|FG003|Overall Study|Adverse Event|1|||
161662737|NCT02150343|583817938|FG000|Overall Study|Withdrawal by Subject|13|||
161662738|NCT02150343|583817939|FG001|Overall Study|Withdrawal by Subject|10|||
161662739|NCT02150343|583817940|FG002|Overall Study|Withdrawal by Subject|9|||
161662740|NCT02150343|583817941|FG003|Overall Study|Withdrawal by Subject|4|||
161662741|NCT02150343|583817938|FG000|Overall Study|Lost to Follow-up|4|||
161662742|NCT02150343|583817939|FG001|Overall Study|Lost to Follow-up|4|||
161662743|NCT02150343|583817940|FG002|Overall Study|Lost to Follow-up|2|||
161662744|NCT02150343|583817941|FG003|Overall Study|Lost to Follow-up|3|||
161662745|NCT02150343|583817938|FG000|Overall Study|Other|2|||
161662746|NCT02150343|583817939|FG001|Overall Study|Other|6|||
161662747|NCT02150343|583817940|FG002|Overall Study|Other|0|||
161662748|NCT02150343|583817941|FG003|Overall Study|Other|2|||
161662749|NCT02891408|583817942|FG000|Overall Study|Lost to Follow-up|0|||
161662750|NCT02891408|583817943|FG001|Overall Study|Lost to Follow-up|0|||
161662751|NCT02891408|583817944|FG002|Overall Study|Lost to Follow-up|1|||
161662752|NCT02891408|583817945|FG003|Overall Study|Lost to Follow-up|0|||
161662753|NCT02891408|583817946|FG004|Overall Study|Lost to Follow-up|0|||
161662754|NCT02891408|583817947|FG005|Overall Study|Lost to Follow-up|0|||
161662755|NCT02891408|583817948|FG006|Overall Study|Lost to Follow-up|0|||
161662756|NCT05249829|583817949|FG000|Overall Study|Participant Relocation|0|||
161662757|NCT05249829|583817950|FG001|Overall Study|Participant Relocation|1|||
161662758|NCT05249829|583817951|FG002|Overall Study|Participant Relocation|2|||
161662759|NCT05249829|583817952|FG003|Overall Study|Participant Relocation|2|||
161662760|NCT05249829|583817949|FG000|Overall Study|Withdrawal by Subject|9|||
161662761|NCT05249829|583817950|FG001|Overall Study|Withdrawal by Subject|17|||
161662762|NCT05249829|583817951|FG002|Overall Study|Withdrawal by Subject|40|||
161662763|NCT05249829|583817952|FG003|Overall Study|Withdrawal by Subject|35|||
161662764|NCT05249829|583817949|FG000|Overall Study|Physician Decision|1|||
161662765|NCT05249829|583817950|FG001|Overall Study|Physician Decision|0|||
161662766|NCT05249829|583817951|FG002|Overall Study|Physician Decision|0|||
161662767|NCT05249829|583817952|FG003|Overall Study|Physician Decision|0|||
161662768|NCT05249829|583817949|FG000|Overall Study|Lost to Follow-up|16|||
161662769|NCT05249829|583817950|FG001|Overall Study|Lost to Follow-up|16|||
161662770|NCT05249829|583817951|FG002|Overall Study|Lost to Follow-up|57|||
161662771|NCT05249829|583817952|FG003|Overall Study|Lost to Follow-up|60|||
161662772|NCT05249829|583817949|FG000|Overall Study|Adverse Event|2|||
161662773|NCT05249829|583817950|FG001|Overall Study|Adverse Event|2|||
161662774|NCT05249829|583817951|FG002|Overall Study|Adverse Event|2|||
161662775|NCT05249829|583817952|FG003|Overall Study|Adverse Event|2|||
161662776|NCT05249829|583817949|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
161662777|NCT05249829|583817950|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
161662778|NCT05249829|583817951|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
161662779|NCT05249829|583817952|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
161662780|NCT05249829|583817949|FG000|Overall Study|Protocol Violation|2|||
161662781|NCT05249829|583817950|FG001|Overall Study|Protocol Violation|0|||
161662782|NCT05249829|583817951|FG002|Overall Study|Protocol Violation|5|||
161662783|NCT05249829|583817952|FG003|Overall Study|Protocol Violation|3|||
161662784|NCT05249829|583817949|FG000|Overall Study|Death|0|||
161662785|NCT05249829|583817950|FG001|Overall Study|Death|1|||
161662786|NCT05249829|583817951|FG002|Overall Study|Death|2|||
161662787|NCT05249829|583817952|FG003|Overall Study|Death|4|||
161662788|NCT00196976|583817953|FG000|Primary Study|Migrated from study area|0|||
161662789|NCT00196976|583817954|FG001|Primary Study|Migrated from study area|0|||
161662790|NCT00196976|583817955|FG002|Primary Study|Migrated from study area|0|||
161662791|NCT00196976|583817956|FG003|Primary Study|Migrated from study area|0|||
161662792|NCT00196976|583817957|FG004|Primary Study|Migrated from study area|0|||
161662793|NCT00196976|583817958|FG005|Primary Study|Migrated from study area|0|||
161714232|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
161714233|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
161714234|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
161714235|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
161714236|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
161714237|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
161714238|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
161714239|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
161714240|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
161714241|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
161714242|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
161714243|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
161714244|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
161714245|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
161714246|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
161714247|NCT01672892|583999618|FG000|Overall Study|Protocol Violation|7|||
161714248|NCT01672892|583999619|FG001|Overall Study|Protocol Violation|3|||
161714249|NCT00573131|583999636|FG000|Overall Study|Withdrawal by Subject|10|||
161714250|NCT00573131|583999637|FG001|Overall Study|Withdrawal by Subject|8|||
161714251|NCT02401256|583999643|FG000|Overall Study|Adverse Event|5|||
161714252|NCT02401256|583999643|FG000|Overall Study|Withdrawal by Subject|12|||
161714253|NCT00893789|583999645|FG000|Overall Study|Withdrawal by Subject|3|||
161714254|NCT00893789|583999646|FG001|Overall Study|Withdrawal by Subject|1|||
161714255|NCT00893789|583999647|FG002|Overall Study|Withdrawal by Subject|3|||
161714256|NCT00893789|583999648|FG003|Overall Study|Withdrawal by Subject|1|||
161714257|NCT00893789|583999645|FG000|Overall Study|Noncompliance With Study Drug|1|||
161714258|NCT00893789|583999646|FG001|Overall Study|Noncompliance With Study Drug|0|||
161714259|NCT00893789|583999647|FG002|Overall Study|Noncompliance With Study Drug|1|||
161714260|NCT00893789|583999648|FG003|Overall Study|Noncompliance With Study Drug|2|||
161714261|NCT00893789|583999645|FG000|Overall Study|Noncompliance With Study Procedures|1|||
161714262|NCT00893789|583999646|FG001|Overall Study|Noncompliance With Study Procedures|0|||
161714263|NCT00893789|583999647|FG002|Overall Study|Noncompliance With Study Procedures|0|||
161714264|NCT00893789|583999648|FG003|Overall Study|Noncompliance With Study Procedures|0|||
161714265|NCT00893789|583999645|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
161714266|NCT00893789|583999646|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
161714267|NCT00893789|583999647|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
161714268|NCT00893789|583999648|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
161714269|NCT00893789|583999645|FG000|Overall Study|Adverse Event|0|||
161714270|NCT00893789|583999646|FG001|Overall Study|Adverse Event|2|||
161714271|NCT00893789|583999647|FG002|Overall Study|Adverse Event|1|||
161714272|NCT00893789|583999648|FG003|Overall Study|Adverse Event|5|||
161714273|NCT00893789|583999645|FG000|Overall Study|Protocol Violation|0|||
161714274|NCT00893789|583999646|FG001|Overall Study|Protocol Violation|1|||
161714275|NCT00893789|583999647|FG002|Overall Study|Protocol Violation|1|||
161714276|NCT00893789|583999648|FG003|Overall Study|Protocol Violation|4|||
161714277|NCT00893789|583999645|FG000|Overall Study|Lost to Follow-up|0|||
161714278|NCT00893789|583999646|FG001|Overall Study|Lost to Follow-up|0|||
161714279|NCT00893789|583999647|FG002|Overall Study|Lost to Follow-up|0|||
161714280|NCT00893789|583999648|FG003|Overall Study|Lost to Follow-up|1|||
161714281|NCT02024464|583999649|FG000|Overall Study|Discontinued|5|||
161714282|NCT02024464|583999650|FG001|Overall Study|Discontinued|4|||
161714283|NCT02024464|583999649|FG000|Overall Study|Missed Visits|1|||
161714284|NCT02024464|583999650|FG001|Overall Study|Missed Visits|0|||
161714285|NCT02024464|583999649|FG000|Overall Study|Lost to Follow-up|4|||
161714286|NCT02024464|583999650|FG001|Overall Study|Lost to Follow-up|7|||
161714287|NCT01575548|583999653|FG000|Overall Study|Adverse Event|15|||
161714288|NCT01575548|583999654|FG001|Overall Study|Adverse Event|2|||
161714289|NCT01575548|583999653|FG000|Overall Study|Disease progression|12|||
161714290|NCT01575548|583999654|FG001|Overall Study|Disease progression|25|||
161714291|NCT01575548|583999653|FG000|Overall Study|Death|1|||
161714292|NCT01575548|583999654|FG001|Overall Study|Death|0|||
161714293|NCT01575548|583999653|FG000|Overall Study|Other complicating disease|1|||
161714294|NCT01575548|583999654|FG001|Overall Study|Other complicating disease|0|||
161714295|NCT01575548|583999653|FG000|Overall Study|Withdrawal by Subject|7|||
161714296|NCT01575548|583999654|FG001|Overall Study|Withdrawal by Subject|3|||
161714297|NCT01575548|583999653|FG000|Overall Study|Noncompliance|1|||
161714298|NCT01575548|583999654|FG001|Overall Study|Noncompliance|0|||
161714299|NCT01575548|583999653|FG000|Overall Study|Anticipated surgery|0|||
161714300|NCT01575548|583999654|FG001|Overall Study|Anticipated surgery|1|||
161714301|NCT01575548|583999653|FG000|Overall Study|Never started protocol therapy|3|||
161714302|NCT01575548|583999654|FG001|Overall Study|Never started protocol therapy|2|||
161714303|NCT03872180|583999657|FG000|Overall Study|Adverse Event|4|||
161714304|NCT03872180|583999657|FG000|Overall Study|Lack of Efficacy|2|||
161714305|NCT01244737|583999659|FG000|Overall Study|Physician Decision|2|||
161714306|NCT01244737|583999660|FG001|Overall Study|Physician Decision|18|||
161714307|NCT01244737|583999661|FG002|Overall Study|Physician Decision|5|||
161714308|NCT01244737|583999659|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
161714309|NCT01244737|583999660|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
161714310|NCT01244737|583999661|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
161714311|NCT01244737|583999659|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
161714312|NCT01244737|583999660|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
161714313|NCT01244737|583999661|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
161714314|NCT01244737|583999659|FG000|Overall Study|MIB immunopathology results not available|3|||
161714315|NCT01244737|583999660|FG001|Overall Study|MIB immunopathology results not available|2|||
161714316|NCT01244737|583999661|FG002|Overall Study|MIB immunopathology results not available|0|||
161714317|NCT01244737|583999659|FG000|Overall Study|PET data failure|0|||
161714318|NCT01244737|583999660|FG001|Overall Study|PET data failure|1|||
161714319|NCT01244737|583999661|FG002|Overall Study|PET data failure|0|||
161714320|NCT01244737|583999659|FG000|Overall Study|Withdrawal by Subject|0|||
161714321|NCT01244737|583999660|FG001|Overall Study|Withdrawal by Subject|0|||
161714322|NCT01244737|583999661|FG002|Overall Study|Withdrawal by Subject|1|||
161714323|NCT00356915|583999668|FG000|Overall Study|Non compliance|1|||
161714324|NCT00356915|583999669|FG001|Overall Study|Non compliance|2|||
161714325|NCT00356915|583999670|FG002|Overall Study|Non compliance|1|||
161714326|NCT00356915|583999668|FG000|Overall Study|Protocol Violation|2|||
161714327|NCT00356915|583999669|FG001|Overall Study|Protocol Violation|3|||
161714328|NCT00356915|583999670|FG002|Overall Study|Protocol Violation|2|||
161714329|NCT00356915|583999668|FG000|Overall Study|Withdrawal by Subject|14|||
161714330|NCT00356915|583999669|FG001|Overall Study|Withdrawal by Subject|14|||
161714331|NCT00356915|583999670|FG002|Overall Study|Withdrawal by Subject|10|||
161714332|NCT00356915|583999668|FG000|Overall Study|Lack of Efficacy|0|||
161714333|NCT00356915|583999669|FG001|Overall Study|Lack of Efficacy|0|||
161714334|NCT00356915|583999670|FG002|Overall Study|Lack of Efficacy|3|||
161714335|NCT00356915|583999668|FG000|Overall Study|Lost to Follow-up|27|||
161714336|NCT00356915|583999669|FG001|Overall Study|Lost to Follow-up|34|||
161714337|NCT00356915|583999670|FG002|Overall Study|Lost to Follow-up|14|||
161714338|NCT00356915|583999668|FG000|Overall Study|Administrative Decision|0|||
161714339|NCT00356915|583999669|FG001|Overall Study|Administrative Decision|0|||
161714340|NCT00356915|583999670|FG002|Overall Study|Administrative Decision|1|||
161714341|NCT00356915|583999668|FG000|Overall Study|Physician Decision|0|||
161714342|NCT00356915|583999669|FG001|Overall Study|Physician Decision|2|||
161714343|NCT00356915|583999670|FG002|Overall Study|Physician Decision|0|||
161714344|NCT00356915|583999668|FG000|Overall Study|Adverse Event|21|||
161714345|NCT00356915|583999669|FG001|Overall Study|Adverse Event|31|||
161714346|NCT00356915|583999670|FG002|Overall Study|Adverse Event|8|||
161714347|NCT00356915|583999668|FG000|Overall Study|Miscellaneous reasons|11|||
161714348|NCT00356915|583999669|FG001|Overall Study|Miscellaneous reasons|8|||
161714349|NCT00356915|583999670|FG002|Overall Study|Miscellaneous reasons|3|||
161714350|NCT02371629|583999679|FG000|Overall Study|Patient decision|14|||
161714351|NCT02371629|583999680|FG001|Overall Study|Patient decision|10|||
161714352|NCT02371629|583999679|FG000|Overall Study|Adverse Event|8|||
161714353|NCT02371629|583999680|FG001|Overall Study|Adverse Event|8|||
161714354|NCT02371629|583999679|FG000|Overall Study|Physician Decision|2|||
161714355|NCT02371629|583999680|FG001|Overall Study|Physician Decision|3|||
161714356|NCT02371629|583999679|FG000|Overall Study|Death|1|||
161714357|NCT02371629|583999680|FG001|Overall Study|Death|1|||
161714358|NCT02371629|583999679|FG000|Overall Study|Noncompliance with study treatment|1|||
161714359|NCT02371629|583999680|FG001|Overall Study|Noncompliance with study treatment|0|||
161714360|NCT02371629|583999679|FG000|Overall Study|Lack of Efficacy|0|||
161714361|NCT02371629|583999680|FG001|Overall Study|Lack of Efficacy|2|||
161714362|NCT02371629|583999679|FG000|Overall Study|Protocol deviation|0|||
161714363|NCT02371629|583999680|FG001|Overall Study|Protocol deviation|1|||
161714364|NCT01193335|583999682|FG000|After Infant Series|Lost to Follow-up|1|||
161714365|NCT01193335|583999683|FG001|After Infant Series|Lost to Follow-up|2|||
161714366|NCT01193335|583999682|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
161714367|NCT01193335|583999683|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
161714368|NCT01193335|583999682|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
161714369|NCT01193335|583999683|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
161714370|NCT01193335|583999682|FG000|1-Year Follow-up|Lost to Follow-up|4|||
161714371|NCT01193335|583999683|FG001|1-Year Follow-up|Lost to Follow-up|0|||
161714372|NCT01193335|583999682|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
161714373|NCT01193335|583999683|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
161714374|NCT01193335|583999682|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
161714375|NCT01193335|583999683|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
161714376|NCT03486314|583999685|FG000|Part A|Adverse Event|1|||
161714377|NCT03486314|583999686|FG001|Part A|Adverse Event|0|||
161714378|NCT03486314|583999687|FG002|Part A|Adverse Event|0|||
161714379|NCT03486314|583999685|FG000|Part A|Symptomatic Deterioration|2|||
161714380|NCT03486314|583999686|FG001|Part A|Symptomatic Deterioration|0|||
161714381|NCT03486314|583999687|FG002|Part A|Symptomatic Deterioration|0|||
161714382|NCT01985321|583999688|FG000|Overall Study|Protocol Violation|4|||
161714383|NCT01985321|583999689|FG001|Overall Study|Protocol Violation|3|||
161714384|NCT01985321|583999688|FG000|Overall Study|Withdrawal by Subject|1|||
161714385|NCT01985321|583999689|FG001|Overall Study|Withdrawal by Subject|0|||
161714386|NCT01985321|583999688|FG000|Overall Study|Lost to Follow-up|5|||
161714387|NCT01985321|583999689|FG001|Overall Study|Lost to Follow-up|2|||
161714388|NCT01985321|583999688|FG000|Overall Study|Subject treated wrong type of sore|1|||
161714389|NCT01985321|583999689|FG001|Overall Study|Subject treated wrong type of sore|0|||
161714390|NCT01364467|583999690|FG000|Overall Study|Lost to Follow-up|1|||
161714391|NCT01364467|583999691|FG001|Overall Study|Lost to Follow-up|2|||
161714392|NCT02502864|583999694|FG000|Overall Study|Withdrawal by Subject|1|||
161714393|NCT00184054|583999698|FG000|Overall Study|Adverse Event|1|||
161714394|NCT02296840|583999699|FG000|Overall Study|Adverse Event|1|||
161714395|NCT02296840|583999700|FG001|Overall Study|Adverse Event|1|||
161714396|NCT02296840|583999699|FG000|Overall Study|Protocol Violation|2|||
161714397|NCT02296840|583999700|FG001|Overall Study|Protocol Violation|1|||
161714398|NCT02296840|583999699|FG000|Overall Study|Lost to Follow-up|6|||
161714399|NCT02296840|583999700|FG001|Overall Study|Lost to Follow-up|17|||
161714400|NCT02485717|583999701|FG000|Overall Study|Lost to Follow-up|6|||
161714401|NCT02485717|583999702|FG001|Overall Study|Lost to Follow-up|0|||
161714402|NCT02485717|583999703|FG002|Overall Study|Lost to Follow-up|0|||
161714403|NCT02485717|583999701|FG000|Overall Study|Withdrawal by Subject|0|||
161714404|NCT02485717|583999702|FG001|Overall Study|Withdrawal by Subject|0|||
161714405|NCT02485717|583999703|FG002|Overall Study|Withdrawal by Subject|1|||
161714406|NCT02485717|583999701|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
161714407|NCT02485717|583999702|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
161714408|NCT02485717|583999703|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
161714409|NCT02485717|583999701|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
161714410|NCT02485717|583999702|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
161714411|NCT02485717|583999703|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
161714412|NCT02827877|583999704|FG000|Overall Study|Withdrawal by Subject|1|||
161714413|NCT00519532|583999707|FG000|Overall Study|Adverse Event|11|||
161714414|NCT00519532|583999707|FG000|Overall Study|Withdrawal by Subject|5|||
161714415|NCT00519532|583999707|FG000|Overall Study|Lost to Follow-up|2|||
161714416|NCT00814710|583999708|FG000|Overall Study|Adverse Event|1|||
161714417|NCT00814710|583999709|FG001|Overall Study|Adverse Event|0|||
161714418|NCT00814710|583999708|FG000|Overall Study|Lost to Follow-up|7|||
161714419|NCT00814710|583999709|FG001|Overall Study|Lost to Follow-up|3|||
161714420|NCT01450540|583999710|FG000|Overall Study|Withdrawal by Subject|19|||
161714421|NCT01450540|583999711|FG001|Overall Study|Withdrawal by Subject|13|||
161714422|NCT01450540|583999710|FG000|Overall Study|protocol deviation|3|||
161714423|NCT01450540|583999711|FG001|Overall Study|protocol deviation|23|||
161714424|NCT00140855|583999712|FG000|Overall Study|Progressive disease|2|||
161714425|NCT03542682|583999713|FG000|Overall Study|COVID-19 Protocol|0|||
161714426|NCT03542682|583999714|FG001|Overall Study|COVID-19 Protocol|1|||
161714427|NCT01682044|583999724|FG000|Overall Study|Death|1|||
161714428|NCT01682044|583999724|FG000|Overall Study|Progression|3|||
161714429|NCT04090164|583999725|FG000|Overall Study|incomplete data on file|245|||
161714430|NCT04090164|583999726|FG001|Overall Study|incomplete data on file|0|||
161714431|NCT00840463|583999731|FG000|Overall Study|Adverse Event|1|||
161714432|NCT00840463|583999732|FG001|Overall Study|Adverse Event|0|||
161714433|NCT01887210|583999736|FG000|Overall Study|Withdrawal by Subject|1|||
161714434|NCT01887210|583999737|FG001|Overall Study|Withdrawal by Subject|3|||
161714435|NCT01887210|583999736|FG000|Overall Study|Lost to Follow-up|0|||
161714436|NCT01887210|583999737|FG001|Overall Study|Lost to Follow-up|1|||
161714437|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Other|0|||
161714438|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Other|0|||
161714439|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Other|1|||
161714440|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Other|4|||
161714441|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
161714442|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
161714443|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
161714444|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
161714445|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
161714446|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
161714447|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
161714448|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
161714449|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
161714450|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
161714451|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
161714452|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
161714453|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Missing|0|||
161714454|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Missing|2|||
161714455|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Missing|2|||
161714456|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Missing|2|||
161714457|NCT00957372|583999748|FG000|PART I|Lost to Follow-up|0|||
161714458|NCT00957372|583999749|FG001|PART I|Lost to Follow-up|0|||
161714459|NCT00957372|583999750|FG002|PART I|Lost to Follow-up|1|||
161714460|NCT00957372|583999751|FG003|PART I|Lost to Follow-up|0|||
161714461|NCT00957372|583999748|FG000|PART II|Withdrawal by Subject|0|||
161714462|NCT00957372|583999749|FG001|PART II|Withdrawal by Subject|0|||
161714463|NCT00957372|583999750|FG002|PART II|Withdrawal by Subject|0|||
161714464|NCT00957372|583999751|FG003|PART II|Withdrawal by Subject|8|||
161714465|NCT00957372|583999748|FG000|PART II|Physician Decision|0|||
161714466|NCT00957372|583999749|FG001|PART II|Physician Decision|0|||
161714467|NCT00957372|583999750|FG002|PART II|Physician Decision|0|||
161714468|NCT00957372|583999751|FG003|PART II|Physician Decision|1|||
161714469|NCT00957372|583999748|FG000|PART II|Pregnancy|0|||
161714470|NCT00957372|583999749|FG001|PART II|Pregnancy|0|||
161714471|NCT00957372|583999750|FG002|PART II|Pregnancy|0|||
161714472|NCT00957372|583999751|FG003|PART II|Pregnancy|1|||
161714473|NCT00957372|583999748|FG000|PART II|Not Know|0|||
161714474|NCT00957372|583999749|FG001|PART II|Not Know|0|||
161714475|NCT00957372|583999750|FG002|PART II|Not Know|0|||
161714476|NCT00957372|583999751|FG003|PART II|Not Know|20|||
161714477|NCT00957372|583999748|FG000|PART II|Adverse Event|0|||
161714478|NCT00957372|583999749|FG001|PART II|Adverse Event|0|||
161714479|NCT00957372|583999750|FG002|PART II|Adverse Event|0|||
161714480|NCT00957372|583999751|FG003|PART II|Adverse Event|10|||
161714481|NCT00957372|583999748|FG000|PART II|Patient non-compliance|0|||
161714482|NCT00957372|583999749|FG001|PART II|Patient non-compliance|0|||
161714483|NCT00957372|583999750|FG002|PART II|Patient non-compliance|0|||
161714484|NCT00957372|583999751|FG003|PART II|Patient non-compliance|4|||
161714485|NCT01444391|583999752|FG000|Overall Study|Death|1|||
161714486|NCT05847881|583999756|FG000|Overall Study|Principal Investigator Decision|8|||
161714487|NCT05847881|583999756|FG000|Overall Study|Withdrawal by Subject|2|||
161714488|NCT03439345|584001285|FG000|Overall Study|Lost to Follow-up|0|||
161714489|NCT03439345|584001286|FG001|Overall Study|Lost to Follow-up|1|||
161714490|NCT03439345|584001285|FG000|Overall Study|Consent withdrawn|0|||
161714491|NCT03439345|584001286|FG001|Overall Study|Consent withdrawn|1|||
161714492|NCT01386385|584001287|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
161714493|NCT01386385|584001288|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714494|NCT01386385|584001289|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714495|NCT01386385|584001290|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714496|NCT01386385|584001291|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714497|NCT01386385|584001292|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714498|NCT01386385|584001293|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714499|NCT01386385|584001294|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714500|NCT01386385|584001287|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
161714501|NCT01386385|584001288|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714502|NCT01386385|584001289|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714503|NCT01386385|584001290|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714504|NCT01386385|584001291|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714505|NCT01386385|584001292|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714506|NCT01386385|584001293|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714507|NCT01386385|584001294|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714508|NCT01386385|584001287|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714509|NCT01386385|584001288|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714510|NCT01386385|584001289|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
161714511|NCT01386385|584001290|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714512|NCT01386385|584001291|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714513|NCT01386385|584001292|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714514|NCT01386385|584001293|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714515|NCT01386385|584001294|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714516|NCT01386385|584001287|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714517|NCT01386385|584001288|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714518|NCT01386385|584001289|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714519|NCT01386385|584001290|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714520|NCT01386385|584001291|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
161714521|NCT01386385|584001292|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714522|NCT01386385|584001293|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714523|NCT01386385|584001294|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714524|NCT01386385|584001287|FG000|Phase II Concurrent CRT|Adverse Event|0|||
161714525|NCT01386385|584001288|FG001|Phase II Concurrent CRT|Adverse Event|0|||
161714526|NCT01386385|584001289|FG002|Phase II Concurrent CRT|Adverse Event|0|||
161714527|NCT01386385|584001290|FG003|Phase II Concurrent CRT|Adverse Event|0|||
161714528|NCT01386385|584001291|FG004|Phase II Concurrent CRT|Adverse Event|0|||
161714529|NCT01386385|584001292|FG005|Phase II Concurrent CRT|Adverse Event|0|||
161714530|NCT01386385|584001293|FG006|Phase II Concurrent CRT|Adverse Event|3|||
161714531|NCT01386385|584001294|FG007|Phase II Concurrent CRT|Adverse Event|3|||
161714532|NCT01386385|584001287|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714533|NCT01386385|584001288|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714534|NCT01386385|584001289|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714535|NCT01386385|584001290|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714536|NCT01386385|584001291|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714537|NCT01386385|584001292|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714538|NCT01386385|584001293|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
161714539|NCT01386385|584001294|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714540|NCT01386385|584001287|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
161714541|NCT01386385|584001288|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
161714542|NCT01386385|584001289|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
161714543|NCT01386385|584001290|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
161714544|NCT01386385|584001291|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
161714545|NCT01386385|584001292|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
161714546|NCT01386385|584001293|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
161714547|NCT01386385|584001294|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
161714548|NCT01386385|584001287|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714549|NCT01386385|584001288|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714550|NCT01386385|584001289|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714551|NCT01386385|584001290|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714552|NCT01386385|584001291|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714553|NCT01386385|584001292|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714554|NCT01386385|584001293|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
161714555|NCT01386385|584001294|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714556|NCT01386385|584001287|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714557|NCT01386385|584001288|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714558|NCT01386385|584001289|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714559|NCT01386385|584001290|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714560|NCT01386385|584001291|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714561|NCT01386385|584001292|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714562|NCT01386385|584001293|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
161714563|NCT01386385|584001294|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
161714564|NCT03746080|584001296|FG000|Overall Study|In follow up|2|||
161714565|NCT03746080|584001296|FG000|Overall Study|Death|15|||
161714566|NCT02128490|584001300|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161714567|NCT02128490|584001301|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161714568|NCT02128490|584001302|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161714569|NCT02128490|584001303|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161714570|NCT02128490|584001304|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161714571|NCT02128490|584001300|FG000|Overall Study|Major Protocol Deviation|1|||
161714572|NCT02128490|584001301|FG001|Overall Study|Major Protocol Deviation|2|||
161714573|NCT02128490|584001302|FG002|Overall Study|Major Protocol Deviation|0|||
161714574|NCT02128490|584001303|FG003|Overall Study|Major Protocol Deviation|2|||
161714575|NCT02128490|584001304|FG004|Overall Study|Major Protocol Deviation|2|||
161714576|NCT02128490|584001300|FG000|Overall Study|Lost to Follow-up|0|||
161714577|NCT02128490|584001301|FG001|Overall Study|Lost to Follow-up|0|||
161714578|NCT02128490|584001302|FG002|Overall Study|Lost to Follow-up|1|||
161714579|NCT02128490|584001303|FG003|Overall Study|Lost to Follow-up|1|||
161714580|NCT02128490|584001304|FG004|Overall Study|Lost to Follow-up|1|||
161714581|NCT02128490|584001300|FG000|Overall Study|Voluntary Withdrawal|3|||
161714582|NCT02128490|584001301|FG001|Overall Study|Voluntary Withdrawal|3|||
161714583|NCT02128490|584001302|FG002|Overall Study|Voluntary Withdrawal|1|||
161714584|NCT02128490|584001303|FG003|Overall Study|Voluntary Withdrawal|1|||
161714585|NCT02128490|584001304|FG004|Overall Study|Voluntary Withdrawal|2|||
161714586|NCT02128490|584001300|FG000|Overall Study|Lack of Efficacy|0|||
161714587|NCT02128490|584001301|FG001|Overall Study|Lack of Efficacy|1|||
161714588|NCT02128490|584001302|FG002|Overall Study|Lack of Efficacy|0|||
161714589|NCT02128490|584001303|FG003|Overall Study|Lack of Efficacy|0|||
161714590|NCT02128490|584001304|FG004|Overall Study|Lack of Efficacy|0|||
161838010|NCT02032706|584450286|FG000|Overall Study|Protocol Violation|1|||
161714591|NCT02128490|584001300|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714592|NCT02128490|584001301|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714593|NCT02128490|584001302|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714594|NCT02128490|584001303|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714595|NCT02128490|584001304|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
161714596|NCT02128490|584001300|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161714597|NCT02128490|584001301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161714598|NCT02128490|584001302|FG002|Overall Study|Other Miscellaneous Reasons|2|||
161714599|NCT02128490|584001303|FG003|Overall Study|Other Miscellaneous Reasons|1|||
161714600|NCT02128490|584001304|FG004|Overall Study|Other Miscellaneous Reasons|1|||
161714601|NCT02243176|584001305|FG000|Overall Study|Other reason|1|||
161714602|NCT02243176|584001306|FG001|Overall Study|Other reason|2|||
161714603|NCT02243176|584001305|FG000|Overall Study|protocol specified withdrawal critera|1|||
161714604|NCT02243176|584001306|FG001|Overall Study|protocol specified withdrawal critera|3|||
161714605|NCT02243176|584001305|FG000|Overall Study|Protocol Violation|2|||
161714606|NCT02243176|584001306|FG001|Overall Study|Protocol Violation|1|||
161714607|NCT02243176|584001305|FG000|Overall Study|Withdrawal by Subject|8|||
161714608|NCT02243176|584001306|FG001|Overall Study|Withdrawal by Subject|7|||
161714609|NCT02243176|584001305|FG000|Overall Study|Adverse Event|2|||
161714610|NCT02243176|584001306|FG001|Overall Study|Adverse Event|2|||
161714611|NCT03311126|584001308|FG000|Induction|Death|1|||
161714612|NCT03311126|584001308|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
161714613|NCT03113500|584001309|FG000|Overall Study|Withdrawal by Subject|1|||
161714614|NCT01348919|584001312|FG000|Overall Study|Adverse Event|3|||
161714615|NCT01348919|584001313|FG001|Overall Study|Adverse Event|1|||
161714616|NCT01348919|584001314|FG002|Overall Study|Adverse Event|0|||
161714617|NCT01348919|584001312|FG000|Overall Study|Withdrawal by Subject|0|||
161714618|NCT01348919|584001313|FG001|Overall Study|Withdrawal by Subject|1|||
161714619|NCT01348919|584001314|FG002|Overall Study|Withdrawal by Subject|0|||
161714620|NCT01348919|584001312|FG000|Overall Study|Disease progression|0|||
161714621|NCT01348919|584001313|FG001|Overall Study|Disease progression|1|||
161714622|NCT01348919|584001314|FG002|Overall Study|Disease progression|1|||
161714623|NCT02517515|584001315|FG000|Overall Study|Adverse Event|0|||
161714624|NCT02517515|584001316|FG001|Overall Study|Adverse Event|1|||
161714625|NCT02517515|584001315|FG000|Overall Study|Withdrew Consent|0|||
161714626|NCT02517515|584001316|FG001|Overall Study|Withdrew Consent|1|||
161714627|NCT02517515|584001315|FG000|Overall Study|Lost to Follow-up|1|||
161714628|NCT02517515|584001316|FG001|Overall Study|Lost to Follow-up|0|||
161714629|NCT02517515|584001315|FG000|Overall Study|Other|1|||
161714630|NCT02517515|584001316|FG001|Overall Study|Other|0|||
161714631|NCT03839524|584001320|FG000|Overall Study|Adverse Event|1|||
161714632|NCT05408858|584001321|FG000|Overall Study|no longer met eligibility criteria|1|||
161714633|NCT02037919|584001322|FG000|Overall Study|Lost to Follow-up|30|||
161714634|NCT02037919|584001323|FG001|Overall Study|Lost to Follow-up|45|||
161662794|NCT00196976|583817959|FG006|Primary Study|Migrated from study area|0|||
161662795|NCT00196976|583817960|FG007|Primary Study|Migrated from study area|1|||
161662796|NCT00196976|583817961|FG008|Primary Study|Migrated from study area|0|||
161662797|NCT00196976|583817962|FG009|Primary Study|Migrated from study area|0|||
161662798|NCT00196976|583817963|FG010|Primary Study|Migrated from study area|0|||
161662799|NCT00196976|583817964|FG011|Primary Study|Migrated from study area|0|||
161662800|NCT00196976|583817965|FG012|Primary Study|Migrated from study area|0|||
161662801|NCT00196976|583817966|FG013|Primary Study|Migrated from study area|0|||
161662802|NCT00196976|583817953|FG000|Primary Study|Protocol Violation|0|||
161662803|NCT00196976|583817954|FG001|Primary Study|Protocol Violation|1|||
161662804|NCT00196976|583817955|FG002|Primary Study|Protocol Violation|1|||
161662805|NCT00196976|583817956|FG003|Primary Study|Protocol Violation|0|||
161662806|NCT00196976|583817957|FG004|Primary Study|Protocol Violation|0|||
161662807|NCT00196976|583817958|FG005|Primary Study|Protocol Violation|0|||
161662808|NCT00196976|583817959|FG006|Primary Study|Protocol Violation|0|||
161662809|NCT00196976|583817960|FG007|Primary Study|Protocol Violation|0|||
161662810|NCT00196976|583817961|FG008|Primary Study|Protocol Violation|0|||
161662811|NCT00196976|583817962|FG009|Primary Study|Protocol Violation|0|||
161662812|NCT00196976|583817963|FG010|Primary Study|Protocol Violation|0|||
161662813|NCT00196976|583817964|FG011|Primary Study|Protocol Violation|0|||
161662814|NCT00196976|583817965|FG012|Primary Study|Protocol Violation|0|||
161662815|NCT00196976|583817966|FG013|Primary Study|Protocol Violation|0|||
161662816|NCT00196976|583817953|FG000|Primary Study|Withdrawal by Subject|1|||
161662817|NCT00196976|583817954|FG001|Primary Study|Withdrawal by Subject|0|||
161662818|NCT00196976|583817955|FG002|Primary Study|Withdrawal by Subject|1|||
161662819|NCT00196976|583817956|FG003|Primary Study|Withdrawal by Subject|1|||
161662820|NCT00196976|583817957|FG004|Primary Study|Withdrawal by Subject|2|||
161714635|NCT00886938|584001324|FG000|Overall Study|Adverse Event|1|||
161714636|NCT00886938|584001324|FG000|Overall Study|Withdrawal by Subject|1|||
161662821|NCT00196976|583817958|FG005|Primary Study|Withdrawal by Subject|1|||
161714637|NCT00917384|584001325|FG000|Overall Study|Lost to Follow-up|4|||
161714638|NCT00917384|584001326|FG001|Overall Study|Lost to Follow-up|2|||
161714639|NCT00917384|584001325|FG000|Overall Study|Withdrawal by Subject|10|||
161714640|NCT00917384|584001326|FG001|Overall Study|Withdrawal by Subject|2|||
161714641|NCT01458340|584001329|FG000|Overall Study|Adverse Event|5|||
161714642|NCT01458340|584001330|FG001|Overall Study|Adverse Event|4|||
161714643|NCT01458340|584001331|FG002|Overall Study|Adverse Event|2|||
161714644|NCT01458340|584001329|FG000|Overall Study|Lost to Follow-up|3|||
161714645|NCT01458340|584001330|FG001|Overall Study|Lost to Follow-up|3|||
161714646|NCT01458340|584001331|FG002|Overall Study|Lost to Follow-up|10|||
161714647|NCT01458340|584001329|FG000|Overall Study|Miscellaneous|0|||
161714648|NCT01458340|584001330|FG001|Overall Study|Miscellaneous|1|||
161714649|NCT01458340|584001331|FG002|Overall Study|Miscellaneous|0|||
161714650|NCT01458340|584001329|FG000|Overall Study|Physician Decision|1|||
161662822|NCT00196976|583817959|FG006|Primary Study|Withdrawal by Subject|0|||
161662823|NCT00196976|583817960|FG007|Primary Study|Withdrawal by Subject|0|||
161662824|NCT00196976|583817961|FG008|Primary Study|Withdrawal by Subject|0|||
161662825|NCT00196976|583817962|FG009|Primary Study|Withdrawal by Subject|1|||
161662826|NCT00196976|583817963|FG010|Primary Study|Withdrawal by Subject|0|||
161662827|NCT00196976|583817964|FG011|Primary Study|Withdrawal by Subject|0|||
161662828|NCT00196976|583817965|FG012|Primary Study|Withdrawal by Subject|0|||
161662829|NCT00196976|583817966|FG013|Primary Study|Withdrawal by Subject|0|||
161662830|NCT00196976|583817953|FG000|Primary Study|Lost to Follow-up|0|||
161662831|NCT00196976|583817954|FG001|Primary Study|Lost to Follow-up|0|||
161662832|NCT00196976|583817955|FG002|Primary Study|Lost to Follow-up|0|||
161662833|NCT00196976|583817956|FG003|Primary Study|Lost to Follow-up|0|||
161662834|NCT00196976|583817957|FG004|Primary Study|Lost to Follow-up|1|||
161662835|NCT00196976|583817958|FG005|Primary Study|Lost to Follow-up|1|||
161662836|NCT00196976|583817959|FG006|Primary Study|Lost to Follow-up|0|||
161662837|NCT00196976|583817960|FG007|Primary Study|Lost to Follow-up|2|||
161662838|NCT00196976|583817961|FG008|Primary Study|Lost to Follow-up|0|||
161662839|NCT00196976|583817962|FG009|Primary Study|Lost to Follow-up|0|||
161662840|NCT00196976|583817963|FG010|Primary Study|Lost to Follow-up|0|||
161662841|NCT00196976|583817964|FG011|Primary Study|Lost to Follow-up|0|||
161662842|NCT00196976|583817965|FG012|Primary Study|Lost to Follow-up|0|||
161662843|NCT00196976|583817966|FG013|Primary Study|Lost to Follow-up|0|||
161662844|NCT00196976|583817953|FG000|Primary Study|Other|0|||
161662845|NCT00196976|583817954|FG001|Primary Study|Other|0|||
161662846|NCT00196976|583817955|FG002|Primary Study|Other|2|||
161662847|NCT00196976|583817956|FG003|Primary Study|Other|0|||
161662848|NCT00196976|583817957|FG004|Primary Study|Other|0|||
161662849|NCT00196976|583817958|FG005|Primary Study|Other|0|||
161662850|NCT00196976|583817959|FG006|Primary Study|Other|0|||
161662851|NCT00196976|583817960|FG007|Primary Study|Other|0|||
161662852|NCT00196976|583817961|FG008|Primary Study|Other|0|||
161662853|NCT00196976|583817962|FG009|Primary Study|Other|0|||
161662854|NCT00196976|583817963|FG010|Primary Study|Other|0|||
161662855|NCT00196976|583817964|FG011|Primary Study|Other|0|||
161662856|NCT00196976|583817965|FG012|Primary Study|Other|0|||
161662857|NCT00196976|583817966|FG013|Primary Study|Other|0|||
161662858|NCT00196976|583817953|FG000|Booster Study|Withdrawal by Subject|0|||
161662859|NCT00196976|583817954|FG001|Booster Study|Withdrawal by Subject|0|||
161662860|NCT00196976|583817955|FG002|Booster Study|Withdrawal by Subject|0|||
161662861|NCT00196976|583817956|FG003|Booster Study|Withdrawal by Subject|0|||
161662862|NCT00196976|583817957|FG004|Booster Study|Withdrawal by Subject|0|||
161662863|NCT00196976|583817958|FG005|Booster Study|Withdrawal by Subject|0|||
161662864|NCT00196976|583817959|FG006|Booster Study|Withdrawal by Subject|0|||
161662865|NCT00196976|583817960|FG007|Booster Study|Withdrawal by Subject|0|||
161662866|NCT00196976|583817961|FG008|Booster Study|Withdrawal by Subject|0|||
161662867|NCT00196976|583817962|FG009|Booster Study|Withdrawal by Subject|0|||
161662868|NCT00196976|583817963|FG010|Booster Study|Withdrawal by Subject|1|||
161662869|NCT00196976|583817964|FG011|Booster Study|Withdrawal by Subject|0|||
161662870|NCT00196976|583817965|FG012|Booster Study|Withdrawal by Subject|0|||
161662871|NCT00196976|583817966|FG013|Booster Study|Withdrawal by Subject|0|||
161662872|NCT00196976|583817953|FG000|Booster Study|Lost to Follow-up|0|||
161662873|NCT00196976|583817954|FG001|Booster Study|Lost to Follow-up|0|||
161662874|NCT00196976|583817955|FG002|Booster Study|Lost to Follow-up|0|||
161662875|NCT00196976|583817956|FG003|Booster Study|Lost to Follow-up|0|||
161662876|NCT00196976|583817957|FG004|Booster Study|Lost to Follow-up|0|||
161662877|NCT00196976|583817958|FG005|Booster Study|Lost to Follow-up|0|||
161662878|NCT00196976|583817959|FG006|Booster Study|Lost to Follow-up|0|||
161662879|NCT00196976|583817960|FG007|Booster Study|Lost to Follow-up|0|||
161662880|NCT00196976|583817961|FG008|Booster Study|Lost to Follow-up|0|||
161714651|NCT01458340|584001330|FG001|Overall Study|Physician Decision|1|||
161662881|NCT00196976|583817962|FG009|Booster Study|Lost to Follow-up|0|||
161662882|NCT00196976|583817963|FG010|Booster Study|Lost to Follow-up|1|||
161662883|NCT00196976|583817964|FG011|Booster Study|Lost to Follow-up|2|||
161662884|NCT00196976|583817965|FG012|Booster Study|Lost to Follow-up|0|||
161662885|NCT00196976|583817966|FG013|Booster Study|Lost to Follow-up|0|||
161662886|NCT01535560|583817967|FG000|Overall Study|Adverse Event|12|||
161662887|NCT01535560|583817968|FG001|Overall Study|Adverse Event|7|||
161662888|NCT01535560|583817967|FG000|Overall Study|Lost to Follow-up|1|||
161662889|NCT01535560|583817968|FG001|Overall Study|Lost to Follow-up|3|||
161662890|NCT01535560|583817967|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
161662891|NCT01535560|583817968|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
161662892|NCT01535560|583817967|FG000|Overall Study|Treatment Failure|21|||
161662893|NCT01535560|583817968|FG001|Overall Study|Treatment Failure|83|||
161662894|NCT01535560|583817967|FG000|Overall Study|Other|0|||
161662895|NCT01535560|583817968|FG001|Overall Study|Other|1|||
161662896|NCT01535560|583817967|FG000|Overall Study|Randomized in Error|0|||
161662897|NCT01535560|583817968|FG001|Overall Study|Randomized in Error|1|||
161662898|NCT02009761|583817969|FG000|Overall Study|Adverse Event|4|||
161662899|NCT02842827|583817970|FG000|Overall Study|Adverse Event|0|||
161662900|NCT02842827|583817971|FG001|Overall Study|Adverse Event|1|||
161662901|NCT02842827|583817972|FG002|Overall Study|Adverse Event|0|||
161662902|NCT02842827|583817973|FG003|Overall Study|Adverse Event|1|||
161662903|NCT02842827|583817974|FG004|Overall Study|Adverse Event|0|||
161662904|NCT02842827|583817975|FG005|Overall Study|Adverse Event|1|||
161662905|NCT02842827|583817976|FG006|Overall Study|Adverse Event|0|||
161662906|NCT02842827|583817977|FG007|Overall Study|Adverse Event|0|||
161662907|NCT02842827|583817970|FG000|Overall Study|Death|1|||
161662908|NCT02842827|583817971|FG001|Overall Study|Death|0|||
161662909|NCT02842827|583817972|FG002|Overall Study|Death|2|||
161662910|NCT02842827|583817973|FG003|Overall Study|Death|3|||
161662911|NCT02842827|583817974|FG004|Overall Study|Death|2|||
161662912|NCT02842827|583817975|FG005|Overall Study|Death|1|||
161662913|NCT02842827|583817976|FG006|Overall Study|Death|0|||
161662914|NCT02842827|583817977|FG007|Overall Study|Death|4|||
161662915|NCT02842827|583817970|FG000|Overall Study|Physician Decision|1|||
161662916|NCT02842827|583817971|FG001|Overall Study|Physician Decision|3|||
161662917|NCT02842827|583817972|FG002|Overall Study|Physician Decision|0|||
161662918|NCT02842827|583817973|FG003|Overall Study|Physician Decision|0|||
161662919|NCT02842827|583817974|FG004|Overall Study|Physician Decision|1|||
161662920|NCT02842827|583817975|FG005|Overall Study|Physician Decision|4|||
161662921|NCT02842827|583817976|FG006|Overall Study|Physician Decision|2|||
161662922|NCT02842827|583817977|FG007|Overall Study|Physician Decision|1|||
161662923|NCT02842827|583817970|FG000|Overall Study|Protocol Defined Disease Progression|0|||
161662924|NCT02842827|583817971|FG001|Overall Study|Protocol Defined Disease Progression|0|||
161662925|NCT02842827|583817972|FG002|Overall Study|Protocol Defined Disease Progression|0|||
161662926|NCT02842827|583817973|FG003|Overall Study|Protocol Defined Disease Progression|0|||
161714652|NCT01458340|584001331|FG002|Overall Study|Physician Decision|2|||
161714653|NCT01458340|584001329|FG000|Overall Study|Protocol Violation|6|||
161714654|NCT01458340|584001330|FG001|Overall Study|Protocol Violation|6|||
161714655|NCT01458340|584001331|FG002|Overall Study|Protocol Violation|5|||
161714656|NCT01458340|584001329|FG000|Overall Study|Withdrawal by Subject|12|||
161714657|NCT01458340|584001330|FG001|Overall Study|Withdrawal by Subject|6|||
161714658|NCT01458340|584001331|FG002|Overall Study|Withdrawal by Subject|4|||
161714659|NCT01021007|584001334|FG000|Overall Study|Lost to Follow-up|1|||
161714660|NCT01021007|584001335|FG001|Overall Study|Lost to Follow-up|1|||
161714661|NCT01021007|584001334|FG000|Overall Study|Adverse Event|1|||
161714662|NCT01021007|584001335|FG001|Overall Study|Adverse Event|3|||
161714663|NCT00947154|584001338|FG000|Overall Study|Lost to Follow-up|1|||
161714664|NCT03293030|584001341|FG000|Overall Study|Withdrawal by Subject|3|||
161714665|NCT04899271|584001342|FG000|Overall Study|Lost to Follow-up|1|||
161714666|NCT04899271|584001343|FG001|Overall Study|Lost to Follow-up|0|||
161714667|NCT04899271|584001342|FG000|Overall Study|Subject request/consent withdrawal|2|||
161714668|NCT04899271|584001343|FG001|Overall Study|Subject request/consent withdrawal|0|||
161714669|NCT00900796|584001344|FG000|Phase 1|Lacked sufficient information|4|||
161714670|NCT00900796|584001344|FG000|Phase 1|Missing information at Week 16|7|||
161714671|NCT00900796|584001344|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
161714672|NCT00900796|584001344|FG000|Phase 2|Lost to Follow-up|5|||
161714673|NCT02318602|584001346|FG000|Overall Study|Adverse Event|0|||
161714674|NCT02318602|584001347|FG001|Overall Study|Adverse Event|1|||
161714675|NCT02318602|584001348|FG002|Overall Study|Adverse Event|1|||
161714676|NCT02318602|584001346|FG000|Overall Study|Withdrawal by Subject|0|||
161714677|NCT02318602|584001347|FG001|Overall Study|Withdrawal by Subject|3|||
161714678|NCT02318602|584001348|FG002|Overall Study|Withdrawal by Subject|0|||
161714679|NCT02318602|584001346|FG000|Overall Study|Death|1|||
161714680|NCT02318602|584001347|FG001|Overall Study|Death|0|||
161714681|NCT02318602|584001348|FG002|Overall Study|Death|0|||
161714682|NCT02318602|584001346|FG000|Overall Study|Guardian decision to withdraw|0|||
161714683|NCT02318602|584001347|FG001|Overall Study|Guardian decision to withdraw|0|||
161714684|NCT02318602|584001348|FG002|Overall Study|Guardian decision to withdraw|1|||
161714685|NCT00693706|584001349|FG000|Overall Study|Protocol Violation|0|||
161714686|NCT00693706|584001350|FG001|Overall Study|Protocol Violation|1|||
161714687|NCT01733329|584001351|FG000|Overall Study|Protocol Violation|1|||
161714688|NCT01733329|584001352|FG001|Overall Study|Protocol Violation|1|||
161714689|NCT01733329|584001351|FG000|Overall Study|Uterine artery injury|1|||
161714690|NCT01733329|584001352|FG001|Overall Study|Uterine artery injury|0|||
161714691|NCT00730236|584001353|FG000|Overall Study|Adverse Event|4|||
161714692|NCT00730236|584001353|FG000|Overall Study|Withdrawal by Subject|1|||
161714693|NCT00730236|584001353|FG000|Overall Study|Non-compliance|1|||
161714694|NCT00498173|584001356|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
161714695|NCT00498173|584001357|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
161714696|NCT00498173|584001358|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
161714697|NCT00542828|584001361|FG000|Overall Study|Physician Decision|1|||
161714698|NCT00542828|584001361|FG000|Overall Study|Need for Prohibited Treatment|3|||
161714699|NCT00542828|584001361|FG000|Overall Study|Study Prematurely Discontinued|7|||
161714700|NCT00542828|584001361|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
161714701|NCT00095303|584001362|FG000|Main Study|Lost to Follow-up|91|||
161714702|NCT00095303|584001363|FG001|Main Study|Lost to Follow-up|87|||
161714703|NCT00095303|584001362|FG000|Follow Up Study|Lost to Follow-up|59|||
161714704|NCT00095303|584001363|FG001|Follow Up Study|Lost to Follow-up|58|||
161714705|NCT03228186|584001364|FG000|Overall Study|Patient never started treatment|1|||
161714706|NCT01634243|584001367|FG000|Overall Study|Adverse Event|5|||
161714707|NCT01634243|584001368|FG001|Overall Study|Adverse Event|5|||
161714708|NCT01634243|584001367|FG000|Overall Study|Lack of Efficacy|1|||
161714709|NCT01634243|584001368|FG001|Overall Study|Lack of Efficacy|0|||
161714710|NCT03953118|584001369|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
161714711|NCT03953118|584001370|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
161714712|NCT00258154|584001371|FG000|Overall Study|Adverse Event|1|||
161714713|NCT00258154|584001372|FG001|Overall Study|Adverse Event|0|||
161714714|NCT00258154|584001371|FG000|Overall Study|Lost to Follow-up|0|||
161714715|NCT00258154|584001372|FG001|Overall Study|Lost to Follow-up|1|||
161714716|NCT00258154|584001371|FG000|Overall Study|Protocol Violation|2|||
161714717|NCT00258154|584001372|FG001|Overall Study|Protocol Violation|1|||
161714718|NCT00258154|584001371|FG000|Overall Study|Withdrawal by Subject|3|||
161714719|NCT00258154|584001372|FG001|Overall Study|Withdrawal by Subject|4|||
161714720|NCT00258154|584001371|FG000|Overall Study|Patient Moved|3|||
161714721|NCT00258154|584001372|FG001|Overall Study|Patient Moved|1|||
161714722|NCT05139030|584001375|FG000|Overall Study|Withdrawal by Subject|1|||
161714723|NCT05139030|584001376|FG001|Overall Study|Withdrawal by Subject|3|||
161714724|NCT05139030|584001375|FG000|Overall Study|Adverse Event|0|||
161714725|NCT05139030|584001376|FG001|Overall Study|Adverse Event|1|||
161714726|NCT05139030|584001375|FG000|Overall Study|Failure to meet continuation criteria|0|||
161714727|NCT05139030|584001376|FG001|Overall Study|Failure to meet continuation criteria|1|||
161662927|NCT02842827|583817974|FG004|Overall Study|Protocol Defined Disease Progression|0|||
161662928|NCT02842827|583817975|FG005|Overall Study|Protocol Defined Disease Progression|1|||
161662929|NCT02842827|583817976|FG006|Overall Study|Protocol Defined Disease Progression|0|||
161662930|NCT02842827|583817977|FG007|Overall Study|Protocol Defined Disease Progression|0|||
161662931|NCT02842827|583817970|FG000|Overall Study|Participant Withdrawal of Consent|1|||
161662932|NCT02842827|583817971|FG001|Overall Study|Participant Withdrawal of Consent|2|||
161662933|NCT02842827|583817972|FG002|Overall Study|Participant Withdrawal of Consent|2|||
161662934|NCT02842827|583817973|FG003|Overall Study|Participant Withdrawal of Consent|2|||
161662935|NCT02842827|583817974|FG004|Overall Study|Participant Withdrawal of Consent|2|||
161662936|NCT02842827|583817975|FG005|Overall Study|Participant Withdrawal of Consent|1|||
161662937|NCT02842827|583817976|FG006|Overall Study|Participant Withdrawal of Consent|2|||
161662938|NCT02842827|583817977|FG007|Overall Study|Participant Withdrawal of Consent|1|||
161714728|NCT00613626|584001384|FG000|Overall Study|Ineligible|0|||
161714729|NCT00613626|584001385|FG001|Overall Study|Ineligible|1|||
161714730|NCT00613626|584001386|FG002|Overall Study|Ineligible|0|||
161714731|NCT00816036|584001387|FG000|Overall Study|Death|47|||
161714732|NCT00816036|584001388|FG001|Overall Study|Death|28|||
161662939|NCT01815138|583817978|FG000|Overall Study|Withdrawal by Subject|0|||
161662940|NCT01815138|583817979|FG001|Overall Study|Withdrawal by Subject|1|||
161662941|NCT01815138|583817978|FG000|Overall Study|Physician Decision|8|||
161662942|NCT01815138|583817979|FG001|Overall Study|Physician Decision|5|||
161662943|NCT00825825|583817980|FG000|First Medication Period (14 Days)|Adverse Event|1|||
161662944|NCT00825825|583817981|FG001|First Medication Period (14 Days)|Adverse Event|0|||
161662945|NCT00825825|583817982|FG002|First Medication Period (14 Days)|Adverse Event|0|||
161662946|NCT00825825|583817983|FG003|First Medication Period (14 Days)|Adverse Event|0|||
161662947|NCT00825825|583817984|FG004|First Medication Period (14 Days)|Adverse Event|0|||
161662948|NCT00825825|583817985|FG005|First Medication Period (14 Days)|Adverse Event|1|||
161662949|NCT00825825|583817980|FG000|First Medication Period (14 Days)|Physician Decision|2|||
161662950|NCT00825825|583817981|FG001|First Medication Period (14 Days)|Physician Decision|0|||
161662951|NCT00825825|583817982|FG002|First Medication Period (14 Days)|Physician Decision|1|||
161662952|NCT00825825|583817983|FG003|First Medication Period (14 Days)|Physician Decision|0|||
161662953|NCT00825825|583817984|FG004|First Medication Period (14 Days)|Physician Decision|0|||
161662954|NCT00825825|583817985|FG005|First Medication Period (14 Days)|Physician Decision|1|||
161662955|NCT00825825|583817980|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
161662956|NCT00825825|583817981|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
161662957|NCT00825825|583817982|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
161662958|NCT00825825|583817983|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
161662959|NCT00825825|583817984|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
161662960|NCT00825825|583817985|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
161662961|NCT00825825|583817980|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
161662962|NCT00825825|583817981|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
161662963|NCT00825825|583817982|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
161662964|NCT00825825|583817983|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
161662965|NCT00825825|583817984|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
161662966|NCT00825825|583817985|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
161662967|NCT00825825|583817980|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
161662968|NCT00825825|583817981|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
161662969|NCT00825825|583817982|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
161662970|NCT00825825|583817983|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
161662971|NCT00825825|583817984|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
161662972|NCT00825825|583817985|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
161662973|NCT00825825|583817980|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
161662974|NCT00825825|583817981|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
161662975|NCT00825825|583817982|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
161662976|NCT00825825|583817983|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
161662977|NCT00825825|583817984|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
161662978|NCT00825825|583817985|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
161662979|NCT00825825|583817980|FG000|Third Medication Period (14 Days)|poor data quality|0|||
161662980|NCT00825825|583817981|FG001|Third Medication Period (14 Days)|poor data quality|1|||
161662981|NCT00825825|583817982|FG002|Third Medication Period (14 Days)|poor data quality|0|||
161662982|NCT00825825|583817983|FG003|Third Medication Period (14 Days)|poor data quality|0|||
161662983|NCT00825825|583817984|FG004|Third Medication Period (14 Days)|poor data quality|0|||
161662984|NCT00825825|583817985|FG005|Third Medication Period (14 Days)|poor data quality|0|||
161662985|NCT02649946|583817991|FG000|Overall Study|Withdrawal by Subject|1|||
161714733|NCT00816036|584001387|FG000|Overall Study|Lost to Follow-up|75|||
161714734|NCT00816036|584001388|FG001|Overall Study|Lost to Follow-up|57|||
161714735|NCT00816036|584001387|FG000|Overall Study|Withdrawal by Subject|54|||
161714736|NCT00816036|584001388|FG001|Overall Study|Withdrawal by Subject|23|||
161714737|NCT00004980|584001389|FG000|Overall Study|Withdrawal by Subject|1|||
161714738|NCT00004980|584001390|FG001|Overall Study|Withdrawal by Subject|0|||
161714739|NCT00004980|584001389|FG000|Overall Study|memory difficulties|1|||
161714740|NCT00004980|584001390|FG001|Overall Study|memory difficulties|1|||
161714741|NCT00004980|584001389|FG000|Overall Study|Physician Decision|0|||
161714742|NCT00004980|584001390|FG001|Overall Study|Physician Decision|1|||
161714743|NCT01299025|584001391|FG000|Overall Study|Withdrawal by Subject|2|||
161714744|NCT01299025|584001392|FG001|Overall Study|Withdrawal by Subject|1|||
161714745|NCT01299025|584001391|FG000|Overall Study|Lost to Follow-up|1|||
161714746|NCT01299025|584001392|FG001|Overall Study|Lost to Follow-up|0|||
161714747|NCT01624194|584001393|FG000|Overall Study|Lost to Follow-up|1|||
161714748|NCT01624194|584001394|FG001|Overall Study|Lost to Follow-up|0|||
161714749|NCT01624194|584001393|FG000|Overall Study|Withdrawal by Subject|1|||
161714750|NCT01624194|584001394|FG001|Overall Study|Withdrawal by Subject|0|||
161714751|NCT03212261|584001398|FG000|Overall Study|Became ineligible d/t tech|2|||
161714752|NCT03212261|584001398|FG000|Overall Study|Tech Trouble- No first study visit|1|||
161714753|NCT03212261|584001398|FG000|Overall Study|Lost to Follow-up|7|||
161714754|NCT03212261|584001398|FG000|Overall Study|Family Emergency|1|||
161714755|NCT03212261|584001398|FG000|Overall Study|Too busy/ No time|5|||
161714756|NCT05480514|584001399|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
161714757|NCT05480514|584001400|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
161714758|NCT05480514|584001399|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
161714759|NCT05480514|584001400|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
161714760|NCT05480514|584001399|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161714761|NCT05480514|584001400|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
161714762|NCT05480514|584001399|FG000|Period 1|Covid-19 Related|1|||
161714763|NCT05480514|584001400|FG001|Period 1|Covid-19 Related|0|||
161714764|NCT05480514|584001399|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
161714765|NCT05480514|584001400|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
161714766|NCT00820040|584001407|FG000|Overall Study|Death|1|||
161714767|NCT00820040|584001407|FG000|Overall Study|Sponsor terminated study|1|||
161714768|NCT00820040|584001407|FG000|Overall Study|Screen failure|1|||
161714769|NCT01259466|584001410|FG000|Overall Study|Withdrawal by Subject|1|||
161714770|NCT01259466|584001411|FG001|Overall Study|Withdrawal by Subject|9|||
161714771|NCT03914300|584001412|FG000|Overall Study|Adverse Event|1|||
161714772|NCT00457639|584001418|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
161714773|NCT00457639|584001419|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
161714774|NCT00457639|584001418|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
161714775|NCT00457639|584001419|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
161714776|NCT00457639|584001418|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
161714777|NCT00457639|584001419|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
161714778|NCT03885284|584001420|FG000|Overall Study|Disease Progression|1|||
161714779|NCT03885284|584001421|FG001|Overall Study|Disease Progression|3|||
161714780|NCT03885284|584001420|FG000|Overall Study|Physician Decision|0|||
161714781|NCT03885284|584001421|FG001|Overall Study|Physician Decision|1|||
161714782|NCT00002850|584001426|FG000|Overall Study|Death|4|||
161714783|NCT00002850|584001427|FG001|Overall Study|Death|1|||
161714784|NCT00002850|584001428|FG002|Overall Study|Death|3|||
161714785|NCT00002850|584001426|FG000|Overall Study|Protocol Violation|1|||
161714786|NCT00002850|584001427|FG001|Overall Study|Protocol Violation|0|||
161714787|NCT00002850|584001428|FG002|Overall Study|Protocol Violation|1|||
161714788|NCT00002850|584001426|FG000|Overall Study|Withdrawal by Subject|0|||
161714789|NCT00002850|584001427|FG001|Overall Study|Withdrawal by Subject|1|||
161714790|NCT00002850|584001428|FG002|Overall Study|Withdrawal by Subject|0|||
161714791|NCT02932267|584001429|FG000|Overall Study|Withdrawal by Subject|3|||
161714792|NCT02932267|584001429|FG000|Overall Study|Lost to Follow-up|4|||
161714793|NCT02932267|584001429|FG000|Overall Study|Pregnancy|1|||
161714794|NCT03476239|584001430|FG000|Overall Study|Withdrawal by Subject|10|||
161714795|NCT03476239|584001430|FG000|Overall Study|Death|80|||
161714796|NCT03476239|584001430|FG000|Overall Study|Lost to Follow-up|8|||
161714797|NCT03750838|584001433|FG000|Overall Study|Lost to Follow-up|10|||
161714798|NCT03750838|584001434|FG001|Overall Study|Lost to Follow-up|6|||
161714799|NCT00630032|584001437|FG000|Overall Study|Death|55|||
161714800|NCT00630032|584001438|FG001|Overall Study|Death|49|||
161714801|NCT00630032|584001437|FG000|Overall Study|Withdrawal by Subject|3|||
161714802|NCT00630032|584001438|FG001|Overall Study|Withdrawal by Subject|2|||
161714803|NCT00630032|584001437|FG000|Overall Study|Lost to Follow-up|18|||
161714804|NCT00630032|584001438|FG001|Overall Study|Lost to Follow-up|31|||
161714805|NCT00630032|584001437|FG000|Overall Study|Protocol Violation|1|||
161714806|NCT00630032|584001438|FG001|Overall Study|Protocol Violation|0|||
161714807|NCT00630032|584001437|FG000|Overall Study|Patient has moved|1|||
161714808|NCT00630032|584001438|FG001|Overall Study|Patient has moved|1|||
161714809|NCT00630032|584001437|FG000|Overall Study|Disease progression|1|||
161714810|NCT00630032|584001438|FG001|Overall Study|Disease progression|1|||
161714811|NCT00630032|584001437|FG000|Overall Study|End of monitoring in US centers|11|||
161714812|NCT00630032|584001438|FG001|Overall Study|End of monitoring in US centers|11|||
161714813|NCT02332915|584001439|FG000|Overall Study|Moved out of region|3|||
161714814|NCT02332915|584001440|FG001|Overall Study|Moved out of region|0|||
161714815|NCT02332915|584001439|FG000|Overall Study|Unrelated illness|1|||
161714816|NCT02332915|584001440|FG001|Overall Study|Unrelated illness|1|||
161714817|NCT02332915|584001439|FG000|Overall Study|Travel distance prohibitive|0|||
161714818|NCT02332915|584001440|FG001|Overall Study|Travel distance prohibitive|1|||
161714819|NCT02332915|584001439|FG000|Overall Study|did not meet inclusion criteria|2|||
161714820|NCT02332915|584001440|FG001|Overall Study|did not meet inclusion criteria|4|||
161714821|NCT03232073|584001441|FG000|Overall Study|Death|1|||
161714822|NCT03232073|584001442|FG001|Overall Study|Death|0|||
161714823|NCT03232073|584001441|FG000|Overall Study|Adverse Event|7|||
161714824|NCT03232073|584001442|FG001|Overall Study|Adverse Event|12|||
161714825|NCT03232073|584001441|FG000|Overall Study|Lost to Follow-up|6|||
161714826|NCT03232073|584001442|FG001|Overall Study|Lost to Follow-up|6|||
161714827|NCT03232073|584001441|FG000|Overall Study|Lack of Efficacy|10|||
161714828|NCT03232073|584001442|FG001|Overall Study|Lack of Efficacy|8|||
161714829|NCT03232073|584001441|FG000|Overall Study|Physician Decision|9|||
161714830|NCT03232073|584001442|FG001|Overall Study|Physician Decision|2|||
161714831|NCT03232073|584001441|FG000|Overall Study|Withdrawal by Subject|54|||
161714832|NCT03232073|584001442|FG001|Overall Study|Withdrawal by Subject|39|||
161714833|NCT02032875|584001443|FG000|Treatment Period|Adverse Event|1|||
161714834|NCT02032875|584001444|FG001|Treatment Period|Adverse Event|0|||
161714835|NCT02032875|584001443|FG000|Treatment Period|Liver transplant, No extension needed|0|||
161714836|NCT02032875|584001444|FG001|Treatment Period|Liver transplant, No extension needed|1|||
161714837|NCT02032875|584001443|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
161714838|NCT02032875|584001444|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
161714839|NCT02032875|584001443|FG000|Follow-up Period|Death|0|||
161714840|NCT02032875|584001444|FG001|Follow-up Period|Death|1|||
161714841|NCT02032875|584001443|FG000|Follow-up Period|Virologic Relapse|3|||
161714842|NCT02032875|584001444|FG001|Follow-up Period|Virologic Relapse|10|||
161714843|NCT03191786|584001449|FG000|Overall Study|Death|236|||
161714844|NCT03191786|584001450|FG001|Overall Study|Death|127|||
161714845|NCT03191786|584001449|FG000|Overall Study|Lost to Follow-up|9|||
161714846|NCT03191786|584001450|FG001|Overall Study|Lost to Follow-up|3|||
161714847|NCT03191786|584001449|FG000|Overall Study|Physician Decision|1|||
161714848|NCT03191786|584001450|FG001|Overall Study|Physician Decision|0|||
161714849|NCT03191786|584001449|FG000|Overall Study|Moved to Post Trial Access Program|30|||
161714850|NCT03191786|584001450|FG001|Overall Study|Moved to Post Trial Access Program|5|||
161714851|NCT03191786|584001449|FG000|Overall Study|Withdrawal by Subject|26|||
161714852|NCT03191786|584001450|FG001|Overall Study|Withdrawal by Subject|16|||
161714853|NCT05781542|584002842|FG000|Overall Study|Lost to Follow-up|1|||
161714854|NCT05781542|584002843|FG001|Overall Study|Lost to Follow-up|0|||
161714855|NCT05781542|584002844|FG002|Overall Study|Lost to Follow-up|1|||
161714856|NCT05405166|584002847|FG000|Overall Study|Death|49|||
161714857|NCT05405166|584002848|FG001|Overall Study|Death|50|||
161714858|NCT05405166|584002847|FG000|Overall Study|Withdrawal by Subject|10|||
161714859|NCT05405166|584002848|FG001|Overall Study|Withdrawal by Subject|3|||
161714860|NCT05405166|584002847|FG000|Overall Study|Ongoing at the time of PCD|209|||
161714861|NCT05405166|584002848|FG001|Overall Study|Ongoing at the time of PCD|210|||
161714862|NCT01843374|584002851|FG000|Overall Study|Death|155|||
161714863|NCT01843374|584002852|FG001|Overall Study|Death|313|||
161714864|NCT01843374|584002851|FG000|Overall Study|Withdrawal by Subject|14|||
161714865|NCT01843374|584002852|FG001|Overall Study|Withdrawal by Subject|20|||
161714866|NCT01843374|584002851|FG000|Overall Study|Withdrawing due to Other reason|20|||
161714867|NCT01843374|584002852|FG001|Overall Study|Withdrawing due to Other reason|46|||
161714868|NCT01826214|584002853|FG000|Overall Study|Adverse Event|7|||
161714869|NCT01826214|584002854|FG001|Overall Study|Adverse Event|6|||
161714870|NCT01826214|584002853|FG000|Overall Study|Death|3|||
161714871|NCT01826214|584002854|FG001|Overall Study|Death|1|||
161714872|NCT01826214|584002853|FG000|Overall Study|Lost to Follow-up|1|||
161714873|NCT01826214|584002854|FG001|Overall Study|Lost to Follow-up|0|||
161714874|NCT01826214|584002853|FG000|Overall Study|Physician Decision|0|||
161714875|NCT01826214|584002854|FG001|Overall Study|Physician Decision|2|||
161714876|NCT01826214|584002853|FG000|Overall Study|Progressive disease|22|||
161714877|NCT01826214|584002854|FG001|Overall Study|Progressive disease|21|||
161714878|NCT01826214|584002853|FG000|Overall Study|Study terminated by Sponsor|0|||
161662986|NCT02649946|583817992|FG001|Overall Study|Withdrawal by Subject|1|||
161662987|NCT02649946|583817991|FG000|Overall Study|Death|7|||
161662988|NCT02649946|583817992|FG001|Overall Study|Death|9|||
161662989|NCT02649946|583817991|FG000|Overall Study|Physician Decision|1|||
161662990|NCT02649946|583817992|FG001|Overall Study|Physician Decision|0|||
161662991|NCT02649946|583817991|FG000|Overall Study|Lost to Follow-up|2|||
161662992|NCT02649946|583817992|FG001|Overall Study|Lost to Follow-up|1|||
161662993|NCT02649946|583817991|FG000|Overall Study|Erroneously enrolled|1|||
161662994|NCT02649946|583817992|FG001|Overall Study|Erroneously enrolled|0|||
161662995|NCT02649946|583817991|FG000|Overall Study|Missed 6-month follow-up visit|0|||
161662996|NCT02649946|583817992|FG001|Overall Study|Missed 6-month follow-up visit|4|||
161662997|NCT00950950|583817993|FG000|Overall Study|Adverse Event|1|||
161662998|NCT00950950|583817994|FG001|Overall Study|Adverse Event|0|||
161662999|NCT00950950|583817993|FG000|Overall Study|Withdrawal by Subject|0|||
161663000|NCT00950950|583817994|FG001|Overall Study|Withdrawal by Subject|1|||
161663001|NCT01047293|583817995|FG000|Overall Study|DLT criteria not fulfilled|1|||
161663002|NCT01047293|583817996|FG001|Overall Study|DLT criteria not fulfilled|1|||
161663003|NCT01047293|583817997|FG002|Overall Study|DLT criteria not fulfilled|0|||
161663004|NCT01047293|583817998|FG003|Overall Study|DLT criteria not fulfilled|0|||
161663005|NCT00757783|583817999|FG000|Overall Study|Adverse Event|0|||
161663006|NCT00757783|583818000|FG001|Overall Study|Adverse Event|2|||
161663007|NCT00757783|583817999|FG000|Overall Study|Lost to Follow-up|1|||
161663008|NCT00757783|583818000|FG001|Overall Study|Lost to Follow-up|1|||
161663009|NCT00757783|583817999|FG000|Overall Study|Protocol Violation|1|||
161663010|NCT00757783|583818000|FG001|Overall Study|Protocol Violation|0|||
161663011|NCT00757783|583817999|FG000|Overall Study|Withdrawal by Subject|2|||
161663012|NCT00757783|583818000|FG001|Overall Study|Withdrawal by Subject|1|||
161663013|NCT00757783|583817999|FG000|Overall Study|Other|1|||
161663014|NCT00757783|583818000|FG001|Overall Study|Other|2|||
161663015|NCT02372136|583818001|FG000|Overall Study|Death|3|||
161663016|NCT02372136|583818002|FG001|Overall Study|Death|1|||
161663017|NCT02679508|583818003|FG000|Healing Phase|Protocol Violation|1|||
161663018|NCT02679508|583818004|FG001|Healing Phase|Protocol Violation|1|||
161663019|NCT02679508|583818003|FG000|Healing Phase|Lost to Follow-up|1|||
161663020|NCT02679508|583818004|FG001|Healing Phase|Lost to Follow-up|0|||
161663021|NCT02679508|583818003|FG000|Maintenance Phase|Adverse Event|12|||
161663022|NCT02679508|583818004|FG001|Maintenance Phase|Adverse Event|2|||
161663023|NCT02679508|583818003|FG000|Maintenance Phase|Lost to Follow-up|0|||
161663024|NCT02679508|583818004|FG001|Maintenance Phase|Lost to Follow-up|1|||
161663025|NCT02679508|583818003|FG000|Maintenance Phase|Withdrawal by Subject|15|||
161663026|NCT02679508|583818004|FG001|Maintenance Phase|Withdrawal by Subject|8|||
161663027|NCT02679508|583818003|FG000|Maintenance Phase|Other|5|||
161663028|NCT02679508|583818004|FG001|Maintenance Phase|Other|4|||
161663029|NCT01588496|583818005|FG000|Overall Study|Withdrawal by Subject|0|||
161663030|NCT01588496|583818006|FG001|Overall Study|Withdrawal by Subject|1|||
161663031|NCT01588496|583818007|FG002|Overall Study|Withdrawal by Subject|0|||
161663032|NCT03143166|583818008|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
161663033|NCT05924945|583818009|FG000|Overall Study|Withdrawal by Subject|3|||
161663034|NCT05924945|583818010|FG001|Overall Study|Withdrawal by Subject|4|||
161663035|NCT02003573|583818025|FG000|Overall Study|Progressive disease|2|||
161663036|NCT02003573|583818026|FG001|Overall Study|Progressive disease|0|||
161663037|NCT02003573|583818027|FG002|Overall Study|Progressive disease|1|||
161663038|NCT02003573|583818025|FG000|Overall Study|Other Adverse event|0|||
161663039|NCT02003573|583818026|FG001|Overall Study|Other Adverse event|1|||
161663040|NCT02003573|583818027|FG002|Overall Study|Other Adverse event|1|||
161663041|NCT02003573|583818025|FG000|Overall Study|Refuse to take trial medication|0|||
161663042|NCT02003573|583818026|FG001|Overall Study|Refuse to take trial medication|1|||
161663043|NCT02003573|583818027|FG002|Overall Study|Refuse to take trial medication|1|||
161663044|NCT02003573|583818025|FG000|Overall Study|Other than specified|1|||
161663045|NCT02003573|583818026|FG001|Overall Study|Other than specified|2|||
161663046|NCT02003573|583818027|FG002|Overall Study|Other than specified|3|||
161663047|NCT03683823|583818034|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
161663048|NCT03683823|583818035|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
161663049|NCT03683823|583818034|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
161663050|NCT03683823|583818035|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
161663051|NCT03683823|583818034|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
161663052|NCT03683823|583818035|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
161663053|NCT05026710|583818037|FG000|Overall Study|No longer met eligibility criteria|3|||
161663054|NCT05026710|583818038|FG001|Overall Study|No longer met eligibility criteria|1|||
161663055|NCT00126503|583818039|FG000|Overall Study|disease progression|23|||
161663056|NCT00126503|583818040|FG001|Overall Study|disease progression|14|||
161663057|NCT00126503|583818039|FG000|Overall Study|Withdrawal by Subject|0|||
161663058|NCT00126503|583818040|FG001|Overall Study|Withdrawal by Subject|1|||
161663059|NCT00126503|583818039|FG000|Overall Study|alternative therapy|1|||
161663060|NCT00126503|583818040|FG001|Overall Study|alternative therapy|1|||
161663061|NCT00126503|583818039|FG000|Overall Study|other complicating disease|4|||
161663062|NCT00126503|583818040|FG001|Overall Study|other complicating disease|1|||
161663063|NCT00126503|583818039|FG000|Overall Study|Death|3|||
161663064|NCT00126503|583818040|FG001|Overall Study|Death|0|||
161663065|NCT00126503|583818039|FG000|Overall Study|Adverse Event|13|||
161663066|NCT00126503|583818040|FG001|Overall Study|Adverse Event|3|||
161663067|NCT00126503|583818039|FG000|Overall Study|non-compliant|1|||
161663068|NCT00126503|583818040|FG001|Overall Study|non-compliant|0|||
161663069|NCT00126503|583818039|FG000|Overall Study|Physician Decision|2|||
161663070|NCT00126503|583818040|FG001|Overall Study|Physician Decision|1|||
161663071|NCT02495792|583818041|FG000|Overall Study|Lost to Follow-up|5|||
161663072|NCT02495792|583818042|FG001|Overall Study|Lost to Follow-up|9|||
161663073|NCT02495792|583818041|FG000|Overall Study|Protocol Violation|32|||
161663074|NCT02495792|583818042|FG001|Overall Study|Protocol Violation|31|||
161663075|NCT03519971|583818043|FG000|Overall Study|Death|142|||
161663076|NCT03519971|583818044|FG001|Overall Study|Death|69|||
161663077|NCT03519971|583818043|FG000|Overall Study|Lost to Follow-up|0|||
161663078|NCT03519971|583818044|FG001|Overall Study|Lost to Follow-up|1|||
161663079|NCT03519971|583818043|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
161663080|NCT03519971|583818044|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
161663081|NCT03519971|583818043|FG000|Overall Study|Withdrawal by Subject|3|||
161663082|NCT03519971|583818044|FG001|Overall Study|Withdrawal by Subject|2|||
161663083|NCT03519971|583818043|FG000|Overall Study|Other|1|||
161663084|NCT03519971|583818044|FG001|Overall Study|Other|0|||
161663085|NCT00925132|583818045|FG000|Overall Study|Withdrawal by Subject|2|||
161663086|NCT00925132|583818046|FG001|Overall Study|Withdrawal by Subject|0|||
161663087|NCT00925132|583818047|FG002|Overall Study|Withdrawal by Subject|0|||
161663088|NCT00925132|583818048|FG003|Overall Study|Withdrawal by Subject|0|||
161663089|NCT00925132|583818049|FG004|Overall Study|Withdrawal by Subject|1|||
161663090|NCT00925132|583818045|FG000|Overall Study|Removed due to disease progression|0|||
161663091|NCT00925132|583818046|FG001|Overall Study|Removed due to disease progression|0|||
161663092|NCT00925132|583818047|FG002|Overall Study|Removed due to disease progression|0|||
161663093|NCT00925132|583818048|FG003|Overall Study|Removed due to disease progression|0|||
161663094|NCT00925132|583818049|FG004|Overall Study|Removed due to disease progression|4|||
161663095|NCT02545933|583818050|FG000|Overall Study|Adverse Event|3|||
161663096|NCT02545933|583818051|FG001|Overall Study|Adverse Event|0|||
161663097|NCT02545933|583818052|FG002|Overall Study|Adverse Event|0|||
161663098|NCT02545933|583818050|FG000|Overall Study|Withdrawal by Subject|2|||
161663099|NCT02545933|583818051|FG001|Overall Study|Withdrawal by Subject|3|||
161663100|NCT02545933|583818052|FG002|Overall Study|Withdrawal by Subject|3|||
161663101|NCT02545933|583818050|FG000|Overall Study|Protocol Violation|1|||
161663102|NCT02545933|583818051|FG001|Overall Study|Protocol Violation|0|||
161663103|NCT02545933|583818052|FG002|Overall Study|Protocol Violation|1|||
161663104|NCT03149549|583818053|FG000|Study Discontinuation--Treatment Period|Death|0|||
161663105|NCT03149549|583818054|FG001|Study Discontinuation--Treatment Period|Death|0|||
161663106|NCT03149549|583818055|FG002|Study Discontinuation--Treatment Period|Death|0|||
161663107|NCT03149549|583818056|FG003|Study Discontinuation--Treatment Period|Death|1|||
161663108|NCT03149549|583818057|FG004|Study Discontinuation--Treatment Period|Death|2|||
161663109|NCT03149549|583818058|FG005|Study Discontinuation--Treatment Period|Death|1|||
161663110|NCT03149549|583818059|FG006|Study Discontinuation--Treatment Period|Death|1|||
161714879|NCT01826214|584002854|FG001|Overall Study|Study terminated by Sponsor|1|||
161714880|NCT01826214|584002853|FG000|Overall Study|Subject/guardian decision|2|||
161714881|NCT01826214|584002854|FG001|Overall Study|Subject/guardian decision|3|||
161714882|NCT00955110|584002855|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
161714883|NCT00955110|584002855|FG000|Treatment Phase|Adverse Event|2|||
161714884|NCT00955110|584002855|FG000|Treatment Phase|Administrative reasons|2|||
161714885|NCT00955110|584002855|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
161714886|NCT00955110|584002855|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
161714887|NCT03704051|584002860|FG000|Overall Study|Withdrawal by Subject|4|||
161714888|NCT03704051|584002861|FG001|Overall Study|Withdrawal by Subject|0|||
161714889|NCT03167619|584002872|FG000|Overall Study|Death|11|||
161714890|NCT03167619|584002873|FG001|Overall Study|Death|8|||
161714891|NCT03167619|584002872|FG000|Overall Study|Withdrawal by Subject|1|||
161714892|NCT03167619|584002873|FG001|Overall Study|Withdrawal by Subject|2|||
161714893|NCT03167619|584002872|FG000|Overall Study|Physician Decision|0|||
161714894|NCT03167619|584002873|FG001|Overall Study|Physician Decision|1|||
161714895|NCT06400238|584002875|FG000|Overall Study|Started Protocol Therapy|2|||
161714896|NCT06400238|584002875|FG000|Overall Study|Adverse Event|1|||
161714897|NCT06400238|584002875|FG000|Overall Study|Death|1|||
161714898|NCT06400238|584002875|FG000|Overall Study|Disease Progression|27|||
161714899|NCT06400238|584002875|FG000|Overall Study|Withdrawal by Subject|2|||
161714900|NCT06400238|584002875|FG000|Overall Study|Physician Decision|2|||
161714901|NCT01362322|584002879|FG000|Overall Study|Withdrawal by Subject|3|||
161714902|NCT01362322|584002880|FG001|Overall Study|Withdrawal by Subject|1|||
161714903|NCT01362322|584002879|FG000|Overall Study|Lost to Follow-up|2|||
161714904|NCT01362322|584002880|FG001|Overall Study|Lost to Follow-up|6|||
161714905|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
161714906|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714907|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714908|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714909|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714910|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
161714911|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
161714912|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
161714913|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
161714914|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
161714915|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
161714916|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714917|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714918|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714919|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714920|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
161714921|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
161714922|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
161714923|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
161714924|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
161714925|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
161714926|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161714927|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161663111|NCT03149549|583818060|FG007|Study Discontinuation--Treatment Period|Death|2|||
161663112|NCT03149549|583818061|FG008|Study Discontinuation--Treatment Period|Death|4|||
161663113|NCT03149549|583818062|FG009|Study Discontinuation--Treatment Period|Death|1|||
161663114|NCT03149549|583818063|FG010|Study Discontinuation--Treatment Period|Death|0|||
161663115|NCT03149549|583818064|FG011|Study Discontinuation--Treatment Period|Death|0|||
161663116|NCT03149549|583818065|FG012|Study Discontinuation--Treatment Period|Death|1|||
161663117|NCT03149549|583818053|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663118|NCT03149549|583818054|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663119|NCT03149549|583818055|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663120|NCT03149549|583818056|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663121|NCT03149549|583818057|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663122|NCT03149549|583818058|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663123|NCT03149549|583818059|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663124|NCT03149549|583818060|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
161714928|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161714929|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161714930|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
161714931|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
161714932|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
161714933|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
161714934|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
161714935|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161714936|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
161714937|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
161714938|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
161714939|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
161714940|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161714941|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
161714942|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
161714943|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
161714944|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
161714945|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
161714946|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161714947|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161714948|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161714949|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161714950|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161714951|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
161714952|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
161714953|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161714954|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
161714955|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161714956|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
161714957|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161714958|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161714959|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161714960|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161714961|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
161714962|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
161714963|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161714964|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
161714965|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
161714966|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
161714967|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
161714968|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
161714969|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
161714970|NCT04430348|584002890|FG000|Overall Study|Death|3|||
161714971|NCT04430348|584002891|FG001|Overall Study|Death|2|||
161714972|NCT04430348|584002892|FG002|Overall Study|Death|2|||
161714973|NCT04430348|584002893|FG003|Overall Study|Death|2|||
161714974|NCT04430348|584002894|FG004|Overall Study|Death|2|||
161714975|NCT04430348|584002895|FG005|Overall Study|Death|3|||
161714976|NCT04430348|584002890|FG000|Overall Study|Lost to Follow-up|0|||
161714977|NCT04430348|584002891|FG001|Overall Study|Lost to Follow-up|0|||
161714978|NCT04430348|584002892|FG002|Overall Study|Lost to Follow-up|0|||
161714979|NCT04430348|584002893|FG003|Overall Study|Lost to Follow-up|1|||
161714980|NCT04430348|584002894|FG004|Overall Study|Lost to Follow-up|0|||
161714981|NCT04430348|584002895|FG005|Overall Study|Lost to Follow-up|0|||
161714982|NCT04430348|584002890|FG000|Overall Study|Adverse Event|0|||
161714983|NCT04430348|584002891|FG001|Overall Study|Adverse Event|0|||
161714984|NCT04430348|584002892|FG002|Overall Study|Adverse Event|0|||
161714985|NCT04430348|584002893|FG003|Overall Study|Adverse Event|0|||
161714986|NCT04430348|584002894|FG004|Overall Study|Adverse Event|0|||
161714987|NCT04430348|584002895|FG005|Overall Study|Adverse Event|1|||
161714988|NCT04430348|584002890|FG000|Overall Study|Withdrawal by Subject|0|||
161714989|NCT04430348|584002891|FG001|Overall Study|Withdrawal by Subject|1|||
161714990|NCT04430348|584002892|FG002|Overall Study|Withdrawal by Subject|0|||
161714991|NCT04430348|584002893|FG003|Overall Study|Withdrawal by Subject|0|||
161714992|NCT04430348|584002894|FG004|Overall Study|Withdrawal by Subject|0|||
161714993|NCT04430348|584002895|FG005|Overall Study|Withdrawal by Subject|1|||
161714994|NCT04430348|584002890|FG000|Overall Study|Study Terminated by Sponsor|0|||
161714995|NCT04430348|584002891|FG001|Overall Study|Study Terminated by Sponsor|0|||
161714996|NCT04430348|584002892|FG002|Overall Study|Study Terminated by Sponsor|2|||
161714997|NCT04430348|584002893|FG003|Overall Study|Study Terminated by Sponsor|0|||
161714998|NCT04430348|584002894|FG004|Overall Study|Study Terminated by Sponsor|1|||
161714999|NCT04430348|584002895|FG005|Overall Study|Study Terminated by Sponsor|1|||
161715000|NCT00384956|584002898|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
161715001|NCT01824602|584002906|FG000|Overall Study|Withdrawal by Subject|0|||
161715002|NCT01824602|584002907|FG001|Overall Study|Withdrawal by Subject|0|||
161715003|NCT01824602|584002908|FG002|Overall Study|Withdrawal by Subject|1|||
161715004|NCT01824602|584002909|FG003|Overall Study|Withdrawal by Subject|2|||
161715005|NCT01824602|584002906|FG000|Overall Study|Patient non-compliance|0|||
161715006|NCT01824602|584002907|FG001|Overall Study|Patient non-compliance|0|||
161715007|NCT01824602|584002908|FG002|Overall Study|Patient non-compliance|1|||
161715008|NCT01824602|584002909|FG003|Overall Study|Patient non-compliance|0|||
161715009|NCT01824602|584002906|FG000|Overall Study|Adverse Event|1|||
161715010|NCT01824602|584002907|FG001|Overall Study|Adverse Event|0|||
161715011|NCT01824602|584002908|FG002|Overall Study|Adverse Event|2|||
161715012|NCT01824602|584002909|FG003|Overall Study|Adverse Event|2|||
161715013|NCT01824602|584002906|FG000|Overall Study|Treatment failure|0|||
161715014|NCT01824602|584002907|FG001|Overall Study|Treatment failure|0|||
161715015|NCT01824602|584002908|FG002|Overall Study|Treatment failure|0|||
161715016|NCT01824602|584002909|FG003|Overall Study|Treatment failure|1|||
161715017|NCT00104871|584002910|FG000|Overall Study|Not evaluable|1|||
161715018|NCT02192359|584002913|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161715019|NCT02192359|584002914|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161715020|NCT02192359|584002915|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
161715021|NCT02192359|584002916|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161715022|NCT02192359|584002913|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
161715023|NCT02192359|584002914|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161715024|NCT02192359|584002915|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161663125|NCT03149549|583818061|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663126|NCT03149549|583818062|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663127|NCT03149549|583818063|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663128|NCT03149549|583818064|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161663129|NCT03149549|583818065|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
161663130|NCT03149549|583818053|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663131|NCT03149549|583818054|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663132|NCT03149549|583818055|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663133|NCT03149549|583818056|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
161663134|NCT03149549|583818057|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
161663135|NCT03149549|583818058|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
161663136|NCT03149549|583818059|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
161663137|NCT03149549|583818060|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663138|NCT03149549|583818061|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
161663139|NCT03149549|583818062|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663140|NCT03149549|583818063|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663141|NCT03149549|583818064|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663142|NCT03149549|583818065|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161663143|NCT03149549|583818053|FG000|Study Discontinuation--Treatment Period|Other|0|||
161663144|NCT03149549|583818054|FG001|Study Discontinuation--Treatment Period|Other|0|||
161663145|NCT03149549|583818055|FG002|Study Discontinuation--Treatment Period|Other|0|||
161663146|NCT03149549|583818056|FG003|Study Discontinuation--Treatment Period|Other|0|||
161663147|NCT03149549|583818057|FG004|Study Discontinuation--Treatment Period|Other|0|||
161663148|NCT03149549|583818058|FG005|Study Discontinuation--Treatment Period|Other|0|||
161663149|NCT03149549|583818059|FG006|Study Discontinuation--Treatment Period|Other|0|||
161663150|NCT03149549|583818060|FG007|Study Discontinuation--Treatment Period|Other|1|||
161663151|NCT03149549|583818061|FG008|Study Discontinuation--Treatment Period|Other|0|||
161663152|NCT03149549|583818062|FG009|Study Discontinuation--Treatment Period|Other|1|||
161663153|NCT03149549|583818063|FG010|Study Discontinuation--Treatment Period|Other|0|||
161663154|NCT03149549|583818064|FG011|Study Discontinuation--Treatment Period|Other|0|||
161663155|NCT03149549|583818065|FG012|Study Discontinuation--Treatment Period|Other|0|||
161663156|NCT03149549|583818053|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663157|NCT03149549|583818054|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663158|NCT03149549|583818055|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663159|NCT03149549|583818056|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663160|NCT03149549|583818057|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161715025|NCT02192359|584002916|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161715026|NCT02192359|584002913|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161715027|NCT02192359|584002914|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161715028|NCT02192359|584002915|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161715029|NCT02192359|584002916|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
161715030|NCT02117687|584002922|FG000|Overall Study|Lost to Follow-up|0|||
161715031|NCT02117687|584002923|FG001|Overall Study|Lost to Follow-up|1|||
161715032|NCT02117687|584002922|FG000|Overall Study|Adverse Event|0|||
161715033|NCT02117687|584002923|FG001|Overall Study|Adverse Event|2|||
161715034|NCT02117687|584002922|FG000|Overall Study|Other Reasons|1|||
161715035|NCT02117687|584002923|FG001|Overall Study|Other Reasons|1|||
161715036|NCT01687673|584002933|FG000|Overall Study|Physician Decision|1|||
161715037|NCT02234622|584002934|FG000|Overall Study|Withdrawal by Subject|16|||
161715038|NCT02234622|584002935|FG001|Overall Study|Withdrawal by Subject|22|||
161715039|NCT02234622|584002934|FG000|Overall Study|Lost to Follow-up|27|||
161715040|NCT02234622|584002935|FG001|Overall Study|Lost to Follow-up|14|||
161715041|NCT00618956|584002936|FG000|Overall Study|Adverse Event|10|||
161715042|NCT00618956|584002937|FG001|Overall Study|Adverse Event|34|||
161715043|NCT00618956|584002936|FG000|Overall Study|Lack of Efficacy|2|||
161715044|NCT00618956|584002937|FG001|Overall Study|Lack of Efficacy|1|||
161715045|NCT00618956|584002936|FG000|Overall Study|Withdrawal by Subject|5|||
161715046|NCT00618956|584002937|FG001|Overall Study|Withdrawal by Subject|7|||
161715047|NCT00618956|584002936|FG000|Overall Study|Lost to Follow-up|4|||
161715048|NCT00618956|584002937|FG001|Overall Study|Lost to Follow-up|5|||
161715049|NCT00618956|584002936|FG000|Overall Study|Protocol Violation|2|||
161715050|NCT00618956|584002937|FG001|Overall Study|Protocol Violation|2|||
161715051|NCT00618956|584002936|FG000|Overall Study|did not meet criteria, non-compliance|2|||
161715052|NCT00618956|584002937|FG001|Overall Study|did not meet criteria, non-compliance|1|||
161715053|NCT03598777|584002938|FG000|Overall Study|Study Terminated by Sponsor|3|||
161715054|NCT03598777|584002939|FG001|Overall Study|Study Terminated by Sponsor|0|||
161715055|NCT03598777|584002940|FG002|Overall Study|Study Terminated by Sponsor|0|||
161715056|NCT03598777|584002941|FG003|Overall Study|Study Terminated by Sponsor|0|||
161715057|NCT03598777|584002942|FG004|Overall Study|Study Terminated by Sponsor|15|||
161715058|NCT03598777|584002938|FG000|Overall Study|Withdrawal by Subject|1|||
161715059|NCT03598777|584002939|FG001|Overall Study|Withdrawal by Subject|1|||
161715060|NCT03598777|584002940|FG002|Overall Study|Withdrawal by Subject|0|||
161715061|NCT03598777|584002941|FG003|Overall Study|Withdrawal by Subject|0|||
161715062|NCT03598777|584002942|FG004|Overall Study|Withdrawal by Subject|0|||
161715063|NCT03598777|584002938|FG000|Overall Study|Adverse Event|1|||
161715064|NCT03598777|584002939|FG001|Overall Study|Adverse Event|0|||
161715065|NCT03598777|584002940|FG002|Overall Study|Adverse Event|0|||
161715066|NCT03598777|584002941|FG003|Overall Study|Adverse Event|0|||
161715067|NCT03598777|584002942|FG004|Overall Study|Adverse Event|0|||
161715068|NCT03598777|584002938|FG000|Overall Study|Lost to Follow-up|1|||
161715069|NCT03598777|584002939|FG001|Overall Study|Lost to Follow-up|0|||
161715070|NCT03598777|584002940|FG002|Overall Study|Lost to Follow-up|0|||
161715071|NCT03598777|584002941|FG003|Overall Study|Lost to Follow-up|0|||
161715072|NCT03598777|584002942|FG004|Overall Study|Lost to Follow-up|0|||
161715073|NCT02006576|584002943|FG000|Overall Study|Withdrawal by Subject|4|||
161715074|NCT02006576|584002944|FG001|Overall Study|Withdrawal by Subject|6|||
161715075|NCT02006576|584002945|FG002|Overall Study|Withdrawal by Subject|2|||
161715076|NCT02006576|584002943|FG000|Overall Study|Death|0|||
161715077|NCT02006576|584002944|FG001|Overall Study|Death|0|||
161715078|NCT02006576|584002945|FG002|Overall Study|Death|1|||
161715079|NCT02006576|584002943|FG000|Overall Study|Lost to Follow-up|1|||
161715080|NCT02006576|584002944|FG001|Overall Study|Lost to Follow-up|0|||
161715081|NCT02006576|584002945|FG002|Overall Study|Lost to Follow-up|1|||
161715082|NCT02006576|584002943|FG000|Overall Study|Screen Failure, too sick, other|13|||
161715083|NCT02006576|584002944|FG001|Overall Study|Screen Failure, too sick, other|1|||
161715084|NCT02006576|584002945|FG002|Overall Study|Screen Failure, too sick, other|13|||
161715085|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
161715086|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
161715087|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
161715088|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
161715089|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
161715090|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161715091|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161715092|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161715093|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161838011|NCT01156142|584450287|FG000|Overall Study|Withdrawal by Subject|8|||
161715094|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
161715095|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715096|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715097|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715098|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
161715099|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715100|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
161715101|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
161715102|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
161715103|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
161715104|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
161715105|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715106|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715107|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715108|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
161715109|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715110|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
161715111|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161715112|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161715113|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
161715114|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161715115|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161715116|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
161715117|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161715118|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161715119|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
161715120|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161715121|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
161715122|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161715123|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161715124|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
161715125|NCT00785577|584002946|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715126|NCT00785577|584002947|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715127|NCT00785577|584002948|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715128|NCT00785577|584002949|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
161715129|NCT00785577|584002950|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715130|NCT00785577|584002946|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
161715131|NCT00785577|584002947|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
161715132|NCT00785577|584002948|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
161715133|NCT00785577|584002949|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
161715134|NCT00785577|584002950|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
161715135|NCT01650805|584002955|FG000|Overall Study|Withdrawal by Subject|1|||
161715136|NCT01650805|584002956|FG001|Overall Study|Withdrawal by Subject|0|||
161715137|NCT04070378|584002962|FG000|Overall Study|Withdrawal by Subject|2|||
161715138|NCT04070378|584002962|FG000|Overall Study|Screen Failure|6|||
161715139|NCT04070378|584002962|FG000|Overall Study|Physician Decision|1|||
161715140|NCT04070378|584002962|FG000|Overall Study|Adverse Event|1|||
161715141|NCT01901328|584002963|FG000|Overall Study|Lost to Follow-up|1|||
161715142|NCT01901328|584002964|FG001|Overall Study|Lost to Follow-up|0|||
161715143|NCT01901328|584002963|FG000|Overall Study|Physician Decision|0|||
161715144|NCT01901328|584002964|FG001|Overall Study|Physician Decision|1|||
161715145|NCT01901328|584002963|FG000|Overall Study|Protocol Violation|1|||
161715146|NCT01901328|584002964|FG001|Overall Study|Protocol Violation|1|||
161715147|NCT01901328|584002963|FG000|Overall Study|Study Terminated by Sponsor|19|||
161715148|NCT01901328|584002964|FG001|Overall Study|Study Terminated by Sponsor|16|||
161715149|NCT01901328|584002963|FG000|Overall Study|Withdrawal by Subject|1|||
161715150|NCT01901328|584002964|FG001|Overall Study|Withdrawal by Subject|2|||
161715151|NCT01901328|584002963|FG000|Overall Study|Lack of Efficacy|0|||
161715152|NCT01901328|584002964|FG001|Overall Study|Lack of Efficacy|1|||
161715153|NCT02462889|584002965|FG000|Overall Study|Withdrawal by Subject|2|||
161715154|NCT02462889|584002966|FG001|Overall Study|Withdrawal by Subject|6|||
161715155|NCT02462889|584002965|FG000|Overall Study|Death|1|||
161715156|NCT02462889|584002966|FG001|Overall Study|Death|5|||
161715157|NCT04358458|584002969|FG000|Overall Study|Death|1|||
161715158|NCT04358458|584002970|FG001|Overall Study|Death|1|||
161715159|NCT04358458|584002971|FG002|Overall Study|Death|3|||
161715160|NCT04358458|584002972|FG003|Overall Study|Death|8|||
161715161|NCT04358458|584002973|FG004|Overall Study|Death|1|||
161715162|NCT04358458|584002974|FG005|Overall Study|Death|6|||
161715163|NCT04358458|584002975|FG006|Overall Study|Death|2|||
161715164|NCT04358458|584002976|FG007|Overall Study|Death|3|||
161715165|NCT04358458|584002969|FG000|Overall Study|Lost to Follow-up|0|||
161715166|NCT04358458|584002970|FG001|Overall Study|Lost to Follow-up|0|||
161715167|NCT04358458|584002971|FG002|Overall Study|Lost to Follow-up|0|||
161715168|NCT04358458|584002972|FG003|Overall Study|Lost to Follow-up|0|||
161715169|NCT04358458|584002973|FG004|Overall Study|Lost to Follow-up|0|||
161715170|NCT04358458|584002974|FG005|Overall Study|Lost to Follow-up|0|||
161715171|NCT04358458|584002975|FG006|Overall Study|Lost to Follow-up|0|||
161715172|NCT04358458|584002976|FG007|Overall Study|Lost to Follow-up|1|||
161715173|NCT04358458|584002969|FG000|Overall Study|Site is closing study participation|0|||
161715174|NCT04358458|584002970|FG001|Overall Study|Site is closing study participation|0|||
161715175|NCT04358458|584002971|FG002|Overall Study|Site is closing study participation|0|||
161715176|NCT04358458|584002972|FG003|Overall Study|Site is closing study participation|1|||
161715177|NCT04358458|584002973|FG004|Overall Study|Site is closing study participation|0|||
161715178|NCT04358458|584002974|FG005|Overall Study|Site is closing study participation|0|||
161715179|NCT04358458|584002975|FG006|Overall Study|Site is closing study participation|0|||
161715180|NCT04358458|584002976|FG007|Overall Study|Site is closing study participation|0|||
161715181|NCT04358458|584002969|FG000|Overall Study|Sponsor request|2|||
161715182|NCT04358458|584002970|FG001|Overall Study|Sponsor request|3|||
161715183|NCT04358458|584002971|FG002|Overall Study|Sponsor request|3|||
161715184|NCT04358458|584002972|FG003|Overall Study|Sponsor request|0|||
161715185|NCT04358458|584002973|FG004|Overall Study|Sponsor request|2|||
161715186|NCT04358458|584002974|FG005|Overall Study|Sponsor request|3|||
161715187|NCT04358458|584002975|FG006|Overall Study|Sponsor request|1|||
161715188|NCT04358458|584002976|FG007|Overall Study|Sponsor request|1|||
161715189|NCT04358458|584002969|FG000|Overall Study|Withdrawal by Subject|0|||
161715190|NCT04358458|584002970|FG001|Overall Study|Withdrawal by Subject|0|||
161715191|NCT04358458|584002971|FG002|Overall Study|Withdrawal by Subject|1|||
161715192|NCT04358458|584002972|FG003|Overall Study|Withdrawal by Subject|1|||
161715193|NCT04358458|584002973|FG004|Overall Study|Withdrawal by Subject|0|||
161715194|NCT04358458|584002974|FG005|Overall Study|Withdrawal by Subject|1|||
161715195|NCT04358458|584002975|FG006|Overall Study|Withdrawal by Subject|0|||
161715196|NCT04358458|584002976|FG007|Overall Study|Withdrawal by Subject|1|||
161715197|NCT01981187|584004562|FG000|Overall Study|Participant/guardian decision|2|||
161715198|NCT01981187|584004562|FG000|Overall Study|Physician Decision|1|||
161715199|NCT01981187|584004562|FG000|Overall Study|Disease progression|2|||
161715200|NCT01981187|584004562|FG000|Overall Study|Adverse Event|7|||
161715201|NCT02082184|584004564|FG000|Overall Study|Adverse Event|1|||
161715202|NCT02082184|584004565|FG001|Overall Study|Adverse Event|0|||
161715203|NCT02082184|584004564|FG000|Overall Study|Medical diagnosis|1|||
161715204|NCT02082184|584004565|FG001|Overall Study|Medical diagnosis|2|||
161715205|NCT02082184|584004564|FG000|Overall Study|Device associated symptoms|5|||
161715206|NCT02082184|584004565|FG001|Overall Study|Device associated symptoms|0|||
161715207|NCT02082184|584004564|FG000|Overall Study|Withdrawal by Subject|3|||
161663161|NCT03149549|583818058|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
161663162|NCT03149549|583818059|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
161663163|NCT03149549|583818060|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663164|NCT03149549|583818061|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
161663165|NCT03149549|583818062|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663166|NCT03149549|583818063|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663167|NCT03149549|583818064|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161663168|NCT03149549|583818065|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161715208|NCT02082184|584004565|FG001|Overall Study|Withdrawal by Subject|2|||
161715209|NCT02082184|584004564|FG000|Overall Study|Protocol Violation|0|||
161715210|NCT02082184|584004565|FG001|Overall Study|Protocol Violation|6|||
161715211|NCT02082184|584004564|FG000|Overall Study|Lost to Follow-up|0|||
161715212|NCT02082184|584004565|FG001|Overall Study|Lost to Follow-up|2|||
161715213|NCT02082184|584004564|FG000|Overall Study|Subject non-compliance|0|||
161715214|NCT02082184|584004565|FG001|Overall Study|Subject non-compliance|1|||
161715215|NCT01943539|584004568|FG000|Overall Study|Non-compliance with at-home intervention|4|||
161715216|NCT01943539|584004569|FG001|Overall Study|Non-compliance with at-home intervention|0|||
161715217|NCT02413398|584004570|FG000|Overall Study|Lost to Follow-up|2|||
161715218|NCT02413398|584004571|FG001|Overall Study|Lost to Follow-up|4|||
161715219|NCT02413398|584004570|FG000|Overall Study|Withdrawal by Subject|1|||
161715220|NCT02413398|584004571|FG001|Overall Study|Withdrawal by Subject|1|||
161715221|NCT02413398|584004570|FG000|Overall Study|Other Eligibility criteria|1|||
161715222|NCT02413398|584004571|FG001|Overall Study|Other Eligibility criteria|2|||
161715223|NCT03715465|584004572|FG000|Overall Study|Withdrawal by Subject|1|||
161715224|NCT03715465|584004573|FG001|Overall Study|Withdrawal by Subject|2|||
161715225|NCT02158533|584004574|FG000|Stage 1|Adverse Event|6|||
161715226|NCT02158533|584004575|FG001|Stage 1|Adverse Event|4|||
161715227|NCT02158533|584004576|FG002|Stage 1|Adverse Event|7|||
161715228|NCT02158533|584004577|FG003|Stage 1|Adverse Event|0|||
161715229|NCT02158533|584004578|FG004|Stage 1|Adverse Event|0|||
161715230|NCT02158533|584004579|FG005|Stage 1|Adverse Event|0|||
161715231|NCT02158533|584004574|FG000|Stage 1|Withdrawal by Subject|3|||
161715232|NCT02158533|584004575|FG001|Stage 1|Withdrawal by Subject|2|||
161715233|NCT02158533|584004576|FG002|Stage 1|Withdrawal by Subject|1|||
161715234|NCT02158533|584004577|FG003|Stage 1|Withdrawal by Subject|0|||
161715235|NCT02158533|584004578|FG004|Stage 1|Withdrawal by Subject|0|||
161715236|NCT02158533|584004579|FG005|Stage 1|Withdrawal by Subject|0|||
161715237|NCT02158533|584004574|FG000|Stage 1|Lack of Efficacy|1|||
161715238|NCT02158533|584004575|FG001|Stage 1|Lack of Efficacy|0|||
161715239|NCT02158533|584004576|FG002|Stage 1|Lack of Efficacy|0|||
161715240|NCT02158533|584004577|FG003|Stage 1|Lack of Efficacy|0|||
161715241|NCT02158533|584004578|FG004|Stage 1|Lack of Efficacy|0|||
161715242|NCT02158533|584004579|FG005|Stage 1|Lack of Efficacy|0|||
161715243|NCT02158533|584004574|FG000|Stage 1|Lost to Follow-up|3|||
161715244|NCT02158533|584004575|FG001|Stage 1|Lost to Follow-up|1|||
161715245|NCT02158533|584004576|FG002|Stage 1|Lost to Follow-up|0|||
161715246|NCT02158533|584004577|FG003|Stage 1|Lost to Follow-up|0|||
161715247|NCT02158533|584004578|FG004|Stage 1|Lost to Follow-up|0|||
161715248|NCT02158533|584004579|FG005|Stage 1|Lost to Follow-up|0|||
161715249|NCT02158533|584004574|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715250|NCT02158533|584004575|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
161715251|NCT02158533|584004576|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715252|NCT02158533|584004577|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715253|NCT02158533|584004578|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715254|NCT02158533|584004579|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715255|NCT02158533|584004574|FG000|Stage 1|Non-compliance with study visits|1|||
161715256|NCT02158533|584004575|FG001|Stage 1|Non-compliance with study visits|0|||
161715257|NCT02158533|584004576|FG002|Stage 1|Non-compliance with study visits|0|||
161715258|NCT02158533|584004577|FG003|Stage 1|Non-compliance with study visits|0|||
161715259|NCT02158533|584004578|FG004|Stage 1|Non-compliance with study visits|0|||
161715260|NCT02158533|584004579|FG005|Stage 1|Non-compliance with study visits|0|||
161715261|NCT02158533|584004574|FG000|Stage 2|Adverse Event|0|||
161715262|NCT02158533|584004575|FG001|Stage 2|Adverse Event|0|||
161715263|NCT02158533|584004576|FG002|Stage 2|Adverse Event|0|||
161715264|NCT02158533|584004577|FG003|Stage 2|Adverse Event|0|||
161715265|NCT02158533|584004578|FG004|Stage 2|Adverse Event|0|||
161715266|NCT02158533|584004579|FG005|Stage 2|Adverse Event|1|||
161715267|NCT02158533|584004574|FG000|Stage 2|Lack of Efficacy|0|||
161715268|NCT02158533|584004575|FG001|Stage 2|Lack of Efficacy|0|||
161715269|NCT02158533|584004576|FG002|Stage 2|Lack of Efficacy|0|||
161715270|NCT02158533|584004577|FG003|Stage 2|Lack of Efficacy|0|||
161715271|NCT02158533|584004578|FG004|Stage 2|Lack of Efficacy|1|||
161715272|NCT02158533|584004579|FG005|Stage 2|Lack of Efficacy|0|||
161715273|NCT02158533|584004574|FG000|Stage 2|Lost to Follow-up|0|||
161715274|NCT02158533|584004575|FG001|Stage 2|Lost to Follow-up|0|||
161715275|NCT02158533|584004576|FG002|Stage 2|Lost to Follow-up|0|||
161715276|NCT02158533|584004577|FG003|Stage 2|Lost to Follow-up|1|||
161715277|NCT02158533|584004578|FG004|Stage 2|Lost to Follow-up|1|||
161715278|NCT02158533|584004579|FG005|Stage 2|Lost to Follow-up|2|||
161715279|NCT02158533|584004574|FG000|Stage 2|Withdrawal by Subject|0|||
161715280|NCT02158533|584004575|FG001|Stage 2|Withdrawal by Subject|0|||
161715281|NCT02158533|584004576|FG002|Stage 2|Withdrawal by Subject|0|||
161715282|NCT02158533|584004577|FG003|Stage 2|Withdrawal by Subject|0|||
161715283|NCT02158533|584004578|FG004|Stage 2|Withdrawal by Subject|1|||
161715284|NCT02158533|584004579|FG005|Stage 2|Withdrawal by Subject|2|||
161715285|NCT02158533|584004574|FG000|Stage 2|Physician Decision|0|||
161715286|NCT02158533|584004575|FG001|Stage 2|Physician Decision|0|||
161715287|NCT02158533|584004576|FG002|Stage 2|Physician Decision|0|||
161715288|NCT02158533|584004577|FG003|Stage 2|Physician Decision|0|||
161715289|NCT02158533|584004578|FG004|Stage 2|Physician Decision|1|||
161715290|NCT02158533|584004579|FG005|Stage 2|Physician Decision|0|||
161715291|NCT02158533|584004574|FG000|Stage 2|Pregnancy|0|||
161715292|NCT02158533|584004575|FG001|Stage 2|Pregnancy|0|||
161715293|NCT02158533|584004576|FG002|Stage 2|Pregnancy|0|||
161715294|NCT02158533|584004577|FG003|Stage 2|Pregnancy|1|||
161715295|NCT02158533|584004578|FG004|Stage 2|Pregnancy|0|||
161715296|NCT02158533|584004579|FG005|Stage 2|Pregnancy|0|||
161715297|NCT02158533|584004574|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
161715298|NCT02158533|584004575|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
161715299|NCT02158533|584004576|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
161715300|NCT02158533|584004577|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
161715301|NCT02158533|584004578|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
161715302|NCT02158533|584004579|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
161715303|NCT02158533|584004574|FG000|Stage 2|Non-adherence with study visits|0|||
161715304|NCT02158533|584004575|FG001|Stage 2|Non-adherence with study visits|0|||
161715305|NCT02158533|584004576|FG002|Stage 2|Non-adherence with study visits|0|||
161715306|NCT02158533|584004577|FG003|Stage 2|Non-adherence with study visits|0|||
161715307|NCT02158533|584004578|FG004|Stage 2|Non-adherence with study visits|0|||
161715308|NCT02158533|584004579|FG005|Stage 2|Non-adherence with study visits|1|||
161715309|NCT00881205|584004590|FG000|Overall Study|Adverse Event|8|||
161715310|NCT00881205|584004591|FG001|Overall Study|Adverse Event|3|||
161715311|NCT00881205|584004590|FG000|Overall Study|Withdrawal by Subject|1|||
161715312|NCT00881205|584004591|FG001|Overall Study|Withdrawal by Subject|2|||
161715313|NCT00881205|584004590|FG000|Overall Study|Lost to Follow-up|0|||
161715314|NCT00881205|584004591|FG001|Overall Study|Lost to Follow-up|1|||
161715315|NCT00881205|584004590|FG000|Overall Study|Administrative problems|1|||
161715316|NCT00881205|584004591|FG001|Overall Study|Administrative problems|1|||
161715317|NCT00881205|584004590|FG000|Overall Study|Condition no longer requires drug|1|||
161715318|NCT00881205|584004591|FG001|Overall Study|Condition no longer requires drug|0|||
161838012|NCT01156142|584450288|FG001|Overall Study|Withdrawal by Subject|6|||
161838013|NCT01156142|584450287|FG000|Overall Study|Ineligible|0|||
161838014|NCT01156142|584450288|FG001|Overall Study|Ineligible|1|||
161838015|NCT00893737|584450289|FG000|Overall Study|Adverse Event|4|||
161838016|NCT00893737|584450289|FG000|Overall Study|Withdrawal by Subject|2|||
161715319|NCT02498652|584004596|FG000|Overall Study|Protocol Violation|0|||
161715320|NCT02498652|584004597|FG001|Overall Study|Protocol Violation|1|||
161715321|NCT01184989|584004602|FG000|Overall Study|Adverse Event|11|||
161715322|NCT01184989|584004602|FG000|Overall Study|Withdrawal by Subject|1|||
161715323|NCT00465569|584004603|FG000|Overall Study|persistent eczema during dose escalation|1|||
161715324|NCT00465569|584004604|FG001|Overall Study|persistent eczema during dose escalation|0|||
161715325|NCT00482001|584004606|FG000|Overall Study|Protocol Violation|1|||
161715326|NCT00482001|584004607|FG001|Overall Study|Protocol Violation|1|||
161715327|NCT04786210|584004608|FG000|Overall Study|Lost to Follow-up|2|||
161715328|NCT04786210|584004608|FG000|Overall Study|Withdrawal by Subject|4|||
161715329|NCT03826914|584004609|FG000|Overall Study|Withdrawal by Subject|1|||
161715330|NCT03826914|584004610|FG001|Overall Study|Withdrawal by Subject|1|||
161715331|NCT04334148|584004612|FG000|Overall Study|positive nasal swab at baseline|0|||
161715332|NCT04334148|584004613|FG001|Overall Study|positive nasal swab at baseline|1|||
161715333|NCT05370157|584004614|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
161715334|NCT05370157|584004615|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
161715335|NCT05370157|584004614|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
161715336|NCT05370157|584004615|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
161715337|NCT01508676|584004616|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
161715338|NCT01508676|584004617|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
161715339|NCT01508676|584004616|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
161715340|NCT01508676|584004617|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
161715341|NCT01508676|584004616|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
161715342|NCT01508676|584004617|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
161715343|NCT01508676|584004616|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
161715344|NCT01508676|584004617|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
161715345|NCT01508676|584004616|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
161715346|NCT01508676|584004617|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
161715347|NCT06129487|584004618|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
161715348|NCT06129487|584004619|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
161715349|NCT03772327|584004620|FG000|Overall Study|Lost to Follow-up|3|||
161715350|NCT03772327|584004621|FG001|Overall Study|Lost to Follow-up|4|||
161715351|NCT03772327|584004620|FG000|Overall Study|Withdrawal by Subject|2|||
161715352|NCT03772327|584004621|FG001|Overall Study|Withdrawal by Subject|3|||
161715353|NCT04689828|584004622|FG000|Overall Study|Subject decision|5|||
161715354|NCT04689828|584004623|FG001|Overall Study|Subject decision|5|||
161715355|NCT04689828|584004622|FG000|Overall Study|Adverse Event|12|||
161715356|NCT04689828|584004623|FG001|Overall Study|Adverse Event|12|||
161715357|NCT04689828|584004622|FG000|Overall Study|Physician Decision|24|||
161715358|NCT04689828|584004623|FG001|Overall Study|Physician Decision|32|||
161715359|NCT04689828|584004622|FG000|Overall Study|Progressive disease|54|||
161715360|NCT04689828|584004623|FG001|Overall Study|Progressive disease|173|||
161715361|NCT04689828|584004622|FG000|Overall Study|Death|0|||
161715362|NCT04689828|584004623|FG001|Overall Study|Death|1|||
161715363|NCT04689828|584004622|FG000|Overall Study|Lost to Follow-up|1|||
161715364|NCT04689828|584004623|FG001|Overall Study|Lost to Follow-up|0|||
161715365|NCT04689828|584004622|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
161715366|NCT04689828|584004623|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
161715367|NCT04689828|584004622|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
161715368|NCT04689828|584004623|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
161715369|NCT04689828|584004622|FG000|Overall Study|Participants not treated|7|||
161715370|NCT04689828|584004623|FG001|Overall Study|Participants not treated|2|||
161715371|NCT00195351|584004628|FG000|Overall Study|Lost to Follow-up|9|||
161715372|NCT00195351|584004629|FG001|Overall Study|Lost to Follow-up|9|||
161715373|NCT00195351|584004628|FG000|Overall Study|Withdrawal by Subject|6|||
161715374|NCT00195351|584004629|FG001|Overall Study|Withdrawal by Subject|3|||
161715375|NCT00195351|584004628|FG000|Overall Study|Protocol Deviation|3|||
161715376|NCT00195351|584004629|FG001|Overall Study|Protocol Deviation|2|||
161715377|NCT00195351|584004628|FG000|Overall Study|Death|3|||
161715378|NCT00195351|584004629|FG001|Overall Study|Death|1|||
161715379|NCT00195351|584004628|FG000|Overall Study|Lack of Efficacy|0|||
161715380|NCT00195351|584004629|FG001|Overall Study|Lack of Efficacy|1|||
161715381|NCT04332419|584004632|FG000|Overall Study|Withdrawal by Subject|1|||
161715382|NCT02493751|584004633|FG000|Overall Study|Withdrawal by Subject|2|||
161715383|NCT02493751|584004634|FG001|Overall Study|Withdrawal by Subject|8|||
161715384|NCT02493751|584004633|FG000|Overall Study|Death|6|||
161715385|NCT02493751|584004634|FG001|Overall Study|Death|13|||
161715386|NCT02493751|584004633|FG000|Overall Study|Lost to Follow-up|2|||
161715387|NCT02493751|584004634|FG001|Overall Study|Lost to Follow-up|3|||
161715388|NCT02493751|584004633|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
161715389|NCT02493751|584004634|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
161715390|NCT01480180|584004635|FG000|Main Phase|Withdrawal criteria|12|||
161715391|NCT01480180|584004636|FG001|Main Phase|Withdrawal criteria|1|||
161715392|NCT01480180|584004637|FG002|Main Phase|Withdrawal criteria|0|||
161715393|NCT01480180|584004638|FG003|Main Phase|Withdrawal criteria|0|||
161715394|NCT01480180|584004639|FG004|Main Phase|Withdrawal criteria|0|||
161715395|NCT01480180|584004640|FG005|Main Phase|Withdrawal criteria|0|||
161715396|NCT01480180|584004635|FG000|Main Phase|Lack of Efficacy|1|||
161715397|NCT01480180|584004636|FG001|Main Phase|Lack of Efficacy|0|||
161715398|NCT01480180|584004637|FG002|Main Phase|Lack of Efficacy|0|||
161715399|NCT01480180|584004638|FG003|Main Phase|Lack of Efficacy|0|||
161715400|NCT01480180|584004639|FG004|Main Phase|Lack of Efficacy|0|||
161715401|NCT01480180|584004640|FG005|Main Phase|Lack of Efficacy|0|||
161715402|NCT01480180|584004635|FG000|Main Phase|Non-compliance|3|||
161715403|NCT01480180|584004636|FG001|Main Phase|Non-compliance|0|||
161715404|NCT01480180|584004637|FG002|Main Phase|Non-compliance|0|||
161715405|NCT01480180|584004638|FG003|Main Phase|Non-compliance|0|||
161715406|NCT01480180|584004639|FG004|Main Phase|Non-compliance|0|||
161715407|NCT01480180|584004640|FG005|Main Phase|Non-compliance|0|||
161715408|NCT01480180|584004635|FG000|Main Phase|Unclassified|3|||
161715409|NCT01480180|584004636|FG001|Main Phase|Unclassified|0|||
161715410|NCT01480180|584004637|FG002|Main Phase|Unclassified|0|||
161715411|NCT01480180|584004638|FG003|Main Phase|Unclassified|0|||
161715412|NCT01480180|584004639|FG004|Main Phase|Unclassified|0|||
161715413|NCT01480180|584004640|FG005|Main Phase|Unclassified|0|||
161715414|NCT01480180|584004635|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
161715415|NCT01480180|584004636|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
161715416|NCT01480180|584004637|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
161715417|NCT01480180|584004638|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
161715418|NCT01480180|584004639|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
161715419|NCT01480180|584004640|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
161715420|NCT01480180|584004635|FG000|Extension Phase, Part 1|Unclassified|0|||
161715421|NCT01480180|584004636|FG001|Extension Phase, Part 1|Unclassified|0|||
161715422|NCT01480180|584004637|FG002|Extension Phase, Part 1|Unclassified|1|||
161715423|NCT01480180|584004638|FG003|Extension Phase, Part 1|Unclassified|0|||
161715424|NCT01480180|584004639|FG004|Extension Phase, Part 1|Unclassified|0|||
161715425|NCT01480180|584004640|FG005|Extension Phase, Part 1|Unclassified|0|||
161715426|NCT01480180|584004635|FG000|Extension Phase, Part 1|Adverse Event|0|||
161715427|NCT01480180|584004636|FG001|Extension Phase, Part 1|Adverse Event|0|||
161715428|NCT01480180|584004637|FG002|Extension Phase, Part 1|Adverse Event|4|||
161715429|NCT01480180|584004638|FG003|Extension Phase, Part 1|Adverse Event|1|||
161715430|NCT01480180|584004639|FG004|Extension Phase, Part 1|Adverse Event|0|||
161715431|NCT01480180|584004640|FG005|Extension Phase, Part 1|Adverse Event|0|||
161715432|NCT01480180|584004635|FG000|Extension Phase, Part 1|Change of treatment|0|||
161715433|NCT01480180|584004636|FG001|Extension Phase, Part 1|Change of treatment|0|||
161715434|NCT01480180|584004637|FG002|Extension Phase, Part 1|Change of treatment|0|||
161715435|NCT01480180|584004638|FG003|Extension Phase, Part 1|Change of treatment|9|||
161715436|NCT01480180|584004639|FG004|Extension Phase, Part 1|Change of treatment|0|||
161715437|NCT01480180|584004640|FG005|Extension Phase, Part 1|Change of treatment|0|||
161715438|NCT01480180|584004635|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
161715439|NCT01480180|584004636|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
161715440|NCT01480180|584004637|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
161715441|NCT01480180|584004638|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
161715442|NCT01480180|584004639|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
161715443|NCT01480180|584004640|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
161715444|NCT01480180|584004635|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
161715445|NCT01480180|584004636|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
161715446|NCT01480180|584004637|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
161715447|NCT01480180|584004638|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
161715448|NCT01480180|584004639|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
161715449|NCT01480180|584004640|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
161715450|NCT01480180|584004635|FG000|Extension Phase, Part 2|Unclassified|0|||
161715451|NCT01480180|584004636|FG001|Extension Phase, Part 2|Unclassified|0|||
161715452|NCT01480180|584004637|FG002|Extension Phase, Part 2|Unclassified|3|||
161715453|NCT01480180|584004638|FG003|Extension Phase, Part 2|Unclassified|1|||
161715454|NCT01480180|584004639|FG004|Extension Phase, Part 2|Unclassified|1|||
161715455|NCT01480180|584004640|FG005|Extension Phase, Part 2|Unclassified|0|||
161715456|NCT00519623|584004641|FG000|Overall Study|Adverse Event|1|||
161715457|NCT04222725|584004644|FG000|Overall Study|Adverse Event|0|||
161715458|NCT04222725|584004645|FG001|Overall Study|Adverse Event|1|||
161715459|NCT04222725|584004646|FG002|Overall Study|Adverse Event|0|||
161715460|NCT04222725|584004647|FG003|Overall Study|Adverse Event|0|||
161715461|NCT03819140|584004648|FG000|Overall Study|Lost to Follow-up|1|||
161715462|NCT03819140|584004649|FG001|Overall Study|Lost to Follow-up|2|||
161715463|NCT03819140|584004648|FG000|Overall Study|Withdrawal by Subject|3|||
161715464|NCT03819140|584004649|FG001|Overall Study|Withdrawal by Subject|2|||
161715465|NCT03819140|584004648|FG000|Overall Study|Adverse Event|0|||
161715466|NCT03819140|584004649|FG001|Overall Study|Adverse Event|1|||
161715467|NCT03819140|584004648|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
161715468|NCT03819140|584004649|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
161715469|NCT03819140|584004648|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
161715470|NCT03819140|584004649|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
161715471|NCT00658333|584004650|FG000|Overall Study|Adverse Event|2|||
161715472|NCT00658333|584004651|FG001|Overall Study|Adverse Event|1|||
161715473|NCT00828451|584004654|FG000|Overall Study|Death|2|||
161715474|NCT00828451|584004654|FG000|Overall Study|Lack of intravenous line|7|||
161715475|NCT00828451|584004654|FG000|Overall Study|Withdrawal by Subject|1|||
161715476|NCT00828451|584004654|FG000|Overall Study|Deterioration in clinical status|1|||
161715477|NCT03256539|584004655|FG000|Overall Study|Withdrawal by Subject|0|||
161715478|NCT03256539|584004656|FG001|Overall Study|Withdrawal by Subject|3|||
161715479|NCT03256539|584004655|FG000|Overall Study|Unexpected closure of study components|8|||
161715480|NCT03256539|584004656|FG001|Overall Study|Unexpected closure of study components|4|||
161715481|NCT05755438|584004659|FG000|12-week DBVC Period|Adverse Event|4|||
161715482|NCT05755438|584004660|FG001|12-week DBVC Period|Adverse Event|1|||
161715483|NCT05755438|584004659|FG000|12-week DBVC Period|Physician Decision|1|||
161715484|NCT05755438|584004660|FG001|12-week DBVC Period|Physician Decision|1|||
161715485|NCT05755438|584004659|FG000|12-week DBVC Period|Protocol Violation|4|||
161715486|NCT05755438|584004660|FG001|12-week DBVC Period|Protocol Violation|2|||
161715487|NCT05755438|584004659|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
161715488|NCT05755438|584004660|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
161715489|NCT05755438|584004659|FG000|12-week DBVC Period|Sponsor Decision|1|||
161715490|NCT05755438|584004660|FG001|12-week DBVC Period|Sponsor Decision|0|||
161715491|NCT05755438|584004659|FG000|40-week OLE Period|Adverse Event|0|||
161715492|NCT05755438|584004660|FG001|40-week OLE Period|Adverse Event|2|||
161715493|NCT05755438|584004659|FG000|40-week OLE Period|Lack of Efficacy|1|||
161715494|NCT05755438|584004660|FG001|40-week OLE Period|Lack of Efficacy|1|||
161715495|NCT05755438|584004659|FG000|40-week OLE Period|Lost to Follow-up|1|||
161715496|NCT05755438|584004660|FG001|40-week OLE Period|Lost to Follow-up|0|||
161715497|NCT05755438|584004659|FG000|40-week OLE Period|Physician Decision|1|||
161715498|NCT05755438|584004660|FG001|40-week OLE Period|Physician Decision|1|||
161715499|NCT05755438|584004659|FG000|40-week OLE Period|Protocol Violation|1|||
161715500|NCT05755438|584004660|FG001|40-week OLE Period|Protocol Violation|1|||
161715501|NCT05755438|584004659|FG000|40-week OLE Period|Withdrawal by Subject|6|||
161715502|NCT05755438|584004660|FG001|40-week OLE Period|Withdrawal by Subject|6|||
161715503|NCT05755438|584004659|FG000|40-week OLE Period|Sponsor Decision|3|||
161715504|NCT05755438|584004660|FG001|40-week OLE Period|Sponsor Decision|0|||
161715505|NCT05755438|584004659|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
161715506|NCT05755438|584004660|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
161715507|NCT05755438|584004659|FG000|40-week OLE Period|Ongoing|46|||
161715508|NCT05755438|584004660|FG001|40-week OLE Period|Ongoing|58|||
161838017|NCT00893737|584450289|FG000|Overall Study|Lost to Follow-up|6|||
161663169|NCT03149549|583818053|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161715509|NCT00624338|584004665|FG000|Overall Study|Adverse Event|14|||
161715510|NCT00624338|584004666|FG001|Overall Study|Adverse Event|14|||
161715511|NCT00624338|584004667|FG002|Overall Study|Adverse Event|18|||
161715512|NCT00624338|584004665|FG000|Overall Study|Lost to Follow-up|1|||
161715513|NCT00624338|584004666|FG001|Overall Study|Lost to Follow-up|0|||
161715514|NCT00624338|584004667|FG002|Overall Study|Lost to Follow-up|0|||
161715515|NCT00624338|584004665|FG000|Overall Study|Lack of Efficacy|11|||
161715516|NCT00624338|584004666|FG001|Overall Study|Lack of Efficacy|3|||
161715517|NCT00624338|584004667|FG002|Overall Study|Lack of Efficacy|14|||
161715518|NCT00624338|584004665|FG000|Overall Study|Protocol Violation|3|||
161715519|NCT00624338|584004666|FG001|Overall Study|Protocol Violation|3|||
161715520|NCT00624338|584004667|FG002|Overall Study|Protocol Violation|2|||
161715521|NCT00624338|584004665|FG000|Overall Study|Death|0|||
161715522|NCT00624338|584004666|FG001|Overall Study|Death|2|||
161715523|NCT00624338|584004667|FG002|Overall Study|Death|0|||
161715524|NCT00624338|584004665|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
161715525|NCT00624338|584004666|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
161715526|NCT00624338|584004667|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
161715527|NCT00624338|584004665|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
161663170|NCT03149549|583818054|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663171|NCT03149549|583818055|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663172|NCT03149549|583818056|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663173|NCT03149549|583818057|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
161663174|NCT03149549|583818058|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663175|NCT03149549|583818059|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663176|NCT03149549|583818060|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
161663177|NCT03149549|583818061|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
161663178|NCT03149549|583818062|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663179|NCT03149549|583818063|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161663180|NCT03149549|583818064|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
161663181|NCT03149549|583818065|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
161663182|NCT03149549|583818053|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663183|NCT03149549|583818054|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663184|NCT03149549|583818055|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663185|NCT03149549|583818056|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663186|NCT03149549|583818057|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161663187|NCT03149549|583818058|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663188|NCT03149549|583818059|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663189|NCT03149549|583818060|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
161663190|NCT03149549|583818061|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161663191|NCT03149549|583818062|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161663192|NCT03149549|583818063|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
161663193|NCT03149549|583818064|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161663194|NCT03149549|583818065|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161663195|NCT03149549|583818053|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
161663196|NCT03149549|583818054|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
161663197|NCT03149549|583818055|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
161663198|NCT03149549|583818056|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
161663199|NCT03149549|583818057|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
161663200|NCT03149549|583818058|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
161663201|NCT03149549|583818059|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
161663202|NCT03149549|583818060|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
161663203|NCT03149549|583818061|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
161663204|NCT03149549|583818062|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
161663205|NCT03149549|583818063|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
161663206|NCT03149549|583818064|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
161663207|NCT03149549|583818065|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
161663208|NCT03149549|583818053|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
161663209|NCT03149549|583818054|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
161663210|NCT03149549|583818055|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
161663211|NCT03149549|583818056|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
161663212|NCT03149549|583818057|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
161663213|NCT03149549|583818058|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
161663214|NCT03149549|583818059|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
161663215|NCT03149549|583818060|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
161663216|NCT03149549|583818061|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
161663217|NCT03149549|583818062|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
161715528|NCT00624338|584004666|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
161715529|NCT00624338|584004667|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
161715530|NCT00624338|584004665|FG000|Overall Study|Other|15|||
161715531|NCT00624338|584004666|FG001|Overall Study|Other|5|||
161715532|NCT00624338|584004667|FG002|Overall Study|Other|9|||
161715533|NCT00624338|584004665|FG000|Overall Study|Randomized but not treated|2|||
161715534|NCT00624338|584004666|FG001|Overall Study|Randomized but not treated|1|||
161715535|NCT00624338|584004667|FG002|Overall Study|Randomized but not treated|3|||
161715536|NCT01548638|584004668|FG000|Overall Study|Protocol Violation|3|||
161715537|NCT01548638|584004668|FG000|Overall Study|Withdrawal by Subject|1|||
161715538|NCT01476787|584004672|FG000|Treatment|Progression|64|||
161715539|NCT01476787|584004673|FG001|Treatment|Progression|71|||
161715540|NCT01476787|584004672|FG000|Treatment|Toxicity|44|||
161715541|NCT01476787|584004673|FG001|Treatment|Toxicity|16|||
161715542|NCT01476787|584004672|FG000|Treatment|Death|0|||
161715543|NCT01476787|584004673|FG001|Treatment|Death|1|||
161715544|NCT01476787|584004672|FG000|Treatment|Withdrawal by Subject|3|||
161715545|NCT01476787|584004673|FG001|Treatment|Withdrawal by Subject|14|||
161715546|NCT01476787|584004672|FG000|Treatment|Major protocol violation|1|||
161715547|NCT01476787|584004673|FG001|Treatment|Major protocol violation|6|||
161715548|NCT01476787|584004672|FG000|Treatment|Other reasons|10|||
161715549|NCT01476787|584004673|FG001|Treatment|Other reasons|22|||
161715550|NCT01476787|584004672|FG000|Treatment|Concurrent illness|12|||
161715551|NCT01476787|584004673|FG001|Treatment|Concurrent illness|9|||
161715552|NCT01476787|584004672|FG000|Treatment|Insufficient response|15|||
161715553|NCT01476787|584004673|FG001|Treatment|Insufficient response|3|||
161715554|NCT01476787|584004672|FG000|Treatment|Voluntary treatment discontinuation|8|||
161715555|NCT01476787|584004673|FG001|Treatment|Voluntary treatment discontinuation|4|||
161715556|NCT01919411|584004684|FG000|Overall Study|Lost to Follow-up|2|||
161715557|NCT01919411|584004685|FG001|Overall Study|Lost to Follow-up|4|||
161715558|NCT01919411|584004684|FG000|Overall Study|Physician Decision|1|||
161715559|NCT01919411|584004685|FG001|Overall Study|Physician Decision|0|||
161715560|NCT01919411|584004684|FG000|Overall Study|Protocol Violation|2|||
161715561|NCT01919411|584004685|FG001|Overall Study|Protocol Violation|1|||
161715562|NCT02403206|584004687|FG000|Overall Study|Lost to Follow-up|4|||
161715563|NCT02403206|584004688|FG001|Overall Study|Lost to Follow-up|3|||
161715564|NCT02403206|584004687|FG000|Overall Study|Physician Decision|2|||
161715565|NCT02403206|584004688|FG001|Overall Study|Physician Decision|0|||
161715566|NCT02403206|584004687|FG000|Overall Study|Withdrawal by Subject|3|||
161715567|NCT02403206|584004688|FG001|Overall Study|Withdrawal by Subject|3|||
161715568|NCT02403206|584004687|FG000|Overall Study|Reason not given|2|||
161715569|NCT02403206|584004688|FG001|Overall Study|Reason not given|4|||
161715570|NCT03567187|584004694|FG000|Overall Study|Lost to Follow-up|18|||
161715571|NCT04636177|584004697|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
161715572|NCT04636177|584004698|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
161715573|NCT04636177|584004697|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
161715574|NCT04636177|584004698|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
161715575|NCT04636177|584004697|FG000|Single-arm portion|Withdrawal by Subject|1|||
161715576|NCT04636177|584004698|FG001|Single-arm portion|Withdrawal by Subject|0|||
161715577|NCT04636177|584004697|FG000|Single-arm portion|Adverse Event|1|||
161715578|NCT04636177|584004698|FG001|Single-arm portion|Adverse Event|0|||
161715579|NCT00443560|584006305|FG000|Overall Study|No intrathecal dose|58|||
161715580|NCT00443560|584006306|FG001|Overall Study|No intrathecal dose|26|||
161715581|NCT00443560|584006305|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
161715582|NCT00443560|584006306|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
161715583|NCT01494038|584006311|FG000|Overall Study|Protocol Violation|1|||
161715584|NCT01494038|584006312|FG001|Overall Study|Protocol Violation|1|||
161663218|NCT03149549|583818063|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
161663219|NCT03149549|583818064|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
161663220|NCT03149549|583818065|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
161663221|NCT05917470|583818066|FG000|Overall Study|Progressive Disease|1|||
161663222|NCT05917470|583818067|FG001|Overall Study|Progressive Disease|1|||
161663223|NCT05917470|583818068|FG002|Overall Study|Progressive Disease|2|||
161663224|NCT05917470|583818069|FG003|Overall Study|Progressive Disease|3|||
161663225|NCT05917470|583818070|FG004|Overall Study|Progressive Disease|1|||
161663226|NCT05917470|583818071|FG005|Overall Study|Progressive Disease|1|||
161663227|NCT05917470|583818072|FG006|Overall Study|Progressive Disease|0|||
161715585|NCT01494038|584006311|FG000|Overall Study|Lost to Follow-up|18|||
161715586|NCT01494038|584006312|FG001|Overall Study|Lost to Follow-up|20|||
161715587|NCT01494038|584006311|FG000|Overall Study|Withdrawal by Subject|44|||
161715588|NCT01494038|584006312|FG001|Overall Study|Withdrawal by Subject|34|||
161715589|NCT01494038|584006311|FG000|Overall Study|Not able to get to clinic|21|||
161715590|NCT01494038|584006312|FG001|Overall Study|Not able to get to clinic|15|||
161715591|NCT01494038|584006311|FG000|Overall Study|Not willing to adhere to reqs|2|||
161715592|NCT01494038|584006312|FG001|Overall Study|Not willing to adhere to reqs|9|||
161715593|NCT01494038|584006311|FG000|Overall Study|Death|2|||
161715594|NCT01494038|584006312|FG001|Overall Study|Death|4|||
161715595|NCT00537940|584006313|FG000|Overall Study|Adverse Event|20|||
161715596|NCT00537940|584006314|FG001|Overall Study|Adverse Event|19|||
161663228|NCT05917470|583818073|FG007|Overall Study|Progressive Disease|0|||
161663229|NCT05917470|583818066|FG000|Overall Study|Withdrawal by Subject|0|||
161838018|NCT00928707|584450290|FG000|Overall Study|Protocol Violation|1|||
161663230|NCT05917470|583818067|FG001|Overall Study|Withdrawal by Subject|0|||
161663231|NCT05917470|583818068|FG002|Overall Study|Withdrawal by Subject|1|||
161663232|NCT05917470|583818069|FG003|Overall Study|Withdrawal by Subject|0|||
161663233|NCT05917470|583818070|FG004|Overall Study|Withdrawal by Subject|0|||
161663234|NCT05917470|583818071|FG005|Overall Study|Withdrawal by Subject|0|||
161663235|NCT05917470|583818072|FG006|Overall Study|Withdrawal by Subject|0|||
161663236|NCT05917470|583818073|FG007|Overall Study|Withdrawal by Subject|0|||
161663237|NCT05917470|583818066|FG000|Overall Study|Sponsor Decision|0|||
161663238|NCT05917470|583818067|FG001|Overall Study|Sponsor Decision|0|||
161663239|NCT05917470|583818068|FG002|Overall Study|Sponsor Decision|1|||
161663240|NCT05917470|583818069|FG003|Overall Study|Sponsor Decision|0|||
161663241|NCT05917470|583818070|FG004|Overall Study|Sponsor Decision|2|||
161663242|NCT05917470|583818071|FG005|Overall Study|Sponsor Decision|1|||
161663243|NCT05917470|583818072|FG006|Overall Study|Sponsor Decision|3|||
161663244|NCT05917470|583818073|FG007|Overall Study|Sponsor Decision|3|||
161663245|NCT05917470|583818066|FG000|Overall Study|Adverse Event|0|||
161663246|NCT05917470|583818067|FG001|Overall Study|Adverse Event|0|||
161663247|NCT05917470|583818068|FG002|Overall Study|Adverse Event|0|||
161663248|NCT05917470|583818069|FG003|Overall Study|Adverse Event|0|||
161663249|NCT05917470|583818070|FG004|Overall Study|Adverse Event|0|||
161663250|NCT05917470|583818071|FG005|Overall Study|Adverse Event|1|||
161663251|NCT05917470|583818072|FG006|Overall Study|Adverse Event|0|||
161663252|NCT05917470|583818073|FG007|Overall Study|Adverse Event|0|||
161663253|NCT02317432|583818074|FG000|Overall Study|Death|4|||
161663254|NCT02317432|583818075|FG001|Overall Study|Death|1|||
161663255|NCT02317432|583818074|FG000|Overall Study|Lost to Follow-up|0|||
161663256|NCT02317432|583818075|FG001|Overall Study|Lost to Follow-up|5|||
161663257|NCT02317432|583818074|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
161663258|NCT02317432|583818075|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
161663259|NCT01328717|583820310|FG000|Overall Study|Adverse Event|1|||
161663260|NCT00346268|583820311|FG000|Overall Study|Adverse Event|1|||
161663261|NCT00346268|583820312|FG001|Overall Study|Adverse Event|0|||
161663262|NCT00346268|583820311|FG000|Overall Study|Protocol Violation|1|||
161663263|NCT00346268|583820312|FG001|Overall Study|Protocol Violation|0|||
161663264|NCT00346268|583820311|FG000|Overall Study|Participant refused|0|||
161663265|NCT00346268|583820312|FG001|Overall Study|Participant refused|3|||
161663266|NCT01557283|583820317|FG000|Overall Study|Lost to Follow-up|7|||
161663267|NCT01557283|583820317|FG000|Overall Study|Non-responder|19|||
161663268|NCT01557283|583820317|FG000|Overall Study|Adverse Event|7|||
161715597|NCT00537940|584006313|FG000|Overall Study|Lack of Efficacy|8|||
161715598|NCT00537940|584006314|FG001|Overall Study|Lack of Efficacy|16|||
161715599|NCT00537940|584006313|FG000|Overall Study|Lost to Follow-up|23|||
161663269|NCT01557283|583820317|FG000|Overall Study|Lack of Efficacy|1|||
161663270|NCT01557283|583820317|FG000|Overall Study|Non-compliance|1|||
161663271|NCT01557283|583820317|FG000|Overall Study|Withdrawal by Subject|1|||
161663272|NCT01557283|583820317|FG000|Overall Study|Participant's weight too high for dose|1|||
161663273|NCT01557283|583820317|FG000|Overall Study|Worsening of psoriasis|1|||
161663274|NCT01557283|583820317|FG000|Overall Study|Other|6|||
161663275|NCT01765192|583820321|FG000|Treatment Period 1|Adverse Event|0|||
161663276|NCT01765192|583820322|FG001|Treatment Period 1|Adverse Event|1|||
161663277|NCT01765192|583820321|FG000|Washout Period|Voluntary Withdrawal|1|||
161663278|NCT01765192|583820322|FG001|Washout Period|Voluntary Withdrawal|1|||
161663279|NCT01765192|583820321|FG000|Washout Period|Reason not specified|1|||
161663280|NCT01765192|583820322|FG001|Washout Period|Reason not specified|0|||
161663281|NCT01765192|583820321|FG000|Treatment Period 2|Reason not specified|0|||
161663282|NCT01765192|583820322|FG001|Treatment Period 2|Reason not specified|2|||
161715600|NCT00537940|584006314|FG001|Overall Study|Lost to Follow-up|29|||
161715601|NCT00537940|584006313|FG000|Overall Study|Withdrawal by Subject|113|||
161715602|NCT00537940|584006314|FG001|Overall Study|Withdrawal by Subject|95|||
161715603|NCT00537940|584006313|FG000|Overall Study|Protocol Violation|6|||
161715604|NCT00537940|584006314|FG001|Overall Study|Protocol Violation|4|||
161715605|NCT00537940|584006313|FG000|Overall Study|Pregnancy|1|||
161715606|NCT00537940|584006314|FG001|Overall Study|Pregnancy|1|||
161715607|NCT00537940|584006313|FG000|Overall Study|Study terminated by sponsor|2|||
161715608|NCT00537940|584006314|FG001|Overall Study|Study terminated by sponsor|3|||
161715609|NCT00537940|584006313|FG000|Overall Study|Other|10|||
161715610|NCT00537940|584006314|FG001|Overall Study|Other|12|||
161715611|NCT02138110|584006319|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
161715612|NCT02138110|584006319|FG000|Overall Scaffold Implantation|Death|3|||
161715613|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
161715614|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
161715615|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
161715616|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
161715617|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
161715618|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
161715619|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
161715620|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
161715621|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
161715622|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
161715623|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
161715624|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
161715625|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
161715626|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
161715627|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
161715628|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
161715629|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
161715630|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
161715631|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Death|0|||
161715632|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Death|1|||
161715633|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Death|0|||
161715634|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
161715635|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
161715636|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
161715637|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
161715638|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
161715639|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
161715640|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
161715641|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
161715642|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
161715643|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
161715644|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
161715645|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
161715646|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
161715647|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
161715648|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
161715649|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
161715650|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
161715651|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
161715652|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
161663283|NCT01765192|583820321|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
161715653|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
161715654|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
161715655|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Other|0|||
161715656|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Other|1|||
161715657|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Other|0|||
161838019|NCT00928707|584450291|FG001|Overall Study|Protocol Violation|0|||
161663284|NCT01765192|583820322|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
161663285|NCT01016977|583820323|FG000|Overall Study|Lost to Follow-up|1|||
161663286|NCT01016977|583820324|FG001|Overall Study|Lost to Follow-up|0|||
161663287|NCT01016977|583820323|FG000|Overall Study|Withdrawal by Subject|2|||
161663288|NCT01016977|583820324|FG001|Overall Study|Withdrawal by Subject|2|||
161663289|NCT02080221|583820325|FG000|Overall Study|Withdrawal by Subject|1|||
161663290|NCT02080221|583820325|FG000|Overall Study|Clinical Progression of Disease|1|||
161663291|NCT03184870|583820331|FG000|Initial Treatment|Death|6|||
161663292|NCT03184870|583820332|FG001|Initial Treatment|Death|6|||
161663293|NCT03184870|583820333|FG002|Initial Treatment|Death|8|||
161663294|NCT03184870|583820334|FG003|Initial Treatment|Death|8|||
161663295|NCT03184870|583820335|FG004|Initial Treatment|Death|6|||
161663296|NCT03184870|583820336|FG005|Initial Treatment|Death|6|||
161663297|NCT03184870|583820337|FG006|Initial Treatment|Death|6|||
161663298|NCT03184870|583820338|FG007|Initial Treatment|Death|7|||
161663299|NCT03184870|583820339|FG008|Initial Treatment|Death|1|||
161663300|NCT03184870|583820340|FG009|Initial Treatment|Death|2|||
161663301|NCT03184870|583820341|FG010|Initial Treatment|Death|26|||
161663302|NCT03184870|583820342|FG011|Initial Treatment|Death|28|||
161663303|NCT03184870|583820343|FG012|Initial Treatment|Death|10|||
161663304|NCT03184870|583820344|FG013|Initial Treatment|Death|33|||
161663305|NCT03184870|583820345|FG014|Initial Treatment|Death|34|||
161663306|NCT03184870|583820346|FG015|Initial Treatment|Death|26|||
161663307|NCT03184870|583820347|FG016|Initial Treatment|Death|20|||
161663308|NCT03184870|583820348|FG017|Initial Treatment|Death|18|||
161663309|NCT03184870|583820331|FG000|Initial Treatment|Other Reasons|2|||
161663310|NCT03184870|583820332|FG001|Initial Treatment|Other Reasons|2|||
161663311|NCT03184870|583820333|FG002|Initial Treatment|Other Reasons|0|||
161663312|NCT03184870|583820334|FG003|Initial Treatment|Other Reasons|1|||
161663313|NCT03184870|583820335|FG004|Initial Treatment|Other Reasons|0|||
161663314|NCT03184870|583820336|FG005|Initial Treatment|Other Reasons|0|||
161663315|NCT03184870|583820337|FG006|Initial Treatment|Other Reasons|0|||
161663316|NCT03184870|583820338|FG007|Initial Treatment|Other Reasons|2|||
161663317|NCT03184870|583820339|FG008|Initial Treatment|Other Reasons|0|||
161663318|NCT03184870|583820340|FG009|Initial Treatment|Other Reasons|0|||
161663319|NCT03184870|583820341|FG010|Initial Treatment|Other Reasons|4|||
161663320|NCT03184870|583820342|FG011|Initial Treatment|Other Reasons|2|||
161663321|NCT03184870|583820343|FG012|Initial Treatment|Other Reasons|2|||
161663322|NCT03184870|583820344|FG013|Initial Treatment|Other Reasons|0|||
161663323|NCT03184870|583820345|FG014|Initial Treatment|Other Reasons|0|||
161663324|NCT03184870|583820346|FG015|Initial Treatment|Other Reasons|1|||
161663325|NCT03184870|583820347|FG016|Initial Treatment|Other Reasons|0|||
161663326|NCT03184870|583820348|FG017|Initial Treatment|Other Reasons|2|||
161663327|NCT03184870|583820331|FG000|Initial Treatment|Lost to Follow-up|2|||
161663328|NCT03184870|583820332|FG001|Initial Treatment|Lost to Follow-up|0|||
161663329|NCT03184870|583820333|FG002|Initial Treatment|Lost to Follow-up|0|||
161663330|NCT03184870|583820334|FG003|Initial Treatment|Lost to Follow-up|1|||
161663331|NCT03184870|583820335|FG004|Initial Treatment|Lost to Follow-up|1|||
161663332|NCT03184870|583820336|FG005|Initial Treatment|Lost to Follow-up|1|||
161663333|NCT03184870|583820337|FG006|Initial Treatment|Lost to Follow-up|0|||
161715658|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
161715659|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
161715660|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
161715661|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
161715662|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
161715663|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
161715664|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
161715665|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
161715666|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
161715667|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
161715668|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
161715669|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
161715670|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
161715671|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
161715672|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
161715673|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
161715674|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
161715675|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
161715676|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
161715677|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
161715678|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
161715679|NCT01389128|584006326|FG000|Overall Study|Fetal distress|1|||
161715680|NCT01389128|584006327|FG001|Overall Study|Fetal distress|0|||
161715681|NCT01389128|584006326|FG000|Overall Study|Cervix dilation stop|1|||
161715682|NCT01389128|584006327|FG001|Overall Study|Cervix dilation stop|2|||
161715683|NCT01389128|584006326|FG000|Overall Study|Rapid labor evolution|3|||
161715684|NCT01389128|584006327|FG001|Overall Study|Rapid labor evolution|2|||
161715685|NCT01389128|584006326|FG000|Overall Study|Intolerance to procedure|0|||
161715686|NCT01389128|584006327|FG001|Overall Study|Intolerance to procedure|2|||
161715687|NCT01451515|584006328|FG000|Overall Study|Death|0|||
161715688|NCT01451515|584006329|FG001|Overall Study|Death|1|||
161715689|NCT01451515|584006330|FG002|Overall Study|Death|0|||
161715690|NCT01451515|584006328|FG000|Overall Study|Withdrawal by Subject|0|||
161715691|NCT01451515|584006329|FG001|Overall Study|Withdrawal by Subject|1|||
161715692|NCT01451515|584006330|FG002|Overall Study|Withdrawal by Subject|0|||
161715693|NCT01451515|584006328|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
161715694|NCT01451515|584006329|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
161715695|NCT01451515|584006330|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
161715696|NCT01451515|584006328|FG000|Overall Study|Relapse (except CNS)|1|||
161715697|NCT01451515|584006329|FG001|Overall Study|Relapse (except CNS)|1|||
161715698|NCT01451515|584006330|FG002|Overall Study|Relapse (except CNS)|0|||
161715699|NCT00174941|584006334|FG000|Overall Study|Adverse Event|1|||
161715700|NCT00174941|584006335|FG001|Overall Study|Adverse Event|10|||
161715701|NCT00174941|584006336|FG002|Overall Study|Adverse Event|2|||
161715702|NCT00174941|584006337|FG003|Overall Study|Adverse Event|13|||
161715703|NCT00174941|584006334|FG000|Overall Study|Protocol Violation|0|||
161715704|NCT00174941|584006335|FG001|Overall Study|Protocol Violation|1|||
161715705|NCT00174941|584006336|FG002|Overall Study|Protocol Violation|0|||
161715706|NCT00174941|584006337|FG003|Overall Study|Protocol Violation|1|||
161715707|NCT00174941|584006334|FG000|Overall Study|Lost to Follow-up|0|||
161715708|NCT00174941|584006335|FG001|Overall Study|Lost to Follow-up|3|||
161715709|NCT00174941|584006336|FG002|Overall Study|Lost to Follow-up|2|||
161715710|NCT00174941|584006337|FG003|Overall Study|Lost to Follow-up|5|||
161715711|NCT00174941|584006334|FG000|Overall Study|Personal Reason(s)|0|||
161715712|NCT00174941|584006335|FG001|Overall Study|Personal Reason(s)|14|||
161715713|NCT00174941|584006336|FG002|Overall Study|Personal Reason(s)|8|||
161715714|NCT00174941|584006337|FG003|Overall Study|Personal Reason(s)|22|||
161715715|NCT00174941|584006334|FG000|Overall Study|Gout Flare|0|||
161715716|NCT00174941|584006335|FG001|Overall Study|Gout Flare|4|||
161715717|NCT00174941|584006336|FG002|Overall Study|Gout Flare|4|||
161715718|NCT00174941|584006337|FG003|Overall Study|Gout Flare|8|||
161715719|NCT00174941|584006334|FG000|Overall Study|Reason Not Specified|1|||
161715720|NCT00174941|584006335|FG001|Overall Study|Reason Not Specified|6|||
161715721|NCT00174941|584006336|FG002|Overall Study|Reason Not Specified|2|||
161715722|NCT00174941|584006337|FG003|Overall Study|Reason Not Specified|9|||
161715723|NCT03230097|584006342|FG000|Overall Study|Adverse Event|2|||
161715724|NCT03230097|584006343|FG001|Overall Study|Adverse Event|1|||
161715725|NCT03230097|584006342|FG000|Overall Study|non-compliance|0|||
161715726|NCT03230097|584006343|FG001|Overall Study|non-compliance|1|||
161715727|NCT03230097|584006342|FG000|Overall Study|Lost to Follow-up|2|||
161715728|NCT03230097|584006343|FG001|Overall Study|Lost to Follow-up|4|||
161715729|NCT03230097|584006342|FG000|Overall Study|Withdrawal by Subject|7|||
161715730|NCT03230097|584006343|FG001|Overall Study|Withdrawal by Subject|3|||
161715731|NCT03230097|584006342|FG000|Overall Study|Trial termination|4|||
161715732|NCT03230097|584006343|FG001|Overall Study|Trial termination|5|||
161715733|NCT03230097|584006342|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
161715734|NCT03230097|584006343|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
161715735|NCT03230097|584006342|FG000|Overall Study|outcome event|0|||
161715736|NCT03230097|584006343|FG001|Overall Study|outcome event|1|||
161715737|NCT01588197|584006360|FG000|Overall Study|Lack of Efficacy|0|||
161715738|NCT01588197|584006361|FG001|Overall Study|Lack of Efficacy|1|||
161715739|NCT01588197|584006360|FG000|Overall Study|No MRI|1|||
161715740|NCT01588197|584006361|FG001|Overall Study|No MRI|0|||
161715741|NCT01844076|584006368|FG000|Overall Study|Adverse Event|1|||
161715742|NCT01844076|584006369|FG001|Overall Study|Adverse Event|0|||
161715743|NCT01844076|584006370|FG002|Overall Study|Adverse Event|0|||
161715744|NCT01844076|584006371|FG003|Overall Study|Adverse Event|0|||
161715745|NCT01844076|584006368|FG000|Overall Study|Withdrawal by Subject|1|||
161715746|NCT01844076|584006369|FG001|Overall Study|Withdrawal by Subject|0|||
161715747|NCT01844076|584006370|FG002|Overall Study|Withdrawal by Subject|0|||
161715748|NCT01844076|584006371|FG003|Overall Study|Withdrawal by Subject|0|||
161715749|NCT00635102|584006379|FG000|Overall Study|Withdrawal by Subject|7|||
161715750|NCT00635102|584006380|FG001|Overall Study|Withdrawal by Subject|8|||
161715751|NCT00440401|584006382|FG000|Overall Study|Adverse Event|2|||
161715752|NCT00440401|584006383|FG001|Overall Study|Adverse Event|1|||
161715753|NCT00440401|584006382|FG000|Overall Study|Other|2|||
161715754|NCT00440401|584006383|FG001|Overall Study|Other|5|||
161715755|NCT01925703|584006384|FG000|Overall Study|Physician Decision|1|||
161715756|NCT01925703|584006384|FG000|Overall Study|Lost to Follow-up|2|||
161715757|NCT01925703|584006384|FG000|Overall Study|Discharge prior to full iron repletion|1|||
161715758|NCT01938625|584006385|FG000|Overall Study|Withdrawal by Subject|0|||
161715759|NCT01938625|584006386|FG001|Overall Study|Withdrawal by Subject|1|||
161715760|NCT01938625|584006385|FG000|Overall Study|Adverse Event|0|||
161715761|NCT01938625|584006386|FG001|Overall Study|Adverse Event|1|||
161715762|NCT02088034|584006387|FG000|Overall Study|Lost to Follow-up|1|||
161715763|NCT02088034|584006388|FG001|Overall Study|Lost to Follow-up|1|||
161715764|NCT02088034|584006389|FG002|Overall Study|Lost to Follow-up|0|||
161715765|NCT02088034|584006387|FG000|Overall Study|Pregnancy|2|||
161715766|NCT02088034|584006388|FG001|Overall Study|Pregnancy|1|||
161715767|NCT02088034|584006389|FG002|Overall Study|Pregnancy|2|||
161715768|NCT01937312|584006390|FG000|Overall Study|Adverse Event|10|||
161715769|NCT01937312|584006391|FG001|Overall Study|Adverse Event|1|||
161715770|NCT01937312|584006390|FG000|Overall Study|Lack of Efficacy|0|||
161715771|NCT01937312|584006391|FG001|Overall Study|Lack of Efficacy|1|||
161715772|NCT01937312|584006390|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
161715773|NCT01937312|584006391|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
161715774|NCT00091793|584006392|FG000|Overall Study|Adverse Event|1|||
161715775|NCT00091793|584006393|FG001|Overall Study|Adverse Event|2|||
161715776|NCT00091793|584006392|FG000|Overall Study|Withdrawal by Subject|10|||
161715777|NCT00091793|584006393|FG001|Overall Study|Withdrawal by Subject|15|||
161715778|NCT00091793|584006392|FG000|Overall Study|Ineligibility determined|2|||
161715779|NCT00091793|584006393|FG001|Overall Study|Ineligibility determined|0|||
161715780|NCT00091793|584006392|FG000|Overall Study|Lost to Follow-up|7|||
161715781|NCT00091793|584006393|FG001|Overall Study|Lost to Follow-up|5|||
161715782|NCT00091793|584006392|FG000|Overall Study|Noncompliance|2|||
161715783|NCT00091793|584006393|FG001|Overall Study|Noncompliance|0|||
161715784|NCT00091793|584006392|FG000|Overall Study|Other|2|||
161715785|NCT00091793|584006393|FG001|Overall Study|Other|0|||
161715786|NCT00308620|584006396|FG000|Overall Study|Death|1|||
161715787|NCT00308620|584006397|FG001|Overall Study|Death|1|||
161715788|NCT00308620|584006398|FG002|Overall Study|Death|0|||
161715789|NCT00308620|584006396|FG000|Overall Study|Lost to Follow-up|0|||
161715790|NCT00308620|584006397|FG001|Overall Study|Lost to Follow-up|0|||
161715791|NCT00308620|584006398|FG002|Overall Study|Lost to Follow-up|1|||
161715792|NCT02424149|584006401|FG000|Overall Study|surgery cancelled|2|||
161715793|NCT02424149|584006402|FG001|Overall Study|surgery cancelled|0|||
161715794|NCT02424149|584006401|FG000|Overall Study|Withdrawal by Subject|0|||
161715795|NCT02424149|584006402|FG001|Overall Study|Withdrawal by Subject|1|||
161715796|NCT05309083|584006403|FG000|Overall Study|Withdrawal by Subject|2|||
161715797|NCT01238120|584006404|FG000|Overall Study|Withdrawal by Subject|4|||
161715798|NCT01238120|584006405|FG001|Overall Study|Withdrawal by Subject|1|||
161715799|NCT01238120|584006406|FG002|Overall Study|Withdrawal by Subject|2|||
161715800|NCT01238120|584006407|FG003|Overall Study|Withdrawal by Subject|5|||
161715801|NCT01238120|584006404|FG000|Overall Study|Lost to Follow-up|2|||
161715802|NCT01238120|584006405|FG001|Overall Study|Lost to Follow-up|0|||
161715803|NCT01238120|584006406|FG002|Overall Study|Lost to Follow-up|1|||
161715804|NCT01238120|584006407|FG003|Overall Study|Lost to Follow-up|1|||
161715805|NCT01238120|584006404|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
161715806|NCT01238120|584006405|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
161715807|NCT01238120|584006406|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
161715808|NCT01238120|584006407|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
161715809|NCT02388776|584006408|FG000|Overall Study|Death|1|||
161715810|NCT02388776|584006408|FG000|Overall Study|Lost to Follow-up|1|||
161715811|NCT04246047|584006415|FG000|Overall Study|Death|50|||
161715812|NCT04246047|584006416|FG001|Overall Study|Death|77|||
161715813|NCT04246047|584006415|FG000|Overall Study|Lost to Follow-up|1|||
161715814|NCT04246047|584006416|FG001|Overall Study|Lost to Follow-up|3|||
161715815|NCT04246047|584006415|FG000|Overall Study|Physician Decision|4|||
161715816|NCT04246047|584006416|FG001|Overall Study|Physician Decision|10|||
161838020|NCT00132028|584450292|FG000|Overall Study|Adverse Event|7|||
161715817|NCT04246047|584006415|FG000|Overall Study|Withdrawal by Subject|19|||
161715818|NCT04246047|584006416|FG001|Overall Study|Withdrawal by Subject|26|||
161715819|NCT04246047|584006415|FG000|Overall Study|Ongoing|169|||
161715820|NCT04246047|584006416|FG001|Overall Study|Ongoing|135|||
161715821|NCT00845429|584006426|FG000|Overall Study|Protocol Violation|5|||
161715822|NCT00845429|584006427|FG001|Overall Study|Protocol Violation|4|||
161715823|NCT00845429|584006428|FG002|Overall Study|Protocol Violation|7|||
161715824|NCT00845429|584006426|FG000|Overall Study|Lost to Follow-up|7|||
161715825|NCT00845429|584006427|FG001|Overall Study|Lost to Follow-up|9|||
161715826|NCT00845429|584006428|FG002|Overall Study|Lost to Follow-up|10|||
161715827|NCT00845429|584006426|FG000|Overall Study|Withdrawal by Subject|2|||
161715828|NCT00845429|584006427|FG001|Overall Study|Withdrawal by Subject|2|||
161715829|NCT00845429|584006428|FG002|Overall Study|Withdrawal by Subject|2|||
161715830|NCT00845429|584006426|FG000|Overall Study|Serious adverse event|0|||
161715831|NCT00845429|584006427|FG001|Overall Study|Serious adverse event|0|||
161715832|NCT00845429|584006428|FG002|Overall Study|Serious adverse event|1|||
161715833|NCT00587223|584006431|FG000|Overall Study|Adverse Event|1|||
161715834|NCT03519178|584006432|FG000|PF-06873600 Treatment|Adverse Event|0|||
161715835|NCT03519178|584006433|FG001|PF-06873600 Treatment|Adverse Event|0|||
161715836|NCT03519178|584006434|FG002|PF-06873600 Treatment|Adverse Event|0|||
161715837|NCT03519178|584006435|FG003|PF-06873600 Treatment|Adverse Event|0|||
161715838|NCT03519178|584006436|FG004|PF-06873600 Treatment|Adverse Event|0|||
161715839|NCT03519178|584006437|FG005|PF-06873600 Treatment|Adverse Event|0|||
161715840|NCT03519178|584006438|FG006|PF-06873600 Treatment|Adverse Event|0|||
161715841|NCT03519178|584006439|FG007|PF-06873600 Treatment|Adverse Event|2|||
161715842|NCT03519178|584006440|FG008|PF-06873600 Treatment|Adverse Event|1|||
161715843|NCT03519178|584006441|FG009|PF-06873600 Treatment|Adverse Event|0|||
161715844|NCT03519178|584006442|FG010|PF-06873600 Treatment|Adverse Event|0|||
161715845|NCT03519178|584006443|FG011|PF-06873600 Treatment|Adverse Event|0|||
161715846|NCT03519178|584006444|FG012|PF-06873600 Treatment|Adverse Event|1|||
161715847|NCT03519178|584006445|FG013|PF-06873600 Treatment|Adverse Event|3|||
161715848|NCT03519178|584006446|FG014|PF-06873600 Treatment|Adverse Event|2|||
161715849|NCT03519178|584006432|FG000|PF-06873600 Treatment|Death|0|||
161715850|NCT03519178|584006433|FG001|PF-06873600 Treatment|Death|0|||
161715851|NCT03519178|584006434|FG002|PF-06873600 Treatment|Death|0|||
161715852|NCT03519178|584006435|FG003|PF-06873600 Treatment|Death|0|||
161715853|NCT03519178|584006436|FG004|PF-06873600 Treatment|Death|0|||
161715854|NCT03519178|584006437|FG005|PF-06873600 Treatment|Death|0|||
161715855|NCT03519178|584006438|FG006|PF-06873600 Treatment|Death|0|||
161715856|NCT03519178|584006439|FG007|PF-06873600 Treatment|Death|0|||
161715857|NCT03519178|584006440|FG008|PF-06873600 Treatment|Death|1|||
161715858|NCT03519178|584006441|FG009|PF-06873600 Treatment|Death|1|||
161715859|NCT03519178|584006442|FG010|PF-06873600 Treatment|Death|0|||
161715860|NCT03519178|584006443|FG011|PF-06873600 Treatment|Death|0|||
161715861|NCT03519178|584006444|FG012|PF-06873600 Treatment|Death|0|||
161715862|NCT03519178|584006445|FG013|PF-06873600 Treatment|Death|0|||
161715863|NCT03519178|584006446|FG014|PF-06873600 Treatment|Death|1|||
161715864|NCT03519178|584006432|FG000|PF-06873600 Treatment|Physician Decision|0|||
161715865|NCT03519178|584006433|FG001|PF-06873600 Treatment|Physician Decision|0|||
161715866|NCT03519178|584006434|FG002|PF-06873600 Treatment|Physician Decision|0|||
161715867|NCT03519178|584006435|FG003|PF-06873600 Treatment|Physician Decision|0|||
161715868|NCT03519178|584006436|FG004|PF-06873600 Treatment|Physician Decision|0|||
161715869|NCT03519178|584006437|FG005|PF-06873600 Treatment|Physician Decision|0|||
161715870|NCT03519178|584006438|FG006|PF-06873600 Treatment|Physician Decision|0|||
161715871|NCT03519178|584006439|FG007|PF-06873600 Treatment|Physician Decision|1|||
161715872|NCT03519178|584006440|FG008|PF-06873600 Treatment|Physician Decision|0|||
161663334|NCT03184870|583820338|FG007|Initial Treatment|Lost to Follow-up|2|||
161663335|NCT03184870|583820339|FG008|Initial Treatment|Lost to Follow-up|0|||
161663336|NCT03184870|583820340|FG009|Initial Treatment|Lost to Follow-up|0|||
161663337|NCT03184870|583820341|FG010|Initial Treatment|Lost to Follow-up|2|||
161663338|NCT03184870|583820342|FG011|Initial Treatment|Lost to Follow-up|0|||
161663339|NCT03184870|583820343|FG012|Initial Treatment|Lost to Follow-up|2|||
161663340|NCT03184870|583820344|FG013|Initial Treatment|Lost to Follow-up|2|||
161715873|NCT03519178|584006441|FG009|PF-06873600 Treatment|Physician Decision|0|||
161715874|NCT03519178|584006442|FG010|PF-06873600 Treatment|Physician Decision|1|||
161715875|NCT03519178|584006443|FG011|PF-06873600 Treatment|Physician Decision|0|||
161715876|NCT03519178|584006444|FG012|PF-06873600 Treatment|Physician Decision|0|||
161715877|NCT03519178|584006445|FG013|PF-06873600 Treatment|Physician Decision|4|||
161715878|NCT03519178|584006446|FG014|PF-06873600 Treatment|Physician Decision|1|||
161715879|NCT03519178|584006432|FG000|PF-06873600 Treatment|Progressive disease|1|||
161715880|NCT03519178|584006433|FG001|PF-06873600 Treatment|Progressive disease|1|||
161715881|NCT03519178|584006434|FG002|PF-06873600 Treatment|Progressive disease|1|||
161715882|NCT03519178|584006435|FG003|PF-06873600 Treatment|Progressive disease|1|||
161715883|NCT03519178|584006436|FG004|PF-06873600 Treatment|Progressive disease|6|||
161663341|NCT03184870|583820345|FG014|Initial Treatment|Lost to Follow-up|0|||
161715884|NCT03519178|584006437|FG005|PF-06873600 Treatment|Progressive disease|7|||
161715885|NCT03519178|584006438|FG006|PF-06873600 Treatment|Progressive disease|3|||
161715886|NCT03519178|584006439|FG007|PF-06873600 Treatment|Progressive disease|7|||
161715887|NCT03519178|584006440|FG008|PF-06873600 Treatment|Progressive disease|3|||
161715888|NCT03519178|584006441|FG009|PF-06873600 Treatment|Progressive disease|5|||
161715889|NCT03519178|584006442|FG010|PF-06873600 Treatment|Progressive disease|4|||
161715890|NCT03519178|584006443|FG011|PF-06873600 Treatment|Progressive disease|3|||
161715891|NCT03519178|584006444|FG012|PF-06873600 Treatment|Progressive disease|4|||
161715892|NCT03519178|584006445|FG013|PF-06873600 Treatment|Progressive disease|28|||
161715893|NCT03519178|584006446|FG014|PF-06873600 Treatment|Progressive disease|8|||
161715894|NCT03519178|584006432|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715895|NCT03519178|584006433|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715896|NCT03519178|584006434|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715897|NCT03519178|584006435|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715898|NCT03519178|584006436|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715899|NCT03519178|584006437|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715900|NCT03519178|584006438|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715901|NCT03519178|584006439|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715902|NCT03519178|584006440|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
161715903|NCT03519178|584006441|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715904|NCT03519178|584006442|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715905|NCT03519178|584006443|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715906|NCT03519178|584006444|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715907|NCT03519178|584006445|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715908|NCT03519178|584006446|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715909|NCT03519178|584006432|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
161715910|NCT03519178|584006433|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
161715911|NCT03519178|584006434|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
161715912|NCT03519178|584006435|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
161715913|NCT03519178|584006436|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
161715914|NCT03519178|584006437|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
161715915|NCT03519178|584006438|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
161715916|NCT03519178|584006439|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
161715917|NCT03519178|584006440|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
161715918|NCT03519178|584006441|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
161715919|NCT03519178|584006442|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
161715920|NCT03519178|584006443|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
161715921|NCT03519178|584006444|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
161715922|NCT03519178|584006445|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
161715923|NCT03519178|584006446|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
161715924|NCT03519178|584006432|FG000|PF-06873600 Treatment|Refused further treatment|0|||
161715925|NCT03519178|584006433|FG001|PF-06873600 Treatment|Refused further treatment|1|||
161715926|NCT03519178|584006434|FG002|PF-06873600 Treatment|Refused further treatment|0|||
161715927|NCT03519178|584006435|FG003|PF-06873600 Treatment|Refused further treatment|0|||
161715928|NCT03519178|584006436|FG004|PF-06873600 Treatment|Refused further treatment|1|||
161715929|NCT03519178|584006437|FG005|PF-06873600 Treatment|Refused further treatment|0|||
161715930|NCT03519178|584006438|FG006|PF-06873600 Treatment|Refused further treatment|0|||
161715931|NCT03519178|584006439|FG007|PF-06873600 Treatment|Refused further treatment|0|||
161715932|NCT03519178|584006440|FG008|PF-06873600 Treatment|Refused further treatment|0|||
161715933|NCT03519178|584006441|FG009|PF-06873600 Treatment|Refused further treatment|0|||
161838021|NCT00132028|584450292|FG000|Overall Study|Death|2|||
161663342|NCT03184870|583820346|FG015|Initial Treatment|Lost to Follow-up|0|||
161663343|NCT03184870|583820347|FG016|Initial Treatment|Lost to Follow-up|2|||
161663344|NCT03184870|583820348|FG017|Initial Treatment|Lost to Follow-up|2|||
161663345|NCT03184870|583820331|FG000|Initial Treatment|Withdrawal by Subject|0|||
161663346|NCT03184870|583820332|FG001|Initial Treatment|Withdrawal by Subject|0|||
161663347|NCT03184870|583820333|FG002|Initial Treatment|Withdrawal by Subject|2|||
161663348|NCT03184870|583820334|FG003|Initial Treatment|Withdrawal by Subject|1|||
161663349|NCT03184870|583820335|FG004|Initial Treatment|Withdrawal by Subject|1|||
161663350|NCT03184870|583820336|FG005|Initial Treatment|Withdrawal by Subject|0|||
161663351|NCT03184870|583820337|FG006|Initial Treatment|Withdrawal by Subject|1|||
161663352|NCT03184870|583820338|FG007|Initial Treatment|Withdrawal by Subject|0|||
161663353|NCT03184870|583820339|FG008|Initial Treatment|Withdrawal by Subject|0|||
161663354|NCT03184870|583820340|FG009|Initial Treatment|Withdrawal by Subject|0|||
161663355|NCT03184870|583820341|FG010|Initial Treatment|Withdrawal by Subject|0|||
161663356|NCT03184870|583820342|FG011|Initial Treatment|Withdrawal by Subject|2|||
161663357|NCT03184870|583820343|FG012|Initial Treatment|Withdrawal by Subject|3|||
161663358|NCT03184870|583820344|FG013|Initial Treatment|Withdrawal by Subject|0|||
161663359|NCT03184870|583820345|FG014|Initial Treatment|Withdrawal by Subject|1|||
161663360|NCT03184870|583820346|FG015|Initial Treatment|Withdrawal by Subject|5|||
161663361|NCT03184870|583820347|FG016|Initial Treatment|Withdrawal by Subject|2|||
161663362|NCT03184870|583820348|FG017|Initial Treatment|Withdrawal by Subject|2|||
161663363|NCT03184870|583820331|FG000|Initial Treatment|Moved to crossover treatment|0|||
161663364|NCT03184870|583820332|FG001|Initial Treatment|Moved to crossover treatment|0|||
161663365|NCT03184870|583820333|FG002|Initial Treatment|Moved to crossover treatment|0|||
161663366|NCT03184870|583820334|FG003|Initial Treatment|Moved to crossover treatment|0|||
161663367|NCT03184870|583820335|FG004|Initial Treatment|Moved to crossover treatment|0|||
161663368|NCT03184870|583820336|FG005|Initial Treatment|Moved to crossover treatment|0|||
161663369|NCT03184870|583820337|FG006|Initial Treatment|Moved to crossover treatment|0|||
161663370|NCT03184870|583820338|FG007|Initial Treatment|Moved to crossover treatment|0|||
161663371|NCT03184870|583820339|FG008|Initial Treatment|Moved to crossover treatment|0|||
161663372|NCT03184870|583820340|FG009|Initial Treatment|Moved to crossover treatment|0|||
161663373|NCT03184870|583820341|FG010|Initial Treatment|Moved to crossover treatment|0|||
161663374|NCT03184870|583820342|FG011|Initial Treatment|Moved to crossover treatment|0|||
161663375|NCT03184870|583820343|FG012|Initial Treatment|Moved to crossover treatment|9|||
161663376|NCT03184870|583820344|FG013|Initial Treatment|Moved to crossover treatment|0|||
161663377|NCT03184870|583820345|FG014|Initial Treatment|Moved to crossover treatment|0|||
161663378|NCT03184870|583820346|FG015|Initial Treatment|Moved to crossover treatment|0|||
161663379|NCT03184870|583820347|FG016|Initial Treatment|Moved to crossover treatment|0|||
161715934|NCT03519178|584006442|FG010|PF-06873600 Treatment|Refused further treatment|0|||
161715935|NCT03519178|584006443|FG011|PF-06873600 Treatment|Refused further treatment|0|||
161715936|NCT03519178|584006444|FG012|PF-06873600 Treatment|Refused further treatment|0|||
161715937|NCT03519178|584006445|FG013|PF-06873600 Treatment|Refused further treatment|0|||
161715938|NCT03519178|584006446|FG014|PF-06873600 Treatment|Refused further treatment|1|||
161715939|NCT03519178|584006432|FG000|PF-06873600 Treatment|Other|0|||
161715940|NCT03519178|584006433|FG001|PF-06873600 Treatment|Other|0|||
161715941|NCT03519178|584006434|FG002|PF-06873600 Treatment|Other|0|||
161715942|NCT03519178|584006435|FG003|PF-06873600 Treatment|Other|0|||
161715943|NCT03519178|584006436|FG004|PF-06873600 Treatment|Other|0|||
161715944|NCT03519178|584006437|FG005|PF-06873600 Treatment|Other|0|||
161715945|NCT03519178|584006438|FG006|PF-06873600 Treatment|Other|0|||
161715946|NCT03519178|584006439|FG007|PF-06873600 Treatment|Other|0|||
161715947|NCT03519178|584006440|FG008|PF-06873600 Treatment|Other|1|||
161715948|NCT03519178|584006441|FG009|PF-06873600 Treatment|Other|0|||
161715949|NCT03519178|584006442|FG010|PF-06873600 Treatment|Other|0|||
161715950|NCT03519178|584006443|FG011|PF-06873600 Treatment|Other|0|||
161715951|NCT03519178|584006444|FG012|PF-06873600 Treatment|Other|0|||
161715952|NCT03519178|584006445|FG013|PF-06873600 Treatment|Other|1|||
161715953|NCT03519178|584006446|FG014|PF-06873600 Treatment|Other|3|||
161715954|NCT03519178|584006432|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
161715955|NCT03519178|584006433|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
161715956|NCT03519178|584006434|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
161715957|NCT03519178|584006435|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
161663380|NCT03184870|583820348|FG017|Initial Treatment|Moved to crossover treatment|0|||
161663381|NCT03184870|583820331|FG000|Crossover Treatment|Other reasons|0|||
161663382|NCT03184870|583820332|FG001|Crossover Treatment|Other reasons|0|||
161663383|NCT03184870|583820333|FG002|Crossover Treatment|Other reasons|0|||
161663384|NCT03184870|583820334|FG003|Crossover Treatment|Other reasons|0|||
161663385|NCT03184870|583820335|FG004|Crossover Treatment|Other reasons|0|||
161663386|NCT03184870|583820336|FG005|Crossover Treatment|Other reasons|0|||
161663387|NCT03184870|583820337|FG006|Crossover Treatment|Other reasons|0|||
161663388|NCT03184870|583820338|FG007|Crossover Treatment|Other reasons|0|||
161663389|NCT03184870|583820339|FG008|Crossover Treatment|Other reasons|0|||
161715958|NCT03519178|584006436|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
161715959|NCT03519178|584006437|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
161715960|NCT03519178|584006438|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
161715961|NCT03519178|584006439|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
161715962|NCT03519178|584006440|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
161715963|NCT03519178|584006441|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
161715964|NCT03519178|584006442|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
161715965|NCT03519178|584006443|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
161715966|NCT03519178|584006444|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
161715967|NCT03519178|584006445|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
161715968|NCT03519178|584006446|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
161715969|NCT03519178|584006432|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715970|NCT03519178|584006433|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715971|NCT03519178|584006434|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715972|NCT03519178|584006435|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715973|NCT03519178|584006436|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715974|NCT03519178|584006437|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715975|NCT03519178|584006438|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715976|NCT03519178|584006439|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715977|NCT03519178|584006440|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715978|NCT03519178|584006441|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715979|NCT03519178|584006442|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715980|NCT03519178|584006443|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715981|NCT03519178|584006444|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715982|NCT03519178|584006445|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
161715983|NCT03519178|584006446|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
161715984|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Adverse Event|0|||
161715985|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Adverse Event|0|||
161715986|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Adverse Event|0|||
161715987|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Adverse Event|0|||
161715988|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Adverse Event|0|||
161715989|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Adverse Event|0|||
161715990|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Adverse Event|0|||
161715991|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Adverse Event|0|||
161715992|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Adverse Event|0|||
161715993|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Adverse Event|0|||
161715994|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Adverse Event|0|||
161715995|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Adverse Event|0|||
161715996|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Adverse Event|0|||
161715997|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Adverse Event|1|||
161715998|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Adverse Event|0|||
161715999|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Death|0|||
161716000|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Death|0|||
161716001|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Death|0|||
161716002|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Death|0|||
161716003|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Death|0|||
161716004|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Death|0|||
161716005|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Death|0|||
161716006|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Death|0|||
161716007|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Death|0|||
161716008|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Death|1|||
161716009|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Death|0|||
161716010|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Death|0|||
161716011|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Death|0|||
161716012|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Death|0|||
161716013|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Death|1|||
161716014|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716015|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716016|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716017|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716018|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716019|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716020|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716021|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716022|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716023|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716024|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716025|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716026|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716027|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716028|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
161716029|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Physician Decision|0|||
161716030|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Physician Decision|0|||
161716031|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Physician Decision|0|||
161716032|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Physician Decision|0|||
161716033|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Physician Decision|0|||
161716034|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Physician Decision|0|||
161716035|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Physician Decision|0|||
161716036|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Physician Decision|0|||
161716037|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Physician Decision|0|||
161716038|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Physician Decision|0|||
161716039|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Physician Decision|0|||
161716040|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Physician Decision|0|||
161716041|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Physician Decision|0|||
161716042|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Physician Decision|4|||
161716043|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Physician Decision|2|||
161716044|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Progressive disease|0|||
161716045|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Progressive disease|0|||
161716046|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Progressive disease|0|||
161716047|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Progressive disease|0|||
161716048|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Progressive disease|0|||
161716049|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Progressive disease|0|||
161716050|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Progressive disease|0|||
161716051|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Progressive disease|0|||
161716052|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Progressive disease|0|||
161716053|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Progressive disease|5|||
161716054|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Progressive disease|0|||
161716055|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Progressive disease|0|||
161716056|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Progressive disease|0|||
161716057|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Progressive disease|30|||
161716058|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Progressive disease|8|||
161716059|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716060|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716061|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716062|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716063|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716064|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716065|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716066|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716067|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716068|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716069|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716070|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716071|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716072|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
161716073|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
161716074|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716075|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716076|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716077|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716078|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716079|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716080|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716081|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716082|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716083|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
161716084|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716085|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716086|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716087|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
161716088|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
161716089|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716090|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716091|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716092|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716093|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716094|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716095|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716096|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716097|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716098|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
161716099|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716100|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716101|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716102|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
161716103|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716104|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
161716105|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
161716106|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
161716107|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
161716108|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
161716109|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
161716110|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
161716111|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
161716112|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
161716113|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
161716114|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
161716115|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
161716116|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
161716117|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
161716118|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
161716119|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Other|0|||
161716120|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Other|0|||
161716121|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Other|0|||
161716122|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Other|0|||
161716123|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Other|0|||
161716124|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Other|0|||
161716125|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Other|0|||
161716126|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Other|0|||
161716127|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Other|0|||
161716128|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Other|0|||
161716129|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Other|0|||
161716130|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Other|0|||
161716131|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Other|0|||
161716132|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Other|1|||
161716133|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Other|3|||
161716134|NCT03519178|584006432|FG000|Letrozole Treatment|Physician Decision|0|||
161716135|NCT03519178|584006433|FG001|Letrozole Treatment|Physician Decision|0|||
161716136|NCT03519178|584006434|FG002|Letrozole Treatment|Physician Decision|0|||
161716137|NCT03519178|584006435|FG003|Letrozole Treatment|Physician Decision|0|||
161716138|NCT03519178|584006436|FG004|Letrozole Treatment|Physician Decision|0|||
161716139|NCT03519178|584006437|FG005|Letrozole Treatment|Physician Decision|0|||
161716140|NCT03519178|584006438|FG006|Letrozole Treatment|Physician Decision|0|||
161716141|NCT03519178|584006439|FG007|Letrozole Treatment|Physician Decision|0|||
161716142|NCT03519178|584006440|FG008|Letrozole Treatment|Physician Decision|0|||
161716143|NCT03519178|584006441|FG009|Letrozole Treatment|Physician Decision|0|||
161716144|NCT03519178|584006442|FG010|Letrozole Treatment|Physician Decision|1|||
161716145|NCT03519178|584006443|FG011|Letrozole Treatment|Physician Decision|0|||
161716146|NCT03519178|584006444|FG012|Letrozole Treatment|Physician Decision|0|||
161716147|NCT03519178|584006445|FG013|Letrozole Treatment|Physician Decision|0|||
161716148|NCT03519178|584006446|FG014|Letrozole Treatment|Physician Decision|0|||
161716149|NCT03519178|584006432|FG000|Letrozole Treatment|Progressive disease|0|||
161716150|NCT03519178|584006433|FG001|Letrozole Treatment|Progressive disease|0|||
161716151|NCT03519178|584006434|FG002|Letrozole Treatment|Progressive disease|0|||
161716152|NCT03519178|584006435|FG003|Letrozole Treatment|Progressive disease|0|||
161716153|NCT03519178|584006436|FG004|Letrozole Treatment|Progressive disease|0|||
161716154|NCT03519178|584006437|FG005|Letrozole Treatment|Progressive disease|0|||
161716155|NCT03519178|584006438|FG006|Letrozole Treatment|Progressive disease|0|||
161716156|NCT03519178|584006439|FG007|Letrozole Treatment|Progressive disease|0|||
161716157|NCT03519178|584006440|FG008|Letrozole Treatment|Progressive disease|0|||
161716158|NCT03519178|584006441|FG009|Letrozole Treatment|Progressive disease|0|||
161716159|NCT03519178|584006442|FG010|Letrozole Treatment|Progressive disease|4|||
161716160|NCT03519178|584006443|FG011|Letrozole Treatment|Progressive disease|0|||
161716161|NCT03519178|584006444|FG012|Letrozole Treatment|Progressive disease|0|||
161716162|NCT03519178|584006445|FG013|Letrozole Treatment|Progressive disease|0|||
161716163|NCT03519178|584006446|FG014|Letrozole Treatment|Progressive disease|0|||
161716164|NCT03519178|584006432|FG000|Letrozole Treatment|Global deterioration of health status|0|||
161716165|NCT03519178|584006433|FG001|Letrozole Treatment|Global deterioration of health status|0|||
161716166|NCT03519178|584006434|FG002|Letrozole Treatment|Global deterioration of health status|0|||
161716167|NCT03519178|584006435|FG003|Letrozole Treatment|Global deterioration of health status|0|||
161716168|NCT03519178|584006436|FG004|Letrozole Treatment|Global deterioration of health status|0|||
161716169|NCT03519178|584006437|FG005|Letrozole Treatment|Global deterioration of health status|0|||
161716170|NCT03519178|584006438|FG006|Letrozole Treatment|Global deterioration of health status|0|||
161716171|NCT03519178|584006439|FG007|Letrozole Treatment|Global deterioration of health status|0|||
161716172|NCT03519178|584006440|FG008|Letrozole Treatment|Global deterioration of health status|0|||
161716173|NCT03519178|584006441|FG009|Letrozole Treatment|Global deterioration of health status|0|||
161716174|NCT03519178|584006442|FG010|Letrozole Treatment|Global deterioration of health status|2|||
161716175|NCT03519178|584006443|FG011|Letrozole Treatment|Global deterioration of health status|0|||
161716176|NCT03519178|584006444|FG012|Letrozole Treatment|Global deterioration of health status|0|||
161716177|NCT03519178|584006445|FG013|Letrozole Treatment|Global deterioration of health status|0|||
161716178|NCT03519178|584006446|FG014|Letrozole Treatment|Global deterioration of health status|0|||
161716179|NCT03519178|584006432|FG000|Follow-Up|Death|0|||
161716180|NCT03519178|584006433|FG001|Follow-Up|Death|0|||
161716181|NCT03519178|584006434|FG002|Follow-Up|Death|0|||
161716182|NCT03519178|584006435|FG003|Follow-Up|Death|0|||
161716183|NCT03519178|584006436|FG004|Follow-Up|Death|0|||
161716184|NCT03519178|584006437|FG005|Follow-Up|Death|0|||
161716185|NCT03519178|584006438|FG006|Follow-Up|Death|0|||
161716186|NCT03519178|584006439|FG007|Follow-Up|Death|0|||
161716187|NCT03519178|584006440|FG008|Follow-Up|Death|3|||
161716188|NCT03519178|584006441|FG009|Follow-Up|Death|1|||
161716189|NCT03519178|584006442|FG010|Follow-Up|Death|0|||
161716190|NCT03519178|584006443|FG011|Follow-Up|Death|0|||
161716191|NCT03519178|584006444|FG012|Follow-Up|Death|2|||
161716192|NCT03519178|584006445|FG013|Follow-Up|Death|0|||
161716193|NCT03519178|584006446|FG014|Follow-Up|Death|0|||
161716194|NCT03519178|584006432|FG000|Follow-Up|Lost to Follow-up|0|||
161716195|NCT03519178|584006433|FG001|Follow-Up|Lost to Follow-up|0|||
161716196|NCT03519178|584006434|FG002|Follow-Up|Lost to Follow-up|0|||
161716197|NCT03519178|584006435|FG003|Follow-Up|Lost to Follow-up|0|||
161716198|NCT03519178|584006436|FG004|Follow-Up|Lost to Follow-up|0|||
161716199|NCT03519178|584006437|FG005|Follow-Up|Lost to Follow-up|3|||
161716200|NCT03519178|584006438|FG006|Follow-Up|Lost to Follow-up|1|||
161716201|NCT03519178|584006439|FG007|Follow-Up|Lost to Follow-up|4|||
161716202|NCT03519178|584006440|FG008|Follow-Up|Lost to Follow-up|1|||
161716203|NCT03519178|584006441|FG009|Follow-Up|Lost to Follow-up|0|||
161716204|NCT03519178|584006442|FG010|Follow-Up|Lost to Follow-up|0|||
161716205|NCT03519178|584006443|FG011|Follow-Up|Lost to Follow-up|0|||
161716206|NCT03519178|584006444|FG012|Follow-Up|Lost to Follow-up|0|||
161716207|NCT03519178|584006445|FG013|Follow-Up|Lost to Follow-up|0|||
161716208|NCT03519178|584006446|FG014|Follow-Up|Lost to Follow-up|0|||
161716209|NCT03519178|584006432|FG000|Follow-Up|Withdrawal by Subject|1|||
161716210|NCT03519178|584006433|FG001|Follow-Up|Withdrawal by Subject|2|||
161716211|NCT03519178|584006434|FG002|Follow-Up|Withdrawal by Subject|2|||
161716212|NCT03519178|584006435|FG003|Follow-Up|Withdrawal by Subject|3|||
161716213|NCT03519178|584006436|FG004|Follow-Up|Withdrawal by Subject|5|||
161716214|NCT03519178|584006437|FG005|Follow-Up|Withdrawal by Subject|1|||
161716215|NCT03519178|584006438|FG006|Follow-Up|Withdrawal by Subject|2|||
161716216|NCT03519178|584006439|FG007|Follow-Up|Withdrawal by Subject|6|||
161716217|NCT03519178|584006440|FG008|Follow-Up|Withdrawal by Subject|5|||
161716218|NCT03519178|584006441|FG009|Follow-Up|Withdrawal by Subject|2|||
161716219|NCT03519178|584006442|FG010|Follow-Up|Withdrawal by Subject|3|||
161716220|NCT03519178|584006443|FG011|Follow-Up|Withdrawal by Subject|5|||
161716221|NCT03519178|584006444|FG012|Follow-Up|Withdrawal by Subject|2|||
161716222|NCT03519178|584006445|FG013|Follow-Up|Withdrawal by Subject|0|||
161716223|NCT03519178|584006446|FG014|Follow-Up|Withdrawal by Subject|0|||
161716224|NCT03519178|584006432|FG000|Follow-Up|Other|0|||
161716225|NCT03519178|584006433|FG001|Follow-Up|Other|0|||
161716226|NCT03519178|584006434|FG002|Follow-Up|Other|0|||
161716227|NCT03519178|584006435|FG003|Follow-Up|Other|0|||
161716228|NCT03519178|584006436|FG004|Follow-Up|Other|0|||
161716229|NCT03519178|584006437|FG005|Follow-Up|Other|0|||
161716230|NCT03519178|584006438|FG006|Follow-Up|Other|0|||
161716231|NCT03519178|584006439|FG007|Follow-Up|Other|1|||
161716232|NCT03519178|584006440|FG008|Follow-Up|Other|0|||
161716233|NCT03519178|584006441|FG009|Follow-Up|Other|0|||
161716234|NCT03519178|584006442|FG010|Follow-Up|Other|0|||
161716235|NCT03519178|584006443|FG011|Follow-Up|Other|0|||
161716236|NCT03519178|584006444|FG012|Follow-Up|Other|0|||
161716237|NCT03519178|584006445|FG013|Follow-Up|Other|0|||
161716238|NCT03519178|584006446|FG014|Follow-Up|Other|0|||
161716239|NCT03519178|584006432|FG000|Long-term Follow-up|Death|0|||
161716240|NCT03519178|584006433|FG001|Long-term Follow-up|Death|0|||
161716241|NCT03519178|584006434|FG002|Long-term Follow-up|Death|0|||
161716242|NCT03519178|584006435|FG003|Long-term Follow-up|Death|0|||
161716243|NCT03519178|584006436|FG004|Long-term Follow-up|Death|0|||
161716244|NCT03519178|584006437|FG005|Long-term Follow-up|Death|0|||
161716245|NCT03519178|584006438|FG006|Long-term Follow-up|Death|0|||
161716246|NCT03519178|584006439|FG007|Long-term Follow-up|Death|0|||
161716247|NCT03519178|584006440|FG008|Long-term Follow-up|Death|0|||
161716248|NCT03519178|584006441|FG009|Long-term Follow-up|Death|0|||
161716249|NCT03519178|584006442|FG010|Long-term Follow-up|Death|0|||
161716250|NCT03519178|584006443|FG011|Long-term Follow-up|Death|0|||
161716251|NCT03519178|584006444|FG012|Long-term Follow-up|Death|0|||
161716252|NCT03519178|584006445|FG013|Long-term Follow-up|Death|4|||
161716253|NCT03519178|584006446|FG014|Long-term Follow-up|Death|4|||
161716254|NCT03519178|584006432|FG000|Long-term Follow-up|Lost to Follow-up|0|||
161716255|NCT03519178|584006433|FG001|Long-term Follow-up|Lost to Follow-up|0|||
161716256|NCT03519178|584006434|FG002|Long-term Follow-up|Lost to Follow-up|0|||
161716257|NCT03519178|584006435|FG003|Long-term Follow-up|Lost to Follow-up|0|||
161716258|NCT03519178|584006436|FG004|Long-term Follow-up|Lost to Follow-up|0|||
161716259|NCT03519178|584006437|FG005|Long-term Follow-up|Lost to Follow-up|0|||
161716260|NCT03519178|584006438|FG006|Long-term Follow-up|Lost to Follow-up|0|||
161716261|NCT03519178|584006439|FG007|Long-term Follow-up|Lost to Follow-up|0|||
161716262|NCT03519178|584006440|FG008|Long-term Follow-up|Lost to Follow-up|0|||
161716263|NCT03519178|584006441|FG009|Long-term Follow-up|Lost to Follow-up|0|||
161716264|NCT03519178|584006442|FG010|Long-term Follow-up|Lost to Follow-up|0|||
161716265|NCT03519178|584006443|FG011|Long-term Follow-up|Lost to Follow-up|0|||
161716266|NCT03519178|584006444|FG012|Long-term Follow-up|Lost to Follow-up|0|||
161716267|NCT03519178|584006445|FG013|Long-term Follow-up|Lost to Follow-up|1|||
161716268|NCT03519178|584006446|FG014|Long-term Follow-up|Lost to Follow-up|1|||
161716269|NCT03519178|584006432|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
161716270|NCT03519178|584006433|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
161716271|NCT03519178|584006434|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
161716272|NCT03519178|584006435|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
161716273|NCT03519178|584006436|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
161716274|NCT03519178|584006437|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
161716275|NCT03519178|584006438|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
161716276|NCT03519178|584006439|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
161716277|NCT03519178|584006440|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
161716278|NCT03519178|584006441|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
161716279|NCT03519178|584006442|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
161716280|NCT03519178|584006443|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
161716281|NCT03519178|584006444|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
161716282|NCT03519178|584006445|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
161716283|NCT03519178|584006446|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
161716284|NCT03519178|584006432|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
161716285|NCT03519178|584006433|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
161716286|NCT03519178|584006434|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
161716287|NCT03519178|584006435|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
161716288|NCT03519178|584006436|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
161716289|NCT03519178|584006437|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
161716290|NCT03519178|584006438|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
161716291|NCT03519178|584006439|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
161716292|NCT03519178|584006440|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
161716293|NCT03519178|584006441|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
161716294|NCT03519178|584006442|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
161716295|NCT03519178|584006443|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
161716296|NCT03519178|584006444|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
161716297|NCT03519178|584006445|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
161716298|NCT03519178|584006446|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
161716299|NCT03519178|584006432|FG000|Long-term Follow-up|Other|0|||
161716300|NCT03519178|584006433|FG001|Long-term Follow-up|Other|0|||
161716301|NCT03519178|584006434|FG002|Long-term Follow-up|Other|0|||
161716302|NCT03519178|584006435|FG003|Long-term Follow-up|Other|0|||
161716303|NCT03519178|584006436|FG004|Long-term Follow-up|Other|0|||
161716304|NCT03519178|584006437|FG005|Long-term Follow-up|Other|0|||
161716305|NCT03519178|584006438|FG006|Long-term Follow-up|Other|0|||
161716306|NCT03519178|584006439|FG007|Long-term Follow-up|Other|0|||
161716307|NCT03519178|584006440|FG008|Long-term Follow-up|Other|0|||
161716308|NCT03519178|584006441|FG009|Long-term Follow-up|Other|0|||
161716309|NCT03519178|584006442|FG010|Long-term Follow-up|Other|0|||
161716310|NCT03519178|584006443|FG011|Long-term Follow-up|Other|0|||
161716311|NCT03519178|584006444|FG012|Long-term Follow-up|Other|0|||
161716312|NCT03519178|584006445|FG013|Long-term Follow-up|Other|0|||
161716313|NCT03519178|584006446|FG014|Long-term Follow-up|Other|1|||
161716314|NCT03519178|584006432|FG000|Long-term Follow-up|Global deterioration of health status|0|||
161716315|NCT03519178|584006433|FG001|Long-term Follow-up|Global deterioration of health status|0|||
161716316|NCT03519178|584006434|FG002|Long-term Follow-up|Global deterioration of health status|0|||
161716317|NCT03519178|584006435|FG003|Long-term Follow-up|Global deterioration of health status|0|||
161716318|NCT03519178|584006436|FG004|Long-term Follow-up|Global deterioration of health status|0|||
161716319|NCT03519178|584006437|FG005|Long-term Follow-up|Global deterioration of health status|0|||
161716320|NCT03519178|584006438|FG006|Long-term Follow-up|Global deterioration of health status|0|||
161716321|NCT03519178|584006439|FG007|Long-term Follow-up|Global deterioration of health status|0|||
161716322|NCT03519178|584006440|FG008|Long-term Follow-up|Global deterioration of health status|0|||
161716323|NCT03519178|584006441|FG009|Long-term Follow-up|Global deterioration of health status|0|||
161716324|NCT03519178|584006442|FG010|Long-term Follow-up|Global deterioration of health status|0|||
161716325|NCT03519178|584006443|FG011|Long-term Follow-up|Global deterioration of health status|0|||
161716326|NCT03519178|584006444|FG012|Long-term Follow-up|Global deterioration of health status|0|||
161716327|NCT03519178|584006445|FG013|Long-term Follow-up|Global deterioration of health status|1|||
161716328|NCT03519178|584006446|FG014|Long-term Follow-up|Global deterioration of health status|0|||
161716329|NCT03497689|584006449|FG000|Overall Study|Adverse Event|2|||
161716330|NCT03497689|584006449|FG000|Overall Study|Death|1|||
161716331|NCT03497689|584006449|FG000|Overall Study|Physician Decision|1|||
161716332|NCT03497689|584006449|FG000|Overall Study|Withdrawal by Subject|1|||
161716333|NCT03497689|584006449|FG000|Overall Study|Protocol Violation|2|||
161716334|NCT05165394|584007837|FG000|Overall Study|Withdrawal by Subject|5|||
161716335|NCT05165394|584007838|FG001|Overall Study|Withdrawal by Subject|1|||
161663390|NCT03184870|583820340|FG009|Crossover Treatment|Other reasons|0|||
161663391|NCT03184870|583820341|FG010|Crossover Treatment|Other reasons|0|||
161663392|NCT03184870|583820342|FG011|Crossover Treatment|Other reasons|0|||
161663393|NCT03184870|583820343|FG012|Crossover Treatment|Other reasons|0|||
161663394|NCT03184870|583820344|FG013|Crossover Treatment|Other reasons|0|||
161663395|NCT03184870|583820345|FG014|Crossover Treatment|Other reasons|0|||
161663396|NCT03184870|583820346|FG015|Crossover Treatment|Other reasons|0|||
161663397|NCT03184870|583820347|FG016|Crossover Treatment|Other reasons|0|||
161663398|NCT03184870|583820348|FG017|Crossover Treatment|Other reasons|2|||
161716336|NCT05165394|584007837|FG000|Overall Study|Lost to Follow-up|1|||
161716337|NCT05165394|584007838|FG001|Overall Study|Lost to Follow-up|2|||
161716338|NCT05165394|584007837|FG000|Overall Study|Other Than Specified|0|||
161716339|NCT05165394|584007838|FG001|Overall Study|Other Than Specified|1|||
161716340|NCT03705494|584007839|FG000|Overall Study|Lost to Follow-up|2|||
161716341|NCT03705494|584007840|FG001|Overall Study|Lost to Follow-up|1|||
161716342|NCT03705494|584007839|FG000|Overall Study|Withdrawal by Subject|5|||
161716343|NCT03705494|584007840|FG001|Overall Study|Withdrawal by Subject|2|||
161716344|NCT02495077|584007841|FG000|Overall Study|Adverse Event|0|||
161716345|NCT02495077|584007842|FG001|Overall Study|Adverse Event|1|||
161716346|NCT02495077|584007843|FG002|Overall Study|Adverse Event|1|||
161716347|NCT02495077|584007844|FG003|Overall Study|Adverse Event|0|||
161716348|NCT02495077|584007841|FG000|Overall Study|Death|3|||
161716349|NCT02495077|584007842|FG001|Overall Study|Death|5|||
161716350|NCT02495077|584007843|FG002|Overall Study|Death|0|||
161716351|NCT02495077|584007844|FG003|Overall Study|Death|0|||
161716352|NCT02495077|584007841|FG000|Overall Study|Lost to Follow-up|6|||
161716353|NCT02495077|584007842|FG001|Overall Study|Lost to Follow-up|4|||
161716354|NCT02495077|584007843|FG002|Overall Study|Lost to Follow-up|0|||
161716355|NCT02495077|584007844|FG003|Overall Study|Lost to Follow-up|0|||
161716356|NCT02495077|584007841|FG000|Overall Study|Physician Decision|2|||
161716357|NCT02495077|584007842|FG001|Overall Study|Physician Decision|1|||
161716358|NCT02495077|584007843|FG002|Overall Study|Physician Decision|4|||
161716359|NCT02495077|584007844|FG003|Overall Study|Physician Decision|0|||
161716360|NCT02495077|584007841|FG000|Overall Study|Protocol Violation|0|||
161663399|NCT03184870|583820331|FG000|Crossover Treatment|Death|0|||
161663400|NCT03184870|583820332|FG001|Crossover Treatment|Death|0|||
161663401|NCT03184870|583820333|FG002|Crossover Treatment|Death|0|||
161663402|NCT03184870|583820334|FG003|Crossover Treatment|Death|0|||
161663403|NCT03184870|583820335|FG004|Crossover Treatment|Death|0|||
161716361|NCT02495077|584007842|FG001|Overall Study|Protocol Violation|1|||
161716362|NCT02495077|584007843|FG002|Overall Study|Protocol Violation|0|||
161716363|NCT02495077|584007844|FG003|Overall Study|Protocol Violation|0|||
161716364|NCT02495077|584007841|FG000|Overall Study|Screen Failure|0|||
161716365|NCT02495077|584007842|FG001|Overall Study|Screen Failure|0|||
161663404|NCT03184870|583820336|FG005|Crossover Treatment|Death|0|||
161716366|NCT02495077|584007843|FG002|Overall Study|Screen Failure|0|||
161716367|NCT02495077|584007844|FG003|Overall Study|Screen Failure|48|||
161716368|NCT02495077|584007841|FG000|Overall Study|Withdrawal by Subject|7|||
161716369|NCT02495077|584007842|FG001|Overall Study|Withdrawal by Subject|7|||
161716370|NCT02495077|584007843|FG002|Overall Study|Withdrawal by Subject|7|||
161716371|NCT02495077|584007844|FG003|Overall Study|Withdrawal by Subject|0|||
161716372|NCT02495077|584007841|FG000|Overall Study|Covid-19 research restrictions|1|||
161716373|NCT02495077|584007842|FG001|Overall Study|Covid-19 research restrictions|0|||
161716374|NCT02495077|584007843|FG002|Overall Study|Covid-19 research restrictions|0|||
161716375|NCT02495077|584007844|FG003|Overall Study|Covid-19 research restrictions|0|||
161716376|NCT02495077|584007841|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
161716377|NCT02495077|584007842|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
161716378|NCT02495077|584007843|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
161716379|NCT02495077|584007844|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
161716380|NCT02495077|584007841|FG000|Overall Study|Incarcerated|0|||
161716381|NCT02495077|584007842|FG001|Overall Study|Incarcerated|1|||
161716382|NCT02495077|584007843|FG002|Overall Study|Incarcerated|0|||
161716383|NCT02495077|584007844|FG003|Overall Study|Incarcerated|0|||
161716384|NCT02495077|584007841|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
161716385|NCT02495077|584007842|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
161716386|NCT02495077|584007843|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
161716387|NCT02495077|584007844|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
161716388|NCT02495077|584007841|FG000|Overall Study|Timing of transplant and randomization|0|||
161716389|NCT02495077|584007842|FG001|Overall Study|Timing of transplant and randomization|0|||
161716390|NCT02495077|584007843|FG002|Overall Study|Timing of transplant and randomization|5|||
161716391|NCT02495077|584007844|FG003|Overall Study|Timing of transplant and randomization|0|||
161716392|NCT02742649|584007845|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
161716393|NCT02742649|584007846|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716394|NCT02742649|584007847|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716395|NCT02742649|584007848|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716396|NCT02742649|584007849|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716397|NCT02742649|584007845|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161716398|NCT02742649|584007846|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161716399|NCT02742649|584007847|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161716400|NCT02742649|584007848|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161716401|NCT02742649|584007849|FG004|Double-Blind Treatment Period|Adverse Event|0|||
161716402|NCT02742649|584007845|FG000|Open-Label Period|Lost to Follow-up|0|||
161716403|NCT02742649|584007846|FG001|Open-Label Period|Lost to Follow-up|0|||
161716404|NCT02742649|584007847|FG002|Open-Label Period|Lost to Follow-up|0|||
161716405|NCT02742649|584007848|FG003|Open-Label Period|Lost to Follow-up|0|||
161716406|NCT02742649|584007849|FG004|Open-Label Period|Lost to Follow-up|1|||
161716407|NCT03937986|584007850|FG000|Overall Study|COVID-19 Pandemic|1|||
161716408|NCT02839746|584007851|FG000|Overall Study|Not met selection criteria|12|||
161716409|NCT02089737|584007852|FG000|Overall Study|Survey form not completed|5|||
161716410|NCT02089737|584007852|FG000|Overall Study|Not treated|1|||
161716411|NCT00744055|584007853|FG000|Overall Study|Withdrawal by Subject|6|||
161716412|NCT00744055|584007854|FG001|Overall Study|Withdrawal by Subject|9|||
161716413|NCT00744055|584007853|FG000|Overall Study|Lack of Efficacy|0|||
161716414|NCT00744055|584007854|FG001|Overall Study|Lack of Efficacy|1|||
161716415|NCT00744055|584007853|FG000|Overall Study|Physician Decision|0|||
161716416|NCT00744055|584007854|FG001|Overall Study|Physician Decision|2|||
161716417|NCT00744055|584007853|FG000|Overall Study|Protocol Violation|1|||
161716418|NCT00744055|584007854|FG001|Overall Study|Protocol Violation|1|||
161716419|NCT00744055|584007853|FG000|Overall Study|Lost to Follow-up|0|||
161716420|NCT00744055|584007854|FG001|Overall Study|Lost to Follow-up|1|||
161716421|NCT04426630|584007855|FG000|Overall Study|Death|4|||
161716422|NCT04426630|584007855|FG000|Overall Study|Lost to Follow-up|2|||
161716423|NCT01123889|584007856|FG000|Overall Study|Lost to Follow-up|3|||
161716424|NCT01123889|584007857|FG001|Overall Study|Lost to Follow-up|1|||
161716425|NCT02333331|584007858|FG000|Overall Study|Adverse Event|1|||
161716426|NCT02333331|584007859|FG001|Overall Study|Adverse Event|0|||
161716427|NCT02333331|584007860|FG002|Overall Study|Adverse Event|4|||
161716428|NCT02333331|584007861|FG003|Overall Study|Adverse Event|1|||
161716429|NCT02333331|584007858|FG000|Overall Study|Death|0|||
161716430|NCT02333331|584007859|FG001|Overall Study|Death|0|||
161716431|NCT02333331|584007860|FG002|Overall Study|Death|2|||
161716432|NCT02333331|584007861|FG003|Overall Study|Death|0|||
161716433|NCT02333331|584007858|FG000|Overall Study|Lost to Follow-up|0|||
161716434|NCT02333331|584007859|FG001|Overall Study|Lost to Follow-up|0|||
161716435|NCT02333331|584007860|FG002|Overall Study|Lost to Follow-up|1|||
161716436|NCT02333331|584007861|FG003|Overall Study|Lost to Follow-up|0|||
161716437|NCT02333331|584007858|FG000|Overall Study|Physician Decision|0|||
161716438|NCT02333331|584007859|FG001|Overall Study|Physician Decision|1|||
161716439|NCT02333331|584007860|FG002|Overall Study|Physician Decision|0|||
161716440|NCT02333331|584007861|FG003|Overall Study|Physician Decision|0|||
161716441|NCT02333331|584007858|FG000|Overall Study|Protocol Deviation|0|||
161716442|NCT02333331|584007859|FG001|Overall Study|Protocol Deviation|3|||
161716443|NCT02333331|584007860|FG002|Overall Study|Protocol Deviation|2|||
161716444|NCT02333331|584007861|FG003|Overall Study|Protocol Deviation|1|||
161716445|NCT02333331|584007858|FG000|Overall Study|Patient/Guardian Decision|1|||
161716446|NCT02333331|584007859|FG001|Overall Study|Patient/Guardian Decision|2|||
161716447|NCT02333331|584007860|FG002|Overall Study|Patient/Guardian Decision|9|||
161716448|NCT02333331|584007861|FG003|Overall Study|Patient/Guardian Decision|1|||
161716449|NCT00685178|584007867|FG000|Overall Study|Adverse Event|1|||
161716450|NCT00685178|584007868|FG001|Overall Study|Adverse Event|5|||
161716451|NCT00685178|584007869|FG002|Overall Study|Adverse Event|2|||
161716452|NCT00685178|584007870|FG003|Overall Study|Adverse Event|4|||
161716453|NCT00685178|584007867|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
161716454|NCT00685178|584007868|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
161716455|NCT00685178|584007869|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
161716456|NCT00685178|584007870|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
161716457|NCT00685178|584007867|FG000|Overall Study|voluntary study discharge|4|||
161716458|NCT00685178|584007868|FG001|Overall Study|voluntary study discharge|5|||
161716459|NCT00685178|584007869|FG002|Overall Study|voluntary study discharge|1|||
161716460|NCT00685178|584007870|FG003|Overall Study|voluntary study discharge|1|||
161716461|NCT00685178|584007867|FG000|Overall Study|incarcerated|1|||
161716462|NCT00685178|584007868|FG001|Overall Study|incarcerated|3|||
161716463|NCT00685178|584007869|FG002|Overall Study|incarcerated|7|||
161716464|NCT00685178|584007870|FG003|Overall Study|incarcerated|0|||
161716465|NCT00685178|584007867|FG000|Overall Study|administrative (disciplinary) discharge|0|||
161716466|NCT00685178|584007868|FG001|Overall Study|administrative (disciplinary) discharge|1|||
161716467|NCT00685178|584007869|FG002|Overall Study|administrative (disciplinary) discharge|0|||
161716468|NCT00685178|584007870|FG003|Overall Study|administrative (disciplinary) discharge|2|||
161716469|NCT00685178|584007867|FG000|Overall Study|Pregnancy|0|||
161716470|NCT00685178|584007868|FG001|Overall Study|Pregnancy|0|||
161716471|NCT00685178|584007869|FG002|Overall Study|Pregnancy|0|||
161716472|NCT00685178|584007870|FG003|Overall Study|Pregnancy|1|||
161716473|NCT05299892|584007884|FG000|Overall Study|Withdrawal by Subject|2|||
161716474|NCT01059812|584007885|FG000|Overall Study|Adverse Event|9|||
161716475|NCT01059812|584007886|FG001|Overall Study|Adverse Event|5|||
161716476|NCT01059812|584007885|FG000|Overall Study|Lack of Efficacy|2|||
161716477|NCT01059812|584007886|FG001|Overall Study|Lack of Efficacy|2|||
161716478|NCT01059812|584007885|FG000|Overall Study|Protocol Violation|3|||
161716479|NCT01059812|584007886|FG001|Overall Study|Protocol Violation|1|||
161716480|NCT01059812|584007885|FG000|Overall Study|Withdrawal Criteria|9|||
161716481|NCT01059812|584007886|FG001|Overall Study|Withdrawal Criteria|4|||
161716482|NCT01059812|584007885|FG000|Overall Study|Unclassified|14|||
161716483|NCT01059812|584007886|FG001|Overall Study|Unclassified|4|||
161716484|NCT00149214|584007887|FG000|Overall Study|Adverse Event|12|||
161716485|NCT00149214|584007888|FG001|Overall Study|Adverse Event|9|||
161716486|NCT00149214|584007887|FG000|Overall Study|Withdrawal by Subject|4|||
161716487|NCT00149214|584007888|FG001|Overall Study|Withdrawal by Subject|1|||
161716488|NCT00149214|584007887|FG000|Overall Study|Physician Decision|3|||
161716489|NCT00149214|584007888|FG001|Overall Study|Physician Decision|3|||
161716490|NCT00149214|584007887|FG000|Overall Study|Sponsor Decision|0|||
161716491|NCT00149214|584007888|FG001|Overall Study|Sponsor Decision|1|||
161716492|NCT00149214|584007887|FG000|Overall Study|Progressive Disease|7|||
161716493|NCT00149214|584007888|FG001|Overall Study|Progressive Disease|3|||
161716494|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161716495|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161716496|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161716497|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161716498|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161716499|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161716500|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
161716501|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
161716502|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Other|2|||
161716503|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Other|2|||
161716504|NCT04329923|584007897|FG000|Overall Study|Withdrawal by Subject|1|||
161716505|NCT04329923|584007898|FG001|Overall Study|Withdrawal by Subject|4|||
161716506|NCT04329923|584007899|FG002|Overall Study|Withdrawal by Subject|1|||
161716507|NCT04329923|584007900|FG003|Overall Study|Withdrawal by Subject|1|||
161716508|NCT04329923|584007901|FG004|Overall Study|Withdrawal by Subject|1|||
161716509|NCT04329923|584007902|FG005|Overall Study|Withdrawal by Subject|1|||
161716510|NCT04329923|584007897|FG000|Overall Study|early termination of study|0|||
161716511|NCT04329923|584007898|FG001|Overall Study|early termination of study|0|||
161716512|NCT04329923|584007899|FG002|Overall Study|early termination of study|0|||
161716513|NCT04329923|584007900|FG003|Overall Study|early termination of study|0|||
161716514|NCT04329923|584007901|FG004|Overall Study|early termination of study|1|||
161716515|NCT04329923|584007902|FG005|Overall Study|early termination of study|2|||
161716516|NCT04329923|584007897|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716517|NCT04329923|584007898|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716518|NCT04329923|584007899|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716519|NCT04329923|584007900|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716520|NCT04329923|584007901|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716521|NCT04329923|584007902|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
161716522|NCT01272180|584007903|FG000|Overall Study|Adverse Event|0|||
161716523|NCT01272180|584007904|FG001|Overall Study|Adverse Event|0|||
161716524|NCT01272180|584007905|FG002|Overall Study|Adverse Event|1|||
161716525|NCT01272180|584007906|FG003|Overall Study|Adverse Event|0|||
161716526|NCT01272180|584007903|FG000|Overall Study|Withdrawal by Subject|2|||
161716527|NCT01272180|584007904|FG001|Overall Study|Withdrawal by Subject|6|||
161716528|NCT01272180|584007905|FG002|Overall Study|Withdrawal by Subject|3|||
161716529|NCT01272180|584007906|FG003|Overall Study|Withdrawal by Subject|2|||
161716530|NCT01272180|584007903|FG000|Overall Study|Lost to Follow-up|15|||
161716531|NCT01272180|584007904|FG001|Overall Study|Lost to Follow-up|14|||
161716532|NCT01272180|584007905|FG002|Overall Study|Lost to Follow-up|8|||
161716533|NCT01272180|584007906|FG003|Overall Study|Lost to Follow-up|10|||
161716534|NCT01272180|584007903|FG000|Overall Study|Inappropriate enrollment|0|||
161716535|NCT01272180|584007904|FG001|Overall Study|Inappropriate enrollment|0|||
161716536|NCT01272180|584007905|FG002|Overall Study|Inappropriate enrollment|1|||
161716537|NCT01272180|584007906|FG003|Overall Study|Inappropriate enrollment|1|||
161716538|NCT01272180|584007903|FG000|Overall Study|Protocol Violation|0|||
161716539|NCT01272180|584007904|FG001|Overall Study|Protocol Violation|1|||
161716540|NCT01272180|584007905|FG002|Overall Study|Protocol Violation|0|||
161716541|NCT01272180|584007906|FG003|Overall Study|Protocol Violation|1|||
161716542|NCT03334214|584007907|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161716543|NCT03334214|584007908|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161716544|NCT03334214|584007907|FG000|Overall Study|Withdrawal by Subject|0|||
161716545|NCT03334214|584007908|FG001|Overall Study|Withdrawal by Subject|1|||
161716546|NCT03334214|584007907|FG000|Overall Study|Other|1|||
161716547|NCT03334214|584007908|FG001|Overall Study|Other|0|||
161716548|NCT01702805|584007913|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
161716549|NCT01702805|584007914|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
161716550|NCT01702805|584007913|FG000|Overall Study|Incomplete Follow-up|18|||
161716551|NCT01702805|584007914|FG001|Overall Study|Incomplete Follow-up|15|||
161716552|NCT01702805|584007913|FG000|Overall Study|Vital Status Assessment Only|40|||
161716553|NCT01702805|584007914|FG001|Overall Study|Vital Status Assessment Only|39|||
161716554|NCT01702805|584007913|FG000|Overall Study|Lost to Follow-up|5|||
161716555|NCT01702805|584007914|FG001|Overall Study|Lost to Follow-up|5|||
161716556|NCT03056287|584007915|FG000|Overall Study|Withdrawal by Subject|0|||
161716557|NCT03056287|584007916|FG001|Overall Study|Withdrawal by Subject|1|||
161716558|NCT03056287|584007917|FG002|Overall Study|Withdrawal by Subject|0|||
161716559|NCT03056287|584007918|FG003|Overall Study|Withdrawal by Subject|0|||
161716560|NCT03056287|584007915|FG000|Overall Study|move out of area|0|||
161716561|NCT03056287|584007916|FG001|Overall Study|move out of area|0|||
161716562|NCT03056287|584007917|FG002|Overall Study|move out of area|1|||
161716563|NCT03056287|584007918|FG003|Overall Study|move out of area|1|||
161716564|NCT01025336|584007923|FG000|Overall Study|Protocol Violation|0|||
161716565|NCT01025336|584007924|FG001|Overall Study|Protocol Violation|0|||
161716566|NCT01025336|584007925|FG002|Overall Study|Protocol Violation|0|||
161716567|NCT01025336|584007926|FG003|Overall Study|Protocol Violation|2|||
161716568|NCT01025336|584007927|FG004|Overall Study|Protocol Violation|0|||
161716569|NCT03794986|584007928|FG000|Overall Study|0 Sessions Attended|34|||
161716570|NCT03794986|584007929|FG001|Overall Study|0 Sessions Attended|37|||
161716571|NCT03794986|584007928|FG000|Overall Study|Withdrawal by Subject|4|||
161716572|NCT03794986|584007929|FG001|Overall Study|Withdrawal by Subject|6|||
161716573|NCT03794986|584007928|FG000|Overall Study|Protocol Violation|1|||
161716574|NCT03794986|584007929|FG001|Overall Study|Protocol Violation|0|||
161716575|NCT00550238|584007935|FG000|Overall Study|Adverse Event|88|||
161716576|NCT00550238|584007935|FG000|Overall Study|Death|34|||
161716577|NCT00550238|584007935|FG000|Overall Study|Disease progression|46|||
161716578|NCT00550238|584007935|FG000|Overall Study|Withdrawal by Subject|167|||
161716579|NCT00550238|584007935|FG000|Overall Study|Physician Decision|31|||
161716580|NCT00550238|584007935|FG000|Overall Study|Patient noncompliance|25|||
161716581|NCT00550238|584007935|FG000|Overall Study|Lost to Follow-up|13|||
161716582|NCT00550238|584007935|FG000|Overall Study|Sponsor decision|55|||
161716583|NCT01486238|584007941|FG000|Overall Study|Death|0|||
161716584|NCT01486238|584007942|FG001|Overall Study|Death|2|||
161716585|NCT01486238|584007941|FG000|Overall Study|Withdrawal by Subject|2|||
161716586|NCT01486238|584007942|FG001|Overall Study|Withdrawal by Subject|1|||
161716587|NCT01486238|584007941|FG000|Overall Study|Lost to Follow-up|0|||
161716588|NCT01486238|584007942|FG001|Overall Study|Lost to Follow-up|3|||
161716589|NCT01050062|584007943|FG000|Overall Study|Adverse Event|75|||
161716590|NCT01050062|584007944|FG001|Overall Study|Adverse Event|22|||
161838022|NCT00132028|584450292|FG000|Overall Study|Lack of Efficacy|11|||
161838023|NCT00132028|584450292|FG000|Overall Study|Withdrawal by Subject|2|||
161838024|NCT00132028|584450292|FG000|Overall Study|not eligible|2|||
161838025|NCT00132028|584450292|FG000|Overall Study|Physician Decision|3|||
161663405|NCT03184870|583820337|FG006|Crossover Treatment|Death|0|||
161663406|NCT03184870|583820338|FG007|Crossover Treatment|Death|0|||
161663407|NCT03184870|583820339|FG008|Crossover Treatment|Death|0|||
161663408|NCT03184870|583820340|FG009|Crossover Treatment|Death|0|||
161663409|NCT03184870|583820341|FG010|Crossover Treatment|Death|0|||
161663410|NCT03184870|583820342|FG011|Crossover Treatment|Death|0|||
161663411|NCT03184870|583820343|FG012|Crossover Treatment|Death|0|||
161663412|NCT03184870|583820344|FG013|Crossover Treatment|Death|0|||
161663413|NCT03184870|583820345|FG014|Crossover Treatment|Death|0|||
161663414|NCT03184870|583820346|FG015|Crossover Treatment|Death|0|||
161663415|NCT03184870|583820347|FG016|Crossover Treatment|Death|0|||
161663416|NCT03184870|583820348|FG017|Crossover Treatment|Death|7|||
161663417|NCT05081388|583820349|FG000|Overall Study|Adverse Event|1|||
161663418|NCT05081388|583820350|FG001|Overall Study|Adverse Event|0|||
161663419|NCT05081388|583820351|FG002|Overall Study|Adverse Event|0|||
161663420|NCT05081388|583820352|FG003|Overall Study|Adverse Event|0|||
161663421|NCT05081388|583820353|FG004|Overall Study|Adverse Event|0|||
161663422|NCT05081388|583820349|FG000|Overall Study|Lost to Follow-up|0|||
161663423|NCT05081388|583820350|FG001|Overall Study|Lost to Follow-up|1|||
161663424|NCT05081388|583820351|FG002|Overall Study|Lost to Follow-up|0|||
161663425|NCT05081388|583820352|FG003|Overall Study|Lost to Follow-up|0|||
161663426|NCT05081388|583820353|FG004|Overall Study|Lost to Follow-up|0|||
161663427|NCT05081388|583820349|FG000|Overall Study|Subject decision|0|||
161663428|NCT05081388|583820350|FG001|Overall Study|Subject decision|0|||
161663429|NCT05081388|583820351|FG002|Overall Study|Subject decision|0|||
161663430|NCT05081388|583820352|FG003|Overall Study|Subject decision|1|||
161663431|NCT05081388|583820353|FG004|Overall Study|Subject decision|0|||
161663432|NCT03786783|583820354|FG000|Overall Study|Death|1|||
161663433|NCT03786783|583820354|FG000|Overall Study|Physician Decision|6|||
161663434|NCT03786783|583820354|FG000|Overall Study|Withdrawal by Subject|2|||
161663435|NCT03786783|583820354|FG000|Overall Study|Disease Progression|7|||
161663436|NCT03786783|583820354|FG000|Overall Study|Patient/Parent Refusal|4|||
161716591|NCT01050062|584007943|FG000|Overall Study|Lost to Follow-up|83|||
161716592|NCT01050062|584007944|FG001|Overall Study|Lost to Follow-up|35|||
161838026|NCT02140411|584450293|FG000|Overall Study|Adverse Event|1|||
161838027|NCT03981419|584450296|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
161838028|NCT03981419|584450297|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
161838029|NCT01330459|584450298|FG000|Overall Study|Physician Decision|0|||
161838030|NCT01330459|584450299|FG001|Overall Study|Physician Decision|2|||
161838031|NCT02272634|584450307|FG000|Overall Study|Adverse Event|1|||
161838032|NCT02272634|584450308|FG001|Overall Study|Adverse Event|0|||
161838033|NCT02272634|584450309|FG002|Overall Study|Adverse Event|0|||
161663437|NCT01776541|583820355|FG000|Overall Study|Administrative Reason|6|||
161663438|NCT01776541|583820356|FG001|Overall Study|Administrative Reason|2|||
161663439|NCT01776541|583820355|FG000|Overall Study|Death|4|||
161716593|NCT01050062|584007943|FG000|Overall Study|Lack of Efficacy|22|||
161716594|NCT01050062|584007944|FG001|Overall Study|Lack of Efficacy|35|||
161838034|NCT02272634|584450307|FG000|Overall Study|Protocol Violation|0|||
161663440|NCT01776541|583820356|FG001|Overall Study|Death|0|||
161663441|NCT01776541|583820355|FG000|Overall Study|Lost to Follow-up|27|||
161663442|NCT01776541|583820356|FG001|Overall Study|Lost to Follow-up|48|||
161663443|NCT01776541|583820355|FG000|Overall Study|Unclassified|5|||
161663444|NCT01776541|583820356|FG001|Overall Study|Unclassified|4|||
161663445|NCT01776541|583820355|FG000|Overall Study|Protocol Violation|2|||
161663446|NCT01776541|583820356|FG001|Overall Study|Protocol Violation|1|||
161663447|NCT01776541|583820355|FG000|Overall Study|Withdrawal by Subject|12|||
161663448|NCT01776541|583820356|FG001|Overall Study|Withdrawal by Subject|20|||
161663449|NCT04279392|583820359|FG000|Overall Study|Physician Decision|1|||
161663450|NCT04279392|583820360|FG001|Overall Study|Physician Decision|0|||
161663451|NCT01981473|583820361|FG000|Overall Study|Incorrect diagnosis of RA|0|||
161663452|NCT01981473|583820362|FG001|Overall Study|Incorrect diagnosis of RA|0|||
161663453|NCT01981473|583820363|FG002|Overall Study|Incorrect diagnosis of RA|1|||
161663454|NCT01981473|583820361|FG000|Overall Study|Received treatment for < 6 months|0|||
161663455|NCT01981473|583820362|FG001|Overall Study|Received treatment for < 6 months|0|||
161663456|NCT01981473|583820363|FG002|Overall Study|Received treatment for < 6 months|1|||
161663457|NCT01981473|583820361|FG000|Overall Study|Received treatment for >24 months|2|||
161663458|NCT01981473|583820362|FG001|Overall Study|Received treatment for >24 months|0|||
161663459|NCT01981473|583820363|FG002|Overall Study|Received treatment for >24 months|6|||
161663460|NCT00738582|583820364|FG000|Combination Therapy|Completed Combination Therapy|1|||
161663461|NCT00738582|583820365|FG001|Combination Therapy|Completed Combination Therapy|0|||
161663462|NCT00738582|583820364|FG000|Combination Therapy|Physician Decision|1|||
161663463|NCT00738582|583820365|FG001|Combination Therapy|Physician Decision|0|||
161663464|NCT00738582|583820364|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
161663465|NCT00738582|583820365|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
161663466|NCT00738582|583820364|FG000|Combination Therapy|Other|5|||
161663467|NCT00738582|583820365|FG001|Combination Therapy|Other|0|||
161663468|NCT00738582|583820364|FG000|Combination Therapy|Adverse Event|16|||
161663469|NCT00738582|583820365|FG001|Combination Therapy|Adverse Event|0|||
161663470|NCT00738582|583820364|FG000|Combination Therapy|Progressive Disease|9|||
161716595|NCT01050062|584007943|FG000|Overall Study|Physician Decision|74|||
161716596|NCT01050062|584007944|FG001|Overall Study|Physician Decision|9|||
161716597|NCT01050062|584007943|FG000|Overall Study|Others|17|||
161716598|NCT01050062|584007944|FG001|Overall Study|Others|11|||
161716599|NCT03894540|584007945|FG000|Overall Study|Adverse Event|0|||
161716600|NCT03894540|584007946|FG001|Overall Study|Adverse Event|0|||
161716601|NCT03894540|584007947|FG002|Overall Study|Adverse Event|0|||
161716602|NCT03894540|584007948|FG003|Overall Study|Adverse Event|0|||
161716603|NCT03894540|584007949|FG004|Overall Study|Adverse Event|1|||
161716604|NCT03894540|584007950|FG005|Overall Study|Adverse Event|0|||
161716605|NCT03894540|584007945|FG000|Overall Study|Withdrawal by Subject|0|||
161716606|NCT03894540|584007946|FG001|Overall Study|Withdrawal by Subject|0|||
161716607|NCT03894540|584007947|FG002|Overall Study|Withdrawal by Subject|0|||
161716608|NCT03894540|584007948|FG003|Overall Study|Withdrawal by Subject|0|||
161716609|NCT03894540|584007949|FG004|Overall Study|Withdrawal by Subject|1|||
161716610|NCT03894540|584007950|FG005|Overall Study|Withdrawal by Subject|0|||
161716611|NCT03894540|584007945|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
161716612|NCT03894540|584007946|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
161716613|NCT03894540|584007947|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
161716614|NCT03894540|584007948|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
161716615|NCT03894540|584007949|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
161716616|NCT03894540|584007950|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
161716617|NCT03894540|584007945|FG000|Overall Study|Progressive Disease Clinical|1|||
161663471|NCT00738582|583820365|FG001|Combination Therapy|Progressive Disease|0|||
161663472|NCT00738582|583820364|FG000|Maintenance Therapy|Other|0|||
161663473|NCT00738582|583820365|FG001|Maintenance Therapy|Other|2|||
161663474|NCT00738582|583820364|FG000|Maintenance Therapy|Adverse Event|0|||
161663475|NCT00738582|583820365|FG001|Maintenance Therapy|Adverse Event|6|||
161663476|NCT00738582|583820364|FG000|Maintenance Therapy|Progressive Disease|0|||
161663477|NCT00738582|583820365|FG001|Maintenance Therapy|Progressive Disease|47|||
161663478|NCT00738582|583820364|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
161663479|NCT00738582|583820365|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
161663480|NCT00903006|583820371|FG000|Overall Study|Withdrawal by Subject|2|||
161838035|NCT02272634|584450308|FG001|Overall Study|Protocol Violation|0|||
161663481|NCT00903006|583820372|FG001|Overall Study|Withdrawal by Subject|0|||
161663482|NCT00903006|583820373|FG002|Overall Study|Withdrawal by Subject|0|||
161663483|NCT00903006|583820374|FG003|Overall Study|Withdrawal by Subject|0|||
161663484|NCT00903006|583820371|FG000|Overall Study|Progressive Disease|0|||
161838036|NCT02272634|584450309|FG002|Overall Study|Protocol Violation|1|||
161663485|NCT00903006|583820372|FG001|Overall Study|Progressive Disease|3|||
161663486|NCT00903006|583820373|FG002|Overall Study|Progressive Disease|1|||
161663487|NCT00903006|583820374|FG003|Overall Study|Progressive Disease|0|||
161663488|NCT03405792|583820375|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
161716618|NCT03894540|584007946|FG001|Overall Study|Progressive Disease Clinical|1|||
161716619|NCT03894540|584007947|FG002|Overall Study|Progressive Disease Clinical|0|||
161716620|NCT03894540|584007948|FG003|Overall Study|Progressive Disease Clinical|1|||
161716621|NCT03894540|584007949|FG004|Overall Study|Progressive Disease Clinical|5|||
161716622|NCT03894540|584007950|FG005|Overall Study|Progressive Disease Clinical|1|||
161716623|NCT03894540|584007945|FG000|Overall Study|Study termination by sponsor|0|||
161716624|NCT03894540|584007946|FG001|Overall Study|Study termination by sponsor|0|||
161716625|NCT03894540|584007947|FG002|Overall Study|Study termination by sponsor|0|||
161716626|NCT03894540|584007948|FG003|Overall Study|Study termination by sponsor|0|||
161716627|NCT03894540|584007949|FG004|Overall Study|Study termination by sponsor|2|||
161716628|NCT03894540|584007950|FG005|Overall Study|Study termination by sponsor|0|||
161716629|NCT03000452|584007951|FG000|Treatment Period|Death|1|||
161716630|NCT03000452|584007951|FG000|Treatment Period|Progressive Disease (PD)|14|||
161716631|NCT03000452|584007951|FG000|Treatment Period|Physician Decision|1|||
161716632|NCT03000452|584007951|FG000|Treatment Period|Miscellaneous|2|||
161716633|NCT03000452|584007951|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
161716634|NCT03000452|584007951|FG000|Follow-Up Period|Death|3|||
161716635|NCT03000452|584007951|FG000|Follow-Up Period|Withdrawal by Subject|3|||
161716636|NCT03043365|584007952|FG000|Weeks 0 to Week 8|Adverse Event|1|||
161716637|NCT03043365|584007953|FG001|Weeks 0 to Week 8|Adverse Event|3|||
161716638|NCT03043365|584007952|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
161716639|NCT03043365|584007953|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
161716640|NCT03043365|584007952|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
161716641|NCT03043365|584007953|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
161716642|NCT00593112|584007954|FG000|Overall Study|Scan Anxiety|3|||
161716643|NCT00593112|584007955|FG001|Overall Study|Scan Anxiety|0|||
161716644|NCT00593112|584007954|FG000|Overall Study|Abnormal Scan|1|||
161716645|NCT00593112|584007955|FG001|Overall Study|Abnormal Scan|0|||
161716646|NCT00593112|584007954|FG000|Overall Study|Unreadable Scan|1|||
161716647|NCT00593112|584007955|FG001|Overall Study|Unreadable Scan|0|||
161716648|NCT00593112|584007954|FG000|Overall Study|Withdrawal by Subject|5|||
161716649|NCT00593112|584007955|FG001|Overall Study|Withdrawal by Subject|0|||
161716650|NCT02723630|584007956|FG000|Intervention Period 1|Adverse Event|1|||
161716651|NCT02723630|584007957|FG001|Intervention Period 1|Adverse Event|0|||
161716652|NCT02723630|584007958|FG002|Intervention Period 1|Adverse Event|0|||
161716653|NCT02723630|584007959|FG003|Intervention Period 1|Adverse Event|0|||
161716654|NCT02723630|584007960|FG004|Intervention Period 1|Adverse Event|0|||
161716655|NCT02723630|584007961|FG005|Intervention Period 1|Adverse Event|0|||
161716656|NCT02723630|584007956|FG000|Intervention Period 3|consumption of restricted item|0|||
161716657|NCT02723630|584007957|FG001|Intervention Period 3|consumption of restricted item|1|||
161716658|NCT02723630|584007958|FG002|Intervention Period 3|consumption of restricted item|0|||
161716659|NCT02723630|584007959|FG003|Intervention Period 3|consumption of restricted item|0|||
161716660|NCT02723630|584007960|FG004|Intervention Period 3|consumption of restricted item|0|||
161716661|NCT02723630|584007961|FG005|Intervention Period 3|consumption of restricted item|0|||
161716662|NCT00852930|584007962|FG000|Overall Study|Withdrawal by Subject|1|||
161716663|NCT00852930|584007963|FG001|Overall Study|Withdrawal by Subject|1|||
161716664|NCT00852930|584007964|FG002|Overall Study|Withdrawal by Subject|1|||
161716665|NCT00852930|584007962|FG000|Overall Study|Physician Decision|0|||
161716666|NCT00852930|584007963|FG001|Overall Study|Physician Decision|0|||
161716667|NCT00852930|584007964|FG002|Overall Study|Physician Decision|1|||
161716668|NCT00537745|584007967|FG000|Overall Study|Did not meet eligibility criteria|2|||
161716669|NCT00537745|584007967|FG000|Overall Study|Withdrawal by Subject|2|||
161716670|NCT00537745|584007967|FG000|Overall Study|Subject unable to provide Interlock info|1|||
161716671|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
161716672|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
161716673|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
161716674|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
161716675|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
161716676|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
161716677|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
161716678|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
161716679|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716680|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716681|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716682|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716683|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716684|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
161716685|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
161716686|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161716687|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
161716688|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
161716689|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
161716690|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161716691|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161716692|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716693|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716694|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716695|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716696|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716697|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161716698|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161716699|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161716700|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
161716701|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
161716702|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
161716703|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
161716704|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
161716705|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716706|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716707|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716708|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716709|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716710|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716711|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716712|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716713|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716714|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716715|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
161716716|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716717|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716718|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716719|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716720|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716721|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716722|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716723|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716724|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161716725|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716726|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161716727|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716728|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161716729|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716730|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716731|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716732|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716733|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716734|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716735|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716736|NCT00923091|584007971|FG000|Period III (Single-Blind)|Adverse Event|5|||
161716737|NCT00923091|584007972|FG001|Period III (Single-Blind)|Adverse Event|0|||
161716738|NCT00923091|584007973|FG002|Period III (Single-Blind)|Adverse Event|0|||
161716739|NCT00923091|584007974|FG003|Period III (Single-Blind)|Adverse Event|0|||
161716740|NCT00923091|584007975|FG004|Period III (Single-Blind)|Adverse Event|0|||
161716741|NCT00923091|584007976|FG005|Period III (Single-Blind)|Adverse Event|0|||
161716742|NCT00923091|584007977|FG006|Period III (Single-Blind)|Adverse Event|0|||
161716743|NCT00923091|584007978|FG007|Period III (Single-Blind)|Adverse Event|0|||
161716744|NCT00923091|584007979|FG008|Period III (Single-Blind)|Adverse Event|0|||
161716745|NCT00923091|584007980|FG009|Period III (Single-Blind)|Adverse Event|0|||
161716746|NCT00923091|584007981|FG010|Period III (Single-Blind)|Adverse Event|0|||
161716747|NCT00923091|584007982|FG011|Period III (Single-Blind)|Adverse Event|0|||
161716748|NCT00923091|584007983|FG012|Period III (Single-Blind)|Adverse Event|0|||
161716749|NCT00923091|584007971|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
161716750|NCT00923091|584007972|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716751|NCT00923091|584007973|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716752|NCT00923091|584007974|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716753|NCT00923091|584007975|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716754|NCT00923091|584007976|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716755|NCT00923091|584007977|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716756|NCT00923091|584007978|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716757|NCT00923091|584007979|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716758|NCT00923091|584007980|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716759|NCT00923091|584007981|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716760|NCT00923091|584007982|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716761|NCT00923091|584007983|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716762|NCT00923091|584007971|FG000|Period III (Single-Blind)|Protocol Violation|3|||
161716763|NCT00923091|584007972|FG001|Period III (Single-Blind)|Protocol Violation|0|||
161716764|NCT00923091|584007973|FG002|Period III (Single-Blind)|Protocol Violation|0|||
161716765|NCT00923091|584007974|FG003|Period III (Single-Blind)|Protocol Violation|0|||
161716766|NCT00923091|584007975|FG004|Period III (Single-Blind)|Protocol Violation|0|||
161716767|NCT00923091|584007976|FG005|Period III (Single-Blind)|Protocol Violation|0|||
161716768|NCT00923091|584007977|FG006|Period III (Single-Blind)|Protocol Violation|0|||
161716769|NCT00923091|584007978|FG007|Period III (Single-Blind)|Protocol Violation|0|||
161716770|NCT00923091|584007979|FG008|Period III (Single-Blind)|Protocol Violation|0|||
161716771|NCT00923091|584007980|FG009|Period III (Single-Blind)|Protocol Violation|0|||
161716772|NCT00923091|584007981|FG010|Period III (Single-Blind)|Protocol Violation|0|||
161716773|NCT00923091|584007982|FG011|Period III (Single-Blind)|Protocol Violation|0|||
161716774|NCT00923091|584007983|FG012|Period III (Single-Blind)|Protocol Violation|0|||
161716775|NCT00923091|584007971|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
161716776|NCT00923091|584007972|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
161716777|NCT00923091|584007973|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
161716778|NCT00923091|584007974|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
161716779|NCT00923091|584007975|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
161716780|NCT00923091|584007976|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
161716781|NCT00923091|584007977|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
161716782|NCT00923091|584007978|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
161716783|NCT00923091|584007979|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
161716784|NCT00923091|584007980|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
161716785|NCT00923091|584007981|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
161716786|NCT00923091|584007982|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
161716787|NCT00923091|584007983|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
161716788|NCT00923091|584007971|FG000|Period IV (Double-Blind)|Adverse Event|2|||
161716789|NCT00923091|584007972|FG001|Period IV (Double-Blind)|Adverse Event|0|||
161716790|NCT00923091|584007973|FG002|Period IV (Double-Blind)|Adverse Event|0|||
161716791|NCT00923091|584007974|FG003|Period IV (Double-Blind)|Adverse Event|0|||
161716792|NCT00923091|584007975|FG004|Period IV (Double-Blind)|Adverse Event|0|||
161716793|NCT00923091|584007976|FG005|Period IV (Double-Blind)|Adverse Event|0|||
161716794|NCT00923091|584007977|FG006|Period IV (Double-Blind)|Adverse Event|0|||
161716795|NCT00923091|584007978|FG007|Period IV (Double-Blind)|Adverse Event|0|||
161716796|NCT00923091|584007979|FG008|Period IV (Double-Blind)|Adverse Event|0|||
161716797|NCT00923091|584007980|FG009|Period IV (Double-Blind)|Adverse Event|0|||
161716798|NCT00923091|584007981|FG010|Period IV (Double-Blind)|Adverse Event|0|||
161716799|NCT00923091|584007982|FG011|Period IV (Double-Blind)|Adverse Event|0|||
161716800|NCT00923091|584007983|FG012|Period IV (Double-Blind)|Adverse Event|0|||
161716801|NCT00923091|584007971|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716802|NCT00923091|584007972|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
161716803|NCT00923091|584007973|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716804|NCT00923091|584007974|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716805|NCT00923091|584007975|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716806|NCT00923091|584007976|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716807|NCT00923091|584007977|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716808|NCT00923091|584007978|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716809|NCT00923091|584007979|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716810|NCT00923091|584007980|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716811|NCT00923091|584007981|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716812|NCT00923091|584007982|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716813|NCT00923091|584007983|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716814|NCT00923091|584007971|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
161716815|NCT00923091|584007972|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
161716816|NCT00923091|584007973|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
161716817|NCT00923091|584007974|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
161716818|NCT00923091|584007975|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
161716819|NCT00923091|584007976|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
161716820|NCT00923091|584007977|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
161716821|NCT00923091|584007978|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
161716822|NCT00923091|584007979|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
161716823|NCT00923091|584007980|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
161716824|NCT00923091|584007981|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
161716825|NCT00923091|584007982|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
161716826|NCT00923091|584007983|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
161663489|NCT03405792|583820376|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
161663490|NCT03405792|583820375|FG000|Overall Study|o Did not receive pembrolizumab|1|||
161663491|NCT03405792|583820376|FG001|Overall Study|o Did not receive pembrolizumab|0|||
161663492|NCT02518490|583820380|FG000|Overall Study|Withdrawal by Subject|1|||
161663493|NCT02518490|583820381|FG001|Overall Study|Withdrawal by Subject|1|||
161663494|NCT00346632|583820382|FG000|Overall Study|Progressive Disease|2|||
161663495|NCT00346632|583820383|FG001|Overall Study|Progressive Disease|2|||
161663496|NCT00346632|583820384|FG002|Overall Study|Progressive Disease|4|||
161663497|NCT00346632|583820385|FG003|Overall Study|Progressive Disease|3|||
161663498|NCT00346632|583820386|FG004|Overall Study|Progressive Disease|3|||
161663499|NCT00346632|583820387|FG005|Overall Study|Progressive Disease|1|||
161663500|NCT00346632|583820388|FG006|Overall Study|Progressive Disease|2|||
161663501|NCT00346632|583820389|FG007|Overall Study|Progressive Disease|2|||
161663502|NCT00346632|583820390|FG008|Overall Study|Progressive Disease|2|||
161663503|NCT00346632|583820391|FG009|Overall Study|Progressive Disease|2|||
161663504|NCT00346632|583820382|FG000|Overall Study|Adverse Event|0|||
161663505|NCT00346632|583820383|FG001|Overall Study|Adverse Event|0|||
161663506|NCT00346632|583820384|FG002|Overall Study|Adverse Event|0|||
161663507|NCT00346632|583820385|FG003|Overall Study|Adverse Event|0|||
161663508|NCT00346632|583820386|FG004|Overall Study|Adverse Event|1|||
161663509|NCT00346632|583820387|FG005|Overall Study|Adverse Event|1|||
161663510|NCT00346632|583820388|FG006|Overall Study|Adverse Event|1|||
161663511|NCT00346632|583820389|FG007|Overall Study|Adverse Event|0|||
161663512|NCT00346632|583820390|FG008|Overall Study|Adverse Event|0|||
161663513|NCT00346632|583820391|FG009|Overall Study|Adverse Event|0|||
161663514|NCT00346632|583820382|FG000|Overall Study|Death|0|||
161663515|NCT00346632|583820383|FG001|Overall Study|Death|0|||
161663516|NCT00346632|583820384|FG002|Overall Study|Death|1|||
161663517|NCT00346632|583820385|FG003|Overall Study|Death|0|||
161663518|NCT00346632|583820386|FG004|Overall Study|Death|0|||
161663519|NCT00346632|583820387|FG005|Overall Study|Death|0|||
161663520|NCT00346632|583820388|FG006|Overall Study|Death|0|||
161663521|NCT00346632|583820389|FG007|Overall Study|Death|0|||
161663522|NCT00346632|583820390|FG008|Overall Study|Death|0|||
161663523|NCT00346632|583820391|FG009|Overall Study|Death|0|||
161663524|NCT00346632|583820382|FG000|Overall Study|Protocol Violation|0|||
161663525|NCT00346632|583820383|FG001|Overall Study|Protocol Violation|0|||
161663526|NCT00346632|583820384|FG002|Overall Study|Protocol Violation|0|||
161663527|NCT00346632|583820385|FG003|Overall Study|Protocol Violation|0|||
161663528|NCT00346632|583820386|FG004|Overall Study|Protocol Violation|0|||
161663529|NCT00346632|583820387|FG005|Overall Study|Protocol Violation|0|||
161663530|NCT00346632|583820388|FG006|Overall Study|Protocol Violation|1|||
161663531|NCT00346632|583820389|FG007|Overall Study|Protocol Violation|0|||
161663532|NCT00346632|583820390|FG008|Overall Study|Protocol Violation|0|||
161663533|NCT00346632|583820391|FG009|Overall Study|Protocol Violation|0|||
161663534|NCT00346632|583820382|FG000|Overall Study|Withdrawal by Subject|0|||
161663535|NCT00346632|583820383|FG001|Overall Study|Withdrawal by Subject|0|||
161663536|NCT00346632|583820384|FG002|Overall Study|Withdrawal by Subject|0|||
161663537|NCT00346632|583820385|FG003|Overall Study|Withdrawal by Subject|0|||
161663538|NCT00346632|583820386|FG004|Overall Study|Withdrawal by Subject|0|||
161663539|NCT00346632|583820387|FG005|Overall Study|Withdrawal by Subject|0|||
161663540|NCT00346632|583820388|FG006|Overall Study|Withdrawal by Subject|1|||
161663541|NCT00346632|583820389|FG007|Overall Study|Withdrawal by Subject|0|||
161663542|NCT00346632|583820390|FG008|Overall Study|Withdrawal by Subject|0|||
161663543|NCT00346632|583820391|FG009|Overall Study|Withdrawal by Subject|0|||
161663544|NCT00346632|583820382|FG000|Overall Study|Switched to alternative treatment|0|||
161663545|NCT00346632|583820383|FG001|Overall Study|Switched to alternative treatment|0|||
161663546|NCT00346632|583820384|FG002|Overall Study|Switched to alternative treatment|1|||
161663547|NCT00346632|583820385|FG003|Overall Study|Switched to alternative treatment|0|||
161663548|NCT00346632|583820386|FG004|Overall Study|Switched to alternative treatment|0|||
161663549|NCT00346632|583820387|FG005|Overall Study|Switched to alternative treatment|0|||
161663550|NCT00346632|583820388|FG006|Overall Study|Switched to alternative treatment|0|||
161663551|NCT00346632|583820389|FG007|Overall Study|Switched to alternative treatment|0|||
161663552|NCT00346632|583820390|FG008|Overall Study|Switched to alternative treatment|0|||
161663553|NCT00346632|583820391|FG009|Overall Study|Switched to alternative treatment|0|||
161663554|NCT00346632|583820382|FG000|Overall Study|Not Stated|1|||
161663555|NCT00346632|583820383|FG001|Overall Study|Not Stated|1|||
161663556|NCT00346632|583820384|FG002|Overall Study|Not Stated|0|||
161663557|NCT00346632|583820385|FG003|Overall Study|Not Stated|0|||
161663558|NCT00346632|583820386|FG004|Overall Study|Not Stated|0|||
161663559|NCT00346632|583820387|FG005|Overall Study|Not Stated|0|||
161716827|NCT00923091|584007971|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716828|NCT00923091|584007972|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716829|NCT00923091|584007973|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716830|NCT00923091|584007974|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716831|NCT00923091|584007975|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716832|NCT00923091|584007976|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716833|NCT00923091|584007977|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716834|NCT00923091|584007978|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716835|NCT00923091|584007979|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
161716836|NCT00923091|584007980|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716837|NCT00923091|584007981|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716838|NCT00923091|584007982|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716839|NCT00923091|584007983|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
161716840|NCT00923091|584007971|FG000|Period V (Double -Blind)|Protocol Violation|0|||
161716841|NCT00923091|584007972|FG001|Period V (Double -Blind)|Protocol Violation|0|||
161716842|NCT00923091|584007973|FG002|Period V (Double -Blind)|Protocol Violation|0|||
161716843|NCT00923091|584007974|FG003|Period V (Double -Blind)|Protocol Violation|0|||
161716844|NCT00923091|584007975|FG004|Period V (Double -Blind)|Protocol Violation|0|||
161716845|NCT00923091|584007976|FG005|Period V (Double -Blind)|Protocol Violation|0|||
161716846|NCT00923091|584007977|FG006|Period V (Double -Blind)|Protocol Violation|0|||
161716847|NCT00923091|584007978|FG007|Period V (Double -Blind)|Protocol Violation|0|||
161716848|NCT00923091|584007979|FG008|Period V (Double -Blind)|Protocol Violation|0|||
161716849|NCT00923091|584007980|FG009|Period V (Double -Blind)|Protocol Violation|0|||
161716850|NCT00923091|584007981|FG010|Period V (Double -Blind)|Protocol Violation|0|||
161663560|NCT00346632|583820388|FG006|Overall Study|Not Stated|0|||
161663561|NCT00346632|583820389|FG007|Overall Study|Not Stated|2|||
161663562|NCT00346632|583820390|FG008|Overall Study|Not Stated|2|||
161663563|NCT00346632|583820391|FG009|Overall Study|Not Stated|1|||
161663564|NCT04882995|583820392|FG000|Overall Study|Withdrawal by Subject|1|||
161663565|NCT04882995|583820393|FG001|Overall Study|Withdrawal by Subject|2|||
161663566|NCT04882995|583820392|FG000|Overall Study|Protocol Violation|4|||
161663567|NCT04882995|583820393|FG001|Overall Study|Protocol Violation|4|||
161663568|NCT04882995|583820392|FG000|Overall Study|Surgery postponed due to COVID|1|||
161663569|NCT04882995|583820393|FG001|Overall Study|Surgery postponed due to COVID|1|||
161663570|NCT03587974|583820394|FG000|Overall Study|caregiver demented, care recipient died|3|||
161663571|NCT03587974|583820395|FG001|Overall Study|caregiver demented, care recipient died|3|||
161663572|NCT03587974|583820394|FG000|Overall Study|Withdrawal by Subject|2|||
161663573|NCT03587974|583820395|FG001|Overall Study|Withdrawal by Subject|1|||
161663574|NCT03486457|583820396|FG000|Up to Month 3|Adverse Event|2|||
161663575|NCT03486457|583820397|FG001|Up to Month 3|Adverse Event|5|||
161663576|NCT03486457|583820396|FG000|Up to Month 3|Lack of Efficacy|1|||
161663577|NCT03486457|583820397|FG001|Up to Month 3|Lack of Efficacy|0|||
161663578|NCT03486457|583820396|FG000|Up to Month 3|Withdrawal by Subject|1|||
161663579|NCT03486457|583820397|FG001|Up to Month 3|Withdrawal by Subject|0|||
161663580|NCT03486457|583820396|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
161663581|NCT03486457|583820397|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
161663582|NCT03486457|583820396|FG000|Up to Month 3|Other|1|||
161663583|NCT03486457|583820397|FG001|Up to Month 3|Other|0|||
161663584|NCT03486457|583820396|FG000|Month 3 to Month 6|Adverse Event|2|||
161663585|NCT03486457|583820397|FG001|Month 3 to Month 6|Adverse Event|0|||
161663586|NCT03486457|583820396|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
161663587|NCT03486457|583820397|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
161663588|NCT03486457|583820396|FG000|Month 3 to Month 6|Pregnancy|0|||
161663589|NCT03486457|583820397|FG001|Month 3 to Month 6|Pregnancy|1|||
161663590|NCT03486457|583820396|FG000|Month 3 to Month 6|Other|1|||
161663591|NCT03486457|583820397|FG001|Month 3 to Month 6|Other|0|||
161663592|NCT00372229|583820398|FG000|Study Phase|Graft loss|0|||
161663593|NCT00372229|583820399|FG001|Study Phase|Graft loss|3|||
161663594|NCT00372229|583820398|FG000|Study Phase|Protocol Violation|3|||
161663595|NCT00372229|583820399|FG001|Study Phase|Protocol Violation|4|||
161663596|NCT00372229|583820398|FG000|Study Phase|Consent withdrawn|16|||
161663597|NCT00372229|583820399|FG001|Study Phase|Consent withdrawn|14|||
161663598|NCT00372229|583820398|FG000|Study Phase|Refused treatment/did not cooperate|3|||
161663599|NCT00372229|583820399|FG001|Study Phase|Refused treatment/did not cooperate|1|||
161663600|NCT00372229|583820398|FG000|Study Phase|Death|3|||
161663601|NCT00372229|583820399|FG001|Study Phase|Death|2|||
161663602|NCT00372229|583820398|FG000|Study Phase|Reason not specified|3|||
161663603|NCT00372229|583820399|FG001|Study Phase|Reason not specified|2|||
161663604|NCT00372229|583820398|FG000|Study Phase|Lost to Follow-up|3|||
161663605|NCT00372229|583820399|FG001|Study Phase|Lost to Follow-up|3|||
161663606|NCT00372229|583820398|FG000|Follow-Up Phase|Graft loss|8|||
161663607|NCT00372229|583820399|FG001|Follow-Up Phase|Graft loss|7|||
161663608|NCT00372229|583820398|FG000|Follow-Up Phase|Consent withdrawn|13|||
161663609|NCT00372229|583820399|FG001|Follow-Up Phase|Consent withdrawn|19|||
161663610|NCT00372229|583820398|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
161663611|NCT00372229|583820399|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
161663612|NCT00372229|583820398|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
161663613|NCT00372229|583820399|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
161663614|NCT00372229|583820398|FG000|Follow-Up Phase|Death|9|||
161663615|NCT00372229|583820399|FG001|Follow-Up Phase|Death|12|||
161663616|NCT00372229|583820398|FG000|Follow-Up Phase|Administrative|1|||
161663617|NCT00372229|583820399|FG001|Follow-Up Phase|Administrative|0|||
161663618|NCT00372229|583820398|FG000|Follow-Up Phase|Reason not specified|2|||
161663619|NCT00372229|583820399|FG001|Follow-Up Phase|Reason not specified|3|||
161663620|NCT00372229|583820398|FG000|Follow-Up Phase|Lost to Follow-up|12|||
161663621|NCT00372229|583820399|FG001|Follow-Up Phase|Lost to Follow-up|10|||
161663622|NCT01347762|583820400|FG000|Overall Study|Lost to Follow-up|0|||
161663623|NCT01347762|583820401|FG001|Overall Study|Lost to Follow-up|1|||
161663624|NCT01347762|583820402|FG002|Overall Study|Lost to Follow-up|6|||
161663625|NCT01347762|583820403|FG003|Overall Study|Lost to Follow-up|5|||
161663626|NCT01347762|583820400|FG000|Overall Study|Withdrawal by Subject|4|||
161663627|NCT01347762|583820401|FG001|Overall Study|Withdrawal by Subject|1|||
161663628|NCT01347762|583820402|FG002|Overall Study|Withdrawal by Subject|3|||
161663629|NCT01347762|583820403|FG003|Overall Study|Withdrawal by Subject|3|||
161663630|NCT03235284|583820404|FG000|Overall Study|Adverse Event|1|||
161663631|NCT03235284|583820405|FG001|Overall Study|Adverse Event|2|||
161663632|NCT03235284|583820406|FG002|Overall Study|Adverse Event|1|||
161663633|NCT01382706|583820407|FG000|Overall Study|Adverse Event|1|||
161663634|NCT01382706|583820407|FG000|Overall Study|Withdrawal by Subject|1|||
161663635|NCT04055090|583820408|FG000|Overall Study|screen failure|1|||
161663636|NCT04055090|583820409|FG001|Overall Study|screen failure|0|||
161663637|NCT04055090|583820408|FG000|Overall Study|Withdrawal by Subject|1|||
161663638|NCT04055090|583820409|FG001|Overall Study|Withdrawal by Subject|0|||
161663639|NCT05478499|583820412|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
161663640|NCT05478499|583820413|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
161663641|NCT05478499|583820412|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
161663642|NCT05478499|583820413|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
161663643|NCT05478499|583820412|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
161663644|NCT05478499|583820413|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
161663645|NCT05478499|583820412|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
161663646|NCT05478499|583820413|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
161663647|NCT05478499|583820412|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
161663648|NCT05478499|583820413|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
161663649|NCT05478499|583820412|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
161663650|NCT05478499|583820413|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
161663651|NCT05478499|583820412|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
161663652|NCT05478499|583820413|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
161663653|NCT05478499|583820412|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
161663654|NCT05478499|583820413|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
161663655|NCT05478499|583820412|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
161663656|NCT05478499|583820413|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
161663657|NCT05478499|583820412|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
161663658|NCT05478499|583820413|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
161663659|NCT05478499|583820412|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
161716851|NCT00923091|584007982|FG011|Period V (Double -Blind)|Protocol Violation|0|||
161716852|NCT00923091|584007983|FG012|Period V (Double -Blind)|Protocol Violation|1|||
161716853|NCT00923091|584007971|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
161716854|NCT00923091|584007972|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
161716855|NCT00923091|584007973|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
161716856|NCT00923091|584007974|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
161716857|NCT00923091|584007975|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
161716858|NCT00923091|584007976|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
161663660|NCT05478499|583820413|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
161663661|NCT00249002|583820417|FG000|Overall Study|Adverse Event|2|||
161663662|NCT00249002|583820417|FG000|Overall Study|Study cancellation|3|||
161663663|NCT00249002|583820417|FG000|Overall Study|Other|2|||
161663664|NCT00552240|583820418|FG000|Overall Study|Adverse Event|9|||
161663665|NCT00552240|583820419|FG001|Overall Study|Adverse Event|9|||
161663666|NCT00552240|583820418|FG000|Overall Study|Protocol Violation|1|||
161663667|NCT00552240|583820419|FG001|Overall Study|Protocol Violation|1|||
161663668|NCT00552240|583820418|FG000|Overall Study|Lost to Follow-up|5|||
161663669|NCT00552240|583820419|FG001|Overall Study|Lost to Follow-up|6|||
161663670|NCT00552240|583820418|FG000|Overall Study|Withdrawal by Subject|2|||
161663671|NCT00552240|583820419|FG001|Overall Study|Withdrawal by Subject|2|||
161663672|NCT00552240|583820418|FG000|Overall Study|Lack of Efficacy|6|||
161663673|NCT00552240|583820419|FG001|Overall Study|Lack of Efficacy|0|||
161663674|NCT00552240|583820418|FG000|Overall Study|Other|1|||
161663675|NCT00552240|583820419|FG001|Overall Study|Other|0|||
161663676|NCT02679573|583820420|FG000|Overall Study|Adverse Event|13|||
161663677|NCT02679573|583820421|FG001|Overall Study|Adverse Event|6|||
161663678|NCT02679573|583820420|FG000|Overall Study|Lack of Efficacy|12|||
161663679|NCT02679573|583820421|FG001|Overall Study|Lack of Efficacy|15|||
161663680|NCT02679573|583820420|FG000|Overall Study|Could not complete required study visits|6|||
161663681|NCT02679573|583820421|FG001|Overall Study|Could not complete required study visits|2|||
161663682|NCT02679573|583820420|FG000|Overall Study|Withdrawal by Subject|2|||
161663683|NCT02679573|583820421|FG001|Overall Study|Withdrawal by Subject|9|||
161663684|NCT02679573|583820420|FG000|Overall Study|Death|2|||
161663685|NCT02679573|583820421|FG001|Overall Study|Death|0|||
161663686|NCT02679573|583820420|FG000|Overall Study|Physician Decision|2|||
161663687|NCT02679573|583820421|FG001|Overall Study|Physician Decision|4|||
161663688|NCT02679573|583820420|FG000|Overall Study|Lost to Follow-up|0|||
161663689|NCT02679573|583820421|FG001|Overall Study|Lost to Follow-up|3|||
161663690|NCT02476279|583820422|FG000|Overall Study|Lost to Follow-up|1|||
161663691|NCT02476279|583820423|FG001|Overall Study|Lost to Follow-up|1|||
161663692|NCT02128542|583820424|FG000|Overall Study|Lost to Follow-up|3|||
161663693|NCT02128542|583820425|FG001|Overall Study|Lost to Follow-up|0|||
161663694|NCT02128542|583820424|FG000|Overall Study|Withdrew Consent|1|||
161663695|NCT02128542|583820425|FG001|Overall Study|Withdrew Consent|0|||
161663696|NCT03451162|583820431|FG000|Overall Study|Lost to Follow-up|1|||
161663697|NCT03451162|583820432|FG001|Overall Study|Lost to Follow-up|0|||
161663698|NCT03451162|583820433|FG002|Overall Study|Lost to Follow-up|0|||
161663699|NCT03451162|583820434|FG003|Overall Study|Lost to Follow-up|0|||
161663700|NCT03451162|583820435|FG004|Overall Study|Lost to Follow-up|0|||
161663701|NCT03451162|583820431|FG000|Overall Study|Physician Decision|0|||
161663702|NCT03451162|583820432|FG001|Overall Study|Physician Decision|1|||
161663703|NCT03451162|583820433|FG002|Overall Study|Physician Decision|0|||
161663704|NCT03451162|583820434|FG003|Overall Study|Physician Decision|0|||
161663705|NCT03451162|583820435|FG004|Overall Study|Physician Decision|0|||
161663706|NCT03451162|583820431|FG000|Overall Study|Withdrawal by Subject|1|||
161663707|NCT03451162|583820432|FG001|Overall Study|Withdrawal by Subject|1|||
161663708|NCT03451162|583820433|FG002|Overall Study|Withdrawal by Subject|0|||
161663709|NCT03451162|583820434|FG003|Overall Study|Withdrawal by Subject|0|||
161663710|NCT03451162|583820435|FG004|Overall Study|Withdrawal by Subject|0|||
161663711|NCT01952054|583820436|FG000|Overall Study|Physician Decision|1|||
161663712|NCT00232544|583820437|FG000|Overall Study|Lost to Follow-up|20|||
161663713|NCT00232544|583820438|FG001|Overall Study|Lost to Follow-up|15|||
161663714|NCT00116753|583820439|FG000|Overall Study|Adverse Event|16|||
161663715|NCT00116753|583820440|FG001|Overall Study|Adverse Event|10|||
161663716|NCT00116753|583820441|FG002|Overall Study|Adverse Event|7|||
161663717|NCT00116753|583820439|FG000|Overall Study|Withdrawal by Subject|11|||
161663718|NCT00116753|583820440|FG001|Overall Study|Withdrawal by Subject|12|||
161663719|NCT00116753|583820441|FG002|Overall Study|Withdrawal by Subject|8|||
161663720|NCT00116753|583820439|FG000|Overall Study|Lost to Follow-up|0|||
161663721|NCT00116753|583820440|FG001|Overall Study|Lost to Follow-up|2|||
161663722|NCT00116753|583820441|FG002|Overall Study|Lost to Follow-up|1|||
161663723|NCT00116753|583820439|FG000|Overall Study|Protocol Violation|0|||
161663724|NCT00116753|583820440|FG001|Overall Study|Protocol Violation|0|||
161663725|NCT00116753|583820441|FG002|Overall Study|Protocol Violation|1|||
161663726|NCT00116753|583820439|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
161663727|NCT00116753|583820440|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
161663728|NCT00116753|583820441|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
161663729|NCT00116753|583820439|FG000|Overall Study|Disease Progression|3|||
161663730|NCT00116753|583820440|FG001|Overall Study|Disease Progression|4|||
161663731|NCT00116753|583820441|FG002|Overall Study|Disease Progression|3|||
161663732|NCT00116753|583820439|FG000|Overall Study|Abnormal Echocardiogram|0|||
161716859|NCT00923091|584007977|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
161716860|NCT00923091|584007978|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
161716861|NCT00923091|584007979|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
161716862|NCT00923091|584007980|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
161716863|NCT00923091|584007981|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
161716864|NCT00923091|584007982|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
161716865|NCT00923091|584007983|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
161716866|NCT00923091|584007971|FG000|Period VI (Open-Label)|Adverse Event|17|||
161716867|NCT00923091|584007972|FG001|Period VI (Open-Label)|Adverse Event|0|||
161716868|NCT00923091|584007973|FG002|Period VI (Open-Label)|Adverse Event|4|||
161716869|NCT00923091|584007974|FG003|Period VI (Open-Label)|Adverse Event|1|||
161716870|NCT00923091|584007975|FG004|Period VI (Open-Label)|Adverse Event|1|||
161716871|NCT00923091|584007976|FG005|Period VI (Open-Label)|Adverse Event|0|||
161716872|NCT00923091|584007977|FG006|Period VI (Open-Label)|Adverse Event|0|||
161716873|NCT00923091|584007978|FG007|Period VI (Open-Label)|Adverse Event|0|||
161716874|NCT00923091|584007979|FG008|Period VI (Open-Label)|Adverse Event|0|||
161716875|NCT00923091|584007980|FG009|Period VI (Open-Label)|Adverse Event|0|||
161716876|NCT00923091|584007981|FG010|Period VI (Open-Label)|Adverse Event|0|||
161716877|NCT00923091|584007982|FG011|Period VI (Open-Label)|Adverse Event|0|||
161716878|NCT00923091|584007983|FG012|Period VI (Open-Label)|Adverse Event|0|||
161716879|NCT00923091|584007971|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
161716880|NCT00923091|584007972|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
161716881|NCT00923091|584007973|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
161716882|NCT00923091|584007974|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716883|NCT00923091|584007975|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
161716884|NCT00923091|584007976|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716885|NCT00923091|584007977|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716886|NCT00923091|584007978|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716887|NCT00923091|584007979|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716888|NCT00923091|584007980|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716889|NCT00923091|584007981|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716890|NCT00923091|584007982|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716891|NCT00923091|584007983|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716892|NCT00923091|584007971|FG000|Period VI (Open-Label)|Protocol Violation|6|||
161716893|NCT00923091|584007972|FG001|Period VI (Open-Label)|Protocol Violation|1|||
161716894|NCT00923091|584007973|FG002|Period VI (Open-Label)|Protocol Violation|3|||
161716895|NCT00923091|584007974|FG003|Period VI (Open-Label)|Protocol Violation|1|||
161716896|NCT00923091|584007975|FG004|Period VI (Open-Label)|Protocol Violation|4|||
161716897|NCT00923091|584007976|FG005|Period VI (Open-Label)|Protocol Violation|0|||
161716898|NCT00923091|584007977|FG006|Period VI (Open-Label)|Protocol Violation|0|||
161716899|NCT00923091|584007978|FG007|Period VI (Open-Label)|Protocol Violation|0|||
161716900|NCT00923091|584007979|FG008|Period VI (Open-Label)|Protocol Violation|0|||
161716901|NCT00923091|584007980|FG009|Period VI (Open-Label)|Protocol Violation|0|||
161716902|NCT00923091|584007981|FG010|Period VI (Open-Label)|Protocol Violation|0|||
161716903|NCT00923091|584007982|FG011|Period VI (Open-Label)|Protocol Violation|0|||
161716904|NCT00923091|584007983|FG012|Period VI (Open-Label)|Protocol Violation|0|||
161716905|NCT00923091|584007971|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
161716906|NCT00923091|584007972|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
161716907|NCT00923091|584007973|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
161716908|NCT00923091|584007974|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
161716909|NCT00923091|584007975|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
161716910|NCT00923091|584007976|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
161716911|NCT00923091|584007977|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
161716912|NCT00923091|584007978|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
161716913|NCT00923091|584007979|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
161716914|NCT00923091|584007980|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
161716915|NCT00923091|584007981|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
161716916|NCT00923091|584007982|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
161716917|NCT00923091|584007983|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
161716918|NCT00923091|584007971|FG000|Period VI (Open-Label)|Other Reason|0|||
161716919|NCT00923091|584007972|FG001|Period VI (Open-Label)|Other Reason|0|||
161716920|NCT00923091|584007973|FG002|Period VI (Open-Label)|Other Reason|0|||
161716921|NCT00923091|584007974|FG003|Period VI (Open-Label)|Other Reason|1|||
161716922|NCT00923091|584007975|FG004|Period VI (Open-Label)|Other Reason|1|||
161716923|NCT00923091|584007976|FG005|Period VI (Open-Label)|Other Reason|0|||
161716924|NCT00923091|584007977|FG006|Period VI (Open-Label)|Other Reason|0|||
161716925|NCT00923091|584007978|FG007|Period VI (Open-Label)|Other Reason|0|||
161716926|NCT00923091|584007979|FG008|Period VI (Open-Label)|Other Reason|0|||
161716927|NCT00923091|584007980|FG009|Period VI (Open-Label)|Other Reason|0|||
161716928|NCT00923091|584007981|FG010|Period VI (Open-Label)|Other Reason|0|||
161716929|NCT00923091|584007982|FG011|Period VI (Open-Label)|Other Reason|0|||
161716930|NCT00923091|584007983|FG012|Period VI (Open-Label)|Other Reason|0|||
161716931|NCT02111369|584007985|FG000|Overall Study|Lost to Follow-up|2|||
161663733|NCT00116753|583820440|FG001|Overall Study|Abnormal Echocardiogram|0|||
161663734|NCT00116753|583820441|FG002|Overall Study|Abnormal Echocardiogram|1|||
161663735|NCT00116753|583820439|FG000|Overall Study|Progressive Parkinson's Disease|1|||
161663736|NCT00116753|583820440|FG001|Overall Study|Progressive Parkinson's Disease|0|||
161663737|NCT00116753|583820441|FG002|Overall Study|Progressive Parkinson's Disease|0|||
161663738|NCT00116753|583820439|FG000|Overall Study|Dosing Error|0|||
161663739|NCT00116753|583820440|FG001|Overall Study|Dosing Error|1|||
161663740|NCT00116753|583820441|FG002|Overall Study|Dosing Error|0|||
161663741|NCT01200589|583820442|FG000|Overall Study|Withdrawal by Subject|13|||
161663742|NCT01200589|583820443|FG001|Overall Study|Withdrawal by Subject|11|||
161663743|NCT01200589|583820442|FG000|Overall Study|Physician Decision|2|||
161716932|NCT02111369|584007985|FG000|Overall Study|Withdrawal by Subject|1|||
161716933|NCT00144300|584007988|FG000|Overall Study|Adverse Event|18|||
161716934|NCT00144300|584007989|FG001|Overall Study|Adverse Event|16|||
161716935|NCT00144300|584007988|FG000|Overall Study|Protocol Violation|1|||
161716936|NCT00144300|584007989|FG001|Overall Study|Protocol Violation|3|||
161716937|NCT00144300|584007988|FG000|Overall Study|Lost to Follow-up|3|||
161716938|NCT00144300|584007989|FG001|Overall Study|Lost to Follow-up|0|||
161716939|NCT00144300|584007988|FG000|Overall Study|Withdrawal by Subject|6|||
161716940|NCT00144300|584007989|FG001|Overall Study|Withdrawal by Subject|6|||
161716941|NCT00144300|584007988|FG000|Overall Study|Other reason (not specified)|1|||
161716942|NCT00144300|584007989|FG001|Overall Study|Other reason (not specified)|3|||
161716943|NCT01933672|584007990|FG000|Metformin Run-in Period|Adverse Event|1|||
161716944|NCT01933672|584007991|FG001|Metformin Run-in Period|Adverse Event|0|||
161716945|NCT01933672|584007992|FG002|Metformin Run-in Period|Adverse Event|0|||
161716946|NCT01933672|584007993|FG003|Metformin Run-in Period|Adverse Event|0|||
161716947|NCT01933672|584007994|FG004|Metformin Run-in Period|Adverse Event|0|||
161716948|NCT01933672|584007995|FG005|Metformin Run-in Period|Adverse Event|0|||
161716949|NCT01933672|584007996|FG006|Metformin Run-in Period|Adverse Event|0|||
161716950|NCT01933672|584007990|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
161716951|NCT01933672|584007991|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716952|NCT01933672|584007992|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716953|NCT01933672|584007993|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716954|NCT01933672|584007994|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716955|NCT01933672|584007995|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716956|NCT01933672|584007996|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716957|NCT01933672|584007990|FG000|Metformin Run-in Period|Other|5|||
161716958|NCT01933672|584007991|FG001|Metformin Run-in Period|Other|0|||
161716959|NCT01933672|584007992|FG002|Metformin Run-in Period|Other|0|||
161716960|NCT01933672|584007993|FG003|Metformin Run-in Period|Other|0|||
161716961|NCT01933672|584007994|FG004|Metformin Run-in Period|Other|0|||
161716962|NCT01933672|584007995|FG005|Metformin Run-in Period|Other|0|||
161716963|NCT01933672|584007996|FG006|Metformin Run-in Period|Other|0|||
161716964|NCT01933672|584007990|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716965|NCT01933672|584007991|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716966|NCT01933672|584007992|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161663744|NCT01200589|583820443|FG001|Overall Study|Physician Decision|2|||
161663745|NCT01200589|583820442|FG000|Overall Study|Lost to Follow-up|5|||
161716967|NCT01933672|584007993|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716968|NCT01933672|584007994|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
161716969|NCT01933672|584007995|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716970|NCT01933672|584007996|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716971|NCT01933672|584007990|FG000|First Intervention Period (12-16 Days)|Other|0|||
161716972|NCT01933672|584007991|FG001|First Intervention Period (12-16 Days)|Other|0|||
161716973|NCT01933672|584007992|FG002|First Intervention Period (12-16 Days)|Other|1|||
161716974|NCT01933672|584007993|FG003|First Intervention Period (12-16 Days)|Other|0|||
161716975|NCT01933672|584007994|FG004|First Intervention Period (12-16 Days)|Other|0|||
161716976|NCT01933672|584007995|FG005|First Intervention Period (12-16 Days)|Other|1|||
161716977|NCT01933672|584007996|FG006|First Intervention Period (12-16 Days)|Other|0|||
161716978|NCT01933672|584007990|FG000|Second Intervention Period (12-16 Days)|Other|0|||
161716979|NCT01933672|584007991|FG001|Second Intervention Period (12-16 Days)|Other|1|||
161716980|NCT01933672|584007992|FG002|Second Intervention Period (12-16 Days)|Other|1|||
161716981|NCT01933672|584007993|FG003|Second Intervention Period (12-16 Days)|Other|0|||
161716982|NCT01933672|584007994|FG004|Second Intervention Period (12-16 Days)|Other|0|||
161716983|NCT01933672|584007995|FG005|Second Intervention Period (12-16 Days)|Other|0|||
161716984|NCT01933672|584007996|FG006|Second Intervention Period (12-16 Days)|Other|0|||
161716985|NCT01933672|584007990|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716986|NCT01933672|584007991|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716987|NCT01933672|584007992|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716988|NCT01933672|584007993|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
161716989|NCT01933672|584007994|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716990|NCT01933672|584007995|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716991|NCT01933672|584007996|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716992|NCT01933672|584007990|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716993|NCT01933672|584007991|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
161716994|NCT01933672|584007992|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716995|NCT01933672|584007993|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716996|NCT01933672|584007994|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716997|NCT01933672|584007995|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716998|NCT01933672|584007996|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716999|NCT01877655|584007997|FG000|Overall Study|Death|57|||
161717000|NCT01877655|584007998|FG001|Overall Study|Death|52|||
161717001|NCT01877655|584007997|FG000|Overall Study|Withdrawal by Subject|18|||
161717002|NCT01877655|584007998|FG001|Overall Study|Withdrawal by Subject|26|||
161717003|NCT01877655|584007997|FG000|Overall Study|Physician Decision|11|||
161717004|NCT01877655|584007998|FG001|Overall Study|Physician Decision|10|||
161717005|NCT01877655|584007997|FG000|Overall Study|Miscellaneous|4|||
161717006|NCT01877655|584007998|FG001|Overall Study|Miscellaneous|4|||
161717007|NCT01877655|584007997|FG000|Overall Study|Randomized but Never Received Drug|8|||
161717008|NCT01877655|584007998|FG001|Overall Study|Randomized but Never Received Drug|5|||
161717009|NCT00095121|584007999|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
161717010|NCT00095121|584008000|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
161717011|NCT00095121|584007999|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
161717012|NCT00095121|584008000|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
161717013|NCT00001259|584010427|FG000|Study 2|Adverse Event|0|||
161717014|NCT00001259|584010428|FG001|Study 2|Adverse Event|0|||
161717015|NCT00001259|584010429|FG002|Study 2|Adverse Event|0|||
161717016|NCT00001259|584010430|FG003|Study 2|Adverse Event|0|||
161717017|NCT00001259|584010431|FG004|Study 2|Adverse Event|2|||
161717018|NCT00001259|584010432|FG005|Study 2|Adverse Event|0|||
161717019|NCT00001259|584010433|FG006|Study 2|Adverse Event|0|||
161717020|NCT01582282|584010434|FG000|Overall Study|Adverse Event|1|||
161717021|NCT01582282|584010435|FG001|Overall Study|Adverse Event|1|||
161717022|NCT01582282|584010436|FG002|Overall Study|Adverse Event|0|||
161717023|NCT01582282|584010434|FG000|Overall Study|Lost to Follow-up|1|||
161717024|NCT01582282|584010435|FG001|Overall Study|Lost to Follow-up|0|||
161717025|NCT01582282|584010436|FG002|Overall Study|Lost to Follow-up|0|||
161717026|NCT01582282|584010434|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
161717027|NCT01582282|584010435|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
161717028|NCT01582282|584010436|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
161717029|NCT02413255|584010440|FG000|Overall Study|Voluntary Withdrawal|0|||
161717030|NCT02413255|584010441|FG001|Overall Study|Voluntary Withdrawal|0|||
161717031|NCT02413255|584010442|FG002|Overall Study|Voluntary Withdrawal|0|||
161717032|NCT02413255|584010443|FG003|Overall Study|Voluntary Withdrawal|0|||
161717033|NCT02413255|584010444|FG004|Overall Study|Voluntary Withdrawal|0|||
161717034|NCT02413255|584010445|FG005|Overall Study|Voluntary Withdrawal|0|||
161717035|NCT02413255|584010446|FG006|Overall Study|Voluntary Withdrawal|0|||
161717036|NCT02413255|584010447|FG007|Overall Study|Voluntary Withdrawal|0|||
161717037|NCT02413255|584010448|FG008|Overall Study|Voluntary Withdrawal|0|||
161717038|NCT02413255|584010449|FG009|Overall Study|Voluntary Withdrawal|0|||
161717039|NCT02413255|584010450|FG010|Overall Study|Voluntary Withdrawal|0|||
161717040|NCT02413255|584010451|FG011|Overall Study|Voluntary Withdrawal|0|||
161717041|NCT02413255|584010452|FG012|Overall Study|Voluntary Withdrawal|0|||
161717042|NCT02413255|584010453|FG013|Overall Study|Voluntary Withdrawal|0|||
161717043|NCT02413255|584010454|FG014|Overall Study|Voluntary Withdrawal|1|||
161717044|NCT02413255|584010455|FG015|Overall Study|Voluntary Withdrawal|0|||
161717045|NCT02413255|584010456|FG016|Overall Study|Voluntary Withdrawal|0|||
161717046|NCT00077623|584010457|FG000|Overall Study|Adverse Event|1|||
161717047|NCT00077623|584010458|FG001|Overall Study|Adverse Event|0|||
161717048|NCT00077623|584010459|FG002|Overall Study|Adverse Event|1|||
161717049|NCT00077623|584010457|FG000|Overall Study|Withdrawal by Subject|2|||
161717050|NCT00077623|584010458|FG001|Overall Study|Withdrawal by Subject|10|||
161717051|NCT00077623|584010459|FG002|Overall Study|Withdrawal by Subject|1|||
161717052|NCT00077623|584010457|FG000|Overall Study|Other-Non safety reason|18|||
161717053|NCT00077623|584010458|FG001|Overall Study|Other-Non safety reason|15|||
161717054|NCT00077623|584010459|FG002|Overall Study|Other-Non safety reason|19|||
161717055|NCT00077623|584010457|FG000|Overall Study|Insufficient therapeutic response|2|||
161717056|NCT00077623|584010458|FG001|Overall Study|Insufficient therapeutic response|0|||
161717057|NCT00077623|584010459|FG002|Overall Study|Insufficient therapeutic response|0|||
161717058|NCT00077623|584010457|FG000|Overall Study|Death|12|||
161717059|NCT00077623|584010458|FG001|Overall Study|Death|18|||
161717060|NCT00077623|584010459|FG002|Overall Study|Death|11|||
161717061|NCT00077623|584010457|FG000|Overall Study|Failure to return|1|||
161717062|NCT00077623|584010458|FG001|Overall Study|Failure to return|0|||
161717063|NCT00077623|584010459|FG002|Overall Study|Failure to return|0|||
161717064|NCT01334125|584010460|FG000|Overall Study|Lost to Follow-up|3|||
161717065|NCT01334125|584010461|FG001|Overall Study|Lost to Follow-up|3|||
161717066|NCT00882713|584010464|FG000|Overall Study|Adverse Event|2|||
161717067|NCT00882713|584010464|FG000|Overall Study|Death|3|||
161717068|NCT00882713|584010464|FG000|Overall Study|Administrative reasons|4|||
161717069|NCT00882713|584010464|FG000|Overall Study|refused treatment/withdrew consent|4|||
161717070|NCT00882713|584010464|FG000|Overall Study|Blood transfusion|2|||
161717071|NCT00882713|584010464|FG000|Overall Study|Insufficient therapeutic response|3|||
161717072|NCT00882713|584010464|FG000|Overall Study|Failure to return|2|||
161717073|NCT00882713|584010464|FG000|Overall Study|Other - Reasons|2|||
161717074|NCT00401973|584010467|FG000|Overall Study|Adverse Event|2|||
161717075|NCT00401973|584010468|FG001|Overall Study|Adverse Event|8|||
161717076|NCT00401973|584010469|FG002|Overall Study|Adverse Event|4|||
161717077|NCT00401973|584010467|FG000|Overall Study|Clinical Relapse|0|||
161717078|NCT00401973|584010468|FG001|Overall Study|Clinical Relapse|1|||
161717079|NCT00401973|584010469|FG002|Overall Study|Clinical Relapse|1|||
161717080|NCT00401973|584010467|FG000|Overall Study|Lack of Efficacy|0|||
161717081|NCT00401973|584010468|FG001|Overall Study|Lack of Efficacy|0|||
161717082|NCT00401973|584010469|FG002|Overall Study|Lack of Efficacy|3|||
161717083|NCT00401973|584010467|FG000|Overall Study|Lost to Follow-up|2|||
161717084|NCT00401973|584010468|FG001|Overall Study|Lost to Follow-up|2|||
161717085|NCT00401973|584010469|FG002|Overall Study|Lost to Follow-up|2|||
161717086|NCT00401973|584010467|FG000|Overall Study|Physician Decision|2|||
161717087|NCT00401973|584010468|FG001|Overall Study|Physician Decision|0|||
161717088|NCT00401973|584010469|FG002|Overall Study|Physician Decision|1|||
161717089|NCT00401973|584010467|FG000|Overall Study|Protocol Violation|1|||
161717090|NCT00401973|584010468|FG001|Overall Study|Protocol Violation|2|||
161717091|NCT00401973|584010469|FG002|Overall Study|Protocol Violation|3|||
161717092|NCT00401973|584010467|FG000|Overall Study|Sponsor Decision|0|||
161717093|NCT00401973|584010468|FG001|Overall Study|Sponsor Decision|1|||
161717094|NCT00401973|584010469|FG002|Overall Study|Sponsor Decision|0|||
161717095|NCT00401973|584010467|FG000|Overall Study|Withdrawal by Subject|4|||
161717096|NCT00401973|584010468|FG001|Overall Study|Withdrawal by Subject|12|||
161717097|NCT00401973|584010469|FG002|Overall Study|Withdrawal by Subject|9|||
161717098|NCT03700892|584010470|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
161717099|NCT03700892|584010471|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
161717100|NCT03700892|584010472|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
161717101|NCT00849212|584010473|FG000|Overall Study|Lack of Efficacy|1|||
161717102|NCT00849212|584010473|FG000|Overall Study|Withdrawal by Subject|3|||
161717103|NCT00849212|584010473|FG000|Overall Study|Adverse Event|2|||
161717104|NCT00849212|584010473|FG000|Overall Study|Miscellaneous|1|||
161717105|NCT02117050|584010484|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
161717106|NCT02460822|584010487|FG000|Overall Study|Withdrawal by Subject|1|||
161717107|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
161717108|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
161717109|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
161717110|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
161717111|NCT00847613|584010489|FG000|Overall Study|Ongoing at cut-off date|250|||
161717112|NCT00847613|584010490|FG001|Overall Study|Ongoing at cut-off date|265|||
161717113|NCT00847613|584010491|FG002|Overall Study|Ongoing at cut-off date|64|||
161717114|NCT00847613|584010492|FG003|Overall Study|Ongoing at cut-off date|64|||
161717115|NCT00847613|584010489|FG000|Overall Study|Death|1|||
161717116|NCT00847613|584010490|FG001|Overall Study|Death|1|||
161717117|NCT00847613|584010491|FG002|Overall Study|Death|0|||
161717118|NCT00847613|584010492|FG003|Overall Study|Death|0|||
161717119|NCT00847613|584010489|FG000|Overall Study|Adverse Event|36|||
161717120|NCT00847613|584010490|FG001|Overall Study|Adverse Event|26|||
161717121|NCT00847613|584010491|FG002|Overall Study|Adverse Event|5|||
161717122|NCT00847613|584010492|FG003|Overall Study|Adverse Event|6|||
161717123|NCT00847613|584010489|FG000|Overall Study|Lack of Efficacy|7|||
161717124|NCT00847613|584010490|FG001|Overall Study|Lack of Efficacy|3|||
161717125|NCT00847613|584010491|FG002|Overall Study|Lack of Efficacy|3|||
161717126|NCT00847613|584010492|FG003|Overall Study|Lack of Efficacy|1|||
161717127|NCT00847613|584010489|FG000|Overall Study|Study terminated by Sponsor|1|||
161717128|NCT00847613|584010490|FG001|Overall Study|Study terminated by Sponsor|0|||
161717129|NCT00847613|584010491|FG002|Overall Study|Study terminated by Sponsor|2|||
161717130|NCT00847613|584010492|FG003|Overall Study|Study terminated by Sponsor|1|||
161717131|NCT00847613|584010489|FG000|Overall Study|Lost to Follow-up|5|||
161717132|NCT00847613|584010490|FG001|Overall Study|Lost to Follow-up|0|||
161717133|NCT00847613|584010491|FG002|Overall Study|Lost to Follow-up|0|||
161717134|NCT00847613|584010492|FG003|Overall Study|Lost to Follow-up|3|||
161717135|NCT00847613|584010489|FG000|Overall Study|Protocol Violation|6|||
161717136|NCT00847613|584010490|FG001|Overall Study|Protocol Violation|6|||
161717137|NCT00847613|584010491|FG002|Overall Study|Protocol Violation|3|||
161717138|NCT00847613|584010492|FG003|Overall Study|Protocol Violation|1|||
161717139|NCT00847613|584010489|FG000|Overall Study|Pregnancy|1|||
161717140|NCT00847613|584010490|FG001|Overall Study|Pregnancy|1|||
161717141|NCT00847613|584010491|FG002|Overall Study|Pregnancy|0|||
161717142|NCT00847613|584010492|FG003|Overall Study|Pregnancy|0|||
161717143|NCT00847613|584010489|FG000|Overall Study|Site closure|1|||
161717144|NCT00847613|584010490|FG001|Overall Study|Site closure|0|||
161717145|NCT00847613|584010491|FG002|Overall Study|Site closure|0|||
161717146|NCT00847613|584010492|FG003|Overall Study|Site closure|1|||
161717147|NCT00847613|584010489|FG000|Overall Study|Withdrawal by Subject|8|||
161717148|NCT00847613|584010490|FG001|Overall Study|Withdrawal by Subject|11|||
161717149|NCT00847613|584010491|FG002|Overall Study|Withdrawal by Subject|2|||
161717150|NCT00847613|584010492|FG003|Overall Study|Withdrawal by Subject|2|||
161717151|NCT00847613|584010489|FG000|Overall Study|Participant moved|4|||
161717152|NCT00847613|584010490|FG001|Overall Study|Participant moved|1|||
161717153|NCT00847613|584010491|FG002|Overall Study|Participant moved|0|||
161717154|NCT00847613|584010492|FG003|Overall Study|Participant moved|0|||
161717155|NCT00847613|584010489|FG000|Overall Study|Sponsor request|0|||
161717156|NCT00847613|584010490|FG001|Overall Study|Sponsor request|1|||
161717157|NCT00847613|584010491|FG002|Overall Study|Sponsor request|0|||
161717158|NCT00847613|584010492|FG003|Overall Study|Sponsor request|0|||
161717159|NCT00847613|584010489|FG000|Overall Study|Randomized, but not treated|0|||
161717160|NCT00847613|584010490|FG001|Overall Study|Randomized, but not treated|3|||
161717161|NCT00847613|584010491|FG002|Overall Study|Randomized, but not treated|0|||
161717162|NCT00847613|584010492|FG003|Overall Study|Randomized, but not treated|0|||
161717163|NCT00847613|584010489|FG000|Overall Study|Other|1|||
161717164|NCT00847613|584010490|FG001|Overall Study|Other|1|||
161717165|NCT00847613|584010491|FG002|Overall Study|Other|2|||
161717166|NCT00847613|584010492|FG003|Overall Study|Other|0|||
161717167|NCT03233048|584010493|FG000|Overall Study|Withdrawal by Subject|1|||
161717168|NCT00491530|584010494|FG000|Overall Study|Adverse Event|6|||
161717169|NCT00491530|584010495|FG001|Overall Study|Adverse Event|1|||
161717170|NCT00491530|584010496|FG002|Overall Study|Adverse Event|2|||
161717171|NCT00491530|584010494|FG000|Overall Study|Withdrawal by Subject|3|||
161717172|NCT00491530|584010495|FG001|Overall Study|Withdrawal by Subject|0|||
161717173|NCT00491530|584010496|FG002|Overall Study|Withdrawal by Subject|0|||
161717174|NCT00491530|584010494|FG000|Overall Study|Lost to Follow-up|3|||
161717175|NCT00491530|584010495|FG001|Overall Study|Lost to Follow-up|2|||
161717176|NCT00491530|584010496|FG002|Overall Study|Lost to Follow-up|2|||
161717177|NCT00491530|584010494|FG000|Overall Study|Lack of Efficacy|0|||
161717178|NCT00491530|584010495|FG001|Overall Study|Lack of Efficacy|1|||
161717179|NCT00491530|584010496|FG002|Overall Study|Lack of Efficacy|0|||
161717180|NCT00491530|584010494|FG000|Overall Study|Investigator Discretion|0|||
161717181|NCT00491530|584010495|FG001|Overall Study|Investigator Discretion|1|||
161717182|NCT00491530|584010496|FG002|Overall Study|Investigator Discretion|0|||
161717183|NCT00491530|584010494|FG000|Overall Study|Patient Request|0|||
161717184|NCT00491530|584010495|FG001|Overall Study|Patient Request|1|||
161717185|NCT00491530|584010496|FG002|Overall Study|Patient Request|0|||
161717186|NCT00491530|584010494|FG000|Overall Study|Use of Prohibited Medication|0|||
161717187|NCT00491530|584010495|FG001|Overall Study|Use of Prohibited Medication|0|||
161717188|NCT00491530|584010496|FG002|Overall Study|Use of Prohibited Medication|1|||
161717189|NCT01856673|584010497|FG000|Overall Study|Withdrawal by Subject|44|||
161717190|NCT01856673|584010498|FG001|Overall Study|Withdrawal by Subject|50|||
161717191|NCT01856673|584010499|FG002|Overall Study|Withdrawal by Subject|33|||
161717192|NCT01856673|584010497|FG000|Overall Study|Lost to Follow-up|31|||
161717193|NCT01856673|584010498|FG001|Overall Study|Lost to Follow-up|34|||
161717194|NCT01856673|584010499|FG002|Overall Study|Lost to Follow-up|0|||
161717195|NCT01856673|584010497|FG000|Overall Study|Unknown reasons|9|||
161717196|NCT01856673|584010498|FG001|Overall Study|Unknown reasons|0|||
161717197|NCT01856673|584010499|FG002|Overall Study|Unknown reasons|0|||
161717198|NCT01856673|584010497|FG000|Overall Study|Psychologist decision|1|||
161717199|NCT01856673|584010498|FG001|Overall Study|Psychologist decision|0|||
161717200|NCT01856673|584010499|FG002|Overall Study|Psychologist decision|0|||
161717201|NCT01856673|584010497|FG000|Overall Study|Paperwork errors|8|||
161717202|NCT01856673|584010498|FG001|Overall Study|Paperwork errors|0|||
161717203|NCT01856673|584010499|FG002|Overall Study|Paperwork errors|0|||
161717204|NCT01856673|584010497|FG000|Overall Study|Death|1|||
161717205|NCT01856673|584010498|FG001|Overall Study|Death|1|||
161717206|NCT01856673|584010499|FG002|Overall Study|Death|0|||
161717207|NCT01856673|584010497|FG000|Overall Study|Protocol Violation|1|||
161717208|NCT01856673|584010498|FG001|Overall Study|Protocol Violation|0|||
161717209|NCT01856673|584010499|FG002|Overall Study|Protocol Violation|1|||
161717210|NCT02859415|584010500|FG000|Overall Study|Physician Decision|1|||
161717211|NCT02859415|584010501|FG001|Overall Study|Physician Decision|0|||
161717212|NCT02859415|584010500|FG000|Overall Study|Off treatment due to cardiac event|0|||
161717213|NCT02859415|584010501|FG001|Overall Study|Off treatment due to cardiac event|1|||
161717214|NCT01396525|584010502|FG000|Overall Study|Withdrawal by Subject|8|||
161717215|NCT01396525|584010502|FG000|Overall Study|Death|14|||
161717216|NCT01396525|584010502|FG000|Overall Study|Lost to Follow-up|4|||
161717217|NCT03114969|584010503|FG000|Overall Study|Lost to Follow-up|0|||
161717218|NCT03114969|584010504|FG001|Overall Study|Lost to Follow-up|0|||
161717219|NCT03114969|584010505|FG002|Overall Study|Lost to Follow-up|3|||
161717220|NCT03114969|584010506|FG003|Overall Study|Lost to Follow-up|2|||
161717221|NCT03114969|584010507|FG004|Overall Study|Lost to Follow-up|0|||
161717222|NCT03114969|584010508|FG005|Overall Study|Lost to Follow-up|0|||
161717223|NCT03114969|584010509|FG006|Overall Study|Lost to Follow-up|0|||
161717224|NCT03114969|584010510|FG007|Overall Study|Lost to Follow-up|0|||
161717225|NCT03114969|584010511|FG008|Overall Study|Lost to Follow-up|0|||
161717226|NCT03114969|584010503|FG000|Overall Study|Adverse Event|0|||
161717227|NCT03114969|584010504|FG001|Overall Study|Adverse Event|0|||
161717228|NCT03114969|584010505|FG002|Overall Study|Adverse Event|1|||
161717229|NCT03114969|584010506|FG003|Overall Study|Adverse Event|0|||
161717230|NCT03114969|584010507|FG004|Overall Study|Adverse Event|0|||
161663746|NCT01200589|583820443|FG001|Overall Study|Lost to Follow-up|4|||
161663747|NCT01200589|583820442|FG000|Overall Study|Study terminated|170|||
161663748|NCT01200589|583820443|FG001|Overall Study|Study terminated|172|||
161663749|NCT00986973|583820444|FG000|Overall Study|Withdrawn by study team|1|||
161663750|NCT00598273|583820445|FG000|Overall Study|Adverse Event|4|||
161663751|NCT00598273|583820446|FG001|Overall Study|Adverse Event|5|||
161663752|NCT00598273|583820447|FG002|Overall Study|Adverse Event|2|||
161717231|NCT03114969|584010508|FG005|Overall Study|Adverse Event|1|||
161663753|NCT00598273|583820445|FG000|Overall Study|Death|6|||
161717232|NCT03114969|584010509|FG006|Overall Study|Adverse Event|1|||
161717233|NCT03114969|584010510|FG007|Overall Study|Adverse Event|0|||
161717234|NCT03114969|584010511|FG008|Overall Study|Adverse Event|2|||
161717235|NCT00971321|584010512|FG000|Up to Month 7|Withdrawal by Subject|1|||
161717236|NCT00971321|584010513|FG001|Up to Month 7|Withdrawal by Subject|0|||
161663754|NCT00598273|583820446|FG001|Overall Study|Death|12|||
161663755|NCT00598273|583820447|FG002|Overall Study|Death|8|||
161663756|NCT00598273|583820445|FG000|Overall Study|Lost to Follow-up|8|||
161663757|NCT00598273|583820446|FG001|Overall Study|Lost to Follow-up|3|||
161663758|NCT00598273|583820447|FG002|Overall Study|Lost to Follow-up|5|||
161663759|NCT00598273|583820445|FG000|Overall Study|Physician Decision|0|||
161663760|NCT00598273|583820446|FG001|Overall Study|Physician Decision|0|||
161663761|NCT00598273|583820447|FG002|Overall Study|Physician Decision|1|||
161663762|NCT00598273|583820445|FG000|Overall Study|Withdrawal by Subject|12|||
161663763|NCT00598273|583820446|FG001|Overall Study|Withdrawal by Subject|10|||
161663764|NCT00598273|583820447|FG002|Overall Study|Withdrawal by Subject|10|||
161663765|NCT00598273|583820445|FG000|Overall Study|Noncompliance|3|||
161663766|NCT00598273|583820446|FG001|Overall Study|Noncompliance|2|||
161663767|NCT00598273|583820447|FG002|Overall Study|Noncompliance|3|||
161663768|NCT00598273|583820445|FG000|Overall Study|Relocation|0|||
161663769|NCT00598273|583820446|FG001|Overall Study|Relocation|2|||
161663770|NCT00598273|583820447|FG002|Overall Study|Relocation|4|||
161663771|NCT00598273|583820445|FG000|Overall Study|Renal transplant|1|||
161663772|NCT00598273|583820446|FG001|Overall Study|Renal transplant|0|||
161663773|NCT00598273|583820447|FG002|Overall Study|Renal transplant|1|||
161663774|NCT00598273|583820445|FG000|Overall Study|Site elected to close|1|||
161663775|NCT00598273|583820446|FG001|Overall Study|Site elected to close|0|||
161663776|NCT00598273|583820447|FG002|Overall Study|Site elected to close|0|||
161663777|NCT00598273|583820445|FG000|Overall Study|Started dialysis|6|||
161663778|NCT00598273|583820446|FG001|Overall Study|Started dialysis|4|||
161663779|NCT00598273|583820447|FG002|Overall Study|Started dialysis|5|||
161663780|NCT01590082|583820448|FG000|Overall Study|Withdrawal by Subject|1|||
161663781|NCT01590082|583820449|FG001|Overall Study|Withdrawal by Subject|0|||
161663782|NCT01590082|583820448|FG000|Overall Study|Ineligible|1|||
161663783|NCT01590082|583820449|FG001|Overall Study|Ineligible|0|||
161663784|NCT02549196|583820450|FG000|Overall Study|Protocol Violation|0|||
161663785|NCT02549196|583820451|FG001|Overall Study|Protocol Violation|0|||
161663786|NCT02549196|583820452|FG002|Overall Study|Protocol Violation|0|||
161663787|NCT02549196|583820453|FG003|Overall Study|Protocol Violation|1|||
161663788|NCT02549196|583820450|FG000|Overall Study|Withdrawal by Subject|1|||
161663789|NCT02549196|583820451|FG001|Overall Study|Withdrawal by Subject|0|||
161663790|NCT02549196|583820452|FG002|Overall Study|Withdrawal by Subject|1|||
161663791|NCT02549196|583820453|FG003|Overall Study|Withdrawal by Subject|0|||
161663792|NCT01442779|583820454|FG000|Overall Study|Withdrawal by Subject|3|||
161663793|NCT01442779|583820454|FG000|Overall Study|Death|3|||
161663794|NCT01442779|583820454|FG000|Overall Study|Non-compliance|1|||
161663795|NCT00994682|583820455|FG000|Double Bilnd|Withdrawal by Subject|5|||
161663796|NCT00994682|583820456|FG001|Double Bilnd|Withdrawal by Subject|6|||
161663797|NCT00994682|583820455|FG000|Double Bilnd|Lost to Follow-up|3|||
161663798|NCT00994682|583820456|FG001|Double Bilnd|Lost to Follow-up|3|||
161663799|NCT00994682|583820455|FG000|Double Bilnd|Adverse Event|1|||
161663800|NCT00994682|583820456|FG001|Double Bilnd|Adverse Event|0|||
161663801|NCT00994682|583820455|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
161663802|NCT00994682|583820456|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
161663803|NCT00994682|583820455|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
161663804|NCT00994682|583820456|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
161717237|NCT00971321|584010512|FG000|Up to Month 7|Migrated/moved from study area|3|||
161717238|NCT00971321|584010513|FG001|Up to Month 7|Migrated/moved from study area|2|||
161717239|NCT00971321|584010512|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
161717240|NCT00971321|584010513|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
161717241|NCT00971321|584010512|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
161717242|NCT00971321|584010513|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
161717243|NCT00971321|584010512|FG000|Up to Month 11-12|Lost to Follow-up|1|||
161717244|NCT00971321|584010513|FG001|Up to Month 11-12|Lost to Follow-up|0|||
161717245|NCT01591330|584010516|FG000|Period 1|Adverse Event|1|||
161717246|NCT01591330|584010517|FG001|Period 1|Adverse Event|0|||
161717247|NCT01591330|584010518|FG002|Period 1|Adverse Event|0|||
161717248|NCT01591330|584010519|FG003|Period 1|Adverse Event|0|||
161717249|NCT01591330|584010516|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
161717250|NCT01591330|584010517|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161717251|NCT01591330|584010518|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161717252|NCT01591330|584010519|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161717253|NCT01591330|584010516|FG000|Period 2|Adverse Event|1|||
161717254|NCT01591330|584010517|FG001|Period 2|Adverse Event|0|||
161717255|NCT01591330|584010518|FG002|Period 2|Adverse Event|0|||
161717256|NCT01591330|584010519|FG003|Period 2|Adverse Event|0|||
161717257|NCT02782715|584010520|FG000|Overall Study|Withdrawal by Subject|1|||
161717258|NCT01662999|584010531|FG000|Period 3|Withdrawal by Subject|0|||
161717259|NCT01662999|584010532|FG001|Period 3|Withdrawal by Subject|1|||
161717260|NCT01662999|584010533|FG002|Period 3|Withdrawal by Subject|0|||
161717261|NCT01662999|584010534|FG003|Period 3|Withdrawal by Subject|0|||
161717262|NCT01662999|584010535|FG004|Period 3|Withdrawal by Subject|0|||
161717263|NCT01662999|584010536|FG005|Period 3|Withdrawal by Subject|0|||
161717264|NCT00196937|584010537|FG000|Overall Study|Serious Adverse Event|1|||
161717265|NCT00196937|584010538|FG001|Overall Study|Serious Adverse Event|0|||
161717266|NCT00196937|584010539|FG002|Overall Study|Serious Adverse Event|0|||
161717267|NCT00196937|584010537|FG000|Overall Study|Non-serious adverse event|1|||
161717268|NCT00196937|584010538|FG001|Overall Study|Non-serious adverse event|1|||
161717269|NCT00196937|584010539|FG002|Overall Study|Non-serious adverse event|1|||
161717270|NCT00196937|584010537|FG000|Overall Study|Withdrawal by Subject|0|||
161717271|NCT00196937|584010538|FG001|Overall Study|Withdrawal by Subject|0|||
161717272|NCT00196937|584010539|FG002|Overall Study|Withdrawal by Subject|2|||
161717273|NCT00196937|584010537|FG000|Overall Study|Lost to Follow-up|4|||
161717274|NCT00196937|584010538|FG001|Overall Study|Lost to Follow-up|3|||
161717275|NCT00196937|584010539|FG002|Overall Study|Lost to Follow-up|3|||
161717276|NCT00196937|584010537|FG000|Overall Study|Other|3|||
161717277|NCT00196937|584010538|FG001|Overall Study|Other|1|||
161717278|NCT00196937|584010539|FG002|Overall Study|Other|1|||
161717279|NCT03368404|584010546|FG000|Overall Study|Adverse Event|2|||
161717280|NCT03368404|584010547|FG001|Overall Study|Adverse Event|1|||
161717281|NCT03368404|584010546|FG000|Overall Study|Withdrawal by Subject|1|||
161717282|NCT03368404|584010547|FG001|Overall Study|Withdrawal by Subject|1|||
161717283|NCT04725682|584010548|FG000|Overall Study|Withdrawal by Subject|7|||
161717284|NCT04725682|584010549|FG001|Overall Study|Withdrawal by Subject|5|||
161717285|NCT04725682|584010548|FG000|Overall Study|Failed to comply with the requirements|2|||
161717286|NCT04725682|584010549|FG001|Overall Study|Failed to comply with the requirements|1|||
161717287|NCT04725682|584010548|FG000|Overall Study|Adverse Event|1|||
161717288|NCT04725682|584010549|FG001|Overall Study|Adverse Event|1|||
161717289|NCT04725682|584010548|FG000|Overall Study|Death|0|||
161717290|NCT04725682|584010549|FG001|Overall Study|Death|1|||
161717291|NCT00964795|584010550|FG000|Overall Study|Withdrawal by Subject|79|||
161717292|NCT00964795|584010550|FG000|Overall Study|Adverse Event|12|||
161717293|NCT00964795|584010550|FG000|Overall Study|Death|14|||
161717294|NCT00964795|584010550|FG000|Overall Study|Lost to Follow-up|7|||
161717295|NCT00964795|584010550|FG000|Overall Study|Termination of Study by Sponsor|169|||
161717296|NCT00964795|584010550|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
161717297|NCT00964795|584010550|FG000|Overall Study|Other|23|||
161717298|NCT00586690|584010558|FG000|Overall Study|Death|2|||
161717299|NCT00586690|584010559|FG001|Overall Study|Death|0|||
161717300|NCT00586690|584010558|FG000|Overall Study|Disease Progression|10|||
161717301|NCT00586690|584010559|FG001|Overall Study|Disease Progression|0|||
161717302|NCT00586690|584010558|FG000|Overall Study|Adverse Event|1|||
161717303|NCT00586690|584010559|FG001|Overall Study|Adverse Event|0|||
161717304|NCT00586690|584010558|FG000|Overall Study|Lack of Efficacy|2|||
161717305|NCT00586690|584010559|FG001|Overall Study|Lack of Efficacy|0|||
161717306|NCT00586690|584010558|FG000|Overall Study|Lab can't accommodate|1|||
161717307|NCT00586690|584010559|FG001|Overall Study|Lab can't accommodate|0|||
161717308|NCT02453841|584010560|FG000|Overall Study|Protocol Violation|1|||
161717309|NCT02453841|584010560|FG000|Overall Study|Unable to obtain blood samples|2|||
161717310|NCT01751646|584010561|FG000|Overall Study|Lost to Follow-up|5|||
161717311|NCT01751646|584010562|FG001|Overall Study|Lost to Follow-up|1|||
161717312|NCT01751646|584010561|FG000|Overall Study|Withdrawal by Subject|0|||
161717313|NCT01751646|584010562|FG001|Overall Study|Withdrawal by Subject|4|||
161717314|NCT01751646|584010561|FG000|Overall Study|Starting hormone therapy|1|||
161717315|NCT01751646|584010562|FG001|Overall Study|Starting hormone therapy|0|||
161717316|NCT01751646|584010561|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
161717317|NCT01751646|584010562|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
161717318|NCT01751646|584010561|FG000|Overall Study|Inadvertent enrollment|1|||
161717319|NCT01751646|584010562|FG001|Overall Study|Inadvertent enrollment|1|||
161717320|NCT01751646|584010561|FG000|Overall Study|Moved out of the area|1|||
161717321|NCT01751646|584010562|FG001|Overall Study|Moved out of the area|5|||
161717322|NCT01751646|584010561|FG000|Overall Study|Inability to attend required visits|0|||
161717323|NCT01751646|584010562|FG001|Overall Study|Inability to attend required visits|1|||
161717324|NCT01751646|584010561|FG000|Overall Study|Off study due to multiple obligations|0|||
161717325|NCT01751646|584010562|FG001|Overall Study|Off study due to multiple obligations|1|||
161717326|NCT01751646|584010561|FG000|Overall Study|Fails to comply with study requirements|0|||
161838037|NCT02272634|584450307|FG000|Overall Study|Withdrawal by Subject|0|||
161838038|NCT02272634|584450308|FG001|Overall Study|Withdrawal by Subject|1|||
161838039|NCT02272634|584450309|FG002|Overall Study|Withdrawal by Subject|0|||
161838040|NCT01437943|584450310|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
161838041|NCT01437943|584450311|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
161838042|NCT01437943|584450310|FG000|Overall Study|Subject expressed pregnancy plans|1|||
161838043|NCT01437943|584450311|FG001|Overall Study|Subject expressed pregnancy plans|0|||
161838044|NCT01437943|584450310|FG000|Overall Study|Adverse Event|2|||
161838045|NCT01437943|584450311|FG001|Overall Study|Adverse Event|0|||
161838046|NCT04647721|584450312|FG000|Overall Study|Withdrawal by Subject|0|||
161838047|NCT04647721|584450313|FG001|Overall Study|Withdrawal by Subject|2|||
161838048|NCT04647721|584450312|FG000|Overall Study|Lost to Follow-up|2|||
161838049|NCT04647721|584450313|FG001|Overall Study|Lost to Follow-up|0|||
161838050|NCT00136318|584450316|FG000|Overall Study|Adverse Event|5|||
161717327|NCT01751646|584010562|FG001|Overall Study|Fails to comply with study requirements|1|||
161717328|NCT01751646|584010561|FG000|Overall Study|Childcare issues|1|||
161663805|NCT00994682|583820455|FG000|Pioglitazone Open Label|Physician Decision|6|||
161663806|NCT00994682|583820456|FG001|Pioglitazone Open Label|Physician Decision|1|||
161663807|NCT01323972|583820457|FG000|Overall Study|Withdrawal by Subject|1|||
161663808|NCT01323972|583820458|FG001|Overall Study|Withdrawal by Subject|0|||
161663809|NCT01323972|583820459|FG002|Overall Study|Withdrawal by Subject|1|||
161663810|NCT01323972|583820460|FG003|Overall Study|Withdrawal by Subject|0|||
161663811|NCT01323972|583820457|FG000|Overall Study|Migrated/moved from study area|1|||
161663812|NCT01323972|583820458|FG001|Overall Study|Migrated/moved from study area|2|||
161663813|NCT01323972|583820459|FG002|Overall Study|Migrated/moved from study area|0|||
161663814|NCT01323972|583820460|FG003|Overall Study|Migrated/moved from study area|0|||
161663815|NCT01323972|583820457|FG000|Overall Study|Lost to Follow-up|0|||
161663816|NCT01323972|583820458|FG001|Overall Study|Lost to Follow-up|1|||
161663817|NCT01323972|583820459|FG002|Overall Study|Lost to Follow-up|1|||
161663818|NCT01323972|583820460|FG003|Overall Study|Lost to Follow-up|1|||
161663819|NCT03218397|583820461|FG000|Overall Study|Prior positive blood culture|8|||
161663820|NCT03218397|583820462|FG001|Overall Study|Prior positive blood culture|13|||
161663821|NCT03218397|583820461|FG000|Overall Study|Comfort care|8|||
161663822|NCT03218397|583820462|FG001|Overall Study|Comfort care|5|||
161663823|NCT03218397|583820461|FG000|Overall Study|Comfort care and positive blood culture|1|||
161663824|NCT03218397|583820462|FG001|Overall Study|Comfort care and positive blood culture|0|||
161663825|NCT03218397|583820461|FG000|Overall Study|Comfort care and mixed culture|0|||
161663826|NCT03218397|583820462|FG001|Overall Study|Comfort care and mixed culture|1|||
161663827|NCT03218397|583820461|FG000|Overall Study|Mixed culture|2|||
161663828|NCT03218397|583820462|FG001|Overall Study|Mixed culture|2|||
161663829|NCT03218397|583820461|FG000|Overall Study|Inaccessible hospital records|2|||
161663830|NCT03218397|583820462|FG001|Overall Study|Inaccessible hospital records|5|||
161663831|NCT03218397|583820461|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
161663832|NCT03218397|583820462|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
161663833|NCT03218397|583820461|FG000|Overall Study|Randomized during laboratory off hours|2|||
161663834|NCT03218397|583820462|FG001|Overall Study|Randomized during laboratory off hours|1|||
161663835|NCT01796548|583820465|FG000|Overall Study|Lost to Follow-up|1|||
161663836|NCT01796548|583820465|FG000|Overall Study|Other|2|||
161663837|NCT01049217|583820468|FG000|Overall Study|Adverse Event|2|||
161663838|NCT01049217|583820469|FG001|Overall Study|Adverse Event|1|||
161663839|NCT01049217|583820468|FG000|Overall Study|Lack of Efficacy|1|||
161663840|NCT01049217|583820469|FG001|Overall Study|Lack of Efficacy|1|||
161663841|NCT01049217|583820468|FG000|Overall Study|Lost to Follow-up|3|||
161663842|NCT01049217|583820469|FG001|Overall Study|Lost to Follow-up|8|||
161663843|NCT01049217|583820468|FG000|Overall Study|Withdrawal by Subject|4|||
161663844|NCT01049217|583820469|FG001|Overall Study|Withdrawal by Subject|3|||
161663845|NCT01049217|583820468|FG000|Overall Study|Protocol Violation|1|||
161663846|NCT01049217|583820469|FG001|Overall Study|Protocol Violation|3|||
161663847|NCT01049217|583820468|FG000|Overall Study|Pregnancy|1|||
161663848|NCT01049217|583820469|FG001|Overall Study|Pregnancy|0|||
161663849|NCT01049217|583820468|FG000|Overall Study|Study Terminated by Sponsor|43|||
161663850|NCT01049217|583820469|FG001|Overall Study|Study Terminated by Sponsor|43|||
161663851|NCT01049217|583820468|FG000|Overall Study|Other|1|||
161663852|NCT01049217|583820469|FG001|Overall Study|Other|2|||
161663853|NCT01049217|583820468|FG000|Overall Study|Randomized but not Treated|0|||
161663854|NCT01049217|583820469|FG001|Overall Study|Randomized but not Treated|2|||
161663855|NCT00589121|583820470|FG000|Overall Study|Protocol Violation|2|||
161663856|NCT00589121|583820471|FG001|Overall Study|Protocol Violation|6|||
161663857|NCT00589121|583820470|FG000|Overall Study|No protocol treatment received|0|||
161663858|NCT00589121|583820471|FG001|Overall Study|No protocol treatment received|1|||
161663859|NCT03141905|583820472|FG000|Overall Study|Death|3|||
161663860|NCT03141905|583820473|FG001|Overall Study|Death|2|||
161663861|NCT03141905|583820472|FG000|Overall Study|Withdrawal by Subject|1|||
161663862|NCT03141905|583820473|FG001|Overall Study|Withdrawal by Subject|0|||
161663863|NCT03141905|583820472|FG000|Overall Study|Lost to Follow-up|3|||
161663864|NCT03141905|583820473|FG001|Overall Study|Lost to Follow-up|7|||
161663865|NCT03141905|583820472|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
161663866|NCT03141905|583820473|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
161663867|NCT05180500|583820474|FG000|Overall Study|Adverse Event|1|||
161663868|NCT05180500|583820475|FG001|Overall Study|Adverse Event|0|||
161663869|NCT05180500|583820474|FG000|Overall Study|Withdrawal by Subject|2|||
161663870|NCT05180500|583820475|FG001|Overall Study|Withdrawal by Subject|0|||
161663871|NCT04927884|583820480|FG000|Overall Study|Progressive Disease|2|||
161663872|NCT01775124|583820481|FG000|Core Period|Disease Progression|0|||
161663873|NCT01775124|583820482|FG001|Core Period|Disease Progression|1|||
161663874|NCT01775124|583820481|FG000|Core Period|Physician Decision|1|||
161663875|NCT01775124|583820482|FG001|Core Period|Physician Decision|1|||
161663876|NCT01775124|583820481|FG000|Core Period|Death|0|||
161663877|NCT01775124|583820482|FG001|Core Period|Death|1|||
161663878|NCT01775124|583820481|FG000|Core Period|Administrative problems|1|||
161663879|NCT01775124|583820482|FG001|Core Period|Administrative problems|0|||
161663880|NCT01775124|583820481|FG000|Core Period|Withdrawal by Subject|4|||
161717329|NCT01751646|584010562|FG001|Overall Study|Childcare issues|1|||
161717330|NCT02190591|584010563|FG000|Overall Study|Withdrawal by Subject|1|||
161717331|NCT02190591|584010564|FG001|Overall Study|Withdrawal by Subject|8|||
161717332|NCT02190591|584010563|FG000|Overall Study|Protocol Violation|1|||
161717333|NCT02190591|584010564|FG001|Overall Study|Protocol Violation|0|||
161717334|NCT02190591|584010563|FG000|Overall Study|did not use peanut ball as instructed|0|||
161717335|NCT02190591|584010564|FG001|Overall Study|did not use peanut ball as instructed|2|||
161717336|NCT02190591|584010563|FG000|Overall Study|face presentation so she was ineligible|0|||
161717337|NCT02190591|584010564|FG001|Overall Study|face presentation so she was ineligible|1|||
161717338|NCT01151137|584010567|FG000|Overall Study|Death|15|||
161717339|NCT01151137|584010568|FG001|Overall Study|Death|27|||
161717340|NCT01151137|584010567|FG000|Overall Study|Lost to Follow-up|1|||
161717341|NCT01151137|584010568|FG001|Overall Study|Lost to Follow-up|1|||
161717342|NCT00072189|584010569|FG000|Overall Study|Withdrawal by Subject|1|||
161717343|NCT02973815|584010573|FG000|Post Intervention|Death|1|||
161717344|NCT02973815|584010574|FG001|Post Intervention|Death|0|||
161717345|NCT02973815|584010573|FG000|Post Intervention|Lost to Follow-up|7|||
161717346|NCT02973815|584010574|FG001|Post Intervention|Lost to Follow-up|24|||
161717347|NCT02973815|584010573|FG000|Follow-up|Lost to Follow-up|2|||
161717348|NCT02973815|584010574|FG001|Follow-up|Lost to Follow-up|0|||
161717349|NCT00524303|584010575|FG000|Overall Study|Lost to Follow-up|6|||
161717350|NCT00524303|584010576|FG001|Overall Study|Lost to Follow-up|0|||
161717351|NCT00524303|584010577|FG002|Overall Study|Lost to Follow-up|3|||
161717352|NCT00524303|584010575|FG000|Overall Study|Protocol Violation|0|||
161717353|NCT00524303|584010576|FG001|Overall Study|Protocol Violation|1|||
161717354|NCT00524303|584010577|FG002|Overall Study|Protocol Violation|1|||
161717355|NCT00524303|584010575|FG000|Overall Study|Withdrawal by Subject|3|||
161717356|NCT00524303|584010576|FG001|Overall Study|Withdrawal by Subject|0|||
161717357|NCT00524303|584010577|FG002|Overall Study|Withdrawal by Subject|4|||
161717358|NCT00524303|584010575|FG000|Overall Study|Death|0|||
161717359|NCT00524303|584010576|FG001|Overall Study|Death|2|||
161717360|NCT00524303|584010577|FG002|Overall Study|Death|3|||
161717361|NCT00524303|584010575|FG000|Overall Study|Adverse Event|1|||
161717362|NCT00524303|584010576|FG001|Overall Study|Adverse Event|2|||
161717363|NCT00524303|584010577|FG002|Overall Study|Adverse Event|3|||
161717364|NCT00524303|584010575|FG000|Overall Study|Did not Complete Study Dosing|1|||
161717365|NCT00524303|584010576|FG001|Overall Study|Did not Complete Study Dosing|0|||
161717366|NCT00524303|584010577|FG002|Overall Study|Did not Complete Study Dosing|0|||
161717367|NCT00524303|584010575|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
161717368|NCT00524303|584010576|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
161717369|NCT00524303|584010577|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
161717370|NCT00524303|584010575|FG000|Overall Study|Disease Progression|0|||
161717371|NCT00524303|584010576|FG001|Overall Study|Disease Progression|4|||
161717372|NCT00524303|584010577|FG002|Overall Study|Disease Progression|1|||
161717373|NCT00524303|584010575|FG000|Overall Study|Disease Recurrence|0|||
161717374|NCT00524303|584010576|FG001|Overall Study|Disease Recurrence|1|||
161717375|NCT00524303|584010577|FG002|Overall Study|Disease Recurrence|0|||
161663881|NCT01775124|583820482|FG001|Core Period|Withdrawal by Subject|2|||
161663882|NCT01775124|583820481|FG000|Core Period|Adverse Event|5|||
161663883|NCT01775124|583820482|FG001|Core Period|Adverse Event|5|||
161663884|NCT01775124|583820481|FG000|Extension Period|Adverse Event|3|||
161663885|NCT01775124|583820482|FG001|Extension Period|Adverse Event|2|||
161663886|NCT01775124|583820481|FG000|Extension Period|Physician Decision|0|||
161663887|NCT01775124|583820482|FG001|Extension Period|Physician Decision|2|||
161663888|NCT01775124|583820481|FG000|Extension Period|Administrative problems|0|||
161663889|NCT01775124|583820482|FG001|Extension Period|Administrative problems|1|||
161663890|NCT01775124|583820481|FG000|Extension Period|Lost to Follow-up|0|||
161663891|NCT01775124|583820482|FG001|Extension Period|Lost to Follow-up|1|||
161663892|NCT01775124|583820481|FG000|Extension Period|Withdrawal by Subject|9|||
161717376|NCT00524303|584010575|FG000|Overall Study|Sponsor Request|0|||
161717377|NCT00524303|584010576|FG001|Overall Study|Sponsor Request|0|||
161663893|NCT01775124|583820482|FG001|Extension Period|Withdrawal by Subject|12|||
161717378|NCT00524303|584010577|FG002|Overall Study|Sponsor Request|1|||
161717379|NCT00524303|584010575|FG000|Overall Study|Physician Decision|0|||
161717380|NCT00524303|584010576|FG001|Overall Study|Physician Decision|0|||
161717381|NCT00524303|584010577|FG002|Overall Study|Physician Decision|1|||
161717382|NCT00524303|584010575|FG000|Overall Study|Completed 5 years|0|||
161663894|NCT00727311|583820483|FG000|Overall Study|Did not receive drug|316|||
161717383|NCT00524303|584010576|FG001|Overall Study|Completed 5 years|0|||
161717384|NCT00524303|584010577|FG002|Overall Study|Completed 5 years|1|||
161717385|NCT03478683|584010578|FG000|Overall Study|Adverse Event|5|||
161717386|NCT03478683|584010579|FG001|Overall Study|Adverse Event|3|||
161663895|NCT00727311|583820483|FG000|Overall Study|Missing end of therapy data|205|||
161663896|NCT00727311|583820483|FG000|Overall Study|Adverse Event|58|||
161717387|NCT03478683|584010578|FG000|Overall Study|Lost to Follow-up|0|||
161717388|NCT03478683|584010579|FG001|Overall Study|Lost to Follow-up|5|||
161717389|NCT03478683|584010578|FG000|Overall Study|Physician Decision|1|||
161717390|NCT03478683|584010579|FG001|Overall Study|Physician Decision|3|||
161717391|NCT03478683|584010578|FG000|Overall Study|Withdrawal by Subject|7|||
161717392|NCT03478683|584010579|FG001|Overall Study|Withdrawal by Subject|7|||
161717393|NCT00970294|584010589|FG000|Overall Study|Physician Decision|4|||
161717394|NCT00970294|584010589|FG000|Overall Study|Withdrawal by Subject|1|||
161717395|NCT01607892|584010594|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
161717396|NCT01607892|584010595|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
161717397|NCT01607892|584010596|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
161717398|NCT01607892|584010597|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
161717399|NCT01607892|584010598|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
161717400|NCT01607892|584010594|FG000|Overall Study|Death|4|||
161717401|NCT01607892|584010595|FG001|Overall Study|Death|2|||
161717402|NCT01607892|584010596|FG002|Overall Study|Death|8|||
161717403|NCT01607892|584010597|FG003|Overall Study|Death|10|||
161717404|NCT01607892|584010598|FG004|Overall Study|Death|3|||
161717405|NCT01607892|584010594|FG000|Overall Study|Investigator discretion|2|||
161717406|NCT01607892|584010595|FG001|Overall Study|Investigator discretion|4|||
161717407|NCT01607892|584010596|FG002|Overall Study|Investigator discretion|4|||
161717408|NCT01607892|584010597|FG003|Overall Study|Investigator discretion|8|||
161717409|NCT01607892|584010598|FG004|Overall Study|Investigator discretion|0|||
161717410|NCT01607892|584010594|FG000|Overall Study|Other treatments became available|1|||
161717411|NCT01607892|584010595|FG001|Overall Study|Other treatments became available|1|||
161717412|NCT01607892|584010596|FG002|Overall Study|Other treatments became available|0|||
161717413|NCT01607892|584010597|FG003|Overall Study|Other treatments became available|0|||
161717414|NCT01607892|584010598|FG004|Overall Study|Other treatments became available|2|||
161717415|NCT01607892|584010594|FG000|Overall Study|Intercurrent illness|1|||
161717416|NCT01607892|584010595|FG001|Overall Study|Intercurrent illness|0|||
161717417|NCT01607892|584010596|FG002|Overall Study|Intercurrent illness|0|||
161717418|NCT01607892|584010597|FG003|Overall Study|Intercurrent illness|3|||
161717419|NCT01607892|584010598|FG004|Overall Study|Intercurrent illness|0|||
161717420|NCT01607892|584010594|FG000|Overall Study|Non-Compliance with study procedures|0|||
161717421|NCT01607892|584010595|FG001|Overall Study|Non-Compliance with study procedures|0|||
161717422|NCT01607892|584010596|FG002|Overall Study|Non-Compliance with study procedures|1|||
161717423|NCT01607892|584010597|FG003|Overall Study|Non-Compliance with study procedures|0|||
161717424|NCT01607892|584010598|FG004|Overall Study|Non-Compliance with study procedures|0|||
161717425|NCT01607892|584010594|FG000|Overall Study|Consent withdrawn by participant|9|||
161717426|NCT01607892|584010595|FG001|Overall Study|Consent withdrawn by participant|4|||
161717427|NCT01607892|584010596|FG002|Overall Study|Consent withdrawn by participant|24|||
161717428|NCT01607892|584010597|FG003|Overall Study|Consent withdrawn by participant|14|||
161717429|NCT01607892|584010598|FG004|Overall Study|Consent withdrawn by participant|4|||
161717430|NCT01607892|584010594|FG000|Overall Study|Disease progression|38|||
161717431|NCT01607892|584010595|FG001|Overall Study|Disease progression|13|||
161717432|NCT01607892|584010596|FG002|Overall Study|Disease progression|37|||
161717433|NCT01607892|584010597|FG003|Overall Study|Disease progression|57|||
161717434|NCT01607892|584010598|FG004|Overall Study|Disease progression|9|||
161717435|NCT01607892|584010594|FG000|Overall Study|Incidence or severity of Adverse events|3|||
161717436|NCT01607892|584010595|FG001|Overall Study|Incidence or severity of Adverse events|3|||
161717437|NCT01607892|584010596|FG002|Overall Study|Incidence or severity of Adverse events|7|||
161717438|NCT01607892|584010597|FG003|Overall Study|Incidence or severity of Adverse events|2|||
161717439|NCT01607892|584010598|FG004|Overall Study|Incidence or severity of Adverse events|6|||
161717440|NCT02273973|584010601|FG000|Overall Study|Adverse Event|4|||
161717441|NCT02273973|584010602|FG001|Overall Study|Adverse Event|0|||
161717442|NCT02273973|584010601|FG000|Overall Study|Withdrawal by Subject|2|||
161717443|NCT02273973|584010602|FG001|Overall Study|Withdrawal by Subject|3|||
161717444|NCT02273973|584010601|FG000|Overall Study|Death|1|||
161717445|NCT02273973|584010602|FG001|Overall Study|Death|0|||
161717446|NCT02273973|584010601|FG000|Overall Study|Non-compliance|1|||
161717447|NCT02273973|584010602|FG001|Overall Study|Non-compliance|0|||
161717448|NCT02273973|584010601|FG000|Overall Study|Protocol Violation|1|||
161717449|NCT02273973|584010602|FG001|Overall Study|Protocol Violation|0|||
161717450|NCT02273973|584010601|FG000|Overall Study|Progression of disease|0|||
161717451|NCT02273973|584010602|FG001|Overall Study|Progression of disease|2|||
161717452|NCT02273973|584010601|FG000|Overall Study|Lost to Follow-up|0|||
161717453|NCT02273973|584010602|FG001|Overall Study|Lost to Follow-up|1|||
161717454|NCT02273973|584010601|FG000|Overall Study|Physician Decision|0|||
161717455|NCT02273973|584010602|FG001|Overall Study|Physician Decision|1|||
161717456|NCT02273973|584010601|FG000|Overall Study|Reason not specified|0|||
161717457|NCT02273973|584010602|FG001|Overall Study|Reason not specified|1|||
161717458|NCT03022422|584010603|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
161717459|NCT03022422|584010604|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
161717460|NCT03022422|584010605|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
161717461|NCT03022422|584010606|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
161717462|NCT03022422|584010607|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
161717463|NCT03022422|584010608|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
161717464|NCT02104180|584010609|FG000|Overall Study|Protocol Violation|1|||
161717465|NCT02104180|584010610|FG001|Overall Study|Protocol Violation|0|||
161717466|NCT01676116|584010611|FG000|Overall Study|Withdrawal criteria|2|||
161717467|NCT01676116|584010612|FG001|Overall Study|Withdrawal criteria|14|||
161717468|NCT01676116|584010611|FG000|Overall Study|Adverse Event|1|||
161717469|NCT01676116|584010612|FG001|Overall Study|Adverse Event|2|||
161717470|NCT01676116|584010611|FG000|Overall Study|Unclassified|4|||
161717471|NCT01676116|584010612|FG001|Overall Study|Unclassified|10|||
161717472|NCT01676116|584010611|FG000|Overall Study|Protocol Violation|9|||
161717473|NCT01676116|584010612|FG001|Overall Study|Protocol Violation|3|||
161717474|NCT00793585|584010613|FG000|Overall Study|Adverse Event|1|||
161717475|NCT00793585|584010614|FG001|Overall Study|Adverse Event|1|||
161717476|NCT00793585|584010613|FG000|Overall Study|Protocol Violation|1|||
161717477|NCT00793585|584010614|FG001|Overall Study|Protocol Violation|2|||
161717478|NCT01821677|584010615|FG000|Overall Study|Adverse Event|4|||
161717479|NCT01821677|584010616|FG001|Overall Study|Adverse Event|6|||
161717480|NCT01821677|584010617|FG002|Overall Study|Adverse Event|5|||
161717481|NCT01821677|584010615|FG000|Overall Study|Physician Decision|1|||
161717482|NCT01821677|584010616|FG001|Overall Study|Physician Decision|4|||
161717483|NCT01821677|584010617|FG002|Overall Study|Physician Decision|1|||
161717484|NCT01821677|584010615|FG000|Overall Study|Non-compliance|0|||
161717485|NCT01821677|584010616|FG001|Overall Study|Non-compliance|1|||
161717486|NCT01821677|584010617|FG002|Overall Study|Non-compliance|2|||
161717487|NCT01821677|584010615|FG000|Overall Study|Lost to Follow-up|2|||
161717488|NCT01821677|584010616|FG001|Overall Study|Lost to Follow-up|1|||
161717489|NCT01821677|584010617|FG002|Overall Study|Lost to Follow-up|3|||
161717490|NCT01821677|584010615|FG000|Overall Study|Protocol Violation|0|||
161717491|NCT01821677|584010616|FG001|Overall Study|Protocol Violation|0|||
161717492|NCT01821677|584010617|FG002|Overall Study|Protocol Violation|2|||
161717493|NCT01821677|584010615|FG000|Overall Study|Withdrawal by Subject|7|||
161717494|NCT01821677|584010616|FG001|Overall Study|Withdrawal by Subject|3|||
161717495|NCT01821677|584010617|FG002|Overall Study|Withdrawal by Subject|2|||
161717496|NCT01821677|584010615|FG000|Overall Study|Other|9|||
161717497|NCT01821677|584010616|FG001|Overall Study|Other|0|||
161717498|NCT01821677|584010617|FG002|Overall Study|Other|0|||
161717499|NCT01769404|584010618|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
161717500|NCT01769404|584010619|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
161717501|NCT01769404|584010618|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161717502|NCT01769404|584010619|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161717503|NCT01769404|584010618|FG000|Treatment Period 1|Sponsor decision|1|||
161717504|NCT01769404|584010619|FG001|Treatment Period 1|Sponsor decision|0|||
161717505|NCT01769404|584010618|FG000|Treatment Period 2|Sponsor decision|7|||
161717506|NCT01769404|584010619|FG001|Treatment Period 2|Sponsor decision|0|||
161717507|NCT00538733|584010620|FG000|Overall Study|Adverse Event|8|||
161717508|NCT00538733|584010620|FG000|Overall Study|Death|1|||
161717509|NCT00538733|584010620|FG000|Overall Study|declined to participate|2|||
161717510|NCT00538733|584010620|FG000|Overall Study|still on therapy|1|||
161717511|NCT04513158|584010629|FG000|Overall Study|Screen Failure|1|||
161717512|NCT05278104|584010630|FG000|Overall Study|Not treated|1|||
161717513|NCT05278104|584010631|FG001|Overall Study|Not treated|0|||
161717514|NCT05278104|584010630|FG000|Overall Study|Adverse Event|2|||
161717515|NCT05278104|584010631|FG001|Overall Study|Adverse Event|1|||
161717516|NCT05278104|584010630|FG000|Overall Study|Exclusion criteria not met|1|||
161717517|NCT05278104|584010631|FG001|Overall Study|Exclusion criteria not met|0|||
161717518|NCT02786537|584012577|FG000|As Randomized|Adverse Event|0|||
161717519|NCT02786537|584012578|FG001|As Randomized|Adverse Event|11|||
161717520|NCT02786537|584012579|FG002|As Randomized|Adverse Event|0|||
161717521|NCT02786537|584012580|FG003|As Randomized|Adverse Event|4|||
161717522|NCT02786537|584012581|FG004|As Randomized|Adverse Event|6|||
161717523|NCT02786537|584012582|FG005|As Randomized|Adverse Event|2|||
161717524|NCT02786537|584012577|FG000|As Randomized|Lack of Efficacy|0|||
161717525|NCT02786537|584012578|FG001|As Randomized|Lack of Efficacy|0|||
161717526|NCT02786537|584012579|FG002|As Randomized|Lack of Efficacy|0|||
161717527|NCT02786537|584012580|FG003|As Randomized|Lack of Efficacy|1|||
161717528|NCT02786537|584012581|FG004|As Randomized|Lack of Efficacy|0|||
161717529|NCT02786537|584012582|FG005|As Randomized|Lack of Efficacy|0|||
161717530|NCT02786537|584012577|FG000|As Randomized|Withdrawal by Subject|1|||
161717531|NCT02786537|584012578|FG001|As Randomized|Withdrawal by Subject|2|||
161717532|NCT02786537|584012579|FG002|As Randomized|Withdrawal by Subject|0|||
161717533|NCT02786537|584012580|FG003|As Randomized|Withdrawal by Subject|1|||
161717534|NCT02786537|584012581|FG004|As Randomized|Withdrawal by Subject|1|||
161717535|NCT02786537|584012582|FG005|As Randomized|Withdrawal by Subject|0|||
161717536|NCT02786537|584012577|FG000|As Randomized|Death|0|||
161717537|NCT02786537|584012578|FG001|As Randomized|Death|2|||
161717538|NCT02786537|584012579|FG002|As Randomized|Death|0|||
161717539|NCT02786537|584012580|FG003|As Randomized|Death|3|||
161717540|NCT02786537|584012581|FG004|As Randomized|Death|1|||
161717541|NCT02786537|584012582|FG005|As Randomized|Death|0|||
161717542|NCT02786537|584012577|FG000|As Randomized|Non-compliance with study drug|1|||
161717543|NCT02786537|584012578|FG001|As Randomized|Non-compliance with study drug|11|||
161717544|NCT02786537|584012579|FG002|As Randomized|Non-compliance with study drug|0|||
161717545|NCT02786537|584012580|FG003|As Randomized|Non-compliance with study drug|1|||
161717546|NCT02786537|584012581|FG004|As Randomized|Non-compliance with study drug|0|||
161717547|NCT02786537|584012582|FG005|As Randomized|Non-compliance with study drug|1|||
161717548|NCT02786537|584012577|FG000|As Randomized|Lost to treatment follow-up|4|||
161717549|NCT02786537|584012578|FG001|As Randomized|Lost to treatment follow-up|32|||
161717550|NCT02786537|584012579|FG002|As Randomized|Lost to treatment follow-up|0|||
161717551|NCT02786537|584012580|FG003|As Randomized|Lost to treatment follow-up|24|||
161717552|NCT02786537|584012581|FG004|As Randomized|Lost to treatment follow-up|4|||
161717553|NCT02786537|584012582|FG005|As Randomized|Lost to treatment follow-up|4|||
161717554|NCT02786537|584012577|FG000|As Randomized|Incarceration|0|||
161717555|NCT02786537|584012578|FG001|As Randomized|Incarceration|1|||
161663897|NCT00727311|583820483|FG000|Overall Study|Lack of Efficacy|242|||
161663898|NCT00727311|583820483|FG000|Overall Study|Lost to Follow-up|73|||
161663899|NCT00727311|583820483|FG000|Overall Study|Withdrawal by Subject|77|||
161663900|NCT00727311|583820483|FG000|Overall Study|Other|97|||
161663901|NCT00727311|583820483|FG000|Overall Study|Multiple reasons|39|||
161663902|NCT03992846|583820484|FG000|Overall Study|Adverse Event|8|||
161663903|NCT03992846|583820485|FG001|Overall Study|Adverse Event|6|||
161663904|NCT03992846|583820486|FG002|Overall Study|Adverse Event|3|||
161663905|NCT03992846|583820484|FG000|Overall Study|Lost to Follow-up|0|||
161663906|NCT03992846|583820485|FG001|Overall Study|Lost to Follow-up|1|||
161663907|NCT03992846|583820486|FG002|Overall Study|Lost to Follow-up|1|||
161663908|NCT03992846|583820484|FG000|Overall Study|Pregnancy|2|||
161663909|NCT03992846|583820485|FG001|Overall Study|Pregnancy|0|||
161663910|NCT03992846|583820486|FG002|Overall Study|Pregnancy|1|||
161663911|NCT03992846|583820484|FG000|Overall Study|Protocol Violation|1|||
161663912|NCT03992846|583820485|FG001|Overall Study|Protocol Violation|2|||
161663913|NCT03992846|583820486|FG002|Overall Study|Protocol Violation|0|||
161663914|NCT03992846|583820484|FG000|Overall Study|Withdrawal by Subject|8|||
161663915|NCT03992846|583820485|FG001|Overall Study|Withdrawal by Subject|10|||
161663916|NCT03992846|583820486|FG002|Overall Study|Withdrawal by Subject|20|||
161663917|NCT03992846|583820484|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
161663918|NCT03992846|583820485|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
161663919|NCT03992846|583820486|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
161663920|NCT00031551|583822138|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
161663921|NCT00031551|583822139|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
161663922|NCT01919814|583822142|FG000|Overall Study|Adverse Event|1|||
161663923|NCT01919814|583822143|FG001|Overall Study|Adverse Event|0|||
161663924|NCT01919814|583822142|FG000|Overall Study|Protocol Violation|1|||
161663925|NCT01919814|583822143|FG001|Overall Study|Protocol Violation|0|||
161663926|NCT01919814|583822142|FG000|Overall Study|Withdrawal by Subject|1|||
161663927|NCT01919814|583822143|FG001|Overall Study|Withdrawal by Subject|0|||
161663928|NCT02164383|583822144|FG000|Overall Study|Lost to Follow-up|1|||
161663929|NCT02164383|583822145|FG001|Overall Study|Lost to Follow-up|0|||
161663930|NCT01036763|583822146|FG000|Overall Study|Adverse Event|25|||
161663931|NCT01036763|583822146|FG000|Overall Study|Lost to Follow-up|28|||
161663932|NCT01036763|583822146|FG000|Overall Study|Other reason (not specified)|40|||
161663933|NCT00743275|583822147|FG000|Overall Study|Protocol Violation|0|||
161663934|NCT00743275|583822148|FG001|Overall Study|Protocol Violation|1|||
161663935|NCT01672723|583822149|FG000|First Intervention|Adverse Event|3|||
161663936|NCT01672723|583822150|FG001|First Intervention|Adverse Event|0|||
161663937|NCT01177722|583822156|FG000|Overall Study|Serious Adverse Event|0|||
161663938|NCT01177722|583822157|FG001|Overall Study|Serious Adverse Event|0|||
161663939|NCT01177722|583822158|FG002|Overall Study|Serious Adverse Event|1|||
161663940|NCT01177722|583822159|FG003|Overall Study|Serious Adverse Event|0|||
161663941|NCT01177722|583822156|FG000|Overall Study|Protocol Violation|0|||
161663942|NCT01177722|583822157|FG001|Overall Study|Protocol Violation|0|||
161663943|NCT01177722|583822158|FG002|Overall Study|Protocol Violation|1|||
161663944|NCT01177722|583822159|FG003|Overall Study|Protocol Violation|0|||
161663945|NCT01177722|583822156|FG000|Overall Study|Lost to Follow-up|3|||
161663946|NCT01177722|583822157|FG001|Overall Study|Lost to Follow-up|4|||
161663947|NCT01177722|583822158|FG002|Overall Study|Lost to Follow-up|3|||
161663948|NCT01177722|583822159|FG003|Overall Study|Lost to Follow-up|1|||
161663949|NCT01177722|583822156|FG000|Overall Study|Withdrawal by Subject|10|||
161663950|NCT01177722|583822157|FG001|Overall Study|Withdrawal by Subject|6|||
161663951|NCT01177722|583822158|FG002|Overall Study|Withdrawal by Subject|4|||
161663952|NCT01177722|583822159|FG003|Overall Study|Withdrawal by Subject|6|||
161663953|NCT02831387|583822160|FG000|Overall Study|Withdrawal by Subject|1|||
161663954|NCT02831387|583822161|FG001|Overall Study|Withdrawal by Subject|1|||
161663955|NCT02831387|583822160|FG000|Overall Study|Discontinued due to stock recovery|0|||
161663956|NCT02831387|583822161|FG001|Overall Study|Discontinued due to stock recovery|1|||
161663957|NCT00192647|583822162|FG000|Overall Study|Death|1|||
161663958|NCT00192647|583822163|FG001|Overall Study|Death|1|||
161663959|NCT00192647|583822162|FG000|Overall Study|Adverse Event|35|||
161663960|NCT00192647|583822163|FG001|Overall Study|Adverse Event|29|||
161663961|NCT00192647|583822162|FG000|Overall Study|Laboratory Test Abnormality|4|||
161663962|NCT00192647|583822163|FG001|Overall Study|Laboratory Test Abnormality|2|||
161663963|NCT00192647|583822162|FG000|Overall Study|Insufficient Therapeutic Response|53|||
161663964|NCT00192647|583822163|FG001|Overall Study|Insufficient Therapeutic Response|83|||
161663965|NCT00192647|583822162|FG000|Overall Study|Entry Criteria Violation|6|||
161717556|NCT02786537|584012579|FG002|As Randomized|Incarceration|0|||
161663966|NCT00192647|583822163|FG001|Overall Study|Entry Criteria Violation|6|||
161663967|NCT00192647|583822162|FG000|Overall Study|Protocol Violation|3|||
161663968|NCT00192647|583822163|FG001|Overall Study|Protocol Violation|1|||
161663969|NCT00192647|583822162|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
161663970|NCT00192647|583822163|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
161663971|NCT00192647|583822162|FG000|Overall Study|Failure to Return|11|||
161663972|NCT00192647|583822163|FG001|Overall Study|Failure to Return|13|||
161663973|NCT00192647|583822162|FG000|Overall Study|Other/Administrative|5|||
161717557|NCT02786537|584012580|FG003|As Randomized|Incarceration|0|||
161663974|NCT00192647|583822163|FG001|Overall Study|Other/Administrative|3|||
161663975|NCT01828073|583822164|FG000|Overall Study|Lost to Follow-up|1|||
161663976|NCT01828073|583822165|FG001|Overall Study|Lost to Follow-up|2|||
161663977|NCT01201317|583822173|FG000|Overall Study|Withdrawal by Subject|5|||
161663978|NCT01201317|583822174|FG001|Overall Study|Withdrawal by Subject|0|||
161663979|NCT01201317|583822175|FG002|Overall Study|Withdrawal by Subject|3|||
161663980|NCT01201317|583822173|FG000|Overall Study|Adverse Event|2|||
161663981|NCT01201317|583822174|FG001|Overall Study|Adverse Event|2|||
161663982|NCT01201317|583822175|FG002|Overall Study|Adverse Event|2|||
161663983|NCT01201317|583822173|FG000|Overall Study|Screen failure|1|||
161663984|NCT01201317|583822174|FG001|Overall Study|Screen failure|1|||
161663985|NCT01201317|583822175|FG002|Overall Study|Screen failure|0|||
161663986|NCT01201317|583822173|FG000|Overall Study|Protocol Violation|0|||
161717558|NCT02786537|584012581|FG004|As Randomized|Incarceration|0|||
161717559|NCT02786537|584012582|FG005|As Randomized|Incarceration|0|||
161717560|NCT02786537|584012577|FG000|As Randomized|Opiate Dependency Relapse|0|||
161717561|NCT02786537|584012578|FG001|As Randomized|Opiate Dependency Relapse|1|||
161717562|NCT02786537|584012579|FG002|As Randomized|Opiate Dependency Relapse|0|||
161717563|NCT02786537|584012580|FG003|As Randomized|Opiate Dependency Relapse|0|||
161717564|NCT02786537|584012581|FG004|As Randomized|Opiate Dependency Relapse|0|||
161717565|NCT02786537|584012582|FG005|As Randomized|Opiate Dependency Relapse|0|||
161717566|NCT02786537|584012577|FG000|As Randomized|HCV drugs stolen from pt|0|||
161717567|NCT02786537|584012578|FG001|As Randomized|HCV drugs stolen from pt|1|||
161717568|NCT02786537|584012579|FG002|As Randomized|HCV drugs stolen from pt|0|||
161717569|NCT02786537|584012580|FG003|As Randomized|HCV drugs stolen from pt|0|||
161717570|NCT02786537|584012581|FG004|As Randomized|HCV drugs stolen from pt|0|||
161717571|NCT02786537|584012582|FG005|As Randomized|HCV drugs stolen from pt|0|||
161717572|NCT02786537|584012577|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
161717573|NCT02786537|584012578|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
161717574|NCT02786537|584012579|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
161717575|NCT02786537|584012580|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
161717576|NCT02786537|584012581|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
161717577|NCT02786537|584012582|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
161717578|NCT02786537|584012577|FG000|As Randomized|Subject lost insurance|0|||
161717579|NCT02786537|584012578|FG001|As Randomized|Subject lost insurance|0|||
161717580|NCT02786537|584012579|FG002|As Randomized|Subject lost insurance|0|||
161717581|NCT02786537|584012580|FG003|As Randomized|Subject lost insurance|1|||
161717582|NCT02786537|584012581|FG004|As Randomized|Subject lost insurance|0|||
161717583|NCT02786537|584012582|FG005|As Randomized|Subject lost insurance|0|||
161717584|NCT02786537|584012577|FG000|As Treated|Adverse Event|0|||
161717585|NCT02786537|584012578|FG001|As Treated|Adverse Event|11|||
161717586|NCT02786537|584012579|FG002|As Treated|Adverse Event|0|||
161717587|NCT02786537|584012580|FG003|As Treated|Adverse Event|4|||
161717588|NCT02786537|584012581|FG004|As Treated|Adverse Event|6|||
161717589|NCT02786537|584012582|FG005|As Treated|Adverse Event|2|||
161717590|NCT02786537|584012577|FG000|As Treated|Death|0|||
161717591|NCT02786537|584012578|FG001|As Treated|Death|2|||
161717592|NCT02786537|584012579|FG002|As Treated|Death|0|||
161717593|NCT02786537|584012580|FG003|As Treated|Death|3|||
161717594|NCT02786537|584012581|FG004|As Treated|Death|1|||
161717595|NCT02786537|584012582|FG005|As Treated|Death|0|||
161717596|NCT02786537|584012577|FG000|As Treated|Lack of Efficacy|0|||
161717597|NCT02786537|584012578|FG001|As Treated|Lack of Efficacy|0|||
161717598|NCT02786537|584012579|FG002|As Treated|Lack of Efficacy|0|||
161717599|NCT02786537|584012580|FG003|As Treated|Lack of Efficacy|1|||
161717600|NCT02786537|584012581|FG004|As Treated|Lack of Efficacy|0|||
161717601|NCT02786537|584012582|FG005|As Treated|Lack of Efficacy|0|||
161717602|NCT02786537|584012577|FG000|As Treated|Lost to Follow-up|4|||
161717603|NCT02786537|584012578|FG001|As Treated|Lost to Follow-up|32|||
161717604|NCT02786537|584012579|FG002|As Treated|Lost to Follow-up|0|||
161717605|NCT02786537|584012580|FG003|As Treated|Lost to Follow-up|25|||
161717606|NCT02786537|584012581|FG004|As Treated|Lost to Follow-up|4|||
161717607|NCT02786537|584012582|FG005|As Treated|Lost to Follow-up|4|||
161717608|NCT02786537|584012577|FG000|As Treated|Non-compliance with study drug|1|||
161717609|NCT02786537|584012578|FG001|As Treated|Non-compliance with study drug|11|||
161717610|NCT02786537|584012579|FG002|As Treated|Non-compliance with study drug|0|||
161717611|NCT02786537|584012580|FG003|As Treated|Non-compliance with study drug|1|||
161717612|NCT02786537|584012581|FG004|As Treated|Non-compliance with study drug|0|||
161717613|NCT02786537|584012582|FG005|As Treated|Non-compliance with study drug|1|||
161717614|NCT02786537|584012577|FG000|As Treated|Lost insurance|0|||
161717615|NCT02786537|584012578|FG001|As Treated|Lost insurance|0|||
161717616|NCT02786537|584012579|FG002|As Treated|Lost insurance|0|||
161717617|NCT02786537|584012580|FG003|As Treated|Lost insurance|1|||
161717618|NCT02786537|584012581|FG004|As Treated|Lost insurance|0|||
161717619|NCT02786537|584012582|FG005|As Treated|Lost insurance|0|||
161717620|NCT02786537|584012577|FG000|As Treated|Withdrawal by Subject|1|||
161717621|NCT02786537|584012578|FG001|As Treated|Withdrawal by Subject|2|||
161663987|NCT01201317|583822174|FG001|Overall Study|Protocol Violation|1|||
161717622|NCT02786537|584012579|FG002|As Treated|Withdrawal by Subject|0|||
161663988|NCT01201317|583822175|FG002|Overall Study|Protocol Violation|1|||
161663989|NCT01201317|583822173|FG000|Overall Study|Death|0|||
161663990|NCT01201317|583822174|FG001|Overall Study|Death|1|||
161663991|NCT01201317|583822175|FG002|Overall Study|Death|0|||
161663992|NCT01201317|583822173|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161663993|NCT01201317|583822174|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161663994|NCT01201317|583822175|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161663995|NCT01201317|583822173|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
161663996|NCT01201317|583822174|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
161663997|NCT01201317|583822175|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
161663998|NCT01201317|583822173|FG000|Overall Study|Decrease in renal function|0|||
161663999|NCT01201317|583822174|FG001|Overall Study|Decrease in renal function|1|||
161664000|NCT01201317|583822175|FG002|Overall Study|Decrease in renal function|0|||
161664001|NCT01201317|583822173|FG000|Overall Study|Lack of Efficacy|1|||
161664002|NCT01201317|583822174|FG001|Overall Study|Lack of Efficacy|0|||
161664003|NCT01201317|583822175|FG002|Overall Study|Lack of Efficacy|0|||
161664004|NCT01201317|583822173|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
161664005|NCT01201317|583822174|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
161664006|NCT01201317|583822175|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
161664007|NCT00876928|583822177|FG000|Overall Study|Lost to Follow-up|2|||
161664008|NCT00876928|583822178|FG001|Overall Study|Lost to Follow-up|5|||
161664009|NCT00876928|583822177|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
161664010|NCT00876928|583822178|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
161664011|NCT02795429|583822179|FG000|Overall Study|Adverse Event|1|||
161664012|NCT02795429|583822180|FG001|Overall Study|Adverse Event|2|||
161664013|NCT02795429|583822181|FG002|Overall Study|Adverse Event|1|||
161664014|NCT02795429|583822182|FG003|Overall Study|Adverse Event|2|||
161664015|NCT02795429|583822183|FG004|Overall Study|Adverse Event|1|||
161664016|NCT02795429|583822179|FG000|Overall Study|Death|1|||
161664017|NCT02795429|583822180|FG001|Overall Study|Death|0|||
161664018|NCT02795429|583822181|FG002|Overall Study|Death|1|||
161664019|NCT02795429|583822182|FG003|Overall Study|Death|2|||
161664020|NCT02795429|583822183|FG004|Overall Study|Death|1|||
161664021|NCT02795429|583822179|FG000|Overall Study|Physician Decision|0|||
161664022|NCT02795429|583822180|FG001|Overall Study|Physician Decision|0|||
161664023|NCT02795429|583822181|FG002|Overall Study|Physician Decision|2|||
161664024|NCT02795429|583822182|FG003|Overall Study|Physician Decision|1|||
161664025|NCT02795429|583822183|FG004|Overall Study|Physician Decision|5|||
161664026|NCT02795429|583822179|FG000|Overall Study|Progressive disease|3|||
161664027|NCT02795429|583822180|FG001|Overall Study|Progressive disease|7|||
161664028|NCT02795429|583822181|FG002|Overall Study|Progressive disease|6|||
161664029|NCT02795429|583822182|FG003|Overall Study|Progressive disease|26|||
161664030|NCT02795429|583822183|FG004|Overall Study|Progressive disease|20|||
161664031|NCT02795429|583822179|FG000|Overall Study|Subject/guardian decision|1|||
161664032|NCT02795429|583822180|FG001|Overall Study|Subject/guardian decision|1|||
161664033|NCT02795429|583822181|FG002|Overall Study|Subject/guardian decision|1|||
161664034|NCT02795429|583822182|FG003|Overall Study|Subject/guardian decision|1|||
161664035|NCT02795429|583822183|FG004|Overall Study|Subject/guardian decision|3|||
161664036|NCT05220254|583822184|FG000|Overall Study|Withdrawal by Subject|4|||
161664037|NCT05220254|583822184|FG000|Overall Study|Removed due to ineligibility|1|||
161664038|NCT05220254|583822184|FG000|Overall Study|Lost to Follow-up|7|||
161664039|NCT01411215|583822187|FG000|Overall Study|Adverse Event|1|||
161664040|NCT01411215|583822188|FG001|Overall Study|Adverse Event|2|||
161664041|NCT01411215|583822187|FG000|Overall Study|Lack of Efficacy|2|||
161664042|NCT01411215|583822188|FG001|Overall Study|Lack of Efficacy|4|||
161664043|NCT01411215|583822187|FG000|Overall Study|Lost to Follow-up|12|||
161664044|NCT01411215|583822188|FG001|Overall Study|Lost to Follow-up|18|||
161664045|NCT01411215|583822187|FG000|Overall Study|Did not meet entrance criteria|0|||
161664046|NCT01411215|583822188|FG001|Overall Study|Did not meet entrance criteria|1|||
161664047|NCT01411215|583822187|FG000|Overall Study|Study terminated by sponsor|2|||
161664048|NCT01411215|583822188|FG001|Overall Study|Study terminated by sponsor|15|||
161664049|NCT01411215|583822187|FG000|Overall Study|Protocol Violation|3|||
161664050|NCT01411215|583822188|FG001|Overall Study|Protocol Violation|5|||
161664051|NCT01411215|583822187|FG000|Overall Study|Withdrawal by Subject|34|||
161664052|NCT01411215|583822188|FG001|Overall Study|Withdrawal by Subject|21|||
161664053|NCT01411215|583822187|FG000|Overall Study|Other|12|||
161664054|NCT01411215|583822188|FG001|Overall Study|Other|17|||
161664055|NCT01411215|583822187|FG000|Overall Study|Screen failure|0|||
161664056|NCT01411215|583822188|FG001|Overall Study|Screen failure|1|||
161664057|NCT00402597|583822189|FG000|Overall Study|Death|15|||
161664058|NCT00402597|583822190|FG001|Overall Study|Death|7|||
161664059|NCT00402597|583822191|FG002|Overall Study|Death|6|||
161664060|NCT00402597|583822192|FG003|Overall Study|Death|4|||
161664061|NCT00402597|583822193|FG004|Overall Study|Death|6|||
161664062|NCT00402597|583822189|FG000|Overall Study|Adverse Event|81|||
161664063|NCT00402597|583822190|FG001|Overall Study|Adverse Event|18|||
161664064|NCT00402597|583822191|FG002|Overall Study|Adverse Event|106|||
161664065|NCT00402597|583822192|FG003|Overall Study|Adverse Event|39|||
161664066|NCT00402597|583822193|FG004|Overall Study|Adverse Event|71|||
161664067|NCT00402597|583822189|FG000|Overall Study|Lost to Follow-up|8|||
161664068|NCT00402597|583822190|FG001|Overall Study|Lost to Follow-up|1|||
161664069|NCT00402597|583822191|FG002|Overall Study|Lost to Follow-up|8|||
161664070|NCT00402597|583822192|FG003|Overall Study|Lost to Follow-up|2|||
161664071|NCT00402597|583822193|FG004|Overall Study|Lost to Follow-up|3|||
161664072|NCT00402597|583822189|FG000|Overall Study|Withdrawal by Subject|57|||
161664073|NCT00402597|583822190|FG001|Overall Study|Withdrawal by Subject|16|||
161664074|NCT00402597|583822191|FG002|Overall Study|Withdrawal by Subject|65|||
161664075|NCT00402597|583822192|FG003|Overall Study|Withdrawal by Subject|15|||
161664076|NCT00402597|583822193|FG004|Overall Study|Withdrawal by Subject|24|||
161664077|NCT00402597|583822189|FG000|Overall Study|reason not specified|30|||
161664078|NCT00402597|583822190|FG001|Overall Study|reason not specified|4|||
161664079|NCT00402597|583822191|FG002|Overall Study|reason not specified|27|||
161664080|NCT00402597|583822192|FG003|Overall Study|reason not specified|14|||
161664081|NCT00402597|583822193|FG004|Overall Study|reason not specified|20|||
161664082|NCT01100034|583822194|FG000|Overall Study|Lost to Follow-up|11|||
161664083|NCT01100034|583822194|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
161664084|NCT01100034|583822194|FG000|Overall Study|Withdrawal by Subject|4|||
161664085|NCT01100034|583822194|FG000|Overall Study|Sponsor decision|21|||
161664086|NCT01100034|583822194|FG000|Overall Study|Participated in another clinical trial|1|||
161664087|NCT01100034|583822194|FG000|Overall Study|Participants moved to another hospital|4|||
161664088|NCT01100034|583822194|FG000|Overall Study|Site closed due to non-responsiveness|1|||
161664089|NCT01831856|583822195|FG000|Overall Study|Adverse Event|5|||
161664090|NCT01831856|583822196|FG001|Overall Study|Adverse Event|8|||
161664091|NCT01831856|583822195|FG000|Overall Study|Lack of Efficacy|13|||
161664092|NCT01831856|583822196|FG001|Overall Study|Lack of Efficacy|11|||
161664093|NCT01831856|583822195|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
161664094|NCT01831856|583822196|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
161664095|NCT05208866|583822198|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
161664096|NCT00836095|583822201|FG000|Overall Study|Physician Decision|0|||
161664097|NCT00836095|583822202|FG001|Overall Study|Physician Decision|3|||
161664098|NCT01602562|583822203|FG000|Overall Study|Adverse Event|3|||
161664099|NCT01602562|583822204|FG001|Overall Study|Adverse Event|1|||
161664100|NCT01602562|583822203|FG000|Overall Study|Physician Decision|1|||
161664101|NCT01602562|583822204|FG001|Overall Study|Physician Decision|1|||
161664102|NCT01602562|583822203|FG000|Overall Study|Withdrawal by Subject|1|||
161664103|NCT01602562|583822204|FG001|Overall Study|Withdrawal by Subject|1|||
161664104|NCT04964414|583822206|FG000|Overall Study|Lost to Follow-up|10|||
161664105|NCT04964414|583822207|FG001|Overall Study|Lost to Follow-up|8|||
161664106|NCT04964414|583822206|FG000|Overall Study|Withdrawal by Subject|1|||
161664107|NCT04964414|583822207|FG001|Overall Study|Withdrawal by Subject|1|||
161664108|NCT03881553|583822208|FG000|Overall Study|Discharged prior to participation|1|||
161664109|NCT03881553|583822209|FG001|Overall Study|Discharged prior to participation|1|||
161664110|NCT03881553|583822210|FG002|Overall Study|Discharged prior to participation|0|||
161664111|NCT03881553|583822208|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
161664112|NCT03881553|583822209|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
161664113|NCT03881553|583822210|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
161664114|NCT00336895|583822215|FG000|Overall Study|diarrhea|1|||
161664115|NCT00336895|583822215|FG000|Overall Study|nausea and upset stomach|1|||
161664116|NCT00336895|583822215|FG000|Overall Study|Physician Decision|1|||
161664117|NCT00336895|583822215|FG000|Overall Study|screen failed|1|||
161664118|NCT01959334|583822216|FG000|Second Dose|Adverse Event|1|||
161664119|NCT01959334|583822217|FG001|Second Dose|Adverse Event|0|||
161664120|NCT01959334|583822216|FG000|Third Dose|Adverse Event|0|||
161664121|NCT01959334|583822217|FG001|Third Dose|Adverse Event|1|||
161664122|NCT01313689|583822218|FG000|24-Week Randomization 1|Adverse Event|10|||
161664123|NCT01313689|583822219|FG001|24-Week Randomization 1|Adverse Event|5|||
161664124|NCT01313689|583822220|FG002|24-Week Randomization 1|Adverse Event|0|||
161664125|NCT01313689|583822221|FG003|24-Week Randomization 1|Adverse Event|0|||
161664126|NCT01313689|583822222|FG004|24-Week Randomization 1|Adverse Event|0|||
161664127|NCT01313689|583822218|FG000|24-Week Randomization 1|Physician Decision|4|||
161664128|NCT01313689|583822219|FG001|24-Week Randomization 1|Physician Decision|5|||
161664129|NCT01313689|583822220|FG002|24-Week Randomization 1|Physician Decision|0|||
161664130|NCT01313689|583822221|FG003|24-Week Randomization 1|Physician Decision|0|||
161664131|NCT01313689|583822222|FG004|24-Week Randomization 1|Physician Decision|0|||
161664132|NCT01313689|583822218|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
161664133|NCT01313689|583822219|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
161664134|NCT01313689|583822220|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
161664135|NCT01313689|583822221|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
161664136|NCT01313689|583822222|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
161664137|NCT01313689|583822218|FG000|24-Week Randomization 2|Adverse Event|0|||
161664138|NCT01313689|583822219|FG001|24-Week Randomization 2|Adverse Event|0|||
161664139|NCT01313689|583822220|FG002|24-Week Randomization 2|Adverse Event|2|||
161664140|NCT01313689|583822221|FG003|24-Week Randomization 2|Adverse Event|0|||
161664141|NCT01313689|583822222|FG004|24-Week Randomization 2|Adverse Event|8|||
161664142|NCT01313689|583822218|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
161664143|NCT01313689|583822219|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
161664144|NCT01313689|583822220|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
161664145|NCT01313689|583822221|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
161717623|NCT02786537|584012580|FG003|As Treated|Withdrawal by Subject|0|||
161717624|NCT02786537|584012581|FG004|As Treated|Withdrawal by Subject|1|||
161717625|NCT02786537|584012582|FG005|As Treated|Withdrawal by Subject|0|||
161717626|NCT02786537|584012577|FG000|As Treated|Incarceration|0|||
161717627|NCT02786537|584012578|FG001|As Treated|Incarceration|1|||
161717628|NCT02786537|584012579|FG002|As Treated|Incarceration|0|||
161717629|NCT02786537|584012580|FG003|As Treated|Incarceration|0|||
161664146|NCT01313689|583822222|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
161717630|NCT02786537|584012581|FG004|As Treated|Incarceration|0|||
161717631|NCT02786537|584012582|FG005|As Treated|Incarceration|0|||
161717632|NCT02786537|584012577|FG000|As Treated|Opiate dependency relapse|0|||
161717633|NCT02786537|584012578|FG001|As Treated|Opiate dependency relapse|1|||
161717634|NCT02786537|584012579|FG002|As Treated|Opiate dependency relapse|0|||
161717635|NCT02786537|584012580|FG003|As Treated|Opiate dependency relapse|0|||
161717636|NCT02786537|584012581|FG004|As Treated|Opiate dependency relapse|0|||
161717637|NCT02786537|584012582|FG005|As Treated|Opiate dependency relapse|0|||
161717638|NCT02786537|584012577|FG000|As Treated|Drugs stolen from patient|0|||
161717639|NCT02786537|584012578|FG001|As Treated|Drugs stolen from patient|1|||
161717640|NCT02786537|584012579|FG002|As Treated|Drugs stolen from patient|0|||
161717641|NCT02786537|584012580|FG003|As Treated|Drugs stolen from patient|0|||
161717642|NCT02786537|584012581|FG004|As Treated|Drugs stolen from patient|0|||
161717643|NCT02786537|584012582|FG005|As Treated|Drugs stolen from patient|0|||
161717644|NCT02786537|584012577|FG000|As Treated|Advised to stop tx after loss of meds|0|||
161717645|NCT02786537|584012578|FG001|As Treated|Advised to stop tx after loss of meds|1|||
161717646|NCT02786537|584012579|FG002|As Treated|Advised to stop tx after loss of meds|0|||
161717647|NCT02786537|584012580|FG003|As Treated|Advised to stop tx after loss of meds|0|||
161717648|NCT02786537|584012581|FG004|As Treated|Advised to stop tx after loss of meds|0|||
161717649|NCT02786537|584012582|FG005|As Treated|Advised to stop tx after loss of meds|0|||
161717650|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
161717651|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
161717652|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
161717653|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
161717654|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
161717655|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
161717656|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161717657|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161664147|NCT01313689|583822218|FG000|24-Week Randomization 2|Physician Decision|0|||
161664148|NCT01313689|583822219|FG001|24-Week Randomization 2|Physician Decision|0|||
161664149|NCT01313689|583822220|FG002|24-Week Randomization 2|Physician Decision|0|||
161664150|NCT01313689|583822221|FG003|24-Week Randomization 2|Physician Decision|0|||
161717658|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
161717659|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
161664151|NCT01313689|583822222|FG004|24-Week Randomization 2|Physician Decision|4|||
161664152|NCT01768637|583822223|FG000|Overall Study|Lost to Follow-up|2|||
161717660|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
161717661|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
161717662|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
161717663|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
161717664|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
161717665|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161717666|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161717667|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161717668|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
161717669|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
161717670|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
161717671|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
161717672|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
161717673|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
161717674|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
161717675|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
161717676|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
161717677|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
161717678|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
161717679|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
161717680|NCT02584634|584012586|FG000|Overall Study|Adverse Event|3|||
161717681|NCT02584634|584012587|FG001|Overall Study|Adverse Event|5|||
161717682|NCT02584634|584012586|FG000|Overall Study|Death|0|||
161717683|NCT02584634|584012587|FG001|Overall Study|Death|1|||
161717684|NCT02584634|584012586|FG000|Overall Study|Lost to Follow-up|0|||
161717685|NCT02584634|584012587|FG001|Overall Study|Lost to Follow-up|1|||
161717686|NCT02584634|584012586|FG000|Overall Study|Physician Decision|1|||
161717687|NCT02584634|584012587|FG001|Overall Study|Physician Decision|2|||
161717688|NCT02584634|584012586|FG000|Overall Study|Progressive disease|7|||
161717689|NCT02584634|584012587|FG001|Overall Study|Progressive disease|15|||
161717690|NCT02584634|584012586|FG000|Overall Study|Withdrawal by Subject|1|||
161717691|NCT02584634|584012587|FG001|Overall Study|Withdrawal by Subject|1|||
161717692|NCT02584634|584012586|FG000|Overall Study|Other|0|||
161717693|NCT02584634|584012587|FG001|Overall Study|Other|6|||
161717694|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
161717695|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
161717696|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
161717697|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
161717698|NCT04075604|584012590|FG000|Overall Study|Adverse Event|0|||
161717699|NCT04075604|584012591|FG001|Overall Study|Adverse Event|0|||
161717700|NCT04075604|584012592|FG002|Overall Study|Adverse Event|3|||
161717701|NCT04075604|584012590|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161717702|NCT04075604|584012591|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161717703|NCT04075604|584012592|FG002|Overall Study|Participant request to discontinue study treatment|1|||
161717704|NCT04075604|584012590|FG000|Overall Study|Participant withdrew consent|0|||
161717705|NCT04075604|584012591|FG001|Overall Study|Participant withdrew consent|0|||
161717706|NCT04075604|584012592|FG002|Overall Study|Participant withdrew consent|1|||
161717707|NCT04075604|584012590|FG000|Overall Study|Other reasons|1|||
161717708|NCT04075604|584012591|FG001|Overall Study|Other reasons|0|||
161717709|NCT04075604|584012592|FG002|Overall Study|Other reasons|0|||
161717710|NCT04075604|584012590|FG000|Overall Study|Disease progression|0|||
161717711|NCT04075604|584012591|FG001|Overall Study|Disease progression|1|||
161717712|NCT04075604|584012592|FG002|Overall Study|Disease progression|0|||
161717713|NCT04075604|584012590|FG000|Overall Study|Study drug toxicity|0|||
161717714|NCT04075604|584012591|FG001|Overall Study|Study drug toxicity|5|||
161717715|NCT04075604|584012592|FG002|Overall Study|Study drug toxicity|1|||
161717716|NCT02760602|584012593|FG000|Overall Study|Withdrawal by Subject|1|||
161717717|NCT02760602|584012594|FG001|Overall Study|Withdrawal by Subject|0|||
161717718|NCT02760602|584012593|FG000|Overall Study|Terminated by sponsor|12|||
161717719|NCT02760602|584012594|FG001|Overall Study|Terminated by sponsor|13|||
161717720|NCT01335971|584012601|FG000|Overall Study|Withdrawal by Subject|1|||
161717721|NCT01335971|584012602|FG001|Overall Study|Withdrawal by Subject|0|||
161717722|NCT01335971|584012603|FG002|Overall Study|Withdrawal by Subject|0|||
161717723|NCT01335971|584012601|FG000|Overall Study|Did not complete bronchoscopy|1|||
161717724|NCT01335971|584012602|FG001|Overall Study|Did not complete bronchoscopy|1|||
161717725|NCT01335971|584012603|FG002|Overall Study|Did not complete bronchoscopy|1|||
161717726|NCT01260181|584012604|FG000|Overall Study|Decision of Investigator|1|||
161717727|NCT03351244|584012605|FG000|Overall Study|Adverse Event|7|||
161717728|NCT03351244|584012606|FG001|Overall Study|Adverse Event|11|||
161717729|NCT03351244|584012607|FG002|Overall Study|Adverse Event|12|||
161717730|NCT03351244|584012605|FG000|Overall Study|Investigator's decision|0|||
161717731|NCT03351244|584012606|FG001|Overall Study|Investigator's decision|0|||
161717732|NCT03351244|584012607|FG002|Overall Study|Investigator's decision|2|||
161717733|NCT03351244|584012605|FG000|Overall Study|System error|0|||
161717734|NCT03351244|584012606|FG001|Overall Study|System error|0|||
161717735|NCT03351244|584012607|FG002|Overall Study|System error|2|||
161717736|NCT03351244|584012605|FG000|Overall Study|COVID-19 restrictions|3|||
161717737|NCT03351244|584012606|FG001|Overall Study|COVID-19 restrictions|0|||
161717738|NCT03351244|584012607|FG002|Overall Study|COVID-19 restrictions|1|||
161717739|NCT03351244|584012605|FG000|Overall Study|Non-compliance|2|||
161717740|NCT03351244|584012606|FG001|Overall Study|Non-compliance|5|||
161717741|NCT03351244|584012607|FG002|Overall Study|Non-compliance|0|||
161717742|NCT03351244|584012605|FG000|Overall Study|Withdrawal by Subject|11|||
161717743|NCT03351244|584012606|FG001|Overall Study|Withdrawal by Subject|16|||
161717744|NCT03351244|584012607|FG002|Overall Study|Withdrawal by Subject|13|||
161717745|NCT03351244|584012605|FG000|Overall Study|Lost to Follow-up|2|||
161717746|NCT03351244|584012606|FG001|Overall Study|Lost to Follow-up|6|||
161717747|NCT03351244|584012607|FG002|Overall Study|Lost to Follow-up|4|||
161717748|NCT03351244|584012605|FG000|Overall Study|Protocol Violation|2|||
161717749|NCT03351244|584012606|FG001|Overall Study|Protocol Violation|2|||
161717750|NCT03351244|584012607|FG002|Overall Study|Protocol Violation|0|||
161717751|NCT00474253|584012610|FG000|Overall Study|Withdrew consent|2|||
161717752|NCT00474253|584012611|FG001|Overall Study|Withdrew consent|0|||
161717753|NCT00474253|584012610|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
161717754|NCT00474253|584012611|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
161717755|NCT00474253|584012610|FG000|Overall Study|Lost to Follow-up|1|||
161717756|NCT00474253|584012611|FG001|Overall Study|Lost to Follow-up|0|||
161717757|NCT00474253|584012610|FG000|Overall Study|Discharged prior to study completion|0|||
161717758|NCT00474253|584012611|FG001|Overall Study|Discharged prior to study completion|1|||
161717759|NCT01165229|584012612|FG000|Overall Study|Serious Adverse Event|456|||
161717760|NCT01165229|584012613|FG001|Overall Study|Serious Adverse Event|487|||
161717761|NCT01165229|584012612|FG000|Overall Study|Non-Serious Adverse Event|47|||
161717762|NCT01165229|584012613|FG001|Overall Study|Non-Serious Adverse Event|15|||
161717763|NCT01165229|584012612|FG000|Overall Study|Protocol Violation|6|||
161717764|NCT01165229|584012613|FG001|Overall Study|Protocol Violation|8|||
161717765|NCT01165229|584012612|FG000|Overall Study|Withdrawal by Subject|387|||
161717766|NCT01165229|584012613|FG001|Overall Study|Withdrawal by Subject|396|||
161717767|NCT01165229|584012612|FG000|Overall Study|Migrated/moved from study area|51|||
161717768|NCT01165229|584012613|FG001|Overall Study|Migrated/moved from study area|46|||
161717769|NCT01165229|584012612|FG000|Overall Study|Lost to Follow-up|123|||
161717770|NCT01165229|584012613|FG001|Overall Study|Lost to Follow-up|133|||
161717771|NCT01165229|584012612|FG000|Overall Study|Suspected HZ Episode|2|||
161717772|NCT01165229|584012613|FG001|Overall Study|Suspected HZ Episode|2|||
161717773|NCT01165229|584012612|FG000|Overall Study|No reason from the subject|108|||
161717774|NCT01165229|584012613|FG001|Overall Study|No reason from the subject|102|||
161717775|NCT01165229|584012612|FG000|Overall Study|Unknown completion status|0|||
161717776|NCT01165229|584012613|FG001|Overall Study|Unknown completion status|1|||
161717777|NCT01357239|584012614|FG000|Stratum: All Patients|Adverse Event|0|||
161717778|NCT01357239|584012615|FG001|Stratum: All Patients|Adverse Event|0|||
161717779|NCT01357239|584012616|FG002|Stratum: All Patients|Adverse Event|1|||
161717780|NCT01357239|584012617|FG003|Stratum: All Patients|Adverse Event|1|||
161717781|NCT01357239|584012614|FG000|Stratum: All Patients|Subject withdrew consent|0|||
161664153|NCT01768637|583822224|FG001|Overall Study|Lost to Follow-up|7|||
161664154|NCT01768637|583822223|FG000|Overall Study|Difficult blood draw|1|||
161664155|NCT01768637|583822224|FG001|Overall Study|Difficult blood draw|0|||
161664156|NCT01054170|583822225|FG000|Overall Study|Protocol Violation|1|||
161664157|NCT01054170|583822226|FG001|Overall Study|Protocol Violation|0|||
161664158|NCT01054170|583822225|FG000|Overall Study|Withdrawal by Subject|3|||
161664159|NCT01054170|583822226|FG001|Overall Study|Withdrawal by Subject|2|||
161664160|NCT01054170|583822225|FG000|Overall Study|Adverse Event|0|||
161664161|NCT01054170|583822226|FG001|Overall Study|Adverse Event|4|||
161664162|NCT02951767|583822227|FG000|Overall Study|Study Terminated By Sponsor|9|||
161664163|NCT02951767|583822227|FG000|Overall Study|Withdrawal by Subject|11|||
161664164|NCT02951767|583822227|FG000|Overall Study|Death|96|||
161664165|NCT02951767|583822227|FG000|Overall Study|Lost to Follow-up|2|||
161664166|NCT02951767|583822227|FG000|Overall Study|Physician Decision|1|||
161664167|NCT01337115|583822228|FG000|Overall Study|Protocol Violation|2|||
161664168|NCT01337115|583822229|FG001|Overall Study|Protocol Violation|0|||
161664169|NCT03426267|583822237|FG000|Overall Study|Physician Decision|1|||
161664170|NCT03426267|583822238|FG001|Overall Study|Physician Decision|4|||
161664171|NCT03426267|583822237|FG000|Overall Study|Lost to Follow-up|1|||
161664172|NCT03426267|583822238|FG001|Overall Study|Lost to Follow-up|0|||
161664173|NCT03426267|583822237|FG000|Overall Study|Withdrawal by Subject|4|||
161664174|NCT03426267|583822238|FG001|Overall Study|Withdrawal by Subject|10|||
161664175|NCT03426267|583822237|FG000|Overall Study|Protocol Violation|1|||
161664176|NCT03426267|583822238|FG001|Overall Study|Protocol Violation|3|||
161664177|NCT03426267|583822237|FG000|Overall Study|Adverse Event|9|||
161664178|NCT03426267|583822238|FG001|Overall Study|Adverse Event|27|||
161664179|NCT03426267|583822237|FG000|Overall Study|Prohibited Treatment Intake|2|||
161664180|NCT03426267|583822238|FG001|Overall Study|Prohibited Treatment Intake|3|||
161664181|NCT03426267|583822237|FG000|Overall Study|Lack of Efficacy|0|||
161664182|NCT03426267|583822238|FG001|Overall Study|Lack of Efficacy|25|||
161664183|NCT03426267|583822237|FG000|Overall Study|other|3|||
161664184|NCT03426267|583822238|FG001|Overall Study|other|0|||
161664185|NCT00609765|583822243|FG000|Overall Study|Study ended prior to 12 months|1|||
161664186|NCT02054520|583822250|FG000|Overall Study|Adverse Event|1|||
161664187|NCT02054520|583822251|FG001|Overall Study|Adverse Event|4|||
161838051|NCT00136318|584450317|FG001|Overall Study|Adverse Event|5|||
161664188|NCT02054520|583822252|FG002|Overall Study|Adverse Event|2|||
161664189|NCT02054520|583822253|FG003|Overall Study|Adverse Event|1|||
161664190|NCT02054520|583822254|FG004|Overall Study|Adverse Event|1|||
161664191|NCT02054520|583822255|FG005|Overall Study|Adverse Event|0|||
161664192|NCT02054520|583822250|FG000|Overall Study|Lack of Efficacy|7|||
161717782|NCT01357239|584012615|FG001|Stratum: All Patients|Subject withdrew consent|0|||
161717783|NCT01357239|584012616|FG002|Stratum: All Patients|Subject withdrew consent|1|||
161717784|NCT01357239|584012617|FG003|Stratum: All Patients|Subject withdrew consent|1|||
161717785|NCT01357239|584012614|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
161717786|NCT01357239|584012615|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
161717787|NCT01357239|584012616|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
161717788|NCT01357239|584012617|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
161717789|NCT01357239|584012614|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
161717790|NCT01357239|584012615|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
161717791|NCT01357239|584012616|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
161717792|NCT01357239|584012617|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
161717793|NCT01357239|584012614|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
161717794|NCT01357239|584012615|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
161717795|NCT01357239|584012616|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
161717796|NCT01357239|584012617|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
161717797|NCT03133481|584012620|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
161717798|NCT03133481|584012621|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
161717799|NCT00637728|584012625|FG000|Double-blind Phase|Adverse Event|1|||
161717800|NCT00637728|584012626|FG001|Double-blind Phase|Adverse Event|0|||
161717801|NCT00637728|584012627|FG002|Double-blind Phase|Adverse Event|0|||
161717802|NCT00637728|584012625|FG000|Double-blind Phase|Non-compliance|2|||
161717803|NCT00637728|584012626|FG001|Double-blind Phase|Non-compliance|0|||
161717804|NCT00637728|584012627|FG002|Double-blind Phase|Non-compliance|0|||
161717805|NCT00637728|584012625|FG000|Double-blind Phase|Study Discontinued|1|||
161717806|NCT00637728|584012626|FG001|Double-blind Phase|Study Discontinued|1|||
161717807|NCT00637728|584012627|FG002|Double-blind Phase|Study Discontinued|0|||
161717808|NCT01873950|584012630|FG000|Period 5|Withdrawal by Subject|0|||
161717809|NCT01873950|584012631|FG001|Period 5|Withdrawal by Subject|0|||
161717810|NCT01873950|584012632|FG002|Period 5|Withdrawal by Subject|0|||
161717811|NCT01873950|584012633|FG003|Period 5|Withdrawal by Subject|1|||
161664193|NCT02054520|583822251|FG001|Overall Study|Lack of Efficacy|0|||
161664194|NCT02054520|583822252|FG002|Overall Study|Lack of Efficacy|2|||
161664195|NCT02054520|583822253|FG003|Overall Study|Lack of Efficacy|1|||
161664196|NCT02054520|583822254|FG004|Overall Study|Lack of Efficacy|3|||
161664197|NCT02054520|583822255|FG005|Overall Study|Lack of Efficacy|2|||
161664198|NCT02054520|583822250|FG000|Overall Study|Withdrawal by Subject|1|||
161664199|NCT02054520|583822251|FG001|Overall Study|Withdrawal by Subject|0|||
161664200|NCT02054520|583822252|FG002|Overall Study|Withdrawal by Subject|0|||
161664201|NCT02054520|583822253|FG003|Overall Study|Withdrawal by Subject|2|||
161664202|NCT02054520|583822254|FG004|Overall Study|Withdrawal by Subject|1|||
161664203|NCT02054520|583822255|FG005|Overall Study|Withdrawal by Subject|0|||
161664204|NCT02054520|583822250|FG000|Overall Study|Physician Decision|0|||
161664205|NCT02054520|583822251|FG001|Overall Study|Physician Decision|1|||
161664206|NCT02054520|583822252|FG002|Overall Study|Physician Decision|0|||
161664207|NCT02054520|583822253|FG003|Overall Study|Physician Decision|1|||
161664208|NCT02054520|583822254|FG004|Overall Study|Physician Decision|0|||
161664209|NCT02054520|583822255|FG005|Overall Study|Physician Decision|1|||
161664210|NCT02054520|583822250|FG000|Overall Study|Study terminated by Sponsor|0|||
161664211|NCT02054520|583822251|FG001|Overall Study|Study terminated by Sponsor|0|||
161664212|NCT02054520|583822252|FG002|Overall Study|Study terminated by Sponsor|2|||
161664213|NCT02054520|583822253|FG003|Overall Study|Study terminated by Sponsor|1|||
161664214|NCT02054520|583822254|FG004|Overall Study|Study terminated by Sponsor|0|||
161664215|NCT02054520|583822255|FG005|Overall Study|Study terminated by Sponsor|0|||
161664216|NCT01272804|583822258|FG000|Overall Study|Adverse Event|1|||
161664217|NCT01272804|583822259|FG001|Overall Study|Adverse Event|0|||
161664218|NCT01272804|583822260|FG002|Overall Study|Adverse Event|0|||
161664219|NCT01272804|583822261|FG003|Overall Study|Adverse Event|0|||
161664220|NCT01272804|583822262|FG004|Overall Study|Adverse Event|2|||
161664221|NCT01272804|583822263|FG005|Overall Study|Adverse Event|1|||
161664222|NCT03801915|583822264|FG000|Overall Study|Screen failure|0|||
161664223|NCT03801915|583822265|FG001|Overall Study|Screen failure|0|||
161664224|NCT03801915|583822266|FG002|Overall Study|Screen failure|1|||
161664225|NCT03801915|583822264|FG000|Overall Study|Ineligible|1|||
161664226|NCT03801915|583822265|FG001|Overall Study|Ineligible|0|||
161664227|NCT03801915|583822266|FG002|Overall Study|Ineligible|0|||
161664228|NCT03801915|583822264|FG000|Overall Study|Physician Decision|2|||
161664229|NCT03801915|583822265|FG001|Overall Study|Physician Decision|1|||
161664230|NCT03801915|583822266|FG002|Overall Study|Physician Decision|0|||
161664231|NCT02308020|583822267|FG000|Overall Study|Lost to Follow-up|1|||
161664232|NCT02308020|583822268|FG001|Overall Study|Lost to Follow-up|7|||
161664233|NCT02308020|583822269|FG002|Overall Study|Lost to Follow-up|0|||
161664234|NCT02308020|583822270|FG003|Overall Study|Lost to Follow-up|0|||
161664235|NCT02308020|583822271|FG004|Overall Study|Lost to Follow-up|1|||
161664236|NCT02308020|583822272|FG005|Overall Study|Lost to Follow-up|2|||
161664237|NCT02308020|583822267|FG000|Overall Study|Sponsor Decision|0|||
161664238|NCT02308020|583822268|FG001|Overall Study|Sponsor Decision|8|||
161664239|NCT02308020|583822269|FG002|Overall Study|Sponsor Decision|0|||
161664240|NCT02308020|583822270|FG003|Overall Study|Sponsor Decision|2|||
161664241|NCT02308020|583822271|FG004|Overall Study|Sponsor Decision|2|||
161664242|NCT02308020|583822272|FG005|Overall Study|Sponsor Decision|1|||
161664243|NCT02308020|583822267|FG000|Overall Study|Withdrawal by Subject|3|||
161664244|NCT02308020|583822268|FG001|Overall Study|Withdrawal by Subject|5|||
161664245|NCT02308020|583822269|FG002|Overall Study|Withdrawal by Subject|3|||
161664246|NCT02308020|583822270|FG003|Overall Study|Withdrawal by Subject|2|||
161664247|NCT02308020|583822271|FG004|Overall Study|Withdrawal by Subject|1|||
161664248|NCT02308020|583822272|FG005|Overall Study|Withdrawal by Subject|2|||
161664249|NCT03265938|583822273|FG000|Overall Study|Withdrawal by Subject|1|||
161664250|NCT03265938|583822273|FG000|Overall Study|Physician Decision|1|||
161664251|NCT03265938|583822273|FG000|Overall Study|friable mass|6|||
161664252|NCT00705523|583822274|FG000|Overall Study|Lost to Follow-up|2|||
161664253|NCT00705523|583822275|FG001|Overall Study|Lost to Follow-up|3|||
161664254|NCT02471833|583822276|FG000|Overall Study|Lost to Follow-up|1|||
161664255|NCT02471833|583822277|FG001|Overall Study|Lost to Follow-up|0|||
161664256|NCT02471833|583822278|FG002|Overall Study|Lost to Follow-up|0|||
161664257|NCT02471833|583822276|FG000|Overall Study|Withdrawal by Subject|2|||
161664258|NCT02471833|583822277|FG001|Overall Study|Withdrawal by Subject|1|||
161664259|NCT02471833|583822278|FG002|Overall Study|Withdrawal by Subject|5|||
161664260|NCT02673515|583822279|FG000|Overall Study|Lack of motivation|2|||
161664261|NCT02673515|583822280|FG001|Overall Study|Lack of motivation|1|||
161717812|NCT01873950|584012634|FG004|Period 5|Withdrawal by Subject|0|||
161717813|NCT05372315|584012636|FG000|Overall Study|Withdrawal by Subject|1|||
161717814|NCT05372315|584012637|FG001|Overall Study|Withdrawal by Subject|0|||
161717815|NCT01512368|584012639|FG000|Overall Study|Protocol Violation|3|||
161717816|NCT00328198|584012640|FG000|Treatment|Adverse Event|21|||
161717817|NCT00328198|584012640|FG000|Treatment|Death|1|||
161717818|NCT00328198|584012640|FG000|Treatment|Physician Decision|5|||
161717819|NCT00328198|584012640|FG000|Treatment|Withdrawal by Subject|5|||
161717820|NCT00328198|584012640|FG000|Treatment|Evidence of disease progression|2|||
161717821|NCT00328198|584012640|FG000|Treatment|Non-compliance|1|||
161717822|NCT00328198|584012640|FG000|Treatment|Confirmed complete response, MRD -|3|||
161717823|NCT00328198|584012640|FG000|Follow-up|Lost to Follow-up|4|||
161717824|NCT00328198|584012640|FG000|Follow-up|Death|31|||
161717825|NCT01570491|584012641|FG000|Overall Study|Lost to Follow-up|3|||
161717826|NCT01570491|584012642|FG001|Overall Study|Lost to Follow-up|1|||
161717827|NCT01570491|584012641|FG000|Overall Study|treatment: not given or discontinued|2|||
161717828|NCT01570491|584012642|FG001|Overall Study|treatment: not given or discontinued|0|||
161717829|NCT02532543|584012647|FG000|Overall Study|Lost to Follow-up|0|||
161717830|NCT02532543|584012648|FG001|Overall Study|Lost to Follow-up|0|||
161717831|NCT02532543|584012649|FG002|Overall Study|Lost to Follow-up|1|||
161717832|NCT02532543|584012650|FG003|Overall Study|Lost to Follow-up|0|||
161717833|NCT00650585|584012651|FG000|Overall Study|Lost to Follow-up|505|||
161717834|NCT00650585|584012652|FG001|Overall Study|Lost to Follow-up|482|||
161717835|NCT00650585|584012651|FG000|Overall Study|No parental consent|935|||
161717836|NCT00650585|584012652|FG001|Overall Study|No parental consent|866|||
161717837|NCT00650585|584012651|FG000|Overall Study|Excluded/ruled ineligible|357|||
161717838|NCT00650585|584012652|FG001|Overall Study|Excluded/ruled ineligible|129|||
161717839|NCT02640612|584012653|FG000|Overall Study|Adverse Event|6|||
161717840|NCT02640612|584012654|FG001|Overall Study|Adverse Event|7|||
161717841|NCT02640612|584012655|FG002|Overall Study|Adverse Event|2|||
161717842|NCT02640612|584012653|FG000|Overall Study|Death|1|||
161717843|NCT02640612|584012654|FG001|Overall Study|Death|0|||
161717844|NCT02640612|584012655|FG002|Overall Study|Death|0|||
161717845|NCT02640612|584012653|FG000|Overall Study|Withdrawal by Subject|10|||
161717846|NCT02640612|584012654|FG001|Overall Study|Withdrawal by Subject|3|||
161717847|NCT02640612|584012655|FG002|Overall Study|Withdrawal by Subject|3|||
161717848|NCT02640612|584012653|FG000|Overall Study|Lost to Follow-up|4|||
161717849|NCT02640612|584012654|FG001|Overall Study|Lost to Follow-up|1|||
161717850|NCT02640612|584012655|FG002|Overall Study|Lost to Follow-up|1|||
161717851|NCT02640612|584012653|FG000|Overall Study|Protocol Violation|0|||
161717852|NCT02640612|584012654|FG001|Overall Study|Protocol Violation|2|||
161717853|NCT02640612|584012655|FG002|Overall Study|Protocol Violation|0|||
161717854|NCT02640612|584012653|FG000|Overall Study|Lack of Efficacy|1|||
161717855|NCT02640612|584012654|FG001|Overall Study|Lack of Efficacy|1|||
161717856|NCT02640612|584012655|FG002|Overall Study|Lack of Efficacy|0|||
161717857|NCT01720667|584012658|FG000|Overall Study|Adverse Event|1|||
161717858|NCT01720667|584012659|FG001|Overall Study|Adverse Event|1|||
161717859|NCT01720667|584012658|FG000|Overall Study|Withdrawal by Subject|3|||
161717860|NCT01720667|584012659|FG001|Overall Study|Withdrawal by Subject|0|||
161717861|NCT04407507|584012660|FG000|Overall Study|Withdrawal by Subject|0|||
161717862|NCT04407507|584012661|FG001|Overall Study|Withdrawal by Subject|1|||
161717863|NCT03472534|584012663|FG000|Overall Study|Withdrawal by Subject|9|||
161717864|NCT03472534|584012663|FG000|Overall Study|Adverse Event|2|||
161717865|NCT02614794|584012664|FG000|Overall Study|Death|258|||
161717866|NCT02614794|584012665|FG001|Overall Study|Death|151|||
161717867|NCT02614794|584012664|FG000|Overall Study|Study closure by Sponsor|119|||
161717868|NCT02614794|584012665|FG001|Overall Study|Study closure by Sponsor|45|||
161664262|NCT01946438|583822281|FG000|Overall Study|Adverse Event|0|||
161664263|NCT01946438|583822282|FG001|Overall Study|Adverse Event|0|||
161664264|NCT01946438|583822283|FG002|Overall Study|Adverse Event|0|||
161664265|NCT01946438|583822284|FG003|Overall Study|Adverse Event|1|||
161664266|NCT01946438|583822281|FG000|Overall Study|Serious Adverse event|1|||
161664267|NCT01946438|583822282|FG001|Overall Study|Serious Adverse event|0|||
161664268|NCT01946438|583822283|FG002|Overall Study|Serious Adverse event|0|||
161717869|NCT02614794|584012664|FG000|Overall Study|Withdrawal by Subject|24|||
161717870|NCT02614794|584012665|FG001|Overall Study|Withdrawal by Subject|5|||
161717871|NCT02614794|584012664|FG000|Overall Study|Lost to Follow-up|7|||
161717872|NCT02614794|584012665|FG001|Overall Study|Lost to Follow-up|0|||
161717873|NCT02614794|584012664|FG000|Overall Study|Physician Decision|1|||
161717874|NCT02614794|584012665|FG001|Overall Study|Physician Decision|1|||
161717875|NCT02614794|584012664|FG000|Overall Study|Hospital closure|1|||
161664269|NCT01946438|583822284|FG003|Overall Study|Serious Adverse event|0|||
161664270|NCT01946438|583822281|FG000|Overall Study|Protocol Violation|0|||
161717876|NCT02614794|584012665|FG001|Overall Study|Hospital closure|0|||
161717877|NCT01499576|584012667|FG000|Overall Study|Physician Decision|12|||
161717878|NCT01499576|584012667|FG000|Overall Study|Withdrawal by Subject|9|||
161717879|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
161717880|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
161664271|NCT01946438|583822282|FG001|Overall Study|Protocol Violation|0|||
161717881|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
161717882|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Death|2|||
161717883|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
161717884|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Death|9|||
161717885|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
161717886|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
161717887|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|study terminated|1|||
161717888|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
161717889|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
161717890|NCT01319929|584012676|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
161717891|NCT01319929|584012677|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
161717892|NCT01319929|584012676|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
161717893|NCT01319929|584012677|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
161717894|NCT01319929|584012676|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
161717895|NCT01319929|584012677|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
161717896|NCT01319929|584012676|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
161717897|NCT01319929|584012677|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
161717898|NCT01319929|584012676|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
161717899|NCT01319929|584012677|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
161717900|NCT03237845|584012678|FG000|Overall Study|Adverse Event|0|||
161717901|NCT03237845|584012679|FG001|Overall Study|Adverse Event|1|||
161717902|NCT03237845|584012678|FG000|Overall Study|Lost to Follow-up|13|||
161717903|NCT03237845|584012679|FG001|Overall Study|Lost to Follow-up|10|||
161717904|NCT03237845|584012678|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
161717905|NCT03237845|584012679|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
161717906|NCT03237845|584012678|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
161717907|NCT03237845|584012679|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
161717908|NCT03237845|584012678|FG000|Overall Study|Physician Decision|1|||
161717909|NCT03237845|584012679|FG001|Overall Study|Physician Decision|2|||
161717910|NCT03237845|584012678|FG000|Overall Study|Pregnancy|1|||
161717911|NCT03237845|584012679|FG001|Overall Study|Pregnancy|0|||
161717912|NCT03237845|584012678|FG000|Overall Study|Protocol Deviation|0|||
161717913|NCT03237845|584012679|FG001|Overall Study|Protocol Deviation|1|||
161717914|NCT03237845|584012678|FG000|Overall Study|Technical Problems|8|||
161717915|NCT03237845|584012679|FG001|Overall Study|Technical Problems|1|||
161717916|NCT03237845|584012678|FG000|Overall Study|Withdrawal by Subject|3|||
161717917|NCT03237845|584012679|FG001|Overall Study|Withdrawal by Subject|3|||
161717918|NCT03237845|584012678|FG000|Overall Study|Other Reasons|4|||
161717919|NCT03237845|584012679|FG001|Overall Study|Other Reasons|0|||
161717920|NCT01221233|584012680|FG000|Overall Study|Withdrawal by Subject|3|||
161717921|NCT01221233|584012681|FG001|Overall Study|Withdrawal by Subject|1|||
161717922|NCT03865407|584012683|FG000|Overall Study|Adverse Event|1|||
161717923|NCT03865407|584012684|FG001|Overall Study|Adverse Event|0|||
161717924|NCT03865407|584012683|FG000|Overall Study|Withdrawal by Subject|1|||
161717925|NCT03865407|584012684|FG001|Overall Study|Withdrawal by Subject|0|||
161717926|NCT03865407|584012683|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
161717927|NCT03865407|584012684|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
161717928|NCT01645280|584012685|FG000|Overall Study|Death|0|||
161717929|NCT01645280|584012686|FG001|Overall Study|Death|1|||
161717930|NCT01645280|584012687|FG002|Overall Study|Death|0|||
161717931|NCT01645280|584012688|FG003|Overall Study|Death|0|||
161717932|NCT01645280|584012689|FG004|Overall Study|Death|0|||
161717933|NCT01645280|584012685|FG000|Overall Study|Withdrawal by Subject|4|||
161717934|NCT01645280|584012686|FG001|Overall Study|Withdrawal by Subject|0|||
161717935|NCT01645280|584012687|FG002|Overall Study|Withdrawal by Subject|2|||
161717936|NCT01645280|584012688|FG003|Overall Study|Withdrawal by Subject|4|||
161717937|NCT01645280|584012689|FG004|Overall Study|Withdrawal by Subject|5|||
161717938|NCT01645280|584012685|FG000|Overall Study|Lost to Follow-up|0|||
161717939|NCT01645280|584012686|FG001|Overall Study|Lost to Follow-up|0|||
161717940|NCT01645280|584012687|FG002|Overall Study|Lost to Follow-up|0|||
161717941|NCT01645280|584012688|FG003|Overall Study|Lost to Follow-up|2|||
161717942|NCT01645280|584012689|FG004|Overall Study|Lost to Follow-up|1|||
161717943|NCT01645280|584012685|FG000|Overall Study|Other|1|||
161717944|NCT01645280|584012686|FG001|Overall Study|Other|1|||
161717945|NCT01645280|584012687|FG002|Overall Study|Other|2|||
161717946|NCT01645280|584012688|FG003|Overall Study|Other|0|||
161717947|NCT01645280|584012689|FG004|Overall Study|Other|0|||
161717948|NCT01645280|584012685|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
161717949|NCT01645280|584012686|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
161717950|NCT01645280|584012687|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
161717951|NCT01645280|584012688|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
161717952|NCT01645280|584012689|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
161717953|NCT00234104|584012694|FG000|Overall Study|Adverse Event|4|||
161717954|NCT00234104|584012695|FG001|Overall Study|Adverse Event|0|||
161717955|NCT00234104|584012696|FG002|Overall Study|Adverse Event|3|||
161717956|NCT00234104|584012697|FG003|Overall Study|Adverse Event|5|||
161717957|NCT00234104|584012694|FG000|Overall Study|Protocol Violation|0|||
161717958|NCT00234104|584012695|FG001|Overall Study|Protocol Violation|0|||
161717959|NCT00234104|584012696|FG002|Overall Study|Protocol Violation|0|||
161717960|NCT00234104|584012697|FG003|Overall Study|Protocol Violation|1|||
161717961|NCT00234104|584012694|FG000|Overall Study|Physician Decision|0|||
161717962|NCT00234104|584012695|FG001|Overall Study|Physician Decision|1|||
161717963|NCT00234104|584012696|FG002|Overall Study|Physician Decision|2|||
161717964|NCT00234104|584012697|FG003|Overall Study|Physician Decision|2|||
161717965|NCT00546819|584012698|FG000|Overall Study|Adverse Event|2|||
161717966|NCT00546819|584012699|FG001|Overall Study|Adverse Event|3|||
161717967|NCT00546819|584012698|FG000|Overall Study|Lost to Follow-up|2|||
161717968|NCT00546819|584012699|FG001|Overall Study|Lost to Follow-up|1|||
161717969|NCT00546819|584012698|FG000|Overall Study|Withdrawal by Subject|4|||
161717970|NCT00546819|584012699|FG001|Overall Study|Withdrawal by Subject|2|||
161717971|NCT02052960|584012701|FG000|Overall Study|Adverse Event|19|||
161717972|NCT02052960|584012702|FG001|Overall Study|Adverse Event|17|||
161717973|NCT02052960|584012701|FG000|Overall Study|Protocol Violation|4|||
161717974|NCT02052960|584012702|FG001|Overall Study|Protocol Violation|3|||
161717975|NCT02052960|584012701|FG000|Overall Study|Withdrawal by Subject|6|||
161717976|NCT02052960|584012702|FG001|Overall Study|Withdrawal by Subject|11|||
161717977|NCT02052960|584012701|FG000|Overall Study|Other|25|||
161717978|NCT02052960|584012702|FG001|Overall Study|Other|15|||
161717979|NCT03849560|584012703|FG000|Overall Study|Withdrawal by Subject|1|||
161717980|NCT03849560|584012704|FG001|Overall Study|Withdrawal by Subject|0|||
161717981|NCT03849560|584012705|FG002|Overall Study|Withdrawal by Subject|0|||
161717982|NCT04045613|584012706|FG000|Overall Study|Adverse Event|2|||
161717983|NCT04045613|584012707|FG001|Overall Study|Adverse Event|2|||
161717984|NCT04045613|584012708|FG002|Overall Study|Adverse Event|1|||
161717985|NCT04045613|584012709|FG003|Overall Study|Adverse Event|1|||
161717986|NCT04045613|584012710|FG004|Overall Study|Adverse Event|0|||
161717987|NCT04045613|584012711|FG005|Overall Study|Adverse Event|0|||
161717988|NCT04045613|584012712|FG006|Overall Study|Adverse Event|1|||
161717989|NCT04045613|584012706|FG000|Overall Study|Withdrawal by Subject|0|||
161717990|NCT04045613|584012707|FG001|Overall Study|Withdrawal by Subject|5|||
161717991|NCT04045613|584012708|FG002|Overall Study|Withdrawal by Subject|0|||
161717992|NCT04045613|584012709|FG003|Overall Study|Withdrawal by Subject|0|||
161717993|NCT04045613|584012710|FG004|Overall Study|Withdrawal by Subject|0|||
161717994|NCT04045613|584012711|FG005|Overall Study|Withdrawal by Subject|1|||
161717995|NCT04045613|584012712|FG006|Overall Study|Withdrawal by Subject|0|||
161717996|NCT04045613|584012706|FG000|Overall Study|Physician Decision|2|||
161717997|NCT04045613|584012707|FG001|Overall Study|Physician Decision|0|||
161717998|NCT04045613|584012708|FG002|Overall Study|Physician Decision|0|||
161717999|NCT04045613|584012709|FG003|Overall Study|Physician Decision|0|||
161718000|NCT04045613|584012710|FG004|Overall Study|Physician Decision|1|||
161718001|NCT04045613|584012711|FG005|Overall Study|Physician Decision|0|||
161718002|NCT04045613|584012712|FG006|Overall Study|Physician Decision|0|||
161718003|NCT04045613|584012706|FG000|Overall Study|Death|3|||
161718004|NCT04045613|584012707|FG001|Overall Study|Death|0|||
161718005|NCT04045613|584012708|FG002|Overall Study|Death|0|||
161718006|NCT04045613|584012709|FG003|Overall Study|Death|0|||
161718007|NCT04045613|584012710|FG004|Overall Study|Death|0|||
161718008|NCT04045613|584012711|FG005|Overall Study|Death|0|||
161718009|NCT04045613|584012712|FG006|Overall Study|Death|1|||
161718010|NCT04045613|584012706|FG000|Overall Study|Other reasons|0|||
161718011|NCT04045613|584012707|FG001|Overall Study|Other reasons|1|||
161718012|NCT04045613|584012708|FG002|Overall Study|Other reasons|0|||
161718013|NCT04045613|584012709|FG003|Overall Study|Other reasons|0|||
161718014|NCT04045613|584012710|FG004|Overall Study|Other reasons|0|||
161718015|NCT04045613|584012711|FG005|Overall Study|Other reasons|0|||
161718016|NCT04045613|584012712|FG006|Overall Study|Other reasons|1|||
161718017|NCT04045613|584012706|FG000|Overall Study|Progressive disease: Clinical progression|1|||
161718018|NCT04045613|584012707|FG001|Overall Study|Progressive disease: Clinical progression|0|||
161718019|NCT04045613|584012708|FG002|Overall Study|Progressive disease: Clinical progression|3|||
161718020|NCT04045613|584012709|FG003|Overall Study|Progressive disease: Clinical progression|1|||
161718021|NCT04045613|584012710|FG004|Overall Study|Progressive disease: Clinical progression|1|||
161718022|NCT04045613|584012711|FG005|Overall Study|Progressive disease: Clinical progression|3|||
161718023|NCT04045613|584012712|FG006|Overall Study|Progressive disease: Clinical progression|3|||
161718024|NCT04045613|584012706|FG000|Overall Study|Progressive disease: Radiological progression|24|||
161718025|NCT04045613|584012707|FG001|Overall Study|Progressive disease: Radiological progression|6|||
161718026|NCT04045613|584012708|FG002|Overall Study|Progressive disease: Radiological progression|8|||
161718027|NCT04045613|584012709|FG003|Overall Study|Progressive disease: Radiological progression|0|||
161718028|NCT04045613|584012710|FG004|Overall Study|Progressive disease: Radiological progression|6|||
161718029|NCT04045613|584012711|FG005|Overall Study|Progressive disease: Radiological progression|6|||
161718030|NCT04045613|584012712|FG006|Overall Study|Progressive disease: Radiological progression|11|||
161718031|NCT01254344|584012722|FG000|Overall Study|Adverse Event|2|||
161718032|NCT01254344|584012723|FG001|Overall Study|Adverse Event|5|||
161718033|NCT01254344|584012722|FG000|Overall Study|Physician Decision|7|||
161718034|NCT01254344|584012723|FG001|Overall Study|Physician Decision|4|||
161718035|NCT01254344|584012722|FG000|Overall Study|Protocol Violation|1|||
161718036|NCT01254344|584012723|FG001|Overall Study|Protocol Violation|4|||
161718037|NCT01254344|584012722|FG000|Overall Study|Withdrawal by Subject|3|||
161718038|NCT01254344|584012723|FG001|Overall Study|Withdrawal by Subject|6|||
161718039|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
161664272|NCT01946438|583822283|FG002|Overall Study|Protocol Violation|1|||
161664273|NCT01946438|583822284|FG003|Overall Study|Protocol Violation|0|||
161664274|NCT01946438|583822281|FG000|Overall Study|Withdrawal by Subject|1|||
161664275|NCT01946438|583822282|FG001|Overall Study|Withdrawal by Subject|0|||
161664276|NCT01946438|583822283|FG002|Overall Study|Withdrawal by Subject|0|||
161664277|NCT01946438|583822284|FG003|Overall Study|Withdrawal by Subject|0|||
161664278|NCT02412371|583822287|FG000|Overall Study|Withdrawal by Subject|0|||
161664279|NCT02412371|583822288|FG001|Overall Study|Withdrawal by Subject|2|||
161664280|NCT02412371|583822289|FG002|Overall Study|Withdrawal by Subject|0|||
161664281|NCT02412371|583822290|FG003|Overall Study|Withdrawal by Subject|1|||
161664282|NCT02412371|583822291|FG004|Overall Study|Withdrawal by Subject|1|||
161664283|NCT02412371|583822292|FG005|Overall Study|Withdrawal by Subject|0|||
161664284|NCT02412371|583822287|FG000|Overall Study|Sponsor Discontinued Study|1|||
161664285|NCT02412371|583822288|FG001|Overall Study|Sponsor Discontinued Study|4|||
161664286|NCT02412371|583822289|FG002|Overall Study|Sponsor Discontinued Study|6|||
161664287|NCT02412371|583822290|FG003|Overall Study|Sponsor Discontinued Study|4|||
161664288|NCT02412371|583822291|FG004|Overall Study|Sponsor Discontinued Study|5|||
161664289|NCT02412371|583822292|FG005|Overall Study|Sponsor Discontinued Study|0|||
161664290|NCT02412371|583822287|FG000|Overall Study|Death|4|||
161664291|NCT02412371|583822288|FG001|Overall Study|Death|2|||
161664292|NCT02412371|583822289|FG002|Overall Study|Death|1|||
161664293|NCT02412371|583822290|FG003|Overall Study|Death|3|||
161664294|NCT02412371|583822291|FG004|Overall Study|Death|5|||
161664295|NCT02412371|583822292|FG005|Overall Study|Death|2|||
161664296|NCT02412371|583822287|FG000|Overall Study|Other|2|||
161664297|NCT02412371|583822288|FG001|Overall Study|Other|1|||
161664298|NCT02412371|583822289|FG002|Overall Study|Other|0|||
161664299|NCT02412371|583822290|FG003|Overall Study|Other|0|||
161664300|NCT02412371|583822291|FG004|Overall Study|Other|1|||
161664301|NCT02412371|583822292|FG005|Overall Study|Other|3|||
161664302|NCT02523599|583822293|FG000|Overall Study|Adverse Event|1|||
161664303|NCT02523599|583822294|FG001|Overall Study|Adverse Event|0|||
161664304|NCT02523599|583822293|FG000|Overall Study|Physician Decision|1|||
161664305|NCT02523599|583822294|FG001|Overall Study|Physician Decision|0|||
161664306|NCT02523599|583822293|FG000|Overall Study|Lost to Follow-up|4|||
161664307|NCT02523599|583822294|FG001|Overall Study|Lost to Follow-up|1|||
161664308|NCT02523599|583822293|FG000|Overall Study|Did not return for Day 30 visit|2|||
161664309|NCT02523599|583822294|FG001|Overall Study|Did not return for Day 30 visit|0|||
161664310|NCT01892540|583822295|FG000|Overall Study|Did not complete PET/MRI|0|||
161664311|NCT01892540|583822296|FG001|Overall Study|Did not complete PET/MRI|0|||
161664312|NCT01892540|583822297|FG002|Overall Study|Did not complete PET/MRI|2|||
161664313|NCT01892540|583822295|FG000|Overall Study|Did not fit in scanner|0|||
161664314|NCT01892540|583822296|FG001|Overall Study|Did not fit in scanner|0|||
161664315|NCT01892540|583822297|FG002|Overall Study|Did not fit in scanner|1|||
161664316|NCT01370590|583822298|FG000|Period 1|Adverse Event|8|||
161664317|NCT01370590|583822299|FG001|Period 1|Adverse Event|4|||
161664318|NCT01370590|583822298|FG000|Period 1|Lost to Follow-up|2|||
161664319|NCT01370590|583822299|FG001|Period 1|Lost to Follow-up|2|||
161664320|NCT01370590|583822298|FG000|Period 1|Protocol Violation|2|||
161664321|NCT01370590|583822299|FG001|Period 1|Protocol Violation|2|||
161664322|NCT01370590|583822298|FG000|Period 1|Withdrawal by Subject|4|||
161664323|NCT01370590|583822299|FG001|Period 1|Withdrawal by Subject|2|||
161664324|NCT01370590|583822298|FG000|Period 1|Could not access randomization system|0|||
161664325|NCT01370590|583822299|FG001|Period 1|Could not access randomization system|1|||
161664326|NCT01370590|583822298|FG000|Crossover Washout Period|Adverse Event|1|||
161664327|NCT01370590|583822299|FG001|Crossover Washout Period|Adverse Event|4|||
161664328|NCT01370590|583822298|FG000|Crossover Washout Period|Lost to Follow-up|2|||
161664329|NCT01370590|583822299|FG001|Crossover Washout Period|Lost to Follow-up|0|||
161664330|NCT01370590|583822298|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
161664331|NCT01370590|583822299|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
161664332|NCT01370590|583822298|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
161664333|NCT01370590|583822299|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
161664334|NCT01370590|583822298|FG000|Period 2|Adverse Event|0|||
161664335|NCT01370590|583822299|FG001|Period 2|Adverse Event|1|||
161664336|NCT01370590|583822298|FG000|Period 2|Withdrawal by Subject|1|||
161664337|NCT01370590|583822299|FG001|Period 2|Withdrawal by Subject|1|||
161664338|NCT03110224|583822300|FG000|Overall Study|Death|3|||
161664339|NCT03110224|583822300|FG000|Overall Study|Lost to Follow-up|132|||
161664340|NCT03110224|583822300|FG000|Overall Study|Physician Decision|2|||
161664341|NCT03110224|583822300|FG000|Overall Study|Site Closed by Physician|35|||
161664342|NCT03110224|583822300|FG000|Overall Study|Site Closed by Sponsor|202|||
161664343|NCT03110224|583822300|FG000|Overall Study|Withdrawal by Subject|9|||
161718040|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
161718041|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
161718042|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
161718043|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
161718044|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
161718045|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
161718046|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718047|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718048|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718049|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718050|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718051|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
161718052|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
161718053|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718054|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718055|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718056|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718057|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
161718058|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
161718059|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718060|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718061|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718062|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718063|NCT00467649|584012724|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718064|NCT00467649|584012725|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718065|NCT00467649|584012726|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718066|NCT00467649|584012727|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
161718067|NCT00467649|584012728|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718068|NCT00467649|584012729|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718069|NCT00467649|584012724|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718070|NCT00467649|584012725|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718071|NCT00467649|584012726|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718072|NCT00467649|584012727|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
161718073|NCT00467649|584012728|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718074|NCT00467649|584012729|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718075|NCT00467649|584012724|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718076|NCT00467649|584012725|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718077|NCT00467649|584012726|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718078|NCT00467649|584012727|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718079|NCT00467649|584012728|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718080|NCT00467649|584012729|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
161718081|NCT01633060|584012730|FG000|Randomization Phase|Protocol deviation|1|||
161718082|NCT01633060|584012731|FG001|Randomization Phase|Protocol deviation|2|||
161718083|NCT01633060|584012730|FG000|Randomization Phase|Technical problem|0|||
161718084|NCT01633060|584012731|FG001|Randomization Phase|Technical problem|1|||
161718085|NCT01633060|584012730|FG000|Treatment Phase|Adverse Event|24|||
161718086|NCT01633060|584012731|FG001|Treatment Phase|Adverse Event|3|||
161718087|NCT01633060|584012730|FG000|Treatment Phase|Lost to Follow-up|1|||
161718088|NCT01633060|584012731|FG001|Treatment Phase|Lost to Follow-up|0|||
161718089|NCT01633060|584012730|FG000|Treatment Phase|Physician Decision|16|||
161718090|NCT01633060|584012731|FG001|Treatment Phase|Physician Decision|7|||
161718091|NCT01633060|584012730|FG000|Treatment Phase|Progressive Disease|210|||
161718092|NCT01633060|584012731|FG001|Treatment Phase|Progressive Disease|120|||
161718093|NCT01633060|584012730|FG000|Treatment Phase|Protocol Deviation|1|||
161718094|NCT01633060|584012731|FG001|Treatment Phase|Protocol Deviation|0|||
161718095|NCT01633060|584012730|FG000|Treatment Phase|Study Terminated by sponsor|7|||
161718096|NCT01633060|584012731|FG001|Treatment Phase|Study Terminated by sponsor|3|||
161718097|NCT01633060|584012730|FG000|Treatment Phase|Subject/guardian decision|25|||
161718098|NCT01633060|584012731|FG001|Treatment Phase|Subject/guardian decision|4|||
161718099|NCT01633060|584012730|FG000|Treatment Phase|Death|4|||
161718100|NCT01633060|584012731|FG001|Treatment Phase|Death|3|||
161718101|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
161718102|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161718103|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
161718104|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
161718105|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
161718106|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
161718107|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
161718108|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
161718109|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161718110|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161718111|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
161718112|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
161718113|NCT00883753|584012734|FG000|Overall Study|Adverse Event|37|||
161718114|NCT00883753|584012734|FG000|Overall Study|Death|2|||
161718115|NCT00883753|584012734|FG000|Overall Study|Insufficient therapeutic response|16|||
161718116|NCT00883753|584012734|FG000|Overall Study|Lost to Follow-up|4|||
161718117|NCT00883753|584012734|FG000|Overall Study|Violation of selection criteria at entry|7|||
161718118|NCT00883753|584012734|FG000|Overall Study|Protocol Violation|2|||
161718119|NCT00883753|584012734|FG000|Overall Study|Refused treatment|4|||
161718120|NCT00883753|584012734|FG000|Overall Study|Withdrew consent|10|||
161718121|NCT00883753|584012734|FG000|Overall Study|Investigator's decision|17|||
161718122|NCT00883753|584012734|FG000|Overall Study|Administrative/Other|8|||
161718123|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Adverse Event|12|||
161718124|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Adverse Event|3|||
161718125|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Adverse Event|4|||
161718126|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Adverse Event|2|||
161718127|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
161718128|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
161718129|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
161718130|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
161718131|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
161718132|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
161718133|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
161718134|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
161718135|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
161718136|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
161718137|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
161718138|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
161718139|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
161718140|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
161718141|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
161718142|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
161718143|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
161718144|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
161718145|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
161718146|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
161718147|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Other Reason|1|||
161718148|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Other Reason|1|||
161718149|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Other Reason|0|||
161718150|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Other Reason|0|||
161718151|NCT02436239|584012738|FG000|Down-Taper Period|Withdrawal by Subject|4|||
161718152|NCT02436239|584012739|FG001|Down-Taper Period|Withdrawal by Subject|4|||
161718153|NCT02436239|584012740|FG002|Down-Taper Period|Withdrawal by Subject|1|||
161718154|NCT02436239|584012741|FG003|Down-Taper Period|Withdrawal by Subject|2|||
161718155|NCT02168946|584012742|FG000|Overall Study|Adverse Event|8|||
161718156|NCT02168946|584012743|FG001|Overall Study|Adverse Event|5|||
161718157|NCT02168946|584012742|FG000|Overall Study|Lost to Follow-up|3|||
161718158|NCT02168946|584012743|FG001|Overall Study|Lost to Follow-up|0|||
161718159|NCT02168946|584012742|FG000|Overall Study|Subject unable to come back for visits|1|||
161718160|NCT02168946|584012743|FG001|Overall Study|Subject unable to come back for visits|0|||
161718161|NCT00450866|584012751|FG000|Overall Study|Adverse Event|0|||
161718162|NCT00450866|584012752|FG001|Overall Study|Adverse Event|1|||
161718163|NCT00450866|584012751|FG000|Overall Study|Withdrawal by Subject|5|||
161718164|NCT00450866|584012752|FG001|Overall Study|Withdrawal by Subject|2|||
161718165|NCT00450866|584012751|FG000|Overall Study|Death|1|||
161718166|NCT00450866|584012752|FG001|Overall Study|Death|0|||
161718167|NCT00450866|584012751|FG000|Overall Study|Physician Decision|1|||
161718168|NCT00450866|584012752|FG001|Overall Study|Physician Decision|0|||
161718169|NCT01743027|584012753|FG000|Overall Study|Adverse Event|2|||
161718170|NCT01743027|584012754|FG001|Overall Study|Adverse Event|0|||
161718171|NCT01743027|584012755|FG002|Overall Study|Adverse Event|0|||
161718172|NCT01743027|584012756|FG003|Overall Study|Adverse Event|0|||
161718173|NCT01743027|584012753|FG000|Overall Study|Lost to Follow-up|0|||
161718174|NCT01743027|584012754|FG001|Overall Study|Lost to Follow-up|0|||
161718175|NCT01743027|584012755|FG002|Overall Study|Lost to Follow-up|2|||
161718176|NCT01743027|584012756|FG003|Overall Study|Lost to Follow-up|0|||
161718177|NCT01743027|584012753|FG000|Overall Study|Progressive Disease|1|||
161718178|NCT01743027|584012754|FG001|Overall Study|Progressive Disease|4|||
161718179|NCT01743027|584012755|FG002|Overall Study|Progressive Disease|3|||
161718180|NCT01743027|584012756|FG003|Overall Study|Progressive Disease|0|||
161718181|NCT01743027|584012753|FG000|Overall Study|Protocol Violation|1|||
161718182|NCT01743027|584012754|FG001|Overall Study|Protocol Violation|1|||
161718183|NCT01743027|584012755|FG002|Overall Study|Protocol Violation|1|||
161718184|NCT01743027|584012756|FG003|Overall Study|Protocol Violation|0|||
161718185|NCT01743027|584012753|FG000|Overall Study|Withdrawal by Subject|1|||
161718186|NCT01743027|584012754|FG001|Overall Study|Withdrawal by Subject|0|||
161718187|NCT01743027|584012755|FG002|Overall Study|Withdrawal by Subject|3|||
161718188|NCT01743027|584012756|FG003|Overall Study|Withdrawal by Subject|1|||
161718189|NCT02675517|584012759|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
161718190|NCT02675517|584012759|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
161718191|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
161718192|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
161718193|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Other|1|||
161718194|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
161718195|NCT02277444|584012765|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
161718196|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
161718197|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
161718198|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
161718199|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
161718200|NCT02699515|584014318|FG000|Overall Study|Death|3|||
161718201|NCT02699515|584014319|FG001|Overall Study|Death|3|||
161718202|NCT02699515|584014320|FG002|Overall Study|Death|3|||
161718203|NCT02699515|584014321|FG003|Overall Study|Death|23|||
161718204|NCT02699515|584014322|FG004|Overall Study|Death|22|||
161718205|NCT02699515|584014323|FG005|Overall Study|Death|23|||
161718206|NCT02699515|584014324|FG006|Overall Study|Death|3|||
161718207|NCT02699515|584014325|FG007|Overall Study|Death|5|||
161718208|NCT02699515|584014318|FG000|Overall Study|Withdrawal by Subject|0|||
161718209|NCT02699515|584014319|FG001|Overall Study|Withdrawal by Subject|0|||
161718210|NCT02699515|584014320|FG002|Overall Study|Withdrawal by Subject|3|||
161718211|NCT02699515|584014321|FG003|Overall Study|Withdrawal by Subject|1|||
161718212|NCT02699515|584014322|FG004|Overall Study|Withdrawal by Subject|5|||
161718213|NCT02699515|584014323|FG005|Overall Study|Withdrawal by Subject|3|||
161718214|NCT02699515|584014324|FG006|Overall Study|Withdrawal by Subject|0|||
161718215|NCT02699515|584014325|FG007|Overall Study|Withdrawal by Subject|1|||
161718216|NCT02699515|584014318|FG000|Overall Study|Other|1|||
161718217|NCT02699515|584014319|FG001|Overall Study|Other|0|||
161718218|NCT02699515|584014320|FG002|Overall Study|Other|1|||
161718219|NCT02699515|584014321|FG003|Overall Study|Other|6|||
161718220|NCT02699515|584014322|FG004|Overall Study|Other|4|||
161718221|NCT02699515|584014323|FG005|Overall Study|Other|3|||
161718222|NCT02699515|584014324|FG006|Overall Study|Other|0|||
161718223|NCT02699515|584014325|FG007|Overall Study|Other|0|||
161718224|NCT05243550|584014326|FG000|Overall Study|Ongoing in the Study|171|||
161718225|NCT05243550|584014326|FG000|Overall Study|Withdrawal by Subject|10|||
161718226|NCT05243550|584014326|FG000|Overall Study|Lost to Follow-up|7|||
161718227|NCT05243550|584014326|FG000|Overall Study|Adverse Event|3|||
161718228|NCT05243550|584014326|FG000|Overall Study|Noncompliance|1|||
161718229|NCT05243550|584014326|FG000|Overall Study|Physician Decision|1|||
161718230|NCT05243550|584014326|FG000|Overall Study|Other Reason|4|||
161718231|NCT02031146|584014329|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161718232|NCT02031146|584014330|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161718233|NCT02031146|584014331|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161718234|NCT02031146|584014332|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
161718235|NCT02031146|584014333|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
161718236|NCT02031146|584014334|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
161718237|NCT02031146|584014335|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
161718238|NCT02452970|584014338|FG000|Overall Study|Adverse Event|1|||
161718239|NCT02100657|584014339|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
161718240|NCT02100657|584014340|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
161718241|NCT02100657|584014341|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
161718242|NCT02100657|584014339|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
161718243|NCT02100657|584014340|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
161718244|NCT02100657|584014341|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
161718245|NCT02100657|584014339|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
161718246|NCT02100657|584014340|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
161718247|NCT02100657|584014341|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
161718248|NCT02100657|584014339|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
161718249|NCT02100657|584014340|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
161718250|NCT02100657|584014341|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
161718251|NCT02100657|584014339|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
161718252|NCT02100657|584014340|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
161718253|NCT02100657|584014341|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
161718254|NCT02100657|584014339|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
161718255|NCT02100657|584014340|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
161718256|NCT02100657|584014341|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
161718257|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
161718258|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
161718259|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
161718260|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Death|0|||
161718261|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Death|0|||
161718262|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Death|1|||
161718263|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
161718264|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
161718265|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
161718266|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
161718267|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
161718268|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
161718269|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
161718270|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
161718271|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
161718272|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
161718273|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
161718274|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
161718275|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
161718276|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
161718277|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
161718278|NCT02629393|584014343|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
161718279|NCT02629393|584014343|FG000|Overall Study|Physician Decision|1|||
161718280|NCT01269125|584014347|FG000|Overall Study|Adverse Event|3|||
161718281|NCT01269125|584014348|FG001|Overall Study|Adverse Event|5|||
161718282|NCT01269125|584014349|FG002|Overall Study|Adverse Event|0|||
161718283|NCT01269125|584014347|FG000|Overall Study|Lost to Follow-up|4|||
161718284|NCT01269125|584014348|FG001|Overall Study|Lost to Follow-up|0|||
161718285|NCT01269125|584014349|FG002|Overall Study|Lost to Follow-up|0|||
161718286|NCT01040832|584014350|FG000|Overall Study|Adverse Event|4|||
161718287|NCT01040832|584014351|FG001|Overall Study|Adverse Event|5|||
161718288|NCT01040832|584014350|FG000|Overall Study|Death|4|||
161718289|NCT01040832|584014351|FG001|Overall Study|Death|6|||
161718290|NCT01040832|584014350|FG000|Overall Study|Withdrawal by Subject|2|||
161718291|NCT01040832|584014351|FG001|Overall Study|Withdrawal by Subject|3|||
161718292|NCT01040832|584014350|FG000|Overall Study|Progressive disease|32|||
161718293|NCT01040832|584014351|FG001|Overall Study|Progressive disease|17|||
161718294|NCT01040832|584014350|FG000|Overall Study|Symptomatic deterioration|2|||
161718295|NCT01040832|584014351|FG001|Overall Study|Symptomatic deterioration|5|||
161718296|NCT01040832|584014350|FG000|Overall Study|Other|2|||
161718297|NCT01040832|584014351|FG001|Overall Study|Other|1|||
161718298|NCT00151411|584014352|FG000|Overall Study|Lost to Follow-up|15|||
161718299|NCT00151411|584014353|FG001|Overall Study|Lost to Follow-up|19|||
161718300|NCT00151411|584014352|FG000|Overall Study|Withdrawal by Subject|12|||
161718301|NCT00151411|584014353|FG001|Overall Study|Withdrawal by Subject|20|||
161718302|NCT00151411|584014352|FG000|Overall Study|Adverse Event|6|||
161718303|NCT00151411|584014353|FG001|Overall Study|Adverse Event|0|||
161718304|NCT00151411|584014352|FG000|Overall Study|Pregnancy|0|||
161718305|NCT00151411|584014353|FG001|Overall Study|Pregnancy|4|||
161718306|NCT00417612|584014354|FG000|Overall Study|Errant diagnosis|0|||
161718307|NCT00417612|584014355|FG001|Overall Study|Errant diagnosis|1|||
161718308|NCT00417612|584014354|FG000|Overall Study|Adverse Event|2|||
161718309|NCT00417612|584014355|FG001|Overall Study|Adverse Event|0|||
161718310|NCT00417612|584014354|FG000|Overall Study|Protocol Violation|0|||
161718311|NCT00417612|584014355|FG001|Overall Study|Protocol Violation|2|||
161718312|NCT00417612|584014354|FG000|Overall Study|Lost to Follow-up|1|||
161718313|NCT00417612|584014355|FG001|Overall Study|Lost to Follow-up|0|||
161718314|NCT01283581|584014358|FG000|Overall Study|Lost to Follow-up|8|||
161718315|NCT01283581|584014359|FG001|Overall Study|Lost to Follow-up|6|||
161718316|NCT01283581|584014360|FG002|Overall Study|Lost to Follow-up|8|||
161718317|NCT01283581|584014358|FG000|Overall Study|Withdrawal by Subject|2|||
161718318|NCT01283581|584014359|FG001|Overall Study|Withdrawal by Subject|5|||
161718319|NCT01283581|584014360|FG002|Overall Study|Withdrawal by Subject|2|||
161718320|NCT01283581|584014358|FG000|Overall Study|Adverse Event|1|||
161718321|NCT01283581|584014359|FG001|Overall Study|Adverse Event|1|||
161718322|NCT01283581|584014360|FG002|Overall Study|Adverse Event|4|||
161718323|NCT01283581|584014358|FG000|Overall Study|Physician Decision|0|||
161718324|NCT01283581|584014359|FG001|Overall Study|Physician Decision|1|||
161718325|NCT01283581|584014360|FG002|Overall Study|Physician Decision|2|||
161718326|NCT01283581|584014358|FG000|Overall Study|Protocol Violation|0|||
161718327|NCT01283581|584014359|FG001|Overall Study|Protocol Violation|1|||
161718328|NCT01283581|584014360|FG002|Overall Study|Protocol Violation|2|||
161718329|NCT01283581|584014358|FG000|Overall Study|Noncompliance|1|||
161718330|NCT01283581|584014359|FG001|Overall Study|Noncompliance|0|||
161718331|NCT01283581|584014360|FG002|Overall Study|Noncompliance|0|||
161718332|NCT01283581|584014358|FG000|Overall Study|Investigator unblinded|0|||
161718333|NCT01283581|584014359|FG001|Overall Study|Investigator unblinded|0|||
161718334|NCT01283581|584014360|FG002|Overall Study|Investigator unblinded|1|||
161718335|NCT01283581|584014358|FG000|Overall Study|"Early termination"|0|||
161718336|NCT01283581|584014359|FG001|Overall Study|"Early termination"|0|||
161718337|NCT01283581|584014360|FG002|Overall Study|"Early termination"|1|||
161718338|NCT01712438|584014361|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
161718339|NCT01712438|584014361|FG000|Overall Study|Ongoing ITI treatment|6|||
161718340|NCT01712438|584014361|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
161718341|NCT01712438|584014361|FG000|Overall Study|Prematurely Discontinued|25|||
161718342|NCT01183858|584014364|FG000|Overall Study|Death not related to Progressive Disease|5|||
161718343|NCT01183858|584014365|FG001|Overall Study|Death not related to Progressive Disease|6|||
161718344|NCT01183858|584014364|FG000|Overall Study|Adverse Event|14|||
161718345|NCT01183858|584014365|FG001|Overall Study|Adverse Event|11|||
161718346|NCT01183858|584014364|FG000|Overall Study|Investigator's Decision|0|||
161718347|NCT01183858|584014365|FG001|Overall Study|Investigator's Decision|3|||
161718348|NCT01183858|584014364|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161718349|NCT01183858|584014365|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161718350|NCT01183858|584014364|FG000|Overall Study|Refused Treatment|1|||
161718351|NCT01183858|584014365|FG001|Overall Study|Refused Treatment|4|||
161718352|NCT01183858|584014364|FG000|Overall Study|Withdrew Consent|4|||
161718353|NCT01183858|584014365|FG001|Overall Study|Withdrew Consent|4|||
161718354|NCT01183858|584014364|FG000|Overall Study|Discontinued Smoking|3|||
161718355|NCT01183858|584014365|FG001|Overall Study|Discontinued Smoking|1|||
161718356|NCT01183858|584014364|FG000|Overall Study|Protocol Violation|1|||
161718357|NCT01183858|584014365|FG001|Overall Study|Protocol Violation|0|||
161718358|NCT01183858|584014364|FG000|Overall Study|Administrative/Other|6|||
161718359|NCT01183858|584014365|FG001|Overall Study|Administrative/Other|6|||
161718360|NCT01183858|584014364|FG000|Overall Study|Progressive Disease|112|||
161718361|NCT01183858|584014365|FG001|Overall Study|Progressive Disease|115|||
161718362|NCT01183858|584014364|FG000|Overall Study|Death related to Progressive Disease|4|||
161718363|NCT01183858|584014365|FG001|Overall Study|Death related to Progressive Disease|5|||
161718364|NCT01183858|584014364|FG000|Overall Study|Lost to Follow-up|1|||
161718365|NCT01183858|584014365|FG001|Overall Study|Lost to Follow-up|1|||
161718366|NCT00098345|584014366|FG000|Overall Study|Adverse Event|7|||
161718367|NCT00098345|584014366|FG000|Overall Study|Withdrawal by Subject|2|||
161718368|NCT00098345|584014366|FG000|Overall Study|progression|4|||
161718369|NCT00414440|584014370|FG000|Core Period|Withdrawal by Subject|70|||
161718370|NCT00414440|584014371|FG001|Core Period|Withdrawal by Subject|32|||
161718371|NCT00414440|584014370|FG000|Extension Period|Lost to Follow-up|44|||
161718372|NCT00414440|584014371|FG001|Extension Period|Lost to Follow-up|52|||
161718373|NCT00414440|584014370|FG000|Extension Period|Did not consent to continue follow up|61|||
161718374|NCT00414440|584014371|FG001|Extension Period|Did not consent to continue follow up|54|||
161718375|NCT00414440|584014370|FG000|Extension Period|Other|1|||
161718376|NCT00414440|584014371|FG001|Extension Period|Other|1|||
161718377|NCT00414440|584014370|FG000|Extension Period|Administrative|16|||
161718378|NCT00414440|584014371|FG001|Extension Period|Administrative|16|||
161718379|NCT00414440|584014370|FG000|Extension Period|Death|1|||
161718380|NCT00414440|584014371|FG001|Extension Period|Death|2|||
161718381|NCT00414440|584014370|FG000|Extension Period|Withdrawal by Subject|9|||
161718382|NCT00414440|584014371|FG001|Extension Period|Withdrawal by Subject|7|||
161718383|NCT00414440|584014370|FG000|Extension Period|Not included in follow up period|18|||
161718384|NCT00414440|584014371|FG001|Extension Period|Not included in follow up period|8|||
161718385|NCT00138151|584014372|FG000|Overall Study|Withdrawal by Subject|3|||
161718386|NCT00138151|584014372|FG000|Overall Study|Physician Decision|1|||
161718387|NCT04925570|584014373|FG000|Overall Study|Protocol Violation|24|||
161718388|NCT04925570|584014374|FG001|Overall Study|Protocol Violation|30|||
161718389|NCT04925570|584014373|FG000|Overall Study|Withdrawal by Subject|0|||
161718390|NCT04925570|584014374|FG001|Overall Study|Withdrawal by Subject|2|||
161718391|NCT01088412|584014375|FG000|Overall Study|Adverse Event|38|||
161718392|NCT01088412|584014376|FG001|Overall Study|Adverse Event|0|||
161718393|NCT01088412|584014377|FG002|Overall Study|Adverse Event|0|||
161718394|NCT01088412|584014375|FG000|Overall Study|Death|42|||
161718395|NCT01088412|584014376|FG001|Overall Study|Death|6|||
161718396|NCT01088412|584014377|FG002|Overall Study|Death|0|||
161718397|NCT01088412|584014375|FG000|Overall Study|Other Reason per Case Report Form|2089|||
161718398|NCT01088412|584014376|FG001|Overall Study|Other Reason per Case Report Form|103|||
161718399|NCT01088412|584014377|FG002|Overall Study|Other Reason per Case Report Form|9|||
161718400|NCT01088412|584014375|FG000|Overall Study|Withdrawal by Subject|1761|||
161718401|NCT01088412|584014376|FG001|Overall Study|Withdrawal by Subject|25|||
161718402|NCT01088412|584014377|FG002|Overall Study|Withdrawal by Subject|1|||
161718403|NCT01088412|584014375|FG000|Overall Study|Received Another GH Product|79|||
161718404|NCT01088412|584014376|FG001|Overall Study|Received Another GH Product|0|||
161718405|NCT01088412|584014377|FG002|Overall Study|Received Another GH Product|0|||
161718406|NCT01088412|584014375|FG000|Overall Study|Participant Moved|601|||
161718407|NCT01088412|584014376|FG001|Overall Study|Participant Moved|21|||
161718408|NCT01088412|584014377|FG002|Overall Study|Participant Moved|2|||
161718409|NCT01088412|584014375|FG000|Overall Study|Physician Decision|1041|||
161718410|NCT01088412|584014376|FG001|Overall Study|Physician Decision|8|||
161718411|NCT01088412|584014377|FG002|Overall Study|Physician Decision|4|||
161718412|NCT01088412|584014375|FG000|Overall Study|Sponsor Decision|4467|||
161718413|NCT01088412|584014376|FG001|Overall Study|Sponsor Decision|79|||
161718414|NCT01088412|584014377|FG002|Overall Study|Sponsor Decision|23|||
161718415|NCT01088412|584014375|FG000|Overall Study|Third Party Required to Change Brand|487|||
161718416|NCT01088412|584014376|FG001|Overall Study|Third Party Required to Change Brand|0|||
161718417|NCT01088412|584014377|FG002|Overall Study|Third Party Required to Change Brand|0|||
161718418|NCT01088412|584014375|FG000|Overall Study|Lost to Follow-up|3052|||
161718419|NCT01088412|584014376|FG001|Overall Study|Lost to Follow-up|130|||
161718420|NCT01088412|584014377|FG002|Overall Study|Lost to Follow-up|11|||
161718421|NCT01088412|584014375|FG000|Overall Study|Study Summary Not Completed|4360|||
161718422|NCT01088412|584014376|FG001|Overall Study|Study Summary Not Completed|64|||
161718423|NCT01088412|584014377|FG002|Overall Study|Study Summary Not Completed|22|||
161718424|NCT00793104|584014378|FG000|Overall Study|Lost to Follow-up|1|||
161718425|NCT03494725|584014381|FG000|Overall Study|Withdrawal by Subject|0|||
161718426|NCT03494725|584014382|FG001|Overall Study|Withdrawal by Subject|2|||
161718427|NCT03494725|584014381|FG000|Overall Study|Antibiotic use|1|||
161718428|NCT03494725|584014382|FG001|Overall Study|Antibiotic use|0|||
161718429|NCT02619253|584014383|FG000|Overall Study|Adverse Event|0|||
161718430|NCT02619253|584014384|FG001|Overall Study|Adverse Event|0|||
161718431|NCT02619253|584014385|FG002|Overall Study|Adverse Event|1|||
161718432|NCT02619253|584014386|FG003|Overall Study|Adverse Event|1|||
161718433|NCT02619253|584014387|FG004|Overall Study|Adverse Event|3|||
161718434|NCT02619253|584014383|FG000|Overall Study|Alternative Therapy|0|||
161718435|NCT02619253|584014384|FG001|Overall Study|Alternative Therapy|0|||
161718436|NCT02619253|584014385|FG002|Overall Study|Alternative Therapy|1|||
161718437|NCT02619253|584014386|FG003|Overall Study|Alternative Therapy|0|||
161718438|NCT02619253|584014387|FG004|Overall Study|Alternative Therapy|0|||
161718439|NCT02619253|584014383|FG000|Overall Study|Death|0|||
161718440|NCT02619253|584014384|FG001|Overall Study|Death|0|||
161718441|NCT02619253|584014385|FG002|Overall Study|Death|0|||
161718442|NCT02619253|584014386|FG003|Overall Study|Death|1|||
161718443|NCT02619253|584014387|FG004|Overall Study|Death|0|||
161718444|NCT02619253|584014383|FG000|Overall Study|Disease Progression|4|||
161718445|NCT02619253|584014384|FG001|Overall Study|Disease Progression|2|||
161718446|NCT02619253|584014385|FG002|Overall Study|Disease Progression|8|||
161718447|NCT02619253|584014386|FG003|Overall Study|Disease Progression|9|||
161718448|NCT02619253|584014387|FG004|Overall Study|Disease Progression|10|||
161718449|NCT02619253|584014383|FG000|Overall Study|Needed a disqualifying therapy|0|||
161718450|NCT02619253|584014384|FG001|Overall Study|Needed a disqualifying therapy|0|||
161718451|NCT02619253|584014385|FG002|Overall Study|Needed a disqualifying therapy|1|||
161718452|NCT02619253|584014386|FG003|Overall Study|Needed a disqualifying therapy|0|||
161718453|NCT02619253|584014387|FG004|Overall Study|Needed a disqualifying therapy|0|||
161718454|NCT02619253|584014383|FG000|Overall Study|Transferred to hospice|0|||
161718455|NCT02619253|584014384|FG001|Overall Study|Transferred to hospice|0|||
161718456|NCT02619253|584014385|FG002|Overall Study|Transferred to hospice|1|||
161718457|NCT02619253|584014386|FG003|Overall Study|Transferred to hospice|0|||
161718458|NCT02619253|584014387|FG004|Overall Study|Transferred to hospice|0|||
161718459|NCT02619253|584014383|FG000|Overall Study|Physician Decision|0|||
161718460|NCT02619253|584014384|FG001|Overall Study|Physician Decision|1|||
161718461|NCT02619253|584014385|FG002|Overall Study|Physician Decision|2|||
161718462|NCT02619253|584014386|FG003|Overall Study|Physician Decision|3|||
161718463|NCT02619253|584014387|FG004|Overall Study|Physician Decision|0|||
161718464|NCT02619253|584014383|FG000|Overall Study|Withdrawal by Subject|0|||
161718465|NCT02619253|584014384|FG001|Overall Study|Withdrawal by Subject|1|||
161718466|NCT02619253|584014385|FG002|Overall Study|Withdrawal by Subject|0|||
161718467|NCT02619253|584014386|FG003|Overall Study|Withdrawal by Subject|0|||
161718468|NCT02619253|584014387|FG004|Overall Study|Withdrawal by Subject|2|||
161718469|NCT02111811|584014388|FG000|Treatment Phase|Lost to Follow-up|22|||
161718470|NCT02111811|584014389|FG001|Treatment Phase|Lost to Follow-up|18|||
161718471|NCT02111811|584014388|FG000|Treatment Phase|Death|2|||
161718472|NCT02111811|584014389|FG001|Treatment Phase|Death|0|||
161718473|NCT02111811|584014388|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
161718474|NCT02111811|584014389|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
161718475|NCT02111811|584014388|FG000|Follow up Period (Aim 2)|Death|2|||
161718476|NCT02111811|584014389|FG001|Follow up Period (Aim 2)|Death|0|||
161718477|NCT03443024|584014392|FG000|Overall Study|Adverse Event|2|||
161718478|NCT03443024|584014393|FG001|Overall Study|Adverse Event|4|||
161718479|NCT03443024|584014394|FG002|Overall Study|Adverse Event|3|||
161718480|NCT03443024|584014395|FG003|Overall Study|Adverse Event|1|||
161718481|NCT03443024|584014392|FG000|Overall Study|Lost to Follow-up|9|||
161718482|NCT03443024|584014393|FG001|Overall Study|Lost to Follow-up|9|||
161718483|NCT03443024|584014394|FG002|Overall Study|Lost to Follow-up|7|||
161718484|NCT03443024|584014395|FG003|Overall Study|Lost to Follow-up|5|||
161718485|NCT03443024|584014392|FG000|Overall Study|Withdrawal by Subject|8|||
161718486|NCT03443024|584014393|FG001|Overall Study|Withdrawal by Subject|15|||
161718487|NCT03443024|584014394|FG002|Overall Study|Withdrawal by Subject|9|||
161718488|NCT03443024|584014395|FG003|Overall Study|Withdrawal by Subject|23|||
161718489|NCT03443024|584014392|FG000|Overall Study|Physician Decision|1|||
161718490|NCT03443024|584014393|FG001|Overall Study|Physician Decision|2|||
161718491|NCT03443024|584014394|FG002|Overall Study|Physician Decision|0|||
161718492|NCT03443024|584014395|FG003|Overall Study|Physician Decision|1|||
161718493|NCT03443024|584014392|FG000|Overall Study|Sponsor Decision|1|||
161718494|NCT03443024|584014393|FG001|Overall Study|Sponsor Decision|1|||
161718495|NCT03443024|584014394|FG002|Overall Study|Sponsor Decision|0|||
161718496|NCT03443024|584014395|FG003|Overall Study|Sponsor Decision|0|||
161718497|NCT03443024|584014392|FG000|Overall Study|Protocol Deviation|0|||
161718498|NCT03443024|584014393|FG001|Overall Study|Protocol Deviation|0|||
161718499|NCT03443024|584014394|FG002|Overall Study|Protocol Deviation|0|||
161718500|NCT03443024|584014395|FG003|Overall Study|Protocol Deviation|2|||
161718501|NCT00301067|584014396|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
161718502|NCT00301067|584014397|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
161718503|NCT00301067|584014398|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
161718504|NCT00301067|584014399|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
161718505|NCT00301067|584014396|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
161718506|NCT00301067|584014397|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
161718507|NCT00301067|584014398|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
161718508|NCT00301067|584014399|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
161718509|NCT00301067|584014396|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
161718510|NCT00301067|584014397|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
161718511|NCT00301067|584014398|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
161718512|NCT00301067|584014399|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
161718513|NCT00301067|584014396|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
161718514|NCT00301067|584014397|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
161718515|NCT00301067|584014398|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
161718516|NCT00301067|584014399|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
161718517|NCT00301067|584014396|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
161718518|NCT00301067|584014397|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
161718519|NCT00301067|584014398|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
161718520|NCT00301067|584014399|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
161718521|NCT00301067|584014396|FG000|Follow up Until Death|Alive at last data cut point|1|||
161718522|NCT00301067|584014397|FG001|Follow up Until Death|Alive at last data cut point|0|||
161718523|NCT00301067|584014398|FG002|Follow up Until Death|Alive at last data cut point|0|||
161718524|NCT00301067|584014399|FG003|Follow up Until Death|Alive at last data cut point|1|||
161718525|NCT00149825|584014400|FG000|Overall Study|Intolerance to medication side effects|1|||
161718526|NCT00149825|584014401|FG001|Overall Study|Intolerance to medication side effects|2|||
161718527|NCT00149825|584014400|FG000|Overall Study|Time commitments|2|||
161718528|NCT00149825|584014401|FG001|Overall Study|Time commitments|1|||
161718529|NCT00149825|584014400|FG000|Overall Study|Not liking insomnia therapy|1|||
161718530|NCT00149825|584014401|FG001|Overall Study|Not liking insomnia therapy|0|||
161718531|NCT00149825|584014400|FG000|Overall Study|Other|1|||
161718532|NCT00149825|584014401|FG001|Overall Study|Other|0|||
161718533|NCT01359982|584014402|FG000|Overall Study|Adverse Event|2|||
161718534|NCT01359982|584014403|FG001|Overall Study|Adverse Event|0|||
161718535|NCT01359982|584014404|FG002|Overall Study|Adverse Event|0|||
161718536|NCT01359982|584014405|FG003|Overall Study|Adverse Event|1|||
161718537|NCT01359982|584014406|FG004|Overall Study|Adverse Event|0|||
161718538|NCT01359982|584014407|FG005|Overall Study|Adverse Event|0|||
161718539|NCT01359982|584014402|FG000|Overall Study|Death|1|||
161718540|NCT01359982|584014403|FG001|Overall Study|Death|0|||
161718541|NCT01359982|584014404|FG002|Overall Study|Death|0|||
161718542|NCT01359982|584014405|FG003|Overall Study|Death|0|||
161718543|NCT01359982|584014406|FG004|Overall Study|Death|0|||
161718544|NCT01359982|584014407|FG005|Overall Study|Death|0|||
161718545|NCT05593432|584014408|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
161718546|NCT05593432|584014409|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
161718547|NCT05593432|584014410|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
161718548|NCT05593432|584014411|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
161718549|NCT05593432|584014408|FG000|16-Week OLE Period|Lack of Efficacy|0|||
161718550|NCT05593432|584014409|FG001|16-Week OLE Period|Lack of Efficacy|0|||
161718551|NCT05593432|584014410|FG002|16-Week OLE Period|Lack of Efficacy|0|||
161718552|NCT05593432|584014411|FG003|16-Week OLE Period|Lack of Efficacy|1|||
161718553|NCT05593432|584014408|FG000|16-Week OLE Period|Lost to Follow-up|0|||
161718554|NCT05593432|584014409|FG001|16-Week OLE Period|Lost to Follow-up|0|||
161718555|NCT05593432|584014410|FG002|16-Week OLE Period|Lost to Follow-up|1|||
161718556|NCT05593432|584014411|FG003|16-Week OLE Period|Lost to Follow-up|2|||
161718557|NCT05593432|584014408|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
161718558|NCT05593432|584014409|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
161718559|NCT05593432|584014410|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
161718560|NCT05593432|584014411|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
161718561|NCT01450137|584014413|FG000|Up to Week 12|Adverse Event|2|||
161718562|NCT01450137|584014414|FG001|Up to Week 12|Adverse Event|1|||
161718563|NCT01450137|584014413|FG000|Up to Week 12|Withdrawal by Subject|0|||
161718564|NCT01450137|584014414|FG001|Up to Week 12|Withdrawal by Subject|2|||
161718565|NCT01450137|584014413|FG000|Week 12 to Study End|Death|0|||
161718566|NCT01450137|584014414|FG001|Week 12 to Study End|Death|1|||
161718567|NCT01450137|584014413|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
161718568|NCT01450137|584014414|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
161718569|NCT01926886|584014415|FG000|Overall Study|Administrative/other|1|||
161718570|NCT01926886|584014416|FG001|Overall Study|Administrative/other|0|||
161718571|NCT01926886|584014415|FG000|Overall Study|Adverse event/intercurrent illness|4|||
161718572|NCT01926886|584014416|FG001|Overall Study|Adverse event/intercurrent illness|0|||
161718573|NCT01926886|584014415|FG000|Overall Study|Disease progression/recurrence|4|||
161718574|NCT01926886|584014416|FG001|Overall Study|Disease progression/recurrence|0|||
161718575|NCT01926886|584014415|FG000|Overall Study|Withdrawal by Subject|15|||
161718576|NCT01926886|584014416|FG001|Overall Study|Withdrawal by Subject|0|||
161718577|NCT01926886|584014415|FG000|Overall Study|Failure to return|3|||
161718578|NCT01926886|584014416|FG001|Overall Study|Failure to return|0|||
161718579|NCT01926886|584014415|FG000|Overall Study|Recurrence of disease|1|||
161718580|NCT01926886|584014416|FG001|Overall Study|Recurrence of disease|0|||
161718581|NCT01926886|584014415|FG000|Overall Study|Progression of disease|2|||
161718582|NCT01926886|584014416|FG001|Overall Study|Progression of disease|0|||
161718583|NCT01926886|584014415|FG000|Overall Study|Death|1|||
161718584|NCT01926886|584014416|FG001|Overall Study|Death|0|||
161718585|NCT01926886|584014415|FG000|Overall Study|Did not cooperate|1|||
161718586|NCT01926886|584014416|FG001|Overall Study|Did not cooperate|0|||
161718587|NCT02986373|584014417|FG000|Overall Study|Adverse Event|4|||
161718588|NCT02986373|584014417|FG000|Overall Study|Lost to Follow-up|1|||
161718589|NCT02986373|584014417|FG000|Overall Study|Withdrawal by Subject|10|||
161718590|NCT02986373|584014417|FG000|Overall Study|Other|24|||
161718591|NCT00069121|584014418|FG000|Overall Study|Death|286|||
161718592|NCT00069121|584014419|FG001|Overall Study|Death|242|||
161718593|NCT00069121|584014418|FG000|Overall Study|Withdrawal by Subject|18|||
161718594|NCT00069121|584014419|FG001|Overall Study|Withdrawal by Subject|20|||
161718595|NCT00069121|584014418|FG000|Overall Study|Lost to Follow-up|63|||
161718596|NCT00069121|584014419|FG001|Overall Study|Lost to Follow-up|63|||
161718597|NCT04800315|584014420|FG000|Randomization|Did not receive study treatment|1|||
161718598|NCT04800315|584014421|FG001|Randomization|Did not receive study treatment|0|||
161718599|NCT04800315|584014422|FG002|Randomization|Did not receive study treatment|0|||
161718600|NCT04800315|584014423|FG003|Randomization|Did not receive study treatment|0|||
161718601|NCT04800315|584014420|FG000|Treatment Period|Adverse Event|4|||
161718602|NCT04800315|584014421|FG001|Treatment Period|Adverse Event|2|||
161718603|NCT04800315|584014422|FG002|Treatment Period|Adverse Event|1|||
161718604|NCT04800315|584014423|FG003|Treatment Period|Adverse Event|2|||
161718605|NCT04800315|584014420|FG000|Treatment Period|Lack of Efficacy|1|||
161718606|NCT04800315|584014421|FG001|Treatment Period|Lack of Efficacy|0|||
161718607|NCT04800315|584014422|FG002|Treatment Period|Lack of Efficacy|0|||
161718608|NCT04800315|584014423|FG003|Treatment Period|Lack of Efficacy|3|||
161718609|NCT04800315|584014420|FG000|Treatment Period|Lost to Follow-up|0|||
161718610|NCT04800315|584014421|FG001|Treatment Period|Lost to Follow-up|1|||
161718611|NCT04800315|584014422|FG002|Treatment Period|Lost to Follow-up|2|||
161718612|NCT04800315|584014423|FG003|Treatment Period|Lost to Follow-up|2|||
161718613|NCT04800315|584014420|FG000|Treatment Period|Withdrawal by participant|0|||
161718614|NCT04800315|584014421|FG001|Treatment Period|Withdrawal by participant|0|||
161718615|NCT04800315|584014422|FG002|Treatment Period|Withdrawal by participant|0|||
161718616|NCT04800315|584014423|FG003|Treatment Period|Withdrawal by participant|4|||
161718617|NCT04800315|584014420|FG000|Treatment Period|Other Reasons|0|||
161718618|NCT04800315|584014421|FG001|Treatment Period|Other Reasons|2|||
161718619|NCT04800315|584014422|FG002|Treatment Period|Other Reasons|0|||
161718620|NCT04800315|584014423|FG003|Treatment Period|Other Reasons|1|||
161718621|NCT00753922|584014424|FG000|Overall Study|Lost to Follow-up|155|||
161718622|NCT00753922|584014425|FG001|Overall Study|Lost to Follow-up|24|||
161718623|NCT00753922|584014426|FG002|Overall Study|Lost to Follow-up|28|||
161718624|NCT00753922|584014427|FG003|Overall Study|Lost to Follow-up|5|||
161718625|NCT00753922|584014424|FG000|Overall Study|Withdrawal by Subject|9|||
161718626|NCT00753922|584014425|FG001|Overall Study|Withdrawal by Subject|11|||
161718627|NCT00753922|584014426|FG002|Overall Study|Withdrawal by Subject|4|||
161718628|NCT00753922|584014427|FG003|Overall Study|Withdrawal by Subject|2|||
161718629|NCT00753922|584014424|FG000|Overall Study|Patient Non-compliance|55|||
161718630|NCT00753922|584014425|FG001|Overall Study|Patient Non-compliance|22|||
161718631|NCT00753922|584014426|FG002|Overall Study|Patient Non-compliance|14|||
161718632|NCT00753922|584014427|FG003|Overall Study|Patient Non-compliance|11|||
161718633|NCT00753922|584014424|FG000|Overall Study|Patients Not Completing Visit|11|||
161718634|NCT00753922|584014425|FG001|Overall Study|Patients Not Completing Visit|0|||
161718635|NCT00753922|584014426|FG002|Overall Study|Patients Not Completing Visit|1|||
161718636|NCT00753922|584014427|FG003|Overall Study|Patients Not Completing Visit|0|||
161718637|NCT00753922|584014424|FG000|Overall Study|Death|2|||
161718638|NCT00753922|584014425|FG001|Overall Study|Death|23|||
161718639|NCT00753922|584014426|FG002|Overall Study|Death|2|||
161718640|NCT00753922|584014427|FG003|Overall Study|Death|1|||
161718641|NCT00753922|584014424|FG000|Overall Study|Discontinuation Due to Explantation|14|||
161718642|NCT00753922|584014425|FG001|Overall Study|Discontinuation Due to Explantation|14|||
161718643|NCT00753922|584014426|FG002|Overall Study|Discontinuation Due to Explantation|14|||
161718644|NCT00753922|584014427|FG003|Overall Study|Discontinuation Due to Explantation|4|||
161718645|NCT02983292|584014432|FG000|Overall Study|Participant unwell & cannot travel|2|||
161718646|NCT02983292|584014432|FG000|Overall Study|Lost to Follow-up|3|||
161718647|NCT02983292|584014432|FG000|Overall Study|Participant withdrew consent|2|||
161718648|NCT02983292|584014432|FG000|Overall Study|Revision|7|||
161718649|NCT02983292|584014432|FG000|Overall Study|Death|1|||
161718650|NCT02983292|584014432|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
161718651|NCT02983292|584014432|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
161718652|NCT02983292|584014432|FG000|Overall Study|Participant relocation|1|||
161718653|NCT00857246|584014433|FG000|Induction Regimen|Adverse Event|1|||
161718654|NCT00857246|584014433|FG000|Induction Regimen|disease-related complications|1|||
161718655|NCT00857246|584014433|FG000|Induction Regimen|Withdrawal by Subject|1|||
161718656|NCT00857246|584014433|FG000|Surgery (Curative)|disease progression|6|||
161718657|NCT00857246|584014433|FG000|ChemoRT|Withdrawal by Subject|1|||
161718658|NCT00857246|584014433|FG000|ChemoRT|Adverse Event|2|||
161718659|NCT03851510|584014434|FG000|Overall Study|Screen Fail|1|||
161718660|NCT03851510|584014434|FG000|Overall Study|Adverse Event|1|||
161718661|NCT03851510|584014434|FG000|Overall Study|Withdrawal by Subject|1|||
161718662|NCT02426086|584014435|FG000|Overall Study|Death|33|||
161718663|NCT02426086|584014436|FG001|Overall Study|Death|36|||
161718664|NCT02426086|584014435|FG000|Overall Study|Lost to Follow-up|2|||
161718665|NCT02426086|584014436|FG001|Overall Study|Lost to Follow-up|0|||
161718666|NCT02426086|584014435|FG000|Overall Study|Study Terminated by Sponsor|5|||
161718667|NCT02426086|584014436|FG001|Overall Study|Study Terminated by Sponsor|14|||
161718668|NCT02426086|584014435|FG000|Overall Study|Withdrawal by Subject|8|||
161718669|NCT02426086|584014436|FG001|Overall Study|Withdrawal by Subject|9|||
161718670|NCT04542291|584014437|FG000|Overall Study|Adverse Event|1|||
161718671|NCT04542291|584014437|FG000|Overall Study|Physician Decision|2|||
161718672|NCT01287117|584014438|FG000|Overall Study|Adverse Event|2|||
161718673|NCT01287117|584014439|FG001|Overall Study|Adverse Event|1|||
161718674|NCT01287117|584014440|FG002|Overall Study|Adverse Event|1|||
161718675|NCT01287117|584014441|FG003|Overall Study|Adverse Event|1|||
161718676|NCT01287117|584014438|FG000|Overall Study|Lost to Follow-up|1|||
161718677|NCT01287117|584014439|FG001|Overall Study|Lost to Follow-up|1|||
161718678|NCT01287117|584014440|FG002|Overall Study|Lost to Follow-up|0|||
161718679|NCT01287117|584014441|FG003|Overall Study|Lost to Follow-up|0|||
161718680|NCT01287117|584014438|FG000|Overall Study|Physician Decision|0|||
161718681|NCT01287117|584014439|FG001|Overall Study|Physician Decision|1|||
161718682|NCT01287117|584014440|FG002|Overall Study|Physician Decision|1|||
161718683|NCT01287117|584014441|FG003|Overall Study|Physician Decision|1|||
161718684|NCT01287117|584014438|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
161718685|NCT01287117|584014439|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
161718686|NCT01287117|584014440|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
161718687|NCT01287117|584014441|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
161718688|NCT01287117|584014438|FG000|Overall Study|Disease Progression|10|||
161718689|NCT01287117|584014439|FG001|Overall Study|Disease Progression|5|||
161718690|NCT01287117|584014440|FG002|Overall Study|Disease Progression|6|||
161718691|NCT01287117|584014441|FG003|Overall Study|Disease Progression|5|||
161718692|NCT00035815|584014449|FG000|Overall Study|Withdrawal by Subject|17|||
161718693|NCT00035815|584014450|FG001|Overall Study|Withdrawal by Subject|11|||
161718694|NCT02606877|584014456|FG000|Overall Study|Adverse Event|3|||
161718695|NCT02606877|584014457|FG001|Overall Study|Adverse Event|0|||
161718696|NCT02606877|584014456|FG000|Overall Study|Non-compliance with protocol|0|||
161718697|NCT02606877|584014457|FG001|Overall Study|Non-compliance with protocol|1|||
161718698|NCT02606877|584014456|FG000|Overall Study|Other than listed above|1|||
161718699|NCT02606877|584014457|FG001|Overall Study|Other than listed above|0|||
161718700|NCT04952389|584014460|FG000|Overall Study|Withdrawal by Subject|8|||
161718701|NCT04952389|584014461|FG001|Overall Study|Withdrawal by Subject|4|||
161718702|NCT04285723|584014464|FG000|Overall Study|Subject decision|1|||
161718703|NCT04285723|584014465|FG001|Overall Study|Subject decision|2|||
161718704|NCT04285723|584014464|FG000|Overall Study|Physician Decision|1|||
161718705|NCT04285723|584014465|FG001|Overall Study|Physician Decision|0|||
161718706|NCT04285723|584014464|FG000|Overall Study|No efficiency|1|||
161718707|NCT04285723|584014465|FG001|Overall Study|No efficiency|0|||
161718708|NCT00778999|584014466|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
161718709|NCT00778999|584014467|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
161718710|NCT00778999|584014466|FG000|Overall Study|Did not receive recFSH|14|||
161718711|NCT00778999|584014467|FG001|Overall Study|Did not receive recFSH|20|||
161718712|NCT02032524|584014468|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
161718713|NCT02032524|584014469|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
161718714|NCT02032524|584014470|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
161718715|NCT02032524|584014471|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
161718716|NCT02032524|584014472|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
161718717|NCT02032524|584014473|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
161718718|NCT02032524|584014468|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718719|NCT02032524|584014469|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718720|NCT02032524|584014470|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718721|NCT02032524|584014471|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
161718722|NCT02032524|584014472|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718723|NCT02032524|584014473|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
161718724|NCT02032524|584014468|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
161718725|NCT02032524|584014469|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
161718726|NCT02032524|584014470|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
161718727|NCT02032524|584014471|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
161718728|NCT02032524|584014472|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
161718729|NCT02032524|584014473|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
161718730|NCT02032524|584014468|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718731|NCT02032524|584014469|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
161718732|NCT02032524|584014470|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718733|NCT02032524|584014471|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718734|NCT02032524|584014472|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
161718735|NCT02032524|584014473|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718736|NCT02032524|584014468|FG000|Period 2: LTS13769 Study|Other|0|||
161718737|NCT02032524|584014469|FG001|Period 2: LTS13769 Study|Other|0|||
161718738|NCT02032524|584014470|FG002|Period 2: LTS13769 Study|Other|0|||
161718739|NCT02032524|584014471|FG003|Period 2: LTS13769 Study|Other|0|||
161718740|NCT02032524|584014472|FG004|Period 2: LTS13769 Study|Other|0|||
161718741|NCT02032524|584014473|FG005|Period 2: LTS13769 Study|Other|1|||
161718742|NCT05635838|584015816|FG000|16-Week DBVC Period|Adverse Event|2|||
161718743|NCT05635838|584015817|FG001|16-Week DBVC Period|Adverse Event|0|||
161718744|NCT05635838|584015818|FG002|16-Week DBVC Period|Adverse Event|0|||
161718745|NCT05635838|584015819|FG003|16-Week DBVC Period|Adverse Event|0|||
161718746|NCT05635838|584015816|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
161718747|NCT05635838|584015817|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
161718748|NCT05635838|584015818|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
161718749|NCT05635838|584015819|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
161718750|NCT05635838|584015816|FG000|16-Week DBVC Period|Physician Decision|0|||
161718751|NCT05635838|584015817|FG001|16-Week DBVC Period|Physician Decision|1|||
161718752|NCT05635838|584015818|FG002|16-Week DBVC Period|Physician Decision|0|||
161718753|NCT05635838|584015819|FG003|16-Week DBVC Period|Physician Decision|0|||
161718754|NCT05635838|584015816|FG000|16-Week DBVC Period|Protocol Violation|1|||
161718755|NCT05635838|584015817|FG001|16-Week DBVC Period|Protocol Violation|0|||
161718756|NCT05635838|584015818|FG002|16-Week DBVC Period|Protocol Violation|0|||
161718757|NCT05635838|584015819|FG003|16-Week DBVC Period|Protocol Violation|0|||
161718758|NCT05635838|584015816|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
161718759|NCT05635838|584015817|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
161718760|NCT05635838|584015818|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
161718761|NCT05635838|584015819|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
161718762|NCT05635838|584015816|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
161718763|NCT05635838|584015817|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161718764|NCT05635838|584015818|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161718765|NCT05635838|584015819|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161718766|NCT05635838|584015816|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
161718767|NCT05635838|584015817|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
161718768|NCT05635838|584015818|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
161718769|NCT05635838|584015819|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
161718770|NCT05635838|584015816|FG000|16-Week OLE Period|Adverse Event|0|||
161718771|NCT05635838|584015817|FG001|16-Week OLE Period|Adverse Event|0|||
161718772|NCT05635838|584015818|FG002|16-Week OLE Period|Adverse Event|0|||
161718773|NCT05635838|584015819|FG003|16-Week OLE Period|Adverse Event|2|||
161718774|NCT05635838|584015816|FG000|16-Week OLE Period|Lost to Follow-up|0|||
161718775|NCT05635838|584015817|FG001|16-Week OLE Period|Lost to Follow-up|0|||
161718776|NCT05635838|584015818|FG002|16-Week OLE Period|Lost to Follow-up|1|||
161718777|NCT05635838|584015819|FG003|16-Week OLE Period|Lost to Follow-up|3|||
161718778|NCT05635838|584015816|FG000|16-Week OLE Period|Physician Decision|0|||
161718779|NCT05635838|584015817|FG001|16-Week OLE Period|Physician Decision|0|||
161718780|NCT05635838|584015818|FG002|16-Week OLE Period|Physician Decision|0|||
161718781|NCT05635838|584015819|FG003|16-Week OLE Period|Physician Decision|1|||
161718782|NCT05635838|584015816|FG000|16-Week OLE Period|Protocol Violation|0|||
161718783|NCT05635838|584015817|FG001|16-Week OLE Period|Protocol Violation|0|||
161718784|NCT05635838|584015818|FG002|16-Week OLE Period|Protocol Violation|1|||
161718785|NCT05635838|584015819|FG003|16-Week OLE Period|Protocol Violation|1|||
161718786|NCT05635838|584015816|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
161718787|NCT05635838|584015817|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
161718788|NCT05635838|584015818|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
161718789|NCT05635838|584015819|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
161718790|NCT05635838|584015816|FG000|16-Week OLE Period|Pregnancy|0|||
161718791|NCT05635838|584015817|FG001|16-Week OLE Period|Pregnancy|0|||
161718792|NCT05635838|584015818|FG002|16-Week OLE Period|Pregnancy|1|||
161718793|NCT05635838|584015819|FG003|16-Week OLE Period|Pregnancy|0|||
161718794|NCT01486316|584015820|FG000|Overall Study|Device explanted with/without re-implant|3|||
161718795|NCT01486316|584015821|FG001|Overall Study|Device explanted with/without re-implant|2|||
161718796|NCT01486316|584015822|FG002|Overall Study|Device explanted with/without re-implant|0|||
161718797|NCT01486316|584015823|FG003|Overall Study|Device explanted with/without re-implant|2|||
161718798|NCT01486316|584015820|FG000|Overall Study|Not meeting eligibility criteria|0|||
161718799|NCT01486316|584015821|FG001|Overall Study|Not meeting eligibility criteria|0|||
161718800|NCT01486316|584015822|FG002|Overall Study|Not meeting eligibility criteria|1|||
161718801|NCT01486316|584015823|FG003|Overall Study|Not meeting eligibility criteria|0|||
161718802|NCT01486316|584015820|FG000|Overall Study|Withdrawal by Subject|1|||
161718803|NCT01486316|584015821|FG001|Overall Study|Withdrawal by Subject|0|||
161718804|NCT01486316|584015822|FG002|Overall Study|Withdrawal by Subject|3|||
161718805|NCT01486316|584015823|FG003|Overall Study|Withdrawal by Subject|0|||
161718806|NCT01486316|584015820|FG000|Overall Study|Physician Decision|0|||
161718807|NCT01486316|584015821|FG001|Overall Study|Physician Decision|0|||
161718808|NCT01486316|584015822|FG002|Overall Study|Physician Decision|1|||
161718809|NCT01486316|584015823|FG003|Overall Study|Physician Decision|0|||
161718810|NCT01486316|584015820|FG000|Overall Study|Death|0|||
161718811|NCT01486316|584015821|FG001|Overall Study|Death|1|||
161718812|NCT01486316|584015822|FG002|Overall Study|Death|0|||
161718813|NCT01486316|584015823|FG003|Overall Study|Death|0|||
161718814|NCT05094154|584015831|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
161718815|NCT05094154|584015832|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
161718816|NCT05094154|584015831|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
161718817|NCT05094154|584015832|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
161718818|NCT01266148|584015839|FG000|Overall Study|Adverse Event|2|||
161718819|NCT01266148|584015840|FG001|Overall Study|Adverse Event|0|||
161718820|NCT01266148|584015839|FG000|Overall Study|Ongoing rejection|1|||
161718821|NCT01266148|584015840|FG001|Overall Study|Ongoing rejection|0|||
161718822|NCT01266148|584015839|FG000|Overall Study|2 2R rejections|1|||
161718823|NCT01266148|584015840|FG001|Overall Study|2 2R rejections|0|||
161718824|NCT01266148|584015839|FG000|Overall Study|Death|2|||
161718825|NCT01266148|584015840|FG001|Overall Study|Death|3|||
161718826|NCT01266148|584015839|FG000|Overall Study|missing mGFR value + AE|1|||
161718827|NCT01266148|584015840|FG001|Overall Study|missing mGFR value + AE|0|||
161718828|NCT02531035|584015841|FG000|Overall Study|Death|0|||
161718829|NCT02531035|584015842|FG001|Overall Study|Death|1|||
161718830|NCT02531035|584015841|FG000|Overall Study|Protocol Violation|1|||
161718831|NCT02531035|584015842|FG001|Overall Study|Protocol Violation|1|||
161718832|NCT02531035|584015841|FG000|Overall Study|Noncompliance with study drug|8|||
161718833|NCT02531035|584015842|FG001|Overall Study|Noncompliance with study drug|3|||
161718834|NCT02531035|584015841|FG000|Overall Study|Physician Decision|1|||
161718835|NCT02531035|584015842|FG001|Overall Study|Physician Decision|0|||
161718836|NCT02531035|584015841|FG000|Overall Study|Adverse Event|16|||
161718837|NCT02531035|584015842|FG001|Overall Study|Adverse Event|45|||
161718838|NCT02531035|584015841|FG000|Overall Study|Other|3|||
161718839|NCT02531035|584015842|FG001|Overall Study|Other|2|||
161718840|NCT02531035|584015841|FG000|Overall Study|Withdrawal by Subject|42|||
161718841|NCT02531035|584015842|FG001|Overall Study|Withdrawal by Subject|32|||
161718842|NCT02531035|584015841|FG000|Overall Study|Lost to Follow-up|8|||
161718843|NCT02531035|584015842|FG001|Overall Study|Lost to Follow-up|10|||
161718844|NCT02531035|584015841|FG000|Overall Study|Randomized, not treated|2|||
161718845|NCT02531035|584015842|FG001|Overall Study|Randomized, not treated|1|||
161718846|NCT01543490|584015843|FG000|Overall Study|Adverse Event|4|||
161718847|NCT01543490|584015844|FG001|Overall Study|Adverse Event|0|||
161718848|NCT01543490|584015843|FG000|Overall Study|Physician Decision|1|||
161718849|NCT01543490|584015844|FG001|Overall Study|Physician Decision|0|||
161718850|NCT01543490|584015843|FG000|Overall Study|Lack of Efficacy|3|||
161718851|NCT01543490|584015844|FG001|Overall Study|Lack of Efficacy|3|||
161718852|NCT01543490|584015843|FG000|Overall Study|Lost to Follow-up|5|||
161718853|NCT01543490|584015844|FG001|Overall Study|Lost to Follow-up|0|||
161718854|NCT01543490|584015843|FG000|Overall Study|Withdrawal by Subject|2|||
161718855|NCT01543490|584015844|FG001|Overall Study|Withdrawal by Subject|0|||
161718856|NCT01543490|584015843|FG000|Overall Study|Other-Various Administrative Reasons|1|||
161718857|NCT01543490|584015844|FG001|Overall Study|Other-Various Administrative Reasons|2|||
161718858|NCT01853228|584015848|FG000|Phase 1|Lack of Efficacy|8|||
161718859|NCT01853228|584015849|FG001|Phase 1|Lack of Efficacy|0|||
161718860|NCT01853228|584015848|FG000|Phase 1|Other|1|||
161718861|NCT01853228|584015849|FG001|Phase 1|Other|0|||
161718862|NCT01853228|584015848|FG000|Phase 2|Physician Decision|0|||
161718863|NCT01853228|584015849|FG001|Phase 2|Physician Decision|1|||
161718864|NCT01853228|584015848|FG000|Phase 2|Proceed To Transplant|0|||
161718865|NCT01853228|584015849|FG001|Phase 2|Proceed To Transplant|3|||
161718866|NCT01853228|584015848|FG000|Phase 2|Lack of Efficacy|0|||
161718867|NCT01853228|584015849|FG001|Phase 2|Lack of Efficacy|4|||
161718868|NCT02400346|584015855|FG000|Overall Study|Adverse Event|24|||
161718869|NCT02400346|584015855|FG000|Overall Study|Lack of Efficacy|9|||
161718870|NCT02400346|584015855|FG000|Overall Study|Non-compliance with IMP|1|||
161718871|NCT02400346|584015855|FG000|Overall Study|Withdrawal by Subject|7|||
161718872|NCT02400346|584015855|FG000|Overall Study|Administrative or other reason(s)|2|||
161718873|NCT02400346|584015855|FG000|Overall Study|Lost to Follow-up|1|||
161718874|NCT01300286|584015856|FG000|Overall Study|did not get dosed|1|||
161718875|NCT03635190|584015857|FG000|Overall Study|Lost to Follow-up|4|||
161718876|NCT03635190|584015857|FG000|Overall Study|Death|3|||
161718877|NCT03635190|584015857|FG000|Overall Study|Withdrawal by Subject|1|||
161718878|NCT03635190|584015857|FG000|Overall Study|Patient moved and did not return for follow up|1|||
161718879|NCT02767570|584015860|FG000|Overall Study|Lost to Follow-up|3|||
161718880|NCT02767570|584015861|FG001|Overall Study|Lost to Follow-up|0|||
161718881|NCT02767570|584015860|FG000|Overall Study|COVID shutdown|2|||
161718882|NCT02767570|584015861|FG001|Overall Study|COVID shutdown|5|||
161718883|NCT02767570|584015860|FG000|Overall Study|Increased pain|2|||
161718884|NCT02767570|584015861|FG001|Overall Study|Increased pain|0|||
161718885|NCT02767570|584015860|FG000|Overall Study|Withdrawal by Subject|1|||
161718886|NCT02767570|584015861|FG001|Overall Study|Withdrawal by Subject|3|||
161718887|NCT02767570|584015860|FG000|Overall Study|Unrelated medical issue|1|||
161718888|NCT02767570|584015861|FG001|Overall Study|Unrelated medical issue|1|||
161718889|NCT02767570|584015860|FG000|Overall Study|Received intra-articular injection|0|||
161718890|NCT02767570|584015861|FG001|Overall Study|Received intra-articular injection|1|||
161718891|NCT03692910|584015863|FG000|Overall Study|Lost to Follow-up|4|||
161718892|NCT03692910|584015864|FG001|Overall Study|Lost to Follow-up|0|||
161718893|NCT03692910|584015865|FG002|Overall Study|Lost to Follow-up|0|||
161718894|NCT03692910|584015863|FG000|Overall Study|Withdrawal by Subject|2|||
161718895|NCT03692910|584015864|FG001|Overall Study|Withdrawal by Subject|0|||
161718896|NCT03692910|584015865|FG002|Overall Study|Withdrawal by Subject|0|||
161718897|NCT03846947|584015870|FG000|Overall Study|technical issues with imaging sequence|2|||
161718898|NCT03060577|584015871|FG000|Overall Study|Withdrawal by Subject|25|||
161718899|NCT03060577|584015872|FG001|Overall Study|Withdrawal by Subject|5|||
161718900|NCT03060577|584015871|FG000|Overall Study|Physician Decision|4|||
161718901|NCT03060577|584015872|FG001|Overall Study|Physician Decision|3|||
161718902|NCT03060577|584015871|FG000|Overall Study|Lost to Follow-up|3|||
161718903|NCT03060577|584015872|FG001|Overall Study|Lost to Follow-up|0|||
161718904|NCT03060577|584015871|FG000|Overall Study|Death|7|||
161718905|NCT03060577|584015872|FG001|Overall Study|Death|1|||
161718906|NCT03060577|584015871|FG000|Overall Study|Adverse Event|9|||
161718907|NCT03060577|584015872|FG001|Overall Study|Adverse Event|1|||
161718908|NCT03060577|584015871|FG000|Overall Study|Inclusion/Exclusion|1|||
161718909|NCT03060577|584015872|FG001|Overall Study|Inclusion/Exclusion|0|||
161718910|NCT03060577|584015871|FG000|Overall Study|Other|8|||
161718911|NCT03060577|584015872|FG001|Overall Study|Other|2|||
161718912|NCT03216265|584015873|FG000|Overall Study|Adverse Event|2|||
161718913|NCT03216265|584015874|FG001|Overall Study|Adverse Event|0|||
161718914|NCT03216265|584015875|FG002|Overall Study|Adverse Event|2|||
161718915|NCT03216265|584015873|FG000|Overall Study|Lost to Follow-up|0|||
161718916|NCT03216265|584015874|FG001|Overall Study|Lost to Follow-up|1|||
161718917|NCT03216265|584015875|FG002|Overall Study|Lost to Follow-up|0|||
161718918|NCT03216265|584015873|FG000|Overall Study|Withdrawal by Subject|0|||
161718919|NCT03216265|584015874|FG001|Overall Study|Withdrawal by Subject|0|||
161718920|NCT03216265|584015875|FG002|Overall Study|Withdrawal by Subject|1|||
161718921|NCT01306058|584015876|FG000|Overall Study|Death|1|||
161718922|NCT01306058|584015876|FG000|Overall Study|Enrolled but did not get treatment|1|||
161718923|NCT01539837|584015877|FG000|Overall Study|reduce neutrophil level|0|||
161718924|NCT01539837|584015878|FG001|Overall Study|reduce neutrophil level|1|||
161718925|NCT01539837|584015879|FG002|Overall Study|reduce neutrophil level|1|||
161718926|NCT01539837|584015877|FG000|Overall Study|bad compliance|0|||
161718927|NCT01539837|584015878|FG001|Overall Study|bad compliance|0|||
161718928|NCT01539837|584015879|FG002|Overall Study|bad compliance|1|||
161718929|NCT00849693|584015880|FG000|Acute Treatment Phase|Adverse Event|12|||
161718930|NCT00849693|584015881|FG001|Acute Treatment Phase|Adverse Event|7|||
161718931|NCT00849693|584015882|FG002|Acute Treatment Phase|Adverse Event|6|||
161718932|NCT00849693|584015883|FG003|Acute Treatment Phase|Adverse Event|4|||
161718933|NCT00849693|584015880|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
161718934|NCT00849693|584015881|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
161718935|NCT00849693|584015882|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
161718936|NCT00849693|584015883|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
161718937|NCT00849693|584015880|FG000|Acute Treatment Phase|Protocol Violation|1|||
161718938|NCT00849693|584015881|FG001|Acute Treatment Phase|Protocol Violation|5|||
161718939|NCT00849693|584015882|FG002|Acute Treatment Phase|Protocol Violation|2|||
161718940|NCT00849693|584015883|FG003|Acute Treatment Phase|Protocol Violation|6|||
161718941|NCT00849693|584015880|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
161718942|NCT00849693|584015881|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
161718943|NCT00849693|584015882|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
161718944|NCT00849693|584015883|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
161718945|NCT00849693|584015880|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
161718946|NCT00849693|584015881|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
161718947|NCT00849693|584015882|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
161718948|NCT00849693|584015883|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
161718949|NCT00849693|584015880|FG000|Acute Treatment Phase|Physician Decision|2|||
161718950|NCT00849693|584015881|FG001|Acute Treatment Phase|Physician Decision|1|||
161718951|NCT00849693|584015882|FG002|Acute Treatment Phase|Physician Decision|2|||
161718952|NCT00849693|584015883|FG003|Acute Treatment Phase|Physician Decision|1|||
161718953|NCT00849693|584015880|FG000|Acute Treatment Phase|Sponsor decision|0|||
161718954|NCT00849693|584015881|FG001|Acute Treatment Phase|Sponsor decision|0|||
161718955|NCT00849693|584015882|FG002|Acute Treatment Phase|Sponsor decision|1|||
161718956|NCT00849693|584015883|FG003|Acute Treatment Phase|Sponsor decision|0|||
161718957|NCT00849693|584015880|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
161718958|NCT00849693|584015881|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
161718959|NCT00849693|584015882|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
161718960|NCT00849693|584015883|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
161718961|NCT00849693|584015880|FG000|Extension Phase|Adverse Event|4|||
161718962|NCT00849693|584015881|FG001|Extension Phase|Adverse Event|6|||
161718963|NCT00849693|584015882|FG002|Extension Phase|Adverse Event|3|||
161718964|NCT00849693|584015883|FG003|Extension Phase|Adverse Event|7|||
161718965|NCT00849693|584015880|FG000|Extension Phase|Lost to Follow-up|7|||
161718966|NCT00849693|584015881|FG001|Extension Phase|Lost to Follow-up|5|||
161718967|NCT00849693|584015882|FG002|Extension Phase|Lost to Follow-up|6|||
161718968|NCT00849693|584015883|FG003|Extension Phase|Lost to Follow-up|6|||
161718969|NCT00849693|584015880|FG000|Extension Phase|Protocol Violation|0|||
161718970|NCT00849693|584015881|FG001|Extension Phase|Protocol Violation|3|||
161718971|NCT00849693|584015882|FG002|Extension Phase|Protocol Violation|2|||
161718972|NCT00849693|584015883|FG003|Extension Phase|Protocol Violation|3|||
161718973|NCT00849693|584015880|FG000|Extension Phase|Withdrawal by Subject|6|||
161718974|NCT00849693|584015881|FG001|Extension Phase|Withdrawal by Subject|9|||
161718975|NCT00849693|584015882|FG002|Extension Phase|Withdrawal by Subject|10|||
161718976|NCT00849693|584015883|FG003|Extension Phase|Withdrawal by Subject|15|||
161718977|NCT00849693|584015880|FG000|Extension Phase|Parent or caregiver decision|9|||
161718978|NCT00849693|584015881|FG001|Extension Phase|Parent or caregiver decision|4|||
161718979|NCT00849693|584015882|FG002|Extension Phase|Parent or caregiver decision|10|||
161718980|NCT00849693|584015883|FG003|Extension Phase|Parent or caregiver decision|5|||
161718981|NCT00849693|584015880|FG000|Extension Phase|Physician Decision|1|||
161718982|NCT00849693|584015881|FG001|Extension Phase|Physician Decision|1|||
161718983|NCT00849693|584015882|FG002|Extension Phase|Physician Decision|2|||
161718984|NCT00849693|584015883|FG003|Extension Phase|Physician Decision|0|||
161718985|NCT00849693|584015880|FG000|Extension Phase|Sponsor decision|1|||
161718986|NCT00849693|584015881|FG001|Extension Phase|Sponsor decision|0|||
161718987|NCT00849693|584015882|FG002|Extension Phase|Sponsor decision|0|||
161718988|NCT00849693|584015883|FG003|Extension Phase|Sponsor decision|1|||
161718989|NCT00849693|584015880|FG000|Extension Phase|Lack of Efficacy|2|||
161718990|NCT00849693|584015881|FG001|Extension Phase|Lack of Efficacy|2|||
161718991|NCT00849693|584015882|FG002|Extension Phase|Lack of Efficacy|2|||
161718992|NCT00849693|584015883|FG003|Extension Phase|Lack of Efficacy|1|||
161718993|NCT01978912|584015886|FG000|Overall Study|Adverse Event|0|||
161718994|NCT01978912|584015887|FG001|Overall Study|Adverse Event|1|||
161718995|NCT01978912|584015888|FG002|Overall Study|Adverse Event|0|||
161718996|NCT01978912|584015889|FG003|Overall Study|Adverse Event|0|||
161718997|NCT01978912|584015886|FG000|Overall Study|Lost to Follow-up|1|||
161718998|NCT01978912|584015887|FG001|Overall Study|Lost to Follow-up|1|||
161718999|NCT01978912|584015888|FG002|Overall Study|Lost to Follow-up|0|||
161719000|NCT01978912|584015889|FG003|Overall Study|Lost to Follow-up|1|||
161719001|NCT01978912|584015886|FG000|Overall Study|Withdrawal by Subject|1|||
161719002|NCT01978912|584015887|FG001|Overall Study|Withdrawal by Subject|0|||
161719003|NCT01978912|584015888|FG002|Overall Study|Withdrawal by Subject|2|||
161719004|NCT01978912|584015889|FG003|Overall Study|Withdrawal by Subject|2|||
161719005|NCT01978912|584015886|FG000|Overall Study|Lumbar Surgery|1|||
161719006|NCT01978912|584015887|FG001|Overall Study|Lumbar Surgery|0|||
161719007|NCT01978912|584015888|FG002|Overall Study|Lumbar Surgery|1|||
161719008|NCT01978912|584015889|FG003|Overall Study|Lumbar Surgery|0|||
161719009|NCT01978912|584015886|FG000|Overall Study|Intradiscal Steroid Injection|0|||
161719010|NCT01978912|584015887|FG001|Overall Study|Intradiscal Steroid Injection|1|||
161719011|NCT01978912|584015888|FG002|Overall Study|Intradiscal Steroid Injection|0|||
161719012|NCT01978912|584015889|FG003|Overall Study|Intradiscal Steroid Injection|0|||
161719013|NCT00224107|584015890|FG000|Overall Study|Adverse Event|20|||
161719014|NCT00224107|584015891|FG001|Overall Study|Adverse Event|6|||
161719015|NCT00224107|584015890|FG000|Overall Study|Protocol Violation|2|||
161719016|NCT00224107|584015891|FG001|Overall Study|Protocol Violation|3|||
161719017|NCT00224107|584015890|FG000|Overall Study|Withdrawal by Subject|1|||
161719018|NCT00224107|584015891|FG001|Overall Study|Withdrawal by Subject|4|||
161719019|NCT00224107|584015890|FG000|Overall Study|Lack of Efficacy|2|||
161719020|NCT00224107|584015891|FG001|Overall Study|Lack of Efficacy|0|||
161719021|NCT00224107|584015890|FG000|Overall Study|Lost to Follow-up|4|||
161719022|NCT00224107|584015891|FG001|Overall Study|Lost to Follow-up|0|||
161719023|NCT00224107|584015890|FG000|Overall Study|Physician Decision|1|||
161719024|NCT00224107|584015891|FG001|Overall Study|Physician Decision|0|||
161719025|NCT00224107|584015890|FG000|Overall Study|Other|1|||
161719026|NCT00224107|584015891|FG001|Overall Study|Other|1|||
161719027|NCT01408537|584015892|FG000|Overall Study|Withdrawal by Subject|2|||
161719028|NCT01408537|584015892|FG000|Overall Study|Protocol Violation|3|||
161719029|NCT01408537|584015892|FG000|Overall Study|Lost to Follow-up|3|||
161719030|NCT03707977|584015897|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
161719031|NCT03707977|584015898|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
161719032|NCT03707977|584015899|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
161719033|NCT03707977|584015897|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
161719034|NCT03707977|584015898|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
161719035|NCT03707977|584015899|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
161719036|NCT03069690|584015900|FG000|Pregnancy Intervention|Pregnancy loss|9|||
161719037|NCT03069690|584015901|FG001|Pregnancy Intervention|Pregnancy loss|4|||
161719038|NCT03069690|584015902|FG002|Pregnancy Intervention|Pregnancy loss|0|||
161719039|NCT03069690|584015903|FG003|Pregnancy Intervention|Pregnancy loss|0|||
161719040|NCT03069690|584015904|FG004|Pregnancy Intervention|Pregnancy loss|0|||
161719041|NCT03069690|584015905|FG005|Pregnancy Intervention|Pregnancy loss|0|||
161719042|NCT03069690|584015900|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
161719043|NCT03069690|584015901|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
161719044|NCT03069690|584015902|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
161719045|NCT03069690|584015903|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
161719046|NCT03069690|584015904|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
161719047|NCT03069690|584015905|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
161719048|NCT03069690|584015900|FG000|Postpartum Intervention|Lost to Follow-up|0|||
161719049|NCT03069690|584015901|FG001|Postpartum Intervention|Lost to Follow-up|0|||
161719050|NCT03069690|584015902|FG002|Postpartum Intervention|Lost to Follow-up|5|||
161719051|NCT03069690|584015903|FG003|Postpartum Intervention|Lost to Follow-up|5|||
161719052|NCT03069690|584015904|FG004|Postpartum Intervention|Lost to Follow-up|2|||
161719053|NCT03069690|584015905|FG005|Postpartum Intervention|Lost to Follow-up|4|||
161719054|NCT02564120|584015906|FG000|Overall Study|Did not return release forms|160|||
161719055|NCT02564120|584015906|FG000|Overall Study|Death|58|||
161719056|NCT02564120|584015906|FG000|Overall Study|Withdrawal by Subject|204|||
161719057|NCT02564120|584015906|FG000|Overall Study|Other medical condition|24|||
161719058|NCT03842709|584015907|FG000|Overall Study|Withdrawal by Subject|3|||
161719059|NCT03842709|584015908|FG001|Overall Study|Withdrawal by Subject|3|||
161719060|NCT03842709|584015907|FG000|Overall Study|Lost to Follow-up|1|||
161719061|NCT03842709|584015908|FG001|Overall Study|Lost to Follow-up|0|||
161719062|NCT00641147|584015909|FG000|Completed 4 Months.|Physician Decision|1|||
161719063|NCT00641147|584015910|FG001|Completed 4 Months.|Physician Decision|0|||
161719064|NCT00641147|584015909|FG000|Completed 4 Months.|Adverse Event|1|||
161719065|NCT00641147|584015910|FG001|Completed 4 Months.|Adverse Event|0|||
161719066|NCT00641147|584015909|FG000|Completed 8 Months.|Physician Decision|2|||
161719067|NCT00641147|584015910|FG001|Completed 8 Months.|Physician Decision|1|||
161719068|NCT00641147|584015909|FG000|Completed 8 Months.|non compliance|1|||
161719069|NCT00641147|584015910|FG001|Completed 8 Months.|non compliance|0|||
161719070|NCT00641147|584015909|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
161719071|NCT00641147|584015910|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
161719072|NCT00641147|584015909|FG000|Completed 12 Months.|Physician Decision|1|||
161719073|NCT00641147|584015910|FG001|Completed 12 Months.|Physician Decision|1|||
161719074|NCT00641147|584015909|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
161719075|NCT00641147|584015910|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
161719076|NCT00641147|584015909|FG000|Completed 16 Months.|Physician Decision|1|||
161719077|NCT00641147|584015910|FG001|Completed 16 Months.|Physician Decision|0|||
161719078|NCT00641147|584015909|FG000|Completed 16 Months.|Lost to Follow-up|1|||
161719079|NCT00641147|584015910|FG001|Completed 16 Months.|Lost to Follow-up|0|||
161719080|NCT00791128|584015911|FG000|Overall Study|Adverse Event|4|||
161719081|NCT00791128|584015911|FG000|Overall Study|Device migration|2|||
161719082|NCT00791128|584015911|FG000|Overall Study|non-compliance by subject|2|||
161719083|NCT00791128|584015911|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
161719084|NCT01629667|584015912|FG000|Overall Study|Lost to Follow-up|0|||
161719085|NCT01629667|584015913|FG001|Overall Study|Lost to Follow-up|1|||
161719086|NCT01629667|584015914|FG002|Overall Study|Lost to Follow-up|1|||
161719087|NCT01629667|584015912|FG000|Overall Study|Withdrawal by Subject|31|||
161719088|NCT01629667|584015913|FG001|Overall Study|Withdrawal by Subject|20|||
161719089|NCT01629667|584015914|FG002|Overall Study|Withdrawal by Subject|28|||
161719090|NCT01629667|584015912|FG000|Overall Study|Death|1|||
161719091|NCT01629667|584015913|FG001|Overall Study|Death|5|||
161719092|NCT01629667|584015914|FG002|Overall Study|Death|3|||
161719093|NCT01629667|584015912|FG000|Overall Study|Randomized, not treated|2|||
161719094|NCT01629667|584015913|FG001|Overall Study|Randomized, not treated|1|||
161719095|NCT01629667|584015914|FG002|Overall Study|Randomized, not treated|0|||
161719096|NCT01629667|584015912|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
161719097|NCT01629667|584015913|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
161719098|NCT01629667|584015914|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
161719099|NCT01629667|584015912|FG000|Overall Study|Requiring lung transplant|2|||
161719100|NCT01629667|584015913|FG001|Overall Study|Requiring lung transplant|1|||
161719101|NCT01629667|584015914|FG002|Overall Study|Requiring lung transplant|3|||
161719102|NCT01629667|584015912|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
161719103|NCT01629667|584015913|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
161719104|NCT01629667|584015914|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
161719105|NCT01629667|584015912|FG000|Overall Study|Started other medicine|1|||
161719106|NCT01629667|584015913|FG001|Overall Study|Started other medicine|0|||
161719107|NCT01629667|584015914|FG002|Overall Study|Started other medicine|1|||
161719108|NCT01629667|584015912|FG000|Overall Study|Site error in safety follow-up|0|||
161719109|NCT01629667|584015913|FG001|Overall Study|Site error in safety follow-up|0|||
161719110|NCT01629667|584015914|FG002|Overall Study|Site error in safety follow-up|1|||
161719111|NCT01629667|584015912|FG000|Overall Study|Enrolled in another clinical study|0|||
161719112|NCT01629667|584015913|FG001|Overall Study|Enrolled in another clinical study|1|||
161719113|NCT01629667|584015914|FG002|Overall Study|Enrolled in another clinical study|0|||
161719114|NCT01629667|584015912|FG000|Overall Study|Code break|1|||
161719115|NCT01629667|584015913|FG001|Overall Study|Code break|0|||
161719116|NCT01629667|584015914|FG002|Overall Study|Code break|0|||
161719117|NCT00984659|584015915|FG000|2-week Run-in Period|Adverse Event|8|||
161719118|NCT00984659|584015916|FG001|2-week Run-in Period|Adverse Event|0|||
161719119|NCT00984659|584015917|FG002|2-week Run-in Period|Adverse Event|0|||
161719120|NCT00984659|584015918|FG003|2-week Run-in Period|Adverse Event|0|||
161719121|NCT00984659|584015915|FG000|2-week Run-in Period|Protocol Violation|5|||
161719122|NCT00984659|584015916|FG001|2-week Run-in Period|Protocol Violation|0|||
161719123|NCT00984659|584015917|FG002|2-week Run-in Period|Protocol Violation|0|||
161719124|NCT00984659|584015918|FG003|2-week Run-in Period|Protocol Violation|0|||
161719125|NCT00984659|584015915|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
161719126|NCT00984659|584015916|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
161719127|NCT00984659|584015917|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
161719128|NCT00984659|584015918|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
161719129|NCT00984659|584015915|FG000|2-week Run-in Period|Lost to Follow-up|3|||
161719130|NCT00984659|584015916|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161719131|NCT00984659|584015917|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161719132|NCT00984659|584015918|FG003|2-week Run-in Period|Lost to Follow-up|0|||
161719133|NCT00984659|584015915|FG000|2-week Run-in Period|Physician Decision|10|||
161719134|NCT00984659|584015916|FG001|2-week Run-in Period|Physician Decision|0|||
161719135|NCT00984659|584015917|FG002|2-week Run-in Period|Physician Decision|0|||
161719136|NCT00984659|584015918|FG003|2-week Run-in Period|Physician Decision|0|||
161719137|NCT00984659|584015915|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
161719138|NCT00984659|584015916|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161719139|NCT00984659|584015917|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161719140|NCT00984659|584015918|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
161719141|NCT00984659|584015915|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
161719142|NCT00984659|584015916|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161719143|NCT00984659|584015917|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161719144|NCT00984659|584015918|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161719145|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
161719146|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
161719147|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
161719148|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
161719149|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
161719150|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
161719151|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
161719152|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
161719153|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
161719154|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
161719155|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
161719156|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
161719157|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161719158|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161719159|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
161719160|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161719161|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161719162|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
161719163|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
161719164|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
161719165|NCT00891657|584015921|FG000|Overall Study|Withdrawal by Subject|1|||
161719166|NCT00891657|584015922|FG001|Overall Study|Withdrawal by Subject|1|||
161719167|NCT00537823|584015930|FG000|Overall Study|Adverse Event|2|||
161719168|NCT00537823|584015931|FG001|Overall Study|Adverse Event|0|||
161719169|NCT03455543|584015932|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
161719170|NCT03455543|584015933|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
161719171|NCT03455543|584015934|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
161719172|NCT03455543|584015932|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
161719173|NCT03455543|584015933|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
161719174|NCT03455543|584015934|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
161719175|NCT03455543|584015932|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
161719176|NCT03455543|584015933|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
161719177|NCT03455543|584015934|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
161719178|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
161719179|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
161719180|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
161719181|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
161719182|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
161719183|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
161719184|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
161719185|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
161719186|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
161719187|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
161719188|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
161719189|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
161719190|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
161719191|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
161719192|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
161719193|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
161719194|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
161719195|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
161719196|NCT00779038|584015935|FG000|Overall Study|Study Prematurely Terminated|13|||
161719197|NCT02717546|584015936|FG000|Overall Study|Lost to Follow-up|12|||
161719198|NCT00909090|584015937|FG000|Overall Study|Lost to Follow-up|17|||
161719199|NCT00909090|584015938|FG001|Overall Study|Lost to Follow-up|17|||
161719200|NCT02926573|584015940|FG000|Overall Study|Nausea|1|||
161719201|NCT02926573|584015941|FG001|Overall Study|Nausea|0|||
161719202|NCT02926573|584015940|FG000|Overall Study|Remain intubated|2|||
161719203|NCT02926573|584015941|FG001|Overall Study|Remain intubated|2|||
161719204|NCT02926573|584015940|FG000|Overall Study|Change in surgery plan|3|||
161719205|NCT02926573|584015941|FG001|Overall Study|Change in surgery plan|1|||
161719206|NCT02926573|584015940|FG000|Overall Study|Change to outpatient status|5|||
161719207|NCT02926573|584015941|FG001|Overall Study|Change to outpatient status|1|||
161719208|NCT02926573|584015940|FG000|Overall Study|Withdrawal by Subject|0|||
161719209|NCT02926573|584015941|FG001|Overall Study|Withdrawal by Subject|2|||
161719210|NCT02926573|584015940|FG000|Overall Study|Return to operating room|0|||
161719211|NCT02926573|584015941|FG001|Overall Study|Return to operating room|2|||
161719212|NCT02926573|584015940|FG000|Overall Study|Delirium|0|||
161719213|NCT02926573|584015941|FG001|Overall Study|Delirium|1|||
161719214|NCT03633331|584015949|FG000|Overall Study|Withdrawal by Subject|1|||
161719215|NCT01009294|584015950|FG000|Overall Study|Study discontinued by Sponsor|6|||
161719216|NCT00949650|584015951|FG000|Overall Study|Progressive disease|188|||
161719217|NCT00949650|584015952|FG001|Overall Study|Progressive disease|19|||
161719218|NCT00949650|584015951|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
161719219|NCT00949650|584015952|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
161719220|NCT00949650|584015951|FG000|Overall Study|Other Adverse Event (AE)|28|||
161719221|NCT00949650|584015952|FG001|Overall Study|Other Adverse Event (AE)|17|||
161719222|NCT00949650|584015951|FG000|Overall Study|Protocol Violation|1|||
161719223|NCT00949650|584015952|FG001|Overall Study|Protocol Violation|4|||
161719224|NCT00949650|584015951|FG000|Overall Study|Refusal to continue medication|7|||
161719225|NCT00949650|584015952|FG001|Overall Study|Refusal to continue medication|11|||
161719226|NCT00949650|584015951|FG000|Overall Study|Not treated|1|||
161719227|NCT00949650|584015952|FG001|Overall Study|Not treated|4|||
161719228|NCT00949650|584015951|FG000|Overall Study|Other not specified above|5|||
161719229|NCT00949650|584015952|FG001|Overall Study|Other not specified above|0|||
161719230|NCT00940342|584015955|FG000|Overall Study|Adverse Event|0|||
161719231|NCT00940342|584015956|FG001|Overall Study|Adverse Event|2|||
161719232|NCT00940342|584015957|FG002|Overall Study|Adverse Event|1|||
161719233|NCT03249350|584015960|FG000|Overall Study|Participant did not initiate treatment|5|||
161719234|NCT03249350|584015961|FG001|Overall Study|Participant did not initiate treatment|8|||
161719235|NCT01716169|584015963|FG000|Overall Study|Adverse Event|1|||
161719236|NCT01716169|584015963|FG000|Overall Study|Lost to Follow-up|1|||
161719237|NCT01716169|584015963|FG000|Overall Study|Withdrawal by Subject|1|||
161719238|NCT01716169|584015963|FG000|Overall Study|inconsistent dressing application|1|||
161719239|NCT00553787|584015964|FG000|Overall Study|Adverse Event|34|||
161719240|NCT00553787|584015965|FG001|Overall Study|Adverse Event|21|||
161719241|NCT00553787|584015966|FG002|Overall Study|Adverse Event|67|||
161719242|NCT00553787|584015964|FG000|Overall Study|Lost to Follow-up|132|||
161719243|NCT00553787|584015965|FG001|Overall Study|Lost to Follow-up|44|||
161719244|NCT00553787|584015966|FG002|Overall Study|Lost to Follow-up|78|||
161719245|NCT00553787|584015964|FG000|Overall Study|Withdrawal by Subject|151|||
161719246|NCT00553787|584015965|FG001|Overall Study|Withdrawal by Subject|40|||
161719247|NCT00553787|584015966|FG002|Overall Study|Withdrawal by Subject|83|||
161719248|NCT00553787|584015964|FG000|Overall Study|Lack of Efficacy|31|||
161719249|NCT00553787|584015965|FG001|Overall Study|Lack of Efficacy|1|||
161719250|NCT00553787|584015966|FG002|Overall Study|Lack of Efficacy|3|||
161719251|NCT00553787|584015964|FG000|Overall Study|Pregnancy|0|||
161719252|NCT00553787|584015965|FG001|Overall Study|Pregnancy|1|||
161719253|NCT00553787|584015966|FG002|Overall Study|Pregnancy|2|||
161719254|NCT00553787|584015964|FG000|Overall Study|non compliance|4|||
161719255|NCT00553787|584015965|FG001|Overall Study|non compliance|0|||
161719256|NCT00553787|584015966|FG002|Overall Study|non compliance|11|||
161719257|NCT00553787|584015964|FG000|Overall Study|Requirement for restricted medication|8|||
161719258|NCT00553787|584015965|FG001|Overall Study|Requirement for restricted medication|7|||
161719259|NCT00553787|584015966|FG002|Overall Study|Requirement for restricted medication|5|||
161719260|NCT00553787|584015964|FG000|Overall Study|Other|18|||
161719261|NCT00553787|584015965|FG001|Overall Study|Other|10|||
161719262|NCT00553787|584015966|FG002|Overall Study|Other|13|||
161719263|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
161719264|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
161719265|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
161719266|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
161719267|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
161719268|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161719269|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161719270|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161719271|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
161719272|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
161719273|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
161719274|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
161719275|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161719276|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161719277|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
161719278|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161719279|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161719280|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161719281|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161719282|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161719283|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161719284|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161719285|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
161719286|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161719287|NCT01894516|584017415|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
161719288|NCT01894516|584017416|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161719289|NCT01894516|584017417|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161719290|NCT01894516|584017418|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
161719291|NCT01894516|584017415|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161719292|NCT01894516|584017416|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161719293|NCT01894516|584017417|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
161719294|NCT01894516|584017418|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161719295|NCT00893113|584017426|FG000|Overall Study|Lost to Follow-up|4|||
161719296|NCT00893113|584017427|FG001|Overall Study|Lost to Follow-up|8|||
161719297|NCT00893113|584017426|FG000|Overall Study|Early Termination|1|||
161719298|NCT00893113|584017427|FG001|Overall Study|Early Termination|1|||
161719299|NCT00893113|584017426|FG000|Overall Study|Withdrew Consent|8|||
161719300|NCT00893113|584017427|FG001|Overall Study|Withdrew Consent|7|||
161719301|NCT01240811|584017430|FG000|Overall Study|Physician Decision|0|||
161719302|NCT01240811|584017431|FG001|Overall Study|Physician Decision|1|||
161719303|NCT01240811|584017432|FG002|Overall Study|Physician Decision|0|||
161719304|NCT01240811|584017430|FG000|Overall Study|Withdrawal by Subject|0|||
161719305|NCT01240811|584017431|FG001|Overall Study|Withdrawal by Subject|0|||
161719306|NCT01240811|584017432|FG002|Overall Study|Withdrawal by Subject|1|||
161719307|NCT04168645|584017442|FG000|Overall Study|Lost to Follow-up|23|||
161719308|NCT04168645|584017443|FG001|Overall Study|Lost to Follow-up|28|||
161719309|NCT04168645|584017444|FG002|Overall Study|Lost to Follow-up|15|||
161719310|NCT04168645|584017445|FG003|Overall Study|Lost to Follow-up|12|||
161719311|NCT04168645|584017442|FG000|Overall Study|Death|1|||
161719312|NCT04168645|584017443|FG001|Overall Study|Death|1|||
161719313|NCT04168645|584017444|FG002|Overall Study|Death|0|||
161719314|NCT04168645|584017445|FG003|Overall Study|Death|0|||
161719315|NCT04168645|584017442|FG000|Overall Study|Withdrawal by Subject|5|||
161719316|NCT04168645|584017443|FG001|Overall Study|Withdrawal by Subject|2|||
161719317|NCT04168645|584017444|FG002|Overall Study|Withdrawal by Subject|2|||
161719318|NCT04168645|584017445|FG003|Overall Study|Withdrawal by Subject|2|||
161719319|NCT04168645|584017442|FG000|Overall Study|Administrative Withdrawal|3|||
161719320|NCT04168645|584017443|FG001|Overall Study|Administrative Withdrawal|1|||
161719321|NCT04168645|584017444|FG002|Overall Study|Administrative Withdrawal|1|||
161719322|NCT04168645|584017445|FG003|Overall Study|Administrative Withdrawal|3|||
161719323|NCT02114203|584017446|FG000|Overall Study|Adverse Event|0|||
161719324|NCT02114203|584017447|FG001|Overall Study|Adverse Event|1|||
161719325|NCT02114203|584017448|FG002|Overall Study|Adverse Event|0|||
161719326|NCT02114203|584017446|FG000|Overall Study|Withdrawal by Subject|0|||
161719327|NCT02114203|584017447|FG001|Overall Study|Withdrawal by Subject|1|||
161719328|NCT02114203|584017448|FG002|Overall Study|Withdrawal by Subject|0|||
161719329|NCT01518699|584017449|FG000|Period 2|Protocol Violation|1|||
161719330|NCT01518699|584017450|FG001|Period 2|Protocol Violation|1|||
161719331|NCT01518699|584017451|FG002|Period 2|Protocol Violation|0|||
161719332|NCT01518699|584017452|FG003|Period 2|Protocol Violation|0|||
161719333|NCT01518699|584017453|FG004|Period 2|Protocol Violation|0|||
161719334|NCT01518699|584017454|FG005|Period 2|Protocol Violation|0|||
161719335|NCT01518699|584017449|FG000|Period 2|Lost to Follow-up|0|||
161719336|NCT01518699|584017450|FG001|Period 2|Lost to Follow-up|1|||
161719337|NCT01518699|584017451|FG002|Period 2|Lost to Follow-up|0|||
161719338|NCT01518699|584017452|FG003|Period 2|Lost to Follow-up|0|||
161719339|NCT01518699|584017453|FG004|Period 2|Lost to Follow-up|0|||
161719340|NCT01518699|584017454|FG005|Period 2|Lost to Follow-up|0|||
161719341|NCT01518699|584017449|FG000|Period 2|Adverse Event|1|||
161719342|NCT01518699|584017450|FG001|Period 2|Adverse Event|0|||
161719343|NCT01518699|584017451|FG002|Period 2|Adverse Event|0|||
161719344|NCT01518699|584017452|FG003|Period 2|Adverse Event|0|||
161719345|NCT01518699|584017453|FG004|Period 2|Adverse Event|0|||
161719346|NCT01518699|584017454|FG005|Period 2|Adverse Event|0|||
161719347|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
161719348|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
161719349|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
161719350|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
161719351|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
161719352|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
161719353|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
161719354|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
161719355|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
161719356|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
161719357|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
161719358|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
161719359|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
161719360|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
161719361|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
161719362|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
161719363|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
161719364|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
161719365|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
161719366|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
161719367|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
161719368|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
161719369|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
161719370|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
161719371|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
161719372|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
161719373|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
161719374|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
161719375|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
161719376|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
161719377|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
161719378|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
161719379|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
161719380|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
161719381|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
161719382|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
161719383|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161719384|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161719385|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
161719386|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161719387|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
161719388|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
161719389|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
161719390|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
161719391|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
161719392|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
161719393|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
161719394|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
161719395|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161719396|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161719397|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161719398|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
161719399|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161719400|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161719401|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
161719402|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161719403|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
161719404|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
161719405|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
161719406|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
161719407|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
161719408|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161719409|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161719410|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161719411|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
161719412|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
161719413|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
161719414|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
161719415|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
161719416|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
161719417|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
161719418|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
161719419|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161719420|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161719421|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
161719422|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161719423|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
161719424|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
161719425|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
161719426|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
161719427|NCT01981122|584017464|FG000|Overall Study|Withdrawal by Subject|0|||
161719428|NCT01981122|584017465|FG001|Overall Study|Withdrawal by Subject|2|||
161719429|NCT01981122|584017464|FG000|Overall Study|Protocol Violation|0|||
161719430|NCT01981122|584017465|FG001|Overall Study|Protocol Violation|1|||
161719431|NCT01981122|584017464|FG000|Overall Study|Lost to Follow-up|0|||
161719432|NCT01981122|584017465|FG001|Overall Study|Lost to Follow-up|1|||
161719433|NCT01981122|584017464|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
161719434|NCT01981122|584017465|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
161719435|NCT01981122|584017464|FG000|Overall Study|Death|14|||
161719436|NCT01981122|584017465|FG001|Overall Study|Death|15|||
161719437|NCT00089843|584017471|FG000|Overall Study|Withdrawal by Subject|1|||
161719438|NCT00089843|584017472|FG001|Overall Study|Withdrawal by Subject|4|||
161719439|NCT00089843|584017473|FG002|Overall Study|Withdrawal by Subject|5|||
161719440|NCT00089843|584017474|FG003|Overall Study|Withdrawal by Subject|6|||
161719441|NCT00089843|584017471|FG000|Overall Study|Physician Decision|1|||
161719442|NCT00089843|584017472|FG001|Overall Study|Physician Decision|0|||
161719443|NCT00089843|584017473|FG002|Overall Study|Physician Decision|0|||
161719444|NCT00089843|584017474|FG003|Overall Study|Physician Decision|1|||
161719445|NCT01295905|584017481|FG000|Overall Study|Did not meet inclusion criteria|1|||
161719446|NCT01295905|584017482|FG001|Overall Study|Did not meet inclusion criteria|0|||
161719447|NCT01295905|584017481|FG000|Overall Study|Met exclusion criteria|1|||
161719448|NCT01295905|584017482|FG001|Overall Study|Met exclusion criteria|0|||
161719449|NCT00553059|584017483|FG000|Overall Study|Deemed ineligible|1|||
161719450|NCT00553059|584017484|FG001|Overall Study|Deemed ineligible|1|||
161719451|NCT00553059|584017483|FG000|Overall Study|Drug supply not available|0|||
161719452|NCT00553059|584017484|FG001|Overall Study|Drug supply not available|1|||
161719453|NCT01966731|584017485|FG000|Overall Study|Death|2|||
161719454|NCT01966731|584017485|FG000|Overall Study|Lost to Follow-up|1|||
161719455|NCT01966731|584017485|FG000|Overall Study|Physician Decision|2|||
161719456|NCT01966731|584017485|FG000|Overall Study|Follow up is not complete|600|||
161719457|NCT01966731|584017485|FG000|Overall Study|Screening Failure|29|||
161719458|NCT01966731|584017485|FG000|Overall Study|Found to be ineligible|1|||
161719459|NCT00592683|584017486|FG000|Overall Study|Found ineligible|0|||
161719460|NCT00592683|584017487|FG001|Overall Study|Found ineligible|1|||
161719461|NCT00592683|584017486|FG000|Overall Study|Withdrawal by Subject|1|||
161719462|NCT00592683|584017487|FG001|Overall Study|Withdrawal by Subject|0|||
161719463|NCT00592683|584017486|FG000|Overall Study|Adverse Event|0|||
161719464|NCT00592683|584017487|FG001|Overall Study|Adverse Event|2|||
161719465|NCT00592683|584017486|FG000|Overall Study|Protocol Violation|1|||
161719466|NCT00592683|584017487|FG001|Overall Study|Protocol Violation|0|||
161719467|NCT00592683|584017486|FG000|Overall Study|Study drug expired|1|||
161719468|NCT00592683|584017487|FG001|Overall Study|Study drug expired|0|||
161719469|NCT00592683|584017486|FG000|Overall Study|Other|1|||
161719470|NCT00592683|584017487|FG001|Overall Study|Other|0|||
161719471|NCT00592683|584017486|FG000|Overall Study|Lost to Follow-up|0|||
161719472|NCT00592683|584017487|FG001|Overall Study|Lost to Follow-up|1|||
161719473|NCT00201201|584017488|FG000|Overall Study|Death|0|||
161719474|NCT00201201|584017489|FG001|Overall Study|Death|2|||
161719475|NCT00201201|584017488|FG000|Overall Study|Withdrawal by Subject|5|||
161719476|NCT00201201|584017489|FG001|Overall Study|Withdrawal by Subject|5|||
161719477|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
161719478|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
161719479|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161719480|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
161719481|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161719482|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161719483|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
161719484|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161719485|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161719486|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161719487|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161719488|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161719489|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
161719490|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
161719491|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
161719492|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
161719493|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
161719494|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
161719495|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161719496|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
161719497|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161719498|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161719499|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
161719500|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161719501|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161719502|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
161719503|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161719504|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161719505|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
161719506|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161719507|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161719508|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
161719509|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161719510|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
161719511|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
161719512|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
161719513|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161719514|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
161719515|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161719516|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161719517|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
161719518|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161719519|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
161719520|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
161719521|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
161719522|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
161719523|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
161719524|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
161719525|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
161719526|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
161719527|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
161719528|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
161719529|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
161719530|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
161719531|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
161719532|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
161719533|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
161719534|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
161719535|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
161719536|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
161719537|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
161719538|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
161719539|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
161719540|NCT03240081|584017500|FG000|Overall Study|Withdrawal by Subject|0|||
161719541|NCT03240081|584017501|FG001|Overall Study|Withdrawal by Subject|2|||
161719542|NCT03240081|584017500|FG000|Overall Study|Lost to Follow-up|0|||
161719543|NCT03240081|584017501|FG001|Overall Study|Lost to Follow-up|1|||
161719544|NCT04601272|584017502|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
161719545|NCT04601272|584017503|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
161719546|NCT04601272|584017504|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
161719547|NCT03671369|584017507|FG000|Overall Study|Other|1|||
161719548|NCT03671369|584017507|FG000|Overall Study|Withdrawal by Subject|289|||
161719549|NCT03671369|584017507|FG000|Overall Study|Not willing to be vaccinated|1|||
161719550|NCT04382651|584017508|FG000|Overall Study|Death|26|||
161719551|NCT04382651|584017509|FG001|Overall Study|Death|23|||
161719552|NCT04382651|584017508|FG000|Overall Study|Lost to Follow-up|3|||
161719553|NCT04382651|584017509|FG001|Overall Study|Lost to Follow-up|4|||
161719554|NCT04382651|584017508|FG000|Overall Study|Withdrawal by Subject|2|||
161719555|NCT04382651|584017509|FG001|Overall Study|Withdrawal by Subject|0|||
161719556|NCT04382651|584017508|FG000|Overall Study|Physician Decision|0|||
161719557|NCT04382651|584017509|FG001|Overall Study|Physician Decision|1|||
161719558|NCT01507545|584017515|FG000|Overall Study|Withdrawal by Subject|6|||
161719559|NCT01507545|584017516|FG001|Overall Study|Withdrawal by Subject|2|||
161719560|NCT01507545|584017515|FG000|Overall Study|Lost to Follow-up|1|||
161719561|NCT01507545|584017516|FG001|Overall Study|Lost to Follow-up|0|||
161719562|NCT01507545|584017515|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
161719563|NCT01507545|584017516|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
161719564|NCT01507545|584017515|FG000|Overall Study|Progressive disease|60|||
161719565|NCT01507545|584017516|FG001|Overall Study|Progressive disease|27|||
161719566|NCT01507545|584017515|FG000|Overall Study|Other|6|||
161719567|NCT01507545|584017516|FG001|Overall Study|Other|4|||
161719568|NCT00790296|584017518|FG000|Overall Study|Did not meet study eligibility criteria|1|||
161719569|NCT00790296|584017519|FG001|Overall Study|Did not meet study eligibility criteria|1|||
161719570|NCT00790296|584017518|FG000|Overall Study|Adverse Event|0|||
161719571|NCT00790296|584017519|FG001|Overall Study|Adverse Event|1|||
161719572|NCT02612077|584017520|FG000|Overall Study|Adverse Event|3|||
161719573|NCT02612077|584017520|FG000|Overall Study|Withdrawal by Subject|9|||
161719574|NCT02612077|584017520|FG000|Overall Study|Protocol Violation|28|||
161719575|NCT02612077|584017520|FG000|Overall Study|Lost to Follow-up|20|||
161719576|NCT02612077|584017520|FG000|Overall Study|Death|377|||
161719577|NCT02612077|584017520|FG000|Overall Study|Moved or Changed Medical Team|23|||
161719578|NCT02612077|584017520|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
161719579|NCT02612077|584017520|FG000|Overall Study|Disease Progression|3|||
161719580|NCT02612077|584017520|FG000|Overall Study|Unknown reason|2|||
161719581|NCT01753518|584017521|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
161719582|NCT01753518|584017522|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
161719583|NCT01753518|584017521|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
161719584|NCT01753518|584017522|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
161719585|NCT01753518|584017521|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
161719586|NCT01753518|584017522|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
161719587|NCT01753518|584017521|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
161719588|NCT01753518|584017522|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
161719589|NCT01971476|584017523|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
161719590|NCT01971476|584017524|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
161719591|NCT01971476|584017525|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
161719592|NCT01971476|584017523|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
161719593|NCT01971476|584017524|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
161719594|NCT01971476|584017525|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
161719595|NCT01971476|584017523|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
161719596|NCT01971476|584017524|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
161719597|NCT01971476|584017525|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
161719598|NCT05121103|584017528|FG000|Overall Study|Progressive disease|2|||
161719599|NCT05121103|584017529|FG001|Overall Study|Progressive disease|1|||
161719600|NCT05121103|584017530|FG002|Overall Study|Progressive disease|6|||
161719601|NCT05121103|584017528|FG000|Overall Study|Physician Decision|2|||
161719602|NCT05121103|584017529|FG001|Overall Study|Physician Decision|1|||
161719603|NCT05121103|584017530|FG002|Overall Study|Physician Decision|0|||
161719604|NCT05121103|584017528|FG000|Overall Study|Withdrawal by Subject|0|||
161719605|NCT05121103|584017529|FG001|Overall Study|Withdrawal by Subject|1|||
161719606|NCT05121103|584017530|FG002|Overall Study|Withdrawal by Subject|0|||
161719607|NCT00514449|584017531|FG000|Overall Study|Withdrawal by Subject|1|||
161719608|NCT00514449|584017532|FG001|Overall Study|Withdrawal by Subject|2|||
161719609|NCT00514449|584017531|FG000|Overall Study|Protocol Violation|1|||
161719610|NCT00514449|584017532|FG001|Overall Study|Protocol Violation|2|||
161719611|NCT00514449|584017531|FG000|Overall Study|Lost to Follow-up|1|||
161719612|NCT00514449|584017532|FG001|Overall Study|Lost to Follow-up|0|||
161719613|NCT05897853|584017542|FG000|Overall Study|Lost to Follow-up|2|||
161719614|NCT05897853|584017543|FG001|Overall Study|Lost to Follow-up|0|||
161719615|NCT05897853|584017542|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
161719616|NCT05897853|584017543|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
161719617|NCT02609399|584017547|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
161719618|NCT02609399|584017548|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
161719619|NCT02609399|584017547|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
161719620|NCT02609399|584017548|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
161719621|NCT02609399|584017547|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
161719622|NCT02609399|584017548|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
161719623|NCT04458857|584017552|FG000|Overall Study|Adverse Event|0|||
161719624|NCT04458857|584017553|FG001|Overall Study|Adverse Event|1|||
161719625|NCT04458857|584017554|FG002|Overall Study|Adverse Event|0|||
161719626|NCT04458857|584017552|FG000|Overall Study|Withdrawal by Subject|2|||
161719627|NCT04458857|584017553|FG001|Overall Study|Withdrawal by Subject|0|||
161719628|NCT04458857|584017554|FG002|Overall Study|Withdrawal by Subject|0|||
161719629|NCT04458857|584017552|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161719630|NCT04458857|584017553|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161719631|NCT04458857|584017554|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161719632|NCT04458857|584017552|FG000|Overall Study|Non-compliance with study drug|0|||
161719633|NCT04458857|584017553|FG001|Overall Study|Non-compliance with study drug|1|||
161719634|NCT04458857|584017554|FG002|Overall Study|Non-compliance with study drug|0|||
161719635|NCT04458857|584017552|FG000|Overall Study|Lost to Follow-up|4|||
161719636|NCT04458857|584017553|FG001|Overall Study|Lost to Follow-up|1|||
161719637|NCT04458857|584017554|FG002|Overall Study|Lost to Follow-up|0|||
161719638|NCT00306891|584017555|FG000|Part A|Withdrawal by Subject|1|||
161719639|NCT00306891|584017556|FG001|Part A|Withdrawal by Subject|1|||
161719640|NCT00306891|584017557|FG002|Part A|Withdrawal by Subject|0|||
161719641|NCT00306891|584017558|FG003|Part A|Withdrawal by Subject|0|||
161719642|NCT00306891|584017555|FG000|Part A|Condition under investigation worsened|2|||
161719643|NCT00306891|584017556|FG001|Part A|Condition under investigation worsened|2|||
161719644|NCT00306891|584017557|FG002|Part A|Condition under investigation worsened|0|||
161719645|NCT00306891|584017558|FG003|Part A|Condition under investigation worsened|0|||
161719646|NCT00306891|584017555|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161719647|NCT00306891|584017556|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
161719648|NCT00306891|584017557|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161719649|NCT00306891|584017558|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161719650|NCT00306891|584017555|FG000|Part A|Partial bowel obstruction|1|||
161719651|NCT00306891|584017556|FG001|Part A|Partial bowel obstruction|0|||
161719652|NCT00306891|584017557|FG002|Part A|Partial bowel obstruction|0|||
161719653|NCT00306891|584017558|FG003|Part A|Partial bowel obstruction|0|||
161719654|NCT00306891|584017555|FG000|Part A|Reaccumul. of ascites following drainage|0|||
161719655|NCT00306891|584017556|FG001|Part A|Reaccumul. of ascites following drainage|1|||
161719656|NCT00306891|584017557|FG002|Part A|Reaccumul. of ascites following drainage|0|||
161719657|NCT00306891|584017558|FG003|Part A|Reaccumul. of ascites following drainage|0|||
161719658|NCT00306891|584017555|FG000|Part A|Suspicion of second malignancy|0|||
161719659|NCT00306891|584017556|FG001|Part A|Suspicion of second malignancy|1|||
161719660|NCT00306891|584017557|FG002|Part A|Suspicion of second malignancy|0|||
161719661|NCT00306891|584017558|FG003|Part A|Suspicion of second malignancy|0|||
161719662|NCT00306891|584017555|FG000|Part A|QTC interval outwith elig. criteria|1|||
161719663|NCT00306891|584017556|FG001|Part A|QTC interval outwith elig. criteria|0|||
161719664|NCT00306891|584017557|FG002|Part A|QTC interval outwith elig. criteria|0|||
161719665|NCT00306891|584017558|FG003|Part A|QTC interval outwith elig. criteria|0|||
161719666|NCT00306891|584017555|FG000|Part B|Death|0|||
161719667|NCT00306891|584017556|FG001|Part B|Death|0|||
161719668|NCT00306891|584017557|FG002|Part B|Death|1|||
161719669|NCT00306891|584017558|FG003|Part B|Death|2|||
161719670|NCT00306891|584017555|FG000|Part B|Adverse Event|0|||
161719671|NCT00306891|584017556|FG001|Part B|Adverse Event|0|||
161719672|NCT00306891|584017557|FG002|Part B|Adverse Event|5|||
161719673|NCT00306891|584017558|FG003|Part B|Adverse Event|5|||
161719674|NCT00306891|584017555|FG000|Part B|Withdrawal by Subject|0|||
161719675|NCT00306891|584017556|FG001|Part B|Withdrawal by Subject|0|||
161719676|NCT00306891|584017557|FG002|Part B|Withdrawal by Subject|3|||
161719677|NCT00306891|584017558|FG003|Part B|Withdrawal by Subject|1|||
161719678|NCT00306891|584017555|FG000|Part B|Condition under investigation worsened|0|||
161719679|NCT00306891|584017556|FG001|Part B|Condition under investigation worsened|0|||
161719680|NCT00306891|584017557|FG002|Part B|Condition under investigation worsened|2|||
161719681|NCT00306891|584017558|FG003|Part B|Condition under investigation worsened|8|||
161719682|NCT00306891|584017555|FG000|Part B|Development of study specific disc crit.|0|||
161719683|NCT00306891|584017556|FG001|Part B|Development of study specific disc crit.|0|||
161719684|NCT00306891|584017557|FG002|Part B|Development of study specific disc crit.|0|||
161719685|NCT00306891|584017558|FG003|Part B|Development of study specific disc crit.|1|||
161719686|NCT00853905|584017562|FG000|Overall Study|Lost to Follow-up|1|||
161719687|NCT00853905|584017563|FG001|Overall Study|Lost to Follow-up|3|||
161719688|NCT00853905|584017562|FG000|Overall Study|Withdrawal by Subject|0|||
161719689|NCT00853905|584017563|FG001|Overall Study|Withdrawal by Subject|1|||
161719690|NCT00853905|584017562|FG000|Overall Study|never had surgery|1|||
161719691|NCT00853905|584017563|FG001|Overall Study|never had surgery|0|||
161719692|NCT00847561|584017566|FG000|Overall Study|Withdrawal by Subject|4|||
161719693|NCT00847561|584017567|FG001|Overall Study|Withdrawal by Subject|3|||
161719694|NCT00847561|584017566|FG000|Overall Study|Unable to schedule|9|||
161719695|NCT00847561|584017567|FG001|Overall Study|Unable to schedule|1|||
161719696|NCT01333189|584017568|FG000|Overall Study|Time constraints|1|||
161719697|NCT01333189|584017569|FG001|Overall Study|Time constraints|0|||
161719698|NCT01333189|584017568|FG000|Overall Study|Adverse Event|1|||
161719699|NCT01333189|584017569|FG001|Overall Study|Adverse Event|0|||
161719700|NCT01333189|584017568|FG000|Overall Study|Transportation difficulties|0|||
161719701|NCT01333189|584017569|FG001|Overall Study|Transportation difficulties|1|||
161719702|NCT01333189|584017568|FG000|Overall Study|Moved from region|0|||
161719703|NCT01333189|584017569|FG001|Overall Study|Moved from region|1|||
161719704|NCT01739595|584017571|FG000|Overall Study|Adverse Event|3|||
161719705|NCT01739595|584017572|FG001|Overall Study|Adverse Event|0|||
161719706|NCT01739595|584017573|FG002|Overall Study|Adverse Event|0|||
161719707|NCT01739595|584017571|FG000|Overall Study|Lost to Follow-up|2|||
161719708|NCT01739595|584017572|FG001|Overall Study|Lost to Follow-up|0|||
161719709|NCT01739595|584017573|FG002|Overall Study|Lost to Follow-up|0|||
161719710|NCT01739595|584017571|FG000|Overall Study|Withdrawal by Subject|2|||
161719711|NCT01739595|584017572|FG001|Overall Study|Withdrawal by Subject|1|||
161719712|NCT01739595|584017573|FG002|Overall Study|Withdrawal by Subject|2|||
161719713|NCT01739595|584017571|FG000|Overall Study|Eligibility issue|3|||
161719714|NCT01739595|584017572|FG001|Overall Study|Eligibility issue|0|||
161719715|NCT01739595|584017573|FG002|Overall Study|Eligibility issue|0|||
161719716|NCT01739595|584017571|FG000|Overall Study|Protocol Violation|1|||
161719717|NCT01739595|584017572|FG001|Overall Study|Protocol Violation|0|||
161719718|NCT01739595|584017573|FG002|Overall Study|Protocol Violation|0|||
161719719|NCT01739595|584017571|FG000|Overall Study|Lab assessment|1|||
161719720|NCT01739595|584017572|FG001|Overall Study|Lab assessment|0|||
161719721|NCT01739595|584017573|FG002|Overall Study|Lab assessment|0|||
161719722|NCT01739595|584017571|FG000|Overall Study|Drug discrepancy|1|||
161719723|NCT01739595|584017572|FG001|Overall Study|Drug discrepancy|0|||
161719724|NCT01739595|584017573|FG002|Overall Study|Drug discrepancy|0|||
161719725|NCT02725177|584017576|FG000|Overall Study|Physician Decision|4|||
161719726|NCT02725177|584017576|FG000|Overall Study|Adverse Event|1|||
161719727|NCT01089725|584017580|FG000|Overall Study|Adverse Event|1|||
161719728|NCT01089725|584017581|FG001|Overall Study|Adverse Event|1|||
161719729|NCT01089725|584017582|FG002|Overall Study|Adverse Event|0|||
161719730|NCT01089725|584017583|FG003|Overall Study|Adverse Event|0|||
161719731|NCT01089725|584017584|FG004|Overall Study|Adverse Event|2|||
161719732|NCT01089725|584017580|FG000|Overall Study|Lack of Efficacy|4|||
161719733|NCT01089725|584017581|FG001|Overall Study|Lack of Efficacy|3|||
161719734|NCT01089725|584017582|FG002|Overall Study|Lack of Efficacy|1|||
161719735|NCT01089725|584017583|FG003|Overall Study|Lack of Efficacy|0|||
161719736|NCT01089725|584017584|FG004|Overall Study|Lack of Efficacy|4|||
161719737|NCT01089725|584017580|FG000|Overall Study|Lost to Follow-up|2|||
161719738|NCT01089725|584017581|FG001|Overall Study|Lost to Follow-up|2|||
161719739|NCT01089725|584017582|FG002|Overall Study|Lost to Follow-up|0|||
161719740|NCT01089725|584017583|FG003|Overall Study|Lost to Follow-up|3|||
161719741|NCT01089725|584017584|FG004|Overall Study|Lost to Follow-up|0|||
161719742|NCT01089725|584017580|FG000|Overall Study|Protocol Violation|0|||
161719743|NCT01089725|584017581|FG001|Overall Study|Protocol Violation|0|||
161719744|NCT01089725|584017582|FG002|Overall Study|Protocol Violation|1|||
161719745|NCT01089725|584017583|FG003|Overall Study|Protocol Violation|1|||
161719746|NCT01089725|584017584|FG004|Overall Study|Protocol Violation|0|||
161719747|NCT01089725|584017580|FG000|Overall Study|Withdrawal by Subject|5|||
161719748|NCT01089725|584017581|FG001|Overall Study|Withdrawal by Subject|5|||
161719749|NCT01089725|584017582|FG002|Overall Study|Withdrawal by Subject|4|||
161719750|NCT01089725|584017583|FG003|Overall Study|Withdrawal by Subject|5|||
161719751|NCT01089725|584017584|FG004|Overall Study|Withdrawal by Subject|4|||
161719752|NCT01089725|584017580|FG000|Overall Study|Study Terminated by Sponsor|51|||
161719753|NCT01089725|584017581|FG001|Overall Study|Study Terminated by Sponsor|56|||
161719754|NCT01089725|584017582|FG002|Overall Study|Study Terminated by Sponsor|53|||
161719755|NCT01089725|584017583|FG003|Overall Study|Study Terminated by Sponsor|68|||
161719756|NCT01089725|584017584|FG004|Overall Study|Study Terminated by Sponsor|68|||
161719757|NCT01089725|584017580|FG000|Overall Study|Randomized, but not treated|0|||
161719758|NCT01089725|584017581|FG001|Overall Study|Randomized, but not treated|1|||
161719759|NCT01089725|584017582|FG002|Overall Study|Randomized, but not treated|2|||
161719760|NCT01089725|584017583|FG003|Overall Study|Randomized, but not treated|1|||
161719761|NCT01089725|584017584|FG004|Overall Study|Randomized, but not treated|2|||
161719762|NCT01089725|584017580|FG000|Overall Study|Other|3|||
161719763|NCT01089725|584017581|FG001|Overall Study|Other|0|||
161719764|NCT01089725|584017582|FG002|Overall Study|Other|0|||
161719765|NCT01089725|584017583|FG003|Overall Study|Other|1|||
161719766|NCT01089725|584017584|FG004|Overall Study|Other|0|||
161719767|NCT00375934|584018908|FG000|Overall Study|Adverse Event|1|||
161719768|NCT00375934|584018909|FG001|Overall Study|Adverse Event|1|||
161719769|NCT00375934|584018908|FG000|Overall Study|Withdrawal by Subject|2|||
161719770|NCT00375934|584018909|FG001|Overall Study|Withdrawal by Subject|2|||
161719771|NCT00375934|584018908|FG000|Overall Study|Lack of Efficacy|0|||
161719772|NCT00375934|584018909|FG001|Overall Study|Lack of Efficacy|2|||
161719773|NCT00375934|584018908|FG000|Overall Study|Physician Decision|0|||
161719774|NCT00375934|584018909|FG001|Overall Study|Physician Decision|1|||
161719775|NCT03191396|584018910|FG000|Overall Study|Lost to Follow-up|0|||
161719776|NCT03191396|584018911|FG001|Overall Study|Lost to Follow-up|3|||
161719777|NCT03191396|584018910|FG000|Overall Study|Withdrawal by Subject|3|||
161719778|NCT03191396|584018911|FG001|Overall Study|Withdrawal by Subject|2|||
161719779|NCT00486226|584018922|FG000|Overall Study|Death|3|||
161719780|NCT00486226|584018922|FG000|Overall Study|Adverse Event|1|||
161719781|NCT00486226|584018922|FG000|Overall Study|Withdrawal by Subject|1|||
161719782|NCT00486226|584018922|FG000|Overall Study|Lost to Follow-up|8|||
161719783|NCT00500149|584018923|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
161719784|NCT00500149|584018924|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
161719785|NCT00500149|584018923|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
161719786|NCT00500149|584018924|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
161719787|NCT00500149|584018923|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
161719788|NCT00500149|584018924|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
161719789|NCT00500149|584018923|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
161719790|NCT00500149|584018924|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
161719791|NCT00500149|584018923|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
161719792|NCT00500149|584018924|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
161719793|NCT00500149|584018923|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
161719794|NCT00500149|584018924|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
161719795|NCT00500149|584018923|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
161719796|NCT00500149|584018924|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
161719797|NCT01157169|584018925|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
161719798|NCT01157169|584018926|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
161719799|NCT01157169|584018925|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
161719800|NCT01157169|584018926|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
161719801|NCT02940886|584018927|FG000|Overall Study|Adverse Event|7|||
161719802|NCT02940886|584018928|FG001|Overall Study|Adverse Event|3|||
161719803|NCT02940886|584018927|FG000|Overall Study|Protocol Violation|0|||
161719804|NCT02940886|584018928|FG001|Overall Study|Protocol Violation|2|||
161719805|NCT02940886|584018927|FG000|Overall Study|Withdrawal by Subject|28|||
161719806|NCT02940886|584018928|FG001|Overall Study|Withdrawal by Subject|20|||
161719807|NCT02940886|584018927|FG000|Overall Study|Death|1|||
161719808|NCT02940886|584018928|FG001|Overall Study|Death|0|||
161719809|NCT02940886|584018927|FG000|Overall Study|Lack of Efficacy|1|||
161719810|NCT02940886|584018928|FG001|Overall Study|Lack of Efficacy|0|||
161719811|NCT02940886|584018927|FG000|Overall Study|Lost to Follow-up|49|||
161719812|NCT02940886|584018928|FG001|Overall Study|Lost to Follow-up|21|||
161719813|NCT02940886|584018927|FG000|Overall Study|Physician Decision|9|||
161719814|NCT02940886|584018928|FG001|Overall Study|Physician Decision|4|||
161719815|NCT02940886|584018927|FG000|Overall Study|Sponsor decision|0|||
161719816|NCT02940886|584018928|FG001|Overall Study|Sponsor decision|1|||
161719817|NCT02940886|584018927|FG000|Overall Study|No treatment|7|||
161719818|NCT02940886|584018928|FG001|Overall Study|No treatment|2|||
161719819|NCT02940886|584018927|FG000|Overall Study|Enrolment error|0|||
161719820|NCT02940886|584018928|FG001|Overall Study|Enrolment error|1|||
161719821|NCT03042611|584018929|FG000|Core Phase|Withdrawal by Subject|13|||
161719822|NCT03042611|584018930|FG001|Core Phase|Withdrawal by Subject|4|||
161719823|NCT03042611|584018931|FG002|Core Phase|Withdrawal by Subject|0|||
161719824|NCT03042611|584018932|FG003|Core Phase|Withdrawal by Subject|0|||
161719825|NCT03042611|584018929|FG000|Core Phase|Death|232|||
161719826|NCT03042611|584018930|FG001|Core Phase|Death|110|||
161719827|NCT03042611|584018931|FG002|Core Phase|Death|0|||
161719828|NCT03042611|584018932|FG003|Core Phase|Death|0|||
161719829|NCT03042611|584018929|FG000|Core Phase|Lost to Follow-up|4|||
161719830|NCT03042611|584018930|FG001|Core Phase|Lost to Follow-up|7|||
161719831|NCT03042611|584018931|FG002|Core Phase|Lost to Follow-up|0|||
161719832|NCT03042611|584018932|FG003|Core Phase|Lost to Follow-up|0|||
161719833|NCT03042611|584018929|FG000|Core Phase|Physician Decision|7|||
161719834|NCT03042611|584018930|FG001|Core Phase|Physician Decision|2|||
161719835|NCT03042611|584018931|FG002|Core Phase|Physician Decision|0|||
161719836|NCT03042611|584018932|FG003|Core Phase|Physician Decision|0|||
161719837|NCT03042611|584018929|FG000|Core Phase|Study Closed|0|||
161719838|NCT03042611|584018930|FG001|Core Phase|Study Closed|1|||
161719839|NCT03042611|584018931|FG002|Core Phase|Study Closed|0|||
161719840|NCT03042611|584018932|FG003|Core Phase|Study Closed|0|||
161719841|NCT03042611|584018929|FG000|Extension Phase|Death|0|||
161719842|NCT03042611|584018930|FG001|Extension Phase|Death|0|||
161719843|NCT03042611|584018931|FG002|Extension Phase|Death|34|||
161719844|NCT03042611|584018932|FG003|Extension Phase|Death|16|||
161719845|NCT03042611|584018929|FG000|Extension Phase|Lost to Follow-up|0|||
161719846|NCT03042611|584018930|FG001|Extension Phase|Lost to Follow-up|0|||
161719847|NCT03042611|584018931|FG002|Extension Phase|Lost to Follow-up|1|||
161719848|NCT03042611|584018932|FG003|Extension Phase|Lost to Follow-up|1|||
161719849|NCT03042611|584018929|FG000|Extension Phase|Study Closed|0|||
161719850|NCT03042611|584018930|FG001|Extension Phase|Study Closed|0|||
161719851|NCT03042611|584018931|FG002|Extension Phase|Study Closed|17|||
161719852|NCT03042611|584018932|FG003|Extension Phase|Study Closed|11|||
161719853|NCT02397655|584018935|FG000|Overall Study|data not completed|1301|||
161719854|NCT00545818|584018943|FG000|Overall Study|Protocol Violation|1|||
161719855|NCT00545818|584018944|FG001|Overall Study|Protocol Violation|0|||
161719856|NCT00545818|584018943|FG000|Overall Study|Adverse Event|1|||
161719857|NCT00545818|584018944|FG001|Overall Study|Adverse Event|1|||
161719858|NCT00545818|584018943|FG000|Overall Study|Lost to Follow-up|1|||
161719859|NCT00545818|584018944|FG001|Overall Study|Lost to Follow-up|6|||
161719860|NCT02623361|584018945|FG000|Overall Study|Protocol Violation|0|||
161719861|NCT02623361|584018946|FG001|Overall Study|Protocol Violation|1|||
161719862|NCT02623361|584018945|FG000|Overall Study|Withdrawal by Subject|0|||
161719863|NCT02623361|584018946|FG001|Overall Study|Withdrawal by Subject|1|||
161719864|NCT02732912|584018949|FG000|Overall Study|Discharged before night|2|||
161719865|NCT02732912|584018950|FG001|Overall Study|Discharged before night|6|||
161719866|NCT02732912|584018949|FG000|Overall Study|Incomplete completion of questionnaire|2|||
161719867|NCT02732912|584018950|FG001|Overall Study|Incomplete completion of questionnaire|3|||
161719868|NCT02732912|584018949|FG000|Overall Study|No outcome; discharged or refused|6|||
161719869|NCT02732912|584018950|FG001|Overall Study|No outcome; discharged or refused|9|||
161719870|NCT01873742|584018951|FG000|Overall Study|Lost to Follow-up|68|||
161719871|NCT01873742|584018952|FG001|Overall Study|Lost to Follow-up|76|||
161719872|NCT02498821|584018953|FG000|Overall Study|Screen failure|3|||
161719873|NCT02498821|584018954|FG001|Overall Study|Screen failure|5|||
161719874|NCT00942708|584018956|FG000|Overall Study|Withdrawal by Subject|1|||
161719875|NCT01457339|584018957|FG000|Period 3 (100 mg)|Adverse Event|0|||
161719876|NCT01457339|584018958|FG001|Period 3 (100 mg)|Adverse Event|1|||
161719877|NCT01457339|584018957|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
161719878|NCT01457339|584018958|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
161719879|NCT01457339|584018957|FG000|Period 6 (250 mg)|Family Emergency|1|||
161719880|NCT01457339|584018958|FG001|Period 6 (250 mg)|Family Emergency|0|||
161719881|NCT01457339|584018957|FG000|Period 6 (250 mg)|Personal appointment|0|||
161719882|NCT01457339|584018958|FG001|Period 6 (250 mg)|Personal appointment|1|||
161719883|NCT00995371|584018959|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
161719884|NCT00995371|584018960|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
161719885|NCT00673673|584018961|FG000|Overall Study|Progressive disease|27|||
161719886|NCT00673673|584018961|FG000|Overall Study|Adverse Event|4|||
161719887|NCT00673673|584018961|FG000|Overall Study|Withdrawal by Subject|3|||
161719888|NCT00673673|584018961|FG000|Overall Study|Investigators' discretion|2|||
161719889|NCT00206518|584018967|FG000|Overall Study|Lack of Efficacy|6|||
161719890|NCT00206518|584018968|FG001|Overall Study|Lack of Efficacy|4|||
161719891|NCT00206518|584018967|FG000|Overall Study|Adverse Event|2|||
161719892|NCT00206518|584018968|FG001|Overall Study|Adverse Event|1|||
161719893|NCT00206518|584018967|FG000|Overall Study|Physician Decision|1|||
161719894|NCT00206518|584018968|FG001|Overall Study|Physician Decision|0|||
161719895|NCT00206518|584018967|FG000|Overall Study|Protocol Violation|1|||
161719896|NCT00206518|584018968|FG001|Overall Study|Protocol Violation|1|||
161719897|NCT02335450|584018969|FG000|Overall Study|Pregnancy|1|||
161719898|NCT02613572|584018970|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
161719899|NCT02613572|584018971|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
161719900|NCT02613572|584018972|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
161719901|NCT02613572|584018970|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
161719902|NCT02613572|584018971|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
161719903|NCT02613572|584018972|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
161719904|NCT00231478|584018978|FG000|Overall Study|Protocol Violation|3|||
161719905|NCT00231478|584018979|FG001|Overall Study|Protocol Violation|2|||
161719906|NCT00231478|584018978|FG000|Overall Study|Refused Treatment|1|||
161719907|NCT00231478|584018979|FG001|Overall Study|Refused Treatment|1|||
161719908|NCT00231478|584018978|FG000|Overall Study|Withdrawal by Subject|1|||
161719909|NCT00231478|584018979|FG001|Overall Study|Withdrawal by Subject|0|||
161719910|NCT00231478|584018978|FG000|Overall Study|Adverse Event|0|||
161719911|NCT00231478|584018979|FG001|Overall Study|Adverse Event|1|||
161719912|NCT00231478|584018978|FG000|Overall Study|Administrative|3|||
161719913|NCT00231478|584018979|FG001|Overall Study|Administrative|2|||
161719914|NCT04538950|584018980|FG000|Overall Study|Pulmonary Issues|2|||
161719915|NCT04538950|584018980|FG000|Overall Study|illness|2|||
161719916|NCT05258058|584018981|FG000|Overall Study|Withdrawal by Subject|2|||
161719917|NCT04579393|584018984|FG000|Overall Study|Withdrawal by Subject|2|||
161719918|NCT04579393|584018985|FG001|Overall Study|Withdrawal by Subject|2|||
161719919|NCT04579393|584018984|FG000|Overall Study|Death|1|||
161719920|NCT04579393|584018985|FG001|Overall Study|Death|3|||
161719921|NCT00393458|584018988|FG000|Overall Study|Adverse Event|35|||
161719922|NCT00393458|584018989|FG001|Overall Study|Adverse Event|24|||
161719923|NCT00393458|584018990|FG002|Overall Study|Adverse Event|40|||
161719924|NCT00393458|584018991|FG003|Overall Study|Adverse Event|35|||
161719925|NCT00393458|584018988|FG000|Overall Study|Subject withdrew consent|27|||
161719926|NCT00393458|584018989|FG001|Overall Study|Subject withdrew consent|40|||
161719927|NCT00393458|584018990|FG002|Overall Study|Subject withdrew consent|33|||
161719928|NCT00393458|584018991|FG003|Overall Study|Subject withdrew consent|50|||
161719929|NCT00393458|584018988|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
161719930|NCT00393458|584018989|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
161719931|NCT00393458|584018990|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
161719932|NCT00393458|584018991|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
161719933|NCT00393458|584018988|FG000|Overall Study|Protocol deviation|11|||
161719934|NCT00393458|584018989|FG001|Overall Study|Protocol deviation|11|||
161719935|NCT00393458|584018990|FG002|Overall Study|Protocol deviation|11|||
161719936|NCT00393458|584018991|FG003|Overall Study|Protocol deviation|10|||
161719937|NCT00393458|584018988|FG000|Overall Study|Administrative problems|7|||
161719938|NCT00393458|584018989|FG001|Overall Study|Administrative problems|8|||
161719939|NCT00393458|584018990|FG002|Overall Study|Administrative problems|5|||
161719940|NCT00393458|584018991|FG003|Overall Study|Administrative problems|2|||
161719941|NCT00393458|584018988|FG000|Overall Study|Lost to Follow-up|5|||
161719942|NCT00393458|584018989|FG001|Overall Study|Lost to Follow-up|6|||
161719943|NCT00393458|584018990|FG002|Overall Study|Lost to Follow-up|5|||
161719944|NCT00393458|584018991|FG003|Overall Study|Lost to Follow-up|3|||
161719945|NCT00393458|584018988|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161719946|NCT00393458|584018989|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161719947|NCT00393458|584018990|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161719948|NCT00393458|584018991|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161719949|NCT00393458|584018988|FG000|Overall Study|Death|1|||
161719950|NCT00393458|584018989|FG001|Overall Study|Death|1|||
161719951|NCT00393458|584018990|FG002|Overall Study|Death|5|||
161719952|NCT00393458|584018991|FG003|Overall Study|Death|5|||
161719953|NCT00393458|584018988|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161719954|NCT00393458|584018989|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161719955|NCT00393458|584018990|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161719956|NCT00393458|584018991|FG003|Overall Study|Abnormal test procedure result(s)|2|||
161719957|NCT00393458|584018988|FG000|Overall Study|Subject no longer requires study drug|0|||
161719958|NCT00393458|584018989|FG001|Overall Study|Subject no longer requires study drug|1|||
161719959|NCT00393458|584018990|FG002|Overall Study|Subject no longer requires study drug|0|||
161719960|NCT00393458|584018991|FG003|Overall Study|Subject no longer requires study drug|0|||
161719961|NCT01282814|584018998|FG000|First Intervention|Emesis During Dosing Interval|0|||
161719962|NCT01282814|584018999|FG001|First Intervention|Emesis During Dosing Interval|3|||
161719963|NCT01282814|584018998|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
161719964|NCT01282814|584018999|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161719965|NCT01524289|584019000|FG000|Overall Study|Lost to Follow-up|0|||
161719966|NCT01524289|584019001|FG001|Overall Study|Lost to Follow-up|1|||
161719967|NCT01524289|584019000|FG000|Overall Study|Physician Decision|1|||
161719968|NCT01524289|584019001|FG001|Overall Study|Physician Decision|0|||
161719969|NCT01524289|584019000|FG000|Overall Study|Protocol Violation|5|||
161719970|NCT01524289|584019001|FG001|Overall Study|Protocol Violation|1|||
161719971|NCT01524289|584019000|FG000|Overall Study|Withdrawal by Subject|11|||
161719972|NCT01524289|584019001|FG001|Overall Study|Withdrawal by Subject|7|||
161719973|NCT01524289|584019000|FG000|Overall Study|Adverse Event|12|||
161719974|NCT01524289|584019001|FG001|Overall Study|Adverse Event|5|||
161719975|NCT01524289|584019000|FG000|Overall Study|Did not take study medication|1|||
161719976|NCT01524289|584019001|FG001|Overall Study|Did not take study medication|0|||
161719977|NCT02704429|584019004|FG000|Part A: 24 Weeks|Adverse Event|3|||
161719978|NCT02704429|584019005|FG001|Part A: 24 Weeks|Adverse Event|0|||
161719979|NCT02704429|584019004|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
161719980|NCT02704429|584019005|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
161719981|NCT02519231|584019006|FG000|Overall Study|Lost to Follow-up|2|||
161719982|NCT02519231|584019007|FG001|Overall Study|Lost to Follow-up|5|||
161719983|NCT02519231|584019006|FG000|Overall Study|Withdrawal by Subject|0|||
161719984|NCT02519231|584019007|FG001|Overall Study|Withdrawal by Subject|1|||
161719985|NCT00104104|584019008|FG000|Overall Study|Adverse Event|8|||
161719986|NCT00104104|584019009|FG001|Overall Study|Adverse Event|8|||
161719987|NCT00104104|584019008|FG000|Overall Study|Abnormal laboratory value(s)|20|||
161719988|NCT00104104|584019009|FG001|Overall Study|Abnormal laboratory value(s)|14|||
161719989|NCT00104104|584019008|FG000|Overall Study|Lack of Efficacy|0|||
161719990|NCT00104104|584019009|FG001|Overall Study|Lack of Efficacy|3|||
161719991|NCT00104104|584019008|FG000|Overall Study|Condition no longer requires study drug|7|||
161719992|NCT00104104|584019009|FG001|Overall Study|Condition no longer requires study drug|4|||
161719993|NCT00104104|584019008|FG000|Overall Study|Protocol Violation|5|||
161719994|NCT00104104|584019009|FG001|Overall Study|Protocol Violation|2|||
161719995|NCT00104104|584019008|FG000|Overall Study|Withdrawal by Subject|11|||
161719996|NCT00104104|584019009|FG001|Overall Study|Withdrawal by Subject|15|||
161719997|NCT00104104|584019008|FG000|Overall Study|Lost to Follow-up|3|||
161719998|NCT00104104|584019009|FG001|Overall Study|Lost to Follow-up|7|||
161719999|NCT00104104|584019008|FG000|Overall Study|Administrative problems|12|||
161720000|NCT00104104|584019009|FG001|Overall Study|Administrative problems|13|||
161720001|NCT00104104|584019008|FG000|Overall Study|Death|9|||
161720002|NCT00104104|584019009|FG001|Overall Study|Death|6|||
161720003|NCT00447421|584019011|FG000|Overall Study|Lack of Efficacy|1|||
161720004|NCT00447421|584019011|FG000|Overall Study|Adverse Event|3|||
161720005|NCT00447421|584019011|FG000|Overall Study|Sponsor Decision|2|||
161720006|NCT01707147|584019012|FG000|Overall Study|Administered Trajenta prior to contract|5|||
161720007|NCT01707147|584019012|FG000|Overall Study|Patients who have not taken Trajenta|1|||
161720008|NCT01707147|584019012|FG000|Overall Study|Follow-up failure|17|||
161720009|NCT01707147|584019012|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
161720010|NCT01326962|584019016|FG000|Overall Study|Adverse Event|1|||
161720011|NCT01326962|584019016|FG000|Overall Study|Withdrawal by Subject|1|||
161720012|NCT01326962|584019016|FG000|Overall Study|Lost to Follow-up|3|||
161720013|NCT01326962|584019016|FG000|Overall Study|Other|2|||
161720014|NCT02053246|584019017|FG000|Overall Study|Withdrawal by Subject|3|||
161720015|NCT02053246|584019017|FG000|Overall Study|Physician Decision|1|||
161720016|NCT02903511|584019021|FG000|Overall Study|Withdrawal by Subject|1|||
161720017|NCT02903511|584019022|FG001|Overall Study|Withdrawal by Subject|0|||
161720018|NCT02903511|584019021|FG000|Overall Study|Lost to Follow-up|3|||
161720019|NCT02903511|584019022|FG001|Overall Study|Lost to Follow-up|2|||
161720020|NCT00969618|584019023|FG000|Overall Study|Adverse Event|29|||
161720021|NCT00969618|584019023|FG000|Overall Study|Entry Criteria Not Met|3|||
161720022|NCT00969618|584019023|FG000|Overall Study|Lack of Efficacy|2|||
161720023|NCT00969618|584019023|FG000|Overall Study|Lost to Follow-up|7|||
161720024|NCT00969618|584019023|FG000|Overall Study|Physician Decision|1|||
161720025|NCT00969618|584019023|FG000|Overall Study|Protocol Violation|9|||
161720026|NCT00969618|584019023|FG000|Overall Study|Withdrawal by Subject|27|||
161720027|NCT01318902|584019024|FG000|Overall Study|Symptomatic Deterioration|0|||
161720028|NCT01318902|584019025|FG001|Overall Study|Symptomatic Deterioration|1|||
161720029|NCT01318902|584019026|FG002|Overall Study|Symptomatic Deterioration|1|||
161720030|NCT01318902|584019027|FG003|Overall Study|Symptomatic Deterioration|2|||
161720031|NCT01318902|584019024|FG000|Overall Study|Withdrawal by Patient|0|||
161720032|NCT01318902|584019025|FG001|Overall Study|Withdrawal by Patient|1|||
161720033|NCT01318902|584019026|FG002|Overall Study|Withdrawal by Patient|0|||
161720034|NCT01318902|584019027|FG003|Overall Study|Withdrawal by Patient|3|||
161720035|NCT01318902|584019024|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161720036|NCT01318902|584019025|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
161720037|NCT01318902|584019026|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161720038|NCT01318902|584019027|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
161720039|NCT01318902|584019024|FG000|Overall Study|Adverse Event|0|||
161720040|NCT01318902|584019025|FG001|Overall Study|Adverse Event|1|||
161720041|NCT01318902|584019026|FG002|Overall Study|Adverse Event|0|||
161720042|NCT01318902|584019027|FG003|Overall Study|Adverse Event|0|||
161720043|NCT01318902|584019024|FG000|Overall Study|Terminated by Sponsor|0|||
161720044|NCT01318902|584019025|FG001|Overall Study|Terminated by Sponsor|0|||
161720045|NCT01318902|584019026|FG002|Overall Study|Terminated by Sponsor|1|||
161720046|NCT01318902|584019027|FG003|Overall Study|Terminated by Sponsor|0|||
161720047|NCT00663858|584020549|FG000|Overall Study|Adverse Event|9|||
161720048|NCT00663858|584020550|FG001|Overall Study|Adverse Event|1|||
161720049|NCT00663858|584020551|FG002|Overall Study|Adverse Event|6|||
161720050|NCT00663858|584020549|FG000|Overall Study|Lack of Efficacy|5|||
161720051|NCT00663858|584020550|FG001|Overall Study|Lack of Efficacy|1|||
161720052|NCT00663858|584020551|FG002|Overall Study|Lack of Efficacy|3|||
161720053|NCT00663858|584020549|FG000|Overall Study|Withdrawal by Subject|7|||
161720054|NCT00663858|584020550|FG001|Overall Study|Withdrawal by Subject|3|||
161720055|NCT00663858|584020551|FG002|Overall Study|Withdrawal by Subject|3|||
161720056|NCT00663858|584020549|FG000|Overall Study|Protocol Violation|5|||
161720057|NCT00663858|584020550|FG001|Overall Study|Protocol Violation|3|||
161720058|NCT00663858|584020551|FG002|Overall Study|Protocol Violation|4|||
161720059|NCT00663858|584020549|FG000|Overall Study|Other|8|||
161720060|NCT00663858|584020550|FG001|Overall Study|Other|2|||
161720061|NCT00663858|584020551|FG002|Overall Study|Other|4|||
161720062|NCT01666444|584020554|FG000|Overall Study|Did not initiate treatment|2|||
161720063|NCT01666444|584020555|FG001|Overall Study|Did not initiate treatment|1|||
161720064|NCT00950690|584020556|FG000|Overall Study|Death|4|||
161720065|NCT00950690|584020556|FG000|Overall Study|Adverse Event|15|||
161720066|NCT00950690|584020556|FG000|Overall Study|Lack of Efficacy|22|||
161720067|NCT00950690|584020556|FG000|Overall Study|Lost to Follow-up|40|||
161720068|NCT00950690|584020556|FG000|Overall Study|Other|163|||
161720069|NCT01713036|584020557|FG000|Overall Study|Death|1|||
161720070|NCT00592358|584020558|FG000|Overall Study|Withdrawal by Subject|2|||
161720071|NCT00592358|584020558|FG000|Overall Study|Adverse Event|1|||
161720072|NCT00592358|584020558|FG000|Overall Study|Lack of Efficacy|2|||
161720073|NCT00592358|584020558|FG000|Overall Study|Inability to swallow pills|1|||
161720074|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
161720075|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
161720076|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
161720077|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
161720078|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
161720079|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
161720080|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
161720081|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
161720082|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
161720083|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
161720084|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
161720085|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
161720086|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
161720087|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
161720088|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
161720089|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
161720090|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
161720091|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
161720092|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
161720093|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
161720094|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
161720095|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
161720096|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
161720097|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
161720098|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
161720099|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
161720100|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
161720101|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
161720102|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
161720103|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
161720104|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
161720105|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
161720106|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
161720107|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
161720108|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
161720109|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
161720110|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
161720111|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
161720112|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
161720113|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
161720114|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
161720115|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
161720116|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
161720117|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
161720118|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
161720119|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
161720120|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
161720121|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
161720122|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
161720123|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
161720124|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
161720125|NCT00092547|584020559|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
161720126|NCT00092547|584020560|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
161720127|NCT00092547|584020561|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
161720128|NCT00092547|584020559|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
161720129|NCT00092547|584020560|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
161720130|NCT00092547|584020561|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
161720131|NCT00092547|584020559|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
161720132|NCT00092547|584020560|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
161720133|NCT00092547|584020561|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
161720134|NCT00092547|584020559|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
161720135|NCT00092547|584020560|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
161720136|NCT00092547|584020561|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
161720137|NCT00084682|584020562|FG000|Overall Study|Withdrawal by Subject|1|||
161720138|NCT01166659|584020563|FG000|Overall Study|Subject Decision|8|||
161720139|NCT01166659|584020563|FG000|Overall Study|Investigator Decision|2|||
161720140|NCT01166659|584020563|FG000|Overall Study|Death|1|||
161720141|NCT01166659|584020563|FG000|Overall Study|Lost to Follow-up|1|||
161720142|NCT01166659|584020563|FG000|Overall Study|Study Closed at Site|1|||
161720143|NCT00474630|584020569|FG000|Overall Study|Adverse Event|98|||
161720144|NCT00474630|584020570|FG001|Overall Study|Adverse Event|26|||
161720145|NCT00474630|584020569|FG000|Overall Study|Lost to Follow-up|22|||
161720146|NCT00474630|584020570|FG001|Overall Study|Lost to Follow-up|15|||
161720147|NCT00474630|584020569|FG000|Overall Study|Withdrawal by Subject|21|||
161720148|NCT00474630|584020570|FG001|Overall Study|Withdrawal by Subject|15|||
161720149|NCT00474630|584020569|FG000|Overall Study|Protocol Violation|3|||
161720150|NCT00474630|584020570|FG001|Overall Study|Protocol Violation|4|||
161720151|NCT00474630|584020569|FG000|Overall Study|Lack of Efficacy|5|||
161720152|NCT00474630|584020570|FG001|Overall Study|Lack of Efficacy|6|||
161720153|NCT00474630|584020569|FG000|Overall Study|Drug noncompliance, other|11|||
161720154|NCT00474630|584020570|FG001|Overall Study|Drug noncompliance, other|4|||
161720155|NCT01650779|584020578|FG000|Overall Study|Withdrawal by Subject|1|||
161720156|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
161720157|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161720158|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161720159|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161720160|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
161720161|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161720162|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161720163|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161720164|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
161720165|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161720166|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161720167|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161720168|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
161720169|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161720170|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161720171|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161720172|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
161720173|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161720174|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161720175|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161720176|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
161720177|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161720178|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161720179|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161720180|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
161720181|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161720182|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161720183|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161720184|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
161720185|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161720186|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161720187|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161720188|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
161720189|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161720190|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161720191|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161720192|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161720193|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
161720194|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161720195|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161720196|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161720197|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
161720198|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161720199|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161720200|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161720201|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
161720202|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161720203|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161720204|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161720205|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
161720206|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161720207|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161720208|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161720209|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
161720210|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161720211|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161720212|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161720213|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
161720214|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161720215|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161720216|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161720217|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
161720218|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161720219|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161720220|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161720221|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
161720222|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161720223|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161720224|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161720225|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
161720226|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161720227|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161720228|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161720229|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
161720230|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161720231|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161720232|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161720233|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
161720234|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161720235|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161720236|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
161720237|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
161720238|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
161720239|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
161720240|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
161720241|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
161720242|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
161720243|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
161720244|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
161720245|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
161720246|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
161720247|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
161720248|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
161720249|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
161720250|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
161720251|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
161720252|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
161720253|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
161720254|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
161720255|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
161720256|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
161720257|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
161720258|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
161720259|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
161720260|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
161720261|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
161720262|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
161720263|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
161720264|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161720265|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161720266|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
161720267|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161720268|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161720269|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161720270|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
161720271|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161720272|NCT00915005|584020584|FG000|Overall Study|Withdrawal by Subject|4|||
161720273|NCT00915005|584020585|FG001|Overall Study|Withdrawal by Subject|4|||
161720274|NCT00915005|584020584|FG000|Overall Study|Patient preferred protons therapy|6|||
161720275|NCT00915005|584020585|FG001|Overall Study|Patient preferred protons therapy|0|||
161720276|NCT00915005|584020584|FG000|Overall Study|Insurance denial|3|||
161720277|NCT00915005|584020585|FG001|Overall Study|Insurance denial|15|||
161720278|NCT00589472|584020596|FG000|Overall Study|Adverse Event|1|||
161720279|NCT00117338|584020597|FG000|Overall Study|Adverse Event|0|||
161720280|NCT00117338|584020598|FG001|Overall Study|Adverse Event|1|||
161720281|NCT00117338|584020597|FG000|Overall Study|Protocol Violation|3|||
161720282|NCT00117338|584020598|FG001|Overall Study|Protocol Violation|2|||
161720283|NCT00117338|584020597|FG000|Overall Study|Withdrawal by Subject|1|||
161720284|NCT00117338|584020598|FG001|Overall Study|Withdrawal by Subject|0|||
161720285|NCT00117338|584020597|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
161720286|NCT00117338|584020598|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
161720287|NCT00117338|584020597|FG000|Overall Study|Lack of Efficacy|0|||
161720288|NCT00117338|584020598|FG001|Overall Study|Lack of Efficacy|1|||
161720289|NCT01380093|584020599|FG000|Naloxone Challenge Phase|Screen failures|21|||
161720290|NCT01380093|584020600|FG001|Naloxone Challenge Phase|Screen failures|0|||
161720291|NCT01380093|584020601|FG002|Naloxone Challenge Phase|Screen failures|0|||
161720292|NCT01380093|584020602|FG003|Naloxone Challenge Phase|Screen failures|0|||
161720293|NCT01380093|584020603|FG004|Naloxone Challenge Phase|Screen failures|0|||
161720294|NCT01380093|584020604|FG005|Naloxone Challenge Phase|Screen failures|0|||
161720295|NCT01380093|584020605|FG006|Naloxone Challenge Phase|Screen failures|0|||
161720296|NCT01380093|584020606|FG007|Naloxone Challenge Phase|Screen failures|0|||
161720297|NCT01380093|584020607|FG008|Naloxone Challenge Phase|Screen failures|0|||
161720298|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720299|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
161720300|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720301|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720302|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720303|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720304|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720305|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720306|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720307|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720308|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
161720309|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
161720310|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720311|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720312|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720313|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720314|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720315|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720316|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720317|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
161720318|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720319|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720320|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720321|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720322|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720323|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720324|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720325|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720326|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
161720327|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
161720328|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720329|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720330|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720331|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720332|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720333|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720334|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720335|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
161720336|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
161720337|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720338|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720339|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720340|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720341|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720342|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720343|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720344|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720345|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
161720346|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720347|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720348|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720349|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720350|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720351|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720352|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720353|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720354|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
161720355|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720356|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720357|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720358|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720359|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720360|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720361|NCT01380093|584020599|FG000|Treatment Phase: Second Intervention|Other|0|||
161720362|NCT01380093|584020600|FG001|Treatment Phase: Second Intervention|Other|0|||
161720363|NCT01380093|584020601|FG002|Treatment Phase: Second Intervention|Other|0|||
161720364|NCT01380093|584020602|FG003|Treatment Phase: Second Intervention|Other|1|||
161720365|NCT01380093|584020603|FG004|Treatment Phase: Second Intervention|Other|0|||
161720366|NCT01380093|584020604|FG005|Treatment Phase: Second Intervention|Other|0|||
161720367|NCT01380093|584020605|FG006|Treatment Phase: Second Intervention|Other|0|||
161720368|NCT01380093|584020606|FG007|Treatment Phase: Second Intervention|Other|0|||
161720369|NCT01380093|584020607|FG008|Treatment Phase: Second Intervention|Other|0|||
161720370|NCT01380093|584020599|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
161720371|NCT01380093|584020600|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
161720372|NCT01380093|584020601|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
161720373|NCT01380093|584020602|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
161720374|NCT01380093|584020603|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
161720375|NCT01380093|584020604|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
161720376|NCT01380093|584020605|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
161720377|NCT01380093|584020606|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
161720378|NCT01380093|584020607|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
161720379|NCT01380093|584020599|FG000|Treatment Phase: Third Intervention|Other|0|||
161720380|NCT01380093|584020600|FG001|Treatment Phase: Third Intervention|Other|0|||
161720381|NCT01380093|584020601|FG002|Treatment Phase: Third Intervention|Other|0|||
161720382|NCT01380093|584020602|FG003|Treatment Phase: Third Intervention|Other|0|||
161720383|NCT01380093|584020603|FG004|Treatment Phase: Third Intervention|Other|0|||
161720384|NCT01380093|584020604|FG005|Treatment Phase: Third Intervention|Other|0|||
161720385|NCT01380093|584020605|FG006|Treatment Phase: Third Intervention|Other|0|||
161720386|NCT01380093|584020606|FG007|Treatment Phase: Third Intervention|Other|0|||
161720387|NCT01380093|584020607|FG008|Treatment Phase: Third Intervention|Other|1|||
161720388|NCT03952650|584020608|FG000|Overall Study|TRAVEL|0|||
161720389|NCT03952650|584020609|FG001|Overall Study|TRAVEL|4|||
161720390|NCT03952650|584020610|FG002|Overall Study|TRAVEL|0|||
161720391|NCT03952650|584020611|FG003|Overall Study|TRAVEL|4|||
161720392|NCT03952650|584020612|FG004|Overall Study|TRAVEL|0|||
161720393|NCT03952650|584020613|FG005|Overall Study|TRAVEL|3|||
161720394|NCT03952650|584020614|FG006|Overall Study|TRAVEL|2|||
161720395|NCT03952650|584020608|FG000|Overall Study|Withdrawal by Subject|0|||
161720396|NCT03952650|584020609|FG001|Overall Study|Withdrawal by Subject|2|||
161720397|NCT03952650|584020610|FG002|Overall Study|Withdrawal by Subject|0|||
161720398|NCT03952650|584020611|FG003|Overall Study|Withdrawal by Subject|3|||
161720399|NCT03952650|584020612|FG004|Overall Study|Withdrawal by Subject|0|||
161720400|NCT03952650|584020613|FG005|Overall Study|Withdrawal by Subject|1|||
161720401|NCT03952650|584020614|FG006|Overall Study|Withdrawal by Subject|1|||
161720402|NCT03952650|584020608|FG000|Overall Study|Lost to Follow-up|0|||
161720403|NCT03952650|584020609|FG001|Overall Study|Lost to Follow-up|1|||
161720404|NCT03952650|584020610|FG002|Overall Study|Lost to Follow-up|0|||
161720405|NCT03952650|584020611|FG003|Overall Study|Lost to Follow-up|0|||
161720406|NCT03952650|584020612|FG004|Overall Study|Lost to Follow-up|0|||
161720407|NCT03952650|584020613|FG005|Overall Study|Lost to Follow-up|1|||
161720408|NCT03952650|584020614|FG006|Overall Study|Lost to Follow-up|1|||
161720409|NCT03952650|584020608|FG000|Overall Study|Received wrong vaccine and travelled|0|||
161720410|NCT03952650|584020609|FG001|Overall Study|Received wrong vaccine and travelled|0|||
161720411|NCT03952650|584020610|FG002|Overall Study|Received wrong vaccine and travelled|0|||
161720412|NCT03952650|584020611|FG003|Overall Study|Received wrong vaccine and travelled|0|||
161720413|NCT03952650|584020612|FG004|Overall Study|Received wrong vaccine and travelled|0|||
161720414|NCT03952650|584020613|FG005|Overall Study|Received wrong vaccine and travelled|1|||
161720415|NCT03952650|584020614|FG006|Overall Study|Received wrong vaccine and travelled|0|||
161720416|NCT03952650|584020608|FG000|Overall Study|Unable to make study visit|0|||
161720417|NCT03952650|584020609|FG001|Overall Study|Unable to make study visit|0|||
161720418|NCT03952650|584020610|FG002|Overall Study|Unable to make study visit|0|||
161720419|NCT03952650|584020611|FG003|Overall Study|Unable to make study visit|0|||
161720420|NCT03952650|584020612|FG004|Overall Study|Unable to make study visit|0|||
161720421|NCT03952650|584020613|FG005|Overall Study|Unable to make study visit|1|||
161720422|NCT03952650|584020614|FG006|Overall Study|Unable to make study visit|0|||
161720423|NCT01342640|584020615|FG000|Overall Study|Adverse Event|3|||
161720424|NCT01342640|584020615|FG000|Overall Study|Protocol Violation|16|||
161720425|NCT01342640|584020615|FG000|Overall Study|Lost to Follow-up|21|||
161720426|NCT01342640|584020615|FG000|Overall Study|Other|1|||
161720427|NCT00670111|584020618|FG000|Enrollment to One Month|Testing Failure|0|||
161720428|NCT00670111|584020619|FG001|Enrollment to One Month|Testing Failure|0|||
161720429|NCT00670111|584020620|FG002|Enrollment to One Month|Testing Failure|13|||
161720430|NCT00670111|584020618|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
161720431|NCT00670111|584020619|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
161720432|NCT00670111|584020620|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
161720433|NCT00670111|584020618|FG000|Enrollment to One Month|Physician Decision|1|||
161720434|NCT00670111|584020619|FG001|Enrollment to One Month|Physician Decision|0|||
161720435|NCT00670111|584020620|FG002|Enrollment to One Month|Physician Decision|0|||
161720436|NCT02441803|584020621|FG000|Overall Study|Physician Decision|0|||
161720437|NCT02441803|584020622|FG001|Overall Study|Physician Decision|2|||
161720438|NCT02441803|584020623|FG002|Overall Study|Physician Decision|2|||
161720439|NCT02873221|584020624|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161720440|NCT02873221|584020625|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
161720441|NCT02873221|584020626|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
161720442|NCT02873221|584020624|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
161720443|NCT02873221|584020625|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
161720444|NCT02873221|584020626|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
161720445|NCT02873221|584020624|FG000|Treatment Period|Protocol Violation|2|||
161720446|NCT02873221|584020625|FG001|Treatment Period|Protocol Violation|5|||
161720447|NCT02873221|584020626|FG002|Treatment Period|Protocol Violation|8|||
161720448|NCT02873221|584020624|FG000|Treatment Period|Pregnancy|4|||
161720449|NCT02873221|584020625|FG001|Treatment Period|Pregnancy|6|||
161720450|NCT02873221|584020626|FG002|Treatment Period|Pregnancy|3|||
161720451|NCT02873221|584020624|FG000|Treatment Period|Lack of Qualifying Event|0|||
161720452|NCT02873221|584020625|FG001|Treatment Period|Lack of Qualifying Event|3|||
161720453|NCT02873221|584020626|FG002|Treatment Period|Lack of Qualifying Event|1|||
161720454|NCT02873221|584020624|FG000|Treatment Period|Withdrawal of Consent|52|||
161720455|NCT02873221|584020625|FG001|Treatment Period|Withdrawal of Consent|51|||
161720456|NCT02873221|584020626|FG002|Treatment Period|Withdrawal of Consent|41|||
161720457|NCT02873221|584020624|FG000|Treatment Period|Lack of Efficacy|0|||
161720458|NCT02873221|584020625|FG001|Treatment Period|Lack of Efficacy|17|||
161720459|NCT02873221|584020626|FG002|Treatment Period|Lack of Efficacy|12|||
161720460|NCT02873221|584020624|FG000|Treatment Period|Adverse Event|4|||
161720461|NCT02873221|584020625|FG001|Treatment Period|Adverse Event|9|||
161720462|NCT02873221|584020626|FG002|Treatment Period|Adverse Event|11|||
161720463|NCT02873221|584020624|FG000|Treatment Period|Lost to Follow-up|26|||
161720464|NCT02873221|584020625|FG001|Treatment Period|Lost to Follow-up|30|||
161720465|NCT02873221|584020626|FG002|Treatment Period|Lost to Follow-up|26|||
161720466|NCT02873221|584020624|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161720467|NCT02873221|584020625|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
161720468|NCT02873221|584020626|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161720469|NCT02873221|584020624|FG000|Safety Follow-up Period|Protocol Violation|0|||
161720470|NCT02873221|584020625|FG001|Safety Follow-up Period|Protocol Violation|0|||
161720471|NCT02873221|584020626|FG002|Safety Follow-up Period|Protocol Violation|1|||
161720472|NCT02873221|584020624|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
161720473|NCT02873221|584020625|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
161720474|NCT02873221|584020626|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
161720475|NCT02873221|584020624|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
161720476|NCT02873221|584020625|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
161720477|NCT02873221|584020626|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
161720478|NCT01325493|584020627|FG000|Overall Study|Protocol Violation|0|||
161720479|NCT01325493|584020628|FG001|Overall Study|Protocol Violation|1|||
161720480|NCT01325493|584020627|FG000|Overall Study|loss of neuromonitoring signals|0|||
161720481|NCT01325493|584020628|FG001|Overall Study|loss of neuromonitoring signals|2|||
161720482|NCT01325493|584020627|FG000|Overall Study|Allergy|1|||
161720483|NCT01325493|584020628|FG001|Overall Study|Allergy|0|||
161720484|NCT01749735|584020629|FG000|Overall Study|Withdrawal by Subject|1|||
161720485|NCT01749735|584020630|FG001|Overall Study|Withdrawal by Subject|0|||
161720486|NCT02234583|584020635|FG000|Overall Study|Adverse Event|172|||
161720487|NCT02234583|584020636|FG001|Overall Study|Adverse Event|156|||
161720488|NCT02234583|584020635|FG000|Overall Study|Withdrawal by Subject|109|||
161720489|NCT02234583|584020636|FG001|Overall Study|Withdrawal by Subject|157|||
161720490|NCT02234583|584020635|FG000|Overall Study|Lost to Follow-up|0|||
161720491|NCT02234583|584020636|FG001|Overall Study|Lost to Follow-up|1|||
161720492|NCT02234583|584020635|FG000|Overall Study|Lack of Efficacy|58|||
161720493|NCT02234583|584020636|FG001|Overall Study|Lack of Efficacy|103|||
161720494|NCT02234583|584020635|FG000|Overall Study|Protocol Violation|35|||
161720495|NCT02234583|584020636|FG001|Overall Study|Protocol Violation|42|||
161720496|NCT02234583|584020635|FG000|Overall Study|Other|39|||
161720497|NCT02234583|584020636|FG001|Overall Study|Other|97|||
161720498|NCT01849250|584020637|FG000|Overall Study|Withdrawal by Subject|1|||
161720499|NCT01849250|584020638|FG001|Overall Study|Withdrawal by Subject|0|||
161720500|NCT01849250|584020637|FG000|Overall Study|Not Evaluable|5|||
161720501|NCT01849250|584020638|FG001|Overall Study|Not Evaluable|3|||
161720502|NCT01849250|584020637|FG000|Overall Study|Screen Failure|1|||
161720503|NCT01849250|584020638|FG001|Overall Study|Screen Failure|0|||
161720504|NCT04504032|584020641|FG000|Overall Study|Adverse Event|1|||
161720505|NCT04504032|584020642|FG001|Overall Study|Adverse Event|2|||
161720506|NCT04504032|584020641|FG000|Overall Study|Lost to Follow-up|6|||
161720507|NCT04504032|584020642|FG001|Overall Study|Lost to Follow-up|9|||
161720508|NCT04504032|584020641|FG000|Overall Study|Protocol Violation|2|||
161720509|NCT04504032|584020642|FG001|Overall Study|Protocol Violation|0|||
161720510|NCT04504032|584020641|FG000|Overall Study|Study terminated by sponsor|1|||
161720511|NCT04504032|584020642|FG001|Overall Study|Study terminated by sponsor|2|||
161720512|NCT04504032|584020641|FG000|Overall Study|Withdrawal by Subject|9|||
161720513|NCT04504032|584020642|FG001|Overall Study|Withdrawal by Subject|11|||
161720514|NCT04504032|584020641|FG000|Overall Study|Disease progression prior to dosing|15|||
161720515|NCT04504032|584020642|FG001|Overall Study|Disease progression prior to dosing|3|||
161720516|NCT04504032|584020641|FG000|Overall Study|Drug supply issues|1|||
161720517|NCT04504032|584020642|FG001|Overall Study|Drug supply issues|1|||
161720518|NCT04504032|584020641|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
161720519|NCT04504032|584020642|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
161720520|NCT00771030|584020643|FG000|Overall Study|Adverse Event|0|||
161720521|NCT00771030|584020644|FG001|Overall Study|Adverse Event|1|||
161720522|NCT00771030|584020645|FG002|Overall Study|Adverse Event|0|||
161720523|NCT00771030|584020646|FG003|Overall Study|Adverse Event|0|||
161720524|NCT00771030|584020647|FG004|Overall Study|Adverse Event|0|||
161720525|NCT00771030|584020648|FG005|Overall Study|Adverse Event|0|||
161720526|NCT00771030|584020649|FG006|Overall Study|Adverse Event|0|||
161720527|NCT04156646|584020655|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
161720528|NCT04156646|584020656|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
161720529|NCT01208181|584020657|FG000|Part 1|Withdrawal by Subject|11|||
161720530|NCT01208181|584020658|FG001|Part 1|Withdrawal by Subject|10|||
161720531|NCT01208181|584020659|FG002|Part 1|Withdrawal by Subject|0|||
161720532|NCT01208181|584020660|FG003|Part 1|Withdrawal by Subject|0|||
161720533|NCT01208181|584020661|FG004|Part 1|Withdrawal by Subject|0|||
161720534|NCT01208181|584020657|FG000|Part 1|Technical problem|5|||
161720535|NCT01208181|584020658|FG001|Part 1|Technical problem|0|||
161720536|NCT01208181|584020659|FG002|Part 1|Technical problem|0|||
161720537|NCT01208181|584020660|FG003|Part 1|Technical problem|0|||
161720538|NCT01208181|584020661|FG004|Part 1|Technical problem|0|||
161720539|NCT01208181|584020657|FG000|Part 1|Protocol Violation|10|||
161720540|NCT01208181|584020658|FG001|Part 1|Protocol Violation|5|||
161720541|NCT01208181|584020659|FG002|Part 1|Protocol Violation|0|||
161720542|NCT01208181|584020660|FG003|Part 1|Protocol Violation|0|||
161720543|NCT01208181|584020661|FG004|Part 1|Protocol Violation|0|||
161720544|NCT01208181|584020657|FG000|Part 1|Physician Decision|4|||
161720545|NCT01208181|584020658|FG001|Part 1|Physician Decision|0|||
161720546|NCT01208181|584020659|FG002|Part 1|Physician Decision|0|||
161720547|NCT01208181|584020660|FG003|Part 1|Physician Decision|0|||
161720548|NCT01208181|584020661|FG004|Part 1|Physician Decision|0|||
161720549|NCT01208181|584020657|FG000|Part 1|Non-compliance with study drug|1|||
161720550|NCT01208181|584020658|FG001|Part 1|Non-compliance with study drug|1|||
161720551|NCT01208181|584020659|FG002|Part 1|Non-compliance with study drug|0|||
161720552|NCT01208181|584020660|FG003|Part 1|Non-compliance with study drug|0|||
161720553|NCT01208181|584020661|FG004|Part 1|Non-compliance with study drug|0|||
161720554|NCT01208181|584020657|FG000|Part 1|Lost to Follow-up|5|||
161720555|NCT01208181|584020658|FG001|Part 1|Lost to Follow-up|3|||
161720556|NCT01208181|584020659|FG002|Part 1|Lost to Follow-up|0|||
161720557|NCT01208181|584020660|FG003|Part 1|Lost to Follow-up|0|||
161720558|NCT01208181|584020661|FG004|Part 1|Lost to Follow-up|1|||
161720559|NCT01208181|584020657|FG000|Part 1|Lack of Efficacy|37|||
161720560|NCT01208181|584020658|FG001|Part 1|Lack of Efficacy|12|||
161720561|NCT01208181|584020659|FG002|Part 1|Lack of Efficacy|0|||
161720562|NCT01208181|584020660|FG003|Part 1|Lack of Efficacy|0|||
161720563|NCT01208181|584020661|FG004|Part 1|Lack of Efficacy|17|||
161720564|NCT01208181|584020657|FG000|Part 1|Adverse Event|26|||
161720565|NCT01208181|584020658|FG001|Part 1|Adverse Event|24|||
161720566|NCT01208181|584020659|FG002|Part 1|Adverse Event|0|||
161720567|NCT01208181|584020660|FG003|Part 1|Adverse Event|0|||
161720568|NCT01208181|584020661|FG004|Part 1|Adverse Event|4|||
161720569|NCT01208181|584020657|FG000|Part 2|Adverse Event|0|||
161720570|NCT01208181|584020658|FG001|Part 2|Adverse Event|0|||
161720571|NCT01208181|584020659|FG002|Part 2|Adverse Event|6|||
161720572|NCT01208181|584020660|FG003|Part 2|Adverse Event|7|||
161720573|NCT01208181|584020661|FG004|Part 2|Adverse Event|0|||
161720574|NCT01208181|584020657|FG000|Part 2|Withdrawal by Subject|0|||
161720575|NCT01208181|584020658|FG001|Part 2|Withdrawal by Subject|0|||
161720576|NCT01208181|584020659|FG002|Part 2|Withdrawal by Subject|1|||
161720577|NCT01208181|584020660|FG003|Part 2|Withdrawal by Subject|1|||
161720578|NCT01208181|584020661|FG004|Part 2|Withdrawal by Subject|0|||
161720579|NCT01208181|584020657|FG000|Part 2|Protocol Violation|0|||
161720580|NCT01208181|584020658|FG001|Part 2|Protocol Violation|0|||
161720581|NCT01208181|584020659|FG002|Part 2|Protocol Violation|1|||
161720582|NCT01208181|584020660|FG003|Part 2|Protocol Violation|0|||
161720583|NCT01208181|584020661|FG004|Part 2|Protocol Violation|0|||
161720584|NCT01208181|584020657|FG000|Part 2|Physician Decision|0|||
161720585|NCT01208181|584020658|FG001|Part 2|Physician Decision|0|||
161720586|NCT01208181|584020659|FG002|Part 2|Physician Decision|1|||
161720587|NCT01208181|584020660|FG003|Part 2|Physician Decision|2|||
161720588|NCT01208181|584020661|FG004|Part 2|Physician Decision|0|||
161720589|NCT01208181|584020657|FG000|Part 2|Non-compliance with study drug|0|||
161720590|NCT01208181|584020658|FG001|Part 2|Non-compliance with study drug|0|||
161720591|NCT01208181|584020659|FG002|Part 2|Non-compliance with study drug|1|||
161720592|NCT01208181|584020660|FG003|Part 2|Non-compliance with study drug|1|||
161720593|NCT01208181|584020661|FG004|Part 2|Non-compliance with study drug|0|||
161720594|NCT01208181|584020657|FG000|Part 2|Lost to Follow-up|0|||
161720595|NCT01208181|584020658|FG001|Part 2|Lost to Follow-up|0|||
161720596|NCT01208181|584020659|FG002|Part 2|Lost to Follow-up|1|||
161720597|NCT01208181|584020660|FG003|Part 2|Lost to Follow-up|2|||
161720598|NCT01208181|584020661|FG004|Part 2|Lost to Follow-up|0|||
161720599|NCT01208181|584020657|FG000|Part 2|Lack of Efficacy|0|||
161720600|NCT01208181|584020658|FG001|Part 2|Lack of Efficacy|0|||
161720601|NCT01208181|584020659|FG002|Part 2|Lack of Efficacy|5|||
161720602|NCT01208181|584020660|FG003|Part 2|Lack of Efficacy|7|||
161720603|NCT01208181|584020661|FG004|Part 2|Lack of Efficacy|0|||
161720604|NCT02707757|584020662|FG000|Overall Study|Protocol Violation|3|||
161720605|NCT02707757|584020663|FG001|Overall Study|Protocol Violation|2|||
161720606|NCT02707757|584020662|FG000|Overall Study|Withdrawal by Subject|2|||
161720607|NCT02707757|584020663|FG001|Overall Study|Withdrawal by Subject|0|||
161720608|NCT02707757|584020662|FG000|Overall Study|Death|0|||
161720609|NCT02707757|584020663|FG001|Overall Study|Death|1|||
161720610|NCT02707757|584020662|FG000|Overall Study|Adverse Event|6|||
161720611|NCT02707757|584020663|FG001|Overall Study|Adverse Event|4|||
161720612|NCT02707757|584020662|FG000|Overall Study|Renal transplant/elective operation|1|||
161720613|NCT02707757|584020663|FG001|Overall Study|Renal transplant/elective operation|5|||
161720614|NCT00815308|584020664|FG000|Overall Study|Adverse Event|4|||
161720615|NCT00815308|584020664|FG000|Overall Study|Withdrawal by Subject|0|||
161720616|NCT00815308|584020664|FG000|Overall Study|Protocol Violation|6|||
161720617|NCT01056523|584020665|FG000|Overall Study|Death|1|||
161720618|NCT01056523|584020666|FG001|Overall Study|Death|0|||
161720619|NCT01056523|584020667|FG002|Overall Study|Death|2|||
161720620|NCT01056523|584020668|FG003|Overall Study|Death|3|||
161720621|NCT01056523|584020669|FG004|Overall Study|Death|0|||
161720622|NCT01056523|584020670|FG005|Overall Study|Death|0|||
161720623|NCT01056523|584020671|FG006|Overall Study|Death|1|||
161720624|NCT03429556|584020672|FG000|Overall Study|Lost to Follow-up|0|||
161720625|NCT03429556|584020673|FG001|Overall Study|Lost to Follow-up|1|||
161720626|NCT03429556|584020674|FG002|Overall Study|Lost to Follow-up|0|||
161720627|NCT03429556|584020675|FG003|Overall Study|Lost to Follow-up|0|||
161720628|NCT00377299|584020678|FG000|Overall Study|Lost to Follow-up|14|||
161720629|NCT00377299|584020679|FG001|Overall Study|Lost to Follow-up|19|||
161720630|NCT00377299|584020678|FG000|Overall Study|Adverse Event|0|||
161720631|NCT00377299|584020679|FG001|Overall Study|Adverse Event|1|||
161720632|NCT00377299|584020678|FG000|Overall Study|Withdrawal by Subject|5|||
161720633|NCT00377299|584020679|FG001|Overall Study|Withdrawal by Subject|4|||
161720634|NCT02209597|584020683|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
161720635|NCT02209597|584020683|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
161720636|NCT02209597|584020683|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
161720637|NCT02209597|584020683|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
161720638|NCT04799782|584020689|FG000|Washout|Physician Decision|2|||
161720639|NCT04799782|584020690|FG001|Washout|Physician Decision|0|||
161720640|NCT04799782|584020689|FG000|Washout|Withdrawal by Subject|0|||
161720641|NCT04799782|584020690|FG001|Washout|Withdrawal by Subject|2|||
161720642|NCT04799782|584020689|FG000|Washout|Lost to Follow-up|0|||
161720643|NCT04799782|584020690|FG001|Washout|Lost to Follow-up|1|||
161720644|NCT02050048|584020691|FG000|Overall Study|Lost to Follow-up|0|||
161720645|NCT02050048|584020692|FG001|Overall Study|Lost to Follow-up|1|||
161720646|NCT02050048|584020691|FG000|Overall Study|Death|1|||
161720647|NCT02050048|584020692|FG001|Overall Study|Death|0|||
161720648|NCT02050048|584020691|FG000|Overall Study|Ineligible after ERCP|4|||
161720649|NCT02050048|584020692|FG001|Overall Study|Ineligible after ERCP|1|||
161720650|NCT03067311|584020694|FG000|Overall Study|Lost to Follow-up|1|||
161720651|NCT03067311|584020695|FG001|Overall Study|Lost to Follow-up|1|||
161720652|NCT03067311|584020694|FG000|Overall Study|Moved away|1|||
161720653|NCT03067311|584020695|FG001|Overall Study|Moved away|1|||
161720654|NCT01589094|584020698|FG000|Overall Study|Did not receive treatment|2|||
161720655|NCT00907738|584020699|FG000|Overall Study|Adverse Event|2|||
161720656|NCT00907738|584020700|FG001|Overall Study|Adverse Event|0|||
161720657|NCT00907738|584020701|FG002|Overall Study|Adverse Event|1|||
161720658|NCT00907738|584020702|FG003|Overall Study|Adverse Event|0|||
161720659|NCT00907738|584020703|FG004|Overall Study|Adverse Event|0|||
161720660|NCT00907738|584020699|FG000|Overall Study|not specified or withdrew consent|3|||
161720661|NCT00907738|584020700|FG001|Overall Study|not specified or withdrew consent|0|||
161720662|NCT00907738|584020701|FG002|Overall Study|not specified or withdrew consent|0|||
161720663|NCT00907738|584020702|FG003|Overall Study|not specified or withdrew consent|0|||
161720664|NCT00907738|584020703|FG004|Overall Study|not specified or withdrew consent|0|||
161720665|NCT00907738|584020699|FG000|Overall Study|Disease progression|8|||
161720666|NCT00907738|584020700|FG001|Overall Study|Disease progression|1|||
161720667|NCT00907738|584020701|FG002|Overall Study|Disease progression|6|||
161720668|NCT00907738|584020702|FG003|Overall Study|Disease progression|4|||
161720669|NCT00907738|584020703|FG004|Overall Study|Disease progression|2|||
161720670|NCT05363293|584020704|FG000|Overall Study|Withdrawal by Subject|1|||
161720671|NCT05363293|584020705|FG001|Overall Study|Withdrawal by Subject|0|||
161720672|NCT05363293|584020706|FG002|Overall Study|Withdrawal by Subject|0|||
161720673|NCT05363293|584020707|FG003|Overall Study|Withdrawal by Subject|0|||
161720674|NCT05363293|584020708|FG004|Overall Study|Withdrawal by Subject|0|||
161720675|NCT05363293|584020709|FG005|Overall Study|Withdrawal by Subject|0|||
161720676|NCT05363293|584020710|FG006|Overall Study|Withdrawal by Subject|0|||
161720677|NCT05363293|584020711|FG007|Overall Study|Withdrawal by Subject|0|||
161720678|NCT05363293|584020712|FG008|Overall Study|Withdrawal by Subject|0|||
161720679|NCT05363293|584020713|FG009|Overall Study|Withdrawal by Subject|0|||
161720680|NCT04773041|584020714|FG000|Overall Study|Unable to data match|1|||
161720681|NCT04773041|584020715|FG001|Overall Study|Unable to data match|0|||
161720682|NCT04773041|584020716|FG002|Overall Study|Unable to data match|0|||
161720683|NCT01988012|584023247|FG000|Overall Study|Adverse Event|5|||
161720684|NCT01988012|584023247|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161720685|NCT01988012|584023247|FG000|Overall Study|Patient Withdrawal of Consent|4|||
161720686|NCT01988012|584023247|FG000|Overall Study|Lost to Follow-up|1|||
161720687|NCT01988012|584023247|FG000|Overall Study|Physician Decision|1|||
161720688|NCT01988012|584023247|FG000|Overall Study|Protocol Violation|1|||
161720689|NCT01058369|584023248|FG000|Overall Study|Adverse Event|1|||
161720690|NCT01058369|584023248|FG000|Overall Study|Early termination study|1|||
161720691|NCT00634543|584023253|FG000|Overall Study|Other|1|||
161720692|NCT00634543|584023254|FG001|Overall Study|Other|2|||
161720693|NCT00634543|584023253|FG000|Overall Study|Protocol Violation|3|||
161720694|NCT00634543|584023254|FG001|Overall Study|Protocol Violation|3|||
161720695|NCT00634543|584023253|FG000|Overall Study|Adverse Event|11|||
161720696|NCT00634543|584023254|FG001|Overall Study|Adverse Event|11|||
161720697|NCT00634543|584023253|FG000|Overall Study|Withdrawal by Subject|4|||
161720698|NCT00634543|584023254|FG001|Overall Study|Withdrawal by Subject|4|||
161720699|NCT00634543|584023253|FG000|Overall Study|Lost to Follow-up|0|||
161720700|NCT00634543|584023254|FG001|Overall Study|Lost to Follow-up|1|||
161720701|NCT01371838|584023255|FG000|Overall Study|Withdrawal by Subject|27|||
161720702|NCT01371838|584023256|FG001|Overall Study|Withdrawal by Subject|33|||
161720703|NCT01371838|584023255|FG000|Overall Study|Lost to Follow-up|10|||
161720704|NCT01371838|584023256|FG001|Overall Study|Lost to Follow-up|20|||
161720705|NCT01371838|584023255|FG000|Overall Study|Death|3|||
161720706|NCT01371838|584023256|FG001|Overall Study|Death|4|||
161720707|NCT01371838|584023255|FG000|Overall Study|Protocol Violation|3|||
161720708|NCT01371838|584023256|FG001|Overall Study|Protocol Violation|0|||
161720709|NCT01371838|584023255|FG000|Overall Study|Investigator Decision|3|||
161720710|NCT01371838|584023256|FG001|Overall Study|Investigator Decision|8|||
161720711|NCT01371838|584023255|FG000|Overall Study|Last follow-up visit not conducted|2|||
161720712|NCT01371838|584023256|FG001|Overall Study|Last follow-up visit not conducted|0|||
161720713|NCT01371838|584023255|FG000|Overall Study|Lack of therapeutic response|0|||
161720714|NCT01371838|584023256|FG001|Overall Study|Lack of therapeutic response|1|||
161720715|NCT01371838|584023255|FG000|Overall Study|Surgery|1|||
161720716|NCT01371838|584023256|FG001|Overall Study|Surgery|0|||
161720717|NCT01103349|584023259|FG000|Overall Study|Adverse Event|8|||
161720718|NCT01103349|584023260|FG001|Overall Study|Adverse Event|5|||
161720719|NCT01103349|584023261|FG002|Overall Study|Adverse Event|3|||
161720720|NCT01103349|584023259|FG000|Overall Study|Consent withdrawn|1|||
161720721|NCT01103349|584023260|FG001|Overall Study|Consent withdrawn|0|||
161720722|NCT01103349|584023261|FG002|Overall Study|Consent withdrawn|0|||
161720723|NCT01103349|584023259|FG000|Overall Study|Incorrectly included in the trial|1|||
161720724|NCT01103349|584023260|FG001|Overall Study|Incorrectly included in the trial|0|||
161720725|NCT01103349|584023261|FG002|Overall Study|Incorrectly included in the trial|0|||
161720726|NCT01103349|584023259|FG000|Overall Study|Withdrawal by Subject|1|||
161720727|NCT01103349|584023260|FG001|Overall Study|Withdrawal by Subject|1|||
161720728|NCT01103349|584023261|FG002|Overall Study|Withdrawal by Subject|0|||
161720729|NCT01103349|584023259|FG000|Overall Study|did not want to take trial medication|0|||
161720730|NCT01103349|584023260|FG001|Overall Study|did not want to take trial medication|1|||
161720731|NCT01103349|584023261|FG002|Overall Study|did not want to take trial medication|0|||
161720732|NCT01103349|584023259|FG000|Overall Study|forgot to take medication|0|||
161720733|NCT01103349|584023260|FG001|Overall Study|forgot to take medication|0|||
161720734|NCT01103349|584023261|FG002|Overall Study|forgot to take medication|1|||
161720735|NCT00972244|584023265|FG000|Overall Study|Incorrect Enrolment|1|||
161720736|NCT00972244|584023266|FG001|Overall Study|Incorrect Enrolment|0|||
161720737|NCT00972244|584023267|FG002|Overall Study|Incorrect Enrolment|0|||
161720738|NCT00972244|584023268|FG003|Overall Study|Incorrect Enrolment|0|||
161720739|NCT00972244|584023269|FG004|Overall Study|Incorrect Enrolment|0|||
161720740|NCT00972244|584023265|FG000|Overall Study|Adverse Event|0|||
161720741|NCT00972244|584023266|FG001|Overall Study|Adverse Event|1|||
161720742|NCT00972244|584023267|FG002|Overall Study|Adverse Event|1|||
161720743|NCT00972244|584023268|FG003|Overall Study|Adverse Event|0|||
161720744|NCT00972244|584023269|FG004|Overall Study|Adverse Event|0|||
161720745|NCT00972244|584023265|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
161720746|NCT00972244|584023266|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
161720747|NCT00972244|584023267|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
161720748|NCT00972244|584023268|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
161720749|NCT00972244|584023269|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
161720750|NCT00972244|584023265|FG000|Overall Study|Withdrawal by Subject|1|||
161720751|NCT00972244|584023266|FG001|Overall Study|Withdrawal by Subject|2|||
161720752|NCT00972244|584023267|FG002|Overall Study|Withdrawal by Subject|1|||
161720753|NCT00972244|584023268|FG003|Overall Study|Withdrawal by Subject|0|||
161720754|NCT00972244|584023269|FG004|Overall Study|Withdrawal by Subject|1|||
161720755|NCT00972244|584023265|FG000|Overall Study|Safety|0|||
161720756|NCT00972244|584023266|FG001|Overall Study|Safety|0|||
161720757|NCT00972244|584023267|FG002|Overall Study|Safety|0|||
161720758|NCT00972244|584023268|FG003|Overall Study|Safety|0|||
161720759|NCT00972244|584023269|FG004|Overall Study|Safety|1|||
161720760|NCT00972244|584023265|FG000|Overall Study|Death|1|||
161720761|NCT00972244|584023266|FG001|Overall Study|Death|0|||
161720762|NCT00972244|584023267|FG002|Overall Study|Death|0|||
161720763|NCT00972244|584023268|FG003|Overall Study|Death|0|||
161720764|NCT00972244|584023269|FG004|Overall Study|Death|0|||
161720765|NCT00972244|584023265|FG000|Overall Study|Various|0|||
161720766|NCT00972244|584023266|FG001|Overall Study|Various|0|||
161720767|NCT00972244|584023267|FG002|Overall Study|Various|0|||
161720768|NCT00972244|584023268|FG003|Overall Study|Various|0|||
161720769|NCT00972244|584023269|FG004|Overall Study|Various|2|||
161720770|NCT01736683|584023270|FG000|Overall Study|Disease Relapse|0|||
161720771|NCT01736683|584023271|FG001|Overall Study|Disease Relapse|0|||
161720772|NCT01736683|584023272|FG002|Overall Study|Disease Relapse|2|||
161720773|NCT01736683|584023273|FG003|Overall Study|Disease Relapse|1|||
161720774|NCT01736683|584023274|FG004|Overall Study|Disease Relapse|0|||
161720775|NCT01736683|584023270|FG000|Overall Study|Adverse Event|0|||
161720776|NCT01736683|584023271|FG001|Overall Study|Adverse Event|2|||
161720777|NCT01736683|584023272|FG002|Overall Study|Adverse Event|2|||
161720778|NCT01736683|584023273|FG003|Overall Study|Adverse Event|3|||
161720779|NCT01736683|584023274|FG004|Overall Study|Adverse Event|2|||
161720780|NCT01736683|584023270|FG000|Overall Study|Withdrawal by Subject|0|||
161720781|NCT01736683|584023271|FG001|Overall Study|Withdrawal by Subject|0|||
161720782|NCT01736683|584023272|FG002|Overall Study|Withdrawal by Subject|3|||
161720783|NCT01736683|584023273|FG003|Overall Study|Withdrawal by Subject|1|||
161720784|NCT01736683|584023274|FG004|Overall Study|Withdrawal by Subject|1|||
161720785|NCT01736683|584023270|FG000|Overall Study|Lack of Therapeutic Effect|7|||
161720786|NCT01736683|584023271|FG001|Overall Study|Lack of Therapeutic Effect|4|||
161720787|NCT01736683|584023272|FG002|Overall Study|Lack of Therapeutic Effect|13|||
161720788|NCT01736683|584023273|FG003|Overall Study|Lack of Therapeutic Effect|20|||
161720789|NCT01736683|584023274|FG004|Overall Study|Lack of Therapeutic Effect|1|||
161720790|NCT01736683|584023270|FG000|Overall Study|Progressive Disease|0|||
161720791|NCT01736683|584023271|FG001|Overall Study|Progressive Disease|0|||
161720792|NCT01736683|584023272|FG002|Overall Study|Progressive Disease|0|||
161720793|NCT01736683|584023273|FG003|Overall Study|Progressive Disease|1|||
161720794|NCT01736683|584023274|FG004|Overall Study|Progressive Disease|0|||
161720795|NCT01736683|584023270|FG000|Overall Study|Other|0|||
161720796|NCT01736683|584023271|FG001|Overall Study|Other|0|||
161720797|NCT01736683|584023272|FG002|Overall Study|Other|1|||
161720798|NCT01736683|584023273|FG003|Overall Study|Other|9|||
161720799|NCT01736683|584023274|FG004|Overall Study|Other|1|||
161720800|NCT00283712|584023280|FG000|Overall Study|Death|0|||
161720801|NCT00283712|584023281|FG001|Overall Study|Death|1|||
161720802|NCT00090285|584023283|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
161720803|NCT00090285|584023284|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
161720804|NCT00090285|584023285|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720805|NCT00090285|584023286|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720806|NCT00090285|584023287|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720807|NCT00090285|584023288|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720808|NCT00090285|584023283|FG000|Base Study Vaccination Period|Adverse Event|2|||
161720809|NCT00090285|584023284|FG001|Base Study Vaccination Period|Adverse Event|4|||
161720810|NCT00090285|584023285|FG002|Base Study Vaccination Period|Adverse Event|0|||
161720811|NCT00090285|584023286|FG003|Base Study Vaccination Period|Adverse Event|0|||
161720812|NCT00090285|584023287|FG004|Base Study Vaccination Period|Adverse Event|0|||
161720813|NCT00090285|584023288|FG005|Base Study Vaccination Period|Adverse Event|0|||
161720814|NCT00090285|584023283|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
161720815|NCT00090285|584023284|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
161720816|NCT00090285|584023285|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161720817|NCT00090285|584023286|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161720818|NCT00090285|584023287|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161720819|NCT00090285|584023288|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
161720820|NCT00090285|584023283|FG000|Base Study Vaccination Period|Protocol Violation|2|||
161720821|NCT00090285|584023284|FG001|Base Study Vaccination Period|Protocol Violation|3|||
161720822|NCT00090285|584023285|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161720823|NCT00090285|584023286|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161720824|NCT00090285|584023287|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161720825|NCT00090285|584023288|FG005|Base Study Vaccination Period|Protocol Violation|0|||
161720826|NCT00090285|584023283|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
161720827|NCT00090285|584023284|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
161720828|NCT00090285|584023285|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720829|NCT00090285|584023286|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720830|NCT00090285|584023287|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720831|NCT00090285|584023288|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720832|NCT00090285|584023283|FG000|Base Study Vaccination Period|Uncooperative|2|||
161720833|NCT00090285|584023284|FG001|Base Study Vaccination Period|Uncooperative|2|||
161720834|NCT00090285|584023285|FG002|Base Study Vaccination Period|Uncooperative|0|||
161720835|NCT00090285|584023286|FG003|Base Study Vaccination Period|Uncooperative|0|||
161720836|NCT00090285|584023287|FG004|Base Study Vaccination Period|Uncooperative|0|||
161720837|NCT00090285|584023288|FG005|Base Study Vaccination Period|Uncooperative|0|||
161720838|NCT00090285|584023283|FG000|Base Study Vaccination Period|Moved|20|||
161720839|NCT00090285|584023284|FG001|Base Study Vaccination Period|Moved|21|||
161720840|NCT00090285|584023285|FG002|Base Study Vaccination Period|Moved|0|||
161720841|NCT00090285|584023286|FG003|Base Study Vaccination Period|Moved|0|||
161720842|NCT00090285|584023287|FG004|Base Study Vaccination Period|Moved|0|||
161720843|NCT00090285|584023288|FG005|Base Study Vaccination Period|Moved|0|||
161720844|NCT00090285|584023283|FG000|Base Study Vaccination Period|Site Terminated|1|||
161720845|NCT00090285|584023284|FG001|Base Study Vaccination Period|Site Terminated|0|||
161720846|NCT00090285|584023285|FG002|Base Study Vaccination Period|Site Terminated|0|||
161720847|NCT00090285|584023286|FG003|Base Study Vaccination Period|Site Terminated|0|||
161720848|NCT00090285|584023287|FG004|Base Study Vaccination Period|Site Terminated|0|||
161720849|NCT00090285|584023288|FG005|Base Study Vaccination Period|Site Terminated|0|||
161720850|NCT00090285|584023283|FG000|Base Study Vaccination Period|Other|2|||
161720851|NCT00090285|584023284|FG001|Base Study Vaccination Period|Other|2|||
161720852|NCT00090285|584023285|FG002|Base Study Vaccination Period|Other|0|||
161720853|NCT00090285|584023286|FG003|Base Study Vaccination Period|Other|0|||
161720854|NCT00090285|584023287|FG004|Base Study Vaccination Period|Other|0|||
161720855|NCT00090285|584023288|FG005|Base Study Vaccination Period|Other|0|||
161720856|NCT00090285|584023283|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
161720857|NCT00090285|584023284|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
161720858|NCT00090285|584023285|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
161720859|NCT00090285|584023286|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
161720860|NCT00090285|584023287|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
161720861|NCT00090285|584023288|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
161720862|NCT00090285|584023283|FG000|Base Study Vaccination Period|HIV positive|1|||
161720863|NCT00090285|584023284|FG001|Base Study Vaccination Period|HIV positive|1|||
161720864|NCT00090285|584023285|FG002|Base Study Vaccination Period|HIV positive|0|||
161720865|NCT00090285|584023286|FG003|Base Study Vaccination Period|HIV positive|0|||
161720866|NCT00090285|584023287|FG004|Base Study Vaccination Period|HIV positive|0|||
161720867|NCT00090285|584023288|FG005|Base Study Vaccination Period|HIV positive|0|||
161720868|NCT00090285|584023283|FG000|Base Study Follow-up Period|Adverse Event|3|||
161720869|NCT00090285|584023284|FG001|Base Study Follow-up Period|Adverse Event|10|||
161720870|NCT00090285|584023285|FG002|Base Study Follow-up Period|Adverse Event|0|||
161720871|NCT00090285|584023286|FG003|Base Study Follow-up Period|Adverse Event|0|||
161720872|NCT00090285|584023287|FG004|Base Study Follow-up Period|Adverse Event|0|||
161720873|NCT00090285|584023288|FG005|Base Study Follow-up Period|Adverse Event|0|||
161720874|NCT00090285|584023283|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
161720875|NCT00090285|584023284|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
161720876|NCT00090285|584023285|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
161720877|NCT00090285|584023286|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
161720878|NCT00090285|584023287|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161720879|NCT00090285|584023288|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
161720880|NCT00090285|584023283|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
161720881|NCT00090285|584023284|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
161720882|NCT00090285|584023285|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720883|NCT00090285|584023286|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720884|NCT00090285|584023287|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720885|NCT00090285|584023288|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720886|NCT00090285|584023283|FG000|Base Study Follow-up Period|Moved|41|||
161720887|NCT00090285|584023284|FG001|Base Study Follow-up Period|Moved|36|||
161720888|NCT00090285|584023285|FG002|Base Study Follow-up Period|Moved|0|||
161720889|NCT00090285|584023286|FG003|Base Study Follow-up Period|Moved|0|||
161720890|NCT00090285|584023287|FG004|Base Study Follow-up Period|Moved|0|||
161720891|NCT00090285|584023288|FG005|Base Study Follow-up Period|Moved|0|||
161720892|NCT00090285|584023283|FG000|Base Study Follow-up Period|Other|2|||
161720893|NCT00090285|584023284|FG001|Base Study Follow-up Period|Other|0|||
161720894|NCT00090285|584023285|FG002|Base Study Follow-up Period|Other|0|||
161720895|NCT00090285|584023286|FG003|Base Study Follow-up Period|Other|0|||
161720896|NCT00090285|584023287|FG004|Base Study Follow-up Period|Other|0|||
161720897|NCT00090285|584023288|FG005|Base Study Follow-up Period|Other|0|||
161720898|NCT00090285|584023283|FG000|Base Study Follow-up Period|Protocol Violation|1|||
161720899|NCT00090285|584023284|FG001|Base Study Follow-up Period|Protocol Violation|0|||
161720900|NCT00090285|584023285|FG002|Base Study Follow-up Period|Protocol Violation|0|||
161720901|NCT00090285|584023286|FG003|Base Study Follow-up Period|Protocol Violation|0|||
161720902|NCT00090285|584023287|FG004|Base Study Follow-up Period|Protocol Violation|0|||
161720903|NCT00090285|584023288|FG005|Base Study Follow-up Period|Protocol Violation|0|||
161720904|NCT00090285|584023283|FG000|Base Study Follow-up Period|Uncooperative|3|||
161720905|NCT00090285|584023284|FG001|Base Study Follow-up Period|Uncooperative|4|||
161720906|NCT00090285|584023285|FG002|Base Study Follow-up Period|Uncooperative|0|||
161720907|NCT00090285|584023286|FG003|Base Study Follow-up Period|Uncooperative|0|||
161720908|NCT00090285|584023287|FG004|Base Study Follow-up Period|Uncooperative|0|||
161720909|NCT00090285|584023288|FG005|Base Study Follow-up Period|Uncooperative|0|||
161720910|NCT00090285|584023283|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
161720911|NCT00090285|584023284|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
161720912|NCT00090285|584023285|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
161720913|NCT00090285|584023286|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
161720914|NCT00090285|584023287|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
161720915|NCT00090285|584023288|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
161720916|NCT00090285|584023283|FG000|Extension 1|Adverse Event|0|||
161720917|NCT00090285|584023284|FG001|Extension 1|Adverse Event|0|||
161720918|NCT00090285|584023285|FG002|Extension 1|Adverse Event|2|||
161720919|NCT00090285|584023286|FG003|Extension 1|Adverse Event|0|||
161720920|NCT00090285|584023287|FG004|Extension 1|Adverse Event|0|||
161720921|NCT00090285|584023288|FG005|Extension 1|Adverse Event|0|||
161720922|NCT00090285|584023283|FG000|Extension 1|Lost to Follow-up|0|||
161720923|NCT00090285|584023284|FG001|Extension 1|Lost to Follow-up|0|||
161720924|NCT00090285|584023285|FG002|Extension 1|Lost to Follow-up|35|||
161720925|NCT00090285|584023286|FG003|Extension 1|Lost to Follow-up|0|||
161720926|NCT00090285|584023287|FG004|Extension 1|Lost to Follow-up|0|||
161720927|NCT00090285|584023288|FG005|Extension 1|Lost to Follow-up|0|||
161720928|NCT00090285|584023283|FG000|Extension 1|Withdrawal by Subject|0|||
161720929|NCT00090285|584023284|FG001|Extension 1|Withdrawal by Subject|0|||
161720930|NCT00090285|584023285|FG002|Extension 1|Withdrawal by Subject|13|||
161720931|NCT00090285|584023286|FG003|Extension 1|Withdrawal by Subject|1|||
161720932|NCT00090285|584023287|FG004|Extension 1|Withdrawal by Subject|0|||
161720933|NCT00090285|584023288|FG005|Extension 1|Withdrawal by Subject|0|||
161720934|NCT00090285|584023283|FG000|Extension 1|Other|0|||
161720935|NCT00090285|584023284|FG001|Extension 1|Other|0|||
161720936|NCT00090285|584023285|FG002|Extension 1|Other|4|||
161720937|NCT00090285|584023286|FG003|Extension 1|Other|0|||
161720938|NCT00090285|584023287|FG004|Extension 1|Other|0|||
161720939|NCT00090285|584023288|FG005|Extension 1|Other|0|||
161720940|NCT00090285|584023283|FG000|Extension 1|Moved|0|||
161720941|NCT00090285|584023284|FG001|Extension 1|Moved|0|||
161720942|NCT00090285|584023285|FG002|Extension 1|Moved|3|||
161720943|NCT00090285|584023286|FG003|Extension 1|Moved|0|||
161720944|NCT00090285|584023287|FG004|Extension 1|Moved|0|||
161720945|NCT00090285|584023288|FG005|Extension 1|Moved|0|||
161720946|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720947|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720948|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720949|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720950|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
161720951|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
161720952|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720953|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720954|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720955|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720956|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
161720957|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
161720958|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720959|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720960|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720961|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720962|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
161720963|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
161720964|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720965|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720966|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720967|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720968|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
161720969|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
161720970|NCT02046564|584023291|FG000|Overall Study|Adverse Event|6|||
161720971|NCT02046564|584023292|FG001|Overall Study|Adverse Event|3|||
161720972|NCT02046564|584023291|FG000|Overall Study|Physician Decision|0|||
161720973|NCT02046564|584023292|FG001|Overall Study|Physician Decision|1|||
161720974|NCT02046564|584023291|FG000|Overall Study|Protocol Violation|3|||
161720975|NCT02046564|584023292|FG001|Overall Study|Protocol Violation|1|||
161720976|NCT02046564|584023291|FG000|Overall Study|Withdrawal by Subject|4|||
161720977|NCT02046564|584023292|FG001|Overall Study|Withdrawal by Subject|10|||
161720978|NCT02046564|584023291|FG000|Overall Study|Subject met withdrawal criteria|2|||
161720979|NCT02046564|584023292|FG001|Overall Study|Subject met withdrawal criteria|5|||
161720980|NCT00907478|584023293|FG000|Overall Study|Ineligibility determined|0|||
161720981|NCT00907478|584023294|FG001|Overall Study|Ineligibility determined|0|||
161720982|NCT00907478|584023295|FG002|Overall Study|Ineligibility determined|1|||
161720983|NCT00907478|584023293|FG000|Overall Study|Noncompliance|0|||
161720984|NCT00907478|584023294|FG001|Overall Study|Noncompliance|0|||
161720985|NCT00907478|584023295|FG002|Overall Study|Noncompliance|1|||
161720986|NCT00907478|584023293|FG000|Overall Study|Adverse Event|3|||
161720987|NCT00907478|584023294|FG001|Overall Study|Adverse Event|1|||
161720988|NCT00907478|584023295|FG002|Overall Study|Adverse Event|2|||
161720989|NCT00907478|584023293|FG000|Overall Study|Withdrawal by Subject|8|||
161720990|NCT00907478|584023294|FG001|Overall Study|Withdrawal by Subject|9|||
161720991|NCT00907478|584023295|FG002|Overall Study|Withdrawal by Subject|6|||
161720992|NCT00907478|584023293|FG000|Overall Study|Requirement for alternative therapy|1|||
161720993|NCT00907478|584023294|FG001|Overall Study|Requirement for alternative therapy|2|||
161720994|NCT00907478|584023295|FG002|Overall Study|Requirement for alternative therapy|3|||
161720995|NCT00907478|584023293|FG000|Overall Study|Physician Decision|2|||
161720996|NCT00907478|584023294|FG001|Overall Study|Physician Decision|0|||
161720997|NCT00907478|584023295|FG002|Overall Study|Physician Decision|3|||
161720998|NCT00907478|584023293|FG000|Overall Study|Death|4|||
161720999|NCT00907478|584023294|FG001|Overall Study|Death|2|||
161721000|NCT00907478|584023295|FG002|Overall Study|Death|1|||
161721001|NCT00907478|584023293|FG000|Overall Study|Protocol-specified criteria|5|||
161721002|NCT00907478|584023294|FG001|Overall Study|Protocol-specified criteria|2|||
161721003|NCT00907478|584023295|FG002|Overall Study|Protocol-specified criteria|3|||
161721004|NCT00907478|584023293|FG000|Overall Study|Pregnancy|0|||
161721005|NCT00907478|584023294|FG001|Overall Study|Pregnancy|1|||
161721006|NCT00907478|584023295|FG002|Overall Study|Pregnancy|1|||
161721007|NCT00907478|584023293|FG000|Overall Study|Lost to Follow-up|1|||
161721008|NCT00907478|584023294|FG001|Overall Study|Lost to Follow-up|0|||
161721009|NCT00907478|584023295|FG002|Overall Study|Lost to Follow-up|0|||
161721010|NCT00907478|584023293|FG000|Overall Study|Other|3|||
161721011|NCT00907478|584023294|FG001|Overall Study|Other|0|||
161721012|NCT00907478|584023295|FG002|Overall Study|Other|1|||
161721013|NCT02747043|584023296|FG000|Overall Study|Other|1|||
161721014|NCT02747043|584023297|FG001|Overall Study|Other|1|||
161721015|NCT02747043|584023296|FG000|Overall Study|Adverse Event|3|||
161721016|NCT02747043|584023297|FG001|Overall Study|Adverse Event|1|||
161721017|NCT02747043|584023296|FG000|Overall Study|Withdrawal by Subject|1|||
161721018|NCT02747043|584023297|FG001|Overall Study|Withdrawal by Subject|1|||
161721019|NCT02747043|584023296|FG000|Overall Study|Physician Decision|1|||
161721020|NCT02747043|584023297|FG001|Overall Study|Physician Decision|1|||
161721021|NCT02747043|584023296|FG000|Overall Study|Protocol Violation|0|||
161721022|NCT02747043|584023297|FG001|Overall Study|Protocol Violation|1|||
161721023|NCT02747043|584023296|FG000|Overall Study|Disease progression|4|||
161721024|NCT02747043|584023297|FG001|Overall Study|Disease progression|0|||
161721025|NCT01936649|584023302|FG000|Overall Study|Withdrawal by Subject|4|||
161721026|NCT01936649|584023302|FG000|Overall Study|Physician Decision|2|||
161721027|NCT01936649|584023302|FG000|Overall Study|Protocol Violation|2|||
161721028|NCT01936649|584023302|FG000|Overall Study|Other than specified above|5|||
161721029|NCT03554005|584023311|FG000|Overall Study|Not in participant's best interest|0|||
161721030|NCT03554005|584023312|FG001|Overall Study|Not in participant's best interest|0|||
161721031|NCT03554005|584023313|FG002|Overall Study|Not in participant's best interest|0|||
161721032|NCT03554005|584023314|FG003|Overall Study|Not in participant's best interest|0|||
161721033|NCT03554005|584023315|FG004|Overall Study|Not in participant's best interest|0|||
161721034|NCT03554005|584023316|FG005|Overall Study|Not in participant's best interest|1|||
161721035|NCT03554005|584023311|FG000|Overall Study|Disease Progression|1|||
161721036|NCT03554005|584023312|FG001|Overall Study|Disease Progression|1|||
161721037|NCT03554005|584023313|FG002|Overall Study|Disease Progression|1|||
161721038|NCT03554005|584023314|FG003|Overall Study|Disease Progression|1|||
161721039|NCT03554005|584023315|FG004|Overall Study|Disease Progression|5|||
161721040|NCT03554005|584023316|FG005|Overall Study|Disease Progression|6|||
161721041|NCT03554005|584023311|FG000|Overall Study|Adverse Event|0|||
161721042|NCT03554005|584023312|FG001|Overall Study|Adverse Event|0|||
161721043|NCT03554005|584023313|FG002|Overall Study|Adverse Event|0|||
161721044|NCT03554005|584023314|FG003|Overall Study|Adverse Event|0|||
161721045|NCT03554005|584023315|FG004|Overall Study|Adverse Event|0|||
161721046|NCT03554005|584023316|FG005|Overall Study|Adverse Event|3|||
161721047|NCT03554005|584023311|FG000|Overall Study|Physician Decision|0|||
161721048|NCT03554005|584023312|FG001|Overall Study|Physician Decision|0|||
161721049|NCT03554005|584023313|FG002|Overall Study|Physician Decision|0|||
161721050|NCT03554005|584023314|FG003|Overall Study|Physician Decision|0|||
161721051|NCT03554005|584023315|FG004|Overall Study|Physician Decision|1|||
161721052|NCT03554005|584023316|FG005|Overall Study|Physician Decision|0|||
161721053|NCT03554005|584023311|FG000|Overall Study|Other|0|||
161721054|NCT03554005|584023312|FG001|Overall Study|Other|0|||
161721055|NCT03554005|584023313|FG002|Overall Study|Other|0|||
161721056|NCT03554005|584023314|FG003|Overall Study|Other|0|||
161721057|NCT03554005|584023315|FG004|Overall Study|Other|0|||
161721058|NCT03554005|584023316|FG005|Overall Study|Other|1|||
161721059|NCT00631488|584023320|FG000|Overall Study|Adverse Event|1|||
161721060|NCT00631488|584023321|FG001|Overall Study|Adverse Event|0|||
161721061|NCT00631488|584023322|FG002|Overall Study|Adverse Event|0|||
161721062|NCT00631488|584023320|FG000|Overall Study|Lost to Follow-up|2|||
161721063|NCT00631488|584023321|FG001|Overall Study|Lost to Follow-up|2|||
161721064|NCT00631488|584023322|FG002|Overall Study|Lost to Follow-up|0|||
161721065|NCT00631488|584023320|FG000|Overall Study|Physician Decision|1|||
161721066|NCT00631488|584023321|FG001|Overall Study|Physician Decision|0|||
161721067|NCT00631488|584023322|FG002|Overall Study|Physician Decision|1|||
161721068|NCT00631488|584023320|FG000|Overall Study|Protocol Violation|0|||
161721069|NCT00631488|584023321|FG001|Overall Study|Protocol Violation|0|||
161721070|NCT00631488|584023322|FG002|Overall Study|Protocol Violation|1|||
161721071|NCT03648476|584023324|FG000|Overall Study|Withdrawal by Subject|2|||
161721072|NCT03648476|584023325|FG001|Overall Study|Withdrawal by Subject|1|||
161721073|NCT02855411|584023330|FG000|Overall Study|Study terminated by sponsor|21|||
161721074|NCT02855411|584023330|FG000|Overall Study|Does not meet entrance criteria|14|||
161721075|NCT00907881|584023331|FG000|Overall Study|Lost to Follow-up|59|||
161721076|NCT00907881|584023331|FG000|Overall Study|Noncompliance|5|||
161721077|NCT00907881|584023331|FG000|Overall Study|Withdrawal by Subject|5|||
161721078|NCT00907881|584023331|FG000|Overall Study|Protocol Violation|1|||
161721079|NCT00907881|584023331|FG000|Overall Study|Missing discontinuation information|15|||
161721080|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
161721081|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
161721082|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
161721083|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721084|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721085|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721086|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721087|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721088|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
161721089|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
161721090|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
161721091|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721092|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721093|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721094|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721095|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721096|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
161721097|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
161721098|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
161721099|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721100|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721101|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721102|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721103|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721104|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161721105|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161721106|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721107|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721108|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721109|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721110|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721111|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721112|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
161721113|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
161721114|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
161721115|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721116|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721117|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721118|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721119|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721120|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
161721121|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
161721122|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721123|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721124|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721125|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721126|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721127|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721128|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
161721129|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
161721130|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721131|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721132|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721133|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721134|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721135|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721136|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721137|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721138|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
161721139|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721140|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721141|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721142|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721143|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721144|NCT01097616|584023334|FG000|Optional DB EXT Phase|Adverse Event|0|||
161721145|NCT01097616|584023335|FG001|Optional DB EXT Phase|Adverse Event|7|||
161721146|NCT01097616|584023336|FG002|Optional DB EXT Phase|Adverse Event|2|||
161721147|NCT01097616|584023337|FG003|Optional DB EXT Phase|Adverse Event|0|||
161721148|NCT01097616|584023338|FG004|Optional DB EXT Phase|Adverse Event|0|||
161721149|NCT01097616|584023339|FG005|Optional DB EXT Phase|Adverse Event|0|||
161721150|NCT01097616|584023340|FG006|Optional DB EXT Phase|Adverse Event|0|||
161721151|NCT01097616|584023341|FG007|Optional DB EXT Phase|Adverse Event|0|||
161721152|NCT01097616|584023334|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
161721153|NCT01097616|584023335|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
161721154|NCT01097616|584023336|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
161721155|NCT01097616|584023337|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721156|NCT01097616|584023338|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721157|NCT01097616|584023339|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721158|NCT01097616|584023340|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721159|NCT01097616|584023341|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721160|NCT01097616|584023334|FG000|Optional DB EXT Phase|Protocol Violation|0|||
161721161|NCT01097616|584023335|FG001|Optional DB EXT Phase|Protocol Violation|2|||
161721162|NCT01097616|584023336|FG002|Optional DB EXT Phase|Protocol Violation|3|||
161721163|NCT01097616|584023337|FG003|Optional DB EXT Phase|Protocol Violation|0|||
161721164|NCT01097616|584023338|FG004|Optional DB EXT Phase|Protocol Violation|0|||
161721165|NCT01097616|584023339|FG005|Optional DB EXT Phase|Protocol Violation|0|||
161721166|NCT01097616|584023340|FG006|Optional DB EXT Phase|Protocol Violation|0|||
161721167|NCT01097616|584023341|FG007|Optional DB EXT Phase|Protocol Violation|0|||
161721168|NCT01097616|584023334|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
161721169|NCT01097616|584023335|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
161721170|NCT01097616|584023336|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
161721171|NCT01097616|584023337|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
161721172|NCT01097616|584023338|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
161721173|NCT01097616|584023339|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
161721174|NCT01097616|584023340|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
161721175|NCT01097616|584023341|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
161721176|NCT01097616|584023334|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
161721177|NCT01097616|584023335|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
161721178|NCT01097616|584023336|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
161721179|NCT01097616|584023337|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
161721180|NCT01097616|584023338|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
161721181|NCT01097616|584023339|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
161721182|NCT01097616|584023340|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
161721183|NCT01097616|584023341|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
161721184|NCT01097616|584023334|FG000|Optional DB EXT Phase|Physician Decision|1|||
161721185|NCT01097616|584023335|FG001|Optional DB EXT Phase|Physician Decision|0|||
161721186|NCT01097616|584023336|FG002|Optional DB EXT Phase|Physician Decision|0|||
161721187|NCT01097616|584023337|FG003|Optional DB EXT Phase|Physician Decision|0|||
161721188|NCT01097616|584023338|FG004|Optional DB EXT Phase|Physician Decision|0|||
161721189|NCT01097616|584023339|FG005|Optional DB EXT Phase|Physician Decision|0|||
161721190|NCT01097616|584023340|FG006|Optional DB EXT Phase|Physician Decision|0|||
161721191|NCT01097616|584023341|FG007|Optional DB EXT Phase|Physician Decision|0|||
161721192|NCT01097616|584023334|FG000|DB RO Phase|Adverse Event|0|||
161721193|NCT01097616|584023335|FG001|DB RO Phase|Adverse Event|0|||
161721194|NCT01097616|584023336|FG002|DB RO Phase|Adverse Event|0|||
161721195|NCT01097616|584023337|FG003|DB RO Phase|Adverse Event|0|||
161721196|NCT01097616|584023338|FG004|DB RO Phase|Adverse Event|0|||
161721197|NCT01097616|584023339|FG005|DB RO Phase|Adverse Event|0|||
161721198|NCT01097616|584023340|FG006|DB RO Phase|Adverse Event|1|||
161721199|NCT01097616|584023341|FG007|DB RO Phase|Adverse Event|0|||
161721200|NCT01097616|584023334|FG000|DB RO Phase|Withdrawal by Subject|0|||
161721201|NCT01097616|584023335|FG001|DB RO Phase|Withdrawal by Subject|0|||
161721202|NCT01097616|584023336|FG002|DB RO Phase|Withdrawal by Subject|0|||
161721203|NCT01097616|584023337|FG003|DB RO Phase|Withdrawal by Subject|0|||
161721204|NCT01097616|584023338|FG004|DB RO Phase|Withdrawal by Subject|0|||
161721205|NCT01097616|584023339|FG005|DB RO Phase|Withdrawal by Subject|1|||
161721206|NCT01097616|584023340|FG006|DB RO Phase|Withdrawal by Subject|0|||
161721207|NCT01097616|584023341|FG007|DB RO Phase|Withdrawal by Subject|0|||
161721208|NCT01097616|584023334|FG000|DB RO Phase|Lost to Follow-up|0|||
161721209|NCT01097616|584023335|FG001|DB RO Phase|Lost to Follow-up|0|||
161721210|NCT01097616|584023336|FG002|DB RO Phase|Lost to Follow-up|0|||
161721211|NCT01097616|584023337|FG003|DB RO Phase|Lost to Follow-up|1|||
161721212|NCT01097616|584023338|FG004|DB RO Phase|Lost to Follow-up|1|||
161721213|NCT01097616|584023339|FG005|DB RO Phase|Lost to Follow-up|0|||
161721214|NCT01097616|584023340|FG006|DB RO Phase|Lost to Follow-up|0|||
161721215|NCT01097616|584023341|FG007|DB RO Phase|Lost to Follow-up|1|||
161721216|NCT01097616|584023334|FG000|DB RO Phase|Not Treated in RO|0|||
161721217|NCT01097616|584023335|FG001|DB RO Phase|Not Treated in RO|0|||
161721218|NCT01097616|584023336|FG002|DB RO Phase|Not Treated in RO|0|||
161721219|NCT01097616|584023337|FG003|DB RO Phase|Not Treated in RO|0|||
161721220|NCT01097616|584023338|FG004|DB RO Phase|Not Treated in RO|0|||
161721221|NCT01097616|584023339|FG005|DB RO Phase|Not Treated in RO|1|||
161721222|NCT01097616|584023340|FG006|DB RO Phase|Not Treated in RO|0|||
161721223|NCT01097616|584023341|FG007|DB RO Phase|Not Treated in RO|0|||
161721224|NCT03988751|584023342|FG000|Overall Study|Withdrawal by Subject|1|||
161721225|NCT03988751|584023343|FG001|Overall Study|Withdrawal by Subject|0|||
161721226|NCT03988751|584023342|FG000|Overall Study|Protocol Violation|0|||
161721227|NCT03988751|584023343|FG001|Overall Study|Protocol Violation|1|||
161721228|NCT00844883|584023344|FG000|Overall Study|Bridged to liver transplant|3|||
161721229|NCT00844883|584023344|FG000|Overall Study|Bridged to resection|1|||
161721230|NCT02927171|584023348|FG000|Overall Study|Lost to Follow-up|0|||
161721231|NCT02927171|584023349|FG001|Overall Study|Lost to Follow-up|1|||
161721232|NCT02240628|584023352|FG000|Overall Study|Physician Decision|6|||
161721233|NCT02240628|584023353|FG001|Overall Study|Physician Decision|5|||
161721234|NCT00850499|584023355|FG000|Overall Study|Adverse Event|3|||
161721235|NCT00850499|584023356|FG001|Overall Study|Adverse Event|1|||
161721236|NCT00850499|584023355|FG000|Overall Study|Lack of Efficacy|0|||
161721237|NCT00850499|584023356|FG001|Overall Study|Lack of Efficacy|1|||
161721238|NCT00552305|584023357|FG000|Overall Study|Adverse Event|43|||
161721239|NCT00552305|584023357|FG000|Overall Study|Lack of Efficacy|120|||
161721240|NCT00552305|584023357|FG000|Overall Study|Lost to Follow-up|4|||
161721241|NCT00552305|584023357|FG000|Overall Study|Protocol Violation|3|||
161721242|NCT00552305|584023357|FG000|Overall Study|Withdrawal by Subject|44|||
161721243|NCT00552305|584023357|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
161721244|NCT00552305|584023357|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
161721245|NCT00552305|584023357|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
161721246|NCT00552305|584023357|FG000|Overall Study|Unsatisfactory compliance|11|||
161721247|NCT00552305|584023357|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
161721248|NCT00552305|584023357|FG000|Overall Study|AE/Other: prohibited drug required|1|||
161721249|NCT00552305|584023357|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
161721250|NCT00552305|584023357|FG000|Overall Study|Other: Site closed|4|||
161721251|NCT00552305|584023357|FG000|Overall Study|Other: Personal problems|1|||
161721252|NCT00552305|584023357|FG000|Overall Study|Other: Unable to attend visits|1|||
161721253|NCT00552305|584023357|FG000|Overall Study|Other: Subject underwent surgery|4|||
161721254|NCT00552305|584023357|FG000|Overall Study|Other: Subject became pregnant|1|||
161721255|NCT00552305|584023357|FG000|Overall Study|Other: Health problems, not drug related|1|||
161721256|NCT00552305|584023357|FG000|Overall Study|Other: Subject moved from area|2|||
161721257|NCT00552305|584023357|FG000|Overall Study|Other: Subject incarcerated|1|||
161721258|NCT00552305|584023357|FG000|Overall Study|Other: Subject went to rehab|1|||
161721259|NCT00718861|584023360|FG000|Overall Study|Withdrawal by Subject|15|||
161721260|NCT00718861|584023361|FG001|Overall Study|Withdrawal by Subject|10|||
161721261|NCT00718861|584023360|FG000|Overall Study|Adverse Event|2|||
161721262|NCT00718861|584023361|FG001|Overall Study|Adverse Event|1|||
161721263|NCT00718861|584023360|FG000|Overall Study|Lost to Follow-up|2|||
161721264|NCT00718861|584023361|FG001|Overall Study|Lost to Follow-up|1|||
161721265|NCT00718861|584023360|FG000|Overall Study|Administrative Problems|1|||
161721266|NCT00718861|584023361|FG001|Overall Study|Administrative Problems|1|||
161721267|NCT00718861|584023360|FG000|Overall Study|Death|1|||
161721268|NCT00718861|584023361|FG001|Overall Study|Death|5|||
161721269|NCT01703819|584023362|FG000|Overall Study|Adverse Event|0|||
161721270|NCT01703819|584023363|FG001|Overall Study|Adverse Event|1|||
161721271|NCT01703819|584023362|FG000|Overall Study|Withdrawal by Subject|0|||
161721272|NCT01703819|584023363|FG001|Overall Study|Withdrawal by Subject|1|||
161721273|NCT04230486|584023370|FG000|Overall Study|Screen Failure|1|||
161721274|NCT01302041|584023371|FG000|Overall Study|Death|5|||
161721275|NCT01302041|584023371|FG000|Overall Study|Withdrawal by Subject|4|||
161721276|NCT01302041|584023371|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
161721277|NCT01302041|584023371|FG000|Overall Study|Other-Miscellaneous Reason|2|||
161721278|NCT01839188|584023372|FG000|Overall Study|Withdrawal by Subject|1|||
161721279|NCT04983901|584023373|FG000|Overall Study|Death|1|||
161721280|NCT04983901|584023374|FG001|Overall Study|Death|4|||
161721281|NCT04983901|584023373|FG000|Overall Study|Lost to Follow-up|3|||
161721282|NCT04983901|584023374|FG001|Overall Study|Lost to Follow-up|0|||
161721283|NCT04983901|584023373|FG000|Overall Study|Protocol Violation|1|||
161721284|NCT04983901|584023374|FG001|Overall Study|Protocol Violation|0|||
161721285|NCT04983901|584023373|FG000|Overall Study|Withdrawal by Subject|1|||
161721286|NCT04983901|584023374|FG001|Overall Study|Withdrawal by Subject|2|||
161721287|NCT01022853|584023381|FG000|Overall Study|Progressive disease|2|||
161721288|NCT01022853|584023382|FG001|Overall Study|Progressive disease|3|||
161721289|NCT01022853|584023383|FG002|Overall Study|Progressive disease|11|||
161721290|NCT01022853|584023384|FG003|Overall Study|Progressive disease|7|||
161721291|NCT01022853|584023385|FG004|Overall Study|Progressive disease|1|||
161721292|NCT01022853|584023381|FG000|Overall Study|Dose-limiting toxicity|0|||
161721293|NCT01022853|584023382|FG001|Overall Study|Dose-limiting toxicity|0|||
161721294|NCT01022853|584023383|FG002|Overall Study|Dose-limiting toxicity|0|||
161721295|NCT01022853|584023384|FG003|Overall Study|Dose-limiting toxicity|0|||
161721296|NCT01022853|584023385|FG004|Overall Study|Dose-limiting toxicity|1|||
161721297|NCT01022853|584023381|FG000|Overall Study|Withdrawal by Subject|0|||
161721298|NCT01022853|584023382|FG001|Overall Study|Withdrawal by Subject|1|||
161721299|NCT01022853|584023383|FG002|Overall Study|Withdrawal by Subject|1|||
161721300|NCT01022853|584023384|FG003|Overall Study|Withdrawal by Subject|1|||
161721301|NCT01022853|584023385|FG004|Overall Study|Withdrawal by Subject|0|||
161721302|NCT01022853|584023381|FG000|Overall Study|Other not stated above|1|||
161721303|NCT01022853|584023382|FG001|Overall Study|Other not stated above|0|||
161721304|NCT01022853|584023383|FG002|Overall Study|Other not stated above|1|||
161721305|NCT01022853|584023384|FG003|Overall Study|Other not stated above|0|||
161721306|NCT01022853|584023385|FG004|Overall Study|Other not stated above|0|||
161721307|NCT02416908|584023386|FG000|Dose Escalation Phase|Adverse Event|0|||
161721308|NCT02416908|584023387|FG001|Dose Escalation Phase|Adverse Event|0|||
161721309|NCT02416908|584023388|FG002|Dose Escalation Phase|Adverse Event|3|||
161721310|NCT02416908|584023389|FG003|Dose Escalation Phase|Adverse Event|0|||
161721311|NCT02416908|584023386|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161721312|NCT02416908|584023387|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161721313|NCT02416908|584023388|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
161721314|NCT02416908|584023389|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161721315|NCT01651052|584023390|FG000|Overall Study|Death|21|||
161721316|NCT01651052|584023390|FG000|Overall Study|Explant|1|||
161721317|NCT01651052|584023390|FG000|Overall Study|Withdrawal by Subject|1|||
161721318|NCT01651052|584023390|FG000|Overall Study|Lost to Follow-up|3|||
161721319|NCT03503773|584023391|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
161721320|NCT03503773|584023392|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
161721321|NCT03503773|584023391|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
161721322|NCT03503773|584023392|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
161721323|NCT03503773|584023391|FG000|Overall Study|Not completing the primary ABPM|3|||
161721324|NCT03503773|584023392|FG001|Overall Study|Not completing the primary ABPM|1|||
161721325|NCT03503773|584023391|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161721326|NCT03503773|584023392|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161721327|NCT02285010|584023396|FG000|Overall Study|not abdominal hysterectomy|2|||
161721328|NCT02285010|584023397|FG001|Overall Study|not abdominal hysterectomy|0|||
161721329|NCT02285010|584023396|FG000|Overall Study|Not spinal anesthesia|3|||
161721330|NCT02285010|584023397|FG001|Overall Study|Not spinal anesthesia|1|||
161721331|NCT01478347|584023407|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
161721332|NCT01478347|584023407|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
161721333|NCT01478347|584023407|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
161721334|NCT01645930|584023408|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
161721335|NCT01645930|584023408|FG000|Overall Study|Progressive Disease|12|||
161721336|NCT01645930|584023408|FG000|Overall Study|Adverse Event|4|||
161721337|NCT01645930|584023408|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
161721338|NCT01645930|584023408|FG000|Overall Study|Withdrawal by Participant|2|||
161721339|NCT01645930|584023408|FG000|Overall Study|Reason not Defined|1|||
161721340|NCT03245814|584023411|FG000|Overall Study|Lost to Follow-up|5|||
161721341|NCT03245814|584023412|FG001|Overall Study|Lost to Follow-up|8|||
161721342|NCT03245814|584023411|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
161721343|NCT03245814|584023412|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
161721344|NCT01164501|584023414|FG000|Overall Study|Not treated|2|||
161721345|NCT01164501|584023415|FG001|Overall Study|Not treated|0|||
161721346|NCT01164501|584023416|FG002|Overall Study|Not treated|1|||
161721347|NCT01164501|584023414|FG000|Overall Study|Adverse Event|18|||
161721348|NCT01164501|584023415|FG001|Overall Study|Adverse Event|4|||
161721349|NCT01164501|584023416|FG002|Overall Study|Adverse Event|21|||
161721350|NCT01164501|584023414|FG000|Overall Study|Lack of Efficacy|0|||
161721351|NCT01164501|584023415|FG001|Overall Study|Lack of Efficacy|0|||
161721352|NCT01164501|584023416|FG002|Overall Study|Lack of Efficacy|1|||
161721353|NCT01164501|584023414|FG000|Overall Study|Non compliant with protocol|1|||
161721354|NCT01164501|584023415|FG001|Overall Study|Non compliant with protocol|1|||
161721355|NCT01164501|584023416|FG002|Overall Study|Non compliant with protocol|4|||
161721356|NCT01164501|584023414|FG000|Overall Study|Lost to Follow-up|3|||
161721357|NCT01164501|584023415|FG001|Overall Study|Lost to Follow-up|0|||
161721358|NCT01164501|584023416|FG002|Overall Study|Lost to Follow-up|3|||
161721359|NCT01164501|584023414|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
161721360|NCT01164501|584023415|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
161721361|NCT01164501|584023416|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
161721362|NCT01164501|584023414|FG000|Overall Study|Other reason not defined above|9|||
161721363|NCT01164501|584023415|FG001|Overall Study|Other reason not defined above|1|||
161721364|NCT01164501|584023416|FG002|Overall Study|Other reason not defined above|4|||
161721365|NCT01096667|584023417|FG000|Overall Study|Lost to Follow-up|1|||
161721366|NCT01096667|584023418|FG001|Overall Study|Lost to Follow-up|1|||
161721367|NCT01096667|584023419|FG002|Overall Study|Lost to Follow-up|1|||
161721368|NCT01096667|584023420|FG003|Overall Study|Lost to Follow-up|0|||
161721369|NCT01096667|584023421|FG004|Overall Study|Lost to Follow-up|0|||
161721370|NCT01096667|584023417|FG000|Overall Study|Withdrawal by Subject|1|||
161721371|NCT01096667|584023418|FG001|Overall Study|Withdrawal by Subject|0|||
161721372|NCT01096667|584023419|FG002|Overall Study|Withdrawal by Subject|0|||
161721373|NCT01096667|584023420|FG003|Overall Study|Withdrawal by Subject|1|||
161721374|NCT01096667|584023421|FG004|Overall Study|Withdrawal by Subject|0|||
161721375|NCT01096667|584023417|FG000|Overall Study|Reason not available|0|||
161721376|NCT01096667|584023418|FG001|Overall Study|Reason not available|1|||
161721377|NCT01096667|584023419|FG002|Overall Study|Reason not available|1|||
161721378|NCT01096667|584023420|FG003|Overall Study|Reason not available|1|||
161721379|NCT01096667|584023421|FG004|Overall Study|Reason not available|0|||
161721380|NCT01096667|584023417|FG000|Overall Study|Protocol Violation|0|||
161721381|NCT01096667|584023418|FG001|Overall Study|Protocol Violation|0|||
161721382|NCT01096667|584023419|FG002|Overall Study|Protocol Violation|0|||
161721383|NCT01096667|584023420|FG003|Overall Study|Protocol Violation|1|||
161721384|NCT01096667|584023421|FG004|Overall Study|Protocol Violation|0|||
161721385|NCT01096667|584023417|FG000|Overall Study|Not treated|1|||
161721386|NCT01096667|584023418|FG001|Overall Study|Not treated|0|||
161721387|NCT01096667|584023419|FG002|Overall Study|Not treated|0|||
161721388|NCT01096667|584023420|FG003|Overall Study|Not treated|0|||
161721389|NCT01096667|584023421|FG004|Overall Study|Not treated|0|||
161721390|NCT02263365|584023425|FG000|Overall Study|Physician Decision|22|||
161721391|NCT02263365|584023426|FG001|Overall Study|Physician Decision|18|||
161721392|NCT01845077|584023427|FG000|Washout Period|Lost to Follow-up|0|||
161721393|NCT01845077|584023428|FG001|Washout Period|Lost to Follow-up|1|||
161721394|NCT01845077|584023429|FG002|Washout Period|Lost to Follow-up|0|||
161721395|NCT01845077|584023430|FG003|Washout Period|Lost to Follow-up|1|||
161721396|NCT01845077|584023431|FG004|Washout Period|Lost to Follow-up|0|||
161721397|NCT01845077|584023432|FG005|Washout Period|Lost to Follow-up|1|||
161721398|NCT01845077|584023427|FG000|Washout Period|Adverse Event|1|||
161721399|NCT01845077|584023428|FG001|Washout Period|Adverse Event|0|||
161721400|NCT01845077|584023429|FG002|Washout Period|Adverse Event|0|||
161721401|NCT01845077|584023430|FG003|Washout Period|Adverse Event|0|||
161721402|NCT01845077|584023431|FG004|Washout Period|Adverse Event|0|||
161721403|NCT01845077|584023432|FG005|Washout Period|Adverse Event|0|||
161721404|NCT01845077|584023427|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721405|NCT01845077|584023428|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721406|NCT01845077|584023429|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
161721407|NCT01845077|584023430|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721408|NCT01845077|584023431|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721409|NCT01845077|584023432|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721410|NCT01845077|584023427|FG000|Washout Period|Protocol Violation|0|||
161721411|NCT01845077|584023428|FG001|Washout Period|Protocol Violation|0|||
161721412|NCT01845077|584023429|FG002|Washout Period|Protocol Violation|0|||
161721413|NCT01845077|584023430|FG003|Washout Period|Protocol Violation|1|||
161721414|NCT01845077|584023431|FG004|Washout Period|Protocol Violation|1|||
161721415|NCT01845077|584023432|FG005|Washout Period|Protocol Violation|0|||
161721416|NCT00312377|584023435|FG000|Overall Study|Death|403|||
161721417|NCT00312377|584023436|FG001|Overall Study|Death|418|||
161721418|NCT00312377|584023435|FG000|Overall Study|Withdrawal by Subject|23|||
161721419|NCT00312377|584023436|FG001|Overall Study|Withdrawal by Subject|30|||
161721420|NCT00312377|584023435|FG000|Overall Study|Lost to Follow-up|9|||
161721421|NCT00312377|584023436|FG001|Overall Study|Lost to Follow-up|12|||
161721422|NCT00312377|584023435|FG000|Overall Study|Non-compliance|0|||
161721423|NCT00312377|584023436|FG001|Overall Study|Non-compliance|2|||
161721424|NCT00312377|584023435|FG000|Overall Study|Randomised but never received treatment|6|||
161721425|NCT00312377|584023436|FG001|Overall Study|Randomised but never received treatment|6|||
161721426|NCT00312377|584023435|FG000|Overall Study|Discontinue treatment survival follow up|202|||
161721427|NCT00312377|584023436|FG001|Overall Study|Discontinue treatment survival follow up|200|||
161721428|NCT00312377|584023435|FG000|Overall Study|Site ended participation in study|1|||
161721429|NCT00312377|584023436|FG001|Overall Study|Site ended participation in study|0|||
161721430|NCT01001494|584023444|FG000|Overall Study|Adverse Event|8|||
161721431|NCT01001494|584023445|FG001|Overall Study|Adverse Event|4|||
161721432|NCT01001494|584023446|FG002|Overall Study|Adverse Event|6|||
161721433|NCT01001494|584023444|FG000|Overall Study|Protocol Violation|0|||
161721434|NCT01001494|584023445|FG001|Overall Study|Protocol Violation|1|||
161721435|NCT01001494|584023446|FG002|Overall Study|Protocol Violation|1|||
161721436|NCT01001494|584023444|FG000|Overall Study|Lost to Follow-up|2|||
161721437|NCT01001494|584023445|FG001|Overall Study|Lost to Follow-up|0|||
161721438|NCT01001494|584023446|FG002|Overall Study|Lost to Follow-up|1|||
161721439|NCT01001494|584023444|FG000|Overall Study|Withdrawal by Subject|9|||
161721440|NCT01001494|584023445|FG001|Overall Study|Withdrawal by Subject|7|||
161721441|NCT01001494|584023446|FG002|Overall Study|Withdrawal by Subject|17|||
161721442|NCT01001494|584023444|FG000|Overall Study|COPD exacerbation|3|||
161721443|NCT01001494|584023445|FG001|Overall Study|COPD exacerbation|4|||
161721444|NCT01001494|584023446|FG002|Overall Study|COPD exacerbation|5|||
161721445|NCT01001494|584023444|FG000|Overall Study|Lack of Efficacy|2|||
161721446|NCT01001494|584023445|FG001|Overall Study|Lack of Efficacy|0|||
161721447|NCT01001494|584023446|FG002|Overall Study|Lack of Efficacy|8|||
161721448|NCT01001494|584023444|FG000|Overall Study|Other|0|||
161721449|NCT01001494|584023445|FG001|Overall Study|Other|1|||
161721450|NCT01001494|584023446|FG002|Overall Study|Other|3|||
161721451|NCT02179398|584023447|FG000|Overall Study|Lack of obligatory data|3|||
161721452|NCT02179398|584023448|FG001|Overall Study|Lack of obligatory data|3|||
161721453|NCT02179398|584023447|FG000|Overall Study|Lost to Follow-up|0|||
161721454|NCT02179398|584023448|FG001|Overall Study|Lost to Follow-up|1|||
161721455|NCT00408681|584023452|FG000|Overall Study|Lack of Efficacy|2|||
161721456|NCT00408681|584023452|FG000|Overall Study|Adverse Event|7|||
161721457|NCT01787591|584023457|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161721458|NCT01787591|584023458|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161721459|NCT01787591|584023459|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161721460|NCT01787591|584023460|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
161721461|NCT02489630|584023463|FG000|Overall Study|Oversedation|1|||
161721462|NCT02489630|584023464|FG001|Overall Study|Oversedation|1|||
161721463|NCT02489630|584023463|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
161721464|NCT02489630|584023464|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
161721465|NCT02975349|584023468|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721466|NCT02975349|584023469|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721467|NCT02975349|584023470|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721468|NCT02975349|584023471|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161721469|NCT02975349|584023472|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161721470|NCT02975349|584023473|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721471|NCT02975349|584023474|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721472|NCT02975349|584023468|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161721473|NCT02975349|584023469|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721474|NCT02975349|584023470|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721475|NCT02975349|584023471|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721476|NCT02975349|584023472|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721477|NCT02975349|584023473|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721478|NCT02975349|584023474|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721479|NCT02975349|584023468|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
161721480|NCT02975349|584023469|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
161721481|NCT02975349|584023470|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
161721482|NCT02975349|584023471|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161721483|NCT02975349|584023472|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161721484|NCT02975349|584023473|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
161721485|NCT02975349|584023474|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161721486|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161721487|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161721488|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161721489|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161721490|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
161721491|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161721492|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161721493|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161721494|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
161721495|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161721496|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
161721497|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
161721498|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
161721499|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161721500|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721501|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721502|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721503|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
161721504|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721505|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721506|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721507|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721508|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
161721509|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721510|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721511|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721512|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721513|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721514|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
161721515|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
161721516|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
161721517|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161721518|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161721519|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
161721520|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161721521|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721522|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721523|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721524|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721525|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
161721526|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721527|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721528|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721529|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721530|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721531|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721532|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
161721533|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721534|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
161721535|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
161721536|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
161721537|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
161721538|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
161721539|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
161721540|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
161721541|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
161721542|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161721543|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161721544|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161721545|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161721546|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161721547|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161721548|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
161721549|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721550|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721551|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
161721552|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721553|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721554|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
161721555|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721556|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
161721557|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
161721558|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
161721559|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
161721560|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
161721561|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
161721562|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
161721563|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
161721564|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
161721565|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
161721566|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
161721567|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
161721568|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
161721569|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
161721570|NCT03270085|584025070|FG000|Overall Study|Withdrawal by Subject|1|||
161721571|NCT03270085|584025071|FG001|Overall Study|Withdrawal by Subject|0|||
161721572|NCT03825042|584025072|FG000|Overall Study|Adverse Event|1|||
161721573|NCT03825042|584025073|FG001|Overall Study|Adverse Event|0|||
161721574|NCT03825042|584025072|FG000|Overall Study|Withdrawal by Subject|1|||
161721575|NCT03825042|584025073|FG001|Overall Study|Withdrawal by Subject|0|||
161721576|NCT00521339|584025076|FG000|Treatment Phase|Adverse Event|2|||
161721577|NCT00521339|584025077|FG001|Treatment Phase|Adverse Event|0|||
161721578|NCT00521339|584025078|FG002|Treatment Phase|Adverse Event|0|||
161721579|NCT00521339|584025076|FG000|Treatment Phase|Intolerability to study drug|2|||
161721580|NCT00521339|584025077|FG001|Treatment Phase|Intolerability to study drug|0|||
161721581|NCT00521339|584025078|FG002|Treatment Phase|Intolerability to study drug|0|||
161721582|NCT00521339|584025076|FG000|Treatment Phase|Lack of Efficacy|3|||
161721583|NCT00521339|584025077|FG001|Treatment Phase|Lack of Efficacy|0|||
161721584|NCT00521339|584025078|FG002|Treatment Phase|Lack of Efficacy|0|||
161721585|NCT00521339|584025076|FG000|Treatment Phase|Withdrawal by Subject|3|||
161721586|NCT00521339|584025077|FG001|Treatment Phase|Withdrawal by Subject|0|||
161721587|NCT00521339|584025078|FG002|Treatment Phase|Withdrawal by Subject|0|||
161721588|NCT00521339|584025076|FG000|Treatment Phase|Lost to Follow-up|1|||
161721589|NCT00521339|584025077|FG001|Treatment Phase|Lost to Follow-up|0|||
161721590|NCT00521339|584025078|FG002|Treatment Phase|Lost to Follow-up|0|||
161721591|NCT00521339|584025076|FG000|Treatment Phase|Protocol Violation|1|||
161721592|NCT00521339|584025077|FG001|Treatment Phase|Protocol Violation|0|||
161721593|NCT00521339|584025078|FG002|Treatment Phase|Protocol Violation|0|||
161721594|NCT00521339|584025076|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
161721595|NCT00521339|584025077|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
161721596|NCT00521339|584025078|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
161721597|NCT00521339|584025076|FG000|Treatment Extension Phase|Death|0|||
161721598|NCT00521339|584025077|FG001|Treatment Extension Phase|Death|0|||
161721599|NCT00521339|584025078|FG002|Treatment Extension Phase|Death|1|||
161721600|NCT03314519|584025079|FG000|Overall Study|Protocol Violation|3|||
161721601|NCT03314519|584025080|FG001|Overall Study|Protocol Violation|2|||
161721602|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
161721603|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
161721604|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
161721605|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
161721606|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
161721607|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
161721608|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
161721609|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161721610|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161721611|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161721612|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
161721613|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
161721614|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
161721615|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
161721616|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
161721617|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
161721618|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
161721619|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
161721620|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
161721621|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
161721622|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
161721623|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
161721624|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
161721625|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
161721626|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
161721627|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
161721628|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
161721629|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
161721630|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
161721631|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
161721632|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
161721633|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161721634|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
161721635|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161721636|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161721637|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
161721638|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
161721639|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
161721640|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
161721641|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
161721642|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
161721643|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
161721644|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
161721645|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
161721646|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
161721647|NCT01912872|584025088|FG000|Overall Study|Lost to Follow-up|2|||
161721648|NCT01912872|584025089|FG001|Overall Study|Lost to Follow-up|3|||
161721649|NCT01912872|584025090|FG002|Overall Study|Lost to Follow-up|5|||
161721650|NCT01912872|584025091|FG003|Overall Study|Lost to Follow-up|5|||
161721651|NCT01912872|584025088|FG000|Overall Study|Other unspecified|3|||
161721652|NCT01912872|584025089|FG001|Overall Study|Other unspecified|1|||
161721653|NCT01912872|584025090|FG002|Overall Study|Other unspecified|3|||
161721654|NCT01912872|584025091|FG003|Overall Study|Other unspecified|0|||
161721655|NCT01912872|584025088|FG000|Overall Study|Informed consent withdrawn|0|||
161721656|NCT01912872|584025089|FG001|Overall Study|Informed consent withdrawn|0|||
161721657|NCT01912872|584025090|FG002|Overall Study|Informed consent withdrawn|1|||
161721658|NCT01912872|584025091|FG003|Overall Study|Informed consent withdrawn|1|||
161721659|NCT01912872|584025088|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
161721660|NCT01912872|584025089|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
161721661|NCT01912872|584025090|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
161721662|NCT01912872|584025091|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
161721663|NCT01912872|584025088|FG000|Overall Study|Protocol Violation|0|||
161721664|NCT01912872|584025089|FG001|Overall Study|Protocol Violation|0|||
161721665|NCT01912872|584025090|FG002|Overall Study|Protocol Violation|1|||
161721666|NCT01912872|584025091|FG003|Overall Study|Protocol Violation|0|||
161721667|NCT01912872|584025088|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161721668|NCT01912872|584025089|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161721669|NCT01912872|584025090|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161721670|NCT01912872|584025091|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161721671|NCT01912872|584025088|FG000|Overall Study|Withdrawal of study medication|0|||
161721672|NCT01912872|584025089|FG001|Overall Study|Withdrawal of study medication|0|||
161721673|NCT01912872|584025090|FG002|Overall Study|Withdrawal of study medication|0|||
161721674|NCT01912872|584025091|FG003|Overall Study|Withdrawal of study medication|2|||
161721675|NCT01912872|584025088|FG000|Overall Study|Missing|0|||
161721676|NCT01912872|584025089|FG001|Overall Study|Missing|0|||
161721677|NCT01912872|584025090|FG002|Overall Study|Missing|0|||
161721678|NCT01912872|584025091|FG003|Overall Study|Missing|1|||
161721679|NCT01277289|584025093|FG000|Overall Study|fragile vein|1|||
161721680|NCT01277289|584025094|FG001|Overall Study|fragile vein|0|||
161721681|NCT01277289|584025093|FG000|Overall Study|Physician Decision|1|||
161721682|NCT01277289|584025094|FG001|Overall Study|Physician Decision|0|||
161721683|NCT01277289|584025093|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
161721684|NCT01277289|584025094|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
161721685|NCT01277289|584025093|FG000|Overall Study|Protocol Violation|1|||
161721686|NCT01277289|584025094|FG001|Overall Study|Protocol Violation|1|||
161721687|NCT01277289|584025093|FG000|Overall Study|Adverse Event|2|||
161721688|NCT01277289|584025094|FG001|Overall Study|Adverse Event|1|||
161721689|NCT01277289|584025093|FG000|Overall Study|consent withdrawn|1|||
161721690|NCT01277289|584025094|FG001|Overall Study|consent withdrawn|1|||
161721691|NCT01277289|584025093|FG000|Overall Study|premature closure of the study|4|||
161721692|NCT01277289|584025094|FG001|Overall Study|premature closure of the study|2|||
161721693|NCT04760314|584025097|FG000|Induction Period|Withdrawal by Subject|0|||
161721694|NCT04760314|584025098|FG001|Induction Period|Withdrawal by Subject|1|||
161721695|NCT04760314|584025099|FG002|Induction Period|Withdrawal by Subject|1|||
161721696|NCT04760314|584025100|FG003|Induction Period|Withdrawal by Subject|0|||
161721697|NCT04760314|584025101|FG004|Induction Period|Withdrawal by Subject|0|||
161721698|NCT04760314|584025102|FG005|Induction Period|Withdrawal by Subject|0|||
161721699|NCT04760314|584025103|FG006|Induction Period|Withdrawal by Subject|0|||
161721700|NCT04760314|584025104|FG007|Induction Period|Withdrawal by Subject|0|||
161721701|NCT04760314|584025105|FG008|Induction Period|Withdrawal by Subject|0|||
161721702|NCT04760314|584025106|FG009|Induction Period|Withdrawal by Subject|0|||
161721703|NCT04760314|584025107|FG010|Induction Period|Withdrawal by Subject|0|||
161721704|NCT04760314|584025097|FG000|Induction Period|Adverse Event|0|||
161721705|NCT04760314|584025098|FG001|Induction Period|Adverse Event|0|||
161721706|NCT04760314|584025099|FG002|Induction Period|Adverse Event|2|||
161721707|NCT04760314|584025100|FG003|Induction Period|Adverse Event|0|||
161721708|NCT04760314|584025101|FG004|Induction Period|Adverse Event|0|||
161721709|NCT04760314|584025102|FG005|Induction Period|Adverse Event|0|||
161721710|NCT04760314|584025103|FG006|Induction Period|Adverse Event|0|||
161721711|NCT04760314|584025104|FG007|Induction Period|Adverse Event|0|||
161721712|NCT04760314|584025105|FG008|Induction Period|Adverse Event|0|||
161721713|NCT04760314|584025106|FG009|Induction Period|Adverse Event|0|||
161721714|NCT04760314|584025107|FG010|Induction Period|Adverse Event|0|||
161721715|NCT04760314|584025097|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721716|NCT04760314|584025098|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721717|NCT04760314|584025099|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721718|NCT04760314|584025100|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
161721719|NCT04760314|584025101|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
161721720|NCT04760314|584025102|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
161721721|NCT04760314|584025103|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
161721722|NCT04760314|584025104|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721723|NCT04760314|584025105|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721724|NCT04760314|584025106|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721725|NCT04760314|584025107|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721726|NCT04760314|584025097|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721727|NCT04760314|584025098|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721728|NCT04760314|584025099|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721729|NCT04760314|584025100|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
161721730|NCT04760314|584025101|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721731|NCT04760314|584025102|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
161721732|NCT04760314|584025103|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
161721733|NCT04760314|584025104|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721734|NCT04760314|584025105|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721735|NCT04760314|584025106|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721736|NCT04760314|584025107|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721737|NCT04760314|584025097|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721738|NCT04760314|584025098|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721739|NCT04760314|584025099|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721740|NCT04760314|584025100|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721741|NCT04760314|584025101|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
161721742|NCT04760314|584025102|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721743|NCT04760314|584025103|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721744|NCT04760314|584025104|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721745|NCT04760314|584025105|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721746|NCT04760314|584025106|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721747|NCT04760314|584025107|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721748|NCT04760314|584025097|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
161721749|NCT04760314|584025098|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
161721750|NCT04760314|584025099|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
161721751|NCT04760314|584025100|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
161721752|NCT04760314|584025101|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
161721753|NCT04760314|584025102|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
161721754|NCT04760314|584025103|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
161721755|NCT04760314|584025104|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
161721756|NCT04760314|584025105|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
161721757|NCT04760314|584025106|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
161721758|NCT04760314|584025107|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
161721759|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721760|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721761|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721762|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721763|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721764|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721765|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721766|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161721767|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721768|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161721769|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161721770|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721771|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721772|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721773|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721774|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721775|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721776|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721777|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
161721778|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
161721779|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
161721780|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721781|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721782|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721783|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721784|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721785|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721786|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721787|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721788|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
161721789|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721790|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721791|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721792|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721793|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721794|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721795|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721796|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721797|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721798|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721799|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721800|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
161721801|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
161721802|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721803|NCT01013883|584025110|FG000|Overall Study|Lost to Follow-up|2|||
161721804|NCT01013883|584025111|FG001|Overall Study|Lost to Follow-up|2|||
161721805|NCT02241512|584025114|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
161721806|NCT02241512|584025115|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
161721807|NCT00641043|584025118|FG000|Overall Study|Adverse Event|6|||
161721808|NCT00641043|584025119|FG001|Overall Study|Adverse Event|4|||
161721809|NCT00641043|584025118|FG000|Overall Study|Protocol Violation|2|||
161721810|NCT00641043|584025119|FG001|Overall Study|Protocol Violation|3|||
161721811|NCT00641043|584025118|FG000|Overall Study|Lost to Follow-up|3|||
161721812|NCT00641043|584025119|FG001|Overall Study|Lost to Follow-up|2|||
161721813|NCT00641043|584025118|FG000|Overall Study|Withdrawal by Subject|4|||
161721814|NCT00641043|584025119|FG001|Overall Study|Withdrawal by Subject|4|||
161721815|NCT00641043|584025118|FG000|Overall Study|Other incl. lack of efficacy|4|||
161721816|NCT00641043|584025119|FG001|Overall Study|Other incl. lack of efficacy|2|||
161721817|NCT03515538|584025120|FG000|Overall Study|Lack of Efficacy|2|||
161721818|NCT03515538|584025121|FG001|Overall Study|Lack of Efficacy|0|||
161721819|NCT03515538|584025122|FG002|Overall Study|Lack of Efficacy|2|||
161721820|NCT03515538|584025123|FG003|Overall Study|Lack of Efficacy|0|||
161721821|NCT03515538|584025120|FG000|Overall Study|Death|0|||
161721822|NCT03515538|584025121|FG001|Overall Study|Death|0|||
161721823|NCT03515538|584025122|FG002|Overall Study|Death|1|||
161721824|NCT03515538|584025123|FG003|Overall Study|Death|0|||
161721825|NCT03515538|584025120|FG000|Overall Study|Protocol Violation|0|||
161721826|NCT03515538|584025121|FG001|Overall Study|Protocol Violation|0|||
161721827|NCT03515538|584025122|FG002|Overall Study|Protocol Violation|0|||
161721828|NCT03515538|584025123|FG003|Overall Study|Protocol Violation|1|||
161721829|NCT03515538|584025120|FG000|Overall Study|Screen failure (baseline dropout)|0|||
161721830|NCT03515538|584025121|FG001|Overall Study|Screen failure (baseline dropout)|1|||
161721831|NCT03515538|584025122|FG002|Overall Study|Screen failure (baseline dropout)|0|||
161721832|NCT03515538|584025123|FG003|Overall Study|Screen failure (baseline dropout)|0|||
161721833|NCT03515538|584025120|FG000|Overall Study|Withdrawal by Subject|2|||
161721834|NCT03515538|584025121|FG001|Overall Study|Withdrawal by Subject|2|||
161721835|NCT03515538|584025122|FG002|Overall Study|Withdrawal by Subject|1|||
161721836|NCT03515538|584025123|FG003|Overall Study|Withdrawal by Subject|3|||
161721837|NCT03515538|584025120|FG000|Overall Study|Physician Decision|1|||
161721838|NCT03515538|584025121|FG001|Overall Study|Physician Decision|0|||
161721839|NCT03515538|584025122|FG002|Overall Study|Physician Decision|0|||
161721840|NCT03515538|584025123|FG003|Overall Study|Physician Decision|1|||
161721841|NCT04275310|584025124|FG000|Overall Study|Non-randomized due to running out of funding|4|||
161721842|NCT04275310|584025125|FG001|Overall Study|Non-randomized due to running out of funding|0|||
161721843|NCT03088605|584025128|FG000|Overall Study|Withdrawal by Subject|1|||
161721844|NCT03088605|584025129|FG001|Overall Study|Withdrawal by Subject|0|||
161721845|NCT02345161|584025130|FG000|Overall Study|Withdrawal by Subject|25|||
161721846|NCT02345161|584025131|FG001|Overall Study|Withdrawal by Subject|33|||
161721847|NCT02345161|584025130|FG000|Overall Study|Adverse Event|16|||
161721848|NCT02345161|584025131|FG001|Overall Study|Adverse Event|19|||
161721849|NCT02345161|584025130|FG000|Overall Study|Physician Decision|4|||
161721850|NCT02345161|584025131|FG001|Overall Study|Physician Decision|4|||
161721851|NCT02345161|584025130|FG000|Overall Study|Lost to Follow-up|0|||
161721852|NCT02345161|584025131|FG001|Overall Study|Lost to Follow-up|1|||
161721853|NCT02225223|584025133|FG000|Overall Study|Death|10|||
161721854|NCT02225223|584025134|FG001|Overall Study|Death|1|||
161721855|NCT02225223|584025133|FG000|Overall Study|Lost to Follow-up|5|||
161721856|NCT02225223|584025134|FG001|Overall Study|Lost to Follow-up|0|||
161721857|NCT02225223|584025133|FG000|Overall Study|Other|1|||
161721858|NCT02225223|584025134|FG001|Overall Study|Other|2|||
161721859|NCT02225223|584025133|FG000|Overall Study|Physician Decision|1|||
161721860|NCT02225223|584025134|FG001|Overall Study|Physician Decision|0|||
161721861|NCT02225223|584025133|FG000|Overall Study|Withdrawal by Subject|2|||
161721862|NCT02225223|584025134|FG001|Overall Study|Withdrawal by Subject|2|||
161721863|NCT03567291|584025135|FG000|Period I|Adverse Event|14|||
161721864|NCT03567291|584025136|FG001|Period I|Adverse Event|0|||
161721865|NCT03567291|584025137|FG002|Period I|Adverse Event|0|||
161721866|NCT03567291|584025138|FG003|Period I|Adverse Event|0|||
161721867|NCT03567291|584025135|FG000|Period I|Protocol Violation|1|||
161721868|NCT03567291|584025136|FG001|Period I|Protocol Violation|0|||
161721869|NCT03567291|584025137|FG002|Period I|Protocol Violation|0|||
161721870|NCT03567291|584025138|FG003|Period I|Protocol Violation|0|||
161721871|NCT03567291|584025135|FG000|Period I|Withdrawal by Subject|23|||
161721872|NCT03567291|584025136|FG001|Period I|Withdrawal by Subject|0|||
161721873|NCT03567291|584025137|FG002|Period I|Withdrawal by Subject|0|||
161721874|NCT03567291|584025138|FG003|Period I|Withdrawal by Subject|0|||
161721875|NCT03567291|584025135|FG000|Period I|Lost to Follow-up|2|||
161721876|NCT03567291|584025136|FG001|Period I|Lost to Follow-up|0|||
161721877|NCT03567291|584025137|FG002|Period I|Lost to Follow-up|0|||
161721878|NCT03567291|584025138|FG003|Period I|Lost to Follow-up|0|||
161721879|NCT03567291|584025135|FG000|Period I|Terminated by sponsor|44|||
161721880|NCT03567291|584025136|FG001|Period I|Terminated by sponsor|0|||
161721881|NCT03567291|584025137|FG002|Period I|Terminated by sponsor|0|||
161721882|NCT03567291|584025138|FG003|Period I|Terminated by sponsor|0|||
161721883|NCT03567291|584025135|FG000|Period I|Missing or unknown|7|||
161721884|NCT03567291|584025136|FG001|Period I|Missing or unknown|0|||
161721885|NCT03567291|584025137|FG002|Period I|Missing or unknown|0|||
161721886|NCT03567291|584025138|FG003|Period I|Missing or unknown|0|||
161721887|NCT03567291|584025135|FG000|Period II|Adverse Event|0|||
161721888|NCT03567291|584025136|FG001|Period II|Adverse Event|1|||
161721889|NCT03567291|584025137|FG002|Period II|Adverse Event|0|||
161721890|NCT03567291|584025138|FG003|Period II|Adverse Event|0|||
161721891|NCT03567291|584025135|FG000|Period II|Missing or unknown|0|||
161721892|NCT03567291|584025136|FG001|Period II|Missing or unknown|2|||
161721893|NCT03567291|584025137|FG002|Period II|Missing or unknown|1|||
161721894|NCT03567291|584025138|FG003|Period II|Missing or unknown|0|||
161721895|NCT03567291|584025135|FG000|Period III|Adverse Event|0|||
161721896|NCT03567291|584025136|FG001|Period III|Adverse Event|0|||
161721897|NCT03567291|584025137|FG002|Period III|Adverse Event|0|||
161721898|NCT03567291|584025138|FG003|Period III|Adverse Event|4|||
161721899|NCT03567291|584025135|FG000|Period III|Withdrawal by Subject|0|||
161721900|NCT03567291|584025136|FG001|Period III|Withdrawal by Subject|0|||
161721901|NCT03567291|584025137|FG002|Period III|Withdrawal by Subject|0|||
161721902|NCT03567291|584025138|FG003|Period III|Withdrawal by Subject|4|||
161721903|NCT03567291|584025135|FG000|Period III|Lost to Follow-up|0|||
161721904|NCT03567291|584025136|FG001|Period III|Lost to Follow-up|0|||
161721905|NCT03567291|584025137|FG002|Period III|Lost to Follow-up|0|||
161721906|NCT03567291|584025138|FG003|Period III|Lost to Follow-up|1|||
161721907|NCT03567291|584025135|FG000|Period III|Terminated by sponsor|0|||
161721908|NCT03567291|584025136|FG001|Period III|Terminated by sponsor|0|||
161721909|NCT03567291|584025137|FG002|Period III|Terminated by sponsor|0|||
161721910|NCT03567291|584025138|FG003|Period III|Terminated by sponsor|68|||
161721911|NCT03567291|584025135|FG000|Period III|Missing or unknown|0|||
161721912|NCT03567291|584025136|FG001|Period III|Missing or unknown|0|||
161721913|NCT03567291|584025137|FG002|Period III|Missing or unknown|0|||
161721914|NCT03567291|584025138|FG003|Period III|Missing or unknown|8|||
161721915|NCT03666143|584025139|FG000|Overall Study|Death|158|||
161721916|NCT03666143|584025139|FG000|Overall Study|Sponsor Decision|31|||
161721917|NCT03666143|584025139|FG000|Overall Study|Withdrawal by Subject|11|||
161721918|NCT03666143|584025139|FG000|Overall Study|Lost to Follow-up|5|||
161721919|NCT03666143|584025139|FG000|Overall Study|Physician Decision|1|||
161721920|NCT03666143|584025139|FG000|Overall Study|Rolled into extension study|9|||
161721921|NCT03666143|584025139|FG000|Overall Study|Progressive Disease|1|||
161721922|NCT04530825|584025143|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
161721923|NCT04530825|584025144|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
161721924|NCT04530825|584025145|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
161721925|NCT04530825|584025146|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
161721926|NCT04530825|584025143|FG000|Overall Study|Did not complete follow-up|3|||
161721927|NCT04530825|584025144|FG001|Overall Study|Did not complete follow-up|0|||
161721928|NCT04530825|584025145|FG002|Overall Study|Did not complete follow-up|0|||
161721929|NCT04530825|584025146|FG003|Overall Study|Did not complete follow-up|0|||
161721930|NCT04101422|584025147|FG000|Overall Study|Ineligible|1|||
161721931|NCT04101422|584025148|FG001|Overall Study|Ineligible|0|||
161721932|NCT04101422|584025149|FG002|Overall Study|Ineligible|9|||
161721933|NCT04101422|584025150|FG003|Overall Study|Ineligible|0|||
161721934|NCT04101422|584025147|FG000|Overall Study|Withdrawal by Subject|0|||
161721935|NCT04101422|584025148|FG001|Overall Study|Withdrawal by Subject|0|||
161721936|NCT04101422|584025149|FG002|Overall Study|Withdrawal by Subject|1|||
161721937|NCT04101422|584025150|FG003|Overall Study|Withdrawal by Subject|0|||
161721938|NCT04101422|584025147|FG000|Overall Study|Not attending to the stimuli|0|||
161721939|NCT04101422|584025148|FG001|Overall Study|Not attending to the stimuli|0|||
161721940|NCT04101422|584025149|FG002|Overall Study|Not attending to the stimuli|4|||
161721941|NCT04101422|584025150|FG003|Overall Study|Not attending to the stimuli|0|||
161721942|NCT04101422|584025147|FG000|Overall Study|Did not download app|0|||
161721943|NCT04101422|584025148|FG001|Overall Study|Did not download app|0|||
161721944|NCT04101422|584025149|FG002|Overall Study|Did not download app|0|||
161721945|NCT04101422|584025150|FG003|Overall Study|Did not download app|17|||
161721946|NCT04101422|584025147|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161721947|NCT04101422|584025148|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161721948|NCT04101422|584025149|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161721949|NCT04101422|584025150|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
161721950|NCT01174784|584025151|FG000|Overall Study|Screen fails|4|||
161721951|NCT01671488|584025154|FG000|Overall Study|Withdrawal by Subject|1|||
161721952|NCT00532883|584025155|FG000|Overall Study|Adverse Event|1|||
161721953|NCT00532883|584025156|FG001|Overall Study|Adverse Event|0|||
161721954|NCT00532883|584025157|FG002|Overall Study|Adverse Event|0|||
161721955|NCT00532883|584025158|FG003|Overall Study|Adverse Event|1|||
161721956|NCT00532883|584025155|FG000|Overall Study|Lost to Follow-up|1|||
161721957|NCT00532883|584025156|FG001|Overall Study|Lost to Follow-up|1|||
161721958|NCT00532883|584025157|FG002|Overall Study|Lost to Follow-up|1|||
161721959|NCT00532883|584025158|FG003|Overall Study|Lost to Follow-up|0|||
161721960|NCT00532883|584025155|FG000|Overall Study|Withdrawal by Subject|0|||
161721961|NCT00532883|584025156|FG001|Overall Study|Withdrawal by Subject|1|||
161721962|NCT00532883|584025157|FG002|Overall Study|Withdrawal by Subject|1|||
161721963|NCT00532883|584025158|FG003|Overall Study|Withdrawal by Subject|0|||
161721964|NCT00532883|584025155|FG000|Overall Study|Subject was Nonadherent|0|||
161721965|NCT00532883|584025156|FG001|Overall Study|Subject was Nonadherent|1|||
161721966|NCT00532883|584025157|FG002|Overall Study|Subject was Nonadherent|1|||
161721967|NCT00532883|584025158|FG003|Overall Study|Subject was Nonadherent|0|||
161721968|NCT00532883|584025155|FG000|Overall Study|Early Study Termination|4|||
161721969|NCT00532883|584025156|FG001|Overall Study|Early Study Termination|4|||
161721970|NCT00532883|584025157|FG002|Overall Study|Early Study Termination|1|||
161721971|NCT00532883|584025158|FG003|Overall Study|Early Study Termination|4|||
161721972|NCT01214434|584025161|FG000|Overall Study|Withdrawal by Subject|1|||
161721973|NCT01214434|584025162|FG001|Overall Study|Withdrawal by Subject|0|||
161721974|NCT01214434|584025161|FG000|Overall Study|Lost to Follow-up|2|||
161721975|NCT01214434|584025162|FG001|Overall Study|Lost to Follow-up|2|||
161721976|NCT01214434|584025161|FG000|Overall Study|Site error|1|||
161721977|NCT01214434|584025162|FG001|Overall Study|Site error|0|||
161721978|NCT02075255|584025164|FG000|Overall Study|Study specific withdrawal criteria|0|||
161721979|NCT02075255|584025165|FG001|Overall Study|Study specific withdrawal criteria|1|||
161721980|NCT02075255|584025166|FG002|Overall Study|Study specific withdrawal criteria|1|||
161721981|NCT02075255|584025164|FG000|Overall Study|Withdrawal by Subject|4|||
161721982|NCT02075255|584025165|FG001|Overall Study|Withdrawal by Subject|1|||
161721983|NCT02075255|584025166|FG002|Overall Study|Withdrawal by Subject|0|||
161721984|NCT02075255|584025164|FG000|Overall Study|Lost to Follow-up|0|||
161721985|NCT02075255|584025165|FG001|Overall Study|Lost to Follow-up|0|||
161721986|NCT02075255|584025166|FG002|Overall Study|Lost to Follow-up|1|||
161721987|NCT02075255|584025164|FG000|Overall Study|Adverse Event|0|||
161721988|NCT02075255|584025165|FG001|Overall Study|Adverse Event|0|||
161721989|NCT02075255|584025166|FG002|Overall Study|Adverse Event|1|||
161721990|NCT02075255|584025164|FG000|Overall Study|Death|0|||
161721991|NCT02075255|584025165|FG001|Overall Study|Death|2|||
161721992|NCT02075255|584025166|FG002|Overall Study|Death|0|||
161721993|NCT03792750|584025167|FG000|Overall Study|Death|3|||
161721994|NCT01879618|584025168|FG000|Overall Study|Does not meet entrance criteria|1|||
161721995|NCT01879618|584025168|FG000|Overall Study|Withdrawal by Subject|1|||
161721996|NCT01879618|584025168|FG000|Overall Study|Surgery;changed schedule; not available|8|||
161721997|NCT01879618|584025168|FG000|Overall Study|Protocol Violation|6|||
161721998|NCT01879618|584025168|FG000|Overall Study|Adverse Event|5|||
161721999|NCT00394914|584025169|FG000|Treatment Period|Adverse Event|0|||
161722000|NCT00394914|584025170|FG001|Treatment Period|Adverse Event|3|||
161722001|NCT00394914|584025171|FG002|Treatment Period|Adverse Event|1|||
161722002|NCT00394914|584025169|FG000|Treatment Period|Lost to Follow-up|0|||
161722003|NCT00394914|584025170|FG001|Treatment Period|Lost to Follow-up|1|||
161722004|NCT00394914|584025171|FG002|Treatment Period|Lost to Follow-up|0|||
161722005|NCT00394914|584025169|FG000|Treatment Period|Withdrawal by Subject|0|||
161722006|NCT00394914|584025170|FG001|Treatment Period|Withdrawal by Subject|2|||
161722007|NCT00394914|584025171|FG002|Treatment Period|Withdrawal by Subject|2|||
161722008|NCT00394914|584025169|FG000|Treatment Period|Noncompliance with protocol|0|||
161722009|NCT00394914|584025170|FG001|Treatment Period|Noncompliance with protocol|3|||
161722010|NCT00394914|584025171|FG002|Treatment Period|Noncompliance with protocol|2|||
161722011|NCT00394914|584025169|FG000|Treatment Period|Did not meet protocol eligibility|0|||
161722012|NCT00394914|584025170|FG001|Treatment Period|Did not meet protocol eligibility|1|||
161722013|NCT00394914|584025171|FG002|Treatment Period|Did not meet protocol eligibility|1|||
161722014|NCT01004146|584025175|FG000|Overall Study|Withdrawal by Subject|4|||
161722015|NCT01004146|584025176|FG001|Overall Study|Withdrawal by Subject|5|||
161722016|NCT00465738|584025185|FG000|Overall Study|Lost to Follow-up|2|||
161722017|NCT00465738|584025186|FG001|Overall Study|Lost to Follow-up|0|||
161722018|NCT00465738|584025185|FG000|Overall Study|Adverse Event|0|||
161722019|NCT00465738|584025186|FG001|Overall Study|Adverse Event|1|||
161722020|NCT00465738|584025185|FG000|Overall Study|Withdrawal by Subject|2|||
161722021|NCT00465738|584025186|FG001|Overall Study|Withdrawal by Subject|0|||
161722022|NCT00465738|584025185|FG000|Overall Study|Other|2|||
161722023|NCT00465738|584025186|FG001|Overall Study|Other|5|||
161722024|NCT00734929|584025187|FG000|Overall Study|Lost to Follow-up|1|||
161722025|NCT00734929|584025188|FG001|Overall Study|Lost to Follow-up|2|||
161722026|NCT00734929|584025187|FG000|Overall Study|No intervention/ screen fail|5|||
161722027|NCT00734929|584025188|FG001|Overall Study|No intervention/ screen fail|3|||
161722028|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Adverse Event|37|||
161722029|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Adverse Event|0|||
161722030|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Adverse Event|0|||
161722031|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Adverse Event|0|||
161722032|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Death|2|||
161722033|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Death|0|||
161722034|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Death|0|||
161722035|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Death|0|||
161722036|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
161722037|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
161722038|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
161722039|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
161722040|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
161722041|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
161722042|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
161722043|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
161722044|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
161722045|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
161722046|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
161722047|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
161722048|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
161722049|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161722050|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161722051|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161722052|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Physician Decision|4|||
161722053|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Physician Decision|0|||
161722054|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Physician Decision|0|||
161722055|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Physician Decision|0|||
161722056|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Pregnancy|1|||
161722057|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Pregnancy|0|||
161722058|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Pregnancy|0|||
161722059|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Pregnancy|0|||
161722060|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
161722061|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
161722062|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
161722063|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
161722064|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
161722065|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
161722066|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
161722067|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
161722068|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Other|4|||
161722069|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Other|0|||
161722070|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Other|0|||
161722071|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Other|0|||
161722072|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
161722073|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
161722074|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
161722075|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
161722076|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161722077|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161722078|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161722079|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
161722080|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
161722081|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
161722082|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
161722083|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
161722084|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
161722085|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
161722086|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
161722087|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
161722088|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
161722089|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
161722090|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
161722091|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
161722092|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
161722093|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
161722094|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
161722095|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
161722096|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
161722097|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
161722098|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
161722099|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
161722100|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
161722101|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
161722102|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
161722103|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
161722104|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
161722105|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
161722106|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
161722107|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
161722108|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Other|0|||
161722109|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Other|0|||
161722110|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Other|0|||
161722111|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Other|1|||
161722112|NCT01863758|584025193|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
161722113|NCT01863758|584025193|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
161722114|NCT02961764|584025194|FG000|Overall Study|Protocol Violation|0|||
161722115|NCT02961764|584025195|FG001|Overall Study|Protocol Violation|1|||
161722116|NCT02961764|584025194|FG000|Overall Study|Death|2|||
161722117|NCT02961764|584025195|FG001|Overall Study|Death|0|||
161722118|NCT02961764|584025194|FG000|Overall Study|Lost to Follow-up|35|||
161722119|NCT02961764|584025195|FG001|Overall Study|Lost to Follow-up|24|||
161722120|NCT02961764|584025194|FG000|Overall Study|Withdrawal by Subject|2|||
161722121|NCT02961764|584025195|FG001|Overall Study|Withdrawal by Subject|0|||
161722122|NCT02369510|584025196|FG000|Overall Study|Spilled Medication|1|||
161722123|NCT02369510|584025197|FG001|Overall Study|Spilled Medication|2|||
161722124|NCT02369510|584025198|FG002|Overall Study|Spilled Medication|1|||
161722125|NCT02369510|584025196|FG000|Overall Study|Epidural Activation|1|||
161722126|NCT02369510|584025197|FG001|Overall Study|Epidural Activation|1|||
161722127|NCT02369510|584025198|FG002|Overall Study|Epidural Activation|5|||
161722128|NCT02160977|584025199|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
161722129|NCT02160977|584025200|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
161722130|NCT02160977|584025199|FG000|Three Months After Surgery|Lost to Follow-up|0|||
161722131|NCT02160977|584025200|FG001|Three Months After Surgery|Lost to Follow-up|2|||
161722132|NCT02160977|584025199|FG000|Six Months After Surgery|Lost to Follow-up|2|||
161722133|NCT02160977|584025200|FG001|Six Months After Surgery|Lost to Follow-up|1|||
161722134|NCT01663740|584025201|FG000|Overall Study|Lost to Follow-up|1|||
161722135|NCT01663740|584025202|FG001|Overall Study|Lost to Follow-up|4|||
161722136|NCT01663740|584025201|FG000|Overall Study|Other|9|||
161722137|NCT01663740|584025202|FG001|Overall Study|Other|2|||
161722138|NCT01663740|584025201|FG000|Overall Study|Inclusion/Exclusion not met|1|||
161722139|NCT01663740|584025202|FG001|Overall Study|Inclusion/Exclusion not met|0|||
161722140|NCT01663740|584025201|FG000|Overall Study|Death|0|||
161722141|NCT01663740|584025202|FG001|Overall Study|Death|1|||
161722142|NCT01663740|584025201|FG000|Overall Study|Withdrawal by Subject|2|||
161722143|NCT01663740|584025202|FG001|Overall Study|Withdrawal by Subject|1|||
161722144|NCT01663740|584025201|FG000|Overall Study|No end of study status|3|||
161722145|NCT01663740|584025202|FG001|Overall Study|No end of study status|0|||
161722146|NCT02658656|584025205|FG000|Screening|Failed eligibility criteria|0|||
161722147|NCT02658656|584025206|FG001|Screening|Failed eligibility criteria|0|||
161722148|NCT02658656|584025207|FG002|Screening|Failed eligibility criteria|263|||
161722149|NCT02658656|584025205|FG000|Randomization|Withdrawal by Subject|8|||
161722150|NCT02658656|584025206|FG001|Randomization|Withdrawal by Subject|7|||
161722151|NCT02658656|584025207|FG002|Randomization|Withdrawal by Subject|0|||
161722152|NCT02658656|584025205|FG000|Randomization|Lost to Follow-up|1|||
161722153|NCT02658656|584025206|FG001|Randomization|Lost to Follow-up|3|||
161722154|NCT02658656|584025207|FG002|Randomization|Lost to Follow-up|0|||
161722155|NCT02658656|584025205|FG000|Randomization|Adverse Event|4|||
161722156|NCT02658656|584025206|FG001|Randomization|Adverse Event|0|||
161722157|NCT02658656|584025207|FG002|Randomization|Adverse Event|0|||
161722158|NCT02658656|584025205|FG000|Randomization|Administrative Termination|3|||
161722159|NCT02658656|584025206|FG001|Randomization|Administrative Termination|1|||
161722160|NCT02658656|584025207|FG002|Randomization|Administrative Termination|0|||
161722161|NCT02658656|584025205|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
161722162|NCT02658656|584025206|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
161722163|NCT02658656|584025207|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
161722164|NCT02658656|584025205|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
161722165|NCT02658656|584025206|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
161722166|NCT02658656|584025207|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
161722167|NCT02658656|584025205|FG000|Randomization|Not eligible for Randomization|1|||
161722168|NCT02658656|584025206|FG001|Randomization|Not eligible for Randomization|0|||
161722169|NCT02658656|584025207|FG002|Randomization|Not eligible for Randomization|0|||
161722170|NCT02658656|584025205|FG000|Randomization|Protocol Violation|1|||
161722171|NCT02658656|584025206|FG001|Randomization|Protocol Violation|0|||
161722172|NCT02658656|584025207|FG002|Randomization|Protocol Violation|0|||
161722173|NCT02112448|584025208|FG000|Overall Study|lab values precluding use of ketorolac|2|||
161722174|NCT02112448|584025209|FG001|Overall Study|lab values precluding use of ketorolac|2|||
161722175|NCT02112448|584025208|FG000|Overall Study|Protocol Violation|1|||
161722176|NCT02112448|584025209|FG001|Overall Study|Protocol Violation|2|||
161722177|NCT02112448|584025208|FG000|Overall Study|Physician Decision|4|||
161722178|NCT02112448|584025209|FG001|Overall Study|Physician Decision|6|||
161722179|NCT02112448|584025208|FG000|Overall Study|required heparin so could not use ketoro|1|||
161722180|NCT02112448|584025209|FG001|Overall Study|required heparin so could not use ketoro|0|||
161838052|NCT00136318|584450316|FG000|Overall Study|Withdrawal by Subject|2|||
161838053|NCT00136318|584450317|FG001|Overall Study|Withdrawal by Subject|2|||
161838054|NCT02005887|584450318|FG000|Overall Study|Protocol Violation|0|||
161838055|NCT02005887|584450319|FG001|Overall Study|Protocol Violation|2|||
161838056|NCT00160641|584450322|FG000|Overall Study|Adverse Event|102|||
161838057|NCT00160641|584450322|FG000|Overall Study|Withdrawal by Subject|87|||
161838058|NCT00160641|584450322|FG000|Overall Study|Lost to Follow-up|8|||
161838059|NCT00160641|584450322|FG000|Overall Study|Lack of Efficacy|12|||
161838060|NCT00160641|584450322|FG000|Overall Study|Protocol Violation|3|||
161838061|NCT00160641|584450322|FG000|Overall Study|Other|9|||
161838062|NCT00985712|584450324|FG000|Overall Study|Adverse Event|0|||
161838063|NCT00985712|584450325|FG001|Overall Study|Adverse Event|1|||
161838064|NCT00985712|584450324|FG000|Overall Study|Lost to Follow-up|2|||
161838065|NCT00985712|584450325|FG001|Overall Study|Lost to Follow-up|2|||
161838066|NCT00985712|584450324|FG000|Overall Study|Protocol Violation|0|||
161838067|NCT00985712|584450325|FG001|Overall Study|Protocol Violation|1|||
161838068|NCT00985712|584450324|FG000|Overall Study|Withdrawal by Subject|4|||
161838069|NCT00985712|584450325|FG001|Overall Study|Withdrawal by Subject|1|||
161838070|NCT00985712|584450324|FG000|Overall Study|Sponsor decision|0|||
161838071|NCT00985712|584450325|FG001|Overall Study|Sponsor decision|2|||
161838072|NCT01843348|584450328|FG000|Overall Study|Withdrawal by Subject|4|||
161838073|NCT01843348|584450329|FG001|Overall Study|Withdrawal by Subject|16|||
161838074|NCT01843348|584450330|FG002|Overall Study|Withdrawal by Subject|18|||
161838075|NCT01843348|584450328|FG000|Overall Study|Lost to Follow-up|5|||
161838076|NCT01843348|584450329|FG001|Overall Study|Lost to Follow-up|4|||
161838077|NCT01843348|584450330|FG002|Overall Study|Lost to Follow-up|2|||
161838078|NCT01843348|584450328|FG000|Overall Study|Death|5|||
161838079|NCT01843348|584450329|FG001|Overall Study|Death|3|||
161838080|NCT01843348|584450330|FG002|Overall Study|Death|4|||
161838081|NCT01843348|584450328|FG000|Overall Study|Graft loss/retransplantation|5|||
161838082|NCT01843348|584450329|FG001|Overall Study|Graft loss/retransplantation|8|||
161838083|NCT01843348|584450330|FG002|Overall Study|Graft loss/retransplantation|11|||
161838084|NCT01843348|584450328|FG000|Overall Study|Various reasons|4|||
161838085|NCT01843348|584450329|FG001|Overall Study|Various reasons|9|||
161838086|NCT01843348|584450330|FG002|Overall Study|Various reasons|6|||
161838087|NCT00257920|584450331|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
161838088|NCT00257920|584450332|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
161838089|NCT00257920|584450331|FG000|Period: Second Intervention|Other|2|||
161838090|NCT00257920|584450332|FG001|Period: Second Intervention|Other|1|||
161722181|NCT05270694|584026694|FG000|Overall Study|Death|1|||
161722182|NCT05270694|584026694|FG000|Overall Study|Medical issues impacted ability to participate|2|||
161722183|NCT05270694|584026694|FG000|Overall Study|Lost to Follow-up|3|||
161722184|NCT05270694|584026694|FG000|Overall Study|Withdrawal by Subject|3|||
161722185|NCT04267562|584026697|FG000|Assessed for Eligibility|Screen Failure|64|||
161722186|NCT04267562|584026697|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
161722187|NCT04267562|584026697|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
161722188|NCT04267562|584026697|FG000|Assessed for Eligibility|Site closure|6|||
161722189|NCT04267562|584026697|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
161722190|NCT04267562|584026697|FG000|Assessed for Eligibility|Physician Decision|1|||
161722191|NCT04267562|584026697|FG000|Month 24|Elective hysterectomy|1|||
161722192|NCT04267562|584026697|FG000|Month 24|Lost to Follow-up|1|||
161722193|NCT04267562|584026697|FG000|Month 36|Elective hysterectomy|2|||
161722194|NCT04267562|584026697|FG000|Month 36|Lost to Follow-up|3|||
161722195|NCT00128206|584026705|FG000|Overall Study|Lost to Follow-up|137|||
161722196|NCT00128206|584026706|FG001|Overall Study|Lost to Follow-up|118|||
161722197|NCT00128206|584026705|FG000|Overall Study|Adverse Event|0|||
161722198|NCT00128206|584026706|FG001|Overall Study|Adverse Event|2|||
161722199|NCT03032068|584026715|FG000|Overall Study|Adverse Event|1|||
161722200|NCT01597622|584026716|FG000|Overall Study|Adverse Event|7|||
161722201|NCT01597622|584026716|FG000|Overall Study|Lack of Efficacy|3|||
161722202|NCT01597622|584026716|FG000|Overall Study|Protocol Violation|1|||
161722203|NCT01597622|584026716|FG000|Overall Study|Lost to Follow-up|1|||
161722204|NCT01597622|584026716|FG000|Overall Study|Investigator Discretion|5|||
161722205|NCT01597622|584026716|FG000|Overall Study|Withdrawal by Subject|20|||
161722206|NCT01597622|584026716|FG000|Overall Study|Death|1|||
161722207|NCT00408421|584026719|FG000|Treatment Initial Randomization|Adverse Event|5|||
161722208|NCT00408421|584026720|FG001|Treatment Initial Randomization|Adverse Event|9|||
161722209|NCT00408421|584026721|FG002|Treatment Initial Randomization|Adverse Event|0|||
161722210|NCT00408421|584026719|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
161722211|NCT00408421|584026720|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
161722212|NCT00408421|584026721|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
161722213|NCT00408421|584026719|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
161722214|NCT00408421|584026720|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
161722215|NCT00408421|584026721|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
161722216|NCT00408421|584026719|FG000|Treatment Initial Randomization|Physician Decision|1|||
161722217|NCT00408421|584026720|FG001|Treatment Initial Randomization|Physician Decision|0|||
161722218|NCT00408421|584026721|FG002|Treatment Initial Randomization|Physician Decision|0|||
161722219|NCT00408421|584026719|FG000|Treatment Initial Randomization|Protocol Violation|0|||
161722220|NCT00408421|584026720|FG001|Treatment Initial Randomization|Protocol Violation|1|||
161722221|NCT00408421|584026721|FG002|Treatment Initial Randomization|Protocol Violation|0|||
161722222|NCT00408421|584026719|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
161722223|NCT00408421|584026720|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
161722224|NCT00408421|584026721|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
161722225|NCT00408421|584026719|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
161722226|NCT00408421|584026720|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
161722227|NCT00408421|584026721|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
161722228|NCT00408421|584026719|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
161722229|NCT00408421|584026720|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
161722230|NCT00408421|584026721|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
161722231|NCT00408421|584026719|FG000|Treatment Re-Randomization|Adverse Event|2|||
161722232|NCT00408421|584026720|FG001|Treatment Re-Randomization|Adverse Event|2|||
161722233|NCT00408421|584026721|FG002|Treatment Re-Randomization|Adverse Event|4|||
161722234|NCT00408421|584026719|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
161722235|NCT00408421|584026720|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
161722236|NCT00408421|584026721|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
161722237|NCT00408421|584026719|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
161722238|NCT00408421|584026720|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
161722239|NCT00408421|584026721|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
161722240|NCT00408421|584026719|FG000|Treatment Re-Randomization|Physician Decision|1|||
161722241|NCT00408421|584026720|FG001|Treatment Re-Randomization|Physician Decision|3|||
161722242|NCT00408421|584026721|FG002|Treatment Re-Randomization|Physician Decision|0|||
161722243|NCT00408421|584026719|FG000|Treatment Re-Randomization|Protocol Violation|1|||
161722244|NCT00408421|584026720|FG001|Treatment Re-Randomization|Protocol Violation|1|||
161722245|NCT00408421|584026721|FG002|Treatment Re-Randomization|Protocol Violation|0|||
161722246|NCT00408421|584026719|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
161722247|NCT00408421|584026720|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
161722248|NCT00408421|584026721|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
161722249|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
161722250|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
161722251|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
161722252|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
161722253|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
161722254|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
161722255|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
161722256|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
161722257|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
161722258|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
161722259|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
161722260|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
161722261|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
161722262|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
161722263|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
161722264|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
161722265|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
161722266|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
161722267|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
161722268|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
161722269|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
161722270|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
161722271|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
161722272|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
161722273|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
161722274|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
161722275|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Death|8|||
161722276|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Death|3|||
161722277|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
161722278|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
161722279|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
161722280|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
161722281|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
161722282|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
161722283|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
161722284|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
161722285|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
161722286|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
161722287|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
161722288|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
161722289|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
161722290|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
161722291|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
161722292|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
161722293|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
161722294|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
161722295|NCT00494871|584026726|FG000|Follow-up (FU) Period|Adverse Event|1|||
161722296|NCT00494871|584026727|FG001|Follow-up (FU) Period|Adverse Event|1|||
161722297|NCT00494871|584026726|FG000|Follow-up (FU) Period|Death|13|||
161722298|NCT00494871|584026727|FG001|Follow-up (FU) Period|Death|12|||
161722299|NCT00494871|584026726|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
161722300|NCT00494871|584026727|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
161722301|NCT00494871|584026726|FG000|Follow-up (FU) Period|Physician Decision|0|||
161722302|NCT00494871|584026727|FG001|Follow-up (FU) Period|Physician Decision|1|||
161722303|NCT00494871|584026726|FG000|Follow-up (FU) Period|Protocol Violation|1|||
161722304|NCT00494871|584026727|FG001|Follow-up (FU) Period|Protocol Violation|0|||
161722305|NCT00494871|584026726|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
161722306|NCT00494871|584026727|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
161722307|NCT00494871|584026726|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
161722308|NCT00494871|584026727|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
161722309|NCT03238248|584026736|FG000|Overall Study|Death|5|||
161722310|NCT03238248|584026736|FG000|Overall Study|Withdrawal by Subject|7|||
161722311|NCT03238248|584026736|FG000|Overall Study|Participant proceeding to transplant|10|||
161722312|NCT03238248|584026736|FG000|Overall Study|Lack of Efficacy|4|||
161722313|NCT03238248|584026736|FG000|Overall Study|Physician Decision|3|||
161722314|NCT03238248|584026736|FG000|Overall Study|Transitioning to another study|1|||
161722315|NCT03238248|584026736|FG000|Overall Study|No longer benefiting|1|||
161722316|NCT03238248|584026736|FG000|Overall Study|Other complicating disease|1|||
161722317|NCT03238248|584026736|FG000|Overall Study|Adverse Event|5|||
161722318|NCT03238248|584026736|FG000|Overall Study|Disease progression|26|||
161722319|NCT03238248|584026736|FG000|Overall Study|N/A participant is still on treatment|1|||
161722320|NCT03238248|584026736|FG000|Overall Study|Decline in condition|1|||
161722321|NCT03238248|584026736|FG000|Overall Study|Alternative therapy|2|||
161722322|NCT02639182|584026743|FG000|Overall Study|Disease Progression|50|||
161722323|NCT02639182|584026744|FG001|Overall Study|Disease Progression|49|||
161722324|NCT02639182|584026743|FG000|Overall Study|Adverse Event|7|||
161722325|NCT02639182|584026744|FG001|Overall Study|Adverse Event|5|||
161722326|NCT02639182|584026743|FG000|Overall Study|Physician Decision|3|||
161722327|NCT02639182|584026744|FG001|Overall Study|Physician Decision|3|||
161722328|NCT02639182|584026743|FG000|Overall Study|Withdrew Consent|5|||
161722329|NCT02639182|584026744|FG001|Overall Study|Withdrew Consent|4|||
161722330|NCT02639182|584026743|FG000|Overall Study|Lost to Follow-up|0|||
161722331|NCT02639182|584026744|FG001|Overall Study|Lost to Follow-up|1|||
161722332|NCT02639182|584026743|FG000|Overall Study|Study Closure|1|||
161722333|NCT02639182|584026744|FG001|Overall Study|Study Closure|2|||
161722334|NCT02639182|584026743|FG000|Overall Study|Sponsor Ended Study|0|||
161722335|NCT02639182|584026744|FG001|Overall Study|Sponsor Ended Study|1|||
161722336|NCT02639182|584026743|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
161722337|NCT02639182|584026744|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
161722338|NCT02546856|584026747|FG000|4 Months Evaluation|Death|2|||
161722339|NCT02546856|584026748|FG001|4 Months Evaluation|Death|3|||
161722340|NCT02546856|584026747|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
161722341|NCT02546856|584026748|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
161722342|NCT02546856|584026747|FG000|4 Months Evaluation|Lost to Follow-up|3|||
161722343|NCT02546856|584026748|FG001|4 Months Evaluation|Lost to Follow-up|3|||
161722344|NCT02546856|584026747|FG000|4 Months Evaluation|Physician Decision|3|||
161722345|NCT02546856|584026748|FG001|4 Months Evaluation|Physician Decision|0|||
161722346|NCT02546856|584026747|FG000|4 Months Evaluation|Working or living abroad|5|||
161722347|NCT02546856|584026748|FG001|4 Months Evaluation|Working or living abroad|1|||
161722348|NCT02546856|584026747|FG000|4 Months Evaluation|reasons not due to titration|4|||
161722349|NCT02546856|584026748|FG001|4 Months Evaluation|reasons not due to titration|1|||
161722350|NCT02546856|584026747|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
161722351|NCT02546856|584026748|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
161722352|NCT02546856|584026747|FG000|6 Months Evaluation|Death|1|||
161722353|NCT02546856|584026748|FG001|6 Months Evaluation|Death|1|||
161722354|NCT02546856|584026747|FG000|6 Months Evaluation|Lost to Follow-up|1|||
161722355|NCT02546856|584026748|FG001|6 Months Evaluation|Lost to Follow-up|1|||
161722356|NCT02546856|584026747|FG000|6 Months Evaluation|Working or living abroad|6|||
161722357|NCT02546856|584026748|FG001|6 Months Evaluation|Working or living abroad|4|||
161722358|NCT02546856|584026747|FG000|6 Months Evaluation|reasons not due to titration|0|||
161722359|NCT02546856|584026748|FG001|6 Months Evaluation|reasons not due to titration|1|||
161722360|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
161722361|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
161722362|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
161722363|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
161722364|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
161722365|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
161722366|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
161722367|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
161722368|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Other|1|||
161722369|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Other|1|||
161722370|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
161722371|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
161722372|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
161722373|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
161722374|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
161722375|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
161722376|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Other|1|||
161722377|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Other|1|||
161722378|NCT04655586|584026755|FG000|Overall Study|Physician Decision|1|||
161722379|NCT04655586|584026756|FG001|Overall Study|Physician Decision|3|||
161722380|NCT04655586|584026757|FG002|Overall Study|Physician Decision|4|||
161722381|NCT04655586|584026755|FG000|Overall Study|Withdrawal by Subject|1|||
161722382|NCT04655586|584026756|FG001|Overall Study|Withdrawal by Subject|3|||
161722383|NCT04655586|584026757|FG002|Overall Study|Withdrawal by Subject|1|||
161722384|NCT03268746|584026761|FG000|Overall Study|Withdrawal by Subject|1|||
161722385|NCT01372878|584026762|FG000|Overall Study|Withdrawal by Subject|63|||
161722386|NCT01372878|584026762|FG000|Overall Study|Protocol Violation|17|||
161722387|NCT01372878|584026762|FG000|Overall Study|incomplete study procedure|104|||
161722388|NCT00546351|584026763|FG000|Overall Study|Adverse Event|76|||
161722389|NCT00546351|584026763|FG000|Overall Study|Lack of Efficacy|15|||
161722390|NCT00546351|584026763|FG000|Overall Study|Withdrawal by Subject|109|||
161722391|NCT00546351|584026763|FG000|Overall Study|Lost to Follow-up|9|||
161722392|NCT00546351|584026763|FG000|Overall Study|Protocol Deviation|1|||
161722393|NCT00546351|584026763|FG000|Overall Study|Unsatisfactory compliance|9|||
161722394|NCT00546351|584026763|FG000|Overall Study|Other reasons for premature termination|17|||
161722395|NCT04734873|584026765|FG000|Overall Study|Lost to Follow-up|1|||
161722396|NCT04734873|584026766|FG001|Overall Study|Lost to Follow-up|3|||
161722397|NCT04734873|584026767|FG002|Overall Study|Lost to Follow-up|2|||
161722398|NCT04734873|584026765|FG000|Overall Study|Randomized but not dosed|1|||
161722399|NCT04734873|584026766|FG001|Overall Study|Randomized but not dosed|0|||
161722400|NCT04734873|584026767|FG002|Overall Study|Randomized but not dosed|1|||
161722401|NCT02616029|584026771|FG000|Overall Study|Adverse Event|1|||
161722402|NCT02616029|584026772|FG001|Overall Study|Adverse Event|0|||
161722403|NCT02616029|584026771|FG000|Overall Study|Death|0|||
161722404|NCT02616029|584026772|FG001|Overall Study|Death|1|||
161722405|NCT02616029|584026771|FG000|Overall Study|Protocol Violation|1|||
161722406|NCT02616029|584026772|FG001|Overall Study|Protocol Violation|0|||
161722407|NCT02616029|584026771|FG000|Overall Study|Withdrew Consent|1|||
161722408|NCT02616029|584026772|FG001|Overall Study|Withdrew Consent|0|||
161722409|NCT02616029|584026771|FG000|Overall Study|Enrolled and Never Treated|1|||
161722410|NCT02616029|584026772|FG001|Overall Study|Enrolled and Never Treated|1|||
161722411|NCT00609609|584026773|FG000|Overall Study|Withdrawal by Subject|2|||
161722412|NCT00609609|584026774|FG001|Overall Study|Withdrawal by Subject|0|||
161722413|NCT00609609|584026773|FG000|Overall Study|Progression|4|||
161722414|NCT00609609|584026774|FG001|Overall Study|Progression|2|||
161722415|NCT03065530|584026775|FG000|Overall Study|Lack of Efficacy|1|||
161722416|NCT03065530|584026776|FG001|Overall Study|Lack of Efficacy|1|||
161722417|NCT03065530|584026777|FG002|Overall Study|Lack of Efficacy|0|||
161722418|NCT03065530|584026778|FG003|Overall Study|Lack of Efficacy|1|||
161722419|NCT03065530|584026775|FG000|Overall Study|Protocol Violation|1|||
161722420|NCT03065530|584026776|FG001|Overall Study|Protocol Violation|0|||
161722421|NCT03065530|584026777|FG002|Overall Study|Protocol Violation|1|||
161722422|NCT03065530|584026778|FG003|Overall Study|Protocol Violation|1|||
161722423|NCT00479466|584026781|FG000|Overall Study|Adverse Event|5|||
161722424|NCT00479466|584026782|FG001|Overall Study|Adverse Event|1|||
161722425|NCT00479466|584026783|FG002|Overall Study|Adverse Event|0|||
161722426|NCT00479466|584026784|FG003|Overall Study|Adverse Event|1|||
161722427|NCT00479466|584026785|FG004|Overall Study|Adverse Event|2|||
161722428|NCT00479466|584026786|FG005|Overall Study|Adverse Event|0|||
161722429|NCT00479466|584026781|FG000|Overall Study|Hyperglycemia|0|||
161722430|NCT00479466|584026782|FG001|Overall Study|Hyperglycemia|0|||
161722431|NCT00479466|584026783|FG002|Overall Study|Hyperglycemia|0|||
161722432|NCT00479466|584026784|FG003|Overall Study|Hyperglycemia|0|||
161722433|NCT00479466|584026785|FG004|Overall Study|Hyperglycemia|0|||
161722434|NCT00479466|584026786|FG005|Overall Study|Hyperglycemia|1|||
161722435|NCT00479466|584026781|FG000|Overall Study|Lack of Efficacy|2|||
161722436|NCT00479466|584026782|FG001|Overall Study|Lack of Efficacy|0|||
161722437|NCT00479466|584026783|FG002|Overall Study|Lack of Efficacy|1|||
161722438|NCT00479466|584026784|FG003|Overall Study|Lack of Efficacy|0|||
161722439|NCT00479466|584026785|FG004|Overall Study|Lack of Efficacy|0|||
161722440|NCT00479466|584026786|FG005|Overall Study|Lack of Efficacy|0|||
161722441|NCT00479466|584026781|FG000|Overall Study|Lost to Follow-up|0|||
161722442|NCT00479466|584026782|FG001|Overall Study|Lost to Follow-up|1|||
161722443|NCT00479466|584026783|FG002|Overall Study|Lost to Follow-up|1|||
161722444|NCT00479466|584026784|FG003|Overall Study|Lost to Follow-up|0|||
161722445|NCT00479466|584026785|FG004|Overall Study|Lost to Follow-up|2|||
161722446|NCT00479466|584026786|FG005|Overall Study|Lost to Follow-up|2|||
161722447|NCT00479466|584026781|FG000|Overall Study|Physician Decision|2|||
161722448|NCT00479466|584026782|FG001|Overall Study|Physician Decision|1|||
161722449|NCT00479466|584026783|FG002|Overall Study|Physician Decision|1|||
161722450|NCT00479466|584026784|FG003|Overall Study|Physician Decision|0|||
161722451|NCT00479466|584026785|FG004|Overall Study|Physician Decision|0|||
161722452|NCT00479466|584026786|FG005|Overall Study|Physician Decision|0|||
161722453|NCT00479466|584026781|FG000|Overall Study|Pregnancy|0|||
161722454|NCT00479466|584026782|FG001|Overall Study|Pregnancy|0|||
161722455|NCT00479466|584026783|FG002|Overall Study|Pregnancy|0|||
161722456|NCT00479466|584026784|FG003|Overall Study|Pregnancy|0|||
161722457|NCT00479466|584026785|FG004|Overall Study|Pregnancy|1|||
161722458|NCT00479466|584026786|FG005|Overall Study|Pregnancy|0|||
161722459|NCT00479466|584026781|FG000|Overall Study|Protocol Violation|1|||
161722460|NCT00479466|584026782|FG001|Overall Study|Protocol Violation|0|||
161722461|NCT00479466|584026783|FG002|Overall Study|Protocol Violation|0|||
161722462|NCT00479466|584026784|FG003|Overall Study|Protocol Violation|0|||
161722463|NCT00479466|584026785|FG004|Overall Study|Protocol Violation|0|||
161722464|NCT00479466|584026786|FG005|Overall Study|Protocol Violation|0|||
161722465|NCT00479466|584026781|FG000|Overall Study|Withdrawal by Subject|3|||
161722466|NCT00479466|584026782|FG001|Overall Study|Withdrawal by Subject|5|||
161722467|NCT00479466|584026783|FG002|Overall Study|Withdrawal by Subject|0|||
161722468|NCT00479466|584026784|FG003|Overall Study|Withdrawal by Subject|2|||
161722469|NCT00479466|584026785|FG004|Overall Study|Withdrawal by Subject|3|||
161722470|NCT00479466|584026786|FG005|Overall Study|Withdrawal by Subject|1|||
161722471|NCT01469013|584026797|FG000|Part A (Treatment Period)|Adverse Event|1|||
161722472|NCT01469013|584026798|FG001|Part A (Treatment Period)|Adverse Event|0|||
161722473|NCT01469013|584026799|FG002|Part A (Treatment Period)|Adverse Event|0|||
161722474|NCT01469013|584026800|FG003|Part A (Treatment Period)|Adverse Event|0|||
161722475|NCT01469013|584026801|FG004|Part A (Treatment Period)|Adverse Event|1|||
161722476|NCT01469013|584026802|FG005|Part A (Treatment Period)|Adverse Event|0|||
161722477|NCT01469013|584026803|FG006|Part A (Treatment Period)|Adverse Event|0|||
161722478|NCT01469013|584026804|FG007|Part A (Treatment Period)|Adverse Event|0|||
161722479|NCT01469013|584026805|FG008|Part A (Treatment Period)|Adverse Event|0|||
161722480|NCT01469013|584026806|FG009|Part A (Treatment Period)|Adverse Event|0|||
161722481|NCT01469013|584026807|FG010|Part A (Treatment Period)|Adverse Event|0|||
161722482|NCT01469013|584026808|FG011|Part A (Treatment Period)|Adverse Event|0|||
161722483|NCT01469013|584026809|FG012|Part A (Treatment Period)|Adverse Event|0|||
161722484|NCT01469013|584026797|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722485|NCT01469013|584026798|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722486|NCT01469013|584026799|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
161722487|NCT01469013|584026800|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722488|NCT01469013|584026801|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722489|NCT01469013|584026802|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722490|NCT01469013|584026803|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722491|NCT01469013|584026804|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722492|NCT01469013|584026805|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722493|NCT01469013|584026806|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722494|NCT01469013|584026807|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722495|NCT01469013|584026808|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722496|NCT01469013|584026809|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722497|NCT01469013|584026797|FG000|Part B (Extension Period)|Adverse Event|0|||
161722498|NCT01469013|584026798|FG001|Part B (Extension Period)|Adverse Event|0|||
161722499|NCT01469013|584026799|FG002|Part B (Extension Period)|Adverse Event|0|||
161722500|NCT01469013|584026800|FG003|Part B (Extension Period)|Adverse Event|0|||
161722501|NCT01469013|584026801|FG004|Part B (Extension Period)|Adverse Event|0|||
161722502|NCT01469013|584026802|FG005|Part B (Extension Period)|Adverse Event|2|||
161722503|NCT01469013|584026803|FG006|Part B (Extension Period)|Adverse Event|5|||
161722504|NCT01469013|584026804|FG007|Part B (Extension Period)|Adverse Event|5|||
161722505|NCT01469013|584026805|FG008|Part B (Extension Period)|Adverse Event|3|||
161722506|NCT01469013|584026806|FG009|Part B (Extension Period)|Adverse Event|3|||
161722507|NCT01469013|584026807|FG010|Part B (Extension Period)|Adverse Event|1|||
161722508|NCT01469013|584026808|FG011|Part B (Extension Period)|Adverse Event|6|||
161722509|NCT01469013|584026809|FG012|Part B (Extension Period)|Adverse Event|3|||
161722510|NCT01469013|584026797|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
161722511|NCT01469013|584026798|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
161722512|NCT01469013|584026799|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
161722513|NCT01469013|584026800|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
161722514|NCT01469013|584026801|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
161722515|NCT01469013|584026802|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
161722516|NCT01469013|584026803|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
161722517|NCT01469013|584026804|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
161722518|NCT01469013|584026805|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
161722519|NCT01469013|584026806|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
161722520|NCT01469013|584026807|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
161722521|NCT01469013|584026808|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
161722522|NCT01469013|584026809|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
161722523|NCT05232097|584026810|FG000|Overall Study|Physician Decision|1|||
161722524|NCT00425438|584026813|FG000|Overall Study|Termination by Sponsor|25|||
161722525|NCT00425438|584026814|FG001|Overall Study|Termination by Sponsor|27|||
161722526|NCT02902809|584026817|FG000|Overall Study|Discontinuation of asthma program|28|||
161722527|NCT00532259|584026818|FG000|Overall Study|Withdrawal by Subject|2|||
161722528|NCT00532259|584026818|FG000|Overall Study|Adverse Event|1|||
161722529|NCT00532259|584026818|FG000|Overall Study|Death|1|||
161722530|NCT00532259|584026818|FG000|Overall Study|Lack of Efficacy|21|||
161722531|NCT00532259|584026818|FG000|Overall Study|Lost to Follow-up|3|||
161722532|NCT00532259|584026818|FG000|Overall Study|Physician Decision|3|||
161722533|NCT00532259|584026818|FG000|Overall Study|Protocol Violation|1|||
161722534|NCT00871858|584026819|FG000|Overall Study|Protocol Violation|3|||
161722535|NCT00871858|584026820|FG001|Overall Study|Protocol Violation|4|||
161722536|NCT00871858|584026819|FG000|Overall Study|Adverse Event|1|||
161722537|NCT00871858|584026820|FG001|Overall Study|Adverse Event|1|||
161722538|NCT00871858|584026819|FG000|Overall Study|Withdrawal by Subject|1|||
161722539|NCT00871858|584026820|FG001|Overall Study|Withdrawal by Subject|1|||
161722540|NCT00871858|584026819|FG000|Overall Study|Lost to Follow-up|0|||
161722541|NCT00871858|584026820|FG001|Overall Study|Lost to Follow-up|1|||
161722542|NCT02795767|584026823|FG000|Overall Study|Received Commercial Emicizumab|1|||
161722543|NCT02795767|584026824|FG001|Overall Study|Received Commercial Emicizumab|0|||
161722544|NCT02795767|584026825|FG002|Overall Study|Received Commercial Emicizumab|0|||
161722545|NCT04983940|584026826|FG000|Overall Study|Lost to Follow-up|14|||
161722546|NCT04983940|584026826|FG000|Overall Study|Lack of Efficacy|2|||
161722547|NCT01748760|584026827|FG000|Overall Study|Withdrawal by Subject|1|||
161722548|NCT01748760|584026828|FG001|Overall Study|Withdrawal by Subject|1|||
161722549|NCT01748760|584026827|FG000|Overall Study|Lost to Follow-up|5|||
161722550|NCT01748760|584026828|FG001|Overall Study|Lost to Follow-up|1|||
161722551|NCT03009539|584028257|FG000|Overall Study|Lost to Follow-up|132|||
161722552|NCT03009539|584028258|FG001|Overall Study|Lost to Follow-up|113|||
161722553|NCT03009539|584028259|FG002|Overall Study|Lost to Follow-up|132|||
161722554|NCT03009539|584028260|FG003|Overall Study|Lost to Follow-up|113|||
161722555|NCT04543955|584028261|FG000|Overall Study|Company cancelled study|1|||
161722556|NCT04543955|584028262|FG001|Overall Study|Company cancelled study|0|||
161722557|NCT03918642|584028263|FG000|Overall Study|Lost to Follow-up|12|||
161722558|NCT03918642|584028264|FG001|Overall Study|Lost to Follow-up|10|||
161722559|NCT01158534|584028265|FG000|Overall Study|Withdrawal by Subject|1|||
161722560|NCT01158534|584028265|FG000|Overall Study|Death|1|||
161722561|NCT01158534|584028265|FG000|Overall Study|Other|1|||
161722562|NCT03504774|584028266|FG000|Overall Study|Adverse Event|2|||
161722563|NCT03504774|584028267|FG001|Overall Study|Adverse Event|0|||
161722564|NCT03504774|584028266|FG000|Overall Study|Lost to Follow-up|0|||
161722565|NCT03504774|584028267|FG001|Overall Study|Lost to Follow-up|1|||
161722566|NCT03504774|584028266|FG000|Overall Study|Protocol Violation|11|||
161722567|NCT03504774|584028267|FG001|Overall Study|Protocol Violation|3|||
161722568|NCT03504774|584028266|FG000|Overall Study|failed wk 52 DBPCFC|1|||
161722569|NCT03504774|584028267|FG001|Overall Study|failed wk 52 DBPCFC|0|||
161722570|NCT01781429|584028268|FG000|Overall Study|Death|0|||
161722571|NCT01781429|584028269|FG001|Overall Study|Death|0|||
161722572|NCT01781429|584028270|FG002|Overall Study|Death|0|||
161722573|NCT01781429|584028271|FG003|Overall Study|Death|0|||
161722574|NCT01781429|584028272|FG004|Overall Study|Death|0|||
161722575|NCT01781429|584028273|FG005|Overall Study|Death|0|||
161722576|NCT01781429|584028274|FG006|Overall Study|Death|0|||
161722577|NCT01781429|584028275|FG007|Overall Study|Death|0|||
161722578|NCT01781429|584028276|FG008|Overall Study|Death|0|||
161722579|NCT01781429|584028277|FG009|Overall Study|Death|1|||
161722580|NCT01781429|584028278|FG010|Overall Study|Death|0|||
161722581|NCT01781429|584028279|FG011|Overall Study|Death|0|||
161722582|NCT01781429|584028280|FG012|Overall Study|Death|1|||
161722583|NCT01781429|584028281|FG013|Overall Study|Death|0|||
161722584|NCT01781429|584028282|FG014|Overall Study|Death|1|||
161722585|NCT01781429|584028283|FG015|Overall Study|Death|0|||
161722586|NCT01781429|584028268|FG000|Overall Study|Withdrawal by Subject|0|||
161722587|NCT01781429|584028269|FG001|Overall Study|Withdrawal by Subject|0|||
161722588|NCT01781429|584028270|FG002|Overall Study|Withdrawal by Subject|0|||
161722589|NCT01781429|584028271|FG003|Overall Study|Withdrawal by Subject|0|||
161722590|NCT01781429|584028272|FG004|Overall Study|Withdrawal by Subject|0|||
161722591|NCT01781429|584028273|FG005|Overall Study|Withdrawal by Subject|0|||
161722592|NCT01781429|584028274|FG006|Overall Study|Withdrawal by Subject|0|||
161722593|NCT01781429|584028275|FG007|Overall Study|Withdrawal by Subject|0|||
161722594|NCT01781429|584028276|FG008|Overall Study|Withdrawal by Subject|1|||
161722595|NCT01781429|584028277|FG009|Overall Study|Withdrawal by Subject|3|||
161722596|NCT01781429|584028278|FG010|Overall Study|Withdrawal by Subject|1|||
161722597|NCT01781429|584028279|FG011|Overall Study|Withdrawal by Subject|1|||
161722598|NCT01781429|584028280|FG012|Overall Study|Withdrawal by Subject|5|||
161722599|NCT01781429|584028281|FG013|Overall Study|Withdrawal by Subject|2|||
161722600|NCT01781429|584028282|FG014|Overall Study|Withdrawal by Subject|3|||
161722601|NCT01781429|584028283|FG015|Overall Study|Withdrawal by Subject|0|||
161722602|NCT01781429|584028268|FG000|Overall Study|Disease Progression|1|||
161722603|NCT01781429|584028269|FG001|Overall Study|Disease Progression|0|||
161722604|NCT01781429|584028270|FG002|Overall Study|Disease Progression|1|||
161722605|NCT01781429|584028271|FG003|Overall Study|Disease Progression|1|||
161722606|NCT01781429|584028272|FG004|Overall Study|Disease Progression|1|||
161722607|NCT01781429|584028273|FG005|Overall Study|Disease Progression|4|||
161722608|NCT01781429|584028274|FG006|Overall Study|Disease Progression|7|||
161722609|NCT01781429|584028275|FG007|Overall Study|Disease Progression|4|||
161722610|NCT01781429|584028276|FG008|Overall Study|Disease Progression|6|||
161722611|NCT01781429|584028277|FG009|Overall Study|Disease Progression|15|||
161722612|NCT01781429|584028278|FG010|Overall Study|Disease Progression|15|||
161722613|NCT01781429|584028279|FG011|Overall Study|Disease Progression|15|||
161722614|NCT01781429|584028280|FG012|Overall Study|Disease Progression|15|||
161722615|NCT01781429|584028281|FG013|Overall Study|Disease Progression|4|||
161722616|NCT01781429|584028282|FG014|Overall Study|Disease Progression|11|||
161722617|NCT01781429|584028283|FG015|Overall Study|Disease Progression|0|||
161722618|NCT01781429|584028268|FG000|Overall Study|Unacceptable Toxicity|0|||
161722619|NCT01781429|584028269|FG001|Overall Study|Unacceptable Toxicity|0|||
161722620|NCT01781429|584028270|FG002|Overall Study|Unacceptable Toxicity|0|||
161722621|NCT01781429|584028271|FG003|Overall Study|Unacceptable Toxicity|0|||
161722622|NCT01781429|584028272|FG004|Overall Study|Unacceptable Toxicity|0|||
161722623|NCT01781429|584028273|FG005|Overall Study|Unacceptable Toxicity|0|||
161722624|NCT01781429|584028274|FG006|Overall Study|Unacceptable Toxicity|0|||
161722625|NCT01781429|584028275|FG007|Overall Study|Unacceptable Toxicity|0|||
161722626|NCT01781429|584028276|FG008|Overall Study|Unacceptable Toxicity|0|||
161722627|NCT01781429|584028277|FG009|Overall Study|Unacceptable Toxicity|0|||
161722628|NCT01781429|584028278|FG010|Overall Study|Unacceptable Toxicity|0|||
161722629|NCT01781429|584028279|FG011|Overall Study|Unacceptable Toxicity|2|||
161722630|NCT01781429|584028280|FG012|Overall Study|Unacceptable Toxicity|0|||
161722631|NCT01781429|584028281|FG013|Overall Study|Unacceptable Toxicity|0|||
161722632|NCT01781429|584028282|FG014|Overall Study|Unacceptable Toxicity|0|||
161722633|NCT01781429|584028283|FG015|Overall Study|Unacceptable Toxicity|0|||
161722634|NCT01781429|584028268|FG000|Overall Study|Patient Condition Changed|0|||
161722635|NCT01781429|584028269|FG001|Overall Study|Patient Condition Changed|0|||
161722636|NCT01781429|584028270|FG002|Overall Study|Patient Condition Changed|0|||
161722637|NCT01781429|584028271|FG003|Overall Study|Patient Condition Changed|0|||
161722638|NCT01781429|584028272|FG004|Overall Study|Patient Condition Changed|0|||
161722639|NCT01781429|584028273|FG005|Overall Study|Patient Condition Changed|0|||
161722640|NCT01781429|584028274|FG006|Overall Study|Patient Condition Changed|0|||
161722641|NCT01781429|584028275|FG007|Overall Study|Patient Condition Changed|0|||
161722642|NCT01781429|584028276|FG008|Overall Study|Patient Condition Changed|0|||
161722643|NCT01781429|584028277|FG009|Overall Study|Patient Condition Changed|4|||
161722644|NCT01781429|584028278|FG010|Overall Study|Patient Condition Changed|0|||
161722645|NCT01781429|584028279|FG011|Overall Study|Patient Condition Changed|1|||
161722646|NCT01781429|584028280|FG012|Overall Study|Patient Condition Changed|0|||
161722647|NCT01781429|584028281|FG013|Overall Study|Patient Condition Changed|1|||
161722648|NCT01781429|584028282|FG014|Overall Study|Patient Condition Changed|0|||
161722649|NCT01781429|584028283|FG015|Overall Study|Patient Condition Changed|0|||
161722650|NCT01781429|584028268|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
161722651|NCT01781429|584028269|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
161722652|NCT01781429|584028270|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
161722653|NCT01781429|584028271|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
161722654|NCT01781429|584028272|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
161722655|NCT01781429|584028273|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
161722656|NCT01781429|584028274|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
161722657|NCT01781429|584028275|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
161722658|NCT01781429|584028276|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
161722659|NCT01781429|584028277|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
161722660|NCT01781429|584028278|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
161722661|NCT01781429|584028279|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
161722662|NCT01781429|584028280|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
161722663|NCT01781429|584028281|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
161722664|NCT01781429|584028282|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
161722665|NCT01781429|584028283|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
161722666|NCT01781429|584028268|FG000|Overall Study|Enrolled, but not treated|0|||
161722667|NCT01781429|584028269|FG001|Overall Study|Enrolled, but not treated|0|||
161722668|NCT01781429|584028270|FG002|Overall Study|Enrolled, but not treated|0|||
161722669|NCT01781429|584028271|FG003|Overall Study|Enrolled, but not treated|0|||
161722670|NCT01781429|584028272|FG004|Overall Study|Enrolled, but not treated|0|||
161722671|NCT01781429|584028273|FG005|Overall Study|Enrolled, but not treated|0|||
161722672|NCT01781429|584028274|FG006|Overall Study|Enrolled, but not treated|0|||
161722673|NCT01781429|584028275|FG007|Overall Study|Enrolled, but not treated|0|||
161722674|NCT01781429|584028276|FG008|Overall Study|Enrolled, but not treated|0|||
161722675|NCT01781429|584028277|FG009|Overall Study|Enrolled, but not treated|0|||
161722676|NCT01781429|584028278|FG010|Overall Study|Enrolled, but not treated|1|||
161722677|NCT01781429|584028279|FG011|Overall Study|Enrolled, but not treated|0|||
161722678|NCT01781429|584028280|FG012|Overall Study|Enrolled, but not treated|0|||
161722679|NCT01781429|584028281|FG013|Overall Study|Enrolled, but not treated|0|||
161722680|NCT01781429|584028282|FG014|Overall Study|Enrolled, but not treated|0|||
161722681|NCT01781429|584028283|FG015|Overall Study|Enrolled, but not treated|0|||
161722682|NCT00986258|584028284|FG000|Observation Period|Not eligible to be dosed|11|||
161722683|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
161722684|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
161722685|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
161722686|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
161722687|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Other|1|||
161722688|NCT00986258|584028284|FG000|Maintenance Period|Adverse Event|5|||
161722689|NCT00986258|584028284|FG000|Maintenance Period|Lack of Efficacy|2|||
161722690|NCT00986258|584028284|FG000|Maintenance Period|Withdrawal by Subject|2|||
161722691|NCT03332667|584028285|FG000|Overall Study|Adverse Event|0|||
161722692|NCT03332667|584028286|FG001|Overall Study|Adverse Event|0|||
161722693|NCT03332667|584028287|FG002|Overall Study|Adverse Event|2|||
161722694|NCT03332667|584028288|FG003|Overall Study|Adverse Event|1|||
161722695|NCT03332667|584028285|FG000|Overall Study|Withdrawal by Subject|2|||
161722696|NCT03332667|584028286|FG001|Overall Study|Withdrawal by Subject|1|||
161722697|NCT03332667|584028287|FG002|Overall Study|Withdrawal by Subject|5|||
161722698|NCT03332667|584028288|FG003|Overall Study|Withdrawal by Subject|1|||
161722699|NCT03332667|584028285|FG000|Overall Study|Disease Progression or Relapse|2|||
161722700|NCT03332667|584028286|FG001|Overall Study|Disease Progression or Relapse|1|||
161722701|NCT03332667|584028287|FG002|Overall Study|Disease Progression or Relapse|3|||
161722702|NCT03332667|584028288|FG003|Overall Study|Disease Progression or Relapse|0|||
161722703|NCT03332667|584028285|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161722704|NCT03332667|584028286|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161722705|NCT03332667|584028287|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
161722706|NCT03332667|584028288|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161722707|NCT03332667|584028285|FG000|Overall Study|No Treatment Received|0|||
161722708|NCT03332667|584028286|FG001|Overall Study|No Treatment Received|0|||
161722709|NCT03332667|584028287|FG002|Overall Study|No Treatment Received|1|||
161722710|NCT03332667|584028288|FG003|Overall Study|No Treatment Received|0|||
161722711|NCT01035606|584028289|FG000|Overall Study|change in health, job demands,family|3|||
161722712|NCT01035606|584028290|FG001|Overall Study|change in health, job demands,family|3|||
161722713|NCT01035606|584028291|FG002|Overall Study|change in health, job demands,family|4|||
161722714|NCT02385123|584028292|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
161722715|NCT04498910|584028293|FG000|Overall Study|Lost to Follow-up|0|||
161722716|NCT04498910|584028294|FG001|Overall Study|Lost to Follow-up|1|||
161722717|NCT04498910|584028293|FG000|Overall Study|Withdrawal by Subject|2|||
161722718|NCT04498910|584028294|FG001|Overall Study|Withdrawal by Subject|1|||
161722719|NCT04498910|584028293|FG000|Overall Study|Adverse Event|1|||
161722720|NCT04498910|584028294|FG001|Overall Study|Adverse Event|0|||
161722721|NCT01070303|584028295|FG000|Overall Study|Adverse Event|39|||
161722722|NCT01070303|584028295|FG000|Overall Study|Withdrawal by Subject|20|||
161722723|NCT01070303|584028295|FG000|Overall Study|Lost to Follow-up|9|||
161722724|NCT01070303|584028295|FG000|Overall Study|Protocol Violation|0|||
161722725|NCT01070303|584028295|FG000|Overall Study|Lack of Efficacy|2|||
161722726|NCT01070303|584028295|FG000|Overall Study|Administrative Reason|1|||
161722727|NCT01070303|584028295|FG000|Overall Study|Other|18|||
161722728|NCT01809262|584028296|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722729|NCT01809262|584028297|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722730|NCT01809262|584028298|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722731|NCT01809262|584028299|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722732|NCT01809262|584028300|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
161722733|NCT01809262|584028301|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722734|NCT01809262|584028302|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722735|NCT01809262|584028303|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722736|NCT01809262|584028304|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722737|NCT01809262|584028305|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722738|NCT01809262|584028296|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722739|NCT01809262|584028297|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
161722740|NCT01809262|584028298|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722741|NCT01809262|584028299|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722742|NCT01809262|584028300|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722743|NCT01809262|584028301|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722744|NCT01809262|584028302|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722745|NCT01809262|584028303|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722746|NCT01809262|584028304|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722747|NCT01809262|584028305|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722748|NCT02345434|584028308|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
161722749|NCT02345434|584028309|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
161722750|NCT00859898|584028311|FG000|Overall Study|Lack of Efficacy|0|||
161722751|NCT00859898|584028312|FG001|Overall Study|Lack of Efficacy|1|||
161722752|NCT00859898|584028313|FG002|Overall Study|Lack of Efficacy|1|||
161722753|NCT00859898|584028311|FG000|Overall Study|Adverse Event|4|||
161722754|NCT00859898|584028312|FG001|Overall Study|Adverse Event|9|||
161722755|NCT00859898|584028313|FG002|Overall Study|Adverse Event|8|||
161722756|NCT00859898|584028311|FG000|Overall Study|Withdrawal by Subject|11|||
161722757|NCT00859898|584028312|FG001|Overall Study|Withdrawal by Subject|8|||
161722758|NCT00859898|584028313|FG002|Overall Study|Withdrawal by Subject|11|||
161722759|NCT00859898|584028311|FG000|Overall Study|Death|0|||
161722760|NCT00859898|584028312|FG001|Overall Study|Death|0|||
161722761|NCT00859898|584028313|FG002|Overall Study|Death|1|||
161722762|NCT00859898|584028311|FG000|Overall Study|Lost to Follow-up|10|||
161722763|NCT00859898|584028312|FG001|Overall Study|Lost to Follow-up|11|||
161722764|NCT00859898|584028313|FG002|Overall Study|Lost to Follow-up|5|||
161722765|NCT00859898|584028311|FG000|Overall Study|poor/non-compliance|2|||
161722766|NCT00859898|584028312|FG001|Overall Study|poor/non-compliance|0|||
161722767|NCT00859898|584028313|FG002|Overall Study|poor/non-compliance|0|||
161722768|NCT00859898|584028311|FG000|Overall Study|No longer meets criteria|0|||
161722769|NCT00859898|584028312|FG001|Overall Study|No longer meets criteria|1|||
161722770|NCT00859898|584028313|FG002|Overall Study|No longer meets criteria|0|||
161722771|NCT00859898|584028311|FG000|Overall Study|non-specified|1|||
161722772|NCT00859898|584028312|FG001|Overall Study|non-specified|1|||
161722773|NCT00859898|584028313|FG002|Overall Study|non-specified|1|||
161722774|NCT03215264|584028315|FG000|Dose Level 2|Adverse Event|0|||
161722775|NCT03215264|584028316|FG001|Dose Level 2|Adverse Event|1|||
161722776|NCT03215264|584028317|FG002|Dose Level 2|Adverse Event|0|||
161722777|NCT03215264|584028315|FG000|Dose Level 3|Withdrawal by Subject|0|||
161722778|NCT03215264|584028316|FG001|Dose Level 3|Withdrawal by Subject|0|||
161722779|NCT03215264|584028317|FG002|Dose Level 3|Withdrawal by Subject|1|||
161722780|NCT02145156|584028318|FG000|Overall Study|No match to vaccination records|60|||
161722781|NCT02145156|584028319|FG001|Overall Study|No match to vaccination records|52|||
161722782|NCT02145156|584028320|FG002|Overall Study|No match to vaccination records|41|||
161722783|NCT02064439|584028322|FG000|Overall Study|Adverse Event|51|||
161722784|NCT02064439|584028323|FG001|Overall Study|Adverse Event|47|||
161722785|NCT02064439|584028324|FG002|Overall Study|Adverse Event|46|||
161722786|NCT02064439|584028322|FG000|Overall Study|Death|0|||
161722787|NCT02064439|584028323|FG001|Overall Study|Death|2|||
161722788|NCT02064439|584028324|FG002|Overall Study|Death|3|||
161722789|NCT02064439|584028322|FG000|Overall Study|Withdrawal by Subject|29|||
161722790|NCT02064439|584028323|FG001|Overall Study|Withdrawal by Subject|18|||
161722791|NCT02064439|584028324|FG002|Overall Study|Withdrawal by Subject|26|||
161722792|NCT02064439|584028322|FG000|Overall Study|Protocol Violation|3|||
161722793|NCT02064439|584028323|FG001|Overall Study|Protocol Violation|5|||
161722794|NCT02064439|584028324|FG002|Overall Study|Protocol Violation|3|||
161722795|NCT02064439|584028322|FG000|Overall Study|Lost to Follow-up|1|||
161722796|NCT02064439|584028323|FG001|Overall Study|Lost to Follow-up|3|||
161722797|NCT02064439|584028324|FG002|Overall Study|Lost to Follow-up|4|||
161722798|NCT02064439|584028322|FG000|Overall Study|Non-compliance with study medication|21|||
161722799|NCT02064439|584028323|FG001|Overall Study|Non-compliance with study medication|19|||
161722800|NCT02064439|584028324|FG002|Overall Study|Non-compliance with study medication|23|||
161722801|NCT02064439|584028322|FG000|Overall Study|Physician Decision|0|||
161722802|NCT02064439|584028323|FG001|Overall Study|Physician Decision|1|||
161722803|NCT02064439|584028324|FG002|Overall Study|Physician Decision|1|||
161722804|NCT02064439|584028322|FG000|Overall Study|Logistical difficulties|6|||
161722805|NCT02064439|584028323|FG001|Overall Study|Logistical difficulties|5|||
161722806|NCT02064439|584028324|FG002|Overall Study|Logistical difficulties|2|||
161722807|NCT02064439|584028322|FG000|Overall Study|Efficacy outcome reached|18|||
161722808|NCT02064439|584028323|FG001|Overall Study|Efficacy outcome reached|16|||
161722809|NCT02064439|584028324|FG002|Overall Study|Efficacy outcome reached|57|||
161722810|NCT02064439|584028322|FG000|Overall Study|Safety outcome reached|12|||
161722811|NCT02064439|584028323|FG001|Overall Study|Safety outcome reached|20|||
161722812|NCT02064439|584028324|FG002|Overall Study|Safety outcome reached|10|||
161722813|NCT02064439|584028322|FG000|Overall Study|Other|2|||
161722814|NCT02064439|584028323|FG001|Overall Study|Other|2|||
161722815|NCT02064439|584028324|FG002|Overall Study|Other|7|||
161722816|NCT02433288|584028325|FG000|Overall Study|Severe non-compliance to protocol|13|||
161722817|NCT02433288|584028326|FG001|Overall Study|Severe non-compliance to protocol|7|||
161722818|NCT02433288|584028325|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
161722819|NCT02433288|584028326|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
161722820|NCT02433288|584028325|FG000|Overall Study|Withdrawal by Subject|101|||
161722821|NCT02433288|584028326|FG001|Overall Study|Withdrawal by Subject|99|||
161722822|NCT02433288|584028325|FG000|Overall Study|Lost to Follow-up|2|||
161722823|NCT02433288|584028326|FG001|Overall Study|Lost to Follow-up|14|||
161722824|NCT02433288|584028325|FG000|Overall Study|Death|0|||
161722825|NCT02433288|584028326|FG001|Overall Study|Death|3|||
161722826|NCT00858702|584028329|FG000|Overall Study|Lack of Efficacy|1|||
161722827|NCT00858702|584028330|FG001|Overall Study|Lack of Efficacy|0|||
161722828|NCT00858702|584028329|FG000|Overall Study|Protocol Violation|1|||
161722829|NCT00858702|584028330|FG001|Overall Study|Protocol Violation|1|||
161722830|NCT00858702|584028329|FG000|Overall Study|Other|2|||
161722831|NCT00858702|584028330|FG001|Overall Study|Other|1|||
161722832|NCT00858702|584028329|FG000|Overall Study|Withdrawal by Subject|1|||
161722833|NCT00858702|584028330|FG001|Overall Study|Withdrawal by Subject|0|||
161722834|NCT01740440|584028333|FG000|Overall Study|Lost to Follow-up|3|||
161722835|NCT00367640|584028334|FG000|Overall Study|Adverse Event|3|||
161722836|NCT00367640|584028335|FG001|Overall Study|Adverse Event|6|||
161722837|NCT00367640|584028336|FG002|Overall Study|Adverse Event|8|||
161722838|NCT00367640|584028337|FG003|Overall Study|Adverse Event|0|||
161722839|NCT00367640|584028334|FG000|Overall Study|Withdrawal by Subject|8|||
161722840|NCT00367640|584028335|FG001|Overall Study|Withdrawal by Subject|11|||
161722841|NCT00367640|584028336|FG002|Overall Study|Withdrawal by Subject|8|||
161722842|NCT00367640|584028337|FG003|Overall Study|Withdrawal by Subject|6|||
161722843|NCT00367640|584028334|FG000|Overall Study|Any other reason not above-mentioned|7|||
161722844|NCT00367640|584028335|FG001|Overall Study|Any other reason not above-mentioned|5|||
161722845|NCT00367640|584028336|FG002|Overall Study|Any other reason not above-mentioned|3|||
161722846|NCT00367640|584028337|FG003|Overall Study|Any other reason not above-mentioned|4|||
161722847|NCT02417233|584028338|FG000|Overall Study|Death|4|||
161722848|NCT02417233|584028339|FG001|Overall Study|Death|10|||
161722849|NCT02417233|584028340|FG002|Overall Study|Death|14|||
161722850|NCT02417233|584028338|FG000|Overall Study|Lost to Follow-up|27|||
161722851|NCT02417233|584028339|FG001|Overall Study|Lost to Follow-up|39|||
161722852|NCT02417233|584028340|FG002|Overall Study|Lost to Follow-up|34|||
161722853|NCT02417233|584028338|FG000|Overall Study|Protocol Violation|2|||
161722854|NCT02417233|584028339|FG001|Overall Study|Protocol Violation|0|||
161722855|NCT02417233|584028340|FG002|Overall Study|Protocol Violation|2|||
161722856|NCT02417233|584028338|FG000|Overall Study|Withdrawal by Subject|2|||
161722857|NCT02417233|584028339|FG001|Overall Study|Withdrawal by Subject|1|||
161722858|NCT02417233|584028340|FG002|Overall Study|Withdrawal by Subject|8|||
161722859|NCT02417233|584028338|FG000|Overall Study|Relocation out of study area|1|||
161722860|NCT02417233|584028339|FG001|Overall Study|Relocation out of study area|0|||
161722861|NCT02417233|584028340|FG002|Overall Study|Relocation out of study area|1|||
161722862|NCT02417233|584028338|FG000|Overall Study|Mentally unstable|0|||
161722863|NCT02417233|584028339|FG001|Overall Study|Mentally unstable|1|||
161722864|NCT02417233|584028340|FG002|Overall Study|Mentally unstable|0|||
161722865|NCT01063751|584028343|FG000|Overall Study|Censored from analyses|42|||
161722866|NCT01063751|584028343|FG000|Overall Study|Withdrawal by Subject|34|||
161722867|NCT01063751|584028343|FG000|Overall Study|Lost to Follow-up|30|||
161722868|NCT01063751|584028343|FG000|Overall Study|Death|13|||
161722869|NCT01063751|584028343|FG000|Overall Study|Sponsored Terminated Study|60|||
161722870|NCT01063751|584028343|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
161722871|NCT01063751|584028343|FG000|Overall Study|Investigator site closed|10|||
161722872|NCT01063751|584028343|FG000|Overall Study|Revision|6|||
161722873|NCT01063751|584028343|FG000|Overall Study|Physician Decision|4|||
161722874|NCT02805907|584028349|FG000|Overall Study|Lost to Follow-up|3|||
161722875|NCT02805907|584028350|FG001|Overall Study|Lost to Follow-up|3|||
161722876|NCT03408873|584028355|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
161722877|NCT03408873|584028355|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
161722878|NCT03408873|584028355|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
161722879|NCT03408873|584028355|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
161722880|NCT03408873|584028355|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
161722881|NCT03408873|584028355|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
161722882|NCT01264965|584028361|FG000|Overall Study|Withdrawal by Subject|10|||
161722883|NCT03799718|584028363|FG000|Overall Study|Adverse Event|2|||
161722884|NCT01327339|584028364|FG000|Overall Study|Protocol Violation|8|||
161722885|NCT01172288|584028365|FG000|Overall Study|Adverse Event|1|||
161722886|NCT01172288|584028366|FG001|Overall Study|Adverse Event|0|||
161722887|NCT01172288|584028365|FG000|Overall Study|Protocol Violation|0|||
161722888|NCT01172288|584028366|FG001|Overall Study|Protocol Violation|1|||
161722889|NCT00700752|584028369|FG000|First Intervention|Withdrawal by Subject|0|||
161722890|NCT00700752|584028370|FG001|First Intervention|Withdrawal by Subject|2|||
161722891|NCT03662334|584028371|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
161722892|NCT03662334|584028372|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
161722893|NCT01097330|584028373|FG000|Overall Study|Study terminated early|7|||
161722894|NCT01097330|584028374|FG001|Overall Study|Study terminated early|5|||
161722895|NCT03303339|584028380|FG000|Overall Study|Death|2|||
161722896|NCT03303339|584028381|FG001|Overall Study|Death|2|||
161722897|NCT03303339|584028382|FG002|Overall Study|Death|2|||
161722898|NCT03303339|584028383|FG003|Overall Study|Death|1|||
161722899|NCT03303339|584028384|FG004|Overall Study|Death|4|||
161722900|NCT03303339|584028385|FG005|Overall Study|Death|2|||
161722901|NCT03303339|584028386|FG006|Overall Study|Death|2|||
161722902|NCT03303339|584028387|FG007|Overall Study|Death|2|||
161722903|NCT03303339|584028388|FG008|Overall Study|Death|3|||
161722904|NCT03303339|584028389|FG009|Overall Study|Death|3|||
161722905|NCT03303339|584028390|FG010|Overall Study|Death|4|||
161722906|NCT03303339|584028391|FG011|Overall Study|Death|24|||
161722907|NCT03303339|584028380|FG000|Overall Study|Study Terminated by Sponsor|0|||
161722908|NCT03303339|584028381|FG001|Overall Study|Study Terminated by Sponsor|0|||
161722909|NCT03303339|584028382|FG002|Overall Study|Study Terminated by Sponsor|0|||
161722910|NCT03303339|584028383|FG003|Overall Study|Study Terminated by Sponsor|0|||
161722911|NCT03303339|584028384|FG004|Overall Study|Study Terminated by Sponsor|0|||
161722912|NCT03303339|584028385|FG005|Overall Study|Study Terminated by Sponsor|0|||
161722913|NCT03303339|584028386|FG006|Overall Study|Study Terminated by Sponsor|0|||
161722914|NCT03303339|584028387|FG007|Overall Study|Study Terminated by Sponsor|0|||
161722915|NCT03303339|584028388|FG008|Overall Study|Study Terminated by Sponsor|1|||
161722916|NCT03303339|584028389|FG009|Overall Study|Study Terminated by Sponsor|0|||
161722917|NCT03303339|584028390|FG010|Overall Study|Study Terminated by Sponsor|1|||
161722918|NCT03303339|584028391|FG011|Overall Study|Study Terminated by Sponsor|1|||
161722919|NCT03303339|584028380|FG000|Overall Study|Withdrawal by Subject|1|||
161722920|NCT03303339|584028381|FG001|Overall Study|Withdrawal by Subject|0|||
161722921|NCT03303339|584028382|FG002|Overall Study|Withdrawal by Subject|0|||
161722922|NCT03303339|584028383|FG003|Overall Study|Withdrawal by Subject|0|||
161722923|NCT03303339|584028384|FG004|Overall Study|Withdrawal by Subject|0|||
161722924|NCT03303339|584028385|FG005|Overall Study|Withdrawal by Subject|1|||
161722925|NCT03303339|584028386|FG006|Overall Study|Withdrawal by Subject|1|||
161722926|NCT03303339|584028387|FG007|Overall Study|Withdrawal by Subject|0|||
161722927|NCT03303339|584028388|FG008|Overall Study|Withdrawal by Subject|0|||
161722928|NCT03303339|584028389|FG009|Overall Study|Withdrawal by Subject|0|||
161722929|NCT03303339|584028390|FG010|Overall Study|Withdrawal by Subject|0|||
161722930|NCT03303339|584028391|FG011|Overall Study|Withdrawal by Subject|2|||
161722931|NCT03303339|584028380|FG000|Overall Study|Physician Decision|0|||
161722932|NCT03303339|584028381|FG001|Overall Study|Physician Decision|0|||
161722933|NCT03303339|584028382|FG002|Overall Study|Physician Decision|0|||
161722934|NCT03303339|584028383|FG003|Overall Study|Physician Decision|0|||
161722935|NCT03303339|584028384|FG004|Overall Study|Physician Decision|1|||
161722936|NCT03303339|584028385|FG005|Overall Study|Physician Decision|0|||
161722937|NCT03303339|584028386|FG006|Overall Study|Physician Decision|0|||
161722938|NCT03303339|584028387|FG007|Overall Study|Physician Decision|0|||
161722939|NCT03303339|584028388|FG008|Overall Study|Physician Decision|0|||
161722940|NCT03303339|584028389|FG009|Overall Study|Physician Decision|0|||
161722941|NCT03303339|584028390|FG010|Overall Study|Physician Decision|0|||
161722942|NCT03303339|584028391|FG011|Overall Study|Physician Decision|0|||
161722943|NCT03303339|584028380|FG000|Overall Study|Safety/Non-compliance|0|||
161722944|NCT03303339|584028381|FG001|Overall Study|Safety/Non-compliance|0|||
161722945|NCT03303339|584028382|FG002|Overall Study|Safety/Non-compliance|0|||
161722946|NCT03303339|584028383|FG003|Overall Study|Safety/Non-compliance|0|||
161722947|NCT03303339|584028384|FG004|Overall Study|Safety/Non-compliance|0|||
161722948|NCT03303339|584028385|FG005|Overall Study|Safety/Non-compliance|0|||
161722949|NCT03303339|584028386|FG006|Overall Study|Safety/Non-compliance|0|||
161722950|NCT03303339|584028387|FG007|Overall Study|Safety/Non-compliance|0|||
161722951|NCT03303339|584028388|FG008|Overall Study|Safety/Non-compliance|0|||
161722952|NCT03303339|584028389|FG009|Overall Study|Safety/Non-compliance|0|||
161722953|NCT03303339|584028390|FG010|Overall Study|Safety/Non-compliance|0|||
161722954|NCT03303339|584028391|FG011|Overall Study|Safety/Non-compliance|1|||
161722955|NCT00510692|584028393|FG000|Overall Study|Adverse Event|1|||
161722956|NCT00510692|584028394|FG001|Overall Study|Adverse Event|3|||
161722957|NCT00510692|584028393|FG000|Overall Study|Withdrawal by Subject|1|||
161722958|NCT00510692|584028394|FG001|Overall Study|Withdrawal by Subject|0|||
161722959|NCT02116972|584028395|FG000|Overall Study|Adverse Event|4|||
161722960|NCT02116972|584028396|FG001|Overall Study|Adverse Event|4|||
161722961|NCT02116972|584028397|FG002|Overall Study|Adverse Event|1|||
161722962|NCT02116972|584028395|FG000|Overall Study|Withdrawal by Subject|1|||
161722963|NCT02116972|584028396|FG001|Overall Study|Withdrawal by Subject|1|||
161722964|NCT02116972|584028397|FG002|Overall Study|Withdrawal by Subject|5|||
161722965|NCT02116972|584028395|FG000|Overall Study|Protocol Violation|1|||
161722966|NCT02116972|584028396|FG001|Overall Study|Protocol Violation|0|||
161722967|NCT02116972|584028397|FG002|Overall Study|Protocol Violation|1|||
161722968|NCT02116972|584028395|FG000|Overall Study|Lost to Follow-up|4|||
161722969|NCT02116972|584028396|FG001|Overall Study|Lost to Follow-up|3|||
161722970|NCT02116972|584028397|FG002|Overall Study|Lost to Follow-up|1|||
161722971|NCT02116972|584028395|FG000|Overall Study|Lack of Efficacy|6|||
161722972|NCT02116972|584028396|FG001|Overall Study|Lack of Efficacy|6|||
161722973|NCT02116972|584028397|FG002|Overall Study|Lack of Efficacy|5|||
161722974|NCT02116972|584028395|FG000|Overall Study|scheduling conflicts and relocation|3|||
161722975|NCT02116972|584028396|FG001|Overall Study|scheduling conflicts and relocation|3|||
161722976|NCT02116972|584028397|FG002|Overall Study|scheduling conflicts and relocation|6|||
161722977|NCT00784784|584028398|FG000|Overall Study|Withdrawal by Subject|2|||
161722978|NCT00784784|584028399|FG001|Overall Study|Withdrawal by Subject|2|||
161722979|NCT00872898|584028401|FG000|Part Two - Double Blind|Adverse Event|4|||
161722980|NCT00872898|584028402|FG001|Part Two - Double Blind|Adverse Event|3|||
161722981|NCT00872898|584028401|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
161722982|NCT00872898|584028402|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
161722983|NCT00872898|584028401|FG000|Part Two - Double Blind|Protocol Violation|1|||
161722984|NCT00872898|584028402|FG001|Part Two - Double Blind|Protocol Violation|0|||
161722985|NCT00872898|584028401|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
161722986|NCT00872898|584028402|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
161722987|NCT00872898|584028401|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
161722988|NCT00872898|584028402|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
161722989|NCT00872898|584028401|FG000|Part Two - Double Blind|Other reasons|2|||
161722990|NCT00872898|584028402|FG001|Part Two - Double Blind|Other reasons|0|||
161722991|NCT03176966|584028407|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
161722992|NCT03176966|584028408|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
161722993|NCT03176966|584028407|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
161722994|NCT03176966|584028408|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
161722995|NCT03176966|584028407|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
161722996|NCT03176966|584028408|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
161722997|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
161722998|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
161722999|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
161723000|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
161723001|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
161723002|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
161723003|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
161723004|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
161723005|NCT01903434|584028413|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
161723006|NCT01903434|584028414|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
161723007|NCT01903434|584028413|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
161723008|NCT01903434|584028414|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
161723009|NCT00404768|584028415|FG000|Part A and B|Withdrawn due to labor progression|1|||
161723010|NCT00404768|584028416|FG001|Part A and B|Withdrawn due to labor progression|0|||
161723011|NCT00404768|584028417|FG002|Part A and B|Withdrawn due to labor progression|0|||
161723012|NCT00404768|584028418|FG003|Part A and B|Withdrawn due to labor progression|0|||
161723013|NCT00404768|584028415|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
161723014|NCT00404768|584028416|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
161723015|NCT00404768|584028417|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
161723016|NCT00404768|584028418|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
161723017|NCT00404768|584028415|FG000|Part C|Adverse Event|0|||
161723018|NCT00404768|584028416|FG001|Part C|Adverse Event|0|||
161723019|NCT00404768|584028417|FG002|Part C|Adverse Event|0|||
161723020|NCT00404768|584028418|FG003|Part C|Adverse Event|3|||
161723021|NCT00404768|584028415|FG000|Part C|Lost to Follow-up|0|||
161723022|NCT00404768|584028416|FG001|Part C|Lost to Follow-up|0|||
161723023|NCT00404768|584028417|FG002|Part C|Lost to Follow-up|3|||
161723024|NCT00404768|584028418|FG003|Part C|Lost to Follow-up|1|||
161723025|NCT00404768|584028415|FG000|Part C|Withdrawal by Subject|0|||
161723026|NCT00404768|584028416|FG001|Part C|Withdrawal by Subject|0|||
161723027|NCT00404768|584028417|FG002|Part C|Withdrawal by Subject|2|||
161723028|NCT00404768|584028418|FG003|Part C|Withdrawal by Subject|1|||
161723029|NCT00404768|584028415|FG000|Part C|Early withdrawal from study medication|0|||
161723030|NCT00404768|584028416|FG001|Part C|Early withdrawal from study medication|0|||
161723031|NCT00404768|584028417|FG002|Part C|Early withdrawal from study medication|1|||
161723032|NCT00404768|584028418|FG003|Part C|Early withdrawal from study medication|0|||
161723033|NCT00404768|584028415|FG000|Part C|Participant did not respond to therapy|0|||
161723034|NCT00404768|584028416|FG001|Part C|Participant did not respond to therapy|0|||
161723035|NCT00404768|584028417|FG002|Part C|Participant did not respond to therapy|1|||
161723036|NCT00404768|584028418|FG003|Part C|Participant did not respond to therapy|1|||
161723037|NCT00404768|584028415|FG000|Part C|Physician withdrew the study medication|0|||
161723038|NCT00404768|584028416|FG001|Part C|Physician withdrew the study medication|0|||
161723039|NCT00404768|584028417|FG002|Part C|Physician withdrew the study medication|1|||
161723040|NCT00404768|584028418|FG003|Part C|Physician withdrew the study medication|0|||
161723041|NCT00404768|584028415|FG000|Part C|Participant delivered baby|0|||
161723042|NCT00404768|584028416|FG001|Part C|Participant delivered baby|0|||
161723043|NCT00404768|584028417|FG002|Part C|Participant delivered baby|0|||
161723044|NCT00404768|584028418|FG003|Part C|Participant delivered baby|1|||
161723045|NCT00404768|584028415|FG000|Part C|Unsatisfactory uterine response to IP|0|||
161723046|NCT00404768|584028416|FG001|Part C|Unsatisfactory uterine response to IP|0|||
161723047|NCT00404768|584028417|FG002|Part C|Unsatisfactory uterine response to IP|0|||
161723048|NCT00404768|584028418|FG003|Part C|Unsatisfactory uterine response to IP|1|||
161723049|NCT00404768|584028415|FG000|Part C|Active labor|0|||
161723050|NCT00404768|584028416|FG001|Part C|Active labor|0|||
161723051|NCT00404768|584028417|FG002|Part C|Active labor|0|||
161723052|NCT00404768|584028418|FG003|Part C|Active labor|1|||
161723053|NCT00404768|584028415|FG000|Part C|Lack of Efficacy|0|||
161723054|NCT00404768|584028416|FG001|Part C|Lack of Efficacy|0|||
161723055|NCT00404768|584028417|FG002|Part C|Lack of Efficacy|0|||
161723056|NCT00404768|584028418|FG003|Part C|Lack of Efficacy|2|||
161723057|NCT00404768|584028415|FG000|Part C|Treatment failure|0|||
161723058|NCT00404768|584028416|FG001|Part C|Treatment failure|0|||
161723059|NCT00404768|584028417|FG002|Part C|Treatment failure|0|||
161723060|NCT00404768|584028418|FG003|Part C|Treatment failure|1|||
161723061|NCT00404768|584028415|FG000|Part C|Investigator discretion|0|||
161723062|NCT00404768|584028416|FG001|Part C|Investigator discretion|0|||
161723063|NCT00404768|584028417|FG002|Part C|Investigator discretion|0|||
161723064|NCT00404768|584028418|FG003|Part C|Investigator discretion|1|||
161723065|NCT00404768|584028415|FG000|Part C|Researcher suspended study medication|0|||
161723066|NCT00404768|584028416|FG001|Part C|Researcher suspended study medication|0|||
161723067|NCT00404768|584028417|FG002|Part C|Researcher suspended study medication|0|||
161723068|NCT00404768|584028418|FG003|Part C|Researcher suspended study medication|1|||
161723069|NCT01118143|584028419|FG000|Overall Study|Withdrawal by Subject|2|||
161723070|NCT01118143|584028420|FG001|Overall Study|Withdrawal by Subject|5|||
161723071|NCT03625986|584030366|FG000|Randomization Period|Lost to Follow-up|7|||
161723072|NCT03625986|584030367|FG001|Randomization Period|Lost to Follow-up|12|||
161723073|NCT03625986|584030366|FG000|Randomization Period|Withdrawal by Subject|10|||
161723074|NCT03625986|584030367|FG001|Randomization Period|Withdrawal by Subject|6|||
161723075|NCT04359823|584030368|FG000|Overall Study|Lost to Follow-up|0|||
161723076|NCT04359823|584030369|FG001|Overall Study|Lost to Follow-up|1|||
161723077|NCT04359823|584030368|FG000|Overall Study|Withdrawal by Subject|0|||
161723078|NCT04359823|584030369|FG001|Overall Study|Withdrawal by Subject|1|||
161723079|NCT01850563|584030370|FG000|Overall Study|Not eligible|3|||
161723080|NCT01850563|584030371|FG001|Overall Study|Not eligible|0|||
161723081|NCT03132805|584030372|FG000|Overall Study|Lost to Follow-up|142|||
161723082|NCT03132805|584030373|FG001|Overall Study|Lost to Follow-up|141|||
161723083|NCT03132805|584030374|FG002|Overall Study|Lost to Follow-up|113|||
161723084|NCT03151148|584030375|FG000|Overall Study|Lost to Follow-up|1|||
161723085|NCT03151148|584030376|FG001|Overall Study|Lost to Follow-up|0|||
161723086|NCT03151148|584030375|FG000|Overall Study|Withdrawal by Subject|1|||
161723087|NCT03151148|584030376|FG001|Overall Study|Withdrawal by Subject|0|||
161723088|NCT01115569|584030381|FG000|Conversion/Titration Phase|Adverse Event|59|||
161723089|NCT01115569|584030382|FG001|Conversion/Titration Phase|Adverse Event|0|||
161723090|NCT01115569|584030381|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
161723091|NCT01115569|584030382|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
161723092|NCT01115569|584030381|FG000|Conversion/Titration Phase|Physician Decision|5|||
161723093|NCT01115569|584030382|FG001|Conversion/Titration Phase|Physician Decision|0|||
161723094|NCT01115569|584030381|FG000|Conversion/Titration Phase|Protocol Violation|68|||
161723095|NCT01115569|584030382|FG001|Conversion/Titration Phase|Protocol Violation|0|||
161723096|NCT01115569|584030381|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
161723097|NCT01115569|584030382|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
161723098|NCT01115569|584030381|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
161723099|NCT01115569|584030382|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
161723100|NCT01115569|584030381|FG000|Maintenance Phase|Adverse Event|0|||
161723101|NCT01115569|584030382|FG001|Maintenance Phase|Adverse Event|43|||
161723102|NCT01115569|584030381|FG000|Maintenance Phase|Lost to Follow-up|0|||
161723103|NCT01115569|584030382|FG001|Maintenance Phase|Lost to Follow-up|8|||
161723104|NCT01115569|584030381|FG000|Maintenance Phase|Physician Decision|0|||
161723105|NCT01115569|584030382|FG001|Maintenance Phase|Physician Decision|3|||
161723106|NCT01115569|584030381|FG000|Maintenance Phase|Protocol Violation|0|||
161723107|NCT01115569|584030382|FG001|Maintenance Phase|Protocol Violation|9|||
161723108|NCT01115569|584030381|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161723109|NCT01115569|584030382|FG001|Maintenance Phase|Withdrawal by Subject|27|||
161723110|NCT01115569|584030381|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
161723111|NCT01115569|584030382|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
161723112|NCT01115569|584030381|FG000|Maintenance Phase|Administrative|0|||
161723113|NCT01115569|584030382|FG001|Maintenance Phase|Administrative|1|||
161723114|NCT01614769|584030383|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
161723115|NCT01614769|584030384|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
161723116|NCT01614769|584030385|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
161723117|NCT01614769|584030386|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
161723118|NCT01614769|584030387|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
161723119|NCT01614769|584030388|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
161723120|NCT01614769|584030383|FG000|Period 1|Protocol Violation|0|||
161723121|NCT01614769|584030384|FG001|Period 1|Protocol Violation|0|||
161723122|NCT01614769|584030385|FG002|Period 1|Protocol Violation|0|||
161723123|NCT01614769|584030386|FG003|Period 1|Protocol Violation|1|||
161723124|NCT01614769|584030387|FG004|Period 1|Protocol Violation|0|||
161723125|NCT01614769|584030388|FG005|Period 1|Protocol Violation|0|||
161723126|NCT01614769|584030383|FG000|Period 1|Withdrawal by Subject|1|||
161723127|NCT01614769|584030384|FG001|Period 1|Withdrawal by Subject|0|||
161723128|NCT01614769|584030385|FG002|Period 1|Withdrawal by Subject|0|||
161723129|NCT01614769|584030386|FG003|Period 1|Withdrawal by Subject|0|||
161723130|NCT01614769|584030387|FG004|Period 1|Withdrawal by Subject|0|||
161723131|NCT01614769|584030388|FG005|Period 1|Withdrawal by Subject|0|||
161723132|NCT01614769|584030383|FG000|Period 3|Withdrawal by Subject|0|||
161723133|NCT01614769|584030384|FG001|Period 3|Withdrawal by Subject|0|||
161723134|NCT01614769|584030385|FG002|Period 3|Withdrawal by Subject|1|||
161723135|NCT01614769|584030386|FG003|Period 3|Withdrawal by Subject|0|||
161723136|NCT01614769|584030387|FG004|Period 3|Withdrawal by Subject|0|||
161723137|NCT01614769|584030388|FG005|Period 3|Withdrawal by Subject|0|||
161723138|NCT01228071|584030389|FG000|Overall Study|Protocol Violation|1|||
161723139|NCT01228071|584030389|FG000|Overall Study|Withdrawal by Subject|1|||
161723140|NCT04439838|584030390|FG000|Overall Study|Withdrawal by Subject|0|||
161723141|NCT04439838|584030391|FG001|Overall Study|Withdrawal by Subject|0|||
161723142|NCT04439838|584030392|FG002|Overall Study|Withdrawal by Subject|0|||
161723143|NCT04439838|584030393|FG003|Overall Study|Withdrawal by Subject|0|||
161723144|NCT04439838|584030394|FG004|Overall Study|Withdrawal by Subject|0|||
161723145|NCT04439838|584030395|FG005|Overall Study|Withdrawal by Subject|0|||
161723146|NCT04439838|584030396|FG006|Overall Study|Withdrawal by Subject|0|||
161723147|NCT04439838|584030397|FG007|Overall Study|Withdrawal by Subject|0|||
161723148|NCT04439838|584030398|FG008|Overall Study|Withdrawal by Subject|1|||
161723149|NCT00960440|584030405|FG000|Overall Study|Death|0|||
161723150|NCT00960440|584030406|FG001|Overall Study|Death|0|||
161723151|NCT00960440|584030407|FG002|Overall Study|Death|0|||
161723152|NCT00960440|584030408|FG003|Overall Study|Death|1|||
161723153|NCT00960440|584030405|FG000|Overall Study|Adverse Event|12|||
161723154|NCT00960440|584030406|FG001|Overall Study|Adverse Event|12|||
161723155|NCT00960440|584030407|FG002|Overall Study|Adverse Event|4|||
161723156|NCT00960440|584030408|FG003|Overall Study|Adverse Event|4|||
161723157|NCT00960440|584030405|FG000|Overall Study|Lack of Efficacy|2|||
161723158|NCT00960440|584030406|FG001|Overall Study|Lack of Efficacy|5|||
161723159|NCT00960440|584030407|FG002|Overall Study|Lack of Efficacy|3|||
161723160|NCT00960440|584030408|FG003|Overall Study|Lack of Efficacy|8|||
161723161|NCT00960440|584030405|FG000|Overall Study|Protocol Violation|2|||
161723162|NCT00960440|584030406|FG001|Overall Study|Protocol Violation|8|||
161723163|NCT00960440|584030407|FG002|Overall Study|Protocol Violation|3|||
161723164|NCT00960440|584030408|FG003|Overall Study|Protocol Violation|4|||
161723165|NCT00960440|584030405|FG000|Overall Study|Withdrawal by Subject|9|||
161723166|NCT00960440|584030406|FG001|Overall Study|Withdrawal by Subject|5|||
161723167|NCT00960440|584030407|FG002|Overall Study|Withdrawal by Subject|2|||
161723168|NCT00960440|584030408|FG003|Overall Study|Withdrawal by Subject|1|||
161723169|NCT00960440|584030405|FG000|Overall Study|Other|1|||
161723170|NCT00960440|584030406|FG001|Overall Study|Other|1|||
161723171|NCT00960440|584030407|FG002|Overall Study|Other|1|||
161723172|NCT00960440|584030408|FG003|Overall Study|Other|0|||
161723173|NCT01188798|584030409|FG000|Overall Study|Death|0|||
161723174|NCT01188798|584030410|FG001|Overall Study|Death|1|||
161723175|NCT01188798|584030409|FG000|Overall Study|Required additional transplant|1|||
161723176|NCT01188798|584030410|FG001|Overall Study|Required additional transplant|1|||
161723177|NCT01188798|584030409|FG000|Overall Study|Protocol closure|1|||
161723178|NCT01188798|584030410|FG001|Overall Study|Protocol closure|1|||
161723179|NCT03964415|584030416|FG000|Overall Study|Sponsor's decision|1563|||
161723180|NCT03964415|584030417|FG001|Overall Study|Sponsor's decision|1528|||
161723181|NCT03964415|584030416|FG000|Overall Study|Lost to Follow-up|139|||
161723182|NCT03964415|584030417|FG001|Overall Study|Lost to Follow-up|146|||
161723183|NCT03964415|584030416|FG000|Overall Study|Withdrawal by Subject|68|||
161723184|NCT03964415|584030417|FG001|Overall Study|Withdrawal by Subject|72|||
161723185|NCT03964415|584030416|FG000|Overall Study|Physician Decision|34|||
161723186|NCT03964415|584030417|FG001|Overall Study|Physician Decision|48|||
161723187|NCT03964415|584030416|FG000|Overall Study|Adverse Event|3|||
161723188|NCT03964415|584030417|FG001|Overall Study|Adverse Event|0|||
161723189|NCT03964415|584030416|FG000|Overall Study|Death|4|||
161723190|NCT03964415|584030417|FG001|Overall Study|Death|6|||
161723191|NCT03964415|584030416|FG000|Overall Study|Protocol Violation|1|||
161723192|NCT03964415|584030417|FG001|Overall Study|Protocol Violation|4|||
161723193|NCT03964415|584030416|FG000|Overall Study|Other|35|||
161723194|NCT03964415|584030417|FG001|Overall Study|Other|38|||
161723195|NCT03964415|584030416|FG000|Overall Study|Randomized but not treated|6|||
161723196|NCT03964415|584030417|FG001|Overall Study|Randomized but not treated|7|||
161723197|NCT01302769|584030422|FG000|Overall Study|Lost to Follow-up|1|||
161723198|NCT01302769|584030423|FG001|Overall Study|Lost to Follow-up|1|||
161723199|NCT01734993|584030427|FG000|Overall Study|Adverse Event|1|||
161723200|NCT01734993|584030427|FG000|Overall Study|Lack of Efficacy|1|||
161723201|NCT00723840|584030428|FG000|Overall Study|Lost to Follow-up|2|||
161723202|NCT00723840|584030428|FG000|Overall Study|Failure to return|18|||
161723203|NCT00723840|584030428|FG000|Overall Study|Withdrawal by Subject|55|||
161723204|NCT00723840|584030428|FG000|Overall Study|Serious Adverse Events|3|||
161723205|NCT00723840|584030428|FG000|Overall Study|Other Medical Event|2|||
161723206|NCT00723840|584030428|FG000|Overall Study|Unspecified reason|2|||
161723207|NCT01426386|584030429|FG000|Overall Study|Adverse Event|0|||
161723208|NCT01426386|584030430|FG001|Overall Study|Adverse Event|1|||
161723209|NCT01426386|584030431|FG002|Overall Study|Adverse Event|0|||
161723210|NCT01426386|584030432|FG003|Overall Study|Adverse Event|0|||
161723211|NCT01426386|584030433|FG004|Overall Study|Adverse Event|0|||
161723212|NCT01426386|584030434|FG005|Overall Study|Adverse Event|0|||
161723213|NCT01426386|584030429|FG000|Overall Study|Did not attend scheduled visit|1|||
161723214|NCT01426386|584030430|FG001|Overall Study|Did not attend scheduled visit|4|||
161723215|NCT01426386|584030431|FG002|Overall Study|Did not attend scheduled visit|0|||
161723216|NCT01426386|584030432|FG003|Overall Study|Did not attend scheduled visit|0|||
161723217|NCT01426386|584030433|FG004|Overall Study|Did not attend scheduled visit|2|||
161723218|NCT01426386|584030434|FG005|Overall Study|Did not attend scheduled visit|1|||
161723219|NCT01426386|584030429|FG000|Overall Study|Poor response|2|||
161723220|NCT01426386|584030430|FG001|Overall Study|Poor response|1|||
161723221|NCT01426386|584030431|FG002|Overall Study|Poor response|2|||
161723222|NCT01426386|584030432|FG003|Overall Study|Poor response|0|||
161723223|NCT01426386|584030433|FG004|Overall Study|Poor response|1|||
161723224|NCT01426386|584030434|FG005|Overall Study|Poor response|0|||
161723225|NCT01426386|584030429|FG000|Overall Study|Personal reasons|0|||
161723226|NCT01426386|584030430|FG001|Overall Study|Personal reasons|0|||
161723227|NCT01426386|584030431|FG002|Overall Study|Personal reasons|0|||
161723228|NCT01426386|584030432|FG003|Overall Study|Personal reasons|0|||
161723229|NCT01426386|584030433|FG004|Overall Study|Personal reasons|1|||
161723230|NCT01426386|584030434|FG005|Overall Study|Personal reasons|0|||
161723231|NCT03694522|584030435|FG000|Overall Study|Withdrawal by Subject|8|||
161723232|NCT03694522|584030436|FG001|Overall Study|Withdrawal by Subject|10|||
161723233|NCT03694522|584030435|FG000|Overall Study|Physician Decision|53|||
161723234|NCT03694522|584030436|FG001|Overall Study|Physician Decision|54|||
161723235|NCT03694522|584030435|FG000|Overall Study|Other|1|||
161723236|NCT03694522|584030436|FG001|Overall Study|Other|1|||
161723237|NCT03694522|584030435|FG000|Overall Study|Lost to Follow-up|0|||
161723238|NCT03694522|584030436|FG001|Overall Study|Lost to Follow-up|1|||
161723239|NCT02760407|584030437|FG000|Overall Study|Death|2|||
161723240|NCT02760407|584030438|FG001|Overall Study|Death|3|||
161723241|NCT02760407|584030439|FG002|Overall Study|Death|1|||
161723242|NCT02760407|584030440|FG003|Overall Study|Death|1|||
161723243|NCT02760407|584030437|FG000|Overall Study|Lost to Follow-up|1|||
161723244|NCT02760407|584030438|FG001|Overall Study|Lost to Follow-up|7|||
161723245|NCT02760407|584030439|FG002|Overall Study|Lost to Follow-up|4|||
161723246|NCT02760407|584030440|FG003|Overall Study|Lost to Follow-up|6|||
161723247|NCT02760407|584030437|FG000|Overall Study|Withdrawal by Subject|25|||
161723248|NCT02760407|584030438|FG001|Overall Study|Withdrawal by Subject|31|||
161723249|NCT02760407|584030439|FG002|Overall Study|Withdrawal by Subject|37|||
161723250|NCT02760407|584030440|FG003|Overall Study|Withdrawal by Subject|25|||
161723251|NCT02760407|584030437|FG000|Overall Study|Violation of Eligibility criteria|0|||
161723252|NCT02760407|584030438|FG001|Overall Study|Violation of Eligibility criteria|0|||
161723253|NCT02760407|584030439|FG002|Overall Study|Violation of Eligibility criteria|1|||
161723254|NCT02760407|584030440|FG003|Overall Study|Violation of Eligibility criteria|1|||
161723255|NCT02760407|584030437|FG000|Overall Study|Personal reasons|0|||
161723256|NCT02760407|584030438|FG001|Overall Study|Personal reasons|0|||
161723257|NCT02760407|584030439|FG002|Overall Study|Personal reasons|0|||
161723258|NCT02760407|584030440|FG003|Overall Study|Personal reasons|1|||
161723259|NCT02760407|584030437|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
161723260|NCT02760407|584030438|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161723261|NCT02760407|584030439|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161723262|NCT02760407|584030440|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161723263|NCT02760407|584030437|FG000|Overall Study|Use of prohibited Medication|0|||
161723264|NCT02760407|584030438|FG001|Overall Study|Use of prohibited Medication|0|||
161723265|NCT02760407|584030439|FG002|Overall Study|Use of prohibited Medication|1|||
161723266|NCT02760407|584030440|FG003|Overall Study|Use of prohibited Medication|0|||
161723267|NCT02760407|584030437|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161723268|NCT02760407|584030438|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161723269|NCT02760407|584030439|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
161723270|NCT02760407|584030440|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161723271|NCT02760407|584030437|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
161723272|NCT02760407|584030438|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161723273|NCT02760407|584030439|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161723274|NCT02760407|584030440|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161723275|NCT02760407|584030437|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
161723276|NCT02760407|584030438|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
161723277|NCT02760407|584030439|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
161723278|NCT02760407|584030440|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
161723279|NCT02760407|584030437|FG000|Overall Study|Inadequately Enrolled|0|||
161723280|NCT02760407|584030438|FG001|Overall Study|Inadequately Enrolled|0|||
161723281|NCT02760407|584030439|FG002|Overall Study|Inadequately Enrolled|0|||
161723282|NCT02760407|584030440|FG003|Overall Study|Inadequately Enrolled|1|||
161723283|NCT02760407|584030437|FG000|Overall Study|Withdrawal By PI's Decision|0|||
161723284|NCT02760407|584030438|FG001|Overall Study|Withdrawal By PI's Decision|1|||
161723285|NCT02760407|584030439|FG002|Overall Study|Withdrawal By PI's Decision|0|||
161723286|NCT02760407|584030440|FG003|Overall Study|Withdrawal By PI's Decision|0|||
161723287|NCT02760407|584030437|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
161723288|NCT02760407|584030438|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
161723289|NCT02760407|584030439|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
161723290|NCT02760407|584030440|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
161723291|NCT02760407|584030437|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161723292|NCT02760407|584030438|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161723293|NCT02760407|584030439|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
161723294|NCT02760407|584030440|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161723295|NCT02760407|584030437|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
161723296|NCT02760407|584030438|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161723297|NCT02760407|584030439|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161723298|NCT02760407|584030440|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161723299|NCT02760407|584030437|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
161723300|NCT02760407|584030438|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
161723301|NCT02760407|584030439|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
161723302|NCT02760407|584030440|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
161723303|NCT02760407|584030437|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
161723304|NCT02760407|584030438|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161723305|NCT02760407|584030439|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161723306|NCT02760407|584030440|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161723307|NCT02760407|584030437|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
161723308|NCT02760407|584030438|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161723309|NCT02760407|584030439|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161723310|NCT02760407|584030440|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161723311|NCT02760407|584030437|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
161723312|NCT02760407|584030438|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
161723313|NCT02760407|584030439|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
161723314|NCT02760407|584030440|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
161723315|NCT02760407|584030437|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
161723316|NCT02760407|584030438|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161723317|NCT02760407|584030439|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161723318|NCT02760407|584030440|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161723319|NCT02760407|584030437|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
161723320|NCT02760407|584030438|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
161723321|NCT02760407|584030439|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
161723322|NCT02760407|584030440|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
161723323|NCT02522377|584030441|FG000|Overall Study|Withdrawal by Subject|1|||
161723324|NCT02522377|584030442|FG001|Overall Study|Withdrawal by Subject|0|||
161723325|NCT02522377|584030441|FG000|Overall Study|Remission Achieved|3|||
161723326|NCT02522377|584030442|FG001|Overall Study|Remission Achieved|0|||
161723327|NCT01158950|584030443|FG000|1st Intervention (1 Day)|Physician Decision|1|||
161723328|NCT01158950|584030444|FG001|1st Intervention (1 Day)|Physician Decision|2|||
161723329|NCT00945191|584030445|FG000|Overall Study|Did not achieve a complete response|18|||
161723330|NCT00945191|584030445|FG000|Overall Study|Participant relocated to another state|1|||
161723331|NCT00945191|584030445|FG000|Overall Study|Disease progression|3|||
161723332|NCT00945191|584030445|FG000|Overall Study|Serious adverse event or adverse event|1|||
161723333|NCT00945191|584030445|FG000|Overall Study|Investigator's discretion|1|||
161723334|NCT02137772|584030453|FG000|Overall Study|Adverse Event|6|||
161723335|NCT02137772|584030454|FG001|Overall Study|Adverse Event|3|||
161723336|NCT02137772|584030453|FG000|Overall Study|Death|71|||
161723337|NCT02137772|584030454|FG001|Overall Study|Death|44|||
161723338|NCT02137772|584030453|FG000|Overall Study|Lost to Follow-up|8|||
161723339|NCT02137772|584030454|FG001|Overall Study|Lost to Follow-up|4|||
161723340|NCT02137772|584030453|FG000|Overall Study|Physician Decision|15|||
161723341|NCT02137772|584030454|FG001|Overall Study|Physician Decision|5|||
161723342|NCT02137772|584030453|FG000|Overall Study|Withdrawal by Subject|28|||
161723343|NCT02137772|584030454|FG001|Overall Study|Withdrawal by Subject|17|||
161723344|NCT02137772|584030453|FG000|Overall Study|Non-compliance with study drug|1|||
161723345|NCT02137772|584030454|FG001|Overall Study|Non-compliance with study drug|0|||
161723346|NCT02137772|584030453|FG000|Overall Study|Not treated|3|||
161723347|NCT02137772|584030454|FG001|Overall Study|Not treated|2|||
161723348|NCT01844700|584030456|FG000|Overall Study|Lack of Efficacy|1|||
161723349|NCT01844700|584030457|FG001|Overall Study|Lack of Efficacy|0|||
161723350|NCT01844700|584030456|FG000|Overall Study|refused medication switch|1|||
161723351|NCT01844700|584030457|FG001|Overall Study|refused medication switch|0|||
161723352|NCT01844700|584030456|FG000|Overall Study|Withdrawal by Subject|1|||
161723353|NCT01844700|584030457|FG001|Overall Study|Withdrawal by Subject|0|||
161723354|NCT01844700|584030456|FG000|Overall Study|stopped taking meds|0|||
161723355|NCT01844700|584030457|FG001|Overall Study|stopped taking meds|1|||
161723356|NCT00863928|584030458|FG000|Overall Study|Protocol Violation|26|||
161723357|NCT00863928|584030459|FG001|Overall Study|Protocol Violation|0|||
161723358|NCT00863928|584030458|FG000|Overall Study|Withdrawal by Subject|3|||
161723359|NCT00863928|584030459|FG001|Overall Study|Withdrawal by Subject|0|||
161723360|NCT00863928|584030458|FG000|Overall Study|surgery cancellation|4|||
161723361|NCT00863928|584030459|FG001|Overall Study|surgery cancellation|0|||
161723362|NCT00863928|584030458|FG000|Overall Study|medication allergy|3|||
161723363|NCT00863928|584030459|FG001|Overall Study|medication allergy|0|||
161723364|NCT03290300|584030460|FG000|Overall Study|Lost to Follow-up|3|||
161723365|NCT02124798|584030461|FG000|Overall Study|Adverse Event|3|||
161723366|NCT02124798|584030461|FG000|Overall Study|Lost to Follow-up|1|||
161723367|NCT01797432|584030462|FG000|Overall Study|Lost to Follow-up|1|||
161723368|NCT01797432|584030462|FG000|Overall Study|Adverse Event|1|||
161723369|NCT01797432|584030462|FG000|Overall Study|Withdrawal by Subject|1|||
161723370|NCT01797432|584030462|FG000|Overall Study|lived too far from study site|1|||
161723371|NCT02792777|584030463|FG000|Overall Study|Withdrawal by Subject|2|||
161723372|NCT02792777|584030464|FG001|Overall Study|Withdrawal by Subject|0|||
161723373|NCT02792777|584030463|FG000|Overall Study|Recording malfunction|2|||
161723374|NCT02792777|584030464|FG001|Overall Study|Recording malfunction|0|||
161723375|NCT02792777|584030463|FG000|Overall Study|Later determined to be ineligible|2|||
161723376|NCT02792777|584030464|FG001|Overall Study|Later determined to be ineligible|0|||
161723377|NCT02792777|584030463|FG000|Overall Study|Participant interviewed twice|1|||
161723378|NCT02792777|584030464|FG001|Overall Study|Participant interviewed twice|0|||
161723379|NCT02795156|584030465|FG000|Overall Study|Progressive Disease|22|||
161723380|NCT02795156|584030466|FG001|Overall Study|Progressive Disease|7|||
161723381|NCT02795156|584030467|FG002|Overall Study|Progressive Disease|34|||
161723382|NCT02795156|584030468|FG003|Overall Study|Progressive Disease|7|||
161723383|NCT02795156|584030465|FG000|Overall Study|Adverse Event|13|||
161723384|NCT02795156|584030466|FG001|Overall Study|Adverse Event|2|||
161723385|NCT02795156|584030467|FG002|Overall Study|Adverse Event|3|||
161723386|NCT02795156|584030468|FG003|Overall Study|Adverse Event|2|||
161723387|NCT02795156|584030465|FG000|Overall Study|Death|1|||
161723388|NCT02795156|584030466|FG001|Overall Study|Death|1|||
161723389|NCT02795156|584030467|FG002|Overall Study|Death|1|||
161723390|NCT02795156|584030468|FG003|Overall Study|Death|0|||
161723391|NCT02795156|584030465|FG000|Overall Study|Physician Decision|1|||
161723392|NCT02795156|584030466|FG001|Overall Study|Physician Decision|0|||
161723393|NCT02795156|584030467|FG002|Overall Study|Physician Decision|1|||
161723394|NCT02795156|584030468|FG003|Overall Study|Physician Decision|0|||
161723395|NCT02795156|584030465|FG000|Overall Study|Withdrawal by Subject|2|||
161723396|NCT02795156|584030466|FG001|Overall Study|Withdrawal by Subject|0|||
161723397|NCT02795156|584030467|FG002|Overall Study|Withdrawal by Subject|3|||
161723398|NCT02795156|584030468|FG003|Overall Study|Withdrawal by Subject|0|||
161723399|NCT00638846|584030472|FG000|Overall Study|Adverse Event|0|||
161723400|NCT00638846|584030473|FG001|Overall Study|Adverse Event|1|||
161723401|NCT00638846|584030472|FG000|Overall Study|Lost to Follow-up|3|||
161723402|NCT00638846|584030473|FG001|Overall Study|Lost to Follow-up|2|||
161723403|NCT00638846|584030472|FG000|Overall Study|lens issue|1|||
161723404|NCT00638846|584030473|FG001|Overall Study|lens issue|3|||
161723405|NCT02746679|584030481|FG000|Overall Study|Lost to Follow-up|4|||
161723406|NCT02746679|584030482|FG001|Overall Study|Lost to Follow-up|6|||
161723407|NCT00487279|584030483|FG000|Overall Study|Death|1|||
161723408|NCT00487279|584030484|FG001|Overall Study|Death|0|||
161723409|NCT00487279|584030483|FG000|Overall Study|Withdrawal by Subject|0|||
161723410|NCT00487279|584030484|FG001|Overall Study|Withdrawal by Subject|2|||
161723411|NCT01171521|584030487|FG000|Overall Study|Lost to Follow-up|5|||
161723412|NCT01171521|584030487|FG000|Overall Study|screen failure|1|||
161723413|NCT00492921|584030488|FG000|Overall Study|Death|1|||
161723414|NCT00492921|584030489|FG001|Overall Study|Death|0|||
161723415|NCT00492921|584030490|FG002|Overall Study|Death|1|||
161723416|NCT00652093|584030491|FG000|Overall Study|Withdrawal by Subject|0|||
161723417|NCT00652093|584030492|FG001|Overall Study|Withdrawal by Subject|0|||
161723418|NCT00652093|584030493|FG002|Overall Study|Withdrawal by Subject|1|||
161723419|NCT00652093|584030494|FG003|Overall Study|Withdrawal by Subject|0|||
161723420|NCT00652093|584030495|FG004|Overall Study|Withdrawal by Subject|1|||
161723421|NCT00652093|584030496|FG005|Overall Study|Withdrawal by Subject|0|||
161723422|NCT00652093|584030491|FG000|Overall Study|Physician Decision|0|||
161723423|NCT00652093|584030492|FG001|Overall Study|Physician Decision|0|||
161723424|NCT00652093|584030493|FG002|Overall Study|Physician Decision|0|||
161723425|NCT00652093|584030494|FG003|Overall Study|Physician Decision|0|||
161723426|NCT00652093|584030495|FG004|Overall Study|Physician Decision|1|||
161723427|NCT00652093|584030496|FG005|Overall Study|Physician Decision|0|||
161723428|NCT01520922|584030500|FG000|Treatment Phase|Physician Decision|2|||
161723429|NCT01520922|584030501|FG001|Treatment Phase|Physician Decision|1|||
161723430|NCT01520922|584030500|FG000|Treatment Phase|Progression|0|||
161723431|NCT01520922|584030501|FG001|Treatment Phase|Progression|2|||
161723432|NCT01520922|584030500|FG000|Treatment Phase|Adverse Event|3|||
161723433|NCT01520922|584030501|FG001|Treatment Phase|Adverse Event|5|||
161723434|NCT01520922|584030500|FG000|Follow up|Lost to Follow-up|0|||
161723435|NCT01520922|584030501|FG001|Follow up|Lost to Follow-up|1|||
161723436|NCT01520922|584030500|FG000|Survival Follow-up|Withdrawal by Subject|1|||
161723437|NCT01520922|584030501|FG001|Survival Follow-up|Withdrawal by Subject|0|||
161723438|NCT01696877|584030502|FG000|Overall Study|Adverse Event|0|||
161723439|NCT01696877|584030503|FG001|Overall Study|Adverse Event|1|||
161723440|NCT01422304|584030508|FG000|Overall Study|Adverse Event|0|||
161723441|NCT01422304|584030509|FG001|Overall Study|Adverse Event|1|||
161723442|NCT01422304|584030508|FG000|Overall Study|Lost to Follow-up|14|||
161723443|NCT01422304|584030509|FG001|Overall Study|Lost to Follow-up|20|||
161723444|NCT01422304|584030508|FG000|Overall Study|Never Entered Follow-up|2|||
161723445|NCT01422304|584030509|FG001|Overall Study|Never Entered Follow-up|1|||
161723446|NCT01422304|584030508|FG000|Overall Study|Protocol Violation|1|||
161723447|NCT01422304|584030509|FG001|Overall Study|Protocol Violation|0|||
161723448|NCT01422304|584030508|FG000|Overall Study|Withdrawal by Subject|4|||
161723449|NCT01422304|584030509|FG001|Overall Study|Withdrawal by Subject|2|||
161723450|NCT01422304|584030508|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161723451|NCT01422304|584030509|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
161723452|NCT01422304|584030508|FG000|Overall Study|Not Treated|3|||
161723453|NCT01422304|584030509|FG001|Overall Study|Not Treated|11|||
161723454|NCT00469014|584030512|FG000|Initial Phase Randomization|Disease Progression|0|||
161723455|NCT00469014|584030513|FG001|Initial Phase Randomization|Disease Progression|1|||
161723456|NCT00469014|584030514|FG002|Initial Phase Randomization|Disease Progression|1|||
161723457|NCT00469014|584030515|FG003|Initial Phase Randomization|Disease Progression|0|||
161723458|NCT00469014|584030512|FG000|Initial Phase Randomization|No Response|1|||
161723459|NCT00469014|584030513|FG001|Initial Phase Randomization|No Response|0|||
161723460|NCT00469014|584030514|FG002|Initial Phase Randomization|No Response|0|||
161723461|NCT00469014|584030515|FG003|Initial Phase Randomization|No Response|1|||
161723462|NCT00469014|584030512|FG000|Adaptive Randomization|Not Evaluable|1|||
161723463|NCT00469014|584030513|FG001|Adaptive Randomization|Not Evaluable|0|||
161723464|NCT00469014|584030514|FG002|Adaptive Randomization|Not Evaluable|0|||
161723465|NCT00469014|584030515|FG003|Adaptive Randomization|Not Evaluable|1|||
161723466|NCT00469014|584030512|FG000|Adaptive Randomization|No Response|0|||
161723467|NCT00469014|584030513|FG001|Adaptive Randomization|No Response|1|||
161723468|NCT00469014|584030514|FG002|Adaptive Randomization|No Response|0|||
161723469|NCT00469014|584030515|FG003|Adaptive Randomization|No Response|0|||
161723470|NCT00469014|584030512|FG000|Adaptive Randomization|Death|0|||
161723471|NCT00469014|584030513|FG001|Adaptive Randomization|Death|0|||
161723472|NCT00469014|584030514|FG002|Adaptive Randomization|Death|1|||
161723473|NCT00469014|584030515|FG003|Adaptive Randomization|Death|0|||
161723474|NCT03461289|584030519|FG000|Overall Study|Death|1|||
161723475|NCT03241173|584030520|FG000|Overall Study|Death|3|||
161723476|NCT03241173|584030521|FG001|Overall Study|Death|2|||
161723477|NCT03241173|584030522|FG002|Overall Study|Death|4|||
161723478|NCT03241173|584030523|FG003|Overall Study|Death|4|||
161723479|NCT03241173|584030524|FG004|Overall Study|Death|2|||
161723480|NCT03241173|584030525|FG005|Overall Study|Death|2|||
161723481|NCT03241173|584030526|FG006|Overall Study|Death|3|||
161723482|NCT03241173|584030527|FG007|Overall Study|Death|1|||
161723483|NCT03241173|584030528|FG008|Overall Study|Death|0|||
161723484|NCT03241173|584030529|FG009|Overall Study|Death|5|||
161723485|NCT03241173|584030530|FG010|Overall Study|Death|4|||
161723486|NCT03241173|584030531|FG011|Overall Study|Death|3|||
161723487|NCT03241173|584030532|FG012|Overall Study|Death|0|||
161723488|NCT03241173|584030533|FG013|Overall Study|Death|0|||
161723489|NCT03241173|584030534|FG014|Overall Study|Death|0|||
161723490|NCT03241173|584030520|FG000|Overall Study|Withdrawal by Subject|0|||
161723491|NCT03241173|584030521|FG001|Overall Study|Withdrawal by Subject|0|||
161723492|NCT03241173|584030522|FG002|Overall Study|Withdrawal by Subject|1|||
161723493|NCT03241173|584030523|FG003|Overall Study|Withdrawal by Subject|0|||
161723494|NCT03241173|584030524|FG004|Overall Study|Withdrawal by Subject|0|||
161723495|NCT03241173|584030525|FG005|Overall Study|Withdrawal by Subject|1|||
161723496|NCT03241173|584030526|FG006|Overall Study|Withdrawal by Subject|0|||
161723497|NCT03241173|584030527|FG007|Overall Study|Withdrawal by Subject|0|||
161723498|NCT03241173|584030528|FG008|Overall Study|Withdrawal by Subject|0|||
161723499|NCT03241173|584030529|FG009|Overall Study|Withdrawal by Subject|0|||
161723500|NCT03241173|584030530|FG010|Overall Study|Withdrawal by Subject|0|||
161723501|NCT03241173|584030531|FG011|Overall Study|Withdrawal by Subject|0|||
161723502|NCT03241173|584030532|FG012|Overall Study|Withdrawal by Subject|0|||
161723503|NCT03241173|584030533|FG013|Overall Study|Withdrawal by Subject|0|||
161723504|NCT03241173|584030534|FG014|Overall Study|Withdrawal by Subject|0|||
161723505|NCT03241173|584030520|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723506|NCT03241173|584030521|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723507|NCT03241173|584030522|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723508|NCT03241173|584030523|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723509|NCT03241173|584030524|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723510|NCT03241173|584030525|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723511|NCT03241173|584030526|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723512|NCT03241173|584030527|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723513|NCT03241173|584030528|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723514|NCT03241173|584030529|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723515|NCT03241173|584030530|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723516|NCT03241173|584030531|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
161723517|NCT03241173|584030532|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723518|NCT03241173|584030533|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723519|NCT03241173|584030534|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723520|NCT03241173|584030520|FG000|Overall Study|Lost to Follow-up|0|||
161723521|NCT03241173|584030521|FG001|Overall Study|Lost to Follow-up|0|||
161723522|NCT03241173|584030522|FG002|Overall Study|Lost to Follow-up|0|||
161723523|NCT03241173|584030523|FG003|Overall Study|Lost to Follow-up|0|||
161723524|NCT03241173|584030524|FG004|Overall Study|Lost to Follow-up|1|||
161723525|NCT03241173|584030525|FG005|Overall Study|Lost to Follow-up|0|||
161723526|NCT03241173|584030526|FG006|Overall Study|Lost to Follow-up|0|||
161723527|NCT03241173|584030527|FG007|Overall Study|Lost to Follow-up|0|||
161723528|NCT03241173|584030528|FG008|Overall Study|Lost to Follow-up|0|||
161723529|NCT03241173|584030529|FG009|Overall Study|Lost to Follow-up|1|||
161723530|NCT03241173|584030530|FG010|Overall Study|Lost to Follow-up|0|||
161723531|NCT03241173|584030531|FG011|Overall Study|Lost to Follow-up|0|||
161723532|NCT03241173|584030532|FG012|Overall Study|Lost to Follow-up|0|||
161723533|NCT03241173|584030533|FG013|Overall Study|Lost to Follow-up|0|||
161723534|NCT03241173|584030534|FG014|Overall Study|Lost to Follow-up|0|||
161723535|NCT00564629|584030535|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
161723536|NCT00564629|584030536|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
161723537|NCT00515463|584030537|FG000|Overall Study|Physician Decision|4|||
161723538|NCT00515463|584030538|FG001|Overall Study|Physician Decision|2|||
161723539|NCT00515463|584030537|FG000|Overall Study|Adverse Event|1|||
161723540|NCT00515463|584030538|FG001|Overall Study|Adverse Event|2|||
161723541|NCT00515463|584030537|FG000|Overall Study|Withdrawal by Subject|3|||
161723542|NCT00515463|584030538|FG001|Overall Study|Withdrawal by Subject|4|||
161723543|NCT00515463|584030537|FG000|Overall Study|Lost to Follow-up|6|||
161723544|NCT00515463|584030538|FG001|Overall Study|Lost to Follow-up|5|||
161723545|NCT00515463|584030537|FG000|Overall Study|Other|0|||
161723546|NCT00515463|584030538|FG001|Overall Study|Other|1|||
161723547|NCT01519427|584030539|FG000|Overall Study|disease progression|2|||
161723548|NCT00633139|584030549|FG000|Overall Study|Non compliance|0|||
161723549|NCT00633139|584030550|FG001|Overall Study|Non compliance|0|||
161723550|NCT00633139|584030551|FG002|Overall Study|Non compliance|1|||
161723551|NCT00633139|584030549|FG000|Overall Study|Withdrawal by Subject|0|||
161723552|NCT00633139|584030550|FG001|Overall Study|Withdrawal by Subject|1|||
161723553|NCT00633139|584030551|FG002|Overall Study|Withdrawal by Subject|0|||
161723554|NCT02269319|584030552|FG000|Overall Study|Lost to Follow-up|4|||
161723555|NCT02269319|584030553|FG001|Overall Study|Lost to Follow-up|3|||
161723556|NCT02269319|584030552|FG000|Overall Study|Adverse Event|0|||
161723557|NCT02269319|584030553|FG001|Overall Study|Adverse Event|1|||
161723558|NCT02269319|584030552|FG000|Overall Study|Instructions not followed|1|||
161723559|NCT02269319|584030553|FG001|Overall Study|Instructions not followed|0|||
161723560|NCT01507246|584030554|FG000|Overall Study|Required different surgical procedures|2|||
161723561|NCT01507246|584030555|FG001|Overall Study|Required different surgical procedures|1|||
161723562|NCT03103750|584030556|FG000|Overall Study|Adverse Event|1|||
161723563|NCT03103750|584030557|FG001|Overall Study|Adverse Event|0|||
161723564|NCT03103750|584030556|FG000|Overall Study|Lost to Follow-up|1|||
161723565|NCT03103750|584030557|FG001|Overall Study|Lost to Follow-up|0|||
161723566|NCT03103750|584030556|FG000|Overall Study|PET Equipment Related|2|||
161723567|NCT03103750|584030557|FG001|Overall Study|PET Equipment Related|2|||
161723568|NCT03575468|584030561|FG000|Overall Study|Withdrawal by Subject|3|||
161723569|NCT03575468|584030562|FG001|Overall Study|Withdrawal by Subject|0|||
161723570|NCT03575468|584030561|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
161723571|NCT03575468|584030562|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
161723572|NCT03575468|584030561|FG000|Overall Study|Lost to Follow-up|13|||
161723573|NCT03575468|584030562|FG001|Overall Study|Lost to Follow-up|17|||
161723574|NCT01522651|584030565|FG000|Overall Study|Adverse Event|3|||
161723575|NCT01522651|584030566|FG001|Overall Study|Adverse Event|4|||
161723576|NCT01522651|584030567|FG002|Overall Study|Adverse Event|4|||
161723577|NCT01522651|584030568|FG003|Overall Study|Adverse Event|5|||
161723578|NCT01522651|584030569|FG004|Overall Study|Adverse Event|4|||
161723579|NCT01522651|584030565|FG000|Overall Study|Cardioversion|1|||
161723580|NCT01522651|584030566|FG001|Overall Study|Cardioversion|0|||
161723581|NCT01522651|584030567|FG002|Overall Study|Cardioversion|0|||
161723582|NCT01522651|584030568|FG003|Overall Study|Cardioversion|0|||
161723583|NCT01522651|584030569|FG004|Overall Study|Cardioversion|0|||
161723584|NCT01522651|584030565|FG000|Overall Study|Device Malfunction|0|||
161723585|NCT01522651|584030566|FG001|Overall Study|Device Malfunction|1|||
161723586|NCT01522651|584030567|FG002|Overall Study|Device Malfunction|0|||
161723587|NCT01522651|584030568|FG003|Overall Study|Device Malfunction|0|||
161723588|NCT01522651|584030569|FG004|Overall Study|Device Malfunction|0|||
161723589|NCT01522651|584030565|FG000|Overall Study|Investigator's Discretion|0|||
161723590|NCT01522651|584030566|FG001|Overall Study|Investigator's Discretion|1|||
161723591|NCT01522651|584030567|FG002|Overall Study|Investigator's Discretion|0|||
161723592|NCT01522651|584030568|FG003|Overall Study|Investigator's Discretion|0|||
161723593|NCT01522651|584030569|FG004|Overall Study|Investigator's Discretion|0|||
161723594|NCT01522651|584030565|FG000|Overall Study|Protocol Violation|3|||
161723595|NCT01522651|584030566|FG001|Overall Study|Protocol Violation|0|||
161723596|NCT01522651|584030567|FG002|Overall Study|Protocol Violation|0|||
161723597|NCT01522651|584030568|FG003|Overall Study|Protocol Violation|0|||
161723598|NCT01522651|584030569|FG004|Overall Study|Protocol Violation|0|||
161723599|NCT01522651|584030565|FG000|Overall Study|Reason Not Specified|0|||
161723600|NCT01522651|584030566|FG001|Overall Study|Reason Not Specified|0|||
161723601|NCT01522651|584030567|FG002|Overall Study|Reason Not Specified|0|||
161723602|NCT01522651|584030568|FG003|Overall Study|Reason Not Specified|1|||
161723603|NCT01522651|584030569|FG004|Overall Study|Reason Not Specified|0|||
161723604|NCT01522651|584030565|FG000|Overall Study|Participant Non-Compliance|1|||
161723605|NCT01522651|584030566|FG001|Overall Study|Participant Non-Compliance|0|||
161723606|NCT01522651|584030567|FG002|Overall Study|Participant Non-Compliance|0|||
161723607|NCT01522651|584030568|FG003|Overall Study|Participant Non-Compliance|0|||
161723608|NCT01522651|584030569|FG004|Overall Study|Participant Non-Compliance|0|||
161723609|NCT01522651|584030565|FG000|Overall Study|Withdrew Consent|1|||
161723610|NCT01522651|584030566|FG001|Overall Study|Withdrew Consent|1|||
161723611|NCT01522651|584030567|FG002|Overall Study|Withdrew Consent|0|||
161723612|NCT01522651|584030568|FG003|Overall Study|Withdrew Consent|1|||
161723613|NCT01522651|584030569|FG004|Overall Study|Withdrew Consent|1|||
161723614|NCT01522651|584030565|FG000|Overall Study|Randomized but Never Treated|0|||
161723615|NCT01522651|584030566|FG001|Overall Study|Randomized but Never Treated|1|||
161723616|NCT01522651|584030567|FG002|Overall Study|Randomized but Never Treated|0|||
161723617|NCT01522651|584030568|FG003|Overall Study|Randomized but Never Treated|1|||
161723618|NCT01522651|584030569|FG004|Overall Study|Randomized but Never Treated|1|||
161723619|NCT02115815|584032205|FG000|Overall Study|Withdrawal by Subject|2|||
161723620|NCT02115815|584032206|FG001|Overall Study|Withdrawal by Subject|0|||
161723621|NCT02115815|584032207|FG002|Overall Study|Withdrawal by Subject|0|||
161723622|NCT02115815|584032208|FG003|Overall Study|Withdrawal by Subject|0|||
161723623|NCT02115815|584032209|FG004|Overall Study|Withdrawal by Subject|0|||
161723624|NCT02115815|584032210|FG005|Overall Study|Withdrawal by Subject|0|||
161723625|NCT02115815|584032211|FG006|Overall Study|Withdrawal by Subject|0|||
161723626|NCT02115815|584032205|FG000|Overall Study|Not enough drug to dose participant|0|||
161723627|NCT02115815|584032206|FG001|Overall Study|Not enough drug to dose participant|0|||
161723628|NCT02115815|584032207|FG002|Overall Study|Not enough drug to dose participant|0|||
161723629|NCT02115815|584032208|FG003|Overall Study|Not enough drug to dose participant|0|||
161723630|NCT02115815|584032209|FG004|Overall Study|Not enough drug to dose participant|0|||
161723631|NCT02115815|584032210|FG005|Overall Study|Not enough drug to dose participant|1|||
161723632|NCT02115815|584032211|FG006|Overall Study|Not enough drug to dose participant|0|||
161723633|NCT02115815|584032205|FG000|Overall Study|Missed appointment, randomized in error|0|||
161723634|NCT02115815|584032206|FG001|Overall Study|Missed appointment, randomized in error|0|||
161723635|NCT02115815|584032207|FG002|Overall Study|Missed appointment, randomized in error|0|||
161723636|NCT02115815|584032208|FG003|Overall Study|Missed appointment, randomized in error|0|||
161723637|NCT02115815|584032209|FG004|Overall Study|Missed appointment, randomized in error|0|||
161723638|NCT02115815|584032210|FG005|Overall Study|Missed appointment, randomized in error|1|||
161723639|NCT02115815|584032211|FG006|Overall Study|Missed appointment, randomized in error|0|||
161723640|NCT01989546|584032212|FG000|Overall Study|Clinical Progression|1|||
161723641|NCT01989546|584032212|FG000|Overall Study|Disease progression on study|8|||
161723642|NCT02819310|584032213|FG000|Overall Study|Withdrawal by Subject|37|||
161723643|NCT02819310|584032213|FG000|Overall Study|Lost to Follow-up|16|||
161723644|NCT02819310|584032213|FG000|Overall Study|Adverse Event|13|||
161723645|NCT02819310|584032213|FG000|Overall Study|Lack of Efficacy|5|||
161723646|NCT02819310|584032213|FG000|Overall Study|Physician Decision|8|||
161723647|NCT02819310|584032213|FG000|Overall Study|Protocol Violation|30|||
161723648|NCT00059215|584032216|FG000|Overall Study|Adverse Event|5|||
161723649|NCT00059215|584032217|FG001|Overall Study|Adverse Event|5|||
161723650|NCT00059215|584032218|FG002|Overall Study|Adverse Event|9|||
161723651|NCT00059215|584032219|FG003|Overall Study|Adverse Event|9|||
161723652|NCT00059215|584032216|FG000|Overall Study|Death|0|||
161723653|NCT00059215|584032217|FG001|Overall Study|Death|0|||
161723654|NCT00059215|584032218|FG002|Overall Study|Death|3|||
161723655|NCT00059215|584032219|FG003|Overall Study|Death|0|||
161723656|NCT00059215|584032216|FG000|Overall Study|Lost to Follow-up|1|||
161723657|NCT00059215|584032217|FG001|Overall Study|Lost to Follow-up|2|||
161723658|NCT00059215|584032218|FG002|Overall Study|Lost to Follow-up|0|||
161723659|NCT00059215|584032219|FG003|Overall Study|Lost to Follow-up|0|||
161723660|NCT00059215|584032216|FG000|Overall Study|Withdrawal by Subject|4|||
161723661|NCT00059215|584032217|FG001|Overall Study|Withdrawal by Subject|4|||
161723662|NCT00059215|584032218|FG002|Overall Study|Withdrawal by Subject|1|||
161723663|NCT00059215|584032219|FG003|Overall Study|Withdrawal by Subject|3|||
161723664|NCT00059215|584032216|FG000|Overall Study|Protocol Violation|1|||
161723665|NCT00059215|584032217|FG001|Overall Study|Protocol Violation|0|||
161723666|NCT00059215|584032218|FG002|Overall Study|Protocol Violation|1|||
161723667|NCT00059215|584032219|FG003|Overall Study|Protocol Violation|0|||
161723668|NCT00059215|584032216|FG000|Overall Study|Protocol entry criteria not met|1|||
161723669|NCT00059215|584032217|FG001|Overall Study|Protocol entry criteria not met|1|||
161723670|NCT00059215|584032218|FG002|Overall Study|Protocol entry criteria not met|0|||
161723671|NCT00059215|584032219|FG003|Overall Study|Protocol entry criteria not met|2|||
161723672|NCT00059215|584032216|FG000|Overall Study|Physician Decision|1|||
161723673|NCT00059215|584032217|FG001|Overall Study|Physician Decision|2|||
161723674|NCT00059215|584032218|FG002|Overall Study|Physician Decision|1|||
161723675|NCT00059215|584032219|FG003|Overall Study|Physician Decision|1|||
161723676|NCT04494633|584032221|FG000|Overall Study|Lost to Follow-up|5|||
161723677|NCT04494633|584032222|FG001|Overall Study|Lost to Follow-up|3|||
161723678|NCT04494633|584032221|FG000|Overall Study|Protocol Violation|1|||
161723679|NCT04494633|584032222|FG001|Overall Study|Protocol Violation|1|||
161723680|NCT01254604|584032225|FG000|Overall Study|Lost to Follow-up|1|||
161723681|NCT01254604|584032226|FG001|Overall Study|Lost to Follow-up|1|||
161723682|NCT01254604|584032225|FG000|Overall Study|Protocol Violation|2|||
161723683|NCT01254604|584032226|FG001|Overall Study|Protocol Violation|2|||
161723684|NCT01254604|584032225|FG000|Overall Study|Withdrawal by Subject|2|||
161723685|NCT01254604|584032226|FG001|Overall Study|Withdrawal by Subject|4|||
161723686|NCT01254604|584032225|FG000|Overall Study|Adverse Event|3|||
161723687|NCT01254604|584032226|FG001|Overall Study|Adverse Event|2|||
161723688|NCT03074162|584032227|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723689|NCT03074162|584032228|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723690|NCT03074162|584032229|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
161723691|NCT03074162|584032230|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723692|NCT03074162|584032231|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723693|NCT03074162|584032232|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723694|NCT03074162|584032227|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723695|NCT03074162|584032228|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723696|NCT03074162|584032229|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
161723697|NCT03074162|584032230|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723698|NCT03074162|584032231|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723699|NCT03074162|584032232|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
161723700|NCT03074162|584032227|FG000|Period 3|Withdrawal by Subject|1|||
161723701|NCT03074162|584032228|FG001|Period 3|Withdrawal by Subject|0|||
161723702|NCT03074162|584032229|FG002|Period 3|Withdrawal by Subject|0|||
161723703|NCT03074162|584032230|FG003|Period 3|Withdrawal by Subject|0|||
161723704|NCT03074162|584032231|FG004|Period 3|Withdrawal by Subject|1|||
161723705|NCT03074162|584032232|FG005|Period 3|Withdrawal by Subject|0|||
161723706|NCT01958671|584032233|FG000|Overall Study|Adverse Event|1|||
161723707|NCT01958671|584032234|FG001|Overall Study|Adverse Event|1|||
161723708|NCT01958671|584032235|FG002|Overall Study|Adverse Event|5|||
161723709|NCT01958671|584032233|FG000|Overall Study|Death|1|||
161723710|NCT01958671|584032234|FG001|Overall Study|Death|0|||
161723711|NCT01958671|584032235|FG002|Overall Study|Death|0|||
161723712|NCT01958671|584032233|FG000|Overall Study|Excluded medication|0|||
161723713|NCT01958671|584032234|FG001|Overall Study|Excluded medication|0|||
161723714|NCT01958671|584032235|FG002|Overall Study|Excluded medication|1|||
161723715|NCT01958671|584032233|FG000|Overall Study|Hyperglycemia|0|||
161723716|NCT01958671|584032234|FG001|Overall Study|Hyperglycemia|0|||
161723717|NCT01958671|584032235|FG002|Overall Study|Hyperglycemia|2|||
161723718|NCT01958671|584032233|FG000|Overall Study|Lost to Follow-up|7|||
161723719|NCT01958671|584032234|FG001|Overall Study|Lost to Follow-up|11|||
161723720|NCT01958671|584032235|FG002|Overall Study|Lost to Follow-up|7|||
161723721|NCT01958671|584032233|FG000|Overall Study|Non-compliance with study drug|1|||
161723722|NCT01958671|584032234|FG001|Overall Study|Non-compliance with study drug|1|||
161723723|NCT01958671|584032235|FG002|Overall Study|Non-compliance with study drug|1|||
161723724|NCT01958671|584032233|FG000|Overall Study|Pregnancy|0|||
161723725|NCT01958671|584032234|FG001|Overall Study|Pregnancy|0|||
161723726|NCT01958671|584032235|FG002|Overall Study|Pregnancy|1|||
161723727|NCT01958671|584032233|FG000|Overall Study|Protocol Violation|0|||
161723728|NCT01958671|584032234|FG001|Overall Study|Protocol Violation|1|||
161723729|NCT01958671|584032235|FG002|Overall Study|Protocol Violation|0|||
161723730|NCT01958671|584032233|FG000|Overall Study|Study site terminated by sponsor|1|||
161723731|NCT01958671|584032234|FG001|Overall Study|Study site terminated by sponsor|0|||
161723732|NCT01958671|584032235|FG002|Overall Study|Study site terminated by sponsor|1|||
161723733|NCT01958671|584032233|FG000|Overall Study|Participant moved|0|||
161723734|NCT01958671|584032234|FG001|Overall Study|Participant moved|0|||
161723735|NCT01958671|584032235|FG002|Overall Study|Participant moved|1|||
161723736|NCT01958671|584032233|FG000|Overall Study|Withdrawal by Subject|8|||
161723737|NCT01958671|584032234|FG001|Overall Study|Withdrawal by Subject|10|||
161723738|NCT01958671|584032235|FG002|Overall Study|Withdrawal by Subject|13|||
161723739|NCT02778867|584032236|FG000|Phase 1|Withdrawal by Subject|2|||
161723740|NCT02778867|584032237|FG001|Phase 1|Withdrawal by Subject|3|||
161723741|NCT02778867|584032238|FG002|Phase 1|Withdrawal by Subject|0|||
161723742|NCT02778867|584032239|FG003|Phase 1|Withdrawal by Subject|0|||
161723743|NCT02778867|584032236|FG000|Phase 2|Withdrawal by Subject|0|||
161723744|NCT02778867|584032237|FG001|Phase 2|Withdrawal by Subject|0|||
161723745|NCT02778867|584032238|FG002|Phase 2|Withdrawal by Subject|1|||
161723746|NCT02778867|584032239|FG003|Phase 2|Withdrawal by Subject|0|||
161723747|NCT02778867|584032236|FG000|Phase 2|Physician Decision|0|||
161723748|NCT02778867|584032237|FG001|Phase 2|Physician Decision|0|||
161723749|NCT02778867|584032238|FG002|Phase 2|Physician Decision|0|||
161723750|NCT02778867|584032239|FG003|Phase 2|Physician Decision|1|||
161723751|NCT02778867|584032236|FG000|Phase 2|Adverse Event|0|||
161723752|NCT02778867|584032237|FG001|Phase 2|Adverse Event|0|||
161723753|NCT02778867|584032238|FG002|Phase 2|Adverse Event|0|||
161723754|NCT02778867|584032239|FG003|Phase 2|Adverse Event|1|||
161723755|NCT02948777|584032240|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
161723756|NCT02311478|584032241|FG000|Overall Study|Withdrawal by Subject|1|||
161723757|NCT02311478|584032241|FG000|Overall Study|Lost to Follow-up|5|||
161723758|NCT02311478|584032241|FG000|Overall Study|Failed IUD Insertion|1|||
161723759|NCT03242928|584032243|FG000|Overall Study|Adverse Event|2|||
161723760|NCT03242928|584032244|FG001|Overall Study|Adverse Event|1|||
161723761|NCT03242928|584032243|FG000|Overall Study|Lost to Follow-up|2|||
161723762|NCT03242928|584032244|FG001|Overall Study|Lost to Follow-up|0|||
161723763|NCT03242928|584032243|FG000|Overall Study|Physician Decision|0|||
161723764|NCT03242928|584032244|FG001|Overall Study|Physician Decision|1|||
161723765|NCT03242928|584032243|FG000|Overall Study|Withdrawal by Subject|5|||
161723766|NCT03242928|584032244|FG001|Overall Study|Withdrawal by Subject|3|||
161723767|NCT03276936|584032245|FG000|Overall Study|Adverse Event|4|||
161723768|NCT03276936|584032246|FG001|Overall Study|Adverse Event|2|||
161723769|NCT03276936|584032245|FG000|Overall Study|Lost to Follow-up|16|||
161723770|NCT03276936|584032246|FG001|Overall Study|Lost to Follow-up|13|||
161723771|NCT03276936|584032245|FG000|Overall Study|Withdrawal by Subject|30|||
161723772|NCT03276936|584032246|FG001|Overall Study|Withdrawal by Subject|20|||
161723773|NCT03276936|584032245|FG000|Overall Study|Not mentioned|6|||
161723774|NCT03276936|584032246|FG001|Overall Study|Not mentioned|3|||
161723775|NCT00943319|584032247|FG000|Overall Study|Death|1|||
161723776|NCT02043301|584032248|FG000|Overall Study|Discontinued|0|||
161723777|NCT02043301|584032249|FG001|Overall Study|Discontinued|1|||
161723778|NCT02043301|584032250|FG002|Overall Study|Discontinued|0|||
161723779|NCT03703375|584032254|FG000|Randomization Period|Withdrawal by Subject|0|||
161723780|NCT03703375|584032255|FG001|Randomization Period|Withdrawal by Subject|0|||
161723781|NCT03703375|584032256|FG002|Randomization Period|Withdrawal by Subject|0|||
161723782|NCT03703375|584032257|FG003|Randomization Period|Withdrawal by Subject|1|||
161723783|NCT03703375|584032254|FG000|Randomization Period|Completed safety run-in treatment|7|||
161723784|NCT03703375|584032255|FG001|Randomization Period|Completed safety run-in treatment|0|||
161723785|NCT03703375|584032256|FG002|Randomization Period|Completed safety run-in treatment|0|||
161723786|NCT03703375|584032257|FG003|Randomization Period|Completed safety run-in treatment|0|||
161723787|NCT03703375|584032254|FG000|Treatment Period|Other Reasons|0|||
161723788|NCT03703375|584032255|FG001|Treatment Period|Other Reasons|1|||
161723789|NCT03703375|584032256|FG002|Treatment Period|Other Reasons|0|||
161723790|NCT03703375|584032257|FG003|Treatment Period|Other Reasons|3|||
161723791|NCT03703375|584032254|FG000|Treatment Period|Consent Withdrawal|0|||
161723792|NCT03703375|584032255|FG001|Treatment Period|Consent Withdrawal|0|||
161723793|NCT03703375|584032256|FG002|Treatment Period|Consent Withdrawal|0|||
161723794|NCT03703375|584032257|FG003|Treatment Period|Consent Withdrawal|1|||
161723795|NCT03703375|584032254|FG000|Treatment Period|Death|1|||
161723796|NCT03703375|584032255|FG001|Treatment Period|Death|0|||
161723797|NCT03703375|584032256|FG002|Treatment Period|Death|1|||
161723798|NCT03703375|584032257|FG003|Treatment Period|Death|2|||
161723799|NCT03703375|584032254|FG000|Treatment Period|Toxicity of Study Treatment|2|||
161723800|NCT03703375|584032255|FG001|Treatment Period|Toxicity of Study Treatment|0|||
161723801|NCT03703375|584032256|FG002|Treatment Period|Toxicity of Study Treatment|4|||
161723802|NCT03703375|584032257|FG003|Treatment Period|Toxicity of Study Treatment|1|||
161723803|NCT03703375|584032254|FG000|Treatment Period|Progression|32|||
161723804|NCT03703375|584032255|FG001|Treatment Period|Progression|1|||
161723805|NCT03703375|584032256|FG002|Treatment Period|Progression|7|||
161723806|NCT03703375|584032257|FG003|Treatment Period|Progression|11|||
161723807|NCT03703375|584032254|FG000|Treatment Period|Completed treatment|7|||
161723808|NCT03703375|584032255|FG001|Treatment Period|Completed treatment|2|||
161723809|NCT03703375|584032256|FG002|Treatment Period|Completed treatment|0|||
161723810|NCT03703375|584032257|FG003|Treatment Period|Completed treatment|0|||
161723811|NCT00625365|584032258|FG000|Overall Study|Withdrawal by Subject|1|||
161723812|NCT00625365|584032258|FG000|Overall Study|No IV access|5|||
161723813|NCT00625365|584032258|FG000|Overall Study|VSD|1|||
161723814|NCT01703286|584032260|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
161723815|NCT01703286|584032261|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
161723816|NCT01703286|584032262|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
161723817|NCT01703286|584032263|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
161723818|NCT01703286|584032264|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
161723819|NCT01703286|584032265|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
161723820|NCT01703286|584032260|FG000|Period 2 Including Washout|Adverse Event|0|||
161723821|NCT01703286|584032261|FG001|Period 2 Including Washout|Adverse Event|0|||
161723822|NCT01703286|584032262|FG002|Period 2 Including Washout|Adverse Event|0|||
161723823|NCT01703286|584032263|FG003|Period 2 Including Washout|Adverse Event|1|||
161723824|NCT01703286|584032264|FG004|Period 2 Including Washout|Adverse Event|0|||
161723825|NCT01703286|584032265|FG005|Period 2 Including Washout|Adverse Event|0|||
161723826|NCT00931892|584032266|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
161723827|NCT00931892|584032267|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
161723828|NCT02207530|584032270|FG000|Overall Study|Worsening condition under investigation|78|||
161723829|NCT02207530|584032270|FG000|Overall Study|Patient decision to stop study treatment|5|||
161723830|NCT02207530|584032270|FG000|Overall Study|Adverse Event|8|||
161723831|NCT03952468|584032279|FG000|Overall Study|Death|0|||
161723832|NCT03952468|584032280|FG001|Overall Study|Death|1|||
161723833|NCT03952468|584032279|FG000|Overall Study|Adverse Event|0|||
161723834|NCT03952468|584032280|FG001|Overall Study|Adverse Event|1|||
161723835|NCT03952468|584032279|FG000|Overall Study|Physician Decision|1|||
161723836|NCT03952468|584032280|FG001|Overall Study|Physician Decision|0|||
161723837|NCT03952468|584032279|FG000|Overall Study|Lost to Follow-up|3|||
161723838|NCT03952468|584032280|FG001|Overall Study|Lost to Follow-up|4|||
161723839|NCT03952468|584032279|FG000|Overall Study|Withdrawal by Subject|2|||
161723840|NCT03952468|584032280|FG001|Overall Study|Withdrawal by Subject|1|||
161723841|NCT06094296|584032281|FG000|Overall Study|Progressive Disease|1|||
161723842|NCT06094296|584032282|FG001|Overall Study|Progressive Disease|0|||
161723843|NCT06094296|584032283|FG002|Overall Study|Progressive Disease|0|||
161723844|NCT06094296|584032284|FG003|Overall Study|Progressive Disease|0|||
161723845|NCT04964063|584032285|FG000|Overall Study|Adverse Event|4|||
161723846|NCT04964063|584032285|FG000|Overall Study|Lost to Follow-up|47|||
161723847|NCT04964063|584032285|FG000|Overall Study|Withdrawal by Subject|5|||
161723848|NCT04964063|584032285|FG000|Overall Study|Baseline Tasks Expired|41|||
161723849|NCT04964063|584032285|FG000|Overall Study|Participant withdrawn in error|1|||
161723850|NCT03350750|584032289|FG000|Overall Study|Death|1|||
161723851|NCT03350750|584032290|FG001|Overall Study|Death|1|||
161723852|NCT00406315|584032292|FG000|Overall Study|Death|1|||
161723853|NCT00406315|584032292|FG000|Overall Study|Adverse Event|39|||
161723854|NCT00406315|584032292|FG000|Overall Study|Laboratory Abnormality|4|||
161723855|NCT00406315|584032292|FG000|Overall Study|Lack of Efficacy|13|||
161723856|NCT00406315|584032292|FG000|Overall Study|Other|33|||
161723857|NCT00406315|584032292|FG000|Overall Study|Lost to Follow-up|21|||
161723858|NCT00406315|584032292|FG000|Overall Study|Withdrawal by Subject|30|||
161723859|NCT01797783|584032295|FG000|Overall Study|Adverse Event|1|||
161723860|NCT01797783|584032296|FG001|Overall Study|Adverse Event|1|||
161723861|NCT01797783|584032295|FG000|Overall Study|Withdrawal by Subject|1|||
161723862|NCT01797783|584032296|FG001|Overall Study|Withdrawal by Subject|0|||
161723863|NCT02202031|584032298|FG000|Overall Study|Lost to Follow-up|1|||
161723864|NCT02202031|584032299|FG001|Overall Study|Lost to Follow-up|0|||
161723865|NCT02202031|584032298|FG000|Overall Study|Too Busy|1|||
161723866|NCT02202031|584032299|FG001|Overall Study|Too Busy|3|||
161723867|NCT02202031|584032298|FG000|Overall Study|Illness/Medical Reason|0|||
161723868|NCT02202031|584032299|FG001|Overall Study|Illness/Medical Reason|2|||
161723869|NCT02202031|584032298|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
161723870|NCT02202031|584032299|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
161723871|NCT02184143|584032300|FG000|Overall Study|Withdrawal by Subject|4|||
161723872|NCT02184143|584032301|FG001|Overall Study|Withdrawal by Subject|4|||
161723873|NCT02184143|584032300|FG000|Overall Study|Lost to Follow-up|5|||
161723874|NCT02184143|584032301|FG001|Overall Study|Lost to Follow-up|3|||
161723875|NCT02184143|584032300|FG000|Overall Study|Death|1|||
161723876|NCT02184143|584032301|FG001|Overall Study|Death|0|||
161723877|NCT00321984|584032302|FG000|Overall Study|Adverse Event|9|||
161723878|NCT00321984|584032303|FG001|Overall Study|Adverse Event|6|||
161723879|NCT00321984|584032304|FG002|Overall Study|Adverse Event|8|||
161723880|NCT00321984|584032302|FG000|Overall Study|Protocol Violation|0|||
161723881|NCT00321984|584032303|FG001|Overall Study|Protocol Violation|1|||
161723882|NCT00321984|584032304|FG002|Overall Study|Protocol Violation|1|||
161723883|NCT00321984|584032302|FG000|Overall Study|Lost to Follow-up|2|||
161723884|NCT00321984|584032303|FG001|Overall Study|Lost to Follow-up|4|||
161723885|NCT00321984|584032304|FG002|Overall Study|Lost to Follow-up|2|||
161723886|NCT00321984|584032302|FG000|Overall Study|Withdrawal by Subject|8|||
161723887|NCT00321984|584032303|FG001|Overall Study|Withdrawal by Subject|6|||
161723888|NCT00321984|584032304|FG002|Overall Study|Withdrawal by Subject|5|||
161723889|NCT00321984|584032302|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
161723890|NCT00321984|584032303|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
161723891|NCT00321984|584032304|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
161723892|NCT00321984|584032302|FG000|Overall Study|Lack of Efficacy|3|||
161723893|NCT00321984|584032303|FG001|Overall Study|Lack of Efficacy|1|||
161723894|NCT00321984|584032304|FG002|Overall Study|Lack of Efficacy|3|||
161723895|NCT00321984|584032302|FG000|Overall Study|Noncompliant|0|||
161723896|NCT00321984|584032303|FG001|Overall Study|Noncompliant|0|||
161723897|NCT00321984|584032304|FG002|Overall Study|Noncompliant|2|||
161723898|NCT00321984|584032302|FG000|Overall Study|Pregnancy|0|||
161723899|NCT00321984|584032303|FG001|Overall Study|Pregnancy|1|||
161723900|NCT00321984|584032304|FG002|Overall Study|Pregnancy|0|||
161723901|NCT00321984|584032302|FG000|Overall Study|Per Subject Request|1|||
161723902|NCT00321984|584032303|FG001|Overall Study|Per Subject Request|0|||
161723903|NCT00321984|584032304|FG002|Overall Study|Per Subject Request|0|||
161723904|NCT00321984|584032302|FG000|Overall Study|Per Investigator Request|1|||
161723905|NCT00321984|584032303|FG001|Overall Study|Per Investigator Request|0|||
161723906|NCT00321984|584032304|FG002|Overall Study|Per Investigator Request|0|||
161723907|NCT00321984|584032302|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
161723908|NCT00321984|584032303|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
161723909|NCT00321984|584032304|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
161723910|NCT01024465|584032305|FG000|Overall Study|Adverse Event|2|||
161723911|NCT01024465|584032305|FG000|Overall Study|Physician Decision|1|||
161723912|NCT00525148|584032309|FG000|Overall Study|Other Adverse Event|3|||
161723913|NCT00525148|584032310|FG001|Overall Study|Other Adverse Event|5|||
161723914|NCT00525148|584032311|FG002|Overall Study|Other Adverse Event|1|||
161723915|NCT00525148|584032312|FG003|Overall Study|Other Adverse Event|8|||
161723916|NCT00525148|584032309|FG000|Overall Study|Progressive disease|18|||
161723917|NCT00525148|584032310|FG001|Overall Study|Progressive disease|30|||
161723918|NCT00525148|584032311|FG002|Overall Study|Progressive disease|6|||
161723919|NCT00525148|584032312|FG003|Overall Study|Progressive disease|49|||
161723920|NCT00525148|584032309|FG000|Overall Study|Refused continuation of study medication|0|||
161723921|NCT00525148|584032310|FG001|Overall Study|Refused continuation of study medication|2|||
161723922|NCT00525148|584032311|FG002|Overall Study|Refused continuation of study medication|0|||
161723923|NCT00525148|584032312|FG003|Overall Study|Refused continuation of study medication|1|||
161723924|NCT00525148|584032309|FG000|Overall Study|Other than stated|2|||
161723925|NCT00525148|584032310|FG001|Overall Study|Other than stated|1|||
161723926|NCT00525148|584032311|FG002|Overall Study|Other than stated|0|||
161723927|NCT00525148|584032312|FG003|Overall Study|Other than stated|3|||
161723928|NCT03078608|584032313|FG000|Overall Study|Death|1|||
161723929|NCT03078608|584032314|FG001|Overall Study|Death|2|||
161723930|NCT03078608|584032315|FG002|Overall Study|Death|0|||
161723931|NCT03078608|584032316|FG003|Overall Study|Death|0|||
161723932|NCT03078608|584032313|FG000|Overall Study|Withdrawal by Subject|8|||
161723933|NCT03078608|584032314|FG001|Overall Study|Withdrawal by Subject|1|||
161723934|NCT03078608|584032315|FG002|Overall Study|Withdrawal by Subject|0|||
161723935|NCT03078608|584032316|FG003|Overall Study|Withdrawal by Subject|0|||
161723936|NCT03078608|584032313|FG000|Overall Study|Lost to Follow-up|5|||
161723937|NCT03078608|584032314|FG001|Overall Study|Lost to Follow-up|8|||
161723938|NCT03078608|584032315|FG002|Overall Study|Lost to Follow-up|4|||
161723939|NCT03078608|584032316|FG003|Overall Study|Lost to Follow-up|1|||
161723940|NCT01905397|584032323|FG000|Overall Study|Death|0|||
161723941|NCT01905397|584032324|FG001|Overall Study|Death|1|||
161723942|NCT01905397|584032323|FG000|Overall Study|Withdrawal by Subject|2|||
161723943|NCT01905397|584032324|FG001|Overall Study|Withdrawal by Subject|0|||
161723944|NCT01905397|584032323|FG000|Overall Study|Surgery canceled/aborted|9|||
161723945|NCT01905397|584032324|FG001|Overall Study|Surgery canceled/aborted|5|||
161723946|NCT01905397|584032323|FG000|Overall Study|Incision < 7 cm|2|||
161723947|NCT01905397|584032324|FG001|Overall Study|Incision < 7 cm|0|||
161723948|NCT01905397|584032323|FG000|Overall Study|Wrong treatment|1|||
161723949|NCT01905397|584032324|FG001|Overall Study|Wrong treatment|1|||
161723950|NCT01905397|584032323|FG000|Overall Study|Device not applied|3|||
161723951|NCT01905397|584032324|FG001|Overall Study|Device not applied|0|||
161723952|NCT01905397|584032323|FG000|Overall Study|Dressing not applied in operating room|1|||
161723953|NCT01905397|584032324|FG001|Overall Study|Dressing not applied in operating room|0|||
161723954|NCT01905397|584032323|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
161723955|NCT01905397|584032324|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
161723956|NCT01921270|584032325|FG000|Overall Study|Withdrawal by Subject|1|||
161723957|NCT00864227|584032326|FG000|Overall Study|Withdrawal by Subject|1|||
161723958|NCT00864227|584032326|FG000|Overall Study|Disease Relapse/Progression|3|||
161723959|NCT01137435|584032327|FG000|Overall Study|Lost to Follow-up|24|||
161723960|NCT01137435|584032327|FG000|Overall Study|Off label usage|4|||
161723961|NCT00501852|584032328|FG000|Overall Study|Adverse Event|3|||
161723962|NCT00501852|584032328|FG000|Overall Study|Withdrawal by Subject|2|||
161723963|NCT01416610|584032329|FG000|Overall Study|Adverse Event|4|||
161723964|NCT01416610|584032329|FG000|Overall Study|Adverse Event -Patient decision|3|||
161723965|NCT01416610|584032329|FG000|Overall Study|Lack of Efficacy|4|||
161723966|NCT01416610|584032329|FG000|Overall Study|No reason given|5|||
161723967|NCT01416610|584032329|FG000|Overall Study|Withdrawal by Subject|13|||
161723968|NCT01416610|584032329|FG000|Overall Study|Lost to Follow-up|7|||
161723969|NCT01416610|584032329|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
161723970|NCT00399802|584032331|FG000|Overall Study|Adverse Event|0|||
161723971|NCT00399802|584032332|FG001|Overall Study|Adverse Event|2|||
161723972|NCT00399802|584032331|FG000|Overall Study|Participant discontinued by mistake|0|||
161723973|NCT00399802|584032332|FG001|Overall Study|Participant discontinued by mistake|1|||
161723974|NCT04172831|584032335|FG000|Overall Study|Adverse Event|21|||
161723975|NCT04172831|584032336|FG001|Overall Study|Adverse Event|9|||
161723976|NCT04172831|584032335|FG000|Overall Study|Lack of Efficacy|2|||
161723977|NCT04172831|584032336|FG001|Overall Study|Lack of Efficacy|8|||
161723978|NCT04172831|584032335|FG000|Overall Study|Physician Decision|0|||
161723979|NCT04172831|584032336|FG001|Overall Study|Physician Decision|1|||
161723980|NCT04172831|584032335|FG000|Overall Study|Withdrawal by Subject|12|||
161723981|NCT04172831|584032336|FG001|Overall Study|Withdrawal by Subject|11|||
161723982|NCT04172831|584032335|FG000|Overall Study|Lost to Follow-up|4|||
161723983|NCT04172831|584032336|FG001|Overall Study|Lost to Follow-up|9|||
161723984|NCT04172831|584032335|FG000|Overall Study|COVID-19 related crisis|3|||
161723985|NCT04172831|584032336|FG001|Overall Study|COVID-19 related crisis|3|||
161723986|NCT04172831|584032335|FG000|Overall Study|Subject non-compliance|1|||
161723987|NCT04172831|584032336|FG001|Overall Study|Subject non-compliance|1|||
161723988|NCT04172831|584032335|FG000|Overall Study|Family emergency|1|||
161723989|NCT04172831|584032336|FG001|Overall Study|Family emergency|0|||
161723990|NCT01899144|584032340|FG000|Treatment Period 2|Other|1|||
161723991|NCT01899144|584032340|FG000|Treatment Period 3|Other|2|||
161723992|NCT01899144|584032340|FG000|Treatment Period 5|Other|1|||
161723993|NCT00866294|584032341|FG000|Overall Study|Adverse Event|12|||
161723994|NCT00866294|584032342|FG001|Overall Study|Adverse Event|13|||
161723995|NCT00866294|584032343|FG002|Overall Study|Adverse Event|9|||
161723996|NCT00866294|584032341|FG000|Overall Study|Lack of Efficacy|7|||
161723997|NCT00866294|584032342|FG001|Overall Study|Lack of Efficacy|1|||
161723998|NCT00866294|584032343|FG002|Overall Study|Lack of Efficacy|0|||
161723999|NCT00866294|584032341|FG000|Overall Study|Protocol Violation|2|||
161724000|NCT00866294|584032342|FG001|Overall Study|Protocol Violation|0|||
161724001|NCT00866294|584032343|FG002|Overall Study|Protocol Violation|0|||
161724002|NCT00866294|584032341|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
161724003|NCT00866294|584032342|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161724004|NCT00866294|584032343|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161724005|NCT00866294|584032341|FG000|Overall Study|Lost to Follow-up|1|||
161724006|NCT00866294|584032342|FG001|Overall Study|Lost to Follow-up|3|||
161724007|NCT00866294|584032343|FG002|Overall Study|Lost to Follow-up|0|||
161724008|NCT00866294|584032341|FG000|Overall Study|Physician Decision|6|||
161724009|NCT00866294|584032342|FG001|Overall Study|Physician Decision|2|||
161724010|NCT00866294|584032343|FG002|Overall Study|Physician Decision|1|||
161724011|NCT00081289|584032344|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
161724012|NCT00081289|584032345|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
161724013|NCT00081289|584032344|FG000|Overall Study|Ineligible / no protocol treatment|3|||
161724014|NCT00081289|584032345|FG001|Overall Study|Ineligible / no protocol treatment|4|||
161724015|NCT00916721|584032348|FG000|Overall Study|Lost to Follow-up|0|||
161724016|NCT00916721|584032349|FG001|Overall Study|Lost to Follow-up|1|||
161724017|NCT00916721|584032348|FG000|Overall Study|Adverse Event|6|||
161724018|NCT00916721|584032349|FG001|Overall Study|Adverse Event|3|||
161724019|NCT00916721|584032348|FG000|Overall Study|Withdrawal by Subject|2|||
161724020|NCT00916721|584032349|FG001|Overall Study|Withdrawal by Subject|2|||
161724021|NCT00916721|584032348|FG000|Overall Study|Protocol Violation|2|||
161724022|NCT00916721|584032349|FG001|Overall Study|Protocol Violation|4|||
161724023|NCT00798967|584032352|FG000|Overall Study|Adverse Event|2|||
161724024|NCT00798967|584032353|FG001|Overall Study|Adverse Event|3|||
161724025|NCT00798967|584032352|FG000|Overall Study|Withdrawal by Subject|0|||
161724026|NCT00798967|584032353|FG001|Overall Study|Withdrawal by Subject|1|||
161724027|NCT00798967|584032352|FG000|Overall Study|Physician Decision|1|||
161724028|NCT00798967|584032353|FG001|Overall Study|Physician Decision|0|||
161724029|NCT00798967|584032352|FG000|Overall Study|Randomized in error by site|1|||
161724030|NCT00798967|584032353|FG001|Overall Study|Randomized in error by site|0|||
161724031|NCT04083222|584032359|FG000|Overall Study|Voluntary Withdrawal|0|||
161724032|NCT04083222|584032360|FG001|Overall Study|Voluntary Withdrawal|1|||
161724033|NCT04083222|584032359|FG000|Overall Study|Reason not Specified|0|||
161724034|NCT04083222|584032360|FG001|Overall Study|Reason not Specified|1|||
161724035|NCT04400318|584034133|FG000|Overall Study|Adverse Event|1|||
161724036|NCT04400318|584034134|FG001|Overall Study|Adverse Event|0|||
161724037|NCT04400318|584034133|FG000|Overall Study|Withdrawal by Subject|1|||
161724038|NCT04400318|584034134|FG001|Overall Study|Withdrawal by Subject|1|||
161724039|NCT04400318|584034133|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
161724040|NCT04400318|584034134|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
161724041|NCT02078713|584034135|FG000|Overall Study|Lost to Follow-up|49|||
161724042|NCT02078713|584034136|FG001|Overall Study|Lost to Follow-up|55|||
161724043|NCT02078713|584034137|FG002|Overall Study|Lost to Follow-up|0|||
161724044|NCT02078713|584034138|FG003|Overall Study|Lost to Follow-up|0|||
161724045|NCT02078713|584034135|FG000|Overall Study|Pregnant at baseline|3|||
161724046|NCT02078713|584034136|FG001|Overall Study|Pregnant at baseline|5|||
161724047|NCT02078713|584034137|FG002|Overall Study|Pregnant at baseline|0|||
161724048|NCT02078713|584034138|FG003|Overall Study|Pregnant at baseline|0|||
161724049|NCT02078713|584034135|FG000|Overall Study|Enrolled twice|0|||
161724050|NCT02078713|584034136|FG001|Overall Study|Enrolled twice|1|||
161724051|NCT02078713|584034137|FG002|Overall Study|Enrolled twice|0|||
161724052|NCT02078713|584034138|FG003|Overall Study|Enrolled twice|0|||
161724053|NCT01793051|584034149|FG000|Overall Study|Withdrawal by Subject|6|||
161724054|NCT01793051|584034150|FG001|Overall Study|Withdrawal by Subject|4|||
161724055|NCT01793051|584034149|FG000|Overall Study|Adverse Event|0|||
161724056|NCT01793051|584034150|FG001|Overall Study|Adverse Event|2|||
161724057|NCT01793051|584034149|FG000|Overall Study|Too ill to continue|1|||
161724058|NCT01793051|584034150|FG001|Overall Study|Too ill to continue|0|||
161724059|NCT01793051|584034149|FG000|Overall Study|Switched chemo|1|||
161724060|NCT01793051|584034150|FG001|Overall Study|Switched chemo|1|||
161724061|NCT01793051|584034149|FG000|Overall Study|Lack of compliance|1|||
161724062|NCT01793051|584034150|FG001|Overall Study|Lack of compliance|0|||
161724063|NCT01793051|584034149|FG000|Overall Study|Requested to be removed from the study|1|||
161724064|NCT01793051|584034150|FG001|Overall Study|Requested to be removed from the study|1|||
161724065|NCT02421120|584034153|FG000|Overall Study|Adverse Event|1|||
161724066|NCT00372190|584034154|FG000|Overall Study|Lost to Follow-up|3|||
161724067|NCT00372190|584034155|FG001|Overall Study|Lost to Follow-up|1|||
161724068|NCT00623467|584034156|FG000|Overall Study|Lost to Follow-up|1|||
161724069|NCT00623467|584034156|FG000|Overall Study|Protocol Violation|4|||
161724070|NCT00623467|584034156|FG000|Overall Study|Withdrawal by Subject|2|||
161724071|NCT00273858|584034170|FG000|Overall Study|Not completed 24 month observation time|334|||
161724072|NCT00273858|584034170|FG000|Overall Study|Lost to Follow-up|101|||
161724073|NCT00273858|584034170|FG000|Overall Study|Withdrawal by Subject|21|||
161724074|NCT00273858|584034170|FG000|Overall Study|Adverse Event|81|||
161724075|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
161724076|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
161724077|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
161724078|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
161724079|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
161724080|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
161724081|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
161724082|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
161724083|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
161724084|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
161724085|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
161724086|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
161724087|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
161724088|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
161724089|NCT02232516|584034171|FG000|Survival Follow-up|Death|15|||
161724090|NCT02232516|584034171|FG000|Survival Follow-up|Withdrawal by Subject|3|||
161724091|NCT02232516|584034171|FG000|Survival Follow-up|Lost to Follow-up|1|||
161724092|NCT02232516|584034171|FG000|Survival Follow-up|Still in follow-up|5|||
161724093|NCT01070550|584034172|FG000|Overall Study|Adverse Event|43|||
161724094|NCT01070550|584034173|FG001|Overall Study|Adverse Event|1|||
161724095|NCT01070550|584034174|FG002|Overall Study|Adverse Event|3|||
161724096|NCT01070550|584034175|FG003|Overall Study|Adverse Event|0|||
161724097|NCT01070550|584034176|FG004|Overall Study|Adverse Event|0|||
161724098|NCT01070550|584034177|FG005|Overall Study|Adverse Event|0|||
161724099|NCT01070550|584034172|FG000|Overall Study|Death|20|||
161724100|NCT01070550|584034173|FG001|Overall Study|Death|4|||
161724101|NCT01070550|584034174|FG002|Overall Study|Death|3|||
161724102|NCT01070550|584034175|FG003|Overall Study|Death|0|||
161724103|NCT01070550|584034176|FG004|Overall Study|Death|0|||
161724104|NCT01070550|584034177|FG005|Overall Study|Death|0|||
161724105|NCT01070550|584034172|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
161724106|NCT01070550|584034173|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161724107|NCT01070550|584034174|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161724108|NCT01070550|584034175|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161724109|NCT01070550|584034176|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161724110|NCT01070550|584034177|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161724111|NCT01070550|584034172|FG000|Overall Study|Early termination|3|||
161724112|NCT01070550|584034173|FG001|Overall Study|Early termination|0|||
161724113|NCT01070550|584034174|FG002|Overall Study|Early termination|0|||
161724114|NCT01070550|584034175|FG003|Overall Study|Early termination|0|||
161724115|NCT01070550|584034176|FG004|Overall Study|Early termination|0|||
161724116|NCT01070550|584034177|FG005|Overall Study|Early termination|0|||
161724117|NCT01070550|584034172|FG000|Overall Study|Failed to return|450|||
161724118|NCT01070550|584034173|FG001|Overall Study|Failed to return|33|||
161724119|NCT01070550|584034174|FG002|Overall Study|Failed to return|144|||
161724120|NCT01070550|584034175|FG003|Overall Study|Failed to return|40|||
161724121|NCT01070550|584034176|FG004|Overall Study|Failed to return|1|||
161724122|NCT01070550|584034177|FG005|Overall Study|Failed to return|2|||
161724123|NCT01070550|584034172|FG000|Overall Study|Incomplete treatment|2|||
161724124|NCT01070550|584034173|FG001|Overall Study|Incomplete treatment|0|||
161724125|NCT01070550|584034174|FG002|Overall Study|Incomplete treatment|0|||
161724126|NCT01070550|584034175|FG003|Overall Study|Incomplete treatment|0|||
161724127|NCT01070550|584034176|FG004|Overall Study|Incomplete treatment|0|||
161724128|NCT01070550|584034177|FG005|Overall Study|Incomplete treatment|0|||
161724129|NCT01070550|584034172|FG000|Overall Study|Lab test not done|22|||
161724130|NCT01070550|584034173|FG001|Overall Study|Lab test not done|3|||
161724131|NCT01070550|584034174|FG002|Overall Study|Lab test not done|4|||
161724132|NCT01070550|584034175|FG003|Overall Study|Lab test not done|1|||
161724133|NCT01070550|584034176|FG004|Overall Study|Lab test not done|0|||
161724134|NCT01070550|584034177|FG005|Overall Study|Lab test not done|1|||
161724135|NCT01070550|584034172|FG000|Overall Study|Lack of Efficacy|65|||
161724136|NCT01070550|584034173|FG001|Overall Study|Lack of Efficacy|1|||
161724137|NCT01070550|584034174|FG002|Overall Study|Lack of Efficacy|5|||
161724138|NCT01070550|584034175|FG003|Overall Study|Lack of Efficacy|5|||
161724139|NCT01070550|584034176|FG004|Overall Study|Lack of Efficacy|0|||
161724140|NCT01070550|584034177|FG005|Overall Study|Lack of Efficacy|1|||
161724141|NCT01070550|584034172|FG000|Overall Study|Miscellaneous|12|||
161724142|NCT01070550|584034173|FG001|Overall Study|Miscellaneous|2|||
161724143|NCT01070550|584034174|FG002|Overall Study|Miscellaneous|3|||
161724144|NCT01070550|584034175|FG003|Overall Study|Miscellaneous|1|||
161724145|NCT01070550|584034176|FG004|Overall Study|Miscellaneous|0|||
161724146|NCT01070550|584034177|FG005|Overall Study|Miscellaneous|0|||
161724147|NCT01070550|584034172|FG000|Overall Study|New treatment started|3|||
161724148|NCT01070550|584034173|FG001|Overall Study|New treatment started|1|||
161724149|NCT01070550|584034174|FG002|Overall Study|New treatment started|0|||
161724150|NCT01070550|584034175|FG003|Overall Study|New treatment started|2|||
161724151|NCT01070550|584034176|FG004|Overall Study|New treatment started|0|||
161724152|NCT01070550|584034177|FG005|Overall Study|New treatment started|0|||
161724153|NCT01070550|584034172|FG000|Overall Study|Non-responders|493|||
161724154|NCT01070550|584034173|FG001|Overall Study|Non-responders|4|||
161724155|NCT01070550|584034174|FG002|Overall Study|Non-responders|21|||
161724156|NCT01070550|584034175|FG003|Overall Study|Non-responders|20|||
161724157|NCT01070550|584034176|FG004|Overall Study|Non-responders|0|||
161724158|NCT01070550|584034177|FG005|Overall Study|Non-responders|2|||
161724159|NCT01070550|584034172|FG000|Overall Study|Not categorized|33|||
161724160|NCT01070550|584034173|FG001|Overall Study|Not categorized|2|||
161724161|NCT01070550|584034174|FG002|Overall Study|Not categorized|6|||
161724162|NCT01070550|584034175|FG003|Overall Study|Not categorized|1|||
161724163|NCT01070550|584034176|FG004|Overall Study|Not categorized|0|||
161724164|NCT01070550|584034177|FG005|Overall Study|Not categorized|1|||
161724165|NCT01070550|584034172|FG000|Overall Study|Protocol Violation|15|||
161724166|NCT01070550|584034173|FG001|Overall Study|Protocol Violation|1|||
161724167|NCT01070550|584034174|FG002|Overall Study|Protocol Violation|1|||
161724168|NCT01070550|584034175|FG003|Overall Study|Protocol Violation|1|||
161724169|NCT01070550|584034176|FG004|Overall Study|Protocol Violation|0|||
161724170|NCT01070550|584034177|FG005|Overall Study|Protocol Violation|0|||
161724171|NCT01070550|584034172|FG000|Overall Study|Relapse|44|||
161724172|NCT01070550|584034173|FG001|Overall Study|Relapse|5|||
161724173|NCT01070550|584034174|FG002|Overall Study|Relapse|14|||
161724174|NCT01070550|584034175|FG003|Overall Study|Relapse|4|||
161724175|NCT01070550|584034176|FG004|Overall Study|Relapse|0|||
161724176|NCT01070550|584034177|FG005|Overall Study|Relapse|0|||
161724177|NCT01070550|584034172|FG000|Overall Study|Result not available|3|||
161724178|NCT01070550|584034173|FG001|Overall Study|Result not available|1|||
161724179|NCT01070550|584034174|FG002|Overall Study|Result not available|3|||
161724180|NCT01070550|584034175|FG003|Overall Study|Result not available|0|||
161724181|NCT01070550|584034176|FG004|Overall Study|Result not available|0|||
161724182|NCT01070550|584034177|FG005|Overall Study|Result not available|0|||
161724183|NCT01070550|584034172|FG000|Overall Study|Screen failure|1|||
161724184|NCT01070550|584034173|FG001|Overall Study|Screen failure|0|||
161724185|NCT01070550|584034174|FG002|Overall Study|Screen failure|0|||
161724186|NCT01070550|584034175|FG003|Overall Study|Screen failure|0|||
161724187|NCT01070550|584034176|FG004|Overall Study|Screen failure|0|||
161724188|NCT01070550|584034177|FG005|Overall Study|Screen failure|0|||
161724189|NCT01070550|584034172|FG000|Overall Study|Sponsor decision|1|||
161724190|NCT01070550|584034173|FG001|Overall Study|Sponsor decision|0|||
161724191|NCT01070550|584034174|FG002|Overall Study|Sponsor decision|0|||
161724192|NCT01070550|584034175|FG003|Overall Study|Sponsor decision|0|||
161724193|NCT01070550|584034176|FG004|Overall Study|Sponsor decision|0|||
161724194|NCT01070550|584034177|FG005|Overall Study|Sponsor decision|0|||
161724195|NCT01070550|584034172|FG000|Overall Study|Treatment duration shortened|1|||
161724196|NCT01070550|584034173|FG001|Overall Study|Treatment duration shortened|0|||
161724197|NCT01070550|584034174|FG002|Overall Study|Treatment duration shortened|0|||
161724198|NCT01070550|584034175|FG003|Overall Study|Treatment duration shortened|0|||
161724199|NCT01070550|584034176|FG004|Overall Study|Treatment duration shortened|0|||
161724200|NCT01070550|584034177|FG005|Overall Study|Treatment duration shortened|0|||
161724201|NCT01070550|584034172|FG000|Overall Study|Treatment interrupted|7|||
161724202|NCT01070550|584034173|FG001|Overall Study|Treatment interrupted|0|||
161724203|NCT01070550|584034174|FG002|Overall Study|Treatment interrupted|1|||
161724204|NCT01070550|584034175|FG003|Overall Study|Treatment interrupted|1|||
161724205|NCT01070550|584034176|FG004|Overall Study|Treatment interrupted|0|||
161724206|NCT01070550|584034177|FG005|Overall Study|Treatment interrupted|0|||
161724207|NCT01070550|584034172|FG000|Overall Study|Treatment not started|14|||
161724208|NCT01070550|584034173|FG001|Overall Study|Treatment not started|2|||
161724209|NCT01070550|584034174|FG002|Overall Study|Treatment not started|4|||
161724210|NCT01070550|584034175|FG003|Overall Study|Treatment not started|0|||
161724211|NCT01070550|584034176|FG004|Overall Study|Treatment not started|0|||
161724212|NCT01070550|584034177|FG005|Overall Study|Treatment not started|0|||
161724213|NCT01070550|584034172|FG000|Overall Study|Treatment restarted|0|||
161724214|NCT01070550|584034173|FG001|Overall Study|Treatment restarted|1|||
161724215|NCT01070550|584034174|FG002|Overall Study|Treatment restarted|0|||
161724216|NCT01070550|584034175|FG003|Overall Study|Treatment restarted|0|||
161724217|NCT01070550|584034176|FG004|Overall Study|Treatment restarted|0|||
161724218|NCT01070550|584034177|FG005|Overall Study|Treatment restarted|0|||
161724219|NCT01070550|584034172|FG000|Overall Study|Treatment stopped|3|||
161724220|NCT01070550|584034173|FG001|Overall Study|Treatment stopped|0|||
161724221|NCT01070550|584034174|FG002|Overall Study|Treatment stopped|0|||
161724222|NCT01070550|584034175|FG003|Overall Study|Treatment stopped|0|||
161724223|NCT01070550|584034176|FG004|Overall Study|Treatment stopped|0|||
161724224|NCT01070550|584034177|FG005|Overall Study|Treatment stopped|0|||
161724225|NCT01070550|584034172|FG000|Overall Study|Treatment unavailable|1|||
161724226|NCT01070550|584034173|FG001|Overall Study|Treatment unavailable|0|||
161724227|NCT01070550|584034174|FG002|Overall Study|Treatment unavailable|0|||
161724228|NCT01070550|584034175|FG003|Overall Study|Treatment unavailable|0|||
161724229|NCT01070550|584034176|FG004|Overall Study|Treatment unavailable|0|||
161724230|NCT01070550|584034177|FG005|Overall Study|Treatment unavailable|0|||
161724231|NCT01070550|584034172|FG000|Overall Study|Treatment was stopped early|7|||
161724232|NCT01070550|584034173|FG001|Overall Study|Treatment was stopped early|0|||
161724233|NCT01070550|584034174|FG002|Overall Study|Treatment was stopped early|0|||
161724234|NCT01070550|584034175|FG003|Overall Study|Treatment was stopped early|0|||
161724235|NCT01070550|584034176|FG004|Overall Study|Treatment was stopped early|0|||
161724236|NCT01070550|584034177|FG005|Overall Study|Treatment was stopped early|0|||
161724237|NCT01070550|584034172|FG000|Overall Study|Other|5|||
161724238|NCT01070550|584034173|FG001|Overall Study|Other|0|||
161724239|NCT01070550|584034174|FG002|Overall Study|Other|0|||
161724240|NCT01070550|584034175|FG003|Overall Study|Other|1|||
161724241|NCT01070550|584034176|FG004|Overall Study|Other|0|||
161724242|NCT01070550|584034177|FG005|Overall Study|Other|0|||
161724243|NCT01070550|584034172|FG000|Overall Study|Withdrawal by Subject|35|||
161724244|NCT01070550|584034173|FG001|Overall Study|Withdrawal by Subject|0|||
161724245|NCT01070550|584034174|FG002|Overall Study|Withdrawal by Subject|3|||
161724246|NCT01070550|584034175|FG003|Overall Study|Withdrawal by Subject|0|||
161724247|NCT01070550|584034176|FG004|Overall Study|Withdrawal by Subject|0|||
161724248|NCT01070550|584034177|FG005|Overall Study|Withdrawal by Subject|0|||
161724249|NCT01585961|584034179|FG000|Overall Study|Death|6|||
161724250|NCT01585961|584034179|FG000|Overall Study|Physician Decision|1|||
161724251|NCT01585961|584034179|FG000|Overall Study|Decision to use non-study catheter|1|||
161724252|NCT01585961|584034179|FG000|Overall Study|Withdrawal by Subject|1|||
161724253|NCT01585961|584034179|FG000|Overall Study|Lost to Follow-up|23|||
161724254|NCT01585961|584034179|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
161724255|NCT01258348|584034180|FG000|Overall Study|Adverse Event|1|||
161724256|NCT01258348|584034181|FG001|Overall Study|Adverse Event|1|||
161724257|NCT01258348|584034182|FG002|Overall Study|Adverse Event|3|||
161724258|NCT01258348|584034183|FG003|Overall Study|Adverse Event|2|||
161724259|NCT01258348|584034184|FG004|Overall Study|Adverse Event|4|||
161724260|NCT01258348|584034180|FG000|Overall Study|Progressive Disease|0|||
161724261|NCT01258348|584034181|FG001|Overall Study|Progressive Disease|3|||
161724262|NCT01258348|584034182|FG002|Overall Study|Progressive Disease|0|||
161724263|NCT01258348|584034183|FG003|Overall Study|Progressive Disease|2|||
161724264|NCT01258348|584034184|FG004|Overall Study|Progressive Disease|2|||
161724265|NCT01258348|584034180|FG000|Overall Study|Physician Decision|0|||
161724266|NCT01258348|584034181|FG001|Overall Study|Physician Decision|0|||
161724267|NCT01258348|584034182|FG002|Overall Study|Physician Decision|0|||
161724268|NCT01258348|584034183|FG003|Overall Study|Physician Decision|2|||
161724269|NCT01258348|584034184|FG004|Overall Study|Physician Decision|0|||
161724270|NCT01258348|584034180|FG000|Overall Study|Withdrawal by Subject|0|||
161724271|NCT01258348|584034181|FG001|Overall Study|Withdrawal by Subject|1|||
161724272|NCT01258348|584034182|FG002|Overall Study|Withdrawal by Subject|0|||
161724273|NCT01258348|584034183|FG003|Overall Study|Withdrawal by Subject|0|||
161724274|NCT01258348|584034184|FG004|Overall Study|Withdrawal by Subject|0|||
161724275|NCT01849848|584034186|FG000|Overall Study|Physician Decision|1|||
161724276|NCT01849848|584034186|FG000|Overall Study|Progression of the primary disease|3|||
161724277|NCT01505491|584034187|FG000|Overall Study|Other reason not listed|1|||
161724278|NCT01505491|584034188|FG001|Overall Study|Other reason not listed|0|||
161724279|NCT01505491|584034189|FG002|Overall Study|Other reason not listed|0|||
161724280|NCT01505491|584034187|FG000|Overall Study|Withdrawal by Subject|1|||
161724281|NCT01505491|584034188|FG001|Overall Study|Withdrawal by Subject|1|||
161724282|NCT01505491|584034189|FG002|Overall Study|Withdrawal by Subject|4|||
161724283|NCT01505491|584034187|FG000|Overall Study|Lost to Follow-up|0|||
161724284|NCT01505491|584034188|FG001|Overall Study|Lost to Follow-up|0|||
161724285|NCT01505491|584034189|FG002|Overall Study|Lost to Follow-up|1|||
161724286|NCT01120093|584034198|FG000|Treatment Period 1|Adverse Event|0|||
161724287|NCT01120093|584034199|FG001|Treatment Period 1|Adverse Event|0|||
161724288|NCT01120093|584034200|FG002|Treatment Period 1|Adverse Event|1|||
161724289|NCT01120093|584034201|FG003|Treatment Period 1|Adverse Event|0|||
161724290|NCT01120093|584034202|FG004|Treatment Period 1|Adverse Event|1|||
161724291|NCT01120093|584034198|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161724292|NCT01120093|584034199|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161724293|NCT01120093|584034200|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161724294|NCT01120093|584034201|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161724295|NCT01120093|584034202|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161724296|NCT01120093|584034198|FG000|Treatment Period 2|Adverse Event|0|||
161724297|NCT01120093|584034199|FG001|Treatment Period 2|Adverse Event|0|||
161724298|NCT01120093|584034200|FG002|Treatment Period 2|Adverse Event|0|||
161724299|NCT01120093|584034201|FG003|Treatment Period 2|Adverse Event|1|||
161724300|NCT01120093|584034202|FG004|Treatment Period 2|Adverse Event|0|||
161724301|NCT01120093|584034198|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161724302|NCT01120093|584034199|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161724303|NCT01120093|584034200|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161724304|NCT01120093|584034201|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161724305|NCT01120093|584034202|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161724306|NCT01120093|584034198|FG000|Treatment Period 3|Lack of Efficacy|0|||
161724307|NCT01120093|584034199|FG001|Treatment Period 3|Lack of Efficacy|0|||
161724308|NCT01120093|584034200|FG002|Treatment Period 3|Lack of Efficacy|0|||
161724309|NCT01120093|584034201|FG003|Treatment Period 3|Lack of Efficacy|1|||
161724310|NCT01120093|584034202|FG004|Treatment Period 3|Lack of Efficacy|0|||
161724311|NCT01120093|584034198|FG000|Treatment Period 3|Adverse Event|0|||
161724312|NCT01120093|584034199|FG001|Treatment Period 3|Adverse Event|0|||
161724313|NCT01120093|584034200|FG002|Treatment Period 3|Adverse Event|0|||
161724314|NCT01120093|584034201|FG003|Treatment Period 3|Adverse Event|0|||
161724315|NCT01120093|584034202|FG004|Treatment Period 3|Adverse Event|1|||
161724316|NCT01120093|584034198|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161724317|NCT01120093|584034199|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161724318|NCT01120093|584034200|FG002|Treatment Period 3|Withdrawal by Subject|1|||
161724319|NCT01120093|584034201|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161724320|NCT01120093|584034202|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161724321|NCT01120093|584034198|FG000|Treatment Period 4|Adverse Event|1|||
161724322|NCT01120093|584034199|FG001|Treatment Period 4|Adverse Event|0|||
161724323|NCT01120093|584034200|FG002|Treatment Period 4|Adverse Event|0|||
161724324|NCT01120093|584034201|FG003|Treatment Period 4|Adverse Event|0|||
161724325|NCT01120093|584034202|FG004|Treatment Period 4|Adverse Event|0|||
161724326|NCT01120093|584034198|FG000|Treatment Period 5|Adverse Event|0|||
161724327|NCT01120093|584034199|FG001|Treatment Period 5|Adverse Event|1|||
161724328|NCT01120093|584034200|FG002|Treatment Period 5|Adverse Event|0|||
161724329|NCT01120093|584034201|FG003|Treatment Period 5|Adverse Event|1|||
161724330|NCT01120093|584034202|FG004|Treatment Period 5|Adverse Event|0|||
161724331|NCT03649321|584034207|FG000|Overall Study|Withdrawal by Subject|1|||
161724332|NCT03649321|584034208|FG001|Overall Study|Withdrawal by Subject|0|||
161724333|NCT03649321|584034207|FG000|Overall Study|Death|1|||
161724334|NCT03649321|584034208|FG001|Overall Study|Death|0|||
161724335|NCT01702363|584034209|FG000|Overall Study|Adverse Event|14|||
161724336|NCT01702363|584034209|FG000|Overall Study|Lack of Efficacy|4|||
161724337|NCT01702363|584034209|FG000|Overall Study|Withdrawal by Subject|2|||
161724338|NCT01312428|584034210|FG000|Overall Study|Study Termination|3|||
161724339|NCT01312428|584034211|FG001|Overall Study|Study Termination|4|||
161724340|NCT02214186|584034217|FG000|Overall Study|Lost to Follow-up|1|||
161724341|NCT02214186|584034218|FG001|Overall Study|Lost to Follow-up|1|||
161724342|NCT02214186|584034217|FG000|Overall Study|Protocol Violation|1|||
161724343|NCT02214186|584034218|FG001|Overall Study|Protocol Violation|1|||
161724344|NCT01525849|584034222|FG000|Overall Study|Lost to Follow-up|3|||
161724345|NCT01525849|584034223|FG001|Overall Study|Lost to Follow-up|2|||
161724346|NCT01525849|584034222|FG000|Overall Study|Withdrawal by Subject|1|||
161724347|NCT01525849|584034223|FG001|Overall Study|Withdrawal by Subject|9|||
161724348|NCT01525849|584034222|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
161724349|NCT01525849|584034223|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
161724350|NCT01525849|584034222|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
161724351|NCT01525849|584034223|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
161724352|NCT00431847|584034224|FG000|Overall Study|completion of less than two study visits|6|||
161724353|NCT00431847|584034225|FG001|Overall Study|completion of less than two study visits|3|||
161724354|NCT00431847|584034226|FG002|Overall Study|completion of less than two study visits|4|||
161724355|NCT00431847|584034227|FG003|Overall Study|completion of less than two study visits|14|||
161724356|NCT00431847|584034228|FG004|Overall Study|completion of less than two study visits|0|||
161724357|NCT00431847|584034224|FG000|Overall Study|Protocol Violation|0|||
161724358|NCT00431847|584034225|FG001|Overall Study|Protocol Violation|0|||
161724359|NCT00431847|584034226|FG002|Overall Study|Protocol Violation|0|||
161724360|NCT00431847|584034227|FG003|Overall Study|Protocol Violation|0|||
161724361|NCT00431847|584034228|FG004|Overall Study|Protocol Violation|1|||
161724362|NCT00339183|584034231|FG000|Overall Study|Adverse Event|5|||
161724363|NCT00339183|584034232|FG001|Overall Study|Adverse Event|3|||
161724364|NCT00339183|584034231|FG000|Overall Study|Withdrawal by Subject|16|||
161724365|NCT00339183|584034232|FG001|Overall Study|Withdrawal by Subject|19|||
161724366|NCT00339183|584034231|FG000|Overall Study|Physician Decision|2|||
161724367|NCT00339183|584034232|FG001|Overall Study|Physician Decision|4|||
161724368|NCT00339183|584034231|FG000|Overall Study|Lost to Follow-up|17|||
161724369|NCT00339183|584034232|FG001|Overall Study|Lost to Follow-up|17|||
161724370|NCT00339183|584034231|FG000|Overall Study|Protocol-specified criteria|12|||
161724371|NCT00339183|584034232|FG001|Overall Study|Protocol-specified criteria|8|||
161724372|NCT00339183|584034231|FG000|Overall Study|Missing reason|3|||
161724373|NCT00339183|584034232|FG001|Overall Study|Missing reason|1|||
161724374|NCT00339183|584034231|FG000|Overall Study|Other|46|||
161724375|NCT00339183|584034232|FG001|Overall Study|Other|40|||
161724376|NCT00339183|584034231|FG000|Overall Study|Ongoing|20|||
161724377|NCT00339183|584034232|FG001|Overall Study|Ongoing|13|||
161724378|NCT00793819|584034233|FG000|Overall Study|Adverse Event|8|||
161724379|NCT00793819|584034234|FG001|Overall Study|Adverse Event|4|||
161724380|NCT00793819|584034233|FG000|Overall Study|Lack of Efficacy|1|||
161724381|NCT00793819|584034234|FG001|Overall Study|Lack of Efficacy|1|||
161724382|NCT00793819|584034233|FG000|Overall Study|Withdrawal by Subject|4|||
161724383|NCT00793819|584034234|FG001|Overall Study|Withdrawal by Subject|3|||
161724384|NCT00793819|584034233|FG000|Overall Study|Lost to Follow-up|1|||
161724385|NCT00793819|584034234|FG001|Overall Study|Lost to Follow-up|1|||
161724386|NCT00002663|584034235|FG000|Overall Study|Death|4|||
161724387|NCT00002663|584034236|FG001|Overall Study|Death|1|||
161724388|NCT00002663|584034237|FG002|Overall Study|Death|1|||
161724389|NCT00002663|584034238|FG003|Overall Study|Death|0|||
161724390|NCT00002663|584034239|FG004|Overall Study|Death|0|||
161724391|NCT00002663|584034240|FG005|Overall Study|Death|13|||
161724392|NCT00002663|584034241|FG006|Overall Study|Death|0|||
161724393|NCT00002663|584034242|FG007|Overall Study|Death|1|||
161724394|NCT00002663|584034243|FG008|Overall Study|Death|1|||
161724395|NCT00002663|584034244|FG009|Overall Study|Death|1|||
161724396|NCT00002663|584034235|FG000|Overall Study|Lost to Follow-up|3|||
161724397|NCT00002663|584034236|FG001|Overall Study|Lost to Follow-up|0|||
161724398|NCT00002663|584034237|FG002|Overall Study|Lost to Follow-up|0|||
161724399|NCT00002663|584034238|FG003|Overall Study|Lost to Follow-up|1|||
161724400|NCT00002663|584034239|FG004|Overall Study|Lost to Follow-up|0|||
161724401|NCT00002663|584034240|FG005|Overall Study|Lost to Follow-up|1|||
161724402|NCT00002663|584034241|FG006|Overall Study|Lost to Follow-up|0|||
161724403|NCT00002663|584034242|FG007|Overall Study|Lost to Follow-up|0|||
161724404|NCT00002663|584034243|FG008|Overall Study|Lost to Follow-up|0|||
161724405|NCT00002663|584034244|FG009|Overall Study|Lost to Follow-up|0|||
161724406|NCT00002663|584034235|FG000|Overall Study|Other|0|||
161724407|NCT00002663|584034236|FG001|Overall Study|Other|1|||
161724408|NCT00002663|584034237|FG002|Overall Study|Other|0|||
161724409|NCT00002663|584034238|FG003|Overall Study|Other|0|||
161724410|NCT00002663|584034239|FG004|Overall Study|Other|0|||
161724411|NCT00002663|584034240|FG005|Overall Study|Other|1|||
161724412|NCT00002663|584034241|FG006|Overall Study|Other|1|||
161724413|NCT00002663|584034242|FG007|Overall Study|Other|0|||
161724414|NCT00002663|584034243|FG008|Overall Study|Other|0|||
161724415|NCT00002663|584034244|FG009|Overall Study|Other|0|||
161724416|NCT00002663|584034235|FG000|Overall Study|Physician Decision|0|||
161724417|NCT00002663|584034236|FG001|Overall Study|Physician Decision|0|||
161724418|NCT00002663|584034237|FG002|Overall Study|Physician Decision|0|||
161724419|NCT00002663|584034238|FG003|Overall Study|Physician Decision|0|||
161724420|NCT00002663|584034239|FG004|Overall Study|Physician Decision|1|||
161724421|NCT00002663|584034240|FG005|Overall Study|Physician Decision|0|||
161724422|NCT00002663|584034241|FG006|Overall Study|Physician Decision|0|||
161724423|NCT00002663|584034242|FG007|Overall Study|Physician Decision|0|||
161724424|NCT00002663|584034243|FG008|Overall Study|Physician Decision|1|||
161724425|NCT00002663|584034244|FG009|Overall Study|Physician Decision|1|||
161724426|NCT00002663|584034235|FG000|Overall Study|Adverse Event|0|||
161724427|NCT00002663|584034236|FG001|Overall Study|Adverse Event|0|||
161724428|NCT00002663|584034237|FG002|Overall Study|Adverse Event|0|||
161724429|NCT00002663|584034238|FG003|Overall Study|Adverse Event|1|||
161724430|NCT00002663|584034239|FG004|Overall Study|Adverse Event|0|||
161724431|NCT00002663|584034240|FG005|Overall Study|Adverse Event|0|||
161724432|NCT00002663|584034241|FG006|Overall Study|Adverse Event|0|||
161724433|NCT00002663|584034242|FG007|Overall Study|Adverse Event|1|||
161724434|NCT00002663|584034243|FG008|Overall Study|Adverse Event|0|||
161724435|NCT00002663|584034244|FG009|Overall Study|Adverse Event|0|||
161724436|NCT00446446|584034248|FG000|Overall Study|Death|10|||
161724437|NCT00446446|584034248|FG000|Overall Study|Withdrawal by Subject|6|||
161724438|NCT00446446|584034248|FG000|Overall Study|Other|4|||
161724439|NCT00446446|584034248|FG000|Overall Study|Disease Progession|2|||
161724440|NCT00446446|584034248|FG000|Overall Study|Adverse Event|1|||
161724441|NCT00446446|584034248|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
161724442|NCT02142894|584034249|FG000|Overall Study|Protocol Violation|8|||
161724443|NCT00611130|584034255|FG000|Overall Study|Lost to Follow-up|25|||
161724444|NCT00611130|584034256|FG001|Overall Study|Lost to Follow-up|29|||
161724445|NCT00611130|584034255|FG000|Overall Study|Protocol noncompliance|7|||
161724446|NCT00611130|584034256|FG001|Overall Study|Protocol noncompliance|6|||
161724447|NCT00611130|584034255|FG000|Overall Study|Withdrawal by Subject|6|||
161724448|NCT00611130|584034256|FG001|Overall Study|Withdrawal by Subject|5|||
161724449|NCT00611130|584034255|FG000|Overall Study|Other|5|||
161724450|NCT00611130|584034256|FG001|Overall Study|Other|4|||
161724451|NCT00611130|584034255|FG000|Overall Study|Incarceration|3|||
161724452|NCT00611130|584034256|FG001|Overall Study|Incarceration|2|||
161724453|NCT00611130|584034255|FG000|Overall Study|Administrative|1|||
161724454|NCT00611130|584034256|FG001|Overall Study|Administrative|1|||
161724455|NCT00611130|584034255|FG000|Overall Study|Adverse Event|1|||
161724456|NCT00611130|584034256|FG001|Overall Study|Adverse Event|0|||
161724457|NCT00611130|584034255|FG000|Overall Study|Death|1|||
161724458|NCT00611130|584034256|FG001|Overall Study|Death|0|||
161724459|NCT05100199|584034262|FG000|Overall Study|Lost to Follow-up|5|||
161724460|NCT05100199|584034263|FG001|Overall Study|Lost to Follow-up|8|||
161724461|NCT05100199|584034264|FG002|Overall Study|Lost to Follow-up|3|||
161724462|NCT05100199|584034265|FG003|Overall Study|Lost to Follow-up|6|||
161724463|NCT05100199|584034262|FG000|Overall Study|Withdrawal by Subject|3|||
161724464|NCT05100199|584034263|FG001|Overall Study|Withdrawal by Subject|3|||
161724465|NCT05100199|584034264|FG002|Overall Study|Withdrawal by Subject|9|||
161724466|NCT05100199|584034265|FG003|Overall Study|Withdrawal by Subject|7|||
161724467|NCT05100199|584034262|FG000|Overall Study|Other|0|||
161724468|NCT05100199|584034263|FG001|Overall Study|Other|0|||
161724469|NCT05100199|584034264|FG002|Overall Study|Other|1|||
161724470|NCT05100199|584034265|FG003|Overall Study|Other|1|||
161724471|NCT01455428|584034266|FG000|Overall Study|Protocol Violation|2|||
161724472|NCT01455428|584034267|FG001|Overall Study|Protocol Violation|1|||
161724473|NCT01455428|584034266|FG000|Overall Study|Adverse Event|6|||
161724474|NCT01455428|584034267|FG001|Overall Study|Adverse Event|2|||
161724475|NCT01455428|584034266|FG000|Overall Study|Lost to Follow-up|1|||
161724476|NCT01455428|584034267|FG001|Overall Study|Lost to Follow-up|1|||
161724477|NCT01455428|584034266|FG000|Overall Study|Withdrawal by Subject|2|||
161724478|NCT01455428|584034267|FG001|Overall Study|Withdrawal by Subject|5|||
161724479|NCT01455428|584034266|FG000|Overall Study|Did not meet entrance criteria|0|||
161724480|NCT01455428|584034267|FG001|Overall Study|Did not meet entrance criteria|2|||
161724481|NCT01455428|584034266|FG000|Overall Study|Insufficient clinical response|0|||
161724482|NCT01455428|584034267|FG001|Overall Study|Insufficient clinical response|2|||
161724483|NCT01455428|584034266|FG000|Overall Study|Did not receive treatment|1|||
161724484|NCT01455428|584034267|FG001|Overall Study|Did not receive treatment|1|||
161724485|NCT01455428|584034266|FG000|Overall Study|Other|2|||
161724486|NCT01455428|584034267|FG001|Overall Study|Other|4|||
161724487|NCT00257192|584034271|FG000|Overall Study|Adverse Event|21|||
161724488|NCT00257192|584034272|FG001|Overall Study|Adverse Event|10|||
161724489|NCT00257192|584034271|FG000|Overall Study|Laboratory abnormality|1|||
161724490|NCT00257192|584034272|FG001|Overall Study|Laboratory abnormality|1|||
161724491|NCT00257192|584034271|FG000|Overall Study|Lost to Follow-up|3|||
161724492|NCT00257192|584034272|FG001|Overall Study|Lost to Follow-up|3|||
161724493|NCT00257192|584034271|FG000|Overall Study|Insufficient clinical response|18|||
161724494|NCT00257192|584034272|FG001|Overall Study|Insufficient clinical response|18|||
161724495|NCT00257192|584034271|FG000|Overall Study|Withdrawal by Subject|14|||
161724496|NCT00257192|584034272|FG001|Overall Study|Withdrawal by Subject|2|||
161724497|NCT00257192|584034271|FG000|Overall Study|Randomized but not treated|0|||
161724498|NCT00257192|584034272|FG001|Overall Study|Randomized but not treated|1|||
161724499|NCT00257192|584034271|FG000|Overall Study|Study terminated by sponsor|1|||
161724500|NCT00257192|584034272|FG001|Overall Study|Study terminated by sponsor|0|||
161724501|NCT00257192|584034271|FG000|Overall Study|Miscellaneous|0|||
161724502|NCT00257192|584034272|FG001|Overall Study|Miscellaneous|4|||
161724503|NCT02062151|584034273|FG000|Overall Study|screen failure|1|||
161724504|NCT02021812|584034276|FG000|Overall Study|Death|8|||
161724505|NCT02021812|584034276|FG000|Overall Study|Withdrawal by Subject|3|||
161724506|NCT02021812|584034276|FG000|Overall Study|Lost to Follow-up|2|||
161724507|NCT02021812|584034276|FG000|Overall Study|Refuse to return, COVD 19|2|||
161724508|NCT02119104|584034278|FG000|Overall Study|Protocol Violation|16|||
161724509|NCT01651260|584034279|FG000|Overall Study|unable to apply product|3|||
161724510|NCT01952015|584034282|FG000|Induction|Protocol Violation|1|||
161724511|NCT01952015|584034282|FG000|Maintenance|Adverse Event|2|||
161724512|NCT01952015|584034282|FG000|Treatment Period 3|Physician Decision|9|||
161724513|NCT02239094|584034283|FG000|Overall Study|Withdrawal by Subject|1|||
161724514|NCT02239094|584034283|FG000|Overall Study|Remitted before started|1|||
161724515|NCT01469052|584034288|FG000|Overall Study|Adverse Event|2|||
161724516|NCT01469052|584034289|FG001|Overall Study|Adverse Event|3|||
161724517|NCT01469052|584034290|FG002|Overall Study|Adverse Event|0|||
161724518|NCT01469052|584034291|FG003|Overall Study|Adverse Event|2|||
161724519|NCT01469052|584034292|FG004|Overall Study|Adverse Event|0|||
161724520|NCT01469052|584034293|FG005|Overall Study|Adverse Event|1|||
161724521|NCT01469052|584034288|FG000|Overall Study|Progressive disease|3|||
161724522|NCT01469052|584034289|FG001|Overall Study|Progressive disease|0|||
161724523|NCT01469052|584034290|FG002|Overall Study|Progressive disease|5|||
161724524|NCT01469052|584034291|FG003|Overall Study|Progressive disease|3|||
161724525|NCT01469052|584034292|FG004|Overall Study|Progressive disease|7|||
161724526|NCT01469052|584034293|FG005|Overall Study|Progressive disease|2|||
161724527|NCT01469052|584034288|FG000|Overall Study|Lack of Efficacy|0|||
161724528|NCT01469052|584034289|FG001|Overall Study|Lack of Efficacy|0|||
161724529|NCT01469052|584034290|FG002|Overall Study|Lack of Efficacy|0|||
161724530|NCT01469052|584034291|FG003|Overall Study|Lack of Efficacy|0|||
161724531|NCT01469052|584034292|FG004|Overall Study|Lack of Efficacy|0|||
161724532|NCT01469052|584034293|FG005|Overall Study|Lack of Efficacy|2|||
161724533|NCT01469052|584034288|FG000|Overall Study|Moved to rollover protocol|1|||
161724534|NCT01469052|584034289|FG001|Overall Study|Moved to rollover protocol|0|||
161724535|NCT01469052|584034290|FG002|Overall Study|Moved to rollover protocol|1|||
161724536|NCT01469052|584034291|FG003|Overall Study|Moved to rollover protocol|0|||
161724537|NCT01469052|584034292|FG004|Overall Study|Moved to rollover protocol|0|||
161724538|NCT01469052|584034293|FG005|Overall Study|Moved to rollover protocol|1|||
161724539|NCT01469052|584034288|FG000|Overall Study|Other|0|||
161724540|NCT01469052|584034289|FG001|Overall Study|Other|1|||
161724541|NCT01469052|584034290|FG002|Overall Study|Other|0|||
161724542|NCT01469052|584034291|FG003|Overall Study|Other|0|||
161724543|NCT01469052|584034292|FG004|Overall Study|Other|1|||
161724544|NCT01469052|584034293|FG005|Overall Study|Other|0|||
161724545|NCT02508701|584034294|FG000|Overall Study|Lost to Follow-up|9|||
161724546|NCT02508701|584034295|FG001|Overall Study|Lost to Follow-up|5|||
161724547|NCT02508701|584034296|FG002|Overall Study|Lost to Follow-up|5|||
161724548|NCT02508701|584034297|FG003|Overall Study|Lost to Follow-up|3|||
161724549|NCT03648996|584034299|FG000|Overall Study|Withdrawal by Subject|0|||
161724550|NCT03648996|584034300|FG001|Overall Study|Withdrawal by Subject|2|||
161724551|NCT03648996|584034301|FG002|Overall Study|Withdrawal by Subject|2|||
161724552|NCT03648996|584034299|FG000|Overall Study|Physician Decision|2|||
161724553|NCT03648996|584034300|FG001|Overall Study|Physician Decision|0|||
161724554|NCT03648996|584034301|FG002|Overall Study|Physician Decision|0|||
161724555|NCT00365976|584034303|FG000|Overall Study|Withdrawal by Subject|1|||
161724556|NCT00365976|584034304|FG001|Overall Study|Withdrawal by Subject|5|||
161724557|NCT01415440|584034305|FG000|Overall Study|Lost to Follow-up|0|||
161724558|NCT01415440|584034306|FG001|Overall Study|Lost to Follow-up|1|||
161724559|NCT01415440|584034307|FG002|Overall Study|Lost to Follow-up|2|||
161724560|NCT01415440|584034305|FG000|Overall Study|Physician Decision|3|||
161724561|NCT01415440|584034306|FG001|Overall Study|Physician Decision|0|||
161724562|NCT01415440|584034307|FG002|Overall Study|Physician Decision|0|||
161724563|NCT01415440|584034305|FG000|Overall Study|Withdrawal by Subject|1|||
161724564|NCT01415440|584034306|FG001|Overall Study|Withdrawal by Subject|0|||
161724565|NCT01415440|584034307|FG002|Overall Study|Withdrawal by Subject|0|||
161724566|NCT01781026|584034308|FG000|Overall Study|Lack of Efficacy|2|||
161724567|NCT03141307|584034309|FG000|In-Hospital|Withdrawal by Subject|0|||
161724568|NCT03141307|584034310|FG001|In-Hospital|Withdrawal by Subject|2|||
161724569|NCT03141307|584034309|FG000|In-Hospital|Protocol Violation|4|||
161724570|NCT03141307|584034310|FG001|In-Hospital|Protocol Violation|0|||
161724571|NCT03141307|584034309|FG000|Follow-Up|Lost to Follow-up|97|||
161724572|NCT03141307|584034310|FG001|Follow-Up|Lost to Follow-up|54|||
161724573|NCT00227877|584034311|FG000|Pre-visit Assessment|Technical difficulties|7|||
161724574|NCT00227877|584034312|FG001|Pre-visit Assessment|Technical difficulties|3|||
161724575|NCT00227877|584034313|FG002|Pre-visit Assessment|Technical difficulties|0|||
161724576|NCT00227877|584034314|FG003|Pre-visit Assessment|Technical difficulties|0|||
161724577|NCT00227877|584034311|FG000|Post-visit Checklist|Lost to Follow-up|24|||
161724578|NCT00227877|584034312|FG001|Post-visit Checklist|Lost to Follow-up|13|||
161724579|NCT00227877|584034313|FG002|Post-visit Checklist|Lost to Follow-up|1|||
161724580|NCT00227877|584034314|FG003|Post-visit Checklist|Lost to Follow-up|0|||
161724581|NCT00227877|584034311|FG000|3-months Follow-up|Completed late|135|||
161724582|NCT00227877|584034312|FG001|3-months Follow-up|Completed late|128|||
161724583|NCT00227877|584034313|FG002|3-months Follow-up|Completed late|34|||
161724584|NCT00227877|584034314|FG003|3-months Follow-up|Completed late|8|||
161724585|NCT00227877|584034311|FG000|3-months Follow-up|Lost to Follow-up|178|||
161724586|NCT00227877|584034312|FG001|3-months Follow-up|Lost to Follow-up|139|||
161724587|NCT00227877|584034313|FG002|3-months Follow-up|Lost to Follow-up|18|||
161724588|NCT00227877|584034314|FG003|3-months Follow-up|Lost to Follow-up|13|||
161724589|NCT00227877|584034311|FG000|12-months Follow-up|Completed late|78|||
161724590|NCT00227877|584034312|FG001|12-months Follow-up|Completed late|74|||
161724591|NCT00227877|584034313|FG002|12-months Follow-up|Completed late|1|||
161724592|NCT00227877|584034314|FG003|12-months Follow-up|Completed late|0|||
161724593|NCT00227877|584034311|FG000|12-months Follow-up|Lost to Follow-up|232|||
161724594|NCT00227877|584034312|FG001|12-months Follow-up|Lost to Follow-up|189|||
161724595|NCT00227877|584034313|FG002|12-months Follow-up|Lost to Follow-up|30|||
161724596|NCT00227877|584034314|FG003|12-months Follow-up|Lost to Follow-up|26|||
161724597|NCT03090737|584034315|FG000|Overall Study|Other reasons|1|||
161724598|NCT03090737|584034315|FG000|Overall Study|Completed treatment as per protocol|17|||
161724599|NCT03090737|584034315|FG000|Overall Study|Maximum clinical benefit|2|||
161724600|NCT03090737|584034315|FG000|Overall Study|Adverse event unrelated to study drug|7|||
161724601|NCT03090737|584034315|FG000|Overall Study|Study drug toxicity|4|||
161724602|NCT03090737|584034315|FG000|Overall Study|Disease progression|98|||
161724603|NCT03596177|584034317|FG000|Single Blind Period|Withdrawal by Subject|1|||
161724604|NCT03596177|584034318|FG001|Single Blind Period|Withdrawal by Subject|1|||
161724605|NCT03596177|584034317|FG000|Single Blind Period|Other|1|||
161724606|NCT03596177|584034318|FG001|Single Blind Period|Other|0|||
161724607|NCT03596177|584034317|FG000|Double Blind Period|Withdrawal by Subject|0|||
161724608|NCT03596177|584034318|FG001|Double Blind Period|Withdrawal by Subject|1|||
161724609|NCT03596177|584034317|FG000|Double Blind Period|Other|0|||
161724610|NCT03596177|584034318|FG001|Double Blind Period|Other|4|||
161724611|NCT03596177|584034317|FG000|Double Blind Period|Death during safety follow-up|0|||
161724612|NCT03596177|584034318|FG001|Double Blind Period|Death during safety follow-up|1|||
161724613|NCT02522481|584034319|FG000|Overall Study|discontinued|1|||
161724614|NCT02522481|584034319|FG000|Overall Study|Not dosed|2|||
161724615|NCT03123939|584034320|FG000|Overall Study|Lack of Efficacy|6|||
161724616|NCT03123939|584034320|FG000|Overall Study|Death|5|||
161724617|NCT03123939|584034320|FG000|Overall Study|Physician Decision|2|||
161724618|NCT03123939|584034320|FG000|Overall Study|Subject/guardian decision|2|||
161724619|NCT03123939|584034320|FG000|Overall Study|Lost to Follow-up|1|||
161724620|NCT03123939|584034320|FG000|Overall Study|New therapy for study indication|1|||
161724621|NCT03123939|584034320|FG000|Overall Study|Protocol deviation|1|||
161724622|NCT03123939|584034320|FG000|Overall Study|Progressive disease|18|||
161724623|NCT03123939|584034320|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
161724624|NCT03123939|584034320|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
161724625|NCT02531373|584035977|FG000|Overall Study|Lack of Efficacy|0|||
161724626|NCT02531373|584035978|FG001|Overall Study|Lack of Efficacy|0|||
161724627|NCT02531373|584035979|FG002|Overall Study|Lack of Efficacy|0|||
161724628|NCT02531373|584035980|FG003|Overall Study|Lack of Efficacy|0|||
161724629|NCT02531373|584035981|FG004|Overall Study|Lack of Efficacy|3|||
161724630|NCT02531373|584035982|FG005|Overall Study|Lack of Efficacy|2|||
161724631|NCT02531373|584035983|FG006|Overall Study|Lack of Efficacy|4|||
161724632|NCT02531373|584035984|FG007|Overall Study|Lack of Efficacy|8|||
161724633|NCT02531373|584035985|FG008|Overall Study|Lack of Efficacy|5|||
161724634|NCT02531373|584035977|FG000|Overall Study|Lost to Follow-up|0|||
161724635|NCT02531373|584035978|FG001|Overall Study|Lost to Follow-up|0|||
161724636|NCT02531373|584035979|FG002|Overall Study|Lost to Follow-up|0|||
161724637|NCT02531373|584035980|FG003|Overall Study|Lost to Follow-up|0|||
161724638|NCT02531373|584035981|FG004|Overall Study|Lost to Follow-up|0|||
161724639|NCT02531373|584035982|FG005|Overall Study|Lost to Follow-up|2|||
161724640|NCT02531373|584035983|FG006|Overall Study|Lost to Follow-up|2|||
161724641|NCT02531373|584035984|FG007|Overall Study|Lost to Follow-up|0|||
161724642|NCT02531373|584035985|FG008|Overall Study|Lost to Follow-up|0|||
161724643|NCT02531373|584035977|FG000|Overall Study|Physician Decision|0|||
161724644|NCT02531373|584035978|FG001|Overall Study|Physician Decision|0|||
161724645|NCT02531373|584035979|FG002|Overall Study|Physician Decision|0|||
161724646|NCT02531373|584035980|FG003|Overall Study|Physician Decision|0|||
161724647|NCT02531373|584035981|FG004|Overall Study|Physician Decision|2|||
161724648|NCT02531373|584035982|FG005|Overall Study|Physician Decision|1|||
161724649|NCT02531373|584035983|FG006|Overall Study|Physician Decision|0|||
161724650|NCT02531373|584035984|FG007|Overall Study|Physician Decision|0|||
161724651|NCT02531373|584035985|FG008|Overall Study|Physician Decision|0|||
161724652|NCT02531373|584035977|FG000|Overall Study|Protocol Violation|0|||
161724653|NCT02531373|584035978|FG001|Overall Study|Protocol Violation|0|||
161724654|NCT02531373|584035979|FG002|Overall Study|Protocol Violation|0|||
161724655|NCT02531373|584035980|FG003|Overall Study|Protocol Violation|0|||
161724656|NCT02531373|584035981|FG004|Overall Study|Protocol Violation|0|||
161724657|NCT02531373|584035982|FG005|Overall Study|Protocol Violation|1|||
161724658|NCT02531373|584035983|FG006|Overall Study|Protocol Violation|1|||
161724659|NCT02531373|584035984|FG007|Overall Study|Protocol Violation|0|||
161724660|NCT02531373|584035985|FG008|Overall Study|Protocol Violation|1|||
161724661|NCT02531373|584035977|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161724662|NCT02531373|584035978|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161724663|NCT02531373|584035979|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161724664|NCT02531373|584035980|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161724665|NCT02531373|584035981|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161724666|NCT02531373|584035982|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
161724667|NCT02531373|584035983|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
161724668|NCT02531373|584035984|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
161724669|NCT02531373|584035985|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
161724670|NCT02531373|584035977|FG000|Overall Study|Withdrawal by Subject|0|||
161724671|NCT02531373|584035978|FG001|Overall Study|Withdrawal by Subject|0|||
161724672|NCT02531373|584035979|FG002|Overall Study|Withdrawal by Subject|0|||
161724673|NCT02531373|584035980|FG003|Overall Study|Withdrawal by Subject|0|||
161724674|NCT02531373|584035981|FG004|Overall Study|Withdrawal by Subject|3|||
161724675|NCT02531373|584035982|FG005|Overall Study|Withdrawal by Subject|0|||
161724676|NCT02531373|584035983|FG006|Overall Study|Withdrawal by Subject|0|||
161724677|NCT02531373|584035984|FG007|Overall Study|Withdrawal by Subject|0|||
161724678|NCT02531373|584035985|FG008|Overall Study|Withdrawal by Subject|0|||
161724679|NCT01675531|584035986|FG000|Overall Study|Adverse Event|9|||
161724680|NCT01675531|584035986|FG000|Overall Study|Withdrawal by Subject|7|||
161724681|NCT01675531|584035986|FG000|Overall Study|Lack of Efficacy|1|||
161724682|NCT01675531|584035986|FG000|Overall Study|Protocol Violation|8|||
161724683|NCT01623531|584035987|FG000|Overall Study|Death|1|||
161724684|NCT01623531|584035988|FG001|Overall Study|Death|0|||
161724685|NCT01623531|584035987|FG000|Overall Study|Protocol Violation|2|||
161724686|NCT01623531|584035988|FG001|Overall Study|Protocol Violation|1|||
161724687|NCT01623531|584035987|FG000|Overall Study|Missing data at primary outcome time poi|1|||
161724688|NCT01623531|584035988|FG001|Overall Study|Missing data at primary outcome time poi|1|||
161724689|NCT02834403|584035989|FG000|Overall Study|Physician Decision|2|||
161724690|NCT02834403|584035990|FG001|Overall Study|Physician Decision|1|||
161724691|NCT02834403|584035991|FG002|Overall Study|Physician Decision|2|||
161724692|NCT02834403|584035992|FG003|Overall Study|Physician Decision|1|||
161724693|NCT02834403|584035993|FG004|Overall Study|Physician Decision|1|||
161724694|NCT02834403|584035994|FG005|Overall Study|Physician Decision|2|||
161724695|NCT02834403|584035995|FG006|Overall Study|Physician Decision|12|||
161724696|NCT02834403|584035989|FG000|Overall Study|Adverse Event|0|||
161724697|NCT02834403|584035990|FG001|Overall Study|Adverse Event|0|||
161724698|NCT02834403|584035991|FG002|Overall Study|Adverse Event|0|||
161724699|NCT02834403|584035992|FG003|Overall Study|Adverse Event|0|||
161724700|NCT02834403|584035993|FG004|Overall Study|Adverse Event|1|||
161724701|NCT02834403|584035994|FG005|Overall Study|Adverse Event|1|||
161724702|NCT02834403|584035995|FG006|Overall Study|Adverse Event|3|||
161724703|NCT02834403|584035989|FG000|Overall Study|Withdrawal by Subject|0|||
161724704|NCT02834403|584035990|FG001|Overall Study|Withdrawal by Subject|1|||
161724705|NCT02834403|584035991|FG002|Overall Study|Withdrawal by Subject|0|||
161724706|NCT02834403|584035992|FG003|Overall Study|Withdrawal by Subject|0|||
161724707|NCT02834403|584035993|FG004|Overall Study|Withdrawal by Subject|1|||
161724708|NCT02834403|584035994|FG005|Overall Study|Withdrawal by Subject|0|||
161724709|NCT02834403|584035995|FG006|Overall Study|Withdrawal by Subject|0|||
161724710|NCT02834403|584035989|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
161724711|NCT02834403|584035990|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
161724712|NCT02834403|584035991|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
161724713|NCT02834403|584035992|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
161724714|NCT02834403|584035993|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
161724715|NCT02834403|584035994|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
161724716|NCT02834403|584035995|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
161724717|NCT04705597|584035996|FG000|Overall Study|Death|16|||
161724718|NCT04705597|584035997|FG001|Overall Study|Death|9|||
161724719|NCT04705597|584035996|FG000|Overall Study|Lost to Follow-up|1|||
161724720|NCT04705597|584035997|FG001|Overall Study|Lost to Follow-up|0|||
161724721|NCT04705597|584035996|FG000|Overall Study|Withdrawal by Subject|1|||
161724722|NCT04705597|584035997|FG001|Overall Study|Withdrawal by Subject|2|||
161724723|NCT02606045|584035998|FG000|Overall Study|Study closed before treament could begin|1|||
161724724|NCT02606045|584035999|FG001|Overall Study|Study closed before treament could begin|2|||
161724725|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
161724726|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
161724727|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724728|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724729|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724730|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724731|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724732|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724733|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
161724734|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724735|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724736|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
161724737|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724738|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724739|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
161724740|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
161724741|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
161724742|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
161724743|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161724744|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161724745|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161724746|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Other|0|||
161724747|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Other|1|||
161724748|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Other|0|||
161724749|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Other|0|||
161724750|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Other|0|||
161724751|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Other|0|||
161724752|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Other|0|||
161724753|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
161724754|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
161724755|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
161724756|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
161724757|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
161724758|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
161724759|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
161724760|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
161724761|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
161724762|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161724763|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
161724764|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
161724765|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161724766|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161724767|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
161724768|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
161724769|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
161724770|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
161724771|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
161724772|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
161724773|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
161724774|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
161724775|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724776|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724777|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
161724778|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
161724779|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724780|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724781|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
161724782|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
161724783|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
161724784|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
161724785|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
161724786|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
161724787|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
161724788|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
161724789|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
161724790|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
161724791|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
161724792|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161724793|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161724794|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161724795|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
161724796|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724797|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724798|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724799|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
161724800|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724801|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724802|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724803|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
161724804|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
161724805|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724806|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724807|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724808|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724809|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
161724810|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
161724811|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
161724812|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
161724813|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
161724814|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
161724815|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
161724816|NCT00365716|584036000|FG000|Extension 1|Lost to Follow-up|0|||
161724817|NCT00365716|584036001|FG001|Extension 1|Lost to Follow-up|0|||
161724818|NCT00365716|584036002|FG002|Extension 1|Lost to Follow-up|0|||
161724819|NCT00365716|584036003|FG003|Extension 1|Lost to Follow-up|0|||
161724820|NCT00365716|584036004|FG004|Extension 1|Lost to Follow-up|0|||
161724821|NCT00365716|584036005|FG005|Extension 1|Lost to Follow-up|1|||
161724822|NCT00365716|584036006|FG006|Extension 1|Lost to Follow-up|0|||
161724823|NCT00365716|584036000|FG000|Extension 1|Other|0|||
161724824|NCT00365716|584036001|FG001|Extension 1|Other|0|||
161724825|NCT00365716|584036002|FG002|Extension 1|Other|0|||
161724826|NCT00365716|584036003|FG003|Extension 1|Other|0|||
161724827|NCT00365716|584036004|FG004|Extension 1|Other|0|||
161724828|NCT00365716|584036005|FG005|Extension 1|Other|9|||
161724829|NCT00365716|584036006|FG006|Extension 1|Other|0|||
161724830|NCT00365716|584036000|FG000|Extension 1|Moved|0|||
161724831|NCT00365716|584036001|FG001|Extension 1|Moved|0|||
161724832|NCT00365716|584036002|FG002|Extension 1|Moved|0|||
161724833|NCT00365716|584036003|FG003|Extension 1|Moved|0|||
161724834|NCT00365716|584036004|FG004|Extension 1|Moved|0|||
161724835|NCT00365716|584036005|FG005|Extension 1|Moved|4|||
161724836|NCT00365716|584036006|FG006|Extension 1|Moved|0|||
161724837|NCT00365716|584036000|FG000|Extension 1|Withdrawal by Subject|0|||
161724838|NCT00365716|584036001|FG001|Extension 1|Withdrawal by Subject|0|||
161724839|NCT00365716|584036002|FG002|Extension 1|Withdrawal by Subject|0|||
161724840|NCT00365716|584036003|FG003|Extension 1|Withdrawal by Subject|0|||
161724841|NCT00365716|584036004|FG004|Extension 1|Withdrawal by Subject|0|||
161724842|NCT00365716|584036005|FG005|Extension 1|Withdrawal by Subject|3|||
161724843|NCT00365716|584036006|FG006|Extension 1|Withdrawal by Subject|0|||
161724844|NCT00365716|584036000|FG000|Extension 1|Pregnancy|0|||
161724845|NCT00365716|584036001|FG001|Extension 1|Pregnancy|0|||
161724846|NCT00365716|584036002|FG002|Extension 1|Pregnancy|0|||
161724847|NCT00365716|584036003|FG003|Extension 1|Pregnancy|0|||
161724848|NCT00365716|584036004|FG004|Extension 1|Pregnancy|0|||
161724849|NCT00365716|584036005|FG005|Extension 1|Pregnancy|4|||
161724850|NCT00365716|584036006|FG006|Extension 1|Pregnancy|0|||
161724851|NCT00365716|584036000|FG000|Extension 1|Protocol Violation|0|||
161724852|NCT00365716|584036001|FG001|Extension 1|Protocol Violation|0|||
161724853|NCT00365716|584036002|FG002|Extension 1|Protocol Violation|0|||
161724854|NCT00365716|584036003|FG003|Extension 1|Protocol Violation|0|||
161724855|NCT00365716|584036004|FG004|Extension 1|Protocol Violation|0|||
161724856|NCT00365716|584036005|FG005|Extension 1|Protocol Violation|1|||
161724857|NCT00365716|584036006|FG006|Extension 1|Protocol Violation|0|||
161724858|NCT00365716|584036000|FG000|Extension 2|Lost to Follow-up|0|||
161724859|NCT00365716|584036001|FG001|Extension 2|Lost to Follow-up|0|||
161724860|NCT00365716|584036002|FG002|Extension 2|Lost to Follow-up|0|||
161724861|NCT00365716|584036003|FG003|Extension 2|Lost to Follow-up|0|||
161724862|NCT00365716|584036004|FG004|Extension 2|Lost to Follow-up|0|||
161724863|NCT00365716|584036005|FG005|Extension 2|Lost to Follow-up|0|||
161724864|NCT00365716|584036006|FG006|Extension 2|Lost to Follow-up|2|||
161724865|NCT00365716|584036000|FG000|Extension 2|Other|0|||
161724866|NCT00365716|584036001|FG001|Extension 2|Other|0|||
161724867|NCT00365716|584036002|FG002|Extension 2|Other|0|||
161724868|NCT00365716|584036003|FG003|Extension 2|Other|0|||
161724869|NCT00365716|584036004|FG004|Extension 2|Other|0|||
161724870|NCT00365716|584036005|FG005|Extension 2|Other|0|||
161724871|NCT00365716|584036006|FG006|Extension 2|Other|3|||
161724872|NCT00365716|584036000|FG000|Extension 2|Withdrawal by Subject|0|||
161724873|NCT00365716|584036001|FG001|Extension 2|Withdrawal by Subject|0|||
161724874|NCT00365716|584036002|FG002|Extension 2|Withdrawal by Subject|0|||
161724875|NCT00365716|584036003|FG003|Extension 2|Withdrawal by Subject|0|||
161724876|NCT00365716|584036004|FG004|Extension 2|Withdrawal by Subject|0|||
161724877|NCT00365716|584036005|FG005|Extension 2|Withdrawal by Subject|0|||
161724878|NCT00365716|584036006|FG006|Extension 2|Withdrawal by Subject|5|||
161724879|NCT02853331|584036007|FG000|Overall Study|Death|59|||
161724880|NCT02853331|584036008|FG001|Overall Study|Death|95|||
161724881|NCT02853331|584036007|FG000|Overall Study|Withdrawal by Subject|5|||
161724882|NCT02853331|584036008|FG001|Overall Study|Withdrawal by Subject|9|||
161724883|NCT02853331|584036007|FG000|Overall Study|Ongoing in study|368|||
161724884|NCT02853331|584036008|FG001|Overall Study|Ongoing in study|325|||
161724885|NCT00751101|584036009|FG000|Overall Study|Withdrawal by Subject|1|||
161724886|NCT00751101|584036010|FG001|Overall Study|Withdrawal by Subject|0|||
161724887|NCT00751101|584036009|FG000|Overall Study|No HFS / Never Started Patch/|0|||
161724888|NCT00751101|584036010|FG001|Overall Study|No HFS / Never Started Patch/|4|||
161724889|NCT00751101|584036009|FG000|Overall Study|Never began capecitabine|1|||
161724890|NCT00751101|584036010|FG001|Overall Study|Never began capecitabine|0|||
161724891|NCT00751101|584036009|FG000|Overall Study|Physician Decision|0|||
161724892|NCT00751101|584036010|FG001|Overall Study|Physician Decision|1|||
161724893|NCT00844428|584036014|FG000|Screening Period|Screen Failure|3|||
161724894|NCT00844428|584036014|FG000|Extension Treatment Period|Death|1|||
161724895|NCT00844428|584036014|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
161724896|NCT00789477|584036015|FG000|Overall Study|Withdrawal by Subject|2|||
161724897|NCT00789477|584036016|FG001|Overall Study|Withdrawal by Subject|1|||
161724898|NCT00789477|584036017|FG002|Overall Study|Withdrawal by Subject|3|||
161724899|NCT00789477|584036018|FG003|Overall Study|Withdrawal by Subject|2|||
161724900|NCT00789477|584036019|FG004|Overall Study|Withdrawal by Subject|3|||
161724901|NCT00789477|584036015|FG000|Overall Study|Protocol Violation|1|||
161724902|NCT00789477|584036016|FG001|Overall Study|Protocol Violation|0|||
161724903|NCT00789477|584036017|FG002|Overall Study|Protocol Violation|0|||
161724904|NCT00789477|584036018|FG003|Overall Study|Protocol Violation|1|||
161724905|NCT00789477|584036019|FG004|Overall Study|Protocol Violation|0|||
161724906|NCT00789477|584036015|FG000|Overall Study|Adverse Event|3|||
161724907|NCT00789477|584036016|FG001|Overall Study|Adverse Event|3|||
161724908|NCT00789477|584036017|FG002|Overall Study|Adverse Event|1|||
161724909|NCT00789477|584036018|FG003|Overall Study|Adverse Event|0|||
161724910|NCT00789477|584036019|FG004|Overall Study|Adverse Event|0|||
161724911|NCT00789477|584036015|FG000|Overall Study|Death|1|||
161724912|NCT00789477|584036016|FG001|Overall Study|Death|1|||
161724913|NCT00789477|584036017|FG002|Overall Study|Death|2|||
161724914|NCT00789477|584036018|FG003|Overall Study|Death|2|||
161724915|NCT00789477|584036019|FG004|Overall Study|Death|0|||
161724916|NCT00789477|584036015|FG000|Overall Study|Lost to Follow-up|0|||
161724917|NCT00789477|584036016|FG001|Overall Study|Lost to Follow-up|1|||
161724918|NCT00789477|584036017|FG002|Overall Study|Lost to Follow-up|4|||
161724919|NCT00789477|584036018|FG003|Overall Study|Lost to Follow-up|2|||
161724920|NCT00789477|584036019|FG004|Overall Study|Lost to Follow-up|4|||
161724921|NCT00789477|584036015|FG000|Overall Study|Lack of Efficacy|2|||
161724922|NCT00789477|584036016|FG001|Overall Study|Lack of Efficacy|0|||
161724923|NCT00789477|584036017|FG002|Overall Study|Lack of Efficacy|0|||
161724924|NCT00789477|584036018|FG003|Overall Study|Lack of Efficacy|0|||
161724925|NCT00789477|584036019|FG004|Overall Study|Lack of Efficacy|0|||
161724926|NCT00789477|584036015|FG000|Overall Study|Other|2|||
161724927|NCT00789477|584036016|FG001|Overall Study|Other|0|||
161724928|NCT00789477|584036017|FG002|Overall Study|Other|1|||
161724929|NCT00789477|584036018|FG003|Overall Study|Other|3|||
161724930|NCT00789477|584036019|FG004|Overall Study|Other|0|||
161724931|NCT00455858|584036020|FG000|Overall Study|Lost to Follow-up|2|||
161724932|NCT00455858|584036020|FG000|Overall Study|Protocol Violation|1|||
161724933|NCT00455858|584036020|FG000|Overall Study|Lack of Efficacy|1|||
161724934|NCT00455858|584036020|FG000|Overall Study|Well controlled FPG without insulin|1|||
161724935|NCT00455858|584036020|FG000|Overall Study|Withdrawal|1|||
161724936|NCT02092389|584036021|FG000|Overall Study|Adverse Event|1|||
161724937|NCT02092389|584036021|FG000|Overall Study|Other|5|||
161724938|NCT01242020|584036022|FG000|Overall Study|Withdrawal by Subject|2|||
161724939|NCT01242020|584036023|FG001|Overall Study|Withdrawal by Subject|0|||
161724940|NCT01242020|584036022|FG000|Overall Study|Failed screening|1|||
161724941|NCT01242020|584036023|FG001|Overall Study|Failed screening|0|||
161724942|NCT02680847|584036024|FG000|Overall Study|Other|2|||
161724943|NCT02680847|584036025|FG001|Overall Study|Other|0|||
161724944|NCT02680847|584036026|FG002|Overall Study|Other|0|||
161724945|NCT02680847|584036024|FG000|Overall Study|No longer met eligibility criteria|2|||
161724946|NCT02680847|584036025|FG001|Overall Study|No longer met eligibility criteria|2|||
161724947|NCT02680847|584036026|FG002|Overall Study|No longer met eligibility criteria|0|||
161724948|NCT02680847|584036024|FG000|Overall Study|Unwilling to participate in study|1|||
161724949|NCT02680847|584036025|FG001|Overall Study|Unwilling to participate in study|1|||
161724950|NCT02680847|584036026|FG002|Overall Study|Unwilling to participate in study|0|||
161724951|NCT02680847|584036024|FG000|Overall Study|Lack of Efficacy|0|||
161724952|NCT02680847|584036025|FG001|Overall Study|Lack of Efficacy|0|||
161724953|NCT02680847|584036026|FG002|Overall Study|Lack of Efficacy|2|||
161724954|NCT02680847|584036024|FG000|Overall Study|Adverse Event|0|||
161724955|NCT02680847|584036025|FG001|Overall Study|Adverse Event|0|||
161724956|NCT02680847|584036026|FG002|Overall Study|Adverse Event|1|||
161724957|NCT02375698|584036027|FG000|Overall Study|Withdrawal by Subject|0|||
161724958|NCT02375698|584036028|FG001|Overall Study|Withdrawal by Subject|2|||
161724959|NCT02375698|584036027|FG000|Overall Study|Physician Decision|2|||
161724960|NCT02375698|584036028|FG001|Overall Study|Physician Decision|0|||
161724961|NCT01927562|584036034|FG000|Overall Study|Lost to Follow-up|30|||
161724962|NCT01927562|584036034|FG000|Overall Study|Withdrawal by Subject|3|||
161724963|NCT01927562|584036034|FG000|Overall Study|Physician Decision|5|||
161724964|NCT00642616|584036035|FG000|Overall Study|Adverse Event|2|||
161724965|NCT00642616|584036036|FG001|Overall Study|Adverse Event|0|||
161724966|NCT00642616|584036037|FG002|Overall Study|Adverse Event|1|||
161724967|NCT00642616|584036038|FG003|Overall Study|Adverse Event|0|||
161724968|NCT00642616|584036035|FG000|Overall Study|Study Terminated by Sponsor|7|||
161724969|NCT00642616|584036036|FG001|Overall Study|Study Terminated by Sponsor|6|||
161724970|NCT00642616|584036037|FG002|Overall Study|Study Terminated by Sponsor|4|||
161724971|NCT00642616|584036038|FG003|Overall Study|Study Terminated by Sponsor|5|||
161724972|NCT00642616|584036035|FG000|Overall Study|Withdrawal by Subject|0|||
161724973|NCT00642616|584036036|FG001|Overall Study|Withdrawal by Subject|1|||
161724974|NCT00642616|584036037|FG002|Overall Study|Withdrawal by Subject|1|||
161724975|NCT00642616|584036038|FG003|Overall Study|Withdrawal by Subject|1|||
161724976|NCT00642616|584036035|FG000|Overall Study|Protocol Violation|0|||
161724977|NCT00642616|584036036|FG001|Overall Study|Protocol Violation|0|||
161724978|NCT00642616|584036037|FG002|Overall Study|Protocol Violation|2|||
161724979|NCT00642616|584036038|FG003|Overall Study|Protocol Violation|0|||
161724980|NCT00642616|584036035|FG000|Overall Study|Physician Decision|0|||
161724981|NCT00642616|584036036|FG001|Overall Study|Physician Decision|0|||
161724982|NCT00642616|584036037|FG002|Overall Study|Physician Decision|1|||
161724983|NCT00642616|584036038|FG003|Overall Study|Physician Decision|1|||
161724984|NCT02955186|584036039|FG000|Overall Study|Withdrawal by Subject|6|||
161724985|NCT02955186|584036040|FG001|Overall Study|Withdrawal by Subject|2|||
161724986|NCT02955186|584036039|FG000|Overall Study|Protocol Violation|1|||
161724987|NCT02955186|584036040|FG001|Overall Study|Protocol Violation|0|||
161724988|NCT01618656|584036041|FG000|Overall Study|Withdrawal by Subject|7|||
161724989|NCT01618656|584036042|FG001|Overall Study|Withdrawal by Subject|3|||
161724990|NCT01618656|584036041|FG000|Overall Study|Physician Decision|1|||
161724991|NCT01618656|584036042|FG001|Overall Study|Physician Decision|1|||
161724992|NCT01276847|584036043|FG000|Overall Study|Withdrawal by Subject|1|||
161724993|NCT01276847|584036044|FG001|Overall Study|Withdrawal by Subject|0|||
161724994|NCT01276847|584036045|FG002|Overall Study|Withdrawal by Subject|0|||
161724995|NCT00751881|584036046|FG000|Core Treatment Period|Not treated|1|||
161724996|NCT00751881|584036047|FG001|Core Treatment Period|Not treated|1|||
161724997|NCT00751881|584036048|FG002|Core Treatment Period|Not treated|2|||
161724998|NCT00751881|584036046|FG000|Core Treatment Period|Adverse Event|26|||
161724999|NCT00751881|584036047|FG001|Core Treatment Period|Adverse Event|54|||
161725000|NCT00751881|584036048|FG002|Core Treatment Period|Adverse Event|58|||
161725001|NCT00751881|584036046|FG000|Core Treatment Period|Lack of Efficacy|37|||
161725002|NCT00751881|584036047|FG001|Core Treatment Period|Lack of Efficacy|30|||
161725003|NCT00751881|584036048|FG002|Core Treatment Period|Lack of Efficacy|20|||
161725004|NCT00751881|584036046|FG000|Core Treatment Period|Poor compliance to protocol|15|||
161725005|NCT00751881|584036047|FG001|Core Treatment Period|Poor compliance to protocol|3|||
161725006|NCT00751881|584036048|FG002|Core Treatment Period|Poor compliance to protocol|4|||
161725007|NCT00751881|584036046|FG000|Core Treatment Period|Lost to Follow-up|6|||
161725008|NCT00751881|584036047|FG001|Core Treatment Period|Lost to Follow-up|4|||
161725009|NCT00751881|584036048|FG002|Core Treatment Period|Lost to Follow-up|3|||
161725010|NCT00751881|584036046|FG000|Core Treatment Period|Other: protocol deviation|3|||
161725011|NCT00751881|584036047|FG001|Core Treatment Period|Other: protocol deviation|3|||
161725012|NCT00751881|584036048|FG002|Core Treatment Period|Other: protocol deviation|7|||
161725013|NCT00751881|584036046|FG000|Core Treatment Period|Other: wish to parent|5|||
161725014|NCT00751881|584036047|FG001|Core Treatment Period|Other: wish to parent|7|||
161725015|NCT00751881|584036048|FG002|Core Treatment Period|Other: wish to parent|4|||
161725016|NCT00751881|584036046|FG000|Core Treatment Period|Other: personal/family constraints|6|||
161725017|NCT00751881|584036047|FG001|Core Treatment Period|Other: personal/family constraints|7|||
161725018|NCT00751881|584036048|FG002|Core Treatment Period|Other: personal/family constraints|10|||
161725019|NCT00751881|584036046|FG000|Core Treatment Period|Other: MS treatment change|6|||
161725020|NCT00751881|584036047|FG001|Core Treatment Period|Other: MS treatment change|4|||
161725021|NCT00751881|584036048|FG002|Core Treatment Period|Other: MS treatment change|4|||
161725022|NCT00751881|584036046|FG000|Core Treatment Period|Other: tolerability complaints|2|||
161725023|NCT00751881|584036047|FG001|Core Treatment Period|Other: tolerability complaints|0|||
161725024|NCT00751881|584036048|FG002|Core Treatment Period|Other: tolerability complaints|0|||
161725025|NCT00751881|584036046|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
161725026|NCT00751881|584036047|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
161725027|NCT00751881|584036048|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
161725028|NCT00751881|584036046|FG000|Extension Study Period|Adverse Event|18|||
161725029|NCT00751881|584036047|FG001|Extension Study Period|Adverse Event|20|||
161725030|NCT00751881|584036048|FG002|Extension Study Period|Adverse Event|21|||
161725031|NCT00751881|584036046|FG000|Extension Study Period|Lack of Efficacy|14|||
161725032|NCT00751881|584036047|FG001|Extension Study Period|Lack of Efficacy|10|||
161725033|NCT00751881|584036048|FG002|Extension Study Period|Lack of Efficacy|20|||
161725034|NCT00751881|584036046|FG000|Extension Study Period|Lost to Follow-up|4|||
161725035|NCT00751881|584036047|FG001|Extension Study Period|Lost to Follow-up|9|||
161725036|NCT00751881|584036048|FG002|Extension Study Period|Lost to Follow-up|6|||
161725037|NCT00751881|584036046|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
161725038|NCT00751881|584036047|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
161725039|NCT00751881|584036048|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
161725040|NCT00751881|584036046|FG000|Extension Study Period|Other than specified above|26|||
161725041|NCT00751881|584036047|FG001|Extension Study Period|Other than specified above|30|||
161725042|NCT00751881|584036048|FG002|Extension Study Period|Other than specified above|18|||
161725043|NCT04770155|584036049|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725044|NCT04770155|584036050|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725045|NCT04770155|584036051|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725046|NCT04770155|584036052|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725047|NCT04770155|584036053|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725048|NCT04770155|584036054|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161838091|NCT00770692|584450333|FG000|Overall Study|Withdrawal by Subject|7|||
161725049|NCT04770155|584036055|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725050|NCT04770155|584036056|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725051|NCT00530712|584036066|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
161725052|NCT00530712|584036066|FG000|30 Day Follow-up Visit|Missed Visit|5|||
161725053|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
161725054|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Missed Visit|3|||
161725055|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
161725056|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Death|2|||
161725057|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
161725058|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Missed Visit|3|||
161725059|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
161725060|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Death|9|||
161725061|NCT02749370|584036069|FG000|Overall Study|Withdrawal by Subject|11|||
161725062|NCT02749370|584036069|FG000|Overall Study|Lost to Follow-up|3|||
161725063|NCT03894904|584036073|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
161725064|NCT03894904|584036074|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
161725065|NCT03894904|584036073|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
161725066|NCT03894904|584036074|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
161725067|NCT03242759|584036075|FG000|Overall Study|Adverse Event|5|||
161725068|NCT03242759|584036076|FG001|Overall Study|Adverse Event|1|||
161725069|NCT03242759|584036075|FG000|Overall Study|Withdrawal by Subject|4|||
161725070|NCT03242759|584036076|FG001|Overall Study|Withdrawal by Subject|3|||
161725071|NCT03242759|584036075|FG000|Overall Study|Lost to Follow-up|3|||
161725072|NCT03242759|584036076|FG001|Overall Study|Lost to Follow-up|1|||
161725073|NCT03242759|584036075|FG000|Overall Study|Administrative problems|1|||
161725074|NCT03242759|584036076|FG001|Overall Study|Administrative problems|1|||
161725075|NCT03242759|584036075|FG000|Overall Study|Death|22|||
161725076|NCT03242759|584036076|FG001|Overall Study|Death|0|||
161725077|NCT03242759|584036075|FG000|Overall Study|Change visit schedule|0|||
161725078|NCT03242759|584036076|FG001|Overall Study|Change visit schedule|1|||
161725079|NCT00504166|584036082|FG000|Overall Study|Adverse Event|1|||
161725080|NCT00504166|584036083|FG001|Overall Study|Adverse Event|4|||
161725081|NCT00504166|584036082|FG000|Overall Study|Withdrawal by Subject|3|||
161725082|NCT00504166|584036083|FG001|Overall Study|Withdrawal by Subject|6|||
161725083|NCT00504166|584036082|FG000|Overall Study|Physician Decision|1|||
161725084|NCT00504166|584036083|FG001|Overall Study|Physician Decision|1|||
161725085|NCT00504166|584036082|FG000|Overall Study|Lost to Follow-up|1|||
161725086|NCT00504166|584036083|FG001|Overall Study|Lost to Follow-up|3|||
161725087|NCT00651118|584036084|FG000|Overall Study|Adverse Event|4|||
161725088|NCT00651118|584036085|FG001|Overall Study|Adverse Event|0|||
161725089|NCT00651118|584036086|FG002|Overall Study|Adverse Event|1|||
161725090|NCT00651118|584036087|FG003|Overall Study|Adverse Event|1|||
161725091|NCT00651118|584036084|FG000|Overall Study|Protocol Violation|2|||
161725092|NCT00651118|584036085|FG001|Overall Study|Protocol Violation|2|||
161725093|NCT00651118|584036086|FG002|Overall Study|Protocol Violation|6|||
161725094|NCT00651118|584036087|FG003|Overall Study|Protocol Violation|2|||
161725095|NCT00651118|584036084|FG000|Overall Study|Lost to Follow-up|2|||
161725096|NCT00651118|584036085|FG001|Overall Study|Lost to Follow-up|0|||
161725097|NCT00651118|584036086|FG002|Overall Study|Lost to Follow-up|1|||
161725098|NCT00651118|584036087|FG003|Overall Study|Lost to Follow-up|2|||
161725099|NCT00651118|584036084|FG000|Overall Study|administrative|1|||
161725100|NCT00651118|584036085|FG001|Overall Study|administrative|4|||
161725101|NCT00651118|584036086|FG002|Overall Study|administrative|2|||
161725102|NCT00651118|584036087|FG003|Overall Study|administrative|1|||
161725103|NCT00651118|584036084|FG000|Overall Study|Withdrawal by Subject|0|||
161725104|NCT00651118|584036085|FG001|Overall Study|Withdrawal by Subject|1|||
161725105|NCT00651118|584036086|FG002|Overall Study|Withdrawal by Subject|1|||
161725106|NCT00651118|584036087|FG003|Overall Study|Withdrawal by Subject|1|||
161725107|NCT03117049|584036088|FG000|Overall Study|Continued the follow-up period|109|||
161725108|NCT03117049|584036089|FG001|Overall Study|Continued the follow-up period|129|||
161725109|NCT03117049|584036088|FG000|Overall Study|Died|82|||
161725110|NCT03117049|584036089|FG001|Overall Study|Died|93|||
161725111|NCT03117049|584036088|FG000|Overall Study|Consent withdrawal|7|||
161725112|NCT03117049|584036089|FG001|Overall Study|Consent withdrawal|6|||
161725113|NCT03117049|584036088|FG000|Overall Study|Missing contact|3|||
161725114|NCT03117049|584036089|FG001|Overall Study|Missing contact|3|||
161725115|NCT01096550|584036090|FG000|Overall Study|discontinued site|10|||
161725116|NCT01096550|584036091|FG001|Overall Study|discontinued site|11|||
161725117|NCT01096550|584036090|FG000|Overall Study|non-regular treatment track at clinic|1|||
161725118|NCT01096550|584036091|FG001|Overall Study|non-regular treatment track at clinic|1|||
161725119|NCT01096550|584036090|FG000|Overall Study|clinic readmission|1|||
161725120|NCT01096550|584036091|FG001|Overall Study|clinic readmission|1|||
161725121|NCT01096550|584036090|FG000|Overall Study|Withdrawal by Subject|0|||
161725122|NCT01096550|584036091|FG001|Overall Study|Withdrawal by Subject|1|||
161725123|NCT01096550|584036090|FG000|Overall Study|non-African American participant|13|||
161725124|NCT01096550|584036091|FG001|Overall Study|non-African American participant|6|||
161725125|NCT01096550|584036090|FG000|Overall Study|Lost to Follow-up|12|||
161725126|NCT01096550|584036091|FG001|Overall Study|Lost to Follow-up|9|||
161725127|NCT00839098|584036094|FG000|Overall Study|Withdrawal by Subject|2|||
161725128|NCT00839098|584036095|FG001|Overall Study|Withdrawal by Subject|1|||
161725129|NCT00839098|584036096|FG002|Overall Study|Withdrawal by Subject|7|||
161725130|NCT01345786|584036097|FG000|Overall Study|Adverse Event|0|||
161725131|NCT01345786|584036098|FG001|Overall Study|Adverse Event|1|||
161725132|NCT01345786|584036099|FG002|Overall Study|Adverse Event|3|||
161725133|NCT01345786|584036100|FG003|Overall Study|Adverse Event|1|||
161725134|NCT01345786|584036097|FG000|Overall Study|Subject withdrew consent|2|||
161725135|NCT01345786|584036098|FG001|Overall Study|Subject withdrew consent|2|||
161725136|NCT01345786|584036099|FG002|Overall Study|Subject withdrew consent|1|||
161725137|NCT01345786|584036100|FG003|Overall Study|Subject withdrew consent|0|||
161725138|NCT01345786|584036097|FG000|Overall Study|Noncompliance with protocol|1|||
161725139|NCT01345786|584036098|FG001|Overall Study|Noncompliance with protocol|0|||
161725140|NCT01345786|584036099|FG002|Overall Study|Noncompliance with protocol|1|||
161725141|NCT01345786|584036100|FG003|Overall Study|Noncompliance with protocol|0|||
161725142|NCT01345786|584036097|FG000|Overall Study|Administrative|3|||
161725143|NCT01345786|584036098|FG001|Overall Study|Administrative|5|||
161725144|NCT01345786|584036099|FG002|Overall Study|Administrative|0|||
161725145|NCT01345786|584036100|FG003|Overall Study|Administrative|0|||
161725146|NCT01345786|584036097|FG000|Overall Study|Lost to Follow-up|0|||
161725147|NCT01345786|584036098|FG001|Overall Study|Lost to Follow-up|0|||
161725148|NCT01345786|584036099|FG002|Overall Study|Lost to Follow-up|0|||
161725149|NCT01345786|584036100|FG003|Overall Study|Lost to Follow-up|2|||
161725150|NCT02190435|584036101|FG000|Overall Study|First 12 patients were lead-ins|12|||
161725151|NCT02190435|584036102|FG001|Overall Study|First 12 patients were lead-ins|0|||
161725152|NCT02190435|584036101|FG000|Overall Study|3 consented screen fails|3|||
161725153|NCT02190435|584036102|FG001|Overall Study|3 consented screen fails|0|||
161725154|NCT02399475|584036111|FG000|Overall Study|Physician Decision|1|||
161725155|NCT02399475|584036112|FG001|Overall Study|Physician Decision|0|||
161725156|NCT02260193|584036113|FG000|Overall Study|Lack of Efficacy|0|||
161725157|NCT02260193|584036114|FG001|Overall Study|Lack of Efficacy|1|||
161725158|NCT02260193|584036115|FG002|Overall Study|Lack of Efficacy|6|||
161725159|NCT02260193|584036113|FG000|Overall Study|Adverse Event|3|||
161725160|NCT02260193|584036114|FG001|Overall Study|Adverse Event|4|||
161725161|NCT02260193|584036115|FG002|Overall Study|Adverse Event|1|||
161725162|NCT02260193|584036113|FG000|Overall Study|Protocol Violation|0|||
161725163|NCT02260193|584036114|FG001|Overall Study|Protocol Violation|4|||
161725164|NCT02260193|584036115|FG002|Overall Study|Protocol Violation|0|||
161725165|NCT02260193|584036113|FG000|Overall Study|Withdrawal by Subject|3|||
161725166|NCT02260193|584036114|FG001|Overall Study|Withdrawal by Subject|0|||
161725167|NCT02260193|584036115|FG002|Overall Study|Withdrawal by Subject|2|||
161725168|NCT02260193|584036113|FG000|Overall Study|Kidney Transplantation|0|||
161725169|NCT02260193|584036114|FG001|Overall Study|Kidney Transplantation|0|||
161725170|NCT02260193|584036115|FG002|Overall Study|Kidney Transplantation|1|||
161725171|NCT01963117|584036116|FG000|Overall Study|Death|1|||
161725172|NCT01070784|584036117|FG000|Overall Study|Withdrawal by Subject|6|||
161725173|NCT01070784|584036118|FG001|Overall Study|Withdrawal by Subject|9|||
161725174|NCT01070784|584036117|FG000|Overall Study|Adverse Event|14|||
161725175|NCT01070784|584036118|FG001|Overall Study|Adverse Event|9|||
161725176|NCT01780389|584036119|FG000|Overall Study|Adverse Event|1|||
161725177|NCT00935220|584036120|FG000|Overall Study|Adverse Event|1|||
161725178|NCT00935220|584036120|FG000|Overall Study|Other reason (not specified)|1|||
161725179|NCT01095250|584036121|FG000|Overall Study|administrative reasons|8|||
161725180|NCT01095250|584036122|FG001|Overall Study|administrative reasons|10|||
161725181|NCT01095250|584036123|FG002|Overall Study|administrative reasons|7|||
161725182|NCT01095250|584036124|FG003|Overall Study|administrative reasons|5|||
161725183|NCT01095250|584036121|FG000|Overall Study|Withdrawal by Subject|0|||
161725184|NCT01095250|584036122|FG001|Overall Study|Withdrawal by Subject|0|||
161725185|NCT01095250|584036123|FG002|Overall Study|Withdrawal by Subject|1|||
161725186|NCT01095250|584036124|FG003|Overall Study|Withdrawal by Subject|0|||
161725187|NCT01000064|584036125|FG000|Overall Study|Withdrawal by Subject|1|||
161725188|NCT01000064|584036126|FG001|Overall Study|Withdrawal by Subject|1|||
161725189|NCT02518620|584036127|FG000|Overall Study|Adverse Event|23|||
161725190|NCT02518620|584036128|FG001|Overall Study|Adverse Event|11|||
161725191|NCT02518620|584036127|FG000|Overall Study|Lack of Efficacy|2|||
161725192|NCT02518620|584036128|FG001|Overall Study|Lack of Efficacy|0|||
161725193|NCT02518620|584036127|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161725194|NCT02518620|584036128|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161725195|NCT02518620|584036127|FG000|Overall Study|Physician Decision|1|||
161725196|NCT02518620|584036128|FG001|Overall Study|Physician Decision|1|||
161725197|NCT02518620|584036127|FG000|Overall Study|Sponsor's Decision|0|||
161725198|NCT02518620|584036128|FG001|Overall Study|Sponsor's Decision|3|||
161725199|NCT02518620|584036127|FG000|Overall Study|Lost to Follow-up|1|||
161725200|NCT02518620|584036128|FG001|Overall Study|Lost to Follow-up|1|||
161725201|NCT02518620|584036127|FG000|Overall Study|Withdrawal by Subject|17|||
161725202|NCT02518620|584036128|FG001|Overall Study|Withdrawal by Subject|9|||
161725203|NCT02518620|584036127|FG000|Overall Study|Death|1|||
161725204|NCT02518620|584036128|FG001|Overall Study|Death|0|||
161725205|NCT02518620|584036127|FG000|Overall Study|Pregnancy Wish|3|||
161725206|NCT02518620|584036128|FG001|Overall Study|Pregnancy Wish|0|||
161725207|NCT02518620|584036127|FG000|Overall Study|Pregnancy|1|||
161725208|NCT02518620|584036128|FG001|Overall Study|Pregnancy|0|||
161725209|NCT02518620|584036127|FG000|Overall Study|Relocation|2|||
161725210|NCT02518620|584036128|FG001|Overall Study|Relocation|1|||
161725211|NCT03844633|584036132|FG000|1 Week FU|Lost to Follow-up|0|||
161725212|NCT03844633|584036133|FG001|1 Week FU|Lost to Follow-up|1|||
161725213|NCT03844633|584036134|FG002|1 Week FU|Lost to Follow-up|4|||
161725214|NCT03844633|584036132|FG000|12-month Follow-up|Lost to Follow-up|7|||
161725215|NCT03844633|584036133|FG001|12-month Follow-up|Lost to Follow-up|5|||
161725216|NCT03844633|584036134|FG002|12-month Follow-up|Lost to Follow-up|8|||
161725217|NCT02588248|584036139|FG000|Overall Study|Physician Decision|4|||
161725218|NCT02588248|584036140|FG001|Overall Study|Physician Decision|3|||
161725219|NCT01355068|584036141|FG000|First Intervention Period|Adverse Event|0|||
161725220|NCT01355068|584036142|FG001|First Intervention Period|Adverse Event|1|||
161725221|NCT01355068|584036141|FG000|First Intervention Period|Withdrawal by Subject|0|||
161725222|NCT01355068|584036142|FG001|First Intervention Period|Withdrawal by Subject|1|||
161725223|NCT00336492|584036145|FG000|Overall Study|Adverse Event|4|||
161725224|NCT00336492|584036146|FG001|Overall Study|Adverse Event|3|||
161725225|NCT00336492|584036147|FG002|Overall Study|Adverse Event|6|||
161725226|NCT00336492|584036145|FG000|Overall Study|Lack of Efficacy|6|||
161725227|NCT00336492|584036146|FG001|Overall Study|Lack of Efficacy|1|||
161725228|NCT00336492|584036147|FG002|Overall Study|Lack of Efficacy|4|||
161725229|NCT00336492|584036145|FG000|Overall Study|Other|5|||
161725230|NCT00336492|584036146|FG001|Overall Study|Other|0|||
161725231|NCT00336492|584036147|FG002|Overall Study|Other|1|||
161725232|NCT04229446|584036148|FG000|Overall Study|Death|12|||
161725233|NCT04229446|584036149|FG001|Overall Study|Death|10|||
161725234|NCT04229446|584036148|FG000|Overall Study|Lost to Follow-up|5|||
161725235|NCT04229446|584036149|FG001|Overall Study|Lost to Follow-up|8|||
161725236|NCT04191967|584037695|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
161725237|NCT04191967|584037695|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
161725238|NCT00953043|584037699|FG000|Overall Study|Withdrawal by Subject|4|||
161725239|NCT00953043|584037700|FG001|Overall Study|Withdrawal by Subject|0|||
161725240|NCT00953043|584037699|FG000|Overall Study|Physician Decision|0|||
161725241|NCT00953043|584037700|FG001|Overall Study|Physician Decision|2|||
161725242|NCT02322892|584037702|FG000|Overall Study|Surgery cancelled|1|||
161725243|NCT02322892|584037703|FG001|Overall Study|Surgery cancelled|2|||
161725244|NCT02322892|584037702|FG000|Overall Study|Met exclusion criteria|0|||
161725245|NCT02322892|584037703|FG001|Overall Study|Met exclusion criteria|1|||
161725246|NCT02322892|584037702|FG000|Overall Study|Protocol Violation|1|||
161725247|NCT02322892|584037703|FG001|Overall Study|Protocol Violation|0|||
161725248|NCT00747617|584037704|FG000|Overall Study|Lost to Follow-up|3|||
161725249|NCT00747617|584037705|FG001|Overall Study|Lost to Follow-up|1|||
161725250|NCT03509207|584037706|FG000|Overall Study|Death|2|||
161725251|NCT02125331|584037707|FG000|Overall Study|Protocol Violation|1|||
161725252|NCT02125331|584037708|FG001|Overall Study|Protocol Violation|0|||
161725253|NCT02125331|584037707|FG000|Overall Study|technical problem|2|||
161725254|NCT02125331|584037708|FG001|Overall Study|technical problem|0|||
161725255|NCT02125331|584037707|FG000|Overall Study|screen failure|2|||
161725256|NCT02125331|584037708|FG001|Overall Study|screen failure|0|||
161725257|NCT01432262|584037709|FG000|Overall Study|Withdrawal by Subject|2|||
161725258|NCT01432262|584037710|FG001|Overall Study|Withdrawal by Subject|1|||
161725259|NCT00165646|584037711|FG000|Overall Study|Adverse Event|1|||
161725260|NCT00165646|584037712|FG001|Overall Study|Adverse Event|1|||
161725261|NCT00165646|584037713|FG002|Overall Study|Adverse Event|1|||
161725262|NCT00165646|584037711|FG000|Overall Study|Lack of Efficacy|1|||
161725263|NCT00165646|584037712|FG001|Overall Study|Lack of Efficacy|2|||
161725264|NCT00165646|584037713|FG002|Overall Study|Lack of Efficacy|0|||
161725265|NCT00165646|584037711|FG000|Overall Study|Withdrawal by Subject|0|||
161725266|NCT00165646|584037712|FG001|Overall Study|Withdrawal by Subject|2|||
161725267|NCT00165646|584037713|FG002|Overall Study|Withdrawal by Subject|1|||
161725268|NCT00165646|584037711|FG000|Overall Study|Physician Decision|2|||
161725269|NCT00165646|584037712|FG001|Overall Study|Physician Decision|0|||
161725270|NCT00165646|584037713|FG002|Overall Study|Physician Decision|2|||
161725271|NCT00165646|584037711|FG000|Overall Study|Protocol Violation|1|||
161725272|NCT00165646|584037712|FG001|Overall Study|Protocol Violation|0|||
161725273|NCT00165646|584037713|FG002|Overall Study|Protocol Violation|0|||
161725274|NCT04657016|584037714|FG000|Overall Study|Adverse Event|2|||
161725275|NCT04657016|584037715|FG001|Overall Study|Adverse Event|4|||
161725276|NCT04657016|584037714|FG000|Overall Study|Death|1|||
161725277|NCT04657016|584037715|FG001|Overall Study|Death|1|||
161725278|NCT04657016|584037714|FG000|Overall Study|Lost to Follow-up|24|||
161725279|NCT04657016|584037715|FG001|Overall Study|Lost to Follow-up|12|||
161725280|NCT04657016|584037714|FG000|Overall Study|Physician Decision|1|||
161725281|NCT04657016|584037715|FG001|Overall Study|Physician Decision|2|||
161725282|NCT04657016|584037714|FG000|Overall Study|Pregnancy|2|||
161725283|NCT04657016|584037715|FG001|Overall Study|Pregnancy|2|||
161725284|NCT04657016|584037714|FG000|Overall Study|Protocol Deviation|1|||
161725285|NCT04657016|584037715|FG001|Overall Study|Protocol Deviation|0|||
161725286|NCT04657016|584037714|FG000|Overall Study|Withdrawal by Subject|28|||
161725287|NCT04657016|584037715|FG001|Overall Study|Withdrawal by Subject|14|||
161725288|NCT04657016|584037714|FG000|Overall Study|Other - as reported by the investigator|6|||
161725289|NCT04657016|584037715|FG001|Overall Study|Other - as reported by the investigator|0|||
161725290|NCT01104558|584037718|FG000|Overall Study|Protocol Violation|6|||
161725291|NCT01104558|584037718|FG000|Overall Study|Missing of primary efficacy assessment|10|||
161725292|NCT01104558|584037718|FG000|Overall Study|Missing of genetic analysis results|1|||
161725293|NCT00523341|584037722|FG000|Overall Study|Withdrawal by Subject|399|||
161725294|NCT00523341|584037723|FG001|Overall Study|Withdrawal by Subject|427|||
161725295|NCT00523341|584037722|FG000|Overall Study|Other|181|||
161725296|NCT00523341|584037723|FG001|Overall Study|Other|198|||
161725297|NCT00523341|584037722|FG000|Overall Study|Adverse Event|122|||
161725298|NCT00523341|584037723|FG001|Overall Study|Adverse Event|155|||
161725299|NCT00523341|584037722|FG000|Overall Study|Death|101|||
161725300|NCT00523341|584037723|FG001|Overall Study|Death|110|||
161725301|NCT00523341|584037722|FG000|Overall Study|Lost to Follow-up|73|||
161725302|NCT00523341|584037723|FG001|Overall Study|Lost to Follow-up|61|||
161725303|NCT00523341|584037722|FG000|Overall Study|Non-compliance|20|||
161725304|NCT00523341|584037723|FG001|Overall Study|Non-compliance|13|||
161725305|NCT00523341|584037722|FG000|Overall Study|Physician Decision|14|||
161725306|NCT00523341|584037723|FG001|Overall Study|Physician Decision|13|||
161725307|NCT00523341|584037722|FG000|Overall Study|Requirement for Alternative Therapy|4|||
161725308|NCT00523341|584037723|FG001|Overall Study|Requirement for Alternative Therapy|14|||
161725309|NCT00523341|584037722|FG000|Overall Study|Protocol Deviation|6|||
161725310|NCT00523341|584037723|FG001|Overall Study|Protocol Deviation|5|||
161725311|NCT00523341|584037722|FG000|Overall Study|Ineligibility Determined|3|||
161725312|NCT00523341|584037723|FG001|Overall Study|Ineligibility Determined|4|||
161725313|NCT00523341|584037722|FG000|Overall Study|Disease Progression|1|||
161725314|NCT00523341|584037723|FG001|Overall Study|Disease Progression|0|||
161725315|NCT02601001|584037724|FG000|Dosing Period 2|Adverse Event|0|||
161725316|NCT02601001|584037725|FG001|Dosing Period 2|Adverse Event|0|||
161725317|NCT02601001|584037726|FG002|Dosing Period 2|Adverse Event|0|||
161725318|NCT02601001|584037727|FG003|Dosing Period 2|Adverse Event|0|||
161725319|NCT02601001|584037728|FG004|Dosing Period 2|Adverse Event|0|||
161725320|NCT02601001|584037729|FG005|Dosing Period 2|Adverse Event|0|||
161725321|NCT02601001|584037730|FG006|Dosing Period 2|Adverse Event|1|||
161725322|NCT01790438|584037731|FG000|Overall Study|Adverse Event|3|||
161725323|NCT01790438|584037732|FG001|Overall Study|Adverse Event|2|||
161725324|NCT01790438|584037731|FG000|Overall Study|Death|4|||
161725325|NCT01790438|584037732|FG001|Overall Study|Death|0|||
161725326|NCT01790438|584037731|FG000|Overall Study|Lost to Follow-up|5|||
161725327|NCT01790438|584037732|FG001|Overall Study|Lost to Follow-up|2|||
161725328|NCT01790438|584037731|FG000|Overall Study|Withdrawal by Subject|13|||
161725329|NCT01790438|584037732|FG001|Overall Study|Withdrawal by Subject|2|||
161725330|NCT01790438|584037731|FG000|Overall Study|Physician Decision|3|||
161725331|NCT01790438|584037732|FG001|Overall Study|Physician Decision|1|||
161725332|NCT01790438|584037731|FG000|Overall Study|Sponsor Decision|0|||
161725333|NCT01790438|584037732|FG001|Overall Study|Sponsor Decision|3|||
161725334|NCT01790438|584037731|FG000|Overall Study|Protocol Required Discontinuation|7|||
161725335|NCT01790438|584037732|FG001|Overall Study|Protocol Required Discontinuation|1|||
161725336|NCT01356602|584037735|FG000|Overall Study|Protocol Deviation|0|||
161725337|NCT01356602|584037736|FG001|Overall Study|Protocol Deviation|1|||
161725338|NCT01356602|584037737|FG002|Overall Study|Protocol Deviation|1|||
161725339|NCT01356602|584037735|FG000|Overall Study|Administrative Problems|1|||
161725340|NCT01356602|584037736|FG001|Overall Study|Administrative Problems|4|||
161725341|NCT01356602|584037737|FG002|Overall Study|Administrative Problems|5|||
161725342|NCT01356602|584037735|FG000|Overall Study|Lost to Follow-up|4|||
161725343|NCT01356602|584037736|FG001|Overall Study|Lost to Follow-up|5|||
161725344|NCT01356602|584037737|FG002|Overall Study|Lost to Follow-up|6|||
161725345|NCT01356602|584037735|FG000|Overall Study|Withdrawal by Subject|4|||
161725346|NCT01356602|584037736|FG001|Overall Study|Withdrawal by Subject|3|||
161725347|NCT01356602|584037737|FG002|Overall Study|Withdrawal by Subject|7|||
161725348|NCT01356602|584037735|FG000|Overall Study|Lack of Efficacy|0|||
161725349|NCT01356602|584037736|FG001|Overall Study|Lack of Efficacy|1|||
161725350|NCT01356602|584037737|FG002|Overall Study|Lack of Efficacy|4|||
161725351|NCT01356602|584037735|FG000|Overall Study|Adverse Event|0|||
161725352|NCT01356602|584037736|FG001|Overall Study|Adverse Event|1|||
161725353|NCT01356602|584037737|FG002|Overall Study|Adverse Event|1|||
161725354|NCT03123354|584037738|FG000|Overall Study|Physician Decision|6|||
161725355|NCT01931462|584037739|FG000|Overall Study|Withdrawal by Subject|1|||
161725356|NCT04907539|584037740|FG000|Overall Study|Consent withdrawn|1|||
161725357|NCT04907539|584037741|FG001|Overall Study|Consent withdrawn|0|||
161725358|NCT04907539|584037740|FG000|Overall Study|Death|14|||
161725359|NCT04907539|584037741|FG001|Overall Study|Death|3|||
161725360|NCT01701583|584037742|FG000|Overall Study|Withdrawal by Subject|2|||
161725361|NCT01701583|584037743|FG001|Overall Study|Withdrawal by Subject|0|||
161725362|NCT05070429|584037749|FG000|Overall Study|Death|0|||
161725363|NCT05070429|584037750|FG001|Overall Study|Death|4|||
161725364|NCT05070429|584037749|FG000|Overall Study|Withdrawal by Subject|2|||
161725365|NCT05070429|584037750|FG001|Overall Study|Withdrawal by Subject|1|||
161725366|NCT05070429|584037749|FG000|Overall Study|Other|15|||
161725367|NCT05070429|584037750|FG001|Overall Study|Other|5|||
161725368|NCT03041116|584037751|FG000|Double-blind|Death|0|||
161725369|NCT03041116|584037752|FG001|Double-blind|Death|2|||
161725370|NCT03041116|584037751|FG000|Double-blind|Withdrawal by Subject|0|||
161725371|NCT03041116|584037752|FG001|Double-blind|Withdrawal by Subject|4|||
161725372|NCT03041116|584037751|FG000|Open-label|Death|1|||
161725373|NCT03041116|584037752|FG001|Open-label|Death|0|||
161725374|NCT03041116|584037751|FG000|Open-label|Termination of the study by Sponsor|39|||
161725375|NCT03041116|584037752|FG001|Open-label|Termination of the study by Sponsor|37|||
161725376|NCT03041116|584037751|FG000|Open-label|Withdrawal by Subject|1|||
161725377|NCT03041116|584037752|FG001|Open-label|Withdrawal by Subject|0|||
161725378|NCT01345123|584037753|FG000|Overall Study|participants no longer with health plan|79|||
161725379|NCT01345123|584037754|FG001|Overall Study|participants no longer with health plan|85|||
161725380|NCT01345123|584037755|FG002|Overall Study|participants no longer with health plan|88|||
161725381|NCT01798134|584037756|FG000|Overall Study|Lost to Follow-up|1|||
161725382|NCT01798134|584037756|FG000|Overall Study|Withdrawal by Subject|3|||
161725383|NCT01798134|584037756|FG000|Overall Study|Death|2|||
161725384|NCT01798134|584037756|FG000|Overall Study|Adverse Event|3|||
161725385|NCT01798134|584037756|FG000|Overall Study|Physician Decision|3|||
161725386|NCT01798134|584037756|FG000|Overall Study|Liver transplant/surgery|4|||
161725387|NCT02653976|584037757|FG000|Overall Study|Withdrawal by Subject|5|||
161725388|NCT02653976|584037757|FG000|Overall Study|Death|4|||
161725389|NCT02436577|584037758|FG000|Overall Study|Protocol Deviation|0|||
161725390|NCT02436577|584037759|FG001|Overall Study|Protocol Deviation|1|||
161725391|NCT02436577|584037760|FG002|Overall Study|Protocol Deviation|0|||
161725392|NCT02436577|584037761|FG003|Overall Study|Protocol Deviation|0|||
161725393|NCT02436577|584037762|FG004|Overall Study|Protocol Deviation|0|||
161725394|NCT02436577|584037763|FG005|Overall Study|Protocol Deviation|0|||
161725395|NCT01675011|584037764|FG000|Overall Study|Trial terminated by Sponsor|3|||
161725396|NCT01675011|584037765|FG001|Overall Study|Trial terminated by Sponsor|1|||
161725397|NCT00615290|584037766|FG000|Overall Study|Adverse Event|2|||
161725398|NCT00615290|584037766|FG000|Overall Study|Lost to Follow-up|3|||
161725399|NCT00615290|584037766|FG000|Overall Study|Withdrawal by Subject|1|||
161725400|NCT00615290|584037766|FG000|Overall Study|Other|2|||
161725401|NCT00366548|584037767|FG000|Infant Series|Adverse Event|1|||
161725402|NCT00366548|584037768|FG001|Infant Series|Adverse Event|3|||
161725403|NCT00366548|584037767|FG000|Infant Series|Protocol Violation|0|||
161725404|NCT00366548|584037768|FG001|Infant Series|Protocol Violation|1|||
161725405|NCT00366548|584037767|FG000|Infant Series|Withdrawal by Subject|3|||
161725406|NCT00366548|584037768|FG001|Infant Series|Withdrawal by Subject|1|||
161725407|NCT00366548|584037767|FG000|After Infant Series|Withdrawal by Subject|3|||
161725408|NCT00366548|584037768|FG001|After Infant Series|Withdrawal by Subject|1|||
161725409|NCT00366548|584037767|FG000|After Infant Series|Adverse Event|2|||
161725410|NCT00366548|584037768|FG001|After Infant Series|Adverse Event|0|||
161725411|NCT00366548|584037767|FG000|After Infant Series|Lost to Follow-up|1|||
161725412|NCT00366548|584037768|FG001|After Infant Series|Lost to Follow-up|0|||
161725413|NCT02849990|584037769|FG000|Overall Study|Adverse Event|1|||
161725414|NCT02849990|584037769|FG000|Overall Study|Withdrawal by Subject|1|||
161725415|NCT01252134|584037770|FG000|Period 1, 8 Hours|Personal Reasons|0|||
161725416|NCT01252134|584037771|FG001|Period 1, 8 Hours|Personal Reasons|1|||
161725417|NCT01252134|584037772|FG002|Period 1, 8 Hours|Personal Reasons|1|||
161725418|NCT01252134|584037773|FG003|Period 1, 8 Hours|Personal Reasons|0|||
161725419|NCT01252134|584037774|FG004|Period 1, 8 Hours|Personal Reasons|0|||
161725420|NCT01252134|584037775|FG005|Period 1, 8 Hours|Personal Reasons|0|||
161725421|NCT03650452|584037776|FG000|Overall Study|Physician Decision|1|||
161725422|NCT03650452|584037777|FG001|Overall Study|Physician Decision|0|||
161725423|NCT03650452|584037776|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161725424|NCT03650452|584037777|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161725425|NCT03650452|584037776|FG000|Overall Study|Adverse Event|3|||
161725426|NCT03650452|584037777|FG001|Overall Study|Adverse Event|4|||
161725427|NCT03650452|584037776|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
161725428|NCT03650452|584037777|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
161725429|NCT02678741|584037779|FG000|Overall Study|Death|4|||
161725430|NCT02678741|584037779|FG000|Overall Study|Withdrawal by Subject|1|||
161725431|NCT02678741|584037779|FG000|Overall Study|ineligible|3|||
161725432|NCT02678741|584037779|FG000|Overall Study|Not RECIST Measurable|2|||
161725433|NCT02678741|584037779|FG000|Overall Study|Lack of Efficacy|10|||
161725434|NCT01795898|584037780|FG000|Overall Study|Adverse Event|27|||
161725435|NCT01795898|584037780|FG000|Overall Study|Lost to Follow-up|20|||
161725436|NCT01795898|584037780|FG000|Overall Study|Withdrawal of consent|6|||
161725437|NCT01795898|584037780|FG000|Overall Study|Diagnosed with metastasis|1|||
161725438|NCT01795898|584037780|FG000|Overall Study|No pain|1|||
161725439|NCT01795898|584037780|FG000|Overall Study|Death|1|||
161725440|NCT01795898|584037780|FG000|Overall Study|Withdrew consent & had adverse events|3|||
161725441|NCT01795898|584037780|FG000|Overall Study|Physician Decision|1|||
161725442|NCT00390780|584037795|FG000|Overall Study|Not completed|10|||
161725443|NCT00390780|584037796|FG001|Overall Study|Not completed|4|||
161725444|NCT00390780|584037795|FG000|Overall Study|Protocol Violation|6|||
161725445|NCT00390780|584037796|FG001|Overall Study|Protocol Violation|4|||
161725446|NCT00390780|584037795|FG000|Overall Study|Lost to Follow-up|3|||
161725447|NCT00390780|584037796|FG001|Overall Study|Lost to Follow-up|6|||
161725448|NCT00390780|584037795|FG000|Overall Study|Adverse Event|2|||
161725449|NCT00390780|584037796|FG001|Overall Study|Adverse Event|3|||
161725450|NCT00390780|584037795|FG000|Overall Study|Death|1|||
161725451|NCT00390780|584037796|FG001|Overall Study|Death|3|||
161725452|NCT00390780|584037795|FG000|Overall Study|Withdrawal by Subject|1|||
161725453|NCT00390780|584037796|FG001|Overall Study|Withdrawal by Subject|2|||
161725454|NCT00390780|584037795|FG000|Overall Study|Inclusion criteria not satisfied|0|||
161725455|NCT00390780|584037796|FG001|Overall Study|Inclusion criteria not satisfied|2|||
161725456|NCT00390780|584037795|FG000|Overall Study|Lost to follow up and other reasons|0|||
161725457|NCT00390780|584037796|FG001|Overall Study|Lost to follow up and other reasons|1|||
161725458|NCT00390780|584037795|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
161725459|NCT00390780|584037796|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
161725460|NCT00390780|584037795|FG000|Overall Study|SAE, death|0|||
161725461|NCT00390780|584037796|FG001|Overall Study|SAE, death|1|||
161725462|NCT00305006|584037797|FG000|Overall Study|Withdrawal by Subject|1|||
161725463|NCT00305006|584037798|FG001|Overall Study|Withdrawal by Subject|0|||
161725464|NCT00305006|584037797|FG000|Overall Study|Failure to complete pretest|0|||
161725465|NCT00305006|584037798|FG001|Overall Study|Failure to complete pretest|1|||
161725466|NCT01996319|584037799|FG000|Overall Study|Protocol Violation|1|||
161725467|NCT01996319|584037800|FG001|Overall Study|Protocol Violation|0|||
161725468|NCT01996319|584037799|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
161725469|NCT01996319|584037800|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
161725470|NCT01996319|584037799|FG000|Overall Study|Adverse Event|2|||
161725471|NCT01996319|584037800|FG001|Overall Study|Adverse Event|2|||
161725472|NCT01671085|584037802|FG000|Overall Study|Withdrawal by Subject|1|||
161725473|NCT01671085|584037803|FG001|Overall Study|Withdrawal by Subject|0|||
161725474|NCT00637273|584037804|FG000|Overall Study|Adverse Event|11|||
161725475|NCT00637273|584037805|FG001|Overall Study|Adverse Event|5|||
161725476|NCT00637273|584037806|FG002|Overall Study|Adverse Event|7|||
161725477|NCT00637273|584037804|FG000|Overall Study|Lost to Follow-up|8|||
161725478|NCT00637273|584037805|FG001|Overall Study|Lost to Follow-up|9|||
161725479|NCT00637273|584037806|FG002|Overall Study|Lost to Follow-up|13|||
161725480|NCT00637273|584037804|FG000|Overall Study|Protocol Violation|2|||
161725481|NCT00637273|584037805|FG001|Overall Study|Protocol Violation|4|||
161725482|NCT00637273|584037806|FG002|Overall Study|Protocol Violation|1|||
161725483|NCT00637273|584037804|FG000|Overall Study|Withdrawal of Consent|18|||
161725484|NCT00637273|584037805|FG001|Overall Study|Withdrawal of Consent|6|||
161725485|NCT00637273|584037806|FG002|Overall Study|Withdrawal of Consent|18|||
161725486|NCT00637273|584037804|FG000|Overall Study|Investigator Decision|1|||
161725487|NCT00637273|584037805|FG001|Overall Study|Investigator Decision|3|||
161725488|NCT00637273|584037806|FG002|Overall Study|Investigator Decision|1|||
161725489|NCT00637273|584037804|FG000|Overall Study|Administrative|2|||
161725490|NCT00637273|584037805|FG001|Overall Study|Administrative|0|||
161725491|NCT00637273|584037806|FG002|Overall Study|Administrative|0|||
161725492|NCT00637273|584037804|FG000|Overall Study|Loss of Glucose Control|1|||
161725493|NCT00637273|584037805|FG001|Overall Study|Loss of Glucose Control|1|||
161725494|NCT00637273|584037806|FG002|Overall Study|Loss of Glucose Control|1|||
161725495|NCT01595646|584037807|FG000|Overall Study|Withdrawal by Subject|1|||
161725496|NCT01595646|584037808|FG001|Overall Study|Withdrawal by Subject|0|||
161725497|NCT01595646|584037809|FG002|Overall Study|Withdrawal by Subject|0|||
161725498|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Adverse Event|3|||
161725499|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Adverse Event|0|||
161725500|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Adverse Event|0|||
161725501|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Other|1|||
161725502|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Other|0|||
161725503|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Other|0|||
161725504|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
161725505|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
161725506|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
161725507|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
161725508|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
161725509|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
161725510|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Subject Choice|3|||
161725511|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Subject Choice|2|||
161725512|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Subject Choice|0|||
161725513|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
161725514|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
161725515|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
161725516|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
161725517|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
161725518|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
161725519|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
161725520|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
161725521|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
161725522|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
161725523|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
161725524|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
161725525|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
161725526|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
161725527|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
161725528|NCT01632878|584037815|FG000|Screening|Physician Decision|268|||
161725529|NCT01632878|584037815|FG000|Treatment|Lost to Follow-up|41|||
161725530|NCT01632878|584037815|FG000|Treatment|Withdrawal by Subject|36|||
161725531|NCT01632878|584037815|FG000|Treatment|Physician Decision|34|||
161725532|NCT01632878|584037815|FG000|Treatment|missing information|4|||
161725533|NCT01632878|584037815|FG000|Treatment|no information on study completion|43|||
161725534|NCT02698423|584037816|FG000|Overall Study|Lost to Follow-up|19|||
161725535|NCT02698423|584037817|FG001|Overall Study|Lost to Follow-up|24|||
161725536|NCT01765764|584037818|FG000|Treatment Period|Adverse Event|1|||
161725537|NCT01765764|584037819|FG001|Treatment Period|Adverse Event|2|||
161725538|NCT01765764|584037820|FG002|Treatment Period|Adverse Event|1|||
161725539|NCT01765764|584037818|FG000|Treatment Period|Lost to Follow-up|0|||
161725540|NCT01765764|584037819|FG001|Treatment Period|Lost to Follow-up|3|||
161725541|NCT01765764|584037820|FG002|Treatment Period|Lost to Follow-up|2|||
161725542|NCT01765764|584037818|FG000|Treatment Period|Personal Reasons|1|||
161725543|NCT01765764|584037819|FG001|Treatment Period|Personal Reasons|2|||
161725544|NCT01765764|584037820|FG002|Treatment Period|Personal Reasons|1|||
161725545|NCT01765764|584037818|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
161725546|NCT01765764|584037819|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
161725547|NCT01765764|584037820|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
161725548|NCT00064662|584037823|FG000|Overall Study|Death|1|||
161725549|NCT00064662|584037824|FG001|Overall Study|Death|1|||
161725550|NCT00064662|584037823|FG000|Overall Study|Lost to Follow-up|57|||
161725551|NCT00064662|584037824|FG001|Overall Study|Lost to Follow-up|44|||
161725552|NCT00064662|584037823|FG000|Overall Study|Withdrawal by Subject|14|||
161725553|NCT00064662|584037824|FG001|Overall Study|Withdrawal by Subject|14|||
161725554|NCT00064662|584037823|FG000|Overall Study|Administratively withdrawn|2|||
161725555|NCT00064662|584037824|FG001|Overall Study|Administratively withdrawn|2|||
161725556|NCT01555463|584037829|FG000|Treatment|Adverse Event|6|||
161725557|NCT01555463|584037830|FG001|Treatment|Adverse Event|12|||
161725558|NCT01555463|584037829|FG000|Treatment|Withdrawal by Subject|24|||
161725559|NCT01555463|584037830|FG001|Treatment|Withdrawal by Subject|36|||
161725560|NCT01555463|584037829|FG000|Treatment|Lost to Follow-up|28|||
161725561|NCT01555463|584037830|FG001|Treatment|Lost to Follow-up|23|||
161725562|NCT01555463|584037829|FG000|Treatment|Protocol Violation|4|||
161725563|NCT01555463|584037830|FG001|Treatment|Protocol Violation|5|||
161725564|NCT01555463|584037829|FG000|Treatment|Other reason|2|||
161725565|NCT01555463|584037830|FG001|Treatment|Other reason|3|||
161725566|NCT01555463|584037829|FG000|Follow up|Adverse Event|2|||
161725567|NCT01555463|584037830|FG001|Follow up|Adverse Event|5|||
161725568|NCT01555463|584037829|FG000|Follow up|Death|0|||
161725569|NCT01555463|584037830|FG001|Follow up|Death|1|||
161725570|NCT01555463|584037829|FG000|Follow up|Withdrawal by Subject|22|||
161725571|NCT01555463|584037830|FG001|Follow up|Withdrawal by Subject|22|||
161725572|NCT01555463|584037829|FG000|Follow up|Lost to Follow-up|9|||
161725573|NCT01555463|584037830|FG001|Follow up|Lost to Follow-up|10|||
161725574|NCT01555463|584037829|FG000|Follow up|Protocol Violation|2|||
161725575|NCT01555463|584037830|FG001|Follow up|Protocol Violation|4|||
161725576|NCT01555463|584037829|FG000|Follow up|Other reason|3|||
161725577|NCT01555463|584037830|FG001|Follow up|Other reason|3|||
161725578|NCT01165203|584037833|FG000|Active Phase|Serious Adverse Event|1|||
161725579|NCT01165203|584037834|FG001|Active Phase|Serious Adverse Event|0|||
161725580|NCT01165203|584037833|FG000|Active Phase|Withdrawal by Subject|2|||
161725581|NCT01165203|584037834|FG001|Active Phase|Withdrawal by Subject|1|||
161725582|NCT01165203|584037833|FG000|Active Phase|Migrated/moved from study area|0|||
161725583|NCT01165203|584037834|FG001|Active Phase|Migrated/moved from study area|1|||
161725584|NCT01165203|584037833|FG000|Active Phase|Lost to Follow-up|2|||
161725585|NCT01165203|584037834|FG001|Active Phase|Lost to Follow-up|0|||
161725586|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
161725587|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
161725588|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
161725589|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
161725590|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
161725591|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
161725592|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
161725593|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
161725594|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
161725595|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
161725596|NCT01323673|584037836|FG000|Overall Study|Adverse Event|0|||
161725597|NCT01323673|584037837|FG001|Overall Study|Adverse Event|1|||
161725598|NCT01323673|584037836|FG000|Overall Study|Lost to Follow-up|0|||
161725599|NCT01323673|584037837|FG001|Overall Study|Lost to Follow-up|1|||
161725600|NCT01323673|584037836|FG000|Overall Study|Protocol Violation|1|||
161725601|NCT01323673|584037837|FG001|Overall Study|Protocol Violation|0|||
161725602|NCT01323673|584037836|FG000|Overall Study|Withdrawal by Subject|2|||
161725603|NCT01323673|584037837|FG001|Overall Study|Withdrawal by Subject|3|||
161725604|NCT01937130|584039801|FG000|Overall Study|Withdrawal by Subject|0|||
161725605|NCT01937130|584039802|FG001|Overall Study|Withdrawal by Subject|0|||
161725606|NCT01937130|584039803|FG002|Overall Study|Withdrawal by Subject|0|||
161725607|NCT01937130|584039804|FG003|Overall Study|Withdrawal by Subject|1|||
161725608|NCT01937130|584039801|FG000|Overall Study|Adverse Event|0|||
161725609|NCT01937130|584039802|FG001|Overall Study|Adverse Event|1|||
161725610|NCT01937130|584039803|FG002|Overall Study|Adverse Event|0|||
161725611|NCT01937130|584039804|FG003|Overall Study|Adverse Event|1|||
161725612|NCT01937130|584039801|FG000|Overall Study|Death|1|||
161725613|NCT01937130|584039802|FG001|Overall Study|Death|1|||
161725614|NCT01937130|584039803|FG002|Overall Study|Death|1|||
161725615|NCT01937130|584039804|FG003|Overall Study|Death|0|||
161725616|NCT01937130|584039801|FG000|Overall Study|Lost to Follow-up|2|||
161725617|NCT01937130|584039802|FG001|Overall Study|Lost to Follow-up|0|||
161725618|NCT01937130|584039803|FG002|Overall Study|Lost to Follow-up|2|||
161725619|NCT01937130|584039804|FG003|Overall Study|Lost to Follow-up|0|||
161725620|NCT01937130|584039801|FG000|Overall Study|Physician Decision|0|||
161725621|NCT01937130|584039802|FG001|Overall Study|Physician Decision|1|||
161725622|NCT01937130|584039803|FG002|Overall Study|Physician Decision|0|||
161725623|NCT01937130|584039804|FG003|Overall Study|Physician Decision|0|||
161725624|NCT01937130|584039801|FG000|Overall Study|Patients unable to swallow|0|||
161725625|NCT01937130|584039802|FG001|Overall Study|Patients unable to swallow|1|||
161725626|NCT01937130|584039803|FG002|Overall Study|Patients unable to swallow|0|||
161725627|NCT01937130|584039804|FG003|Overall Study|Patients unable to swallow|0|||
161725628|NCT01937130|584039801|FG000|Overall Study|Patient lost to FU due to death|2|||
161725629|NCT01937130|584039802|FG001|Overall Study|Patient lost to FU due to death|0|||
161725630|NCT01937130|584039803|FG002|Overall Study|Patient lost to FU due to death|0|||
161725631|NCT01937130|584039804|FG003|Overall Study|Patient lost to FU due to death|0|||
161725632|NCT01431144|584039805|FG000|Overall Study|Implant mobility and removal|2|||
161725633|NCT01431144|584039806|FG001|Overall Study|Implant mobility and removal|0|||
161725634|NCT01746732|584039812|FG000|Lead-In Period|Withdrawal by Subject|1|||
161725635|NCT01746732|584039813|FG001|Lead-In Period|Withdrawal by Subject|0|||
161725636|NCT01746732|584039814|FG002|Lead-In Period|Withdrawal by Subject|0|||
161725637|NCT01746732|584039812|FG000|Period 1|Physician Decision|0|||
161725638|NCT01746732|584039813|FG001|Period 1|Physician Decision|1|||
161725639|NCT01746732|584039814|FG002|Period 1|Physician Decision|0|||
161725640|NCT01746732|584039812|FG000|Period 2|Withdrawal by Subject|0|||
161725641|NCT01746732|584039813|FG001|Period 2|Withdrawal by Subject|0|||
161725642|NCT01746732|584039814|FG002|Period 2|Withdrawal by Subject|2|||
161725643|NCT01746732|584039812|FG000|Period 2|Adverse Event|0|||
161725644|NCT01746732|584039813|FG001|Period 2|Adverse Event|0|||
161725645|NCT01746732|584039814|FG002|Period 2|Adverse Event|1|||
161725646|NCT01746732|584039812|FG000|Period 2|Lost to Follow-up|0|||
161725647|NCT01746732|584039813|FG001|Period 2|Lost to Follow-up|0|||
161725648|NCT01746732|584039814|FG002|Period 2|Lost to Follow-up|1|||
161725649|NCT02817555|584039815|FG000|Overall Study|Death|1|||
161725650|NCT02817555|584039816|FG001|Overall Study|Death|3|||
161725651|NCT02817555|584039815|FG000|Overall Study|moved away|1|||
161725652|NCT02817555|584039816|FG001|Overall Study|moved away|0|||
161725653|NCT02817555|584039815|FG000|Overall Study|transplant|1|||
161725654|NCT02817555|584039816|FG001|Overall Study|transplant|1|||
161725655|NCT02817555|584039815|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
161725656|NCT02817555|584039816|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
161725657|NCT00137436|584039817|FG000|Overall Study|Adverse Event|13|||
161725658|NCT00137436|584039817|FG000|Overall Study|Death|2|||
161725659|NCT00137436|584039817|FG000|Overall Study|Lack of Efficacy|17|||
161725660|NCT00137436|584039817|FG000|Overall Study|Withdrawal by Subject|6|||
161725661|NCT00137436|584039817|FG000|Overall Study|Other|5|||
161725662|NCT00701727|584039818|FG000|First Treatment Period|Adverse Event|0|||
161725663|NCT00701727|584039819|FG001|First Treatment Period|Adverse Event|0|||
161725664|NCT00701727|584039818|FG000|First Treatment Period|Withdrawal by Subject|1|||
161725665|NCT00701727|584039819|FG001|First Treatment Period|Withdrawal by Subject|0|||
161725666|NCT00701727|584039818|FG000|First Treatment Period|sponsor decision|0|||
161725667|NCT00701727|584039819|FG001|First Treatment Period|sponsor decision|1|||
161725668|NCT00701727|584039818|FG000|First Treatment Period|Lost to Follow-up|0|||
161725669|NCT00701727|584039819|FG001|First Treatment Period|Lost to Follow-up|1|||
161725670|NCT00701727|584039818|FG000|Second Treatment Period|Withdrawal by Subject|2|||
161725671|NCT00701727|584039819|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161725672|NCT00696657|584039820|FG000|Overall Study|Protocol Violation|0|||
161725673|NCT00696657|584039821|FG001|Overall Study|Protocol Violation|0|||
161725674|NCT00696657|584039822|FG002|Overall Study|Protocol Violation|0|||
161725675|NCT00696657|584039823|FG003|Overall Study|Protocol Violation|0|||
161725676|NCT00696657|584039824|FG004|Overall Study|Protocol Violation|0|||
161725677|NCT00696657|584039825|FG005|Overall Study|Protocol Violation|1|||
161725678|NCT00696657|584039826|FG006|Overall Study|Protocol Violation|0|||
161725679|NCT00696657|584039827|FG007|Overall Study|Protocol Violation|0|||
161725680|NCT00696657|584039828|FG008|Overall Study|Protocol Violation|1|||
161725681|NCT00696657|584039820|FG000|Overall Study|Lack of Efficacy|0|||
161725682|NCT00696657|584039821|FG001|Overall Study|Lack of Efficacy|1|||
161725683|NCT00696657|584039822|FG002|Overall Study|Lack of Efficacy|0|||
161725684|NCT00696657|584039823|FG003|Overall Study|Lack of Efficacy|0|||
161725685|NCT00696657|584039824|FG004|Overall Study|Lack of Efficacy|0|||
161725686|NCT00696657|584039825|FG005|Overall Study|Lack of Efficacy|0|||
161725687|NCT00696657|584039826|FG006|Overall Study|Lack of Efficacy|0|||
161725688|NCT00696657|584039827|FG007|Overall Study|Lack of Efficacy|0|||
161725689|NCT00696657|584039828|FG008|Overall Study|Lack of Efficacy|0|||
161725690|NCT00696657|584039820|FG000|Overall Study|Withdrawal criteria|1|||
161725691|NCT00696657|584039821|FG001|Overall Study|Withdrawal criteria|3|||
161725692|NCT00696657|584039822|FG002|Overall Study|Withdrawal criteria|2|||
161725693|NCT00696657|584039823|FG003|Overall Study|Withdrawal criteria|2|||
161725694|NCT00696657|584039824|FG004|Overall Study|Withdrawal criteria|0|||
161725695|NCT00696657|584039825|FG005|Overall Study|Withdrawal criteria|0|||
161725696|NCT00696657|584039826|FG006|Overall Study|Withdrawal criteria|1|||
161725697|NCT00696657|584039827|FG007|Overall Study|Withdrawal criteria|1|||
161725698|NCT00696657|584039828|FG008|Overall Study|Withdrawal criteria|2|||
161725699|NCT00696657|584039820|FG000|Overall Study|Unclassified|0|||
161725700|NCT00696657|584039821|FG001|Overall Study|Unclassified|1|||
161725701|NCT00696657|584039822|FG002|Overall Study|Unclassified|3|||
161725702|NCT00696657|584039823|FG003|Overall Study|Unclassified|2|||
161725703|NCT00696657|584039824|FG004|Overall Study|Unclassified|4|||
161725704|NCT00696657|584039825|FG005|Overall Study|Unclassified|2|||
161725705|NCT00696657|584039826|FG006|Overall Study|Unclassified|0|||
161725706|NCT00696657|584039827|FG007|Overall Study|Unclassified|0|||
161725707|NCT00696657|584039828|FG008|Overall Study|Unclassified|1|||
161725708|NCT00696657|584039820|FG000|Overall Study|Adverse Event|0|||
161725709|NCT00696657|584039821|FG001|Overall Study|Adverse Event|0|||
161725710|NCT00696657|584039822|FG002|Overall Study|Adverse Event|3|||
161725711|NCT00696657|584039823|FG003|Overall Study|Adverse Event|7|||
161725712|NCT00696657|584039824|FG004|Overall Study|Adverse Event|6|||
161725713|NCT00696657|584039825|FG005|Overall Study|Adverse Event|9|||
161725714|NCT00696657|584039826|FG006|Overall Study|Adverse Event|14|||
161725715|NCT00696657|584039827|FG007|Overall Study|Adverse Event|2|||
161725716|NCT00696657|584039828|FG008|Overall Study|Adverse Event|5|||
161725717|NCT00912015|584039831|FG000|Overall Study|Lack of Efficacy|1|||
161725718|NCT00912015|584039832|FG001|Overall Study|Lack of Efficacy|0|||
161725719|NCT00912015|584039833|FG002|Overall Study|Lack of Efficacy|0|||
161725720|NCT00912015|584039834|FG003|Overall Study|Lack of Efficacy|0|||
161725721|NCT00912015|584039831|FG000|Overall Study|Withdrawal by Subject|8|||
161725722|NCT00912015|584039832|FG001|Overall Study|Withdrawal by Subject|8|||
161725723|NCT00912015|584039833|FG002|Overall Study|Withdrawal by Subject|3|||
161725724|NCT00912015|584039834|FG003|Overall Study|Withdrawal by Subject|0|||
161725725|NCT00912015|584039831|FG000|Overall Study|Protocol Violation|1|||
161725726|NCT00912015|584039832|FG001|Overall Study|Protocol Violation|0|||
161725727|NCT00912015|584039833|FG002|Overall Study|Protocol Violation|0|||
161725728|NCT00912015|584039834|FG003|Overall Study|Protocol Violation|1|||
161725729|NCT00912015|584039831|FG000|Overall Study|Adverse Event|6|||
161725730|NCT00912015|584039832|FG001|Overall Study|Adverse Event|0|||
161725731|NCT00912015|584039833|FG002|Overall Study|Adverse Event|0|||
161725732|NCT00912015|584039834|FG003|Overall Study|Adverse Event|1|||
161725733|NCT05137041|584039835|FG000|Overall Study|Lost to Follow-up|1|||
161725734|NCT05137041|584039836|FG001|Overall Study|Lost to Follow-up|1|||
161725735|NCT05137041|584039835|FG000|Overall Study|Withdrawal by Subject|0|||
161725736|NCT05137041|584039836|FG001|Overall Study|Withdrawal by Subject|2|||
161725737|NCT05137041|584039835|FG000|Overall Study|Reason not Specified|0|||
161725738|NCT05137041|584039836|FG001|Overall Study|Reason not Specified|1|||
161725739|NCT02433210|584039837|FG000|Overall Study|Physician Decision|1|||
161725740|NCT02433210|584039838|FG001|Overall Study|Physician Decision|0|||
161725741|NCT02433210|584039839|FG002|Overall Study|Physician Decision|0|||
161725742|NCT02090114|584039840|FG000|Overall Study|Withdrawal by Subject|3|||
161725743|NCT02090114|584039841|FG001|Overall Study|Withdrawal by Subject|6|||
161725744|NCT02090114|584039842|FG002|Overall Study|Withdrawal by Subject|2|||
161725745|NCT02090114|584039843|FG003|Overall Study|Withdrawal by Subject|1|||
161725746|NCT02090114|584039840|FG000|Overall Study|Physician Decision|5|||
161725747|NCT02090114|584039841|FG001|Overall Study|Physician Decision|0|||
161725748|NCT02090114|584039842|FG002|Overall Study|Physician Decision|1|||
161725749|NCT02090114|584039843|FG003|Overall Study|Physician Decision|1|||
161725750|NCT02090114|584039840|FG000|Overall Study|Adverse Event|1|||
161725751|NCT02090114|584039841|FG001|Overall Study|Adverse Event|2|||
161725752|NCT02090114|584039842|FG002|Overall Study|Adverse Event|2|||
161725753|NCT02090114|584039843|FG003|Overall Study|Adverse Event|0|||
161725754|NCT02090114|584039840|FG000|Overall Study|Progressive Disease|20|||
161725755|NCT02090114|584039841|FG001|Overall Study|Progressive Disease|21|||
161725756|NCT02090114|584039842|FG002|Overall Study|Progressive Disease|23|||
161725757|NCT02090114|584039843|FG003|Overall Study|Progressive Disease|6|||
161725758|NCT02090114|584039840|FG000|Overall Study|Death|1|||
161725759|NCT02090114|584039841|FG001|Overall Study|Death|0|||
161725760|NCT02090114|584039842|FG002|Overall Study|Death|1|||
161725761|NCT02090114|584039843|FG003|Overall Study|Death|0|||
161725762|NCT01605071|584039844|FG000|Overall Study|Withdrawal by Subject|3|||
161725763|NCT01605071|584039845|FG001|Overall Study|Withdrawal by Subject|2|||
161725764|NCT00051558|584039848|FG000|Overall Study|Adverse Event|30|||
161725765|NCT00051558|584039849|FG001|Overall Study|Adverse Event|18|||
161725766|NCT00051558|584039848|FG000|Overall Study|Withdrawal by Subject|29|||
161725767|NCT00051558|584039849|FG001|Overall Study|Withdrawal by Subject|42|||
161725768|NCT00051558|584039848|FG000|Overall Study|Death|9|||
161725769|NCT00051558|584039849|FG001|Overall Study|Death|15|||
161725770|NCT00051558|584039848|FG000|Overall Study|Lost to Follow-up|4|||
161725771|NCT00051558|584039849|FG001|Overall Study|Lost to Follow-up|13|||
161725772|NCT00051558|584039848|FG000|Overall Study|Protocol Violation|3|||
161725773|NCT00051558|584039849|FG001|Overall Study|Protocol Violation|4|||
161725774|NCT00051558|584039848|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
161725775|NCT00051558|584039849|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
161725776|NCT00051558|584039848|FG000|Overall Study|Sponsor Decision|6|||
161725777|NCT00051558|584039849|FG001|Overall Study|Sponsor Decision|1|||
161725778|NCT00051558|584039848|FG000|Overall Study|Other|2|||
161725779|NCT00051558|584039849|FG001|Overall Study|Other|1|||
161725780|NCT00051558|584039848|FG000|Overall Study|Significant Lab Value|2|||
161725781|NCT00051558|584039849|FG001|Overall Study|Significant Lab Value|0|||
161725782|NCT00051558|584039848|FG000|Overall Study|Physician Decision|5|||
161725783|NCT00051558|584039849|FG001|Overall Study|Physician Decision|0|||
161725784|NCT02163993|584039851|FG000|Treatment Period|Adverse Event|0|||
161725785|NCT02163993|584039852|FG001|Treatment Period|Adverse Event|1|||
161725786|NCT02163993|584039853|FG002|Treatment Period|Adverse Event|0|||
161725787|NCT02163993|584039854|FG003|Treatment Period|Adverse Event|0|||
161725788|NCT02163993|584039855|FG004|Treatment Period|Adverse Event|1|||
161725789|NCT02163993|584039851|FG000|Treatment Period|Lost to Follow-up|2|||
161725790|NCT02163993|584039852|FG001|Treatment Period|Lost to Follow-up|3|||
161725791|NCT02163993|584039853|FG002|Treatment Period|Lost to Follow-up|1|||
161725792|NCT02163993|584039854|FG003|Treatment Period|Lost to Follow-up|3|||
161725793|NCT02163993|584039855|FG004|Treatment Period|Lost to Follow-up|1|||
161725794|NCT02163993|584039851|FG000|Treatment Period|Physician Decision|1|||
161725795|NCT02163993|584039852|FG001|Treatment Period|Physician Decision|0|||
161725796|NCT02163993|584039853|FG002|Treatment Period|Physician Decision|0|||
161725797|NCT02163993|584039854|FG003|Treatment Period|Physician Decision|0|||
161725798|NCT02163993|584039855|FG004|Treatment Period|Physician Decision|0|||
161725799|NCT02163993|584039851|FG000|Treatment Period|Protocol Violation|2|||
161725800|NCT02163993|584039852|FG001|Treatment Period|Protocol Violation|1|||
161725801|NCT02163993|584039853|FG002|Treatment Period|Protocol Violation|0|||
161725802|NCT02163993|584039854|FG003|Treatment Period|Protocol Violation|1|||
161725803|NCT02163993|584039855|FG004|Treatment Period|Protocol Violation|2|||
161725804|NCT02163993|584039851|FG000|Treatment Period|Withdrawal by Subject|6|||
161725805|NCT02163993|584039852|FG001|Treatment Period|Withdrawal by Subject|4|||
161725806|NCT02163993|584039853|FG002|Treatment Period|Withdrawal by Subject|1|||
161725807|NCT02163993|584039854|FG003|Treatment Period|Withdrawal by Subject|4|||
161725808|NCT02163993|584039855|FG004|Treatment Period|Withdrawal by Subject|1|||
161725809|NCT02163993|584039851|FG000|Treatment Period|Not treated|1|||
161725810|NCT02163993|584039852|FG001|Treatment Period|Not treated|0|||
161725811|NCT02163993|584039853|FG002|Treatment Period|Not treated|0|||
161725812|NCT02163993|584039854|FG003|Treatment Period|Not treated|1|||
161725813|NCT02163993|584039855|FG004|Treatment Period|Not treated|2|||
161725814|NCT02163993|584039851|FG000|Post-treatment Period|Adverse Event|0|||
161725815|NCT02163993|584039852|FG001|Post-treatment Period|Adverse Event|0|||
161725816|NCT02163993|584039853|FG002|Post-treatment Period|Adverse Event|1|||
161725817|NCT02163993|584039854|FG003|Post-treatment Period|Adverse Event|0|||
161725818|NCT02163993|584039855|FG004|Post-treatment Period|Adverse Event|0|||
161725819|NCT02163993|584039851|FG000|Post-treatment Period|Lost to Follow-up|2|||
161725820|NCT02163993|584039852|FG001|Post-treatment Period|Lost to Follow-up|2|||
161725821|NCT02163993|584039853|FG002|Post-treatment Period|Lost to Follow-up|3|||
161725822|NCT02163993|584039854|FG003|Post-treatment Period|Lost to Follow-up|1|||
161725823|NCT02163993|584039855|FG004|Post-treatment Period|Lost to Follow-up|0|||
161725824|NCT02163993|584039851|FG000|Post-treatment Period|Protocol Violation|0|||
161725825|NCT02163993|584039852|FG001|Post-treatment Period|Protocol Violation|0|||
161725826|NCT02163993|584039853|FG002|Post-treatment Period|Protocol Violation|0|||
161725827|NCT02163993|584039854|FG003|Post-treatment Period|Protocol Violation|0|||
161725828|NCT02163993|584039855|FG004|Post-treatment Period|Protocol Violation|1|||
161725829|NCT02163993|584039851|FG000|Post-treatment Period|Withdrawal by Subject|2|||
161725830|NCT02163993|584039852|FG001|Post-treatment Period|Withdrawal by Subject|4|||
161725831|NCT02163993|584039853|FG002|Post-treatment Period|Withdrawal by Subject|0|||
161725832|NCT02163993|584039854|FG003|Post-treatment Period|Withdrawal by Subject|1|||
161725833|NCT02163993|584039855|FG004|Post-treatment Period|Withdrawal by Subject|2|||
161725834|NCT01808118|584039856|FG000|Period 1|Adverse Event|15|||
161725835|NCT01808118|584039857|FG001|Period 1|Adverse Event|0|||
161725836|NCT01808118|584039858|FG002|Period 1|Adverse Event|0|||
161725837|NCT01808118|584039856|FG000|Period 1|Withdrew consent|24|||
161725838|NCT01808118|584039857|FG001|Period 1|Withdrew consent|0|||
161725839|NCT01808118|584039858|FG002|Period 1|Withdrew consent|0|||
161725840|NCT01808118|584039856|FG000|Period 1|Lost to Follow-up|9|||
161725841|NCT01808118|584039857|FG001|Period 1|Lost to Follow-up|0|||
161725842|NCT01808118|584039858|FG002|Period 1|Lost to Follow-up|0|||
161725843|NCT01808118|584039856|FG000|Period 1|Did not meet criteria for remission|303|||
161725844|NCT01808118|584039857|FG001|Period 1|Did not meet criteria for remission|0|||
161725845|NCT01808118|584039858|FG002|Period 1|Did not meet criteria for remission|0|||
161725846|NCT01808118|584039856|FG000|Period 1|Enrolled in error|7|||
161725847|NCT01808118|584039857|FG001|Period 1|Enrolled in error|0|||
161725848|NCT01808118|584039858|FG002|Period 1|Enrolled in error|0|||
161725849|NCT01808118|584039856|FG000|Period 1|Did not meet inclusion criteria|3|||
161725850|NCT01808118|584039857|FG001|Period 1|Did not meet inclusion criteria|0|||
161725851|NCT01808118|584039858|FG002|Period 1|Did not meet inclusion criteria|0|||
161725852|NCT01808118|584039856|FG000|Period 1|Non-conformance with inclusion criteria|3|||
161725853|NCT01808118|584039857|FG001|Period 1|Non-conformance with inclusion criteria|0|||
161725854|NCT01808118|584039858|FG002|Period 1|Non-conformance with inclusion criteria|0|||
161725855|NCT01808118|584039856|FG000|Period 1|Investigator decision: site closure|2|||
161725856|NCT01808118|584039857|FG001|Period 1|Investigator decision: site closure|0|||
161725857|NCT01808118|584039858|FG002|Period 1|Investigator decision: site closure|0|||
161725858|NCT01808118|584039856|FG000|Period 1|Non-compliance per sponsor|1|||
161725859|NCT01808118|584039857|FG001|Period 1|Non-compliance per sponsor|0|||
161725860|NCT01808118|584039858|FG002|Period 1|Non-compliance per sponsor|0|||
161725861|NCT01808118|584039856|FG000|Period 1|Lack of Efficacy|1|||
161725862|NCT01808118|584039857|FG001|Period 1|Lack of Efficacy|0|||
161725863|NCT01808118|584039858|FG002|Period 1|Lack of Efficacy|0|||
161725864|NCT01808118|584039856|FG000|Period 2|Adverse Event|0|||
161725865|NCT01808118|584039857|FG001|Period 2|Adverse Event|4|||
161725866|NCT01808118|584039858|FG002|Period 2|Adverse Event|0|||
161725867|NCT01808118|584039856|FG000|Period 2|Withdrew consent|0|||
161725868|NCT01808118|584039857|FG001|Period 2|Withdrew consent|7|||
161725869|NCT01808118|584039858|FG002|Period 2|Withdrew consent|6|||
161725870|NCT01808118|584039856|FG000|Period 2|Lost to Follow-up|0|||
161725871|NCT01808118|584039857|FG001|Period 2|Lost to Follow-up|0|||
161725872|NCT01808118|584039858|FG002|Period 2|Lost to Follow-up|2|||
161725873|NCT01808118|584039856|FG000|Period 2|Investigator no longer conducting trials|0|||
161725874|NCT01808118|584039857|FG001|Period 2|Investigator no longer conducting trials|1|||
161725875|NCT01808118|584039858|FG002|Period 2|Investigator no longer conducting trials|0|||
161725876|NCT01808118|584039856|FG000|Period 2|Switched to other therapy|0|||
161725877|NCT01808118|584039857|FG001|Period 2|Switched to other therapy|1|||
161725878|NCT01808118|584039858|FG002|Period 2|Switched to other therapy|0|||
161725879|NCT03097328|584039864|FG000|Overall Study|Still on Therapy|2|||
161725880|NCT03097328|584039864|FG000|Overall Study|Progressive Disease|29|||
161725881|NCT03097328|584039864|FG000|Overall Study|Adverse Event|4|||
161725882|NCT03097328|584039864|FG000|Overall Study|Withdrawal by Subject|1|||
161725883|NCT03097328|584039864|FG000|Overall Study|Physician Decision|1|||
161725884|NCT03097328|584039864|FG000|Overall Study|Patient Decision|1|||
161725885|NCT03097328|584039864|FG000|Overall Study|Ineligible for Study Drug|1|||
161725886|NCT02023164|584039865|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
161725887|NCT02023164|584039866|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
161725888|NCT01984346|584039870|FG000|Overall Study|Physician Decision|4|||
161725889|NCT01984346|584039871|FG001|Overall Study|Physician Decision|2|||
161725890|NCT01984346|584039870|FG000|Overall Study|Withdrawal by Subject|2|||
161725891|NCT01984346|584039871|FG001|Overall Study|Withdrawal by Subject|2|||
161725892|NCT01984346|584039870|FG000|Overall Study|Enrollment Closed|8|||
161725893|NCT01984346|584039871|FG001|Overall Study|Enrollment Closed|1|||
161725894|NCT01984346|584039870|FG000|Overall Study|Insurance Coverage|1|||
161725895|NCT01984346|584039871|FG001|Overall Study|Insurance Coverage|0|||
161725896|NCT01984346|584039870|FG000|Overall Study|Intra-operative Exclusion|2|||
161725897|NCT01984346|584039871|FG001|Overall Study|Intra-operative Exclusion|0|||
161725898|NCT02042404|584039874|FG000|Overall Study|Death|1|||
161725899|NCT02042404|584039875|FG001|Overall Study|Death|0|||
161725900|NCT02042404|584039874|FG000|Overall Study|Unrelated Adverse Event|3|||
161725901|NCT02042404|584039875|FG001|Overall Study|Unrelated Adverse Event|0|||
161725902|NCT02042404|584039874|FG000|Overall Study|Inability to meet time requirements|1|||
161725903|NCT02042404|584039875|FG001|Overall Study|Inability to meet time requirements|0|||
161725904|NCT03100942|584039876|FG000|Randomized Treatment Period|Withdrew Consent|4|||
161725905|NCT03100942|584039877|FG001|Randomized Treatment Period|Withdrew Consent|5|||
161725906|NCT03100942|584039878|FG002|Randomized Treatment Period|Withdrew Consent|3|||
161725907|NCT03100942|584039879|FG003|Randomized Treatment Period|Withdrew Consent|3|||
161725908|NCT03100942|584039880|FG004|Randomized Treatment Period|Withdrew Consent|0|||
161725909|NCT03100942|584039881|FG005|Randomized Treatment Period|Withdrew Consent|0|||
161725910|NCT03100942|584039882|FG006|Randomized Treatment Period|Withdrew Consent|0|||
161725911|NCT03100942|584039876|FG000|Randomized Treatment Period|Adverse Event|5|||
161725912|NCT03100942|584039877|FG001|Randomized Treatment Period|Adverse Event|2|||
161725913|NCT03100942|584039878|FG002|Randomized Treatment Period|Adverse Event|1|||
161725914|NCT03100942|584039879|FG003|Randomized Treatment Period|Adverse Event|0|||
161725915|NCT03100942|584039880|FG004|Randomized Treatment Period|Adverse Event|0|||
161725916|NCT03100942|584039881|FG005|Randomized Treatment Period|Adverse Event|0|||
161725917|NCT03100942|584039882|FG006|Randomized Treatment Period|Adverse Event|0|||
161725918|NCT03100942|584039876|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
161725919|NCT03100942|584039877|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
161725920|NCT03100942|584039878|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
161725921|NCT03100942|584039879|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
161725922|NCT03100942|584039880|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
161725923|NCT03100942|584039881|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
161725924|NCT03100942|584039882|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
161725925|NCT03100942|584039876|FG000|Randomized Treatment Period|Protocol Violation|0|||
161725926|NCT03100942|584039877|FG001|Randomized Treatment Period|Protocol Violation|1|||
161725927|NCT03100942|584039878|FG002|Randomized Treatment Period|Protocol Violation|1|||
161725928|NCT03100942|584039879|FG003|Randomized Treatment Period|Protocol Violation|1|||
161725929|NCT03100942|584039880|FG004|Randomized Treatment Period|Protocol Violation|0|||
161725930|NCT03100942|584039881|FG005|Randomized Treatment Period|Protocol Violation|0|||
161725931|NCT03100942|584039882|FG006|Randomized Treatment Period|Protocol Violation|0|||
161725932|NCT03100942|584039876|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
161725933|NCT03100942|584039877|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
161725934|NCT03100942|584039878|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
161725935|NCT03100942|584039879|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
161725936|NCT03100942|584039880|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
161725937|NCT03100942|584039881|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
161725938|NCT03100942|584039882|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
161725939|NCT03100942|584039876|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
161725940|NCT03100942|584039877|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725941|NCT03100942|584039878|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725942|NCT03100942|584039879|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
161725943|NCT03100942|584039880|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725944|NCT03100942|584039881|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725945|NCT03100942|584039882|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725946|NCT03100942|584039876|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725947|NCT03100942|584039877|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725948|NCT03100942|584039878|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725949|NCT03100942|584039879|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725950|NCT03100942|584039880|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725951|NCT03100942|584039881|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725952|NCT03100942|584039882|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
161725953|NCT01876732|584039887|FG000|Overall Study|MMA was not over 800mg/dL|75|||
161725954|NCT00536731|584039888|FG000|Overall Study|Adverse Event|3|||
161725955|NCT00536731|584039889|FG001|Overall Study|Adverse Event|2|||
161725956|NCT00536731|584039890|FG002|Overall Study|Adverse Event|3|||
161725957|NCT00536731|584039888|FG000|Overall Study|Withdrawal by Subject|0|||
161725958|NCT00536731|584039889|FG001|Overall Study|Withdrawal by Subject|2|||
161725959|NCT00536731|584039890|FG002|Overall Study|Withdrawal by Subject|0|||
161725960|NCT00536731|584039888|FG000|Overall Study|Intake of prohibited conc. medication|0|||
161725961|NCT00536731|584039889|FG001|Overall Study|Intake of prohibited conc. medication|0|||
161725962|NCT00536731|584039890|FG002|Overall Study|Intake of prohibited conc. medication|1|||
161725963|NCT00536731|584039888|FG000|Overall Study|Safety reasons|0|||
161725964|NCT00536731|584039889|FG001|Overall Study|Safety reasons|0|||
161725965|NCT00536731|584039890|FG002|Overall Study|Safety reasons|1|||
161725966|NCT00536731|584039888|FG000|Overall Study|Other|1|||
161725967|NCT00536731|584039889|FG001|Overall Study|Other|1|||
161725968|NCT00536731|584039890|FG002|Overall Study|Other|0|||
161725969|NCT00718419|584039891|FG000|Overall Study|Adverse Event|2|||
161725970|NCT00718419|584039892|FG001|Overall Study|Adverse Event|1|||
161725971|NCT00718419|584039891|FG000|Overall Study|Physician Decision|1|||
161725972|NCT00718419|584039892|FG001|Overall Study|Physician Decision|6|||
161725973|NCT00718419|584039891|FG000|Overall Study|Sponsor decision|0|||
161725974|NCT00718419|584039892|FG001|Overall Study|Sponsor decision|1|||
161725975|NCT00718419|584039891|FG000|Overall Study|Withdrawal by Subject|0|||
161725976|NCT00718419|584039892|FG001|Overall Study|Withdrawal by Subject|5|||
161725977|NCT00718419|584039891|FG000|Overall Study|Progressive Disease|7|||
161725978|NCT00718419|584039892|FG001|Overall Study|Progressive Disease|25|||
161725979|NCT00718419|584039891|FG000|Overall Study|Death Due to Progressive Disease|2|||
161725980|NCT00718419|584039892|FG001|Overall Study|Death Due to Progressive Disease|0|||
161725981|NCT00718419|584039891|FG000|Overall Study|Death Due to Study Drug Related|0|||
161725982|NCT00718419|584039892|FG001|Overall Study|Death Due to Study Drug Related|1|||
161725983|NCT00718419|584039891|FG000|Overall Study|Death Due to Adverse Events|1|||
161725984|NCT00718419|584039892|FG001|Overall Study|Death Due to Adverse Events|0|||
161725985|NCT04184622|584039895|FG000|Primary Treatment Period|Adverse Event|6|||
161725986|NCT04184622|584039896|FG001|Primary Treatment Period|Adverse Event|4|||
161725987|NCT04184622|584039897|FG002|Primary Treatment Period|Adverse Event|8|||
161725988|NCT04184622|584039898|FG003|Primary Treatment Period|Adverse Event|6|||
161725989|NCT04184622|584039895|FG000|Primary Treatment Period|Death|4|||
161725990|NCT04184622|584039896|FG001|Primary Treatment Period|Death|4|||
161725991|NCT04184622|584039897|FG002|Primary Treatment Period|Death|2|||
161725992|NCT04184622|584039898|FG003|Primary Treatment Period|Death|1|||
161725993|NCT04184622|584039895|FG000|Primary Treatment Period|Lost to Follow-up|41|||
161725994|NCT04184622|584039896|FG001|Primary Treatment Period|Lost to Follow-up|17|||
161725995|NCT04184622|584039897|FG002|Primary Treatment Period|Lost to Follow-up|15|||
161725996|NCT04184622|584039898|FG003|Primary Treatment Period|Lost to Follow-up|13|||
161725997|NCT04184622|584039895|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
161725998|NCT04184622|584039896|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
161725999|NCT04184622|584039897|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
161726000|NCT04184622|584039898|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
161726001|NCT04184622|584039895|FG000|Primary Treatment Period|Physician Decision|0|||
161726002|NCT04184622|584039896|FG001|Primary Treatment Period|Physician Decision|0|||
161726003|NCT04184622|584039897|FG002|Primary Treatment Period|Physician Decision|3|||
161726004|NCT04184622|584039898|FG003|Primary Treatment Period|Physician Decision|1|||
161726005|NCT04184622|584039895|FG000|Primary Treatment Period|Pregnancy|4|||
161726006|NCT04184622|584039896|FG001|Primary Treatment Period|Pregnancy|3|||
161726007|NCT04184622|584039897|FG002|Primary Treatment Period|Pregnancy|4|||
161726008|NCT04184622|584039898|FG003|Primary Treatment Period|Pregnancy|1|||
161726009|NCT04184622|584039895|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
161726010|NCT04184622|584039896|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
161726011|NCT04184622|584039897|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
161726012|NCT04184622|584039898|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
161726013|NCT04184622|584039895|FG000|Additional Treatment Period|Adverse Event|1|||
161726014|NCT04184622|584039896|FG001|Additional Treatment Period|Adverse Event|2|||
161726015|NCT04184622|584039897|FG002|Additional Treatment Period|Adverse Event|1|||
161726016|NCT04184622|584039898|FG003|Additional Treatment Period|Adverse Event|0|||
161726017|NCT04184622|584039895|FG000|Additional Treatment Period|Death|0|||
161726018|NCT04184622|584039896|FG001|Additional Treatment Period|Death|0|||
161726019|NCT04184622|584039897|FG002|Additional Treatment Period|Death|1|||
161726020|NCT04184622|584039898|FG003|Additional Treatment Period|Death|1|||
161726021|NCT04184622|584039895|FG000|Additional Treatment Period|Lost to Follow-up|6|||
161726022|NCT04184622|584039896|FG001|Additional Treatment Period|Lost to Follow-up|4|||
161726023|NCT04184622|584039897|FG002|Additional Treatment Period|Lost to Follow-up|8|||
161726024|NCT04184622|584039898|FG003|Additional Treatment Period|Lost to Follow-up|6|||
161726025|NCT04184622|584039895|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
161726026|NCT04184622|584039896|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
161726027|NCT04184622|584039897|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
161726028|NCT04184622|584039898|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
161726029|NCT04184622|584039895|FG000|Additional Treatment Period|Physician Decision|0|||
161726030|NCT04184622|584039896|FG001|Additional Treatment Period|Physician Decision|0|||
161726031|NCT04184622|584039897|FG002|Additional Treatment Period|Physician Decision|1|||
161726032|NCT04184622|584039898|FG003|Additional Treatment Period|Physician Decision|0|||
161726033|NCT04184622|584039895|FG000|Additional Treatment Period|Pregnancy|0|||
161726034|NCT04184622|584039896|FG001|Additional Treatment Period|Pregnancy|0|||
161726035|NCT04184622|584039897|FG002|Additional Treatment Period|Pregnancy|0|||
161726036|NCT04184622|584039898|FG003|Additional Treatment Period|Pregnancy|1|||
161726037|NCT04184622|584039895|FG000|Additional Treatment Period|Protocol deviation|0|||
161726038|NCT04184622|584039896|FG001|Additional Treatment Period|Protocol deviation|0|||
161726039|NCT04184622|584039897|FG002|Additional Treatment Period|Protocol deviation|1|||
161726040|NCT04184622|584039898|FG003|Additional Treatment Period|Protocol deviation|0|||
161726041|NCT04184622|584039895|FG000|Additional Treatment Period|Site closed|1|||
161726042|NCT04184622|584039896|FG001|Additional Treatment Period|Site closed|0|||
161726043|NCT04184622|584039897|FG002|Additional Treatment Period|Site closed|1|||
161726044|NCT04184622|584039898|FG003|Additional Treatment Period|Site closed|0|||
161726045|NCT04184622|584039895|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
161726046|NCT04184622|584039896|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
161726047|NCT04184622|584039897|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
161726048|NCT04184622|584039898|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
161726049|NCT04184622|584039895|FG000|Safety Follow-up Period|Adverse Event|6|||
161726050|NCT04184622|584039896|FG001|Safety Follow-up Period|Adverse Event|8|||
161726051|NCT04184622|584039897|FG002|Safety Follow-up Period|Adverse Event|9|||
161726052|NCT04184622|584039898|FG003|Safety Follow-up Period|Adverse Event|16|||
161726053|NCT04184622|584039895|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
161726054|NCT04184622|584039896|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
161726055|NCT04184622|584039897|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
161726056|NCT04184622|584039898|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
161726057|NCT04184622|584039895|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
161726058|NCT04184622|584039896|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
161726059|NCT04184622|584039897|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
161726060|NCT04184622|584039898|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
161726061|NCT04184622|584039895|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
161726062|NCT04184622|584039896|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
161726063|NCT04184622|584039897|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
161726064|NCT04184622|584039898|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
161726065|NCT04184622|584039895|FG000|Safety Follow-up Period|Physician Decision|1|||
161726066|NCT04184622|584039896|FG001|Safety Follow-up Period|Physician Decision|0|||
161726067|NCT04184622|584039897|FG002|Safety Follow-up Period|Physician Decision|0|||
161726068|NCT04184622|584039898|FG003|Safety Follow-up Period|Physician Decision|1|||
161726069|NCT04184622|584039895|FG000|Safety Follow-up Period|Pregnancy|1|||
161726070|NCT04184622|584039896|FG001|Safety Follow-up Period|Pregnancy|3|||
161726071|NCT04184622|584039897|FG002|Safety Follow-up Period|Pregnancy|0|||
161726072|NCT04184622|584039898|FG003|Safety Follow-up Period|Pregnancy|6|||
161726073|NCT04184622|584039895|FG000|Safety Follow-up Period|Protocol deviation|1|||
161726074|NCT04184622|584039896|FG001|Safety Follow-up Period|Protocol deviation|0|||
161726075|NCT04184622|584039897|FG002|Safety Follow-up Period|Protocol deviation|0|||
161726076|NCT04184622|584039898|FG003|Safety Follow-up Period|Protocol deviation|0|||
161726077|NCT04184622|584039895|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
161726078|NCT04184622|584039896|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
161726079|NCT04184622|584039897|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
161726080|NCT04184622|584039898|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
161726081|NCT02795988|584039899|FG000|Phase 1b|Withdrawal by Subject|0|||
161726082|NCT02795988|584039900|FG001|Phase 1b|Withdrawal by Subject|1|||
161726083|NCT02795988|584039901|FG002|Phase 1b|Withdrawal by Subject|0|||
161726084|NCT02795988|584039902|FG003|Phase 1b|Withdrawal by Subject|0|||
161726085|NCT02795988|584039903|FG004|Phase 1b|Withdrawal by Subject|0|||
161726086|NCT02795988|584039904|FG005|Phase 1b|Withdrawal by Subject|0|||
161726087|NCT02795988|584039905|FG006|Phase 1b|Withdrawal by Subject|0|||
161726088|NCT02795988|584039899|FG000|Phase 1b|Death|1|||
161726089|NCT02795988|584039900|FG001|Phase 1b|Death|2|||
161726090|NCT02795988|584039901|FG002|Phase 1b|Death|1|||
161726091|NCT02795988|584039902|FG003|Phase 1b|Death|0|||
161726092|NCT02795988|584039903|FG004|Phase 1b|Death|0|||
161726093|NCT02795988|584039904|FG005|Phase 1b|Death|0|||
161726094|NCT02795988|584039905|FG006|Phase 1b|Death|0|||
161726095|NCT02795988|584039899|FG000|Phase 1b|Physician Decision|0|||
161726096|NCT02795988|584039900|FG001|Phase 1b|Physician Decision|0|||
161726097|NCT02795988|584039901|FG002|Phase 1b|Physician Decision|1|||
161726098|NCT02795988|584039902|FG003|Phase 1b|Physician Decision|0|||
161726099|NCT02795988|584039903|FG004|Phase 1b|Physician Decision|0|||
161726100|NCT02795988|584039904|FG005|Phase 1b|Physician Decision|0|||
161726101|NCT02795988|584039905|FG006|Phase 1b|Physician Decision|0|||
161726102|NCT02795988|584039899|FG000|Phase 1b|Progressive Disease|2|||
161726103|NCT02795988|584039900|FG001|Phase 1b|Progressive Disease|2|||
161726104|NCT02795988|584039901|FG002|Phase 1b|Progressive Disease|0|||
161726105|NCT02795988|584039902|FG003|Phase 1b|Progressive Disease|0|||
161726106|NCT02795988|584039903|FG004|Phase 1b|Progressive Disease|0|||
161726107|NCT02795988|584039904|FG005|Phase 1b|Progressive Disease|0|||
161726108|NCT02795988|584039905|FG006|Phase 1b|Progressive Disease|0|||
161726109|NCT02795988|584039899|FG000|Phase 2|Withdrawal by Subject|0|||
161726110|NCT02795988|584039900|FG001|Phase 2|Withdrawal by Subject|0|||
161726111|NCT02795988|584039901|FG002|Phase 2|Withdrawal by Subject|0|||
161726112|NCT02795988|584039902|FG003|Phase 2|Withdrawal by Subject|1|||
161726113|NCT02795988|584039903|FG004|Phase 2|Withdrawal by Subject|0|||
161726114|NCT02795988|584039904|FG005|Phase 2|Withdrawal by Subject|0|||
161726115|NCT02795988|584039905|FG006|Phase 2|Withdrawal by Subject|0|||
161726116|NCT02795988|584039899|FG000|Phase 2|Death|0|||
161726117|NCT02795988|584039900|FG001|Phase 2|Death|0|||
161726118|NCT02795988|584039901|FG002|Phase 2|Death|0|||
161726119|NCT02795988|584039902|FG003|Phase 2|Death|17|||
161726120|NCT02795988|584039903|FG004|Phase 2|Death|17|||
161726121|NCT02795988|584039904|FG005|Phase 2|Death|0|||
161726122|NCT02795988|584039905|FG006|Phase 2|Death|0|||
161726123|NCT02795988|584039899|FG000|Phase 2|Other|0|||
161726124|NCT02795988|584039900|FG001|Phase 2|Other|0|||
161726125|NCT02795988|584039901|FG002|Phase 2|Other|0|||
161726126|NCT02795988|584039902|FG003|Phase 2|Other|1|||
161726127|NCT02795988|584039903|FG004|Phase 2|Other|0|||
161726128|NCT02795988|584039904|FG005|Phase 2|Other|0|||
161726129|NCT02795988|584039905|FG006|Phase 2|Other|0|||
161726130|NCT02795988|584039899|FG000|Phase 2 Extension|Death|0|||
161726131|NCT02795988|584039900|FG001|Phase 2 Extension|Death|0|||
161726132|NCT02795988|584039901|FG002|Phase 2 Extension|Death|0|||
161726133|NCT02795988|584039902|FG003|Phase 2 Extension|Death|0|||
161726134|NCT02795988|584039903|FG004|Phase 2 Extension|Death|0|||
161726135|NCT02795988|584039904|FG005|Phase 2 Extension|Death|5|||
161726136|NCT02795988|584039905|FG006|Phase 2 Extension|Death|6|||
161726137|NCT02795988|584039899|FG000|Phase 2 Extension|Other reasons|0|||
161726138|NCT02795988|584039900|FG001|Phase 2 Extension|Other reasons|0|||
161726139|NCT02795988|584039901|FG002|Phase 2 Extension|Other reasons|0|||
161726140|NCT02795988|584039902|FG003|Phase 2 Extension|Other reasons|0|||
161726141|NCT02795988|584039903|FG004|Phase 2 Extension|Other reasons|0|||
161726142|NCT02795988|584039904|FG005|Phase 2 Extension|Other reasons|2|||
161726143|NCT02795988|584039905|FG006|Phase 2 Extension|Other reasons|1|||
161726144|NCT02341014|584039906|FG000|Overall Study|Adverse Event|0|||
161726145|NCT02341014|584039907|FG001|Overall Study|Adverse Event|1|||
161726146|NCT02341014|584039908|FG002|Overall Study|Adverse Event|0|||
161726147|NCT02341014|584039909|FG003|Overall Study|Adverse Event|0|||
161726148|NCT02341014|584039910|FG004|Overall Study|Adverse Event|2|||
161726149|NCT00726323|584039911|FG000|Overall Study|Withdrawal by Subject|3|||
161726150|NCT00726323|584039912|FG001|Overall Study|Withdrawal by Subject|1|||
161726151|NCT00726323|584039911|FG000|Overall Study|Physician Decision|1|||
161726152|NCT00726323|584039912|FG001|Overall Study|Physician Decision|0|||
161726153|NCT00726323|584039911|FG000|Overall Study|Progressive disease|23|||
161726154|NCT00726323|584039912|FG001|Overall Study|Progressive disease|16|||
161726155|NCT00726323|584039911|FG000|Overall Study|Clinical progression|0|||
161726156|NCT00726323|584039912|FG001|Overall Study|Clinical progression|3|||
161726157|NCT00726323|584039911|FG000|Overall Study|Adverse Event|9|||
161726158|NCT00726323|584039912|FG001|Overall Study|Adverse Event|9|||
161726159|NCT00726323|584039911|FG000|Overall Study|Death|1|||
161726160|NCT00726323|584039912|FG001|Overall Study|Death|0|||
161726161|NCT00726323|584039911|FG000|Overall Study|Participant wished to discontinue|0|||
161726162|NCT00726323|584039912|FG001|Overall Study|Participant wished to discontinue|1|||
161726163|NCT00726323|584039911|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
161726164|NCT00726323|584039912|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
161726165|NCT05058664|584039913|FG000|Overall Study|No follow-up data provided|4|||
161726166|NCT05058664|584039914|FG001|Overall Study|No follow-up data provided|0|||
161726167|NCT05058664|584039915|FG002|Overall Study|No follow-up data provided|2|||
161726168|NCT05058664|584039913|FG000|Overall Study|Withdrawal by Subject|0|||
161726169|NCT05058664|584039914|FG001|Overall Study|Withdrawal by Subject|0|||
161726170|NCT05058664|584039915|FG002|Overall Study|Withdrawal by Subject|1|||
161726171|NCT01617681|584039916|FG000|Period 1 Double Blind|Adverse Event|2|||
161726172|NCT01617681|584039917|FG001|Period 1 Double Blind|Adverse Event|0|||
161726173|NCT01617681|584039918|FG002|Period 1 Double Blind|Adverse Event|0|||
161726174|NCT01617681|584039919|FG003|Period 1 Double Blind|Adverse Event|2|||
161726175|NCT01617681|584039920|FG004|Period 1 Double Blind|Adverse Event|0|||
161726176|NCT01617681|584039916|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
161726177|NCT01617681|584039917|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
161726178|NCT01617681|584039918|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
161726179|NCT01617681|584039919|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
161726180|NCT01617681|584039920|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
161726181|NCT01617681|584039916|FG000|Period 2 Open Label|Adverse Event|0|||
161726182|NCT01617681|584039917|FG001|Period 2 Open Label|Adverse Event|0|||
161726183|NCT01617681|584039918|FG002|Period 2 Open Label|Adverse Event|0|||
161726184|NCT01617681|584039919|FG003|Period 2 Open Label|Adverse Event|0|||
161726185|NCT01617681|584039920|FG004|Period 2 Open Label|Adverse Event|3|||
161726186|NCT01617681|584039916|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
161726187|NCT01617681|584039917|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
161726188|NCT01617681|584039918|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
161726189|NCT01617681|584039919|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
161726190|NCT01617681|584039920|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
161726191|NCT00109733|584039927|FG000|Overall Study|Protocol Violation|0|||
161726192|NCT00109733|584039928|FG001|Overall Study|Protocol Violation|1|||
161726193|NCT00109733|584039927|FG000|Overall Study|Stopped taking study drug|1|||
161726194|NCT00109733|584039928|FG001|Overall Study|Stopped taking study drug|1|||
161726195|NCT00109733|584039927|FG000|Overall Study|Non-compliant|0|||
161726196|NCT00109733|584039928|FG001|Overall Study|Non-compliant|1|||
161726197|NCT00109733|584039927|FG000|Overall Study|Could not commit time for study|1|||
161726198|NCT00109733|584039928|FG001|Overall Study|Could not commit time for study|1|||
161726199|NCT01234402|584039937|FG000|Overall Study|Lost to Follow-up|0|||
161726200|NCT01234402|584039938|FG001|Overall Study|Lost to Follow-up|1|||
161726201|NCT01234402|584039939|FG002|Overall Study|Lost to Follow-up|3|||
161726202|NCT01234402|584039937|FG000|Overall Study|Withdrawal by Subject|1|||
161726203|NCT01234402|584039938|FG001|Overall Study|Withdrawal by Subject|3|||
161726204|NCT01234402|584039939|FG002|Overall Study|Withdrawal by Subject|4|||
161726205|NCT01234402|584039937|FG000|Overall Study|Never treated: Death|0|||
161726206|NCT01234402|584039938|FG001|Overall Study|Never treated: Death|0|||
161726207|NCT01234402|584039939|FG002|Overall Study|Never treated: Death|1|||
161726208|NCT01234402|584039937|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
161726209|NCT01234402|584039938|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
161726210|NCT01234402|584039939|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
161726211|NCT01234402|584039937|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
161726212|NCT01234402|584039938|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
161726213|NCT01234402|584039939|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
161726214|NCT02280291|584039941|FG000|Overall Study|Lost to Follow-up|2|||
161726215|NCT02280291|584039942|FG001|Overall Study|Lost to Follow-up|1|||
161726216|NCT02280291|584039943|FG002|Overall Study|Lost to Follow-up|3|||
161726217|NCT02280291|584039944|FG003|Overall Study|Lost to Follow-up|8|||
161726218|NCT02280291|584039941|FG000|Overall Study|Protocol Violation|1|||
161726219|NCT02280291|584039942|FG001|Overall Study|Protocol Violation|0|||
161726220|NCT02280291|584039943|FG002|Overall Study|Protocol Violation|0|||
161726221|NCT02280291|584039944|FG003|Overall Study|Protocol Violation|0|||
161726222|NCT02280291|584039941|FG000|Overall Study|Other|1|||
161726223|NCT02280291|584039942|FG001|Overall Study|Other|1|||
161726224|NCT02280291|584039943|FG002|Overall Study|Other|0|||
161726225|NCT02280291|584039944|FG003|Overall Study|Other|0|||
161726226|NCT00316303|584039946|FG000|Overall Study|Lost to Follow-up|11|||
161726227|NCT00316303|584039947|FG001|Overall Study|Lost to Follow-up|16|||
161726228|NCT01106534|584039948|FG000|Overall Study|Withdrawal by Subject|18|||
161726229|NCT01106534|584039948|FG000|Overall Study|Lost to Follow-up|2|||
161726230|NCT01106534|584039948|FG000|Overall Study|Death|16|||
161726231|NCT01106534|584039948|FG000|Overall Study|Physician Decision|1|||
161726232|NCT00570739|584039949|FG000|Overall Study|Adverse Event|8|||
161726233|NCT00570739|584039950|FG001|Overall Study|Adverse Event|6|||
161726234|NCT00570739|584039951|FG002|Overall Study|Adverse Event|2|||
161726235|NCT00570739|584039952|FG003|Overall Study|Adverse Event|2|||
161726236|NCT00570739|584039949|FG000|Overall Study|Lost to Follow-up|4|||
161726237|NCT00570739|584039950|FG001|Overall Study|Lost to Follow-up|5|||
161726238|NCT00570739|584039951|FG002|Overall Study|Lost to Follow-up|4|||
161726239|NCT00570739|584039952|FG003|Overall Study|Lost to Follow-up|1|||
161726240|NCT00570739|584039949|FG000|Overall Study|Physician Decision|1|||
161726241|NCT00570739|584039950|FG001|Overall Study|Physician Decision|1|||
161726242|NCT00570739|584039951|FG002|Overall Study|Physician Decision|0|||
161726243|NCT00570739|584039952|FG003|Overall Study|Physician Decision|0|||
161726244|NCT00570739|584039949|FG000|Overall Study|Withdrawal by Subject|7|||
161726245|NCT00570739|584039950|FG001|Overall Study|Withdrawal by Subject|7|||
161726246|NCT00570739|584039951|FG002|Overall Study|Withdrawal by Subject|3|||
161726247|NCT00570739|584039952|FG003|Overall Study|Withdrawal by Subject|5|||
161726248|NCT00570739|584039949|FG000|Overall Study|Required restricted medication|0|||
161726249|NCT00570739|584039950|FG001|Overall Study|Required restricted medication|0|||
161726250|NCT00570739|584039951|FG002|Overall Study|Required restricted medication|1|||
161726251|NCT00570739|584039952|FG003|Overall Study|Required restricted medication|0|||
161726252|NCT00570739|584039949|FG000|Overall Study|Met discontinuation criteria|1|||
161726253|NCT00570739|584039950|FG001|Overall Study|Met discontinuation criteria|0|||
161726254|NCT00570739|584039951|FG002|Overall Study|Met discontinuation criteria|1|||
161726255|NCT00570739|584039952|FG003|Overall Study|Met discontinuation criteria|1|||
161726256|NCT00570739|584039949|FG000|Overall Study|Other|0|||
161726257|NCT00570739|584039950|FG001|Overall Study|Other|2|||
161726258|NCT00570739|584039951|FG002|Overall Study|Other|5|||
161726259|NCT00570739|584039952|FG003|Overall Study|Other|3|||
161726260|NCT02086565|584039954|FG000|Overall Study|Lost to Follow-up|9|||
161726261|NCT02086565|584039955|FG001|Overall Study|Lost to Follow-up|7|||
161726262|NCT02086565|584039954|FG000|Overall Study|Withdrawal by Subject|2|||
161726263|NCT02086565|584039955|FG001|Overall Study|Withdrawal by Subject|1|||
161726264|NCT02086565|584039954|FG000|Overall Study|Death|3|||
161726265|NCT02086565|584039955|FG001|Overall Study|Death|2|||
161726266|NCT02086565|584039954|FG000|Overall Study|withdrawn by research team|2|||
161726267|NCT02086565|584039955|FG001|Overall Study|withdrawn by research team|2|||
161726268|NCT00739297|584039956|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
161726269|NCT00739297|584039957|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
161726270|NCT00739297|584039958|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
161726271|NCT00739297|584039959|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
161726272|NCT00739297|584039960|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
161726273|NCT00739297|584039961|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
161726274|NCT00739297|584039962|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
161726275|NCT00739297|584039956|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726276|NCT00739297|584039957|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726277|NCT00739297|584039958|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726278|NCT00739297|584039959|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726279|NCT00739297|584039960|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726280|NCT00739297|584039961|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
161726281|NCT00739297|584039962|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
161726282|NCT01400971|584039963|FG000|Overall Study|Death|82|||
161726283|NCT01400971|584039963|FG000|Overall Study|Lost to Follow-up|196|||
161726284|NCT01400971|584039963|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
161726285|NCT01400971|584039963|FG000|Overall Study|Physician Decision|57|||
161726286|NCT01400971|584039963|FG000|Overall Study|Withdrawal by Subject|158|||
161726287|NCT01400971|584039963|FG000|Overall Study|Other|422|||
161726288|NCT01041573|584039973|FG000|Overall Study|Withdrawal by Subject|2|||
161726289|NCT01041573|584039974|FG001|Overall Study|Withdrawal by Subject|5|||
161726290|NCT01041573|584039975|FG002|Overall Study|Withdrawal by Subject|2|||
161726291|NCT01041573|584039976|FG003|Overall Study|Withdrawal by Subject|0|||
161726292|NCT01041573|584039973|FG000|Overall Study|Death|1|||
161726293|NCT01041573|584039974|FG001|Overall Study|Death|0|||
161726294|NCT01041573|584039975|FG002|Overall Study|Death|0|||
161726295|NCT01041573|584039976|FG003|Overall Study|Death|0|||
161726296|NCT01041573|584039973|FG000|Overall Study|Lost to Follow-up|0|||
161726297|NCT01041573|584039974|FG001|Overall Study|Lost to Follow-up|1|||
161726298|NCT01041573|584039975|FG002|Overall Study|Lost to Follow-up|2|||
161726299|NCT01041573|584039976|FG003|Overall Study|Lost to Follow-up|1|||
161726300|NCT01041573|584039973|FG000|Overall Study|Adverse Event|0|||
161726301|NCT01041573|584039974|FG001|Overall Study|Adverse Event|2|||
161726302|NCT01041573|584039975|FG002|Overall Study|Adverse Event|0|||
161726303|NCT01041573|584039976|FG003|Overall Study|Adverse Event|0|||
161726304|NCT01041573|584039973|FG000|Overall Study|relocation|1|||
161726305|NCT01041573|584039974|FG001|Overall Study|relocation|4|||
161726306|NCT01041573|584039975|FG002|Overall Study|relocation|3|||
161726307|NCT01041573|584039976|FG003|Overall Study|relocation|1|||
161726308|NCT01041573|584039973|FG000|Overall Study|further blood extraction|0|||
161726309|NCT01041573|584039974|FG001|Overall Study|further blood extraction|1|||
161726310|NCT01041573|584039975|FG002|Overall Study|further blood extraction|0|||
161726311|NCT01041573|584039976|FG003|Overall Study|further blood extraction|0|||
161726312|NCT01041573|584039973|FG000|Overall Study|positive to anti-HCV|1|||
161726313|NCT01041573|584039974|FG001|Overall Study|positive to anti-HCV|0|||
161726314|NCT01041573|584039975|FG002|Overall Study|positive to anti-HCV|0|||
161726315|NCT01041573|584039976|FG003|Overall Study|positive to anti-HCV|0|||
161726316|NCT03634072|584039977|FG000|Overall Study|Early termination of overall study|1|||
161726317|NCT03634072|584039978|FG001|Overall Study|Early termination of overall study|0|||
161726318|NCT00620321|584041278|FG000|Overall Study|Adverse Event|1|||
161726319|NCT00620321|584041279|FG001|Overall Study|Adverse Event|1|||
161726320|NCT00620321|584041278|FG000|Overall Study|Death|1|||
161726321|NCT00620321|584041279|FG001|Overall Study|Death|1|||
161726322|NCT00620321|584041278|FG000|Overall Study|Physician Decision|0|||
161726323|NCT00620321|584041279|FG001|Overall Study|Physician Decision|7|||
161726324|NCT00620321|584041278|FG000|Overall Study|Progressive Disease|5|||
161726325|NCT00620321|584041279|FG001|Overall Study|Progressive Disease|5|||
161726326|NCT00620321|584041278|FG000|Overall Study|Sponsor Decision|0|||
161726327|NCT00620321|584041279|FG001|Overall Study|Sponsor Decision|1|||
161726328|NCT00620321|584041278|FG000|Overall Study|Withdrawal by Subject|1|||
161726329|NCT00620321|584041279|FG001|Overall Study|Withdrawal by Subject|1|||
161726330|NCT00643487|584041283|FG000|Overall Study|Technical difficulty|3|||
161726331|NCT05628181|584041288|FG000|Overall Study|Death|2|||
161726332|NCT05628181|584041289|FG001|Overall Study|Death|4|||
161726333|NCT05628181|584041290|FG002|Overall Study|Death|0|||
161726334|NCT03508622|584041291|FG000|Overall Study|Protocol Violation|1|||
161726335|NCT03508622|584041292|FG001|Overall Study|Protocol Violation|0|||
161726336|NCT03508622|584041291|FG000|Overall Study|Withdrawal by Subject|1|||
161726337|NCT03508622|584041292|FG001|Overall Study|Withdrawal by Subject|0|||
161726338|NCT03508622|584041291|FG000|Overall Study|Lost to Follow-up|16|||
161726339|NCT03508622|584041292|FG001|Overall Study|Lost to Follow-up|0|||
161726340|NCT03508622|584041291|FG000|Overall Study|Incomplete data|0|||
161726341|NCT03508622|584041292|FG001|Overall Study|Incomplete data|24|||
161726342|NCT00506077|584041293|FG000|Treatment Period 1|Adverse Event|2|||
161726343|NCT00506077|584041294|FG001|Treatment Period 1|Adverse Event|1|||
161726344|NCT00506077|584041293|FG000|Treatment Period 1|Lost to Follow-up|0|||
161726345|NCT00506077|584041294|FG001|Treatment Period 1|Lost to Follow-up|2|||
161726346|NCT00506077|584041293|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161726347|NCT00506077|584041294|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161726348|NCT00506077|584041293|FG000|Treatment Period 2|Adverse Event|0|||
161726349|NCT00506077|584041294|FG001|Treatment Period 2|Adverse Event|1|||
161726350|NCT00506077|584041293|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161726351|NCT00506077|584041294|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161726352|NCT02985450|584041306|FG000|Overall Study|Lost to Follow-up|7|||
161726353|NCT00069576|584041307|FG000|Original Trial|Lost to Follow-up|25|||
161726354|NCT00069576|584041308|FG001|Original Trial|Lost to Follow-up|33|||
161726355|NCT00069576|584041307|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
161726356|NCT00069576|584041308|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
161726357|NCT00905307|584041309|FG000|Overall Study|Switched to Open Label Rescue|7|||
161726358|NCT00905307|584041310|FG001|Overall Study|Switched to Open Label Rescue|17|||
161726359|NCT00905307|584041311|FG002|Overall Study|Switched to Open Label Rescue|11|||
161726360|NCT00905307|584041312|FG003|Overall Study|Switched to Open Label Rescue|11|||
161726361|NCT00905307|584041313|FG004|Overall Study|Switched to Open Label Rescue|4|||
161726362|NCT00905307|584041314|FG005|Overall Study|Switched to Open Label Rescue|15|||
161726363|NCT00905307|584041309|FG000|Overall Study|Lost to Follow-up|0|||
161726364|NCT00905307|584041310|FG001|Overall Study|Lost to Follow-up|0|||
161726365|NCT00905307|584041311|FG002|Overall Study|Lost to Follow-up|0|||
161726366|NCT00905307|584041312|FG003|Overall Study|Lost to Follow-up|0|||
161726367|NCT00905307|584041313|FG004|Overall Study|Lost to Follow-up|1|||
161726368|NCT00905307|584041314|FG005|Overall Study|Lost to Follow-up|1|||
161726369|NCT00905307|584041309|FG000|Overall Study|Adverse Event|3|||
161726370|NCT00905307|584041310|FG001|Overall Study|Adverse Event|4|||
161726371|NCT00905307|584041311|FG002|Overall Study|Adverse Event|5|||
161726372|NCT00905307|584041312|FG003|Overall Study|Adverse Event|11|||
161726373|NCT00905307|584041313|FG004|Overall Study|Adverse Event|3|||
161726374|NCT00905307|584041314|FG005|Overall Study|Adverse Event|5|||
161726375|NCT00905307|584041309|FG000|Overall Study|Withdrawal by Subject|5|||
161726376|NCT00905307|584041310|FG001|Overall Study|Withdrawal by Subject|13|||
161726377|NCT00905307|584041311|FG002|Overall Study|Withdrawal by Subject|15|||
161726378|NCT00905307|584041312|FG003|Overall Study|Withdrawal by Subject|11|||
161726379|NCT00905307|584041313|FG004|Overall Study|Withdrawal by Subject|4|||
161726380|NCT00905307|584041314|FG005|Overall Study|Withdrawal by Subject|13|||
161726381|NCT00905307|584041309|FG000|Overall Study|Protocol Violation|1|||
161726382|NCT00905307|584041310|FG001|Overall Study|Protocol Violation|0|||
161726383|NCT00905307|584041311|FG002|Overall Study|Protocol Violation|1|||
161726384|NCT00905307|584041312|FG003|Overall Study|Protocol Violation|0|||
161726385|NCT00905307|584041313|FG004|Overall Study|Protocol Violation|0|||
161726386|NCT00905307|584041314|FG005|Overall Study|Protocol Violation|0|||
161726387|NCT00905307|584041309|FG000|Overall Study|Lack of Efficacy|6|||
161726388|NCT00905307|584041310|FG001|Overall Study|Lack of Efficacy|3|||
161726389|NCT00905307|584041311|FG002|Overall Study|Lack of Efficacy|5|||
161726390|NCT00905307|584041312|FG003|Overall Study|Lack of Efficacy|4|||
161726391|NCT00905307|584041313|FG004|Overall Study|Lack of Efficacy|4|||
161726392|NCT00905307|584041314|FG005|Overall Study|Lack of Efficacy|8|||
161726393|NCT05590793|584041315|FG000|Overall Study|Withdrawal by Subject|6|||
161726394|NCT05590793|584041315|FG000|Overall Study|Physician Decision|1|||
161726395|NCT04060667|584041316|FG000|Overall Study|Lost to Follow-up|75|||
161726396|NCT04060667|584041317|FG001|Overall Study|Lost to Follow-up|10|||
161726397|NCT03015610|584041318|FG000|Overall Study|Lost to Follow-up|1|||
161726398|NCT03015610|584041319|FG001|Overall Study|Lost to Follow-up|5|||
161726399|NCT01603641|584041320|FG000|Overall Study|Did not Receive Treatment|3|||
161726400|NCT01603641|584041320|FG000|Overall Study|Adverse Event|1|||
161726401|NCT01603641|584041320|FG000|Overall Study|Lack of Efficacy|1|||
161726402|NCT01603641|584041320|FG000|Overall Study|Lost to Follow-up|6|||
161726403|NCT01603641|584041320|FG000|Overall Study|Personal Reasons|18|||
161726404|NCT01603641|584041320|FG000|Overall Study|Other Miscellaneous Reasons|6|||
161726405|NCT00358917|584041321|FG000|Overall Study|Adverse Event|14|||
161726406|NCT00358917|584041322|FG001|Overall Study|Adverse Event|21|||
161726407|NCT00358917|584041321|FG000|Overall Study|Withdrawal by Subject|5|||
161726408|NCT00358917|584041322|FG001|Overall Study|Withdrawal by Subject|7|||
161726409|NCT00358917|584041321|FG000|Overall Study|Lost to Follow-up|20|||
161726410|NCT00358917|584041322|FG001|Overall Study|Lost to Follow-up|17|||
161726411|NCT00358917|584041321|FG000|Overall Study|Noncompliance|12|||
161726412|NCT00358917|584041322|FG001|Overall Study|Noncompliance|11|||
161726413|NCT00358917|584041321|FG000|Overall Study|Death|2|||
161726414|NCT00358917|584041322|FG001|Overall Study|Death|3|||
161726415|NCT00358917|584041321|FG000|Overall Study|Virologic failure|11|||
161726416|NCT00358917|584041322|FG001|Overall Study|Virologic failure|8|||
161726417|NCT00358917|584041321|FG000|Overall Study|Unable to Continue Participation|2|||
161726418|NCT00358917|584041322|FG001|Overall Study|Unable to Continue Participation|2|||
161726419|NCT01757704|584041327|FG000|Overall Study|Protocol Violation|1|||
161726420|NCT01757704|584041328|FG001|Overall Study|Protocol Violation|3|||
161726421|NCT02890329|584041329|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726422|NCT02890329|584041330|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
161726423|NCT02890329|584041331|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726424|NCT02890329|584041332|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726425|NCT02890329|584041333|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726426|NCT02890329|584041334|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726427|NCT02890329|584041329|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
161726428|NCT02890329|584041330|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
161726429|NCT02890329|584041331|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726430|NCT02890329|584041332|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726431|NCT02890329|584041333|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726432|NCT02890329|584041334|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726433|NCT02890329|584041329|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726434|NCT02890329|584041330|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726435|NCT02890329|584041331|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726436|NCT02890329|584041332|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
161726437|NCT02890329|584041333|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726438|NCT02890329|584041334|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726439|NCT02890329|584041329|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726440|NCT02890329|584041330|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726441|NCT02890329|584041331|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
161726442|NCT02890329|584041332|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726443|NCT02890329|584041333|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726444|NCT02890329|584041334|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726445|NCT01379534|584041335|FG000|Treatment Phase|Withdrawal by Subject|2|||
161726446|NCT01379534|584041336|FG001|Treatment Phase|Withdrawal by Subject|2|||
161726447|NCT01379534|584041335|FG000|Treatment Phase|Progressive disease|13|||
161726448|NCT01379534|584041336|FG001|Treatment Phase|Progressive disease|22|||
161726449|NCT01379534|584041335|FG000|Treatment Phase|Adverse Event|7|||
161726450|NCT01379534|584041336|FG001|Treatment Phase|Adverse Event|7|||
161726451|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
161726452|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
161726453|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
161726454|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
161726455|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
161726456|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
161726457|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
161726458|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
161726459|NCT00616239|584041338|FG000|Overall Study|Withdrawal by Subject|2|||
161726460|NCT01558089|584041341|FG000|Overall Study|Adverse Event|1|||
161726461|NCT01558089|584041341|FG000|Overall Study|Lack of Efficacy|1|||
161726462|NCT01558089|584041341|FG000|Overall Study|Lost to Follow-up|5|||
161726463|NCT01558089|584041341|FG000|Overall Study|Withdrawal by Subject|6|||
161726464|NCT01597193|584041342|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
161726465|NCT01597193|584041343|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
161726466|NCT01597193|584041344|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726467|NCT01597193|584041345|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726468|NCT01597193|584041346|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726469|NCT01597193|584041347|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726470|NCT01597193|584041348|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726471|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726472|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726473|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726474|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
161726475|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
161726476|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
161726477|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726478|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
161726479|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
161726480|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
161726481|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
161726482|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
161726483|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
161726484|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
161726485|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726486|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726487|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726488|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726489|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726490|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
161726491|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726492|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726493|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726494|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726495|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
161726496|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726497|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
161726498|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726499|NCT03184701|584041350|FG000|Overall Study|Death|3|||
161726500|NCT03184701|584041350|FG000|Overall Study|Physician Decision|3|||
161726501|NCT03184701|584041350|FG000|Overall Study|Withdrawal by Subject|6|||
161726502|NCT03184701|584041350|FG000|Overall Study|Lost to Follow-up|5|||
161726503|NCT00590681|584041353|FG000|Overall Study|Withdrawal by Subject|7|||
161726504|NCT00590681|584041353|FG000|Overall Study|Adverse Event|8|||
161726505|NCT00590681|584041353|FG000|Overall Study|Death|3|||
161726506|NCT00590681|584041353|FG000|Overall Study|Lost to Follow-up|1|||
161726507|NCT00590681|584041353|FG000|Overall Study|disease progression|1|||
161726508|NCT01259297|584041354|FG000|Double Blind Randomized Period|Death|1|||
161726509|NCT01259297|584041355|FG001|Double Blind Randomized Period|Death|1|||
161726510|NCT01259297|584041356|FG002|Double Blind Randomized Period|Death|1|||
161726511|NCT01259297|584041357|FG003|Double Blind Randomized Period|Death|2|||
161726512|NCT01259297|584041358|FG004|Double Blind Randomized Period|Death|1|||
161726513|NCT01259297|584041359|FG005|Double Blind Randomized Period|Death|5|||
161726514|NCT01259297|584041360|FG006|Double Blind Randomized Period|Death|2|||
161726515|NCT01259297|584041361|FG007|Double Blind Randomized Period|Death|1|||
161726516|NCT01259297|584041354|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726517|NCT01259297|584041355|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726518|NCT01259297|584041356|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
161726519|NCT01259297|584041357|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
161726520|NCT01259297|584041358|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
161726521|NCT01259297|584041359|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726522|NCT01259297|584041360|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726523|NCT01259297|584041361|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726524|NCT01259297|584041354|FG000|Double Blind Randomized Period|Other reasons|0|||
161726525|NCT01259297|584041355|FG001|Double Blind Randomized Period|Other reasons|1|||
161726526|NCT01259297|584041356|FG002|Double Blind Randomized Period|Other reasons|0|||
161726527|NCT01259297|584041357|FG003|Double Blind Randomized Period|Other reasons|0|||
161726528|NCT01259297|584041358|FG004|Double Blind Randomized Period|Other reasons|1|||
161726529|NCT01259297|584041359|FG005|Double Blind Randomized Period|Other reasons|2|||
161726530|NCT01259297|584041360|FG006|Double Blind Randomized Period|Other reasons|3|||
161726531|NCT01259297|584041361|FG007|Double Blind Randomized Period|Other reasons|1|||
161726532|NCT00933335|584041362|FG000|Overall Study|Lost to Follow-up|1|||
161726533|NCT00933335|584041363|FG001|Overall Study|Lost to Follow-up|3|||
161726534|NCT00933335|584041362|FG000|Overall Study|Withdrawal by Subject|0|||
161726535|NCT00933335|584041363|FG001|Overall Study|Withdrawal by Subject|1|||
161726536|NCT00933335|584041362|FG000|Overall Study|Progressive Disease|0|||
161726537|NCT00933335|584041363|FG001|Overall Study|Progressive Disease|11|||
161726538|NCT00933335|584041362|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
161726539|NCT00933335|584041363|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
161726540|NCT00933335|584041362|FG000|Overall Study|Co-morbid Illness|1|||
161726541|NCT00933335|584041363|FG001|Overall Study|Co-morbid Illness|0|||
161726542|NCT02229864|584041364|FG000|Overall Study|Death|2|||
161726543|NCT02229864|584041364|FG000|Overall Study|Lost to Follow-up|1|||
161726544|NCT02650284|584041367|FG000|Overall Study|Lost to Follow-up|3|||
161726545|NCT02650284|584041368|FG001|Overall Study|Lost to Follow-up|3|||
161726546|NCT02650284|584041367|FG000|Overall Study|Consent incorrectly taken|0|||
161726547|NCT02650284|584041368|FG001|Overall Study|Consent incorrectly taken|1|||
161726548|NCT00374907|584041373|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
161726549|NCT00374907|584041374|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
161726550|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
161726551|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
161726552|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
161726553|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
161726554|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
161726555|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
161726556|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
161726557|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
161726558|NCT02815397|584041378|FG000|Overall Study|Physician Decision|2|||
161726559|NCT00085540|584041381|FG000|Overall Study|Withdrawal by Subject|0|||
161726560|NCT00085540|584041382|FG001|Overall Study|Withdrawal by Subject|1|||
161726561|NCT00085540|584041381|FG000|Overall Study|Protocol Violation|0|||
161726562|NCT00085540|584041382|FG001|Overall Study|Protocol Violation|1|||
161726563|NCT01605396|584041383|FG000|Overall Study|Adverse Event|5|||
161726564|NCT01605396|584041384|FG001|Overall Study|Adverse Event|3|||
161726565|NCT01605396|584041383|FG000|Overall Study|Lost to Follow-up|1|||
161726566|NCT01605396|584041384|FG001|Overall Study|Lost to Follow-up|0|||
161726567|NCT01605396|584041383|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161726568|NCT01605396|584041384|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161726569|NCT01605396|584041383|FG000|Overall Study|Physician Decision|2|||
161726570|NCT01605396|584041384|FG001|Overall Study|Physician Decision|2|||
161726571|NCT01605396|584041383|FG000|Overall Study|Progressive Disease|23|||
161726572|NCT01605396|584041384|FG001|Overall Study|Progressive Disease|27|||
161726573|NCT01605396|584041383|FG000|Overall Study|Withdrawal by Subject|4|||
161726574|NCT01605396|584041384|FG001|Overall Study|Withdrawal by Subject|2|||
161726575|NCT01605396|584041383|FG000|Overall Study|Transfer Off Study|4|||
161726576|NCT01605396|584041384|FG001|Overall Study|Transfer Off Study|5|||
161726577|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
161726578|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
161726579|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Death|2|||
161726580|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Death|1|||
161726581|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
161726582|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
161726583|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Ineligible|4|||
161726584|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Ineligible|3|||
161726585|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Partner refusal|0|||
161726586|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Partner refusal|1|||
161726587|NCT04598165|584041385|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
161726588|NCT04598165|584041386|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
161726589|NCT00878072|584041387|FG000|Overall Study|Withdrew consent|2|||
161726590|NCT00426751|584041398|FG000|Overall Study|Adverse Event|8|||
161726591|NCT00426751|584041399|FG001|Overall Study|Adverse Event|1|||
161726592|NCT00426751|584041398|FG000|Overall Study|Lost to Follow-up|7|||
161726593|NCT00426751|584041399|FG001|Overall Study|Lost to Follow-up|6|||
161726594|NCT00426751|584041398|FG000|Overall Study|Consent Withdrawn|0|||
161726595|NCT00426751|584041399|FG001|Overall Study|Consent Withdrawn|1|||
161726596|NCT00426751|584041398|FG000|Overall Study|Other Reasons|7|||
161726597|NCT00426751|584041399|FG001|Overall Study|Other Reasons|12|||
161726598|NCT01200511|584041400|FG000|Overall Study|Lost to Follow-up|3|||
161726599|NCT01200511|584041400|FG000|Overall Study|Withdrawal by Subject|1|||
161726600|NCT01200511|584041400|FG000|Overall Study|Adverse Event|1|||
161726601|NCT00576693|584041401|FG000|Overall Study|Lost to Follow-up|7|||
161726602|NCT00576693|584041402|FG001|Overall Study|Lost to Follow-up|11|||
161726603|NCT00576693|584041401|FG000|Overall Study|Withdrawal by Subject|3|||
161726604|NCT00576693|584041402|FG001|Overall Study|Withdrawal by Subject|13|||
161726605|NCT00705224|584041403|FG000|Overall Study|Adverse Event|1|||
161726606|NCT00705224|584041403|FG000|Overall Study|Lack of Efficacy|2|||
161726607|NCT00705224|584041403|FG000|Overall Study|Withdrawal by Subject|3|||
161726608|NCT00705224|584041403|FG000|Overall Study|Lost to Follow-up|5|||
161726609|NCT01721408|584041404|FG000|Overall Study|Adverse Event|6|||
161726610|NCT01721408|584041405|FG001|Overall Study|Adverse Event|1|||
161726611|NCT01721408|584041404|FG000|Overall Study|Death|1|||
161726612|NCT01721408|584041405|FG001|Overall Study|Death|0|||
161726613|NCT01721408|584041404|FG000|Overall Study|Insufficient clinical response|15|||
161726614|NCT01721408|584041405|FG001|Overall Study|Insufficient clinical response|6|||
161726615|NCT01721408|584041404|FG000|Overall Study|No longer willing to participate study|9|||
161726616|NCT01721408|584041405|FG001|Overall Study|No longer willing to participate study|10|||
161726617|NCT01721408|584041404|FG000|Overall Study|Protocol Violation|0|||
161726618|NCT01721408|584041405|FG001|Overall Study|Protocol Violation|2|||
161726619|NCT01721408|584041404|FG000|Overall Study|Other|3|||
161726620|NCT01721408|584041405|FG001|Overall Study|Other|3|||
161726621|NCT01721408|584041404|FG000|Overall Study|Lost to Follow-up|1|||
161726622|NCT01721408|584041405|FG001|Overall Study|Lost to Follow-up|2|||
161726623|NCT01721408|584041404|FG000|Overall Study|Does not meet entrance criteria|1|||
161726624|NCT01721408|584041405|FG001|Overall Study|Does not meet entrance criteria|0|||
161726625|NCT01187901|584041406|FG000|Overall Study|Protocol Violation|1|||
161726626|NCT01187901|584041407|FG001|Overall Study|Protocol Violation|0|||
161726627|NCT01187901|584041406|FG000|Overall Study|Lost to Follow-up|1|||
161726628|NCT01187901|584041407|FG001|Overall Study|Lost to Follow-up|2|||
161726629|NCT01187901|584041406|FG000|Overall Study|Unrelated Health Reasons|1|||
161726630|NCT01187901|584041407|FG001|Overall Study|Unrelated Health Reasons|2|||
161726631|NCT01187901|584041406|FG000|Overall Study|Suspected Allergic Reaction|1|||
161726632|NCT01187901|584041407|FG001|Overall Study|Suspected Allergic Reaction|1|||
161726633|NCT01187901|584041406|FG000|Overall Study|Adverse Event|3|||
161726634|NCT01187901|584041407|FG001|Overall Study|Adverse Event|0|||
161726635|NCT01187901|584041406|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
161726636|NCT01187901|584041407|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
161726637|NCT01187901|584041406|FG000|Overall Study|Pregnancy|0|||
161726638|NCT01187901|584041407|FG001|Overall Study|Pregnancy|2|||
161726639|NCT04160468|584041408|FG000|Overall Study|Lost to Follow-up|19|||
161726640|NCT04160468|584041409|FG001|Overall Study|Lost to Follow-up|4|||
161726641|NCT04160468|584041408|FG000|Overall Study|Randomized but not dosed|6|||
161726642|NCT04160468|584041409|FG001|Overall Study|Randomized but not dosed|0|||
161726643|NCT04160468|584041408|FG000|Overall Study|Withdrawal by Subject|4|||
161726644|NCT04160468|584041409|FG001|Overall Study|Withdrawal by Subject|1|||
161726645|NCT04160468|584041408|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
161726646|NCT04160468|584041409|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
161726647|NCT04160468|584041408|FG000|Overall Study|Participant incarcerated|1|||
161726648|NCT04160468|584041409|FG001|Overall Study|Participant incarcerated|0|||
161726649|NCT03987620|584041412|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
161726650|NCT03987620|584041413|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
161726651|NCT03987620|584041412|FG000|Overall Study|Adverse Event|3|||
161726652|NCT03987620|584041413|FG001|Overall Study|Adverse Event|0|||
161726653|NCT03987620|584041412|FG000|Overall Study|Lost to Follow-up|1|||
161726654|NCT03987620|584041413|FG001|Overall Study|Lost to Follow-up|2|||
161726655|NCT03987620|584041412|FG000|Overall Study|Physician Decision|0|||
161726656|NCT03987620|584041413|FG001|Overall Study|Physician Decision|1|||
161726657|NCT03987620|584041412|FG000|Overall Study|Pregnancy|1|||
161726658|NCT03987620|584041413|FG001|Overall Study|Pregnancy|0|||
161726659|NCT03987620|584041412|FG000|Overall Study|Withdrawal by Subject|7|||
161726660|NCT03987620|584041413|FG001|Overall Study|Withdrawal by Subject|1|||
161726661|NCT03987620|584041412|FG000|Overall Study|Other|2|||
161726662|NCT03987620|584041413|FG001|Overall Study|Other|5|||
161726663|NCT02149836|584041414|FG000|Overall Study|Withdrawal by Subject|1|||
161726664|NCT00376688|584041415|FG000|Overall Study|Adverse Event|3|||
161726665|NCT00376688|584041415|FG000|Overall Study|Death|1|||
161726666|NCT01770353|584041416|FG000|Overall Study|Progressive disease|2|||
161726667|NCT01770353|584041417|FG001|Overall Study|Progressive disease|1|||
161726668|NCT01770353|584041416|FG000|Overall Study|Adverse Event|0|||
161726669|NCT01770353|584041417|FG001|Overall Study|Adverse Event|1|||
161726670|NCT01770353|584041416|FG000|Overall Study|Protocol Violation|1|||
161726671|NCT01770353|584041417|FG001|Overall Study|Protocol Violation|0|||
161726672|NCT01770353|584041416|FG000|Overall Study|Physician Decision|0|||
161726673|NCT01770353|584041417|FG001|Overall Study|Physician Decision|3|||
161726674|NCT01770353|584041416|FG000|Overall Study|Clinical deterioration|3|||
161726675|NCT01770353|584041417|FG001|Overall Study|Clinical deterioration|6|||
161726676|NCT01770353|584041416|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
161726677|NCT01770353|584041417|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
161726678|NCT05128162|584041418|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
161726679|NCT05128162|584041418|FG000|Overall Study|Physician Decision|1|||
161726680|NCT00370149|584041419|FG000|Overall Study|Physician Decision|16|||
161726681|NCT00370149|584041420|FG001|Overall Study|Physician Decision|16|||
161726682|NCT00370149|584041419|FG000|Overall Study|Protocol Violation|1|||
161726683|NCT00370149|584041420|FG001|Overall Study|Protocol Violation|0|||
161726684|NCT00370149|584041419|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
161726685|NCT00370149|584041420|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
161726686|NCT00370149|584041419|FG000|Overall Study|Pre-existing infection|0|||
161726687|NCT00370149|584041420|FG001|Overall Study|Pre-existing infection|1|||
161726688|NCT00370149|584041419|FG000|Overall Study|Antibiotic coated dressing placed|0|||
161726689|NCT00370149|584041420|FG001|Overall Study|Antibiotic coated dressing placed|1|||
161726690|NCT04920084|584042987|FG000|Overall Study|Adverse Event|1|||
161726691|NCT04920084|584042987|FG000|Overall Study|Lost to Follow-up|2|||
161726692|NCT04920084|584042987|FG000|Overall Study|Withdrawal by Subject|2|||
161726693|NCT01096446|584042988|FG000|Overall Study|Death|1|||
161726694|NCT01096446|584042989|FG001|Overall Study|Death|0|||
161726695|NCT01096446|584042988|FG000|Overall Study|Protocol Violation|2|||
161726696|NCT01096446|584042989|FG001|Overall Study|Protocol Violation|0|||
161726697|NCT02410902|584042990|FG000|Overall Study|Adverse Event|2|||
161726698|NCT02410902|584042991|FG001|Overall Study|Adverse Event|3|||
161726699|NCT02410902|584042990|FG000|Overall Study|Lost to Follow-up|4|||
161726700|NCT02410902|584042991|FG001|Overall Study|Lost to Follow-up|1|||
161726701|NCT02410902|584042990|FG000|Overall Study|Protocol Violation|1|||
161726702|NCT02410902|584042991|FG001|Overall Study|Protocol Violation|4|||
161726703|NCT02410902|584042990|FG000|Overall Study|Withdrawal by Subject|6|||
161726704|NCT02410902|584042991|FG001|Overall Study|Withdrawal by Subject|8|||
161726705|NCT02410902|584042990|FG000|Overall Study|Non-Compliance|8|||
161726706|NCT02410902|584042991|FG001|Overall Study|Non-Compliance|2|||
161726707|NCT02279524|584042993|FG000|Overall Study|Withdrawal by Subject|3|||
161726708|NCT02279524|584042994|FG001|Overall Study|Withdrawal by Subject|6|||
161726709|NCT02279524|584042995|FG002|Overall Study|Withdrawal by Subject|3|||
161726710|NCT02279524|584042993|FG000|Overall Study|Adverse Event|4|||
161726711|NCT02279524|584042994|FG001|Overall Study|Adverse Event|3|||
161726712|NCT02279524|584042995|FG002|Overall Study|Adverse Event|2|||
161726713|NCT02279524|584042993|FG000|Overall Study|Lost to Follow-up|1|||
161726714|NCT02279524|584042994|FG001|Overall Study|Lost to Follow-up|1|||
161726715|NCT02279524|584042995|FG002|Overall Study|Lost to Follow-up|0|||
161726716|NCT02279524|584042993|FG000|Overall Study|Disallowed medication|1|||
161726717|NCT02279524|584042994|FG001|Overall Study|Disallowed medication|1|||
161726718|NCT02279524|584042995|FG002|Overall Study|Disallowed medication|2|||
161726719|NCT02279524|584042993|FG000|Overall Study|Bariatric surgery|1|||
161726720|NCT02279524|584042994|FG001|Overall Study|Bariatric surgery|0|||
161726721|NCT02279524|584042995|FG002|Overall Study|Bariatric surgery|0|||
161726722|NCT00392171|584043000|FG000|Overall Study|Did not meet inclusion criteria|4|||
161726723|NCT00392171|584043000|FG000|Overall Study|Disease progression|101|||
161726724|NCT03488472|584043001|FG000|Overall Study|disease progression additional mets|1|||
161726725|NCT00028002|584043002|FG000|Overall Study|Withdrawal by Subject|3|||
161726726|NCT00028002|584043002|FG000|Overall Study|Ineligible|8|||
161726727|NCT00414310|584043006|FG000|Overall Study|Not treated|1|||
161726728|NCT00414310|584043007|FG001|Overall Study|Not treated|0|||
161726729|NCT01441440|584043011|FG000|Overall Study|Death|1|||
161726730|NCT01441440|584043012|FG001|Overall Study|Death|0|||
161726731|NCT01441440|584043013|FG002|Overall Study|Death|1|||
161726732|NCT01441440|584043011|FG000|Overall Study|Adverse Event|2|||
161726733|NCT01441440|584043012|FG001|Overall Study|Adverse Event|9|||
161726734|NCT01441440|584043013|FG002|Overall Study|Adverse Event|9|||
161726735|NCT01441440|584043011|FG000|Overall Study|Lost to Follow-up|0|||
161726736|NCT01441440|584043012|FG001|Overall Study|Lost to Follow-up|2|||
161726737|NCT01441440|584043013|FG002|Overall Study|Lost to Follow-up|1|||
161726738|NCT01441440|584043011|FG000|Overall Study|Withdrawal by Subject|11|||
161726739|NCT01441440|584043012|FG001|Overall Study|Withdrawal by Subject|9|||
161726740|NCT01441440|584043013|FG002|Overall Study|Withdrawal by Subject|9|||
161726741|NCT01441440|584043011|FG000|Overall Study|Pregnancy|1|||
161726742|NCT01441440|584043012|FG001|Overall Study|Pregnancy|0|||
161726743|NCT01441440|584043013|FG002|Overall Study|Pregnancy|0|||
161726744|NCT01441440|584043011|FG000|Overall Study|Lack of Efficacy|1|||
161726745|NCT01441440|584043012|FG001|Overall Study|Lack of Efficacy|0|||
161726746|NCT01441440|584043013|FG002|Overall Study|Lack of Efficacy|1|||
161726747|NCT01441440|584043011|FG000|Overall Study|Moving|0|||
161726748|NCT01441440|584043012|FG001|Overall Study|Moving|1|||
161726749|NCT01441440|584043013|FG002|Overall Study|Moving|1|||
161726750|NCT01441440|584043011|FG000|Overall Study|Work-related matter|0|||
161726751|NCT01441440|584043012|FG001|Overall Study|Work-related matter|1|||
161726752|NCT01441440|584043013|FG002|Overall Study|Work-related matter|0|||
161726753|NCT01441440|584043011|FG000|Overall Study|Difficllty in keeping the schedule|1|||
161726754|NCT01441440|584043012|FG001|Overall Study|Difficllty in keeping the schedule|1|||
161726755|NCT01441440|584043013|FG002|Overall Study|Difficllty in keeping the schedule|0|||
161726756|NCT01993329|584043014|FG000|Period 2|Adverse Event|0|||
161726757|NCT01993329|584043015|FG001|Period 2|Adverse Event|0|||
161726758|NCT01993329|584043016|FG002|Period 2|Adverse Event|0|||
161726759|NCT01993329|584043017|FG003|Period 2|Adverse Event|0|||
161726760|NCT01993329|584043018|FG004|Period 2|Adverse Event|0|||
161726761|NCT01993329|584043019|FG005|Period 2|Adverse Event|1|||
161726762|NCT01993329|584043014|FG000|Wash-out|Personal reasons|0|||
161726763|NCT01993329|584043015|FG001|Wash-out|Personal reasons|1|||
161726764|NCT01993329|584043016|FG002|Wash-out|Personal reasons|0|||
161726765|NCT01993329|584043017|FG003|Wash-out|Personal reasons|0|||
161726766|NCT01993329|584043018|FG004|Wash-out|Personal reasons|0|||
161726767|NCT01993329|584043019|FG005|Wash-out|Personal reasons|0|||
161726768|NCT00883558|584043020|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
161726769|NCT00883558|584043021|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
161726770|NCT00883558|584043022|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
161726771|NCT00883558|584043020|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
161726772|NCT00883558|584043021|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
161726773|NCT00883558|584043022|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
161726774|NCT00883558|584043020|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
161726775|NCT00883558|584043021|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
161726776|NCT00883558|584043022|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
161726777|NCT00883558|584043020|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
161726778|NCT00883558|584043021|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
161726779|NCT00883558|584043022|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
161726780|NCT00883558|584043020|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
161726781|NCT00883558|584043021|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
161726782|NCT00883558|584043022|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
161726783|NCT03539458|584043023|FG000|Overall Study|Death|1|||
161726784|NCT02750800|584043026|FG000|Overall Study|Adverse Event|18|||
161726785|NCT02750800|584043026|FG000|Overall Study|Lost to Follow-up|12|||
161726786|NCT02750800|584043026|FG000|Overall Study|Investigator decision|53|||
161726787|NCT02750800|584043026|FG000|Overall Study|Patient request|12|||
161726788|NCT02750800|584043026|FG000|Overall Study|Other, not specified|3|||
161726789|NCT00879814|584043027|FG000|Overall Study|Adverse Event|0|||
161726790|NCT00879814|584043028|FG001|Overall Study|Adverse Event|1|||
161726791|NCT00879814|584043029|FG002|Overall Study|Adverse Event|0|||
161726792|NCT00879814|584043030|FG003|Overall Study|Adverse Event|0|||
161726793|NCT00879814|584043027|FG000|Overall Study|Lost to Follow-up|1|||
161726794|NCT00879814|584043028|FG001|Overall Study|Lost to Follow-up|0|||
161726795|NCT00879814|584043029|FG002|Overall Study|Lost to Follow-up|0|||
161726796|NCT00879814|584043030|FG003|Overall Study|Lost to Follow-up|2|||
161726797|NCT00879814|584043027|FG000|Overall Study|Participant Failed to Return|0|||
161726798|NCT00879814|584043028|FG001|Overall Study|Participant Failed to Return|0|||
161726799|NCT00879814|584043029|FG002|Overall Study|Participant Failed to Return|0|||
161726800|NCT00879814|584043030|FG003|Overall Study|Participant Failed to Return|1|||
161726801|NCT00879814|584043027|FG000|Overall Study|Withdrawal by Subject|3|||
161726802|NCT00879814|584043028|FG001|Overall Study|Withdrawal by Subject|1|||
161726803|NCT00879814|584043029|FG002|Overall Study|Withdrawal by Subject|1|||
161726804|NCT00879814|584043030|FG003|Overall Study|Withdrawal by Subject|2|||
161726805|NCT00879814|584043027|FG000|Overall Study|Physician Decision|0|||
161726806|NCT00879814|584043028|FG001|Overall Study|Physician Decision|0|||
161726807|NCT00879814|584043029|FG002|Overall Study|Physician Decision|1|||
161726808|NCT00879814|584043030|FG003|Overall Study|Physician Decision|0|||
161726809|NCT00879814|584043027|FG000|Overall Study|Other|0|||
161726810|NCT00879814|584043028|FG001|Overall Study|Other|0|||
161726811|NCT00879814|584043029|FG002|Overall Study|Other|1|||
161726812|NCT00879814|584043030|FG003|Overall Study|Other|0|||
161726813|NCT00972478|584043031|FG000|Overall Study|Adverse Event|3|||
161726814|NCT00972478|584043032|FG001|Overall Study|Adverse Event|16|||
161726815|NCT00972478|584043031|FG000|Overall Study|Withdrawal by Subject|1|||
161726816|NCT00972478|584043032|FG001|Overall Study|Withdrawal by Subject|8|||
161726817|NCT00972478|584043031|FG000|Overall Study|Progression/Relapse|0|||
161726818|NCT00972478|584043032|FG001|Overall Study|Progression/Relapse|2|||
161726819|NCT00972478|584043031|FG000|Overall Study|Death|0|||
161726820|NCT00972478|584043032|FG001|Overall Study|Death|2|||
161726821|NCT00972478|584043031|FG000|Overall Study|Not protocol specified|1|||
161726822|NCT00972478|584043032|FG001|Overall Study|Not protocol specified|1|||
161726823|NCT00972478|584043031|FG000|Overall Study|Ineligible|1|||
161726824|NCT00972478|584043032|FG001|Overall Study|Ineligible|7|||
161726825|NCT00972478|584043031|FG000|Overall Study|Not start protocol treatment|1|||
161726826|NCT00972478|584043032|FG001|Overall Study|Not start protocol treatment|2|||
161726827|NCT04742907|584043039|FG000|Overall Study|Adverse Event|1|||
161726828|NCT04742907|584043040|FG001|Overall Study|Adverse Event|0|||
161726829|NCT04742907|584043041|FG002|Overall Study|Adverse Event|1|||
161726830|NCT04742907|584043039|FG000|Overall Study|Lost to Follow-up|3|||
161726831|NCT04742907|584043040|FG001|Overall Study|Lost to Follow-up|3|||
161726832|NCT04742907|584043041|FG002|Overall Study|Lost to Follow-up|2|||
161726833|NCT04742907|584043039|FG000|Overall Study|Physician Decision|0|||
161726834|NCT04742907|584043040|FG001|Overall Study|Physician Decision|1|||
161726835|NCT04742907|584043041|FG002|Overall Study|Physician Decision|0|||
161726836|NCT04742907|584043039|FG000|Overall Study|Protocol Violation|1|||
161726837|NCT04742907|584043040|FG001|Overall Study|Protocol Violation|1|||
161726838|NCT04742907|584043041|FG002|Overall Study|Protocol Violation|1|||
161726839|NCT04742907|584043039|FG000|Overall Study|Withdrawal by Subject|5|||
161726840|NCT04742907|584043040|FG001|Overall Study|Withdrawal by Subject|6|||
161726841|NCT04742907|584043041|FG002|Overall Study|Withdrawal by Subject|4|||
161726842|NCT04742907|584043039|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
161726843|NCT04742907|584043040|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
161726844|NCT04742907|584043041|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
161726845|NCT04742907|584043039|FG000|Overall Study|Did Not Receive the Study Drug|2|||
161726846|NCT04742907|584043040|FG001|Overall Study|Did Not Receive the Study Drug|4|||
161726847|NCT04742907|584043041|FG002|Overall Study|Did Not Receive the Study Drug|4|||
161726848|NCT01428063|584043042|FG000|Overall Study|Lack of Efficacy|8|||
161726849|NCT01428063|584043043|FG001|Overall Study|Lack of Efficacy|4|||
161726850|NCT01428063|584043044|FG002|Overall Study|Lack of Efficacy|1|||
161726851|NCT01428063|584043042|FG000|Overall Study|Adverse Event|2|||
161726852|NCT01428063|584043043|FG001|Overall Study|Adverse Event|3|||
161726853|NCT01428063|584043044|FG002|Overall Study|Adverse Event|0|||
161726854|NCT01428063|584043042|FG000|Overall Study|Lost to Follow-up|0|||
161726855|NCT01428063|584043043|FG001|Overall Study|Lost to Follow-up|2|||
161726856|NCT01428063|584043044|FG002|Overall Study|Lost to Follow-up|0|||
161726857|NCT01428063|584043042|FG000|Overall Study|No longer meets study criteria|0|||
161726858|NCT01428063|584043043|FG001|Overall Study|No longer meets study criteria|1|||
161726859|NCT01428063|584043044|FG002|Overall Study|No longer meets study criteria|0|||
161726860|NCT01005719|584043045|FG000|Period 1|Adverse Event|0|||
161726861|NCT01005719|584043046|FG001|Period 1|Adverse Event|0|||
161726862|NCT01005719|584043047|FG002|Period 1|Adverse Event|0|||
161726863|NCT01005719|584043048|FG003|Period 1|Adverse Event|1|||
161726864|NCT01005719|584043049|FG004|Period 1|Adverse Event|0|||
161726865|NCT01005719|584043050|FG005|Period 1|Adverse Event|0|||
161726866|NCT01005719|584043045|FG000|Period 1|Delay in completing study procedures|0|||
161726867|NCT01005719|584043046|FG001|Period 1|Delay in completing study procedures|0|||
161726868|NCT01005719|584043047|FG002|Period 1|Delay in completing study procedures|0|||
161726869|NCT01005719|584043048|FG003|Period 1|Delay in completing study procedures|0|||
161726870|NCT01005719|584043049|FG004|Period 1|Delay in completing study procedures|0|||
161726871|NCT01005719|584043050|FG005|Period 1|Delay in completing study procedures|1|||
161726872|NCT01005719|584043045|FG000|Period 2|Adverse Event|0|||
161726873|NCT01005719|584043046|FG001|Period 2|Adverse Event|0|||
161726874|NCT01005719|584043047|FG002|Period 2|Adverse Event|0|||
161726875|NCT01005719|584043048|FG003|Period 2|Adverse Event|0|||
161726876|NCT01005719|584043049|FG004|Period 2|Adverse Event|1|||
161726877|NCT01005719|584043050|FG005|Period 2|Adverse Event|1|||
161726878|NCT01753076|584043051|FG000|Overall Study|Adverse Event|17|||
161726879|NCT01753076|584043052|FG001|Overall Study|Adverse Event|18|||
161726880|NCT01753076|584043051|FG000|Overall Study|Lack of Efficacy|3|||
161726881|NCT01753076|584043052|FG001|Overall Study|Lack of Efficacy|1|||
161726882|NCT01753076|584043051|FG000|Overall Study|Lost to Follow-up|2|||
161726883|NCT01753076|584043052|FG001|Overall Study|Lost to Follow-up|1|||
161726884|NCT01753076|584043051|FG000|Overall Study|Physician Decision|4|||
161726885|NCT01753076|584043052|FG001|Overall Study|Physician Decision|2|||
161726886|NCT01753076|584043051|FG000|Overall Study|Withdrawal by Subject|14|||
161726887|NCT01753076|584043052|FG001|Overall Study|Withdrawal by Subject|24|||
161726888|NCT01753076|584043051|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
161726889|NCT01753076|584043052|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
161726890|NCT01259856|584043053|FG000|Overall Study|Adverse Event|12|||
161726891|NCT01259856|584043054|FG001|Overall Study|Adverse Event|9|||
161726892|NCT01259856|584043053|FG000|Overall Study|Death|0|||
161726893|NCT01259856|584043054|FG001|Overall Study|Death|1|||
161726894|NCT01259856|584043053|FG000|Overall Study|Lack of Efficacy|3|||
161726895|NCT01259856|584043054|FG001|Overall Study|Lack of Efficacy|1|||
161726896|NCT01259856|584043053|FG000|Overall Study|Lost to Follow-up|1|||
161726897|NCT01259856|584043054|FG001|Overall Study|Lost to Follow-up|1|||
161726898|NCT01259856|584043053|FG000|Overall Study|Physician Decision|2|||
161726899|NCT01259856|584043054|FG001|Overall Study|Physician Decision|1|||
161726900|NCT01259856|584043053|FG000|Overall Study|Withdrawal by Subject|9|||
161726901|NCT01259856|584043054|FG001|Overall Study|Withdrawal by Subject|10|||
161726902|NCT01259856|584043053|FG000|Overall Study|Treatment never started|0|||
161726903|NCT01259856|584043054|FG001|Overall Study|Treatment never started|6|||
161726904|NCT01259856|584043053|FG000|Overall Study|Study closure by sponsor|40|||
161726905|NCT01259856|584043054|FG001|Overall Study|Study closure by sponsor|41|||
161726906|NCT01259856|584043053|FG000|Overall Study|Patient developed other disease|0|||
161726907|NCT01259856|584043054|FG001|Overall Study|Patient developed other disease|1|||
161726908|NCT01259856|584043053|FG000|Overall Study|Transfer to another study|0|||
161726909|NCT01259856|584043054|FG001|Overall Study|Transfer to another study|1|||
161726910|NCT01259856|584043053|FG000|Overall Study|Unknown/missing|2|||
161726911|NCT01259856|584043054|FG001|Overall Study|Unknown/missing|2|||
161726912|NCT00788775|584043055|FG000|Overall Study|Progressive Disease|8|||
161726913|NCT00788775|584043056|FG001|Overall Study|Progressive Disease|6|||
161726914|NCT00788775|584043055|FG000|Overall Study|Withdrawal by Subject|0|||
161726915|NCT00788775|584043056|FG001|Overall Study|Withdrawal by Subject|2|||
161726916|NCT00788775|584043055|FG000|Overall Study|Patient Non-Compliance|1|||
161726917|NCT00788775|584043056|FG001|Overall Study|Patient Non-Compliance|0|||
161726918|NCT00788775|584043055|FG000|Overall Study|Patient's measurable disease resected.|1|||
161726919|NCT00788775|584043056|FG001|Overall Study|Patient's measurable disease resected.|0|||
161726920|NCT04488822|584043059|FG000|Overall Study|Adverse Event|8|||
161726921|NCT04488822|584043059|FG000|Overall Study|Withdrawal by Subject|1|||
161726922|NCT03838367|584043060|FG000|Overall Study|Early termination of study|3|||
161726923|NCT03838367|584043061|FG001|Overall Study|Early termination of study|4|||
161726924|NCT03838367|584043062|FG002|Overall Study|Early termination of study|3|||
161726925|NCT03838367|584043063|FG003|Overall Study|Early termination of study|0|||
161726926|NCT03406104|584043064|FG000|Overall Study|Lost to Follow-up|2|||
161726927|NCT03406104|584043064|FG000|Overall Study|Withdrawal by Subject|2|||
161726928|NCT03406104|584043064|FG000|Overall Study|due to Covid patient did not want to travel|1|||
161726929|NCT03406104|584043064|FG000|Overall Study|Death|2|||
161726930|NCT00114972|584043069|FG000|Overall Study|Withdrawal by Subject|40|||
161726931|NCT00114972|584043070|FG001|Overall Study|Withdrawal by Subject|7|||
161726932|NCT00114972|584043069|FG000|Overall Study|Lost to Follow-up|8|||
161726933|NCT00114972|584043070|FG001|Overall Study|Lost to Follow-up|5|||
161726934|NCT01035255|584043079|FG000|Overall Study|Death|724|||
161726935|NCT01035255|584043080|FG001|Overall Study|Death|844|||
161726936|NCT01035255|584043079|FG000|Overall Study|Lost to Follow-up|2|||
161726937|NCT01035255|584043080|FG001|Overall Study|Lost to Follow-up|5|||
161726938|NCT01035255|584043079|FG000|Overall Study|patient's request|15|||
161726939|NCT01035255|584043080|FG001|Overall Study|patient's request|13|||
161726940|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Adverse Event|0|||
161726941|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Adverse Event|1|||
161726942|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Adverse Event|0|||
161726943|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Adverse Event|1|||
161726944|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Adverse Event|1|||
161726945|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Adverse Event|0|||
161726946|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Adverse Event|3|||
161726947|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Adverse Event|0|||
161726948|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Adverse Event|0|||
161726949|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Adverse Event|0|||
161726950|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Adverse Event|0|||
161726951|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726952|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726953|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726954|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726955|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161726956|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726957|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726958|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161726959|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726960|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726961|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726962|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Death|0|||
161726963|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Death|0|||
161726964|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Death|0|||
161726965|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Death|0|||
161726966|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Death|0|||
161726967|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Death|0|||
161726968|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Death|0|||
161726969|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Death|1|||
161726970|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Death|0|||
161726971|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Death|0|||
161726972|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Death|0|||
161726973|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Disease Progression|3|||
161726974|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Disease Progression|2|||
161726975|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Disease Progression|5|||
161726976|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Disease Progression|6|||
161726977|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Disease Progression|4|||
161726978|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Disease Progression|6|||
161726979|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Disease Progression|7|||
161726980|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Disease Progression|4|||
161726981|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Disease Progression|0|||
161726982|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Disease Progression|0|||
161726983|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Disease Progression|0|||
161726984|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726985|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726986|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726987|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726988|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726989|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726990|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726991|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726992|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726993|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726994|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726995|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726996|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726997|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726998|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726999|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727000|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727001|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727002|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727003|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
161727004|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
161727005|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
161727006|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727007|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727008|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727009|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727010|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727011|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727012|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727013|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727014|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
161727015|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
161727016|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
161727017|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727018|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727019|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727020|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727021|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727022|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727023|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727024|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727025|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
161727026|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
161727027|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
161727028|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727029|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727030|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727031|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727032|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727033|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727034|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727035|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727036|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
161727037|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
161727038|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
161727039|NCT02749721|584043097|FG000|Screening|Withdrawal by Subject|1|||
161727040|NCT02749721|584043097|FG000|Screening|Lost to Follow-up|2|||
161727041|NCT02749721|584043097|FG000|Screening|Protocol Violation|3|||
161727042|NCT02749721|584043097|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
161727043|NCT02749721|584043097|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
161727044|NCT00772967|584043098|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727045|NCT00772967|584043099|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727046|NCT00772967|584043100|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727047|NCT00772967|584043101|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
161727048|NCT00772967|584043102|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727049|NCT00772967|584043103|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727050|NCT00772967|584043098|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727051|NCT00772967|584043099|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
161727052|NCT00772967|584043100|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727053|NCT00772967|584043101|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727054|NCT00772967|584043102|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727055|NCT00772967|584043103|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727056|NCT00772967|584043098|FG000|Crossover Treatment 3|Adverse Event|0|||
161727057|NCT00772967|584043099|FG001|Crossover Treatment 3|Adverse Event|0|||
161727058|NCT00772967|584043100|FG002|Crossover Treatment 3|Adverse Event|0|||
161727059|NCT00772967|584043101|FG003|Crossover Treatment 3|Adverse Event|0|||
161727060|NCT00772967|584043102|FG004|Crossover Treatment 3|Adverse Event|1|||
161727061|NCT00772967|584043103|FG005|Crossover Treatment 3|Adverse Event|0|||
161727062|NCT00231062|584043104|FG000|Overall Study|Physician Decision|6|||
161727063|NCT00803244|584043105|FG000|Overall Study|Adverse Event|1|||
161727064|NCT00803244|584043106|FG001|Overall Study|Adverse Event|2|||
161727065|NCT00803244|584043105|FG000|Overall Study|Withdrawal by Subject|2|||
161727066|NCT00803244|584043106|FG001|Overall Study|Withdrawal by Subject|3|||
161727067|NCT00803244|584043105|FG000|Overall Study|Any other reason not above-mentioned|4|||
161727068|NCT00803244|584043106|FG001|Overall Study|Any other reason not above-mentioned|10|||
161727069|NCT03321929|584043107|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
161727070|NCT00443430|584043110|FG000|Overall Study|Lack of Efficacy|3|||
161727071|NCT00443430|584043111|FG001|Overall Study|Lack of Efficacy|3|||
161727072|NCT00443430|584043110|FG000|Overall Study|Adverse Event|1|||
161727073|NCT00443430|584043111|FG001|Overall Study|Adverse Event|1|||
161727074|NCT02379923|584043114|FG000|Overall Study|Death|5|||
161727075|NCT03288779|584043119|FG000|Overall Study|Withdrawal by Subject|3|||
161727076|NCT03382899|584043120|FG000|Overall Study|Ineligibility Determined|0|||
161727077|NCT03382899|584043121|FG001|Overall Study|Ineligibility Determined|1|||
161727078|NCT03382899|584043120|FG000|Overall Study|Lost to Follow-up|0|||
161727079|NCT03382899|584043121|FG001|Overall Study|Lost to Follow-up|1|||
161727080|NCT03382899|584043120|FG000|Overall Study|Sponsor's decision|31|||
161727081|NCT03382899|584043121|FG001|Overall Study|Sponsor's decision|28|||
161727082|NCT03382899|584043120|FG000|Overall Study|Withdrawal by Subject|0|||
161727083|NCT03382899|584043121|FG001|Overall Study|Withdrawal by Subject|5|||
161727084|NCT00524745|584043123|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
161727085|NCT00524745|584043124|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
161727086|NCT00524745|584043125|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
161727087|NCT00524745|584043126|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
161727088|NCT02504892|584043127|FG000|Overall Study|Adverse event-pneumonitis|2|||
161727089|NCT01413178|584043128|FG000|Overall Study|Toxicity|1|||
161727090|NCT01413178|584043129|FG001|Overall Study|Toxicity|0|||
161727091|NCT01413178|584043128|FG000|Overall Study|Ineligible|0|||
161727092|NCT01413178|584043129|FG001|Overall Study|Ineligible|2|||
161727093|NCT00540449|584043130|FG000|Overall Study|Adverse Event|12|||
161727094|NCT00540449|584043131|FG001|Overall Study|Adverse Event|32|||
161727095|NCT00540449|584043130|FG000|Overall Study|Sponsor's Decision|1|||
161727096|NCT00540449|584043131|FG001|Overall Study|Sponsor's Decision|1|||
161727097|NCT00540449|584043130|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161727098|NCT00540449|584043131|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
161727099|NCT00540449|584043130|FG000|Overall Study|Lost to Follow-up|19|||
161727100|NCT00540449|584043131|FG001|Overall Study|Lost to Follow-up|17|||
161727101|NCT00540449|584043130|FG000|Overall Study|Subject Non-Compliant|7|||
161727102|NCT00540449|584043131|FG001|Overall Study|Subject Non-Compliant|5|||
161727103|NCT00540449|584043130|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
161727104|NCT00540449|584043131|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
161727105|NCT00540449|584043130|FG000|Overall Study|Withdrawal by Subject|10|||
161727106|NCT00540449|584043131|FG001|Overall Study|Withdrawal by Subject|10|||
161727107|NCT00540449|584043130|FG000|Overall Study|Other|1|||
161727108|NCT00540449|584043131|FG001|Overall Study|Other|4|||
161727109|NCT03283163|584043132|FG000|Overall Study|Lost to Follow-up|1|||
161727110|NCT03283163|584043132|FG000|Overall Study|other life commitments|6|||
161727111|NCT03283163|584043132|FG000|Overall Study|COVID-19 institution wide halting|1|||
161727112|NCT03283163|584043132|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
161727113|NCT03283163|584043132|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
161727114|NCT00237796|584043133|FG000|Overall Study|Baseline and one other ILSS required|10|||
161727115|NCT00237796|584043134|FG001|Overall Study|Baseline and one other ILSS required|5|||
161727116|NCT04238663|584043135|FG000|Overall Study|Lost to Follow-up|0|||
161727117|NCT04238663|584043136|FG001|Overall Study|Lost to Follow-up|1|||
161727118|NCT04238663|584043137|FG002|Overall Study|Lost to Follow-up|0|||
161727119|NCT02566525|584043138|FG000|Overall Study|Protocol Violation|3|||
161727120|NCT02566525|584043139|FG001|Overall Study|Protocol Violation|5|||
161727121|NCT00337467|584043140|FG000|Overall Study|Adverse Event|3|||
161727122|NCT00337467|584043140|FG000|Overall Study|Subject Withdrew Consent|2|||
161727123|NCT00337467|584043140|FG000|Overall Study|Pregnancy|1|||
161727124|NCT00337467|584043140|FG000|Overall Study|Lost to Follow-up|2|||
161727125|NCT00337467|584043140|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
161727126|NCT03141086|584043143|FG000|Overall Study|Study Terminated By Sponsor|1|||
161727127|NCT03141086|584043144|FG001|Overall Study|Study Terminated By Sponsor|1|||
161727128|NCT03141086|584043143|FG000|Overall Study|Withdrawal by Subject|0|||
161727129|NCT03141086|584043144|FG001|Overall Study|Withdrawal by Subject|1|||
161727130|NCT03141086|584043143|FG000|Overall Study|Protocol Violation|0|||
161727131|NCT03141086|584043144|FG001|Overall Study|Protocol Violation|1|||
161727132|NCT03141086|584043143|FG000|Overall Study|Adverse Event|0|||
161727133|NCT03141086|584043144|FG001|Overall Study|Adverse Event|2|||
161727134|NCT04430582|584043146|FG000|Overall Study|Found to meet exclusionary criteria|1|||
161727135|NCT04430582|584043147|FG001|Overall Study|Found to meet exclusionary criteria|0|||
161727136|NCT04430582|584043146|FG000|Overall Study|Withdrawal by Subject|0|||
161727137|NCT04430582|584043147|FG001|Overall Study|Withdrawal by Subject|1|||
161727138|NCT03607682|584043148|FG000|Overall Study|Withdrawal by Subject|1|||
161727139|NCT03607682|584043148|FG000|Overall Study|Disease progression|1|||
161727140|NCT00074412|584044121|FG000|Overall Study|Death|30|||
161727141|NCT00074412|584044122|FG001|Overall Study|Death|26|||
161727142|NCT00074412|584044121|FG000|Overall Study|Lost to Follow-up|52|||
161727143|NCT00074412|584044122|FG001|Overall Study|Lost to Follow-up|58|||
161727144|NCT01043185|584044123|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
161727145|NCT01043185|584044124|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
161727146|NCT01043185|584044125|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
161727147|NCT01043185|584044126|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
161727148|NCT01043185|584044127|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
161727149|NCT01043185|584044128|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
161727150|NCT01043185|584044129|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
161727151|NCT01043185|584044130|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
161727152|NCT01043185|584044131|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
161727153|NCT01043185|584044132|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
161727154|NCT01881620|584044135|FG000|Overall Study|Protocol Violation|4|||
161727155|NCT02561000|584044137|FG000|Overall Study|Withdrawal by Subject|2|||
161727156|NCT02561000|584044138|FG001|Overall Study|Withdrawal by Subject|3|||
161727157|NCT02561000|584044139|FG002|Overall Study|Withdrawal by Subject|0|||
161727158|NCT02561000|584044137|FG000|Overall Study|Adverse Event|0|||
161727159|NCT02561000|584044138|FG001|Overall Study|Adverse Event|1|||
161727160|NCT02561000|584044139|FG002|Overall Study|Adverse Event|0|||
161727161|NCT03430245|584044142|FG000|Overall Study|Withdrawal by Subject|6|||
161727162|NCT03430245|584044142|FG000|Overall Study|Lost to Follow-up|1|||
161727163|NCT03656926|584044143|FG000|Overall Study|Adverse Event|5|||
161727164|NCT03656926|584044144|FG001|Overall Study|Adverse Event|4|||
161727165|NCT03656926|584044143|FG000|Overall Study|Withdrawal by Subject|7|||
161727166|NCT03656926|584044144|FG001|Overall Study|Withdrawal by Subject|2|||
161727167|NCT03656926|584044143|FG000|Overall Study|Screen fail after randomization|1|||
161727168|NCT03656926|584044144|FG001|Overall Study|Screen fail after randomization|0|||
161727169|NCT03656926|584044143|FG000|Overall Study|PI decision due to patient condition|1|||
161838092|NCT00770692|584450334|FG001|Overall Study|Withdrawal by Subject|9|||
161838093|NCT00770692|584450335|FG002|Overall Study|Withdrawal by Subject|9|||
161838094|NCT00770692|584450336|FG003|Overall Study|Withdrawal by Subject|6|||
161838095|NCT00770692|584450333|FG000|Overall Study|Adverse Event|3|||
161838096|NCT00770692|584450334|FG001|Overall Study|Adverse Event|0|||
161838097|NCT00770692|584450335|FG002|Overall Study|Adverse Event|4|||
161838098|NCT00770692|584450336|FG003|Overall Study|Adverse Event|4|||
161838099|NCT00770692|584450333|FG000|Overall Study|Investigator judgment|2|||
161838100|NCT00770692|584450334|FG001|Overall Study|Investigator judgment|0|||
161838101|NCT00770692|584450335|FG002|Overall Study|Investigator judgment|1|||
161838102|NCT00770692|584450336|FG003|Overall Study|Investigator judgment|1|||
161838103|NCT01230892|584450337|FG000|Overall Study|Withdrawal by Subject|1|||
161838104|NCT01230892|584450338|FG001|Overall Study|Withdrawal by Subject|1|||
161838105|NCT01230892|584450337|FG000|Overall Study|Lost to Follow-up|2|||
161727170|NCT03656926|584044144|FG001|Overall Study|PI decision due to patient condition|0|||
161727171|NCT03656926|584044143|FG000|Overall Study|Patient unresponsiveness|1|||
161727172|NCT03656926|584044144|FG001|Overall Study|Patient unresponsiveness|0|||
161727173|NCT00850759|584044149|FG000|Overall Study|Lost to Follow-up|7|||
161727174|NCT00850759|584044150|FG001|Overall Study|Lost to Follow-up|5|||
161727175|NCT00850759|584044151|FG002|Overall Study|Lost to Follow-up|5|||
161727176|NCT00850759|584044152|FG003|Overall Study|Lost to Follow-up|3|||
161727177|NCT03196505|584044153|FG000|Overall Study|Physician Decision|26|||
161838106|NCT01230892|584450338|FG001|Overall Study|Lost to Follow-up|0|||
161727178|NCT03196505|584044154|FG001|Overall Study|Physician Decision|26|||
161727179|NCT02575079|584044156|FG000|Overall Study|Death|3|||
161727180|NCT02575079|584044157|FG001|Overall Study|Death|0|||
161727181|NCT02575079|584044156|FG000|Overall Study|Withdrawal by Subject|3|||
161727182|NCT02575079|584044157|FG001|Overall Study|Withdrawal by Subject|0|||
161727183|NCT02918266|584044158|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
161727184|NCT02918266|584044159|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727185|NCT02918266|584044160|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727186|NCT02918266|584044161|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727187|NCT02918266|584044162|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727188|NCT02918266|584044163|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727189|NCT02918266|584044164|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
161727190|NCT02918266|584044165|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727191|NCT02918266|584044166|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
161727192|NCT02918266|584044167|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727193|NCT02918266|584044168|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727194|NCT00578864|584044171|FG000|Overall Study|Death|1|||
161727195|NCT00578864|584044172|FG001|Overall Study|Death|0|||
161727196|NCT01293032|584044176|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161727197|NCT01293032|584044177|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161727198|NCT01293032|584044178|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
161727199|NCT01293032|584044179|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161727200|NCT01293032|584044176|FG000|Treatment|Adverse Event|0|||
161727201|NCT01293032|584044177|FG001|Treatment|Adverse Event|0|||
161727202|NCT01293032|584044178|FG002|Treatment|Adverse Event|1|||
161727203|NCT01293032|584044179|FG003|Treatment|Adverse Event|1|||
161727204|NCT01293032|584044176|FG000|Treatment|Withdrawal by Subject|2|||
161727205|NCT01293032|584044177|FG001|Treatment|Withdrawal by Subject|4|||
161727206|NCT01293032|584044178|FG002|Treatment|Withdrawal by Subject|0|||
161727207|NCT01293032|584044179|FG003|Treatment|Withdrawal by Subject|0|||
161727208|NCT01293032|584044176|FG000|Treatment|Disease Progression, relapse|0|||
161727209|NCT01293032|584044177|FG001|Treatment|Disease Progression, relapse|1|||
161727210|NCT01293032|584044178|FG002|Treatment|Disease Progression, relapse|0|||
161727211|NCT01293032|584044179|FG003|Treatment|Disease Progression, relapse|0|||
161727212|NCT01253044|584044180|FG000|Overall Study|Lost to Follow-up|38|||
161727213|NCT01253044|584044181|FG001|Overall Study|Lost to Follow-up|29|||
161727214|NCT01087528|584044184|FG000|Overall Study|Withdrawal by Subject|1|||
161727215|NCT01087528|584044184|FG000|Overall Study|Incomplete CE procedure|6|||
161727216|NCT03116399|584044185|FG000|Overall Study|Death|8|||
161727217|NCT03116399|584044186|FG001|Overall Study|Death|3|||
161727218|NCT03116399|584044185|FG000|Overall Study|Lost to Follow-up|7|||
161727219|NCT03116399|584044186|FG001|Overall Study|Lost to Follow-up|11|||
161727220|NCT03116399|584044185|FG000|Overall Study|Investigator Decision|1|||
161727221|NCT03116399|584044186|FG001|Overall Study|Investigator Decision|1|||
161727222|NCT03116399|584044185|FG000|Overall Study|Withdrawal by Subject|24|||
161727223|NCT03116399|584044186|FG001|Overall Study|Withdrawal by Subject|9|||
161727224|NCT00987623|584044188|FG000|Overall Study|Lost to Follow-up|2|||
161727225|NCT00987623|584044189|FG001|Overall Study|Lost to Follow-up|1|||
161727226|NCT00987623|584044188|FG000|Overall Study|Time/job conflict|2|||
161727227|NCT00987623|584044189|FG001|Overall Study|Time/job conflict|0|||
161727228|NCT00987623|584044188|FG000|Overall Study|Discomfort|1|||
161727229|NCT00987623|584044189|FG001|Overall Study|Discomfort|0|||
161727230|NCT00987623|584044188|FG000|Overall Study|Biomicroscopy|0|||
161727231|NCT00987623|584044189|FG001|Overall Study|Biomicroscopy|1|||
161727232|NCT00987623|584044188|FG000|Overall Study|Influenza|0|||
161727233|NCT00987623|584044189|FG001|Overall Study|Influenza|1|||
161727234|NCT02691247|584044192|FG000|Overall Study|Withdrawal by Subject|1|||
161727235|NCT02691247|584044193|FG001|Overall Study|Withdrawal by Subject|2|||
161727236|NCT02691247|584044194|FG002|Overall Study|Withdrawal by Subject|2|||
161727237|NCT02691247|584044192|FG000|Overall Study|Lost to Follow-up|2|||
161727238|NCT02691247|584044193|FG001|Overall Study|Lost to Follow-up|0|||
161727239|NCT02691247|584044194|FG002|Overall Study|Lost to Follow-up|1|||
161727240|NCT01519245|584044195|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
161727241|NCT01519245|584044196|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
161727242|NCT02873715|584044199|FG000|Overall Study|Lost to Follow-up|84|||
161727243|NCT02873715|584044200|FG001|Overall Study|Lost to Follow-up|94|||
161727244|NCT02873715|584044199|FG000|Overall Study|Withdrawal by Subject|7|||
161727245|NCT02873715|584044200|FG001|Overall Study|Withdrawal by Subject|26|||
161727246|NCT02144220|584044204|FG000|Overall Study|technology incompatibility|9|||
161727247|NCT02144220|584044204|FG000|Overall Study|Lack of Efficacy|4|||
161727248|NCT02144220|584044204|FG000|Overall Study|Physician Decision|3|||
161727249|NCT02144220|584044204|FG000|Overall Study|Withdrawal by Subject|2|||
161727250|NCT02144220|584044204|FG000|Overall Study|Protocol Violation|1|||
161727251|NCT00592501|584044207|FG000|Overall Study|Withdrawal by Subject|1|||
161727252|NCT00592501|584044207|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
161727253|NCT00053846|584044208|FG000|Overall Study|Changed mind|8|||
161727254|NCT00053846|584044209|FG001|Overall Study|Changed mind|13|||
161727255|NCT00053846|584044208|FG000|Overall Study|Became too ill|8|||
161727256|NCT00053846|584044209|FG001|Overall Study|Became too ill|7|||
161727257|NCT00053846|584044208|FG000|Overall Study|Expired|5|||
161727258|NCT00053846|584044209|FG001|Overall Study|Expired|0|||
161727259|NCT00053846|584044208|FG000|Overall Study|Became ineligible|3|||
161727260|NCT00053846|584044209|FG001|Overall Study|Became ineligible|1|||
161727261|NCT00053846|584044208|FG000|Overall Study|Did not return data|1|||
161727262|NCT00053846|584044209|FG001|Overall Study|Did not return data|2|||
161727263|NCT00053846|584044208|FG000|Overall Study|Quit due to side effects|1|||
161727264|NCT00053846|584044209|FG001|Overall Study|Quit due to side effects|3|||
161727265|NCT00053846|584044208|FG000|Overall Study|Pills too large|0|||
161727266|NCT00053846|584044209|FG001|Overall Study|Pills too large|1|||
161727267|NCT03880227|584044210|FG000|First Visit|Withdrawal by Subject|1|||
161727268|NCT03880227|584044211|FG001|First Visit|Withdrawal by Subject|0|||
161727269|NCT03880227|584044212|FG002|First Visit|Withdrawal by Subject|0|||
161727270|NCT03880227|584044213|FG003|First Visit|Withdrawal by Subject|0|||
161727271|NCT03880227|584044210|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
161727272|NCT03880227|584044211|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
161727273|NCT03880227|584044212|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
161727274|NCT03880227|584044213|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
161727275|NCT03880227|584044210|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161727276|NCT03880227|584044211|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161727277|NCT03880227|584044212|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
161727278|NCT03880227|584044213|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161727279|NCT03880227|584044210|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161727280|NCT03880227|584044211|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161727281|NCT03880227|584044212|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
161727282|NCT03880227|584044213|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161727283|NCT04590937|584044214|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
161727284|NCT01635933|584044215|FG000|Overall Study|Adverse Event|1|||
161727285|NCT01635933|584044216|FG001|Overall Study|Adverse Event|0|||
161727286|NCT01635933|584044215|FG000|Overall Study|Lost to Follow-up|0|||
161727287|NCT01635933|584044216|FG001|Overall Study|Lost to Follow-up|5|||
161727288|NCT01635933|584044215|FG000|Overall Study|Subject decision|1|||
161727289|NCT01635933|584044216|FG001|Overall Study|Subject decision|1|||
161727290|NCT01635933|584044215|FG000|Overall Study|Noncompliance|0|||
161727291|NCT01635933|584044216|FG001|Overall Study|Noncompliance|1|||
161727292|NCT01635933|584044215|FG000|Overall Study|No longer had transportation|0|||
161727293|NCT01635933|584044216|FG001|Overall Study|No longer had transportation|1|||
161727294|NCT01544595|584044217|FG000|Status at Week 68|Adverse Event|3|||
161727295|NCT01544595|584044218|FG001|Status at Week 68|Adverse Event|2|||
161727296|NCT01544595|584044219|FG002|Status at Week 68|Adverse Event|1|||
161727297|NCT01544595|584044220|FG003|Status at Week 68|Adverse Event|0|||
161727298|NCT01544595|584044221|FG004|Status at Week 68|Adverse Event|0|||
161727299|NCT01544595|584044222|FG005|Status at Week 68|Adverse Event|0|||
161727300|NCT01544595|584044217|FG000|Status at Week 68|Lack of Efficacy|1|||
161727301|NCT01544595|584044218|FG001|Status at Week 68|Lack of Efficacy|0|||
161727302|NCT01544595|584044219|FG002|Status at Week 68|Lack of Efficacy|0|||
161727303|NCT01544595|584044220|FG003|Status at Week 68|Lack of Efficacy|0|||
161727304|NCT01544595|584044221|FG004|Status at Week 68|Lack of Efficacy|0|||
161727305|NCT01544595|584044222|FG005|Status at Week 68|Lack of Efficacy|0|||
161727306|NCT01544595|584044217|FG000|Status at Week 68|Lost to Follow-up|1|||
161727307|NCT01544595|584044218|FG001|Status at Week 68|Lost to Follow-up|1|||
161727308|NCT01544595|584044219|FG002|Status at Week 68|Lost to Follow-up|0|||
161727309|NCT01544595|584044220|FG003|Status at Week 68|Lost to Follow-up|0|||
161727310|NCT01544595|584044221|FG004|Status at Week 68|Lost to Follow-up|0|||
161727311|NCT01544595|584044222|FG005|Status at Week 68|Lost to Follow-up|0|||
161727312|NCT01544595|584044217|FG000|Status at Week 68|Non-compliance with study treatment|1|||
161727313|NCT01544595|584044218|FG001|Status at Week 68|Non-compliance with study treatment|0|||
161727314|NCT01544595|584044219|FG002|Status at Week 68|Non-compliance with study treatment|0|||
161727315|NCT01544595|584044220|FG003|Status at Week 68|Non-compliance with study treatment|1|||
161727316|NCT01544595|584044221|FG004|Status at Week 68|Non-compliance with study treatment|0|||
161727317|NCT01544595|584044222|FG005|Status at Week 68|Non-compliance with study treatment|0|||
161727318|NCT01544595|584044217|FG000|Status at Week 68|Protocol Violation|2|||
161727319|NCT01544595|584044218|FG001|Status at Week 68|Protocol Violation|0|||
161727320|NCT01544595|584044219|FG002|Status at Week 68|Protocol Violation|1|||
161727321|NCT01544595|584044220|FG003|Status at Week 68|Protocol Violation|1|||
161727322|NCT01544595|584044221|FG004|Status at Week 68|Protocol Violation|0|||
161727323|NCT01544595|584044222|FG005|Status at Week 68|Protocol Violation|0|||
161727324|NCT01544595|584044217|FG000|Status at Week 68|Technical problems|1|||
161727325|NCT01544595|584044218|FG001|Status at Week 68|Technical problems|0|||
161727326|NCT01544595|584044219|FG002|Status at Week 68|Technical problems|0|||
161727327|NCT01544595|584044220|FG003|Status at Week 68|Technical problems|1|||
161727328|NCT01544595|584044221|FG004|Status at Week 68|Technical problems|0|||
161727329|NCT01544595|584044222|FG005|Status at Week 68|Technical problems|0|||
161727330|NCT01544595|584044217|FG000|Status at Week 68|Withdrawal by Subject|0|||
161727331|NCT01544595|584044218|FG001|Status at Week 68|Withdrawal by Subject|1|||
161727332|NCT01544595|584044219|FG002|Status at Week 68|Withdrawal by Subject|1|||
161727333|NCT01544595|584044220|FG003|Status at Week 68|Withdrawal by Subject|2|||
161727334|NCT01544595|584044221|FG004|Status at Week 68|Withdrawal by Subject|0|||
161727335|NCT01544595|584044222|FG005|Status at Week 68|Withdrawal by Subject|0|||
161727336|NCT01544595|584044217|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
161727337|NCT01544595|584044218|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
161727338|NCT01544595|584044219|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
161727339|NCT01544595|584044220|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
161727340|NCT01544595|584044221|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
161727341|NCT01544595|584044222|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
161727342|NCT01544595|584044217|FG000|Status at Week 156|Withdrawal by Subject|9|||
161727343|NCT01544595|584044218|FG001|Status at Week 156|Withdrawal by Subject|10|||
161727344|NCT01544595|584044219|FG002|Status at Week 156|Withdrawal by Subject|4|||
161727345|NCT01544595|584044220|FG003|Status at Week 156|Withdrawal by Subject|9|||
161727346|NCT01544595|584044221|FG004|Status at Week 156|Withdrawal by Subject|20|||
161727347|NCT01544595|584044222|FG005|Status at Week 156|Withdrawal by Subject|6|||
161727348|NCT01544595|584044217|FG000|Status at Week 156|Adverse Event|9|||
161727349|NCT01544595|584044218|FG001|Status at Week 156|Adverse Event|11|||
161727350|NCT01544595|584044219|FG002|Status at Week 156|Adverse Event|1|||
161727351|NCT01544595|584044220|FG003|Status at Week 156|Adverse Event|3|||
161727352|NCT01544595|584044221|FG004|Status at Week 156|Adverse Event|4|||
161727353|NCT01544595|584044222|FG005|Status at Week 156|Adverse Event|2|||
161727354|NCT01544595|584044217|FG000|Status at Week 156|Lost to Follow-up|4|||
161727355|NCT01544595|584044218|FG001|Status at Week 156|Lost to Follow-up|4|||
161727356|NCT01544595|584044219|FG002|Status at Week 156|Lost to Follow-up|0|||
161727357|NCT01544595|584044220|FG003|Status at Week 156|Lost to Follow-up|1|||
161727358|NCT01544595|584044221|FG004|Status at Week 156|Lost to Follow-up|4|||
161727359|NCT01544595|584044222|FG005|Status at Week 156|Lost to Follow-up|1|||
161727360|NCT01544595|584044217|FG000|Status at Week 156|Non-compliance with study treatement|0|||
161727361|NCT01544595|584044218|FG001|Status at Week 156|Non-compliance with study treatement|1|||
161727362|NCT01544595|584044219|FG002|Status at Week 156|Non-compliance with study treatement|0|||
161727363|NCT01544595|584044220|FG003|Status at Week 156|Non-compliance with study treatement|1|||
161727364|NCT01544595|584044221|FG004|Status at Week 156|Non-compliance with study treatement|0|||
161727365|NCT01544595|584044222|FG005|Status at Week 156|Non-compliance with study treatement|1|||
161727366|NCT01544595|584044217|FG000|Status at Week 156|Physician Decision|0|||
161727367|NCT01544595|584044218|FG001|Status at Week 156|Physician Decision|3|||
161727368|NCT01544595|584044219|FG002|Status at Week 156|Physician Decision|1|||
161727369|NCT01544595|584044220|FG003|Status at Week 156|Physician Decision|0|||
161727370|NCT01544595|584044221|FG004|Status at Week 156|Physician Decision|0|||
161727371|NCT01544595|584044222|FG005|Status at Week 156|Physician Decision|0|||
161727372|NCT01544595|584044217|FG000|Status at Week 156|Pregnancy|2|||
161727373|NCT01544595|584044218|FG001|Status at Week 156|Pregnancy|3|||
161727374|NCT01544595|584044219|FG002|Status at Week 156|Pregnancy|0|||
161727375|NCT01544595|584044220|FG003|Status at Week 156|Pregnancy|0|||
161727376|NCT01544595|584044221|FG004|Status at Week 156|Pregnancy|0|||
161727377|NCT01544595|584044222|FG005|Status at Week 156|Pregnancy|0|||
161727378|NCT01544595|584044217|FG000|Status at Week 156|Protocol Violation|3|||
161727379|NCT01544595|584044218|FG001|Status at Week 156|Protocol Violation|1|||
161727380|NCT01544595|584044219|FG002|Status at Week 156|Protocol Violation|2|||
161727381|NCT01544595|584044220|FG003|Status at Week 156|Protocol Violation|2|||
161727382|NCT01544595|584044221|FG004|Status at Week 156|Protocol Violation|0|||
161727383|NCT01544595|584044222|FG005|Status at Week 156|Protocol Violation|0|||
161727384|NCT01544595|584044217|FG000|Status at Week 156|Technical problems|3|||
161727385|NCT01544595|584044218|FG001|Status at Week 156|Technical problems|1|||
161727386|NCT01544595|584044219|FG002|Status at Week 156|Technical problems|0|||
161727387|NCT01544595|584044220|FG003|Status at Week 156|Technical problems|1|||
161727388|NCT01544595|584044221|FG004|Status at Week 156|Technical problems|0|||
161727389|NCT01544595|584044222|FG005|Status at Week 156|Technical problems|0|||
161727390|NCT01544595|584044217|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
161727391|NCT01544595|584044218|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
161727392|NCT01544595|584044219|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
161727393|NCT01544595|584044220|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
161727394|NCT01544595|584044221|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
161727395|NCT01544595|584044222|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
161727396|NCT01544595|584044217|FG000|Status at Week 156|Lack of Efficacy|1|||
161727397|NCT01544595|584044218|FG001|Status at Week 156|Lack of Efficacy|0|||
161727398|NCT01544595|584044219|FG002|Status at Week 156|Lack of Efficacy|1|||
161727399|NCT01544595|584044220|FG003|Status at Week 156|Lack of Efficacy|4|||
161727400|NCT01544595|584044221|FG004|Status at Week 156|Lack of Efficacy|10|||
161727401|NCT01544595|584044222|FG005|Status at Week 156|Lack of Efficacy|5|||
161727402|NCT01929044|584044223|FG000|Overall Study|Adverse Event|1|||
161727403|NCT01929044|584044224|FG001|Overall Study|Adverse Event|0|||
161727404|NCT01929044|584044223|FG000|Overall Study|Protocol Violation|9|||
161727405|NCT01929044|584044224|FG001|Overall Study|Protocol Violation|14|||
161727406|NCT01929044|584044223|FG000|Overall Study|Not Treated|1|||
161727407|NCT01929044|584044224|FG001|Overall Study|Not Treated|3|||
161727408|NCT02275026|584044229|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
161727409|NCT02275026|584044229|FG000|Overall Study|Withdrawal by Subject|4|||
161727410|NCT02275026|584044229|FG000|Overall Study|Ineligible due to medical history|13|||
161727411|NCT02275026|584044229|FG000|Overall Study|MRI malfunction precluded testing|1|||
161727412|NCT02275026|584044229|FG000|Overall Study|Ineligible after MRI findings|1|||
161727413|NCT02275026|584044229|FG000|Overall Study|Lost to Follow-up|2|||
161727414|NCT02275026|584044229|FG000|Overall Study|Scanner failure|1|||
161727415|NCT03643432|584044230|FG000|Overall Study|Lost to Follow-up|1|||
161727416|NCT03643432|584044231|FG001|Overall Study|Lost to Follow-up|0|||
161727417|NCT02574312|584044237|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
161727418|NCT02574312|584044238|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
161727419|NCT02326467|584045763|FG000|Overall Study|Withdrawal by Subject|1|||
161727420|NCT04467164|584045765|FG000|Washout (1 Week)|Lost to Follow-up|2|||
161727421|NCT04467164|584045766|FG001|Washout (1 Week)|Lost to Follow-up|0|||
161727422|NCT01998581|584045767|FG000|Overall Study|Refused repeat treatment|20|||
161727423|NCT01998581|584045768|FG001|Overall Study|Refused repeat treatment|4|||
161727424|NCT01998581|584045767|FG000|Overall Study|Protocol Violation|1|||
161727425|NCT01998581|584045768|FG001|Overall Study|Protocol Violation|0|||
161727426|NCT01998581|584045767|FG000|Overall Study|Withdrawal by Subject|8|||
161727427|NCT01998581|584045768|FG001|Overall Study|Withdrawal by Subject|1|||
161727428|NCT01998581|584045767|FG000|Overall Study|Lost to Follow-up|12|||
161727429|NCT01998581|584045768|FG001|Overall Study|Lost to Follow-up|4|||
161727430|NCT01998581|584045767|FG000|Overall Study|Adverse Event|1|||
161727431|NCT01998581|584045768|FG001|Overall Study|Adverse Event|1|||
161727432|NCT01998581|584045767|FG000|Overall Study|Other reasons|3|||
161727433|NCT01998581|584045768|FG001|Overall Study|Other reasons|2|||
161727434|NCT01998581|584045767|FG000|Overall Study|Randomized but withdrew before treatment|1|||
161727435|NCT01998581|584045768|FG001|Overall Study|Randomized but withdrew before treatment|0|||
161727436|NCT02273050|584045771|FG000|Overall Study|Adverse Event|4|||
161727437|NCT02273050|584045772|FG001|Overall Study|Adverse Event|3|||
161727438|NCT02273050|584045773|FG002|Overall Study|Adverse Event|3|||
161727439|NCT02273050|584045771|FG000|Overall Study|Death|0|||
161727440|NCT02273050|584045772|FG001|Overall Study|Death|0|||
161727441|NCT02273050|584045773|FG002|Overall Study|Death|1|||
161727442|NCT02273050|584045771|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
161727443|NCT02273050|584045772|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
161727444|NCT02273050|584045773|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
161727445|NCT02273050|584045771|FG000|Overall Study|Lack of Efficacy|0|||
161727446|NCT02273050|584045772|FG001|Overall Study|Lack of Efficacy|1|||
161727447|NCT02273050|584045773|FG002|Overall Study|Lack of Efficacy|1|||
161727448|NCT02273050|584045771|FG000|Overall Study|Withdrawal by Subject|17|||
161727449|NCT02273050|584045772|FG001|Overall Study|Withdrawal by Subject|14|||
161727450|NCT02273050|584045773|FG002|Overall Study|Withdrawal by Subject|16|||
161727451|NCT02273050|584045771|FG000|Overall Study|Lost to Follow-up|0|||
161727452|NCT02273050|584045772|FG001|Overall Study|Lost to Follow-up|2|||
161727453|NCT02273050|584045773|FG002|Overall Study|Lost to Follow-up|3|||
161727454|NCT02273050|584045771|FG000|Overall Study|Protocol Violation|3|||
161727455|NCT02273050|584045772|FG001|Overall Study|Protocol Violation|1|||
161727456|NCT02273050|584045773|FG002|Overall Study|Protocol Violation|4|||
161727457|NCT02273752|584045774|FG000|Overall Study|Trial was terminated early|2|||
161727458|NCT00903032|584045775|FG000|Overall Study|Withdrawal by Subject|5|||
161727459|NCT00903032|584045776|FG001|Overall Study|Withdrawal by Subject|3|||
161727460|NCT00903032|584045775|FG000|Overall Study|Lost to Follow-up|2|||
161727461|NCT00903032|584045776|FG001|Overall Study|Lost to Follow-up|2|||
161727462|NCT05619172|584045777|FG000|Safety Cohort 1|Death|7|||
161727463|NCT05619172|584045778|FG001|Safety Cohort 1|Death|0|||
161727464|NCT05619172|584045777|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
161727465|NCT05619172|584045778|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
161727466|NCT05619172|584045777|FG000|Safety Cohort 2|Death|0|||
161727467|NCT05619172|584045778|FG001|Safety Cohort 2|Death|1|||
161727468|NCT05619172|584045777|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
161727469|NCT05619172|584045778|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
161727470|NCT01429792|584045779|FG000|Overall Study|Other Reasons|67|||
161727471|NCT01429792|584045779|FG000|Overall Study|Unknown Disposition|94|||
161727472|NCT01429792|584045779|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
161727473|NCT01429792|584045779|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
161727474|NCT01429792|584045779|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
161727475|NCT01429792|584045779|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
161727476|NCT01429792|584045779|FG000|Overall Study|Withdrawal by Subject|70|||
161727477|NCT01429792|584045779|FG000|Overall Study|Lost to Follow-up|88|||
161727478|NCT01763905|584045782|FG000|Overall Study|Withdrawal by Subject|1|||
161727479|NCT01763905|584045783|FG001|Overall Study|Withdrawal by Subject|1|||
161727480|NCT01763905|584045784|FG002|Overall Study|Withdrawal by Subject|0|||
161727481|NCT01763905|584045785|FG003|Overall Study|Withdrawal by Subject|1|||
161727482|NCT01763905|584045782|FG000|Overall Study|Decision by sponsor|5|||
161727483|NCT01763905|584045783|FG001|Overall Study|Decision by sponsor|0|||
161727484|NCT01763905|584045784|FG002|Overall Study|Decision by sponsor|8|||
161727485|NCT01763905|584045785|FG003|Overall Study|Decision by sponsor|0|||
161727486|NCT01763905|584045782|FG000|Overall Study|Lost to Follow-up|0|||
161727487|NCT01763905|584045783|FG001|Overall Study|Lost to Follow-up|0|||
161727488|NCT01763905|584045784|FG002|Overall Study|Lost to Follow-up|1|||
161727489|NCT01763905|584045785|FG003|Overall Study|Lost to Follow-up|0|||
161727490|NCT04346628|584045786|FG000|Overall Study|Lost to Follow-up|4|||
161727491|NCT04346628|584045787|FG001|Overall Study|Lost to Follow-up|4|||
161727492|NCT04346628|584045786|FG000|Overall Study|Withdrew (had personal reasons)|2|||
161727493|NCT04346628|584045787|FG001|Overall Study|Withdrew (had personal reasons)|5|||
161727494|NCT04346628|584045786|FG000|Overall Study|Withdrew (medication intolerant)|0|||
161727495|NCT04346628|584045787|FG001|Overall Study|Withdrew (medication intolerant)|3|||
161727496|NCT04346628|584045786|FG000|Overall Study|Withdrew (declined intervention)|0|||
161727497|NCT04346628|584045787|FG001|Overall Study|Withdrew (declined intervention)|1|||
161727498|NCT01457118|584045788|FG000|Overall Study|Adverse Event|1|||
161727499|NCT01457118|584045789|FG001|Overall Study|Adverse Event|0|||
161727500|NCT01457118|584045790|FG002|Overall Study|Adverse Event|0|||
161727501|NCT01457118|584045791|FG003|Overall Study|Adverse Event|1|||
161727502|NCT01457118|584045788|FG000|Overall Study|Clinical Progression|0|||
161727503|NCT01457118|584045789|FG001|Overall Study|Clinical Progression|1|||
161727504|NCT01457118|584045790|FG002|Overall Study|Clinical Progression|0|||
161727505|NCT01457118|584045791|FG003|Overall Study|Clinical Progression|1|||
161727506|NCT01457118|584045788|FG000|Overall Study|Physician Decision|2|||
161727507|NCT01457118|584045789|FG001|Overall Study|Physician Decision|0|||
161727508|NCT01457118|584045790|FG002|Overall Study|Physician Decision|0|||
161727509|NCT01457118|584045791|FG003|Overall Study|Physician Decision|0|||
161727510|NCT01457118|584045788|FG000|Overall Study|Progressive Disease by RECIST|12|||
161727511|NCT01457118|584045789|FG001|Overall Study|Progressive Disease by RECIST|3|||
161727512|NCT01457118|584045790|FG002|Overall Study|Progressive Disease by RECIST|1|||
161727513|NCT01457118|584045791|FG003|Overall Study|Progressive Disease by RECIST|0|||
161727514|NCT01457118|584045788|FG000|Overall Study|Withdrawal by Subject|5|||
161727515|NCT01457118|584045789|FG001|Overall Study|Withdrawal by Subject|0|||
161727516|NCT01457118|584045790|FG002|Overall Study|Withdrawal by Subject|0|||
161727517|NCT01457118|584045791|FG003|Overall Study|Withdrawal by Subject|0|||
161727518|NCT03456713|584045794|FG000|Overall Study|Lost to Follow-up|1|||
161727519|NCT03456713|584045795|FG001|Overall Study|Lost to Follow-up|0|||
161727520|NCT03456713|584045796|FG002|Overall Study|Lost to Follow-up|0|||
161727521|NCT03456713|584045797|FG003|Overall Study|Lost to Follow-up|0|||
161727522|NCT01263691|584045798|FG000|Overall Study|Lost to Follow-up|1|||
161727523|NCT01263691|584045799|FG001|Overall Study|Lost to Follow-up|0|||
161727524|NCT01263691|584045800|FG002|Overall Study|Lost to Follow-up|1|||
161727525|NCT01263691|584045801|FG003|Overall Study|Lost to Follow-up|1|||
161727526|NCT01263691|584045802|FG004|Overall Study|Lost to Follow-up|0|||
161727527|NCT01263691|584045803|FG005|Overall Study|Lost to Follow-up|0|||
161727528|NCT01263691|584045798|FG000|Overall Study|Withdrawal by Subject|1|||
161727529|NCT01263691|584045799|FG001|Overall Study|Withdrawal by Subject|0|||
161727530|NCT01263691|584045800|FG002|Overall Study|Withdrawal by Subject|0|||
161727531|NCT01263691|584045801|FG003|Overall Study|Withdrawal by Subject|0|||
161727532|NCT01263691|584045802|FG004|Overall Study|Withdrawal by Subject|0|||
161727533|NCT01263691|584045803|FG005|Overall Study|Withdrawal by Subject|0|||
161727534|NCT01263691|584045798|FG000|Overall Study|Adverse Event|1|||
161727535|NCT01263691|584045799|FG001|Overall Study|Adverse Event|0|||
161727536|NCT01263691|584045800|FG002|Overall Study|Adverse Event|0|||
161727537|NCT01263691|584045801|FG003|Overall Study|Adverse Event|0|||
161727538|NCT01263691|584045802|FG004|Overall Study|Adverse Event|0|||
161727539|NCT01263691|584045803|FG005|Overall Study|Adverse Event|0|||
161727540|NCT00630812|584045815|FG000|Randomisation to First Dose|Adverse Event|1|||
161727541|NCT00630812|584045816|FG001|Randomisation to First Dose|Adverse Event|1|||
161727542|NCT00630812|584045815|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
161727543|NCT00630812|584045816|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
161727544|NCT00630812|584045815|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
161727545|NCT00630812|584045816|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
161727546|NCT00630812|584045815|FG000|Randomisation to First Dose|Protocol Violation|4|||
161727547|NCT00630812|584045816|FG001|Randomisation to First Dose|Protocol Violation|1|||
161727548|NCT00630812|584045815|FG000|Double Blind Treatment Period|Adverse Event|13|||
161727549|NCT00630812|584045816|FG001|Double Blind Treatment Period|Adverse Event|5|||
161727550|NCT00630812|584045815|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
161727551|NCT00630812|584045816|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161727552|NCT00630812|584045815|FG000|Double Blind Treatment Period|Physician Decision|2|||
161727553|NCT00630812|584045816|FG001|Double Blind Treatment Period|Physician Decision|1|||
161727554|NCT00630812|584045815|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161727555|NCT00630812|584045816|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161727556|NCT00630812|584045815|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
161727557|NCT00630812|584045816|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
161727558|NCT00630812|584045815|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
161727559|NCT00630812|584045816|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
161727560|NCT00630812|584045815|FG000|Double Blind Treatment Period|Non-compliance|0|||
161727561|NCT00630812|584045816|FG001|Double Blind Treatment Period|Non-compliance|1|||
161727562|NCT05761444|584045817|FG000|Overall Study|Protocol Violation|2|||
161727563|NCT05761444|584045818|FG001|Overall Study|Protocol Violation|1|||
161727564|NCT05761444|584045817|FG000|Overall Study|Adverse Event|2|||
161727565|NCT05761444|584045818|FG001|Overall Study|Adverse Event|2|||
161727566|NCT05761444|584045817|FG000|Overall Study|Withdrawal by Subject|3|||
161727567|NCT05761444|584045818|FG001|Overall Study|Withdrawal by Subject|2|||
161727568|NCT05761444|584045817|FG000|Overall Study|Other|1|||
161727569|NCT05761444|584045818|FG001|Overall Study|Other|0|||
161727570|NCT01842308|584045820|FG000|Overall Study|Withdrawal by Subject|0|||
161727571|NCT01842308|584045821|FG001|Overall Study|Withdrawal by Subject|0|||
161727572|NCT01842308|584045822|FG002|Overall Study|Withdrawal by Subject|0|||
161727573|NCT01842308|584045823|FG003|Overall Study|Withdrawal by Subject|0|||
161727574|NCT01842308|584045824|FG004|Overall Study|Withdrawal by Subject|1|||
161727575|NCT02868216|584045825|FG000|Overall Study|Death|0|||
161727576|NCT02868216|584045826|FG001|Overall Study|Death|1|||
161727577|NCT02868216|584045825|FG000|Overall Study|coronary artery bypass|1|||
161727578|NCT02868216|584045826|FG001|Overall Study|coronary artery bypass|0|||
161727579|NCT02868216|584045825|FG000|Overall Study|Withdrawal by Subject|7|||
161727580|NCT02868216|584045826|FG001|Overall Study|Withdrawal by Subject|5|||
161727581|NCT03161678|584045827|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161727582|NCT03161678|584045828|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161727583|NCT03161678|584045829|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161727584|NCT03161678|584045830|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
161727585|NCT03161678|584045831|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161727586|NCT03161678|584045832|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161727587|NCT03161678|584045827|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
161727588|NCT03161678|584045828|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
161727589|NCT03161678|584045829|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
161727590|NCT03161678|584045830|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
161727591|NCT03161678|584045831|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
161727592|NCT03161678|584045832|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
161727593|NCT03161678|584045827|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
161727594|NCT03161678|584045828|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
161727595|NCT03161678|584045829|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
161727596|NCT03161678|584045830|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
161727597|NCT03161678|584045831|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
161727598|NCT03161678|584045832|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
161727599|NCT03161678|584045827|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727600|NCT03161678|584045828|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727601|NCT03161678|584045829|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727602|NCT03161678|584045830|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
161727603|NCT03161678|584045831|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727604|NCT03161678|584045832|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727605|NCT00752609|584045833|FG000|Overall Study|Adverse Event|2|||
161727606|NCT00752609|584045834|FG001|Overall Study|Adverse Event|2|||
161727607|NCT00752609|584045833|FG000|Overall Study|Withdrawal by Subject|3|||
161727608|NCT00752609|584045834|FG001|Overall Study|Withdrawal by Subject|0|||
161727609|NCT00752609|584045833|FG000|Overall Study|Physician Decision|1|||
161727610|NCT00752609|584045834|FG001|Overall Study|Physician Decision|0|||
161727611|NCT00752609|584045833|FG000|Overall Study|Death|1|||
161727612|NCT00752609|584045834|FG001|Overall Study|Death|0|||
161727613|NCT00752609|584045833|FG000|Overall Study|Met exclusion criteria|1|||
161727614|NCT00752609|584045834|FG001|Overall Study|Met exclusion criteria|0|||
161727615|NCT00752609|584045833|FG000|Overall Study|Received Aranesp in error|1|||
161727616|NCT00752609|584045834|FG001|Overall Study|Received Aranesp in error|0|||
161727617|NCT00938327|584045835|FG000|Overall Study|Adverse Event|2|||
161727618|NCT00938327|584045835|FG000|Overall Study|Protocol Violation|1|||
161727619|NCT00938327|584045835|FG000|Overall Study|Withdrawal by Subject|4|||
161838107|NCT02037165|584450339|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838108|NCT02037165|584450340|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838109|NCT02037165|584450341|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838110|NCT02037165|584450342|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838111|NCT02037165|584450343|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
161838112|NCT00673933|584450344|FG000|Overall Study|Withdrawal by Subject|2|||
161838113|NCT00673933|584450344|FG000|Overall Study|Lost to Follow-up|1|||
161838114|NCT02206620|584450345|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161838115|NCT02206620|584450346|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161838116|NCT02206620|584450345|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
161838117|NCT02206620|584450346|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
161838118|NCT05816200|584450347|FG000|Overall Study|Lost to Follow-up|2|||
161838119|NCT05816200|584450348|FG001|Overall Study|Lost to Follow-up|1|||
161838120|NCT02394730|584450349|FG000|Overall Study|Lost to Follow-up|1|||
161838121|NCT02394730|584450350|FG001|Overall Study|Lost to Follow-up|0|||
161838122|NCT02394730|584450349|FG000|Overall Study|Withdrawal by Subject|0|||
161838123|NCT02394730|584450350|FG001|Overall Study|Withdrawal by Subject|1|||
161838124|NCT00588640|584450351|FG000|Overall Study|Physician Decision|1|||
161838125|NCT00588640|584450351|FG000|Overall Study|Ineligible Patient|1|||
161838126|NCT01393730|584450352|FG000|Overall Study|Withdrawal by Subject|3|||
161838127|NCT01393730|584450352|FG000|Overall Study|Other|2|||
161838128|NCT01393730|584450352|FG000|Overall Study|Adverse Event|1|||
161838129|NCT00321828|584451783|FG000|Overall Study|Ineligible|3|||
161838130|NCT00321828|584451783|FG000|Overall Study|No follow up data|1|||
161838131|NCT00678041|584451795|FG000|Overall Study|Physician Decision|5|||
161838132|NCT00678041|584451796|FG001|Overall Study|Physician Decision|5|||
161838133|NCT00577395|584451799|FG000|Overall Study|Study was terminated early by Sponsor|7|||
161838134|NCT00577395|584451800|FG001|Overall Study|Study was terminated early by Sponsor|6|||
161838135|NCT03084367|584451803|FG000|Overall Study|Lost to Follow-up|32|||
161838136|NCT03084367|584451803|FG000|Overall Study|Withdrawal by Subject|4|||
161838137|NCT03084367|584451803|FG000|Overall Study|Other|1|||
161838138|NCT01206101|584451804|FG000|Overall Study|Adverse Event|1|||
161838139|NCT01206101|584451805|FG001|Overall Study|Adverse Event|0|||
161838140|NCT01206101|584451804|FG000|Overall Study|Physician Decision|0|||
161838141|NCT01206101|584451805|FG001|Overall Study|Physician Decision|1|||
161838142|NCT01206101|584451804|FG000|Overall Study|Unclassified|1|||
161838143|NCT01206101|584451805|FG001|Overall Study|Unclassified|0|||
161838144|NCT00368979|584451811|FG000|Overall Study|Adverse Event|9|||
161838145|NCT00368979|584451812|FG001|Overall Study|Adverse Event|16|||
161838146|NCT00368979|584451811|FG000|Overall Study|Lack of Efficacy|5|||
161838147|NCT00368979|584451812|FG001|Overall Study|Lack of Efficacy|3|||
161838148|NCT00368979|584451811|FG000|Overall Study|Other|3|||
161838149|NCT00368979|584451812|FG001|Overall Study|Other|1|||
161838150|NCT00368979|584451811|FG000|Overall Study|Lost to Follow-up|1|||
161838151|NCT00368979|584451812|FG001|Overall Study|Lost to Follow-up|0|||
161838152|NCT00368979|584451811|FG000|Overall Study|Protocol Violation|2|||
161838153|NCT00368979|584451812|FG001|Overall Study|Protocol Violation|1|||
161838154|NCT00368979|584451811|FG000|Overall Study|Withdrawal by Subject|5|||
161838155|NCT00368979|584451812|FG001|Overall Study|Withdrawal by Subject|9|||
161838156|NCT00103311|584451813|FG000|Overall Study|Lost to Follow-up|1|||
161838157|NCT00103311|584451814|FG001|Overall Study|Lost to Follow-up|0|||
161838158|NCT00103311|584451813|FG000|Overall Study|Withdrawal by Subject|2|||
161838159|NCT00103311|584451814|FG001|Overall Study|Withdrawal by Subject|1|||
161838160|NCT00103311|584451813|FG000|Overall Study|Adverse Event|1|||
161838161|NCT00103311|584451814|FG001|Overall Study|Adverse Event|0|||
161838162|NCT00912093|584451815|FG000|The Controlled Phase|Death|0|||
161838163|NCT00912093|584451816|FG001|The Controlled Phase|Death|1|||
161838164|NCT00912093|584451817|FG002|The Controlled Phase|Death|0|||
161838165|NCT00912093|584451818|FG003|The Controlled Phase|Death|0|||
161838166|NCT00912093|584451819|FG004|The Controlled Phase|Death|0|||
161838167|NCT00912093|584451815|FG000|The Controlled Phase|Medical Condition|0|||
161838168|NCT00912093|584451816|FG001|The Controlled Phase|Medical Condition|1|||
161838169|NCT00912093|584451817|FG002|The Controlled Phase|Medical Condition|0|||
161838170|NCT00912093|584451818|FG003|The Controlled Phase|Medical Condition|0|||
161838171|NCT00912093|584451819|FG004|The Controlled Phase|Medical Condition|0|||
161838172|NCT00912093|584451815|FG000|The Controlled Phase|Lost to Follow-up|0|||
161838173|NCT00912093|584451816|FG001|The Controlled Phase|Lost to Follow-up|0|||
161838174|NCT00912093|584451817|FG002|The Controlled Phase|Lost to Follow-up|0|||
161838175|NCT00912093|584451818|FG003|The Controlled Phase|Lost to Follow-up|0|||
161838176|NCT00912093|584451819|FG004|The Controlled Phase|Lost to Follow-up|1|||
161838177|NCT00394524|584451820|FG000|Overall Study|Protocol Violation|2|||
161838178|NCT00394524|584451821|FG001|Overall Study|Protocol Violation|3|||
161838179|NCT00394524|584451820|FG000|Overall Study|Death|1|||
161838180|NCT00394524|584451821|FG001|Overall Study|Death|0|||
161838181|NCT00394524|584451820|FG000|Overall Study|Withdrawal by Subject|0|||
161838182|NCT00394524|584451821|FG001|Overall Study|Withdrawal by Subject|1|||
161838183|NCT01462318|584451824|FG000|Main Study / TP-DI Study|Other|2|||
161838184|NCT01462318|584451825|FG001|Main Study / TP-DI Study|Other|0|||
161838185|NCT01462318|584451826|FG002|Main Study / TP-DI Study|Other|0|||
161838186|NCT01462318|584451824|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
161838187|NCT01462318|584451825|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
161838188|NCT01462318|584451826|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
161838189|NCT01462318|584451824|FG000|Main Study / TP-DI Study|Adverse Event|4|||
161838190|NCT01462318|584451825|FG001|Main Study / TP-DI Study|Adverse Event|0|||
161838191|NCT01462318|584451826|FG002|Main Study / TP-DI Study|Adverse Event|0|||
161838192|NCT01462318|584451824|FG000|Extension Phase|Lost to Follow-up|0|||
161838193|NCT01462318|584451825|FG001|Extension Phase|Lost to Follow-up|0|||
161838194|NCT01462318|584451826|FG002|Extension Phase|Lost to Follow-up|1|||
161838195|NCT01462318|584451824|FG000|Extension Phase|Other|0|||
161838196|NCT01462318|584451825|FG001|Extension Phase|Other|0|||
161838197|NCT01462318|584451826|FG002|Extension Phase|Other|1|||
161838198|NCT01462318|584451824|FG000|Extension Phase|Disease Progression|0|||
161838199|NCT01462318|584451825|FG001|Extension Phase|Disease Progression|0|||
161838200|NCT01462318|584451826|FG002|Extension Phase|Disease Progression|1|||
161838201|NCT01462318|584451824|FG000|Extension Phase|Withdrawal by Subject|0|||
161838202|NCT01462318|584451825|FG001|Extension Phase|Withdrawal by Subject|0|||
161838203|NCT01462318|584451826|FG002|Extension Phase|Withdrawal by Subject|15|||
161838204|NCT01462318|584451824|FG000|Extension Phase|Investigator Decision|0|||
161838205|NCT01462318|584451825|FG001|Extension Phase|Investigator Decision|0|||
161838206|NCT01462318|584451826|FG002|Extension Phase|Investigator Decision|5|||
161838207|NCT01462318|584451824|FG000|Extension Phase|Adverse Event|0|||
161838208|NCT01462318|584451825|FG001|Extension Phase|Adverse Event|0|||
161838209|NCT01462318|584451826|FG002|Extension Phase|Adverse Event|22|||
161838210|NCT03827564|584451827|FG000|Overall Study|Discontinued due to Study Termination|1|||
161838211|NCT03827564|584451828|FG001|Overall Study|Discontinued due to Study Termination|0|||
161838212|NCT02238626|584451829|FG000|Overall Study|Adverse Event|3|||
161838213|NCT02238626|584451830|FG001|Overall Study|Adverse Event|5|||
161838214|NCT02238626|584451831|FG002|Overall Study|Adverse Event|0|||
161838215|NCT02238626|584451832|FG003|Overall Study|Adverse Event|3|||
161838216|NCT02238626|584451829|FG000|Overall Study|Lost to Follow-up|2|||
161838217|NCT02238626|584451830|FG001|Overall Study|Lost to Follow-up|4|||
161838218|NCT02238626|584451831|FG002|Overall Study|Lost to Follow-up|2|||
161838219|NCT02238626|584451832|FG003|Overall Study|Lost to Follow-up|2|||
161838220|NCT02238626|584451829|FG000|Overall Study|Withdrawal by Subject|0|||
161838221|NCT02238626|584451830|FG001|Overall Study|Withdrawal by Subject|3|||
161838222|NCT02238626|584451831|FG002|Overall Study|Withdrawal by Subject|0|||
161838223|NCT02238626|584451832|FG003|Overall Study|Withdrawal by Subject|1|||
161838224|NCT02238626|584451829|FG000|Overall Study|Death|0|||
161838225|NCT02238626|584451830|FG001|Overall Study|Death|0|||
161838226|NCT02238626|584451831|FG002|Overall Study|Death|1|||
161838227|NCT02238626|584451832|FG003|Overall Study|Death|1|||
161838228|NCT02238626|584451829|FG000|Overall Study|Other|0|||
161838229|NCT02238626|584451830|FG001|Overall Study|Other|2|||
161838230|NCT02238626|584451831|FG002|Overall Study|Other|0|||
161838231|NCT02238626|584451832|FG003|Overall Study|Other|0|||
161838232|NCT00270257|584451833|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
161838233|NCT00270257|584451834|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
161838234|NCT01195103|584451837|FG000|Overall Study|Withdrawal by Subject|1|||
161838235|NCT01195103|584451838|FG001|Overall Study|Withdrawal by Subject|0|||
161838236|NCT01195103|584451839|FG002|Overall Study|Withdrawal by Subject|0|||
161838237|NCT00450619|584451846|FG000|Overall Study|refused treatment after randomization|2|||
161838238|NCT00450619|584451847|FG001|Overall Study|refused treatment after randomization|0|||
161838239|NCT00450619|584451846|FG000|Overall Study|did not progress; refused further trmt|1|||
161838240|NCT00450619|584451847|FG001|Overall Study|did not progress; refused further trmt|1|||
161838241|NCT00450619|584451846|FG000|Overall Study|Adverse Event|1|||
161838242|NCT00450619|584451847|FG001|Overall Study|Adverse Event|0|||
161838243|NCT02963311|584451848|FG000|Overall Study|Withdrawal by Subject|1|||
161838244|NCT02963311|584451848|FG000|Overall Study|Screen Failure|4|||
161838245|NCT04442490|584451851|FG000|Overall Study|Withdrawal by Subject|18|||
161838246|NCT04442490|584451852|FG001|Overall Study|Withdrawal by Subject|10|||
161838247|NCT04442490|584451851|FG000|Overall Study|Lost to Follow-up|7|||
161727620|NCT00938327|584045835|FG000|Overall Study|Lost to Follow-up|37|||
161727621|NCT00938327|584045835|FG000|Overall Study|2nd dose received outside of the study|7|||
161727622|NCT00938327|584045835|FG000|Overall Study|Vaccine not received as out of stock|9|||
161727623|NCT01425190|584045836|FG000|Overall Study|Full dose not consumed.|1|||
161727624|NCT01425190|584045837|FG001|Overall Study|Full dose not consumed.|0|||
161727625|NCT01425190|584045838|FG002|Overall Study|Full dose not consumed.|0|||
161727626|NCT02552355|584045840|FG000|Overall Study|Adverse Event|0|||
161727627|NCT02552355|584045841|FG001|Overall Study|Adverse Event|2|||
161727628|NCT02552355|584045842|FG002|Overall Study|Adverse Event|2|||
161727629|NCT02552355|584045843|FG003|Overall Study|Adverse Event|0|||
161727630|NCT02552355|584045840|FG000|Overall Study|Withdrawal by Subject|0|||
161727631|NCT02552355|584045841|FG001|Overall Study|Withdrawal by Subject|0|||
161727632|NCT02552355|584045842|FG002|Overall Study|Withdrawal by Subject|0|||
161727633|NCT02552355|584045843|FG003|Overall Study|Withdrawal by Subject|1|||
161727634|NCT00850460|584045846|FG000|Overall Study|Lost to Follow-up|4|||
161727635|NCT00850460|584045847|FG001|Overall Study|Lost to Follow-up|4|||
161727636|NCT02084134|584045852|FG000|Overall Study|Protocol Violation|4|||
161727637|NCT02084134|584045853|FG001|Overall Study|Protocol Violation|2|||
161727638|NCT02084134|584045852|FG000|Overall Study|Death|0|||
161727639|NCT02084134|584045853|FG001|Overall Study|Death|1|||
161727640|NCT02026271|584045854|FG000|Overall Study|Adverse Event|2|||
161727641|NCT02026271|584045855|FG001|Overall Study|Adverse Event|3|||
161727642|NCT02026271|584045856|FG002|Overall Study|Adverse Event|2|||
161727643|NCT02026271|584045857|FG003|Overall Study|Adverse Event|3|||
161727644|NCT02026271|584045858|FG004|Overall Study|Adverse Event|0|||
161727645|NCT02026271|584045854|FG000|Overall Study|Withdrawal by Subject|0|||
161727646|NCT02026271|584045855|FG001|Overall Study|Withdrawal by Subject|0|||
161727647|NCT02026271|584045856|FG002|Overall Study|Withdrawal by Subject|0|||
161727648|NCT02026271|584045857|FG003|Overall Study|Withdrawal by Subject|0|||
161727649|NCT02026271|584045858|FG004|Overall Study|Withdrawal by Subject|1|||
161727650|NCT04333433|584045859|FG000|Overall Study|Withdrawal by Subject|6|||
161727651|NCT04333433|584045860|FG001|Overall Study|Withdrawal by Subject|3|||
161727652|NCT04333433|584045859|FG000|Overall Study|Death|3|||
161727653|NCT04333433|584045860|FG001|Overall Study|Death|0|||
161727654|NCT04333433|584045859|FG000|Overall Study|Lost to Follow-up|6|||
161727655|NCT04333433|584045860|FG001|Overall Study|Lost to Follow-up|1|||
161727656|NCT04333433|584045859|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
161727657|NCT04333433|584045860|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
161727658|NCT02807454|584045861|FG000|Overall Study|Adverse Event|1|||
161727659|NCT02807454|584045862|FG001|Overall Study|Adverse Event|0|||
161727660|NCT02807454|584045861|FG000|Overall Study|Withdrawal by Subject|0|||
161727661|NCT02807454|584045862|FG001|Overall Study|Withdrawal by Subject|1|||
161727662|NCT02807454|584045861|FG000|Overall Study|Progressive Disease|30|||
161727663|NCT02807454|584045862|FG001|Overall Study|Progressive Disease|3|||
161727664|NCT02807454|584045861|FG000|Overall Study|Other Reasons|1|||
161727665|NCT02807454|584045862|FG001|Overall Study|Other Reasons|1|||
161727666|NCT05468086|584045865|FG000|Overall Study|Withdrawal by Subject|3|||
161727667|NCT05468086|584045865|FG000|Overall Study|Subject was found ineligible after consent|1|||
161727668|NCT01108809|584045866|FG000|Overall Study|Adverse Event|3|||
161727669|NCT01108809|584045866|FG000|Overall Study|Lost to Follow-up|1|||
161727670|NCT00001262|584045872|FG000|Overall Study|Death|10|||
161727671|NCT00001262|584045873|FG001|Overall Study|Death|11|||
161727672|NCT00001262|584045874|FG002|Overall Study|Death|0|||
161727673|NCT00001262|584045872|FG000|Overall Study|Withdrawal by Subject|0|||
161727674|NCT00001262|584045873|FG001|Overall Study|Withdrawal by Subject|3|||
161727675|NCT00001262|584045874|FG002|Overall Study|Withdrawal by Subject|0|||
161838248|NCT04442490|584451852|FG001|Overall Study|Lost to Follow-up|7|||
161727676|NCT00783705|584045875|FG000|Overall Study|Adverse Event|2|||
161727677|NCT00783705|584045876|FG001|Overall Study|Adverse Event|0|||
161727678|NCT00783705|584045875|FG000|Overall Study|Withdrawal by Subject|3|||
161727679|NCT00783705|584045876|FG001|Overall Study|Withdrawal by Subject|2|||
161727680|NCT00783705|584045875|FG000|Overall Study|Lost to Follow-up|1|||
161727681|NCT00783705|584045876|FG001|Overall Study|Lost to Follow-up|3|||
161727682|NCT00748540|584045878|FG000|Overall Study|Physician Decision|1|||
161727683|NCT04743635|584045879|FG000|Overall Study|Lost to Follow-up|2|||
161727684|NCT04743635|584045880|FG001|Overall Study|Lost to Follow-up|0|||
161727685|NCT00804193|584045881|FG000|Overall Study|Lack of baseline fungus|32|||
161727686|NCT00804193|584045882|FG001|Overall Study|Lack of baseline fungus|31|||
161727687|NCT00804193|584045883|FG002|Overall Study|Lack of baseline fungus|19|||
161727688|NCT00804193|584045881|FG000|Overall Study|Adverse Event|0|||
161727689|NCT00804193|584045882|FG001|Overall Study|Adverse Event|0|||
161727690|NCT00804193|584045883|FG002|Overall Study|Adverse Event|2|||
161727691|NCT00804193|584045881|FG000|Overall Study|Lack of Efficacy|1|||
161727692|NCT00804193|584045882|FG001|Overall Study|Lack of Efficacy|1|||
161727693|NCT00804193|584045883|FG002|Overall Study|Lack of Efficacy|3|||
161727694|NCT00804193|584045881|FG000|Overall Study|Protocol Violation|0|||
161727695|NCT00804193|584045882|FG001|Overall Study|Protocol Violation|8|||
161727696|NCT00804193|584045883|FG002|Overall Study|Protocol Violation|2|||
161727697|NCT00804193|584045881|FG000|Overall Study|Lost to Follow-up|3|||
161727698|NCT00804193|584045882|FG001|Overall Study|Lost to Follow-up|3|||
161727699|NCT00804193|584045883|FG002|Overall Study|Lost to Follow-up|4|||
161727700|NCT00804193|584045881|FG000|Overall Study|Withdrawal by Subject|3|||
161727701|NCT00804193|584045882|FG001|Overall Study|Withdrawal by Subject|1|||
161727702|NCT00804193|584045883|FG002|Overall Study|Withdrawal by Subject|2|||
161727703|NCT01193348|584045886|FG000|Screening Period|Screen Failure|5|||
161727704|NCT01193348|584045886|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
161727705|NCT01193348|584045886|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
161727706|NCT01193348|584045886|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
161727707|NCT01193348|584045886|FG000|Extension Treatment Period|Physician Decision|1|||
161727708|NCT01193348|584045886|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
161727709|NCT00968253|584045887|FG000|Overall Study|Death|0|||
161727710|NCT00968253|584045888|FG001|Overall Study|Death|0|||
161727711|NCT00968253|584045889|FG002|Overall Study|Death|2|||
161727712|NCT00968253|584045887|FG000|Overall Study|Withdrawal by Subject|0|||
161727713|NCT00968253|584045888|FG001|Overall Study|Withdrawal by Subject|0|||
161727714|NCT00968253|584045889|FG002|Overall Study|Withdrawal by Subject|1|||
161727715|NCT00968253|584045887|FG000|Overall Study|Disease Progression|0|||
161727716|NCT00968253|584045888|FG001|Overall Study|Disease Progression|3|||
161727717|NCT00968253|584045889|FG002|Overall Study|Disease Progression|3|||
161727718|NCT00968253|584045887|FG000|Overall Study|Adverse Event|0|||
161727719|NCT00968253|584045888|FG001|Overall Study|Adverse Event|0|||
161727720|NCT00968253|584045889|FG002|Overall Study|Adverse Event|1|||
161727721|NCT01402284|584045890|FG000|Overall Study|Withdrawal consent|2|||
161727722|NCT01402284|584045890|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
161727723|NCT01402284|584045890|FG000|Overall Study|Physician Decision|1|||
161727724|NCT01402284|584045890|FG000|Overall Study|Disease progression on study|10|||
161727725|NCT01745393|584045892|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
161727726|NCT01745393|584045893|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
161727727|NCT01745393|584045892|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
161727728|NCT01745393|584045893|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
161727729|NCT01745393|584045892|FG000|12-month Follow-up|Lost to Follow-up|6|||
161727730|NCT01745393|584045893|FG001|12-month Follow-up|Lost to Follow-up|5|||
161727731|NCT00905021|584045898|FG000|Overall Study|Adverse Event|2|||
161727732|NCT02488759|584045900|FG000|Overall Study|Disease progression|73|||
161727733|NCT02488759|584045901|FG001|Overall Study|Disease progression|111|||
161727734|NCT02488759|584045902|FG002|Overall Study|Disease progression|62|||
161727735|NCT02488759|584045903|FG003|Overall Study|Disease progression|7|||
161727736|NCT02488759|584045904|FG004|Overall Study|Disease progression|4|||
161727737|NCT02488759|584045905|FG005|Overall Study|Disease progression|2|||
161727738|NCT02488759|584045900|FG000|Overall Study|Study drug toxicity|11|||
161727739|NCT02488759|584045901|FG001|Overall Study|Study drug toxicity|33|||
161727740|NCT02488759|584045902|FG002|Overall Study|Study drug toxicity|31|||
161727741|NCT02488759|584045903|FG003|Overall Study|Study drug toxicity|0|||
161727742|NCT02488759|584045904|FG004|Overall Study|Study drug toxicity|0|||
161727743|NCT02488759|584045905|FG005|Overall Study|Study drug toxicity|2|||
161727744|NCT02488759|584045900|FG000|Overall Study|Adverse event unrelated to study drug|9|||
161727745|NCT02488759|584045901|FG001|Overall Study|Adverse event unrelated to study drug|11|||
161727746|NCT02488759|584045902|FG002|Overall Study|Adverse event unrelated to study drug|7|||
161727747|NCT02488759|584045903|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161727748|NCT02488759|584045904|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161727749|NCT02488759|584045905|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161727750|NCT02488759|584045900|FG000|Overall Study|Participant request to discontinue study treatment|6|||
161727751|NCT02488759|584045901|FG001|Overall Study|Participant request to discontinue study treatment|8|||
161727752|NCT02488759|584045902|FG002|Overall Study|Participant request to discontinue study treatment|4|||
161727753|NCT02488759|584045903|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161838249|NCT04442490|584451851|FG000|Overall Study|Adverse Event|2|||
161727754|NCT02488759|584045904|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161727755|NCT02488759|584045905|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161727756|NCT02488759|584045900|FG000|Overall Study|Withdrawal by Subject|4|||
161727757|NCT02488759|584045901|FG001|Overall Study|Withdrawal by Subject|0|||
161727758|NCT02488759|584045902|FG002|Overall Study|Withdrawal by Subject|3|||
161727759|NCT02488759|584045903|FG003|Overall Study|Withdrawal by Subject|0|||
161727760|NCT02488759|584045904|FG004|Overall Study|Withdrawal by Subject|0|||
161727761|NCT02488759|584045905|FG005|Overall Study|Withdrawal by Subject|2|||
161727762|NCT02488759|584045900|FG000|Overall Study|Lost to Follow-up|0|||
161727763|NCT02488759|584045901|FG001|Overall Study|Lost to Follow-up|0|||
161727764|NCT02488759|584045902|FG002|Overall Study|Lost to Follow-up|2|||
161727765|NCT02488759|584045903|FG003|Overall Study|Lost to Follow-up|0|||
161727766|NCT02488759|584045904|FG004|Overall Study|Lost to Follow-up|0|||
161727767|NCT02488759|584045905|FG005|Overall Study|Lost to Follow-up|0|||
161727768|NCT02488759|584045900|FG000|Overall Study|Maximum clinical benefit|3|||
161727769|NCT02488759|584045901|FG001|Overall Study|Maximum clinical benefit|0|||
161727770|NCT02488759|584045902|FG002|Overall Study|Maximum clinical benefit|1|||
161727771|NCT02488759|584045903|FG003|Overall Study|Maximum clinical benefit|0|||
161727772|NCT02488759|584045904|FG004|Overall Study|Maximum clinical benefit|0|||
161727773|NCT02488759|584045905|FG005|Overall Study|Maximum clinical benefit|0|||
161727774|NCT02488759|584045900|FG000|Overall Study|Other reasons|7|||
161727775|NCT02488759|584045901|FG001|Overall Study|Other reasons|32|||
161727776|NCT02488759|584045902|FG002|Overall Study|Other reasons|23|||
161727777|NCT02488759|584045903|FG003|Overall Study|Other reasons|1|||
161727778|NCT02488759|584045904|FG004|Overall Study|Other reasons|1|||
161727779|NCT02488759|584045905|FG005|Overall Study|Other reasons|1|||
161727780|NCT03860844|584045906|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
161727781|NCT03860844|584045907|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
161727782|NCT03860844|584045908|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
161727783|NCT03860844|584045906|FG000|Overall Study|Progressive disease|5|||
161727784|NCT03860844|584045907|FG001|Overall Study|Progressive disease|3|||
161727785|NCT03860844|584045908|FG002|Overall Study|Progressive disease|4|||
161727786|NCT03860844|584045906|FG000|Overall Study|Other, Not related to COVID-19|0|||
161727787|NCT03860844|584045907|FG001|Overall Study|Other, Not related to COVID-19|1|||
161727788|NCT03860844|584045908|FG002|Overall Study|Other, Not related to COVID-19|0|||
161727789|NCT01678807|584045911|FG000|Overall Study|Adverse Event|4|||
161727790|NCT01678807|584045912|FG001|Overall Study|Adverse Event|4|||
161727791|NCT01678807|584045913|FG002|Overall Study|Adverse Event|0|||
161727792|NCT01678807|584045911|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
161727793|NCT01678807|584045912|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
161727794|NCT01678807|584045913|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161727795|NCT05281523|584045914|FG000|Overall Study|Adverse Event|1|||
161727796|NCT05281523|584045915|FG001|Overall Study|Adverse Event|1|||
161727797|NCT05281523|584045914|FG000|Overall Study|Physician Decision|1|||
161727798|NCT05281523|584045915|FG001|Overall Study|Physician Decision|1|||
161727799|NCT05281523|584045914|FG000|Overall Study|Withdrawal by Subject|5|||
161727800|NCT05281523|584045915|FG001|Overall Study|Withdrawal by Subject|15|||
161727801|NCT05281523|584045914|FG000|Overall Study|GCP violations|3|||
161727802|NCT05281523|584045915|FG001|Overall Study|GCP violations|4|||
161727803|NCT04038255|584047773|FG000|Overall Study|Lost to Follow-up|0|||
161727804|NCT04038255|584047774|FG001|Overall Study|Lost to Follow-up|9|||
161727805|NCT04038255|584047775|FG002|Overall Study|Lost to Follow-up|5|||
161727806|NCT04038255|584047773|FG000|Overall Study|Withdrawal by Subject|0|||
161727807|NCT04038255|584047774|FG001|Overall Study|Withdrawal by Subject|0|||
161727808|NCT04038255|584047775|FG002|Overall Study|Withdrawal by Subject|1|||
161727809|NCT05183867|584047776|FG000|Overall Study|Withdrawal by Subject|3|||
161727810|NCT05183867|584047777|FG001|Overall Study|Withdrawal by Subject|2|||
161727811|NCT05183867|584047778|FG002|Overall Study|Withdrawal by Subject|0|||
161727812|NCT05306873|584047781|FG000|Stage 2|Study stopped|1|||
161727813|NCT05306873|584047782|FG001|Stage 2|Study stopped|1|||
161727814|NCT05306873|584047783|FG002|Stage 2|Study stopped|0|||
161727815|NCT05306873|584047784|FG003|Stage 2|Study stopped|0|||
161727816|NCT05306873|584047781|FG000|Stage 2|Stage 2 Treatment Failure|2|||
161727817|NCT05306873|584047782|FG001|Stage 2|Stage 2 Treatment Failure|3|||
161727818|NCT05306873|584047783|FG002|Stage 2|Stage 2 Treatment Failure|0|||
161727819|NCT05306873|584047784|FG003|Stage 2|Stage 2 Treatment Failure|0|||
161727820|NCT05306873|584047781|FG000|Stage 2|Logistical issues due to participant moving|1|||
161727821|NCT05306873|584047782|FG001|Stage 2|Logistical issues due to participant moving|0|||
161727822|NCT05306873|584047783|FG002|Stage 2|Logistical issues due to participant moving|0|||
161727823|NCT05306873|584047784|FG003|Stage 2|Logistical issues due to participant moving|0|||
161727824|NCT05306873|584047781|FG000|Stage 3|Stage 3 Treatment Failure|0|||
161727825|NCT05306873|584047782|FG001|Stage 3|Stage 3 Treatment Failure|0|||
161727826|NCT05306873|584047783|FG002|Stage 3|Stage 3 Treatment Failure|0|||
161727827|NCT05306873|584047784|FG003|Stage 3|Stage 3 Treatment Failure|1|||
161727828|NCT05306873|584047781|FG000|Stage 3|Study Stopped|0|||
161727829|NCT05306873|584047782|FG001|Stage 3|Study Stopped|0|||
161727830|NCT05306873|584047783|FG002|Stage 3|Study Stopped|1|||
161727831|NCT05306873|584047784|FG003|Stage 3|Study Stopped|0|||
161727832|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
161727833|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
161727834|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
161727835|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
161838250|NCT04442490|584451852|FG001|Overall Study|Adverse Event|6|||
161838251|NCT04442490|584451851|FG000|Overall Study|Noncompliance|3|||
161838252|NCT04442490|584451852|FG001|Overall Study|Noncompliance|1|||
161727836|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
161727837|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
161727838|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
161727839|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
161727840|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
161727841|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
161727842|NCT02614287|584047785|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
161727843|NCT02614287|584047786|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
161727844|NCT02614287|584047785|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
161727845|NCT02614287|584047786|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
161727846|NCT02614287|584047785|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
161727847|NCT02614287|584047786|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
161727848|NCT00418834|584047787|FG000|Overall Study|Adverse Event|16|||
161727849|NCT00418834|584047788|FG001|Overall Study|Adverse Event|9|||
161727850|NCT00418834|584047787|FG000|Overall Study|Lost to Follow-up|0|||
161727851|NCT00418834|584047788|FG001|Overall Study|Lost to Follow-up|1|||
161727852|NCT00418834|584047787|FG000|Overall Study|Protocol Violation|4|||
161727853|NCT00418834|584047788|FG001|Overall Study|Protocol Violation|3|||
161727854|NCT00418834|584047787|FG000|Overall Study|Withdrawal by Subject|3|||
161727855|NCT00418834|584047788|FG001|Overall Study|Withdrawal by Subject|7|||
161727856|NCT01953328|584047789|FG000|Overall Study|Withdrawal by Subject|0|||
161727857|NCT01953328|584047790|FG001|Overall Study|Withdrawal by Subject|0|||
161727858|NCT01953328|584047791|FG002|Overall Study|Withdrawal by Subject|0|||
161727859|NCT01953328|584047792|FG003|Overall Study|Withdrawal by Subject|0|||
161727860|NCT01953328|584047793|FG004|Overall Study|Withdrawal by Subject|1|||
161727861|NCT01953328|584047794|FG005|Overall Study|Withdrawal by Subject|0|||
161727862|NCT01953328|584047795|FG006|Overall Study|Withdrawal by Subject|0|||
161727863|NCT01953328|584047796|FG007|Overall Study|Withdrawal by Subject|0|||
161727864|NCT01953328|584047789|FG000|Overall Study|Lost to Follow-up|0|||
161727865|NCT01953328|584047790|FG001|Overall Study|Lost to Follow-up|0|||
161727866|NCT01953328|584047791|FG002|Overall Study|Lost to Follow-up|0|||
161727867|NCT01953328|584047792|FG003|Overall Study|Lost to Follow-up|0|||
161727868|NCT01953328|584047793|FG004|Overall Study|Lost to Follow-up|1|||
161727869|NCT01953328|584047794|FG005|Overall Study|Lost to Follow-up|0|||
161727870|NCT01953328|584047795|FG006|Overall Study|Lost to Follow-up|0|||
161727871|NCT01953328|584047796|FG007|Overall Study|Lost to Follow-up|0|||
161727872|NCT01755195|584047799|FG000|Overall Study|Participant noncompliance|2|||
161727873|NCT01755195|584047799|FG000|Overall Study|Switched to alternative treatment|4|||
161727874|NCT01755195|584047799|FG000|Overall Study|Withdrawal by Subject|1|||
161727875|NCT01755195|584047799|FG000|Overall Study|Participant refused to start treatment|1|||
161727876|NCT01755195|584047799|FG000|Overall Study|Participant has been consented for another trial|1|||
161727877|NCT01755195|584047799|FG000|Overall Study|Refused further treatment|3|||
161727878|NCT01755195|584047799|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
161838253|NCT04442490|584451851|FG000|Overall Study|Physician Decision|2|||
161838254|NCT04442490|584451852|FG001|Overall Study|Physician Decision|1|||
161838255|NCT04442490|584451851|FG000|Overall Study|Reason not Specified|2|||
161838256|NCT04442490|584451852|FG001|Overall Study|Reason not Specified|1|||
161838257|NCT04442490|584451851|FG000|Overall Study|Randomized but not Treated|3|||
161838258|NCT04442490|584451852|FG001|Overall Study|Randomized but not Treated|3|||
161838259|NCT00415194|584451857|FG000|Overall Study|Adverse Event|37|||
161838260|NCT00415194|584451858|FG001|Overall Study|Adverse Event|32|||
161838261|NCT00415194|584451857|FG000|Overall Study|Entry Criteria Not Met|4|||
161838262|NCT00415194|584451858|FG001|Overall Study|Entry Criteria Not Met|8|||
161838263|NCT00415194|584451857|FG000|Overall Study|Lost to Follow-up|1|||
161727879|NCT05113953|584047800|FG000|Overall Study|Adverse Event|5|||
161727880|NCT05113953|584047801|FG001|Overall Study|Adverse Event|0|||
161838264|NCT00415194|584451858|FG001|Overall Study|Lost to Follow-up|0|||
161838265|NCT00415194|584451857|FG000|Overall Study|Physician Decision|10|||
161727881|NCT05113953|584047802|FG002|Overall Study|Adverse Event|3|||
161727882|NCT05113953|584047800|FG000|Overall Study|Lost to Follow-up|3|||
161727883|NCT05113953|584047801|FG001|Overall Study|Lost to Follow-up|4|||
161727884|NCT05113953|584047802|FG002|Overall Study|Lost to Follow-up|2|||
161727885|NCT05113953|584047800|FG000|Overall Study|Non-compliance with Study Drug|1|||
161727886|NCT05113953|584047801|FG001|Overall Study|Non-compliance with Study Drug|0|||
161838266|NCT00415194|584451858|FG001|Overall Study|Physician Decision|16|||
161838267|NCT00415194|584451857|FG000|Overall Study|Progressive Disease|180|||
161838268|NCT00415194|584451858|FG001|Overall Study|Progressive Disease|217|||
161838269|NCT00415194|584451857|FG000|Overall Study|Protocol Violation|4|||
161727887|NCT05113953|584047802|FG002|Overall Study|Non-compliance with Study Drug|0|||
161727888|NCT05113953|584047800|FG000|Overall Study|Withdrawal by Subject|2|||
161727889|NCT05113953|584047801|FG001|Overall Study|Withdrawal by Subject|6|||
161727890|NCT05113953|584047802|FG002|Overall Study|Withdrawal by Subject|4|||
161727891|NCT05113953|584047800|FG000|Overall Study|Reason not Specified|2|||
161727892|NCT05113953|584047801|FG001|Overall Study|Reason not Specified|0|||
161727893|NCT05113953|584047802|FG002|Overall Study|Reason not Specified|0|||
161727894|NCT00492856|584047804|FG000|Induction|Adverse Event|2|||
161727895|NCT00492856|584047805|FG001|Induction|Adverse Event|0|||
161727896|NCT00492856|584047806|FG002|Induction|Adverse Event|0|||
161727897|NCT00492856|584047807|FG003|Induction|Adverse Event|0|||
161727898|NCT00492856|584047804|FG000|Induction|Withdrawal by Subject|1|||
161727899|NCT00492856|584047805|FG001|Induction|Withdrawal by Subject|0|||
161727900|NCT00492856|584047806|FG002|Induction|Withdrawal by Subject|0|||
161727901|NCT00492856|584047807|FG003|Induction|Withdrawal by Subject|0|||
161727902|NCT00492856|584047804|FG000|Induction|Death|3|||
161727903|NCT00492856|584047805|FG001|Induction|Death|0|||
161727904|NCT00492856|584047806|FG002|Induction|Death|0|||
161727905|NCT00492856|584047807|FG003|Induction|Death|0|||
161727906|NCT00492856|584047804|FG000|Consolidation|Adverse Event|6|||
161727907|NCT00492856|584047805|FG001|Consolidation|Adverse Event|0|||
161727908|NCT00492856|584047806|FG002|Consolidation|Adverse Event|0|||
161727909|NCT00492856|584047807|FG003|Consolidation|Adverse Event|0|||
161727910|NCT00492856|584047804|FG000|Consolidation|Not protocol specified|2|||
161727911|NCT00492856|584047805|FG001|Consolidation|Not protocol specified|0|||
161838270|NCT00415194|584451858|FG001|Overall Study|Protocol Violation|2|||
161838271|NCT00415194|584451857|FG000|Overall Study|Withdrawal by Subject|28|||
161838272|NCT00415194|584451858|FG001|Overall Study|Withdrawal by Subject|21|||
161838273|NCT00415194|584451857|FG000|Overall Study|Death Due to Study Disease|26|||
161838274|NCT00415194|584451858|FG001|Overall Study|Death Due to Study Disease|29|||
161838275|NCT00415194|584451857|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
161838276|NCT00415194|584451858|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
161838277|NCT00415194|584451857|FG000|Overall Study|Death Due to Procedural Related AE|0|||
161838278|NCT00415194|584451858|FG001|Overall Study|Death Due to Procedural Related AE|1|||
161838279|NCT00415194|584451857|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
161838280|NCT00415194|584451858|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
161838281|NCT01297465|584451859|FG000|Overall Study|Lack of Ovarian Response|1|||
161838282|NCT01297465|584451860|FG001|Overall Study|Lack of Ovarian Response|1|||
161838283|NCT01297465|584451859|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
161838284|NCT01297465|584451860|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161838285|NCT01297465|584451859|FG000|Overall Study|No Oocytes Retrieved|1|||
161838286|NCT01297465|584451860|FG001|Overall Study|No Oocytes Retrieved|1|||
161838287|NCT01297465|584451859|FG000|Overall Study|Poor oocyte quality|0|||
161838288|NCT01297465|584451860|FG001|Overall Study|Poor oocyte quality|1|||
161838289|NCT01297465|584451859|FG000|Overall Study|No Fertilization|6|||
161838290|NCT01297465|584451860|FG001|Overall Study|No Fertilization|4|||
161838291|NCT01297465|584451859|FG000|Overall Study|All Embryos Discarded|0|||
161838292|NCT01297465|584451860|FG001|Overall Study|All Embryos Discarded|1|||
161838293|NCT01297465|584451859|FG000|Overall Study|Intention to Freeze all Embryos|0|||
161838294|NCT01297465|584451860|FG001|Overall Study|Intention to Freeze all Embryos|1|||
161838295|NCT00969540|584451861|FG000|Overall Study|Lost to Follow-up|1|||
161838296|NCT00969540|584451862|FG001|Overall Study|Lost to Follow-up|1|||
161838297|NCT04078126|584451865|FG000|Washout|Study put on hold due to COVID-19|0|||
161838298|NCT04078126|584451866|FG001|Washout|Study put on hold due to COVID-19|2|||
161727912|NCT00492856|584047806|FG002|Consolidation|Not protocol specified|0|||
161727913|NCT00492856|584047807|FG003|Consolidation|Not protocol specified|0|||
161727914|NCT00492856|584047804|FG000|Consolidation|Lost to Follow-up|1|||
161727915|NCT00492856|584047805|FG001|Consolidation|Lost to Follow-up|0|||
161727916|NCT00492856|584047806|FG002|Consolidation|Lost to Follow-up|0|||
161727917|NCT00492856|584047807|FG003|Consolidation|Lost to Follow-up|0|||
161727918|NCT00492856|584047804|FG000|Post-consolidation|Adverse Event|0|||
161727919|NCT00492856|584047805|FG001|Post-consolidation|Adverse Event|4|||
161727920|NCT00492856|584047806|FG002|Post-consolidation|Adverse Event|0|||
161727921|NCT00492856|584047807|FG003|Post-consolidation|Adverse Event|1|||
161727922|NCT00492856|584047804|FG000|Post-consolidation|Withdrawal by Subject|0|||
161727923|NCT00492856|584047805|FG001|Post-consolidation|Withdrawal by Subject|4|||
161838299|NCT04078126|584451865|FG000|Period 2|Study put on hold due to COVID-19|1|||
161727924|NCT00492856|584047806|FG002|Post-consolidation|Withdrawal by Subject|0|||
161727925|NCT00492856|584047807|FG003|Post-consolidation|Withdrawal by Subject|0|||
161727926|NCT00492856|584047804|FG000|Post-consolidation|Death|0|||
161727927|NCT00492856|584047805|FG001|Post-consolidation|Death|1|||
161727928|NCT00492856|584047806|FG002|Post-consolidation|Death|0|||
161727929|NCT00492856|584047807|FG003|Post-consolidation|Death|0|||
161727930|NCT00492856|584047804|FG000|Post-consolidation|Not protocol specified|0|||
161727931|NCT00492856|584047805|FG001|Post-consolidation|Not protocol specified|1|||
161727932|NCT00492856|584047806|FG002|Post-consolidation|Not protocol specified|0|||
161727933|NCT00492856|584047807|FG003|Post-consolidation|Not protocol specified|0|||
161727934|NCT00492856|584047804|FG000|Post-consolidation|Lost to Follow-up|0|||
161727935|NCT00492856|584047805|FG001|Post-consolidation|Lost to Follow-up|2|||
161727936|NCT00492856|584047806|FG002|Post-consolidation|Lost to Follow-up|0|||
161727937|NCT00492856|584047807|FG003|Post-consolidation|Lost to Follow-up|0|||
161727938|NCT00492856|584047804|FG000|Post-consolidation|Observation Arm|0|||
161727939|NCT00492856|584047805|FG001|Post-consolidation|Observation Arm|0|||
161727940|NCT00492856|584047806|FG002|Post-consolidation|Observation Arm|27|||
161727941|NCT00492856|584047807|FG003|Post-consolidation|Observation Arm|0|||
161727942|NCT03987919|584047808|FG000|Overall Study|Adverse Event|1|||
161727943|NCT03987919|584047809|FG001|Overall Study|Adverse Event|4|||
161727944|NCT03987919|584047810|FG002|Overall Study|Adverse Event|1|||
161727945|NCT03987919|584047811|FG003|Overall Study|Adverse Event|3|||
161727946|NCT03987919|584047808|FG000|Overall Study|Death|4|||
161727947|NCT03987919|584047809|FG001|Overall Study|Death|4|||
161727948|NCT03987919|584047810|FG002|Overall Study|Death|4|||
161727949|NCT03987919|584047811|FG003|Overall Study|Death|1|||
161727950|NCT03987919|584047808|FG000|Overall Study|Lost to Follow-up|5|||
161727951|NCT03987919|584047809|FG001|Overall Study|Lost to Follow-up|6|||
161727952|NCT03987919|584047810|FG002|Overall Study|Lost to Follow-up|8|||
161727953|NCT03987919|584047811|FG003|Overall Study|Lost to Follow-up|12|||
161727954|NCT03987919|584047808|FG000|Overall Study|Physician Decision|0|||
161727955|NCT03987919|584047809|FG001|Overall Study|Physician Decision|2|||
161727956|NCT03987919|584047810|FG002|Overall Study|Physician Decision|0|||
161727957|NCT03987919|584047811|FG003|Overall Study|Physician Decision|4|||
161727958|NCT03987919|584047808|FG000|Overall Study|Pregnancy|1|||
161727959|NCT03987919|584047809|FG001|Overall Study|Pregnancy|0|||
161727960|NCT03987919|584047810|FG002|Overall Study|Pregnancy|1|||
161727961|NCT03987919|584047811|FG003|Overall Study|Pregnancy|1|||
161727962|NCT03987919|584047808|FG000|Overall Study|Protocol Violation|0|||
161727963|NCT03987919|584047809|FG001|Overall Study|Protocol Violation|1|||
161727964|NCT03987919|584047810|FG002|Overall Study|Protocol Violation|0|||
161727965|NCT03987919|584047811|FG003|Overall Study|Protocol Violation|0|||
161727966|NCT03987919|584047808|FG000|Overall Study|Site terminated by Sponsor|0|||
161727967|NCT03987919|584047809|FG001|Overall Study|Site terminated by Sponsor|0|||
161727968|NCT03987919|584047810|FG002|Overall Study|Site terminated by Sponsor|0|||
161727969|NCT03987919|584047811|FG003|Overall Study|Site terminated by Sponsor|1|||
161727970|NCT03987919|584047808|FG000|Overall Study|Withdrawal by Subject|7|||
161727971|NCT03987919|584047809|FG001|Overall Study|Withdrawal by Subject|7|||
161727972|NCT03987919|584047810|FG002|Overall Study|Withdrawal by Subject|8|||
161727973|NCT03987919|584047811|FG003|Overall Study|Withdrawal by Subject|4|||
161727974|NCT03987919|584047808|FG000|Overall Study|Other - as reported by the investigator|1|||
161727975|NCT03987919|584047809|FG001|Overall Study|Other - as reported by the investigator|3|||
161727976|NCT03987919|584047810|FG002|Overall Study|Other - as reported by the investigator|2|||
161727977|NCT03987919|584047811|FG003|Overall Study|Other - as reported by the investigator|0|||
161727978|NCT03470922|584047817|FG000|Overall Study|Death|107|||
161727979|NCT03470922|584047818|FG001|Overall Study|Death|118|||
161727980|NCT03470922|584047817|FG000|Overall Study|Lost to Follow-up|5|||
161727981|NCT03470922|584047818|FG001|Overall Study|Lost to Follow-up|5|||
161727982|NCT03470922|584047817|FG000|Overall Study|Participant Withdrew Consent|4|||
161727983|NCT03470922|584047818|FG001|Overall Study|Participant Withdrew Consent|9|||
161727984|NCT03470922|584047817|FG000|Overall Study|Other reasons|1|||
161727985|NCT03470922|584047818|FG001|Overall Study|Other reasons|0|||
161727986|NCT03470922|584047817|FG000|Overall Study|Not reported|1|||
161727987|NCT03470922|584047818|FG001|Overall Study|Not reported|0|||
161727988|NCT02340819|584047819|FG000|Overall Study|Adverse Event|1|||
161727989|NCT02340819|584047819|FG000|Overall Study|Withdrawal by Subject|2|||
161727990|NCT02340819|584047819|FG000|Overall Study|Discontinued with other reason|1|||
161727991|NCT02626819|584047820|FG000|Overall Study|Lost to Follow-up|3|||
161727992|NCT02626819|584047821|FG001|Overall Study|Lost to Follow-up|2|||
161727993|NCT02626819|584047820|FG000|Overall Study|Withdrawal by Subject|1|||
161727994|NCT02626819|584047821|FG001|Overall Study|Withdrawal by Subject|0|||
161727995|NCT02626819|584047820|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
161727996|NCT02626819|584047821|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
161727997|NCT02361762|584047822|FG000|Overall Study|Withdrawal by Subject|0|||
161727998|NCT02361762|584047823|FG001|Overall Study|Withdrawal by Subject|1|||
161838300|NCT04078126|584451866|FG001|Period 2|Study put on hold due to COVID-19|1|||
161838301|NCT02149108|584451869|FG000|Overall Study|Not treated|1|||
161838302|NCT02149108|584451870|FG001|Overall Study|Not treated|2|||
161838303|NCT02149108|584451869|FG000|Overall Study|Progressive Disease (PD)|324|||
161838304|NCT02149108|584451870|FG001|Overall Study|Progressive Disease (PD)|318|||
161838305|NCT02149108|584451869|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
161838306|NCT02149108|584451870|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
161838307|NCT02149108|584451869|FG000|Overall Study|Other Adverse Event (AE)|8|||
161838308|NCT02149108|584451870|FG001|Overall Study|Other Adverse Event (AE)|18|||
161838309|NCT02149108|584451869|FG000|Overall Study|Other not defined above|0|||
161838310|NCT02149108|584451870|FG001|Overall Study|Other not defined above|2|||
161838311|NCT02149108|584451869|FG000|Overall Study|Refusal to continue trial medication|15|||
161838312|NCT02149108|584451870|FG001|Overall Study|Refusal to continue trial medication|11|||
161838313|NCT02149108|584451869|FG000|Overall Study|Lost to Follow-up|1|||
161838314|NCT02149108|584451870|FG001|Overall Study|Lost to Follow-up|0|||
161838315|NCT00950963|584451871|FG000|Overall Study|Lost to Follow-up|29|||
161838316|NCT00950963|584451872|FG001|Overall Study|Lost to Follow-up|24|||
161838317|NCT01675661|584451873|FG000|Overall Study|Lost to Follow-up|22|||
161838318|NCT01675661|584451874|FG001|Overall Study|Lost to Follow-up|23|||
161838319|NCT01675661|584451873|FG000|Overall Study|Practical problems|9|||
161838320|NCT01675661|584451874|FG001|Overall Study|Practical problems|5|||
161838321|NCT01675661|584451873|FG000|Overall Study|Moved away|5|||
161838322|NCT01675661|584451874|FG001|Overall Study|Moved away|6|||
161838323|NCT01675661|584451873|FG000|Overall Study|Withdrawal by Subject|3|||
161838324|NCT01675661|584451874|FG001|Overall Study|Withdrawal by Subject|7|||
161838325|NCT01675661|584451873|FG000|Overall Study|Physician Decision|0|||
161838326|NCT01675661|584451874|FG001|Overall Study|Physician Decision|2|||
161838327|NCT01675661|584451873|FG000|Overall Study|Death|0|||
161838328|NCT01675661|584451874|FG001|Overall Study|Death|1|||
161838329|NCT01675661|584451873|FG000|Overall Study|Other reason|1|||
161838330|NCT01675661|584451874|FG001|Overall Study|Other reason|2|||
161838331|NCT00987389|584451875|FG000|Overall Study|Ineligible|0|||
161727999|NCT02361762|584047822|FG000|Overall Study|Lost to Follow-up|0|||
161728000|NCT02361762|584047823|FG001|Overall Study|Lost to Follow-up|1|||
161728001|NCT00502307|584047824|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
161728002|NCT00502307|584047825|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
161728003|NCT00502307|584047826|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
161728004|NCT00502307|584047824|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
161728005|NCT00502307|584047825|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
161728006|NCT00502307|584047826|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
161728007|NCT00502307|584047824|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
161728008|NCT00502307|584047825|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
161728009|NCT00502307|584047826|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
161728010|NCT00502307|584047824|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
161728011|NCT00502307|584047825|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
161728012|NCT00502307|584047826|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
161728013|NCT00502307|584047824|FG000|Maintenance Period|Progressive disease|80|||
161728014|NCT00502307|584047825|FG001|Maintenance Period|Progressive disease|0|||
161728015|NCT00502307|584047826|FG002|Maintenance Period|Progressive disease|0|||
161728016|NCT00502307|584047824|FG000|Maintenance Period|Discontinued due to other reasons|68|||
161728017|NCT00502307|584047825|FG001|Maintenance Period|Discontinued due to other reasons|0|||
161728018|NCT00502307|584047826|FG002|Maintenance Period|Discontinued due to other reasons|0|||
161728019|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
161728020|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
161728021|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
161838332|NCT00987389|584451876|FG001|Overall Study|Ineligible|3|||
161838333|NCT00987389|584451877|FG002|Overall Study|Ineligible|0|||
161838334|NCT00987389|584451878|FG003|Overall Study|Ineligible|0|||
161838335|NCT00987389|584451875|FG000|Overall Study|Lost to Follow-up|4|||
161838336|NCT00987389|584451876|FG001|Overall Study|Lost to Follow-up|1|||
161838337|NCT00987389|584451877|FG002|Overall Study|Lost to Follow-up|3|||
161838338|NCT00987389|584451878|FG003|Overall Study|Lost to Follow-up|1|||
161728022|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
161728023|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
161728024|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
161838339|NCT00987389|584451875|FG000|Overall Study|Withdrawal by Subject|4|||
161838340|NCT00987389|584451876|FG001|Overall Study|Withdrawal by Subject|3|||
161838341|NCT00987389|584451877|FG002|Overall Study|Withdrawal by Subject|2|||
161838342|NCT00987389|584451878|FG003|Overall Study|Withdrawal by Subject|1|||
161838343|NCT00987389|584451875|FG000|Overall Study|Withdrawn from Treatment|0|||
161838344|NCT00987389|584451876|FG001|Overall Study|Withdrawn from Treatment|1|||
161728025|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
161728026|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161728027|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
161728028|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
161728029|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
161728030|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161728031|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
161728032|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
161728033|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
161728034|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
161728035|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
161728036|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
161728037|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
161728038|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
161728039|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
161728040|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161728041|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161728042|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161728043|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
161728044|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
161728045|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
161728046|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
161728047|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161728048|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161728049|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161728050|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
161728051|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161728052|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161728053|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161728054|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
161728055|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161728056|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161728057|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161728058|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
161728059|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Death|0|||
161728060|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Death|0|||
161728061|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Death|0|||
161728062|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Death|2|||
161728063|NCT03331666|584047831|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
161728064|NCT03331666|584047832|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
161728065|NCT00434512|584047833|FG000|Overall Study|Migrated/moved from study area|0|||
161728066|NCT00434512|584047834|FG001|Overall Study|Migrated/moved from study area|0|||
161728067|NCT00434512|584047835|FG002|Overall Study|Migrated/moved from study area|0|||
161728068|NCT00434512|584047836|FG003|Overall Study|Migrated/moved from study area|1|||
161728069|NCT00434512|584047837|FG004|Overall Study|Migrated/moved from study area|1|||
161728070|NCT00434512|584047838|FG005|Overall Study|Migrated/moved from study area|1|||
161728071|NCT00434512|584047833|FG000|Overall Study|Other|0|||
161728072|NCT00434512|584047834|FG001|Overall Study|Other|1|||
161728073|NCT00434512|584047835|FG002|Overall Study|Other|0|||
161728074|NCT00434512|584047836|FG003|Overall Study|Other|0|||
161728075|NCT00434512|584047837|FG004|Overall Study|Other|0|||
161728076|NCT00434512|584047838|FG005|Overall Study|Other|0|||
161728077|NCT02750813|584047841|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
161728078|NCT02750813|584047842|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
161728079|NCT02750813|584047841|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
161728080|NCT02750813|584047842|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
161728081|NCT00441441|584047843|FG000|Overall Study|Adverse Event|2|||
161728082|NCT00441441|584047844|FG001|Overall Study|Adverse Event|1|||
161728083|NCT00441441|584047843|FG000|Overall Study|Protocol Violation|4|||
161728084|NCT00441441|584047844|FG001|Overall Study|Protocol Violation|6|||
161728085|NCT00441441|584047843|FG000|Overall Study|Exacerbation of asthma|1|||
161728086|NCT00441441|584047844|FG001|Overall Study|Exacerbation of asthma|2|||
161728087|NCT00441441|584047843|FG000|Overall Study|Withdrawal by Subject|1|||
161728088|NCT00441441|584047844|FG001|Overall Study|Withdrawal by Subject|2|||
161728089|NCT00441441|584047843|FG000|Overall Study|Other|3|||
161728090|NCT00441441|584047844|FG001|Overall Study|Other|3|||
161728091|NCT03165721|584047855|FG000|Overall Study|Refused further treatment|3|||
161728092|NCT03165721|584047856|FG001|Overall Study|Refused further treatment|0|||
161728093|NCT03165721|584047857|FG002|Overall Study|Refused further treatment|0|||
161728094|NCT03165721|584047855|FG000|Overall Study|Physician Decision|1|||
161728095|NCT03165721|584047856|FG001|Overall Study|Physician Decision|0|||
161728096|NCT03165721|584047857|FG002|Overall Study|Physician Decision|0|||
161728097|NCT02324842|584047859|FG000|Overall Study|Lost to Follow-up|1|||
161728098|NCT02324842|584047860|FG001|Overall Study|Lost to Follow-up|1|||
161728099|NCT02324842|584047861|FG002|Overall Study|Lost to Follow-up|2|||
161728100|NCT03298412|584047862|FG000|Run-in Period|Other, Not Specified|1|||
161728101|NCT03298412|584047862|FG000|Run-in Period|Disease Progression|1|||
161728102|NCT03298412|584047862|FG000|Run-in Period|Ineligibility Determined|1|||
161728103|NCT03298412|584047862|FG000|Run-in Period|Decision by Sponsor|6|||
161728104|NCT01202227|584047865|FG000|Overall Study|Adverse Event|16|||
161728105|NCT01202227|584047865|FG000|Overall Study|Withdrawal by Subject|2|||
161728106|NCT01202227|584047865|FG000|Overall Study|Lack of Efficacy|1|||
161728107|NCT01894477|584047866|FG000|Overall Study|Protocol Violation|0|||
161728108|NCT01894477|584047867|FG001|Overall Study|Protocol Violation|1|||
161728109|NCT01894477|584047866|FG000|Overall Study|protocol changed due SC changed to cord|0|||
161728110|NCT01894477|584047867|FG001|Overall Study|protocol changed due SC changed to cord|1|||
161728111|NCT01533935|584047868|FG000|Overall Study|Adverse Event|5|||
161728112|NCT01533935|584047869|FG001|Overall Study|Adverse Event|7|||
161728113|NCT01533935|584047870|FG002|Overall Study|Adverse Event|1|||
161728114|NCT01533935|584047871|FG003|Overall Study|Adverse Event|5|||
161728115|NCT01533935|584047872|FG004|Overall Study|Adverse Event|3|||
161728116|NCT01533935|584047868|FG000|Overall Study|Protocol Violation|0|||
161728117|NCT01533935|584047869|FG001|Overall Study|Protocol Violation|2|||
161728118|NCT01533935|584047870|FG002|Overall Study|Protocol Violation|0|||
161728119|NCT01533935|584047871|FG003|Overall Study|Protocol Violation|0|||
161728120|NCT01533935|584047872|FG004|Overall Study|Protocol Violation|0|||
161728121|NCT01533935|584047868|FG000|Overall Study|Lost to Follow-up|0|||
161728122|NCT01533935|584047869|FG001|Overall Study|Lost to Follow-up|0|||
161728123|NCT01533935|584047870|FG002|Overall Study|Lost to Follow-up|1|||
161728124|NCT01533935|584047871|FG003|Overall Study|Lost to Follow-up|0|||
161728125|NCT01533935|584047872|FG004|Overall Study|Lost to Follow-up|0|||
161728126|NCT01533935|584047868|FG000|Overall Study|Withdrawal by Subject|0|||
161728127|NCT01533935|584047869|FG001|Overall Study|Withdrawal by Subject|4|||
161728128|NCT01533935|584047870|FG002|Overall Study|Withdrawal by Subject|5|||
161728129|NCT01533935|584047871|FG003|Overall Study|Withdrawal by Subject|2|||
161728130|NCT01533935|584047872|FG004|Overall Study|Withdrawal by Subject|4|||
161728131|NCT01533935|584047868|FG000|Overall Study|Other reason not defined above|1|||
161728132|NCT01533935|584047869|FG001|Overall Study|Other reason not defined above|0|||
161728133|NCT01533935|584047870|FG002|Overall Study|Other reason not defined above|1|||
161728134|NCT01533935|584047871|FG003|Overall Study|Other reason not defined above|0|||
161728135|NCT01533935|584047872|FG004|Overall Study|Other reason not defined above|1|||
161728136|NCT01554956|584047875|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
161728137|NCT01554956|584047876|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
161728138|NCT01554956|584047877|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
161728139|NCT01554956|584047875|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
161728140|NCT01554956|584047876|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
161728141|NCT01554956|584047877|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
161728142|NCT01554956|584047875|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
161728143|NCT01554956|584047876|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
161728144|NCT01554956|584047877|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
161728145|NCT00069095|584047878|FG000|Primary Treatment Phase|Ongoing|0|||
161728146|NCT00069095|584047879|FG001|Primary Treatment Phase|Ongoing|0|||
161728147|NCT00069095|584047880|FG002|Primary Treatment Phase|Ongoing|5|||
161728148|NCT00069095|584047881|FG003|Primary Treatment Phase|Ongoing|7|||
161728149|NCT00069095|584047882|FG004|Primary Treatment Phase|Ongoing|7|||
161728150|NCT00069095|584047883|FG005|Primary Treatment Phase|Ongoing|4|||
161728151|NCT00069095|584047878|FG000|Primary Treatment Phase|Admin/Other|29|||
161728152|NCT00069095|584047879|FG001|Primary Treatment Phase|Admin/Other|38|||
161728153|NCT00069095|584047880|FG002|Primary Treatment Phase|Admin/Other|31|||
161728154|NCT00069095|584047881|FG003|Primary Treatment Phase|Admin/Other|45|||
161728155|NCT00069095|584047882|FG004|Primary Treatment Phase|Admin/Other|48|||
161728156|NCT00069095|584047883|FG005|Primary Treatment Phase|Admin/Other|42|||
161728157|NCT00069095|584047878|FG000|Primary Treatment Phase|Adverse Event|99|||
161728158|NCT00069095|584047879|FG001|Primary Treatment Phase|Adverse Event|92|||
161728159|NCT00069095|584047880|FG002|Primary Treatment Phase|Adverse Event|71|||
161728160|NCT00069095|584047881|FG003|Primary Treatment Phase|Adverse Event|72|||
161728161|NCT00069095|584047882|FG004|Primary Treatment Phase|Adverse Event|109|||
161728162|NCT00069095|584047883|FG005|Primary Treatment Phase|Adverse Event|101|||
161728163|NCT00069095|584047878|FG000|Primary Treatment Phase|Death|14|||
161728164|NCT00069095|584047879|FG001|Primary Treatment Phase|Death|8|||
161728165|NCT00069095|584047880|FG002|Primary Treatment Phase|Death|2|||
161728166|NCT00069095|584047881|FG003|Primary Treatment Phase|Death|5|||
161728167|NCT00069095|584047882|FG004|Primary Treatment Phase|Death|8|||
161728168|NCT00069095|584047883|FG005|Primary Treatment Phase|Death|8|||
161728169|NCT00069095|584047878|FG000|Primary Treatment Phase|Failure to return|5|||
161728170|NCT00069095|584047879|FG001|Primary Treatment Phase|Failure to return|5|||
161728171|NCT00069095|584047880|FG002|Primary Treatment Phase|Failure to return|0|||
161728172|NCT00069095|584047881|FG003|Primary Treatment Phase|Failure to return|0|||
161728173|NCT00069095|584047882|FG004|Primary Treatment Phase|Failure to return|0|||
161728174|NCT00069095|584047883|FG005|Primary Treatment Phase|Failure to return|2|||
161728175|NCT00069095|584047878|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
161728176|NCT00069095|584047879|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
161728177|NCT00069095|584047880|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
161728178|NCT00069095|584047881|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
161728179|NCT00069095|584047882|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
161728180|NCT00069095|584047883|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
161728181|NCT00069095|584047878|FG000|Primary Treatment Phase|Refused treatment|15|||
161728182|NCT00069095|584047879|FG001|Primary Treatment Phase|Refused treatment|26|||
161728183|NCT00069095|584047880|FG002|Primary Treatment Phase|Refused treatment|17|||
161728184|NCT00069095|584047881|FG003|Primary Treatment Phase|Refused treatment|31|||
161728185|NCT00069095|584047882|FG004|Primary Treatment Phase|Refused treatment|24|||
161728186|NCT00069095|584047883|FG005|Primary Treatment Phase|Refused treatment|27|||
161728187|NCT00069095|584047878|FG000|Primary Treatment Phase|Withdrew|2|||
161728188|NCT00069095|584047879|FG001|Primary Treatment Phase|Withdrew|3|||
161728189|NCT00069095|584047880|FG002|Primary Treatment Phase|Withdrew|8|||
161728190|NCT00069095|584047881|FG003|Primary Treatment Phase|Withdrew|2|||
161728191|NCT00069095|584047882|FG004|Primary Treatment Phase|Withdrew|4|||
161728192|NCT00069095|584047883|FG005|Primary Treatment Phase|Withdrew|9|||
161728193|NCT00069095|584047878|FG000|Primary Treatment Phase|Other Violation|0|||
161728194|NCT00069095|584047879|FG001|Primary Treatment Phase|Other Violation|1|||
161728195|NCT00069095|584047880|FG002|Primary Treatment Phase|Other Violation|1|||
161728196|NCT00069095|584047881|FG003|Primary Treatment Phase|Other Violation|1|||
161728197|NCT00069095|584047882|FG004|Primary Treatment Phase|Other Violation|0|||
161728198|NCT00069095|584047883|FG005|Primary Treatment Phase|Other Violation|1|||
161728199|NCT00069095|584047878|FG000|Primary Treatment Phase|Violation criteria|0|||
161728200|NCT00069095|584047879|FG001|Primary Treatment Phase|Violation criteria|2|||
161728201|NCT00069095|584047880|FG002|Primary Treatment Phase|Violation criteria|4|||
161728202|NCT00069095|584047881|FG003|Primary Treatment Phase|Violation criteria|3|||
161728203|NCT00069095|584047882|FG004|Primary Treatment Phase|Violation criteria|1|||
161728204|NCT00069095|584047883|FG005|Primary Treatment Phase|Violation criteria|5|||
161728205|NCT00069095|584047878|FG000|Post-study Treatment Phase|Missing reason|1|||
161728206|NCT00069095|584047879|FG001|Post-study Treatment Phase|Missing reason|3|||
161728207|NCT00069095|584047880|FG002|Post-study Treatment Phase|Missing reason|12|||
161728208|NCT00069095|584047881|FG003|Post-study Treatment Phase|Missing reason|8|||
161728209|NCT00069095|584047882|FG004|Post-study Treatment Phase|Missing reason|18|||
161728210|NCT00069095|584047883|FG005|Post-study Treatment Phase|Missing reason|17|||
161728211|NCT00069095|584047878|FG000|Post-study Treatment Phase|Adverse Event|2|||
161728212|NCT00069095|584047879|FG001|Post-study Treatment Phase|Adverse Event|3|||
161728213|NCT00069095|584047880|FG002|Post-study Treatment Phase|Adverse Event|1|||
161728214|NCT00069095|584047881|FG003|Post-study Treatment Phase|Adverse Event|0|||
161728215|NCT00069095|584047882|FG004|Post-study Treatment Phase|Adverse Event|5|||
161728216|NCT00069095|584047883|FG005|Post-study Treatment Phase|Adverse Event|1|||
161728217|NCT00069095|584047878|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
161728218|NCT00069095|584047879|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
161728219|NCT00069095|584047880|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
161728220|NCT00069095|584047881|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
161728221|NCT00069095|584047882|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
161728222|NCT00069095|584047883|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
161728223|NCT00069095|584047878|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
161728224|NCT00069095|584047879|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
161728225|NCT00069095|584047880|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
161728226|NCT00069095|584047881|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
161728227|NCT00069095|584047882|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
161728228|NCT00069095|584047883|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
161728229|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
161838345|NCT00987389|584451877|FG002|Overall Study|Withdrawn from Treatment|0|||
161838346|NCT00987389|584451878|FG003|Overall Study|Withdrawn from Treatment|0|||
161838347|NCT00987389|584451875|FG000|Overall Study|Multiple different reasons|1|||
161838348|NCT00987389|584451876|FG001|Overall Study|Multiple different reasons|0|||
161838349|NCT00987389|584451877|FG002|Overall Study|Multiple different reasons|3|||
161838350|NCT00987389|584451878|FG003|Overall Study|Multiple different reasons|1|||
161838351|NCT02992418|584451881|FG000|Overall Study|Withdrawal by Subject|11|||
161838352|NCT02992418|584451882|FG001|Overall Study|Withdrawal by Subject|12|||
161838353|NCT02992418|584451881|FG000|Overall Study|Non-compliance with the protocol|308|||
161838354|NCT02992418|584451882|FG001|Overall Study|Non-compliance with the protocol|308|||
161838355|NCT02992418|584451881|FG000|Overall Study|Lost to Follow-up|27|||
161838356|NCT02992418|584451882|FG001|Overall Study|Lost to Follow-up|22|||
161838357|NCT00289536|584451883|FG000|Period 3|Lost to Follow-up|0|||
161838358|NCT00289536|584451884|FG001|Period 3|Lost to Follow-up|0|||
161838359|NCT00289536|584451885|FG002|Period 3|Lost to Follow-up|1|||
161838360|NCT01974440|584451886|FG000|Overall Study|Lost to Follow-up|7|||
161838361|NCT01974440|584451887|FG001|Overall Study|Lost to Follow-up|7|||
161838362|NCT01974440|584451886|FG000|Overall Study|Withdrawal by Subject|24|||
161838363|NCT01974440|584451887|FG001|Overall Study|Withdrawal by Subject|20|||
161838364|NCT01974440|584451886|FG000|Overall Study|Sponsor decision|109|||
161838365|NCT01974440|584451887|FG001|Overall Study|Sponsor decision|110|||
161838366|NCT02749292|584451890|FG000|Overall Study|Physician Decision|1|||
161838367|NCT02749292|584451891|FG001|Overall Study|Physician Decision|0|||
161838368|NCT02749292|584451890|FG000|Overall Study|Withdrawal by Subject|5|||
161838369|NCT02749292|584451891|FG001|Overall Study|Withdrawal by Subject|7|||
161838370|NCT02749292|584451890|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
161838371|NCT02749292|584451891|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
161838372|NCT02749292|584451890|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
161838373|NCT02749292|584451891|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
161838374|NCT02749292|584451890|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
161838375|NCT02749292|584451891|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
161838376|NCT02749292|584451890|FG000|Overall Study|Adverse Event|4|||
161838377|NCT02749292|584451891|FG001|Overall Study|Adverse Event|1|||
161838378|NCT02749292|584451890|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
161838379|NCT02749292|584451891|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
161838380|NCT02749292|584451890|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
161838381|NCT02749292|584451891|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
161838382|NCT02749292|584451890|FG000|Overall Study|Requiring glucocorticoids|0|||
161838383|NCT02749292|584451891|FG001|Overall Study|Requiring glucocorticoids|3|||
161838384|NCT02749292|584451890|FG000|Overall Study|Cancer|1|||
161838385|NCT02749292|584451891|FG001|Overall Study|Cancer|0|||
161838386|NCT00251641|584451892|FG000|Overall Study|Adverse Event|80|||
161838387|NCT00251641|584451893|FG001|Overall Study|Adverse Event|8|||
161838388|NCT00251641|584451892|FG000|Overall Study|Lack of Efficacy|2|||
161838389|NCT00251641|584451893|FG001|Overall Study|Lack of Efficacy|1|||
161838390|NCT00251641|584451892|FG000|Overall Study|Progression of Disease|0|||
161838391|NCT00251641|584451893|FG001|Overall Study|Progression of Disease|2|||
161838392|NCT00251641|584451892|FG000|Overall Study|Lost to Follow-up|3|||
161838393|NCT00251641|584451893|FG001|Overall Study|Lost to Follow-up|3|||
161838394|NCT00251641|584451892|FG000|Overall Study|Withdrawal by Subject|6|||
161838395|NCT00251641|584451893|FG001|Overall Study|Withdrawal by Subject|8|||
161838396|NCT00251641|584451892|FG000|Overall Study|Protocol Violation|10|||
161838397|NCT00251641|584451893|FG001|Overall Study|Protocol Violation|2|||
161838398|NCT00251641|584451892|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
161838399|NCT00251641|584451893|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
161838400|NCT00251641|584451892|FG000|Overall Study|Switched Treatment|9|||
161838401|NCT00251641|584451893|FG001|Overall Study|Switched Treatment|63|||
161838402|NCT00876018|584451894|FG000|Overall Study|Lost to Follow-up|0|||
161838403|NCT00876018|584451895|FG001|Overall Study|Lost to Follow-up|1|||
161838404|NCT00876018|584451896|FG002|Overall Study|Lost to Follow-up|1|||
161838405|NCT00876018|584451894|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
161838406|NCT00876018|584451895|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
161838407|NCT00876018|584451896|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
161838408|NCT01000493|584451899|FG000|Overall Study|Adverse Event|3|||
161838409|NCT01000493|584451900|FG001|Overall Study|Adverse Event|6|||
161838410|NCT01000493|584451899|FG000|Overall Study|Lack of Efficacy|1|||
161838411|NCT01000493|584451900|FG001|Overall Study|Lack of Efficacy|1|||
161838412|NCT01000493|584451899|FG000|Overall Study|Protocol Violation|1|||
161838413|NCT01000493|584451900|FG001|Overall Study|Protocol Violation|8|||
161838414|NCT01000493|584451899|FG000|Overall Study|Study closed/terminated|25|||
161838415|NCT01000493|584451900|FG001|Overall Study|Study closed/terminated|23|||
161838416|NCT01000493|584451899|FG000|Overall Study|Lost to Follow-up|5|||
161838417|NCT01000493|584451900|FG001|Overall Study|Lost to Follow-up|9|||
161838418|NCT01000493|584451899|FG000|Overall Study|Physician Decision|1|||
161838419|NCT01000493|584451900|FG001|Overall Study|Physician Decision|1|||
161838420|NCT01000493|584451899|FG000|Overall Study|Withdrawal by Subject|3|||
161838421|NCT01000493|584451900|FG001|Overall Study|Withdrawal by Subject|7|||
161838422|NCT03629028|584451901|FG000|Overall Study|Lost to Follow-up|26|||
161838423|NCT03629028|584451902|FG001|Overall Study|Lost to Follow-up|23|||
161838424|NCT03629028|584451901|FG000|Overall Study|Pregnancy|4|||
161838425|NCT03629028|584451902|FG001|Overall Study|Pregnancy|2|||
161838426|NCT03629028|584451901|FG000|Overall Study|intolerance to examination|2|||
161838427|NCT03629028|584451902|FG001|Overall Study|intolerance to examination|0|||
161838428|NCT03828448|584451904|FG000|Overall Study|Sponsor's Discretion|34|||
161838429|NCT02192164|584451910|FG000|Overall Study|Other|8|||
161838430|NCT02192164|584451910|FG000|Overall Study|Withdrawal by Subject|1|||
161838431|NCT02192164|584451910|FG000|Overall Study|Physician Decision|4|||
161838432|NCT02192164|584451910|FG000|Overall Study|Did not meet the exclusion criteria|1|||
161838433|NCT03123861|584451911|FG000|Overall Study|Protocol Violation|1|||
161838434|NCT03123861|584451912|FG001|Overall Study|Protocol Violation|1|||
161838435|NCT03123861|584451911|FG000|Overall Study|Withdrawal by Subject|2|||
161838436|NCT03123861|584451912|FG001|Overall Study|Withdrawal by Subject|2|||
161838437|NCT05069155|584451913|FG000|Overall Study|Withdrawal by Subject|1|||
161838438|NCT05069155|584451914|FG001|Overall Study|Withdrawal by Subject|3|||
161838439|NCT01929031|584451915|FG000|Overall Study|Adverse Event|3|||
161838440|NCT01929031|584451916|FG001|Overall Study|Adverse Event|1|||
161838441|NCT01929031|584451917|FG002|Overall Study|Adverse Event|1|||
161838442|NCT01929031|584451918|FG003|Overall Study|Adverse Event|0|||
161838443|NCT01929031|584451919|FG004|Overall Study|Adverse Event|0|||
161838444|NCT01929031|584451920|FG005|Overall Study|Adverse Event|0|||
161838445|NCT01929031|584451915|FG000|Overall Study|Protocol Violation|1|||
161838446|NCT01929031|584451916|FG001|Overall Study|Protocol Violation|0|||
161728230|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728231|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728232|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728233|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728234|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
161728235|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant had complete response|1|||
161728236|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant had complete response|1|||
161728237|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant had complete response|0|||
161728238|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant had complete response|0|||
161728239|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant had complete response|0|||
161728240|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant had complete response|0|||
161728241|NCT00069095|584047878|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728242|NCT00069095|584047879|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
161728243|NCT00069095|584047880|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728244|NCT00069095|584047881|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728245|NCT00069095|584047882|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728246|NCT00069095|584047883|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728247|NCT00069095|584047878|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161728248|NCT00069095|584047879|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161728249|NCT00069095|584047880|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161728250|NCT00069095|584047881|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161728251|NCT00069095|584047882|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161728252|NCT00069095|584047883|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161728253|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
161728254|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
161838447|NCT01929031|584451917|FG002|Overall Study|Protocol Violation|0|||
161838448|NCT01929031|584451918|FG003|Overall Study|Protocol Violation|0|||
161838449|NCT01929031|584451919|FG004|Overall Study|Protocol Violation|0|||
161838450|NCT01929031|584451920|FG005|Overall Study|Protocol Violation|1|||
161838451|NCT01929031|584451915|FG000|Overall Study|Reason other than specified above|0|||
161838452|NCT01929031|584451916|FG001|Overall Study|Reason other than specified above|1|||
161838453|NCT01929031|584451917|FG002|Overall Study|Reason other than specified above|0|||
161838454|NCT01929031|584451918|FG003|Overall Study|Reason other than specified above|0|||
161838455|NCT01929031|584451919|FG004|Overall Study|Reason other than specified above|1|||
161838456|NCT01929031|584451920|FG005|Overall Study|Reason other than specified above|0|||
161838457|NCT01366443|584451921|FG000|Overall Study|Lost to Follow-up|2|||
161838458|NCT01366443|584451921|FG000|Overall Study|Under 18 yo|1|||
161838459|NCT00731549|584451922|FG000|Overall Study|Lost to Follow-up|19|||
161838460|NCT00731549|584451922|FG000|Overall Study|Met withdrawal criteria|24|||
161838461|NCT00731549|584451922|FG000|Overall Study|Physician Decision|16|||
161728255|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
161728256|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
161728257|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
161728258|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
161728259|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
161728260|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
161728261|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
161728262|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
161728263|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
161728264|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
161728265|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728266|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728267|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728268|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
161728269|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728270|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728271|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
161728272|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
161728273|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
161728274|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
161728275|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
161728276|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
161728277|NCT00069095|584047878|FG000|Post-study Treatment Phase|Surgery|0|||
161728278|NCT00069095|584047879|FG001|Post-study Treatment Phase|Surgery|0|||
161728279|NCT00069095|584047880|FG002|Post-study Treatment Phase|Surgery|0|||
161728280|NCT00069095|584047881|FG003|Post-study Treatment Phase|Surgery|1|||
161728281|NCT00069095|584047882|FG004|Post-study Treatment Phase|Surgery|1|||
161728282|NCT00069095|584047883|FG005|Post-study Treatment Phase|Surgery|0|||
161728283|NCT00069095|584047878|FG000|Post-study Treatment Phase|Death|0|||
161728284|NCT00069095|584047879|FG001|Post-study Treatment Phase|Death|0|||
161728285|NCT00069095|584047880|FG002|Post-study Treatment Phase|Death|0|||
161728286|NCT00069095|584047881|FG003|Post-study Treatment Phase|Death|0|||
161728287|NCT00069095|584047882|FG004|Post-study Treatment Phase|Death|1|||
161728288|NCT00069095|584047883|FG005|Post-study Treatment Phase|Death|0|||
161728289|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
161728290|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
161728291|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
161728292|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
161728293|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
161728294|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
161728295|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728296|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728297|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728298|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728299|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
161728300|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728301|NCT00069095|584047878|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728302|NCT00069095|584047879|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728303|NCT00069095|584047880|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728304|NCT00069095|584047881|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728305|NCT00069095|584047882|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
161728306|NCT00069095|584047883|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728307|NCT00069095|584047878|FG000|Post-study Treatment Phase|Investigator decision|0|||
161728308|NCT00069095|584047879|FG001|Post-study Treatment Phase|Investigator decision|0|||
161728309|NCT00069095|584047880|FG002|Post-study Treatment Phase|Investigator decision|0|||
161728310|NCT00069095|584047881|FG003|Post-study Treatment Phase|Investigator decision|0|||
161728311|NCT00069095|584047882|FG004|Post-study Treatment Phase|Investigator decision|0|||
161728312|NCT00069095|584047883|FG005|Post-study Treatment Phase|Investigator decision|1|||
161728313|NCT00069095|584047878|FG000|Follow-up Phase|Death|174|||
161728314|NCT00069095|584047879|FG001|Follow-up Phase|Death|206|||
161728315|NCT00069095|584047880|FG002|Follow-up Phase|Death|120|||
161728316|NCT00069095|584047881|FG003|Follow-up Phase|Death|112|||
161728317|NCT00069095|584047882|FG004|Follow-up Phase|Death|92|||
161728318|NCT00069095|584047883|FG005|Follow-up Phase|Death|101|||
161728319|NCT05610176|584047884|FG000|Overall Study|Death|6|||
161728320|NCT01727713|584047889|FG000|Overall Study|Lost to Follow-up|5|||
161728321|NCT01727713|584047889|FG000|Overall Study|Adverse Event|10|||
161728322|NCT01727713|584047889|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
161728323|NCT01727713|584047889|FG000|Overall Study|Withdrawal by Subject|13|||
161728324|NCT01727713|584047889|FG000|Overall Study|Protocol Deviation|2|||
161728325|NCT02389816|584047890|FG000|Overall Study|Randomized but Not Treated|1|||
161728326|NCT02389816|584047891|FG001|Overall Study|Randomized but Not Treated|0|||
161728327|NCT02389816|584047892|FG002|Overall Study|Randomized but Not Treated|0|||
161728328|NCT02389816|584047890|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
161728329|NCT02389816|584047891|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
161728330|NCT02389816|584047892|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
161728331|NCT02389816|584047890|FG000|Overall Study|Major Protocol Deviation|1|||
161728332|NCT02389816|584047891|FG001|Overall Study|Major Protocol Deviation|0|||
161728333|NCT02389816|584047892|FG002|Overall Study|Major Protocol Deviation|0|||
161728334|NCT02389816|584047890|FG000|Overall Study|Lost to Follow-up|1|||
161728335|NCT02389816|584047891|FG001|Overall Study|Lost to Follow-up|0|||
161728336|NCT02389816|584047892|FG002|Overall Study|Lost to Follow-up|0|||
161728337|NCT02389816|584047890|FG000|Overall Study|Withdrawal of Consent|6|||
161728338|NCT02389816|584047891|FG001|Overall Study|Withdrawal of Consent|4|||
161728339|NCT02389816|584047892|FG002|Overall Study|Withdrawal of Consent|4|||
161728340|NCT02389816|584047890|FG000|Overall Study|Lack of Efficacy|1|||
161728341|NCT02389816|584047891|FG001|Overall Study|Lack of Efficacy|0|||
161728342|NCT02389816|584047892|FG002|Overall Study|Lack of Efficacy|0|||
161728343|NCT02389816|584047890|FG000|Overall Study|Non Compliance with Study Drug|1|||
161728344|NCT02389816|584047891|FG001|Overall Study|Non Compliance with Study Drug|1|||
161728345|NCT02389816|584047892|FG002|Overall Study|Non Compliance with Study Drug|1|||
161728346|NCT02389816|584047890|FG000|Overall Study|Reason not Specified|0|||
161728347|NCT02389816|584047891|FG001|Overall Study|Reason not Specified|2|||
161728348|NCT02389816|584047892|FG002|Overall Study|Reason not Specified|0|||
161728349|NCT01217190|584047899|FG000|Second Dosing|Withdrawal by Subject|0|||
161728350|NCT01217190|584047900|FG001|Second Dosing|Withdrawal by Subject|2|||
161728351|NCT01594476|584047901|FG000|Overall Study|Protocol Violation|1|||
161728352|NCT01594476|584047902|FG001|Overall Study|Protocol Violation|3|||
161728353|NCT05114590|584047903|FG000|Overall Study|Adverse Event|1|||
161728354|NCT05114590|584047903|FG000|Overall Study|Investigator decision|1|||
161728355|NCT05114590|584047903|FG000|Overall Study|Lost to Follow-up|5|||
161728356|NCT05114590|584047903|FG000|Overall Study|Withdrawal by Subject|5|||
161728357|NCT05114590|584047903|FG000|Overall Study|Other|2|||
161728358|NCT03007953|584047904|FG000|Overall Study|Withdrawal by Subject|5|||
161728359|NCT03007953|584047905|FG001|Overall Study|Withdrawal by Subject|2|||
161728360|NCT03007953|584047904|FG000|Overall Study|Death|5|||
161728361|NCT03007953|584047905|FG001|Overall Study|Death|7|||
161728362|NCT03007953|584047904|FG000|Overall Study|Lost to Follow-up|3|||
161728363|NCT03007953|584047905|FG001|Overall Study|Lost to Follow-up|2|||
161728364|NCT03007953|584047904|FG000|Overall Study|Enrolled in Hospice|3|||
161728365|NCT03007953|584047905|FG001|Overall Study|Enrolled in Hospice|2|||
161728366|NCT02224846|584047906|FG000|Period 1 (Month 3)|Adverse Event|2|||
161728367|NCT02224846|584047907|FG001|Period 1 (Month 3)|Adverse Event|1|||
161728368|NCT02224846|584047906|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
161728369|NCT02224846|584047907|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
161728370|NCT02224846|584047906|FG000|Period 1 (Month 3)|Protocol Violation|4|||
161728371|NCT02224846|584047907|FG001|Period 1 (Month 3)|Protocol Violation|8|||
161728372|NCT02224846|584047906|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
161728373|NCT02224846|584047907|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
161728374|NCT02224846|584047906|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
161728375|NCT02224846|584047907|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
161728376|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
161728377|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
161728378|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
161728379|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
161728380|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
161728381|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
161728382|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
161728383|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
161728384|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
161728385|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
161728386|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
161728387|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
161728388|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
161728389|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
161728390|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
161728391|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
161728392|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
161728393|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
161728394|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
161728395|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
161728396|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
161728397|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
161728398|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
161728399|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
161728400|NCT03196297|584047908|FG000|Main Period|Withdrawal by Subject|4|||
161728401|NCT03196297|584047908|FG000|Extension Period|Withdrawal by Subject|1|||
161728402|NCT03196297|584047908|FG000|Extension Period|Lack of Efficacy|2|||
161728403|NCT00320385|584047912|FG000|Overall Study|Lost to Follow-up|7|||
161728404|NCT00320385|584047913|FG001|Overall Study|Lost to Follow-up|10|||
161728405|NCT00320385|584047912|FG000|Overall Study|Withdrawal by Subject|6|||
161728406|NCT00320385|584047913|FG001|Overall Study|Withdrawal by Subject|7|||
161728407|NCT00320385|584047912|FG000|Overall Study|Sponsor Terminated Study|2|||
161728408|NCT00320385|584047913|FG001|Overall Study|Sponsor Terminated Study|1|||
161728409|NCT00320385|584047912|FG000|Overall Study|Investigator Decision|0|||
161728410|NCT00320385|584047913|FG001|Overall Study|Investigator Decision|1|||
161728411|NCT00320385|584047912|FG000|Overall Study|Death|1|||
161728412|NCT00320385|584047913|FG001|Overall Study|Death|2|||
161728413|NCT00320385|584047912|FG000|Overall Study|Serious Adverse Event|1|||
161728414|NCT00320385|584047913|FG001|Overall Study|Serious Adverse Event|0|||
161728415|NCT00320385|584047912|FG000|Overall Study|Withdrew Consent|1|||
161728416|NCT00320385|584047913|FG001|Overall Study|Withdrew Consent|0|||
161728417|NCT00320385|584047912|FG000|Overall Study|Adverse Event|0|||
161728418|NCT00320385|584047913|FG001|Overall Study|Adverse Event|1|||
161728419|NCT04370028|584047914|FG000|Overall Study|Withdrawal by Subject|695|||
161728420|NCT04370028|584047914|FG000|Overall Study|Protocol Violation|9|||
161728421|NCT04370028|584047914|FG000|Overall Study|Adverse Event|3|||
161728422|NCT00872170|584047915|FG000|Overall Study|Adverse Event|1|||
161728423|NCT00872170|584047916|FG001|Overall Study|Adverse Event|0|||
161728424|NCT02928406|584047917|FG000|Overall Study|Death|780|||
161728425|NCT02928406|584047917|FG000|Overall Study|Progressive disease|3|||
161728426|NCT02928406|584047917|FG000|Overall Study|Lost to Follow-up|49|||
161728427|NCT02928406|584047917|FG000|Overall Study|Non-compliance|2|||
161728428|NCT02928406|584047917|FG000|Overall Study|Withdrawal by Subject|40|||
161728429|NCT02928406|584047917|FG000|Overall Study|Study terminated by sponsor|57|||
161728430|NCT02928406|584047917|FG000|Overall Study|Physician Decision|1|||
161728431|NCT02928406|584047917|FG000|Overall Study|Various reasons|72|||
161728432|NCT00786838|584047918|FG000|Overall Study|Physician Decision|4|||
161728433|NCT00786838|584047918|FG000|Overall Study|Death|4|||
161728434|NCT00786838|584047918|FG000|Overall Study|Adverse Event|6|||
161728435|NCT00786838|584047918|FG000|Overall Study|Progressive disease|31|||
161728436|NCT00786838|584047918|FG000|Overall Study|Withdrawal by Subject|4|||
161728437|NCT04937816|584047919|FG000|Overall Study|Study drug stopped, reason missing|5|||
161728438|NCT04937816|584047920|FG001|Overall Study|Study drug stopped, reason missing|3|||
161728439|NCT04937816|584047921|FG002|Overall Study|Study drug stopped, reason missing|4|||
161728440|NCT04937816|584047922|FG003|Overall Study|Study drug stopped, reason missing|6|||
161728441|NCT04937816|584047923|FG004|Overall Study|Study drug stopped, reason missing|1|||
161728442|NCT04937816|584047924|FG005|Overall Study|Study drug stopped, reason missing|0|||
161728443|NCT04937816|584047925|FG006|Overall Study|Study drug stopped, reason missing|0|||
161728444|NCT04937816|584047919|FG000|Overall Study|Other than stated below|173|||
161728445|NCT04937816|584047920|FG001|Overall Study|Other than stated below|143|||
161728446|NCT04937816|584047921|FG002|Overall Study|Other than stated below|125|||
161728447|NCT04937816|584047922|FG003|Overall Study|Other than stated below|44|||
161728448|NCT04937816|584047923|FG004|Overall Study|Other than stated below|45|||
161728449|NCT04937816|584047924|FG005|Overall Study|Other than stated below|28|||
161728450|NCT04937816|584047925|FG006|Overall Study|Other than stated below|31|||
161728451|NCT04937816|584047919|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
161728452|NCT04937816|584047920|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
161728453|NCT04937816|584047921|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
161728454|NCT04937816|584047922|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
161728455|NCT04937816|584047923|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
161728456|NCT04937816|584047924|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
161728457|NCT04937816|584047925|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
161728458|NCT04937816|584047919|FG000|Overall Study|Lost to Follow-up|15|||
161728459|NCT04937816|584047920|FG001|Overall Study|Lost to Follow-up|9|||
161728460|NCT04937816|584047921|FG002|Overall Study|Lost to Follow-up|6|||
161728461|NCT04937816|584047922|FG003|Overall Study|Lost to Follow-up|6|||
161728462|NCT04937816|584047923|FG004|Overall Study|Lost to Follow-up|16|||
161728463|NCT04937816|584047924|FG005|Overall Study|Lost to Follow-up|11|||
161728464|NCT04937816|584047925|FG006|Overall Study|Lost to Follow-up|17|||
161728465|NCT04937816|584047919|FG000|Overall Study|Protocol Violation|15|||
161728466|NCT04937816|584047920|FG001|Overall Study|Protocol Violation|15|||
161728467|NCT04937816|584047921|FG002|Overall Study|Protocol Violation|12|||
161728468|NCT04937816|584047922|FG003|Overall Study|Protocol Violation|30|||
161728469|NCT04937816|584047923|FG004|Overall Study|Protocol Violation|24|||
161728470|NCT04937816|584047924|FG005|Overall Study|Protocol Violation|5|||
161728471|NCT04937816|584047925|FG006|Overall Study|Protocol Violation|5|||
161728472|NCT04937816|584047919|FG000|Overall Study|Adverse Event|303|||
161728473|NCT04937816|584047920|FG001|Overall Study|Adverse Event|267|||
161728474|NCT04937816|584047921|FG002|Overall Study|Adverse Event|273|||
161728475|NCT04937816|584047922|FG003|Overall Study|Adverse Event|553|||
161728476|NCT04937816|584047923|FG004|Overall Study|Adverse Event|575|||
161728477|NCT04937816|584047924|FG005|Overall Study|Adverse Event|343|||
161728478|NCT04937816|584047925|FG006|Overall Study|Adverse Event|337|||
161728479|NCT04937816|584047919|FG000|Overall Study|Not treated|4|||
161728480|NCT04937816|584047920|FG001|Overall Study|Not treated|2|||
161728481|NCT04937816|584047921|FG002|Overall Study|Not treated|2|||
161728482|NCT04937816|584047922|FG003|Overall Study|Not treated|2|||
161728483|NCT04937816|584047923|FG004|Overall Study|Not treated|1|||
161728484|NCT04937816|584047924|FG005|Overall Study|Not treated|4|||
161728485|NCT04937816|584047925|FG006|Overall Study|Not treated|0|||
161728486|NCT00436215|584047926|FG000|Overall Study|Refused further treatment|3|||
161728487|NCT00436215|584047926|FG000|Overall Study|Small bowel obstruction|1|||
161728488|NCT05513053|584047927|FG000|Overall Study|Lost to Follow-up|9|||
161728489|NCT05513053|584047928|FG001|Overall Study|Lost to Follow-up|11|||
161728490|NCT05513053|584047927|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161728491|NCT05513053|584047928|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161728492|NCT05513053|584047927|FG000|Overall Study|Withdrawal by Subject|2|||
161728493|NCT05513053|584047928|FG001|Overall Study|Withdrawal by Subject|9|||
161728494|NCT05513053|584047927|FG000|Overall Study|Protocol Violation|6|||
161728495|NCT05513053|584047928|FG001|Overall Study|Protocol Violation|3|||
161728496|NCT05513053|584047927|FG000|Overall Study|Adverse Event|0|||
161728497|NCT05513053|584047928|FG001|Overall Study|Adverse Event|2|||
161728498|NCT04491877|584049714|FG000|Overall Study|Protocol Deviation|1|||
161728499|NCT04491877|584049715|FG001|Overall Study|Protocol Deviation|0|||
161728500|NCT04491877|584049716|FG002|Overall Study|Protocol Deviation|2|||
161728501|NCT04491877|584049717|FG003|Overall Study|Protocol Deviation|0|||
161728502|NCT04491877|584049718|FG004|Overall Study|Protocol Deviation|0|||
161728503|NCT04491877|584049719|FG005|Overall Study|Protocol Deviation|0|||
161728504|NCT04491877|584049720|FG006|Overall Study|Protocol Deviation|1|||
161728505|NCT04491877|584049721|FG007|Overall Study|Protocol Deviation|1|||
161728506|NCT04491877|584049722|FG008|Overall Study|Protocol Deviation|0|||
161728507|NCT04491877|584049714|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161728508|NCT04491877|584049715|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161728509|NCT04491877|584049716|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161728510|NCT04491877|584049717|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
161728511|NCT04491877|584049718|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161728512|NCT04491877|584049719|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
161728513|NCT04491877|584049720|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
161728514|NCT04491877|584049721|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
161728515|NCT04491877|584049722|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
161728516|NCT04491877|584049714|FG000|Overall Study|Lost to Follow-up|0|||
161728517|NCT04491877|584049715|FG001|Overall Study|Lost to Follow-up|2|||
161728518|NCT04491877|584049716|FG002|Overall Study|Lost to Follow-up|0|||
161728519|NCT04491877|584049717|FG003|Overall Study|Lost to Follow-up|0|||
161728520|NCT04491877|584049718|FG004|Overall Study|Lost to Follow-up|0|||
161728521|NCT04491877|584049719|FG005|Overall Study|Lost to Follow-up|0|||
161728522|NCT04491877|584049720|FG006|Overall Study|Lost to Follow-up|2|||
161728523|NCT04491877|584049721|FG007|Overall Study|Lost to Follow-up|1|||
161728524|NCT04491877|584049722|FG008|Overall Study|Lost to Follow-up|1|||
161728525|NCT02429258|584049726|FG000|Overall Study|Withdrawal by Subject|2|||
161728526|NCT02429258|584049727|FG001|Overall Study|Withdrawal by Subject|0|||
161728527|NCT02429258|584049726|FG000|Overall Study|Protocol Violation|0|||
161728528|NCT02429258|584049727|FG001|Overall Study|Protocol Violation|1|||
161728529|NCT03364335|584049728|FG000|Overall Study|Adverse Event|3|||
161728530|NCT03364335|584049729|FG001|Overall Study|Adverse Event|4|||
161728531|NCT03364335|584049730|FG002|Overall Study|Adverse Event|1|||
161728532|NCT03364335|584049731|FG003|Overall Study|Adverse Event|2|||
161728533|NCT03364335|584049732|FG004|Overall Study|Adverse Event|0|||
161728534|NCT03364335|584049728|FG000|Overall Study|Lost to Follow-up|7|||
161728535|NCT03364335|584049729|FG001|Overall Study|Lost to Follow-up|7|||
161728536|NCT03364335|584049730|FG002|Overall Study|Lost to Follow-up|10|||
161728537|NCT03364335|584049731|FG003|Overall Study|Lost to Follow-up|11|||
161728538|NCT03364335|584049732|FG004|Overall Study|Lost to Follow-up|11|||
161728539|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
161728540|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
161728541|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
161728542|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728543|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728544|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728545|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728546|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728547|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
161728548|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
161728549|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
161728550|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728551|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728552|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728553|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728554|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728555|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
161728556|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728557|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728558|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728559|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728560|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728561|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728562|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728563|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
161728564|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728565|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728566|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728567|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728568|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728569|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728570|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728571|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161728572|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161728573|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161728574|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728575|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728576|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728577|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728578|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728579|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728580|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728581|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
161728582|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728583|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728584|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728585|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728586|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728587|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161728588|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161728589|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161728590|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
161728591|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
161728592|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
161728593|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
161728594|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
161728595|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161728596|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161728597|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161728598|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
161728599|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
161728600|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
161728601|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
161728602|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
161728603|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728604|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728605|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728606|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
161728607|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728608|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728609|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
161728610|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
161728611|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728612|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728613|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728614|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728615|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728616|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728617|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
161728618|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728619|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728620|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728621|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728622|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728623|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728624|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
161728625|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728626|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728627|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728628|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728629|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728630|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
161728631|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728632|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728633|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
161728634|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
161728635|NCT01520324|584049743|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
161728636|NCT01328249|584049746|FG000|Overall Study|Adverse Event|3|||
161728637|NCT01328249|584049747|FG001|Overall Study|Adverse Event|0|||
161728638|NCT01328249|584049746|FG000|Overall Study|Disease progression|1|||
161728639|NCT01328249|584049747|FG001|Overall Study|Disease progression|0|||
161728640|NCT01328249|584049746|FG000|Overall Study|Withdrawal by Subject|1|||
161728641|NCT01328249|584049747|FG001|Overall Study|Withdrawal by Subject|1|||
161728642|NCT01328249|584049746|FG000|Overall Study|Moved before end of treatment visit|1|||
161728643|NCT01328249|584049747|FG001|Overall Study|Moved before end of treatment visit|0|||
161728644|NCT01328249|584049746|FG000|Overall Study|Subject choice|1|||
161728645|NCT01328249|584049747|FG001|Overall Study|Subject choice|1|||
161728646|NCT01328249|584049746|FG000|Overall Study|Protocol Violation|0|||
161728647|NCT01328249|584049747|FG001|Overall Study|Protocol Violation|1|||
161728648|NCT00748553|584049748|FG000|Overall Study|Adverse Event|0|||
161728649|NCT00748553|584049749|FG001|Overall Study|Adverse Event|1|||
161728650|NCT00748553|584049748|FG000|Overall Study|disease progression|2|||
161728651|NCT00748553|584049749|FG001|Overall Study|disease progression|0|||
161728652|NCT00748553|584049748|FG000|Overall Study|noncompliance|1|||
161728653|NCT00748553|584049749|FG001|Overall Study|noncompliance|0|||
161728654|NCT02330549|584049751|FG000|Overall Study|Adverse Event|1|||
161728655|NCT02330549|584049752|FG001|Overall Study|Adverse Event|0|||
161728656|NCT02330549|584049751|FG000|Overall Study|Subject withdrew consent|2|||
161728657|NCT02330549|584049752|FG001|Overall Study|Subject withdrew consent|1|||
161728658|NCT02330549|584049751|FG000|Overall Study|Failure to meet randomization criteria|1|||
161728659|NCT02330549|584049752|FG001|Overall Study|Failure to meet randomization criteria|0|||
161728660|NCT00745368|584049753|FG000|Overall Study|Unable to provide sample|3|||
161728661|NCT00495495|584049755|FG000|Overall Study|Protocol Violation|99|||
161728662|NCT02245568|584049756|FG000|Overall Study|Study terminated by Sponsor|346|||
161728663|NCT02245568|584049756|FG000|Overall Study|Adverse Event|144|||
161728664|NCT02245568|584049756|FG000|Overall Study|Lack of Efficacy|98|||
161728665|NCT02245568|584049756|FG000|Overall Study|Withdrawal by Caregiver|85|||
161728666|NCT02245568|584049756|FG000|Overall Study|Withdrawal by Subject|77|||
161728667|NCT02245568|584049756|FG000|Overall Study|Withdrawal by Legal Representative|31|||
161728668|NCT02245568|584049756|FG000|Overall Study|Missing (Site closure)|16|||
161728669|NCT02245568|584049756|FG000|Overall Study|Physician Decision|14|||
161728670|NCT02245568|584049756|FG000|Overall Study|Non-compliance with study drug|11|||
161728671|NCT02245568|584049756|FG000|Overall Study|Death|9|||
161728672|NCT02245568|584049756|FG000|Overall Study|Blue staining|6|||
161728673|NCT02245568|584049756|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
161728674|NCT02245568|584049756|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
161728675|NCT02245568|584049756|FG000|Overall Study|Lost to Follow-up|5|||
161728676|NCT04009096|584049760|FG000|Overall Study|Withdrawal by Subject|0|||
161728677|NCT04009096|584049761|FG001|Overall Study|Withdrawal by Subject|7|||
161728678|NCT04009096|584049762|FG002|Overall Study|Withdrawal by Subject|0|||
161728679|NCT04009096|584049760|FG000|Overall Study|Physician Decision|0|||
161728680|NCT04009096|584049761|FG001|Overall Study|Physician Decision|1|||
161728681|NCT04009096|584049762|FG002|Overall Study|Physician Decision|0|||
161728682|NCT04263142|584049763|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728683|NCT04263142|584049764|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728684|NCT04263142|584049765|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728685|NCT04263142|584049766|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728686|NCT04263142|584049767|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
161728687|NCT04263142|584049763|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728688|NCT04263142|584049764|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728689|NCT04263142|584049765|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728690|NCT04263142|584049766|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728691|NCT04263142|584049767|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
161728692|NCT00769704|584049768|FG000|Overall Study|Lost to Follow-up|3|||
161728693|NCT00769704|584049769|FG001|Overall Study|Lost to Follow-up|2|||
161728694|NCT00769704|584049768|FG000|Overall Study|Death|95|||
161728695|NCT00769704|584049769|FG001|Overall Study|Death|190|||
161728696|NCT00769704|584049768|FG000|Overall Study|Withdrawal by Subject|12|||
161728697|NCT00769704|584049769|FG001|Overall Study|Withdrawal by Subject|5|||
161728698|NCT00769704|584049768|FG000|Overall Study|Other|1|||
161728699|NCT00769704|584049769|FG001|Overall Study|Other|2|||
161728700|NCT00450372|584049770|FG000|Overall Study|Physician Decision|1|||
161728701|NCT03010423|584049771|FG000|Overall Study|Study termination|8|||
161728702|NCT00520676|584049772|FG000|Overall Study|Death|84|||
161728703|NCT00520676|584049773|FG001|Overall Study|Death|81|||
161728704|NCT00520676|584049772|FG000|Overall Study|Lost to Follow-up|6|||
161728705|NCT00520676|584049773|FG001|Overall Study|Lost to Follow-up|10|||
161728706|NCT00520676|584049772|FG000|Overall Study|Physician Decision|4|||
161728707|NCT00520676|584049773|FG001|Overall Study|Physician Decision|1|||
161728708|NCT00520676|584049772|FG000|Overall Study|Withdrawal by Subject|7|||
161728709|NCT00520676|584049773|FG001|Overall Study|Withdrawal by Subject|11|||
161728710|NCT03439748|584049774|FG000|Overall Study|Withdrawal by Subject|11|||
161728711|NCT03439748|584049775|FG001|Overall Study|Withdrawal by Subject|17|||
161728712|NCT05131451|584049776|FG000|Overall Study|Protocol Violation|1|||
161728713|NCT05131451|584049777|FG001|Overall Study|Protocol Violation|0|||
161728714|NCT01856595|584049784|FG000|Overall Study|Withdrawal by Subject|0|||
161728715|NCT01856595|584049785|FG001|Overall Study|Withdrawal by Subject|1|||
161728716|NCT01856595|584049786|FG002|Overall Study|Withdrawal by Subject|0|||
161728717|NCT01856595|584049787|FG003|Overall Study|Withdrawal by Subject|0|||
161728718|NCT01856595|584049788|FG004|Overall Study|Withdrawal by Subject|0|||
161728719|NCT01856595|584049789|FG005|Overall Study|Withdrawal by Subject|0|||
161728720|NCT01856595|584049790|FG006|Overall Study|Withdrawal by Subject|1|||
161728721|NCT01856595|584049791|FG007|Overall Study|Withdrawal by Subject|0|||
161728722|NCT01856595|584049792|FG008|Overall Study|Withdrawal by Subject|0|||
161728723|NCT04426825|584049794|FG000|Overall Study|Death|17|||
161728724|NCT04426825|584049794|FG000|Overall Study|Lost to Follow-up|1|||
161728725|NCT04426825|584049794|FG000|Overall Study|Study terminated by sponsor|5|||
161728726|NCT02582749|584049807|FG000|Overall Study|Study terminated by funder|5|||
161728727|NCT02582749|584049808|FG001|Overall Study|Study terminated by funder|10|||
161728728|NCT02582749|584049807|FG000|Overall Study|Withdrawal by Subject|0|||
161728729|NCT02582749|584049808|FG001|Overall Study|Withdrawal by Subject|1|||
161728730|NCT02213198|584049809|FG000|Baseline|No show for intake|7|||
161728731|NCT02213198|584049810|FG001|Baseline|No show for intake|9|||
161728732|NCT02213198|584049809|FG000|Baseline|Withdrawal by Subject|34|||
161728733|NCT02213198|584049810|FG001|Baseline|Withdrawal by Subject|11|||
161838462|NCT00731549|584451922|FG000|Overall Study|Withdrawal by Subject|89|||
161728734|NCT02213198|584049809|FG000|Baseline|transferred out of clinic|7|||
161728735|NCT02213198|584049810|FG001|Baseline|transferred out of clinic|9|||
161838463|NCT00731549|584451922|FG000|Overall Study|Protocol deviation|1|||
161728736|NCT02213198|584049809|FG000|Baseline|Lost to Follow-up|40|||
161728737|NCT02213198|584049810|FG001|Baseline|Lost to Follow-up|21|||
161728738|NCT02213198|584049809|FG000|Baseline|incarcerated,violent|0|||
161728739|NCT02213198|584049810|FG001|Baseline|incarcerated,violent|1|||
161728740|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
161728741|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
161728742|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
161728743|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
161728744|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
161728745|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
161728746|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
161728747|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
161728748|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
161728749|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
161728750|NCT02213198|584049809|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
161728751|NCT02213198|584049810|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
161728752|NCT01518192|584049811|FG000|Overall Study|Lost to Follow-up|29|||
161728753|NCT01518192|584049812|FG001|Overall Study|Lost to Follow-up|26|||
161728754|NCT01518192|584049813|FG002|Overall Study|Lost to Follow-up|35|||
161728755|NCT01954121|584049815|FG000|Overall Study|Lack of Efficacy|94|||
161728756|NCT01954121|584049816|FG001|Overall Study|Lack of Efficacy|41|||
161728757|NCT01954121|584049815|FG000|Overall Study|Protocol Violation|0|||
161728758|NCT01954121|584049816|FG001|Overall Study|Protocol Violation|2|||
161728759|NCT01954121|584049815|FG000|Overall Study|Lost to Follow-up|5|||
161728760|NCT01954121|584049816|FG001|Overall Study|Lost to Follow-up|6|||
161728761|NCT01954121|584049815|FG000|Overall Study|Withdrawal by Subject|18|||
161728762|NCT01954121|584049816|FG001|Overall Study|Withdrawal by Subject|12|||
161728763|NCT01954121|584049815|FG000|Overall Study|Pregnancy|1|||
161728764|NCT01954121|584049816|FG001|Overall Study|Pregnancy|1|||
161728765|NCT01954121|584049815|FG000|Overall Study|AE, serious fatal|1|||
161728766|NCT01954121|584049816|FG001|Overall Study|AE, serious fatal|0|||
161728767|NCT01954121|584049815|FG000|Overall Study|AE, non-serious non-fatal|5|||
161728768|NCT01954121|584049816|FG001|Overall Study|AE, non-serious non-fatal|22|||
161728769|NCT01954121|584049815|FG000|Overall Study|SAE, non-fatal|1|||
161728770|NCT01954121|584049816|FG001|Overall Study|SAE, non-fatal|4|||
161728771|NCT01954121|584049815|FG000|Overall Study|Non-compliant with study procedures|1|||
161728772|NCT01954121|584049816|FG001|Overall Study|Non-compliant with study procedures|0|||
161728773|NCT01954121|584049815|FG000|Overall Study|Non-compliant patient|1|||
161728774|NCT01954121|584049816|FG001|Overall Study|Non-compliant patient|1|||
161728775|NCT01954121|584049815|FG000|Overall Study|Subject did not follow instructions|0|||
161728776|NCT01954121|584049816|FG001|Overall Study|Subject did not follow instructions|2|||
161728777|NCT00601523|584049817|FG000|Overall Study|Adverse Event|42|||
161728778|NCT00601523|584049818|FG001|Overall Study|Adverse Event|14|||
161728779|NCT00601523|584049817|FG000|Overall Study|Lack of Efficacy|3|||
161728780|NCT00601523|584049818|FG001|Overall Study|Lack of Efficacy|0|||
161728781|NCT00601523|584049817|FG000|Overall Study|Protocol Violation|5|||
161728782|NCT00601523|584049818|FG001|Overall Study|Protocol Violation|1|||
161728783|NCT00601523|584049817|FG000|Overall Study|Lost to Follow-up|0|||
161728784|NCT00601523|584049818|FG001|Overall Study|Lost to Follow-up|1|||
161728785|NCT00601523|584049817|FG000|Overall Study|Withdrawal by Subject|18|||
161728786|NCT00601523|584049818|FG001|Overall Study|Withdrawal by Subject|9|||
161728787|NCT00601523|584049817|FG000|Overall Study|Other|9|||
161728788|NCT00601523|584049818|FG001|Overall Study|Other|1|||
161728789|NCT01987986|584049819|FG000|Overall Study|Lost to Follow-up|1|||
161728790|NCT01987986|584049820|FG001|Overall Study|Lost to Follow-up|0|||
161728791|NCT01987986|584049821|FG002|Overall Study|Lost to Follow-up|0|||
161838464|NCT00731549|584451922|FG000|Overall Study|Adverse Event|31|||
161838465|NCT00731549|584451922|FG000|Overall Study|Lack of efficacy with AE|37|||
161838466|NCT00731549|584451922|FG000|Overall Study|Lack of efficacy without AE|6|||
161728792|NCT01987986|584049822|FG003|Overall Study|Lost to Follow-up|0|||
161728793|NCT01987986|584049819|FG000|Overall Study|Adverse Event|1|||
161728794|NCT01987986|584049820|FG001|Overall Study|Adverse Event|0|||
161838467|NCT00448136|584451925|FG000|Overall Study|Death|3|||
161838468|NCT00448136|584451926|FG001|Overall Study|Death|8|||
161838469|NCT00448136|584451925|FG000|Overall Study|Investigator's decision (progression)|1|||
161728795|NCT01987986|584049821|FG002|Overall Study|Adverse Event|2|||
161728796|NCT01987986|584049822|FG003|Overall Study|Adverse Event|0|||
161728797|NCT01617434|584049823|FG000|Overall Study|Adverse Event|12|||
161728798|NCT01617434|584049824|FG001|Overall Study|Adverse Event|3|||
161728799|NCT01617434|584049823|FG000|Overall Study|Protocol Violation|8|||
161728800|NCT01617434|584049824|FG001|Overall Study|Protocol Violation|7|||
161728801|NCT01617434|584049823|FG000|Overall Study|Withdrawal Criteria|12|||
161728802|NCT01617434|584049824|FG001|Overall Study|Withdrawal Criteria|37|||
161838470|NCT00448136|584451926|FG001|Overall Study|Investigator's decision (progression)|0|||
161838471|NCT00609466|584451927|FG000|Overall Study|Withdrawal by Subject|0|||
161728803|NCT01617434|584049823|FG000|Overall Study|Unclassified|3|||
161728804|NCT01617434|584049824|FG001|Overall Study|Unclassified|4|||
161728805|NCT03342469|584049831|FG000|Overall Study|Withdrawal by Subject|0|||
161728806|NCT03342469|584049832|FG001|Overall Study|Withdrawal by Subject|1|||
161728807|NCT03342469|584049833|FG002|Overall Study|Withdrawal by Subject|0|||
161728808|NCT03342469|584049834|FG003|Overall Study|Withdrawal by Subject|0|||
161728809|NCT05515601|584049838|FG000|Overall Study|Withdrawal by Subject|1|||
161728810|NCT05515601|584049839|FG001|Overall Study|Withdrawal by Subject|3|||
161728811|NCT05515601|584049840|FG002|Overall Study|Withdrawal by Subject|2|||
161728812|NCT05515601|584049841|FG003|Overall Study|Withdrawal by Subject|1|||
161728813|NCT05515601|584049842|FG004|Overall Study|Withdrawal by Subject|1|||
161728814|NCT05515601|584049843|FG005|Overall Study|Withdrawal by Subject|1|||
161728815|NCT05515601|584049838|FG000|Overall Study|Lost to Follow-up|0|||
161728816|NCT05515601|584049839|FG001|Overall Study|Lost to Follow-up|0|||
161728817|NCT05515601|584049840|FG002|Overall Study|Lost to Follow-up|0|||
161728818|NCT05515601|584049841|FG003|Overall Study|Lost to Follow-up|0|||
161728819|NCT05515601|584049842|FG004|Overall Study|Lost to Follow-up|1|||
161728820|NCT05515601|584049843|FG005|Overall Study|Lost to Follow-up|0|||
161728821|NCT00540436|584049844|FG000|First 12-Week Treatment Period|Adverse Event|1|||
161728822|NCT00540436|584049844|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
161728823|NCT00540436|584049844|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
161728824|NCT00540436|584049844|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
161728825|NCT01515306|584049845|FG000|Overall Study|Adverse Event|3|||
161728826|NCT01515306|584049846|FG001|Overall Study|Adverse Event|2|||
161728827|NCT01515306|584049845|FG000|Overall Study|Progressive Disease|19|||
161728828|NCT01515306|584049846|FG001|Overall Study|Progressive Disease|9|||
161728829|NCT01515306|584049845|FG000|Overall Study|Withdrawal by Subject|1|||
161728830|NCT01515306|584049846|FG001|Overall Study|Withdrawal by Subject|2|||
161728831|NCT01515306|584049845|FG000|Overall Study|Physician Decision|1|||
161728832|NCT01515306|584049846|FG001|Overall Study|Physician Decision|1|||
161728833|NCT02678780|584049848|FG000|Overall Study|Adverse Event|11|||
161728834|NCT02678780|584049849|FG001|Overall Study|Adverse Event|14|||
161728835|NCT02678780|584049848|FG000|Overall Study|Withdrawal by Subject|2|||
161728836|NCT02678780|584049849|FG001|Overall Study|Withdrawal by Subject|1|||
161728837|NCT02678780|584049848|FG000|Overall Study|Sponsor discontinuation|7|||
161728838|NCT02678780|584049849|FG001|Overall Study|Sponsor discontinuation|4|||
161728839|NCT02678780|584049848|FG000|Overall Study|Death|1|||
161728840|NCT02678780|584049849|FG001|Overall Study|Death|1|||
161728841|NCT02678780|584049848|FG000|Overall Study|Other|6|||
161728842|NCT02678780|584049849|FG001|Overall Study|Other|8|||
161728843|NCT01064648|584049862|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
161728844|NCT01064648|584049863|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
161728845|NCT01064648|584049864|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
161728846|NCT01064648|584049865|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
161728847|NCT01064648|584049862|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
161728848|NCT01064648|584049863|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161728849|NCT01064648|584049864|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161728850|NCT01064648|584049865|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161728851|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161728852|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
161728853|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161728854|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161728855|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161728856|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
161728857|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161728858|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161728859|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
161728860|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
161728861|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
161728862|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
161728863|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161728864|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
161728865|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161728866|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161728867|NCT01064648|584049862|FG000|Phase II|Adverse Event|0|||
161728868|NCT01064648|584049863|FG001|Phase II|Adverse Event|0|||
161728869|NCT01064648|584049864|FG002|Phase II|Adverse Event|15|||
161728870|NCT01064648|584049865|FG003|Phase II|Adverse Event|8|||
161728871|NCT01064648|584049862|FG000|Phase II|Death|0|||
161728872|NCT01064648|584049863|FG001|Phase II|Death|0|||
161728873|NCT01064648|584049864|FG002|Phase II|Death|4|||
161728874|NCT01064648|584049865|FG003|Phase II|Death|5|||
161728875|NCT01064648|584049862|FG000|Phase II|Withdrawal by Subject|0|||
161728876|NCT01064648|584049863|FG001|Phase II|Withdrawal by Subject|0|||
161728877|NCT01064648|584049864|FG002|Phase II|Withdrawal by Subject|2|||
161728878|NCT01064648|584049865|FG003|Phase II|Withdrawal by Subject|5|||
161728879|NCT01064648|584049862|FG000|Phase II|Progression|0|||
161728880|NCT01064648|584049863|FG001|Phase II|Progression|0|||
161728881|NCT01064648|584049864|FG002|Phase II|Progression|21|||
161728882|NCT01064648|584049865|FG003|Phase II|Progression|27|||
161728883|NCT01064648|584049862|FG000|Phase II|Non-protocol specified|0|||
161728884|NCT01064648|584049863|FG001|Phase II|Non-protocol specified|0|||
161728885|NCT01064648|584049864|FG002|Phase II|Non-protocol specified|5|||
161728886|NCT01064648|584049865|FG003|Phase II|Non-protocol specified|3|||
161728887|NCT01064648|584049862|FG000|Phase II|Under Review|0|||
161728888|NCT01064648|584049863|FG001|Phase II|Under Review|0|||
161728889|NCT01064648|584049864|FG002|Phase II|Under Review|2|||
161728890|NCT01064648|584049865|FG003|Phase II|Under Review|0|||
161728891|NCT05513391|584049866|FG000|Overall Study|Adverse Event|1|||
161728892|NCT05513391|584049867|FG001|Overall Study|Adverse Event|0|||
161728893|NCT05513391|584049866|FG000|Overall Study|Protocol Deviation|0|||
161728894|NCT05513391|584049867|FG001|Overall Study|Protocol Deviation|1|||
161728895|NCT05513391|584049866|FG000|Overall Study|Withdrawal by Subject|3|||
161728896|NCT05513391|584049867|FG001|Overall Study|Withdrawal by Subject|1|||
161728897|NCT05513391|584049866|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161728898|NCT05513391|584049867|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161728899|NCT05513391|584049866|FG000|Overall Study|Lost to Follow-up|0|||
161728900|NCT05513391|584049867|FG001|Overall Study|Lost to Follow-up|2|||
161728901|NCT02429427|584049868|FG000|Overall Study|Adverse Event|220|||
161728902|NCT02429427|584049869|FG001|Overall Study|Adverse Event|92|||
161728903|NCT02429427|584049868|FG000|Overall Study|Protocol Violation|10|||
161728904|NCT02429427|584049869|FG001|Overall Study|Protocol Violation|6|||
161728905|NCT02429427|584049868|FG000|Overall Study|Lost to Follow-up|15|||
161728906|NCT02429427|584049869|FG001|Overall Study|Lost to Follow-up|6|||
161728907|NCT02429427|584049868|FG000|Overall Study|Withdrawal by Subject|64|||
161728908|NCT02429427|584049869|FG001|Overall Study|Withdrawal by Subject|34|||
161728909|NCT02429427|584049868|FG000|Overall Study|Other|62|||
161728910|NCT02429427|584049869|FG001|Overall Study|Other|41|||
161728911|NCT00719732|584049870|FG000|Overall Study|Lost to Follow-up|20|||
161728912|NCT00719732|584049870|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
161728913|NCT00719732|584049870|FG000|Overall Study|Illness not associated with device|1|||
161728914|NCT00309777|584049875|FG000|Overall Study|Adverse Event|13|||
161728915|NCT00309777|584049876|FG001|Overall Study|Adverse Event|2|||
161728916|NCT00309777|584049877|FG002|Overall Study|Adverse Event|8|||
161728917|NCT00309777|584049878|FG003|Overall Study|Adverse Event|1|||
161728918|NCT00309777|584049875|FG000|Overall Study|Protocol Violation|4|||
161728919|NCT00309777|584049876|FG001|Overall Study|Protocol Violation|1|||
161728920|NCT00309777|584049877|FG002|Overall Study|Protocol Violation|3|||
161728921|NCT00309777|584049878|FG003|Overall Study|Protocol Violation|1|||
161728922|NCT00309777|584049875|FG000|Overall Study|Withdrawal by Subject|6|||
161728923|NCT00309777|584049876|FG001|Overall Study|Withdrawal by Subject|5|||
161728924|NCT00309777|584049877|FG002|Overall Study|Withdrawal by Subject|7|||
161728925|NCT00309777|584049878|FG003|Overall Study|Withdrawal by Subject|2|||
161728926|NCT00309777|584049875|FG000|Overall Study|Lost to Follow-up|0|||
161728927|NCT00309777|584049876|FG001|Overall Study|Lost to Follow-up|0|||
161728928|NCT00309777|584049877|FG002|Overall Study|Lost to Follow-up|1|||
161728929|NCT00309777|584049878|FG003|Overall Study|Lost to Follow-up|0|||
161728930|NCT00309777|584049875|FG000|Overall Study|Death|0|||
161728931|NCT00309777|584049876|FG001|Overall Study|Death|1|||
161728932|NCT00309777|584049877|FG002|Overall Study|Death|0|||
161728933|NCT00309777|584049878|FG003|Overall Study|Death|0|||
161728934|NCT00683475|584051750|FG000|Overall Study|Withdrawal by Subject|1|||
161728935|NCT00683475|584051751|FG001|Overall Study|Withdrawal by Subject|0|||
161728936|NCT00683475|584051750|FG000|Overall Study|Never Treated: Adverse Event|2|||
161728937|NCT00683475|584051751|FG001|Overall Study|Never Treated: Adverse Event|3|||
161728938|NCT00683475|584051750|FG000|Overall Study|Never Treated: Progressive Disease|1|||
161728939|NCT00683475|584051751|FG001|Overall Study|Never Treated: Progressive Disease|0|||
161728940|NCT00948818|584051755|FG000|Overall Study|Adverse Event|10|||
161728941|NCT00948818|584051756|FG001|Overall Study|Adverse Event|32|||
161728942|NCT00948818|584051755|FG000|Overall Study|Protocol Violation|9|||
161728943|NCT00948818|584051756|FG001|Overall Study|Protocol Violation|10|||
161728944|NCT00948818|584051755|FG000|Overall Study|Withdrawal by Subject|25|||
161728945|NCT00948818|584051756|FG001|Overall Study|Withdrawal by Subject|25|||
161728946|NCT00948818|584051755|FG000|Overall Study|Lost to Follow-up|10|||
161728947|NCT00948818|584051756|FG001|Overall Study|Lost to Follow-up|17|||
161728948|NCT00948818|584051755|FG000|Overall Study|Lack of Efficacy|4|||
161728949|NCT00948818|584051756|FG001|Overall Study|Lack of Efficacy|5|||
161728950|NCT00948818|584051755|FG000|Overall Study|Other Reason|4|||
161728951|NCT00948818|584051756|FG001|Overall Study|Other Reason|5|||
161728952|NCT02364947|584051759|FG000|Overall Study|Withdrawal by Subject|10|||
161728953|NCT02364947|584051760|FG001|Overall Study|Withdrawal by Subject|8|||
161728954|NCT02364947|584051761|FG002|Overall Study|Withdrawal by Subject|9|||
161728955|NCT02364947|584051759|FG000|Overall Study|Adverse Event|45|||
161728956|NCT02364947|584051760|FG001|Overall Study|Adverse Event|33|||
161728957|NCT02364947|584051761|FG002|Overall Study|Adverse Event|11|||
161728958|NCT02364947|584051759|FG000|Overall Study|Protocol Violation|1|||
161728959|NCT02364947|584051760|FG001|Overall Study|Protocol Violation|1|||
161728960|NCT02364947|584051761|FG002|Overall Study|Protocol Violation|1|||
161728961|NCT02364947|584051759|FG000|Overall Study|Physician Decision|3|||
161728962|NCT02364947|584051760|FG001|Overall Study|Physician Decision|2|||
161728963|NCT02364947|584051761|FG002|Overall Study|Physician Decision|5|||
161728964|NCT02364947|584051759|FG000|Overall Study|Death|0|||
161728965|NCT02364947|584051760|FG001|Overall Study|Death|1|||
161728966|NCT02364947|584051761|FG002|Overall Study|Death|0|||
161728967|NCT02702518|584051765|FG000|Overall Study|Lost to Follow-up|3|||
161728968|NCT02702518|584051766|FG001|Overall Study|Lost to Follow-up|4|||
161728969|NCT00853489|584051767|FG000|Overall Study|Lost to Follow-up|5|||
161728970|NCT00853489|584051768|FG001|Overall Study|Lost to Follow-up|2|||
161728971|NCT01251276|584051770|FG000|Overall Study|Protocol Violation|1|||
161728972|NCT01251276|584051771|FG001|Overall Study|Protocol Violation|0|||
161728973|NCT01251276|584051770|FG000|Overall Study|Lost to Follow-up|0|||
161728974|NCT01251276|584051771|FG001|Overall Study|Lost to Follow-up|1|||
161728975|NCT00262080|584051777|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
161728976|NCT00262080|584051778|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161728977|NCT00262080|584051779|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
161728978|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
161728979|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
161728980|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
161728981|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
161728982|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
161728983|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
161728984|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
161728985|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
161728986|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
161728987|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
161728988|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
161728989|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
161728990|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
161728991|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
161728992|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
161728993|NCT01051986|584051780|FG000|Overall Study|Death|1|||
161728994|NCT01051986|584051781|FG001|Overall Study|Death|0|||
161728995|NCT01051986|584051780|FG000|Overall Study|Withdrawal by Subject|2|||
161728996|NCT01051986|584051781|FG001|Overall Study|Withdrawal by Subject|1|||
161728997|NCT01051986|584051780|FG000|Overall Study|Protocol Violation|2|||
161728998|NCT01051986|584051781|FG001|Overall Study|Protocol Violation|3|||
161728999|NCT01725152|584051783|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
161729000|NCT01725152|584051784|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
161729001|NCT01725152|584051783|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
161729002|NCT01725152|584051784|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
161729003|NCT01725152|584051783|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
161729004|NCT01725152|584051784|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
161729005|NCT01725152|584051783|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
161729006|NCT01725152|584051784|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
161838472|NCT00609466|584451928|FG001|Overall Study|Withdrawal by Subject|1|||
161838473|NCT00609466|584451929|FG002|Overall Study|Withdrawal by Subject|1|||
161838474|NCT00609466|584451927|FG000|Overall Study|Adverse Event|2|||
161729007|NCT02044159|584051785|FG000|Overall Study|Consent declined (deferred consent)|2|||
161729008|NCT02044159|584051786|FG001|Overall Study|Consent declined (deferred consent)|4|||
161729009|NCT02044159|584051785|FG000|Overall Study|No longer eligible, drug not given|1|||
161729010|NCT02044159|584051786|FG001|Overall Study|No longer eligible, drug not given|0|||
161729011|NCT02044159|584051785|FG000|Overall Study|Nurse declined to give study drug|1|||
161729012|NCT02044159|584051786|FG001|Overall Study|Nurse declined to give study drug|0|||
161729013|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
161729014|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729015|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729016|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729017|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729018|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
161729019|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729020|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729021|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729022|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729023|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
161729024|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729025|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729026|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729027|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729028|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
161729029|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729030|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729031|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729032|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729033|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
161729034|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729035|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729036|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729037|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729038|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
161729039|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729040|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729041|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729042|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729043|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
161729044|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729045|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729046|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729047|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729048|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161729049|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161729050|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161729051|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161729052|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161729053|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161729054|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161729055|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
161729056|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161729057|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
161729058|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161729059|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
161729060|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
161729061|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161729062|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161729063|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729064|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729065|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729066|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729067|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
161729068|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729069|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729070|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729071|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
161729072|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729073|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729074|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729075|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729076|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
161729077|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729078|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729079|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729080|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729081|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729082|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
161729083|NCT03580382|584051798|FG000|Overall Study|Early Termination of Study|0|||
161729084|NCT03580382|584051799|FG001|Overall Study|Early Termination of Study|3|||
161729085|NCT02808312|584051800|FG000|Overall Study|Enrolled but Never Treated|0|||
161729086|NCT02808312|584051801|FG001|Overall Study|Enrolled but Never Treated|0|||
161729087|NCT02808312|584051802|FG002|Overall Study|Enrolled but Never Treated|1|||
161729088|NCT02808312|584051803|FG003|Overall Study|Enrolled but Never Treated|0|||
161729089|NCT02808312|584051804|FG004|Overall Study|Enrolled but Never Treated|0|||
161729090|NCT03628417|584051805|FG000|Overall Study|Death|1|||
161729091|NCT03628417|584051806|FG001|Overall Study|Death|1|||
161729092|NCT02420223|584051807|FG000|Overall Study|Adverse Event|1|||
161729093|NCT02420223|584051808|FG001|Overall Study|Adverse Event|0|||
161729094|NCT02420223|584051807|FG000|Overall Study|Physician Decision|0|||
161729095|NCT02420223|584051808|FG001|Overall Study|Physician Decision|2|||
161729096|NCT01361009|584051809|FG000|Overall Study|Protocol Violation|116|||
161729097|NCT01826422|584051810|FG000|Overall Study|Withdrawal by Subject|1|||
161729098|NCT01826422|584051811|FG001|Overall Study|Withdrawal by Subject|3|||
161729099|NCT03484923|584051817|FG000|Overall Study|Adverse Event|3|||
161729100|NCT03484923|584051818|FG001|Overall Study|Adverse Event|3|||
161729101|NCT03484923|584051819|FG002|Overall Study|Adverse Event|5|||
161729102|NCT03484923|584051820|FG003|Overall Study|Adverse Event|11|||
161729103|NCT03484923|584051821|FG004|Overall Study|Adverse Event|1|||
161729104|NCT03484923|584051817|FG000|Overall Study|Death|2|||
161729105|NCT03484923|584051818|FG001|Overall Study|Death|2|||
161729106|NCT03484923|584051819|FG002|Overall Study|Death|3|||
161729107|NCT03484923|584051820|FG003|Overall Study|Death|0|||
161729108|NCT03484923|584051821|FG004|Overall Study|Death|1|||
161729109|NCT03484923|584051817|FG000|Overall Study|Physician Decision|6|||
161729110|NCT03484923|584051818|FG001|Overall Study|Physician Decision|7|||
161729111|NCT03484923|584051819|FG002|Overall Study|Physician Decision|6|||
161729112|NCT03484923|584051820|FG003|Overall Study|Physician Decision|3|||
161729113|NCT03484923|584051821|FG004|Overall Study|Physician Decision|2|||
161729114|NCT03484923|584051817|FG000|Overall Study|Progressive disease|33|||
161729115|NCT03484923|584051818|FG001|Overall Study|Progressive disease|28|||
161729116|NCT03484923|584051819|FG002|Overall Study|Progressive disease|26|||
161729117|NCT03484923|584051820|FG003|Overall Study|Progressive disease|30|||
161729118|NCT03484923|584051821|FG004|Overall Study|Progressive disease|16|||
161729119|NCT03484923|584051817|FG000|Overall Study|Subject Decision|1|||
161729120|NCT03484923|584051818|FG001|Overall Study|Subject Decision|3|||
161729121|NCT03484923|584051819|FG002|Overall Study|Subject Decision|3|||
161729122|NCT03484923|584051820|FG003|Overall Study|Subject Decision|0|||
161729123|NCT03484923|584051821|FG004|Overall Study|Subject Decision|1|||
161729124|NCT01863849|584051822|FG000|Overall Study|Lost to Follow-up|1|||
161729125|NCT01863849|584051823|FG001|Overall Study|Lost to Follow-up|0|||
161729126|NCT04402008|584051826|FG000|Overall Study|Adverse Event|0|||
161729127|NCT04402008|584051827|FG001|Overall Study|Adverse Event|0|||
161729128|NCT04402008|584051828|FG002|Overall Study|Adverse Event|0|||
161729129|NCT04402008|584051829|FG003|Overall Study|Adverse Event|1|||
161729130|NCT04402008|584051830|FG004|Overall Study|Adverse Event|0|||
161729131|NCT04402008|584051831|FG005|Overall Study|Adverse Event|0|||
161729132|NCT04402008|584051832|FG006|Overall Study|Adverse Event|0|||
161729133|NCT04402008|584051826|FG000|Overall Study|Disease Progression|3|||
161729134|NCT04402008|584051827|FG001|Overall Study|Disease Progression|2|||
161729135|NCT04402008|584051828|FG002|Overall Study|Disease Progression|3|||
161729136|NCT04402008|584051829|FG003|Overall Study|Disease Progression|3|||
161729137|NCT04402008|584051830|FG004|Overall Study|Disease Progression|4|||
161729138|NCT04402008|584051831|FG005|Overall Study|Disease Progression|3|||
161729139|NCT04402008|584051832|FG006|Overall Study|Disease Progression|10|||
161729140|NCT04402008|584051826|FG000|Overall Study|Withdrawal by Subject|0|||
161729141|NCT04402008|584051827|FG001|Overall Study|Withdrawal by Subject|1|||
161729142|NCT04402008|584051828|FG002|Overall Study|Withdrawal by Subject|0|||
161729143|NCT04402008|584051829|FG003|Overall Study|Withdrawal by Subject|0|||
161729144|NCT04402008|584051830|FG004|Overall Study|Withdrawal by Subject|1|||
161729145|NCT04402008|584051831|FG005|Overall Study|Withdrawal by Subject|0|||
161729146|NCT04402008|584051832|FG006|Overall Study|Withdrawal by Subject|0|||
161729147|NCT04402008|584051826|FG000|Overall Study|Sponsor Decision|0|||
161729148|NCT04402008|584051827|FG001|Overall Study|Sponsor Decision|0|||
161729149|NCT04402008|584051828|FG002|Overall Study|Sponsor Decision|0|||
161729150|NCT04402008|584051829|FG003|Overall Study|Sponsor Decision|0|||
161729151|NCT04402008|584051830|FG004|Overall Study|Sponsor Decision|0|||
161729152|NCT04402008|584051831|FG005|Overall Study|Sponsor Decision|0|||
161729153|NCT04402008|584051832|FG006|Overall Study|Sponsor Decision|3|||
161729154|NCT04402008|584051826|FG000|Overall Study|Death|0|||
161729155|NCT04402008|584051827|FG001|Overall Study|Death|0|||
161729156|NCT04402008|584051828|FG002|Overall Study|Death|0|||
161729157|NCT04402008|584051829|FG003|Overall Study|Death|0|||
161729158|NCT04402008|584051830|FG004|Overall Study|Death|1|||
161729159|NCT04402008|584051831|FG005|Overall Study|Death|0|||
161729160|NCT04402008|584051832|FG006|Overall Study|Death|2|||
161729161|NCT04402008|584051826|FG000|Overall Study|Other|0|||
161729162|NCT04402008|584051827|FG001|Overall Study|Other|0|||
161729163|NCT04402008|584051828|FG002|Overall Study|Other|0|||
161729164|NCT04402008|584051829|FG003|Overall Study|Other|0|||
161729165|NCT04402008|584051830|FG004|Overall Study|Other|0|||
161729166|NCT04402008|584051831|FG005|Overall Study|Other|0|||
161729167|NCT04402008|584051832|FG006|Overall Study|Other|5|||
161729168|NCT00913978|584051833|FG000|Overall Study|Surgeon choice|1|||
161729169|NCT00913978|584051834|FG001|Overall Study|Surgeon choice|3|||
161729170|NCT04716933|584051835|FG000|Overall Study|Sponsor Decision|36|||
161729171|NCT04716933|584051836|FG001|Overall Study|Sponsor Decision|33|||
161729172|NCT04716933|584051835|FG000|Overall Study|Death|65|||
161729173|NCT04716933|584051836|FG001|Overall Study|Death|67|||
161729174|NCT01327651|584051837|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
161729175|NCT01327651|584051838|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
161729176|NCT01327651|584051839|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
161729177|NCT01327651|584051840|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
161729178|NCT01327651|584051841|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
161729179|NCT01327651|584051842|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
161729180|NCT01327651|584051843|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
161729181|NCT01327651|584051844|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
161729182|NCT01327651|584051845|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
161729183|NCT01327651|584051837|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
161729184|NCT01327651|584051838|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729185|NCT01327651|584051839|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729186|NCT01327651|584051840|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729187|NCT01327651|584051841|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729188|NCT01327651|584051842|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729189|NCT01327651|584051843|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729190|NCT01327651|584051844|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729191|NCT01327651|584051845|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729192|NCT01327651|584051837|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729193|NCT01327651|584051838|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
161729194|NCT01327651|584051839|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729195|NCT01327651|584051840|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
161729196|NCT01327651|584051841|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729197|NCT01327651|584051842|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729198|NCT01327651|584051843|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
161838475|NCT00609466|584451928|FG001|Overall Study|Adverse Event|3|||
161838476|NCT00609466|584451929|FG002|Overall Study|Adverse Event|1|||
161729199|NCT01327651|584051844|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
161729200|NCT01327651|584051845|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
161838477|NCT00609466|584451927|FG000|Overall Study|Lack of Efficacy|0|||
161729201|NCT01327651|584051837|FG000|Post Study Follow-up|Lost to Follow-up|0|||
161729202|NCT01327651|584051838|FG001|Post Study Follow-up|Lost to Follow-up|1|||
161729203|NCT01327651|584051839|FG002|Post Study Follow-up|Lost to Follow-up|1|||
161729204|NCT01327651|584051840|FG003|Post Study Follow-up|Lost to Follow-up|0|||
161729205|NCT01327651|584051841|FG004|Post Study Follow-up|Lost to Follow-up|0|||
161838478|NCT00609466|584451928|FG001|Overall Study|Lack of Efficacy|2|||
161729206|NCT01327651|584051842|FG005|Post Study Follow-up|Lost to Follow-up|0|||
161729207|NCT01327651|584051843|FG006|Post Study Follow-up|Lost to Follow-up|4|||
161729208|NCT01327651|584051844|FG007|Post Study Follow-up|Lost to Follow-up|1|||
161729209|NCT01327651|584051845|FG008|Post Study Follow-up|Lost to Follow-up|2|||
161729210|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Death|1|||
161729211|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Death|1|||
161729212|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Death|0|||
161729213|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Death|2|||
161729214|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Death|3|||
161729215|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Death|2|||
161729216|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Death|2|||
161729217|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Death|4|||
161729218|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Death|2|||
161729219|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Death|1|||
161729220|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Death|7|||
161729221|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Death|7|||
161729222|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Death|12|||
161729223|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Death|7|||
161729224|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Death|0|||
161729225|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Death|4|||
161729226|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Death|4|||
161729227|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Death|12|||
161729228|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Death|6|||
161729229|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Death|4|||
161729230|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Death|2|||
161729231|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Death|3|||
161729232|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Death|1|||
161729233|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Death|1|||
161729234|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Death|4|||
161729235|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Death|0|||
161729236|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Death|0|||
161729237|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Death|0|||
161729238|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Death|0|||
161729239|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Death|0|||
161729240|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Death|0|||
161729241|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Death|0|||
161729242|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Death|0|||
161729243|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729244|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729245|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729246|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729247|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729248|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729249|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
161729250|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729251|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
161729252|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729253|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
161729254|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161729255|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
161729256|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161729257|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729258|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729259|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161729260|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729261|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729262|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729263|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729264|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729265|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729266|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729267|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729268|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729269|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729270|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729271|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729272|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729273|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729274|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729275|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729276|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
161729277|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
161729278|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
161729279|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
161729280|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
161729281|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
161729282|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
161729283|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
161729284|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
161729285|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
161729286|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
161729287|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
161729288|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
161729289|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
161729290|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
161729291|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
161729292|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
161729293|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
161729294|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
161729295|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
161729296|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
161729297|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
161729298|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
161729299|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
161729300|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
161729301|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
161729302|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
161729303|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
161729304|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
161729305|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
161729306|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
161729307|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
161729308|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
161729309|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729310|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729311|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729312|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729313|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729314|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729315|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729316|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729317|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
161729318|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729319|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729320|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729321|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729322|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729323|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729324|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729325|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
161729326|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
161729327|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729328|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
161729329|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729330|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729331|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729332|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729333|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729334|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729335|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729336|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729337|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729338|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729339|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729340|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729341|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729342|NCT03249792|584051846|FG000|Switch Over Period|Withdrawal by Subject|0|||
161729343|NCT03249792|584051847|FG001|Switch Over Period|Withdrawal by Subject|0|||
161729344|NCT03249792|584051848|FG002|Switch Over Period|Withdrawal by Subject|0|||
161729345|NCT03249792|584051849|FG003|Switch Over Period|Withdrawal by Subject|0|||
161729346|NCT03249792|584051850|FG004|Switch Over Period|Withdrawal by Subject|0|||
161729347|NCT03249792|584051851|FG005|Switch Over Period|Withdrawal by Subject|0|||
161838479|NCT00609466|584451929|FG002|Overall Study|Lack of Efficacy|2|||
161838480|NCT03407430|584451930|FG000|Washout|Protocol Violation|1|||
161729348|NCT03249792|584051852|FG006|Switch Over Period|Withdrawal by Subject|0|||
161729349|NCT03249792|584051853|FG007|Switch Over Period|Withdrawal by Subject|0|||
161729350|NCT03249792|584051854|FG008|Switch Over Period|Withdrawal by Subject|0|||
161729351|NCT03249792|584051855|FG009|Switch Over Period|Withdrawal by Subject|0|||
161729352|NCT03249792|584051856|FG010|Switch Over Period|Withdrawal by Subject|0|||
161729353|NCT03249792|584051857|FG011|Switch Over Period|Withdrawal by Subject|0|||
161729354|NCT03249792|584051858|FG012|Switch Over Period|Withdrawal by Subject|0|||
161729355|NCT03249792|584051859|FG013|Switch Over Period|Withdrawal by Subject|0|||
161729356|NCT03249792|584051860|FG014|Switch Over Period|Withdrawal by Subject|0|||
161729357|NCT03249792|584051861|FG015|Switch Over Period|Withdrawal by Subject|0|||
161729358|NCT03249792|584051862|FG016|Switch Over Period|Withdrawal by Subject|0|||
161729359|NCT03249792|584051863|FG017|Switch Over Period|Withdrawal by Subject|0|||
161729360|NCT03249792|584051864|FG018|Switch Over Period|Withdrawal by Subject|0|||
161729361|NCT03249792|584051865|FG019|Switch Over Period|Withdrawal by Subject|0|||
161838481|NCT03407430|584451931|FG001|Washout|Protocol Violation|0|||
161838482|NCT00922987|584451933|FG000|Overall Study|Insufficient clinical response|1|||
161838483|NCT00922987|584451933|FG000|Overall Study|Protocol Violation|2|||
161838484|NCT00922987|584451933|FG000|Overall Study|Adverse Event|1|||
161838485|NCT01334710|584451940|FG000|Overall Study|Trial was terminated|3|||
161838486|NCT05011123|584453434|FG000|Overall Study|Withdrawal by Subject|4|||
161838487|NCT05011123|584453435|FG001|Overall Study|Withdrawal by Subject|2|||
161838488|NCT05011123|584453434|FG000|Overall Study|Lost to Follow-up|7|||
161729362|NCT03249792|584051866|FG020|Switch Over Period|Withdrawal by Subject|0|||
161729363|NCT03249792|584051867|FG021|Switch Over Period|Withdrawal by Subject|0|||
161729364|NCT03249792|584051868|FG022|Switch Over Period|Withdrawal by Subject|0|||
161729365|NCT03249792|584051869|FG023|Switch Over Period|Withdrawal by Subject|0|||
161729366|NCT03249792|584051870|FG024|Switch Over Period|Withdrawal by Subject|0|||
161729367|NCT03249792|584051871|FG025|Switch Over Period|Withdrawal by Subject|0|||
161729368|NCT03249792|584051872|FG026|Switch Over Period|Withdrawal by Subject|0|||
161729369|NCT03249792|584051873|FG027|Switch Over Period|Withdrawal by Subject|0|||
161729370|NCT03249792|584051874|FG028|Switch Over Period|Withdrawal by Subject|0|||
161729371|NCT03249792|584051875|FG029|Switch Over Period|Withdrawal by Subject|0|||
161729372|NCT03249792|584051876|FG030|Switch Over Period|Withdrawal by Subject|0|||
161729373|NCT03249792|584051877|FG031|Switch Over Period|Withdrawal by Subject|1|||
161729374|NCT03249792|584051878|FG032|Switch Over Period|Withdrawal by Subject|0|||
161729375|NCT03249792|584051846|FG000|Switch Over Period|Progressive Disease|0|||
161729376|NCT03249792|584051847|FG001|Switch Over Period|Progressive Disease|0|||
161729377|NCT03249792|584051848|FG002|Switch Over Period|Progressive Disease|0|||
161729378|NCT03249792|584051849|FG003|Switch Over Period|Progressive Disease|0|||
161729379|NCT03249792|584051850|FG004|Switch Over Period|Progressive Disease|0|||
161729380|NCT03249792|584051851|FG005|Switch Over Period|Progressive Disease|0|||
161729381|NCT03249792|584051852|FG006|Switch Over Period|Progressive Disease|0|||
161729382|NCT03249792|584051853|FG007|Switch Over Period|Progressive Disease|0|||
161729383|NCT03249792|584051854|FG008|Switch Over Period|Progressive Disease|0|||
161729384|NCT03249792|584051855|FG009|Switch Over Period|Progressive Disease|0|||
161729385|NCT03249792|584051856|FG010|Switch Over Period|Progressive Disease|0|||
161729386|NCT03249792|584051857|FG011|Switch Over Period|Progressive Disease|0|||
161729387|NCT03249792|584051858|FG012|Switch Over Period|Progressive Disease|0|||
161729388|NCT03249792|584051859|FG013|Switch Over Period|Progressive Disease|0|||
161729389|NCT03249792|584051860|FG014|Switch Over Period|Progressive Disease|0|||
161729390|NCT03249792|584051861|FG015|Switch Over Period|Progressive Disease|0|||
161729391|NCT03249792|584051862|FG016|Switch Over Period|Progressive Disease|0|||
161729392|NCT03249792|584051863|FG017|Switch Over Period|Progressive Disease|0|||
161729393|NCT03249792|584051864|FG018|Switch Over Period|Progressive Disease|0|||
161729394|NCT03249792|584051865|FG019|Switch Over Period|Progressive Disease|0|||
161729395|NCT03249792|584051866|FG020|Switch Over Period|Progressive Disease|0|||
161729396|NCT03249792|584051867|FG021|Switch Over Period|Progressive Disease|0|||
161729397|NCT03249792|584051868|FG022|Switch Over Period|Progressive Disease|0|||
161729398|NCT03249792|584051869|FG023|Switch Over Period|Progressive Disease|0|||
161729399|NCT03249792|584051870|FG024|Switch Over Period|Progressive Disease|0|||
161729400|NCT03249792|584051871|FG025|Switch Over Period|Progressive Disease|0|||
161729401|NCT03249792|584051872|FG026|Switch Over Period|Progressive Disease|1|||
161729402|NCT03249792|584051873|FG027|Switch Over Period|Progressive Disease|0|||
161729403|NCT03249792|584051874|FG028|Switch Over Period|Progressive Disease|1|||
161729404|NCT03249792|584051875|FG029|Switch Over Period|Progressive Disease|2|||
161729405|NCT03249792|584051876|FG030|Switch Over Period|Progressive Disease|1|||
161729406|NCT03249792|584051877|FG031|Switch Over Period|Progressive Disease|0|||
161729407|NCT03249792|584051878|FG032|Switch Over Period|Progressive Disease|1|||
161729408|NCT03249792|584051846|FG000|Switch Over Period|Adverse Event|0|||
161729409|NCT03249792|584051847|FG001|Switch Over Period|Adverse Event|0|||
161729410|NCT03249792|584051848|FG002|Switch Over Period|Adverse Event|0|||
161729411|NCT03249792|584051849|FG003|Switch Over Period|Adverse Event|0|||
161729412|NCT03249792|584051850|FG004|Switch Over Period|Adverse Event|0|||
161729413|NCT03249792|584051851|FG005|Switch Over Period|Adverse Event|0|||
161729414|NCT03249792|584051852|FG006|Switch Over Period|Adverse Event|0|||
161729415|NCT03249792|584051853|FG007|Switch Over Period|Adverse Event|0|||
161838489|NCT05011123|584453435|FG001|Overall Study|Lost to Follow-up|6|||
161729416|NCT03249792|584051854|FG008|Switch Over Period|Adverse Event|0|||
161729417|NCT03249792|584051855|FG009|Switch Over Period|Adverse Event|0|||
161729418|NCT03249792|584051856|FG010|Switch Over Period|Adverse Event|0|||
161729419|NCT03249792|584051857|FG011|Switch Over Period|Adverse Event|0|||
161729420|NCT03249792|584051858|FG012|Switch Over Period|Adverse Event|0|||
161729421|NCT03249792|584051859|FG013|Switch Over Period|Adverse Event|0|||
161729422|NCT03249792|584051860|FG014|Switch Over Period|Adverse Event|0|||
161729423|NCT03249792|584051861|FG015|Switch Over Period|Adverse Event|0|||
161729424|NCT03249792|584051862|FG016|Switch Over Period|Adverse Event|0|||
161729425|NCT03249792|584051863|FG017|Switch Over Period|Adverse Event|0|||
161838490|NCT05011123|584453434|FG000|Overall Study|Ongoing at the time of DBL date|36|||
161838491|NCT05011123|584453435|FG001|Overall Study|Ongoing at the time of DBL date|10|||
161729426|NCT03249792|584051864|FG018|Switch Over Period|Adverse Event|0|||
161729427|NCT03249792|584051865|FG019|Switch Over Period|Adverse Event|0|||
161729428|NCT03249792|584051866|FG020|Switch Over Period|Adverse Event|0|||
161729429|NCT03249792|584051867|FG021|Switch Over Period|Adverse Event|0|||
161729430|NCT03249792|584051868|FG022|Switch Over Period|Adverse Event|0|||
161729431|NCT03249792|584051869|FG023|Switch Over Period|Adverse Event|0|||
161729432|NCT03249792|584051870|FG024|Switch Over Period|Adverse Event|0|||
161729433|NCT03249792|584051871|FG025|Switch Over Period|Adverse Event|1|||
161729434|NCT03249792|584051872|FG026|Switch Over Period|Adverse Event|0|||
161729435|NCT03249792|584051873|FG027|Switch Over Period|Adverse Event|1|||
161729436|NCT03249792|584051874|FG028|Switch Over Period|Adverse Event|0|||
161729437|NCT03249792|584051875|FG029|Switch Over Period|Adverse Event|0|||
161729438|NCT03249792|584051876|FG030|Switch Over Period|Adverse Event|0|||
161729439|NCT03249792|584051877|FG031|Switch Over Period|Adverse Event|0|||
161729440|NCT03249792|584051878|FG032|Switch Over Period|Adverse Event|0|||
161729441|NCT00532948|584051882|FG000|Overall Study|Protocol Violation|1|||
161729442|NCT00532948|584051883|FG001|Overall Study|Protocol Violation|0|||
161729443|NCT00532948|584051884|FG002|Overall Study|Protocol Violation|0|||
161729444|NCT00532948|584051882|FG000|Overall Study|Death|3|||
161729445|NCT00532948|584051883|FG001|Overall Study|Death|3|||
161729446|NCT00532948|584051884|FG002|Overall Study|Death|4|||
161729447|NCT00532948|584051882|FG000|Overall Study|Violation of selection criteria at entry|0|||
161729448|NCT00532948|584051883|FG001|Overall Study|Violation of selection criteria at entry|1|||
161729449|NCT00532948|584051884|FG002|Overall Study|Violation of selection criteria at entry|0|||
161729450|NCT00532948|584051882|FG000|Overall Study|Failure to return|0|||
161729451|NCT00532948|584051883|FG001|Overall Study|Failure to return|1|||
161729452|NCT00532948|584051884|FG002|Overall Study|Failure to return|0|||
161729453|NCT01201798|584051893|FG000|Overall Study|Adverse Event|2|||
161729454|NCT01201798|584051894|FG001|Overall Study|Adverse Event|0|||
161729455|NCT01201798|584051893|FG000|Overall Study|Lost to Follow-up|3|||
161729456|NCT01201798|584051894|FG001|Overall Study|Lost to Follow-up|5|||
161729457|NCT01201798|584051893|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
161729458|NCT01201798|584051894|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
161729459|NCT01201798|584051893|FG000|Overall Study|Noncompliance|1|||
161729460|NCT01201798|584051894|FG001|Overall Study|Noncompliance|0|||
161729461|NCT01201798|584051893|FG000|Overall Study|Protocol Violation|1|||
161729462|NCT01201798|584051894|FG001|Overall Study|Protocol Violation|1|||
161729463|NCT01201798|584051893|FG000|Overall Study|Treatment Failure|1|||
161729464|NCT01201798|584051894|FG001|Overall Study|Treatment Failure|8|||
161729465|NCT02509598|584051895|FG000|Overall Study|Withdrawal by Subject|1|||
161729466|NCT05692154|584051896|FG000|Overall Study|Adverse Event|0|||
161729467|NCT05692154|584051897|FG001|Overall Study|Adverse Event|1|||
161729468|NCT03609359|584051900|FG000|Overall Study|Progression of primary disease (PD)|25|||
161729469|NCT03609359|584051900|FG000|Overall Study|Patient's refusal|1|||
161729470|NCT03609359|584051900|FG000|Overall Study|Physician Decision|1|||
161729471|NCT03609359|584051900|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
161729472|NCT01912729|584051901|FG000|Overall Study|Withdrawal by Subject|0|||
161729473|NCT01912729|584051902|FG001|Overall Study|Withdrawal by Subject|1|||
161729474|NCT01952834|584051909|FG000|Overall Study|Adverse Event|1|||
161729475|NCT01975272|584051912|FG000|Overall Study|Excluded after protocol amendment|1|||
161729476|NCT01975272|584051913|FG001|Overall Study|Excluded after protocol amendment|1|||
161729477|NCT01975272|584051914|FG002|Overall Study|Excluded after protocol amendment|2|||
161729478|NCT00740779|584051921|FG000|Overall Study|Adverse Event|4|||
161729479|NCT00740779|584051922|FG001|Overall Study|Adverse Event|6|||
161729480|NCT00740779|584051923|FG002|Overall Study|Adverse Event|3|||
161729481|NCT00740779|584051921|FG000|Overall Study|Protocol Violation|1|||
161729482|NCT00740779|584051922|FG001|Overall Study|Protocol Violation|1|||
161729483|NCT00740779|584051923|FG002|Overall Study|Protocol Violation|1|||
161729484|NCT00740779|584051921|FG000|Overall Study|Lack of Efficacy|0|||
161729485|NCT00740779|584051922|FG001|Overall Study|Lack of Efficacy|0|||
161729486|NCT00740779|584051923|FG002|Overall Study|Lack of Efficacy|2|||
161729487|NCT00740779|584051921|FG000|Overall Study|Withdrawal by Subject|2|||
161729488|NCT00740779|584051922|FG001|Overall Study|Withdrawal by Subject|4|||
161729489|NCT00740779|584051923|FG002|Overall Study|Withdrawal by Subject|2|||
161729490|NCT00740779|584051921|FG000|Overall Study|Lost to Follow-up|2|||
161729491|NCT00740779|584051922|FG001|Overall Study|Lost to Follow-up|3|||
161729492|NCT00740779|584051923|FG002|Overall Study|Lost to Follow-up|5|||
161729493|NCT00988559|584051929|FG000|Overall Study|Withdrawal by Subject|1|||
161729494|NCT00988559|584051930|FG001|Overall Study|Withdrawal by Subject|1|||
161729495|NCT00988559|584051931|FG002|Overall Study|Withdrawal by Subject|0|||
161729496|NCT00988559|584051932|FG003|Overall Study|Withdrawal by Subject|1|||
161729497|NCT00988559|584051929|FG000|Overall Study|Pregnancy|0|||
161729498|NCT00988559|584051930|FG001|Overall Study|Pregnancy|1|||
161729499|NCT00988559|584051931|FG002|Overall Study|Pregnancy|1|||
161729500|NCT00988559|584051932|FG003|Overall Study|Pregnancy|0|||
161729501|NCT00988559|584051929|FG000|Overall Study|Lost to Follow-up|0|||
161729502|NCT00988559|584051930|FG001|Overall Study|Lost to Follow-up|0|||
161729503|NCT00988559|584051931|FG002|Overall Study|Lost to Follow-up|1|||
161729504|NCT00988559|584051932|FG003|Overall Study|Lost to Follow-up|0|||
161729505|NCT01052012|584051933|FG000|Overall Study|Not treated|2|||
161729506|NCT01052012|584051934|FG001|Overall Study|Not treated|5|||
161729507|NCT01052012|584051935|FG002|Overall Study|Not treated|0|||
161729508|NCT01052012|584051936|FG003|Overall Study|Not treated|0|||
161729509|NCT01052012|584051937|FG004|Overall Study|Not treated|11|||
161729510|NCT01052012|584051938|FG005|Overall Study|Not treated|8|||
161729511|NCT01052012|584051933|FG000|Overall Study|Adverse Event|1|||
161729512|NCT01052012|584051934|FG001|Overall Study|Adverse Event|0|||
161729513|NCT01052012|584051935|FG002|Overall Study|Adverse Event|0|||
161729514|NCT01052012|584051936|FG003|Overall Study|Adverse Event|1|||
161729515|NCT01052012|584051937|FG004|Overall Study|Adverse Event|0|||
161729516|NCT01052012|584051938|FG005|Overall Study|Adverse Event|0|||
161729517|NCT01052012|584051933|FG000|Overall Study|Lost to Follow-up|0|||
161729518|NCT01052012|584051934|FG001|Overall Study|Lost to Follow-up|0|||
161729519|NCT01052012|584051935|FG002|Overall Study|Lost to Follow-up|0|||
161729520|NCT01052012|584051936|FG003|Overall Study|Lost to Follow-up|0|||
161729521|NCT01052012|584051937|FG004|Overall Study|Lost to Follow-up|1|||
161729522|NCT01052012|584051938|FG005|Overall Study|Lost to Follow-up|0|||
161729523|NCT01052012|584051933|FG000|Overall Study|Withdrawal by Subject|1|||
161729524|NCT01052012|584051934|FG001|Overall Study|Withdrawal by Subject|1|||
161729525|NCT01052012|584051935|FG002|Overall Study|Withdrawal by Subject|0|||
161729526|NCT01052012|584051936|FG003|Overall Study|Withdrawal by Subject|0|||
161729527|NCT01052012|584051937|FG004|Overall Study|Withdrawal by Subject|3|||
161729528|NCT01052012|584051938|FG005|Overall Study|Withdrawal by Subject|1|||
161729529|NCT01052012|584051933|FG000|Overall Study|Physician Decision|0|||
161729530|NCT01052012|584051934|FG001|Overall Study|Physician Decision|0|||
161729531|NCT01052012|584051935|FG002|Overall Study|Physician Decision|0|||
161729532|NCT01052012|584051936|FG003|Overall Study|Physician Decision|0|||
161729533|NCT01052012|584051937|FG004|Overall Study|Physician Decision|0|||
161729534|NCT01052012|584051938|FG005|Overall Study|Physician Decision|1|||
161729535|NCT01052012|584051933|FG000|Overall Study|Other|0|||
161729536|NCT01052012|584051934|FG001|Overall Study|Other|0|||
161729537|NCT01052012|584051935|FG002|Overall Study|Other|0|||
161729538|NCT01052012|584051936|FG003|Overall Study|Other|0|||
161729539|NCT01052012|584051937|FG004|Overall Study|Other|1|||
161729540|NCT01052012|584051938|FG005|Overall Study|Other|0|||
161729541|NCT00829166|584051942|FG000|Overall Study|Death|305|||
161729542|NCT00829166|584051943|FG001|Overall Study|Death|333|||
161729543|NCT00829166|584051942|FG000|Overall Study|Lost to Follow-up|5|||
161729544|NCT00829166|584051943|FG001|Overall Study|Lost to Follow-up|4|||
161729545|NCT00829166|584051942|FG000|Overall Study|Physician's Decision|4|||
161729546|NCT00829166|584051943|FG001|Overall Study|Physician's Decision|3|||
161729547|NCT00829166|584051942|FG000|Overall Study|Subject's Decision|41|||
161729548|NCT00829166|584051943|FG001|Overall Study|Subject's Decision|55|||
161729549|NCT00829166|584051942|FG000|Overall Study|Sponsor's Decision|137|||
161729550|NCT00829166|584051943|FG001|Overall Study|Sponsor's Decision|98|||
161729551|NCT00829166|584051942|FG000|Overall Study|Reason Not Specified|3|||
161729552|NCT00829166|584051943|FG001|Overall Study|Reason Not Specified|3|||
161729553|NCT02538666|584051944|FG000|Pre-Treatment|Disease progression|1|||
161729554|NCT02538666|584051945|FG001|Pre-Treatment|Disease progression|0|||
161729555|NCT02538666|584051946|FG002|Pre-Treatment|Disease progression|0|||
161729556|NCT02538666|584051944|FG000|Pre-Treatment|no longer meets study criteria|1|||
161729557|NCT02538666|584051945|FG001|Pre-Treatment|no longer meets study criteria|0|||
161729558|NCT02538666|584051946|FG002|Pre-Treatment|no longer meets study criteria|0|||
161729559|NCT02538666|584051944|FG000|Pre-Treatment|Withdrew Consent|0|||
161729560|NCT02538666|584051945|FG001|Pre-Treatment|Withdrew Consent|1|||
161729561|NCT02538666|584051946|FG002|Pre-Treatment|Withdrew Consent|1|||
161729562|NCT02538666|584051944|FG000|Treatment|Disease progression|270|||
161729563|NCT02538666|584051945|FG001|Treatment|Disease progression|227|||
161729564|NCT02538666|584051946|FG002|Treatment|Disease progression|165|||
161729565|NCT02538666|584051944|FG000|Treatment|Study drug toxicity|1|||
161729566|NCT02538666|584051945|FG001|Treatment|Study drug toxicity|29|||
161729567|NCT02538666|584051946|FG002|Treatment|Study drug toxicity|92|||
161729568|NCT02538666|584051944|FG000|Treatment|Death|0|||
161729569|NCT02538666|584051945|FG001|Treatment|Death|2|||
161729570|NCT02538666|584051946|FG002|Treatment|Death|3|||
161729571|NCT02538666|584051944|FG000|Treatment|Adverse event unrelated to study drug|8|||
161729572|NCT02538666|584051945|FG001|Treatment|Adverse event unrelated to study drug|10|||
161729573|NCT02538666|584051946|FG002|Treatment|Adverse event unrelated to study drug|15|||
161729574|NCT02538666|584051944|FG000|Treatment|Participant request to discontinue study treatment|3|||
161729575|NCT02538666|584051945|FG001|Treatment|Participant request to discontinue study treatment|6|||
161729576|NCT02538666|584051946|FG002|Treatment|Participant request to discontinue study treatment|11|||
161729577|NCT02538666|584051944|FG000|Treatment|Participant withdrew consent|2|||
161729578|NCT02538666|584051945|FG001|Treatment|Participant withdrew consent|5|||
161729579|NCT02538666|584051946|FG002|Treatment|Participant withdrew consent|3|||
161838492|NCT05011123|584453434|FG000|Overall Study|Randomized but did not receive vaccination|1|||
161838493|NCT05011123|584453435|FG001|Overall Study|Randomized but did not receive vaccination|0|||
161838494|NCT04221789|584453436|FG000|Overall Study|deviation from protoco|22|||
161838495|NCT04221789|584453437|FG001|Overall Study|deviation from protoco|8|||
161838496|NCT02068092|584453440|FG000|Overall Study|Physician Decision|2|||
161838497|NCT02068092|584453440|FG000|Overall Study|Adverse Event|2|||
161838498|NCT02068092|584453440|FG000|Overall Study|Lost to Follow-up|4|||
161838499|NCT02068092|584453440|FG000|Overall Study|Withdrawal by Subject|2|||
161838500|NCT03502707|584453441|FG000|Overall Study|Adverse Event|0|||
161838501|NCT03502707|584453442|FG001|Overall Study|Adverse Event|0|||
161838502|NCT03502707|584453443|FG002|Overall Study|Adverse Event|0|||
161838503|NCT03502707|584453444|FG003|Overall Study|Adverse Event|0|||
161838504|NCT03502707|584453445|FG004|Overall Study|Adverse Event|0|||
161838505|NCT03502707|584453446|FG005|Overall Study|Adverse Event|0|||
161838506|NCT03502707|584453447|FG006|Overall Study|Adverse Event|0|||
161838507|NCT03502707|584453448|FG007|Overall Study|Adverse Event|0|||
161838508|NCT03502707|584453449|FG008|Overall Study|Adverse Event|0|||
161838509|NCT03502707|584453450|FG009|Overall Study|Adverse Event|0|||
161838510|NCT03502707|584453451|FG010|Overall Study|Adverse Event|0|||
161838511|NCT03502707|584453452|FG011|Overall Study|Adverse Event|0|||
161838512|NCT03502707|584453453|FG012|Overall Study|Adverse Event|0|||
161838513|NCT03502707|584453454|FG013|Overall Study|Adverse Event|0|||
161838514|NCT03502707|584453455|FG014|Overall Study|Adverse Event|0|||
161838515|NCT03502707|584453456|FG015|Overall Study|Adverse Event|1|||
161838516|NCT03502707|584453457|FG016|Overall Study|Adverse Event|5|||
161838517|NCT03502707|584453458|FG017|Overall Study|Adverse Event|0|||
161838518|NCT03502707|584453441|FG000|Overall Study|Death|0|||
161838519|NCT03502707|584453442|FG001|Overall Study|Death|0|||
161838520|NCT03502707|584453443|FG002|Overall Study|Death|0|||
161838521|NCT03502707|584453444|FG003|Overall Study|Death|1|||
161838522|NCT03502707|584453445|FG004|Overall Study|Death|0|||
161838523|NCT03502707|584453446|FG005|Overall Study|Death|0|||
161838524|NCT03502707|584453447|FG006|Overall Study|Death|0|||
161838525|NCT03502707|584453448|FG007|Overall Study|Death|0|||
161838526|NCT03502707|584453449|FG008|Overall Study|Death|1|||
161729580|NCT02538666|584051944|FG000|Treatment|Lost to Follow-up|0|||
161729581|NCT02538666|584051945|FG001|Treatment|Lost to Follow-up|1|||
161729582|NCT02538666|584051946|FG002|Treatment|Lost to Follow-up|1|||
161729583|NCT02538666|584051944|FG000|Treatment|Maximum clinical benefit|4|||
161729584|NCT02538666|584051945|FG001|Treatment|Maximum clinical benefit|3|||
161729585|NCT02538666|584051946|FG002|Treatment|Maximum clinical benefit|4|||
161729586|NCT02538666|584051944|FG000|Treatment|Poor/non-compliance|0|||
161729587|NCT02538666|584051945|FG001|Treatment|Poor/non-compliance|1|||
161729588|NCT02538666|584051946|FG002|Treatment|Poor/non-compliance|0|||
161729589|NCT02538666|584051944|FG000|Treatment|Participant no longer meets study criteria|0|||
161729590|NCT02538666|584051945|FG001|Treatment|Participant no longer meets study criteria|2|||
161729591|NCT02538666|584051946|FG002|Treatment|Participant no longer meets study criteria|0|||
161729592|NCT02538666|584051944|FG000|Treatment|Administrative reason by sponsor|0|||
161729593|NCT02538666|584051945|FG001|Treatment|Administrative reason by sponsor|0|||
161729594|NCT02538666|584051946|FG002|Treatment|Administrative reason by sponsor|1|||
161729595|NCT02538666|584051944|FG000|Treatment|Other reasons|8|||
161729596|NCT02538666|584051945|FG001|Treatment|Other reasons|15|||
161729597|NCT02538666|584051946|FG002|Treatment|Other reasons|5|||
161838527|NCT03502707|584453450|FG009|Overall Study|Death|1|||
161838528|NCT03502707|584453451|FG010|Overall Study|Death|0|||
161838529|NCT03502707|584453452|FG011|Overall Study|Death|0|||
161838530|NCT03502707|584453453|FG012|Overall Study|Death|1|||
161838531|NCT03502707|584453454|FG013|Overall Study|Death|0|||
161729598|NCT02538666|584051944|FG000|Treatment|Not reported|2|||
161729599|NCT02538666|584051945|FG001|Treatment|Not reported|2|||
161838532|NCT03502707|584453455|FG014|Overall Study|Death|0|||
161838533|NCT03502707|584453456|FG015|Overall Study|Death|1|||
161838534|NCT03502707|584453457|FG016|Overall Study|Death|0|||
161838535|NCT03502707|584453458|FG017|Overall Study|Death|0|||
161729600|NCT02538666|584051946|FG002|Treatment|Not reported|2|||
161729601|NCT01465178|584051951|FG000|Overall Study|Withdrawal by Subject|1|||
161729602|NCT01465178|584051952|FG001|Overall Study|Withdrawal by Subject|0|||
161729603|NCT04072146|584051953|FG000|Overall Study|Adverse Event|0|||
161729604|NCT04072146|584051954|FG001|Overall Study|Adverse Event|1|||
161729605|NCT02993224|584051955|FG000|Core Phase - Period 1|Adverse Event|4|||
161838536|NCT03502707|584453441|FG000|Overall Study|Lost to Follow-up|0|||
161838537|NCT03502707|584453442|FG001|Overall Study|Lost to Follow-up|0|||
161838538|NCT03502707|584453443|FG002|Overall Study|Lost to Follow-up|0|||
161838539|NCT03502707|584453444|FG003|Overall Study|Lost to Follow-up|0|||
161838540|NCT03502707|584453445|FG004|Overall Study|Lost to Follow-up|0|||
161838541|NCT03502707|584453446|FG005|Overall Study|Lost to Follow-up|0|||
161838542|NCT03502707|584453447|FG006|Overall Study|Lost to Follow-up|0|||
161838543|NCT03502707|584453448|FG007|Overall Study|Lost to Follow-up|5|||
161838544|NCT03502707|584453449|FG008|Overall Study|Lost to Follow-up|0|||
161838545|NCT03502707|584453450|FG009|Overall Study|Lost to Follow-up|2|||
161838546|NCT03502707|584453451|FG010|Overall Study|Lost to Follow-up|1|||
161729606|NCT02993224|584051955|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
161729607|NCT02993224|584051955|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
161729608|NCT02993224|584051955|FG000|Core Phase- Period 2|Adverse Event|1|||
161729609|NCT02993224|584051955|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
161729610|NCT02993224|584051955|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
161729611|NCT02993224|584051955|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
161729612|NCT02993224|584051955|FG000|Extension Phase|Adverse Event|3|||
161729613|NCT02993224|584051955|FG000|Extension Phase|Withdrawal by Subject|3|||
161729614|NCT02993224|584051955|FG000|Extension Phase|Lost to Follow-up|2|||
161729615|NCT02993224|584051955|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
161729616|NCT00111475|584053556|FG000|Overall Study|Lost to Follow-up|0|||
161729617|NCT00111475|584053557|FG001|Overall Study|Lost to Follow-up|0|||
161729618|NCT00111475|584053558|FG002|Overall Study|Lost to Follow-up|0|||
161729619|NCT00111475|584053559|FG003|Overall Study|Lost to Follow-up|0|||
161729620|NCT00111475|584053560|FG004|Overall Study|Lost to Follow-up|0|||
161729621|NCT00111475|584053561|FG005|Overall Study|Lost to Follow-up|1|||
161729622|NCT00111475|584053562|FG006|Overall Study|Lost to Follow-up|0|||
161729623|NCT00111475|584053563|FG007|Overall Study|Lost to Follow-up|0|||
161729624|NCT00111475|584053564|FG008|Overall Study|Lost to Follow-up|0|||
161729625|NCT00111475|584053565|FG009|Overall Study|Lost to Follow-up|0|||
161729626|NCT01597557|584053569|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
161729627|NCT01597557|584053570|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
161729628|NCT00115349|584053573|FG000|Overall Study|Study closed due to low enrollment.|11|||
161729629|NCT00115349|584053574|FG001|Overall Study|Study closed due to low enrollment.|9|||
161729630|NCT02935634|584053578|FG000|Randomization|Participant withdrew consent|0|||
161729631|NCT02935634|584053579|FG001|Randomization|Participant withdrew consent|1|||
161729632|NCT02935634|584053580|FG002|Randomization|Participant withdrew consent|0|||
161729633|NCT02935634|584053581|FG003|Randomization|Participant withdrew consent|0|||
161729634|NCT02935634|584053582|FG004|Randomization|Participant withdrew consent|0|||
161729635|NCT02935634|584053583|FG005|Randomization|Participant withdrew consent|0|||
161729636|NCT02935634|584053578|FG000|Randomization|Death|2|||
161729637|NCT02935634|584053579|FG001|Randomization|Death|1|||
161729638|NCT02935634|584053580|FG002|Randomization|Death|1|||
161729639|NCT02935634|584053581|FG003|Randomization|Death|0|||
161729640|NCT02935634|584053582|FG004|Randomization|Death|0|||
161729641|NCT02935634|584053583|FG005|Randomization|Death|0|||
161729642|NCT02935634|584053578|FG000|Randomization|Other reasons|0|||
161729643|NCT02935634|584053579|FG001|Randomization|Other reasons|2|||
161729644|NCT02935634|584053580|FG002|Randomization|Other reasons|2|||
161729645|NCT02935634|584053581|FG003|Randomization|Other reasons|0|||
161729646|NCT02935634|584053582|FG004|Randomization|Other reasons|0|||
161729647|NCT02935634|584053583|FG005|Randomization|Other reasons|0|||
161729648|NCT02935634|584053578|FG000|Treatment: Track 1|Disease progression|15|||
161729649|NCT02935634|584053579|FG001|Treatment: Track 1|Disease progression|17|||
161729650|NCT02935634|584053580|FG002|Treatment: Track 1|Disease progression|28|||
161729651|NCT02935634|584053581|FG003|Treatment: Track 1|Disease progression|4|||
161729652|NCT02935634|584053582|FG004|Treatment: Track 1|Disease progression|6|||
161729653|NCT02935634|584053583|FG005|Treatment: Track 1|Disease progression|2|||
161729654|NCT02935634|584053578|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
161729655|NCT02935634|584053579|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
161729656|NCT02935634|584053580|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
161729657|NCT02935634|584053581|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
161729658|NCT02935634|584053582|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
161729659|NCT02935634|584053583|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
161729660|NCT02935634|584053578|FG000|Treatment: Track 1|Lost to Follow-up|1|||
161729661|NCT02935634|584053579|FG001|Treatment: Track 1|Lost to Follow-up|0|||
161729662|NCT02935634|584053580|FG002|Treatment: Track 1|Lost to Follow-up|0|||
161729663|NCT02935634|584053581|FG003|Treatment: Track 1|Lost to Follow-up|0|||
161729664|NCT02935634|584053582|FG004|Treatment: Track 1|Lost to Follow-up|0|||
161729665|NCT02935634|584053583|FG005|Treatment: Track 1|Lost to Follow-up|0|||
161729666|NCT02935634|584053578|FG000|Treatment: Track 1|Study drug toxicity|2|||
161729667|NCT02935634|584053579|FG001|Treatment: Track 1|Study drug toxicity|1|||
161729668|NCT02935634|584053580|FG002|Treatment: Track 1|Study drug toxicity|3|||
161729669|NCT02935634|584053581|FG003|Treatment: Track 1|Study drug toxicity|0|||
161729670|NCT02935634|584053582|FG004|Treatment: Track 1|Study drug toxicity|0|||
161729671|NCT02935634|584053583|FG005|Treatment: Track 1|Study drug toxicity|1|||
161729672|NCT02935634|584053578|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
161729673|NCT02935634|584053579|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
161729674|NCT02935634|584053580|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
161729675|NCT02935634|584053581|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
161729676|NCT02935634|584053582|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
161729677|NCT02935634|584053583|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
161729678|NCT02935634|584053578|FG000|Treatment: Track 1|Participant withdrew consent|2|||
161729679|NCT02935634|584053579|FG001|Treatment: Track 1|Participant withdrew consent|0|||
161729680|NCT02935634|584053580|FG002|Treatment: Track 1|Participant withdrew consent|1|||
161729681|NCT02935634|584053581|FG003|Treatment: Track 1|Participant withdrew consent|0|||
161729682|NCT02935634|584053582|FG004|Treatment: Track 1|Participant withdrew consent|1|||
161729683|NCT02935634|584053583|FG005|Treatment: Track 1|Participant withdrew consent|0|||
161729684|NCT02935634|584053578|FG000|Treatment: Track 1|Other reasons|0|||
161729685|NCT02935634|584053579|FG001|Treatment: Track 1|Other reasons|0|||
161729686|NCT02935634|584053580|FG002|Treatment: Track 1|Other reasons|2|||
161729687|NCT02935634|584053581|FG003|Treatment: Track 1|Other reasons|0|||
161729688|NCT02935634|584053582|FG004|Treatment: Track 1|Other reasons|0|||
161729689|NCT02935634|584053583|FG005|Treatment: Track 1|Other reasons|0|||
161729690|NCT02935634|584053578|FG000|Treatment: Track 2|Disease progression|13|||
161729691|NCT02935634|584053579|FG001|Treatment: Track 2|Disease progression|26|||
161729692|NCT02935634|584053580|FG002|Treatment: Track 2|Disease progression|20|||
161729693|NCT02935634|584053581|FG003|Treatment: Track 2|Disease progression|5|||
161729694|NCT02935634|584053582|FG004|Treatment: Track 2|Disease progression|1|||
161729695|NCT02935634|584053583|FG005|Treatment: Track 2|Disease progression|4|||
161729696|NCT02935634|584053578|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
161729697|NCT02935634|584053579|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
161729698|NCT02935634|584053580|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729699|NCT02935634|584053581|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729700|NCT02935634|584053582|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729701|NCT02935634|584053583|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729702|NCT02935634|584053578|FG000|Treatment: Track 2|Study drug toxicity|7|||
161729703|NCT02935634|584053579|FG001|Treatment: Track 2|Study drug toxicity|3|||
161729704|NCT02935634|584053580|FG002|Treatment: Track 2|Study drug toxicity|0|||
161729705|NCT02935634|584053581|FG003|Treatment: Track 2|Study drug toxicity|0|||
161729706|NCT02935634|584053582|FG004|Treatment: Track 2|Study drug toxicity|0|||
161729707|NCT02935634|584053583|FG005|Treatment: Track 2|Study drug toxicity|0|||
161729708|NCT02935634|584053578|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729709|NCT02935634|584053579|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
161729710|NCT02935634|584053580|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
161729711|NCT02935634|584053581|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729712|NCT02935634|584053582|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729713|NCT02935634|584053583|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729714|NCT02935634|584053578|FG000|Treatment: Track 2|Participant withdrew consent|0|||
161729715|NCT02935634|584053579|FG001|Treatment: Track 2|Participant withdrew consent|1|||
161729716|NCT02935634|584053580|FG002|Treatment: Track 2|Participant withdrew consent|1|||
161729717|NCT02935634|584053581|FG003|Treatment: Track 2|Participant withdrew consent|0|||
161729718|NCT02935634|584053582|FG004|Treatment: Track 2|Participant withdrew consent|1|||
161729719|NCT02935634|584053583|FG005|Treatment: Track 2|Participant withdrew consent|0|||
161729720|NCT06150573|584053586|FG000|Overall Study|Did not meet study criteria|1|||
161729721|NCT06150573|584053587|FG001|Overall Study|Did not meet study criteria|0|||
161729722|NCT06150573|584053586|FG000|Overall Study|Adverse Event|1|||
161729723|NCT06150573|584053587|FG001|Overall Study|Adverse Event|0|||
161729724|NCT06150573|584053586|FG000|Overall Study|Lost to Follow-up|0|||
161729725|NCT06150573|584053587|FG001|Overall Study|Lost to Follow-up|1|||
161729726|NCT06150573|584053586|FG000|Overall Study|Protocol Violation|0|||
161729727|NCT06150573|584053587|FG001|Overall Study|Protocol Violation|1|||
161729728|NCT06150573|584053586|FG000|Overall Study|Withdrawal by Subject|2|||
161729729|NCT06150573|584053587|FG001|Overall Study|Withdrawal by Subject|0|||
161729730|NCT00210158|584053588|FG000|Overall Study|Protocol Violation|0|||
161729731|NCT00210158|584053589|FG001|Overall Study|Protocol Violation|2|||
161729732|NCT02284906|584053594|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161729733|NCT02284906|584053595|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161729734|NCT02284906|584053596|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161729735|NCT02284906|584053594|FG000|Overall Study|Major Protocol Deviation|0|||
161729736|NCT02284906|584053595|FG001|Overall Study|Major Protocol Deviation|1|||
161729737|NCT02284906|584053596|FG002|Overall Study|Major Protocol Deviation|0|||
161729738|NCT02284906|584053594|FG000|Overall Study|Voluntary Withdrawal|2|||
161729739|NCT02284906|584053595|FG001|Overall Study|Voluntary Withdrawal|4|||
161729740|NCT02284906|584053596|FG002|Overall Study|Voluntary Withdrawal|5|||
161729741|NCT02284906|584053594|FG000|Overall Study|Study Termination|0|||
161729742|NCT02284906|584053595|FG001|Overall Study|Study Termination|11|||
161729743|NCT02284906|584053596|FG002|Overall Study|Study Termination|14|||
161729744|NCT02284906|584053594|FG000|Overall Study|Reason not Specified|1|||
161729745|NCT02284906|584053595|FG001|Overall Study|Reason not Specified|1|||
161729746|NCT02284906|584053596|FG002|Overall Study|Reason not Specified|0|||
161729747|NCT01409031|584053597|FG000|Overall Study|transferred to other hosp|1|||
161729748|NCT01409031|584053598|FG001|Overall Study|transferred to other hosp|0|||
161729749|NCT00995345|584053599|FG000|Overall Study|Withdrawal by Subject|4|||
161729750|NCT00995345|584053600|FG001|Overall Study|Withdrawal by Subject|2|||
161729751|NCT00995345|584053601|FG002|Overall Study|Withdrawal by Subject|1|||
161729752|NCT00995345|584053602|FG003|Overall Study|Withdrawal by Subject|3|||
161729753|NCT00995345|584053603|FG004|Overall Study|Withdrawal by Subject|1|||
161729754|NCT00995345|584053599|FG000|Overall Study|Adverse Event|3|||
161729755|NCT00995345|584053600|FG001|Overall Study|Adverse Event|1|||
161729756|NCT00995345|584053601|FG002|Overall Study|Adverse Event|2|||
161729757|NCT00995345|584053602|FG003|Overall Study|Adverse Event|0|||
161729758|NCT00995345|584053603|FG004|Overall Study|Adverse Event|1|||
161729759|NCT00995345|584053599|FG000|Overall Study|Lost to Follow-up|2|||
161729760|NCT00995345|584053600|FG001|Overall Study|Lost to Follow-up|2|||
161729761|NCT00995345|584053601|FG002|Overall Study|Lost to Follow-up|2|||
161729762|NCT00995345|584053602|FG003|Overall Study|Lost to Follow-up|1|||
161729763|NCT00995345|584053603|FG004|Overall Study|Lost to Follow-up|0|||
161729764|NCT00995345|584053599|FG000|Overall Study|all other reasons combined|2|||
161729765|NCT00995345|584053600|FG001|Overall Study|all other reasons combined|2|||
161729766|NCT00995345|584053601|FG002|Overall Study|all other reasons combined|2|||
161729767|NCT00995345|584053602|FG003|Overall Study|all other reasons combined|1|||
161729768|NCT00995345|584053603|FG004|Overall Study|all other reasons combined|3|||
161729769|NCT03885726|584053605|FG000|Overall Study|Staffing issues/lost interest|1|||
161729770|NCT03885726|584053605|FG000|Overall Study|Early discharge from hospital|3|||
161729771|NCT02702193|584053606|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
161729772|NCT02702193|584053607|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
161729773|NCT02702193|584053606|FG000|4 Month Follow up|Withdrawal by Subject|1|||
161729774|NCT02702193|584053607|FG001|4 Month Follow up|Withdrawal by Subject|0|||
161729775|NCT02702193|584053606|FG000|4 Month Follow up|Lost to Follow-up|17|||
161729776|NCT02702193|584053607|FG001|4 Month Follow up|Lost to Follow-up|18|||
161729777|NCT02702193|584053606|FG000|8 Month Follow up|Withdrawal by Subject|1|||
161729778|NCT02702193|584053607|FG001|8 Month Follow up|Withdrawal by Subject|0|||
161729779|NCT02702193|584053606|FG000|8 Month Follow up|Lost to Follow-up|14|||
161729780|NCT02702193|584053607|FG001|8 Month Follow up|Lost to Follow-up|18|||
161729781|NCT02702193|584053606|FG000|12 Month Follow up|Withdrawal by Subject|1|||
161729782|NCT02702193|584053607|FG001|12 Month Follow up|Withdrawal by Subject|0|||
161729783|NCT02702193|584053606|FG000|12 Month Follow up|Lost to Follow-up|16|||
161729784|NCT02702193|584053607|FG001|12 Month Follow up|Lost to Follow-up|18|||
161729785|NCT04056455|584053609|FG000|Overall Study|Adverse Event|1|||
161729786|NCT04056455|584053610|FG001|Overall Study|Adverse Event|0|||
161729787|NCT02512068|584053611|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
161729788|NCT02512068|584053612|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161729789|NCT02512068|584053611|FG000|Overall Study|Major Protocol Deviation|1|||
161729790|NCT02512068|584053612|FG001|Overall Study|Major Protocol Deviation|0|||
161729791|NCT02512068|584053611|FG000|Overall Study|Voluntary Withdrawal|0|||
161729792|NCT02512068|584053612|FG001|Overall Study|Voluntary Withdrawal|1|||
161729793|NCT02512068|584053611|FG000|Overall Study|Lack of Efficacy|0|||
161729794|NCT02512068|584053612|FG001|Overall Study|Lack of Efficacy|1|||
161729795|NCT02512068|584053611|FG000|Overall Study|Reason Not Specified|3|||
161729796|NCT02512068|584053612|FG001|Overall Study|Reason Not Specified|5|||
161729797|NCT03521687|584053614|FG000|Overall Study|Adverse Event|4|||
161729798|NCT03521687|584053614|FG000|Overall Study|Physician Decision|1|||
161729799|NCT01276457|584053620|FG000|Core Study|Adverse Event|6|||
161729800|NCT01276457|584053621|FG001|Core Study|Adverse Event|3|||
161729801|NCT01276457|584053620|FG000|Core Study|Lost to Follow-up|1|||
161729802|NCT01276457|584053621|FG001|Core Study|Lost to Follow-up|2|||
161729803|NCT01276457|584053620|FG000|Core Study|Administrative problems|1|||
161729804|NCT01276457|584053621|FG001|Core Study|Administrative problems|1|||
161729805|NCT01276457|584053620|FG000|Core Study|Death|2|||
161729806|NCT01276457|584053621|FG001|Core Study|Death|2|||
161729807|NCT01276457|584053620|FG000|Core Study|Lack of Efficacy|3|||
161729808|NCT01276457|584053621|FG001|Core Study|Lack of Efficacy|12|||
161729809|NCT01276457|584053620|FG000|Extension Study|Lost to Follow-up|3|||
161729810|NCT01276457|584053621|FG001|Extension Study|Lost to Follow-up|0|||
161729811|NCT01276457|584053620|FG000|Extension Study|Death|0|||
161729812|NCT01276457|584053621|FG001|Extension Study|Death|1|||
161729813|NCT01276457|584053620|FG000|Extension Study|Lack of Efficacy|3|||
161729814|NCT01276457|584053621|FG001|Extension Study|Lack of Efficacy|1|||
161729815|NCT04891770|584053626|FG000|Overall Study|Withdrew consent|1|||
161729816|NCT04891770|584053627|FG001|Overall Study|Withdrew consent|3|||
161729817|NCT04891770|584053628|FG002|Overall Study|Withdrew consent|0|||
161729818|NCT04891770|584053626|FG000|Overall Study|Enrolled but never treated|0|||
161729819|NCT04891770|584053627|FG001|Overall Study|Enrolled but never treated|0|||
161729820|NCT04891770|584053628|FG002|Overall Study|Enrolled but never treated|1|||
161729821|NCT04891770|584053626|FG000|Overall Study|Investigator's discretion|0|||
161729822|NCT04891770|584053627|FG001|Overall Study|Investigator's discretion|1|||
161729823|NCT04891770|584053628|FG002|Overall Study|Investigator's discretion|0|||
161729824|NCT05122650|584053629|FG000|Overall Study|Adverse Event|4|||
161729825|NCT05122650|584053630|FG001|Overall Study|Adverse Event|16|||
161729826|NCT05122650|584053631|FG002|Overall Study|Adverse Event|11|||
161729827|NCT05122650|584053632|FG003|Overall Study|Adverse Event|12|||
161729828|NCT05122650|584053629|FG000|Overall Study|Lack of Efficacy|0|||
161729829|NCT05122650|584053630|FG001|Overall Study|Lack of Efficacy|1|||
161729830|NCT05122650|584053631|FG002|Overall Study|Lack of Efficacy|1|||
161729831|NCT05122650|584053632|FG003|Overall Study|Lack of Efficacy|2|||
161729832|NCT05122650|584053629|FG000|Overall Study|Lost to Follow-up|1|||
161729833|NCT05122650|584053630|FG001|Overall Study|Lost to Follow-up|1|||
161729834|NCT05122650|584053631|FG002|Overall Study|Lost to Follow-up|3|||
161729835|NCT05122650|584053632|FG003|Overall Study|Lost to Follow-up|0|||
161729836|NCT05122650|584053629|FG000|Overall Study|Non-compliance with study intervention|0|||
161729837|NCT05122650|584053630|FG001|Overall Study|Non-compliance with study intervention|0|||
161729838|NCT05122650|584053631|FG002|Overall Study|Non-compliance with study intervention|0|||
161729839|NCT05122650|584053632|FG003|Overall Study|Non-compliance with study intervention|2|||
161729840|NCT05122650|584053629|FG000|Overall Study|Protocol Violation|0|||
161729841|NCT05122650|584053630|FG001|Overall Study|Protocol Violation|1|||
161729842|NCT05122650|584053631|FG002|Overall Study|Protocol Violation|0|||
161729843|NCT05122650|584053632|FG003|Overall Study|Protocol Violation|1|||
161729844|NCT05122650|584053629|FG000|Overall Study|Randomized by mistake|0|||
161729845|NCT05122650|584053630|FG001|Overall Study|Randomized by mistake|0|||
161729846|NCT05122650|584053631|FG002|Overall Study|Randomized by mistake|3|||
161729847|NCT05122650|584053632|FG003|Overall Study|Randomized by mistake|2|||
161729848|NCT05122650|584053629|FG000|Overall Study|Sponsor request|0|||
161729849|NCT05122650|584053630|FG001|Overall Study|Sponsor request|1|||
161729850|NCT05122650|584053631|FG002|Overall Study|Sponsor request|1|||
161729851|NCT05122650|584053632|FG003|Overall Study|Sponsor request|2|||
161729852|NCT05122650|584053629|FG000|Overall Study|Withdrawal by Subject|3|||
161729853|NCT05122650|584053630|FG001|Overall Study|Withdrawal by Subject|7|||
161729854|NCT05122650|584053631|FG002|Overall Study|Withdrawal by Subject|4|||
161729855|NCT05122650|584053632|FG003|Overall Study|Withdrawal by Subject|8|||
161729856|NCT05122650|584053629|FG000|Overall Study|Other|5|||
161729857|NCT05122650|584053630|FG001|Overall Study|Other|0|||
161729858|NCT05122650|584053631|FG002|Overall Study|Other|0|||
161729859|NCT05122650|584053632|FG003|Overall Study|Other|0|||
161729860|NCT03280550|584053636|FG000|Overall Study|Withdrawal by Subject|2|||
161729861|NCT03280550|584053637|FG001|Overall Study|Withdrawal by Subject|2|||
161729862|NCT03280550|584053636|FG000|Overall Study|Physician Decision|0|||
161729863|NCT03280550|584053637|FG001|Overall Study|Physician Decision|1|||
161729864|NCT01318083|584053638|FG000|Overall Study|Adverse Event|4|||
161729865|NCT01318083|584053639|FG001|Overall Study|Adverse Event|1|||
161729866|NCT01318083|584053640|FG002|Overall Study|Adverse Event|2|||
161729867|NCT01318083|584053638|FG000|Overall Study|Withdrawal by Subject|1|||
161729868|NCT01318083|584053639|FG001|Overall Study|Withdrawal by Subject|0|||
161729869|NCT01318083|584053640|FG002|Overall Study|Withdrawal by Subject|2|||
161729870|NCT01318083|584053638|FG000|Overall Study|Lack of Efficacy|0|||
161729871|NCT01318083|584053639|FG001|Overall Study|Lack of Efficacy|0|||
161729872|NCT01318083|584053640|FG002|Overall Study|Lack of Efficacy|1|||
161729873|NCT01318083|584053638|FG000|Overall Study|Treatment Complications|1|||
161729874|NCT01318083|584053639|FG001|Overall Study|Treatment Complications|0|||
161729875|NCT01318083|584053640|FG002|Overall Study|Treatment Complications|0|||
161729876|NCT01318083|584053638|FG000|Overall Study|Lack of Study Medication Compliance|0|||
161729877|NCT01318083|584053639|FG001|Overall Study|Lack of Study Medication Compliance|1|||
161729878|NCT01318083|584053640|FG002|Overall Study|Lack of Study Medication Compliance|0|||
161729879|NCT05896761|584053641|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
161729880|NCT05896761|584053642|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
161729881|NCT05896761|584053641|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
161729882|NCT05896761|584053642|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
161729883|NCT02028338|584053645|FG000|Overall Study|Withdrawal by Subject|3|||
161729884|NCT02028338|584053646|FG001|Overall Study|Withdrawal by Subject|1|||
161729885|NCT02028338|584053645|FG000|Overall Study|Unable to contact participant|1|||
161729886|NCT02028338|584053646|FG001|Overall Study|Unable to contact participant|0|||
161729887|NCT03552549|584053648|FG000|Overall Study|Disease progression|25|||
161729888|NCT03552549|584053649|FG001|Overall Study|Disease progression|17|||
161729889|NCT03552549|584053648|FG000|Overall Study|Adverse event in first 12 months|12|||
161729890|NCT03552549|584053649|FG001|Overall Study|Adverse event in first 12 months|8|||
161729891|NCT03552549|584053648|FG000|Overall Study|Withdrawal by Subject|7|||
161729892|NCT03552549|584053649|FG001|Overall Study|Withdrawal by Subject|7|||
161729893|NCT03552549|584053648|FG000|Overall Study|Unknown (no reason provided)|4|||
161729894|NCT03552549|584053649|FG001|Overall Study|Unknown (no reason provided)|2|||
161838547|NCT03502707|584453452|FG011|Overall Study|Lost to Follow-up|2|||
161838548|NCT03502707|584453453|FG012|Overall Study|Lost to Follow-up|1|||
161838549|NCT03502707|584453454|FG013|Overall Study|Lost to Follow-up|1|||
161838550|NCT03502707|584453455|FG014|Overall Study|Lost to Follow-up|0|||
161838551|NCT03502707|584453456|FG015|Overall Study|Lost to Follow-up|4|||
161838552|NCT03502707|584453457|FG016|Overall Study|Lost to Follow-up|9|||
161838553|NCT03502707|584453458|FG017|Overall Study|Lost to Follow-up|2|||
161838554|NCT03502707|584453441|FG000|Overall Study|Physician Decision|0|||
161838555|NCT03502707|584453442|FG001|Overall Study|Physician Decision|0|||
161838556|NCT03502707|584453443|FG002|Overall Study|Physician Decision|0|||
161838557|NCT03502707|584453444|FG003|Overall Study|Physician Decision|0|||
161838558|NCT03502707|584453445|FG004|Overall Study|Physician Decision|0|||
161838559|NCT03502707|584453446|FG005|Overall Study|Physician Decision|0|||
161838560|NCT03502707|584453447|FG006|Overall Study|Physician Decision|0|||
161838561|NCT03502707|584453448|FG007|Overall Study|Physician Decision|0|||
161838562|NCT03502707|584453449|FG008|Overall Study|Physician Decision|2|||
161838563|NCT03502707|584453450|FG009|Overall Study|Physician Decision|1|||
161838564|NCT03502707|584453451|FG010|Overall Study|Physician Decision|0|||
161838565|NCT03502707|584453452|FG011|Overall Study|Physician Decision|0|||
161838566|NCT03502707|584453453|FG012|Overall Study|Physician Decision|0|||
161838567|NCT03502707|584453454|FG013|Overall Study|Physician Decision|0|||
161838568|NCT03502707|584453455|FG014|Overall Study|Physician Decision|1|||
161838569|NCT03502707|584453456|FG015|Overall Study|Physician Decision|3|||
161838570|NCT03502707|584453457|FG016|Overall Study|Physician Decision|0|||
161838571|NCT03502707|584453458|FG017|Overall Study|Physician Decision|0|||
161838572|NCT03502707|584453441|FG000|Overall Study|Protocol Violation|0|||
161838573|NCT03502707|584453442|FG001|Overall Study|Protocol Violation|0|||
161838574|NCT03502707|584453443|FG002|Overall Study|Protocol Violation|0|||
161838575|NCT03502707|584453444|FG003|Overall Study|Protocol Violation|0|||
161838576|NCT03502707|584453445|FG004|Overall Study|Protocol Violation|0|||
161838577|NCT03502707|584453446|FG005|Overall Study|Protocol Violation|0|||
161838578|NCT03502707|584453447|FG006|Overall Study|Protocol Violation|0|||
161838579|NCT03502707|584453448|FG007|Overall Study|Protocol Violation|0|||
161838580|NCT03502707|584453449|FG008|Overall Study|Protocol Violation|0|||
161838581|NCT03502707|584453450|FG009|Overall Study|Protocol Violation|0|||
161838582|NCT03502707|584453451|FG010|Overall Study|Protocol Violation|0|||
161838583|NCT03502707|584453452|FG011|Overall Study|Protocol Violation|0|||
161838584|NCT03502707|584453453|FG012|Overall Study|Protocol Violation|0|||
161838585|NCT03502707|584453454|FG013|Overall Study|Protocol Violation|0|||
161729895|NCT03552549|584053648|FG000|Overall Study|Not in participant's best interest|2|||
161729896|NCT03552549|584053649|FG001|Overall Study|Not in participant's best interest|1|||
161729897|NCT03552549|584053648|FG000|Overall Study|Did not complete study treatment|2|||
161729898|NCT03552549|584053649|FG001|Overall Study|Did not complete study treatment|3|||
161729899|NCT03552549|584053648|FG000|Overall Study|Did not meet eligibility criteria|1|||
161729900|NCT03552549|584053649|FG001|Overall Study|Did not meet eligibility criteria|0|||
161729901|NCT03552549|584053648|FG000|Overall Study|Administrative|0|||
161729902|NCT03552549|584053649|FG001|Overall Study|Administrative|14|||
161729903|NCT02761993|584053658|FG000|Overall Study|Adverse Event|0|||
161729904|NCT02761993|584053659|FG001|Overall Study|Adverse Event|2|||
161729905|NCT02761993|584053660|FG002|Overall Study|Adverse Event|0|||
161729906|NCT02761993|584053658|FG000|Overall Study|Lost to Follow-up|1|||
161729907|NCT02761993|584053659|FG001|Overall Study|Lost to Follow-up|3|||
161729908|NCT02761993|584053660|FG002|Overall Study|Lost to Follow-up|2|||
161729909|NCT02761993|584053658|FG000|Overall Study|Withdrawal by Subject|1|||
161729910|NCT02761993|584053659|FG001|Overall Study|Withdrawal by Subject|1|||
161729911|NCT02761993|584053660|FG002|Overall Study|Withdrawal by Subject|2|||
161729912|NCT00256867|584053661|FG000|Overall Study|Adverse Event|0|||
161729913|NCT00256867|584053662|FG001|Overall Study|Adverse Event|1|||
161729914|NCT00256867|584053663|FG002|Overall Study|Adverse Event|1|||
161729915|NCT00256867|584053664|FG003|Overall Study|Adverse Event|1|||
161729916|NCT00256867|584053665|FG004|Overall Study|Adverse Event|2|||
161838586|NCT03502707|584453455|FG014|Overall Study|Protocol Violation|0|||
161838587|NCT03502707|584453456|FG015|Overall Study|Protocol Violation|1|||
161838588|NCT03502707|584453457|FG016|Overall Study|Protocol Violation|0|||
161838589|NCT03502707|584453458|FG017|Overall Study|Protocol Violation|0|||
161838590|NCT03502707|584453441|FG000|Overall Study|Withdrawal by Subject|1|||
161729917|NCT00256867|584053666|FG005|Overall Study|Adverse Event|2|||
161838591|NCT03502707|584453442|FG001|Overall Study|Withdrawal by Subject|1|||
161838592|NCT03502707|584453443|FG002|Overall Study|Withdrawal by Subject|0|||
161838593|NCT03502707|584453444|FG003|Overall Study|Withdrawal by Subject|0|||
161838594|NCT03502707|584453445|FG004|Overall Study|Withdrawal by Subject|0|||
161838595|NCT03502707|584453446|FG005|Overall Study|Withdrawal by Subject|2|||
161729918|NCT00256867|584053667|FG006|Overall Study|Adverse Event|1|||
161729919|NCT00256867|584053668|FG007|Overall Study|Adverse Event|4|||
161729920|NCT00256867|584053661|FG000|Overall Study|Lost to Follow-up|2|||
161838596|NCT03502707|584453447|FG006|Overall Study|Withdrawal by Subject|0|||
161838597|NCT03502707|584453448|FG007|Overall Study|Withdrawal by Subject|3|||
161838598|NCT03502707|584453449|FG008|Overall Study|Withdrawal by Subject|1|||
161838599|NCT03502707|584453450|FG009|Overall Study|Withdrawal by Subject|2|||
161838600|NCT03502707|584453451|FG010|Overall Study|Withdrawal by Subject|12|||
161838601|NCT03502707|584453452|FG011|Overall Study|Withdrawal by Subject|23|||
161838602|NCT03502707|584453453|FG012|Overall Study|Withdrawal by Subject|5|||
161838603|NCT03502707|584453454|FG013|Overall Study|Withdrawal by Subject|3|||
161838604|NCT03502707|584453455|FG014|Overall Study|Withdrawal by Subject|3|||
161838605|NCT03502707|584453456|FG015|Overall Study|Withdrawal by Subject|43|||
161838606|NCT03502707|584453457|FG016|Overall Study|Withdrawal by Subject|44|||
161838607|NCT03502707|584453458|FG017|Overall Study|Withdrawal by Subject|18|||
161838608|NCT03502707|584453441|FG000|Overall Study|Sponsor's Decision|1|||
161838609|NCT03502707|584453442|FG001|Overall Study|Sponsor's Decision|0|||
161838610|NCT03502707|584453443|FG002|Overall Study|Sponsor's Decision|0|||
161838611|NCT03502707|584453444|FG003|Overall Study|Sponsor's Decision|0|||
161838612|NCT03502707|584453445|FG004|Overall Study|Sponsor's Decision|0|||
161838613|NCT03502707|584453446|FG005|Overall Study|Sponsor's Decision|0|||
161838614|NCT03502707|584453447|FG006|Overall Study|Sponsor's Decision|0|||
161838615|NCT03502707|584453448|FG007|Overall Study|Sponsor's Decision|0|||
161838616|NCT03502707|584453449|FG008|Overall Study|Sponsor's Decision|0|||
161838617|NCT03502707|584453450|FG009|Overall Study|Sponsor's Decision|1|||
161838618|NCT03502707|584453451|FG010|Overall Study|Sponsor's Decision|0|||
161838619|NCT03502707|584453452|FG011|Overall Study|Sponsor's Decision|0|||
161838620|NCT03502707|584453453|FG012|Overall Study|Sponsor's Decision|0|||
161838621|NCT03502707|584453454|FG013|Overall Study|Sponsor's Decision|0|||
161838622|NCT03502707|584453455|FG014|Overall Study|Sponsor's Decision|0|||
161838623|NCT03502707|584453456|FG015|Overall Study|Sponsor's Decision|2|||
161838624|NCT03502707|584453457|FG016|Overall Study|Sponsor's Decision|1|||
161838625|NCT03502707|584453458|FG017|Overall Study|Sponsor's Decision|0|||
161838626|NCT03502707|584453441|FG000|Overall Study|Initiated Prohibited Medication|0|||
161838627|NCT03502707|584453442|FG001|Overall Study|Initiated Prohibited Medication|0|||
161838628|NCT03502707|584453443|FG002|Overall Study|Initiated Prohibited Medication|0|||
161838629|NCT03502707|584453444|FG003|Overall Study|Initiated Prohibited Medication|0|||
161838630|NCT03502707|584453445|FG004|Overall Study|Initiated Prohibited Medication|0|||
161838631|NCT03502707|584453446|FG005|Overall Study|Initiated Prohibited Medication|0|||
161838632|NCT03502707|584453447|FG006|Overall Study|Initiated Prohibited Medication|0|||
161838633|NCT03502707|584453448|FG007|Overall Study|Initiated Prohibited Medication|0|||
161838634|NCT03502707|584453449|FG008|Overall Study|Initiated Prohibited Medication|0|||
161838635|NCT03502707|584453450|FG009|Overall Study|Initiated Prohibited Medication|0|||
161838636|NCT03502707|584453451|FG010|Overall Study|Initiated Prohibited Medication|0|||
161838637|NCT03502707|584453452|FG011|Overall Study|Initiated Prohibited Medication|0|||
161838638|NCT03502707|584453453|FG012|Overall Study|Initiated Prohibited Medication|0|||
161838639|NCT03502707|584453454|FG013|Overall Study|Initiated Prohibited Medication|0|||
161838640|NCT03502707|584453455|FG014|Overall Study|Initiated Prohibited Medication|0|||
161838641|NCT03502707|584453456|FG015|Overall Study|Initiated Prohibited Medication|0|||
161838642|NCT03502707|584453457|FG016|Overall Study|Initiated Prohibited Medication|1|||
161729921|NCT00256867|584053662|FG001|Overall Study|Lost to Follow-up|2|||
161729922|NCT00256867|584053663|FG002|Overall Study|Lost to Follow-up|2|||
161729923|NCT00256867|584053664|FG003|Overall Study|Lost to Follow-up|3|||
161729924|NCT00256867|584053665|FG004|Overall Study|Lost to Follow-up|2|||
161729925|NCT00256867|584053666|FG005|Overall Study|Lost to Follow-up|0|||
161729926|NCT00256867|584053667|FG006|Overall Study|Lost to Follow-up|1|||
161729927|NCT00256867|584053668|FG007|Overall Study|Lost to Follow-up|2|||
161729928|NCT00256867|584053661|FG000|Overall Study|Protocol Violation|0|||
161729929|NCT00256867|584053662|FG001|Overall Study|Protocol Violation|0|||
161729930|NCT00256867|584053663|FG002|Overall Study|Protocol Violation|0|||
161729931|NCT00256867|584053664|FG003|Overall Study|Protocol Violation|1|||
161729932|NCT00256867|584053665|FG004|Overall Study|Protocol Violation|0|||
161729933|NCT00256867|584053666|FG005|Overall Study|Protocol Violation|1|||
161729934|NCT00256867|584053667|FG006|Overall Study|Protocol Violation|0|||
161729935|NCT00256867|584053668|FG007|Overall Study|Protocol Violation|1|||
161729936|NCT00256867|584053661|FG000|Overall Study|Withdrawal by Subject|0|||
161729937|NCT00256867|584053662|FG001|Overall Study|Withdrawal by Subject|0|||
161838643|NCT03502707|584453458|FG017|Overall Study|Initiated Prohibited Medication|0|||
161838644|NCT03502707|584453441|FG000|Overall Study|Other|0|||
161838645|NCT03502707|584453442|FG001|Overall Study|Other|0|||
161838646|NCT03502707|584453443|FG002|Overall Study|Other|0|||
161838647|NCT03502707|584453444|FG003|Overall Study|Other|0|||
161838648|NCT03502707|584453445|FG004|Overall Study|Other|0|||
161838649|NCT03502707|584453446|FG005|Overall Study|Other|0|||
161729938|NCT00256867|584053663|FG002|Overall Study|Withdrawal by Subject|1|||
161838650|NCT03502707|584453447|FG006|Overall Study|Other|0|||
161838651|NCT03502707|584453448|FG007|Overall Study|Other|0|||
161838652|NCT03502707|584453449|FG008|Overall Study|Other|1|||
161838653|NCT03502707|584453450|FG009|Overall Study|Other|1|||
161838654|NCT03502707|584453451|FG010|Overall Study|Other|2|||
161729939|NCT00256867|584053664|FG003|Overall Study|Withdrawal by Subject|1|||
161729940|NCT00256867|584053665|FG004|Overall Study|Withdrawal by Subject|2|||
161729941|NCT00256867|584053666|FG005|Overall Study|Withdrawal by Subject|2|||
161729942|NCT00256867|584053667|FG006|Overall Study|Withdrawal by Subject|3|||
161729943|NCT00256867|584053668|FG007|Overall Study|Withdrawal by Subject|2|||
161729944|NCT00256867|584053661|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729945|NCT00256867|584053662|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
161729946|NCT00256867|584053663|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729947|NCT00256867|584053664|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729948|NCT00256867|584053665|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729949|NCT00256867|584053666|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729950|NCT00256867|584053667|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729951|NCT00256867|584053668|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729952|NCT00256867|584053661|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729953|NCT00256867|584053662|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729954|NCT00256867|584053663|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729955|NCT00256867|584053664|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729956|NCT00256867|584053665|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729957|NCT00256867|584053666|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729958|NCT00256867|584053667|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729959|NCT00256867|584053668|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
161729960|NCT00256867|584053661|FG000|Overall Study|Investigator's Decision|0|||
161729961|NCT00256867|584053662|FG001|Overall Study|Investigator's Decision|0|||
161729962|NCT00256867|584053663|FG002|Overall Study|Investigator's Decision|0|||
161729963|NCT00256867|584053664|FG003|Overall Study|Investigator's Decision|0|||
161729964|NCT00256867|584053665|FG004|Overall Study|Investigator's Decision|1|||
161729965|NCT00256867|584053666|FG005|Overall Study|Investigator's Decision|0|||
161729966|NCT00256867|584053667|FG006|Overall Study|Investigator's Decision|0|||
161729967|NCT00256867|584053668|FG007|Overall Study|Investigator's Decision|0|||
161729968|NCT00256867|584053661|FG000|Overall Study|Non-compliance with study medication|0|||
161729969|NCT00256867|584053662|FG001|Overall Study|Non-compliance with study medication|0|||
161729970|NCT00256867|584053663|FG002|Overall Study|Non-compliance with study medication|0|||
161729971|NCT00256867|584053664|FG003|Overall Study|Non-compliance with study medication|0|||
161729972|NCT00256867|584053665|FG004|Overall Study|Non-compliance with study medication|0|||
161729973|NCT00256867|584053666|FG005|Overall Study|Non-compliance with study medication|0|||
161729974|NCT00256867|584053667|FG006|Overall Study|Non-compliance with study medication|0|||
161729975|NCT00256867|584053668|FG007|Overall Study|Non-compliance with study medication|1|||
161729976|NCT00256867|584053661|FG000|Overall Study|Participant travelled Overseas|0|||
161729977|NCT00256867|584053662|FG001|Overall Study|Participant travelled Overseas|1|||
161729978|NCT00256867|584053663|FG002|Overall Study|Participant travelled Overseas|0|||
161729979|NCT00256867|584053664|FG003|Overall Study|Participant travelled Overseas|0|||
161729980|NCT00256867|584053665|FG004|Overall Study|Participant travelled Overseas|0|||
161729981|NCT00256867|584053666|FG005|Overall Study|Participant travelled Overseas|0|||
161729982|NCT00256867|584053667|FG006|Overall Study|Participant travelled Overseas|0|||
161729983|NCT00256867|584053668|FG007|Overall Study|Participant travelled Overseas|0|||
161729984|NCT00256867|584053661|FG000|Overall Study|Participant out of assessment window|0|||
161729985|NCT00256867|584053662|FG001|Overall Study|Participant out of assessment window|0|||
161729986|NCT00256867|584053663|FG002|Overall Study|Participant out of assessment window|1|||
161729987|NCT00256867|584053664|FG003|Overall Study|Participant out of assessment window|0|||
161729988|NCT00256867|584053665|FG004|Overall Study|Participant out of assessment window|0|||
161729989|NCT00256867|584053666|FG005|Overall Study|Participant out of assessment window|0|||
161729990|NCT00256867|584053667|FG006|Overall Study|Participant out of assessment window|0|||
161729991|NCT00256867|584053668|FG007|Overall Study|Participant out of assessment window|0|||
161729992|NCT00256867|584053661|FG000|Overall Study|Withdrawal by participant|0|||
161729993|NCT00256867|584053662|FG001|Overall Study|Withdrawal by participant|0|||
161729994|NCT00256867|584053663|FG002|Overall Study|Withdrawal by participant|0|||
161729995|NCT00256867|584053664|FG003|Overall Study|Withdrawal by participant|0|||
161729996|NCT00256867|584053665|FG004|Overall Study|Withdrawal by participant|0|||
161729997|NCT00256867|584053666|FG005|Overall Study|Withdrawal by participant|1|||
161729998|NCT00256867|584053667|FG006|Overall Study|Withdrawal by participant|0|||
161729999|NCT00256867|584053668|FG007|Overall Study|Withdrawal by participant|0|||
161730000|NCT00527111|584053673|FG000|Overall Study|Adverse Event|14|||
161730001|NCT00527111|584053674|FG001|Overall Study|Adverse Event|13|||
161730002|NCT00527111|584053673|FG000|Overall Study|Death|0|||
161730003|NCT00527111|584053674|FG001|Overall Study|Death|1|||
161730004|NCT00527111|584053673|FG000|Overall Study|Investigator Request|2|||
161730005|NCT00527111|584053674|FG001|Overall Study|Investigator Request|1|||
161730006|NCT00527111|584053673|FG000|Overall Study|Patient Request|2|||
161730007|NCT00527111|584053674|FG001|Overall Study|Patient Request|5|||
161730008|NCT00527111|584053673|FG000|Overall Study|Other|2|||
161730009|NCT00527111|584053674|FG001|Overall Study|Other|2|||
161730010|NCT01930799|584053678|FG000|Overall Study|Withdrawal by Subject|3|||
161730011|NCT01930799|584053678|FG000|Overall Study|Lost to Follow-up|5|||
161730012|NCT00875017|584053679|FG000|First Intervention|Withdrawal by Subject|1|||
161730013|NCT00875017|584053680|FG001|First Intervention|Withdrawal by Subject|0|||
161730014|NCT00875017|584053681|FG002|First Intervention|Withdrawal by Subject|1|||
161730015|NCT00875017|584053682|FG003|First Intervention|Withdrawal by Subject|0|||
161730016|NCT00875017|584053683|FG004|First Intervention|Withdrawal by Subject|0|||
161730017|NCT00875017|584053684|FG005|First Intervention|Withdrawal by Subject|0|||
161730018|NCT00875017|584053679|FG000|First Intervention|Adverse Event|0|||
161730019|NCT00875017|584053680|FG001|First Intervention|Adverse Event|0|||
161730020|NCT00875017|584053681|FG002|First Intervention|Adverse Event|0|||
161730021|NCT00875017|584053682|FG003|First Intervention|Adverse Event|1|||
161730022|NCT00875017|584053683|FG004|First Intervention|Adverse Event|0|||
161730023|NCT00875017|584053684|FG005|First Intervention|Adverse Event|0|||
161730024|NCT00875017|584053679|FG000|First Intervention|Problems collecting rectal effluent|1|||
161730025|NCT00875017|584053680|FG001|First Intervention|Problems collecting rectal effluent|0|||
161730026|NCT00875017|584053681|FG002|First Intervention|Problems collecting rectal effluent|0|||
161730027|NCT00875017|584053682|FG003|First Intervention|Problems collecting rectal effluent|0|||
161730028|NCT00875017|584053683|FG004|First Intervention|Problems collecting rectal effluent|0|||
161730029|NCT00875017|584053684|FG005|First Intervention|Problems collecting rectal effluent|0|||
161730030|NCT00875017|584053679|FG000|First Intervention|Intolerance to nasogastric tube|0|||
161730031|NCT00875017|584053680|FG001|First Intervention|Intolerance to nasogastric tube|0|||
161730032|NCT00875017|584053681|FG002|First Intervention|Intolerance to nasogastric tube|0|||
161730033|NCT00875017|584053682|FG003|First Intervention|Intolerance to nasogastric tube|0|||
161730034|NCT00875017|584053683|FG004|First Intervention|Intolerance to nasogastric tube|1|||
161730035|NCT00875017|584053684|FG005|First Intervention|Intolerance to nasogastric tube|0|||
161730036|NCT00875017|584053679|FG000|Washout|Problem collecting rectal effluent|0|||
161730037|NCT00875017|584053680|FG001|Washout|Problem collecting rectal effluent|0|||
161730038|NCT00875017|584053681|FG002|Washout|Problem collecting rectal effluent|1|||
161730039|NCT00875017|584053682|FG003|Washout|Problem collecting rectal effluent|0|||
161730040|NCT00875017|584053683|FG004|Washout|Problem collecting rectal effluent|0|||
161730041|NCT00875017|584053684|FG005|Washout|Problem collecting rectal effluent|0|||
161730042|NCT00875017|584053679|FG000|Second Intervention|Adverse Event|0|||
161730043|NCT00875017|584053680|FG001|Second Intervention|Adverse Event|0|||
161730044|NCT00875017|584053681|FG002|Second Intervention|Adverse Event|0|||
161730045|NCT00875017|584053682|FG003|Second Intervention|Adverse Event|1|||
161730046|NCT00875017|584053683|FG004|Second Intervention|Adverse Event|0|||
161730047|NCT00875017|584053684|FG005|Second Intervention|Adverse Event|0|||
161730048|NCT00875017|584053679|FG000|Washout|Problems collecting rectal effluent|0|||
161730049|NCT00875017|584053680|FG001|Washout|Problems collecting rectal effluent|1|||
161730050|NCT00875017|584053681|FG002|Washout|Problems collecting rectal effluent|0|||
161730051|NCT00875017|584053682|FG003|Washout|Problems collecting rectal effluent|0|||
161730052|NCT00875017|584053683|FG004|Washout|Problems collecting rectal effluent|0|||
161730053|NCT00875017|584053684|FG005|Washout|Problems collecting rectal effluent|0|||
161730054|NCT00875017|584053679|FG000|Third Intervention|Adverse Event|0|||
161730055|NCT00875017|584053680|FG001|Third Intervention|Adverse Event|1|||
161730056|NCT00875017|584053681|FG002|Third Intervention|Adverse Event|1|||
161730057|NCT00875017|584053682|FG003|Third Intervention|Adverse Event|0|||
161730058|NCT00875017|584053683|FG004|Third Intervention|Adverse Event|0|||
161730059|NCT00875017|584053684|FG005|Third Intervention|Adverse Event|0|||
161730060|NCT00875017|584053679|FG000|Washout|Withdrawal by Subject|0|||
161730061|NCT00875017|584053680|FG001|Washout|Withdrawal by Subject|0|||
161730062|NCT00875017|584053681|FG002|Washout|Withdrawal by Subject|0|||
161730063|NCT00875017|584053682|FG003|Washout|Withdrawal by Subject|0|||
161730064|NCT00875017|584053683|FG004|Washout|Withdrawal by Subject|1|||
161730065|NCT00875017|584053684|FG005|Washout|Withdrawal by Subject|0|||
161730066|NCT00875017|584053679|FG000|Fourth Intervention|Inability to comply with fasting|0|||
161730067|NCT00875017|584053680|FG001|Fourth Intervention|Inability to comply with fasting|0|||
161730068|NCT00875017|584053681|FG002|Fourth Intervention|Inability to comply with fasting|0|||
161730069|NCT00875017|584053682|FG003|Fourth Intervention|Inability to comply with fasting|0|||
161730070|NCT00875017|584053683|FG004|Fourth Intervention|Inability to comply with fasting|0|||
161730071|NCT00875017|584053684|FG005|Fourth Intervention|Inability to comply with fasting|1|||
161730072|NCT02689219|584053685|FG000|Overall Study|Death|1|||
161838655|NCT03502707|584453452|FG011|Overall Study|Other|0|||
161838656|NCT03502707|584453453|FG012|Overall Study|Other|0|||
161730073|NCT02689219|584053686|FG001|Overall Study|Death|1|||
161730074|NCT02689219|584053685|FG000|Overall Study|Disease Progression|10|||
161730075|NCT02689219|584053686|FG001|Overall Study|Disease Progression|6|||
161730076|NCT01477892|584053687|FG000|Overall Study|Withdrawal by Subject|0|||
161730077|NCT01477892|584053688|FG001|Overall Study|Withdrawal by Subject|2|||
161730078|NCT01921257|584053693|FG000|Overall Study|Adverse Event|1|||
161730079|NCT01921257|584053693|FG000|Overall Study|Protocol Violation|1|||
161730080|NCT01921257|584053693|FG000|Overall Study|Withdrawal by Subject|1|||
161730081|NCT00364845|584053694|FG000|Overall Study|Adverse Event|1|||
161730082|NCT00364845|584053695|FG001|Overall Study|Adverse Event|0|||
161730083|NCT00364845|584053694|FG000|Overall Study|Withdrawal by Subject|2|||
161730084|NCT00364845|584053695|FG001|Overall Study|Withdrawal by Subject|1|||
161838657|NCT03502707|584453454|FG013|Overall Study|Other|0|||
161838658|NCT03502707|584453455|FG014|Overall Study|Other|0|||
161730085|NCT00364845|584053694|FG000|Overall Study|Physician Decision|8|||
161730086|NCT00364845|584053695|FG001|Overall Study|Physician Decision|8|||
161730087|NCT00364845|584053694|FG000|Overall Study|Lost to Follow-up|0|||
161730088|NCT00364845|584053695|FG001|Overall Study|Lost to Follow-up|1|||
161730089|NCT00364845|584053694|FG000|Overall Study|Death|0|||
161730090|NCT00364845|584053695|FG001|Overall Study|Death|1|||
161730091|NCT02426658|584053696|FG000|Overall Study|Withdrawal by Subject|1|||
161730092|NCT02426658|584053696|FG000|Overall Study|Patient expired before treatment|2|||
161730093|NCT03255291|584053699|FG000|Overall Study|Determined to be ineligible|10|||
161730094|NCT03255291|584053700|FG001|Overall Study|Determined to be ineligible|12|||
161730095|NCT03255291|584053701|FG002|Overall Study|Determined to be ineligible|6|||
161730096|NCT03255291|584053702|FG003|Overall Study|Determined to be ineligible|6|||
161730097|NCT03255291|584053703|FG004|Overall Study|Determined to be ineligible|5|||
161730098|NCT03255291|584053704|FG005|Overall Study|Determined to be ineligible|10|||
161730099|NCT03255291|584053699|FG000|Overall Study|Baseline data collection issues|3|||
161730100|NCT03255291|584053700|FG001|Overall Study|Baseline data collection issues|0|||
161730101|NCT03255291|584053701|FG002|Overall Study|Baseline data collection issues|0|||
161730102|NCT03255291|584053702|FG003|Overall Study|Baseline data collection issues|0|||
161730103|NCT03255291|584053703|FG004|Overall Study|Baseline data collection issues|2|||
161730104|NCT03255291|584053704|FG005|Overall Study|Baseline data collection issues|0|||
161730105|NCT01423617|584053705|FG000|Overall Study|Lost to Follow-up|0|||
161730106|NCT01423617|584053706|FG001|Overall Study|Lost to Follow-up|1|||
161730107|NCT00634244|584053707|FG000|Overall Study|Never started treatment|0|||
161730108|NCT00634244|584053708|FG001|Overall Study|Never started treatment|1|||
161730109|NCT00634244|584053709|FG002|Overall Study|Never started treatment|0|||
161730110|NCT00634244|584053707|FG000|Overall Study|Death|1|||
161730111|NCT00634244|584053708|FG001|Overall Study|Death|6|||
161730112|NCT00634244|584053709|FG002|Overall Study|Death|0|||
161730113|NCT00634244|584053707|FG000|Overall Study|Adverse Event|0|||
161730114|NCT00634244|584053708|FG001|Overall Study|Adverse Event|2|||
161730115|NCT00634244|584053709|FG002|Overall Study|Adverse Event|0|||
161730116|NCT00634244|584053707|FG000|Overall Study|Withdrawal by Subject|0|||
161730117|NCT00634244|584053708|FG001|Overall Study|Withdrawal by Subject|1|||
161730118|NCT00634244|584053709|FG002|Overall Study|Withdrawal by Subject|0|||
161730119|NCT00634244|584053707|FG000|Overall Study|Physician Decision|0|||
161730120|NCT00634244|584053708|FG001|Overall Study|Physician Decision|1|||
161730121|NCT00634244|584053709|FG002|Overall Study|Physician Decision|0|||
161730122|NCT00634244|584053707|FG000|Overall Study|Disease progression/relapse|0|||
161730123|NCT00634244|584053708|FG001|Overall Study|Disease progression/relapse|1|||
161730124|NCT00634244|584053709|FG002|Overall Study|Disease progression/relapse|0|||
161730125|NCT00634244|584053707|FG000|Overall Study|Other complicating disease|0|||
161730126|NCT00634244|584053708|FG001|Overall Study|Other complicating disease|1|||
161730127|NCT00634244|584053709|FG002|Overall Study|Other complicating disease|0|||
161730128|NCT01204658|584053711|FG000|Primary Phase|Adverse Event|0|||
161730129|NCT01204658|584053712|FG001|Primary Phase|Adverse Event|0|||
161730130|NCT01204658|584053713|FG002|Primary Phase|Adverse Event|1|||
161730131|NCT01204658|584053714|FG003|Primary Phase|Adverse Event|0|||
161730132|NCT04594239|584053719|FG000|Overall Study|Withdrawal by Subject|3|||
161730133|NCT04594239|584053720|FG001|Overall Study|Withdrawal by Subject|4|||
161730134|NCT04594239|584053721|FG002|Overall Study|Withdrawal by Subject|2|||
161730135|NCT04594239|584053722|FG003|Overall Study|Withdrawal by Subject|4|||
161730136|NCT04594239|584053719|FG000|Overall Study|Lost to Follow-up|8|||
161730137|NCT04594239|584053720|FG001|Overall Study|Lost to Follow-up|5|||
161730138|NCT04594239|584053721|FG002|Overall Study|Lost to Follow-up|4|||
161730139|NCT04594239|584053722|FG003|Overall Study|Lost to Follow-up|6|||
161730140|NCT04594239|584053719|FG000|Overall Study|Subject relocated|0|||
161730141|NCT04594239|584053720|FG001|Overall Study|Subject relocated|0|||
161730142|NCT04594239|584053721|FG002|Overall Study|Subject relocated|0|||
161730143|NCT04594239|584053722|FG003|Overall Study|Subject relocated|1|||
161730144|NCT03050359|584055811|FG000|Overall Study|Randomized But Not Treated|2|||
161730145|NCT03050359|584055812|FG001|Overall Study|Randomized But Not Treated|0|||
161730146|NCT03050359|584055811|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
161730147|NCT03050359|584055812|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
161730148|NCT03050359|584055811|FG000|Overall Study|Significant Protocol Deviation|2|||
161730149|NCT03050359|584055812|FG001|Overall Study|Significant Protocol Deviation|3|||
161730150|NCT03050359|584055811|FG000|Overall Study|Lost to Follow-up|2|||
161730151|NCT03050359|584055812|FG001|Overall Study|Lost to Follow-up|1|||
161730152|NCT03050359|584055811|FG000|Overall Study|Voluntary Withdrawal|4|||
161838659|NCT03502707|584453456|FG015|Overall Study|Other|4|||
161730153|NCT03050359|584055812|FG001|Overall Study|Voluntary Withdrawal|6|||
161730154|NCT03050359|584055811|FG000|Overall Study|Pregnancy|1|||
161730155|NCT03050359|584055812|FG001|Overall Study|Pregnancy|0|||
161730156|NCT03050359|584055811|FG000|Overall Study|Reason Not Specified|1|||
161730157|NCT03050359|584055812|FG001|Overall Study|Reason Not Specified|0|||
161730158|NCT02020031|584055813|FG000|Overall Study|Physician Decision|1|||
161838660|NCT03502707|584453457|FG016|Overall Study|Other|1|||
161730159|NCT02020031|584055814|FG001|Overall Study|Physician Decision|1|||
161730160|NCT00755846|584055817|FG000|Overall Study|Adverse Event|0|||
161730161|NCT00755846|584055818|FG001|Overall Study|Adverse Event|0|||
161730162|NCT00755846|584055819|FG002|Overall Study|Adverse Event|0|||
161730163|NCT00755846|584055820|FG003|Overall Study|Adverse Event|1|||
161730164|NCT00755846|584055821|FG004|Overall Study|Adverse Event|3|||
161730165|NCT00755846|584055822|FG005|Overall Study|Adverse Event|2|||
161730166|NCT00755846|584055817|FG000|Overall Study|Protocol Violation|1|||
161730167|NCT00755846|584055818|FG001|Overall Study|Protocol Violation|1|||
161730168|NCT00755846|584055819|FG002|Overall Study|Protocol Violation|1|||
161730169|NCT00755846|584055820|FG003|Overall Study|Protocol Violation|1|||
161730170|NCT00755846|584055821|FG004|Overall Study|Protocol Violation|1|||
161730171|NCT00755846|584055822|FG005|Overall Study|Protocol Violation|1|||
161730172|NCT00755846|584055817|FG000|Overall Study|Lost to Follow-up|0|||
161730173|NCT00755846|584055818|FG001|Overall Study|Lost to Follow-up|2|||
161730174|NCT00755846|584055819|FG002|Overall Study|Lost to Follow-up|1|||
161730175|NCT00755846|584055820|FG003|Overall Study|Lost to Follow-up|0|||
161730176|NCT00755846|584055821|FG004|Overall Study|Lost to Follow-up|4|||
161730177|NCT00755846|584055822|FG005|Overall Study|Lost to Follow-up|2|||
161730178|NCT00755846|584055817|FG000|Overall Study|Withdrawal by Subject|2|||
161730179|NCT00755846|584055818|FG001|Overall Study|Withdrawal by Subject|3|||
161730180|NCT00755846|584055819|FG002|Overall Study|Withdrawal by Subject|5|||
161730181|NCT00755846|584055820|FG003|Overall Study|Withdrawal by Subject|2|||
161730182|NCT00755846|584055821|FG004|Overall Study|Withdrawal by Subject|0|||
161730183|NCT00755846|584055822|FG005|Overall Study|Withdrawal by Subject|1|||
161730184|NCT00755846|584055817|FG000|Overall Study|Hyperglycemic Rescue|21|||
161730185|NCT00755846|584055818|FG001|Overall Study|Hyperglycemic Rescue|7|||
161730186|NCT00755846|584055819|FG002|Overall Study|Hyperglycemic Rescue|5|||
161730187|NCT00755846|584055820|FG003|Overall Study|Hyperglycemic Rescue|8|||
161730188|NCT00755846|584055821|FG004|Overall Study|Hyperglycemic Rescue|8|||
161730189|NCT00755846|584055822|FG005|Overall Study|Hyperglycemic Rescue|7|||
161730190|NCT00755846|584055817|FG000|Overall Study|Physician Decision|1|||
161730191|NCT00755846|584055818|FG001|Overall Study|Physician Decision|3|||
161730192|NCT00755846|584055819|FG002|Overall Study|Physician Decision|0|||
161730193|NCT00755846|584055820|FG003|Overall Study|Physician Decision|1|||
161730194|NCT00755846|584055821|FG004|Overall Study|Physician Decision|0|||
161730195|NCT00755846|584055822|FG005|Overall Study|Physician Decision|1|||
161730196|NCT00755846|584055817|FG000|Overall Study|Administrative Error|0|||
161730197|NCT00755846|584055818|FG001|Overall Study|Administrative Error|1|||
161730198|NCT00755846|584055819|FG002|Overall Study|Administrative Error|0|||
161730199|NCT00755846|584055820|FG003|Overall Study|Administrative Error|0|||
161730200|NCT00755846|584055821|FG004|Overall Study|Administrative Error|0|||
161730201|NCT00755846|584055822|FG005|Overall Study|Administrative Error|0|||
161730202|NCT00755846|584055817|FG000|Overall Study|Participant Non-compliance|0|||
161730203|NCT00755846|584055818|FG001|Overall Study|Participant Non-compliance|0|||
161730204|NCT00755846|584055819|FG002|Overall Study|Participant Non-compliance|0|||
161730205|NCT00755846|584055820|FG003|Overall Study|Participant Non-compliance|0|||
161730206|NCT00755846|584055821|FG004|Overall Study|Participant Non-compliance|1|||
161730207|NCT00755846|584055822|FG005|Overall Study|Participant Non-compliance|0|||
161730208|NCT02723604|584055835|FG000|Overall Study|ineligible|1|||
161730209|NCT02723604|584055835|FG000|Overall Study|never received treatment|1|||
161730210|NCT00762372|584055836|FG000|Overall Study|Adverse Event|1|||
161730211|NCT00762372|584055837|FG001|Overall Study|Adverse Event|0|||
161730212|NCT00762372|584055838|FG002|Overall Study|Adverse Event|0|||
161730213|NCT02616185|584055839|FG000|Overall Study|Death|0|||
161730214|NCT02616185|584055840|FG001|Overall Study|Death|0|||
161730215|NCT02616185|584055841|FG002|Overall Study|Death|0|||
161730216|NCT02616185|584055842|FG003|Overall Study|Death|1|||
161730217|NCT02616185|584055843|FG004|Overall Study|Death|2|||
161730218|NCT02616185|584055844|FG005|Overall Study|Death|0|||
161730219|NCT02616185|584055845|FG006|Overall Study|Death|0|||
161838661|NCT03502707|584453458|FG017|Overall Study|Other|0|||
161838662|NCT03502707|584453441|FG000|Overall Study|Randomized but not vaccinated|0|||
161838663|NCT03502707|584453442|FG001|Overall Study|Randomized but not vaccinated|0|||
161730220|NCT02616185|584055846|FG007|Overall Study|Death|2|||
161730221|NCT02616185|584055847|FG008|Overall Study|Death|1|||
161730222|NCT02616185|584055839|FG000|Overall Study|Study terminated by sponsor|0|||
161730223|NCT02616185|584055840|FG001|Overall Study|Study terminated by sponsor|0|||
161730224|NCT02616185|584055841|FG002|Overall Study|Study terminated by sponsor|1|||
161730225|NCT02616185|584055842|FG003|Overall Study|Study terminated by sponsor|0|||
161730226|NCT02616185|584055843|FG004|Overall Study|Study terminated by sponsor|0|||
161730227|NCT02616185|584055844|FG005|Overall Study|Study terminated by sponsor|0|||
161730228|NCT02616185|584055845|FG006|Overall Study|Study terminated by sponsor|5|||
161730229|NCT02616185|584055846|FG007|Overall Study|Study terminated by sponsor|2|||
161730230|NCT02616185|584055847|FG008|Overall Study|Study terminated by sponsor|0|||
161730231|NCT02616185|584055839|FG000|Overall Study|Participant refused further follow-up|1|||
161730232|NCT02616185|584055840|FG001|Overall Study|Participant refused further follow-up|1|||
161730233|NCT02616185|584055841|FG002|Overall Study|Participant refused further follow-up|2|||
161730234|NCT02616185|584055842|FG003|Overall Study|Participant refused further follow-up|3|||
161730235|NCT02616185|584055843|FG004|Overall Study|Participant refused further follow-up|4|||
161730236|NCT02616185|584055844|FG005|Overall Study|Participant refused further follow-up|0|||
161730237|NCT02616185|584055845|FG006|Overall Study|Participant refused further follow-up|3|||
161730238|NCT02616185|584055846|FG007|Overall Study|Participant refused further follow-up|4|||
161730239|NCT02616185|584055847|FG008|Overall Study|Participant refused further follow-up|3|||
161730240|NCT02616185|584055839|FG000|Overall Study|Not reported|0|||
161730241|NCT02616185|584055840|FG001|Overall Study|Not reported|0|||
161730242|NCT02616185|584055841|FG002|Overall Study|Not reported|0|||
161730243|NCT02616185|584055842|FG003|Overall Study|Not reported|1|||
161730244|NCT02616185|584055843|FG004|Overall Study|Not reported|3|||
161730245|NCT02616185|584055844|FG005|Overall Study|Not reported|1|||
161730246|NCT02616185|584055845|FG006|Overall Study|Not reported|0|||
161730247|NCT02616185|584055846|FG007|Overall Study|Not reported|5|||
161730248|NCT02616185|584055847|FG008|Overall Study|Not reported|2|||
161730249|NCT03303092|584055848|FG000|Overall Study|Adverse Event|1|||
161730250|NCT03303092|584055849|FG001|Overall Study|Adverse Event|0|||
161730251|NCT03303092|584055850|FG002|Overall Study|Adverse Event|1|||
161730252|NCT03303092|584055848|FG000|Overall Study|Protocol Violation|1|||
161730253|NCT03303092|584055849|FG001|Overall Study|Protocol Violation|5|||
161730254|NCT03303092|584055850|FG002|Overall Study|Protocol Violation|1|||
161730255|NCT03303092|584055848|FG000|Overall Study|Withdrawal by Subject|1|||
161730256|NCT03303092|584055849|FG001|Overall Study|Withdrawal by Subject|1|||
161730257|NCT03303092|584055850|FG002|Overall Study|Withdrawal by Subject|3|||
161730258|NCT01995136|584055856|FG000|Overall Study|Change in residence|1|||
161730259|NCT00833248|584055860|FG000|Overall Study|Adverse Event|3|||
161730260|NCT00833248|584055861|FG001|Overall Study|Adverse Event|0|||
161730261|NCT00833248|584055860|FG000|Overall Study|Protocol Violation|1|||
161730262|NCT00833248|584055861|FG001|Overall Study|Protocol Violation|2|||
161730263|NCT00833248|584055860|FG000|Overall Study|Withdrawal by Subject|0|||
161730264|NCT00833248|584055861|FG001|Overall Study|Withdrawal by Subject|1|||
161730265|NCT01830543|584055862|FG000|Overall Study|Subject Decision|19|||
161730266|NCT01830543|584055863|FG001|Overall Study|Subject Decision|21|||
161730267|NCT01830543|584055864|FG002|Overall Study|Subject Decision|57|||
161730268|NCT01830543|584055862|FG000|Overall Study|Adverse Event|91|||
161730269|NCT01830543|584055863|FG001|Overall Study|Adverse Event|77|||
161730270|NCT01830543|584055864|FG002|Overall Study|Adverse Event|76|||
161730271|NCT01830543|584055862|FG000|Overall Study|Death|20|||
161730272|NCT01830543|584055863|FG001|Overall Study|Death|22|||
161730273|NCT01830543|584055864|FG002|Overall Study|Death|22|||
161730274|NCT01830543|584055862|FG000|Overall Study|Protocol Violation|3|||
161730275|NCT01830543|584055863|FG001|Overall Study|Protocol Violation|7|||
161730276|NCT01830543|584055864|FG002|Overall Study|Protocol Violation|7|||
161730277|NCT01830543|584055862|FG000|Overall Study|Physician Decision|11|||
161730278|NCT01830543|584055863|FG001|Overall Study|Physician Decision|5|||
161730279|NCT01830543|584055864|FG002|Overall Study|Physician Decision|12|||
161730280|NCT01830543|584055862|FG000|Overall Study|Withdrawal by consent|3|||
161730281|NCT01830543|584055863|FG001|Overall Study|Withdrawal by consent|3|||
161730282|NCT01830543|584055864|FG002|Overall Study|Withdrawal by consent|3|||
161730283|NCT01830543|584055862|FG000|Overall Study|Other|12|||
161730284|NCT01830543|584055863|FG001|Overall Study|Other|17|||
161730285|NCT01830543|584055864|FG002|Overall Study|Other|37|||
161730286|NCT02585999|584055869|FG000|Overall Study|Lost to Follow-up|1|||
161730287|NCT02585999|584055869|FG000|Overall Study|Protocol Violation|1|||
161730288|NCT01028651|584055872|FG000|Overall Study|Death|2|||
161730289|NCT01028651|584055872|FG000|Overall Study|Adverse Event|1|||
161730290|NCT00390416|584055874|FG000|Overall Study|Withdrawal by Subject|1|||
161730291|NCT00390416|584055874|FG000|Overall Study|Not treated|3|||
161730292|NCT01592409|584055875|FG000|Overall Study|Withdrawal by Subject|0|||
161730293|NCT01592409|584055876|FG001|Overall Study|Withdrawal by Subject|1|||
161730294|NCT01728584|584055877|FG000|Overall Study|Adverse Event|1|||
161730295|NCT01728584|584055878|FG001|Overall Study|Adverse Event|0|||
161730296|NCT01728584|584055879|FG002|Overall Study|Adverse Event|0|||
161730297|NCT01728584|584055880|FG003|Overall Study|Adverse Event|0|||
161730298|NCT01728584|584055877|FG000|Overall Study|Physician Decision|4|||
161730299|NCT01728584|584055878|FG001|Overall Study|Physician Decision|0|||
161730300|NCT01728584|584055879|FG002|Overall Study|Physician Decision|1|||
161838664|NCT03502707|584453443|FG002|Overall Study|Randomized but not vaccinated|0|||
161730301|NCT01728584|584055880|FG003|Overall Study|Physician Decision|0|||
161730302|NCT01728584|584055877|FG000|Overall Study|Withdrawal by Subject|1|||
161730303|NCT01728584|584055878|FG001|Overall Study|Withdrawal by Subject|0|||
161730304|NCT01728584|584055879|FG002|Overall Study|Withdrawal by Subject|0|||
161730305|NCT01728584|584055880|FG003|Overall Study|Withdrawal by Subject|0|||
161730306|NCT01728584|584055877|FG000|Overall Study|Screen failure|1|||
161730307|NCT01728584|584055878|FG001|Overall Study|Screen failure|0|||
161838665|NCT03502707|584453444|FG003|Overall Study|Randomized but not vaccinated|0|||
161838666|NCT03502707|584453445|FG004|Overall Study|Randomized but not vaccinated|0|||
161838667|NCT03502707|584453446|FG005|Overall Study|Randomized but not vaccinated|0|||
161838668|NCT03502707|584453447|FG006|Overall Study|Randomized but not vaccinated|0|||
161838669|NCT03502707|584453448|FG007|Overall Study|Randomized but not vaccinated|0|||
161838670|NCT03502707|584453449|FG008|Overall Study|Randomized but not vaccinated|0|||
161838671|NCT03502707|584453450|FG009|Overall Study|Randomized but not vaccinated|0|||
161838672|NCT03502707|584453451|FG010|Overall Study|Randomized but not vaccinated|0|||
161838673|NCT03502707|584453452|FG011|Overall Study|Randomized but not vaccinated|1|||
161838674|NCT03502707|584453453|FG012|Overall Study|Randomized but not vaccinated|0|||
161838675|NCT03502707|584453454|FG013|Overall Study|Randomized but not vaccinated|0|||
161838676|NCT03502707|584453455|FG014|Overall Study|Randomized but not vaccinated|0|||
161838677|NCT03502707|584453456|FG015|Overall Study|Randomized but not vaccinated|0|||
161838678|NCT03502707|584453457|FG016|Overall Study|Randomized but not vaccinated|0|||
161838679|NCT03502707|584453458|FG017|Overall Study|Randomized but not vaccinated|1|||
161838680|NCT00461253|584453459|FG000|Overall Study|Death|985|||
161838681|NCT00461253|584453460|FG001|Overall Study|Death|0|||
161838682|NCT00461253|584453459|FG000|Overall Study|Protocol Violation|613|||
161838683|NCT00461253|584453460|FG001|Overall Study|Protocol Violation|236|||
161838684|NCT00461253|584453459|FG000|Overall Study|no response|2609|||
161838685|NCT00461253|584453460|FG001|Overall Study|no response|11789|||
161838686|NCT00461253|584453459|FG000|Overall Study|administrative|773|||
161838687|NCT00461253|584453460|FG001|Overall Study|administrative|7773|||
161838688|NCT01933113|584453461|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
161838689|NCT02297438|584453462|FG000|Overall Study|Death|79|||
161838690|NCT02297438|584453463|FG001|Overall Study|Death|86|||
161838691|NCT02297438|584453462|FG000|Overall Study|Lost to Follow-up|9|||
161838692|NCT02297438|584453463|FG001|Overall Study|Lost to Follow-up|7|||
161838693|NCT02297438|584453462|FG000|Overall Study|Withdrawal by Subject|7|||
161838694|NCT02297438|584453463|FG001|Overall Study|Withdrawal by Subject|0|||
161838695|NCT02297438|584453462|FG000|Overall Study|Other|9|||
161838696|NCT02297438|584453463|FG001|Overall Study|Other|5|||
161838697|NCT02297438|584453462|FG000|Overall Study|Ongoing|65|||
161838698|NCT02297438|584453463|FG001|Overall Study|Ongoing|73|||
161838699|NCT02358343|584453466|FG000|Screening Intervention|Death|0|||
161838700|NCT02358343|584453467|FG001|Screening Intervention|Death|2|||
161838701|NCT02358343|584453468|FG002|Screening Intervention|Death|0|||
161838702|NCT02358343|584453469|FG003|Screening Intervention|Death|0|||
161838703|NCT02358343|584453470|FG004|Screening Intervention|Death|0|||
161838704|NCT02358343|584453466|FG000|Screening Intervention|Withdrawal by Subject|1|||
161838705|NCT02358343|584453467|FG001|Screening Intervention|Withdrawal by Subject|0|||
161838706|NCT02358343|584453468|FG002|Screening Intervention|Withdrawal by Subject|0|||
161838707|NCT02358343|584453469|FG003|Screening Intervention|Withdrawal by Subject|0|||
161838708|NCT02358343|584453470|FG004|Screening Intervention|Withdrawal by Subject|0|||
161838709|NCT02358343|584453466|FG000|Screening Intervention|Determined Ineligible|5|||
161838710|NCT02358343|584453467|FG001|Screening Intervention|Determined Ineligible|6|||
161838711|NCT02358343|584453468|FG002|Screening Intervention|Determined Ineligible|0|||
161838712|NCT02358343|584453469|FG003|Screening Intervention|Determined Ineligible|0|||
161838713|NCT02358343|584453470|FG004|Screening Intervention|Determined Ineligible|0|||
161838714|NCT02358343|584453466|FG000|Comparative Efficacy Trial / Observation|Death|0|||
161838715|NCT02358343|584453467|FG001|Comparative Efficacy Trial / Observation|Death|0|||
161838716|NCT02358343|584453468|FG002|Comparative Efficacy Trial / Observation|Death|2|||
161838717|NCT02358343|584453469|FG003|Comparative Efficacy Trial / Observation|Death|0|||
161838718|NCT02358343|584453470|FG004|Comparative Efficacy Trial / Observation|Death|0|||
161838719|NCT02358343|584453466|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
161838720|NCT02358343|584453467|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
161838721|NCT02358343|584453468|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161838722|NCT02358343|584453469|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161838723|NCT02358343|584453470|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161838724|NCT02358343|584453466|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838725|NCT02358343|584453467|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838726|NCT02358343|584453468|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
161838727|NCT02358343|584453469|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838728|NCT02358343|584453470|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838729|NCT01951885|584453472|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
161838730|NCT01951885|584453473|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
161838731|NCT01951885|584453472|FG000|Overall Study|Adverse Event|1|||
161838732|NCT01951885|584453473|FG001|Overall Study|Adverse Event|0|||
161838733|NCT01951885|584453472|FG000|Overall Study|Withdrawal by Subject|0|||
161838734|NCT01951885|584453473|FG001|Overall Study|Withdrawal by Subject|1|||
161838735|NCT01951885|584453472|FG000|Overall Study|ineligible due to a change in donor|0|||
161838736|NCT01951885|584453473|FG001|Overall Study|ineligible due to a change in donor|1|||
161730308|NCT01728584|584055879|FG002|Overall Study|Screen failure|0|||
161730309|NCT01728584|584055880|FG003|Overall Study|Screen failure|0|||
161730310|NCT01728584|584055877|FG000|Overall Study|Other reason (not specified)|1|||
161730311|NCT01728584|584055878|FG001|Overall Study|Other reason (not specified)|0|||
161730312|NCT01728584|584055879|FG002|Overall Study|Other reason (not specified)|0|||
161730313|NCT01728584|584055880|FG003|Overall Study|Other reason (not specified)|1|||
161730314|NCT05132569|584055882|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
161730315|NCT05132569|584055883|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
161730316|NCT05132569|584055882|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
161730317|NCT05132569|584055883|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
161730318|NCT05132569|584055882|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
161730319|NCT05132569|584055883|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
161730320|NCT02345252|584055898|FG000|Double-Blind Phase|Adverse Event|2|||
161730321|NCT02345252|584055899|FG001|Double-Blind Phase|Adverse Event|3|||
161730322|NCT02345252|584055898|FG000|Double-Blind Phase|Death|1|||
161730323|NCT02345252|584055899|FG001|Double-Blind Phase|Death|2|||
161730324|NCT02345252|584055898|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161730325|NCT02345252|584055899|FG001|Double-Blind Phase|Lack of Efficacy|0|||
161730326|NCT02345252|584055898|FG000|Double-Blind Phase|Investigator's Discretion|4|||
161730327|NCT02345252|584055899|FG001|Double-Blind Phase|Investigator's Discretion|6|||
161730328|NCT02345252|584055898|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161730329|NCT02345252|584055899|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
161730330|NCT02345252|584055898|FG000|Double-Blind Phase|Protocol Violation|2|||
161730331|NCT02345252|584055899|FG001|Double-Blind Phase|Protocol Violation|1|||
161730332|NCT02345252|584055898|FG000|Double-Blind Phase|Withdrew Consent|21|||
161730333|NCT02345252|584055899|FG001|Double-Blind Phase|Withdrew Consent|23|||
161730334|NCT02345252|584055898|FG000|Double-Blind Phase|Lost to Follow-up|8|||
161730335|NCT02345252|584055899|FG001|Double-Blind Phase|Lost to Follow-up|10|||
161730336|NCT02345252|584055898|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
161730337|NCT02345252|584055899|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
161730338|NCT00471536|584055910|FG000|Overall Study|Withdrawal by Subject|1|||
161730339|NCT01188564|584055913|FG000|Double-blind Phase|randomized not treated|1|||
161730340|NCT01188564|584055914|FG001|Double-blind Phase|randomized not treated|0|||
161730341|NCT01094730|584055917|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
161730342|NCT01094730|584055918|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
161730343|NCT01094730|584055917|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
161730344|NCT01094730|584055918|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
161730345|NCT01094730|584055917|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
161730346|NCT01094730|584055918|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
161730347|NCT01094730|584055917|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
161730348|NCT01094730|584055918|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
161730349|NCT01094730|584055917|FG000|Period 2 (14 Days)|Protocol Violation|2|||
161730350|NCT01094730|584055918|FG001|Period 2 (14 Days)|Protocol Violation|0|||
161730351|NCT01094730|584055917|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
161730352|NCT01094730|584055918|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
161730353|NCT01094730|584055917|FG000|Period 2 (14 Days)|Adverse Event|0|||
161730354|NCT01094730|584055918|FG001|Period 2 (14 Days)|Adverse Event|1|||
161730355|NCT01094730|584055917|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
161730356|NCT01094730|584055918|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
161730357|NCT04171037|584055919|FG000|Overall Study|Lost to Follow-up|1|||
161730358|NCT04171037|584055920|FG001|Overall Study|Lost to Follow-up|0|||
161730359|NCT04171037|584055919|FG000|Overall Study|Physician Decision|3|||
161730360|NCT04171037|584055920|FG001|Overall Study|Physician Decision|3|||
161730361|NCT01934894|584055921|FG000|Overall Study|Adverse Event|1|||
161730362|NCT01934894|584055922|FG001|Overall Study|Adverse Event|2|||
161730363|NCT01934894|584055921|FG000|Overall Study|Death|2|||
161730364|NCT01934894|584055922|FG001|Overall Study|Death|0|||
161730365|NCT01934894|584055921|FG000|Overall Study|Withdrawal by Subject|0|||
161730366|NCT01934894|584055922|FG001|Overall Study|Withdrawal by Subject|1|||
161730367|NCT01934894|584055921|FG000|Overall Study|Progressive Disease|3|||
161730368|NCT01934894|584055922|FG001|Overall Study|Progressive Disease|2|||
161730369|NCT01954251|584055923|FG000|Overall Study|Adverse Event|5|||
161730370|NCT01954251|584055924|FG001|Overall Study|Adverse Event|7|||
161730371|NCT01954251|584055923|FG000|Overall Study|Lost to Follow-up|6|||
161730372|NCT01954251|584055924|FG001|Overall Study|Lost to Follow-up|6|||
161730373|NCT01954251|584055923|FG000|Overall Study|Withdrawal by Subject|2|||
161730374|NCT01954251|584055924|FG001|Overall Study|Withdrawal by Subject|6|||
161730375|NCT02864940|584055925|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
161730376|NCT02864940|584055926|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
161730377|NCT02232087|584055927|FG000|Overall Study|Withdrawal by Subject|2|||
161730378|NCT02232087|584055928|FG001|Overall Study|Withdrawal by Subject|0|||
161730379|NCT02232087|584055929|FG002|Overall Study|Withdrawal by Subject|0|||
161730380|NCT02232087|584055930|FG003|Overall Study|Withdrawal by Subject|0|||
161730381|NCT02232087|584055931|FG004|Overall Study|Withdrawal by Subject|0|||
161730382|NCT02232087|584055932|FG005|Overall Study|Withdrawal by Subject|1|||
161730383|NCT02232087|584055927|FG000|Overall Study|poor inhalation technique|0|||
161730384|NCT02232087|584055928|FG001|Overall Study|poor inhalation technique|1|||
161730385|NCT02232087|584055929|FG002|Overall Study|poor inhalation technique|0|||
161730386|NCT02232087|584055930|FG003|Overall Study|poor inhalation technique|0|||
161730387|NCT02232087|584055931|FG004|Overall Study|poor inhalation technique|0|||
161730388|NCT02232087|584055932|FG005|Overall Study|poor inhalation technique|2|||
161730389|NCT02232087|584055927|FG000|Overall Study|protocol stop criteria|0|||
161730390|NCT02232087|584055928|FG001|Overall Study|protocol stop criteria|1|||
161730391|NCT02232087|584055929|FG002|Overall Study|protocol stop criteria|0|||
161730392|NCT02232087|584055930|FG003|Overall Study|protocol stop criteria|1|||
161730393|NCT02232087|584055931|FG004|Overall Study|protocol stop criteria|0|||
161730394|NCT02232087|584055932|FG005|Overall Study|protocol stop criteria|0|||
161730395|NCT02232087|584055927|FG000|Overall Study|Adverse Event|0|||
161730396|NCT02232087|584055928|FG001|Overall Study|Adverse Event|0|||
161730397|NCT02232087|584055929|FG002|Overall Study|Adverse Event|0|||
161730398|NCT02232087|584055930|FG003|Overall Study|Adverse Event|0|||
161730399|NCT02232087|584055931|FG004|Overall Study|Adverse Event|1|||
161730400|NCT02232087|584055932|FG005|Overall Study|Adverse Event|0|||
161730401|NCT01958125|584055933|FG000|Overall Study|Missing diary data|2|||
161730402|NCT01958125|584055934|FG001|Overall Study|Missing diary data|6|||
161730403|NCT01958125|584055933|FG000|Overall Study|No headache attacks|0|||
161730404|NCT01958125|584055934|FG001|Overall Study|No headache attacks|2|||
161730405|NCT04096326|584055935|FG000|Overall Study|Withdrawal by Subject|0|||
161730406|NCT04096326|584055936|FG001|Overall Study|Withdrawal by Subject|0|||
161730407|NCT04096326|584055937|FG002|Overall Study|Withdrawal by Subject|0|||
161730408|NCT04096326|584055938|FG003|Overall Study|Withdrawal by Subject|0|||
161730409|NCT04096326|584055939|FG004|Overall Study|Withdrawal by Subject|0|||
161730410|NCT04096326|584055940|FG005|Overall Study|Withdrawal by Subject|0|||
161730411|NCT04096326|584055941|FG006|Overall Study|Withdrawal by Subject|1|||
161730412|NCT04096326|584055942|FG007|Overall Study|Withdrawal by Subject|0|||
161730413|NCT04096326|584055943|FG008|Overall Study|Withdrawal by Subject|0|||
161730414|NCT04096326|584055944|FG009|Overall Study|Withdrawal by Subject|0|||
161730415|NCT04096326|584055935|FG000|Overall Study|Lost to Follow-up|0|||
161730416|NCT04096326|584055936|FG001|Overall Study|Lost to Follow-up|1|||
161730417|NCT04096326|584055937|FG002|Overall Study|Lost to Follow-up|0|||
161730418|NCT04096326|584055938|FG003|Overall Study|Lost to Follow-up|0|||
161730419|NCT04096326|584055939|FG004|Overall Study|Lost to Follow-up|0|||
161730420|NCT04096326|584055940|FG005|Overall Study|Lost to Follow-up|0|||
161730421|NCT04096326|584055941|FG006|Overall Study|Lost to Follow-up|0|||
161730422|NCT04096326|584055942|FG007|Overall Study|Lost to Follow-up|0|||
161730423|NCT04096326|584055943|FG008|Overall Study|Lost to Follow-up|0|||
161730424|NCT04096326|584055944|FG009|Overall Study|Lost to Follow-up|0|||
161730425|NCT04096326|584055935|FG000|Overall Study|COVID-19-related reasons|0|||
161730426|NCT04096326|584055936|FG001|Overall Study|COVID-19-related reasons|0|||
161730427|NCT04096326|584055937|FG002|Overall Study|COVID-19-related reasons|0|||
161730428|NCT04096326|584055938|FG003|Overall Study|COVID-19-related reasons|0|||
161730429|NCT04096326|584055939|FG004|Overall Study|COVID-19-related reasons|1|||
161730430|NCT04096326|584055940|FG005|Overall Study|COVID-19-related reasons|5|||
161730431|NCT04096326|584055941|FG006|Overall Study|COVID-19-related reasons|0|||
161730432|NCT04096326|584055942|FG007|Overall Study|COVID-19-related reasons|0|||
161730433|NCT04096326|584055943|FG008|Overall Study|COVID-19-related reasons|0|||
161730434|NCT04096326|584055944|FG009|Overall Study|COVID-19-related reasons|0|||
161730435|NCT04804033|584055945|FG000|Period 1: DBT Phase|Adverse Event|1|||
161730436|NCT04804033|584055946|FG001|Period 1: DBT Phase|Adverse Event|5|||
161730437|NCT04804033|584055947|FG002|Period 1: DBT Phase|Adverse Event|3|||
161730438|NCT04804033|584055948|FG003|Period 1: DBT Phase|Adverse Event|4|||
161730439|NCT04804033|584055945|FG000|Period 1: DBT Phase|Death|1|||
161838737|NCT01951885|584453472|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
161838738|NCT01951885|584453473|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
161730440|NCT04804033|584055946|FG001|Period 1: DBT Phase|Death|0|||
161730441|NCT04804033|584055947|FG002|Period 1: DBT Phase|Death|0|||
161730442|NCT04804033|584055948|FG003|Period 1: DBT Phase|Death|0|||
161730443|NCT04804033|584055945|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
161730444|NCT04804033|584055946|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
161838739|NCT01687478|584453474|FG000|Overall Study|Adverse Event|3|||
161730445|NCT04804033|584055947|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
161730446|NCT04804033|584055948|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
161838740|NCT01687478|584453475|FG001|Overall Study|Adverse Event|10|||
161730447|NCT04804033|584055945|FG000|Period 1: DBT Phase|Non-compliance|1|||
161730448|NCT04804033|584055946|FG001|Period 1: DBT Phase|Non-compliance|0|||
161730449|NCT04804033|584055947|FG002|Period 1: DBT Phase|Non-compliance|1|||
161730450|NCT04804033|584055948|FG003|Period 1: DBT Phase|Non-compliance|2|||
161730451|NCT04804033|584055945|FG000|Period 1: DBT Phase|Other|0|||
161730452|NCT04804033|584055946|FG001|Period 1: DBT Phase|Other|1|||
161730453|NCT04804033|584055947|FG002|Period 1: DBT Phase|Other|0|||
161838741|NCT01687478|584453474|FG000|Overall Study|Lost to Follow-up|1|||
161838742|NCT01687478|584453475|FG001|Overall Study|Lost to Follow-up|3|||
161838743|NCT01687478|584453474|FG000|Overall Study|Protocol Violation|0|||
161838744|NCT01687478|584453475|FG001|Overall Study|Protocol Violation|2|||
161838745|NCT01687478|584453474|FG000|Overall Study|Withdrawal by Subject|21|||
161838746|NCT01687478|584453475|FG001|Overall Study|Withdrawal by Subject|19|||
161838747|NCT01687478|584453474|FG000|Overall Study|Physician Decision|1|||
161838748|NCT01687478|584453475|FG001|Overall Study|Physician Decision|3|||
161838749|NCT01687478|584453474|FG000|Overall Study|Entry Criteria Not Met|6|||
161838750|NCT01687478|584453475|FG001|Overall Study|Entry Criteria Not Met|2|||
161838751|NCT03188718|584453476|FG000|Overall Study|Participant noncompliance|4|||
161838752|NCT03188718|584453476|FG000|Overall Study|Withdrawal by Subject|1|||
161838753|NCT03188718|584453476|FG000|Overall Study|Device failure|3|||
161838754|NCT04322149|584453477|FG000|Overall Study|Adverse Event|1|||
161838755|NCT04322149|584453478|FG001|Overall Study|Adverse Event|1|||
161838756|NCT04322149|584453479|FG002|Overall Study|Adverse Event|0|||
161838757|NCT04322149|584453480|FG003|Overall Study|Adverse Event|0|||
161838758|NCT04322149|584453477|FG000|Overall Study|Withdrawal by Subject|0|||
161838759|NCT04322149|584453478|FG001|Overall Study|Withdrawal by Subject|0|||
161838760|NCT04322149|584453479|FG002|Overall Study|Withdrawal by Subject|0|||
161838761|NCT04322149|584453480|FG003|Overall Study|Withdrawal by Subject|2|||
161838762|NCT04322149|584453477|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161838763|NCT04322149|584453478|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
161838764|NCT04322149|584453479|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161838765|NCT04322149|584453480|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161838766|NCT01700049|584453487|FG000|Overall Study|Withdrawal by Subject|1|||
161730454|NCT04804033|584055948|FG003|Period 1: DBT Phase|Other|0|||
161730455|NCT04804033|584055945|FG000|Period 1: DBT Phase|Pregnancy|2|||
161730456|NCT04804033|584055946|FG001|Period 1: DBT Phase|Pregnancy|0|||
161730457|NCT04804033|584055947|FG002|Period 1: DBT Phase|Pregnancy|0|||
161730458|NCT04804033|584055948|FG003|Period 1: DBT Phase|Pregnancy|0|||
161730459|NCT04804033|584055945|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
161730460|NCT04804033|584055946|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
161730461|NCT04804033|584055947|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
161730462|NCT04804033|584055948|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
161730463|NCT04804033|584055945|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
161730464|NCT04804033|584055946|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
161730465|NCT04804033|584055947|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
161838767|NCT00792935|584453488|FG000|Overall Study|Adverse Event|2|||
161838768|NCT00792935|584453489|FG001|Overall Study|Adverse Event|1|||
161838769|NCT00792935|584453488|FG000|Overall Study|Lost to Follow-up|0|||
161838770|NCT00792935|584453489|FG001|Overall Study|Lost to Follow-up|1|||
161838771|NCT00792935|584453488|FG000|Overall Study|Protocol Violation|2|||
161838772|NCT00792935|584453489|FG001|Overall Study|Protocol Violation|0|||
161838773|NCT00792935|584453488|FG000|Overall Study|Withdrawal by Subject|0|||
161838774|NCT00792935|584453489|FG001|Overall Study|Withdrawal by Subject|1|||
161838775|NCT01155024|584453497|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
161838776|NCT01155024|584453498|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
161838777|NCT01155024|584453497|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
161838778|NCT01155024|584453498|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
161838779|NCT01155024|584453497|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
161838780|NCT01155024|584453498|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
161838781|NCT01593696|584453499|FG000|Dose Escalation|Progressive Disease|2|||
161838782|NCT01593696|584453500|FG001|Dose Escalation|Progressive Disease|0|||
161838783|NCT01593696|584453501|FG002|Dose Escalation|Progressive Disease|0|||
161838784|NCT01593696|584453502|FG003|Dose Escalation|Progressive Disease|0|||
161838785|NCT01593696|584453499|FG000|Dose Expansion|Fungal infection|0|||
161838786|NCT01593696|584453500|FG001|Dose Expansion|Fungal infection|0|||
161730466|NCT04804033|584055948|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
161730467|NCT04804033|584055945|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
161730468|NCT04804033|584055946|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
161730469|NCT04804033|584055947|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
161838787|NCT01593696|584453501|FG002|Dose Expansion|Fungal infection|1|||
161838788|NCT01593696|584453502|FG003|Dose Expansion|Fungal infection|0|||
161838789|NCT00369655|584453503|FG000|Overall Study|Refusal of further treatment|2|||
161838790|NCT03402750|584453504|FG000|Overall Study|Lost to Follow-up|2|||
161838791|NCT03402750|584453505|FG001|Overall Study|Lost to Follow-up|1|||
161730470|NCT04804033|584055948|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
161730471|NCT04804033|584055945|FG000|Period 2: OLE Phase|Adverse Event|3|||
161730472|NCT04804033|584055946|FG001|Period 2: OLE Phase|Adverse Event|4|||
161730473|NCT04804033|584055947|FG002|Period 2: OLE Phase|Adverse Event|2|||
161730474|NCT04804033|584055948|FG003|Period 2: OLE Phase|Adverse Event|0|||
161730475|NCT04804033|584055945|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
161730476|NCT04804033|584055946|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
161730477|NCT04804033|584055947|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
161730478|NCT04804033|584055948|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
161730479|NCT04804033|584055945|FG000|Period 2: OLE Phase|Non-compliance|2|||
161730480|NCT04804033|584055946|FG001|Period 2: OLE Phase|Non-compliance|2|||
161730481|NCT04804033|584055947|FG002|Period 2: OLE Phase|Non-compliance|0|||
161730482|NCT04804033|584055948|FG003|Period 2: OLE Phase|Non-compliance|1|||
161730483|NCT04804033|584055945|FG000|Period 2: OLE Phase|Other|0|||
161730484|NCT04804033|584055946|FG001|Period 2: OLE Phase|Other|2|||
161730485|NCT04804033|584055947|FG002|Period 2: OLE Phase|Other|0|||
161730486|NCT04804033|584055948|FG003|Period 2: OLE Phase|Other|0|||
161730487|NCT04804033|584055945|FG000|Period 2: OLE Phase|Physician Decision|1|||
161730488|NCT04804033|584055946|FG001|Period 2: OLE Phase|Physician Decision|1|||
161730489|NCT04804033|584055947|FG002|Period 2: OLE Phase|Physician Decision|0|||
161730490|NCT04804033|584055948|FG003|Period 2: OLE Phase|Physician Decision|0|||
161730491|NCT04804033|584055945|FG000|Period 2: OLE Phase|Pregnancy|0|||
161730492|NCT04804033|584055946|FG001|Period 2: OLE Phase|Pregnancy|0|||
161730493|NCT04804033|584055947|FG002|Period 2: OLE Phase|Pregnancy|2|||
161730494|NCT04804033|584055948|FG003|Period 2: OLE Phase|Pregnancy|0|||
161730495|NCT04804033|584055945|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
161730496|NCT04804033|584055946|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
161730497|NCT04804033|584055947|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
161730498|NCT04804033|584055948|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
161730499|NCT04804033|584055945|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
161730500|NCT04804033|584055946|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
161730501|NCT04804033|584055947|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
161730502|NCT04804033|584055948|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
161730503|NCT04804033|584055945|FG000|Period 2: OLE Phase|Not reported|0|||
161730504|NCT04804033|584055946|FG001|Period 2: OLE Phase|Not reported|2|||
161730505|NCT04804033|584055947|FG002|Period 2: OLE Phase|Not reported|0|||
161730506|NCT04804033|584055948|FG003|Period 2: OLE Phase|Not reported|0|||
161730507|NCT04804033|584055945|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
161730508|NCT04804033|584055946|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
161730509|NCT04804033|584055947|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161730510|NCT04804033|584055948|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161730511|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
161730512|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
161730513|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
161730514|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
161730515|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Other|0|||
161730516|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Other|1|||
161730517|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Other|2|||
161730518|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Other|1|||
161730519|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
161730520|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
161730521|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
161730522|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
161730523|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Not reported|18|||
161730524|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Not reported|15|||
161730525|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Not reported|1|||
161730526|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Not reported|4|||
161730527|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
161730528|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
161730529|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
161730530|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
161730531|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161730532|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
161730533|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
161730534|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
161730535|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
161730536|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
161730537|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
161730538|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
161730539|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
161730540|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
161730541|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
161730542|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
161730543|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161730544|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161730545|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
161730546|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
161730547|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
161730548|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161730549|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161730550|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161730551|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Other|8|||
161730552|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Other|7|||
161730553|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Other|4|||
161730554|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161730555|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161730556|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
161730557|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161730558|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
161730559|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161730560|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161730561|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161730562|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161730563|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161730564|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161730565|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161730566|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
161730567|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161730568|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161730569|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
161730570|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
161730571|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
161730572|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161730573|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161730574|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161730575|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Other|5|||
161730576|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161730577|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161730578|NCT02496585|584055954|FG000|Overall Study|Death|3|||
161730579|NCT02496585|584055955|FG001|Overall Study|Death|0|||
161730580|NCT02496585|584055954|FG000|Overall Study|Lost to Follow-up|2|||
161730581|NCT02496585|584055955|FG001|Overall Study|Lost to Follow-up|0|||
161730582|NCT02496585|584055954|FG000|Overall Study|Withdrawal by Subject|1|||
161730583|NCT02496585|584055955|FG001|Overall Study|Withdrawal by Subject|2|||
161730584|NCT02496585|584055954|FG000|Overall Study|Progression of Malignancy|4|||
161730585|NCT02496585|584055955|FG001|Overall Study|Progression of Malignancy|1|||
161730586|NCT01864018|584055959|FG000|Overall Study|Ineligible|3|||
161730587|NCT01864018|584055960|FG001|Overall Study|Ineligible|1|||
161730588|NCT05372575|584055964|FG000|Overall Study|Protocol Violation|7|||
161730589|NCT05372575|584055965|FG001|Overall Study|Protocol Violation|16|||
161730590|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
161730591|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
161730592|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
161730593|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161730594|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161730595|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161730596|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
161730597|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
161730598|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
161730599|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161730600|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161730601|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161730602|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730603|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
161730604|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730605|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730606|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730607|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730608|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
161730609|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
161838792|NCT02981303|584453506|FG000|Overall Study|Progressive Disease|17|||
161838793|NCT02981303|584453507|FG001|Overall Study|Progressive Disease|37|||
161838794|NCT02981303|584453506|FG000|Overall Study|Adverse Event|1|||
161838795|NCT02981303|584453507|FG001|Overall Study|Adverse Event|4|||
161838796|NCT02981303|584453506|FG000|Overall Study|Withdrawal by Subject|0|||
161838797|NCT02981303|584453507|FG001|Overall Study|Withdrawal by Subject|1|||
161838798|NCT00848107|584453508|FG000|Overall Study|Lost to Follow-up|2|||
161838799|NCT00848107|584453508|FG000|Overall Study|Withdrawal by Subject|8|||
161838800|NCT00848107|584453508|FG000|Overall Study|Adverse Event|9|||
161838801|NCT00848107|584453508|FG000|Overall Study|Death|1|||
161838802|NCT00848107|584453508|FG000|Overall Study|Pregnancy|1|||
161838803|NCT02266134|584453512|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
161838804|NCT02266134|584453513|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
161838805|NCT02266134|584453514|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
161838806|NCT02266134|584453515|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
161838807|NCT02266134|584453512|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
161838808|NCT02266134|584453513|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
161838809|NCT02266134|584453514|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
161838810|NCT02266134|584453515|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
161838811|NCT02266134|584453512|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
161838812|NCT02266134|584453513|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
161838813|NCT02266134|584453514|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
161838814|NCT02266134|584453515|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
161838815|NCT02266134|584453512|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
161838816|NCT02266134|584453513|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161838817|NCT02266134|584453514|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161838818|NCT02266134|584453515|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161838819|NCT02266134|584453512|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
161838820|NCT02266134|584453513|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
161838821|NCT02266134|584453514|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
161838822|NCT02266134|584453515|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
161838823|NCT02266134|584453512|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
161838824|NCT02266134|584453513|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161838825|NCT02266134|584453514|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161838826|NCT02266134|584453515|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161838827|NCT00762437|584453516|FG000|Overall Study|Lost to Follow-up|7|||
161838828|NCT00762437|584453516|FG000|Overall Study|Missed final study visit|11|||
161838829|NCT00762437|584453516|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
161838830|NCT00302081|584453520|FG000|Overall Study|Adverse Event|6|||
161838831|NCT00302081|584453521|FG001|Overall Study|Adverse Event|5|||
161730610|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730611|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730612|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730613|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730614|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
161730615|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
161730616|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
161730617|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161730618|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161730619|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161730620|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730621|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730622|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730623|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
161730624|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
161730625|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730626|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730627|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730628|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730629|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730630|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
161730631|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
161730632|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730633|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730634|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730635|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730636|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730637|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
161730638|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161730639|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161730640|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161730641|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
161730642|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
161730643|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
161730644|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730645|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730646|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730647|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730648|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
161838832|NCT00302081|584453522|FG002|Overall Study|Adverse Event|4|||
161838833|NCT00302081|584453520|FG000|Overall Study|Lost to Follow-up|21|||
161838834|NCT00302081|584453521|FG001|Overall Study|Lost to Follow-up|18|||
161838835|NCT00302081|584453522|FG002|Overall Study|Lost to Follow-up|28|||
161838836|NCT00302081|584453520|FG000|Overall Study|Withdrawal by Subject|8|||
161838837|NCT00302081|584453521|FG001|Overall Study|Withdrawal by Subject|12|||
161838838|NCT00302081|584453522|FG002|Overall Study|Withdrawal by Subject|8|||
161838839|NCT00302081|584453520|FG000|Overall Study|Protocol Violation|5|||
161838840|NCT00302081|584453521|FG001|Overall Study|Protocol Violation|1|||
161838841|NCT00302081|584453522|FG002|Overall Study|Protocol Violation|2|||
161838842|NCT00302081|584453520|FG000|Overall Study|Lack of Efficacy|1|||
161838843|NCT00302081|584453521|FG001|Overall Study|Lack of Efficacy|0|||
161838844|NCT00302081|584453522|FG002|Overall Study|Lack of Efficacy|5|||
161838845|NCT00302081|584453520|FG000|Overall Study|Death|2|||
161838846|NCT00302081|584453521|FG001|Overall Study|Death|1|||
161838847|NCT00302081|584453522|FG002|Overall Study|Death|0|||
161838848|NCT00302081|584453520|FG000|Overall Study|Other|13|||
161838849|NCT00302081|584453521|FG001|Overall Study|Other|6|||
161838850|NCT00302081|584453522|FG002|Overall Study|Other|5|||
161838851|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
161838852|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
161838853|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
161838854|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
161838855|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
161838856|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
161838857|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
161838858|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
161838859|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
161838860|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
161838861|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
161838862|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
161838863|NCT04771403|584453523|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
161838864|NCT04771403|584453524|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
161838865|NCT04771403|584453523|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
161838866|NCT04771403|584453524|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
161838867|NCT00857259|584453525|FG000|Overall Study|Protocol Violation|1|||
161838868|NCT00857259|584453526|FG001|Overall Study|Protocol Violation|0|||
161838869|NCT00857259|584453527|FG002|Overall Study|Protocol Violation|1|||
161838870|NCT02701413|584453528|FG000|Overall Study|Withdrawal by Subject|7|||
161838871|NCT02701413|584453529|FG001|Overall Study|Withdrawal by Subject|11|||
161838872|NCT02138136|584453530|FG000|Overall Study|Protocol Violation|4|||
161838873|NCT02138136|584453530|FG000|Overall Study|Physician Decision|7|||
161838874|NCT02138136|584453530|FG000|Overall Study|Lack of Efficacy|35|||
161838875|NCT02138136|584453530|FG000|Overall Study|Pregnancy|2|||
161838876|NCT02138136|584453530|FG000|Overall Study|Adverse Event|18|||
161838877|NCT02138136|584453530|FG000|Overall Study|Withdrawal by Subject|36|||
161838878|NCT02138136|584453530|FG000|Overall Study|Lost to Follow-up|32|||
161838879|NCT02138136|584453530|FG000|Overall Study|Withdrawn by Sponsor|5|||
161838880|NCT01359644|584453535|FG000|Treatment Period|Lack of Efficacy|0|||
161838881|NCT01359644|584453536|FG001|Treatment Period|Lack of Efficacy|1|||
161838882|NCT01359644|584453537|FG002|Treatment Period|Lack of Efficacy|0|||
161838883|NCT01359644|584453538|FG003|Treatment Period|Lack of Efficacy|0|||
161838884|NCT01359644|584453539|FG004|Treatment Period|Lack of Efficacy|0|||
161838885|NCT01359644|584453540|FG005|Treatment Period|Lack of Efficacy|0|||
161838886|NCT01359644|584453541|FG006|Treatment Period|Lack of Efficacy|0|||
161838887|NCT01359644|584453542|FG007|Treatment Period|Lack of Efficacy|0|||
161838888|NCT01359644|584453543|FG008|Treatment Period|Lack of Efficacy|0|||
161838889|NCT01359644|584453544|FG009|Treatment Period|Lack of Efficacy|0|||
161838890|NCT01359644|584453535|FG000|Treatment Period|Adverse Event|0|||
161838891|NCT01359644|584453536|FG001|Treatment Period|Adverse Event|0|||
161838892|NCT01359644|584453537|FG002|Treatment Period|Adverse Event|1|||
161838893|NCT01359644|584453538|FG003|Treatment Period|Adverse Event|0|||
161838894|NCT01359644|584453539|FG004|Treatment Period|Adverse Event|0|||
161838895|NCT01359644|584453540|FG005|Treatment Period|Adverse Event|1|||
161838896|NCT01359644|584453541|FG006|Treatment Period|Adverse Event|0|||
161838897|NCT01359644|584453542|FG007|Treatment Period|Adverse Event|0|||
161838898|NCT01359644|584453543|FG008|Treatment Period|Adverse Event|0|||
161838899|NCT01359644|584453544|FG009|Treatment Period|Adverse Event|0|||
161838900|NCT01359644|584453535|FG000|Treatment Period|Lost to Follow-up|0|||
161838901|NCT01359644|584453536|FG001|Treatment Period|Lost to Follow-up|0|||
161838902|NCT01359644|584453537|FG002|Treatment Period|Lost to Follow-up|0|||
161838903|NCT01359644|584453538|FG003|Treatment Period|Lost to Follow-up|0|||
161838904|NCT01359644|584453539|FG004|Treatment Period|Lost to Follow-up|0|||
161838905|NCT01359644|584453540|FG005|Treatment Period|Lost to Follow-up|1|||
161838906|NCT01359644|584453541|FG006|Treatment Period|Lost to Follow-up|0|||
161838907|NCT01359644|584453542|FG007|Treatment Period|Lost to Follow-up|0|||
161838908|NCT01359644|584453543|FG008|Treatment Period|Lost to Follow-up|0|||
161838909|NCT01359644|584453544|FG009|Treatment Period|Lost to Follow-up|0|||
161730649|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730650|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161730651|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161730652|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161730653|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161730654|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161730655|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161730656|NCT03510663|584055972|FG000|Overall Study|Withdrawal by Subject|0|||
161730657|NCT03510663|584055973|FG001|Overall Study|Withdrawal by Subject|1|||
161730658|NCT03510663|584055974|FG002|Overall Study|Withdrawal by Subject|0|||
161730659|NCT03510663|584055975|FG003|Overall Study|Withdrawal by Subject|0|||
161730660|NCT03510663|584055976|FG004|Overall Study|Withdrawal by Subject|0|||
161730661|NCT03510663|584055977|FG005|Overall Study|Withdrawal by Subject|0|||
161730662|NCT03510663|584055978|FG006|Overall Study|Withdrawal by Subject|0|||
161730663|NCT03510663|584055979|FG007|Overall Study|Withdrawal by Subject|0|||
161730664|NCT00222729|584055982|FG000|Overall Study|Adverse Event|3|||
161730665|NCT01915849|584055985|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
161730666|NCT01915849|584055986|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161730667|NCT01915849|584055987|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161730668|NCT01915849|584055988|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161730669|NCT01915849|584055985|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161730670|NCT01915849|584055986|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161730671|NCT01915849|584055987|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161730672|NCT01915849|584055988|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161730673|NCT01798706|584055989|FG000|Overall Study|Adverse Event|15|||
161730674|NCT01798706|584055990|FG001|Overall Study|Adverse Event|10|||
161730675|NCT01798706|584055989|FG000|Overall Study|Lack of Efficacy|0|||
161730676|NCT01798706|584055990|FG001|Overall Study|Lack of Efficacy|2|||
161730677|NCT01798706|584055989|FG000|Overall Study|Poor compliance to protocol|1|||
161730678|NCT01798706|584055990|FG001|Overall Study|Poor compliance to protocol|0|||
161730679|NCT01798706|584055989|FG000|Overall Study|Other than specified above|5|||
161730680|NCT01798706|584055990|FG001|Overall Study|Other than specified above|9|||
161730681|NCT02775864|584055991|FG000|Overall Study|Data ended end of 2010|1764|||
161730682|NCT02775864|584055992|FG001|Overall Study|Data ended end of 2010|2880|||
161730683|NCT02775864|584055993|FG002|Overall Study|Data ended end of 2010|1140|||
161730684|NCT02775864|584055994|FG003|Overall Study|Data ended end of 2010|1194|||
161730685|NCT02775864|584055991|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
161730686|NCT02775864|584055992|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
161730687|NCT02775864|584055993|FG002|Overall Study|Medicaid eligibility discontinued|720|||
161730688|NCT02775864|584055994|FG003|Overall Study|Medicaid eligibility discontinued|890|||
161730689|NCT04369430|584056002|FG000|Overall Study|Adverse Event|2|||
161730690|NCT04369430|584056003|FG001|Overall Study|Adverse Event|3|||
161730691|NCT04369430|584056002|FG000|Overall Study|Death|1|||
161730692|NCT04369430|584056003|FG001|Overall Study|Death|0|||
161730693|NCT04369430|584056002|FG000|Overall Study|Withdrawal by Subject|4|||
161730694|NCT04369430|584056003|FG001|Overall Study|Withdrawal by Subject|3|||
161730695|NCT04369430|584056002|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
161730696|NCT04369430|584056003|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
161730697|NCT04369430|584056002|FG000|Overall Study|Lost to Follow-up|0|||
161730698|NCT04369430|584056003|FG001|Overall Study|Lost to Follow-up|1|||
161730699|NCT04737031|584056004|FG000|Overall Study|Patients who did not have a treatment visit|0|||
161730700|NCT04737031|584056005|FG001|Overall Study|Patients who did not have a treatment visit|31|||
161730701|NCT04737031|584056006|FG002|Overall Study|Patients who did not have a treatment visit|93|||
161730702|NCT04737031|584056007|FG003|Overall Study|Patients who did not have a treatment visit|227|||
161730703|NCT02669862|584057965|FG000|Overall Study|Lost to Follow-up|0|||
161730704|NCT02669862|584057966|FG001|Overall Study|Lost to Follow-up|2|||
161730705|NCT02669862|584057967|FG002|Overall Study|Lost to Follow-up|1|||
161730706|NCT02669862|584057965|FG000|Overall Study|Withdrawal by Subject|2|||
161730707|NCT02669862|584057966|FG001|Overall Study|Withdrawal by Subject|2|||
161730708|NCT02669862|584057967|FG002|Overall Study|Withdrawal by Subject|3|||
161730709|NCT02669862|584057965|FG000|Overall Study|moved|0|||
161730710|NCT02669862|584057966|FG001|Overall Study|moved|1|||
161730711|NCT02669862|584057967|FG002|Overall Study|moved|0|||
161730712|NCT02669862|584057965|FG000|Overall Study|Protocol Violation|0|||
161730713|NCT02669862|584057966|FG001|Overall Study|Protocol Violation|0|||
161730714|NCT02669862|584057967|FG002|Overall Study|Protocol Violation|1|||
161730715|NCT01194804|584057968|FG000|Overall Study|Withdrawal by Subject|1|||
161730716|NCT02670915|584057969|FG000|Overall Study|Withdrawal by Subject|0|||
161730717|NCT02670915|584057970|FG001|Overall Study|Withdrawal by Subject|1|||
161730718|NCT02670915|584057971|FG002|Overall Study|Withdrawal by Subject|4|||
161730719|NCT02670915|584057969|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161730720|NCT02670915|584057970|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161730721|NCT02670915|584057971|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161730722|NCT02670915|584057969|FG000|Overall Study|Unclassified|0|||
161838910|NCT01359644|584453535|FG000|Follow-up Period|Withdrawal by Subject|0|||
161838911|NCT01359644|584453536|FG001|Follow-up Period|Withdrawal by Subject|0|||
161838912|NCT01359644|584453537|FG002|Follow-up Period|Withdrawal by Subject|0|||
161838913|NCT01359644|584453538|FG003|Follow-up Period|Withdrawal by Subject|0|||
161838914|NCT01359644|584453539|FG004|Follow-up Period|Withdrawal by Subject|0|||
161838915|NCT01359644|584453540|FG005|Follow-up Period|Withdrawal by Subject|1|||
161838916|NCT01359644|584453541|FG006|Follow-up Period|Withdrawal by Subject|0|||
161838917|NCT01359644|584453542|FG007|Follow-up Period|Withdrawal by Subject|0|||
161838918|NCT01359644|584453543|FG008|Follow-up Period|Withdrawal by Subject|0|||
161838919|NCT01359644|584453544|FG009|Follow-up Period|Withdrawal by Subject|0|||
161838920|NCT01359644|584453535|FG000|Follow-up Period|Lost to Follow-up|0|||
161730723|NCT02670915|584057970|FG001|Overall Study|Unclassified|3|||
161730724|NCT02670915|584057971|FG002|Overall Study|Unclassified|0|||
161730725|NCT00818207|584057972|FG000|Overall Study|Adverse Event|6|||
161730726|NCT00818207|584057973|FG001|Overall Study|Adverse Event|0|||
161730727|NCT00818207|584057972|FG000|Overall Study|Lost to Follow-up|160|||
161730728|NCT00818207|584057973|FG001|Overall Study|Lost to Follow-up|146|||
161730729|NCT00818207|584057972|FG000|Overall Study|Multiple reasons|11|||
161730730|NCT00818207|584057973|FG001|Overall Study|Multiple reasons|12|||
161730731|NCT00818207|584057972|FG000|Overall Study|Withdrawal by Subject|42|||
161730732|NCT00818207|584057973|FG001|Overall Study|Withdrawal by Subject|104|||
161730733|NCT00818207|584057972|FG000|Overall Study|Death|3|||
161730734|NCT00818207|584057973|FG001|Overall Study|Death|5|||
161730735|NCT01303380|584057974|FG000|Overall Study|Lack of compliance to study procedures|1|||
161730736|NCT01030458|584057975|FG000|Overall Study|Lost to Follow-up|9|||
161730737|NCT01030458|584057976|FG001|Overall Study|Lost to Follow-up|10|||
161730738|NCT01030458|584057975|FG000|Overall Study|Withdrawal by Subject|2|||
161730739|NCT01030458|584057976|FG001|Overall Study|Withdrawal by Subject|3|||
161730740|NCT01030458|584057975|FG000|Overall Study|Logistical reasons|9|||
161730741|NCT01030458|584057976|FG001|Overall Study|Logistical reasons|5|||
161730742|NCT01030458|584057975|FG000|Overall Study|Moved or changed job|6|||
161730743|NCT01030458|584057976|FG001|Overall Study|Moved or changed job|13|||
161730744|NCT01030458|584057975|FG000|Overall Study|Side effect of medication|1|||
161730745|NCT01030458|584057976|FG001|Overall Study|Side effect of medication|1|||
161730746|NCT00839423|584057979|FG000|Overall Study|Adverse Event|4|||
161730747|NCT00839423|584057980|FG001|Overall Study|Adverse Event|3|||
161730748|NCT00839423|584057981|FG002|Overall Study|Adverse Event|7|||
161730749|NCT00839423|584057982|FG003|Overall Study|Adverse Event|16|||
161730750|NCT00839423|584057979|FG000|Overall Study|Lack of Efficacy|6|||
161730751|NCT00839423|584057980|FG001|Overall Study|Lack of Efficacy|6|||
161730752|NCT00839423|584057981|FG002|Overall Study|Lack of Efficacy|3|||
161730753|NCT00839423|584057982|FG003|Overall Study|Lack of Efficacy|2|||
161730754|NCT00839423|584057979|FG000|Overall Study|Non-compliance|0|||
161730755|NCT00839423|584057980|FG001|Overall Study|Non-compliance|0|||
161730756|NCT00839423|584057981|FG002|Overall Study|Non-compliance|0|||
161730757|NCT00839423|584057982|FG003|Overall Study|Non-compliance|1|||
161730758|NCT00839423|584057979|FG000|Overall Study|Protocol Violation|0|||
161730759|NCT00839423|584057980|FG001|Overall Study|Protocol Violation|1|||
161730760|NCT00839423|584057981|FG002|Overall Study|Protocol Violation|2|||
161730761|NCT00839423|584057982|FG003|Overall Study|Protocol Violation|0|||
161730762|NCT00839423|584057979|FG000|Overall Study|Withdrawal of consent|4|||
161730763|NCT00839423|584057980|FG001|Overall Study|Withdrawal of consent|0|||
161730764|NCT00839423|584057981|FG002|Overall Study|Withdrawal of consent|4|||
161730765|NCT00839423|584057982|FG003|Overall Study|Withdrawal of consent|1|||
161730766|NCT00839423|584057979|FG000|Overall Study|Lost to Follow-up|1|||
161838921|NCT01359644|584453536|FG001|Follow-up Period|Lost to Follow-up|0|||
161838922|NCT01359644|584453537|FG002|Follow-up Period|Lost to Follow-up|0|||
161838923|NCT01359644|584453538|FG003|Follow-up Period|Lost to Follow-up|0|||
161838924|NCT01359644|584453539|FG004|Follow-up Period|Lost to Follow-up|0|||
161838925|NCT01359644|584453540|FG005|Follow-up Period|Lost to Follow-up|0|||
161838926|NCT01359644|584453541|FG006|Follow-up Period|Lost to Follow-up|1|||
161838927|NCT01359644|584453542|FG007|Follow-up Period|Lost to Follow-up|2|||
161838928|NCT01359644|584453543|FG008|Follow-up Period|Lost to Follow-up|0|||
161730767|NCT00839423|584057980|FG001|Overall Study|Lost to Follow-up|0|||
161838929|NCT01359644|584453544|FG009|Follow-up Period|Lost to Follow-up|0|||
161838930|NCT01660334|584453546|FG000|Overall Study|Lost to Follow-up|1|||
161730768|NCT00839423|584057981|FG002|Overall Study|Lost to Follow-up|1|||
161730769|NCT00839423|584057982|FG003|Overall Study|Lost to Follow-up|0|||
161838931|NCT00311311|584453547|FG000|Overall Study|Adverse Event|3|||
161730770|NCT00839423|584057979|FG000|Overall Study|Administrative or other reasons|3|||
161730771|NCT00839423|584057980|FG001|Overall Study|Administrative or other reasons|0|||
161730772|NCT00839423|584057981|FG002|Overall Study|Administrative or other reasons|1|||
161730773|NCT00839423|584057982|FG003|Overall Study|Administrative or other reasons|0|||
161730774|NCT01071096|584057983|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
161730775|NCT01071096|584057984|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
161730776|NCT01369849|584057985|FG000|Overall Study|Ineligible prior to treatment|0|||
161730777|NCT01369849|584057986|FG001|Overall Study|Ineligible prior to treatment|0|||
161730778|NCT01369849|584057987|FG002|Overall Study|Ineligible prior to treatment|1|||
161730779|NCT01369849|584057985|FG000|Overall Study|Ineligible after receiving treatment|0|||
161730780|NCT01369849|584057986|FG001|Overall Study|Ineligible after receiving treatment|1|||
161730781|NCT01369849|584057987|FG002|Overall Study|Ineligible after receiving treatment|0|||
161730782|NCT00756886|584057988|FG000|Overall Study|Lost to Follow-up|1|||
161730783|NCT00756886|584057989|FG001|Overall Study|Lost to Follow-up|0|||
161730784|NCT00756886|584057988|FG000|Overall Study|Adverse Event|0|||
161730785|NCT00756886|584057989|FG001|Overall Study|Adverse Event|3|||
161730786|NCT00756886|584057988|FG000|Overall Study|Lack of Efficacy|1|||
161730787|NCT00756886|584057989|FG001|Overall Study|Lack of Efficacy|0|||
161730788|NCT00756886|584057988|FG000|Overall Study|Ineligible|9|||
161730789|NCT00756886|584057989|FG001|Overall Study|Ineligible|4|||
161730790|NCT00871377|584057994|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730791|NCT00871377|584057995|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730792|NCT00871377|584057996|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
161730793|NCT00871377|584057997|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730794|NCT00871377|584057998|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730795|NCT00871377|584057999|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730796|NCT00871377|584057994|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730797|NCT00871377|584057995|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730798|NCT00871377|584057996|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730799|NCT00871377|584057997|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730800|NCT00871377|584057998|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730801|NCT00871377|584057999|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
161730802|NCT00871377|584057994|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
161730803|NCT00871377|584057995|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730804|NCT00871377|584057996|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730805|NCT00871377|584057997|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730806|NCT00871377|584057998|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730807|NCT00871377|584057999|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730808|NCT00871377|584057994|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730809|NCT00871377|584057995|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730810|NCT00871377|584057996|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730811|NCT00871377|584057997|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730812|NCT00871377|584057998|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730813|NCT00871377|584057999|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
161730814|NCT00871377|584057994|FG000|Third Intervention (10 Weeks)|Death|0|||
161730815|NCT00871377|584057995|FG001|Third Intervention (10 Weeks)|Death|0|||
161730816|NCT00871377|584057996|FG002|Third Intervention (10 Weeks)|Death|0|||
161730817|NCT00871377|584057997|FG003|Third Intervention (10 Weeks)|Death|1|||
161730818|NCT00871377|584057998|FG004|Third Intervention (10 Weeks)|Death|0|||
161730819|NCT00871377|584057999|FG005|Third Intervention (10 Weeks)|Death|0|||
161730820|NCT04348656|584058000|FG000|Overall Study|Withdrawal by Subject|2|||
161730821|NCT04348656|584058001|FG001|Overall Study|Withdrawal by Subject|0|||
161730822|NCT04348656|584058000|FG000|Overall Study|Lost to Follow-up|11|||
161730823|NCT04348656|584058001|FG001|Overall Study|Lost to Follow-up|6|||
161730824|NCT00288860|584058006|FG000|Overall Study|Did not complete intake|4|||
161730825|NCT00288860|584058007|FG001|Overall Study|Did not complete intake|8|||
161730826|NCT00288860|584058006|FG000|Overall Study|Death|4|||
161730827|NCT00288860|584058007|FG001|Overall Study|Death|3|||
161730828|NCT00288860|584058006|FG000|Overall Study|Withdrawal by Subject|20|||
161730829|NCT00288860|584058007|FG001|Overall Study|Withdrawal by Subject|15|||
161730830|NCT00288860|584058006|FG000|Overall Study|Lost to Follow-up|74|||
161730831|NCT00288860|584058007|FG001|Overall Study|Lost to Follow-up|71|||
161730832|NCT05142332|584058012|FG000|Overall Study|Withdrawal by Subject|0|||
161730833|NCT05142332|584058013|FG001|Overall Study|Withdrawal by Subject|1|||
161730834|NCT05142332|584058014|FG002|Overall Study|Withdrawal by Subject|2|||
161730835|NCT05142332|584058015|FG003|Overall Study|Withdrawal by Subject|0|||
161730836|NCT05142332|584058016|FG004|Overall Study|Withdrawal by Subject|0|||
161730837|NCT05142332|584058017|FG005|Overall Study|Withdrawal by Subject|2|||
161730838|NCT05142332|584058018|FG006|Overall Study|Withdrawal by Subject|6|||
161730839|NCT05142332|584058012|FG000|Overall Study|Left ED|3|||
161730840|NCT05142332|584058013|FG001|Overall Study|Left ED|0|||
161730841|NCT05142332|584058014|FG002|Overall Study|Left ED|4|||
161730842|NCT05142332|584058015|FG003|Overall Study|Left ED|6|||
161730843|NCT05142332|584058016|FG004|Overall Study|Left ED|1|||
161730844|NCT05142332|584058017|FG005|Overall Study|Left ED|2|||
161730845|NCT05142332|584058018|FG006|Overall Study|Left ED|6|||
161730846|NCT05142332|584058012|FG000|Overall Study|Physician Decision|0|||
161730847|NCT05142332|584058013|FG001|Overall Study|Physician Decision|0|||
161730848|NCT05142332|584058014|FG002|Overall Study|Physician Decision|2|||
161838932|NCT00311311|584453548|FG001|Overall Study|Adverse Event|2|||
161838933|NCT00311311|584453547|FG000|Overall Study|Withdrawal by Subject|1|||
161838934|NCT00311311|584453548|FG001|Overall Study|Withdrawal by Subject|1|||
161838935|NCT00311311|584453547|FG000|Overall Study|Noncompliance|0|||
161838936|NCT00311311|584453548|FG001|Overall Study|Noncompliance|1|||
161838937|NCT00311311|584453547|FG000|Overall Study|Study Termination by Sponsor|3|||
161838938|NCT00311311|584453548|FG001|Overall Study|Study Termination by Sponsor|4|||
161838939|NCT00311311|584453547|FG000|Overall Study|Death|1|||
161838940|NCT00311311|584453548|FG001|Overall Study|Death|0|||
161838941|NCT00311311|584453547|FG000|Overall Study|Lack of ancillary assistance|0|||
161838942|NCT00311311|584453548|FG001|Overall Study|Lack of ancillary assistance|1|||
161838943|NCT00536263|584453549|FG000|Overall Study|Adverse Event|5|||
161838944|NCT00536263|584453550|FG001|Overall Study|Adverse Event|5|||
161838945|NCT00536263|584453551|FG002|Overall Study|Adverse Event|7|||
161838946|NCT00536263|584453549|FG000|Overall Study|Lost to Follow-up|3|||
161838947|NCT00536263|584453550|FG001|Overall Study|Lost to Follow-up|4|||
161838948|NCT00536263|584453551|FG002|Overall Study|Lost to Follow-up|4|||
161838949|NCT00536263|584453549|FG000|Overall Study|Subject withdrew - not treatment related|2|||
161838950|NCT00536263|584453550|FG001|Overall Study|Subject withdrew - not treatment related|0|||
161838951|NCT00536263|584453551|FG002|Overall Study|Subject withdrew - not treatment related|5|||
161838952|NCT00536263|584453549|FG000|Overall Study|Subject withdrew - treatment related|0|||
161838953|NCT00536263|584453550|FG001|Overall Study|Subject withdrew - treatment related|3|||
161838954|NCT00536263|584453551|FG002|Overall Study|Subject withdrew - treatment related|2|||
161838955|NCT00536263|584453549|FG000|Overall Study|Noncompliance with protocol|0|||
161838956|NCT00536263|584453550|FG001|Overall Study|Noncompliance with protocol|0|||
161838957|NCT00536263|584453551|FG002|Overall Study|Noncompliance with protocol|1|||
161838958|NCT00536263|584453549|FG000|Overall Study|Did not meet protocol eligibility|1|||
161838959|NCT00536263|584453550|FG001|Overall Study|Did not meet protocol eligibility|2|||
161838960|NCT00536263|584453551|FG002|Overall Study|Did not meet protocol eligibility|2|||
161838961|NCT00826449|584453552|FG000|Overall Study|Disease Progression|4|||
161838962|NCT00826449|584453552|FG000|Overall Study|Withdrawal by Subject|1|||
161838963|NCT01640873|584453571|FG000|Overall Study|Protocol Violation|2|||
161838964|NCT01640873|584453572|FG001|Overall Study|Protocol Violation|1|||
161838965|NCT01875471|584453573|FG000|Overall Study|Adverse Event|0|||
161838966|NCT01875471|584453574|FG001|Overall Study|Adverse Event|1|||
161838967|NCT01875471|584453573|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
161838968|NCT01875471|584453574|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
161838969|NCT01321008|584453575|FG000|Overall Study|Early Study Termination|1|||
161838970|NCT02458092|584453576|FG000|Overall Study|Withdrawal by Subject|1|||
161838971|NCT02458092|584453577|FG001|Overall Study|Withdrawal by Subject|0|||
161838972|NCT00679913|584453578|FG000|Overall Study|Protocol Violation|18|||
161838973|NCT00679913|584453579|FG001|Overall Study|Protocol Violation|13|||
161838974|NCT00456495|584453588|FG000|Overall Study|Physician Decision|2|||
161838975|NCT01301508|584453589|FG000|Overall Study|Withdrawal by Subject|1|||
161838976|NCT01301508|584453590|FG001|Overall Study|Withdrawal by Subject|2|||
161838977|NCT01301508|584453589|FG000|Overall Study|Lost to Follow-up|0|||
161838978|NCT01301508|584453590|FG001|Overall Study|Lost to Follow-up|1|||
161838979|NCT01300923|584453591|FG000|Overall Study|Physician Decision|0|||
161838980|NCT01300923|584453592|FG001|Overall Study|Physician Decision|2|||
161838981|NCT02707861|584453595|FG000|Overall Study|Went onto commercial drug|30|||
161838982|NCT02707861|584453596|FG001|Overall Study|Went onto commercial drug|23|||
161838983|NCT02707861|584453595|FG000|Overall Study|Adverse Event|2|||
161838984|NCT02707861|584453596|FG001|Overall Study|Adverse Event|3|||
161838985|NCT02707861|584453595|FG000|Overall Study|Death|5|||
161838986|NCT02707861|584453596|FG001|Overall Study|Death|2|||
161838987|NCT02707861|584453595|FG000|Overall Study|Lack of Efficacy|0|||
161838988|NCT02707861|584453596|FG001|Overall Study|Lack of Efficacy|2|||
161838989|NCT02707861|584453595|FG000|Overall Study|Physician Decision|1|||
161838990|NCT02707861|584453596|FG001|Overall Study|Physician Decision|4|||
161838991|NCT02707861|584453595|FG000|Overall Study|Withdrawal by Subject|2|||
161838992|NCT02707861|584453596|FG001|Overall Study|Withdrawal by Subject|1|||
161730849|NCT05142332|584058015|FG003|Overall Study|Physician Decision|1|||
161730850|NCT05142332|584058016|FG004|Overall Study|Physician Decision|0|||
161730851|NCT05142332|584058017|FG005|Overall Study|Physician Decision|0|||
161730852|NCT05142332|584058018|FG006|Overall Study|Physician Decision|3|||
161730853|NCT05142332|584058012|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
161730854|NCT05142332|584058013|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161730855|NCT05142332|584058014|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
161730856|NCT05142332|584058015|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
161730857|NCT05142332|584058016|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161730858|NCT05142332|584058017|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
161730859|NCT05142332|584058018|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161730860|NCT02116660|584058019|FG000|Overall Study|Deteriorating renal function|0|||
161730861|NCT02116660|584058020|FG001|Overall Study|Deteriorating renal function|1|||
161730862|NCT02116660|584058019|FG000|Overall Study|Adverse Event|1|||
161730863|NCT02116660|584058020|FG001|Overall Study|Adverse Event|1|||
161730864|NCT02116660|584058019|FG000|Overall Study|Withdrawal by Subject|0|||
161730865|NCT02116660|584058020|FG001|Overall Study|Withdrawal by Subject|2|||
161730866|NCT02116660|584058019|FG000|Overall Study|Organization reason|1|||
161730867|NCT02116660|584058020|FG001|Overall Study|Organization reason|0|||
161730868|NCT00937560|584058026|FG000|Initial Treatment|Death|6|||
161730869|NCT00937560|584058026|FG000|Initial Treatment|Withdraw consent|3|||
161730870|NCT00937560|584058026|FG000|Initial Treatment|Adverse Event|1|||
161730871|NCT00937560|584058026|FG000|Initial Treatment|Lost to Follow-up|1|||
161730872|NCT00937560|584058026|FG000|Initial Treatment|No end of study page|10|||
161730873|NCT00937560|584058026|FG000|Maintenance Treatment|Death|12|||
161730874|NCT00937560|584058026|FG000|Maintenance Treatment|Withdraw consent|5|||
161730875|NCT00937560|584058026|FG000|Maintenance Treatment|According to protocol|1|||
161730876|NCT00411788|584058027|FG000|Overall Study|Protocol Violation|1|||
161730877|NCT00411788|584058027|FG000|Overall Study|Adverse Event|1|||
161730878|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
161730879|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
161730880|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
161730881|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
161730882|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
161730883|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
161730884|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
161730885|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
161730886|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
161730887|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
161730888|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
161730889|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
161730890|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
161730891|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
161730892|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
161730893|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
161730894|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
161730895|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
161730896|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
161730897|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
161730898|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
161730899|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
161730900|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
161730901|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
161730902|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
161730903|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
161730904|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Other|5|||
161730905|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Other|6|||
161730906|NCT02561299|584058030|FG000|Overall Study|Death|2|||
161730907|NCT02561299|584058031|FG001|Overall Study|Death|4|||
161730908|NCT02561299|584058030|FG000|Overall Study|Lost to Follow-up|1|||
161730909|NCT02561299|584058031|FG001|Overall Study|Lost to Follow-up|0|||
161730910|NCT02561299|584058030|FG000|Overall Study|Withdrawal by Subject|2|||
161730911|NCT02561299|584058031|FG001|Overall Study|Withdrawal by Subject|2|||
161730912|NCT05631548|584058032|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
161838993|NCT02707861|584453595|FG000|Overall Study|Lost to Follow-up|1|||
161838994|NCT02707861|584453596|FG001|Overall Study|Lost to Follow-up|3|||
161838995|NCT01346774|584453599|FG000|Overall Study|Did not take a single dose|6|||
161838996|NCT01346774|584453600|FG001|Overall Study|Did not take a single dose|4|||
161838997|NCT01346774|584453599|FG000|Overall Study|Lost to Follow-up|3|||
161838998|NCT01346774|584453600|FG001|Overall Study|Lost to Follow-up|4|||
161838999|NCT01346774|584453599|FG000|Overall Study|Withdrawal by Subject|1|||
161839000|NCT01346774|584453600|FG001|Overall Study|Withdrawal by Subject|4|||
161839001|NCT01346774|584453599|FG000|Overall Study|Protocol Violation|2|||
161839002|NCT01346774|584453600|FG001|Overall Study|Protocol Violation|3|||
161839003|NCT01346774|584453599|FG000|Overall Study|Adverse Event|1|||
161839004|NCT01346774|584453600|FG001|Overall Study|Adverse Event|2|||
161839005|NCT00369382|584453608|FG000|Overall Study|Death|0|||
161839006|NCT00369382|584453609|FG001|Overall Study|Death|2|||
161839007|NCT00369382|584453608|FG000|Overall Study|Physician Decision|2|||
161839008|NCT00369382|584453609|FG001|Overall Study|Physician Decision|1|||
161839009|NCT00369382|584453608|FG000|Overall Study|Withdrawal by Subject|5|||
161839010|NCT00369382|584453609|FG001|Overall Study|Withdrawal by Subject|0|||
161839011|NCT00369382|584453608|FG000|Overall Study|Randomized, not treated|2|||
161839012|NCT00369382|584453609|FG001|Overall Study|Randomized, not treated|0|||
161839013|NCT00369382|584453608|FG000|Overall Study|Other|1|||
161839014|NCT00369382|584453609|FG001|Overall Study|Other|0|||
161839015|NCT00507546|584453610|FG000|Overall Study|Withdrawal by Subject|1|||
161839016|NCT00507546|584453611|FG001|Overall Study|Withdrawal by Subject|0|||
161839017|NCT00507546|584453610|FG000|Overall Study|Protocol Violation|1|||
161839018|NCT00507546|584453611|FG001|Overall Study|Protocol Violation|0|||
161839019|NCT00507546|584453610|FG000|Overall Study|Physician Decision|0|||
161839020|NCT00507546|584453611|FG001|Overall Study|Physician Decision|1|||
161839021|NCT03512262|584453615|FG000|Overall Study|Adverse Event|8|||
161839022|NCT03512262|584453616|FG001|Overall Study|Adverse Event|3|||
161839023|NCT03512262|584453615|FG000|Overall Study|Death (non-treatment emergent)|1|||
161839024|NCT03512262|584453616|FG001|Overall Study|Death (non-treatment emergent)|0|||
161839025|NCT03512262|584453615|FG000|Overall Study|Withdrawal by Subject|17|||
161839026|NCT03512262|584453616|FG001|Overall Study|Withdrawal by Subject|9|||
161839027|NCT03512262|584453615|FG000|Overall Study|Lost to Follow-up|7|||
161839028|NCT03512262|584453616|FG001|Overall Study|Lost to Follow-up|1|||
161839029|NCT03512262|584453615|FG000|Overall Study|Other than Specified|2|||
161839030|NCT03512262|584453616|FG001|Overall Study|Other than Specified|2|||
161839031|NCT01299805|584453619|FG000|Overall Study|Adverse Event|2|||
161839032|NCT01299805|584453620|FG001|Overall Study|Adverse Event|0|||
161839033|NCT04394351|584455262|FG000|Part A (16 Weeks)|Adverse Event|1|||
161839034|NCT04394351|584455263|FG001|Part A (16 Weeks)|Adverse Event|0|||
161839035|NCT04394351|584455264|FG002|Part A (16 Weeks)|Adverse Event|0|||
161839036|NCT04394351|584455265|FG003|Part A (16 Weeks)|Adverse Event|0|||
161839037|NCT04394351|584455266|FG004|Part A (16 Weeks)|Adverse Event|0|||
161839038|NCT04394351|584455267|FG005|Part A (16 Weeks)|Adverse Event|0|||
161839039|NCT04394351|584455268|FG006|Part A (16 Weeks)|Adverse Event|0|||
161839040|NCT04394351|584455269|FG007|Part A (16 Weeks)|Adverse Event|0|||
161839041|NCT04394351|584455262|FG000|Part A (16 Weeks)|Physician Decision|0|||
161839042|NCT04394351|584455263|FG001|Part A (16 Weeks)|Physician Decision|1|||
161839043|NCT04394351|584455264|FG002|Part A (16 Weeks)|Physician Decision|0|||
161839044|NCT04394351|584455265|FG003|Part A (16 Weeks)|Physician Decision|0|||
161839045|NCT04394351|584455266|FG004|Part A (16 Weeks)|Physician Decision|0|||
161839046|NCT04394351|584455267|FG005|Part A (16 Weeks)|Physician Decision|0|||
161839047|NCT04394351|584455268|FG006|Part A (16 Weeks)|Physician Decision|0|||
161839048|NCT04394351|584455269|FG007|Part A (16 Weeks)|Physician Decision|0|||
161839049|NCT04394351|584455262|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839050|NCT04394351|584455263|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
161839051|NCT04394351|584455264|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839052|NCT04394351|584455265|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839053|NCT04394351|584455266|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839054|NCT04394351|584455267|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839055|NCT04394351|584455268|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839056|NCT04394351|584455269|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839057|NCT04394351|584455262|FG000|Part B (36 Weeks)|Adverse Event|0|||
161839058|NCT04394351|584455263|FG001|Part B (36 Weeks)|Adverse Event|0|||
161839059|NCT04394351|584455264|FG002|Part B (36 Weeks)|Adverse Event|0|||
161839060|NCT04394351|584455265|FG003|Part B (36 Weeks)|Adverse Event|0|||
161839061|NCT04394351|584455266|FG004|Part B (36 Weeks)|Adverse Event|0|||
161839062|NCT04394351|584455267|FG005|Part B (36 Weeks)|Adverse Event|0|||
161839063|NCT04394351|584455268|FG006|Part B (36 Weeks)|Adverse Event|1|||
161839064|NCT04394351|584455269|FG007|Part B (36 Weeks)|Adverse Event|0|||
161839065|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839066|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839067|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839068|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839069|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161730913|NCT05631548|584058033|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
161730914|NCT01219959|584058034|FG000|Overall Study|Adverse Event|6|||
161730915|NCT01219959|584058035|FG001|Overall Study|Adverse Event|14|||
161730916|NCT01219959|584058034|FG000|Overall Study|Physician Decision|0|||
161730917|NCT01219959|584058035|FG001|Overall Study|Physician Decision|4|||
161730918|NCT01219959|584058034|FG000|Overall Study|Withdrawal by Subject|0|||
161730919|NCT01219959|584058035|FG001|Overall Study|Withdrawal by Subject|2|||
161730920|NCT01219959|584058034|FG000|Overall Study|Renal Transplantation|0|||
161730921|NCT01219959|584058035|FG001|Overall Study|Renal Transplantation|3|||
161730922|NCT01219959|584058034|FG000|Overall Study|Other|1|||
161730923|NCT01219959|584058035|FG001|Overall Study|Other|0|||
161730924|NCT05906732|584058036|FG000|Overall Study|Withdrawal by Subject|1|||
161730925|NCT05906732|584058037|FG001|Overall Study|Withdrawal by Subject|0|||
161730926|NCT05906732|584058038|FG002|Overall Study|Withdrawal by Subject|0|||
161730927|NCT05906732|584058039|FG003|Overall Study|Withdrawal by Subject|0|||
161730928|NCT05906732|584058036|FG000|Overall Study|Physician Decision|2|||
161730929|NCT05906732|584058037|FG001|Overall Study|Physician Decision|4|||
161730930|NCT05906732|584058038|FG002|Overall Study|Physician Decision|0|||
161730931|NCT05906732|584058039|FG003|Overall Study|Physician Decision|0|||
161730932|NCT01248130|584058040|FG000|Overall Study|Protocol Violation|1|||
161730933|NCT01248130|584058041|FG001|Overall Study|Protocol Violation|0|||
161730934|NCT01248130|584058040|FG000|Overall Study|Ineligible|1|||
161730935|NCT01248130|584058041|FG001|Overall Study|Ineligible|0|||
161730936|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161730937|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161730938|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161730939|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
161730940|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161730941|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
161730942|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730943|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
161730944|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
161730945|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161730946|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
161730947|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
161730948|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161730949|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
161730950|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730951|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730952|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730953|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730954|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730955|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730956|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730957|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730958|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730959|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730960|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730961|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730962|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730963|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730964|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730965|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
161730966|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730967|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730968|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730969|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730970|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730971|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730972|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
161730973|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730974|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730975|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730976|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730977|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730978|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730979|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730980|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730981|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730982|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730983|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730984|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730985|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730986|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730987|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730988|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730989|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730990|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730991|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730992|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730993|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730994|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730995|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
161730996|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730997|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730998|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730999|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731000|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731001|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731002|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731003|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731004|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731005|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
161731006|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
161731007|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
161731008|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
161731009|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
161731010|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
161731011|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
161731012|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
161731013|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
161731014|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
161731015|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
161731016|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
161731017|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
161731018|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
161731019|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
161731020|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
161731021|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
161731022|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
161731023|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
161731024|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
161731025|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
161731026|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
161731027|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
161731028|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731029|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731030|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731031|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731032|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731033|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731034|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731035|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731036|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
161731037|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731038|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731039|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731040|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731041|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
161731042|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731043|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731044|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731045|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731046|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731047|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731048|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731049|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731050|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731051|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731052|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731053|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731054|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731055|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731056|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
161731057|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731058|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731059|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731060|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731061|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731062|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731063|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
161731064|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731065|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731066|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731067|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731068|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731069|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731070|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731071|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731072|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731073|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731074|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731075|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731076|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731077|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731078|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731079|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731080|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731081|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731082|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731083|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731084|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731085|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731086|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731087|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731088|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
161731089|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
161731090|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
161731091|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
161731092|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
161731093|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
161731094|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
161731095|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
161731096|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731097|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731098|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731099|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731100|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731101|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731102|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731103|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731104|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731105|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731106|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731107|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731108|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731109|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731110|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731111|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
161731112|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
161731113|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731114|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
161731115|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
161731116|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
161731117|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
161731118|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
161731119|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731120|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731121|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731122|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731123|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731124|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731125|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731126|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731127|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731128|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731129|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731130|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731131|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731132|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731133|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731134|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
161731135|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161731136|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
161731137|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731138|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
161731139|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161731140|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731141|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731142|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731143|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731144|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731145|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731146|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731147|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731148|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731149|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731150|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731151|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731152|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731153|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731154|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731155|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731156|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731157|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
161731158|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
161731159|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731160|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731161|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731162|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731163|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731164|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731165|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731166|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731167|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731168|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731169|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731170|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731171|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731172|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731173|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731174|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731175|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731176|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731177|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731178|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731179|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731180|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
161731181|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
161731182|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731183|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731184|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731185|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
161731186|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731187|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731188|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731189|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
161731190|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
161731191|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
161731192|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
161731193|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
161731194|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
161731195|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
161731196|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
161731197|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
161731198|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
161731199|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
161731200|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
161731201|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
161731202|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
161731203|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
161731204|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
161731205|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
161731206|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
161731207|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
161731208|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
161731209|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
161731210|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
161731211|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
161731212|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731213|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731214|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731215|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731216|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731217|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731218|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731219|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731220|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731221|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731222|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731223|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731224|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731225|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161839070|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161731226|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731227|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731228|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731229|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731230|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731231|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731232|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731233|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731234|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731235|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731236|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731237|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731238|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731239|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731240|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731241|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731242|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731243|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731244|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731245|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731246|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731247|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731248|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731249|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731250|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731251|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731252|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731253|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731254|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731255|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731256|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731257|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
161731258|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731259|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731260|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731261|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731262|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731263|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731264|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731265|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731266|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731267|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731268|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731269|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731270|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731271|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731272|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731273|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731274|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731275|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731276|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731277|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731278|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731279|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731280|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
161731281|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731282|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731283|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731284|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731285|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731286|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731287|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731288|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731289|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731290|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731291|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731292|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731293|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731294|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731295|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731296|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731297|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731298|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731299|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731300|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731301|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731302|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731303|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
161731304|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731305|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731306|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731307|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731308|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731309|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731310|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731311|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731312|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731313|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731314|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731315|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731316|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731317|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731318|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731319|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731320|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731321|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731322|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731323|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731324|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731325|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731326|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
161731327|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731328|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731329|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731330|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731331|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731332|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731333|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731334|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731335|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731336|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731337|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731338|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731339|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731340|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731341|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731342|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731343|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731344|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731345|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731346|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731347|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731348|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731349|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
161731350|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
161731351|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
161731352|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
161731353|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
161731354|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
161839071|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839072|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
161839073|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839074|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839075|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839076|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839077|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839078|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839079|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839080|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
161839081|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839082|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839083|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839084|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839085|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839086|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839087|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839088|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
161839089|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839090|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839091|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839092|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839093|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839094|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839095|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839096|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
161839097|NCT03653507|584455270|FG000|Overall Study|Miscellaneous|28|||
161839098|NCT03653507|584455271|FG001|Overall Study|Miscellaneous|19|||
161839099|NCT03653507|584455270|FG000|Overall Study|Withdrawal by Subject|37|||
161839100|NCT03653507|584455271|FG001|Overall Study|Withdrawal by Subject|22|||
161839101|NCT03653507|584455270|FG000|Overall Study|Protocol Deviation|2|||
161839102|NCT03653507|584455271|FG001|Overall Study|Protocol Deviation|1|||
161839103|NCT03653507|584455270|FG000|Overall Study|Progressive disease|117|||
161839104|NCT03653507|584455271|FG001|Overall Study|Progressive disease|168|||
161839105|NCT03653507|584455270|FG000|Overall Study|Lost to Follow-up|1|||
161839106|NCT03653507|584455271|FG001|Overall Study|Lost to Follow-up|1|||
161839107|NCT03653507|584455270|FG000|Overall Study|Death|25|||
161839108|NCT03653507|584455271|FG001|Overall Study|Death|22|||
161839109|NCT03653507|584455270|FG000|Overall Study|Adverse Event|35|||
161839110|NCT03653507|584455271|FG001|Overall Study|Adverse Event|14|||
161839111|NCT01288053|584455278|FG000|Overall Study|Death|1|||
161839112|NCT03188666|584455279|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161839113|NCT03188666|584455280|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
161839114|NCT03188666|584455281|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161839115|NCT03188666|584455282|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161839116|NCT03188666|584455279|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
161839117|NCT03188666|584455280|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
161839118|NCT03188666|584455281|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
161839119|NCT03188666|584455282|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
161839120|NCT03188666|584455279|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161839121|NCT03188666|584455280|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161839122|NCT03188666|584455281|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
161839123|NCT03188666|584455282|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161839124|NCT03188666|584455279|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
161839125|NCT03188666|584455280|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
161839126|NCT03188666|584455281|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
161839127|NCT03188666|584455282|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
161839128|NCT00144781|584455283|FG000|Overall Study|Adverse Event|0|||
161839129|NCT00144781|584455284|FG001|Overall Study|Adverse Event|1|||
161839130|NCT00144781|584455285|FG002|Overall Study|Adverse Event|0|||
161839131|NCT00144781|584455286|FG003|Overall Study|Adverse Event|0|||
161839132|NCT00144781|584455283|FG000|Overall Study|Non-compliant|0|||
161839133|NCT00144781|584455284|FG001|Overall Study|Non-compliant|1|||
161839134|NCT00144781|584455285|FG002|Overall Study|Non-compliant|0|||
161731355|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
161731356|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
161731357|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
161731358|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
161731359|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
161731360|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
161731361|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
161731362|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
161839135|NCT00144781|584455286|FG003|Overall Study|Non-compliant|0|||
161839136|NCT03696953|584455287|FG000|Overall Study|Withdrawal by Subject|6|||
161839137|NCT03696953|584455288|FG001|Overall Study|Withdrawal by Subject|1|||
161839138|NCT03696953|584455287|FG000|Overall Study|missed GBS swabs|2|||
161839139|NCT03696953|584455288|FG001|Overall Study|missed GBS swabs|2|||
161839140|NCT03696953|584455287|FG000|Overall Study|lost study bottle containing capsules|2|||
161839141|NCT03696953|584455288|FG001|Overall Study|lost study bottle containing capsules|0|||
161839142|NCT03696953|584455287|FG000|Overall Study|Premature birth|1|||
161839143|NCT03696953|584455288|FG001|Overall Study|Premature birth|4|||
161839144|NCT03696953|584455287|FG000|Overall Study|Gestational hypertension|1|||
161839145|NCT03696953|584455288|FG001|Overall Study|Gestational hypertension|1|||
161839146|NCT03696953|584455287|FG000|Overall Study|Gestational diabetes|2|||
161839147|NCT03696953|584455288|FG001|Overall Study|Gestational diabetes|1|||
161839148|NCT03696953|584455287|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
161839149|NCT03696953|584455288|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
161839150|NCT03696953|584455287|FG000|Overall Study|Changed prenatal provider|1|||
161839151|NCT03696953|584455288|FG001|Overall Study|Changed prenatal provider|1|||
161839152|NCT04092894|584455289|FG000|Overall Study|Withdrawal by Subject|2|||
161839153|NCT04092894|584455290|FG001|Overall Study|Withdrawal by Subject|4|||
161839154|NCT04092894|584455289|FG000|Overall Study|Discontinued EEG after randomization|10|||
161839155|NCT04092894|584455290|FG001|Overall Study|Discontinued EEG after randomization|6|||
161839156|NCT01106014|584455291|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
161839157|NCT01106014|584455292|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
161839158|NCT01106014|584455291|FG000|Overall Study|Adverse Event|78|||
161839159|NCT01106014|584455292|FG001|Overall Study|Adverse Event|42|||
161839160|NCT01106014|584455291|FG000|Overall Study|Withdrawal by Subject|43|||
161839161|NCT01106014|584455292|FG001|Overall Study|Withdrawal by Subject|37|||
161839162|NCT01106014|584455291|FG000|Overall Study|Administrative reason|7|||
161839163|NCT01106014|584455292|FG001|Overall Study|Administrative reason|6|||
161839164|NCT01106014|584455291|FG000|Overall Study|Lost to Follow-up|2|||
161839165|NCT01106014|584455292|FG001|Overall Study|Lost to Follow-up|3|||
161839166|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
161839167|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839168|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839169|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839170|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839171|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
161839172|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
161839173|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
161839174|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
161839175|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
161839176|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839177|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
161839178|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839179|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839180|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839181|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
161839182|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
161839183|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161839184|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161839185|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161839186|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
161839187|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
161839188|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
161839189|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
161839190|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
161839191|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839192|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
161839193|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839194|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839195|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839196|NCT02935686|584455293|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
161839197|NCT02935686|584455294|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
161839198|NCT02935686|584455295|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161839199|NCT02935686|584455296|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161731363|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
161731364|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
161731365|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
161731366|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
161731367|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
161731368|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
161731369|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
161731370|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
161731371|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
161731372|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
161731373|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731374|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731375|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731376|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731377|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731378|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731379|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731380|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731381|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731382|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731383|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731384|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731385|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731386|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731387|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731388|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731389|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731390|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731391|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731392|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731393|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731394|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731395|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
161731396|NCT02651194|584058069|FG000|Overall Study|Lost to Follow-up|3|||
161731397|NCT02651194|584058069|FG000|Overall Study|Other|2|||
161731398|NCT01980706|584058070|FG000|Overall Study|Withdrawal by Subject|9|||
161731399|NCT01980706|584058071|FG001|Overall Study|Withdrawal by Subject|6|||
161731400|NCT01980706|584058072|FG002|Overall Study|Withdrawal by Subject|2|||
161731401|NCT01980706|584058070|FG000|Overall Study|Adverse Event|1|||
161731402|NCT01980706|584058071|FG001|Overall Study|Adverse Event|2|||
161731403|NCT01980706|584058072|FG002|Overall Study|Adverse Event|5|||
161731404|NCT01980706|584058070|FG000|Overall Study|Lost to Follow-up|3|||
161731405|NCT01980706|584058071|FG001|Overall Study|Lost to Follow-up|4|||
161731406|NCT01980706|584058072|FG002|Overall Study|Lost to Follow-up|3|||
161731407|NCT01980706|584058070|FG000|Overall Study|miscellaneous|4|||
161731408|NCT01980706|584058071|FG001|Overall Study|miscellaneous|5|||
161731409|NCT01980706|584058072|FG002|Overall Study|miscellaneous|3|||
161731410|NCT02546674|584058073|FG000|Overall Study|Adverse Event|19|||
161731411|NCT02546674|584058073|FG000|Overall Study|Death|1|||
161731412|NCT02546674|584058073|FG000|Overall Study|Lost to Follow-up|1|||
161731413|NCT02546674|584058073|FG000|Overall Study|Physician Decision|13|||
161731414|NCT02546674|584058073|FG000|Overall Study|Pregnancy|1|||
161731415|NCT02546674|584058073|FG000|Overall Study|Progressive Disease|2|||
161731416|NCT02546674|584058073|FG000|Overall Study|Protocol Deviation|2|||
161731417|NCT02546674|584058073|FG000|Overall Study|Subject/Guardian Decision|6|||
161731418|NCT02546674|584058073|FG000|Overall Study|Withdrawal of Informed Consent|3|||
161731419|NCT02208024|584058074|FG000|Overall Study|Withdrawal by Subject|1|||
161731420|NCT00830037|584058078|FG000|Overall Study|Withdrawal by Subject|2|||
161731421|NCT00830037|584058079|FG001|Overall Study|Withdrawal by Subject|3|||
161731422|NCT00830037|584058078|FG000|Overall Study|Lost to Follow-up|1|||
161731423|NCT00830037|584058079|FG001|Overall Study|Lost to Follow-up|2|||
161731424|NCT00830037|584058078|FG000|Overall Study|Active when terminated by DSMB|15|||
161731425|NCT00830037|584058079|FG001|Overall Study|Active when terminated by DSMB|14|||
161731426|NCT01401010|584058080|FG000|Overall Study|Could not interpret assay results|1|||
161731427|NCT01401010|584058081|FG001|Overall Study|Could not interpret assay results|0|||
161731428|NCT04285346|584058084|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
161731429|NCT04285346|584058085|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
161731430|NCT04285346|584058084|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
161731431|NCT04285346|584058085|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161731432|NCT04285346|584058084|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
161731433|NCT04285346|584058085|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161731434|NCT00610935|584058086|FG000|Overall Study|Lost to Follow-up|0|||
161731435|NCT00610935|584058087|FG001|Overall Study|Lost to Follow-up|1|||
161731436|NCT00610935|584058086|FG000|Overall Study|Withdrawal by Subject|0|||
161731437|NCT00610935|584058087|FG001|Overall Study|Withdrawal by Subject|2|||
161731438|NCT00610935|584058086|FG000|Overall Study|Sponsor Discontinuation|1|||
161731439|NCT00610935|584058087|FG001|Overall Study|Sponsor Discontinuation|0|||
161731440|NCT04360187|584058090|FG000|Double-Blind Treatment|Adverse Event|9|||
161731441|NCT04360187|584058091|FG001|Double-Blind Treatment|Adverse Event|11|||
161731442|NCT04360187|584058090|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
161731443|NCT04360187|584058091|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
161731444|NCT04360187|584058090|FG000|Double-Blind Treatment|Physician Decision|1|||
161731445|NCT04360187|584058091|FG001|Double-Blind Treatment|Physician Decision|0|||
161731446|NCT04360187|584058090|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
161731447|NCT04360187|584058091|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
161731448|NCT04360187|584058090|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
161839200|NCT02935686|584455297|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161839201|NCT02935686|584455293|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839202|NCT02935686|584455294|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
161839203|NCT02935686|584455295|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839204|NCT02935686|584455296|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839205|NCT02935686|584455297|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839206|NCT02935686|584455293|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839207|NCT02935686|584455294|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
161839208|NCT02935686|584455295|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839209|NCT02935686|584455296|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839210|NCT02935686|584455297|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839211|NCT02935686|584455293|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839212|NCT02935686|584455294|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839213|NCT02935686|584455295|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839214|NCT02935686|584455296|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839215|NCT02935686|584455297|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
161839216|NCT02935686|584455293|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161839217|NCT02935686|584455294|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161839218|NCT02935686|584455295|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161839219|NCT02935686|584455296|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
161839220|NCT02935686|584455297|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
161839221|NCT00062010|584455300|FG000|Overall Study|Ineligible|3|||
161839222|NCT00852969|584455301|FG000|Overall Study|Adverse Event|0|||
161839223|NCT00852969|584455302|FG001|Overall Study|Adverse Event|1|||
161839224|NCT00852969|584455301|FG000|Overall Study|Lost to Follow-up|0|||
161839225|NCT00852969|584455302|FG001|Overall Study|Lost to Follow-up|1|||
161839226|NCT03986138|584455306|FG000|First MRI Examination|Physician Decision|0|||
161839227|NCT03986138|584455307|FG001|First MRI Examination|Physician Decision|1|||
161839228|NCT03986138|584455306|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
161839229|NCT03986138|584455307|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
161839230|NCT03986138|584455306|FG000|Washout|Withdrawal by Subject|4|||
161839231|NCT03986138|584455307|FG001|Washout|Withdrawal by Subject|5|||
161839232|NCT03986138|584455306|FG000|Washout|Lost to Follow-up|0|||
161839233|NCT03986138|584455307|FG001|Washout|Lost to Follow-up|2|||
161839234|NCT03986138|584455306|FG000|Washout|Adverse Event|1|||
161839235|NCT03986138|584455307|FG001|Washout|Adverse Event|1|||
161839236|NCT03986138|584455306|FG000|Washout|Other reason|5|||
161839237|NCT03986138|584455307|FG001|Washout|Other reason|5|||
161839238|NCT03986138|584455306|FG000|Second MRI Examination|Withdrawal by Subject|0|||
161839239|NCT03986138|584455307|FG001|Second MRI Examination|Withdrawal by Subject|2|||
161839240|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
161839241|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
161839242|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
161839243|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
161839244|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
161731449|NCT04360187|584058091|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
161731450|NCT04360187|584058090|FG000|Follow-Up|Lost to Follow-up|1|||
161731451|NCT04360187|584058091|FG001|Follow-Up|Lost to Follow-up|0|||
161839245|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
161839246|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
161839247|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
161839248|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
161839249|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
161839250|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
161731452|NCT02399813|584058092|FG000|Overall Study|Progressive Disease-Radiographic|2|||
161839251|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
161839252|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
161839253|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
161839254|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
161839255|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
161839256|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
161839257|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
161839258|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
161839259|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
161839260|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
161839261|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
161839262|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
161839263|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
161839264|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
161839265|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
161839266|NCT02049450|584455313|FG000|Overall Study|Adverse Event|2|||
161839267|NCT02049450|584455313|FG000|Overall Study|Withdrawal by Subject|1|||
161839268|NCT02049450|584455313|FG000|Overall Study|Patients/guardian decision|1|||
161839269|NCT03186781|584455314|FG000|Overall Study|Lost to Follow-up|0|||
161839270|NCT03186781|584455315|FG001|Overall Study|Lost to Follow-up|0|||
161839271|NCT03186781|584455316|FG002|Overall Study|Lost to Follow-up|1|||
161839272|NCT03186781|584455317|FG003|Overall Study|Lost to Follow-up|0|||
161839273|NCT03186781|584455318|FG004|Overall Study|Lost to Follow-up|1|||
161839274|NCT03186781|584455319|FG005|Overall Study|Lost to Follow-up|0|||
161839275|NCT03186781|584455314|FG000|Overall Study|Moved from Area|0|||
161839276|NCT03186781|584455315|FG001|Overall Study|Moved from Area|0|||
161839277|NCT03186781|584455316|FG002|Overall Study|Moved from Area|0|||
161839278|NCT03186781|584455317|FG003|Overall Study|Moved from Area|0|||
161839279|NCT03186781|584455318|FG004|Overall Study|Moved from Area|1|||
161839280|NCT03186781|584455319|FG005|Overall Study|Moved from Area|0|||
161839281|NCT03186781|584455314|FG000|Overall Study|Withdrawal by Subject|0|||
161839282|NCT03186781|584455315|FG001|Overall Study|Withdrawal by Subject|0|||
161839283|NCT03186781|584455316|FG002|Overall Study|Withdrawal by Subject|0|||
161839284|NCT03186781|584455317|FG003|Overall Study|Withdrawal by Subject|0|||
161839285|NCT03186781|584455318|FG004|Overall Study|Withdrawal by Subject|1|||
161839286|NCT03186781|584455319|FG005|Overall Study|Withdrawal by Subject|0|||
161839287|NCT04709835|584455320|FG000|Overall Study|Withdrawal by Subject|0|||
161839288|NCT04709835|584455321|FG001|Overall Study|Withdrawal by Subject|1|||
161839289|NCT04709835|584455322|FG002|Overall Study|Withdrawal by Subject|0|||
161839290|NCT01570686|584455323|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161839291|NCT01570686|584455324|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161839292|NCT01570686|584455323|FG000|Overall Study|Administrative problems|0|||
161839293|NCT01570686|584455324|FG001|Overall Study|Administrative problems|1|||
161839294|NCT01570686|584455323|FG000|Overall Study|Adverse Event|8|||
161839295|NCT01570686|584455324|FG001|Overall Study|Adverse Event|6|||
161839296|NCT01570686|584455323|FG000|Overall Study|Lost to Follow-up|4|||
161839297|NCT01570686|584455324|FG001|Overall Study|Lost to Follow-up|3|||
161839298|NCT01570686|584455323|FG000|Overall Study|Protocol Deviation|3|||
161839299|NCT01570686|584455324|FG001|Overall Study|Protocol Deviation|0|||
161839300|NCT01570686|584455323|FG000|Overall Study|Withdrawal by Subject|4|||
161839301|NCT01570686|584455324|FG001|Overall Study|Withdrawal by Subject|4|||
161839302|NCT01570686|584455323|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161839303|NCT01570686|584455324|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161839304|NCT02372071|584455325|FG000|Overall Study|Protocol Violation|18|||
161731453|NCT02399813|584058092|FG000|Overall Study|Death|20|||
161731454|NCT02399813|584058092|FG000|Overall Study|Withdrawal by Subject|3|||
161731455|NCT02399813|584058092|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
161731456|NCT02399813|584058092|FG000|Overall Study|Lost to Follow-up|2|||
161731457|NCT02399813|584058092|FG000|Overall Study|Other than specified|5|||
161731458|NCT02203838|584058095|FG000|Overall Study|Lack of Efficacy|7|||
161731459|NCT02203838|584058096|FG001|Overall Study|Lack of Efficacy|0|||
161731460|NCT02203838|584058097|FG002|Overall Study|Lack of Efficacy|1|||
161731461|NCT02203838|584058098|FG003|Overall Study|Lack of Efficacy|1|||
161731462|NCT02203838|584058095|FG000|Overall Study|Adverse Event|46|||
161731463|NCT02203838|584058096|FG001|Overall Study|Adverse Event|6|||
161731464|NCT02203838|584058097|FG002|Overall Study|Adverse Event|3|||
161731465|NCT02203838|584058098|FG003|Overall Study|Adverse Event|2|||
161731466|NCT02203838|584058095|FG000|Overall Study|Lost to Follow-up|39|||
161731467|NCT02203838|584058096|FG001|Overall Study|Lost to Follow-up|3|||
161731468|NCT02203838|584058097|FG002|Overall Study|Lost to Follow-up|2|||
161731469|NCT02203838|584058098|FG003|Overall Study|Lost to Follow-up|1|||
161731470|NCT02203838|584058095|FG000|Overall Study|Protocol Violation|7|||
161731471|NCT02203838|584058096|FG001|Overall Study|Protocol Violation|3|||
161731472|NCT02203838|584058097|FG002|Overall Study|Protocol Violation|0|||
161731473|NCT02203838|584058098|FG003|Overall Study|Protocol Violation|0|||
161731474|NCT02203838|584058095|FG000|Overall Study|Withdrawal by Subject|83|||
161731475|NCT02203838|584058096|FG001|Overall Study|Withdrawal by Subject|10|||
161731476|NCT02203838|584058097|FG002|Overall Study|Withdrawal by Subject|8|||
161731477|NCT02203838|584058098|FG003|Overall Study|Withdrawal by Subject|11|||
161731478|NCT02203838|584058095|FG000|Overall Study|Physician Decision|27|||
161731479|NCT02203838|584058096|FG001|Overall Study|Physician Decision|0|||
161731480|NCT02203838|584058097|FG002|Overall Study|Physician Decision|2|||
161731481|NCT02203838|584058098|FG003|Overall Study|Physician Decision|3|||
161731482|NCT02203838|584058095|FG000|Overall Study|Other|1|||
161731483|NCT02203838|584058096|FG001|Overall Study|Other|0|||
161731484|NCT02203838|584058097|FG002|Overall Study|Other|0|||
161731485|NCT02203838|584058098|FG003|Overall Study|Other|0|||
161731486|NCT05091060|584058101|FG000|Overall Study|Lost to Follow-up|1|||
161731487|NCT02739594|584058102|FG000|Overall Study|Undesired Event|3|||
161731488|NCT02739594|584058103|FG001|Overall Study|Undesired Event|4|||
161731489|NCT02739594|584058102|FG000|Overall Study|Violation of Eligibility Criteria|1|||
161731490|NCT02739594|584058103|FG001|Overall Study|Violation of Eligibility Criteria|2|||
161731491|NCT02739594|584058102|FG000|Overall Study|Protocol Violation|5|||
161731492|NCT02739594|584058103|FG001|Overall Study|Protocol Violation|6|||
161731493|NCT02739594|584058102|FG000|Overall Study|Death|4|||
161731494|NCT02739594|584058103|FG001|Overall Study|Death|2|||
161731495|NCT02739594|584058102|FG000|Overall Study|Renal Insufficiency|4|||
161731496|NCT02739594|584058103|FG001|Overall Study|Renal Insufficiency|6|||
161731497|NCT02739594|584058102|FG000|Overall Study|Administrative Reasons|1|||
161731498|NCT02739594|584058103|FG001|Overall Study|Administrative Reasons|3|||
161731499|NCT02739594|584058102|FG000|Overall Study|Withdrawal by Subject|1|||
161731500|NCT02739594|584058103|FG001|Overall Study|Withdrawal by Subject|1|||
161731501|NCT02739594|584058102|FG000|Overall Study|Lost to Follow-up|0|||
161731502|NCT02739594|584058103|FG001|Overall Study|Lost to Follow-up|1|||
161731503|NCT02739594|584058102|FG000|Overall Study|Elevated Serum Creatinine|0|||
161731504|NCT02739594|584058103|FG001|Overall Study|Elevated Serum Creatinine|1|||
161731505|NCT02739594|584058102|FG000|Overall Study|Other|6|||
161731506|NCT02739594|584058103|FG001|Overall Study|Other|2|||
161731507|NCT00952289|584058106|FG000|All Participants|Death|9|||
161731508|NCT00952289|584058107|FG001|All Participants|Death|9|||
161731509|NCT00952289|584058106|FG000|All Participants|Adverse Event|8|||
161731510|NCT00952289|584058107|FG001|All Participants|Adverse Event|8|||
161731511|NCT00952289|584058106|FG000|All Participants|Disease progression|3|||
161731512|NCT00952289|584058107|FG001|All Participants|Disease progression|12|||
161731513|NCT00952289|584058106|FG000|All Participants|Withdrawal by Subject|1|||
161731514|NCT00952289|584058107|FG001|All Participants|Withdrawal by Subject|10|||
161731515|NCT00952289|584058106|FG000|All Participants|Data lost during site relocation|0|||
161731516|NCT00952289|584058107|FG001|All Participants|Data lost during site relocation|1|||
161731517|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
161731518|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
161731519|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
161731520|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
161731521|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
161731522|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
161731523|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
161731524|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
161731525|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
161731526|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
161731527|NCT03259334|584058108|FG000|Overall Study|Adverse Event|3|||
161731528|NCT03259334|584058109|FG001|Overall Study|Adverse Event|8|||
161731529|NCT03259334|584058110|FG002|Overall Study|Adverse Event|5|||
161731530|NCT03259334|584058108|FG000|Overall Study|Withdrawal by Subject|4|||
161731531|NCT03259334|584058109|FG001|Overall Study|Withdrawal by Subject|2|||
161731532|NCT03259334|584058110|FG002|Overall Study|Withdrawal by Subject|4|||
161731533|NCT03259334|584058108|FG000|Overall Study|Physician Decision|1|||
161731534|NCT03259334|584058109|FG001|Overall Study|Physician Decision|0|||
161731535|NCT03259334|584058110|FG002|Overall Study|Physician Decision|0|||
161731536|NCT03259334|584058108|FG000|Overall Study|Lost to Follow-up|0|||
161731537|NCT03259334|584058109|FG001|Overall Study|Lost to Follow-up|2|||
161731538|NCT03259334|584058110|FG002|Overall Study|Lost to Follow-up|1|||
161731539|NCT03259334|584058108|FG000|Overall Study|Protocol Deviation|0|||
161731540|NCT03259334|584058109|FG001|Overall Study|Protocol Deviation|3|||
161731541|NCT03259334|584058110|FG002|Overall Study|Protocol Deviation|2|||
161731542|NCT03259334|584058108|FG000|Overall Study|Lack of Efficacy|2|||
161731543|NCT03259334|584058109|FG001|Overall Study|Lack of Efficacy|0|||
161731544|NCT03259334|584058110|FG002|Overall Study|Lack of Efficacy|1|||
161731545|NCT03259334|584058108|FG000|Overall Study|Randomized but never treated|0|||
161731546|NCT03259334|584058109|FG001|Overall Study|Randomized but never treated|2|||
161731547|NCT03259334|584058110|FG002|Overall Study|Randomized but never treated|0|||
161731548|NCT03375112|584058111|FG000|Overall Study|Withdrawal by Subject|3|||
161731549|NCT03375112|584058112|FG001|Overall Study|Withdrawal by Subject|0|||
161731550|NCT03599141|584058113|FG000|Overall Study|Lost to Follow-up|3|||
161731551|NCT03599141|584058114|FG001|Overall Study|Lost to Follow-up|1|||
161731552|NCT00777491|584058115|FG000|Overall Study|Protocol Violation|0|||
161731553|NCT00777491|584058116|FG001|Overall Study|Protocol Violation|2|||
161731554|NCT00777491|584058115|FG000|Overall Study|Did not receive any protocol treatment|2|||
161731555|NCT00777491|584058116|FG001|Overall Study|Did not receive any protocol treatment|0|||
161731556|NCT01689207|584058117|FG000|Overall Study|Adverse Event|0|||
161731557|NCT01689207|584058118|FG001|Overall Study|Adverse Event|1|||
161731558|NCT01689207|584058119|FG002|Overall Study|Adverse Event|0|||
161731559|NCT01689207|584058120|FG003|Overall Study|Adverse Event|0|||
161731560|NCT01689207|584058121|FG004|Overall Study|Adverse Event|2|||
161731561|NCT01689207|584058122|FG005|Overall Study|Adverse Event|1|||
161731562|NCT01689207|584058123|FG006|Overall Study|Adverse Event|0|||
161731563|NCT01689207|584058124|FG007|Overall Study|Adverse Event|0|||
161731564|NCT01689207|584058125|FG008|Overall Study|Adverse Event|1|||
161731565|NCT01689207|584058126|FG009|Overall Study|Adverse Event|0|||
161731566|NCT01689207|584058127|FG010|Overall Study|Adverse Event|0|||
161731567|NCT01912768|584058128|FG000|Overall Study|Adverse Event|2|||
161731568|NCT01912768|584058129|FG001|Overall Study|Adverse Event|0|||
161731569|NCT01912768|584058128|FG000|Overall Study|Lost to Follow-up|2|||
161731570|NCT01912768|584058129|FG001|Overall Study|Lost to Follow-up|1|||
161731571|NCT01912768|584058128|FG000|Overall Study|Withdrawal by Subject|5|||
161731572|NCT01912768|584058129|FG001|Overall Study|Withdrawal by Subject|3|||
161731573|NCT01912768|584058128|FG000|Overall Study|Randomized in error|1|||
161731574|NCT01912768|584058129|FG001|Overall Study|Randomized in error|0|||
161731575|NCT03591146|584058130|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731576|NCT03591146|584058131|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731577|NCT03591146|584058132|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731578|NCT03591146|584058133|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731579|NCT03591146|584058134|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
161731580|NCT03591146|584058130|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731581|NCT03591146|584058131|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
161731582|NCT03591146|584058132|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731583|NCT03591146|584058133|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731584|NCT03591146|584058134|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731585|NCT03591146|584058130|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731586|NCT03591146|584058131|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731587|NCT03591146|584058132|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731588|NCT03591146|584058133|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731589|NCT03591146|584058134|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
161731590|NCT03591146|584058130|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161731591|NCT03591146|584058131|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161731592|NCT03591146|584058132|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
161731593|NCT03591146|584058133|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161731594|NCT03591146|584058134|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
161731595|NCT03453151|584058135|FG000|Overall Study|Withdrawal by Subject|1|||
161731596|NCT03453151|584058135|FG000|Overall Study|Physician Decision|3|||
161731597|NCT00142519|584058136|FG000|Overall Study|Not Treated|7|||
161731598|NCT00142519|584058137|FG001|Overall Study|Not Treated|9|||
161731599|NCT00142519|584058136|FG000|Overall Study|Protocol Violation|1|||
161731600|NCT00142519|584058137|FG001|Overall Study|Protocol Violation|0|||
161731601|NCT00142519|584058136|FG000|Overall Study|Withdrawal by Subject|10|||
161731602|NCT00142519|584058137|FG001|Overall Study|Withdrawal by Subject|7|||
161731603|NCT01468909|584058138|FG000|Overall Study|Never Treated|2|||
161731604|NCT01468909|584058139|FG001|Overall Study|Never Treated|2|||
161731605|NCT01511419|584058142|FG000|Dose 2|Physician Decision|1|||
161731606|NCT01511419|584058143|FG001|Dose 2|Physician Decision|0|||
161731607|NCT00937768|584058144|FG000|Overall Study|Refused Further Treatment|3|||
161731608|NCT00937768|584058145|FG001|Overall Study|Refused Further Treatment|2|||
161731609|NCT00937768|584058144|FG000|Overall Study|Disease Progression|1|||
161731610|NCT00937768|584058145|FG001|Overall Study|Disease Progression|1|||
161731611|NCT00937768|584058144|FG000|Overall Study|Alternate Treatment|0|||
161731612|NCT00937768|584058145|FG001|Overall Study|Alternate Treatment|1|||
161731613|NCT00937768|584058144|FG000|Overall Study|No Further Funding|4|||
161731614|NCT00937768|584058145|FG001|Overall Study|No Further Funding|4|||
161731615|NCT03229759|584058151|FG000|Overall Study|Screen Failure|30|||
161731616|NCT00311181|584059751|FG000|Overall Study|Final DFTs were not obtained|96|||
161731617|NCT02294318|584059752|FG000|Overall Study|Worsening of drinking|3|||
161731618|NCT02294318|584059753|FG001|Overall Study|Worsening of drinking|0|||
161731619|NCT02294318|584059752|FG000|Overall Study|Not exposed to intervention|0|||
161731620|NCT02294318|584059753|FG001|Overall Study|Not exposed to intervention|2|||
161731621|NCT01694420|584059757|FG000|Overall Study|Lost to Follow-up|3|||
161731622|NCT00506948|584059758|FG000|Overall Study|Death|4|||
161731623|NCT00506948|584059758|FG000|Overall Study|Adverse Event|5|||
161731624|NCT00506948|584059758|FG000|Overall Study|Physician Decision|1|||
161731625|NCT02395653|584059759|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
161731626|NCT02395653|584059759|FG000|Overall Study|Consent Withdrawn at Screening|1|||
161731627|NCT02395653|584059759|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
161731628|NCT02395653|584059759|FG000|Overall Study|Investigator Decision at Screening|1|||
161731629|NCT02395653|584059759|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
161731630|NCT02395653|584059759|FG000|Overall Study|Withdrawal by Subject|1|||
161731631|NCT02395653|584059759|FG000|Overall Study|Lost to Follow-up|1|||
161731632|NCT02494778|584059760|FG000|Overall Study|Death|3|||
161731633|NCT02494778|584059760|FG000|Overall Study|Other|173|||
161731634|NCT02494778|584059760|FG000|Overall Study|Lack of Efficacy|4|||
161731635|NCT02494778|584059760|FG000|Overall Study|Adverse Event|18|||
161731636|NCT02494778|584059760|FG000|Overall Study|Withdrawal by Subject|20|||
161731637|NCT02494778|584059760|FG000|Overall Study|Lost to Follow-up|2|||
161731638|NCT02494778|584059760|FG000|Overall Study|Noncompliant with study drug admin.|1|||
161731639|NCT03621943|584059761|FG000|First Randomized Intervention|Lost to Follow-up|51|||
161731640|NCT03621943|584059762|FG001|First Randomized Intervention|Lost to Follow-up|54|||
161731641|NCT03621943|584059761|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
161731642|NCT03621943|584059762|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
161731643|NCT03621943|584059761|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
161731644|NCT03621943|584059762|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
161731645|NCT03621943|584059761|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
161731646|NCT03621943|584059762|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
161731647|NCT00967226|584059763|FG000|Overall Study|Adverse Event|0|||
161731648|NCT00967226|584059764|FG001|Overall Study|Adverse Event|5|||
161731649|NCT00967226|584059763|FG000|Overall Study|Protocol Violation|2|||
161731650|NCT00967226|584059764|FG001|Overall Study|Protocol Violation|0|||
161731651|NCT00967226|584059763|FG000|Overall Study|Physician Decision|0|||
161731652|NCT00967226|584059764|FG001|Overall Study|Physician Decision|1|||
161731653|NCT02174861|584059765|FG000|Overall Study|Decision by sponsor|8|||
161731654|NCT02174861|584059765|FG000|Overall Study|Withdrawal by Subject|124|||
161731655|NCT02174861|584059765|FG000|Overall Study|Lost to Follow-up|26|||
161731656|NCT01670656|584059766|FG000|Overall Study|Non-compliance with study drug|0|||
161731657|NCT01670656|584059767|FG001|Overall Study|Non-compliance with study drug|0|||
161731658|NCT01670656|584059768|FG002|Overall Study|Non-compliance with study drug|3|||
161731659|NCT01670656|584059769|FG003|Overall Study|Non-compliance with study drug|0|||
161731660|NCT01670656|584059770|FG004|Overall Study|Non-compliance with study drug|1|||
161731661|NCT01670656|584059766|FG000|Overall Study|Pregnancy|0|||
161731662|NCT01670656|584059767|FG001|Overall Study|Pregnancy|0|||
161731663|NCT01670656|584059768|FG002|Overall Study|Pregnancy|0|||
161731664|NCT01670656|584059769|FG003|Overall Study|Pregnancy|0|||
161731665|NCT01670656|584059770|FG004|Overall Study|Pregnancy|1|||
161731666|NCT01670656|584059766|FG000|Overall Study|Withdrawal by Subject|1|||
161731667|NCT01670656|584059767|FG001|Overall Study|Withdrawal by Subject|1|||
161731668|NCT01670656|584059768|FG002|Overall Study|Withdrawal by Subject|0|||
161731669|NCT01670656|584059769|FG003|Overall Study|Withdrawal by Subject|0|||
161731670|NCT01670656|584059770|FG004|Overall Study|Withdrawal by Subject|0|||
161839305|NCT03347422|584455329|FG000|Part A (26 Weeks)|Adverse Event|3|||
161839306|NCT03347422|584455330|FG001|Part A (26 Weeks)|Adverse Event|0|||
161731671|NCT01670656|584059766|FG000|Overall Study|Non-compliance with protocol|0|||
161731672|NCT01670656|584059767|FG001|Overall Study|Non-compliance with protocol|3|||
161731673|NCT01670656|584059768|FG002|Overall Study|Non-compliance with protocol|1|||
161731674|NCT01670656|584059769|FG003|Overall Study|Non-compliance with protocol|1|||
161731675|NCT01670656|584059770|FG004|Overall Study|Non-compliance with protocol|2|||
161731676|NCT01670656|584059766|FG000|Overall Study|Adverse Event|2|||
161731677|NCT01670656|584059767|FG001|Overall Study|Adverse Event|2|||
161731678|NCT01670656|584059768|FG002|Overall Study|Adverse Event|2|||
161731679|NCT01670656|584059769|FG003|Overall Study|Adverse Event|3|||
161839307|NCT03347422|584455329|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
161839308|NCT03347422|584455330|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
161839309|NCT03347422|584455329|FG000|Part B (149 Weeks)|Adverse Event|0|||
161839310|NCT03347422|584455330|FG001|Part B (149 Weeks)|Adverse Event|1|||
161839311|NCT03347422|584455329|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
161839312|NCT03347422|584455330|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
161839313|NCT03347422|584455329|FG000|Part B (149 Weeks)|Other|1|||
161839314|NCT03347422|584455330|FG001|Part B (149 Weeks)|Other|0|||
161839315|NCT00622466|584455337|FG000|Overall Study|Death|1|||
161839316|NCT00622466|584455337|FG000|Overall Study|Adverse Event|1|||
161839317|NCT00622466|584455337|FG000|Overall Study|Withdrawal by Subject|2|||
161839318|NCT01936623|584455349|FG000|Overall Study|Lost to Follow-up|0|||
161839319|NCT01936623|584455350|FG001|Overall Study|Lost to Follow-up|5|||
161839320|NCT01383135|584455351|FG000|Overall Study|Not Scanned / Imaged|1|||
161839321|NCT01383135|584455352|FG001|Overall Study|Not Scanned / Imaged|0|||
161839322|NCT01383135|584455353|FG002|Overall Study|Not Scanned / Imaged|1|||
161839323|NCT01383135|584455354|FG003|Overall Study|Not Scanned / Imaged|0|||
161839324|NCT02534844|584455359|FG000|Part B|Withdrawal by Subject|0|||
161839325|NCT02534844|584455360|FG001|Part B|Withdrawal by Subject|0|||
161839326|NCT02534844|584455361|FG002|Part B|Withdrawal by Subject|0|||
161839327|NCT02534844|584455362|FG003|Part B|Withdrawal by Subject|0|||
161839328|NCT02534844|584455363|FG004|Part B|Withdrawal by Subject|2|||
161839329|NCT02534844|584455364|FG005|Part B|Withdrawal by Subject|1|||
161839330|NCT01971970|584455365|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
161839331|NCT01971970|584455366|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
161839332|NCT01971970|584455365|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
161839333|NCT01971970|584455366|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
161839334|NCT01971970|584455365|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
161839335|NCT01971970|584455366|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
161839336|NCT01971970|584455365|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
161839337|NCT01971970|584455366|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
161839338|NCT01971970|584455365|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
161839339|NCT01971970|584455366|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
161839340|NCT01971970|584455365|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
161839341|NCT01971970|584455366|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
161839342|NCT01971970|584455365|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
161839343|NCT01971970|584455366|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
161839344|NCT01831765|584455367|FG000|Overall Study|Lack of Efficacy|1|||
161839345|NCT01831765|584455368|FG001|Overall Study|Lack of Efficacy|0|||
161839346|NCT01831765|584455369|FG002|Overall Study|Lack of Efficacy|0|||
161839347|NCT01831765|584455367|FG000|Overall Study|Other, sponsor withdrew subject|0|||
161839348|NCT01831765|584455368|FG001|Overall Study|Other, sponsor withdrew subject|1|||
161839349|NCT01831765|584455369|FG002|Overall Study|Other, sponsor withdrew subject|0|||
161839350|NCT01831765|584455367|FG000|Overall Study|Pregnancy|1|||
161839351|NCT01831765|584455368|FG001|Overall Study|Pregnancy|1|||
161839352|NCT01831765|584455369|FG002|Overall Study|Pregnancy|2|||
161839353|NCT01831765|584455367|FG000|Overall Study|Death|0|||
161839354|NCT01831765|584455368|FG001|Overall Study|Death|1|||
161839355|NCT01831765|584455369|FG002|Overall Study|Death|1|||
161839356|NCT01831765|584455367|FG000|Overall Study|Other, site closed|1|||
161839357|NCT01831765|584455368|FG001|Overall Study|Other, site closed|1|||
161839358|NCT01831765|584455369|FG002|Overall Study|Other, site closed|0|||
161839359|NCT01831765|584455367|FG000|Overall Study|Adverse Event|5|||
161839360|NCT01831765|584455368|FG001|Overall Study|Adverse Event|3|||
161839361|NCT01831765|584455369|FG002|Overall Study|Adverse Event|3|||
161839362|NCT01831765|584455367|FG000|Overall Study|Withdrawal by Subject|22|||
161839363|NCT01831765|584455368|FG001|Overall Study|Withdrawal by Subject|7|||
161839364|NCT01831765|584455369|FG002|Overall Study|Withdrawal by Subject|17|||
161839365|NCT01831765|584455367|FG000|Overall Study|Withdrawal criteria|12|||
161839366|NCT01831765|584455368|FG001|Overall Study|Withdrawal criteria|10|||
161839367|NCT01831765|584455369|FG002|Overall Study|Withdrawal criteria|16|||
161839368|NCT01831765|584455367|FG000|Overall Study|Lost to Follow-up|2|||
161839369|NCT01831765|584455368|FG001|Overall Study|Lost to Follow-up|3|||
161839370|NCT01831765|584455369|FG002|Overall Study|Lost to Follow-up|3|||
161839371|NCT00859586|584455370|FG000|Overall Study|Donors|4|||
161839372|NCT00080938|584455371|FG000|Overall Study|Adverse Event|3|||
161839373|NCT00080938|584455371|FG000|Overall Study|Withdrawal by Subject|6|||
161839374|NCT00080938|584455371|FG000|Overall Study|Death|2|||
161839375|NCT00080938|584455371|FG000|Overall Study|Lack of Efficacy|7|||
161839376|NCT00080938|584455371|FG000|Overall Study|other disease|1|||
161839377|NCT00080938|584455371|FG000|Overall Study|Not started protocol therapy|1|||
161731680|NCT01670656|584059770|FG004|Overall Study|Adverse Event|3|||
161731681|NCT01670656|584059766|FG000|Overall Study|Subject withdrew consent|0|||
161731682|NCT01670656|584059767|FG001|Overall Study|Subject withdrew consent|1|||
161731683|NCT01670656|584059768|FG002|Overall Study|Subject withdrew consent|2|||
161731684|NCT01670656|584059769|FG003|Overall Study|Subject withdrew consent|1|||
161731685|NCT01670656|584059770|FG004|Overall Study|Subject withdrew consent|1|||
161731686|NCT01670656|584059766|FG000|Overall Study|Lost to Follow-up|0|||
161731687|NCT01670656|584059767|FG001|Overall Study|Lost to Follow-up|0|||
161731688|NCT01670656|584059768|FG002|Overall Study|Lost to Follow-up|0|||
161731689|NCT01670656|584059769|FG003|Overall Study|Lost to Follow-up|0|||
161731690|NCT01670656|584059770|FG004|Overall Study|Lost to Follow-up|3|||
161731691|NCT01670656|584059766|FG000|Overall Study|Subject moved|0|||
161731692|NCT01670656|584059767|FG001|Overall Study|Subject moved|0|||
161731693|NCT01670656|584059768|FG002|Overall Study|Subject moved|0|||
161731694|NCT01670656|584059769|FG003|Overall Study|Subject moved|1|||
161731695|NCT01670656|584059770|FG004|Overall Study|Subject moved|0|||
161731696|NCT00165841|584059771|FG000|Overall Study|Adverse Event|2|||
161731697|NCT00165841|584059772|FG001|Overall Study|Adverse Event|3|||
161731698|NCT00165841|584059771|FG000|Overall Study|Lack of Efficacy|6|||
161731699|NCT00165841|584059772|FG001|Overall Study|Lack of Efficacy|33|||
161731700|NCT00165841|584059771|FG000|Overall Study|Lost to Follow-up|4|||
161731701|NCT00165841|584059772|FG001|Overall Study|Lost to Follow-up|4|||
161731702|NCT00165841|584059771|FG000|Overall Study|Withdrawal by Subject|7|||
161731703|NCT00165841|584059772|FG001|Overall Study|Withdrawal by Subject|8|||
161731704|NCT00165841|584059771|FG000|Overall Study|Physician Decision|1|||
161731705|NCT00165841|584059772|FG001|Overall Study|Physician Decision|0|||
161731706|NCT00165841|584059771|FG000|Overall Study|Protocol Violation|6|||
161731707|NCT00165841|584059772|FG001|Overall Study|Protocol Violation|8|||
161731708|NCT00165841|584059771|FG000|Overall Study|Other|3|||
161731709|NCT00165841|584059772|FG001|Overall Study|Other|5|||
161731710|NCT00165841|584059771|FG000|Overall Study|Medication Noncompliance|1|||
161731711|NCT00165841|584059772|FG001|Overall Study|Medication Noncompliance|1|||
161731712|NCT00789958|584059773|FG000|Overall Study|Adverse Event|3|||
161731713|NCT00789958|584059773|FG000|Overall Study|Withdrawal by Subject|4|||
161731714|NCT00789958|584059773|FG000|Overall Study|Progression|3|||
161731715|NCT00789958|584059773|FG000|Overall Study|not protocol specified|1|||
161731716|NCT00789958|584059773|FG000|Overall Study|Not eligible/not analyzable|26|||
161731717|NCT00487084|584059774|FG000|Overall Study|Did not receive intervention|4|||
161731718|NCT00487084|584059775|FG001|Overall Study|Did not receive intervention|3|||
161731719|NCT00487084|584059776|FG002|Overall Study|Did not receive intervention|5|||
161731720|NCT01697267|584059777|FG000|Overall Study|Death|3|||
161731721|NCT01697267|584059778|FG001|Overall Study|Death|1|||
161731722|NCT01697267|584059777|FG000|Overall Study|Withdrawal by Subject|5|||
161731723|NCT01697267|584059778|FG001|Overall Study|Withdrawal by Subject|5|||
161731724|NCT01697267|584059777|FG000|Overall Study|Adverse Event|2|||
161731725|NCT01697267|584059778|FG001|Overall Study|Adverse Event|1|||
161731726|NCT01697267|584059777|FG000|Overall Study|Lost to Follow-up|2|||
161731727|NCT01697267|584059778|FG001|Overall Study|Lost to Follow-up|4|||
161731728|NCT01697267|584059777|FG000|Overall Study|Physician Decision|2|||
161731729|NCT01697267|584059778|FG001|Overall Study|Physician Decision|4|||
161731730|NCT02796391|584059781|FG000|Overall Study|Lost to Follow-up|2|||
161731731|NCT02796391|584059782|FG001|Overall Study|Lost to Follow-up|2|||
161731732|NCT02796391|584059783|FG002|Overall Study|Lost to Follow-up|13|||
161731733|NCT02796391|584059784|FG003|Overall Study|Lost to Follow-up|8|||
161731734|NCT02796391|584059785|FG004|Overall Study|Lost to Follow-up|14|||
161731735|NCT02796391|584059786|FG005|Overall Study|Lost to Follow-up|13|||
161731736|NCT02796391|584059781|FG000|Overall Study|COVID|0|||
161731737|NCT02796391|584059782|FG001|Overall Study|COVID|0|||
161731738|NCT02796391|584059783|FG002|Overall Study|COVID|5|||
161731739|NCT02796391|584059784|FG003|Overall Study|COVID|5|||
161731740|NCT02796391|584059785|FG004|Overall Study|COVID|2|||
161839378|NCT00080938|584455371|FG000|Overall Study|Ineligible|4|||
161839379|NCT00706511|584455374|FG000|Overall Study|Withdrawal by Subject|1|||
161731741|NCT02796391|584059786|FG005|Overall Study|COVID|4|||
161731742|NCT02796391|584059781|FG000|Overall Study|Participant did not like study cigarettes|0|||
161731743|NCT02796391|584059782|FG001|Overall Study|Participant did not like study cigarettes|0|||
161839380|NCT00706511|584455375|FG001|Overall Study|Withdrawal by Subject|0|||
161731744|NCT02796391|584059783|FG002|Overall Study|Participant did not like study cigarettes|3|||
161731745|NCT02796391|584059784|FG003|Overall Study|Participant did not like study cigarettes|0|||
161731746|NCT02796391|584059785|FG004|Overall Study|Participant did not like study cigarettes|0|||
161731747|NCT02796391|584059786|FG005|Overall Study|Participant did not like study cigarettes|0|||
161731748|NCT02796391|584059781|FG000|Overall Study|Withdrawal by Subject|1|||
161731749|NCT02796391|584059782|FG001|Overall Study|Withdrawal by Subject|1|||
161731750|NCT02796391|584059783|FG002|Overall Study|Withdrawal by Subject|4|||
161839381|NCT00706511|584455376|FG002|Overall Study|Withdrawal by Subject|0|||
161731751|NCT02796391|584059784|FG003|Overall Study|Withdrawal by Subject|3|||
161731752|NCT02796391|584059785|FG004|Overall Study|Withdrawal by Subject|4|||
161731753|NCT02796391|584059786|FG005|Overall Study|Withdrawal by Subject|3|||
161731754|NCT02796391|584059781|FG000|Overall Study|Adverse Event|0|||
161731755|NCT02796391|584059782|FG001|Overall Study|Adverse Event|0|||
161731756|NCT02796391|584059783|FG002|Overall Study|Adverse Event|0|||
161731757|NCT02796391|584059784|FG003|Overall Study|Adverse Event|1|||
161731758|NCT02796391|584059785|FG004|Overall Study|Adverse Event|0|||
161731759|NCT02796391|584059786|FG005|Overall Study|Adverse Event|0|||
161731760|NCT02796391|584059781|FG000|Overall Study|Protocol Violation|0|||
161731761|NCT02796391|584059782|FG001|Overall Study|Protocol Violation|0|||
161731762|NCT02796391|584059783|FG002|Overall Study|Protocol Violation|0|||
161731763|NCT02796391|584059784|FG003|Overall Study|Protocol Violation|1|||
161731764|NCT02796391|584059785|FG004|Overall Study|Protocol Violation|0|||
161731765|NCT02796391|584059786|FG005|Overall Study|Protocol Violation|0|||
161731766|NCT02681055|584059787|FG000|Weeks 5-12|Adverse Event|1|||
161731767|NCT00377611|584059790|FG000|Overall Study|Adverse Event|2|||
161731768|NCT00377611|584059791|FG001|Overall Study|Adverse Event|9|||
161731769|NCT00377611|584059790|FG000|Overall Study|Protocol Violation|2|||
161731770|NCT00377611|584059791|FG001|Overall Study|Protocol Violation|0|||
161731771|NCT00377611|584059790|FG000|Overall Study|Withdrawal by Subject|0|||
161731772|NCT00377611|584059791|FG001|Overall Study|Withdrawal by Subject|5|||
161731773|NCT00377611|584059790|FG000|Overall Study|Lost to Follow-up|18|||
161731774|NCT00377611|584059791|FG001|Overall Study|Lost to Follow-up|16|||
161731775|NCT00377611|584059790|FG000|Overall Study|Other|0|||
161731776|NCT00377611|584059791|FG001|Overall Study|Other|3|||
161731777|NCT03446651|584059797|FG000|Overall Study|Lost to Follow-up|4|||
161731778|NCT03446651|584059798|FG001|Overall Study|Lost to Follow-up|0|||
161731779|NCT03446651|584059797|FG000|Overall Study|Open Label Participants|5|||
161731780|NCT03446651|584059798|FG001|Overall Study|Open Label Participants|0|||
161731781|NCT00343291|584059799|FG000|Overall Study|Adverse Event|13|||
161731782|NCT00343291|584059800|FG001|Overall Study|Adverse Event|13|||
161731783|NCT00343291|584059799|FG000|Overall Study|Death|3|||
161731784|NCT00343291|584059800|FG001|Overall Study|Death|2|||
161731785|NCT00343291|584059799|FG000|Overall Study|Progressive disease|33|||
161731786|NCT00343291|584059800|FG001|Overall Study|Progressive disease|34|||
161731787|NCT00343291|584059799|FG000|Overall Study|Withdrawal by Subject|0|||
161731788|NCT00343291|584059800|FG001|Overall Study|Withdrawal by Subject|2|||
161731789|NCT00343291|584059799|FG000|Overall Study|Other|8|||
161731790|NCT00343291|584059800|FG001|Overall Study|Other|5|||
161731791|NCT04831515|584059801|FG000|First Intervention|Adverse Event|0|||
161731792|NCT04831515|584059802|FG001|First Intervention|Adverse Event|1|||
161731793|NCT03712345|584059805|FG000|Overall Study|Failure to meet randomization criteria|0|||
161731794|NCT03712345|584059806|FG001|Overall Study|Failure to meet randomization criteria|0|||
161731795|NCT03712345|584059807|FG002|Overall Study|Failure to meet randomization criteria|1|||
161731796|NCT00960934|584059808|FG000|Overall Study|Adverse Event|2|||
161731797|NCT00960934|584059809|FG001|Overall Study|Adverse Event|3|||
161731798|NCT00960934|584059810|FG002|Overall Study|Adverse Event|3|||
161731799|NCT00960934|584059811|FG003|Overall Study|Adverse Event|2|||
161731800|NCT00960934|584059812|FG004|Overall Study|Adverse Event|4|||
161731801|NCT00960934|584059813|FG005|Overall Study|Adverse Event|3|||
161731802|NCT00960934|584059808|FG000|Overall Study|Lack of Efficacy|1|||
161731803|NCT00960934|584059809|FG001|Overall Study|Lack of Efficacy|0|||
161731804|NCT00960934|584059810|FG002|Overall Study|Lack of Efficacy|0|||
161731805|NCT00960934|584059811|FG003|Overall Study|Lack of Efficacy|0|||
161731806|NCT00960934|584059812|FG004|Overall Study|Lack of Efficacy|0|||
161731807|NCT00960934|584059813|FG005|Overall Study|Lack of Efficacy|0|||
161731808|NCT00960934|584059808|FG000|Overall Study|Lost to Follow-up|0|||
161731809|NCT00960934|584059809|FG001|Overall Study|Lost to Follow-up|1|||
161731810|NCT00960934|584059810|FG002|Overall Study|Lost to Follow-up|0|||
161731811|NCT00960934|584059811|FG003|Overall Study|Lost to Follow-up|0|||
161731812|NCT00960934|584059812|FG004|Overall Study|Lost to Follow-up|0|||
161731813|NCT00960934|584059813|FG005|Overall Study|Lost to Follow-up|0|||
161731814|NCT00960934|584059808|FG000|Overall Study|Other|2|||
161731815|NCT00960934|584059809|FG001|Overall Study|Other|1|||
161731816|NCT00960934|584059810|FG002|Overall Study|Other|5|||
161731817|NCT00960934|584059811|FG003|Overall Study|Other|4|||
161731818|NCT00960934|584059812|FG004|Overall Study|Other|2|||
161731819|NCT00960934|584059813|FG005|Overall Study|Other|2|||
161731820|NCT00960934|584059808|FG000|Overall Study|Physician Decision|0|||
161731821|NCT00960934|584059809|FG001|Overall Study|Physician Decision|1|||
161731822|NCT00960934|584059810|FG002|Overall Study|Physician Decision|0|||
161731823|NCT00960934|584059811|FG003|Overall Study|Physician Decision|0|||
161839382|NCT00706511|584455377|FG003|Overall Study|Withdrawal by Subject|0|||
161731824|NCT00960934|584059812|FG004|Overall Study|Physician Decision|0|||
161731825|NCT00960934|584059813|FG005|Overall Study|Physician Decision|0|||
161731826|NCT00960934|584059808|FG000|Overall Study|Progressive Disease|1|||
161731827|NCT00960934|584059809|FG001|Overall Study|Progressive Disease|1|||
161731828|NCT00960934|584059810|FG002|Overall Study|Progressive Disease|0|||
161731829|NCT00960934|584059811|FG003|Overall Study|Progressive Disease|0|||
161731830|NCT00960934|584059812|FG004|Overall Study|Progressive Disease|1|||
161731831|NCT00960934|584059813|FG005|Overall Study|Progressive Disease|1|||
161731832|NCT00960934|584059808|FG000|Overall Study|Protocol Violation|3|||
161731833|NCT00960934|584059809|FG001|Overall Study|Protocol Violation|4|||
161731834|NCT00960934|584059810|FG002|Overall Study|Protocol Violation|0|||
161731835|NCT00960934|584059811|FG003|Overall Study|Protocol Violation|3|||
161731836|NCT00960934|584059812|FG004|Overall Study|Protocol Violation|3|||
161731837|NCT00960934|584059813|FG005|Overall Study|Protocol Violation|2|||
161731838|NCT00960934|584059808|FG000|Overall Study|Withdrawal by Subject|5|||
161731839|NCT00960934|584059809|FG001|Overall Study|Withdrawal by Subject|6|||
161731840|NCT00960934|584059810|FG002|Overall Study|Withdrawal by Subject|4|||
161731841|NCT00960934|584059811|FG003|Overall Study|Withdrawal by Subject|5|||
161731842|NCT00960934|584059812|FG004|Overall Study|Withdrawal by Subject|5|||
161731843|NCT00960934|584059813|FG005|Overall Study|Withdrawal by Subject|7|||
161731844|NCT00960934|584059808|FG000|Overall Study|Study Terminated by Sponsor|50|||
161731845|NCT00960934|584059809|FG001|Overall Study|Study Terminated by Sponsor|46|||
161731846|NCT00960934|584059810|FG002|Overall Study|Study Terminated by Sponsor|52|||
161731847|NCT00960934|584059811|FG003|Overall Study|Study Terminated by Sponsor|50|||
161731848|NCT00960934|584059812|FG004|Overall Study|Study Terminated by Sponsor|49|||
161731849|NCT00960934|584059813|FG005|Overall Study|Study Terminated by Sponsor|49|||
161731850|NCT02338492|584059825|FG000|Overall Study|Death|32|||
161731851|NCT02338492|584059825|FG000|Overall Study|Adverse Event|3|||
161731852|NCT02338492|584059825|FG000|Overall Study|Lost to Follow-up|4|||
161731853|NCT02338492|584059825|FG000|Overall Study|Reason not captured above|6|||
161731854|NCT01332019|584059826|FG000|Overall Study|Was Not Dosed|1|||
161731855|NCT01332019|584059827|FG001|Overall Study|Was Not Dosed|0|||
161731856|NCT01332019|584059826|FG000|Overall Study|Other|16|||
161731857|NCT01332019|584059827|FG001|Overall Study|Other|18|||
161731858|NCT01332019|584059826|FG000|Overall Study|Death|2|||
161731859|NCT01332019|584059827|FG001|Overall Study|Death|1|||
161731860|NCT01332019|584059826|FG000|Overall Study|Physician Decision|4|||
161731861|NCT01332019|584059827|FG001|Overall Study|Physician Decision|3|||
161731862|NCT01332019|584059826|FG000|Overall Study|Withdrawal by Subject|73|||
161731863|NCT01332019|584059827|FG001|Overall Study|Withdrawal by Subject|71|||
161731864|NCT01332019|584059826|FG000|Overall Study|Lost to Follow-up|4|||
161731865|NCT01332019|584059827|FG001|Overall Study|Lost to Follow-up|7|||
161731866|NCT01332019|584059826|FG000|Overall Study|Adverse Event|13|||
161731867|NCT01332019|584059827|FG001|Overall Study|Adverse Event|22|||
161731868|NCT04281030|584059830|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
161731869|NCT04281030|584059831|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
161731870|NCT04281030|584059830|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
161731871|NCT04281030|584059831|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
161731872|NCT01395368|584059832|FG000|Overall Study|Physician Decision|14|||
161731873|NCT01395368|584059832|FG000|Overall Study|Withdrawal by Subject|2|||
161731874|NCT00310388|584059833|FG000|Primary Reporting Phase|Adverse Event|101|||
161731875|NCT00310388|584059834|FG001|Primary Reporting Phase|Adverse Event|0|||
161731876|NCT00310388|584059833|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
161731877|NCT00310388|584059834|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
161731878|NCT00310388|584059833|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
161731879|NCT00310388|584059834|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
161731880|NCT00310388|584059833|FG000|Primary Reporting Phase|Protocol Violation|10|||
161731881|NCT00310388|584059834|FG001|Primary Reporting Phase|Protocol Violation|0|||
161731882|NCT00310388|584059833|FG000|Primary Reporting Phase|Pregnancy|3|||
161731883|NCT00310388|584059834|FG001|Primary Reporting Phase|Pregnancy|0|||
161731884|NCT00310388|584059833|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
161731885|NCT00310388|584059834|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
161731886|NCT00310388|584059833|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
161731887|NCT00310388|584059834|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
161731888|NCT00310388|584059833|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
161731889|NCT00310388|584059834|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
161731890|NCT00310388|584059833|FG000|Primary Reporting Phase|Physician Decision|2|||
161731891|NCT00310388|584059834|FG001|Primary Reporting Phase|Physician Decision|0|||
161731892|NCT00310388|584059833|FG000|Primary Reporting Phase|Request of the sponsor|19|||
161731893|NCT00310388|584059834|FG001|Primary Reporting Phase|Request of the sponsor|0|||
161731894|NCT00310388|584059833|FG000|Primary Reporting Phase|Failed to return|8|||
161731895|NCT00310388|584059834|FG001|Primary Reporting Phase|Failed to return|0|||
161731896|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
161839383|NCT02605993|584455378|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161731897|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
161731898|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant request|2|||
161731899|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant request|0|||
161731900|NCT00310388|584059833|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
161731901|NCT00310388|584059834|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
161731902|NCT00310388|584059833|FG000|Primary Reporting Phase|Discontinuation of study|1|||
161731903|NCT00310388|584059834|FG001|Primary Reporting Phase|Discontinuation of study|0|||
161731904|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
161731905|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
161731906|NCT00310388|584059833|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
161731907|NCT00310388|584059834|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
161731908|NCT00310388|584059833|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
161731909|NCT00310388|584059834|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
161731910|NCT00310388|584059833|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
161731911|NCT00310388|584059834|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
161731912|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant passed away|1|||
161731913|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant passed away|0|||
161731914|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
161731915|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
161731916|NCT00310388|584059833|FG000|Primary Reporting Phase|Missing|1|||
161731917|NCT00310388|584059834|FG001|Primary Reporting Phase|Missing|0|||
161731918|NCT00310388|584059833|FG000|Primary Reporting Phase|Other|1|||
161731919|NCT00310388|584059834|FG001|Primary Reporting Phase|Other|0|||
161731920|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
161731921|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
161731922|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
161731923|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
161731924|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
161731925|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
161731926|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
161731927|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
161731928|NCT00882999|584059839|FG000|Overall Study|Adverse Event|0|||
161731929|NCT00882999|584059840|FG001|Overall Study|Adverse Event|0|||
161731930|NCT00882999|584059841|FG002|Overall Study|Adverse Event|0|||
161731931|NCT00882999|584059842|FG003|Overall Study|Adverse Event|0|||
161731932|NCT00882999|584059843|FG004|Overall Study|Adverse Event|1|||
161731933|NCT00882999|584059844|FG005|Overall Study|Adverse Event|0|||
161731934|NCT00882999|584059845|FG006|Overall Study|Adverse Event|0|||
161731935|NCT00882999|584059839|FG000|Overall Study|Death|0|||
161731936|NCT00882999|584059840|FG001|Overall Study|Death|1|||
161731937|NCT00882999|584059841|FG002|Overall Study|Death|0|||
161731938|NCT00882999|584059842|FG003|Overall Study|Death|0|||
161731939|NCT00882999|584059843|FG004|Overall Study|Death|0|||
161731940|NCT00882999|584059844|FG005|Overall Study|Death|0|||
161731941|NCT00882999|584059845|FG006|Overall Study|Death|0|||
161731942|NCT00882999|584059839|FG000|Overall Study|Withdrawal by Subject|7|||
161731943|NCT00882999|584059840|FG001|Overall Study|Withdrawal by Subject|6|||
161731944|NCT00882999|584059841|FG002|Overall Study|Withdrawal by Subject|3|||
161731945|NCT00882999|584059842|FG003|Overall Study|Withdrawal by Subject|3|||
161731946|NCT00882999|584059843|FG004|Overall Study|Withdrawal by Subject|6|||
161731947|NCT00882999|584059844|FG005|Overall Study|Withdrawal by Subject|5|||
161731948|NCT00882999|584059845|FG006|Overall Study|Withdrawal by Subject|5|||
161731949|NCT00882999|584059839|FG000|Overall Study|Lost to Follow-up|0|||
161731950|NCT00882999|584059840|FG001|Overall Study|Lost to Follow-up|1|||
161731951|NCT00882999|584059841|FG002|Overall Study|Lost to Follow-up|1|||
161731952|NCT00882999|584059842|FG003|Overall Study|Lost to Follow-up|2|||
161731953|NCT00882999|584059843|FG004|Overall Study|Lost to Follow-up|1|||
161731954|NCT00882999|584059844|FG005|Overall Study|Lost to Follow-up|1|||
161731955|NCT00882999|584059845|FG006|Overall Study|Lost to Follow-up|2|||
161731956|NCT00882999|584059839|FG000|Overall Study|Physician Decision|1|||
161731957|NCT00882999|584059840|FG001|Overall Study|Physician Decision|0|||
161731958|NCT00882999|584059841|FG002|Overall Study|Physician Decision|0|||
161731959|NCT00882999|584059842|FG003|Overall Study|Physician Decision|0|||
161731960|NCT00882999|584059843|FG004|Overall Study|Physician Decision|0|||
161731961|NCT00882999|584059844|FG005|Overall Study|Physician Decision|1|||
161731962|NCT00882999|584059845|FG006|Overall Study|Physician Decision|1|||
161731963|NCT01757405|584059848|FG000|Overall Study|Lost to Follow-up|1|||
161731964|NCT01757405|584059849|FG001|Overall Study|Lost to Follow-up|1|||
161731965|NCT01757405|584059848|FG000|Overall Study|Withdrawal by Subject|0|||
161731966|NCT01757405|584059849|FG001|Overall Study|Withdrawal by Subject|1|||
161731967|NCT00082758|584059850|FG000|Overall Study|Adverse Event|0|||
161731968|NCT00082758|584059851|FG001|Overall Study|Adverse Event|2|||
161731969|NCT00082758|584059852|FG002|Overall Study|Adverse Event|0|||
161731970|NCT00082758|584059850|FG000|Overall Study|Lack of Efficacy|12|||
161731971|NCT00082758|584059851|FG001|Overall Study|Lack of Efficacy|13|||
161731972|NCT00082758|584059852|FG002|Overall Study|Lack of Efficacy|0|||
161731973|NCT00082758|584059850|FG000|Overall Study|Physician Decision|0|||
161731974|NCT00082758|584059851|FG001|Overall Study|Physician Decision|1|||
161731975|NCT00082758|584059852|FG002|Overall Study|Physician Decision|0|||
161731976|NCT00082758|584059850|FG000|Overall Study|Withdrawal by Subject|3|||
161731977|NCT00082758|584059851|FG001|Overall Study|Withdrawal by Subject|0|||
161731978|NCT00082758|584059852|FG002|Overall Study|Withdrawal by Subject|0|||
161731979|NCT00082758|584059850|FG000|Overall Study|Protocol Violation|0|||
161731980|NCT00082758|584059851|FG001|Overall Study|Protocol Violation|1|||
161731981|NCT00082758|584059852|FG002|Overall Study|Protocol Violation|0|||
161731982|NCT01994226|584059855|FG000|Overall Study|Protocol Violation|13|||
161731983|NCT01994226|584059856|FG001|Overall Study|Protocol Violation|10|||
161731984|NCT01994226|584059855|FG000|Overall Study|Early Cessation of treatment|6|||
161731985|NCT01994226|584059856|FG001|Overall Study|Early Cessation of treatment|11|||
161731986|NCT02488551|584059857|FG000|Overall Study|Lost to Follow-up|4|||
161731987|NCT02488551|584059858|FG001|Overall Study|Lost to Follow-up|7|||
161731988|NCT02488551|584059859|FG002|Overall Study|Lost to Follow-up|0|||
161731989|NCT02488551|584059860|FG003|Overall Study|Lost to Follow-up|0|||
161731990|NCT02488551|584059857|FG000|Overall Study|Military Deployment|1|||
161731991|NCT02488551|584059858|FG001|Overall Study|Military Deployment|1|||
161731992|NCT02488551|584059859|FG002|Overall Study|Military Deployment|0|||
161731993|NCT02488551|584059860|FG003|Overall Study|Military Deployment|0|||
161731994|NCT00436566|584059861|FG000|Overall Study|Withdrawal by Subject|2|||
161731995|NCT00436566|584059861|FG000|Overall Study|Protocol Violation|1|||
161731996|NCT02841787|584059871|FG000|Overall Study|Lost to Follow-up|1|||
161731997|NCT02841787|584059872|FG001|Overall Study|Lost to Follow-up|0|||
161731998|NCT02841787|584059873|FG002|Overall Study|Lost to Follow-up|0|||
161731999|NCT02841787|584059871|FG000|Overall Study|Symptoms dropped below threshold|1|||
161732000|NCT02841787|584059872|FG001|Overall Study|Symptoms dropped below threshold|0|||
161732001|NCT02841787|584059873|FG002|Overall Study|Symptoms dropped below threshold|0|||
161732002|NCT02841787|584059871|FG000|Overall Study|Withdrawal by Subject|1|||
161732003|NCT02841787|584059872|FG001|Overall Study|Withdrawal by Subject|4|||
161732004|NCT02841787|584059873|FG002|Overall Study|Withdrawal by Subject|0|||
161732005|NCT01474746|584059874|FG000|Overall Study|Lost to Follow-up|1|||
161732006|NCT01474746|584059875|FG001|Overall Study|Lost to Follow-up|1|||
161732007|NCT01474746|584059874|FG000|Overall Study|Withdrawal by Subject|2|||
161732008|NCT01474746|584059875|FG001|Overall Study|Withdrawal by Subject|1|||
161732009|NCT00524316|584059876|FG000|Overall Study|Withdrawal by Subject|2|||
161732010|NCT00524316|584059876|FG000|Overall Study|Adverse Event|7|||
161732011|NCT00524316|584059876|FG000|Overall Study|Disease Progression|7|||
161732012|NCT01199263|584059877|FG000|Overall Study|Ineligible|0|||
161732013|NCT01199263|584059878|FG001|Overall Study|Ineligible|2|||
161732014|NCT01199263|584059877|FG000|Overall Study|Never Treated|6|||
161732015|NCT01199263|584059878|FG001|Overall Study|Never Treated|0|||
161732016|NCT01687413|584059883|FG000|Overall Study|Withdrawal by Subject|0|||
161732017|NCT01687413|584059884|FG001|Overall Study|Withdrawal by Subject|2|||
161732018|NCT01687413|584059883|FG000|Overall Study|Not eligible|0|||
161732019|NCT01687413|584059884|FG001|Overall Study|Not eligible|2|||
161732020|NCT01687413|584059883|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
161732021|NCT01687413|584059884|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
161732022|NCT04973228|584059887|FG000|Overall Study|Adverse Event|2|||
161732023|NCT04973228|584059888|FG001|Overall Study|Adverse Event|3|||
161732024|NCT04973228|584059887|FG000|Overall Study|Lack of Efficacy|1|||
161732025|NCT04973228|584059888|FG001|Overall Study|Lack of Efficacy|3|||
161732026|NCT04973228|584059887|FG000|Overall Study|Lost to Follow-up|12|||
161732027|NCT04973228|584059888|FG001|Overall Study|Lost to Follow-up|4|||
161732028|NCT04973228|584059887|FG000|Overall Study|Withdrawal by Subject|11|||
161732029|NCT04973228|584059888|FG001|Overall Study|Withdrawal by Subject|4|||
161732030|NCT04973228|584059887|FG000|Overall Study|Did not tolerate application|1|||
161732031|NCT04973228|584059888|FG001|Overall Study|Did not tolerate application|0|||
161732032|NCT04973228|584059887|FG000|Overall Study|Wanted to early terminate and use own product|0|||
161732033|NCT04973228|584059888|FG001|Overall Study|Wanted to early terminate and use own product|1|||
161732034|NCT04973228|584059887|FG000|Overall Study|Missed visits due to new work schedule|1|||
161732035|NCT04973228|584059888|FG001|Overall Study|Missed visits due to new work schedule|0|||
161732036|NCT00091390|584059894|FG000|Overall Study|Protocol Violation|1|||
161732037|NCT00091390|584059894|FG000|Overall Study|No protocol treatment|3|||
161732038|NCT00406640|584059899|FG000|Acute Phase|Adverse Event|18|||
161732039|NCT00406640|584059900|FG001|Acute Phase|Adverse Event|13|||
161732040|NCT00406640|584059899|FG000|Acute Phase|Failed to Return|5|||
161732041|NCT00406640|584059900|FG001|Acute Phase|Failed to Return|1|||
161732042|NCT00406640|584059899|FG000|Acute Phase|Physician Decision|0|||
161732043|NCT00406640|584059900|FG001|Acute Phase|Physician Decision|1|||
161732044|NCT00406640|584059899|FG000|Acute Phase|Lost to Follow-up|7|||
161732045|NCT00406640|584059900|FG001|Acute Phase|Lost to Follow-up|4|||
161732046|NCT00406640|584059899|FG000|Acute Phase|Protocol deviation|4|||
161732047|NCT00406640|584059900|FG001|Acute Phase|Protocol deviation|10|||
161732048|NCT00406640|584059899|FG000|Acute Phase|Protocol Violation|3|||
161839384|NCT02605993|584455379|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161839385|NCT02605993|584455380|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
161839386|NCT02605993|584455381|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161732049|NCT00406640|584059900|FG001|Acute Phase|Protocol Violation|2|||
161732050|NCT00406640|584059899|FG000|Acute Phase|Withdrawal by Subject|11|||
161839387|NCT02116608|584455389|FG000|Overall Study|Lost to Follow-up|0|||
161839388|NCT02116608|584455390|FG001|Overall Study|Lost to Follow-up|0|||
161839389|NCT02116608|584455391|FG002|Overall Study|Lost to Follow-up|1|||
161839390|NCT02116608|584455389|FG000|Overall Study|Physician Decision|0|||
161839391|NCT02116608|584455390|FG001|Overall Study|Physician Decision|1|||
161839392|NCT02116608|584455391|FG002|Overall Study|Physician Decision|0|||
161839393|NCT02116608|584455389|FG000|Overall Study|Death|0|||
161839394|NCT02116608|584455390|FG001|Overall Study|Death|1|||
161839395|NCT02116608|584455391|FG002|Overall Study|Death|0|||
161839396|NCT01169532|584455394|FG000|Overall Study|Withdrawal by Subject|1|||
161839397|NCT00117325|584455395|FG000|Overall Study|Adverse Event|3|||
161839398|NCT00117325|584455396|FG001|Overall Study|Adverse Event|3|||
161839399|NCT00117325|584455395|FG000|Overall Study|Lost to Follow-up|1|||
161839400|NCT00117325|584455396|FG001|Overall Study|Lost to Follow-up|1|||
161839401|NCT00117325|584455395|FG000|Overall Study|Protocol Violation|2|||
161839402|NCT00117325|584455396|FG001|Overall Study|Protocol Violation|3|||
161839403|NCT00117325|584455395|FG000|Overall Study|Withdrawal by Subject|3|||
161839404|NCT00117325|584455396|FG001|Overall Study|Withdrawal by Subject|2|||
161839405|NCT00117325|584455395|FG000|Overall Study|Lack of Efficacy|1|||
161839406|NCT00117325|584455396|FG001|Overall Study|Lack of Efficacy|0|||
161839407|NCT00117325|584455395|FG000|Overall Study|Use of prohibited medicine|1|||
161839408|NCT00117325|584455396|FG001|Overall Study|Use of prohibited medicine|2|||
161839409|NCT00117325|584455395|FG000|Overall Study|Early termination|1|||
161839410|NCT00117325|584455396|FG001|Overall Study|Early termination|1|||
161839411|NCT00117325|584455395|FG000|Overall Study|Admisnitrative|1|||
161732051|NCT00406640|584059900|FG001|Acute Phase|Withdrawal by Subject|9|||
161732052|NCT00406640|584059899|FG000|Acute Phase|Lack of Efficacy|3|||
161732053|NCT00406640|584059900|FG001|Acute Phase|Lack of Efficacy|3|||
161732054|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
161732055|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
161732056|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Death|1|||
161732057|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Death|0|||
161732058|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
161732059|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
161732060|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
161732061|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
161732062|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
161732063|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
161732064|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|non-compliance|7|||
161732065|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|non-compliance|5|||
161732066|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
161732067|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
161732068|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
161732069|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
161732070|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
161839412|NCT00117325|584455396|FG001|Overall Study|Admisnitrative|0|||
161839413|NCT01468818|584455400|FG000|Overall Study|Death during treatment|2|||
161839414|NCT04620135|584455402|FG000|Study Completion|Adverse Event|2|||
161839415|NCT04620135|584455403|FG001|Study Completion|Adverse Event|3|||
161839416|NCT04620135|584455402|FG000|Study Completion|Withdrawal by Subject|2|||
161839417|NCT04620135|584455403|FG001|Study Completion|Withdrawal by Subject|0|||
161839418|NCT01442688|584455404|FG000|First Intervention|Withdrawal by Subject|1|||
161839419|NCT01442688|584455405|FG001|First Intervention|Withdrawal by Subject|0|||
161839420|NCT01442688|584455404|FG000|First Intervention|subject incarcerated|1|||
161839421|NCT01442688|584455405|FG001|First Intervention|subject incarcerated|0|||
161839422|NCT01442688|584455404|FG000|Second Intervention|Adverse Event|1|||
161839423|NCT01442688|584455405|FG001|Second Intervention|Adverse Event|0|||
161839424|NCT04480021|584455406|FG000|Overall Study|Lost to Follow-up|3|||
161839425|NCT04480021|584455407|FG001|Overall Study|Lost to Follow-up|4|||
161839426|NCT00546572|584455408|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
161839427|NCT00546572|584455409|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
161839428|NCT00546572|584455408|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
161839429|NCT00546572|584455409|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
161839430|NCT00546572|584455408|FG000|Vax 1 / Year 0|Protocol Violation|3|||
161839431|NCT00546572|584455409|FG001|Vax 1 / Year 0|Protocol Violation|4|||
161839432|NCT00546572|584455408|FG000|Vax 1 / Year 0|Death|2|||
161839433|NCT00546572|584455409|FG001|Vax 1 / Year 0|Death|2|||
161839434|NCT00546572|584455408|FG000|Vax 1 / Year 0|Adverse Event|0|||
161839435|NCT00546572|584455409|FG001|Vax 1 / Year 0|Adverse Event|1|||
161839436|NCT00546572|584455408|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
161839437|NCT00546572|584455409|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
161839438|NCT00546572|584455408|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
161839439|NCT00546572|584455409|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
161839440|NCT00546572|584455408|FG000|Vax 2 / Year 1|Other|1|||
161839441|NCT00546572|584455409|FG001|Vax 2 / Year 1|Other|1|||
161839442|NCT00546572|584455408|FG000|Vax 2 / Year 1|Adverse Event|1|||
161839443|NCT00546572|584455409|FG001|Vax 2 / Year 1|Adverse Event|0|||
161839444|NCT00546572|584455408|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
161839445|NCT00546572|584455409|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
161839446|NCT03979820|584455410|FG000|Overall Study|Protocol Violation|1|||
161839447|NCT03979820|584455411|FG001|Overall Study|Protocol Violation|0|||
161839448|NCT03979820|584455412|FG002|Overall Study|Protocol Violation|0|||
161839449|NCT03979820|584455413|FG003|Overall Study|Protocol Violation|0|||
161839450|NCT03979820|584455410|FG000|Overall Study|Withdrawal by Subject|0|||
161839451|NCT03979820|584455411|FG001|Overall Study|Withdrawal by Subject|0|||
161839452|NCT03979820|584455412|FG002|Overall Study|Withdrawal by Subject|1|||
161839453|NCT03979820|584455413|FG003|Overall Study|Withdrawal by Subject|0|||
161839454|NCT03979820|584455410|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
161839455|NCT03979820|584455411|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
161839456|NCT03979820|584455412|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
161839457|NCT03979820|584455413|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
161839458|NCT02685202|584455414|FG000|Overall Study|Lost to Follow-up|9|||
161839459|NCT01229735|584455415|FG000|Overall Study|Lack of Efficacy|8|||
161839460|NCT01229735|584455416|FG001|Overall Study|Lack of Efficacy|8|||
161839461|NCT01229735|584455415|FG000|Overall Study|Protocol Violation|13|||
161839462|NCT01229735|584455416|FG001|Overall Study|Protocol Violation|8|||
161839463|NCT01229735|584455415|FG000|Overall Study|Lost to Follow-up|0|||
161839464|NCT01229735|584455416|FG001|Overall Study|Lost to Follow-up|2|||
161839465|NCT01229735|584455415|FG000|Overall Study|Withdrawal by Subject|18|||
161839466|NCT01229735|584455416|FG001|Overall Study|Withdrawal by Subject|17|||
161839467|NCT01229735|584455415|FG000|Overall Study|Other Reason|13|||
161839468|NCT01229735|584455416|FG001|Overall Study|Other Reason|10|||
161839469|NCT01229735|584455415|FG000|Overall Study|SAE, non-fatal|0|||
161839470|NCT01229735|584455416|FG001|Overall Study|SAE, non-fatal|4|||
161839471|NCT01229735|584455415|FG000|Overall Study|AE, non-serious non-fatal|13|||
161839472|NCT01229735|584455416|FG001|Overall Study|AE, non-serious non-fatal|17|||
161839473|NCT01229735|584455415|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161839474|NCT01229735|584455416|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161839475|NCT02130882|584455417|FG000|Overall Study|Withdrawal by Subject|0|||
161839476|NCT02130882|584455418|FG001|Overall Study|Withdrawal by Subject|1|||
161839477|NCT02331368|584455423|FG000|Overall Study|Withdrawal by Subject|3|||
161732071|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
161732072|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
161732073|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
161732074|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
161732075|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
161732076|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
161732077|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
161732078|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
161732079|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
161732080|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
161732081|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
161732082|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
161732083|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
161732084|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
161732085|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
161732086|NCT01116687|584061482|FG000|Overall Study|Withdrawal by Subject|4|||
161732087|NCT03497429|584061483|FG000|Overall Study|Progressive disease|3|||
161732088|NCT03497429|584061484|FG001|Overall Study|Progressive disease|4|||
161732089|NCT03497429|584061483|FG000|Overall Study|Adverse Event|0|||
161732090|NCT03497429|584061484|FG001|Overall Study|Adverse Event|2|||
161732091|NCT01215734|584061485|FG000|Overall Study|Death|0|||
161732092|NCT01215734|584061486|FG001|Overall Study|Death|1|||
161732093|NCT00315705|584061487|FG000|Phase 1|Refused further treatment|1|||
161732094|NCT00315705|584061487|FG000|Phase 1|Failure to achieve response|8|||
161732095|NCT00315705|584061487|FG000|Phase 1|Disease relapse|4|||
161732096|NCT00315705|584061487|FG000|Phase 1|Scheduled for transplant|9|||
161732097|NCT00315705|584061487|FG000|Phase 1|Death|3|||
161732098|NCT00315705|584061487|FG000|Phase 2|Physician Decision|4|||
161732099|NCT00315705|584061487|FG000|Phase 2|Adverse Event|1|||
161732100|NCT00315705|584061487|FG000|Phase 2|Failure to achieve response|3|||
161732101|NCT00315705|584061487|FG000|Phase 2|Disease relapse|1|||
161732102|NCT00315705|584061487|FG000|Phase 2|Scheduled for transplant|8|||
161732103|NCT00315705|584061487|FG000|Phase 2|Other|1|||
161732104|NCT00315705|584061487|FG000|Phase 2|Death|7|||
161732105|NCT01346371|584061488|FG000|Overall Study|Lost to Follow-up|2|||
161732106|NCT01346371|584061489|FG001|Overall Study|Lost to Follow-up|0|||
161732107|NCT01716533|584061490|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
161732108|NCT01716533|584061491|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
161732109|NCT01716533|584061492|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
161732110|NCT01716533|584061493|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
161732111|NCT01716533|584061490|FG000|Overall Study|Withdrawal by Subject|0|||
161732112|NCT01716533|584061491|FG001|Overall Study|Withdrawal by Subject|0|||
161732113|NCT01716533|584061492|FG002|Overall Study|Withdrawal by Subject|0|||
161732114|NCT01716533|584061493|FG003|Overall Study|Withdrawal by Subject|5|||
161732115|NCT01716533|584061490|FG000|Overall Study|Death|0|||
161732116|NCT01716533|584061491|FG001|Overall Study|Death|0|||
161732117|NCT01716533|584061492|FG002|Overall Study|Death|0|||
161732118|NCT01716533|584061493|FG003|Overall Study|Death|2|||
161732119|NCT01716533|584061490|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
161732120|NCT01716533|584061491|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
161732121|NCT01716533|584061492|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
161732122|NCT01716533|584061493|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
161732123|NCT02622724|584061503|FG000|Overall Study|Death|51|||
161732124|NCT02622724|584061504|FG001|Overall Study|Death|53|||
161732125|NCT02622724|584061503|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
161732126|NCT02622724|584061504|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
161732127|NCT02622724|584061503|FG000|Overall Study|Early termination of study|38|||
161732128|NCT02622724|584061504|FG001|Overall Study|Early termination of study|43|||
161732129|NCT00254293|584061505|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732130|NCT00254293|584061506|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
161732131|NCT00254293|584061507|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732132|NCT00254293|584061508|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
161732133|NCT00254293|584061509|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732134|NCT00254293|584061510|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732135|NCT00254293|584061511|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732136|NCT00254293|584061505|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732137|NCT00254293|584061506|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732138|NCT00254293|584061507|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
161732139|NCT00254293|584061508|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732140|NCT00254293|584061509|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732141|NCT00254293|584061510|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732142|NCT00254293|584061511|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161839478|NCT02302859|584455424|FG000|Overall Study|Lost Phone|1|||
161839479|NCT02302859|584455425|FG001|Overall Study|Lost Phone|1|||
161839480|NCT02302859|584455424|FG000|Overall Study|Withdrawal by Subject|0|||
161839481|NCT02302859|584455425|FG001|Overall Study|Withdrawal by Subject|1|||
161839482|NCT00424775|584455426|FG000|Overall Study|Adverse Event|2|||
161839483|NCT00424775|584455427|FG001|Overall Study|Adverse Event|0|||
161839484|NCT00424775|584455426|FG000|Overall Study|Lack of Efficacy|1|||
161839485|NCT00424775|584455427|FG001|Overall Study|Lack of Efficacy|0|||
161839486|NCT02384850|584455431|FG000|Overall Study|Withdrawal by Subject|2|||
161839487|NCT02384850|584455432|FG001|Overall Study|Withdrawal by Subject|2|||
161839488|NCT02312063|584455433|FG000|Overall Study|Withdrawal by Subject|0|||
161839489|NCT02312063|584455434|FG001|Overall Study|Withdrawal by Subject|1|||
161839490|NCT03548064|584458504|FG000|Overall Study|Withdrawal by Subject|0|||
161839491|NCT03548064|584458505|FG001|Overall Study|Withdrawal by Subject|0|||
161839492|NCT03548064|584458506|FG002|Overall Study|Withdrawal by Subject|0|||
161839493|NCT03548064|584458507|FG003|Overall Study|Withdrawal by Subject|1|||
161732143|NCT00254293|584061505|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732144|NCT00254293|584061506|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732145|NCT00254293|584061507|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
161732146|NCT00254293|584061508|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732147|NCT00254293|584061509|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732148|NCT00254293|584061510|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732149|NCT00254293|584061511|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732150|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Death|0|||
161732151|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Death|0|||
161732152|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Death|1|||
161732153|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Death|0|||
161732154|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Death|0|||
161732155|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Death|0|||
161732156|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Death|0|||
161732157|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
161732158|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732159|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
161732160|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732161|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
161732162|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732163|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732164|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
161732165|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732166|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
161732167|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732168|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
161732169|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732170|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732171|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732172|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732173|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
161732174|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732175|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732176|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732177|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732178|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732179|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732180|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
161732181|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732182|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732183|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732184|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732185|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732186|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161839494|NCT03548064|584458508|FG004|Overall Study|Withdrawal by Subject|0|||
161732187|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
161839495|NCT03548064|584458509|FG005|Overall Study|Withdrawal by Subject|0|||
161839496|NCT03548064|584458510|FG006|Overall Study|Withdrawal by Subject|0|||
161839497|NCT03548064|584458511|FG007|Overall Study|Withdrawal by Subject|0|||
161839498|NCT03548064|584458504|FG000|Overall Study|Lost to Follow-up|0|||
161732188|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732189|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732190|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732191|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732192|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Other|0|||
161732193|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Other|0|||
161732194|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Other|2|||
161732195|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Other|0|||
161732196|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Other|0|||
161732197|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Other|0|||
161732198|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Other|0|||
161732199|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Death|0|||
161732200|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Death|0|||
161732201|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Death|0|||
161732202|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Death|0|||
161732203|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Death|0|||
161732204|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Death|0|||
161732205|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Death|3|||
161732206|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732207|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732208|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732209|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732210|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732211|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732212|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
161732213|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732214|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732215|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732216|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732217|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732218|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732219|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
161732220|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732221|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732222|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732223|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732224|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732225|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732226|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
161732227|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732228|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732229|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732230|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732231|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732232|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732233|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
161732234|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732235|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732236|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732237|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732238|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732239|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732240|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
161732241|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Other|0|||
161732242|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Other|0|||
161732243|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Other|0|||
161732244|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Other|0|||
161732245|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Other|0|||
161732246|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Other|0|||
161732247|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Other|1|||
161732248|NCT01575197|584061512|FG000|Overall Study|Migration out of study area|1|||
161732249|NCT01575197|584061513|FG001|Overall Study|Migration out of study area|5|||
161732250|NCT01575197|584061514|FG002|Overall Study|Migration out of study area|4|||
161732251|NCT01575197|584061512|FG000|Overall Study|SAE|0|||
161732252|NCT01575197|584061513|FG001|Overall Study|SAE|1|||
161732253|NCT01575197|584061514|FG002|Overall Study|SAE|0|||
161732254|NCT01575197|584061512|FG000|Overall Study|Lost to Follow-up|0|||
161732255|NCT01575197|584061513|FG001|Overall Study|Lost to Follow-up|1|||
161732256|NCT01575197|584061514|FG002|Overall Study|Lost to Follow-up|0|||
161732257|NCT01575197|584061512|FG000|Overall Study|Withdrawal by Subject|0|||
161839499|NCT03548064|584458505|FG001|Overall Study|Lost to Follow-up|0|||
161732258|NCT01575197|584061513|FG001|Overall Study|Withdrawal by Subject|1|||
161732259|NCT01575197|584061514|FG002|Overall Study|Withdrawal by Subject|1|||
161732260|NCT01575197|584061512|FG000|Overall Study|Protocol Violation|2|||
161732261|NCT01575197|584061513|FG001|Overall Study|Protocol Violation|1|||
161732262|NCT01575197|584061514|FG002|Overall Study|Protocol Violation|1|||
161732263|NCT01000727|584061515|FG000|Overall Study|Lost to Follow-up|41|||
161732264|NCT01000727|584061516|FG001|Overall Study|Lost to Follow-up|43|||
161732265|NCT01000727|584061515|FG000|Overall Study|Withdrawal by Subject|111|||
161732266|NCT01000727|584061516|FG001|Overall Study|Withdrawal by Subject|109|||
161732267|NCT01000727|584061515|FG000|Overall Study|Study closed/terminated|23|||
161732268|NCT01000727|584061516|FG001|Overall Study|Study closed/terminated|24|||
161732269|NCT03196193|584061517|FG000|Overall Study|Adverse Event|1|||
161732270|NCT03196193|584061518|FG001|Overall Study|Adverse Event|0|||
161732271|NCT03196193|584061517|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
161732272|NCT03196193|584061518|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
161732273|NCT02709083|584061519|FG000|Overall Study|Original PI left institution|7|||
161732274|NCT01026389|584061523|FG000|Overall Study|Withdrawal by Subject|1|||
161732275|NCT01026389|584061524|FG001|Overall Study|Withdrawal by Subject|3|||
161732276|NCT01026389|584061523|FG000|Overall Study|change of treatment, patient moved|4|||
161732277|NCT01026389|584061524|FG001|Overall Study|change of treatment, patient moved|2|||
161732278|NCT03544268|584061525|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
161732279|NCT03544268|584061526|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
161732280|NCT04410198|584061527|FG000|Overall Study|Death|10|||
161732281|NCT04410198|584061527|FG000|Overall Study|Withdrawal by Subject|7|||
161732282|NCT04410198|584061527|FG000|Overall Study|Transferred/Relocation|4|||
161732283|NCT04410198|584061527|FG000|Overall Study|Kidney Transplant|9|||
161732284|NCT04410198|584061527|FG000|Overall Study|Adverse Event|4|||
161732285|NCT04410198|584061527|FG000|Overall Study|Physician Decision|2|||
161732286|NCT04410198|584061527|FG000|Overall Study|Other than specified|1|||
161732287|NCT01626352|584061531|FG000|Overall Study|Disease Progression|3|||
161732288|NCT01626352|584061531|FG000|Overall Study|Intercurrent Illness|2|||
161732289|NCT01626352|584061531|FG000|Overall Study|Death|2|||
161732290|NCT01626352|584061531|FG000|Overall Study|Withdrawal by Subject|1|||
161732291|NCT01626352|584061531|FG000|Overall Study|Non-Compliance|1|||
161732292|NCT01626352|584061531|FG000|Overall Study|Never Treated|1|||
161732293|NCT03583372|584061534|FG000|Overall Study|Withdrawal by Subject|6|||
161732294|NCT03583372|584061535|FG001|Overall Study|Withdrawal by Subject|11|||
161732295|NCT03583372|584061536|FG002|Overall Study|Withdrawal by Subject|7|||
161732296|NCT03583372|584061537|FG003|Overall Study|Withdrawal by Subject|8|||
161732297|NCT03583372|584061534|FG000|Overall Study|Lost to Follow-up|4|||
161732298|NCT03583372|584061535|FG001|Overall Study|Lost to Follow-up|6|||
161732299|NCT03583372|584061536|FG002|Overall Study|Lost to Follow-up|3|||
161732300|NCT03583372|584061537|FG003|Overall Study|Lost to Follow-up|2|||
161732301|NCT03583372|584061534|FG000|Overall Study|Adverse Event|1|||
161732302|NCT03583372|584061535|FG001|Overall Study|Adverse Event|3|||
161732303|NCT03583372|584061536|FG002|Overall Study|Adverse Event|4|||
161732304|NCT03583372|584061537|FG003|Overall Study|Adverse Event|4|||
161732305|NCT03583372|584061534|FG000|Overall Study|Physician Decision|0|||
161732306|NCT03583372|584061535|FG001|Overall Study|Physician Decision|1|||
161732307|NCT03583372|584061536|FG002|Overall Study|Physician Decision|1|||
161732308|NCT03583372|584061537|FG003|Overall Study|Physician Decision|1|||
161732309|NCT03583372|584061534|FG000|Overall Study|Lack of Efficacy|0|||
161732310|NCT03583372|584061535|FG001|Overall Study|Lack of Efficacy|1|||
161732311|NCT03583372|584061536|FG002|Overall Study|Lack of Efficacy|0|||
161732312|NCT03583372|584061537|FG003|Overall Study|Lack of Efficacy|1|||
161732313|NCT03583372|584061534|FG000|Overall Study|Death|1|||
161732314|NCT03583372|584061535|FG001|Overall Study|Death|0|||
161732315|NCT03583372|584061536|FG002|Overall Study|Death|0|||
161732316|NCT03583372|584061537|FG003|Overall Study|Death|0|||
161732317|NCT03583372|584061534|FG000|Overall Study|Protocol Violation|0|||
161732318|NCT03583372|584061535|FG001|Overall Study|Protocol Violation|1|||
161732319|NCT03583372|584061536|FG002|Overall Study|Protocol Violation|0|||
161732320|NCT03583372|584061537|FG003|Overall Study|Protocol Violation|0|||
161732321|NCT03583372|584061534|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
161839500|NCT03548064|584458506|FG002|Overall Study|Lost to Follow-up|0|||
161839501|NCT03548064|584458507|FG003|Overall Study|Lost to Follow-up|0|||
161732322|NCT03583372|584061535|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
161732323|NCT03583372|584061536|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
161732324|NCT03583372|584061537|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
161732325|NCT03583372|584061534|FG000|Overall Study|Did Not Receive Study Drug|0|||
161732326|NCT03583372|584061535|FG001|Overall Study|Did Not Receive Study Drug|1|||
161732327|NCT03583372|584061536|FG002|Overall Study|Did Not Receive Study Drug|0|||
161732328|NCT03583372|584061537|FG003|Overall Study|Did Not Receive Study Drug|0|||
161839502|NCT03548064|584458508|FG004|Overall Study|Lost to Follow-up|2|||
161732329|NCT03583372|584061534|FG000|Overall Study|Captured as Other in the Database|1|||
161732330|NCT03583372|584061535|FG001|Overall Study|Captured as Other in the Database|2|||
161732331|NCT03583372|584061536|FG002|Overall Study|Captured as Other in the Database|4|||
161732332|NCT03583372|584061537|FG003|Overall Study|Captured as Other in the Database|1|||
161732333|NCT02695524|584061538|FG000|Overall Study|Lost to Follow-up|3|||
161732334|NCT02695524|584061539|FG001|Overall Study|Lost to Follow-up|2|||
161732335|NCT02695524|584061538|FG000|Overall Study|Death|0|||
161732336|NCT02695524|584061539|FG001|Overall Study|Death|1|||
161732337|NCT00798655|584061542|FG000|Overall Study|Did not receive at least one dose of pan|2|||
161732338|NCT00174785|584061549|FG000|Overall Study|Adverse Event|293|||
161732339|NCT00174785|584061550|FG001|Overall Study|Adverse Event|191|||
161732340|NCT00174785|584061549|FG000|Overall Study|Protocol Violation|14|||
161732341|NCT00174785|584061550|FG001|Overall Study|Protocol Violation|14|||
161732342|NCT00174785|584061549|FG000|Overall Study|Withdrawal by Subject|173|||
161732343|NCT00174785|584061550|FG001|Overall Study|Withdrawal by Subject|175|||
161732344|NCT00174785|584061549|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
161732345|NCT00174785|584061550|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
161732346|NCT00174785|584061549|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
161732347|NCT00174785|584061550|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
161732348|NCT00174785|584061549|FG000|Overall Study|Other prohibited medication|5|||
161732349|NCT00174785|584061550|FG001|Overall Study|Other prohibited medication|3|||
161732350|NCT00174785|584061549|FG000|Overall Study|Family request|6|||
161732351|NCT00174785|584061550|FG001|Overall Study|Family request|8|||
161732352|NCT00174785|584061549|FG000|Overall Study|Not pre-specified/Not coded|56|||
161732353|NCT00174785|584061550|FG001|Overall Study|Not pre-specified/Not coded|70|||
161732354|NCT00120289|584061551|FG000|Overall Study|Death|96|||
161732355|NCT00120289|584061552|FG001|Overall Study|Death|82|||
161732356|NCT00120289|584061551|FG000|Overall Study|Lost to Follow-up|11|||
161732357|NCT00120289|584061552|FG001|Overall Study|Lost to Follow-up|14|||
161732358|NCT00120289|584061551|FG000|Overall Study|Withdrawal by Subject|14|||
161732359|NCT00120289|584061552|FG001|Overall Study|Withdrawal by Subject|13|||
161732360|NCT02179515|584061556|FG000|Overall Study|switched to alternative treatment|0|||
161732361|NCT02179515|584061557|FG001|Overall Study|switched to alternative treatment|1|||
161732362|NCT02179515|584061558|FG002|Overall Study|switched to alternative treatment|1|||
161732363|NCT02179515|584061556|FG000|Overall Study|Death|0|||
161732364|NCT02179515|584061557|FG001|Overall Study|Death|1|||
161732365|NCT02179515|584061558|FG002|Overall Study|Death|1|||
161732366|NCT02179515|584061556|FG000|Overall Study|refused further treatment|0|||
161732367|NCT02179515|584061557|FG001|Overall Study|refused further treatment|3|||
161732368|NCT02179515|584061558|FG002|Overall Study|refused further treatment|4|||
161732369|NCT02179515|584061556|FG000|Overall Study|Disease progression on study|2|||
161732370|NCT02179515|584061557|FG001|Overall Study|Disease progression on study|11|||
161732371|NCT02179515|584061558|FG002|Overall Study|Disease progression on study|8|||
161732372|NCT00782418|584061559|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
161732373|NCT00782418|584061560|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732374|NCT00782418|584061561|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732375|NCT00782418|584061562|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732376|NCT00782418|584061563|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732377|NCT00782418|584061564|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732378|NCT00782418|584061565|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732379|NCT00782418|584061559|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161732380|NCT00782418|584061560|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732381|NCT00782418|584061561|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732382|NCT00782418|584061562|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732383|NCT00782418|584061563|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161732384|NCT00782418|584061564|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161732385|NCT00782418|584061565|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732386|NCT01718509|584061566|FG000|Overall Study|Lost to Follow-up|18|||
161732387|NCT01718509|584061567|FG001|Overall Study|Lost to Follow-up|15|||
161732388|NCT01718509|584061566|FG000|Overall Study|Withdrawal by Subject|7|||
161732389|NCT01718509|584061567|FG001|Overall Study|Withdrawal by Subject|13|||
161732390|NCT01718509|584061566|FG000|Overall Study|Adverse Event|5|||
161732391|NCT01718509|584061567|FG001|Overall Study|Adverse Event|7|||
161732392|NCT01718509|584061566|FG000|Overall Study|Other|13|||
161732393|NCT01718509|584061567|FG001|Overall Study|Other|11|||
161732394|NCT01718509|584061566|FG000|Overall Study|Protocol Violation|4|||
161732395|NCT01718509|584061567|FG001|Overall Study|Protocol Violation|2|||
161732396|NCT01718509|584061566|FG000|Overall Study|Lack of Efficacy|1|||
161732397|NCT01718509|584061567|FG001|Overall Study|Lack of Efficacy|0|||
161839503|NCT03548064|584458509|FG005|Overall Study|Lost to Follow-up|0|||
161732398|NCT00238303|584061568|FG000|Overall Study|Withdrawal by Subject|11|||
161732399|NCT00238303|584061569|FG001|Overall Study|Withdrawal by Subject|1|||
161732400|NCT00238303|584061570|FG002|Overall Study|Withdrawal by Subject|2|||
161732401|NCT00238303|584061568|FG000|Overall Study|Death|1|||
161732402|NCT00238303|584061569|FG001|Overall Study|Death|0|||
161732403|NCT00238303|584061570|FG002|Overall Study|Death|1|||
161732404|NCT00238303|584061568|FG000|Overall Study|Other Medical Problems|2|||
161732405|NCT00238303|584061569|FG001|Overall Study|Other Medical Problems|0|||
161732406|NCT00238303|584061570|FG002|Overall Study|Other Medical Problems|2|||
161732407|NCT00238303|584061568|FG000|Overall Study|Poor tolerance of study treatment|1|||
161732408|NCT00238303|584061569|FG001|Overall Study|Poor tolerance of study treatment|0|||
161732409|NCT00238303|584061570|FG002|Overall Study|Poor tolerance of study treatment|1|||
161732410|NCT00238303|584061568|FG000|Overall Study|Adverse Event|0|||
161732411|NCT00238303|584061569|FG001|Overall Study|Adverse Event|1|||
161732412|NCT00238303|584061570|FG002|Overall Study|Adverse Event|3|||
161732413|NCT04507867|584061577|FG000|Overall Study|Death|7|||
161732414|NCT04507867|584061578|FG001|Overall Study|Death|1|||
161732415|NCT01860534|584061581|FG000|ROP #1|Needed treatment for ROP|0|||
161732416|NCT01860534|584061582|FG001|ROP #1|Needed treatment for ROP|1|||
161732417|NCT01860534|584061581|FG000|ROP #2|discharged prior to ROP #2|1|||
161732418|NCT01860534|584061582|FG001|ROP #2|discharged prior to ROP #2|0|||
161732419|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
161732420|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732421|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732422|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732423|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732424|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732425|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732426|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732427|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732428|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
161732429|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732430|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732431|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732432|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732433|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732434|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732435|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732436|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732437|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
161732438|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732439|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732440|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732441|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732442|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732443|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732444|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732445|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732446|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
161732447|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732448|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732449|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732450|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732451|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732452|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
161839504|NCT03548064|584458510|FG006|Overall Study|Lost to Follow-up|0|||
161839505|NCT03548064|584458511|FG007|Overall Study|Lost to Follow-up|0|||
161839506|NCT03548064|584458504|FG000|Overall Study|Covid-19 Pandemic|0|||
161839507|NCT03548064|584458505|FG001|Overall Study|Covid-19 Pandemic|0|||
161839508|NCT03548064|584458506|FG002|Overall Study|Covid-19 Pandemic|0|||
161732453|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732454|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732455|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
161732456|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732457|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732458|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732459|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161839509|NCT03548064|584458507|FG003|Overall Study|Covid-19 Pandemic|0|||
161839510|NCT03548064|584458508|FG004|Overall Study|Covid-19 Pandemic|10|||
161839511|NCT03548064|584458509|FG005|Overall Study|Covid-19 Pandemic|3|||
161732460|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732461|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732462|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732463|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732464|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
161732465|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732466|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732467|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732468|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732469|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732470|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732471|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732472|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732473|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Other|8|||
161732474|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Other|0|||
161732475|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Other|0|||
161732476|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Other|0|||
161732477|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Other|0|||
161732478|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Other|0|||
161732479|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Other|0|||
161732480|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Other|0|||
161732481|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Other|0|||
161732482|NCT02175771|584061588|FG000|Treatment Period|Adverse Event|0|||
161732483|NCT02175771|584061589|FG001|Treatment Period|Adverse Event|2|||
161732484|NCT02175771|584061590|FG002|Treatment Period|Adverse Event|1|||
161732485|NCT02175771|584061591|FG003|Treatment Period|Adverse Event|1|||
161732486|NCT02175771|584061592|FG004|Treatment Period|Adverse Event|1|||
161732487|NCT02175771|584061593|FG005|Treatment Period|Adverse Event|3|||
161732488|NCT02175771|584061594|FG006|Treatment Period|Adverse Event|2|||
161732489|NCT02175771|584061595|FG007|Treatment Period|Adverse Event|0|||
161732490|NCT02175771|584061596|FG008|Treatment Period|Adverse Event|1|||
161732491|NCT02175771|584061588|FG000|Treatment Period|Withdrawal by Subject|0|||
161732492|NCT02175771|584061589|FG001|Treatment Period|Withdrawal by Subject|9|||
161732493|NCT02175771|584061590|FG002|Treatment Period|Withdrawal by Subject|3|||
161732494|NCT02175771|584061591|FG003|Treatment Period|Withdrawal by Subject|6|||
161732495|NCT02175771|584061592|FG004|Treatment Period|Withdrawal by Subject|2|||
161732496|NCT02175771|584061593|FG005|Treatment Period|Withdrawal by Subject|4|||
161732497|NCT02175771|584061594|FG006|Treatment Period|Withdrawal by Subject|2|||
161732498|NCT02175771|584061595|FG007|Treatment Period|Withdrawal by Subject|9|||
161732499|NCT02175771|584061596|FG008|Treatment Period|Withdrawal by Subject|2|||
161732500|NCT02175771|584061588|FG000|Treatment Period|Noncompliance|0|||
161732501|NCT02175771|584061589|FG001|Treatment Period|Noncompliance|1|||
161732502|NCT02175771|584061590|FG002|Treatment Period|Noncompliance|2|||
161732503|NCT02175771|584061591|FG003|Treatment Period|Noncompliance|0|||
161732504|NCT02175771|584061592|FG004|Treatment Period|Noncompliance|0|||
161732505|NCT02175771|584061593|FG005|Treatment Period|Noncompliance|0|||
161732506|NCT02175771|584061594|FG006|Treatment Period|Noncompliance|0|||
161732507|NCT02175771|584061595|FG007|Treatment Period|Noncompliance|0|||
161732508|NCT02175771|584061596|FG008|Treatment Period|Noncompliance|1|||
161732509|NCT02175771|584061588|FG000|Treatment Period|Protocol Violation|0|||
161732510|NCT02175771|584061589|FG001|Treatment Period|Protocol Violation|0|||
161732511|NCT02175771|584061590|FG002|Treatment Period|Protocol Violation|0|||
161732512|NCT02175771|584061591|FG003|Treatment Period|Protocol Violation|0|||
161732513|NCT02175771|584061592|FG004|Treatment Period|Protocol Violation|0|||
161732514|NCT02175771|584061593|FG005|Treatment Period|Protocol Violation|0|||
161732515|NCT02175771|584061594|FG006|Treatment Period|Protocol Violation|0|||
161732516|NCT02175771|584061595|FG007|Treatment Period|Protocol Violation|1|||
161732517|NCT02175771|584061596|FG008|Treatment Period|Protocol Violation|0|||
161732518|NCT02175771|584061588|FG000|Treatment Period|Disease progression|0|||
161732519|NCT02175771|584061589|FG001|Treatment Period|Disease progression|0|||
161732520|NCT02175771|584061590|FG002|Treatment Period|Disease progression|0|||
161732521|NCT02175771|584061591|FG003|Treatment Period|Disease progression|0|||
161732522|NCT02175771|584061592|FG004|Treatment Period|Disease progression|0|||
161732523|NCT02175771|584061593|FG005|Treatment Period|Disease progression|0|||
161732524|NCT02175771|584061594|FG006|Treatment Period|Disease progression|0|||
161732525|NCT02175771|584061595|FG007|Treatment Period|Disease progression|2|||
161732526|NCT02175771|584061596|FG008|Treatment Period|Disease progression|0|||
161732527|NCT02175771|584061588|FG000|Treatment Period|Lost to Follow-up|0|||
161732528|NCT02175771|584061589|FG001|Treatment Period|Lost to Follow-up|3|||
161732529|NCT02175771|584061590|FG002|Treatment Period|Lost to Follow-up|1|||
161732530|NCT02175771|584061591|FG003|Treatment Period|Lost to Follow-up|3|||
161732531|NCT02175771|584061592|FG004|Treatment Period|Lost to Follow-up|1|||
161732532|NCT02175771|584061593|FG005|Treatment Period|Lost to Follow-up|2|||
161732533|NCT02175771|584061594|FG006|Treatment Period|Lost to Follow-up|1|||
161732534|NCT02175771|584061595|FG007|Treatment Period|Lost to Follow-up|2|||
161732535|NCT02175771|584061596|FG008|Treatment Period|Lost to Follow-up|2|||
161732536|NCT02175771|584061588|FG000|Treatment Period|Lack of Efficacy|0|||
161732537|NCT02175771|584061589|FG001|Treatment Period|Lack of Efficacy|0|||
161732538|NCT02175771|584061590|FG002|Treatment Period|Lack of Efficacy|0|||
161732539|NCT02175771|584061591|FG003|Treatment Period|Lack of Efficacy|0|||
161732540|NCT02175771|584061592|FG004|Treatment Period|Lack of Efficacy|0|||
161732541|NCT02175771|584061593|FG005|Treatment Period|Lack of Efficacy|1|||
161732542|NCT02175771|584061594|FG006|Treatment Period|Lack of Efficacy|0|||
161732543|NCT02175771|584061595|FG007|Treatment Period|Lack of Efficacy|1|||
161732544|NCT02175771|584061596|FG008|Treatment Period|Lack of Efficacy|0|||
161732545|NCT02175771|584061588|FG000|Treatment Period|Other|0|||
161732546|NCT02175771|584061589|FG001|Treatment Period|Other|1|||
161732547|NCT02175771|584061590|FG002|Treatment Period|Other|0|||
161732548|NCT02175771|584061591|FG003|Treatment Period|Other|3|||
161732549|NCT02175771|584061592|FG004|Treatment Period|Other|1|||
161732550|NCT02175771|584061593|FG005|Treatment Period|Other|0|||
161732551|NCT02175771|584061594|FG006|Treatment Period|Other|0|||
161732552|NCT02175771|584061595|FG007|Treatment Period|Other|2|||
161732553|NCT02175771|584061596|FG008|Treatment Period|Other|0|||
161732554|NCT03364673|584061597|FG000|Overall Study|Withdrawal by Subject|2|||
161732555|NCT03364673|584061597|FG000|Overall Study|Injury unrelated to study|3|||
161732556|NCT00779324|584061598|FG000|Overall Study|Lost to Follow-up|2|||
161732557|NCT00779324|584061599|FG001|Overall Study|Lost to Follow-up|1|||
161732558|NCT00779324|584061598|FG000|Overall Study|Withdrawal by Subject|4|||
161732559|NCT00779324|584061599|FG001|Overall Study|Withdrawal by Subject|2|||
161732560|NCT00779324|584061598|FG000|Overall Study|Missed visit|1|||
161732561|NCT00779324|584061599|FG001|Overall Study|Missed visit|1|||
161732562|NCT02207556|584061600|FG000|Overall Study|Physician Decision|1|||
161732563|NCT02207556|584061601|FG001|Overall Study|Physician Decision|0|||
161732564|NCT02207556|584061600|FG000|Overall Study|Withdrawal by Subject|1|||
161732565|NCT02207556|584061601|FG001|Overall Study|Withdrawal by Subject|0|||
161732566|NCT02207556|584061600|FG000|Overall Study|Death|0|||
161732567|NCT02207556|584061601|FG001|Overall Study|Death|5|||
161732568|NCT03558555|584061602|FG000|Overall Study|Lost to Follow-up|2|||
161732569|NCT03558555|584061603|FG001|Overall Study|Lost to Follow-up|1|||
161732570|NCT00194025|584061604|FG000|Overall Study|Adverse Event|1|||
161732571|NCT00194025|584061604|FG000|Overall Study|non-adherence with study medication|4|||
161732572|NCT01766336|584061605|FG000|Overall Study|Adverse Event|11|||
161732573|NCT01766336|584061606|FG001|Overall Study|Adverse Event|8|||
161839512|NCT03548064|584458510|FG006|Overall Study|Covid-19 Pandemic|0|||
161839513|NCT03548064|584458511|FG007|Overall Study|Covid-19 Pandemic|0|||
161732574|NCT01766336|584061605|FG000|Overall Study|Death|4|||
161732575|NCT01766336|584061606|FG001|Overall Study|Death|3|||
161732576|NCT01766336|584061605|FG000|Overall Study|Lost to Follow-up|1|||
161732577|NCT01766336|584061606|FG001|Overall Study|Lost to Follow-up|3|||
161732578|NCT01766336|584061605|FG000|Overall Study|Physician Decision|4|||
161732579|NCT01766336|584061606|FG001|Overall Study|Physician Decision|2|||
161732580|NCT01766336|584061605|FG000|Overall Study|Protocol Violation|0|||
161732581|NCT01766336|584061606|FG001|Overall Study|Protocol Violation|1|||
161732582|NCT01766336|584061605|FG000|Overall Study|Sponsor Decision|52|||
161732583|NCT01766336|584061606|FG001|Overall Study|Sponsor Decision|43|||
161732584|NCT01766336|584061605|FG000|Overall Study|Withdrawal by Subject|18|||
161839514|NCT06077487|584458514|FG000|Overall Study|Withdrawal by Subject|0|||
161732585|NCT01766336|584061606|FG001|Overall Study|Withdrawal by Subject|15|||
161732586|NCT03029650|584061607|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
161732587|NCT03029650|584061608|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
161732588|NCT03029650|584061607|FG000|Washout (1 Week)|Physician Decision|0|||
161732589|NCT03029650|584061608|FG001|Washout (1 Week)|Physician Decision|1|||
161732590|NCT01814800|584061611|FG000|Overall Study|Adverse Event|2|||
161732591|NCT01814800|584061611|FG000|Overall Study|Pregnancy|1|||
161732592|NCT01814800|584061611|FG000|Overall Study|Sponsor decision|1|||
161732593|NCT01814800|584061611|FG000|Overall Study|Subject relocation|1|||
161732594|NCT02402218|584061612|FG000|Overall Study|Did not pickup study medication|12|||
161732595|NCT02402218|584061613|FG001|Overall Study|Did not pickup study medication|9|||
161732596|NCT02402218|584061614|FG002|Overall Study|Did not pickup study medication|13|||
161732597|NCT02402218|584061612|FG000|Overall Study|Lack of Efficacy|0|||
161732598|NCT02402218|584061613|FG001|Overall Study|Lack of Efficacy|1|||
161732599|NCT02402218|584061614|FG002|Overall Study|Lack of Efficacy|1|||
161732600|NCT02402218|584061612|FG000|Overall Study|Death|1|||
161732601|NCT02402218|584061613|FG001|Overall Study|Death|0|||
161732602|NCT02402218|584061614|FG002|Overall Study|Death|0|||
161732603|NCT02402218|584061612|FG000|Overall Study|Reinfection|0|||
161732604|NCT02402218|584061613|FG001|Overall Study|Reinfection|0|||
161732605|NCT02402218|584061614|FG002|Overall Study|Reinfection|1|||
161732606|NCT02402218|584061612|FG000|Overall Study|Adverse Event|0|||
161732607|NCT02402218|584061613|FG001|Overall Study|Adverse Event|2|||
161732608|NCT02402218|584061614|FG002|Overall Study|Adverse Event|1|||
161732609|NCT02402218|584061612|FG000|Overall Study|Withdrawal by Subject|1|||
161732610|NCT02402218|584061613|FG001|Overall Study|Withdrawal by Subject|1|||
161732611|NCT02402218|584061614|FG002|Overall Study|Withdrawal by Subject|1|||
161732612|NCT03827473|584061615|FG000|Overall Study|Withdrawal by Subject|1|||
161732613|NCT03827473|584061616|FG001|Overall Study|Withdrawal by Subject|0|||
161732614|NCT04436822|584061617|FG000|Overall Study|Physician Decision|2|||
161732615|NCT04436822|584061618|FG001|Overall Study|Physician Decision|0|||
161732616|NCT04436822|584061617|FG000|Overall Study|Sponsor request|1|||
161732617|NCT04436822|584061618|FG001|Overall Study|Sponsor request|0|||
161732618|NCT04436822|584061617|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161732619|NCT04436822|584061618|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161732620|NCT04436822|584061617|FG000|Overall Study|Unsuccessful procedure|0|||
161732621|NCT04436822|584061618|FG001|Overall Study|Unsuccessful procedure|1|||
161732622|NCT04436822|584061617|FG000|Overall Study|Withdrawal due to Covid-19|8|||
161732623|NCT04436822|584061618|FG001|Overall Study|Withdrawal due to Covid-19|1|||
161732624|NCT04436822|584061617|FG000|Overall Study|Withdrawal by Subject|1|||
161732625|NCT04436822|584061618|FG001|Overall Study|Withdrawal by Subject|0|||
161732626|NCT04436822|584061617|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
161732627|NCT04436822|584061618|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
161732628|NCT03807739|584061619|FG000|Overall Study|Adverse Event|1|||
161732629|NCT03807739|584061620|FG001|Overall Study|Adverse Event|0|||
161732630|NCT03807739|584061621|FG002|Overall Study|Adverse Event|0|||
161732631|NCT03807739|584061622|FG003|Overall Study|Adverse Event|0|||
161732632|NCT03807739|584061619|FG000|Overall Study|Withdrawal by Subject|1|||
161732633|NCT03807739|584061620|FG001|Overall Study|Withdrawal by Subject|0|||
161732634|NCT03807739|584061621|FG002|Overall Study|Withdrawal by Subject|0|||
161732635|NCT03807739|584061622|FG003|Overall Study|Withdrawal by Subject|0|||
161732636|NCT00488033|584061632|FG000|Overall Study|Withdrawal by Subject|1|||
161732637|NCT00488033|584061633|FG001|Overall Study|Withdrawal by Subject|0|||
161732638|NCT00369668|584061634|FG000|Overall Study|Lack of Efficacy|4|||
161732639|NCT00369668|584061635|FG001|Overall Study|Lack of Efficacy|5|||
161732640|NCT00369668|584061636|FG002|Overall Study|Lack of Efficacy|7|||
161732641|NCT00303108|584061639|FG000|Overall Study|Adverse Event|5|||
161732642|NCT00303108|584061640|FG001|Overall Study|Adverse Event|6|||
161732643|NCT00303108|584061641|FG002|Overall Study|Adverse Event|7|||
161732644|NCT00303108|584061639|FG000|Overall Study|Patient Request|4|||
161732645|NCT00303108|584061640|FG001|Overall Study|Patient Request|2|||
161732646|NCT00303108|584061641|FG002|Overall Study|Patient Request|8|||
161732647|NCT00303108|584061639|FG000|Overall Study|Failed Entry|1|||
161732648|NCT00303108|584061640|FG001|Overall Study|Failed Entry|0|||
161732649|NCT00303108|584061641|FG002|Overall Study|Failed Entry|1|||
161732650|NCT00303108|584061639|FG000|Overall Study|ineligible|2|||
161732651|NCT00303108|584061640|FG001|Overall Study|ineligible|1|||
161732652|NCT00303108|584061641|FG002|Overall Study|ineligible|0|||
161732653|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
161732654|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
161732655|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
161732656|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
161732657|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
161732658|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
161732659|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
161732660|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
161732661|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
161732662|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
161732663|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
161732664|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
161732665|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
161732666|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
161732667|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
161732668|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
161732669|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161732670|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161732671|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
161732672|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
161732673|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
161732674|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
161732675|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
161732676|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
161732677|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
161732678|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
161732679|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
161732680|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
161732681|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
161732682|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
161732683|NCT02427477|584061645|FG000|Period 1|Adverse Event|1|||
161732684|NCT02427477|584061646|FG001|Period 1|Adverse Event|0|||
161732685|NCT02435277|584061647|FG000|Overall Study|Adverse Event|1|||
161732686|NCT02435277|584061648|FG001|Overall Study|Adverse Event|1|||
161732687|NCT02435277|584061649|FG002|Overall Study|Adverse Event|0|||
161732688|NCT02435277|584061650|FG003|Overall Study|Adverse Event|0|||
161732689|NCT02435277|584061647|FG000|Overall Study|Withdrawal by Subject|1|||
161732690|NCT02435277|584061648|FG001|Overall Study|Withdrawal by Subject|0|||
161732691|NCT02435277|584061649|FG002|Overall Study|Withdrawal by Subject|0|||
161732692|NCT02435277|584061650|FG003|Overall Study|Withdrawal by Subject|0|||
161732693|NCT00444626|584061653|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
161732694|NCT00444626|584061653|FG000|Initial Treatment Period|Adverse Event|1|||
161732695|NCT00444626|584061653|FG000|Initial Treatment Period|Lost to Follow-up|9|||
161732696|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
161732697|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
161732698|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
161732699|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
161732700|NCT00008138|584061654|FG000|Interval Debulking|Withdrawal by Subject|2|||
161732701|NCT00008138|584061654|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
161732702|NCT00008138|584061654|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
161732703|NCT00008138|584061654|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
161732704|NCT03213626|584061655|FG000|Overall Study|Adverse Event|1|||
161732705|NCT03213626|584061655|FG000|Overall Study|Progressive Disease|6|||
161732706|NCT02635737|584061656|FG000|Overall Study|Protocol Violation|1|||
161732707|NCT01005732|584061657|FG000|Overall Study|Lost to Follow-up|10|||
161732708|NCT01005732|584061657|FG000|Overall Study|Death|1|||
161732709|NCT01552928|584061658|FG000|Period 3|Adverse Event|0|||
161732710|NCT01552928|584061659|FG001|Period 3|Adverse Event|0|||
161732711|NCT01552928|584061660|FG002|Period 3|Adverse Event|1|||
161732712|NCT01552928|584061661|FG003|Period 3|Adverse Event|0|||
161732713|NCT02349789|584063597|FG000|Overall Study|Withdrawal by Subject|2|||
161732714|NCT00786032|584063600|FG000|Overall Study|Death|4|||
161732715|NCT00786032|584063600|FG000|Overall Study|Withdrawal by Subject|14|||
161732716|NCT00786032|584063600|FG000|Overall Study|Did not complete in the timeframe|6|||
161732717|NCT02457182|584063601|FG000|Overall Study|Lost to Follow-up|1|||
161732718|NCT02457182|584063602|FG001|Overall Study|Lost to Follow-up|0|||
161732719|NCT00424528|584063605|FG000|Overall Study|Adverse Event|2|||
161732720|NCT00424528|584063606|FG001|Overall Study|Adverse Event|1|||
161732721|NCT00424528|584063607|FG002|Overall Study|Adverse Event|2|||
161732722|NCT00424528|584063605|FG000|Overall Study|Protocol Violation|1|||
161732723|NCT00424528|584063606|FG001|Overall Study|Protocol Violation|1|||
161732724|NCT00424528|584063607|FG002|Overall Study|Protocol Violation|0|||
161732725|NCT00424528|584063605|FG000|Overall Study|Lost to Follow-up|0|||
161732726|NCT00424528|584063606|FG001|Overall Study|Lost to Follow-up|1|||
161732727|NCT00424528|584063607|FG002|Overall Study|Lost to Follow-up|0|||
161732728|NCT00424528|584063605|FG000|Overall Study|noncompliance with study requirements|2|||
161732729|NCT00424528|584063606|FG001|Overall Study|noncompliance with study requirements|1|||
161732730|NCT00424528|584063607|FG002|Overall Study|noncompliance with study requirements|2|||
161732731|NCT01009983|584063611|FG000|Overall Study|necessary scans not completed|1|||
161732732|NCT03137121|584063620|FG000|Overall Study|Withdrawal by Subject|0|||
161732733|NCT03137121|584063621|FG001|Overall Study|Withdrawal by Subject|1|||
161732734|NCT02871401|584063622|FG000|Overall Study|Adverse Event|1|||
161732735|NCT02871401|584063623|FG001|Overall Study|Adverse Event|0|||
161732736|NCT02282982|584063624|FG000|Overall Study|Lost to Follow-up|15|||
161732737|NCT02282982|584063624|FG000|Overall Study|Withdrew consent|2|||
161732738|NCT02282982|584063624|FG000|Overall Study|Death|4|||
161732739|NCT02282982|584063624|FG000|Overall Study|Lack of product|156|||
161732740|NCT02282982|584063624|FG000|Overall Study|Palivizumab is ended|11|||
161732741|NCT02282982|584063624|FG000|Overall Study|Other, not specified|18|||
161732742|NCT02006667|584063625|FG000|Overall Study|Adverse Event|3|||
161732743|NCT02006667|584063625|FG000|Overall Study|Death|2|||
161732744|NCT02006667|584063625|FG000|Overall Study|Withdrawal by Subject|1|||
161732745|NCT02939937|584063626|FG000|Overall Study|Adverse Event|5|||
161732746|NCT02939937|584063627|FG001|Overall Study|Adverse Event|0|||
161732747|NCT02939937|584063626|FG000|Overall Study|Lost to Follow-up|1|||
161732748|NCT02939937|584063627|FG001|Overall Study|Lost to Follow-up|3|||
161732749|NCT00568958|584063629|FG000|Allocation|Withdrawal by Subject|7|||
161732750|NCT00568958|584063630|FG001|Allocation|Withdrawal by Subject|3|||
161732751|NCT00568958|584063629|FG000|Allocation|Physician Decision|2|||
161732752|NCT00568958|584063630|FG001|Allocation|Physician Decision|0|||
161732753|NCT00568958|584063629|FG000|Follow-Up|Withdrawal by Subject|6|||
161732754|NCT00568958|584063630|FG001|Follow-Up|Withdrawal by Subject|6|||
161732755|NCT00568958|584063629|FG000|Follow-Up|Physician Decision|1|||
161732756|NCT00568958|584063630|FG001|Follow-Up|Physician Decision|1|||
161732757|NCT00568958|584063629|FG000|Follow-Up|Family Emergency|1|||
161732758|NCT00568958|584063630|FG001|Follow-Up|Family Emergency|0|||
161732759|NCT00568958|584063629|FG000|Follow-Up|Adverse Event|1|||
161732760|NCT00568958|584063630|FG001|Follow-Up|Adverse Event|0|||
161732761|NCT05254613|584063636|FG000|Overall Study|Lost to Follow-up|0|||
161732762|NCT05254613|584063637|FG001|Overall Study|Lost to Follow-up|0|||
161732763|NCT05254613|584063638|FG002|Overall Study|Lost to Follow-up|1|||
161732764|NCT02387372|584063639|FG000|Overall Study|Not Treated|1|||
161732765|NCT02387372|584063640|FG001|Overall Study|Not Treated|0|||
161732766|NCT01911845|584063642|FG000|Overall Study|Adverse Event|2|||
161732767|NCT01911845|584063642|FG000|Overall Study|Lost to Follow-up|1|||
161732768|NCT01911845|584063642|FG000|Overall Study|Other (not specified)|3|||
161732769|NCT01576016|584063643|FG000|Lead Safety|Death|132|||
161732770|NCT01576016|584063644|FG001|Lead Safety|Death|0|||
161732771|NCT01576016|584063643|FG000|Lead Safety|Withdrawal by Subject|81|||
161732772|NCT01576016|584063644|FG001|Lead Safety|Withdrawal by Subject|0|||
161732773|NCT01576016|584063643|FG000|Lead Safety|System Explanted without Replacement|24|||
161732774|NCT01576016|584063644|FG001|Lead Safety|System Explanted without Replacement|0|||
161732775|NCT01576016|584063643|FG000|Lead Safety|Physician Decision|14|||
161732776|NCT01576016|584063644|FG001|Lead Safety|Physician Decision|0|||
161732777|NCT01576016|584063643|FG000|Lead Safety|Lost to Follow-up|13|||
161732778|NCT01576016|584063644|FG001|Lead Safety|Lost to Follow-up|0|||
161732779|NCT01576016|584063643|FG000|Lead Safety|Unsuccessful implant|2|||
161732780|NCT01576016|584063644|FG001|Lead Safety|Unsuccessful implant|0|||
161732781|NCT01576016|584063643|FG000|Lead Safety|Sponsor request|1|||
161732782|NCT01576016|584063644|FG001|Lead Safety|Sponsor request|0|||
161732783|NCT01576016|584063643|FG000|Lead Safety|Device replaced with CRT-D|1|||
161732784|NCT01576016|584063644|FG001|Lead Safety|Device replaced with CRT-D|0|||
161732785|NCT01576016|584063643|FG000|Lead Safety|Patient on Palliative Care|1|||
161732786|NCT01576016|584063644|FG001|Lead Safety|Patient on Palliative Care|0|||
161732787|NCT01576016|584063643|FG000|Lead Safety|Patient noncompliance|1|||
161732788|NCT01576016|584063644|FG001|Lead Safety|Patient noncompliance|0|||
161839515|NCT06077487|584458515|FG001|Overall Study|Withdrawal by Subject|1|||
161839516|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
161839517|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
161839518|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
161839519|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
161839520|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
161732789|NCT01576016|584063643|FG000|Lead Safety|Too far from study site|1|||
161732790|NCT01576016|584063644|FG001|Lead Safety|Too far from study site|0|||
161732791|NCT01576016|584063643|FG000|Lead Safety|System deactivated|1|||
161732792|NCT01576016|584063644|FG001|Lead Safety|System deactivated|0|||
161732793|NCT01576016|584063643|FG000|Lead Safety|Patient no longer followed by study PI|1|||
161732794|NCT01576016|584063644|FG001|Lead Safety|Patient no longer followed by study PI|0|||
161732795|NCT01576016|584063643|FG000|MRI Safety|Withdrawal by Subject|0|||
161732796|NCT01576016|584063644|FG001|MRI Safety|Withdrawal by Subject|10|||
161732797|NCT01576016|584063643|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
161732798|NCT01576016|584063644|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
161732799|NCT01576016|584063643|FG000|MRI Safety|Has not yet completed MRI scan|0|||
161732800|NCT01576016|584063644|FG001|MRI Safety|Has not yet completed MRI scan|56|||
161732801|NCT01576016|584063643|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
161732802|NCT01576016|584063644|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
161732803|NCT01774344|584063645|FG000|Overall Study|Withdrawal by Subject|3|||
161732804|NCT01774344|584063646|FG001|Overall Study|Withdrawal by Subject|10|||
161732805|NCT01774344|584063645|FG000|Overall Study|Protocol Violation|0|||
161732806|NCT01774344|584063646|FG001|Overall Study|Protocol Violation|1|||
161732807|NCT01774344|584063645|FG000|Overall Study|Lost to Follow-up|4|||
161732808|NCT01774344|584063646|FG001|Overall Study|Lost to Follow-up|10|||
161732809|NCT01774344|584063645|FG000|Overall Study|End of survival follow-up not available|2|||
161732810|NCT01774344|584063646|FG001|Overall Study|End of survival follow-up not available|2|||
161732811|NCT01774344|584063645|FG000|Overall Study|Data collection finished|4|||
161732812|NCT01774344|584063646|FG001|Overall Study|Data collection finished|14|||
161732813|NCT01774344|584063645|FG000|Overall Study|Other|0|||
161732814|NCT01774344|584063646|FG001|Overall Study|Other|1|||
161732815|NCT01774344|584063645|FG000|Overall Study|Did not enter Survival Follow up|49|||
161732816|NCT01774344|584063646|FG001|Overall Study|Did not enter Survival Follow up|83|||
161732817|NCT00502320|584063655|FG000|Overall Study|Lost to Follow-up|1|||
161732818|NCT00502320|584063656|FG001|Overall Study|Lost to Follow-up|1|||
161732819|NCT00502320|584063655|FG000|Overall Study|Withdrew Consent|1|||
161732820|NCT00502320|584063656|FG001|Overall Study|Withdrew Consent|0|||
161732821|NCT00502320|584063655|FG000|Overall Study|No longer met criteria|1|||
161732822|NCT00502320|584063656|FG001|Overall Study|No longer met criteria|0|||
161732823|NCT00502320|584063655|FG000|Overall Study|Screen Failure|0|||
161732824|NCT00502320|584063656|FG001|Overall Study|Screen Failure|1|||
161732825|NCT00502320|584063655|FG000|Overall Study|Adverse Event|3|||
161732826|NCT00502320|584063656|FG001|Overall Study|Adverse Event|5|||
161732827|NCT00543569|584063660|FG000|Overall Study|Death|2|||
161732828|NCT00543569|584063661|FG001|Overall Study|Death|2|||
161732829|NCT00543569|584063662|FG002|Overall Study|Death|3|||
161732830|NCT00543569|584063663|FG003|Overall Study|Death|1|||
161732831|NCT00543569|584063660|FG000|Overall Study|Lost to Follow-up|0|||
161732832|NCT00543569|584063661|FG001|Overall Study|Lost to Follow-up|0|||
161732833|NCT00543569|584063662|FG002|Overall Study|Lost to Follow-up|1|||
161732834|NCT00543569|584063663|FG003|Overall Study|Lost to Follow-up|1|||
161732835|NCT00543569|584063660|FG000|Overall Study|Miscellaneous Reasons|7|||
161732836|NCT00543569|584063661|FG001|Overall Study|Miscellaneous Reasons|3|||
161732837|NCT00543569|584063662|FG002|Overall Study|Miscellaneous Reasons|11|||
161732838|NCT00543569|584063663|FG003|Overall Study|Miscellaneous Reasons|4|||
161732839|NCT00543569|584063660|FG000|Overall Study|Randomized but never received study drug|3|||
161732840|NCT00543569|584063661|FG001|Overall Study|Randomized but never received study drug|3|||
161732841|NCT00543569|584063662|FG002|Overall Study|Randomized but never received study drug|5|||
161732842|NCT00543569|584063663|FG003|Overall Study|Randomized but never received study drug|3|||
161732843|NCT00862849|584063665|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732844|NCT00862849|584063666|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
161732845|NCT00862849|584063667|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732846|NCT00862849|584063668|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732847|NCT00862849|584063669|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732848|NCT00862849|584063670|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732849|NCT00862849|584063665|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732850|NCT00862849|584063666|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
161732851|NCT00862849|584063667|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732852|NCT00862849|584063668|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732853|NCT00862849|584063669|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732854|NCT00862849|584063670|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732855|NCT00617409|584063671|FG000|Overall Study|Withdrawal by Subject|4|||
161732856|NCT00617409|584063672|FG001|Overall Study|Withdrawal by Subject|1|||
161732857|NCT00617409|584063673|FG002|Overall Study|Withdrawal by Subject|2|||
161732858|NCT00617409|584063671|FG000|Overall Study|Adverse Event|0|||
161732859|NCT00617409|584063672|FG001|Overall Study|Adverse Event|2|||
161732860|NCT00617409|584063673|FG002|Overall Study|Adverse Event|3|||
161732861|NCT00617409|584063671|FG000|Overall Study|Disease Progression|8|||
161732862|NCT00617409|584063672|FG001|Overall Study|Disease Progression|8|||
161732863|NCT00617409|584063673|FG002|Overall Study|Disease Progression|18|||
161732864|NCT00617409|584063671|FG000|Overall Study|Death|3|||
161732865|NCT00617409|584063672|FG001|Overall Study|Death|5|||
161732866|NCT00617409|584063673|FG002|Overall Study|Death|4|||
161732867|NCT00617409|584063671|FG000|Overall Study|Alternative Therapy|1|||
161732868|NCT00617409|584063672|FG001|Overall Study|Alternative Therapy|2|||
161732869|NCT00617409|584063673|FG002|Overall Study|Alternative Therapy|0|||
161732870|NCT02124707|584063682|FG000|Overall Study|Adverse Event|5|||
161732871|NCT02124707|584063682|FG000|Overall Study|Physician Decision|1|||
161732872|NCT02124707|584063682|FG000|Overall Study|Death|1|||
161732873|NCT01363713|584063693|FG000|Overall Study|Adverse Event|1|||
161732874|NCT01363713|584063693|FG000|Overall Study|Protocol Violation|3|||
161732875|NCT01363713|584063693|FG000|Overall Study|Withdrawal by Subject|2|||
161732876|NCT01199055|584063694|FG000|Overall Study|Death|0|||
161732877|NCT01199055|584063695|FG001|Overall Study|Death|1|||
161732878|NCT01199055|584063696|FG002|Overall Study|Death|0|||
161732879|NCT01199055|584063694|FG000|Overall Study|Physician Decision|0|||
161732880|NCT01199055|584063695|FG001|Overall Study|Physician Decision|1|||
161732881|NCT01199055|584063696|FG002|Overall Study|Physician Decision|1|||
161732882|NCT01199055|584063694|FG000|Overall Study|Progressive disease|2|||
161732883|NCT01199055|584063695|FG001|Overall Study|Progressive disease|1|||
161732884|NCT01199055|584063696|FG002|Overall Study|Progressive disease|2|||
161732885|NCT01199055|584063694|FG000|Overall Study|Withdrawal by Subject|0|||
161732886|NCT01199055|584063695|FG001|Overall Study|Withdrawal by Subject|0|||
161732887|NCT01199055|584063696|FG002|Overall Study|Withdrawal by Subject|1|||
161732888|NCT00511342|584063697|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
161732889|NCT00511342|584063698|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
161732890|NCT00511342|584063697|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
161732891|NCT00511342|584063698|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
161732892|NCT00511342|584063697|FG000|Overall Study|Pregnancy|0|||
161732893|NCT00511342|584063698|FG001|Overall Study|Pregnancy|1|||
161732894|NCT00511342|584063697|FG000|Overall Study|Pregnancy wish|0|||
161732895|NCT00511342|584063698|FG001|Overall Study|Pregnancy wish|1|||
161732896|NCT00511342|584063697|FG000|Overall Study|Lost to Follow-up|1|||
161732897|NCT00511342|584063698|FG001|Overall Study|Lost to Follow-up|5|||
161732898|NCT00511342|584063697|FG000|Overall Study|Other Reason|2|||
161732899|NCT00511342|584063698|FG001|Overall Study|Other Reason|2|||
161732900|NCT02432040|584063699|FG000|Overall Study|Lack of Efficacy|3|||
161732901|NCT02432040|584063700|FG001|Overall Study|Lack of Efficacy|0|||
161732902|NCT02432040|584063699|FG000|Overall Study|Lost to Follow-up|4|||
161732903|NCT02432040|584063700|FG001|Overall Study|Lost to Follow-up|5|||
161732904|NCT02432040|584063699|FG000|Overall Study|Physician Decision|1|||
161732905|NCT02432040|584063700|FG001|Overall Study|Physician Decision|1|||
161732906|NCT00718666|584063701|FG000|Booster Phase Year 5|No active participation request|0|||
161732907|NCT00718666|584063702|FG001|Booster Phase Year 5|No active participation request|0|||
161732908|NCT00718666|584063703|FG002|Booster Phase Year 5|No active participation request|1|||
161732909|NCT00718666|584063701|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
161732910|NCT00718666|584063702|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
161732911|NCT00718666|584063703|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
161732912|NCT00718666|584063701|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
161732913|NCT00718666|584063702|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
161732914|NCT00718666|584063703|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
161732915|NCT00718666|584063701|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
161732916|NCT00718666|584063702|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
161732917|NCT00718666|584063703|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
161732918|NCT02196038|584063704|FG000|Overall Study|Death|16|||
161732919|NCT02196038|584063705|FG001|Overall Study|Death|21|||
161732920|NCT02196038|584063704|FG000|Overall Study|Withdrawal by Subject|0|||
161732921|NCT02196038|584063705|FG001|Overall Study|Withdrawal by Subject|1|||
161732922|NCT02196038|584063704|FG000|Overall Study|Lost to Follow-up|1|||
161732923|NCT02196038|584063705|FG001|Overall Study|Lost to Follow-up|0|||
161732924|NCT04544709|584063718|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
161732925|NCT03135028|584063719|FG000|Overall Study|Death|6|||
161732926|NCT03135028|584063719|FG000|Overall Study|Study Terminated by Sponsor|2|||
161732927|NCT03135028|584063719|FG000|Overall Study|Withdrew Consent|1|||
161732928|NCT00496873|584063720|FG000|Overall Study|Ineligible|2|||
161732929|NCT00496873|584063720|FG000|Overall Study|Death|2|||
161732930|NCT00496873|584063720|FG000|Overall Study|Withdrawal by Subject|3|||
161732931|NCT02065869|584063721|FG000|Overall Study|Death|7|||
161732932|NCT02065869|584063721|FG000|Overall Study|Disease relapse|16|||
161732933|NCT02065869|584063721|FG000|Overall Study|Lost to Follow-up|4|||
161732934|NCT02065869|584063721|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
161732935|NCT02065869|584063721|FG000|Overall Study|Withdrawal by Subject|1|||
161732936|NCT01842620|584063722|FG000|Period 1|Withdrawal by Subject|1|||
161732937|NCT01842620|584063723|FG001|Period 1|Withdrawal by Subject|0|||
161732938|NCT02371759|584063724|FG000|Overall Study|Protocol Violation|3|||
161732939|NCT02371759|584063725|FG001|Overall Study|Protocol Violation|1|||
161732940|NCT02371759|584063726|FG002|Overall Study|Protocol Violation|1|||
161732941|NCT02371759|584063727|FG003|Overall Study|Protocol Violation|0|||
161732942|NCT02371759|584063728|FG004|Overall Study|Protocol Violation|3|||
161732943|NCT02371759|584063729|FG005|Overall Study|Protocol Violation|1|||
161732944|NCT02371759|584063730|FG006|Overall Study|Protocol Violation|0|||
161732945|NCT02371759|584063731|FG007|Overall Study|Protocol Violation|3|||
161732946|NCT02371759|584063724|FG000|Overall Study|Withdrawal by Subject|0|||
161732947|NCT02371759|584063725|FG001|Overall Study|Withdrawal by Subject|0|||
161732948|NCT02371759|584063726|FG002|Overall Study|Withdrawal by Subject|0|||
161732949|NCT02371759|584063727|FG003|Overall Study|Withdrawal by Subject|0|||
161732950|NCT02371759|584063728|FG004|Overall Study|Withdrawal by Subject|0|||
161732951|NCT02371759|584063729|FG005|Overall Study|Withdrawal by Subject|0|||
161732952|NCT02371759|584063730|FG006|Overall Study|Withdrawal by Subject|0|||
161732953|NCT02371759|584063731|FG007|Overall Study|Withdrawal by Subject|1|||
161732954|NCT03136185|584063735|FG000|Overall Study|Adverse Event|0|||
161732955|NCT03136185|584063736|FG001|Overall Study|Adverse Event|1|||
161732956|NCT03136185|584063737|FG002|Overall Study|Adverse Event|3|||
161732957|NCT03136185|584063738|FG003|Overall Study|Adverse Event|1|||
161732958|NCT03136185|584063739|FG004|Overall Study|Adverse Event|2|||
161732959|NCT03136185|584063740|FG005|Overall Study|Adverse Event|2|||
161732960|NCT03136185|584063741|FG006|Overall Study|Adverse Event|5|||
161732961|NCT03136185|584063742|FG007|Overall Study|Adverse Event|1|||
161732962|NCT03136185|584063743|FG008|Overall Study|Adverse Event|1|||
161732963|NCT03136185|584063735|FG000|Overall Study|Death|0|||
161732964|NCT03136185|584063736|FG001|Overall Study|Death|0|||
161732965|NCT03136185|584063737|FG002|Overall Study|Death|0|||
161732966|NCT03136185|584063738|FG003|Overall Study|Death|1|||
161732967|NCT03136185|584063739|FG004|Overall Study|Death|1|||
161732968|NCT03136185|584063740|FG005|Overall Study|Death|0|||
161732969|NCT03136185|584063741|FG006|Overall Study|Death|1|||
161732970|NCT03136185|584063742|FG007|Overall Study|Death|0|||
161732971|NCT03136185|584063743|FG008|Overall Study|Death|0|||
161732972|NCT03136185|584063735|FG000|Overall Study|Physician Decision|3|||
161732973|NCT03136185|584063736|FG001|Overall Study|Physician Decision|1|||
161732974|NCT03136185|584063737|FG002|Overall Study|Physician Decision|1|||
161732975|NCT03136185|584063738|FG003|Overall Study|Physician Decision|2|||
161732976|NCT03136185|584063739|FG004|Overall Study|Physician Decision|1|||
161732977|NCT03136185|584063740|FG005|Overall Study|Physician Decision|2|||
161732978|NCT03136185|584063741|FG006|Overall Study|Physician Decision|1|||
161732979|NCT03136185|584063742|FG007|Overall Study|Physician Decision|0|||
161732980|NCT03136185|584063743|FG008|Overall Study|Physician Decision|1|||
161732981|NCT03136185|584063735|FG000|Overall Study|Protocol Defined Disease Progression|0|||
161732982|NCT03136185|584063736|FG001|Overall Study|Protocol Defined Disease Progression|0|||
161732983|NCT03136185|584063737|FG002|Overall Study|Protocol Defined Disease Progression|1|||
161732984|NCT03136185|584063738|FG003|Overall Study|Protocol Defined Disease Progression|0|||
161732985|NCT03136185|584063739|FG004|Overall Study|Protocol Defined Disease Progression|0|||
161732986|NCT03136185|584063740|FG005|Overall Study|Protocol Defined Disease Progression|1|||
161732987|NCT03136185|584063741|FG006|Overall Study|Protocol Defined Disease Progression|0|||
161732988|NCT03136185|584063742|FG007|Overall Study|Protocol Defined Disease Progression|1|||
161732989|NCT03136185|584063743|FG008|Overall Study|Protocol Defined Disease Progression|1|||
161732990|NCT03136185|584063735|FG000|Overall Study|Withdrawal by Subject|1|||
161732991|NCT03136185|584063736|FG001|Overall Study|Withdrawal by Subject|0|||
161732992|NCT03136185|584063737|FG002|Overall Study|Withdrawal by Subject|1|||
161732993|NCT03136185|584063738|FG003|Overall Study|Withdrawal by Subject|1|||
161732994|NCT03136185|584063739|FG004|Overall Study|Withdrawal by Subject|1|||
161732995|NCT03136185|584063740|FG005|Overall Study|Withdrawal by Subject|1|||
161732996|NCT03136185|584063741|FG006|Overall Study|Withdrawal by Subject|2|||
161732997|NCT03136185|584063742|FG007|Overall Study|Withdrawal by Subject|3|||
161732998|NCT03136185|584063743|FG008|Overall Study|Withdrawal by Subject|3|||
161732999|NCT03136185|584063735|FG000|Overall Study|Not Reported|4|||
161733000|NCT03136185|584063736|FG001|Overall Study|Not Reported|1|||
161733001|NCT03136185|584063737|FG002|Overall Study|Not Reported|0|||
161733002|NCT03136185|584063738|FG003|Overall Study|Not Reported|1|||
161733003|NCT03136185|584063739|FG004|Overall Study|Not Reported|0|||
161733004|NCT03136185|584063740|FG005|Overall Study|Not Reported|2|||
161733005|NCT03136185|584063741|FG006|Overall Study|Not Reported|1|||
161733006|NCT03136185|584063742|FG007|Overall Study|Not Reported|1|||
161733007|NCT03136185|584063743|FG008|Overall Study|Not Reported|0|||
161733008|NCT05118386|584063747|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733009|NCT05118386|584063748|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733010|NCT05118386|584063749|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733011|NCT05118386|584063750|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
161733012|NCT05118386|584063751|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733013|NCT05118386|584063752|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733014|NCT05118386|584063747|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733015|NCT05118386|584063748|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733016|NCT05118386|584063749|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733017|NCT05118386|584063750|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733018|NCT05118386|584063751|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
161733019|NCT05118386|584063752|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733020|NCT00894413|584063753|FG000|Overall Study|Physician Decision|0|||
161733021|NCT00894413|584063754|FG001|Overall Study|Physician Decision|2|||
161733022|NCT00894413|584063753|FG000|Overall Study|Adverse Event|0|||
161733023|NCT00894413|584063754|FG001|Overall Study|Adverse Event|2|||
161733024|NCT00894413|584063753|FG000|Overall Study|Withdrawal by Subject|0|||
161733025|NCT00894413|584063754|FG001|Overall Study|Withdrawal by Subject|4|||
161733026|NCT01067508|584063761|FG000|Overall Study|Physician Decision|0|||
161733027|NCT01067508|584063762|FG001|Overall Study|Physician Decision|1|||
161733028|NCT01067508|584063761|FG000|Overall Study|Withdrawal by Subject|0|||
161733029|NCT01067508|584063762|FG001|Overall Study|Withdrawal by Subject|1|||
161733030|NCT00632463|584063767|FG000|Overall Study|Adverse Event|0|||
161733031|NCT00632463|584063768|FG001|Overall Study|Adverse Event|1|||
161733032|NCT00632463|584063769|FG002|Overall Study|Adverse Event|0|||
161733033|NCT02065622|584063770|FG000|Induction Study|Adverse Event|13|||
161733034|NCT02065622|584063771|FG001|Induction Study|Adverse Event|19|||
161733035|NCT02065622|584063772|FG002|Induction Study|Adverse Event|0|||
161733036|NCT02065622|584063773|FG003|Induction Study|Adverse Event|0|||
161733037|NCT02065622|584063774|FG004|Induction Study|Adverse Event|0|||
161733038|NCT02065622|584063770|FG000|Induction Study|Withdrawal by Subject|3|||
161733039|NCT02065622|584063771|FG001|Induction Study|Withdrawal by Subject|5|||
161733040|NCT02065622|584063772|FG002|Induction Study|Withdrawal by Subject|0|||
161733041|NCT02065622|584063773|FG003|Induction Study|Withdrawal by Subject|0|||
161733042|NCT02065622|584063774|FG004|Induction Study|Withdrawal by Subject|0|||
161733043|NCT02065622|584063770|FG000|Induction Study|Lost to Follow-up|1|||
161733044|NCT02065622|584063771|FG001|Induction Study|Lost to Follow-up|0|||
161733045|NCT02065622|584063772|FG002|Induction Study|Lost to Follow-up|0|||
161733046|NCT02065622|584063773|FG003|Induction Study|Lost to Follow-up|0|||
161733047|NCT02065622|584063774|FG004|Induction Study|Lost to Follow-up|0|||
161733048|NCT02065622|584063770|FG000|Induction Study|Lack of Efficacy|22|||
161733049|NCT02065622|584063771|FG001|Induction Study|Lack of Efficacy|27|||
161733050|NCT02065622|584063772|FG002|Induction Study|Lack of Efficacy|0|||
161733051|NCT02065622|584063773|FG003|Induction Study|Lack of Efficacy|0|||
161733052|NCT02065622|584063774|FG004|Induction Study|Lack of Efficacy|0|||
161733053|NCT02065622|584063770|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
161733054|NCT02065622|584063771|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
161733055|NCT02065622|584063772|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161733056|NCT02065622|584063773|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161733057|NCT02065622|584063774|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161733058|NCT02065622|584063770|FG000|Induction Study|Subject Noncompliance|1|||
161733059|NCT02065622|584063771|FG001|Induction Study|Subject Noncompliance|1|||
161733060|NCT02065622|584063772|FG002|Induction Study|Subject Noncompliance|0|||
161733061|NCT02065622|584063773|FG003|Induction Study|Subject Noncompliance|0|||
161733062|NCT02065622|584063774|FG004|Induction Study|Subject Noncompliance|0|||
161733063|NCT02065622|584063770|FG000|Induction Study|Other, Not Specified|3|||
161733064|NCT02065622|584063771|FG001|Induction Study|Other, Not Specified|2|||
161733065|NCT02065622|584063772|FG002|Induction Study|Other, Not Specified|0|||
161733066|NCT02065622|584063773|FG003|Induction Study|Other, Not Specified|0|||
161733067|NCT02065622|584063774|FG004|Induction Study|Other, Not Specified|0|||
161733068|NCT02065622|584063770|FG000|Maintenance Study|Adverse Event|0|||
161733069|NCT02065622|584063771|FG001|Maintenance Study|Adverse Event|0|||
161733070|NCT02065622|584063772|FG002|Maintenance Study|Adverse Event|25|||
161733071|NCT02065622|584063773|FG003|Maintenance Study|Adverse Event|22|||
161733072|NCT02065622|584063774|FG004|Maintenance Study|Adverse Event|11|||
161733073|NCT02065622|584063770|FG000|Maintenance Study|Withdrawal by Subject|0|||
161733074|NCT02065622|584063771|FG001|Maintenance Study|Withdrawal by Subject|0|||
161733075|NCT02065622|584063772|FG002|Maintenance Study|Withdrawal by Subject|11|||
161733076|NCT02065622|584063773|FG003|Maintenance Study|Withdrawal by Subject|5|||
161733077|NCT02065622|584063774|FG004|Maintenance Study|Withdrawal by Subject|7|||
161733078|NCT02065622|584063770|FG000|Maintenance Study|Lost to Follow-up|0|||
161733079|NCT02065622|584063771|FG001|Maintenance Study|Lost to Follow-up|0|||
161733080|NCT02065622|584063772|FG002|Maintenance Study|Lost to Follow-up|4|||
161733081|NCT02065622|584063773|FG003|Maintenance Study|Lost to Follow-up|1|||
161733082|NCT02065622|584063774|FG004|Maintenance Study|Lost to Follow-up|1|||
161733083|NCT02065622|584063770|FG000|Maintenance Study|Lack of Efficacy|0|||
161733084|NCT02065622|584063771|FG001|Maintenance Study|Lack of Efficacy|0|||
161733085|NCT02065622|584063772|FG002|Maintenance Study|Lack of Efficacy|70|||
161733086|NCT02065622|584063773|FG003|Maintenance Study|Lack of Efficacy|55|||
161733087|NCT02065622|584063774|FG004|Maintenance Study|Lack of Efficacy|19|||
161733088|NCT02065622|584063770|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
161733089|NCT02065622|584063771|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
161733090|NCT02065622|584063772|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
161733091|NCT02065622|584063773|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
161733092|NCT02065622|584063774|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
161733093|NCT02065622|584063770|FG000|Maintenance Study|Subject Non-Compliance|0|||
161733094|NCT02065622|584063771|FG001|Maintenance Study|Subject Non-Compliance|0|||
161733095|NCT02065622|584063772|FG002|Maintenance Study|Subject Non-Compliance|1|||
161733096|NCT02065622|584063773|FG003|Maintenance Study|Subject Non-Compliance|3|||
161733097|NCT02065622|584063774|FG004|Maintenance Study|Subject Non-Compliance|2|||
161733098|NCT02065622|584063770|FG000|Maintenance Study|Other, Not Specified|0|||
161733099|NCT02065622|584063771|FG001|Maintenance Study|Other, Not Specified|0|||
161733100|NCT02065622|584063772|FG002|Maintenance Study|Other, Not Specified|6|||
161733101|NCT02065622|584063773|FG003|Maintenance Study|Other, Not Specified|14|||
161733102|NCT02065622|584063774|FG004|Maintenance Study|Other, Not Specified|2|||
161733103|NCT02065622|584063770|FG000|Maintenance Study|Unknown Reason|0|||
161733104|NCT02065622|584063771|FG001|Maintenance Study|Unknown Reason|0|||
161733105|NCT02065622|584063772|FG002|Maintenance Study|Unknown Reason|0|||
161733106|NCT02065622|584063773|FG003|Maintenance Study|Unknown Reason|1|||
161733107|NCT02065622|584063774|FG004|Maintenance Study|Unknown Reason|0|||
161733108|NCT00488618|584063785|FG000|Overall Study|Adverse Event|13|||
161733109|NCT00488618|584063786|FG001|Overall Study|Adverse Event|17|||
161733110|NCT00488618|584063785|FG000|Overall Study|Insufficient Therapeutic Response|18|||
161733111|NCT00488618|584063786|FG001|Overall Study|Insufficient Therapeutic Response|11|||
161733112|NCT00488618|584063785|FG000|Overall Study|Protocol Violation|0|||
161733113|NCT00488618|584063786|FG001|Overall Study|Protocol Violation|2|||
161733114|NCT00488618|584063785|FG000|Overall Study|Withdrawal of Consent|15|||
161733115|NCT00488618|584063786|FG001|Overall Study|Withdrawal of Consent|13|||
161733116|NCT00488618|584063785|FG000|Overall Study|Lost to Follow-up|1|||
161733117|NCT00488618|584063786|FG001|Overall Study|Lost to Follow-up|0|||
161733118|NCT02198651|584065643|FG000|Lead-in Period|Withdrew consent|13|||
161733119|NCT02198651|584065644|FG001|Lead-in Period|Withdrew consent|0|||
161733120|NCT02198651|584065645|FG002|Lead-in Period|Withdrew consent|0|||
161733121|NCT02198651|584065646|FG003|Lead-in Period|Withdrew consent|0|||
161733122|NCT02198651|584065647|FG004|Lead-in Period|Withdrew consent|0|||
161733123|NCT02198651|584065643|FG000|Lead-in Period|Adverse Event|2|||
161733124|NCT02198651|584065644|FG001|Lead-in Period|Adverse Event|0|||
161733125|NCT02198651|584065645|FG002|Lead-in Period|Adverse Event|0|||
161733126|NCT02198651|584065646|FG003|Lead-in Period|Adverse Event|0|||
161733127|NCT02198651|584065647|FG004|Lead-in Period|Adverse Event|0|||
161733128|NCT02198651|584065643|FG000|Lead-in Period|Other, not specified|22|||
161733129|NCT02198651|584065644|FG001|Lead-in Period|Other, not specified|0|||
161733130|NCT02198651|584065645|FG002|Lead-in Period|Other, not specified|0|||
161733131|NCT02198651|584065646|FG003|Lead-in Period|Other, not specified|0|||
161733132|NCT02198651|584065647|FG004|Lead-in Period|Other, not specified|0|||
161733133|NCT02198651|584065643|FG000|Double-blind Period|Withdrew consent|0|||
161733134|NCT02198651|584065644|FG001|Double-blind Period|Withdrew consent|4|||
161733135|NCT02198651|584065645|FG002|Double-blind Period|Withdrew consent|0|||
161733136|NCT02198651|584065646|FG003|Double-blind Period|Withdrew consent|0|||
161733137|NCT02198651|584065647|FG004|Double-blind Period|Withdrew consent|0|||
161733138|NCT02198651|584065643|FG000|Double-blind Period|Adverse Event|0|||
161733139|NCT02198651|584065644|FG001|Double-blind Period|Adverse Event|1|||
161733140|NCT02198651|584065645|FG002|Double-blind Period|Adverse Event|0|||
161733141|NCT02198651|584065646|FG003|Double-blind Period|Adverse Event|0|||
161733142|NCT02198651|584065647|FG004|Double-blind Period|Adverse Event|0|||
161733143|NCT02198651|584065643|FG000|Double-blind Period|Other, not specified|0|||
161733144|NCT02198651|584065644|FG001|Double-blind Period|Other, not specified|4|||
161733145|NCT02198651|584065645|FG002|Double-blind Period|Other, not specified|1|||
161733146|NCT02198651|584065646|FG003|Double-blind Period|Other, not specified|0|||
161733147|NCT02198651|584065647|FG004|Double-blind Period|Other, not specified|0|||
161733148|NCT02198651|584065643|FG000|Open-label Rescue Period|Withdrew consent|0|||
161733149|NCT02198651|584065644|FG001|Open-label Rescue Period|Withdrew consent|0|||
161733150|NCT02198651|584065645|FG002|Open-label Rescue Period|Withdrew consent|0|||
161733151|NCT02198651|584065646|FG003|Open-label Rescue Period|Withdrew consent|2|||
161733152|NCT02198651|584065647|FG004|Open-label Rescue Period|Withdrew consent|0|||
161733153|NCT02198651|584065643|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733154|NCT02198651|584065644|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733155|NCT02198651|584065645|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733156|NCT02198651|584065646|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
161733157|NCT02198651|584065647|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733158|NCT02922634|584065650|FG000|Overall Study|Withdrawal by Subject|5|||
161733159|NCT02922634|584065650|FG000|Overall Study|Did not have their surgery|5|||
161733160|NCT02625324|584065651|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
161733161|NCT02625324|584065651|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
161733162|NCT02625324|584065651|FG000|6-Month Follow-up Subject Accountability|Death|5|||
161733163|NCT02625324|584065651|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
161733164|NCT02625324|584065651|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
161733165|NCT02625324|584065651|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161733166|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161733167|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
161733168|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
161733169|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
161733170|NCT02625324|584065651|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
161733171|NCT02625324|584065651|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161733172|NCT02625324|584065651|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
161733173|NCT02625324|584065651|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161733174|NCT02625324|584065651|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161733175|NCT02625324|584065651|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
161733176|NCT02625324|584065651|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161733177|NCT00352755|584065652|FG000|Overall Study|Physician Decision|1|||
161733178|NCT00352755|584065652|FG000|Overall Study|Adverse Event|1|||
161733179|NCT02397694|584065655|FG000|Double-Blinded Phase|Adverse Event|1|||
161733180|NCT02397694|584065656|FG001|Double-Blinded Phase|Adverse Event|0|||
161733181|NCT02397694|584065655|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
161733182|NCT02397694|584065656|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
161733183|NCT02397694|584065655|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
161733184|NCT02397694|584065656|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
161733185|NCT02397694|584065655|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
161733186|NCT02397694|584065656|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
161733187|NCT02397694|584065655|FG000|Open Label Extension Phase|Protocol Violation|1|||
161733188|NCT02397694|584065656|FG001|Open Label Extension Phase|Protocol Violation|0|||
161733189|NCT02397694|584065655|FG000|Open Label Extension Phase|Withdrew Consent|3|||
161733190|NCT02397694|584065656|FG001|Open Label Extension Phase|Withdrew Consent|1|||
161733191|NCT02397694|584065655|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
161733192|NCT02397694|584065656|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
161733193|NCT02115113|584065657|FG000|Participants in Run-in Period|Death|0|||
161733194|NCT02115113|584065658|FG001|Participants in Run-in Period|Death|0|||
161733195|NCT02115113|584065659|FG002|Participants in Run-in Period|Death|1|||
161733196|NCT02115113|584065657|FG000|Participants in Run-in Period|Administrative problems|0|||
161733197|NCT02115113|584065658|FG001|Participants in Run-in Period|Administrative problems|0|||
161733198|NCT02115113|584065659|FG002|Participants in Run-in Period|Administrative problems|1|||
161733199|NCT02115113|584065657|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
161733200|NCT02115113|584065658|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
161733201|NCT02115113|584065659|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
161733202|NCT02115113|584065657|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
161733203|NCT02115113|584065658|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
161733204|NCT02115113|584065659|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
161733205|NCT02115113|584065657|FG000|Participants Randomized|Lost to Follow-up|1|||
161733206|NCT02115113|584065658|FG001|Participants Randomized|Lost to Follow-up|0|||
161733207|NCT02115113|584065659|FG002|Participants Randomized|Lost to Follow-up|0|||
161733208|NCT02115113|584065657|FG000|Participants Randomized|Death|1|||
161733209|NCT02115113|584065658|FG001|Participants Randomized|Death|0|||
161733210|NCT02115113|584065659|FG002|Participants Randomized|Death|0|||
161733211|NCT00789191|584065661|FG000|Overall Study|Adverse Event|2|||
161733212|NCT00789191|584065662|FG001|Overall Study|Adverse Event|4|||
161733213|NCT00789191|584065661|FG000|Overall Study|Lack of Efficacy|0|||
161733214|NCT00789191|584065662|FG001|Overall Study|Lack of Efficacy|5|||
161733215|NCT00789191|584065661|FG000|Overall Study|Protocol Violation|5|||
161733216|NCT00789191|584065662|FG001|Overall Study|Protocol Violation|3|||
161733217|NCT00789191|584065661|FG000|Overall Study|Withdrawal Criteria|2|||
161733218|NCT00789191|584065662|FG001|Overall Study|Withdrawal Criteria|4|||
161733219|NCT00789191|584065661|FG000|Overall Study|Unclassified|5|||
161733220|NCT00789191|584065662|FG001|Overall Study|Unclassified|3|||
161733221|NCT00296725|584065668|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
161733222|NCT00296725|584065668|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
161733223|NCT00296725|584065668|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
161733224|NCT00356863|584065669|FG000|Overall Study|Death|16|||
161733225|NCT00356863|584065670|FG001|Overall Study|Death|32|||
161733226|NCT00356863|584065669|FG000|Overall Study|Lost to Follow-up|76|||
161733227|NCT00356863|584065670|FG001|Overall Study|Lost to Follow-up|43|||
161733228|NCT00836277|584065678|FG000|Overall Study|Not evaluable for response|6|||
161733229|NCT00280150|584065679|FG000|Overall Study|Adverse Event|0|||
161733230|NCT00280150|584065680|FG001|Overall Study|Adverse Event|1|||
161733231|NCT00280150|584065681|FG002|Overall Study|Adverse Event|2|||
161733232|NCT00280150|584065682|FG003|Overall Study|Adverse Event|3|||
161733233|NCT00280150|584065679|FG000|Overall Study|Lack of Efficacy|0|||
161733234|NCT00280150|584065680|FG001|Overall Study|Lack of Efficacy|0|||
161733235|NCT00280150|584065681|FG002|Overall Study|Lack of Efficacy|0|||
161733236|NCT00280150|584065682|FG003|Overall Study|Lack of Efficacy|3|||
161733237|NCT00280150|584065679|FG000|Overall Study|Physician Decision|0|||
161733238|NCT00280150|584065680|FG001|Overall Study|Physician Decision|0|||
161733239|NCT00280150|584065681|FG002|Overall Study|Physician Decision|0|||
161733240|NCT00280150|584065682|FG003|Overall Study|Physician Decision|1|||
161733241|NCT00280150|584065679|FG000|Overall Study|Protocol Violation|0|||
161733242|NCT00280150|584065680|FG001|Overall Study|Protocol Violation|0|||
161733243|NCT00280150|584065681|FG002|Overall Study|Protocol Violation|0|||
161733244|NCT00280150|584065682|FG003|Overall Study|Protocol Violation|1|||
161733245|NCT00280150|584065679|FG000|Overall Study|Withdrawal by Subject|0|||
161733246|NCT00280150|584065680|FG001|Overall Study|Withdrawal by Subject|0|||
161733247|NCT00280150|584065681|FG002|Overall Study|Withdrawal by Subject|0|||
161733248|NCT00280150|584065682|FG003|Overall Study|Withdrawal by Subject|1|||
161733249|NCT00280150|584065679|FG000|Overall Study|Did not get consolidation therapy|3|||
161733250|NCT00280150|584065680|FG001|Overall Study|Did not get consolidation therapy|0|||
161733251|NCT00280150|584065681|FG002|Overall Study|Did not get consolidation therapy|3|||
161733252|NCT00280150|584065682|FG003|Overall Study|Did not get consolidation therapy|0|||
161733253|NCT00280150|584065679|FG000|Overall Study|Declining Performance Status|0|||
161733254|NCT00280150|584065680|FG001|Overall Study|Declining Performance Status|0|||
161733255|NCT00280150|584065681|FG002|Overall Study|Declining Performance Status|0|||
161733256|NCT00280150|584065682|FG003|Overall Study|Declining Performance Status|1|||
161733257|NCT01944969|584065692|FG000|Overall Study|Adverse Event|1|||
161733258|NCT01944969|584065692|FG000|Overall Study|Lack of Efficacy|1|||
161733259|NCT01944969|584065692|FG000|Overall Study|Non-compliance with IMP|1|||
161733260|NCT01944969|584065692|FG000|Overall Study|Administrative or other reasons|23|||
161733261|NCT03198754|584065696|FG000|Overall Study|Withdrawal by Subject|5|||
161733262|NCT03198754|584065697|FG001|Overall Study|Withdrawal by Subject|4|||
161733263|NCT03198754|584065696|FG000|Overall Study|Lost to Follow-up|4|||
161733264|NCT03198754|584065697|FG001|Overall Study|Lost to Follow-up|3|||
161733265|NCT03198754|584065696|FG000|Overall Study|Ineligible|2|||
161733266|NCT03198754|584065697|FG001|Overall Study|Ineligible|1|||
161733267|NCT03247413|584065703|FG000|Overall Study|Lost to Follow-up|28|||
161733268|NCT00668200|584065704|FG000|Overall Study|Withdrawal by Subject|2|||
161733269|NCT00668200|584065704|FG000|Overall Study|Lost to Follow-up|1|||
161733270|NCT00642746|584065705|FG000|Overall Study|Patient unevaluable|1|||
161733271|NCT00642746|584065706|FG001|Overall Study|Patient unevaluable|0|||
161733272|NCT00424294|584065710|FG000|Overall Study|Adverse Event|4|||
161733273|NCT00424294|584065711|FG001|Overall Study|Adverse Event|10|||
161733274|NCT00424294|584065710|FG000|Overall Study|Lack of Efficacy|2|||
161733275|NCT00424294|584065711|FG001|Overall Study|Lack of Efficacy|1|||
161733276|NCT00424294|584065710|FG000|Overall Study|Withdrawal by Subject|1|||
161733277|NCT00424294|584065711|FG001|Overall Study|Withdrawal by Subject|2|||
161733278|NCT00424294|584065710|FG000|Overall Study|Other|0|||
161733279|NCT00424294|584065711|FG001|Overall Study|Other|2|||
161733280|NCT00424294|584065710|FG000|Overall Study|Randomized but not Treated|1|||
161733281|NCT00424294|584065711|FG001|Overall Study|Randomized but not Treated|0|||
161733282|NCT01100307|584065712|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
161733283|NCT01100307|584065713|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
161733284|NCT01100307|584065712|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
161733285|NCT01100307|584065713|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
161733286|NCT01100307|584065712|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
161733287|NCT01100307|584065713|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
161733288|NCT01100307|584065712|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
161733289|NCT01100307|584065713|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
161733290|NCT01100307|584065712|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
161733291|NCT01100307|584065713|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
161733292|NCT01100307|584065712|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
161733293|NCT01100307|584065713|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
161733294|NCT01496430|584065714|FG000|Overall Study|Adverse Event|0|||
161733295|NCT01496430|584065715|FG001|Overall Study|Adverse Event|0|||
161733296|NCT01496430|584065716|FG002|Overall Study|Adverse Event|1|||
161733297|NCT01496430|584065714|FG000|Overall Study|Major Protocol Deviation|0|||
161733298|NCT01496430|584065715|FG001|Overall Study|Major Protocol Deviation|0|||
161733299|NCT01496430|584065716|FG002|Overall Study|Major Protocol Deviation|1|||
161733300|NCT01496430|584065714|FG000|Overall Study|Lost to Follow-up|2|||
161733301|NCT01496430|584065715|FG001|Overall Study|Lost to Follow-up|3|||
161733302|NCT01496430|584065716|FG002|Overall Study|Lost to Follow-up|1|||
161733303|NCT01496430|584065714|FG000|Overall Study|Voluntary Withdrawal|2|||
161733304|NCT01496430|584065715|FG001|Overall Study|Voluntary Withdrawal|1|||
161733305|NCT01496430|584065716|FG002|Overall Study|Voluntary Withdrawal|6|||
161733306|NCT01496430|584065714|FG000|Overall Study|Principal Investigator Discretion|0|||
161733307|NCT01496430|584065715|FG001|Overall Study|Principal Investigator Discretion|1|||
161733308|NCT01496430|584065716|FG002|Overall Study|Principal Investigator Discretion|1|||
161733309|NCT01496430|584065714|FG000|Overall Study|Other|2|||
161733310|NCT01496430|584065715|FG001|Overall Study|Other|0|||
161733311|NCT01496430|584065716|FG002|Overall Study|Other|0|||
161733312|NCT02108951|584065717|FG000|Overall Study|Lost to Follow-up|1|||
161733313|NCT02108951|584065717|FG000|Overall Study|Patient's/guardian's decision|1|||
161733314|NCT02108951|584065717|FG000|Overall Study|Study Terminated by Sponsor|14|||
161733315|NCT00997321|584065718|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
161733316|NCT00997321|584065719|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
161733317|NCT01151579|584065728|FG000|Overall Study|Physician Decision|3|||
161733318|NCT01151579|584065729|FG001|Overall Study|Physician Decision|1|||
161733319|NCT01151579|584065728|FG000|Overall Study|Withdrawal by Subject|3|||
161733320|NCT01151579|584065729|FG001|Overall Study|Withdrawal by Subject|2|||
161733321|NCT01151579|584065728|FG000|Overall Study|Not meet inclusion criteria|6|||
161733322|NCT01151579|584065729|FG001|Overall Study|Not meet inclusion criteria|4|||
161733323|NCT00608530|584065730|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
161733324|NCT00608530|584065731|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
161733325|NCT00608530|584065732|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
161733326|NCT00608530|584065733|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
161733327|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
161733328|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
161733329|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
161733330|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
161733331|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
161733332|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
161733333|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
161733334|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
161733335|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161733336|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161733337|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
161733338|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161733339|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
161733340|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
161733341|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
161733342|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
161733343|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161733344|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161733345|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
161839521|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
161839522|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
161733346|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161733347|NCT00077610|584065734|FG000|Overall Study|Adverse Event|9|||
161733348|NCT00077610|584065735|FG001|Overall Study|Adverse Event|7|||
161733349|NCT00077610|584065736|FG002|Overall Study|Adverse Event|1|||
161733350|NCT00077610|584065734|FG000|Overall Study|Lost to Follow-up|0|||
161733351|NCT00077610|584065735|FG001|Overall Study|Lost to Follow-up|1|||
161839523|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
161733352|NCT00077610|584065736|FG002|Overall Study|Lost to Follow-up|2|||
161733353|NCT00077610|584065734|FG000|Overall Study|Withdrawal by Subject|4|||
161733354|NCT00077610|584065735|FG001|Overall Study|Withdrawal by Subject|10|||
161733355|NCT00077610|584065736|FG002|Overall Study|Withdrawal by Subject|6|||
161733356|NCT00077610|584065734|FG000|Overall Study|Death|17|||
161733357|NCT00077610|584065735|FG001|Overall Study|Death|13|||
161733358|NCT00077610|584065736|FG002|Overall Study|Death|13|||
161733359|NCT00077610|584065734|FG000|Overall Study|Renal transplant|12|||
161733360|NCT00077610|584065735|FG001|Overall Study|Renal transplant|15|||
161733361|NCT00077610|584065736|FG002|Overall Study|Renal transplant|11|||
161733362|NCT00077610|584065734|FG000|Overall Study|Withdrew from dialysis care|5|||
161733363|NCT00077610|584065735|FG001|Overall Study|Withdrew from dialysis care|0|||
161733364|NCT00077610|584065736|FG002|Overall Study|Withdrew from dialysis care|3|||
161733365|NCT00077610|584065734|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161733366|NCT00077610|584065735|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161733367|NCT00077610|584065736|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161733368|NCT00077610|584065734|FG000|Overall Study|Multiple blood transfusions|0|||
161733369|NCT00077610|584065735|FG001|Overall Study|Multiple blood transfusions|0|||
161733370|NCT00077610|584065736|FG002|Overall Study|Multiple blood transfusions|1|||
161733371|NCT00077610|584065734|FG000|Overall Study|Principal Investigator's decision|1|||
161733372|NCT00077610|584065735|FG001|Overall Study|Principal Investigator's decision|0|||
161733373|NCT00077610|584065736|FG002|Overall Study|Principal Investigator's decision|1|||
161733374|NCT00077610|584065734|FG000|Overall Study|Worsening of health condition|1|||
161733375|NCT00077610|584065735|FG001|Overall Study|Worsening of health condition|1|||
161733376|NCT00077610|584065736|FG002|Overall Study|Worsening of health condition|0|||
161733377|NCT00077610|584065734|FG000|Overall Study|Given Epogen in hospital|1|||
161733378|NCT00077610|584065735|FG001|Overall Study|Given Epogen in hospital|0|||
161733379|NCT00077610|584065736|FG002|Overall Study|Given Epogen in hospital|0|||
161733380|NCT00077610|584065734|FG000|Overall Study|Transferred to other unit|0|||
161733381|NCT00077610|584065735|FG001|Overall Study|Transferred to other unit|0|||
161733382|NCT00077610|584065736|FG002|Overall Study|Transferred to other unit|1|||
161733383|NCT00077610|584065734|FG000|Overall Study|Transferred to nursing home|0|||
161733384|NCT00077610|584065735|FG001|Overall Study|Transferred to nursing home|0|||
161733385|NCT00077610|584065736|FG002|Overall Study|Transferred to nursing home|1|||
161733386|NCT00077610|584065734|FG000|Overall Study|Transfer to satellite unit|1|||
161733387|NCT00077610|584065735|FG001|Overall Study|Transfer to satellite unit|0|||
161733388|NCT00077610|584065736|FG002|Overall Study|Transfer to satellite unit|0|||
161733389|NCT00077610|584065734|FG000|Overall Study|Transfer to other center for surgery|1|||
161733390|NCT00077610|584065735|FG001|Overall Study|Transfer to other center for surgery|0|||
161733391|NCT00077610|584065736|FG002|Overall Study|Transfer to other center for surgery|0|||
161733392|NCT00077610|584065734|FG000|Overall Study|Change in dialysis modality|1|||
161733393|NCT00077610|584065735|FG001|Overall Study|Change in dialysis modality|0|||
161733394|NCT00077610|584065736|FG002|Overall Study|Change in dialysis modality|0|||
161733395|NCT00077610|584065734|FG000|Overall Study|Relocation|0|||
161733396|NCT00077610|584065735|FG001|Overall Study|Relocation|8|||
161733397|NCT00077610|584065736|FG002|Overall Study|Relocation|5|||
161733398|NCT00077610|584065734|FG000|Overall Study|Financial issues|0|||
161733399|NCT00077610|584065735|FG001|Overall Study|Financial issues|1|||
161733400|NCT00077610|584065736|FG002|Overall Study|Financial issues|0|||
161733401|NCT00077610|584065734|FG000|Overall Study|Sponsors decision to withdraw|0|||
161733402|NCT00077610|584065735|FG001|Overall Study|Sponsors decision to withdraw|0|||
161733403|NCT00077610|584065736|FG002|Overall Study|Sponsors decision to withdraw|1|||
161733404|NCT01357915|584065740|FG000|Overall Study|Lost to Follow-up|3|||
161733405|NCT01357915|584065741|FG001|Overall Study|Lost to Follow-up|0|||
161733406|NCT00305253|584065744|FG000|Overall Study|Withdrawal by Subject|0|||
161733407|NCT00305253|584065745|FG001|Overall Study|Withdrawal by Subject|1|||
161733408|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
161733409|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
161733410|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
161733411|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
161733412|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
161733413|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
161733414|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
161733415|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
161733416|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
161733417|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
161733418|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
161733419|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
161733420|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161733421|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
161733422|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161733423|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161733424|NCT01098461|584065746|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161839524|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
161839525|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
161839526|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
161839527|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
161839528|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
161839529|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
161839530|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
161839531|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Other|3|||
161839532|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Other|0|||
161839533|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Other|0|||
161839534|NCT02788045|584458516|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
161839535|NCT02788045|584458517|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
161839536|NCT02788045|584458518|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
161839537|NCT02788045|584458516|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
161839538|NCT02788045|584458517|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
161839539|NCT02788045|584458518|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
161839540|NCT02788045|584458516|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
161839541|NCT02788045|584458517|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
161839542|NCT02788045|584458518|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
161839543|NCT02128217|584458525|FG000|Overall Study|Lost to Follow-up|0|||
161839544|NCT02128217|584458526|FG001|Overall Study|Lost to Follow-up|1|||
161839545|NCT05071313|584458529|FG000|Overall Study|Lost to Follow-up|17|||
161839546|NCT05071313|584458530|FG001|Overall Study|Lost to Follow-up|10|||
161839547|NCT05071313|584458529|FG000|Overall Study|Physician Decision|1|||
161839548|NCT05071313|584458530|FG001|Overall Study|Physician Decision|6|||
161839549|NCT05071313|584458529|FG000|Overall Study|Death|1|||
161839550|NCT05071313|584458530|FG001|Overall Study|Death|0|||
161839551|NCT05071313|584458529|FG000|Overall Study|Withdrawal by Subject|10|||
161733425|NCT01098461|584065747|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
161733426|NCT01098461|584065748|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161733427|NCT01098461|584065749|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161733428|NCT01098461|584065746|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161733429|NCT01098461|584065747|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
161733430|NCT01098461|584065748|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161733431|NCT01098461|584065749|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161733432|NCT01098461|584065746|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161733433|NCT01098461|584065747|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
161733434|NCT01098461|584065748|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
161733435|NCT01098461|584065749|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161733436|NCT02662985|584065752|FG000|Treatment Period 1|Adverse Event|0|||
161733437|NCT02662985|584065753|FG001|Treatment Period 1|Adverse Event|2|||
161733438|NCT02662985|584065752|FG000|Treatment Period 1|Protocol Violation|0|||
161733439|NCT02662985|584065753|FG001|Treatment Period 1|Protocol Violation|1|||
161733440|NCT02662985|584065752|FG000|Treatment Period 1|Physician Decision|1|||
161733441|NCT02662985|584065753|FG001|Treatment Period 1|Physician Decision|0|||
161733442|NCT02662985|584065752|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161733443|NCT02662985|584065753|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161733444|NCT02662985|584065752|FG000|Treatment Period 2|Lack of Efficacy|0|||
161733445|NCT02662985|584065753|FG001|Treatment Period 2|Lack of Efficacy|1|||
161733446|NCT02662985|584065752|FG000|Treatment Period 2|Lost to Follow-up|1|||
161839552|NCT05071313|584458530|FG001|Overall Study|Withdrawal by Subject|15|||
161839553|NCT05071313|584458529|FG000|Overall Study|Other|1|||
161839554|NCT05071313|584458530|FG001|Overall Study|Other|0|||
161839555|NCT05071313|584458529|FG000|Overall Study|Randomized but not vaccinated|4|||
161839556|NCT05071313|584458530|FG001|Overall Study|Randomized but not vaccinated|2|||
161839557|NCT00541970|584458531|FG000|Month 7|Protocol Violation|9|||
161839558|NCT00541970|584458532|FG001|Month 7|Protocol Violation|13|||
161839559|NCT00541970|584458533|FG002|Month 7|Protocol Violation|11|||
161839560|NCT00541970|584458534|FG003|Month 7|Protocol Violation|5|||
161839561|NCT00541970|584458531|FG000|Month 12|Adverse Event|0|||
161733447|NCT02662985|584065753|FG001|Treatment Period 2|Lost to Follow-up|0|||
161733448|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
161733449|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
161733450|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
161733451|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
161733452|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
161733453|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
161733454|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
161733455|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
161733456|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Death|0|||
161733457|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Death|1|||
161733458|NCT01153763|584065754|FG000|Overall Study|Study Closed|16|||
161733459|NCT01153763|584065754|FG000|Overall Study|Lost to Follow-up|1|||
161733460|NCT01153763|584065754|FG000|Overall Study|Physician Decision|2|||
161733461|NCT01153763|584065754|FG000|Overall Study|Withdrawal by Subject|2|||
161733462|NCT05373706|584065759|FG000|Overall Study|Lost to Follow-up|2|||
161733463|NCT05373706|584065760|FG001|Overall Study|Lost to Follow-up|2|||
161733464|NCT01486784|584065761|FG000|Overall Study|Withdrawal by Subject|0|||
161733465|NCT01486784|584065762|FG001|Overall Study|Withdrawal by Subject|0|||
161733466|NCT01486784|584065763|FG002|Overall Study|Withdrawal by Subject|1|||
161733467|NCT01486784|584065764|FG003|Overall Study|Withdrawal by Subject|0|||
161733468|NCT01486784|584065765|FG004|Overall Study|Withdrawal by Subject|1|||
161733469|NCT01486784|584065766|FG005|Overall Study|Withdrawal by Subject|2|||
161733470|NCT01486784|584065761|FG000|Overall Study|Subject did not meet entry criteria|0|||
161733471|NCT01486784|584065762|FG001|Overall Study|Subject did not meet entry criteria|0|||
161733472|NCT01486784|584065763|FG002|Overall Study|Subject did not meet entry criteria|0|||
161733473|NCT01486784|584065764|FG003|Overall Study|Subject did not meet entry criteria|0|||
161733474|NCT01486784|584065765|FG004|Overall Study|Subject did not meet entry criteria|1|||
161733475|NCT01486784|584065766|FG005|Overall Study|Subject did not meet entry criteria|0|||
161733476|NCT01486784|584065761|FG000|Overall Study|Death|0|||
161733477|NCT01486784|584065762|FG001|Overall Study|Death|0|||
161733478|NCT01486784|584065763|FG002|Overall Study|Death|0|||
161733479|NCT01486784|584065764|FG003|Overall Study|Death|0|||
161733480|NCT01486784|584065765|FG004|Overall Study|Death|0|||
161733481|NCT01486784|584065766|FG005|Overall Study|Death|1|||
161733482|NCT03491553|584065767|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
161733483|NCT03491553|584065768|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
161733484|NCT03491553|584065769|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
161733485|NCT03491553|584065770|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
161733486|NCT03491553|584065771|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
161733487|NCT03491553|584065772|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
161733488|NCT03491553|584065767|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
161733489|NCT03491553|584065768|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
161733490|NCT03491553|584065769|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733491|NCT03491553|584065770|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733492|NCT03491553|584065771|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733493|NCT03491553|584065772|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733494|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
161733495|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
161733496|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Death|2|||
161733497|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Death|1|||
161733498|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
161733499|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
161733500|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
161733501|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
161733502|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
161733503|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
161733504|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
161733505|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
161733506|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
161733507|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
161733508|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
161733509|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
161733510|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
161733511|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
161733512|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
161733513|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
161733514|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
161733515|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
161733516|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
161733517|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
161733518|NCT01479374|584065781|FG000|Overall Study|Adverse Event|2|||
161733519|NCT01479374|584065782|FG001|Overall Study|Adverse Event|1|||
161733520|NCT01479374|584065783|FG002|Overall Study|Adverse Event|0|||
161733521|NCT01479374|584065781|FG000|Overall Study|Lost to Follow-up|1|||
161733522|NCT01479374|584065782|FG001|Overall Study|Lost to Follow-up|2|||
161733523|NCT01479374|584065783|FG002|Overall Study|Lost to Follow-up|0|||
161733524|NCT01479374|584065781|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
161733525|NCT01479374|584065782|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
161733526|NCT01479374|584065783|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
161733527|NCT01479374|584065781|FG000|Overall Study|Other|0|||
161733528|NCT01479374|584065782|FG001|Overall Study|Other|4|||
161733529|NCT01479374|584065783|FG002|Overall Study|Other|5|||
161733530|NCT01606761|584065785|FG000|Prior to Week 24|Lost to Follow-up|0|||
161733531|NCT01606761|584065786|FG001|Prior to Week 24|Lost to Follow-up|3|||
161733532|NCT01606761|584065787|FG002|Prior to Week 24|Lost to Follow-up|2|||
161733533|NCT01606761|584065788|FG003|Prior to Week 24|Lost to Follow-up|0|||
161733534|NCT01606761|584065789|FG004|Prior to Week 24|Lost to Follow-up|0|||
161733535|NCT01606761|584065785|FG000|Prior to Week 24|Withdrawal by Subject|12|||
161733536|NCT01606761|584065786|FG001|Prior to Week 24|Withdrawal by Subject|10|||
161733537|NCT01606761|584065787|FG002|Prior to Week 24|Withdrawal by Subject|9|||
161733538|NCT01606761|584065788|FG003|Prior to Week 24|Withdrawal by Subject|0|||
161733539|NCT01606761|584065789|FG004|Prior to Week 24|Withdrawal by Subject|0|||
161733540|NCT01606761|584065785|FG000|Prior to Week 24|Adverse Event|11|||
161733541|NCT01606761|584065786|FG001|Prior to Week 24|Adverse Event|18|||
161733542|NCT01606761|584065787|FG002|Prior to Week 24|Adverse Event|22|||
161733543|NCT01606761|584065788|FG003|Prior to Week 24|Adverse Event|0|||
161733544|NCT01606761|584065789|FG004|Prior to Week 24|Adverse Event|0|||
161733545|NCT01606761|584065785|FG000|Prior to Week 24|Lack of Efficacy|15|||
161733546|NCT01606761|584065786|FG001|Prior to Week 24|Lack of Efficacy|14|||
161733547|NCT01606761|584065787|FG002|Prior to Week 24|Lack of Efficacy|8|||
161733548|NCT01606761|584065788|FG003|Prior to Week 24|Lack of Efficacy|0|||
161733549|NCT01606761|584065789|FG004|Prior to Week 24|Lack of Efficacy|0|||
161733550|NCT01606761|584065785|FG000|Prior to Week 24|Physician Decision|0|||
161733551|NCT01606761|584065786|FG001|Prior to Week 24|Physician Decision|3|||
161733552|NCT01606761|584065787|FG002|Prior to Week 24|Physician Decision|1|||
161733553|NCT01606761|584065788|FG003|Prior to Week 24|Physician Decision|0|||
161733554|NCT01606761|584065789|FG004|Prior to Week 24|Physician Decision|0|||
161733555|NCT01606761|584065785|FG000|Prior to Week 24|Other|4|||
161733556|NCT01606761|584065786|FG001|Prior to Week 24|Other|7|||
161733557|NCT01606761|584065787|FG002|Prior to Week 24|Other|5|||
161733558|NCT01606761|584065788|FG003|Prior to Week 24|Other|0|||
161733559|NCT01606761|584065789|FG004|Prior to Week 24|Other|0|||
161733560|NCT01606761|584065785|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
161733561|NCT01606761|584065786|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
161733562|NCT01606761|584065787|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
161733563|NCT01606761|584065788|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
161733564|NCT01606761|584065789|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
161733565|NCT01606761|584065785|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
161733566|NCT01606761|584065786|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
161733567|NCT01606761|584065787|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
161733568|NCT01606761|584065788|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
161733569|NCT01606761|584065789|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
161733570|NCT01606761|584065785|FG000|Week 24 to Week 52|Adverse Event|0|||
161733571|NCT01606761|584065786|FG001|Week 24 to Week 52|Adverse Event|11|||
161733572|NCT01606761|584065787|FG002|Week 24 to Week 52|Adverse Event|14|||
161733573|NCT01606761|584065788|FG003|Week 24 to Week 52|Adverse Event|3|||
161733574|NCT01606761|584065789|FG004|Week 24 to Week 52|Adverse Event|15|||
161733575|NCT01606761|584065785|FG000|Week 24 to Week 52|Death|0|||
161733576|NCT01606761|584065786|FG001|Week 24 to Week 52|Death|0|||
161733577|NCT01606761|584065787|FG002|Week 24 to Week 52|Death|2|||
161733578|NCT01606761|584065788|FG003|Week 24 to Week 52|Death|1|||
161733579|NCT01606761|584065789|FG004|Week 24 to Week 52|Death|0|||
161733580|NCT01606761|584065785|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
161733581|NCT01606761|584065786|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
161733582|NCT01606761|584065787|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
161733583|NCT01606761|584065788|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
161733584|NCT01606761|584065789|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
161733585|NCT01606761|584065785|FG000|Week 24 to Week 52|Physician Decision|0|||
161733586|NCT01606761|584065786|FG001|Week 24 to Week 52|Physician Decision|1|||
161733587|NCT01606761|584065787|FG002|Week 24 to Week 52|Physician Decision|1|||
161839562|NCT00541970|584458532|FG001|Month 12|Adverse Event|1|||
161839563|NCT00541970|584458533|FG002|Month 12|Adverse Event|1|||
161733588|NCT01606761|584065788|FG003|Week 24 to Week 52|Physician Decision|0|||
161733589|NCT01606761|584065789|FG004|Week 24 to Week 52|Physician Decision|0|||
161733590|NCT01606761|584065785|FG000|Week 24 to Week 52|Other|0|||
161733591|NCT01606761|584065786|FG001|Week 24 to Week 52|Other|1|||
161733592|NCT01606761|584065787|FG002|Week 24 to Week 52|Other|5|||
161839564|NCT00541970|584458534|FG003|Month 12|Adverse Event|1|||
161733593|NCT01606761|584065788|FG003|Week 24 to Week 52|Other|2|||
161733594|NCT01606761|584065789|FG004|Week 24 to Week 52|Other|2|||
161733595|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
161733596|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
161733597|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
161733598|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
161733599|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
161733600|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
161733601|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
161733602|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
161733603|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
161733604|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
161733605|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
161733606|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
161733607|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
161733608|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
161733609|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
161733610|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
161733611|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
161733612|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
161733613|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
161733614|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
161733615|NCT00992446|584065795|FG000|Overall Study|Disease Progression|1|||
161733616|NCT00992446|584065795|FG000|Overall Study|Withdrawal by Subject|2|||
161733617|NCT00992446|584065795|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
161733618|NCT00333619|584067644|FG000|Overall Study|Death|12|||
161733619|NCT00333619|584067645|FG001|Overall Study|Death|6|||
161733620|NCT00333619|584067644|FG000|Overall Study|Withdrawal by Subject|6|||
161733621|NCT00333619|584067645|FG001|Overall Study|Withdrawal by Subject|1|||
161733622|NCT00333619|584067644|FG000|Overall Study|Lost to Follow-up|3|||
161733623|NCT00333619|584067645|FG001|Overall Study|Lost to Follow-up|3|||
161733624|NCT01120379|584067654|FG000|One Year Timepoint|Withdrawal by Subject|41|||
161733625|NCT01120379|584067654|FG000|One Year Timepoint|Lost to Follow-up|115|||
161733626|NCT01120379|584067654|FG000|One Year Timepoint|Death|108|||
161733627|NCT01120379|584067654|FG000|One Year Timepoint|Physician Decision|9|||
161733628|NCT01120379|584067654|FG000|One Year Timepoint|Any other reason for early termination|5|||
161733629|NCT01120379|584067654|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
161733630|NCT01120379|584067654|FG000|Two Year Timepoint|Lost to Follow-up|87|||
161733631|NCT01120379|584067654|FG000|Two Year Timepoint|Death|123|||
161733632|NCT01120379|584067654|FG000|Two Year Timepoint|Physician Decision|12|||
161733633|NCT01120379|584067654|FG000|Two Year Timepoint|Any other reason for early termination|4|||
161733634|NCT01120379|584067654|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
161733635|NCT01120379|584067654|FG000|Three Year Timepoint|Lost to Follow-up|43|||
161733636|NCT01120379|584067654|FG000|Three Year Timepoint|Death|120|||
161733637|NCT01120379|584067654|FG000|Three Year Timepoint|Physician Decision|9|||
161733638|NCT01120379|584067654|FG000|Three Year Timepoint|Any other reason for early termination|17|||
161733639|NCT01120379|584067654|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
161733640|NCT01120379|584067654|FG000|Four Year Timepoint|Lost to Follow-up|10|||
161733641|NCT01120379|584067654|FG000|Four Year Timepoint|Death|131|||
161733642|NCT01120379|584067654|FG000|Four Year Timepoint|Physician Decision|5|||
161733643|NCT01120379|584067654|FG000|Four Year Timepoint|Any other reason for early termination|217|||
161733644|NCT03162055|584067655|FG000|Overall Study|Adverse Event|6|||
161733645|NCT03162055|584067656|FG001|Overall Study|Adverse Event|5|||
161733646|NCT03162055|584067655|FG000|Overall Study|Death|3|||
161733647|NCT03162055|584067656|FG001|Overall Study|Death|3|||
161733648|NCT03162055|584067655|FG000|Overall Study|Lost to Follow-up|0|||
161733649|NCT03162055|584067656|FG001|Overall Study|Lost to Follow-up|1|||
161733650|NCT03162055|584067655|FG000|Overall Study|Study-specific withdrawal criteria|22|||
161733651|NCT03162055|584067656|FG001|Overall Study|Study-specific withdrawal criteria|14|||
161733652|NCT03162055|584067655|FG000|Overall Study|Withdrawal by Subject|17|||
161733653|NCT03162055|584067656|FG001|Overall Study|Withdrawal by Subject|2|||
161733654|NCT03162055|584067655|FG000|Overall Study|Did not receive treatment|2|||
161839565|NCT00541970|584458531|FG000|Month 12|Protocol Violation|12|||
161733655|NCT03162055|584067656|FG001|Overall Study|Did not receive treatment|0|||
161733656|NCT03162055|584067655|FG000|Overall Study|Incorrect randomization|4|||
161733657|NCT03162055|584067656|FG001|Overall Study|Incorrect randomization|3|||
161733658|NCT03162055|584067655|FG000|Overall Study|Other|8|||
161839566|NCT00541970|584458532|FG001|Month 12|Protocol Violation|21|||
161839567|NCT00541970|584458533|FG002|Month 12|Protocol Violation|20|||
161839568|NCT00541970|584458534|FG003|Month 12|Protocol Violation|15|||
161839569|NCT00541970|584458531|FG000|Month 18|Adverse Event|0|||
161839570|NCT00541970|584458532|FG001|Month 18|Adverse Event|1|||
161733659|NCT03162055|584067656|FG001|Overall Study|Other|15|||
161733660|NCT04031404|584067657|FG000|Baseline|Lost to Follow-up|0|||
161733661|NCT04031404|584067658|FG001|Baseline|Lost to Follow-up|1|||
161839571|NCT00541970|584458533|FG002|Month 18|Adverse Event|1|||
161839572|NCT00541970|584458534|FG003|Month 18|Adverse Event|1|||
161839573|NCT00541970|584458531|FG000|Month 18|Protocol Violation|14|||
161839574|NCT00541970|584458532|FG001|Month 18|Protocol Violation|23|||
161839575|NCT00541970|584458533|FG002|Month 18|Protocol Violation|24|||
161839576|NCT00541970|584458534|FG003|Month 18|Protocol Violation|16|||
161839577|NCT00541970|584458531|FG000|Month 24|Adverse Event|0|||
161839578|NCT00541970|584458532|FG001|Month 24|Adverse Event|1|||
161839579|NCT00541970|584458533|FG002|Month 24|Adverse Event|1|||
161839580|NCT00541970|584458534|FG003|Month 24|Adverse Event|1|||
161839581|NCT00541970|584458531|FG000|Month 24|Protocol Violation|29|||
161839582|NCT00541970|584458532|FG001|Month 24|Protocol Violation|31|||
161839583|NCT00541970|584458533|FG002|Month 24|Protocol Violation|31|||
161839584|NCT00541970|584458534|FG003|Month 24|Protocol Violation|21|||
161839585|NCT00541970|584458531|FG000|Month 36|Protocol Violation|61|||
161839586|NCT00541970|584458532|FG001|Month 36|Protocol Violation|66|||
161839587|NCT00541970|584458533|FG002|Month 36|Protocol Violation|66|||
161839588|NCT00541970|584458534|FG003|Month 36|Protocol Violation|60|||
161839589|NCT00541970|584458531|FG000|Month 48|Withdrawal by Subject|2|||
161839590|NCT00541970|584458532|FG001|Month 48|Withdrawal by Subject|4|||
161839591|NCT00541970|584458533|FG002|Month 48|Withdrawal by Subject|4|||
161839592|NCT00541970|584458534|FG003|Month 48|Withdrawal by Subject|2|||
161839593|NCT00541970|584458531|FG000|Month 48|Other|3|||
161839594|NCT00541970|584458532|FG001|Month 48|Other|1|||
161839595|NCT00541970|584458533|FG002|Month 48|Other|1|||
161839596|NCT00541970|584458534|FG003|Month 48|Other|0|||
161839597|NCT00541970|584458531|FG000|Month 48|Lost to Follow-up|66|||
161839598|NCT00541970|584458532|FG001|Month 48|Lost to Follow-up|68|||
161839599|NCT00541970|584458533|FG002|Month 48|Lost to Follow-up|68|||
161839600|NCT00541970|584458534|FG003|Month 48|Lost to Follow-up|73|||
161839601|NCT00541970|584458531|FG000|Month 60|Protocol Violation|78|||
161839602|NCT00541970|584458532|FG001|Month 60|Protocol Violation|77|||
161839603|NCT00541970|584458533|FG002|Month 60|Protocol Violation|82|||
161733662|NCT04031404|584067657|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
161733663|NCT04031404|584067658|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
161733664|NCT04031404|584067657|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
161733665|NCT04031404|584067658|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
161733666|NCT04031404|584067657|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
161733667|NCT04031404|584067658|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
161733668|NCT04031404|584067657|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
161733669|NCT04031404|584067658|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
161839604|NCT00541970|584458534|FG003|Month 60|Protocol Violation|72|||
161839605|NCT03107026|584458535|FG000|Overall Study|Adverse Event|2|||
161839606|NCT03107026|584458536|FG001|Overall Study|Adverse Event|14|||
161839607|NCT03107026|584458537|FG002|Overall Study|Adverse Event|23|||
161839608|NCT03107026|584458535|FG000|Overall Study|Lost to Follow-up|12|||
161839609|NCT03107026|584458536|FG001|Overall Study|Lost to Follow-up|12|||
161839610|NCT03107026|584458537|FG002|Overall Study|Lost to Follow-up|13|||
161839611|NCT03107026|584458535|FG000|Overall Study|Protocol Violation|1|||
161733670|NCT01104584|584067663|FG000|Overall Study|Study drug never administered|21|||
161839612|NCT03107026|584458536|FG001|Overall Study|Protocol Violation|2|||
161839613|NCT03107026|584458537|FG002|Overall Study|Protocol Violation|0|||
161839614|NCT03107026|584458535|FG000|Overall Study|Pregnancy|1|||
161839615|NCT03107026|584458536|FG001|Overall Study|Pregnancy|0|||
161839616|NCT03107026|584458537|FG002|Overall Study|Pregnancy|0|||
161839617|NCT03107026|584458535|FG000|Overall Study|Withdrawal by Subject|13|||
161839618|NCT03107026|584458536|FG001|Overall Study|Withdrawal by Subject|5|||
161839619|NCT03107026|584458537|FG002|Overall Study|Withdrawal by Subject|17|||
161839620|NCT03107026|584458535|FG000|Overall Study|non compliance with study visits|1|||
161839621|NCT03107026|584458536|FG001|Overall Study|non compliance with study visits|2|||
161839622|NCT03107026|584458537|FG002|Overall Study|non compliance with study visits|0|||
161839623|NCT03107026|584458535|FG000|Overall Study|non-compliance with study drug|2|||
161839624|NCT03107026|584458536|FG001|Overall Study|non-compliance with study drug|2|||
161839625|NCT03107026|584458537|FG002|Overall Study|non-compliance with study drug|3|||
161839626|NCT03107026|584458535|FG000|Overall Study|Physician Decision|0|||
161839627|NCT03107026|584458536|FG001|Overall Study|Physician Decision|1|||
161839628|NCT03107026|584458537|FG002|Overall Study|Physician Decision|0|||
161839629|NCT01183221|584458538|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
161733671|NCT01104584|584067663|FG000|Overall Study|Study prematurely discontinued|2|||
161733672|NCT02370498|584067664|FG000|Overall Study|Adverse Event|10|||
161733673|NCT02370498|584067665|FG001|Overall Study|Adverse Event|8|||
161733674|NCT02370498|584067664|FG000|Overall Study|Death|263|||
161733675|NCT02370498|584067665|FG001|Overall Study|Death|265|||
161733676|NCT02370498|584067664|FG000|Overall Study|Protocol Violation|1|||
161733677|NCT02370498|584067665|FG001|Overall Study|Protocol Violation|2|||
161733678|NCT02370498|584067664|FG000|Overall Study|Withdrawal by Subject|7|||
161733679|NCT02370498|584067665|FG001|Overall Study|Withdrawal by Subject|12|||
161733680|NCT02370498|584067664|FG000|Overall Study|Sponsor's decision|15|||
161733681|NCT02370498|584067665|FG001|Overall Study|Sponsor's decision|9|||
161733682|NCT04017442|584067666|FG000|Overall Study|Withdrawal by Subject|0|||
161733683|NCT04017442|584067667|FG001|Overall Study|Withdrawal by Subject|3|||
161733684|NCT04017442|584067666|FG000|Overall Study|Lost to Follow-up|21|||
161733685|NCT04017442|584067667|FG001|Overall Study|Lost to Follow-up|19|||
161733686|NCT03225716|584067671|FG000|Overall Study|Withdrawal by Subject|2|||
161733687|NCT03225716|584067672|FG001|Overall Study|Withdrawal by Subject|2|||
161733688|NCT03225716|584067673|FG002|Overall Study|Withdrawal by Subject|0|||
161733689|NCT03225716|584067671|FG000|Overall Study|Lack of Efficacy|1|||
161733690|NCT03225716|584067672|FG001|Overall Study|Lack of Efficacy|0|||
161733691|NCT03225716|584067673|FG002|Overall Study|Lack of Efficacy|0|||
161733692|NCT03225716|584067671|FG000|Overall Study|Adverse Event|2|||
161733693|NCT03225716|584067672|FG001|Overall Study|Adverse Event|0|||
161733694|NCT03225716|584067673|FG002|Overall Study|Adverse Event|1|||
161733695|NCT03225716|584067671|FG000|Overall Study|Study early termination by Sponsor|0|||
161733696|NCT03225716|584067672|FG001|Overall Study|Study early termination by Sponsor|0|||
161733697|NCT03225716|584067673|FG002|Overall Study|Study early termination by Sponsor|2|||
161733698|NCT00848250|584067674|FG000|Overall Study|surgery was completed without cardiopulm|0|||
161733699|NCT00848250|584067675|FG001|Overall Study|surgery was completed without cardiopulm|1|||
161733700|NCT02883049|584067683|FG000|Induction|Adverse Event|52|||
161733701|NCT02883049|584067684|FG001|Induction|Adverse Event|2|||
161733702|NCT02883049|584067685|FG002|Induction|Adverse Event|0|||
161733703|NCT02883049|584067686|FG003|Induction|Adverse Event|0|||
161733704|NCT02883049|584067687|FG004|Induction|Adverse Event|0|||
161733705|NCT02883049|584067688|FG005|Induction|Adverse Event|0|||
161733706|NCT02883049|584067689|FG006|Induction|Adverse Event|0|||
161733707|NCT02883049|584067690|FG007|Induction|Adverse Event|0|||
161733708|NCT02883049|584067691|FG008|Induction|Adverse Event|0|||
161733709|NCT02883049|584067692|FG009|Induction|Adverse Event|0|||
161733710|NCT02883049|584067693|FG010|Induction|Adverse Event|0|||
161733711|NCT02883049|584067694|FG011|Induction|Adverse Event|0|||
161733712|NCT02883049|584067695|FG012|Induction|Adverse Event|0|||
161733713|NCT02883049|584067696|FG013|Induction|Adverse Event|0|||
161733714|NCT02883049|584067697|FG014|Induction|Adverse Event|0|||
161733715|NCT02883049|584067698|FG015|Induction|Adverse Event|0|||
161733716|NCT02883049|584067683|FG000|Induction|Death|76|||
161733717|NCT02883049|584067684|FG001|Induction|Death|8|||
161733718|NCT02883049|584067685|FG002|Induction|Death|0|||
161733719|NCT02883049|584067686|FG003|Induction|Death|0|||
161733720|NCT02883049|584067687|FG004|Induction|Death|0|||
161733721|NCT02883049|584067688|FG005|Induction|Death|0|||
161733722|NCT02883049|584067689|FG006|Induction|Death|0|||
161733723|NCT02883049|584067690|FG007|Induction|Death|0|||
161733724|NCT02883049|584067691|FG008|Induction|Death|0|||
161733725|NCT02883049|584067692|FG009|Induction|Death|0|||
161733726|NCT02883049|584067693|FG010|Induction|Death|0|||
161733727|NCT02883049|584067694|FG011|Induction|Death|0|||
161733728|NCT02883049|584067695|FG012|Induction|Death|0|||
161733729|NCT02883049|584067696|FG013|Induction|Death|0|||
161733730|NCT02883049|584067697|FG014|Induction|Death|0|||
161733731|NCT02883049|584067698|FG015|Induction|Death|0|||
161733732|NCT02883049|584067683|FG000|Induction|Lost to Follow-up|2|||
161733733|NCT02883049|584067684|FG001|Induction|Lost to Follow-up|0|||
161733734|NCT02883049|584067685|FG002|Induction|Lost to Follow-up|0|||
161733735|NCT02883049|584067686|FG003|Induction|Lost to Follow-up|0|||
161733736|NCT02883049|584067687|FG004|Induction|Lost to Follow-up|0|||
161733737|NCT02883049|584067688|FG005|Induction|Lost to Follow-up|0|||
161733738|NCT02883049|584067689|FG006|Induction|Lost to Follow-up|0|||
161733739|NCT02883049|584067690|FG007|Induction|Lost to Follow-up|0|||
161733740|NCT02883049|584067691|FG008|Induction|Lost to Follow-up|0|||
161733741|NCT02883049|584067692|FG009|Induction|Lost to Follow-up|0|||
161733742|NCT02883049|584067693|FG010|Induction|Lost to Follow-up|0|||
161733743|NCT02883049|584067694|FG011|Induction|Lost to Follow-up|0|||
161733744|NCT02883049|584067695|FG012|Induction|Lost to Follow-up|0|||
161733745|NCT02883049|584067696|FG013|Induction|Lost to Follow-up|0|||
161733746|NCT02883049|584067697|FG014|Induction|Lost to Follow-up|0|||
161733747|NCT02883049|584067698|FG015|Induction|Lost to Follow-up|0|||
161733748|NCT02883049|584067683|FG000|Induction|Physician Decision|1407|||
161733749|NCT02883049|584067684|FG001|Induction|Physician Decision|8|||
161733750|NCT02883049|584067685|FG002|Induction|Physician Decision|0|||
161733751|NCT02883049|584067686|FG003|Induction|Physician Decision|0|||
161733752|NCT02883049|584067687|FG004|Induction|Physician Decision|0|||
161733753|NCT02883049|584067688|FG005|Induction|Physician Decision|0|||
161733754|NCT02883049|584067689|FG006|Induction|Physician Decision|0|||
161733755|NCT02883049|584067690|FG007|Induction|Physician Decision|0|||
161733756|NCT02883049|584067691|FG008|Induction|Physician Decision|0|||
161733757|NCT02883049|584067692|FG009|Induction|Physician Decision|0|||
161733758|NCT02883049|584067693|FG010|Induction|Physician Decision|0|||
161733759|NCT02883049|584067694|FG011|Induction|Physician Decision|0|||
161733760|NCT02883049|584067695|FG012|Induction|Physician Decision|0|||
161733761|NCT02883049|584067696|FG013|Induction|Physician Decision|0|||
161733762|NCT02883049|584067697|FG014|Induction|Physician Decision|0|||
161733763|NCT02883049|584067698|FG015|Induction|Physician Decision|0|||
161733764|NCT02883049|584067683|FG000|Induction|Protocol Violation|6|||
161733765|NCT02883049|584067684|FG001|Induction|Protocol Violation|0|||
161733766|NCT02883049|584067685|FG002|Induction|Protocol Violation|0|||
161733767|NCT02883049|584067686|FG003|Induction|Protocol Violation|0|||
161733768|NCT02883049|584067687|FG004|Induction|Protocol Violation|0|||
161733769|NCT02883049|584067688|FG005|Induction|Protocol Violation|0|||
161733770|NCT02883049|584067689|FG006|Induction|Protocol Violation|0|||
161733771|NCT02883049|584067690|FG007|Induction|Protocol Violation|0|||
161733772|NCT02883049|584067691|FG008|Induction|Protocol Violation|0|||
161733773|NCT02883049|584067692|FG009|Induction|Protocol Violation|0|||
161733774|NCT02883049|584067693|FG010|Induction|Protocol Violation|0|||
161733775|NCT02883049|584067694|FG011|Induction|Protocol Violation|0|||
161733776|NCT02883049|584067695|FG012|Induction|Protocol Violation|0|||
161733777|NCT02883049|584067696|FG013|Induction|Protocol Violation|0|||
161733778|NCT02883049|584067697|FG014|Induction|Protocol Violation|0|||
161733779|NCT02883049|584067698|FG015|Induction|Protocol Violation|0|||
161733780|NCT02883049|584067683|FG000|Induction|Withdrawal by Subject|6|||
161733781|NCT02883049|584067684|FG001|Induction|Withdrawal by Subject|0|||
161733782|NCT02883049|584067685|FG002|Induction|Withdrawal by Subject|0|||
161733783|NCT02883049|584067686|FG003|Induction|Withdrawal by Subject|0|||
161733784|NCT02883049|584067687|FG004|Induction|Withdrawal by Subject|0|||
161733785|NCT02883049|584067688|FG005|Induction|Withdrawal by Subject|0|||
161733786|NCT02883049|584067689|FG006|Induction|Withdrawal by Subject|0|||
161733787|NCT02883049|584067690|FG007|Induction|Withdrawal by Subject|0|||
161733788|NCT02883049|584067691|FG008|Induction|Withdrawal by Subject|0|||
161733789|NCT02883049|584067692|FG009|Induction|Withdrawal by Subject|0|||
161733790|NCT02883049|584067693|FG010|Induction|Withdrawal by Subject|0|||
161733791|NCT02883049|584067694|FG011|Induction|Withdrawal by Subject|0|||
161733792|NCT02883049|584067695|FG012|Induction|Withdrawal by Subject|0|||
161733793|NCT02883049|584067696|FG013|Induction|Withdrawal by Subject|0|||
161733794|NCT02883049|584067697|FG014|Induction|Withdrawal by Subject|0|||
161733795|NCT02883049|584067698|FG015|Induction|Withdrawal by Subject|0|||
161733796|NCT02883049|584067683|FG000|Induction|Ineligible|35|||
161733797|NCT02883049|584067684|FG001|Induction|Ineligible|1|||
161733798|NCT02883049|584067685|FG002|Induction|Ineligible|0|||
161733799|NCT02883049|584067686|FG003|Induction|Ineligible|0|||
161733800|NCT02883049|584067687|FG004|Induction|Ineligible|0|||
161733801|NCT02883049|584067688|FG005|Induction|Ineligible|0|||
161733802|NCT02883049|584067689|FG006|Induction|Ineligible|0|||
161733803|NCT02883049|584067690|FG007|Induction|Ineligible|0|||
161733804|NCT02883049|584067691|FG008|Induction|Ineligible|0|||
161733805|NCT02883049|584067692|FG009|Induction|Ineligible|0|||
161733806|NCT02883049|584067693|FG010|Induction|Ineligible|0|||
161733807|NCT02883049|584067694|FG011|Induction|Ineligible|0|||
161733808|NCT02883049|584067695|FG012|Induction|Ineligible|0|||
161733809|NCT02883049|584067696|FG013|Induction|Ineligible|0|||
161733810|NCT02883049|584067697|FG014|Induction|Ineligible|0|||
161733811|NCT02883049|584067698|FG015|Induction|Ineligible|0|||
161733812|NCT02883049|584067683|FG000|Induction|Refusal of further protocol therapy|466|||
161733813|NCT02883049|584067684|FG001|Induction|Refusal of further protocol therapy|2|||
161733814|NCT02883049|584067685|FG002|Induction|Refusal of further protocol therapy|0|||
161733815|NCT02883049|584067686|FG003|Induction|Refusal of further protocol therapy|0|||
161733816|NCT02883049|584067687|FG004|Induction|Refusal of further protocol therapy|0|||
161733817|NCT02883049|584067688|FG005|Induction|Refusal of further protocol therapy|0|||
161733818|NCT02883049|584067689|FG006|Induction|Refusal of further protocol therapy|0|||
161733819|NCT02883049|584067690|FG007|Induction|Refusal of further protocol therapy|0|||
161733820|NCT02883049|584067691|FG008|Induction|Refusal of further protocol therapy|0|||
161733821|NCT02883049|584067692|FG009|Induction|Refusal of further protocol therapy|0|||
161733822|NCT02883049|584067693|FG010|Induction|Refusal of further protocol therapy|0|||
161733823|NCT02883049|584067694|FG011|Induction|Refusal of further protocol therapy|0|||
161733824|NCT02883049|584067695|FG012|Induction|Refusal of further protocol therapy|0|||
161733825|NCT02883049|584067696|FG013|Induction|Refusal of further protocol therapy|0|||
161733826|NCT02883049|584067697|FG014|Induction|Refusal of further protocol therapy|0|||
161733827|NCT02883049|584067698|FG015|Induction|Refusal of further protocol therapy|0|||
161839630|NCT01183221|584458539|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
161733828|NCT02883049|584067683|FG000|Induction|Identified as Ph+ patients|279|||
161733829|NCT02883049|584067684|FG001|Induction|Identified as Ph+ patients|1|||
161733830|NCT02883049|584067685|FG002|Induction|Identified as Ph+ patients|0|||
161733831|NCT02883049|584067686|FG003|Induction|Identified as Ph+ patients|0|||
161733832|NCT02883049|584067687|FG004|Induction|Identified as Ph+ patients|0|||
161733833|NCT02883049|584067688|FG005|Induction|Identified as Ph+ patients|0|||
161733834|NCT02883049|584067689|FG006|Induction|Identified as Ph+ patients|0|||
161733835|NCT02883049|584067690|FG007|Induction|Identified as Ph+ patients|0|||
161733836|NCT02883049|584067691|FG008|Induction|Identified as Ph+ patients|0|||
161733837|NCT02883049|584067692|FG009|Induction|Identified as Ph+ patients|0|||
161733838|NCT02883049|584067693|FG010|Induction|Identified as Ph+ patients|0|||
161733839|NCT02883049|584067694|FG011|Induction|Identified as Ph+ patients|0|||
161733840|NCT02883049|584067695|FG012|Induction|Identified as Ph+ patients|0|||
161733841|NCT02883049|584067696|FG013|Induction|Identified as Ph+ patients|0|||
161733842|NCT02883049|584067697|FG014|Induction|Identified as Ph+ patients|0|||
161733843|NCT02883049|584067698|FG015|Induction|Identified as Ph+ patients|0|||
161733844|NCT02883049|584067683|FG000|Induction|M3 Marrow at Day29|8|||
161733845|NCT02883049|584067684|FG001|Induction|M3 Marrow at Day29|1|||
161733846|NCT02883049|584067685|FG002|Induction|M3 Marrow at Day29|0|||
161733847|NCT02883049|584067686|FG003|Induction|M3 Marrow at Day29|0|||
161733848|NCT02883049|584067687|FG004|Induction|M3 Marrow at Day29|0|||
161733849|NCT02883049|584067688|FG005|Induction|M3 Marrow at Day29|0|||
161733850|NCT02883049|584067689|FG006|Induction|M3 Marrow at Day29|0|||
161733851|NCT02883049|584067690|FG007|Induction|M3 Marrow at Day29|0|||
161733852|NCT02883049|584067691|FG008|Induction|M3 Marrow at Day29|0|||
161733853|NCT02883049|584067692|FG009|Induction|M3 Marrow at Day29|0|||
161733854|NCT02883049|584067693|FG010|Induction|M3 Marrow at Day29|0|||
161733855|NCT02883049|584067694|FG011|Induction|M3 Marrow at Day29|0|||
161733856|NCT02883049|584067695|FG012|Induction|M3 Marrow at Day29|0|||
161733857|NCT02883049|584067696|FG013|Induction|M3 Marrow at Day29|0|||
161733858|NCT02883049|584067697|FG014|Induction|M3 Marrow at Day29|0|||
161733859|NCT02883049|584067698|FG015|Induction|M3 Marrow at Day29|0|||
161733860|NCT02883049|584067683|FG000|Induction|Inevaluable|33|||
161733861|NCT02883049|584067684|FG001|Induction|Inevaluable|1|||
161733862|NCT02883049|584067685|FG002|Induction|Inevaluable|0|||
161733863|NCT02883049|584067686|FG003|Induction|Inevaluable|0|||
161733864|NCT02883049|584067687|FG004|Induction|Inevaluable|0|||
161733865|NCT02883049|584067688|FG005|Induction|Inevaluable|0|||
161733866|NCT02883049|584067689|FG006|Induction|Inevaluable|0|||
161733867|NCT02883049|584067690|FG007|Induction|Inevaluable|0|||
161733868|NCT02883049|584067691|FG008|Induction|Inevaluable|0|||
161733869|NCT02883049|584067692|FG009|Induction|Inevaluable|0|||
161733870|NCT02883049|584067693|FG010|Induction|Inevaluable|0|||
161733871|NCT02883049|584067694|FG011|Induction|Inevaluable|0|||
161733872|NCT02883049|584067695|FG012|Induction|Inevaluable|0|||
161733873|NCT02883049|584067696|FG013|Induction|Inevaluable|0|||
161733874|NCT02883049|584067697|FG014|Induction|Inevaluable|0|||
161733875|NCT02883049|584067698|FG015|Induction|Inevaluable|0|||
161733876|NCT02883049|584067683|FG000|Induction|Identified as VHR at end of Induction|244|||
161733877|NCT02883049|584067684|FG001|Induction|Identified as VHR at end of Induction|0|||
161733878|NCT02883049|584067685|FG002|Induction|Identified as VHR at end of Induction|0|||
161733879|NCT02883049|584067686|FG003|Induction|Identified as VHR at end of Induction|0|||
161733880|NCT02883049|584067687|FG004|Induction|Identified as VHR at end of Induction|0|||
161733881|NCT02883049|584067688|FG005|Induction|Identified as VHR at end of Induction|0|||
161733882|NCT02883049|584067689|FG006|Induction|Identified as VHR at end of Induction|0|||
161733883|NCT02883049|584067690|FG007|Induction|Identified as VHR at end of Induction|0|||
161733884|NCT02883049|584067691|FG008|Induction|Identified as VHR at end of Induction|0|||
161733885|NCT02883049|584067692|FG009|Induction|Identified as VHR at end of Induction|0|||
161733886|NCT02883049|584067693|FG010|Induction|Identified as VHR at end of Induction|0|||
161733887|NCT02883049|584067694|FG011|Induction|Identified as VHR at end of Induction|0|||
161733888|NCT02883049|584067695|FG012|Induction|Identified as VHR at end of Induction|0|||
161733889|NCT02883049|584067696|FG013|Induction|Identified as VHR at end of Induction|0|||
161733890|NCT02883049|584067697|FG014|Induction|Identified as VHR at end of Induction|0|||
161733891|NCT02883049|584067698|FG015|Induction|Identified as VHR at end of Induction|0|||
161733892|NCT02883049|584067683|FG000|Induction|Moved to another non-COG institution|3|||
161733893|NCT02883049|584067684|FG001|Induction|Moved to another non-COG institution|0|||
161733894|NCT02883049|584067685|FG002|Induction|Moved to another non-COG institution|0|||
161733895|NCT02883049|584067686|FG003|Induction|Moved to another non-COG institution|0|||
161733896|NCT02883049|584067687|FG004|Induction|Moved to another non-COG institution|0|||
161733897|NCT02883049|584067688|FG005|Induction|Moved to another non-COG institution|0|||
161733898|NCT02883049|584067689|FG006|Induction|Moved to another non-COG institution|0|||
161733899|NCT02883049|584067690|FG007|Induction|Moved to another non-COG institution|0|||
161733900|NCT02883049|584067691|FG008|Induction|Moved to another non-COG institution|0|||
161733901|NCT02883049|584067692|FG009|Induction|Moved to another non-COG institution|0|||
161733902|NCT02883049|584067693|FG010|Induction|Moved to another non-COG institution|0|||
161733903|NCT02883049|584067694|FG011|Induction|Moved to another non-COG institution|0|||
161733904|NCT02883049|584067695|FG012|Induction|Moved to another non-COG institution|0|||
161733905|NCT02883049|584067696|FG013|Induction|Moved to another non-COG institution|0|||
161733906|NCT02883049|584067697|FG014|Induction|Moved to another non-COG institution|0|||
161733907|NCT02883049|584067698|FG015|Induction|Moved to another non-COG institution|0|||
161733908|NCT02883049|584067683|FG000|Induction|Randomization closed|41|||
161733909|NCT02883049|584067684|FG001|Induction|Randomization closed|0|||
161733910|NCT02883049|584067685|FG002|Induction|Randomization closed|0|||
161733911|NCT02883049|584067686|FG003|Induction|Randomization closed|0|||
161733912|NCT02883049|584067687|FG004|Induction|Randomization closed|0|||
161733913|NCT02883049|584067688|FG005|Induction|Randomization closed|0|||
161733914|NCT02883049|584067689|FG006|Induction|Randomization closed|0|||
161733915|NCT02883049|584067690|FG007|Induction|Randomization closed|0|||
161733916|NCT02883049|584067691|FG008|Induction|Randomization closed|0|||
161733917|NCT02883049|584067692|FG009|Induction|Randomization closed|0|||
161733918|NCT02883049|584067693|FG010|Induction|Randomization closed|0|||
161733919|NCT02883049|584067694|FG011|Induction|Randomization closed|0|||
161733920|NCT02883049|584067695|FG012|Induction|Randomization closed|0|||
161733921|NCT02883049|584067696|FG013|Induction|Randomization closed|0|||
161733922|NCT02883049|584067697|FG014|Induction|Randomization closed|0|||
161733923|NCT02883049|584067698|FG015|Induction|Randomization closed|0|||
161733924|NCT02883049|584067683|FG000|Induction|MRD negative|36|||
161733925|NCT02883049|584067684|FG001|Induction|MRD negative|0|||
161733926|NCT02883049|584067685|FG002|Induction|MRD negative|0|||
161733927|NCT02883049|584067686|FG003|Induction|MRD negative|0|||
161733928|NCT02883049|584067687|FG004|Induction|MRD negative|0|||
161733929|NCT02883049|584067688|FG005|Induction|MRD negative|0|||
161733930|NCT02883049|584067689|FG006|Induction|MRD negative|0|||
161733931|NCT02883049|584067690|FG007|Induction|MRD negative|0|||
161733932|NCT02883049|584067691|FG008|Induction|MRD negative|0|||
161733933|NCT02883049|584067692|FG009|Induction|MRD negative|0|||
161733934|NCT02883049|584067693|FG010|Induction|MRD negative|0|||
161733935|NCT02883049|584067694|FG011|Induction|MRD negative|0|||
161733936|NCT02883049|584067695|FG012|Induction|MRD negative|0|||
161733937|NCT02883049|584067696|FG013|Induction|MRD negative|0|||
161733938|NCT02883049|584067697|FG014|Induction|MRD negative|0|||
161733939|NCT02883049|584067698|FG015|Induction|MRD negative|0|||
161733940|NCT02883049|584067683|FG000|Induction|Identified as HR patients|165|||
161733941|NCT02883049|584067684|FG001|Induction|Identified as HR patients|0|||
161733942|NCT02883049|584067685|FG002|Induction|Identified as HR patients|0|||
161733943|NCT02883049|584067686|FG003|Induction|Identified as HR patients|0|||
161733944|NCT02883049|584067687|FG004|Induction|Identified as HR patients|0|||
161733945|NCT02883049|584067688|FG005|Induction|Identified as HR patients|0|||
161733946|NCT02883049|584067689|FG006|Induction|Identified as HR patients|0|||
161733947|NCT02883049|584067690|FG007|Induction|Identified as HR patients|0|||
161733948|NCT02883049|584067691|FG008|Induction|Identified as HR patients|0|||
161733949|NCT02883049|584067692|FG009|Induction|Identified as HR patients|0|||
161733950|NCT02883049|584067693|FG010|Induction|Identified as HR patients|0|||
161733951|NCT02883049|584067694|FG011|Induction|Identified as HR patients|0|||
161733952|NCT02883049|584067695|FG012|Induction|Identified as HR patients|0|||
161733953|NCT02883049|584067696|FG013|Induction|Identified as HR patients|0|||
161733954|NCT02883049|584067697|FG014|Induction|Identified as HR patients|0|||
161733955|NCT02883049|584067698|FG015|Induction|Identified as HR patients|0|||
161733956|NCT02883049|584067683|FG000|Induction|Developed SMN|0|||
161733957|NCT02883049|584067684|FG001|Induction|Developed SMN|1|||
161733958|NCT02883049|584067685|FG002|Induction|Developed SMN|0|||
161733959|NCT02883049|584067686|FG003|Induction|Developed SMN|0|||
161733960|NCT02883049|584067687|FG004|Induction|Developed SMN|0|||
161733961|NCT02883049|584067688|FG005|Induction|Developed SMN|0|||
161733962|NCT02883049|584067689|FG006|Induction|Developed SMN|0|||
161839631|NCT03596151|584458544|FG000|Overall Study|Withdrawal by Subject|1|||
161733963|NCT02883049|584067690|FG007|Induction|Developed SMN|0|||
161733964|NCT02883049|584067691|FG008|Induction|Developed SMN|0|||
161733965|NCT02883049|584067692|FG009|Induction|Developed SMN|0|||
161839632|NCT00807248|584458546|FG000|Overall Study|Adverse Event|1|||
161839633|NCT00807248|584458547|FG001|Overall Study|Adverse Event|2|||
161839634|NCT00807248|584458548|FG002|Overall Study|Adverse Event|2|||
161839635|NCT00807248|584458549|FG003|Overall Study|Adverse Event|6|||
161839636|NCT00807248|584458546|FG000|Overall Study|Lack of Efficacy|14|||
161839637|NCT00807248|584458547|FG001|Overall Study|Lack of Efficacy|4|||
161839638|NCT00807248|584458548|FG002|Overall Study|Lack of Efficacy|8|||
161839639|NCT00807248|584458549|FG003|Overall Study|Lack of Efficacy|3|||
161839640|NCT00807248|584458546|FG000|Overall Study|Protocol Violation|0|||
161839641|NCT00807248|584458547|FG001|Overall Study|Protocol Violation|1|||
161839642|NCT00807248|584458548|FG002|Overall Study|Protocol Violation|1|||
161733966|NCT02883049|584067693|FG010|Induction|Developed SMN|0|||
161733967|NCT02883049|584067694|FG011|Induction|Developed SMN|0|||
161733968|NCT02883049|584067695|FG012|Induction|Developed SMN|0|||
161733969|NCT02883049|584067696|FG013|Induction|Developed SMN|0|||
161733970|NCT02883049|584067697|FG014|Induction|Developed SMN|0|||
161733971|NCT02883049|584067698|FG015|Induction|Developed SMN|0|||
161733972|NCT02883049|584067683|FG000|Induction|Enrolled onto another COG study|72|||
161733973|NCT02883049|584067684|FG001|Induction|Enrolled onto another COG study|0|||
161733974|NCT02883049|584067685|FG002|Induction|Enrolled onto another COG study|0|||
161733975|NCT02883049|584067686|FG003|Induction|Enrolled onto another COG study|0|||
161733976|NCT02883049|584067687|FG004|Induction|Enrolled onto another COG study|0|||
161733977|NCT02883049|584067688|FG005|Induction|Enrolled onto another COG study|0|||
161733978|NCT02883049|584067689|FG006|Induction|Enrolled onto another COG study|0|||
161733979|NCT02883049|584067690|FG007|Induction|Enrolled onto another COG study|0|||
161733980|NCT02883049|584067691|FG008|Induction|Enrolled onto another COG study|0|||
161733981|NCT02883049|584067692|FG009|Induction|Enrolled onto another COG study|0|||
161733982|NCT02883049|584067693|FG010|Induction|Enrolled onto another COG study|0|||
161733983|NCT02883049|584067694|FG011|Induction|Enrolled onto another COG study|0|||
161733984|NCT02883049|584067695|FG012|Induction|Enrolled onto another COG study|0|||
161733985|NCT02883049|584067696|FG013|Induction|Enrolled onto another COG study|0|||
161733986|NCT02883049|584067697|FG014|Induction|Enrolled onto another COG study|0|||
161733987|NCT02883049|584067698|FG015|Induction|Enrolled onto another COG study|0|||
161733988|NCT02883049|584067683|FG000|Induction|Incomplete induction data|17|||
161733989|NCT02883049|584067684|FG001|Induction|Incomplete induction data|0|||
161733990|NCT02883049|584067685|FG002|Induction|Incomplete induction data|0|||
161733991|NCT02883049|584067686|FG003|Induction|Incomplete induction data|0|||
161733992|NCT02883049|584067687|FG004|Induction|Incomplete induction data|0|||
161733993|NCT02883049|584067688|FG005|Induction|Incomplete induction data|0|||
161733994|NCT02883049|584067689|FG006|Induction|Incomplete induction data|0|||
161733995|NCT02883049|584067690|FG007|Induction|Incomplete induction data|0|||
161733996|NCT02883049|584067691|FG008|Induction|Incomplete induction data|0|||
161733997|NCT02883049|584067692|FG009|Induction|Incomplete induction data|0|||
161733998|NCT02883049|584067693|FG010|Induction|Incomplete induction data|0|||
161733999|NCT02883049|584067694|FG011|Induction|Incomplete induction data|0|||
161734000|NCT02883049|584067695|FG012|Induction|Incomplete induction data|0|||
161734001|NCT02883049|584067696|FG013|Induction|Incomplete induction data|0|||
161734002|NCT02883049|584067697|FG014|Induction|Incomplete induction data|0|||
161734003|NCT02883049|584067698|FG015|Induction|Incomplete induction data|0|||
161734004|NCT02883049|584067683|FG000|Post Induction|Adverse Event|0|||
161734005|NCT02883049|584067684|FG001|Post Induction|Adverse Event|0|||
161734006|NCT02883049|584067685|FG002|Post Induction|Adverse Event|0|||
161734007|NCT02883049|584067686|FG003|Post Induction|Adverse Event|7|||
161734008|NCT02883049|584067687|FG004|Post Induction|Adverse Event|8|||
161734009|NCT02883049|584067688|FG005|Post Induction|Adverse Event|3|||
161734010|NCT02883049|584067689|FG006|Post Induction|Adverse Event|4|||
161734011|NCT02883049|584067690|FG007|Post Induction|Adverse Event|5|||
161734012|NCT02883049|584067691|FG008|Post Induction|Adverse Event|6|||
161734013|NCT02883049|584067692|FG009|Post Induction|Adverse Event|7|||
161734014|NCT02883049|584067693|FG010|Post Induction|Adverse Event|2|||
161734015|NCT02883049|584067694|FG011|Post Induction|Adverse Event|2|||
161734016|NCT02883049|584067695|FG012|Post Induction|Adverse Event|0|||
161734017|NCT02883049|584067696|FG013|Post Induction|Adverse Event|0|||
161734018|NCT02883049|584067697|FG014|Post Induction|Adverse Event|5|||
161734019|NCT02883049|584067698|FG015|Post Induction|Adverse Event|2|||
161839643|NCT00807248|584458549|FG003|Overall Study|Protocol Violation|0|||
161839644|NCT00807248|584458546|FG000|Overall Study|Withdrawal of Consent|5|||
161839645|NCT00807248|584458547|FG001|Overall Study|Withdrawal of Consent|5|||
161734020|NCT02883049|584067683|FG000|Post Induction|Death|0|||
161839646|NCT00807248|584458548|FG002|Overall Study|Withdrawal of Consent|5|||
161839647|NCT00807248|584458549|FG003|Overall Study|Withdrawal of Consent|5|||
161839648|NCT00807248|584458546|FG000|Overall Study|Lost to Follow-up|1|||
161839649|NCT00807248|584458547|FG001|Overall Study|Lost to Follow-up|0|||
161839650|NCT00807248|584458548|FG002|Overall Study|Lost to Follow-up|0|||
161734021|NCT02883049|584067684|FG001|Post Induction|Death|0|||
161734022|NCT02883049|584067685|FG002|Post Induction|Death|0|||
161734023|NCT02883049|584067686|FG003|Post Induction|Death|9|||
161734024|NCT02883049|584067687|FG004|Post Induction|Death|9|||
161734025|NCT02883049|584067688|FG005|Post Induction|Death|0|||
161734026|NCT02883049|584067689|FG006|Post Induction|Death|1|||
161734027|NCT02883049|584067690|FG007|Post Induction|Death|6|||
161734028|NCT02883049|584067691|FG008|Post Induction|Death|5|||
161734029|NCT02883049|584067692|FG009|Post Induction|Death|3|||
161839651|NCT00807248|584458549|FG003|Overall Study|Lost to Follow-up|0|||
161734030|NCT02883049|584067693|FG010|Post Induction|Death|1|||
161734031|NCT02883049|584067694|FG011|Post Induction|Death|0|||
161734032|NCT02883049|584067695|FG012|Post Induction|Death|1|||
161734033|NCT02883049|584067696|FG013|Post Induction|Death|1|||
161734034|NCT02883049|584067697|FG014|Post Induction|Death|10|||
161734035|NCT02883049|584067698|FG015|Post Induction|Death|2|||
161734036|NCT02883049|584067683|FG000|Post Induction|Lost to Follow-up|0|||
161734037|NCT02883049|584067684|FG001|Post Induction|Lost to Follow-up|0|||
161734038|NCT02883049|584067685|FG002|Post Induction|Lost to Follow-up|0|||
161734039|NCT02883049|584067686|FG003|Post Induction|Lost to Follow-up|0|||
161734040|NCT02883049|584067687|FG004|Post Induction|Lost to Follow-up|1|||
161734041|NCT02883049|584067688|FG005|Post Induction|Lost to Follow-up|1|||
161734042|NCT02883049|584067689|FG006|Post Induction|Lost to Follow-up|0|||
161734043|NCT02883049|584067690|FG007|Post Induction|Lost to Follow-up|0|||
161734044|NCT02883049|584067691|FG008|Post Induction|Lost to Follow-up|3|||
161734045|NCT02883049|584067692|FG009|Post Induction|Lost to Follow-up|0|||
161734046|NCT02883049|584067693|FG010|Post Induction|Lost to Follow-up|1|||
161734047|NCT02883049|584067694|FG011|Post Induction|Lost to Follow-up|0|||
161734048|NCT02883049|584067695|FG012|Post Induction|Lost to Follow-up|0|||
161734049|NCT02883049|584067696|FG013|Post Induction|Lost to Follow-up|0|||
161734050|NCT02883049|584067697|FG014|Post Induction|Lost to Follow-up|0|||
161734051|NCT02883049|584067698|FG015|Post Induction|Lost to Follow-up|0|||
161734052|NCT02883049|584067683|FG000|Post Induction|Physician Decision|0|||
161734053|NCT02883049|584067684|FG001|Post Induction|Physician Decision|0|||
161734054|NCT02883049|584067685|FG002|Post Induction|Physician Decision|0|||
161734055|NCT02883049|584067686|FG003|Post Induction|Physician Decision|27|||
161734056|NCT02883049|584067687|FG004|Post Induction|Physician Decision|27|||
161734057|NCT02883049|584067688|FG005|Post Induction|Physician Decision|23|||
161734058|NCT02883049|584067689|FG006|Post Induction|Physician Decision|30|||
161734059|NCT02883049|584067690|FG007|Post Induction|Physician Decision|56|||
161734060|NCT02883049|584067691|FG008|Post Induction|Physician Decision|85|||
161734061|NCT02883049|584067692|FG009|Post Induction|Physician Decision|12|||
161734062|NCT02883049|584067693|FG010|Post Induction|Physician Decision|5|||
161734063|NCT02883049|584067694|FG011|Post Induction|Physician Decision|14|||
161734064|NCT02883049|584067695|FG012|Post Induction|Physician Decision|1|||
161734065|NCT02883049|584067696|FG013|Post Induction|Physician Decision|11|||
161734066|NCT02883049|584067697|FG014|Post Induction|Physician Decision|19|||
161734067|NCT02883049|584067698|FG015|Post Induction|Physician Decision|5|||
161734068|NCT02883049|584067683|FG000|Post Induction|Protocol Violation|0|||
161734069|NCT02883049|584067684|FG001|Post Induction|Protocol Violation|0|||
161734070|NCT02883049|584067685|FG002|Post Induction|Protocol Violation|0|||
161734071|NCT02883049|584067686|FG003|Post Induction|Protocol Violation|0|||
161734072|NCT02883049|584067687|FG004|Post Induction|Protocol Violation|0|||
161734073|NCT02883049|584067688|FG005|Post Induction|Protocol Violation|0|||
161734074|NCT02883049|584067689|FG006|Post Induction|Protocol Violation|0|||
161734075|NCT02883049|584067690|FG007|Post Induction|Protocol Violation|1|||
161734076|NCT02883049|584067691|FG008|Post Induction|Protocol Violation|0|||
161734077|NCT02883049|584067692|FG009|Post Induction|Protocol Violation|0|||
161734078|NCT02883049|584067693|FG010|Post Induction|Protocol Violation|0|||
161734079|NCT02883049|584067694|FG011|Post Induction|Protocol Violation|0|||
161734080|NCT02883049|584067695|FG012|Post Induction|Protocol Violation|0|||
161734081|NCT02883049|584067696|FG013|Post Induction|Protocol Violation|0|||
161734082|NCT02883049|584067697|FG014|Post Induction|Protocol Violation|0|||
161734083|NCT02883049|584067698|FG015|Post Induction|Protocol Violation|0|||
161734084|NCT02883049|584067683|FG000|Post Induction|Withdrawal by Subject|0|||
161734085|NCT02883049|584067684|FG001|Post Induction|Withdrawal by Subject|0|||
161734086|NCT02883049|584067685|FG002|Post Induction|Withdrawal by Subject|0|||
161734087|NCT02883049|584067686|FG003|Post Induction|Withdrawal by Subject|5|||
161734088|NCT02883049|584067687|FG004|Post Induction|Withdrawal by Subject|2|||
161839652|NCT00807248|584458546|FG000|Overall Study|Other Reason|0|||
161839653|NCT00807248|584458547|FG001|Overall Study|Other Reason|0|||
161839654|NCT00807248|584458548|FG002|Overall Study|Other Reason|2|||
161839655|NCT00807248|584458549|FG003|Overall Study|Other Reason|0|||
161839656|NCT02444793|584458550|FG000|Overall Study|Lost to Follow-up|2|||
161839657|NCT02444793|584458551|FG001|Overall Study|Lost to Follow-up|2|||
161734089|NCT02883049|584067688|FG005|Post Induction|Withdrawal by Subject|1|||
161734090|NCT02883049|584067689|FG006|Post Induction|Withdrawal by Subject|0|||
161734091|NCT02883049|584067690|FG007|Post Induction|Withdrawal by Subject|0|||
161734092|NCT02883049|584067691|FG008|Post Induction|Withdrawal by Subject|2|||
161734093|NCT02883049|584067692|FG009|Post Induction|Withdrawal by Subject|0|||
161734094|NCT02883049|584067693|FG010|Post Induction|Withdrawal by Subject|1|||
161734095|NCT02883049|584067694|FG011|Post Induction|Withdrawal by Subject|1|||
161734096|NCT02883049|584067695|FG012|Post Induction|Withdrawal by Subject|0|||
161734097|NCT02883049|584067696|FG013|Post Induction|Withdrawal by Subject|0|||
161734098|NCT02883049|584067697|FG014|Post Induction|Withdrawal by Subject|1|||
161734099|NCT02883049|584067698|FG015|Post Induction|Withdrawal by Subject|0|||
161734100|NCT02883049|584067683|FG000|Post Induction|Ineligible|0|||
161734101|NCT02883049|584067684|FG001|Post Induction|Ineligible|0|||
161734102|NCT02883049|584067685|FG002|Post Induction|Ineligible|2|||
161734103|NCT02883049|584067686|FG003|Post Induction|Ineligible|0|||
161839658|NCT02444793|584458552|FG002|Overall Study|Lost to Follow-up|0|||
161734104|NCT02883049|584067687|FG004|Post Induction|Ineligible|0|||
161734105|NCT02883049|584067688|FG005|Post Induction|Ineligible|0|||
161734106|NCT02883049|584067689|FG006|Post Induction|Ineligible|1|||
161734107|NCT02883049|584067690|FG007|Post Induction|Ineligible|0|||
161734108|NCT02883049|584067691|FG008|Post Induction|Ineligible|0|||
161734109|NCT02883049|584067692|FG009|Post Induction|Ineligible|0|||
161734110|NCT02883049|584067693|FG010|Post Induction|Ineligible|1|||
161734111|NCT02883049|584067694|FG011|Post Induction|Ineligible|0|||
161734112|NCT02883049|584067695|FG012|Post Induction|Ineligible|0|||
161734113|NCT02883049|584067696|FG013|Post Induction|Ineligible|0|||
161734114|NCT02883049|584067697|FG014|Post Induction|Ineligible|0|||
161734115|NCT02883049|584067698|FG015|Post Induction|Ineligible|1|||
161734116|NCT02883049|584067683|FG000|Post Induction|Refusal of further protocol therapy|0|||
161734117|NCT02883049|584067684|FG001|Post Induction|Refusal of further protocol therapy|0|||
161734118|NCT02883049|584067685|FG002|Post Induction|Refusal of further protocol therapy|0|||
161734119|NCT02883049|584067686|FG003|Post Induction|Refusal of further protocol therapy|11|||
161734120|NCT02883049|584067687|FG004|Post Induction|Refusal of further protocol therapy|15|||
161734121|NCT02883049|584067688|FG005|Post Induction|Refusal of further protocol therapy|9|||
161734122|NCT02883049|584067689|FG006|Post Induction|Refusal of further protocol therapy|13|||
161734123|NCT02883049|584067690|FG007|Post Induction|Refusal of further protocol therapy|5|||
161734124|NCT02883049|584067691|FG008|Post Induction|Refusal of further protocol therapy|21|||
161734125|NCT02883049|584067692|FG009|Post Induction|Refusal of further protocol therapy|7|||
161734126|NCT02883049|584067693|FG010|Post Induction|Refusal of further protocol therapy|0|||
161734127|NCT02883049|584067694|FG011|Post Induction|Refusal of further protocol therapy|7|||
161734128|NCT02883049|584067695|FG012|Post Induction|Refusal of further protocol therapy|3|||
161734129|NCT02883049|584067696|FG013|Post Induction|Refusal of further protocol therapy|0|||
161734130|NCT02883049|584067697|FG014|Post Induction|Refusal of further protocol therapy|4|||
161734131|NCT02883049|584067698|FG015|Post Induction|Refusal of further protocol therapy|1|||
161734132|NCT02883049|584067683|FG000|Post Induction|Inevaluable|0|||
161734133|NCT02883049|584067684|FG001|Post Induction|Inevaluable|0|||
161734134|NCT02883049|584067685|FG002|Post Induction|Inevaluable|0|||
161734135|NCT02883049|584067686|FG003|Post Induction|Inevaluable|1|||
161734136|NCT02883049|584067687|FG004|Post Induction|Inevaluable|1|||
161734137|NCT02883049|584067688|FG005|Post Induction|Inevaluable|2|||
161734138|NCT02883049|584067689|FG006|Post Induction|Inevaluable|7|||
161734139|NCT02883049|584067690|FG007|Post Induction|Inevaluable|6|||
161734140|NCT02883049|584067691|FG008|Post Induction|Inevaluable|4|||
161734141|NCT02883049|584067692|FG009|Post Induction|Inevaluable|4|||
161734142|NCT02883049|584067693|FG010|Post Induction|Inevaluable|1|||
161734143|NCT02883049|584067694|FG011|Post Induction|Inevaluable|1|||
161734144|NCT02883049|584067695|FG012|Post Induction|Inevaluable|2|||
161734145|NCT02883049|584067696|FG013|Post Induction|Inevaluable|0|||
161734146|NCT02883049|584067697|FG014|Post Induction|Inevaluable|0|||
161734147|NCT02883049|584067698|FG015|Post Induction|Inevaluable|1|||
161734148|NCT02883049|584067683|FG000|Post Induction|Moved to another non-COG institution|0|||
161734149|NCT02883049|584067684|FG001|Post Induction|Moved to another non-COG institution|0|||
161734150|NCT02883049|584067685|FG002|Post Induction|Moved to another non-COG institution|0|||
161734151|NCT02883049|584067686|FG003|Post Induction|Moved to another non-COG institution|0|||
161734152|NCT02883049|584067687|FG004|Post Induction|Moved to another non-COG institution|0|||
161734153|NCT02883049|584067688|FG005|Post Induction|Moved to another non-COG institution|0|||
161734154|NCT02883049|584067689|FG006|Post Induction|Moved to another non-COG institution|0|||
161734155|NCT02883049|584067690|FG007|Post Induction|Moved to another non-COG institution|2|||
161734156|NCT02883049|584067691|FG008|Post Induction|Moved to another non-COG institution|2|||
161734157|NCT02883049|584067692|FG009|Post Induction|Moved to another non-COG institution|0|||
161734158|NCT02883049|584067693|FG010|Post Induction|Moved to another non-COG institution|0|||
161734159|NCT02883049|584067694|FG011|Post Induction|Moved to another non-COG institution|1|||
161734160|NCT02883049|584067695|FG012|Post Induction|Moved to another non-COG institution|0|||
161734161|NCT02883049|584067696|FG013|Post Induction|Moved to another non-COG institution|0|||
161734162|NCT02883049|584067697|FG014|Post Induction|Moved to another non-COG institution|0|||
161734163|NCT02883049|584067698|FG015|Post Induction|Moved to another non-COG institution|0|||
161734164|NCT02883049|584067683|FG000|Post Induction|Randomization closed|0|||
161734165|NCT02883049|584067684|FG001|Post Induction|Randomization closed|0|||
161734166|NCT02883049|584067685|FG002|Post Induction|Randomization closed|0|||
161734167|NCT02883049|584067686|FG003|Post Induction|Randomization closed|0|||
161734168|NCT02883049|584067687|FG004|Post Induction|Randomization closed|0|||
161734169|NCT02883049|584067688|FG005|Post Induction|Randomization closed|0|||
161734170|NCT02883049|584067689|FG006|Post Induction|Randomization closed|0|||
161734171|NCT02883049|584067690|FG007|Post Induction|Randomization closed|20|||
161734172|NCT02883049|584067691|FG008|Post Induction|Randomization closed|0|||
161734173|NCT02883049|584067692|FG009|Post Induction|Randomization closed|0|||
161734174|NCT02883049|584067693|FG010|Post Induction|Randomization closed|0|||
161734175|NCT02883049|584067694|FG011|Post Induction|Randomization closed|0|||
161734176|NCT02883049|584067695|FG012|Post Induction|Randomization closed|0|||
161734177|NCT02883049|584067696|FG013|Post Induction|Randomization closed|0|||
161734178|NCT02883049|584067697|FG014|Post Induction|Randomization closed|0|||
161734179|NCT02883049|584067698|FG015|Post Induction|Randomization closed|0|||
161734180|NCT02883049|584067683|FG000|Post Induction|MRD negative|0|||
161734181|NCT02883049|584067684|FG001|Post Induction|MRD negative|0|||
161734182|NCT02883049|584067685|FG002|Post Induction|MRD negative|0|||
161734183|NCT02883049|584067686|FG003|Post Induction|MRD negative|0|||
161734184|NCT02883049|584067687|FG004|Post Induction|MRD negative|0|||
161734185|NCT02883049|584067688|FG005|Post Induction|MRD negative|0|||
161734186|NCT02883049|584067689|FG006|Post Induction|MRD negative|0|||
161734187|NCT02883049|584067690|FG007|Post Induction|MRD negative|11|||
161734188|NCT02883049|584067691|FG008|Post Induction|MRD negative|0|||
161734189|NCT02883049|584067692|FG009|Post Induction|MRD negative|0|||
161734190|NCT02883049|584067693|FG010|Post Induction|MRD negative|0|||
161734191|NCT02883049|584067694|FG011|Post Induction|MRD negative|0|||
161734192|NCT02883049|584067695|FG012|Post Induction|MRD negative|0|||
161734193|NCT02883049|584067696|FG013|Post Induction|MRD negative|0|||
161734194|NCT02883049|584067697|FG014|Post Induction|MRD negative|0|||
161734195|NCT02883049|584067698|FG015|Post Induction|MRD negative|0|||
161734196|NCT02883049|584067683|FG000|Post Induction|Developed SMN|0|||
161734197|NCT02883049|584067684|FG001|Post Induction|Developed SMN|0|||
161734198|NCT02883049|584067685|FG002|Post Induction|Developed SMN|0|||
161734199|NCT02883049|584067686|FG003|Post Induction|Developed SMN|0|||
161734200|NCT02883049|584067687|FG004|Post Induction|Developed SMN|1|||
161734201|NCT02883049|584067688|FG005|Post Induction|Developed SMN|0|||
161734202|NCT02883049|584067689|FG006|Post Induction|Developed SMN|1|||
161734203|NCT02883049|584067690|FG007|Post Induction|Developed SMN|0|||
161734204|NCT02883049|584067691|FG008|Post Induction|Developed SMN|0|||
161734205|NCT02883049|584067692|FG009|Post Induction|Developed SMN|0|||
161734206|NCT02883049|584067693|FG010|Post Induction|Developed SMN|1|||
161734207|NCT02883049|584067694|FG011|Post Induction|Developed SMN|1|||
161734208|NCT02883049|584067695|FG012|Post Induction|Developed SMN|0|||
161734209|NCT02883049|584067696|FG013|Post Induction|Developed SMN|0|||
161734210|NCT02883049|584067697|FG014|Post Induction|Developed SMN|1|||
161734211|NCT02883049|584067698|FG015|Post Induction|Developed SMN|0|||
161734212|NCT02883049|584067683|FG000|Post Induction|Enrolled onto another COG study|0|||
161734213|NCT02883049|584067684|FG001|Post Induction|Enrolled onto another COG study|0|||
161734214|NCT02883049|584067685|FG002|Post Induction|Enrolled onto another COG study|0|||
161734215|NCT02883049|584067686|FG003|Post Induction|Enrolled onto another COG study|1|||
161734216|NCT02883049|584067687|FG004|Post Induction|Enrolled onto another COG study|1|||
161734217|NCT02883049|584067688|FG005|Post Induction|Enrolled onto another COG study|0|||
161734218|NCT02883049|584067689|FG006|Post Induction|Enrolled onto another COG study|0|||
161734219|NCT02883049|584067690|FG007|Post Induction|Enrolled onto another COG study|4|||
161734220|NCT02883049|584067691|FG008|Post Induction|Enrolled onto another COG study|0|||
161734221|NCT02883049|584067692|FG009|Post Induction|Enrolled onto another COG study|0|||
161734222|NCT02883049|584067693|FG010|Post Induction|Enrolled onto another COG study|0|||
161734223|NCT02883049|584067694|FG011|Post Induction|Enrolled onto another COG study|2|||
161734224|NCT02883049|584067695|FG012|Post Induction|Enrolled onto another COG study|0|||
161734225|NCT02883049|584067696|FG013|Post Induction|Enrolled onto another COG study|1|||
161734226|NCT02883049|584067697|FG014|Post Induction|Enrolled onto another COG study|0|||
161734227|NCT02883049|584067698|FG015|Post Induction|Enrolled onto another COG study|0|||
161734228|NCT02883049|584067683|FG000|Post Induction|Recurrent leukemia|0|||
161734229|NCT02883049|584067684|FG001|Post Induction|Recurrent leukemia|0|||
161734230|NCT02883049|584067685|FG002|Post Induction|Recurrent leukemia|0|||
161734231|NCT02883049|584067686|FG003|Post Induction|Recurrent leukemia|17|||
161734232|NCT02883049|584067687|FG004|Post Induction|Recurrent leukemia|12|||
161734233|NCT02883049|584067688|FG005|Post Induction|Recurrent leukemia|4|||
161734234|NCT02883049|584067689|FG006|Post Induction|Recurrent leukemia|1|||
161734235|NCT02883049|584067690|FG007|Post Induction|Recurrent leukemia|13|||
161734236|NCT02883049|584067691|FG008|Post Induction|Recurrent leukemia|27|||
161734237|NCT02883049|584067692|FG009|Post Induction|Recurrent leukemia|5|||
161734238|NCT02883049|584067693|FG010|Post Induction|Recurrent leukemia|3|||
161734239|NCT02883049|584067694|FG011|Post Induction|Recurrent leukemia|12|||
161734240|NCT02883049|584067695|FG012|Post Induction|Recurrent leukemia|1|||
161734241|NCT02883049|584067696|FG013|Post Induction|Recurrent leukemia|1|||
161734242|NCT02883049|584067697|FG014|Post Induction|Recurrent leukemia|9|||
161734243|NCT02883049|584067698|FG015|Post Induction|Recurrent leukemia|3|||
161734244|NCT02883049|584067683|FG000|Post Induction|Induction Failure|0|||
161734245|NCT02883049|584067684|FG001|Post Induction|Induction Failure|0|||
161734246|NCT02883049|584067685|FG002|Post Induction|Induction Failure|0|||
161734247|NCT02883049|584067686|FG003|Post Induction|Induction Failure|0|||
161734248|NCT02883049|584067687|FG004|Post Induction|Induction Failure|0|||
161734249|NCT02883049|584067688|FG005|Post Induction|Induction Failure|0|||
161734250|NCT02883049|584067689|FG006|Post Induction|Induction Failure|0|||
161734251|NCT02883049|584067690|FG007|Post Induction|Induction Failure|2|||
161734252|NCT02883049|584067691|FG008|Post Induction|Induction Failure|2|||
161734253|NCT02883049|584067692|FG009|Post Induction|Induction Failure|0|||
161734254|NCT02883049|584067693|FG010|Post Induction|Induction Failure|0|||
161734255|NCT02883049|584067694|FG011|Post Induction|Induction Failure|0|||
161734256|NCT02883049|584067695|FG012|Post Induction|Induction Failure|0|||
161734257|NCT02883049|584067696|FG013|Post Induction|Induction Failure|2|||
161734258|NCT02883049|584067697|FG014|Post Induction|Induction Failure|0|||
161734259|NCT02883049|584067698|FG015|Post Induction|Induction Failure|0|||
161734260|NCT03421964|584067701|FG000|Overall Study|Lost to Follow-up|11|||
161734261|NCT03421964|584067702|FG001|Overall Study|Lost to Follow-up|21|||
161734262|NCT03421964|584067701|FG000|Overall Study|Withdrawal by Subject|9|||
161734263|NCT03421964|584067702|FG001|Overall Study|Withdrawal by Subject|3|||
161734264|NCT03421964|584067701|FG000|Overall Study|Incarcerated|1|||
161734265|NCT03421964|584067702|FG001|Overall Study|Incarcerated|0|||
161734266|NCT03421964|584067701|FG000|Overall Study|Inpt Treatment Facility|1|||
161734267|NCT03421964|584067702|FG001|Overall Study|Inpt Treatment Facility|1|||
161734268|NCT03421964|584067701|FG000|Overall Study|Virtual Platform Issues|1|||
161734269|NCT03421964|584067702|FG001|Overall Study|Virtual Platform Issues|1|||
161734270|NCT02106455|584067710|FG000|Overall Study|Case Report Form Uncollected|6|||
161734271|NCT02106455|584067710|FG000|Overall Study|Protocol Deviation|2|||
161734272|NCT03364608|584067711|FG000|Overall Study|Withdrawal by Subject|4|||
161734273|NCT03364608|584067711|FG000|Overall Study|Protocol Violation|2|||
161734274|NCT03364608|584067711|FG000|Overall Study|Lost to Follow-up|2|||
161734275|NCT03888391|584067712|FG000|Overall Study|Lost to Follow-up|15|||
161734276|NCT02504268|584067715|FG000|Overall Study|Adverse Event|18|||
161734277|NCT02504268|584067716|FG001|Overall Study|Adverse Event|8|||
161734278|NCT02504268|584067717|FG002|Overall Study|Adverse Event|14|||
161734279|NCT02504268|584067718|FG003|Overall Study|Adverse Event|0|||
161734280|NCT02504268|584067719|FG004|Overall Study|Adverse Event|0|||
161734281|NCT02504268|584067720|FG005|Overall Study|Adverse Event|0|||
161734282|NCT02504268|584067721|FG006|Overall Study|Adverse Event|0|||
161734283|NCT02504268|584067722|FG007|Overall Study|Adverse Event|0|||
161734284|NCT02504268|584067723|FG008|Overall Study|Adverse Event|0|||
161734285|NCT02504268|584067715|FG000|Overall Study|Withdrawal of Consent|11|||
161734286|NCT02504268|584067716|FG001|Overall Study|Withdrawal of Consent|10|||
161734287|NCT02504268|584067717|FG002|Overall Study|Withdrawal of Consent|3|||
161734288|NCT02504268|584067718|FG003|Overall Study|Withdrawal of Consent|0|||
161734289|NCT02504268|584067719|FG004|Overall Study|Withdrawal of Consent|0|||
161734290|NCT02504268|584067720|FG005|Overall Study|Withdrawal of Consent|0|||
161734291|NCT02504268|584067721|FG006|Overall Study|Withdrawal of Consent|0|||
161734292|NCT02504268|584067722|FG007|Overall Study|Withdrawal of Consent|0|||
161734293|NCT02504268|584067723|FG008|Overall Study|Withdrawal of Consent|0|||
161734294|NCT02504268|584067715|FG000|Overall Study|Pregnancy|2|||
161734295|NCT02504268|584067716|FG001|Overall Study|Pregnancy|0|||
161734296|NCT02504268|584067717|FG002|Overall Study|Pregnancy|0|||
161734297|NCT02504268|584067718|FG003|Overall Study|Pregnancy|0|||
161734298|NCT02504268|584067719|FG004|Overall Study|Pregnancy|0|||
161734299|NCT02504268|584067720|FG005|Overall Study|Pregnancy|0|||
161734300|NCT02504268|584067721|FG006|Overall Study|Pregnancy|0|||
161734301|NCT02504268|584067722|FG007|Overall Study|Pregnancy|0|||
161734302|NCT02504268|584067723|FG008|Overall Study|Pregnancy|0|||
161734303|NCT02504268|584067715|FG000|Overall Study|Lost to Follow-up|3|||
161734304|NCT02504268|584067716|FG001|Overall Study|Lost to Follow-up|6|||
161734305|NCT02504268|584067717|FG002|Overall Study|Lost to Follow-up|4|||
161734306|NCT02504268|584067718|FG003|Overall Study|Lost to Follow-up|0|||
161734307|NCT02504268|584067719|FG004|Overall Study|Lost to Follow-up|0|||
161734308|NCT02504268|584067720|FG005|Overall Study|Lost to Follow-up|0|||
161734309|NCT02504268|584067721|FG006|Overall Study|Lost to Follow-up|0|||
161734310|NCT02504268|584067722|FG007|Overall Study|Lost to Follow-up|0|||
161734311|NCT02504268|584067723|FG008|Overall Study|Lost to Follow-up|0|||
161734312|NCT02504268|584067715|FG000|Overall Study|Death|1|||
161734313|NCT02504268|584067716|FG001|Overall Study|Death|1|||
161734314|NCT02504268|584067717|FG002|Overall Study|Death|0|||
161734315|NCT02504268|584067718|FG003|Overall Study|Death|0|||
161734316|NCT02504268|584067719|FG004|Overall Study|Death|0|||
161734317|NCT02504268|584067720|FG005|Overall Study|Death|0|||
161839659|NCT02444793|584458553|FG003|Overall Study|Lost to Follow-up|0|||
161839660|NCT02444793|584458550|FG000|Overall Study|Death|0|||
161839661|NCT02444793|584458551|FG001|Overall Study|Death|3|||
161839662|NCT02444793|584458552|FG002|Overall Study|Death|0|||
161839663|NCT02444793|584458553|FG003|Overall Study|Death|0|||
161839664|NCT02444793|584458550|FG000|Overall Study|Other|0|||
161839665|NCT02444793|584458551|FG001|Overall Study|Other|0|||
161839666|NCT02444793|584458552|FG002|Overall Study|Other|2|||
161839667|NCT02444793|584458553|FG003|Overall Study|Other|0|||
161839668|NCT02444793|584458550|FG000|Overall Study|Objective progression or relapse|9|||
161839669|NCT02444793|584458551|FG001|Overall Study|Objective progression or relapse|1|||
161839670|NCT02444793|584458552|FG002|Overall Study|Objective progression or relapse|2|||
161839671|NCT02444793|584458553|FG003|Overall Study|Objective progression or relapse|3|||
161839672|NCT02504671|584458555|FG000|Overall Study|Withdrawal by Subject|1|||
161839673|NCT02504671|584458556|FG001|Overall Study|Withdrawal by Subject|5|||
161839674|NCT02504671|584458557|FG002|Overall Study|Withdrawal by Subject|4|||
161839675|NCT02504671|584458558|FG003|Overall Study|Withdrawal by Subject|4|||
161839676|NCT02504671|584458559|FG004|Overall Study|Withdrawal by Subject|5|||
161839677|NCT02504671|584458560|FG005|Overall Study|Withdrawal by Subject|3|||
161839678|NCT02504671|584458555|FG000|Overall Study|Lack of Efficacy|1|||
161839679|NCT02504671|584458556|FG001|Overall Study|Lack of Efficacy|3|||
161839680|NCT02504671|584458557|FG002|Overall Study|Lack of Efficacy|1|||
161839681|NCT02504671|584458558|FG003|Overall Study|Lack of Efficacy|0|||
161839682|NCT02504671|584458559|FG004|Overall Study|Lack of Efficacy|4|||
161839683|NCT02504671|584458560|FG005|Overall Study|Lack of Efficacy|4|||
161839684|NCT02504671|584458555|FG000|Overall Study|Adverse Event|1|||
161839685|NCT02504671|584458556|FG001|Overall Study|Adverse Event|1|||
161839686|NCT02504671|584458557|FG002|Overall Study|Adverse Event|0|||
161839687|NCT02504671|584458558|FG003|Overall Study|Adverse Event|1|||
161839688|NCT02504671|584458559|FG004|Overall Study|Adverse Event|0|||
161839689|NCT02504671|584458560|FG005|Overall Study|Adverse Event|2|||
161839690|NCT02504671|584458555|FG000|Overall Study|Protocol Violation|2|||
161839691|NCT02504671|584458556|FG001|Overall Study|Protocol Violation|1|||
161839692|NCT02504671|584458557|FG002|Overall Study|Protocol Violation|0|||
161839693|NCT02504671|584458558|FG003|Overall Study|Protocol Violation|0|||
161839694|NCT02504671|584458559|FG004|Overall Study|Protocol Violation|0|||
161839695|NCT02504671|584458560|FG005|Overall Study|Protocol Violation|1|||
161839696|NCT02504671|584458555|FG000|Overall Study|Lost to Follow-up|0|||
161839697|NCT02504671|584458556|FG001|Overall Study|Lost to Follow-up|0|||
161839698|NCT02504671|584458557|FG002|Overall Study|Lost to Follow-up|2|||
161839699|NCT02504671|584458558|FG003|Overall Study|Lost to Follow-up|0|||
161839700|NCT02504671|584458559|FG004|Overall Study|Lost to Follow-up|0|||
161839701|NCT02504671|584458560|FG005|Overall Study|Lost to Follow-up|1|||
161839702|NCT02504671|584458555|FG000|Overall Study|Protocol defined stopping criteria|7|||
161839703|NCT02504671|584458556|FG001|Overall Study|Protocol defined stopping criteria|4|||
161839704|NCT02504671|584458557|FG002|Overall Study|Protocol defined stopping criteria|3|||
161839705|NCT02504671|584458558|FG003|Overall Study|Protocol defined stopping criteria|5|||
161839706|NCT02504671|584458559|FG004|Overall Study|Protocol defined stopping criteria|3|||
161839707|NCT02504671|584458560|FG005|Overall Study|Protocol defined stopping criteria|3|||
161839708|NCT00210249|584458561|FG000|Overall Study|Lost to Follow-up|5|||
161839709|NCT00210249|584458561|FG000|Overall Study|Protocol Violation|11|||
161839710|NCT03222583|584458562|FG000|Overall Study|Withdrawal by Subject|3|||
161839711|NCT03222583|584458563|FG001|Overall Study|Withdrawal by Subject|3|||
161839712|NCT03222583|584458562|FG000|Overall Study|Lost to Follow-up|1|||
161839713|NCT03222583|584458563|FG001|Overall Study|Lost to Follow-up|0|||
161839714|NCT03222583|584458562|FG000|Overall Study|Other|1|||
161839715|NCT03222583|584458563|FG001|Overall Study|Other|3|||
161839716|NCT04280705|584458564|FG000|Overall Study|Enrolled but not treated|4|||
161839717|NCT04280705|584458565|FG001|Overall Study|Enrolled but not treated|10|||
161839718|NCT04280705|584458564|FG000|Overall Study|Physician Decision|1|||
161839719|NCT04280705|584458565|FG001|Overall Study|Physician Decision|0|||
161839720|NCT04280705|584458564|FG000|Overall Study|Withdrawal by Subject|7|||
161839721|NCT04280705|584458565|FG001|Overall Study|Withdrawal by Subject|9|||
161839722|NCT04280705|584458564|FG000|Overall Study|Adverse Event|0|||
161839723|NCT04280705|584458565|FG001|Overall Study|Adverse Event|4|||
161839724|NCT04280705|584458564|FG000|Overall Study|Transferred to another hospital|1|||
161839725|NCT04280705|584458565|FG001|Overall Study|Transferred to another hospital|1|||
161839726|NCT02518919|584458568|FG000|Overall Study|Protocol Violation|1|||
161839727|NCT02518919|584458569|FG001|Overall Study|Protocol Violation|1|||
161839728|NCT02518919|584458570|FG002|Overall Study|Protocol Violation|2|||
161839729|NCT04498403|584458571|FG000|Overall Study|Adverse Event|1|||
161839730|NCT04498403|584458572|FG001|Overall Study|Adverse Event|0|||
161839731|NCT04498403|584458571|FG000|Overall Study|Study Terminated By Sponsor|29|||
161839732|NCT04498403|584458572|FG001|Overall Study|Study Terminated By Sponsor|10|||
161839733|NCT02492880|584458573|FG000|Overall Study|Lost to Follow-up|1|||
161839734|NCT02492880|584458573|FG000|Overall Study|Protocol Violation|1|||
161839735|NCT01200992|584458574|FG000|Overall Study|Study terminated early|35|||
161839736|NCT01200992|584458575|FG001|Overall Study|Study terminated early|41|||
161839737|NCT01200992|584458574|FG000|Overall Study|Randomized but not treated|2|||
161839738|NCT01200992|584458575|FG001|Overall Study|Randomized but not treated|0|||
161839739|NCT00667810|584458576|FG000|Overall Study|Adverse Event|13|||
161839740|NCT00667810|584458577|FG001|Overall Study|Adverse Event|14|||
161839741|NCT00667810|584458578|FG002|Overall Study|Adverse Event|19|||
161839742|NCT00667810|584458579|FG003|Overall Study|Adverse Event|1|||
161839743|NCT00667810|584458576|FG000|Overall Study|Death|1|||
161839744|NCT00667810|584458577|FG001|Overall Study|Death|1|||
161839745|NCT00667810|584458578|FG002|Overall Study|Death|3|||
161839746|NCT00667810|584458579|FG003|Overall Study|Death|0|||
161839747|NCT00667810|584458576|FG000|Overall Study|Lack of Efficacy|1|||
161839748|NCT00667810|584458577|FG001|Overall Study|Lack of Efficacy|0|||
161839749|NCT00667810|584458578|FG002|Overall Study|Lack of Efficacy|2|||
161839750|NCT00667810|584458579|FG003|Overall Study|Lack of Efficacy|0|||
161839751|NCT00667810|584458576|FG000|Overall Study|Lost to Follow-up|1|||
161839752|NCT00667810|584458577|FG001|Overall Study|Lost to Follow-up|4|||
161839753|NCT00667810|584458578|FG002|Overall Study|Lost to Follow-up|2|||
161839754|NCT00667810|584458579|FG003|Overall Study|Lost to Follow-up|0|||
161839755|NCT00667810|584458576|FG000|Overall Study|Physician Decision|1|||
161839756|NCT00667810|584458577|FG001|Overall Study|Physician Decision|1|||
161839757|NCT00667810|584458578|FG002|Overall Study|Physician Decision|2|||
161839758|NCT00667810|584458579|FG003|Overall Study|Physician Decision|0|||
161839759|NCT00667810|584458576|FG000|Overall Study|Protocol Violation|0|||
161839760|NCT00667810|584458577|FG001|Overall Study|Protocol Violation|2|||
161839761|NCT00667810|584458578|FG002|Overall Study|Protocol Violation|0|||
161839762|NCT00667810|584458579|FG003|Overall Study|Protocol Violation|0|||
161839763|NCT00667810|584458576|FG000|Overall Study|Withdrawal by Subject|14|||
161839764|NCT00667810|584458577|FG001|Overall Study|Withdrawal by Subject|20|||
161839765|NCT00667810|584458578|FG002|Overall Study|Withdrawal by Subject|29|||
161839766|NCT00667810|584458579|FG003|Overall Study|Withdrawal by Subject|1|||
161839767|NCT00667810|584458576|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
161839768|NCT00667810|584458577|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
161839769|NCT00667810|584458578|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
161839770|NCT00667810|584458579|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161839771|NCT00667810|584458576|FG000|Overall Study|Failed to Return|0|||
161839772|NCT00667810|584458577|FG001|Overall Study|Failed to Return|0|||
161839773|NCT00667810|584458578|FG002|Overall Study|Failed to Return|2|||
161839774|NCT00667810|584458579|FG003|Overall Study|Failed to Return|0|||
161839775|NCT00667810|584458576|FG000|Overall Study|Loss of Caregiver|0|||
161839776|NCT00667810|584458577|FG001|Overall Study|Loss of Caregiver|1|||
161839777|NCT00667810|584458578|FG002|Overall Study|Loss of Caregiver|3|||
161839778|NCT00667810|584458579|FG003|Overall Study|Loss of Caregiver|0|||
161839779|NCT00667810|584458576|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
161839780|NCT00667810|584458577|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
161839781|NCT00667810|584458578|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
161839782|NCT00667810|584458579|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
161839783|NCT00667810|584458576|FG000|Overall Study|Other|6|||
161839784|NCT00667810|584458577|FG001|Overall Study|Other|6|||
161839785|NCT00667810|584458578|FG002|Overall Study|Other|5|||
161839786|NCT00667810|584458579|FG003|Overall Study|Other|0|||
161839787|NCT00754650|584458582|FG000|Overall Study|Disease Progression|2|||
161839788|NCT00158600|584458592|FG000|Overall Study|unable to commit time to study|0|||
161839789|NCT00158600|584458593|FG001|Overall Study|unable to commit time to study|1|||
161839790|NCT00158600|584458592|FG000|Overall Study|Adverse Event|2|||
161839791|NCT00158600|584458593|FG001|Overall Study|Adverse Event|1|||
161839792|NCT00158600|584458592|FG000|Overall Study|Death|1|||
161839793|NCT00158600|584458593|FG001|Overall Study|Death|0|||
161839794|NCT00158600|584458592|FG000|Overall Study|Withdrawal by Subject|2|||
161839795|NCT00158600|584458593|FG001|Overall Study|Withdrawal by Subject|2|||
161839796|NCT02570113|584458594|FG000|Overall Study|Withdrawal by Subject|3|||
161839797|NCT02038907|584458595|FG000|Overall Study|Protocol Violation|0|||
161839798|NCT02038907|584458596|FG001|Overall Study|Protocol Violation|0|||
161839799|NCT02038907|584458597|FG002|Overall Study|Protocol Violation|0|||
161839800|NCT02038907|584458598|FG003|Overall Study|Protocol Violation|0|||
161839801|NCT02038907|584458599|FG004|Overall Study|Protocol Violation|0|||
161839802|NCT02038907|584458600|FG005|Overall Study|Protocol Violation|0|||
161839803|NCT02038907|584458601|FG006|Overall Study|Protocol Violation|0|||
161839804|NCT02038907|584458602|FG007|Overall Study|Protocol Violation|0|||
161839805|NCT02038907|584458603|FG008|Overall Study|Protocol Violation|0|||
161839806|NCT02038907|584458604|FG009|Overall Study|Protocol Violation|0|||
161839807|NCT02038907|584458605|FG010|Overall Study|Protocol Violation|1|||
161839808|NCT02038907|584458606|FG011|Overall Study|Protocol Violation|0|||
161839809|NCT02038907|584458607|FG012|Overall Study|Protocol Violation|0|||
161839810|NCT02038907|584458608|FG013|Overall Study|Protocol Violation|0|||
161839811|NCT02038907|584458595|FG000|Overall Study|Withdrawal by Subject|0|||
161839812|NCT02038907|584458596|FG001|Overall Study|Withdrawal by Subject|0|||
161839813|NCT02038907|584458597|FG002|Overall Study|Withdrawal by Subject|0|||
161839814|NCT02038907|584458598|FG003|Overall Study|Withdrawal by Subject|0|||
161734318|NCT02504268|584067721|FG006|Overall Study|Death|0|||
161734319|NCT02504268|584067722|FG007|Overall Study|Death|0|||
161734320|NCT02504268|584067723|FG008|Overall Study|Death|0|||
161734321|NCT02504268|584067715|FG000|Overall Study|Subject Request to Discontinue|11|||
161734322|NCT02504268|584067716|FG001|Overall Study|Subject Request to Discontinue|3|||
161734323|NCT02504268|584067717|FG002|Overall Study|Subject Request to Discontinue|6|||
161734324|NCT02504268|584067718|FG003|Overall Study|Subject Request to Discontinue|0|||
161734325|NCT02504268|584067719|FG004|Overall Study|Subject Request to Discontinue|0|||
161734326|NCT02504268|584067720|FG005|Overall Study|Subject Request to Discontinue|0|||
161734327|NCT02504268|584067721|FG006|Overall Study|Subject Request to Discontinue|0|||
161734328|NCT02504268|584067722|FG007|Overall Study|Subject Request to Discontinue|0|||
161734329|NCT02504268|584067723|FG008|Overall Study|Subject Request to Discontinue|0|||
161734330|NCT02504268|584067715|FG000|Overall Study|No Longer Meets Study Criteria|2|||
161734331|NCT02504268|584067716|FG001|Overall Study|No Longer Meets Study Criteria|3|||
161734332|NCT02504268|584067717|FG002|Overall Study|No Longer Meets Study Criteria|0|||
161734333|NCT02504268|584067718|FG003|Overall Study|No Longer Meets Study Criteria|0|||
161734334|NCT02504268|584067719|FG004|Overall Study|No Longer Meets Study Criteria|0|||
161734335|NCT02504268|584067720|FG005|Overall Study|No Longer Meets Study Criteria|0|||
161734336|NCT02504268|584067721|FG006|Overall Study|No Longer Meets Study Criteria|0|||
161734337|NCT02504268|584067722|FG007|Overall Study|No Longer Meets Study Criteria|0|||
161734338|NCT02504268|584067723|FG008|Overall Study|No Longer Meets Study Criteria|0|||
161734339|NCT02504268|584067715|FG000|Overall Study|Lack of Efficacy|11|||
161734340|NCT02504268|584067716|FG001|Overall Study|Lack of Efficacy|35|||
161734341|NCT02504268|584067717|FG002|Overall Study|Lack of Efficacy|9|||
161734342|NCT02504268|584067718|FG003|Overall Study|Lack of Efficacy|0|||
161734343|NCT02504268|584067719|FG004|Overall Study|Lack of Efficacy|0|||
161734344|NCT02504268|584067720|FG005|Overall Study|Lack of Efficacy|0|||
161734345|NCT02504268|584067721|FG006|Overall Study|Lack of Efficacy|0|||
161734346|NCT02504268|584067722|FG007|Overall Study|Lack of Efficacy|0|||
161734347|NCT02504268|584067723|FG008|Overall Study|Lack of Efficacy|0|||
161734348|NCT02504268|584067715|FG000|Overall Study|Poor/Non-Compliance|3|||
161734349|NCT02504268|584067716|FG001|Overall Study|Poor/Non-Compliance|2|||
161734350|NCT02504268|584067717|FG002|Overall Study|Poor/Non-Compliance|3|||
161734351|NCT02504268|584067718|FG003|Overall Study|Poor/Non-Compliance|0|||
161734352|NCT02504268|584067719|FG004|Overall Study|Poor/Non-Compliance|0|||
161734353|NCT02504268|584067720|FG005|Overall Study|Poor/Non-Compliance|0|||
161734354|NCT02504268|584067721|FG006|Overall Study|Poor/Non-Compliance|0|||
161734355|NCT02504268|584067722|FG007|Overall Study|Poor/Non-Compliance|0|||
161734356|NCT02504268|584067723|FG008|Overall Study|Poor/Non-Compliance|0|||
161734357|NCT02504268|584067715|FG000|Overall Study|Not Disclosed|1|||
161734358|NCT02504268|584067716|FG001|Overall Study|Not Disclosed|0|||
161734359|NCT02504268|584067717|FG002|Overall Study|Not Disclosed|2|||
161734360|NCT02504268|584067718|FG003|Overall Study|Not Disclosed|0|||
161734361|NCT02504268|584067719|FG004|Overall Study|Not Disclosed|0|||
161734362|NCT02504268|584067720|FG005|Overall Study|Not Disclosed|0|||
161734363|NCT02504268|584067721|FG006|Overall Study|Not Disclosed|0|||
161734364|NCT02504268|584067722|FG007|Overall Study|Not Disclosed|0|||
161734365|NCT02504268|584067723|FG008|Overall Study|Not Disclosed|0|||
161734366|NCT03654755|584067727|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
161734367|NCT03654755|584067728|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
161734368|NCT03654755|584067729|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
161734369|NCT03654755|584067727|FG000|Overall Study|Withdrawal by Subject|2|||
161734370|NCT03654755|584067728|FG001|Overall Study|Withdrawal by Subject|4|||
161734371|NCT03654755|584067729|FG002|Overall Study|Withdrawal by Subject|8|||
161734372|NCT03654755|584067727|FG000|Overall Study|Lost to Follow-up|1|||
161734373|NCT03654755|584067728|FG001|Overall Study|Lost to Follow-up|3|||
161839815|NCT02038907|584458599|FG004|Overall Study|Withdrawal by Subject|0|||
161839816|NCT02038907|584458600|FG005|Overall Study|Withdrawal by Subject|0|||
161734374|NCT03654755|584067729|FG002|Overall Study|Lost to Follow-up|7|||
161734375|NCT03654755|584067727|FG000|Overall Study|Physician Decision|0|||
161734376|NCT03654755|584067728|FG001|Overall Study|Physician Decision|1|||
161734377|NCT03654755|584067729|FG002|Overall Study|Physician Decision|0|||
161734378|NCT03654755|584067727|FG000|Overall Study|Adverse Event|0|||
161734379|NCT03654755|584067728|FG001|Overall Study|Adverse Event|0|||
161734380|NCT03654755|584067729|FG002|Overall Study|Adverse Event|4|||
161734381|NCT03654755|584067727|FG000|Overall Study|Lack of Efficacy|0|||
161734382|NCT03654755|584067728|FG001|Overall Study|Lack of Efficacy|0|||
161734383|NCT03654755|584067729|FG002|Overall Study|Lack of Efficacy|1|||
161734384|NCT00992784|584067731|FG000|Overall Study|Adverse Event|2|||
161734385|NCT00992784|584067732|FG001|Overall Study|Adverse Event|1|||
161734386|NCT00992784|584067733|FG002|Overall Study|Adverse Event|0|||
161734387|NCT00992784|584067731|FG000|Overall Study|Withdrawal by Subject|1|||
161734388|NCT00992784|584067732|FG001|Overall Study|Withdrawal by Subject|1|||
161734389|NCT00992784|584067733|FG002|Overall Study|Withdrawal by Subject|1|||
161734390|NCT03442829|584067736|FG000|Overall Study|Scheduling clash|3|||
161734391|NCT03442829|584067737|FG001|Overall Study|Scheduling clash|1|||
161734392|NCT03442829|584067736|FG000|Overall Study|Illness unrelated to study|1|||
161734393|NCT03442829|584067737|FG001|Overall Study|Illness unrelated to study|1|||
161734394|NCT05086289|584067738|FG000|Overall Study|Adverse Event|4|||
161734395|NCT05086289|584067739|FG001|Overall Study|Adverse Event|2|||
161734396|NCT05086289|584067738|FG000|Overall Study|Lost to Follow-up|2|||
161734397|NCT05086289|584067739|FG001|Overall Study|Lost to Follow-up|0|||
161734398|NCT05086289|584067738|FG000|Overall Study|Non-compliance with study drug|2|||
161734399|NCT05086289|584067739|FG001|Overall Study|Non-compliance with study drug|1|||
161734400|NCT05086289|584067738|FG000|Overall Study|Physician Decision|2|||
161734401|NCT05086289|584067739|FG001|Overall Study|Physician Decision|0|||
161734402|NCT05086289|584067738|FG000|Overall Study|Withdrawal by Subject|5|||
161734403|NCT05086289|584067739|FG001|Overall Study|Withdrawal by Subject|2|||
161734404|NCT01996748|584067745|FG000|Overall Study|Personal reason|1|||
161734405|NCT01996748|584067746|FG001|Overall Study|Personal reason|0|||
161734406|NCT01996748|584067745|FG000|Overall Study|Physician Decision|2|||
161734407|NCT01996748|584067746|FG001|Overall Study|Physician Decision|0|||
161734408|NCT01996748|584067745|FG000|Overall Study|Adverse Event|1|||
161734409|NCT01996748|584067746|FG001|Overall Study|Adverse Event|4|||
161734410|NCT01996748|584067745|FG000|Overall Study|Withdrawal by Subject|0|||
161734411|NCT01996748|584067746|FG001|Overall Study|Withdrawal by Subject|1|||
161734412|NCT01996748|584067745|FG000|Overall Study|Lost to Follow-up|4|||
161734413|NCT01996748|584067746|FG001|Overall Study|Lost to Follow-up|1|||
161734414|NCT03628508|584067747|FG000|Overall Study|Lost to Follow-up|1|||
161734415|NCT03238235|584067748|FG000|Overall Study|Adverse Event|2|||
161734416|NCT03238235|584067749|FG001|Overall Study|Adverse Event|0|||
161734417|NCT03238235|584067748|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
161734418|NCT03238235|584067749|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
161734419|NCT00243230|584067755|FG000|Double-Blind Period|Adverse Event|0|||
161734420|NCT00243230|584067756|FG001|Double-Blind Period|Adverse Event|2|||
161734421|NCT00243230|584067757|FG002|Double-Blind Period|Adverse Event|2|||
161734422|NCT00243230|584067758|FG003|Double-Blind Period|Adverse Event|0|||
161734423|NCT00243230|584067755|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161734424|NCT00243230|584067756|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161734425|NCT00243230|584067757|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161734426|NCT00243230|584067758|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161734427|NCT00243230|584067755|FG000|Double-Blind Period|Protocol Violation|0|||
161734428|NCT00243230|584067756|FG001|Double-Blind Period|Protocol Violation|0|||
161734429|NCT00243230|584067757|FG002|Double-Blind Period|Protocol Violation|1|||
161734430|NCT00243230|584067758|FG003|Double-Blind Period|Protocol Violation|0|||
161734431|NCT00243230|584067755|FG000|Double-Blind Period|Randomized but Not Treated|0|||
161734432|NCT00243230|584067756|FG001|Double-Blind Period|Randomized but Not Treated|0|||
161734433|NCT00243230|584067757|FG002|Double-Blind Period|Randomized but Not Treated|2|||
161734434|NCT00243230|584067758|FG003|Double-Blind Period|Randomized but Not Treated|0|||
161839817|NCT02038907|584458601|FG006|Overall Study|Withdrawal by Subject|0|||
161839818|NCT02038907|584458602|FG007|Overall Study|Withdrawal by Subject|0|||
161734435|NCT00243230|584067755|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
161734436|NCT00243230|584067756|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
161734437|NCT00243230|584067757|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
161734438|NCT00243230|584067758|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
161734439|NCT00243230|584067755|FG000|Open Label Period|Adverse Event|0|||
161734440|NCT00243230|584067756|FG001|Open Label Period|Adverse Event|0|||
161734441|NCT00243230|584067757|FG002|Open Label Period|Adverse Event|0|||
161734442|NCT00243230|584067758|FG003|Open Label Period|Adverse Event|2|||
161734443|NCT00243230|584067755|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
161734444|NCT00243230|584067756|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
161734445|NCT00243230|584067757|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
161839819|NCT02038907|584458603|FG008|Overall Study|Withdrawal by Subject|0|||
161734446|NCT00243230|584067758|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
161734447|NCT00243230|584067755|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161734448|NCT00243230|584067756|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161734449|NCT00243230|584067757|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161734450|NCT00243230|584067758|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
161734451|NCT00243230|584067755|FG000|Open Label Period|Lost to Follow-up|0|||
161734452|NCT00243230|584067756|FG001|Open Label Period|Lost to Follow-up|0|||
161734453|NCT00243230|584067757|FG002|Open Label Period|Lost to Follow-up|0|||
161734454|NCT00243230|584067758|FG003|Open Label Period|Lost to Follow-up|2|||
161734455|NCT00243230|584067755|FG000|Open Label Period|Withdrawal by Subject|0|||
161734456|NCT00243230|584067756|FG001|Open Label Period|Withdrawal by Subject|0|||
161734457|NCT00243230|584067757|FG002|Open Label Period|Withdrawal by Subject|0|||
161734458|NCT00243230|584067758|FG003|Open Label Period|Withdrawal by Subject|2|||
161734459|NCT00243230|584067755|FG000|Open Label Period|Protocol Violation|0|||
161734460|NCT00243230|584067756|FG001|Open Label Period|Protocol Violation|0|||
161734461|NCT00243230|584067757|FG002|Open Label Period|Protocol Violation|0|||
161734462|NCT00243230|584067758|FG003|Open Label Period|Protocol Violation|2|||
161734463|NCT00243230|584067755|FG000|Open Label Period|Administrative Reason|0|||
161734464|NCT00243230|584067756|FG001|Open Label Period|Administrative Reason|0|||
161734465|NCT00243230|584067757|FG002|Open Label Period|Administrative Reason|0|||
161734466|NCT00243230|584067758|FG003|Open Label Period|Administrative Reason|63|||
161734467|NCT03011840|584067759|FG000|Overall Study|Not received PIL in post PIL phase|0|||
161734468|NCT03011840|584067760|FG001|Overall Study|Not received PIL in post PIL phase|21|||
161734469|NCT03201198|584067766|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
161734470|NCT03201198|584067767|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
161734471|NCT03201198|584067766|FG000|Overall Study|Withdrawal by Subject|2|||
161734472|NCT03201198|584067767|FG001|Overall Study|Withdrawal by Subject|3|||
161734473|NCT00471445|584067768|FG000|Overall Study|Withdrawal by Subject|1|||
161734474|NCT00471445|584067769|FG001|Overall Study|Withdrawal by Subject|1|||
161734475|NCT00471445|584067768|FG000|Overall Study|Ineligible|1|||
161734476|NCT00471445|584067769|FG001|Overall Study|Ineligible|0|||
161734477|NCT00471445|584067768|FG000|Overall Study|Protocol Violation|0|||
161734478|NCT00471445|584067769|FG001|Overall Study|Protocol Violation|1|||
161734479|NCT04715230|584067770|FG000|Overall Study|Withdrawal by Subject|1|||
161734480|NCT04715230|584067771|FG001|Overall Study|Withdrawal by Subject|0|||
161734481|NCT04715230|584067772|FG002|Overall Study|Withdrawal by Subject|0|||
161734482|NCT04715230|584067770|FG000|Overall Study|Lost to Follow-up|0|||
161734483|NCT04715230|584067771|FG001|Overall Study|Lost to Follow-up|5|||
161734484|NCT04715230|584067772|FG002|Overall Study|Lost to Follow-up|1|||
161734485|NCT02596711|584067779|FG000|Overall Study|Lost to Follow-up|1|||
161734486|NCT02596711|584067780|FG001|Overall Study|Lost to Follow-up|2|||
161734487|NCT02596711|584067781|FG002|Overall Study|Lost to Follow-up|3|||
161734488|NCT00586924|584067782|FG000|Overall Study|Adverse event/serious adverse event|0|||
161734489|NCT00586924|584067783|FG001|Overall Study|Adverse event/serious adverse event|0|||
161734490|NCT00586924|584067784|FG002|Overall Study|Adverse event/serious adverse event|0|||
161734491|NCT00586924|584067785|FG003|Overall Study|Adverse event/serious adverse event|1|||
161734492|NCT00586924|584067786|FG004|Overall Study|Adverse event/serious adverse event|0|||
161734493|NCT00586924|584067787|FG005|Overall Study|Adverse event/serious adverse event|2|||
161734494|NCT00586924|584067782|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
161734495|NCT00586924|584067783|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
161734496|NCT00586924|584067784|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
161734497|NCT00586924|584067785|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
161734498|NCT00586924|584067786|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
161734499|NCT00586924|584067787|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
161734500|NCT00586924|584067782|FG000|Overall Study|Disease progression|0|||
161734501|NCT00586924|584067783|FG001|Overall Study|Disease progression|0|||
161734502|NCT00586924|584067784|FG002|Overall Study|Disease progression|0|||
161734503|NCT00586924|584067785|FG003|Overall Study|Disease progression|1|||
161734504|NCT00586924|584067786|FG004|Overall Study|Disease progression|1|||
161734505|NCT00586924|584067787|FG005|Overall Study|Disease progression|0|||
161734506|NCT00586924|584067782|FG000|Overall Study|Development of neutralizing antibodies|2|||
161734507|NCT00586924|584067783|FG001|Overall Study|Development of neutralizing antibodies|2|||
161734508|NCT00586924|584067784|FG002|Overall Study|Development of neutralizing antibodies|2|||
161734509|NCT00586924|584067785|FG003|Overall Study|Development of neutralizing antibodies|0|||
161734510|NCT00586924|584067786|FG004|Overall Study|Development of neutralizing antibodies|0|||
161734511|NCT00586924|584067787|FG005|Overall Study|Development of neutralizing antibodies|22|||
161734512|NCT00586924|584067782|FG000|Overall Study|Complete response|0|||
161734513|NCT00586924|584067783|FG001|Overall Study|Complete response|1|||
161734514|NCT00586924|584067784|FG002|Overall Study|Complete response|0|||
161734515|NCT00586924|584067785|FG003|Overall Study|Complete response|0|||
161734516|NCT00586924|584067786|FG004|Overall Study|Complete response|2|||
161734517|NCT00586924|584067787|FG005|Overall Study|Complete response|2|||
161734518|NCT00586924|584067782|FG000|Overall Study|Other|1|||
161734519|NCT00586924|584067783|FG001|Overall Study|Other|0|||
161734520|NCT00586924|584067784|FG002|Overall Study|Other|1|||
161734521|NCT00586924|584067785|FG003|Overall Study|Other|1|||
161734522|NCT00586924|584067786|FG004|Overall Study|Other|1|||
161839820|NCT02038907|584458604|FG009|Overall Study|Withdrawal by Subject|0|||
161734523|NCT00586924|584067787|FG005|Overall Study|Other|6|||
161734524|NCT01767194|584067791|FG000|Overall Study|Adverse Event|1|||
161734525|NCT01767194|584067792|FG001|Overall Study|Adverse Event|1|||
161734526|NCT01767194|584067791|FG000|Overall Study|Death|0|||
161734527|NCT01767194|584067792|FG001|Overall Study|Death|1|||
161734528|NCT01767194|584067791|FG000|Overall Study|Lack of Efficacy|12|||
161734529|NCT01767194|584067792|FG001|Overall Study|Lack of Efficacy|11|||
161734530|NCT01767194|584067791|FG000|Overall Study|Physician Decision|2|||
161734531|NCT01767194|584067792|FG001|Overall Study|Physician Decision|23|||
161734532|NCT01767194|584067791|FG000|Overall Study|Withdrawal by Subject|0|||
161734533|NCT01767194|584067792|FG001|Overall Study|Withdrawal by Subject|1|||
161734534|NCT01767194|584067791|FG000|Overall Study|Ineligible|1|||
161734535|NCT01767194|584067792|FG001|Overall Study|Ineligible|1|||
161734536|NCT01767194|584067791|FG000|Overall Study|Refusal by patient/parent|2|||
161734537|NCT01767194|584067792|FG001|Overall Study|Refusal by patient/parent|4|||
161734538|NCT01767194|584067791|FG000|Overall Study|Criteria not met on time for next cycle|0|||
161734539|NCT01767194|584067792|FG001|Overall Study|Criteria not met on time for next cycle|1|||
161734540|NCT02112994|584067793|FG000|Overall Study|Progressive Disease|0|||
161734541|NCT02112994|584067794|FG001|Overall Study|Progressive Disease|0|||
161734542|NCT02112994|584067795|FG002|Overall Study|Progressive Disease|1|||
161734543|NCT02112994|584067793|FG000|Overall Study|Pregnancy|0|||
161734544|NCT02112994|584067794|FG001|Overall Study|Pregnancy|1|||
161734545|NCT02112994|584067795|FG002|Overall Study|Pregnancy|1|||
161734546|NCT02112994|584067793|FG000|Overall Study|Liver Transplant|0|||
161734547|NCT02112994|584067794|FG001|Overall Study|Liver Transplant|1|||
161734548|NCT02112994|584067795|FG002|Overall Study|Liver Transplant|0|||
161734549|NCT02112994|584067793|FG000|Overall Study|Withdrawal by Subject|0|||
161734550|NCT02112994|584067794|FG001|Overall Study|Withdrawal by Subject|0|||
161734551|NCT02112994|584067795|FG002|Overall Study|Withdrawal by Subject|1|||
161734552|NCT04191577|584067799|FG000|Overall Study|Withdrawal by Subject|2|||
161734553|NCT04191577|584067800|FG001|Overall Study|Withdrawal by Subject|2|||
161734554|NCT04191577|584067801|FG002|Overall Study|Withdrawal by Subject|1|||
161734555|NCT04191577|584067799|FG000|Overall Study|Physician Decision|1|||
161734556|NCT04191577|584067800|FG001|Overall Study|Physician Decision|1|||
161734557|NCT04191577|584067801|FG002|Overall Study|Physician Decision|0|||
161734558|NCT04191577|584067799|FG000|Overall Study|Adverse Event|0|||
161734559|NCT04191577|584067800|FG001|Overall Study|Adverse Event|0|||
161734560|NCT04191577|584067801|FG002|Overall Study|Adverse Event|1|||
161734561|NCT04191577|584067799|FG000|Overall Study|Death|0|||
161734562|NCT04191577|584067800|FG001|Overall Study|Death|0|||
161734563|NCT04191577|584067801|FG002|Overall Study|Death|1|||
161734564|NCT01927744|584069247|FG000|Overall Study|Death|2|||
161734565|NCT01927744|584069248|FG001|Overall Study|Death|9|||
161734566|NCT00369967|584069249|FG000|Overall Study|Lost to Follow-up|23|||
161734567|NCT00369967|584069250|FG001|Overall Study|Lost to Follow-up|12|||
161734568|NCT00605722|584069255|FG000|Overall Study|Adverse Event|6|||
161734569|NCT00605722|584069255|FG000|Overall Study|Insufficient therapeutic response|44|||
161734570|NCT00605722|584069255|FG000|Overall Study|Failure to return|1|||
161734571|NCT03073213|584069256|FG000|Multiple Dose Period|Protocol Violation|0|||
161734572|NCT03073213|584069257|FG001|Multiple Dose Period|Protocol Violation|0|||
161734573|NCT03073213|584069258|FG002|Multiple Dose Period|Protocol Violation|1|||
161734574|NCT01993615|584069264|FG000|Overall Study|Death|1|||
161734575|NCT01993615|584069265|FG001|Overall Study|Death|0|||
161734576|NCT02064205|584069271|FG000|Overall Study|Withdrawal by Subject|1|||
161734577|NCT01354353|584069275|FG000|Overall Study|Adverse Event|1|||
161734578|NCT01354353|584069276|FG001|Overall Study|Adverse Event|0|||
161734579|NCT01354353|584069277|FG002|Overall Study|Adverse Event|0|||
161734580|NCT01354353|584069278|FG003|Overall Study|Adverse Event|4|||
161734581|NCT01354353|584069279|FG004|Overall Study|Adverse Event|0|||
161734582|NCT01354353|584069280|FG005|Overall Study|Adverse Event|5|||
161734583|NCT01354353|584069275|FG000|Overall Study|Entry Criteria Not Met|0|||
161734584|NCT01354353|584069276|FG001|Overall Study|Entry Criteria Not Met|0|||
161734585|NCT01354353|584069277|FG002|Overall Study|Entry Criteria Not Met|0|||
161734586|NCT01354353|584069278|FG003|Overall Study|Entry Criteria Not Met|1|||
161734587|NCT01354353|584069279|FG004|Overall Study|Entry Criteria Not Met|1|||
161734588|NCT01354353|584069280|FG005|Overall Study|Entry Criteria Not Met|0|||
161734589|NCT01354353|584069275|FG000|Overall Study|Physician Decision|0|||
161734590|NCT01354353|584069276|FG001|Overall Study|Physician Decision|1|||
161734591|NCT01354353|584069277|FG002|Overall Study|Physician Decision|1|||
161734592|NCT01354353|584069278|FG003|Overall Study|Physician Decision|0|||
161734593|NCT01354353|584069279|FG004|Overall Study|Physician Decision|0|||
161734594|NCT01354353|584069280|FG005|Overall Study|Physician Decision|0|||
161734595|NCT01354353|584069275|FG000|Overall Study|Withdrawal by Subject|2|||
161734596|NCT01354353|584069276|FG001|Overall Study|Withdrawal by Subject|0|||
161734597|NCT01354353|584069277|FG002|Overall Study|Withdrawal by Subject|1|||
161734598|NCT01354353|584069278|FG003|Overall Study|Withdrawal by Subject|0|||
161734599|NCT01354353|584069279|FG004|Overall Study|Withdrawal by Subject|0|||
161734600|NCT01354353|584069280|FG005|Overall Study|Withdrawal by Subject|1|||
161734601|NCT00831441|584069281|FG000|Randomized|Death|82|||
161734602|NCT00831441|584069282|FG001|Randomized|Death|81|||
161839821|NCT02038907|584458605|FG010|Overall Study|Withdrawal by Subject|1|||
161839822|NCT02038907|584458606|FG011|Overall Study|Withdrawal by Subject|0|||
161839823|NCT02038907|584458607|FG012|Overall Study|Withdrawal by Subject|0|||
161839824|NCT02038907|584458608|FG013|Overall Study|Withdrawal by Subject|0|||
161839825|NCT02746471|584458609|FG000|Overall Study|Death|43|||
161839826|NCT02746471|584458609|FG000|Overall Study|Exited before 36 months|1119|||
161839827|NCT02564211|584458610|FG000|Overall Study|Adverse Event|4|||
161839828|NCT02618408|584458612|FG000|Overall Study|Withdrawal by Subject|1|||
161839829|NCT02618408|584458613|FG001|Overall Study|Withdrawal by Subject|0|||
161839830|NCT02618408|584458614|FG002|Overall Study|Withdrawal by Subject|4|||
161839831|NCT02618408|584458612|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
161839832|NCT02618408|584458613|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
161839833|NCT02618408|584458614|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
161839834|NCT02618408|584458612|FG000|Overall Study|Lost to Follow-up|4|||
161839835|NCT02618408|584458613|FG001|Overall Study|Lost to Follow-up|2|||
161839836|NCT02618408|584458614|FG002|Overall Study|Lost to Follow-up|6|||
161839837|NCT02618408|584458612|FG000|Overall Study|Adverse Event|4|||
161839838|NCT02618408|584458613|FG001|Overall Study|Adverse Event|0|||
161839839|NCT02618408|584458614|FG002|Overall Study|Adverse Event|10|||
161839840|NCT02618408|584458612|FG000|Overall Study|Physician Decision|1|||
161839841|NCT02618408|584458613|FG001|Overall Study|Physician Decision|1|||
161839842|NCT02618408|584458614|FG002|Overall Study|Physician Decision|2|||
161839843|NCT02618408|584458612|FG000|Overall Study|Protocol Violation|1|||
161839844|NCT02618408|584458613|FG001|Overall Study|Protocol Violation|1|||
161839845|NCT02618408|584458614|FG002|Overall Study|Protocol Violation|2|||
161839846|NCT02618408|584458612|FG000|Overall Study|Other, Multiple Categories|0|||
161839847|NCT02618408|584458613|FG001|Overall Study|Other, Multiple Categories|0|||
161839848|NCT02618408|584458614|FG002|Overall Study|Other, Multiple Categories|4|||
161839849|NCT03914950|584458619|FG000|Overall Study|Physician Decision|54|||
161839850|NCT03167723|584458625|FG000|Overall Study|Protocol Violation|4|||
161839851|NCT03167723|584458626|FG001|Overall Study|Protocol Violation|6|||
161839852|NCT03397771|584458627|FG000|Overall Study|2 erroneously randomized, never treated|3|||
161839853|NCT03397771|584458628|FG001|Overall Study|2 erroneously randomized, never treated|1|||
161839854|NCT03397771|584458627|FG000|Overall Study|Withdrawal by Subject|1|||
161734603|NCT00831441|584069281|FG000|Randomized|Adverse Event|248|||
161734604|NCT00831441|584069282|FG001|Randomized|Adverse Event|321|||
161734605|NCT00831441|584069281|FG000|Randomized|Emergency procedure|2|||
161734606|NCT00831441|584069282|FG001|Randomized|Emergency procedure|2|||
161734607|NCT00831441|584069281|FG000|Randomized|Elective procedure|26|||
161734608|NCT00831441|584069282|FG001|Randomized|Elective procedure|25|||
161734609|NCT00831441|584069281|FG000|Randomized|Physician Decision|26|||
161734610|NCT00831441|584069282|FG001|Randomized|Physician Decision|35|||
161734611|NCT00831441|584069281|FG000|Randomized|No longer met criteria|13|||
161734612|NCT00831441|584069282|FG001|Randomized|No longer met criteria|19|||
161734613|NCT00831441|584069281|FG000|Randomized|Withdrawal by Subject|178|||
161734614|NCT00831441|584069282|FG001|Randomized|Withdrawal by Subject|212|||
161734615|NCT00831441|584069281|FG000|Randomized|Lost to Follow-up|26|||
161734616|NCT00831441|584069282|FG001|Randomized|Lost to Follow-up|35|||
161734617|NCT00831441|584069281|FG000|Randomized|Administrative reason by sponsor|2780|||
161734618|NCT00831441|584069282|FG001|Randomized|Administrative reason by sponsor|2671|||
161734619|NCT00831441|584069281|FG000|Randomized|poor/non-compliance|30|||
161734620|NCT00831441|584069282|FG001|Randomized|poor/non-compliance|38|||
161734621|NCT00831441|584069281|FG000|Randomized|non-specified|276|||
161734622|NCT00831441|584069282|FG001|Randomized|non-specified|266|||
161734623|NCT00831441|584069281|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
161734624|NCT00831441|584069282|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
161734625|NCT00831441|584069281|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
161839855|NCT03397771|584458628|FG001|Overall Study|Withdrawal by Subject|3|||
161839856|NCT03397771|584458627|FG000|Overall Study|Protocol Violation|2|||
161839857|NCT03397771|584458628|FG001|Overall Study|Protocol Violation|2|||
161839858|NCT03397771|584458627|FG000|Overall Study|Adverse Event|2|||
161839859|NCT03397771|584458628|FG001|Overall Study|Adverse Event|1|||
161734626|NCT00831441|584069282|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
161734627|NCT00831441|584069281|FG000|Follow Up (30 Days)|Death|63|||
161734628|NCT00831441|584069282|FG001|Follow Up (30 Days)|Death|86|||
161734629|NCT00831441|584069281|FG000|Follow Up (30 Days)|non-specified|16|||
161734630|NCT00831441|584069282|FG001|Follow Up (30 Days)|non-specified|26|||
161734631|NCT00831441|584069281|FG000|Follow Up (30 Days)|missing end of study status|0|||
161734632|NCT00831441|584069282|FG001|Follow Up (30 Days)|missing end of study status|1|||
161839860|NCT02669758|584458631|FG000|Overall Study|Withdrawal by Subject|43|||
161839861|NCT02669758|584458631|FG000|Overall Study|Lost to Follow-up|19|||
161839862|NCT02669758|584458631|FG000|Overall Study|Adverse Event|16|||
161839863|NCT02669758|584458631|FG000|Overall Study|Non-Compliance with Study Drug|8|||
161734633|NCT05674344|584069283|FG000|Overall Study|Screen Fail|21|||
161734634|NCT05674344|584069283|FG000|Overall Study|Incomplete study procedures|3|||
161734635|NCT00111917|584069284|FG000|Overall Study|Withdrawal by Subject|1|||
161734636|NCT00111917|584069285|FG001|Overall Study|Withdrawal by Subject|1|||
161734637|NCT01640925|584069286|FG000|Overall Study|Withdrawal by Subject|1|||
161734638|NCT01640925|584069287|FG001|Overall Study|Withdrawal by Subject|0|||
161734639|NCT01640925|584069286|FG000|Overall Study|Previously enrolled in this trial|13|||
161734640|NCT01640925|584069287|FG001|Overall Study|Previously enrolled in this trial|11|||
161734641|NCT02156492|584069288|FG000|Period 1|No Reason Given|0|||
161734642|NCT02156492|584069289|FG001|Period 1|No Reason Given|1|||
161734643|NCT02156492|584069290|FG002|Period 1|No Reason Given|0|||
161734644|NCT02156492|584069288|FG000|Period 3|Adverse Event|0|||
161734645|NCT02156492|584069289|FG001|Period 3|Adverse Event|1|||
161734646|NCT02156492|584069290|FG002|Period 3|Adverse Event|0|||
161734647|NCT00485589|584069299|FG000|Overall Study|Death|2|||
161734648|NCT00485589|584069300|FG001|Overall Study|Death|2|||
161734649|NCT00485589|584069301|FG002|Overall Study|Death|0|||
161734650|NCT00485589|584069299|FG000|Overall Study|Failure to return|6|||
161734651|NCT00485589|584069300|FG001|Overall Study|Failure to return|5|||
161734652|NCT00485589|584069301|FG002|Overall Study|Failure to return|1|||
161734653|NCT00485589|584069299|FG000|Overall Study|Protocol Violation|1|||
161734654|NCT00485589|584069300|FG001|Overall Study|Protocol Violation|0|||
161734655|NCT00485589|584069301|FG002|Overall Study|Protocol Violation|0|||
161734656|NCT00485589|584069299|FG000|Overall Study|Violation of selection criteria at entry|0|||
161734657|NCT00485589|584069300|FG001|Overall Study|Violation of selection criteria at entry|3|||
161734658|NCT00485589|584069301|FG002|Overall Study|Violation of selection criteria at entry|1|||
161734659|NCT00485589|584069299|FG000|Overall Study|Administrative/Other|1|||
161734660|NCT00485589|584069300|FG001|Overall Study|Administrative/Other|2|||
161734661|NCT00485589|584069301|FG002|Overall Study|Administrative/Other|1|||
161734662|NCT00485589|584069299|FG000|Overall Study|Insufficient therapeutic response|10|||
161734663|NCT00485589|584069300|FG001|Overall Study|Insufficient therapeutic response|3|||
161734664|NCT00485589|584069301|FG002|Overall Study|Insufficient therapeutic response|1|||
161734665|NCT00485589|584069299|FG000|Overall Study|Refused treatment/did not cooperate|1|||
161734666|NCT00485589|584069300|FG001|Overall Study|Refused treatment/did not cooperate|0|||
161734667|NCT00485589|584069301|FG002|Overall Study|Refused treatment/did not cooperate|2|||
161734668|NCT00485589|584069299|FG000|Overall Study|Withdrawal by Subject|3|||
161734669|NCT00485589|584069300|FG001|Overall Study|Withdrawal by Subject|2|||
161734670|NCT00485589|584069301|FG002|Overall Study|Withdrawal by Subject|2|||
161734671|NCT00485589|584069299|FG000|Overall Study|Adverse Event|3|||
161734672|NCT00485589|584069300|FG001|Overall Study|Adverse Event|3|||
161734673|NCT00485589|584069301|FG002|Overall Study|Adverse Event|10|||
161734674|NCT02924688|584069304|FG000|Overall Study|Adverse Event|9|||
161734675|NCT02924688|584069305|FG001|Overall Study|Adverse Event|3|||
161734676|NCT02924688|584069306|FG002|Overall Study|Adverse Event|2|||
161734677|NCT02924688|584069307|FG003|Overall Study|Adverse Event|2|||
161734678|NCT02924688|584069308|FG004|Overall Study|Adverse Event|3|||
161734679|NCT02924688|584069309|FG005|Overall Study|Adverse Event|2|||
161734680|NCT02924688|584069304|FG000|Overall Study|Lack of Efficacy|2|||
161734681|NCT02924688|584069305|FG001|Overall Study|Lack of Efficacy|3|||
161734682|NCT02924688|584069306|FG002|Overall Study|Lack of Efficacy|4|||
161734683|NCT02924688|584069307|FG003|Overall Study|Lack of Efficacy|2|||
161734684|NCT02924688|584069308|FG004|Overall Study|Lack of Efficacy|1|||
161734685|NCT02924688|584069309|FG005|Overall Study|Lack of Efficacy|1|||
161734686|NCT02924688|584069304|FG000|Overall Study|Protocol Violation|3|||
161734687|NCT02924688|584069305|FG001|Overall Study|Protocol Violation|7|||
161734688|NCT02924688|584069306|FG002|Overall Study|Protocol Violation|5|||
161734689|NCT02924688|584069307|FG003|Overall Study|Protocol Violation|6|||
161734690|NCT02924688|584069308|FG004|Overall Study|Protocol Violation|2|||
161734691|NCT02924688|584069309|FG005|Overall Study|Protocol Violation|2|||
161734692|NCT02924688|584069304|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
161734693|NCT02924688|584069305|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
161734694|NCT02924688|584069306|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
161734695|NCT02924688|584069307|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
161734696|NCT02924688|584069308|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
161734697|NCT02924688|584069309|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
161734698|NCT02924688|584069304|FG000|Overall Study|Lost to Follow-up|2|||
161734699|NCT02924688|584069305|FG001|Overall Study|Lost to Follow-up|4|||
161734700|NCT02924688|584069306|FG002|Overall Study|Lost to Follow-up|2|||
161734701|NCT02924688|584069307|FG003|Overall Study|Lost to Follow-up|4|||
161734702|NCT02924688|584069308|FG004|Overall Study|Lost to Follow-up|2|||
161734703|NCT02924688|584069309|FG005|Overall Study|Lost to Follow-up|4|||
161734704|NCT02924688|584069304|FG000|Overall Study|Physician Decision|2|||
161734705|NCT02924688|584069305|FG001|Overall Study|Physician Decision|1|||
161734706|NCT02924688|584069306|FG002|Overall Study|Physician Decision|0|||
161734707|NCT02924688|584069307|FG003|Overall Study|Physician Decision|1|||
161734708|NCT02924688|584069308|FG004|Overall Study|Physician Decision|1|||
161734709|NCT02924688|584069309|FG005|Overall Study|Physician Decision|1|||
161734710|NCT02924688|584069304|FG000|Overall Study|Withdrawal by Subject|14|||
161734711|NCT02924688|584069305|FG001|Overall Study|Withdrawal by Subject|13|||
161734712|NCT02924688|584069306|FG002|Overall Study|Withdrawal by Subject|9|||
161734713|NCT02924688|584069307|FG003|Overall Study|Withdrawal by Subject|12|||
161839864|NCT02669758|584458631|FG000|Overall Study|Lack of Efficacy|5|||
161734714|NCT02924688|584069308|FG004|Overall Study|Withdrawal by Subject|13|||
161734715|NCT02924688|584069309|FG005|Overall Study|Withdrawal by Subject|14|||
161734716|NCT03072719|584069311|FG000|Overall Study|Adverse Event|1|||
161734717|NCT03072719|584069312|FG001|Overall Study|Adverse Event|1|||
161734718|NCT02586233|584069314|FG000|Overall Study|Randomized but did not receive treatment|0|||
161734719|NCT02586233|584069315|FG001|Overall Study|Randomized but did not receive treatment|1|||
161734720|NCT02586233|584069316|FG002|Overall Study|Randomized but did not receive treatment|0|||
161734721|NCT02586233|584069317|FG003|Overall Study|Randomized but did not receive treatment|0|||
161734722|NCT02586233|584069318|FG004|Overall Study|Randomized but did not receive treatment|0|||
161734723|NCT02586233|584069319|FG005|Overall Study|Randomized but did not receive treatment|2|||
161734724|NCT02586233|584069320|FG006|Overall Study|Randomized but did not receive treatment|2|||
161734725|NCT02586233|584069314|FG000|Overall Study|Death|0|||
161734726|NCT02586233|584069315|FG001|Overall Study|Death|1|||
161734727|NCT02586233|584069316|FG002|Overall Study|Death|0|||
161734728|NCT02586233|584069317|FG003|Overall Study|Death|0|||
161734729|NCT02586233|584069318|FG004|Overall Study|Death|2|||
161734730|NCT02586233|584069319|FG005|Overall Study|Death|0|||
161734731|NCT02586233|584069320|FG006|Overall Study|Death|0|||
161734732|NCT01205451|584069321|FG000|Overall Study|Lost to Follow-up|1|||
161734733|NCT01205451|584069322|FG001|Overall Study|Lost to Follow-up|1|||
161734734|NCT01205451|584069321|FG000|Overall Study|Withdrawal by Subject|5|||
161734735|NCT01205451|584069322|FG001|Overall Study|Withdrawal by Subject|9|||
161734736|NCT02226146|584069326|FG000|Overall Study|Received rescue therapy|1|||
161734737|NCT02226146|584069326|FG000|Overall Study|Withdrawal by Subject|2|||
161734738|NCT05464836|584069327|FG000|Overall Study|Progression of Disease|1|||
161734739|NCT05464836|584069327|FG000|Overall Study|Physician Decision|1|||
161734740|NCT01522976|584069328|FG000|Overall Study|Ineligible|4|||
161734741|NCT01522976|584069329|FG001|Overall Study|Ineligible|0|||
161734742|NCT01522976|584069330|FG002|Overall Study|Ineligible|1|||
161734743|NCT01522976|584069328|FG000|Overall Study|Death|7|||
161734744|NCT01522976|584069329|FG001|Overall Study|Death|6|||
161734745|NCT01522976|584069330|FG002|Overall Study|Death|2|||
161734746|NCT01522976|584069328|FG000|Overall Study|Still on treatment|9|||
161734747|NCT01522976|584069329|FG001|Overall Study|Still on treatment|9|||
161734748|NCT01522976|584069330|FG002|Overall Study|Still on treatment|6|||
161734749|NCT01522976|584069328|FG000|Overall Study|Disease progression|28|||
161734750|NCT01522976|584069329|FG001|Overall Study|Disease progression|30|||
161734751|NCT01522976|584069330|FG002|Overall Study|Disease progression|25|||
161734752|NCT01522976|584069328|FG000|Overall Study|Adverse Event|17|||
161734753|NCT01522976|584069329|FG001|Overall Study|Adverse Event|7|||
161734754|NCT01522976|584069330|FG002|Overall Study|Adverse Event|18|||
161734755|NCT01522976|584069328|FG000|Overall Study|Refusal unrelated to adverse event|10|||
161734756|NCT01522976|584069329|FG001|Overall Study|Refusal unrelated to adverse event|13|||
161734757|NCT01522976|584069330|FG002|Overall Study|Refusal unrelated to adverse event|14|||
161734758|NCT01522976|584069328|FG000|Overall Study|Not protocol specified|22|||
161734759|NCT01522976|584069329|FG001|Overall Study|Not protocol specified|27|||
161734760|NCT01522976|584069330|FG002|Overall Study|Not protocol specified|27|||
161734761|NCT02938585|584069331|FG000|Overall Study|Withdrawal by parent or guardian|0|||
161734762|NCT02938585|584069332|FG001|Overall Study|Withdrawal by parent or guardian|1|||
161734763|NCT02938585|584069333|FG002|Overall Study|Withdrawal by parent or guardian|0|||
161734764|NCT02938585|584069334|FG003|Overall Study|Withdrawal by parent or guardian|0|||
161734765|NCT02938585|584069331|FG000|Overall Study|Withdrawal by Subject|0|||
161734766|NCT02938585|584069332|FG001|Overall Study|Withdrawal by Subject|0|||
161734767|NCT02938585|584069333|FG002|Overall Study|Withdrawal by Subject|0|||
161734768|NCT02938585|584069334|FG003|Overall Study|Withdrawal by Subject|5|||
161734769|NCT00213980|584069335|FG000|Overall Study|Withdrawal by Subject|3|||
161734770|NCT00213980|584069336|FG001|Overall Study|Withdrawal by Subject|1|||
161734771|NCT00213980|584069335|FG000|Overall Study|Adverse Event|1|||
161734772|NCT00213980|584069336|FG001|Overall Study|Adverse Event|1|||
161734773|NCT00213980|584069335|FG000|Overall Study|Disease progression|0|||
161734774|NCT00213980|584069336|FG001|Overall Study|Disease progression|2|||
161734775|NCT00213980|584069335|FG000|Overall Study|Developed ovarian cancer|1|||
161734776|NCT00213980|584069336|FG001|Overall Study|Developed ovarian cancer|0|||
161734777|NCT00213980|584069335|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
161734778|NCT00213980|584069336|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
161734779|NCT03607838|584069337|FG000|Overall Study|Lack of Efficacy|14|||
161734780|NCT03607838|584069338|FG001|Overall Study|Lack of Efficacy|20|||
161734781|NCT03607838|584069337|FG000|Overall Study|Withdrawal by Subject|13|||
161734782|NCT03607838|584069338|FG001|Overall Study|Withdrawal by Subject|8|||
161734783|NCT03607838|584069337|FG000|Overall Study|Lost to Follow-up|6|||
161734784|NCT03607838|584069338|FG001|Overall Study|Lost to Follow-up|11|||
161734785|NCT03607838|584069337|FG000|Overall Study|Adverse Event|2|||
161734786|NCT03607838|584069338|FG001|Overall Study|Adverse Event|2|||
161734787|NCT03607838|584069337|FG000|Overall Study|Physician Decision|2|||
161734788|NCT03607838|584069338|FG001|Overall Study|Physician Decision|0|||
161734789|NCT03607838|584069337|FG000|Overall Study|Failure to meet randomization criteria|1|||
161734790|NCT03607838|584069338|FG001|Overall Study|Failure to meet randomization criteria|2|||
161734791|NCT03607838|584069337|FG000|Overall Study|Pregnancy|1|||
161734792|NCT03607838|584069338|FG001|Overall Study|Pregnancy|0|||
161734793|NCT03607838|584069337|FG000|Overall Study|Protocol Violation|1|||
161734794|NCT03607838|584069338|FG001|Overall Study|Protocol Violation|0|||
161734795|NCT03607838|584069337|FG000|Overall Study|Due to work|1|||
161734796|NCT03607838|584069338|FG001|Overall Study|Due to work|0|||
161734797|NCT03607838|584069337|FG000|Overall Study|Litigation|0|||
161734798|NCT03607838|584069338|FG001|Overall Study|Litigation|1|||
161734799|NCT03607838|584069337|FG000|Overall Study|Temperature excursion for study drug|0|||
161734800|NCT03607838|584069338|FG001|Overall Study|Temperature excursion for study drug|1|||
161734801|NCT03607838|584069337|FG000|Overall Study|Change of mind|0|||
161734802|NCT03607838|584069338|FG001|Overall Study|Change of mind|1|||
161734803|NCT02411201|584069339|FG000|Overall Study|Adverse Event|2|||
161734804|NCT02411201|584069339|FG000|Overall Study|Withdrawal by Subject|2|||
161734805|NCT02411201|584069339|FG000|Overall Study|Age group completed|2|||
161734806|NCT01260467|584069340|FG000|Overall Study|Withdrawal by Subject|2|||
161734807|NCT00798694|584069341|FG000|Overall Study|Lost to Follow-up|1|||
161734808|NCT00798694|584069342|FG001|Overall Study|Lost to Follow-up|1|||
161734809|NCT00798694|584069341|FG000|Overall Study|Physician Decision|1|||
161734810|NCT00798694|584069342|FG001|Overall Study|Physician Decision|0|||
161734811|NCT01163253|584069348|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
161734812|NCT01163253|584069349|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
161734813|NCT01163253|584069348|FG000|Overall Study|Study Terminated by Sponsor|978|||
161734814|NCT01163253|584069349|FG001|Overall Study|Study Terminated by Sponsor|349|||
161734815|NCT01163253|584069348|FG000|Overall Study|Protocol Violation|43|||
161734816|NCT01163253|584069349|FG001|Overall Study|Protocol Violation|12|||
161734817|NCT01163253|584069348|FG000|Overall Study|Withdrawal by Subject|199|||
161734818|NCT01163253|584069349|FG001|Overall Study|Withdrawal by Subject|50|||
161734819|NCT01163253|584069348|FG000|Overall Study|Medication Error|1|||
161734820|NCT01163253|584069349|FG001|Overall Study|Medication Error|0|||
161734821|NCT01163253|584069348|FG000|Overall Study|Lost to Follow-up|125|||
161734822|NCT01163253|584069349|FG001|Overall Study|Lost to Follow-up|23|||
161734823|NCT01163253|584069348|FG000|Overall Study|Insufficient Clinical Response|423|||
161734824|NCT01163253|584069349|FG001|Overall Study|Insufficient Clinical Response|29|||
161734825|NCT01163253|584069348|FG000|Overall Study|Adverse Event|300|||
161734826|NCT01163253|584069349|FG001|Overall Study|Adverse Event|78|||
161734827|NCT01163253|584069348|FG000|Overall Study|Death|17|||
161734828|NCT01163253|584069349|FG001|Overall Study|Death|5|||
161734829|NCT01163253|584069348|FG000|Overall Study|Ongoing|13|||
161734830|NCT01163253|584069349|FG001|Overall Study|Ongoing|4|||
161734831|NCT01163253|584069348|FG000|Overall Study|Other Unspecified|170|||
161734832|NCT01163253|584069349|FG001|Overall Study|Other Unspecified|34|||
161734833|NCT03025217|584069355|FG000|Overall Study|Pregnancy|1|||
161734834|NCT03025217|584069355|FG000|Overall Study|Lost to Follow-up|1|||
161734835|NCT03025217|584069355|FG000|Overall Study|Not eligible, poor English|2|||
161734836|NCT00781599|584069358|FG000|Overall Study|Lost to Follow-up|7|||
161734837|NCT00781599|584069359|FG001|Overall Study|Lost to Follow-up|4|||
161734838|NCT01088438|584069360|FG000|Overall Study|Withdrawal by Subject|11|||
161734839|NCT01088438|584069361|FG001|Overall Study|Withdrawal by Subject|6|||
161734840|NCT01088438|584069360|FG000|Overall Study|Lost to Follow-up|18|||
161734841|NCT01088438|584069361|FG001|Overall Study|Lost to Follow-up|30|||
161734842|NCT02605447|584069367|FG000|Overall Study|Death|66|||
161734843|NCT02605447|584069367|FG000|Overall Study|Physician Decision|1|||
161734844|NCT02605447|584069367|FG000|Overall Study|Lost to Follow-up|24|||
161734845|NCT02605447|584069367|FG000|Overall Study|Withdrawal by Subject|10|||
161734846|NCT02605447|584069367|FG000|Overall Study|Not disclosed|1|||
161734847|NCT02237157|584069368|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
161734848|NCT02237157|584069369|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161734849|NCT02237157|584069370|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161734850|NCT02237157|584069371|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161734851|NCT02237157|584069368|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
161734852|NCT02237157|584069369|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161734853|NCT02237157|584069370|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161734854|NCT02237157|584069371|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161734855|NCT04533815|584069376|FG000|Overall Study|Adverse Event|2|||
161734856|NCT04533815|584069376|FG000|Overall Study|Site withdrew|5|||
161734857|NCT02045212|584069377|FG000|Overall Study|Adverse Event|0|||
161734858|NCT02045212|584069378|FG001|Overall Study|Adverse Event|1|||
161839865|NCT02669758|584458631|FG000|Overall Study|Pregnancy|1|||
161839866|NCT02669758|584458631|FG000|Overall Study|Study noncompliance|1|||
161734859|NCT02045212|584069377|FG000|Overall Study|Withdrawal by Subject|1|||
161734860|NCT02045212|584069378|FG001|Overall Study|Withdrawal by Subject|0|||
161734861|NCT02045212|584069377|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
161734862|NCT02045212|584069378|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
161734863|NCT00488592|584069379|FG000|Overall Study|Withdrawal by Subject|1|||
161734864|NCT00488592|584069379|FG000|Overall Study|Disease progression|1|||
161839867|NCT02669758|584458631|FG000|Overall Study|Protocol Violation|1|||
161839868|NCT02455050|584458632|FG000|Treatment Period 1|Lost to Follow-up|1|||
161839869|NCT02455050|584458633|FG001|Treatment Period 1|Lost to Follow-up|1|||
161839870|NCT02455050|584458634|FG002|Treatment Period 1|Lost to Follow-up|1|||
161839871|NCT02455050|584458635|FG003|Treatment Period 1|Lost to Follow-up|2|||
161839872|NCT02455050|584458632|FG000|Treatment Period 2|Lost to Follow-up|1|||
161839873|NCT02455050|584458633|FG001|Treatment Period 2|Lost to Follow-up|0|||
161839874|NCT02455050|584458634|FG002|Treatment Period 2|Lost to Follow-up|2|||
161839875|NCT02455050|584458635|FG003|Treatment Period 2|Lost to Follow-up|1|||
161839876|NCT03393806|584458638|FG000|Overall Study|Physician Decision|1|||
161839877|NCT03393806|584458639|FG001|Overall Study|Physician Decision|0|||
161839878|NCT01259115|584458640|FG000|Period 1|Adverse Event|1|||
161839879|NCT01259115|584458641|FG001|Period 1|Adverse Event|0|||
161839880|NCT01259115|584458640|FG000|Period 1|Protocol Violation|2|||
161839881|NCT01259115|584458641|FG001|Period 1|Protocol Violation|0|||
161839882|NCT01259115|584458640|FG000|Period 1|Lost to Follow-up|0|||
161839883|NCT01259115|584458641|FG001|Period 1|Lost to Follow-up|1|||
161839884|NCT01259115|584458640|FG000|Period 2|Adverse Event|1|||
161839885|NCT01259115|584458641|FG001|Period 2|Adverse Event|0|||
161839886|NCT03493386|584458642|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161839887|NCT03493386|584458643|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161839888|NCT03493386|584458644|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161839889|NCT03493386|584458645|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161839890|NCT00988442|584458647|FG000|Overall Study|Death|1|||
161839891|NCT00988442|584458648|FG001|Overall Study|Death|2|||
161839892|NCT00988442|584458647|FG000|Overall Study|Lost to Follow-up|0|||
161839893|NCT00988442|584458648|FG001|Overall Study|Lost to Follow-up|1|||
161839894|NCT00988442|584458647|FG000|Overall Study|Early Study Closure|29|||
161839895|NCT00988442|584458648|FG001|Overall Study|Early Study Closure|25|||
161839896|NCT02731326|584458651|FG000|Overall Study|Withdrawal by Subject|4|||
161839897|NCT02731326|584458652|FG001|Overall Study|Withdrawal by Subject|1|||
161839898|NCT02731326|584458651|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
161839899|NCT02731326|584458652|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
161839900|NCT02731326|584458651|FG000|Overall Study|Discharged without AliveCor|10|||
161839901|NCT02731326|584458652|FG001|Overall Study|Discharged without AliveCor|0|||
161839902|NCT02731326|584458651|FG000|Overall Study|Duplicate Participant|1|||
161839903|NCT02731326|584458652|FG001|Overall Study|Duplicate Participant|1|||
161839904|NCT04453202|584458657|FG000|Overall Study|Adverse Event|0|||
161839905|NCT04453202|584458658|FG001|Overall Study|Adverse Event|0|||
161839906|NCT04453202|584458659|FG002|Overall Study|Adverse Event|0|||
161839907|NCT04453202|584458660|FG003|Overall Study|Adverse Event|0|||
161839908|NCT04453202|584458661|FG004|Overall Study|Adverse Event|0|||
161839909|NCT04453202|584458662|FG005|Overall Study|Adverse Event|0|||
161839910|NCT04453202|584458663|FG006|Overall Study|Adverse Event|1|||
161734865|NCT00488592|584069379|FG000|Overall Study|Enrolled but not treated|1|||
161734866|NCT00441103|584069380|FG000|Overall Study|Adverse Event|2|||
161734867|NCT00441103|584069381|FG001|Overall Study|Adverse Event|1|||
161734868|NCT00441103|584069380|FG000|Overall Study|Death|1|||
161839911|NCT04453202|584458664|FG007|Overall Study|Adverse Event|0|||
161839912|NCT04453202|584458665|FG008|Overall Study|Adverse Event|0|||
161839913|NCT04453202|584458666|FG009|Overall Study|Adverse Event|0|||
161839914|NCT04453202|584458667|FG010|Overall Study|Adverse Event|0|||
161734869|NCT00441103|584069381|FG001|Overall Study|Death|0|||
161734870|NCT00441103|584069380|FG000|Overall Study|Disease Progression|2|||
161839915|NCT04453202|584458657|FG000|Overall Study|Death|0|||
161839916|NCT04453202|584458658|FG001|Overall Study|Death|0|||
161839917|NCT04453202|584458659|FG002|Overall Study|Death|0|||
161839918|NCT04453202|584458660|FG003|Overall Study|Death|0|||
161839919|NCT04453202|584458661|FG004|Overall Study|Death|0|||
161839920|NCT04453202|584458662|FG005|Overall Study|Death|0|||
161839921|NCT04453202|584458663|FG006|Overall Study|Death|0|||
161839922|NCT04453202|584458664|FG007|Overall Study|Death|0|||
161839923|NCT04453202|584458665|FG008|Overall Study|Death|0|||
161839924|NCT04453202|584458666|FG009|Overall Study|Death|1|||
161839925|NCT04453202|584458667|FG010|Overall Study|Death|0|||
161839926|NCT04453202|584458657|FG000|Overall Study|Lost to Follow-up|0|||
161839927|NCT04453202|584458658|FG001|Overall Study|Lost to Follow-up|1|||
161839928|NCT04453202|584458659|FG002|Overall Study|Lost to Follow-up|0|||
161839929|NCT04453202|584458660|FG003|Overall Study|Lost to Follow-up|1|||
161839930|NCT04453202|584458661|FG004|Overall Study|Lost to Follow-up|0|||
161839931|NCT04453202|584458662|FG005|Overall Study|Lost to Follow-up|0|||
161839932|NCT04453202|584458663|FG006|Overall Study|Lost to Follow-up|0|||
161839933|NCT04453202|584458664|FG007|Overall Study|Lost to Follow-up|0|||
161839934|NCT04453202|584458665|FG008|Overall Study|Lost to Follow-up|0|||
161839935|NCT04453202|584458666|FG009|Overall Study|Lost to Follow-up|1|||
161839936|NCT04453202|584458667|FG010|Overall Study|Lost to Follow-up|1|||
161839937|NCT04453202|584458657|FG000|Overall Study|Withdrawal by Subject|1|||
161839938|NCT04453202|584458658|FG001|Overall Study|Withdrawal by Subject|2|||
161839939|NCT04453202|584458659|FG002|Overall Study|Withdrawal by Subject|1|||
161839940|NCT04453202|584458660|FG003|Overall Study|Withdrawal by Subject|2|||
161839941|NCT04453202|584458661|FG004|Overall Study|Withdrawal by Subject|1|||
161839942|NCT04453202|584458662|FG005|Overall Study|Withdrawal by Subject|1|||
161839943|NCT04453202|584458663|FG006|Overall Study|Withdrawal by Subject|0|||
161839944|NCT04453202|584458664|FG007|Overall Study|Withdrawal by Subject|0|||
161839945|NCT04453202|584458665|FG008|Overall Study|Withdrawal by Subject|0|||
161839946|NCT04453202|584458666|FG009|Overall Study|Withdrawal by Subject|1|||
161839947|NCT04453202|584458667|FG010|Overall Study|Withdrawal by Subject|0|||
161839948|NCT04453202|584458657|FG000|Overall Study|Adverse Event|0|||
161839949|NCT04453202|584458658|FG001|Overall Study|Adverse Event|0|||
161839950|NCT04453202|584458659|FG002|Overall Study|Adverse Event|0|||
161839951|NCT04453202|584458660|FG003|Overall Study|Adverse Event|0|||
161839952|NCT04453202|584458661|FG004|Overall Study|Adverse Event|0|||
161839953|NCT04453202|584458662|FG005|Overall Study|Adverse Event|1|||
161839954|NCT04453202|584458663|FG006|Overall Study|Adverse Event|0|||
161839955|NCT04453202|584458664|FG007|Overall Study|Adverse Event|0|||
161839956|NCT04453202|584458665|FG008|Overall Study|Adverse Event|0|||
161839957|NCT04453202|584458666|FG009|Overall Study|Adverse Event|0|||
161839958|NCT04453202|584458667|FG010|Overall Study|Adverse Event|0|||
161839959|NCT01355159|584458672|FG000|Overall Study|Withdrew consent|39|||
161839960|NCT01355159|584458673|FG001|Overall Study|Withdrew consent|47|||
161839961|NCT01355159|584458672|FG000|Overall Study|No primary outcome data|17|||
161839962|NCT01355159|584458673|FG001|Overall Study|No primary outcome data|11|||
161839963|NCT01355159|584458672|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
161839964|NCT01355159|584458673|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
161839965|NCT01355159|584458672|FG000|Overall Study|Early intrauterine fetal death|6|||
161839966|NCT01355159|584458673|FG001|Overall Study|Early intrauterine fetal death|6|||
161839967|NCT03276221|584458674|FG000|Overall Study|Lost to Follow-up|6|||
161839968|NCT03276221|584458675|FG001|Overall Study|Lost to Follow-up|2|||
161839969|NCT03276221|584458676|FG002|Overall Study|Lost to Follow-up|0|||
161839970|NCT03276221|584458674|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
161839971|NCT03276221|584458675|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
161839972|NCT03276221|584458676|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
161839973|NCT02615171|584458677|FG000|Overall Study|Lost to Follow-up|2|||
161839974|NCT02615171|584458678|FG001|Overall Study|Lost to Follow-up|1|||
161734871|NCT00441103|584069381|FG001|Overall Study|Disease Progression|0|||
161734872|NCT00441103|584069380|FG000|Overall Study|Lost to Follow-up|1|||
161734873|NCT00441103|584069381|FG001|Overall Study|Lost to Follow-up|0|||
161734874|NCT00441103|584069380|FG000|Overall Study|Protocol Violation|1|||
161734875|NCT00441103|584069381|FG001|Overall Study|Protocol Violation|0|||
161734876|NCT00441103|584069380|FG000|Overall Study|Participant unable to use Rebiject II|1|||
161734877|NCT00441103|584069381|FG001|Overall Study|Participant unable to use Rebiject II|0|||
161734878|NCT00441103|584069380|FG000|Overall Study|Participant refused MRI|1|||
161734879|NCT00441103|584069381|FG001|Overall Study|Participant refused MRI|0|||
161734880|NCT00441103|584069380|FG000|Overall Study|Inclusion criteria absent|1|||
161734881|NCT00441103|584069381|FG001|Overall Study|Inclusion criteria absent|0|||
161734882|NCT00441103|584069380|FG000|Overall Study|Non-compliant|0|||
161734883|NCT00441103|584069381|FG001|Overall Study|Non-compliant|1|||
161734884|NCT00441103|584069380|FG000|Overall Study|Participant decided to withdraw|1|||
161734885|NCT00441103|584069381|FG001|Overall Study|Participant decided to withdraw|0|||
161839975|NCT00975286|584458683|FG000|Overall Study|Adverse Event|9|||
161839976|NCT00975286|584458684|FG001|Overall Study|Adverse Event|19|||
161839977|NCT00975286|584458683|FG000|Overall Study|Protocol Violation|1|||
161839978|NCT00975286|584458684|FG001|Overall Study|Protocol Violation|2|||
161839979|NCT00975286|584458683|FG000|Overall Study|Withdrawal by Subject|0|||
161839980|NCT00975286|584458684|FG001|Overall Study|Withdrawal by Subject|2|||
161839981|NCT00975286|584458683|FG000|Overall Study|Familial and Personal Reasons|2|||
161839982|NCT00975286|584458684|FG001|Overall Study|Familial and Personal Reasons|2|||
161734886|NCT00441103|584069380|FG000|Overall Study|Participant's reason|0|||
161734887|NCT00441103|584069381|FG001|Overall Study|Participant's reason|1|||
161734888|NCT00441103|584069380|FG000|Overall Study|Participant decided to stop|0|||
161734889|NCT00441103|584069381|FG001|Overall Study|Participant decided to stop|1|||
161734890|NCT00515008|584069382|FG000|Overall Study|Lost to Follow-up|1|||
161734891|NCT00515008|584069383|FG001|Overall Study|Lost to Follow-up|0|||
161734892|NCT00515008|584069382|FG000|Overall Study|Declined|0|||
161734893|NCT00515008|584069383|FG001|Overall Study|Declined|3|||
161734894|NCT00515008|584069382|FG000|Overall Study|Left the Boston Area|1|||
161734895|NCT00515008|584069383|FG001|Overall Study|Left the Boston Area|1|||
161734896|NCT00515008|584069382|FG000|Overall Study|Scheduling conflict|1|||
161734897|NCT00515008|584069383|FG001|Overall Study|Scheduling conflict|0|||
161734898|NCT05836818|584069384|FG000|Overall Study|Physician Decision|1|||
161734899|NCT05836818|584069385|FG001|Overall Study|Physician Decision|1|||
161734900|NCT05836818|584069386|FG002|Overall Study|Physician Decision|0|||
161734901|NCT05836818|584069384|FG000|Overall Study|Withdrawal by Subject|0|||
161734902|NCT05836818|584069385|FG001|Overall Study|Withdrawal by Subject|0|||
161734903|NCT05836818|584069386|FG002|Overall Study|Withdrawal by Subject|1|||
161734904|NCT05836818|584069384|FG000|Overall Study|Later found to be previously vaccinated|0|||
161734905|NCT05836818|584069385|FG001|Overall Study|Later found to be previously vaccinated|1|||
161734906|NCT05836818|584069386|FG002|Overall Study|Later found to be previously vaccinated|3|||
161734907|NCT05836818|584069384|FG000|Overall Study|Pregnancy|0|||
161734908|NCT05836818|584069385|FG001|Overall Study|Pregnancy|1|||
161734909|NCT05836818|584069386|FG002|Overall Study|Pregnancy|0|||
161734910|NCT05836818|584069384|FG000|Overall Study|Allergic to vaccines|0|||
161734911|NCT05836818|584069385|FG001|Overall Study|Allergic to vaccines|1|||
161734912|NCT05836818|584069386|FG002|Overall Study|Allergic to vaccines|0|||
161734913|NCT03738566|584069387|FG000|Initial Study Phase|Withdrawal by Subject|1|||
161734914|NCT03738566|584069388|FG001|Initial Study Phase|Withdrawal by Subject|1|||
161734915|NCT03738566|584069389|FG002|Initial Study Phase|Withdrawal by Subject|2|||
161734916|NCT03738566|584069390|FG003|Initial Study Phase|Withdrawal by Subject|0|||
161734917|NCT03738566|584069387|FG000|Initial Study Phase|Death|0|||
161734918|NCT03738566|584069388|FG001|Initial Study Phase|Death|1|||
161734919|NCT03738566|584069389|FG002|Initial Study Phase|Death|0|||
161734920|NCT03738566|584069390|FG003|Initial Study Phase|Death|0|||
161734921|NCT03738566|584069387|FG000|Initial Study Phase|Treatment failure|5|||
161734922|NCT03738566|584069388|FG001|Initial Study Phase|Treatment failure|0|||
161734923|NCT03738566|584069389|FG002|Initial Study Phase|Treatment failure|0|||
161734924|NCT03738566|584069390|FG003|Initial Study Phase|Treatment failure|0|||
161734925|NCT03738566|584069387|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161734926|NCT03738566|584069388|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161734927|NCT03738566|584069389|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161734928|NCT03738566|584069390|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
161734929|NCT03126539|584069399|FG000|Overall Study|Lost to Follow-up|1|||
161734930|NCT03126539|584069400|FG001|Overall Study|Lost to Follow-up|1|||
161734931|NCT03126539|584069401|FG002|Overall Study|Lost to Follow-up|1|||
161734932|NCT03126539|584069402|FG003|Overall Study|Lost to Follow-up|0|||
161734933|NCT03126539|584069403|FG004|Overall Study|Lost to Follow-up|0|||
161734934|NCT01627067|584069404|FG000|Overall Study|Screen Failure|1|||
161734935|NCT00926796|584069405|FG000|Overall Study|Did not receive randomized treatment|4|||
161734936|NCT00926796|584069406|FG001|Overall Study|Did not receive randomized treatment|7|||
161734937|NCT00926796|584069405|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
161734938|NCT00926796|584069406|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
161734939|NCT00926796|584069405|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
161734940|NCT00926796|584069406|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
161734941|NCT00926796|584069405|FG000|Overall Study|Adverse Event|7|||
161734942|NCT00926796|584069406|FG001|Overall Study|Adverse Event|14|||
161734943|NCT00926796|584069405|FG000|Overall Study|Lost to Follow-up|22|||
161734944|NCT00926796|584069406|FG001|Overall Study|Lost to Follow-up|13|||
161734945|NCT00926796|584069405|FG000|Overall Study|Protocol Violation|15|||
161734946|NCT00926796|584069406|FG001|Overall Study|Protocol Violation|11|||
161734947|NCT00926796|584069405|FG000|Overall Study|Withdrawal by Subject|1|||
161734948|NCT00926796|584069406|FG001|Overall Study|Withdrawal by Subject|0|||
161734949|NCT01683071|584069408|FG000|Part 1|Lack of Efficacy|1|||
161734950|NCT01683071|584069409|FG001|Part 1|Lack of Efficacy|0|||
161734951|NCT01683071|584069410|FG002|Part 1|Lack of Efficacy|0|||
161734952|NCT01683071|584069411|FG003|Part 1|Lack of Efficacy|3|||
161734953|NCT01683071|584069412|FG004|Part 1|Lack of Efficacy|0|||
161734954|NCT01683071|584069413|FG005|Part 1|Lack of Efficacy|0|||
161734955|NCT01683071|584069408|FG000|Part 1|Withdrawal by Subject|1|||
161734956|NCT01683071|584069409|FG001|Part 1|Withdrawal by Subject|2|||
161734957|NCT01683071|584069410|FG002|Part 1|Withdrawal by Subject|2|||
161734958|NCT01683071|584069411|FG003|Part 1|Withdrawal by Subject|1|||
161734959|NCT01683071|584069412|FG004|Part 1|Withdrawal by Subject|0|||
161734960|NCT01683071|584069413|FG005|Part 1|Withdrawal by Subject|0|||
161734961|NCT01683071|584069408|FG000|Part 1|Surgery Cancelled|1|||
161734962|NCT01683071|584069409|FG001|Part 1|Surgery Cancelled|0|||
161734963|NCT01683071|584069410|FG002|Part 1|Surgery Cancelled|0|||
161734964|NCT01683071|584069411|FG003|Part 1|Surgery Cancelled|0|||
161734965|NCT01683071|584069412|FG004|Part 1|Surgery Cancelled|0|||
161734966|NCT01683071|584069413|FG005|Part 1|Surgery Cancelled|0|||
161734967|NCT01683071|584069408|FG000|Part 1|Did not receive study drug|1|||
161734968|NCT01683071|584069409|FG001|Part 1|Did not receive study drug|0|||
161734969|NCT01683071|584069410|FG002|Part 1|Did not receive study drug|0|||
161734970|NCT01683071|584069411|FG003|Part 1|Did not receive study drug|1|||
161734971|NCT01683071|584069412|FG004|Part 1|Did not receive study drug|0|||
161734972|NCT01683071|584069413|FG005|Part 1|Did not receive study drug|0|||
161734973|NCT01683071|584069408|FG000|Part 1|Early termination; met exclusion criteria|0|||
161734974|NCT01683071|584069409|FG001|Part 1|Early termination; met exclusion criteria|2|||
161734975|NCT01683071|584069410|FG002|Part 1|Early termination; met exclusion criteria|1|||
161734976|NCT01683071|584069411|FG003|Part 1|Early termination; met exclusion criteria|0|||
161734977|NCT01683071|584069412|FG004|Part 1|Early termination; met exclusion criteria|0|||
161734978|NCT01683071|584069413|FG005|Part 1|Early termination; met exclusion criteria|0|||
161734979|NCT01683071|584069408|FG000|Part 2|Lack of Efficacy|0|||
161734980|NCT01683071|584069409|FG001|Part 2|Lack of Efficacy|0|||
161734981|NCT01683071|584069410|FG002|Part 2|Lack of Efficacy|0|||
161734982|NCT01683071|584069411|FG003|Part 2|Lack of Efficacy|0|||
161734983|NCT01683071|584069412|FG004|Part 2|Lack of Efficacy|3|||
161734984|NCT01683071|584069413|FG005|Part 2|Lack of Efficacy|4|||
161734985|NCT01683071|584069408|FG000|Part 2|Lost to Follow-up|0|||
161734986|NCT01683071|584069409|FG001|Part 2|Lost to Follow-up|0|||
161734987|NCT01683071|584069410|FG002|Part 2|Lost to Follow-up|0|||
161734988|NCT01683071|584069411|FG003|Part 2|Lost to Follow-up|0|||
161734989|NCT01683071|584069412|FG004|Part 2|Lost to Follow-up|2|||
161734990|NCT01683071|584069413|FG005|Part 2|Lost to Follow-up|0|||
161734991|NCT01683071|584069408|FG000|Part 2|Withdrawal by Subject|0|||
161734992|NCT01683071|584069409|FG001|Part 2|Withdrawal by Subject|0|||
161734993|NCT01683071|584069410|FG002|Part 2|Withdrawal by Subject|0|||
161734994|NCT01683071|584069411|FG003|Part 2|Withdrawal by Subject|0|||
161734995|NCT01683071|584069412|FG004|Part 2|Withdrawal by Subject|3|||
161734996|NCT01683071|584069413|FG005|Part 2|Withdrawal by Subject|3|||
161734997|NCT01683071|584069408|FG000|Part 2|Surgery cancelled|0|||
161734998|NCT01683071|584069409|FG001|Part 2|Surgery cancelled|0|||
161734999|NCT01683071|584069410|FG002|Part 2|Surgery cancelled|0|||
161735000|NCT01683071|584069411|FG003|Part 2|Surgery cancelled|0|||
161735001|NCT01683071|584069412|FG004|Part 2|Surgery cancelled|4|||
161735002|NCT01683071|584069413|FG005|Part 2|Surgery cancelled|2|||
161735003|NCT01683071|584069408|FG000|Part 2|Did not receive study drug|0|||
161735004|NCT01683071|584069409|FG001|Part 2|Did not receive study drug|0|||
161735005|NCT01683071|584069410|FG002|Part 2|Did not receive study drug|0|||
161735006|NCT01683071|584069411|FG003|Part 2|Did not receive study drug|0|||
161735007|NCT01683071|584069412|FG004|Part 2|Did not receive study drug|2|||
161735008|NCT01683071|584069413|FG005|Part 2|Did not receive study drug|1|||
161735009|NCT01683071|584069408|FG000|Part 2|Met exclusion criterion|0|||
161735010|NCT01683071|584069409|FG001|Part 2|Met exclusion criterion|0|||
161735011|NCT01683071|584069410|FG002|Part 2|Met exclusion criterion|0|||
161735012|NCT01683071|584069411|FG003|Part 2|Met exclusion criterion|0|||
161735013|NCT01683071|584069412|FG004|Part 2|Met exclusion criterion|1|||
161735014|NCT01683071|584069413|FG005|Part 2|Met exclusion criterion|1|||
161735015|NCT01683071|584069408|FG000|Part 2|Protocol deviation|0|||
161735016|NCT01683071|584069409|FG001|Part 2|Protocol deviation|0|||
161735017|NCT01683071|584069410|FG002|Part 2|Protocol deviation|0|||
161735018|NCT01683071|584069411|FG003|Part 2|Protocol deviation|0|||
161735019|NCT01683071|584069412|FG004|Part 2|Protocol deviation|1|||
161735020|NCT01683071|584069413|FG005|Part 2|Protocol deviation|2|||
161735021|NCT01683071|584069408|FG000|Part 2|Withdrawal by investigator decision|0|||
161735022|NCT01683071|584069409|FG001|Part 2|Withdrawal by investigator decision|0|||
161735023|NCT01683071|584069410|FG002|Part 2|Withdrawal by investigator decision|0|||
161735024|NCT01683071|584069411|FG003|Part 2|Withdrawal by investigator decision|0|||
161735025|NCT01683071|584069412|FG004|Part 2|Withdrawal by investigator decision|1|||
161735026|NCT01683071|584069413|FG005|Part 2|Withdrawal by investigator decision|2|||
161735027|NCT01708941|584070886|FG000|Overall Study|Adverse Event|4|||
161735028|NCT01708941|584070887|FG001|Overall Study|Adverse Event|6|||
161735029|NCT01708941|584070888|FG002|Overall Study|Adverse Event|1|||
161735030|NCT01708941|584070889|FG003|Overall Study|Adverse Event|0|||
161735031|NCT01708941|584070886|FG000|Overall Study|Death|1|||
161735032|NCT01708941|584070887|FG001|Overall Study|Death|1|||
161735033|NCT01708941|584070888|FG002|Overall Study|Death|2|||
161735034|NCT01708941|584070889|FG003|Overall Study|Death|14|||
161735035|NCT01708941|584070886|FG000|Overall Study|Withdrawal by Subject|1|||
161735036|NCT01708941|584070887|FG001|Overall Study|Withdrawal by Subject|0|||
161735037|NCT01708941|584070888|FG002|Overall Study|Withdrawal by Subject|3|||
161735038|NCT01708941|584070889|FG003|Overall Study|Withdrawal by Subject|4|||
161735039|NCT01708941|584070886|FG000|Overall Study|Disease progression|9|||
161735040|NCT01708941|584070887|FG001|Overall Study|Disease progression|10|||
161735041|NCT01708941|584070888|FG002|Overall Study|Disease progression|8|||
161735042|NCT01708941|584070889|FG003|Overall Study|Disease progression|0|||
161735043|NCT01708941|584070886|FG000|Overall Study|Alternative therapy|0|||
161735044|NCT01708941|584070887|FG001|Overall Study|Alternative therapy|0|||
161735045|NCT01708941|584070888|FG002|Overall Study|Alternative therapy|2|||
161735046|NCT01708941|584070889|FG003|Overall Study|Alternative therapy|0|||
161735047|NCT01708941|584070886|FG000|Overall Study|Ineligible and never started treatment|1|||
161735048|NCT01708941|584070887|FG001|Overall Study|Ineligible and never started treatment|0|||
161735049|NCT01708941|584070888|FG002|Overall Study|Ineligible and never started treatment|1|||
161735050|NCT01708941|584070889|FG003|Overall Study|Ineligible and never started treatment|0|||
161735051|NCT01708941|584070886|FG000|Overall Study|Never started treatment|2|||
161735052|NCT01708941|584070887|FG001|Overall Study|Never started treatment|1|||
161735053|NCT01708941|584070888|FG002|Overall Study|Never started treatment|0|||
161735054|NCT01708941|584070889|FG003|Overall Study|Never started treatment|0|||
161735055|NCT01708941|584070886|FG000|Overall Study|Ineligible|0|||
161735056|NCT01708941|584070887|FG001|Overall Study|Ineligible|0|||
161735057|NCT01708941|584070888|FG002|Overall Study|Ineligible|2|||
161735058|NCT01708941|584070889|FG003|Overall Study|Ineligible|0|||
161735059|NCT00229203|584070890|FG000|Overall Study|Progressive disease|18|||
161735060|NCT00229203|584070891|FG001|Overall Study|Progressive disease|9|||
161735061|NCT00229203|584070890|FG000|Overall Study|Toxicity|6|||
161735062|NCT00229203|584070891|FG001|Overall Study|Toxicity|1|||
161735063|NCT00229203|584070890|FG000|Overall Study|Death|4|||
161735064|NCT00229203|584070891|FG001|Overall Study|Death|2|||
161735065|NCT00229203|584070890|FG000|Overall Study|Other|3|||
161735066|NCT00229203|584070891|FG001|Overall Study|Other|3|||
161735067|NCT00229203|584070890|FG000|Overall Study|Withdrawal by Subject|1|||
161735068|NCT00229203|584070891|FG001|Overall Study|Withdrawal by Subject|4|||
161735069|NCT03457103|584070892|FG000|Overall Study|illness/hospitalization|4|||
161735070|NCT03457103|584070893|FG001|Overall Study|illness/hospitalization|2|||
161735071|NCT03457103|584070892|FG000|Overall Study|Lost to Follow-up|2|||
161735072|NCT03457103|584070893|FG001|Overall Study|Lost to Follow-up|1|||
161735073|NCT03457103|584070892|FG000|Overall Study|Withdrawal by Subject|1|||
161735074|NCT03457103|584070893|FG001|Overall Study|Withdrawal by Subject|2|||
161735075|NCT03457103|584070892|FG000|Overall Study|financial/ insurance issues|1|||
161735076|NCT03457103|584070893|FG001|Overall Study|financial/ insurance issues|1|||
161735077|NCT00423735|584070894|FG000|Overall Study|Ineligible / No protocol treatment|8|||
161735078|NCT00423735|584070895|FG001|Overall Study|Ineligible / No protocol treatment|6|||
161735079|NCT00423735|584070896|FG002|Overall Study|Ineligible / No protocol treatment|0|||
161735080|NCT02394808|584070897|FG000|Period 1|Unsatisfactory lens fitting|0|||
161735081|NCT02394808|584070898|FG001|Period 1|Unsatisfactory lens fitting|1|||
161735082|NCT02394808|584070897|FG000|Period 2|Lost to Follow-up|1|||
161735083|NCT02394808|584070898|FG001|Period 2|Lost to Follow-up|0|||
161735084|NCT03150095|584070899|FG000|Overall Study|Death|0|||
161735085|NCT03150095|584070900|FG001|Overall Study|Death|1|||
161735086|NCT03150095|584070899|FG000|Overall Study|Lost to Follow-up|1|||
161735087|NCT03150095|584070900|FG001|Overall Study|Lost to Follow-up|1|||
161735088|NCT03150095|584070899|FG000|Overall Study|Withdrawal by Subject|4|||
161735089|NCT03150095|584070900|FG001|Overall Study|Withdrawal by Subject|0|||
161735090|NCT03150095|584070899|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
161735091|NCT03150095|584070900|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
161735092|NCT04032171|584070902|FG000|Overall Study|Study Termination|1|||
161735093|NCT04032171|584070903|FG001|Overall Study|Study Termination|0|||
161735094|NCT00089479|584070913|FG000|Overall Study|Death|108|||
161735095|NCT00089479|584070914|FG001|Overall Study|Death|75|||
161735096|NCT00089479|584070913|FG000|Overall Study|Withdrawal by Subject|86|||
161735097|NCT00089479|584070914|FG001|Overall Study|Withdrawal by Subject|107|||
161735098|NCT00089479|584070913|FG000|Overall Study|Lost to Follow-up|137|||
161735099|NCT00089479|584070914|FG001|Overall Study|Lost to Follow-up|107|||
161839983|NCT00975286|584458683|FG000|Overall Study|Poor Compliance to Protocol|0|||
161839984|NCT00975286|584458684|FG001|Overall Study|Poor Compliance to Protocol|2|||
161735100|NCT03943953|584070915|FG000|Trial of ITG 1|Lost to Follow-up|19|||
161735101|NCT03943953|584070916|FG001|Trial of ITG 1|Lost to Follow-up|1|||
161735102|NCT03943953|584070915|FG000|Trial of ITG 2|Lost to Follow-up|8|||
161735103|NCT03943953|584070916|FG001|Trial of ITG 2|Lost to Follow-up|0|||
161735104|NCT03943953|584070915|FG000|Trial of ITG 3|Lost to Follow-up|2|||
161735105|NCT03943953|584070916|FG001|Trial of ITG 3|Lost to Follow-up|0|||
161735106|NCT03943953|584070915|FG000|Trial of ITG 4|Lost to Follow-up|2|||
161735107|NCT03943953|584070916|FG001|Trial of ITG 4|Lost to Follow-up|0|||
161735108|NCT00289185|584070919|FG000|Overall Study|Withdrawal by Subject|4|||
161735109|NCT00289185|584070920|FG001|Overall Study|Withdrawal by Subject|8|||
161735110|NCT00289185|584070919|FG000|Overall Study|Lost to Follow-up|23|||
161735111|NCT00289185|584070920|FG001|Overall Study|Lost to Follow-up|17|||
161735112|NCT00289185|584070919|FG000|Overall Study|Death|1|||
161735113|NCT00289185|584070920|FG001|Overall Study|Death|1|||
161735114|NCT01124448|584070921|FG000|Overall Study|Lost to Follow-up|0|||
161735115|NCT01124448|584070922|FG001|Overall Study|Lost to Follow-up|3|||
161735116|NCT01124448|584070921|FG000|Overall Study|Protocol Violation|2|||
161735117|NCT01124448|584070922|FG001|Overall Study|Protocol Violation|0|||
161735118|NCT03337152|584070927|FG000|Overall Study|Physician Decision|1|||
161735119|NCT03337152|584070928|FG001|Overall Study|Physician Decision|0|||
161735120|NCT03337152|584070927|FG000|Overall Study|Lost to Follow-up|1|||
161735121|NCT03337152|584070928|FG001|Overall Study|Lost to Follow-up|3|||
161735122|NCT03337152|584070927|FG000|Overall Study|Adverse Event|3|||
161735123|NCT03337152|584070928|FG001|Overall Study|Adverse Event|1|||
161735124|NCT03337152|584070927|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
161735125|NCT03337152|584070928|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
161735126|NCT00421343|584070929|FG000|Overall Study|Death|1|||
161839985|NCT00975286|584458683|FG000|Overall Study|Sponsor Decision|0|||
161839986|NCT00975286|584458684|FG001|Overall Study|Sponsor Decision|2|||
161735127|NCT00421343|584070929|FG000|Overall Study|Withdrawal by Subject|2|||
161735128|NCT00421343|584070929|FG000|Overall Study|Lost to Follow-up|3|||
161735129|NCT03471767|584070930|FG000|Overall Study|Withdrawal by Subject|3|||
161735130|NCT03471767|584070931|FG001|Overall Study|Withdrawal by Subject|1|||
161735131|NCT03471767|584070930|FG000|Overall Study|Adverse Event|1|||
161735132|NCT03471767|584070931|FG001|Overall Study|Adverse Event|0|||
161735133|NCT03471767|584070930|FG000|Overall Study|Lost to Follow-up|1|||
161735134|NCT03471767|584070931|FG001|Overall Study|Lost to Follow-up|0|||
161735135|NCT03471767|584070930|FG000|Overall Study|PI Withdrawal|1|||
161735136|NCT03471767|584070931|FG001|Overall Study|PI Withdrawal|3|||
161735137|NCT00678587|584070932|FG000|Overall Study|Adverse Event|3|||
161735138|NCT00678587|584070933|FG001|Overall Study|Adverse Event|3|||
161735139|NCT00678587|584070932|FG000|Overall Study|Lack of Efficacy|1|||
161735140|NCT00678587|584070933|FG001|Overall Study|Lack of Efficacy|0|||
161735141|NCT00678587|584070932|FG000|Overall Study|Protocol Violation|2|||
161735142|NCT00678587|584070933|FG001|Overall Study|Protocol Violation|1|||
161735143|NCT00678587|584070932|FG000|Overall Study|Study Closed/Terminated|1|||
161735144|NCT00678587|584070933|FG001|Overall Study|Study Closed/Terminated|0|||
161735145|NCT00678587|584070932|FG000|Overall Study|Lost to Follow-up|3|||
161735146|NCT00678587|584070933|FG001|Overall Study|Lost to Follow-up|5|||
161735147|NCT00678587|584070932|FG000|Overall Study|Investigator Discretion|2|||
161735148|NCT00678587|584070933|FG001|Overall Study|Investigator Discretion|6|||
161735149|NCT00678587|584070932|FG000|Overall Study|Withdrew Consent|8|||
161735150|NCT00678587|584070933|FG001|Overall Study|Withdrew Consent|3|||
161735151|NCT01952730|584070936|FG000|Overall Study|FDA shut down core lab used by study|1|||
161735152|NCT00976950|584070940|FG000|Overall Study|Adverse Event|3|||
161735153|NCT00976950|584070940|FG000|Overall Study|Events with no relationship to Aptivus|3|||
161735154|NCT01514188|584070943|FG000|Overall Study|Adverse Event|3|||
161735155|NCT01514188|584070944|FG001|Overall Study|Adverse Event|5|||
161735156|NCT01514188|584070943|FG000|Overall Study|Withdrawal by Subject|2|||
161735157|NCT01514188|584070944|FG001|Overall Study|Withdrawal by Subject|4|||
161735158|NCT01514188|584070943|FG000|Overall Study|Protocol Violation|2|||
161735159|NCT01514188|584070944|FG001|Overall Study|Protocol Violation|4|||
161735160|NCT01514188|584070943|FG000|Overall Study|Physician Decision|0|||
161735161|NCT01514188|584070944|FG001|Overall Study|Physician Decision|2|||
161735162|NCT01514188|584070943|FG000|Overall Study|Disease Progression|13|||
161735163|NCT01514188|584070944|FG001|Overall Study|Disease Progression|14|||
161735164|NCT01514188|584070943|FG000|Overall Study|Death|1|||
161735165|NCT01514188|584070944|FG001|Overall Study|Death|3|||
161735166|NCT01514188|584070943|FG000|Overall Study|Other|2|||
161735167|NCT01514188|584070944|FG001|Overall Study|Other|1|||
161735168|NCT01019486|584070945|FG000|Overall Study|Withdrawal by Subject|1|||
161735169|NCT01019486|584070946|FG001|Overall Study|Withdrawal by Subject|1|||
161735170|NCT01019486|584070947|FG002|Overall Study|Withdrawal by Subject|1|||
161735171|NCT02932332|584070948|FG000|Overall Study|Withdrawal by Subject|1|||
161735172|NCT02932332|584070949|FG001|Overall Study|Withdrawal by Subject|1|||
161735173|NCT02932332|584070950|FG002|Overall Study|Withdrawal by Subject|0|||
161735174|NCT02932332|584070951|FG003|Overall Study|Withdrawal by Subject|1|||
161735175|NCT02932332|584070948|FG000|Overall Study|Chest pain|0|||
161735176|NCT02932332|584070949|FG001|Overall Study|Chest pain|0|||
161735177|NCT02932332|584070950|FG002|Overall Study|Chest pain|0|||
161735178|NCT02932332|584070951|FG003|Overall Study|Chest pain|1|||
161735179|NCT02932332|584070948|FG000|Overall Study|Not Dyspneic cough|1|||
161735180|NCT02932332|584070949|FG001|Overall Study|Not Dyspneic cough|2|||
161735181|NCT02932332|584070950|FG002|Overall Study|Not Dyspneic cough|1|||
161735182|NCT02932332|584070951|FG003|Overall Study|Not Dyspneic cough|0|||
161735183|NCT01069523|584070953|FG000|Overall Study|Withdrawal by Subject|4|||
161735184|NCT01069523|584070954|FG001|Overall Study|Withdrawal by Subject|7|||
161735185|NCT01875367|584070955|FG000|Overall Study|Not complete at least 2 questionaries|4|||
161735186|NCT01875367|584070956|FG001|Overall Study|Not complete at least 2 questionaries|2|||
161735187|NCT01875367|584070955|FG000|Overall Study|Not receive study treatment|1|||
161735188|NCT01875367|584070956|FG001|Overall Study|Not receive study treatment|0|||
161735189|NCT02951988|584070957|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
161735190|NCT02951988|584070958|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161735191|NCT02951988|584070959|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161735192|NCT02951988|584070960|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161735193|NCT02951988|584070957|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
161735194|NCT02951988|584070958|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
161735195|NCT02951988|584070959|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
161735196|NCT02951988|584070960|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
161839987|NCT03456960|584458689|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161735197|NCT02951988|584070957|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
161735198|NCT02951988|584070958|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161735199|NCT02951988|584070959|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161735200|NCT02951988|584070960|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161735201|NCT02951988|584070957|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
161735202|NCT02951988|584070958|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
161735203|NCT02951988|584070959|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
161735204|NCT02951988|584070960|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
161735205|NCT02951988|584070957|FG000|Open-Label Treatment Period|Protocol Violation|22|||
161735206|NCT02951988|584070958|FG001|Open-Label Treatment Period|Protocol Violation|0|||
161735207|NCT02951988|584070959|FG002|Open-Label Treatment Period|Protocol Violation|0|||
161735208|NCT02951988|584070960|FG003|Open-Label Treatment Period|Protocol Violation|0|||
161735209|NCT02951988|584070957|FG000|Open-Label Treatment Period|Pregnancy|2|||
161735210|NCT02951988|584070958|FG001|Open-Label Treatment Period|Pregnancy|0|||
161735211|NCT02951988|584070959|FG002|Open-Label Treatment Period|Pregnancy|0|||
161735212|NCT02951988|584070960|FG003|Open-Label Treatment Period|Pregnancy|0|||
161735213|NCT02951988|584070957|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
161735214|NCT02951988|584070958|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
161735215|NCT02951988|584070959|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
161735216|NCT02951988|584070960|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
161735217|NCT02951988|584070957|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
161735218|NCT02951988|584070958|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
161735219|NCT02951988|584070959|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
161735220|NCT02951988|584070960|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
161735221|NCT02951988|584070957|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
161735222|NCT02951988|584070958|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161735223|NCT02951988|584070959|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161735224|NCT02951988|584070960|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
161735225|NCT02951988|584070957|FG000|Open-Label Treatment Period|Adverse Event|45|||
161735226|NCT02951988|584070958|FG001|Open-Label Treatment Period|Adverse Event|0|||
161735227|NCT02951988|584070959|FG002|Open-Label Treatment Period|Adverse Event|0|||
161735228|NCT02951988|584070960|FG003|Open-Label Treatment Period|Adverse Event|0|||
161735229|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
161735230|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
161735231|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
161735232|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
161735233|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
161735234|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
161735235|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
161735236|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
161735237|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
161735238|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
161735239|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
161735240|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
161735241|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161735242|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
161735243|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
161735244|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
161735245|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Pregnancy|0|||
161735246|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Pregnancy|1|||
161735247|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Pregnancy|1|||
161735248|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Pregnancy|0|||
161735249|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161735250|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
161735251|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
161735252|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
161735253|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161735254|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
161735255|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
161735256|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
161735257|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161735258|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Adverse Event|8|||
161735259|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Adverse Event|3|||
161735260|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Adverse Event|6|||
161735261|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
161735262|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
161735263|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
161735264|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
161735265|NCT03352414|584070964|FG000|Overall Study|Ineligible by operative criteria|12|||
161735266|NCT03352414|584070965|FG001|Overall Study|Ineligible by operative criteria|10|||
161735267|NCT00516269|584070966|FG000|Overall Study|Adverse Event|2|||
161735268|NCT00516269|584070967|FG001|Overall Study|Adverse Event|1|||
161735269|NCT00516269|584070966|FG000|Overall Study|Lost to Follow-up|0|||
161735270|NCT00516269|584070967|FG001|Overall Study|Lost to Follow-up|1|||
161735271|NCT00516269|584070966|FG000|Overall Study|Protocol Violation|0|||
161735272|NCT00516269|584070967|FG001|Overall Study|Protocol Violation|1|||
161735273|NCT04570657|584070970|FG000|Overall Study|Adverse Event|0|||
161735274|NCT04570657|584070971|FG001|Overall Study|Adverse Event|0|||
161735275|NCT04570657|584070972|FG002|Overall Study|Adverse Event|1|||
161735276|NCT04570657|584070970|FG000|Overall Study|Lost to Follow-up|0|||
161735277|NCT04570657|584070971|FG001|Overall Study|Lost to Follow-up|0|||
161735278|NCT04570657|584070972|FG002|Overall Study|Lost to Follow-up|1|||
161735279|NCT04570657|584070970|FG000|Overall Study|Physician Decision|0|||
161735280|NCT04570657|584070971|FG001|Overall Study|Physician Decision|1|||
161735281|NCT04570657|584070972|FG002|Overall Study|Physician Decision|0|||
161735282|NCT04570657|584070970|FG000|Overall Study|Withdrawal by Subject|1|||
161735283|NCT04570657|584070971|FG001|Overall Study|Withdrawal by Subject|2|||
161735284|NCT04570657|584070972|FG002|Overall Study|Withdrawal by Subject|2|||
161735285|NCT01079962|584070973|FG000|Overall Study|Adverse Event|2|||
161735286|NCT01079962|584070974|FG001|Overall Study|Adverse Event|2|||
161735287|NCT01079962|584070973|FG000|Overall Study|Withdrawal by Subject|5|||
161735288|NCT01079962|584070974|FG001|Overall Study|Withdrawal by Subject|7|||
161735289|NCT01079962|584070973|FG000|Overall Study|Protocol Violation|2|||
161735290|NCT01079962|584070974|FG001|Overall Study|Protocol Violation|2|||
161735291|NCT01079962|584070973|FG000|Overall Study|No blood pressure (BP) control|3|||
161735292|NCT01079962|584070974|FG001|Overall Study|No blood pressure (BP) control|0|||
161735293|NCT01079962|584070973|FG000|Overall Study|Inclusion/exclusion criteria|1|||
161735294|NCT01079962|584070974|FG001|Overall Study|Inclusion/exclusion criteria|3|||
161735295|NCT01079962|584070973|FG000|Overall Study|Participant not returning for next visit|1|||
161735296|NCT01079962|584070974|FG001|Overall Study|Participant not returning for next visit|0|||
161735297|NCT01079962|584070973|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
161735298|NCT01079962|584070974|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
161735299|NCT01331239|584070975|FG000|Part II: Core Study|Adverse Event|0|||
161735300|NCT01331239|584070976|FG001|Part II: Core Study|Adverse Event|3|||
161735301|NCT01331239|584070977|FG002|Part II: Core Study|Adverse Event|0|||
161735302|NCT01331239|584070975|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
161735303|NCT01331239|584070976|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
161735304|NCT01331239|584070977|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
161735305|NCT01331239|584070975|FG000|Part II: Core Study|Withdrawal by Subject|0|||
161735306|NCT01331239|584070976|FG001|Part II: Core Study|Withdrawal by Subject|2|||
161735307|NCT01331239|584070977|FG002|Part II: Core Study|Withdrawal by Subject|0|||
161735308|NCT01331239|584070975|FG000|Part II: Core Study|Administrative problems|0|||
161735309|NCT01331239|584070976|FG001|Part II: Core Study|Administrative problems|1|||
161839988|NCT03456960|584458690|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161735310|NCT01331239|584070977|FG002|Part II: Core Study|Administrative problems|0|||
161735311|NCT01072539|584070978|FG000|Overall Study|Treated prior to the Site Initiation|1|||
161735312|NCT01072539|584070978|FG000|Overall Study|Protocol Violation|2|||
161735313|NCT00946530|584070979|FG000|Overall Study|Withdrawal by Subject|0|||
161735314|NCT00946530|584070980|FG001|Overall Study|Withdrawal by Subject|3|||
161735315|NCT00946530|584070981|FG002|Overall Study|Withdrawal by Subject|0|||
161735316|NCT00946530|584070982|FG003|Overall Study|Withdrawal by Subject|3|||
161735317|NCT00946530|584070979|FG000|Overall Study|Physician Decision|1|||
161735318|NCT00946530|584070980|FG001|Overall Study|Physician Decision|1|||
161735319|NCT00946530|584070981|FG002|Overall Study|Physician Decision|1|||
161735320|NCT00946530|584070982|FG003|Overall Study|Physician Decision|1|||
161735321|NCT04167306|584070983|FG000|Overall Study|Lost to Follow-up|2|||
161735322|NCT04167306|584070984|FG001|Overall Study|Lost to Follow-up|2|||
161735323|NCT04167306|584070985|FG002|Overall Study|Lost to Follow-up|5|||
161735324|NCT04167306|584070986|FG003|Overall Study|Lost to Follow-up|5|||
161735325|NCT04167306|584070983|FG000|Overall Study|Adverse Event|13|||
161735326|NCT04167306|584070984|FG001|Overall Study|Adverse Event|14|||
161735327|NCT04167306|584070985|FG002|Overall Study|Adverse Event|5|||
161735328|NCT04167306|584070986|FG003|Overall Study|Adverse Event|4|||
161735329|NCT04167306|584070983|FG000|Overall Study|Withdrawal by Subject|4|||
161735330|NCT04167306|584070984|FG001|Overall Study|Withdrawal by Subject|6|||
161735331|NCT04167306|584070985|FG002|Overall Study|Withdrawal by Subject|8|||
161735332|NCT04167306|584070986|FG003|Overall Study|Withdrawal by Subject|3|||
161735333|NCT04167306|584070983|FG000|Overall Study|covid|1|||
161735334|NCT04167306|584070984|FG001|Overall Study|covid|1|||
161735335|NCT04167306|584070985|FG002|Overall Study|covid|2|||
161735336|NCT04167306|584070986|FG003|Overall Study|covid|1|||
161735337|NCT04167306|584070983|FG000|Overall Study|concomitant medication|0|||
161735338|NCT04167306|584070984|FG001|Overall Study|concomitant medication|0|||
161735339|NCT04167306|584070985|FG002|Overall Study|concomitant medication|0|||
161735340|NCT04167306|584070986|FG003|Overall Study|concomitant medication|1|||
161735341|NCT04167306|584070983|FG000|Overall Study|Alcohol treatment|0|||
161735342|NCT04167306|584070984|FG001|Overall Study|Alcohol treatment|4|||
161735343|NCT04167306|584070985|FG002|Overall Study|Alcohol treatment|3|||
161735344|NCT04167306|584070986|FG003|Overall Study|Alcohol treatment|2|||
161735345|NCT04167306|584070983|FG000|Overall Study|non-compliance|0|||
161735346|NCT04167306|584070984|FG001|Overall Study|non-compliance|0|||
161735347|NCT04167306|584070985|FG002|Overall Study|non-compliance|1|||
161735348|NCT04167306|584070986|FG003|Overall Study|non-compliance|0|||
161735349|NCT04167306|584070983|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
161735350|NCT04167306|584070984|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
161735351|NCT04167306|584070985|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
161735352|NCT04167306|584070986|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
161735353|NCT00621855|584070987|FG000|Overall Study|Adverse Event|32|||
161735354|NCT00621855|584070988|FG001|Overall Study|Adverse Event|31|||
161735355|NCT00621855|584070989|FG002|Overall Study|Adverse Event|48|||
161735356|NCT00621855|584070990|FG003|Overall Study|Adverse Event|34|||
161735357|NCT00621855|584070991|FG004|Overall Study|Adverse Event|31|||
161735358|NCT00621855|584070987|FG000|Overall Study|Lost to Follow-up|0|||
161735359|NCT00621855|584070988|FG001|Overall Study|Lost to Follow-up|1|||
161735360|NCT00621855|584070989|FG002|Overall Study|Lost to Follow-up|3|||
161735361|NCT00621855|584070990|FG003|Overall Study|Lost to Follow-up|4|||
161735362|NCT00621855|584070991|FG004|Overall Study|Lost to Follow-up|1|||
161735363|NCT00621855|584070987|FG000|Overall Study|Protocol Violation|16|||
161735364|NCT00621855|584070988|FG001|Overall Study|Protocol Violation|8|||
161735365|NCT00621855|584070989|FG002|Overall Study|Protocol Violation|6|||
161735366|NCT00621855|584070990|FG003|Overall Study|Protocol Violation|7|||
161735367|NCT00621855|584070991|FG004|Overall Study|Protocol Violation|8|||
161839989|NCT03456960|584458691|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
161839990|NCT03456960|584458692|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
161735368|NCT00621855|584070987|FG000|Overall Study|Withdrawal by Subject|16|||
161735369|NCT00621855|584070988|FG001|Overall Study|Withdrawal by Subject|11|||
161839991|NCT03456960|584458693|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161839992|NCT03456960|584458694|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161839993|NCT03456960|584458689|FG000|Period 2 (1 Day)|Adverse Event|1|||
161735370|NCT00621855|584070989|FG002|Overall Study|Withdrawal by Subject|13|||
161735371|NCT00621855|584070990|FG003|Overall Study|Withdrawal by Subject|13|||
161735372|NCT00621855|584070991|FG004|Overall Study|Withdrawal by Subject|9|||
161735373|NCT00621855|584070987|FG000|Overall Study|Other|9|||
161735374|NCT00621855|584070988|FG001|Overall Study|Other|7|||
161735375|NCT00621855|584070989|FG002|Overall Study|Other|6|||
161735376|NCT00621855|584070990|FG003|Overall Study|Other|5|||
161735377|NCT00621855|584070991|FG004|Overall Study|Other|4|||
161735378|NCT00621855|584070987|FG000|Overall Study|Patients did not receive study drug|3|||
161735379|NCT00621855|584070988|FG001|Overall Study|Patients did not receive study drug|3|||
161735380|NCT00621855|584070989|FG002|Overall Study|Patients did not receive study drug|5|||
161735381|NCT00621855|584070990|FG003|Overall Study|Patients did not receive study drug|4|||
161735382|NCT00621855|584070991|FG004|Overall Study|Patients did not receive study drug|2|||
161735383|NCT03731364|584070992|FG000|Overall Study|Adverse Event|0|||
161735384|NCT03731364|584070993|FG001|Overall Study|Adverse Event|0|||
161735385|NCT03731364|584070994|FG002|Overall Study|Adverse Event|1|||
161735386|NCT03731364|584070995|FG003|Overall Study|Adverse Event|2|||
161735387|NCT03731364|584070996|FG004|Overall Study|Adverse Event|1|||
161735388|NCT04387136|584070997|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
161735389|NCT04387136|584070998|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
161735390|NCT00417976|584070999|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
161735391|NCT00417976|584070999|FG000|Overall Study|Treatment -related toxicity|2|||
161735392|NCT02358369|584071000|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
161735393|NCT02358369|584071001|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735394|NCT02358369|584071002|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735395|NCT02358369|584071003|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735396|NCT02358369|584071004|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735397|NCT02358369|584071000|FG000|Treatment Period A/B|Adverse Event|0|||
161735398|NCT02358369|584071001|FG001|Treatment Period A/B|Adverse Event|0|||
161735399|NCT02358369|584071002|FG002|Treatment Period A/B|Adverse Event|1|||
161735400|NCT02358369|584071003|FG003|Treatment Period A/B|Adverse Event|2|||
161735401|NCT02358369|584071004|FG004|Treatment Period A/B|Adverse Event|0|||
161735402|NCT02358369|584071000|FG000|Treatment Period A/B|Death|0|||
161735403|NCT02358369|584071001|FG001|Treatment Period A/B|Death|0|||
161735404|NCT02358369|584071002|FG002|Treatment Period A/B|Death|1|||
161735405|NCT02358369|584071003|FG003|Treatment Period A/B|Death|0|||
161735406|NCT02358369|584071004|FG004|Treatment Period A/B|Death|0|||
161735407|NCT02358369|584071000|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
161735408|NCT02358369|584071001|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
161735409|NCT02358369|584071002|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
161735410|NCT02358369|584071003|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
161735411|NCT02358369|584071004|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
161735412|NCT02358369|584071000|FG000|Treatment Period C|Adverse Event|0|||
161735413|NCT02358369|584071001|FG001|Treatment Period C|Adverse Event|0|||
161735414|NCT02358369|584071002|FG002|Treatment Period C|Adverse Event|0|||
161735415|NCT02358369|584071003|FG003|Treatment Period C|Adverse Event|0|||
161735416|NCT02358369|584071004|FG004|Treatment Period C|Adverse Event|7|||
161735417|NCT03655717|584071005|FG000|Overall Study|Withdrawal by Subject|4|||
161735418|NCT03655717|584071006|FG001|Overall Study|Withdrawal by Subject|8|||
161735419|NCT03655717|584071007|FG002|Overall Study|Withdrawal by Subject|1|||
161735420|NCT03655717|584071008|FG003|Overall Study|Withdrawal by Subject|0|||
161735421|NCT03655717|584071009|FG004|Overall Study|Withdrawal by Subject|0|||
161735422|NCT03655717|584071010|FG005|Overall Study|Withdrawal by Subject|1|||
161735423|NCT03655717|584071011|FG006|Overall Study|Withdrawal by Subject|3|||
161735424|NCT03655717|584071012|FG007|Overall Study|Withdrawal by Subject|1|||
161735425|NCT03655717|584071013|FG008|Overall Study|Withdrawal by Subject|2|||
161735426|NCT03655717|584071014|FG009|Overall Study|Withdrawal by Subject|0|||
161735427|NCT03655717|584071015|FG010|Overall Study|Withdrawal by Subject|0|||
161735428|NCT03655717|584071016|FG011|Overall Study|Withdrawal by Subject|1|||
161735429|NCT03655717|584071017|FG012|Overall Study|Withdrawal by Subject|0|||
161735430|NCT03655717|584071018|FG013|Overall Study|Withdrawal by Subject|3|||
161735431|NCT03655717|584071019|FG014|Overall Study|Withdrawal by Subject|0|||
161735432|NCT03655717|584071020|FG015|Overall Study|Withdrawal by Subject|1|||
161735433|NCT03655717|584071021|FG016|Overall Study|Withdrawal by Subject|0|||
161735434|NCT03655717|584071022|FG017|Overall Study|Withdrawal by Subject|0|||
161735435|NCT03655717|584071023|FG018|Overall Study|Withdrawal by Subject|1|||
161735436|NCT03655717|584071024|FG019|Overall Study|Withdrawal by Subject|0|||
161735437|NCT03655717|584071025|FG020|Overall Study|Withdrawal by Subject|0|||
161735438|NCT03655717|584071026|FG021|Overall Study|Withdrawal by Subject|1|||
161735439|NCT03655717|584071027|FG022|Overall Study|Withdrawal by Subject|2|||
161735440|NCT03655717|584071028|FG023|Overall Study|Withdrawal by Subject|1|||
161735441|NCT03655717|584071029|FG024|Overall Study|Withdrawal by Subject|1|||
161735442|NCT03655717|584071030|FG025|Overall Study|Withdrawal by Subject|0|||
161735443|NCT03655717|584071005|FG000|Overall Study|Physician Decision|3|||
161735444|NCT03655717|584071006|FG001|Overall Study|Physician Decision|3|||
161735445|NCT03655717|584071007|FG002|Overall Study|Physician Decision|0|||
161735446|NCT03655717|584071008|FG003|Overall Study|Physician Decision|0|||
161735447|NCT03655717|584071009|FG004|Overall Study|Physician Decision|0|||
161735448|NCT03655717|584071010|FG005|Overall Study|Physician Decision|0|||
161735449|NCT03655717|584071011|FG006|Overall Study|Physician Decision|0|||
161735450|NCT03655717|584071012|FG007|Overall Study|Physician Decision|0|||
161735451|NCT03655717|584071013|FG008|Overall Study|Physician Decision|0|||
161735452|NCT03655717|584071014|FG009|Overall Study|Physician Decision|1|||
161735453|NCT03655717|584071015|FG010|Overall Study|Physician Decision|0|||
161735454|NCT03655717|584071016|FG011|Overall Study|Physician Decision|0|||
161735455|NCT03655717|584071017|FG012|Overall Study|Physician Decision|0|||
161735456|NCT03655717|584071018|FG013|Overall Study|Physician Decision|0|||
161735457|NCT03655717|584071019|FG014|Overall Study|Physician Decision|0|||
161735458|NCT03655717|584071020|FG015|Overall Study|Physician Decision|0|||
161735459|NCT03655717|584071021|FG016|Overall Study|Physician Decision|0|||
161735460|NCT03655717|584071022|FG017|Overall Study|Physician Decision|0|||
161735461|NCT03655717|584071023|FG018|Overall Study|Physician Decision|0|||
161735462|NCT03655717|584071024|FG019|Overall Study|Physician Decision|1|||
161735463|NCT03655717|584071025|FG020|Overall Study|Physician Decision|0|||
161735464|NCT03655717|584071026|FG021|Overall Study|Physician Decision|0|||
161735465|NCT03655717|584071027|FG022|Overall Study|Physician Decision|0|||
161735466|NCT03655717|584071028|FG023|Overall Study|Physician Decision|1|||
161735467|NCT03655717|584071029|FG024|Overall Study|Physician Decision|0|||
161735468|NCT03655717|584071030|FG025|Overall Study|Physician Decision|0|||
161735469|NCT03655717|584071005|FG000|Overall Study|Lost to Follow-up|3|||
161735470|NCT03655717|584071006|FG001|Overall Study|Lost to Follow-up|1|||
161735471|NCT03655717|584071007|FG002|Overall Study|Lost to Follow-up|0|||
161735472|NCT03655717|584071008|FG003|Overall Study|Lost to Follow-up|1|||
161735473|NCT03655717|584071009|FG004|Overall Study|Lost to Follow-up|0|||
161735474|NCT03655717|584071010|FG005|Overall Study|Lost to Follow-up|1|||
161735475|NCT03655717|584071011|FG006|Overall Study|Lost to Follow-up|0|||
161735476|NCT03655717|584071012|FG007|Overall Study|Lost to Follow-up|0|||
161735477|NCT03655717|584071013|FG008|Overall Study|Lost to Follow-up|0|||
161735478|NCT03655717|584071014|FG009|Overall Study|Lost to Follow-up|0|||
161735479|NCT03655717|584071015|FG010|Overall Study|Lost to Follow-up|0|||
161735480|NCT03655717|584071016|FG011|Overall Study|Lost to Follow-up|1|||
161735481|NCT03655717|584071017|FG012|Overall Study|Lost to Follow-up|0|||
161735482|NCT03655717|584071018|FG013|Overall Study|Lost to Follow-up|0|||
161735483|NCT03655717|584071019|FG014|Overall Study|Lost to Follow-up|0|||
161735484|NCT03655717|584071020|FG015|Overall Study|Lost to Follow-up|0|||
161735485|NCT03655717|584071021|FG016|Overall Study|Lost to Follow-up|0|||
161735486|NCT03655717|584071022|FG017|Overall Study|Lost to Follow-up|0|||
161735487|NCT03655717|584071023|FG018|Overall Study|Lost to Follow-up|0|||
161735488|NCT03655717|584071024|FG019|Overall Study|Lost to Follow-up|0|||
161735489|NCT03655717|584071025|FG020|Overall Study|Lost to Follow-up|0|||
161735490|NCT03655717|584071026|FG021|Overall Study|Lost to Follow-up|0|||
161735491|NCT03655717|584071027|FG022|Overall Study|Lost to Follow-up|0|||
161735492|NCT03655717|584071028|FG023|Overall Study|Lost to Follow-up|0|||
161735493|NCT03655717|584071029|FG024|Overall Study|Lost to Follow-up|0|||
161735494|NCT03655717|584071030|FG025|Overall Study|Lost to Follow-up|0|||
161735495|NCT01185249|584071031|FG000|Overall Study|Patients discharged or change in status|42|||
161735496|NCT01973452|584071032|FG000|Overall Study|Lack of Efficacy|0|||
161735497|NCT01973452|584071033|FG001|Overall Study|Lack of Efficacy|1|||
161735498|NCT01973452|584071032|FG000|Overall Study|Lost to Follow-up|1|||
161735499|NCT01973452|584071033|FG001|Overall Study|Lost to Follow-up|0|||
161839994|NCT03456960|584458690|FG001|Period 2 (1 Day)|Adverse Event|0|||
161839995|NCT03456960|584458691|FG002|Period 2 (1 Day)|Adverse Event|0|||
161839996|NCT03456960|584458692|FG003|Period 2 (1 Day)|Adverse Event|1|||
161839997|NCT03456960|584458693|FG004|Period 2 (1 Day)|Adverse Event|0|||
161839998|NCT03456960|584458694|FG005|Period 2 (1 Day)|Adverse Event|0|||
161839999|NCT02989168|584458695|FG000|Overall Study|Withdrawal by Subject|2|||
161840000|NCT02989168|584458696|FG001|Overall Study|Withdrawal by Subject|0|||
161840001|NCT02989168|584458695|FG000|Overall Study|Physician Decision|0|||
161840002|NCT02989168|584458696|FG001|Overall Study|Physician Decision|1|||
161840003|NCT02989168|584458695|FG000|Overall Study|Adverse Event|1|||
161840004|NCT02989168|584458696|FG001|Overall Study|Adverse Event|2|||
161840005|NCT02989168|584458695|FG000|Overall Study|Sponsor stopped study.|1|||
161840006|NCT02989168|584458696|FG001|Overall Study|Sponsor stopped study.|0|||
161840007|NCT01940497|584458697|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
161840008|NCT01940497|584458698|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
161840009|NCT01940497|584458697|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
161840010|NCT01940497|584458698|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
161840011|NCT01940497|584458697|FG000|Overall Study|Violation of Entry Criteria|1|||
161840012|NCT01940497|584458698|FG001|Overall Study|Violation of Entry Criteria|1|||
161735500|NCT01973452|584071032|FG000|Overall Study|Withdrawal by Subject|10|||
161735501|NCT01973452|584071033|FG001|Overall Study|Withdrawal by Subject|9|||
161735502|NCT01973452|584071032|FG000|Overall Study|Ineligible|1|||
161735503|NCT01973452|584071033|FG001|Overall Study|Ineligible|1|||
161735504|NCT01973452|584071032|FG000|Overall Study|Surgery canceled by participant|5|||
161840013|NCT01940497|584458697|FG000|Overall Study|Refused Treatment|1|||
161735505|NCT01973452|584071033|FG001|Overall Study|Surgery canceled by participant|3|||
161735506|NCT00064350|584071035|FG000|Induction Treatment|Disease Progression|5|||
161735507|NCT00064350|584071036|FG001|Induction Treatment|Disease Progression|1|||
161840014|NCT01940497|584458698|FG001|Overall Study|Refused Treatment|3|||
161735508|NCT00064350|584071037|FG002|Induction Treatment|Disease Progression|110|||
161735509|NCT00064350|584071035|FG000|Induction Treatment|Adverse Event|0|||
161735510|NCT00064350|584071036|FG001|Induction Treatment|Adverse Event|2|||
161735511|NCT00064350|584071037|FG002|Induction Treatment|Adverse Event|49|||
161735512|NCT00064350|584071035|FG000|Induction Treatment|Death|0|||
161735513|NCT00064350|584071036|FG001|Induction Treatment|Death|0|||
161735514|NCT00064350|584071037|FG002|Induction Treatment|Death|9|||
161735515|NCT00064350|584071035|FG000|Induction Treatment|Withdrawal by Subject|0|||
161840015|NCT01940497|584458697|FG000|Overall Study|Withdrew Consent|6|||
161840016|NCT01940497|584458698|FG001|Overall Study|Withdrew Consent|2|||
161735516|NCT00064350|584071036|FG001|Induction Treatment|Withdrawal by Subject|0|||
161735517|NCT00064350|584071037|FG002|Induction Treatment|Withdrawal by Subject|21|||
161735518|NCT00064350|584071035|FG000|Induction Treatment|Ineligible or never started treatment|3|||
161735519|NCT00064350|584071036|FG001|Induction Treatment|Ineligible or never started treatment|6|||
161735520|NCT00064350|584071037|FG002|Induction Treatment|Ineligible or never started treatment|34|||
161735521|NCT00064350|584071035|FG000|Induction Treatment|Other|0|||
161735522|NCT00064350|584071036|FG001|Induction Treatment|Other|0|||
161735523|NCT00064350|584071037|FG002|Induction Treatment|Other|13|||
161735524|NCT00064350|584071035|FG000|Randomization|Adverse Event|8|||
161735525|NCT00064350|584071036|FG001|Randomization|Adverse Event|3|||
161735526|NCT00064350|584071037|FG002|Randomization|Adverse Event|0|||
161735527|NCT00064350|584071035|FG000|Randomization|Death|3|||
161735528|NCT00064350|584071036|FG001|Randomization|Death|0|||
161735529|NCT00064350|584071037|FG002|Randomization|Death|0|||
161735530|NCT00064350|584071035|FG000|Randomization|Withdrawal by Subject|1|||
161735531|NCT00064350|584071036|FG001|Randomization|Withdrawal by Subject|0|||
161735532|NCT00064350|584071037|FG002|Randomization|Withdrawal by Subject|0|||
161735533|NCT00064350|584071035|FG000|Randomization|Ineligible or never started treatment|9|||
161735534|NCT00064350|584071036|FG001|Randomization|Ineligible or never started treatment|15|||
161735535|NCT00064350|584071037|FG002|Randomization|Ineligible or never started treatment|0|||
161735536|NCT00064350|584071035|FG000|Randomization|Other|5|||
161735537|NCT00064350|584071036|FG001|Randomization|Other|0|||
161735538|NCT00064350|584071037|FG002|Randomization|Other|0|||
161735539|NCT00064350|584071035|FG000|Cross-Over|Adverse Event|0|||
161735540|NCT00064350|584071036|FG001|Cross-Over|Adverse Event|1|||
161735541|NCT00064350|584071037|FG002|Cross-Over|Adverse Event|0|||
161735542|NCT00064350|584071035|FG000|Cross-Over|Death|1|||
161735543|NCT00064350|584071036|FG001|Cross-Over|Death|3|||
161735544|NCT00064350|584071037|FG002|Cross-Over|Death|0|||
161735545|NCT00064350|584071035|FG000|Cross-Over|Withdrawal by Subject|2|||
161735546|NCT00064350|584071036|FG001|Cross-Over|Withdrawal by Subject|2|||
161735547|NCT00064350|584071037|FG002|Cross-Over|Withdrawal by Subject|0|||
161735548|NCT00064350|584071035|FG000|Cross-Over|Ineligible or never started treatment|3|||
161735549|NCT00064350|584071036|FG001|Cross-Over|Ineligible or never started treatment|6|||
161735550|NCT00064350|584071037|FG002|Cross-Over|Ineligible or never started treatment|0|||
161735551|NCT00064350|584071035|FG000|Cross-Over|Other|0|||
161735552|NCT00064350|584071036|FG001|Cross-Over|Other|2|||
161735553|NCT00064350|584071037|FG002|Cross-Over|Other|0|||
161735554|NCT00115765|584071038|FG000|Overall Study|Withdrawal by Subject|22|||
161735555|NCT00115765|584071039|FG001|Overall Study|Withdrawal by Subject|53|||
161735556|NCT00115765|584071040|FG002|Overall Study|Withdrawal by Subject|76|||
161735557|NCT00115765|584071041|FG003|Overall Study|Withdrawal by Subject|15|||
161735558|NCT00115765|584071038|FG000|Overall Study|Physician Decision|4|||
161735559|NCT00115765|584071039|FG001|Overall Study|Physician Decision|15|||
161735560|NCT00115765|584071040|FG002|Overall Study|Physician Decision|18|||
161735561|NCT00115765|584071041|FG003|Overall Study|Physician Decision|13|||
161735562|NCT00115765|584071038|FG000|Overall Study|Lost to Follow-up|3|||
161735563|NCT00115765|584071039|FG001|Overall Study|Lost to Follow-up|20|||
161735564|NCT00115765|584071040|FG002|Overall Study|Lost to Follow-up|18|||
161735565|NCT00115765|584071041|FG003|Overall Study|Lost to Follow-up|1|||
161735566|NCT00115765|584071038|FG000|Overall Study|Other|6|||
161735567|NCT00115765|584071039|FG001|Overall Study|Other|12|||
161735568|NCT00115765|584071040|FG002|Overall Study|Other|9|||
161735569|NCT00115765|584071041|FG003|Overall Study|Other|2|||
161735570|NCT03707158|584071044|FG000|Midtreatment|Lost to Follow-up|16|||
161735571|NCT03707158|584071045|FG001|Midtreatment|Lost to Follow-up|7|||
161735572|NCT03707158|584071044|FG000|Midtreatment|Withdrawal by Subject|28|||
161735573|NCT03707158|584071045|FG001|Midtreatment|Withdrawal by Subject|19|||
161735574|NCT03707158|584071044|FG000|Posttreatment|Lost to Follow-up|0|||
161735575|NCT03707158|584071045|FG001|Posttreatment|Lost to Follow-up|5|||
161840017|NCT01940497|584458697|FG000|Overall Study|Administrative/Other|1|||
161735576|NCT03707158|584071044|FG000|Follow-up|Lost to Follow-up|19|||
161735577|NCT03707158|584071045|FG001|Follow-up|Lost to Follow-up|18|||
161735578|NCT03707158|584071044|FG000|Follow-up|Withdrawal by Subject|13|||
161735579|NCT03707158|584071045|FG001|Follow-up|Withdrawal by Subject|6|||
161735580|NCT01454401|584071046|FG000|Overall Study|Death|1|||
161840018|NCT01940497|584458698|FG001|Overall Study|Administrative/Other|1|||
161840019|NCT00502801|584458699|FG000|Treatment Period|Withdrawal by Subject|3|||
161735581|NCT01454401|584071046|FG000|Overall Study|hospitalised|1|||
161735582|NCT01454401|584071046|FG000|Overall Study|osteomyelitis|2|||
161735583|NCT01454401|584071046|FG000|Overall Study|non-adherence|1|||
161735584|NCT01968187|584071049|FG000|Overall Study|Adverse Event|0|||
161735585|NCT01968187|584071050|FG001|Overall Study|Adverse Event|1|||
161735586|NCT01968187|584071049|FG000|Overall Study|Randomized but not treated|1|||
161735587|NCT01968187|584071050|FG001|Overall Study|Randomized but not treated|0|||
161735588|NCT00430521|584071051|FG000|Overall Study|Adverse Event|0|||
161735589|NCT00430521|584071052|FG001|Overall Study|Adverse Event|0|||
161735590|NCT00430521|584071053|FG002|Overall Study|Adverse Event|0|||
161735591|NCT00430521|584071054|FG003|Overall Study|Adverse Event|0|||
161735592|NCT00430521|584071055|FG004|Overall Study|Adverse Event|0|||
161735593|NCT00430521|584071056|FG005|Overall Study|Adverse Event|2|||
161735594|NCT00430521|584071057|FG006|Overall Study|Adverse Event|1|||
161735595|NCT00430521|584071058|FG007|Overall Study|Adverse Event|0|||
161735596|NCT00430521|584071051|FG000|Overall Study|Lost to Follow-up|7|||
161735597|NCT00430521|584071052|FG001|Overall Study|Lost to Follow-up|8|||
161735598|NCT00430521|584071053|FG002|Overall Study|Lost to Follow-up|3|||
161735599|NCT00430521|584071054|FG003|Overall Study|Lost to Follow-up|5|||
161735600|NCT00430521|584071055|FG004|Overall Study|Lost to Follow-up|5|||
161735601|NCT00430521|584071056|FG005|Overall Study|Lost to Follow-up|2|||
161735602|NCT00430521|584071057|FG006|Overall Study|Lost to Follow-up|8|||
161735603|NCT00430521|584071058|FG007|Overall Study|Lost to Follow-up|10|||
161735604|NCT00430521|584071051|FG000|Overall Study|Pregnancy|0|||
161735605|NCT00430521|584071052|FG001|Overall Study|Pregnancy|0|||
161735606|NCT00430521|584071053|FG002|Overall Study|Pregnancy|0|||
161735607|NCT00430521|584071054|FG003|Overall Study|Pregnancy|0|||
161735608|NCT00430521|584071055|FG004|Overall Study|Pregnancy|0|||
161735609|NCT00430521|584071056|FG005|Overall Study|Pregnancy|0|||
161735610|NCT00430521|584071057|FG006|Overall Study|Pregnancy|1|||
161735611|NCT00430521|584071058|FG007|Overall Study|Pregnancy|0|||
161735612|NCT00430521|584071051|FG000|Overall Study|Vaccine Expired|0|||
161735613|NCT00430521|584071052|FG001|Overall Study|Vaccine Expired|0|||
161735614|NCT00430521|584071053|FG002|Overall Study|Vaccine Expired|0|||
161735615|NCT00430521|584071054|FG003|Overall Study|Vaccine Expired|0|||
161735616|NCT00430521|584071055|FG004|Overall Study|Vaccine Expired|0|||
161735617|NCT00430521|584071056|FG005|Overall Study|Vaccine Expired|1|||
161735618|NCT00430521|584071057|FG006|Overall Study|Vaccine Expired|0|||
161735619|NCT00430521|584071058|FG007|Overall Study|Vaccine Expired|0|||
161735620|NCT00430521|584071051|FG000|Overall Study|Protocol Violation|1|||
161735621|NCT00430521|584071052|FG001|Overall Study|Protocol Violation|0|||
161735622|NCT00430521|584071053|FG002|Overall Study|Protocol Violation|0|||
161735623|NCT00430521|584071054|FG003|Overall Study|Protocol Violation|0|||
161735624|NCT00430521|584071055|FG004|Overall Study|Protocol Violation|0|||
161735625|NCT00430521|584071056|FG005|Overall Study|Protocol Violation|0|||
161735626|NCT00430521|584071057|FG006|Overall Study|Protocol Violation|0|||
161735627|NCT00430521|584071058|FG007|Overall Study|Protocol Violation|0|||
161735628|NCT00430521|584071051|FG000|Overall Study|Withdrawal by Subject|3|||
161735629|NCT00430521|584071052|FG001|Overall Study|Withdrawal by Subject|1|||
161735630|NCT00430521|584071053|FG002|Overall Study|Withdrawal by Subject|0|||
161735631|NCT00430521|584071054|FG003|Overall Study|Withdrawal by Subject|3|||
161735632|NCT00430521|584071055|FG004|Overall Study|Withdrawal by Subject|0|||
161735633|NCT00430521|584071056|FG005|Overall Study|Withdrawal by Subject|0|||
161735634|NCT00430521|584071057|FG006|Overall Study|Withdrawal by Subject|0|||
161735635|NCT00430521|584071058|FG007|Overall Study|Withdrawal by Subject|2|||
161735636|NCT03675737|584071059|FG000|Overall Study|Death|593|||
161735637|NCT03675737|584071060|FG001|Overall Study|Death|660|||
161735638|NCT03675737|584071059|FG000|Overall Study|Lost to Follow-up|1|||
161735639|NCT03675737|584071060|FG001|Overall Study|Lost to Follow-up|5|||
161735640|NCT03675737|584071059|FG000|Overall Study|Physician Decision|1|||
161735641|NCT03675737|584071060|FG001|Overall Study|Physician Decision|0|||
161735642|NCT03675737|584071059|FG000|Overall Study|Withdrawal by Subject|14|||
161735643|NCT03675737|584071060|FG001|Overall Study|Withdrawal by Subject|12|||
161735644|NCT03675737|584071059|FG000|Overall Study|Ongoing in Study|181|||
161735645|NCT03675737|584071060|FG001|Overall Study|Ongoing in Study|112|||
161735646|NCT03422133|584071061|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
161735647|NCT03422133|584071062|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
161735648|NCT01274338|584073219|FG000|Overall Study|Lack of Efficacy|72|||
161735649|NCT01274338|584073220|FG001|Overall Study|Lack of Efficacy|108|||
161735650|NCT01274338|584073221|FG002|Overall Study|Lack of Efficacy|116|||
161735651|NCT01274338|584073222|FG003|Overall Study|Lack of Efficacy|0|||
161735652|NCT01274338|584073223|FG004|Overall Study|Lack of Efficacy|0|||
161735653|NCT01274338|584073224|FG005|Overall Study|Lack of Efficacy|0|||
161735654|NCT01274338|584073219|FG000|Overall Study|Adverse Event|272|||
161735655|NCT01274338|584073220|FG001|Overall Study|Adverse Event|105|||
161735656|NCT01274338|584073221|FG002|Overall Study|Adverse Event|180|||
161735657|NCT01274338|584073222|FG003|Overall Study|Adverse Event|1|||
161735658|NCT01274338|584073223|FG004|Overall Study|Adverse Event|0|||
161735659|NCT01274338|584073224|FG005|Overall Study|Adverse Event|0|||
161735660|NCT01274338|584073219|FG000|Overall Study|Death|8|||
161735661|NCT01274338|584073220|FG001|Overall Study|Death|1|||
161735662|NCT01274338|584073221|FG002|Overall Study|Death|0|||
161735663|NCT01274338|584073222|FG003|Overall Study|Death|0|||
161735664|NCT01274338|584073223|FG004|Overall Study|Death|0|||
161735665|NCT01274338|584073224|FG005|Overall Study|Death|0|||
161735666|NCT01274338|584073219|FG000|Overall Study|Withdrawal by Subject|27|||
161735667|NCT01274338|584073220|FG001|Overall Study|Withdrawal by Subject|99|||
161735668|NCT01274338|584073221|FG002|Overall Study|Withdrawal by Subject|17|||
161735669|NCT01274338|584073222|FG003|Overall Study|Withdrawal by Subject|0|||
161735670|NCT01274338|584073223|FG004|Overall Study|Withdrawal by Subject|0|||
161735671|NCT01274338|584073224|FG005|Overall Study|Withdrawal by Subject|0|||
161735672|NCT01274338|584073219|FG000|Overall Study|Did not start treatment|8|||
161735673|NCT01274338|584073220|FG001|Overall Study|Did not start treatment|116|||
161735674|NCT01274338|584073221|FG002|Overall Study|Did not start treatment|7|||
161735675|NCT01274338|584073222|FG003|Overall Study|Did not start treatment|0|||
161735676|NCT01274338|584073223|FG004|Overall Study|Did not start treatment|0|||
161735677|NCT01274338|584073224|FG005|Overall Study|Did not start treatment|0|||
161735678|NCT01274338|584073219|FG000|Overall Study|Alternative therapy|0|||
161735679|NCT01274338|584073220|FG001|Overall Study|Alternative therapy|1|||
161735680|NCT01274338|584073221|FG002|Overall Study|Alternative therapy|0|||
161735681|NCT01274338|584073222|FG003|Overall Study|Alternative therapy|0|||
161735682|NCT01274338|584073223|FG004|Overall Study|Alternative therapy|0|||
161735683|NCT01274338|584073224|FG005|Overall Study|Alternative therapy|0|||
161735684|NCT01274338|584073219|FG000|Overall Study|Other complicating diseases|0|||
161735685|NCT01274338|584073220|FG001|Overall Study|Other complicating diseases|3|||
161735686|NCT01274338|584073221|FG002|Overall Study|Other complicating diseases|1|||
161735687|NCT01274338|584073222|FG003|Overall Study|Other complicating diseases|0|||
161735688|NCT01274338|584073223|FG004|Overall Study|Other complicating diseases|0|||
161735689|NCT01274338|584073224|FG005|Overall Study|Other complicating diseases|0|||
161735690|NCT01274338|584073219|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
161735691|NCT01274338|584073220|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735692|NCT01274338|584073221|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735693|NCT01274338|584073222|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735694|NCT01274338|584073223|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735695|NCT01274338|584073224|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735696|NCT01274338|584073219|FG000|Overall Study|Pregnancy|0|||
161735697|NCT01274338|584073220|FG001|Overall Study|Pregnancy|0|||
161735698|NCT01274338|584073221|FG002|Overall Study|Pregnancy|1|||
161735699|NCT01274338|584073222|FG003|Overall Study|Pregnancy|0|||
161735700|NCT01274338|584073223|FG004|Overall Study|Pregnancy|0|||
161735701|NCT01274338|584073224|FG005|Overall Study|Pregnancy|0|||
161735702|NCT01274338|584073219|FG000|Overall Study|Reason not reported|12|||
161735703|NCT01274338|584073220|FG001|Overall Study|Reason not reported|21|||
161735704|NCT01274338|584073221|FG002|Overall Study|Reason not reported|3|||
161735705|NCT01274338|584073222|FG003|Overall Study|Reason not reported|0|||
161735706|NCT01274338|584073223|FG004|Overall Study|Reason not reported|1|||
161735707|NCT01274338|584073224|FG005|Overall Study|Reason not reported|0|||
161735708|NCT03004469|584073225|FG000|Overall Study|Adverse Event|6|||
161735709|NCT03004469|584073226|FG001|Overall Study|Adverse Event|4|||
161735710|NCT03004469|584073227|FG002|Overall Study|Adverse Event|6|||
161735711|NCT03004469|584073225|FG000|Overall Study|Lack of Efficacy|1|||
161735712|NCT03004469|584073226|FG001|Overall Study|Lack of Efficacy|0|||
161735713|NCT03004469|584073227|FG002|Overall Study|Lack of Efficacy|1|||
161735714|NCT03004469|584073225|FG000|Overall Study|Lost to Follow-up|23|||
161735715|NCT03004469|584073226|FG001|Overall Study|Lost to Follow-up|14|||
161735716|NCT03004469|584073227|FG002|Overall Study|Lost to Follow-up|6|||
161735717|NCT03004469|584073225|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161735718|NCT03004469|584073226|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161735719|NCT03004469|584073227|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161735720|NCT03004469|584073225|FG000|Overall Study|Protocol Violation|0|||
161735721|NCT03004469|584073226|FG001|Overall Study|Protocol Violation|0|||
161735722|NCT03004469|584073227|FG002|Overall Study|Protocol Violation|1|||
161735723|NCT03004469|584073225|FG000|Overall Study|Withdrawal by Subject|29|||
161735724|NCT03004469|584073226|FG001|Overall Study|Withdrawal by Subject|27|||
161735725|NCT03004469|584073227|FG002|Overall Study|Withdrawal by Subject|10|||
161735726|NCT03004469|584073225|FG000|Overall Study|Other unspecified reason|0|||
161735727|NCT03004469|584073226|FG001|Overall Study|Other unspecified reason|4|||
161735728|NCT03004469|584073227|FG002|Overall Study|Other unspecified reason|1|||
161735729|NCT01397552|584073228|FG000|Overall Study|Adverse Event|1|||
161735730|NCT01397552|584073229|FG001|Overall Study|Adverse Event|0|||
161735731|NCT01397552|584073228|FG000|Overall Study|Withdrawal by Subject|2|||
161735732|NCT01397552|584073229|FG001|Overall Study|Withdrawal by Subject|1|||
161735733|NCT00579501|584073232|FG000|Overall Study|Death|1|||
161735734|NCT00579501|584073232|FG000|Overall Study|End of neoadjuvant therapy|25|||
161735735|NCT00579501|584073232|FG000|Overall Study|toxicity|1|||
161735736|NCT00579501|584073232|FG000|Overall Study|Secondary lesion|1|||
161735737|NCT00579501|584073232|FG000|Overall Study|Radiation therapy before surgery|1|||
161735738|NCT00190983|584073233|FG000|Overall Study|Inevaluable (never treated)|2|||
161735739|NCT02287402|584073234|FG000|Treatment Period|Adverse Event|17|||
161735740|NCT02287402|584073234|FG000|Treatment Period|Voluntary Withdrawal|10|||
161735741|NCT02287402|584073234|FG000|Follow-up|Lost to Follow-up|1|||
161735742|NCT02287402|584073234|FG000|Follow-up|Voluntary Withdrawal|2|||
161735743|NCT04247815|584073235|FG000|Overall Study|Adverse Event|1|||
161735744|NCT04247815|584073236|FG001|Overall Study|Adverse Event|0|||
161735745|NCT04247815|584073235|FG000|Overall Study|Withdrawal by Subject|1|||
161735746|NCT04247815|584073236|FG001|Overall Study|Withdrawal by Subject|0|||
161735747|NCT04247815|584073235|FG000|Overall Study|Protocol Violation|0|||
161735748|NCT04247815|584073236|FG001|Overall Study|Protocol Violation|1|||
161735749|NCT02130427|584073240|FG000|Overall Study|Imaging results not interpretable|30|||
161735750|NCT02108600|584073241|FG000|Overall Study|Withdrawal by Subject|2|||
161840020|NCT00502801|584458699|FG000|Treatment Period|Adverse Event|7|||
161840021|NCT00502801|584458699|FG000|Treatment Period|Death|14|||
161840022|NCT00502801|584458699|FG000|Treatment Period|OTHER|30|||
161735751|NCT02108600|584073242|FG001|Overall Study|Withdrawal by Subject|0|||
161735752|NCT02108600|584073241|FG000|Overall Study|Lost to Follow-up|1|||
161735753|NCT02108600|584073242|FG001|Overall Study|Lost to Follow-up|1|||
161735754|NCT01295580|584073245|FG000|Overall Study|Protocol Violation|4|||
161735755|NCT01295580|584073246|FG001|Overall Study|Protocol Violation|2|||
161735756|NCT01295580|584073245|FG000|Overall Study|Withdrawal by Subject|1|||
161735757|NCT01295580|584073246|FG001|Overall Study|Withdrawal by Subject|4|||
161735758|NCT01295580|584073245|FG000|Overall Study|Adverse Event|2|||
161735759|NCT01295580|584073246|FG001|Overall Study|Adverse Event|1|||
161735760|NCT01295580|584073245|FG000|Overall Study|Lost to Follow-up|1|||
161735761|NCT01295580|584073246|FG001|Overall Study|Lost to Follow-up|0|||
161735762|NCT01295580|584073245|FG000|Overall Study|Lack of Efficacy|1|||
161840023|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
161840024|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
161840025|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|Death|3|||
161840026|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|OTHER|2|||
161840027|NCT03071094|584458703|FG000|Overall Study|Death|1|||
161840028|NCT03071094|584458704|FG001|Overall Study|Death|1|||
161840029|NCT03071094|584458703|FG000|Overall Study|Adverse Event|1|||
161840030|NCT03071094|584458704|FG001|Overall Study|Adverse Event|0|||
161840031|NCT01195272|584458708|FG000|Overall Study|Adverse Event|1|||
161840032|NCT01195272|584458708|FG000|Overall Study|Lack of Efficacy|3|||
161840033|NCT01769339|584458711|FG000|Overall Study|Lost to Follow-up|42|||
161840034|NCT01769339|584458711|FG000|Overall Study|Adverse Event|1|||
161840035|NCT04969861|584458712|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
161840036|NCT04969861|584458713|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
161840037|NCT06218823|584460409|FG000|Overall Study|Death|3|||
161840038|NCT06218823|584460410|FG001|Overall Study|Death|0|||
161840039|NCT06218823|584460409|FG000|Overall Study|Lost to Follow-up|0|||
161840040|NCT06218823|584460410|FG001|Overall Study|Lost to Follow-up|2|||
161840041|NCT05101486|584460411|FG000|Overall Study|Death|1|||
161840042|NCT05101486|584460412|FG001|Overall Study|Death|0|||
161840043|NCT05101486|584460413|FG002|Overall Study|Death|1|||
161840044|NCT05101486|584460411|FG000|Overall Study|Lost to Follow-up|12|||
161840045|NCT05101486|584460412|FG001|Overall Study|Lost to Follow-up|8|||
161840046|NCT05101486|584460413|FG002|Overall Study|Lost to Follow-up|17|||
161840047|NCT05101486|584460411|FG000|Overall Study|Physician Decision|1|||
161840048|NCT05101486|584460412|FG001|Overall Study|Physician Decision|0|||
161840049|NCT05101486|584460413|FG002|Overall Study|Physician Decision|0|||
161840050|NCT05101486|584460411|FG000|Overall Study|Protocol Violation|0|||
161840051|NCT05101486|584460412|FG001|Overall Study|Protocol Violation|0|||
161840052|NCT05101486|584460413|FG002|Overall Study|Protocol Violation|1|||
161840053|NCT05101486|584460411|FG000|Overall Study|Withdrawal by Subject|5|||
161840054|NCT05101486|584460412|FG001|Overall Study|Withdrawal by Subject|2|||
161840055|NCT05101486|584460413|FG002|Overall Study|Withdrawal by Subject|4|||
161840056|NCT05101486|584460411|FG000|Overall Study|Randomized but not vaccinated|1|||
161840057|NCT05101486|584460412|FG001|Overall Study|Randomized but not vaccinated|1|||
161840058|NCT05101486|584460413|FG002|Overall Study|Randomized but not vaccinated|1|||
161840059|NCT00292188|584460419|FG000|Single-Blind|Adverse Event|14|||
161840060|NCT00292188|584460420|FG001|Single-Blind|Adverse Event|0|||
161840061|NCT00292188|584460421|FG002|Single-Blind|Adverse Event|0|||
161840062|NCT00292188|584460419|FG000|Single-Blind|Lack of Efficacy|2|||
161840063|NCT00292188|584460420|FG001|Single-Blind|Lack of Efficacy|0|||
161840064|NCT00292188|584460421|FG002|Single-Blind|Lack of Efficacy|0|||
161840065|NCT00292188|584460419|FG000|Single-Blind|Laboratory Abnormality|5|||
161840066|NCT00292188|584460420|FG001|Single-Blind|Laboratory Abnormality|0|||
161840067|NCT00292188|584460421|FG002|Single-Blind|Laboratory Abnormality|0|||
161840068|NCT00292188|584460419|FG000|Single-Blind|Lost to Follow-up|3|||
161840069|NCT00292188|584460420|FG001|Single-Blind|Lost to Follow-up|0|||
161840070|NCT00292188|584460421|FG002|Single-Blind|Lost to Follow-up|0|||
161840071|NCT00292188|584460419|FG000|Single-Blind|Other|77|||
161840072|NCT00292188|584460420|FG001|Single-Blind|Other|0|||
161840073|NCT00292188|584460421|FG002|Single-Blind|Other|0|||
161840074|NCT00292188|584460419|FG000|Single-Blind|Withdrawal by Subject|12|||
161840075|NCT00292188|584460420|FG001|Single-Blind|Withdrawal by Subject|0|||
161840076|NCT00292188|584460421|FG002|Single-Blind|Withdrawal by Subject|0|||
161840077|NCT00292188|584460419|FG000|Single-Blind|Did not receive treatment|1|||
161840078|NCT00292188|584460420|FG001|Single-Blind|Did not receive treatment|0|||
161840079|NCT00292188|584460421|FG002|Single-Blind|Did not receive treatment|0|||
161840080|NCT00292188|584460419|FG000|Double-Blind|Adverse Event|0|||
161840081|NCT00292188|584460420|FG001|Double-Blind|Adverse Event|25|||
161840082|NCT00292188|584460421|FG002|Double-Blind|Adverse Event|9|||
161840083|NCT00292188|584460419|FG000|Double-Blind|Lack of Efficacy|0|||
161840084|NCT00292188|584460420|FG001|Double-Blind|Lack of Efficacy|2|||
161840085|NCT00292188|584460421|FG002|Double-Blind|Lack of Efficacy|12|||
161840086|NCT00292188|584460419|FG000|Double-Blind|Lost to Follow-up|0|||
161840087|NCT00292188|584460420|FG001|Double-Blind|Lost to Follow-up|1|||
161840088|NCT00292188|584460421|FG002|Double-Blind|Lost to Follow-up|0|||
161840089|NCT00292188|584460419|FG000|Double-Blind|Other|0|||
161840090|NCT00292188|584460420|FG001|Double-Blind|Other|3|||
161840091|NCT00292188|584460421|FG002|Double-Blind|Other|4|||
161840092|NCT00292188|584460419|FG000|Double-Blind|Withdrawal by Subject|0|||
161840093|NCT00292188|584460420|FG001|Double-Blind|Withdrawal by Subject|0|||
161840094|NCT00292188|584460421|FG002|Double-Blind|Withdrawal by Subject|3|||
161840095|NCT00292188|584460419|FG000|Double-Blind|Laboratory Abnormality|0|||
161840096|NCT00292188|584460420|FG001|Double-Blind|Laboratory Abnormality|0|||
161840097|NCT00292188|584460421|FG002|Double-Blind|Laboratory Abnormality|1|||
161840098|NCT00824616|584460422|FG000|Overall Study|Adverse Event|2|||
161735763|NCT01295580|584073246|FG001|Overall Study|Lack of Efficacy|0|||
161735764|NCT01295580|584073245|FG000|Overall Study|Other: inconvenience|1|||
161735765|NCT01295580|584073246|FG001|Overall Study|Other: inconvenience|0|||
161735766|NCT01295580|584073245|FG000|Overall Study|Other: family objection|0|||
161840099|NCT00824616|584460423|FG001|Overall Study|Adverse Event|1|||
161840100|NCT00824616|584460422|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
161840101|NCT00824616|584460423|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
161735767|NCT01295580|584073246|FG001|Overall Study|Other: family objection|1|||
161735768|NCT01742078|584073247|FG000|Overall Study|Withdrawal by Subject|0|||
161735769|NCT01742078|584073248|FG001|Overall Study|Withdrawal by Subject|0|||
161735770|NCT01742078|584073249|FG002|Overall Study|Withdrawal by Subject|0|||
161735771|NCT01742078|584073250|FG003|Overall Study|Withdrawal by Subject|1|||
161735772|NCT01742078|584073251|FG004|Overall Study|Withdrawal by Subject|0|||
161735773|NCT01742078|584073252|FG005|Overall Study|Withdrawal by Subject|0|||
161735774|NCT01742078|584073253|FG006|Overall Study|Withdrawal by Subject|0|||
161735775|NCT01742078|584073254|FG007|Overall Study|Withdrawal by Subject|0|||
161735776|NCT01742078|584073255|FG008|Overall Study|Withdrawal by Subject|0|||
161735777|NCT05025787|584073258|FG000|Overall Study|Lack of Efficacy|0|||
161735778|NCT05025787|584073259|FG001|Overall Study|Lack of Efficacy|1|||
161735779|NCT05025787|584073258|FG000|Overall Study|Adverse Event|2|||
161735780|NCT05025787|584073259|FG001|Overall Study|Adverse Event|4|||
161735781|NCT05025787|584073258|FG000|Overall Study|Non compliance|0|||
161735782|NCT05025787|584073259|FG001|Overall Study|Non compliance|1|||
161735783|NCT05025787|584073258|FG000|Overall Study|Protocol Violation|3|||
161735784|NCT05025787|584073259|FG001|Overall Study|Protocol Violation|1|||
161735785|NCT05025787|584073258|FG000|Overall Study|Stopping criteria met|1|||
161735786|NCT05025787|584073259|FG001|Overall Study|Stopping criteria met|1|||
161735787|NCT05025787|584073258|FG000|Overall Study|Withdrawal by Subject|3|||
161735788|NCT05025787|584073259|FG001|Overall Study|Withdrawal by Subject|1|||
161735789|NCT03806179|584073260|FG000|Overall Study|Progressive disease|0|||
161735790|NCT03806179|584073261|FG001|Overall Study|Progressive disease|2|||
161735791|NCT05600309|584073262|FG000|Overall Study|Death|41|||
161735792|NCT05600309|584073263|FG001|Overall Study|Death|38|||
161735793|NCT05600309|584073262|FG000|Overall Study|Sponsor Decision|9|||
161735794|NCT05600309|584073263|FG001|Overall Study|Sponsor Decision|6|||
161840102|NCT00824616|584460422|FG000|Overall Study|Hyperglycemia|1|||
161840103|NCT00824616|584460423|FG001|Overall Study|Hyperglycemia|1|||
161840104|NCT00824616|584460422|FG000|Overall Study|Lack of Efficacy|2|||
161840105|NCT00824616|584460423|FG001|Overall Study|Lack of Efficacy|1|||
161735795|NCT05822830|584073264|FG000|Overall Study|Adverse Event|6|||
161840106|NCT00824616|584460422|FG000|Overall Study|Lost to Follow-up|0|||
161840107|NCT00824616|584460423|FG001|Overall Study|Lost to Follow-up|1|||
161840108|NCT00824616|584460422|FG000|Overall Study|Withdrawal by Subject|1|||
161840109|NCT00824616|584460423|FG001|Overall Study|Withdrawal by Subject|1|||
161840110|NCT00721630|584460424|FG000|Overall Study|Participant found to be ineligible|1|||
161840111|NCT04711902|584460428|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840112|NCT04711902|584460429|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
161735796|NCT05822830|584073265|FG001|Overall Study|Adverse Event|6|||
161735797|NCT05822830|584073264|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161735798|NCT05822830|584073265|FG001|Overall Study|Assigned Treatment by Mistake|3|||
161735799|NCT05822830|584073264|FG000|Overall Study|Lost to Follow-up|16|||
161735800|NCT05822830|584073265|FG001|Overall Study|Lost to Follow-up|18|||
161735801|NCT05822830|584073264|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161735802|NCT05822830|584073265|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161735803|NCT05822830|584073264|FG000|Overall Study|Participant was Out of the Country|0|||
161735804|NCT05822830|584073265|FG001|Overall Study|Participant was Out of the Country|1|||
161735805|NCT05822830|584073264|FG000|Overall Study|Pregnancy|1|||
161735806|NCT05822830|584073265|FG001|Overall Study|Pregnancy|2|||
161735807|NCT05822830|584073264|FG000|Overall Study|Withdrawal by Subject|27|||
161735808|NCT05822830|584073265|FG001|Overall Study|Withdrawal by Subject|26|||
161735809|NCT00807846|584073266|FG000|Overall Study|Adverse Event|5|||
161735810|NCT00807846|584073267|FG001|Overall Study|Adverse Event|0|||
161735811|NCT00807846|584073266|FG000|Overall Study|Lack of Efficacy|2|||
161735812|NCT00807846|584073267|FG001|Overall Study|Lack of Efficacy|0|||
161735813|NCT00807846|584073266|FG000|Overall Study|Protocol Violation|2|||
161735814|NCT00807846|584073267|FG001|Overall Study|Protocol Violation|1|||
161735815|NCT00807846|584073266|FG000|Overall Study|Withdrawal by Subject|2|||
161735816|NCT00807846|584073267|FG001|Overall Study|Withdrawal by Subject|1|||
161735817|NCT00807846|584073266|FG000|Overall Study|Other|1|||
161735818|NCT00807846|584073267|FG001|Overall Study|Other|2|||
161735819|NCT01081873|584073268|FG000|Overall Study|Death|86|||
161735820|NCT01081873|584073268|FG000|Overall Study|Withdrawal by Subject|10|||
161735821|NCT01081873|584073268|FG000|Overall Study|Lost to Follow-up|142|||
161735822|NCT01081873|584073268|FG000|Overall Study|Progression of prostate cancer|13|||
161735823|NCT01081873|584073268|FG000|Overall Study|Other|47|||
161735824|NCT01165021|584073270|FG000|Overall Study|Death|1|||
161735825|NCT02491073|584073271|FG000|Overall Study|screen failure|1|||
161735826|NCT02491073|584073272|FG001|Overall Study|screen failure|0|||
161735827|NCT01419665|584073273|FG000|Combination Treatment|Adverse Event|7|||
161735828|NCT01419665|584073274|FG001|Combination Treatment|Adverse Event|10|||
161735829|NCT01419665|584073273|FG000|Combination Treatment|Physician Decision|5|||
161735830|NCT01419665|584073274|FG001|Combination Treatment|Physician Decision|8|||
161735831|NCT01419665|584073273|FG000|Combination Treatment|Protocol Violation|6|||
161735832|NCT01419665|584073274|FG001|Combination Treatment|Protocol Violation|2|||
161735833|NCT01419665|584073273|FG000|Combination Treatment|disease progression|10|||
161735834|NCT01419665|584073274|FG001|Combination Treatment|disease progression|9|||
161735835|NCT01419665|584073273|FG000|Combination Treatment|Death|5|||
161735836|NCT01419665|584073274|FG001|Combination Treatment|Death|7|||
161735837|NCT01419665|584073273|FG000|Combination Treatment|administrative problems|0|||
161735838|NCT01419665|584073274|FG001|Combination Treatment|administrative problems|1|||
161735839|NCT01419665|584073273|FG000|Combination Treatment|Withdrawal by Subject|5|||
161735840|NCT01419665|584073274|FG001|Combination Treatment|Withdrawal by Subject|4|||
161735841|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
161735842|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
161735843|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
161735844|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
161735845|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
161735846|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
161735847|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
161735848|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
161735849|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
161735850|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
161735851|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
161735852|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
161735853|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Death|1|||
161735854|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Death|2|||
161735855|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
161735856|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
161735857|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
161735858|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
161735859|NCT01419665|584073273|FG000|Open Label Phase|Death|1|||
161735860|NCT01419665|584073274|FG001|Open Label Phase|Death|0|||
161735861|NCT01419665|584073273|FG000|Open Label Phase|disease progression|0|||
161735862|NCT01419665|584073274|FG001|Open Label Phase|disease progression|1|||
161735863|NCT03977727|584073275|FG000|Second Treatment|Lost to Follow-up|0|||
161735864|NCT03977727|584073276|FG001|Second Treatment|Lost to Follow-up|3|||
161735865|NCT01655823|584073278|FG000|Overall Study|Lost to Follow-up|0|||
161735866|NCT01655823|584073279|FG001|Overall Study|Lost to Follow-up|1|||
161735867|NCT01655823|584073280|FG002|Overall Study|Lost to Follow-up|0|||
161735868|NCT01655823|584073281|FG003|Overall Study|Lost to Follow-up|0|||
161840113|NCT04711902|584460430|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
161840114|NCT04711902|584460431|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840115|NCT04711902|584460432|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840116|NCT04711902|584460433|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840117|NCT03786718|584460434|FG000|Overall Study|Lost to Follow-up|3|||
161840118|NCT03786718|584460434|FG000|Overall Study|Withdrawal by Subject|1|||
161840119|NCT03786718|584460434|FG000|Overall Study|Did not use the intervention|2|||
161840120|NCT03786718|584460434|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
161840121|NCT00372411|584460441|FG000|Overall Study|Withdrawal by Subject|3|||
161840122|NCT00372411|584460442|FG001|Overall Study|Withdrawal by Subject|4|||
161840123|NCT00372411|584460443|FG002|Overall Study|Withdrawal by Subject|1|||
161840124|NCT00372411|584460441|FG000|Overall Study|Death|0|||
161840125|NCT00372411|584460442|FG001|Overall Study|Death|2|||
161840126|NCT00372411|584460443|FG002|Overall Study|Death|1|||
161840127|NCT00372411|584460441|FG000|Overall Study|Lost to Follow-up|1|||
161840128|NCT00372411|584460442|FG001|Overall Study|Lost to Follow-up|1|||
161840129|NCT00372411|584460443|FG002|Overall Study|Lost to Follow-up|1|||
161840130|NCT00372411|584460441|FG000|Overall Study|Adverse Event|1|||
161840131|NCT00372411|584460442|FG001|Overall Study|Adverse Event|1|||
161840132|NCT00372411|584460443|FG002|Overall Study|Adverse Event|0|||
161735869|NCT01655823|584073282|FG004|Overall Study|Lost to Follow-up|1|||
161735870|NCT01655823|584073278|FG000|Overall Study|Withdrawal by Subject|0|||
161735871|NCT01655823|584073279|FG001|Overall Study|Withdrawal by Subject|1|||
161735872|NCT01655823|584073280|FG002|Overall Study|Withdrawal by Subject|0|||
161735873|NCT01655823|584073281|FG003|Overall Study|Withdrawal by Subject|1|||
161735874|NCT01655823|584073282|FG004|Overall Study|Withdrawal by Subject|0|||
161735875|NCT02683525|584073283|FG000|Overall Study|Lost to Follow-up|1|||
161735876|NCT02683525|584073283|FG000|Overall Study|Physician Decision|1|||
161735877|NCT02683525|584073283|FG000|Overall Study|Disease Progression|6|||
161735878|NCT02632110|584073288|FG000|Overall Study|Withdrawal by Subject|1|||
161735879|NCT02632110|584073289|FG001|Overall Study|Withdrawal by Subject|1|||
161735880|NCT02632110|584073290|FG002|Overall Study|Withdrawal by Subject|0|||
161735881|NCT02632110|584073291|FG003|Overall Study|Withdrawal by Subject|0|||
161735882|NCT02632110|584073292|FG004|Overall Study|Withdrawal by Subject|1|||
161735883|NCT02632110|584073293|FG005|Overall Study|Withdrawal by Subject|1|||
161735884|NCT02632110|584073294|FG006|Overall Study|Withdrawal by Subject|3|||
161735885|NCT02632110|584073295|FG007|Overall Study|Withdrawal by Subject|3|||
161735886|NCT02632110|584073296|FG008|Overall Study|Withdrawal by Subject|1|||
161735887|NCT02632110|584073297|FG009|Overall Study|Withdrawal by Subject|1|||
161735888|NCT01008995|584073302|FG000|Controlled Period|Adverse Event|1|||
161735889|NCT01008995|584073303|FG001|Controlled Period|Adverse Event|2|||
161735890|NCT01008995|584073304|FG002|Controlled Period|Adverse Event|0|||
161735891|NCT01008995|584073305|FG003|Controlled Period|Adverse Event|0|||
161735892|NCT01008995|584073302|FG000|Controlled Period|Other|2|||
161735893|NCT01008995|584073303|FG001|Controlled Period|Other|1|||
161735894|NCT01008995|584073304|FG002|Controlled Period|Other|0|||
161735895|NCT01008995|584073305|FG003|Controlled Period|Other|0|||
161735896|NCT01008995|584073302|FG000|After Controlled Period|Adverse Event|0|||
161735897|NCT01008995|584073303|FG001|After Controlled Period|Adverse Event|0|||
161735898|NCT01008995|584073304|FG002|After Controlled Period|Adverse Event|1|||
161735899|NCT01008995|584073305|FG003|After Controlled Period|Adverse Event|1|||
161735900|NCT01008995|584073302|FG000|After Controlled Period|Other|0|||
161735901|NCT01008995|584073303|FG001|After Controlled Period|Other|0|||
161735902|NCT01008995|584073304|FG002|After Controlled Period|Other|1|||
161735903|NCT01008995|584073305|FG003|After Controlled Period|Other|0|||
161735904|NCT00115804|584073308|FG000|Overall Study|Adverse Event|2|||
161735905|NCT00403559|584073309|FG000|Overall Study|Adverse Event|0|||
161840133|NCT01398514|584460444|FG000|Overall Study|Adverse Event|1|||
161840134|NCT01398514|584460445|FG001|Overall Study|Adverse Event|0|||
161840135|NCT01398514|584460444|FG000|Overall Study|Non-compliance with study procedures|2|||
161840136|NCT01398514|584460445|FG001|Overall Study|Non-compliance with study procedures|0|||
161840137|NCT01398514|584460444|FG000|Overall Study|Physiologic non-responsiveness|1|||
161840138|NCT01398514|584460445|FG001|Overall Study|Physiologic non-responsiveness|3|||
161840139|NCT01398514|584460444|FG000|Overall Study|Failure to show a conditioned response|4|||
161735906|NCT00403559|584073310|FG001|Overall Study|Adverse Event|1|||
161735907|NCT00403559|584073309|FG000|Overall Study|Lost to Follow-up|3|||
161840140|NCT01398514|584460445|FG001|Overall Study|Failure to show a conditioned response|3|||
161840141|NCT02227147|584460455|FG000|Controlled Treatment Period|Adverse Event|4|||
161735908|NCT00403559|584073310|FG001|Overall Study|Lost to Follow-up|3|||
161735909|NCT00403559|584073309|FG000|Overall Study|Withdrawal by Subject|1|||
161735910|NCT00403559|584073310|FG001|Overall Study|Withdrawal by Subject|0|||
161735911|NCT00547378|584073311|FG000|Randomized Cohort|Withdrawal by Subject|7|||
161735912|NCT00547378|584073312|FG001|Randomized Cohort|Withdrawal by Subject|5|||
161735913|NCT00547378|584073313|FG002|Randomized Cohort|Withdrawal by Subject|0|||
161735914|NCT00547378|584073311|FG000|Randomized Cohort|Death|0|||
161735915|NCT00547378|584073312|FG001|Randomized Cohort|Death|1|||
161735916|NCT00547378|584073313|FG002|Randomized Cohort|Death|0|||
161735917|NCT00547378|584073311|FG000|Randomized Cohort|Lost to Follow-up|1|||
161735918|NCT00547378|584073312|FG001|Randomized Cohort|Lost to Follow-up|0|||
161735919|NCT00547378|584073313|FG002|Randomized Cohort|Lost to Follow-up|0|||
161735920|NCT00547378|584073311|FG000|Randomized Cohort|Adverse Event|1|||
161735921|NCT00547378|584073312|FG001|Randomized Cohort|Adverse Event|0|||
161735922|NCT00547378|584073313|FG002|Randomized Cohort|Adverse Event|0|||
161735923|NCT00547378|584073311|FG000|Randomized Cohort|Other reasons|2|||
161735924|NCT00547378|584073312|FG001|Randomized Cohort|Other reasons|0|||
161735925|NCT00547378|584073313|FG002|Randomized Cohort|Other reasons|0|||
161735926|NCT00547378|584073311|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
161735927|NCT00547378|584073312|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
161735928|NCT00547378|584073313|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
161735929|NCT00547378|584073311|FG000|All Implanted Cohort|Adverse Event|4|||
161735930|NCT00547378|584073312|FG001|All Implanted Cohort|Adverse Event|10|||
161735931|NCT00547378|584073313|FG002|All Implanted Cohort|Adverse Event|17|||
161735932|NCT00547378|584073311|FG000|All Implanted Cohort|Lost to Follow-up|0|||
161735933|NCT00547378|584073312|FG001|All Implanted Cohort|Lost to Follow-up|1|||
161735934|NCT00547378|584073313|FG002|All Implanted Cohort|Lost to Follow-up|14|||
161735935|NCT00547378|584073311|FG000|All Implanted Cohort|Death|3|||
161735936|NCT00547378|584073312|FG001|All Implanted Cohort|Death|1|||
161735937|NCT00547378|584073313|FG002|All Implanted Cohort|Death|4|||
161735938|NCT00547378|584073311|FG000|All Implanted Cohort|Physician Decision|0|||
161735939|NCT00547378|584073312|FG001|All Implanted Cohort|Physician Decision|2|||
161735940|NCT00547378|584073313|FG002|All Implanted Cohort|Physician Decision|6|||
161735941|NCT00547378|584073311|FG000|All Implanted Cohort|Site closure|2|||
161735942|NCT00547378|584073312|FG001|All Implanted Cohort|Site closure|0|||
161735943|NCT00547378|584073313|FG002|All Implanted Cohort|Site closure|1|||
161735944|NCT00547378|584073311|FG000|All Implanted Cohort|Other reasons|1|||
161735945|NCT00547378|584073312|FG001|All Implanted Cohort|Other reasons|0|||
161735946|NCT00547378|584073313|FG002|All Implanted Cohort|Other reasons|1|||
161735947|NCT01982773|584073316|FG000|Overall Study|Withdrawal by Subject|1|||
161735948|NCT01982773|584073317|FG001|Overall Study|Withdrawal by Subject|3|||
161735949|NCT01982773|584073316|FG000|Overall Study|Lost to Follow-up|7|||
161735950|NCT01982773|584073317|FG001|Overall Study|Lost to Follow-up|1|||
161735951|NCT01029886|584073318|FG000|Overall Study|Adverse Event|12|||
161735952|NCT01029886|584073319|FG001|Overall Study|Adverse Event|25|||
161735953|NCT01029886|584073318|FG000|Overall Study|Lost to Follow-up|1|||
161735954|NCT01029886|584073319|FG001|Overall Study|Lost to Follow-up|0|||
161735955|NCT01029886|584073318|FG000|Overall Study|Physician Decision|2|||
161735956|NCT01029886|584073319|FG001|Overall Study|Physician Decision|6|||
161735957|NCT01029886|584073318|FG000|Overall Study|Protocol Violation|17|||
161735958|NCT01029886|584073319|FG001|Overall Study|Protocol Violation|5|||
161735959|NCT01029886|584073318|FG000|Overall Study|Withdrawal by Subject|8|||
161735960|NCT01029886|584073319|FG001|Overall Study|Withdrawal by Subject|18|||
161735961|NCT01029886|584073318|FG000|Overall Study|Entry Criteria Not Met|13|||
161735962|NCT01029886|584073319|FG001|Overall Study|Entry Criteria Not Met|5|||
161735963|NCT01029886|584073318|FG000|Overall Study|Sponsor Decision|1|||
161735964|NCT01029886|584073319|FG001|Overall Study|Sponsor Decision|0|||
161735965|NCT01029886|584073318|FG000|Overall Study|Loss Glucose Control|7|||
161735966|NCT01029886|584073319|FG001|Overall Study|Loss Glucose Control|1|||
161735967|NCT03294681|584073320|FG000|Overall Study|Withdrawal by Subject|1|||
161735968|NCT02720016|584073323|FG000|Overall Study|Separation of couple|6|||
161735969|NCT02720016|584073324|FG001|Overall Study|Separation of couple|8|||
161735970|NCT02720016|584073325|FG002|Overall Study|Separation of couple|2|||
161735971|NCT02720016|584073323|FG000|Overall Study|Withdrawal by Subject|6|||
161735972|NCT02720016|584073324|FG001|Overall Study|Withdrawal by Subject|6|||
161735973|NCT02720016|584073325|FG002|Overall Study|Withdrawal by Subject|4|||
161735974|NCT02720016|584073323|FG000|Overall Study|Scheduling issues|2|||
161735975|NCT02720016|584073324|FG001|Overall Study|Scheduling issues|4|||
161735976|NCT02720016|584073325|FG002|Overall Study|Scheduling issues|7|||
161735977|NCT02720016|584073323|FG000|Overall Study|Childcare|2|||
161735978|NCT02720016|584073324|FG001|Overall Study|Childcare|0|||
161735979|NCT02720016|584073325|FG002|Overall Study|Childcare|2|||
161735980|NCT02720016|584073323|FG000|Overall Study|Withdrawal by PI|2|||
161735981|NCT02720016|584073324|FG001|Overall Study|Withdrawal by PI|2|||
161735982|NCT02720016|584073325|FG002|Overall Study|Withdrawal by PI|0|||
161735983|NCT02720016|584073323|FG000|Overall Study|Moved away|2|||
161735984|NCT02720016|584073324|FG001|Overall Study|Moved away|0|||
161735985|NCT02720016|584073325|FG002|Overall Study|Moved away|0|||
161735986|NCT02720016|584073323|FG000|Overall Study|Not Primary Health Concern|0|||
161735987|NCT02720016|584073324|FG001|Overall Study|Not Primary Health Concern|0|||
161735988|NCT02720016|584073325|FG002|Overall Study|Not Primary Health Concern|2|||
161735989|NCT02720016|584073323|FG000|Overall Study|Transportation issues|0|||
161735990|NCT02720016|584073324|FG001|Overall Study|Transportation issues|0|||
161735991|NCT02720016|584073325|FG002|Overall Study|Transportation issues|1|||
161735992|NCT02720016|584073323|FG000|Overall Study|Other|0|||
161735993|NCT02720016|584073324|FG001|Overall Study|Other|0|||
161735994|NCT02720016|584073325|FG002|Overall Study|Other|2|||
161735995|NCT04501679|584073326|FG000|Overall Study|Pregnancy|0|||
161735996|NCT04501679|584073327|FG001|Overall Study|Pregnancy|1|||
161735997|NCT04501679|584073326|FG000|Overall Study|Adverse Event|4|||
161735998|NCT04501679|584073327|FG001|Overall Study|Adverse Event|2|||
161735999|NCT04501679|584073326|FG000|Overall Study|Withdrawal by Subject|2|||
161736000|NCT04501679|584073327|FG001|Overall Study|Withdrawal by Subject|0|||
161736001|NCT04501679|584073326|FG000|Overall Study|Physician Decision|1|||
161736002|NCT04501679|584073327|FG001|Overall Study|Physician Decision|0|||
161736003|NCT04501679|584073326|FG000|Overall Study|Lost to Follow-up|2|||
161736004|NCT04501679|584073327|FG001|Overall Study|Lost to Follow-up|0|||
161736005|NCT02121756|584073331|FG000|Overall Study|Adverse Event|3|||
161736006|NCT02121756|584073332|FG001|Overall Study|Adverse Event|0|||
161736007|NCT02121756|584073331|FG000|Overall Study|Protocol Violation|1|||
161736008|NCT02121756|584073332|FG001|Overall Study|Protocol Violation|1|||
161736009|NCT02121756|584073331|FG000|Overall Study|Physician Decision|2|||
161736010|NCT02121756|584073332|FG001|Overall Study|Physician Decision|1|||
161736011|NCT05319080|584073333|FG000|Overall Study|Withdrawal by Subject|2|||
161736012|NCT05319080|584073333|FG000|Overall Study|Physician Decision|4|||
161736013|NCT00751114|584073334|FG000|Overall Study|Adverse Event|2|||
161736014|NCT00751114|584073335|FG001|Overall Study|Adverse Event|4|||
161736015|NCT00751114|584073334|FG000|Overall Study|Protocol Violation|8|||
161736016|NCT00751114|584073335|FG001|Overall Study|Protocol Violation|9|||
161736017|NCT00751114|584073334|FG000|Overall Study|Withdrawal by Subject|9|||
161736018|NCT00751114|584073335|FG001|Overall Study|Withdrawal by Subject|4|||
161736019|NCT00751114|584073334|FG000|Overall Study|Lost to Follow-up|4|||
161736020|NCT00751114|584073335|FG001|Overall Study|Lost to Follow-up|7|||
161736021|NCT00751114|584073334|FG000|Overall Study|Lack of Efficacy|0|||
161736022|NCT00751114|584073335|FG001|Overall Study|Lack of Efficacy|7|||
161736023|NCT00751114|584073334|FG000|Overall Study|Not Treated|13|||
161736024|NCT00751114|584073335|FG001|Overall Study|Not Treated|1|||
161736025|NCT00751114|584073334|FG000|Overall Study|Out of country for 2 months|1|||
161736026|NCT00751114|584073335|FG001|Overall Study|Out of country for 2 months|0|||
161736027|NCT00751114|584073334|FG000|Overall Study|Move to another city|1|||
161736028|NCT00751114|584073335|FG001|Overall Study|Move to another city|0|||
161736029|NCT03095521|584073336|FG000|Overall Study|Withdrawal by Subject|0|||
161736030|NCT03095521|584073337|FG001|Overall Study|Withdrawal by Subject|1|||
161736031|NCT03095521|584073336|FG000|Overall Study|Lost to Follow-up|0|||
161736032|NCT03095521|584073337|FG001|Overall Study|Lost to Follow-up|1|||
161736033|NCT01536119|584073340|FG000|Overall Study|Lost to Follow-up|17|||
161736034|NCT01536119|584073341|FG001|Overall Study|Lost to Follow-up|14|||
161736035|NCT00448916|584073342|FG000|Overall Study|Adverse Event|2|||
161736036|NCT00448916|584073343|FG001|Overall Study|Adverse Event|2|||
161736037|NCT00448916|584073344|FG002|Overall Study|Adverse Event|3|||
161736038|NCT00448916|584073345|FG003|Overall Study|Adverse Event|2|||
161736039|NCT00448916|584073342|FG000|Overall Study|Lack of Efficacy|1|||
161736040|NCT00448916|584073343|FG001|Overall Study|Lack of Efficacy|0|||
161736041|NCT00448916|584073344|FG002|Overall Study|Lack of Efficacy|2|||
161736042|NCT00448916|584073345|FG003|Overall Study|Lack of Efficacy|1|||
161736043|NCT00448916|584073342|FG000|Overall Study|Withdrawal by Subject|3|||
161736044|NCT00448916|584073343|FG001|Overall Study|Withdrawal by Subject|3|||
161736045|NCT00448916|584073344|FG002|Overall Study|Withdrawal by Subject|1|||
161736046|NCT00448916|584073345|FG003|Overall Study|Withdrawal by Subject|1|||
161736047|NCT00448916|584073342|FG000|Overall Study|Other|1|||
161736048|NCT00448916|584073343|FG001|Overall Study|Other|0|||
161736049|NCT00448916|584073344|FG002|Overall Study|Other|0|||
161736050|NCT00448916|584073345|FG003|Overall Study|Other|0|||
161736051|NCT00448916|584073342|FG000|Overall Study|Lost to Follow-up|0|||
161736052|NCT00448916|584073343|FG001|Overall Study|Lost to Follow-up|1|||
161736053|NCT00448916|584073344|FG002|Overall Study|Lost to Follow-up|0|||
161736054|NCT00448916|584073345|FG003|Overall Study|Lost to Follow-up|1|||
161736055|NCT00448916|584073342|FG000|Overall Study|Protocol Violation|0|||
161736056|NCT00448916|584073343|FG001|Overall Study|Protocol Violation|0|||
161736057|NCT00448916|584073344|FG002|Overall Study|Protocol Violation|0|||
161736058|NCT00448916|584073345|FG003|Overall Study|Protocol Violation|1|||
161736059|NCT02365584|584073346|FG000|Overall Study|Adverse Event|2|||
161736060|NCT02365584|584073347|FG001|Overall Study|Adverse Event|2|||
161736061|NCT02365584|584073346|FG000|Overall Study|Withdrawal by Subject|1|||
161736062|NCT02365584|584073347|FG001|Overall Study|Withdrawal by Subject|0|||
161736063|NCT02365584|584073346|FG000|Overall Study|Disease Progression|9|||
161736064|NCT02365584|584073347|FG001|Overall Study|Disease Progression|12|||
161736065|NCT03521193|584073348|FG000|Overall Study|Withdrawal by Subject|8|||
161736066|NCT03521193|584073349|FG001|Overall Study|Withdrawal by Subject|0|||
161736067|NCT03521193|584073348|FG000|Overall Study|non compliant to ASA treatment|8|||
161736068|NCT03521193|584073349|FG001|Overall Study|non compliant to ASA treatment|0|||
161736069|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
161736070|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
161736071|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
161736072|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
161736073|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
161736074|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
161736075|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
161736076|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161736077|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
161736078|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
161736079|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
161736080|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
161736081|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
161736082|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
161736083|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
161736084|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
161736085|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Missing|3|||
161736086|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Missing|1|||
161736087|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
161736088|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161736089|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
161736090|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
161736091|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
161736092|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
161736093|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
161736094|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
161736095|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
161736096|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
161736097|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
161736098|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
161736099|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
161736100|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
161736101|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
161736102|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
161736103|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161736104|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
161736105|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Missing|3|||
161736106|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Missing|0|||
161736107|NCT01927419|584073352|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161736108|NCT01927419|584073353|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161736109|NCT01927419|584073352|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
161736110|NCT01927419|584073353|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
161736111|NCT01927419|584073352|FG000|Treatment Period|Disease progression|17|||
161736112|NCT01927419|584073353|FG001|Treatment Period|Disease progression|20|||
161736113|NCT01927419|584073352|FG000|Treatment Period|Study drug toxicity|48|||
161736114|NCT01927419|584073353|FG001|Treatment Period|Study drug toxicity|10|||
161736115|NCT01927419|584073352|FG000|Treatment Period|Death|0|||
161736116|NCT01927419|584073353|FG001|Treatment Period|Death|1|||
161736117|NCT01927419|584073352|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
161736118|NCT01927419|584073353|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
161736119|NCT01927419|584073352|FG000|Treatment Period|Participant request to discontinue|12|||
161736120|NCT01927419|584073353|FG001|Treatment Period|Participant request to discontinue|4|||
161736121|NCT01927419|584073352|FG000|Treatment Period|Withdrawal by Subject|1|||
161736122|NCT01927419|584073353|FG001|Treatment Period|Withdrawal by Subject|1|||
161736123|NCT01927419|584073352|FG000|Treatment Period|Maximum Clinical Benefit|6|||
161736124|NCT01927419|584073353|FG001|Treatment Period|Maximum Clinical Benefit|2|||
161736125|NCT01927419|584073352|FG000|Treatment Period|Other reasons|3|||
161736126|NCT01927419|584073353|FG001|Treatment Period|Other reasons|4|||
161736127|NCT01927419|584073352|FG000|Treatment Period|Not Reported|1|||
161736128|NCT01927419|584073353|FG001|Treatment Period|Not Reported|1|||
161736129|NCT01935336|584073356|FG000|Overall Study|Adverse Event|1|||
161736130|NCT01935336|584073357|FG001|Overall Study|Adverse Event|0|||
161736131|NCT01935336|584073358|FG002|Overall Study|Adverse Event|0|||
161736132|NCT01935336|584073359|FG003|Overall Study|Adverse Event|0|||
161736133|NCT01935336|584073356|FG000|Overall Study|Progressive disease|5|||
161736134|NCT01935336|584073357|FG001|Overall Study|Progressive disease|3|||
161736135|NCT01935336|584073358|FG002|Overall Study|Progressive disease|47|||
161736136|NCT01935336|584073359|FG003|Overall Study|Progressive disease|66|||
161736137|NCT02773238|584073361|FG000|Overall Study|Lack of Efficacy|4|||
161736138|NCT03260205|584073362|FG000|Overall Study|Adverse Event|2|||
161736139|NCT03260205|584073363|FG001|Overall Study|Adverse Event|0|||
161736140|NCT03260205|584073364|FG002|Overall Study|Adverse Event|2|||
161736141|NCT03260205|584073365|FG003|Overall Study|Adverse Event|2|||
161736142|NCT03260205|584073366|FG004|Overall Study|Adverse Event|4|||
161736143|NCT03260205|584073362|FG000|Overall Study|Lost to Follow-up|2|||
161736144|NCT03260205|584073363|FG001|Overall Study|Lost to Follow-up|2|||
161736145|NCT03260205|584073364|FG002|Overall Study|Lost to Follow-up|1|||
161736146|NCT03260205|584073365|FG003|Overall Study|Lost to Follow-up|1|||
161736147|NCT03260205|584073366|FG004|Overall Study|Lost to Follow-up|5|||
161736148|NCT03260205|584073362|FG000|Overall Study|Protocol Violation|0|||
161736149|NCT03260205|584073363|FG001|Overall Study|Protocol Violation|0|||
161736150|NCT03260205|584073364|FG002|Overall Study|Protocol Violation|2|||
161736151|NCT03260205|584073365|FG003|Overall Study|Protocol Violation|0|||
161736152|NCT03260205|584073366|FG004|Overall Study|Protocol Violation|1|||
161736153|NCT03260205|584073362|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
161736154|NCT03260205|584073363|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
161736155|NCT03260205|584073364|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
161736156|NCT03260205|584073365|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
161736157|NCT03260205|584073366|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
161736158|NCT03260205|584073362|FG000|Overall Study|Other: Unspecified|0|||
161736159|NCT03260205|584073363|FG001|Overall Study|Other: Unspecified|0|||
161736160|NCT03260205|584073364|FG002|Overall Study|Other: Unspecified|3|||
161736161|NCT03260205|584073365|FG003|Overall Study|Other: Unspecified|1|||
161736162|NCT03260205|584073366|FG004|Overall Study|Other: Unspecified|1|||
161736163|NCT03260205|584073362|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
161736164|NCT03260205|584073363|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
161736165|NCT03260205|584073364|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
161736166|NCT03260205|584073365|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
161736167|NCT03260205|584073366|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
161736168|NCT00479557|584073369|FG000|Overall Study|Death|0|||
161736169|NCT00479557|584073370|FG001|Overall Study|Death|0|||
161736170|NCT00479557|584073371|FG002|Overall Study|Death|0|||
161736171|NCT00479557|584073372|FG003|Overall Study|Death|0|||
161736172|NCT00479557|584073373|FG004|Overall Study|Death|0|||
161736173|NCT00479557|584073374|FG005|Overall Study|Death|1|||
161736174|NCT00479557|584073375|FG006|Overall Study|Death|0|||
161736175|NCT00479557|584073369|FG000|Overall Study|Lack of Efficacy|1|||
161736176|NCT00479557|584073370|FG001|Overall Study|Lack of Efficacy|0|||
161736177|NCT00479557|584073371|FG002|Overall Study|Lack of Efficacy|0|||
161736178|NCT00479557|584073372|FG003|Overall Study|Lack of Efficacy|0|||
161736179|NCT00479557|584073373|FG004|Overall Study|Lack of Efficacy|0|||
161736180|NCT00479557|584073374|FG005|Overall Study|Lack of Efficacy|0|||
161736181|NCT00479557|584073375|FG006|Overall Study|Lack of Efficacy|0|||
161736182|NCT00479557|584073369|FG000|Overall Study|Lost to Follow-up|0|||
161736183|NCT00479557|584073370|FG001|Overall Study|Lost to Follow-up|2|||
161736184|NCT00479557|584073371|FG002|Overall Study|Lost to Follow-up|0|||
161736185|NCT00479557|584073372|FG003|Overall Study|Lost to Follow-up|2|||
161736186|NCT00479557|584073373|FG004|Overall Study|Lost to Follow-up|0|||
161736187|NCT00479557|584073374|FG005|Overall Study|Lost to Follow-up|0|||
161736188|NCT00479557|584073375|FG006|Overall Study|Lost to Follow-up|0|||
161736189|NCT00479557|584073369|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161736190|NCT00479557|584073370|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161736191|NCT00479557|584073371|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
161736192|NCT00479557|584073372|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
161736193|NCT00479557|584073373|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161736194|NCT00479557|584073374|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161736195|NCT00479557|584073375|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161736196|NCT00479557|584073369|FG000|Overall Study|AE not related to Study Drug|1|||
161736197|NCT00479557|584073370|FG001|Overall Study|AE not related to Study Drug|3|||
161736198|NCT00479557|584073371|FG002|Overall Study|AE not related to Study Drug|0|||
161736199|NCT00479557|584073372|FG003|Overall Study|AE not related to Study Drug|0|||
161736200|NCT00479557|584073373|FG004|Overall Study|AE not related to Study Drug|2|||
161736201|NCT00479557|584073374|FG005|Overall Study|AE not related to Study Drug|2|||
161840142|NCT02227147|584460456|FG001|Controlled Treatment Period|Adverse Event|3|||
161840143|NCT02227147|584460455|FG000|Controlled Treatment Period|Other|2|||
161736202|NCT00479557|584073375|FG006|Overall Study|AE not related to Study Drug|1|||
161736203|NCT00479557|584073369|FG000|Overall Study|Caregiver Request|2|||
161736204|NCT00479557|584073370|FG001|Overall Study|Caregiver Request|2|||
161736205|NCT00479557|584073371|FG002|Overall Study|Caregiver Request|2|||
161736206|NCT00479557|584073372|FG003|Overall Study|Caregiver Request|0|||
161736207|NCT00479557|584073373|FG004|Overall Study|Caregiver Request|1|||
161736208|NCT00479557|584073374|FG005|Overall Study|Caregiver Request|2|||
161736209|NCT00479557|584073375|FG006|Overall Study|Caregiver Request|0|||
161736210|NCT00479557|584073369|FG000|Overall Study|Investigator Request|0|||
161736211|NCT00479557|584073370|FG001|Overall Study|Investigator Request|0|||
161736212|NCT00479557|584073371|FG002|Overall Study|Investigator Request|1|||
161736213|NCT00479557|584073372|FG003|Overall Study|Investigator Request|0|||
161736214|NCT00479557|584073373|FG004|Overall Study|Investigator Request|0|||
161736215|NCT00479557|584073374|FG005|Overall Study|Investigator Request|0|||
161736216|NCT00479557|584073375|FG006|Overall Study|Investigator Request|0|||
161736217|NCT00479557|584073369|FG000|Overall Study|Subject Request|3|||
161736218|NCT00479557|584073370|FG001|Overall Study|Subject Request|0|||
161736219|NCT00479557|584073371|FG002|Overall Study|Subject Request|1|||
161736220|NCT00479557|584073372|FG003|Overall Study|Subject Request|1|||
161736221|NCT00479557|584073373|FG004|Overall Study|Subject Request|1|||
161736222|NCT00479557|584073374|FG005|Overall Study|Subject Request|4|||
161736223|NCT00479557|584073375|FG006|Overall Study|Subject Request|1|||
161736224|NCT00479557|584073369|FG000|Overall Study|Other|2|||
161736225|NCT00479557|584073370|FG001|Overall Study|Other|3|||
161736226|NCT00479557|584073371|FG002|Overall Study|Other|1|||
161736227|NCT00479557|584073372|FG003|Overall Study|Other|0|||
161736228|NCT00479557|584073373|FG004|Overall Study|Other|0|||
161736229|NCT00479557|584073374|FG005|Overall Study|Other|3|||
161736230|NCT00479557|584073375|FG006|Overall Study|Other|0|||
161736231|NCT01511107|584073378|FG000|Overall Study|Ineligible|3|||
161736232|NCT01511107|584073379|FG001|Overall Study|Ineligible|2|||
161736233|NCT01511107|584073378|FG000|Overall Study|Lost to Follow-up|10|||
161736234|NCT01511107|584073379|FG001|Overall Study|Lost to Follow-up|19|||
161736235|NCT01511107|584073378|FG000|Overall Study|Withdrawal by Subject|9|||
161736236|NCT01511107|584073379|FG001|Overall Study|Withdrawal by Subject|20|||
161736237|NCT05371912|584073380|FG000|Overall Study|Lost to Follow-up|3|||
161736238|NCT05371912|584073381|FG001|Overall Study|Lost to Follow-up|2|||
161736239|NCT04752189|584073382|FG000|Overall Study|Withdrawal by Subject|0|||
161736240|NCT04752189|584073383|FG001|Overall Study|Withdrawal by Subject|150|||
161736241|NCT04752189|584073382|FG000|Overall Study|Lost to Follow-up|261|||
161736242|NCT04752189|584073383|FG001|Overall Study|Lost to Follow-up|126|||
161736243|NCT00975195|584073384|FG000|Overall Study|Adverse Event|108|||
161736244|NCT00975195|584073385|FG001|Overall Study|Adverse Event|101|||
161736245|NCT00975195|584073384|FG000|Overall Study|Lack of Efficacy|6|||
161736246|NCT00975195|584073385|FG001|Overall Study|Lack of Efficacy|6|||
161736247|NCT00975195|584073384|FG000|Overall Study|Protocol Violation|27|||
161736248|NCT00975195|584073385|FG001|Overall Study|Protocol Violation|23|||
161736249|NCT00975195|584073384|FG000|Overall Study|Lost to Follow-up|9|||
161736250|NCT00975195|584073385|FG001|Overall Study|Lost to Follow-up|7|||
161736251|NCT00975195|584073384|FG000|Overall Study|Withdrawal by Subject|48|||
161736252|NCT00975195|584073385|FG001|Overall Study|Withdrawal by Subject|61|||
161736253|NCT00975195|584073384|FG000|Overall Study|Other reason not defined above|29|||
161736254|NCT00975195|584073385|FG001|Overall Study|Other reason not defined above|33|||
161736255|NCT00975195|584073384|FG000|Overall Study|Not treated|1|||
161736256|NCT00975195|584073385|FG001|Overall Study|Not treated|2|||
161736257|NCT02180724|584074692|FG000|Overall Study|Death|26|||
161736258|NCT02180724|584074693|FG001|Overall Study|Death|1|||
161736259|NCT02180724|584074692|FG000|Overall Study|Lost to Follow-up|3|||
161736260|NCT02180724|584074693|FG001|Overall Study|Lost to Follow-up|1|||
161736261|NCT02180724|584074692|FG000|Overall Study|Withdrawal by Subject|4|||
161736262|NCT02180724|584074693|FG001|Overall Study|Withdrawal by Subject|2|||
161736263|NCT02180724|584074692|FG000|Overall Study|PI Decision|5|||
161736264|NCT02180724|584074693|FG001|Overall Study|PI Decision|2|||
161736265|NCT02180724|584074692|FG000|Overall Study|Study terminated by sponsor|54|||
161736266|NCT02180724|584074693|FG001|Overall Study|Study terminated by sponsor|8|||
161736267|NCT05195359|584074694|FG000|Overall Study|Lost to Follow-up|124|||
161736268|NCT05195359|584074695|FG001|Overall Study|Lost to Follow-up|34|||
161736269|NCT01146951|584074696|FG000|Overall Study|Adverse Event|4|||
161736270|NCT01146951|584074697|FG001|Overall Study|Adverse Event|1|||
161736271|NCT01747811|584074701|FG000|Overall Study|Lack of Efficacy|2|||
161736272|NCT01747811|584074702|FG001|Overall Study|Lack of Efficacy|4|||
161736273|NCT02492997|584074704|FG000|Overall Study|Withdrawal by Subject|1|||
161736274|NCT02492997|584074705|FG001|Overall Study|Withdrawal by Subject|0|||
161736275|NCT02492997|584074704|FG000|Overall Study|Gained Weight|1|||
161736276|NCT02492997|584074705|FG001|Overall Study|Gained Weight|0|||
161736277|NCT02492997|584074704|FG000|Overall Study|Lost to Follow-up|0|||
161736278|NCT02492997|584074705|FG001|Overall Study|Lost to Follow-up|1|||
161736279|NCT01089582|584074706|FG000|Overall Study|Death|2|||
161736280|NCT01089582|584074706|FG000|Overall Study|Adverse Event|15|||
161736281|NCT01089582|584074706|FG000|Overall Study|Lost to Follow-up|8|||
161736282|NCT01089582|584074706|FG000|Overall Study|Other|4|||
161736283|NCT01089582|584074706|FG000|Overall Study|Withdrawal by Subject|1|||
161736284|NCT04069156|584074707|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
161736285|NCT04069156|584074708|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
161736286|NCT04069156|584074707|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
161736287|NCT04069156|584074708|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
161736288|NCT04069156|584074707|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
161736289|NCT04069156|584074708|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
161736290|NCT04069156|584074707|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
161736291|NCT04069156|584074708|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
161736292|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
161840144|NCT02227147|584460456|FG001|Controlled Treatment Period|Other|0|||
161840145|NCT02227147|584460455|FG000|Follow-up Period|Other|3|||
161840146|NCT02227147|584460456|FG001|Follow-up Period|Other|5|||
161840147|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
161840148|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
161840149|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
161840150|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
161840151|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
161840152|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
161840153|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
161840154|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
161840155|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
161840156|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
161840157|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
161840158|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
161840159|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
161840160|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
161840161|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
161840162|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
161840163|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
161840164|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
161840165|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
161840166|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
161840167|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
161840168|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161840169|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161840170|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161840171|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161840172|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
161840173|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161840174|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161840175|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
161840176|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
161840177|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
161840178|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
161840179|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
161840180|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
161840181|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
161840182|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
161840183|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
161840184|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
161840185|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
161840186|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
161840187|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
161840188|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
161840189|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
161840190|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
161840191|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
161840192|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
161840193|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
161840194|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
161840195|NCT01345175|584460464|FG000|Overall Study|Physician Decision|0|||
161840196|NCT01345175|584460465|FG001|Overall Study|Physician Decision|1|||
161840197|NCT01345175|584460464|FG000|Overall Study|Withdrawal by Subject|1|||
161840198|NCT01345175|584460465|FG001|Overall Study|Withdrawal by Subject|1|||
161840199|NCT01345175|584460464|FG000|Overall Study|Failed to complete BFI|3|||
161736293|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
161736294|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
161736295|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
161736296|NCT05441592|584074724|FG000|Overall Study|Lost to Follow-up|1|||
161736297|NCT05441592|584074725|FG001|Overall Study|Lost to Follow-up|5|||
161736298|NCT01021852|584074726|FG000|Treatment Period 1|Adverse Event|3|||
161736299|NCT01021852|584074727|FG001|Treatment Period 1|Adverse Event|1|||
161736300|NCT01021852|584074728|FG002|Treatment Period 1|Adverse Event|1|||
161736301|NCT01021852|584074729|FG003|Treatment Period 1|Adverse Event|0|||
161736302|NCT01021852|584074730|FG004|Treatment Period 1|Adverse Event|2|||
161736303|NCT01021852|584074731|FG005|Treatment Period 1|Adverse Event|2|||
161736304|NCT01021852|584074732|FG006|Treatment Period 1|Adverse Event|0|||
161736305|NCT01021852|584074733|FG007|Treatment Period 1|Adverse Event|0|||
161736306|NCT01021852|584074726|FG000|Treatment Period 1|Pregnancy|0|||
161736307|NCT01021852|584074727|FG001|Treatment Period 1|Pregnancy|0|||
161736308|NCT01021852|584074728|FG002|Treatment Period 1|Pregnancy|1|||
161736309|NCT01021852|584074729|FG003|Treatment Period 1|Pregnancy|0|||
161736310|NCT01021852|584074730|FG004|Treatment Period 1|Pregnancy|0|||
161736311|NCT01021852|584074731|FG005|Treatment Period 1|Pregnancy|0|||
161736312|NCT01021852|584074732|FG006|Treatment Period 1|Pregnancy|0|||
161736313|NCT01021852|584074733|FG007|Treatment Period 1|Pregnancy|0|||
161736314|NCT01021852|584074726|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161736315|NCT01021852|584074727|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161736316|NCT01021852|584074728|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161736317|NCT01021852|584074729|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161736318|NCT01021852|584074730|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161736319|NCT01021852|584074731|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161736320|NCT01021852|584074732|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161736321|NCT01021852|584074733|FG007|Treatment Period 1|Withdrawal by Subject|1|||
161736322|NCT01021852|584074726|FG000|Treatment Period 1|Not Treated|0|||
161736323|NCT01021852|584074727|FG001|Treatment Period 1|Not Treated|0|||
161736324|NCT01021852|584074728|FG002|Treatment Period 1|Not Treated|0|||
161736325|NCT01021852|584074729|FG003|Treatment Period 1|Not Treated|2|||
161736326|NCT01021852|584074730|FG004|Treatment Period 1|Not Treated|0|||
161736327|NCT01021852|584074731|FG005|Treatment Period 1|Not Treated|0|||
161736328|NCT01021852|584074732|FG006|Treatment Period 1|Not Treated|0|||
161736329|NCT01021852|584074733|FG007|Treatment Period 1|Not Treated|0|||
161736330|NCT01021852|584074726|FG000|Washout Period-Placebo|Adverse Event|0|||
161736331|NCT01021852|584074727|FG001|Washout Period-Placebo|Adverse Event|0|||
161736332|NCT01021852|584074728|FG002|Washout Period-Placebo|Adverse Event|0|||
161736333|NCT01021852|584074729|FG003|Washout Period-Placebo|Adverse Event|1|||
161736334|NCT01021852|584074730|FG004|Washout Period-Placebo|Adverse Event|0|||
161736335|NCT01021852|584074731|FG005|Washout Period-Placebo|Adverse Event|1|||
161736336|NCT01021852|584074732|FG006|Washout Period-Placebo|Adverse Event|0|||
161736337|NCT01021852|584074733|FG007|Washout Period-Placebo|Adverse Event|0|||
161736338|NCT01021852|584074726|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
161736339|NCT01021852|584074727|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
161736340|NCT01021852|584074728|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
161736341|NCT01021852|584074729|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
161736342|NCT01021852|584074730|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
161736343|NCT01021852|584074731|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
161736344|NCT01021852|584074732|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
161736345|NCT01021852|584074733|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
161736346|NCT01021852|584074726|FG000|Washout Period-Placebo|Protocol Violation|0|||
161736347|NCT01021852|584074727|FG001|Washout Period-Placebo|Protocol Violation|0|||
161736348|NCT01021852|584074728|FG002|Washout Period-Placebo|Protocol Violation|0|||
161736349|NCT01021852|584074729|FG003|Washout Period-Placebo|Protocol Violation|0|||
161736350|NCT01021852|584074730|FG004|Washout Period-Placebo|Protocol Violation|0|||
161736351|NCT01021852|584074731|FG005|Washout Period-Placebo|Protocol Violation|0|||
161736352|NCT01021852|584074732|FG006|Washout Period-Placebo|Protocol Violation|1|||
161736353|NCT01021852|584074733|FG007|Washout Period-Placebo|Protocol Violation|0|||
161736354|NCT01021852|584074726|FG000|Washout Period-No Drug|Adverse Event|1|||
161736355|NCT01021852|584074727|FG001|Washout Period-No Drug|Adverse Event|0|||
161736356|NCT01021852|584074728|FG002|Washout Period-No Drug|Adverse Event|0|||
161736357|NCT01021852|584074729|FG003|Washout Period-No Drug|Adverse Event|0|||
161736358|NCT01021852|584074730|FG004|Washout Period-No Drug|Adverse Event|0|||
161736359|NCT01021852|584074731|FG005|Washout Period-No Drug|Adverse Event|1|||
161736360|NCT01021852|584074732|FG006|Washout Period-No Drug|Adverse Event|0|||
161736361|NCT01021852|584074733|FG007|Washout Period-No Drug|Adverse Event|0|||
161736362|NCT01021852|584074726|FG000|Treatment Period 2|Adverse Event|0|||
161736363|NCT01021852|584074727|FG001|Treatment Period 2|Adverse Event|1|||
161736364|NCT01021852|584074728|FG002|Treatment Period 2|Adverse Event|0|||
161736365|NCT01021852|584074729|FG003|Treatment Period 2|Adverse Event|0|||
161736366|NCT01021852|584074730|FG004|Treatment Period 2|Adverse Event|1|||
161736367|NCT01021852|584074731|FG005|Treatment Period 2|Adverse Event|0|||
161736368|NCT01021852|584074732|FG006|Treatment Period 2|Adverse Event|1|||
161736369|NCT01021852|584074733|FG007|Treatment Period 2|Adverse Event|0|||
161736370|NCT01021852|584074726|FG000|Treatment Period 2|Lack of Efficacy|0|||
161736371|NCT01021852|584074727|FG001|Treatment Period 2|Lack of Efficacy|0|||
161736372|NCT01021852|584074728|FG002|Treatment Period 2|Lack of Efficacy|0|||
161736373|NCT01021852|584074729|FG003|Treatment Period 2|Lack of Efficacy|0|||
161736374|NCT01021852|584074730|FG004|Treatment Period 2|Lack of Efficacy|0|||
161736375|NCT01021852|584074731|FG005|Treatment Period 2|Lack of Efficacy|1|||
161736376|NCT01021852|584074732|FG006|Treatment Period 2|Lack of Efficacy|0|||
161736377|NCT01021852|584074733|FG007|Treatment Period 2|Lack of Efficacy|0|||
161736378|NCT01021852|584074726|FG000|Treatment Period 2|Physician Decision|0|||
161736379|NCT01021852|584074727|FG001|Treatment Period 2|Physician Decision|0|||
161736380|NCT01021852|584074728|FG002|Treatment Period 2|Physician Decision|1|||
161736381|NCT01021852|584074729|FG003|Treatment Period 2|Physician Decision|0|||
161736382|NCT01021852|584074730|FG004|Treatment Period 2|Physician Decision|0|||
161736383|NCT01021852|584074731|FG005|Treatment Period 2|Physician Decision|0|||
161736384|NCT01021852|584074732|FG006|Treatment Period 2|Physician Decision|0|||
161736385|NCT01021852|584074733|FG007|Treatment Period 2|Physician Decision|0|||
161736386|NCT01021852|584074726|FG000|Treatment Period 2|Protocol Violation|0|||
161736387|NCT01021852|584074727|FG001|Treatment Period 2|Protocol Violation|0|||
161736388|NCT01021852|584074728|FG002|Treatment Period 2|Protocol Violation|0|||
161736389|NCT01021852|584074729|FG003|Treatment Period 2|Protocol Violation|0|||
161736390|NCT01021852|584074730|FG004|Treatment Period 2|Protocol Violation|1|||
161736391|NCT01021852|584074731|FG005|Treatment Period 2|Protocol Violation|0|||
161736392|NCT01021852|584074732|FG006|Treatment Period 2|Protocol Violation|1|||
161736393|NCT01021852|584074733|FG007|Treatment Period 2|Protocol Violation|0|||
161736394|NCT01021852|584074726|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161736395|NCT01021852|584074727|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161736396|NCT01021852|584074728|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161736397|NCT01021852|584074729|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161736398|NCT01021852|584074730|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161736399|NCT01021852|584074731|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161736400|NCT01021852|584074732|FG006|Treatment Period 2|Withdrawal by Subject|1|||
161736401|NCT01021852|584074733|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161736402|NCT01371981|584074734|FG000|Overall Study|Adverse Event|12|||
161736403|NCT01371981|584074735|FG001|Overall Study|Adverse Event|17|||
161736404|NCT01371981|584074736|FG002|Overall Study|Adverse Event|0|||
161736405|NCT01371981|584074737|FG003|Overall Study|Adverse Event|4|||
161736406|NCT01371981|584074738|FG004|Overall Study|Adverse Event|1|||
161736407|NCT01371981|584074739|FG005|Overall Study|Adverse Event|0|||
161736408|NCT01371981|584074734|FG000|Overall Study|Death|22|||
161736409|NCT01371981|584074735|FG001|Overall Study|Death|16|||
161736410|NCT01371981|584074736|FG002|Overall Study|Death|0|||
161736411|NCT01371981|584074737|FG003|Overall Study|Death|0|||
161736412|NCT01371981|584074738|FG004|Overall Study|Death|2|||
161736413|NCT01371981|584074739|FG005|Overall Study|Death|2|||
161736414|NCT01371981|584074734|FG000|Overall Study|Lack of Efficacy|69|||
161736415|NCT01371981|584074735|FG001|Overall Study|Lack of Efficacy|61|||
161736416|NCT01371981|584074736|FG002|Overall Study|Lack of Efficacy|4|||
161736417|NCT01371981|584074737|FG003|Overall Study|Lack of Efficacy|8|||
161736418|NCT01371981|584074738|FG004|Overall Study|Lack of Efficacy|5|||
161736419|NCT01371981|584074739|FG005|Overall Study|Lack of Efficacy|0|||
161736420|NCT01371981|584074734|FG000|Overall Study|Physician Decision|48|||
161736421|NCT01371981|584074735|FG001|Overall Study|Physician Decision|63|||
161736422|NCT01371981|584074736|FG002|Overall Study|Physician Decision|1|||
161736423|NCT01371981|584074737|FG003|Overall Study|Physician Decision|7|||
161736424|NCT01371981|584074738|FG004|Overall Study|Physician Decision|14|||
161736425|NCT01371981|584074739|FG005|Overall Study|Physician Decision|3|||
161736426|NCT01371981|584074734|FG000|Overall Study|Withdrawal by Subject|12|||
161736427|NCT01371981|584074735|FG001|Overall Study|Withdrawal by Subject|19|||
161736428|NCT01371981|584074736|FG002|Overall Study|Withdrawal by Subject|1|||
161736429|NCT01371981|584074737|FG003|Overall Study|Withdrawal by Subject|2|||
161736430|NCT01371981|584074738|FG004|Overall Study|Withdrawal by Subject|10|||
161736431|NCT01371981|584074739|FG005|Overall Study|Withdrawal by Subject|3|||
161736432|NCT01371981|584074734|FG000|Overall Study|Ineligible|19|||
161736433|NCT01371981|584074735|FG001|Overall Study|Ineligible|13|||
161736434|NCT01371981|584074736|FG002|Overall Study|Ineligible|0|||
161736435|NCT01371981|584074737|FG003|Overall Study|Ineligible|0|||
161736436|NCT01371981|584074738|FG004|Overall Study|Ineligible|0|||
161736437|NCT01371981|584074739|FG005|Overall Study|Ineligible|4|||
161736438|NCT01371981|584074734|FG000|Overall Study|Did not start treatment|2|||
161736439|NCT01371981|584074735|FG001|Overall Study|Did not start treatment|3|||
161736440|NCT01371981|584074736|FG002|Overall Study|Did not start treatment|0|||
161736441|NCT01371981|584074737|FG003|Overall Study|Did not start treatment|0|||
161736442|NCT01371981|584074738|FG004|Overall Study|Did not start treatment|0|||
161736443|NCT01371981|584074739|FG005|Overall Study|Did not start treatment|2|||
161736444|NCT02493426|584074740|FG000|Overall Study|Withdrawal by Subject|0|||
161736445|NCT02493426|584074741|FG001|Overall Study|Withdrawal by Subject|1|||
161736446|NCT01025817|584074743|FG000|Completed Study Medication|Adverse Event|66|||
161736447|NCT01025817|584074744|FG001|Completed Study Medication|Adverse Event|39|||
161736448|NCT01025817|584074743|FG000|Completed Study Medication|Protocol Deviation|9|||
161736449|NCT01025817|584074744|FG001|Completed Study Medication|Protocol Deviation|8|||
161736450|NCT01025817|584074743|FG000|Completed Study Medication|Withdrawal by Subject|8|||
161736451|NCT01025817|584074744|FG001|Completed Study Medication|Withdrawal by Subject|9|||
161736452|NCT01025817|584074743|FG000|Completed Study Medication|Administrative problems|7|||
161736453|NCT01025817|584074744|FG001|Completed Study Medication|Administrative problems|5|||
161736454|NCT01025817|584074743|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
161736455|NCT01025817|584074744|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
161736456|NCT01025817|584074743|FG000|Completed Study Medication|Abnormal test procedure|4|||
161736457|NCT01025817|584074744|FG001|Completed Study Medication|Abnormal test procedure|0|||
161736458|NCT01025817|584074743|FG000|Completed Study Medication|Graft loss|2|||
161736459|NCT01025817|584074744|FG001|Completed Study Medication|Graft loss|5|||
161736460|NCT01025817|584074743|FG000|Completed Study Medication|Death|2|||
161736461|NCT01025817|584074744|FG001|Completed Study Medication|Death|2|||
161736462|NCT01025817|584074743|FG000|Completed Study Medication|Abnormal lab values|0|||
161736463|NCT01025817|584074744|FG001|Completed Study Medication|Abnormal lab values|2|||
161736464|NCT01025817|584074743|FG000|Completed Study Medication|Subject no longer required study drug|0|||
161736465|NCT01025817|584074744|FG001|Completed Study Medication|Subject no longer required study drug|1|||
161736466|NCT01025817|584074743|FG000|Completed Study Medication|Lost to Follow-up|0|||
161736467|NCT01025817|584074744|FG001|Completed Study Medication|Lost to Follow-up|1|||
161736468|NCT01025817|584074743|FG000|Completed Study|Withdrawal by Subject|8|||
161736469|NCT01025817|584074744|FG001|Completed Study|Withdrawal by Subject|16|||
161736470|NCT01025817|584074743|FG000|Completed Study|Death|6|||
161736471|NCT01025817|584074744|FG001|Completed Study|Death|5|||
161736472|NCT01025817|584074743|FG000|Completed Study|Missing|2|||
161736473|NCT01025817|584074744|FG001|Completed Study|Missing|0|||
161736474|NCT01025817|584074743|FG000|Completed Study|Lost to Follow-up|0|||
161736475|NCT01025817|584074744|FG001|Completed Study|Lost to Follow-up|1|||
161736476|NCT01153893|584074747|FG000|Overall Study|Adverse Event|1|||
161736477|NCT01153893|584074748|FG001|Overall Study|Adverse Event|0|||
161736478|NCT04799405|584074749|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
161736479|NCT01029002|584074750|FG000|Overall Study|Lost to Follow-up|2|||
161736480|NCT01029002|584074751|FG001|Overall Study|Lost to Follow-up|4|||
161736481|NCT00118482|584074752|FG000|Overall Study|Lost to Follow-up|7|||
161736482|NCT00118482|584074753|FG001|Overall Study|Lost to Follow-up|7|||
161736483|NCT00118482|584074752|FG000|Overall Study|Withdrawal by Subject|23|||
161736484|NCT00118482|584074753|FG001|Overall Study|Withdrawal by Subject|22|||
161736485|NCT01934192|584074758|FG000|Overall Study|Protocol Violation|0|||
161736486|NCT01934192|584074759|FG001|Overall Study|Protocol Violation|0|||
161736487|NCT01934192|584074760|FG002|Overall Study|Protocol Violation|0|||
161736488|NCT01934192|584074761|FG003|Overall Study|Protocol Violation|1|||
161736489|NCT01934192|584074758|FG000|Overall Study|Other: reached stopping criteria|6|||
161736490|NCT01934192|584074759|FG001|Overall Study|Other: reached stopping criteria|5|||
161736491|NCT01934192|584074760|FG002|Overall Study|Other: reached stopping criteria|1|||
161736492|NCT01934192|584074761|FG003|Overall Study|Other: reached stopping criteria|0|||
161736493|NCT01934192|584074758|FG000|Overall Study|Physician Decision|3|||
161736494|NCT01934192|584074759|FG001|Overall Study|Physician Decision|2|||
161736495|NCT01934192|584074760|FG002|Overall Study|Physician Decision|0|||
161736496|NCT01934192|584074761|FG003|Overall Study|Physician Decision|0|||
161736497|NCT01737840|584074762|FG000|Overall Study|Diagnosed with an other pathology|2|||
161736498|NCT01737840|584074763|FG001|Overall Study|Diagnosed with an other pathology|2|||
161736499|NCT01189435|584074764|FG000|Overall Study|Withdrawal by Subject|1|||
161736500|NCT01189435|584074764|FG000|Overall Study|Physician Decision|1|||
161736501|NCT04105244|584074767|FG000|Overall Study|Withdrawal by Subject|10|||
161736502|NCT04105244|584074768|FG001|Overall Study|Withdrawal by Subject|12|||
161736503|NCT04105244|584074767|FG000|Overall Study|Lost to Follow-up|20|||
161736504|NCT04105244|584074768|FG001|Overall Study|Lost to Follow-up|15|||
161736505|NCT04105244|584074767|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
161736506|NCT04105244|584074768|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
161736507|NCT04105244|584074767|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
161736508|NCT04105244|584074768|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
161736509|NCT01449682|584074769|FG000|Overall Study|Death|0|||
161736510|NCT01449682|584074770|FG001|Overall Study|Death|1|||
161736511|NCT01449682|584074769|FG000|Overall Study|Adverse Event|1|||
161736512|NCT01449682|584074770|FG001|Overall Study|Adverse Event|0|||
161736513|NCT02768194|584074771|FG000|Period 1|Adverse Event|0|||
161736514|NCT02768194|584074772|FG001|Period 1|Adverse Event|0|||
161736515|NCT02768194|584074773|FG002|Period 1|Adverse Event|0|||
161736516|NCT02768194|584074774|FG003|Period 1|Adverse Event|1|||
161736517|NCT02768194|584074775|FG004|Period 1|Adverse Event|0|||
161736518|NCT02768194|584074776|FG005|Period 1|Adverse Event|0|||
161736519|NCT02768194|584074771|FG000|Period 2|Other (Reason not specified)|1|||
161736520|NCT02768194|584074772|FG001|Period 2|Other (Reason not specified)|0|||
161736521|NCT02768194|584074773|FG002|Period 2|Other (Reason not specified)|0|||
161736522|NCT02768194|584074774|FG003|Period 2|Other (Reason not specified)|0|||
161736523|NCT02768194|584074775|FG004|Period 2|Other (Reason not specified)|0|||
161736524|NCT02768194|584074776|FG005|Period 2|Other (Reason not specified)|0|||
161736525|NCT02768194|584074771|FG000|Period 3|Other (Reason not specified)|0|||
161736526|NCT02768194|584074772|FG001|Period 3|Other (Reason not specified)|1|||
161736527|NCT02768194|584074773|FG002|Period 3|Other (Reason not specified)|0|||
161736528|NCT02768194|584074774|FG003|Period 3|Other (Reason not specified)|0|||
161736529|NCT02768194|584074775|FG004|Period 3|Other (Reason not specified)|0|||
161736530|NCT02768194|584074776|FG005|Period 3|Other (Reason not specified)|0|||
161736531|NCT04863014|584074777|FG000|Overall Study|Lost to Follow-up|3|||
161736532|NCT04863014|584074778|FG001|Overall Study|Lost to Follow-up|2|||
161736533|NCT04863014|584074777|FG000|Overall Study|Subject Decision|0|||
161736534|NCT04863014|584074778|FG001|Overall Study|Subject Decision|4|||
161736535|NCT04633473|584074779|FG000|Overall Study|Withdrawal by Subject|6|||
161736536|NCT01822691|584074785|FG000|Overall Study|Withdrawal by Subject|2|||
161736537|NCT01553916|584074786|FG000|Overall Study|Withdrawal by Subject|2|||
161736538|NCT01553916|584074786|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
161736539|NCT03089216|584074787|FG000|Overall Study|Adverse Event|0|||
161736540|NCT03089216|584074788|FG001|Overall Study|Adverse Event|0|||
161736541|NCT03089216|584074789|FG002|Overall Study|Adverse Event|0|||
161736542|NCT03089216|584074790|FG003|Overall Study|Adverse Event|1|||
161736543|NCT03259490|584074791|FG000|Period 1|Withdrawal by Subject|0|||
161736544|NCT03259490|584074792|FG001|Period 1|Withdrawal by Subject|1|||
161736545|NCT03259490|584074791|FG000|Period 2|Protocol Violation|1|||
161736546|NCT03259490|584074792|FG001|Period 2|Protocol Violation|0|||
161736547|NCT00819585|584074795|FG000|Core Study|Adverse Event|2|||
161736548|NCT00819585|584074796|FG001|Core Study|Adverse Event|1|||
161736549|NCT00819585|584074797|FG002|Core Study|Adverse Event|1|||
161736550|NCT00819585|584074798|FG003|Core Study|Adverse Event|4|||
161736551|NCT00819585|584074799|FG004|Core Study|Adverse Event|1|||
161736552|NCT00819585|584074800|FG005|Core Study|Adverse Event|0|||
161736553|NCT00819585|584074801|FG006|Core Study|Adverse Event|2|||
161736554|NCT00819585|584074802|FG007|Core Study|Adverse Event|0|||
161736555|NCT00819585|584074803|FG008|Core Study|Adverse Event|0|||
161736556|NCT00819585|584074804|FG009|Core Study|Adverse Event|0|||
161736557|NCT00819585|584074805|FG010|Core Study|Adverse Event|0|||
161736558|NCT00819585|584074795|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
161736559|NCT00819585|584074796|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
161736560|NCT00819585|584074797|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
161840200|NCT01345175|584460465|FG001|Overall Study|Failed to complete BFI|2|||
161736561|NCT00819585|584074798|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
161736562|NCT00819585|584074799|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
161736563|NCT00819585|584074800|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
161736564|NCT00819585|584074801|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
161736565|NCT00819585|584074802|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
161736566|NCT00819585|584074803|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
161736567|NCT00819585|584074804|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
161736568|NCT00819585|584074805|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
161736569|NCT00819585|584074795|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
161840201|NCT01345175|584460464|FG000|Overall Study|Stopped taking medication|2|||
161840202|NCT01345175|584460465|FG001|Overall Study|Stopped taking medication|2|||
161736570|NCT00819585|584074796|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
161736571|NCT00819585|584074797|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736572|NCT00819585|584074798|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736573|NCT00819585|584074799|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736574|NCT00819585|584074800|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736575|NCT00819585|584074801|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
161736576|NCT00819585|584074802|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736577|NCT00819585|584074803|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736578|NCT00819585|584074804|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736579|NCT00819585|584074805|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736580|NCT00819585|584074795|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
161736581|NCT00819585|584074796|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
161736582|NCT00819585|584074797|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
161736583|NCT00819585|584074798|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
161736584|NCT00819585|584074799|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
161736585|NCT00819585|584074800|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
161736586|NCT00819585|584074801|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
161736587|NCT00819585|584074802|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
161736588|NCT00819585|584074803|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
161736589|NCT00819585|584074804|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
161736590|NCT00819585|584074805|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
161736591|NCT00819585|584074795|FG000|Core Study|Subject Withdrew Consent|0|||
161736592|NCT00819585|584074796|FG001|Core Study|Subject Withdrew Consent|3|||
161736593|NCT00819585|584074797|FG002|Core Study|Subject Withdrew Consent|2|||
161736594|NCT00819585|584074798|FG003|Core Study|Subject Withdrew Consent|1|||
161736595|NCT00819585|584074799|FG004|Core Study|Subject Withdrew Consent|0|||
161736596|NCT00819585|584074800|FG005|Core Study|Subject Withdrew Consent|0|||
161736597|NCT00819585|584074801|FG006|Core Study|Subject Withdrew Consent|3|||
161736598|NCT00819585|584074802|FG007|Core Study|Subject Withdrew Consent|0|||
161736599|NCT00819585|584074803|FG008|Core Study|Subject Withdrew Consent|0|||
161736600|NCT00819585|584074804|FG009|Core Study|Subject Withdrew Consent|0|||
161736601|NCT00819585|584074805|FG010|Core Study|Subject Withdrew Consent|0|||
161736602|NCT00819585|584074795|FG000|Core Study|Lost to Follow-up|2|||
161736603|NCT00819585|584074796|FG001|Core Study|Lost to Follow-up|1|||
161736604|NCT00819585|584074797|FG002|Core Study|Lost to Follow-up|2|||
161736605|NCT00819585|584074798|FG003|Core Study|Lost to Follow-up|0|||
161736606|NCT00819585|584074799|FG004|Core Study|Lost to Follow-up|1|||
161736607|NCT00819585|584074800|FG005|Core Study|Lost to Follow-up|1|||
161736608|NCT00819585|584074801|FG006|Core Study|Lost to Follow-up|1|||
161736609|NCT00819585|584074802|FG007|Core Study|Lost to Follow-up|0|||
161736610|NCT00819585|584074803|FG008|Core Study|Lost to Follow-up|0|||
161736611|NCT00819585|584074804|FG009|Core Study|Lost to Follow-up|0|||
161736612|NCT00819585|584074805|FG010|Core Study|Lost to Follow-up|0|||
161736613|NCT00819585|584074795|FG000|Core Study|Administrative Problems|0|||
161736614|NCT00819585|584074796|FG001|Core Study|Administrative Problems|0|||
161736615|NCT00819585|584074797|FG002|Core Study|Administrative Problems|0|||
161736616|NCT00819585|584074798|FG003|Core Study|Administrative Problems|0|||
161736617|NCT00819585|584074799|FG004|Core Study|Administrative Problems|0|||
161736618|NCT00819585|584074800|FG005|Core Study|Administrative Problems|0|||
161736619|NCT00819585|584074801|FG006|Core Study|Administrative Problems|2|||
161736620|NCT00819585|584074802|FG007|Core Study|Administrative Problems|0|||
161736621|NCT00819585|584074803|FG008|Core Study|Administrative Problems|0|||
161736622|NCT00819585|584074804|FG009|Core Study|Administrative Problems|0|||
161736623|NCT00819585|584074805|FG010|Core Study|Administrative Problems|0|||
161736624|NCT00819585|584074795|FG000|Core Study|Death|0|||
161736625|NCT00819585|584074796|FG001|Core Study|Death|0|||
161736626|NCT00819585|584074797|FG002|Core Study|Death|0|||
161736627|NCT00819585|584074798|FG003|Core Study|Death|0|||
161736628|NCT00819585|584074799|FG004|Core Study|Death|0|||
161736629|NCT00819585|584074800|FG005|Core Study|Death|0|||
161736630|NCT00819585|584074801|FG006|Core Study|Death|1|||
161736631|NCT00819585|584074802|FG007|Core Study|Death|0|||
161736632|NCT00819585|584074803|FG008|Core Study|Death|0|||
161736633|NCT00819585|584074804|FG009|Core Study|Death|0|||
161736634|NCT00819585|584074805|FG010|Core Study|Death|0|||
161736635|NCT00819585|584074795|FG000|Core Study|Protocol Violation|0|||
161736636|NCT00819585|584074796|FG001|Core Study|Protocol Violation|0|||
161736637|NCT00819585|584074797|FG002|Core Study|Protocol Violation|1|||
161736638|NCT00819585|584074798|FG003|Core Study|Protocol Violation|0|||
161736639|NCT00819585|584074799|FG004|Core Study|Protocol Violation|0|||
161736640|NCT00819585|584074800|FG005|Core Study|Protocol Violation|1|||
161736641|NCT00819585|584074801|FG006|Core Study|Protocol Violation|3|||
161736642|NCT00819585|584074802|FG007|Core Study|Protocol Violation|0|||
161736643|NCT00819585|584074803|FG008|Core Study|Protocol Violation|0|||
161736644|NCT00819585|584074804|FG009|Core Study|Protocol Violation|0|||
161736645|NCT00819585|584074805|FG010|Core Study|Protocol Violation|0|||
161736646|NCT00819585|584074795|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
161736647|NCT00819585|584074796|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
161736648|NCT00819585|584074797|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
161736649|NCT00819585|584074798|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
161736650|NCT00819585|584074799|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
161736651|NCT00819585|584074800|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
161736652|NCT00819585|584074801|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
161736653|NCT00819585|584074802|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
161736654|NCT00819585|584074803|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
161736655|NCT00819585|584074804|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
161736656|NCT00819585|584074805|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
161736657|NCT00819585|584074795|FG000|Extension Study|Subject Withdrew Consent|0|||
161736658|NCT00819585|584074796|FG001|Extension Study|Subject Withdrew Consent|0|||
161736659|NCT00819585|584074797|FG002|Extension Study|Subject Withdrew Consent|0|||
161736660|NCT00819585|584074798|FG003|Extension Study|Subject Withdrew Consent|0|||
161736661|NCT00819585|584074799|FG004|Extension Study|Subject Withdrew Consent|0|||
161736662|NCT00819585|584074800|FG005|Extension Study|Subject Withdrew Consent|0|||
161736663|NCT00819585|584074801|FG006|Extension Study|Subject Withdrew Consent|0|||
161736664|NCT00819585|584074802|FG007|Extension Study|Subject Withdrew Consent|0|||
161736665|NCT00819585|584074803|FG008|Extension Study|Subject Withdrew Consent|3|||
161736666|NCT00819585|584074804|FG009|Extension Study|Subject Withdrew Consent|0|||
161736667|NCT00819585|584074805|FG010|Extension Study|Subject Withdrew Consent|1|||
161736668|NCT00819585|584074795|FG000|Extension Study|Lost to Follow-up|0|||
161736669|NCT00819585|584074796|FG001|Extension Study|Lost to Follow-up|0|||
161736670|NCT00819585|584074797|FG002|Extension Study|Lost to Follow-up|0|||
161736671|NCT00819585|584074798|FG003|Extension Study|Lost to Follow-up|0|||
161736672|NCT00819585|584074799|FG004|Extension Study|Lost to Follow-up|0|||
161736673|NCT00819585|584074800|FG005|Extension Study|Lost to Follow-up|0|||
161736674|NCT00819585|584074801|FG006|Extension Study|Lost to Follow-up|0|||
161736675|NCT00819585|584074802|FG007|Extension Study|Lost to Follow-up|0|||
161736676|NCT00819585|584074803|FG008|Extension Study|Lost to Follow-up|2|||
161736677|NCT00819585|584074804|FG009|Extension Study|Lost to Follow-up|1|||
161736678|NCT00819585|584074805|FG010|Extension Study|Lost to Follow-up|1|||
161736679|NCT00819585|584074795|FG000|Extension Study|Death|0|||
161736680|NCT00819585|584074796|FG001|Extension Study|Death|0|||
161736681|NCT00819585|584074797|FG002|Extension Study|Death|0|||
161736682|NCT00819585|584074798|FG003|Extension Study|Death|0|||
161736683|NCT00819585|584074799|FG004|Extension Study|Death|0|||
161736684|NCT00819585|584074800|FG005|Extension Study|Death|0|||
161736685|NCT00819585|584074801|FG006|Extension Study|Death|0|||
161736686|NCT00819585|584074802|FG007|Extension Study|Death|0|||
161736687|NCT00819585|584074803|FG008|Extension Study|Death|2|||
161736688|NCT00819585|584074804|FG009|Extension Study|Death|0|||
161736689|NCT00819585|584074805|FG010|Extension Study|Death|0|||
161840203|NCT04112173|584460467|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
161840204|NCT01561430|584460468|FG000|Overall Study|Adverse Event|0|||
161840205|NCT01561430|584460469|FG001|Overall Study|Adverse Event|0|||
161840206|NCT01561430|584460470|FG002|Overall Study|Adverse Event|3|||
161840207|NCT01561430|584460471|FG003|Overall Study|Adverse Event|1|||
161840208|NCT01561430|584460468|FG000|Overall Study|Withdrawal by Subject|0|||
161840209|NCT01561430|584460469|FG001|Overall Study|Withdrawal by Subject|0|||
161840210|NCT01561430|584460470|FG002|Overall Study|Withdrawal by Subject|1|||
161840211|NCT01561430|584460471|FG003|Overall Study|Withdrawal by Subject|0|||
161840212|NCT01561430|584460468|FG000|Overall Study|Physician Decision|0|||
161840213|NCT01561430|584460469|FG001|Overall Study|Physician Decision|1|||
161840214|NCT01561430|584460470|FG002|Overall Study|Physician Decision|0|||
161840215|NCT01561430|584460471|FG003|Overall Study|Physician Decision|0|||
161840216|NCT01561430|584460468|FG000|Overall Study|Sponsor Decision|1|||
161840217|NCT01561430|584460469|FG001|Overall Study|Sponsor Decision|14|||
161840218|NCT01561430|584460470|FG002|Overall Study|Sponsor Decision|13|||
161840219|NCT01561430|584460471|FG003|Overall Study|Sponsor Decision|12|||
161840220|NCT04234984|584460472|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
161840221|NCT04234984|584460472|FG000|Follow-up at the Second Time Point|Death|1|||
161736690|NCT01877382|584074806|FG000|Dose Escalation|Progressive disease|2|||
161736691|NCT01877382|584074807|FG001|Dose Escalation|Progressive disease|0|||
161736692|NCT01877382|584074808|FG002|Dose Escalation|Progressive disease|1|||
161840222|NCT04234984|584460472|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
161840223|NCT01055132|584460473|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
161840224|NCT01055132|584460474|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
161840225|NCT01055132|584460473|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
161840226|NCT01055132|584460474|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
161840227|NCT00910091|584460475|FG000|Pre-assignment|Withdrawal by Subject|0|||
161840228|NCT00910091|584460476|FG001|Pre-assignment|Withdrawal by Subject|2|||
161840229|NCT00910091|584460475|FG000|Treatment and Survival|Withdrawal by Subject|3|||
161840230|NCT00910091|584460476|FG001|Treatment and Survival|Withdrawal by Subject|4|||
161736693|NCT01877382|584074809|FG003|Dose Escalation|Progressive disease|6|||
161736694|NCT01877382|584074810|FG004|Dose Escalation|Progressive disease|1|||
161736695|NCT01877382|584074811|FG005|Dose Escalation|Progressive disease|0|||
161736696|NCT01877382|584074812|FG006|Dose Escalation|Progressive disease|3|||
161736697|NCT01877382|584074813|FG007|Dose Escalation|Progressive disease|10|||
161736698|NCT01877382|584074814|FG008|Dose Escalation|Progressive disease|4|||
161736699|NCT01877382|584074815|FG009|Dose Escalation|Progressive disease|2|||
161736700|NCT01877382|584074816|FG010|Dose Escalation|Progressive disease|3|||
161736701|NCT01877382|584074817|FG011|Dose Escalation|Progressive disease|3|||
161736702|NCT01877382|584074818|FG012|Dose Escalation|Progressive disease|13|||
161736703|NCT01877382|584074819|FG013|Dose Escalation|Progressive disease|1|||
161736704|NCT01877382|584074820|FG014|Dose Escalation|Progressive disease|0|||
161736705|NCT01877382|584074806|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736706|NCT01877382|584074807|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736707|NCT01877382|584074808|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736708|NCT01877382|584074809|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736709|NCT01877382|584074810|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736710|NCT01877382|584074811|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736711|NCT01877382|584074812|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736712|NCT01877382|584074813|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736713|NCT01877382|584074814|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736714|NCT01877382|584074815|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736715|NCT01877382|584074816|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736716|NCT01877382|584074817|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736717|NCT01877382|584074818|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736718|NCT01877382|584074819|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736719|NCT01877382|584074820|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736720|NCT01877382|584074806|FG000|Dose Escalation|Clinical progression|0|||
161736721|NCT01877382|584074807|FG001|Dose Escalation|Clinical progression|1|||
161736722|NCT01877382|584074808|FG002|Dose Escalation|Clinical progression|0|||
161736723|NCT01877382|584074809|FG003|Dose Escalation|Clinical progression|2|||
161736724|NCT01877382|584074810|FG004|Dose Escalation|Clinical progression|0|||
161736725|NCT01877382|584074811|FG005|Dose Escalation|Clinical progression|0|||
161736726|NCT01877382|584074812|FG006|Dose Escalation|Clinical progression|1|||
161736727|NCT01877382|584074813|FG007|Dose Escalation|Clinical progression|0|||
161736728|NCT01877382|584074814|FG008|Dose Escalation|Clinical progression|0|||
161736729|NCT01877382|584074815|FG009|Dose Escalation|Clinical progression|1|||
161736730|NCT01877382|584074816|FG010|Dose Escalation|Clinical progression|0|||
161736731|NCT01877382|584074817|FG011|Dose Escalation|Clinical progression|0|||
161736732|NCT01877382|584074818|FG012|Dose Escalation|Clinical progression|2|||
161736733|NCT01877382|584074819|FG013|Dose Escalation|Clinical progression|1|||
161736734|NCT01877382|584074820|FG014|Dose Escalation|Clinical progression|0|||
161736735|NCT01877382|584074806|FG000|Dose Escalation|Adverse Event|0|||
161736736|NCT01877382|584074807|FG001|Dose Escalation|Adverse Event|0|||
161736737|NCT01877382|584074808|FG002|Dose Escalation|Adverse Event|0|||
161736738|NCT01877382|584074809|FG003|Dose Escalation|Adverse Event|4|||
161736739|NCT01877382|584074810|FG004|Dose Escalation|Adverse Event|1|||
161736740|NCT01877382|584074811|FG005|Dose Escalation|Adverse Event|2|||
161736741|NCT01877382|584074812|FG006|Dose Escalation|Adverse Event|1|||
161736742|NCT01877382|584074813|FG007|Dose Escalation|Adverse Event|2|||
161736743|NCT01877382|584074814|FG008|Dose Escalation|Adverse Event|0|||
161736744|NCT01877382|584074815|FG009|Dose Escalation|Adverse Event|0|||
161736745|NCT01877382|584074816|FG010|Dose Escalation|Adverse Event|0|||
161736746|NCT01877382|584074817|FG011|Dose Escalation|Adverse Event|0|||
161736747|NCT01877382|584074818|FG012|Dose Escalation|Adverse Event|1|||
161736748|NCT01877382|584074819|FG013|Dose Escalation|Adverse Event|0|||
161736749|NCT01877382|584074820|FG014|Dose Escalation|Adverse Event|0|||
161736750|NCT01877382|584074806|FG000|Dose Escalation|Withdrawal by Subject|0|||
161736751|NCT01877382|584074807|FG001|Dose Escalation|Withdrawal by Subject|0|||
161736752|NCT01877382|584074808|FG002|Dose Escalation|Withdrawal by Subject|0|||
161736753|NCT01877382|584074809|FG003|Dose Escalation|Withdrawal by Subject|0|||
161736754|NCT01877382|584074810|FG004|Dose Escalation|Withdrawal by Subject|0|||
161736755|NCT01877382|584074811|FG005|Dose Escalation|Withdrawal by Subject|3|||
161736756|NCT01877382|584074812|FG006|Dose Escalation|Withdrawal by Subject|2|||
161736757|NCT01877382|584074813|FG007|Dose Escalation|Withdrawal by Subject|1|||
161736758|NCT01877382|584074814|FG008|Dose Escalation|Withdrawal by Subject|1|||
161736759|NCT01877382|584074815|FG009|Dose Escalation|Withdrawal by Subject|0|||
161736760|NCT01877382|584074816|FG010|Dose Escalation|Withdrawal by Subject|0|||
161736761|NCT01877382|584074817|FG011|Dose Escalation|Withdrawal by Subject|0|||
161736762|NCT01877382|584074818|FG012|Dose Escalation|Withdrawal by Subject|0|||
161736763|NCT01877382|584074819|FG013|Dose Escalation|Withdrawal by Subject|0|||
161736764|NCT01877382|584074820|FG014|Dose Escalation|Withdrawal by Subject|0|||
161736765|NCT01877382|584074806|FG000|Dose Escalation|Protocol Violation|0|||
161736766|NCT01877382|584074807|FG001|Dose Escalation|Protocol Violation|0|||
161736767|NCT01877382|584074808|FG002|Dose Escalation|Protocol Violation|0|||
161736768|NCT01877382|584074809|FG003|Dose Escalation|Protocol Violation|0|||
161840231|NCT00910091|584460475|FG000|Treatment and Survival|Adverse Event|1|||
161840232|NCT00910091|584460476|FG001|Treatment and Survival|Adverse Event|0|||
161840233|NCT01908816|584460479|FG000|Overall Study|Subject's no longer requires study drug|0|||
161840234|NCT01908816|584460480|FG001|Overall Study|Subject's no longer requires study drug|0|||
161840235|NCT01908816|584460481|FG002|Overall Study|Subject's no longer requires study drug|0|||
161840236|NCT01908816|584460482|FG003|Overall Study|Subject's no longer requires study drug|1|||
161840237|NCT01908816|584460479|FG000|Overall Study|Protocol deviation|1|||
161840238|NCT01908816|584460480|FG001|Overall Study|Protocol deviation|2|||
161840239|NCT01908816|584460481|FG002|Overall Study|Protocol deviation|1|||
161840240|NCT01908816|584460482|FG003|Overall Study|Protocol deviation|1|||
161840241|NCT01908816|584460479|FG000|Overall Study|Withdrawal by Subject|0|||
161840242|NCT01908816|584460480|FG001|Overall Study|Withdrawal by Subject|4|||
161840243|NCT01908816|584460481|FG002|Overall Study|Withdrawal by Subject|2|||
161840244|NCT01908816|584460482|FG003|Overall Study|Withdrawal by Subject|2|||
161840245|NCT01908816|584460479|FG000|Overall Study|Lost to Follow-up|3|||
161840246|NCT01908816|584460480|FG001|Overall Study|Lost to Follow-up|5|||
161840247|NCT01908816|584460481|FG002|Overall Study|Lost to Follow-up|4|||
161840248|NCT01908816|584460482|FG003|Overall Study|Lost to Follow-up|2|||
161840249|NCT01908816|584460479|FG000|Overall Study|Death|1|||
161840250|NCT01908816|584460480|FG001|Overall Study|Death|0|||
161840251|NCT01908816|584460481|FG002|Overall Study|Death|7|||
161840252|NCT01908816|584460482|FG003|Overall Study|Death|1|||
161840253|NCT01908816|584460479|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161840254|NCT01908816|584460480|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161840255|NCT01908816|584460481|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161840256|NCT01908816|584460482|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161840257|NCT01908816|584460479|FG000|Overall Study|Early termination|87|||
161840258|NCT01908816|584460480|FG001|Overall Study|Early termination|60|||
161840259|NCT01908816|584460481|FG002|Overall Study|Early termination|43|||
161840260|NCT01908816|584460482|FG003|Overall Study|Early termination|28|||
161840261|NCT05183217|584460483|FG000|Overall Study|Withdrawal by Subject|1|||
161840262|NCT05183217|584460484|FG001|Overall Study|Withdrawal by Subject|1|||
161840263|NCT00507130|584460485|FG000|Overall Study|Lost to Follow-up|0|||
161840264|NCT00507130|584460486|FG001|Overall Study|Lost to Follow-up|0|||
161840265|NCT00507130|584460487|FG002|Overall Study|Lost to Follow-up|1|||
161840266|NCT00507130|584460488|FG003|Overall Study|Lost to Follow-up|1|||
161840267|NCT00507130|584460485|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
161840268|NCT00507130|584460486|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161840269|NCT00507130|584460487|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161840270|NCT00507130|584460488|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161840271|NCT02524730|584460489|FG000|Overall Study|Lost to Follow-up|5|||
161840272|NCT02524730|584460489|FG000|Overall Study|Withdrawal by Subject|18|||
161840273|NCT02524730|584460489|FG000|Overall Study|Death|10|||
161840274|NCT02524730|584460489|FG000|Overall Study|Adverse Event|8|||
161840275|NCT02524730|584460489|FG000|Overall Study|Protocol Violation|1|||
161840276|NCT02524730|584460489|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
161840277|NCT03678285|584460501|FG000|Overall Study|Adverse Event|2|||
161840278|NCT03678285|584460501|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
161840279|NCT03678285|584460501|FG000|Overall Study|Dehydrated prior to start of workout|1|||
161840280|NCT01447420|584460504|FG000|Overall Study|Adverse Event|2|||
161840281|NCT01447420|584460505|FG001|Overall Study|Adverse Event|4|||
161840282|NCT01447420|584460506|FG002|Overall Study|Adverse Event|2|||
161840283|NCT01447420|584460504|FG000|Overall Study|Protocol Violation|3|||
161840284|NCT01447420|584460505|FG001|Overall Study|Protocol Violation|3|||
161840285|NCT01447420|584460506|FG002|Overall Study|Protocol Violation|0|||
161840286|NCT01447420|584460504|FG000|Overall Study|Withdrawal by Subject|4|||
161840287|NCT01447420|584460505|FG001|Overall Study|Withdrawal by Subject|1|||
161840288|NCT01447420|584460506|FG002|Overall Study|Withdrawal by Subject|0|||
161840289|NCT01447420|584460504|FG000|Overall Study|Lack of Efficacy|1|||
161840290|NCT01447420|584460505|FG001|Overall Study|Lack of Efficacy|19|||
161840291|NCT01447420|584460506|FG002|Overall Study|Lack of Efficacy|8|||
161840292|NCT04480710|584460510|FG000|Overall Study|Adverse Event|0|||
161840293|NCT04480710|584460511|FG001|Overall Study|Adverse Event|2|||
161840294|NCT04480710|584460512|FG002|Overall Study|Adverse Event|0|||
161840295|NCT04480710|584460513|FG003|Overall Study|Adverse Event|0|||
161840296|NCT04480710|584460510|FG000|Overall Study|Withdrawal by Subject|0|||
161840297|NCT04480710|584460511|FG001|Overall Study|Withdrawal by Subject|1|||
161840298|NCT04480710|584460512|FG002|Overall Study|Withdrawal by Subject|0|||
161840299|NCT04480710|584460513|FG003|Overall Study|Withdrawal by Subject|0|||
161840300|NCT04480710|584460510|FG000|Overall Study|Physician Decision|0|||
161840301|NCT04480710|584460511|FG001|Overall Study|Physician Decision|0|||
161840302|NCT04480710|584460512|FG002|Overall Study|Physician Decision|1|||
161840303|NCT04480710|584460513|FG003|Overall Study|Physician Decision|0|||
161840304|NCT01103466|584460521|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
161840305|NCT01103466|584460522|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
161736769|NCT01877382|584074810|FG004|Dose Escalation|Protocol Violation|0|||
161736770|NCT01877382|584074811|FG005|Dose Escalation|Protocol Violation|0|||
161736771|NCT01877382|584074812|FG006|Dose Escalation|Protocol Violation|1|||
161736772|NCT01877382|584074813|FG007|Dose Escalation|Protocol Violation|0|||
161736773|NCT01877382|584074814|FG008|Dose Escalation|Protocol Violation|0|||
161736774|NCT01877382|584074815|FG009|Dose Escalation|Protocol Violation|0|||
161736775|NCT01877382|584074816|FG010|Dose Escalation|Protocol Violation|0|||
161736776|NCT01877382|584074817|FG011|Dose Escalation|Protocol Violation|0|||
161736777|NCT01877382|584074818|FG012|Dose Escalation|Protocol Violation|0|||
161736778|NCT01877382|584074819|FG013|Dose Escalation|Protocol Violation|0|||
161736779|NCT01877382|584074820|FG014|Dose Escalation|Protocol Violation|0|||
161736780|NCT01877382|584074806|FG000|Dose Escalation|Study terminated by sponsor|0|||
161736781|NCT01877382|584074807|FG001|Dose Escalation|Study terminated by sponsor|0|||
161736782|NCT01877382|584074808|FG002|Dose Escalation|Study terminated by sponsor|0|||
161736783|NCT01877382|584074809|FG003|Dose Escalation|Study terminated by sponsor|0|||
161736784|NCT01877382|584074810|FG004|Dose Escalation|Study terminated by sponsor|0|||
161736785|NCT01877382|584074811|FG005|Dose Escalation|Study terminated by sponsor|0|||
161736786|NCT01877382|584074812|FG006|Dose Escalation|Study terminated by sponsor|0|||
161736787|NCT01877382|584074813|FG007|Dose Escalation|Study terminated by sponsor|1|||
161736788|NCT01877382|584074814|FG008|Dose Escalation|Study terminated by sponsor|1|||
161736789|NCT01877382|584074815|FG009|Dose Escalation|Study terminated by sponsor|0|||
161736790|NCT01877382|584074816|FG010|Dose Escalation|Study terminated by sponsor|0|||
161736791|NCT01877382|584074817|FG011|Dose Escalation|Study terminated by sponsor|0|||
161736792|NCT01877382|584074818|FG012|Dose Escalation|Study terminated by sponsor|3|||
161736793|NCT01877382|584074819|FG013|Dose Escalation|Study terminated by sponsor|0|||
161736794|NCT01877382|584074820|FG014|Dose Escalation|Study terminated by sponsor|0|||
161736795|NCT01877382|584074806|FG000|Dose Escalation|Death|0|||
161736796|NCT01877382|584074807|FG001|Dose Escalation|Death|0|||
161736797|NCT01877382|584074808|FG002|Dose Escalation|Death|0|||
161736798|NCT01877382|584074809|FG003|Dose Escalation|Death|0|||
161736799|NCT01877382|584074810|FG004|Dose Escalation|Death|0|||
161736800|NCT01877382|584074811|FG005|Dose Escalation|Death|0|||
161736801|NCT01877382|584074812|FG006|Dose Escalation|Death|0|||
161736802|NCT01877382|584074813|FG007|Dose Escalation|Death|1|||
161736803|NCT01877382|584074814|FG008|Dose Escalation|Death|0|||
161736804|NCT01877382|584074815|FG009|Dose Escalation|Death|0|||
161736805|NCT01877382|584074816|FG010|Dose Escalation|Death|0|||
161736806|NCT01877382|584074817|FG011|Dose Escalation|Death|0|||
161736807|NCT01877382|584074818|FG012|Dose Escalation|Death|1|||
161736808|NCT01877382|584074819|FG013|Dose Escalation|Death|1|||
161736809|NCT01877382|584074820|FG014|Dose Escalation|Death|0|||
161736810|NCT01877382|584074806|FG000|Dose Expansion|Progressive disease|0|||
161736811|NCT01877382|584074807|FG001|Dose Expansion|Progressive disease|0|||
161736812|NCT01877382|584074808|FG002|Dose Expansion|Progressive disease|0|||
161736813|NCT01877382|584074809|FG003|Dose Expansion|Progressive disease|0|||
161736814|NCT01877382|584074810|FG004|Dose Expansion|Progressive disease|0|||
161736815|NCT01877382|584074811|FG005|Dose Expansion|Progressive disease|0|||
161736816|NCT01877382|584074812|FG006|Dose Expansion|Progressive disease|0|||
161736817|NCT01877382|584074813|FG007|Dose Expansion|Progressive disease|0|||
161736818|NCT01877382|584074814|FG008|Dose Expansion|Progressive disease|0|||
161736819|NCT01877382|584074815|FG009|Dose Expansion|Progressive disease|0|||
161736820|NCT01877382|584074816|FG010|Dose Expansion|Progressive disease|0|||
161736821|NCT01877382|584074817|FG011|Dose Expansion|Progressive disease|0|||
161736822|NCT01877382|584074818|FG012|Dose Expansion|Progressive disease|0|||
161736823|NCT01877382|584074819|FG013|Dose Expansion|Progressive disease|0|||
161736824|NCT01877382|584074820|FG014|Dose Expansion|Progressive disease|11|||
161736825|NCT01877382|584074806|FG000|Dose Expansion|Clinical progression|0|||
161736826|NCT01877382|584074807|FG001|Dose Expansion|Clinical progression|0|||
161736827|NCT01877382|584074808|FG002|Dose Expansion|Clinical progression|0|||
161736828|NCT01877382|584074809|FG003|Dose Expansion|Clinical progression|0|||
161736829|NCT01877382|584074810|FG004|Dose Expansion|Clinical progression|0|||
161736830|NCT01877382|584074811|FG005|Dose Expansion|Clinical progression|0|||
161736831|NCT01877382|584074812|FG006|Dose Expansion|Clinical progression|0|||
161736832|NCT01877382|584074813|FG007|Dose Expansion|Clinical progression|0|||
161736833|NCT01877382|584074814|FG008|Dose Expansion|Clinical progression|0|||
161736834|NCT01877382|584074815|FG009|Dose Expansion|Clinical progression|0|||
161736835|NCT01877382|584074816|FG010|Dose Expansion|Clinical progression|0|||
161736836|NCT01877382|584074817|FG011|Dose Expansion|Clinical progression|0|||
161736837|NCT01877382|584074818|FG012|Dose Expansion|Clinical progression|0|||
161736838|NCT01877382|584074819|FG013|Dose Expansion|Clinical progression|0|||
161736839|NCT01877382|584074820|FG014|Dose Expansion|Clinical progression|6|||
161736840|NCT01877382|584074806|FG000|Dose Expansion|Adverse Event|0|||
161736841|NCT01877382|584074807|FG001|Dose Expansion|Adverse Event|0|||
161736842|NCT01877382|584074808|FG002|Dose Expansion|Adverse Event|0|||
161736843|NCT01877382|584074809|FG003|Dose Expansion|Adverse Event|0|||
161736844|NCT01877382|584074810|FG004|Dose Expansion|Adverse Event|0|||
161736845|NCT01877382|584074811|FG005|Dose Expansion|Adverse Event|0|||
161736846|NCT01877382|584074812|FG006|Dose Expansion|Adverse Event|0|||
161736847|NCT01877382|584074813|FG007|Dose Expansion|Adverse Event|0|||
161736848|NCT01877382|584074814|FG008|Dose Expansion|Adverse Event|0|||
161736849|NCT01877382|584074815|FG009|Dose Expansion|Adverse Event|0|||
161736850|NCT01877382|584074816|FG010|Dose Expansion|Adverse Event|0|||
161736851|NCT01877382|584074817|FG011|Dose Expansion|Adverse Event|0|||
161736852|NCT01877382|584074818|FG012|Dose Expansion|Adverse Event|0|||
161736853|NCT01877382|584074819|FG013|Dose Expansion|Adverse Event|0|||
161736854|NCT01877382|584074820|FG014|Dose Expansion|Adverse Event|1|||
161736855|NCT01877382|584074806|FG000|Dose Expansion|Death|0|||
161736856|NCT01877382|584074807|FG001|Dose Expansion|Death|0|||
161736857|NCT01877382|584074808|FG002|Dose Expansion|Death|0|||
161736858|NCT01877382|584074809|FG003|Dose Expansion|Death|0|||
161736859|NCT01877382|584074810|FG004|Dose Expansion|Death|0|||
161736860|NCT01877382|584074811|FG005|Dose Expansion|Death|0|||
161736861|NCT01877382|584074812|FG006|Dose Expansion|Death|0|||
161736862|NCT01877382|584074813|FG007|Dose Expansion|Death|0|||
161736863|NCT01877382|584074814|FG008|Dose Expansion|Death|0|||
161736864|NCT01877382|584074815|FG009|Dose Expansion|Death|0|||
161736865|NCT01877382|584074816|FG010|Dose Expansion|Death|0|||
161736866|NCT01877382|584074817|FG011|Dose Expansion|Death|0|||
161736867|NCT01877382|584074818|FG012|Dose Expansion|Death|0|||
161736868|NCT01877382|584074819|FG013|Dose Expansion|Death|0|||
161736869|NCT01877382|584074820|FG014|Dose Expansion|Death|1|||
161736870|NCT01877382|584074806|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736871|NCT01877382|584074807|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736872|NCT01877382|584074808|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736873|NCT01877382|584074809|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736874|NCT01877382|584074810|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736875|NCT01877382|584074811|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736876|NCT01877382|584074812|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736877|NCT01877382|584074813|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736878|NCT01877382|584074814|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736879|NCT01877382|584074815|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736880|NCT01877382|584074816|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736881|NCT01877382|584074817|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736882|NCT01877382|584074818|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736883|NCT01877382|584074819|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736884|NCT01877382|584074820|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736885|NCT03423979|584074821|FG000|Overall Study|Death|5|||
161736886|NCT03423979|584074821|FG000|Overall Study|Adverse Event|4|||
161736887|NCT03423979|584074821|FG000|Overall Study|Withdrawal by Subject|3|||
161736888|NCT03423979|584074821|FG000|Overall Study|Lost to Follow-up|16|||
161840306|NCT01103466|584460523|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
161840307|NCT01103466|584460521|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
161840308|NCT01103466|584460522|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
161736889|NCT00808249|584074824|FG000|Overall Study|Adverse Event|4|||
161736890|NCT00808249|584074825|FG001|Overall Study|Adverse Event|7|||
161736891|NCT00808249|584074826|FG002|Overall Study|Adverse Event|10|||
161736892|NCT00808249|584074827|FG003|Overall Study|Adverse Event|6|||
161736893|NCT00808249|584074824|FG000|Overall Study|Lost to Follow-up|2|||
161736894|NCT00808249|584074825|FG001|Overall Study|Lost to Follow-up|3|||
161736895|NCT00808249|584074826|FG002|Overall Study|Lost to Follow-up|3|||
161736896|NCT00808249|584074827|FG003|Overall Study|Lost to Follow-up|5|||
161736897|NCT00808249|584074824|FG000|Overall Study|Withdrawal by Subject|4|||
161736898|NCT00808249|584074825|FG001|Overall Study|Withdrawal by Subject|0|||
161736899|NCT00808249|584074826|FG002|Overall Study|Withdrawal by Subject|2|||
161736900|NCT00808249|584074827|FG003|Overall Study|Withdrawal by Subject|4|||
161736901|NCT00808249|584074824|FG000|Overall Study|Protocol Violation|3|||
161736902|NCT00808249|584074825|FG001|Overall Study|Protocol Violation|3|||
161736903|NCT00808249|584074826|FG002|Overall Study|Protocol Violation|3|||
161736904|NCT00808249|584074827|FG003|Overall Study|Protocol Violation|0|||
161840309|NCT01103466|584460523|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
161736905|NCT00808249|584074824|FG000|Overall Study|Lack of Efficacy|1|||
161736906|NCT00808249|584074825|FG001|Overall Study|Lack of Efficacy|1|||
161736907|NCT00808249|584074826|FG002|Overall Study|Lack of Efficacy|0|||
161736908|NCT00808249|584074827|FG003|Overall Study|Lack of Efficacy|0|||
161840310|NCT01103466|584460521|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161736909|NCT00808249|584074824|FG000|Overall Study|study specific discontinuation criteria|1|||
161736910|NCT00808249|584074825|FG001|Overall Study|study specific discontinuation criteria|0|||
161736911|NCT00808249|584074826|FG002|Overall Study|study specific discontinuation criteria|1|||
161736912|NCT00808249|584074827|FG003|Overall Study|study specific discontinuation criteria|0|||
161736913|NCT00808249|584074824|FG000|Overall Study|All other reasons|2|||
161736914|NCT00808249|584074825|FG001|Overall Study|All other reasons|1|||
161736915|NCT00808249|584074826|FG002|Overall Study|All other reasons|3|||
161736916|NCT00808249|584074827|FG003|Overall Study|All other reasons|1|||
161736917|NCT05108805|584074831|FG000|Overall Study|T-cell expansion was not successful.|5|||
161736918|NCT04095286|584074832|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736919|NCT04095286|584074833|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
161736920|NCT04095286|584074834|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736921|NCT04095286|584074835|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736922|NCT04095286|584074836|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736923|NCT04095286|584074837|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736924|NCT04095286|584074832|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
161736925|NCT04095286|584074833|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736926|NCT04095286|584074834|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736927|NCT04095286|584074835|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736928|NCT04095286|584074836|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736929|NCT04095286|584074837|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736930|NCT04095286|584074832|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736931|NCT04095286|584074833|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736932|NCT04095286|584074834|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
161736933|NCT04095286|584074835|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736934|NCT04095286|584074836|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736935|NCT04095286|584074837|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736936|NCT04095286|584074832|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736937|NCT04095286|584074833|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736938|NCT04095286|584074834|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
161736939|NCT04095286|584074835|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736940|NCT04095286|584074836|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736941|NCT04095286|584074837|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736942|NCT04095286|584074832|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736943|NCT04095286|584074833|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736944|NCT04095286|584074834|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736945|NCT04095286|584074835|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736946|NCT04095286|584074836|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
161736947|NCT04095286|584074837|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736948|NCT03003403|584074838|FG000|Overall Study|Ineligible|8|||
161736949|NCT03003403|584074839|FG001|Overall Study|Ineligible|7|||
161736950|NCT03003403|584074838|FG000|Overall Study|Withdrawal by Subject|3|||
161736951|NCT03003403|584074839|FG001|Overall Study|Withdrawal by Subject|1|||
161736952|NCT01255306|584076628|FG000|Overall Study|Physician Decision|1|||
161736953|NCT01255306|584076629|FG001|Overall Study|Physician Decision|1|||
161736954|NCT01617655|584076635|FG000|Overall Study|Adverse Event|2|||
161736955|NCT01617655|584076636|FG001|Overall Study|Adverse Event|3|||
161736956|NCT01617655|584076635|FG000|Overall Study|Poor compliance to protocol|1|||
161736957|NCT01617655|584076636|FG001|Overall Study|Poor compliance to protocol|4|||
161736958|NCT01617655|584076635|FG000|Overall Study|Participants moved|0|||
161736959|NCT01617655|584076636|FG001|Overall Study|Participants moved|4|||
161736960|NCT01617655|584076635|FG000|Overall Study|Consent withdrawn by participant|1|||
161736961|NCT01617655|584076636|FG001|Overall Study|Consent withdrawn by participant|1|||
161736962|NCT01617655|584076635|FG000|Overall Study|Last visit outside protocol visit window|1|||
161840311|NCT01103466|584460522|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161736963|NCT01617655|584076636|FG001|Overall Study|Last visit outside protocol visit window|10|||
161736964|NCT01617655|584076635|FG000|Overall Study|Site closure|3|||
161736965|NCT01617655|584076636|FG001|Overall Study|Site closure|5|||
161736966|NCT01617655|584076635|FG000|Overall Study|Other than specified above|1|||
161736967|NCT01617655|584076636|FG001|Overall Study|Other than specified above|2|||
161736968|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
161736969|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
161736970|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|Death|1|||
161736971|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|Death|0|||
161736972|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
161736973|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
161736974|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
161840312|NCT01103466|584460523|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161840313|NCT01103466|584460521|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
161840314|NCT01103466|584460522|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
161840315|NCT01103466|584460523|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
161840316|NCT01103466|584460521|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161840317|NCT01103466|584460522|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161840318|NCT01103466|584460523|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161840319|NCT01103466|584460521|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
161840320|NCT01103466|584460522|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
161840321|NCT01103466|584460523|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
161840322|NCT02994940|584460524|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
161840323|NCT02994940|584460525|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
161840324|NCT02994940|584460524|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
161840325|NCT02994940|584460525|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
161736975|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
161736976|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
161736977|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
161736978|NCT01175213|584076639|FG000|Safety Follow-up|Adverse Event|1|||
161736979|NCT01175213|584076640|FG001|Safety Follow-up|Adverse Event|0|||
161736980|NCT01517412|584076646|FG000|Overall Study|Adverse Event|10|||
161736981|NCT01517412|584076647|FG001|Overall Study|Adverse Event|11|||
161736982|NCT01517412|584076646|FG000|Overall Study|Lack of Efficacy|10|||
161736983|NCT01517412|584076647|FG001|Overall Study|Lack of Efficacy|5|||
161736984|NCT01517412|584076646|FG000|Overall Study|Poor compliance to protocol|8|||
161736985|NCT01517412|584076647|FG001|Overall Study|Poor compliance to protocol|3|||
161736986|NCT01517412|584076646|FG000|Overall Study|Other than specified above|8|||
161736987|NCT01517412|584076647|FG001|Overall Study|Other than specified above|5|||
161736988|NCT01253187|584076648|FG000|Period 2|Withdrawal by Subject|0|||
161736989|NCT01253187|584076649|FG001|Period 2|Withdrawal by Subject|0|||
161736990|NCT01253187|584076650|FG002|Period 2|Withdrawal by Subject|0|||
161736991|NCT01253187|584076651|FG003|Period 2|Withdrawal by Subject|0|||
161736992|NCT01253187|584076652|FG004|Period 2|Withdrawal by Subject|1|||
161736993|NCT01253187|584076653|FG005|Period 2|Withdrawal by Subject|0|||
161736994|NCT01253187|584076648|FG000|Period 3|Pregnancy|1|||
161736995|NCT01253187|584076649|FG001|Period 3|Pregnancy|0|||
161736996|NCT01253187|584076650|FG002|Period 3|Pregnancy|0|||
161736997|NCT01253187|584076651|FG003|Period 3|Pregnancy|0|||
161736998|NCT01253187|584076652|FG004|Period 3|Pregnancy|0|||
161736999|NCT01253187|584076653|FG005|Period 3|Pregnancy|0|||
161737000|NCT01253187|584076648|FG000|Period 3|difficulty with blood sampling|0|||
161737001|NCT01253187|584076649|FG001|Period 3|difficulty with blood sampling|1|||
161737002|NCT01253187|584076650|FG002|Period 3|difficulty with blood sampling|0|||
161737003|NCT01253187|584076651|FG003|Period 3|difficulty with blood sampling|0|||
161737004|NCT01253187|584076652|FG004|Period 3|difficulty with blood sampling|0|||
161737005|NCT01253187|584076653|FG005|Period 3|difficulty with blood sampling|0|||
161737006|NCT01253187|584076648|FG000|Period 3|non-compliance|0|||
161737007|NCT01253187|584076649|FG001|Period 3|non-compliance|0|||
161737008|NCT01253187|584076650|FG002|Period 3|non-compliance|0|||
161737009|NCT01253187|584076651|FG003|Period 3|non-compliance|0|||
161737010|NCT01253187|584076652|FG004|Period 3|non-compliance|1|||
161737011|NCT01253187|584076653|FG005|Period 3|non-compliance|0|||
161737012|NCT03569449|584076654|FG000|Overall Study|Lost to Follow-up|0|||
161737013|NCT03569449|584076655|FG001|Overall Study|Lost to Follow-up|1|||
161737014|NCT03569449|584076656|FG002|Overall Study|Lost to Follow-up|0|||
161737015|NCT03569449|584076657|FG003|Overall Study|Lost to Follow-up|2|||
161737016|NCT03569449|584076658|FG004|Overall Study|Lost to Follow-up|0|||
161840326|NCT02994940|584460524|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
161840327|NCT02994940|584460525|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
161840328|NCT02987959|584460530|FG000|Overall Study|Grantor stopped supply of drugs|6|||
161840329|NCT04126213|584460533|FG000|Overall Study|Lost to Follow-up|9|||
161840330|NCT04126213|584460534|FG001|Overall Study|Lost to Follow-up|1|||
161840331|NCT04126213|584460535|FG002|Overall Study|Lost to Follow-up|5|||
161737017|NCT03569449|584076659|FG005|Overall Study|Lost to Follow-up|0|||
161737018|NCT03569449|584076660|FG006|Overall Study|Lost to Follow-up|0|||
161737019|NCT03569449|584076661|FG007|Overall Study|Lost to Follow-up|0|||
161737020|NCT03569449|584076662|FG008|Overall Study|Lost to Follow-up|0|||
161737021|NCT03569449|584076663|FG009|Overall Study|Lost to Follow-up|0|||
161737022|NCT03569449|584076664|FG010|Overall Study|Lost to Follow-up|0|||
161737023|NCT03569449|584076665|FG011|Overall Study|Lost to Follow-up|0|||
161737024|NCT03569449|584076666|FG012|Overall Study|Lost to Follow-up|0|||
161737025|NCT03569449|584076667|FG013|Overall Study|Lost to Follow-up|0|||
161737026|NCT03569449|584076668|FG014|Overall Study|Lost to Follow-up|1|||
161840332|NCT04126213|584460536|FG003|Overall Study|Lost to Follow-up|10|||
161840333|NCT04126213|584460537|FG004|Overall Study|Lost to Follow-up|4|||
161840334|NCT04126213|584460538|FG005|Overall Study|Lost to Follow-up|7|||
161840335|NCT04126213|584460533|FG000|Overall Study|Withdrawal by Subject|3|||
161840336|NCT04126213|584460534|FG001|Overall Study|Withdrawal by Subject|2|||
161840337|NCT04126213|584460535|FG002|Overall Study|Withdrawal by Subject|1|||
161840338|NCT04126213|584460536|FG003|Overall Study|Withdrawal by Subject|1|||
161840339|NCT04126213|584460537|FG004|Overall Study|Withdrawal by Subject|1|||
161840340|NCT04126213|584460538|FG005|Overall Study|Withdrawal by Subject|1|||
161840341|NCT04126213|584460533|FG000|Overall Study|Other|0|||
161840342|NCT04126213|584460534|FG001|Overall Study|Other|0|||
161840343|NCT04126213|584460535|FG002|Overall Study|Other|2|||
161840344|NCT04126213|584460536|FG003|Overall Study|Other|2|||
161840345|NCT04126213|584460537|FG004|Overall Study|Other|0|||
161840346|NCT04126213|584460538|FG005|Overall Study|Other|1|||
161840347|NCT04126213|584460533|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161840348|NCT04126213|584460534|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161840349|NCT04126213|584460535|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161840350|NCT04126213|584460536|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161840351|NCT04126213|584460537|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161840352|NCT04126213|584460538|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161840353|NCT02853370|584460539|FG000|Overall Study|Physician Decision|1|||
161840354|NCT02853370|584460539|FG000|Overall Study|Lack of Efficacy|2|||
161840355|NCT02853370|584460539|FG000|Overall Study|Death|1|||
161840356|NCT02853370|584460539|FG000|Overall Study|Adverse Event|4|||
161840357|NCT02853370|584460539|FG000|Overall Study|Withdrawal by Subject|3|||
161840358|NCT03283761|584460543|FG000|Study Treatment|Patient Non-Compliance|1|||
161840359|NCT03283761|584460543|FG000|Study Treatment|Alternative Cancer Therapy|7|||
161840360|NCT03283761|584460543|FG000|Study Treatment|Disease progression|21|||
161840361|NCT03283761|584460543|FG000|Study Treatment|Adverse Event|3|||
161840362|NCT03283761|584460543|FG000|Study Treatment|Withdrawal by Subject|4|||
161840363|NCT03283761|584460543|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
161840364|NCT03283761|584460543|FG000|Study Treatment|Symptomatic Deterioration|1|||
161840365|NCT03283761|584460543|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
161840366|NCT03283761|584460543|FG000|Follow up|Lost to Follow-up|1|||
161840367|NCT03283761|584460543|FG000|Follow up|Symptomatic Deterioration|1|||
161840368|NCT03283761|584460543|FG000|Follow up|Death|29|||
161840369|NCT03283761|584460543|FG000|Follow up|study terminated|4|||
161840370|NCT03283761|584460543|FG000|Follow up|Primary Investigator Withdrawal|1|||
161840371|NCT03283761|584460543|FG000|Follow up|Switched to alternative therapy|1|||
161840372|NCT03283761|584460543|FG000|Follow up|Subject is now in Hospice|1|||
161840373|NCT00741936|584460546|FG000|Overall Study|Lost to Follow-up|1|||
161840374|NCT00741936|584460547|FG001|Overall Study|Lost to Follow-up|1|||
161737027|NCT03569449|584076669|FG015|Overall Study|Lost to Follow-up|0|||
161737028|NCT03569449|584076654|FG000|Overall Study|Withdrawal by Subject|0|||
161737029|NCT03569449|584076655|FG001|Overall Study|Withdrawal by Subject|1|||
161737030|NCT03569449|584076656|FG002|Overall Study|Withdrawal by Subject|0|||
161737031|NCT03569449|584076657|FG003|Overall Study|Withdrawal by Subject|0|||
161737032|NCT03569449|584076658|FG004|Overall Study|Withdrawal by Subject|1|||
161737033|NCT03569449|584076659|FG005|Overall Study|Withdrawal by Subject|0|||
161737034|NCT03569449|584076660|FG006|Overall Study|Withdrawal by Subject|0|||
161737035|NCT03569449|584076661|FG007|Overall Study|Withdrawal by Subject|0|||
161737036|NCT03569449|584076662|FG008|Overall Study|Withdrawal by Subject|0|||
161737037|NCT03569449|584076663|FG009|Overall Study|Withdrawal by Subject|0|||
161737038|NCT03569449|584076664|FG010|Overall Study|Withdrawal by Subject|0|||
161737039|NCT03569449|584076665|FG011|Overall Study|Withdrawal by Subject|0|||
161840375|NCT00741936|584460546|FG000|Overall Study|Adverse Event|3|||
161840376|NCT00741936|584460547|FG001|Overall Study|Adverse Event|4|||
161840377|NCT00741936|584460546|FG000|Overall Study|Pregnancy|0|||
161840378|NCT00741936|584460547|FG001|Overall Study|Pregnancy|1|||
161737040|NCT03569449|584076666|FG012|Overall Study|Withdrawal by Subject|0|||
161737041|NCT03569449|584076667|FG013|Overall Study|Withdrawal by Subject|0|||
161840379|NCT00741936|584460546|FG000|Overall Study|Protocol Violation|2|||
161840380|NCT00741936|584460547|FG001|Overall Study|Protocol Violation|0|||
161840381|NCT00741936|584460546|FG000|Overall Study|Lack of Efficacy|0|||
161840382|NCT00741936|584460547|FG001|Overall Study|Lack of Efficacy|2|||
161840383|NCT00741936|584460546|FG000|Overall Study|Low compliance|3|||
161840384|NCT00741936|584460547|FG001|Overall Study|Low compliance|0|||
161840385|NCT01941940|584460548|FG000|Overall Study|Adverse Event|11|||
161840386|NCT01941940|584460548|FG000|Overall Study|Lost to Follow-up|2|||
161840387|NCT01941940|584460548|FG000|Overall Study|Physician Decision|2|||
161840388|NCT01941940|584460548|FG000|Overall Study|Withdrawal by Subject|15|||
161840389|NCT01941940|584460548|FG000|Overall Study|Death|1|||
161737042|NCT03569449|584076668|FG014|Overall Study|Withdrawal by Subject|0|||
161737043|NCT03569449|584076669|FG015|Overall Study|Withdrawal by Subject|0|||
161737044|NCT04124692|584076670|FG000|Overall Study|Medical reason|0|||
161737045|NCT04124692|584076671|FG001|Overall Study|Medical reason|1|||
161737046|NCT04124692|584076670|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
161737047|NCT04124692|584076671|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
161737048|NCT04124692|584076670|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
161737049|NCT04124692|584076671|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
161737050|NCT04124692|584076670|FG000|Overall Study|Lost to Follow-up|2|||
161737051|NCT04124692|584076671|FG001|Overall Study|Lost to Follow-up|4|||
161737052|NCT04124692|584076670|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
161737053|NCT04124692|584076671|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
161737054|NCT05279898|584076683|FG000|Overall Study|Withdrawal by Subject|1|||
161737055|NCT05279898|584076684|FG001|Overall Study|Withdrawal by Subject|0|||
161737056|NCT05279898|584076683|FG000|Overall Study|Physician Decision|1|||
161737057|NCT05279898|584076684|FG001|Overall Study|Physician Decision|1|||
161737058|NCT05136170|584076685|FG000|Overall Study|Withdrawal by Subject|2|||
161737059|NCT05136170|584076686|FG001|Overall Study|Withdrawal by Subject|2|||
161737060|NCT05136170|584076685|FG000|Overall Study|Can no longer make office visits|1|||
161737061|NCT05136170|584076686|FG001|Overall Study|Can no longer make office visits|0|||
161737062|NCT04393038|584076687|FG000|Overall Study|Adverse Event|11|||
161737063|NCT04393038|584076688|FG001|Overall Study|Adverse Event|2|||
161737064|NCT04393038|584076687|FG000|Overall Study|Protocol Violation|1|||
161737065|NCT04393038|584076688|FG001|Overall Study|Protocol Violation|0|||
161737066|NCT04393038|584076687|FG000|Overall Study|Death|6|||
161737067|NCT04393038|584076688|FG001|Overall Study|Death|4|||
161737068|NCT04393038|584076687|FG000|Overall Study|Withdrawal by Subject|24|||
161737069|NCT04393038|584076688|FG001|Overall Study|Withdrawal by Subject|8|||
161737070|NCT04393038|584076687|FG000|Overall Study|Lost to Follow-up|5|||
161737071|NCT04393038|584076688|FG001|Overall Study|Lost to Follow-up|4|||
161737072|NCT04393038|584076687|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
161737073|NCT04393038|584076688|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
161737074|NCT04393038|584076687|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
161737075|NCT04393038|584076688|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
161737076|NCT05168813|584076689|FG000|Part A (Open-label)|Lost to Follow-up|21|||
161737077|NCT05168813|584076690|FG001|Part A (Open-label)|Lost to Follow-up|39|||
161737078|NCT05168813|584076691|FG002|Part A (Open-label)|Lost to Follow-up|8|||
161737079|NCT05168813|584076692|FG003|Part A (Open-label)|Lost to Follow-up|26|||
161737080|NCT05168813|584076693|FG004|Part A (Open-label)|Lost to Follow-up|0|||
161737081|NCT05168813|584076694|FG005|Part A (Open-label)|Lost to Follow-up|0|||
161737082|NCT05168813|584076689|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
161737083|NCT05168813|584076690|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
161737084|NCT05168813|584076691|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
161737085|NCT05168813|584076692|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
161737086|NCT05168813|584076693|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
161737087|NCT05168813|584076694|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
161737088|NCT05168813|584076689|FG000|Part A (Open-label)|Death|23|||
161737089|NCT05168813|584076690|FG001|Part A (Open-label)|Death|28|||
161737090|NCT05168813|584076691|FG002|Part A (Open-label)|Death|1|||
161737091|NCT05168813|584076692|FG003|Part A (Open-label)|Death|9|||
161737092|NCT05168813|584076693|FG004|Part A (Open-label)|Death|0|||
161737093|NCT05168813|584076694|FG005|Part A (Open-label)|Death|0|||
161737094|NCT05168813|584076689|FG000|Part A (Open-label)|Physician Decision|0|||
161737095|NCT05168813|584076690|FG001|Part A (Open-label)|Physician Decision|1|||
161737096|NCT05168813|584076691|FG002|Part A (Open-label)|Physician Decision|0|||
161737097|NCT05168813|584076692|FG003|Part A (Open-label)|Physician Decision|2|||
161737098|NCT05168813|584076693|FG004|Part A (Open-label)|Physician Decision|0|||
161840390|NCT01941940|584460548|FG000|Overall Study|Other|1|||
161840391|NCT01941940|584460548|FG000|Overall Study|Other|1|||
161840392|NCT00532935|584460549|FG000|Overall Study|Adverse Event|11|||
161840393|NCT00532935|584460550|FG001|Overall Study|Adverse Event|12|||
161840394|NCT00532935|584460549|FG000|Overall Study|Lack of Efficacy|0|||
161840395|NCT00532935|584460550|FG001|Overall Study|Lack of Efficacy|3|||
161840396|NCT00532935|584460549|FG000|Overall Study|Lost to Follow-up|10|||
161840397|NCT00532935|584460550|FG001|Overall Study|Lost to Follow-up|6|||
161737099|NCT05168813|584076694|FG005|Part A (Open-label)|Physician Decision|0|||
161737100|NCT05168813|584076689|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
161737101|NCT05168813|584076690|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
161737102|NCT05168813|584076691|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161737103|NCT05168813|584076692|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
161737104|NCT05168813|584076693|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161737105|NCT05168813|584076694|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161737106|NCT05168813|584076689|FG000|Part A (Open-label)|Protocol Violation|0|||
161840398|NCT00532935|584460549|FG000|Overall Study|Physician Decision|4|||
161737107|NCT05168813|584076690|FG001|Part A (Open-label)|Protocol Violation|1|||
161737108|NCT05168813|584076691|FG002|Part A (Open-label)|Protocol Violation|0|||
161737109|NCT05168813|584076692|FG003|Part A (Open-label)|Protocol Violation|0|||
161737110|NCT05168813|584076693|FG004|Part A (Open-label)|Protocol Violation|0|||
161737111|NCT05168813|584076694|FG005|Part A (Open-label)|Protocol Violation|0|||
161737112|NCT05168813|584076689|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
161737113|NCT05168813|584076690|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
161737114|NCT05168813|584076691|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
161737115|NCT05168813|584076692|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
161737116|NCT05168813|584076693|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
161737117|NCT05168813|584076694|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
161737118|NCT05168813|584076689|FG000|Part A (Open-label)|Other|0|||
161737119|NCT05168813|584076690|FG001|Part A (Open-label)|Other|1|||
161737120|NCT05168813|584076691|FG002|Part A (Open-label)|Other|0|||
161737121|NCT05168813|584076692|FG003|Part A (Open-label)|Other|0|||
161737122|NCT05168813|584076693|FG004|Part A (Open-label)|Other|0|||
161737123|NCT05168813|584076694|FG005|Part A (Open-label)|Other|0|||
161737124|NCT05168813|584076689|FG000|Part B (Blinded)|Lost to Follow-up|0|||
161737125|NCT05168813|584076690|FG001|Part B (Blinded)|Lost to Follow-up|0|||
161737126|NCT05168813|584076691|FG002|Part B (Blinded)|Lost to Follow-up|0|||
161737127|NCT05168813|584076692|FG003|Part B (Blinded)|Lost to Follow-up|0|||
161737128|NCT05168813|584076693|FG004|Part B (Blinded)|Lost to Follow-up|219|||
161737129|NCT05168813|584076694|FG005|Part B (Blinded)|Lost to Follow-up|88|||
161737130|NCT05168813|584076689|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
161737131|NCT05168813|584076690|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
161737132|NCT05168813|584076691|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
161737133|NCT05168813|584076692|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
161737134|NCT05168813|584076693|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
161737135|NCT05168813|584076694|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
161737136|NCT05168813|584076689|FG000|Part B (Blinded)|Death|0|||
161737137|NCT05168813|584076690|FG001|Part B (Blinded)|Death|0|||
161737138|NCT05168813|584076691|FG002|Part B (Blinded)|Death|0|||
161737139|NCT05168813|584076692|FG003|Part B (Blinded)|Death|0|||
161737140|NCT05168813|584076693|FG004|Part B (Blinded)|Death|63|||
161737141|NCT05168813|584076694|FG005|Part B (Blinded)|Death|19|||
161737142|NCT05168813|584076689|FG000|Part B (Blinded)|Physician Decision|0|||
161737143|NCT05168813|584076690|FG001|Part B (Blinded)|Physician Decision|0|||
161737144|NCT05168813|584076691|FG002|Part B (Blinded)|Physician Decision|0|||
161737145|NCT05168813|584076692|FG003|Part B (Blinded)|Physician Decision|0|||
161737146|NCT05168813|584076693|FG004|Part B (Blinded)|Physician Decision|6|||
161737147|NCT05168813|584076694|FG005|Part B (Blinded)|Physician Decision|1|||
161737148|NCT05168813|584076689|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737149|NCT05168813|584076690|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737150|NCT05168813|584076691|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737151|NCT05168813|584076692|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737152|NCT05168813|584076693|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
161737153|NCT05168813|584076694|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
161737154|NCT05168813|584076689|FG000|Part B (Blinded)|Pregnancy|0|||
161737155|NCT05168813|584076690|FG001|Part B (Blinded)|Pregnancy|0|||
161737156|NCT05168813|584076691|FG002|Part B (Blinded)|Pregnancy|0|||
161737157|NCT05168813|584076692|FG003|Part B (Blinded)|Pregnancy|0|||
161737158|NCT05168813|584076693|FG004|Part B (Blinded)|Pregnancy|1|||
161737159|NCT05168813|584076694|FG005|Part B (Blinded)|Pregnancy|0|||
161737160|NCT05168813|584076689|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737161|NCT05168813|584076690|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737162|NCT05168813|584076691|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737163|NCT05168813|584076692|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737164|NCT05168813|584076693|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
161737165|NCT05168813|584076694|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
161737166|NCT05168813|584076689|FG000|Part B (Blinded)|Other|0|||
161737167|NCT05168813|584076690|FG001|Part B (Blinded)|Other|0|||
161737168|NCT05168813|584076691|FG002|Part B (Blinded)|Other|0|||
161737169|NCT05168813|584076692|FG003|Part B (Blinded)|Other|0|||
161737170|NCT05168813|584076693|FG004|Part B (Blinded)|Other|41|||
161737171|NCT05168813|584076694|FG005|Part B (Blinded)|Other|27|||
161737172|NCT04580394|584076695|FG000|First Intervention|Incorrectly Randomized|1|||
161737173|NCT04580394|584076695|FG000|First Intervention|Physician Decision|1|||
161737174|NCT04580394|584076695|FG000|First Intervention|Lost to Follow-up|1|||
161737175|NCT04580394|584076695|FG000|Washout (One Week)|Withdrawal by Subject|1|||
161737176|NCT04580394|584076695|FG000|Washout (One Week)|Adverse Event|1|||
161737177|NCT04580394|584076695|FG000|Washout (One Week)|Withdrawal by Subject|2|||
161737178|NCT04580394|584076695|FG000|Third Intervention|Adverse Event|1|||
161737179|NCT04580394|584076695|FG000|Third Intervention|Withdrawal by Subject|1|||
161737180|NCT04580394|584076695|FG000|Washout (One Week)|Withdrawal by Subject|2|||
161737181|NCT03201965|584076698|FG000|Overall Study|Death|5|||
161737182|NCT03201965|584076699|FG001|Overall Study|Death|65|||
161737183|NCT03201965|584076700|FG002|Overall Study|Death|47|||
161840399|NCT00532935|584460550|FG001|Overall Study|Physician Decision|5|||
161840400|NCT00532935|584460549|FG000|Overall Study|Pregnancy|1|||
161840401|NCT00532935|584460550|FG001|Overall Study|Pregnancy|0|||
161840402|NCT00532935|584460549|FG000|Overall Study|Protocol Violation|4|||
161840403|NCT00532935|584460550|FG001|Overall Study|Protocol Violation|2|||
161840404|NCT00532935|584460549|FG000|Overall Study|Withdrawal by Subject|10|||
161840405|NCT00532935|584460550|FG001|Overall Study|Withdrawal by Subject|9|||
161840406|NCT00532935|584460549|FG000|Overall Study|Protocol Specific Criteria|11|||
161840407|NCT00532935|584460550|FG001|Overall Study|Protocol Specific Criteria|15|||
161840408|NCT03212521|584460553|FG000|Overall Study|Adverse Event|1|||
161840409|NCT03212521|584460553|FG000|Overall Study|Lost to Follow-up|4|||
161840410|NCT03212521|584460553|FG000|Overall Study|Withdrawal by Subject|1|||
161840411|NCT03212521|584460553|FG000|Overall Study|Other|1|||
161840412|NCT02435836|584460556|FG000|Overall Study|Lost to Follow-up|21|||
161840413|NCT02435836|584460556|FG000|Overall Study|Lack of Efficacy|1|||
161840414|NCT02435836|584460556|FG000|Overall Study|Withdrawal by Subject|236|||
161840415|NCT02435836|584460556|FG000|Overall Study|Insufficient Clinical Response|26|||
161840416|NCT02435836|584460556|FG000|Overall Study|Adverse Event|44|||
161840417|NCT02435836|584460556|FG000|Overall Study|Sponsor discontinued trial|167|||
161840418|NCT02435836|584460556|FG000|Overall Study|Noncompliance|27|||
161840419|NCT02435836|584460556|FG000|Overall Study|Protocol Violation|6|||
161840420|NCT02435836|584460556|FG000|Overall Study|Met Withdrawal Criteria|7|||
161840421|NCT02435836|584460556|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
161840422|NCT00914459|584460557|FG000|Overall Study|Protocol Violation|0|||
161840423|NCT00914459|584460558|FG001|Overall Study|Protocol Violation|1|||
161840424|NCT00914459|584460557|FG000|Overall Study|Parent/Legal guardian request|1|||
161840425|NCT00914459|584460558|FG001|Overall Study|Parent/Legal guardian request|0|||
161840426|NCT03176459|584460559|FG000|Overall Study|Lost to Follow-up|5|||
161840427|NCT03176459|584460560|FG001|Overall Study|Lost to Follow-up|7|||
161840428|NCT01661179|584460561|FG000|Overall Study|Death|1|||
161840429|NCT01661179|584460561|FG000|Overall Study|Withdrawal by Subject|1|||
161840430|NCT01661179|584460561|FG000|Overall Study|Other Eligibility criteria|4|||
161840431|NCT01083810|584460562|FG000|Overall Study|Lost to Follow-up|23|||
161840432|NCT01083810|584460563|FG001|Overall Study|Lost to Follow-up|11|||
161840433|NCT01083810|584460564|FG002|Overall Study|Lost to Follow-up|4|||
161840434|NCT01083810|584460562|FG000|Overall Study|Adverse Event|15|||
161840435|NCT01083810|584460563|FG001|Overall Study|Adverse Event|11|||
161840436|NCT01083810|584460564|FG002|Overall Study|Adverse Event|4|||
161840437|NCT01083810|584460562|FG000|Overall Study|Withdrawal by Subject|7|||
161840438|NCT01083810|584460563|FG001|Overall Study|Withdrawal by Subject|2|||
161840439|NCT01083810|584460564|FG002|Overall Study|Withdrawal by Subject|4|||
161840440|NCT01083810|584460562|FG000|Overall Study|Reason not reported|6|||
161840441|NCT01083810|584460563|FG001|Overall Study|Reason not reported|1|||
161840442|NCT01083810|584460564|FG002|Overall Study|Reason not reported|1|||
161840443|NCT01083810|584460562|FG000|Overall Study|Non-compliance|4|||
161840444|NCT01083810|584460563|FG001|Overall Study|Non-compliance|7|||
161840445|NCT01083810|584460564|FG002|Overall Study|Non-compliance|2|||
161840446|NCT01083810|584460562|FG000|Overall Study|Simplification|4|||
161840447|NCT01083810|584460563|FG001|Overall Study|Simplification|1|||
161840448|NCT01083810|584460564|FG002|Overall Study|Simplification|0|||
161840449|NCT01083810|584460562|FG000|Overall Study|Death|2|||
161840450|NCT01083810|584460563|FG001|Overall Study|Death|2|||
161840451|NCT01083810|584460564|FG002|Overall Study|Death|3|||
161840452|NCT01083810|584460562|FG000|Overall Study|Co-morbidities|1|||
161840453|NCT01083810|584460563|FG001|Overall Study|Co-morbidities|0|||
161840454|NCT01083810|584460564|FG002|Overall Study|Co-morbidities|0|||
161840455|NCT01083810|584460562|FG000|Overall Study|Participation in study|1|||
161840456|NCT01083810|584460563|FG001|Overall Study|Participation in study|0|||
161840457|NCT01083810|584460564|FG002|Overall Study|Participation in study|0|||
161840458|NCT01083810|584460562|FG000|Overall Study|Therapy break|1|||
161840459|NCT01083810|584460563|FG001|Overall Study|Therapy break|2|||
161840460|NCT01083810|584460564|FG002|Overall Study|Therapy break|2|||
161840461|NCT01083810|584460562|FG000|Overall Study|Virologic failure|1|||
161840462|NCT01083810|584460563|FG001|Overall Study|Virologic failure|8|||
161840463|NCT01083810|584460564|FG002|Overall Study|Virologic failure|0|||
161840464|NCT01602965|584460565|FG000|Overall Study|Lost to Follow-up|4|||
161840465|NCT01602965|584460566|FG001|Overall Study|Lost to Follow-up|2|||
161840466|NCT00446199|584460569|FG000|Overall Study|Adverse Event|7|||
161840467|NCT00446199|584460570|FG001|Overall Study|Adverse Event|4|||
161840468|NCT00446199|584460571|FG002|Overall Study|Adverse Event|6|||
161840469|NCT00446199|584460572|FG003|Overall Study|Adverse Event|4|||
161840470|NCT00446199|584460569|FG000|Overall Study|Lost to Follow-up|4|||
161840471|NCT00446199|584460570|FG001|Overall Study|Lost to Follow-up|5|||
161840472|NCT00446199|584460571|FG002|Overall Study|Lost to Follow-up|2|||
161840473|NCT00446199|584460572|FG003|Overall Study|Lost to Follow-up|6|||
161840474|NCT00446199|584460569|FG000|Overall Study|Protocol Violation|1|||
161840475|NCT00446199|584460570|FG001|Overall Study|Protocol Violation|2|||
161840476|NCT00446199|584460571|FG002|Overall Study|Protocol Violation|1|||
161840477|NCT00446199|584460572|FG003|Overall Study|Protocol Violation|3|||
161840478|NCT00446199|584460569|FG000|Overall Study|Withdrawal by Subject|2|||
161737184|NCT03201965|584076698|FG000|Overall Study|Lost to Follow-up|0|||
161737185|NCT03201965|584076699|FG001|Overall Study|Lost to Follow-up|6|||
161737186|NCT03201965|584076700|FG002|Overall Study|Lost to Follow-up|0|||
161737187|NCT03201965|584076698|FG000|Overall Study|Withdrawal by Subject|3|||
161737188|NCT03201965|584076699|FG001|Overall Study|Withdrawal by Subject|23|||
161737189|NCT03201965|584076700|FG002|Overall Study|Withdrawal by Subject|8|||
161737190|NCT03201965|584076698|FG000|Overall Study|Sponsor's Decision|20|||
161737191|NCT03201965|584076699|FG001|Overall Study|Sponsor's Decision|99|||
161737192|NCT03201965|584076700|FG002|Overall Study|Sponsor's Decision|140|||
161737193|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
161737194|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
161737195|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
161737196|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
161737197|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
161737198|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
161737199|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
161737200|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
161737201|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
161737202|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
161737203|NCT00603980|584076705|FG000|Study Qualification|Protocol Violation|3|||
161737204|NCT00603980|584076705|FG000|Study Qualification|Inconsistent data reporting|13|||
161737205|NCT00603980|584076705|FG000|Main Study|14th subject completed trial|1|||
161737206|NCT01577160|584076706|FG000|Overall Study|Adverse Event|9|||
161737207|NCT01577160|584076706|FG000|Overall Study|Lack of Efficacy|15|||
161737208|NCT01577160|584076706|FG000|Overall Study|Lost to Follow-up|40|||
161737209|NCT01577160|584076706|FG000|Overall Study|Withdrawal by Subject|18|||
161737210|NCT01577160|584076706|FG000|Overall Study|Subject Uncooperative|7|||
161737211|NCT01577160|584076706|FG000|Overall Study|Other|9|||
161737212|NCT01341652|584076707|FG000|Overall Study|Incorrect Random Assignment|0|||
161737213|NCT01341652|584076708|FG001|Overall Study|Incorrect Random Assignment|1|||
161737214|NCT01341652|584076707|FG000|Overall Study|ineligible; presence metastatic disease|0|||
161737215|NCT01341652|584076708|FG001|Overall Study|ineligible; presence metastatic disease|1|||
161737216|NCT02618928|584076711|FG000|Overall Study|Failure to Return|28|||
161737217|NCT02618928|584076711|FG000|Overall Study|Insufficient Virological Response|1|||
161737218|NCT02618928|584076711|FG000|Overall Study|Withdrawal by Subject|2|||
161737219|NCT02618928|584076711|FG000|Overall Study|Death|3|||
161737220|NCT02618928|584076711|FG000|Overall Study|Other|11|||
161737221|NCT02618928|584076711|FG000|Overall Study|Missing|6|||
161737222|NCT02618928|584076711|FG000|Overall Study|Treatment Never Started|7|||
161737223|NCT01096849|584076716|FG000|Overall Study|Consent Withdrawn|1|||
161737224|NCT01096849|584076717|FG001|Overall Study|Consent Withdrawn|4|||
161737225|NCT01096849|584076718|FG002|Overall Study|Consent Withdrawn|2|||
161737226|NCT01096849|584076716|FG000|Overall Study|Lack of Efficacy|0|||
161737227|NCT01096849|584076717|FG001|Overall Study|Lack of Efficacy|2|||
161737228|NCT01096849|584076718|FG002|Overall Study|Lack of Efficacy|0|||
161737229|NCT01096849|584076716|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
161737230|NCT01096849|584076717|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
161737231|NCT01096849|584076718|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
161737232|NCT01096849|584076716|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
161737233|NCT01096849|584076717|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
161737234|NCT01096849|584076718|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
161737235|NCT01096849|584076716|FG000|Overall Study|Administrative Reasons|0|||
161737236|NCT01096849|584076717|FG001|Overall Study|Administrative Reasons|1|||
161737237|NCT01096849|584076718|FG002|Overall Study|Administrative Reasons|2|||
161737238|NCT01096849|584076716|FG000|Overall Study|Lost to Follow-up|1|||
161737239|NCT01096849|584076717|FG001|Overall Study|Lost to Follow-up|3|||
161737240|NCT01096849|584076718|FG002|Overall Study|Lost to Follow-up|1|||
161737241|NCT02998554|584076719|FG000|Overall Study|Adverse Event|8|||
161737242|NCT02998554|584076720|FG001|Overall Study|Adverse Event|3|||
161737243|NCT02998554|584076719|FG000|Overall Study|Protocol deviation|1|||
161737244|NCT02998554|584076720|FG001|Overall Study|Protocol deviation|0|||
161737245|NCT02998554|584076719|FG000|Overall Study|Withdrawal by Subject|2|||
161737246|NCT02998554|584076720|FG001|Overall Study|Withdrawal by Subject|6|||
161737247|NCT02998554|584076719|FG000|Overall Study|Lost to Follow-up|0|||
161737248|NCT02998554|584076720|FG001|Overall Study|Lost to Follow-up|1|||
161737249|NCT02998554|584076719|FG000|Overall Study|Lack of Efficacy|0|||
161737250|NCT02998554|584076720|FG001|Overall Study|Lack of Efficacy|1|||
161737251|NCT04146467|584076721|FG000|Overall Study|Adverse Event|0|||
161737252|NCT04146467|584076722|FG001|Overall Study|Adverse Event|1|||
161737253|NCT04146467|584076721|FG000|Overall Study|Lost to Follow-up|0|||
161737254|NCT04146467|584076722|FG001|Overall Study|Lost to Follow-up|2|||
161737255|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
161737256|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
161737257|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
161737258|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
161737259|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
161737260|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161737261|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161737262|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161737263|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
161737264|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737265|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
161737266|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737267|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
161737268|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737269|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737270|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737271|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737272|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161737273|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737274|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161737275|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161737276|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737277|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737278|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737279|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737280|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737281|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
161737282|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
161737283|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737284|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737285|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737286|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737287|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737288|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737289|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737290|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737291|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737292|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
161737293|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
161737294|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
161737295|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737296|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737297|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737298|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737299|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737300|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
161737301|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
161737302|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
161737303|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161840479|NCT00446199|584460570|FG001|Overall Study|Withdrawal by Subject|5|||
161840480|NCT00446199|584460571|FG002|Overall Study|Withdrawal by Subject|9|||
161840481|NCT00446199|584460572|FG003|Overall Study|Withdrawal by Subject|10|||
161840482|NCT00446199|584460569|FG000|Overall Study|Site termination|2|||
161840483|NCT00446199|584460570|FG001|Overall Study|Site termination|0|||
161840484|NCT00446199|584460571|FG002|Overall Study|Site termination|0|||
161840485|NCT00446199|584460572|FG003|Overall Study|Site termination|1|||
161840486|NCT00446199|584460569|FG000|Overall Study|Randomization in Error|2|||
161840487|NCT00446199|584460570|FG001|Overall Study|Randomization in Error|0|||
161840488|NCT00446199|584460571|FG002|Overall Study|Randomization in Error|1|||
161840489|NCT00446199|584460572|FG003|Overall Study|Randomization in Error|1|||
161840490|NCT00446199|584460569|FG000|Overall Study|Lack of Efficacy|1|||
161840491|NCT00446199|584460570|FG001|Overall Study|Lack of Efficacy|0|||
161840492|NCT00446199|584460571|FG002|Overall Study|Lack of Efficacy|0|||
161737304|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737305|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737306|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737307|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737308|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
161737309|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
161737310|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
161737311|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737312|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737313|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737314|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737315|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737316|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737317|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
161737318|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737319|NCT02128763|584076733|FG000|Overall Study|Death|1|||
161737320|NCT02128763|584076734|FG001|Overall Study|Death|0|||
161737321|NCT02128763|584076733|FG000|Overall Study|Lost to Follow-up|19|||
161737322|NCT02128763|584076734|FG001|Overall Study|Lost to Follow-up|16|||
161737323|NCT02357849|584076737|FG000|Overall Study|Withdrawal by Subject|2|||
161737324|NCT02357849|584076738|FG001|Overall Study|Withdrawal by Subject|3|||
161737325|NCT03105700|584076741|FG000|Overall Study|screen fail|3|||
161737326|NCT03105700|584076741|FG000|Overall Study|Lost to Follow-up|4|||
161737327|NCT01253421|584076742|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
161737328|NCT01253421|584076743|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
161737329|NCT01253421|584076744|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
161737330|NCT01253421|584076745|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
161737331|NCT01253421|584076746|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
161737332|NCT01253421|584076742|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
161737333|NCT01253421|584076743|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
161737334|NCT01253421|584076744|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
161737335|NCT01253421|584076745|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
161737336|NCT01253421|584076746|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
161737337|NCT01253421|584076742|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
161737338|NCT01253421|584076743|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
161737339|NCT01253421|584076744|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
161737340|NCT01253421|584076745|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
161737341|NCT01253421|584076746|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
161737342|NCT01253421|584076742|FG000|Assessment and Scheduling|Physician Decision|1|||
161737343|NCT01253421|584076743|FG001|Assessment and Scheduling|Physician Decision|0|||
161737344|NCT01253421|584076744|FG002|Assessment and Scheduling|Physician Decision|0|||
161737345|NCT01253421|584076745|FG003|Assessment and Scheduling|Physician Decision|0|||
161737346|NCT01253421|584076746|FG004|Assessment and Scheduling|Physician Decision|0|||
161737347|NCT01253421|584076742|FG000|Drug+Scanning Visit|Physician Decision|0|||
161737348|NCT01253421|584076743|FG001|Drug+Scanning Visit|Physician Decision|0|||
161737349|NCT01253421|584076744|FG002|Drug+Scanning Visit|Physician Decision|0|||
161737350|NCT01253421|584076745|FG003|Drug+Scanning Visit|Physician Decision|0|||
161737351|NCT01253421|584076746|FG004|Drug+Scanning Visit|Physician Decision|1|||
161737352|NCT01608724|584076748|FG000|Overall Study|Withdrawal by Subject|131|||
161737353|NCT01608724|584076748|FG000|Overall Study|Lost to Follow-up|41|||
161737354|NCT01608724|584076748|FG000|Overall Study|Study-specific discontinuation criteria|32|||
161737355|NCT01608724|584076748|FG000|Overall Study|Adverse Event|29|||
161737356|NCT01608724|584076748|FG000|Overall Study|Protocol Violation|6|||
161737357|NCT01608724|584076748|FG000|Overall Study|bood sugar too high, etc.|3|||
161737358|NCT01608724|584076748|FG000|Overall Study|Safety reasons|1|||
161737359|NCT00099359|584076749|FG000|Overall Study|Death|11|||
161737360|NCT00099359|584076750|FG001|Overall Study|Death|15|||
161737361|NCT00099359|584076751|FG002|Overall Study|Death|17|||
161737362|NCT00099359|584076749|FG000|Overall Study|Withdrawal by Subject|19|||
161737363|NCT00099359|584076750|FG001|Overall Study|Withdrawal by Subject|19|||
161737364|NCT00099359|584076751|FG002|Overall Study|Withdrawal by Subject|23|||
161737365|NCT00099359|584076749|FG000|Overall Study|Lost to Follow-up|15|||
161737366|NCT00099359|584076750|FG001|Overall Study|Lost to Follow-up|24|||
161737367|NCT00099359|584076751|FG002|Overall Study|Lost to Follow-up|24|||
161737368|NCT00099359|584076749|FG000|Overall Study|moved out of area|9|||
161737369|NCT00099359|584076750|FG001|Overall Study|moved out of area|7|||
161737370|NCT00099359|584076751|FG002|Overall Study|moved out of area|4|||
161737371|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
161737372|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
161737373|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
161737374|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
161840493|NCT00446199|584460572|FG003|Overall Study|Lack of Efficacy|1|||
161737375|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Death|0|||
161737376|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Death|1|||
161737377|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
161737378|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
161737379|NCT00717366|584076752|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
161737380|NCT00717366|584076753|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
161737381|NCT00717366|584076752|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
161737382|NCT00717366|584076753|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
161737383|NCT00717366|584076752|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
161737384|NCT00717366|584076753|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
161737385|NCT02104804|584076756|FG000|Overall Study|Did not take study medication|0|||
161737386|NCT02104804|584076757|FG001|Overall Study|Did not take study medication|1|||
161737387|NCT02104804|584076756|FG000|Overall Study|Study specific discontinuation criteria|6|||
161737388|NCT02104804|584076757|FG001|Overall Study|Study specific discontinuation criteria|1|||
161737389|NCT02104804|584076756|FG000|Overall Study|Other listed|2|||
161737390|NCT02104804|584076757|FG001|Overall Study|Other listed|1|||
161737391|NCT02104804|584076756|FG000|Overall Study|Protocol Violation|0|||
161737392|NCT02104804|584076757|FG001|Overall Study|Protocol Violation|1|||
161737393|NCT02104804|584076756|FG000|Overall Study|Adverse Event|4|||
161737394|NCT02104804|584076757|FG001|Overall Study|Adverse Event|3|||
161737395|NCT02104804|584076756|FG000|Overall Study|Withdrawal by Subject|4|||
161737396|NCT02104804|584076757|FG001|Overall Study|Withdrawal by Subject|12|||
161737397|NCT01364233|584076758|FG000|Overall Study|Lost to Follow-up|1|||
161737398|NCT00406783|584076759|FG000|Overall Study|Adverse Event|4|||
161737399|NCT00406783|584076760|FG001|Overall Study|Adverse Event|4|||
161737400|NCT00406783|584076759|FG000|Overall Study|Treatment Failure|2|||
161737401|NCT00406783|584076760|FG001|Overall Study|Treatment Failure|3|||
161737402|NCT00406783|584076759|FG000|Overall Study|Lost to Follow-up|3|||
161737403|NCT00406783|584076760|FG001|Overall Study|Lost to Follow-up|0|||
161737404|NCT00406783|584076759|FG000|Overall Study|Withdrawal by Subject|1|||
161737405|NCT00406783|584076760|FG001|Overall Study|Withdrawal by Subject|4|||
161737406|NCT00406783|584076759|FG000|Overall Study|Protocol Violation|4|||
161737407|NCT00406783|584076760|FG001|Overall Study|Protocol Violation|4|||
161737408|NCT02034474|584076761|FG000|Overall Study|Adverse Event|3|||
161737409|NCT02034474|584076762|FG001|Overall Study|Adverse Event|2|||
161737410|NCT02034474|584076761|FG000|Overall Study|Withdrawal by Subject|1|||
161737411|NCT02034474|584076762|FG001|Overall Study|Withdrawal by Subject|2|||
161737412|NCT01391819|584076763|FG000|Overall Study|Withdrawal by Subject|56|||
161737413|NCT01391819|584076763|FG000|Overall Study|Migrated/moved from study area|82|||
161737414|NCT01391819|584076763|FG000|Overall Study|Lost to Follow-up|252|||
161737415|NCT01391819|584076763|FG000|Overall Study|Death|3|||
161737416|NCT01391819|584076763|FG000|Overall Study|Other|9|||
161737417|NCT00995670|584076764|FG000|Overall Study|Failed arterial cannulation|1|||
161737418|NCT00995670|584076765|FG001|Overall Study|Failed arterial cannulation|0|||
161737419|NCT00995670|584076766|FG002|Overall Study|Failed arterial cannulation|3|||
161737420|NCT00675103|584076767|FG000|Overall Study|Lack of Efficacy|2|||
161737421|NCT00675103|584076767|FG000|Overall Study|Adverse Event|1|||
161737422|NCT01810042|584076770|FG000|Overall Study|Lost to Follow-up|10|||
161737423|NCT01208038|584076773|FG000|Overall Study|Withdrawal by Subject|1|||
161737424|NCT02509494|584076776|FG000|Overall Study|Lost to Follow-up|8|||
161737425|NCT02509494|584076777|FG001|Overall Study|Lost to Follow-up|47|||
161737426|NCT02509494|584076778|FG002|Overall Study|Lost to Follow-up|19|||
161737427|NCT02509494|584076779|FG003|Overall Study|Lost to Follow-up|6|||
161737428|NCT02509494|584076780|FG004|Overall Study|Lost to Follow-up|3|||
161737429|NCT02509494|584076781|FG005|Overall Study|Lost to Follow-up|3|||
161737430|NCT02509494|584076782|FG006|Overall Study|Lost to Follow-up|1|||
161737431|NCT02509494|584076783|FG007|Overall Study|Lost to Follow-up|3|||
161737432|NCT02509494|584076784|FG008|Overall Study|Lost to Follow-up|1|||
161737433|NCT02509494|584076776|FG000|Overall Study|Physician Decision|2|||
161737434|NCT02509494|584076777|FG001|Overall Study|Physician Decision|1|||
161737435|NCT02509494|584076778|FG002|Overall Study|Physician Decision|0|||
161737436|NCT02509494|584076779|FG003|Overall Study|Physician Decision|0|||
161737437|NCT02509494|584076780|FG004|Overall Study|Physician Decision|0|||
161737438|NCT02509494|584076781|FG005|Overall Study|Physician Decision|0|||
161737439|NCT02509494|584076782|FG006|Overall Study|Physician Decision|0|||
161737440|NCT02509494|584076783|FG007|Overall Study|Physician Decision|0|||
161737441|NCT02509494|584076784|FG008|Overall Study|Physician Decision|0|||
161737442|NCT02509494|584076776|FG000|Overall Study|Withdrawal by Subject|4|||
161737443|NCT02509494|584076777|FG001|Overall Study|Withdrawal by Subject|17|||
161737444|NCT02509494|584076778|FG002|Overall Study|Withdrawal by Subject|7|||
161737445|NCT02509494|584076779|FG003|Overall Study|Withdrawal by Subject|5|||
161737446|NCT02509494|584076780|FG004|Overall Study|Withdrawal by Subject|0|||
161737447|NCT02509494|584076781|FG005|Overall Study|Withdrawal by Subject|6|||
161737448|NCT02509494|584076782|FG006|Overall Study|Withdrawal by Subject|1|||
161737449|NCT02509494|584076783|FG007|Overall Study|Withdrawal by Subject|2|||
161737450|NCT02509494|584076784|FG008|Overall Study|Withdrawal by Subject|1|||
161737451|NCT02509494|584076776|FG000|Overall Study|Death|0|||
161737452|NCT02509494|584076777|FG001|Overall Study|Death|1|||
161737453|NCT02509494|584076778|FG002|Overall Study|Death|0|||
161737454|NCT02509494|584076779|FG003|Overall Study|Death|0|||
161737455|NCT02509494|584076780|FG004|Overall Study|Death|1|||
161737456|NCT02509494|584076781|FG005|Overall Study|Death|0|||
161737457|NCT02509494|584076782|FG006|Overall Study|Death|0|||
161737458|NCT02509494|584076783|FG007|Overall Study|Death|1|||
161737459|NCT02509494|584076784|FG008|Overall Study|Death|0|||
161737460|NCT02509494|584076776|FG000|Overall Study|Other|0|||
161737461|NCT02509494|584076777|FG001|Overall Study|Other|4|||
161737462|NCT02509494|584076778|FG002|Overall Study|Other|5|||
161737463|NCT02509494|584076779|FG003|Overall Study|Other|0|||
161737464|NCT02509494|584076780|FG004|Overall Study|Other|0|||
161737465|NCT02509494|584076781|FG005|Overall Study|Other|0|||
161737466|NCT02509494|584076782|FG006|Overall Study|Other|0|||
161737467|NCT02509494|584076783|FG007|Overall Study|Other|0|||
161737468|NCT02509494|584076784|FG008|Overall Study|Other|0|||
161737469|NCT02509494|584076776|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161737470|NCT02509494|584076777|FG001|Overall Study|Non-Compliance With Study Drug|11|||
161737471|NCT02509494|584076778|FG002|Overall Study|Non-Compliance With Study Drug|7|||
161737472|NCT02509494|584076779|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161737473|NCT02509494|584076780|FG004|Overall Study|Non-Compliance With Study Drug|1|||
161737474|NCT02509494|584076781|FG005|Overall Study|Non-Compliance With Study Drug|2|||
161737475|NCT02509494|584076782|FG006|Overall Study|Non-Compliance With Study Drug|1|||
161737476|NCT02509494|584076783|FG007|Overall Study|Non-Compliance With Study Drug|1|||
161737477|NCT02509494|584076784|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161737478|NCT05084053|584079050|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
161737479|NCT05084053|584079051|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161737480|NCT05084053|584079052|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161737481|NCT05084053|584079053|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161737482|NCT05084053|584079050|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
161737483|NCT05084053|584079051|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
161737484|NCT05084053|584079052|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
161737485|NCT05084053|584079053|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
161737486|NCT05084053|584079050|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
161737487|NCT05084053|584079051|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
161737488|NCT05084053|584079052|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
161737489|NCT05084053|584079053|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
161737490|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
161737491|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
161737492|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
161737493|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
161737494|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
161737495|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161737496|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
161737497|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
161737498|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Other|2|||
161737499|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Other|4|||
161737500|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
161737501|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
161737502|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
161737503|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
161737504|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
161737505|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
161737506|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
161737507|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
161737508|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
161737509|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
161737510|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Other|7|||
161737511|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Other|4|||
161737512|NCT04092816|584079059|FG000|Overall Study|Lost to Follow-up|1|||
161737513|NCT04092816|584079060|FG001|Overall Study|Lost to Follow-up|2|||
161737514|NCT01677624|584079061|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
161840494|NCT00446199|584460569|FG000|Overall Study|Non-compliant with study drug|1|||
161737515|NCT01337167|584079065|FG000|Infant Series|Adverse Event|1|||
161737516|NCT01337167|584079066|FG001|Infant Series|Adverse Event|1|||
161840495|NCT00446199|584460570|FG001|Overall Study|Non-compliant with study drug|0|||
161737517|NCT01337167|584079065|FG000|Infant Series|Death|1|||
161737518|NCT01337167|584079066|FG001|Infant Series|Death|1|||
161737519|NCT01337167|584079065|FG000|Infant Series|Lost to Follow-up|13|||
161737520|NCT01337167|584079066|FG001|Infant Series|Lost to Follow-up|7|||
161737521|NCT01337167|584079065|FG000|Infant Series|Non-compliance with study drug|2|||
161737522|NCT01337167|584079066|FG001|Infant Series|Non-compliance with study drug|1|||
161737523|NCT01337167|584079065|FG000|Infant Series|Physician Decision|3|||
161737524|NCT01337167|584079066|FG001|Infant Series|Physician Decision|1|||
161737525|NCT01337167|584079065|FG000|Infant Series|Protocol Violation|22|||
161737526|NCT01337167|584079066|FG001|Infant Series|Protocol Violation|9|||
161737527|NCT01337167|584079065|FG000|Infant Series|Withdrawal by Subject|15|||
161737528|NCT01337167|584079066|FG001|Infant Series|Withdrawal by Subject|4|||
161737529|NCT01337167|584079065|FG000|Infant Series|Randomized but not vaccinated|5|||
161737530|NCT01337167|584079066|FG001|Infant Series|Randomized but not vaccinated|3|||
161737531|NCT01337167|584079065|FG000|Interim Period|Lost to Follow-up|51|||
161737532|NCT01337167|584079066|FG001|Interim Period|Lost to Follow-up|23|||
161737533|NCT01337167|584079065|FG000|Interim Period|Non-compliance with study drug|1|||
161737534|NCT01337167|584079066|FG001|Interim Period|Non-compliance with study drug|0|||
161737535|NCT01337167|584079065|FG000|Interim Period|Physician Decision|6|||
161737536|NCT01337167|584079066|FG001|Interim Period|Physician Decision|3|||
161737537|NCT01337167|584079065|FG000|Interim Period|Protocol Violation|5|||
161737538|NCT01337167|584079066|FG001|Interim Period|Protocol Violation|3|||
161737539|NCT01337167|584079065|FG000|Interim Period|Withdrawal by Subject|18|||
161737540|NCT01337167|584079066|FG001|Interim Period|Withdrawal by Subject|10|||
161737541|NCT01337167|584079065|FG000|Interim Period|Other protocol criterion not met|0|||
161737542|NCT01337167|584079066|FG001|Interim Period|Other protocol criterion not met|1|||
161737543|NCT01337167|584079065|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
161737544|NCT01337167|584079066|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
161737545|NCT01337167|584079065|FG000|Toddler Vaccinations|Protocol Violation|0|||
161737546|NCT01337167|584079066|FG001|Toddler Vaccinations|Protocol Violation|1|||
161737547|NCT01337167|584079065|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
161737548|NCT01337167|584079066|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
161737549|NCT03833817|584079067|FG000|Overall Study|Withdrawal by Subject|3|||
161737550|NCT03833817|584079068|FG001|Overall Study|Withdrawal by Subject|3|||
161737551|NCT03833817|584079067|FG000|Overall Study|Lost to Follow-up|3|||
161737552|NCT03833817|584079068|FG001|Overall Study|Lost to Follow-up|3|||
161737553|NCT02126670|584079073|FG000|Overall Study|Withdrawal by Subject|1|||
161737554|NCT02126670|584079074|FG001|Overall Study|Withdrawal by Subject|0|||
161737555|NCT02126670|584079075|FG002|Overall Study|Withdrawal by Subject|0|||
161737556|NCT02126670|584079076|FG003|Overall Study|Withdrawal by Subject|1|||
161737557|NCT03363919|584079079|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
161737558|NCT03363919|584079080|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
161737559|NCT03363919|584079079|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
161737560|NCT03363919|584079080|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
161737561|NCT01975246|584079081|FG000|Overall Study|Adverse Event|2|||
161737562|NCT01975246|584079082|FG001|Overall Study|Adverse Event|1|||
161737563|NCT01975246|584079081|FG000|Overall Study|Lack of Efficacy|1|||
161737564|NCT01975246|584079082|FG001|Overall Study|Lack of Efficacy|0|||
161737565|NCT01975246|584079081|FG000|Overall Study|Protocol Violation|1|||
161737566|NCT01975246|584079082|FG001|Overall Study|Protocol Violation|0|||
161737567|NCT01975246|584079081|FG000|Overall Study|Other than stated|0|||
161737568|NCT01975246|584079082|FG001|Overall Study|Other than stated|1|||
161737569|NCT01646398|584079083|FG000|Overall Study|Withdrawal by Subject|1|||
161737570|NCT01646398|584079084|FG001|Overall Study|Withdrawal by Subject|0|||
161737571|NCT01263093|584079085|FG000|Washout|Physician Decision|1|||
161737572|NCT01263093|584079086|FG001|Washout|Physician Decision|0|||
161737573|NCT01263093|584079085|FG000|Period 2|Adverse Event|1|||
161737574|NCT01263093|584079086|FG001|Period 2|Adverse Event|0|||
161737575|NCT01827319|584079087|FG000|Overall Study|Lost to Follow-up|3|||
161737576|NCT00574119|584079089|FG000|Overall Study|Adverse Event|1|||
161737577|NCT00574119|584079089|FG000|Overall Study|Protocol Violation|1|||
161737578|NCT00574119|584079089|FG000|Overall Study|Withdrawal by Subject|1|||
161737579|NCT00574119|584079089|FG000|Overall Study|Physician Decision|1|||
161737580|NCT03287245|584079090|FG000|Overall Study|Study terminated by sponsor|3|||
161737581|NCT03287245|584079091|FG001|Overall Study|Study terminated by sponsor|0|||
161737582|NCT03287245|584079092|FG002|Overall Study|Study terminated by sponsor|3|||
161737583|NCT03287245|584079093|FG003|Overall Study|Study terminated by sponsor|1|||
161737584|NCT03287245|584079090|FG000|Overall Study|Adverse Event|1|||
161737585|NCT03287245|584079091|FG001|Overall Study|Adverse Event|0|||
161737586|NCT03287245|584079092|FG002|Overall Study|Adverse Event|0|||
161737587|NCT03287245|584079093|FG003|Overall Study|Adverse Event|0|||
161737588|NCT03287245|584079090|FG000|Overall Study|Withdrawal by Subject|8|||
161737589|NCT03287245|584079091|FG001|Overall Study|Withdrawal by Subject|3|||
161737590|NCT03287245|584079092|FG002|Overall Study|Withdrawal by Subject|3|||
161737591|NCT03287245|584079093|FG003|Overall Study|Withdrawal by Subject|0|||
161737592|NCT03287245|584079090|FG000|Overall Study|Physician Decision|3|||
161737593|NCT03287245|584079091|FG001|Overall Study|Physician Decision|2|||
161737594|NCT03287245|584079092|FG002|Overall Study|Physician Decision|0|||
161737595|NCT03287245|584079093|FG003|Overall Study|Physician Decision|0|||
161737596|NCT02862548|584079094|FG000|Randomized Phase (Up to Week 48)|Death|0|||
161737597|NCT02862548|584079095|FG001|Randomized Phase (Up to Week 48)|Death|1|||
161737598|NCT02862548|584079094|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
161737599|NCT02862548|584079095|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
161737600|NCT02862548|584079094|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
161737601|NCT02862548|584079095|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
161737602|NCT02862548|584079094|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
161737603|NCT02862548|584079095|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
161737604|NCT00880763|584079096|FG000|Extension Period (Part 2)|Adverse Event|0|||
161737605|NCT00880763|584079097|FG001|Extension Period (Part 2)|Adverse Event|0|||
161737606|NCT00880763|584079098|FG002|Extension Period (Part 2)|Adverse Event|1|||
161737607|NCT00880763|584079099|FG003|Extension Period (Part 2)|Adverse Event|1|||
161737608|NCT00880763|584079096|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
161737609|NCT00880763|584079097|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
161737610|NCT00880763|584079098|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
161737611|NCT00880763|584079099|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
161737612|NCT00880763|584079096|FG000|Extension Period (Part 2)|Physician Decision|0|||
161737613|NCT00880763|584079097|FG001|Extension Period (Part 2)|Physician Decision|1|||
161737614|NCT00880763|584079098|FG002|Extension Period (Part 2)|Physician Decision|1|||
161737615|NCT00880763|584079099|FG003|Extension Period (Part 2)|Physician Decision|0|||
161737616|NCT00880763|584079096|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
161737617|NCT00880763|584079097|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
161737618|NCT00880763|584079098|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
161737619|NCT00880763|584079099|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
161737620|NCT00205699|584079107|FG000|Overall Study|Lost to Follow-up|1|||
161737621|NCT00205699|584079108|FG001|Overall Study|Lost to Follow-up|3|||
161737622|NCT00205699|584079109|FG002|Overall Study|Lost to Follow-up|5|||
161737623|NCT00205699|584079107|FG000|Overall Study|Adverse Event|1|||
161737624|NCT00205699|584079108|FG001|Overall Study|Adverse Event|0|||
161737625|NCT00205699|584079109|FG002|Overall Study|Adverse Event|0|||
161737626|NCT00205699|584079107|FG000|Overall Study|Withdrawal by Subject|1|||
161737627|NCT00205699|584079108|FG001|Overall Study|Withdrawal by Subject|2|||
161737628|NCT00205699|584079109|FG002|Overall Study|Withdrawal by Subject|1|||
161737629|NCT00205699|584079107|FG000|Overall Study|Lack of Efficacy|0|||
161737630|NCT00205699|584079108|FG001|Overall Study|Lack of Efficacy|1|||
161737631|NCT00205699|584079109|FG002|Overall Study|Lack of Efficacy|0|||
161737632|NCT01754922|584079111|FG000|Overall Study|Adverse Event|0|||
161737633|NCT01754922|584079112|FG001|Overall Study|Adverse Event|1|||
161737634|NCT01207388|584079115|FG000|Overall Study|Death|67|||
161737635|NCT01207388|584079115|FG000|Overall Study|Withdrawal by Subject|1|||
161737636|NCT01885078|584079116|FG000|Treatment Period|Adverse Event|52|||
161737637|NCT01885078|584079117|FG001|Treatment Period|Adverse Event|136|||
161737638|NCT01885078|584079118|FG002|Treatment Period|Adverse Event|30|||
161737639|NCT01885078|584079119|FG003|Treatment Period|Adverse Event|73|||
161737640|NCT01885078|584079120|FG004|Treatment Period|Adverse Event|17|||
161737641|NCT01885078|584079121|FG005|Treatment Period|Adverse Event|72|||
161737642|NCT01885078|584079122|FG006|Treatment Period|Adverse Event|24|||
161737643|NCT01885078|584079123|FG007|Treatment Period|Adverse Event|5|||
161737644|NCT01885078|584079124|FG008|Treatment Period|Adverse Event|0|||
161737645|NCT01885078|584079125|FG009|Treatment Period|Adverse Event|0|||
161737646|NCT01885078|584079116|FG000|Treatment Period|Death|13|||
161737647|NCT01885078|584079117|FG001|Treatment Period|Death|33|||
161737648|NCT01885078|584079118|FG002|Treatment Period|Death|5|||
161737649|NCT01885078|584079119|FG003|Treatment Period|Death|9|||
161737650|NCT01885078|584079120|FG004|Treatment Period|Death|2|||
161737651|NCT01885078|584079121|FG005|Treatment Period|Death|10|||
161737652|NCT01885078|584079122|FG006|Treatment Period|Death|3|||
161737653|NCT01885078|584079123|FG007|Treatment Period|Death|2|||
161737654|NCT01885078|584079124|FG008|Treatment Period|Death|0|||
161737655|NCT01885078|584079125|FG009|Treatment Period|Death|0|||
161737656|NCT01885078|584079116|FG000|Treatment Period|Lack of Efficacy|12|||
161737657|NCT01885078|584079117|FG001|Treatment Period|Lack of Efficacy|33|||
161737658|NCT01885078|584079118|FG002|Treatment Period|Lack of Efficacy|10|||
161737659|NCT01885078|584079119|FG003|Treatment Period|Lack of Efficacy|23|||
161737660|NCT01885078|584079120|FG004|Treatment Period|Lack of Efficacy|24|||
161737661|NCT01885078|584079121|FG005|Treatment Period|Lack of Efficacy|58|||
161737662|NCT01885078|584079122|FG006|Treatment Period|Lack of Efficacy|9|||
161737663|NCT01885078|584079123|FG007|Treatment Period|Lack of Efficacy|5|||
161737664|NCT01885078|584079124|FG008|Treatment Period|Lack of Efficacy|0|||
161737665|NCT01885078|584079125|FG009|Treatment Period|Lack of Efficacy|0|||
161737666|NCT01885078|584079116|FG000|Treatment Period|Lost to Follow-up|16|||
161737667|NCT01885078|584079117|FG001|Treatment Period|Lost to Follow-up|19|||
161737668|NCT01885078|584079118|FG002|Treatment Period|Lost to Follow-up|7|||
161737669|NCT01885078|584079119|FG003|Treatment Period|Lost to Follow-up|9|||
161737670|NCT01885078|584079120|FG004|Treatment Period|Lost to Follow-up|2|||
161737671|NCT01885078|584079121|FG005|Treatment Period|Lost to Follow-up|8|||
161737672|NCT01885078|584079122|FG006|Treatment Period|Lost to Follow-up|2|||
161737673|NCT01885078|584079123|FG007|Treatment Period|Lost to Follow-up|0|||
161737674|NCT01885078|584079124|FG008|Treatment Period|Lost to Follow-up|0|||
161737675|NCT01885078|584079125|FG009|Treatment Period|Lost to Follow-up|0|||
161737676|NCT01885078|584079116|FG000|Treatment Period|Physician Decision|19|||
161737677|NCT01885078|584079117|FG001|Treatment Period|Physician Decision|21|||
161737678|NCT01885078|584079118|FG002|Treatment Period|Physician Decision|5|||
161737679|NCT01885078|584079119|FG003|Treatment Period|Physician Decision|12|||
161737680|NCT01885078|584079120|FG004|Treatment Period|Physician Decision|9|||
161737681|NCT01885078|584079121|FG005|Treatment Period|Physician Decision|24|||
161737682|NCT01885078|584079122|FG006|Treatment Period|Physician Decision|4|||
161737683|NCT01885078|584079123|FG007|Treatment Period|Physician Decision|3|||
161737684|NCT01885078|584079124|FG008|Treatment Period|Physician Decision|0|||
161737685|NCT01885078|584079125|FG009|Treatment Period|Physician Decision|0|||
161737686|NCT01885078|584079116|FG000|Treatment Period|Protocol Violation|3|||
161737687|NCT01885078|584079117|FG001|Treatment Period|Protocol Violation|5|||
161737688|NCT01885078|584079118|FG002|Treatment Period|Protocol Violation|0|||
161737689|NCT01885078|584079119|FG003|Treatment Period|Protocol Violation|3|||
161737690|NCT01885078|584079120|FG004|Treatment Period|Protocol Violation|1|||
161737691|NCT01885078|584079121|FG005|Treatment Period|Protocol Violation|6|||
161737692|NCT01885078|584079122|FG006|Treatment Period|Protocol Violation|0|||
161737693|NCT01885078|584079123|FG007|Treatment Period|Protocol Violation|0|||
161737694|NCT01885078|584079124|FG008|Treatment Period|Protocol Violation|0|||
161737695|NCT01885078|584079125|FG009|Treatment Period|Protocol Violation|0|||
161737696|NCT01885078|584079116|FG000|Treatment Period|Sponsor Decision|245|||
161737697|NCT01885078|584079117|FG001|Treatment Period|Sponsor Decision|648|||
161737698|NCT01885078|584079118|FG002|Treatment Period|Sponsor Decision|49|||
161737699|NCT01885078|584079119|FG003|Treatment Period|Sponsor Decision|90|||
161737700|NCT01885078|584079120|FG004|Treatment Period|Sponsor Decision|20|||
161737701|NCT01885078|584079121|FG005|Treatment Period|Sponsor Decision|38|||
161737702|NCT01885078|584079122|FG006|Treatment Period|Sponsor Decision|162|||
161737703|NCT01885078|584079123|FG007|Treatment Period|Sponsor Decision|3|||
161737704|NCT01885078|584079124|FG008|Treatment Period|Sponsor Decision|0|||
161737705|NCT01885078|584079125|FG009|Treatment Period|Sponsor Decision|0|||
161737706|NCT01885078|584079116|FG000|Treatment Period|Withdrawal by Subject|72|||
161737707|NCT01885078|584079117|FG001|Treatment Period|Withdrawal by Subject|132|||
161737708|NCT01885078|584079118|FG002|Treatment Period|Withdrawal by Subject|25|||
161737709|NCT01885078|584079119|FG003|Treatment Period|Withdrawal by Subject|63|||
161737710|NCT01885078|584079120|FG004|Treatment Period|Withdrawal by Subject|15|||
161737711|NCT01885078|584079121|FG005|Treatment Period|Withdrawal by Subject|34|||
161737712|NCT01885078|584079122|FG006|Treatment Period|Withdrawal by Subject|17|||
161737713|NCT01885078|584079123|FG007|Treatment Period|Withdrawal by Subject|10|||
161737714|NCT01885078|584079124|FG008|Treatment Period|Withdrawal by Subject|0|||
161737715|NCT01885078|584079125|FG009|Treatment Period|Withdrawal by Subject|0|||
161737716|NCT01885078|584079116|FG000|Treatment Period|Other|0|||
161737717|NCT01885078|584079117|FG001|Treatment Period|Other|0|||
161737718|NCT01885078|584079118|FG002|Treatment Period|Other|0|||
161737719|NCT01885078|584079119|FG003|Treatment Period|Other|1|||
161737720|NCT01885078|584079120|FG004|Treatment Period|Other|0|||
161737721|NCT01885078|584079121|FG005|Treatment Period|Other|0|||
161737722|NCT01885078|584079122|FG006|Treatment Period|Other|0|||
161737723|NCT01885078|584079123|FG007|Treatment Period|Other|0|||
161737724|NCT01885078|584079124|FG008|Treatment Period|Other|0|||
161737725|NCT01885078|584079125|FG009|Treatment Period|Other|0|||
161737726|NCT01885078|584079116|FG000|Step-down Period|Sponsor Decision|0|||
161737727|NCT01885078|584079117|FG001|Step-down Period|Sponsor Decision|0|||
161737728|NCT01885078|584079118|FG002|Step-down Period|Sponsor Decision|0|||
161737729|NCT01885078|584079119|FG003|Step-down Period|Sponsor Decision|0|||
161737730|NCT01885078|584079120|FG004|Step-down Period|Sponsor Decision|0|||
161737731|NCT01885078|584079121|FG005|Step-down Period|Sponsor Decision|0|||
161737732|NCT01885078|584079122|FG006|Step-down Period|Sponsor Decision|0|||
161737733|NCT01885078|584079123|FG007|Step-down Period|Sponsor Decision|0|||
161737734|NCT01885078|584079124|FG008|Step-down Period|Sponsor Decision|1|||
161737735|NCT01885078|584079125|FG009|Step-down Period|Sponsor Decision|1|||
161737736|NCT01885078|584079116|FG000|Step-down Period|Adverse Event|0|||
161737737|NCT01885078|584079117|FG001|Step-down Period|Adverse Event|0|||
161737738|NCT01885078|584079118|FG002|Step-down Period|Adverse Event|0|||
161737739|NCT01885078|584079119|FG003|Step-down Period|Adverse Event|0|||
161737740|NCT01885078|584079120|FG004|Step-down Period|Adverse Event|0|||
161737741|NCT01885078|584079121|FG005|Step-down Period|Adverse Event|0|||
161737742|NCT01885078|584079122|FG006|Step-down Period|Adverse Event|0|||
161737743|NCT01885078|584079123|FG007|Step-down Period|Adverse Event|0|||
161737744|NCT01885078|584079124|FG008|Step-down Period|Adverse Event|29|||
161737745|NCT01885078|584079125|FG009|Step-down Period|Adverse Event|38|||
161737746|NCT01885078|584079116|FG000|Step-down Period|Withdrawal by Subject|0|||
161737747|NCT01885078|584079117|FG001|Step-down Period|Withdrawal by Subject|0|||
161737748|NCT01885078|584079118|FG002|Step-down Period|Withdrawal by Subject|0|||
161737749|NCT01885078|584079119|FG003|Step-down Period|Withdrawal by Subject|0|||
161737750|NCT01885078|584079120|FG004|Step-down Period|Withdrawal by Subject|0|||
161737751|NCT01885078|584079121|FG005|Step-down Period|Withdrawal by Subject|0|||
161737752|NCT01885078|584079122|FG006|Step-down Period|Withdrawal by Subject|0|||
161737753|NCT01885078|584079123|FG007|Step-down Period|Withdrawal by Subject|0|||
161737754|NCT01885078|584079124|FG008|Step-down Period|Withdrawal by Subject|25|||
161737755|NCT01885078|584079125|FG009|Step-down Period|Withdrawal by Subject|15|||
161737756|NCT01885078|584079116|FG000|Step-down Period|Physician Decision|0|||
161737757|NCT01885078|584079117|FG001|Step-down Period|Physician Decision|0|||
161737758|NCT01885078|584079118|FG002|Step-down Period|Physician Decision|0|||
161737759|NCT01885078|584079119|FG003|Step-down Period|Physician Decision|0|||
161737760|NCT01885078|584079120|FG004|Step-down Period|Physician Decision|0|||
161737761|NCT01885078|584079121|FG005|Step-down Period|Physician Decision|0|||
161737762|NCT01885078|584079122|FG006|Step-down Period|Physician Decision|0|||
161737763|NCT01885078|584079123|FG007|Step-down Period|Physician Decision|0|||
161737764|NCT01885078|584079124|FG008|Step-down Period|Physician Decision|7|||
161737765|NCT01885078|584079125|FG009|Step-down Period|Physician Decision|2|||
161737766|NCT01885078|584079116|FG000|Step-down Period|Death|0|||
161737767|NCT01885078|584079117|FG001|Step-down Period|Death|0|||
161737768|NCT01885078|584079118|FG002|Step-down Period|Death|0|||
161737769|NCT01885078|584079119|FG003|Step-down Period|Death|0|||
161737770|NCT01885078|584079120|FG004|Step-down Period|Death|0|||
161737771|NCT01885078|584079121|FG005|Step-down Period|Death|0|||
161737772|NCT01885078|584079122|FG006|Step-down Period|Death|0|||
161737773|NCT01885078|584079123|FG007|Step-down Period|Death|0|||
161737774|NCT01885078|584079124|FG008|Step-down Period|Death|4|||
161737775|NCT01885078|584079125|FG009|Step-down Period|Death|3|||
161737776|NCT01885078|584079116|FG000|Step-down Period|Lost to Follow-up|0|||
161737777|NCT01885078|584079117|FG001|Step-down Period|Lost to Follow-up|0|||
161737778|NCT01885078|584079118|FG002|Step-down Period|Lost to Follow-up|0|||
161737779|NCT01885078|584079119|FG003|Step-down Period|Lost to Follow-up|0|||
161737780|NCT01885078|584079120|FG004|Step-down Period|Lost to Follow-up|0|||
161737781|NCT01885078|584079121|FG005|Step-down Period|Lost to Follow-up|0|||
161737782|NCT01885078|584079122|FG006|Step-down Period|Lost to Follow-up|0|||
161737783|NCT01885078|584079123|FG007|Step-down Period|Lost to Follow-up|0|||
161737784|NCT01885078|584079124|FG008|Step-down Period|Lost to Follow-up|1|||
161737785|NCT01885078|584079125|FG009|Step-down Period|Lost to Follow-up|1|||
161737786|NCT01885078|584079116|FG000|Step-down Period|Lack of Efficacy|0|||
161737787|NCT01885078|584079117|FG001|Step-down Period|Lack of Efficacy|0|||
161737788|NCT01885078|584079118|FG002|Step-down Period|Lack of Efficacy|0|||
161737789|NCT01885078|584079119|FG003|Step-down Period|Lack of Efficacy|0|||
161737790|NCT01885078|584079120|FG004|Step-down Period|Lack of Efficacy|0|||
161737791|NCT01885078|584079121|FG005|Step-down Period|Lack of Efficacy|0|||
161737792|NCT01885078|584079122|FG006|Step-down Period|Lack of Efficacy|0|||
161737793|NCT01885078|584079123|FG007|Step-down Period|Lack of Efficacy|0|||
161737794|NCT01885078|584079124|FG008|Step-down Period|Lack of Efficacy|1|||
161737795|NCT01885078|584079125|FG009|Step-down Period|Lack of Efficacy|0|||
161737796|NCT01885078|584079116|FG000|Step-down Period|Protocol Violation|0|||
161737797|NCT01885078|584079117|FG001|Step-down Period|Protocol Violation|0|||
161737798|NCT01885078|584079118|FG002|Step-down Period|Protocol Violation|0|||
161737799|NCT01885078|584079119|FG003|Step-down Period|Protocol Violation|0|||
161737800|NCT01885078|584079120|FG004|Step-down Period|Protocol Violation|0|||
161737801|NCT01885078|584079121|FG005|Step-down Period|Protocol Violation|0|||
161737802|NCT01885078|584079122|FG006|Step-down Period|Protocol Violation|0|||
161737803|NCT01885078|584079123|FG007|Step-down Period|Protocol Violation|0|||
161737804|NCT01885078|584079124|FG008|Step-down Period|Protocol Violation|1|||
161737805|NCT01885078|584079125|FG009|Step-down Period|Protocol Violation|1|||
161737806|NCT02680587|584079126|FG000|Overall Study|Withdrawal by Subject|1|||
161737807|NCT02680587|584079127|FG001|Overall Study|Withdrawal by Subject|0|||
161737808|NCT00571688|584079131|FG000|Overall Study|Lost to Follow-up|3|||
161737809|NCT00571688|584079132|FG001|Overall Study|Lost to Follow-up|6|||
161737810|NCT00571688|584079131|FG000|Overall Study|subject did not tolerate Consta|1|||
161737811|NCT00571688|584079132|FG001|Overall Study|subject did not tolerate Consta|0|||
161737812|NCT00571688|584079131|FG000|Overall Study|subject moved out of the area|1|||
161737813|NCT00571688|584079132|FG001|Overall Study|subject moved out of the area|0|||
161737814|NCT01194869|584079133|FG000|Overall Study|Disease Progression|2|||
161737815|NCT01194869|584079133|FG000|Overall Study|Toxicity|2|||
161737816|NCT00259740|584079137|FG000|Overall Study|Physician Decision|1|||
161737817|NCT00259740|584079138|FG001|Overall Study|Physician Decision|1|||
161737818|NCT00259740|584079137|FG000|Overall Study|Adverse Event|0|||
161737819|NCT00259740|584079138|FG001|Overall Study|Adverse Event|2|||
161737820|NCT00259740|584079137|FG000|Overall Study|Withdrawal by Subject|2|||
161737821|NCT00259740|584079138|FG001|Overall Study|Withdrawal by Subject|6|||
161737822|NCT00259740|584079137|FG000|Overall Study|Death|1|||
161737823|NCT00259740|584079138|FG001|Overall Study|Death|1|||
161737824|NCT00259740|584079137|FG000|Overall Study|Disease progression|19|||
161737825|NCT00259740|584079138|FG001|Overall Study|Disease progression|36|||
161737826|NCT00259740|584079137|FG000|Overall Study|Ongoing|17|||
161737827|NCT00259740|584079138|FG001|Overall Study|Ongoing|3|||
161737828|NCT00259740|584079137|FG000|Overall Study|Other|3|||
161737829|NCT00259740|584079138|FG001|Overall Study|Other|0|||
161737830|NCT00259740|584079137|FG000|Overall Study|Requirement for alternative therapy|0|||
161737831|NCT00259740|584079138|FG001|Overall Study|Requirement for alternative therapy|4|||
161737832|NCT01844830|584079143|FG000|Overall Study|Withdrawal by Subject|1|||
161737833|NCT01844830|584079144|FG001|Overall Study|Withdrawal by Subject|0|||
161737834|NCT04735393|584079148|FG000|Overall Study|Lost to Follow-up|46|||
161737835|NCT04735393|584079149|FG001|Overall Study|Lost to Follow-up|24|||
161737836|NCT04735393|584079148|FG000|Overall Study|Physician Decision|2|||
161737837|NCT04735393|584079149|FG001|Overall Study|Physician Decision|1|||
161737838|NCT04735393|584079148|FG000|Overall Study|Not Detailed|1|||
161737839|NCT04735393|584079149|FG001|Overall Study|Not Detailed|2|||
161737840|NCT04735393|584079148|FG000|Overall Study|Withdrawal by Subject|71|||
161737841|NCT04735393|584079149|FG001|Overall Study|Withdrawal by Subject|28|||
161737842|NCT04735393|584079148|FG000|Overall Study|Adverse Event|56|||
161737843|NCT04735393|584079149|FG001|Overall Study|Adverse Event|7|||
161737844|NCT04735393|584079148|FG000|Overall Study|Protocol Violation|6|||
161737845|NCT04735393|584079149|FG001|Overall Study|Protocol Violation|1|||
161737846|NCT04735393|584079148|FG000|Overall Study|Trial terminated by Sponsor|49|||
161737847|NCT04735393|584079149|FG001|Overall Study|Trial terminated by Sponsor|29|||
161737848|NCT00209170|584079150|FG000|Overall Study|Adverse Event|0|||
161737849|NCT00209170|584079151|FG001|Overall Study|Adverse Event|1|||
161737850|NCT00209170|584079150|FG000|Overall Study|Withdrawal by Subject|2|||
161737851|NCT00209170|584079151|FG001|Overall Study|Withdrawal by Subject|1|||
161737852|NCT00209170|584079150|FG000|Overall Study|Lack of Efficacy|0|||
161737853|NCT00209170|584079151|FG001|Overall Study|Lack of Efficacy|1|||
161737854|NCT03224104|584079155|FG000|Overall Study|Lack of Efficacy|2|||
161737855|NCT03224104|584079156|FG001|Overall Study|Lack of Efficacy|6|||
161737856|NCT03224104|584079157|FG002|Overall Study|Lack of Efficacy|3|||
161737857|NCT03224104|584079158|FG003|Overall Study|Lack of Efficacy|4|||
161737858|NCT03224104|584079159|FG004|Overall Study|Lack of Efficacy|42|||
161737859|NCT03224104|584079155|FG000|Overall Study|Withdrawal by Subject|0|||
161737860|NCT03224104|584079156|FG001|Overall Study|Withdrawal by Subject|2|||
161737861|NCT03224104|584079157|FG002|Overall Study|Withdrawal by Subject|0|||
161737862|NCT03224104|584079158|FG003|Overall Study|Withdrawal by Subject|1|||
161737863|NCT03224104|584079159|FG004|Overall Study|Withdrawal by Subject|3|||
161737864|NCT03224104|584079155|FG000|Overall Study|Death|0|||
161737865|NCT03224104|584079156|FG001|Overall Study|Death|1|||
161737866|NCT03224104|584079157|FG002|Overall Study|Death|0|||
161737867|NCT03224104|584079158|FG003|Overall Study|Death|0|||
161737868|NCT03224104|584079159|FG004|Overall Study|Death|0|||
161737869|NCT03224104|584079155|FG000|Overall Study|Adverse Event|1|||
161737870|NCT03224104|584079156|FG001|Overall Study|Adverse Event|0|||
161737871|NCT03224104|584079157|FG002|Overall Study|Adverse Event|0|||
161737872|NCT03224104|584079158|FG003|Overall Study|Adverse Event|1|||
161737873|NCT03224104|584079159|FG004|Overall Study|Adverse Event|3|||
161737874|NCT03224104|584079155|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
161737875|NCT03224104|584079156|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
161737876|NCT03224104|584079157|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
161737877|NCT03224104|584079158|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
161737878|NCT03224104|584079159|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
161737879|NCT03224104|584079155|FG000|Overall Study|Treatment ongoing|0|||
161737880|NCT03224104|584079156|FG001|Overall Study|Treatment ongoing|0|||
161737881|NCT03224104|584079157|FG002|Overall Study|Treatment ongoing|0|||
161737882|NCT03224104|584079158|FG003|Overall Study|Treatment ongoing|0|||
161737883|NCT03224104|584079159|FG004|Overall Study|Treatment ongoing|1|||
161737884|NCT04397718|584079160|FG000|Overall Study|Death|7|||
161737885|NCT04397718|584079161|FG001|Overall Study|Death|11|||
161737886|NCT04397718|584079160|FG000|Overall Study|Lost to Follow-up|0|||
161737887|NCT04397718|584079161|FG001|Overall Study|Lost to Follow-up|4|||
161840496|NCT00446199|584460571|FG002|Overall Study|Non-compliant with study drug|5|||
161737888|NCT06087328|584079162|FG000|28-Day Treatment|Lost to Follow-up|7|||
161737889|NCT06087328|584079163|FG001|28-Day Treatment|Lost to Follow-up|3|||
161737890|NCT06087328|584079164|FG002|28-Day Treatment|Lost to Follow-up|4|||
161737891|NCT06087328|584079162|FG000|1-month Follow-up|Lost to Follow-up|0|||
161737892|NCT06087328|584079163|FG001|1-month Follow-up|Lost to Follow-up|1|||
161737893|NCT06087328|584079164|FG002|1-month Follow-up|Lost to Follow-up|1|||
161737894|NCT01778127|584079167|FG000|Overall Study|Lost to Follow-up|5|||
161737895|NCT01778127|584079168|FG001|Overall Study|Lost to Follow-up|1|||
161737896|NCT01778127|584079169|FG002|Overall Study|Lost to Follow-up|2|||
161737897|NCT01778127|584079167|FG000|Overall Study|Withdrawal by Subject|3|||
161737898|NCT01778127|584079168|FG001|Overall Study|Withdrawal by Subject|1|||
161737899|NCT01778127|584079169|FG002|Overall Study|Withdrawal by Subject|4|||
161737900|NCT01348425|584079170|FG000|Overall Study|Imaging was not taken.|1|||
161737901|NCT01348425|584079171|FG001|Overall Study|Imaging was not taken.|1|||
161737902|NCT01968954|584079181|FG000|Overall Study|Adverse Event|6|||
161737903|NCT01968954|584079182|FG001|Overall Study|Adverse Event|3|||
161737904|NCT01968954|584079181|FG000|Overall Study|Death|1|||
161737905|NCT01968954|584079182|FG001|Overall Study|Death|2|||
161737906|NCT01968954|584079181|FG000|Overall Study|Lost to Follow-up|6|||
161737907|NCT01968954|584079182|FG001|Overall Study|Lost to Follow-up|4|||
161737908|NCT01968954|584079181|FG000|Overall Study|Withdrawal by Subject|20|||
161737909|NCT01968954|584079182|FG001|Overall Study|Withdrawal by Subject|23|||
161737910|NCT01968954|584079181|FG000|Overall Study|Other|7|||
161737911|NCT01968954|584079182|FG001|Overall Study|Other|8|||
161737912|NCT01968954|584079181|FG000|Overall Study|Protocol Violation|0|||
161737913|NCT01968954|584079182|FG001|Overall Study|Protocol Violation|1|||
161737914|NCT01968954|584079181|FG000|Overall Study|Did not met inclusion criteria|0|||
161737915|NCT01968954|584079182|FG001|Overall Study|Did not met inclusion criteria|2|||
161737916|NCT00645567|584079185|FG000|Overall Study|Adverse Event|1|||
161737917|NCT00255086|584079189|FG000|Overall Study|Adverse Event|1|||
161737918|NCT00255086|584079190|FG001|Overall Study|Adverse Event|1|||
161737919|NCT00255086|584079189|FG000|Overall Study|Protocol Violation|1|||
161737920|NCT00255086|584079190|FG001|Overall Study|Protocol Violation|1|||
161737921|NCT00434122|584079191|FG000|Overall Study|Non-compliance with protocol|0|||
161737922|NCT00434122|584079192|FG001|Overall Study|Non-compliance with protocol|1|||
161737923|NCT00434122|584079191|FG000|Overall Study|loss of subject contact|1|||
161737924|NCT00434122|584079192|FG001|Overall Study|loss of subject contact|1|||
161737925|NCT00434122|584079191|FG000|Overall Study|Personal reasons|1|||
161737926|NCT00434122|584079192|FG001|Overall Study|Personal reasons|1|||
161737927|NCT00434122|584079191|FG000|Overall Study|Large follicle size|2|||
161737928|NCT00434122|584079192|FG001|Overall Study|Large follicle size|2|||
161737929|NCT00434122|584079191|FG000|Overall Study|Low follicular response.|1|||
161737930|NCT00434122|584079192|FG001|Overall Study|Low follicular response.|2|||
161737931|NCT00434122|584079191|FG000|Overall Study|Travelling of subject.|1|||
161737932|NCT00434122|584079192|FG001|Overall Study|Travelling of subject.|0|||
161737933|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
161737934|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161737935|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
161737936|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
161737937|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161737938|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161737939|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161737940|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
161737941|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
161737942|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
161737943|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161737944|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161737945|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737946|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737947|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
161737948|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737949|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161840497|NCT00446199|584460572|FG003|Overall Study|Non-compliant with study drug|0|||
161737950|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737951|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737952|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737953|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
161737954|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
161737955|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737956|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737957|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
161737958|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
161737959|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
161737960|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
161737961|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
161737962|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
161737963|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737964|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737965|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737966|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
161737967|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737968|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737969|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737970|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737971|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737972|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
161737973|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737974|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737975|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737976|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737977|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737978|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737979|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
161737980|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
161737981|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737982|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737983|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737984|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737985|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
161737986|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
161737987|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737988|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737989|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737990|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737991|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737992|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
161737993|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737994|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737995|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737996|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737997|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737998|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
161737999|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738000|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738001|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738002|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738003|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
161738004|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
161738005|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738006|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738007|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738008|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738009|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
161738010|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
161738011|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738012|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738013|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738014|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738015|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738016|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
161738017|NCT00438399|584079199|FG000|Overall Study|Lost to Follow-up|2|||
161738018|NCT00438399|584079200|FG001|Overall Study|Lost to Follow-up|2|||
161738019|NCT00438399|584079201|FG002|Overall Study|Lost to Follow-up|1|||
161738020|NCT00438399|584079202|FG003|Overall Study|Lost to Follow-up|1|||
161840498|NCT00446199|584460569|FG000|Overall Study|Non-compliant with visit schedule|1|||
161840499|NCT00446199|584460570|FG001|Overall Study|Non-compliant with visit schedule|1|||
161840500|NCT00446199|584460571|FG002|Overall Study|Non-compliant with visit schedule|1|||
161738021|NCT00438399|584079203|FG004|Overall Study|Lost to Follow-up|1|||
161738022|NCT00438399|584079204|FG005|Overall Study|Lost to Follow-up|1|||
161738023|NCT00438399|584079199|FG000|Overall Study|Adverse Event|0|||
161738024|NCT00438399|584079200|FG001|Overall Study|Adverse Event|0|||
161738025|NCT00438399|584079201|FG002|Overall Study|Adverse Event|1|||
161738026|NCT00438399|584079202|FG003|Overall Study|Adverse Event|1|||
161738027|NCT00438399|584079203|FG004|Overall Study|Adverse Event|0|||
161738028|NCT00438399|584079204|FG005|Overall Study|Adverse Event|1|||
161738029|NCT00438399|584079199|FG000|Overall Study|Withdrawal by Subject|5|||
161738030|NCT00438399|584079200|FG001|Overall Study|Withdrawal by Subject|6|||
161738031|NCT00438399|584079201|FG002|Overall Study|Withdrawal by Subject|3|||
161738032|NCT00438399|584079202|FG003|Overall Study|Withdrawal by Subject|2|||
161738033|NCT00438399|584079203|FG004|Overall Study|Withdrawal by Subject|2|||
161738034|NCT00438399|584079204|FG005|Overall Study|Withdrawal by Subject|2|||
161738035|NCT00438399|584079199|FG000|Overall Study|Protocol Violation|0|||
161738036|NCT00438399|584079200|FG001|Overall Study|Protocol Violation|0|||
161738037|NCT00438399|584079201|FG002|Overall Study|Protocol Violation|1|||
161738038|NCT00438399|584079202|FG003|Overall Study|Protocol Violation|0|||
161738039|NCT00438399|584079203|FG004|Overall Study|Protocol Violation|0|||
161738040|NCT00438399|584079204|FG005|Overall Study|Protocol Violation|1|||
161738041|NCT00438399|584079199|FG000|Overall Study|Subje stopped study|0|||
161738042|NCT00438399|584079200|FG001|Overall Study|Subje stopped study|0|||
161738043|NCT00438399|584079201|FG002|Overall Study|Subje stopped study|1|||
161738044|NCT00438399|584079202|FG003|Overall Study|Subje stopped study|0|||
161738045|NCT00438399|584079203|FG004|Overall Study|Subje stopped study|0|||
161738046|NCT00438399|584079204|FG005|Overall Study|Subje stopped study|0|||
161738047|NCT00438399|584079199|FG000|Overall Study|Pregnancy|0|||
161738048|NCT00438399|584079200|FG001|Overall Study|Pregnancy|0|||
161738049|NCT00438399|584079201|FG002|Overall Study|Pregnancy|0|||
161738050|NCT00438399|584079202|FG003|Overall Study|Pregnancy|0|||
161738051|NCT00438399|584079203|FG004|Overall Study|Pregnancy|0|||
161738052|NCT00438399|584079204|FG005|Overall Study|Pregnancy|1|||
161738053|NCT00438399|584079199|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
161738054|NCT00438399|584079200|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
161738055|NCT00438399|584079201|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
161738056|NCT00438399|584079202|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
161738057|NCT00438399|584079203|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
161738058|NCT00438399|584079204|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
161738059|NCT03334396|584079206|FG000|Overall Study|Adverse Event|1|||
161738060|NCT03334396|584079207|FG001|Overall Study|Adverse Event|0|||
161738061|NCT03334396|584079208|FG002|Overall Study|Adverse Event|1|||
161738062|NCT03334396|584079209|FG003|Overall Study|Adverse Event|0|||
161738063|NCT03334396|584079210|FG004|Overall Study|Adverse Event|0|||
161738064|NCT03334396|584079211|FG005|Overall Study|Adverse Event|0|||
161738065|NCT03334396|584079212|FG006|Overall Study|Adverse Event|0|||
161738066|NCT03334396|584079213|FG007|Overall Study|Adverse Event|0|||
161738067|NCT03334396|584079206|FG000|Overall Study|Lack of Efficacy|10|||
161738068|NCT03334396|584079207|FG001|Overall Study|Lack of Efficacy|4|||
161738069|NCT03334396|584079208|FG002|Overall Study|Lack of Efficacy|1|||
161738070|NCT03334396|584079209|FG003|Overall Study|Lack of Efficacy|3|||
161738071|NCT03334396|584079210|FG004|Overall Study|Lack of Efficacy|1|||
161738072|NCT03334396|584079211|FG005|Overall Study|Lack of Efficacy|0|||
161738073|NCT03334396|584079212|FG006|Overall Study|Lack of Efficacy|0|||
161738074|NCT03334396|584079213|FG007|Overall Study|Lack of Efficacy|1|||
161738075|NCT03334396|584079206|FG000|Overall Study|Lost to Follow-up|0|||
161738076|NCT03334396|584079207|FG001|Overall Study|Lost to Follow-up|0|||
161738077|NCT03334396|584079208|FG002|Overall Study|Lost to Follow-up|1|||
161738078|NCT03334396|584079209|FG003|Overall Study|Lost to Follow-up|0|||
161738079|NCT03334396|584079210|FG004|Overall Study|Lost to Follow-up|0|||
161738080|NCT03334396|584079211|FG005|Overall Study|Lost to Follow-up|0|||
161738081|NCT03334396|584079212|FG006|Overall Study|Lost to Follow-up|1|||
161738082|NCT03334396|584079213|FG007|Overall Study|Lost to Follow-up|0|||
161738083|NCT03334396|584079206|FG000|Overall Study|Physician Decision|1|||
161738084|NCT03334396|584079207|FG001|Overall Study|Physician Decision|0|||
161738085|NCT03334396|584079208|FG002|Overall Study|Physician Decision|0|||
161738086|NCT03334396|584079209|FG003|Overall Study|Physician Decision|0|||
161738087|NCT03334396|584079210|FG004|Overall Study|Physician Decision|0|||
161738088|NCT03334396|584079211|FG005|Overall Study|Physician Decision|0|||
161738089|NCT03334396|584079212|FG006|Overall Study|Physician Decision|0|||
161738090|NCT03334396|584079213|FG007|Overall Study|Physician Decision|0|||
161738091|NCT03334396|584079206|FG000|Overall Study|Withdrawal by Subject|10|||
161738092|NCT03334396|584079207|FG001|Overall Study|Withdrawal by Subject|5|||
161738093|NCT03334396|584079208|FG002|Overall Study|Withdrawal by Subject|7|||
161738094|NCT03334396|584079209|FG003|Overall Study|Withdrawal by Subject|2|||
161738095|NCT03334396|584079210|FG004|Overall Study|Withdrawal by Subject|2|||
161738096|NCT03334396|584079211|FG005|Overall Study|Withdrawal by Subject|1|||
161738097|NCT03334396|584079212|FG006|Overall Study|Withdrawal by Subject|2|||
161738098|NCT03334396|584079213|FG007|Overall Study|Withdrawal by Subject|0|||
161738099|NCT03334396|584079206|FG000|Overall Study|Pregnancy|0|||
161738100|NCT03334396|584079207|FG001|Overall Study|Pregnancy|1|||
161738101|NCT03334396|584079208|FG002|Overall Study|Pregnancy|0|||
161738102|NCT03334396|584079209|FG003|Overall Study|Pregnancy|0|||
161738103|NCT03334396|584079210|FG004|Overall Study|Pregnancy|0|||
161738104|NCT03334396|584079211|FG005|Overall Study|Pregnancy|0|||
161738105|NCT03334396|584079212|FG006|Overall Study|Pregnancy|0|||
161738106|NCT03334396|584079213|FG007|Overall Study|Pregnancy|0|||
161738107|NCT03334396|584079206|FG000|Overall Study|Ineligible|0|||
161738108|NCT03334396|584079207|FG001|Overall Study|Ineligible|1|||
161738109|NCT03334396|584079208|FG002|Overall Study|Ineligible|0|||
161738110|NCT03334396|584079209|FG003|Overall Study|Ineligible|0|||
161738111|NCT03334396|584079210|FG004|Overall Study|Ineligible|0|||
161738112|NCT03334396|584079211|FG005|Overall Study|Ineligible|0|||
161738113|NCT03334396|584079212|FG006|Overall Study|Ineligible|0|||
161738114|NCT03334396|584079213|FG007|Overall Study|Ineligible|0|||
161738115|NCT03334396|584079206|FG000|Overall Study|Started New Job|1|||
161738116|NCT03334396|584079207|FG001|Overall Study|Started New Job|0|||
161738117|NCT03334396|584079208|FG002|Overall Study|Started New Job|0|||
161738118|NCT03334396|584079209|FG003|Overall Study|Started New Job|0|||
161738119|NCT03334396|584079210|FG004|Overall Study|Started New Job|0|||
161738120|NCT03334396|584079211|FG005|Overall Study|Started New Job|0|||
161738121|NCT03334396|584079212|FG006|Overall Study|Started New Job|0|||
161738122|NCT03334396|584079213|FG007|Overall Study|Started New Job|0|||
161738123|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
161738124|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161738125|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161738126|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161738127|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
161738128|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161738129|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161738130|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161738131|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
161738132|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161738133|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161738134|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161738135|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
161738136|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161738137|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161738138|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161738139|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
161738140|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161738141|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161738142|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161738143|NCT03600714|584079219|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
161738144|NCT00592553|584079221|FG000|Overall Study|Protocol Noncompliance|1|||
161738145|NCT00592553|584079222|FG001|Overall Study|Protocol Noncompliance|0|||
161738146|NCT00592553|584079223|FG002|Overall Study|Protocol Noncompliance|0|||
161738147|NCT03829332|584079224|FG000|Overall Study|Death|225|||
161738148|NCT03829332|584079225|FG001|Overall Study|Death|230|||
161738149|NCT03829332|584079224|FG000|Overall Study|Lost to Follow-up|1|||
161738150|NCT03829332|584079225|FG001|Overall Study|Lost to Follow-up|3|||
161738151|NCT03829332|584079224|FG000|Overall Study|Physician Decision|1|||
161738152|NCT03829332|584079225|FG001|Overall Study|Physician Decision|0|||
161738153|NCT03829332|584079224|FG000|Overall Study|Sponsor Decision|71|||
161738154|NCT03829332|584079225|FG001|Overall Study|Sponsor Decision|72|||
161738155|NCT03829332|584079224|FG000|Overall Study|Withdrawal by Subject|11|||
161738156|NCT03829332|584079225|FG001|Overall Study|Withdrawal by Subject|9|||
161738157|NCT01283997|584081329|FG000|Overall Study|Physician Decision|8|||
161738158|NCT01283997|584081330|FG001|Overall Study|Physician Decision|10|||
161738159|NCT01283997|584081329|FG000|Overall Study|Withdrawal by Subject|3|||
161738160|NCT01283997|584081330|FG001|Overall Study|Withdrawal by Subject|2|||
161738161|NCT01283997|584081329|FG000|Overall Study|Physically unable to continue|0|||
161738162|NCT01283997|584081330|FG001|Overall Study|Physically unable to continue|1|||
161738163|NCT01283997|584081329|FG000|Overall Study|Progressive disease|1|||
161738164|NCT01283997|584081330|FG001|Overall Study|Progressive disease|0|||
161738165|NCT01283997|584081329|FG000|Overall Study|Other|4|||
161738166|NCT01283997|584081330|FG001|Overall Study|Other|4|||
161738167|NCT02109744|584081331|FG000|Overall Study|Death|1|||
161738168|NCT02109744|584081332|FG001|Overall Study|Death|1|||
161738169|NCT02109744|584081331|FG000|Overall Study|no marrow exam|1|||
161738170|NCT02109744|584081332|FG001|Overall Study|no marrow exam|0|||
161738171|NCT04095442|584081336|FG000|Overall Study|Lost to Follow-up|0|||
161738172|NCT04095442|584081337|FG001|Overall Study|Lost to Follow-up|1|||
161738173|NCT04095442|584081336|FG000|Overall Study|Screen failure|1|||
161738174|NCT04095442|584081337|FG001|Overall Study|Screen failure|0|||
161738175|NCT00884221|584081342|FG000|Overall Study|Withdrawal by Subject|0|||
161738176|NCT00884221|584081343|FG001|Overall Study|Withdrawal by Subject|3|||
161738177|NCT00884221|584081342|FG000|Overall Study|Adverse Event|6|||
161738178|NCT00884221|584081343|FG001|Overall Study|Adverse Event|3|||
161738179|NCT00884221|584081342|FG000|Overall Study|Protocol Violation|16|||
161738180|NCT00884221|584081343|FG001|Overall Study|Protocol Violation|13|||
161738181|NCT00884221|584081342|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
161738182|NCT00884221|584081343|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
161738183|NCT00255034|584081344|FG000|Overall Study|Withdrawal by Subject|15|||
161738184|NCT00255034|584081345|FG001|Overall Study|Withdrawal by Subject|38|||
161738185|NCT00424346|584081346|FG000|Core Study|Adverse Event|5|||
161738186|NCT00424346|584081347|FG001|Core Study|Adverse Event|3|||
161738187|NCT00424346|584081348|FG002|Core Study|Adverse Event|1|||
161738188|NCT00424346|584081349|FG003|Core Study|Adverse Event|1|||
161738189|NCT00424346|584081346|FG000|Core Study|Abnormal Laboratory Values|0|||
161738190|NCT00424346|584081347|FG001|Core Study|Abnormal Laboratory Values|1|||
161738191|NCT00424346|584081348|FG002|Core Study|Abnormal Laboratory Values|0|||
161738192|NCT00424346|584081349|FG003|Core Study|Abnormal Laboratory Values|0|||
161738193|NCT00424346|584081346|FG000|Core Study|Lack of Efficacy|1|||
161738194|NCT00424346|584081347|FG001|Core Study|Lack of Efficacy|3|||
161738195|NCT00424346|584081348|FG002|Core Study|Lack of Efficacy|0|||
161738196|NCT00424346|584081349|FG003|Core Study|Lack of Efficacy|4|||
161738197|NCT00424346|584081346|FG000|Core Study|Withdrawal by Subject|1|||
161738198|NCT00424346|584081347|FG001|Core Study|Withdrawal by Subject|0|||
161738199|NCT00424346|584081348|FG002|Core Study|Withdrawal by Subject|0|||
161738200|NCT00424346|584081349|FG003|Core Study|Withdrawal by Subject|2|||
161738201|NCT00424346|584081346|FG000|Core Study|Lost to Follow-up|1|||
161738202|NCT00424346|584081347|FG001|Core Study|Lost to Follow-up|1|||
161738203|NCT00424346|584081348|FG002|Core Study|Lost to Follow-up|0|||
161738204|NCT00424346|584081349|FG003|Core Study|Lost to Follow-up|0|||
161738205|NCT00424346|584081346|FG000|Core Study|Administrative Problems|1|||
161738206|NCT00424346|584081347|FG001|Core Study|Administrative Problems|0|||
161738207|NCT00424346|584081348|FG002|Core Study|Administrative Problems|1|||
161738208|NCT00424346|584081349|FG003|Core Study|Administrative Problems|0|||
161738209|NCT00424346|584081346|FG000|Core Study|Protocol Violation|0|||
161738210|NCT00424346|584081347|FG001|Core Study|Protocol Violation|0|||
161738211|NCT00424346|584081348|FG002|Core Study|Protocol Violation|2|||
161738212|NCT00424346|584081349|FG003|Core Study|Protocol Violation|0|||
161738213|NCT00424346|584081346|FG000|Extension Phase|Adverse Event|0|||
161738214|NCT00424346|584081347|FG001|Extension Phase|Adverse Event|9|||
161738215|NCT00424346|584081348|FG002|Extension Phase|Adverse Event|5|||
161738216|NCT00424346|584081349|FG003|Extension Phase|Adverse Event|4|||
161738217|NCT00424346|584081346|FG000|Extension Phase|Lack of Efficacy|0|||
161738218|NCT00424346|584081347|FG001|Extension Phase|Lack of Efficacy|16|||
161738219|NCT00424346|584081348|FG002|Extension Phase|Lack of Efficacy|14|||
161738220|NCT00424346|584081349|FG003|Extension Phase|Lack of Efficacy|11|||
161738221|NCT00424346|584081346|FG000|Extension Phase|Withdrawal by Subject|0|||
161738222|NCT00424346|584081347|FG001|Extension Phase|Withdrawal by Subject|5|||
161738223|NCT00424346|584081348|FG002|Extension Phase|Withdrawal by Subject|3|||
161738224|NCT00424346|584081349|FG003|Extension Phase|Withdrawal by Subject|4|||
161738225|NCT00424346|584081346|FG000|Extension Phase|Lost to Follow-up|0|||
161738226|NCT00424346|584081347|FG001|Extension Phase|Lost to Follow-up|2|||
161738227|NCT00424346|584081348|FG002|Extension Phase|Lost to Follow-up|0|||
161738228|NCT00424346|584081349|FG003|Extension Phase|Lost to Follow-up|0|||
161738229|NCT00424346|584081346|FG000|Extension Phase|Administrative Problems|0|||
161738230|NCT00424346|584081347|FG001|Extension Phase|Administrative Problems|69|||
161738231|NCT00424346|584081348|FG002|Extension Phase|Administrative Problems|32|||
161738232|NCT00424346|584081349|FG003|Extension Phase|Administrative Problems|35|||
161738233|NCT00424346|584081346|FG000|Extension Phase|Death|0|||
161738234|NCT00424346|584081347|FG001|Extension Phase|Death|0|||
161738235|NCT00424346|584081348|FG002|Extension Phase|Death|0|||
161738236|NCT00424346|584081349|FG003|Extension Phase|Death|1|||
161738237|NCT00424346|584081346|FG000|Extension Phase|Protocol Violation|0|||
161738238|NCT00424346|584081347|FG001|Extension Phase|Protocol Violation|1|||
161738239|NCT00424346|584081348|FG002|Extension Phase|Protocol Violation|1|||
161738240|NCT00424346|584081349|FG003|Extension Phase|Protocol Violation|0|||
161738241|NCT00571519|584081350|FG000|Overall Study|Subject withdrew consent|0|||
161738242|NCT00571519|584081351|FG001|Overall Study|Subject withdrew consent|1|||
161738243|NCT00571519|584081352|FG002|Overall Study|Subject withdrew consent|0|||
161738244|NCT00571519|584081353|FG003|Overall Study|Subject withdrew consent|2|||
161738245|NCT00571519|584081354|FG004|Overall Study|Subject withdrew consent|1|||
161840501|NCT00446199|584460572|FG003|Overall Study|Non-compliant with visit schedule|2|||
161840502|NCT00446199|584460569|FG000|Overall Study|Hormone fear|0|||
161738246|NCT00571519|584081355|FG005|Overall Study|Subject withdrew consent|1|||
161738247|NCT00571519|584081356|FG006|Overall Study|Subject withdrew consent|2|||
161738248|NCT00571519|584081350|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161840503|NCT00446199|584460570|FG001|Overall Study|Hormone fear|0|||
161738249|NCT00571519|584081351|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738250|NCT00571519|584081352|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161738251|NCT00571519|584081353|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161738252|NCT00571519|584081354|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738253|NCT00571519|584081355|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738254|NCT00571519|584081356|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738255|NCT00571519|584081350|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738256|NCT00571519|584081351|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
161738257|NCT00571519|584081352|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738258|NCT00571519|584081353|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738259|NCT00571519|584081354|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738260|NCT00571519|584081355|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738261|NCT00571519|584081356|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738262|NCT00571519|584081350|FG000|Overall Study|Termination of study by Sponsor|2|||
161738263|NCT00571519|584081351|FG001|Overall Study|Termination of study by Sponsor|7|||
161738264|NCT00571519|584081352|FG002|Overall Study|Termination of study by Sponsor|10|||
161738265|NCT00571519|584081353|FG003|Overall Study|Termination of study by Sponsor|24|||
161738266|NCT00571519|584081354|FG004|Overall Study|Termination of study by Sponsor|8|||
161738267|NCT00571519|584081355|FG005|Overall Study|Termination of study by Sponsor|9|||
161738268|NCT00571519|584081356|FG006|Overall Study|Termination of study by Sponsor|22|||
161738269|NCT00571519|584081350|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738270|NCT00571519|584081351|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738271|NCT00571519|584081352|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
161738272|NCT00571519|584081353|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738273|NCT00571519|584081354|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738274|NCT00571519|584081355|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738275|NCT00571519|584081356|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738276|NCT03947255|584081358|FG000|Overall Study|Study Closure by Sponsor|2|||
161738277|NCT03947255|584081359|FG001|Overall Study|Study Closure by Sponsor|2|||
161738278|NCT03947255|584081358|FG000|Overall Study|Withdrawal by Subject|2|||
161738279|NCT03947255|584081359|FG001|Overall Study|Withdrawal by Subject|2|||
161738280|NCT03947255|584081358|FG000|Overall Study|Lost to Follow-up|2|||
161738281|NCT03947255|584081359|FG001|Overall Study|Lost to Follow-up|0|||
161738282|NCT03947255|584081358|FG000|Overall Study|Death|0|||
161738283|NCT03947255|584081359|FG001|Overall Study|Death|2|||
161738284|NCT02499575|584081360|FG000|Overall Study|Protocol Violation|0|||
161738285|NCT02499575|584081361|FG001|Overall Study|Protocol Violation|1|||
161738286|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Adverse Event|2|||
161738287|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Adverse Event|1|||
161738288|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Adverse Event|1|||
161738289|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
161738290|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
161738291|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
161738292|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
161738293|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
161738294|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
161738295|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
161738296|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
161738297|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
161738298|NCT05458011|584081362|FG000|OL Period (12 Weeks)|Adverse Event|1|||
161738299|NCT05458011|584081363|FG001|OL Period (12 Weeks)|Adverse Event|2|||
161738300|NCT05458011|584081364|FG002|OL Period (12 Weeks)|Adverse Event|1|||
161738301|NCT05458011|584081362|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
161738302|NCT05458011|584081363|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
161738303|NCT05458011|584081364|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
161738304|NCT02690207|584081372|FG000|Overall Study|Lost to Follow-up|48|||
161738305|NCT02690207|584081372|FG000|Overall Study|Withdrawal by Subject|46|||
161738306|NCT02690207|584081372|FG000|Overall Study|Protocol Violation|2|||
161738307|NCT02690207|584081372|FG000|Overall Study|Serious adverse event|110|||
161738308|NCT02690207|584081372|FG000|Overall Study|Non-serious Adverse Event|18|||
161738309|NCT02690207|584081372|FG000|Overall Study|Migrated/moved from study area|5|||
161738310|NCT02690207|584081372|FG000|Overall Study|Suspected HZ Episode|1|||
161738311|NCT02690207|584081372|FG000|Overall Study|Other reasons for withdrawal|23|||
161738312|NCT04656418|584081375|FG000|Overall Study|Withdrawal by Subject|1|||
161738313|NCT04656418|584081376|FG001|Overall Study|Withdrawal by Subject|3|||
161738314|NCT02586077|584081377|FG000|Overall Study|Withdrawal by Subject|1|||
161738315|NCT02586077|584081377|FG000|Overall Study|Physician Decision|4|||
161840504|NCT00446199|584460571|FG002|Overall Study|Hormone fear|0|||
161840505|NCT00446199|584460572|FG003|Overall Study|Hormone fear|1|||
161840506|NCT00446199|584460569|FG000|Overall Study|Lost interest in study participation|0|||
161840507|NCT00446199|584460570|FG001|Overall Study|Lost interest in study participation|1|||
161840508|NCT00446199|584460571|FG002|Overall Study|Lost interest in study participation|0|||
161738316|NCT02586077|584081377|FG000|Overall Study|Lost to Follow-up|3|||
161738317|NCT02701192|584081378|FG000|Overall Study|Protocol Violation|2|||
161738318|NCT02701192|584081378|FG000|Overall Study|Lost to Follow-up|4|||
161738319|NCT01245764|584081380|FG000|Study Phase A|Other|3|||
161738320|NCT01245764|584081381|FG001|Study Phase A|Other|2|||
161840509|NCT00446199|584460572|FG003|Overall Study|Lost interest in study participation|0|||
161738321|NCT01245764|584081382|FG002|Study Phase A|Other|3|||
161738322|NCT01245764|584081383|FG003|Study Phase A|Other|1|||
161738323|NCT01245764|584081380|FG000|Study Phase A|Protocol Violation|6|||
161738324|NCT01245764|584081381|FG001|Study Phase A|Protocol Violation|3|||
161738325|NCT01245764|584081382|FG002|Study Phase A|Protocol Violation|2|||
161738326|NCT01245764|584081383|FG003|Study Phase A|Protocol Violation|2|||
161738327|NCT01245764|584081380|FG000|Study Phase A|Lost to Follow-up|0|||
161738328|NCT01245764|584081381|FG001|Study Phase A|Lost to Follow-up|0|||
161738329|NCT01245764|584081382|FG002|Study Phase A|Lost to Follow-up|5|||
161738330|NCT01245764|584081383|FG003|Study Phase A|Lost to Follow-up|0|||
161738331|NCT00003476|584081384|FG000|Overall Study|Not evaluable|1|||
161738332|NCT02667457|584081387|FG000|Overall Study|Withdrawal by Subject|1|||
161738333|NCT02667457|584081388|FG001|Overall Study|Withdrawal by Subject|0|||
161738334|NCT02667457|584081387|FG000|Overall Study|Other Reason|0|||
161738335|NCT02667457|584081388|FG001|Overall Study|Other Reason|2|||
161738336|NCT02475850|584081389|FG000|Overall Study|Death|155|||
161738337|NCT02475850|584081390|FG001|Overall Study|Death|141|||
161738338|NCT02475850|584081389|FG000|Overall Study|Lost to Follow-up|217|||
161738339|NCT02475850|584081390|FG001|Overall Study|Lost to Follow-up|188|||
161738340|NCT02475850|584081389|FG000|Overall Study|Withdrawal by Subject|221|||
161738341|NCT02475850|584081390|FG001|Overall Study|Withdrawal by Subject|155|||
161738342|NCT03097614|584081392|FG000|Overall Study|Adverse Event|3|||
161738343|NCT03057951|584081398|FG000|Overall Study|Adverse Event|553|||
161738344|NCT03057951|584081399|FG001|Overall Study|Adverse Event|575|||
161738345|NCT03057951|584081398|FG000|Overall Study|Protocol Violation|30|||
161738346|NCT03057951|584081399|FG001|Overall Study|Protocol Violation|24|||
161738347|NCT03057951|584081398|FG000|Overall Study|Lost to Follow-up|6|||
161738348|NCT03057951|584081399|FG001|Overall Study|Lost to Follow-up|16|||
161738349|NCT03057951|584081398|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
161738350|NCT03057951|584081399|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
161738351|NCT03057951|584081398|FG000|Overall Study|Study drug stopped, reason missing|6|||
161738352|NCT03057951|584081399|FG001|Overall Study|Study drug stopped, reason missing|1|||
161738353|NCT03057951|584081398|FG000|Overall Study|Medical advice|6|||
161738354|NCT03057951|584081399|FG001|Overall Study|Medical advice|2|||
161738355|NCT03057951|584081398|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
161738356|NCT03057951|584081399|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
161738357|NCT03057951|584081398|FG000|Overall Study|Investigator decision|2|||
161738358|NCT03057951|584081399|FG001|Overall Study|Investigator decision|0|||
161738359|NCT03057951|584081398|FG000|Overall Study|Patient decision|5|||
161738360|NCT03057951|584081399|FG001|Overall Study|Patient decision|2|||
161738361|NCT03057951|584081398|FG000|Overall Study|Not attending study visits|3|||
161738362|NCT03057951|584081399|FG001|Overall Study|Not attending study visits|0|||
161738363|NCT03057951|584081398|FG000|Overall Study|Patient moved away|3|||
161738364|NCT03057951|584081399|FG001|Overall Study|Patient moved away|4|||
161738365|NCT03057951|584081398|FG000|Overall Study|Other reason than stated above|23|||
161738366|NCT03057951|584081399|FG001|Overall Study|Other reason than stated above|29|||
161738367|NCT03057951|584081398|FG000|Overall Study|Not treated|2|||
161738368|NCT03057951|584081399|FG001|Overall Study|Not treated|1|||
161738369|NCT02700919|584081400|FG000|Overall Study|Physician Decision|1|||
161738370|NCT02700919|584081401|FG001|Overall Study|Physician Decision|0|||
161738371|NCT02700919|584081402|FG002|Overall Study|Physician Decision|0|||
161738372|NCT02700919|584081400|FG000|Overall Study|Protocol Violation|1|||
161738373|NCT02700919|584081401|FG001|Overall Study|Protocol Violation|0|||
161738374|NCT02700919|584081402|FG002|Overall Study|Protocol Violation|0|||
161738375|NCT02700919|584081400|FG000|Overall Study|Adverse Event|1|||
161738376|NCT02700919|584081401|FG001|Overall Study|Adverse Event|3|||
161738377|NCT02700919|584081402|FG002|Overall Study|Adverse Event|1|||
161738378|NCT02700919|584081400|FG000|Overall Study|Withdrawal by Subject|5|||
161738379|NCT02700919|584081401|FG001|Overall Study|Withdrawal by Subject|8|||
161738380|NCT02700919|584081402|FG002|Overall Study|Withdrawal by Subject|2|||
161738381|NCT02700919|584081400|FG000|Overall Study|Lost to Follow-up|2|||
161738382|NCT02700919|584081401|FG001|Overall Study|Lost to Follow-up|0|||
161738383|NCT02700919|584081402|FG002|Overall Study|Lost to Follow-up|0|||
161738384|NCT02700919|584081400|FG000|Overall Study|Other|2|||
161738385|NCT02700919|584081401|FG001|Overall Study|Other|1|||
161738386|NCT02700919|584081402|FG002|Overall Study|Other|1|||
161738387|NCT03434418|584081403|FG000|Overall Study|Disease Progression|11|||
161738388|NCT03434418|584081403|FG000|Overall Study|Adverse Event|2|||
161738389|NCT03434418|584081403|FG000|Overall Study|Physician Decision|1|||
161738390|NCT03434418|584081403|FG000|Overall Study|Decline in Performance Status (PS)|1|||
161738391|NCT00696436|584081405|FG000|Overall Study|Adverse Event|7|||
161840510|NCT00446199|584460569|FG000|Overall Study|In-/Exclusion criterion violated|2|||
161840511|NCT00446199|584460570|FG001|Overall Study|In-/Exclusion criterion violated|1|||
161738392|NCT00696436|584081406|FG001|Overall Study|Adverse Event|9|||
161738393|NCT00696436|584081407|FG002|Overall Study|Adverse Event|8|||
161738394|NCT00696436|584081408|FG003|Overall Study|Adverse Event|6|||
161738395|NCT00696436|584081409|FG004|Overall Study|Adverse Event|4|||
161738396|NCT00696436|584081405|FG000|Overall Study|Protocol Violation|3|||
161738397|NCT00696436|584081406|FG001|Overall Study|Protocol Violation|2|||
161738398|NCT00696436|584081407|FG002|Overall Study|Protocol Violation|2|||
161738399|NCT00696436|584081408|FG003|Overall Study|Protocol Violation|0|||
161738400|NCT00696436|584081409|FG004|Overall Study|Protocol Violation|1|||
161738401|NCT00696436|584081405|FG000|Overall Study|Lost to Follow-up|1|||
161738402|NCT00696436|584081406|FG001|Overall Study|Lost to Follow-up|6|||
161738403|NCT00696436|584081407|FG002|Overall Study|Lost to Follow-up|2|||
161738404|NCT00696436|584081408|FG003|Overall Study|Lost to Follow-up|4|||
161738405|NCT00696436|584081409|FG004|Overall Study|Lost to Follow-up|3|||
161738406|NCT00696436|584081405|FG000|Overall Study|Withdrawal by Subject|4|||
161738407|NCT00696436|584081406|FG001|Overall Study|Withdrawal by Subject|11|||
161738408|NCT00696436|584081407|FG002|Overall Study|Withdrawal by Subject|5|||
161738409|NCT00696436|584081408|FG003|Overall Study|Withdrawal by Subject|7|||
161738410|NCT00696436|584081409|FG004|Overall Study|Withdrawal by Subject|1|||
161738411|NCT00696436|584081405|FG000|Overall Study|Lack of Efficacy|3|||
161738412|NCT00696436|584081406|FG001|Overall Study|Lack of Efficacy|1|||
161738413|NCT00696436|584081407|FG002|Overall Study|Lack of Efficacy|5|||
161738414|NCT00696436|584081408|FG003|Overall Study|Lack of Efficacy|2|||
161738415|NCT00696436|584081409|FG004|Overall Study|Lack of Efficacy|4|||
161738416|NCT00696436|584081405|FG000|Overall Study|Participant Unavailability|2|||
161738417|NCT00696436|584081406|FG001|Overall Study|Participant Unavailability|0|||
161738418|NCT00696436|584081407|FG002|Overall Study|Participant Unavailability|2|||
161738419|NCT00696436|584081408|FG003|Overall Study|Participant Unavailability|1|||
161738420|NCT00696436|584081409|FG004|Overall Study|Participant Unavailability|0|||
161738421|NCT00696436|584081405|FG000|Overall Study|Administrative Error|2|||
161738422|NCT00696436|584081406|FG001|Overall Study|Administrative Error|0|||
161738423|NCT00696436|584081407|FG002|Overall Study|Administrative Error|2|||
161738424|NCT00696436|584081408|FG003|Overall Study|Administrative Error|0|||
161738425|NCT00696436|584081409|FG004|Overall Study|Administrative Error|0|||
161738426|NCT00696436|584081405|FG000|Overall Study|Participant Non-compliance|0|||
161738427|NCT00696436|584081406|FG001|Overall Study|Participant Non-compliance|0|||
161738428|NCT00696436|584081407|FG002|Overall Study|Participant Non-compliance|1|||
161738429|NCT00696436|584081408|FG003|Overall Study|Participant Non-compliance|2|||
161738430|NCT00696436|584081409|FG004|Overall Study|Participant Non-compliance|0|||
161738431|NCT00696436|584081405|FG000|Overall Study|Administrative Decision|1|||
161738432|NCT00696436|584081406|FG001|Overall Study|Administrative Decision|0|||
161738433|NCT00696436|584081407|FG002|Overall Study|Administrative Decision|0|||
161738434|NCT00696436|584081408|FG003|Overall Study|Administrative Decision|0|||
161738435|NCT00696436|584081409|FG004|Overall Study|Administrative Decision|0|||
161738436|NCT00696436|584081405|FG000|Overall Study|Missing|0|||
161738437|NCT00696436|584081406|FG001|Overall Study|Missing|1|||
161738438|NCT00696436|584081407|FG002|Overall Study|Missing|1|||
161738439|NCT00696436|584081408|FG003|Overall Study|Missing|0|||
161738440|NCT00696436|584081409|FG004|Overall Study|Missing|0|||
161738441|NCT03039738|584081411|FG000|Overall Study|Incomplete data sets|54|||
161738442|NCT03039738|584081412|FG001|Overall Study|Incomplete data sets|0|||
161738443|NCT01293006|584081414|FG000|Period 2|Lost to Follow-up|1|||
161738444|NCT01293006|584081415|FG001|Period 2|Lost to Follow-up|0|||
161738445|NCT01293006|584081416|FG002|Period 2|Lost to Follow-up|0|||
161738446|NCT01293006|584081417|FG003|Period 2|Lost to Follow-up|0|||
161738447|NCT01494987|584081418|FG000|Overall Study|Adverse Event|6|||
161738448|NCT01494987|584081419|FG001|Overall Study|Adverse Event|5|||
161738449|NCT01494987|584081418|FG000|Overall Study|Hyperglycemia|6|||
161738450|NCT01494987|584081419|FG001|Overall Study|Hyperglycemia|4|||
161738451|NCT01494987|584081418|FG000|Overall Study|Investigator's Discretion|1|||
161738452|NCT01494987|584081419|FG001|Overall Study|Investigator's Discretion|2|||
161738453|NCT01494987|584081418|FG000|Overall Study|Lost to Follow-up|1|||
161738454|NCT01494987|584081419|FG001|Overall Study|Lost to Follow-up|1|||
161738455|NCT01494987|584081418|FG000|Overall Study|Protocol Violation|3|||
161738456|NCT01494987|584081419|FG001|Overall Study|Protocol Violation|3|||
161738457|NCT01494987|584081418|FG000|Overall Study|Subject Non-Compliance|9|||
161738458|NCT01494987|584081419|FG001|Overall Study|Subject Non-Compliance|10|||
161738459|NCT01494987|584081418|FG000|Overall Study|Subject Withdrew Consent|2|||
161738460|NCT01494987|584081419|FG001|Overall Study|Subject Withdrew Consent|3|||
161738461|NCT00600028|584081422|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161738462|NCT00600028|584081423|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161738463|NCT00600028|584081422|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
161738464|NCT00600028|584081423|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
161738465|NCT00600028|584081422|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
161738466|NCT00600028|584081423|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
161738467|NCT01830816|584081424|FG000|Overall Study|Progressive Disease|12|||
161738468|NCT01830816|584081425|FG001|Overall Study|Progressive Disease|7|||
161738469|NCT01830816|584081426|FG002|Overall Study|Progressive Disease|7|||
161738470|NCT01830816|584081424|FG000|Overall Study|Adverse Event|3|||
161738471|NCT01830816|584081425|FG001|Overall Study|Adverse Event|4|||
161738472|NCT01830816|584081426|FG002|Overall Study|Adverse Event|0|||
161738473|NCT01830816|584081424|FG000|Overall Study|Study Terminated by Sponsor|1|||
161738474|NCT01830816|584081425|FG001|Overall Study|Study Terminated by Sponsor|1|||
161738475|NCT01830816|584081426|FG002|Overall Study|Study Terminated by Sponsor|0|||
161738476|NCT01830816|584081424|FG000|Overall Study|Withdrawal by Subject|1|||
161738477|NCT01830816|584081425|FG001|Overall Study|Withdrawal by Subject|1|||
161738478|NCT01830816|584081426|FG002|Overall Study|Withdrawal by Subject|0|||
161738479|NCT01830816|584081424|FG000|Overall Study|Lost to Follow-up|0|||
161738480|NCT01830816|584081425|FG001|Overall Study|Lost to Follow-up|1|||
161738481|NCT01830816|584081426|FG002|Overall Study|Lost to Follow-up|0|||
161738482|NCT01830816|584081424|FG000|Overall Study|Symptomatic Deterioration|1|||
161738483|NCT01830816|584081425|FG001|Overall Study|Symptomatic Deterioration|0|||
161738484|NCT01830816|584081426|FG002|Overall Study|Symptomatic Deterioration|0|||
161738485|NCT01830816|584081424|FG000|Overall Study|Reason not Specified|2|||
161738486|NCT01830816|584081425|FG001|Overall Study|Reason not Specified|0|||
161738487|NCT01830816|584081426|FG002|Overall Study|Reason not Specified|0|||
161738488|NCT01586156|584081429|FG000|Overall Study|Pregnancy|0|||
161738489|NCT01586156|584081430|FG001|Overall Study|Pregnancy|1|||
161738490|NCT01586156|584081431|FG002|Overall Study|Pregnancy|0|||
161738491|NCT04465396|584081432|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
161738492|NCT04465396|584081433|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
161738493|NCT04465396|584081434|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
161738494|NCT04465396|584081435|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
161738495|NCT00349752|584081437|FG000|Overall Study|Adverse Event|8|||
161738496|NCT00349752|584081438|FG001|Overall Study|Adverse Event|12|||
161738497|NCT00349752|584081437|FG000|Overall Study|Lack of Efficacy|37|||
161738498|NCT00349752|584081438|FG001|Overall Study|Lack of Efficacy|42|||
161738499|NCT00349752|584081437|FG000|Overall Study|Lost to Follow-up|4|||
161738500|NCT00349752|584081438|FG001|Overall Study|Lost to Follow-up|2|||
161738501|NCT00349752|584081437|FG000|Overall Study|Personal reasons|6|||
161738502|NCT00349752|584081438|FG001|Overall Study|Personal reasons|5|||
161738503|NCT00349752|584081437|FG000|Overall Study|Other: Required exclusionary medication|0|||
161738504|NCT00349752|584081438|FG001|Overall Study|Other: Required exclusionary medication|1|||
161738505|NCT00349752|584081437|FG000|Overall Study|Other: Non compliance|0|||
161738506|NCT00349752|584081438|FG001|Overall Study|Other: Non compliance|1|||
161738507|NCT00349752|584081437|FG000|Overall Study|Other: Patient stopped steroids|0|||
161738508|NCT00349752|584081438|FG001|Overall Study|Other: Patient stopped steroids|1|||
161738509|NCT00349752|584081437|FG000|Overall Study|Other: Patient's steroid use|1|||
161738510|NCT00349752|584081438|FG001|Overall Study|Other: Patient's steroid use|0|||
161738511|NCT00349752|584081437|FG000|Overall Study|Other: Ineligible|1|||
161738512|NCT00349752|584081438|FG001|Overall Study|Other: Ineligible|0|||
161738513|NCT00349752|584081437|FG000|Overall Study|Other: Inadvertently unblinded|1|||
161738514|NCT00349752|584081438|FG001|Overall Study|Other: Inadvertently unblinded|0|||
161738515|NCT00349752|584081437|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
161738516|NCT00349752|584081438|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
161738517|NCT05294211|584081441|FG000|Overall Study|Withdrawal by Subject|3|||
161738518|NCT05294211|584081441|FG000|Overall Study|Physician Decision|2|||
161738519|NCT05294211|584081441|FG000|Overall Study|Progressed to active labor|1|||
161738520|NCT05294211|584081441|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
161738521|NCT05294211|584081441|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
161738522|NCT01842607|584081443|FG000|Overall Study|Adverse Event|11|||
161738523|NCT01842607|584081443|FG000|Overall Study|Lack of Efficacy|19|||
161738524|NCT01842607|584081443|FG000|Overall Study|Protocol Violation|8|||
161738525|NCT01842607|584081443|FG000|Overall Study|Protocol defined stopping criteria|2|||
161738526|NCT01842607|584081443|FG000|Overall Study|Lost to Follow-up|3|||
161738527|NCT01842607|584081443|FG000|Overall Study|Physician Decision|9|||
161738528|NCT01842607|584081443|FG000|Overall Study|Withdrawal by Subject|14|||
161738529|NCT00012012|584081444|FG000|Overall Study|Protocol Violation|1|||
161738530|NCT00012012|584081445|FG001|Overall Study|Protocol Violation|1|||
161738531|NCT00012012|584081444|FG000|Overall Study|Withdrawal by Subject|0|||
161738532|NCT00012012|584081445|FG001|Overall Study|Withdrawal by Subject|2|||
161738533|NCT02159469|584081446|FG000|Overall Study|Missing Completion status|1|||
161738534|NCT02159469|584081446|FG000|Overall Study|Adverse Event|5|||
161738535|NCT02159469|584081446|FG000|Overall Study|Non-compliance|2|||
161738536|NCT02159469|584081446|FG000|Overall Study|Withdrawal by Subject|9|||
161738537|NCT02159469|584081446|FG000|Overall Study|Lost to Follow-up|1|||
161738538|NCT02159469|584081446|FG000|Overall Study|Sponsor's request|2|||
161738539|NCT02159469|584081446|FG000|Overall Study|Met Stopping Criteria|3|||
161738540|NCT02159469|584081446|FG000|Overall Study|Other|1|||
161738541|NCT02159469|584081446|FG000|Overall Study|Multiple|29|||
161738542|NCT03629041|584081447|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161738543|NCT03629041|584081448|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
161738544|NCT03629041|584081449|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161738545|NCT03629041|584081450|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161738546|NCT03730194|584081456|FG000|First Stage Treatment|Withdrawal by Subject|1|||
161738547|NCT03730194|584081457|FG001|First Stage Treatment|Withdrawal by Subject|1|||
161738548|NCT03730194|584081458|FG002|First Stage Treatment|Withdrawal by Subject|0|||
161738549|NCT03730194|584081459|FG003|First Stage Treatment|Withdrawal by Subject|0|||
161738550|NCT03730194|584081460|FG004|First Stage Treatment|Withdrawal by Subject|0|||
161738551|NCT03730194|584081461|FG005|First Stage Treatment|Withdrawal by Subject|0|||
161738552|NCT03730194|584081456|FG000|First Stage Treatment|Protocol Violation|3|||
161738553|NCT03730194|584081457|FG001|First Stage Treatment|Protocol Violation|3|||
161738554|NCT03730194|584081458|FG002|First Stage Treatment|Protocol Violation|0|||
161738555|NCT03730194|584081459|FG003|First Stage Treatment|Protocol Violation|0|||
161738556|NCT03730194|584081460|FG004|First Stage Treatment|Protocol Violation|0|||
161738557|NCT03730194|584081461|FG005|First Stage Treatment|Protocol Violation|0|||
161738558|NCT01766817|584081464|FG000|Overall Study|Drug-related adverse event|1|||
161738559|NCT01766817|584081465|FG001|Overall Study|Drug-related adverse event|2|||
161738560|NCT01766817|584081466|FG002|Overall Study|Drug-related adverse event|1|||
161738561|NCT01766817|584081464|FG000|Overall Study|Drug-unrelated adverse event|3|||
161738562|NCT01766817|584081465|FG001|Overall Study|Drug-unrelated adverse event|3|||
161738563|NCT01766817|584081466|FG002|Overall Study|Drug-unrelated adverse event|3|||
161738564|NCT01766817|584081464|FG000|Overall Study|Death|1|||
161738565|NCT01766817|584081465|FG001|Overall Study|Death|1|||
161738566|NCT01766817|584081466|FG002|Overall Study|Death|0|||
161738567|NCT01766817|584081464|FG000|Overall Study|Unable to take study drug|0|||
161738568|NCT01766817|584081465|FG001|Overall Study|Unable to take study drug|1|||
161738569|NCT01766817|584081466|FG002|Overall Study|Unable to take study drug|0|||
161738570|NCT01766817|584081464|FG000|Overall Study|Withdrawal by Subject|2|||
161738571|NCT01766817|584081465|FG001|Overall Study|Withdrawal by Subject|0|||
161738572|NCT01766817|584081466|FG002|Overall Study|Withdrawal by Subject|3|||
161738573|NCT01766817|584081464|FG000|Overall Study|Subject non-compliance|0|||
161738574|NCT01766817|584081465|FG001|Overall Study|Subject non-compliance|1|||
161738575|NCT01766817|584081466|FG002|Overall Study|Subject non-compliance|2|||
161738576|NCT01766817|584081464|FG000|Overall Study|Physician Decision|3|||
161738577|NCT01766817|584081465|FG001|Overall Study|Physician Decision|3|||
161738578|NCT01766817|584081466|FG002|Overall Study|Physician Decision|4|||
161738579|NCT01766817|584081464|FG000|Overall Study|Other|1|||
161738580|NCT01766817|584081465|FG001|Overall Study|Other|0|||
161738581|NCT01766817|584081466|FG002|Overall Study|Other|0|||
161738582|NCT03814590|584081467|FG000|Overall Study|Adverse Event|0|||
161738583|NCT03814590|584081468|FG001|Overall Study|Adverse Event|0|||
161738584|NCT03814590|584081469|FG002|Overall Study|Adverse Event|0|||
161738585|NCT03814590|584081470|FG003|Overall Study|Adverse Event|0|||
161738586|NCT03814590|584081471|FG004|Overall Study|Adverse Event|0|||
161738587|NCT03814590|584081472|FG005|Overall Study|Adverse Event|1|||
161738588|NCT03814590|584081473|FG006|Overall Study|Adverse Event|1|||
161738589|NCT03814590|584081474|FG007|Overall Study|Adverse Event|1|||
161738590|NCT03814590|584081475|FG008|Overall Study|Adverse Event|0|||
161738591|NCT03814590|584081476|FG009|Overall Study|Adverse Event|0|||
161738592|NCT03814590|584081477|FG010|Overall Study|Adverse Event|1|||
161738593|NCT03814590|584081478|FG011|Overall Study|Adverse Event|0|||
161738594|NCT03814590|584081479|FG012|Overall Study|Adverse Event|3|||
161738595|NCT03814590|584081480|FG013|Overall Study|Adverse Event|0|||
161738596|NCT03814590|584081467|FG000|Overall Study|Lost to Follow-up|0|||
161738597|NCT03814590|584081468|FG001|Overall Study|Lost to Follow-up|2|||
161738598|NCT03814590|584081469|FG002|Overall Study|Lost to Follow-up|1|||
161738599|NCT03814590|584081470|FG003|Overall Study|Lost to Follow-up|0|||
161738600|NCT03814590|584081471|FG004|Overall Study|Lost to Follow-up|1|||
161738601|NCT03814590|584081472|FG005|Overall Study|Lost to Follow-up|1|||
161738602|NCT03814590|584081473|FG006|Overall Study|Lost to Follow-up|1|||
161738603|NCT03814590|584081474|FG007|Overall Study|Lost to Follow-up|1|||
161738604|NCT03814590|584081475|FG008|Overall Study|Lost to Follow-up|0|||
161738605|NCT03814590|584081476|FG009|Overall Study|Lost to Follow-up|0|||
161738606|NCT03814590|584081477|FG010|Overall Study|Lost to Follow-up|1|||
161738607|NCT03814590|584081478|FG011|Overall Study|Lost to Follow-up|0|||
161738608|NCT03814590|584081479|FG012|Overall Study|Lost to Follow-up|0|||
161738609|NCT03814590|584081480|FG013|Overall Study|Lost to Follow-up|1|||
161738610|NCT03814590|584081467|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738611|NCT03814590|584081468|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738612|NCT03814590|584081469|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738613|NCT03814590|584081470|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738614|NCT03814590|584081471|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738615|NCT03814590|584081472|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738616|NCT03814590|584081473|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738617|NCT03814590|584081474|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738618|NCT03814590|584081475|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738619|NCT03814590|584081476|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
161738620|NCT03814590|584081477|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738621|NCT03814590|584081478|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738622|NCT03814590|584081479|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738623|NCT03814590|584081480|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738624|NCT03814590|584081467|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738625|NCT03814590|584081468|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738626|NCT03814590|584081469|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738627|NCT03814590|584081470|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738628|NCT03814590|584081471|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738629|NCT03814590|584081472|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
161738630|NCT03814590|584081473|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161738631|NCT03814590|584081474|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
161738632|NCT03814590|584081475|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738633|NCT03814590|584081476|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
161738634|NCT03814590|584081477|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161738635|NCT03814590|584081478|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738636|NCT03814590|584081479|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161738637|NCT03814590|584081480|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
161738638|NCT03814590|584081467|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738639|NCT03814590|584081468|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738640|NCT03814590|584081469|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738641|NCT03814590|584081470|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738642|NCT03814590|584081471|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738643|NCT03814590|584081472|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738644|NCT03814590|584081473|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738645|NCT03814590|584081474|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161738646|NCT03814590|584081475|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738647|NCT03814590|584081476|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161738648|NCT03814590|584081477|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738649|NCT03814590|584081478|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738650|NCT03814590|584081479|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738651|NCT03814590|584081480|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738652|NCT03814590|584081467|FG000|Overall Study|UNKNOWN REASON|0|||
161738653|NCT03814590|584081468|FG001|Overall Study|UNKNOWN REASON|0|||
161738654|NCT03814590|584081469|FG002|Overall Study|UNKNOWN REASON|0|||
161738655|NCT03814590|584081470|FG003|Overall Study|UNKNOWN REASON|0|||
161738656|NCT03814590|584081471|FG004|Overall Study|UNKNOWN REASON|0|||
161738657|NCT03814590|584081472|FG005|Overall Study|UNKNOWN REASON|0|||
161738658|NCT03814590|584081473|FG006|Overall Study|UNKNOWN REASON|0|||
161738659|NCT03814590|584081474|FG007|Overall Study|UNKNOWN REASON|1|||
161738660|NCT03814590|584081475|FG008|Overall Study|UNKNOWN REASON|0|||
161738661|NCT03814590|584081476|FG009|Overall Study|UNKNOWN REASON|0|||
161738662|NCT03814590|584081477|FG010|Overall Study|UNKNOWN REASON|0|||
161738663|NCT03814590|584081478|FG011|Overall Study|UNKNOWN REASON|0|||
161738664|NCT03814590|584081479|FG012|Overall Study|UNKNOWN REASON|0|||
161738665|NCT03814590|584081480|FG013|Overall Study|UNKNOWN REASON|0|||
161738666|NCT03519516|584081483|FG000|Overall Study|Adverse Event|0|||
161738667|NCT03519516|584081484|FG001|Overall Study|Adverse Event|1|||
161738668|NCT01244191|584081487|FG000|Overall Study|Progressive disease|295|||
161738669|NCT01244191|584081488|FG001|Overall Study|Progressive disease|350|||
161738670|NCT01244191|584081487|FG000|Overall Study|Clinical disease progression|54|||
161738671|NCT01244191|584081488|FG001|Overall Study|Clinical disease progression|36|||
161738672|NCT01244191|584081487|FG000|Overall Study|Adverse Event|65|||
161738673|NCT01244191|584081488|FG001|Overall Study|Adverse Event|48|||
161738674|NCT01244191|584081487|FG000|Overall Study|Death|22|||
161738675|NCT01244191|584081488|FG001|Overall Study|Death|29|||
161738676|NCT01244191|584081487|FG000|Overall Study|Lost to Follow-up|0|||
161738677|NCT01244191|584081488|FG001|Overall Study|Lost to Follow-up|2|||
161738678|NCT01244191|584081487|FG000|Overall Study|Protocol Violation|1|||
161738679|NCT01244191|584081488|FG001|Overall Study|Protocol Violation|2|||
161738680|NCT01244191|584081487|FG000|Overall Study|Withdrawal by Subject|31|||
161738681|NCT01244191|584081488|FG001|Overall Study|Withdrawal by Subject|23|||
161738682|NCT01244191|584081487|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
161738683|NCT01244191|584081488|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
161738684|NCT01752842|584081489|FG000|Overall Study|Adverse Event|3|||
161738685|NCT01752842|584081490|FG001|Overall Study|Adverse Event|0|||
161738686|NCT01752842|584081489|FG000|Overall Study|Withdrawal by Subject|0|||
161738687|NCT01752842|584081490|FG001|Overall Study|Withdrawal by Subject|2|||
161738688|NCT02164513|584081491|FG000|Overall Study|Adverse Event|162|||
161738689|NCT02164513|584081492|FG001|Overall Study|Adverse Event|180|||
161738690|NCT02164513|584081493|FG002|Overall Study|Adverse Event|111|||
161738691|NCT02164513|584081491|FG000|Overall Study|Other: Study Closed or terminated|5|||
161738692|NCT02164513|584081492|FG001|Overall Study|Other: Study Closed or terminated|2|||
161738693|NCT02164513|584081493|FG002|Overall Study|Other: Study Closed or terminated|4|||
161738694|NCT02164513|584081491|FG000|Overall Study|Lost to Follow-up|30|||
161738695|NCT02164513|584081492|FG001|Overall Study|Lost to Follow-up|36|||
161738696|NCT02164513|584081493|FG002|Overall Study|Lost to Follow-up|22|||
161738697|NCT02164513|584081491|FG000|Overall Study|Physician Decision|47|||
161738698|NCT02164513|584081492|FG001|Overall Study|Physician Decision|57|||
161738699|NCT02164513|584081493|FG002|Overall Study|Physician Decision|28|||
161738700|NCT02164513|584081491|FG000|Overall Study|Withdrawal by Subject|192|||
161738701|NCT02164513|584081492|FG001|Overall Study|Withdrawal by Subject|261|||
161738702|NCT02164513|584081493|FG002|Overall Study|Withdrawal by Subject|130|||
161738703|NCT02164513|584081491|FG000|Overall Study|Other: Reason not provided by site|1|||
161738704|NCT02164513|584081492|FG001|Overall Study|Other: Reason not provided by site|0|||
161738705|NCT02164513|584081493|FG002|Overall Study|Other: Reason not provided by site|0|||
161738706|NCT05301322|584081494|FG000|Overall Study|Adverse Event|7|||
161738707|NCT05301322|584081495|FG001|Overall Study|Adverse Event|3|||
161738708|NCT05301322|584081494|FG000|Overall Study|Death|0|||
161738709|NCT05301322|584081495|FG001|Overall Study|Death|1|||
161738710|NCT05301322|584081494|FG000|Overall Study|Lost to Follow-up|2|||
161738711|NCT05301322|584081495|FG001|Overall Study|Lost to Follow-up|1|||
161738712|NCT05301322|584081494|FG000|Overall Study|Protocol Violation|3|||
161738713|NCT05301322|584081495|FG001|Overall Study|Protocol Violation|1|||
161738714|NCT05301322|584081494|FG000|Overall Study|Withdrawal by Subject|3|||
161738715|NCT05301322|584081495|FG001|Overall Study|Withdrawal by Subject|0|||
161738716|NCT05301322|584081494|FG000|Overall Study|Other|4|||
161738717|NCT05301322|584081495|FG001|Overall Study|Other|0|||
161738718|NCT04971785|584081496|FG000|Overall Study|Withdrew Consent|5|||
161738719|NCT04971785|584081497|FG001|Overall Study|Withdrew Consent|5|||
161738720|NCT04971785|584081498|FG002|Overall Study|Withdrew Consent|17|||
161738721|NCT04971785|584081499|FG003|Overall Study|Withdrew Consent|7|||
161738722|NCT04971785|584081496|FG000|Overall Study|Adverse Event|7|||
161738723|NCT04971785|584081497|FG001|Overall Study|Adverse Event|8|||
161738724|NCT04971785|584081498|FG002|Overall Study|Adverse Event|6|||
161738725|NCT04971785|584081499|FG003|Overall Study|Adverse Event|3|||
161738726|NCT04971785|584081496|FG000|Overall Study|Lost to Follow-up|2|||
161738727|NCT04971785|584081497|FG001|Overall Study|Lost to Follow-up|1|||
161738728|NCT04971785|584081498|FG002|Overall Study|Lost to Follow-up|6|||
161738729|NCT04971785|584081499|FG003|Overall Study|Lost to Follow-up|7|||
161738730|NCT04971785|584081496|FG000|Overall Study|Protocol Violation|3|||
161738731|NCT04971785|584081497|FG001|Overall Study|Protocol Violation|1|||
161738732|NCT04971785|584081498|FG002|Overall Study|Protocol Violation|1|||
161738733|NCT04971785|584081499|FG003|Overall Study|Protocol Violation|2|||
161738734|NCT04971785|584081496|FG000|Overall Study|Investigator's Discretion|3|||
161738735|NCT04971785|584081497|FG001|Overall Study|Investigator's Discretion|1|||
161738736|NCT04971785|584081498|FG002|Overall Study|Investigator's Discretion|1|||
161738737|NCT04971785|584081499|FG003|Overall Study|Investigator's Discretion|0|||
161738738|NCT04971785|584081496|FG000|Overall Study|Randomized but Never Treated|1|||
161738739|NCT04971785|584081497|FG001|Overall Study|Randomized but Never Treated|2|||
161738740|NCT04971785|584081498|FG002|Overall Study|Randomized but Never Treated|0|||
161738741|NCT04971785|584081499|FG003|Overall Study|Randomized but Never Treated|1|||
161738742|NCT04971785|584081496|FG000|Overall Study|Death|0|||
161738743|NCT04971785|584081497|FG001|Overall Study|Death|1|||
161738744|NCT04971785|584081498|FG002|Overall Study|Death|1|||
161738745|NCT04971785|584081499|FG003|Overall Study|Death|0|||
161738746|NCT04971785|584081496|FG000|Overall Study|Site Terminated by Sponsor|1|||
161738747|NCT04971785|584081497|FG001|Overall Study|Site Terminated by Sponsor|1|||
161738748|NCT04971785|584081498|FG002|Overall Study|Site Terminated by Sponsor|0|||
161738749|NCT04971785|584081499|FG003|Overall Study|Site Terminated by Sponsor|0|||
161738750|NCT00781963|584083139|FG000|Overall Study|Death|3|||
161738751|NCT00781963|584083140|FG001|Overall Study|Death|0|||
161738752|NCT00781963|584083139|FG000|Overall Study|Lost to Follow-up|2|||
161738753|NCT00781963|584083140|FG001|Overall Study|Lost to Follow-up|1|||
161738754|NCT00781963|584083139|FG000|Overall Study|Withdrawal by Subject|3|||
161738755|NCT00781963|584083140|FG001|Overall Study|Withdrawal by Subject|1|||
161738756|NCT00781963|584083139|FG000|Overall Study|Refused follow-up|9|||
161738757|NCT00781963|584083140|FG001|Overall Study|Refused follow-up|0|||
161738758|NCT03297216|584083141|FG000|Overall Study|Death|0|||
161738759|NCT03297216|584083142|FG001|Overall Study|Death|1|||
161738760|NCT03297216|584083141|FG000|Overall Study|Miscarriage|0|||
161738761|NCT03297216|584083142|FG001|Overall Study|Miscarriage|2|||
161738762|NCT03297216|584083141|FG000|Overall Study|Lost to Follow-up|3|||
161738763|NCT03297216|584083142|FG001|Overall Study|Lost to Follow-up|2|||
161738764|NCT00912340|584083151|FG000|Overall Study|Adverse Event|2|||
161738765|NCT00912340|584083152|FG001|Overall Study|Adverse Event|4|||
161738766|NCT00912340|584083153|FG002|Overall Study|Adverse Event|0|||
161738767|NCT00912340|584083151|FG000|Overall Study|Protocol revised to remove arm|0|||
161738768|NCT00912340|584083152|FG001|Overall Study|Protocol revised to remove arm|0|||
161738769|NCT00912340|584083153|FG002|Overall Study|Protocol revised to remove arm|4|||
161738770|NCT00436982|584083158|FG000|Overall Study|Withdrawal by Subject|3|||
161738771|NCT00436982|584083159|FG001|Overall Study|Withdrawal by Subject|1|||
161738772|NCT00436982|584083158|FG000|Overall Study|Did not receive allocated intervention|0|||
161738773|NCT00436982|584083159|FG001|Overall Study|Did not receive allocated intervention|1|||
161738774|NCT00436982|584083158|FG000|Overall Study|no RSA data|1|||
161738775|NCT00436982|584083159|FG001|Overall Study|no RSA data|2|||
161738776|NCT00953225|584083163|FG000|Overall Study|Withdrawal by Subject|2|||
161738777|NCT00953225|584083164|FG001|Overall Study|Withdrawal by Subject|0|||
161738778|NCT02254551|584083165|FG000|Dose Escalation|Physician Decision|1|||
161738779|NCT02254551|584083165|FG000|Dose Escalation|Dose-limiting toxicity|2|||
161738780|NCT04058158|584083166|FG000|Period 1|Death|1|||
161738781|NCT04058158|584083167|FG001|Period 1|Death|0|||
161738782|NCT04058158|584083166|FG000|Period 1|Adverse Event|1|||
161738783|NCT04058158|584083167|FG001|Period 1|Adverse Event|1|||
161738784|NCT04058158|584083166|FG000|Period 1|Pregnancy|0|||
161738785|NCT04058158|584083167|FG001|Period 1|Pregnancy|1|||
161738786|NCT02215616|584083168|FG000|Overall Study|Sponsor requested to stop study drug|0|||
161738787|NCT02215616|584083169|FG001|Overall Study|Sponsor requested to stop study drug|0|||
161738788|NCT02215616|584083170|FG002|Overall Study|Sponsor requested to stop study drug|1|||
161738789|NCT02215616|584083171|FG003|Overall Study|Sponsor requested to stop study drug|4|||
161738790|NCT02215616|584083168|FG000|Overall Study|Death|1|||
161738791|NCT02215616|584083169|FG001|Overall Study|Death|0|||
161738792|NCT02215616|584083170|FG002|Overall Study|Death|0|||
161738793|NCT02215616|584083171|FG003|Overall Study|Death|0|||
161738794|NCT02215616|584083168|FG000|Overall Study|Adverse Event|7|||
161738795|NCT02215616|584083169|FG001|Overall Study|Adverse Event|4|||
161738796|NCT02215616|584083170|FG002|Overall Study|Adverse Event|9|||
161738797|NCT02215616|584083171|FG003|Overall Study|Adverse Event|2|||
161738798|NCT02215616|584083168|FG000|Overall Study|Withdrawal by Subject|1|||
161738799|NCT02215616|584083169|FG001|Overall Study|Withdrawal by Subject|8|||
161738800|NCT02215616|584083170|FG002|Overall Study|Withdrawal by Subject|2|||
161738801|NCT02215616|584083171|FG003|Overall Study|Withdrawal by Subject|5|||
161738802|NCT02215616|584083168|FG000|Overall Study|Non-compliance|0|||
161738803|NCT02215616|584083169|FG001|Overall Study|Non-compliance|2|||
161738804|NCT02215616|584083170|FG002|Overall Study|Non-compliance|1|||
161738805|NCT02215616|584083171|FG003|Overall Study|Non-compliance|0|||
161738806|NCT02215616|584083168|FG000|Overall Study|Protocol Violation|0|||
161738807|NCT02215616|584083169|FG001|Overall Study|Protocol Violation|2|||
161738808|NCT02215616|584083170|FG002|Overall Study|Protocol Violation|0|||
161738809|NCT02215616|584083171|FG003|Overall Study|Protocol Violation|0|||
161738810|NCT02215616|584083168|FG000|Overall Study|Lost to Follow-up|1|||
161738811|NCT02215616|584083169|FG001|Overall Study|Lost to Follow-up|1|||
161738812|NCT02215616|584083170|FG002|Overall Study|Lost to Follow-up|0|||
161738813|NCT02215616|584083171|FG003|Overall Study|Lost to Follow-up|1|||
161738814|NCT02215616|584083168|FG000|Overall Study|Other than specified|1|||
161738815|NCT02215616|584083169|FG001|Overall Study|Other than specified|0|||
161738816|NCT02215616|584083170|FG002|Overall Study|Other than specified|1|||
161738817|NCT02215616|584083171|FG003|Overall Study|Other than specified|1|||
161738818|NCT01634113|584083172|FG000|Overall Study|Not treated|0|||
161738819|NCT01634113|584083173|FG001|Overall Study|Not treated|0|||
161738820|NCT01634113|584083174|FG002|Overall Study|Not treated|1|||
161840512|NCT00446199|584460571|FG002|Overall Study|In-/Exclusion criterion violated|2|||
161738821|NCT00520299|584083177|FG000|Overall Study|Withdrawal by Subject|0|||
161738822|NCT00520299|584083178|FG001|Overall Study|Withdrawal by Subject|0|||
161738823|NCT00520299|584083179|FG002|Overall Study|Withdrawal by Subject|2|||
161738824|NCT00520299|584083177|FG000|Overall Study|Progressive disease|0|||
161738825|NCT00520299|584083178|FG001|Overall Study|Progressive disease|3|||
161738826|NCT00520299|584083179|FG002|Overall Study|Progressive disease|4|||
161738827|NCT01352845|584083180|FG000|Overall Study|Lost to Follow-up|313|||
161840513|NCT00446199|584460572|FG003|Overall Study|In-/Exclusion criterion violated|1|||
161738828|NCT01352845|584083181|FG001|Overall Study|Lost to Follow-up|92|||
161840514|NCT00446199|584460569|FG000|Overall Study|Move|0|||
161840515|NCT00446199|584460570|FG001|Overall Study|Move|1|||
161840516|NCT00446199|584460571|FG002|Overall Study|Move|0|||
161738829|NCT01352845|584083180|FG000|Overall Study|No Longer Willing to Participate|205|||
161738830|NCT01352845|584083181|FG001|Overall Study|No Longer Willing to Participate|58|||
161738831|NCT01352845|584083180|FG000|Overall Study|Withdrawal by Subject|48|||
161738832|NCT01352845|584083181|FG001|Overall Study|Withdrawal by Subject|16|||
161840517|NCT00446199|584460572|FG003|Overall Study|Move|0|||
161738833|NCT01352845|584083180|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
161738834|NCT01352845|584083181|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
161738835|NCT01352845|584083180|FG000|Overall Study|Pregnancy|27|||
161738836|NCT01352845|584083181|FG001|Overall Study|Pregnancy|7|||
161738837|NCT01352845|584083180|FG000|Overall Study|Adverse Event|22|||
161738838|NCT01352845|584083181|FG001|Overall Study|Adverse Event|6|||
161738839|NCT01352845|584083180|FG000|Overall Study|Other|17|||
161738840|NCT01352845|584083181|FG001|Overall Study|Other|7|||
161738841|NCT01352845|584083180|FG000|Overall Study|Protocol Violation|12|||
161738842|NCT01352845|584083181|FG001|Overall Study|Protocol Violation|6|||
161738843|NCT01352845|584083180|FG000|Overall Study|Death|3|||
161738844|NCT01352845|584083181|FG001|Overall Study|Death|0|||
161738845|NCT02062463|584083182|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
161738846|NCT02062463|584083183|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
161738847|NCT02062463|584083184|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
161738848|NCT02062463|584083185|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
161738849|NCT02062463|584083182|FG000|Stage 2|Adverse Event|0|||
161738850|NCT02062463|584083183|FG001|Stage 2|Adverse Event|0|||
161738851|NCT02062463|584083184|FG002|Stage 2|Adverse Event|12|||
161738852|NCT02062463|584083185|FG003|Stage 2|Adverse Event|20|||
161738853|NCT02062463|584083182|FG000|Stage 2|Lack of Efficacy|0|||
161738854|NCT02062463|584083183|FG001|Stage 2|Lack of Efficacy|0|||
161738855|NCT02062463|584083184|FG002|Stage 2|Lack of Efficacy|3|||
161738856|NCT02062463|584083185|FG003|Stage 2|Lack of Efficacy|4|||
161738857|NCT02062463|584083182|FG000|Stage 2|Lost to Follow-up|0|||
161738858|NCT02062463|584083183|FG001|Stage 2|Lost to Follow-up|0|||
161738859|NCT02062463|584083184|FG002|Stage 2|Lost to Follow-up|20|||
161738860|NCT02062463|584083185|FG003|Stage 2|Lost to Follow-up|20|||
161738861|NCT02062463|584083182|FG000|Stage 2|Non-Compliance|0|||
161738862|NCT02062463|584083183|FG001|Stage 2|Non-Compliance|0|||
161738863|NCT02062463|584083184|FG002|Stage 2|Non-Compliance|0|||
161738864|NCT02062463|584083185|FG003|Stage 2|Non-Compliance|1|||
161738865|NCT02062463|584083182|FG000|Stage 2|Other than specified|0|||
161738866|NCT02062463|584083183|FG001|Stage 2|Other than specified|0|||
161738867|NCT02062463|584083184|FG002|Stage 2|Other than specified|3|||
161738868|NCT02062463|584083185|FG003|Stage 2|Other than specified|1|||
161738869|NCT02062463|584083182|FG000|Stage 2|Withdrawal by Subject|0|||
161738870|NCT02062463|584083183|FG001|Stage 2|Withdrawal by Subject|0|||
161738871|NCT02062463|584083184|FG002|Stage 2|Withdrawal by Subject|15|||
161738872|NCT02062463|584083185|FG003|Stage 2|Withdrawal by Subject|10|||
161738873|NCT01956240|584083194|FG000|Overall Study|Lost to Follow-up|6|||
161738874|NCT01956240|584083195|FG001|Overall Study|Lost to Follow-up|20|||
161738875|NCT01956240|584083194|FG000|Overall Study|Adverse Event|17|||
161738876|NCT01956240|584083195|FG001|Overall Study|Adverse Event|4|||
161738877|NCT03172481|584083199|FG000|Double-blind|Withdrawal by Subject|1|||
161738878|NCT03172481|584083200|FG001|Double-blind|Withdrawal by Subject|0|||
161738879|NCT02716194|584083201|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
161738880|NCT02716194|584083202|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
161738881|NCT02716194|584083203|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
161738882|NCT00363051|584083207|FG000|Overall Study|Adminstrative problems|1|||
161738883|NCT00363051|584083208|FG001|Overall Study|Adminstrative problems|1|||
161738884|NCT00363051|584083207|FG000|Overall Study|Adverse Event|21|||
161738885|NCT00363051|584083208|FG001|Overall Study|Adverse Event|12|||
161738886|NCT00363051|584083207|FG000|Overall Study|New Cancer Therapy|2|||
161738887|NCT00363051|584083208|FG001|Overall Study|New Cancer Therapy|1|||
161738888|NCT00363051|584083207|FG000|Overall Study|Withdrawal by Subject|11|||
161738889|NCT00363051|584083208|FG001|Overall Study|Withdrawal by Subject|3|||
161738890|NCT00363051|584083207|FG000|Overall Study|Lost to Follow-up|0|||
161738891|NCT00363051|584083208|FG001|Overall Study|Lost to Follow-up|1|||
161738892|NCT00363051|584083207|FG000|Overall Study|Protocol Violation|0|||
161738893|NCT00363051|584083208|FG001|Overall Study|Protocol Violation|2|||
161738894|NCT00363051|584083207|FG000|Overall Study|Death|3|||
161738895|NCT00363051|584083208|FG001|Overall Study|Death|2|||
161738896|NCT02759562|584083209|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
161738897|NCT02759562|584083210|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
161738898|NCT02759562|584083209|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
161738899|NCT02759562|584083210|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
161738900|NCT02293993|584083211|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
161738901|NCT02293993|584083212|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
161738902|NCT02293993|584083213|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
161738903|NCT02293993|584083214|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
161738904|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
161738905|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
161738906|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
161738907|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
161738908|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161738909|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161738910|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
161738911|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161738912|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
161738913|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
161738914|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
161738915|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
161738916|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161738917|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
161738918|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161738919|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161738920|NCT01957709|584083215|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
161738921|NCT03587584|584083216|FG000|Overall Study|SOC deviations|4|||
161738922|NCT03587584|584083217|FG001|Overall Study|SOC deviations|6|||
161738923|NCT03587584|584083216|FG000|Overall Study|Incomplete data|0|||
161738924|NCT03587584|584083217|FG001|Overall Study|Incomplete data|3|||
161738925|NCT00830115|584083218|FG000|Overall Study|Adverse Event|2|||
161738926|NCT00830115|584083218|FG000|Overall Study|Improvement/recovery|1|||
161738927|NCT01061736|584083226|FG000|Overall Study|Dose regimen not selected|0|||
161738928|NCT01061736|584083227|FG001|Overall Study|Dose regimen not selected|0|||
161738929|NCT01061736|584083228|FG002|Overall Study|Dose regimen not selected|0|||
161738930|NCT01061736|584083229|FG003|Overall Study|Dose regimen not selected|0|||
161738931|NCT01061736|584083230|FG004|Overall Study|Dose regimen not selected|0|||
161738932|NCT01061736|584083231|FG005|Overall Study|Dose regimen not selected|0|||
161738933|NCT01061736|584083232|FG006|Overall Study|Dose regimen not selected|79|||
161738934|NCT01061736|584083233|FG007|Overall Study|Dose regimen not selected|0|||
161738935|NCT01061736|584083234|FG008|Overall Study|Dose regimen not selected|0|||
161738936|NCT01061736|584083235|FG009|Overall Study|Dose regimen not selected|0|||
161738937|NCT01061736|584083226|FG000|Overall Study|Adverse Event|13|||
161738938|NCT01061736|584083227|FG001|Overall Study|Adverse Event|1|||
161738939|NCT01061736|584083228|FG002|Overall Study|Adverse Event|3|||
161738940|NCT01061736|584083229|FG003|Overall Study|Adverse Event|2|||
161738941|NCT01061736|584083230|FG004|Overall Study|Adverse Event|4|||
161738942|NCT01061736|584083231|FG005|Overall Study|Adverse Event|1|||
161738943|NCT01061736|584083232|FG006|Overall Study|Adverse Event|4|||
161738944|NCT01061736|584083233|FG007|Overall Study|Adverse Event|63|||
161738945|NCT01061736|584083234|FG008|Overall Study|Adverse Event|67|||
161738946|NCT01061736|584083235|FG009|Overall Study|Adverse Event|34|||
161738947|NCT01061736|584083226|FG000|Overall Study|Lack of Efficacy|0|||
161738948|NCT01061736|584083227|FG001|Overall Study|Lack of Efficacy|2|||
161738949|NCT01061736|584083228|FG002|Overall Study|Lack of Efficacy|1|||
161738950|NCT01061736|584083229|FG003|Overall Study|Lack of Efficacy|1|||
161738951|NCT01061736|584083230|FG004|Overall Study|Lack of Efficacy|1|||
161738952|NCT01061736|584083231|FG005|Overall Study|Lack of Efficacy|2|||
161738953|NCT01061736|584083232|FG006|Overall Study|Lack of Efficacy|1|||
161738954|NCT01061736|584083233|FG007|Overall Study|Lack of Efficacy|9|||
161738955|NCT01061736|584083234|FG008|Overall Study|Lack of Efficacy|9|||
161738956|NCT01061736|584083235|FG009|Overall Study|Lack of Efficacy|10|||
161738957|NCT01061736|584083226|FG000|Overall Study|Poor compliance to protocol|0|||
161738958|NCT01061736|584083227|FG001|Overall Study|Poor compliance to protocol|0|||
161738959|NCT01061736|584083228|FG002|Overall Study|Poor compliance to protocol|0|||
161738960|NCT01061736|584083229|FG003|Overall Study|Poor compliance to protocol|0|||
161738961|NCT01061736|584083230|FG004|Overall Study|Poor compliance to protocol|0|||
161738962|NCT01061736|584083231|FG005|Overall Study|Poor compliance to protocol|0|||
161738963|NCT01061736|584083232|FG006|Overall Study|Poor compliance to protocol|0|||
161738964|NCT01061736|584083233|FG007|Overall Study|Poor compliance to protocol|2|||
161738965|NCT01061736|584083234|FG008|Overall Study|Poor compliance to protocol|5|||
161738966|NCT01061736|584083235|FG009|Overall Study|Poor compliance to protocol|9|||
161738967|NCT01061736|584083226|FG000|Overall Study|Not treated|0|||
161738968|NCT01061736|584083227|FG001|Overall Study|Not treated|0|||
161738969|NCT01061736|584083228|FG002|Overall Study|Not treated|0|||
161738970|NCT01061736|584083229|FG003|Overall Study|Not treated|0|||
161738971|NCT01061736|584083230|FG004|Overall Study|Not treated|1|||
161738972|NCT01061736|584083231|FG005|Overall Study|Not treated|0|||
161738973|NCT01061736|584083232|FG006|Overall Study|Not treated|0|||
161738974|NCT01061736|584083233|FG007|Overall Study|Not treated|2|||
161738975|NCT01061736|584083234|FG008|Overall Study|Not treated|1|||
161738976|NCT01061736|584083235|FG009|Overall Study|Not treated|0|||
161738977|NCT01061736|584083226|FG000|Overall Study|Other than specified above|0|||
161738978|NCT01061736|584083227|FG001|Overall Study|Other than specified above|1|||
161738979|NCT01061736|584083228|FG002|Overall Study|Other than specified above|2|||
161738980|NCT01061736|584083229|FG003|Overall Study|Other than specified above|0|||
161738981|NCT01061736|584083230|FG004|Overall Study|Other than specified above|1|||
161738982|NCT01061736|584083231|FG005|Overall Study|Other than specified above|0|||
161738983|NCT01061736|584083232|FG006|Overall Study|Other than specified above|0|||
161738984|NCT01061736|584083233|FG007|Overall Study|Other than specified above|18|||
161738985|NCT01061736|584083234|FG008|Overall Study|Other than specified above|15|||
161738986|NCT01061736|584083235|FG009|Overall Study|Other than specified above|21|||
161738987|NCT01925612|584083236|FG000|Overall Study|Progressive Disease|1|||
161738988|NCT01925612|584083237|FG001|Overall Study|Progressive Disease|1|||
161738989|NCT01925612|584083238|FG002|Overall Study|Progressive Disease|1|||
161738990|NCT01925612|584083239|FG003|Overall Study|Progressive Disease|0|||
161738991|NCT01925612|584083240|FG004|Overall Study|Progressive Disease|0|||
161738992|NCT01925612|584083236|FG000|Overall Study|Adverse Event|3|||
161738993|NCT01925612|584083237|FG001|Overall Study|Adverse Event|3|||
161738994|NCT01925612|584083238|FG002|Overall Study|Adverse Event|0|||
161738995|NCT01925612|584083239|FG003|Overall Study|Adverse Event|1|||
161738996|NCT01925612|584083240|FG004|Overall Study|Adverse Event|2|||
161738997|NCT01107405|584083245|FG000|Overall Study|Adverse Event|1|||
161738998|NCT01107405|584083246|FG001|Overall Study|Adverse Event|1|||
161738999|NCT01107405|584083247|FG002|Overall Study|Adverse Event|0|||
161739000|NCT01107405|584083248|FG003|Overall Study|Adverse Event|0|||
161739001|NCT01107405|584083249|FG004|Overall Study|Adverse Event|2|||
161739002|NCT01107405|584083245|FG000|Overall Study|Withdrawal by Subject|1|||
161739003|NCT01107405|584083246|FG001|Overall Study|Withdrawal by Subject|0|||
161739004|NCT01107405|584083247|FG002|Overall Study|Withdrawal by Subject|1|||
161739005|NCT01107405|584083248|FG003|Overall Study|Withdrawal by Subject|2|||
161739006|NCT01107405|584083249|FG004|Overall Study|Withdrawal by Subject|1|||
161739007|NCT01107405|584083245|FG000|Overall Study|Protocol Violation|0|||
161739008|NCT01107405|584083246|FG001|Overall Study|Protocol Violation|0|||
161739009|NCT01107405|584083247|FG002|Overall Study|Protocol Violation|1|||
161739010|NCT01107405|584083248|FG003|Overall Study|Protocol Violation|1|||
161739011|NCT01107405|584083249|FG004|Overall Study|Protocol Violation|0|||
161739012|NCT01895452|584083256|FG000|Overall Study|Adverse Event|1|||
161739013|NCT01895452|584083257|FG001|Overall Study|Adverse Event|4|||
161739014|NCT01895452|584083256|FG000|Overall Study|Lost to Follow-up|1|||
161739015|NCT01895452|584083257|FG001|Overall Study|Lost to Follow-up|5|||
161739016|NCT01895452|584083256|FG000|Overall Study|Pregnancy|0|||
161739017|NCT01895452|584083257|FG001|Overall Study|Pregnancy|1|||
161739018|NCT01895452|584083256|FG000|Overall Study|Withdrawal by Subject|2|||
161739019|NCT01895452|584083257|FG001|Overall Study|Withdrawal by Subject|14|||
161739020|NCT01895452|584083256|FG000|Overall Study|Underlying disease|0|||
161739021|NCT01895452|584083257|FG001|Overall Study|Underlying disease|3|||
161739022|NCT01895452|584083256|FG000|Overall Study|Noncompliance with study drug|0|||
161739023|NCT01895452|584083257|FG001|Overall Study|Noncompliance with study drug|1|||
161739024|NCT01653158|584083258|FG000|Overall Study|Death|0|||
161739025|NCT01653158|584083259|FG001|Overall Study|Death|0|||
161739026|NCT01653158|584083260|FG002|Overall Study|Death|0|||
161739027|NCT01653158|584083261|FG003|Overall Study|Death|1|||
161739028|NCT01653158|584083262|FG004|Overall Study|Death|0|||
161739029|NCT01653158|584083263|FG005|Overall Study|Death|0|||
161739030|NCT01653158|584083264|FG006|Overall Study|Death|0|||
161739031|NCT01653158|584083265|FG007|Overall Study|Death|2|||
161739032|NCT01653158|584083258|FG000|Overall Study|Adverse Event|0|||
161739033|NCT01653158|584083259|FG001|Overall Study|Adverse Event|0|||
161739034|NCT01653158|584083260|FG002|Overall Study|Adverse Event|0|||
161739035|NCT01653158|584083261|FG003|Overall Study|Adverse Event|1|||
161739036|NCT01653158|584083262|FG004|Overall Study|Adverse Event|0|||
161739037|NCT01653158|584083263|FG005|Overall Study|Adverse Event|0|||
161739038|NCT01653158|584083264|FG006|Overall Study|Adverse Event|0|||
161739039|NCT01653158|584083265|FG007|Overall Study|Adverse Event|3|||
161739040|NCT01653158|584083258|FG000|Overall Study|Other|0|||
161739041|NCT01653158|584083259|FG001|Overall Study|Other|0|||
161739042|NCT01653158|584083260|FG002|Overall Study|Other|0|||
161739043|NCT01653158|584083261|FG003|Overall Study|Other|0|||
161739044|NCT01653158|584083262|FG004|Overall Study|Other|0|||
161739045|NCT01653158|584083263|FG005|Overall Study|Other|0|||
161739046|NCT01653158|584083264|FG006|Overall Study|Other|0|||
161739047|NCT01653158|584083265|FG007|Overall Study|Other|1|||
161739048|NCT01653158|584083258|FG000|Overall Study|Progressive disease|0|||
161739049|NCT01653158|584083259|FG001|Overall Study|Progressive disease|0|||
161739050|NCT01653158|584083260|FG002|Overall Study|Progressive disease|0|||
161739051|NCT01653158|584083261|FG003|Overall Study|Progressive disease|0|||
161739052|NCT01653158|584083262|FG004|Overall Study|Progressive disease|1|||
161739053|NCT01653158|584083263|FG005|Overall Study|Progressive disease|1|||
161739054|NCT01653158|584083264|FG006|Overall Study|Progressive disease|2|||
161739055|NCT01653158|584083265|FG007|Overall Study|Progressive disease|9|||
161739056|NCT01653158|584083258|FG000|Overall Study|Withdrawal by Subject|1|||
161739057|NCT01653158|584083259|FG001|Overall Study|Withdrawal by Subject|0|||
161739058|NCT01653158|584083260|FG002|Overall Study|Withdrawal by Subject|0|||
161739059|NCT01653158|584083261|FG003|Overall Study|Withdrawal by Subject|0|||
161739060|NCT01653158|584083262|FG004|Overall Study|Withdrawal by Subject|0|||
161739061|NCT01653158|584083263|FG005|Overall Study|Withdrawal by Subject|0|||
161739062|NCT01653158|584083264|FG006|Overall Study|Withdrawal by Subject|0|||
161739063|NCT01653158|584083265|FG007|Overall Study|Withdrawal by Subject|0|||
161739064|NCT00980343|584083266|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
161739065|NCT00980343|584083267|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
161739066|NCT01188538|584083274|FG000|Overall Study|Lost to Follow-up|0|||
161739067|NCT01188538|584083275|FG001|Overall Study|Lost to Follow-up|1|||
161739068|NCT01170702|584083278|FG000|Overall Study|Exclusion criteria met after consent|1|||
161739069|NCT01170702|584083279|FG001|Overall Study|Exclusion criteria met after consent|2|||
161739070|NCT01170702|584083280|FG002|Overall Study|Exclusion criteria met after consent|0|||
161739071|NCT01170702|584083281|FG003|Overall Study|Exclusion criteria met after consent|2|||
161739072|NCT01677507|584083282|FG000|Initial Assignment|Adverse Event|0|||
161739073|NCT01677507|584083283|FG001|Initial Assignment|Adverse Event|1|||
161739074|NCT01677507|584083282|FG000|Initial Assignment|Protocol Violation|0|||
161739075|NCT01677507|584083283|FG001|Initial Assignment|Protocol Violation|1|||
161739076|NCT01677507|584083282|FG000|Second Assigment|Withdrawal by Subject|2|||
161739077|NCT01677507|584083283|FG001|Second Assigment|Withdrawal by Subject|2|||
161739078|NCT01677507|584083282|FG000|Second Assigment|Adverse Event|1|||
161739079|NCT01677507|584083283|FG001|Second Assigment|Adverse Event|3|||
161739080|NCT00469209|584083284|FG000|Overall Study|Adverse Event|1|||
161739081|NCT00469209|584083285|FG001|Overall Study|Adverse Event|0|||
161739082|NCT00469209|584083286|FG002|Overall Study|Adverse Event|1|||
161739083|NCT04999969|584083289|FG000|Overall Study|Death|76|||
161739084|NCT04999969|584083289|FG000|Overall Study|Progressive Disease|1|||
161739085|NCT04999969|584083289|FG000|Overall Study|Withdrawal by Subject|8|||
161739086|NCT06964165|584083291|FG000|Overall Study|Death|4|||
161739087|NCT06964165|584083292|FG001|Overall Study|Death|4|||
161739088|NCT06964165|584083291|FG000|Overall Study|Physician Decision|1|||
161739089|NCT06964165|584083292|FG001|Overall Study|Physician Decision|1|||
161739090|NCT06964165|584083291|FG000|Overall Study|Withdrawal by Subject|0|||
161739091|NCT06964165|584083292|FG001|Overall Study|Withdrawal by Subject|2|||
161739092|NCT06964165|584083291|FG000|Overall Study|Study terminated by sponsor|12|||
161739093|NCT06964165|584083292|FG001|Overall Study|Study terminated by sponsor|10|||
161739094|NCT06964165|584083291|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
161739095|NCT06964165|584083292|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
161739096|NCT06964165|584083291|FG000|Overall Study|Participant removed due to non-compliance|0|||
161739097|NCT06964165|584083292|FG001|Overall Study|Participant removed due to non-compliance|1|||
161739098|NCT00085917|584083293|FG000|Overall Study|Adverse Event|4|||
161739099|NCT00085917|584083294|FG001|Overall Study|Adverse Event|3|||
161739100|NCT01464788|584083295|FG000|Overall Study|Lost to Follow-up|0|||
161739101|NCT01464788|584083296|FG001|Overall Study|Lost to Follow-up|1|||
161739102|NCT01464788|584083297|FG002|Overall Study|Lost to Follow-up|0|||
161739103|NCT01464788|584083295|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
161739104|NCT01464788|584083296|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
161739105|NCT01464788|584083297|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
161739106|NCT01551758|584083298|FG000|Overall Study|Adverse Event|29|||
161739107|NCT01551758|584083299|FG001|Overall Study|Adverse Event|43|||
161739108|NCT01551758|584083298|FG000|Overall Study|Lack of Efficacy|0|||
161739109|NCT01551758|584083299|FG001|Overall Study|Lack of Efficacy|1|||
161739110|NCT01551758|584083298|FG000|Overall Study|Protocol Violation|5|||
161739111|NCT01551758|584083299|FG001|Overall Study|Protocol Violation|6|||
161739112|NCT01551758|584083298|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
161739113|NCT01551758|584083299|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
161739114|NCT01551758|584083298|FG000|Overall Study|Lost to Follow-up|29|||
161739115|NCT01551758|584083299|FG001|Overall Study|Lost to Follow-up|25|||
161739116|NCT01551758|584083298|FG000|Overall Study|Physician Decision|9|||
161739117|NCT01551758|584083299|FG001|Overall Study|Physician Decision|3|||
161739118|NCT01551758|584083298|FG000|Overall Study|Withdrawal by Subject|14|||
161739119|NCT01551758|584083299|FG001|Overall Study|Withdrawal by Subject|17|||
161739120|NCT00125190|584083301|FG000|Overall Study|Subject/Parent Decision|7|||
161739121|NCT00125190|584083301|FG000|Overall Study|Non-compliance|2|||
161739122|NCT00125190|584083301|FG000|Overall Study|Adverse Event|1|||
161739123|NCT00125190|584083301|FG000|Overall Study|Other|1|||
161739124|NCT00125190|584083301|FG000|Overall Study|Lost to Follow-up|4|||
161739125|NCT05584202|584083305|FG000|Overall Study|Withdrawal of Consent|3|||
161739126|NCT05584202|584083306|FG001|Overall Study|Withdrawal of Consent|2|||
161739127|NCT05584202|584083305|FG000|Overall Study|Lost to Follow-up|2|||
161739128|NCT05584202|584083306|FG001|Overall Study|Lost to Follow-up|1|||
161739129|NCT05584202|584083305|FG000|Overall Study|Death|0|||
161739130|NCT05584202|584083306|FG001|Overall Study|Death|1|||
161739131|NCT00646113|584084643|FG000|Overall Study|Lost to Follow-up|5|||
161739132|NCT00646113|584084643|FG000|Overall Study|Adverse Event|3|||
161739133|NCT00603733|584084646|FG000|Active Phase ITT|Adverse Event|8|||
161739134|NCT00603733|584084647|FG001|Active Phase ITT|Adverse Event|7|||
161739135|NCT00603733|584084646|FG000|Active Phase ITT|Withdrawal by Subject|0|||
161739136|NCT00603733|584084647|FG001|Active Phase ITT|Withdrawal by Subject|3|||
161739137|NCT00603733|584084646|FG000|Active Phase ITT|Lost to Follow-up|0|||
161739138|NCT00603733|584084647|FG001|Active Phase ITT|Lost to Follow-up|1|||
161739139|NCT00603733|584084646|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
161739140|NCT00603733|584084647|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
161739141|NCT00603733|584084646|FG000|Active Phase ITT|Lack of Efficacy|1|||
161739142|NCT00603733|584084647|FG001|Active Phase ITT|Lack of Efficacy|2|||
161739143|NCT00603733|584084646|FG000|Active Phase ITT|Subject moved, site closed|1|||
161739144|NCT00603733|584084647|FG001|Active Phase ITT|Subject moved, site closed|1|||
161739145|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
161739146|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
161739147|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
161739148|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
161739149|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
161739150|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
161739151|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
161739152|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
161739153|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
161739154|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
161739155|NCT00603733|584084646|FG000|Maintenance Phase ITT|Adverse Event|3|||
161739156|NCT00603733|584084647|FG001|Maintenance Phase ITT|Adverse Event|6|||
161739157|NCT00603733|584084646|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
161739158|NCT00603733|584084647|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
161739159|NCT00603733|584084646|FG000|Maintenance Phase ITT|Protocol Violation|1|||
161739160|NCT00603733|584084647|FG001|Maintenance Phase ITT|Protocol Violation|1|||
161739161|NCT00603733|584084646|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
161739162|NCT00603733|584084647|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
161739163|NCT00603733|584084646|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
161739164|NCT00603733|584084647|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
161739165|NCT00603733|584084646|FG000|Maintenance Phase ITT|Physician Decision|0|||
161739166|NCT00603733|584084647|FG001|Maintenance Phase ITT|Physician Decision|1|||
161739167|NCT00603733|584084646|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
161739168|NCT00603733|584084647|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
161739169|NCT01093755|584084648|FG000|Overall Study|Withdrawal by Subject|3|||
161739170|NCT01093755|584084649|FG001|Overall Study|Withdrawal by Subject|4|||
161739171|NCT03115112|584084650|FG000|Overall Study|Adverse Event|5|||
161739172|NCT03115112|584084651|FG001|Overall Study|Adverse Event|1|||
161739173|NCT03115112|584084650|FG000|Overall Study|Withdrawal by Subject|4|||
161739174|NCT03115112|584084651|FG001|Overall Study|Withdrawal by Subject|2|||
161739175|NCT03115112|584084650|FG000|Overall Study|Lost to Follow-up|0|||
161739176|NCT03115112|584084651|FG001|Overall Study|Lost to Follow-up|1|||
161739177|NCT03115112|584084650|FG000|Overall Study|Death|1|||
161739178|NCT03115112|584084651|FG001|Overall Study|Death|0|||
161739179|NCT03115112|584084650|FG000|Overall Study|Pregnancy|1|||
161739180|NCT03115112|584084651|FG001|Overall Study|Pregnancy|0|||
161739181|NCT03115112|584084650|FG000|Overall Study|Site closure|1|||
161739182|NCT03115112|584084651|FG001|Overall Study|Site closure|1|||
161739183|NCT01610076|584084652|FG000|Overall Study|Technical issue with video|0|||
161739184|NCT01610076|584084653|FG001|Overall Study|Technical issue with video|1|||
161739185|NCT01610076|584084652|FG000|Overall Study|Lost to Follow-up|3|||
161739186|NCT01610076|584084653|FG001|Overall Study|Lost to Follow-up|4|||
161739187|NCT02168803|584084654|FG000|Overall Study|Lost to Follow-up|1|||
161739188|NCT02168803|584084655|FG001|Overall Study|Lost to Follow-up|0|||
161739189|NCT02168803|584084656|FG002|Overall Study|Lost to Follow-up|1|||
161840518|NCT01079832|584460573|FG000|Overall Study|Withdrawal by Subject|1|||
161840519|NCT00290251|584460574|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161840520|NCT00290251|584460575|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739190|NCT02168803|584084654|FG000|Overall Study|Withdrawal by Subject|1|||
161739191|NCT02168803|584084655|FG001|Overall Study|Withdrawal by Subject|1|||
161840521|NCT00290251|584460576|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739192|NCT02168803|584084656|FG002|Overall Study|Withdrawal by Subject|2|||
161739193|NCT02168803|584084654|FG000|Overall Study|Physician Decision|0|||
161739194|NCT02168803|584084655|FG001|Overall Study|Physician Decision|1|||
161840522|NCT00290251|584460577|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739195|NCT02168803|584084656|FG002|Overall Study|Physician Decision|0|||
161739196|NCT02168803|584084654|FG000|Overall Study|Adverse Event|0|||
161840523|NCT00290251|584460578|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739197|NCT02168803|584084655|FG001|Overall Study|Adverse Event|1|||
161739198|NCT02168803|584084656|FG002|Overall Study|Adverse Event|1|||
161739199|NCT02168803|584084654|FG000|Overall Study|Death|0|||
161739200|NCT02168803|584084655|FG001|Overall Study|Death|0|||
161739201|NCT02168803|584084656|FG002|Overall Study|Death|1|||
161739202|NCT02168803|584084654|FG000|Overall Study|Sponsor Decision|0|||
161739203|NCT02168803|584084655|FG001|Overall Study|Sponsor Decision|0|||
161739204|NCT02168803|584084656|FG002|Overall Study|Sponsor Decision|1|||
161739205|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161739206|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161739207|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161739208|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
161739209|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
161739210|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
161739211|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
161739212|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
161739213|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161739214|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161739215|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161739216|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
161739217|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161739218|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161739219|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161739220|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
161739221|NCT00433446|584084671|FG000|Overall Study|Adverse Event|4|||
161739222|NCT00433446|584084671|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161739223|NCT00433446|584084671|FG000|Overall Study|Progression|44|||
161739224|NCT00433446|584084671|FG000|Overall Study|Other - Not Protocol specified|3|||
161739225|NCT00433446|584084671|FG000|Overall Study|Ineligible|9|||
161739226|NCT02899377|584084672|FG000|Overall Study|Adverse Event|1|||
161739227|NCT02899377|584084673|FG001|Overall Study|Adverse Event|0|||
161739228|NCT01231607|584084677|FG000|Overall Study|Adverse Event|0|||
161739229|NCT01231607|584084678|FG001|Overall Study|Adverse Event|8|||
161739230|NCT01231607|584084679|FG002|Overall Study|Adverse Event|4|||
161739231|NCT01231607|584084680|FG003|Overall Study|Adverse Event|4|||
161739232|NCT01231607|584084681|FG004|Overall Study|Adverse Event|5|||
161739233|NCT01231607|584084677|FG000|Overall Study|Lost to Follow-up|13|||
161739234|NCT01231607|584084678|FG001|Overall Study|Lost to Follow-up|11|||
161739235|NCT01231607|584084679|FG002|Overall Study|Lost to Follow-up|10|||
161739236|NCT01231607|584084680|FG003|Overall Study|Lost to Follow-up|10|||
161739237|NCT01231607|584084681|FG004|Overall Study|Lost to Follow-up|4|||
161739238|NCT01231607|584084677|FG000|Overall Study|Physician Decision|4|||
161739239|NCT01231607|584084678|FG001|Overall Study|Physician Decision|4|||
161739240|NCT01231607|584084679|FG002|Overall Study|Physician Decision|3|||
161739241|NCT01231607|584084680|FG003|Overall Study|Physician Decision|5|||
161739242|NCT01231607|584084681|FG004|Overall Study|Physician Decision|4|||
161739243|NCT01231607|584084677|FG000|Overall Study|Protocol Violation|3|||
161739244|NCT01231607|584084678|FG001|Overall Study|Protocol Violation|2|||
161739245|NCT01231607|584084679|FG002|Overall Study|Protocol Violation|0|||
161739246|NCT01231607|584084680|FG003|Overall Study|Protocol Violation|2|||
161739247|NCT01231607|584084681|FG004|Overall Study|Protocol Violation|2|||
161739248|NCT01231607|584084677|FG000|Overall Study|Withdrawal by Subject|9|||
161739249|NCT01231607|584084678|FG001|Overall Study|Withdrawal by Subject|9|||
161739250|NCT01231607|584084679|FG002|Overall Study|Withdrawal by Subject|14|||
161739251|NCT01231607|584084680|FG003|Overall Study|Withdrawal by Subject|17|||
161739252|NCT01231607|584084681|FG004|Overall Study|Withdrawal by Subject|9|||
161739253|NCT03779334|584084685|FG000|Overall Study|Withdrawal by Subject|3|||
161739254|NCT03779334|584084686|FG001|Overall Study|Withdrawal by Subject|0|||
161739255|NCT03779334|584084687|FG002|Overall Study|Withdrawal by Subject|0|||
161739256|NCT03779334|584084685|FG000|Overall Study|Ongoing in Study|5|||
161739257|NCT03779334|584084686|FG001|Overall Study|Ongoing in Study|13|||
161739258|NCT03779334|584084687|FG002|Overall Study|Ongoing in Study|5|||
161739259|NCT04321252|584084694|FG000|Overall Study|Withdrawal by Subject|0|||
161739260|NCT04321252|584084695|FG001|Overall Study|Withdrawal by Subject|0|||
161739261|NCT04321252|584084696|FG002|Overall Study|Withdrawal by Subject|0|||
161739262|NCT04321252|584084697|FG003|Overall Study|Withdrawal by Subject|0|||
161739263|NCT04321252|584084698|FG004|Overall Study|Withdrawal by Subject|0|||
161739264|NCT04321252|584084699|FG005|Overall Study|Withdrawal by Subject|1|||
161739265|NCT04321252|584084700|FG006|Overall Study|Withdrawal by Subject|0|||
161739266|NCT04321252|584084701|FG007|Overall Study|Withdrawal by Subject|0|||
161739267|NCT04321252|584084702|FG008|Overall Study|Withdrawal by Subject|0|||
161739268|NCT06245044|584084703|FG000|No MI help|Technical issues|18|||
161739269|NCT01082367|584084706|FG000|Double-blind Period|Administrative problems|0|||
161739270|NCT01082367|584084707|FG001|Double-blind Period|Administrative problems|1|||
161739271|NCT01082367|584084706|FG000|Double-blind Period|Lack of Efficacy|5|||
161739272|NCT01082367|584084707|FG001|Double-blind Period|Lack of Efficacy|11|||
161739273|NCT01082367|584084706|FG000|Double-blind Period|Adverse Event|0|||
161739274|NCT01082367|584084707|FG001|Double-blind Period|Adverse Event|1|||
161739275|NCT01082367|584084706|FG000|Follow-up (F-U) Period|Administrative problems|1|||
161739276|NCT01082367|584084707|FG001|Follow-up (F-U) Period|Administrative problems|0|||
161739277|NCT01082367|584084706|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
161739278|NCT01082367|584084707|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
161739279|NCT01082367|584084706|FG000|Follow-up (F-U) Period|Adverse Event|0|||
161739280|NCT01082367|584084707|FG001|Follow-up (F-U) Period|Adverse Event|1|||
161739281|NCT00098020|584084710|FG000|Overall Study|Adverse Event|2|||
161739282|NCT00098020|584084710|FG000|Overall Study|Lost to Follow-up|1|||
161739283|NCT00098020|584084710|FG000|Overall Study|elevated liver enzymes|1|||
161739284|NCT00098020|584084710|FG000|Overall Study|Low urine PCR|1|||
161739285|NCT00098020|584084710|FG000|Overall Study|Low epidermal growth factor receptor|1|||
161739286|NCT00865189|584084717|FG000|Overall Study|Other|1|||
161739287|NCT00865189|584084718|FG001|Overall Study|Other|2|||
161739288|NCT00865189|584084717|FG000|Overall Study|Death|4|||
161739289|NCT00865189|584084718|FG001|Overall Study|Death|11|||
161739290|NCT00865189|584084717|FG000|Overall Study|Lost to Follow-up|6|||
161739291|NCT00865189|584084718|FG001|Overall Study|Lost to Follow-up|6|||
161739292|NCT00865189|584084717|FG000|Overall Study|Withdrawal by Subject|1|||
161739293|NCT00865189|584084718|FG001|Overall Study|Withdrawal by Subject|0|||
161739294|NCT01658579|584084720|FG000|Treatment Period A|Other|0|||
161739295|NCT01658579|584084721|FG001|Treatment Period A|Other|0|||
161739296|NCT01658579|584084722|FG002|Treatment Period A|Other|1|||
161739297|NCT01658579|584084723|FG003|Treatment Period A|Other|1|||
161739298|NCT01658579|584084720|FG000|Treatment Period A|Adverse Event|1|||
161739299|NCT01658579|584084721|FG001|Treatment Period A|Adverse Event|0|||
161739300|NCT01658579|584084722|FG002|Treatment Period A|Adverse Event|0|||
161739301|NCT01658579|584084723|FG003|Treatment Period A|Adverse Event|0|||
161739302|NCT01658579|584084720|FG000|Treatment Period B|Other|0|||
161739303|NCT01658579|584084721|FG001|Treatment Period B|Other|0|||
161739304|NCT01658579|584084722|FG002|Treatment Period B|Other|0|||
161739305|NCT01658579|584084723|FG003|Treatment Period B|Other|1|||
161739306|NCT05590767|584084724|FG000|Overall Study|Protocol Violation|1|||
161739307|NCT05590767|584084724|FG000|Overall Study|surgery canceled|1|||
161739308|NCT05590767|584084724|FG000|Overall Study|interscalene brachial block not performed|1|||
161739309|NCT00084929|584084725|FG000|Overall Study|ineligible - medical contraindication|1|||
161739310|NCT00084929|584084725|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
161739311|NCT00084929|584084725|FG000|Overall Study|Ineligible - Medical history|6|||
161739312|NCT00084929|584084725|FG000|Overall Study|Withdrawal by Subject|10|||
161739313|NCT00084929|584084725|FG000|Overall Study|Missing/incomplete CTC exam|9|||
161739314|NCT00084929|584084725|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
161739315|NCT00664209|584084726|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
161739316|NCT00664209|584084726|FG000|Study Treatment Period|Physician Decision|4|||
161739317|NCT00664209|584084726|FG000|Study Treatment Period|Withdrawal by Subject|2|||
161739318|NCT02767856|584084737|FG000|Overall Study|Lost to Follow-up|9|||
161739319|NCT02767856|584084738|FG001|Overall Study|Lost to Follow-up|1|||
161739320|NCT02767856|584084737|FG000|Overall Study|Withdrawal by Subject|2|||
161739321|NCT02767856|584084738|FG001|Overall Study|Withdrawal by Subject|1|||
161739322|NCT00091026|584084741|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
161739323|NCT00091026|584084742|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
161739324|NCT00091026|584084741|FG000|Overall Study|Patient withdrew and never received trea|0|||
161739325|NCT00091026|584084742|FG001|Overall Study|Patient withdrew and never received trea|2|||
161739326|NCT00091026|584084741|FG000|Overall Study|Unknown-never received treatment|0|||
161739327|NCT00091026|584084742|FG001|Overall Study|Unknown-never received treatment|1|||
161739328|NCT00418379|584084745|FG000|Year 1|Adverse Event|9|||
161739329|NCT00418379|584084746|FG001|Year 1|Adverse Event|15|||
161739330|NCT00418379|584084747|FG002|Year 1|Adverse Event|3|||
161739331|NCT00418379|584084745|FG000|Year 1|Withdrawal by Subject|7|||
161739332|NCT00418379|584084746|FG001|Year 1|Withdrawal by Subject|8|||
161739333|NCT00418379|584084747|FG002|Year 1|Withdrawal by Subject|5|||
161739334|NCT00418379|584084745|FG000|Year 1|Any other reason not above-mentioned|2|||
161739335|NCT00418379|584084746|FG001|Year 1|Any other reason not above-mentioned|5|||
161739336|NCT00418379|584084747|FG002|Year 1|Any other reason not above-mentioned|7|||
161739337|NCT00418379|584084745|FG000|Year 2|Adverse Event|5|||
161739338|NCT00418379|584084746|FG001|Year 2|Adverse Event|2|||
161739339|NCT00418379|584084747|FG002|Year 2|Adverse Event|1|||
161739340|NCT00418379|584084745|FG000|Year 2|Withdrawal by Subject|1|||
161739341|NCT00418379|584084746|FG001|Year 2|Withdrawal by Subject|1|||
161739342|NCT00418379|584084747|FG002|Year 2|Withdrawal by Subject|3|||
161739343|NCT00418379|584084745|FG000|Year 2|Any other reason not above-mentioned|2|||
161739344|NCT00418379|584084746|FG001|Year 2|Any other reason not above-mentioned|1|||
161739345|NCT00418379|584084747|FG002|Year 2|Any other reason not above-mentioned|6|||
161739346|NCT00418379|584084745|FG000|Year 3|Withdrawal by Subject|1|||
161739347|NCT00418379|584084746|FG001|Year 3|Withdrawal by Subject|1|||
161739348|NCT00418379|584084747|FG002|Year 3|Withdrawal by Subject|2|||
161739349|NCT00418379|584084745|FG000|Year 3|Any other reason not above-mentioned|2|||
161739350|NCT00418379|584084746|FG001|Year 3|Any other reason not above-mentioned|1|||
161739351|NCT00418379|584084747|FG002|Year 3|Any other reason not above-mentioned|1|||
161739352|NCT00418379|584084745|FG000|Year 4|Adverse Event|0|||
161739353|NCT00418379|584084746|FG001|Year 4|Adverse Event|1|||
161739354|NCT00418379|584084747|FG002|Year 4|Adverse Event|0|||
161739355|NCT00418379|584084745|FG000|Year 4|Withdrawal by Subject|2|||
161739356|NCT00418379|584084746|FG001|Year 4|Withdrawal by Subject|3|||
161739357|NCT00418379|584084747|FG002|Year 4|Withdrawal by Subject|2|||
161739358|NCT00418379|584084745|FG000|Year 4|Any other reason not above-mentioned|1|||
161739359|NCT00418379|584084746|FG001|Year 4|Any other reason not above-mentioned|1|||
161739360|NCT00418379|584084747|FG002|Year 4|Any other reason not above-mentioned|0|||
161739361|NCT00418379|584084745|FG000|Year 5|Adverse Event|0|||
161739362|NCT00418379|584084746|FG001|Year 5|Adverse Event|1|||
161739363|NCT00418379|584084747|FG002|Year 5|Adverse Event|0|||
161739364|NCT00418379|584084745|FG000|Year 5|Any other reason not above-mentioned|2|||
161739365|NCT00418379|584084746|FG001|Year 5|Any other reason not above-mentioned|4|||
161739366|NCT00418379|584084747|FG002|Year 5|Any other reason not above-mentioned|3|||
161739367|NCT00843843|584084748|FG000|Overall Study|Physician Decision|1|||
161739368|NCT00843843|584084749|FG001|Overall Study|Physician Decision|1|||
161739369|NCT00843843|584084748|FG000|Overall Study|Protocol Violation|1|||
161739370|NCT00843843|584084749|FG001|Overall Study|Protocol Violation|1|||
161739371|NCT01797965|584084750|FG000|Overall Study|Adverse Event|104|||
161739372|NCT01797965|584084751|FG001|Overall Study|Adverse Event|129|||
161739373|NCT01797965|584084752|FG002|Overall Study|Adverse Event|4|||
161739374|NCT01797965|584084753|FG003|Overall Study|Adverse Event|21|||
161739375|NCT01797965|584084750|FG000|Overall Study|Lost to Follow-up|9|||
161739376|NCT01797965|584084751|FG001|Overall Study|Lost to Follow-up|8|||
161739377|NCT01797965|584084752|FG002|Overall Study|Lost to Follow-up|1|||
161739378|NCT01797965|584084753|FG003|Overall Study|Lost to Follow-up|2|||
161739379|NCT01797965|584084750|FG000|Overall Study|Consent withdrawn|130|||
161739380|NCT01797965|584084751|FG001|Overall Study|Consent withdrawn|117|||
161739381|NCT01797965|584084752|FG002|Overall Study|Consent withdrawn|3|||
161739382|NCT01797965|584084753|FG003|Overall Study|Consent withdrawn|35|||
161739383|NCT01797965|584084750|FG000|Overall Study|Investigator decision|21|||
161739384|NCT01797965|584084751|FG001|Overall Study|Investigator decision|15|||
161739385|NCT01797965|584084752|FG002|Overall Study|Investigator decision|0|||
161739386|NCT01797965|584084753|FG003|Overall Study|Investigator decision|0|||
161739387|NCT01797965|584084750|FG000|Overall Study|Death|2|||
161739388|NCT01797965|584084751|FG001|Overall Study|Death|4|||
161739389|NCT01797965|584084752|FG002|Overall Study|Death|0|||
161739390|NCT01797965|584084753|FG003|Overall Study|Death|0|||
161739391|NCT01797965|584084750|FG000|Overall Study|Disease progression, defined by protocol|3|||
161739392|NCT01797965|584084751|FG001|Overall Study|Disease progression, defined by protocol|1|||
161739393|NCT01797965|584084752|FG002|Overall Study|Disease progression, defined by protocol|0|||
161739394|NCT01797965|584084753|FG003|Overall Study|Disease progression, defined by protocol|0|||
161739395|NCT01797965|584084750|FG000|Overall Study|Reason Not Specified|280|||
161739396|NCT01797965|584084751|FG001|Overall Study|Reason Not Specified|295|||
161739397|NCT01797965|584084752|FG002|Overall Study|Reason Not Specified|0|||
161739398|NCT01797965|584084753|FG003|Overall Study|Reason Not Specified|15|||
161739399|NCT01764256|584084754|FG000|Received All Vaccinations|Adverse Event|1|||
161739400|NCT01764256|584084755|FG001|Received All Vaccinations|Adverse Event|1|||
161739401|NCT01764256|584084756|FG002|Received All Vaccinations|Adverse Event|0|||
161739402|NCT01764256|584084757|FG003|Received All Vaccinations|Adverse Event|0|||
161739403|NCT01764256|584084754|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
161739404|NCT01764256|584084755|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
161739405|NCT01764256|584084756|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
161739406|NCT01764256|584084757|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
161739407|NCT01764256|584084754|FG000|Received All Vaccinations|Lost to Follow-up|1|||
161739408|NCT01764256|584084755|FG001|Received All Vaccinations|Lost to Follow-up|0|||
161739409|NCT01764256|584084756|FG002|Received All Vaccinations|Lost to Follow-up|0|||
161739410|NCT01764256|584084757|FG003|Received All Vaccinations|Lost to Follow-up|0|||
161739411|NCT01764256|584084754|FG000|Completed Study|Lost to Follow-up|0|||
161739412|NCT01764256|584084755|FG001|Completed Study|Lost to Follow-up|0|||
161739413|NCT01764256|584084756|FG002|Completed Study|Lost to Follow-up|0|||
161739414|NCT01764256|584084757|FG003|Completed Study|Lost to Follow-up|1|||
161739415|NCT00304915|584084758|FG000|Overall Study|Lost to Follow-up|11|||
161739416|NCT00304915|584084759|FG001|Overall Study|Lost to Follow-up|11|||
161739417|NCT00304915|584084758|FG000|Overall Study|Death|4|||
161739418|NCT00304915|584084759|FG001|Overall Study|Death|5|||
161739419|NCT00304915|584084758|FG000|Overall Study|Withdrawal by Subject|3|||
161739420|NCT00304915|584084759|FG001|Overall Study|Withdrawal by Subject|0|||
161739421|NCT00565058|584084760|FG000|Overall Study|Adverse Event|1|||
161739422|NCT00565058|584084761|FG001|Overall Study|Adverse Event|0|||
161739423|NCT02029638|584084762|FG000|Overall Study|Death|0|||
161739424|NCT02029638|584084763|FG001|Overall Study|Death|0|||
161739425|NCT02029638|584084764|FG002|Overall Study|Death|1|||
161739426|NCT02029638|584084762|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
161739427|NCT02029638|584084763|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
161739428|NCT02029638|584084764|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
161739429|NCT00363246|584084774|FG000|Overall Study|Death|40|||
161739430|NCT00363246|584084774|FG000|Overall Study|Withdrawal by Subject|19|||
161739431|NCT00363246|584084774|FG000|Overall Study|Lost to Follow-up|14|||
161739432|NCT00363246|584084774|FG000|Overall Study|Bad health|6|||
161739433|NCT00363246|584084774|FG000|Overall Study|Stopped using wheelchair|11|||
161739434|NCT00363246|584084774|FG000|Overall Study|Subject expressed security concerns|2|||
161739435|NCT00363246|584084774|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
161739436|NCT00264849|584084775|FG000|Overall Study|Adverse Event|7|||
161739437|NCT00264849|584084776|FG001|Overall Study|Adverse Event|2|||
161739438|NCT00264849|584084775|FG000|Overall Study|Withdrawal by Subject|7|||
161739439|NCT00264849|584084776|FG001|Overall Study|Withdrawal by Subject|11|||
161739440|NCT00264849|584084775|FG000|Overall Study|Protocol Violation|5|||
161739441|NCT00264849|584084776|FG001|Overall Study|Protocol Violation|3|||
161739442|NCT00264849|584084775|FG000|Overall Study|Lack of Efficacy|1|||
161739443|NCT00264849|584084776|FG001|Overall Study|Lack of Efficacy|6|||
161739444|NCT00264849|584084775|FG000|Overall Study|Lost to Follow-up|0|||
161739445|NCT00264849|584084776|FG001|Overall Study|Lost to Follow-up|2|||
161739446|NCT00264849|584084775|FG000|Overall Study|Death|0|||
161739447|NCT00264849|584084776|FG001|Overall Study|Death|1|||
161739448|NCT00264849|584084775|FG000|Overall Study|Administrative Problems|2|||
161739449|NCT00264849|584084776|FG001|Overall Study|Administrative Problems|0|||
161739450|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
161739451|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
161739452|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
161739453|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
161739454|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
161739455|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
161739456|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161739457|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161739458|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
161739459|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
161739460|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161739461|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161739462|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161739463|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161739464|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
161739465|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
161739466|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
161739467|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
161739468|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
161739469|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
161739470|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
161739471|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
161739472|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
161739473|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
161739474|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
161739475|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
161739476|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
161739477|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
161739478|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
161739479|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
161739480|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161739481|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
161739482|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
161739483|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
161739484|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
161739485|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
161739486|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
161739487|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
161739488|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
161739489|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
161739490|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
161739491|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739492|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739493|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739494|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739495|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
161739496|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
161739497|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
161739498|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
161739499|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
161739500|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161739501|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
161739502|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
161739503|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161739504|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161739505|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
161739506|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161739507|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161739508|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161739509|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161739510|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
161739511|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
161739512|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
161739513|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
161739514|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
161739515|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739516|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739517|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739518|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739519|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
161739520|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
161739521|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161739522|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161739523|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
161739524|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
161739525|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161739526|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161739527|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161739528|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161739529|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161739530|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Administrative|1|||
161739531|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Administrative|2|||
161840524|NCT00290251|584460579|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
161840525|NCT00290251|584460574|FG000|Treatment 1 (Months 2-4)|headache|0|||
161840526|NCT00290251|584460575|FG001|Treatment 1 (Months 2-4)|headache|0|||
161840527|NCT00290251|584460576|FG002|Treatment 1 (Months 2-4)|headache|0|||
161840528|NCT00290251|584460577|FG003|Treatment 1 (Months 2-4)|headache|0|||
161840529|NCT00290251|584460578|FG004|Treatment 1 (Months 2-4)|headache|1|||
161840530|NCT00290251|584460579|FG005|Treatment 1 (Months 2-4)|headache|0|||
161840531|NCT00290251|584460574|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
161840532|NCT00290251|584460575|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
161840533|NCT00290251|584460576|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
161739532|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Administrative|3|||
161739533|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Administrative|1|||
161739534|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Administrative|0|||
161739535|NCT00949910|584086521|FG000|Overall Study|Progressive Disease|3750|||
161739536|NCT00949910|584086521|FG000|Overall Study|Symptomatic Deterioration|1088|||
161739537|NCT00949910|584086521|FG000|Overall Study|Lost to Follow-up|100|||
161739538|NCT00949910|584086521|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
161739539|NCT00949910|584086521|FG000|Overall Study|Participant Refusal|390|||
161739540|NCT00949910|584086521|FG000|Overall Study|Death Due to Malignant Disease|456|||
161739541|NCT00949910|584086521|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
161739542|NCT00949910|584086521|FG000|Overall Study|Death Due to Adverse Event|115|||
161739543|NCT00949910|584086521|FG000|Overall Study|Death Due to Toxicity|3|||
161739544|NCT00949910|584086521|FG000|Overall Study|Death from Unknown Cause|5|||
161739545|NCT00949910|584086521|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
161739546|NCT00949910|584086521|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
161739547|NCT00949910|584086521|FG000|Overall Study|Switched to Commercial Treatment|4|||
161739548|NCT00949910|584086521|FG000|Overall Study|Violation of Eligibility|23|||
161739549|NCT00949910|584086521|FG000|Overall Study|Logistical Reasons|13|||
161739550|NCT00949910|584086521|FG000|Overall Study|Non-Compliance|10|||
161739551|NCT00949910|584086521|FG000|Overall Study|Prolonged Dosing Interruption|4|||
161739552|NCT00949910|584086521|FG000|Overall Study|Adverse Event|83|||
161739553|NCT00949910|584086521|FG000|Overall Study|Serious Adverse Event|6|||
161739554|NCT00949910|584086521|FG000|Overall Study|Physician/Participant Decision|7|||
161739555|NCT00949910|584086521|FG000|Overall Study|Other|4|||
161739556|NCT00949910|584086521|FG000|Overall Study|No Data|9|||
161739557|NCT00971425|584086522|FG000|Overall Study|Adverse Event|1|||
161739558|NCT00971425|584086523|FG001|Overall Study|Adverse Event|1|||
161739559|NCT00971425|584086522|FG000|Overall Study|Withdrawal by Subject|0|||
161739560|NCT00971425|584086523|FG001|Overall Study|Withdrawal by Subject|1|||
161739561|NCT00132314|584086524|FG000|Overall Study|Lost to Follow-up|70|||
161739562|NCT00132314|584086525|FG001|Overall Study|Lost to Follow-up|62|||
161739563|NCT00132314|584086524|FG000|Overall Study|Lacked SSN|1|||
161739564|NCT00132314|584086525|FG001|Overall Study|Lacked SSN|3|||
161739565|NCT00132314|584086524|FG000|Overall Study|Refused intervention at baseline|2|||
161739566|NCT00132314|584086525|FG001|Overall Study|Refused intervention at baseline|7|||
161739567|NCT01453998|584086542|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
161739568|NCT01453998|584086543|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
161739569|NCT01453998|584086544|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
161739570|NCT01840228|584086551|FG000|Overall Study|Lost to Follow-up|1|||
161739571|NCT01840228|584086552|FG001|Overall Study|Lost to Follow-up|1|||
161739572|NCT00712933|584086553|FG000|Overall Study|Adverse Event|69|||
161739573|NCT00712933|584086553|FG000|Overall Study|Lack of Efficacy|6|||
161739574|NCT00712933|584086553|FG000|Overall Study|Lost to Follow-up|22|||
161739575|NCT00712933|584086553|FG000|Overall Study|Non-compliance with study drug|13|||
161739576|NCT00712933|584086553|FG000|Overall Study|Other Pregnancy|37|||
161739577|NCT00712933|584086553|FG000|Overall Study|Sponsor decision|14|||
161739578|NCT00712933|584086553|FG000|Overall Study|Withdrew consent|4|||
161739579|NCT00712933|584086553|FG000|Overall Study|Hip replacement surgery|1|||
161739580|NCT00712933|584086553|FG000|Overall Study|Involved in Clinical research|3|||
161739581|NCT00712933|584086553|FG000|Overall Study|Participant hospitalized|1|||
161739582|NCT00712933|584086553|FG000|Overall Study|Participant travelled overseas|2|||
161739583|NCT00712933|584086553|FG000|Overall Study|Death of patient|1|||
161739584|NCT00712933|584086553|FG000|Overall Study|Other Physician decision|1|||
161739585|NCT00712933|584086553|FG000|Overall Study|Not committed to contraception|1|||
161739586|NCT00712933|584086553|FG000|Overall Study|Participant received medication|1|||
161739587|NCT00712933|584086553|FG000|Overall Study|Physician Decision|36|||
161739588|NCT00712933|584086553|FG000|Overall Study|Protocol Violation|4|||
161739589|NCT00712933|584086553|FG000|Overall Study|Withdrawal by Subject|151|||
161739590|NCT02022033|584086559|FG000|Overall Study|Physician Decision|1|||
161739591|NCT01429077|584086560|FG000|Overall Study|Lost to Follow-up|0|||
161739592|NCT01429077|584086561|FG001|Overall Study|Lost to Follow-up|3|||
161739593|NCT01413542|584086563|FG000|Overall Study|Physician Decision|1|||
161739594|NCT01413542|584086564|FG001|Overall Study|Physician Decision|0|||
161739595|NCT01413542|584086565|FG002|Overall Study|Physician Decision|3|||
161739596|NCT01413542|584086566|FG003|Overall Study|Physician Decision|0|||
161739597|NCT01413542|584086563|FG000|Overall Study|Adverse Event|0|||
161739598|NCT01413542|584086564|FG001|Overall Study|Adverse Event|0|||
161739599|NCT01413542|584086565|FG002|Overall Study|Adverse Event|0|||
161739600|NCT01413542|584086566|FG003|Overall Study|Adverse Event|1|||
161739601|NCT00065442|584086568|FG000|Overall Study|Lost to Follow-up|1|||
161739602|NCT00065442|584086569|FG001|Overall Study|Lost to Follow-up|1|||
161739603|NCT00065442|584086568|FG000|Overall Study|Death|121|||
161739604|NCT00065442|584086569|FG001|Overall Study|Death|210|||
161739605|NCT00065442|584086568|FG000|Overall Study|Withdrawal by Subject|3|||
161739606|NCT00065442|584086569|FG001|Overall Study|Withdrawal by Subject|9|||
161739607|NCT05489081|584086573|FG000|Overall Study|student left classroom|0|||
161739608|NCT05489081|584086574|FG001|Overall Study|student left classroom|1|||
161739609|NCT05489081|584086573|FG000|Overall Study|teacher left school|0|||
161739610|NCT05489081|584086574|FG001|Overall Study|teacher left school|2|||
161739611|NCT00712322|584086578|FG000|Overall Study|Protocol deviation|0|||
161739612|NCT00712322|584086579|FG001|Overall Study|Protocol deviation|1|||
161739613|NCT00712322|584086580|FG002|Overall Study|Protocol deviation|0|||
161739614|NCT00973921|584086582|FG000|Overall Study|IVUS results were not available|9|||
161739615|NCT00400712|584086593|FG000|Overall Study|Death|1|||
161739616|NCT00400712|584086594|FG001|Overall Study|Death|0|||
161739617|NCT00400712|584086593|FG000|Overall Study|Withdrawal by Subject|11|||
161739618|NCT00400712|584086594|FG001|Overall Study|Withdrawal by Subject|12|||
161739619|NCT00400712|584086593|FG000|Overall Study|Physician Decision|5|||
161739620|NCT00400712|584086594|FG001|Overall Study|Physician Decision|4|||
161739621|NCT02670330|584086595|FG000|Overall Study|Protocol Deviation|1|||
161739622|NCT02670330|584086596|FG001|Overall Study|Protocol Deviation|0|||
161739623|NCT02670330|584086595|FG000|Overall Study|Study Terminated By Sponsor|36|||
161739624|NCT02670330|584086596|FG001|Overall Study|Study Terminated By Sponsor|43|||
161739625|NCT02670330|584086595|FG000|Overall Study|Adverse Event|1|||
161739626|NCT02670330|584086596|FG001|Overall Study|Adverse Event|3|||
161739627|NCT02670330|584086595|FG000|Overall Study|Withdrawal by Subject|34|||
161739628|NCT02670330|584086596|FG001|Overall Study|Withdrawal by Subject|29|||
161739629|NCT02670330|584086595|FG000|Overall Study|Lost to Follow-up|3|||
161739630|NCT02670330|584086596|FG001|Overall Study|Lost to Follow-up|2|||
161739631|NCT04404010|584086597|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
161739632|NCT04404010|584086598|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
161739633|NCT02120157|584086599|FG000|Overall Study|Death|8|||
161739634|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
161739635|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
161739636|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
161739637|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
161739638|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
161739639|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
161739640|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Death|1|||
161739641|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Death|3|||
161739642|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
161739643|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
161739644|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
161739645|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
161739646|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
161739647|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
161739648|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
161739649|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
161739650|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
161739651|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
161739652|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
161739653|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
161739654|NCT00634114|584086605|FG000|Overall Study|Adverse Event|6|||
161739655|NCT00634114|584086606|FG001|Overall Study|Adverse Event|8|||
161739656|NCT00634114|584086607|FG002|Overall Study|Adverse Event|3|||
161739657|NCT00634114|584086605|FG000|Overall Study|Withdrawal by Subject|9|||
161739658|NCT00634114|584086606|FG001|Overall Study|Withdrawal by Subject|6|||
161739659|NCT00634114|584086607|FG002|Overall Study|Withdrawal by Subject|11|||
161739660|NCT00634114|584086605|FG000|Overall Study|Lost to Follow-up|0|||
161739661|NCT00634114|584086606|FG001|Overall Study|Lost to Follow-up|0|||
161739662|NCT00634114|584086607|FG002|Overall Study|Lost to Follow-up|1|||
161739663|NCT00634114|584086605|FG000|Overall Study|Protocol Violation|3|||
161739664|NCT00634114|584086606|FG001|Overall Study|Protocol Violation|3|||
161739665|NCT00634114|584086607|FG002|Overall Study|Protocol Violation|1|||
161739666|NCT00634114|584086605|FG000|Overall Study|Pregnancy|1|||
161739667|NCT00634114|584086606|FG001|Overall Study|Pregnancy|0|||
161739668|NCT00634114|584086607|FG002|Overall Study|Pregnancy|0|||
161739669|NCT00634114|584086605|FG000|Overall Study|Incorrect enrolment|0|||
161739670|NCT00634114|584086606|FG001|Overall Study|Incorrect enrolment|1|||
161739671|NCT00634114|584086607|FG002|Overall Study|Incorrect enrolment|0|||
161739672|NCT00634114|584086605|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
161739673|NCT00634114|584086606|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
161739674|NCT00634114|584086607|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
161739675|NCT00634114|584086605|FG000|Overall Study|Difficult to continue|3|||
161739676|NCT00634114|584086606|FG001|Overall Study|Difficult to continue|1|||
161739677|NCT00634114|584086607|FG002|Overall Study|Difficult to continue|1|||
161739678|NCT00634114|584086605|FG000|Overall Study|Other reason|1|||
161739679|NCT00634114|584086606|FG001|Overall Study|Other reason|1|||
161739680|NCT00634114|584086607|FG002|Overall Study|Other reason|1|||
161739681|NCT01599754|584086608|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
161739682|NCT01599754|584086609|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
161739683|NCT01599754|584086608|FG000|Overall Study|Participant noncompliance|4|||
161739684|NCT01599754|584086609|FG001|Overall Study|Participant noncompliance|4|||
161739685|NCT01599754|584086608|FG000|Overall Study|Lost to Follow-up|13|||
161739686|NCT01599754|584086609|FG001|Overall Study|Lost to Follow-up|6|||
161739687|NCT01599754|584086608|FG000|Overall Study|Death|31|||
161739688|NCT01599754|584086609|FG001|Overall Study|Death|33|||
161739689|NCT01599754|584086608|FG000|Overall Study|Adverse Event|3|||
161739690|NCT01599754|584086609|FG001|Overall Study|Adverse Event|2|||
161739691|NCT01599754|584086608|FG000|Overall Study|Investigator decision|1|||
161739692|NCT01599754|584086609|FG001|Overall Study|Investigator decision|3|||
161739693|NCT01599754|584086608|FG000|Overall Study|Withdrawal by Subject|24|||
161739694|NCT01599754|584086609|FG001|Overall Study|Withdrawal by Subject|25|||
161739695|NCT01599754|584086608|FG000|Overall Study|Study terminated by sponsor|282|||
161739696|NCT01599754|584086609|FG001|Overall Study|Study terminated by sponsor|285|||
161739697|NCT03670641|584086614|FG000|Overall Study|Lost to Follow-up|3|||
161739698|NCT00916370|584086620|FG000|Overall Study|Death|3|||
161739699|NCT00916370|584086621|FG001|Overall Study|Death|1|||
161739700|NCT00916370|584086620|FG000|Overall Study|Withdrawal by Subject|2|||
161739701|NCT00916370|584086621|FG001|Overall Study|Withdrawal by Subject|0|||
161739702|NCT00916370|584086620|FG000|Overall Study|Physician Decision|0|||
161739703|NCT00916370|584086621|FG001|Overall Study|Physician Decision|1|||
161739704|NCT03550131|584086622|FG000|Overall Study|Lost to Follow-up|16|||
161739705|NCT03550131|584086623|FG001|Overall Study|Lost to Follow-up|24|||
161739706|NCT03550131|584086622|FG000|Overall Study|Withdrawal by Subject|36|||
161739707|NCT03550131|584086623|FG001|Overall Study|Withdrawal by Subject|28|||
161739708|NCT03550131|584086622|FG000|Overall Study|Illness of dyad member|10|||
161739709|NCT03550131|584086623|FG001|Overall Study|Illness of dyad member|2|||
161739710|NCT03550131|584086622|FG000|Overall Study|Death of person with dementia|4|||
161739711|NCT03550131|584086623|FG001|Overall Study|Death of person with dementia|8|||
161739712|NCT00414960|584086624|FG000|Overall Study|Adverse Event|4|||
161739713|NCT00414960|584086625|FG001|Overall Study|Adverse Event|0|||
161739714|NCT00414960|584086624|FG000|Overall Study|Withdrawal by Subject|3|||
161739715|NCT00414960|584086625|FG001|Overall Study|Withdrawal by Subject|0|||
161739716|NCT00414960|584086624|FG000|Overall Study|Physician Decision|0|||
161739717|NCT00414960|584086625|FG001|Overall Study|Physician Decision|1|||
161739718|NCT01318512|584086626|FG000|Maintenance Period (6 Months)|Death|2|||
161739719|NCT01318512|584086626|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
161739720|NCT02756650|584086629|FG000|Overall Study|Physician Decision|1|||
161739721|NCT02756650|584086629|FG000|Overall Study|Adverse Event|1|||
161739722|NCT00622869|584086634|FG000|Overall Study|Subject Withdrew Consent|13|||
161739723|NCT00622869|584086635|FG001|Overall Study|Subject Withdrew Consent|17|||
161739724|NCT00622869|584086636|FG002|Overall Study|Subject Withdrew Consent|11|||
161739725|NCT00622869|584086634|FG000|Overall Study|Administrative Problems|11|||
161739726|NCT00622869|584086635|FG001|Overall Study|Administrative Problems|17|||
161739727|NCT00622869|584086636|FG002|Overall Study|Administrative Problems|13|||
161739728|NCT00622869|584086634|FG000|Overall Study|Death|12|||
161739729|NCT00622869|584086635|FG001|Overall Study|Death|15|||
161840534|NCT00290251|584460577|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
161739730|NCT00622869|584086636|FG002|Overall Study|Death|10|||
161739731|NCT00622869|584086634|FG000|Overall Study|Lost to Follow-up|2|||
161739732|NCT00622869|584086635|FG001|Overall Study|Lost to Follow-up|4|||
161739733|NCT00622869|584086636|FG002|Overall Study|Lost to Follow-up|2|||
161739734|NCT00622869|584086634|FG000|Overall Study|Graft Loss|5|||
161739735|NCT00622869|584086635|FG001|Overall Study|Graft Loss|3|||
161739736|NCT00622869|584086636|FG002|Overall Study|Graft Loss|2|||
161739737|NCT00622869|584086634|FG000|Overall Study|Missing|0|||
161739738|NCT00622869|584086635|FG001|Overall Study|Missing|1|||
161739739|NCT00622869|584086636|FG002|Overall Study|Missing|1|||
161739740|NCT04348591|584086637|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
161739741|NCT04348591|584086638|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
161739742|NCT04348591|584086637|FG000|Imaging Session (120 Min)|Physician Decision|0|||
161739743|NCT04348591|584086638|FG001|Imaging Session (120 Min)|Physician Decision|1|||
161739744|NCT04348591|584086637|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
161739745|NCT04348591|584086638|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
161739746|NCT03722784|584086642|FG000|Overall Study|Withdrawal by Subject|1|||
161739747|NCT03722784|584086643|FG001|Overall Study|Withdrawal by Subject|0|||
161739748|NCT03722784|584086642|FG000|Overall Study|Physician Decision|1|||
161739749|NCT03722784|584086643|FG001|Overall Study|Physician Decision|1|||
161739750|NCT03722784|584086642|FG000|Overall Study|Protocol Violation|0|||
161739751|NCT03722784|584086643|FG001|Overall Study|Protocol Violation|1|||
161739752|NCT00910429|584086646|FG000|Overall Study|Death|18|||
161739753|NCT00910429|584086647|FG001|Overall Study|Death|12|||
161739754|NCT00910429|584086646|FG000|Overall Study|Withdrawal by Subject|3|||
161739755|NCT00910429|584086647|FG001|Overall Study|Withdrawal by Subject|2|||
161739756|NCT00910429|584086646|FG000|Overall Study|Protocol Violation|1|||
161739757|NCT00910429|584086647|FG001|Overall Study|Protocol Violation|0|||
161739758|NCT00910429|584086646|FG000|Overall Study|Lost to Follow-up|2|||
161739759|NCT00910429|584086647|FG001|Overall Study|Lost to Follow-up|1|||
161739760|NCT00910429|584086646|FG000|Overall Study|Adverse Event|10|||
161739761|NCT00910429|584086647|FG001|Overall Study|Adverse Event|5|||
161739762|NCT00910429|584086646|FG000|Overall Study|Drug non-compliance|1|||
161739763|NCT00910429|584086647|FG001|Overall Study|Drug non-compliance|0|||
161739764|NCT00910429|584086646|FG000|Overall Study|Lack of Efficacy|4|||
161739765|NCT00910429|584086647|FG001|Overall Study|Lack of Efficacy|1|||
161739766|NCT01317615|584086648|FG000|Overall Study|Disease progression|25|||
161739767|NCT01317615|584086648|FG000|Overall Study|New cancer therapy|5|||
161739768|NCT01317615|584086648|FG000|Overall Study|Death|6|||
161739769|NCT01317615|584086648|FG000|Overall Study|Withdrawal by Subject|5|||
161739770|NCT01317615|584086648|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161739771|NCT01317615|584086648|FG000|Overall Study|Adverse Event|7|||
161739772|NCT02648724|584086651|FG000|Overall Study|Withdrawal by Subject|0|||
161739773|NCT02648724|584086652|FG001|Overall Study|Withdrawal by Subject|1|||
161739774|NCT02648724|584086653|FG002|Overall Study|Withdrawal by Subject|1|||
161739775|NCT02648724|584086654|FG003|Overall Study|Withdrawal by Subject|0|||
161739776|NCT02648724|584086655|FG004|Overall Study|Withdrawal by Subject|1|||
161739777|NCT02648724|584086656|FG005|Overall Study|Withdrawal by Subject|0|||
161739778|NCT02648724|584086657|FG006|Overall Study|Withdrawal by Subject|0|||
161739779|NCT02648724|584086651|FG000|Overall Study|Progressive disease|2|||
161739780|NCT02648724|584086652|FG001|Overall Study|Progressive disease|2|||
161739781|NCT02648724|584086653|FG002|Overall Study|Progressive disease|2|||
161840535|NCT00290251|584460578|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
161739782|NCT02648724|584086654|FG003|Overall Study|Progressive disease|3|||
161739783|NCT02648724|584086655|FG004|Overall Study|Progressive disease|22|||
161739784|NCT02648724|584086656|FG005|Overall Study|Progressive disease|7|||
161739785|NCT02648724|584086657|FG006|Overall Study|Progressive disease|8|||
161739786|NCT02648724|584086651|FG000|Overall Study|Other reason (unknown)|1|||
161840536|NCT00290251|584460579|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
161840537|NCT04941729|584462787|FG000|Overall Study|Death|0|||
161840538|NCT04941729|584462788|FG001|Overall Study|Death|1|||
161739787|NCT02648724|584086652|FG001|Overall Study|Other reason (unknown)|0|||
161739788|NCT02648724|584086653|FG002|Overall Study|Other reason (unknown)|0|||
161840539|NCT04941729|584462787|FG000|Overall Study|Study terminated by sponsor|11|||
161840540|NCT04941729|584462788|FG001|Overall Study|Study terminated by sponsor|10|||
161739789|NCT02648724|584086654|FG003|Overall Study|Other reason (unknown)|0|||
161739790|NCT02648724|584086655|FG004|Overall Study|Other reason (unknown)|0|||
161739791|NCT02648724|584086656|FG005|Overall Study|Other reason (unknown)|0|||
161739792|NCT02648724|584086657|FG006|Overall Study|Other reason (unknown)|0|||
161739793|NCT02648724|584086651|FG000|Overall Study|Protocol Violation|0|||
161739794|NCT02648724|584086652|FG001|Overall Study|Protocol Violation|0|||
161739795|NCT02648724|584086653|FG002|Overall Study|Protocol Violation|0|||
161739796|NCT02648724|584086654|FG003|Overall Study|Protocol Violation|0|||
161739797|NCT02648724|584086655|FG004|Overall Study|Protocol Violation|1|||
161840541|NCT00006721|584462789|FG000|Overall Study|Adverse Event|0|||
161840542|NCT00006721|584462790|FG001|Overall Study|Adverse Event|4|||
161840543|NCT00006721|584462791|FG002|Overall Study|Adverse Event|4|||
161840544|NCT00006721|584462789|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161840545|NCT00006721|584462790|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
161840546|NCT00006721|584462791|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
161840547|NCT00006721|584462789|FG000|Overall Study|Progression/Relapse|0|||
161840548|NCT00006721|584462790|FG001|Overall Study|Progression/Relapse|1|||
161840549|NCT00006721|584462791|FG002|Overall Study|Progression/Relapse|2|||
161840550|NCT00006721|584462789|FG000|Overall Study|Death|0|||
161840551|NCT00006721|584462790|FG001|Overall Study|Death|1|||
161840552|NCT00006721|584462791|FG002|Overall Study|Death|2|||
161840553|NCT00006721|584462789|FG000|Overall Study|Other - Not Protocol Specified|0|||
161840554|NCT00006721|584462790|FG001|Overall Study|Other - Not Protocol Specified|7|||
161840555|NCT00006721|584462791|FG002|Overall Study|Other - Not Protocol Specified|7|||
161840556|NCT00006721|584462789|FG000|Overall Study|Ineligible|2|||
161840557|NCT00006721|584462790|FG001|Overall Study|Ineligible|12|||
161840558|NCT00006721|584462791|FG002|Overall Study|Ineligible|10|||
161840559|NCT00006721|584462789|FG000|Overall Study|Eligible but no Treatment Received|1|||
161840560|NCT00006721|584462790|FG001|Overall Study|Eligible but no Treatment Received|0|||
161840561|NCT00006721|584462791|FG002|Overall Study|Eligible but no Treatment Received|0|||
161739798|NCT02648724|584086656|FG005|Overall Study|Protocol Violation|0|||
161739799|NCT02648724|584086657|FG006|Overall Study|Protocol Violation|0|||
161739800|NCT02648724|584086651|FG000|Overall Study|Death|0|||
161739801|NCT02648724|584086652|FG001|Overall Study|Death|0|||
161739802|NCT02648724|584086653|FG002|Overall Study|Death|0|||
161739803|NCT02648724|584086654|FG003|Overall Study|Death|0|||
161739804|NCT02648724|584086655|FG004|Overall Study|Death|0|||
161739805|NCT02648724|584086656|FG005|Overall Study|Death|0|||
161739806|NCT02648724|584086657|FG006|Overall Study|Death|3|||
161739807|NCT02648724|584086651|FG000|Overall Study|Physician Decision|0|||
161739808|NCT02648724|584086652|FG001|Overall Study|Physician Decision|0|||
161739809|NCT02648724|584086653|FG002|Overall Study|Physician Decision|0|||
161739810|NCT02648724|584086654|FG003|Overall Study|Physician Decision|0|||
161739811|NCT02648724|584086655|FG004|Overall Study|Physician Decision|1|||
161739812|NCT02648724|584086656|FG005|Overall Study|Physician Decision|0|||
161739813|NCT02648724|584086657|FG006|Overall Study|Physician Decision|1|||
161739814|NCT02648724|584086651|FG000|Overall Study|Transferred to named patient program|0|||
161739815|NCT02648724|584086652|FG001|Overall Study|Transferred to named patient program|0|||
161739816|NCT02648724|584086653|FG002|Overall Study|Transferred to named patient program|0|||
161739817|NCT02648724|584086654|FG003|Overall Study|Transferred to named patient program|0|||
161739818|NCT02648724|584086655|FG004|Overall Study|Transferred to named patient program|0|||
161739819|NCT02648724|584086656|FG005|Overall Study|Transferred to named patient program|1|||
161739820|NCT02648724|584086657|FG006|Overall Study|Transferred to named patient program|0|||
161739821|NCT00302718|584086659|FG000|Overall Study|Participant left the hospital|1|||
161739822|NCT00302718|584086660|FG001|Overall Study|Participant left the hospital|0|||
161739823|NCT00302718|584086661|FG002|Overall Study|Participant left the hospital|0|||
161739824|NCT00302718|584086662|FG003|Overall Study|Participant left the hospital|1|||
161739825|NCT00302718|584086659|FG000|Overall Study|Withdrawal by Subject|0|||
161739826|NCT00302718|584086660|FG001|Overall Study|Withdrawal by Subject|1|||
161739827|NCT00302718|584086661|FG002|Overall Study|Withdrawal by Subject|0|||
161739828|NCT00302718|584086662|FG003|Overall Study|Withdrawal by Subject|0|||
161739829|NCT00302718|584086659|FG000|Overall Study|Participant left primary care setting|0|||
161739830|NCT00302718|584086660|FG001|Overall Study|Participant left primary care setting|0|||
161739831|NCT00302718|584086661|FG002|Overall Study|Participant left primary care setting|2|||
161739832|NCT00302718|584086662|FG003|Overall Study|Participant left primary care setting|1|||
161739833|NCT00738374|584086663|FG000|Induction Treatment Phase|Adverse Event|14|||
161739834|NCT00738374|584086664|FG001|Induction Treatment Phase|Adverse Event|0|||
161739835|NCT00738374|584086665|FG002|Induction Treatment Phase|Adverse Event|0|||
161739836|NCT00738374|584086666|FG003|Induction Treatment Phase|Adverse Event|0|||
161739837|NCT00738374|584086663|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
161739838|NCT00738374|584086664|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161739839|NCT00738374|584086665|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161739840|NCT00738374|584086666|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161739841|NCT00738374|584086663|FG000|Induction Treatment Phase|Physician Decision|2|||
161739842|NCT00738374|584086664|FG001|Induction Treatment Phase|Physician Decision|0|||
161840562|NCT03845296|584462792|FG000|Overall Study|On Treatment|2|||
161840563|NCT03845296|584462793|FG001|Overall Study|On Treatment|1|||
161840564|NCT03845296|584462792|FG000|Overall Study|Adverse Event|4|||
161840565|NCT03845296|584462793|FG001|Overall Study|Adverse Event|11|||
161739843|NCT00738374|584086665|FG002|Induction Treatment Phase|Physician Decision|0|||
161739844|NCT00738374|584086666|FG003|Induction Treatment Phase|Physician Decision|0|||
161739845|NCT00738374|584086663|FG000|Induction Treatment Phase|Protocol Violation|2|||
161739846|NCT00738374|584086664|FG001|Induction Treatment Phase|Protocol Violation|0|||
161739847|NCT00738374|584086665|FG002|Induction Treatment Phase|Protocol Violation|0|||
161739848|NCT00738374|584086666|FG003|Induction Treatment Phase|Protocol Violation|0|||
161739849|NCT00738374|584086663|FG000|Induction Treatment Phase|Non-compliance|1|||
161739850|NCT00738374|584086664|FG001|Induction Treatment Phase|Non-compliance|0|||
161739851|NCT00738374|584086665|FG002|Induction Treatment Phase|Non-compliance|0|||
161739852|NCT00738374|584086666|FG003|Induction Treatment Phase|Non-compliance|0|||
161739853|NCT00738374|584086663|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
161739854|NCT00738374|584086664|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
161739855|NCT00738374|584086665|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
161739856|NCT00738374|584086666|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
161739857|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
161739858|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
161739859|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
161739860|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
161739861|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
161739862|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
161739863|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
161739864|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
161739865|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161739866|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161739867|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161739868|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
161739869|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161739870|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
161739871|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161739872|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161739873|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Other|0|||
161739874|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Other|1|||
161739875|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Other|0|||
161739876|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Other|0|||
161739877|NCT00632541|584086667|FG000|Overall Study|Adverse Event|7|||
161739878|NCT02927873|584086668|FG000|Overall Study|Lost to Follow-up|0|||
161739879|NCT02927873|584086669|FG001|Overall Study|Lost to Follow-up|1|||
161739880|NCT02927873|584086670|FG002|Overall Study|Lost to Follow-up|0|||
161739881|NCT02927873|584086671|FG003|Overall Study|Lost to Follow-up|0|||
161739882|NCT02927873|584086672|FG004|Overall Study|Lost to Follow-up|0|||
161739883|NCT02927873|584086673|FG005|Overall Study|Lost to Follow-up|0|||
161739884|NCT02927873|584086668|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739885|NCT02927873|584086669|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161739886|NCT02927873|584086670|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739887|NCT02927873|584086671|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739888|NCT02927873|584086672|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739889|NCT02927873|584086673|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739890|NCT02927873|584086668|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739891|NCT02927873|584086669|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739892|NCT02927873|584086670|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739893|NCT02927873|584086671|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739894|NCT02927873|584086672|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739895|NCT02927873|584086673|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161739896|NCT02927873|584086668|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739897|NCT02927873|584086669|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
161739898|NCT02927873|584086670|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739899|NCT02927873|584086671|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739900|NCT02927873|584086672|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739901|NCT02927873|584086673|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739902|NCT02927873|584086668|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
161739903|NCT02927873|584086669|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739904|NCT02927873|584086670|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739905|NCT02927873|584086671|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161840566|NCT03845296|584462792|FG000|Overall Study|Refusal unrelated to adverse event|0|||
161840567|NCT03845296|584462793|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161840568|NCT03845296|584462792|FG000|Overall Study|Progression/relapse|14|||
161840569|NCT03845296|584462793|FG001|Overall Study|Progression/relapse|18|||
161840570|NCT03845296|584462792|FG000|Overall Study|Death|4|||
161840571|NCT03845296|584462793|FG001|Overall Study|Death|0|||
161840572|NCT03845296|584462792|FG000|Overall Study|Other - not protocol specified|1|||
161840573|NCT03845296|584462793|FG001|Overall Study|Other - not protocol specified|3|||
161840574|NCT05424042|584462794|FG000|Overall Study|Withdrawal by Subject|2|||
161840575|NCT05424042|584462795|FG001|Overall Study|Withdrawal by Subject|0|||
161840576|NCT05424042|584462796|FG002|Overall Study|Withdrawal by Subject|4|||
161840577|NCT05424042|584462794|FG000|Overall Study|Lost to Follow-up|0|||
161840578|NCT05424042|584462795|FG001|Overall Study|Lost to Follow-up|0|||
161840579|NCT05424042|584462796|FG002|Overall Study|Lost to Follow-up|1|||
161840580|NCT05091307|584462797|FG000|Overall Study|Death|0|||
161840581|NCT05091307|584462798|FG001|Overall Study|Death|0|||
161840582|NCT05091307|584462799|FG002|Overall Study|Death|1|||
161840583|NCT05091307|584462800|FG003|Overall Study|Death|0|||
161840584|NCT05091307|584462797|FG000|Overall Study|Lost to Follow-up|33|||
161840585|NCT05091307|584462798|FG001|Overall Study|Lost to Follow-up|33|||
161840586|NCT05091307|584462799|FG002|Overall Study|Lost to Follow-up|2|||
161840587|NCT05091307|584462800|FG003|Overall Study|Lost to Follow-up|0|||
161840588|NCT05091307|584462797|FG000|Overall Study|Physician Decision|1|||
161840589|NCT05091307|584462798|FG001|Overall Study|Physician Decision|0|||
161840590|NCT05091307|584462799|FG002|Overall Study|Physician Decision|0|||
161840591|NCT05091307|584462800|FG003|Overall Study|Physician Decision|0|||
161840592|NCT05091307|584462797|FG000|Overall Study|Protocol Violation|1|||
161840593|NCT05091307|584462798|FG001|Overall Study|Protocol Violation|0|||
161840594|NCT05091307|584462799|FG002|Overall Study|Protocol Violation|0|||
161840595|NCT05091307|584462800|FG003|Overall Study|Protocol Violation|0|||
161840596|NCT05091307|584462797|FG000|Overall Study|Withdrawal by Subject|16|||
161840597|NCT05091307|584462798|FG001|Overall Study|Withdrawal by Subject|16|||
161840598|NCT05091307|584462799|FG002|Overall Study|Withdrawal by Subject|0|||
161840599|NCT05091307|584462800|FG003|Overall Study|Withdrawal by Subject|1|||
161840600|NCT05091307|584462797|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
161840601|NCT05091307|584462798|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
161840602|NCT05091307|584462799|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
161840603|NCT05091307|584462800|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
161840604|NCT05091307|584462797|FG000|Overall Study|Initiated Prohibited Medication|1|||
161840605|NCT05091307|584462798|FG001|Overall Study|Initiated Prohibited Medication|0|||
161840606|NCT05091307|584462799|FG002|Overall Study|Initiated Prohibited Medication|0|||
161840607|NCT05091307|584462800|FG003|Overall Study|Initiated Prohibited Medication|0|||
161840608|NCT05091307|584462797|FG000|Overall Study|Other|4|||
161840609|NCT05091307|584462798|FG001|Overall Study|Other|4|||
161840610|NCT05091307|584462799|FG002|Overall Study|Other|0|||
161840611|NCT05091307|584462800|FG003|Overall Study|Other|0|||
161840612|NCT05091307|584462797|FG000|Overall Study|Randomized but not vaccinated|0|||
161840613|NCT05091307|584462798|FG001|Overall Study|Randomized but not vaccinated|2|||
161840614|NCT05091307|584462799|FG002|Overall Study|Randomized but not vaccinated|0|||
161840615|NCT05091307|584462800|FG003|Overall Study|Randomized but not vaccinated|0|||
161840616|NCT04732221|584462803|FG000|Base Period|Death|2|||
161840617|NCT04732221|584462804|FG001|Base Period|Death|0|||
161840618|NCT04732221|584462805|FG002|Base Period|Death|0|||
161840619|NCT04732221|584462806|FG003|Base Period|Death|0|||
161840620|NCT04732221|584462807|FG004|Base Period|Death|0|||
161840621|NCT04732221|584462808|FG005|Base Period|Death|0|||
161840622|NCT04732221|584462809|FG006|Base Period|Death|0|||
161840623|NCT04732221|584462803|FG000|Base Period|Withdrawal by Subject|0|||
161840624|NCT04732221|584462804|FG001|Base Period|Withdrawal by Subject|1|||
161840625|NCT04732221|584462805|FG002|Base Period|Withdrawal by Subject|1|||
161840626|NCT04732221|584462806|FG003|Base Period|Withdrawal by Subject|0|||
161840627|NCT04732221|584462807|FG004|Base Period|Withdrawal by Subject|0|||
161840628|NCT04732221|584462808|FG005|Base Period|Withdrawal by Subject|0|||
161840629|NCT04732221|584462809|FG006|Base Period|Withdrawal by Subject|0|||
161840630|NCT04732221|584462803|FG000|Extension Period|Adverse Event|0|||
161840631|NCT04732221|584462804|FG001|Extension Period|Adverse Event|0|||
161739906|NCT02927873|584086672|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739907|NCT02927873|584086673|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739908|NCT02927873|584086668|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
161739909|NCT02927873|584086669|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739910|NCT02927873|584086670|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739911|NCT02927873|584086671|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739912|NCT02927873|584086672|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739913|NCT02927873|584086673|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739914|NCT05757427|584086677|FG000|Overall Study|Adverse Event|1|||
161739915|NCT05757427|584086677|FG000|Overall Study|Device deficiency|1|||
161739916|NCT05757427|584086677|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
161739917|NCT05757427|584086677|FG000|Overall Study|MWBI scan of only 1 breast|3|||
161739918|NCT05757427|584086677|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
161739919|NCT02017899|584088727|FG000|Overall Study|Withdrawal by Subject|0|||
161739920|NCT02017899|584088728|FG001|Overall Study|Withdrawal by Subject|0|||
161739921|NCT02017899|584088729|FG002|Overall Study|Withdrawal by Subject|0|||
161739922|NCT02017899|584088730|FG003|Overall Study|Withdrawal by Subject|1|||
161739923|NCT02017899|584088731|FG004|Overall Study|Withdrawal by Subject|1|||
161739924|NCT02017899|584088732|FG005|Overall Study|Withdrawal by Subject|0|||
161739925|NCT02843178|584088733|FG000|Overall Study|Lost to Follow-up|8|||
161739926|NCT02843178|584088734|FG001|Overall Study|Lost to Follow-up|8|||
161739927|NCT02843178|584088735|FG002|Overall Study|Lost to Follow-up|6|||
161739928|NCT02843178|584088736|FG003|Overall Study|Lost to Follow-up|3|||
161739929|NCT02843178|584088733|FG000|Overall Study|Withdrawal by Subject|0|||
161739930|NCT02843178|584088734|FG001|Overall Study|Withdrawal by Subject|0|||
161739931|NCT02843178|584088735|FG002|Overall Study|Withdrawal by Subject|1|||
161739932|NCT02843178|584088736|FG003|Overall Study|Withdrawal by Subject|1|||
161739933|NCT02420795|584088744|FG000|Overall Study|Withdrawal by Subject|1|||
161739934|NCT02420795|584088745|FG001|Overall Study|Withdrawal by Subject|0|||
161739935|NCT02420795|584088746|FG002|Overall Study|Withdrawal by Subject|0|||
161739936|NCT02420795|584088744|FG000|Overall Study|Adverse Event|1|||
161739937|NCT02420795|584088745|FG001|Overall Study|Adverse Event|0|||
161739938|NCT02420795|584088746|FG002|Overall Study|Adverse Event|0|||
161739939|NCT02420795|584088744|FG000|Overall Study|Progressive disease|2|||
161739940|NCT02420795|584088745|FG001|Overall Study|Progressive disease|2|||
161739941|NCT02420795|584088746|FG002|Overall Study|Progressive disease|4|||
161739942|NCT02420795|584088744|FG000|Overall Study|Death|0|||
161739943|NCT02420795|584088745|FG001|Overall Study|Death|0|||
161739944|NCT02420795|584088746|FG002|Overall Study|Death|1|||
161739945|NCT02528253|584088749|FG000|Overall Study|Adverse Event|3|||
161739946|NCT02528253|584088750|FG001|Overall Study|Adverse Event|4|||
161739947|NCT02528253|584088751|FG002|Overall Study|Adverse Event|4|||
161739948|NCT02528253|584088752|FG003|Overall Study|Adverse Event|8|||
161739949|NCT02528253|584088753|FG004|Overall Study|Adverse Event|18|||
161739950|NCT02528253|584088749|FG000|Overall Study|Death|2|||
161739951|NCT02528253|584088750|FG001|Overall Study|Death|2|||
161739952|NCT02528253|584088751|FG002|Overall Study|Death|1|||
161739953|NCT02528253|584088752|FG003|Overall Study|Death|0|||
161739954|NCT02528253|584088753|FG004|Overall Study|Death|1|||
161739955|NCT02528253|584088749|FG000|Overall Study|Insufficient clinical response|7|||
161739956|NCT02528253|584088750|FG001|Overall Study|Insufficient clinical response|10|||
161739957|NCT02528253|584088751|FG002|Overall Study|Insufficient clinical response|13|||
161739958|NCT02528253|584088752|FG003|Overall Study|Insufficient clinical response|12|||
161739959|NCT02528253|584088753|FG004|Overall Study|Insufficient clinical response|16|||
161739960|NCT02528253|584088749|FG000|Overall Study|Lost to Follow-up|16|||
161739961|NCT02528253|584088750|FG001|Overall Study|Lost to Follow-up|9|||
161739962|NCT02528253|584088751|FG002|Overall Study|Lost to Follow-up|31|||
161739963|NCT02528253|584088752|FG003|Overall Study|Lost to Follow-up|16|||
161739964|NCT02528253|584088753|FG004|Overall Study|Lost to Follow-up|34|||
161739965|NCT02528253|584088749|FG000|Overall Study|Other|21|||
161739966|NCT02528253|584088750|FG001|Overall Study|Other|22|||
161739967|NCT02528253|584088751|FG002|Overall Study|Other|58|||
161739968|NCT02528253|584088752|FG003|Overall Study|Other|52|||
161739969|NCT02528253|584088753|FG004|Overall Study|Other|76|||
161739970|NCT02528253|584088749|FG000|Overall Study|Withdrawal by Subject|25|||
161739971|NCT02528253|584088750|FG001|Overall Study|Withdrawal by Subject|20|||
161739972|NCT02528253|584088751|FG002|Overall Study|Withdrawal by Subject|29|||
161739973|NCT02528253|584088752|FG003|Overall Study|Withdrawal by Subject|48|||
161739974|NCT02528253|584088753|FG004|Overall Study|Withdrawal by Subject|73|||
161739975|NCT02528253|584088749|FG000|Overall Study|Protocol Violation|1|||
161840632|NCT04732221|584462805|FG002|Extension Period|Adverse Event|0|||
161739976|NCT02528253|584088750|FG001|Overall Study|Protocol Violation|2|||
161739977|NCT02528253|584088751|FG002|Overall Study|Protocol Violation|4|||
161739978|NCT02528253|584088752|FG003|Overall Study|Protocol Violation|0|||
161739979|NCT02528253|584088753|FG004|Overall Study|Protocol Violation|4|||
161739980|NCT02528253|584088749|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
161739981|NCT02528253|584088750|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
161739982|NCT02528253|584088751|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
161739983|NCT02528253|584088752|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
161739984|NCT02528253|584088753|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
161739985|NCT00505752|584088754|FG000|Overall Study|Adverse Event|1|||
161739986|NCT00505752|584088755|FG001|Overall Study|Adverse Event|0|||
161739987|NCT00505752|584088756|FG002|Overall Study|Adverse Event|1|||
161739988|NCT00505752|584088757|FG003|Overall Study|Adverse Event|0|||
161739989|NCT00505752|584088754|FG000|Overall Study|Lost to Follow-up|1|||
161739990|NCT00505752|584088755|FG001|Overall Study|Lost to Follow-up|0|||
161739991|NCT00505752|584088756|FG002|Overall Study|Lost to Follow-up|0|||
161739992|NCT00505752|584088757|FG003|Overall Study|Lost to Follow-up|0|||
161739993|NCT00505752|584088754|FG000|Overall Study|Lack of ovarian response|1|||
161739994|NCT00505752|584088755|FG001|Overall Study|Lack of ovarian response|3|||
161739995|NCT00505752|584088756|FG002|Overall Study|Lack of ovarian response|0|||
161739996|NCT00505752|584088757|FG003|Overall Study|Lack of ovarian response|0|||
161739997|NCT00505752|584088754|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161739998|NCT00505752|584088755|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161739999|NCT00505752|584088756|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161740000|NCT00505752|584088757|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161740001|NCT00505752|584088754|FG000|Overall Study|No oocytes retrieved|0|||
161740002|NCT00505752|584088755|FG001|Overall Study|No oocytes retrieved|2|||
161740003|NCT00505752|584088756|FG002|Overall Study|No oocytes retrieved|0|||
161740004|NCT00505752|584088757|FG003|Overall Study|No oocytes retrieved|1|||
161740005|NCT00505752|584088754|FG000|Overall Study|No Fertilization|1|||
161740006|NCT00505752|584088755|FG001|Overall Study|No Fertilization|1|||
161740007|NCT00505752|584088756|FG002|Overall Study|No Fertilization|2|||
161740008|NCT00505752|584088757|FG003|Overall Study|No Fertilization|1|||
161740009|NCT00505752|584088754|FG000|Overall Study|All embryos/blastocysts discarded|0|||
161740010|NCT00505752|584088755|FG001|Overall Study|All embryos/blastocysts discarded|0|||
161740011|NCT00505752|584088756|FG002|Overall Study|All embryos/blastocysts discarded|1|||
161740012|NCT00505752|584088757|FG003|Overall Study|All embryos/blastocysts discarded|1|||
161740013|NCT00505752|584088754|FG000|Overall Study|Other|1|||
161740014|NCT00505752|584088755|FG001|Overall Study|Other|2|||
161740015|NCT00505752|584088756|FG002|Overall Study|Other|1|||
161740016|NCT00505752|584088757|FG003|Overall Study|Other|2|||
161740017|NCT01624506|584088758|FG000|Overall Study|Lost to Follow-up|29|||
161740018|NCT01624506|584088759|FG001|Overall Study|Lost to Follow-up|15|||
161740019|NCT01624506|584088758|FG000|Overall Study|Withdrawal by Subject|9|||
161740020|NCT01624506|584088759|FG001|Overall Study|Withdrawal by Subject|2|||
161740021|NCT01624506|584088758|FG000|Overall Study|Death|1|||
161740022|NCT01624506|584088759|FG001|Overall Study|Death|0|||
161740023|NCT01624506|584088758|FG000|Overall Study|LINX explants|23|||
161740024|NCT01624506|584088759|FG001|Overall Study|LINX explants|0|||
161740025|NCT01624506|584088758|FG000|Overall Study|Adverse Event|3|||
161740026|NCT01624506|584088759|FG001|Overall Study|Adverse Event|0|||
161740027|NCT00225147|584088761|FG000|Open-label Phase|Lost to Follow-up|0|||
161740028|NCT00225147|584088762|FG001|Open-label Phase|Lost to Follow-up|0|||
161740029|NCT00225147|584088763|FG002|Open-label Phase|Lost to Follow-up|0|||
161740030|NCT00225147|584088764|FG003|Open-label Phase|Lost to Follow-up|4|||
161740031|NCT00225147|584088761|FG000|Open-label Phase|Withdrawal by Subject|0|||
161740032|NCT00225147|584088762|FG001|Open-label Phase|Withdrawal by Subject|0|||
161740033|NCT00225147|584088763|FG002|Open-label Phase|Withdrawal by Subject|0|||
161740034|NCT00225147|584088764|FG003|Open-label Phase|Withdrawal by Subject|6|||
161740035|NCT04019795|584088765|FG000|Overall Study|Withdrawal by Subject|1|||
161740036|NCT04019795|584088766|FG001|Overall Study|Withdrawal by Subject|2|||
161740037|NCT04019795|584088767|FG002|Overall Study|Withdrawal by Subject|2|||
161740038|NCT04019795|584088768|FG003|Overall Study|Withdrawal by Subject|1|||
161740039|NCT04019795|584088765|FG000|Overall Study|Lost to Follow-up|0|||
161740040|NCT04019795|584088766|FG001|Overall Study|Lost to Follow-up|1|||
161740041|NCT04019795|584088767|FG002|Overall Study|Lost to Follow-up|1|||
161740042|NCT04019795|584088768|FG003|Overall Study|Lost to Follow-up|2|||
161740043|NCT04019795|584088765|FG000|Overall Study|Treatment non-compliance|3|||
161740044|NCT04019795|584088766|FG001|Overall Study|Treatment non-compliance|1|||
161740045|NCT04019795|584088767|FG002|Overall Study|Treatment non-compliance|2|||
161740046|NCT04019795|584088768|FG003|Overall Study|Treatment non-compliance|0|||
161740047|NCT04019795|584088765|FG000|Overall Study|Physician Decision|0|||
161740048|NCT04019795|584088766|FG001|Overall Study|Physician Decision|0|||
161740049|NCT04019795|584088767|FG002|Overall Study|Physician Decision|1|||
161740050|NCT04019795|584088768|FG003|Overall Study|Physician Decision|0|||
161740051|NCT04019795|584088765|FG000|Overall Study|Adverse Event|1|||
161740052|NCT04019795|584088766|FG001|Overall Study|Adverse Event|0|||
161740053|NCT04019795|584088767|FG002|Overall Study|Adverse Event|0|||
161740054|NCT04019795|584088768|FG003|Overall Study|Adverse Event|0|||
161740055|NCT03625141|584088769|FG000|Overall Study|Adverse Event|0|||
161740056|NCT03625141|584088770|FG001|Overall Study|Adverse Event|2|||
161740057|NCT03625141|584088769|FG000|Overall Study|Study Terminated By Sponsor|1|||
161740058|NCT03625141|584088770|FG001|Overall Study|Study Terminated By Sponsor|13|||
161740059|NCT03625141|584088769|FG000|Overall Study|Withdrawal by Subject|3|||
161740060|NCT03625141|584088770|FG001|Overall Study|Withdrawal by Subject|0|||
161740061|NCT03625141|584088769|FG000|Overall Study|Withdrawal Of Consent|0|||
161740062|NCT03625141|584088770|FG001|Overall Study|Withdrawal Of Consent|1|||
161740063|NCT03625141|584088769|FG000|Overall Study|Death|11|||
161740064|NCT03625141|584088770|FG001|Overall Study|Death|47|||
161740065|NCT03625141|584088769|FG000|Overall Study|Progressive Disease|0|||
161740066|NCT03625141|584088770|FG001|Overall Study|Progressive Disease|2|||
161740067|NCT03250377|584088771|FG000|Overall Study|Adverse Event|2|||
161740068|NCT03250377|584088772|FG001|Overall Study|Adverse Event|4|||
161740069|NCT03250377|584088773|FG002|Overall Study|Adverse Event|0|||
161740070|NCT03250377|584088774|FG003|Overall Study|Adverse Event|4|||
161740071|NCT03250377|584088771|FG000|Overall Study|Lack of Efficacy|5|||
161740072|NCT03250377|584088772|FG001|Overall Study|Lack of Efficacy|14|||
161740073|NCT03250377|584088773|FG002|Overall Study|Lack of Efficacy|1|||
161740074|NCT03250377|584088774|FG003|Overall Study|Lack of Efficacy|3|||
161740075|NCT03250377|584088771|FG000|Overall Study|Protocol Violation|0|||
161740076|NCT03250377|584088772|FG001|Overall Study|Protocol Violation|2|||
161740077|NCT03250377|584088773|FG002|Overall Study|Protocol Violation|0|||
161740078|NCT03250377|584088774|FG003|Overall Study|Protocol Violation|1|||
161740079|NCT03250377|584088771|FG000|Overall Study|Lost to Follow-up|0|||
161740080|NCT03250377|584088772|FG001|Overall Study|Lost to Follow-up|1|||
161740081|NCT03250377|584088773|FG002|Overall Study|Lost to Follow-up|0|||
161740082|NCT03250377|584088774|FG003|Overall Study|Lost to Follow-up|0|||
161740083|NCT03250377|584088771|FG000|Overall Study|Withdrawal by Subject|7|||
161740084|NCT03250377|584088772|FG001|Overall Study|Withdrawal by Subject|7|||
161740085|NCT03250377|584088773|FG002|Overall Study|Withdrawal by Subject|0|||
161740086|NCT03250377|584088774|FG003|Overall Study|Withdrawal by Subject|4|||
161740087|NCT03250377|584088771|FG000|Overall Study|Investigator's Judgment|1|||
161740088|NCT03250377|584088772|FG001|Overall Study|Investigator's Judgment|0|||
161740089|NCT03250377|584088773|FG002|Overall Study|Investigator's Judgment|0|||
161740090|NCT03250377|584088774|FG003|Overall Study|Investigator's Judgment|0|||
161740091|NCT03250377|584088771|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
161740092|NCT03250377|584088772|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
161740093|NCT03250377|584088773|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
161740094|NCT03250377|584088774|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
161740095|NCT03250377|584088771|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
161740096|NCT03250377|584088772|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
161740097|NCT03250377|584088773|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
161740098|NCT03250377|584088774|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
161740099|NCT03250377|584088771|FG000|Overall Study|Epilepsy Surgery|0|||
161740100|NCT03250377|584088772|FG001|Overall Study|Epilepsy Surgery|1|||
161740101|NCT03250377|584088773|FG002|Overall Study|Epilepsy Surgery|2|||
161740102|NCT03250377|584088774|FG003|Overall Study|Epilepsy Surgery|0|||
161740103|NCT03250377|584088771|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161740104|NCT03250377|584088772|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
161740105|NCT03250377|584088773|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161740106|NCT03250377|584088774|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161740107|NCT03250377|584088771|FG000|Overall Study|Request From The Sponsor|0|||
161740108|NCT03250377|584088772|FG001|Overall Study|Request From The Sponsor|1|||
161740109|NCT03250377|584088773|FG002|Overall Study|Request From The Sponsor|0|||
161740110|NCT03250377|584088774|FG003|Overall Study|Request From The Sponsor|0|||
161740111|NCT03250377|584088771|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
161740112|NCT03250377|584088772|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
161740113|NCT03250377|584088773|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
161740114|NCT03250377|584088774|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
161740115|NCT03250377|584088771|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
161740116|NCT03250377|584088772|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
161740117|NCT03250377|584088773|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
161740118|NCT03250377|584088774|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
161740119|NCT03250377|584088771|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
161740120|NCT03250377|584088772|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
161740121|NCT03250377|584088773|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
161740122|NCT03250377|584088774|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
161740123|NCT03250377|584088771|FG000|Overall Study|Pregnancy Event|0|||
161740124|NCT03250377|584088772|FG001|Overall Study|Pregnancy Event|1|||
161840633|NCT04732221|584462806|FG003|Extension Period|Adverse Event|0|||
161740125|NCT03250377|584088773|FG002|Overall Study|Pregnancy Event|0|||
161740126|NCT03250377|584088774|FG003|Overall Study|Pregnancy Event|0|||
161740127|NCT03250377|584088771|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161740128|NCT03250377|584088772|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
161740129|NCT03250377|584088773|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161740130|NCT03250377|584088774|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161740131|NCT03250377|584088771|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161740132|NCT03250377|584088772|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
161740133|NCT03250377|584088773|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161740134|NCT03250377|584088774|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161740135|NCT03250377|584088771|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161740136|NCT03250377|584088772|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
161740137|NCT03250377|584088773|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161740138|NCT03250377|584088774|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161740139|NCT03250377|584088771|FG000|Overall Study|Patient requested to change hospital|0|||
161740140|NCT03250377|584088772|FG001|Overall Study|Patient requested to change hospital|0|||
161740141|NCT03250377|584088773|FG002|Overall Study|Patient requested to change hospital|0|||
161740142|NCT03250377|584088774|FG003|Overall Study|Patient requested to change hospital|1|||
161740143|NCT03250377|584088771|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
161740144|NCT03250377|584088772|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
161740145|NCT03250377|584088773|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
161740146|NCT03250377|584088774|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
161740147|NCT01114373|584088775|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
161740148|NCT01114373|584088776|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
161740149|NCT01114373|584088775|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
161740150|NCT01114373|584088776|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
161740151|NCT01114373|584088775|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
161740152|NCT01114373|584088776|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
161740153|NCT01114373|584088775|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
161740154|NCT01114373|584088776|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
161740155|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161840634|NCT04732221|584462807|FG004|Extension Period|Adverse Event|0|||
161840635|NCT04732221|584462808|FG005|Extension Period|Adverse Event|1|||
161840636|NCT04732221|584462809|FG006|Extension Period|Adverse Event|0|||
161840637|NCT04732221|584462803|FG000|Extension Period|Death|0|||
161840638|NCT04732221|584462804|FG001|Extension Period|Death|0|||
161840639|NCT04732221|584462805|FG002|Extension Period|Death|0|||
161840640|NCT04732221|584462806|FG003|Extension Period|Death|0|||
161840641|NCT04732221|584462807|FG004|Extension Period|Death|1|||
161840642|NCT04732221|584462808|FG005|Extension Period|Death|0|||
161840643|NCT04732221|584462809|FG006|Extension Period|Death|2|||
161840644|NCT04732221|584462803|FG000|Extension Period|Pregnancy|0|||
161840645|NCT04732221|584462804|FG001|Extension Period|Pregnancy|0|||
161840646|NCT04732221|584462805|FG002|Extension Period|Pregnancy|0|||
161840647|NCT04732221|584462806|FG003|Extension Period|Pregnancy|0|||
161840648|NCT04732221|584462807|FG004|Extension Period|Pregnancy|1|||
161840649|NCT04732221|584462808|FG005|Extension Period|Pregnancy|0|||
161840650|NCT04732221|584462809|FG006|Extension Period|Pregnancy|0|||
161840651|NCT04732221|584462803|FG000|Extension Period|Sponsors Decision|0|||
161840652|NCT04732221|584462804|FG001|Extension Period|Sponsors Decision|0|||
161840653|NCT04732221|584462805|FG002|Extension Period|Sponsors Decision|0|||
161840654|NCT04732221|584462806|FG003|Extension Period|Sponsors Decision|0|||
161840655|NCT04732221|584462807|FG004|Extension Period|Sponsors Decision|41|||
161840656|NCT04732221|584462808|FG005|Extension Period|Sponsors Decision|40|||
161840657|NCT04732221|584462809|FG006|Extension Period|Sponsors Decision|40|||
161840658|NCT04732221|584462803|FG000|Extension Period|Withdrawal by Subject|0|||
161840659|NCT04732221|584462804|FG001|Extension Period|Withdrawal by Subject|0|||
161840660|NCT04732221|584462805|FG002|Extension Period|Withdrawal by Subject|0|||
161840661|NCT04732221|584462806|FG003|Extension Period|Withdrawal by Subject|0|||
161740156|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161740157|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
161740158|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
161740159|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161740160|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161740161|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
161740162|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
161740163|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
161740164|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161740165|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161740166|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161740167|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
161740168|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
161740169|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
161740170|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161740171|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161740172|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161740173|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
161740174|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
161740175|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740176|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740177|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740178|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740179|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
161740180|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
161740181|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740182|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740183|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740184|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740185|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
161740186|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740187|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740188|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740189|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740190|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740191|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
161740192|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
161740193|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
161740194|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
161740195|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
161740196|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
161740197|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
161740198|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
161740199|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740200|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740201|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740202|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740203|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
161740204|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740205|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740206|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740207|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740208|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740209|NCT03444870|584088777|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740210|NCT03444870|584088778|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740211|NCT03444870|584088779|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740212|NCT03444870|584088780|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740213|NCT03444870|584088781|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161740214|NCT03444870|584088782|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161740215|NCT03444870|584088777|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740216|NCT03444870|584088778|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740217|NCT03444870|584088779|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740218|NCT03444870|584088780|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740219|NCT03444870|584088781|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
161740220|NCT03444870|584088782|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740221|NCT03444870|584088777|FG000|Open-Label Extension (OLE) Period|Death|0|||
161740222|NCT03444870|584088778|FG001|Open-Label Extension (OLE) Period|Death|0|||
161740223|NCT03444870|584088779|FG002|Open-Label Extension (OLE) Period|Death|0|||
161740224|NCT03444870|584088780|FG003|Open-Label Extension (OLE) Period|Death|0|||
161740225|NCT03444870|584088781|FG004|Open-Label Extension (OLE) Period|Death|1|||
161740226|NCT03444870|584088782|FG005|Open-Label Extension (OLE) Period|Death|0|||
161740227|NCT02034552|584088783|FG000|Overall Study|Never treated|3|||
161740228|NCT02034552|584088784|FG001|Overall Study|Never treated|2|||
161740229|NCT02034552|584088785|FG002|Overall Study|Never treated|0|||
161740230|NCT02034552|584088783|FG000|Overall Study|Radiological progression|3|||
161740231|NCT02034552|584088784|FG001|Overall Study|Radiological progression|5|||
161740232|NCT02034552|584088785|FG002|Overall Study|Radiological progression|4|||
161740233|NCT02034552|584088783|FG000|Overall Study|AE not assoc. with disease progression|1|||
161740234|NCT02034552|584088784|FG001|Overall Study|AE not assoc. with disease progression|4|||
161740235|NCT02034552|584088785|FG002|Overall Study|AE not assoc. with disease progression|2|||
161740236|NCT02034552|584088783|FG000|Overall Study|AE associated with disease progression|0|||
161740237|NCT02034552|584088784|FG001|Overall Study|AE associated with disease progression|1|||
161740238|NCT02034552|584088785|FG002|Overall Study|AE associated with disease progression|0|||
161740239|NCT02034552|584088783|FG000|Overall Study|Withdrawal by Subject|2|||
161740240|NCT02034552|584088784|FG001|Overall Study|Withdrawal by Subject|1|||
161740241|NCT02034552|584088785|FG002|Overall Study|Withdrawal by Subject|1|||
161740242|NCT02034552|584088783|FG000|Overall Study|Non-compliance with study drug|0|||
161740243|NCT02034552|584088784|FG001|Overall Study|Non-compliance with study drug|0|||
161740244|NCT02034552|584088785|FG002|Overall Study|Non-compliance with study drug|1|||
161740245|NCT02034552|584088783|FG000|Overall Study|Clinical progression|5|||
161740246|NCT02034552|584088784|FG001|Overall Study|Clinical progression|7|||
161740247|NCT02034552|584088785|FG002|Overall Study|Clinical progression|9|||
161740248|NCT03819218|584088788|FG000|Overall Study|Protocol Violation|1|||
161740249|NCT02501902|584088789|FG000|Overall Study|Subject Refused Further Follow-up|0|||
161740250|NCT02501902|584088790|FG001|Overall Study|Subject Refused Further Follow-up|0|||
161740251|NCT02501902|584088791|FG002|Overall Study|Subject Refused Further Follow-up|0|||
161740252|NCT02501902|584088792|FG003|Overall Study|Subject Refused Further Follow-up|0|||
161740253|NCT02501902|584088793|FG004|Overall Study|Subject Refused Further Follow-up|0|||
161740254|NCT02501902|584088794|FG005|Overall Study|Subject Refused Further Follow-up|0|||
161740255|NCT02501902|584088795|FG006|Overall Study|Subject Refused Further Follow-up|0|||
161740256|NCT02501902|584088796|FG007|Overall Study|Subject Refused Further Follow-up|1|||
161740257|NCT02501902|584088789|FG000|Overall Study|Study Terminated by Sponsor|0|||
161740258|NCT02501902|584088790|FG001|Overall Study|Study Terminated by Sponsor|3|||
161740259|NCT02501902|584088791|FG002|Overall Study|Study Terminated by Sponsor|0|||
161740260|NCT02501902|584088792|FG003|Overall Study|Study Terminated by Sponsor|1|||
161740261|NCT02501902|584088793|FG004|Overall Study|Study Terminated by Sponsor|1|||
161740262|NCT02501902|584088794|FG005|Overall Study|Study Terminated by Sponsor|0|||
161740263|NCT02501902|584088795|FG006|Overall Study|Study Terminated by Sponsor|2|||
161740264|NCT02501902|584088796|FG007|Overall Study|Study Terminated by Sponsor|4|||
161740265|NCT02501902|584088789|FG000|Overall Study|Death|3|||
161740266|NCT02501902|584088790|FG001|Overall Study|Death|4|||
161740267|NCT02501902|584088791|FG002|Overall Study|Death|4|||
161740268|NCT02501902|584088792|FG003|Overall Study|Death|10|||
161740269|NCT02501902|584088793|FG004|Overall Study|Death|10|||
161740270|NCT02501902|584088794|FG005|Overall Study|Death|11|||
161740271|NCT02501902|584088795|FG006|Overall Study|Death|7|||
161740272|NCT02501902|584088796|FG007|Overall Study|Death|15|||
161740273|NCT02267278|584088797|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
161740274|NCT02267278|584088797|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
161740275|NCT02267278|584088797|FG000|Overall Study|Developed new cancer diagnoses|2|||
161740276|NCT02267278|584088797|FG000|Overall Study|prescribed prohibited medication|1|||
161740277|NCT02513771|584088798|FG000|Overall Study|Lost to Follow-up|1|||
161740278|NCT02513771|584088799|FG001|Overall Study|Lost to Follow-up|1|||
161740279|NCT02513771|584088798|FG000|Overall Study|Not being able to get to clinic|1|||
161740280|NCT02513771|584088799|FG001|Overall Study|Not being able to get to clinic|0|||
161740281|NCT04295356|584088800|FG000|Overall Study|Physician Decision|1|||
161740282|NCT04295356|584088801|FG001|Overall Study|Physician Decision|0|||
161740283|NCT04295356|584088800|FG000|Overall Study|Lost to Follow-up|0|||
161740284|NCT04295356|584088801|FG001|Overall Study|Lost to Follow-up|3|||
161740285|NCT04295356|584088800|FG000|Overall Study|Protocol Violation|0|||
161740286|NCT04295356|584088801|FG001|Overall Study|Protocol Violation|1|||
161740287|NCT01280266|584088802|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
161840662|NCT04732221|584462807|FG004|Extension Period|Withdrawal by Subject|1|||
161840663|NCT04732221|584462808|FG005|Extension Period|Withdrawal by Subject|5|||
161840664|NCT04732221|584462809|FG006|Extension Period|Withdrawal by Subject|2|||
161840665|NCT03611543|584462810|FG000|Overall Study|Withdrawal by Subject|4|||
161840666|NCT03611543|584462811|FG001|Overall Study|Withdrawal by Subject|4|||
161840667|NCT03611543|584462810|FG000|Overall Study|Physician Decision|1|||
161840668|NCT03611543|584462811|FG001|Overall Study|Physician Decision|1|||
161840669|NCT03611543|584462810|FG000|Overall Study|Protocol Violation|2|||
161840670|NCT03611543|584462811|FG001|Overall Study|Protocol Violation|2|||
161840671|NCT03611543|584462810|FG000|Overall Study|Device failure|2|||
161840672|NCT03611543|584462811|FG001|Overall Study|Device failure|2|||
161840673|NCT03611543|584462810|FG000|Overall Study|Missing information|5|||
161840674|NCT03611543|584462811|FG001|Overall Study|Missing information|5|||
161840675|NCT00379340|584462812|FG000|Overall Study|Death|0|||
161840676|NCT00379340|584462813|FG001|Overall Study|Death|0|||
161840677|NCT00379340|584462814|FG002|Overall Study|Death|0|||
161840678|NCT00379340|584462815|FG003|Overall Study|Death|2|||
161840679|NCT00379340|584462816|FG004|Overall Study|Death|0|||
161840680|NCT00379340|584462812|FG000|Overall Study|Lack of Efficacy|6|||
161840681|NCT00379340|584462813|FG001|Overall Study|Lack of Efficacy|1|||
161840682|NCT00379340|584462814|FG002|Overall Study|Lack of Efficacy|0|||
161840683|NCT00379340|584462815|FG003|Overall Study|Lack of Efficacy|4|||
161840684|NCT00379340|584462816|FG004|Overall Study|Lack of Efficacy|3|||
161840685|NCT00379340|584462812|FG000|Overall Study|Physician Decision|6|||
161840686|NCT00379340|584462813|FG001|Overall Study|Physician Decision|2|||
161840687|NCT00379340|584462814|FG002|Overall Study|Physician Decision|1|||
161840688|NCT00379340|584462815|FG003|Overall Study|Physician Decision|2|||
161840689|NCT00379340|584462816|FG004|Overall Study|Physician Decision|3|||
161840690|NCT00379340|584462812|FG000|Overall Study|Withdrawal by Subject|0|||
161840691|NCT00379340|584462813|FG001|Overall Study|Withdrawal by Subject|0|||
161840692|NCT00379340|584462814|FG002|Overall Study|Withdrawal by Subject|0|||
161840693|NCT00379340|584462815|FG003|Overall Study|Withdrawal by Subject|1|||
161840694|NCT00379340|584462816|FG004|Overall Study|Withdrawal by Subject|0|||
161840695|NCT00379340|584462812|FG000|Overall Study|Refusal of further protocol therapy|1|||
161840696|NCT00379340|584462813|FG001|Overall Study|Refusal of further protocol therapy|0|||
161740288|NCT01280266|584088803|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
161740289|NCT01280266|584088802|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
161740290|NCT01280266|584088803|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
161740291|NCT04116073|584088806|FG000|Overall Study|Withdrawal by Subject|2|||
161740292|NCT04116073|584088806|FG000|Overall Study|failed to maintained eligibility|1|||
161740293|NCT04268004|584088807|FG000|Overall Study|Excluded from analyses|0|||
161740294|NCT04268004|584088808|FG001|Overall Study|Excluded from analyses|1|||
161740295|NCT03495453|584088809|FG000|Overall Study|Withdrawal by Subject|0|||
161740296|NCT03495453|584088810|FG001|Overall Study|Withdrawal by Subject|1|||
161740297|NCT01879319|584088815|FG000|Overall Study|Withdrawal by Subject|1|||
161740298|NCT01879319|584088816|FG001|Overall Study|Withdrawal by Subject|0|||
161740299|NCT01879319|584088815|FG000|Overall Study|Lost to Follow-up|1|||
161740300|NCT01879319|584088816|FG001|Overall Study|Lost to Follow-up|5|||
161740301|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
161740302|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Death|5|||
161740303|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
161740304|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
161840697|NCT00379340|584462814|FG002|Overall Study|Refusal of further protocol therapy|1|||
161840698|NCT00379340|584462815|FG003|Overall Study|Refusal of further protocol therapy|1|||
161840699|NCT00379340|584462816|FG004|Overall Study|Refusal of further protocol therapy|7|||
161840700|NCT00379340|584462812|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
161840701|NCT00379340|584462813|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
161840702|NCT00379340|584462814|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
161840703|NCT00379340|584462815|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
161840704|NCT00379340|584462816|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
161740305|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
161740306|NCT01360762|584088817|FG000|Whole Study Period|Lost to Follow-up|10|||
161740307|NCT01360762|584088817|FG000|Whole Study Period|Death|7|||
161840705|NCT00379340|584462812|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
161840706|NCT00379340|584462813|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
161840707|NCT00379340|584462814|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
161840708|NCT00379340|584462815|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
161840709|NCT00379340|584462816|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
161840710|NCT03047473|584462820|FG000|Overall Study|Lost to Follow-up|2|||
161840711|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Death|89|||
161840712|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Death|193|||
161840713|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Death|198|||
161840714|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
161740308|NCT01360762|584088817|FG000|Whole Study Period|Patient relapsed|18|||
161740309|NCT01360762|584088817|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
161740310|NCT01103778|584088818|FG000|Overall Study|Lost to Follow-up|1|||
161740311|NCT01103778|584088818|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
161740312|NCT01103778|584088818|FG000|Overall Study|Screen failure|1|||
161740313|NCT03067129|584088819|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161740314|NCT03067129|584088820|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161740315|NCT03067129|584088821|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161740316|NCT03067129|584088822|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
161740317|NCT03067129|584088819|FG000|Overall Study|Withdrawal by Subject|0|||
161740318|NCT03067129|584088820|FG001|Overall Study|Withdrawal by Subject|0|||
161740319|NCT03067129|584088821|FG002|Overall Study|Withdrawal by Subject|1|||
161740320|NCT03067129|584088822|FG003|Overall Study|Withdrawal by Subject|2|||
161740321|NCT03067129|584088819|FG000|Overall Study|Lost to Follow-up|5|||
161740322|NCT03067129|584088820|FG001|Overall Study|Lost to Follow-up|5|||
161740323|NCT03067129|584088821|FG002|Overall Study|Lost to Follow-up|4|||
161740324|NCT03067129|584088822|FG003|Overall Study|Lost to Follow-up|3|||
161740325|NCT03372603|584088823|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
161740326|NCT03372603|584088824|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
161740327|NCT03372603|584088823|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
161740328|NCT03372603|584088824|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
161740329|NCT03084718|584088825|FG000|Overall Study|Withdrawal by Subject|4|||
161740330|NCT03084718|584088826|FG001|Overall Study|Withdrawal by Subject|3|||
161740331|NCT03084718|584088827|FG002|Overall Study|Withdrawal by Subject|4|||
161740332|NCT03084718|584088828|FG003|Overall Study|Withdrawal by Subject|0|||
161740333|NCT03084718|584088829|FG004|Overall Study|Withdrawal by Subject|0|||
161740334|NCT03084718|584088825|FG000|Overall Study|Physician Decision|1|||
161740335|NCT03084718|584088826|FG001|Overall Study|Physician Decision|0|||
161740336|NCT03084718|584088827|FG002|Overall Study|Physician Decision|0|||
161740337|NCT03084718|584088828|FG003|Overall Study|Physician Decision|0|||
161740338|NCT03084718|584088829|FG004|Overall Study|Physician Decision|0|||
161740339|NCT03084718|584088825|FG000|Overall Study|Adverse Event|3|||
161740340|NCT03084718|584088826|FG001|Overall Study|Adverse Event|5|||
161740341|NCT03084718|584088827|FG002|Overall Study|Adverse Event|5|||
161740342|NCT03084718|584088828|FG003|Overall Study|Adverse Event|8|||
161740343|NCT03084718|584088829|FG004|Overall Study|Adverse Event|2|||
161740344|NCT03084718|584088825|FG000|Overall Study|Lack of Efficacy|2|||
161740345|NCT03084718|584088826|FG001|Overall Study|Lack of Efficacy|0|||
161740346|NCT03084718|584088827|FG002|Overall Study|Lack of Efficacy|1|||
161740347|NCT03084718|584088828|FG003|Overall Study|Lack of Efficacy|4|||
161740348|NCT03084718|584088829|FG004|Overall Study|Lack of Efficacy|0|||
161740349|NCT03084718|584088825|FG000|Overall Study|Lost to Follow-up|0|||
161740350|NCT03084718|584088826|FG001|Overall Study|Lost to Follow-up|1|||
161740351|NCT03084718|584088827|FG002|Overall Study|Lost to Follow-up|0|||
161740352|NCT03084718|584088828|FG003|Overall Study|Lost to Follow-up|0|||
161740353|NCT03084718|584088829|FG004|Overall Study|Lost to Follow-up|2|||
161740354|NCT03084718|584088825|FG000|Overall Study|Protocol Violation|0|||
161740355|NCT03084718|584088826|FG001|Overall Study|Protocol Violation|0|||
161740356|NCT03084718|584088827|FG002|Overall Study|Protocol Violation|1|||
161740357|NCT03084718|584088828|FG003|Overall Study|Protocol Violation|0|||
161740358|NCT03084718|584088829|FG004|Overall Study|Protocol Violation|0|||
161740359|NCT03084718|584088825|FG000|Overall Study|Death|0|||
161740360|NCT03084718|584088826|FG001|Overall Study|Death|1|||
161740361|NCT03084718|584088827|FG002|Overall Study|Death|0|||
161740362|NCT03084718|584088828|FG003|Overall Study|Death|0|||
161740363|NCT03084718|584088829|FG004|Overall Study|Death|0|||
161740364|NCT03084718|584088825|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
161740365|NCT03084718|584088826|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
161740366|NCT03084718|584088827|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
161740367|NCT03084718|584088828|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
161740368|NCT03084718|584088829|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
161740369|NCT03986190|584088830|FG000|Overall Study|Withdrawal by Subject|12|||
161740370|NCT03986190|584088831|FG001|Overall Study|Withdrawal by Subject|0|||
161740371|NCT02806947|584088832|FG000|Overall Study|Withdrawal by Subject|5|||
161740372|NCT02806947|584088833|FG001|Overall Study|Withdrawal by Subject|1|||
161840715|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
161740373|NCT04929613|584088834|FG000|Overall Study|Withdrawal by Subject|12|||
161740374|NCT00844649|584088841|FG000|Overall Study|Progressive Disease|196|||
161740375|NCT00844649|584088842|FG001|Overall Study|Progressive Disease|245|||
161740376|NCT00844649|584088841|FG000|Overall Study|Adverse Event|128|||
161740377|NCT00844649|584088842|FG001|Overall Study|Adverse Event|73|||
161740378|NCT00844649|584088841|FG000|Overall Study|Physician Decision|25|||
161740379|NCT00844649|584088842|FG001|Overall Study|Physician Decision|18|||
161740380|NCT00844649|584088841|FG000|Overall Study|Protocol Violation|10|||
161740381|NCT00844649|584088842|FG001|Overall Study|Protocol Violation|6|||
161740382|NCT00844649|584088841|FG000|Overall Study|Withdrawal by Subject|28|||
161740383|NCT00844649|584088842|FG001|Overall Study|Withdrawal by Subject|39|||
161740384|NCT00844649|584088841|FG000|Overall Study|Other|7|||
161740385|NCT00844649|584088842|FG001|Overall Study|Other|10|||
161740386|NCT00844649|584088841|FG000|Overall Study|Withdrew prior to starting treatment|11|||
161740387|NCT00844649|584088842|FG001|Overall Study|Withdrew prior to starting treatment|27|||
161740388|NCT01594333|584088843|FG000|Overall Study|Death|96|||
161740389|NCT01594333|584088844|FG001|Overall Study|Death|83|||
161740390|NCT01594333|584088843|FG000|Overall Study|Lost to Follow-up|5|||
161740391|NCT01594333|584088844|FG001|Overall Study|Lost to Follow-up|5|||
161740392|NCT01594333|584088843|FG000|Overall Study|Withdrawal by Subject|60|||
161740393|NCT01594333|584088844|FG001|Overall Study|Withdrawal by Subject|63|||
161740394|NCT00242580|584088848|FG000|Overall Study|Adverse Event|3|||
161740395|NCT00242580|584088849|FG001|Overall Study|Adverse Event|0|||
161740396|NCT00242580|584088850|FG002|Overall Study|Adverse Event|2|||
161740397|NCT00242580|584088848|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161740398|NCT00242580|584088849|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161740399|NCT00242580|584088850|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
161740400|NCT00242580|584088848|FG000|Overall Study|Protocol Violation|0|||
161740401|NCT00242580|584088849|FG001|Overall Study|Protocol Violation|0|||
161740402|NCT00242580|584088850|FG002|Overall Study|Protocol Violation|1|||
161740403|NCT00242580|584088848|FG000|Overall Study|Subject withdrew consent|2|||
161740404|NCT00242580|584088849|FG001|Overall Study|Subject withdrew consent|2|||
161740405|NCT00242580|584088850|FG002|Overall Study|Subject withdrew consent|5|||
161740406|NCT00242580|584088848|FG000|Overall Study|Lost to Follow-up|0|||
161740407|NCT00242580|584088849|FG001|Overall Study|Lost to Follow-up|3|||
161740408|NCT00242580|584088850|FG002|Overall Study|Lost to Follow-up|0|||
161740409|NCT00242580|584088848|FG000|Overall Study|Death|1|||
161740410|NCT00242580|584088849|FG001|Overall Study|Death|2|||
161740411|NCT00242580|584088850|FG002|Overall Study|Death|1|||
161740412|NCT03666858|584088853|FG000|Cohort 1|Adverse Event|1|||
161740413|NCT03666858|584088854|FG001|Cohort 1|Adverse Event|0|||
161740414|NCT03666858|584088853|FG000|Cohort 2|Adverse Event|0|||
161740415|NCT03666858|584088854|FG001|Cohort 2|Adverse Event|1|||
161740416|NCT03282357|584088855|FG000|Overall Study|Lost to Follow-up|3|||
161740417|NCT03282357|584088855|FG000|Overall Study|Withdrawal by Subject|4|||
161740418|NCT03282357|584088855|FG000|Overall Study|Adverse Event|1|||
161740419|NCT03282357|584088855|FG000|Overall Study|Other|9|||
161740420|NCT00393913|584088857|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
161740421|NCT00393913|584088857|FG000|Initial Assessment|Withdrawal by Subject|16|||
161740422|NCT00393913|584088857|FG000|CPAP|Withdrawal by Subject|3|||
161740423|NCT00393913|584088857|FG000|CPAP|Physician Decision|1|||
161740424|NCT00393913|584088857|FG000|CPAP|TEchnical problem with CPAP|3|||
161740425|NCT01518244|584088858|FG000|Overall Study|Adverse Event|3|||
161740426|NCT04900038|584088860|FG000|Overall Study|Adverse Event|1|||
161740427|NCT04900038|584088861|FG001|Overall Study|Adverse Event|0|||
161740428|NCT04900038|584088862|FG002|Overall Study|Adverse Event|1|||
161740429|NCT04900038|584088863|FG003|Overall Study|Adverse Event|1|||
161740430|NCT04900038|584088860|FG000|Overall Study|Withdrawal by Subject|0|||
161740431|NCT04900038|584088861|FG001|Overall Study|Withdrawal by Subject|1|||
161740432|NCT04900038|584088862|FG002|Overall Study|Withdrawal by Subject|0|||
161740433|NCT04900038|584088863|FG003|Overall Study|Withdrawal by Subject|0|||
161740434|NCT04900038|584088860|FG000|Overall Study|Study terminated by sponsor|18|||
161740435|NCT04900038|584088861|FG001|Overall Study|Study terminated by sponsor|15|||
161740436|NCT04900038|584088862|FG002|Overall Study|Study terminated by sponsor|17|||
161740437|NCT04900038|584088863|FG003|Overall Study|Study terminated by sponsor|14|||
161740438|NCT04900038|584088860|FG000|Overall Study|Protocol Deviation|1|||
161740439|NCT04900038|584088861|FG001|Overall Study|Protocol Deviation|1|||
161740440|NCT04900038|584088862|FG002|Overall Study|Protocol Deviation|0|||
161740441|NCT04900038|584088863|FG003|Overall Study|Protocol Deviation|0|||
161740442|NCT04900038|584088860|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
161740443|NCT04900038|584088861|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
161740444|NCT04900038|584088862|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
161740445|NCT04900038|584088863|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
161740446|NCT04900038|584088860|FG000|Overall Study|Lost to Follow-up|0|||
161740447|NCT04900038|584088861|FG001|Overall Study|Lost to Follow-up|0|||
161740448|NCT04900038|584088862|FG002|Overall Study|Lost to Follow-up|0|||
161740449|NCT04900038|584088863|FG003|Overall Study|Lost to Follow-up|1|||
161740450|NCT00594204|584088865|FG000|Overall Study|Adverse Event|15|||
161740451|NCT00594204|584088866|FG001|Overall Study|Adverse Event|3|||
161740452|NCT00594204|584088865|FG000|Overall Study|Lost to Follow-up|9|||
161740453|NCT00594204|584088866|FG001|Overall Study|Lost to Follow-up|5|||
161740454|NCT00594204|584088865|FG000|Overall Study|Withdrawal by Subject|23|||
161740455|NCT00594204|584088866|FG001|Overall Study|Withdrawal by Subject|29|||
161740456|NCT00594204|584088865|FG000|Overall Study|Other|4|||
161740457|NCT00594204|584088866|FG001|Overall Study|Other|3|||
161840716|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
161840717|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
161840718|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
161840719|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
161840720|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
161840721|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
161840722|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
161840723|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
161840724|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
161840725|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
161840726|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
161840727|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
161840728|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
161840729|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
161840730|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
161840731|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
161840732|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Death|36|||
161840733|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Death|87|||
161840734|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Death|100|||
161840735|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
161740458|NCT00594204|584088865|FG000|Overall Study|Lack of Efficacy|3|||
161740459|NCT00594204|584088866|FG001|Overall Study|Lack of Efficacy|4|||
161740460|NCT00594204|584088865|FG000|Overall Study|Randomized but not treated|4|||
161740461|NCT00594204|584088866|FG001|Overall Study|Randomized but not treated|1|||
161740462|NCT01740388|584088867|FG000|Overall Study|Withdrawal by Subject|1|||
161740463|NCT01740388|584088868|FG001|Overall Study|Withdrawal by Subject|2|||
161740464|NCT01740388|584088867|FG000|Overall Study|Lost to Follow-up|2|||
161740465|NCT01740388|584088868|FG001|Overall Study|Lost to Follow-up|0|||
161740466|NCT01740388|584088867|FG000|Overall Study|Physician Decision|2|||
161740467|NCT01740388|584088868|FG001|Overall Study|Physician Decision|6|||
161740468|NCT01740388|584088867|FG000|Overall Study|Subjects missing data, completed|41|||
161740469|NCT01740388|584088868|FG001|Overall Study|Subjects missing data, completed|36|||
161740470|NCT01582971|584088871|FG000|Overall Study|Death|2|||
161740471|NCT01582971|584088872|FG001|Overall Study|Death|1|||
161740472|NCT01582971|584088871|FG000|Overall Study|Lost to Follow-up|18|||
161740473|NCT01582971|584088872|FG001|Overall Study|Lost to Follow-up|21|||
161740474|NCT01582971|584088871|FG000|Overall Study|Withdrawal by Subject|4|||
161740475|NCT01582971|584088872|FG001|Overall Study|Withdrawal by Subject|2|||
161740476|NCT01582971|584088871|FG000|Overall Study|Other|15|||
161740477|NCT01582971|584088872|FG001|Overall Study|Other|13|||
161740478|NCT01641991|584088873|FG000|Overall Study|Physician Decision|0|||
161740479|NCT01641991|584088874|FG001|Overall Study|Physician Decision|1|||
161740480|NCT01641991|584088875|FG002|Overall Study|Physician Decision|7|||
161740481|NCT01641991|584088876|FG003|Overall Study|Physician Decision|5|||
161740482|NCT01641991|584088873|FG000|Overall Study|Withdrawal by Subject|4|||
161740483|NCT01641991|584088874|FG001|Overall Study|Withdrawal by Subject|2|||
161740484|NCT01641991|584088875|FG002|Overall Study|Withdrawal by Subject|1|||
161740485|NCT01641991|584088876|FG003|Overall Study|Withdrawal by Subject|5|||
161740486|NCT01641991|584088873|FG000|Overall Study|Adverse Event|2|||
161740487|NCT01641991|584088874|FG001|Overall Study|Adverse Event|1|||
161740488|NCT01641991|584088875|FG002|Overall Study|Adverse Event|2|||
161740489|NCT01641991|584088876|FG003|Overall Study|Adverse Event|1|||
161740490|NCT01641991|584088873|FG000|Overall Study|Lost to Follow-up|0|||
161740491|NCT01641991|584088874|FG001|Overall Study|Lost to Follow-up|2|||
161740492|NCT01641991|584088875|FG002|Overall Study|Lost to Follow-up|3|||
161740493|NCT01641991|584088876|FG003|Overall Study|Lost to Follow-up|1|||
161840736|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
161840737|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
161740494|NCT01641991|584088873|FG000|Overall Study|Protocol Violation|1|||
161740495|NCT01641991|584088874|FG001|Overall Study|Protocol Violation|1|||
161740496|NCT01641991|584088875|FG002|Overall Study|Protocol Violation|3|||
161740497|NCT01641991|584088876|FG003|Overall Study|Protocol Violation|0|||
161740498|NCT01641991|584088873|FG000|Overall Study|Pregnancy|0|||
161740499|NCT01641991|584088874|FG001|Overall Study|Pregnancy|0|||
161840738|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Physician Decision|0|||
161840739|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Physician Decision|1|||
161840740|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Physician Decision|0|||
161840741|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
161840742|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
161840743|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
161840744|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
161840745|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
161840746|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
161840747|NCT02031458|584462821|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
161840748|NCT02031458|584462822|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
161840749|NCT02031458|584462823|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
161840750|NCT02031458|584462821|FG000|Baseline to May 8, 2015|On Treatment|43|||
161840751|NCT02031458|584462822|FG001|Baseline to May 8, 2015|On Treatment|81|||
161840752|NCT02031458|584462823|FG002|Baseline to May 8, 2015|On Treatment|73|||
161840753|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
161840754|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
161840755|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
161840756|NCT04305587|584462824|FG000|Overall Study|Withdrawal by Subject|0|||
161840757|NCT04305587|584462825|FG001|Overall Study|Withdrawal by Subject|0|||
161840758|NCT04305587|584462826|FG002|Overall Study|Withdrawal by Subject|0|||
161840759|NCT04305587|584462827|FG003|Overall Study|Withdrawal by Subject|1|||
161840760|NCT04305587|584462828|FG004|Overall Study|Withdrawal by Subject|0|||
161840761|NCT04305587|584462829|FG005|Overall Study|Withdrawal by Subject|0|||
161840762|NCT04305587|584462830|FG006|Overall Study|Withdrawal by Subject|0|||
161840763|NCT04305587|584462831|FG007|Overall Study|Withdrawal by Subject|0|||
161840764|NCT04305587|584462832|FG008|Overall Study|Withdrawal by Subject|0|||
161840765|NCT02752906|584462833|FG000|Overall Study|Protocol Violation|2|||
161840766|NCT02752906|584462834|FG001|Overall Study|Protocol Violation|1|||
161840767|NCT02752906|584462833|FG000|Overall Study|Withdrawal by Subject|2|||
161840768|NCT02752906|584462834|FG001|Overall Study|Withdrawal by Subject|2|||
161840769|NCT02752906|584462833|FG000|Overall Study|Lost to Follow-up|3|||
161840770|NCT02752906|584462834|FG001|Overall Study|Lost to Follow-up|2|||
161840771|NCT01007942|584462836|FG000|Overall Study|Adverse Event|29|||
161840772|NCT01007942|584462837|FG001|Overall Study|Adverse Event|14|||
161840773|NCT01007942|584462836|FG000|Overall Study|Abnormal test procedure|0|||
161840774|NCT01007942|584462837|FG001|Overall Study|Abnormal test procedure|1|||
161840775|NCT01007942|584462836|FG000|Overall Study|Disease progression|217|||
161840776|NCT01007942|584462837|FG001|Overall Study|Disease progression|242|||
161840777|NCT01007942|584462836|FG000|Overall Study|New cancer therapy|5|||
161840778|NCT01007942|584462837|FG001|Overall Study|New cancer therapy|1|||
161840779|NCT01007942|584462836|FG000|Overall Study|Protocol Violation|1|||
161840780|NCT01007942|584462837|FG001|Overall Study|Protocol Violation|1|||
161840781|NCT01007942|584462836|FG000|Overall Study|Withdrawal by Subject|19|||
161840782|NCT01007942|584462837|FG001|Overall Study|Withdrawal by Subject|14|||
161840783|NCT01007942|584462836|FG000|Overall Study|Lost to Follow-up|1|||
161840784|NCT01007942|584462837|FG001|Overall Study|Lost to Follow-up|0|||
161840785|NCT01007942|584462836|FG000|Overall Study|Administrative problems|2|||
161840786|NCT01007942|584462837|FG001|Overall Study|Administrative problems|0|||
161840787|NCT01007942|584462836|FG000|Overall Study|Death|3|||
161840788|NCT01007942|584462837|FG001|Overall Study|Death|2|||
161840789|NCT01007942|584462836|FG000|Overall Study|Patients untreated|4|||
161840790|NCT01007942|584462837|FG001|Overall Study|Patients untreated|3|||
161840791|NCT03412396|584462838|FG000|Overall Study|Withdrawal by Subject|2|||
161740500|NCT01641991|584088875|FG002|Overall Study|Pregnancy|1|||
161740501|NCT01641991|584088876|FG003|Overall Study|Pregnancy|0|||
161740502|NCT01641991|584088873|FG000|Overall Study|no longer eligible|2|||
161740503|NCT01641991|584088874|FG001|Overall Study|no longer eligible|1|||
161740504|NCT01641991|584088875|FG002|Overall Study|no longer eligible|0|||
161740505|NCT01641991|584088876|FG003|Overall Study|no longer eligible|4|||
161740506|NCT03245723|584088877|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
161740507|NCT03245723|584088878|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
161740508|NCT03245723|584088877|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
161740509|NCT03245723|584088878|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
161740510|NCT03245723|584088877|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
161740511|NCT03245723|584088878|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
161740512|NCT03245723|584088877|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
161740513|NCT03245723|584088878|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
161740514|NCT00077376|584088879|FG000|Overall Study|Adverse Event|8|||
161740515|NCT00077376|584088879|FG000|Overall Study|Withdrawal by Subject|2|||
161740516|NCT00077376|584088879|FG000|Overall Study|Death|1|||
161740517|NCT00077376|584088879|FG000|Overall Study|Physician Decision|1|||
161740518|NCT00077376|584088879|FG000|Overall Study|Alternative therapy|5|||
161740519|NCT00077376|584088879|FG000|Overall Study|Complicating disease|1|||
161740520|NCT00077376|584088879|FG000|Overall Study|Still on treatment|1|||
161740521|NCT00077376|584088879|FG000|Overall Study|Symptomatic deterioration|1|||
161740522|NCT00077376|584088879|FG000|Overall Study|Surgery|1|||
161740523|NCT00077376|584088879|FG000|Overall Study|Insurance ran out|1|||
161740524|NCT03927911|584090433|FG000|Overall Study|problems with eDiary|0|||
161740525|NCT03927911|584090434|FG001|Overall Study|problems with eDiary|1|||
161740526|NCT03927911|584090435|FG002|Overall Study|problems with eDiary|0|||
161740527|NCT03927911|584090436|FG003|Overall Study|problems with eDiary|1|||
161740528|NCT03927911|584090437|FG004|Overall Study|problems with eDiary|0|||
161740529|NCT03927911|584090438|FG005|Overall Study|problems with eDiary|4|||
161740530|NCT03927911|584090433|FG000|Overall Study|Adverse Event|0|||
161740531|NCT03927911|584090434|FG001|Overall Study|Adverse Event|0|||
161740532|NCT03927911|584090435|FG002|Overall Study|Adverse Event|0|||
161740533|NCT03927911|584090436|FG003|Overall Study|Adverse Event|0|||
161740534|NCT03927911|584090437|FG004|Overall Study|Adverse Event|0|||
161740535|NCT03927911|584090438|FG005|Overall Study|Adverse Event|1|||
161740536|NCT03927911|584090433|FG000|Overall Study|not treated -study terminated by sponsor|0|||
161740537|NCT03927911|584090434|FG001|Overall Study|not treated -study terminated by sponsor|1|||
161740538|NCT03927911|584090435|FG002|Overall Study|not treated -study terminated by sponsor|0|||
161740539|NCT03927911|584090436|FG003|Overall Study|not treated -study terminated by sponsor|0|||
161740540|NCT03927911|584090437|FG004|Overall Study|not treated -study terminated by sponsor|0|||
161740541|NCT03927911|584090438|FG005|Overall Study|not treated -study terminated by sponsor|0|||
161740542|NCT03927911|584090433|FG000|Overall Study|Surgery cancelled|0|||
161740543|NCT03927911|584090434|FG001|Overall Study|Surgery cancelled|0|||
161740544|NCT03927911|584090435|FG002|Overall Study|Surgery cancelled|0|||
161740545|NCT03927911|584090436|FG003|Overall Study|Surgery cancelled|1|||
161740546|NCT03927911|584090437|FG004|Overall Study|Surgery cancelled|0|||
161740547|NCT03927911|584090438|FG005|Overall Study|Surgery cancelled|1|||
161740548|NCT03927911|584090433|FG000|Overall Study|Protocol Violation|0|||
161740549|NCT03927911|584090434|FG001|Overall Study|Protocol Violation|0|||
161740550|NCT03927911|584090435|FG002|Overall Study|Protocol Violation|0|||
161740551|NCT03927911|584090436|FG003|Overall Study|Protocol Violation|0|||
161740552|NCT03927911|584090437|FG004|Overall Study|Protocol Violation|0|||
161740553|NCT03927911|584090438|FG005|Overall Study|Protocol Violation|1|||
161740554|NCT02658968|584090439|FG000|Received Rituximab|Adverse Event|0|||
161740555|NCT02658968|584090440|FG001|Received Rituximab|Adverse Event|0|||
161740556|NCT02658968|584090441|FG002|Received Rituximab|Adverse Event|0|||
161740557|NCT02658968|584090442|FG003|Received Rituximab|Adverse Event|0|||
161740558|NCT02658968|584090443|FG004|Received Rituximab|Adverse Event|1|||
161740559|NCT02658968|584090439|FG000|Received Rituximab|Progressive disease|0|||
161740560|NCT02658968|584090440|FG001|Received Rituximab|Progressive disease|0|||
161740561|NCT02658968|584090441|FG002|Received Rituximab|Progressive disease|0|||
161740562|NCT02658968|584090442|FG003|Received Rituximab|Progressive disease|0|||
161740563|NCT02658968|584090443|FG004|Received Rituximab|Progressive disease|1|||
161740564|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
161740565|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
161740566|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
161740567|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
161740568|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
161740569|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
161740570|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
161740571|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
161740572|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
161740573|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
161740574|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161740575|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
161740576|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161740577|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
161740578|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161740579|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740580|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
161740581|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740582|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740583|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740584|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
161740585|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
161740586|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
161740587|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
161740588|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
161740589|NCT01149343|584090444|FG000|Overall Study|Withdrawal by Subject|1|||
161740590|NCT01149343|584090445|FG001|Overall Study|Withdrawal by Subject|1|||
161740591|NCT01149343|584090446|FG002|Overall Study|Withdrawal by Subject|1|||
161740592|NCT01149343|584090447|FG003|Overall Study|Withdrawal by Subject|5|||
161740593|NCT01149343|584090444|FG000|Overall Study|Death|10|||
161740594|NCT01149343|584090445|FG001|Overall Study|Death|13|||
161740595|NCT01149343|584090446|FG002|Overall Study|Death|18|||
161740596|NCT01149343|584090447|FG003|Overall Study|Death|18|||
161740597|NCT01149343|584090444|FG000|Overall Study|Lost to Follow-up|1|||
161740598|NCT01149343|584090445|FG001|Overall Study|Lost to Follow-up|0|||
161740599|NCT01149343|584090446|FG002|Overall Study|Lost to Follow-up|0|||
161740600|NCT01149343|584090447|FG003|Overall Study|Lost to Follow-up|1|||
161740601|NCT01149343|584090444|FG000|Overall Study|Other|8|||
161740602|NCT01149343|584090445|FG001|Overall Study|Other|10|||
161740603|NCT01149343|584090446|FG002|Overall Study|Other|2|||
161740604|NCT01149343|584090447|FG003|Overall Study|Other|14|||
161740605|NCT01149343|584090444|FG000|Overall Study|Sponsor study termination|0|||
161740606|NCT01149343|584090445|FG001|Overall Study|Sponsor study termination|0|||
161740607|NCT01149343|584090446|FG002|Overall Study|Sponsor study termination|0|||
161740608|NCT01149343|584090447|FG003|Overall Study|Sponsor study termination|2|||
161740609|NCT01149343|584090444|FG000|Overall Study|Recurrence / Progressive disease|0|||
161740610|NCT01149343|584090445|FG001|Overall Study|Recurrence / Progressive disease|0|||
161740611|NCT01149343|584090446|FG002|Overall Study|Recurrence / Progressive disease|1|||
161740612|NCT01149343|584090447|FG003|Overall Study|Recurrence / Progressive disease|0|||
161740613|NCT03472040|584090464|FG000|Overall Study|Physician Decision|0|||
161740614|NCT03472040|584090465|FG001|Overall Study|Physician Decision|3|||
161740615|NCT03472040|584090464|FG000|Overall Study|Withdrawal by Subject|10|||
161740616|NCT03472040|584090465|FG001|Overall Study|Withdrawal by Subject|23|||
161740617|NCT03472040|584090464|FG000|Overall Study|Perceived Lack of Efficacy|29|||
161740618|NCT03472040|584090465|FG001|Overall Study|Perceived Lack of Efficacy|30|||
161740619|NCT03472040|584090464|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
161740620|NCT03472040|584090465|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
161740621|NCT03472040|584090464|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
161740622|NCT03472040|584090465|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
161740623|NCT03472040|584090464|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
161740624|NCT03472040|584090465|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
161740625|NCT03472040|584090464|FG000|Overall Study|Subject Non-compliance|2|||
161740626|NCT03472040|584090465|FG001|Overall Study|Subject Non-compliance|5|||
161740627|NCT03472040|584090464|FG000|Overall Study|Discontinuation due to Rash|0|||
161740628|NCT03472040|584090465|FG001|Overall Study|Discontinuation due to Rash|1|||
161740629|NCT03472040|584090464|FG000|Overall Study|Subsequent Ineligibility|0|||
161740630|NCT03472040|584090465|FG001|Overall Study|Subsequent Ineligibility|2|||
161840792|NCT03412396|584462838|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
161840793|NCT03412396|584462838|FG000|Overall Study|Did not undergo RP|2|||
161840794|NCT00655876|584462840|FG000|Overall Study|Protocol Violation|9|||
161740631|NCT03472040|584090464|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
161740632|NCT03472040|584090465|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
161840795|NCT00655876|584462841|FG001|Overall Study|Protocol Violation|7|||
161840796|NCT00470067|584462844|FG000|Overall Study|Death|1|||
161740633|NCT02769832|584090466|FG000|Overall Study|Death|30|||
161740634|NCT02197897|584090467|FG000|Overall Study|not eligible|1|||
161840797|NCT00470067|584462844|FG000|Overall Study|Disease Progression|6|||
161840798|NCT01460901|584462845|FG000|Overall Study|Withdrawal by Subject|2|||
161840799|NCT01059539|584462848|FG000|Overall Study|Adverse Event|66|||
161840800|NCT01059539|584462848|FG000|Overall Study|Insufficient Therapeutic Response|26|||
161840801|NCT01059539|584462848|FG000|Overall Study|Protocol Violation|55|||
161840802|NCT01059539|584462848|FG000|Overall Study|Withdrawal of Consent|80|||
161840803|NCT01059539|584462848|FG000|Overall Study|Lost to Follow-up|42|||
161840804|NCT01059539|584462848|FG000|Overall Study|Reason Not Specified|2|||
161840805|NCT04091659|584462852|FG000|Overall Study|Protocol Violation|3|||
161840806|NCT04091659|584462853|FG001|Overall Study|Protocol Violation|0|||
161840807|NCT04091659|584462852|FG000|Overall Study|Lost to Follow-up|0|||
161840808|NCT04091659|584462853|FG001|Overall Study|Lost to Follow-up|1|||
161840809|NCT00895947|584462854|FG000|Overall Study|Adverse Event|3|||
161840810|NCT00895947|584462855|FG001|Overall Study|Adverse Event|4|||
161740635|NCT00650091|584090469|FG000|Amended Study Design|Withdrawal by Subject|12|||
161740636|NCT00650091|584090470|FG001|Amended Study Design|Withdrawal by Subject|11|||
161740637|NCT00650091|584090471|FG002|Amended Study Design|Withdrawal by Subject|0|||
161740638|NCT00650091|584090469|FG000|Amended Study Design|Physician Decision|5|||
161740639|NCT00650091|584090470|FG001|Amended Study Design|Physician Decision|0|||
161740640|NCT00650091|584090471|FG002|Amended Study Design|Physician Decision|0|||
161740641|NCT00650091|584090469|FG000|Amended Study Design|Adverse Event|1|||
161740642|NCT00650091|584090470|FG001|Amended Study Design|Adverse Event|4|||
161740643|NCT00650091|584090471|FG002|Amended Study Design|Adverse Event|0|||
161740644|NCT00650091|584090469|FG000|Amended Study Design|Lung transplantation|4|||
161740645|NCT00650091|584090470|FG001|Amended Study Design|Lung transplantation|2|||
161740646|NCT00650091|584090471|FG002|Amended Study Design|Lung transplantation|0|||
161740647|NCT00650091|584090469|FG000|Amended Study Design|Other|1|||
161740648|NCT00650091|584090470|FG001|Amended Study Design|Other|3|||
161740649|NCT00650091|584090471|FG002|Amended Study Design|Other|0|||
161740650|NCT04724733|584090491|FG000|Overall Study|Lost to Follow-up|1|||
161740651|NCT04724733|584090492|FG001|Overall Study|Lost to Follow-up|1|||
161740652|NCT04724733|584090493|FG002|Overall Study|Lost to Follow-up|1|||
161740653|NCT03341923|584090494|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
161740654|NCT03341923|584090495|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
161740655|NCT04511819|584090496|FG000|Overall Study|Non-compliance with study drug|5|||
161740656|NCT04511819|584090497|FG001|Overall Study|Non-compliance with study drug|1|||
161740657|NCT04511819|584090496|FG000|Overall Study|Withdrawal by Subject|0|||
161740658|NCT04511819|584090497|FG001|Overall Study|Withdrawal by Subject|3|||
161740659|NCT04511819|584090496|FG000|Overall Study|Adverse Event|0|||
161740660|NCT04511819|584090497|FG001|Overall Study|Adverse Event|1|||
161740661|NCT04511819|584090496|FG000|Overall Study|Protocol deviation|1|||
161740662|NCT04511819|584090497|FG001|Overall Study|Protocol deviation|0|||
161740663|NCT00168064|584090500|FG000|Overall Study|Adverse Event|26|||
161740664|NCT00168064|584090501|FG001|Overall Study|Adverse Event|22|||
161740665|NCT00168064|584090500|FG000|Overall Study|Withdrawal by Subject|3|||
161740666|NCT00168064|584090501|FG001|Overall Study|Withdrawal by Subject|4|||
161740667|NCT00168064|584090500|FG000|Overall Study|Lack of Efficacy|4|||
161740668|NCT00168064|584090501|FG001|Overall Study|Lack of Efficacy|4|||
161740669|NCT00168064|584090500|FG000|Overall Study|Lost to Follow-up|4|||
161740670|NCT00168064|584090501|FG001|Overall Study|Lost to Follow-up|3|||
161740671|NCT00168064|584090500|FG000|Overall Study|Non-compliance|2|||
161740672|NCT00168064|584090501|FG001|Overall Study|Non-compliance|3|||
161740673|NCT00168064|584090500|FG000|Overall Study|Concurrent Illness|4|||
161740674|NCT00168064|584090501|FG001|Overall Study|Concurrent Illness|3|||
161740675|NCT00168064|584090500|FG000|Overall Study|Subject's Best interest|2|||
161740676|NCT00168064|584090501|FG001|Overall Study|Subject's Best interest|2|||
161740677|NCT00168064|584090500|FG000|Overall Study|Various|4|||
161740678|NCT00168064|584090501|FG001|Overall Study|Various|3|||
161740679|NCT00589979|584090503|FG000|Run-In Period|Adverse Event|5|||
161740680|NCT00589979|584090504|FG001|Run-In Period|Adverse Event|0|||
161740681|NCT00589979|584090505|FG002|Run-In Period|Adverse Event|0|||
161740682|NCT00589979|584090503|FG000|Run-In Period|Protocol Violation|3|||
161740683|NCT00589979|584090504|FG001|Run-In Period|Protocol Violation|0|||
161740684|NCT00589979|584090505|FG002|Run-In Period|Protocol Violation|0|||
161740685|NCT00589979|584090503|FG000|Run-In Period|Did not qualify for randomization|54|||
161740686|NCT00589979|584090504|FG001|Run-In Period|Did not qualify for randomization|0|||
161740687|NCT00589979|584090505|FG002|Run-In Period|Did not qualify for randomization|0|||
161740688|NCT00589979|584090503|FG000|Run-In Period|Withdrawal by Subject|10|||
161740689|NCT00589979|584090504|FG001|Run-In Period|Withdrawal by Subject|0|||
161740690|NCT00589979|584090505|FG002|Run-In Period|Withdrawal by Subject|0|||
161740691|NCT00589979|584090503|FG000|Run-In Period|Informed Consent Withdrawn|4|||
161740692|NCT00589979|584090504|FG001|Run-In Period|Informed Consent Withdrawn|0|||
161740693|NCT00589979|584090505|FG002|Run-In Period|Informed Consent Withdrawn|0|||
161740694|NCT00589979|584090503|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
161740695|NCT00589979|584090504|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
161740696|NCT00589979|584090505|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
161740697|NCT00589979|584090503|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
161740698|NCT00589979|584090504|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
161740699|NCT00589979|584090505|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
161740700|NCT00589979|584090503|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161740701|NCT00589979|584090504|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161740702|NCT00589979|584090505|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
161740703|NCT00589979|584090503|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
161740704|NCT00589979|584090504|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
161740705|NCT00589979|584090505|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
161740706|NCT00589979|584090503|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161740707|NCT00589979|584090504|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161740708|NCT00589979|584090505|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
161740709|NCT00589979|584090503|FG000|Double-Blind Treatment Period 2|Other|0|||
161740710|NCT00589979|584090504|FG001|Double-Blind Treatment Period 2|Other|0|||
161740711|NCT00589979|584090505|FG002|Double-Blind Treatment Period 2|Other|1|||
161740712|NCT00589979|584090503|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
161740713|NCT00589979|584090504|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
161740714|NCT00589979|584090505|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
161740715|NCT00589979|584090503|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
161740716|NCT00589979|584090504|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
161740717|NCT00589979|584090505|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
161740718|NCT01153841|584090506|FG000|Overall Study|Adverse Event|1|||
161740719|NCT01153841|584090507|FG001|Overall Study|Adverse Event|0|||
161740720|NCT01153841|584090506|FG000|Overall Study|Withdrawal by Subject|1|||
161740721|NCT01153841|584090507|FG001|Overall Study|Withdrawal by Subject|0|||
161740722|NCT01153841|584090506|FG000|Overall Study|Protocol Violation|2|||
161740723|NCT01153841|584090507|FG001|Overall Study|Protocol Violation|0|||
161740724|NCT01153841|584090506|FG000|Overall Study|Lost to Follow-up|2|||
161740725|NCT01153841|584090507|FG001|Overall Study|Lost to Follow-up|0|||
161740726|NCT03428997|584090513|FG000|Overall Study|Sponsor decision.|1|||
161740727|NCT03428997|584090513|FG000|Overall Study|Withdrawal by Subject|3|||
161740728|NCT03428997|584090513|FG000|Overall Study|Lost to Follow-up|4|||
161740729|NCT00510068|584090517|FG000|Double-blind Period|Disease progression|98|||
161740730|NCT00510068|584090518|FG001|Double-blind Period|Disease progression|169|||
161740731|NCT00510068|584090517|FG000|Double-blind Period|Final primary analysis|52|||
161740732|NCT00510068|584090518|FG001|Double-blind Period|Final primary analysis|18|||
161740733|NCT00510068|584090517|FG000|Double-blind Period|Adverse Event|37|||
161740734|NCT00510068|584090518|FG001|Double-blind Period|Adverse Event|7|||
161740735|NCT00510068|584090517|FG000|Double-blind Period|Withdrawal by Subject|8|||
161740736|NCT00510068|584090518|FG001|Double-blind Period|Withdrawal by Subject|6|||
161740737|NCT00510068|584090517|FG000|Double-blind Period|Death|4|||
161740738|NCT00510068|584090518|FG001|Double-blind Period|Death|3|||
161740739|NCT00510068|584090517|FG000|Double-blind Period|Abnormal test result (s)|1|||
161740740|NCT00510068|584090518|FG001|Double-blind Period|Abnormal test result (s)|0|||
161740741|NCT00510068|584090517|FG000|Double-blind Period|Lost to Follow-up|1|||
161740742|NCT00510068|584090518|FG001|Double-blind Period|Lost to Follow-up|0|||
161740743|NCT00510068|584090517|FG000|Double-blind Period|Protocol Violation|6|||
161740744|NCT00510068|584090518|FG001|Double-blind Period|Protocol Violation|0|||
161740745|NCT00510068|584090517|FG000|Open-label Period|Disease Progression|124|||
161740746|NCT00510068|584090518|FG001|Open-label Period|Disease Progression|0|||
161740747|NCT00510068|584090517|FG000|Open-label Period|Adverse Event|46|||
161740748|NCT00510068|584090518|FG001|Open-label Period|Adverse Event|0|||
161740749|NCT00510068|584090517|FG000|Open-label Period|Withdrawal by Subject|21|||
161740750|NCT00510068|584090518|FG001|Open-label Period|Withdrawal by Subject|0|||
161740751|NCT00510068|584090517|FG000|Open-label Period|Administrative problems|17|||
161740752|NCT00510068|584090518|FG001|Open-label Period|Administrative problems|0|||
161740753|NCT00510068|584090517|FG000|Open-label Period|Death|7|||
161740754|NCT00510068|584090518|FG001|Open-label Period|Death|0|||
161740755|NCT00510068|584090517|FG000|Open-label Period|New cancer therapy|7|||
161740756|NCT00510068|584090518|FG001|Open-label Period|New cancer therapy|0|||
161740757|NCT00510068|584090517|FG000|Open-label Period|Protocol Violation|2|||
161740758|NCT00510068|584090518|FG001|Open-label Period|Protocol Violation|0|||
161740759|NCT00510068|584090517|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
161740760|NCT00510068|584090518|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
161740761|NCT01354431|584090520|FG000|Pre-Treatment Period|Not reported|1|||
161740762|NCT01354431|584090521|FG001|Pre-Treatment Period|Not reported|0|||
161740763|NCT01354431|584090522|FG002|Pre-Treatment Period|Not reported|0|||
161740764|NCT01354431|584090520|FG000|Treatment Period|Disease Progression|50|||
161740765|NCT01354431|584090521|FG001|Treatment Period|Disease Progression|40|||
161740766|NCT01354431|584090522|FG002|Treatment Period|Disease Progression|44|||
161740767|NCT01354431|584090520|FG000|Treatment Period|Study Drug Toxicity|5|||
161740768|NCT01354431|584090521|FG001|Treatment Period|Study Drug Toxicity|8|||
161740769|NCT01354431|584090522|FG002|Treatment Period|Study Drug Toxicity|4|||
161740770|NCT01354431|584090520|FG000|Treatment Period|Death|0|||
161740771|NCT01354431|584090521|FG001|Treatment Period|Death|1|||
161740772|NCT01354431|584090522|FG002|Treatment Period|Death|0|||
161740773|NCT01354431|584090520|FG000|Treatment Period|AE unrelated to study drug|1|||
161740774|NCT01354431|584090521|FG001|Treatment Period|AE unrelated to study drug|2|||
161740775|NCT01354431|584090522|FG002|Treatment Period|AE unrelated to study drug|5|||
161740776|NCT01354431|584090520|FG000|Treatment Period|Participant request to discontinue|2|||
161740777|NCT01354431|584090521|FG001|Treatment Period|Participant request to discontinue|2|||
161740778|NCT01354431|584090522|FG002|Treatment Period|Participant request to discontinue|1|||
161740779|NCT01354431|584090520|FG000|Treatment Period|Participant withdrew consent|0|||
161740780|NCT01354431|584090521|FG001|Treatment Period|Participant withdrew consent|1|||
161740781|NCT01354431|584090522|FG002|Treatment Period|Participant withdrew consent|0|||
161740782|NCT01354431|584090520|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
161740783|NCT01354431|584090521|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
161740784|NCT01354431|584090522|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
161740785|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Adverse Event|1|||
161740786|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Adverse Event|0|||
161740787|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Adverse Event|1|||
161740788|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Adverse Event|0|||
161740789|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Physician Decision|1|||
161740790|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Physician Decision|1|||
161740791|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Physician Decision|2|||
161740792|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Physician Decision|0|||
161740793|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
161740794|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
161740795|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
161740796|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
161740797|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Progressive disease|3|||
161740798|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Progressive disease|1|||
161740799|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Progressive disease|3|||
161740800|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Progressive disease|0|||
161740801|NCT02802878|584090527|FG000|Overall Study|Withdrawal by Subject|3|||
161740802|NCT02802878|584090528|FG001|Overall Study|Withdrawal by Subject|3|||
161740803|NCT02802878|584090527|FG000|Overall Study|Protocol Violation|1|||
161740804|NCT02802878|584090528|FG001|Overall Study|Protocol Violation|0|||
161740805|NCT00702052|584090529|FG000|Overall Study|Adverse Event|23|||
161740806|NCT00702052|584090529|FG000|Overall Study|Disease Progression|30|||
161740807|NCT00702052|584090529|FG000|Overall Study|Withdrawal by Subject|5|||
161740808|NCT00101192|584090530|FG000|Overall Study|Ineligible|6|||
161740809|NCT00101192|584090530|FG000|Overall Study|Inevaluable|1|||
161740810|NCT03691610|584090531|FG000|Overall Study|Adverse Event|0|||
161740811|NCT03691610|584090532|FG001|Overall Study|Adverse Event|1|||
161740812|NCT03691610|584090533|FG002|Overall Study|Adverse Event|0|||
161740813|NCT03691610|584090534|FG003|Overall Study|Adverse Event|0|||
161740814|NCT03691610|584090531|FG000|Overall Study|Protocol Deviation|15|||
161740815|NCT03691610|584090532|FG001|Overall Study|Protocol Deviation|8|||
161740816|NCT03691610|584090533|FG002|Overall Study|Protocol Deviation|1|||
161740817|NCT03691610|584090534|FG003|Overall Study|Protocol Deviation|2|||
161740818|NCT03691610|584090531|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
161740819|NCT03691610|584090532|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
161740820|NCT03691610|584090533|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
161740821|NCT03691610|584090534|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
161740822|NCT03691610|584090531|FG000|Overall Study|Lost to Follow-up|20|||
161740823|NCT03691610|584090532|FG001|Overall Study|Lost to Follow-up|11|||
161740824|NCT03691610|584090533|FG002|Overall Study|Lost to Follow-up|5|||
161740825|NCT03691610|584090534|FG003|Overall Study|Lost to Follow-up|2|||
161740826|NCT00536978|584090535|FG000|Overall Study|Not eligible for Adback Infusion|22|||
161740827|NCT01232894|584090536|FG000|Overall Study|Lost to Follow-up|0|||
161740828|NCT01232894|584090537|FG001|Overall Study|Lost to Follow-up|1|||
161740829|NCT01232894|584090536|FG000|Overall Study|Death|1|||
161740830|NCT01232894|584090537|FG001|Overall Study|Death|0|||
161740831|NCT01232894|584090536|FG000|Overall Study|Protocol Violation|1|||
161740832|NCT01232894|584090537|FG001|Overall Study|Protocol Violation|1|||
161740833|NCT01232894|584090536|FG000|Overall Study|Withdrawal by Subject|8|||
161740834|NCT01232894|584090537|FG001|Overall Study|Withdrawal by Subject|5|||
161740835|NCT01232894|584090536|FG000|Overall Study|Physician Decision|2|||
161740836|NCT01232894|584090537|FG001|Overall Study|Physician Decision|1|||
161740837|NCT03970395|584090538|FG000|Overall Study|Withdrawal by Subject|3|||
161740838|NCT03970395|584090539|FG001|Overall Study|Withdrawal by Subject|4|||
161740839|NCT03970395|584090538|FG000|Overall Study|Lost to Follow-up|4|||
161740840|NCT03970395|584090539|FG001|Overall Study|Lost to Follow-up|8|||
161740841|NCT02921919|584090540|FG000|Overall Study|Other|5|||
161740842|NCT02921919|584090541|FG001|Overall Study|Other|6|||
161740843|NCT02921919|584090540|FG000|Overall Study|Lost to Follow-up|0|||
161740844|NCT02921919|584090541|FG001|Overall Study|Lost to Follow-up|1|||
161740845|NCT02921919|584090540|FG000|Overall Study|Withdrawal by Subject|5|||
161740846|NCT02921919|584090541|FG001|Overall Study|Withdrawal by Subject|1|||
161740847|NCT02921919|584090540|FG000|Overall Study|Disease Progression|47|||
161740848|NCT02921919|584090541|FG001|Overall Study|Disease Progression|38|||
161740849|NCT02921919|584090540|FG000|Overall Study|Physician Decision|3|||
161740850|NCT02921919|584090541|FG001|Overall Study|Physician Decision|2|||
161740851|NCT02921919|584090540|FG000|Overall Study|Adverse Event|6|||
161740852|NCT02921919|584090541|FG001|Overall Study|Adverse Event|4|||
161740853|NCT04664855|584090542|FG000|Overall Study|Withdrawal by Subject|0|||
161740854|NCT04664855|584090543|FG001|Overall Study|Withdrawal by Subject|2|||
161740855|NCT01086150|584090551|FG000|Overall Study|Withdrawal by Subject|0|||
161740856|NCT01086150|584090552|FG001|Overall Study|Withdrawal by Subject|4|||
161740857|NCT01086150|584090553|FG002|Overall Study|Withdrawal by Subject|1|||
161740858|NCT01086150|584090551|FG000|Overall Study|Lost to Follow-up|0|||
161740859|NCT01086150|584090552|FG001|Overall Study|Lost to Follow-up|1|||
161740860|NCT01086150|584090553|FG002|Overall Study|Lost to Follow-up|0|||
161740861|NCT01086150|584090551|FG000|Overall Study|Screen Failure|0|||
161740862|NCT01086150|584090552|FG001|Overall Study|Screen Failure|1|||
161740863|NCT01086150|584090553|FG002|Overall Study|Screen Failure|0|||
161740864|NCT00178464|584090555|FG000|Overall Study|Withdrawal by Subject|1|||
161740865|NCT00178464|584090555|FG000|Overall Study|Physician Decision|1|||
161740866|NCT00870818|584090556|FG000|Overall Study|Lost to Follow-up|3|||
161740867|NCT00870818|584090557|FG001|Overall Study|Lost to Follow-up|2|||
161740868|NCT00870818|584090558|FG002|Overall Study|Lost to Follow-up|1|||
161740869|NCT00870818|584090559|FG003|Overall Study|Lost to Follow-up|0|||
161740870|NCT00870818|584090560|FG004|Overall Study|Lost to Follow-up|0|||
161740871|NCT00870818|584090556|FG000|Overall Study|Withdrawal by Subject|0|||
161740872|NCT00870818|584090557|FG001|Overall Study|Withdrawal by Subject|0|||
161740873|NCT00870818|584090558|FG002|Overall Study|Withdrawal by Subject|1|||
161740874|NCT00870818|584090559|FG003|Overall Study|Withdrawal by Subject|2|||
161740875|NCT00870818|584090560|FG004|Overall Study|Withdrawal by Subject|0|||
161740876|NCT00870818|584090556|FG000|Overall Study|Terminated by sponsor|29|||
161740877|NCT00870818|584090557|FG001|Overall Study|Terminated by sponsor|70|||
161740878|NCT00870818|584090558|FG002|Overall Study|Terminated by sponsor|36|||
161740879|NCT00870818|584090559|FG003|Overall Study|Terminated by sponsor|36|||
161740880|NCT00870818|584090560|FG004|Overall Study|Terminated by sponsor|38|||
161740881|NCT00870818|584090556|FG000|Overall Study|Other|0|||
161740882|NCT00870818|584090557|FG001|Overall Study|Other|1|||
161740883|NCT00870818|584090558|FG002|Overall Study|Other|0|||
161740884|NCT00870818|584090559|FG003|Overall Study|Other|0|||
161740885|NCT00870818|584090560|FG004|Overall Study|Other|0|||
161740886|NCT02260648|584090563|FG000|Overall Study|Adverse Event|3|||
161740887|NCT02260648|584090564|FG001|Overall Study|Adverse Event|0|||
161740888|NCT02260648|584090565|FG002|Overall Study|Adverse Event|1|||
161740889|NCT02260648|584090563|FG000|Overall Study|Withdrawal by Subject|1|||
161740890|NCT02260648|584090564|FG001|Overall Study|Withdrawal by Subject|1|||
161740891|NCT02260648|584090565|FG002|Overall Study|Withdrawal by Subject|0|||
161740892|NCT02260648|584090563|FG000|Overall Study|Protocol Violation|1|||
161740893|NCT02260648|584090564|FG001|Overall Study|Protocol Violation|0|||
161740894|NCT02260648|584090565|FG002|Overall Study|Protocol Violation|0|||
161740895|NCT02260648|584090563|FG000|Overall Study|Discontinue Due to Study Termination|13|||
161740896|NCT02260648|584090564|FG001|Overall Study|Discontinue Due to Study Termination|12|||
161740897|NCT02260648|584090565|FG002|Overall Study|Discontinue Due to Study Termination|7|||
161740898|NCT04093258|584090566|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
161740899|NCT04093258|584090567|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
161740900|NCT01890512|584090568|FG000|Overall Study|Physician Decision|1|||
161740901|NCT01890512|584090568|FG000|Overall Study|Withdrawal by Subject|1|||
161740902|NCT01890512|584090568|FG000|Overall Study|Protocol Violation|1|||
161740903|NCT01529385|584090569|FG000|Overall Study|Lost to Follow-up|2|||
161740904|NCT01529385|584090570|FG001|Overall Study|Lost to Follow-up|1|||
161740905|NCT00805545|584090571|FG000|Overall Study|Protocol Violation|3|||
161740906|NCT00805545|584090572|FG001|Overall Study|Protocol Violation|2|||
161740907|NCT00805545|584090571|FG000|Overall Study|Protocol Violation|3|||
161740908|NCT00805545|584090572|FG001|Overall Study|Protocol Violation|1|||
161740909|NCT03543358|584090573|FG000|Overall Study|Death|1|||
161740910|NCT03543358|584090574|FG001|Overall Study|Death|0|||
161740911|NCT03543358|584090573|FG000|Overall Study|Disease Progression|1|||
161740912|NCT03543358|584090574|FG001|Overall Study|Disease Progression|0|||
161740913|NCT03543358|584090573|FG000|Overall Study|Parent Study Closure|1|||
161740914|NCT03543358|584090574|FG001|Overall Study|Parent Study Closure|0|||
161740915|NCT00986427|584090575|FG000|Overall Study|Lost to Follow-up|2|||
161740916|NCT00986427|584090576|FG001|Overall Study|Lost to Follow-up|0|||
161740917|NCT00986427|584090575|FG000|Overall Study|Lack of Efficacy|1|||
161740918|NCT00986427|584090576|FG001|Overall Study|Lack of Efficacy|0|||
161740919|NCT00986427|584090575|FG000|Overall Study|Withdrawal by Subject|1|||
161740920|NCT00986427|584090576|FG001|Overall Study|Withdrawal by Subject|0|||
161740921|NCT01401465|584090577|FG000|Treatment Period 1|Adverse Event|4|||
161740922|NCT01401465|584090578|FG001|Treatment Period 1|Adverse Event|1|||
161740923|NCT01401465|584090577|FG000|Treatment Period 1|Pregnancy|0|||
161740924|NCT01401465|584090578|FG001|Treatment Period 1|Pregnancy|1|||
161740925|NCT01401465|584090577|FG000|Treatment Period 1|Protocol Violation|5|||
161740926|NCT01401465|584090578|FG001|Treatment Period 1|Protocol Violation|0|||
161740927|NCT01401465|584090577|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161740928|NCT01401465|584090578|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161740929|NCT01401465|584090577|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
161740930|NCT01401465|584090578|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
161740931|NCT01401465|584090577|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
161740932|NCT01401465|584090578|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
161740933|NCT01401465|584090577|FG000|Treatment Period 1|Scheduling Difficulties|1|||
161740934|NCT01401465|584090578|FG001|Treatment Period 1|Scheduling Difficulties|1|||
161740935|NCT01401465|584090577|FG000|Treatment Period 2|Lost to Follow-up|0|||
161740936|NCT01401465|584090578|FG001|Treatment Period 2|Lost to Follow-up|1|||
161740937|NCT01401465|584090577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161740938|NCT01401465|584090578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161740939|NCT01115738|584090579|FG000|Overall Study|Death|1|||
161740940|NCT01115738|584090580|FG001|Overall Study|Death|0|||
161740941|NCT01115738|584090581|FG002|Overall Study|Death|0|||
161740942|NCT01115738|584090579|FG000|Overall Study|Lost to Follow-up|0|||
161740943|NCT01115738|584090580|FG001|Overall Study|Lost to Follow-up|0|||
161740944|NCT01115738|584090581|FG002|Overall Study|Lost to Follow-up|1|||
161740945|NCT01115738|584090579|FG000|Overall Study|Physician Decision|18|||
161740946|NCT01115738|584090580|FG001|Overall Study|Physician Decision|15|||
161740947|NCT01115738|584090581|FG002|Overall Study|Physician Decision|17|||
161740948|NCT01115738|584090579|FG000|Overall Study|Withdrawal by Subject|6|||
161740949|NCT01115738|584090580|FG001|Overall Study|Withdrawal by Subject|6|||
161740950|NCT01115738|584090581|FG002|Overall Study|Withdrawal by Subject|9|||
161740951|NCT02379390|584090586|FG000|Overall Study|Adverse Event|1|||
161740952|NCT02379390|584090587|FG001|Overall Study|Adverse Event|1|||
161740953|NCT02379390|584090586|FG000|Overall Study|Investigator's decision|1|||
161740954|NCT02379390|584090587|FG001|Overall Study|Investigator's decision|0|||
161740955|NCT02379390|584090586|FG000|Overall Study|Study Termination|0|||
161740956|NCT02379390|584090587|FG001|Overall Study|Study Termination|1|||
161740957|NCT00575094|584090588|FG000|Overall Study|Adverse Event|2|||
161740958|NCT00575094|584090588|FG000|Overall Study|Withdrawal by Subject|1|||
161740959|NCT00643604|584090592|FG000|Overall Study|Death|1|||
161740960|NCT02702011|584090593|FG000|Overall Study|Withdrawal by Subject|0|||
161740961|NCT02702011|584090594|FG001|Overall Study|Withdrawal by Subject|1|||
161740962|NCT02702011|584090595|FG002|Overall Study|Withdrawal by Subject|0|||
161740963|NCT02702011|584090596|FG003|Overall Study|Withdrawal by Subject|0|||
161740964|NCT02721251|584090598|FG000|Overall Study|Withdrawal by Subject|8|||
161740965|NCT02721251|584090599|FG001|Overall Study|Withdrawal by Subject|7|||
161740966|NCT02721251|584090600|FG002|Overall Study|Withdrawal by Subject|9|||
161740967|NCT02721251|584090598|FG000|Overall Study|poor adherence|2|||
161740968|NCT02721251|584090599|FG001|Overall Study|poor adherence|2|||
161740969|NCT02721251|584090600|FG002|Overall Study|poor adherence|2|||
161740970|NCT02921763|584090603|FG000|Overall Study|Adverse Event|4|||
161740971|NCT02921763|584090603|FG000|Overall Study|Lost to Follow-up|4|||
161740972|NCT02921763|584090603|FG000|Overall Study|Lack of Efficacy|3|||
161740973|NCT02921763|584090603|FG000|Overall Study|Protocol Violation|2|||
161740974|NCT02921763|584090603|FG000|Overall Study|Withdrawal by Subject|2|||
161740975|NCT02921763|584090603|FG000|Overall Study|Physician Decision|1|||
161740976|NCT02921763|584090603|FG000|Overall Study|No data obtained|2|||
161740977|NCT03784027|584090618|FG000|Period 1|Withdrawal by Subject|0|||
161740978|NCT03784027|584090619|FG001|Period 1|Withdrawal by Subject|1|||
161740979|NCT06025396|584091856|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
161740980|NCT06025396|584091857|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
161740981|NCT06025396|584091858|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
161740982|NCT06025396|584091859|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
161740983|NCT06025396|584091860|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
161740984|NCT06025396|584091856|FG000|Overall Study|Withdrawal by Subject|0|||
161740985|NCT06025396|584091857|FG001|Overall Study|Withdrawal by Subject|1|||
161740986|NCT06025396|584091858|FG002|Overall Study|Withdrawal by Subject|1|||
161740987|NCT06025396|584091859|FG003|Overall Study|Withdrawal by Subject|0|||
161740988|NCT06025396|584091860|FG004|Overall Study|Withdrawal by Subject|0|||
161740989|NCT05691829|584091861|FG000|Overall Study|Physician Decision|2|||
161740990|NCT05691829|584091861|FG000|Overall Study|Eligibility criteria not met|3|||
161740991|NCT01512108|584091862|FG000|Overall Study|Adverse Event|9|||
161740992|NCT01512108|584091863|FG001|Overall Study|Adverse Event|4|||
161740993|NCT01512108|584091862|FG000|Overall Study|Protocol Violation|1|||
161740994|NCT01512108|584091863|FG001|Overall Study|Protocol Violation|2|||
161740995|NCT01512108|584091862|FG000|Overall Study|Withdrawal Criteria|1|||
161740996|NCT01512108|584091863|FG001|Overall Study|Withdrawal Criteria|0|||
161740997|NCT01512108|584091862|FG000|Overall Study|Unclassified|11|||
161740998|NCT01512108|584091863|FG001|Overall Study|Unclassified|3|||
161740999|NCT06422377|584091868|FG000|Overall Study|Study Terminated by Sponsor|1|||
161741000|NCT03287869|584091869|FG000|Overall Study|Adverse Event|14|||
161741001|NCT03287869|584091870|FG001|Overall Study|Adverse Event|12|||
161741002|NCT03287869|584091869|FG000|Overall Study|Lack of Efficacy|1|||
161741003|NCT03287869|584091870|FG001|Overall Study|Lack of Efficacy|0|||
161741004|NCT03287869|584091869|FG000|Overall Study|Lost to Follow-up|13|||
161741005|NCT03287869|584091870|FG001|Overall Study|Lost to Follow-up|19|||
161741006|NCT03287869|584091869|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161741007|NCT03287869|584091870|FG001|Overall Study|Non-Compliance With Study Drug|9|||
161741008|NCT03287869|584091869|FG000|Overall Study|Progressive Disease|1|||
161741009|NCT03287869|584091870|FG001|Overall Study|Progressive Disease|0|||
161741010|NCT03287869|584091869|FG000|Overall Study|Protocol Deviation|2|||
161741011|NCT03287869|584091870|FG001|Overall Study|Protocol Deviation|1|||
161741012|NCT03287869|584091869|FG000|Overall Study|Withdrawal by Subject|36|||
161741013|NCT03287869|584091870|FG001|Overall Study|Withdrawal by Subject|43|||
161741014|NCT03287869|584091869|FG000|Overall Study|Early Closure of the Site|0|||
161741015|NCT03287869|584091870|FG001|Overall Study|Early Closure of the Site|1|||
161741016|NCT03287869|584091869|FG000|Overall Study|Physician Decision|5|||
161741017|NCT03287869|584091870|FG001|Overall Study|Physician Decision|5|||
161741018|NCT03287869|584091869|FG000|Overall Study|Reason not Specified|6|||
161741019|NCT03287869|584091870|FG001|Overall Study|Reason not Specified|3|||
161741020|NCT04847141|584091871|FG000|Overall Study|Adverse Event|1|||
161741021|NCT04847141|584091872|FG001|Overall Study|Adverse Event|0|||
161741022|NCT04847141|584091873|FG002|Overall Study|Adverse Event|1|||
161741023|NCT04847141|584091871|FG000|Overall Study|Withdrawal by Subject|2|||
161741024|NCT04847141|584091872|FG001|Overall Study|Withdrawal by Subject|4|||
161741025|NCT04847141|584091873|FG002|Overall Study|Withdrawal by Subject|3|||
161741026|NCT04847141|584091871|FG000|Overall Study|Lost to Follow-up|7|||
161741027|NCT04847141|584091872|FG001|Overall Study|Lost to Follow-up|5|||
161741028|NCT04847141|584091873|FG002|Overall Study|Lost to Follow-up|7|||
161741029|NCT04847141|584091871|FG000|Overall Study|Reason not Specified|0|||
161741030|NCT04847141|584091872|FG001|Overall Study|Reason not Specified|1|||
161741031|NCT04847141|584091873|FG002|Overall Study|Reason not Specified|0|||
161741032|NCT00324740|584091874|FG000|Overall Study|Withdrawal by Subject|1|||
161741033|NCT00324740|584091875|FG001|Overall Study|Withdrawal by Subject|0|||
161741034|NCT00324740|584091876|FG002|Overall Study|Withdrawal by Subject|1|||
161840811|NCT00895947|584462854|FG000|Overall Study|Lost to Follow-up|3|||
161840812|NCT00895947|584462855|FG001|Overall Study|Lost to Follow-up|4|||
161741035|NCT01357980|584091881|FG000|Overall Study|Lack of Efficacy|0|||
161741036|NCT01357980|584091882|FG001|Overall Study|Lack of Efficacy|1|||
161741037|NCT01357980|584091883|FG002|Overall Study|Lack of Efficacy|0|||
161741038|NCT01357980|584091884|FG003|Overall Study|Lack of Efficacy|0|||
161741039|NCT01357980|584091881|FG000|Overall Study|Consent withdrawn|0|||
161741040|NCT01357980|584091882|FG001|Overall Study|Consent withdrawn|0|||
161741041|NCT01357980|584091883|FG002|Overall Study|Consent withdrawn|1|||
161741042|NCT01357980|584091884|FG003|Overall Study|Consent withdrawn|0|||
161741043|NCT00094835|584091888|FG000|Overall Study|Physician Decision|1|||
161741044|NCT00094835|584091889|FG001|Overall Study|Physician Decision|0|||
161741045|NCT00094835|584091890|FG002|Overall Study|Physician Decision|0|||
161741046|NCT00094835|584091891|FG003|Overall Study|Physician Decision|0|||
161741047|NCT00094835|584091892|FG004|Overall Study|Physician Decision|0|||
161840813|NCT00895947|584462854|FG000|Overall Study|Protocol Violation|4|||
161840814|NCT00895947|584462855|FG001|Overall Study|Protocol Violation|2|||
161840815|NCT00895947|584462854|FG000|Overall Study|Withdrawal by Subject|2|||
161840816|NCT00895947|584462855|FG001|Overall Study|Withdrawal by Subject|0|||
161840817|NCT00123474|584462864|FG000|Randomized to Treatment|Randomized, never treated|1|||
161840818|NCT00123474|584462865|FG001|Randomized to Treatment|Randomized, never treated|4|||
161840819|NCT00123474|584462866|FG002|Randomized to Treatment|Randomized, never treated|2|||
161840820|NCT00123474|584462867|FG003|Randomized to Treatment|Randomized, never treated|1|||
161840821|NCT00123474|584462864|FG000|As Treated at Study Closure|not reported when site closed|1|||
161840822|NCT00123474|584462865|FG001|As Treated at Study Closure|not reported when site closed|0|||
161840823|NCT00123474|584462866|FG002|As Treated at Study Closure|not reported when site closed|1|||
161840824|NCT00123474|584462867|FG003|As Treated at Study Closure|not reported when site closed|0|||
161840825|NCT00123474|584462864|FG000|As Treated at Study Closure|Adverse Event|10|||
161840826|NCT00123474|584462865|FG001|As Treated at Study Closure|Adverse Event|4|||
161840827|NCT00123474|584462866|FG002|As Treated at Study Closure|Adverse Event|10|||
161840828|NCT00123474|584462867|FG003|As Treated at Study Closure|Adverse Event|8|||
161840829|NCT00123474|584462864|FG000|As Treated at Study Closure|Disease Progression|35|||
161840830|NCT00123474|584462865|FG001|As Treated at Study Closure|Disease Progression|42|||
161840831|NCT00123474|584462866|FG002|As Treated at Study Closure|Disease Progression|29|||
161840832|NCT00123474|584462867|FG003|As Treated at Study Closure|Disease Progression|27|||
161840833|NCT00123474|584462864|FG000|As Treated at Study Closure|Investigator Request|12|||
161840834|NCT00123474|584462865|FG001|As Treated at Study Closure|Investigator Request|6|||
161840835|NCT00123474|584462866|FG002|As Treated at Study Closure|Investigator Request|7|||
161840836|NCT00123474|584462867|FG003|As Treated at Study Closure|Investigator Request|5|||
161840837|NCT00123474|584462864|FG000|As Treated at Study Closure|non-specified|54|||
161840838|NCT00123474|584462865|FG001|As Treated at Study Closure|non-specified|47|||
161840839|NCT00123474|584462866|FG002|As Treated at Study Closure|non-specified|57|||
161840840|NCT00123474|584462867|FG003|As Treated at Study Closure|non-specified|60|||
161840841|NCT00123474|584462864|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
161840842|NCT00123474|584462865|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
161840843|NCT00123474|584462866|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
161840844|NCT00123474|584462867|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
161840845|NCT00123474|584462864|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
161840846|NCT00123474|584462865|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
161840847|NCT00123474|584462866|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
161840848|NCT00123474|584462867|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
161840849|NCT01059344|584462868|FG000|Overall Study|Adverse Event|12|||
161840850|NCT01059344|584462869|FG001|Overall Study|Adverse Event|30|||
161840851|NCT01059344|584462868|FG000|Overall Study|Withdrawal by Subject|6|||
161840852|NCT01059344|584462869|FG001|Overall Study|Withdrawal by Subject|9|||
161840853|NCT01059344|584462868|FG000|Overall Study|Lost to Follow-up|1|||
161840854|NCT01059344|584462869|FG001|Overall Study|Lost to Follow-up|1|||
161840855|NCT01059344|584462868|FG000|Overall Study|Other|3|||
161840856|NCT01059344|584462869|FG001|Overall Study|Other|6|||
161840857|NCT00616629|584462870|FG000|Overall Study|Protocol Violation|1|||
161840858|NCT00616629|584462871|FG001|Overall Study|Protocol Violation|2|||
161840859|NCT00616629|584462872|FG002|Overall Study|Protocol Violation|1|||
161840860|NCT00616629|584462873|FG003|Overall Study|Protocol Violation|0|||
161840861|NCT00616629|584462874|FG004|Overall Study|Protocol Violation|0|||
161840862|NCT00616629|584462870|FG000|Overall Study|AV-block|1|||
161840863|NCT00616629|584462871|FG001|Overall Study|AV-block|0|||
161840864|NCT00616629|584462872|FG002|Overall Study|AV-block|0|||
161840865|NCT00616629|584462873|FG003|Overall Study|AV-block|0|||
161840866|NCT00616629|584462874|FG004|Overall Study|AV-block|0|||
161840867|NCT01739348|584462875|FG000|Part I (Base Study)|Adverse Event|41|||
161840868|NCT01739348|584462876|FG001|Part I (Base Study)|Adverse Event|52|||
161840869|NCT01739348|584462877|FG002|Part I (Base Study)|Adverse Event|8|||
161840870|NCT01739348|584462878|FG003|Part I (Base Study)|Adverse Event|33|||
161741048|NCT00094835|584091893|FG005|Overall Study|Physician Decision|1|||
161741049|NCT00094835|584091894|FG006|Overall Study|Physician Decision|0|||
161741050|NCT00094835|584091888|FG000|Overall Study|Withdrawal by Subject|0|||
161741051|NCT00094835|584091889|FG001|Overall Study|Withdrawal by Subject|0|||
161741052|NCT00094835|584091890|FG002|Overall Study|Withdrawal by Subject|0|||
161741053|NCT00094835|584091891|FG003|Overall Study|Withdrawal by Subject|0|||
161741054|NCT00094835|584091892|FG004|Overall Study|Withdrawal by Subject|0|||
161741055|NCT00094835|584091893|FG005|Overall Study|Withdrawal by Subject|0|||
161840871|NCT01739348|584462875|FG000|Part I (Base Study)|Death|10|||
161741056|NCT00094835|584091894|FG006|Overall Study|Withdrawal by Subject|1|||
161741057|NCT00094835|584091888|FG000|Overall Study|Lost to Follow-up|0|||
161840872|NCT01739348|584462876|FG001|Part I (Base Study)|Death|7|||
161840873|NCT01739348|584462877|FG002|Part I (Base Study)|Death|2|||
161840874|NCT01739348|584462878|FG003|Part I (Base Study)|Death|8|||
161840875|NCT01739348|584462875|FG000|Part I (Base Study)|Lack of Efficacy|3|||
161840876|NCT01739348|584462876|FG001|Part I (Base Study)|Lack of Efficacy|8|||
161741058|NCT00094835|584091889|FG001|Overall Study|Lost to Follow-up|0|||
161741059|NCT00094835|584091890|FG002|Overall Study|Lost to Follow-up|0|||
161741060|NCT00094835|584091891|FG003|Overall Study|Lost to Follow-up|0|||
161741061|NCT00094835|584091892|FG004|Overall Study|Lost to Follow-up|1|||
161741062|NCT00094835|584091893|FG005|Overall Study|Lost to Follow-up|0|||
161741063|NCT00094835|584091894|FG006|Overall Study|Lost to Follow-up|0|||
161741064|NCT00094835|584091888|FG000|Overall Study|Death|1|||
161741065|NCT00094835|584091889|FG001|Overall Study|Death|0|||
161741066|NCT00094835|584091890|FG002|Overall Study|Death|0|||
161741067|NCT00094835|584091891|FG003|Overall Study|Death|0|||
161741068|NCT00094835|584091892|FG004|Overall Study|Death|1|||
161741069|NCT00094835|584091893|FG005|Overall Study|Death|0|||
161741070|NCT00094835|584091894|FG006|Overall Study|Death|0|||
161741071|NCT00094835|584091888|FG000|Overall Study|Non-compliance|1|||
161741072|NCT00094835|584091889|FG001|Overall Study|Non-compliance|2|||
161741073|NCT00094835|584091890|FG002|Overall Study|Non-compliance|2|||
161741074|NCT00094835|584091891|FG003|Overall Study|Non-compliance|0|||
161741075|NCT00094835|584091892|FG004|Overall Study|Non-compliance|2|||
161741076|NCT00094835|584091893|FG005|Overall Study|Non-compliance|2|||
161741077|NCT00094835|584091894|FG006|Overall Study|Non-compliance|1|||
161741078|NCT00094835|584091888|FG000|Overall Study|Other|1|||
161741079|NCT00094835|584091889|FG001|Overall Study|Other|1|||
161741080|NCT00094835|584091890|FG002|Overall Study|Other|1|||
161741081|NCT00094835|584091891|FG003|Overall Study|Other|1|||
161741082|NCT00094835|584091892|FG004|Overall Study|Other|0|||
161741083|NCT00094835|584091893|FG005|Overall Study|Other|0|||
161741084|NCT00094835|584091894|FG006|Overall Study|Other|0|||
161741085|NCT00387348|584091895|FG000|Overall Study|Death|1|||
161741086|NCT00387348|584091896|FG001|Overall Study|Death|1|||
161741087|NCT00387348|584091897|FG002|Overall Study|Death|0|||
161741088|NCT00387348|584091895|FG000|Overall Study|Physician Decision|1|||
161741089|NCT00387348|584091896|FG001|Overall Study|Physician Decision|0|||
161741090|NCT00387348|584091897|FG002|Overall Study|Physician Decision|1|||
161741091|NCT00387348|584091895|FG000|Overall Study|Withdrawal by Subject|0|||
161741092|NCT00387348|584091896|FG001|Overall Study|Withdrawal by Subject|2|||
161741093|NCT00387348|584091897|FG002|Overall Study|Withdrawal by Subject|2|||
161741094|NCT00387348|584091895|FG000|Overall Study|Adverse Event|1|||
161741095|NCT00387348|584091896|FG001|Overall Study|Adverse Event|0|||
161741096|NCT00387348|584091897|FG002|Overall Study|Adverse Event|1|||
161741097|NCT03628599|584091898|FG000|Overall Study|Adverse Event|0|||
161741098|NCT03628599|584091899|FG001|Overall Study|Adverse Event|1|||
161741099|NCT00868166|584091903|FG000|Overall Study|Death|58|||
161741100|NCT00868166|584091904|FG001|Overall Study|Death|65|||
161741101|NCT00868166|584091903|FG000|Overall Study|Withdrawal by Subject|33|||
161741102|NCT00868166|584091904|FG001|Overall Study|Withdrawal by Subject|25|||
161741103|NCT00868166|584091903|FG000|Overall Study|Protocol Violation|1|||
161741104|NCT00868166|584091904|FG001|Overall Study|Protocol Violation|0|||
161741105|NCT00868166|584091903|FG000|Overall Study|Lost to Follow-up|1|||
161741106|NCT00868166|584091904|FG001|Overall Study|Lost to Follow-up|3|||
161741107|NCT00868166|584091903|FG000|Overall Study|Adverse Event|9|||
161741108|NCT00868166|584091904|FG001|Overall Study|Adverse Event|10|||
161741109|NCT00868166|584091903|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
161741110|NCT00868166|584091904|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
161741111|NCT00868166|584091903|FG000|Overall Study|Non-compliance with IMP|1|||
161741112|NCT00868166|584091904|FG001|Overall Study|Non-compliance with IMP|1|||
161741113|NCT01204697|584091912|FG000|Overall Study|Death|26|||
161741114|NCT01204697|584091913|FG001|Overall Study|Death|27|||
161741115|NCT01204697|584091912|FG000|Overall Study|Lost to Follow-up|3|||
161741116|NCT01204697|584091913|FG001|Overall Study|Lost to Follow-up|4|||
161741117|NCT01204697|584091912|FG000|Overall Study|Withdrawal by Subject|2|||
161741118|NCT01204697|584091913|FG001|Overall Study|Withdrawal by Subject|4|||
161741119|NCT01204697|584091912|FG000|Overall Study|Randomized, but not treated|0|||
161741120|NCT01204697|584091913|FG001|Overall Study|Randomized, but not treated|1|||
161741121|NCT03939637|584091914|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
161741122|NCT03939637|584091915|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
161741123|NCT03939637|584091914|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
161741124|NCT03939637|584091915|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
161741125|NCT00830804|584091916|FG000|Overall Study|Lost to Follow-up|4|||
161741126|NCT00830804|584091916|FG000|Overall Study|Death|1|||
161741127|NCT00830804|584091916|FG000|Overall Study|Unable to get to clinic|7|||
161741128|NCT00830804|584091916|FG000|Overall Study|Consent withdrawn|2|||
161741129|NCT00830804|584091916|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161741130|NCT01397448|584091918|FG000|Overall Study|Adverse Event|4|||
161741131|NCT01397448|584091919|FG001|Overall Study|Adverse Event|4|||
161741132|NCT01397448|584091920|FG002|Overall Study|Adverse Event|6|||
161741133|NCT01397448|584091918|FG000|Overall Study|Withdrawal by Subject|4|||
161741134|NCT01397448|584091919|FG001|Overall Study|Withdrawal by Subject|4|||
161741135|NCT01397448|584091920|FG002|Overall Study|Withdrawal by Subject|3|||
161741136|NCT01397448|584091918|FG000|Overall Study|Lack of Efficacy|2|||
161741137|NCT01397448|584091919|FG001|Overall Study|Lack of Efficacy|0|||
161741138|NCT01397448|584091920|FG002|Overall Study|Lack of Efficacy|5|||
161741139|NCT01397448|584091918|FG000|Overall Study|Other|8|||
161741140|NCT01397448|584091919|FG001|Overall Study|Other|7|||
161741141|NCT01397448|584091920|FG002|Overall Study|Other|4|||
161741142|NCT02180217|584091927|FG000|Overall Study|Adverse Event|3|||
161741143|NCT02180217|584091928|FG001|Overall Study|Adverse Event|2|||
161741144|NCT02180217|584091929|FG002|Overall Study|Adverse Event|22|||
161741145|NCT02180217|584091927|FG000|Overall Study|Death|1|||
161741146|NCT02180217|584091928|FG001|Overall Study|Death|1|||
161741147|NCT02180217|584091929|FG002|Overall Study|Death|0|||
161741148|NCT02180217|584091927|FG000|Overall Study|Withdrawal by Subject|1|||
161741149|NCT02180217|584091928|FG001|Overall Study|Withdrawal by Subject|1|||
161741150|NCT02180217|584091929|FG002|Overall Study|Withdrawal by Subject|4|||
161741151|NCT02180217|584091927|FG000|Overall Study|Subject/Guardian decision|5|||
161741152|NCT02180217|584091928|FG001|Overall Study|Subject/Guardian decision|3|||
161741153|NCT02180217|584091929|FG002|Overall Study|Subject/Guardian decision|6|||
161741154|NCT02180217|584091927|FG000|Overall Study|Physician Decision|1|||
161741155|NCT02180217|584091928|FG001|Overall Study|Physician Decision|1|||
161741156|NCT02180217|584091929|FG002|Overall Study|Physician Decision|6|||
161741157|NCT02180217|584091927|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161741158|NCT02180217|584091928|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161741159|NCT02180217|584091929|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161741160|NCT00776555|584091932|FG000|Overall Study|Study terminated|3|||
161741161|NCT00776555|584091933|FG001|Overall Study|Study terminated|0|||
161741162|NCT03483116|584091935|FG000|Overall Study|Adverse Event|0|||
161741163|NCT03483116|584091936|FG001|Overall Study|Adverse Event|1|||
161741164|NCT03483116|584091937|FG002|Overall Study|Adverse Event|0|||
161741165|NCT03483116|584091938|FG003|Overall Study|Adverse Event|1|||
161741166|NCT03483116|584091935|FG000|Overall Study|Protocol Violation|1|||
161741167|NCT03483116|584091936|FG001|Overall Study|Protocol Violation|0|||
161741168|NCT03483116|584091937|FG002|Overall Study|Protocol Violation|0|||
161741169|NCT03483116|584091938|FG003|Overall Study|Protocol Violation|7|||
161741170|NCT03483116|584091935|FG000|Overall Study|Lost to Follow-up|9|||
161741171|NCT03483116|584091936|FG001|Overall Study|Lost to Follow-up|4|||
161741172|NCT03483116|584091937|FG002|Overall Study|Lost to Follow-up|9|||
161741173|NCT03483116|584091938|FG003|Overall Study|Lost to Follow-up|5|||
161741174|NCT03483116|584091935|FG000|Overall Study|Death|1|||
161741175|NCT03483116|584091936|FG001|Overall Study|Death|0|||
161741176|NCT03483116|584091937|FG002|Overall Study|Death|2|||
161741177|NCT03483116|584091938|FG003|Overall Study|Death|1|||
161741178|NCT03483116|584091935|FG000|Overall Study|Withdrawal by Subject|14|||
161741179|NCT03483116|584091936|FG001|Overall Study|Withdrawal by Subject|16|||
161741180|NCT03483116|584091937|FG002|Overall Study|Withdrawal by Subject|14|||
161741181|NCT03483116|584091938|FG003|Overall Study|Withdrawal by Subject|16|||
161741182|NCT03483116|584091935|FG000|Overall Study|Unknown other reason|3|||
161741183|NCT03483116|584091936|FG001|Overall Study|Unknown other reason|2|||
161741184|NCT03483116|584091937|FG002|Overall Study|Unknown other reason|1|||
161741185|NCT03483116|584091938|FG003|Overall Study|Unknown other reason|1|||
161741186|NCT01181102|584091939|FG000|Overall Study|Adverse Event|28|||
161741187|NCT01181102|584091940|FG001|Overall Study|Adverse Event|26|||
161741188|NCT01181102|584091939|FG000|Overall Study|Lack of Efficacy|3|||
161741189|NCT01181102|584091940|FG001|Overall Study|Lack of Efficacy|1|||
161741190|NCT01181102|584091939|FG000|Overall Study|Lost to Follow-up|2|||
161741191|NCT01181102|584091940|FG001|Overall Study|Lost to Follow-up|0|||
161741192|NCT01181102|584091939|FG000|Overall Study|Physician Decision|3|||
161741193|NCT01181102|584091940|FG001|Overall Study|Physician Decision|1|||
161741194|NCT01181102|584091939|FG000|Overall Study|Protocol Violation|5|||
161741195|NCT01181102|584091940|FG001|Overall Study|Protocol Violation|6|||
161741196|NCT01181102|584091939|FG000|Overall Study|Withdrawal by Subject|10|||
161741197|NCT01181102|584091940|FG001|Overall Study|Withdrawal by Subject|12|||
161741198|NCT00239837|584091945|FG000|Overall Study|Lost to Follow-up|3|||
161741199|NCT00239837|584091946|FG001|Overall Study|Lost to Follow-up|7|||
161741200|NCT01838590|584091947|FG000|Overall Study|Lack of Efficacy|12|||
161741201|NCT01838590|584091948|FG001|Overall Study|Lack of Efficacy|4|||
161741202|NCT01838590|584091947|FG000|Overall Study|Lost to Follow-up|0|||
161741203|NCT01838590|584091948|FG001|Overall Study|Lost to Follow-up|1|||
161741204|NCT04685499|584091949|FG000|Overall Study|Study Terminated Early|1|||
161741205|NCT01996904|584091950|FG000|Overall Study|Lost to Follow-up|38|||
161741206|NCT01996904|584091951|FG001|Overall Study|Lost to Follow-up|27|||
161741207|NCT00929734|584091955|FG000|Overall Study|Lost to Follow-up|2|||
161741208|NCT00929734|584091956|FG001|Overall Study|Lost to Follow-up|1|||
161741209|NCT00929734|584091955|FG000|Overall Study|Withdrawal by Subject|0|||
161741210|NCT00929734|584091956|FG001|Overall Study|Withdrawal by Subject|2|||
161741211|NCT00980980|584091957|FG000|Overall Study|Withdrawal by Hospital|0|||
161741212|NCT00980980|584091958|FG001|Overall Study|Withdrawal by Hospital|1|||
161741213|NCT00980980|584091959|FG002|Overall Study|Withdrawal by Hospital|0|||
161741214|NCT00121992|584091960|FG000|Overall Study|Treatment not received|2|||
161741215|NCT00121992|584091961|FG001|Overall Study|Treatment not received|11|||
161741216|NCT03076190|584091962|FG000|Overall Study|Lost to Follow-up|9|||
161741217|NCT03076190|584091963|FG001|Overall Study|Lost to Follow-up|34|||
161741218|NCT03076190|584091962|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
161741219|NCT03076190|584091963|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
161741220|NCT01441115|584091964|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
161741221|NCT02475395|584091965|FG000|Overall Study|Protocol Violation|30|||
161741222|NCT02475395|584091966|FG001|Overall Study|Protocol Violation|3|||
161741223|NCT01681576|584091967|FG000|Period 1|Adverse Event|1|||
161741224|NCT01681576|584091968|FG001|Period 1|Adverse Event|0|||
161741225|NCT01681576|584091967|FG000|Period 1|Protocol Deviation|1|||
161741226|NCT01681576|584091968|FG001|Period 1|Protocol Deviation|0|||
161741227|NCT01681576|584091967|FG000|Period 2|subject/guardian decision|3|||
161741228|NCT01681576|584091968|FG001|Period 2|subject/guardian decision|1|||
161741229|NCT01681576|584091967|FG000|Period 2|Non-compliance with study treatment|1|||
161741230|NCT01681576|584091968|FG001|Period 2|Non-compliance with study treatment|0|||
161741231|NCT00764478|584091969|FG000|Overall Study|Adverse Event|1|||
161741232|NCT00764478|584091970|FG001|Overall Study|Adverse Event|1|||
161741233|NCT00764478|584091971|FG002|Overall Study|Adverse Event|1|||
161741234|NCT00764478|584091969|FG000|Overall Study|Withdrawal by Subject|7|||
161741235|NCT00764478|584091970|FG001|Overall Study|Withdrawal by Subject|12|||
161741236|NCT00764478|584091971|FG002|Overall Study|Withdrawal by Subject|1|||
161741237|NCT00764478|584091969|FG000|Overall Study|Lost to Follow-up|7|||
161741238|NCT00764478|584091970|FG001|Overall Study|Lost to Follow-up|8|||
161741239|NCT00764478|584091971|FG002|Overall Study|Lost to Follow-up|5|||
161741240|NCT00764478|584091969|FG000|Overall Study|Protocol Violation|0|||
161741241|NCT00764478|584091970|FG001|Overall Study|Protocol Violation|1|||
161741242|NCT00764478|584091971|FG002|Overall Study|Protocol Violation|1|||
161741243|NCT04142216|584091972|FG000|Overall Study|Hospitalization|0|||
161741244|NCT04142216|584091973|FG001|Overall Study|Hospitalization|2|||
161741245|NCT04142216|584091972|FG000|Overall Study|Death|3|||
161741246|NCT04142216|584091973|FG001|Overall Study|Death|1|||
161741247|NCT04142216|584091972|FG000|Overall Study|Referral to another hemodialysis unit|3|||
161741248|NCT04142216|584091973|FG001|Overall Study|Referral to another hemodialysis unit|2|||
161741249|NCT04142216|584091972|FG000|Overall Study|Use of clove|0|||
161741250|NCT04142216|584091973|FG001|Overall Study|Use of clove|1|||
161741251|NCT00862121|584091974|FG000|Overall Study|Adverse Event|1|||
161741252|NCT00862121|584091975|FG001|Overall Study|Adverse Event|2|||
161741253|NCT00862121|584091974|FG000|Overall Study|Lack of Efficacy|0|||
161741254|NCT00862121|584091975|FG001|Overall Study|Lack of Efficacy|3|||
161741255|NCT00862121|584091974|FG000|Overall Study|Protocol Violation|0|||
161741256|NCT00862121|584091975|FG001|Overall Study|Protocol Violation|1|||
161741257|NCT00862121|584091974|FG000|Overall Study|Exclusion criterion violation|0|||
161741258|NCT00862121|584091975|FG001|Overall Study|Exclusion criterion violation|1|||
161741259|NCT00862121|584091974|FG000|Overall Study|Incorrect randomisation|0|||
161741260|NCT00862121|584091975|FG001|Overall Study|Incorrect randomisation|1|||
161741261|NCT02007954|584091976|FG000|Overall Study|Received liver transplant|3|||
161741262|NCT02007954|584091976|FG000|Overall Study|Switch in treatment modality|2|||
161741263|NCT02007954|584091976|FG000|Overall Study|Disease progression and unrelated AE|1|||
161741264|NCT02007954|584091976|FG000|Overall Study|Death|1|||
161741265|NCT01054976|584091981|FG000|Overall Study|Adverse Event|16|||
161741266|NCT01054976|584091981|FG000|Overall Study|Uncooperative participations to study|7|||
161741267|NCT01054976|584091981|FG000|Overall Study|Withdrawal by Subject|4|||
161741268|NCT01054976|584091981|FG000|Overall Study|Other|8|||
161741269|NCT01195363|584091983|FG000|Overall Study|Lost to Follow-up|7|||
161741270|NCT01195363|584091984|FG001|Overall Study|Lost to Follow-up|4|||
161741271|NCT01195363|584091983|FG000|Overall Study|Adverse Event|3|||
161741272|NCT01195363|584091984|FG001|Overall Study|Adverse Event|1|||
161741273|NCT01195363|584091983|FG000|Overall Study|Lack of Efficacy|0|||
161741274|NCT01195363|584091984|FG001|Overall Study|Lack of Efficacy|4|||
161741275|NCT01195363|584091983|FG000|Overall Study|incarceration|1|||
161741276|NCT01195363|584091984|FG001|Overall Study|incarceration|0|||
161741277|NCT01164865|584091986|FG000|Overall Study|Lost to Follow-up|2|||
161741278|NCT01164865|584091987|FG001|Overall Study|Lost to Follow-up|1|||
161741279|NCT00475540|584091989|FG000|36 Months|Lost to Follow-up|4|||
161741280|NCT00475540|584091990|FG001|36 Months|Lost to Follow-up|4|||
161741281|NCT00475540|584091989|FG000|36 Months|Death|1|||
161741282|NCT00475540|584091990|FG001|36 Months|Death|2|||
161741283|NCT00475540|584091989|FG000|36 Months|Censored due to reoperation|3|||
161741284|NCT00475540|584091990|FG001|36 Months|Censored due to reoperation|0|||
161741285|NCT00377429|584091991|FG000|Overall Study|Withdrawal by Subject|5|||
161741286|NCT00377429|584091991|FG000|Overall Study|Adverse Event|8|||
161741287|NCT00377429|584091991|FG000|Overall Study|Physician Decision|1|||
161741288|NCT00377429|584091991|FG000|Overall Study|Patient non-compliance|1|||
161741289|NCT02394795|584091994|FG000|Overall Study|Adverse Event|92|||
161741290|NCT02394795|584091995|FG001|Overall Study|Adverse Event|70|||
161741291|NCT02394795|584091994|FG000|Overall Study|Lost to Follow-up|0|||
161741292|NCT02394795|584091995|FG001|Overall Study|Lost to Follow-up|1|||
161741293|NCT02394795|584091994|FG000|Overall Study|Withdrawal by Subject|17|||
161741294|NCT02394795|584091995|FG001|Overall Study|Withdrawal by Subject|26|||
161741295|NCT02394795|584091994|FG000|Overall Study|Lack of Efficacy|181|||
161741296|NCT02394795|584091995|FG001|Overall Study|Lack of Efficacy|211|||
161741297|NCT02394795|584091994|FG000|Overall Study|Death|4|||
161741298|NCT02394795|584091995|FG001|Overall Study|Death|5|||
161741299|NCT02394795|584091994|FG000|Overall Study|Physician Decision|109|||
161741300|NCT02394795|584091995|FG001|Overall Study|Physician Decision|93|||
161741301|NCT00453180|584093261|FG000|Overall Study|Lost to Follow-up|2|||
161741302|NCT00453180|584093262|FG001|Overall Study|Lost to Follow-up|1|||
161741303|NCT00453180|584093261|FG000|Overall Study|Adverse Event|1|||
161741304|NCT00453180|584093262|FG001|Overall Study|Adverse Event|2|||
161741305|NCT00804843|584093263|FG000|Overall Study|Protocol Violation|1|||
161741306|NCT00804843|584093264|FG001|Overall Study|Protocol Violation|0|||
161741307|NCT00804843|584093263|FG000|Overall Study|Adverse Event|8|||
161741308|NCT00804843|584093264|FG001|Overall Study|Adverse Event|5|||
161741309|NCT00804843|584093263|FG000|Overall Study|Withdrawal by Subject|1|||
161741310|NCT00804843|584093264|FG001|Overall Study|Withdrawal by Subject|2|||
161741311|NCT03326869|584093270|FG000|Overall Study|Study data has been lost to natural disa|1|||
161741312|NCT03326869|584093271|FG001|Overall Study|Study data has been lost to natural disa|1|||
161741313|NCT01002742|584093274|FG000|Overall Study|Determined to be ineligible|0|||
161741314|NCT01002742|584093275|FG001|Overall Study|Determined to be ineligible|1|||
161741315|NCT00562640|584093276|FG000|Overall Study|Death|0|||
161741316|NCT00562640|584093277|FG001|Overall Study|Death|1|||
161741317|NCT00562640|584093278|FG002|Overall Study|Death|1|||
161741318|NCT00562640|584093279|FG003|Overall Study|Death|0|||
161741319|NCT05263921|584093280|FG000|Overall Study|Other: family emergency.|0|||
161741320|NCT05263921|584093281|FG001|Overall Study|Other: family emergency.|0|||
161741321|NCT05263921|584093282|FG002|Overall Study|Other: family emergency.|1|||
161741322|NCT05263921|584093283|FG003|Overall Study|Other: family emergency.|0|||
161741323|NCT01297309|584093288|FG000|Overall Study|Eligibility failure|2|||
161741324|NCT01297309|584093288|FG000|Overall Study|Screen failure|2|||
161741325|NCT01297309|584093288|FG000|Overall Study|Withdrawal by Subject|5|||
161741326|NCT01297309|584093288|FG000|Overall Study|Adverse Event|1|||
161741327|NCT01297309|584093288|FG000|Overall Study|Investigator Decision|2|||
161741328|NCT01297309|584093288|FG000|Overall Study|Death|1|||
161741329|NCT01297309|584093288|FG000|Overall Study|Participant not entering extensionperiod|1|||
161741330|NCT02670928|584093289|FG000|Overall Study|Adverse Event|3|||
161741331|NCT02670928|584093290|FG001|Overall Study|Adverse Event|1|||
161741332|NCT02670928|584093289|FG000|Overall Study|Withdrawal by Subject|4|||
161741333|NCT02670928|584093290|FG001|Overall Study|Withdrawal by Subject|0|||
161741334|NCT02670928|584093289|FG000|Overall Study|Lost to Follow-up|1|||
161741335|NCT02670928|584093290|FG001|Overall Study|Lost to Follow-up|0|||
161741336|NCT02670928|584093289|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
161741337|NCT02670928|584093290|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
161741338|NCT02678312|584093291|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
161741339|NCT02678312|584093292|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741340|NCT02678312|584093293|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741341|NCT02678312|584093294|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741342|NCT02678312|584093295|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741343|NCT02678312|584093291|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
161741344|NCT02678312|584093292|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741345|NCT02678312|584093293|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741346|NCT02678312|584093294|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741347|NCT02678312|584093295|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741348|NCT02678312|584093291|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
161741349|NCT02678312|584093292|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741350|NCT02678312|584093293|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741351|NCT02678312|584093294|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741352|NCT02678312|584093295|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741353|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
161741354|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
161741355|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
161741356|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
161741357|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
161741358|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Death|0|||
161741359|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Death|0|||
161741360|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Death|0|||
161741361|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Death|8|||
161741362|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Death|12|||
161840877|NCT01739348|584462877|FG002|Part I (Base Study)|Lack of Efficacy|0|||
161741363|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
161741364|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
161741365|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
161741366|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
161741367|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
161741368|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741369|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741370|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741371|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741372|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
161741373|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161741374|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161741375|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161741376|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
161741377|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
161741378|NCT02591238|584093296|FG000|Overall Study|Pregnancy|1|||
161741379|NCT02591238|584093297|FG001|Overall Study|Pregnancy|0|||
161741380|NCT02591238|584093298|FG002|Overall Study|Pregnancy|0|||
161741381|NCT02591238|584093299|FG003|Overall Study|Pregnancy|0|||
161741382|NCT02591238|584093296|FG000|Overall Study|Withdrawal by Subject|0|||
161741383|NCT02591238|584093297|FG001|Overall Study|Withdrawal by Subject|0|||
161741384|NCT02591238|584093298|FG002|Overall Study|Withdrawal by Subject|0|||
161741385|NCT02591238|584093299|FG003|Overall Study|Withdrawal by Subject|1|||
161741386|NCT02591238|584093296|FG000|Overall Study|influenza|0|||
161741387|NCT02591238|584093297|FG001|Overall Study|influenza|0|||
161741388|NCT02591238|584093298|FG002|Overall Study|influenza|0|||
161741389|NCT02591238|584093299|FG003|Overall Study|influenza|1|||
161741390|NCT02591238|584093296|FG000|Overall Study|personal circumstances|0|||
161741391|NCT02591238|584093297|FG001|Overall Study|personal circumstances|0|||
161741392|NCT02591238|584093298|FG002|Overall Study|personal circumstances|0|||
161741393|NCT02591238|584093299|FG003|Overall Study|personal circumstances|1|||
161741394|NCT02591238|584093296|FG000|Overall Study|personal circumstances|0|||
161741395|NCT02591238|584093297|FG001|Overall Study|personal circumstances|1|||
161741396|NCT02591238|584093298|FG002|Overall Study|personal circumstances|0|||
161741397|NCT02591238|584093299|FG003|Overall Study|personal circumstances|0|||
161741398|NCT00656084|584093300|FG000|Overall Study|Adverse Event|4|||
161741399|NCT00656084|584093300|FG000|Overall Study|Withdrawal by Subject|1|||
161741400|NCT00656084|584093300|FG000|Overall Study|Patient Request|1|||
161741401|NCT00656084|584093300|FG000|Overall Study|Investigator Request|1|||
161741402|NCT00640146|584093304|FG000|Overall Study|Adverse Event|2|||
161741403|NCT00640146|584093305|FG001|Overall Study|Adverse Event|0|||
161741404|NCT00640146|584093304|FG000|Overall Study|Lost to Follow-up|0|||
161741405|NCT00640146|584093305|FG001|Overall Study|Lost to Follow-up|1|||
161741406|NCT00640146|584093304|FG000|Overall Study|Lack of Efficacy|0|||
161741407|NCT00640146|584093305|FG001|Overall Study|Lack of Efficacy|1|||
161741408|NCT00640146|584093304|FG000|Overall Study|Withdrawal by Subject|1|||
161741409|NCT00640146|584093305|FG001|Overall Study|Withdrawal by Subject|1|||
161741410|NCT00640146|584093304|FG000|Overall Study|Randomized but not treated|1|||
161741411|NCT00640146|584093305|FG001|Overall Study|Randomized but not treated|3|||
161741412|NCT00525785|584093309|FG000|Overall Study|Withdrawal by Subject|1|||
161741413|NCT00525785|584093309|FG000|Overall Study|Lack of Efficacy|1|||
161741414|NCT00525785|584093309|FG000|Overall Study|Physician Decision|1|||
161741415|NCT02455388|584093310|FG000|Overall Study|Protocol Violation|1|||
161741416|NCT02455388|584093311|FG001|Overall Study|Protocol Violation|0|||
161741417|NCT02455388|584093312|FG002|Overall Study|Protocol Violation|4|||
161741418|NCT02455388|584093310|FG000|Overall Study|Withdrawal by Subject|0|||
161741419|NCT02455388|584093311|FG001|Overall Study|Withdrawal by Subject|0|||
161741420|NCT02455388|584093312|FG002|Overall Study|Withdrawal by Subject|7|||
161741421|NCT04507776|584093314|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
161741422|NCT04624672|584093317|FG000|Overall Study|Early Study Closure|2|||
161741423|NCT04624672|584093318|FG001|Overall Study|Early Study Closure|1|||
161741424|NCT05905601|584093325|FG000|Overall Study|Lost to Follow-up|1|||
161741425|NCT05905601|584093326|FG001|Overall Study|Lost to Follow-up|3|||
161741426|NCT03024255|584093327|FG000|Overall Study|Adverse Event|1|||
161741427|NCT03024255|584093328|FG001|Overall Study|Adverse Event|4|||
161741428|NCT03024255|584093329|FG002|Overall Study|Adverse Event|8|||
161741429|NCT03024255|584093330|FG003|Overall Study|Adverse Event|0|||
161741430|NCT03024255|584093327|FG000|Overall Study|Withdrawal by Subject|3|||
161741431|NCT03024255|584093328|FG001|Overall Study|Withdrawal by Subject|1|||
161741432|NCT03024255|584093329|FG002|Overall Study|Withdrawal by Subject|0|||
161741433|NCT03024255|584093330|FG003|Overall Study|Withdrawal by Subject|3|||
161741434|NCT03024255|584093327|FG000|Overall Study|Protocol Violation|0|||
161741435|NCT03024255|584093328|FG001|Overall Study|Protocol Violation|0|||
161741436|NCT03024255|584093329|FG002|Overall Study|Protocol Violation|2|||
161741437|NCT03024255|584093330|FG003|Overall Study|Protocol Violation|0|||
161741438|NCT03024255|584093327|FG000|Overall Study|Lost to Follow-up|1|||
161741439|NCT03024255|584093328|FG001|Overall Study|Lost to Follow-up|2|||
161741440|NCT03024255|584093329|FG002|Overall Study|Lost to Follow-up|1|||
161741441|NCT03024255|584093330|FG003|Overall Study|Lost to Follow-up|1|||
161741442|NCT03024255|584093327|FG000|Overall Study|Lack of Efficacy|1|||
161741443|NCT03024255|584093328|FG001|Overall Study|Lack of Efficacy|0|||
161741444|NCT03024255|584093329|FG002|Overall Study|Lack of Efficacy|0|||
161741445|NCT03024255|584093330|FG003|Overall Study|Lack of Efficacy|0|||
161741446|NCT03024255|584093327|FG000|Overall Study|Protocol Noncompliance|1|||
161741447|NCT03024255|584093328|FG001|Overall Study|Protocol Noncompliance|1|||
161741448|NCT03024255|584093329|FG002|Overall Study|Protocol Noncompliance|0|||
161741449|NCT03024255|584093330|FG003|Overall Study|Protocol Noncompliance|1|||
161741450|NCT01779648|584093335|FG000|Overall Study|Protocol Violation|1|||
161741451|NCT01779648|584093336|FG001|Overall Study|Protocol Violation|0|||
161741452|NCT01797445|584093337|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
161741453|NCT01797445|584093338|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
161741454|NCT01797445|584093337|FG000|Double-Blind Phase|Adverse Event|3|||
161741455|NCT01797445|584093338|FG001|Double-Blind Phase|Adverse Event|0|||
161741456|NCT01797445|584093337|FG000|Double-Blind Phase|Death|5|||
161741457|NCT01797445|584093338|FG001|Double-Blind Phase|Death|4|||
161741458|NCT01797445|584093337|FG000|Double-Blind Phase|Pregnancy|0|||
161741459|NCT01797445|584093338|FG001|Double-Blind Phase|Pregnancy|1|||
161741460|NCT01797445|584093337|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161741461|NCT01797445|584093338|FG001|Double-Blind Phase|Lack of Efficacy|2|||
161741462|NCT01797445|584093337|FG000|Double-Blind Phase|Investigator's Discretion|15|||
161741463|NCT01797445|584093338|FG001|Double-Blind Phase|Investigator's Discretion|17|||
161741464|NCT01797445|584093337|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
161741465|NCT01797445|584093338|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
161741466|NCT01797445|584093337|FG000|Double-Blind Phase|Protocol Violation|0|||
161741467|NCT01797445|584093338|FG001|Double-Blind Phase|Protocol Violation|1|||
161741468|NCT01797445|584093337|FG000|Double-Blind Phase|Withdrew Consent|20|||
161741469|NCT01797445|584093338|FG001|Double-Blind Phase|Withdrew Consent|35|||
161741470|NCT01797445|584093337|FG000|Double-Blind Phase|Lost to Follow-up|34|||
161741471|NCT01797445|584093338|FG001|Double-Blind Phase|Lost to Follow-up|26|||
161741472|NCT01797445|584093337|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
161741473|NCT01797445|584093338|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161741474|NCT02119026|584093341|FG000|1st-line Treatment|Adverse Event|9|||
161741475|NCT02119026|584093342|FG001|1st-line Treatment|Adverse Event|14|||
161741476|NCT02119026|584093341|FG000|1st-line Treatment|Physician Decision|3|||
161741477|NCT02119026|584093342|FG001|1st-line Treatment|Physician Decision|8|||
161741478|NCT02119026|584093341|FG000|1st-line Treatment|Withdrawal by Subject|4|||
161741479|NCT02119026|584093342|FG001|1st-line Treatment|Withdrawal by Subject|10|||
161741480|NCT02119026|584093341|FG000|1st-line Treatment|Patient condition or compliance|6|||
161741481|NCT02119026|584093342|FG001|1st-line Treatment|Patient condition or compliance|4|||
161741482|NCT02119026|584093341|FG000|1st-line Treatment|Surgery of metastases|2|||
161741483|NCT02119026|584093342|FG001|1st-line Treatment|Surgery of metastases|1|||
161741484|NCT02119026|584093341|FG000|1st-line Treatment|Death|2|||
161741485|NCT02119026|584093342|FG001|1st-line Treatment|Death|1|||
161741486|NCT02119026|584093341|FG000|2nd-line Treatment|Lost to Follow-up|2|||
161741487|NCT02119026|584093342|FG001|2nd-line Treatment|Lost to Follow-up|0|||
161741488|NCT02119026|584093341|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
161741489|NCT02119026|584093342|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
161741490|NCT02119026|584093341|FG000|2nd-line Treatment|Adverse Event|4|||
161741491|NCT02119026|584093342|FG001|2nd-line Treatment|Adverse Event|1|||
161741492|NCT01143714|584093343|FG000|Overall Study|Adverse Event|4|||
161741493|NCT01143714|584093344|FG001|Overall Study|Adverse Event|2|||
161741494|NCT01143714|584093343|FG000|Overall Study|Withdrawal by Subject|1|||
161741495|NCT01143714|584093344|FG001|Overall Study|Withdrawal by Subject|0|||
161741496|NCT01143714|584093343|FG000|Overall Study|Subject non-compliance|0|||
161741497|NCT01143714|584093344|FG001|Overall Study|Subject non-compliance|1|||
161741498|NCT01143714|584093343|FG000|Overall Study|wound closed = deemed healed|1|||
161741499|NCT01143714|584093344|FG001|Overall Study|wound closed = deemed healed|0|||
161741500|NCT01143714|584093343|FG000|Overall Study|wound size increased|1|||
161741501|NCT01143714|584093344|FG001|Overall Study|wound size increased|0|||
161741502|NCT04190186|584093345|FG000|Overall Study|ILR is no longer functioning|0|||
161741503|NCT04190186|584093346|FG001|Overall Study|ILR is no longer functioning|1|||
161741504|NCT04190186|584093345|FG000|Overall Study|Lost to Follow-up|0|||
161741505|NCT04190186|584093346|FG001|Overall Study|Lost to Follow-up|1|||
161741506|NCT04190186|584093345|FG000|Overall Study|Withdrawal by Subject|2|||
161741507|NCT04190186|584093346|FG001|Overall Study|Withdrawal by Subject|0|||
161741508|NCT04190186|584093345|FG000|Overall Study|Subject choice to explant|1|||
161741509|NCT04190186|584093346|FG001|Overall Study|Subject choice to explant|0|||
161741510|NCT04190186|584093345|FG000|Overall Study|Physician Decision|0|||
161741511|NCT04190186|584093346|FG001|Overall Study|Physician Decision|1|||
161741512|NCT04190186|584093345|FG000|Overall Study|Study was stopped|4|||
161741513|NCT04190186|584093346|FG001|Overall Study|Study was stopped|5|||
161741514|NCT02016898|584093347|FG000|Overall Study|Death|1|||
161741515|NCT02016898|584093348|FG001|Overall Study|Death|1|||
161741516|NCT02016898|584093347|FG000|Overall Study|Lost to Follow-up|4|||
161741517|NCT02016898|584093348|FG001|Overall Study|Lost to Follow-up|4|||
161840878|NCT01739348|584462878|FG003|Part I (Base Study)|Lack of Efficacy|7|||
161840879|NCT01739348|584462875|FG000|Part I (Base Study)|Lost to Follow-up|4|||
161741518|NCT01381718|584093349|FG000|Overall Study|Withdrawal by Subject|2|||
161741519|NCT01381718|584093350|FG001|Overall Study|Withdrawal by Subject|5|||
161741520|NCT01381718|584093349|FG000|Overall Study|Lost to Follow-up|3|||
161741521|NCT01381718|584093350|FG001|Overall Study|Lost to Follow-up|5|||
161741522|NCT01381718|584093349|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
161741523|NCT01381718|584093350|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
161741524|NCT03017846|584093351|FG000|Overall Study|Lost to Follow-up|3|||
161741525|NCT03017846|584093351|FG000|Overall Study|Adverse Event|2|||
161741526|NCT00992186|584093354|FG000|Overall Study|Withdrawal by Subject|2|||
161741527|NCT00992186|584093354|FG000|Overall Study|Protocol Violation|1|||
161741528|NCT00992186|584093354|FG000|Overall Study|Physician Decision|1|||
161741529|NCT00992186|584093354|FG000|Overall Study|Adverse Event|9|||
161741530|NCT00992186|584093354|FG000|Overall Study|Progressive Disease|30|||
161741531|NCT00992186|584093354|FG000|Overall Study|Refusal To Receive Study Agent|3|||
161741532|NCT00171314|584093358|FG000|Overall Study|Adverse Event|44|||
161741533|NCT00171314|584093359|FG001|Overall Study|Adverse Event|41|||
161741534|NCT00171314|584093358|FG000|Overall Study|Lack of Efficacy|19|||
161741535|NCT00171314|584093359|FG001|Overall Study|Lack of Efficacy|14|||
161741536|NCT00171314|584093358|FG000|Overall Study|Withdrawal by Subject|9|||
161741537|NCT00171314|584093359|FG001|Overall Study|Withdrawal by Subject|6|||
161741538|NCT00171314|584093358|FG000|Overall Study|Abnormal Test Procedure Results|9|||
161741539|NCT00171314|584093359|FG001|Overall Study|Abnormal Test Procedure Results|3|||
161741540|NCT00171314|584093358|FG000|Overall Study|Protocol Violation|3|||
161741541|NCT00171314|584093359|FG001|Overall Study|Protocol Violation|7|||
161741542|NCT00171314|584093358|FG000|Overall Study|Administrative Problems|4|||
161741543|NCT00171314|584093359|FG001|Overall Study|Administrative Problems|3|||
161741544|NCT00171314|584093358|FG000|Overall Study|Lost to Follow-up|1|||
161741545|NCT00171314|584093359|FG001|Overall Study|Lost to Follow-up|3|||
161741546|NCT00171314|584093358|FG000|Overall Study|Death|2|||
161741547|NCT00171314|584093359|FG001|Overall Study|Death|1|||
161741548|NCT00318565|584093360|FG000|Overall Study|Excluded per protocol|24|||
161741549|NCT00493467|584093361|FG000|Overall Study|Death|1|||
161741550|NCT01409993|584093364|FG000|Overall Study|Adverse Event|4|||
161741551|NCT01409993|584093365|FG001|Overall Study|Adverse Event|4|||
161741552|NCT01409993|584093366|FG002|Overall Study|Adverse Event|3|||
161741553|NCT01409993|584093367|FG003|Overall Study|Adverse Event|1|||
161741554|NCT01409993|584093364|FG000|Overall Study|Withdrawal by Subject|0|||
161741555|NCT01409993|584093365|FG001|Overall Study|Withdrawal by Subject|0|||
161741556|NCT01409993|584093366|FG002|Overall Study|Withdrawal by Subject|0|||
161741557|NCT01409993|584093367|FG003|Overall Study|Withdrawal by Subject|4|||
161741558|NCT01409993|584093364|FG000|Overall Study|Lost to Follow-up|0|||
161741559|NCT01409993|584093365|FG001|Overall Study|Lost to Follow-up|1|||
161741560|NCT01409993|584093366|FG002|Overall Study|Lost to Follow-up|0|||
161741561|NCT01409993|584093367|FG003|Overall Study|Lost to Follow-up|0|||
161741562|NCT03074149|584093370|FG000|Overall Study|Reason unknown|22|||
161741563|NCT03074149|584093371|FG001|Overall Study|Reason unknown|35|||
161741564|NCT03074149|584093370|FG000|Overall Study|Death|10|||
161741565|NCT03074149|584093371|FG001|Overall Study|Death|45|||
161741566|NCT00830960|584093372|FG000|Overall Study|Death|5|||
161741567|NCT00830960|584093373|FG001|Overall Study|Death|4|||
161741568|NCT00830960|584093374|FG002|Overall Study|Death|3|||
161741569|NCT00830960|584093375|FG003|Overall Study|Death|2|||
161741570|NCT00830960|584093376|FG004|Overall Study|Death|6|||
161741571|NCT00830960|584093377|FG005|Overall Study|Death|1|||
161741572|NCT00830960|584093372|FG000|Overall Study|Lost to Follow-up|1|||
161741573|NCT00830960|584093373|FG001|Overall Study|Lost to Follow-up|1|||
161741574|NCT00830960|584093374|FG002|Overall Study|Lost to Follow-up|1|||
161741575|NCT00830960|584093375|FG003|Overall Study|Lost to Follow-up|0|||
161741576|NCT00830960|584093376|FG004|Overall Study|Lost to Follow-up|0|||
161741577|NCT00830960|584093377|FG005|Overall Study|Lost to Follow-up|1|||
161840880|NCT01739348|584462876|FG001|Part I (Base Study)|Lost to Follow-up|2|||
161741578|NCT00830960|584093372|FG000|Overall Study|Withdrawal by Subject|19|||
161741579|NCT00830960|584093373|FG001|Overall Study|Withdrawal by Subject|19|||
161741580|NCT00830960|584093374|FG002|Overall Study|Withdrawal by Subject|18|||
161741581|NCT00830960|584093375|FG003|Overall Study|Withdrawal by Subject|23|||
161741582|NCT00830960|584093376|FG004|Overall Study|Withdrawal by Subject|16|||
161741583|NCT00830960|584093377|FG005|Overall Study|Withdrawal by Subject|21|||
161741584|NCT00830960|584093372|FG000|Overall Study|Sponsor Decision|1|||
161741585|NCT00830960|584093373|FG001|Overall Study|Sponsor Decision|2|||
161741586|NCT00830960|584093374|FG002|Overall Study|Sponsor Decision|3|||
161741587|NCT00830960|584093375|FG003|Overall Study|Sponsor Decision|4|||
161741588|NCT00830960|584093376|FG004|Overall Study|Sponsor Decision|5|||
161741589|NCT00830960|584093377|FG005|Overall Study|Sponsor Decision|7|||
161840881|NCT01739348|584462877|FG002|Part I (Base Study)|Lost to Follow-up|4|||
161741590|NCT00830960|584093372|FG000|Overall Study|No study drug received|7|||
161741591|NCT00830960|584093373|FG001|Overall Study|No study drug received|2|||
161741592|NCT00830960|584093374|FG002|Overall Study|No study drug received|4|||
161741593|NCT00830960|584093375|FG003|Overall Study|No study drug received|3|||
161741594|NCT00830960|584093376|FG004|Overall Study|No study drug received|5|||
161741595|NCT00830960|584093377|FG005|Overall Study|No study drug received|7|||
161741596|NCT01309841|584093380|FG000|Overall Study|Other|0|||
161741597|NCT01309841|584093381|FG001|Overall Study|Other|1|||
161741598|NCT01309841|584093382|FG002|Overall Study|Other|1|||
161741599|NCT01309841|584093380|FG000|Overall Study|Lost to Follow-up|7|||
161741600|NCT01309841|584093381|FG001|Overall Study|Lost to Follow-up|6|||
161741601|NCT01309841|584093382|FG002|Overall Study|Lost to Follow-up|4|||
161741602|NCT01309841|584093380|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
161741603|NCT01309841|584093381|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161741604|NCT01309841|584093382|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
161741605|NCT01309841|584093380|FG000|Overall Study|Lack of Efficacy|0|||
161741606|NCT01309841|584093381|FG001|Overall Study|Lack of Efficacy|0|||
161741607|NCT01309841|584093382|FG002|Overall Study|Lack of Efficacy|2|||
161741608|NCT01309841|584093380|FG000|Overall Study|Adverse Event|9|||
161741609|NCT01309841|584093381|FG001|Overall Study|Adverse Event|22|||
161741610|NCT01309841|584093382|FG002|Overall Study|Adverse Event|11|||
161741611|NCT01309841|584093380|FG000|Overall Study|Death|1|||
161741612|NCT01309841|584093381|FG001|Overall Study|Death|0|||
161741613|NCT01309841|584093382|FG002|Overall Study|Death|0|||
161741614|NCT01309841|584093380|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161741615|NCT01309841|584093381|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161741616|NCT01309841|584093382|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
161741617|NCT01309841|584093380|FG000|Overall Study|Withdrawal by Subject|17|||
161741618|NCT01309841|584093381|FG001|Overall Study|Withdrawal by Subject|6|||
161741619|NCT01309841|584093382|FG002|Overall Study|Withdrawal by Subject|13|||
161741620|NCT01309841|584093380|FG000|Overall Study|Did Not Receive Treatment|2|||
161741621|NCT01309841|584093381|FG001|Overall Study|Did Not Receive Treatment|0|||
161741622|NCT01309841|584093382|FG002|Overall Study|Did Not Receive Treatment|1|||
161741623|NCT01309841|584093380|FG000|Overall Study|Severe non-compliance with protocol|0|||
161741624|NCT01309841|584093381|FG001|Overall Study|Severe non-compliance with protocol|5|||
161741625|NCT01309841|584093382|FG002|Overall Study|Severe non-compliance with protocol|2|||
161741626|NCT03448224|584093386|FG000|Overall Study|Provided same answer to every question|1|||
161741627|NCT03448224|584093387|FG001|Overall Study|Provided same answer to every question|0|||
161741628|NCT03103906|584093388|FG000|Overall Study|Adverse Event|2|||
161741629|NCT03103906|584093389|FG001|Overall Study|Adverse Event|3|||
161741630|NCT03103906|584093388|FG000|Overall Study|Other|2|||
161741631|NCT03103906|584093389|FG001|Overall Study|Other|0|||
161741632|NCT03498287|584093393|FG000|Overall Study|Withdrawal by Subject|3|||
161741633|NCT03498287|584093394|FG001|Overall Study|Withdrawal by Subject|0|||
161741634|NCT03498287|584093393|FG000|Overall Study|Protocol Violation|0|||
161741635|NCT03498287|584093394|FG001|Overall Study|Protocol Violation|4|||
161741636|NCT03498287|584093393|FG000|Overall Study|Adverse Event|0|||
161741637|NCT03498287|584093394|FG001|Overall Study|Adverse Event|1|||
161741638|NCT02939599|584093395|FG000|Overall Study|Adverse Event|1|||
161741639|NCT02939599|584093396|FG001|Overall Study|Adverse Event|0|||
161741640|NCT02939599|584093395|FG000|Overall Study|Study Terminated By Sponsor|2|||
161741641|NCT02939599|584093396|FG001|Overall Study|Study Terminated By Sponsor|2|||
161741642|NCT01669811|584093397|FG000|Overall Study|Investigator decision|0|||
161741643|NCT01669811|584093398|FG001|Overall Study|Investigator decision|1|||
161741644|NCT01669811|584093397|FG000|Overall Study|Withdrawal by Subject|1|||
161741645|NCT01669811|584093398|FG001|Overall Study|Withdrawal by Subject|2|||
161741646|NCT01669811|584093397|FG000|Overall Study|Adverse Event|2|||
161741647|NCT01669811|584093398|FG001|Overall Study|Adverse Event|6|||
161741648|NCT01669811|584093397|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161741649|NCT01669811|584093398|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
161741650|NCT03288493|584093403|FG000|Overall Study|Withdrawal by Subject|4|||
161741651|NCT03288493|584093404|FG001|Overall Study|Withdrawal by Subject|0|||
161741652|NCT03288493|584093405|FG002|Overall Study|Withdrawal by Subject|0|||
161741653|NCT03288493|584093406|FG003|Overall Study|Withdrawal by Subject|0|||
161741654|NCT03288493|584093407|FG004|Overall Study|Withdrawal by Subject|0|||
161741655|NCT03288493|584093408|FG005|Overall Study|Withdrawal by Subject|2|||
161741656|NCT03288493|584093409|FG006|Overall Study|Withdrawal by Subject|0|||
161741657|NCT03288493|584093403|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
161840882|NCT01739348|584462878|FG003|Part I (Base Study)|Lost to Follow-up|4|||
161840883|NCT01739348|584462875|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
161840884|NCT01739348|584462876|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
161840885|NCT01739348|584462877|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
161840886|NCT01739348|584462878|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
161840887|NCT01739348|584462875|FG000|Part I (Base Study)|Physician Decision|10|||
161840888|NCT01739348|584462876|FG001|Part I (Base Study)|Physician Decision|7|||
161840889|NCT01739348|584462877|FG002|Part I (Base Study)|Physician Decision|1|||
161840890|NCT01739348|584462878|FG003|Part I (Base Study)|Physician Decision|4|||
161840891|NCT01739348|584462875|FG000|Part I (Base Study)|Protocol Violation|2|||
161840892|NCT01739348|584462876|FG001|Part I (Base Study)|Protocol Violation|0|||
161840893|NCT01739348|584462877|FG002|Part I (Base Study)|Protocol Violation|1|||
161840894|NCT01739348|584462878|FG003|Part I (Base Study)|Protocol Violation|2|||
161840895|NCT01739348|584462875|FG000|Part I (Base Study)|Screen Failure|2|||
161840896|NCT01739348|584462876|FG001|Part I (Base Study)|Screen Failure|0|||
161840897|NCT01739348|584462877|FG002|Part I (Base Study)|Screen Failure|0|||
161840898|NCT01739348|584462878|FG003|Part I (Base Study)|Screen Failure|0|||
161840899|NCT01739348|584462875|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
161840900|NCT01739348|584462876|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
161840901|NCT01739348|584462877|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
161840902|NCT01739348|584462878|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
161840903|NCT01739348|584462875|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
161840904|NCT01739348|584462876|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
161840905|NCT01739348|584462877|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
161840906|NCT01739348|584462878|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
161840907|NCT01739348|584462875|FG000|Part I (Base Study)|Participant Moved|4|||
161840908|NCT01739348|584462876|FG001|Part I (Base Study)|Participant Moved|3|||
161840909|NCT01739348|584462877|FG002|Part I (Base Study)|Participant Moved|1|||
161840910|NCT01739348|584462878|FG003|Part I (Base Study)|Participant Moved|7|||
161840911|NCT01739348|584462875|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
161840912|NCT01739348|584462876|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
161840913|NCT01739348|584462877|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
161840914|NCT01739348|584462878|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
161840915|NCT01739348|584462875|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
161840916|NCT01739348|584462876|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
161840917|NCT01739348|584462877|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
161840918|NCT01739348|584462878|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
161840919|NCT01739348|584462875|FG000|Part II (Extension Study)|Adverse Event|10|||
161840920|NCT01739348|584462876|FG001|Part II (Extension Study)|Adverse Event|11|||
161840921|NCT01739348|584462877|FG002|Part II (Extension Study)|Adverse Event|7|||
161840922|NCT01739348|584462878|FG003|Part II (Extension Study)|Adverse Event|26|||
161840923|NCT01739348|584462875|FG000|Part II (Extension Study)|Death|3|||
161840924|NCT01739348|584462876|FG001|Part II (Extension Study)|Death|3|||
161840925|NCT01739348|584462877|FG002|Part II (Extension Study)|Death|2|||
161840926|NCT01739348|584462878|FG003|Part II (Extension Study)|Death|6|||
161840927|NCT01739348|584462875|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
161840928|NCT01739348|584462876|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
161741658|NCT03288493|584093404|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
161741659|NCT03288493|584093405|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
161741660|NCT03288493|584093406|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
161741661|NCT03288493|584093407|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
161741662|NCT03288493|584093408|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
161741663|NCT03288493|584093409|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
161741664|NCT03288493|584093403|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
161741665|NCT03288493|584093404|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161840929|NCT01739348|584462877|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
161840930|NCT01739348|584462878|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
161840931|NCT01739348|584462875|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
161840932|NCT01739348|584462876|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
161840933|NCT01739348|584462877|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
161840934|NCT01739348|584462878|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
161840935|NCT01739348|584462875|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161840936|NCT01739348|584462876|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161840937|NCT01739348|584462877|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161840938|NCT01739348|584462878|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
161840939|NCT01739348|584462875|FG000|Part II (Extension Study)|Physician Decision|7|||
161741666|NCT03288493|584093405|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161840940|NCT01739348|584462876|FG001|Part II (Extension Study)|Physician Decision|11|||
161840941|NCT01739348|584462877|FG002|Part II (Extension Study)|Physician Decision|6|||
161840942|NCT01739348|584462878|FG003|Part II (Extension Study)|Physician Decision|12|||
161840943|NCT01739348|584462875|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
161840944|NCT01739348|584462876|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
161840945|NCT01739348|584462877|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
161840946|NCT01739348|584462878|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
161840947|NCT01739348|584462875|FG000|Part II (Extension Study)|Participant Moved|3|||
161840948|NCT01739348|584462876|FG001|Part II (Extension Study)|Participant Moved|3|||
161840949|NCT01739348|584462877|FG002|Part II (Extension Study)|Participant Moved|0|||
161840950|NCT01739348|584462878|FG003|Part II (Extension Study)|Participant Moved|3|||
161840951|NCT01739348|584462875|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
161840952|NCT01739348|584462876|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
161840953|NCT01739348|584462877|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
161840954|NCT01739348|584462878|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
161840955|NCT01739348|584462875|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
161840956|NCT01739348|584462876|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
161840957|NCT01739348|584462877|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
161840958|NCT01739348|584462878|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
161840959|NCT01085201|584462888|FG000|Overall Study|Scheduling conflict|1|||
161840960|NCT01085201|584462889|FG001|Overall Study|Scheduling conflict|0|||
161741667|NCT03288493|584093406|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
161741668|NCT03288493|584093407|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161741669|NCT03288493|584093408|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
161741670|NCT03288493|584093409|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161741671|NCT03288493|584093403|FG000|Overall Study|Death|2|||
161741672|NCT03288493|584093404|FG001|Overall Study|Death|0|||
161741673|NCT03288493|584093405|FG002|Overall Study|Death|0|||
161741674|NCT03288493|584093406|FG003|Overall Study|Death|0|||
161741675|NCT03288493|584093407|FG004|Overall Study|Death|0|||
161741676|NCT03288493|584093408|FG005|Overall Study|Death|0|||
161741677|NCT03288493|584093409|FG006|Overall Study|Death|0|||
161741678|NCT03288493|584093403|FG000|Overall Study|other reason not listed above|2|||
161741679|NCT03288493|584093404|FG001|Overall Study|other reason not listed above|0|||
161741680|NCT03288493|584093405|FG002|Overall Study|other reason not listed above|0|||
161741681|NCT03288493|584093406|FG003|Overall Study|other reason not listed above|0|||
161741682|NCT03288493|584093407|FG004|Overall Study|other reason not listed above|0|||
161741683|NCT03288493|584093408|FG005|Overall Study|other reason not listed above|0|||
161741684|NCT03288493|584093409|FG006|Overall Study|other reason not listed above|0|||
161741685|NCT01136746|584095894|FG000|Overall Study|Lost to Follow-up|0|||
161741686|NCT01136746|584095895|FG001|Overall Study|Lost to Follow-up|2|||
161741687|NCT01136746|584095894|FG000|Overall Study|Protocol Violation|2|||
161741688|NCT01136746|584095895|FG001|Overall Study|Protocol Violation|1|||
161741689|NCT01136746|584095894|FG000|Overall Study|Death|1|||
161741690|NCT01136746|584095895|FG001|Overall Study|Death|0|||
161741691|NCT00092677|584095901|FG000|Overall Study|Lost to Follow-up|0|||
161741692|NCT00092677|584095902|FG001|Overall Study|Lost to Follow-up|2|||
161741693|NCT00092677|584095901|FG000|Overall Study|Adminstrative|5|||
161741694|NCT00092677|584095902|FG001|Overall Study|Adminstrative|9|||
161741695|NCT00010803|584095907|FG000|Overall Study|Withdrawal by Subject|97|||
161741696|NCT00010803|584095908|FG001|Overall Study|Withdrawal by Subject|98|||
161741697|NCT01415908|584095909|FG000|Overall Study|Withdrawal by Subject|1|||
161741698|NCT01415908|584095910|FG001|Overall Study|Withdrawal by Subject|0|||
161741699|NCT02685995|584095911|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
161741700|NCT02685995|584095912|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
161741701|NCT01188096|584095913|FG000|Overall Study|progression of disease|4|||
161741702|NCT01188096|584095913|FG000|Overall Study|Withdrawal by Subject|2|||
161741703|NCT02384395|584095914|FG000|Overall Study|Physician Decision|4|||
161741704|NCT02384395|584095914|FG000|Overall Study|Withdrawal by Subject|3|||
161741705|NCT02384395|584095914|FG000|Overall Study|Lost to Follow-up|3|||
161741706|NCT03485222|584095915|FG000|Overall Study|Death|0|||
161741707|NCT03485222|584095916|FG001|Overall Study|Death|1|||
161741708|NCT03485222|584095915|FG000|Overall Study|Lost to Follow-up|2|||
161741709|NCT03485222|584095916|FG001|Overall Study|Lost to Follow-up|1|||
161741710|NCT00688545|584095917|FG000|Overall Study|Lost to Follow-up|1|||
161741711|NCT00688545|584095918|FG001|Overall Study|Lost to Follow-up|4|||
161741712|NCT00688545|584095917|FG000|Overall Study|Insurance/cost of drug|0|||
161741713|NCT00688545|584095918|FG001|Overall Study|Insurance/cost of drug|1|||
161741714|NCT00688545|584095917|FG000|Overall Study|Withdrawal by Subject|2|||
161741715|NCT00688545|584095918|FG001|Overall Study|Withdrawal by Subject|3|||
161840961|NCT01085201|584462890|FG002|Overall Study|Scheduling conflict|1|||
161741716|NCT00688545|584095917|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
161741717|NCT00688545|584095918|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
161741718|NCT01878097|584095921|FG000|Baseline|Surveys not fully completed|2497|||
161741719|NCT01878097|584095922|FG001|Baseline|Surveys not fully completed|1800|||
161741720|NCT01878097|584095921|FG000|Implementation Year 1|Surveys not fully completed|3202|||
161741721|NCT01878097|584095922|FG001|Implementation Year 1|Surveys not fully completed|2549|||
161741722|NCT01878097|584095921|FG000|Implementation Year 2|Surveys not fully completed|3281|||
161741723|NCT01878097|584095922|FG001|Implementation Year 2|Surveys not fully completed|2841|||
161741724|NCT01878097|584095921|FG000|Implementation Year 3|Surveys not fully completed|3494|||
161741725|NCT01878097|584095922|FG001|Implementation Year 3|Surveys not fully completed|2980|||
161741726|NCT01878097|584095921|FG000|Implementation Year 4|Surveys not fully completed|3604|||
161741727|NCT01878097|584095922|FG001|Implementation Year 4|Surveys not fully completed|3007|||
161741728|NCT01595438|584095923|FG000|Overall Study|Lost to Follow-up|20|||
161741729|NCT01595438|584095924|FG001|Overall Study|Lost to Follow-up|20|||
161741730|NCT01595438|584095923|FG000|Overall Study|Withdrawal by Subject|12|||
161741731|NCT01595438|584095924|FG001|Overall Study|Withdrawal by Subject|12|||
161741732|NCT01595438|584095923|FG000|Overall Study|Other Eligibility criteria|11|||
161741733|NCT01595438|584095924|FG001|Overall Study|Other Eligibility criteria|9|||
161741734|NCT00985738|584095926|FG000|Overall Study|Study closed prematurely|8|||
161741735|NCT00985738|584095927|FG001|Overall Study|Study closed prematurely|8|||
161741736|NCT01373918|584095932|FG000|Overall Study|Physician Decision|0|||
161741737|NCT01373918|584095933|FG001|Overall Study|Physician Decision|1|||
161741738|NCT00340834|584095937|FG000|Core Phase of Study|Adverse Event|26|||
161741739|NCT00340834|584095938|FG001|Core Phase of Study|Adverse Event|9|||
161741740|NCT00340834|584095939|FG002|Core Phase of Study|Adverse Event|9|||
161741741|NCT00340834|584095940|FG003|Core Phase of Study|Adverse Event|0|||
161741742|NCT00340834|584095941|FG004|Core Phase of Study|Adverse Event|0|||
161741743|NCT00340834|584095937|FG000|Core Phase of Study|Withdrawal by Subject|11|||
161741744|NCT00340834|584095938|FG001|Core Phase of Study|Withdrawal by Subject|9|||
161741745|NCT00340834|584095939|FG002|Core Phase of Study|Withdrawal by Subject|16|||
161741746|NCT00340834|584095940|FG003|Core Phase of Study|Withdrawal by Subject|0|||
161741747|NCT00340834|584095941|FG004|Core Phase of Study|Withdrawal by Subject|0|||
161741748|NCT00340834|584095937|FG000|Core Phase of Study|Administrative Problems|6|||
161741749|NCT00340834|584095938|FG001|Core Phase of Study|Administrative Problems|2|||
161741750|NCT00340834|584095939|FG002|Core Phase of Study|Administrative Problems|7|||
161741751|NCT00340834|584095940|FG003|Core Phase of Study|Administrative Problems|0|||
161741752|NCT00340834|584095941|FG004|Core Phase of Study|Administrative Problems|0|||
161741753|NCT00340834|584095937|FG000|Core Phase of Study|Lack of Efficacy|3|||
161741754|NCT00340834|584095938|FG001|Core Phase of Study|Lack of Efficacy|3|||
161741755|NCT00340834|584095939|FG002|Core Phase of Study|Lack of Efficacy|7|||
161741756|NCT00340834|584095940|FG003|Core Phase of Study|Lack of Efficacy|0|||
161741757|NCT00340834|584095941|FG004|Core Phase of Study|Lack of Efficacy|0|||
161741758|NCT00340834|584095937|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
161741759|NCT00340834|584095938|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
161741760|NCT00340834|584095939|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
161741761|NCT00340834|584095940|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
161741762|NCT00340834|584095941|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
161741763|NCT00340834|584095937|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
161741764|NCT00340834|584095938|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
161741765|NCT00340834|584095939|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
161741766|NCT00340834|584095940|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
161741767|NCT00340834|584095941|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
161741768|NCT00340834|584095937|FG000|Core Phase of Study|Lost to Follow-up|1|||
161741769|NCT00340834|584095938|FG001|Core Phase of Study|Lost to Follow-up|1|||
161741770|NCT00340834|584095939|FG002|Core Phase of Study|Lost to Follow-up|4|||
161741771|NCT00340834|584095940|FG003|Core Phase of Study|Lost to Follow-up|0|||
161741772|NCT00340834|584095941|FG004|Core Phase of Study|Lost to Follow-up|0|||
161741773|NCT00340834|584095937|FG000|Core Phase of Study|Death|2|||
161741774|NCT00340834|584095938|FG001|Core Phase of Study|Death|0|||
161741775|NCT00340834|584095939|FG002|Core Phase of Study|Death|0|||
161741776|NCT00340834|584095940|FG003|Core Phase of Study|Death|0|||
161741777|NCT00340834|584095941|FG004|Core Phase of Study|Death|0|||
161741778|NCT00340834|584095937|FG000|Core Phase of Study|Protocol Violation|0|||
161741779|NCT00340834|584095938|FG001|Core Phase of Study|Protocol Violation|0|||
161741780|NCT00340834|584095939|FG002|Core Phase of Study|Protocol Violation|2|||
161741781|NCT00340834|584095940|FG003|Core Phase of Study|Protocol Violation|0|||
161741782|NCT00340834|584095941|FG004|Core Phase of Study|Protocol Violation|0|||
161741783|NCT00340834|584095937|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
161741784|NCT00340834|584095938|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
161741785|NCT00340834|584095939|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
161741786|NCT00340834|584095940|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
161741787|NCT00340834|584095941|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
161741788|NCT00340834|584095937|FG000|Extension Phase of Study|Subject withdrew consent|26|||
161840962|NCT01085201|584462891|FG003|Overall Study|Scheduling conflict|0|||
161840963|NCT01085201|584462892|FG004|Overall Study|Scheduling conflict|0|||
161840964|NCT01085201|584462888|FG000|Overall Study|Unknown- no study drug|2|||
161840965|NCT01085201|584462889|FG001|Overall Study|Unknown- no study drug|0|||
161840966|NCT01085201|584462890|FG002|Overall Study|Unknown- no study drug|0|||
161840967|NCT01085201|584462891|FG003|Overall Study|Unknown- no study drug|0|||
161840968|NCT01085201|584462892|FG004|Overall Study|Unknown- no study drug|0|||
161840969|NCT01085201|584462888|FG000|Overall Study|Fond ineligible after consent|0|||
161840970|NCT01085201|584462889|FG001|Overall Study|Fond ineligible after consent|1|||
161840971|NCT01085201|584462890|FG002|Overall Study|Fond ineligible after consent|1|||
161840972|NCT01085201|584462891|FG003|Overall Study|Fond ineligible after consent|0|||
161840973|NCT01085201|584462892|FG004|Overall Study|Fond ineligible after consent|0|||
161840974|NCT00528411|584462893|FG000|Overall Study|Adverse Event|4|||
161840975|NCT00528411|584462894|FG001|Overall Study|Adverse Event|0|||
161840976|NCT00528411|584462895|FG002|Overall Study|Adverse Event|1|||
161840977|NCT00528411|584462893|FG000|Overall Study|Incorrect Enrolment|1|||
161840978|NCT00528411|584462894|FG001|Overall Study|Incorrect Enrolment|1|||
161840979|NCT00528411|584462895|FG002|Overall Study|Incorrect Enrolment|0|||
161840980|NCT00528411|584462893|FG000|Overall Study|Severe non-compliance to protocol|0|||
161840981|NCT00528411|584462894|FG001|Overall Study|Severe non-compliance to protocol|1|||
161840982|NCT00528411|584462895|FG002|Overall Study|Severe non-compliance to protocol|0|||
161840983|NCT00528411|584462893|FG000|Overall Study|Prior commitment medication|0|||
161840984|NCT00528411|584462894|FG001|Overall Study|Prior commitment medication|1|||
161840985|NCT00528411|584462895|FG002|Overall Study|Prior commitment medication|0|||
161840986|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
161840987|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
161840988|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840989|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840990|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
161840991|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840992|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840993|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840994|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840995|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161840996|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
161840997|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161840998|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161840999|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841000|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841001|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841002|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161741789|NCT00340834|584095938|FG001|Extension Phase of Study|Subject withdrew consent|31|||
161741790|NCT00340834|584095939|FG002|Extension Phase of Study|Subject withdrew consent|0|||
161741791|NCT00340834|584095940|FG003|Extension Phase of Study|Subject withdrew consent|12|||
161741792|NCT00340834|584095941|FG004|Extension Phase of Study|Subject withdrew consent|15|||
161741793|NCT00340834|584095937|FG000|Extension Phase of Study|Adverse Event|21|||
161741794|NCT00340834|584095938|FG001|Extension Phase of Study|Adverse Event|22|||
161741795|NCT00340834|584095939|FG002|Extension Phase of Study|Adverse Event|0|||
161741796|NCT00340834|584095940|FG003|Extension Phase of Study|Adverse Event|19|||
161741797|NCT00340834|584095941|FG004|Extension Phase of Study|Adverse Event|7|||
161741798|NCT00340834|584095937|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
161741799|NCT00340834|584095938|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
161741800|NCT00340834|584095939|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
161741801|NCT00340834|584095940|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
161741802|NCT00340834|584095941|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
161841003|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841004|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841005|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
161841006|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841007|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
161841008|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841009|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841010|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841011|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841012|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841013|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841014|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
161841015|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841016|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
161841017|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841018|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841019|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841020|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841021|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841022|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
161841023|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
161841024|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
161841025|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841026|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
161841027|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841028|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841029|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841030|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841031|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841032|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
161841033|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841034|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841035|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841036|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841037|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841038|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841039|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841040|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841041|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841042|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841043|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
161841044|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841045|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841046|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841047|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841048|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841049|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841050|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
161841051|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
161841052|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
161841053|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841054|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161741803|NCT00340834|584095937|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
161741804|NCT00340834|584095938|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
161741805|NCT00340834|584095939|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
161741806|NCT00340834|584095940|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
161741807|NCT00340834|584095941|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
161741808|NCT00340834|584095937|FG000|Extension Phase of Study|Lost to Follow-up|1|||
161741809|NCT00340834|584095938|FG001|Extension Phase of Study|Lost to Follow-up|1|||
161741810|NCT00340834|584095939|FG002|Extension Phase of Study|Lost to Follow-up|0|||
161741811|NCT00340834|584095940|FG003|Extension Phase of Study|Lost to Follow-up|2|||
161741812|NCT00340834|584095941|FG004|Extension Phase of Study|Lost to Follow-up|3|||
161741813|NCT00340834|584095937|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
161741814|NCT00340834|584095938|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
161741815|NCT00340834|584095939|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
161741816|NCT00340834|584095940|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
161741817|NCT00340834|584095941|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
161741818|NCT00340834|584095937|FG000|Extension Phase of Study|Administrative problems|3|||
161741819|NCT00340834|584095938|FG001|Extension Phase of Study|Administrative problems|0|||
161741820|NCT00340834|584095939|FG002|Extension Phase of Study|Administrative problems|0|||
161741821|NCT00340834|584095940|FG003|Extension Phase of Study|Administrative problems|1|||
161741822|NCT00340834|584095941|FG004|Extension Phase of Study|Administrative problems|1|||
161741823|NCT00340834|584095937|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161741824|NCT00340834|584095938|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
161741825|NCT00340834|584095939|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161741826|NCT00340834|584095940|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161741827|NCT00340834|584095941|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
161741828|NCT00340834|584095937|FG000|Extension Phase of Study|Protocol Violation|3|||
161741829|NCT00340834|584095938|FG001|Extension Phase of Study|Protocol Violation|0|||
161741830|NCT00340834|584095939|FG002|Extension Phase of Study|Protocol Violation|0|||
161741831|NCT00340834|584095940|FG003|Extension Phase of Study|Protocol Violation|0|||
161741832|NCT00340834|584095941|FG004|Extension Phase of Study|Protocol Violation|0|||
161741833|NCT00340834|584095937|FG000|Extension Phase of Study|Death|0|||
161741834|NCT00340834|584095938|FG001|Extension Phase of Study|Death|0|||
161741835|NCT00340834|584095939|FG002|Extension Phase of Study|Death|0|||
161741836|NCT00340834|584095940|FG003|Extension Phase of Study|Death|0|||
161741837|NCT00340834|584095941|FG004|Extension Phase of Study|Death|1|||
161741838|NCT00291499|584095942|FG000|Overall Study|Adverse Event|3|||
161741839|NCT00291499|584095943|FG001|Overall Study|Adverse Event|8|||
161741840|NCT00291499|584095942|FG000|Overall Study|Change to other therapy|2|||
161741841|NCT00291499|584095943|FG001|Overall Study|Change to other therapy|1|||
161741842|NCT00291499|584095942|FG000|Overall Study|Intercurrent illness|1|||
161741843|NCT00291499|584095943|FG001|Overall Study|Intercurrent illness|0|||
161741844|NCT00291499|584095942|FG000|Overall Study|Protocol Violation|2|||
161741845|NCT00291499|584095943|FG001|Overall Study|Protocol Violation|2|||
161741846|NCT00291499|584095942|FG000|Overall Study|Other reasons|1|||
161741847|NCT00291499|584095943|FG001|Overall Study|Other reasons|4|||
161741848|NCT02786836|584095944|FG000|Overall Study|Death|1|||
161741849|NCT02786836|584095944|FG000|Overall Study|Lack of Efficacy|2|||
161741850|NCT02786836|584095944|FG000|Overall Study|Protocol Violation|3|||
161741851|NCT02786836|584095944|FG000|Overall Study|Withdrawal by Subject|3|||
161741852|NCT02786836|584095944|FG000|Overall Study|Liver Transplantation|2|||
161741853|NCT02786836|584095944|FG000|Overall Study|Device or Pharmacy Issues|3|||
161741854|NCT03783442|584095955|FG000|Overall Study|Death|252|||
161741855|NCT03783442|584095956|FG001|Overall Study|Death|268|||
161741856|NCT03783442|584095955|FG000|Overall Study|Withdrawal by Subject|19|||
161741857|NCT03783442|584095956|FG001|Overall Study|Withdrawal by Subject|21|||
161741858|NCT03783442|584095955|FG000|Overall Study|Lost to Follow-up|7|||
161741859|NCT03783442|584095956|FG001|Overall Study|Lost to Follow-up|6|||
161741860|NCT03783442|584095955|FG000|Overall Study|Sponsor Ended Study|48|||
161741861|NCT03783442|584095956|FG001|Overall Study|Sponsor Ended Study|28|||
161741862|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
161741863|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
161741864|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
161741865|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
161741866|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
161741867|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741868|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741869|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741870|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741871|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
161741872|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
161741873|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741874|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741875|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741876|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741877|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
161741878|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161741879|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
161741880|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161741881|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161741882|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161741883|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161741884|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161741885|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
161741886|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
161741887|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
161741888|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
161741889|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
161741890|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
161741891|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
161741892|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
161741893|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
161741894|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
161741895|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
161741896|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
161741897|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
161741898|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
161741899|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
161741900|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
161741901|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
161741902|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741903|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741904|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741905|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
161741906|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741907|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
161741908|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
161741909|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
161741910|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
161741911|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
161741912|NCT01457924|584095957|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
161741913|NCT01457924|584095958|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161741914|NCT01457924|584095959|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
161741915|NCT01457924|584095960|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161741916|NCT01457924|584095961|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161741917|NCT01457924|584095957|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
161741918|NCT01457924|584095958|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
161741919|NCT01457924|584095959|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
161741920|NCT01457924|584095960|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
161741921|NCT01457924|584095961|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
161741922|NCT01457924|584095957|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161741923|NCT01457924|584095958|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
161741924|NCT01457924|584095959|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161741925|NCT01457924|584095960|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
161741926|NCT01457924|584095961|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161741927|NCT02505542|584095964|FG000|Part A: Open-Label Period|Adverse Event|31|||
161741928|NCT02505542|584095965|FG001|Part A: Open-Label Period|Adverse Event|0|||
161741929|NCT02505542|584095966|FG002|Part A: Open-Label Period|Adverse Event|0|||
161741930|NCT02505542|584095967|FG003|Part A: Open-Label Period|Adverse Event|0|||
161741931|NCT02505542|584095964|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
161741932|NCT02505542|584095965|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
161741933|NCT02505542|584095966|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
161741934|NCT02505542|584095967|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
161741935|NCT02505542|584095964|FG000|Part A: Open-Label Period|Protocol Violation|1|||
161741936|NCT02505542|584095965|FG001|Part A: Open-Label Period|Protocol Violation|0|||
161741937|NCT02505542|584095966|FG002|Part A: Open-Label Period|Protocol Violation|0|||
161741938|NCT02505542|584095967|FG003|Part A: Open-Label Period|Protocol Violation|0|||
161741939|NCT02505542|584095964|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
161741940|NCT02505542|584095965|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
161741941|NCT02505542|584095966|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
161841055|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841056|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841057|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841058|NCT03893565|584462896|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
161841059|NCT03893565|584462897|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
161841060|NCT03893565|584462898|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
161841061|NCT03893565|584462899|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
161841062|NCT03893565|584462900|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
161841063|NCT03893565|584462901|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
161841064|NCT03893565|584462902|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
161841065|NCT03893565|584462903|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
161841066|NCT03893565|584462904|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
161741942|NCT02505542|584095967|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
161741943|NCT02505542|584095964|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
161741944|NCT02505542|584095965|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
161741945|NCT02505542|584095966|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
161741946|NCT02505542|584095967|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
161741947|NCT02505542|584095964|FG000|Part A: Open-Label Period|New medical history available|1|||
161741948|NCT02505542|584095965|FG001|Part A: Open-Label Period|New medical history available|0|||
161741949|NCT02505542|584095966|FG002|Part A: Open-Label Period|New medical history available|0|||
161741950|NCT02505542|584095967|FG003|Part A: Open-Label Period|New medical history available|0|||
161741951|NCT02505542|584095964|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
161741952|NCT02505542|584095965|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161741953|NCT02505542|584095966|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161741954|NCT02505542|584095967|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161741955|NCT02505542|584095964|FG000|Part A: Open-Label Period|Pregnancy|2|||
161741956|NCT02505542|584095965|FG001|Part A: Open-Label Period|Pregnancy|0|||
161741957|NCT02505542|584095966|FG002|Part A: Open-Label Period|Pregnancy|0|||
161741958|NCT02505542|584095967|FG003|Part A: Open-Label Period|Pregnancy|0|||
161741959|NCT02505542|584095964|FG000|Part A: Open-Label Period|Sponsor directive|1|||
161741960|NCT02505542|584095965|FG001|Part A: Open-Label Period|Sponsor directive|0|||
161741961|NCT02505542|584095966|FG002|Part A: Open-Label Period|Sponsor directive|0|||
161741962|NCT02505542|584095967|FG003|Part A: Open-Label Period|Sponsor directive|0|||
161741963|NCT02505542|584095964|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
161741964|NCT02505542|584095965|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
161741965|NCT02505542|584095966|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
161741966|NCT02505542|584095967|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
161741967|NCT02505542|584095964|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
161741968|NCT02505542|584095965|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161741969|NCT02505542|584095966|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161741970|NCT02505542|584095967|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161741971|NCT02505542|584095964|FG000|Part A: Open-Label Period|Non-compliance|1|||
161741972|NCT02505542|584095965|FG001|Part A: Open-Label Period|Non-compliance|0|||
161741973|NCT02505542|584095966|FG002|Part A: Open-Label Period|Non-compliance|0|||
161741974|NCT02505542|584095967|FG003|Part A: Open-Label Period|Non-compliance|0|||
161741975|NCT02505542|584095964|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
161741976|NCT02505542|584095965|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161741977|NCT02505542|584095966|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161741978|NCT02505542|584095967|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161741979|NCT02505542|584095964|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
161741980|NCT02505542|584095965|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161741981|NCT02505542|584095966|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161741982|NCT02505542|584095967|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161741983|NCT02505542|584095964|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
161741984|NCT02505542|584095965|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161741985|NCT02505542|584095966|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161741986|NCT02505542|584095967|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161741987|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Adverse Event|0|||
161741988|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Adverse Event|0|||
161741989|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Adverse Event|1|||
161741990|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Adverse Event|3|||
161741991|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
161741992|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
161741993|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
161741994|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
161741995|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
161741996|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
161741997|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
161741998|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
161741999|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
161742000|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
161742001|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
161742002|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
161742003|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
161742004|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
161742005|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
161742006|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
161742007|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
161742008|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
161742009|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
161742010|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
161742011|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
161742012|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
161742013|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
161742014|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
161841067|NCT03893565|584462896|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841068|NCT03893565|584462897|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841069|NCT03893565|584462898|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841070|NCT03893565|584462899|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841071|NCT03893565|584462900|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841072|NCT03893565|584462901|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841073|NCT03893565|584462902|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
161841074|NCT03893565|584462903|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841075|NCT03893565|584462904|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841076|NCT03893565|584462896|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841077|NCT03893565|584462897|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841078|NCT03893565|584462898|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841079|NCT03893565|584462899|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841080|NCT03893565|584462900|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841081|NCT03893565|584462901|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
161841082|NCT03893565|584462902|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
161841083|NCT03893565|584462903|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841084|NCT03893565|584462904|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841085|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
161841086|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
161841087|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
161841088|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
161742015|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Miscalculation|0|||
161841089|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
161841090|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
161742016|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Miscalculation|1|||
161742017|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Miscalculation|0|||
161742018|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Miscalculation|0|||
161742019|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161742020|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
161742021|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161742022|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161742023|NCT01438307|584095970|FG000|Overall Study|Death|1|||
161742024|NCT01438307|584095971|FG001|Overall Study|Death|1|||
161742025|NCT02378883|584095972|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
161742026|NCT02378883|584095972|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
161742027|NCT02378883|584095972|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
161742028|NCT02378883|584095972|FG000|30 Day Follow-Up|Physician Decision|2|||
161742029|NCT02378883|584095972|FG000|30 Day Follow-Up|Missed Visit|2|||
161742030|NCT02378883|584095972|FG000|30 Day Follow-Up|Death|1|||
161742031|NCT02378883|584095972|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
161742032|NCT02378883|584095972|FG000|12 Months Follow-Up|Death|2|||
161742033|NCT01588353|584095973|FG000|Step2|Withdrawal by Subject|0|||
161742034|NCT01588353|584095974|FG001|Step2|Withdrawal by Subject|1|||
161742035|NCT01588353|584095975|FG002|Step2|Withdrawal by Subject|0|||
161742036|NCT01588353|584095973|FG000|Step3|Adverse Event|0|||
161742037|NCT01588353|584095974|FG001|Step3|Adverse Event|0|||
161742038|NCT01588353|584095975|FG002|Step3|Adverse Event|2|||
161742039|NCT02855450|584095979|FG000|Overall Study|Adverse Event|1|||
161742040|NCT02855450|584095980|FG001|Overall Study|Adverse Event|0|||
161742041|NCT02855450|584095979|FG000|Overall Study|Lost to Follow-up|4|||
161742042|NCT02855450|584095980|FG001|Overall Study|Lost to Follow-up|0|||
161742043|NCT01504971|584095982|FG000|Overall Study|Physician Decision|13|||
161742044|NCT00936117|584095985|FG000|Overall Study|Adverse Event|7|||
161742045|NCT00936117|584095985|FG000|Overall Study|Unable to continue oral medication|3|||
161742046|NCT04581863|584095986|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
161742047|NCT04581863|584095987|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
161742048|NCT01803711|584095996|FG000|Overall Study|Adverse Event|1|||
161742049|NCT01803711|584095997|FG001|Overall Study|Adverse Event|1|||
161742050|NCT00225212|584095998|FG000|Overall Study|Disease progression|2|||
161742051|NCT00225212|584095998|FG000|Overall Study|Death|1|||
161841091|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
161841092|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
161841093|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
161742052|NCT00225212|584095998|FG000|Overall Study|Adverse Event|2|||
161742053|NCT00225212|584095998|FG000|Overall Study|Intercurrent illness|1|||
161742054|NCT05159362|584096001|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
161742055|NCT05159362|584096002|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
161742056|NCT05159362|584096003|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
161742057|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
161742058|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742059|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742060|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742061|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742062|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
161742063|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742064|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742065|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742066|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742067|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
161742068|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742069|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742070|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742071|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742072|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
161742073|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742074|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742075|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742076|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742077|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
161742078|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742079|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742080|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742081|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742082|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161742083|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
161742084|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
161742085|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
161742086|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
161742087|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161742088|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
161742089|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
161742090|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
161742091|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
161742092|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161742093|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161742094|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161742095|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161742096|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
161742097|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161742098|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
161742099|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
161742100|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
161742101|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161742102|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161742103|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161742104|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161742105|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161742106|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161742107|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161742108|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
161742109|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161742110|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
161742111|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
161742112|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161742113|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
161742114|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161742115|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
161742116|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
161742117|NCT01357889|584096009|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
161742118|NCT01357889|584096010|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
161742119|NCT01357889|584096009|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
161742120|NCT01357889|584096010|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
161742121|NCT01357889|584096009|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
161742122|NCT01357889|584096010|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
161742123|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
161742124|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
161742125|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
161742126|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
161742127|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
161742128|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
161742129|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
161742130|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
161742131|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
161742132|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
161742133|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
161742134|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
161742135|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
161742136|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
161742137|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
161742138|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
161742139|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
161742140|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
161742141|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
161742142|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
161742143|NCT01335698|584096011|FG000|Treatment Stage 1|Lack of Efficacy|3|||
161742144|NCT01335698|584096012|FG001|Treatment Stage 1|Lack of Efficacy|1|||
161742145|NCT01335698|584096013|FG002|Treatment Stage 1|Lack of Efficacy|3|||
161742146|NCT01335698|584096014|FG003|Treatment Stage 1|Lack of Efficacy|3|||
161742147|NCT01335698|584096015|FG004|Treatment Stage 1|Lack of Efficacy|1|||
161742148|NCT01335698|584096011|FG000|Treatment Stage 1|Adverse Event|1|||
161742149|NCT01335698|584096012|FG001|Treatment Stage 1|Adverse Event|2|||
161742150|NCT01335698|584096013|FG002|Treatment Stage 1|Adverse Event|2|||
161742151|NCT01335698|584096014|FG003|Treatment Stage 1|Adverse Event|1|||
161742152|NCT01335698|584096015|FG004|Treatment Stage 1|Adverse Event|1|||
161742153|NCT01335698|584096011|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
161742154|NCT01335698|584096012|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
161742155|NCT01335698|584096013|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
161742156|NCT01335698|584096014|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
161742157|NCT01335698|584096015|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
161742158|NCT01335698|584096011|FG000|Treatment Stage 1|Lost to Follow-up|1|||
161742159|NCT01335698|584096012|FG001|Treatment Stage 1|Lost to Follow-up|1|||
161742160|NCT01335698|584096013|FG002|Treatment Stage 1|Lost to Follow-up|0|||
161742161|NCT01335698|584096014|FG003|Treatment Stage 1|Lost to Follow-up|0|||
161742162|NCT01335698|584096015|FG004|Treatment Stage 1|Lost to Follow-up|0|||
161742163|NCT01335698|584096011|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
161742164|NCT01335698|584096012|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
161742165|NCT01335698|584096013|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
161742166|NCT01335698|584096014|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
161742167|NCT01335698|584096015|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
161742168|NCT01335698|584096011|FG000|Treatment Stage 1|No longer meets study criteria|1|||
161742169|NCT01335698|584096012|FG001|Treatment Stage 1|No longer meets study criteria|1|||
161742170|NCT01335698|584096013|FG002|Treatment Stage 1|No longer meets study criteria|0|||
161742171|NCT01335698|584096014|FG003|Treatment Stage 1|No longer meets study criteria|1|||
161742172|NCT01335698|584096015|FG004|Treatment Stage 1|No longer meets study criteria|0|||
161742173|NCT01335698|584096011|FG000|Treatment Stage 1|Other|1|||
161742174|NCT01335698|584096012|FG001|Treatment Stage 1|Other|0|||
161742175|NCT01335698|584096013|FG002|Treatment Stage 1|Other|0|||
161742176|NCT01335698|584096014|FG003|Treatment Stage 1|Other|1|||
161742177|NCT01335698|584096015|FG004|Treatment Stage 1|Other|0|||
161742178|NCT01335698|584096011|FG000|Treatment Stage 2|Lack of Efficacy|2|||
161742179|NCT01335698|584096012|FG001|Treatment Stage 2|Lack of Efficacy|1|||
161742180|NCT01335698|584096013|FG002|Treatment Stage 2|Lack of Efficacy|3|||
161742181|NCT01335698|584096014|FG003|Treatment Stage 2|Lack of Efficacy|1|||
161742182|NCT01335698|584096015|FG004|Treatment Stage 2|Lack of Efficacy|0|||
161742183|NCT01335698|584096011|FG000|Treatment Stage 2|Adverse Event|2|||
161742184|NCT01335698|584096012|FG001|Treatment Stage 2|Adverse Event|0|||
161841094|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841095|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161742185|NCT01335698|584096013|FG002|Treatment Stage 2|Adverse Event|0|||
161841096|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841097|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841098|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841099|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841100|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841101|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
161841102|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841103|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841104|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841105|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841106|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841107|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841108|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841109|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841110|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
161841111|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841112|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841113|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841114|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841115|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841116|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841117|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841118|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841119|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
161841120|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841121|NCT03893565|584462896|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841122|NCT03893565|584462897|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841123|NCT03893565|584462898|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841124|NCT03893565|584462899|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841125|NCT03893565|584462900|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841126|NCT03893565|584462901|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841127|NCT03893565|584462902|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841128|NCT03893565|584462903|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841129|NCT03893565|584462904|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
161841130|NCT03870477|584462909|FG000|Overall Study|Early Study Termination|1|||
161841131|NCT02256436|584462916|FG000|Overall Study|Adverse Event|9|||
161841132|NCT02256436|584462917|FG001|Overall Study|Adverse Event|14|||
161841133|NCT02256436|584462916|FG000|Overall Study|Death|216|||
161841134|NCT02256436|584462917|FG001|Overall Study|Death|208|||
161841135|NCT02256436|584462916|FG000|Overall Study|Lost to Follow-up|1|||
161841136|NCT02256436|584462917|FG001|Overall Study|Lost to Follow-up|2|||
161841137|NCT02256436|584462916|FG000|Overall Study|Physician Decision|1|||
161841138|NCT02256436|584462917|FG001|Overall Study|Physician Decision|0|||
161841139|NCT02256436|584462916|FG000|Overall Study|Protocol Violation|0|||
161841140|NCT02256436|584462917|FG001|Overall Study|Protocol Violation|1|||
161841141|NCT02256436|584462916|FG000|Overall Study|Withdrawal by Subject|26|||
161841142|NCT02256436|584462917|FG001|Overall Study|Withdrawal by Subject|10|||
161841143|NCT02256436|584462916|FG000|Overall Study|Transferred to Extension Study|11|||
161841144|NCT02256436|584462917|FG001|Overall Study|Transferred to Extension Study|23|||
161742186|NCT01335698|584096014|FG003|Treatment Stage 2|Adverse Event|3|||
161742187|NCT01335698|584096015|FG004|Treatment Stage 2|Adverse Event|0|||
161742188|NCT01335698|584096011|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
161742189|NCT01335698|584096012|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
161742190|NCT01335698|584096013|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
161742191|NCT01335698|584096014|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
161742192|NCT01335698|584096015|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
161742193|NCT01335698|584096011|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
161841145|NCT02256436|584462916|FG000|Overall Study|Did Not Continue on Extension Study|8|||
161742194|NCT01335698|584096012|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
161742195|NCT01335698|584096013|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
161742196|NCT01335698|584096014|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
161742197|NCT01335698|584096015|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
161742198|NCT01335698|584096011|FG000|Treatment Stage 2|Lost to Follow-up|1|||
161742199|NCT01335698|584096012|FG001|Treatment Stage 2|Lost to Follow-up|0|||
161742200|NCT01335698|584096013|FG002|Treatment Stage 2|Lost to Follow-up|0|||
161742201|NCT01335698|584096014|FG003|Treatment Stage 2|Lost to Follow-up|0|||
161742202|NCT01335698|584096015|FG004|Treatment Stage 2|Lost to Follow-up|0|||
161742203|NCT01335698|584096011|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
161742204|NCT01335698|584096012|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
161742205|NCT01335698|584096013|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
161742206|NCT01335698|584096014|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
161742207|NCT01335698|584096015|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
161742208|NCT01335698|584096011|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742209|NCT01335698|584096012|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742210|NCT01335698|584096013|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742211|NCT01335698|584096014|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
161742212|NCT01335698|584096015|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742213|NCT01335698|584096011|FG000|Treatment Stage 2|Switched to another formulation|1|||
161742214|NCT01335698|584096012|FG001|Treatment Stage 2|Switched to another formulation|1|||
161742215|NCT01335698|584096013|FG002|Treatment Stage 2|Switched to another formulation|0|||
161742216|NCT01335698|584096014|FG003|Treatment Stage 2|Switched to another formulation|0|||
161742217|NCT01335698|584096015|FG004|Treatment Stage 2|Switched to another formulation|0|||
161742218|NCT01170221|584096016|FG000|Overall Study|Lost to Follow-up|22|||
161742219|NCT01170221|584096017|FG001|Overall Study|Lost to Follow-up|21|||
161742220|NCT01170221|584096016|FG000|Overall Study|Withdrawal by Subject|9|||
161742221|NCT01170221|584096017|FG001|Overall Study|Withdrawal by Subject|7|||
161742222|NCT01170221|584096016|FG000|Overall Study|Subject completed only screening and LFU|1|||
161742223|NCT01170221|584096017|FG001|Overall Study|Subject completed only screening and LFU|0|||
161742224|NCT01170221|584096016|FG000|Overall Study|Randomized but not treated|1|||
161742225|NCT01170221|584096017|FG001|Overall Study|Randomized but not treated|0|||
161742226|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
161742227|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
161742228|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
161742229|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
161742230|NCT02693691|584096018|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
161742231|NCT02693691|584096018|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
161742232|NCT02693691|584096018|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
161742233|NCT00416312|584096019|FG000|Overall Study|tumors not visible on imaging|2|||
161742234|NCT00050960|584096020|FG000|Overall Study|Progressive Disease|137|||
161742235|NCT00050960|584096021|FG001|Overall Study|Progressive Disease|93|||
161742236|NCT00050960|584096020|FG000|Overall Study|Stable Disease|19|||
161742237|NCT00050960|584096021|FG001|Overall Study|Stable Disease|48|||
161742238|NCT00050960|584096020|FG000|Overall Study|Partial Response|14|||
161742239|NCT00050960|584096021|FG001|Overall Study|Partial Response|19|||
161742240|NCT00050960|584096020|FG000|Overall Study|Complete Response|0|||
161742241|NCT00050960|584096021|FG001|Overall Study|Complete Response|2|||
161742242|NCT00050960|584096020|FG000|Overall Study|Adverse Event|62|||
161742243|NCT00050960|584096021|FG001|Overall Study|Adverse Event|61|||
161742244|NCT00050960|584096020|FG000|Overall Study|Lost to Follow-up|0|||
161742245|NCT00050960|584096021|FG001|Overall Study|Lost to Follow-up|1|||
161742246|NCT00050960|584096020|FG000|Overall Study|Withdrawal by Subject|23|||
161742247|NCT00050960|584096021|FG001|Overall Study|Withdrawal by Subject|18|||
161742248|NCT00050960|584096020|FG000|Overall Study|Administrative|31|||
161742249|NCT00050960|584096021|FG001|Overall Study|Administrative|46|||
161742250|NCT00050960|584096020|FG000|Overall Study|Non-compliance|3|||
161742251|NCT00050960|584096021|FG001|Overall Study|Non-compliance|1|||
161742252|NCT00050960|584096020|FG000|Overall Study|Death|13|||
161742253|NCT00050960|584096021|FG001|Overall Study|Death|15|||
161742254|NCT02727660|584096022|FG000|Overall Study|Lack of Efficacy|40|||
161742255|NCT02727660|584096023|FG001|Overall Study|Lack of Efficacy|40|||
161742256|NCT02727660|584096024|FG002|Overall Study|Lack of Efficacy|70|||
161742257|NCT02727660|584096022|FG000|Overall Study|Adverse Event|28|||
161742258|NCT02727660|584096023|FG001|Overall Study|Adverse Event|21|||
161841146|NCT02256436|584462917|FG001|Overall Study|Did Not Continue on Extension Study|12|||
161742259|NCT02727660|584096024|FG002|Overall Study|Adverse Event|32|||
161742260|NCT02727660|584096022|FG000|Overall Study|Withdrawal by Subject|26|||
161742261|NCT02727660|584096023|FG001|Overall Study|Withdrawal by Subject|25|||
161742262|NCT02727660|584096024|FG002|Overall Study|Withdrawal by Subject|30|||
161742263|NCT02727660|584096022|FG000|Overall Study|Physician Decision|3|||
161742264|NCT02727660|584096023|FG001|Overall Study|Physician Decision|8|||
161742265|NCT02727660|584096024|FG002|Overall Study|Physician Decision|14|||
161742266|NCT02727660|584096022|FG000|Overall Study|Lost to Follow-up|5|||
161742267|NCT02727660|584096023|FG001|Overall Study|Lost to Follow-up|9|||
161742268|NCT02727660|584096024|FG002|Overall Study|Lost to Follow-up|8|||
161742269|NCT02727660|584096022|FG000|Overall Study|Protocol Violation|7|||
161742270|NCT02727660|584096023|FG001|Overall Study|Protocol Violation|5|||
161742271|NCT02727660|584096024|FG002|Overall Study|Protocol Violation|5|||
161742272|NCT02727660|584096022|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
161742273|NCT02727660|584096023|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
161742274|NCT02727660|584096024|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
161742275|NCT02727660|584096022|FG000|Overall Study|Administrative Reasons|2|||
161742276|NCT02727660|584096023|FG001|Overall Study|Administrative Reasons|3|||
161742277|NCT02727660|584096024|FG002|Overall Study|Administrative Reasons|4|||
161742278|NCT00764946|584096029|FG000|Overall Study|Lack of Efficacy|1|||
161742279|NCT00764946|584096030|FG001|Overall Study|Lack of Efficacy|0|||
161742280|NCT00764946|584096031|FG002|Overall Study|Lack of Efficacy|0|||
161742281|NCT00764946|584096029|FG000|Overall Study|Lost to Follow-up|3|||
161742282|NCT00764946|584096030|FG001|Overall Study|Lost to Follow-up|4|||
161742283|NCT00764946|584096031|FG002|Overall Study|Lost to Follow-up|0|||
161742284|NCT00764946|584096029|FG000|Overall Study|Physician Decision|2|||
161742285|NCT00764946|584096030|FG001|Overall Study|Physician Decision|4|||
161742286|NCT00764946|584096031|FG002|Overall Study|Physician Decision|0|||
161742287|NCT00764946|584096029|FG000|Overall Study|Adverse Event|3|||
161742288|NCT00764946|584096030|FG001|Overall Study|Adverse Event|2|||
161742289|NCT00764946|584096031|FG002|Overall Study|Adverse Event|1|||
161742290|NCT00764946|584096029|FG000|Overall Study|Withdrawal by Subject|3|||
161742291|NCT00764946|584096030|FG001|Overall Study|Withdrawal by Subject|6|||
161742292|NCT00764946|584096031|FG002|Overall Study|Withdrawal by Subject|2|||
161742293|NCT00764946|584096029|FG000|Overall Study|Never Treated|1|||
161742294|NCT00764946|584096030|FG001|Overall Study|Never Treated|1|||
161742295|NCT00764946|584096031|FG002|Overall Study|Never Treated|1|||
161742296|NCT01162304|584096032|FG000|Overall Study|Beck scale to high|11|||
161742297|NCT01315847|584096033|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
161742298|NCT01315847|584096034|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
161742299|NCT01315847|584096033|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
161742300|NCT01315847|584096034|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
161742301|NCT02940626|584096035|FG000|Overall Study|Death|40|||
161742302|NCT02940626|584096036|FG001|Overall Study|Death|32|||
161742303|NCT02940626|584096035|FG000|Overall Study|Lost to Follow-up|5|||
161742304|NCT02940626|584096036|FG001|Overall Study|Lost to Follow-up|2|||
161742305|NCT02940626|584096035|FG000|Overall Study|Withdrawal by Subject|1|||
161742306|NCT02940626|584096036|FG001|Overall Study|Withdrawal by Subject|0|||
161742307|NCT02940626|584096035|FG000|Overall Study|Transfer to Hospice Care|1|||
161742308|NCT02940626|584096036|FG001|Overall Study|Transfer to Hospice Care|0|||
161742309|NCT02940626|584096035|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161742310|NCT02940626|584096036|FG001|Overall Study|Prohibited Concomitant Medication|1|||
161742311|NCT00585923|584096038|FG000|Overall Study|Physician decided not to continue|31|||
161742312|NCT00585923|584096039|FG001|Overall Study|Physician decided not to continue|33|||
161742313|NCT01324622|584096040|FG000|Overall Study|Lost to Follow-up|7|||
161742314|NCT01324622|584096041|FG001|Overall Study|Lost to Follow-up|7|||
161742315|NCT01324622|584096040|FG000|Overall Study|Death|1|||
161742316|NCT01324622|584096041|FG001|Overall Study|Death|0|||
161742317|NCT01324622|584096040|FG000|Overall Study|Lack of Efficacy|1|||
161742318|NCT01324622|584096041|FG001|Overall Study|Lack of Efficacy|0|||
161742319|NCT00878215|584096042|FG000|Overall Study|Determined to be ineligible|0|||
161742320|NCT00878215|584096043|FG001|Overall Study|Determined to be ineligible|10|||
161742321|NCT00878215|584096044|FG002|Overall Study|Determined to be ineligible|0|||
161742322|NCT00878215|584096045|FG003|Overall Study|Determined to be ineligible|0|||
161742323|NCT00138424|584096046|FG000|Overall Study|Physician Decision|0|||
161841147|NCT05961215|584462918|FG000|Overall Study|Withdrawal by Subject|1|||
161841148|NCT01394952|584462919|FG000|Overall Study|Lost to Follow-up|0|||
161841149|NCT01394952|584462920|FG001|Overall Study|Lost to Follow-up|5|||
161841150|NCT01394952|584462919|FG000|Overall Study|Withdrawal by Subject|10|||
161841151|NCT01394952|584462920|FG001|Overall Study|Withdrawal by Subject|5|||
161841152|NCT01394952|584462919|FG000|Overall Study|Physician Decision|2|||
161841153|NCT01394952|584462920|FG001|Overall Study|Physician Decision|0|||
161841154|NCT01394952|584462919|FG000|Overall Study|Sponsor Decision|5|||
161841155|NCT01394952|584462920|FG001|Overall Study|Sponsor Decision|7|||
161841156|NCT01986010|584462921|FG000|Overall Study|Adverse Event|0|||
161841157|NCT01986010|584462922|FG001|Overall Study|Adverse Event|1|||
161841158|NCT01986010|584462923|FG002|Overall Study|Adverse Event|0|||
161841159|NCT01986010|584462924|FG003|Overall Study|Adverse Event|0|||
161841160|NCT01986010|584462925|FG004|Overall Study|Adverse Event|0|||
161841161|NCT01986010|584462926|FG005|Overall Study|Adverse Event|0|||
161841162|NCT01986010|584462927|FG006|Overall Study|Adverse Event|0|||
161841163|NCT01986010|584462928|FG007|Overall Study|Adverse Event|0|||
161841164|NCT01986010|584462929|FG008|Overall Study|Adverse Event|0|||
161841165|NCT01986010|584462930|FG009|Overall Study|Adverse Event|0|||
161841166|NCT01986010|584462931|FG010|Overall Study|Adverse Event|0|||
161841167|NCT01986010|584462932|FG011|Overall Study|Adverse Event|0|||
161841168|NCT01986010|584462933|FG012|Overall Study|Adverse Event|0|||
161841169|NCT01986010|584462934|FG013|Overall Study|Adverse Event|0|||
161841170|NCT01986010|584462935|FG014|Overall Study|Adverse Event|0|||
161841171|NCT01986010|584462936|FG015|Overall Study|Adverse Event|1|||
161841172|NCT01986010|584462937|FG016|Overall Study|Adverse Event|0|||
161841173|NCT01986010|584462921|FG000|Overall Study|Lost to Follow-up|2|||
161841174|NCT01986010|584462922|FG001|Overall Study|Lost to Follow-up|1|||
161841175|NCT01986010|584462923|FG002|Overall Study|Lost to Follow-up|2|||
161841176|NCT01986010|584462924|FG003|Overall Study|Lost to Follow-up|2|||
161841177|NCT01986010|584462925|FG004|Overall Study|Lost to Follow-up|2|||
161841178|NCT01986010|584462926|FG005|Overall Study|Lost to Follow-up|2|||
161841179|NCT01986010|584462927|FG006|Overall Study|Lost to Follow-up|0|||
161841180|NCT01986010|584462928|FG007|Overall Study|Lost to Follow-up|0|||
161841181|NCT01986010|584462929|FG008|Overall Study|Lost to Follow-up|4|||
161841182|NCT01986010|584462930|FG009|Overall Study|Lost to Follow-up|2|||
161841183|NCT01986010|584462931|FG010|Overall Study|Lost to Follow-up|0|||
161841184|NCT01986010|584462932|FG011|Overall Study|Lost to Follow-up|1|||
161841185|NCT01986010|584462933|FG012|Overall Study|Lost to Follow-up|1|||
161841186|NCT01986010|584462934|FG013|Overall Study|Lost to Follow-up|1|||
161841187|NCT01986010|584462935|FG014|Overall Study|Lost to Follow-up|2|||
161841188|NCT01986010|584462936|FG015|Overall Study|Lost to Follow-up|0|||
161841189|NCT01986010|584462937|FG016|Overall Study|Lost to Follow-up|0|||
161841190|NCT01986010|584462921|FG000|Overall Study|Physician Decision|0|||
161841191|NCT01986010|584462922|FG001|Overall Study|Physician Decision|0|||
161841192|NCT01986010|584462923|FG002|Overall Study|Physician Decision|0|||
161841193|NCT01986010|584462924|FG003|Overall Study|Physician Decision|0|||
161841194|NCT01986010|584462925|FG004|Overall Study|Physician Decision|0|||
161841195|NCT01986010|584462926|FG005|Overall Study|Physician Decision|0|||
161841196|NCT01986010|584462927|FG006|Overall Study|Physician Decision|0|||
161841197|NCT01986010|584462928|FG007|Overall Study|Physician Decision|0|||
161841198|NCT01986010|584462929|FG008|Overall Study|Physician Decision|0|||
161841199|NCT01986010|584462930|FG009|Overall Study|Physician Decision|0|||
161841200|NCT01986010|584462931|FG010|Overall Study|Physician Decision|0|||
161841201|NCT01986010|584462932|FG011|Overall Study|Physician Decision|0|||
161841202|NCT01986010|584462933|FG012|Overall Study|Physician Decision|0|||
161841203|NCT01986010|584462934|FG013|Overall Study|Physician Decision|0|||
161841204|NCT01986010|584462935|FG014|Overall Study|Physician Decision|1|||
161841205|NCT01986010|584462936|FG015|Overall Study|Physician Decision|0|||
161841206|NCT01986010|584462937|FG016|Overall Study|Physician Decision|0|||
161841207|NCT01986010|584462921|FG000|Overall Study|Withdrawal by Subject|2|||
161841208|NCT01986010|584462922|FG001|Overall Study|Withdrawal by Subject|2|||
161841209|NCT01986010|584462923|FG002|Overall Study|Withdrawal by Subject|3|||
161841210|NCT01986010|584462924|FG003|Overall Study|Withdrawal by Subject|0|||
161841211|NCT01986010|584462925|FG004|Overall Study|Withdrawal by Subject|2|||
161841212|NCT01986010|584462926|FG005|Overall Study|Withdrawal by Subject|4|||
161841213|NCT01986010|584462927|FG006|Overall Study|Withdrawal by Subject|0|||
161742324|NCT00138424|584096047|FG001|Overall Study|Physician Decision|1|||
161742325|NCT00138424|584096048|FG002|Overall Study|Physician Decision|0|||
161742326|NCT00138424|584096049|FG003|Overall Study|Physician Decision|0|||
161742327|NCT00413062|584096056|FG000|Overall Study|Adverse event/serious adverse event|289|||
161742328|NCT00413062|584096057|FG001|Overall Study|Adverse event/serious adverse event|56|||
161742329|NCT00413062|584096056|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
161742330|NCT00413062|584096057|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
161742331|NCT00413062|584096056|FG000|Overall Study|Withdrawal of informed consent|111|||
161742332|NCT00413062|584096057|FG001|Overall Study|Withdrawal of informed consent|36|||
161742333|NCT00413062|584096056|FG000|Overall Study|Pregnancy|15|||
161742334|NCT00413062|584096057|FG001|Overall Study|Pregnancy|5|||
161742335|NCT00413062|584096056|FG000|Overall Study|Pregnancy wish|17|||
161742336|NCT00413062|584096057|FG001|Overall Study|Pregnancy wish|6|||
161742337|NCT00413062|584096056|FG000|Overall Study|Lost to Follow-up|175|||
161742338|NCT00413062|584096057|FG001|Overall Study|Lost to Follow-up|73|||
161742339|NCT00413062|584096056|FG000|Overall Study|Other reason|70|||
161742340|NCT00413062|584096057|FG001|Overall Study|Other reason|34|||
161742341|NCT02176291|584096058|FG000|Overall Study|Death|1|||
161742342|NCT02176291|584096059|FG001|Overall Study|Death|0|||
161742343|NCT02176291|584096058|FG000|Overall Study|non compliance with protocol|2|||
161742344|NCT02176291|584096059|FG001|Overall Study|non compliance with protocol|0|||
161742345|NCT02176291|584096058|FG000|Overall Study|Withdrawal by Subject|2|||
161742346|NCT02176291|584096059|FG001|Overall Study|Withdrawal by Subject|0|||
161742347|NCT02815293|584096060|FG000|Overall Study|Study termination by sponsor|10|||
161742348|NCT02815293|584096061|FG001|Overall Study|Study termination by sponsor|7|||
161742349|NCT02815293|584096062|FG002|Overall Study|Study termination by sponsor|0|||
161742350|NCT02815293|584096060|FG000|Overall Study|Participants not randomized|0|||
161742351|NCT02815293|584096061|FG001|Overall Study|Participants not randomized|0|||
161742352|NCT02815293|584096062|FG002|Overall Study|Participants not randomized|18|||
161742353|NCT02815293|584096060|FG000|Overall Study|Adverse Event|0|||
161742354|NCT02815293|584096061|FG001|Overall Study|Adverse Event|1|||
161742355|NCT02815293|584096062|FG002|Overall Study|Adverse Event|0|||
161742356|NCT02431468|584096063|FG000|Overall Study|Adverse Event|2|||
161742357|NCT02431468|584096064|FG001|Overall Study|Adverse Event|4|||
161742358|NCT02431468|584096065|FG002|Overall Study|Adverse Event|5|||
161742359|NCT02431468|584096063|FG000|Overall Study|Withdrawal by Subject|4|||
161742360|NCT02431468|584096064|FG001|Overall Study|Withdrawal by Subject|12|||
161742361|NCT02431468|584096065|FG002|Overall Study|Withdrawal by Subject|2|||
161742362|NCT02431468|584096063|FG000|Overall Study|noncompliance, investigator termination,|2|||
161742363|NCT02431468|584096064|FG001|Overall Study|noncompliance, investigator termination,|2|||
161742364|NCT02431468|584096065|FG002|Overall Study|noncompliance, investigator termination,|2|||
161742365|NCT00006604|584096066|FG000|Overall Study|Met study objective - no further FU|1|||
161742366|NCT00006604|584096067|FG001|Overall Study|Met study objective - no further FU|0|||
161742367|NCT00006604|584096068|FG002|Overall Study|Met study objective - no further FU|0|||
161742368|NCT00006604|584096069|FG003|Overall Study|Met study objective - no further FU|0|||
161742369|NCT00006604|584096070|FG004|Overall Study|Met study objective - no further FU|0|||
161742370|NCT00006604|584096071|FG005|Overall Study|Met study objective - no further FU|0|||
161742371|NCT00006604|584096072|FG006|Overall Study|Met study objective - no further FU|0|||
161742372|NCT00006604|584096073|FG007|Overall Study|Met study objective - no further FU|0|||
161742373|NCT00006604|584096074|FG008|Overall Study|Met study objective - no further FU|0|||
161742374|NCT00006604|584096075|FG009|Overall Study|Met study objective - no further FU|0|||
161742375|NCT00006604|584096076|FG010|Overall Study|Met study objective - no further FU|0|||
161742376|NCT00006604|584096077|FG011|Overall Study|Met study objective - no further FU|0|||
161742377|NCT00006604|584096078|FG012|Overall Study|Met study objective - no further FU|0|||
161742378|NCT00006604|584096079|FG013|Overall Study|Met study objective - no further FU|0|||
161742379|NCT00006604|584096080|FG014|Overall Study|Met study objective - no further FU|1|||
161742380|NCT00006604|584096081|FG015|Overall Study|Met study objective - no further FU|1|||
161742381|NCT00006604|584096082|FG016|Overall Study|Met study objective - no further FU|0|||
161742382|NCT00006604|584096066|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
161742383|NCT00006604|584096067|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
161742384|NCT00006604|584096068|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
161742385|NCT00006604|584096069|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
161742386|NCT00006604|584096070|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
161742387|NCT00006604|584096071|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
161742388|NCT00006604|584096072|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
161742389|NCT00006604|584096073|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
161742390|NCT00006604|584096074|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
161742391|NCT00006604|584096075|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
161742392|NCT00006604|584096076|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
161742393|NCT00006604|584096077|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
161742394|NCT00006604|584096078|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
161742395|NCT00006604|584096079|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
161742396|NCT00006604|584096080|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
161742397|NCT00006604|584096081|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
161742398|NCT00006604|584096082|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
161742399|NCT00006604|584096066|FG000|Overall Study|Death|0|||
161742400|NCT00006604|584096067|FG001|Overall Study|Death|0|||
161742401|NCT00006604|584096068|FG002|Overall Study|Death|0|||
161742402|NCT00006604|584096069|FG003|Overall Study|Death|0|||
161742403|NCT00006604|584096070|FG004|Overall Study|Death|0|||
161742404|NCT00006604|584096071|FG005|Overall Study|Death|0|||
161742405|NCT00006604|584096072|FG006|Overall Study|Death|0|||
161742406|NCT00006604|584096073|FG007|Overall Study|Death|0|||
161742407|NCT00006604|584096074|FG008|Overall Study|Death|0|||
161742408|NCT00006604|584096075|FG009|Overall Study|Death|1|||
161742409|NCT00006604|584096076|FG010|Overall Study|Death|1|||
161742410|NCT00006604|584096077|FG011|Overall Study|Death|1|||
161742411|NCT00006604|584096078|FG012|Overall Study|Death|0|||
161742412|NCT00006604|584096079|FG013|Overall Study|Death|0|||
161742413|NCT00006604|584096080|FG014|Overall Study|Death|0|||
161742414|NCT00006604|584096081|FG015|Overall Study|Death|0|||
161742415|NCT00006604|584096082|FG016|Overall Study|Death|0|||
161742416|NCT00006604|584096066|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161742417|NCT00006604|584096067|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161742418|NCT00006604|584096068|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161742419|NCT00006604|584096069|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161742420|NCT00006604|584096070|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161742421|NCT00006604|584096071|FG005|Overall Study|Severe debilitation, unable to continue|0|||
161742422|NCT00006604|584096072|FG006|Overall Study|Severe debilitation, unable to continue|3|||
161742423|NCT00006604|584096073|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161742424|NCT00006604|584096074|FG008|Overall Study|Severe debilitation, unable to continue|0|||
161742425|NCT00006604|584096075|FG009|Overall Study|Severe debilitation, unable to continue|5|||
161742426|NCT00006604|584096076|FG010|Overall Study|Severe debilitation, unable to continue|0|||
161742427|NCT00006604|584096077|FG011|Overall Study|Severe debilitation, unable to continue|2|||
161742428|NCT00006604|584096078|FG012|Overall Study|Severe debilitation, unable to continue|1|||
161742429|NCT00006604|584096079|FG013|Overall Study|Severe debilitation, unable to continue|0|||
161742430|NCT00006604|584096080|FG014|Overall Study|Severe debilitation, unable to continue|2|||
161742431|NCT00006604|584096081|FG015|Overall Study|Severe debilitation, unable to continue|0|||
161742432|NCT00006604|584096082|FG016|Overall Study|Severe debilitation, unable to continue|0|||
161742433|NCT00006604|584096066|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
161742434|NCT00006604|584096067|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
161742435|NCT00006604|584096068|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
161742436|NCT00006604|584096069|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
161742437|NCT00006604|584096070|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
161742438|NCT00006604|584096071|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
161742439|NCT00006604|584096072|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
161742440|NCT00006604|584096073|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
161742441|NCT00006604|584096074|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
161742442|NCT00006604|584096075|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
161742443|NCT00006604|584096076|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
161742444|NCT00006604|584096077|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
161742445|NCT00006604|584096078|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
161742446|NCT00006604|584096079|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
161742447|NCT00006604|584096080|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
161742448|NCT00006604|584096081|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
161742449|NCT00006604|584096082|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
161742450|NCT00006604|584096066|FG000|Overall Study|Site closing|0|||
161742451|NCT00006604|584096067|FG001|Overall Study|Site closing|0|||
161742452|NCT00006604|584096068|FG002|Overall Study|Site closing|1|||
161742453|NCT00006604|584096069|FG003|Overall Study|Site closing|1|||
161742454|NCT00006604|584096070|FG004|Overall Study|Site closing|0|||
161742455|NCT00006604|584096071|FG005|Overall Study|Site closing|0|||
161742456|NCT00006604|584096072|FG006|Overall Study|Site closing|0|||
161742457|NCT00006604|584096073|FG007|Overall Study|Site closing|1|||
161742458|NCT00006604|584096074|FG008|Overall Study|Site closing|0|||
161742459|NCT00006604|584096075|FG009|Overall Study|Site closing|0|||
161742460|NCT00006604|584096076|FG010|Overall Study|Site closing|0|||
161742461|NCT00006604|584096077|FG011|Overall Study|Site closing|1|||
161742462|NCT00006604|584096078|FG012|Overall Study|Site closing|1|||
161742463|NCT00006604|584096079|FG013|Overall Study|Site closing|1|||
161742464|NCT00006604|584096080|FG014|Overall Study|Site closing|0|||
161742465|NCT00006604|584096081|FG015|Overall Study|Site closing|0|||
161742466|NCT00006604|584096082|FG016|Overall Study|Site closing|1|||
161742467|NCT00006604|584096066|FG000|Overall Study|Withdrawal by Subject|1|||
161742468|NCT00006604|584096067|FG001|Overall Study|Withdrawal by Subject|0|||
161742469|NCT00006604|584096068|FG002|Overall Study|Withdrawal by Subject|2|||
161742470|NCT00006604|584096069|FG003|Overall Study|Withdrawal by Subject|0|||
161742471|NCT00006604|584096070|FG004|Overall Study|Withdrawal by Subject|1|||
161742472|NCT00006604|584096071|FG005|Overall Study|Withdrawal by Subject|2|||
161742473|NCT00006604|584096072|FG006|Overall Study|Withdrawal by Subject|2|||
161742474|NCT00006604|584096073|FG007|Overall Study|Withdrawal by Subject|0|||
161742475|NCT00006604|584096074|FG008|Overall Study|Withdrawal by Subject|1|||
161742476|NCT00006604|584096075|FG009|Overall Study|Withdrawal by Subject|3|||
161742477|NCT00006604|584096076|FG010|Overall Study|Withdrawal by Subject|2|||
161742478|NCT00006604|584096077|FG011|Overall Study|Withdrawal by Subject|0|||
161742479|NCT00006604|584096078|FG012|Overall Study|Withdrawal by Subject|1|||
161742480|NCT00006604|584096079|FG013|Overall Study|Withdrawal by Subject|2|||
161742481|NCT00006604|584096080|FG014|Overall Study|Withdrawal by Subject|1|||
161742482|NCT00006604|584096081|FG015|Overall Study|Withdrawal by Subject|0|||
161742483|NCT00006604|584096082|FG016|Overall Study|Withdrawal by Subject|1|||
161742484|NCT00006604|584096066|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
161742485|NCT00006604|584096067|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
161742486|NCT00006604|584096068|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
161742487|NCT00006604|584096069|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
161742488|NCT00006604|584096070|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
161742489|NCT00006604|584096071|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
161742490|NCT00006604|584096072|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
161742491|NCT00006604|584096073|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
161742492|NCT00006604|584096074|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
161742493|NCT00006604|584096075|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
161742494|NCT00006604|584096076|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
161742495|NCT00006604|584096077|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
161742496|NCT00006604|584096078|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
161742497|NCT00006604|584096079|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
161742498|NCT00006604|584096080|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
161742499|NCT00006604|584096081|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
161742500|NCT00006604|584096082|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
161742501|NCT00006604|584096066|FG000|Overall Study|Lost to Follow-up|0|||
161742502|NCT00006604|584096067|FG001|Overall Study|Lost to Follow-up|0|||
161742503|NCT00006604|584096068|FG002|Overall Study|Lost to Follow-up|0|||
161742504|NCT00006604|584096069|FG003|Overall Study|Lost to Follow-up|0|||
161742505|NCT00006604|584096070|FG004|Overall Study|Lost to Follow-up|0|||
161742506|NCT00006604|584096071|FG005|Overall Study|Lost to Follow-up|0|||
161742507|NCT00006604|584096072|FG006|Overall Study|Lost to Follow-up|0|||
161742508|NCT00006604|584096073|FG007|Overall Study|Lost to Follow-up|1|||
161742509|NCT00006604|584096074|FG008|Overall Study|Lost to Follow-up|0|||
161742510|NCT00006604|584096075|FG009|Overall Study|Lost to Follow-up|2|||
161742511|NCT00006604|584096076|FG010|Overall Study|Lost to Follow-up|0|||
161742512|NCT00006604|584096077|FG011|Overall Study|Lost to Follow-up|0|||
161742513|NCT00006604|584096078|FG012|Overall Study|Lost to Follow-up|0|||
161742514|NCT00006604|584096079|FG013|Overall Study|Lost to Follow-up|0|||
161742515|NCT00006604|584096080|FG014|Overall Study|Lost to Follow-up|0|||
161742516|NCT00006604|584096081|FG015|Overall Study|Lost to Follow-up|1|||
161742517|NCT00006604|584096082|FG016|Overall Study|Lost to Follow-up|3|||
161742518|NCT00006604|584096066|FG000|Overall Study|Other Reason|0|||
161742519|NCT00006604|584096067|FG001|Overall Study|Other Reason|0|||
161742520|NCT00006604|584096068|FG002|Overall Study|Other Reason|0|||
161742521|NCT00006604|584096069|FG003|Overall Study|Other Reason|0|||
161742522|NCT00006604|584096070|FG004|Overall Study|Other Reason|0|||
161742523|NCT00006604|584096071|FG005|Overall Study|Other Reason|1|||
161742524|NCT00006604|584096072|FG006|Overall Study|Other Reason|0|||
161742525|NCT00006604|584096073|FG007|Overall Study|Other Reason|0|||
161742526|NCT00006604|584096074|FG008|Overall Study|Other Reason|0|||
161742527|NCT00006604|584096075|FG009|Overall Study|Other Reason|1|||
161742528|NCT00006604|584096076|FG010|Overall Study|Other Reason|0|||
161742529|NCT00006604|584096077|FG011|Overall Study|Other Reason|0|||
161742530|NCT00006604|584096078|FG012|Overall Study|Other Reason|0|||
161742531|NCT00006604|584096079|FG013|Overall Study|Other Reason|0|||
161742532|NCT00006604|584096080|FG014|Overall Study|Other Reason|0|||
161742533|NCT00006604|584096081|FG015|Overall Study|Other Reason|0|||
161742534|NCT00006604|584096082|FG016|Overall Study|Other Reason|0|||
161742535|NCT01361919|584096083|FG000|Overall Study|technical issues|10|||
161742536|NCT01361919|584096084|FG001|Overall Study|technical issues|12|||
161742537|NCT01361919|584096085|FG002|Overall Study|technical issues|10|||
161742538|NCT01056341|584096086|FG000|Overall Study|Treatment Intolerance|0|||
161742539|NCT01056341|584096087|FG001|Overall Study|Treatment Intolerance|2|||
161742540|NCT01056341|584096088|FG002|Overall Study|Treatment Intolerance|0|||
161742541|NCT01056341|584096089|FG003|Overall Study|Treatment Intolerance|2|||
161742542|NCT01056341|584096090|FG004|Overall Study|Treatment Intolerance|0|||
161742543|NCT01056341|584096086|FG000|Overall Study|Lack of Efficacy|32|||
161742544|NCT01056341|584096087|FG001|Overall Study|Lack of Efficacy|30|||
161742545|NCT01056341|584096088|FG002|Overall Study|Lack of Efficacy|7|||
161742546|NCT01056341|584096089|FG003|Overall Study|Lack of Efficacy|25|||
161742547|NCT01056341|584096090|FG004|Overall Study|Lack of Efficacy|9|||
161742548|NCT01056341|584096086|FG000|Overall Study|Other reasons|4|||
161742549|NCT01056341|584096087|FG001|Overall Study|Other reasons|4|||
161742550|NCT01056341|584096088|FG002|Overall Study|Other reasons|8|||
161742551|NCT01056341|584096089|FG003|Overall Study|Other reasons|9|||
161742552|NCT01056341|584096090|FG004|Overall Study|Other reasons|5|||
161742553|NCT03454412|584096091|FG000|Baseline Assesment|Physician Decision|12|||
161742554|NCT01167582|584096094|FG000|Overall Study|Lost to Follow-up|0|||
161742555|NCT01167582|584096095|FG001|Overall Study|Lost to Follow-up|1|||
161742556|NCT03956225|584096096|FG000|Overall Study|Lack of Efficacy|1|||
161742557|NCT03956225|584096097|FG001|Overall Study|Lack of Efficacy|1|||
161742558|NCT03956225|584096096|FG000|Overall Study|Lost to Follow-up|0|||
161742559|NCT03956225|584096097|FG001|Overall Study|Lost to Follow-up|1|||
161742560|NCT03956225|584096096|FG000|Overall Study|Withdrawal by Subject|2|||
161742561|NCT03956225|584096097|FG001|Overall Study|Withdrawal by Subject|1|||
161742562|NCT03956225|584096096|FG000|Overall Study|Other Reasons|2|||
161742563|NCT03956225|584096097|FG001|Overall Study|Other Reasons|1|||
161742564|NCT00567541|584096098|FG000|Overall Study|Adverse Event|0|||
161742565|NCT00567541|584096099|FG001|Overall Study|Adverse Event|1|||
161742566|NCT02157506|584096100|FG000|Overall Study|Adverse Event|0|||
161742567|NCT02157506|584096101|FG001|Overall Study|Adverse Event|1|||
161742568|NCT02157506|584096102|FG002|Overall Study|Adverse Event|0|||
161742569|NCT02157506|584096103|FG003|Overall Study|Adverse Event|0|||
161841214|NCT01986010|584462928|FG007|Overall Study|Withdrawal by Subject|0|||
161841215|NCT01986010|584462929|FG008|Overall Study|Withdrawal by Subject|0|||
161841216|NCT01986010|584462930|FG009|Overall Study|Withdrawal by Subject|0|||
161841217|NCT01986010|584462931|FG010|Overall Study|Withdrawal by Subject|0|||
161841218|NCT01986010|584462932|FG011|Overall Study|Withdrawal by Subject|2|||
161841219|NCT01986010|584462933|FG012|Overall Study|Withdrawal by Subject|0|||
161841220|NCT01986010|584462934|FG013|Overall Study|Withdrawal by Subject|1|||
161841221|NCT01986010|584462935|FG014|Overall Study|Withdrawal by Subject|2|||
161841222|NCT01986010|584462936|FG015|Overall Study|Withdrawal by Subject|0|||
161841223|NCT01986010|584462937|FG016|Overall Study|Withdrawal by Subject|0|||
161841224|NCT01986010|584462921|FG000|Overall Study|Status Not Recorded|2|||
161841225|NCT01986010|584462922|FG001|Overall Study|Status Not Recorded|4|||
161841226|NCT01986010|584462923|FG002|Overall Study|Status Not Recorded|2|||
161841227|NCT01986010|584462924|FG003|Overall Study|Status Not Recorded|0|||
161841228|NCT01986010|584462925|FG004|Overall Study|Status Not Recorded|1|||
161841229|NCT01986010|584462926|FG005|Overall Study|Status Not Recorded|2|||
161841230|NCT01986010|584462927|FG006|Overall Study|Status Not Recorded|0|||
161841231|NCT01986010|584462928|FG007|Overall Study|Status Not Recorded|0|||
161841232|NCT01986010|584462929|FG008|Overall Study|Status Not Recorded|2|||
161841233|NCT01986010|584462930|FG009|Overall Study|Status Not Recorded|1|||
161841234|NCT01986010|584462931|FG010|Overall Study|Status Not Recorded|7|||
161841235|NCT01986010|584462932|FG011|Overall Study|Status Not Recorded|7|||
161841236|NCT01986010|584462933|FG012|Overall Study|Status Not Recorded|9|||
161841237|NCT01986010|584462934|FG013|Overall Study|Status Not Recorded|9|||
161841238|NCT01986010|584462935|FG014|Overall Study|Status Not Recorded|5|||
161841239|NCT01986010|584462936|FG015|Overall Study|Status Not Recorded|10|||
161841240|NCT01986010|584462937|FG016|Overall Study|Status Not Recorded|4|||
161841241|NCT01335997|584462938|FG000|Period I and II|Adverse Event|63|||
161841242|NCT01335997|584462939|FG001|Period I and II|Adverse Event|43|||
161841243|NCT01335997|584462938|FG000|Period I and II|Noncompliance with Study Drug|1|||
161841244|NCT01335997|584462939|FG001|Period I and II|Noncompliance with Study Drug|1|||
161841245|NCT01335997|584462938|FG000|Period I and II|Lost to Follow-up|3|||
161841246|NCT01335997|584462939|FG001|Period I and II|Lost to Follow-up|5|||
161841247|NCT01335997|584462938|FG000|Period I and II|Withdrawal by Subject|9|||
161841248|NCT01335997|584462939|FG001|Period I and II|Withdrawal by Subject|4|||
161742570|NCT02157506|584096104|FG004|Overall Study|Adverse Event|0|||
161841249|NCT01335997|584462938|FG000|Period I and II|Study Terminated by Sponsor|406|||
161742571|NCT02157506|584096100|FG000|Overall Study|Lost to Follow-up|0|||
161742572|NCT02157506|584096101|FG001|Overall Study|Lost to Follow-up|0|||
161742573|NCT02157506|584096102|FG002|Overall Study|Lost to Follow-up|1|||
161742574|NCT02157506|584096103|FG003|Overall Study|Lost to Follow-up|0|||
161742575|NCT02157506|584096104|FG004|Overall Study|Lost to Follow-up|0|||
161742576|NCT01763866|584096105|FG000|Overall Study|Withdrawal by Subject|2|||
161742577|NCT01763866|584096106|FG001|Overall Study|Withdrawal by Subject|1|||
161742578|NCT01763866|584096107|FG002|Overall Study|Withdrawal by Subject|4|||
161841250|NCT01335997|584462939|FG001|Period I and II|Study Terminated by Sponsor|415|||
161841251|NCT01335997|584462938|FG000|Period I and II|Protocol Violation|9|||
161841252|NCT01335997|584462939|FG001|Period I and II|Protocol Violation|10|||
161841253|NCT01335997|584462938|FG000|Period I and II|Physician Decision|2|||
161841254|NCT01335997|584462939|FG001|Period I and II|Physician Decision|1|||
161841255|NCT01335997|584462938|FG000|Period III|Adverse Event|0|||
161841256|NCT01335997|584462939|FG001|Period III|Adverse Event|2|||
161841257|NCT01335997|584462938|FG000|Period III|Study Terminated by Sponsor|77|||
161841258|NCT01335997|584462939|FG001|Period III|Study Terminated by Sponsor|76|||
161841259|NCT01335997|584462938|FG000|Period III|Protocol Violation|0|||
161841260|NCT01335997|584462939|FG001|Period III|Protocol Violation|1|||
161841261|NCT01335997|584462938|FG000|Period III|Lost to Follow-up|1|||
161841262|NCT01335997|584462939|FG001|Period III|Lost to Follow-up|0|||
161841263|NCT04740814|584462942|FG000|Overall Study|Adverse Event|3|||
161841264|NCT04740814|584462942|FG000|Overall Study|Protocol Violation|2|||
161841265|NCT04740814|584462942|FG000|Overall Study|Lost to Follow-up|2|||
161742579|NCT01763866|584096108|FG003|Overall Study|Withdrawal by Subject|0|||
161742580|NCT01763866|584096109|FG004|Overall Study|Withdrawal by Subject|0|||
161742581|NCT01763866|584096110|FG005|Overall Study|Withdrawal by Subject|3|||
161742582|NCT01763866|584096111|FG006|Overall Study|Withdrawal by Subject|4|||
161742583|NCT01763866|584096112|FG007|Overall Study|Withdrawal by Subject|0|||
161742584|NCT01763866|584096113|FG008|Overall Study|Withdrawal by Subject|1|||
161742585|NCT01763866|584096114|FG009|Overall Study|Withdrawal by Subject|1|||
161742586|NCT01763866|584096115|FG010|Overall Study|Withdrawal by Subject|2|||
161742587|NCT01763866|584096116|FG011|Overall Study|Withdrawal by Subject|2|||
161742588|NCT01763866|584096117|FG012|Overall Study|Withdrawal by Subject|2|||
161742589|NCT01763866|584096118|FG013|Overall Study|Withdrawal by Subject|0|||
161742590|NCT01763866|584096119|FG014|Overall Study|Withdrawal by Subject|6|||
161742591|NCT01763866|584096120|FG015|Overall Study|Withdrawal by Subject|3|||
161742592|NCT01763866|584096121|FG016|Overall Study|Withdrawal by Subject|0|||
161742593|NCT01763866|584096122|FG017|Overall Study|Withdrawal by Subject|1|||
161742594|NCT01763866|584096123|FG018|Overall Study|Withdrawal by Subject|1|||
161742595|NCT01763866|584096124|FG019|Overall Study|Withdrawal by Subject|1|||
161742596|NCT01763866|584096125|FG020|Overall Study|Withdrawal by Subject|2|||
161742597|NCT01763866|584096126|FG021|Overall Study|Withdrawal by Subject|1|||
161742598|NCT01763866|584096127|FG022|Overall Study|Withdrawal by Subject|2|||
161742599|NCT01763866|584096128|FG023|Overall Study|Withdrawal by Subject|1|||
161742600|NCT01763866|584096105|FG000|Overall Study|Decision by sponsor|0|||
161742601|NCT01763866|584096106|FG001|Overall Study|Decision by sponsor|0|||
161742602|NCT01763866|584096107|FG002|Overall Study|Decision by sponsor|1|||
161742603|NCT01763866|584096108|FG003|Overall Study|Decision by sponsor|0|||
161742604|NCT01763866|584096109|FG004|Overall Study|Decision by sponsor|2|||
161742605|NCT01763866|584096110|FG005|Overall Study|Decision by sponsor|0|||
161742606|NCT01763866|584096111|FG006|Overall Study|Decision by sponsor|2|||
161742607|NCT01763866|584096112|FG007|Overall Study|Decision by sponsor|0|||
161742608|NCT01763866|584096113|FG008|Overall Study|Decision by sponsor|2|||
161742609|NCT01763866|584096114|FG009|Overall Study|Decision by sponsor|0|||
161742610|NCT01763866|584096115|FG010|Overall Study|Decision by sponsor|6|||
161742611|NCT01763866|584096116|FG011|Overall Study|Decision by sponsor|0|||
161841266|NCT04740814|584462942|FG000|Overall Study|Withdrawal by Subject|3|||
161841267|NCT00085423|584462943|FG000|Overall Study|Withdrawal by Subject|1|||
161841268|NCT00085423|584462943|FG000|Overall Study|screen failure|1|||
161841269|NCT02317614|584462949|FG000|Overall Study|Lost to Follow-up|1|||
161841270|NCT02317614|584462950|FG001|Overall Study|Lost to Follow-up|1|||
161742612|NCT01763866|584096117|FG012|Overall Study|Decision by sponsor|1|||
161742613|NCT01763866|584096118|FG013|Overall Study|Decision by sponsor|0|||
161742614|NCT01763866|584096119|FG014|Overall Study|Decision by sponsor|5|||
161742615|NCT01763866|584096120|FG015|Overall Study|Decision by sponsor|0|||
161742616|NCT01763866|584096121|FG016|Overall Study|Decision by sponsor|0|||
161841271|NCT02317614|584462949|FG000|Overall Study|Withdrawal by Subject|1|||
161841272|NCT02317614|584462950|FG001|Overall Study|Withdrawal by Subject|0|||
161742617|NCT01763866|584096122|FG017|Overall Study|Decision by sponsor|0|||
161742618|NCT01763866|584096123|FG018|Overall Study|Decision by sponsor|4|||
161742619|NCT01763866|584096124|FG019|Overall Study|Decision by sponsor|0|||
161742620|NCT01763866|584096125|FG020|Overall Study|Decision by sponsor|2|||
161841273|NCT02317614|584462949|FG000|Overall Study|Death|1|||
161841274|NCT02317614|584462950|FG001|Overall Study|Death|1|||
161841275|NCT03285308|584462951|FG000|Overall Study|Adverse Event|3|||
161841276|NCT03285308|584462952|FG001|Overall Study|Adverse Event|7|||
161841277|NCT03285308|584462951|FG000|Overall Study|Withdrawal by Subject|8|||
161841278|NCT03285308|584462952|FG001|Overall Study|Withdrawal by Subject|9|||
161841279|NCT03285308|584462951|FG000|Overall Study|Lost to Follow-up|3|||
161841280|NCT03285308|584462952|FG001|Overall Study|Lost to Follow-up|1|||
161841281|NCT03285308|584462951|FG000|Overall Study|Protocol Deviation|6|||
161841282|NCT03285308|584462952|FG001|Overall Study|Protocol Deviation|5|||
161841283|NCT03285308|584462951|FG000|Overall Study|Reason not Specified|0|||
161841284|NCT03285308|584462952|FG001|Overall Study|Reason not Specified|1|||
161841285|NCT01910389|584462953|FG000|Overall Study|Withdrawal by Subject|2|||
161841286|NCT01910389|584462954|FG001|Overall Study|Withdrawal by Subject|0|||
161841287|NCT01910389|584462953|FG000|Overall Study|Study Closed|13|||
161841288|NCT01910389|584462954|FG001|Overall Study|Study Closed|8|||
161841289|NCT01898650|584462955|FG000|Overall Study|the subject would not lie still for imaging|1|||
161841290|NCT02912650|584462957|FG000|Overall Study|Withdrawal by Subject|1|||
161841291|NCT02912650|584462958|FG001|Overall Study|Withdrawal by Subject|0|||
161841292|NCT02912650|584462959|FG002|Overall Study|Withdrawal by Subject|1|||
161841293|NCT02912650|584462960|FG003|Overall Study|Withdrawal by Subject|5|||
161841294|NCT02912650|584462957|FG000|Overall Study|Adverse Event|0|||
161841295|NCT02912650|584462958|FG001|Overall Study|Adverse Event|0|||
161841296|NCT02912650|584462959|FG002|Overall Study|Adverse Event|1|||
161841297|NCT02912650|584462960|FG003|Overall Study|Adverse Event|0|||
161841298|NCT02357342|584462961|FG000|First 6 Months|Death|2|||
161841299|NCT02357342|584462962|FG001|First 6 Months|Death|0|||
161841300|NCT01674647|584462963|FG000|Treatment Period|Death|4|||
161841301|NCT01674647|584462964|FG001|Treatment Period|Death|1|||
161841302|NCT01674647|584462963|FG000|Treatment Period|Efficacy outcome reached|0|||
161841303|NCT01674647|584462964|FG001|Treatment Period|Efficacy outcome reached|1|||
161841304|NCT01674647|584462963|FG000|Treatment Period|Physician Decision|3|||
161841305|NCT01674647|584462964|FG001|Treatment Period|Physician Decision|1|||
161841306|NCT01674647|584462963|FG000|Treatment Period|Adverse Event|60|||
161841307|NCT01674647|584462964|FG001|Treatment Period|Adverse Event|22|||
161841308|NCT01674647|584462963|FG000|Treatment Period|Non-compliance with study drug|3|||
161841309|NCT01674647|584462964|FG001|Treatment Period|Non-compliance with study drug|0|||
161841310|NCT01674647|584462963|FG000|Treatment Period|Lost to Follow-up|1|||
161841311|NCT01674647|584462964|FG001|Treatment Period|Lost to Follow-up|1|||
161841312|NCT01674647|584462963|FG000|Treatment Period|Withdrawal by Subject|19|||
161841313|NCT01674647|584462964|FG001|Treatment Period|Withdrawal by Subject|16|||
161841314|NCT01674647|584462963|FG000|Treatment Period|Switching to other therapy|5|||
161841315|NCT01674647|584462964|FG001|Treatment Period|Switching to other therapy|2|||
161841316|NCT01674647|584462963|FG000|Treatment Period|Logistical difficulties|5|||
161841317|NCT01674647|584462964|FG001|Treatment Period|Logistical difficulties|8|||
161841318|NCT01674647|584462963|FG000|Treatment Period|Treatment failure|0|||
161841319|NCT01674647|584462964|FG001|Treatment Period|Treatment failure|14|||
161841320|NCT01674647|584462963|FG000|Treatment Period|Protocol Violation|56|||
161742621|NCT01763866|584096126|FG021|Overall Study|Decision by sponsor|0|||
161742622|NCT01763866|584096127|FG022|Overall Study|Decision by sponsor|1|||
161742623|NCT01763866|584096128|FG023|Overall Study|Decision by sponsor|0|||
161742624|NCT01763866|584096105|FG000|Overall Study|Lost to Follow-up|0|||
161742625|NCT01763866|584096106|FG001|Overall Study|Lost to Follow-up|0|||
161742626|NCT01763866|584096107|FG002|Overall Study|Lost to Follow-up|0|||
161742627|NCT01763866|584096108|FG003|Overall Study|Lost to Follow-up|0|||
161742628|NCT01763866|584096109|FG004|Overall Study|Lost to Follow-up|0|||
161742629|NCT01763866|584096110|FG005|Overall Study|Lost to Follow-up|0|||
161742630|NCT01763866|584096111|FG006|Overall Study|Lost to Follow-up|1|||
161742631|NCT01763866|584096112|FG007|Overall Study|Lost to Follow-up|0|||
161841321|NCT01674647|584462964|FG001|Treatment Period|Protocol Violation|36|||
161742632|NCT01763866|584096113|FG008|Overall Study|Lost to Follow-up|0|||
161742633|NCT01763866|584096114|FG009|Overall Study|Lost to Follow-up|0|||
161841322|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Death|3|||
161841323|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Death|2|||
161841324|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
161841325|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
161841326|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
161841327|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
161841328|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
161841329|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
161841330|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
161841331|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
161742634|NCT01763866|584096115|FG010|Overall Study|Lost to Follow-up|0|||
161841332|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
161841333|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
161841334|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
161841335|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
161841336|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
161841337|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
161841338|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
161841339|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
161841340|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
161841341|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
161841342|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
161841343|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
161841344|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
161841345|NCT03923530|584462966|FG000|Overall Study|Withdrawal by Subject|1|||
161841346|NCT03923530|584462966|FG000|Overall Study|screen failure|3|||
161841347|NCT04135196|584462967|FG000|Overall Study|Lost to Follow-up|8|||
161841348|NCT04135196|584462968|FG001|Overall Study|Lost to Follow-up|7|||
161841349|NCT04135196|584462969|FG002|Overall Study|Lost to Follow-up|8|||
161841350|NCT04135196|584462970|FG003|Overall Study|Lost to Follow-up|9|||
161841351|NCT04135196|584462971|FG004|Overall Study|Lost to Follow-up|1|||
161841352|NCT04135196|584462967|FG000|Overall Study|Pregnancy|0|||
161841353|NCT04135196|584462968|FG001|Overall Study|Pregnancy|0|||
161841354|NCT04135196|584462969|FG002|Overall Study|Pregnancy|1|||
161841355|NCT04135196|584462970|FG003|Overall Study|Pregnancy|0|||
161841356|NCT04135196|584462971|FG004|Overall Study|Pregnancy|0|||
161841357|NCT04135196|584462967|FG000|Overall Study|Withdrawal by Subject|0|||
161841358|NCT04135196|584462968|FG001|Overall Study|Withdrawal by Subject|0|||
161841359|NCT04135196|584462969|FG002|Overall Study|Withdrawal by Subject|0|||
161841360|NCT04135196|584462970|FG003|Overall Study|Withdrawal by Subject|0|||
161841361|NCT04135196|584462971|FG004|Overall Study|Withdrawal by Subject|1|||
161841362|NCT00444457|584462973|FG000|Infant Series|Other|0|||
161841363|NCT00444457|584462974|FG001|Infant Series|Other|1|||
161841364|NCT00444457|584462975|FG002|Infant Series|Other|0|||
161841365|NCT00444457|584462976|FG003|Infant Series|Other|0|||
161841366|NCT00444457|584462973|FG000|Infant Series|Parent or legal guardian request|18|||
161841367|NCT00444457|584462974|FG001|Infant Series|Parent or legal guardian request|29|||
161841368|NCT00444457|584462975|FG002|Infant Series|Parent or legal guardian request|34|||
161841369|NCT00444457|584462976|FG003|Infant Series|Parent or legal guardian request|14|||
161841370|NCT00444457|584462973|FG000|Infant Series|Lost to Follow-up|10|||
161841371|NCT00444457|584462974|FG001|Infant Series|Lost to Follow-up|11|||
161841372|NCT00444457|584462975|FG002|Infant Series|Lost to Follow-up|7|||
161841373|NCT00444457|584462976|FG003|Infant Series|Lost to Follow-up|6|||
161841374|NCT00444457|584462973|FG000|Infant Series|Protocol Violation|16|||
161841375|NCT00444457|584462974|FG001|Infant Series|Protocol Violation|8|||
161841376|NCT00444457|584462975|FG002|Infant Series|Protocol Violation|6|||
161841377|NCT00444457|584462976|FG003|Infant Series|Protocol Violation|3|||
161841378|NCT00444457|584462973|FG000|Infant Series|Failed to return|5|||
161841379|NCT00444457|584462974|FG001|Infant Series|Failed to return|4|||
161841380|NCT00444457|584462975|FG002|Infant Series|Failed to return|4|||
161841381|NCT00444457|584462976|FG003|Infant Series|Failed to return|2|||
161841382|NCT00444457|584462973|FG000|Infant Series|Investigator request|4|||
161841383|NCT00444457|584462974|FG001|Infant Series|Investigator request|3|||
161841384|NCT00444457|584462975|FG002|Infant Series|Investigator request|3|||
161841385|NCT00444457|584462976|FG003|Infant Series|Investigator request|2|||
161841386|NCT00444457|584462973|FG000|Infant Series|Other|0|||
161841387|NCT00444457|584462974|FG001|Infant Series|Other|2|||
161841388|NCT00444457|584462975|FG002|Infant Series|Other|4|||
161841389|NCT00444457|584462976|FG003|Infant Series|Other|0|||
161841390|NCT00444457|584462973|FG000|Infant Series|Adverse Event|1|||
161841391|NCT00444457|584462974|FG001|Infant Series|Adverse Event|2|||
161841392|NCT00444457|584462975|FG002|Infant Series|Adverse Event|2|||
161841393|NCT00444457|584462976|FG003|Infant Series|Adverse Event|0|||
161841394|NCT00444457|584462973|FG000|Infant Series|Death|0|||
161841395|NCT00444457|584462974|FG001|Infant Series|Death|1|||
161841396|NCT00444457|584462975|FG002|Infant Series|Death|1|||
161841397|NCT00444457|584462976|FG003|Infant Series|Death|1|||
161841398|NCT00444457|584462973|FG000|After Infant Series|Other|0|||
161841399|NCT00444457|584462974|FG001|After Infant Series|Other|1|||
161841400|NCT00444457|584462975|FG002|After Infant Series|Other|1|||
161841401|NCT00444457|584462976|FG003|After Infant Series|Other|1|||
161841402|NCT00444457|584462973|FG000|After Infant Series|Parent or legal guardian request|4|||
161841403|NCT00444457|584462974|FG001|After Infant Series|Parent or legal guardian request|11|||
161841404|NCT00444457|584462975|FG002|After Infant Series|Parent or legal guardian request|6|||
161841405|NCT00444457|584462976|FG003|After Infant Series|Parent or legal guardian request|3|||
161841406|NCT00444457|584462973|FG000|After Infant Series|Failed to return|7|||
161841407|NCT00444457|584462974|FG001|After Infant Series|Failed to return|6|||
161841408|NCT00444457|584462975|FG002|After Infant Series|Failed to return|5|||
161841409|NCT00444457|584462976|FG003|After Infant Series|Failed to return|1|||
161841410|NCT00444457|584462973|FG000|After Infant Series|Lost to Follow-up|5|||
161841411|NCT00444457|584462974|FG001|After Infant Series|Lost to Follow-up|5|||
161841412|NCT00444457|584462975|FG002|After Infant Series|Lost to Follow-up|5|||
161841413|NCT00444457|584462976|FG003|After Infant Series|Lost to Follow-up|2|||
161841414|NCT00444457|584462973|FG000|After Infant Series|Protocol Violation|2|||
161841415|NCT00444457|584462974|FG001|After Infant Series|Protocol Violation|4|||
161841416|NCT00444457|584462975|FG002|After Infant Series|Protocol Violation|2|||
161841417|NCT00444457|584462976|FG003|After Infant Series|Protocol Violation|2|||
161841418|NCT00444457|584462973|FG000|After Infant Series|Adverse Event|2|||
161841419|NCT00444457|584462974|FG001|After Infant Series|Adverse Event|2|||
161841420|NCT00444457|584462975|FG002|After Infant Series|Adverse Event|0|||
161841421|NCT00444457|584462976|FG003|After Infant Series|Adverse Event|0|||
161841422|NCT00444457|584462973|FG000|After Infant Series|Investigator request|0|||
161841423|NCT00444457|584462974|FG001|After Infant Series|Investigator request|0|||
161841424|NCT00444457|584462975|FG002|After Infant Series|Investigator request|0|||
161841425|NCT00444457|584462976|FG003|After Infant Series|Investigator request|1|||
161841426|NCT00444457|584462973|FG000|After Infant Series|Other|0|||
161841427|NCT00444457|584462974|FG001|After Infant Series|Other|1|||
161841428|NCT00444457|584462975|FG002|After Infant Series|Other|0|||
161841429|NCT00444457|584462976|FG003|After Infant Series|Other|0|||
161841430|NCT00444457|584462973|FG000|Toddler Dose|Lost to Follow-up|4|||
161841431|NCT00444457|584462974|FG001|Toddler Dose|Lost to Follow-up|1|||
161841432|NCT00444457|584462975|FG002|Toddler Dose|Lost to Follow-up|1|||
161841433|NCT00444457|584462976|FG003|Toddler Dose|Lost to Follow-up|3|||
161841434|NCT00444457|584462973|FG000|Toddler Dose|Failed to return|2|||
161841435|NCT00444457|584462974|FG001|Toddler Dose|Failed to return|2|||
161841436|NCT00444457|584462975|FG002|Toddler Dose|Failed to return|1|||
161841437|NCT00444457|584462976|FG003|Toddler Dose|Failed to return|3|||
161841438|NCT00444457|584462973|FG000|Toddler Dose|Parent or legal guardian request|0|||
161841439|NCT00444457|584462974|FG001|Toddler Dose|Parent or legal guardian request|3|||
161841440|NCT00444457|584462975|FG002|Toddler Dose|Parent or legal guardian request|2|||
161841441|NCT00444457|584462976|FG003|Toddler Dose|Parent or legal guardian request|1|||
161841442|NCT00444457|584462973|FG000|Toddler Dose|Protocol Violation|1|||
161841443|NCT00444457|584462974|FG001|Toddler Dose|Protocol Violation|0|||
161841444|NCT00444457|584462975|FG002|Toddler Dose|Protocol Violation|0|||
161841445|NCT00444457|584462976|FG003|Toddler Dose|Protocol Violation|1|||
161841446|NCT01946191|584462977|FG000|Allocation|Did not complete orientation|1|||
161841447|NCT01946191|584462978|FG001|Allocation|Did not complete orientation|1|||
161841448|NCT01946191|584462977|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
161841449|NCT01946191|584462978|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
161841450|NCT01946191|584462977|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
161841451|NCT01946191|584462978|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
161841452|NCT01946191|584462977|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
161841453|NCT01946191|584462978|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
161841454|NCT02799095|584466179|FG000|Part A|Adverse Event|1|||
161841455|NCT02799095|584466180|FG001|Part A|Adverse Event|0|||
161841456|NCT02799095|584466181|FG002|Part A|Adverse Event|1|||
161742635|NCT01763866|584096116|FG011|Overall Study|Lost to Follow-up|0|||
161742636|NCT01763866|584096117|FG012|Overall Study|Lost to Follow-up|1|||
161742637|NCT01763866|584096118|FG013|Overall Study|Lost to Follow-up|0|||
161742638|NCT01763866|584096119|FG014|Overall Study|Lost to Follow-up|1|||
161742639|NCT01763866|584096120|FG015|Overall Study|Lost to Follow-up|0|||
161742640|NCT01763866|584096121|FG016|Overall Study|Lost to Follow-up|0|||
161742641|NCT01763866|584096122|FG017|Overall Study|Lost to Follow-up|0|||
161742642|NCT01763866|584096123|FG018|Overall Study|Lost to Follow-up|1|||
161742643|NCT01763866|584096124|FG019|Overall Study|Lost to Follow-up|1|||
161841457|NCT02799095|584466182|FG003|Part A|Adverse Event|4|||
161841458|NCT02799095|584466183|FG004|Part A|Adverse Event|1|||
161841459|NCT02799095|584466184|FG005|Part A|Adverse Event|0|||
161841460|NCT02799095|584466185|FG006|Part A|Adverse Event|0|||
161841461|NCT02799095|584466186|FG007|Part A|Adverse Event|0|||
161841462|NCT02799095|584466187|FG008|Part A|Adverse Event|0|||
161841463|NCT02799095|584466188|FG009|Part A|Adverse Event|0|||
161841464|NCT02799095|584466189|FG010|Part A|Adverse Event|0|||
161841465|NCT02799095|584466190|FG011|Part A|Adverse Event|0|||
161841466|NCT02799095|584466191|FG012|Part A|Adverse Event|0|||
161841467|NCT02799095|584466192|FG013|Part A|Adverse Event|0|||
161742644|NCT01763866|584096125|FG020|Overall Study|Lost to Follow-up|0|||
161742645|NCT01763866|584096126|FG021|Overall Study|Lost to Follow-up|0|||
161742646|NCT01763866|584096127|FG022|Overall Study|Lost to Follow-up|0|||
161841468|NCT02799095|584466193|FG014|Part A|Adverse Event|0|||
161841469|NCT02799095|584466194|FG015|Part A|Adverse Event|0|||
161841470|NCT02799095|584466195|FG016|Part A|Adverse Event|0|||
161742647|NCT01763866|584096128|FG023|Overall Study|Lost to Follow-up|1|||
161841471|NCT02799095|584466179|FG000|Part A|Death|0|||
161841472|NCT02799095|584466180|FG001|Part A|Death|0|||
161841473|NCT02799095|584466181|FG002|Part A|Death|0|||
161841474|NCT02799095|584466182|FG003|Part A|Death|0|||
161841475|NCT02799095|584466183|FG004|Part A|Death|0|||
161841476|NCT02799095|584466184|FG005|Part A|Death|0|||
161841477|NCT02799095|584466185|FG006|Part A|Death|3|||
161742648|NCT01763866|584096105|FG000|Overall Study|Death|0|||
161742649|NCT01763866|584096106|FG001|Overall Study|Death|0|||
161742650|NCT01763866|584096107|FG002|Overall Study|Death|0|||
161742651|NCT01763866|584096108|FG003|Overall Study|Death|0|||
161742652|NCT01763866|584096109|FG004|Overall Study|Death|0|||
161742653|NCT01763866|584096110|FG005|Overall Study|Death|0|||
161742654|NCT01763866|584096111|FG006|Overall Study|Death|0|||
161742655|NCT01763866|584096112|FG007|Overall Study|Death|0|||
161742656|NCT01763866|584096113|FG008|Overall Study|Death|0|||
161742657|NCT01763866|584096114|FG009|Overall Study|Death|0|||
161742658|NCT01763866|584096115|FG010|Overall Study|Death|0|||
161742659|NCT01763866|584096116|FG011|Overall Study|Death|0|||
161742660|NCT01763866|584096117|FG012|Overall Study|Death|0|||
161742661|NCT01763866|584096118|FG013|Overall Study|Death|0|||
161742662|NCT01763866|584096119|FG014|Overall Study|Death|0|||
161742663|NCT01763866|584096120|FG015|Overall Study|Death|0|||
161742664|NCT01763866|584096121|FG016|Overall Study|Death|1|||
161742665|NCT01763866|584096122|FG017|Overall Study|Death|0|||
161742666|NCT01763866|584096123|FG018|Overall Study|Death|0|||
161742667|NCT01763866|584096124|FG019|Overall Study|Death|0|||
161742668|NCT01763866|584096125|FG020|Overall Study|Death|0|||
161742669|NCT01763866|584096126|FG021|Overall Study|Death|0|||
161742670|NCT01763866|584096127|FG022|Overall Study|Death|0|||
161742671|NCT01763866|584096128|FG023|Overall Study|Death|0|||
161742672|NCT00093470|584097860|FG000|Overall Study|Disease progression|39|||
161742673|NCT00093470|584097861|FG001|Overall Study|Disease progression|0|||
161742674|NCT00093470|584097860|FG000|Overall Study|Adverse Event|15|||
161742675|NCT00093470|584097861|FG001|Overall Study|Adverse Event|0|||
161742676|NCT00093470|584097860|FG000|Overall Study|Death|2|||
161742677|NCT00093470|584097861|FG001|Overall Study|Death|0|||
161742678|NCT00093470|584097860|FG000|Overall Study|Withdrawal by Subject|8|||
161742679|NCT00093470|584097861|FG001|Overall Study|Withdrawal by Subject|0|||
161742680|NCT00093470|584097860|FG000|Overall Study|Alternative therapy|2|||
161742681|NCT00093470|584097861|FG001|Overall Study|Alternative therapy|0|||
161742682|NCT00093470|584097860|FG000|Overall Study|Other complicating disease|3|||
161742683|NCT00093470|584097861|FG001|Overall Study|Other complicating disease|0|||
161742684|NCT00093470|584097860|FG000|Overall Study|Physician Decision|2|||
161742685|NCT00093470|584097861|FG001|Overall Study|Physician Decision|0|||
161742686|NCT00093470|584097860|FG000|Overall Study|Never started treatment|1|||
161742687|NCT00093470|584097861|FG001|Overall Study|Never started treatment|0|||
161742688|NCT00093470|584097860|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
161742689|NCT00093470|584097861|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
161742690|NCT01019252|584097862|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
161742691|NCT01019252|584097863|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
161742692|NCT01019252|584097862|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
161742693|NCT01019252|584097863|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
161742694|NCT01019252|584097862|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
161742695|NCT01019252|584097863|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
161742696|NCT01019252|584097862|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
161742697|NCT01019252|584097863|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
161742698|NCT02514772|584097864|FG000|Overall Study|Adverse Event|1|||
161742699|NCT02514772|584097865|FG001|Overall Study|Adverse Event|0|||
161742700|NCT02514772|584097864|FG000|Overall Study|Death|0|||
161742701|NCT02514772|584097865|FG001|Overall Study|Death|1|||
161742702|NCT02514772|584097864|FG000|Overall Study|Withdrawal by Subject|2|||
161742703|NCT02514772|584097865|FG001|Overall Study|Withdrawal by Subject|1|||
161742704|NCT00877006|584097866|FG000|Treatment Period|Death|2|||
161742705|NCT00877006|584097867|FG001|Treatment Period|Death|1|||
161742706|NCT00877006|584097866|FG000|Treatment Period|Adverse Event|10|||
161742707|NCT00877006|584097867|FG001|Treatment Period|Adverse Event|3|||
161742708|NCT00877006|584097866|FG000|Treatment Period|Withdrawal by Subject|2|||
161742709|NCT00877006|584097867|FG001|Treatment Period|Withdrawal by Subject|3|||
161742710|NCT00877006|584097866|FG000|Treatment Period|Protocol Violation|1|||
161742711|NCT00877006|584097867|FG001|Treatment Period|Protocol Violation|0|||
161742712|NCT00877006|584097866|FG000|Treatment Period|Lost to Follow-up|0|||
161742713|NCT00877006|584097867|FG001|Treatment Period|Lost to Follow-up|1|||
161742714|NCT00877006|584097866|FG000|Treatment Period|Disease Progression|1|||
161742715|NCT00877006|584097867|FG001|Treatment Period|Disease Progression|2|||
161742716|NCT00877006|584097866|FG000|Treatment Period|Started New Treatment Regimen|2|||
161742717|NCT00877006|584097867|FG001|Treatment Period|Started New Treatment Regimen|5|||
161742718|NCT00877006|584097866|FG000|Treatment Period|Other|4|||
161742719|NCT00877006|584097867|FG001|Treatment Period|Other|4|||
161742720|NCT00877006|584097866|FG000|Treatment Period|Randomized but Not Treated|3|||
161742721|NCT00877006|584097867|FG001|Treatment Period|Randomized but Not Treated|8|||
161742722|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
161742723|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
161742724|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
161742725|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
161742726|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Death|26|||
161841478|NCT02799095|584466186|FG007|Part A|Death|0|||
161841479|NCT02799095|584466187|FG008|Part A|Death|0|||
161841480|NCT02799095|584466188|FG009|Part A|Death|0|||
161841481|NCT02799095|584466189|FG010|Part A|Death|0|||
161841482|NCT02799095|584466190|FG011|Part A|Death|0|||
161841483|NCT02799095|584466191|FG012|Part A|Death|0|||
161841484|NCT02799095|584466192|FG013|Part A|Death|0|||
161841485|NCT02799095|584466193|FG014|Part A|Death|0|||
161841486|NCT02799095|584466194|FG015|Part A|Death|0|||
161841487|NCT02799095|584466195|FG016|Part A|Death|0|||
161841488|NCT02799095|584466179|FG000|Part A|Lost to Follow-up|0|||
161841489|NCT02799095|584466180|FG001|Part A|Lost to Follow-up|1|||
161841490|NCT02799095|584466181|FG002|Part A|Lost to Follow-up|0|||
161841491|NCT02799095|584466182|FG003|Part A|Lost to Follow-up|0|||
161841492|NCT02799095|584466183|FG004|Part A|Lost to Follow-up|0|||
161841493|NCT02799095|584466184|FG005|Part A|Lost to Follow-up|0|||
161841494|NCT02799095|584466185|FG006|Part A|Lost to Follow-up|1|||
161841495|NCT02799095|584466186|FG007|Part A|Lost to Follow-up|0|||
161742727|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Death|18|||
161742728|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Other|7|||
161742729|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Other|9|||
161742730|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
161742731|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
161742732|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
161742733|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
161742734|NCT04671342|584097868|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
161742735|NCT04671342|584097868|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
161742736|NCT03583606|584097869|FG000|Overall Study|Lost to Follow-up|0|||
161742737|NCT03583606|584097870|FG001|Overall Study|Lost to Follow-up|1|||
161742738|NCT03583606|584097871|FG002|Overall Study|Lost to Follow-up|0|||
161742739|NCT03583606|584097869|FG000|Overall Study|Ineligible at baseline|1|||
161742740|NCT03583606|584097870|FG001|Overall Study|Ineligible at baseline|0|||
161742741|NCT03583606|584097871|FG002|Overall Study|Ineligible at baseline|0|||
161742742|NCT00817206|584097872|FG000|Overall Study|Adverse Event|10|||
161742743|NCT00817206|584097873|FG001|Overall Study|Adverse Event|3|||
161742744|NCT00817206|584097872|FG000|Overall Study|Protocol Violation|0|||
161742745|NCT00817206|584097873|FG001|Overall Study|Protocol Violation|2|||
161742746|NCT00817206|584097872|FG000|Overall Study|Lost to Follow-up|0|||
161742747|NCT00817206|584097873|FG001|Overall Study|Lost to Follow-up|1|||
161742748|NCT00817206|584097872|FG000|Overall Study|Death|2|||
161742749|NCT00817206|584097873|FG001|Overall Study|Death|0|||
161742750|NCT00817206|584097872|FG000|Overall Study|Withdrawal by Subject|7|||
161742751|NCT00817206|584097873|FG001|Overall Study|Withdrawal by Subject|3|||
161742752|NCT00817206|584097872|FG000|Overall Study|Physician Decision|2|||
161742753|NCT00817206|584097873|FG001|Overall Study|Physician Decision|0|||
161742754|NCT00126581|584097874|FG000|Overall Study|Adverse Event|3|||
161742755|NCT00126581|584097875|FG001|Overall Study|Adverse Event|7|||
161742756|NCT00126581|584097874|FG000|Overall Study|Death|3|||
161742757|NCT00126581|584097875|FG001|Overall Study|Death|2|||
161742758|NCT00126581|584097874|FG000|Overall Study|Withdrawal by Subject|1|||
161742759|NCT00126581|584097875|FG001|Overall Study|Withdrawal by Subject|4|||
161742760|NCT00126581|584097874|FG000|Overall Study|Alternative therapy|3|||
161742761|NCT00126581|584097875|FG001|Overall Study|Alternative therapy|3|||
161742762|NCT00126581|584097874|FG000|Overall Study|Other illness/MD discretion|3|||
161742763|NCT00126581|584097875|FG001|Overall Study|Other illness/MD discretion|4|||
161742764|NCT00793182|584097876|FG000|Overall Study|Adverse Event|0|||
161742765|NCT00793182|584097877|FG001|Overall Study|Adverse Event|1|||
161742766|NCT03728140|584097878|FG000|Overall Study|Abnormal embryo transfer operation|10|||
161742767|NCT03728140|584097879|FG001|Overall Study|Abnormal embryo transfer operation|7|||
161742768|NCT02273037|584097881|FG000|Overall Study|Lost to Follow-up|1|||
161742769|NCT02273037|584097882|FG001|Overall Study|Lost to Follow-up|0|||
161742770|NCT02273037|584097881|FG000|Overall Study|Delivered before monitoring initiated|1|||
161742771|NCT02273037|584097882|FG001|Overall Study|Delivered before monitoring initiated|3|||
161742772|NCT02273037|584097881|FG000|Overall Study|Breech delivery|2|||
161742773|NCT02273037|584097882|FG001|Overall Study|Breech delivery|3|||
161742774|NCT02273037|584097881|FG000|Overall Study|Multiple delivery|2|||
161742775|NCT02273037|584097882|FG001|Overall Study|Multiple delivery|2|||
161742776|NCT02273037|584097881|FG000|Overall Study|Other complication|2|||
161742777|NCT02273037|584097882|FG001|Overall Study|Other complication|0|||
161742778|NCT00851253|584097883|FG000|Overall Study|Disease Progression|1|||
161742779|NCT00851253|584097884|FG001|Overall Study|Disease Progression|0|||
161841496|NCT02799095|584466187|FG008|Part A|Lost to Follow-up|0|||
161841497|NCT02799095|584466188|FG009|Part A|Lost to Follow-up|0|||
161841498|NCT02799095|584466189|FG010|Part A|Lost to Follow-up|0|||
161841499|NCT02799095|584466190|FG011|Part A|Lost to Follow-up|0|||
161841500|NCT02799095|584466191|FG012|Part A|Lost to Follow-up|0|||
161841501|NCT02799095|584466192|FG013|Part A|Lost to Follow-up|0|||
161841502|NCT02799095|584466193|FG014|Part A|Lost to Follow-up|0|||
161841503|NCT02799095|584466194|FG015|Part A|Lost to Follow-up|0|||
161841504|NCT02799095|584466195|FG016|Part A|Lost to Follow-up|0|||
161841505|NCT02799095|584466179|FG000|Part A|Progressive Disease|3|||
161841506|NCT02799095|584466180|FG001|Part A|Progressive Disease|3|||
161841507|NCT02799095|584466181|FG002|Part A|Progressive Disease|3|||
161841508|NCT02799095|584466182|FG003|Part A|Progressive Disease|2|||
161841509|NCT02799095|584466183|FG004|Part A|Progressive Disease|2|||
161841510|NCT02799095|584466184|FG005|Part A|Progressive Disease|0|||
161841511|NCT02799095|584466185|FG006|Part A|Progressive Disease|0|||
161841512|NCT02799095|584466186|FG007|Part A|Progressive Disease|0|||
161841513|NCT02799095|584466187|FG008|Part A|Progressive Disease|0|||
161841514|NCT02799095|584466188|FG009|Part A|Progressive Disease|0|||
161841515|NCT02799095|584466189|FG010|Part A|Progressive Disease|0|||
161841516|NCT02799095|584466190|FG011|Part A|Progressive Disease|0|||
161841517|NCT02799095|584466191|FG012|Part A|Progressive Disease|0|||
161841518|NCT02799095|584466192|FG013|Part A|Progressive Disease|0|||
161841519|NCT02799095|584466193|FG014|Part A|Progressive Disease|0|||
161841520|NCT02799095|584466194|FG015|Part A|Progressive Disease|0|||
161841521|NCT02799095|584466195|FG016|Part A|Progressive Disease|0|||
161841522|NCT02799095|584466179|FG000|Part A|Clinical Progression|1|||
161841523|NCT02799095|584466180|FG001|Part A|Clinical Progression|0|||
161841524|NCT02799095|584466181|FG002|Part A|Clinical Progression|2|||
161841525|NCT02799095|584466182|FG003|Part A|Clinical Progression|1|||
161841526|NCT02799095|584466183|FG004|Part A|Clinical Progression|5|||
161841527|NCT02799095|584466184|FG005|Part A|Clinical Progression|0|||
161841528|NCT02799095|584466185|FG006|Part A|Clinical Progression|0|||
161841529|NCT02799095|584466186|FG007|Part A|Clinical Progression|0|||
161841530|NCT02799095|584466187|FG008|Part A|Clinical Progression|0|||
161841531|NCT02799095|584466188|FG009|Part A|Clinical Progression|0|||
161841532|NCT02799095|584466189|FG010|Part A|Clinical Progression|0|||
161841533|NCT02799095|584466190|FG011|Part A|Clinical Progression|0|||
161841534|NCT02799095|584466191|FG012|Part A|Clinical Progression|0|||
161841535|NCT02799095|584466192|FG013|Part A|Clinical Progression|0|||
161841536|NCT02799095|584466193|FG014|Part A|Clinical Progression|0|||
161841537|NCT02799095|584466194|FG015|Part A|Clinical Progression|0|||
161841538|NCT02799095|584466195|FG016|Part A|Clinical Progression|0|||
161841539|NCT02799095|584466179|FG000|Part A|Protocol Deviation|0|||
161841540|NCT02799095|584466180|FG001|Part A|Protocol Deviation|0|||
161841541|NCT02799095|584466181|FG002|Part A|Protocol Deviation|1|||
161841542|NCT02799095|584466182|FG003|Part A|Protocol Deviation|0|||
161841543|NCT02799095|584466183|FG004|Part A|Protocol Deviation|0|||
161841544|NCT02799095|584466184|FG005|Part A|Protocol Deviation|0|||
161841545|NCT02799095|584466185|FG006|Part A|Protocol Deviation|0|||
161841546|NCT02799095|584466186|FG007|Part A|Protocol Deviation|0|||
161841547|NCT02799095|584466187|FG008|Part A|Protocol Deviation|0|||
161841548|NCT02799095|584466188|FG009|Part A|Protocol Deviation|0|||
161841549|NCT02799095|584466189|FG010|Part A|Protocol Deviation|0|||
161841550|NCT02799095|584466190|FG011|Part A|Protocol Deviation|0|||
161841551|NCT02799095|584466191|FG012|Part A|Protocol Deviation|0|||
161841552|NCT02799095|584466192|FG013|Part A|Protocol Deviation|0|||
161841553|NCT02799095|584466193|FG014|Part A|Protocol Deviation|0|||
161841554|NCT02799095|584466194|FG015|Part A|Protocol Deviation|0|||
161841555|NCT02799095|584466195|FG016|Part A|Protocol Deviation|0|||
161841556|NCT02799095|584466179|FG000|Part A|Withdrawal by Subject|0|||
161841557|NCT02799095|584466180|FG001|Part A|Withdrawal by Subject|0|||
161841558|NCT02799095|584466181|FG002|Part A|Withdrawal by Subject|0|||
161841559|NCT02799095|584466182|FG003|Part A|Withdrawal by Subject|1|||
161841560|NCT02799095|584466183|FG004|Part A|Withdrawal by Subject|3|||
161841561|NCT02799095|584466184|FG005|Part A|Withdrawal by Subject|1|||
161841562|NCT02799095|584466185|FG006|Part A|Withdrawal by Subject|1|||
161841563|NCT02799095|584466186|FG007|Part A|Withdrawal by Subject|0|||
161841564|NCT02799095|584466187|FG008|Part A|Withdrawal by Subject|0|||
161841565|NCT02799095|584466188|FG009|Part A|Withdrawal by Subject|0|||
161841566|NCT02799095|584466189|FG010|Part A|Withdrawal by Subject|0|||
161841567|NCT02799095|584466190|FG011|Part A|Withdrawal by Subject|0|||
161841568|NCT02799095|584466191|FG012|Part A|Withdrawal by Subject|0|||
161841569|NCT02799095|584466192|FG013|Part A|Withdrawal by Subject|0|||
161841570|NCT02799095|584466193|FG014|Part A|Withdrawal by Subject|0|||
161841571|NCT02799095|584466194|FG015|Part A|Withdrawal by Subject|0|||
161841572|NCT02799095|584466195|FG016|Part A|Withdrawal by Subject|0|||
161841573|NCT02799095|584466179|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
161841574|NCT02799095|584466180|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
161841575|NCT02799095|584466181|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
161841576|NCT02799095|584466182|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
161841577|NCT02799095|584466183|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
161841578|NCT02799095|584466184|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
161841579|NCT02799095|584466185|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
161841580|NCT02799095|584466186|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
161841581|NCT02799095|584466187|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
161841582|NCT02799095|584466188|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
161841583|NCT02799095|584466189|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
161841584|NCT02799095|584466190|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
161841585|NCT02799095|584466191|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
161841586|NCT02799095|584466192|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
161841587|NCT02799095|584466193|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
161841588|NCT02799095|584466194|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
161841589|NCT02799095|584466195|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
161841590|NCT02799095|584466179|FG000|Part B|Death|0|||
161841591|NCT02799095|584466180|FG001|Part B|Death|0|||
161841592|NCT02799095|584466181|FG002|Part B|Death|0|||
161841593|NCT02799095|584466182|FG003|Part B|Death|0|||
161841594|NCT02799095|584466183|FG004|Part B|Death|0|||
161841595|NCT02799095|584466184|FG005|Part B|Death|0|||
161841596|NCT02799095|584466185|FG006|Part B|Death|0|||
161841597|NCT02799095|584466186|FG007|Part B|Death|7|||
161841598|NCT02799095|584466187|FG008|Part B|Death|7|||
161841599|NCT02799095|584466188|FG009|Part B|Death|0|||
161841600|NCT02799095|584466189|FG010|Part B|Death|0|||
161841601|NCT02799095|584466190|FG011|Part B|Death|0|||
161841602|NCT02799095|584466191|FG012|Part B|Death|0|||
161841603|NCT02799095|584466192|FG013|Part B|Death|0|||
161841604|NCT02799095|584466193|FG014|Part B|Death|0|||
161841605|NCT02799095|584466194|FG015|Part B|Death|0|||
161841606|NCT02799095|584466195|FG016|Part B|Death|0|||
161841607|NCT02799095|584466179|FG000|Part B|Progressive Disease|0|||
161841608|NCT02799095|584466180|FG001|Part B|Progressive Disease|0|||
161841609|NCT02799095|584466181|FG002|Part B|Progressive Disease|0|||
161841610|NCT02799095|584466182|FG003|Part B|Progressive Disease|0|||
161841611|NCT02799095|584466183|FG004|Part B|Progressive Disease|0|||
161841612|NCT02799095|584466184|FG005|Part B|Progressive Disease|0|||
161841613|NCT02799095|584466185|FG006|Part B|Progressive Disease|0|||
161841614|NCT02799095|584466186|FG007|Part B|Progressive Disease|1|||
161841615|NCT02799095|584466187|FG008|Part B|Progressive Disease|0|||
161841616|NCT02799095|584466188|FG009|Part B|Progressive Disease|0|||
161841617|NCT02799095|584466189|FG010|Part B|Progressive Disease|0|||
161841618|NCT02799095|584466190|FG011|Part B|Progressive Disease|0|||
161841619|NCT02799095|584466191|FG012|Part B|Progressive Disease|0|||
161841620|NCT02799095|584466192|FG013|Part B|Progressive Disease|0|||
161841621|NCT02799095|584466193|FG014|Part B|Progressive Disease|0|||
161841622|NCT02799095|584466194|FG015|Part B|Progressive Disease|0|||
161841623|NCT02799095|584466195|FG016|Part B|Progressive Disease|0|||
161841624|NCT02799095|584466179|FG000|Part B|Withdrawal by Subject|0|||
161841625|NCT02799095|584466180|FG001|Part B|Withdrawal by Subject|0|||
161841626|NCT02799095|584466181|FG002|Part B|Withdrawal by Subject|0|||
161841627|NCT02799095|584466182|FG003|Part B|Withdrawal by Subject|0|||
161841628|NCT02799095|584466183|FG004|Part B|Withdrawal by Subject|0|||
161841629|NCT02799095|584466184|FG005|Part B|Withdrawal by Subject|0|||
161841630|NCT02799095|584466185|FG006|Part B|Withdrawal by Subject|0|||
161841631|NCT02799095|584466186|FG007|Part B|Withdrawal by Subject|10|||
161841632|NCT02799095|584466187|FG008|Part B|Withdrawal by Subject|7|||
161841633|NCT02799095|584466188|FG009|Part B|Withdrawal by Subject|0|||
161841634|NCT02799095|584466189|FG010|Part B|Withdrawal by Subject|0|||
161841635|NCT02799095|584466190|FG011|Part B|Withdrawal by Subject|0|||
161841636|NCT02799095|584466191|FG012|Part B|Withdrawal by Subject|0|||
161841637|NCT02799095|584466192|FG013|Part B|Withdrawal by Subject|0|||
161841638|NCT02799095|584466193|FG014|Part B|Withdrawal by Subject|0|||
161841639|NCT02799095|584466194|FG015|Part B|Withdrawal by Subject|0|||
161841640|NCT02799095|584466195|FG016|Part B|Withdrawal by Subject|0|||
161841641|NCT02799095|584466179|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
161841642|NCT02799095|584466180|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
161841643|NCT02799095|584466181|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
161841644|NCT02799095|584466182|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
161841645|NCT02799095|584466183|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
161841646|NCT02799095|584466184|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
161841647|NCT02799095|584466185|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
161841648|NCT02799095|584466186|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
161841649|NCT02799095|584466187|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
161841650|NCT02799095|584466188|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
161841651|NCT02799095|584466189|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
161841652|NCT02799095|584466190|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
161841653|NCT02799095|584466191|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
161841654|NCT02799095|584466192|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
161841655|NCT02799095|584466193|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
161841656|NCT02799095|584466194|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
161841657|NCT02799095|584466195|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
161841658|NCT02799095|584466179|FG000|Part C|Adverse Event|0|||
161841659|NCT02799095|584466180|FG001|Part C|Adverse Event|0|||
161841660|NCT02799095|584466181|FG002|Part C|Adverse Event|0|||
161841661|NCT02799095|584466182|FG003|Part C|Adverse Event|0|||
161841662|NCT02799095|584466183|FG004|Part C|Adverse Event|0|||
161841663|NCT02799095|584466184|FG005|Part C|Adverse Event|0|||
161841664|NCT02799095|584466185|FG006|Part C|Adverse Event|0|||
161742780|NCT03657810|584097889|FG000|Overall Study|Adverse Event|0|||
161742781|NCT03657810|584097890|FG001|Overall Study|Adverse Event|1|||
161742782|NCT03657810|584097891|FG002|Overall Study|Adverse Event|0|||
161742783|NCT03657810|584097889|FG000|Overall Study|Lack of Efficacy|4|||
161742784|NCT03657810|584097890|FG001|Overall Study|Lack of Efficacy|1|||
161742785|NCT03657810|584097891|FG002|Overall Study|Lack of Efficacy|3|||
161742786|NCT03657810|584097889|FG000|Overall Study|Protocol Violation|1|||
161742787|NCT03657810|584097890|FG001|Overall Study|Protocol Violation|0|||
161742788|NCT03657810|584097891|FG002|Overall Study|Protocol Violation|0|||
161742789|NCT03657810|584097889|FG000|Overall Study|Lost to Follow-up|0|||
161742790|NCT03657810|584097890|FG001|Overall Study|Lost to Follow-up|1|||
161742791|NCT03657810|584097891|FG002|Overall Study|Lost to Follow-up|0|||
161742792|NCT03657810|584097889|FG000|Overall Study|Not provided|0|||
161742793|NCT03657810|584097890|FG001|Overall Study|Not provided|1|||
161742794|NCT03657810|584097891|FG002|Overall Study|Not provided|0|||
161742795|NCT00574496|584097895|FG000|Overall Study|Withdrawal by Subject|1|||
161742796|NCT01969799|584097896|FG000|Overall Study|Adverse Event|0|||
161742797|NCT01969799|584097897|FG001|Overall Study|Adverse Event|1|||
161742798|NCT01969799|584097896|FG000|Overall Study|Death|16|||
161742799|NCT01969799|584097897|FG001|Overall Study|Death|11|||
161742800|NCT01969799|584097896|FG000|Overall Study|Lost to Follow-up|0|||
161742801|NCT01969799|584097897|FG001|Overall Study|Lost to Follow-up|2|||
161742802|NCT01969799|584097896|FG000|Overall Study|Physician Decision|1|||
161742803|NCT01969799|584097897|FG001|Overall Study|Physician Decision|0|||
161742804|NCT02227108|584097900|FG000|Overall Study|Did not receive treatment|2|||
161742805|NCT02227108|584097900|FG000|Overall Study|Other|3|||
161742806|NCT02227108|584097900|FG000|Overall Study|Progressive disease|17|||
161742807|NCT02227108|584097900|FG000|Overall Study|Initiation of alternative therapy|2|||
161742808|NCT02227108|584097900|FG000|Overall Study|Investigator discretion|1|||
161742809|NCT02227108|584097900|FG000|Overall Study|Adverse Event|6|||
161742810|NCT02486952|584097901|FG000|Overall Study|Not Started Induction Therapy|3|||
161742811|NCT02486952|584097901|FG000|Overall Study|Adverse Event|1|||
161742812|NCT02486952|584097901|FG000|Overall Study|Death|15|||
161742813|NCT02486952|584097901|FG000|Overall Study|Lack of Efficacy|3|||
161742814|NCT02486952|584097901|FG000|Overall Study|Lost to Follow-up|26|||
161742815|NCT02486952|584097901|FG000|Overall Study|Other|2|||
161742816|NCT04111107|584097902|FG000|Overall Study|Withdrawal by Subject|6|||
161742817|NCT04111107|584097902|FG000|Overall Study|Declining Health|5|||
161742818|NCT01928485|584097903|FG000|Overall Study|Physician Decision|0|||
161742819|NCT01928485|584097904|FG001|Overall Study|Physician Decision|1|||
161742820|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742821|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
161742822|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742823|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742824|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742825|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742826|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742827|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
161742828|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742829|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742830|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742831|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
161742832|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742833|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742834|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742835|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742836|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742837|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
161742838|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742839|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742840|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742841|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
161742842|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742843|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742844|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742845|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
161742846|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
161742847|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
161841665|NCT02799095|584466186|FG007|Part C|Adverse Event|0|||
161841666|NCT02799095|584466187|FG008|Part C|Adverse Event|0|||
161841667|NCT02799095|584466188|FG009|Part C|Adverse Event|0|||
161742848|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
161742849|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
161742850|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
161742851|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
161742852|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
161742853|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
161742854|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
161742855|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742856|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
161742857|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742858|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742859|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742860|NCT00039741|584097912|FG000|Overall Study|Death|0|||
161742861|NCT00039741|584097913|FG001|Overall Study|Death|1|||
161742862|NCT00039741|584097914|FG002|Overall Study|Death|0|||
161742863|NCT00039741|584097915|FG003|Overall Study|Death|0|||
161742864|NCT00039741|584097912|FG000|Overall Study|Lost to Follow-up|3|||
161742865|NCT00039741|584097913|FG001|Overall Study|Lost to Follow-up|1|||
161742866|NCT00039741|584097914|FG002|Overall Study|Lost to Follow-up|5|||
161742867|NCT00039741|584097915|FG003|Overall Study|Lost to Follow-up|2|||
161742868|NCT00039741|584097912|FG000|Overall Study|Confounding medical condition|1|||
161742869|NCT00039741|584097913|FG001|Overall Study|Confounding medical condition|0|||
161742870|NCT00039741|584097914|FG002|Overall Study|Confounding medical condition|0|||
161742871|NCT00039741|584097915|FG003|Overall Study|Confounding medical condition|0|||
161742872|NCT00039741|584097912|FG000|Overall Study|Not able to get to clinic|5|||
161742873|NCT00039741|584097913|FG001|Overall Study|Not able to get to clinic|2|||
161742874|NCT00039741|584097914|FG002|Overall Study|Not able to get to clinic|0|||
161742875|NCT00039741|584097915|FG003|Overall Study|Not able to get to clinic|3|||
161742876|NCT00039741|584097912|FG000|Overall Study|Moved|3|||
161742877|NCT00039741|584097913|FG001|Overall Study|Moved|2|||
161742878|NCT00039741|584097914|FG002|Overall Study|Moved|3|||
161742879|NCT00039741|584097915|FG003|Overall Study|Moved|6|||
161742880|NCT00039741|584097912|FG000|Overall Study|Non-compliance with protocol|1|||
161742881|NCT00039741|584097913|FG001|Overall Study|Non-compliance with protocol|0|||
161742882|NCT00039741|584097914|FG002|Overall Study|Non-compliance with protocol|1|||
161742883|NCT00039741|584097915|FG003|Overall Study|Non-compliance with protocol|0|||
161742884|NCT00039741|584097912|FG000|Overall Study|Withdrew consent|0|||
161742885|NCT00039741|584097913|FG001|Overall Study|Withdrew consent|5|||
161742886|NCT00039741|584097914|FG002|Overall Study|Withdrew consent|0|||
161742887|NCT00039741|584097915|FG003|Overall Study|Withdrew consent|1|||
161742888|NCT00039741|584097912|FG000|Overall Study|Missed final visit|2|||
161742889|NCT00039741|584097913|FG001|Overall Study|Missed final visit|1|||
161742890|NCT00039741|584097914|FG002|Overall Study|Missed final visit|2|||
161742891|NCT00039741|584097915|FG003|Overall Study|Missed final visit|2|||
161742892|NCT00946881|584097916|FG000|First Treatment|Withdrawal by Subject|1|||
161742893|NCT00946881|584097916|FG000|First Treatment|Patient relocated to another state|1|||
161742894|NCT00946881|584097916|FG000|Retreatment|Withdrawal by Subject|1|||
161742895|NCT00293423|584097917|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
161742896|NCT00293423|584097918|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
161742897|NCT00293423|584097917|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
161742898|NCT00293423|584097918|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
161742899|NCT00293423|584097917|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
161742900|NCT00293423|584097918|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
161742901|NCT00293423|584097917|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
161742902|NCT00293423|584097918|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
161742903|NCT00293423|584097917|FG000|Surgical Resection|processing error during surgical resection|1|||
161742904|NCT00293423|584097918|FG001|Surgical Resection|processing error during surgical resection|0|||
161742905|NCT00293423|584097917|FG000|Surgical Resection|Withdrawal by Subject|4|||
161742906|NCT00293423|584097918|FG001|Surgical Resection|Withdrawal by Subject|0|||
161742907|NCT00293423|584097917|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
161742908|NCT00293423|584097918|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
161742909|NCT01182337|584097925|FG000|Overall Study|Withdrawal by Subject|3|||
161742910|NCT01182337|584097926|FG001|Overall Study|Withdrawal by Subject|1|||
161742911|NCT01182337|584097925|FG000|Overall Study|Lost to Follow-up|0|||
161841668|NCT02799095|584466189|FG010|Part C|Adverse Event|3|||
161841669|NCT02799095|584466190|FG011|Part C|Adverse Event|1|||
161841670|NCT02799095|584466191|FG012|Part C|Adverse Event|0|||
161841671|NCT02799095|584466192|FG013|Part C|Adverse Event|1|||
161841672|NCT02799095|584466193|FG014|Part C|Adverse Event|0|||
161841673|NCT02799095|584466194|FG015|Part C|Adverse Event|0|||
161841674|NCT02799095|584466195|FG016|Part C|Adverse Event|0|||
161841675|NCT02799095|584466179|FG000|Part C|Death|0|||
161841676|NCT02799095|584466180|FG001|Part C|Death|0|||
161841677|NCT02799095|584466181|FG002|Part C|Death|0|||
161742912|NCT01182337|584097926|FG001|Overall Study|Lost to Follow-up|1|||
161742913|NCT03571256|584097927|FG000|Overall Study|Adverse Event|3|||
161742914|NCT03571256|584097928|FG001|Overall Study|Adverse Event|0|||
161742915|NCT03571256|584097929|FG002|Overall Study|Adverse Event|1|||
161742916|NCT03571256|584097927|FG000|Overall Study|Withdrawal by Subject|3|||
161742917|NCT03571256|584097928|FG001|Overall Study|Withdrawal by Subject|1|||
161742918|NCT03571256|584097929|FG002|Overall Study|Withdrawal by Subject|1|||
161742919|NCT03571256|584097927|FG000|Overall Study|Other than specified|0|||
161742920|NCT03571256|584097928|FG001|Overall Study|Other than specified|1|||
161742921|NCT03571256|584097929|FG002|Overall Study|Other than specified|1|||
161742922|NCT03571256|584097927|FG000|Overall Study|Protocol Violation|0|||
161742923|NCT03571256|584097928|FG001|Overall Study|Protocol Violation|1|||
161742924|NCT03571256|584097929|FG002|Overall Study|Protocol Violation|1|||
161742925|NCT02270684|584097930|FG000|Overall Study|Lost to Follow-up|0|||
161742926|NCT02270684|584097931|FG001|Overall Study|Lost to Follow-up|3|||
161742927|NCT02270684|584097930|FG000|Overall Study|Study terminated|1|||
161742928|NCT02270684|584097931|FG001|Overall Study|Study terminated|0|||
161742929|NCT02247401|584097934|FG000|Overall Study|Adverse Event|1|||
161742930|NCT02247401|584097935|FG001|Overall Study|Adverse Event|0|||
161742931|NCT02247401|584097936|FG002|Overall Study|Adverse Event|0|||
161742932|NCT02247401|584097934|FG000|Overall Study|Withdrawal by Subject|4|||
161742933|NCT02247401|584097935|FG001|Overall Study|Withdrawal by Subject|1|||
161742934|NCT02247401|584097936|FG002|Overall Study|Withdrawal by Subject|1|||
161742935|NCT02247401|584097934|FG000|Overall Study|Lost to Follow-up|1|||
161742936|NCT02247401|584097935|FG001|Overall Study|Lost to Follow-up|1|||
161742937|NCT02247401|584097936|FG002|Overall Study|Lost to Follow-up|1|||
161742938|NCT01714817|584097937|FG000|Year 1 Period|Lack of Efficacy|11|||
161742939|NCT01714817|584097938|FG001|Year 1 Period|Lack of Efficacy|9|||
161742940|NCT01714817|584097937|FG000|Year 1 Period|Adverse Event|20|||
161742941|NCT01714817|584097938|FG001|Year 1 Period|Adverse Event|17|||
161742942|NCT01714817|584097937|FG000|Year 1 Period|Withdrawal by Subject|6|||
161742943|NCT01714817|584097938|FG001|Year 1 Period|Withdrawal by Subject|7|||
161742944|NCT01714817|584097937|FG000|Year 1 Period|Death|1|||
161742945|NCT01714817|584097938|FG001|Year 1 Period|Death|1|||
161742946|NCT01714817|584097937|FG000|Year 1 Period|Lost to Follow-up|0|||
161742947|NCT01714817|584097938|FG001|Year 1 Period|Lost to Follow-up|2|||
161742948|NCT01714817|584097937|FG000|Year 1 Period|Poor / non-compliance|0|||
161742949|NCT01714817|584097938|FG001|Year 1 Period|Poor / non-compliance|1|||
161742950|NCT01714817|584097937|FG000|Year 1 Period|Pregnancy|2|||
161742951|NCT01714817|584097938|FG001|Year 1 Period|Pregnancy|0|||
161742952|NCT01714817|584097937|FG000|Year 1 Period|Participant no longer meets criteria|6|||
161742953|NCT01714817|584097938|FG001|Year 1 Period|Participant no longer meets criteria|2|||
161742954|NCT01714817|584097937|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
161742955|NCT01714817|584097938|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
161742956|NCT01714817|584097937|FG000|Year 1 Period|Change in Concomitant Medication|0|||
161742957|NCT01714817|584097938|FG001|Year 1 Period|Change in Concomitant Medication|1|||
161742958|NCT01714817|584097937|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
161742959|NCT01714817|584097938|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
161742960|NCT01714817|584097937|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
161742961|NCT01714817|584097938|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
161742962|NCT01714817|584097937|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
161742963|NCT01714817|584097938|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
161742964|NCT01714817|584097937|FG000|Year 2 Period|Lack of Efficacy|4|||
161742965|NCT01714817|584097938|FG001|Year 2 Period|Lack of Efficacy|12|||
161742966|NCT01714817|584097937|FG000|Year 2 Period|Adverse Event|7|||
161742967|NCT01714817|584097938|FG001|Year 2 Period|Adverse Event|6|||
161742968|NCT01714817|584097937|FG000|Year 2 Period|Participant request to stop treatment|4|||
161742969|NCT01714817|584097938|FG001|Year 2 Period|Participant request to stop treatment|4|||
161742970|NCT01714817|584097937|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
161742971|NCT01714817|584097938|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
161742972|NCT01714817|584097937|FG000|Year 2 Period|Participant withdrew consent|1|||
161742973|NCT01714817|584097938|FG001|Year 2 Period|Participant withdrew consent|5|||
161742974|NCT01714817|584097937|FG000|Year 2 Period|Participant no longer meets criteria|1|||
161742975|NCT01714817|584097938|FG001|Year 2 Period|Participant no longer meets criteria|4|||
161742976|NCT01714817|584097937|FG000|Year 2 Period|Lost to Follow-up|2|||
161742977|NCT01714817|584097938|FG001|Year 2 Period|Lost to Follow-up|0|||
161841678|NCT02799095|584466182|FG003|Part C|Death|0|||
161742978|NCT01714817|584097937|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
161742979|NCT01714817|584097938|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
161742980|NCT01714817|584097937|FG000|Year 2 Period|Pregnancy|1|||
161742981|NCT01714817|584097938|FG001|Year 2 Period|Pregnancy|1|||
161742982|NCT01714817|584097937|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
161742983|NCT01714817|584097938|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
161742984|NCT01714817|584097937|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
161742985|NCT01714817|584097938|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
161742986|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
161742987|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
161742988|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
161742989|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
161742990|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
161742991|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
161742992|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
161742993|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
161742994|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
161742995|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
161742996|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
161742997|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
161742998|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161742999|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
161743000|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
161743001|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
161743002|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
161743003|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
161743004|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
161743005|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
161743006|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
161743007|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
161743008|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
161743009|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
161743010|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
161743011|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
161743012|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
161743013|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
161743014|NCT01374217|584097939|FG000|Overall Study|Lack of Efficacy|13|||
161743015|NCT04169061|584097940|FG000|Overall Study|Adverse Event|2|||
161743016|NCT04169061|584097940|FG000|Overall Study|Death|1|||
161743017|NCT04169061|584097940|FG000|Overall Study|Withdrawal by Subject|1|||
161743018|NCT04169061|584097940|FG000|Overall Study|Protocol Violation|1|||
161743019|NCT02555657|584097943|FG000|Overall Study|Death|274|||
161743020|NCT02555657|584097944|FG001|Overall Study|Death|262|||
161743021|NCT02555657|584097943|FG000|Overall Study|Physician Decision|0|||
161841679|NCT02799095|584466183|FG004|Part C|Death|0|||
161743022|NCT02555657|584097944|FG001|Overall Study|Physician Decision|1|||
161743023|NCT02555657|584097943|FG000|Overall Study|Sponsor Decision|27|||
161841680|NCT02799095|584466184|FG005|Part C|Death|0|||
161841681|NCT02799095|584466185|FG006|Part C|Death|0|||
161841682|NCT02799095|584466186|FG007|Part C|Death|0|||
161841683|NCT02799095|584466187|FG008|Part C|Death|0|||
161841684|NCT02799095|584466188|FG009|Part C|Death|0|||
161841685|NCT02799095|584466189|FG010|Part C|Death|7|||
161841686|NCT02799095|584466190|FG011|Part C|Death|5|||
161841687|NCT02799095|584466191|FG012|Part C|Death|6|||
161841688|NCT02799095|584466192|FG013|Part C|Death|8|||
161841689|NCT02799095|584466193|FG014|Part C|Death|1|||
161841690|NCT02799095|584466194|FG015|Part C|Death|8|||
161841691|NCT02799095|584466195|FG016|Part C|Death|1|||
161841692|NCT02799095|584466179|FG000|Part C|Lost to Follow-up|0|||
161841693|NCT02799095|584466180|FG001|Part C|Lost to Follow-up|0|||
161841694|NCT02799095|584466181|FG002|Part C|Lost to Follow-up|0|||
161841695|NCT02799095|584466182|FG003|Part C|Lost to Follow-up|0|||
161841696|NCT02799095|584466183|FG004|Part C|Lost to Follow-up|0|||
161841697|NCT02799095|584466184|FG005|Part C|Lost to Follow-up|0|||
161841698|NCT02799095|584466185|FG006|Part C|Lost to Follow-up|0|||
161841699|NCT02799095|584466186|FG007|Part C|Lost to Follow-up|0|||
161841700|NCT02799095|584466187|FG008|Part C|Lost to Follow-up|0|||
161841701|NCT02799095|584466188|FG009|Part C|Lost to Follow-up|0|||
161841702|NCT02799095|584466189|FG010|Part C|Lost to Follow-up|1|||
161841703|NCT02799095|584466190|FG011|Part C|Lost to Follow-up|1|||
161841704|NCT02799095|584466191|FG012|Part C|Lost to Follow-up|1|||
161841705|NCT02799095|584466192|FG013|Part C|Lost to Follow-up|3|||
161841706|NCT02799095|584466193|FG014|Part C|Lost to Follow-up|0|||
161841707|NCT02799095|584466194|FG015|Part C|Lost to Follow-up|0|||
161841708|NCT02799095|584466195|FG016|Part C|Lost to Follow-up|0|||
161841709|NCT02799095|584466179|FG000|Part C|Progressive Disease|0|||
161841710|NCT02799095|584466180|FG001|Part C|Progressive Disease|0|||
161841711|NCT02799095|584466181|FG002|Part C|Progressive Disease|0|||
161841712|NCT02799095|584466182|FG003|Part C|Progressive Disease|0|||
161841713|NCT02799095|584466183|FG004|Part C|Progressive Disease|0|||
161841714|NCT02799095|584466184|FG005|Part C|Progressive Disease|0|||
161841715|NCT02799095|584466185|FG006|Part C|Progressive Disease|0|||
161841716|NCT02799095|584466186|FG007|Part C|Progressive Disease|0|||
161841717|NCT02799095|584466187|FG008|Part C|Progressive Disease|0|||
161841718|NCT02799095|584466188|FG009|Part C|Progressive Disease|2|||
161841719|NCT02799095|584466189|FG010|Part C|Progressive Disease|13|||
161841720|NCT02799095|584466190|FG011|Part C|Progressive Disease|2|||
161841721|NCT02799095|584466191|FG012|Part C|Progressive Disease|0|||
161841722|NCT02799095|584466192|FG013|Part C|Progressive Disease|1|||
161841723|NCT02799095|584466193|FG014|Part C|Progressive Disease|0|||
161841724|NCT02799095|584466194|FG015|Part C|Progressive Disease|0|||
161841725|NCT02799095|584466195|FG016|Part C|Progressive Disease|0|||
161841726|NCT02799095|584466179|FG000|Part C|Clinical Progression|0|||
161841727|NCT02799095|584466180|FG001|Part C|Clinical Progression|0|||
161841728|NCT02799095|584466181|FG002|Part C|Clinical Progression|0|||
161841729|NCT02799095|584466182|FG003|Part C|Clinical Progression|0|||
161841730|NCT02799095|584466183|FG004|Part C|Clinical Progression|0|||
161841731|NCT02799095|584466184|FG005|Part C|Clinical Progression|0|||
161841732|NCT02799095|584466185|FG006|Part C|Clinical Progression|0|||
161841733|NCT02799095|584466186|FG007|Part C|Clinical Progression|0|||
161841734|NCT02799095|584466187|FG008|Part C|Clinical Progression|0|||
161841735|NCT02799095|584466188|FG009|Part C|Clinical Progression|1|||
161841736|NCT02799095|584466189|FG010|Part C|Clinical Progression|3|||
161841737|NCT02799095|584466190|FG011|Part C|Clinical Progression|0|||
161841738|NCT02799095|584466191|FG012|Part C|Clinical Progression|0|||
161841739|NCT02799095|584466192|FG013|Part C|Clinical Progression|1|||
161841740|NCT02799095|584466193|FG014|Part C|Clinical Progression|0|||
161841741|NCT02799095|584466194|FG015|Part C|Clinical Progression|0|||
161841742|NCT02799095|584466195|FG016|Part C|Clinical Progression|0|||
161841743|NCT02799095|584466179|FG000|Part C|Withdrawal by Subject|0|||
161841744|NCT02799095|584466180|FG001|Part C|Withdrawal by Subject|0|||
161841745|NCT02799095|584466181|FG002|Part C|Withdrawal by Subject|0|||
161841746|NCT02799095|584466182|FG003|Part C|Withdrawal by Subject|0|||
161841747|NCT02799095|584466183|FG004|Part C|Withdrawal by Subject|0|||
161841748|NCT02799095|584466184|FG005|Part C|Withdrawal by Subject|0|||
161841749|NCT02799095|584466185|FG006|Part C|Withdrawal by Subject|0|||
161841750|NCT02799095|584466186|FG007|Part C|Withdrawal by Subject|0|||
161841751|NCT02799095|584466187|FG008|Part C|Withdrawal by Subject|0|||
161841752|NCT02799095|584466188|FG009|Part C|Withdrawal by Subject|0|||
161841753|NCT02799095|584466189|FG010|Part C|Withdrawal by Subject|13|||
161743024|NCT02555657|584097944|FG001|Overall Study|Sponsor Decision|15|||
161743025|NCT02555657|584097943|FG000|Overall Study|Withdrawal by Subject|11|||
161743026|NCT02555657|584097944|FG001|Overall Study|Withdrawal by Subject|32|||
161743027|NCT02807363|584097945|FG000|Dosing Period|Adverse Event|0|||
161743028|NCT02807363|584097946|FG001|Dosing Period|Adverse Event|1|||
161743029|NCT02807363|584097947|FG002|Dosing Period|Adverse Event|0|||
161743030|NCT02807363|584097948|FG003|Dosing Period|Adverse Event|0|||
161743031|NCT02188719|584097949|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161743032|NCT02188719|584097950|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
161743033|NCT02188719|584097951|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161743034|NCT02188719|584097952|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161743035|NCT00192036|584097956|FG000|Overall Study|Protocol Violation|3|||
161743036|NCT00192036|584097956|FG000|Overall Study|Adverse Event|6|||
161743037|NCT00192036|584097956|FG000|Overall Study|Patient/Physician Perception|1|||
161743038|NCT00192036|584097956|FG000|Overall Study|Objective Tumor Progression|4|||
161743039|NCT00192036|584097956|FG000|Overall Study|Clinical Disease Progression|1|||
161743040|NCT00192036|584097956|FG000|Overall Study|Death|1|||
161743041|NCT00192036|584097956|FG000|Overall Study|Unknown or Not Specified|5|||
161743042|NCT03371732|584097957|FG000|Overall Study|Withdrawal by Subject|9|||
161743043|NCT03371732|584097958|FG001|Overall Study|Withdrawal by Subject|3|||
161743044|NCT03371732|584097957|FG000|Overall Study|Refusal to continue|3|||
161743045|NCT03371732|584097958|FG001|Overall Study|Refusal to continue|4|||
161743046|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
161743047|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
161743048|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
161743049|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
161743050|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
161743051|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
161743052|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
161743053|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
161743054|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
161743055|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
161743056|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
161743057|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
161743058|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161743059|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
161743060|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161743061|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161743062|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
161743063|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
161743064|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
161743065|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
161743066|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
161743067|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
161743068|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
161743069|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
161743070|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
161743071|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
161743072|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
161743073|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
161743074|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
161743075|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
161743076|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
161743077|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
161743078|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161743079|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161743080|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161743081|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
161743082|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
161743083|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
161743084|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
161743085|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
161743086|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Death|0|||
161743087|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Death|0|||
161841754|NCT02799095|584466190|FG011|Part C|Withdrawal by Subject|15|||
161841755|NCT02799095|584466191|FG012|Part C|Withdrawal by Subject|13|||
161841756|NCT02799095|584466192|FG013|Part C|Withdrawal by Subject|21|||
161841757|NCT02799095|584466193|FG014|Part C|Withdrawal by Subject|0|||
161841758|NCT02799095|584466194|FG015|Part C|Withdrawal by Subject|12|||
161841759|NCT02799095|584466195|FG016|Part C|Withdrawal by Subject|1|||
161841760|NCT02799095|584466179|FG000|Part C|Physician Decision|0|||
161841761|NCT02799095|584466180|FG001|Part C|Physician Decision|0|||
161841762|NCT02799095|584466181|FG002|Part C|Physician Decision|0|||
161841763|NCT02799095|584466182|FG003|Part C|Physician Decision|0|||
161841764|NCT02799095|584466183|FG004|Part C|Physician Decision|0|||
161841765|NCT02799095|584466184|FG005|Part C|Physician Decision|0|||
161841766|NCT02799095|584466185|FG006|Part C|Physician Decision|0|||
161841767|NCT02799095|584466186|FG007|Part C|Physician Decision|0|||
161841768|NCT02799095|584466187|FG008|Part C|Physician Decision|0|||
161841769|NCT02799095|584466188|FG009|Part C|Physician Decision|0|||
161841770|NCT02799095|584466189|FG010|Part C|Physician Decision|1|||
161841771|NCT02799095|584466190|FG011|Part C|Physician Decision|0|||
161841772|NCT02799095|584466191|FG012|Part C|Physician Decision|0|||
161743088|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Death|0|||
161743089|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Death|7|||
161743090|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161743091|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161743092|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161743093|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
161743094|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161743095|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161743096|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161743097|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
161743098|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161743099|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161743100|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161743101|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
161743102|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
161743103|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
161743104|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
161743105|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
161743106|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
161743107|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
161743108|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
161743109|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
161743110|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
161743111|NCT03479216|584097979|FG000|Overall Study|Withdrawal by Subject|3|||
161743112|NCT03479216|584097980|FG001|Overall Study|Withdrawal by Subject|2|||
161743113|NCT03479216|584097979|FG000|Overall Study|Physician Decision|2|||
161743114|NCT03479216|584097980|FG001|Overall Study|Physician Decision|3|||
161743115|NCT02031432|584097983|FG000|Overall Study|Protocol Violation|1|||
161743116|NCT02031432|584097983|FG000|Overall Study|Lack of Efficacy|5|||
161743117|NCT02031432|584097983|FG000|Overall Study|Cancer Progression|2|||
161743118|NCT02031432|584097983|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
161743119|NCT02031432|584097983|FG000|Overall Study|Adverse Event|8|||
161743120|NCT02031432|584097983|FG000|Overall Study|Withdrawal by Subject|5|||
161743121|NCT02031432|584097983|FG000|Overall Study|Lost to Follow-up|1|||
161743122|NCT02031432|584097983|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
161743123|NCT02031432|584097983|FG000|Overall Study|Death|10|||
161743124|NCT02148211|584097984|FG000|Overall Study|Lost to Follow-up|352|||
161743125|NCT01617187|584097986|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161743126|NCT01617187|584097987|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161743127|NCT01617187|584097988|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161743128|NCT01617187|584097989|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
161743129|NCT01617187|584097986|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161743130|NCT01617187|584097987|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161841773|NCT02799095|584466192|FG013|Part C|Physician Decision|0|||
161841774|NCT02799095|584466193|FG014|Part C|Physician Decision|0|||
161841775|NCT02799095|584466194|FG015|Part C|Physician Decision|0|||
161841776|NCT02799095|584466195|FG016|Part C|Physician Decision|0|||
161841777|NCT02799095|584466179|FG000|Part C|Other|0|||
161841778|NCT02799095|584466180|FG001|Part C|Other|0|||
161841779|NCT02799095|584466181|FG002|Part C|Other|0|||
161841780|NCT02799095|584466182|FG003|Part C|Other|0|||
161841781|NCT02799095|584466183|FG004|Part C|Other|0|||
161841782|NCT02799095|584466184|FG005|Part C|Other|0|||
161841783|NCT02799095|584466185|FG006|Part C|Other|0|||
161841784|NCT02799095|584466186|FG007|Part C|Other|0|||
161841785|NCT02799095|584466187|FG008|Part C|Other|0|||
161841786|NCT02799095|584466188|FG009|Part C|Other|0|||
161841787|NCT02799095|584466189|FG010|Part C|Other|0|||
161841788|NCT02799095|584466190|FG011|Part C|Other|2|||
161841789|NCT02799095|584466191|FG012|Part C|Other|2|||
161841790|NCT02799095|584466192|FG013|Part C|Other|0|||
161841791|NCT02799095|584466193|FG014|Part C|Other|0|||
161841792|NCT02799095|584466194|FG015|Part C|Other|0|||
161841793|NCT02799095|584466195|FG016|Part C|Other|0|||
161841794|NCT05327816|584466197|FG000|Overall Study|Lost to Follow-up|1|||
161841795|NCT05327816|584466198|FG001|Overall Study|Lost to Follow-up|0|||
161841796|NCT05327816|584466199|FG002|Overall Study|Lost to Follow-up|0|||
161841797|NCT05327816|584466200|FG003|Overall Study|Lost to Follow-up|0|||
161841798|NCT05327816|584466201|FG004|Overall Study|Lost to Follow-up|0|||
161841799|NCT05327816|584466202|FG005|Overall Study|Lost to Follow-up|0|||
161841800|NCT05327816|584466203|FG006|Overall Study|Lost to Follow-up|0|||
161841801|NCT05327816|584466204|FG007|Overall Study|Lost to Follow-up|0|||
161841802|NCT05327816|584466205|FG008|Overall Study|Lost to Follow-up|0|||
161841803|NCT05327816|584466206|FG009|Overall Study|Lost to Follow-up|1|||
161841804|NCT05327816|584466207|FG010|Overall Study|Lost to Follow-up|0|||
161841805|NCT05327816|584466197|FG000|Overall Study|Withdrawal by Subject|0|||
161841806|NCT05327816|584466198|FG001|Overall Study|Withdrawal by Subject|0|||
161841807|NCT05327816|584466199|FG002|Overall Study|Withdrawal by Subject|0|||
161841808|NCT05327816|584466200|FG003|Overall Study|Withdrawal by Subject|0|||
161841809|NCT05327816|584466201|FG004|Overall Study|Withdrawal by Subject|1|||
161841810|NCT05327816|584466202|FG005|Overall Study|Withdrawal by Subject|1|||
161841811|NCT05327816|584466203|FG006|Overall Study|Withdrawal by Subject|0|||
161841812|NCT05327816|584466204|FG007|Overall Study|Withdrawal by Subject|0|||
161841813|NCT05327816|584466205|FG008|Overall Study|Withdrawal by Subject|0|||
161841814|NCT05327816|584466206|FG009|Overall Study|Withdrawal by Subject|0|||
161841815|NCT05327816|584466207|FG010|Overall Study|Withdrawal by Subject|0|||
161841816|NCT05327816|584466197|FG000|Overall Study|Study Terminated by Sponsor|11|||
161841817|NCT05327816|584466198|FG001|Overall Study|Study Terminated by Sponsor|12|||
161841818|NCT05327816|584466199|FG002|Overall Study|Study Terminated by Sponsor|12|||
161841819|NCT05327816|584466200|FG003|Overall Study|Study Terminated by Sponsor|12|||
161841820|NCT05327816|584466201|FG004|Overall Study|Study Terminated by Sponsor|11|||
161841821|NCT05327816|584466202|FG005|Overall Study|Study Terminated by Sponsor|11|||
161841822|NCT05327816|584466203|FG006|Overall Study|Study Terminated by Sponsor|11|||
161841823|NCT05327816|584466204|FG007|Overall Study|Study Terminated by Sponsor|11|||
161841824|NCT05327816|584466205|FG008|Overall Study|Study Terminated by Sponsor|11|||
161841825|NCT05327816|584466206|FG009|Overall Study|Study Terminated by Sponsor|11|||
161841826|NCT05327816|584466207|FG010|Overall Study|Study Terminated by Sponsor|12|||
161841827|NCT05327816|584466197|FG000|Overall Study|Randomized but not treated|0|||
161841828|NCT05327816|584466198|FG001|Overall Study|Randomized but not treated|0|||
161841829|NCT05327816|584466199|FG002|Overall Study|Randomized but not treated|0|||
161841830|NCT05327816|584466200|FG003|Overall Study|Randomized but not treated|0|||
161841831|NCT05327816|584466201|FG004|Overall Study|Randomized but not treated|0|||
161841832|NCT05327816|584466202|FG005|Overall Study|Randomized but not treated|0|||
161841833|NCT05327816|584466203|FG006|Overall Study|Randomized but not treated|1|||
161841834|NCT05327816|584466204|FG007|Overall Study|Randomized but not treated|1|||
161841835|NCT05327816|584466205|FG008|Overall Study|Randomized but not treated|1|||
161841836|NCT05327816|584466206|FG009|Overall Study|Randomized but not treated|0|||
161841837|NCT05327816|584466207|FG010|Overall Study|Randomized but not treated|0|||
161841838|NCT00759902|584466208|FG000|Overall Study|Adverse Event|0|||
161841839|NCT00759902|584466209|FG001|Overall Study|Adverse Event|1|||
161841840|NCT00658658|584466214|FG000|Overall Study|Withdrawal by Subject|0|||
161841841|NCT00658658|584466215|FG001|Overall Study|Withdrawal by Subject|1|||
161841842|NCT00658658|584466216|FG002|Overall Study|Withdrawal by Subject|0|||
161841843|NCT00658658|584466217|FG003|Overall Study|Withdrawal by Subject|0|||
161841844|NCT00658658|584466218|FG004|Overall Study|Withdrawal by Subject|0|||
161841845|NCT00658658|584466214|FG000|Overall Study|Death|4|||
161841846|NCT00658658|584466215|FG001|Overall Study|Death|0|||
161841847|NCT00658658|584466216|FG002|Overall Study|Death|0|||
161841848|NCT00658658|584466217|FG003|Overall Study|Death|1|||
161841849|NCT00658658|584466218|FG004|Overall Study|Death|1|||
161841850|NCT00658658|584466214|FG000|Overall Study|Disease Progression|0|||
161841851|NCT00658658|584466215|FG001|Overall Study|Disease Progression|1|||
161841852|NCT00658658|584466216|FG002|Overall Study|Disease Progression|0|||
161743131|NCT01617187|584097988|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161743132|NCT01617187|584097989|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
161743133|NCT01617187|584097986|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
161743134|NCT01617187|584097987|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161743135|NCT01617187|584097988|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161743136|NCT01617187|584097989|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161743137|NCT01617187|584097986|FG000|Treatment Through Study Completion|Adverse Event|1|||
161743138|NCT01617187|584097987|FG001|Treatment Through Study Completion|Adverse Event|1|||
161743139|NCT01617187|584097988|FG002|Treatment Through Study Completion|Adverse Event|0|||
161743140|NCT01617187|584097989|FG003|Treatment Through Study Completion|Adverse Event|1|||
161743141|NCT01617187|584097986|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
161743142|NCT01617187|584097987|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
161743143|NCT01617187|584097988|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
161743144|NCT01617187|584097989|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
161743145|NCT01617187|584097986|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
161743146|NCT01617187|584097987|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
161743147|NCT01617187|584097988|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
161743148|NCT01617187|584097989|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
161743149|NCT01617187|584097986|FG000|Treatment Through Study Completion|Protocol Violation|1|||
161743150|NCT01617187|584097987|FG001|Treatment Through Study Completion|Protocol Violation|0|||
161743151|NCT01617187|584097988|FG002|Treatment Through Study Completion|Protocol Violation|0|||
161743152|NCT01617187|584097989|FG003|Treatment Through Study Completion|Protocol Violation|1|||
161743153|NCT01265420|584097990|FG000|Overall Study|Lost to Follow-up|1|||
161743154|NCT03337139|584097994|FG000|Phase I|Withdrawal by Subject|10|||
161743155|NCT03337139|584097995|FG001|Phase I|Withdrawal by Subject|0|||
161743156|NCT01561560|584098000|FG000|First Two Weeks of Wear|Time/job conflict|0|||
161743157|NCT01561560|584098001|FG001|First Two Weeks of Wear|Time/job conflict|1|||
161743158|NCT01561560|584098000|FG000|First Two Weeks of Wear|Adverse Event|0|||
161743159|NCT01561560|584098001|FG001|First Two Weeks of Wear|Adverse Event|1|||
161743160|NCT01561560|584098000|FG000|Second Two Weeks of Wear|Adverse Event|0|||
161743161|NCT01561560|584098001|FG001|Second Two Weeks of Wear|Adverse Event|1|||
161743162|NCT03862131|584098002|FG000|Overall Study|Lost to Follow-up|1|||
161743163|NCT03862131|584098003|FG001|Overall Study|Lost to Follow-up|0|||
161743164|NCT03862131|584098004|FG002|Overall Study|Lost to Follow-up|1|||
161743165|NCT03862131|584098002|FG000|Overall Study|Determined to be ineligible|0|||
161743166|NCT03862131|584098003|FG001|Overall Study|Determined to be ineligible|0|||
161743167|NCT03862131|584098004|FG002|Overall Study|Determined to be ineligible|5|||
161743168|NCT03862131|584098002|FG000|Overall Study|Death|4|||
161743169|NCT03862131|584098003|FG001|Overall Study|Death|4|||
161743170|NCT03862131|584098004|FG002|Overall Study|Death|0|||
161743171|NCT03862131|584098002|FG000|Overall Study|Withdrawal by Subject|5|||
161743172|NCT03862131|584098003|FG001|Overall Study|Withdrawal by Subject|3|||
161743173|NCT03862131|584098004|FG002|Overall Study|Withdrawal by Subject|0|||
161743174|NCT03862131|584098002|FG000|Overall Study|Physician Decision|0|||
161743175|NCT03862131|584098003|FG001|Overall Study|Physician Decision|1|||
161743176|NCT03862131|584098004|FG002|Overall Study|Physician Decision|0|||
161743177|NCT01871896|584098007|FG000|Overall Study|Lost to Follow-up|1|||
161743178|NCT05406440|584099688|FG000|Overall Study|Lost to Follow-up|0|||
161743179|NCT05406440|584099689|FG001|Overall Study|Lost to Follow-up|0|||
161743180|NCT05406440|584099690|FG002|Overall Study|Lost to Follow-up|0|||
161743181|NCT05406440|584099691|FG003|Overall Study|Lost to Follow-up|0|||
161743182|NCT05406440|584099692|FG004|Overall Study|Lost to Follow-up|2|||
161743183|NCT05406440|584099693|FG005|Overall Study|Lost to Follow-up|0|||
161743184|NCT05406440|584099694|FG006|Overall Study|Lost to Follow-up|0|||
161743185|NCT05406440|584099688|FG000|Overall Study|Physician Decision|0|||
161743186|NCT05406440|584099689|FG001|Overall Study|Physician Decision|0|||
161743187|NCT05406440|584099690|FG002|Overall Study|Physician Decision|0|||
161743188|NCT05406440|584099691|FG003|Overall Study|Physician Decision|0|||
161743189|NCT05406440|584099692|FG004|Overall Study|Physician Decision|1|||
161743190|NCT05406440|584099693|FG005|Overall Study|Physician Decision|0|||
161743191|NCT05406440|584099694|FG006|Overall Study|Physician Decision|0|||
161743192|NCT05406440|584099688|FG000|Overall Study|Withdrawal by Subject|0|||
161743193|NCT05406440|584099689|FG001|Overall Study|Withdrawal by Subject|0|||
161743194|NCT05406440|584099690|FG002|Overall Study|Withdrawal by Subject|0|||
161743195|NCT05406440|584099691|FG003|Overall Study|Withdrawal by Subject|0|||
161841853|NCT00658658|584466217|FG003|Overall Study|Disease Progression|1|||
161841854|NCT00658658|584466218|FG004|Overall Study|Disease Progression|3|||
161841855|NCT00658658|584466214|FG000|Overall Study|Protocol-specified Criteria|1|||
161841856|NCT00658658|584466215|FG001|Overall Study|Protocol-specified Criteria|0|||
161841857|NCT00658658|584466216|FG002|Overall Study|Protocol-specified Criteria|0|||
161841858|NCT00658658|584466217|FG003|Overall Study|Protocol-specified Criteria|0|||
161841859|NCT00658658|584466218|FG004|Overall Study|Protocol-specified Criteria|0|||
161841860|NCT00658658|584466214|FG000|Overall Study|Other|0|||
161841861|NCT00658658|584466215|FG001|Overall Study|Other|0|||
161841862|NCT00658658|584466216|FG002|Overall Study|Other|0|||
161841863|NCT00658658|584466217|FG003|Overall Study|Other|0|||
161841864|NCT00658658|584466218|FG004|Overall Study|Other|1|||
161841865|NCT01167257|584466219|FG000|Overall Study|Lost to Follow-up|2|||
161841866|NCT01167257|584466220|FG001|Overall Study|Lost to Follow-up|2|||
161841867|NCT01167257|584466219|FG000|Overall Study|Withdrew consent|1|||
161841868|NCT01167257|584466220|FG001|Overall Study|Withdrew consent|1|||
161841869|NCT01523457|584466221|FG000|Overall Study|Withdrawal by Subject|7|||
161841870|NCT01523457|584466222|FG001|Overall Study|Withdrawal by Subject|2|||
161841871|NCT01367665|584466223|FG000|Overall Study|Death|102|||
161743196|NCT05406440|584099692|FG004|Overall Study|Withdrawal by Subject|0|||
161743197|NCT05406440|584099693|FG005|Overall Study|Withdrawal by Subject|2|||
161743198|NCT05406440|584099694|FG006|Overall Study|Withdrawal by Subject|0|||
161743199|NCT01412151|584099695|FG000|Week 0 - 306 - Treatment Period|Death|1|||
161743200|NCT01412151|584099695|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
161743201|NCT01412151|584099695|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
161743202|NCT01412151|584099695|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
161743203|NCT03127852|584099696|FG000|Overall Study|Withdrawal by Subject|4|||
161743204|NCT03127852|584099697|FG001|Overall Study|Withdrawal by Subject|1|||
161743205|NCT03127852|584099696|FG000|Overall Study|Death|1|||
161743206|NCT03127852|584099697|FG001|Overall Study|Death|1|||
161743207|NCT03621189|584099698|FG000|Overall Study|Withdrawal by Subject|0|||
161743208|NCT03621189|584099699|FG001|Overall Study|Withdrawal by Subject|3|||
161743209|NCT03621189|584099698|FG000|Overall Study|Physician Decision|0|||
161743210|NCT03621189|584099699|FG001|Overall Study|Physician Decision|2|||
161743211|NCT01824693|584099700|FG000|Overall Study|Death|0|||
161743212|NCT01824693|584099701|FG001|Overall Study|Death|1|||
161743213|NCT01824693|584099702|FG002|Overall Study|Death|0|||
161743214|NCT01824693|584099700|FG000|Overall Study|Physician Decision|1|||
161743215|NCT01824693|584099701|FG001|Overall Study|Physician Decision|1|||
161743216|NCT01824693|584099702|FG002|Overall Study|Physician Decision|1|||
161743217|NCT01824693|584099700|FG000|Overall Study|Withdrawal by Subject|0|||
161743218|NCT01824693|584099701|FG001|Overall Study|Withdrawal by Subject|0|||
161743219|NCT01824693|584099702|FG002|Overall Study|Withdrawal by Subject|1|||
161743220|NCT01824693|584099700|FG000|Overall Study|Progressive Disease|0|||
161743221|NCT01824693|584099701|FG001|Overall Study|Progressive Disease|5|||
161743222|NCT01824693|584099702|FG002|Overall Study|Progressive Disease|0|||
161743223|NCT01824693|584099700|FG000|Overall Study|Ineligible|0|||
161743224|NCT01824693|584099701|FG001|Overall Study|Ineligible|0|||
161743225|NCT01824693|584099702|FG002|Overall Study|Ineligible|3|||
161743226|NCT01824693|584099700|FG000|Overall Study|No Transplant Planned|0|||
161743227|NCT01824693|584099701|FG001|Overall Study|No Transplant Planned|0|||
161743228|NCT01824693|584099702|FG002|Overall Study|No Transplant Planned|10|||
161743229|NCT02150213|584099703|FG000|Overall Study|Lost to Follow-up|1|||
161743230|NCT02150213|584099703|FG000|Overall Study|Withdrawal by Subject|1|||
161743231|NCT03488238|584099704|FG000|Overall Study|Equipment malfunction|1|||
161841872|NCT01367665|584466224|FG001|Overall Study|Death|19|||
161743232|NCT03488238|584099704|FG000|Overall Study|Adverse Event|1|||
161743233|NCT01432457|584099705|FG000|Overall Study|Adverse Event|7|||
161743234|NCT01432457|584099706|FG001|Overall Study|Adverse Event|10|||
161743235|NCT01432457|584099707|FG002|Overall Study|Adverse Event|16|||
161743236|NCT01432457|584099705|FG000|Overall Study|Lack of Efficacy|2|||
161841873|NCT01367665|584466223|FG000|Overall Study|Lost to Follow-up|222|||
161841874|NCT01367665|584466224|FG001|Overall Study|Lost to Follow-up|22|||
161841875|NCT01367665|584466223|FG000|Overall Study|Not Done|118|||
161841876|NCT01367665|584466224|FG001|Overall Study|Not Done|14|||
161841877|NCT03283319|584466225|FG000|Overall Study|Lost to Follow-up|5|||
161743237|NCT01432457|584099706|FG001|Overall Study|Lack of Efficacy|1|||
161743238|NCT01432457|584099707|FG002|Overall Study|Lack of Efficacy|1|||
161743239|NCT01432457|584099705|FG000|Overall Study|Lost to Follow-up|11|||
161743240|NCT01432457|584099706|FG001|Overall Study|Lost to Follow-up|15|||
161743241|NCT01432457|584099707|FG002|Overall Study|Lost to Follow-up|20|||
161743242|NCT01432457|584099705|FG000|Overall Study|Protocol Violation|3|||
161743243|NCT01432457|584099706|FG001|Overall Study|Protocol Violation|2|||
161743244|NCT01432457|584099707|FG002|Overall Study|Protocol Violation|6|||
161743245|NCT01432457|584099705|FG000|Overall Study|Withdrawal by Subject|6|||
161743246|NCT01432457|584099706|FG001|Overall Study|Withdrawal by Subject|11|||
161743247|NCT01432457|584099707|FG002|Overall Study|Withdrawal by Subject|9|||
161743248|NCT01432457|584099705|FG000|Overall Study|Reasons not defined|2|||
161743249|NCT01432457|584099706|FG001|Overall Study|Reasons not defined|3|||
161743250|NCT01432457|584099707|FG002|Overall Study|Reasons not defined|4|||
161743251|NCT01432457|584099705|FG000|Overall Study|Did not take study drug|6|||
161743252|NCT01432457|584099706|FG001|Overall Study|Did not take study drug|6|||
161841878|NCT03283319|584466226|FG001|Overall Study|Lost to Follow-up|4|||
161841879|NCT03283319|584466227|FG002|Overall Study|Lost to Follow-up|5|||
161841880|NCT03283319|584466228|FG003|Overall Study|Lost to Follow-up|5|||
161841881|NCT03283319|584466229|FG004|Overall Study|Lost to Follow-up|4|||
161841882|NCT03283319|584466230|FG005|Overall Study|Lost to Follow-up|3|||
161841883|NCT03283319|584466225|FG000|Overall Study|Withdrawal by Subject|2|||
161841884|NCT03283319|584466226|FG001|Overall Study|Withdrawal by Subject|2|||
161841885|NCT03283319|584466227|FG002|Overall Study|Withdrawal by Subject|2|||
161841886|NCT03283319|584466228|FG003|Overall Study|Withdrawal by Subject|1|||
161841887|NCT03283319|584466229|FG004|Overall Study|Withdrawal by Subject|0|||
161841888|NCT03283319|584466230|FG005|Overall Study|Withdrawal by Subject|1|||
161841889|NCT03283319|584466225|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841890|NCT03283319|584466226|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841891|NCT03283319|584466227|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841892|NCT03283319|584466228|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
161841893|NCT03283319|584466229|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841894|NCT03283319|584466230|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841895|NCT03954834|584466233|FG000|Overall Study|Adverse Event|1|||
161841896|NCT03954834|584466234|FG001|Overall Study|Adverse Event|3|||
161841897|NCT03954834|584466235|FG002|Overall Study|Adverse Event|1|||
161841898|NCT03954834|584466236|FG003|Overall Study|Adverse Event|1|||
161841899|NCT03954834|584466233|FG000|Overall Study|Death|0|||
161841900|NCT03954834|584466234|FG001|Overall Study|Death|0|||
161841901|NCT03954834|584466235|FG002|Overall Study|Death|0|||
161841902|NCT03954834|584466236|FG003|Overall Study|Death|1|||
161841903|NCT03954834|584466233|FG000|Overall Study|Physician Decision|0|||
161841904|NCT03954834|584466234|FG001|Overall Study|Physician Decision|1|||
161841905|NCT03954834|584466235|FG002|Overall Study|Physician Decision|0|||
161841906|NCT03954834|584466236|FG003|Overall Study|Physician Decision|2|||
161841907|NCT03954834|584466233|FG000|Overall Study|Protocol Violation|1|||
161841908|NCT03954834|584466234|FG001|Overall Study|Protocol Violation|0|||
161841909|NCT03954834|584466235|FG002|Overall Study|Protocol Violation|0|||
161841910|NCT03954834|584466236|FG003|Overall Study|Protocol Violation|1|||
161841911|NCT03954834|584466233|FG000|Overall Study|Withdrawal by Subject|2|||
161841912|NCT03954834|584466234|FG001|Overall Study|Withdrawal by Subject|3|||
161841913|NCT03954834|584466235|FG002|Overall Study|Withdrawal by Subject|13|||
161841914|NCT03954834|584466236|FG003|Overall Study|Withdrawal by Subject|6|||
161841915|NCT03954834|584466233|FG000|Overall Study|Participant left the country|0|||
161841916|NCT03954834|584466234|FG001|Overall Study|Participant left the country|0|||
161841917|NCT03954834|584466235|FG002|Overall Study|Participant left the country|1|||
161841918|NCT03954834|584466236|FG003|Overall Study|Participant left the country|0|||
161841919|NCT03954834|584466233|FG000|Overall Study|Lost to Follow-up|3|||
161841920|NCT03954834|584466234|FG001|Overall Study|Lost to Follow-up|2|||
161841921|NCT03954834|584466235|FG002|Overall Study|Lost to Follow-up|3|||
161841922|NCT03954834|584466236|FG003|Overall Study|Lost to Follow-up|5|||
161841923|NCT00540293|584466242|FG000|Overall Study|Adverse event related to study drug|10|||
161841924|NCT00540293|584466242|FG000|Overall Study|Adverse event not related to study drug|7|||
161841925|NCT00540293|584466242|FG000|Overall Study|Withdrawal by Subject|6|||
161841926|NCT00540293|584466242|FG000|Overall Study|Protocol violation, & subject schedule|12|||
161841927|NCT04492020|584466245|FG000|Overall Study|Adverse Event|1|||
161841928|NCT04492020|584466246|FG001|Overall Study|Adverse Event|3|||
161841929|NCT04492020|584466245|FG000|Overall Study|Withdrawal by Subject|4|||
161841930|NCT04492020|584466246|FG001|Overall Study|Withdrawal by Subject|3|||
161841931|NCT04492020|584466245|FG000|Overall Study|Lost to Follow-up|4|||
161841932|NCT04492020|584466246|FG001|Overall Study|Lost to Follow-up|3|||
161841933|NCT04492020|584466245|FG000|Overall Study|Protocol Violation|5|||
161841934|NCT04492020|584466246|FG001|Overall Study|Protocol Violation|2|||
161841935|NCT04492020|584466245|FG000|Overall Study|Lack of Qualifying Event|25|||
161841936|NCT04492020|584466246|FG001|Overall Study|Lack of Qualifying Event|27|||
161841937|NCT04492020|584466245|FG000|Overall Study|Non-compliance with Study Drug|2|||
161841938|NCT04492020|584466246|FG001|Overall Study|Non-compliance with Study Drug|1|||
161841939|NCT00325195|584466247|FG000|Randomized|Not dosed|5|||
161841940|NCT00325195|584466248|FG001|Randomized|Not dosed|5|||
161841941|NCT00325195|584466249|FG002|Randomized|Not dosed|3|||
161841942|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Adverse Event|15|||
161841943|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Adverse Event|17|||
161841944|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Adverse Event|1|||
161743253|NCT01432457|584099707|FG002|Overall Study|Did not take study drug|3|||
161743254|NCT03382262|584099708|FG000|Overall Study|Physician Decision|0|||
161743255|NCT03382262|584099709|FG001|Overall Study|Physician Decision|0|||
161743256|NCT03382262|584099710|FG002|Overall Study|Physician Decision|1|||
161743257|NCT03382262|584099711|FG003|Overall Study|Physician Decision|0|||
161743258|NCT03382262|584099708|FG000|Overall Study|Withdrawal by Subject|0|||
161743259|NCT03382262|584099709|FG001|Overall Study|Withdrawal by Subject|0|||
161743260|NCT03382262|584099710|FG002|Overall Study|Withdrawal by Subject|0|||
161743261|NCT03382262|584099711|FG003|Overall Study|Withdrawal by Subject|1|||
161743262|NCT02966353|584099712|FG000|Overall Study|Withdrawal by Subject|7|||
161743263|NCT02966353|584099712|FG000|Overall Study|Adverse Event|4|||
161743264|NCT02966353|584099712|FG000|Overall Study|Death|4|||
161743265|NCT02966353|584099712|FG000|Overall Study|Physician Decision|3|||
161743266|NCT02966353|584099712|FG000|Overall Study|Progressive disease|2|||
161743267|NCT02966353|584099712|FG000|Overall Study|Protocol deviation|2|||
161743268|NCT01090102|584099713|FG000|First 12 Weeks|Withdrawal by Subject|1|||
161743269|NCT01090102|584099714|FG001|First 12 Weeks|Withdrawal by Subject|1|||
161743270|NCT01090102|584099713|FG000|First 12 Weeks|Adverse Event|2|||
161743271|NCT01090102|584099714|FG001|First 12 Weeks|Adverse Event|0|||
161743272|NCT01090102|584099713|FG000|First 12 Weeks|Death|1|||
161743273|NCT01090102|584099714|FG001|First 12 Weeks|Death|1|||
161743274|NCT01090102|584099713|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
161743275|NCT01090102|584099714|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
161743276|NCT03518034|584099717|FG000|Overall Study|Not Treated|5|||
161743277|NCT03518034|584099718|FG001|Overall Study|Not Treated|1|||
161743278|NCT03518034|584099717|FG000|Overall Study|Withdrawal by Subject|309|||
161743279|NCT03518034|584099718|FG001|Overall Study|Withdrawal by Subject|351|||
161743280|NCT03518034|584099717|FG000|Overall Study|Lost to Follow-up|446|||
161743281|NCT03518034|584099718|FG001|Overall Study|Lost to Follow-up|458|||
161743282|NCT03518034|584099717|FG000|Overall Study|Adverse Event|138|||
161743283|NCT03518034|584099718|FG001|Overall Study|Adverse Event|130|||
161743284|NCT03518034|584099717|FG000|Overall Study|Lack of Efficacy|11|||
161743285|NCT03518034|584099718|FG001|Overall Study|Lack of Efficacy|23|||
161743286|NCT03518034|584099717|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
161743287|NCT03518034|584099718|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
161743288|NCT03518034|584099717|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
161743289|NCT03518034|584099718|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
161743290|NCT03518034|584099717|FG000|Overall Study|Other, Not Specified|84|||
161743291|NCT03518034|584099718|FG001|Overall Study|Other, Not Specified|53|||
161743292|NCT03518034|584099717|FG000|Overall Study|Reason Missing|2|||
161743293|NCT03518034|584099718|FG001|Overall Study|Reason Missing|3|||
161743294|NCT01527110|584099719|FG000|Overall Study|Adverse Event|1|||
161743295|NCT02007252|584099720|FG000|Overall Study|Administrative problems|3|||
161743296|NCT02007252|584099721|FG001|Overall Study|Administrative problems|7|||
161743297|NCT02007252|584099720|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161743298|NCT02007252|584099721|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161743299|NCT02007252|584099720|FG000|Overall Study|Adverse Event|7|||
161743300|NCT02007252|584099721|FG001|Overall Study|Adverse Event|4|||
161743301|NCT00367341|584099722|FG000|Overall Study|Physician Decision|1|||
161743302|NCT00367341|584099723|FG001|Overall Study|Physician Decision|0|||
161743303|NCT00367341|584099722|FG000|Overall Study|Protocol Violation|1|||
161743304|NCT00367341|584099723|FG001|Overall Study|Protocol Violation|0|||
161743305|NCT03325556|584099724|FG000|Open-label Period|Lack of Response in OL period|70|||
161743306|NCT03325556|584099725|FG001|Open-label Period|Lack of Response in OL period|0|||
161743307|NCT03325556|584099726|FG002|Open-label Period|Lack of Response in OL period|0|||
161743308|NCT03325556|584099724|FG000|Open-label Period|Adverse Event|27|||
161743309|NCT03325556|584099725|FG001|Open-label Period|Adverse Event|0|||
161743310|NCT03325556|584099726|FG002|Open-label Period|Adverse Event|0|||
161743311|NCT03325556|584099724|FG000|Open-label Period|Death|1|||
161743312|NCT03325556|584099725|FG001|Open-label Period|Death|0|||
161743313|NCT03325556|584099726|FG002|Open-label Period|Death|0|||
161743314|NCT03325556|584099724|FG000|Open-label Period|Lost to Follow-up|1|||
161743315|NCT03325556|584099725|FG001|Open-label Period|Lost to Follow-up|0|||
161743316|NCT03325556|584099726|FG002|Open-label Period|Lost to Follow-up|0|||
161743317|NCT03325556|584099724|FG000|Open-label Period|Non-compliance with study drug|5|||
161743318|NCT03325556|584099725|FG001|Open-label Period|Non-compliance with study drug|0|||
161743319|NCT03325556|584099726|FG002|Open-label Period|Non-compliance with study drug|0|||
161743320|NCT03325556|584099724|FG000|Open-label Period|Use of prohibited medication|1|||
161743321|NCT03325556|584099725|FG001|Open-label Period|Use of prohibited medication|0|||
161743322|NCT03325556|584099726|FG002|Open-label Period|Use of prohibited medication|0|||
161743323|NCT03325556|584099724|FG000|Open-label Period|Protocol Violation|4|||
161743324|NCT03325556|584099725|FG001|Open-label Period|Protocol Violation|0|||
161743325|NCT03325556|584099726|FG002|Open-label Period|Protocol Violation|0|||
161743326|NCT03325556|584099724|FG000|Open-label Period|Withdrawal by Subject|17|||
161743327|NCT03325556|584099725|FG001|Open-label Period|Withdrawal by Subject|0|||
161743328|NCT03325556|584099726|FG002|Open-label Period|Withdrawal by Subject|0|||
161743329|NCT03325556|584099724|FG000|Open-label Period|Not otherwise specified|8|||
161743330|NCT03325556|584099725|FG001|Open-label Period|Not otherwise specified|0|||
161743331|NCT03325556|584099726|FG002|Open-label Period|Not otherwise specified|0|||
161743332|NCT03325556|584099724|FG000|Open-label Period|Administrative discont. at study termination|41|||
161743333|NCT03325556|584099725|FG001|Open-label Period|Administrative discont. at study termination|0|||
161743334|NCT03325556|584099726|FG002|Open-label Period|Administrative discont. at study termination|0|||
161743335|NCT03325556|584099724|FG000|Double-blind Period|Relapse|0|||
161743336|NCT03325556|584099725|FG001|Double-blind Period|Relapse|15|||
161743337|NCT03325556|584099726|FG002|Double-blind Period|Relapse|34|||
161743338|NCT03325556|584099724|FG000|Double-blind Period|Adverse Event|0|||
161743339|NCT03325556|584099725|FG001|Double-blind Period|Adverse Event|3|||
161743340|NCT03325556|584099726|FG002|Double-blind Period|Adverse Event|1|||
161743341|NCT03325556|584099724|FG000|Double-blind Period|Noncompliance with study drug|0|||
161743342|NCT03325556|584099725|FG001|Double-blind Period|Noncompliance with study drug|0|||
161743343|NCT03325556|584099726|FG002|Double-blind Period|Noncompliance with study drug|1|||
161743344|NCT03325556|584099724|FG000|Double-blind Period|Use of prohibited medication|0|||
161743345|NCT03325556|584099725|FG001|Double-blind Period|Use of prohibited medication|1|||
161743346|NCT03325556|584099726|FG002|Double-blind Period|Use of prohibited medication|0|||
161743347|NCT03325556|584099724|FG000|Double-blind Period|Physician Decision|0|||
161743348|NCT03325556|584099725|FG001|Double-blind Period|Physician Decision|0|||
161743349|NCT03325556|584099726|FG002|Double-blind Period|Physician Decision|1|||
161743350|NCT03325556|584099724|FG000|Double-blind Period|Withdrawal by Subject|0|||
161743351|NCT03325556|584099725|FG001|Double-blind Period|Withdrawal by Subject|6|||
161743352|NCT03325556|584099726|FG002|Double-blind Period|Withdrawal by Subject|4|||
161743353|NCT03325556|584099724|FG000|Double-blind Period|Not otherwise specified|0|||
161743354|NCT03325556|584099725|FG001|Double-blind Period|Not otherwise specified|1|||
161743355|NCT03325556|584099726|FG002|Double-blind Period|Not otherwise specified|5|||
161743356|NCT03325556|584099724|FG000|Double-blind Period|Administrative discont. at study termination|0|||
161743357|NCT03325556|584099725|FG001|Double-blind Period|Administrative discont. at study termination|35|||
161743358|NCT03325556|584099726|FG002|Double-blind Period|Administrative discont. at study termination|31|||
161743359|NCT01705587|584099727|FG000|Overall Study|Withdrawal by Subject|0|||
161743360|NCT01705587|584099728|FG001|Overall Study|Withdrawal by Subject|1|||
161743361|NCT00762268|584099729|FG000|Overall Study|Withdrawal by Subject|3|||
161743362|NCT00762268|584099730|FG001|Overall Study|Withdrawal by Subject|3|||
161743363|NCT03892707|584099737|FG000|Overall Study|Screen failure|6|||
161743364|NCT03892707|584099738|FG001|Overall Study|Screen failure|0|||
161743365|NCT03892707|584099737|FG000|Overall Study|Pain resolution|0|||
161743366|NCT03892707|584099738|FG001|Overall Study|Pain resolution|4|||
161743367|NCT03892707|584099737|FG000|Overall Study|Withdrawal by Subject|0|||
161743368|NCT03892707|584099738|FG001|Overall Study|Withdrawal by Subject|1|||
161743369|NCT03892707|584099737|FG000|Overall Study|Other (long business trip)|0|||
161743370|NCT03892707|584099738|FG001|Overall Study|Other (long business trip)|1|||
161743371|NCT05224076|584099741|FG000|Overall Study|Lost to Follow-up|24|||
161743372|NCT01807949|584099743|FG000|Overall Study|Adverse Event|1|||
161743373|NCT01807949|584099744|FG001|Overall Study|Adverse Event|2|||
161743374|NCT01807949|584099745|FG002|Overall Study|Adverse Event|2|||
161743375|NCT01807949|584099743|FG000|Overall Study|Withdrawal by Subject|1|||
161743376|NCT01807949|584099744|FG001|Overall Study|Withdrawal by Subject|2|||
161743377|NCT01807949|584099745|FG002|Overall Study|Withdrawal by Subject|2|||
161743378|NCT01807949|584099743|FG000|Overall Study|Non-Compliance|0|||
161743379|NCT01807949|584099744|FG001|Overall Study|Non-Compliance|0|||
161743380|NCT01807949|584099745|FG002|Overall Study|Non-Compliance|1|||
161743381|NCT01807949|584099743|FG000|Overall Study|Undefined|0|||
161743382|NCT01807949|584099744|FG001|Overall Study|Undefined|1|||
161743383|NCT01807949|584099745|FG002|Overall Study|Undefined|2|||
161743384|NCT01807949|584099743|FG000|Overall Study|Randomized But Not Treated|0|||
161743385|NCT01807949|584099744|FG001|Overall Study|Randomized But Not Treated|2|||
161743386|NCT01807949|584099745|FG002|Overall Study|Randomized But Not Treated|2|||
161743387|NCT04325906|584099748|FG000|Overall Study|Withdrawal by Subject|2|||
161743388|NCT04325906|584099749|FG001|Overall Study|Withdrawal by Subject|0|||
161743389|NCT00881361|584099750|FG000|Overall Study|Terminated prior to surgery|27|||
161743390|NCT00881361|584099751|FG001|Overall Study|Terminated prior to surgery|7|||
161743391|NCT00881361|584099752|FG002|Overall Study|Terminated prior to surgery|0|||
161743392|NCT00881361|584099750|FG000|Overall Study|Ineligible|17|||
161743393|NCT00881361|584099751|FG001|Overall Study|Ineligible|2|||
161743394|NCT00881361|584099752|FG002|Overall Study|Ineligible|2|||
161743395|NCT02141217|584099753|FG000|Overall Study|Adverse Event|1|||
161743396|NCT02141217|584099754|FG001|Overall Study|Adverse Event|2|||
161743397|NCT02141217|584099753|FG000|Overall Study|Protocol Violation|1|||
161743398|NCT02141217|584099754|FG001|Overall Study|Protocol Violation|4|||
161743399|NCT02141217|584099753|FG000|Overall Study|Withdrawal by Subject|6|||
161743400|NCT02141217|584099754|FG001|Overall Study|Withdrawal by Subject|0|||
161743401|NCT02141217|584099753|FG000|Overall Study|Lost to Follow-up|1|||
161841945|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Death|3|||
161841946|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Death|1|||
161841947|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Death|0|||
161841948|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
161841949|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
161841950|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
161841951|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
161841952|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
161841953|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
161841954|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
161841955|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
161841956|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
161841957|NCT04594707|584466250|FG000|Overall Study|Adverse Event|0|||
161841958|NCT04594707|584466251|FG001|Overall Study|Adverse Event|0|||
161841959|NCT04594707|584466252|FG002|Overall Study|Adverse Event|1|||
161841960|NCT04594707|584466250|FG000|Overall Study|Death|0|||
161841961|NCT04594707|584466251|FG001|Overall Study|Death|2|||
161841962|NCT04594707|584466252|FG002|Overall Study|Death|2|||
161841963|NCT04594707|584466250|FG000|Overall Study|Lung Transplant|0|||
161841964|NCT04594707|584466251|FG001|Overall Study|Lung Transplant|0|||
161841965|NCT04594707|584466252|FG002|Overall Study|Lung Transplant|1|||
161841966|NCT04594707|584466250|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
161841967|NCT04594707|584466251|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
161841968|NCT04594707|584466252|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
161841969|NCT04594707|584466250|FG000|Overall Study|Study Terminated By Sponsor|19|||
161841970|NCT04594707|584466251|FG001|Overall Study|Study Terminated By Sponsor|47|||
161841971|NCT04594707|584466252|FG002|Overall Study|Study Terminated By Sponsor|41|||
161841972|NCT04594707|584466250|FG000|Overall Study|Withdrawal by Subject|1|||
161841973|NCT04594707|584466251|FG001|Overall Study|Withdrawal by Subject|0|||
161841974|NCT04594707|584466252|FG002|Overall Study|Withdrawal by Subject|2|||
161743402|NCT02141217|584099754|FG001|Overall Study|Lost to Follow-up|1|||
161743403|NCT02141217|584099753|FG000|Overall Study|Physician Decision|1|||
161743404|NCT02141217|584099754|FG001|Overall Study|Physician Decision|0|||
161743405|NCT02141217|584099753|FG000|Overall Study|Surgical Intervention|1|||
161743406|NCT02141217|584099754|FG001|Overall Study|Surgical Intervention|1|||
161743407|NCT04603391|584099759|FG000|First Intervention (4 Days)|Adverse Event|1|||
161743408|NCT04603391|584099760|FG001|First Intervention (4 Days)|Adverse Event|0|||
161743409|NCT04603391|584099759|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
161743410|NCT04603391|584099760|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
161743411|NCT02759861|584099763|FG000|Overall Study|Death|1|||
161743412|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743413|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
161743414|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743415|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743416|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743417|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743418|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743419|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
161743420|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743421|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743422|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743423|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743424|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743425|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
161743426|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743427|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743428|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743429|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743430|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
161743431|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
161743432|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743433|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743434|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743435|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743436|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
161743437|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743438|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743439|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743440|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743441|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743442|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743443|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743444|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
161743445|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743446|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743447|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743448|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
161743449|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
161743450|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
161743451|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
161743452|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
161743453|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
161743454|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743455|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743456|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
161743457|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
161743458|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743459|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743460|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743461|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743462|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
161743463|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743464|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743465|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743466|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743467|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743468|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
161743469|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743470|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743471|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743472|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743473|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743474|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
161743475|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161841975|NCT01175811|584466253|FG000|Overall Study|Adverse Event|1|||
161743476|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743477|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743478|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
161743479|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
161743480|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
161743481|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
161743482|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
161743483|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
161743484|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
161743485|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
161743486|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
161743487|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
161743488|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
161743489|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
161743490|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743491|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743492|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
161743493|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743494|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743495|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743496|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743497|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743498|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743499|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743500|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743501|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
161743502|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743503|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743504|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743505|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743506|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743507|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
161743508|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743509|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743510|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743511|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743512|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743513|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
161743514|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743515|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743516|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743517|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743518|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743519|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
161743520|NCT02988219|584099770|FG000|Overall Study|Lack of Efficacy|1|||
161743521|NCT02988219|584099771|FG001|Overall Study|Lack of Efficacy|1|||
161743522|NCT02988219|584099770|FG000|Overall Study|Withdrawal by Subject|0|||
161743523|NCT02988219|584099771|FG001|Overall Study|Withdrawal by Subject|2|||
161743524|NCT01522443|584099772|FG000|Overall Study|No longer receiving clinical benefit|36|||
161743525|NCT01522443|584099773|FG001|Overall Study|No longer receiving clinical benefit|28|||
161743526|NCT01522443|584099772|FG000|Overall Study|Adverse Event|10|||
161743527|NCT01522443|584099773|FG001|Overall Study|Adverse Event|15|||
161743528|NCT01522443|584099772|FG000|Overall Study|Withdrawal by Subject|5|||
161743529|NCT01522443|584099773|FG001|Overall Study|Withdrawal by Subject|8|||
161743530|NCT01522443|584099772|FG000|Overall Study|No study treatment given|1|||
161743531|NCT01522443|584099773|FG001|Overall Study|No study treatment given|1|||
161743532|NCT01522443|584099772|FG000|Overall Study|Other|1|||
161743533|NCT01522443|584099773|FG001|Overall Study|Other|3|||
161743534|NCT03260894|584099774|FG000|Overall Study|Death|6|||
161743535|NCT03260894|584099775|FG001|Overall Study|Death|8|||
161743536|NCT03260894|584099774|FG000|Overall Study|Withdrawal by Subject|4|||
161743537|NCT03260894|584099775|FG001|Overall Study|Withdrawal by Subject|11|||
161743538|NCT03260894|584099774|FG000|Overall Study|On-going at clinical cut off date|36|||
161743539|NCT03260894|584099775|FG001|Overall Study|On-going at clinical cut off date|31|||
161743540|NCT00973622|584099776|FG000|Overall Study|did not attend MRI|14|||
161743541|NCT00973622|584099777|FG001|Overall Study|did not attend MRI|3|||
161743542|NCT00973622|584099776|FG000|Overall Study|did not pass MRI screen|6|||
161743543|NCT00973622|584099777|FG001|Overall Study|did not pass MRI screen|0|||
161743544|NCT00973622|584099776|FG000|Overall Study|did not complete rTMS sessions|11|||
161743545|NCT00973622|584099777|FG001|Overall Study|did not complete rTMS sessions|2|||
161743546|NCT00555568|584099778|FG000|Overall Study|Lost to Follow-up|26|||
161743547|NCT00555568|584099779|FG001|Overall Study|Lost to Follow-up|16|||
161743548|NCT00555568|584099780|FG002|Overall Study|Lost to Follow-up|16|||
161743549|NCT06000501|584099781|FG000|Overall Study|Screen failure|3|||
161743550|NCT06000501|584099781|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
161743551|NCT06000501|584099781|FG000|Overall Study|Physician Decision|4|||
161743552|NCT06000501|584099781|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
161743553|NCT06000501|584099781|FG000|Overall Study|Scheduling issues|2|||
161743554|NCT02677220|584099782|FG000|Overall Study|Adverse Event|1|||
161743555|NCT00067470|584099783|FG000|Overall Study|Withdrawal by Subject|0|||
161743556|NCT00067470|584099784|FG001|Overall Study|Withdrawal by Subject|1|||
161743557|NCT01074658|584099785|FG000|Overall Study|No implant attempted|19|||
161743558|NCT00050622|584099786|FG000|Overall Study|Adverse Event|1|||
161743559|NCT01342952|584099787|FG000|Overall Study|Adverse Event|0|||
161743560|NCT01342952|584099788|FG001|Overall Study|Adverse Event|5|||
161743561|NCT01342952|584099789|FG002|Overall Study|Adverse Event|1|||
161743562|NCT01342952|584099790|FG003|Overall Study|Adverse Event|0|||
161743563|NCT01342952|584099787|FG000|Overall Study|Lost to Follow-up|0|||
161743564|NCT01342952|584099788|FG001|Overall Study|Lost to Follow-up|2|||
161743565|NCT01342952|584099789|FG002|Overall Study|Lost to Follow-up|0|||
161743566|NCT01342952|584099790|FG003|Overall Study|Lost to Follow-up|0|||
161743567|NCT01342952|584099787|FG000|Overall Study|Withdrawal by Subject|1|||
161743568|NCT01342952|584099788|FG001|Overall Study|Withdrawal by Subject|1|||
161743569|NCT01342952|584099789|FG002|Overall Study|Withdrawal by Subject|0|||
161743570|NCT01342952|584099790|FG003|Overall Study|Withdrawal by Subject|0|||
161743571|NCT01342952|584099787|FG000|Overall Study|Physician Decision|3|||
161743572|NCT01342952|584099788|FG001|Overall Study|Physician Decision|3|||
161743573|NCT01342952|584099789|FG002|Overall Study|Physician Decision|1|||
161743574|NCT01342952|584099790|FG003|Overall Study|Physician Decision|0|||
161743575|NCT00426556|584099791|FG000|Phase I - Core Phase|Disease Progression|0|||
161743576|NCT00426556|584099792|FG001|Phase I - Core Phase|Disease Progression|6|||
161743577|NCT00426556|584099793|FG002|Phase I - Core Phase|Disease Progression|2|||
161743578|NCT00426556|584099794|FG003|Phase I - Core Phase|Disease Progression|0|||
161743579|NCT00426556|584099791|FG000|Phase I - Core Phase|Adverse Event|1|||
161743580|NCT00426556|584099792|FG001|Phase I - Core Phase|Adverse Event|3|||
161743581|NCT00426556|584099793|FG002|Phase I - Core Phase|Adverse Event|1|||
161743582|NCT00426556|584099794|FG003|Phase I - Core Phase|Adverse Event|0|||
161743583|NCT00426556|584099791|FG000|Phase I - Core Phase|Death|0|||
161743584|NCT00426556|584099792|FG001|Phase I - Core Phase|Death|1|||
161743585|NCT00426556|584099793|FG002|Phase I - Core Phase|Death|0|||
161743586|NCT00426556|584099794|FG003|Phase I - Core Phase|Death|0|||
161743587|NCT00426556|584099791|FG000|Phase I - Extension Phase|Adverse Event|0|||
161743588|NCT00426556|584099792|FG001|Phase I - Extension Phase|Adverse Event|1|||
161743589|NCT00426556|584099793|FG002|Phase I - Extension Phase|Adverse Event|1|||
161743590|NCT00426556|584099794|FG003|Phase I - Extension Phase|Adverse Event|0|||
161743591|NCT00426556|584099791|FG000|Phase I - Extension Phase|Disease Progression|5|||
161743592|NCT00426556|584099792|FG001|Phase I - Extension Phase|Disease Progression|5|||
161743593|NCT00426556|584099793|FG002|Phase I - Extension Phase|Disease Progression|6|||
161743594|NCT00426556|584099794|FG003|Phase I - Extension Phase|Disease Progression|0|||
161743595|NCT00426556|584099791|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
161743596|NCT00426556|584099792|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
161743597|NCT00426556|584099793|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
161743598|NCT00426556|584099794|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
161743599|NCT00426556|584099791|FG000|Phase II - Core Phase|Disease Progression|0|||
161743600|NCT00426556|584099792|FG001|Phase II - Core Phase|Disease Progression|0|||
161743601|NCT00426556|584099793|FG002|Phase II - Core Phase|Disease Progression|0|||
161743602|NCT00426556|584099794|FG003|Phase II - Core Phase|Disease Progression|16|||
161743603|NCT00426556|584099791|FG000|Phase II - Core Phase|Adverse Event|0|||
161743604|NCT00426556|584099792|FG001|Phase II - Core Phase|Adverse Event|0|||
161743605|NCT00426556|584099793|FG002|Phase II - Core Phase|Adverse Event|0|||
161743606|NCT00426556|584099794|FG003|Phase II - Core Phase|Adverse Event|8|||
161743607|NCT00426556|584099791|FG000|Phase II - Extension Phase|Disease Progression|0|||
161743608|NCT00426556|584099792|FG001|Phase II - Extension Phase|Disease Progression|0|||
161743609|NCT00426556|584099793|FG002|Phase II - Extension Phase|Disease Progression|0|||
161743610|NCT00426556|584099794|FG003|Phase II - Extension Phase|Disease Progression|21|||
161743611|NCT00426556|584099791|FG000|Phase II - Extension Phase|Adverse Event|0|||
161743612|NCT00426556|584099792|FG001|Phase II - Extension Phase|Adverse Event|0|||
161743613|NCT00426556|584099793|FG002|Phase II - Extension Phase|Adverse Event|0|||
161743614|NCT00426556|584099794|FG003|Phase II - Extension Phase|Adverse Event|2|||
161743615|NCT01192204|584099800|FG000|Overall Study|could not keep recall appointments|1|||
161743616|NCT01192204|584099801|FG001|Overall Study|could not keep recall appointments|0|||
161743617|NCT02146248|584099802|FG000|Overall Study|Withdrawal by Subject|2|||
161743618|NCT00425100|584099803|FG000|Overall Study|Adverse Event|36|||
161743619|NCT00425100|584099803|FG000|Overall Study|Lack of Efficacy|4|||
161743620|NCT00425100|584099803|FG000|Overall Study|Lost to Follow-up|2|||
161743621|NCT00425100|584099803|FG000|Overall Study|Protocol Violation|4|||
161743622|NCT00425100|584099803|FG000|Overall Study|Withdrawal by Subject|7|||
161743623|NCT03699631|584099807|FG000|Overall Study|Adverse Event|3|||
161743624|NCT02219087|584099808|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
161743625|NCT02219087|584099809|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
161743626|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
161743627|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
161743628|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
161743629|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
161743630|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Physician Decision|1|||
161743631|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Physician Decision|0|||
161743632|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Physician Decision|0|||
161743633|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Physician Decision|0|||
161743634|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
161743635|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
161743636|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
161743637|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
161743638|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161743639|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
161743640|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161743641|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161743642|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161743643|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
161743644|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161743645|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161743646|NCT05127421|584099810|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
161743647|NCT05127421|584099811|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
161743648|NCT05127421|584099812|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
161743649|NCT05127421|584099813|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
161743650|NCT05127421|584099810|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
161743651|NCT05127421|584099811|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
161743652|NCT05127421|584099812|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
161743653|NCT05127421|584099813|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
161743654|NCT05127421|584099810|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161743655|NCT05127421|584099811|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161743656|NCT05127421|584099812|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161743657|NCT05127421|584099813|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
161743658|NCT00618449|584099814|FG000|Overall Study|Lost to Follow-up|98|||
161743659|NCT00618449|584099815|FG001|Overall Study|Lost to Follow-up|110|||
161743660|NCT04311177|584099816|FG000|Overall Study|Adverse Event|3|||
161743661|NCT04311177|584099817|FG001|Overall Study|Adverse Event|1|||
161743662|NCT04311177|584099816|FG000|Overall Study|Physician Decision|4|||
161743663|NCT04311177|584099817|FG001|Overall Study|Physician Decision|3|||
161743664|NCT04311177|584099816|FG000|Overall Study|Withdrawal by Subject|1|||
161743665|NCT04311177|584099817|FG001|Overall Study|Withdrawal by Subject|0|||
161743666|NCT00599027|584099820|FG000|Overall Study|Withdrawal by Subject|1|||
161743667|NCT00599027|584099821|FG001|Overall Study|Withdrawal by Subject|1|||
161743668|NCT00599027|584099820|FG000|Overall Study|Adverse Event|0|||
161743669|NCT00599027|584099821|FG001|Overall Study|Adverse Event|1|||
161743670|NCT00599027|584099820|FG000|Overall Study|Treatment Failure|0|||
161743671|NCT00599027|584099821|FG001|Overall Study|Treatment Failure|1|||
161743672|NCT02581982|584099822|FG000|Overall Study|Lack of Efficacy|12|||
161743673|NCT02581982|584099822|FG000|Overall Study|Adverse Event|3|||
161743674|NCT02581982|584099822|FG000|Overall Study|Physician Decision|1|||
161743675|NCT00405821|584099823|FG000|Overall Study|Death|5|||
161743676|NCT00405821|584099824|FG001|Overall Study|Death|7|||
161743677|NCT00405821|584099823|FG000|Overall Study|Lost to Follow-up|7|||
161743678|NCT00405821|584099824|FG001|Overall Study|Lost to Follow-up|7|||
161743679|NCT00405821|584099823|FG000|Overall Study|Protocol Violation|1|||
161743680|NCT00405821|584099824|FG001|Overall Study|Protocol Violation|0|||
161743681|NCT00405821|584099823|FG000|Overall Study|initiated ART|9|||
161743682|NCT00405821|584099824|FG001|Overall Study|initiated ART|8|||
161743683|NCT02554253|584099835|FG000|Overall Study|ineligible after enrollment|1|||
161743684|NCT02554253|584099836|FG001|Overall Study|ineligible after enrollment|0|||
161743685|NCT02554253|584099835|FG000|Overall Study|converted to transcatheter procedure|0|||
161743686|NCT02554253|584099836|FG001|Overall Study|converted to transcatheter procedure|1|||
161743687|NCT02554253|584099835|FG000|Overall Study|received both drugs|0|||
161743688|NCT02554253|584099836|FG001|Overall Study|received both drugs|1|||
161743689|NCT02559206|584099839|FG000|Overall Study|Adverse Event|0|||
161743690|NCT02559206|584099840|FG001|Overall Study|Adverse Event|4|||
161743691|NCT02559206|584099841|FG002|Overall Study|Adverse Event|1|||
161743692|NCT02559206|584099842|FG003|Overall Study|Adverse Event|5|||
161743693|NCT02559206|584099843|FG004|Overall Study|Adverse Event|3|||
161743694|NCT02559206|584099844|FG005|Overall Study|Adverse Event|0|||
161743695|NCT02559206|584099845|FG006|Overall Study|Adverse Event|1|||
161743696|NCT02559206|584099846|FG007|Overall Study|Adverse Event|0|||
161743697|NCT02559206|584099839|FG000|Overall Study|Protocol Violation|1|||
161743698|NCT02559206|584099840|FG001|Overall Study|Protocol Violation|0|||
161743699|NCT02559206|584099841|FG002|Overall Study|Protocol Violation|1|||
161743700|NCT02559206|584099842|FG003|Overall Study|Protocol Violation|0|||
161743701|NCT02559206|584099843|FG004|Overall Study|Protocol Violation|0|||
161743702|NCT02559206|584099844|FG005|Overall Study|Protocol Violation|2|||
161743703|NCT02559206|584099845|FG006|Overall Study|Protocol Violation|0|||
161743704|NCT02559206|584099846|FG007|Overall Study|Protocol Violation|0|||
161743705|NCT02559206|584099839|FG000|Overall Study|Withdrawal by Subject|3|||
161743706|NCT02559206|584099840|FG001|Overall Study|Withdrawal by Subject|3|||
161743707|NCT02559206|584099841|FG002|Overall Study|Withdrawal by Subject|1|||
161743708|NCT02559206|584099842|FG003|Overall Study|Withdrawal by Subject|3|||
161743709|NCT02559206|584099843|FG004|Overall Study|Withdrawal by Subject|5|||
161743710|NCT02559206|584099844|FG005|Overall Study|Withdrawal by Subject|4|||
161743711|NCT02559206|584099845|FG006|Overall Study|Withdrawal by Subject|1|||
161743712|NCT02559206|584099846|FG007|Overall Study|Withdrawal by Subject|2|||
161743713|NCT02559206|584099839|FG000|Overall Study|Lost to Follow-up|3|||
161743714|NCT02559206|584099840|FG001|Overall Study|Lost to Follow-up|5|||
161743715|NCT02559206|584099841|FG002|Overall Study|Lost to Follow-up|3|||
161743716|NCT02559206|584099842|FG003|Overall Study|Lost to Follow-up|3|||
161743717|NCT02559206|584099843|FG004|Overall Study|Lost to Follow-up|2|||
161743718|NCT02559206|584099844|FG005|Overall Study|Lost to Follow-up|5|||
161743719|NCT02559206|584099845|FG006|Overall Study|Lost to Follow-up|1|||
161743720|NCT02559206|584099846|FG007|Overall Study|Lost to Follow-up|4|||
161743721|NCT02559206|584099839|FG000|Overall Study|Lack of Efficacy|1|||
161743722|NCT02559206|584099840|FG001|Overall Study|Lack of Efficacy|0|||
161743723|NCT02559206|584099841|FG002|Overall Study|Lack of Efficacy|3|||
161743724|NCT02559206|584099842|FG003|Overall Study|Lack of Efficacy|2|||
161743725|NCT02559206|584099843|FG004|Overall Study|Lack of Efficacy|2|||
161743726|NCT02559206|584099844|FG005|Overall Study|Lack of Efficacy|3|||
161743727|NCT02559206|584099845|FG006|Overall Study|Lack of Efficacy|3|||
161743728|NCT02559206|584099846|FG007|Overall Study|Lack of Efficacy|3|||
161743729|NCT02559206|584099839|FG000|Overall Study|Other Not Specified|0|||
161743730|NCT02559206|584099840|FG001|Overall Study|Other Not Specified|0|||
161743731|NCT02559206|584099841|FG002|Overall Study|Other Not Specified|0|||
161743732|NCT02559206|584099842|FG003|Overall Study|Other Not Specified|1|||
161743733|NCT02559206|584099843|FG004|Overall Study|Other Not Specified|0|||
161743734|NCT02559206|584099844|FG005|Overall Study|Other Not Specified|0|||
161743735|NCT02559206|584099845|FG006|Overall Study|Other Not Specified|0|||
161743736|NCT02559206|584099846|FG007|Overall Study|Other Not Specified|0|||
161743737|NCT01770145|584101997|FG000|Baseline|Adverse Event|20|||
161743738|NCT01770145|584101997|FG000|Baseline|Withdrawal by Subject|1|||
161743739|NCT01770145|584101997|FG000|Baseline|Lost to Follow-up|1|||
161743740|NCT01770145|584101997|FG000|Baseline|Unable to define optimal dose|4|||
161743741|NCT01770145|584101997|FG000|Treatment|Adverse Event|3|||
161743742|NCT01770145|584101997|FG000|Treatment|Withdrawal by Subject|1|||
161743743|NCT01102140|584101998|FG000|Overall Study|Lost to Follow-up|1|||
161743744|NCT01102140|584101999|FG001|Overall Study|Lost to Follow-up|0|||
161743745|NCT01102140|584101998|FG000|Overall Study|Investigator terminated study|2|||
161743746|NCT01102140|584101999|FG001|Overall Study|Investigator terminated study|2|||
161743747|NCT04134728|584102005|FG000|Overall Study|Adverse Event|3|||
161743748|NCT04134728|584102006|FG001|Overall Study|Adverse Event|2|||
161743749|NCT04134728|584102007|FG002|Overall Study|Adverse Event|9|||
161743750|NCT04134728|584102008|FG003|Overall Study|Adverse Event|0|||
161743751|NCT04134728|584102009|FG004|Overall Study|Adverse Event|0|||
161743752|NCT04134728|584102010|FG005|Overall Study|Adverse Event|0|||
161743753|NCT04134728|584102005|FG000|Overall Study|Lack of Efficacy|3|||
161743754|NCT04134728|584102006|FG001|Overall Study|Lack of Efficacy|3|||
161743755|NCT04134728|584102007|FG002|Overall Study|Lack of Efficacy|1|||
161743756|NCT04134728|584102008|FG003|Overall Study|Lack of Efficacy|2|||
161743757|NCT04134728|584102009|FG004|Overall Study|Lack of Efficacy|0|||
161743758|NCT04134728|584102010|FG005|Overall Study|Lack of Efficacy|0|||
161743759|NCT04134728|584102005|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161743760|NCT04134728|584102006|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743761|NCT04134728|584102007|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
161743762|NCT04134728|584102008|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743763|NCT04134728|584102009|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743764|NCT04134728|584102010|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743765|NCT04134728|584102005|FG000|Overall Study|Protocol Deviation|0|||
161743766|NCT04134728|584102006|FG001|Overall Study|Protocol Deviation|0|||
161743767|NCT04134728|584102007|FG002|Overall Study|Protocol Deviation|1|||
161743768|NCT04134728|584102008|FG003|Overall Study|Protocol Deviation|0|||
161743769|NCT04134728|584102009|FG004|Overall Study|Protocol Deviation|0|||
161743770|NCT04134728|584102010|FG005|Overall Study|Protocol Deviation|0|||
161743771|NCT04134728|584102005|FG000|Overall Study|Informed Consent Withdrawn|3|||
161743772|NCT04134728|584102006|FG001|Overall Study|Informed Consent Withdrawn|6|||
161743773|NCT04134728|584102007|FG002|Overall Study|Informed Consent Withdrawn|8|||
161743774|NCT04134728|584102008|FG003|Overall Study|Informed Consent Withdrawn|1|||
161743775|NCT04134728|584102009|FG004|Overall Study|Informed Consent Withdrawn|1|||
161743776|NCT04134728|584102010|FG005|Overall Study|Informed Consent Withdrawn|0|||
161743777|NCT04134728|584102005|FG000|Overall Study|Physician Decision|2|||
161743778|NCT04134728|584102006|FG001|Overall Study|Physician Decision|0|||
161743779|NCT04134728|584102007|FG002|Overall Study|Physician Decision|0|||
161743780|NCT04134728|584102008|FG003|Overall Study|Physician Decision|0|||
161743781|NCT04134728|584102009|FG004|Overall Study|Physician Decision|0|||
161743782|NCT04134728|584102010|FG005|Overall Study|Physician Decision|0|||
161743783|NCT04134728|584102005|FG000|Overall Study|Lost to Follow-up|1|||
161743784|NCT04134728|584102006|FG001|Overall Study|Lost to Follow-up|2|||
161743785|NCT04134728|584102007|FG002|Overall Study|Lost to Follow-up|1|||
161743786|NCT04134728|584102008|FG003|Overall Study|Lost to Follow-up|0|||
161743787|NCT04134728|584102009|FG004|Overall Study|Lost to Follow-up|0|||
161743788|NCT04134728|584102010|FG005|Overall Study|Lost to Follow-up|1|||
161743789|NCT04134728|584102005|FG000|Overall Study|Investigator Site Closed|0|||
161743790|NCT04134728|584102006|FG001|Overall Study|Investigator Site Closed|1|||
161743791|NCT04134728|584102007|FG002|Overall Study|Investigator Site Closed|1|||
161743792|NCT04134728|584102008|FG003|Overall Study|Investigator Site Closed|0|||
161743793|NCT04134728|584102009|FG004|Overall Study|Investigator Site Closed|0|||
161743794|NCT04134728|584102010|FG005|Overall Study|Investigator Site Closed|0|||
161743795|NCT00801892|584102011|FG000|Main Study Period|Withdrawal by Subject|0|||
161743796|NCT00801892|584102012|FG001|Main Study Period|Withdrawal by Subject|1|||
161743797|NCT00801892|584102011|FG000|Sham Crossover Period|Lost to Follow-up|0|||
161743798|NCT00801892|584102012|FG001|Sham Crossover Period|Lost to Follow-up|2|||
161743799|NCT01175590|584102018|FG000|Overall Study|Lost to Follow-up|1|||
161743800|NCT01175590|584102019|FG001|Overall Study|Lost to Follow-up|0|||
161743801|NCT01175590|584102018|FG000|Overall Study|Withdrawal by Subject|0|||
161743802|NCT01175590|584102019|FG001|Overall Study|Withdrawal by Subject|2|||
161743803|NCT01175590|584102018|FG000|Overall Study|Adverse Event|4|||
161743804|NCT01175590|584102019|FG001|Overall Study|Adverse Event|0|||
161743805|NCT01175590|584102018|FG000|Overall Study|Physician Decision|1|||
161743806|NCT01175590|584102019|FG001|Overall Study|Physician Decision|4|||
161743807|NCT01175590|584102018|FG000|Overall Study|Lack of Efficacy|1|||
161743808|NCT01175590|584102019|FG001|Overall Study|Lack of Efficacy|1|||
161743809|NCT01175590|584102018|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
161743810|NCT01175590|584102019|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
161743811|NCT01175590|584102018|FG000|Overall Study|Treated not as randomized|3|||
161743812|NCT01175590|584102019|FG001|Overall Study|Treated not as randomized|2|||
161743813|NCT01175590|584102018|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
161743814|NCT01175590|584102019|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
161743815|NCT01175590|584102018|FG000|Overall Study|Protocol Violation|0|||
161743816|NCT01175590|584102019|FG001|Overall Study|Protocol Violation|1|||
161743817|NCT02062398|584102020|FG000|Overall Study|Implant removal|1|||
161743818|NCT03351478|584102021|FG000|Overall Study|At the subject's own request|11|||
161743819|NCT03351478|584102022|FG001|Overall Study|At the subject's own request|12|||
161743820|NCT03351478|584102023|FG002|Overall Study|At the subject's own request|5|||
161743821|NCT03351478|584102021|FG000|Overall Study|Adverse Event|1|||
161743822|NCT03351478|584102022|FG001|Overall Study|Adverse Event|2|||
161743823|NCT03351478|584102023|FG002|Overall Study|Adverse Event|1|||
161743824|NCT03351478|584102021|FG000|Overall Study|Poor compliance to protocol|1|||
161743825|NCT03351478|584102022|FG001|Overall Study|Poor compliance to protocol|0|||
161743826|NCT03351478|584102023|FG002|Overall Study|Poor compliance to protocol|0|||
161743827|NCT03351478|584102021|FG000|Overall Study|Reason not Specified|1|||
161743828|NCT03351478|584102022|FG001|Overall Study|Reason not Specified|3|||
161743829|NCT03351478|584102023|FG002|Overall Study|Reason not Specified|0|||
161743830|NCT03351478|584102021|FG000|Overall Study|Lost to Follow-up|0|||
161743831|NCT03351478|584102022|FG001|Overall Study|Lost to Follow-up|0|||
161743832|NCT03351478|584102023|FG002|Overall Study|Lost to Follow-up|1|||
161743833|NCT03911869|584102024|FG000|Safety Lead-in Phase|Death|7|||
161743834|NCT03911869|584102025|FG001|Safety Lead-in Phase|Death|0|||
161743835|NCT03911869|584102026|FG002|Safety Lead-in Phase|Death|0|||
161743836|NCT03911869|584102024|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
161743837|NCT03911869|584102025|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
161743838|NCT03911869|584102026|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
161743839|NCT03911869|584102024|FG000|Safety Lead-in Phase|Other|1|||
161743840|NCT03911869|584102025|FG001|Safety Lead-in Phase|Other|0|||
161743841|NCT03911869|584102026|FG002|Safety Lead-in Phase|Other|0|||
161743842|NCT03911869|584102024|FG000|Phase 2|Death|0|||
161743843|NCT03911869|584102025|FG001|Phase 2|Death|3|||
161743844|NCT03911869|584102026|FG002|Phase 2|Death|0|||
161743845|NCT01106391|584102028|FG000|Overall Study|Death|12|||
161743846|NCT01106391|584102028|FG000|Overall Study|Withdrawal by Subject|7|||
161743847|NCT01387074|584102029|FG000|Overall Study|Lost to Follow-up|7|||
161743848|NCT01387074|584102029|FG000|Overall Study|Lack of Efficacy|1|||
161743849|NCT00150345|584102030|FG000|Overall Study|Death|5|||
161743850|NCT00150345|584102031|FG001|Overall Study|Death|2|||
161743851|NCT00150345|584102030|FG000|Overall Study|Adverse Event|8|||
161743852|NCT00150345|584102031|FG001|Overall Study|Adverse Event|6|||
161743853|NCT00150345|584102030|FG000|Overall Study|Lack of Efficacy|5|||
161743854|NCT00150345|584102031|FG001|Overall Study|Lack of Efficacy|4|||
161743855|NCT00150345|584102030|FG000|Overall Study|Withdrawal by Subject|3|||
161743856|NCT00150345|584102031|FG001|Overall Study|Withdrawal by Subject|4|||
161743857|NCT00150345|584102030|FG000|Overall Study|Laboratory abnormality|1|||
161743858|NCT00150345|584102031|FG001|Overall Study|Laboratory abnormality|2|||
161743859|NCT00150345|584102030|FG000|Overall Study|Other|12|||
161743860|NCT00150345|584102031|FG001|Overall Study|Other|14|||
161743861|NCT01392742|584102032|FG000|Overall Study|Premature study termination|42|||
161743862|NCT01392742|584102032|FG000|Overall Study|Failure to return|35|||
161743863|NCT01392742|584102032|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
161743864|NCT01392742|584102032|FG000|Overall Study|Lost to Follow-up|34|||
161743865|NCT01392742|584102032|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
161743866|NCT01392742|584102032|FG000|Overall Study|ITR and Protocol deviation|1|||
161743867|NCT01392742|584102032|FG000|Overall Study|Adverse event/intercurrent illness|17|||
161743868|NCT01392742|584102032|FG000|Overall Study|Protocol Violation|14|||
161743869|NCT01392742|584102032|FG000|Overall Study|Other|3|||
161743870|NCT01392742|584102032|FG000|Overall Study|Missing information|13|||
161743871|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743872|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
161743873|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743874|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743875|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743876|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743877|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743878|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743879|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743880|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743881|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743882|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743883|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743884|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743885|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743886|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743887|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743888|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743889|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743890|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743891|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743892|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743893|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743894|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743895|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743896|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743897|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743898|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743899|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743900|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743901|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743902|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743903|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743904|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
161743905|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743906|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743907|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743908|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743909|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743910|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743911|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743912|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743913|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743914|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743915|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743916|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743917|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743918|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743919|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743920|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743921|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743922|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743923|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743924|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743925|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743926|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743927|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743928|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743929|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743930|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743931|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743932|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743933|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743934|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743935|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
161743936|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
161743937|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
161743938|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
161743939|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
161743940|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
161743941|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
161743942|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
161743943|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
161743944|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
161743945|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
161743946|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
161743947|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
161743948|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
161743949|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
161743950|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
161743951|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
161743952|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
161743953|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
161743954|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
161743955|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
161743956|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
161743957|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
161743958|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
161743959|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
161743960|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
161743961|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
161743962|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
161743963|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
161743964|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
161743965|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
161743966|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
161743967|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Other|1|||
161743968|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Other|0|||
161743969|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Other|0|||
161743970|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Other|0|||
161743971|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Other|0|||
161743972|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Other|0|||
161743973|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Other|0|||
161743974|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Other|0|||
161743975|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Other|0|||
161743976|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Other|0|||
161743977|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Other|0|||
161743978|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Other|0|||
161743979|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Other|0|||
161743980|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Other|0|||
161743981|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Other|0|||
161743982|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Other|0|||
161743983|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Other|0|||
161743984|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Other|0|||
161743985|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Other|0|||
161743986|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Other|0|||
161743987|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Other|0|||
161743988|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Other|0|||
161743989|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Other|0|||
161743990|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Other|0|||
161743991|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Other|0|||
161743992|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Other|0|||
161743993|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Other|0|||
161743994|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Other|0|||
161743995|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Other|0|||
161743996|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Other|0|||
161743997|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Other|0|||
161743998|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Other|0|||
161743999|NCT01998958|584102033|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
161744000|NCT01998958|584102034|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
161744001|NCT01998958|584102035|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
161744002|NCT01998958|584102036|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
161744003|NCT01998958|584102037|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
161744004|NCT01998958|584102038|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
161744005|NCT01998958|584102039|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
161744006|NCT01998958|584102040|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
161744007|NCT01998958|584102041|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
161744008|NCT01998958|584102042|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
161744009|NCT01998958|584102043|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
161744010|NCT01998958|584102044|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
161744011|NCT01998958|584102045|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
161744012|NCT01998958|584102046|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
161744013|NCT01998958|584102047|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
161744014|NCT01998958|584102048|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
161744015|NCT01998958|584102049|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
161744016|NCT01998958|584102050|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
161744017|NCT01998958|584102051|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
161744018|NCT01998958|584102052|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
161744019|NCT01998958|584102053|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
161744020|NCT01998958|584102054|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
161744021|NCT01998958|584102055|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
161744022|NCT01998958|584102056|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
161744023|NCT01998958|584102057|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
161744024|NCT01998958|584102058|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
161744025|NCT01998958|584102059|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
161744026|NCT01998958|584102060|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
161744027|NCT01998958|584102061|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
161744028|NCT01998958|584102062|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
161744029|NCT01998958|584102063|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
161744030|NCT01998958|584102064|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
161744031|NCT01998958|584102033|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744032|NCT01998958|584102034|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744033|NCT01998958|584102035|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744034|NCT01998958|584102036|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744035|NCT01998958|584102037|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744036|NCT01998958|584102038|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744037|NCT01998958|584102039|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744038|NCT01998958|584102040|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744039|NCT01998958|584102041|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744040|NCT01998958|584102042|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744041|NCT01998958|584102043|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744042|NCT01998958|584102044|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744043|NCT01998958|584102045|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744044|NCT01998958|584102046|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744045|NCT01998958|584102047|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
161744046|NCT01998958|584102048|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744047|NCT01998958|584102049|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744048|NCT01998958|584102050|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744049|NCT01998958|584102051|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
161744050|NCT01998958|584102052|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744051|NCT01998958|584102053|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744052|NCT01998958|584102054|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744053|NCT01998958|584102055|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744054|NCT01998958|584102056|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744055|NCT01998958|584102057|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161841976|NCT01175811|584466254|FG001|Overall Study|Adverse Event|1|||
161744056|NCT01998958|584102058|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744057|NCT01998958|584102059|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744058|NCT01998958|584102060|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744059|NCT01998958|584102061|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744060|NCT01998958|584102062|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744061|NCT01998958|584102063|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744062|NCT01998958|584102064|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744063|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Adverse Event|0|||
161744064|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Adverse Event|0|||
161744065|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Adverse Event|0|||
161744066|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Adverse Event|0|||
161744067|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Adverse Event|0|||
161744068|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Adverse Event|0|||
161744069|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Adverse Event|0|||
161744070|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Adverse Event|0|||
161744071|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Adverse Event|0|||
161744072|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Adverse Event|0|||
161744073|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Adverse Event|0|||
161744074|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Adverse Event|0|||
161744075|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Adverse Event|0|||
161744076|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Adverse Event|0|||
161744077|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Adverse Event|0|||
161744078|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Adverse Event|0|||
161744079|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Adverse Event|0|||
161744080|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Adverse Event|0|||
161744081|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Adverse Event|0|||
161744082|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Adverse Event|0|||
161744083|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Adverse Event|0|||
161744084|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Adverse Event|0|||
161744085|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Adverse Event|0|||
161744086|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Adverse Event|1|||
161744087|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Adverse Event|0|||
161744088|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Adverse Event|0|||
161744089|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Adverse Event|0|||
161744090|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Adverse Event|0|||
161744091|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Adverse Event|0|||
161744092|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Adverse Event|0|||
161744093|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Adverse Event|0|||
161744094|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Adverse Event|0|||
161744095|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Other|0|||
161744096|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Other|0|||
161744097|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Other|0|||
161744098|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Other|0|||
161744099|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Other|0|||
161744100|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Other|0|||
161744101|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Other|0|||
161744102|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Other|0|||
161744103|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Other|0|||
161744104|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Other|0|||
161744105|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Other|0|||
161744106|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Other|0|||
161744107|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Other|0|||
161744108|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Other|0|||
161744109|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Other|0|||
161744110|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Other|0|||
161744111|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Other|0|||
161744112|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Other|0|||
161744113|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Other|0|||
161744114|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Other|0|||
161744115|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Other|0|||
161744116|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Other|0|||
161744117|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Other|5|||
161744118|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Other|1|||
161744119|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Other|0|||
161744120|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Other|0|||
161744121|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Other|0|||
161744122|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Other|0|||
161744123|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Other|0|||
161744124|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Other|0|||
161744125|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Other|0|||
161744126|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Other|0|||
161744127|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744128|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744129|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744130|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744131|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744132|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744133|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744134|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744135|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744136|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744137|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744138|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744139|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744140|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744141|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744142|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744143|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744144|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744145|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744146|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744147|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744148|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744149|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
161744150|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744151|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744152|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744153|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744154|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744155|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744156|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744157|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744158|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744159|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744160|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744161|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744162|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744163|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744164|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744165|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744166|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744167|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744168|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744169|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744170|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744171|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744172|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744173|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744174|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744175|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744176|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744177|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744178|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744179|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744180|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
161744181|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
161744182|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744183|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744184|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744185|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744186|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744187|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744188|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744189|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744190|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744191|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744192|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744193|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744194|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744195|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744196|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744197|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744198|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744199|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744200|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744201|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744202|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744203|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744204|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744205|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744206|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744207|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744208|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744209|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744210|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744211|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744212|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
161744213|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
161744214|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
161744215|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744216|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744217|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744218|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744219|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744220|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744221|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744222|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744223|NCT02432703|584102065|FG000|Overall Study|Adverse Event|1|||
161744224|NCT02432703|584102066|FG001|Overall Study|Adverse Event|4|||
161744225|NCT02432703|584102065|FG000|Overall Study|Lack of Efficacy|1|||
161744226|NCT02432703|584102066|FG001|Overall Study|Lack of Efficacy|0|||
161744227|NCT02432703|584102065|FG000|Overall Study|Lost to Follow-up|5|||
161744228|NCT02432703|584102066|FG001|Overall Study|Lost to Follow-up|3|||
161744229|NCT02432703|584102065|FG000|Overall Study|Withdrawal by Subject|9|||
161744230|NCT02432703|584102066|FG001|Overall Study|Withdrawal by Subject|6|||
161744231|NCT02432703|584102065|FG000|Overall Study|Other|6|||
161744232|NCT02432703|584102066|FG001|Overall Study|Other|5|||
161744233|NCT02137837|584102072|FG000|Overall Study|Adverse Event|0|||
161744234|NCT02137837|584102073|FG001|Overall Study|Adverse Event|2|||
161744235|NCT02137837|584102074|FG002|Overall Study|Adverse Event|1|||
161744236|NCT02137837|584102072|FG000|Overall Study|Refusal unrelated to adverse event|2|||
161744237|NCT02137837|584102073|FG001|Overall Study|Refusal unrelated to adverse event|2|||
161744238|NCT02137837|584102074|FG002|Overall Study|Refusal unrelated to adverse event|1|||
161744239|NCT02137837|584102072|FG000|Overall Study|Progression/relapse|9|||
161744240|NCT02137837|584102073|FG001|Overall Study|Progression/relapse|7|||
161744241|NCT02137837|584102074|FG002|Overall Study|Progression/relapse|7|||
161744242|NCT02137837|584102072|FG000|Overall Study|Not protocol specified|2|||
161744243|NCT02137837|584102073|FG001|Overall Study|Not protocol specified|1|||
161744244|NCT02137837|584102074|FG002|Overall Study|Not protocol specified|3|||
161744245|NCT01628393|584102075|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
161744246|NCT01628393|584102076|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744247|NCT01628393|584102077|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744248|NCT01628393|584102078|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744249|NCT01628393|584102079|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744250|NCT01628393|584102075|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744251|NCT01628393|584102076|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
161744252|NCT01628393|584102077|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744253|NCT01628393|584102078|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744254|NCT01628393|584102079|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744255|NCT01628393|584102075|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
161744256|NCT01628393|584102076|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
161744257|NCT01628393|584102077|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
161744258|NCT01628393|584102078|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161744259|NCT01628393|584102079|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161744260|NCT01628393|584102075|FG000|Blinded Active Extension Period|Adverse Event|0|||
161744261|NCT01628393|584102076|FG001|Blinded Active Extension Period|Adverse Event|1|||
161744262|NCT01628393|584102077|FG002|Blinded Active Extension Period|Adverse Event|0|||
161744263|NCT01628393|584102078|FG003|Blinded Active Extension Period|Adverse Event|2|||
161744264|NCT01628393|584102079|FG004|Blinded Active Extension Period|Adverse Event|2|||
161744265|NCT01628393|584102075|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
161744266|NCT01628393|584102076|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
161744267|NCT01628393|584102077|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
161744268|NCT01628393|584102078|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
161744269|NCT01628393|584102079|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
161744270|NCT01628393|584102075|FG000|Blinded Active Extension Period|Physician Decision|0|||
161744271|NCT01628393|584102076|FG001|Blinded Active Extension Period|Physician Decision|3|||
161744272|NCT01628393|584102077|FG002|Blinded Active Extension Period|Physician Decision|0|||
161744273|NCT01628393|584102078|FG003|Blinded Active Extension Period|Physician Decision|1|||
161744274|NCT01628393|584102079|FG004|Blinded Active Extension Period|Physician Decision|0|||
161744275|NCT01628393|584102075|FG000|Blinded Active Extension Period|Protocol Violation|0|||
161744276|NCT01628393|584102076|FG001|Blinded Active Extension Period|Protocol Violation|0|||
161744277|NCT01628393|584102077|FG002|Blinded Active Extension Period|Protocol Violation|2|||
161744278|NCT01628393|584102078|FG003|Blinded Active Extension Period|Protocol Violation|1|||
161744279|NCT01628393|584102079|FG004|Blinded Active Extension Period|Protocol Violation|0|||
161744280|NCT01628393|584102075|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
161744281|NCT01628393|584102076|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
161744282|NCT01628393|584102077|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
161744283|NCT01628393|584102078|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
161744284|NCT01628393|584102079|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
161744285|NCT01329341|584102080|FG000|Overall Study|Withdrawal by Subject|44|||
161744286|NCT00448760|584102081|FG000|Overall Study|Death|3|||
161744287|NCT00561340|584102082|FG000|Overall Study|refused to drink pediasure|6|||
161744288|NCT00561340|584102083|FG001|Overall Study|refused to drink pediasure|0|||
161744289|NCT00618995|584102089|FG000|Period 1|Adverse Event|0|||
161744290|NCT00618995|584102090|FG001|Period 1|Adverse Event|0|||
161744291|NCT00618995|584102091|FG002|Period 1|Adverse Event|1|||
161744292|NCT00618995|584102092|FG003|Period 1|Adverse Event|0|||
161744293|NCT00618995|584102089|FG000|Period 1|Protocol Violation|0|||
161744294|NCT00618995|584102090|FG001|Period 1|Protocol Violation|1|||
161744295|NCT00618995|584102091|FG002|Period 1|Protocol Violation|1|||
161744296|NCT00618995|584102092|FG003|Period 1|Protocol Violation|0|||
161744297|NCT00618995|584102089|FG000|Period 2|Protocol Violation|0|||
161744298|NCT00618995|584102090|FG001|Period 2|Protocol Violation|0|||
161744299|NCT00618995|584102091|FG002|Period 2|Protocol Violation|1|||
161744300|NCT00618995|584102092|FG003|Period 2|Protocol Violation|0|||
161744301|NCT00618995|584102089|FG000|Period 4|Adverse Event|1|||
161744302|NCT00618995|584102090|FG001|Period 4|Adverse Event|0|||
161744303|NCT00618995|584102091|FG002|Period 4|Adverse Event|0|||
161744304|NCT00618995|584102092|FG003|Period 4|Adverse Event|0|||
161744305|NCT01306032|584102093|FG000|First Intervention|Adverse Event|1|||
161744306|NCT01306032|584102094|FG001|First Intervention|Adverse Event|0|||
161744307|NCT01306032|584102095|FG002|First Intervention|Adverse Event|1|||
161744308|NCT01306032|584102096|FG003|First Intervention|Adverse Event|0|||
161744309|NCT01306032|584102097|FG004|First Intervention|Adverse Event|0|||
161744310|NCT01306032|584102098|FG005|First Intervention|Adverse Event|1|||
161744311|NCT01306032|584102093|FG000|First Intervention|Withdrawal by Subject|0|||
161744312|NCT01306032|584102094|FG001|First Intervention|Withdrawal by Subject|2|||
161744313|NCT01306032|584102095|FG002|First Intervention|Withdrawal by Subject|0|||
161744314|NCT01306032|584102096|FG003|First Intervention|Withdrawal by Subject|1|||
161744315|NCT01306032|584102097|FG004|First Intervention|Withdrawal by Subject|0|||
161744316|NCT01306032|584102098|FG005|First Intervention|Withdrawal by Subject|0|||
161744317|NCT01306032|584102093|FG000|First Intervention|Death|0|||
161744318|NCT01306032|584102094|FG001|First Intervention|Death|0|||
161744319|NCT01306032|584102095|FG002|First Intervention|Death|1|||
161744320|NCT01306032|584102096|FG003|First Intervention|Death|0|||
161744321|NCT01306032|584102097|FG004|First Intervention|Death|0|||
161744322|NCT01306032|584102098|FG005|First Intervention|Death|0|||
161744323|NCT01306032|584102093|FG000|First Intervention|Ineligible|0|||
161744324|NCT01306032|584102094|FG001|First Intervention|Ineligible|0|||
161744325|NCT01306032|584102095|FG002|First Intervention|Ineligible|0|||
161744326|NCT01306032|584102096|FG003|First Intervention|Ineligible|0|||
161744327|NCT01306032|584102097|FG004|First Intervention|Ineligible|0|||
161744328|NCT01306032|584102098|FG005|First Intervention|Ineligible|1|||
161744329|NCT01306032|584102093|FG000|First Intervention|Progressive disease|0|||
161744330|NCT01306032|584102094|FG001|First Intervention|Progressive disease|0|||
161744331|NCT01306032|584102095|FG002|First Intervention|Progressive disease|0|||
161744332|NCT01306032|584102096|FG003|First Intervention|Progressive disease|0|||
161744333|NCT01306032|584102097|FG004|First Intervention|Progressive disease|2|||
161744334|NCT01306032|584102098|FG005|First Intervention|Progressive disease|0|||
161744335|NCT01306032|584102093|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744336|NCT01306032|584102094|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744337|NCT01306032|584102095|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744338|NCT01306032|584102096|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
161744339|NCT01306032|584102097|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744340|NCT01306032|584102098|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744341|NCT01306032|584102093|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
161744342|NCT01306032|584102094|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
161744343|NCT01306032|584102095|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
161744344|NCT01306032|584102096|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
161744345|NCT01306032|584102097|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
161744346|NCT01306032|584102098|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
161744347|NCT01213264|584102099|FG000|Overall Study|Adverse Event|1|||
161744348|NCT01213264|584102100|FG001|Overall Study|Adverse Event|0|||
161744349|NCT01213264|584102101|FG002|Overall Study|Adverse Event|0|||
161744350|NCT01213264|584102099|FG000|Overall Study|Lost to Follow-up|1|||
161744351|NCT01213264|584102100|FG001|Overall Study|Lost to Follow-up|2|||
161744352|NCT01213264|584102101|FG002|Overall Study|Lost to Follow-up|6|||
161744353|NCT00290589|584102105|FG000|Overall Study|Lost to Follow-up|2|||
161744354|NCT00290589|584102106|FG001|Overall Study|Lost to Follow-up|2|||
161744355|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
161744356|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
161744357|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
161744358|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
161744359|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
161744360|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
161744361|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
161744362|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
161744363|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
161744364|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
161744365|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
161841977|NCT01175811|584466253|FG000|Overall Study|Entry criteria not met|3|||
161841978|NCT01175811|584466254|FG001|Overall Study|Entry criteria not met|1|||
161841979|NCT01175811|584466253|FG000|Overall Study|Lack of Efficacy|1|||
161841980|NCT01175811|584466254|FG001|Overall Study|Lack of Efficacy|0|||
161841981|NCT01175811|584466253|FG000|Overall Study|Lost to Follow-up|3|||
161841982|NCT01175811|584466254|FG001|Overall Study|Lost to Follow-up|2|||
161841983|NCT01175811|584466253|FG000|Overall Study|Physician Decision|1|||
161841984|NCT01175811|584466254|FG001|Overall Study|Physician Decision|1|||
161841985|NCT01175811|584466253|FG000|Overall Study|Protocol Violation|1|||
161841986|NCT01175811|584466254|FG001|Overall Study|Protocol Violation|2|||
161841987|NCT01175811|584466253|FG000|Overall Study|Withdrawal by Subject|6|||
161841988|NCT01175811|584466254|FG001|Overall Study|Withdrawal by Subject|7|||
161841989|NCT02628743|584466256|FG000|Overall Study|Other|3|||
161841990|NCT02628743|584466256|FG000|Overall Study|Withdrawal by Subject|50|||
161841991|NCT02628743|584466256|FG000|Overall Study|Study Terminated by Sponsor|76|||
161841992|NCT02628743|584466256|FG000|Overall Study|Physician Decision|2|||
161841993|NCT04715932|584466257|FG000|Overall Study|Lost to Follow-up|1|||
161841994|NCT04715932|584466258|FG001|Overall Study|Lost to Follow-up|0|||
161841995|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
161841996|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
161841997|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161841998|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161841999|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
161842000|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
161842001|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
161842002|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
161842003|NCT03560986|584466259|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
161842004|NCT03560986|584466260|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
161842005|NCT03560986|584466259|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
161842006|NCT03560986|584466260|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
161842007|NCT03560986|584466259|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
161842008|NCT03560986|584466260|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
161842009|NCT00326963|584466261|FG000|Overall Study|Adverse Event|2|||
161842010|NCT00326963|584466261|FG000|Overall Study|Injection site reaction|1|||
161842011|NCT00326963|584466261|FG000|Overall Study|Death|1|||
161842012|NCT00326963|584466261|FG000|Overall Study|Failure to return|10|||
161842013|NCT00326963|584466261|FG000|Overall Study|Withdrawal by Subject|10|||
161842014|NCT00326963|584466261|FG000|Overall Study|Refused treatment / did not cooperate|5|||
161842015|NCT00326963|584466261|FG000|Overall Study|Violation of selection criteria at entry|2|||
161842016|NCT00326963|584466261|FG000|Overall Study|Other protocol violation|1|||
161842017|NCT00326963|584466261|FG000|Overall Study|Administrative / other|1|||
161842018|NCT00699374|584466262|FG000|Overall Study|Death|93|||
161842019|NCT00699374|584466263|FG001|Overall Study|Death|83|||
161842020|NCT00699374|584466262|FG000|Overall Study|Adverse Event|70|||
161842021|NCT00699374|584466263|FG001|Overall Study|Adverse Event|67|||
161842022|NCT00699374|584466262|FG000|Overall Study|Global deterioration of health status|7|||
161842023|NCT00699374|584466263|FG001|Overall Study|Global deterioration of health status|8|||
161842024|NCT00699374|584466262|FG000|Overall Study|Lost to Follow-up|3|||
161842025|NCT00699374|584466263|FG001|Overall Study|Lost to Follow-up|5|||
161842026|NCT00699374|584466262|FG000|Overall Study|Withdrawal by Subject|34|||
161842027|NCT00699374|584466263|FG001|Overall Study|Withdrawal by Subject|44|||
161842028|NCT00699374|584466262|FG000|Overall Study|Objective progression or relapse|281|||
161842029|NCT00699374|584466263|FG001|Overall Study|Objective progression or relapse|277|||
161842030|NCT00699374|584466262|FG000|Overall Study|Other|18|||
161842031|NCT00699374|584466263|FG001|Overall Study|Other|15|||
161842032|NCT00699374|584466262|FG000|Overall Study|Protocol Violation|2|||
161842033|NCT00699374|584466263|FG001|Overall Study|Protocol Violation|6|||
161842034|NCT00699374|584466262|FG000|Overall Study|Study terminated by sponsor|13|||
161842035|NCT00699374|584466263|FG001|Overall Study|Study terminated by sponsor|28|||
161842036|NCT00699374|584466262|FG000|Overall Study|Randomized but not treated|4|||
161842037|NCT00699374|584466263|FG001|Overall Study|Randomized but not treated|2|||
161842038|NCT00699374|584466262|FG000|Overall Study|Died 28 days after last dose|5|||
161842039|NCT00699374|584466263|FG001|Overall Study|Died 28 days after last dose|9|||
161842040|NCT01783548|584466267|FG000|Overall Study|Adverse Event|8|||
161842041|NCT01783548|584466268|FG001|Overall Study|Adverse Event|4|||
161842042|NCT01783548|584466267|FG000|Overall Study|Withdrawal by Subject|11|||
161842043|NCT01783548|584466268|FG001|Overall Study|Withdrawal by Subject|8|||
161842044|NCT01783548|584466267|FG000|Overall Study|Non-compliance|4|||
161842045|NCT01783548|584466268|FG001|Overall Study|Non-compliance|0|||
161842046|NCT01783548|584466267|FG000|Overall Study|Protocol Violation|2|||
161842047|NCT01783548|584466268|FG001|Overall Study|Protocol Violation|2|||
161842048|NCT01783548|584466267|FG000|Overall Study|Lost to Follow-up|8|||
161842049|NCT01783548|584466268|FG001|Overall Study|Lost to Follow-up|3|||
161842050|NCT01783548|584466267|FG000|Overall Study|Lack of Efficacy|1|||
161842051|NCT01783548|584466268|FG001|Overall Study|Lack of Efficacy|1|||
161842052|NCT04645966|584466269|FG000|Vaccination Phase|Adverse Event|1|||
161842053|NCT04645966|584466270|FG001|Vaccination Phase|Adverse Event|0|||
161842054|NCT04645966|584466271|FG002|Vaccination Phase|Adverse Event|0|||
161842055|NCT04645966|584466272|FG003|Vaccination Phase|Adverse Event|0|||
161842056|NCT04645966|584466273|FG004|Vaccination Phase|Adverse Event|0|||
161842057|NCT04645966|584466274|FG005|Vaccination Phase|Adverse Event|0|||
161842058|NCT04645966|584466275|FG006|Vaccination Phase|Adverse Event|1|||
161842059|NCT04645966|584466276|FG007|Vaccination Phase|Adverse Event|0|||
161842060|NCT04645966|584466277|FG008|Vaccination Phase|Adverse Event|0|||
161842061|NCT04645966|584466269|FG000|Vaccination Phase|Death|0|||
161842062|NCT04645966|584466270|FG001|Vaccination Phase|Death|0|||
161842063|NCT04645966|584466271|FG002|Vaccination Phase|Death|0|||
161842064|NCT04645966|584466272|FG003|Vaccination Phase|Death|0|||
161842065|NCT04645966|584466273|FG004|Vaccination Phase|Death|0|||
161842066|NCT04645966|584466274|FG005|Vaccination Phase|Death|1|||
161842067|NCT04645966|584466275|FG006|Vaccination Phase|Death|0|||
161842068|NCT04645966|584466276|FG007|Vaccination Phase|Death|0|||
161842069|NCT04645966|584466277|FG008|Vaccination Phase|Death|0|||
161842070|NCT04645966|584466269|FG000|Vaccination Phase|Protocol Violation|0|||
161842071|NCT04645966|584466270|FG001|Vaccination Phase|Protocol Violation|0|||
161842072|NCT04645966|584466271|FG002|Vaccination Phase|Protocol Violation|0|||
161842073|NCT04645966|584466272|FG003|Vaccination Phase|Protocol Violation|0|||
161842074|NCT04645966|584466273|FG004|Vaccination Phase|Protocol Violation|1|||
161842075|NCT04645966|584466274|FG005|Vaccination Phase|Protocol Violation|0|||
161842076|NCT04645966|584466275|FG006|Vaccination Phase|Protocol Violation|0|||
161842077|NCT04645966|584466276|FG007|Vaccination Phase|Protocol Violation|0|||
161842078|NCT04645966|584466277|FG008|Vaccination Phase|Protocol Violation|0|||
161842079|NCT04645966|584466269|FG000|Vaccination Phase|Study terminated by sponsor|0|||
161842080|NCT04645966|584466270|FG001|Vaccination Phase|Study terminated by sponsor|0|||
161842081|NCT04645966|584466271|FG002|Vaccination Phase|Study terminated by sponsor|14|||
161842082|NCT04645966|584466272|FG003|Vaccination Phase|Study terminated by sponsor|15|||
161842083|NCT04645966|584466273|FG004|Vaccination Phase|Study terminated by sponsor|47|||
161842084|NCT04645966|584466274|FG005|Vaccination Phase|Study terminated by sponsor|43|||
161842085|NCT04645966|584466275|FG006|Vaccination Phase|Study terminated by sponsor|29|||
161842086|NCT04645966|584466276|FG007|Vaccination Phase|Study terminated by sponsor|29|||
161842087|NCT04645966|584466277|FG008|Vaccination Phase|Study terminated by sponsor|12|||
161842088|NCT04645966|584466269|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842089|NCT04645966|584466270|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842090|NCT04645966|584466271|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
161842091|NCT04645966|584466272|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
161842092|NCT04645966|584466273|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
161842093|NCT04645966|584466274|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
161842094|NCT04645966|584466275|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842095|NCT04645966|584466276|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
161842096|NCT04645966|584466277|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842097|NCT04645966|584466269|FG000|Vaccination Phase|Other|0|||
161842098|NCT04645966|584466270|FG001|Vaccination Phase|Other|0|||
161842099|NCT04645966|584466271|FG002|Vaccination Phase|Other|0|||
161842100|NCT04645966|584466272|FG003|Vaccination Phase|Other|0|||
161842101|NCT04645966|584466273|FG004|Vaccination Phase|Other|0|||
161842102|NCT04645966|584466274|FG005|Vaccination Phase|Other|2|||
161842103|NCT04645966|584466275|FG006|Vaccination Phase|Other|0|||
161842104|NCT04645966|584466276|FG007|Vaccination Phase|Other|0|||
161842105|NCT04645966|584466277|FG008|Vaccination Phase|Other|0|||
161842106|NCT04645966|584466269|FG000|Vaccination Phase|Lost to Follow-up|0|||
161744366|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
161744367|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
161744368|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
161744369|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
161744370|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
161744371|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
161744372|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
161744373|NCT01700985|584102111|FG000|Overall Study|Incarcerated|0|||
161744374|NCT01700985|584102112|FG001|Overall Study|Incarcerated|1|||
161744375|NCT00965146|584102113|FG000|Overall Study|Death|7|||
161744376|NCT00965146|584102113|FG000|Overall Study|Lost to Follow-up|22|||
161744377|NCT00965146|584102113|FG000|Overall Study|Withdrawal by Subject|17|||
161744378|NCT00965146|584102113|FG000|Overall Study|Unable to return|1|||
161744379|NCT00965146|584102113|FG000|Overall Study|Unwilling to return|11|||
161744380|NCT00965146|584102113|FG000|Overall Study|Intercurrent illness|1|||
161744381|NCT00965146|584102113|FG000|Overall Study|Revision / Removal of Study Implant|6|||
161744382|NCT00965146|584102113|FG000|Overall Study|Overall Study Termination|145|||
161744383|NCT05067452|584102114|FG000|Overall Study|Lost to Follow-up|0|||
161744384|NCT05067452|584102115|FG001|Overall Study|Lost to Follow-up|4|||
161744385|NCT01135017|584102116|FG000|Overall Study|Adverse Event|3|||
161744386|NCT01135017|584102117|FG001|Overall Study|Adverse Event|8|||
161744387|NCT01135017|584102116|FG000|Overall Study|Other than above|3|||
161744388|NCT01135017|584102117|FG001|Overall Study|Other than above|4|||
161744389|NCT01148693|584102118|FG000|Overall Study|Attempts for cannulation were failed|13|||
161744390|NCT01148693|584102119|FG001|Overall Study|Attempts for cannulation were failed|10|||
161744391|NCT00432562|584102120|FG000|Overall Study|Death|3|||
161744392|NCT00432562|584102121|FG001|Overall Study|Death|0|||
161744393|NCT03970824|584102122|FG000|Overall Study|Withdrawal by Subject|1|||
161744394|NCT03970824|584102123|FG001|Overall Study|Withdrawal by Subject|1|||
161744395|NCT03970824|584102124|FG002|Overall Study|Withdrawal by Subject|3|||
161744396|NCT03970824|584102122|FG000|Overall Study|Lost to Follow-up|0|||
161744397|NCT03970824|584102123|FG001|Overall Study|Lost to Follow-up|2|||
161744398|NCT03970824|584102124|FG002|Overall Study|Lost to Follow-up|1|||
161744399|NCT03970824|584102122|FG000|Overall Study|Adverse Event|1|||
161744400|NCT03970824|584102123|FG001|Overall Study|Adverse Event|0|||
161744401|NCT03970824|584102124|FG002|Overall Study|Adverse Event|0|||
161744402|NCT00507416|584102127|FG000|Overall Study|Adverse Event|58|||
161744403|NCT00507416|584102128|FG001|Overall Study|Adverse Event|67|||
161744404|NCT00507416|584102129|FG002|Overall Study|Adverse Event|65|||
161744405|NCT00507416|584102127|FG000|Overall Study|Protocol Violation|1|||
161744406|NCT00507416|584102128|FG001|Overall Study|Protocol Violation|2|||
161744407|NCT00507416|584102129|FG002|Overall Study|Protocol Violation|0|||
161744408|NCT00507416|584102127|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
161744409|NCT00507416|584102128|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
161744410|NCT00507416|584102129|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
161744411|NCT00507416|584102127|FG000|Overall Study|Progressive Disease|20|||
161744412|NCT00507416|584102128|FG001|Overall Study|Progressive Disease|10|||
161744413|NCT00507416|584102129|FG002|Overall Study|Progressive Disease|13|||
161744414|NCT00507416|584102127|FG000|Overall Study|Patient declined further treatment|18|||
161744415|NCT00507416|584102128|FG001|Overall Study|Patient declined further treatment|14|||
161744416|NCT00507416|584102129|FG002|Overall Study|Patient declined further treatment|11|||
161744417|NCT00507416|584102127|FG000|Overall Study|Other|11|||
161744418|NCT00507416|584102128|FG001|Overall Study|Other|16|||
161744419|NCT00507416|584102129|FG002|Overall Study|Other|13|||
161744420|NCT00507416|584102127|FG000|Overall Study|Did not Receive Study Treatment|3|||
161744421|NCT00507416|584102128|FG001|Overall Study|Did not Receive Study Treatment|9|||
161744422|NCT00507416|584102129|FG002|Overall Study|Did not Receive Study Treatment|4|||
161744423|NCT00964158|584102130|FG000|Overall Study|Lost to Follow-up|0|||
161744424|NCT00964158|584102131|FG001|Overall Study|Lost to Follow-up|1|||
161744425|NCT00964158|584102132|FG002|Overall Study|Lost to Follow-up|2|||
161744426|NCT00964158|584102130|FG000|Overall Study|Withdrawal by Subject|0|||
161842107|NCT04645966|584466270|FG001|Vaccination Phase|Lost to Follow-up|0|||
161744427|NCT00964158|584102131|FG001|Overall Study|Withdrawal by Subject|0|||
161744428|NCT00964158|584102132|FG002|Overall Study|Withdrawal by Subject|6|||
161744429|NCT03101514|584102133|FG000|Overall Study|Withdrawal by Subject|4|||
161744430|NCT03101514|584102133|FG000|Overall Study|Protocol Violation|2|||
161744431|NCT03101514|584102133|FG000|Overall Study|patient's information was incomplete|1|||
161744432|NCT03695393|584102142|FG000|Overall Study|Death|3|||
161744433|NCT03695393|584102143|FG001|Overall Study|Death|1|||
161744434|NCT03695393|584102142|FG000|Overall Study|Lost to Follow-up|0|||
161744435|NCT03695393|584102143|FG001|Overall Study|Lost to Follow-up|1|||
161744436|NCT04585451|584102144|FG000|Overall Study|Withdrawal by Subject|26|||
161744437|NCT04585451|584102145|FG001|Overall Study|Withdrawal by Subject|0|||
161744438|NCT01578785|584102146|FG000|Overall Study|Withdrawal by Subject|0|||
161744439|NCT01578785|584102147|FG001|Overall Study|Withdrawal by Subject|1|||
161842108|NCT04645966|584466271|FG002|Vaccination Phase|Lost to Follow-up|0|||
161744440|NCT01578785|584102146|FG000|Overall Study|Study terminated by sponsor|59|||
161744441|NCT01578785|584102147|FG001|Overall Study|Study terminated by sponsor|118|||
161744442|NCT00966693|584102148|FG000|Overall Study|Adverse Event|0|||
161744443|NCT00966693|584102149|FG001|Overall Study|Adverse Event|0|||
161744444|NCT00966693|584102150|FG002|Overall Study|Adverse Event|1|||
161744445|NCT00966693|584102151|FG003|Overall Study|Adverse Event|2|||
161744446|NCT00966693|584102148|FG000|Overall Study|Death|0|||
161744447|NCT00966693|584102149|FG001|Overall Study|Death|0|||
161744448|NCT00966693|584102150|FG002|Overall Study|Death|1|||
161744449|NCT00966693|584102151|FG003|Overall Study|Death|0|||
161744450|NCT00966693|584102148|FG000|Overall Study|Withdrawal by Subject|1|||
161744451|NCT00966693|584102149|FG001|Overall Study|Withdrawal by Subject|0|||
161744452|NCT00966693|584102150|FG002|Overall Study|Withdrawal by Subject|0|||
161744453|NCT00966693|584102151|FG003|Overall Study|Withdrawal by Subject|5|||
161744454|NCT00966693|584102148|FG000|Overall Study|Disease Progression|0|||
161744455|NCT00966693|584102149|FG001|Overall Study|Disease Progression|0|||
161744456|NCT00966693|584102150|FG002|Overall Study|Disease Progression|1|||
161744457|NCT00966693|584102151|FG003|Overall Study|Disease Progression|16|||
161744458|NCT01769469|584102152|FG000|Overall Study|Consent Withdrawn|5|||
161744459|NCT01769469|584102152|FG000|Overall Study|Moved Out Of Area|3|||
161744460|NCT01769469|584102152|FG000|Overall Study|Lost to Follow-up|17|||
161744461|NCT01769469|584102152|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
161744462|NCT01769469|584102152|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
161744463|NCT02713789|584102164|FG000|Overall Study|Lost to Follow-up|0|||
161744464|NCT02713789|584102165|FG001|Overall Study|Lost to Follow-up|1|||
161744465|NCT02713789|584102166|FG002|Overall Study|Lost to Follow-up|1|||
161744466|NCT04186663|584102175|FG000|Overall Study|Lost to Follow-up|1|||
161744467|NCT04186663|584102175|FG000|Overall Study|Unable to complete blood draw|3|||
161744468|NCT01736254|584102177|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
161744469|NCT01736254|584102177|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
161744470|NCT01375647|584103611|FG000|Overall Study|Lost to Follow-up|3|||
161744471|NCT01375647|584103612|FG001|Overall Study|Lost to Follow-up|3|||
161744472|NCT01375647|584103613|FG002|Overall Study|Lost to Follow-up|7|||
161744473|NCT01375647|584103614|FG003|Overall Study|Lost to Follow-up|10|||
161744474|NCT01375647|584103611|FG000|Overall Study|Death|1|||
161744475|NCT01375647|584103612|FG001|Overall Study|Death|2|||
161744476|NCT01375647|584103613|FG002|Overall Study|Death|1|||
161744477|NCT01375647|584103614|FG003|Overall Study|Death|0|||
161744478|NCT01375647|584103611|FG000|Overall Study|Withdrawal by Subject|17|||
161744479|NCT01375647|584103612|FG001|Overall Study|Withdrawal by Subject|20|||
161744480|NCT01375647|584103613|FG002|Overall Study|Withdrawal by Subject|26|||
161744481|NCT01375647|584103614|FG003|Overall Study|Withdrawal by Subject|14|||
161744482|NCT01375647|584103611|FG000|Overall Study|Physician Decision|1|||
161744483|NCT01375647|584103612|FG001|Overall Study|Physician Decision|0|||
161744484|NCT01375647|584103613|FG002|Overall Study|Physician Decision|0|||
161744485|NCT01375647|584103614|FG003|Overall Study|Physician Decision|0|||
161744486|NCT03788967|584103617|FG000|Overall Study|Lost to Follow-up|14|||
161744487|NCT03788967|584103618|FG001|Overall Study|Lost to Follow-up|10|||
161744488|NCT03788967|584103617|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
161744489|NCT03788967|584103618|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
161744490|NCT03788967|584103617|FG000|Overall Study|Participant Withdrawal of Consent|13|||
161744491|NCT03788967|584103618|FG001|Overall Study|Participant Withdrawal of Consent|5|||
161744492|NCT03788967|584103617|FG000|Overall Study|Adverse Event|1|||
161744493|NCT03788967|584103618|FG001|Overall Study|Adverse Event|1|||
161744494|NCT03788967|584103617|FG000|Overall Study|COVID-19|1|||
161744495|NCT03788967|584103618|FG001|Overall Study|COVID-19|2|||
161744496|NCT04268303|584103619|FG000|Overall Study|Lost to Follow-up|1|||
161744497|NCT04268303|584103620|FG001|Overall Study|Lost to Follow-up|1|||
161744498|NCT04268303|584103621|FG002|Overall Study|Lost to Follow-up|2|||
161744499|NCT04268303|584103619|FG000|Overall Study|Withdrawal by Subject|0|||
161744500|NCT04268303|584103620|FG001|Overall Study|Withdrawal by Subject|1|||
161744501|NCT04268303|584103621|FG002|Overall Study|Withdrawal by Subject|1|||
161744502|NCT04268303|584103619|FG000|Overall Study|Adverse Event|2|||
161744503|NCT04268303|584103620|FG001|Overall Study|Adverse Event|0|||
161744504|NCT04268303|584103621|FG002|Overall Study|Adverse Event|0|||
161744505|NCT00355134|584103622|FG000|Core Phase|Withdrawal by Subject|35|||
161744506|NCT00355134|584103623|FG001|Core Phase|Withdrawal by Subject|24|||
161744507|NCT00355134|584103624|FG002|Core Phase|Withdrawal by Subject|35|||
161744508|NCT00355134|584103625|FG003|Core Phase|Withdrawal by Subject|0|||
161744509|NCT00355134|584103626|FG004|Core Phase|Withdrawal by Subject|0|||
161744510|NCT00355134|584103622|FG000|Core Phase|Adverse Event|28|||
161744511|NCT00355134|584103623|FG001|Core Phase|Adverse Event|22|||
161744512|NCT00355134|584103624|FG002|Core Phase|Adverse Event|16|||
161744513|NCT00355134|584103625|FG003|Core Phase|Adverse Event|0|||
161744514|NCT00355134|584103626|FG004|Core Phase|Adverse Event|0|||
161744515|NCT00355134|584103622|FG000|Core Phase|Lost to Follow-up|17|||
161744516|NCT00355134|584103623|FG001|Core Phase|Lost to Follow-up|13|||
161744517|NCT00355134|584103624|FG002|Core Phase|Lost to Follow-up|21|||
161744518|NCT00355134|584103625|FG003|Core Phase|Lost to Follow-up|0|||
161744519|NCT00355134|584103626|FG004|Core Phase|Lost to Follow-up|0|||
161744520|NCT00355134|584103622|FG000|Core Phase|Abnormal laboratory value(s)|19|||
161744521|NCT00355134|584103623|FG001|Core Phase|Abnormal laboratory value(s)|14|||
161744522|NCT00355134|584103624|FG002|Core Phase|Abnormal laboratory value(s)|2|||
161744523|NCT00355134|584103625|FG003|Core Phase|Abnormal laboratory value(s)|0|||
161744524|NCT00355134|584103626|FG004|Core Phase|Abnormal laboratory value(s)|0|||
161744525|NCT00355134|584103622|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
161744526|NCT00355134|584103623|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
161744527|NCT00355134|584103624|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
161744528|NCT00355134|584103625|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
161744529|NCT00355134|584103626|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
161744530|NCT00355134|584103622|FG000|Core Phase|Administrative problems|5|||
161744531|NCT00355134|584103623|FG001|Core Phase|Administrative problems|3|||
161744532|NCT00355134|584103624|FG002|Core Phase|Administrative problems|5|||
161744533|NCT00355134|584103625|FG003|Core Phase|Administrative problems|0|||
161744534|NCT00355134|584103626|FG004|Core Phase|Administrative problems|0|||
161744535|NCT00355134|584103622|FG000|Core Phase|Protocol Violation|3|||
161744536|NCT00355134|584103623|FG001|Core Phase|Protocol Violation|2|||
161744537|NCT00355134|584103624|FG002|Core Phase|Protocol Violation|2|||
161744538|NCT00355134|584103625|FG003|Core Phase|Protocol Violation|0|||
161744539|NCT00355134|584103626|FG004|Core Phase|Protocol Violation|0|||
161744540|NCT00355134|584103622|FG000|Core Phase|Abnormal test procedure result(s)|1|||
161744541|NCT00355134|584103623|FG001|Core Phase|Abnormal test procedure result(s)|2|||
161744542|NCT00355134|584103624|FG002|Core Phase|Abnormal test procedure result(s)|1|||
161744543|NCT00355134|584103625|FG003|Core Phase|Abnormal test procedure result(s)|0|||
161744544|NCT00355134|584103626|FG004|Core Phase|Abnormal test procedure result(s)|0|||
161744545|NCT00355134|584103622|FG000|Core Phase|Condition no longer requires study drug|1|||
161744546|NCT00355134|584103623|FG001|Core Phase|Condition no longer requires study drug|0|||
161744547|NCT00355134|584103624|FG002|Core Phase|Condition no longer requires study drug|1|||
161744548|NCT00355134|584103625|FG003|Core Phase|Condition no longer requires study drug|0|||
161744549|NCT00355134|584103626|FG004|Core Phase|Condition no longer requires study drug|0|||
161744550|NCT00355134|584103622|FG000|Extension Phase|Withdrawal by Subject|7|||
161744551|NCT00355134|584103623|FG001|Extension Phase|Withdrawal by Subject|11|||
161744552|NCT00355134|584103624|FG002|Extension Phase|Withdrawal by Subject|0|||
161744553|NCT00355134|584103625|FG003|Extension Phase|Withdrawal by Subject|7|||
161744554|NCT00355134|584103626|FG004|Extension Phase|Withdrawal by Subject|5|||
161744555|NCT00355134|584103622|FG000|Extension Phase|Adverse Event|13|||
161744556|NCT00355134|584103623|FG001|Extension Phase|Adverse Event|9|||
161744557|NCT00355134|584103624|FG002|Extension Phase|Adverse Event|0|||
161744558|NCT00355134|584103625|FG003|Extension Phase|Adverse Event|3|||
161744559|NCT00355134|584103626|FG004|Extension Phase|Adverse Event|5|||
161744560|NCT00355134|584103622|FG000|Extension Phase|Lost to Follow-up|2|||
161744561|NCT00355134|584103623|FG001|Extension Phase|Lost to Follow-up|6|||
161744562|NCT00355134|584103624|FG002|Extension Phase|Lost to Follow-up|0|||
161842109|NCT04645966|584466272|FG003|Vaccination Phase|Lost to Follow-up|0|||
161744563|NCT00355134|584103625|FG003|Extension Phase|Lost to Follow-up|2|||
161744564|NCT00355134|584103626|FG004|Extension Phase|Lost to Follow-up|4|||
161744565|NCT00355134|584103622|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
161744566|NCT00355134|584103623|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
161744567|NCT00355134|584103624|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
161744568|NCT00355134|584103625|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
161842110|NCT04645966|584466273|FG004|Vaccination Phase|Lost to Follow-up|0|||
161744569|NCT00355134|584103626|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
161744570|NCT00355134|584103622|FG000|Extension Phase|Administrative problems|2|||
161744571|NCT00355134|584103623|FG001|Extension Phase|Administrative problems|4|||
161744572|NCT00355134|584103624|FG002|Extension Phase|Administrative problems|0|||
161744573|NCT00355134|584103625|FG003|Extension Phase|Administrative problems|1|||
161744574|NCT00355134|584103626|FG004|Extension Phase|Administrative problems|1|||
161744575|NCT00355134|584103622|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
161744576|NCT00355134|584103623|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
161744577|NCT00355134|584103624|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161744578|NCT00355134|584103625|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
161744579|NCT00355134|584103626|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
161744580|NCT00355134|584103622|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
161744581|NCT00355134|584103623|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
161744582|NCT00355134|584103624|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
161744583|NCT00355134|584103625|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
161744584|NCT00355134|584103626|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
161744585|NCT00355134|584103622|FG000|Extension Phase|Protocol Violation|0|||
161744586|NCT00355134|584103623|FG001|Extension Phase|Protocol Violation|0|||
161744587|NCT00355134|584103624|FG002|Extension Phase|Protocol Violation|0|||
161744588|NCT00355134|584103625|FG003|Extension Phase|Protocol Violation|1|||
161744589|NCT00355134|584103626|FG004|Extension Phase|Protocol Violation|0|||
161744590|NCT01316939|584103629|FG000|Overall Study|Study closed/terminated|26|||
161744591|NCT01316939|584103630|FG001|Overall Study|Study closed/terminated|25|||
161744592|NCT01316939|584103631|FG002|Overall Study|Study closed/terminated|23|||
161744593|NCT01316939|584103629|FG000|Overall Study|Lack of Efficacy|24|||
161744594|NCT01316939|584103630|FG001|Overall Study|Lack of Efficacy|25|||
161744595|NCT01316939|584103631|FG002|Overall Study|Lack of Efficacy|25|||
161744596|NCT01316939|584103629|FG000|Overall Study|Adverse Event|9|||
161744597|NCT01316939|584103630|FG001|Overall Study|Adverse Event|12|||
161744598|NCT01316939|584103631|FG002|Overall Study|Adverse Event|11|||
161744599|NCT01316939|584103629|FG000|Overall Study|Withdrawal by Subject|1|||
161744600|NCT01316939|584103630|FG001|Overall Study|Withdrawal by Subject|3|||
161744601|NCT01316939|584103631|FG002|Overall Study|Withdrawal by Subject|6|||
161744602|NCT01316939|584103629|FG000|Overall Study|Physician Decision|2|||
161744603|NCT01316939|584103630|FG001|Overall Study|Physician Decision|2|||
161744604|NCT01316939|584103631|FG002|Overall Study|Physician Decision|1|||
161744605|NCT01316939|584103629|FG000|Overall Study|Lost to Follow-up|0|||
161744606|NCT01316939|584103630|FG001|Overall Study|Lost to Follow-up|0|||
161744607|NCT01316939|584103631|FG002|Overall Study|Lost to Follow-up|2|||
161744608|NCT01316939|584103629|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
161744609|NCT01316939|584103630|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
161744610|NCT01316939|584103631|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
161744611|NCT01316939|584103629|FG000|Overall Study|Protocol Violation|0|||
161744612|NCT01316939|584103630|FG001|Overall Study|Protocol Violation|1|||
161744613|NCT01316939|584103631|FG002|Overall Study|Protocol Violation|0|||
161744614|NCT02715804|584103632|FG000|Overall Study|Death|222|||
161744615|NCT02715804|584103633|FG001|Overall Study|Death|106|||
161744616|NCT02715804|584103632|FG000|Overall Study|Withdrawal by Subject|5|||
161744617|NCT02715804|584103633|FG001|Overall Study|Withdrawal by Subject|4|||
161744618|NCT02715804|584103632|FG000|Overall Study|Other than specified|2|||
161744619|NCT02715804|584103633|FG001|Overall Study|Other than specified|3|||
161744620|NCT01625611|584103636|FG000|Overall Study|No adlib drinks Lab 1|3|||
161744621|NCT01625611|584103637|FG001|Overall Study|No adlib drinks Lab 1|0|||
161744622|NCT01625611|584103636|FG000|Overall Study|Technical issues with PET|1|||
161744623|NCT01625611|584103637|FG001|Overall Study|Technical issues with PET|0|||
161744624|NCT01625611|584103636|FG000|Overall Study|Unable to complete study procedures|1|||
161744625|NCT01625611|584103637|FG001|Overall Study|Unable to complete study procedures|0|||
161744626|NCT01625611|584103636|FG000|Overall Study|Withdrawal by Subject|3|||
161744627|NCT01625611|584103637|FG001|Overall Study|Withdrawal by Subject|0|||
161842111|NCT04645966|584466274|FG005|Vaccination Phase|Lost to Follow-up|0|||
161842112|NCT04645966|584466275|FG006|Vaccination Phase|Lost to Follow-up|0|||
161842113|NCT04645966|584466276|FG007|Vaccination Phase|Lost to Follow-up|1|||
161744628|NCT00948194|584103638|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
161744629|NCT00948194|584103639|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
161744630|NCT00233324|584103640|FG000|Main Study|Death|68|||
161744631|NCT00233324|584103641|FG001|Main Study|Death|60|||
161744632|NCT00233324|584103642|FG002|Main Study|Death|62|||
161744633|NCT00233324|584103643|FG003|Main Study|Death|47|||
161744634|NCT00233324|584103640|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
161744635|NCT00233324|584103641|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
161842114|NCT04645966|584466277|FG008|Vaccination Phase|Lost to Follow-up|0|||
161744636|NCT00233324|584103642|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
161744637|NCT00233324|584103643|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
161744638|NCT00233324|584103640|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
161744639|NCT00233324|584103641|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
161744640|NCT00233324|584103642|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
161744641|NCT00233324|584103643|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
161744642|NCT01281189|584103650|FG000|Overall Study|Adverse Event|7|||
161744643|NCT01281189|584103651|FG001|Overall Study|Adverse Event|9|||
161744644|NCT01281189|584103650|FG000|Overall Study|Lost to Follow-up|6|||
161744645|NCT01281189|584103651|FG001|Overall Study|Lost to Follow-up|4|||
161744646|NCT01281189|584103650|FG000|Overall Study|Withdrawal by Subject|21|||
161744647|NCT01281189|584103651|FG001|Overall Study|Withdrawal by Subject|24|||
161744648|NCT01281189|584103650|FG000|Overall Study|Physician Decision|2|||
161744649|NCT01281189|584103651|FG001|Overall Study|Physician Decision|3|||
161744650|NCT01281189|584103650|FG000|Overall Study|Death|103|||
161744651|NCT01281189|584103651|FG001|Overall Study|Death|91|||
161744652|NCT01281189|584103650|FG000|Overall Study|Other|8|||
161744653|NCT01281189|584103651|FG001|Overall Study|Other|12|||
161744654|NCT00527072|584103658|FG000|Overall Study|Adverse Event|13|||
161744655|NCT00527072|584103658|FG000|Overall Study|Lack of Efficacy|11|||
161744656|NCT00527072|584103658|FG000|Overall Study|Lost to Follow-up|3|||
161744657|NCT00527072|584103658|FG000|Overall Study|Protocol Violation|2|||
161744658|NCT00527072|584103658|FG000|Overall Study|Withdrawal by Subject|7|||
161744659|NCT02657434|584103659|FG000|Overall Study|Study Terminated By Sponsor|64|||
161744660|NCT02657434|584103660|FG001|Overall Study|Study Terminated By Sponsor|82|||
161744661|NCT02657434|584103659|FG000|Overall Study|Death|189|||
161744662|NCT02657434|584103660|FG001|Overall Study|Death|190|||
161744663|NCT02657434|584103659|FG000|Overall Study|Lost to Follow-up|2|||
161744664|NCT02657434|584103660|FG001|Overall Study|Lost to Follow-up|2|||
161744665|NCT02657434|584103659|FG000|Overall Study|Randomization by Error|2|||
161744666|NCT02657434|584103660|FG001|Overall Study|Randomization by Error|0|||
161744667|NCT02657434|584103659|FG000|Overall Study|Withdrawal by Subject|28|||
161744668|NCT02657434|584103660|FG001|Overall Study|Withdrawal by Subject|17|||
161744669|NCT02657434|584103659|FG000|Overall Study|Protocol Violation|1|||
161744670|NCT02657434|584103660|FG001|Overall Study|Protocol Violation|0|||
161744671|NCT02657434|584103659|FG000|Overall Study|Physician Decision|0|||
161744672|NCT02657434|584103660|FG001|Overall Study|Physician Decision|1|||
161744673|NCT00608881|584103661|FG000|Overall Study|Death|22|||
161744674|NCT00608881|584103662|FG001|Overall Study|Death|13|||
161744675|NCT00608881|584103661|FG000|Overall Study|Adverse Event|5|||
161744676|NCT00608881|584103662|FG001|Overall Study|Adverse Event|3|||
161744677|NCT00608881|584103661|FG000|Overall Study|Lost to Follow-up|28|||
161744678|NCT00608881|584103662|FG001|Overall Study|Lost to Follow-up|14|||
161744679|NCT00608881|584103661|FG000|Overall Study|Withdrawal by Subject|18|||
161744680|NCT00608881|584103662|FG001|Overall Study|Withdrawal by Subject|29|||
161744681|NCT00608881|584103661|FG000|Overall Study|Physician Decision|5|||
161744682|NCT00608881|584103662|FG001|Overall Study|Physician Decision|5|||
161744683|NCT00608881|584103661|FG000|Overall Study|Institutionalized|1|||
161744684|NCT00608881|584103662|FG001|Overall Study|Institutionalized|2|||
161744685|NCT00510484|584103663|FG000|Wash-out Period|Adverse Event|0|||
161744686|NCT00510484|584103664|FG001|Wash-out Period|Adverse Event|1|||
161744687|NCT01590212|584103665|FG000|Overall Study|Withdrawal by Subject|2|||
161744688|NCT01590212|584103666|FG001|Overall Study|Withdrawal by Subject|2|||
161744689|NCT01590212|584103667|FG002|Overall Study|Withdrawal by Subject|2|||
161744690|NCT01590212|584103665|FG000|Overall Study|Lost to Follow-up|1|||
161744691|NCT01590212|584103666|FG001|Overall Study|Lost to Follow-up|2|||
161744692|NCT01590212|584103667|FG002|Overall Study|Lost to Follow-up|3|||
161744693|NCT03004976|584103668|FG000|Overall Study|Lost to Follow-up|7|||
161744694|NCT03004976|584103669|FG001|Overall Study|Lost to Follow-up|5|||
161744695|NCT03004976|584103668|FG000|Overall Study|Physician Decision|1|||
161744696|NCT03004976|584103669|FG001|Overall Study|Physician Decision|0|||
161744697|NCT03004976|584103668|FG000|Overall Study|Withdrawal by Subject|1|||
161744698|NCT03004976|584103669|FG001|Overall Study|Withdrawal by Subject|0|||
161744699|NCT03004976|584103668|FG000|Overall Study|Death|4|||
161744700|NCT03004976|584103669|FG001|Overall Study|Death|1|||
161744701|NCT02533401|584103670|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
161744702|NCT02533401|584103670|FG000|Overall Study|Death|5|||
161842115|NCT04645966|584466269|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
161842116|NCT04645966|584466270|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
161842117|NCT04645966|584466271|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
161842118|NCT04645966|584466272|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
161842119|NCT04645966|584466273|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
161842120|NCT04645966|584466274|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
161842121|NCT04645966|584466275|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
161842122|NCT04645966|584466276|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
161842123|NCT04645966|584466277|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
161842124|NCT04645966|584466269|FG000|Follow-up Phase|Lost to Follow-up|0|||
161842125|NCT04645966|584466270|FG001|Follow-up Phase|Lost to Follow-up|0|||
161842126|NCT04645966|584466271|FG002|Follow-up Phase|Lost to Follow-up|0|||
161842127|NCT04645966|584466272|FG003|Follow-up Phase|Lost to Follow-up|0|||
161842128|NCT04645966|584466273|FG004|Follow-up Phase|Lost to Follow-up|0|||
161842129|NCT04645966|584466274|FG005|Follow-up Phase|Lost to Follow-up|0|||
161842130|NCT04645966|584466275|FG006|Follow-up Phase|Lost to Follow-up|0|||
161842131|NCT04645966|584466276|FG007|Follow-up Phase|Lost to Follow-up|1|||
161842132|NCT04645966|584466277|FG008|Follow-up Phase|Lost to Follow-up|0|||
161842133|NCT00552578|584466281|FG000|Overall Study|Lost to Follow-up|1|||
161842134|NCT00552578|584466282|FG001|Overall Study|Lost to Follow-up|1|||
161842135|NCT04729309|584466283|FG000|Period 1|Subject unable to return for Period 2|3|||
161842136|NCT04729309|584466284|FG001|Period 1|Subject unable to return for Period 2|0|||
161842137|NCT04729309|584466283|FG000|Period 1|Lost to Follow-up|1|||
161842138|NCT04729309|584466284|FG001|Period 1|Lost to Follow-up|0|||
161842139|NCT02695537|584466294|FG000|Overall Study|Adverse Event|3|||
161842140|NCT02695537|584466294|FG000|Overall Study|Lack of Efficacy|28|||
161842141|NCT02695537|584466294|FG000|Overall Study|Withdrawal by Subject|4|||
161842142|NCT02695537|584466294|FG000|Overall Study|Protocol Violation|3|||
161842143|NCT04015908|584466295|FG000|Overall Study|Lost to Follow-up|0|||
161842144|NCT04015908|584466296|FG001|Overall Study|Lost to Follow-up|1|||
161842145|NCT02792699|584466297|FG000|Overall Study|Adverse Event|1|||
161842146|NCT02792699|584466298|FG001|Overall Study|Adverse Event|2|||
161842147|NCT02792699|584466299|FG002|Overall Study|Adverse Event|4|||
161842148|NCT02792699|584466297|FG000|Overall Study|Withdrawal by Subject|4|||
161842149|NCT02792699|584466298|FG001|Overall Study|Withdrawal by Subject|4|||
161842150|NCT02792699|584466299|FG002|Overall Study|Withdrawal by Subject|3|||
161842151|NCT02792699|584466297|FG000|Overall Study|Lost to Follow-up|0|||
161842152|NCT02792699|584466298|FG001|Overall Study|Lost to Follow-up|1|||
161842153|NCT02792699|584466299|FG002|Overall Study|Lost to Follow-up|2|||
161842154|NCT02792699|584466297|FG000|Overall Study|Physician Decision|2|||
161842155|NCT02792699|584466298|FG001|Overall Study|Physician Decision|0|||
161842156|NCT02792699|584466299|FG002|Overall Study|Physician Decision|0|||
161842157|NCT02792699|584466297|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
161842158|NCT02792699|584466298|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
161842159|NCT02792699|584466299|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
161842160|NCT02792699|584466297|FG000|Overall Study|Other|1|||
161842161|NCT02792699|584466298|FG001|Overall Study|Other|0|||
161842162|NCT02792699|584466299|FG002|Overall Study|Other|0|||
161842163|NCT01715571|584466302|FG000|Overall Study|Lost to Follow-up|8|||
161842164|NCT00077857|584466305|FG000|Overall Study|Adverse Event|30|||
161842165|NCT00077857|584466306|FG001|Overall Study|Adverse Event|32|||
161842166|NCT00077857|584466305|FG000|Overall Study|Death|7|||
161842167|NCT00077857|584466306|FG001|Overall Study|Death|3|||
161842168|NCT00077857|584466305|FG000|Overall Study|Insufficient therapeutic response|112|||
161842169|NCT00077857|584466306|FG001|Overall Study|Insufficient therapeutic response|128|||
161842170|NCT00077857|584466305|FG000|Overall Study|Violation of selection criteria at entry|3|||
161842171|NCT00077857|584466306|FG001|Overall Study|Violation of selection criteria at entry|1|||
161842172|NCT00077857|584466305|FG000|Overall Study|Other protocol violation|0|||
161842173|NCT00077857|584466306|FG001|Overall Study|Other protocol violation|1|||
161842174|NCT00077857|584466305|FG000|Overall Study|Refused treatment|29|||
161744703|NCT02533401|584103670|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
161744704|NCT02533401|584103670|FG000|Overall Study|Lost to Follow-up|1|||
161744705|NCT02533401|584103670|FG000|Overall Study|Violation of Selection Criteria|1|||
161842175|NCT00077857|584466306|FG001|Overall Study|Refused treatment|21|||
161842176|NCT00077857|584466305|FG000|Overall Study|Failure to return|5|||
161842177|NCT00077857|584466306|FG001|Overall Study|Failure to return|5|||
161744706|NCT04897594|584103675|FG000|Overall Study|Lost to Follow-up|0|||
161744707|NCT04897594|584103676|FG001|Overall Study|Lost to Follow-up|1|||
161744708|NCT04897594|584103677|FG002|Overall Study|Lost to Follow-up|1|||
161744709|NCT04897594|584103675|FG000|Overall Study|Sponsor Decision|0|||
161744710|NCT04897594|584103676|FG001|Overall Study|Sponsor Decision|0|||
161744711|NCT04897594|584103677|FG002|Overall Study|Sponsor Decision|1|||
161744712|NCT04897594|584103675|FG000|Overall Study|Withdrawal by Subject|1|||
161744713|NCT04897594|584103676|FG001|Overall Study|Withdrawal by Subject|0|||
161744714|NCT04897594|584103677|FG002|Overall Study|Withdrawal by Subject|1|||
161744715|NCT02147691|584103680|FG000|Overall Study|Withdrawal by Subject|2|||
161744716|NCT02147691|584103681|FG001|Overall Study|Withdrawal by Subject|0|||
161744717|NCT02147691|584103680|FG000|Overall Study|Adverse Event|2|||
161744718|NCT02147691|584103681|FG001|Overall Study|Adverse Event|0|||
161744719|NCT02147691|584103680|FG000|Overall Study|Lost to Follow-up|0|||
161744720|NCT02147691|584103681|FG001|Overall Study|Lost to Follow-up|1|||
161744721|NCT01181141|584103684|FG000|Overall Study|Adverse Event|2|||
161744722|NCT01181141|584103685|FG001|Overall Study|Adverse Event|1|||
161744723|NCT01181141|584103684|FG000|Overall Study|Lack of Efficacy|1|||
161744724|NCT01181141|584103685|FG001|Overall Study|Lack of Efficacy|0|||
161744725|NCT01181141|584103684|FG000|Overall Study|Lost to Follow-up|1|||
161744726|NCT01181141|584103685|FG001|Overall Study|Lost to Follow-up|1|||
161744727|NCT01181141|584103684|FG000|Overall Study|Physician Decision|2|||
161744728|NCT01181141|584103685|FG001|Overall Study|Physician Decision|0|||
161744729|NCT01181141|584103684|FG000|Overall Study|Protocol Violation|3|||
161744730|NCT01181141|584103685|FG001|Overall Study|Protocol Violation|1|||
161744731|NCT01181141|584103684|FG000|Overall Study|Withdrawal by Subject|3|||
161744732|NCT01181141|584103685|FG001|Overall Study|Withdrawal by Subject|1|||
161744733|NCT01665768|584103686|FG000|Overall Study|Adverse Event|3|||
161744734|NCT01665768|584103686|FG000|Overall Study|Lack of Efficacy|19|||
161744735|NCT01665768|584103686|FG000|Overall Study|Withdrawal by Subject|1|||
161744736|NCT00118911|584103687|FG000|Overall Study|Withdrawal by Subject|2|||
161744737|NCT00118911|584103688|FG001|Overall Study|Withdrawal by Subject|5|||
161744738|NCT05014542|584103689|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
161744739|NCT05014542|584103690|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
161744740|NCT05014542|584103689|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
161744741|NCT05014542|584103690|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
161744742|NCT05014542|584103689|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
161744743|NCT05014542|584103690|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
161744744|NCT05014542|584103689|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
161744745|NCT05014542|584103690|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
161744746|NCT03496662|584103691|FG000|Overall Study|Adverse Event|0|||
161744747|NCT03496662|584103692|FG001|Overall Study|Adverse Event|0|||
161744748|NCT03496662|584103693|FG002|Overall Study|Adverse Event|4|||
161744749|NCT03496662|584103691|FG000|Overall Study|Withdrawal by Subject|1|||
161744750|NCT03496662|584103692|FG001|Overall Study|Withdrawal by Subject|0|||
161744751|NCT03496662|584103693|FG002|Overall Study|Withdrawal by Subject|2|||
161744752|NCT03496662|584103691|FG000|Overall Study|Death|0|||
161744753|NCT03496662|584103692|FG001|Overall Study|Death|0|||
161744754|NCT03496662|584103693|FG002|Overall Study|Death|2|||
161744755|NCT03496662|584103691|FG000|Overall Study|Noncompliance|0|||
161744756|NCT03496662|584103692|FG001|Overall Study|Noncompliance|0|||
161744757|NCT03496662|584103693|FG002|Overall Study|Noncompliance|1|||
161744758|NCT01467661|584103694|FG000|Overall Study|Adverse Event|16|||
161744759|NCT01467661|584103694|FG000|Overall Study|Withdrawal by Subject|1|||
161744760|NCT01467661|584103694|FG000|Overall Study|Lack of Efficacy|3|||
161744761|NCT01467661|584103694|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
161744762|NCT00691093|584103696|FG000|Overall Study|Adverse Event|1|||
161744763|NCT00691093|584103696|FG000|Overall Study|Lost to Follow-up|1|||
161744764|NCT00691093|584103696|FG000|Overall Study|Lack of Efficacy|1|||
161744765|NCT00691093|584103696|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
161744766|NCT03395223|584103698|FG000|Overall Study|Lost to Follow-up|3|||
161744767|NCT03395223|584103698|FG000|Overall Study|Other|1|||
161744768|NCT00810810|584103699|FG000|Overall Study|Withdrawal by Subject|0|||
161744769|NCT00810810|584103700|FG001|Overall Study|Withdrawal by Subject|8|||
161744770|NCT00810810|584103701|FG002|Overall Study|Withdrawal by Subject|10|||
161744771|NCT00810810|584103702|FG003|Overall Study|Withdrawal by Subject|8|||
161744772|NCT00810810|584103699|FG000|Overall Study|Physician Decision|0|||
161842178|NCT00077857|584466305|FG000|Overall Study|Other|15|||
161744773|NCT00810810|584103700|FG001|Overall Study|Physician Decision|3|||
161744774|NCT00810810|584103701|FG002|Overall Study|Physician Decision|1|||
161842179|NCT00077857|584466306|FG001|Overall Study|Other|13|||
161842180|NCT05084963|584466310|FG000|Overall Study|Withdrawal by Subject|0|||
161842181|NCT05084963|584466311|FG001|Overall Study|Withdrawal by Subject|0|||
161842182|NCT05084963|584466312|FG002|Overall Study|Withdrawal by Subject|1|||
161842183|NCT06187909|584466313|FG000|Overall Study|Withdrawal by Subject|2|||
161842184|NCT06187909|584466314|FG001|Overall Study|Withdrawal by Subject|2|||
161842185|NCT03569228|584466315|FG000|Overall Study|Withdrawal by PI|0|||
161842186|NCT03569228|584466316|FG001|Overall Study|Withdrawal by PI|0|||
161842187|NCT03569228|584466317|FG002|Overall Study|Withdrawal by PI|2|||
161842188|NCT03569228|584466318|FG003|Overall Study|Withdrawal by PI|2|||
161842189|NCT03569228|584466319|FG004|Overall Study|Withdrawal by PI|1|||
161744775|NCT00810810|584103702|FG003|Overall Study|Physician Decision|5|||
161744776|NCT01896856|584103703|FG000|Overall Study|Transportation issues / Non-compliance|0|||
161744777|NCT01896856|584103704|FG001|Overall Study|Transportation issues / Non-compliance|0|||
161744778|NCT01896856|584103705|FG002|Overall Study|Transportation issues / Non-compliance|1|||
161744779|NCT01896856|584103706|FG003|Overall Study|Transportation issues / Non-compliance|0|||
161744780|NCT01896856|584103707|FG004|Overall Study|Transportation issues / Non-compliance|0|||
161744781|NCT01896856|584103708|FG005|Overall Study|Transportation issues / Non-compliance|0|||
161744782|NCT01156532|584103709|FG000|Overall Study|Family Reasons|1|||
161744783|NCT01156532|584103709|FG000|Overall Study|Lost to Follow-up|1|||
161744784|NCT02563925|584103712|FG000|Overall Study|Withdrawal by Subject|2|||
161744785|NCT00282867|584103716|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
161744786|NCT00282867|584103717|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
161744787|NCT00282867|584103718|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
161744788|NCT00673894|584103731|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
161744789|NCT00673894|584103732|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
161744790|NCT00673894|584103731|FG000|First Intervention 4 Weeks|Adverse Event|1|||
161744791|NCT00673894|584103732|FG001|First Intervention 4 Weeks|Adverse Event|0|||
161744792|NCT01688635|584103740|FG000|Washout 1|Withdrawal by Subject|1|||
161744793|NCT01688635|584103741|FG001|Washout 1|Withdrawal by Subject|0|||
161744794|NCT01688635|584103740|FG000|Washout 1|Adverse Event|0|||
161744795|NCT01688635|584103741|FG001|Washout 1|Adverse Event|1|||
161744796|NCT01688635|584103740|FG000|Washout 1|Physician Decision|0|||
161744797|NCT01688635|584103741|FG001|Washout 1|Physician Decision|1|||
161744798|NCT01688635|584103740|FG000|Washout 2|Physician Decision|1|||
161744799|NCT01688635|584103741|FG001|Washout 2|Physician Decision|0|||
161744800|NCT01688635|584103740|FG000|Washout 2|Withdrawal by Subject|1|||
161744801|NCT01688635|584103741|FG001|Washout 2|Withdrawal by Subject|0|||
161744802|NCT01688635|584103740|FG000|Washout 2|Sponsor Decision|1|||
161744803|NCT01688635|584103741|FG001|Washout 2|Sponsor Decision|2|||
161744804|NCT01688635|584103740|FG000|Washout 3|Withdrawal by Subject|1|||
161744805|NCT01688635|584103741|FG001|Washout 3|Withdrawal by Subject|0|||
161744806|NCT03820726|584103742|FG000|Overall Study|Other than listed|23|||
161744807|NCT03820726|584103742|FG000|Overall Study|Withdrawal by Subject|37|||
161744808|NCT03820726|584103742|FG000|Overall Study|Lost to Follow-up|3|||
161744809|NCT03820726|584103742|FG000|Overall Study|Protocol deviation|1|||
161744810|NCT03820726|584103742|FG000|Overall Study|Adverse Event|146|||
161744811|NCT03820726|584103742|FG000|Overall Study|Not treated|1|||
161744812|NCT00141037|584103746|FG000|Overall Study|Physician Decision|1|||
161744813|NCT00141037|584103747|FG001|Overall Study|Physician Decision|2|||
161744814|NCT00141037|584103746|FG000|Overall Study|Lost to Follow-up|3|||
161744815|NCT00141037|584103747|FG001|Overall Study|Lost to Follow-up|1|||
161744816|NCT00141037|584103746|FG000|Overall Study|Protocol Violation|0|||
161744817|NCT00141037|584103747|FG001|Overall Study|Protocol Violation|2|||
161744818|NCT00141037|584103746|FG000|Overall Study|Withdrawal by Subject|2|||
161744819|NCT00141037|584103747|FG001|Overall Study|Withdrawal by Subject|1|||
161744820|NCT00141037|584103746|FG000|Overall Study|Other|0|||
161744821|NCT00141037|584103747|FG001|Overall Study|Other|1|||
161744822|NCT00141037|584103746|FG000|Overall Study|Moved from area|1|||
161744823|NCT00141037|584103747|FG001|Overall Study|Moved from area|7|||
161744824|NCT00141037|584103746|FG000|Overall Study|Graft Failure|3|||
161744825|NCT00141037|584103747|FG001|Overall Study|Graft Failure|4|||
161744826|NCT00888615|584103748|FG000|Overall Study|No treatment|2|||
161842190|NCT03569228|584466320|FG005|Overall Study|Withdrawal by PI|0|||
161842191|NCT03569228|584466321|FG006|Overall Study|Withdrawal by PI|0|||
161842192|NCT03569228|584466322|FG007|Overall Study|Withdrawal by PI|0|||
161744827|NCT00861380|584103749|FG000|Overall Study|Withdrawal Information not recorded|8427|||
161744828|NCT00861380|584103750|FG001|Overall Study|Withdrawal Information not recorded|9112|||
161744829|NCT00861380|584103751|FG002|Overall Study|Withdrawal Information not recorded|8872|||
161744830|NCT00861380|584103752|FG003|Overall Study|Withdrawal Information not recorded|3689|||
161744831|NCT00861380|584103753|FG004|Overall Study|Withdrawal Information not recorded|1812|||
161842193|NCT03569228|584466323|FG008|Overall Study|Withdrawal by PI|0|||
161842194|NCT03569228|584466315|FG000|Overall Study|Lost to Follow-up|0|||
161744832|NCT00861380|584103754|FG005|Overall Study|Withdrawal Information not recorded|6249|||
161744833|NCT00861380|584103755|FG006|Overall Study|Withdrawal Information not recorded|3020|||
161744834|NCT00637377|584103756|FG000|Overall Study|Adverse Event|2|||
161842195|NCT03569228|584466316|FG001|Overall Study|Lost to Follow-up|0|||
161842196|NCT03569228|584466317|FG002|Overall Study|Lost to Follow-up|0|||
161842197|NCT03569228|584466318|FG003|Overall Study|Lost to Follow-up|0|||
161842198|NCT03569228|584466319|FG004|Overall Study|Lost to Follow-up|0|||
161842199|NCT03569228|584466320|FG005|Overall Study|Lost to Follow-up|0|||
161842200|NCT03569228|584466321|FG006|Overall Study|Lost to Follow-up|0|||
161842201|NCT03569228|584466322|FG007|Overall Study|Lost to Follow-up|0|||
161842202|NCT03569228|584466323|FG008|Overall Study|Lost to Follow-up|1|||
161842203|NCT03569228|584466315|FG000|Overall Study|Screen Fail|2|||
161842204|NCT03569228|584466316|FG001|Overall Study|Screen Fail|2|||
161842205|NCT03569228|584466317|FG002|Overall Study|Screen Fail|1|||
161842206|NCT03569228|584466318|FG003|Overall Study|Screen Fail|1|||
161842207|NCT03569228|584466319|FG004|Overall Study|Screen Fail|1|||
161842208|NCT03569228|584466320|FG005|Overall Study|Screen Fail|3|||
161842209|NCT03569228|584466321|FG006|Overall Study|Screen Fail|1|||
161842210|NCT03569228|584466322|FG007|Overall Study|Screen Fail|5|||
161842211|NCT03569228|584466323|FG008|Overall Study|Screen Fail|2|||
161842212|NCT06354998|584466324|FG000|Overall Study|Withdrawal by Subject|3|||
161842213|NCT06354998|584466325|FG001|Overall Study|Withdrawal by Subject|0|||
161842214|NCT05442866|584466326|FG000|Overall Study|Death|1|||
161842215|NCT05442866|584466326|FG000|Overall Study|Lost to Follow-up|9|||
161842216|NCT05442866|584466326|FG000|Overall Study|Protocol Violation|1|||
161842217|NCT03819049|584466327|FG000|Overall Study|Lost to Follow-up|1|||
161842218|NCT03819049|584466328|FG001|Overall Study|Lost to Follow-up|2|||
161842219|NCT03819049|584466329|FG002|Overall Study|Lost to Follow-up|9|||
161842220|NCT03819049|584466330|FG003|Overall Study|Lost to Follow-up|0|||
161842221|NCT03819049|584466331|FG004|Overall Study|Lost to Follow-up|3|||
161842222|NCT03819049|584466332|FG005|Overall Study|Lost to Follow-up|1|||
161842223|NCT03819049|584466333|FG006|Overall Study|Lost to Follow-up|0|||
161842224|NCT03819049|584466327|FG000|Overall Study|Withdrawal by Subject|0|||
161842225|NCT03819049|584466328|FG001|Overall Study|Withdrawal by Subject|0|||
161842226|NCT03819049|584466329|FG002|Overall Study|Withdrawal by Subject|18|||
161842227|NCT03819049|584466330|FG003|Overall Study|Withdrawal by Subject|0|||
161842228|NCT03819049|584466331|FG004|Overall Study|Withdrawal by Subject|10|||
161842229|NCT03819049|584466332|FG005|Overall Study|Withdrawal by Subject|9|||
161842230|NCT03819049|584466333|FG006|Overall Study|Withdrawal by Subject|1|||
161842231|NCT03819049|584466327|FG000|Overall Study|Ongoing|0|||
161842232|NCT03819049|584466328|FG001|Overall Study|Ongoing|0|||
161842233|NCT03819049|584466329|FG002|Overall Study|Ongoing|75|||
161842234|NCT03819049|584466330|FG003|Overall Study|Ongoing|0|||
161842235|NCT03819049|584466331|FG004|Overall Study|Ongoing|41|||
161842236|NCT03819049|584466332|FG005|Overall Study|Ongoing|0|||
161842237|NCT03819049|584466333|FG006|Overall Study|Ongoing|0|||
161842238|NCT03819049|584466327|FG000|Overall Study|Other|0|||
161842239|NCT03819049|584466328|FG001|Overall Study|Other|0|||
161842240|NCT03819049|584466329|FG002|Overall Study|Other|2|||
161842241|NCT03819049|584466330|FG003|Overall Study|Other|0|||
161842242|NCT03819049|584466331|FG004|Overall Study|Other|0|||
161842243|NCT03819049|584466332|FG005|Overall Study|Other|0|||
161842244|NCT03819049|584466333|FG006|Overall Study|Other|0|||
161842245|NCT03819049|584466327|FG000|Overall Study|Randomized but not vaccinated|0|||
161842246|NCT03819049|584466328|FG001|Overall Study|Randomized but not vaccinated|0|||
161842247|NCT03819049|584466329|FG002|Overall Study|Randomized but not vaccinated|0|||
161842248|NCT03819049|584466330|FG003|Overall Study|Randomized but not vaccinated|1|||
161842249|NCT03819049|584466331|FG004|Overall Study|Randomized but not vaccinated|0|||
161842250|NCT03819049|584466332|FG005|Overall Study|Randomized but not vaccinated|2|||
161842251|NCT03819049|584466333|FG006|Overall Study|Randomized but not vaccinated|1|||
161842252|NCT03819049|584466327|FG000|Overall Study|Physician Decision|0|||
161842253|NCT03819049|584466328|FG001|Overall Study|Physician Decision|0|||
161842254|NCT03819049|584466329|FG002|Overall Study|Physician Decision|0|||
161842255|NCT03819049|584466330|FG003|Overall Study|Physician Decision|0|||
161842256|NCT03819049|584466331|FG004|Overall Study|Physician Decision|0|||
161842257|NCT03819049|584466332|FG005|Overall Study|Physician Decision|0|||
161842258|NCT03819049|584466333|FG006|Overall Study|Physician Decision|1|||
161842259|NCT02440568|584466334|FG000|Overall Study|Death|1|||
161842260|NCT02440568|584466335|FG001|Overall Study|Death|3|||
161842261|NCT02440568|584466336|FG002|Overall Study|Death|4|||
161842262|NCT02440568|584466337|FG003|Overall Study|Death|2|||
161842263|NCT02440568|584466334|FG000|Overall Study|Lack of Efficacy|2|||
161842264|NCT02440568|584466335|FG001|Overall Study|Lack of Efficacy|0|||
161842265|NCT02440568|584466336|FG002|Overall Study|Lack of Efficacy|1|||
161842266|NCT02440568|584466337|FG003|Overall Study|Lack of Efficacy|0|||
161842267|NCT02440568|584466334|FG000|Overall Study|Lost to Follow-up|1|||
161842268|NCT02440568|584466335|FG001|Overall Study|Lost to Follow-up|0|||
161744835|NCT00637377|584103757|FG001|Overall Study|Adverse Event|6|||
161744836|NCT00637377|584103758|FG002|Overall Study|Adverse Event|8|||
161744837|NCT00637377|584103759|FG003|Overall Study|Adverse Event|9|||
161744838|NCT00637377|584103756|FG000|Overall Study|Death|1|||
161744839|NCT00637377|584103757|FG001|Overall Study|Death|3|||
161744840|NCT00637377|584103758|FG002|Overall Study|Death|2|||
161744841|NCT00637377|584103759|FG003|Overall Study|Death|1|||
161744842|NCT00637377|584103756|FG000|Overall Study|Lack of Efficacy|0|||
161744843|NCT00637377|584103757|FG001|Overall Study|Lack of Efficacy|0|||
161744844|NCT00637377|584103758|FG002|Overall Study|Lack of Efficacy|1|||
161744845|NCT00637377|584103759|FG003|Overall Study|Lack of Efficacy|1|||
161744846|NCT00637377|584103756|FG000|Overall Study|Lost to Follow-up|4|||
161744847|NCT00637377|584103757|FG001|Overall Study|Lost to Follow-up|1|||
161744848|NCT00637377|584103758|FG002|Overall Study|Lost to Follow-up|2|||
161744849|NCT00637377|584103759|FG003|Overall Study|Lost to Follow-up|2|||
161744850|NCT00637377|584103756|FG000|Overall Study|Protocol Violation|2|||
161744851|NCT00637377|584103757|FG001|Overall Study|Protocol Violation|1|||
161744852|NCT00637377|584103758|FG002|Overall Study|Protocol Violation|1|||
161744853|NCT00637377|584103759|FG003|Overall Study|Protocol Violation|0|||
161744854|NCT00637377|584103756|FG000|Overall Study|Withdrawal by Subject|11|||
161744855|NCT00637377|584103757|FG001|Overall Study|Withdrawal by Subject|15|||
161744856|NCT00637377|584103758|FG002|Overall Study|Withdrawal by Subject|13|||
161744857|NCT00637377|584103759|FG003|Overall Study|Withdrawal by Subject|11|||
161744858|NCT00637377|584103756|FG000|Overall Study|Other (no further information available)|7|||
161744859|NCT00637377|584103757|FG001|Overall Study|Other (no further information available)|6|||
161744860|NCT00637377|584103758|FG002|Overall Study|Other (no further information available)|10|||
161744861|NCT00637377|584103759|FG003|Overall Study|Other (no further information available)|5|||
161744862|NCT01293084|584103760|FG000|Overall Study|Physician Decision|3|||
161744863|NCT01293084|584103760|FG000|Overall Study|Withdrawal by Subject|2|||
161744864|NCT00107172|584105976|FG000|Overall Study|Withdrawal by Subject|1|||
161744865|NCT00107172|584105977|FG001|Overall Study|Withdrawal by Subject|0|||
161744866|NCT00107172|584105976|FG000|Overall Study|Death|0|||
161744867|NCT00107172|584105977|FG001|Overall Study|Death|2|||
161744868|NCT00107172|584105976|FG000|Overall Study|Other Reason|4|||
161744869|NCT00107172|584105977|FG001|Overall Study|Other Reason|3|||
161744870|NCT04432376|584105978|FG000|Double-blind Treatment Period|Adverse Event|2|||
161744871|NCT04432376|584105979|FG001|Double-blind Treatment Period|Adverse Event|6|||
161744872|NCT04432376|584105980|FG002|Double-blind Treatment Period|Adverse Event|0|||
161744873|NCT04432376|584105978|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
161744874|NCT04432376|584105979|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161744875|NCT04432376|584105980|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161744876|NCT04432376|584105978|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161744877|NCT04432376|584105979|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161744878|NCT04432376|584105980|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161744879|NCT04432376|584105978|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161744880|NCT04432376|584105979|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161744881|NCT04432376|584105980|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161744882|NCT04432376|584105978|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
161744883|NCT04432376|584105979|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
161744884|NCT04432376|584105980|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
161744885|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
161744886|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
161744887|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
161744888|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744889|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744890|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744891|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744892|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
161744893|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
161744894|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
161744895|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744896|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744897|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744898|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744899|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
161744900|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
161744901|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
161744902|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744903|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744904|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744905|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744906|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Other|2|||
161842269|NCT02440568|584466336|FG002|Overall Study|Lost to Follow-up|0|||
161842270|NCT02440568|584466337|FG003|Overall Study|Lost to Follow-up|0|||
161842271|NCT01584843|584466341|FG000|First Treatment Period|Adverse Event|0|||
161842272|NCT01584843|584466342|FG001|First Treatment Period|Adverse Event|0|||
161842273|NCT01584843|584466343|FG002|First Treatment Period|Adverse Event|1|||
161842274|NCT01584843|584466344|FG003|First Treatment Period|Adverse Event|0|||
161842275|NCT01584843|584466345|FG004|First Treatment Period|Adverse Event|0|||
161842276|NCT01584843|584466346|FG005|First Treatment Period|Adverse Event|0|||
161842277|NCT01584843|584466341|FG000|First Treatment Period|Protocol Violation|0|||
161842278|NCT01584843|584466342|FG001|First Treatment Period|Protocol Violation|0|||
161842279|NCT01584843|584466343|FG002|First Treatment Period|Protocol Violation|0|||
161842280|NCT01584843|584466344|FG003|First Treatment Period|Protocol Violation|0|||
161842281|NCT01584843|584466345|FG004|First Treatment Period|Protocol Violation|0|||
161744907|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Other|0|||
161744908|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Other|2|||
161744909|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Other|0|||
161744910|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Other|0|||
161744911|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Other|0|||
161744912|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Other|0|||
161744913|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744914|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744915|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744916|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
161744917|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
161744918|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
161744919|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744920|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161744921|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161744922|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161744923|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
161744924|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
161744925|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
161744926|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
161744927|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744928|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744929|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744930|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744931|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744932|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
161744933|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
161744934|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Other|0|||
161744935|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Other|0|||
161744936|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Other|0|||
161744937|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Other|4|||
161744938|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Other|5|||
161744939|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Other|23|||
161744940|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Other|17|||
161744941|NCT00927758|584105988|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744942|NCT00927758|584105989|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744943|NCT00927758|584105990|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744944|NCT00927758|584105991|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
161744945|NCT00927758|584105992|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744946|NCT00927758|584105993|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
161744947|NCT00927758|584105988|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161744948|NCT00927758|584105989|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161842282|NCT01584843|584466346|FG005|First Treatment Period|Protocol Violation|1|||
161842283|NCT01584843|584466341|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842284|NCT01584843|584466342|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842285|NCT01584843|584466343|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842286|NCT01584843|584466344|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842287|NCT01584843|584466345|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842288|NCT01584843|584466346|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
161842289|NCT01584843|584466341|FG000|Second Treatment Period|Withdrawal by Subject|0|||
161842290|NCT01584843|584466342|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161842291|NCT01584843|584466343|FG002|Second Treatment Period|Withdrawal by Subject|0|||
161842292|NCT01584843|584466344|FG003|Second Treatment Period|Withdrawal by Subject|0|||
161744949|NCT00927758|584105990|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161744950|NCT00927758|584105991|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161744951|NCT00927758|584105992|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161842293|NCT01584843|584466345|FG004|Second Treatment Period|Withdrawal by Subject|0|||
161744952|NCT00927758|584105993|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161744953|NCT00439725|584105994|FG000|Treatment Period|Withdrawal by Subject|22|||
161744954|NCT00439725|584105995|FG001|Treatment Period|Withdrawal by Subject|19|||
161744955|NCT00439725|584105994|FG000|Treatment Period|Study terminated by sponsor|156|||
161744956|NCT00439725|584105995|FG001|Treatment Period|Study terminated by sponsor|148|||
161744957|NCT00439725|584105994|FG000|Treatment Period|Site closed by investigator|1|||
161744958|NCT00439725|584105995|FG001|Treatment Period|Site closed by investigator|2|||
161744959|NCT00439725|584105994|FG000|Treatment Period|Adverse Event|39|||
161744960|NCT00439725|584105995|FG001|Treatment Period|Adverse Event|18|||
161744961|NCT00439725|584105994|FG000|Treatment Period|Physician Decision|1|||
161744962|NCT00439725|584105995|FG001|Treatment Period|Physician Decision|1|||
161744963|NCT00439725|584105994|FG000|Treatment Period|Protocol Violation|2|||
161744964|NCT00439725|584105995|FG001|Treatment Period|Protocol Violation|1|||
161744965|NCT00439725|584105994|FG000|Treatment Period|Clinical endpoint reached|6|||
161744966|NCT00439725|584105995|FG001|Treatment Period|Clinical endpoint reached|50|||
161744967|NCT00439725|584105994|FG000|Treatment Period|Technical problems|1|||
161744968|NCT00439725|584105995|FG001|Treatment Period|Technical problems|0|||
161744969|NCT00439725|584105994|FG000|Treatment Period|Lost to Follow-up|1|||
161744970|NCT00439725|584105995|FG001|Treatment Period|Lost to Follow-up|1|||
161744971|NCT00439725|584105994|FG000|Treatment Period|Participant convenience|1|||
161744972|NCT00439725|584105995|FG001|Treatment Period|Participant convenience|0|||
161744973|NCT00439725|584105994|FG000|Treatment Period|Protocol driven decision point|1|||
161744974|NCT00439725|584105995|FG001|Treatment Period|Protocol driven decision point|1|||
161744975|NCT00439725|584105994|FG000|Treatment Period|Death|1|||
161744976|NCT00439725|584105995|FG001|Treatment Period|Death|1|||
161744977|NCT00439725|584105994|FG000|Treatment Period|Participant did not receive treatment|4|||
161744978|NCT00439725|584105995|FG001|Treatment Period|Participant did not receive treatment|4|||
161744979|NCT00439725|584105994|FG000|Observational Period|Withdrawal by Subject|2|||
161744980|NCT00439725|584105995|FG001|Observational Period|Withdrawal by Subject|2|||
161744981|NCT00439725|584105994|FG000|Observational Period|Lost to Follow-up|0|||
161744982|NCT00439725|584105995|FG001|Observational Period|Lost to Follow-up|1|||
161744983|NCT00439725|584105994|FG000|Observational Period|Death|0|||
161744984|NCT00439725|584105995|FG001|Observational Period|Death|2|||
161744985|NCT00439725|584105994|FG000|Observational Period|Study termination by sponsor|1|||
161744986|NCT00439725|584105995|FG001|Observational Period|Study termination by sponsor|1|||
161744987|NCT00439725|584105994|FG000|Observational Period|Clinical endpoint reached|3|||
161744988|NCT00439725|584105995|FG001|Observational Period|Clinical endpoint reached|1|||
161744989|NCT00439725|584105994|FG000|Observational Period|Technical problems|1|||
161744990|NCT00439725|584105995|FG001|Observational Period|Technical problems|0|||
161744991|NCT00439725|584105994|FG000|Observational Period|Participant convenience|1|||
161744992|NCT00439725|584105995|FG001|Observational Period|Participant convenience|0|||
161744993|NCT02848313|584105996|FG000|Overall Study|Adverse Event|1|||
161744994|NCT02848313|584105997|FG001|Overall Study|Adverse Event|2|||
161744995|NCT02848313|584105996|FG000|Overall Study|Lack of Efficacy|0|||
161744996|NCT02848313|584105997|FG001|Overall Study|Lack of Efficacy|1|||
161744997|NCT02848313|584105996|FG000|Overall Study|Withdrawal by Subject|1|||
161744998|NCT02848313|584105997|FG001|Overall Study|Withdrawal by Subject|1|||
161744999|NCT02848313|584105996|FG000|Overall Study|Lost to follow up|1|||
161745000|NCT02848313|584105997|FG001|Overall Study|Lost to follow up|0|||
161745001|NCT03984812|584105998|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745002|NCT03984812|584105999|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745003|NCT03984812|584106000|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
161745004|NCT03984812|584106001|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745005|NCT03984812|584106002|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745006|NCT03984812|584106003|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745007|NCT03984812|584106004|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745008|NCT03984812|584106005|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745009|NCT03984812|584106006|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745010|NCT03984812|584106007|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745011|NCT03984812|584106008|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745012|NCT03510910|584106009|FG000|Overall Study|Incomplete Survey|2|||
161745013|NCT03510910|584106010|FG001|Overall Study|Incomplete Survey|3|||
161745014|NCT01673490|584106011|FG000|Overall Study|Lost to Follow-up|1|||
161745015|NCT01673490|584106011|FG000|Overall Study|Adverse Event|3|||
161842294|NCT01584843|584466346|FG005|Second Treatment Period|Withdrawal by Subject|1|||
161745016|NCT01673490|584106011|FG000|Overall Study|Withdrawal by Subject|3|||
161745017|NCT00379236|584106012|FG000|Double-blind|Adverse Event|11|||
161745018|NCT00379236|584106013|FG001|Double-blind|Adverse Event|6|||
161745019|NCT00379236|584106014|FG002|Double-blind|Adverse Event|0|||
161745020|NCT00379236|584106012|FG000|Double-blind|Protocol Violation|3|||
161745021|NCT00379236|584106013|FG001|Double-blind|Protocol Violation|3|||
161745022|NCT00379236|584106014|FG002|Double-blind|Protocol Violation|0|||
161745023|NCT00379236|584106012|FG000|Double-blind|Withdrawal by Subject|12|||
161745024|NCT00379236|584106013|FG001|Double-blind|Withdrawal by Subject|13|||
161745025|NCT00379236|584106014|FG002|Double-blind|Withdrawal by Subject|0|||
161745026|NCT00379236|584106012|FG000|Double-blind|Lost to Follow-up|4|||
161745027|NCT00379236|584106013|FG001|Double-blind|Lost to Follow-up|3|||
161745028|NCT00379236|584106014|FG002|Double-blind|Lost to Follow-up|0|||
161745029|NCT00379236|584106012|FG000|Double-blind|Use of exclusionary medication|1|||
161745030|NCT00379236|584106013|FG001|Double-blind|Use of exclusionary medication|2|||
161745031|NCT00379236|584106014|FG002|Double-blind|Use of exclusionary medication|0|||
161745032|NCT00379236|584106012|FG000|Double-blind|Other|3|||
161745033|NCT00379236|584106013|FG001|Double-blind|Other|7|||
161745034|NCT00379236|584106014|FG002|Double-blind|Other|0|||
161745035|NCT00379236|584106012|FG000|Double-blind|Data could not be retrieved|2|||
161745036|NCT00379236|584106013|FG001|Double-blind|Data could not be retrieved|2|||
161745037|NCT00379236|584106014|FG002|Double-blind|Data could not be retrieved|0|||
161745038|NCT00379236|584106012|FG000|Open-label Extension|Adverse Event|0|||
161745039|NCT00379236|584106013|FG001|Open-label Extension|Adverse Event|0|||
161745040|NCT00379236|584106014|FG002|Open-label Extension|Adverse Event|13|||
161745041|NCT00379236|584106012|FG000|Open-label Extension|Protocol Violation|0|||
161745042|NCT00379236|584106013|FG001|Open-label Extension|Protocol Violation|0|||
161745043|NCT00379236|584106014|FG002|Open-label Extension|Protocol Violation|7|||
161745044|NCT00379236|584106012|FG000|Open-label Extension|Withdrawal by Subject|0|||
161745045|NCT00379236|584106013|FG001|Open-label Extension|Withdrawal by Subject|0|||
161745046|NCT00379236|584106014|FG002|Open-label Extension|Withdrawal by Subject|13|||
161745047|NCT00379236|584106012|FG000|Open-label Extension|Lost to Follow-up|0|||
161745048|NCT00379236|584106013|FG001|Open-label Extension|Lost to Follow-up|0|||
161745049|NCT00379236|584106014|FG002|Open-label Extension|Lost to Follow-up|12|||
161745050|NCT00379236|584106012|FG000|Open-label Extension|Use of exclusionary medication|0|||
161745051|NCT00379236|584106013|FG001|Open-label Extension|Use of exclusionary medication|0|||
161745052|NCT00379236|584106014|FG002|Open-label Extension|Use of exclusionary medication|3|||
161745053|NCT00379236|584106012|FG000|Open-label Extension|Other|0|||
161745054|NCT00379236|584106013|FG001|Open-label Extension|Other|0|||
161745055|NCT00379236|584106014|FG002|Open-label Extension|Other|7|||
161745056|NCT02940860|584106022|FG000|Overall Study|Non-serious AE|1|||
161745057|NCT02940860|584106023|FG001|Overall Study|Non-serious AE|2|||
161745058|NCT02940860|584106022|FG000|Overall Study|Serious AE|7|||
161745059|NCT02940860|584106023|FG001|Overall Study|Serious AE|3|||
161745060|NCT02940860|584106022|FG000|Overall Study|Withdrawal by Subject|19|||
161745061|NCT02940860|584106023|FG001|Overall Study|Withdrawal by Subject|9|||
161745062|NCT02940860|584106022|FG000|Overall Study|Lost to Follow-up|13|||
161745063|NCT02940860|584106023|FG001|Overall Study|Lost to Follow-up|7|||
161745064|NCT02940860|584106022|FG000|Overall Study|Physician Decision|5|||
161745065|NCT02940860|584106023|FG001|Overall Study|Physician Decision|3|||
161745066|NCT02940860|584106022|FG000|Overall Study|Sponsor Decision|0|||
161745067|NCT02940860|584106023|FG001|Overall Study|Sponsor Decision|1|||
161745068|NCT02940860|584106022|FG000|Overall Study|Protocol Violation|0|||
161745069|NCT02940860|584106023|FG001|Overall Study|Protocol Violation|2|||
161745070|NCT02940860|584106022|FG000|Overall Study|Death|3|||
161745071|NCT02940860|584106023|FG001|Overall Study|Death|2|||
161745072|NCT02940860|584106022|FG000|Overall Study|Moved, poor venous access, transport|6|||
161745073|NCT02940860|584106023|FG001|Overall Study|Moved, poor venous access, transport|4|||
161745074|NCT02940860|584106022|FG000|Overall Study|Not treated|2|||
161745075|NCT02940860|584106023|FG001|Overall Study|Not treated|2|||
161745076|NCT04914819|584106024|FG000|Overall Study|Pregnancy|3|||
161745077|NCT04914819|584106025|FG001|Overall Study|Pregnancy|1|||
161745078|NCT04914819|584106024|FG000|Overall Study|Discontinued study|4|||
161842295|NCT00643565|584466347|FG000|Overall Study|Death|12|||
161842296|NCT00643565|584466348|FG001|Overall Study|Death|11|||
161842297|NCT00643565|584466347|FG000|Overall Study|Withdrawal by Subject|4|||
161842298|NCT00643565|584466348|FG001|Overall Study|Withdrawal by Subject|1|||
161745079|NCT04914819|584106025|FG001|Overall Study|Discontinued study|1|||
161842299|NCT00643565|584466347|FG000|Overall Study|Lost to Follow-up|0|||
161745080|NCT04914819|584106024|FG000|Overall Study|Lost to Follow-up|7|||
161745081|NCT04914819|584106025|FG001|Overall Study|Lost to Follow-up|0|||
161745082|NCT02431793|584106027|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
161745083|NCT02431793|584106028|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
161745084|NCT02431793|584106029|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
161745085|NCT02431793|584106027|FG000|Overall Study|Withdrawal by Subject|7|||
161745086|NCT02431793|584106028|FG001|Overall Study|Withdrawal by Subject|5|||
161745087|NCT02431793|584106029|FG002|Overall Study|Withdrawal by Subject|5|||
161745088|NCT02431793|584106027|FG000|Overall Study|Lost to Follow-up|101|||
161745089|NCT02431793|584106028|FG001|Overall Study|Lost to Follow-up|122|||
161745090|NCT02431793|584106029|FG002|Overall Study|Lost to Follow-up|104|||
161745091|NCT01711541|584106036|FG000|Overall Study|Cancel prior to treatment|0|||
161745092|NCT01711541|584106037|FG001|Overall Study|Cancel prior to treatment|0|||
161745093|NCT01711541|584106038|FG002|Overall Study|Cancel prior to treatment|0|||
161745094|NCT01711541|584106039|FG003|Overall Study|Cancel prior to treatment|1|||
161745095|NCT01711541|584106040|FG004|Overall Study|Cancel prior to treatment|0|||
161745096|NCT01711541|584106036|FG000|Overall Study|Ineligible|0|||
161745097|NCT01711541|584106037|FG001|Overall Study|Ineligible|1|||
161745098|NCT01711541|584106038|FG002|Overall Study|Ineligible|0|||
161745099|NCT01711541|584106039|FG003|Overall Study|Ineligible|0|||
161745100|NCT01711541|584106040|FG004|Overall Study|Ineligible|0|||
161745101|NCT00438464|584106041|FG000|Overall Study|Terminated Early|14|||
161745102|NCT00438464|584106042|FG001|Overall Study|Terminated Early|5|||
161745103|NCT00438464|584106041|FG000|Overall Study|Incomplete data submission|0|||
161745104|NCT00438464|584106042|FG001|Overall Study|Incomplete data submission|2|||
161745105|NCT00728936|584106043|FG000|Overall Study|Withdrawal by Subject|0|||
161745106|NCT00728936|584106044|FG001|Overall Study|Withdrawal by Subject|0|||
161745107|NCT00728936|584106045|FG002|Overall Study|Withdrawal by Subject|0|||
161745108|NCT00728936|584106046|FG003|Overall Study|Withdrawal by Subject|0|||
161745109|NCT00728936|584106047|FG004|Overall Study|Withdrawal by Subject|0|||
161745110|NCT00728936|584106048|FG005|Overall Study|Withdrawal by Subject|1|||
161745111|NCT00728936|584106049|FG006|Overall Study|Withdrawal by Subject|0|||
161745112|NCT03943446|584106050|FG000|Overall Study|Lost to Follow-up|0|||
161745113|NCT03943446|584106051|FG001|Overall Study|Lost to Follow-up|0|||
161745114|NCT03943446|584106052|FG002|Overall Study|Lost to Follow-up|1|||
161745115|NCT03943446|584106050|FG000|Overall Study|Withdrawal by Subject|1|||
161745116|NCT03943446|584106051|FG001|Overall Study|Withdrawal by Subject|1|||
161745117|NCT03943446|584106052|FG002|Overall Study|Withdrawal by Subject|2|||
161745118|NCT03943446|584106050|FG000|Overall Study|Study Terminated by Sponsor|1|||
161745119|NCT03943446|584106051|FG001|Overall Study|Study Terminated by Sponsor|2|||
161745120|NCT03943446|584106052|FG002|Overall Study|Study Terminated by Sponsor|1|||
161745121|NCT03943446|584106050|FG000|Overall Study|Reason not Specified|5|||
161745122|NCT03943446|584106051|FG001|Overall Study|Reason not Specified|1|||
161745123|NCT03943446|584106052|FG002|Overall Study|Reason not Specified|3|||
161745124|NCT02905825|584106060|FG000|Overall Study|Protocol Violation|11|||
161745125|NCT02905825|584106060|FG000|Overall Study|Device Malfunction|1|||
161745126|NCT01563107|584106061|FG000|Overall Study|Physician Decision|0|||
161745127|NCT01563107|584106062|FG001|Overall Study|Physician Decision|1|||
161745128|NCT01563107|584106063|FG002|Overall Study|Physician Decision|1|||
161745129|NCT01563107|584106064|FG003|Overall Study|Physician Decision|3|||
161745130|NCT01563107|584106061|FG000|Overall Study|Withdrawal by Subject|1|||
161745131|NCT01563107|584106062|FG001|Overall Study|Withdrawal by Subject|2|||
161745132|NCT01563107|584106063|FG002|Overall Study|Withdrawal by Subject|1|||
161745133|NCT01563107|584106064|FG003|Overall Study|Withdrawal by Subject|2|||
161745134|NCT05355818|584106065|FG000|Overall Study|Adverse Event|1|||
161745135|NCT05355818|584106066|FG001|Overall Study|Adverse Event|1|||
161745136|NCT05355818|584106065|FG000|Overall Study|Lack of Efficacy|2|||
161745137|NCT05355818|584106066|FG001|Overall Study|Lack of Efficacy|1|||
161745138|NCT05355818|584106065|FG000|Overall Study|Lost to Follow-up|0|||
161745139|NCT05355818|584106066|FG001|Overall Study|Lost to Follow-up|1|||
161745140|NCT02707601|584106067|FG000|Overall Study|Death|0|||
161745141|NCT02707601|584106068|FG001|Overall Study|Death|1|||
161745142|NCT02707601|584106067|FG000|Overall Study|Lack of Efficacy|0|||
161745143|NCT02707601|584106068|FG001|Overall Study|Lack of Efficacy|1|||
161745144|NCT02707601|584106067|FG000|Overall Study|Investigator's Discretion|1|||
161745145|NCT02707601|584106068|FG001|Overall Study|Investigator's Discretion|0|||
161745146|NCT02707601|584106067|FG000|Overall Study|Withdrew Consent|0|||
161745147|NCT02707601|584106068|FG001|Overall Study|Withdrew Consent|1|||
161745148|NCT02707601|584106067|FG000|Overall Study|Lost to Follow-up|1|||
161745149|NCT02707601|584106068|FG001|Overall Study|Lost to Follow-up|1|||
161745150|NCT02707601|584106067|FG000|Overall Study|Participants Randomized but Not Treated|2|||
161745151|NCT02707601|584106068|FG001|Overall Study|Participants Randomized but Not Treated|0|||
161745152|NCT00063986|584106070|FG000|Overall Study|Withdrawal by Subject|1|||
161745153|NCT00063986|584106070|FG000|Overall Study|Ineligible|1|||
161745154|NCT00063986|584106070|FG000|Overall Study|Intra-operatively ineligible|4|||
161745155|NCT01601704|584106071|FG000|Overall Study|Randomized but not dispensed study med|1|||
161745156|NCT01601704|584106072|FG001|Overall Study|Randomized but not dispensed study med|4|||
161745157|NCT01021813|584106075|FG000|DB Treatment Phase|Adverse Event|60|||
161745158|NCT01021813|584106076|FG001|DB Treatment Phase|Adverse Event|22|||
161745159|NCT01021813|584106077|FG002|DB Treatment Phase|Adverse Event|0|||
161745160|NCT01021813|584106078|FG003|DB Treatment Phase|Adverse Event|0|||
161745161|NCT01021813|584106079|FG004|DB Treatment Phase|Adverse Event|0|||
161745162|NCT01021813|584106075|FG000|DB Treatment Phase|Lack of Efficacy|44|||
161745163|NCT01021813|584106076|FG001|DB Treatment Phase|Lack of Efficacy|28|||
161745164|NCT01021813|584106077|FG002|DB Treatment Phase|Lack of Efficacy|0|||
161745165|NCT01021813|584106078|FG003|DB Treatment Phase|Lack of Efficacy|0|||
161745166|NCT01021813|584106079|FG004|DB Treatment Phase|Lack of Efficacy|0|||
161745167|NCT01021813|584106075|FG000|DB Treatment Phase|Lost to Follow-up|14|||
161745168|NCT01021813|584106076|FG001|DB Treatment Phase|Lost to Follow-up|12|||
161745169|NCT01021813|584106077|FG002|DB Treatment Phase|Lost to Follow-up|0|||
161745170|NCT01021813|584106078|FG003|DB Treatment Phase|Lost to Follow-up|0|||
161745171|NCT01021813|584106079|FG004|DB Treatment Phase|Lost to Follow-up|0|||
161745172|NCT01021813|584106075|FG000|DB Treatment Phase|Physician Decision|17|||
161745173|NCT01021813|584106076|FG001|DB Treatment Phase|Physician Decision|8|||
161745174|NCT01021813|584106077|FG002|DB Treatment Phase|Physician Decision|0|||
161745175|NCT01021813|584106078|FG003|DB Treatment Phase|Physician Decision|0|||
161745176|NCT01021813|584106079|FG004|DB Treatment Phase|Physician Decision|0|||
161745177|NCT01021813|584106075|FG000|DB Treatment Phase|Pregnancy|1|||
161745178|NCT01021813|584106076|FG001|DB Treatment Phase|Pregnancy|0|||
161745179|NCT01021813|584106077|FG002|DB Treatment Phase|Pregnancy|0|||
161745180|NCT01021813|584106078|FG003|DB Treatment Phase|Pregnancy|0|||
161745181|NCT01021813|584106079|FG004|DB Treatment Phase|Pregnancy|0|||
161745182|NCT01021813|584106075|FG000|DB Treatment Phase|Protocol Violation|4|||
161745183|NCT01021813|584106076|FG001|DB Treatment Phase|Protocol Violation|3|||
161745184|NCT01021813|584106077|FG002|DB Treatment Phase|Protocol Violation|0|||
161745185|NCT01021813|584106078|FG003|DB Treatment Phase|Protocol Violation|0|||
161745186|NCT01021813|584106079|FG004|DB Treatment Phase|Protocol Violation|0|||
161745187|NCT01021813|584106075|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
161745188|NCT01021813|584106076|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
161745189|NCT01021813|584106077|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
161745190|NCT01021813|584106078|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
161745191|NCT01021813|584106079|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
161745192|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
161745193|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
161745194|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
161745195|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
161745196|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
161745197|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745198|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745199|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745200|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
161745201|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745202|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745203|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745204|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745205|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745206|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
161745207|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745208|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745209|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
161745210|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745211|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745212|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
161745213|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
161745214|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
161745215|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
161745216|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
161745217|NCT00493974|584106081|FG000|Overall Study|Death|1|||
161745218|NCT00493974|584106082|FG001|Overall Study|Death|2|||
161745219|NCT00493974|584106081|FG000|Overall Study|Withdrawal by Subject|8|||
161745220|NCT00493974|584106082|FG001|Overall Study|Withdrawal by Subject|6|||
161745221|NCT00493974|584106081|FG000|Overall Study|Lost to Follow-up|4|||
161745222|NCT00493974|584106082|FG001|Overall Study|Lost to Follow-up|6|||
161745223|NCT00326417|584106083|FG000|Overall Study|Withdrawal by Subject|0|||
161745224|NCT00326417|584106084|FG001|Overall Study|Withdrawal by Subject|0|||
161745225|NCT00326417|584106085|FG002|Overall Study|Withdrawal by Subject|1|||
161745226|NCT00326417|584106086|FG003|Overall Study|Withdrawal by Subject|0|||
161745227|NCT00326417|584106083|FG000|Overall Study|Arm Closed|7|||
161745228|NCT00326417|584106084|FG001|Overall Study|Arm Closed|0|||
161745229|NCT00326417|584106085|FG002|Overall Study|Arm Closed|0|||
161842300|NCT00643565|584466348|FG001|Overall Study|Lost to Follow-up|6|||
161842301|NCT00643565|584466347|FG000|Overall Study|Other|7|||
161745230|NCT00326417|584106086|FG003|Overall Study|Arm Closed|3|||
161745231|NCT00326417|584106083|FG000|Overall Study|Death|7|||
161745232|NCT00326417|584106084|FG001|Overall Study|Death|0|||
161745233|NCT00326417|584106085|FG002|Overall Study|Death|0|||
161745234|NCT00326417|584106086|FG003|Overall Study|Death|0|||
161745235|NCT00844285|584106087|FG000|Overall Study|Other|0|||
161745236|NCT00844285|584106088|FG001|Overall Study|Other|1|||
161745237|NCT00844285|584106089|FG002|Overall Study|Other|0|||
161745238|NCT00844285|584106087|FG000|Overall Study|Other than specified|95|||
161745239|NCT00844285|584106088|FG001|Overall Study|Other than specified|129|||
161745240|NCT00844285|584106089|FG002|Overall Study|Other than specified|12|||
161745241|NCT00844285|584106087|FG000|Overall Study|Site closure|256|||
161745242|NCT00844285|584106088|FG001|Overall Study|Site closure|450|||
161745243|NCT00844285|584106089|FG002|Overall Study|Site closure|50|||
161745244|NCT00844285|584106087|FG000|Overall Study|Follow-up < 8 years|16|||
161745245|NCT00844285|584106088|FG001|Overall Study|Follow-up < 8 years|23|||
161745246|NCT00844285|584106089|FG002|Overall Study|Follow-up < 8 years|4|||
161745247|NCT00844285|584106087|FG000|Overall Study|Protocol Violation|26|||
161745248|NCT00844285|584106088|FG001|Overall Study|Protocol Violation|28|||
161745249|NCT00844285|584106089|FG002|Overall Study|Protocol Violation|54|||
161745250|NCT00844285|584106087|FG000|Overall Study|Death|22|||
161745251|NCT00844285|584106088|FG001|Overall Study|Death|21|||
161745252|NCT00844285|584106089|FG002|Overall Study|Death|8|||
161745253|NCT00844285|584106087|FG000|Overall Study|Withdrew Consent|344|||
161745254|NCT00844285|584106088|FG001|Overall Study|Withdrew Consent|466|||
161745255|NCT00844285|584106089|FG002|Overall Study|Withdrew Consent|70|||
161745256|NCT00844285|584106087|FG000|Overall Study|Lost to Follow-up|330|||
161745257|NCT00844285|584106088|FG001|Overall Study|Lost to Follow-up|486|||
161745258|NCT00844285|584106089|FG002|Overall Study|Lost to Follow-up|74|||
161745259|NCT04682353|584106090|FG000|Overall Study|Lost to Follow-up|0|||
161745260|NCT04682353|584106091|FG001|Overall Study|Lost to Follow-up|1|||
161745261|NCT04682353|584106092|FG002|Overall Study|Lost to Follow-up|0|||
161745262|NCT04682353|584106093|FG003|Overall Study|Lost to Follow-up|1|||
161745263|NCT04682353|584106090|FG000|Overall Study|Personal reasons|0|||
161745264|NCT04682353|584106091|FG001|Overall Study|Personal reasons|1|||
161745265|NCT04682353|584106092|FG002|Overall Study|Personal reasons|0|||
161745266|NCT04682353|584106093|FG003|Overall Study|Personal reasons|0|||
161745267|NCT00862654|584106094|FG000|Overall Study|Lack of Efficacy|1|||
161745268|NCT00862654|584106095|FG001|Overall Study|Lack of Efficacy|0|||
161745269|NCT00862654|584106096|FG002|Overall Study|Lack of Efficacy|1|||
161745270|NCT00862654|584106097|FG003|Overall Study|Lack of Efficacy|0|||
161745271|NCT00862654|584106094|FG000|Overall Study|Lost to Follow-up|1|||
161745272|NCT00862654|584106095|FG001|Overall Study|Lost to Follow-up|2|||
161745273|NCT00862654|584106096|FG002|Overall Study|Lost to Follow-up|1|||
161745274|NCT00862654|584106097|FG003|Overall Study|Lost to Follow-up|3|||
161745275|NCT00862654|584106094|FG000|Overall Study|Adverse Event|0|||
161745276|NCT00862654|584106095|FG001|Overall Study|Adverse Event|1|||
161745277|NCT00862654|584106096|FG002|Overall Study|Adverse Event|1|||
161745278|NCT00862654|584106097|FG003|Overall Study|Adverse Event|0|||
161745279|NCT00862654|584106094|FG000|Overall Study|Pregnancy|1|||
161745280|NCT00862654|584106095|FG001|Overall Study|Pregnancy|1|||
161745281|NCT00862654|584106096|FG002|Overall Study|Pregnancy|0|||
161745282|NCT00862654|584106097|FG003|Overall Study|Pregnancy|0|||
161745283|NCT00862654|584106094|FG000|Overall Study|Withdrawal by Subject|2|||
161745284|NCT00862654|584106095|FG001|Overall Study|Withdrawal by Subject|2|||
161745285|NCT00862654|584106096|FG002|Overall Study|Withdrawal by Subject|2|||
161745286|NCT00862654|584106097|FG003|Overall Study|Withdrawal by Subject|3|||
161745287|NCT00862654|584106094|FG000|Overall Study|Subject mistake|0|||
161745288|NCT00862654|584106095|FG001|Overall Study|Subject mistake|1|||
161745289|NCT00862654|584106096|FG002|Overall Study|Subject mistake|0|||
161745290|NCT00862654|584106097|FG003|Overall Study|Subject mistake|0|||
161745291|NCT00862654|584106094|FG000|Overall Study|Familly constraint|0|||
161842302|NCT00643565|584466348|FG001|Overall Study|Other|8|||
161842303|NCT00643565|584466347|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
161842304|NCT00643565|584466348|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
161842305|NCT00643565|584466347|FG000|Overall Study|Recurrence of Disease|2|||
161745292|NCT00862654|584106095|FG001|Overall Study|Familly constraint|1|||
161745293|NCT00862654|584106096|FG002|Overall Study|Familly constraint|0|||
161745294|NCT00862654|584106097|FG003|Overall Study|Familly constraint|0|||
161745295|NCT00862654|584106094|FG000|Overall Study|Never used study drugs|1|||
161745296|NCT00862654|584106095|FG001|Overall Study|Never used study drugs|0|||
161745297|NCT00862654|584106096|FG002|Overall Study|Never used study drugs|0|||
161745298|NCT00862654|584106097|FG003|Overall Study|Never used study drugs|0|||
161745299|NCT00862654|584106094|FG000|Overall Study|Included after end of inclusions|0|||
161745300|NCT00862654|584106095|FG001|Overall Study|Included after end of inclusions|0|||
161745301|NCT00862654|584106096|FG002|Overall Study|Included after end of inclusions|1|||
161745302|NCT00862654|584106097|FG003|Overall Study|Included after end of inclusions|0|||
161745303|NCT03219567|584106098|FG000|Overall Study|Withdrawal by Subject|0|||
161745304|NCT03219567|584106099|FG001|Overall Study|Withdrawal by Subject|1|||
161745305|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
161745306|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
161745307|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
161745308|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
161745309|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
161745310|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
161745311|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
161745312|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
161745313|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
161745314|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
161745315|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
161745316|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
161745317|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
161745318|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
161745319|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
161745320|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
161745321|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
161745322|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
161745323|NCT01151540|584106103|FG000|Overall Study|Other|2|||
161745324|NCT01151540|584106103|FG000|Overall Study|Adverse event, non-fatal|4|||
161745325|NCT01151540|584106103|FG000|Overall Study|Withdrawal by Subject|7|||
161745326|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
161745327|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
161745328|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
161745329|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
161745330|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
161745331|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
161745332|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
161745333|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
161745334|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
161745335|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
161745336|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
161745337|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
161745338|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
161745339|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
161745340|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
161745341|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
161745342|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
161745343|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
161745344|NCT01412060|584106107|FG000|Period Between RIP and SP|Adverse Event|4|||
161745345|NCT01412060|584106108|FG001|Period Between RIP and SP|Adverse Event|0|||
161745346|NCT01412060|584106109|FG002|Period Between RIP and SP|Adverse Event|0|||
161745347|NCT01412060|584106107|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
161745348|NCT01412060|584106108|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
161745349|NCT01412060|584106109|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
161745350|NCT01412060|584106107|FG000|Period Between RIP and SP|Protocol Violation|2|||
161745351|NCT01412060|584106108|FG001|Period Between RIP and SP|Protocol Violation|0|||
161745352|NCT01412060|584106109|FG002|Period Between RIP and SP|Protocol Violation|0|||
161745353|NCT01412060|584106107|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
161745354|NCT01412060|584106108|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
161745355|NCT01412060|584106109|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
161745356|NCT01412060|584106107|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
161745357|NCT01412060|584106108|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
161745358|NCT01412060|584106109|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
161745359|NCT01412060|584106107|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
161745360|NCT01412060|584106108|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
161745361|NCT01412060|584106109|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
161745362|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
161745363|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
161745364|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
161745365|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
161745366|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
161745367|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
161745368|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
161745369|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
161745370|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
161745371|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
161745372|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
161842306|NCT00643565|584466348|FG001|Overall Study|Recurrence of Disease|1|||
161842307|NCT00643565|584466347|FG000|Overall Study|Progression of Disease|18|||
161842308|NCT00643565|584466348|FG001|Overall Study|Progression of Disease|14|||
161842309|NCT00643565|584466347|FG000|Overall Study|Protocol Violation|3|||
161842310|NCT00643565|584466348|FG001|Overall Study|Protocol Violation|0|||
161842311|NCT00643565|584466347|FG000|Overall Study|Did Not Cooperate|0|||
161842312|NCT00643565|584466348|FG001|Overall Study|Did Not Cooperate|1|||
161842313|NCT00643565|584466347|FG000|Overall Study|Administrative|22|||
161842314|NCT00643565|584466348|FG001|Overall Study|Administrative|16|||
161842315|NCT00643565|584466347|FG000|Overall Study|Adverse Event|5|||
161842316|NCT00643565|584466348|FG001|Overall Study|Adverse Event|8|||
161842317|NCT02283983|584466349|FG000|Overall Study|Inclusion criteria not met|0|||
161842318|NCT02283983|584466350|FG001|Overall Study|Inclusion criteria not met|1|||
161842319|NCT02283983|584466349|FG000|Overall Study|Withdrawal by Subject|4|||
161842320|NCT02283983|584466350|FG001|Overall Study|Withdrawal by Subject|2|||
161842321|NCT02283983|584466349|FG000|Overall Study|Protocol Violation|0|||
161842322|NCT02283983|584466350|FG001|Overall Study|Protocol Violation|4|||
161842323|NCT02283983|584466349|FG000|Overall Study|Physician Decision|2|||
161842324|NCT02283983|584466350|FG001|Overall Study|Physician Decision|4|||
161842325|NCT02283983|584466349|FG000|Overall Study|Death|1|||
161842326|NCT02283983|584466350|FG001|Overall Study|Death|0|||
161842327|NCT02283983|584466349|FG000|Overall Study|Adverse Event|1|||
161842328|NCT02283983|584466350|FG001|Overall Study|Adverse Event|0|||
161842329|NCT02283983|584466349|FG000|Overall Study|Lost to Follow-up|9|||
161842330|NCT02283983|584466350|FG001|Overall Study|Lost to Follow-up|8|||
161842331|NCT02283983|584466349|FG000|Overall Study|Relapse|1|||
161842332|NCT02283983|584466350|FG001|Overall Study|Relapse|0|||
161842333|NCT03275064|584466351|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842334|NCT03275064|584466352|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842335|NCT03275064|584466353|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842336|NCT03275064|584466354|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
161842337|NCT03275064|584466355|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842338|NCT03275064|584466351|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
161842339|NCT03275064|584466352|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842340|NCT03275064|584466353|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842341|NCT03275064|584466354|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842342|NCT03275064|584466355|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842343|NCT03275064|584466351|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
161842344|NCT03275064|584466352|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
161842345|NCT03275064|584466353|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
161842346|NCT03275064|584466354|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
161842347|NCT03275064|584466355|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
161842348|NCT03275064|584466351|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842349|NCT03275064|584466352|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842350|NCT03275064|584466353|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842351|NCT03275064|584466354|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
161842352|NCT03275064|584466355|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842353|NCT03275064|584466351|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
161842354|NCT03275064|584466352|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161842355|NCT03275064|584466353|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
161842356|NCT03275064|584466354|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161842357|NCT03275064|584466355|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161842358|NCT00620555|584466358|FG000|Overall Study|Adverse Event|4|||
161842359|NCT00620555|584466358|FG000|Overall Study|Protocol Violation|2|||
161842360|NCT00620555|584466358|FG000|Overall Study|Lack of Efficacy|12|||
161842361|NCT00620555|584466358|FG000|Overall Study|Withdrawal by Subject|1|||
161842362|NCT00620555|584466358|FG000|Overall Study|Choice of other treatment|1|||
161842363|NCT00620555|584466358|FG000|Overall Study|Visit failure against planned|1|||
161842364|NCT03796039|584466359|FG000|Overall Study|Death|2|||
161842365|NCT03796039|584466360|FG001|Overall Study|Death|1|||
161842366|NCT03796039|584466359|FG000|Overall Study|Withdrawal by Subject|7|||
161842367|NCT03796039|584466360|FG001|Overall Study|Withdrawal by Subject|4|||
161842368|NCT01140503|584466361|FG000|Overall Study|Withdrawal by Subject|1|||
161842369|NCT00669071|584466363|FG000|Overall Study|Lost to Follow-up|3|||
161842370|NCT00669071|584466363|FG000|Overall Study|Final visit 40 days out of window|1|||
161842371|NCT04305496|584466364|FG000|Global Cohort|Withdrawal by Subject|13|||
161842372|NCT04305496|584466365|FG001|Global Cohort|Withdrawal by Subject|6|||
161842373|NCT04305496|584466364|FG000|Global Cohort|Physician Decision|1|||
161842374|NCT04305496|584466365|FG001|Global Cohort|Physician Decision|1|||
161842375|NCT04305496|584466364|FG000|Global Cohort|Subjective disease progression|16|||
161842376|NCT04305496|584466365|FG001|Global Cohort|Subjective disease progression|17|||
161842377|NCT04305496|584466364|FG000|Global Cohort|Condition under investigation worsened|209|||
161842378|NCT04305496|584466365|FG001|Global Cohort|Condition under investigation worsened|273|||
161842379|NCT04305496|584466364|FG000|Global Cohort|Protocol Violation|2|||
161842380|NCT04305496|584466365|FG001|Global Cohort|Protocol Violation|0|||
161842381|NCT04305496|584466364|FG000|Global Cohort|Adverse Event|44|||
161745373|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
161745374|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
161745375|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
161842382|NCT04305496|584466365|FG001|Global Cohort|Adverse Event|6|||
161842383|NCT04305496|584466364|FG000|Global Cohort|Death|3|||
161842384|NCT04305496|584466365|FG001|Global Cohort|Death|2|||
161842385|NCT04305496|584466364|FG000|Global Cohort|Any reason not specifically recorded|4|||
161842386|NCT04305496|584466365|FG001|Global Cohort|Any reason not specifically recorded|5|||
161842387|NCT04305496|584466364|FG000|China Cohort|Any reason not specifically recorded|1|||
161842388|NCT04305496|584466365|FG001|China Cohort|Any reason not specifically recorded|1|||
161842389|NCT04305496|584466364|FG000|China Cohort|Adverse Event|8|||
161842390|NCT04305496|584466365|FG001|China Cohort|Adverse Event|2|||
161745376|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
161745377|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
161745378|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
161745379|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
161745380|NCT01412060|584106107|FG000|Period Between SP and DBP|Protocol Violation|2|||
161745381|NCT01412060|584106108|FG001|Period Between SP and DBP|Protocol Violation|0|||
161745382|NCT01412060|584106109|FG002|Period Between SP and DBP|Protocol Violation|0|||
161745383|NCT01412060|584106107|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
161745384|NCT01412060|584106108|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
161745385|NCT01412060|584106109|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
161745386|NCT01412060|584106107|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
161745387|NCT01412060|584106108|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
161745388|NCT01412060|584106109|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
161745389|NCT01412060|584106107|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
161745390|NCT01412060|584106108|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
161745391|NCT01412060|584106109|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
161745392|NCT01412060|584106107|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
161745393|NCT01412060|584106108|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
161745394|NCT01412060|584106109|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
161745395|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
161745396|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
161745397|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
161745398|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
161745399|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
161745400|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
161745401|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
161745402|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
161745403|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
161745404|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
161745405|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
161745406|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
161842391|NCT04305496|584466364|FG000|China Cohort|Condition under investigation worsened|40|||
161842392|NCT04305496|584466365|FG001|China Cohort|Condition under investigation worsened|47|||
161842393|NCT04305496|584466364|FG000|China Cohort|Subjective disease progression|2|||
161842394|NCT04305496|584466365|FG001|China Cohort|Subjective disease progression|2|||
161842395|NCT04305496|584466364|FG000|China Cohort|Withdrawal by Subject|2|||
161842396|NCT04305496|584466365|FG001|China Cohort|Withdrawal by Subject|1|||
161842397|NCT01157897|584466367|FG000|Overall Study|Lost to Follow-up|2|||
161842398|NCT01157897|584466368|FG001|Overall Study|Lost to Follow-up|0|||
161842399|NCT01157897|584466369|FG002|Overall Study|Lost to Follow-up|0|||
161842400|NCT01157897|584466370|FG003|Overall Study|Lost to Follow-up|1|||
161842401|NCT01157897|584466367|FG000|Overall Study|Relocated|0|||
161842402|NCT01157897|584466368|FG001|Overall Study|Relocated|2|||
161842403|NCT01157897|584466369|FG002|Overall Study|Relocated|0|||
161842404|NCT01157897|584466370|FG003|Overall Study|Relocated|0|||
161842405|NCT00681590|584466372|FG000|Overall Study|Withdrawal by Subject|2|||
161842406|NCT00681590|584466373|FG001|Overall Study|Withdrawal by Subject|12|||
161842407|NCT01791153|584466376|FG000|Part 1: Blinded Period|Adverse Event|7|||
161745407|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
161842408|NCT01791153|584466377|FG001|Part 1: Blinded Period|Adverse Event|3|||
161842409|NCT01791153|584466378|FG002|Part 1: Blinded Period|Adverse Event|2|||
161842410|NCT01791153|584466379|FG003|Part 1: Blinded Period|Adverse Event|0|||
161842411|NCT01791153|584466380|FG004|Part 1: Blinded Period|Adverse Event|0|||
161842412|NCT01791153|584466381|FG005|Part 1: Blinded Period|Adverse Event|0|||
161842413|NCT01791153|584466382|FG006|Part 1: Blinded Period|Adverse Event|0|||
161842414|NCT01791153|584466383|FG007|Part 1: Blinded Period|Adverse Event|0|||
161842415|NCT01791153|584466376|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
161842416|NCT01791153|584466377|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
161842417|NCT01791153|584466378|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
161842418|NCT01791153|584466379|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
161842419|NCT01791153|584466380|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
161842420|NCT01791153|584466381|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
161842421|NCT01791153|584466382|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
161842422|NCT01791153|584466383|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
161842423|NCT01791153|584466376|FG000|Part 1: Blinded Period|Non-Compliance|1|||
161745408|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
161745409|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
161745410|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
161745411|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
161745412|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
161745413|NCT00004732|584106110|FG000|Overall Study|Withdrawal by Subject|36|||
161745414|NCT00004732|584106111|FG001|Overall Study|Withdrawal by Subject|64|||
161745415|NCT00004732|584106110|FG000|Overall Study|Lost to Follow-up|33|||
161745416|NCT00004732|584106111|FG001|Overall Study|Lost to Follow-up|47|||
161745417|NCT02674685|584106112|FG000|Overall Study|Withdrawal by Subject|4|||
161745418|NCT01181778|584106113|FG000|Overall Study|Physician Decision|48|||
161745419|NCT02726113|584106116|FG000|Total Enrollment|Physician Decision|0|||
161745420|NCT02726113|584106117|FG001|Total Enrollment|Physician Decision|1|||
161745421|NCT02726113|584106116|FG000|Total Enrollment|Protocol Violation|1|||
161745422|NCT02726113|584106117|FG001|Total Enrollment|Protocol Violation|0|||
161745423|NCT02726113|584106116|FG000|Total Enrollment|Withdrawal by Subject|2|||
161745424|NCT02726113|584106117|FG001|Total Enrollment|Withdrawal by Subject|1|||
161745425|NCT02726113|584106116|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
161745426|NCT02726113|584106117|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
161745427|NCT02726113|584106116|FG000|Genomic Analysis|Protocol Violation|1|||
161745428|NCT02726113|584106117|FG001|Genomic Analysis|Protocol Violation|0|||
161745429|NCT02726113|584106116|FG000|Genomic Analysis|Withdrawal by Subject|2|||
161745430|NCT02726113|584106117|FG001|Genomic Analysis|Withdrawal by Subject|1|||
161745431|NCT02726113|584106116|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
161745432|NCT02726113|584106117|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
161745433|NCT03549117|584106121|FG000|Overall Study|Withdrawal by Subject|1|||
161745434|NCT03549117|584106122|FG001|Overall Study|Withdrawal by Subject|0|||
161745435|NCT02661464|584106123|FG000|Overall Study|Lost to Follow-up|28|||
161745436|NCT02661464|584106124|FG001|Overall Study|Lost to Follow-up|0|||
161745437|NCT02661464|584106125|FG002|Overall Study|Lost to Follow-up|0|||
161842424|NCT01791153|584466377|FG001|Part 1: Blinded Period|Non-Compliance|0|||
161842425|NCT01791153|584466378|FG002|Part 1: Blinded Period|Non-Compliance|0|||
161842426|NCT01791153|584466379|FG003|Part 1: Blinded Period|Non-Compliance|0|||
161842427|NCT01791153|584466380|FG004|Part 1: Blinded Period|Non-Compliance|0|||
161842428|NCT01791153|584466381|FG005|Part 1: Blinded Period|Non-Compliance|0|||
161842429|NCT01791153|584466382|FG006|Part 1: Blinded Period|Non-Compliance|0|||
161842430|NCT01791153|584466383|FG007|Part 1: Blinded Period|Non-Compliance|0|||
161842431|NCT01791153|584466376|FG000|Part 1: Blinded Period|Physician Decision|0|||
161842432|NCT01791153|584466377|FG001|Part 1: Blinded Period|Physician Decision|0|||
161842433|NCT01791153|584466378|FG002|Part 1: Blinded Period|Physician Decision|0|||
161842434|NCT01791153|584466379|FG003|Part 1: Blinded Period|Physician Decision|1|||
161842435|NCT01791153|584466380|FG004|Part 1: Blinded Period|Physician Decision|0|||
161842436|NCT01791153|584466381|FG005|Part 1: Blinded Period|Physician Decision|0|||
161745438|NCT02661464|584106126|FG003|Overall Study|Lost to Follow-up|0|||
161745439|NCT02661464|584106123|FG000|Overall Study|Withdrawal by Subject|3|||
161745440|NCT02661464|584106124|FG001|Overall Study|Withdrawal by Subject|1|||
161745441|NCT02661464|584106125|FG002|Overall Study|Withdrawal by Subject|0|||
161745442|NCT02661464|584106126|FG003|Overall Study|Withdrawal by Subject|0|||
161745443|NCT02661464|584106123|FG000|Overall Study|Participants terminated prematurely|288|||
161745444|NCT02661464|584106124|FG001|Overall Study|Participants terminated prematurely|52|||
161745445|NCT02661464|584106125|FG002|Overall Study|Participants terminated prematurely|1|||
161842437|NCT01791153|584466382|FG006|Part 1: Blinded Period|Physician Decision|0|||
161842438|NCT01791153|584466383|FG007|Part 1: Blinded Period|Physician Decision|0|||
161842439|NCT01791153|584466376|FG000|Part 1: Blinded Period|Protocol Violation|0|||
161745446|NCT02661464|584106126|FG003|Overall Study|Participants terminated prematurely|1|||
161745447|NCT02661464|584106123|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
161745448|NCT02661464|584106124|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
161745449|NCT02661464|584106125|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
161745450|NCT02661464|584106126|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
161745451|NCT03148756|584106128|FG000|Overall Study|Study Terminated|0|||
161745452|NCT03148756|584106129|FG001|Overall Study|Study Terminated|1|||
161745453|NCT05567393|584106130|FG000|Overall Study|Voluntary Withdrawal|0|||
161745454|NCT05567393|584106131|FG001|Overall Study|Voluntary Withdrawal|0|||
161745455|NCT05567393|584106132|FG002|Overall Study|Voluntary Withdrawal|0|||
161745456|NCT05567393|584106133|FG003|Overall Study|Voluntary Withdrawal|0|||
161745457|NCT05567393|584106134|FG004|Overall Study|Voluntary Withdrawal|0|||
161745458|NCT05567393|584106135|FG005|Overall Study|Voluntary Withdrawal|0|||
161745459|NCT05567393|584106136|FG006|Overall Study|Voluntary Withdrawal|0|||
161745460|NCT05567393|584106137|FG007|Overall Study|Voluntary Withdrawal|0|||
161745461|NCT05567393|584106138|FG008|Overall Study|Voluntary Withdrawal|0|||
161745462|NCT05567393|584106139|FG009|Overall Study|Voluntary Withdrawal|0|||
161745463|NCT05567393|584106140|FG010|Overall Study|Voluntary Withdrawal|0|||
161745464|NCT05567393|584106141|FG011|Overall Study|Voluntary Withdrawal|0|||
161745465|NCT05567393|584106142|FG012|Overall Study|Voluntary Withdrawal|0|||
161745466|NCT05567393|584106143|FG013|Overall Study|Voluntary Withdrawal|1|||
161745467|NCT05567393|584106144|FG014|Overall Study|Voluntary Withdrawal|0|||
161745468|NCT05567393|584106145|FG015|Overall Study|Voluntary Withdrawal|0|||
161745469|NCT05567393|584106146|FG016|Overall Study|Voluntary Withdrawal|0|||
161745470|NCT05567393|584106147|FG017|Overall Study|Voluntary Withdrawal|0|||
161745471|NCT01924299|584106151|FG000|Period 2|Withdrawal by Subject|1|||
161745472|NCT01924299|584106152|FG001|Period 2|Withdrawal by Subject|0|||
161745473|NCT01924299|584106151|FG000|Period 2|Adverse Event|0|||
161745474|NCT01924299|584106152|FG001|Period 2|Adverse Event|1|||
161745475|NCT02177175|584106153|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
161745476|NCT02177175|584106154|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
161745477|NCT04199793|584106155|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
161745478|NCT04199793|584106156|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
161745479|NCT04199793|584106155|FG000|Overall Study|Withdrawal by Subject|1|||
161745480|NCT04199793|584106156|FG001|Overall Study|Withdrawal by Subject|1|||
161745481|NCT00628758|584106157|FG000|Overall Study|Adverse Event|2|||
161745482|NCT00628758|584106158|FG001|Overall Study|Adverse Event|3|||
161745483|NCT00628758|584106157|FG000|Overall Study|Withdrawal by Subject|6|||
161745484|NCT00628758|584106158|FG001|Overall Study|Withdrawal by Subject|3|||
161745485|NCT00628758|584106157|FG000|Overall Study|Death|1|||
161745486|NCT00628758|584106158|FG001|Overall Study|Death|0|||
161745487|NCT00628758|584106157|FG000|Overall Study|Protocol Violation|5|||
161745488|NCT00628758|584106158|FG001|Overall Study|Protocol Violation|1|||
161745489|NCT00628758|584106157|FG000|Overall Study|Lost to Follow-up|25|||
161745490|NCT00628758|584106158|FG001|Overall Study|Lost to Follow-up|31|||
161745491|NCT00628758|584106157|FG000|Overall Study|Pregnancy|2|||
161745492|NCT00628758|584106158|FG001|Overall Study|Pregnancy|2|||
161745493|NCT00628758|584106157|FG000|Overall Study|Investigator Moved|3|||
161745494|NCT00628758|584106158|FG001|Overall Study|Investigator Moved|0|||
161745495|NCT00628758|584106157|FG000|Overall Study|Treatment Failure|0|||
161745496|NCT00628758|584106158|FG001|Overall Study|Treatment Failure|2|||
161745497|NCT00719862|584106170|FG000|Overall Study|Adverse Event|1|||
161745498|NCT00719862|584106171|FG001|Overall Study|Adverse Event|2|||
161745499|NCT00719862|584106170|FG000|Overall Study|Lack of Efficacy|3|||
161745500|NCT00719862|584106171|FG001|Overall Study|Lack of Efficacy|0|||
161745501|NCT00719862|584106170|FG000|Overall Study|Non-Compliance|1|||
161745502|NCT00719862|584106171|FG001|Overall Study|Non-Compliance|0|||
161745503|NCT00719862|584106170|FG000|Overall Study|Withdrawal by Subject|1|||
161745504|NCT00719862|584106171|FG001|Overall Study|Withdrawal by Subject|0|||
161745505|NCT00719862|584106170|FG000|Overall Study|Lost to Follow-up|0|||
161745506|NCT00719862|584106171|FG001|Overall Study|Lost to Follow-up|1|||
161745507|NCT00719862|584106170|FG000|Overall Study|Other|2|||
161745508|NCT00719862|584106171|FG001|Overall Study|Other|3|||
161745509|NCT01184846|584106172|FG000|Overall Study|Adverse Event|2|||
161745510|NCT01184846|584106172|FG000|Overall Study|Insufficient response|1|||
161745511|NCT04021706|584108096|FG000|Overall Study|Adverse Event|2|||
161745512|NCT04021706|584108097|FG001|Overall Study|Adverse Event|0|||
161745513|NCT04021706|584108096|FG000|Overall Study|Withdrawal by Subject|1|||
161745514|NCT04021706|584108097|FG001|Overall Study|Withdrawal by Subject|2|||
161745515|NCT04021706|584108096|FG000|Overall Study|Physician Decision|1|||
161745516|NCT04021706|584108097|FG001|Overall Study|Physician Decision|0|||
161745517|NCT02332798|584108098|FG000|Overall Study|Unwilling to Participate in Study|0|||
161745518|NCT02332798|584108099|FG001|Overall Study|Unwilling to Participate in Study|1|||
161745519|NCT02332798|584108100|FG002|Overall Study|Unwilling to Participate in Study|1|||
161745520|NCT02332798|584108098|FG000|Overall Study|Positive Urine Drug Test|0|||
161745521|NCT02332798|584108099|FG001|Overall Study|Positive Urine Drug Test|1|||
161745522|NCT02332798|584108100|FG002|Overall Study|Positive Urine Drug Test|0|||
161745523|NCT02332798|584108098|FG000|Overall Study|Abnormal Laboratory Findings|1|||
161745524|NCT02332798|584108099|FG001|Overall Study|Abnormal Laboratory Findings|0|||
161745525|NCT02332798|584108100|FG002|Overall Study|Abnormal Laboratory Findings|0|||
161745526|NCT00595868|584108101|FG000|Overall Study|Lost to Follow-up|45|||
161745527|NCT00595868|584108102|FG001|Overall Study|Lost to Follow-up|50|||
161745528|NCT02688153|584108103|FG000|Overall Study|Death|7|||
161745529|NCT02688153|584108104|FG001|Overall Study|Death|5|||
161745530|NCT02688153|584108103|FG000|Overall Study|Withdrawal by Subject|4|||
161745531|NCT02688153|584108104|FG001|Overall Study|Withdrawal by Subject|2|||
161745532|NCT02688153|584108103|FG000|Overall Study|Valve Explant|1|||
161745533|NCT02688153|584108104|FG001|Overall Study|Valve Explant|0|||
161745534|NCT02688153|584108103|FG000|Overall Study|Conversion to Commercial Valve|3|||
161745535|NCT02688153|584108104|FG001|Overall Study|Conversion to Commercial Valve|0|||
161745536|NCT00859573|584108105|FG000|Overall Study|Withdrawal by Subject|4|||
161745537|NCT00859573|584108106|FG001|Overall Study|Withdrawal by Subject|1|||
161745538|NCT00859573|584108105|FG000|Overall Study|Physician Decision|1|||
161745539|NCT00859573|584108106|FG001|Overall Study|Physician Decision|1|||
161745540|NCT01135394|584108118|FG000|Screening|Lost to Follow-up|2|||
161745541|NCT01135394|584108118|FG000|Screening|Withdrawal by Subject|10|||
161745542|NCT01135394|584108118|FG000|Screening|Screening failure|16|||
161745543|NCT01135394|584108118|FG000|Screening|Physician Decision|5|||
161745544|NCT01135394|584108118|FG000|Baseline Assessment|Withdrawal by Subject|9|||
161745545|NCT01135394|584108118|FG000|Baseline Assessment|Physician Decision|3|||
161745546|NCT01135394|584108118|FG000|Baseline Assessment|Lost to Follow-up|2|||
161745547|NCT01135394|584108118|FG000|Baseline Assessment|Adverse Event|1|||
161745548|NCT01135394|584108118|FG000|Study Treatment|Withdrawal by Subject|1|||
161745549|NCT01135394|584108118|FG000|Study Treatment|Physician Decision|1|||
161745550|NCT01135394|584108118|FG000|Study Treatment|Adverse Event|2|||
161745551|NCT00462488|584108119|FG000|Overall Study|Protocol Violation|1|||
161745552|NCT00462488|584108120|FG001|Overall Study|Protocol Violation|0|||
161745553|NCT00462488|584108119|FG000|Overall Study|Lack of Efficacy|19|||
161745554|NCT00462488|584108120|FG001|Overall Study|Lack of Efficacy|17|||
161745555|NCT01742091|584108125|FG000|Overall Study|Adverse Event|0|||
161745556|NCT01742091|584108126|FG001|Overall Study|Adverse Event|0|||
161745557|NCT01742091|584108127|FG002|Overall Study|Adverse Event|0|||
161745558|NCT01742091|584108128|FG003|Overall Study|Adverse Event|0|||
161745559|NCT01742091|584108129|FG004|Overall Study|Adverse Event|1|||
161745560|NCT01742091|584108130|FG005|Overall Study|Adverse Event|0|||
161745561|NCT01742091|584108125|FG000|Overall Study|Physician Decision|0|||
161745562|NCT01742091|584108126|FG001|Overall Study|Physician Decision|0|||
161745563|NCT01742091|584108127|FG002|Overall Study|Physician Decision|0|||
161745564|NCT01742091|584108128|FG003|Overall Study|Physician Decision|0|||
161745565|NCT01742091|584108129|FG004|Overall Study|Physician Decision|0|||
161745566|NCT01742091|584108130|FG005|Overall Study|Physician Decision|1|||
161745567|NCT01742091|584108125|FG000|Overall Study|Withdrawal by Subject|0|||
161745568|NCT01742091|584108126|FG001|Overall Study|Withdrawal by Subject|0|||
161745569|NCT01742091|584108127|FG002|Overall Study|Withdrawal by Subject|0|||
161745570|NCT01742091|584108128|FG003|Overall Study|Withdrawal by Subject|1|||
161745571|NCT01742091|584108129|FG004|Overall Study|Withdrawal by Subject|0|||
161745572|NCT01742091|584108130|FG005|Overall Study|Withdrawal by Subject|0|||
161745573|NCT01742091|584108125|FG000|Overall Study|Lost to Follow-up|0|||
161745574|NCT01742091|584108126|FG001|Overall Study|Lost to Follow-up|0|||
161745575|NCT01742091|584108127|FG002|Overall Study|Lost to Follow-up|0|||
161745576|NCT01742091|584108128|FG003|Overall Study|Lost to Follow-up|0|||
161745577|NCT01742091|584108129|FG004|Overall Study|Lost to Follow-up|0|||
161745578|NCT01742091|584108130|FG005|Overall Study|Lost to Follow-up|1|||
161745579|NCT02088541|584108131|FG000|Overall Study|Adverse Event|3|||
161745580|NCT02088541|584108132|FG001|Overall Study|Adverse Event|0|||
161745581|NCT02088541|584108133|FG002|Overall Study|Adverse Event|3|||
161745582|NCT02088541|584108134|FG003|Overall Study|Adverse Event|3|||
161745583|NCT02088541|584108135|FG004|Overall Study|Adverse Event|0|||
161745584|NCT02088541|584108131|FG000|Overall Study|Death|51|||
161745585|NCT02088541|584108132|FG001|Overall Study|Death|21|||
161745586|NCT02088541|584108133|FG002|Overall Study|Death|85|||
161745587|NCT02088541|584108134|FG003|Overall Study|Death|28|||
161745588|NCT02088541|584108135|FG004|Overall Study|Death|38|||
161745589|NCT02088541|584108131|FG000|Overall Study|Lost to Follow-up|2|||
161745590|NCT02088541|584108132|FG001|Overall Study|Lost to Follow-up|0|||
161745591|NCT02088541|584108133|FG002|Overall Study|Lost to Follow-up|1|||
161745592|NCT02088541|584108134|FG003|Overall Study|Lost to Follow-up|0|||
161745593|NCT02088541|584108135|FG004|Overall Study|Lost to Follow-up|0|||
161745594|NCT02088541|584108131|FG000|Overall Study|Physician Decision|2|||
161745595|NCT02088541|584108132|FG001|Overall Study|Physician Decision|1|||
161745596|NCT02088541|584108133|FG002|Overall Study|Physician Decision|2|||
161745597|NCT02088541|584108134|FG003|Overall Study|Physician Decision|0|||
161745598|NCT02088541|584108135|FG004|Overall Study|Physician Decision|2|||
161745599|NCT02088541|584108131|FG000|Overall Study|Disease progression|7|||
161745600|NCT02088541|584108132|FG001|Overall Study|Disease progression|1|||
161745601|NCT02088541|584108133|FG002|Overall Study|Disease progression|2|||
161745602|NCT02088541|584108134|FG003|Overall Study|Disease progression|3|||
161745603|NCT02088541|584108135|FG004|Overall Study|Disease progression|1|||
161745604|NCT02088541|584108131|FG000|Overall Study|Study terminated by sponsor|1|||
161842440|NCT01791153|584466377|FG001|Part 1: Blinded Period|Protocol Violation|0|||
161842441|NCT01791153|584466378|FG002|Part 1: Blinded Period|Protocol Violation|0|||
161842442|NCT01791153|584466379|FG003|Part 1: Blinded Period|Protocol Violation|1|||
161842443|NCT01791153|584466380|FG004|Part 1: Blinded Period|Protocol Violation|0|||
161842444|NCT01791153|584466381|FG005|Part 1: Blinded Period|Protocol Violation|0|||
161842445|NCT01791153|584466382|FG006|Part 1: Blinded Period|Protocol Violation|0|||
161842446|NCT01791153|584466383|FG007|Part 1: Blinded Period|Protocol Violation|0|||
161842447|NCT01791153|584466376|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
161842448|NCT01791153|584466377|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
161842449|NCT01791153|584466378|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
161842450|NCT01791153|584466379|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
161842451|NCT01791153|584466380|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842452|NCT01791153|584466381|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842453|NCT01791153|584466382|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842454|NCT01791153|584466383|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842455|NCT01791153|584466376|FG000|Part 2: Open-label Period|Adverse Event|0|||
161842456|NCT01791153|584466377|FG001|Part 2: Open-label Period|Adverse Event|0|||
161842457|NCT01791153|584466378|FG002|Part 2: Open-label Period|Adverse Event|0|||
161842458|NCT01791153|584466379|FG003|Part 2: Open-label Period|Adverse Event|0|||
161842459|NCT01791153|584466380|FG004|Part 2: Open-label Period|Adverse Event|0|||
161842460|NCT01791153|584466381|FG005|Part 2: Open-label Period|Adverse Event|1|||
161842461|NCT01791153|584466382|FG006|Part 2: Open-label Period|Adverse Event|1|||
161842462|NCT01791153|584466383|FG007|Part 2: Open-label Period|Adverse Event|2|||
161842463|NCT01791153|584466376|FG000|Part 2: Open-label Period|Death|0|||
161842464|NCT01791153|584466377|FG001|Part 2: Open-label Period|Death|0|||
161842465|NCT01791153|584466378|FG002|Part 2: Open-label Period|Death|0|||
161842466|NCT01791153|584466379|FG003|Part 2: Open-label Period|Death|0|||
161842467|NCT01791153|584466380|FG004|Part 2: Open-label Period|Death|0|||
161842468|NCT01791153|584466381|FG005|Part 2: Open-label Period|Death|1|||
161842469|NCT01791153|584466382|FG006|Part 2: Open-label Period|Death|1|||
161842470|NCT01791153|584466383|FG007|Part 2: Open-label Period|Death|1|||
161842471|NCT01791153|584466376|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
161842472|NCT01791153|584466377|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
161842473|NCT01791153|584466378|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
161842474|NCT01791153|584466379|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
161842475|NCT01791153|584466380|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
161842476|NCT01791153|584466381|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
161745605|NCT02088541|584108132|FG001|Overall Study|Study terminated by sponsor|1|||
161745606|NCT02088541|584108133|FG002|Overall Study|Study terminated by sponsor|12|||
161745607|NCT02088541|584108134|FG003|Overall Study|Study terminated by sponsor|2|||
161745608|NCT02088541|584108135|FG004|Overall Study|Study terminated by sponsor|6|||
161745609|NCT02088541|584108131|FG000|Overall Study|Withdrawal by Subject|3|||
161842477|NCT01791153|584466382|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
161842478|NCT01791153|584466383|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
161745610|NCT02088541|584108132|FG001|Overall Study|Withdrawal by Subject|2|||
161745611|NCT02088541|584108133|FG002|Overall Study|Withdrawal by Subject|9|||
161745612|NCT02088541|584108134|FG003|Overall Study|Withdrawal by Subject|7|||
161745613|NCT02088541|584108135|FG004|Overall Study|Withdrawal by Subject|10|||
161745614|NCT02088541|584108131|FG000|Overall Study|Other|2|||
161745615|NCT02088541|584108132|FG001|Overall Study|Other|1|||
161745616|NCT02088541|584108133|FG002|Overall Study|Other|3|||
161745617|NCT02088541|584108134|FG003|Overall Study|Other|1|||
161745618|NCT02088541|584108135|FG004|Overall Study|Other|1|||
161745619|NCT05742841|584108136|FG000|Overall Study|Withdrawal by Subject|1|||
161745620|NCT05742841|584108136|FG000|Overall Study|Lost to Follow-up|1|||
161745621|NCT03750240|584108138|FG000|Overall Study|Technical Difficulties|2|||
161745622|NCT00247273|584108142|FG000|Overall Study|Adverse Event|85|||
161745623|NCT00247273|584108143|FG001|Overall Study|Adverse Event|80|||
161842479|NCT01791153|584466376|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
161745624|NCT00247273|584108142|FG000|Overall Study|Physician Decision|6|||
161842480|NCT01791153|584466377|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
161842481|NCT01791153|584466378|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
161745625|NCT00247273|584108143|FG001|Overall Study|Physician Decision|3|||
161745626|NCT00247273|584108142|FG000|Overall Study|Lost to Follow-up|7|||
161745627|NCT00247273|584108143|FG001|Overall Study|Lost to Follow-up|7|||
161842482|NCT01791153|584466379|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
161842483|NCT01791153|584466380|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
161842484|NCT01791153|584466381|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
161842485|NCT01791153|584466382|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
161842486|NCT01791153|584466383|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
161842487|NCT01791153|584466376|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842488|NCT01791153|584466377|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842489|NCT01791153|584466378|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842490|NCT01791153|584466379|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842491|NCT01791153|584466380|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
161842492|NCT01791153|584466381|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
161842493|NCT01791153|584466382|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
161842494|NCT01791153|584466383|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
161842495|NCT01791153|584466376|FG000|Part 2: Open-label Period|Physician Decision|0|||
161842496|NCT01791153|584466377|FG001|Part 2: Open-label Period|Physician Decision|0|||
161842497|NCT01791153|584466378|FG002|Part 2: Open-label Period|Physician Decision|0|||
161842498|NCT01791153|584466379|FG003|Part 2: Open-label Period|Physician Decision|0|||
161842499|NCT01791153|584466380|FG004|Part 2: Open-label Period|Physician Decision|1|||
161842500|NCT01791153|584466381|FG005|Part 2: Open-label Period|Physician Decision|1|||
161842501|NCT01791153|584466382|FG006|Part 2: Open-label Period|Physician Decision|0|||
161842502|NCT01791153|584466383|FG007|Part 2: Open-label Period|Physician Decision|0|||
161842503|NCT02562482|584466384|FG000|Overall Study|Enrolled, but did not receive product|4|||
161842504|NCT02562482|584466385|FG001|Overall Study|Enrolled, but did not receive product|0|||
161842505|NCT02562482|584466384|FG000|Overall Study|Lost to Follow-up|9|||
161842506|NCT02562482|584466385|FG001|Overall Study|Lost to Follow-up|6|||
161842507|NCT02562482|584466384|FG000|Overall Study|Moved from area|2|||
161842508|NCT02562482|584466385|FG001|Overall Study|Moved from area|3|||
161842509|NCT02562482|584466384|FG000|Overall Study|Withdrawal by Subject|5|||
161842510|NCT02562482|584466385|FG001|Overall Study|Withdrawal by Subject|3|||
161842511|NCT02562482|584466384|FG000|Overall Study|Physician Decision|1|||
161842512|NCT02562482|584466385|FG001|Overall Study|Physician Decision|3|||
161842513|NCT02562482|584466384|FG000|Overall Study|Illness/Injury unrelated to product|0|||
161842514|NCT02562482|584466385|FG001|Overall Study|Illness/Injury unrelated to product|1|||
161842515|NCT05896202|584466388|FG000|Overall Study|Lost to Follow-up|2|||
161842516|NCT05896202|584466389|FG001|Overall Study|Lost to Follow-up|2|||
161842517|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
161842518|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
161842519|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
161842520|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
161842521|NCT02041091|584466393|FG000|Treatment|Adverse Event|3|||
161842522|NCT02041091|584466394|FG001|Treatment|Adverse Event|3|||
161842523|NCT02041091|584466393|FG000|Treatment|Withdrawal by Subject|2|||
161842524|NCT02041091|584466394|FG001|Treatment|Withdrawal by Subject|4|||
161842525|NCT02041091|584466393|FG000|Treatment|Physician Decision|1|||
161842526|NCT02041091|584466394|FG001|Treatment|Physician Decision|0|||
161842527|NCT02041091|584466393|FG000|Treatment|Sponsor Decision|15|||
161842528|NCT02041091|584466394|FG001|Treatment|Sponsor Decision|16|||
161842529|NCT02041091|584466393|FG000|Treatment|Lost to Follow-up|1|||
161842530|NCT02041091|584466394|FG001|Treatment|Lost to Follow-up|0|||
161842531|NCT02041091|584466393|FG000|Optional Safety Extension Period|Adverse Event|4|||
161842532|NCT02041091|584466394|FG001|Optional Safety Extension Period|Adverse Event|2|||
161842533|NCT02041091|584466393|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
161842534|NCT02041091|584466394|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
161842535|NCT02041091|584466393|FG000|Optional Safety Extension Period|Protocol Violation|2|||
161842536|NCT02041091|584466394|FG001|Optional Safety Extension Period|Protocol Violation|0|||
161842537|NCT02041091|584466393|FG000|Optional Safety Extension Period|Physician Decision|2|||
161842538|NCT02041091|584466394|FG001|Optional Safety Extension Period|Physician Decision|1|||
161842539|NCT02041091|584466393|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
161842540|NCT02041091|584466394|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
161842541|NCT02041091|584466393|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
161842542|NCT02041091|584466394|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
161842543|NCT03970837|584466395|FG000|Overall Study|Adverse Event|23|||
161842544|NCT03970837|584466396|FG001|Overall Study|Adverse Event|20|||
161842545|NCT03970837|584466397|FG002|Overall Study|Adverse Event|16|||
161842546|NCT03970837|584466398|FG003|Overall Study|Adverse Event|6|||
161842547|NCT03970837|584466399|FG004|Overall Study|Adverse Event|4|||
161842548|NCT03970837|584466400|FG005|Overall Study|Adverse Event|5|||
161842549|NCT03970837|584466401|FG006|Overall Study|Adverse Event|1|||
161842550|NCT03970837|584466402|FG007|Overall Study|Adverse Event|5|||
161842551|NCT03970837|584466403|FG008|Overall Study|Adverse Event|0|||
161842552|NCT03970837|584466404|FG009|Overall Study|Adverse Event|0|||
161842553|NCT03970837|584466405|FG010|Overall Study|Adverse Event|1|||
161842554|NCT03970837|584466406|FG011|Overall Study|Adverse Event|1|||
161842555|NCT03970837|584466395|FG000|Overall Study|Lack of Efficacy|14|||
161842556|NCT03970837|584466396|FG001|Overall Study|Lack of Efficacy|12|||
161842557|NCT03970837|584466397|FG002|Overall Study|Lack of Efficacy|1|||
161842558|NCT03970837|584466398|FG003|Overall Study|Lack of Efficacy|2|||
161842559|NCT03970837|584466399|FG004|Overall Study|Lack of Efficacy|3|||
161842560|NCT03970837|584466400|FG005|Overall Study|Lack of Efficacy|4|||
161842561|NCT03970837|584466401|FG006|Overall Study|Lack of Efficacy|6|||
161842562|NCT03970837|584466402|FG007|Overall Study|Lack of Efficacy|1|||
161842563|NCT03970837|584466403|FG008|Overall Study|Lack of Efficacy|1|||
161842564|NCT03970837|584466404|FG009|Overall Study|Lack of Efficacy|0|||
161842565|NCT03970837|584466405|FG010|Overall Study|Lack of Efficacy|0|||
161842566|NCT03970837|584466406|FG011|Overall Study|Lack of Efficacy|0|||
161842567|NCT03970837|584466395|FG000|Overall Study|Lost to Follow-up|6|||
161842568|NCT03970837|584466396|FG001|Overall Study|Lost to Follow-up|5|||
161842569|NCT03970837|584466397|FG002|Overall Study|Lost to Follow-up|5|||
161842570|NCT03970837|584466398|FG003|Overall Study|Lost to Follow-up|1|||
161842571|NCT03970837|584466399|FG004|Overall Study|Lost to Follow-up|0|||
161842572|NCT03970837|584466400|FG005|Overall Study|Lost to Follow-up|2|||
161842573|NCT03970837|584466401|FG006|Overall Study|Lost to Follow-up|0|||
161842574|NCT03970837|584466402|FG007|Overall Study|Lost to Follow-up|0|||
161842575|NCT03970837|584466403|FG008|Overall Study|Lost to Follow-up|0|||
161842576|NCT03970837|584466404|FG009|Overall Study|Lost to Follow-up|0|||
161842577|NCT03970837|584466405|FG010|Overall Study|Lost to Follow-up|0|||
161842578|NCT03970837|584466406|FG011|Overall Study|Lost to Follow-up|0|||
161842579|NCT03970837|584466395|FG000|Overall Study|Protocol Violation|1|||
161842580|NCT03970837|584466396|FG001|Overall Study|Protocol Violation|0|||
161842581|NCT03970837|584466397|FG002|Overall Study|Protocol Violation|0|||
161842582|NCT03970837|584466398|FG003|Overall Study|Protocol Violation|0|||
161842583|NCT03970837|584466399|FG004|Overall Study|Protocol Violation|0|||
161842584|NCT03970837|584466400|FG005|Overall Study|Protocol Violation|0|||
161842585|NCT03970837|584466401|FG006|Overall Study|Protocol Violation|0|||
161842586|NCT03970837|584466402|FG007|Overall Study|Protocol Violation|0|||
161842587|NCT03970837|584466403|FG008|Overall Study|Protocol Violation|0|||
161842588|NCT03970837|584466404|FG009|Overall Study|Protocol Violation|0|||
161842589|NCT03970837|584466405|FG010|Overall Study|Protocol Violation|0|||
161842590|NCT03970837|584466406|FG011|Overall Study|Protocol Violation|0|||
161842591|NCT03970837|584466395|FG000|Overall Study|Physician Decision|5|||
161842592|NCT03970837|584466396|FG001|Overall Study|Physician Decision|8|||
161842593|NCT03970837|584466397|FG002|Overall Study|Physician Decision|4|||
161842594|NCT03970837|584466398|FG003|Overall Study|Physician Decision|1|||
161842595|NCT03970837|584466399|FG004|Overall Study|Physician Decision|5|||
161842596|NCT03970837|584466400|FG005|Overall Study|Physician Decision|2|||
161842597|NCT03970837|584466401|FG006|Overall Study|Physician Decision|4|||
161842598|NCT03970837|584466402|FG007|Overall Study|Physician Decision|5|||
161842599|NCT03970837|584466403|FG008|Overall Study|Physician Decision|0|||
161842600|NCT03970837|584466404|FG009|Overall Study|Physician Decision|1|||
161842601|NCT03970837|584466405|FG010|Overall Study|Physician Decision|0|||
161842602|NCT03970837|584466406|FG011|Overall Study|Physician Decision|0|||
161842603|NCT03970837|584466395|FG000|Overall Study|Withdrawal by Subject|32|||
161842604|NCT03970837|584466396|FG001|Overall Study|Withdrawal by Subject|35|||
161842605|NCT03970837|584466397|FG002|Overall Study|Withdrawal by Subject|12|||
161842606|NCT03970837|584466398|FG003|Overall Study|Withdrawal by Subject|8|||
161842607|NCT03970837|584466399|FG004|Overall Study|Withdrawal by Subject|6|||
161842608|NCT03970837|584466400|FG005|Overall Study|Withdrawal by Subject|8|||
161842609|NCT03970837|584466401|FG006|Overall Study|Withdrawal by Subject|2|||
161842610|NCT03970837|584466402|FG007|Overall Study|Withdrawal by Subject|3|||
161842611|NCT03970837|584466403|FG008|Overall Study|Withdrawal by Subject|0|||
161842612|NCT03970837|584466404|FG009|Overall Study|Withdrawal by Subject|0|||
161842613|NCT03970837|584466405|FG010|Overall Study|Withdrawal by Subject|0|||
161842614|NCT03970837|584466406|FG011|Overall Study|Withdrawal by Subject|1|||
161842615|NCT03970837|584466395|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
161842616|NCT03970837|584466396|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
161842617|NCT03970837|584466397|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
161842618|NCT03970837|584466398|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842619|NCT03970837|584466399|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
161842620|NCT03970837|584466400|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842621|NCT03970837|584466401|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842622|NCT03970837|584466402|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842623|NCT03970837|584466403|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842624|NCT03970837|584466404|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842625|NCT03970837|584466405|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842626|NCT03970837|584466406|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842627|NCT03970837|584466395|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842628|NCT03970837|584466396|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842629|NCT03970837|584466397|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842630|NCT03970837|584466398|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842631|NCT03970837|584466399|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842632|NCT03970837|584466400|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842633|NCT03970837|584466401|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
161842634|NCT03970837|584466402|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
161842635|NCT03970837|584466403|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
161842636|NCT03970837|584466404|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
161842637|NCT03970837|584466405|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
161842638|NCT03970837|584466406|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
161842639|NCT03190330|584469930|FG000|Overall Study|Adverse Event|2|||
161842640|NCT03190330|584469930|FG000|Overall Study|Death|10|||
161842641|NCT03190330|584469930|FG000|Overall Study|Lost to Follow-up|1|||
161842642|NCT03190330|584469930|FG000|Overall Study|Withdrawal by Subject|6|||
161842643|NCT03190330|584469930|FG000|Overall Study|Progressive Disease|1|||
161842644|NCT02081209|584469931|FG000|Overall Study|Withdrawal by Subject|1|||
161842645|NCT02370329|584469932|FG000|Overall Study|Alternate treatment|1|||
161842646|NCT02370329|584469932|FG000|Overall Study|Adverse Event|1|||
161842647|NCT02370329|584469932|FG000|Overall Study|Disease progression|3|||
161842648|NCT02370329|584469932|FG000|Overall Study|Physician Decision|2|||
161842649|NCT02370329|584469932|FG000|Overall Study|Study closure|4|||
161842650|NCT02022748|584469933|FG000|Overall Study|Adverse Event|1|||
161842651|NCT02022748|584469934|FG001|Overall Study|Adverse Event|1|||
161842652|NCT02022748|584469935|FG002|Overall Study|Adverse Event|0|||
161842653|NCT02022748|584469933|FG000|Overall Study|Withdrawal by Subject|0|||
161842654|NCT02022748|584469934|FG001|Overall Study|Withdrawal by Subject|1|||
161842655|NCT02022748|584469935|FG002|Overall Study|Withdrawal by Subject|0|||
161842656|NCT04347122|584469936|FG000|Overall Study|Physician Decision|0|||
161842657|NCT04347122|584469937|FG001|Overall Study|Physician Decision|3|||
161842658|NCT04347122|584469938|FG002|Overall Study|Physician Decision|3|||
161842659|NCT04347122|584469939|FG003|Overall Study|Physician Decision|6|||
161842660|NCT03510598|584469940|FG000|Overall Study|Withdrawal by Subject|1|||
161842661|NCT00112866|584469941|FG000|Overall Study|Protocol Violation|1|||
161842662|NCT00112866|584469942|FG001|Overall Study|Protocol Violation|0|||
161842663|NCT00112866|584469941|FG000|Overall Study|did not start treatment post-op|1|||
161842664|NCT00112866|584469942|FG001|Overall Study|did not start treatment post-op|2|||
161842665|NCT04663295|584469943|FG000|Run-in Period|Withdrawal by Subject|3|||
161842666|NCT04663295|584469943|FG000|Overall Study Period|Pregnancy|1|||
161842667|NCT04663295|584469943|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
161842668|NCT00554190|584469944|FG000|Overall Study|Termination forms not completed|10|||
161842669|NCT01502410|584469945|FG000|Overall Study|Adverse Event|1|||
161842670|NCT01502410|584469946|FG001|Overall Study|Adverse Event|2|||
161842671|NCT01502410|584469947|FG002|Overall Study|Adverse Event|0|||
161842672|NCT01502410|584469948|FG003|Overall Study|Adverse Event|0|||
161842673|NCT01502410|584469945|FG000|Overall Study|Lack of Efficacy|7|||
161842674|NCT01502410|584469946|FG001|Overall Study|Lack of Efficacy|7|||
161842675|NCT01502410|584469947|FG002|Overall Study|Lack of Efficacy|0|||
161842676|NCT01502410|584469948|FG003|Overall Study|Lack of Efficacy|0|||
161842677|NCT01502410|584469945|FG000|Overall Study|Physician Decision|0|||
161842678|NCT01502410|584469946|FG001|Overall Study|Physician Decision|1|||
161842679|NCT01502410|584469947|FG002|Overall Study|Physician Decision|0|||
161842680|NCT01502410|584469948|FG003|Overall Study|Physician Decision|0|||
161842681|NCT01502410|584469945|FG000|Overall Study|Withdrawal by Subject|2|||
161842682|NCT01502410|584469946|FG001|Overall Study|Withdrawal by Subject|0|||
161842683|NCT01502410|584469947|FG002|Overall Study|Withdrawal by Subject|0|||
161842684|NCT01502410|584469948|FG003|Overall Study|Withdrawal by Subject|0|||
161842685|NCT03700385|584469952|FG000|Overall Study|Lost to Follow-up|1|||
161842686|NCT00699283|584469953|FG000|Overall Study|Lack of Efficacy|15|||
161842687|NCT00699283|584469954|FG001|Overall Study|Lack of Efficacy|5|||
161745628|NCT00247273|584108142|FG000|Overall Study|Withdrawal by Subject|46|||
161745629|NCT00247273|584108143|FG001|Overall Study|Withdrawal by Subject|47|||
161745630|NCT00247273|584108142|FG000|Overall Study|Did not take any study drug|2|||
161745631|NCT00247273|584108143|FG001|Overall Study|Did not take any study drug|0|||
161745632|NCT03276572|584108144|FG000|Overall Study|In follow-up|0|||
161745633|NCT03276572|584108145|FG001|Overall Study|In follow-up|0|||
161745634|NCT03276572|584108146|FG002|Overall Study|In follow-up|0|||
161745635|NCT03276572|584108147|FG003|Overall Study|In follow-up|0|||
161745636|NCT03276572|584108148|FG004|Overall Study|In follow-up|0|||
161745637|NCT03276572|584108149|FG005|Overall Study|In follow-up|1|||
161745638|NCT03276572|584108150|FG006|Overall Study|In follow-up|1|||
161745639|NCT03276572|584108144|FG000|Overall Study|Lost to Follow-up|0|||
161745640|NCT03276572|584108145|FG001|Overall Study|Lost to Follow-up|0|||
161745641|NCT03276572|584108146|FG002|Overall Study|Lost to Follow-up|0|||
161745642|NCT03276572|584108147|FG003|Overall Study|Lost to Follow-up|0|||
161745643|NCT03276572|584108148|FG004|Overall Study|Lost to Follow-up|0|||
161745644|NCT03276572|584108149|FG005|Overall Study|Lost to Follow-up|0|||
161745645|NCT03276572|584108150|FG006|Overall Study|Lost to Follow-up|1|||
161745646|NCT02580240|584108151|FG000|Overall Study|Physician Decision|2|||
161745647|NCT02580240|584108152|FG001|Overall Study|Physician Decision|0|||
161745648|NCT01709708|584108165|FG000|Overall Study|Protocol Violation|1|||
161745649|NCT01709708|584108166|FG001|Overall Study|Protocol Violation|2|||
161745650|NCT00511108|584108169|FG000|Overall Study|Adverse Event|2|||
161745651|NCT00511108|584108170|FG001|Overall Study|Adverse Event|0|||
161745652|NCT00511108|584108171|FG002|Overall Study|Adverse Event|1|||
161745653|NCT00511108|584108172|FG003|Overall Study|Adverse Event|2|||
161745654|NCT00511108|584108169|FG000|Overall Study|Lost to Follow-up|0|||
161745655|NCT00511108|584108170|FG001|Overall Study|Lost to Follow-up|2|||
161745656|NCT00511108|584108171|FG002|Overall Study|Lost to Follow-up|1|||
161745657|NCT00511108|584108172|FG003|Overall Study|Lost to Follow-up|0|||
161745658|NCT00511108|584108169|FG000|Overall Study|Physician Decision|0|||
161745659|NCT00511108|584108170|FG001|Overall Study|Physician Decision|0|||
161745660|NCT00511108|584108171|FG002|Overall Study|Physician Decision|0|||
161745661|NCT00511108|584108172|FG003|Overall Study|Physician Decision|1|||
161745662|NCT00511108|584108169|FG000|Overall Study|Withdrawal by Subject|4|||
161745663|NCT00511108|584108170|FG001|Overall Study|Withdrawal by Subject|0|||
161745664|NCT00511108|584108171|FG002|Overall Study|Withdrawal by Subject|3|||
161745665|NCT00511108|584108172|FG003|Overall Study|Withdrawal by Subject|2|||
161745666|NCT02954952|584108173|FG000|Overall Study|Withdrawal by Subject|1|||
161745667|NCT02954952|584108174|FG001|Overall Study|Withdrawal by Subject|0|||
161745668|NCT02954952|584108175|FG002|Overall Study|Withdrawal by Subject|0|||
161745669|NCT02954952|584108173|FG000|Overall Study|No data collected|0|||
161745670|NCT02954952|584108174|FG001|Overall Study|No data collected|1|||
161745671|NCT02954952|584108175|FG002|Overall Study|No data collected|0|||
161745672|NCT02911519|584108176|FG000|Overall Study|Lost to Follow-up|2|||
161745673|NCT02911519|584108177|FG001|Overall Study|Lost to Follow-up|2|||
161745674|NCT02911519|584108176|FG000|Overall Study|Death|0|||
161745675|NCT02911519|584108177|FG001|Overall Study|Death|2|||
161745676|NCT00810043|584108178|FG000|Overall Study|Withdrawal by Subject|1|||
161745677|NCT00810043|584108179|FG001|Overall Study|Withdrawal by Subject|0|||
161745678|NCT00810043|584108180|FG002|Overall Study|Withdrawal by Subject|2|||
161745679|NCT00810043|584108178|FG000|Overall Study|Lost to Follow-up|1|||
161745680|NCT00810043|584108179|FG001|Overall Study|Lost to Follow-up|0|||
161745681|NCT00810043|584108180|FG002|Overall Study|Lost to Follow-up|0|||
161745682|NCT00810043|584108178|FG000|Overall Study|Physician Decision|0|||
161745683|NCT00810043|584108179|FG001|Overall Study|Physician Decision|0|||
161745684|NCT00810043|584108180|FG002|Overall Study|Physician Decision|2|||
161745685|NCT00810043|584108178|FG000|Overall Study|Death|2|||
161745686|NCT00810043|584108179|FG001|Overall Study|Death|0|||
161745687|NCT00810043|584108180|FG002|Overall Study|Death|0|||
161745688|NCT00810043|584108178|FG000|Overall Study|Unrelated medical problem|0|||
161745689|NCT00810043|584108179|FG001|Overall Study|Unrelated medical problem|1|||
161745690|NCT00810043|584108180|FG002|Overall Study|Unrelated medical problem|0|||
161745691|NCT00810043|584108178|FG000|Overall Study|Non-medical problem|0|||
161745692|NCT00810043|584108179|FG001|Overall Study|Non-medical problem|0|||
161745693|NCT00810043|584108180|FG002|Overall Study|Non-medical problem|1|||
161745694|NCT00810043|584108178|FG000|Overall Study|No longer met enrollment criteria|0|||
161745695|NCT00810043|584108179|FG001|Overall Study|No longer met enrollment criteria|0|||
161745696|NCT00810043|584108180|FG002|Overall Study|No longer met enrollment criteria|3|||
161745697|NCT02001688|584108181|FG000|Overall Study|Withdrawal by Subject|0|||
161745698|NCT02001688|584108182|FG001|Overall Study|Withdrawal by Subject|0|||
161745699|NCT02001688|584108183|FG002|Overall Study|Withdrawal by Subject|1|||
161745700|NCT02001688|584108181|FG000|Overall Study|Adverse Event|0|||
161745701|NCT02001688|584108182|FG001|Overall Study|Adverse Event|1|||
161745702|NCT02001688|584108183|FG002|Overall Study|Adverse Event|0|||
161745703|NCT01675141|584108187|FG000|Overall Study|Lenalidomide outside NIH|3|||
161745704|NCT01675141|584108187|FG000|Overall Study|Withdrawal by Subject|3|||
161745705|NCT01675141|584108187|FG000|Overall Study|Physician Decision|4|||
161745706|NCT01675141|584108187|FG000|Overall Study|No treatment, per protocol|1|||
161745707|NCT00105183|584108191|FG000|Overall Study|Death|19|||
161745708|NCT00105183|584108192|FG001|Overall Study|Death|13|||
161745709|NCT00105183|584108193|FG002|Overall Study|Death|15|||
161745710|NCT00105183|584108191|FG000|Overall Study|Withdrawal by Subject|1|||
161745711|NCT00105183|584108192|FG001|Overall Study|Withdrawal by Subject|1|||
161745712|NCT00105183|584108193|FG002|Overall Study|Withdrawal by Subject|4|||
161745713|NCT00105183|584108191|FG000|Overall Study|Physician Decision|1|||
161745714|NCT00105183|584108192|FG001|Overall Study|Physician Decision|2|||
161745715|NCT00105183|584108193|FG002|Overall Study|Physician Decision|3|||
161745716|NCT00105183|584108191|FG000|Overall Study|Lost to Follow-up|0|||
161745717|NCT00105183|584108192|FG001|Overall Study|Lost to Follow-up|1|||
161745718|NCT00105183|584108193|FG002|Overall Study|Lost to Follow-up|1|||
161745719|NCT00105183|584108191|FG000|Overall Study|Other reason|1|||
161745720|NCT00105183|584108192|FG001|Overall Study|Other reason|2|||
161745721|NCT00105183|584108193|FG002|Overall Study|Other reason|0|||
161745722|NCT00270998|584108198|FG000|3 Month Follow-up|Adverse Event|1|||
161745723|NCT00270998|584108199|FG001|3 Month Follow-up|Adverse Event|0|||
161745724|NCT00270998|584108200|FG002|3 Month Follow-up|Adverse Event|0|||
161745725|NCT00270998|584108198|FG000|3 Month Follow-up|Lack of Efficacy|1|||
161745726|NCT00270998|584108199|FG001|3 Month Follow-up|Lack of Efficacy|2|||
161745727|NCT00270998|584108200|FG002|3 Month Follow-up|Lack of Efficacy|1|||
161745728|NCT00270998|584108198|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
161745729|NCT00270998|584108199|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
161745730|NCT00270998|584108200|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
161745731|NCT00270998|584108198|FG000|3 Month Follow-up|Pessary did not fit|12|||
161745732|NCT00270998|584108199|FG001|3 Month Follow-up|Pessary did not fit|0|||
161745733|NCT00270998|584108200|FG002|3 Month Follow-up|Pessary did not fit|0|||
161745734|NCT00270998|584108198|FG000|3 Month Follow-up|Personal/family health|1|||
161745735|NCT00270998|584108199|FG001|3 Month Follow-up|Personal/family health|1|||
161745736|NCT00270998|584108200|FG002|3 Month Follow-up|Personal/family health|0|||
161745737|NCT00270998|584108198|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
161745738|NCT00270998|584108199|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
161745739|NCT00270998|584108200|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
161745740|NCT00270998|584108198|FG000|12 Month Follow-up|Lack of Efficacy|5|||
161745741|NCT00270998|584108199|FG001|12 Month Follow-up|Lack of Efficacy|4|||
161745742|NCT00270998|584108200|FG002|12 Month Follow-up|Lack of Efficacy|3|||
161745743|NCT00270998|584108198|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
161745744|NCT00270998|584108199|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
161745745|NCT00270998|584108200|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
161745746|NCT00270998|584108198|FG000|12 Month Follow-up|Pessary did not fit|1|||
161745747|NCT00270998|584108199|FG001|12 Month Follow-up|Pessary did not fit|0|||
161745748|NCT00270998|584108200|FG002|12 Month Follow-up|Pessary did not fit|0|||
161745749|NCT00270998|584108198|FG000|12 Month Follow-up|Personal/family health|0|||
161745750|NCT00270998|584108199|FG001|12 Month Follow-up|Personal/family health|5|||
161745751|NCT00270998|584108200|FG002|12 Month Follow-up|Personal/family health|1|||
161745752|NCT00270998|584108198|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
161745753|NCT00270998|584108199|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
161745754|NCT00270998|584108200|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
161745755|NCT04075396|584108203|FG000|Overall Study|Death|11|||
161745756|NCT04075396|584108204|FG001|Overall Study|Death|9|||
161745757|NCT04075396|584108203|FG000|Overall Study|Withdrawal by Subject|1|||
161745758|NCT04075396|584108204|FG001|Overall Study|Withdrawal by Subject|2|||
161745759|NCT04075396|584108203|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
161745760|NCT04075396|584108204|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
161745761|NCT04075396|584108203|FG000|Overall Study|Enrolled but not-treated|0|||
161745762|NCT04075396|584108204|FG001|Overall Study|Enrolled but not-treated|1|||
161842688|NCT00699283|584469953|FG000|Overall Study|Lost to Follow-up|2|||
161842689|NCT00699283|584469954|FG001|Overall Study|Lost to Follow-up|0|||
161842690|NCT00699283|584469953|FG000|Overall Study|Withdrawal by Subject|1|||
161842691|NCT00699283|584469954|FG001|Overall Study|Withdrawal by Subject|0|||
161842692|NCT00699283|584469953|FG000|Overall Study|Other Reason|5|||
161842693|NCT00699283|584469954|FG001|Overall Study|Other Reason|1|||
161842694|NCT00699283|584469953|FG000|Overall Study|SAE, non-fatal|1|||
161842695|NCT00699283|584469954|FG001|Overall Study|SAE, non-fatal|1|||
161842696|NCT00699283|584469953|FG000|Overall Study|AE, non-serious non-fatal|8|||
161745763|NCT02443805|584108209|FG000|Overall Study|Adverse Event|100|||
161745764|NCT02443805|584108210|FG001|Overall Study|Adverse Event|18|||
161745765|NCT02443805|584108209|FG000|Overall Study|Withdrawal by Subject|73|||
161745766|NCT02443805|584108210|FG001|Overall Study|Withdrawal by Subject|74|||
161745767|NCT02443805|584108209|FG000|Overall Study|Lost to Follow-up|19|||
161745768|NCT02443805|584108210|FG001|Overall Study|Lost to Follow-up|14|||
161745769|NCT02443805|584108209|FG000|Overall Study|Pregnancy|6|||
161745770|NCT02443805|584108210|FG001|Overall Study|Pregnancy|5|||
161745771|NCT02443805|584108209|FG000|Overall Study|Protocol Violation|2|||
161745772|NCT02443805|584108210|FG001|Overall Study|Protocol Violation|4|||
161745773|NCT02443805|584108209|FG000|Overall Study|Lack of Efficacy|1|||
161745774|NCT02443805|584108210|FG001|Overall Study|Lack of Efficacy|1|||
161745775|NCT02443805|584108209|FG000|Overall Study|Non-compliance with study drug|6|||
161745776|NCT02443805|584108210|FG001|Overall Study|Non-compliance with study drug|4|||
161745777|NCT02443805|584108209|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161745778|NCT02443805|584108210|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161745779|NCT02443805|584108209|FG000|Overall Study|Any other reason not above-mentioned|3|||
161745780|NCT02443805|584108210|FG001|Overall Study|Any other reason not above-mentioned|2|||
161745781|NCT00961116|584108211|FG000|Washout Period of 7 Days|Adverse Event|1|||
161745782|NCT00961116|584108212|FG001|Washout Period of 7 Days|Adverse Event|1|||
161745783|NCT00961116|584108211|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161745784|NCT00961116|584108212|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161745785|NCT00961116|584108211|FG000|Washout Period of 7 Days|Protocol Violation|0|||
161745786|NCT00961116|584108212|FG001|Washout Period of 7 Days|Protocol Violation|1|||
161745787|NCT00968708|584108213|FG000|Overall Study|Adverse Event|169|||
161745788|NCT00968708|584108214|FG001|Overall Study|Adverse Event|150|||
161745789|NCT00968708|584108213|FG000|Overall Study|Major Protocol Deviation|0|||
161842697|NCT00699283|584469954|FG001|Overall Study|AE, non-serious non-fatal|1|||
161842698|NCT00699283|584469953|FG000|Overall Study|AE of unknown type|1|||
161842699|NCT00699283|584469954|FG001|Overall Study|AE of unknown type|0|||
161842700|NCT04590040|584469960|FG000|Treatment Period|Lost to Follow-up|2|||
161842701|NCT04590040|584469961|FG001|Treatment Period|Lost to Follow-up|5|||
161745790|NCT00968708|584108214|FG001|Overall Study|Major Protocol Deviation|1|||
161745791|NCT00968708|584108213|FG000|Overall Study|Lost to Follow-up|19|||
161745792|NCT00968708|584108214|FG001|Overall Study|Lost to Follow-up|11|||
161745793|NCT00968708|584108213|FG000|Overall Study|Voluntary Withdrawal|104|||
161745794|NCT00968708|584108214|FG001|Overall Study|Voluntary Withdrawal|101|||
161745795|NCT00968708|584108213|FG000|Overall Study|Investigator Discretion|0|||
161745796|NCT00968708|584108214|FG001|Overall Study|Investigator Discretion|1|||
161745797|NCT00968708|584108213|FG000|Overall Study|Other|26|||
161745798|NCT00968708|584108214|FG001|Overall Study|Other|34|||
161745799|NCT02708966|584108215|FG000|Overall Study|Lost to Follow-up|2|||
161745800|NCT02708966|584108216|FG001|Overall Study|Lost to Follow-up|2|||
161745801|NCT00389441|584108217|FG000|Overall Study|Adverse Event|7|||
161745802|NCT00389441|584108217|FG000|Overall Study|Death|4|||
161745803|NCT00389441|584108217|FG000|Overall Study|Lost to Follow-up|2|||
161745804|NCT00389441|584108217|FG000|Overall Study|Withdrawal by Subject|4|||
161745805|NCT00389441|584108217|FG000|Overall Study|Physician Decision|1|||
161745806|NCT00389441|584108217|FG000|Overall Study|Protocol Violation|1|||
161745807|NCT00389441|584108217|FG000|Overall Study|Global deterioration of health status|4|||
161745808|NCT00389441|584108217|FG000|Overall Study|Objective progression or relapse|26|||
161745809|NCT00389441|584108217|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
161745810|NCT00389441|584108217|FG000|Overall Study|Clinical progression|1|||
161745811|NCT01981109|584108218|FG000|Overall Study|Death|36|||
161745812|NCT01981109|584108218|FG000|Overall Study|Withdrawal by Subject|40|||
161745813|NCT01981109|584108218|FG000|Overall Study|Lost to Follow-up|9|||
161745814|NCT01981109|584108218|FG000|Overall Study|No Discontinuation Documentation|37|||
161745815|NCT01981109|584108218|FG000|Overall Study|Study Termination|100|||
161745816|NCT01981109|584108218|FG000|Overall Study|No data available|2|||
161745817|NCT03407170|584108219|FG000|Overall Study|Adverse Event|1|||
161745818|NCT00105560|584108221|FG000|Overall Study|Lost to Follow-up|1|||
161745819|NCT00636441|584108222|FG000|Overall Study|Adverse Event|0|||
161745820|NCT00636441|584108223|FG001|Overall Study|Adverse Event|1|||
161745821|NCT00636441|584108224|FG002|Overall Study|Adverse Event|1|||
161745822|NCT00636441|584108225|FG003|Overall Study|Adverse Event|0|||
161745823|NCT00636441|584108226|FG004|Overall Study|Adverse Event|0|||
161745824|NCT00636441|584108227|FG005|Overall Study|Adverse Event|1|||
161745825|NCT00636441|584108228|FG006|Overall Study|Adverse Event|0|||
161745826|NCT00636441|584108222|FG000|Overall Study|Late, ineligible|0|||
161745827|NCT00636441|584108223|FG001|Overall Study|Late, ineligible|0|||
161745828|NCT00636441|584108224|FG002|Overall Study|Late, ineligible|0|||
161745829|NCT00636441|584108225|FG003|Overall Study|Late, ineligible|0|||
161745830|NCT00636441|584108226|FG004|Overall Study|Late, ineligible|0|||
161745831|NCT00636441|584108227|FG005|Overall Study|Late, ineligible|0|||
161745832|NCT00636441|584108228|FG006|Overall Study|Late, ineligible|1|||
161745833|NCT00636441|584108222|FG000|Overall Study|Screen Failure|0|||
161745834|NCT00636441|584108223|FG001|Overall Study|Screen Failure|0|||
161745835|NCT00636441|584108224|FG002|Overall Study|Screen Failure|0|||
161745836|NCT00636441|584108225|FG003|Overall Study|Screen Failure|0|||
161745837|NCT00636441|584108226|FG004|Overall Study|Screen Failure|0|||
161745838|NCT00636441|584108227|FG005|Overall Study|Screen Failure|0|||
161745839|NCT00636441|584108228|FG006|Overall Study|Screen Failure|17|||
161745840|NCT00305604|584108230|FG000|Overall Study|Adverse Event|6|||
161745841|NCT00305604|584108231|FG001|Overall Study|Adverse Event|3|||
161745842|NCT00305604|584108230|FG000|Overall Study|Lack of Efficacy|11|||
161745843|NCT00305604|584108231|FG001|Overall Study|Lack of Efficacy|18|||
161745844|NCT00305604|584108230|FG000|Overall Study|Lost to Follow-up|0|||
161745845|NCT00305604|584108231|FG001|Overall Study|Lost to Follow-up|4|||
161745846|NCT00305604|584108230|FG000|Overall Study|Protocol Violation|2|||
161745847|NCT00305604|584108231|FG001|Overall Study|Protocol Violation|1|||
161745848|NCT00305604|584108230|FG000|Overall Study|Withdrawal by Subject|12|||
161745849|NCT00305604|584108231|FG001|Overall Study|Withdrawal by Subject|21|||
161745850|NCT00305604|584108230|FG000|Overall Study|Patient moved|1|||
161745851|NCT00305604|584108231|FG001|Overall Study|Patient moved|0|||
161745852|NCT01248364|584108233|FG000|Overall Study|Adverse Event|0|||
161745853|NCT01248364|584108234|FG001|Overall Study|Adverse Event|1|||
161745854|NCT01248364|584108235|FG002|Overall Study|Adverse Event|0|||
161745855|NCT01248364|584108236|FG003|Overall Study|Adverse Event|0|||
161745856|NCT02559713|584108239|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
161745857|NCT01767519|584108241|FG000|Overall Study|Other Reasons|4|||
161745858|NCT01767519|584108242|FG001|Overall Study|Other Reasons|4|||
161745859|NCT01767519|584108243|FG002|Overall Study|Other Reasons|2|||
161745860|NCT01767519|584108241|FG000|Overall Study|Protocol Violation|0|||
161745861|NCT01767519|584108242|FG001|Overall Study|Protocol Violation|3|||
161745862|NCT01767519|584108243|FG002|Overall Study|Protocol Violation|0|||
161745863|NCT01767519|584108241|FG000|Overall Study|Personal Reasons|1|||
161745864|NCT01767519|584108242|FG001|Overall Study|Personal Reasons|0|||
161745865|NCT01767519|584108243|FG002|Overall Study|Personal Reasons|0|||
161745866|NCT01767519|584108241|FG000|Overall Study|Lost to Follow-up|3|||
161745867|NCT01767519|584108242|FG001|Overall Study|Lost to Follow-up|1|||
161745868|NCT01767519|584108243|FG002|Overall Study|Lost to Follow-up|2|||
161745869|NCT01767519|584108241|FG000|Overall Study|Lack of Efficacy|1|||
161745870|NCT01767519|584108242|FG001|Overall Study|Lack of Efficacy|0|||
161745871|NCT01767519|584108243|FG002|Overall Study|Lack of Efficacy|0|||
161745872|NCT01767519|584108241|FG000|Overall Study|Adverse Event|5|||
161745873|NCT01767519|584108242|FG001|Overall Study|Adverse Event|5|||
161745874|NCT01767519|584108243|FG002|Overall Study|Adverse Event|1|||
161745875|NCT01117012|584108245|FG000|Overall Study|Adverse Event|0|||
161745876|NCT01117012|584108246|FG001|Overall Study|Adverse Event|1|||
161745877|NCT01117012|584108245|FG000|Overall Study|Death|1|||
161745878|NCT01117012|584108246|FG001|Overall Study|Death|1|||
161745879|NCT01117012|584108245|FG000|Overall Study|Withdrawal by Subject|3|||
161745880|NCT01117012|584108246|FG001|Overall Study|Withdrawal by Subject|0|||
161745881|NCT01117012|584108245|FG000|Overall Study|Undefined|4|||
161745882|NCT01117012|584108246|FG001|Overall Study|Undefined|3|||
161745883|NCT01586806|584108254|FG000|Overall Study|Protocol Violation|0|||
161745884|NCT01586806|584108255|FG001|Overall Study|Protocol Violation|1|||
161745885|NCT01586806|584108256|FG002|Overall Study|Protocol Violation|0|||
161745886|NCT01586806|584108254|FG000|Overall Study|Withdrawal by Subject|1|||
161745887|NCT01586806|584108255|FG001|Overall Study|Withdrawal by Subject|0|||
161745888|NCT01586806|584108256|FG002|Overall Study|Withdrawal by Subject|0|||
161745889|NCT01586806|584108254|FG000|Overall Study|Lost to Follow-up|2|||
161745890|NCT01586806|584108255|FG001|Overall Study|Lost to Follow-up|3|||
161745891|NCT01586806|584108256|FG002|Overall Study|Lost to Follow-up|2|||
161745892|NCT00555906|584108257|FG000|Phase 1|Objective Progression or Relapse|3|||
161745893|NCT00555906|584108258|FG001|Phase 1|Objective Progression or Relapse|5|||
161745894|NCT00555906|584108259|FG002|Phase 1|Objective Progression or Relapse|3|||
161745895|NCT00555906|584108260|FG003|Phase 1|Objective Progression or Relapse|1|||
161745896|NCT00555906|584108261|FG004|Phase 1|Objective Progression or Relapse|0|||
161745897|NCT00555906|584108257|FG000|Phase 1|Global Deterioration of Health Status|0|||
161745898|NCT00555906|584108258|FG001|Phase 1|Global Deterioration of Health Status|1|||
161745899|NCT00555906|584108259|FG002|Phase 1|Global Deterioration of Health Status|1|||
161745900|NCT00555906|584108260|FG003|Phase 1|Global Deterioration of Health Status|1|||
161745901|NCT00555906|584108261|FG004|Phase 1|Global Deterioration of Health Status|0|||
161745902|NCT00555906|584108257|FG000|Phase 1|Adverse Event|0|||
161745903|NCT00555906|584108258|FG001|Phase 1|Adverse Event|0|||
161745904|NCT00555906|584108259|FG002|Phase 1|Adverse Event|3|||
161745905|NCT00555906|584108260|FG003|Phase 1|Adverse Event|2|||
161745906|NCT00555906|584108261|FG004|Phase 1|Adverse Event|0|||
161745907|NCT00555906|584108257|FG000|Phase 1|Withdrawal by Subject|0|||
161745908|NCT00555906|584108258|FG001|Phase 1|Withdrawal by Subject|0|||
161745909|NCT00555906|584108259|FG002|Phase 1|Withdrawal by Subject|0|||
161745910|NCT00555906|584108260|FG003|Phase 1|Withdrawal by Subject|1|||
161745911|NCT00555906|584108261|FG004|Phase 1|Withdrawal by Subject|0|||
161745912|NCT00555906|584108257|FG000|Phase 2|Adverse Event|0|||
161745913|NCT00555906|584108258|FG001|Phase 2|Adverse Event|0|||
161745914|NCT00555906|584108259|FG002|Phase 2|Adverse Event|0|||
161745915|NCT00555906|584108260|FG003|Phase 2|Adverse Event|0|||
161745916|NCT00555906|584108261|FG004|Phase 2|Adverse Event|4|||
161745917|NCT00555906|584108257|FG000|Phase 2|Global Deterioration of Health Status|0|||
161745918|NCT00555906|584108258|FG001|Phase 2|Global Deterioration of Health Status|0|||
161745919|NCT00555906|584108259|FG002|Phase 2|Global Deterioration of Health Status|0|||
161745920|NCT00555906|584108260|FG003|Phase 2|Global Deterioration of Health Status|0|||
161745921|NCT00555906|584108261|FG004|Phase 2|Global Deterioration of Health Status|2|||
161745922|NCT00555906|584108257|FG000|Phase 2|Objective Progression or Relapse|0|||
161745923|NCT00555906|584108258|FG001|Phase 2|Objective Progression or Relapse|0|||
161745924|NCT00555906|584108259|FG002|Phase 2|Objective Progression or Relapse|0|||
161745925|NCT00555906|584108260|FG003|Phase 2|Objective Progression or Relapse|0|||
161745926|NCT00555906|584108261|FG004|Phase 2|Objective Progression or Relapse|16|||
161745927|NCT00555906|584108257|FG000|Phase 2|Withdrawal by Subject|0|||
161745928|NCT00555906|584108258|FG001|Phase 2|Withdrawal by Subject|0|||
161745929|NCT00555906|584108259|FG002|Phase 2|Withdrawal by Subject|0|||
161745930|NCT00555906|584108260|FG003|Phase 2|Withdrawal by Subject|0|||
161745931|NCT00555906|584108261|FG004|Phase 2|Withdrawal by Subject|2|||
161745932|NCT00555906|584108257|FG000|Phase 2|Other|0|||
161745933|NCT00555906|584108258|FG001|Phase 2|Other|0|||
161745934|NCT00555906|584108259|FG002|Phase 2|Other|0|||
161745935|NCT00555906|584108260|FG003|Phase 2|Other|0|||
161745936|NCT00555906|584108261|FG004|Phase 2|Other|6|||
161745937|NCT00555906|584108257|FG000|Phase 2|Randomized but not Treated|0|||
161745938|NCT00555906|584108258|FG001|Phase 2|Randomized but not Treated|0|||
161745939|NCT00555906|584108259|FG002|Phase 2|Randomized but not Treated|0|||
161745940|NCT00555906|584108260|FG003|Phase 2|Randomized but not Treated|0|||
161745941|NCT00555906|584108261|FG004|Phase 2|Randomized but not Treated|2|||
161745942|NCT02193828|584108262|FG000|Overall Study|Withdrawal by Subject|0|||
161745943|NCT02193828|584108263|FG001|Overall Study|Withdrawal by Subject|0|||
161745944|NCT02193828|584108264|FG002|Overall Study|Withdrawal by Subject|1|||
161745945|NCT02193828|584108265|FG003|Overall Study|Withdrawal by Subject|1|||
161745946|NCT02983799|584108268|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
161745947|NCT02983799|584108269|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
161745948|NCT02983799|584108270|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
161745949|NCT02983799|584108271|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
161745950|NCT02983799|584108272|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
161745951|NCT02983799|584108268|FG000|Overall Study|Death|20|||
161745952|NCT02983799|584108269|FG001|Overall Study|Death|5|||
161745953|NCT02983799|584108270|FG002|Overall Study|Death|23|||
161745954|NCT02983799|584108271|FG003|Overall Study|Death|47|||
161745955|NCT02983799|584108272|FG004|Overall Study|Death|7|||
161745956|NCT02983799|584108268|FG000|Overall Study|Withdrawal by Subject|1|||
161745957|NCT02983799|584108269|FG001|Overall Study|Withdrawal by Subject|0|||
161745958|NCT02983799|584108270|FG002|Overall Study|Withdrawal by Subject|3|||
161745959|NCT02983799|584108271|FG003|Overall Study|Withdrawal by Subject|4|||
161745960|NCT02983799|584108272|FG004|Overall Study|Withdrawal by Subject|1|||
161745961|NCT02983799|584108268|FG000|Overall Study|Protocol Violation|0|||
161745962|NCT02983799|584108269|FG001|Overall Study|Protocol Violation|1|||
161745963|NCT02983799|584108270|FG002|Overall Study|Protocol Violation|0|||
161745964|NCT02983799|584108271|FG003|Overall Study|Protocol Violation|0|||
161745965|NCT02983799|584108272|FG004|Overall Study|Protocol Violation|1|||
161745966|NCT02983799|584108268|FG000|Overall Study|Lost to Follow-up|1|||
161745967|NCT02983799|584108269|FG001|Overall Study|Lost to Follow-up|0|||
161745968|NCT02983799|584108270|FG002|Overall Study|Lost to Follow-up|1|||
161745969|NCT02983799|584108271|FG003|Overall Study|Lost to Follow-up|0|||
161745970|NCT02983799|584108272|FG004|Overall Study|Lost to Follow-up|0|||
161745971|NCT01626989|584108273|FG000|Screening Period|Screen Failure|15|||
161745972|NCT01626989|584108274|FG001|Screening Period|Screen Failure|0|||
161745973|NCT01626989|584108275|FG002|Screening Period|Screen Failure|0|||
161745974|NCT01626989|584108273|FG000|Screening Period|Withdrawal by Subject|2|||
161745975|NCT01626989|584108274|FG001|Screening Period|Withdrawal by Subject|0|||
161745976|NCT01626989|584108275|FG002|Screening Period|Withdrawal by Subject|0|||
161745977|NCT02293902|584108284|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
161745978|NCT02293902|584108285|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
161745979|NCT02293902|584108286|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
161745980|NCT02293902|584108287|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
161745981|NCT02293902|584108288|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
161745982|NCT02293902|584108284|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
161745983|NCT02293902|584108285|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
161745984|NCT02293902|584108286|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
161745985|NCT02293902|584108287|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
161745986|NCT02293902|584108288|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
161745987|NCT02293902|584108284|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
161745988|NCT02293902|584108285|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745989|NCT02293902|584108286|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745990|NCT02293902|584108287|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745991|NCT02293902|584108288|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745992|NCT02293902|584108284|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
161745993|NCT02293902|584108285|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
161745994|NCT02293902|584108286|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
161745995|NCT02293902|584108287|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
161745996|NCT02293902|584108288|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
161745997|NCT02293902|584108284|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161745998|NCT02293902|584108285|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
161745999|NCT02293902|584108286|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
161746000|NCT02293902|584108287|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161746001|NCT02293902|584108288|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161746002|NCT03366844|584110322|FG000|Overall Study|Physician Decision|1|||
161746003|NCT03366844|584110322|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
161746004|NCT02687711|584110325|FG000|Overall Study|Adverse Event|89|||
161746005|NCT02687711|584110325|FG000|Overall Study|Lack of Efficacy|70|||
161746006|NCT02687711|584110325|FG000|Overall Study|Lost to Follow-up|20|||
161746007|NCT02687711|584110325|FG000|Overall Study|Consent withdrawn|15|||
161746008|NCT02687711|584110325|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
161746009|NCT02687711|584110325|FG000|Overall Study|Too expensive|4|||
161746010|NCT02687711|584110325|FG000|Overall Study|Participant moved abroad|1|||
161746011|NCT02687711|584110325|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
161746012|NCT02687711|584110325|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
161746013|NCT02687711|584110325|FG000|Overall Study|Disliked taste|1|||
161746014|NCT02687711|584110325|FG000|Overall Study|Low mood|1|||
161746015|NCT02687711|584110325|FG000|Overall Study|Side effects|1|||
161746016|NCT02687711|584110325|FG000|Overall Study|Change of Hospital|1|||
161746017|NCT02687711|584110325|FG000|Overall Study|Liver Encephalopathy|1|||
161842702|NCT04590040|584469962|FG002|Treatment Period|Lost to Follow-up|0|||
161842703|NCT04590040|584469960|FG000|Treatment Period|Physician Decision|0|||
161842704|NCT04590040|584469961|FG001|Treatment Period|Physician Decision|0|||
161842705|NCT04590040|584469962|FG002|Treatment Period|Physician Decision|2|||
161842706|NCT00000378|584469965|FG000|Overall Study|Lack of Efficacy|16|||
161842707|NCT00000378|584469966|FG001|Overall Study|Lack of Efficacy|14|||
161842708|NCT01284361|584469969|FG000|Overall Study|Withdrawal by Subject|1|||
161842709|NCT01284361|584469969|FG000|Overall Study|Protocol Violation|5|||
161842710|NCT01284361|584469969|FG000|Overall Study|Adverse Event|1|||
161842711|NCT01284361|584469969|FG000|Overall Study|Lost to Follow-up|2|||
161842712|NCT00805675|584469970|FG000|Overall Study|Adverse Event|0|||
161842713|NCT00805675|584469971|FG001|Overall Study|Adverse Event|0|||
161842714|NCT00805675|584469972|FG002|Overall Study|Adverse Event|1|||
161842715|NCT02771795|584469976|FG000|Overall Study|Withdrawal by Subject|47|||
161842716|NCT02771795|584469977|FG001|Overall Study|Withdrawal by Subject|37|||
161842717|NCT02771795|584469976|FG000|Overall Study|Termination by premature discontinuation of study|168|||
161842718|NCT02771795|584469977|FG001|Overall Study|Termination by premature discontinuation of study|185|||
161842719|NCT01957397|584469979|FG000|Test Period 1|sudden leakage/small bag|1|||
161842720|NCT01957397|584469980|FG001|Test Period 1|sudden leakage/small bag|1|||
161842721|NCT01957397|584469979|FG000|Test Period 1|Withdrawal by Subject|1|||
161842722|NCT01957397|584469980|FG001|Test Period 1|Withdrawal by Subject|0|||
161842723|NCT01957397|584469979|FG000|Test Period 2|Adverse Event|0|||
161842724|NCT01957397|584469980|FG001|Test Period 2|Adverse Event|1|||
161842725|NCT01957397|584469979|FG000|Test Period 3|Adverse Event|1|||
161842726|NCT01957397|584469980|FG001|Test Period 3|Adverse Event|2|||
161842727|NCT01957397|584469979|FG000|Test Period 3|the adhesive did not work|1|||
161842728|NCT01957397|584469980|FG001|Test Period 3|the adhesive did not work|0|||
161842729|NCT00505375|584469981|FG000|Overall Study|Death|1|||
161842730|NCT00505375|584469982|FG001|Overall Study|Death|0|||
161842731|NCT00505375|584469981|FG000|Overall Study|Withdrawal by Subject|2|||
161842732|NCT00505375|584469982|FG001|Overall Study|Withdrawal by Subject|2|||
161842733|NCT00505375|584469981|FG000|Overall Study|Lost to Follow-up|0|||
161842734|NCT00505375|584469982|FG001|Overall Study|Lost to Follow-up|2|||
161842735|NCT00505375|584469981|FG000|Overall Study|Pregnancy|1|||
161842736|NCT00505375|584469982|FG001|Overall Study|Pregnancy|0|||
161842737|NCT00505375|584469981|FG000|Overall Study|Travel issues|0|||
161842738|NCT00505375|584469982|FG001|Overall Study|Travel issues|1|||
161842739|NCT02906930|584469983|FG000|Overall Study|Withdrawal by Subject|0|||
161842740|NCT02906930|584469984|FG001|Overall Study|Withdrawal by Subject|5|||
161842741|NCT02906930|584469985|FG002|Overall Study|Withdrawal by Subject|5|||
161842742|NCT02906930|584469986|FG003|Overall Study|Withdrawal by Subject|4|||
161746018|NCT02687711|584110325|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
161746019|NCT02687711|584110325|FG000|Overall Study|Withdrawn due to intake interruption|1|||
161746020|NCT02687711|584110325|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
161746021|NCT02687711|584110325|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
161746022|NCT02687711|584110325|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
161746023|NCT02971007|584110327|FG000|Overall Study|Adverse Event|1|||
161746024|NCT02971007|584110328|FG001|Overall Study|Adverse Event|0|||
161842743|NCT02906930|584469983|FG000|Overall Study|Lost to Follow-up|5|||
161842744|NCT02906930|584469984|FG001|Overall Study|Lost to Follow-up|7|||
161842745|NCT02906930|584469985|FG002|Overall Study|Lost to Follow-up|5|||
161842746|NCT02906930|584469986|FG003|Overall Study|Lost to Follow-up|2|||
161746025|NCT02971007|584110329|FG002|Overall Study|Adverse Event|0|||
161746026|NCT02971007|584110327|FG000|Overall Study|Lost to Follow-up|0|||
161746027|NCT02971007|584110328|FG001|Overall Study|Lost to Follow-up|1|||
161746028|NCT02971007|584110329|FG002|Overall Study|Lost to Follow-up|1|||
161746029|NCT02971007|584110327|FG000|Overall Study|Withdrawal by Subject|0|||
161746030|NCT02971007|584110328|FG001|Overall Study|Withdrawal by Subject|1|||
161746031|NCT02971007|584110329|FG002|Overall Study|Withdrawal by Subject|0|||
161746032|NCT02971007|584110327|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
161746033|NCT02971007|584110328|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
161746034|NCT02971007|584110329|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
161746035|NCT02971007|584110327|FG000|Overall Study|Patient discontinued study drug|0|||
161746036|NCT02971007|584110328|FG001|Overall Study|Patient discontinued study drug|1|||
161746037|NCT02971007|584110329|FG002|Overall Study|Patient discontinued study drug|0|||
161746038|NCT00607919|584110330|FG000|Acute Phase|Adverse Event|9|||
161746039|NCT00607919|584110331|FG001|Acute Phase|Adverse Event|2|||
161746040|NCT00607919|584110330|FG000|Acute Phase|Entry Criteria Not Met|1|||
161746041|NCT00607919|584110331|FG001|Acute Phase|Entry Criteria Not Met|1|||
161746042|NCT00607919|584110330|FG000|Acute Phase|Lack of Efficacy|1|||
161746043|NCT00607919|584110331|FG001|Acute Phase|Lack of Efficacy|2|||
161746044|NCT00607919|584110330|FG000|Acute Phase|Lost to Follow-up|9|||
161746045|NCT00607919|584110331|FG001|Acute Phase|Lost to Follow-up|3|||
161746046|NCT00607919|584110330|FG000|Acute Phase|Parent/Caregiver Decision|6|||
161746047|NCT00607919|584110331|FG001|Acute Phase|Parent/Caregiver Decision|4|||
161746048|NCT00607919|584110330|FG000|Acute Phase|Protocol Violation|5|||
161746049|NCT00607919|584110331|FG001|Acute Phase|Protocol Violation|1|||
161746050|NCT00607919|584110330|FG000|Acute Phase|Withdrawal by Subject|3|||
161746051|NCT00607919|584110331|FG001|Acute Phase|Withdrawal by Subject|3|||
161746052|NCT00607919|584110330|FG000|Open-Label Phase|Adverse Event|1|||
161746053|NCT00607919|584110331|FG001|Open-Label Phase|Adverse Event|5|||
161746054|NCT00607919|584110330|FG000|Open-Label Phase|Lost to Follow-up|4|||
161746055|NCT00607919|584110331|FG001|Open-Label Phase|Lost to Follow-up|1|||
161746056|NCT00607919|584110330|FG000|Open-Label Phase|Protocol Violation|2|||
161746057|NCT00607919|584110331|FG001|Open-Label Phase|Protocol Violation|2|||
161746058|NCT00607919|584110330|FG000|Open-Label Phase|Withdrawal by Subject|2|||
161746059|NCT00607919|584110331|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161746060|NCT00607919|584110330|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
161746061|NCT00607919|584110331|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
161746062|NCT00724815|584110336|FG000|Overall Study|Randomized, not treated|31|||
161746063|NCT00724815|584110337|FG001|Overall Study|Randomized, not treated|30|||
161746064|NCT00724815|584110336|FG000|Overall Study|Adverse Event|5|||
161746065|NCT00724815|584110337|FG001|Overall Study|Adverse Event|3|||
161746066|NCT00724815|584110336|FG000|Overall Study|Lost to Follow-up|4|||
161746067|NCT00724815|584110337|FG001|Overall Study|Lost to Follow-up|1|||
161746068|NCT00724815|584110336|FG000|Overall Study|Other Various|3|||
161746069|NCT00724815|584110337|FG001|Overall Study|Other Various|5|||
161746070|NCT03862495|584110340|FG000|Overall Study|Lost to Follow-up|37|||
161746071|NCT03862495|584110341|FG001|Overall Study|Lost to Follow-up|35|||
161746072|NCT00064077|584110342|FG000|Overall Study|Improper prior treatment|1|||
161746073|NCT00064077|584110343|FG001|Overall Study|Improper prior treatment|0|||
161746074|NCT00064077|584110344|FG002|Overall Study|Improper prior treatment|0|||
161746075|NCT00064077|584110345|FG003|Overall Study|Improper prior treatment|0|||
161746076|NCT00064077|584110342|FG000|Overall Study|Poor risk|2|||
161746077|NCT00064077|584110343|FG001|Overall Study|Poor risk|0|||
161746078|NCT00064077|584110344|FG002|Overall Study|Poor risk|1|||
161746079|NCT00064077|584110345|FG003|Overall Study|Poor risk|1|||
161746080|NCT00064077|584110342|FG000|Overall Study|Pathology|10|||
161746081|NCT00064077|584110343|FG001|Overall Study|Pathology|7|||
161746082|NCT00064077|584110344|FG002|Overall Study|Pathology|3|||
161842747|NCT02906930|584469983|FG000|Overall Study|Death|0|||
161746083|NCT00064077|584110345|FG003|Overall Study|Pathology|4|||
161746084|NCT00064077|584110342|FG000|Overall Study|No surgery|0|||
161746085|NCT00064077|584110343|FG001|Overall Study|No surgery|0|||
161746086|NCT00064077|584110344|FG002|Overall Study|No surgery|1|||
161842748|NCT02906930|584469984|FG001|Overall Study|Death|0|||
161842749|NCT02906930|584469985|FG002|Overall Study|Death|1|||
161842750|NCT02906930|584469986|FG003|Overall Study|Death|0|||
161842751|NCT02906930|584469983|FG000|Overall Study|Other|1|||
161842752|NCT02906930|584469984|FG001|Overall Study|Other|2|||
161842753|NCT02906930|584469985|FG002|Overall Study|Other|1|||
161842754|NCT02906930|584469986|FG003|Overall Study|Other|2|||
161842755|NCT03537599|584469987|FG000|Overall Study|Disease Progression|2|||
161842756|NCT03537599|584469988|FG001|Overall Study|Disease Progression|1|||
161842757|NCT03537599|584469987|FG000|Overall Study|Death|0|||
161842758|NCT03537599|584469988|FG001|Overall Study|Death|1|||
161842759|NCT04585789|584469989|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
161842760|NCT04585789|584469990|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
161842761|NCT04585789|584469991|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
161842762|NCT04585789|584469989|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
161842763|NCT04585789|584469990|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
161842764|NCT04585789|584469991|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
161842765|NCT05083585|584469992|FG000|Overall Study|Death|1|||
161842766|NCT05083585|584469993|FG001|Overall Study|Death|1|||
161842767|NCT05083585|584469992|FG000|Overall Study|Lost to Follow-up|1|||
161842768|NCT05083585|584469993|FG001|Overall Study|Lost to Follow-up|1|||
161842769|NCT05083585|584469992|FG000|Overall Study|Withdrawal by Subject|2|||
161842770|NCT05083585|584469993|FG001|Overall Study|Withdrawal by Subject|0|||
161842771|NCT05083585|584469992|FG000|Overall Study|Randomized but not vaccinated|2|||
161842772|NCT05083585|584469993|FG001|Overall Study|Randomized but not vaccinated|0|||
161842773|NCT00114166|584469994|FG000|Overall Study|Wrong primary|0|||
161842774|NCT00114166|584469995|FG001|Overall Study|Wrong primary|1|||
161842775|NCT03469336|584469996|FG000|Overall Study|Adverse Event|1|||
161842776|NCT02740699|584469999|FG000|Overall Study|Lost to Follow-up|5|||
161842777|NCT02740699|584469999|FG000|Overall Study|Withdrawal by Subject|14|||
161842778|NCT02740699|584469999|FG000|Overall Study|Physician Decision|5|||
161842779|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842780|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161842781|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842782|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842783|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842784|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161842785|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161842786|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842787|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842788|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842789|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842790|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842791|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842792|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842793|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842794|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842795|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842796|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842797|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842798|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842799|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842800|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842801|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842802|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842803|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842804|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842805|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
161842806|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842807|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842808|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842809|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161746087|NCT00064077|584110345|FG003|Overall Study|No surgery|0|||
161746088|NCT00064077|584110342|FG000|Overall Study|No tumor|0|||
161746089|NCT00064077|584110343|FG001|Overall Study|No tumor|0|||
161746090|NCT00064077|584110344|FG002|Overall Study|No tumor|1|||
161746091|NCT00064077|584110345|FG003|Overall Study|No tumor|0|||
161746092|NCT00064077|584110342|FG000|Overall Study|Other reasons|2|||
161746093|NCT00064077|584110343|FG001|Overall Study|Other reasons|2|||
161746094|NCT00064077|584110344|FG002|Overall Study|Other reasons|1|||
161746095|NCT00064077|584110345|FG003|Overall Study|Other reasons|2|||
161746096|NCT00615914|584110346|FG000|Overall Study|Adverse Event|274|||
161746097|NCT00615914|584110346|FG000|Overall Study|Death|20|||
161746098|NCT00615914|584110346|FG000|Overall Study|Lack of Efficacy|59|||
161746099|NCT00615914|584110346|FG000|Overall Study|Lost to Follow-up|187|||
161746100|NCT00615914|584110346|FG000|Overall Study|Withdrawal by Subject|16|||
161746101|NCT00615914|584110346|FG000|Overall Study|Physician Decision|4|||
161746102|NCT00615914|584110346|FG000|Overall Study|No data was collected.|65|||
161746103|NCT00615914|584110346|FG000|Overall Study|No treatment|2|||
161746104|NCT00615914|584110346|FG000|Overall Study|Irregularly enrolled patients|10|||
161746105|NCT03673956|584110347|FG000|Overall Study|Lost to Follow-up|1|||
161746106|NCT03673956|584110348|FG001|Overall Study|Lost to Follow-up|0|||
161746107|NCT03673956|584110349|FG002|Overall Study|Lost to Follow-up|0|||
161746108|NCT03673956|584110350|FG003|Overall Study|Lost to Follow-up|0|||
161746109|NCT03673956|584110347|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
161746110|NCT03673956|584110348|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161746111|NCT03673956|584110349|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161746112|NCT03673956|584110350|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161746113|NCT03037307|584110353|FG000|Period 1|Did Not Meet Study Criteria|0|||
161746114|NCT03037307|584110354|FG001|Period 1|Did Not Meet Study Criteria|0|||
161746115|NCT03037307|584110355|FG002|Period 1|Did Not Meet Study Criteria|0|||
161746116|NCT03037307|584110356|FG003|Period 1|Did Not Meet Study Criteria|1|||
161746117|NCT03037307|584110357|FG004|Period 1|Did Not Meet Study Criteria|0|||
161746118|NCT03037307|584110358|FG005|Period 1|Did Not Meet Study Criteria|0|||
161746119|NCT04397796|584110359|FG000|Overall Study|Death|3|||
161746120|NCT04397796|584110360|FG001|Overall Study|Death|1|||
161746121|NCT00802867|584110363|FG000|Overall Study|Lost to Follow-up|6|||
161746122|NCT00802867|584110363|FG000|Overall Study|Protocol Violation|6|||
161746123|NCT00802867|584110363|FG000|Overall Study|Withdrawal by Subject|1|||
161746124|NCT00770224|584110366|FG000|Step 1: Induction|Adverse Event|3|||
161746125|NCT00770224|584110367|FG001|Step 1: Induction|Adverse Event|0|||
161746126|NCT00770224|584110366|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
161746127|NCT00770224|584110367|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
161746128|NCT00770224|584110366|FG000|Step 1: Induction|Other reason not protocol specified|2|||
161746129|NCT00770224|584110367|FG001|Step 1: Induction|Other reason not protocol specified|0|||
161746130|NCT00770224|584110366|FG000|Step 1: Induction|Ineligible|2|||
161746131|NCT00770224|584110367|FG001|Step 1: Induction|Ineligible|0|||
161746132|NCT00770224|584110366|FG000|Step 1: Induction|No protocol treatment given|1|||
161746133|NCT00770224|584110367|FG001|Step 1: Induction|No protocol treatment given|0|||
161746134|NCT00770224|584110366|FG000|Step 2: Maintenance|Adverse Event|0|||
161746135|NCT00770224|584110367|FG001|Step 2: Maintenance|Adverse Event|10|||
161746136|NCT00770224|584110366|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
161746137|NCT00770224|584110367|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
161746138|NCT00770224|584110366|FG000|Step 2: Maintenance|Progression/relapse|0|||
161746139|NCT00770224|584110367|FG001|Step 2: Maintenance|Progression/relapse|1|||
161746140|NCT00770224|584110366|FG000|Step 2: Maintenance|Death|0|||
161746141|NCT00770224|584110367|FG001|Step 2: Maintenance|Death|2|||
161746142|NCT00770224|584110366|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
161746143|NCT00770224|584110367|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
161746144|NCT00770224|584110366|FG000|Step 2: Maintenance|Ineligible|0|||
161746145|NCT00770224|584110367|FG001|Step 2: Maintenance|Ineligible|2|||
161746146|NCT04737759|584110368|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
161746147|NCT04737759|584110369|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
161746148|NCT04737759|584110368|FG000|Overall Study|Death|2|||
161746149|NCT04737759|584110369|FG001|Overall Study|Death|0|||
161746150|NCT04737759|584110368|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
161746151|NCT04737759|584110369|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
161746152|NCT04737759|584110368|FG000|Overall Study|Lost to Follow-up|4|||
161746153|NCT04737759|584110369|FG001|Overall Study|Lost to Follow-up|12|||
161746154|NCT01484561|584110370|FG000|Overall Study|Lack of Efficacy|3|||
161746155|NCT01484561|584110371|FG001|Overall Study|Lack of Efficacy|1|||
161746156|NCT01484561|584110370|FG000|Overall Study|Lost to Follow-up|1|||
161746157|NCT01484561|584110371|FG001|Overall Study|Lost to Follow-up|0|||
161746158|NCT01484561|584110370|FG000|Overall Study|Withdrawal by Subject|3|||
161746159|NCT01484561|584110371|FG001|Overall Study|Withdrawal by Subject|0|||
161746160|NCT01484561|584110370|FG000|Overall Study|Other|1|||
161746161|NCT01484561|584110371|FG001|Overall Study|Other|1|||
161746162|NCT01484561|584110370|FG000|Overall Study|Adverse Event|1|||
161746163|NCT01484561|584110371|FG001|Overall Study|Adverse Event|4|||
161746164|NCT01112982|584110372|FG000|Overall Study|Withdrawal by Subject|1|||
161746165|NCT01112982|584110372|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
161746166|NCT03371251|584110373|FG000|Overall Study|Withdrawal by Subject|1|||
161746167|NCT03371251|584110374|FG001|Overall Study|Withdrawal by Subject|0|||
161746168|NCT03371251|584110375|FG002|Overall Study|Withdrawal by Subject|1|||
161746169|NCT03371251|584110376|FG003|Overall Study|Withdrawal by Subject|0|||
161746170|NCT03371251|584110377|FG004|Overall Study|Withdrawal by Subject|2|||
161746171|NCT03371251|584110378|FG005|Overall Study|Withdrawal by Subject|2|||
161746172|NCT03371251|584110373|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
161746173|NCT03371251|584110374|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161746174|NCT03371251|584110375|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161746175|NCT03371251|584110376|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161746176|NCT03371251|584110377|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
161746177|NCT03371251|584110378|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
161746178|NCT03371251|584110373|FG000|Overall Study|Adverse Event|0|||
161746179|NCT03371251|584110374|FG001|Overall Study|Adverse Event|0|||
161746180|NCT03371251|584110375|FG002|Overall Study|Adverse Event|0|||
161746181|NCT03371251|584110376|FG003|Overall Study|Adverse Event|0|||
161746182|NCT03371251|584110377|FG004|Overall Study|Adverse Event|1|||
161746183|NCT03371251|584110378|FG005|Overall Study|Adverse Event|0|||
161746184|NCT03371251|584110373|FG000|Overall Study|Decision by Sponsor|0|||
161746185|NCT03371251|584110374|FG001|Overall Study|Decision by Sponsor|0|||
161746186|NCT03371251|584110375|FG002|Overall Study|Decision by Sponsor|0|||
161746187|NCT03371251|584110376|FG003|Overall Study|Decision by Sponsor|0|||
161746188|NCT03371251|584110377|FG004|Overall Study|Decision by Sponsor|2|||
161746189|NCT03371251|584110378|FG005|Overall Study|Decision by Sponsor|0|||
161746190|NCT00294684|584110381|FG000|Overall Study|Lost to Follow-up|5|||
161746191|NCT00294684|584110382|FG001|Overall Study|Lost to Follow-up|8|||
161746192|NCT02260388|584110385|FG000|Overall Study|Lost to Follow-up|2|||
161746193|NCT02260388|584110386|FG001|Overall Study|Lost to Follow-up|8|||
161746194|NCT02260388|584110387|FG002|Overall Study|Lost to Follow-up|3|||
161746195|NCT02260388|584110388|FG003|Overall Study|Lost to Follow-up|4|||
161746196|NCT05425719|584110389|FG000|Overall Study|Lost to Follow-up|4|||
161746197|NCT05425719|584110390|FG001|Overall Study|Lost to Follow-up|0|||
161746198|NCT05425719|584110389|FG000|Overall Study|Withdrew consent|1|||
161746199|NCT05425719|584110390|FG001|Overall Study|Withdrew consent|1|||
161746200|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
161746201|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
161746202|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
161746203|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161746204|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
161746205|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
161746206|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
161746207|NCT00996593|584110391|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
161746208|NCT00996593|584110391|FG000|Long-Term Follow-Up|Site Closed|1|||
161746209|NCT01033487|584110392|FG000|Fourth Intervention Period|Adverse Event|0|||
161746210|NCT01033487|584110393|FG001|Fourth Intervention Period|Adverse Event|0|||
161746211|NCT01033487|584110394|FG002|Fourth Intervention Period|Adverse Event|0|||
161746212|NCT01033487|584110395|FG003|Fourth Intervention Period|Adverse Event|0|||
161746213|NCT01033487|584110396|FG004|Fourth Intervention Period|Adverse Event|0|||
161746214|NCT01033487|584110397|FG005|Fourth Intervention Period|Adverse Event|0|||
161746215|NCT01033487|584110398|FG006|Fourth Intervention Period|Adverse Event|0|||
161746216|NCT01033487|584110399|FG007|Fourth Intervention Period|Adverse Event|0|||
161746217|NCT01033487|584110400|FG008|Fourth Intervention Period|Adverse Event|1|||
161746218|NCT01033487|584110401|FG009|Fourth Intervention Period|Adverse Event|0|||
161746219|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
161746220|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
161746221|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
161746222|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
161746223|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
161746224|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
161746225|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
161746226|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
161746227|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
161746228|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
161746229|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
161746230|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
161746231|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
161746232|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
161746233|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
161746234|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
161746235|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
161746236|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
161746237|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
161746238|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
161746239|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
161746240|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161746241|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161746242|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161746243|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
161746244|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
161746245|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
161746246|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
161746247|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
161746248|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161746249|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161746250|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161746251|NCT02849626|584110402|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161746252|NCT02849626|584110403|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161746253|NCT02849626|584110404|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
161746254|NCT02849626|584110405|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161746255|NCT02849626|584110402|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161746256|NCT02849626|584110403|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161746257|NCT02849626|584110404|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
161746258|NCT02849626|584110405|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161746259|NCT02849626|584110402|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
161746260|NCT02849626|584110403|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
161746261|NCT02849626|584110404|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
161746262|NCT02849626|584110405|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
161746263|NCT00889681|584110406|FG000|Overall Study|Not meeting qualification Criteria|2|||
161746264|NCT00889681|584110406|FG000|Overall Study|Insurance disapproval|1|||
161746265|NCT01185704|584110407|FG000|Overall Study|Randomized but not treated|3|||
161746266|NCT01185704|584110408|FG001|Overall Study|Randomized but not treated|3|||
161746267|NCT01185704|584110407|FG000|Overall Study|Lack of ovarian response|5|||
161746268|NCT01185704|584110408|FG001|Overall Study|Lack of ovarian response|1|||
161746269|NCT01185704|584110407|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
161746270|NCT01185704|584110408|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161746271|NCT01185704|584110407|FG000|Overall Study|Ectopic pregnancy|0|||
161746272|NCT01185704|584110408|FG001|Overall Study|Ectopic pregnancy|1|||
161746273|NCT00871572|584110409|FG000|Overall Study|Adverse Event|0|||
161746274|NCT00871572|584110410|FG001|Overall Study|Adverse Event|2|||
161746275|NCT00871572|584110411|FG002|Overall Study|Adverse Event|0|||
161746276|NCT00871572|584110412|FG003|Overall Study|Adverse Event|3|||
161746277|NCT00871572|584110409|FG000|Overall Study|Investigator Decision|0|||
161746278|NCT00871572|584110410|FG001|Overall Study|Investigator Decision|1|||
161746279|NCT00871572|584110411|FG002|Overall Study|Investigator Decision|0|||
161746280|NCT00871572|584110412|FG003|Overall Study|Investigator Decision|1|||
161746281|NCT00871572|584110409|FG000|Overall Study|Lost to Follow-up|0|||
161746282|NCT00871572|584110410|FG001|Overall Study|Lost to Follow-up|1|||
161746283|NCT00871572|584110411|FG002|Overall Study|Lost to Follow-up|0|||
161746284|NCT00871572|584110412|FG003|Overall Study|Lost to Follow-up|1|||
161746285|NCT00871572|584110409|FG000|Overall Study|Protocol Violation|0|||
161746286|NCT00871572|584110410|FG001|Overall Study|Protocol Violation|0|||
161746287|NCT00871572|584110411|FG002|Overall Study|Protocol Violation|1|||
161746288|NCT00871572|584110412|FG003|Overall Study|Protocol Violation|1|||
161746289|NCT00871572|584110409|FG000|Overall Study|Sponsor Decision|1|||
161746290|NCT00871572|584110410|FG001|Overall Study|Sponsor Decision|0|||
161746291|NCT00871572|584110411|FG002|Overall Study|Sponsor Decision|0|||
161746292|NCT00871572|584110412|FG003|Overall Study|Sponsor Decision|0|||
161746293|NCT00871572|584110409|FG000|Overall Study|Withdrawal by Subject|1|||
161746294|NCT00871572|584110410|FG001|Overall Study|Withdrawal by Subject|2|||
161746295|NCT00871572|584110411|FG002|Overall Study|Withdrawal by Subject|3|||
161746296|NCT00871572|584110412|FG003|Overall Study|Withdrawal by Subject|1|||
161746297|NCT04176445|584110417|FG000|Overall Study|Adverse Event|0|||
161746298|NCT04176445|584110418|FG001|Overall Study|Adverse Event|1|||
161746299|NCT04176445|584110417|FG000|Overall Study|change plans weaning after first intervention|0|||
161746300|NCT04176445|584110418|FG001|Overall Study|change plans weaning after first intervention|1|||
161746301|NCT00187889|584110419|FG000|Overall Study|Withdrawal by Subject|6|||
161746302|NCT00187889|584110420|FG001|Overall Study|Withdrawal by Subject|4|||
161746303|NCT04046341|584110421|FG000|Overall Study|Lost to Follow-up|2|||
161746304|NCT04046341|584110421|FG000|Overall Study|Withdrawal by Subject|1|||
161746305|NCT04377672|584110422|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
161746306|NCT03954444|584110423|FG000|Overall Study|Withdrawal by Subject|5|||
161746307|NCT03954444|584110424|FG001|Overall Study|Withdrawal by Subject|5|||
161746308|NCT03954444|584110425|FG002|Overall Study|Withdrawal by Subject|5|||
161746309|NCT03954444|584110423|FG000|Overall Study|Adverse Event|1|||
161746310|NCT03954444|584110424|FG001|Overall Study|Adverse Event|3|||
161746311|NCT03954444|584110425|FG002|Overall Study|Adverse Event|2|||
161746312|NCT03954444|584110423|FG000|Overall Study|Protocol Violation|0|||
161746313|NCT03954444|584110424|FG001|Overall Study|Protocol Violation|3|||
161746314|NCT03954444|584110425|FG002|Overall Study|Protocol Violation|5|||
161842810|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842811|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842812|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842813|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842814|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842815|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842816|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842817|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842818|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842819|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842820|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842821|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842822|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842823|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842824|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842825|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842826|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842827|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842828|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842829|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
161842830|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
161842831|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
161842832|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
161842833|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
161842834|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
161842835|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
161746315|NCT03954444|584110423|FG000|Overall Study|Use of prohibited therapy|1|||
161746316|NCT03954444|584110424|FG001|Overall Study|Use of prohibited therapy|1|||
161746317|NCT03954444|584110425|FG002|Overall Study|Use of prohibited therapy|2|||
161746318|NCT03954444|584110423|FG000|Overall Study|Lost to Follow-up|1|||
161746319|NCT03954444|584110424|FG001|Overall Study|Lost to Follow-up|0|||
161746320|NCT03954444|584110425|FG002|Overall Study|Lost to Follow-up|1|||
161746321|NCT03954444|584110423|FG000|Overall Study|Non-compliant with study drug application|2|||
161746322|NCT03954444|584110424|FG001|Overall Study|Non-compliant with study drug application|2|||
161746323|NCT03954444|584110425|FG002|Overall Study|Non-compliant with study drug application|0|||
161746324|NCT03954444|584110423|FG000|Overall Study|Administrative reasons|0|||
161746325|NCT03954444|584110424|FG001|Overall Study|Administrative reasons|0|||
161746326|NCT03954444|584110425|FG002|Overall Study|Administrative reasons|1|||
161746327|NCT03954444|584110423|FG000|Overall Study|Miscellaneous|3|||
161746328|NCT03954444|584110424|FG001|Overall Study|Miscellaneous|2|||
161746329|NCT03954444|584110425|FG002|Overall Study|Miscellaneous|1|||
161746330|NCT02447458|584110426|FG000|Overall Study|Other|0|||
161746331|NCT02447458|584110427|FG001|Overall Study|Other|0|||
161746332|NCT02447458|584110428|FG002|Overall Study|Other|1|||
161746333|NCT02447458|584110429|FG003|Overall Study|Other|0|||
161746334|NCT02447458|584110430|FG004|Overall Study|Other|0|||
161746335|NCT02447458|584110431|FG005|Overall Study|Other|0|||
161746336|NCT00405652|584110432|FG000|Overall Study|Adverse Event|4|||
161746337|NCT00435994|584110435|FG000|Overall Study|Lost to Follow-up|7|||
161746338|NCT00435994|584110436|FG001|Overall Study|Lost to Follow-up|0|||
161746339|NCT00435994|584110437|FG002|Overall Study|Lost to Follow-up|0|||
161746340|NCT03505749|584110438|FG000|Overall Study|Lost to Follow-up|7|||
161746341|NCT03505749|584110439|FG001|Overall Study|Lost to Follow-up|11|||
161746342|NCT03505749|584110438|FG000|Overall Study|Withdrawal by Subject|6|||
161746343|NCT03505749|584110439|FG001|Overall Study|Withdrawal by Subject|0|||
161746344|NCT03505749|584110438|FG000|Overall Study|Discharged from treatment|3|||
161746345|NCT03505749|584110439|FG001|Overall Study|Discharged from treatment|6|||
161746346|NCT03846219|584110441|FG000|Overall Study|Withdrawal by Subject|3|||
161746347|NCT03846219|584110442|FG001|Overall Study|Withdrawal by Subject|2|||
161746348|NCT03846219|584110443|FG002|Overall Study|Withdrawal by Subject|2|||
161746349|NCT03846219|584110441|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
161746350|NCT03846219|584110442|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
161746351|NCT03846219|584110443|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
161842836|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
161842837|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
161842838|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
161746352|NCT03846219|584110441|FG000|Overall Study|Physician Decision|0|||
161746353|NCT03846219|584110442|FG001|Overall Study|Physician Decision|0|||
161746354|NCT03846219|584110443|FG002|Overall Study|Physician Decision|2|||
161746355|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
161746356|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
161746357|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
161746358|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
161746359|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
161746360|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
161746361|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
161746362|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
161746363|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
161746364|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
161746365|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
161746366|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
161746367|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
161746368|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
161746369|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
161746370|NCT03094832|584110451|FG000|Overall Study|Lost to Follow-up|0|||
161746371|NCT03094832|584110452|FG001|Overall Study|Lost to Follow-up|0|||
161746372|NCT03094832|584110453|FG002|Overall Study|Lost to Follow-up|0|||
161746373|NCT03094832|584110454|FG003|Overall Study|Lost to Follow-up|1|||
161746374|NCT03094832|584110455|FG004|Overall Study|Lost to Follow-up|1|||
161746375|NCT03094832|584110451|FG000|Overall Study|Death|1|||
161746376|NCT03094832|584110452|FG001|Overall Study|Death|0|||
161746377|NCT03094832|584110453|FG002|Overall Study|Death|0|||
161746378|NCT03094832|584110454|FG003|Overall Study|Death|0|||
161746379|NCT03094832|584110455|FG004|Overall Study|Death|0|||
161746380|NCT03094832|584110451|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161746381|NCT03094832|584110452|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161746382|NCT03094832|584110453|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161746383|NCT03094832|584110454|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161746384|NCT03094832|584110455|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161746385|NCT03094832|584110451|FG000|Overall Study|Other|13|||
161746386|NCT03094832|584110452|FG001|Overall Study|Other|20|||
161746387|NCT03094832|584110453|FG002|Overall Study|Other|1|||
161746388|NCT03094832|584110454|FG003|Overall Study|Other|7|||
161746389|NCT03094832|584110455|FG004|Overall Study|Other|1|||
161746390|NCT01392378|584110458|FG000|Infant Series|Adverse Event|0|||
161746391|NCT01392378|584110459|FG001|Infant Series|Adverse Event|0|||
161746392|NCT01392378|584110460|FG002|Infant Series|Adverse Event|0|||
161746393|NCT01392378|584110461|FG003|Infant Series|Adverse Event|1|||
161746394|NCT01392378|584110462|FG004|Infant Series|Adverse Event|0|||
161746395|NCT01392378|584110458|FG000|Infant Series|Lost to Follow-up|0|||
161746396|NCT01392378|584110459|FG001|Infant Series|Lost to Follow-up|0|||
161746397|NCT01392378|584110460|FG002|Infant Series|Lost to Follow-up|0|||
161746398|NCT01392378|584110461|FG003|Infant Series|Lost to Follow-up|1|||
161746399|NCT01392378|584110462|FG004|Infant Series|Lost to Follow-up|0|||
161746400|NCT01392378|584110458|FG000|Infant Series|Protocol Violation|0|||
161746401|NCT01392378|584110459|FG001|Infant Series|Protocol Violation|1|||
161746402|NCT01392378|584110460|FG002|Infant Series|Protocol Violation|0|||
161746403|NCT01392378|584110461|FG003|Infant Series|Protocol Violation|0|||
161746404|NCT01392378|584110462|FG004|Infant Series|Protocol Violation|0|||
161746405|NCT01392378|584110458|FG000|Infant Series|Withdrawal by Parent|4|||
161746406|NCT01392378|584110459|FG001|Infant Series|Withdrawal by Parent|1|||
161746407|NCT01392378|584110460|FG002|Infant Series|Withdrawal by Parent|0|||
161746408|NCT01392378|584110461|FG003|Infant Series|Withdrawal by Parent|0|||
161746409|NCT01392378|584110462|FG004|Infant Series|Withdrawal by Parent|0|||
161746410|NCT01392378|584110458|FG000|After Infant Series|Lost to Follow-up|0|||
161746411|NCT01392378|584110459|FG001|After Infant Series|Lost to Follow-up|0|||
161746412|NCT01392378|584110460|FG002|After Infant Series|Lost to Follow-up|1|||
161746413|NCT01392378|584110461|FG003|After Infant Series|Lost to Follow-up|0|||
161746414|NCT01392378|584110462|FG004|After Infant Series|Lost to Follow-up|0|||
161746415|NCT01392378|584110458|FG000|After Infant Series|Withdrawal by Parent|0|||
161746416|NCT01392378|584110459|FG001|After Infant Series|Withdrawal by Parent|1|||
161746417|NCT01392378|584110460|FG002|After Infant Series|Withdrawal by Parent|1|||
161746418|NCT01392378|584110461|FG003|After Infant Series|Withdrawal by Parent|0|||
161746419|NCT01392378|584110462|FG004|After Infant Series|Withdrawal by Parent|1|||
161746420|NCT01392378|584110458|FG000|Toddler Dose|Lost to Follow-up|0|||
161746421|NCT01392378|584110459|FG001|Toddler Dose|Lost to Follow-up|0|||
161746422|NCT01392378|584110460|FG002|Toddler Dose|Lost to Follow-up|0|||
161746423|NCT01392378|584110461|FG003|Toddler Dose|Lost to Follow-up|1|||
161746424|NCT01392378|584110462|FG004|Toddler Dose|Lost to Follow-up|0|||
161746425|NCT01392378|584110458|FG000|Toddler Dose|Withdrawal by Parent|0|||
161746426|NCT01392378|584110459|FG001|Toddler Dose|Withdrawal by Parent|1|||
161746427|NCT01392378|584110460|FG002|Toddler Dose|Withdrawal by Parent|0|||
161746428|NCT01392378|584110461|FG003|Toddler Dose|Withdrawal by Parent|1|||
161746429|NCT01392378|584110462|FG004|Toddler Dose|Withdrawal by Parent|1|||
161746430|NCT02322411|584110465|FG000|Overall Study|Lost to Follow-up|4|||
161746431|NCT02322411|584110466|FG001|Overall Study|Lost to Follow-up|7|||
161746432|NCT02322411|584110465|FG000|Overall Study|Withdrawal by Subject|1|||
161746433|NCT02322411|584110466|FG001|Overall Study|Withdrawal by Subject|0|||
161746434|NCT00788697|584110467|FG000|Overall Study|No study drug administered|12|||
161746435|NCT00788697|584110467|FG000|Overall Study|Training Patients|74|||
161746436|NCT00788697|584110467|FG000|Overall Study|no truth standard procedure available|5|||
161746437|NCT00788697|584110467|FG000|Overall Study|Technically inadequate truth standard|1|||
161746438|NCT00788697|584110467|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
161746439|NCT01998880|584110469|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
161746440|NCT01998880|584110470|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
161746441|NCT01998880|584110469|FG000|Overall Study|Disease Progression|1|||
161746442|NCT01998880|584110470|FG001|Overall Study|Disease Progression|8|||
161746443|NCT01998880|584110469|FG000|Overall Study|Withdrew Consent|2|||
161746444|NCT01998880|584110470|FG001|Overall Study|Withdrew Consent|1|||
161746445|NCT01998880|584110469|FG000|Overall Study|Death|3|||
161746446|NCT01998880|584110470|FG001|Overall Study|Death|6|||
161746447|NCT01998880|584110469|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161746448|NCT01998880|584110470|FG001|Overall Study|Insufficient Therapeutic Response|5|||
161746449|NCT01998880|584110469|FG000|Overall Study|Administrative/Other|1|||
161746450|NCT01998880|584110470|FG001|Overall Study|Administrative/Other|1|||
161746451|NCT01998880|584110469|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
161746452|NCT01998880|584110470|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161746453|NCT01998880|584110469|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161746454|NCT01998880|584110470|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161746455|NCT01998880|584110469|FG000|Overall Study|Did Not Receive Treatment|3|||
161746456|NCT01998880|584110470|FG001|Overall Study|Did Not Receive Treatment|2|||
161746457|NCT02248857|584110471|FG000|3 Month|Withdrawal by Subject|9|||
161746458|NCT02248857|584110472|FG001|3 Month|Withdrawal by Subject|3|||
161746459|NCT02248857|584110473|FG002|3 Month|Withdrawal by Subject|4|||
161746460|NCT02248857|584110471|FG000|3 Month|Unable to reach for 3 month|35|||
161746461|NCT02248857|584110472|FG001|3 Month|Unable to reach for 3 month|29|||
161746462|NCT02248857|584110473|FG002|3 Month|Unable to reach for 3 month|26|||
161746463|NCT02248857|584110471|FG000|3 Month|Partially completed, unable to finish|2|||
161746464|NCT02248857|584110472|FG001|3 Month|Partially completed, unable to finish|2|||
161746465|NCT02248857|584110473|FG002|3 Month|Partially completed, unable to finish|1|||
161746466|NCT02248857|584110471|FG000|6 Month|Lost to Follow-up|27|||
161746467|NCT02248857|584110472|FG001|6 Month|Lost to Follow-up|26|||
161746468|NCT02248857|584110473|FG002|6 Month|Lost to Follow-up|15|||
161746469|NCT02248857|584110471|FG000|6 Month|Partially completed, unable to finish|0|||
161746470|NCT02248857|584110472|FG001|6 Month|Partially completed, unable to finish|1|||
161746471|NCT02248857|584110473|FG002|6 Month|Partially completed, unable to finish|0|||
161746472|NCT02248857|584110471|FG000|6 Month|Withdrawal by Subject|0|||
161746473|NCT02248857|584110472|FG001|6 Month|Withdrawal by Subject|2|||
161746474|NCT02248857|584110473|FG002|6 Month|Withdrawal by Subject|2|||
161746475|NCT02248857|584110471|FG000|6 Month|Death|1|||
161746476|NCT02248857|584110472|FG001|6 Month|Death|0|||
161746477|NCT02248857|584110473|FG002|6 Month|Death|0|||
161746478|NCT02671461|584110474|FG000|Treatment|Adverse Event|0|||
161746479|NCT02671461|584110475|FG001|Treatment|Adverse Event|0|||
161746480|NCT02671461|584110476|FG002|Treatment|Adverse Event|1|||
161746481|NCT02671461|584110474|FG000|Treatment|Administrative Reason by Sponsor|1|||
161746482|NCT02671461|584110475|FG001|Treatment|Administrative Reason by Sponsor|3|||
161746483|NCT02671461|584110476|FG002|Treatment|Administrative Reason by Sponsor|4|||
161746484|NCT02671461|584110474|FG000|Treatment|Randomized, not treated|1|||
161746485|NCT02671461|584110475|FG001|Treatment|Randomized, not treated|0|||
161746486|NCT02671461|584110476|FG002|Treatment|Randomized, not treated|0|||
161746487|NCT02671461|584110474|FG000|Follow-up|Withdrawal by Subject|1|||
161842839|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
161746488|NCT02671461|584110475|FG001|Follow-up|Withdrawal by Subject|0|||
161746489|NCT02671461|584110476|FG002|Follow-up|Withdrawal by Subject|0|||
161746490|NCT02671461|584110474|FG000|Follow-up|Lost to Follow-up|0|||
161746491|NCT02671461|584110475|FG001|Follow-up|Lost to Follow-up|0|||
161746492|NCT02671461|584110476|FG002|Follow-up|Lost to Follow-up|1|||
161746493|NCT02671461|584110474|FG000|Follow-up|Administrative Reason by Sponsor|0|||
161746494|NCT02671461|584110475|FG001|Follow-up|Administrative Reason by Sponsor|1|||
161746495|NCT02671461|584110476|FG002|Follow-up|Administrative Reason by Sponsor|0|||
161746496|NCT02261883|584110477|FG000|Overall Study|Death|3|||
161746497|NCT02261883|584110478|FG001|Overall Study|Death|2|||
161746498|NCT02261883|584110477|FG000|Overall Study|Physician Decision|1|||
161746499|NCT02261883|584110478|FG001|Overall Study|Physician Decision|0|||
161746500|NCT02261883|584110477|FG000|Overall Study|Protocol Violation|1|||
161746501|NCT02261883|584110478|FG001|Overall Study|Protocol Violation|0|||
161746502|NCT02261883|584110477|FG000|Overall Study|Withdrawal by Subject|0|||
161746503|NCT02261883|584110478|FG001|Overall Study|Withdrawal by Subject|1|||
161746504|NCT02261883|584110477|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
161746505|NCT02261883|584110478|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
161746506|NCT00367432|584110480|FG000|First Period (16 Weeks)|Adverse Event|6|||
161746507|NCT00367432|584110481|FG001|First Period (16 Weeks)|Adverse Event|0|||
161746508|NCT00367432|584110480|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
161746509|NCT00367432|584110481|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
161746510|NCT00367432|584110480|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
161746511|NCT00367432|584110481|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
161746512|NCT00367432|584110480|FG000|First Period (16 Weeks)|Other Reason|2|||
161746513|NCT00367432|584110481|FG001|First Period (16 Weeks)|Other Reason|0|||
161746514|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
161746515|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
161746516|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
161746517|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
161746518|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
161746519|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
161746520|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
161746521|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
161746522|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Other Reason|6|||
161746523|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Other Reason|2|||
161746524|NCT00903370|584110482|FG000|Overall Study|Death|13|||
161746525|NCT00903370|584110483|FG001|Overall Study|Death|10|||
161746526|NCT00903370|584110482|FG000|Overall Study|Withdrawal by Subject|9|||
161746527|NCT00903370|584110483|FG001|Overall Study|Withdrawal by Subject|6|||
161746528|NCT00903370|584110482|FG000|Overall Study|Lost to Follow-up|6|||
161746529|NCT00903370|584110483|FG001|Overall Study|Lost to Follow-up|8|||
161746530|NCT00014911|584110484|FG000|Overall Study|Adverse Event|1|||
161746531|NCT00014911|584110484|FG000|Overall Study|Lost to Follow-up|1|||
161746532|NCT00014911|584110484|FG000|Overall Study|Withdrawal by Subject|6|||
161746533|NCT00014911|584110484|FG000|Overall Study|Unknown Reasons|2|||
161746534|NCT00014911|584110484|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
161746535|NCT01105936|584112564|FG000|Period 1|Adverse Event|0|||
161746536|NCT01105936|584112565|FG001|Period 1|Adverse Event|0|||
161746537|NCT01105936|584112566|FG002|Period 1|Adverse Event|0|||
161746538|NCT01105936|584112567|FG003|Period 1|Adverse Event|1|||
161746539|NCT01105936|584112564|FG000|Period 2|Adverse Event|1|||
161746540|NCT01105936|584112565|FG001|Period 2|Adverse Event|0|||
161746541|NCT01105936|584112566|FG002|Period 2|Adverse Event|0|||
161746542|NCT01105936|584112567|FG003|Period 2|Adverse Event|0|||
161746543|NCT01105936|584112564|FG000|Period 3|Protocol Violation|0|||
161746544|NCT01105936|584112565|FG001|Period 3|Protocol Violation|2|||
161746545|NCT01105936|584112566|FG002|Period 3|Protocol Violation|0|||
161746546|NCT01105936|584112567|FG003|Period 3|Protocol Violation|0|||
161746547|NCT03170258|584112570|FG000|Overall Study|Physician Decision|4|||
161746548|NCT03170258|584112571|FG001|Overall Study|Physician Decision|0|||
161746549|NCT03170258|584112570|FG000|Overall Study|Equipment issues|1|||
161746550|NCT03170258|584112571|FG001|Overall Study|Equipment issues|0|||
161746551|NCT03170258|584112570|FG000|Overall Study|Medication|1|||
161746552|NCT03170258|584112571|FG001|Overall Study|Medication|0|||
161746553|NCT03170258|584112570|FG000|Overall Study|Sleep issues|1|||
161746554|NCT03170258|584112571|FG001|Overall Study|Sleep issues|0|||
161746555|NCT02471586|584112572|FG000|Overall Study|Lost to Follow-up|3|||
161746556|NCT02471586|584112573|FG001|Overall Study|Lost to Follow-up|8|||
161746557|NCT02471586|584112574|FG002|Overall Study|Lost to Follow-up|4|||
161746558|NCT02471586|584112572|FG000|Overall Study|Death|2|||
161746559|NCT02471586|584112573|FG001|Overall Study|Death|2|||
161746560|NCT02471586|584112574|FG002|Overall Study|Death|0|||
161746561|NCT01510028|584112577|FG000|Overall Study|Lack of Efficacy|1|||
161746562|NCT01510028|584112578|FG001|Overall Study|Lack of Efficacy|0|||
161746563|NCT01510028|584112579|FG002|Overall Study|Lack of Efficacy|0|||
161746564|NCT01510028|584112580|FG003|Overall Study|Lack of Efficacy|0|||
161746565|NCT05091918|584112581|FG000|Overall Study|Adverse Event|1|||
161746566|NCT05091918|584112581|FG000|Overall Study|Withdrawal by Subject|81|||
161746567|NCT01100658|584112586|FG000|Overall Study|Withdrawal by Subject|1|||
161746568|NCT00239356|584112587|FG000|Overall Study|Lack of Efficacy|1|||
161746569|NCT00239356|584112588|FG001|Overall Study|Lack of Efficacy|0|||
161746570|NCT00239356|584112587|FG000|Overall Study|Adverse Event|6|||
161746571|NCT00239356|584112588|FG001|Overall Study|Adverse Event|0|||
161746572|NCT00239356|584112587|FG000|Overall Study|Withdrawal by Subject|15|||
161746573|NCT00239356|584112588|FG001|Overall Study|Withdrawal by Subject|6|||
161746574|NCT00239356|584112587|FG000|Overall Study|Lost to Follow-up|3|||
161746575|NCT00239356|584112588|FG001|Overall Study|Lost to Follow-up|0|||
161746576|NCT00239356|584112587|FG000|Overall Study|poor/non-compliance|2|||
161746577|NCT00239356|584112588|FG001|Overall Study|poor/non-compliance|0|||
161746578|NCT00239356|584112587|FG000|Overall Study|Pregnancy|1|||
161746579|NCT00239356|584112588|FG001|Overall Study|Pregnancy|0|||
161746580|NCT00239356|584112587|FG000|Overall Study|Administrative reason|0|||
161746581|NCT00239356|584112588|FG001|Overall Study|Administrative reason|1|||
161746582|NCT00239356|584112587|FG000|Overall Study|Drug available on market|11|||
161746583|NCT00239356|584112588|FG001|Overall Study|Drug available on market|2|||
161746584|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
161746585|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
161746586|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
161746587|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
161746588|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
161746589|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
161746590|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
161746591|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
161746592|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
161746593|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
161746594|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
161746595|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
161746596|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
161746597|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
161746598|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
161746599|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
161746600|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
161746601|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
161746602|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
161746603|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
161842840|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
161842841|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
161842842|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
161842843|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
161842844|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
161842845|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
161842846|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
161842847|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
161842848|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
161842849|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
161842850|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
161842851|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
161842852|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
161842853|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
161842854|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
161842855|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842856|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842857|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842858|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842859|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842860|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842861|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842862|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842863|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842864|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842865|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842866|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842867|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161746604|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
161746605|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
161746606|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
161746607|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
161746608|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161746609|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
161746610|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
161746611|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161746612|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
161746613|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
161746614|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
161746615|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
161746616|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
161746617|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161746618|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161746619|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
161746620|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
161746621|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
161746622|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
161746623|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161746624|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161746625|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161746626|NCT01094808|584112592|FG000|Overall Study|Withdrawal by Subject|1|||
161842868|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842869|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842870|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842871|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842872|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842873|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842874|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842875|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842876|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842877|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161746627|NCT01094808|584112593|FG001|Overall Study|Withdrawal by Subject|1|||
161746628|NCT01094808|584112594|FG002|Overall Study|Withdrawal by Subject|0|||
161746629|NCT02044822|584112595|FG000|Overall Study|Study Terminated by Sponsor|77|||
161746630|NCT02044822|584112595|FG000|Overall Study|Investigator's Discretion|10|||
161746631|NCT02044822|584112595|FG000|Overall Study|Withdrew Consent|3|||
161746632|NCT02044822|584112595|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
161746633|NCT02044822|584112595|FG000|Overall Study|Lost to Follow-up|1|||
161746634|NCT02025530|584112598|FG000|Overall Study|No longer met elligibility criteria|5|||
161746635|NCT02025530|584112599|FG001|Overall Study|No longer met elligibility criteria|1|||
161746636|NCT03551626|584112600|FG000|Overall Study|Adverse Event|88|||
161746637|NCT03551626|584112600|FG000|Overall Study|Disease relapse|18|||
161746638|NCT03551626|584112600|FG000|Overall Study|Withdrawal of informed consent|6|||
161746639|NCT03551626|584112600|FG000|Overall Study|Patient decision|5|||
161746640|NCT03551626|584112600|FG000|Overall Study|Physician Decision|4|||
161746641|NCT03551626|584112600|FG000|Overall Study|Lost to Follow-up|3|||
161746642|NCT03551626|584112600|FG000|Overall Study|Pregnancy|1|||
161746643|NCT03551626|584112600|FG000|Overall Study|Protocol deviation|1|||
161746644|NCT03551626|584112600|FG000|Overall Study|Technical problems|1|||
161746645|NCT00653328|584112601|FG000|Overall Study|Withdrawal by Subject|1|||
161746646|NCT00653328|584112601|FG000|Overall Study|Adverse Event|2|||
161746647|NCT00653328|584112601|FG000|Overall Study|Disease progression|10|||
161746648|NCT00653328|584112601|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
161746649|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
161746650|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746651|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746652|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746653|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746654|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746655|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
161746656|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746657|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746658|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746659|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161842878|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842879|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842880|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842881|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842882|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161746660|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746661|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
161746662|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746663|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746664|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746665|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746666|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746667|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
161746668|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746669|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746670|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746671|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746672|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746673|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
161746674|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746675|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746676|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746677|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746678|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746679|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
161746680|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
161746681|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
161746682|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
161746683|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
161746684|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
161746685|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
161746686|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
161746687|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
161746688|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
161746689|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
161746690|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
161746691|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161746692|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
161746693|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
161746694|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
161746695|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161746696|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161746697|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746698|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746699|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746700|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746701|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746702|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
161746703|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
161746704|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746705|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746706|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
161746707|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746708|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746709|NCT00443846|584112617|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
161746710|NCT00443846|584112618|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
161746711|NCT00443846|584112617|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
161746712|NCT00443846|584112618|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
161746713|NCT00443846|584112617|FG000|Overall Study|Adverse Event|0|||
161746714|NCT00443846|584112618|FG001|Overall Study|Adverse Event|1|||
161746715|NCT00443846|584112617|FG000|Overall Study|Personal reason|8|||
161746716|NCT00443846|584112618|FG001|Overall Study|Personal reason|3|||
161746717|NCT00443846|584112617|FG000|Overall Study|Lost to Follow-up|1|||
161746718|NCT00443846|584112618|FG001|Overall Study|Lost to Follow-up|2|||
161746719|NCT00445341|584112625|FG000|Overall Study|refused further treatment|1|||
161746720|NCT00445341|584112625|FG000|Overall Study|taken off treatment too early|1|||
161746721|NCT03051217|584112626|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
161746722|NCT03051217|584112627|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746723|NCT03051217|584112628|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161746724|NCT03051217|584112629|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746725|NCT03051217|584112630|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746726|NCT03051217|584112631|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746727|NCT03051217|584112632|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746728|NCT03051217|584112626|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746729|NCT03051217|584112627|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
161746730|NCT03051217|584112628|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746731|NCT03051217|584112629|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746732|NCT03051217|584112630|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746733|NCT03051217|584112631|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746734|NCT03051217|584112632|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746735|NCT03051217|584112626|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161746736|NCT03051217|584112627|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161746737|NCT03051217|584112628|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161746738|NCT03051217|584112629|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746739|NCT03051217|584112630|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746740|NCT03051217|584112631|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746741|NCT03051217|584112632|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746742|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161746743|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161746744|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161746745|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161746746|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
161746747|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161746748|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161746749|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746750|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746751|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746752|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
161746753|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746754|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746755|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746756|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746757|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746758|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746759|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
161746760|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746761|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746762|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746763|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746764|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746765|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746766|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746767|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
161746768|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746769|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746770|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746771|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746772|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746773|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746774|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746775|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
161746776|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746777|NCT00641706|584112633|FG000|Overall Study|Adverse Event|2|||
161746778|NCT00641706|584112634|FG001|Overall Study|Adverse Event|1|||
161746779|NCT00641706|584112633|FG000|Overall Study|Withdrawal by Subject|6|||
161746780|NCT00641706|584112634|FG001|Overall Study|Withdrawal by Subject|1|||
161746781|NCT00641706|584112633|FG000|Overall Study|Clinical Decline|1|||
161746782|NCT00641706|584112634|FG001|Overall Study|Clinical Decline|0|||
161746783|NCT00641706|584112633|FG000|Overall Study|Lead Investigator Decision|0|||
161746784|NCT00641706|584112634|FG001|Overall Study|Lead Investigator Decision|1|||
161746785|NCT00109772|584112635|FG000|Double-blind Treatment|Adverse Event|14|||
161746786|NCT00109772|584112636|FG001|Double-blind Treatment|Adverse Event|5|||
161746787|NCT00109772|584112635|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161746788|NCT00109772|584112636|FG001|Double-blind Treatment|Lack of Efficacy|0|||
161746789|NCT00109772|584112635|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
161746790|NCT00109772|584112636|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
161746791|NCT00109772|584112635|FG000|Double-blind Treatment|Lost to Follow-up|2|||
161746792|NCT00109772|584112636|FG001|Double-blind Treatment|Lost to Follow-up|3|||
161746793|NCT00109772|584112635|FG000|Double-blind Treatment|Protocol Violation|0|||
161746794|NCT00109772|584112636|FG001|Double-blind Treatment|Protocol Violation|1|||
161746795|NCT00109772|584112635|FG000|Double-blind Treatment|Other|0|||
161746796|NCT00109772|584112636|FG001|Double-blind Treatment|Other|4|||
161746797|NCT00109772|584112635|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
161746798|NCT00109772|584112636|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
161746799|NCT00109772|584112635|FG000|Open-label Extension|Adverse Event|10|||
161746800|NCT00109772|584112636|FG001|Open-label Extension|Adverse Event|19|||
161746801|NCT00109772|584112635|FG000|Open-label Extension|Lack of Efficacy|19|||
161746802|NCT00109772|584112636|FG001|Open-label Extension|Lack of Efficacy|11|||
161746803|NCT00109772|584112635|FG000|Open-label Extension|Withdrawal by Subject|9|||
161746804|NCT00109772|584112636|FG001|Open-label Extension|Withdrawal by Subject|6|||
161746805|NCT00109772|584112635|FG000|Open-label Extension|Lost to Follow-up|1|||
161746806|NCT00109772|584112636|FG001|Open-label Extension|Lost to Follow-up|0|||
161746807|NCT00109772|584112635|FG000|Open-label Extension|Death|0|||
161746808|NCT00109772|584112636|FG001|Open-label Extension|Death|1|||
161746809|NCT00109772|584112635|FG000|Open-label Extension|Protocol Violation|2|||
161746810|NCT00109772|584112636|FG001|Open-label Extension|Protocol Violation|2|||
161746811|NCT00109772|584112635|FG000|Open-label Extension|Other|4|||
161746812|NCT00109772|584112636|FG001|Open-label Extension|Other|10|||
161746813|NCT00391807|584112640|FG000|Overall Study|Did not receive study medication|23|||
161746814|NCT00391807|584112640|FG000|Overall Study|Adverse Event|177|||
161746815|NCT00391807|584112640|FG000|Overall Study|Pregnancy|25|||
161746816|NCT00391807|584112640|FG000|Overall Study|Lost to Follow-up|227|||
161746817|NCT00391807|584112640|FG000|Overall Study|Withdrawal by Subject|147|||
161746818|NCT00391807|584112640|FG000|Overall Study|Protocol Violation|20|||
161746819|NCT00391807|584112640|FG000|Overall Study|Various|96|||
161746820|NCT05441540|584112643|FG000|Overall Study|Withdrawal by Subject|2|||
161746821|NCT00813917|584112644|FG000|Overall Study|Adverse Event|0|||
161746822|NCT00813917|584112645|FG001|Overall Study|Adverse Event|1|||
161746823|NCT00813917|584112644|FG000|Overall Study|Withdrawal by Subject|3|||
161746824|NCT00813917|584112645|FG001|Overall Study|Withdrawal by Subject|4|||
161746825|NCT00813917|584112644|FG000|Overall Study|Lost to Follow-up|3|||
161746826|NCT00813917|584112645|FG001|Overall Study|Lost to Follow-up|1|||
161746827|NCT01359046|584112646|FG000|Overall Study|Did not receive allocated intervention|6|||
161746828|NCT01359046|584112647|FG001|Overall Study|Did not receive allocated intervention|6|||
161746829|NCT01359046|584112646|FG000|Overall Study|Physician Decision|1|||
161746830|NCT01359046|584112647|FG001|Overall Study|Physician Decision|11|||
161746831|NCT01369225|584112652|FG000|Overall Study|Withdrawal by Subject|1|||
161746832|NCT01369225|584112653|FG001|Overall Study|Withdrawal by Subject|0|||
161746833|NCT01369225|584112654|FG002|Overall Study|Withdrawal by Subject|2|||
161746834|NCT01369225|584112655|FG003|Overall Study|Withdrawal by Subject|1|||
161746835|NCT01369225|584112656|FG004|Overall Study|Withdrawal by Subject|0|||
161746836|NCT01369225|584112657|FG005|Overall Study|Withdrawal by Subject|0|||
161746837|NCT01369225|584112652|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
161746838|NCT01369225|584112653|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
161746839|NCT01369225|584112654|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
161746840|NCT01369225|584112655|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
161746841|NCT01369225|584112656|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
161746842|NCT01369225|584112657|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
161746843|NCT01369225|584112652|FG000|Overall Study|Other|1|||
161746844|NCT01369225|584112653|FG001|Overall Study|Other|0|||
161746845|NCT01369225|584112654|FG002|Overall Study|Other|0|||
161746846|NCT01369225|584112655|FG003|Overall Study|Other|0|||
161746847|NCT01369225|584112656|FG004|Overall Study|Other|1|||
161746848|NCT01369225|584112657|FG005|Overall Study|Other|0|||
161746849|NCT01369225|584112652|FG000|Overall Study|Adverse Event|0|||
161746850|NCT01369225|584112653|FG001|Overall Study|Adverse Event|0|||
161746851|NCT01369225|584112654|FG002|Overall Study|Adverse Event|0|||
161746852|NCT01369225|584112655|FG003|Overall Study|Adverse Event|1|||
161746853|NCT01369225|584112656|FG004|Overall Study|Adverse Event|1|||
161746854|NCT01369225|584112657|FG005|Overall Study|Adverse Event|0|||
161746855|NCT04539262|584112659|FG000|Overall Study|Adverse Event|0|||
161746856|NCT04539262|584112660|FG001|Overall Study|Adverse Event|0|||
161746857|NCT04539262|584112661|FG002|Overall Study|Adverse Event|1|||
161746858|NCT04539262|584112662|FG003|Overall Study|Adverse Event|0|||
161746859|NCT04539262|584112663|FG004|Overall Study|Adverse Event|0|||
161746860|NCT04539262|584112664|FG005|Overall Study|Adverse Event|0|||
161746861|NCT04539262|584112665|FG006|Overall Study|Adverse Event|0|||
161746862|NCT04539262|584112666|FG007|Overall Study|Adverse Event|0|||
161746863|NCT04539262|584112659|FG000|Overall Study|Withdrew Consent|0|||
161746864|NCT04539262|584112660|FG001|Overall Study|Withdrew Consent|0|||
161746865|NCT04539262|584112661|FG002|Overall Study|Withdrew Consent|0|||
161746866|NCT04539262|584112662|FG003|Overall Study|Withdrew Consent|1|||
161746867|NCT04539262|584112663|FG004|Overall Study|Withdrew Consent|0|||
161746868|NCT04539262|584112664|FG005|Overall Study|Withdrew Consent|0|||
161746869|NCT04539262|584112665|FG006|Overall Study|Withdrew Consent|0|||
161746870|NCT04539262|584112666|FG007|Overall Study|Withdrew Consent|0|||
161746871|NCT04539262|584112659|FG000|Overall Study|Randomized, Not treated|0|||
161746872|NCT04539262|584112660|FG001|Overall Study|Randomized, Not treated|1|||
161746873|NCT04539262|584112661|FG002|Overall Study|Randomized, Not treated|0|||
161746874|NCT04539262|584112662|FG003|Overall Study|Randomized, Not treated|0|||
161746875|NCT04539262|584112663|FG004|Overall Study|Randomized, Not treated|0|||
161746876|NCT04539262|584112664|FG005|Overall Study|Randomized, Not treated|0|||
161746877|NCT04539262|584112665|FG006|Overall Study|Randomized, Not treated|1|||
161746878|NCT04539262|584112666|FG007|Overall Study|Randomized, Not treated|0|||
161746879|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
161746880|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
161746881|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
161746882|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
161746883|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
161746884|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161746885|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
161746886|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161746887|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161746888|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
161746889|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746890|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746891|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746892|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
161746893|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746894|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
161746895|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
161746896|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
161746897|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
161746898|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
161746899|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
161746900|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161746901|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
161746902|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161746903|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161746904|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Other|1|||
161746905|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Other|0|||
161746906|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Other|0|||
161746907|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Other|0|||
161746908|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Other|1|||
161746909|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
161746910|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
161746911|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
161746912|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
161746913|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
161746914|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Adverse Event|0|||
161746915|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Adverse Event|0|||
161746916|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Adverse Event|0|||
161746917|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Adverse Event|1|||
161746918|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Adverse Event|1|||
161746919|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161746920|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
161746921|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
161746922|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161746923|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161746924|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746925|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746926|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
161746927|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746928|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746929|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Pregnancy|0|||
161746930|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Pregnancy|0|||
161746931|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Pregnancy|1|||
161746932|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Pregnancy|1|||
161746933|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Pregnancy|0|||
161746934|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
161746935|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161746936|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
161746937|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161746938|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161746939|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Other|0|||
161746940|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Other|0|||
161746941|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Other|1|||
161746942|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Other|1|||
161746943|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Other|3|||
161746944|NCT00792701|584112674|FG000|Overall Study|Adverse Event|0|||
161746945|NCT00792701|584112675|FG001|Overall Study|Adverse Event|22|||
161746946|NCT00792701|584112674|FG000|Overall Study|Ineligible|1|||
161746947|NCT00792701|584112675|FG001|Overall Study|Ineligible|3|||
161746948|NCT00792701|584112674|FG000|Overall Study|Withdrawal by Subject|1|||
161746949|NCT00792701|584112675|FG001|Overall Study|Withdrawal by Subject|19|||
161746950|NCT00792701|584112674|FG000|Overall Study|Not protocol specified|17|||
161746951|NCT00792701|584112675|FG001|Overall Study|Not protocol specified|0|||
161746952|NCT05507580|584112678|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746953|NCT05507580|584112679|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161746954|NCT05507580|584112680|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746955|NCT05507580|584112681|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746956|NCT05507580|584112682|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746957|NCT05507580|584112683|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746958|NCT05507580|584112678|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
161746959|NCT05507580|584112679|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161746960|NCT05507580|584112680|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746961|NCT05507580|584112681|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746962|NCT05507580|584112682|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746963|NCT05507580|584112683|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746964|NCT05507580|584112678|FG000|Double-Blind Treatment Period|Other, not specified|5|||
161746965|NCT05507580|584112679|FG001|Double-Blind Treatment Period|Other, not specified|4|||
161746966|NCT05507580|584112680|FG002|Double-Blind Treatment Period|Other, not specified|0|||
161746967|NCT05507580|584112681|FG003|Double-Blind Treatment Period|Other, not specified|0|||
161746968|NCT05507580|584112682|FG004|Double-Blind Treatment Period|Other, not specified|0|||
161746969|NCT05507580|584112683|FG005|Double-Blind Treatment Period|Other, not specified|0|||
161746970|NCT05507580|584112678|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
161746971|NCT05507580|584112679|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
161746972|NCT05507580|584112680|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
161842883|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161746973|NCT05507580|584112681|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
161746974|NCT05507580|584112682|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
161746975|NCT05507580|584112683|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
161746976|NCT05507580|584112678|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161746977|NCT05507580|584112679|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161746978|NCT05507580|584112680|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161842884|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
161746979|NCT05507580|584112681|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
161746980|NCT05507580|584112682|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
161746981|NCT05507580|584112683|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
161746982|NCT05507580|584112678|FG000|Single-Blind Treatment Period|Other, not specified|0|||
161746983|NCT05507580|584112679|FG001|Single-Blind Treatment Period|Other, not specified|0|||
161746984|NCT05507580|584112680|FG002|Single-Blind Treatment Period|Other, not specified|2|||
161363817|NCT02544763|582720032|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161746985|NCT05507580|584112681|FG003|Single-Blind Treatment Period|Other, not specified|7|||
161746986|NCT05507580|584112682|FG004|Single-Blind Treatment Period|Other, not specified|3|||
161746987|NCT05507580|584112683|FG005|Single-Blind Treatment Period|Other, not specified|5|||
161746988|NCT04702984|584112689|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
161746989|NCT00618813|584112690|FG000|Overall Study|Lack of Efficacy|1|||
161746990|NCT00618813|584112690|FG000|Overall Study|Physician Decision|2|||
161746991|NCT00618813|584112690|FG000|Overall Study|Withdrawal by Subject|1|||
161746992|NCT01809197|584112691|FG000|Overall Study|Lost to Follow-up|4|||
161746993|NCT01809197|584112692|FG001|Overall Study|Lost to Follow-up|2|||
161746994|NCT01809197|584112691|FG000|Overall Study|Adverse Event|2|||
161746995|NCT01809197|584112692|FG001|Overall Study|Adverse Event|3|||
161746996|NCT01809197|584112691|FG000|Overall Study|Failed slit lamp exam|1|||
161842885|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
161842886|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161746997|NCT01809197|584112692|FG001|Overall Study|Failed slit lamp exam|0|||
161746998|NCT01809197|584112691|FG000|Overall Study|Non-Compliance|1|||
161746999|NCT01809197|584112692|FG001|Overall Study|Non-Compliance|1|||
161747000|NCT01809197|584112691|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
161747001|NCT01809197|584112692|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
161747002|NCT01809197|584112691|FG000|Overall Study|Withdrawal by Subject|1|||
161747003|NCT01809197|584112692|FG001|Overall Study|Withdrawal by Subject|1|||
161747004|NCT01809197|584112691|FG000|Overall Study|Product not available|0|||
161747005|NCT01809197|584112692|FG001|Overall Study|Product not available|1|||
161747006|NCT01855945|584112693|FG000|Overall Study|Adverse Event|0|||
161747007|NCT01855945|584112694|FG001|Overall Study|Adverse Event|0|||
161842887|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842888|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
161842889|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842890|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842891|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842892|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842893|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842894|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842895|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842896|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842897|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842898|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842899|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842900|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842901|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842902|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842903|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842904|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842905|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842906|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842907|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842908|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842909|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842910|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
161842911|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842912|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842913|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842914|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842915|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842916|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842917|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842918|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842919|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842920|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842921|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842922|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842923|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842924|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842925|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842926|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842927|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842928|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842929|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842930|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842931|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842932|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842933|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842934|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161747008|NCT01855945|584112695|FG002|Overall Study|Adverse Event|0|||
161747009|NCT01855945|584112696|FG003|Overall Study|Adverse Event|0|||
161842935|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842936|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842937|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842938|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842939|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842940|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
161842941|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
161842942|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
161842943|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
161842944|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842945|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842946|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842947|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842948|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842949|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842950|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842951|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842952|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842953|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842954|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842955|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842956|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842957|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842958|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842959|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842960|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842961|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842962|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842963|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842964|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
161842965|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
161842966|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842967|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842968|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842969|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842970|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842971|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842972|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842973|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842974|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842975|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842976|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842977|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842978|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842979|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
161747010|NCT01855945|584112697|FG004|Overall Study|Adverse Event|0|||
161747011|NCT01855945|584112698|FG005|Overall Study|Adverse Event|0|||
161747012|NCT01855945|584112699|FG006|Overall Study|Adverse Event|1|||
161747013|NCT01855945|584112700|FG007|Overall Study|Adverse Event|0|||
161747014|NCT01855945|584112701|FG008|Overall Study|Adverse Event|0|||
161747015|NCT01855945|584112702|FG009|Overall Study|Adverse Event|0|||
161747016|NCT01855945|584112703|FG010|Overall Study|Adverse Event|0|||
161747017|NCT01855945|584112704|FG011|Overall Study|Adverse Event|0|||
161747018|NCT01855945|584112693|FG000|Overall Study|Death|0|||
161747019|NCT01855945|584112694|FG001|Overall Study|Death|0|||
161747020|NCT01855945|584112695|FG002|Overall Study|Death|0|||
161747021|NCT01855945|584112696|FG003|Overall Study|Death|0|||
161747022|NCT01855945|584112697|FG004|Overall Study|Death|0|||
161747023|NCT01855945|584112698|FG005|Overall Study|Death|0|||
161747024|NCT01855945|584112699|FG006|Overall Study|Death|2|||
161747025|NCT01855945|584112700|FG007|Overall Study|Death|0|||
161747026|NCT01855945|584112701|FG008|Overall Study|Death|0|||
161747027|NCT01855945|584112702|FG009|Overall Study|Death|0|||
161747028|NCT01855945|584112703|FG010|Overall Study|Death|0|||
161747029|NCT01855945|584112704|FG011|Overall Study|Death|0|||
161747030|NCT01855945|584112693|FG000|Overall Study|Lost to Follow-up|11|||
161747031|NCT01855945|584112694|FG001|Overall Study|Lost to Follow-up|10|||
161747032|NCT01855945|584112695|FG002|Overall Study|Lost to Follow-up|7|||
161747033|NCT01855945|584112696|FG003|Overall Study|Lost to Follow-up|3|||
161747034|NCT01855945|584112697|FG004|Overall Study|Lost to Follow-up|0|||
161747035|NCT01855945|584112698|FG005|Overall Study|Lost to Follow-up|3|||
161747036|NCT01855945|584112699|FG006|Overall Study|Lost to Follow-up|4|||
161747037|NCT01855945|584112700|FG007|Overall Study|Lost to Follow-up|7|||
161747038|NCT01855945|584112701|FG008|Overall Study|Lost to Follow-up|2|||
161747039|NCT01855945|584112702|FG009|Overall Study|Lost to Follow-up|0|||
161747040|NCT01855945|584112703|FG010|Overall Study|Lost to Follow-up|0|||
161747041|NCT01855945|584112704|FG011|Overall Study|Lost to Follow-up|2|||
161747042|NCT01855945|584112693|FG000|Overall Study|Other - Unclassified|1|||
161747043|NCT01855945|584112694|FG001|Overall Study|Other - Unclassified|1|||
161747044|NCT01855945|584112695|FG002|Overall Study|Other - Unclassified|1|||
161747045|NCT01855945|584112696|FG003|Overall Study|Other - Unclassified|0|||
161747046|NCT01855945|584112697|FG004|Overall Study|Other - Unclassified|0|||
161747047|NCT01855945|584112698|FG005|Overall Study|Other - Unclassified|0|||
161747048|NCT01855945|584112699|FG006|Overall Study|Other - Unclassified|2|||
161747049|NCT01855945|584112700|FG007|Overall Study|Other - Unclassified|1|||
161747050|NCT01855945|584112701|FG008|Overall Study|Other - Unclassified|0|||
161747051|NCT01855945|584112702|FG009|Overall Study|Other - Unclassified|0|||
161747052|NCT01855945|584112703|FG010|Overall Study|Other - Unclassified|1|||
161747053|NCT01855945|584112704|FG011|Overall Study|Other - Unclassified|0|||
161747054|NCT01855945|584112693|FG000|Overall Study|Withdrawal by Subject|4|||
161747055|NCT01855945|584112694|FG001|Overall Study|Withdrawal by Subject|0|||
161747056|NCT01855945|584112695|FG002|Overall Study|Withdrawal by Subject|4|||
161747057|NCT01855945|584112696|FG003|Overall Study|Withdrawal by Subject|1|||
161747058|NCT01855945|584112697|FG004|Overall Study|Withdrawal by Subject|1|||
161747059|NCT01855945|584112698|FG005|Overall Study|Withdrawal by Subject|0|||
161747060|NCT01855945|584112699|FG006|Overall Study|Withdrawal by Subject|1|||
161842980|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
161842981|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
161842982|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
161842983|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
161842984|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
161842985|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
161842986|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
161842987|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
161842988|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
161842989|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
161842990|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
161842991|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
161842992|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
161842993|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
161842994|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
161842995|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
161842996|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
161747061|NCT01855945|584112700|FG007|Overall Study|Withdrawal by Subject|0|||
161747062|NCT01855945|584112701|FG008|Overall Study|Withdrawal by Subject|0|||
161747063|NCT01855945|584112702|FG009|Overall Study|Withdrawal by Subject|2|||
161747064|NCT01855945|584112703|FG010|Overall Study|Withdrawal by Subject|4|||
161747065|NCT01855945|584112704|FG011|Overall Study|Withdrawal by Subject|1|||
161747066|NCT02156804|584112709|FG000|Overall Study|Withdrawal by Subject|1|||
161747067|NCT03228394|584112710|FG000|Overall Study|Lost to Follow-up|0|||
161747068|NCT03228394|584112711|FG001|Overall Study|Lost to Follow-up|0|||
161747069|NCT03228394|584112712|FG002|Overall Study|Lost to Follow-up|1|||
161747070|NCT03228394|584112713|FG003|Overall Study|Lost to Follow-up|1|||
161747071|NCT03228394|584112714|FG004|Overall Study|Lost to Follow-up|0|||
161747072|NCT03228394|584112715|FG005|Overall Study|Lost to Follow-up|0|||
161747073|NCT03228394|584112716|FG006|Overall Study|Lost to Follow-up|2|||
161747074|NCT03228394|584112717|FG007|Overall Study|Lost to Follow-up|0|||
161747075|NCT03228394|584112710|FG000|Overall Study|Withdrawal by Subject|0|||
161747076|NCT03228394|584112711|FG001|Overall Study|Withdrawal by Subject|0|||
161747077|NCT03228394|584112712|FG002|Overall Study|Withdrawal by Subject|1|||
161747078|NCT03228394|584112713|FG003|Overall Study|Withdrawal by Subject|0|||
161747079|NCT03228394|584112714|FG004|Overall Study|Withdrawal by Subject|0|||
161747080|NCT03228394|584112715|FG005|Overall Study|Withdrawal by Subject|0|||
161747081|NCT03228394|584112716|FG006|Overall Study|Withdrawal by Subject|1|||
161747082|NCT03228394|584112717|FG007|Overall Study|Withdrawal by Subject|3|||
161747083|NCT03228394|584112710|FG000|Overall Study|Protocol Violation|0|||
161747084|NCT03228394|584112711|FG001|Overall Study|Protocol Violation|0|||
161747085|NCT03228394|584112712|FG002|Overall Study|Protocol Violation|0|||
161747086|NCT03228394|584112713|FG003|Overall Study|Protocol Violation|1|||
161747087|NCT03228394|584112714|FG004|Overall Study|Protocol Violation|0|||
161747088|NCT03228394|584112715|FG005|Overall Study|Protocol Violation|0|||
161747089|NCT03228394|584112716|FG006|Overall Study|Protocol Violation|0|||
161747090|NCT03228394|584112717|FG007|Overall Study|Protocol Violation|0|||
161747091|NCT03228394|584112710|FG000|Overall Study|Physician Decision|0|||
161747092|NCT03228394|584112711|FG001|Overall Study|Physician Decision|0|||
161747093|NCT03228394|584112712|FG002|Overall Study|Physician Decision|0|||
161747094|NCT03228394|584112713|FG003|Overall Study|Physician Decision|0|||
161747095|NCT03228394|584112714|FG004|Overall Study|Physician Decision|0|||
161747096|NCT03228394|584112715|FG005|Overall Study|Physician Decision|0|||
161842997|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
161842998|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
161842999|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
161843000|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
161843001|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
161843002|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
161843003|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
161843004|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747097|NCT03228394|584112716|FG006|Overall Study|Physician Decision|1|||
161843005|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843006|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747098|NCT03228394|584112717|FG007|Overall Study|Physician Decision|0|||
161747099|NCT03228394|584112710|FG000|Overall Study|Noncompliance|0|||
161747100|NCT03228394|584112711|FG001|Overall Study|Noncompliance|0|||
161747101|NCT03228394|584112712|FG002|Overall Study|Noncompliance|0|||
161843007|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747102|NCT03228394|584112713|FG003|Overall Study|Noncompliance|0|||
161747103|NCT03228394|584112714|FG004|Overall Study|Noncompliance|0|||
161747104|NCT03228394|584112715|FG005|Overall Study|Noncompliance|0|||
161747105|NCT03228394|584112716|FG006|Overall Study|Noncompliance|1|||
161747106|NCT03228394|584112717|FG007|Overall Study|Noncompliance|0|||
161747107|NCT03000686|584112718|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161747108|NCT03000686|584112719|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
161747109|NCT03000686|584112720|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161747110|NCT03000686|584112721|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161747111|NCT01851863|584112726|FG000|Overall Study|Did not receive study medication|2|||
161747112|NCT01851863|584112727|FG001|Overall Study|Did not receive study medication|5|||
161747113|NCT01851863|584112728|FG002|Overall Study|Did not receive study medication|3|||
161747114|NCT01851863|584112729|FG003|Overall Study|Did not receive study medication|0|||
161747115|NCT01851863|584112726|FG000|Overall Study|Lost to Follow-up|3|||
161747116|NCT01851863|584112727|FG001|Overall Study|Lost to Follow-up|4|||
161747117|NCT01851863|584112728|FG002|Overall Study|Lost to Follow-up|2|||
161747118|NCT01851863|584112729|FG003|Overall Study|Lost to Follow-up|3|||
161747119|NCT00753623|584112730|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
161747120|NCT00753623|584112731|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
161747121|NCT00753623|584112730|FG000|Phase I (14 Days)|Physician Decision|1|||
161747122|NCT00753623|584112731|FG001|Phase I (14 Days)|Physician Decision|2|||
161747123|NCT00753623|584112730|FG000|Phase I (14 Days)|Adverse Event|0|||
161747124|NCT00753623|584112731|FG001|Phase I (14 Days)|Adverse Event|1|||
161747125|NCT00753623|584112730|FG000|Washout (7 Days)|Physician Decision|1|||
161747126|NCT00753623|584112731|FG001|Washout (7 Days)|Physician Decision|0|||
161747127|NCT00753623|584112730|FG000|Phase II (14 Days)|Physician Decision|0|||
161747128|NCT00753623|584112731|FG001|Phase II (14 Days)|Physician Decision|1|||
161747129|NCT03332303|584112732|FG000|Overall Study|Participant did not dose|1|||
161747130|NCT03332303|584112733|FG001|Overall Study|Participant did not dose|2|||
161747131|NCT03332303|584112734|FG002|Overall Study|Participant did not dose|0|||
161747132|NCT03332303|584112732|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
161747133|NCT03332303|584112733|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
161747134|NCT03332303|584112734|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
161747135|NCT03332303|584112732|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
161747136|NCT03332303|584112733|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
161747137|NCT03332303|584112734|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
161747138|NCT03332303|584112732|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
161747139|NCT03332303|584112733|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
161747140|NCT03332303|584112734|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
161747141|NCT03332303|584112732|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
161747142|NCT03332303|584112733|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
161747143|NCT03332303|584112734|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
161747144|NCT03332303|584112732|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
161747145|NCT03332303|584112733|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
161747146|NCT03332303|584112734|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
161747147|NCT03332303|584112732|FG000|Overall Study|Participant had a significant protocol deviation|0|||
161747148|NCT03332303|584112733|FG001|Overall Study|Participant had a significant protocol deviation|1|||
161747149|NCT03332303|584112734|FG002|Overall Study|Participant had a significant protocol deviation|0|||
161747150|NCT00345540|584112735|FG000|Overall Study|Withdrawal by Subject|1|||
161747151|NCT04179786|584112736|FG000|Overall Study|Withdrawal by Subject|8|||
161747152|NCT01938001|584112737|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
161747153|NCT01938001|584112738|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
161747154|NCT01938001|584112737|FG000|Pre-Treatment|Death|1|||
161747155|NCT01938001|584112738|FG001|Pre-Treatment|Death|0|||
161747156|NCT01938001|584112737|FG000|Treatment|Death|2|||
161747157|NCT01938001|584112738|FG001|Treatment|Death|0|||
161747158|NCT01938001|584112737|FG000|Treatment|Adverse Event|14|||
161747159|NCT01938001|584112738|FG001|Treatment|Adverse Event|8|||
161747160|NCT01938001|584112737|FG000|Treatment|Progressive Disease|21|||
161747161|NCT01938001|584112738|FG001|Treatment|Progressive Disease|54|||
161843008|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843009|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843010|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843011|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843012|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843013|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747162|NCT01938001|584112737|FG000|Treatment|Withdrawal by Subject|13|||
161747163|NCT01938001|584112738|FG001|Treatment|Withdrawal by Subject|7|||
161747164|NCT01938001|584112737|FG000|Treatment|Other reasons|2|||
161747165|NCT01938001|584112738|FG001|Treatment|Other reasons|1|||
161747166|NCT03310580|584112739|FG000|Overall Study|Adverse Event|0|||
161747167|NCT03310580|584112740|FG001|Overall Study|Adverse Event|1|||
161747168|NCT03310580|584112741|FG002|Overall Study|Adverse Event|0|||
161747169|NCT03205982|584112742|FG000|Overall Study|Lost to Follow-up|20|||
161747170|NCT03205982|584112743|FG001|Overall Study|Lost to Follow-up|19|||
161747171|NCT03205982|584112742|FG000|Overall Study|Withdrawal by Subject|4|||
161747172|NCT03205982|584112743|FG001|Overall Study|Withdrawal by Subject|3|||
161747173|NCT03205982|584112742|FG000|Overall Study|Withdrawal by PI|0|||
161747174|NCT03205982|584112743|FG001|Overall Study|Withdrawal by PI|1|||
161747175|NCT00418717|584112744|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
161747176|NCT00418717|584112744|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
161747177|NCT02762708|584112749|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161747178|NCT02762708|584112750|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
161747179|NCT02762708|584112751|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161747180|NCT02762708|584112752|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161747181|NCT01468701|584112753|FG000|Overall Study|Not eligible|91|||
161747182|NCT01468701|584112754|FG001|Overall Study|Not eligible|140|||
161747183|NCT01468701|584112755|FG002|Overall Study|Not eligible|29|||
161747184|NCT01468701|584112756|FG003|Overall Study|Not eligible|12|||
161747185|NCT01468701|584112757|FG004|Overall Study|Not eligible|22|||
161747186|NCT01468701|584112758|FG005|Overall Study|Not eligible|2|||
161747187|NCT01468701|584112759|FG006|Overall Study|Not eligible|39|||
161747188|NCT01468701|584112760|FG007|Overall Study|Not eligible|1|||
161747189|NCT01468701|584112761|FG008|Overall Study|Not eligible|40|||
161747190|NCT01468701|584112762|FG009|Overall Study|Not eligible|126|||
161747191|NCT01468701|584112763|FG010|Overall Study|Not eligible|39|||
161747192|NCT01468701|584112764|FG011|Overall Study|Not eligible|33|||
161747193|NCT01468701|584112765|FG012|Overall Study|Not eligible|1|||
161747194|NCT01468701|584112766|FG013|Overall Study|Not eligible|19|||
161747195|NCT01468701|584112767|FG014|Overall Study|Not eligible|1|||
161747196|NCT01468701|584112768|FG015|Overall Study|Not eligible|32|||
161747197|NCT01468701|584112769|FG016|Overall Study|Not eligible|0|||
161747198|NCT01468701|584112753|FG000|Overall Study|Lost to Follow-up|306|||
161747199|NCT01468701|584112754|FG001|Overall Study|Lost to Follow-up|0|||
161747200|NCT01468701|584112755|FG002|Overall Study|Lost to Follow-up|0|||
161747201|NCT01468701|584112756|FG003|Overall Study|Lost to Follow-up|0|||
161747202|NCT01468701|584112757|FG004|Overall Study|Lost to Follow-up|0|||
161747203|NCT01468701|584112758|FG005|Overall Study|Lost to Follow-up|0|||
161747204|NCT01468701|584112759|FG006|Overall Study|Lost to Follow-up|0|||
161747205|NCT01468701|584112760|FG007|Overall Study|Lost to Follow-up|0|||
161747206|NCT01468701|584112761|FG008|Overall Study|Lost to Follow-up|215|||
161747207|NCT01468701|584112762|FG009|Overall Study|Lost to Follow-up|309|||
161747208|NCT01468701|584112763|FG010|Overall Study|Lost to Follow-up|224|||
161747209|NCT01468701|584112764|FG011|Overall Study|Lost to Follow-up|212|||
161747210|NCT01468701|584112765|FG012|Overall Study|Lost to Follow-up|11|||
161747211|NCT01468701|584112766|FG013|Overall Study|Lost to Follow-up|164|||
161843014|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843015|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
161747212|NCT01468701|584112767|FG014|Overall Study|Lost to Follow-up|17|||
161747213|NCT01468701|584112768|FG015|Overall Study|Lost to Follow-up|127|||
161747214|NCT01468701|584112769|FG016|Overall Study|Lost to Follow-up|1|||
161747215|NCT01468701|584112753|FG000|Overall Study|Withdrawal by Subject|165|||
161747216|NCT01468701|584112754|FG001|Overall Study|Withdrawal by Subject|0|||
161747217|NCT01468701|584112755|FG002|Overall Study|Withdrawal by Subject|0|||
161747218|NCT01468701|584112756|FG003|Overall Study|Withdrawal by Subject|0|||
161747219|NCT01468701|584112757|FG004|Overall Study|Withdrawal by Subject|0|||
161747220|NCT01468701|584112758|FG005|Overall Study|Withdrawal by Subject|0|||
161747221|NCT01468701|584112759|FG006|Overall Study|Withdrawal by Subject|0|||
161747222|NCT01468701|584112760|FG007|Overall Study|Withdrawal by Subject|0|||
161747223|NCT01468701|584112761|FG008|Overall Study|Withdrawal by Subject|83|||
161747224|NCT01468701|584112762|FG009|Overall Study|Withdrawal by Subject|88|||
161747225|NCT01468701|584112763|FG010|Overall Study|Withdrawal by Subject|100|||
161747226|NCT01468701|584112764|FG011|Overall Study|Withdrawal by Subject|114|||
161747227|NCT01468701|584112765|FG012|Overall Study|Withdrawal by Subject|9|||
161747228|NCT01468701|584112766|FG013|Overall Study|Withdrawal by Subject|47|||
161747229|NCT01468701|584112767|FG014|Overall Study|Withdrawal by Subject|6|||
161747230|NCT01468701|584112768|FG015|Overall Study|Withdrawal by Subject|31|||
161747231|NCT01468701|584112769|FG016|Overall Study|Withdrawal by Subject|0|||
161747232|NCT01468701|584112753|FG000|Overall Study|Other reasons than listed|437|||
161747233|NCT01468701|584112754|FG001|Overall Study|Other reasons than listed|0|||
161747234|NCT01468701|584112755|FG002|Overall Study|Other reasons than listed|0|||
161747235|NCT01468701|584112756|FG003|Overall Study|Other reasons than listed|0|||
161747236|NCT01468701|584112757|FG004|Overall Study|Other reasons than listed|0|||
161747237|NCT01468701|584112758|FG005|Overall Study|Other reasons than listed|0|||
161747238|NCT01468701|584112759|FG006|Overall Study|Other reasons than listed|0|||
161747239|NCT01468701|584112760|FG007|Overall Study|Other reasons than listed|0|||
161747240|NCT01468701|584112761|FG008|Overall Study|Other reasons than listed|318|||
161747241|NCT01468701|584112762|FG009|Overall Study|Other reasons than listed|658|||
161747242|NCT01468701|584112763|FG010|Overall Study|Other reasons than listed|433|||
161747243|NCT01468701|584112764|FG011|Overall Study|Other reasons than listed|504|||
161747244|NCT01468701|584112765|FG012|Overall Study|Other reasons than listed|28|||
161747245|NCT01468701|584112766|FG013|Overall Study|Other reasons than listed|239|||
161747246|NCT01468701|584112767|FG014|Overall Study|Other reasons than listed|39|||
161747247|NCT01468701|584112768|FG015|Overall Study|Other reasons than listed|172|||
161747248|NCT01468701|584112769|FG016|Overall Study|Other reasons than listed|0|||
161747249|NCT01468701|584112753|FG000|Overall Study|No end of study case report form|0|||
161747250|NCT01468701|584112754|FG001|Overall Study|No end of study case report form|0|||
161747251|NCT01468701|584112755|FG002|Overall Study|No end of study case report form|0|||
161747252|NCT01468701|584112756|FG003|Overall Study|No end of study case report form|0|||
161747253|NCT01468701|584112757|FG004|Overall Study|No end of study case report form|0|||
161747254|NCT01468701|584112758|FG005|Overall Study|No end of study case report form|0|||
161747255|NCT01468701|584112759|FG006|Overall Study|No end of study case report form|0|||
161747256|NCT01468701|584112760|FG007|Overall Study|No end of study case report form|0|||
161747257|NCT01468701|584112761|FG008|Overall Study|No end of study case report form|4|||
161747258|NCT01468701|584112762|FG009|Overall Study|No end of study case report form|1|||
161747259|NCT01468701|584112763|FG010|Overall Study|No end of study case report form|2|||
161747260|NCT01468701|584112764|FG011|Overall Study|No end of study case report form|3|||
161747261|NCT01468701|584112765|FG012|Overall Study|No end of study case report form|0|||
161747262|NCT01468701|584112766|FG013|Overall Study|No end of study case report form|1|||
161747263|NCT01468701|584112767|FG014|Overall Study|No end of study case report form|0|||
161747264|NCT01468701|584112768|FG015|Overall Study|No end of study case report form|0|||
161747265|NCT01468701|584112769|FG016|Overall Study|No end of study case report form|0|||
161747266|NCT01468701|584112753|FG000|Overall Study|Not being followed up|0|||
161747267|NCT01468701|584112754|FG001|Overall Study|Not being followed up|4963|||
161747268|NCT01468701|584112755|FG002|Overall Study|Not being followed up|1755|||
161747269|NCT01468701|584112756|FG003|Overall Study|Not being followed up|703|||
161747270|NCT01468701|584112757|FG004|Overall Study|Not being followed up|1714|||
161747271|NCT01468701|584112758|FG005|Overall Study|Not being followed up|126|||
161747272|NCT01468701|584112759|FG006|Overall Study|Not being followed up|1170|||
161747273|NCT01468701|584112760|FG007|Overall Study|Not being followed up|4|||
161747274|NCT01468701|584112761|FG008|Overall Study|Not being followed up|0|||
161747275|NCT01468701|584112762|FG009|Overall Study|Not being followed up|0|||
161747276|NCT01468701|584112763|FG010|Overall Study|Not being followed up|0|||
161747277|NCT01468701|584112764|FG011|Overall Study|Not being followed up|0|||
161747278|NCT01468701|584112765|FG012|Overall Study|Not being followed up|0|||
161747279|NCT01468701|584112766|FG013|Overall Study|Not being followed up|0|||
161747280|NCT01468701|584112767|FG014|Overall Study|Not being followed up|0|||
161747281|NCT01468701|584112768|FG015|Overall Study|Not being followed up|0|||
161747282|NCT01468701|584112769|FG016|Overall Study|Not being followed up|0|||
161747283|NCT00970268|584112774|FG000|Overall Study|Withdrawal by Subject|12|||
161747284|NCT00970268|584112775|FG001|Overall Study|Withdrawal by Subject|19|||
161747285|NCT00970268|584112774|FG000|Overall Study|Adverse Event|15|||
161747286|NCT00970268|584112775|FG001|Overall Study|Adverse Event|12|||
161843016|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843017|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
161747287|NCT00970268|584112774|FG000|Overall Study|Lack of Efficacy|3|||
161747288|NCT00970268|584112775|FG001|Overall Study|Lack of Efficacy|6|||
161747289|NCT00970268|584112774|FG000|Overall Study|Protocol Violation|4|||
161747290|NCT00970268|584112775|FG001|Overall Study|Protocol Violation|7|||
161747291|NCT00970268|584112774|FG000|Overall Study|Other Reason|3|||
161747292|NCT00970268|584112775|FG001|Overall Study|Other Reason|1|||
161747293|NCT00970268|584112774|FG000|Overall Study|COPD Exacerbation|4|||
161747294|NCT00970268|584112775|FG001|Overall Study|COPD Exacerbation|2|||
161747295|NCT00970268|584112774|FG000|Overall Study|Lost to Follow-up|1|||
161747296|NCT00970268|584112775|FG001|Overall Study|Lost to Follow-up|2|||
161747297|NCT00970268|584112774|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
161843018|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747298|NCT00970268|584112775|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161747299|NCT01079195|584112779|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
161747300|NCT01079195|584112779|FG000|Overall Study|No Documentation Available|437|||
161747301|NCT01079195|584112779|FG000|Overall Study|Adverse Event|157|||
161747302|NCT01079195|584112779|FG000|Overall Study|Reason Unknown|39|||
161747303|NCT01079195|584112779|FG000|Overall Study|Withdrawal by Subject|18|||
161747304|NCT01079195|584112779|FG000|Overall Study|Financial Reasons|15|||
161843019|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843020|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843021|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843022|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747305|NCT01079195|584112779|FG000|Overall Study|Lack of Effectiveness|12|||
161747306|NCT01079195|584112779|FG000|Overall Study|Physician Decision|4|||
161747307|NCT01079195|584112779|FG000|Overall Study|Improved Status of Participant|4|||
161747308|NCT01079195|584112779|FG000|Overall Study|No Follow-up Documentation Available|4|||
161747309|NCT01079195|584112779|FG000|Overall Study|Non-compliance|2|||
161747310|NCT01999946|584112780|FG000|Overall Study|Participant not released from jail|2|||
161747311|NCT01999946|584112781|FG001|Overall Study|Participant not released from jail|2|||
161747312|NCT01999946|584112782|FG002|Overall Study|Participant not released from jail|0|||
161747313|NCT01999946|584112780|FG000|Overall Study|Not included in primary outcome analysis|0|||
161747314|NCT01999946|584112781|FG001|Overall Study|Not included in primary outcome analysis|0|||
161747315|NCT01999946|584112782|FG002|Overall Study|Not included in primary outcome analysis|79|||
161747316|NCT03906136|584114192|FG000|Overall Study|Adverse Event|1|||
161747317|NCT03906136|584114193|FG001|Overall Study|Adverse Event|0|||
161747318|NCT03906136|584114192|FG000|Overall Study|Lost to Follow-up|7|||
161747319|NCT03906136|584114193|FG001|Overall Study|Lost to Follow-up|4|||
161747320|NCT03906136|584114192|FG000|Overall Study|Physician Decision|1|||
161747321|NCT03906136|584114193|FG001|Overall Study|Physician Decision|0|||
161747322|NCT03906136|584114192|FG000|Overall Study|Withdrawal by Subject|3|||
161747323|NCT03906136|584114193|FG001|Overall Study|Withdrawal by Subject|7|||
161747324|NCT01696396|584114198|FG000|Overall Study|Withdrawal by Subject|19|||
161747325|NCT01696396|584114199|FG001|Overall Study|Withdrawal by Subject|5|||
161747326|NCT01696396|584114200|FG002|Overall Study|Withdrawal by Subject|19|||
161747327|NCT01696396|584114201|FG003|Overall Study|Withdrawal by Subject|11|||
161747328|NCT01696396|584114198|FG000|Overall Study|Decision by Sponsor|3|||
161747329|NCT01696396|584114199|FG001|Overall Study|Decision by Sponsor|1|||
161747330|NCT01696396|584114200|FG002|Overall Study|Decision by Sponsor|2|||
161747331|NCT01696396|584114201|FG003|Overall Study|Decision by Sponsor|2|||
161747332|NCT01696396|584114198|FG000|Overall Study|Lost to Follow-up|9|||
161747333|NCT01696396|584114199|FG001|Overall Study|Lost to Follow-up|1|||
161747334|NCT01696396|584114200|FG002|Overall Study|Lost to Follow-up|4|||
161747335|NCT01696396|584114201|FG003|Overall Study|Lost to Follow-up|1|||
161747336|NCT01696396|584114198|FG000|Overall Study|Death|0|||
161747337|NCT01696396|584114199|FG001|Overall Study|Death|0|||
161747338|NCT01696396|584114200|FG002|Overall Study|Death|1|||
161747339|NCT01696396|584114201|FG003|Overall Study|Death|0|||
161747340|NCT02371980|584114207|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
161747341|NCT02371980|584114208|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747342|NCT02371980|584114209|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747343|NCT02371980|584114210|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747344|NCT02371980|584114211|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747345|NCT02371980|584114207|FG000|Open-label Period|Significant Protocol Deviation|19|||
161747346|NCT02371980|584114208|FG001|Open-label Period|Significant Protocol Deviation|0|||
161843023|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843024|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843025|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843026|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843027|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843028|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843029|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161747347|NCT02371980|584114209|FG002|Open-label Period|Significant Protocol Deviation|0|||
161747348|NCT02371980|584114210|FG003|Open-label Period|Significant Protocol Deviation|0|||
161747349|NCT02371980|584114211|FG004|Open-label Period|Significant Protocol Deviation|0|||
161747350|NCT02371980|584114207|FG000|Open-label Period|Noncompliance with Study Drug|10|||
161747351|NCT02371980|584114208|FG001|Open-label Period|Noncompliance with Study Drug|0|||
161747352|NCT02371980|584114209|FG002|Open-label Period|Noncompliance with Study Drug|0|||
161747353|NCT02371980|584114210|FG003|Open-label Period|Noncompliance with Study Drug|0|||
161843030|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161747354|NCT02371980|584114211|FG004|Open-label Period|Noncompliance with Study Drug|0|||
161747355|NCT02371980|584114207|FG000|Open-label Period|Lost to Follow-up|55|||
161747356|NCT02371980|584114208|FG001|Open-label Period|Lost to Follow-up|0|||
161747357|NCT02371980|584114209|FG002|Open-label Period|Lost to Follow-up|0|||
161747358|NCT02371980|584114210|FG003|Open-label Period|Lost to Follow-up|0|||
161747359|NCT02371980|584114211|FG004|Open-label Period|Lost to Follow-up|0|||
161747360|NCT02371980|584114207|FG000|Open-label Period|Voluntary Withdrawal|91|||
161747361|NCT02371980|584114208|FG001|Open-label Period|Voluntary Withdrawal|0|||
161747362|NCT02371980|584114209|FG002|Open-label Period|Voluntary Withdrawal|0|||
161747363|NCT02371980|584114210|FG003|Open-label Period|Voluntary Withdrawal|0|||
161747364|NCT02371980|584114211|FG004|Open-label Period|Voluntary Withdrawal|0|||
161747365|NCT02371980|584114207|FG000|Open-label Period|Pregnancy|1|||
161747366|NCT02371980|584114208|FG001|Open-label Period|Pregnancy|0|||
161747367|NCT02371980|584114209|FG002|Open-label Period|Pregnancy|0|||
161747368|NCT02371980|584114210|FG003|Open-label Period|Pregnancy|0|||
161747369|NCT02371980|584114211|FG004|Open-label Period|Pregnancy|0|||
161747370|NCT02371980|584114207|FG000|Open-label Period|Lack of Efficacy|116|||
161747371|NCT02371980|584114208|FG001|Open-label Period|Lack of Efficacy|0|||
161747372|NCT02371980|584114209|FG002|Open-label Period|Lack of Efficacy|0|||
161843031|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843032|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843033|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843034|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161747373|NCT02371980|584114210|FG003|Open-label Period|Lack of Efficacy|0|||
161747374|NCT02371980|584114211|FG004|Open-label Period|Lack of Efficacy|0|||
161843035|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843036|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843037|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843038|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843039|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843040|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843041|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843042|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843043|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843044|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843045|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843046|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843047|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161843048|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843049|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
161843050|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161843051|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843052|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161843053|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843054|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Death|0|||
161843055|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Death|0|||
161747375|NCT02371980|584114207|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
161747376|NCT02371980|584114208|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
161747377|NCT02371980|584114209|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
161747378|NCT02371980|584114210|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
161747379|NCT02371980|584114211|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
161747380|NCT02371980|584114207|FG000|Open-label Period|Reason not Specified|9|||
161747381|NCT02371980|584114208|FG001|Open-label Period|Reason not Specified|0|||
161747382|NCT02371980|584114209|FG002|Open-label Period|Reason not Specified|0|||
161747383|NCT02371980|584114210|FG003|Open-label Period|Reason not Specified|0|||
161747384|NCT02371980|584114211|FG004|Open-label Period|Reason not Specified|0|||
161747385|NCT02371980|584114207|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
161747386|NCT02371980|584114208|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
161747387|NCT02371980|584114209|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
161747388|NCT02371980|584114210|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
161747389|NCT02371980|584114211|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
161747390|NCT02371980|584114207|FG000|Double-blind Period|Significant Protocol Deviation|0|||
161747391|NCT02371980|584114208|FG001|Double-blind Period|Significant Protocol Deviation|2|||
161747392|NCT02371980|584114209|FG002|Double-blind Period|Significant Protocol Deviation|7|||
161747393|NCT02371980|584114210|FG003|Double-blind Period|Significant Protocol Deviation|3|||
161747394|NCT02371980|584114211|FG004|Double-blind Period|Significant Protocol Deviation|3|||
161747395|NCT02371980|584114207|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
161747396|NCT02371980|584114208|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
161747397|NCT02371980|584114209|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
161747398|NCT02371980|584114210|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
161747399|NCT02371980|584114211|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
161747400|NCT02371980|584114207|FG000|Double-blind Period|Lost to Follow-up|0|||
161747401|NCT02371980|584114208|FG001|Double-blind Period|Lost to Follow-up|8|||
161747402|NCT02371980|584114209|FG002|Double-blind Period|Lost to Follow-up|8|||
161747403|NCT02371980|584114210|FG003|Double-blind Period|Lost to Follow-up|6|||
161747404|NCT02371980|584114211|FG004|Double-blind Period|Lost to Follow-up|5|||
161747405|NCT02371980|584114207|FG000|Double-blind Period|Voluntary Withdrawal|0|||
161747406|NCT02371980|584114208|FG001|Double-blind Period|Voluntary Withdrawal|12|||
161747407|NCT02371980|584114209|FG002|Double-blind Period|Voluntary Withdrawal|8|||
161747408|NCT02371980|584114210|FG003|Double-blind Period|Voluntary Withdrawal|9|||
161747409|NCT02371980|584114211|FG004|Double-blind Period|Voluntary Withdrawal|11|||
161843056|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Death|0|||
161747410|NCT02371980|584114207|FG000|Double-blind Period|Relapse|0|||
161747411|NCT02371980|584114208|FG001|Double-blind Period|Relapse|50|||
161747412|NCT02371980|584114209|FG002|Double-blind Period|Relapse|25|||
161843057|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Death|0|||
161843058|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Death|0|||
161843059|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Death|0|||
161843060|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Death|0|||
161843061|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Death|0|||
161747413|NCT02371980|584114210|FG003|Double-blind Period|Relapse|25|||
161747414|NCT02371980|584114211|FG004|Double-blind Period|Relapse|26|||
161747415|NCT02371980|584114207|FG000|Double-blind Period|Reason not Specified|0|||
161747416|NCT02371980|584114208|FG001|Double-blind Period|Reason not Specified|3|||
161747417|NCT02371980|584114209|FG002|Double-blind Period|Reason not Specified|3|||
161747418|NCT02371980|584114210|FG003|Double-blind Period|Reason not Specified|2|||
161747419|NCT02371980|584114211|FG004|Double-blind Period|Reason not Specified|1|||
161747420|NCT02371980|584114207|FG000|Double-blind Period|Missing|0|||
161747421|NCT02371980|584114208|FG001|Double-blind Period|Missing|1|||
161747422|NCT02371980|584114209|FG002|Double-blind Period|Missing|0|||
161747423|NCT02371980|584114210|FG003|Double-blind Period|Missing|0|||
161747424|NCT02371980|584114211|FG004|Double-blind Period|Missing|0|||
161747425|NCT01280812|584114213|FG000|Overall Study|Withdrawal by Subject|2|||
161747426|NCT01280812|584114214|FG001|Overall Study|Withdrawal by Subject|1|||
161747427|NCT01280812|584114215|FG002|Overall Study|Withdrawal by Subject|0|||
161747428|NCT01280812|584114213|FG000|Overall Study|Lost to Follow-up|1|||
161747429|NCT01280812|584114214|FG001|Overall Study|Lost to Follow-up|1|||
161747430|NCT01280812|584114215|FG002|Overall Study|Lost to Follow-up|1|||
161747431|NCT03907969|584114219|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
161747432|NCT03907969|584114220|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
161747433|NCT03907969|584114221|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
161747434|NCT03907969|584114222|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
161747435|NCT03907969|584114223|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
161747436|NCT03907969|584114224|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
161747437|NCT03907969|584114225|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
161747438|NCT03907969|584114226|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
161747439|NCT03907969|584114227|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
161747440|NCT03907969|584114228|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
161747441|NCT03907969|584114229|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
161747442|NCT03907969|584114219|FG000|Monotherapy Part A|Progressive Disease|0|||
161747443|NCT03907969|584114220|FG001|Monotherapy Part A|Progressive Disease|1|||
161747444|NCT03907969|584114221|FG002|Monotherapy Part A|Progressive Disease|0|||
161747445|NCT03907969|584114222|FG003|Monotherapy Part A|Progressive Disease|0|||
161747446|NCT03907969|584114223|FG004|Monotherapy Part A|Progressive Disease|0|||
161747447|NCT03907969|584114224|FG005|Monotherapy Part A|Progressive Disease|1|||
161747448|NCT03907969|584114225|FG006|Monotherapy Part A|Progressive Disease|2|||
161747449|NCT03907969|584114226|FG007|Monotherapy Part A|Progressive Disease|0|||
161747450|NCT03907969|584114227|FG008|Monotherapy Part A|Progressive Disease|0|||
161747451|NCT03907969|584114228|FG009|Monotherapy Part A|Progressive Disease|0|||
161747452|NCT03907969|584114229|FG010|Monotherapy Part A|Progressive Disease|0|||
161747453|NCT03907969|584114219|FG000|Monotherapy Part A|Death|0|||
161747454|NCT03907969|584114220|FG001|Monotherapy Part A|Death|0|||
161747455|NCT03907969|584114221|FG002|Monotherapy Part A|Death|1|||
161747456|NCT03907969|584114222|FG003|Monotherapy Part A|Death|1|||
161747457|NCT03907969|584114223|FG004|Monotherapy Part A|Death|0|||
161747458|NCT03907969|584114224|FG005|Monotherapy Part A|Death|1|||
161747459|NCT03907969|584114225|FG006|Monotherapy Part A|Death|0|||
161747460|NCT03907969|584114226|FG007|Monotherapy Part A|Death|0|||
161747461|NCT03907969|584114227|FG008|Monotherapy Part A|Death|0|||
161747462|NCT03907969|584114228|FG009|Monotherapy Part A|Death|0|||
161747463|NCT03907969|584114229|FG010|Monotherapy Part A|Death|0|||
161747464|NCT03907969|584114219|FG000|Combination Therapy Part A|Adverse Event|0|||
161747465|NCT03907969|584114220|FG001|Combination Therapy Part A|Adverse Event|0|||
161747466|NCT03907969|584114221|FG002|Combination Therapy Part A|Adverse Event|0|||
161747467|NCT03907969|584114222|FG003|Combination Therapy Part A|Adverse Event|0|||
161747468|NCT03907969|584114223|FG004|Combination Therapy Part A|Adverse Event|0|||
161747469|NCT03907969|584114224|FG005|Combination Therapy Part A|Adverse Event|0|||
161747470|NCT03907969|584114225|FG006|Combination Therapy Part A|Adverse Event|0|||
161747471|NCT03907969|584114226|FG007|Combination Therapy Part A|Adverse Event|0|||
161747472|NCT03907969|584114227|FG008|Combination Therapy Part A|Adverse Event|0|||
161747473|NCT03907969|584114228|FG009|Combination Therapy Part A|Adverse Event|1|||
161747474|NCT03907969|584114229|FG010|Combination Therapy Part A|Adverse Event|1|||
161747475|NCT03907969|584114219|FG000|Combination Therapy Part A|Progressive disease|0|||
161747476|NCT03907969|584114220|FG001|Combination Therapy Part A|Progressive disease|0|||
161747477|NCT03907969|584114221|FG002|Combination Therapy Part A|Progressive disease|0|||
161747478|NCT03907969|584114222|FG003|Combination Therapy Part A|Progressive disease|0|||
161747479|NCT03907969|584114223|FG004|Combination Therapy Part A|Progressive disease|0|||
161747480|NCT03907969|584114224|FG005|Combination Therapy Part A|Progressive disease|0|||
161747481|NCT03907969|584114225|FG006|Combination Therapy Part A|Progressive disease|0|||
161747482|NCT03907969|584114226|FG007|Combination Therapy Part A|Progressive disease|1|||
161747483|NCT03907969|584114227|FG008|Combination Therapy Part A|Progressive disease|0|||
161747484|NCT03907969|584114228|FG009|Combination Therapy Part A|Progressive disease|2|||
161747485|NCT03907969|584114229|FG010|Combination Therapy Part A|Progressive disease|3|||
161747486|NCT03907969|584114219|FG000|Combination Therapy Part A|Death|0|||
161747487|NCT03907969|584114220|FG001|Combination Therapy Part A|Death|0|||
161747488|NCT03907969|584114221|FG002|Combination Therapy Part A|Death|0|||
161747489|NCT03907969|584114222|FG003|Combination Therapy Part A|Death|0|||
161747490|NCT03907969|584114223|FG004|Combination Therapy Part A|Death|0|||
161747491|NCT03907969|584114224|FG005|Combination Therapy Part A|Death|0|||
161747492|NCT03907969|584114225|FG006|Combination Therapy Part A|Death|0|||
161747493|NCT03907969|584114226|FG007|Combination Therapy Part A|Death|0|||
161747494|NCT03907969|584114227|FG008|Combination Therapy Part A|Death|1|||
161747495|NCT03907969|584114228|FG009|Combination Therapy Part A|Death|0|||
161747496|NCT03907969|584114229|FG010|Combination Therapy Part A|Death|1|||
161747497|NCT03907969|584114219|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
161747498|NCT03907969|584114220|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
161747499|NCT03907969|584114221|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
161747500|NCT03907969|584114222|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
161747501|NCT03907969|584114223|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
161747502|NCT03907969|584114224|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
161747503|NCT03907969|584114225|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
161747504|NCT03907969|584114226|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
161747505|NCT03907969|584114227|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
161747506|NCT03907969|584114228|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
161747507|NCT03907969|584114229|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
161747508|NCT03907969|584114219|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
161747509|NCT03907969|584114220|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
161747510|NCT03907969|584114221|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
161747511|NCT03907969|584114222|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
161747512|NCT03907969|584114223|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
161747513|NCT03907969|584114224|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
161747514|NCT03907969|584114225|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
161747515|NCT03907969|584114226|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
161747516|NCT03907969|584114227|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
161747517|NCT03907969|584114228|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
161747518|NCT03907969|584114229|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
161747519|NCT03907969|584114219|FG000|Combination Therapy Part A|Physician Decision|0|||
161747520|NCT03907969|584114220|FG001|Combination Therapy Part A|Physician Decision|0|||
161747521|NCT03907969|584114221|FG002|Combination Therapy Part A|Physician Decision|0|||
161747522|NCT03907969|584114222|FG003|Combination Therapy Part A|Physician Decision|0|||
161747523|NCT03907969|584114223|FG004|Combination Therapy Part A|Physician Decision|0|||
161747524|NCT03907969|584114224|FG005|Combination Therapy Part A|Physician Decision|0|||
161747525|NCT03907969|584114225|FG006|Combination Therapy Part A|Physician Decision|0|||
161747526|NCT03907969|584114226|FG007|Combination Therapy Part A|Physician Decision|1|||
161747527|NCT03907969|584114227|FG008|Combination Therapy Part A|Physician Decision|0|||
161747528|NCT03907969|584114228|FG009|Combination Therapy Part A|Physician Decision|0|||
161747529|NCT03907969|584114229|FG010|Combination Therapy Part A|Physician Decision|1|||
161747530|NCT00666536|584114230|FG000|Overall Study|Adverse Event|9|||
161747531|NCT00666536|584114231|FG001|Overall Study|Adverse Event|19|||
161747532|NCT00666536|584114230|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161747533|NCT00666536|584114231|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161747534|NCT00666536|584114230|FG000|Overall Study|Protocol deviation(s)|8|||
161747535|NCT00666536|584114231|FG001|Overall Study|Protocol deviation(s)|6|||
161747536|NCT00666536|584114230|FG000|Overall Study|Withdrawal by Subject|10|||
161747537|NCT00666536|584114231|FG001|Overall Study|Withdrawal by Subject|9|||
161747538|NCT00666536|584114230|FG000|Overall Study|Lost to Follow-up|4|||
161747539|NCT00666536|584114231|FG001|Overall Study|Lost to Follow-up|3|||
161747540|NCT02853123|584114235|FG000|Treatment Period 1|Adverse Event|0|||
161747541|NCT02853123|584114236|FG001|Treatment Period 1|Adverse Event|3|||
161747542|NCT02853123|584114235|FG000|Washout Period|Worsening of COPD|0|||
161747543|NCT02853123|584114236|FG001|Washout Period|Worsening of COPD|3|||
161747544|NCT02853123|584114235|FG000|Washout Period|Adverse Event|1|||
161747545|NCT02853123|584114236|FG001|Washout Period|Adverse Event|0|||
161747546|NCT01419015|584114247|FG000|Overall Study|Death|2|||
161747547|NCT04209530|584114248|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
161747548|NCT04209530|584114249|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
161747549|NCT04209530|584114248|FG000|Overall Study|Withdrawal by Subject|0|||
161747550|NCT04209530|584114249|FG001|Overall Study|Withdrawal by Subject|1|||
161747551|NCT04839393|584114250|FG000|Overall Study|Adverse Event|0|||
161747552|NCT04839393|584114251|FG001|Overall Study|Adverse Event|0|||
161747553|NCT04839393|584114252|FG002|Overall Study|Adverse Event|2|||
161747554|NCT04839393|584114250|FG000|Overall Study|Withdrawal by participant|0|||
161747555|NCT04839393|584114251|FG001|Overall Study|Withdrawal by participant|0|||
161747556|NCT04839393|584114252|FG002|Overall Study|Withdrawal by participant|1|||
161747557|NCT00633893|584114255|FG000|Overall Study|Death|1|||
161747558|NCT00633893|584114256|FG001|Overall Study|Death|3|||
161747559|NCT00633893|584114257|FG002|Overall Study|Death|9|||
161747560|NCT00633893|584114255|FG000|Overall Study|Adverse Event|65|||
161747561|NCT00633893|584114256|FG001|Overall Study|Adverse Event|58|||
161747562|NCT00633893|584114257|FG002|Overall Study|Adverse Event|126|||
161747563|NCT00633893|584114255|FG000|Overall Study|Withdrawal by Subject|7|||
161747564|NCT00633893|584114256|FG001|Overall Study|Withdrawal by Subject|12|||
161747565|NCT00633893|584114257|FG002|Overall Study|Withdrawal by Subject|6|||
161747566|NCT00633893|584114255|FG000|Overall Study|Lost to Follow-up|2|||
161747567|NCT00633893|584114256|FG001|Overall Study|Lost to Follow-up|4|||
161747568|NCT00633893|584114257|FG002|Overall Study|Lost to Follow-up|8|||
161747569|NCT00633893|584114255|FG000|Overall Study|Poor/non-compliance|5|||
161747570|NCT00633893|584114256|FG001|Overall Study|Poor/non-compliance|12|||
161747571|NCT00633893|584114257|FG002|Overall Study|Poor/non-compliance|3|||
161747572|NCT00633893|584114255|FG000|Overall Study|Pregnancy|2|||
161747573|NCT00633893|584114256|FG001|Overall Study|Pregnancy|1|||
161747574|NCT00633893|584114257|FG002|Overall Study|Pregnancy|1|||
161747575|NCT00633893|584114255|FG000|Overall Study|Not meet/no longer meets criteria|4|||
161747576|NCT00633893|584114256|FG001|Overall Study|Not meet/no longer meets criteria|6|||
161747577|NCT00633893|584114257|FG002|Overall Study|Not meet/no longer meets criteria|4|||
161747578|NCT00633893|584114255|FG000|Overall Study|Other|28|||
161747579|NCT00633893|584114256|FG001|Overall Study|Other|33|||
161747580|NCT00633893|584114257|FG002|Overall Study|Other|31|||
161747581|NCT02741310|584114258|FG000|Overall Study|Sponsor Decision|2|||
161747582|NCT02741310|584114259|FG001|Overall Study|Sponsor Decision|2|||
161747583|NCT01784211|584114260|FG000|Part A (Days 1-15)|Adverse Event|1|||
161747584|NCT01784211|584114261|FG001|Part A (Days 1-15)|Adverse Event|1|||
161747585|NCT01784211|584114262|FG002|Part A (Days 1-15)|Adverse Event|0|||
161747586|NCT01784211|584114263|FG003|Part A (Days 1-15)|Adverse Event|0|||
161843062|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Death|0|||
161747587|NCT01784211|584114264|FG004|Part A (Days 1-15)|Adverse Event|0|||
161747588|NCT01784211|584114265|FG005|Part A (Days 1-15)|Adverse Event|0|||
161747589|NCT01784211|584114260|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
161747590|NCT01784211|584114261|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
161747591|NCT01784211|584114262|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
161843063|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Death|0|||
161747592|NCT01784211|584114263|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
161747593|NCT01784211|584114264|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
161843064|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Death|0|||
161747594|NCT01784211|584114265|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
161747595|NCT00369278|584114268|FG000|Overall Study|Adverse Event|14|||
161747596|NCT00369278|584114269|FG001|Overall Study|Adverse Event|11|||
161747597|NCT00369278|584114268|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161747598|NCT00369278|584114269|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161747599|NCT00369278|584114268|FG000|Overall Study|Protocol Violation|2|||
161747600|NCT00369278|584114269|FG001|Overall Study|Protocol Violation|1|||
161747601|NCT00369278|584114268|FG000|Overall Study|Withdrawal by Subject|2|||
161747602|NCT00369278|584114269|FG001|Overall Study|Withdrawal by Subject|2|||
161747603|NCT00369278|584114268|FG000|Overall Study|Lost to Follow-up|1|||
161747604|NCT00369278|584114269|FG001|Overall Study|Lost to Follow-up|0|||
161747605|NCT00369278|584114268|FG000|Overall Study|Graft loss|1|||
161747606|NCT00369278|584114269|FG001|Overall Study|Graft loss|2|||
161747607|NCT01017549|584114274|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
161747608|NCT01017549|584114274|FG000|One-year Follow-up|Lost to Follow-up|2|||
161747609|NCT01017549|584114274|FG000|One-year Follow-up|Withdrawal by Subject|5|||
161747610|NCT01017549|584114274|FG000|5 Year Follow-up|Lost to Follow-up|9|||
161747611|NCT01017549|584114274|FG000|5 Year Follow-up|Mastectomy|3|||
161747612|NCT01989754|584114277|FG000|Overall Study|Withdrawal by Subject|10|||
161747613|NCT01989754|584114278|FG001|Overall Study|Withdrawal by Subject|14|||
161747614|NCT01989754|584114277|FG000|Overall Study|Lost to Follow-up|28|||
161747615|NCT01989754|584114278|FG001|Overall Study|Lost to Follow-up|20|||
161747616|NCT01989754|584114277|FG000|Overall Study|Closed Site|1|||
161747617|NCT01989754|584114278|FG001|Overall Study|Closed Site|1|||
161747618|NCT03725293|584114285|FG000|Overall Study|Physician Decision|9|||
161747619|NCT03725293|584114286|FG001|Overall Study|Physician Decision|6|||
161747620|NCT03725293|584114285|FG000|Overall Study|alternative vascular access needs|1|||
161747621|NCT03725293|584114286|FG001|Overall Study|alternative vascular access needs|2|||
161747622|NCT03725293|584114285|FG000|Overall Study|venous anatomy screen failures|2|||
161747623|NCT03725293|584114286|FG001|Overall Study|venous anatomy screen failures|1|||
161747624|NCT02143141|584114287|FG000|Overall Study|pain scores at 24 hours not collected|1|||
161747625|NCT02143141|584114288|FG001|Overall Study|pain scores at 24 hours not collected|0|||
161747626|NCT01057862|584114289|FG000|Overall Study|Withdrawal by Subject|1|||
161747627|NCT01057862|584114290|FG001|Overall Study|Withdrawal by Subject|2|||
161747628|NCT03363165|584114291|FG000|3-month Follow-up|Death|0|||
161747629|NCT03363165|584114292|FG001|3-month Follow-up|Death|1|||
161747630|NCT03363165|584114291|FG000|6-month Follow-up|Death|0|||
161747631|NCT03363165|584114292|FG001|6-month Follow-up|Death|1|||
161747632|NCT03363165|584114291|FG000|6-month Follow-up|Withdrawal by Subject|1|||
161747633|NCT03363165|584114292|FG001|6-month Follow-up|Withdrawal by Subject|1|||
161747634|NCT03363165|584114291|FG000|12-month Follow-up|Death|1|||
161747635|NCT03363165|584114292|FG001|12-month Follow-up|Death|1|||
161747636|NCT03363165|584114291|FG000|12-month Follow-up|Withdrawal by Subject|1|||
161747637|NCT03363165|584114292|FG001|12-month Follow-up|Withdrawal by Subject|1|||
161747638|NCT02255760|584114293|FG000|Overall Study|Lost to Follow-up|0|||
161747639|NCT02255760|584114294|FG001|Overall Study|Lost to Follow-up|1|||
161747640|NCT02255760|584114295|FG002|Overall Study|Lost to Follow-up|0|||
161747641|NCT02255760|584114296|FG003|Overall Study|Lost to Follow-up|0|||
161747642|NCT02255760|584114297|FG004|Overall Study|Lost to Follow-up|0|||
161747643|NCT00003838|584114298|FG000|Overall Study|Death|0|||
161747644|NCT00003838|584114299|FG001|Overall Study|Death|12|||
161747645|NCT00003838|584114300|FG002|Overall Study|Death|7|||
161747646|NCT00003838|584114298|FG000|Overall Study|Lost to Follow-up|0|||
161747647|NCT00003838|584114299|FG001|Overall Study|Lost to Follow-up|1|||
161747648|NCT00003838|584114300|FG002|Overall Study|Lost to Follow-up|1|||
161747649|NCT00003838|584114298|FG000|Overall Study|Disease Progression|0|||
161747650|NCT00003838|584114299|FG001|Overall Study|Disease Progression|12|||
161747651|NCT00003838|584114300|FG002|Overall Study|Disease Progression|0|||
161747652|NCT01296698|584114301|FG000|Overall Study|Adverse Event|1|||
161747653|NCT01296698|584114302|FG001|Overall Study|Adverse Event|0|||
161747654|NCT01296698|584114301|FG000|Overall Study|Death|1|||
161747655|NCT01296698|584114302|FG001|Overall Study|Death|0|||
161747656|NCT01296698|584114301|FG000|Overall Study|Lost to Follow-up|19|||
161747657|NCT01296698|584114302|FG001|Overall Study|Lost to Follow-up|1|||
161747658|NCT01296698|584114301|FG000|Overall Study|Withdrawal by Subject|12|||
161747659|NCT01296698|584114302|FG001|Overall Study|Withdrawal by Subject|0|||
161747660|NCT01296698|584114301|FG000|Overall Study|Difficulty Contacting Subject|2|||
161747661|NCT01296698|584114302|FG001|Overall Study|Difficulty Contacting Subject|0|||
161747662|NCT01296698|584114301|FG000|Overall Study|Study Terminated by Sponsor|209|||
161747663|NCT01296698|584114302|FG001|Overall Study|Study Terminated by Sponsor|12|||
161747664|NCT03495817|584114306|FG000|26 Week Open Label|Adverse Event|3|||
161747665|NCT03495817|584114306|FG000|26 Week Open Label|Withdrawal by Subject|4|||
161747666|NCT03495817|584114306|FG000|26 Week Open Label|Lost to Follow-up|1|||
161747667|NCT03495817|584114306|FG000|26 Week Extension|Lost to Follow-up|2|||
161747668|NCT01957787|584114307|FG000|Overall Study|Death|18|||
161747669|NCT01957787|584114307|FG000|Overall Study|Lost to Follow-up|3|||
161747670|NCT01957787|584114307|FG000|Overall Study|Withdrawal by Subject|3|||
161747671|NCT01957787|584114307|FG000|Overall Study|Entered Hospice or Similar Program|2|||
161747672|NCT01957787|584114307|FG000|Overall Study|Index Tumor(s) Resected|2|||
161747673|NCT01957787|584114307|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
161747674|NCT01957787|584114307|FG000|Overall Study|Local therapy, not cryoablation|6|||
161747675|NCT01686958|584114308|FG000|Overall Study|Withdrawal by Subject|1|||
161747676|NCT04294095|584114317|FG000|Overall Study|Adverse Event|1|||
161747677|NCT04294095|584114318|FG001|Overall Study|Adverse Event|0|||
161747678|NCT02224638|584114322|FG000|Overall Study|Adverse Event|1|||
161747679|NCT02224638|584114323|FG001|Overall Study|Adverse Event|1|||
161747680|NCT01400139|584114329|FG000|HYD Core Study|Adverse Event|210|||
161747681|NCT01400139|584114329|FG000|HYD Core Study|Lack of Efficacy|59|||
161747682|NCT01400139|584114329|FG000|HYD Core Study|Withdrawal by Subject|114|||
161747683|NCT01400139|584114329|FG000|HYD Core Study|Lost to Follow-up|39|||
161747684|NCT01400139|584114329|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
161747685|NCT01400139|584114329|FG000|HYD Core Study|Administrative|56|||
161747686|NCT01400139|584114329|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
161747687|NCT01400139|584114329|FG000|HYD Extension Period|Adverse Event|8|||
161747688|NCT01400139|584114329|FG000|HYD Extension Period|Withdrawal by Subject|5|||
161747689|NCT01400139|584114329|FG000|HYD Extension Period|Administrative|10|||
161747690|NCT00631540|584114330|FG000|Overall Study|Withdrawal by Subject|5|||
161747691|NCT00631540|584114330|FG000|Overall Study|Death|4|||
161747692|NCT00631540|584114330|FG000|Overall Study|Lost to Follow-up|2|||
161747693|NCT00631540|584114330|FG000|Overall Study|Core Lab Data Unavailable|3|||
161747694|NCT00795509|584114331|FG000|Overall Study|Protocol Violation|31|||
161747695|NCT00719953|584114334|FG000|Overall Study|Adverse Event|4|||
161747696|NCT03726333|584114338|FG000|Overall Study|Progressive Disease|0|||
161747697|NCT03726333|584114339|FG001|Overall Study|Progressive Disease|0|||
161747698|NCT03726333|584114340|FG002|Overall Study|Progressive Disease|1|||
161747699|NCT03726333|584114341|FG003|Overall Study|Progressive Disease|0|||
161747700|NCT03726333|584114342|FG004|Overall Study|Progressive Disease|0|||
161747701|NCT02947022|584114343|FG000|Overall Study|Study Stopped|1|||
161747702|NCT01230749|584114344|FG000|Overall Study|Adverse Event|0|||
161747703|NCT01230749|584114345|FG001|Overall Study|Adverse Event|0|||
161747704|NCT01230749|584114346|FG002|Overall Study|Adverse Event|0|||
161747705|NCT01230749|584114347|FG003|Overall Study|Adverse Event|1|||
161747706|NCT01230749|584114344|FG000|Overall Study|Physician Decision|0|||
161747707|NCT01230749|584114345|FG001|Overall Study|Physician Decision|0|||
161747708|NCT01230749|584114346|FG002|Overall Study|Physician Decision|1|||
161747709|NCT01230749|584114347|FG003|Overall Study|Physician Decision|0|||
161747710|NCT01230749|584114344|FG000|Overall Study|Withdrawal by Subject|0|||
161747711|NCT01230749|584114345|FG001|Overall Study|Withdrawal by Subject|1|||
161747712|NCT01230749|584114346|FG002|Overall Study|Withdrawal by Subject|0|||
161747713|NCT01230749|584114347|FG003|Overall Study|Withdrawal by Subject|0|||
161747714|NCT01230749|584114344|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
161747715|NCT01230749|584114345|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161747716|NCT01230749|584114346|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161747717|NCT01230749|584114347|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161747718|NCT00959894|584116153|FG000|Overall Study|Lost to Follow-up|10|||
161747719|NCT00959894|584116153|FG000|Overall Study|Adverse Event|3|||
161747720|NCT00959894|584116153|FG000|Overall Study|Withdrawal by Subject|1|||
161747721|NCT00959894|584116153|FG000|Overall Study|Need for contraindicated medication|1|||
161747722|NCT00959894|584116153|FG000|Overall Study|Subject moved out of town|1|||
161747723|NCT00922974|584116154|FG000|Phase II Component|Protocol Violation|2|||
161747724|NCT00922974|584116155|FG001|Phase II Component|Protocol Violation|0|||
161747725|NCT00922974|584116154|FG000|Phase II Component|Not evaluable for treatment review|5|||
161747726|NCT00922974|584116155|FG001|Phase II Component|Not evaluable for treatment review|0|||
161747727|NCT00922974|584116154|FG000|Phase III Component|Protocol Violation|8|||
161747728|NCT00922974|584116155|FG001|Phase III Component|Protocol Violation|6|||
161747729|NCT03682055|584116156|FG000|Overall Study|Lack of Efficacy|1|||
161747730|NCT03682055|584116157|FG001|Overall Study|Lack of Efficacy|2|||
161747731|NCT03682055|584116158|FG002|Overall Study|Lack of Efficacy|1|||
161747732|NCT03682055|584116159|FG003|Overall Study|Lack of Efficacy|2|||
161747733|NCT03682055|584116160|FG004|Overall Study|Lack of Efficacy|1|||
161747734|NCT03682055|584116161|FG005|Overall Study|Lack of Efficacy|3|||
161747735|NCT03682055|584116156|FG000|Overall Study|Withdrawal by Subject|0|||
161747736|NCT03682055|584116157|FG001|Overall Study|Withdrawal by Subject|0|||
161747737|NCT03682055|584116158|FG002|Overall Study|Withdrawal by Subject|0|||
161747738|NCT03682055|584116159|FG003|Overall Study|Withdrawal by Subject|0|||
161747739|NCT03682055|584116160|FG004|Overall Study|Withdrawal by Subject|0|||
161747740|NCT03682055|584116161|FG005|Overall Study|Withdrawal by Subject|1|||
161747741|NCT03682055|584116156|FG000|Overall Study|Termination of Study by Sponsor|0|||
161747742|NCT03682055|584116157|FG001|Overall Study|Termination of Study by Sponsor|0|||
161747743|NCT03682055|584116158|FG002|Overall Study|Termination of Study by Sponsor|0|||
161747744|NCT03682055|584116159|FG003|Overall Study|Termination of Study by Sponsor|0|||
161747745|NCT03682055|584116160|FG004|Overall Study|Termination of Study by Sponsor|0|||
161747746|NCT03682055|584116161|FG005|Overall Study|Termination of Study by Sponsor|3|||
161747747|NCT00191386|584116162|FG000|Overall Study|Adverse Event|16|||
161747748|NCT00191386|584116162|FG000|Overall Study|Lost to Follow-up|1|||
161747749|NCT00191386|584116162|FG000|Overall Study|Entry Criteria Exclusion|3|||
161747750|NCT00191386|584116162|FG000|Overall Study|Protocol Violation|18|||
161747751|NCT00191386|584116162|FG000|Overall Study|Withdrawal by Subject|96|||
161747752|NCT00191386|584116162|FG000|Overall Study|Physician Decision|11|||
161747753|NCT00191386|584116162|FG000|Overall Study|Lack of Efficacy|15|||
161747754|NCT03077243|584116164|FG000|Overall Study|Death|1|||
161747755|NCT03077243|584116165|FG001|Overall Study|Death|2|||
161747756|NCT03077243|584116166|FG002|Overall Study|Death|0|||
161747757|NCT03077243|584116167|FG003|Overall Study|Death|0|||
161747758|NCT03077243|584116164|FG000|Overall Study|Withdrawal by Subject|1|||
161747759|NCT03077243|584116165|FG001|Overall Study|Withdrawal by Subject|3|||
161747760|NCT03077243|584116166|FG002|Overall Study|Withdrawal by Subject|0|||
161747761|NCT03077243|584116167|FG003|Overall Study|Withdrawal by Subject|0|||
161747762|NCT03077243|584116164|FG000|Overall Study|Physician Decision|1|||
161747763|NCT03077243|584116165|FG001|Overall Study|Physician Decision|0|||
161747764|NCT03077243|584116166|FG002|Overall Study|Physician Decision|0|||
161747765|NCT03077243|584116167|FG003|Overall Study|Physician Decision|0|||
161747766|NCT03077243|584116164|FG000|Overall Study|Research at two study sites terminated early|0|||
161747767|NCT03077243|584116165|FG001|Overall Study|Research at two study sites terminated early|0|||
161747768|NCT03077243|584116166|FG002|Overall Study|Research at two study sites terminated early|0|||
161747769|NCT03077243|584116167|FG003|Overall Study|Research at two study sites terminated early|69|||
161747770|NCT01544478|584116168|FG000|Overall Study|Adverse Event|1|||
161747771|NCT01544478|584116168|FG000|Overall Study|Death|1|||
161747772|NCT01544478|584116168|FG000|Overall Study|Lost to Follow-up|48|||
161747773|NCT01544478|584116168|FG000|Overall Study|Physician Decision|15|||
161747774|NCT01544478|584116168|FG000|Overall Study|Pregnancy|1|||
161747775|NCT01544478|584116168|FG000|Overall Study|Withdrawal by Subject|52|||
161747776|NCT00212758|584116169|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
161747777|NCT00212758|584116170|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
161747778|NCT00212758|584116169|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
161747779|NCT00212758|584116170|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
161747780|NCT02574481|584116171|FG000|Overall Study|Withdrawal by Subject|29|||
161747781|NCT02574481|584116172|FG001|Overall Study|Withdrawal by Subject|15|||
161747782|NCT02574481|584116173|FG002|Overall Study|Withdrawal by Subject|4|||
161747783|NCT02574481|584116174|FG003|Overall Study|Withdrawal by Subject|1|||
161747784|NCT02574481|584116171|FG000|Overall Study|Adverse Event|5|||
161747785|NCT02574481|584116172|FG001|Overall Study|Adverse Event|1|||
161747786|NCT02574481|584116173|FG002|Overall Study|Adverse Event|1|||
161747787|NCT02574481|584116174|FG003|Overall Study|Adverse Event|0|||
161747788|NCT02574481|584116171|FG000|Overall Study|Visit Missed|15|||
161747789|NCT02574481|584116172|FG001|Overall Study|Visit Missed|7|||
161747790|NCT02574481|584116173|FG002|Overall Study|Visit Missed|5|||
161747791|NCT02574481|584116174|FG003|Overall Study|Visit Missed|0|||
161747792|NCT02574481|584116171|FG000|Overall Study|Other|7|||
161747793|NCT02574481|584116172|FG001|Overall Study|Other|2|||
161747794|NCT02574481|584116173|FG002|Overall Study|Other|0|||
161747795|NCT02574481|584116174|FG003|Overall Study|Other|0|||
161747796|NCT02574481|584116171|FG000|Overall Study|Death|48|||
161747797|NCT02574481|584116172|FG001|Overall Study|Death|26|||
161747798|NCT02574481|584116173|FG002|Overall Study|Death|12|||
161747799|NCT02574481|584116174|FG003|Overall Study|Death|4|||
161843065|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Death|0|||
161843066|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Death|0|||
161843067|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Death|0|||
161843068|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Death|0|||
161843069|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Death|1|||
161843070|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Death|7|||
161843071|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Death|5|||
161843072|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Death|5|||
161843073|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Death|3|||
161843074|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Death|7|||
161843075|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Death|5|||
161843076|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Death|6|||
161843077|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Death|3|||
161843078|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Death|0|||
161843079|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843080|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843081|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843082|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843083|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843084|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843085|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843086|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843087|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843088|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843089|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843090|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843091|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843092|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843093|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843094|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843095|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843096|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843097|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843098|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843099|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843100|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843101|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843102|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
161843103|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843104|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Disease Progression|0|||
161843105|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Disease Progression|0|||
161843106|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Disease Progression|0|||
161843107|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Disease Progression|0|||
161843108|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Disease Progression|0|||
161843109|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Disease Progression|0|||
161843110|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Disease Progression|0|||
161843111|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Disease Progression|0|||
161843112|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Disease Progression|0|||
161843113|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Disease Progression|0|||
161843114|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Disease Progression|0|||
161843115|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Disease Progression|0|||
161747800|NCT02574481|584116171|FG000|Overall Study|Physician Decision|5|||
161747801|NCT02574481|584116172|FG001|Overall Study|Physician Decision|2|||
161747802|NCT02574481|584116173|FG002|Overall Study|Physician Decision|0|||
161747803|NCT02574481|584116174|FG003|Overall Study|Physician Decision|0|||
161747804|NCT02574481|584116171|FG000|Overall Study|Lost to Follow-up|5|||
161747805|NCT02574481|584116172|FG001|Overall Study|Lost to Follow-up|1|||
161747806|NCT02574481|584116173|FG002|Overall Study|Lost to Follow-up|3|||
161747807|NCT02574481|584116174|FG003|Overall Study|Lost to Follow-up|0|||
161747808|NCT00446641|584116178|FG000|Overall Study|Withdrawal by Subject|8|||
161747809|NCT00446641|584116179|FG001|Overall Study|Withdrawal by Subject|3|||
161747810|NCT00446641|584116178|FG000|Overall Study|poor compliance|8|||
161747811|NCT00446641|584116179|FG001|Overall Study|poor compliance|6|||
161747812|NCT00446641|584116178|FG000|Overall Study|Lost to Follow-up|1|||
161747813|NCT00446641|584116179|FG001|Overall Study|Lost to Follow-up|1|||
161843116|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Disease Progression|0|||
161843117|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Disease Progression|0|||
161843118|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Disease Progression|0|||
161843119|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Disease Progression|0|||
161843120|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Disease Progression|0|||
161747814|NCT01826448|584116181|FG000|Overall Study|Adverse Event|1|||
161747815|NCT01826448|584116182|FG001|Overall Study|Adverse Event|3|||
161747816|NCT01826448|584116181|FG000|Overall Study|Disease progression|2|||
161747817|NCT01826448|584116182|FG001|Overall Study|Disease progression|4|||
161747818|NCT01826448|584116181|FG000|Overall Study|Withdrawal by Subject|1|||
161747819|NCT01826448|584116182|FG001|Overall Study|Withdrawal by Subject|0|||
161747820|NCT01826448|584116181|FG000|Overall Study|Physician Decision|0|||
161747821|NCT01826448|584116182|FG001|Overall Study|Physician Decision|1|||
161747822|NCT01826448|584116181|FG000|Overall Study|2 active cancers|0|||
161747823|NCT01826448|584116182|FG001|Overall Study|2 active cancers|1|||
161747824|NCT02038790|584116187|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
161747825|NCT02038790|584116188|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
161747826|NCT00784459|584116190|FG000|Overall Study|Adverse Event|0|||
161747827|NCT00784459|584116191|FG001|Overall Study|Adverse Event|2|||
161747828|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
161747829|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747830|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747831|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747832|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747833|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747834|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747835|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
161747836|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747837|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747838|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747839|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747840|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747841|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
161747842|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
161747843|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747844|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747845|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747846|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747847|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747848|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
161747849|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
161747850|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747851|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747852|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747853|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747854|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747855|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
161747856|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
161747857|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747858|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747859|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747860|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747861|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747862|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747863|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747864|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
161747865|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
161747866|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747867|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747868|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747869|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747870|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747871|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
161747872|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
161747873|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747874|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747875|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747876|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747877|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747878|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
161747879|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
161747880|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747881|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747882|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747883|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747884|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747885|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
161747886|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747887|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747888|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747889|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747890|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747891|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
161747892|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
161747893|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
161747894|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
161747895|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
161747896|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
161747897|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
161747898|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747899|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747900|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
161747901|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747902|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747903|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747904|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747905|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747906|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747907|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747908|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
161747909|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
161747910|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747911|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747912|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747913|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747914|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747915|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
161747916|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747917|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
161747918|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747919|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747920|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747921|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747922|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
161747923|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
161747924|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
161747925|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747926|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
161747927|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
161747928|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
161747929|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
161747930|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
161747931|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
161747932|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
161747933|NCT01376388|584116213|FG000|Overall Study|Adverse Event|13|||
161747934|NCT01376388|584116213|FG000|Overall Study|Lack of Efficacy|2|||
161747935|NCT01376388|584116213|FG000|Overall Study|Withdrawal by Subject|3|||
161747936|NCT02009930|584116214|FG000|Overall Study|withdrawn|5|||
161747937|NCT00425113|584116226|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
161747938|NCT00425113|584116227|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
161747939|NCT00425113|584116226|FG000|Overall Study|diagnosis of abdominal TB|0|||
161747940|NCT00425113|584116227|FG001|Overall Study|diagnosis of abdominal TB|1|||
161747941|NCT00425113|584116226|FG000|Overall Study|missing study drug more than 14 days|0|||
161747942|NCT00425113|584116227|FG001|Overall Study|missing study drug more than 14 days|1|||
161747943|NCT00425113|584116226|FG000|Overall Study|Withdrawal by Subject|1|||
161747944|NCT00425113|584116227|FG001|Overall Study|Withdrawal by Subject|0|||
161747945|NCT00879437|584116228|FG000|Overall Study|Protocol Violation|0|||
161747946|NCT00879437|584116229|FG001|Overall Study|Protocol Violation|1|||
161747947|NCT00879437|584116228|FG000|Overall Study|Death|1|||
161747948|NCT00879437|584116229|FG001|Overall Study|Death|0|||
161747949|NCT02920450|584116230|FG000|Overall Study|Death|1|||
161747950|NCT02920450|584116231|FG001|Overall Study|Death|0|||
161747951|NCT02920450|584116232|FG002|Overall Study|Death|0|||
161747952|NCT02920450|584116233|FG003|Overall Study|Death|0|||
161747953|NCT02920450|584116230|FG000|Overall Study|Withdrawal by Subject|1|||
161747954|NCT02920450|584116231|FG001|Overall Study|Withdrawal by Subject|0|||
161747955|NCT02920450|584116232|FG002|Overall Study|Withdrawal by Subject|0|||
161747956|NCT02920450|584116233|FG003|Overall Study|Withdrawal by Subject|0|||
161747957|NCT00291187|584116234|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
161747958|NCT00291187|584116235|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
161747959|NCT00291187|584116236|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
161747960|NCT00291187|584116237|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
161747961|NCT02023268|584116238|FG000|Overall Study|Lack of Efficacy|0|||
161747962|NCT02023268|584116239|FG001|Overall Study|Lack of Efficacy|1|||
161747963|NCT02023268|584116238|FG000|Overall Study|Adverse Event|0|||
161747964|NCT02023268|584116239|FG001|Overall Study|Adverse Event|2|||
161747965|NCT02023268|584116238|FG000|Overall Study|Withdrawal by Subject|0|||
161747966|NCT02023268|584116239|FG001|Overall Study|Withdrawal by Subject|1|||
161747967|NCT00126672|584116241|FG000|Overall Study|Adverse Event|4|||
161747968|NCT00126672|584116241|FG000|Overall Study|Lost to Follow-up|4|||
161747969|NCT01001234|584116243|FG000|Overall Study|Withdrawal by Subject|2|||
161747970|NCT01001234|584116244|FG001|Overall Study|Withdrawal by Subject|0|||
161747971|NCT01001234|584116245|FG002|Overall Study|Withdrawal by Subject|3|||
161747972|NCT01001234|584116246|FG003|Overall Study|Withdrawal by Subject|0|||
161747973|NCT01001234|584116247|FG004|Overall Study|Withdrawal by Subject|0|||
161747974|NCT01001234|584116243|FG000|Overall Study|Protocol Violation|34|||
161747975|NCT01001234|584116244|FG001|Overall Study|Protocol Violation|3|||
161747976|NCT01001234|584116245|FG002|Overall Study|Protocol Violation|19|||
161747977|NCT01001234|584116246|FG003|Overall Study|Protocol Violation|18|||
161747978|NCT01001234|584116247|FG004|Overall Study|Protocol Violation|0|||
161747979|NCT01001234|584116243|FG000|Overall Study|Lost to Follow-up|0|||
161747980|NCT01001234|584116244|FG001|Overall Study|Lost to Follow-up|0|||
161747981|NCT01001234|584116245|FG002|Overall Study|Lost to Follow-up|1|||
161747982|NCT01001234|584116246|FG003|Overall Study|Lost to Follow-up|2|||
161747983|NCT01001234|584116247|FG004|Overall Study|Lost to Follow-up|0|||
161747984|NCT01001234|584116243|FG000|Overall Study|Physician Decision|1|||
161747985|NCT01001234|584116244|FG001|Overall Study|Physician Decision|0|||
161747986|NCT01001234|584116245|FG002|Overall Study|Physician Decision|0|||
161747987|NCT01001234|584116246|FG003|Overall Study|Physician Decision|0|||
161747988|NCT01001234|584116247|FG004|Overall Study|Physician Decision|0|||
161747989|NCT01001234|584116243|FG000|Overall Study|Not Treated: Adverse Event|1|||
161747990|NCT01001234|584116244|FG001|Overall Study|Not Treated: Adverse Event|0|||
161747991|NCT01001234|584116245|FG002|Overall Study|Not Treated: Adverse Event|0|||
161747992|NCT01001234|584116246|FG003|Overall Study|Not Treated: Adverse Event|0|||
161747993|NCT01001234|584116247|FG004|Overall Study|Not Treated: Adverse Event|0|||
161747994|NCT01001234|584116243|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
161747995|NCT01001234|584116244|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
161747996|NCT01001234|584116245|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
161747997|NCT01001234|584116246|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
161843121|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Disease Progression|0|||
161747998|NCT01001234|584116247|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
161747999|NCT01001234|584116243|FG000|Overall Study|Not Treated: Protocol Violation|3|||
161748000|NCT01001234|584116244|FG001|Overall Study|Not Treated: Protocol Violation|0|||
161748001|NCT01001234|584116245|FG002|Overall Study|Not Treated: Protocol Violation|0|||
161748002|NCT01001234|584116246|FG003|Overall Study|Not Treated: Protocol Violation|0|||
161748003|NCT01001234|584116247|FG004|Overall Study|Not Treated: Protocol Violation|0|||
161748004|NCT01001234|584116243|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
161748005|NCT01001234|584116244|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
161748006|NCT01001234|584116245|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
161748007|NCT01001234|584116246|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
161748008|NCT01001234|584116247|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
161748009|NCT01001234|584116243|FG000|Overall Study|Not Treated: Pregnancy|3|||
161748010|NCT01001234|584116244|FG001|Overall Study|Not Treated: Pregnancy|0|||
161748011|NCT01001234|584116245|FG002|Overall Study|Not Treated: Pregnancy|0|||
161748012|NCT01001234|584116246|FG003|Overall Study|Not Treated: Pregnancy|0|||
161748013|NCT01001234|584116247|FG004|Overall Study|Not Treated: Pregnancy|0|||
161748014|NCT01001234|584116243|FG000|Overall Study|Not Treated: Physician Decision|37|||
161748015|NCT01001234|584116244|FG001|Overall Study|Not Treated: Physician Decision|4|||
161748016|NCT01001234|584116245|FG002|Overall Study|Not Treated: Physician Decision|0|||
161748017|NCT01001234|584116246|FG003|Overall Study|Not Treated: Physician Decision|0|||
161748018|NCT01001234|584116247|FG004|Overall Study|Not Treated: Physician Decision|0|||
161748019|NCT01001234|584116243|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
161748020|NCT01001234|584116244|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
161748021|NCT01001234|584116245|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161748022|NCT01001234|584116246|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161748023|NCT01001234|584116247|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161748024|NCT02475629|584116253|FG000|Overall Study|Adverse Event|1|||
161748025|NCT02475629|584116253|FG000|Overall Study|Death|4|||
161748026|NCT02475629|584116253|FG000|Overall Study|Physician Decision|1|||
161748027|NCT02475629|584116253|FG000|Overall Study|Withdrawal by Subject|1|||
161748028|NCT02475629|584116253|FG000|Overall Study|Lost to Follow-up|1|||
161748029|NCT02475629|584116253|FG000|Overall Study|Subject non-compliance|1|||
161748030|NCT03379376|584116254|FG000|Overall Study|Lost to Follow-up|2|||
161748031|NCT03379376|584116254|FG000|Overall Study|Did not wish to complete follow up|1|||
161748032|NCT03379376|584116254|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
161748033|NCT03379376|584116254|FG000|Overall Study|Death|1|||
161748034|NCT01611298|584116255|FG000|Overall Study|Relapsed|2|||
161748035|NCT03238352|584116256|FG000|Overall Study|Lost to Follow-up|0|||
161748036|NCT03238352|584116257|FG001|Overall Study|Lost to Follow-up|2|||
161748037|NCT03238352|584116258|FG002|Overall Study|Lost to Follow-up|1|||
161748038|NCT03238352|584116256|FG000|Overall Study|Withdrawal by Subject|0|||
161748039|NCT03238352|584116257|FG001|Overall Study|Withdrawal by Subject|1|||
161748040|NCT03238352|584116258|FG002|Overall Study|Withdrawal by Subject|0|||
161748041|NCT00928512|584116259|FG000|Overall Study|Adverse Event|4|||
161748042|NCT00928512|584116260|FG001|Overall Study|Adverse Event|3|||
161748043|NCT00928512|584116261|FG002|Overall Study|Adverse Event|2|||
161748044|NCT00928512|584116262|FG003|Overall Study|Adverse Event|8|||
161748045|NCT00928512|584116263|FG004|Overall Study|Adverse Event|6|||
161748046|NCT00928512|584116259|FG000|Overall Study|Lack of Efficacy|2|||
161748047|NCT00928512|584116260|FG001|Overall Study|Lack of Efficacy|0|||
161748048|NCT00928512|584116261|FG002|Overall Study|Lack of Efficacy|4|||
161748049|NCT00928512|584116262|FG003|Overall Study|Lack of Efficacy|7|||
161748050|NCT00928512|584116263|FG004|Overall Study|Lack of Efficacy|3|||
161748051|NCT00928512|584116259|FG000|Overall Study|Protocol Violation|0|||
161748052|NCT00928512|584116260|FG001|Overall Study|Protocol Violation|1|||
161748053|NCT00928512|584116261|FG002|Overall Study|Protocol Violation|0|||
161748054|NCT00928512|584116262|FG003|Overall Study|Protocol Violation|1|||
161748055|NCT00928512|584116263|FG004|Overall Study|Protocol Violation|3|||
161748056|NCT00928512|584116259|FG000|Overall Study|Withdrawal by Subject|3|||
161748057|NCT00928512|584116260|FG001|Overall Study|Withdrawal by Subject|0|||
161748058|NCT00928512|584116261|FG002|Overall Study|Withdrawal by Subject|3|||
161748059|NCT00928512|584116262|FG003|Overall Study|Withdrawal by Subject|4|||
161748060|NCT00928512|584116263|FG004|Overall Study|Withdrawal by Subject|0|||
161748061|NCT00928512|584116259|FG000|Overall Study|Lost to Follow-up|1|||
161748062|NCT00928512|584116260|FG001|Overall Study|Lost to Follow-up|1|||
161748063|NCT00928512|584116261|FG002|Overall Study|Lost to Follow-up|2|||
161748064|NCT00928512|584116262|FG003|Overall Study|Lost to Follow-up|1|||
161748065|NCT00928512|584116263|FG004|Overall Study|Lost to Follow-up|3|||
161748066|NCT00928512|584116259|FG000|Overall Study|Administrative Problems|0|||
161748067|NCT00928512|584116260|FG001|Overall Study|Administrative Problems|1|||
161748068|NCT00928512|584116261|FG002|Overall Study|Administrative Problems|0|||
161748069|NCT00928512|584116262|FG003|Overall Study|Administrative Problems|0|||
161748070|NCT00928512|584116263|FG004|Overall Study|Administrative Problems|0|||
161748071|NCT01963780|584116264|FG000|Overall Study|Death|7|||
161748072|NCT04153929|584116265|FG000|Overall Study|Other than listed|2|||
161748073|NCT04153929|584116266|FG001|Overall Study|Other than listed|2|||
161748074|NCT04153929|584116267|FG002|Overall Study|Other than listed|0|||
161748075|NCT04153929|584116268|FG003|Overall Study|Other than listed|1|||
161748076|NCT04153929|584116269|FG004|Overall Study|Other than listed|0|||
161748077|NCT04153929|584116270|FG005|Overall Study|Other than listed|2|||
161748078|NCT04153929|584116271|FG006|Overall Study|Other than listed|2|||
161748079|NCT04153929|584116272|FG007|Overall Study|Other than listed|1|||
161748080|NCT04153929|584116265|FG000|Overall Study|Lost to Follow-up|2|||
161748081|NCT04153929|584116266|FG001|Overall Study|Lost to Follow-up|1|||
161748082|NCT04153929|584116267|FG002|Overall Study|Lost to Follow-up|0|||
161748083|NCT04153929|584116268|FG003|Overall Study|Lost to Follow-up|1|||
161748084|NCT04153929|584116269|FG004|Overall Study|Lost to Follow-up|1|||
161748085|NCT04153929|584116270|FG005|Overall Study|Lost to Follow-up|0|||
161748086|NCT04153929|584116271|FG006|Overall Study|Lost to Follow-up|0|||
161748087|NCT04153929|584116272|FG007|Overall Study|Lost to Follow-up|0|||
161748088|NCT04153929|584116265|FG000|Overall Study|Withdrawal by Subject|3|||
161748089|NCT04153929|584116266|FG001|Overall Study|Withdrawal by Subject|1|||
161748090|NCT04153929|584116267|FG002|Overall Study|Withdrawal by Subject|0|||
161748091|NCT04153929|584116268|FG003|Overall Study|Withdrawal by Subject|3|||
161748092|NCT04153929|584116269|FG004|Overall Study|Withdrawal by Subject|1|||
161748093|NCT04153929|584116270|FG005|Overall Study|Withdrawal by Subject|0|||
161748094|NCT04153929|584116271|FG006|Overall Study|Withdrawal by Subject|1|||
161748095|NCT04153929|584116272|FG007|Overall Study|Withdrawal by Subject|0|||
161748096|NCT04153929|584116265|FG000|Overall Study|Protocol Violation|0|||
161748097|NCT04153929|584116266|FG001|Overall Study|Protocol Violation|0|||
161748098|NCT04153929|584116267|FG002|Overall Study|Protocol Violation|0|||
161748099|NCT04153929|584116268|FG003|Overall Study|Protocol Violation|0|||
161748100|NCT04153929|584116269|FG004|Overall Study|Protocol Violation|0|||
161748101|NCT04153929|584116270|FG005|Overall Study|Protocol Violation|0|||
161748102|NCT04153929|584116271|FG006|Overall Study|Protocol Violation|1|||
161748103|NCT04153929|584116272|FG007|Overall Study|Protocol Violation|2|||
161748104|NCT04153929|584116265|FG000|Overall Study|Adverse Event|3|||
161748105|NCT04153929|584116266|FG001|Overall Study|Adverse Event|5|||
161748106|NCT04153929|584116267|FG002|Overall Study|Adverse Event|5|||
161748107|NCT04153929|584116268|FG003|Overall Study|Adverse Event|11|||
161748108|NCT04153929|584116269|FG004|Overall Study|Adverse Event|15|||
161748109|NCT04153929|584116270|FG005|Overall Study|Adverse Event|4|||
161748110|NCT04153929|584116271|FG006|Overall Study|Adverse Event|8|||
161748111|NCT04153929|584116272|FG007|Overall Study|Adverse Event|2|||
161748112|NCT04153929|584116265|FG000|Overall Study|Not treated|1|||
161748113|NCT04153929|584116266|FG001|Overall Study|Not treated|0|||
161748114|NCT04153929|584116267|FG002|Overall Study|Not treated|0|||
161748115|NCT04153929|584116268|FG003|Overall Study|Not treated|0|||
161748116|NCT04153929|584116269|FG004|Overall Study|Not treated|0|||
161748117|NCT04153929|584116270|FG005|Overall Study|Not treated|0|||
161748118|NCT04153929|584116271|FG006|Overall Study|Not treated|1|||
161748119|NCT04153929|584116272|FG007|Overall Study|Not treated|0|||
161748120|NCT04083794|584116273|FG000|Overall Study|Lost to Follow-up|9|||
161748121|NCT03383614|584116274|FG000|Overall Study|Withdrawal by Subject|0|||
161748122|NCT03383614|584116275|FG001|Overall Study|Withdrawal by Subject|1|||
161748123|NCT03383614|584116276|FG002|Overall Study|Withdrawal by Subject|0|||
161748124|NCT03383614|584116277|FG003|Overall Study|Withdrawal by Subject|0|||
161748125|NCT03595384|584116280|FG000|Overall Study|Other time commitments|8|||
161748126|NCT03595384|584116280|FG000|Overall Study|Changes to session time|7|||
161748127|NCT03595384|584116280|FG000|Overall Study|Relocation out of country|1|||
161748128|NCT03803202|584116281|FG000|Overall Study|Other|0|||
161748129|NCT03803202|584116282|FG001|Overall Study|Other|1|||
161748130|NCT03803202|584116283|FG002|Overall Study|Other|0|||
161748131|NCT03803202|584116284|FG003|Overall Study|Other|0|||
161748132|NCT03803202|584116285|FG004|Overall Study|Other|0|||
161748133|NCT03803202|584116286|FG005|Overall Study|Other|0|||
161748134|NCT03803202|584116287|FG006|Overall Study|Other|0|||
161748135|NCT03803202|584116288|FG007|Overall Study|Other|0|||
161748136|NCT03803202|584116289|FG008|Overall Study|Other|0|||
161748137|NCT03803202|584116281|FG000|Overall Study|Death|0|||
161748138|NCT03803202|584116282|FG001|Overall Study|Death|0|||
161748139|NCT03803202|584116283|FG002|Overall Study|Death|0|||
161748140|NCT03803202|584116284|FG003|Overall Study|Death|0|||
161748141|NCT03803202|584116285|FG004|Overall Study|Death|0|||
161748142|NCT03803202|584116286|FG005|Overall Study|Death|1|||
161748143|NCT03803202|584116287|FG006|Overall Study|Death|0|||
161748144|NCT03803202|584116288|FG007|Overall Study|Death|0|||
161748145|NCT03803202|584116289|FG008|Overall Study|Death|0|||
161748146|NCT03803202|584116281|FG000|Overall Study|Withdrawal by Subject|0|||
161748147|NCT03803202|584116282|FG001|Overall Study|Withdrawal by Subject|0|||
161748148|NCT03803202|584116283|FG002|Overall Study|Withdrawal by Subject|1|||
161748149|NCT03803202|584116284|FG003|Overall Study|Withdrawal by Subject|0|||
161748150|NCT03803202|584116285|FG004|Overall Study|Withdrawal by Subject|0|||
161748151|NCT03803202|584116286|FG005|Overall Study|Withdrawal by Subject|0|||
161748152|NCT03803202|584116287|FG006|Overall Study|Withdrawal by Subject|0|||
161748153|NCT03803202|584116288|FG007|Overall Study|Withdrawal by Subject|1|||
161748154|NCT03803202|584116289|FG008|Overall Study|Withdrawal by Subject|0|||
161748155|NCT03803202|584116281|FG000|Overall Study|Lost to Follow-up|0|||
161748156|NCT03803202|584116282|FG001|Overall Study|Lost to Follow-up|0|||
161748157|NCT03803202|584116283|FG002|Overall Study|Lost to Follow-up|0|||
161748158|NCT03803202|584116284|FG003|Overall Study|Lost to Follow-up|1|||
161748159|NCT03803202|584116285|FG004|Overall Study|Lost to Follow-up|1|||
161748160|NCT03803202|584116286|FG005|Overall Study|Lost to Follow-up|0|||
161748161|NCT03803202|584116287|FG006|Overall Study|Lost to Follow-up|1|||
161748162|NCT03803202|584116288|FG007|Overall Study|Lost to Follow-up|0|||
161748163|NCT03803202|584116289|FG008|Overall Study|Lost to Follow-up|0|||
161748164|NCT00293241|584116290|FG000|Overall Study|Lost to Follow-up|9|||
161748165|NCT00293241|584116291|FG001|Overall Study|Lost to Follow-up|16|||
161748166|NCT00293241|584116290|FG000|Overall Study|Physician Decision|23|||
161748167|NCT00293241|584116291|FG001|Overall Study|Physician Decision|17|||
161748168|NCT00293241|584116290|FG000|Overall Study|Withdrawal by Subject|4|||
161748169|NCT00293241|584116291|FG001|Overall Study|Withdrawal by Subject|8|||
161748170|NCT01125293|584116292|FG000|Overall Study|Disease Progression|1|||
161748171|NCT01125293|584116293|FG001|Overall Study|Disease Progression|3|||
161748172|NCT01125293|584116294|FG002|Overall Study|Disease Progression|4|||
161748173|NCT01125293|584116295|FG003|Overall Study|Disease Progression|3|||
161748174|NCT01125293|584116296|FG004|Overall Study|Disease Progression|5|||
161748175|NCT01125293|584116297|FG005|Overall Study|Disease Progression|12|||
161748176|NCT01125293|584116292|FG000|Overall Study|Adverse Event|1|||
161748177|NCT01125293|584116293|FG001|Overall Study|Adverse Event|0|||
161748178|NCT01125293|584116294|FG002|Overall Study|Adverse Event|0|||
161748179|NCT01125293|584116295|FG003|Overall Study|Adverse Event|0|||
161748180|NCT01125293|584116296|FG004|Overall Study|Adverse Event|2|||
161748181|NCT01125293|584116297|FG005|Overall Study|Adverse Event|8|||
161748182|NCT01125293|584116292|FG000|Overall Study|Symptomatic Deterioration|1|||
161748183|NCT01125293|584116293|FG001|Overall Study|Symptomatic Deterioration|0|||
161748184|NCT01125293|584116294|FG002|Overall Study|Symptomatic Deterioration|0|||
161748185|NCT01125293|584116295|FG003|Overall Study|Symptomatic Deterioration|0|||
161748186|NCT01125293|584116296|FG004|Overall Study|Symptomatic Deterioration|0|||
161748187|NCT01125293|584116297|FG005|Overall Study|Symptomatic Deterioration|0|||
161748188|NCT01125293|584116292|FG000|Overall Study|Death|0|||
161748189|NCT01125293|584116293|FG001|Overall Study|Death|0|||
161748190|NCT01125293|584116294|FG002|Overall Study|Death|0|||
161748191|NCT01125293|584116295|FG003|Overall Study|Death|0|||
161748192|NCT01125293|584116296|FG004|Overall Study|Death|1|||
161748193|NCT01125293|584116297|FG005|Overall Study|Death|0|||
161748194|NCT01125293|584116292|FG000|Overall Study|Withdrawal by Subject|0|||
161748195|NCT01125293|584116293|FG001|Overall Study|Withdrawal by Subject|0|||
161748196|NCT01125293|584116294|FG002|Overall Study|Withdrawal by Subject|0|||
161748197|NCT01125293|584116295|FG003|Overall Study|Withdrawal by Subject|0|||
161748198|NCT01125293|584116296|FG004|Overall Study|Withdrawal by Subject|2|||
161748199|NCT01125293|584116297|FG005|Overall Study|Withdrawal by Subject|1|||
161748200|NCT01125293|584116292|FG000|Overall Study|Physician Decision|0|||
161748201|NCT01125293|584116293|FG001|Overall Study|Physician Decision|0|||
161748202|NCT01125293|584116294|FG002|Overall Study|Physician Decision|0|||
161748203|NCT01125293|584116295|FG003|Overall Study|Physician Decision|0|||
161748204|NCT01125293|584116296|FG004|Overall Study|Physician Decision|0|||
161748205|NCT01125293|584116297|FG005|Overall Study|Physician Decision|2|||
161748206|NCT01270958|584116298|FG000|Overall Study|Lost to Follow-up|2|||
161748207|NCT01270958|584116298|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
161748208|NCT01406652|584116301|FG000|Overall Study|Lost-to-follow-up|3|||
161748209|NCT01406652|584116302|FG001|Overall Study|Lost-to-follow-up|4|||
161748210|NCT01406652|584116301|FG000|Overall Study|Withdrawal by Subject|2|||
161748211|NCT01406652|584116302|FG001|Overall Study|Withdrawal by Subject|2|||
161748212|NCT01406652|584116301|FG000|Overall Study|Insufficient follow-up|5|||
161748213|NCT01406652|584116302|FG001|Overall Study|Insufficient follow-up|4|||
161748214|NCT01406652|584116301|FG000|Overall Study|Infection not sure|10|||
161748215|NCT01406652|584116302|FG001|Overall Study|Infection not sure|10|||
161748216|NCT00260429|584116305|FG000|Overall Study|failure to follow appointments|1|||
161748217|NCT00260429|584116306|FG001|Overall Study|failure to follow appointments|0|||
161748218|NCT00260429|584116305|FG000|Overall Study|scheduled hand surgery|1|||
161748219|NCT00260429|584116306|FG001|Overall Study|scheduled hand surgery|0|||
161748220|NCT00659126|584116307|FG000|Overall Study|Adverse Event|2|||
161748221|NCT00659126|584116308|FG001|Overall Study|Adverse Event|2|||
161748222|NCT00659126|584116307|FG000|Overall Study|Screen failure|1|||
161748223|NCT00659126|584116308|FG001|Overall Study|Screen failure|1|||
161748224|NCT00659126|584116307|FG000|Overall Study|Technical problems with MRI|0|||
161748225|NCT00659126|584116308|FG001|Overall Study|Technical problems with MRI|1|||
161748226|NCT02228564|584116312|FG000|Overall Study|Withdrawal by Subject|10|||
161748227|NCT02228564|584116312|FG000|Overall Study|Death|11|||
161748228|NCT02228564|584116312|FG000|Overall Study|Physician Decision|5|||
161748229|NCT02228564|584116312|FG000|Overall Study|Lost to Follow-up|17|||
161748230|NCT02228564|584116312|FG000|Overall Study|Other|6|||
161748231|NCT02633046|584116313|FG000|Overall Study|Adverse Event|8|||
161748232|NCT02633046|584116313|FG000|Overall Study|Physician Decision|7|||
161748233|NCT02633046|584116313|FG000|Overall Study|Withdrawal by Subject|8|||
161748234|NCT02633046|584116313|FG000|Overall Study|Increased proteinuria|2|||
161748235|NCT02633046|584116313|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
161748236|NCT02633046|584116313|FG000|Overall Study|Mutual decision patient and physician|1|||
161748237|NCT03136367|584116321|FG000|T1 Consultation|discontinued mistakenly included|2|||
161748238|NCT03136367|584116322|FG001|T1 Consultation|discontinued mistakenly included|6|||
161748239|NCT03136367|584116323|FG002|T1 Consultation|discontinued mistakenly included|1|||
161748240|NCT03136367|584116321|FG000|T1 Consultation|Discontinued other|0|||
161748241|NCT03136367|584116322|FG001|T1 Consultation|Discontinued other|1|||
161748242|NCT03136367|584116323|FG002|T1 Consultation|Discontinued other|0|||
161748243|NCT03136367|584116321|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
161748244|NCT03136367|584116322|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
161748245|NCT03136367|584116323|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
161748246|NCT03136367|584116321|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
161748247|NCT03136367|584116322|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
161748248|NCT03136367|584116323|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
161748249|NCT03136367|584116321|FG000|T2 Post-consultation|Discontinued other|0|||
161748250|NCT03136367|584116322|FG001|T2 Post-consultation|Discontinued other|2|||
161748251|NCT03136367|584116323|FG002|T2 Post-consultation|Discontinued other|6|||
161748252|NCT03136367|584116321|FG000|T2 Post-consultation|Discontinued transferred care|0|||
161748253|NCT03136367|584116322|FG001|T2 Post-consultation|Discontinued transferred care|0|||
161748254|NCT03136367|584116323|FG002|T2 Post-consultation|Discontinued transferred care|3|||
161748255|NCT03136367|584116321|FG000|T2 Post-consultation|Discontinued lost contact|0|||
161748256|NCT03136367|584116322|FG001|T2 Post-consultation|Discontinued lost contact|1|||
161748257|NCT03136367|584116323|FG002|T2 Post-consultation|Discontinued lost contact|0|||
161748258|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
161748259|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
161748260|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
161748261|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
161748262|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
161748263|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
161748264|NCT03136367|584116321|FG000|T3 1 Week After Surgery|other discontinued|2|||
161748265|NCT03136367|584116322|FG001|T3 1 Week After Surgery|other discontinued|4|||
161748266|NCT03136367|584116323|FG002|T3 1 Week After Surgery|other discontinued|3|||
161748267|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
161748268|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
161748269|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
161748270|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
161748271|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
161748272|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
161748273|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
161748274|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
161748275|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
161748276|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|Death|0|||
161748277|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|Death|1|||
161748278|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|Death|3|||
161748279|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
161748280|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
161748281|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
161748282|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
161748283|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
161748284|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
161748285|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
161748286|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
161748287|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
161748288|NCT03136367|584116321|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161748289|NCT03136367|584116322|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161748290|NCT03136367|584116323|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161748291|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
161748292|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
161748293|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
161748294|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Death|0|||
161748295|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Death|0|||
161748296|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Death|1|||
161748297|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
161748298|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
161748299|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
161748300|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
161748301|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
161748302|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
161748303|NCT03136367|584116321|FG000|T5 1 Year After Surgery|study ended before due|31|||
161748304|NCT03136367|584116322|FG001|T5 1 Year After Surgery|study ended before due|103|||
161748305|NCT03136367|584116323|FG002|T5 1 Year After Surgery|study ended before due|110|||
161748306|NCT03136367|584116321|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
161748307|NCT03136367|584116322|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
161748308|NCT03136367|584116323|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
161748309|NCT01594749|584118575|FG000|Overall Study|Adverse Event|2|||
161748310|NCT01594749|584118576|FG001|Overall Study|Adverse Event|1|||
161748311|NCT01594749|584118575|FG000|Overall Study|Withdrawal by Subject|2|||
161748312|NCT01594749|584118576|FG001|Overall Study|Withdrawal by Subject|2|||
161748313|NCT01594749|584118575|FG000|Overall Study|Protocol Violation|2|||
161748314|NCT01594749|584118576|FG001|Overall Study|Protocol Violation|0|||
161748315|NCT01594749|584118575|FG000|Overall Study|Physician Decision|1|||
161748316|NCT01594749|584118576|FG001|Overall Study|Physician Decision|1|||
161748317|NCT01594749|584118575|FG000|Overall Study|Non-compliance with Protocol|0|||
161748318|NCT01594749|584118576|FG001|Overall Study|Non-compliance with Protocol|1|||
161748319|NCT01594749|584118575|FG000|Overall Study|Lost to Follow-up|1|||
161748320|NCT01594749|584118576|FG001|Overall Study|Lost to Follow-up|0|||
161748321|NCT01594749|584118575|FG000|Overall Study|Death|9|||
161748322|NCT01594749|584118576|FG001|Overall Study|Death|3|||
161748323|NCT01594749|584118575|FG000|Overall Study|Not Treated|4|||
161748324|NCT01594749|584118576|FG001|Overall Study|Not Treated|10|||
161748325|NCT01594749|584118575|FG000|Overall Study|Lost Source Documentation|1|||
161748326|NCT01594749|584118576|FG001|Overall Study|Lost Source Documentation|0|||
161748327|NCT02578992|584118578|FG000|Overall Study|equipment not available or malfunction|3|||
161748328|NCT02578992|584118579|FG001|Overall Study|equipment not available or malfunction|3|||
161748329|NCT00086385|584118580|FG000|Overall Study|Death|2|||
161748330|NCT00086385|584118581|FG001|Overall Study|Death|2|||
161748331|NCT00086385|584118582|FG002|Overall Study|Death|1|||
161748332|NCT00086385|584118583|FG003|Overall Study|Death|1|||
161748333|NCT00880100|584118584|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
161748334|NCT00880100|584118584|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
161748335|NCT00880100|584118584|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
161748336|NCT04038385|584118586|FG000|Overall Study|Completed baseline assessment only|7|||
161748337|NCT04038385|584118587|FG001|Overall Study|Completed baseline assessment only|4|||
161748338|NCT04038385|584118586|FG000|Overall Study|Moved out of area|4|||
161748339|NCT04038385|584118587|FG001|Overall Study|Moved out of area|2|||
161748340|NCT04038385|584118586|FG000|Overall Study|Discontinued study involvement|6|||
161748341|NCT04038385|584118587|FG001|Overall Study|Discontinued study involvement|1|||
161748342|NCT03424044|584118588|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748343|NCT03424044|584118589|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748344|NCT03424044|584118590|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
161748345|NCT03424044|584118591|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748346|NCT03424044|584118592|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748347|NCT03424044|584118593|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748348|NCT03424044|584118594|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748349|NCT03424044|584118595|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748350|NCT03424044|584118596|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748351|NCT03424044|584118588|FG000|First Intervention (76 Hours)|Adverse Event|0|||
161748352|NCT03424044|584118589|FG001|First Intervention (76 Hours)|Adverse Event|0|||
161748353|NCT03424044|584118590|FG002|First Intervention (76 Hours)|Adverse Event|0|||
161748354|NCT03424044|584118591|FG003|First Intervention (76 Hours)|Adverse Event|0|||
161748355|NCT03424044|584118592|FG004|First Intervention (76 Hours)|Adverse Event|1|||
161748356|NCT03424044|584118593|FG005|First Intervention (76 Hours)|Adverse Event|0|||
161748357|NCT03424044|584118594|FG006|First Intervention (76 Hours)|Adverse Event|0|||
161748358|NCT03424044|584118595|FG007|First Intervention (76 Hours)|Adverse Event|0|||
161748359|NCT03424044|584118596|FG008|First Intervention (76 Hours)|Adverse Event|0|||
161748360|NCT03424044|584118588|FG000|First Intervention (76 Hours)|device issues|0|||
161748361|NCT03424044|584118589|FG001|First Intervention (76 Hours)|device issues|0|||
161748362|NCT03424044|584118590|FG002|First Intervention (76 Hours)|device issues|0|||
161748363|NCT03424044|584118591|FG003|First Intervention (76 Hours)|device issues|0|||
161748364|NCT03424044|584118592|FG004|First Intervention (76 Hours)|device issues|0|||
161748365|NCT03424044|584118593|FG005|First Intervention (76 Hours)|device issues|0|||
161748366|NCT03424044|584118594|FG006|First Intervention (76 Hours)|device issues|1|||
161748367|NCT03424044|584118595|FG007|First Intervention (76 Hours)|device issues|1|||
161748368|NCT03424044|584118596|FG008|First Intervention (76 Hours)|device issues|1|||
161748369|NCT03424044|584118588|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
161748370|NCT03424044|584118589|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
161748371|NCT03424044|584118590|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
161748372|NCT03424044|584118591|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
161748373|NCT03424044|584118592|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
161748374|NCT03424044|584118593|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
161748375|NCT03424044|584118594|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
161748376|NCT03424044|584118595|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
161748377|NCT03424044|584118596|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
161748378|NCT03424044|584118588|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748379|NCT03424044|584118589|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748380|NCT03424044|584118590|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748381|NCT03424044|584118591|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
161748382|NCT03424044|584118592|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748383|NCT03424044|584118593|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748384|NCT03424044|584118594|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748385|NCT03424044|584118595|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748386|NCT03424044|584118596|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748387|NCT00402285|584118603|FG000|Overall Study|insufficient RNA quality|7|||
161748388|NCT00402285|584118604|FG001|Overall Study|insufficient RNA quality|6|||
161748389|NCT00402285|584118605|FG002|Overall Study|insufficient RNA quality|2|||
161748390|NCT00405275|584118608|FG000|Overall Study|Death|1|||
161748391|NCT00405275|584118609|FG001|Overall Study|Death|0|||
161748392|NCT00405275|584118608|FG000|Overall Study|Lost to Follow-up|5|||
161748393|NCT00405275|584118609|FG001|Overall Study|Lost to Follow-up|1|||
161748394|NCT00405275|584118608|FG000|Overall Study|Withdrawal by Subject|7|||
161748395|NCT00405275|584118609|FG001|Overall Study|Withdrawal by Subject|9|||
161748396|NCT00405275|584118608|FG000|Overall Study|Unwilling to continue|10|||
161748397|NCT00405275|584118609|FG001|Overall Study|Unwilling to continue|9|||
161748398|NCT00088595|584118610|FG000|Overall Study|Adverse Event|11|||
161748399|NCT00088595|584118610|FG000|Overall Study|Withdrawal by Subject|8|||
161748400|NCT00088595|584118610|FG000|Overall Study|Ongoing (After Core)|7|||
161748401|NCT00088595|584118610|FG000|Overall Study|New Cancer Therapy|2|||
161748402|NCT02959970|584118620|FG000|Overall Study|Adverse Event|1|||
161748403|NCT02959970|584118621|FG001|Overall Study|Adverse Event|0|||
161748404|NCT02959970|584118620|FG000|Overall Study|Withdrawal by Subject|0|||
161748405|NCT02959970|584118621|FG001|Overall Study|Withdrawal by Subject|2|||
161748406|NCT02959970|584118620|FG000|Overall Study|Lost to Follow-up|1|||
161748407|NCT02959970|584118621|FG001|Overall Study|Lost to Follow-up|5|||
161748408|NCT03235726|584118622|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748409|NCT03235726|584118623|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748410|NCT03235726|584118624|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748411|NCT03235726|584118625|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748412|NCT03235726|584118626|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
161748413|NCT03235726|584118627|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748414|NCT03235726|584118628|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748415|NCT03235726|584118629|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748416|NCT03235726|584118630|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748417|NCT03235726|584118631|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748418|NCT03235726|584118622|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748419|NCT03235726|584118623|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748420|NCT03235726|584118624|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748421|NCT03235726|584118625|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748422|NCT03235726|584118626|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
161748423|NCT03235726|584118627|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748424|NCT03235726|584118628|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748425|NCT03235726|584118629|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748426|NCT03235726|584118630|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748427|NCT03235726|584118631|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748428|NCT00268463|584118632|FG000|Overall Study|study terminated due to low accrual|10|||
161748429|NCT00268463|584118633|FG001|Overall Study|study terminated due to low accrual|12|||
161748430|NCT04685538|584118634|FG000|Overall Study|Adverse Event|0|||
161748431|NCT04685538|584118635|FG001|Overall Study|Adverse Event|1|||
161748432|NCT04685538|584118634|FG000|Overall Study|Lost to Follow-up|0|||
161748433|NCT04685538|584118635|FG001|Overall Study|Lost to Follow-up|2|||
161748434|NCT01040845|584118636|FG000|Overall Study|Withdrawal by Subject|1|||
161748435|NCT01040845|584118637|FG001|Overall Study|Withdrawal by Subject|1|||
161748436|NCT01040845|584118636|FG000|Overall Study|Physician Decision|1|||
161748437|NCT01040845|584118637|FG001|Overall Study|Physician Decision|0|||
161748438|NCT04362813|584118638|FG000|Overall Study|Death|12|||
161748439|NCT04362813|584118639|FG001|Overall Study|Death|16|||
161748440|NCT04362813|584118638|FG000|Overall Study|Withdrawal by Subject|3|||
161748441|NCT04362813|584118639|FG001|Overall Study|Withdrawal by Subject|1|||
161748442|NCT04362813|584118638|FG000|Overall Study|Protocol Violation|0|||
161748443|NCT04362813|584118639|FG001|Overall Study|Protocol Violation|3|||
161748444|NCT04362813|584118638|FG000|Overall Study|Lost to Follow-up|1|||
161748445|NCT04362813|584118639|FG001|Overall Study|Lost to Follow-up|1|||
161748446|NCT04362813|584118638|FG000|Overall Study|Enrolled but did not receive treatment|2|||
161748447|NCT04362813|584118639|FG001|Overall Study|Enrolled but did not receive treatment|4|||
161748448|NCT01732107|584118643|FG000|Overall Study|Adverse Event|2|||
161748449|NCT01732107|584118643|FG000|Overall Study|Disease Progression|8|||
161748450|NCT01732107|584118643|FG000|Overall Study|Physician Decision|1|||
161748451|NCT01732107|584118643|FG000|Overall Study|Withdrawal by Subject|2|||
161748452|NCT04445688|584118645|FG000|Washout (One Week)|Adverse Event|2|||
161748453|NCT04445688|584118645|FG000|Washout (One Week)|Withdrawal by Subject|1|||
161748454|NCT00918346|584118647|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
161748455|NCT00918346|584118648|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
161748456|NCT01749800|584118649|FG000|Overall Study|not meeting inclusion criteria|3|||
161748457|NCT01749800|584118650|FG001|Overall Study|not meeting inclusion criteria|0|||
161748458|NCT01749800|584118651|FG002|Overall Study|not meeting inclusion criteria|0|||
161748459|NCT01749800|584118649|FG000|Overall Study|Withdrawal by Subject|0|||
161748460|NCT01749800|584118650|FG001|Overall Study|Withdrawal by Subject|1|||
161748461|NCT01749800|584118651|FG002|Overall Study|Withdrawal by Subject|0|||
161748462|NCT00224003|584118656|FG000|Overall Study|Adverse Event|1|||
161748463|NCT00224003|584118656|FG000|Overall Study|Protocol Violation|2|||
161748464|NCT00224003|584118656|FG000|Overall Study|Withdrawal by Subject|1|||
161748465|NCT00224003|584118656|FG000|Overall Study|unk|3|||
161748466|NCT03549429|584118657|FG000|Overall Study|Protocol Violation|5|||
161748467|NCT03549429|584118658|FG001|Overall Study|Protocol Violation|3|||
161748468|NCT00729326|584118668|FG000|Overall Study|Lost to Follow-up|2|||
161748469|NCT00729326|584118669|FG001|Overall Study|Lost to Follow-up|0|||
161748470|NCT00729326|584118668|FG000|Overall Study|Physician Decision|0|||
161748471|NCT00729326|584118669|FG001|Overall Study|Physician Decision|1|||
161748472|NCT00729326|584118668|FG000|Overall Study|Protocol Violation|3|||
161748473|NCT00729326|584118669|FG001|Overall Study|Protocol Violation|2|||
161748474|NCT00729326|584118668|FG000|Overall Study|Subject Decision|4|||
161748475|NCT00729326|584118669|FG001|Overall Study|Subject Decision|4|||
161748476|NCT00729326|584118668|FG000|Overall Study|Sponsor Decision|1|||
161748477|NCT00729326|584118669|FG001|Overall Study|Sponsor Decision|2|||
161748478|NCT01235728|584118670|FG000|Overall Study|Protocol Violation|0|||
161748479|NCT01235728|584118671|FG001|Overall Study|Protocol Violation|0|||
161748480|NCT01235728|584118672|FG002|Overall Study|Protocol Violation|0|||
161748481|NCT01235728|584118673|FG003|Overall Study|Protocol Violation|1|||
161748482|NCT01235728|584118674|FG004|Overall Study|Protocol Violation|0|||
161748483|NCT01235728|584118675|FG005|Overall Study|Protocol Violation|0|||
161748484|NCT01235728|584118676|FG006|Overall Study|Protocol Violation|0|||
161748485|NCT01235728|584118677|FG007|Overall Study|Protocol Violation|0|||
161748486|NCT01000025|584118678|FG000|Overall Study|Adverse Event|43|||
161748487|NCT01000025|584118679|FG001|Overall Study|Adverse Event|2|||
161748488|NCT01000025|584118678|FG000|Overall Study|Withdrawal by Subject|13|||
161748489|NCT01000025|584118679|FG001|Overall Study|Withdrawal by Subject|8|||
161748490|NCT01000025|584118678|FG000|Overall Study|Death|23|||
161748491|NCT01000025|584118679|FG001|Overall Study|Death|13|||
161748492|NCT01000025|584118678|FG000|Overall Study|Lack of Efficacy|363|||
161748493|NCT01000025|584118679|FG001|Overall Study|Lack of Efficacy|208|||
161748494|NCT01000025|584118678|FG000|Overall Study|Intercurrent Illness|26|||
161748495|NCT01000025|584118679|FG001|Overall Study|Intercurrent Illness|7|||
161748496|NCT04423757|584118680|FG000|Overall Study|Adverse Event|2|||
161748497|NCT04423757|584118681|FG001|Overall Study|Adverse Event|0|||
161748498|NCT04423757|584118680|FG000|Overall Study|Not treated|1|||
161748499|NCT04423757|584118681|FG001|Overall Study|Not treated|1|||
161748500|NCT01202760|584118682|FG000|Overall Study|Entry Criteria Not Met|0|||
161748501|NCT01202760|584118683|FG001|Overall Study|Entry Criteria Not Met|3|||
161748502|NCT01202760|584118684|FG002|Overall Study|Entry Criteria Not Met|1|||
161748503|NCT01202760|584118682|FG000|Overall Study|Adverse Event|11|||
161748504|NCT01202760|584118683|FG001|Overall Study|Adverse Event|9|||
161748505|NCT01202760|584118684|FG002|Overall Study|Adverse Event|10|||
161748506|NCT01202760|584118682|FG000|Overall Study|Death|2|||
161748507|NCT01202760|584118683|FG001|Overall Study|Death|1|||
161748508|NCT01202760|584118684|FG002|Overall Study|Death|0|||
161748509|NCT01202760|584118682|FG000|Overall Study|Lack of Efficacy|6|||
161748510|NCT01202760|584118683|FG001|Overall Study|Lack of Efficacy|8|||
161748511|NCT01202760|584118684|FG002|Overall Study|Lack of Efficacy|7|||
161748512|NCT01202760|584118682|FG000|Overall Study|Lost to Follow-up|0|||
161748513|NCT01202760|584118683|FG001|Overall Study|Lost to Follow-up|2|||
161748514|NCT01202760|584118684|FG002|Overall Study|Lost to Follow-up|1|||
161843122|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Disease Progression|0|||
161843123|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Disease Progression|0|||
161748515|NCT01202760|584118682|FG000|Overall Study|Parent / Caregiver Decision|0|||
161748516|NCT01202760|584118683|FG001|Overall Study|Parent / Caregiver Decision|1|||
161748517|NCT01202760|584118684|FG002|Overall Study|Parent / Caregiver Decision|0|||
161748518|NCT01202760|584118682|FG000|Overall Study|Withdrawal by Subject|17|||
161748519|NCT01202760|584118683|FG001|Overall Study|Withdrawal by Subject|18|||
161748520|NCT01202760|584118684|FG002|Overall Study|Withdrawal by Subject|14|||
161748521|NCT01202760|584118682|FG000|Overall Study|Physician Decision|0|||
161748522|NCT01202760|584118683|FG001|Overall Study|Physician Decision|1|||
161748523|NCT01202760|584118684|FG002|Overall Study|Physician Decision|0|||
161748524|NCT01202760|584118682|FG000|Overall Study|Protocol Violation|7|||
161748525|NCT01202760|584118683|FG001|Overall Study|Protocol Violation|5|||
161748526|NCT01202760|584118684|FG002|Overall Study|Protocol Violation|2|||
161748527|NCT01202760|584118682|FG000|Overall Study|Sponsor Decision|4|||
161748528|NCT01202760|584118683|FG001|Overall Study|Sponsor Decision|4|||
161843124|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Disease Progression|2|||
161748529|NCT01202760|584118684|FG002|Overall Study|Sponsor Decision|0|||
161748530|NCT01654523|584118685|FG000|Overall Study|Withdrawal by Subject|1|||
161748531|NCT02810951|584118686|FG000|Overall Study|Adverse Event|1|||
161748532|NCT03199638|584118687|FG000|Overall Study|inability to drink glutamine during regularly|0|||
161748533|NCT03199638|584118688|FG001|Overall Study|inability to drink glutamine during regularly|2|||
161748534|NCT01575899|584118691|FG000|Overall Study|Lost to Follow-up|3|||
161748535|NCT01575899|584118692|FG001|Overall Study|Lost to Follow-up|4|||
161748536|NCT01575899|584118693|FG002|Overall Study|Lost to Follow-up|2|||
161748537|NCT01575899|584118691|FG000|Overall Study|Protocol Violation|2|||
161748538|NCT01575899|584118692|FG001|Overall Study|Protocol Violation|1|||
161748539|NCT01575899|584118693|FG002|Overall Study|Protocol Violation|0|||
161748540|NCT02807844|584118694|FG000|Overall Study|Physician Decision|0|||
161748541|NCT02807844|584118695|FG001|Overall Study|Physician Decision|0|||
161748542|NCT02807844|584118696|FG002|Overall Study|Physician Decision|0|||
161748543|NCT02807844|584118697|FG003|Overall Study|Physician Decision|0|||
161748544|NCT02807844|584118698|FG004|Overall Study|Physician Decision|0|||
161748545|NCT02807844|584118699|FG005|Overall Study|Physician Decision|0|||
161748546|NCT02807844|584118700|FG006|Overall Study|Physician Decision|3|||
161748547|NCT02807844|584118701|FG007|Overall Study|Physician Decision|0|||
161748548|NCT02807844|584118702|FG008|Overall Study|Physician Decision|1|||
161748549|NCT02807844|584118703|FG009|Overall Study|Physician Decision|2|||
161748550|NCT02807844|584118694|FG000|Overall Study|Death|0|||
161748551|NCT02807844|584118695|FG001|Overall Study|Death|0|||
161748552|NCT02807844|584118696|FG002|Overall Study|Death|2|||
161748553|NCT02807844|584118697|FG003|Overall Study|Death|4|||
161748554|NCT02807844|584118698|FG004|Overall Study|Death|1|||
161748555|NCT02807844|584118699|FG005|Overall Study|Death|2|||
161748556|NCT02807844|584118700|FG006|Overall Study|Death|1|||
161748557|NCT02807844|584118701|FG007|Overall Study|Death|2|||
161748558|NCT02807844|584118702|FG008|Overall Study|Death|0|||
161748559|NCT02807844|584118703|FG009|Overall Study|Death|1|||
161748560|NCT02807844|584118694|FG000|Overall Study|Withdrawal by Subject|0|||
161748561|NCT02807844|584118695|FG001|Overall Study|Withdrawal by Subject|0|||
161748562|NCT02807844|584118696|FG002|Overall Study|Withdrawal by Subject|2|||
161748563|NCT02807844|584118697|FG003|Overall Study|Withdrawal by Subject|1|||
161748564|NCT02807844|584118698|FG004|Overall Study|Withdrawal by Subject|1|||
161748565|NCT02807844|584118699|FG005|Overall Study|Withdrawal by Subject|0|||
161748566|NCT02807844|584118700|FG006|Overall Study|Withdrawal by Subject|1|||
161748567|NCT02807844|584118701|FG007|Overall Study|Withdrawal by Subject|0|||
161748568|NCT02807844|584118702|FG008|Overall Study|Withdrawal by Subject|0|||
161748569|NCT02807844|584118703|FG009|Overall Study|Withdrawal by Subject|0|||
161748570|NCT02807844|584118694|FG000|Overall Study|Progressive disease|5|||
161748571|NCT02807844|584118695|FG001|Overall Study|Progressive disease|12|||
161748572|NCT02807844|584118696|FG002|Overall Study|Progressive disease|8|||
161748573|NCT02807844|584118697|FG003|Overall Study|Progressive disease|8|||
161748574|NCT02807844|584118698|FG004|Overall Study|Progressive disease|3|||
161748575|NCT02807844|584118699|FG005|Overall Study|Progressive disease|8|||
161748576|NCT02807844|584118700|FG006|Overall Study|Progressive disease|14|||
161748577|NCT02807844|584118701|FG007|Overall Study|Progressive disease|17|||
161748578|NCT02807844|584118702|FG008|Overall Study|Progressive disease|19|||
161748579|NCT02807844|584118703|FG009|Overall Study|Progressive disease|15|||
161748580|NCT02807844|584118694|FG000|Overall Study|Adverse Event|1|||
161748581|NCT02807844|584118695|FG001|Overall Study|Adverse Event|0|||
161748582|NCT02807844|584118696|FG002|Overall Study|Adverse Event|0|||
161748583|NCT02807844|584118697|FG003|Overall Study|Adverse Event|0|||
161748584|NCT02807844|584118698|FG004|Overall Study|Adverse Event|1|||
161748585|NCT02807844|584118699|FG005|Overall Study|Adverse Event|1|||
161748586|NCT02807844|584118700|FG006|Overall Study|Adverse Event|1|||
161748587|NCT02807844|584118701|FG007|Overall Study|Adverse Event|1|||
161748588|NCT02807844|584118702|FG008|Overall Study|Adverse Event|1|||
161748589|NCT02807844|584118703|FG009|Overall Study|Adverse Event|2|||
161748590|NCT03097029|584118704|FG000|Overall Study|Withdrawal by Subject|1|||
161748591|NCT00709124|584118705|FG000|Overall Study|Death|3|||
161748592|NCT00709124|584118706|FG001|Overall Study|Death|1|||
161748593|NCT00709124|584118705|FG000|Overall Study|encephalopathy; can't do assessment|1|||
161748594|NCT00709124|584118706|FG001|Overall Study|encephalopathy; can't do assessment|0|||
161748595|NCT00373490|584118707|FG000|Overall Study|Adverse Event|0|||
161748596|NCT00373490|584118708|FG001|Overall Study|Adverse Event|1|||
161748597|NCT00373490|584118707|FG000|Overall Study|Lack of Efficacy|9|||
161748598|NCT00373490|584118708|FG001|Overall Study|Lack of Efficacy|4|||
161748599|NCT00373490|584118707|FG000|Overall Study|Withdrawal by Subject|0|||
161748600|NCT00373490|584118708|FG001|Overall Study|Withdrawal by Subject|1|||
161748601|NCT00753688|584118715|FG000|Overall Study|Death|102|||
161748602|NCT00753688|584118716|FG001|Overall Study|Death|203|||
161748603|NCT00753688|584118715|FG000|Overall Study|Missing|4|||
161748604|NCT00753688|584118716|FG001|Overall Study|Missing|9|||
161748605|NCT00753688|584118715|FG000|Overall Study|Participant Withdrew Consent|2|||
161748606|NCT00753688|584118716|FG001|Overall Study|Participant Withdrew Consent|2|||
161843125|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Disease Progression|1|||
161843126|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Disease Progression|0|||
161843127|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Disease Progression|0|||
161843128|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Disease Progression|0|||
161843129|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843130|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843131|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843132|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843133|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843134|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843135|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843136|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843137|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843138|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843139|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843140|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843141|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843142|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843143|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843144|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843145|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843146|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843147|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843148|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843149|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
161843150|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
161843151|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843152|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843153|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843154|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843155|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843156|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843157|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843158|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843159|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843160|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843161|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843162|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843163|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843164|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843165|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843166|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843167|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843168|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843169|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843170|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843171|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843172|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843173|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843174|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
161843175|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843176|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843177|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843178|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843179|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Adverse Event|0|||
161843180|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Adverse Event|0|||
161843181|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Adverse Event|0|||
161843182|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Adverse Event|0|||
161843183|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Adverse Event|0|||
161843184|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Adverse Event|0|||
161748607|NCT00753688|584118715|FG000|Overall Study|Ongoing - in Follow-up|15|||
161748608|NCT00753688|584118716|FG001|Overall Study|Ongoing - in Follow-up|31|||
161748609|NCT00753688|584118715|FG000|Overall Study|Adverse Event|0|||
161748610|NCT00753688|584118716|FG001|Overall Study|Adverse Event|1|||
161748611|NCT01250756|584118717|FG000|Infant Series|Withdrawal by Subject|4|||
161748612|NCT01250756|584118718|FG001|Infant Series|Withdrawal by Subject|5|||
161748613|NCT01250756|584118717|FG000|Infant Series|Randomized, Not Vaccinated|2|||
161748614|NCT01250756|584118718|FG001|Infant Series|Randomized, Not Vaccinated|2|||
161748615|NCT01250756|584118717|FG000|Infant Series|Other|22|||
161748616|NCT01250756|584118718|FG001|Infant Series|Other|0|||
161748617|NCT01250756|584118717|FG000|After Infant Series|Adverse Event|5|||
161748618|NCT01250756|584118718|FG001|After Infant Series|Adverse Event|2|||
161748619|NCT01250756|584118717|FG000|After Infant Series|Withdrawal by Subject|4|||
161748620|NCT01250756|584118718|FG001|After Infant Series|Withdrawal by Subject|1|||
161748621|NCT01250756|584118717|FG000|After Infant Series|Other|2|||
161748622|NCT01250756|584118718|FG001|After Infant Series|Other|1|||
161748623|NCT01250756|584118717|FG000|Toddler Dose|Adverse Event|0|||
161748624|NCT01250756|584118718|FG001|Toddler Dose|Adverse Event|1|||
161748625|NCT01250756|584118717|FG000|After Toddler Dose|Adverse Event|0|||
161748626|NCT01250756|584118718|FG001|After Toddler Dose|Adverse Event|1|||
161748627|NCT00108953|584118719|FG000|Follow-up|Death|18|||
161748628|NCT00108953|584118720|FG001|Follow-up|Death|26|||
161748629|NCT00108953|584118719|FG000|Follow-up|Lost to Follow-up|1|||
161748630|NCT00108953|584118720|FG001|Follow-up|Lost to Follow-up|1|||
161748631|NCT00108953|584118719|FG000|Follow-up|Study terminated by sponsor|10|||
161748632|NCT00108953|584118720|FG001|Follow-up|Study terminated by sponsor|6|||
161748633|NCT02999100|584118723|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
161748634|NCT02999100|584118724|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
161748635|NCT02999100|584118725|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
161748636|NCT02999100|584118726|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
161748637|NCT02999100|584118727|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
161748638|NCT02999100|584118728|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
161748639|NCT02999100|584118723|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748640|NCT02999100|584118724|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748641|NCT02999100|584118725|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748642|NCT02999100|584118726|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748643|NCT02999100|584118727|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748644|NCT02999100|584118728|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
161748645|NCT02999100|584118723|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748646|NCT02999100|584118724|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748647|NCT02999100|584118725|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
161748648|NCT02999100|584118726|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748649|NCT02999100|584118727|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748650|NCT02999100|584118728|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748651|NCT02925312|584118732|FG000|Overall Study|Lost to Follow-up|25|||
161748652|NCT02925312|584118733|FG001|Overall Study|Lost to Follow-up|0|||
161748653|NCT02925312|584118732|FG000|Overall Study|Adverse Event|2|||
161748654|NCT02925312|584118733|FG001|Overall Study|Adverse Event|0|||
161748655|NCT02142504|584118734|FG000|Overall Study|Protocol Violation|2|||
161748656|NCT02142504|584118735|FG001|Overall Study|Protocol Violation|1|||
161748657|NCT02142504|584118736|FG002|Overall Study|Protocol Violation|2|||
161748658|NCT02142504|584118734|FG000|Overall Study|Adverse Event|2|||
161748659|NCT02142504|584118735|FG001|Overall Study|Adverse Event|3|||
161748660|NCT02142504|584118736|FG002|Overall Study|Adverse Event|4|||
161748661|NCT02142504|584118734|FG000|Overall Study|Lost to Follow-up|12|||
161748662|NCT02142504|584118735|FG001|Overall Study|Lost to Follow-up|19|||
161748663|NCT02142504|584118736|FG002|Overall Study|Lost to Follow-up|17|||
161748664|NCT02142504|584118734|FG000|Overall Study|Withdrawal by Subject|7|||
161748665|NCT02142504|584118735|FG001|Overall Study|Withdrawal by Subject|9|||
161748666|NCT02142504|584118736|FG002|Overall Study|Withdrawal by Subject|11|||
161748667|NCT02142504|584118734|FG000|Overall Study|Pregnancy|4|||
161748668|NCT02142504|584118735|FG001|Overall Study|Pregnancy|4|||
161748669|NCT02142504|584118736|FG002|Overall Study|Pregnancy|2|||
161748670|NCT02142504|584118734|FG000|Overall Study|Physician Decision|0|||
161748671|NCT02142504|584118735|FG001|Overall Study|Physician Decision|1|||
161748672|NCT02142504|584118736|FG002|Overall Study|Physician Decision|3|||
161748673|NCT02142504|584118734|FG000|Overall Study|Reason Not Specified|4|||
161748674|NCT02142504|584118735|FG001|Overall Study|Reason Not Specified|5|||
161748675|NCT02142504|584118736|FG002|Overall Study|Reason Not Specified|4|||
161748676|NCT04114539|584118744|FG000|Overall Study|Adverse Event|14|||
161748677|NCT04114539|584118744|FG000|Overall Study|Lost to Follow-up|2|||
161748678|NCT04114539|584118744|FG000|Overall Study|Non-compliance with Protocol|2|||
161748679|NCT04114539|584118744|FG000|Overall Study|Non-compliance with Study Drug|1|||
161748680|NCT04114539|584118744|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
161748681|NCT04114539|584118744|FG000|Overall Study|Withdrew consent|10|||
161843185|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Adverse Event|0|||
161843186|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Adverse Event|0|||
161843187|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Adverse Event|0|||
161843188|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Adverse Event|0|||
161843189|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Adverse Event|0|||
161843190|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Adverse Event|0|||
161843191|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Adverse Event|0|||
161843192|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Adverse Event|0|||
161843193|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Adverse Event|0|||
161843194|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Adverse Event|0|||
161843195|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Adverse Event|0|||
161843196|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Adverse Event|0|||
161843197|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Adverse Event|0|||
161843198|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Adverse Event|0|||
161843199|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Adverse Event|0|||
161843200|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Adverse Event|0|||
161843201|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Adverse Event|0|||
161843202|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Adverse Event|1|||
161843203|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Adverse Event|0|||
161843204|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843205|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843206|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843207|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843208|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843209|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843210|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843211|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843212|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843213|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843214|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843215|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843216|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843217|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843218|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843219|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843220|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843221|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843222|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843223|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843224|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843225|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843226|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843227|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
161843228|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843229|NCT02585934|584470025|FG000|Overall Study|Lost to Follow-up|2|||
161843230|NCT02585934|584470026|FG001|Overall Study|Lost to Follow-up|2|||
161843231|NCT02585934|584470025|FG000|Overall Study|Protocol Violation|14|||
161843232|NCT02585934|584470026|FG001|Overall Study|Protocol Violation|11|||
161843233|NCT02585934|584470025|FG000|Overall Study|Adverse Event|21|||
161843234|NCT02585934|584470026|FG001|Overall Study|Adverse Event|22|||
161843235|NCT02585934|584470025|FG000|Overall Study|Physician Decision|3|||
161843236|NCT02585934|584470026|FG001|Overall Study|Physician Decision|2|||
161843237|NCT02585934|584470025|FG000|Overall Study|Withdrawal by Subject|7|||
161843238|NCT02585934|584470026|FG001|Overall Study|Withdrawal by Subject|21|||
161843239|NCT02585934|584470025|FG000|Overall Study|Lack of Efficacy|2|||
161843240|NCT02585934|584470026|FG001|Overall Study|Lack of Efficacy|1|||
161843241|NCT02585934|584470025|FG000|Overall Study|Death|2|||
161843242|NCT02585934|584470026|FG001|Overall Study|Death|0|||
161843243|NCT02585934|584470025|FG000|Overall Study|Caregiver Withdrew Consent|7|||
161843244|NCT02585934|584470026|FG001|Overall Study|Caregiver Withdrew Consent|7|||
161843245|NCT02585934|584470025|FG000|Overall Study|Sponsor Termination|1|||
161843246|NCT02585934|584470026|FG001|Overall Study|Sponsor Termination|2|||
161843247|NCT02585934|584470025|FG000|Overall Study|Another Reason|10|||
161843248|NCT02585934|584470026|FG001|Overall Study|Another Reason|5|||
161843249|NCT01359969|584470039|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
161843250|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
161843251|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
161843252|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
161748682|NCT04114539|584118744|FG000|Overall Study|Others not specified|5|||
161748683|NCT04114539|584118744|FG000|Overall Study|Investigator Decision|2|||
161748684|NCT01455415|584118747|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
161748685|NCT01455415|584118748|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
161748686|NCT01455415|584118747|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
161748687|NCT01455415|584118748|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
161748688|NCT01455415|584118747|FG000|Period 1|Drug Error not Associated to AE|0|||
161748689|NCT01455415|584118748|FG001|Period 1|Drug Error not Associated to AE|1|||
161748690|NCT01455415|584118747|FG000|Period 1|AE Not Related to Study Drug|2|||
161748691|NCT01455415|584118748|FG001|Period 1|AE Not Related to Study Drug|6|||
161748692|NCT01455415|584118747|FG000|Period 1|Withdrawal by Subject|4|||
161748693|NCT01455415|584118748|FG001|Period 1|Withdrawal by Subject|5|||
161748694|NCT01455415|584118747|FG000|Period 1|Unspecified Reason|1|||
161748695|NCT01455415|584118748|FG001|Period 1|Unspecified Reason|1|||
161748696|NCT01455415|584118747|FG000|Period 1|Protocol Violation|0|||
161748697|NCT01455415|584118748|FG001|Period 1|Protocol Violation|2|||
161748698|NCT01455415|584118747|FG000|Washout|AE Related to Study Drug|2|||
161748699|NCT01455415|584118748|FG001|Washout|AE Related to Study Drug|0|||
161748700|NCT01455415|584118747|FG000|Washout|Lost to Follow-up|1|||
161748701|NCT01455415|584118748|FG001|Washout|Lost to Follow-up|0|||
161748702|NCT01455415|584118747|FG000|Washout|Drug Error not Associated to AE|2|||
161748703|NCT01455415|584118748|FG001|Washout|Drug Error not Associated to AE|1|||
161748704|NCT01455415|584118747|FG000|Washout|AE Not Related to Study Drug|2|||
161748705|NCT01455415|584118748|FG001|Washout|AE Not Related to Study Drug|3|||
161748706|NCT01455415|584118747|FG000|Washout|Unspecified Reason|1|||
161748707|NCT01455415|584118748|FG001|Washout|Unspecified Reason|2|||
161748708|NCT01455415|584118747|FG000|Washout|Protocol Violation|0|||
161748709|NCT01455415|584118748|FG001|Washout|Protocol Violation|1|||
161748710|NCT01455415|584118747|FG000|Period 2|AE Related to Study Drug|1|||
161748711|NCT01455415|584118748|FG001|Period 2|AE Related to Study Drug|2|||
161748712|NCT01455415|584118747|FG000|Period 2|Lost to Follow-up|2|||
161748713|NCT01455415|584118748|FG001|Period 2|Lost to Follow-up|1|||
161748714|NCT01455415|584118747|FG000|Period 2|AE Not Related to Study Drug|2|||
161748715|NCT01455415|584118748|FG001|Period 2|AE Not Related to Study Drug|1|||
161748716|NCT01455415|584118747|FG000|Period 2|Lack of Efficacy|2|||
161748717|NCT01455415|584118748|FG001|Period 2|Lack of Efficacy|0|||
161748718|NCT01455415|584118747|FG000|Period 2|Withdrawal by Subject|2|||
161748719|NCT01455415|584118748|FG001|Period 2|Withdrawal by Subject|3|||
161748720|NCT01455415|584118747|FG000|Period 2|Unspecified Reason|2|||
161748721|NCT01455415|584118748|FG001|Period 2|Unspecified Reason|3|||
161748722|NCT01455415|584118747|FG000|Period 2|Protocol Violation|2|||
161748723|NCT01455415|584118748|FG001|Period 2|Protocol Violation|0|||
161748724|NCT01455415|584118747|FG000|Follow-up|AE Related to Study Drug|0|||
161748725|NCT01455415|584118748|FG001|Follow-up|AE Related to Study Drug|1|||
161748726|NCT01455415|584118747|FG000|Follow-up|Lack of Efficacy|0|||
161748727|NCT01455415|584118748|FG001|Follow-up|Lack of Efficacy|1|||
161748728|NCT01455415|584118747|FG000|Follow-up|Withdrawal by Subject|2|||
161748729|NCT01455415|584118748|FG001|Follow-up|Withdrawal by Subject|0|||
161748730|NCT01455415|584118747|FG000|Follow-up|Unspecified Reason|1|||
161748731|NCT01455415|584118748|FG001|Follow-up|Unspecified Reason|0|||
161748732|NCT00587301|584118749|FG000|Overall Study|Screen Failure|9|||
161748733|NCT00587301|584118749|FG000|Overall Study|Lost to Follow-up|22|||
161748734|NCT00587301|584118749|FG000|Overall Study|Withdrawal by Subject|7|||
161748735|NCT00587301|584118749|FG000|Overall Study|Protocol Violation|7|||
161748736|NCT02460978|584118751|FG000|Overall Study|Adverse Event|17|||
161748737|NCT02460978|584118752|FG001|Overall Study|Adverse Event|11|||
161748738|NCT02460978|584118753|FG002|Overall Study|Adverse Event|11|||
161748739|NCT02460978|584118751|FG000|Overall Study|Withdrawal by Subject|5|||
161748740|NCT02460978|584118752|FG001|Overall Study|Withdrawal by Subject|5|||
161748741|NCT02460978|584118753|FG002|Overall Study|Withdrawal by Subject|14|||
161843253|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
161843254|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161843255|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161843256|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161843257|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
161843258|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161748742|NCT02460978|584118751|FG000|Overall Study|Lost to Follow-up|2|||
161748743|NCT02460978|584118752|FG001|Overall Study|Lost to Follow-up|3|||
161748744|NCT02460978|584118753|FG002|Overall Study|Lost to Follow-up|1|||
161748745|NCT02460978|584118751|FG000|Overall Study|Protocol Violation|1|||
161748746|NCT02460978|584118752|FG001|Overall Study|Protocol Violation|1|||
161748747|NCT02460978|584118753|FG002|Overall Study|Protocol Violation|1|||
161748748|NCT02460978|584118751|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
161748749|NCT02460978|584118752|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
161748750|NCT02460978|584118753|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
161748751|NCT02460978|584118751|FG000|Overall Study|Pregnancy|0|||
161748752|NCT02460978|584118752|FG001|Overall Study|Pregnancy|0|||
161748753|NCT02460978|584118753|FG002|Overall Study|Pregnancy|2|||
161748754|NCT00719537|584118754|FG000|Overall Study|Withdrawal by Subject|1|||
161748755|NCT00719537|584118755|FG001|Overall Study|Withdrawal by Subject|0|||
161748756|NCT00719537|584118754|FG000|Overall Study|Lost to Follow-up|0|||
161748757|NCT00719537|584118755|FG001|Overall Study|Lost to Follow-up|1|||
161748758|NCT01142193|584118756|FG000|Overall Study|Adverse Event|12|||
161748759|NCT01142193|584118757|FG001|Overall Study|Adverse Event|4|||
161748760|NCT01142193|584118756|FG000|Overall Study|Lack of Efficacy|2|||
161748761|NCT01142193|584118757|FG001|Overall Study|Lack of Efficacy|1|||
161748762|NCT01142193|584118756|FG000|Overall Study|Physician Decision|1|||
161748763|NCT01142193|584118757|FG001|Overall Study|Physician Decision|1|||
161748764|NCT01142193|584118756|FG000|Overall Study|Withdrawal by Subject|4|||
161748765|NCT01142193|584118757|FG001|Overall Study|Withdrawal by Subject|3|||
161748766|NCT01142193|584118756|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
161748767|NCT01142193|584118757|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
161748768|NCT01142193|584118756|FG000|Overall Study|Other|1|||
161748769|NCT01142193|584118757|FG001|Overall Study|Other|2|||
161748770|NCT00994162|584118758|FG000|Overall Study|Withdrawal by Subject|1|||
161748771|NCT00994162|584118758|FG000|Overall Study|Lost to Follow-up|2|||
161748772|NCT00994162|584118758|FG000|Overall Study|Product Complaint|1|||
161748773|NCT00994162|584118758|FG000|Overall Study|Poor Compliance|5|||
161748774|NCT00994162|584118758|FG000|Overall Study|Lack of Response|3|||
161748775|NCT00994162|584118758|FG000|Overall Study|Discharged from Hospital|4|||
161748776|NCT00994162|584118758|FG000|Overall Study|Death|2|||
161748777|NCT00994162|584118758|FG000|Overall Study|Care Transferred to Another Physician|2|||
161748778|NCT00994162|584118758|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
161748779|NCT00994162|584118758|FG000|Overall Study|Physician Decision|2|||
161748780|NCT00994162|584118758|FG000|Overall Study|Surrounding Wound Erythematous|1|||
161748781|NCT00994162|584118758|FG000|Overall Study|Machine Losing Vaccum|1|||
161748782|NCT00994162|584118758|FG000|Overall Study|Patient Lived Too Far Away|1|||
161748783|NCT00994162|584118758|FG000|Overall Study|Above Knee Amputation|1|||
161748784|NCT00994162|584118758|FG000|Overall Study|Reason Not Reported By Site|1|||
161748785|NCT01225172|584118762|FG000|Overall Study|Subject decision to stop|1|||
161748786|NCT01225172|584118763|FG001|Overall Study|Subject decision to stop|0|||
161748787|NCT01225172|584118762|FG000|Overall Study|Subject request to discontinue treatment|3|||
161748788|NCT01225172|584118763|FG001|Overall Study|Subject request to discontinue treatment|1|||
161748789|NCT01225172|584118762|FG000|Overall Study|Subject no longer meets study criteria|1|||
161748790|NCT01225172|584118763|FG001|Overall Study|Subject no longer meets study criteria|0|||
161748791|NCT01225172|584118762|FG000|Overall Study|Withdrawal by Subject|1|||
161748792|NCT01225172|584118763|FG001|Overall Study|Withdrawal by Subject|0|||
161748793|NCT03175562|584118772|FG000|Overall Study|Adverse Event|1|||
161748794|NCT03175562|584118772|FG000|Overall Study|Lost to Follow-up|3|||
161748795|NCT03175562|584118772|FG000|Overall Study|Withdrawal by Subject|7|||
161748796|NCT03175562|584118772|FG000|Overall Study|Other (Not Specified)|5|||
161748797|NCT02146833|584118773|FG000|Overall Study|Death|10|||
161748798|NCT02146833|584118773|FG000|Overall Study|No longer consented to study treatment|1|||
161748799|NCT01946412|584118774|FG000|Overall Study|Adverse Event|1|||
161748800|NCT01946412|584118774|FG000|Overall Study|Non-Compliance|1|||
161748801|NCT01946412|584118774|FG000|Overall Study|Continued with commercial Kalydeco|2|||
161748802|NCT01946412|584118774|FG000|Overall Study|Difficulty in swallowing|1|||
161748803|NCT00323310|584120633|FG000|Overall Study|Withdrawal by Subject|1|||
161748804|NCT00323310|584120633|FG000|Overall Study|a parent refused blood draw|1|||
161748805|NCT00323310|584120633|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
161748806|NCT03565991|584120634|FG000|Overall Study|Other|11|||
161748807|NCT03565991|584120635|FG001|Overall Study|Other|0|||
161748808|NCT03565991|584120634|FG000|Overall Study|Global deterioration of health status|14|||
161748809|NCT03565991|584120635|FG001|Overall Study|Global deterioration of health status|4|||
161748810|NCT03565991|584120634|FG000|Overall Study|Withdrawal by Subject|2|||
161748811|NCT03565991|584120635|FG001|Overall Study|Withdrawal by Subject|6|||
161748812|NCT03565991|584120634|FG000|Overall Study|Progressive disease|121|||
161748813|NCT03565991|584120635|FG001|Overall Study|Progressive disease|29|||
161748814|NCT03565991|584120634|FG000|Overall Study|Death|3|||
161748815|NCT03565991|584120635|FG001|Overall Study|Death|0|||
161748816|NCT03565991|584120634|FG000|Overall Study|Adverse Event|7|||
161748817|NCT03565991|584120635|FG001|Overall Study|Adverse Event|2|||
161748818|NCT02944513|584120636|FG000|Overall Study|Withdrawal by Subject|4|||
161748819|NCT02944513|584120637|FG001|Overall Study|Withdrawal by Subject|1|||
161748820|NCT00937326|584120638|FG000|Overall Study|Adverse Event|0|||
161748821|NCT00937326|584120639|FG001|Overall Study|Adverse Event|3|||
161748822|NCT00937326|584120640|FG002|Overall Study|Adverse Event|1|||
161748823|NCT00937326|584120641|FG003|Overall Study|Adverse Event|1|||
161748824|NCT00937326|584120642|FG004|Overall Study|Adverse Event|2|||
161748825|NCT00937326|584120638|FG000|Overall Study|Death|0|||
161748826|NCT00937326|584120639|FG001|Overall Study|Death|0|||
161748827|NCT00937326|584120640|FG002|Overall Study|Death|1|||
161748828|NCT00937326|584120641|FG003|Overall Study|Death|0|||
161748829|NCT00937326|584120642|FG004|Overall Study|Death|0|||
161748830|NCT00937326|584120638|FG000|Overall Study|Withdrawal by Subject|3|||
161748831|NCT00937326|584120639|FG001|Overall Study|Withdrawal by Subject|4|||
161748832|NCT00937326|584120640|FG002|Overall Study|Withdrawal by Subject|1|||
161748833|NCT00937326|584120641|FG003|Overall Study|Withdrawal by Subject|4|||
161748834|NCT00937326|584120642|FG004|Overall Study|Withdrawal by Subject|3|||
161748835|NCT00937326|584120638|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748836|NCT00937326|584120639|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748837|NCT00937326|584120640|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
161748838|NCT00937326|584120641|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748839|NCT00937326|584120642|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748840|NCT01308853|584120643|FG000|Overall Study|Adverse Event|1|||
161748841|NCT01308853|584120643|FG000|Overall Study|Lost to Follow-up|2|||
161748842|NCT01308853|584120643|FG000|Overall Study|Insertion of permanent implants|1|||
161748843|NCT01473355|584120648|FG000|Overall Study|Protocol Violation|2|||
161748844|NCT01473355|584120648|FG000|Overall Study|Adverse Event|2|||
161748845|NCT01473355|584120648|FG000|Overall Study|Lost to Follow-up|2|||
161748846|NCT00106249|584120649|FG000|Overall Study|Lost to Follow-up|3|||
161748847|NCT00106249|584120650|FG001|Overall Study|Lost to Follow-up|2|||
161748848|NCT01843205|584120653|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
161748849|NCT01843205|584120654|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
161748850|NCT00606177|584120655|FG000|Overall Study|Adverse Event|9|||
161748851|NCT00606177|584120656|FG001|Overall Study|Adverse Event|5|||
161748852|NCT00606177|584120655|FG000|Overall Study|Lack of Efficacy|3|||
161748853|NCT00606177|584120656|FG001|Overall Study|Lack of Efficacy|7|||
161748854|NCT00606177|584120655|FG000|Overall Study|Physician Decision|1|||
161748855|NCT00606177|584120656|FG001|Overall Study|Physician Decision|0|||
161748856|NCT00606177|584120655|FG000|Overall Study|Protocol Violation|1|||
161748857|NCT00606177|584120656|FG001|Overall Study|Protocol Violation|4|||
161748858|NCT00606177|584120655|FG000|Overall Study|Withdrawal by Subject|5|||
161748859|NCT00606177|584120656|FG001|Overall Study|Withdrawal by Subject|6|||
161748860|NCT00606177|584120655|FG000|Overall Study|Progression to depressive phase|6|||
161748861|NCT00606177|584120656|FG001|Overall Study|Progression to depressive phase|1|||
161748862|NCT00606177|584120655|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
161748863|NCT00606177|584120656|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
161748864|NCT00606177|584120655|FG000|Overall Study|Change of residence or other commitments|1|||
161748865|NCT00606177|584120656|FG001|Overall Study|Change of residence or other commitments|1|||
161748866|NCT00136357|584120657|FG000|Overall Study|Withdrawal by Subject|3|||
161748867|NCT00136357|584120658|FG001|Overall Study|Withdrawal by Subject|2|||
161748868|NCT01518309|584120663|FG000|Overall Study|Adverse Event|6|||
161748869|NCT01518309|584120663|FG000|Overall Study|Death|6|||
161748870|NCT01518309|584120663|FG000|Overall Study|Lack of Efficacy|7|||
161748871|NCT01518309|584120663|FG000|Overall Study|Withdrawal by Subject|6|||
161748872|NCT01518309|584120663|FG000|Overall Study|Physician Decision|3|||
161748873|NCT01518309|584120663|FG000|Overall Study|Sponsor Decision|2|||
161748874|NCT01518309|584120663|FG000|Overall Study|Not in Predefined Categories|9|||
161748875|NCT02603172|584120664|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748876|NCT02603172|584120665|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748877|NCT02603172|584120666|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
161748878|NCT02603172|584120667|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748879|NCT02603172|584120668|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748880|NCT02603172|584120669|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748881|NCT02603172|584120670|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748882|NCT02603172|584120671|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748883|NCT00863317|584120672|FG000|Overall Study|Lost to Follow-up|8|||
161748884|NCT00863317|584120673|FG001|Overall Study|Lost to Follow-up|9|||
161748885|NCT00038142|584120676|FG000|Overall Study|Ineligible|1|||
161748886|NCT00038142|584120677|FG001|Overall Study|Ineligible|0|||
161748887|NCT00038142|584120676|FG000|Overall Study|Progressive Disease|11|||
161748888|NCT00038142|584120677|FG001|Overall Study|Progressive Disease|7|||
161748889|NCT00038142|584120676|FG000|Overall Study|Death|1|||
161748890|NCT00038142|584120677|FG001|Overall Study|Death|0|||
161748891|NCT00038142|584120676|FG000|Overall Study|Adverse Event|1|||
161748892|NCT00038142|584120677|FG001|Overall Study|Adverse Event|0|||
161748893|NCT00038142|584120676|FG000|Overall Study|Unknown Reason|8|||
161748894|NCT00038142|584120677|FG001|Overall Study|Unknown Reason|0|||
161748895|NCT00441727|584120678|FG000|Overall Study|Protocol Violation|19|||
161748896|NCT00441727|584120679|FG001|Overall Study|Protocol Violation|28|||
161748897|NCT00441727|584120680|FG002|Overall Study|Protocol Violation|32|||
161748898|NCT00441727|584120678|FG000|Overall Study|Adverse Event|26|||
161748899|NCT00441727|584120679|FG001|Overall Study|Adverse Event|33|||
161748900|NCT00441727|584120680|FG002|Overall Study|Adverse Event|28|||
161748901|NCT00441727|584120678|FG000|Overall Study|Lack of Efficacy|7|||
161748902|NCT00441727|584120679|FG001|Overall Study|Lack of Efficacy|8|||
161748903|NCT00441727|584120680|FG002|Overall Study|Lack of Efficacy|48|||
161748904|NCT00441727|584120678|FG000|Overall Study|Withdrawal by Subject|40|||
161748905|NCT00441727|584120679|FG001|Overall Study|Withdrawal by Subject|34|||
161748906|NCT00441727|584120680|FG002|Overall Study|Withdrawal by Subject|47|||
161748907|NCT00441727|584120678|FG000|Overall Study|Lost to Follow-up|5|||
161748908|NCT00441727|584120679|FG001|Overall Study|Lost to Follow-up|6|||
161748909|NCT00441727|584120680|FG002|Overall Study|Lost to Follow-up|5|||
161748910|NCT00441727|584120678|FG000|Overall Study|Safety Reasons|3|||
161748911|NCT00441727|584120679|FG001|Overall Study|Safety Reasons|1|||
161748912|NCT00441727|584120680|FG002|Overall Study|Safety Reasons|3|||
161748913|NCT00441727|584120678|FG000|Overall Study|Various reason specified|6|||
161748914|NCT00441727|584120679|FG001|Overall Study|Various reason specified|8|||
161748915|NCT00441727|584120680|FG002|Overall Study|Various reason specified|5|||
161748916|NCT03417505|584120683|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
161748917|NCT03417505|584120684|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
161748918|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
161748919|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
161748920|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
161748921|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
161748922|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
161748923|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
161748924|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Other|2|||
161748925|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Other|2|||
161748926|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
161748927|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
161748928|NCT02133001|584120687|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
161748929|NCT02133001|584120688|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
161748930|NCT02133001|584120687|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
161748931|NCT02133001|584120688|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
161748932|NCT02133001|584120687|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
161748933|NCT02133001|584120688|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
161748934|NCT04211961|584120689|FG000|Overall Study|Death|0|||
161748935|NCT04211961|584120690|FG001|Overall Study|Death|1|||
161748936|NCT04211961|584120689|FG000|Overall Study|Lost to Follow-up|0|||
161748937|NCT04211961|584120690|FG001|Overall Study|Lost to Follow-up|1|||
161748938|NCT04211961|584120689|FG000|Overall Study|Withdrawal by Subject|0|||
161748939|NCT04211961|584120690|FG001|Overall Study|Withdrawal by Subject|1|||
161748940|NCT01831804|584120693|FG000|Overall Study|Adverse Event|0|||
161748941|NCT01831804|584120694|FG001|Overall Study|Adverse Event|0|||
161748942|NCT01831804|584120695|FG002|Overall Study|Adverse Event|0|||
161748943|NCT01831804|584120696|FG003|Overall Study|Adverse Event|0|||
161748944|NCT01831804|584120697|FG004|Overall Study|Adverse Event|0|||
161748945|NCT01831804|584120698|FG005|Overall Study|Adverse Event|0|||
161748946|NCT01831804|584120699|FG006|Overall Study|Adverse Event|1|||
161748947|NCT01831804|584120700|FG007|Overall Study|Adverse Event|0|||
161748948|NCT01831804|584120701|FG008|Overall Study|Adverse Event|1|||
161748949|NCT01831804|584120693|FG000|Overall Study|Protocol Violation|0|||
161748950|NCT01831804|584120694|FG001|Overall Study|Protocol Violation|0|||
161748951|NCT01831804|584120695|FG002|Overall Study|Protocol Violation|2|||
161748952|NCT01831804|584120696|FG003|Overall Study|Protocol Violation|0|||
161748953|NCT01831804|584120697|FG004|Overall Study|Protocol Violation|0|||
161748954|NCT01831804|584120698|FG005|Overall Study|Protocol Violation|0|||
161748955|NCT01831804|584120699|FG006|Overall Study|Protocol Violation|0|||
161748956|NCT01831804|584120700|FG007|Overall Study|Protocol Violation|0|||
161748957|NCT01831804|584120701|FG008|Overall Study|Protocol Violation|0|||
161748958|NCT01831804|584120693|FG000|Overall Study|Protocol defined stopping criteria|1|||
161748959|NCT01831804|584120694|FG001|Overall Study|Protocol defined stopping criteria|1|||
161748960|NCT01831804|584120695|FG002|Overall Study|Protocol defined stopping criteria|3|||
161748961|NCT01831804|584120696|FG003|Overall Study|Protocol defined stopping criteria|0|||
161748962|NCT01831804|584120697|FG004|Overall Study|Protocol defined stopping criteria|1|||
161748963|NCT01831804|584120698|FG005|Overall Study|Protocol defined stopping criteria|0|||
161748964|NCT01831804|584120699|FG006|Overall Study|Protocol defined stopping criteria|0|||
161748965|NCT01831804|584120700|FG007|Overall Study|Protocol defined stopping criteria|0|||
161748966|NCT01831804|584120701|FG008|Overall Study|Protocol defined stopping criteria|0|||
161748967|NCT01831804|584120693|FG000|Overall Study|Lost to Follow-up|0|||
161748968|NCT01831804|584120694|FG001|Overall Study|Lost to Follow-up|0|||
161748969|NCT01831804|584120695|FG002|Overall Study|Lost to Follow-up|1|||
161748970|NCT01831804|584120696|FG003|Overall Study|Lost to Follow-up|0|||
161748971|NCT01831804|584120697|FG004|Overall Study|Lost to Follow-up|0|||
161748972|NCT01831804|584120698|FG005|Overall Study|Lost to Follow-up|0|||
161843259|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161843260|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161843261|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
161748973|NCT01831804|584120699|FG006|Overall Study|Lost to Follow-up|0|||
161748974|NCT01831804|584120700|FG007|Overall Study|Lost to Follow-up|0|||
161748975|NCT01831804|584120701|FG008|Overall Study|Lost to Follow-up|1|||
161748976|NCT01831804|584120693|FG000|Overall Study|Investigator discretion|0|||
161748977|NCT01831804|584120694|FG001|Overall Study|Investigator discretion|0|||
161748978|NCT01831804|584120695|FG002|Overall Study|Investigator discretion|0|||
161748979|NCT01831804|584120696|FG003|Overall Study|Investigator discretion|0|||
161748980|NCT01831804|584120697|FG004|Overall Study|Investigator discretion|1|||
161748981|NCT01831804|584120698|FG005|Overall Study|Investigator discretion|0|||
161748982|NCT01831804|584120699|FG006|Overall Study|Investigator discretion|0|||
161748983|NCT01831804|584120700|FG007|Overall Study|Investigator discretion|1|||
161748984|NCT01831804|584120701|FG008|Overall Study|Investigator discretion|0|||
161748985|NCT01831804|584120693|FG000|Overall Study|Withdrew Consent|0|||
161748986|NCT01831804|584120694|FG001|Overall Study|Withdrew Consent|1|||
161748987|NCT01831804|584120695|FG002|Overall Study|Withdrew Consent|0|||
161748988|NCT01831804|584120696|FG003|Overall Study|Withdrew Consent|0|||
161748989|NCT01831804|584120697|FG004|Overall Study|Withdrew Consent|0|||
161748990|NCT01831804|584120698|FG005|Overall Study|Withdrew Consent|0|||
161748991|NCT01831804|584120699|FG006|Overall Study|Withdrew Consent|0|||
161748992|NCT01831804|584120700|FG007|Overall Study|Withdrew Consent|2|||
161748993|NCT01831804|584120701|FG008|Overall Study|Withdrew Consent|0|||
161748994|NCT01819506|584120702|FG000|Overall Study|Physician Decision|5|||
161748995|NCT01819506|584120703|FG001|Overall Study|Physician Decision|2|||
161748996|NCT01819506|584120702|FG000|Overall Study|Withdrawal by Subject|3|||
161748997|NCT01819506|584120703|FG001|Overall Study|Withdrawal by Subject|3|||
161748998|NCT01505114|584120706|FG000|Overall Study|Withdrawal by Subject|5|||
161748999|NCT01505114|584120707|FG001|Overall Study|Withdrawal by Subject|4|||
161749000|NCT01505114|584120708|FG002|Overall Study|Withdrawal by Subject|4|||
161749001|NCT01505114|584120709|FG003|Overall Study|Withdrawal by Subject|7|||
161749002|NCT01505114|584120706|FG000|Overall Study|Death|1|||
161749003|NCT01505114|584120707|FG001|Overall Study|Death|0|||
161749004|NCT01505114|584120708|FG002|Overall Study|Death|0|||
161749005|NCT01505114|584120709|FG003|Overall Study|Death|1|||
161749006|NCT01505114|584120706|FG000|Overall Study|unable to adhere to visit schedule|3|||
161749007|NCT01505114|584120707|FG001|Overall Study|unable to adhere to visit schedule|2|||
161749008|NCT01505114|584120708|FG002|Overall Study|unable to adhere to visit schedule|3|||
161749009|NCT01505114|584120709|FG003|Overall Study|unable to adhere to visit schedule|3|||
161749010|NCT01505114|584120706|FG000|Overall Study|Lost to Follow-up|11|||
161749011|NCT01505114|584120707|FG001|Overall Study|Lost to Follow-up|5|||
161749012|NCT01505114|584120708|FG002|Overall Study|Lost to Follow-up|8|||
161749013|NCT01505114|584120709|FG003|Overall Study|Lost to Follow-up|7|||
161749014|NCT01505114|584120706|FG000|Overall Study|relocated|4|||
161749015|NCT01505114|584120707|FG001|Overall Study|relocated|2|||
161749016|NCT01505114|584120708|FG002|Overall Study|relocated|2|||
161749017|NCT01505114|584120709|FG003|Overall Study|relocated|3|||
161749018|NCT01505114|584120706|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
161749019|NCT01505114|584120707|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
161749020|NCT01505114|584120708|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
161749021|NCT01505114|584120709|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
161749022|NCT01505114|584120706|FG000|Overall Study|staff safety concerns|0|||
161749023|NCT01505114|584120707|FG001|Overall Study|staff safety concerns|0|||
161749024|NCT01505114|584120708|FG002|Overall Study|staff safety concerns|0|||
161749025|NCT01505114|584120709|FG003|Overall Study|staff safety concerns|1|||
161749026|NCT01505114|584120706|FG000|Overall Study|investigator decision|1|||
161749027|NCT01505114|584120707|FG001|Overall Study|investigator decision|0|||
161749028|NCT01505114|584120708|FG002|Overall Study|investigator decision|1|||
161749029|NCT01505114|584120709|FG003|Overall Study|investigator decision|0|||
161749030|NCT00615459|584120710|FG000|Period I|Adverse Event|2|||
161749031|NCT00615459|584120711|FG001|Period I|Adverse Event|0|||
161749032|NCT00615459|584120712|FG002|Period I|Adverse Event|1|||
161749033|NCT00615459|584120713|FG003|Period I|Adverse Event|0|||
161749034|NCT00615459|584120710|FG000|Period I|Subject withdrew consent|1|||
161749035|NCT00615459|584120711|FG001|Period I|Subject withdrew consent|0|||
161749036|NCT00615459|584120712|FG002|Period I|Subject withdrew consent|0|||
161749037|NCT00615459|584120713|FG003|Period I|Subject withdrew consent|1|||
161749038|NCT00615459|584120710|FG000|Period I|Abnormal test procedure results|1|||
161749039|NCT00615459|584120711|FG001|Period I|Abnormal test procedure results|1|||
161749040|NCT00615459|584120712|FG002|Period I|Abnormal test procedure results|1|||
161749041|NCT00615459|584120713|FG003|Period I|Abnormal test procedure results|0|||
161749042|NCT00615459|584120710|FG000|Period II|Adverse Event|1|||
161749043|NCT00615459|584120711|FG001|Period II|Adverse Event|0|||
161749044|NCT00615459|584120712|FG002|Period II|Adverse Event|0|||
161749045|NCT00615459|584120713|FG003|Period II|Adverse Event|0|||
161749046|NCT00615459|584120710|FG000|Period II|Lost to Follow-up|0|||
161749047|NCT00615459|584120711|FG001|Period II|Lost to Follow-up|0|||
161749048|NCT00615459|584120712|FG002|Period II|Lost to Follow-up|0|||
161749049|NCT00615459|584120713|FG003|Period II|Lost to Follow-up|1|||
161749050|NCT00615459|584120710|FG000|Period III|Adverse Event|0|||
161749051|NCT00615459|584120711|FG001|Period III|Adverse Event|1|||
161749052|NCT00615459|584120712|FG002|Period III|Adverse Event|0|||
161749053|NCT00615459|584120713|FG003|Period III|Adverse Event|0|||
161749054|NCT00615459|584120710|FG000|Period III|Administrative problems|0|||
161749055|NCT00615459|584120711|FG001|Period III|Administrative problems|1|||
161749056|NCT00615459|584120712|FG002|Period III|Administrative problems|1|||
161749057|NCT00615459|584120713|FG003|Period III|Administrative problems|0|||
161749058|NCT00615459|584120710|FG000|Period III|Unsatisfactory therapeutic effect|0|||
161749059|NCT00615459|584120711|FG001|Period III|Unsatisfactory therapeutic effect|1|||
161749060|NCT00615459|584120712|FG002|Period III|Unsatisfactory therapeutic effect|0|||
161749061|NCT00615459|584120713|FG003|Period III|Unsatisfactory therapeutic effect|0|||
161749062|NCT02017704|584120720|FG000|Overall Study|Withdrawal by Subject|2|||
161749063|NCT02017704|584120721|FG001|Overall Study|Withdrawal by Subject|0|||
161749064|NCT02076334|584120722|FG000|Overall Study|Protocol Violation|1|||
161749065|NCT02076334|584120723|FG001|Overall Study|Protocol Violation|0|||
161749066|NCT02076334|584120724|FG002|Overall Study|Protocol Violation|0|||
161749067|NCT02076334|584120725|FG003|Overall Study|Protocol Violation|0|||
161749068|NCT02076334|584120722|FG000|Overall Study|Lost to Follow-up|0|||
161749069|NCT02076334|584120723|FG001|Overall Study|Lost to Follow-up|1|||
161749070|NCT02076334|584120724|FG002|Overall Study|Lost to Follow-up|1|||
161749071|NCT02076334|584120725|FG003|Overall Study|Lost to Follow-up|0|||
161749072|NCT02076334|584120722|FG000|Overall Study|muscle soreness|0|||
161749073|NCT02076334|584120723|FG001|Overall Study|muscle soreness|0|||
161749074|NCT02076334|584120724|FG002|Overall Study|muscle soreness|0|||
161749075|NCT02076334|584120725|FG003|Overall Study|muscle soreness|1|||
161749076|NCT01975675|584120726|FG000|Overall Study|Death|0|||
161749077|NCT01975675|584120727|FG001|Overall Study|Death|1|||
161749078|NCT01975675|584120728|FG002|Overall Study|Death|0|||
161749079|NCT01975675|584120729|FG003|Overall Study|Death|0|||
161749080|NCT03639987|584120730|FG000|Overall Study|Study terminated by sponsor|26|||
161749081|NCT03639987|584120731|FG001|Overall Study|Study terminated by sponsor|25|||
161749082|NCT03639987|584120730|FG000|Overall Study|Lost to Follow-up|0|||
161749083|NCT03639987|584120731|FG001|Overall Study|Lost to Follow-up|1|||
161749084|NCT02738580|584120732|FG000|Overall Study|Adverse Event|1|||
161749085|NCT02738580|584120733|FG001|Overall Study|Adverse Event|0|||
161749086|NCT02738580|584120732|FG000|Overall Study|Lack of Efficacy|3|||
161749087|NCT02738580|584120733|FG001|Overall Study|Lack of Efficacy|2|||
161749088|NCT02738580|584120732|FG000|Overall Study|Withdrawal by Subject|0|||
161749089|NCT02738580|584120733|FG001|Overall Study|Withdrawal by Subject|1|||
161749090|NCT02738580|584120732|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
161749091|NCT02738580|584120733|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
161749092|NCT04354155|584120734|FG000|Overall Study|Withdrawal by Subject|1|||
161749093|NCT04354155|584120734|FG000|Overall Study|Did not meet criteria for study intervention|1|||
161749094|NCT01015820|584120737|FG000|Overall Study|Suboptimal measurements|1|||
161749095|NCT01015820|584120738|FG001|Overall Study|Suboptimal measurements|0|||
161749096|NCT01998399|584120742|FG000|Overall Study|Lost to Follow-up|1|||
161749097|NCT01998399|584120743|FG001|Overall Study|Lost to Follow-up|3|||
161749098|NCT01998399|584120742|FG000|Overall Study|Death|4|||
161749099|NCT01998399|584120743|FG001|Overall Study|Death|2|||
161749100|NCT01998399|584120742|FG000|Overall Study|Study stopped before dosing completed|3|||
161749101|NCT01998399|584120743|FG001|Overall Study|Study stopped before dosing completed|3|||
161749102|NCT01998399|584120742|FG000|Overall Study|Withdrawal by Subject|0|||
161749103|NCT01998399|584120743|FG001|Overall Study|Withdrawal by Subject|1|||
161749104|NCT00617591|584120744|FG000|Overall Study|Withdrew consent during Induction|4|||
161749105|NCT00617591|584120744|FG000|Overall Study|Withdrew consent during Maintenance|6|||
161749106|NCT00376246|584120745|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
161749107|NCT00376246|584120746|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
161749108|NCT00376246|584120745|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161749109|NCT00376246|584120746|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161749110|NCT00376246|584120745|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161749111|NCT00376246|584120746|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161749112|NCT00351819|584120749|FG000|Overall Study|Lost to Follow-up|4|||
161749113|NCT00351819|584120750|FG001|Overall Study|Lost to Follow-up|4|||
161749114|NCT00351819|584120749|FG000|Overall Study|Withdrawal by Subject|0|||
161749115|NCT00351819|584120750|FG001|Overall Study|Withdrawal by Subject|4|||
161749116|NCT00351819|584120749|FG000|Overall Study|Elevated PSA|1|||
161749117|NCT00351819|584120750|FG001|Overall Study|Elevated PSA|1|||
161749118|NCT00351819|584120749|FG000|Overall Study|Traumatic ankle fracture|1|||
161749119|NCT00351819|584120750|FG001|Overall Study|Traumatic ankle fracture|0|||
161749120|NCT00351819|584120749|FG000|Overall Study|Unprofessional behavior|1|||
161749121|NCT00351819|584120750|FG001|Overall Study|Unprofessional behavior|0|||
161749122|NCT00351819|584120749|FG000|Overall Study|Non-compliance|0|||
161749123|NCT00351819|584120750|FG001|Overall Study|Non-compliance|1|||
161749124|NCT00351819|584120749|FG000|Overall Study|Incarcerated|0|||
161749125|NCT00351819|584120750|FG001|Overall Study|Incarcerated|1|||
161749126|NCT00351819|584120749|FG000|Overall Study|Enrolled in another trial|0|||
161749127|NCT00351819|584120750|FG001|Overall Study|Enrolled in another trial|1|||
161843262|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
161843263|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
161843264|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
161843265|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
161843266|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161843267|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161843268|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161749128|NCT01459068|584120752|FG000|Overall Study|Withdrawal by Subject|8|||
161749129|NCT01459068|584120753|FG001|Overall Study|Withdrawal by Subject|18|||
161749130|NCT01459068|584120752|FG000|Overall Study|Lost to Follow-up|31|||
161749131|NCT01459068|584120753|FG001|Overall Study|Lost to Follow-up|15|||
161749132|NCT01459068|584120752|FG000|Overall Study|Death|0|||
161749133|NCT01459068|584120753|FG001|Overall Study|Death|1|||
161749134|NCT02023112|584120756|FG000|Overall Study|Withdrawal by Subject|2|||
161749135|NCT02023112|584120757|FG001|Overall Study|Withdrawal by Subject|1|||
161749136|NCT01425749|584120758|FG000|Overall Study|progression of melanoma|0|||
161749137|NCT01425749|584120759|FG001|Overall Study|progression of melanoma|1|||
161749138|NCT02910219|584120760|FG000|Overall Study|Withdrawal by Subject|1|||
161749139|NCT02910219|584120761|FG001|Overall Study|Withdrawal by Subject|1|||
161749140|NCT02096042|584120764|FG000|Overall Study|Disease Progression|1|||
161749141|NCT02096042|584120765|FG001|Overall Study|Disease Progression|0|||
161749142|NCT02096042|584120766|FG002|Overall Study|Disease Progression|0|||
161749143|NCT00701441|584120770|FG000|Overall Study|failure in cpap compliance|0|||
161749144|NCT00701441|584120771|FG001|Overall Study|failure in cpap compliance|4|||
161749145|NCT03034057|584120772|FG000|Overall Study|Withdrawal by Subject|10|||
161749146|NCT03034057|584120772|FG000|Overall Study|Protocol Violation|1|||
161749147|NCT03034057|584120772|FG000|Overall Study|Not defined|2|||
161749148|NCT03034057|584120772|FG000|Overall Study|Lost to Follow-up|19|||
161749149|NCT03034057|584120772|FG000|Overall Study|Adverse Event|22|||
161749150|NCT03034057|584120772|FG000|Overall Study|Medication error without associated AE|1|||
161749151|NCT03339401|584120774|FG000|Overall Study|Death|2|||
161749152|NCT03339401|584120775|FG001|Overall Study|Death|1|||
161749153|NCT03339401|584120774|FG000|Overall Study|Withdrawal by Subject|2|||
161749154|NCT03339401|584120775|FG001|Overall Study|Withdrawal by Subject|0|||
161749155|NCT03339401|584120774|FG000|Overall Study|Study terminated|4|||
161749156|NCT03339401|584120775|FG001|Overall Study|Study terminated|3|||
161749157|NCT03339401|584120774|FG000|Overall Study|Investigator Decision|1|||
161749158|NCT03339401|584120775|FG001|Overall Study|Investigator Decision|0|||
161749159|NCT00718523|584120776|FG000|Overall Study|Withdrawal by Subject|5|||
161749160|NCT00718523|584120777|FG001|Overall Study|Withdrawal by Subject|7|||
161749161|NCT00718523|584120776|FG000|Overall Study|Death|13|||
161749162|NCT00718523|584120777|FG001|Overall Study|Death|17|||
161749163|NCT01313078|584120778|FG000|Overall Study|Death|1|||
161749164|NCT01313078|584120778|FG000|Overall Study|Discontinued study drug|1|||
161749165|NCT01313078|584120778|FG000|Overall Study|Withdrawal by Subject|1|||
161749166|NCT00910728|584120779|FG000|Overall Study|Lack of Efficacy|2|||
161749167|NCT00910728|584120780|FG001|Overall Study|Lack of Efficacy|3|||
161749168|NCT00910728|584120781|FG002|Overall Study|Lack of Efficacy|1|||
161749169|NCT00910728|584120782|FG003|Overall Study|Lack of Efficacy|2|||
161749170|NCT00910728|584120783|FG004|Overall Study|Lack of Efficacy|1|||
161749171|NCT00910728|584120784|FG005|Overall Study|Lack of Efficacy|0|||
161749172|NCT00910728|584120785|FG006|Overall Study|Lack of Efficacy|2|||
161749173|NCT00910728|584120786|FG007|Overall Study|Lack of Efficacy|2|||
161749174|NCT00910728|584120787|FG008|Overall Study|Lack of Efficacy|2|||
161749175|NCT00910728|584120779|FG000|Overall Study|Withdrawal by Subject|0|||
161749176|NCT00910728|584120780|FG001|Overall Study|Withdrawal by Subject|0|||
161749177|NCT00910728|584120781|FG002|Overall Study|Withdrawal by Subject|0|||
161749178|NCT00910728|584120782|FG003|Overall Study|Withdrawal by Subject|0|||
161749179|NCT00910728|584120783|FG004|Overall Study|Withdrawal by Subject|3|||
161749180|NCT00910728|584120784|FG005|Overall Study|Withdrawal by Subject|1|||
161749181|NCT00910728|584120785|FG006|Overall Study|Withdrawal by Subject|2|||
161749182|NCT00910728|584120786|FG007|Overall Study|Withdrawal by Subject|0|||
161749183|NCT00910728|584120787|FG008|Overall Study|Withdrawal by Subject|0|||
161749184|NCT00910728|584120779|FG000|Overall Study|(not specified)|2|||
161749185|NCT00910728|584120780|FG001|Overall Study|(not specified)|0|||
161749186|NCT00910728|584120781|FG002|Overall Study|(not specified)|1|||
161749187|NCT00910728|584120782|FG003|Overall Study|(not specified)|0|||
161749188|NCT00910728|584120783|FG004|Overall Study|(not specified)|1|||
161749189|NCT00910728|584120784|FG005|Overall Study|(not specified)|0|||
161749190|NCT00910728|584120785|FG006|Overall Study|(not specified)|0|||
161749191|NCT00910728|584120786|FG007|Overall Study|(not specified)|0|||
161749192|NCT00910728|584120787|FG008|Overall Study|(not specified)|0|||
161749193|NCT00910728|584120779|FG000|Overall Study|Adverse Event|2|||
161749194|NCT00910728|584120780|FG001|Overall Study|Adverse Event|0|||
161843269|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
161843270|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Various|0|||
161843271|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Various|0|||
161843272|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Various|0|||
161749195|NCT00910728|584120781|FG002|Overall Study|Adverse Event|1|||
161749196|NCT00910728|584120782|FG003|Overall Study|Adverse Event|1|||
161749197|NCT00910728|584120783|FG004|Overall Study|Adverse Event|0|||
161749198|NCT00910728|584120784|FG005|Overall Study|Adverse Event|0|||
161749199|NCT00910728|584120785|FG006|Overall Study|Adverse Event|2|||
161749200|NCT00910728|584120786|FG007|Overall Study|Adverse Event|1|||
161749201|NCT00910728|584120787|FG008|Overall Study|Adverse Event|1|||
161749202|NCT01068717|584120791|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
161843273|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Various|25|||
161843274|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
161749203|NCT01068717|584120792|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161749204|NCT01068717|584120793|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161749205|NCT01068717|584120794|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161749206|NCT01822223|584120795|FG000|Overall Study|Death|0|||
161749207|NCT01822223|584120796|FG001|Overall Study|Death|1|||
161749208|NCT01449955|584120799|FG000|Overall Study|Withdrawal by Subject|1|||
161749209|NCT01449955|584120800|FG001|Overall Study|Withdrawal by Subject|2|||
161749210|NCT03404518|584120805|FG000|Overall Study|Lost to Follow-up|28|||
161749211|NCT03404518|584120806|FG001|Overall Study|Lost to Follow-up|30|||
161749212|NCT03404518|584120805|FG000|Overall Study|Protocol Violation|13|||
161749213|NCT03404518|584120806|FG001|Overall Study|Protocol Violation|6|||
161749214|NCT03693404|584120809|FG000|Overall Study|Withdrawal by Subject|1|||
161749215|NCT03693404|584120810|FG001|Overall Study|Withdrawal by Subject|0|||
161749216|NCT03693404|584120809|FG000|Overall Study|Lost to Follow-up|0|||
161749217|NCT03693404|584120810|FG001|Overall Study|Lost to Follow-up|5|||
161749218|NCT03693404|584120809|FG000|Overall Study|Excluded from Analysis|0|||
161749219|NCT03693404|584120810|FG001|Overall Study|Excluded from Analysis|1|||
161749220|NCT01176240|584120811|FG000|Study 306A|Lack of Efficacy|2|||
161749221|NCT01176240|584120812|FG001|Study 306A|Lack of Efficacy|1|||
161749222|NCT01176240|584120811|FG000|Study 306A|Protocol Violation|0|||
161749223|NCT01176240|584120812|FG001|Study 306A|Protocol Violation|1|||
161749224|NCT01176240|584120811|FG000|Study 306A|Withdrawal by Subject|0|||
161749225|NCT01176240|584120812|FG001|Study 306A|Withdrawal by Subject|1|||
161749226|NCT01176240|584120811|FG000|Study 306A|Stop due to diverse problems|1|||
161749227|NCT01176240|584120812|FG001|Study 306A|Stop due to diverse problems|0|||
161749228|NCT01176240|584120811|FG000|Study 306B|Lack of Efficacy|5|||
161749229|NCT01176240|584120812|FG001|Study 306B|Lack of Efficacy|3|||
161749230|NCT01176240|584120811|FG000|Study 306B|Adverse Event|10|||
161749231|NCT01176240|584120812|FG001|Study 306B|Adverse Event|5|||
161749232|NCT01176240|584120811|FG000|Study 306B|Protocol Violation|2|||
161749233|NCT01176240|584120812|FG001|Study 306B|Protocol Violation|3|||
161749234|NCT01176240|584120811|FG000|Study 306B|Withdrawal by Subject|4|||
161749235|NCT01176240|584120812|FG001|Study 306B|Withdrawal by Subject|1|||
161749236|NCT01176240|584120811|FG000|Study 306B|Physician Decision|2|||
161749237|NCT01176240|584120812|FG001|Study 306B|Physician Decision|1|||
161749238|NCT01176240|584120811|FG000|Study 306B|Supine Hypertension|1|||
161749239|NCT01176240|584120812|FG001|Study 306B|Supine Hypertension|2|||
161749240|NCT01176240|584120811|FG000|Study 306B|Lost to Follow-up|0|||
161749241|NCT01176240|584120812|FG001|Study 306B|Lost to Follow-up|1|||
161749242|NCT01176240|584120811|FG000|Study 306B|withdrew prior to dosing|2|||
161749243|NCT01176240|584120812|FG001|Study 306B|withdrew prior to dosing|1|||
161749244|NCT05200455|584120815|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
161749245|NCT00807014|584120816|FG000|Overall Study|Participant Considered Disease Cured|13|||
161749246|NCT00807014|584120817|FG001|Overall Study|Participant Considered Disease Cured|2|||
161749247|NCT00807014|584120816|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
161749248|NCT00807014|584120817|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
161749249|NCT00807014|584120816|FG000|Overall Study|Protocol Violation|2|||
161749250|NCT00807014|584120817|FG001|Overall Study|Protocol Violation|8|||
161749251|NCT00807014|584120816|FG000|Overall Study|Adverse Event|0|||
161749252|NCT00807014|584120817|FG001|Overall Study|Adverse Event|2|||
161749253|NCT00807014|584120816|FG000|Overall Study|Lost to Follow-up|9|||
161749254|NCT00807014|584120817|FG001|Overall Study|Lost to Follow-up|7|||
161749255|NCT00807014|584120816|FG000|Overall Study|Recovery|1|||
161749256|NCT00807014|584120817|FG001|Overall Study|Recovery|0|||
161749257|NCT00807014|584120816|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
161749258|NCT00807014|584120817|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
161749259|NCT00651313|584120818|FG000|Overall Study|Adverse Event|0|||
161749260|NCT00651313|584120819|FG001|Overall Study|Adverse Event|1|||
161749261|NCT00651313|584120818|FG000|Overall Study|Withdrawal by Subject|3|||
161749262|NCT00651313|584120819|FG001|Overall Study|Withdrawal by Subject|1|||
161749263|NCT00651313|584120818|FG000|Overall Study|Lost to Follow-up|1|||
161749264|NCT00651313|584120819|FG001|Overall Study|Lost to Follow-up|1|||
161749265|NCT00651313|584120818|FG000|Overall Study|Adminstrative Discontinuation|2|||
161749266|NCT00651313|584120819|FG001|Overall Study|Adminstrative Discontinuation|3|||
161749267|NCT01731990|584122972|FG000|Overall Study|Adverse Event|1|||
161749268|NCT01731990|584122973|FG001|Overall Study|Adverse Event|5|||
161749269|NCT01731990|584122972|FG000|Overall Study|Withdrawal by Subject|1|||
161749270|NCT01731990|584122973|FG001|Overall Study|Withdrawal by Subject|1|||
161749271|NCT01731990|584122972|FG000|Overall Study|Protocol deviation|1|||
161749272|NCT01731990|584122973|FG001|Overall Study|Protocol deviation|2|||
161749273|NCT01731990|584122972|FG000|Overall Study|Death|1|||
161749274|NCT01731990|584122973|FG001|Overall Study|Death|0|||
161749275|NCT01183104|584122976|FG000|Overall Study|Adverse Event|8|||
161749276|NCT01183104|584122977|FG001|Overall Study|Adverse Event|6|||
161749277|NCT01183104|584122976|FG000|Overall Study|Death|0|||
161749278|NCT01183104|584122977|FG001|Overall Study|Death|1|||
161749279|NCT01183104|584122976|FG000|Overall Study|Lost to Follow-up|14|||
161749280|NCT01183104|584122977|FG001|Overall Study|Lost to Follow-up|7|||
161749281|NCT01183104|584122976|FG000|Overall Study|Physician Decision|5|||
161749282|NCT01183104|584122977|FG001|Overall Study|Physician Decision|8|||
161749283|NCT01183104|584122976|FG000|Overall Study|Withdrawal by Subject|6|||
161749284|NCT01183104|584122977|FG001|Overall Study|Withdrawal by Subject|11|||
161749285|NCT01183104|584122976|FG000|Overall Study|Nonparticipation in Extension Study|39|||
161749286|NCT01183104|584122977|FG001|Overall Study|Nonparticipation in Extension Study|50|||
161749287|NCT01183104|584122976|FG000|Overall Study|Did not receive study drug|5|||
161749288|NCT01183104|584122977|FG001|Overall Study|Did not receive study drug|9|||
161749289|NCT00790218|584122978|FG000|Overall Study|Death|1|||
161749290|NCT00790218|584122979|FG001|Overall Study|Death|0|||
161749291|NCT00790218|584122980|FG002|Overall Study|Death|0|||
161749292|NCT04402385|584122986|FG000|Overall Study|Withdrawal by Subject|4|||
161749293|NCT04402385|584122987|FG001|Overall Study|Withdrawal by Subject|4|||
161749294|NCT04402385|584122986|FG000|Overall Study|Lost to Follow-up|1|||
161749295|NCT04402385|584122987|FG001|Overall Study|Lost to Follow-up|1|||
161749296|NCT04402385|584122986|FG000|Overall Study|Physician Decision|0|||
161749297|NCT04402385|584122987|FG001|Overall Study|Physician Decision|1|||
161749298|NCT00731666|584122988|FG000|Overall Study|Adverse Event|2|||
161749299|NCT00731666|584122988|FG000|Overall Study|Lost to Follow-up|8|||
161749300|NCT00731666|584122988|FG000|Overall Study|Withdrawal by Subject|2|||
161749301|NCT03250624|584122990|FG000|Overall Study|Lack of Efficacy|1|||
161749302|NCT03250624|584122991|FG001|Overall Study|Lack of Efficacy|4|||
161749303|NCT03250624|584122990|FG000|Overall Study|Adverse Event|0|||
161749304|NCT03250624|584122991|FG001|Overall Study|Adverse Event|1|||
161749305|NCT03250624|584122990|FG000|Overall Study|Other|1|||
161749306|NCT03250624|584122991|FG001|Overall Study|Other|2|||
161749307|NCT00948428|584122992|FG000|Overall Study|Withdrawal by Subject|6|||
161749308|NCT00948428|584122993|FG001|Overall Study|Withdrawal by Subject|12|||
161749309|NCT00948428|584122994|FG002|Overall Study|Withdrawal by Subject|7|||
161749310|NCT00948428|584122992|FG000|Overall Study|Adverse Event|6|||
161749311|NCT00948428|584122993|FG001|Overall Study|Adverse Event|3|||
161749312|NCT00948428|584122994|FG002|Overall Study|Adverse Event|0|||
161749313|NCT00948428|584122992|FG000|Overall Study|Lost to Follow-up|2|||
161749314|NCT00948428|584122993|FG001|Overall Study|Lost to Follow-up|1|||
161749315|NCT00948428|584122994|FG002|Overall Study|Lost to Follow-up|1|||
161749316|NCT00948428|584122992|FG000|Overall Study|Death|2|||
161749317|NCT00948428|584122993|FG001|Overall Study|Death|0|||
161749318|NCT00948428|584122994|FG002|Overall Study|Death|0|||
161749319|NCT00948428|584122992|FG000|Overall Study|Intercurrent Illness|1|||
161749320|NCT00948428|584122993|FG001|Overall Study|Intercurrent Illness|0|||
161749321|NCT00948428|584122994|FG002|Overall Study|Intercurrent Illness|0|||
161749322|NCT00948428|584122992|FG000|Overall Study|Non-compliance|1|||
161749323|NCT00948428|584122993|FG001|Overall Study|Non-compliance|2|||
161749324|NCT00948428|584122994|FG002|Overall Study|Non-compliance|0|||
161749325|NCT05516134|584123003|FG000|Overall Study|Lost to Follow-up|1|||
161749326|NCT05516134|584123004|FG001|Overall Study|Lost to Follow-up|0|||
161749327|NCT05516134|584123005|FG002|Overall Study|Lost to Follow-up|0|||
161749328|NCT01355497|584123016|FG000|Overall Study|Death|19|||
161749329|NCT01355497|584123017|FG001|Overall Study|Death|18|||
161749330|NCT01355497|584123016|FG000|Overall Study|Lost to Follow-up|3|||
161749331|NCT01355497|584123017|FG001|Overall Study|Lost to Follow-up|0|||
161749332|NCT01355497|584123016|FG000|Overall Study|Protocol Violation|0|||
161749333|NCT01355497|584123017|FG001|Overall Study|Protocol Violation|1|||
161749334|NCT01355497|584123016|FG000|Overall Study|other-not provided|9|||
161749335|NCT01355497|584123017|FG001|Overall Study|other-not provided|4|||
161749336|NCT01355497|584123016|FG000|Overall Study|Withdrawal by Subject|12|||
161749337|NCT01355497|584123017|FG001|Overall Study|Withdrawal by Subject|20|||
161749338|NCT01355497|584123016|FG000|Overall Study|noncompliance|1|||
161749339|NCT01355497|584123017|FG001|Overall Study|noncompliance|2|||
161749340|NCT01355497|584123016|FG000|Overall Study|progressive disease|11|||
161749341|NCT01355497|584123017|FG001|Overall Study|progressive disease|8|||
161749342|NCT01355497|584123016|FG000|Overall Study|Adverse Event|11|||
161749343|NCT01355497|584123017|FG001|Overall Study|Adverse Event|10|||
161749344|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Death|3|||
161749345|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Death|0|||
161749346|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Death|0|||
161749347|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Death|0|||
161749348|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Death|0|||
161749349|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
161749350|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
161749351|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
161749352|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
161749353|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
161749354|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161749355|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
161749356|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
161749357|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161749358|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
161749359|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Other|0|||
161749360|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Other|0|||
161749361|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Other|1|||
161749362|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Other|0|||
161749363|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Other|0|||
161749364|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
161749365|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
161749366|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
161749367|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
161749368|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
161749369|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
161749370|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
161749371|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
161749372|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
161749373|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
161749374|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161749375|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161749376|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161749377|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161749378|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161749379|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Death|0|||
161749380|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Death|0|||
161749381|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Death|0|||
161749382|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Death|1|||
161749383|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Death|3|||
161749384|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161749385|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161749386|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161749387|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
161749388|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
161749389|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161749390|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161749391|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161749392|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
161749393|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
161749394|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161749395|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161749396|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161749397|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
161749398|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
161749399|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Other|0|||
161749400|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Other|0|||
161749401|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Other|0|||
161749402|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Other|5|||
161749403|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Other|3|||
161749404|NCT00420342|584123026|FG000|Overall Study|Lost to Follow-up|1|||
161749405|NCT00420342|584123027|FG001|Overall Study|Lost to Follow-up|0|||
161749406|NCT00420342|584123028|FG002|Overall Study|Lost to Follow-up|1|||
161749407|NCT00420342|584123026|FG000|Overall Study|Withdrawal by Subject|0|||
161749408|NCT00420342|584123027|FG001|Overall Study|Withdrawal by Subject|2|||
161749409|NCT00420342|584123028|FG002|Overall Study|Withdrawal by Subject|0|||
161749410|NCT00839436|584123031|FG000|Overall Study|Developed exclusionary condition|1|||
161749411|NCT00839436|584123032|FG001|Overall Study|Developed exclusionary condition|0|||
161749412|NCT00839436|584123033|FG002|Overall Study|Developed exclusionary condition|0|||
161749413|NCT00839436|584123031|FG000|Overall Study|Withdrawal by Subject|0|||
161749414|NCT00839436|584123032|FG001|Overall Study|Withdrawal by Subject|1|||
161749415|NCT00839436|584123033|FG002|Overall Study|Withdrawal by Subject|0|||
161749416|NCT00839436|584123031|FG000|Overall Study|Study drug no longer available|0|||
161749417|NCT00839436|584123032|FG001|Overall Study|Study drug no longer available|0|||
161749418|NCT00839436|584123033|FG002|Overall Study|Study drug no longer available|1|||
161749419|NCT01440972|584123034|FG000|Overall Study|Withdrawal by Subject|3|||
161749420|NCT01440972|584123035|FG001|Overall Study|Withdrawal by Subject|2|||
161749421|NCT03933215|584123036|FG000|Overall Study|Other|6|||
161749422|NCT03933215|584123036|FG000|Overall Study|Sponsor decision|5|||
161749423|NCT03933215|584123036|FG000|Overall Study|Protocol Violation|5|||
161749424|NCT03933215|584123036|FG000|Overall Study|Withdrawal by Subject|6|||
161749425|NCT03933215|584123036|FG000|Overall Study|Lost to Follow-up|6|||
161749426|NCT03933215|584123036|FG000|Overall Study|Enrolled but not treated|38|||
161749427|NCT04072575|584123039|FG000|Overall Study|Physician Decision|1|||
161749428|NCT04072575|584123039|FG000|Overall Study|Adverse Event|7|||
161749429|NCT04072575|584123039|FG000|Overall Study|Withdrawal by Subject|14|||
161749430|NCT04072575|584123039|FG000|Overall Study|Other|2|||
161749431|NCT05784129|584123040|FG000|Overall Study|Study terminated by sponsor|2|||
161749432|NCT05784129|584123041|FG001|Overall Study|Study terminated by sponsor|2|||
161749433|NCT01444898|584123042|FG000|Overall Study|Withdrawal by Subject|1|||
161749434|NCT02580591|584123043|FG000|Overall Study|Adverse Event|0|||
161749435|NCT02580591|584123044|FG001|Overall Study|Adverse Event|1|||
161749436|NCT02580591|584123045|FG002|Overall Study|Adverse Event|2|||
161749437|NCT02580591|584123046|FG003|Overall Study|Adverse Event|5|||
161749438|NCT02580591|584123043|FG000|Overall Study|Protocol Violation|3|||
161749439|NCT02580591|584123044|FG001|Overall Study|Protocol Violation|2|||
161749440|NCT02580591|584123045|FG002|Overall Study|Protocol Violation|1|||
161749441|NCT02580591|584123046|FG003|Overall Study|Protocol Violation|1|||
161749442|NCT02580591|584123043|FG000|Overall Study|Lost to Follow-up|5|||
161749443|NCT02580591|584123044|FG001|Overall Study|Lost to Follow-up|3|||
161749444|NCT02580591|584123045|FG002|Overall Study|Lost to Follow-up|3|||
161749445|NCT02580591|584123046|FG003|Overall Study|Lost to Follow-up|1|||
161749446|NCT02580591|584123043|FG000|Overall Study|Withdrawal by Subject|6|||
161749447|NCT02580591|584123044|FG001|Overall Study|Withdrawal by Subject|1|||
161749448|NCT02580591|584123045|FG002|Overall Study|Withdrawal by Subject|2|||
161749449|NCT02580591|584123046|FG003|Overall Study|Withdrawal by Subject|3|||
161749450|NCT02580591|584123043|FG000|Overall Study|Not treated|1|||
161749451|NCT02580591|584123044|FG001|Overall Study|Not treated|1|||
161749452|NCT02580591|584123045|FG002|Overall Study|Not treated|0|||
161749453|NCT02580591|584123046|FG003|Overall Study|Not treated|0|||
161749454|NCT02580591|584123043|FG000|Overall Study|Other than specified|3|||
161749455|NCT02580591|584123044|FG001|Overall Study|Other than specified|2|||
161749456|NCT02580591|584123045|FG002|Overall Study|Other than specified|5|||
161749457|NCT02580591|584123046|FG003|Overall Study|Other than specified|2|||
161749458|NCT01599806|584123048|FG000|Overall Study|Lost to Follow-up|20|||
161749459|NCT01599806|584123049|FG001|Overall Study|Lost to Follow-up|20|||
161749460|NCT01599806|584123048|FG000|Overall Study|Withdrawal by Subject|12|||
161749461|NCT01599806|584123049|FG001|Overall Study|Withdrawal by Subject|12|||
161749462|NCT01599806|584123048|FG000|Overall Study|Other Eligibility criteria|11|||
161749463|NCT01599806|584123049|FG001|Overall Study|Other Eligibility criteria|9|||
161749464|NCT04583969|584123050|FG000|Overall Study|Death|31|||
161749465|NCT04583969|584123051|FG001|Overall Study|Death|38|||
161749466|NCT04583969|584123050|FG000|Overall Study|Lost to Follow-up|16|||
161843275|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
161843276|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
161843277|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
161843278|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
161843279|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
161843280|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
161843281|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
161843282|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
161843283|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
161843284|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
161843285|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
161843286|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Various|1|||
161843287|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Various|1|||
161843288|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Various|1|||
161843289|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Various|0|||
161843290|NCT01868893|584470047|FG000|Overall Study|Adverse Event|2|||
161843291|NCT01868893|584470047|FG000|Overall Study|Commercial availability of study drug|17|||
161843292|NCT01868893|584470047|FG000|Overall Study|Neutropenia|1|||
161843293|NCT01857271|584470048|FG000|Overall Study|Lost to Follow-up|1|||
161843294|NCT03825341|584470051|FG000|Overall Study|Withdrawal by Subject|0|||
161843295|NCT03825341|584470052|FG001|Overall Study|Withdrawal by Subject|1|||
161843296|NCT04283500|584470055|FG000|Overall Study|Lost to Follow-up|8|||
161843297|NCT04283500|584470055|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
161843298|NCT00338455|584470065|FG000|Overall Study|Death|2|||
161843299|NCT00338455|584470066|FG001|Overall Study|Death|1|||
161843300|NCT00338455|584470065|FG000|Overall Study|Physician Decision|1|||
161843301|NCT00338455|584470066|FG001|Overall Study|Physician Decision|0|||
161843302|NCT01517373|584470067|FG000|Run-in Period|Death|1|||
161843303|NCT01517373|584470068|FG001|Run-in Period|Death|0|||
161843304|NCT01517373|584470069|FG002|Run-in Period|Death|0|||
161843305|NCT01517373|584470070|FG003|Run-in Period|Death|0|||
161843306|NCT01517373|584470071|FG004|Run-in Period|Death|0|||
161843307|NCT01517373|584470072|FG005|Run-in Period|Death|0|||
161843308|NCT01517373|584470067|FG000|Run-in Period|Adverse Event|5|||
161843309|NCT01517373|584470068|FG001|Run-in Period|Adverse Event|0|||
161843310|NCT01517373|584470069|FG002|Run-in Period|Adverse Event|0|||
161843311|NCT01517373|584470070|FG003|Run-in Period|Adverse Event|0|||
161843312|NCT01517373|584470071|FG004|Run-in Period|Adverse Event|0|||
161843313|NCT01517373|584470072|FG005|Run-in Period|Adverse Event|0|||
161843314|NCT01517373|584470067|FG000|Run-in Period|Did not meet eligibility criteria|34|||
161843315|NCT01517373|584470068|FG001|Run-in Period|Did not meet eligibility criteria|0|||
161843316|NCT01517373|584470069|FG002|Run-in Period|Did not meet eligibility criteria|0|||
161843317|NCT01517373|584470070|FG003|Run-in Period|Did not meet eligibility criteria|0|||
161843318|NCT01517373|584470071|FG004|Run-in Period|Did not meet eligibility criteria|0|||
161843319|NCT01517373|584470072|FG005|Run-in Period|Did not meet eligibility criteria|0|||
161843320|NCT01517373|584470067|FG000|Run-in Period|Lost to Follow-up|1|||
161843321|NCT01517373|584470068|FG001|Run-in Period|Lost to Follow-up|0|||
161843322|NCT01517373|584470069|FG002|Run-in Period|Lost to Follow-up|0|||
161843323|NCT01517373|584470070|FG003|Run-in Period|Lost to Follow-up|0|||
161843324|NCT01517373|584470071|FG004|Run-in Period|Lost to Follow-up|0|||
161843325|NCT01517373|584470072|FG005|Run-in Period|Lost to Follow-up|0|||
161843326|NCT01517373|584470067|FG000|Run-in Period|Withdrawal by Subject|12|||
161843327|NCT01517373|584470068|FG001|Run-in Period|Withdrawal by Subject|0|||
161843328|NCT01517373|584470069|FG002|Run-in Period|Withdrawal by Subject|0|||
161843329|NCT01517373|584470070|FG003|Run-in Period|Withdrawal by Subject|0|||
161843330|NCT01517373|584470071|FG004|Run-in Period|Withdrawal by Subject|0|||
161843331|NCT01517373|584470072|FG005|Run-in Period|Withdrawal by Subject|0|||
161843332|NCT01517373|584470067|FG000|Run-in Period|Sponsor Decision|3|||
161843333|NCT01517373|584470068|FG001|Run-in Period|Sponsor Decision|0|||
161843334|NCT01517373|584470069|FG002|Run-in Period|Sponsor Decision|0|||
161843335|NCT01517373|584470070|FG003|Run-in Period|Sponsor Decision|0|||
161843336|NCT01517373|584470071|FG004|Run-in Period|Sponsor Decision|0|||
161843337|NCT01517373|584470072|FG005|Run-in Period|Sponsor Decision|0|||
161843338|NCT01517373|584470067|FG000|Run-in Period|Other|1|||
161843339|NCT01517373|584470068|FG001|Run-in Period|Other|0|||
161843340|NCT01517373|584470069|FG002|Run-in Period|Other|0|||
161843341|NCT01517373|584470070|FG003|Run-in Period|Other|0|||
161843342|NCT01517373|584470071|FG004|Run-in Period|Other|0|||
161843343|NCT01517373|584470072|FG005|Run-in Period|Other|0|||
161843344|NCT01517373|584470067|FG000|Treatment Period|Adverse Event|0|||
161843345|NCT01517373|584470068|FG001|Treatment Period|Adverse Event|0|||
161749467|NCT04583969|584123051|FG001|Overall Study|Lost to Follow-up|13|||
161749468|NCT04583969|584123050|FG000|Overall Study|Protocol Violation|1|||
161749469|NCT04583969|584123051|FG001|Overall Study|Protocol Violation|0|||
161749470|NCT04583969|584123050|FG000|Overall Study|Withdrawal by Subject|3|||
161749471|NCT04583969|584123051|FG001|Overall Study|Withdrawal by Subject|3|||
161749472|NCT04583969|584123050|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
161749473|NCT04583969|584123051|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
161749474|NCT04583969|584123050|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
161749475|NCT04583969|584123051|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
161749476|NCT04583969|584123050|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
161749477|NCT04583969|584123051|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
161749478|NCT04583969|584123050|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
161749479|NCT04583969|584123051|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
161749480|NCT04583969|584123050|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
161749481|NCT04583969|584123051|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
161749482|NCT02873208|584123052|FG000|Overall Study|Withdrawal by Subject|36|||
161749483|NCT02873208|584123052|FG000|Overall Study|Lost to Follow-up|22|||
161749484|NCT02873208|584123052|FG000|Overall Study|Adverse Event|15|||
161749485|NCT02873208|584123052|FG000|Overall Study|Non-compliance with study drug|12|||
161749486|NCT02873208|584123052|FG000|Overall Study|Protocol Violation|8|||
161749487|NCT02873208|584123052|FG000|Overall Study|Pregnancy|2|||
161749488|NCT02873208|584123052|FG000|Overall Study|Incarceration|1|||
161749489|NCT02873208|584123052|FG000|Overall Study|Lack of Efficacy|1|||
161749490|NCT02873208|584123052|FG000|Overall Study|Physician Decision|1|||
161749491|NCT00415584|584123053|FG000|Overall Study|Withdrawal by Subject|1|||
161749492|NCT01061567|584123054|FG000|Overall Study|Adverse Event|32|||
161749493|NCT01061567|584123054|FG000|Overall Study|Death|2|||
161749494|NCT01061567|584123054|FG000|Overall Study|Lack of Efficacy|3|||
161749495|NCT01061567|584123054|FG000|Overall Study|Lost to Follow-up|24|||
161749496|NCT01061567|584123054|FG000|Overall Study|Protocol Violation|1|||
161749497|NCT01061567|584123054|FG000|Overall Study|Withdrawal by Subject|11|||
161749498|NCT01061567|584123054|FG000|Overall Study|Other reason than stated above|3|||
161749499|NCT00563368|584123055|FG000|Overall Study|Lost to Follow-up|14|||
161749500|NCT00563368|584123056|FG001|Overall Study|Lost to Follow-up|14|||
161749501|NCT00563368|584123057|FG002|Overall Study|Lost to Follow-up|12|||
161749502|NCT00563368|584123058|FG003|Overall Study|Lost to Follow-up|6|||
161749503|NCT00563368|584123059|FG004|Overall Study|Lost to Follow-up|9|||
161749504|NCT00563368|584123060|FG005|Overall Study|Lost to Follow-up|8|||
161749505|NCT00563368|584123061|FG006|Overall Study|Lost to Follow-up|9|||
161749506|NCT00563368|584123055|FG000|Overall Study|Adverse Event|3|||
161749507|NCT00563368|584123056|FG001|Overall Study|Adverse Event|4|||
161749508|NCT00563368|584123057|FG002|Overall Study|Adverse Event|5|||
161749509|NCT00563368|584123058|FG003|Overall Study|Adverse Event|9|||
161749510|NCT00563368|584123059|FG004|Overall Study|Adverse Event|6|||
161749511|NCT00563368|584123060|FG005|Overall Study|Adverse Event|10|||
161749512|NCT00563368|584123061|FG006|Overall Study|Adverse Event|17|||
161749513|NCT00563368|584123055|FG000|Overall Study|Withdrawal by Subject|11|||
161749514|NCT00563368|584123056|FG001|Overall Study|Withdrawal by Subject|6|||
161749515|NCT00563368|584123057|FG002|Overall Study|Withdrawal by Subject|5|||
161749516|NCT00563368|584123058|FG003|Overall Study|Withdrawal by Subject|7|||
161749517|NCT00563368|584123059|FG004|Overall Study|Withdrawal by Subject|8|||
161749518|NCT00563368|584123060|FG005|Overall Study|Withdrawal by Subject|5|||
161749519|NCT00563368|584123061|FG006|Overall Study|Withdrawal by Subject|4|||
161749520|NCT00563368|584123055|FG000|Overall Study|protocol non-compliance|1|||
161749521|NCT00563368|584123056|FG001|Overall Study|protocol non-compliance|1|||
161749522|NCT00563368|584123057|FG002|Overall Study|protocol non-compliance|2|||
161749523|NCT00563368|584123058|FG003|Overall Study|protocol non-compliance|1|||
161749524|NCT00563368|584123059|FG004|Overall Study|protocol non-compliance|0|||
161749525|NCT00563368|584123060|FG005|Overall Study|protocol non-compliance|1|||
161749526|NCT00563368|584123061|FG006|Overall Study|protocol non-compliance|3|||
161749527|NCT00563368|584123055|FG000|Overall Study|Pregnancy|1|||
161749528|NCT00563368|584123056|FG001|Overall Study|Pregnancy|0|||
161749529|NCT00563368|584123057|FG002|Overall Study|Pregnancy|1|||
161749530|NCT00563368|584123058|FG003|Overall Study|Pregnancy|2|||
161749531|NCT00563368|584123059|FG004|Overall Study|Pregnancy|1|||
161749532|NCT00563368|584123060|FG005|Overall Study|Pregnancy|2|||
161749533|NCT00563368|584123061|FG006|Overall Study|Pregnancy|0|||
161749534|NCT00563368|584123055|FG000|Overall Study|requirement for restricted medication|0|||
161749535|NCT00563368|584123056|FG001|Overall Study|requirement for restricted medication|0|||
161749536|NCT00563368|584123057|FG002|Overall Study|requirement for restricted medication|2|||
161749537|NCT00563368|584123058|FG003|Overall Study|requirement for restricted medication|0|||
161749538|NCT00563368|584123059|FG004|Overall Study|requirement for restricted medication|0|||
161749539|NCT00563368|584123060|FG005|Overall Study|requirement for restricted medication|0|||
161749540|NCT00563368|584123061|FG006|Overall Study|requirement for restricted medication|0|||
161749541|NCT00563368|584123055|FG000|Overall Study|Other|5|||
161749542|NCT00563368|584123056|FG001|Overall Study|Other|5|||
161749543|NCT00563368|584123057|FG002|Overall Study|Other|3|||
161749544|NCT00563368|584123058|FG003|Overall Study|Other|4|||
161749545|NCT00563368|584123059|FG004|Overall Study|Other|4|||
161749546|NCT00563368|584123060|FG005|Overall Study|Other|4|||
161749547|NCT00563368|584123061|FG006|Overall Study|Other|0|||
161749548|NCT00114218|584123073|FG000|Overall Study|Wrong Cell Type|2|||
161749549|NCT00114218|584123073|FG000|Overall Study|Wrong Primary|1|||
161749550|NCT00114218|584123073|FG000|Overall Study|Never Treated|1|||
161749551|NCT03168555|584123074|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
161749552|NCT03168555|584123074|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
161749553|NCT03168555|584123074|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
161749554|NCT03168555|584123074|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
161749555|NCT02959190|584123076|FG000|Open Label|Adverse Event|5|||
161749556|NCT02959190|584123077|FG001|Open Label|Adverse Event|7|||
161749557|NCT02959190|584123078|FG002|Open Label|Adverse Event|3|||
161749558|NCT02959190|584123079|FG003|Open Label|Adverse Event|4|||
161749559|NCT02959190|584123076|FG000|Open Label|Pregnancy|0|||
161749560|NCT02959190|584123077|FG001|Open Label|Pregnancy|1|||
161749561|NCT02959190|584123078|FG002|Open Label|Pregnancy|0|||
161749562|NCT02959190|584123079|FG003|Open Label|Pregnancy|0|||
161749563|NCT02959190|584123076|FG000|Open Label|Withdrawal by Subject|2|||
161749564|NCT02959190|584123077|FG001|Open Label|Withdrawal by Subject|8|||
161749565|NCT02959190|584123078|FG002|Open Label|Withdrawal by Subject|0|||
161749566|NCT02959190|584123079|FG003|Open Label|Withdrawal by Subject|0|||
161749567|NCT02959190|584123076|FG000|Open Label|Physician Decision|0|||
161749568|NCT02959190|584123077|FG001|Open Label|Physician Decision|0|||
161749569|NCT02959190|584123078|FG002|Open Label|Physician Decision|1|||
161749570|NCT02959190|584123079|FG003|Open Label|Physician Decision|0|||
161749571|NCT02959190|584123076|FG000|Open Label|Protocol Violation|0|||
161749572|NCT02959190|584123077|FG001|Open Label|Protocol Violation|0|||
161749573|NCT02959190|584123078|FG002|Open Label|Protocol Violation|0|||
161749574|NCT02959190|584123079|FG003|Open Label|Protocol Violation|2|||
161749575|NCT02959190|584123076|FG000|Post Treatment Follow Up|Adverse Event|1|||
161749576|NCT02959190|584123077|FG001|Post Treatment Follow Up|Adverse Event|1|||
161749577|NCT02959190|584123078|FG002|Post Treatment Follow Up|Adverse Event|0|||
161749578|NCT02959190|584123079|FG003|Post Treatment Follow Up|Adverse Event|0|||
161749579|NCT02959190|584123076|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
161749580|NCT02959190|584123077|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
161749581|NCT02959190|584123078|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
161749582|NCT02959190|584123079|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
161749583|NCT01235507|584123081|FG000|Overall Study|Adverse Event|1|||
161749584|NCT01235507|584123081|FG000|Overall Study|Withdrawal by Subject|1|||
161749585|NCT00588523|584123086|FG000|Overall Study|Not treated|3|||
161749586|NCT02679781|584123087|FG000|Overall Study|Lost to Follow-up|1|||
161749587|NCT02679781|584123088|FG001|Overall Study|Lost to Follow-up|2|||
161749588|NCT02679781|584123087|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
161749589|NCT02679781|584123088|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
161749590|NCT04209400|584123091|FG000|Overall Study|Withdrawal by Subject|0|||
161843346|NCT01517373|584470069|FG002|Treatment Period|Adverse Event|0|||
161843347|NCT01517373|584470070|FG003|Treatment Period|Adverse Event|0|||
161843348|NCT01517373|584470071|FG004|Treatment Period|Adverse Event|0|||
161843349|NCT01517373|584470072|FG005|Treatment Period|Adverse Event|2|||
161843350|NCT01517373|584470067|FG000|Treatment Period|Lost to Follow-up|0|||
161843351|NCT01517373|584470068|FG001|Treatment Period|Lost to Follow-up|0|||
161843352|NCT01517373|584470069|FG002|Treatment Period|Lost to Follow-up|1|||
161843353|NCT01517373|584470070|FG003|Treatment Period|Lost to Follow-up|1|||
161843354|NCT01517373|584470071|FG004|Treatment Period|Lost to Follow-up|0|||
161843355|NCT01517373|584470072|FG005|Treatment Period|Lost to Follow-up|0|||
161843356|NCT01517373|584470067|FG000|Treatment Period|Withdrawal by Subject|0|||
161843357|NCT01517373|584470068|FG001|Treatment Period|Withdrawal by Subject|3|||
161843358|NCT01517373|584470069|FG002|Treatment Period|Withdrawal by Subject|2|||
161843359|NCT01517373|584470070|FG003|Treatment Period|Withdrawal by Subject|2|||
161843360|NCT01517373|584470071|FG004|Treatment Period|Withdrawal by Subject|2|||
161843361|NCT01517373|584470072|FG005|Treatment Period|Withdrawal by Subject|3|||
161749591|NCT04209400|584123092|FG001|Overall Study|Withdrawal by Subject|1|||
161749592|NCT01496274|584123093|FG000|Overall Study|Protocol Violation|0|||
161749593|NCT01496274|584123094|FG001|Overall Study|Protocol Violation|1|||
161749594|NCT01496274|584123093|FG000|Overall Study|Adverse Event|1|||
161749595|NCT01496274|584123094|FG001|Overall Study|Adverse Event|1|||
161749596|NCT01496274|584123093|FG000|Overall Study|Withdrawal by Subject|2|||
161749597|NCT01496274|584123094|FG001|Overall Study|Withdrawal by Subject|0|||
161749598|NCT01496274|584123093|FG000|Overall Study|Lost to Follow-up|0|||
161843362|NCT01517373|584470067|FG000|Treatment Period|Other|0|||
161749599|NCT01496274|584123094|FG001|Overall Study|Lost to Follow-up|3|||
161749600|NCT05041062|584123096|FG000|Overall Study|Adverse Event|2|||
161749601|NCT04968353|584123100|FG000|Overall Study|Non-compliance|1|||
161749602|NCT04968353|584123101|FG001|Overall Study|Non-compliance|0|||
161749603|NCT04968353|584123102|FG002|Overall Study|Non-compliance|2|||
161749604|NCT04968353|584123103|FG003|Overall Study|Non-compliance|0|||
161749605|NCT00318370|584123104|FG000|Period 1|Lack of Efficacy|5|||
161749606|NCT00318370|584123105|FG001|Period 1|Lack of Efficacy|0|||
161749607|NCT00318370|584123106|FG002|Period 1|Lack of Efficacy|0|||
161749608|NCT00318370|584123104|FG000|Period 1|Physician Decision|1|||
161749609|NCT00318370|584123105|FG001|Period 1|Physician Decision|0|||
161749610|NCT00318370|584123106|FG002|Period 1|Physician Decision|0|||
161749611|NCT00318370|584123104|FG000|Period 1|Withdrawal by Subject|1|||
161749612|NCT00318370|584123105|FG001|Period 1|Withdrawal by Subject|0|||
161749613|NCT00318370|584123106|FG002|Period 1|Withdrawal by Subject|0|||
161749614|NCT00318370|584123104|FG000|Period 2|Adverse Event|0|||
161843363|NCT01517373|584470068|FG001|Treatment Period|Other|0|||
161843364|NCT01517373|584470069|FG002|Treatment Period|Other|0|||
161749615|NCT00318370|584123105|FG001|Period 2|Adverse Event|3|||
161843365|NCT01517373|584470070|FG003|Treatment Period|Other|0|||
161749616|NCT00318370|584123106|FG002|Period 2|Adverse Event|0|||
161749617|NCT00318370|584123104|FG000|Period 2|Lack of Efficacy|0|||
161843366|NCT01517373|584470071|FG004|Treatment Period|Other|1|||
161749618|NCT00318370|584123105|FG001|Period 2|Lack of Efficacy|5|||
161749619|NCT00318370|584123106|FG002|Period 2|Lack of Efficacy|0|||
161749620|NCT00318370|584123104|FG000|Period 2|Physician Decision|0|||
161749621|NCT00318370|584123105|FG001|Period 2|Physician Decision|1|||
161749622|NCT00318370|584123106|FG002|Period 2|Physician Decision|0|||
161749623|NCT00318370|584123104|FG000|Period 2|Withdrawal by Subject|0|||
161749624|NCT00318370|584123105|FG001|Period 2|Withdrawal by Subject|1|||
161749625|NCT00318370|584123106|FG002|Period 2|Withdrawal by Subject|0|||
161749626|NCT00318370|584123104|FG000|Period 2|Other|0|||
161749627|NCT00318370|584123105|FG001|Period 2|Other|1|||
161749628|NCT00318370|584123106|FG002|Period 2|Other|0|||
161749629|NCT00318370|584123104|FG000|Period 3|Adverse Event|0|||
161749630|NCT00318370|584123105|FG001|Period 3|Adverse Event|0|||
161749631|NCT00318370|584123106|FG002|Period 3|Adverse Event|1|||
161749632|NCT00318370|584123104|FG000|Period 3|Lack of Efficacy|0|||
161749633|NCT00318370|584123105|FG001|Period 3|Lack of Efficacy|0|||
161749634|NCT00318370|584123106|FG002|Period 3|Lack of Efficacy|24|||
161749635|NCT00318370|584123104|FG000|Period 3|Death|0|||
161749636|NCT00318370|584123105|FG001|Period 3|Death|0|||
161749637|NCT00318370|584123106|FG002|Period 3|Death|1|||
161749638|NCT00318370|584123104|FG000|Period 3|Physician Decision|0|||
161749639|NCT00318370|584123105|FG001|Period 3|Physician Decision|0|||
161749640|NCT00318370|584123106|FG002|Period 3|Physician Decision|1|||
161749641|NCT00318370|584123104|FG000|Period 3|Withdrawal by Subject|0|||
161749642|NCT00318370|584123105|FG001|Period 3|Withdrawal by Subject|0|||
161749643|NCT00318370|584123106|FG002|Period 3|Withdrawal by Subject|3|||
161749644|NCT00318370|584123104|FG000|Period 3|Other|0|||
161749645|NCT00318370|584123105|FG001|Period 3|Other|0|||
161749646|NCT00318370|584123106|FG002|Period 3|Other|3|||
161749647|NCT00892957|584123112|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
161749648|NCT00892957|584123113|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
161749649|NCT00892957|584123112|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
161749650|NCT00892957|584123113|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
161749651|NCT03307629|584123119|FG000|Overall Study|Withdrawal by Subject|0|||
161749652|NCT03307629|584123120|FG001|Overall Study|Withdrawal by Subject|0|||
161749653|NCT03307629|584123121|FG002|Overall Study|Withdrawal by Subject|0|||
161749654|NCT03307629|584123122|FG003|Overall Study|Withdrawal by Subject|2|||
161749655|NCT03307629|584123119|FG000|Overall Study|Disease Progression|0|||
161749656|NCT03307629|584123120|FG001|Overall Study|Disease Progression|0|||
161749657|NCT03307629|584123121|FG002|Overall Study|Disease Progression|0|||
161749658|NCT03307629|584123122|FG003|Overall Study|Disease Progression|3|||
161749659|NCT03307629|584123119|FG000|Overall Study|Death|0|||
161749660|NCT03307629|584123120|FG001|Overall Study|Death|3|||
161749661|NCT03307629|584123121|FG002|Overall Study|Death|0|||
161749662|NCT03307629|584123122|FG003|Overall Study|Death|1|||
161749663|NCT02853032|584123127|FG000|Overall Study|Adverse Event|4|||
161749664|NCT02853032|584123128|FG001|Overall Study|Adverse Event|0|||
161749665|NCT02853032|584123127|FG000|Overall Study|Withdrawal by Subject|3|||
161749666|NCT02853032|584123128|FG001|Overall Study|Withdrawal by Subject|1|||
161749667|NCT02853032|584123127|FG000|Overall Study|Requested to withdraw from all treatment|2|||
161749668|NCT02853032|584123128|FG001|Overall Study|Requested to withdraw from all treatment|2|||
161749669|NCT03700736|584123129|FG000|Overall Study|Pregnancy|1|||
161749670|NCT03700736|584123130|FG001|Overall Study|Pregnancy|1|||
161749671|NCT03700736|584123129|FG000|Overall Study|Withdrawal by Subject|2|||
161749672|NCT03700736|584123130|FG001|Overall Study|Withdrawal by Subject|6|||
161749673|NCT04126031|584123132|FG000|Part A|Withdrawal by Subject|0|||
161749674|NCT04126031|584123133|FG001|Part A|Withdrawal by Subject|0|||
161749675|NCT04126031|584123134|FG002|Part A|Withdrawal by Subject|1|||
161749676|NCT04126031|584123135|FG003|Part A|Withdrawal by Subject|0|||
161749677|NCT04126031|584123136|FG004|Part A|Withdrawal by Subject|0|||
161749678|NCT04126031|584123137|FG005|Part A|Withdrawal by Subject|0|||
161749679|NCT04126031|584123132|FG000|Part A|Other|1|||
161749680|NCT04126031|584123133|FG001|Part A|Other|0|||
161749681|NCT04126031|584123134|FG002|Part A|Other|0|||
161749682|NCT04126031|584123135|FG003|Part A|Other|0|||
161749683|NCT04126031|584123136|FG004|Part A|Other|0|||
161749684|NCT04126031|584123137|FG005|Part A|Other|0|||
161749685|NCT04126031|584123132|FG000|Part B|Adverse Event|0|||
161749686|NCT04126031|584123133|FG001|Part B|Adverse Event|0|||
161749687|NCT04126031|584123134|FG002|Part B|Adverse Event|0|||
161749688|NCT04126031|584123135|FG003|Part B|Adverse Event|0|||
161749689|NCT04126031|584123136|FG004|Part B|Adverse Event|0|||
161749690|NCT04126031|584123137|FG005|Part B|Adverse Event|2|||
161749691|NCT04126031|584123132|FG000|Part B|Pre-existing hypertransaminasemia|0|||
161749692|NCT04126031|584123133|FG001|Part B|Pre-existing hypertransaminasemia|0|||
161749693|NCT04126031|584123134|FG002|Part B|Pre-existing hypertransaminasemia|0|||
161749694|NCT04126031|584123135|FG003|Part B|Pre-existing hypertransaminasemia|0|||
161749695|NCT04126031|584123136|FG004|Part B|Pre-existing hypertransaminasemia|1|||
161749696|NCT04126031|584123137|FG005|Part B|Pre-existing hypertransaminasemia|0|||
161749697|NCT00131664|584123138|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
161749698|NCT00131664|584123139|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
161749699|NCT00131664|584123140|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
161749700|NCT00131664|584123141|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
161749701|NCT00131664|584123142|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
161749702|NCT00131664|584123143|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
161749703|NCT00131664|584123138|FG000|First Period (First 6 Months)|Death|0|||
161749704|NCT00131664|584123139|FG001|First Period (First 6 Months)|Death|1|||
161749705|NCT00131664|584123140|FG002|First Period (First 6 Months)|Death|0|||
161749706|NCT00131664|584123141|FG003|First Period (First 6 Months)|Death|0|||
161749707|NCT00131664|584123142|FG004|First Period (First 6 Months)|Death|0|||
161749708|NCT00131664|584123143|FG005|First Period (First 6 Months)|Death|0|||
161749709|NCT00131664|584123138|FG000|First Period (First 6 Months)|Protocol Violation|2|||
161749710|NCT00131664|584123139|FG001|First Period (First 6 Months)|Protocol Violation|2|||
161749711|NCT00131664|584123140|FG002|First Period (First 6 Months)|Protocol Violation|1|||
161749712|NCT00131664|584123141|FG003|First Period (First 6 Months)|Protocol Violation|0|||
161749713|NCT00131664|584123142|FG004|First Period (First 6 Months)|Protocol Violation|0|||
161749714|NCT00131664|584123143|FG005|First Period (First 6 Months)|Protocol Violation|0|||
161749715|NCT00131664|584123138|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
161749716|NCT00131664|584123139|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
161749717|NCT00131664|584123140|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
161749718|NCT00131664|584123141|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
161749719|NCT00131664|584123142|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
161749720|NCT00131664|584123143|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
161749721|NCT00131664|584123138|FG000|First Period (First 6 Months)|Adverse Event|9|||
161749722|NCT00131664|584123139|FG001|First Period (First 6 Months)|Adverse Event|4|||
161749723|NCT00131664|584123140|FG002|First Period (First 6 Months)|Adverse Event|5|||
161749724|NCT00131664|584123141|FG003|First Period (First 6 Months)|Adverse Event|0|||
161749725|NCT00131664|584123142|FG004|First Period (First 6 Months)|Adverse Event|0|||
161749726|NCT00131664|584123143|FG005|First Period (First 6 Months)|Adverse Event|0|||
161749727|NCT00131664|584123138|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
161749728|NCT00131664|584123139|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
161749729|NCT00131664|584123140|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749730|NCT00131664|584123141|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749731|NCT00131664|584123142|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749732|NCT00131664|584123143|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749733|NCT00131664|584123138|FG000|First Period (First 6 Months)|Administrative reasons|2|||
161749734|NCT00131664|584123139|FG001|First Period (First 6 Months)|Administrative reasons|0|||
161749735|NCT00131664|584123140|FG002|First Period (First 6 Months)|Administrative reasons|5|||
161749736|NCT00131664|584123141|FG003|First Period (First 6 Months)|Administrative reasons|0|||
161749737|NCT00131664|584123142|FG004|First Period (First 6 Months)|Administrative reasons|0|||
161749738|NCT00131664|584123143|FG005|First Period (First 6 Months)|Administrative reasons|0|||
161749739|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
161749740|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
161749741|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
161749742|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
161749743|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
161749744|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
161749745|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749746|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
161749747|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
161749748|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749749|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749750|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749751|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
161749752|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749753|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749754|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749755|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749756|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161843367|NCT01517373|584470072|FG005|Treatment Period|Other|0|||
161843368|NCT01517373|584470067|FG000|Treatment Period|Protocol Violation|0|||
161749757|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
161749758|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
161749759|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
161749760|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
161749761|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
161749762|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
161749763|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749764|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749765|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749766|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
161749767|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749768|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749769|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
161749770|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
161749771|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
161749772|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
161749773|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
161749774|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
161749775|NCT01495689|584124515|FG000|Overall Study|Death|0|||
161749776|NCT01495689|584124516|FG001|Overall Study|Death|1|||
161749777|NCT01495689|584124515|FG000|Overall Study|Withdrawal by Subject|3|||
161749778|NCT01495689|584124516|FG001|Overall Study|Withdrawal by Subject|0|||
161749779|NCT01495689|584124515|FG000|Overall Study|Lost to Follow-up|7|||
161749780|NCT01495689|584124516|FG001|Overall Study|Lost to Follow-up|6|||
161749781|NCT01119963|584124517|FG000|Overall Study|Lost to Follow-up|1|||
161749782|NCT01119963|584124518|FG001|Overall Study|Lost to Follow-up|1|||
161749783|NCT00254163|584124519|FG000|Overall Study|Adverse Event|29|||
161749784|NCT00254163|584124520|FG001|Overall Study|Adverse Event|26|||
161749785|NCT00254163|584124519|FG000|Overall Study|Patient request/withdrew consent|6|||
161749786|NCT00254163|584124520|FG001|Overall Study|Patient request/withdrew consent|4|||
161749787|NCT00254163|584124519|FG000|Overall Study|Investigator request|1|||
161749788|NCT00254163|584124520|FG001|Overall Study|Investigator request|3|||
161749789|NCT00254163|584124519|FG000|Overall Study|Failed entry|1|||
161749790|NCT00254163|584124520|FG001|Overall Study|Failed entry|3|||
161749791|NCT00254163|584124519|FG000|Overall Study|Progressive disease|0|||
161749792|NCT00254163|584124520|FG001|Overall Study|Progressive disease|1|||
161749793|NCT00254163|584124519|FG000|Overall Study|Death|0|||
161749794|NCT00254163|584124520|FG001|Overall Study|Death|1|||
161749795|NCT00254163|584124519|FG000|Overall Study|Other|8|||
161749796|NCT00254163|584124520|FG001|Overall Study|Other|8|||
161749797|NCT02579863|584124521|FG000|Overall Study|Final Disposition Unknown|2|||
161749798|NCT02579863|584124522|FG001|Overall Study|Final Disposition Unknown|1|||
161749799|NCT02579863|584124521|FG000|Overall Study|Adverse Event|18|||
161749800|NCT02579863|584124522|FG001|Overall Study|Adverse Event|11|||
161749801|NCT02579863|584124521|FG000|Overall Study|Death|31|||
161749802|NCT02579863|584124522|FG001|Overall Study|Death|29|||
161749803|NCT02579863|584124521|FG000|Overall Study|Lost to Follow-up|2|||
161749804|NCT02579863|584124522|FG001|Overall Study|Lost to Follow-up|1|||
161749805|NCT02579863|584124521|FG000|Overall Study|Physician Decision|1|||
161749806|NCT02579863|584124522|FG001|Overall Study|Physician Decision|2|||
161749807|NCT02579863|584124521|FG000|Overall Study|Screen Failure|0|||
161749808|NCT02579863|584124522|FG001|Overall Study|Screen Failure|2|||
161749809|NCT02579863|584124521|FG000|Overall Study|Study Terminated at Selected Sites|82|||
161749810|NCT02579863|584124522|FG001|Overall Study|Study Terminated at Selected Sites|88|||
161749811|NCT02579863|584124521|FG000|Overall Study|Withdrawal by Subject|20|||
161749812|NCT02579863|584124522|FG001|Overall Study|Withdrawal by Subject|20|||
161749813|NCT00809614|584124527|FG000|Overall Study|Lack of Efficacy|2|||
161749814|NCT00809614|584124528|FG001|Overall Study|Lack of Efficacy|3|||
161749815|NCT00809614|584124527|FG000|Overall Study|Withdrawal by Subject|1|||
161749816|NCT00809614|584124528|FG001|Overall Study|Withdrawal by Subject|1|||
161749817|NCT00446797|584124529|FG000|Overall Study|Lack of Efficacy|0|||
161749818|NCT00446797|584124530|FG001|Overall Study|Lack of Efficacy|2|||
161749819|NCT00446797|584124529|FG000|Overall Study|Lost to Follow-up|5|||
161749820|NCT00446797|584124530|FG001|Overall Study|Lost to Follow-up|3|||
161749821|NCT00446797|584124529|FG000|Overall Study|Withdrawal by Subject|2|||
161749822|NCT00446797|584124530|FG001|Overall Study|Withdrawal by Subject|2|||
161749823|NCT00446797|584124529|FG000|Overall Study|Protocol Violation|1|||
161749824|NCT00446797|584124530|FG001|Overall Study|Protocol Violation|3|||
161749825|NCT00446797|584124529|FG000|Overall Study|subject entered at another site|0|||
161749826|NCT00446797|584124530|FG001|Overall Study|subject entered at another site|1|||
161749827|NCT00446797|584124529|FG000|Overall Study|did not meet entrance criteria|0|||
161749828|NCT00446797|584124530|FG001|Overall Study|did not meet entrance criteria|1|||
161749829|NCT00364832|584124531|FG000|Core Period|Early Withdrawals|2|||
161749830|NCT00364832|584124532|FG001|Core Period|Early Withdrawals|2|||
161749831|NCT00364832|584124533|FG002|Core Period|Early Withdrawals|1|||
161749832|NCT00364832|584124534|FG003|Core Period|Early Withdrawals|1|||
161749833|NCT00364832|584124535|FG004|Core Period|Early Withdrawals|0|||
161749834|NCT00364832|584124536|FG005|Core Period|Early Withdrawals|0|||
161749835|NCT00364832|584124537|FG006|Core Period|Early Withdrawals|4|||
161749836|NCT00364832|584124538|FG007|Core Period|Early Withdrawals|1|||
161749837|NCT00364832|584124539|FG008|Core Period|Early Withdrawals|0|||
161749838|NCT00364832|584124540|FG009|Core Period|Early Withdrawals|0|||
161749839|NCT00364832|584124541|FG010|Core Period|Early Withdrawals|0|||
161749840|NCT00364832|584124542|FG011|Core Period|Early Withdrawals|0|||
161749841|NCT00364832|584124531|FG000|Extension Year 1|Early Withdrawals|0|||
161749842|NCT00364832|584124532|FG001|Extension Year 1|Early Withdrawals|0|||
161749843|NCT00364832|584124533|FG002|Extension Year 1|Early Withdrawals|0|||
161749844|NCT00364832|584124534|FG003|Extension Year 1|Early Withdrawals|0|||
161749845|NCT00364832|584124535|FG004|Extension Year 1|Early Withdrawals|0|||
161749846|NCT00364832|584124536|FG005|Extension Year 1|Early Withdrawals|0|||
161749847|NCT00364832|584124537|FG006|Extension Year 1|Early Withdrawals|0|||
161749848|NCT00364832|584124538|FG007|Extension Year 1|Early Withdrawals|0|||
161749849|NCT00364832|584124539|FG008|Extension Year 1|Early Withdrawals|0|||
161749850|NCT00364832|584124540|FG009|Extension Year 1|Early Withdrawals|4|||
161749851|NCT00364832|584124541|FG010|Extension Year 1|Early Withdrawals|2|||
161749852|NCT00364832|584124542|FG011|Extension Year 1|Early Withdrawals|10|||
161749853|NCT00364832|584124531|FG000|Extension Year 2|Early Withdrawals|0|||
161749854|NCT00364832|584124532|FG001|Extension Year 2|Early Withdrawals|0|||
161749855|NCT00364832|584124533|FG002|Extension Year 2|Early Withdrawals|0|||
161749856|NCT00364832|584124534|FG003|Extension Year 2|Early Withdrawals|0|||
161749857|NCT00364832|584124535|FG004|Extension Year 2|Early Withdrawals|0|||
161749858|NCT00364832|584124536|FG005|Extension Year 2|Early Withdrawals|0|||
161749859|NCT00364832|584124537|FG006|Extension Year 2|Early Withdrawals|0|||
161749860|NCT00364832|584124538|FG007|Extension Year 2|Early Withdrawals|0|||
161749861|NCT00364832|584124539|FG008|Extension Year 2|Early Withdrawals|0|||
161749862|NCT00364832|584124540|FG009|Extension Year 2|Early Withdrawals|5|||
161749863|NCT00364832|584124541|FG010|Extension Year 2|Early Withdrawals|5|||
161749864|NCT00364832|584124542|FG011|Extension Year 2|Early Withdrawals|3|||
161749865|NCT03210220|584124543|FG000|Overall Study|Physician Decision|1|||
161749866|NCT03210220|584124544|FG001|Overall Study|Physician Decision|0|||
161749867|NCT00407550|584124545|FG000|Overall Study|Adverse Event|0|||
161749868|NCT00407550|584124546|FG001|Overall Study|Adverse Event|1|||
161749869|NCT00407550|584124545|FG000|Overall Study|Withdrawal by Subject|0|||
161749870|NCT00407550|584124546|FG001|Overall Study|Withdrawal by Subject|2|||
161749871|NCT00407550|584124545|FG000|Overall Study|Death|1|||
161749872|NCT00407550|584124546|FG001|Overall Study|Death|0|||
161749873|NCT00407550|584124545|FG000|Overall Study|Insurance or Other medical condition|2|||
161749874|NCT00407550|584124546|FG001|Overall Study|Insurance or Other medical condition|1|||
161749875|NCT03006926|584124548|FG000|Overall Study|Adverse Event|0|||
161749876|NCT03006926|584124549|FG001|Overall Study|Adverse Event|27|||
161749877|NCT03006926|584124548|FG000|Overall Study|Withdrawal by Subject|0|||
161749878|NCT03006926|584124549|FG001|Overall Study|Withdrawal by Subject|1|||
161749879|NCT03006926|584124548|FG000|Overall Study|Radiological Disease Progression|0|||
161749880|NCT03006926|584124549|FG001|Overall Study|Radiological Disease Progression|52|||
161749881|NCT03006926|584124548|FG000|Overall Study|Clinical Disease Progression|0|||
161749882|NCT03006926|584124549|FG001|Overall Study|Clinical Disease Progression|10|||
161749883|NCT03006926|584124548|FG000|Overall Study|Other|0|||
161749884|NCT03006926|584124549|FG001|Overall Study|Other|8|||
161749885|NCT01838213|584124550|FG000|Overall Study|Ineligible|166|||
161749886|NCT01838213|584124551|FG001|Overall Study|Ineligible|191|||
161749887|NCT04882072|584124556|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
161749888|NCT04882072|584124557|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
161749889|NCT04882072|584124556|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
161749890|NCT04882072|584124557|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
161749891|NCT04882072|584124556|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
161749892|NCT04882072|584124557|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
161749893|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
161749894|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
161749895|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
161749896|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
161749897|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
161749898|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749899|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749900|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749901|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
161749902|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749903|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749904|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749905|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749906|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
161749907|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749908|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
161749909|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
161749910|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161749911|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161749912|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161749913|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749914|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749915|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749916|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
161749917|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749918|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
161749919|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
161749920|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
161749921|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
161749922|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
161749923|NCT02918318|584124558|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749924|NCT02918318|584124559|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749925|NCT02918318|584124560|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749926|NCT02918318|584124561|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
161749927|NCT02918318|584124562|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749928|NCT02918318|584124558|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749929|NCT02918318|584124559|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749930|NCT02918318|584124560|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749931|NCT02918318|584124561|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749932|NCT02918318|584124562|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749933|NCT02918318|584124558|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
161749934|NCT02918318|584124559|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161749935|NCT02918318|584124560|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161749936|NCT02918318|584124561|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
161749937|NCT02918318|584124562|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161749938|NCT02918318|584124558|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
161749939|NCT02918318|584124559|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
161749940|NCT02918318|584124560|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
161749941|NCT02918318|584124561|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
161749942|NCT02918318|584124562|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
161749943|NCT02918318|584124558|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749944|NCT02918318|584124559|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749945|NCT02918318|584124560|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749946|NCT02918318|584124561|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749947|NCT02918318|584124562|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
161749948|NCT02918318|584124558|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749949|NCT02918318|584124559|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749950|NCT02918318|584124560|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749951|NCT02918318|584124561|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749952|NCT02918318|584124562|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749953|NCT00990249|584124563|FG000|Overall Study|Disease Progression|8|||
161749954|NCT00990249|584124563|FG000|Overall Study|Non-Compliance|1|||
161749955|NCT00990249|584124563|FG000|Overall Study|Death|2|||
161749956|NCT00990249|584124563|FG000|Overall Study|Not treated|2|||
161749957|NCT01548417|584124564|FG000|Overall Study|Withdrawal by Subject|0|||
161749958|NCT01548417|584124565|FG001|Overall Study|Withdrawal by Subject|2|||
161749959|NCT01098032|584124570|FG000|Overall Study|Withdrawal by Subject|1|||
161749960|NCT01098032|584124571|FG001|Overall Study|Withdrawal by Subject|1|||
161749961|NCT01421069|584124572|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
161749962|NCT01421069|584124572|FG000|Parent Study|Failed to return|3|||
161749963|NCT01421069|584124572|FG000|Parent Study|Withdrawal by Subject|1|||
161749964|NCT01421069|584124572|FG000|Parent Study|Lost to Follow-up|2|||
161749965|NCT01421069|584124572|FG000|Parent Study|Lack of Efficacy|1|||
161749966|NCT01421069|584124572|FG000|Overall Period for Extension Study|Other|2|||
161749967|NCT01421069|584124572|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
161749968|NCT01421069|584124572|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
161749969|NCT01421069|584124572|FG000|Overall Period for Extension Study|Pregnancy|1|||
161749970|NCT01421069|584124572|FG000|Overall Period for Extension Study|Adverse Event|1|||
161749971|NCT01421069|584124572|FG000|Overall Period for Extension Study|Protocol Violation|1|||
161749972|NCT01421069|584124572|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
161749973|NCT01421069|584124572|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
161749974|NCT01421069|584124572|FG000|Active Treatment Period|Other|1|||
161749975|NCT01421069|584124572|FG000|Active Treatment Period|No longer willing to participate in study|8|||
161749976|NCT01421069|584124572|FG000|Active Treatment Period|Insufficient clinical response|1|||
161749977|NCT01421069|584124572|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
161749978|NCT01421069|584124572|FG000|Active Treatment Period|Pregnancy|1|||
161749979|NCT01421069|584124572|FG000|Active Treatment Period|Adverse Event|1|||
161749980|NCT01421069|584124572|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
161749981|NCT01421069|584124572|FG000|Active Treatment Period|Enrolled in observational period|29|||
161749982|NCT01421069|584124572|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
161749983|NCT01421069|584124572|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
161749984|NCT01421069|584124572|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
161749985|NCT01421069|584124572|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
161749986|NCT01421069|584124572|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
161749987|NCT01421069|584124572|FG000|2b. Retreatment Period|Protocol Violation|1|||
161749988|NCT01421069|584124572|FG000|Observational Period|Other|1|||
161749989|NCT01421069|584124572|FG000|Observational Period|No longer willing to participate in study|4|||
161749990|NCT01421069|584124572|FG000|Observational Period|Lost to Follow-up|3|||
161749991|NCT01641081|584124573|FG000|Period 1|Sponsor request (potential unblinding)|0|||
161749992|NCT01641081|584124574|FG001|Period 1|Sponsor request (potential unblinding)|0|||
161749993|NCT01641081|584124575|FG002|Period 1|Sponsor request (potential unblinding)|0|||
161749994|NCT01641081|584124576|FG003|Period 1|Sponsor request (potential unblinding)|0|||
161749995|NCT01641081|584124577|FG004|Period 1|Sponsor request (potential unblinding)|0|||
161749996|NCT01641081|584124578|FG005|Period 1|Sponsor request (potential unblinding)|0|||
161749997|NCT01641081|584124579|FG006|Period 1|Sponsor request (potential unblinding)|1|||
161749998|NCT01641081|584124580|FG007|Period 1|Sponsor request (potential unblinding)|0|||
161749999|NCT01641081|584124581|FG008|Period 1|Sponsor request (potential unblinding)|0|||
161750000|NCT01641081|584124582|FG009|Period 1|Sponsor request (potential unblinding)|0|||
161750001|NCT01641081|584124573|FG000|Period 1|Protocol Violation|0|||
161750002|NCT01641081|584124574|FG001|Period 1|Protocol Violation|0|||
161750003|NCT01641081|584124575|FG002|Period 1|Protocol Violation|0|||
161750004|NCT01641081|584124576|FG003|Period 1|Protocol Violation|0|||
161750005|NCT01641081|584124577|FG004|Period 1|Protocol Violation|1|||
161750006|NCT01641081|584124578|FG005|Period 1|Protocol Violation|0|||
161750007|NCT01641081|584124579|FG006|Period 1|Protocol Violation|0|||
161750008|NCT01641081|584124580|FG007|Period 1|Protocol Violation|1|||
161750009|NCT01641081|584124581|FG008|Period 1|Protocol Violation|0|||
161750010|NCT01641081|584124582|FG009|Period 1|Protocol Violation|0|||
161750011|NCT01641081|584124573|FG000|Period 1|Adverse Event|1|||
161750012|NCT01641081|584124574|FG001|Period 1|Adverse Event|0|||
161750013|NCT01641081|584124575|FG002|Period 1|Adverse Event|0|||
161750014|NCT01641081|584124576|FG003|Period 1|Adverse Event|0|||
161750015|NCT01641081|584124577|FG004|Period 1|Adverse Event|0|||
161750016|NCT01641081|584124578|FG005|Period 1|Adverse Event|0|||
161750017|NCT01641081|584124579|FG006|Period 1|Adverse Event|0|||
161750018|NCT01641081|584124580|FG007|Period 1|Adverse Event|2|||
161750019|NCT01641081|584124581|FG008|Period 1|Adverse Event|0|||
161750020|NCT01641081|584124582|FG009|Period 1|Adverse Event|0|||
161750021|NCT01641081|584124573|FG000|Period 2|Adverse Event|0|||
161750022|NCT01641081|584124574|FG001|Period 2|Adverse Event|0|||
161750023|NCT01641081|584124575|FG002|Period 2|Adverse Event|0|||
161750024|NCT01641081|584124576|FG003|Period 2|Adverse Event|0|||
161750025|NCT01641081|584124577|FG004|Period 2|Adverse Event|0|||
161750026|NCT01641081|584124578|FG005|Period 2|Adverse Event|1|||
161750027|NCT01641081|584124579|FG006|Period 2|Adverse Event|0|||
161750028|NCT01641081|584124580|FG007|Period 2|Adverse Event|0|||
161750029|NCT01641081|584124581|FG008|Period 2|Adverse Event|0|||
161750030|NCT01641081|584124582|FG009|Period 2|Adverse Event|0|||
161750031|NCT01641081|584124573|FG000|Period 2|Withdrawal by Subject|0|||
161750032|NCT01641081|584124574|FG001|Period 2|Withdrawal by Subject|0|||
161750033|NCT01641081|584124575|FG002|Period 2|Withdrawal by Subject|0|||
161750034|NCT01641081|584124576|FG003|Period 2|Withdrawal by Subject|1|||
161750035|NCT01641081|584124577|FG004|Period 2|Withdrawal by Subject|0|||
161750036|NCT01641081|584124578|FG005|Period 2|Withdrawal by Subject|0|||
161750037|NCT01641081|584124579|FG006|Period 2|Withdrawal by Subject|2|||
161750038|NCT01641081|584124580|FG007|Period 2|Withdrawal by Subject|0|||
161750039|NCT01641081|584124581|FG008|Period 2|Withdrawal by Subject|0|||
161750040|NCT01641081|584124582|FG009|Period 2|Withdrawal by Subject|0|||
161750041|NCT01641081|584124573|FG000|Period 2|Protocol Violation|1|||
161750042|NCT01641081|584124574|FG001|Period 2|Protocol Violation|0|||
161750043|NCT01641081|584124575|FG002|Period 2|Protocol Violation|0|||
161750044|NCT01641081|584124576|FG003|Period 2|Protocol Violation|0|||
161750045|NCT01641081|584124577|FG004|Period 2|Protocol Violation|0|||
161750046|NCT01641081|584124578|FG005|Period 2|Protocol Violation|0|||
161750047|NCT01641081|584124579|FG006|Period 2|Protocol Violation|0|||
161750048|NCT01641081|584124580|FG007|Period 2|Protocol Violation|0|||
161750049|NCT01641081|584124581|FG008|Period 2|Protocol Violation|0|||
161750050|NCT01641081|584124582|FG009|Period 2|Protocol Violation|0|||
161750051|NCT01641081|584124573|FG000|Period 3|Adverse Event|0|||
161750052|NCT01641081|584124574|FG001|Period 3|Adverse Event|0|||
161750053|NCT01641081|584124575|FG002|Period 3|Adverse Event|1|||
161750054|NCT01641081|584124576|FG003|Period 3|Adverse Event|0|||
161750055|NCT01641081|584124577|FG004|Period 3|Adverse Event|0|||
161750056|NCT01641081|584124578|FG005|Period 3|Adverse Event|0|||
161750057|NCT01641081|584124579|FG006|Period 3|Adverse Event|0|||
161750058|NCT01641081|584124580|FG007|Period 3|Adverse Event|0|||
161750059|NCT01641081|584124581|FG008|Period 3|Adverse Event|0|||
161750060|NCT01641081|584124582|FG009|Period 3|Adverse Event|0|||
161750061|NCT01641081|584124573|FG000|Period 3|Withdrawal by Subject|0|||
161750062|NCT01641081|584124574|FG001|Period 3|Withdrawal by Subject|0|||
161750063|NCT01641081|584124575|FG002|Period 3|Withdrawal by Subject|0|||
161750064|NCT01641081|584124576|FG003|Period 3|Withdrawal by Subject|0|||
161750065|NCT01641081|584124577|FG004|Period 3|Withdrawal by Subject|0|||
161750066|NCT01641081|584124578|FG005|Period 3|Withdrawal by Subject|0|||
161750067|NCT01641081|584124579|FG006|Period 3|Withdrawal by Subject|0|||
161750068|NCT01641081|584124580|FG007|Period 3|Withdrawal by Subject|0|||
161750069|NCT01641081|584124581|FG008|Period 3|Withdrawal by Subject|1|||
161750070|NCT01641081|584124582|FG009|Period 3|Withdrawal by Subject|0|||
161750071|NCT01641081|584124573|FG000|Period 4|Adverse Event|0|||
161750072|NCT01641081|584124574|FG001|Period 4|Adverse Event|1|||
161750073|NCT01641081|584124575|FG002|Period 4|Adverse Event|0|||
161750074|NCT01641081|584124576|FG003|Period 4|Adverse Event|1|||
161750075|NCT01641081|584124577|FG004|Period 4|Adverse Event|0|||
161750076|NCT01641081|584124578|FG005|Period 4|Adverse Event|0|||
161750077|NCT01641081|584124579|FG006|Period 4|Adverse Event|0|||
161750078|NCT01641081|584124580|FG007|Period 4|Adverse Event|0|||
161750079|NCT01641081|584124581|FG008|Period 4|Adverse Event|0|||
161750080|NCT01641081|584124582|FG009|Period 4|Adverse Event|0|||
161750081|NCT01641081|584124573|FG000|Period 5|Adverse Event|0|||
161750082|NCT01641081|584124574|FG001|Period 5|Adverse Event|0|||
161750083|NCT01641081|584124575|FG002|Period 5|Adverse Event|2|||
161750084|NCT01641081|584124576|FG003|Period 5|Adverse Event|0|||
161750085|NCT01641081|584124577|FG004|Period 5|Adverse Event|0|||
161750086|NCT01641081|584124578|FG005|Period 5|Adverse Event|0|||
161750087|NCT01641081|584124579|FG006|Period 5|Adverse Event|0|||
161750088|NCT01641081|584124580|FG007|Period 5|Adverse Event|0|||
161750089|NCT01641081|584124581|FG008|Period 5|Adverse Event|0|||
161750090|NCT01641081|584124582|FG009|Period 5|Adverse Event|0|||
161750091|NCT01095666|584124586|FG000|Overall Study|Lack of Efficacy|0|||
161750092|NCT01095666|584124587|FG001|Overall Study|Lack of Efficacy|0|||
161843369|NCT01517373|584470068|FG001|Treatment Period|Protocol Violation|0|||
161843370|NCT01517373|584470069|FG002|Treatment Period|Protocol Violation|0|||
161750093|NCT01095666|584124588|FG002|Overall Study|Lack of Efficacy|1|||
161750094|NCT01095666|584124586|FG000|Overall Study|Adverse Event|2|||
161750095|NCT01095666|584124587|FG001|Overall Study|Adverse Event|1|||
161750096|NCT01095666|584124588|FG002|Overall Study|Adverse Event|3|||
161750097|NCT01095666|584124586|FG000|Overall Study|Lost to Follow-up|2|||
161750098|NCT01095666|584124587|FG001|Overall Study|Lost to Follow-up|2|||
161750099|NCT01095666|584124588|FG002|Overall Study|Lost to Follow-up|0|||
161750100|NCT01095666|584124586|FG000|Overall Study|Withdrawal by Subject|6|||
161750101|NCT01095666|584124587|FG001|Overall Study|Withdrawal by Subject|6|||
161750102|NCT01095666|584124588|FG002|Overall Study|Withdrawal by Subject|1|||
161750103|NCT01095666|584124586|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
161750104|NCT01095666|584124587|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
161750105|NCT01095666|584124588|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
161750106|NCT00841672|584124595|FG000|Overall Study|Adverse Event|7|||
161750107|NCT00841672|584124596|FG001|Overall Study|Adverse Event|16|||
161750108|NCT00841672|584124595|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161750109|NCT00841672|584124596|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161750110|NCT00841672|584124595|FG000|Overall Study|Subject withdrew consent|2|||
161750111|NCT00841672|584124596|FG001|Overall Study|Subject withdrew consent|4|||
161750112|NCT00841672|584124595|FG000|Overall Study|Lost to Follow-up|1|||
161750113|NCT00841672|584124596|FG001|Overall Study|Lost to Follow-up|1|||
161750114|NCT00841672|584124595|FG000|Overall Study|Administrative problems|9|||
161750115|NCT00841672|584124596|FG001|Overall Study|Administrative problems|9|||
161750116|NCT00841672|584124595|FG000|Overall Study|Misrandomized|1|||
161750117|NCT00841672|584124596|FG001|Overall Study|Misrandomized|0|||
161750118|NCT00841672|584124595|FG000|Overall Study|Protocol Deviation|0|||
161750119|NCT00841672|584124596|FG001|Overall Study|Protocol Deviation|1|||
161750120|NCT00166517|584124597|FG000|Overall Study|Lost to Follow-up|1|||
161750121|NCT00166517|584124598|FG001|Overall Study|Lost to Follow-up|0|||
161750122|NCT00166517|584124597|FG000|Overall Study|Protocol Violation|4|||
161750123|NCT00166517|584124598|FG001|Overall Study|Protocol Violation|1|||
161750124|NCT00166517|584124597|FG000|Overall Study|Withdrawal by Subject|0|||
161750125|NCT00166517|584124598|FG001|Overall Study|Withdrawal by Subject|1|||
161750126|NCT03094611|584124602|FG000|Overall Study|Lack of Efficacy|1|||
161750127|NCT03094611|584124602|FG000|Overall Study|Stem Cell Transplant|1|||
161750128|NCT04285853|584124603|FG000|Overall Study|Withdrawal by Subject|1|||
161750129|NCT04285853|584124604|FG001|Overall Study|Withdrawal by Subject|0|||
161750130|NCT04285853|584124603|FG000|Overall Study|Lost to Follow-up|9|||
161750131|NCT04285853|584124604|FG001|Overall Study|Lost to Follow-up|5|||
161750132|NCT02758613|584124607|FG000|Treatment|Physician and Sponsor Decision|1|||
161750133|NCT02758613|584124608|FG001|Treatment|Physician and Sponsor Decision|0|||
161750134|NCT02758613|584124609|FG002|Treatment|Physician and Sponsor Decision|0|||
161750135|NCT02758613|584124610|FG003|Treatment|Physician and Sponsor Decision|0|||
161750136|NCT02758613|584124607|FG000|Treatment|Withdrawal by Subject|1|||
161750137|NCT02758613|584124608|FG001|Treatment|Withdrawal by Subject|0|||
161750138|NCT02758613|584124609|FG002|Treatment|Withdrawal by Subject|1|||
161750139|NCT02758613|584124610|FG003|Treatment|Withdrawal by Subject|0|||
161750140|NCT00196196|584124616|FG000|Overall Study|Withdrawal by Subject|2|||
161750141|NCT00196196|584124616|FG000|Overall Study|Did not have required condition (hydroce|5|||
161750142|NCT02343952|584124617|FG000|Study Treatment|Disease Progression|23|||
161750143|NCT02343952|584124617|FG000|Study Treatment|Death|3|||
161750144|NCT02343952|584124617|FG000|Study Treatment|Adverse Event|19|||
161750145|NCT02343952|584124617|FG000|Study Treatment|Withdrawal by Subject|7|||
161750146|NCT02343952|584124617|FG000|Study Treatment|other complicating Diseases|1|||
161750147|NCT02343952|584124617|FG000|Follow up|Withdrawal by Subject|3|||
161750148|NCT02343952|584124617|FG000|Follow up|Death|33|||
161750149|NCT02343952|584124617|FG000|Follow up|Patient does not meet eligibility for study.|1|||
161750150|NCT02343952|584124617|FG000|Follow up|Research department closed by the practice.|5|||
161750151|NCT02343952|584124617|FG000|Follow up|Patient went home to Russia|1|||
161750152|NCT02343952|584124617|FG000|Follow up|Disease Progression|1|||
161750153|NCT02343952|584124617|FG000|Follow up|study terminated|1|||
161750154|NCT04018612|584124618|FG000|Overall Study|Withdrawal by Subject|1|||
161750155|NCT04018612|584124619|FG001|Overall Study|Withdrawal by Subject|0|||
161750156|NCT04018612|584124620|FG002|Overall Study|Withdrawal by Subject|1|||
161750157|NCT00361218|584124621|FG000|Overall Study|Lost to Follow-up|11|||
161750158|NCT00361218|584124621|FG000|Overall Study|Personal Reasons|7|||
161750159|NCT00361218|584124621|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
161750160|NCT02671760|584124622|FG000|Overall Study|Lost to Follow-up|0|||
161750161|NCT02671760|584124623|FG001|Overall Study|Lost to Follow-up|1|||
161750162|NCT02671760|584124624|FG002|Overall Study|Lost to Follow-up|0|||
161750163|NCT02079519|584124634|FG000|Overall Study|Disease Progression|9|||
161750164|NCT02079519|584124634|FG000|Overall Study|Adverse Event|1|||
161750165|NCT01802515|584124635|FG000|Overall Study|Withdrawal by Subject|3|||
161750166|NCT01802515|584124636|FG001|Overall Study|Withdrawal by Subject|0|||
161750167|NCT01802515|584124637|FG002|Overall Study|Withdrawal by Subject|0|||
161750168|NCT02566109|584124638|FG000|Overall Study|Withdrawal by Subject|1|||
161750169|NCT01041404|584124641|FG000|Overall Study|Adverse Event|45|||
161750170|NCT01041404|584124642|FG001|Overall Study|Adverse Event|35|||
161750171|NCT01041404|584124641|FG000|Overall Study|Lack of Efficacy|200|||
161750172|NCT01041404|584124642|FG001|Overall Study|Lack of Efficacy|210|||
161750173|NCT01041404|584124641|FG000|Overall Study|Violation of Selection Criteria|0|||
161750174|NCT01041404|584124642|FG001|Overall Study|Violation of Selection Criteria|1|||
161750175|NCT01041404|584124641|FG000|Overall Study|Protocol Violation|4|||
161750176|NCT01041404|584124642|FG001|Overall Study|Protocol Violation|0|||
161750177|NCT01041404|584124641|FG000|Overall Study|Withdrawal by Subject|29|||
161750178|NCT01041404|584124642|FG001|Overall Study|Withdrawal by Subject|23|||
161750179|NCT01041404|584124641|FG000|Overall Study|Failure to Return|1|||
161750180|NCT01041404|584124642|FG001|Overall Study|Failure to Return|2|||
161750181|NCT01041404|584124641|FG000|Overall Study|Other|11|||
161750182|NCT01041404|584124642|FG001|Overall Study|Other|23|||
161750183|NCT01750840|584124643|FG000|Overall Study|Lost to Follow-up|4|||
161750184|NCT02091921|584124644|FG000|Overall Study|Adverse Event|3|||
161843371|NCT01517373|584470070|FG003|Treatment Period|Protocol Violation|0|||
161843372|NCT01517373|584470071|FG004|Treatment Period|Protocol Violation|1|||
161843373|NCT01517373|584470072|FG005|Treatment Period|Protocol Violation|0|||
161843374|NCT01517373|584470067|FG000|Treatment Period|Lack of Efficacy|0|||
161843375|NCT01517373|584470068|FG001|Treatment Period|Lack of Efficacy|1|||
161843376|NCT01517373|584470069|FG002|Treatment Period|Lack of Efficacy|1|||
161843377|NCT01517373|584470070|FG003|Treatment Period|Lack of Efficacy|3|||
161843378|NCT01517373|584470071|FG004|Treatment Period|Lack of Efficacy|2|||
161843379|NCT01517373|584470072|FG005|Treatment Period|Lack of Efficacy|0|||
161843380|NCT01517373|584470067|FG000|Treatment Period|Medication error without AEs|0|||
161843381|NCT01517373|584470068|FG001|Treatment Period|Medication error without AEs|0|||
161843382|NCT01517373|584470069|FG002|Treatment Period|Medication error without AEs|2|||
161843383|NCT01517373|584470070|FG003|Treatment Period|Medication error without AEs|1|||
161843384|NCT01517373|584470071|FG004|Treatment Period|Medication error without AEs|0|||
161843385|NCT01517373|584470072|FG005|Treatment Period|Medication error without AEs|2|||
161843386|NCT05005312|584470079|FG000|Overall Study|Enrolled, but not treated|0|||
161843387|NCT05005312|584470080|FG001|Overall Study|Enrolled, but not treated|1|||
161843388|NCT00851318|584470081|FG000|Overall Study|Withdrawal by Subject|7|||
161843389|NCT00851318|584470082|FG001|Overall Study|Withdrawal by Subject|1|||
161843390|NCT00851318|584470083|FG002|Overall Study|Withdrawal by Subject|5|||
161843391|NCT00851318|584470084|FG003|Overall Study|Withdrawal by Subject|3|||
161843392|NCT00851318|584470081|FG000|Overall Study|Adverse Event|13|||
161843393|NCT00851318|584470082|FG001|Overall Study|Adverse Event|2|||
161843394|NCT00851318|584470083|FG002|Overall Study|Adverse Event|9|||
161843395|NCT00851318|584470084|FG003|Overall Study|Adverse Event|12|||
161843396|NCT00851318|584470081|FG000|Overall Study|Pregnancy|0|||
161843397|NCT00851318|584470082|FG001|Overall Study|Pregnancy|0|||
161843398|NCT00851318|584470083|FG002|Overall Study|Pregnancy|1|||
161843399|NCT00851318|584470084|FG003|Overall Study|Pregnancy|1|||
161843400|NCT00851318|584470081|FG000|Overall Study|Lack of Efficacy|8|||
161843401|NCT00851318|584470082|FG001|Overall Study|Lack of Efficacy|2|||
161750185|NCT02483078|584124645|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
161750186|NCT02483078|584124646|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
161750187|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
161750188|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
161750189|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161843402|NCT00851318|584470083|FG002|Overall Study|Lack of Efficacy|4|||
161750190|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
161750191|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
161750192|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
161750193|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
161750194|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
161750195|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
161750196|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
161750197|NCT04876599|584124647|FG000|Overall Study|Missed|2|||
161750198|NCT04876599|584124648|FG001|Overall Study|Missed|0|||
161750199|NCT04876599|584124647|FG000|Overall Study|Declined|2|||
161750200|NCT04876599|584124648|FG001|Overall Study|Declined|3|||
161750201|NCT00676208|584124655|FG000|Overall Study|Lost to Follow-up|0|||
161750202|NCT00676208|584124656|FG001|Overall Study|Lost to Follow-up|2|||
161750203|NCT00676208|584124655|FG000|Overall Study|Incomplete data|2|||
161750204|NCT00676208|584124656|FG001|Overall Study|Incomplete data|4|||
161750205|NCT00669032|584124657|FG000|Overall Study|Lost to Follow-up|6|||
161750206|NCT00669032|584124658|FG001|Overall Study|Lost to Follow-up|5|||
161750207|NCT00669032|584124657|FG000|Overall Study|Lack of Efficacy|8|||
161750208|NCT00669032|584124658|FG001|Overall Study|Lack of Efficacy|19|||
161750209|NCT00669032|584124657|FG000|Overall Study|Withdrawal by Subject|12|||
161750210|NCT00669032|584124658|FG001|Overall Study|Withdrawal by Subject|13|||
161750211|NCT00669032|584124657|FG000|Overall Study|Adverse Event|12|||
161750212|NCT00669032|584124658|FG001|Overall Study|Adverse Event|16|||
161750213|NCT00669032|584124657|FG000|Overall Study|Physician Decision|1|||
161750214|NCT00669032|584124658|FG001|Overall Study|Physician Decision|1|||
161750215|NCT00669032|584124657|FG000|Overall Study|No fulfilment of the selection criteria|5|||
161750216|NCT00669032|584124658|FG001|Overall Study|No fulfilment of the selection criteria|5|||
161750217|NCT01607073|584124661|FG000|Overall Study|Adverse Event|1|||
161750218|NCT00642018|584124662|FG000|Overall Study|Adverse Event|11|||
161750219|NCT00642018|584124663|FG001|Overall Study|Adverse Event|36|||
161750220|NCT00642018|584124662|FG000|Overall Study|Withdrawal by Subject|4|||
161750221|NCT00642018|584124663|FG001|Overall Study|Withdrawal by Subject|10|||
161750222|NCT00642018|584124662|FG000|Overall Study|Progressive Disease|13|||
161750223|NCT00642018|584124663|FG001|Overall Study|Progressive Disease|18|||
161750224|NCT00642018|584124662|FG000|Overall Study|Physician Decision|0|||
161750225|NCT00642018|584124663|FG001|Overall Study|Physician Decision|10|||
161750226|NCT00642018|584124662|FG000|Overall Study|Protocol Violation|0|||
161750227|NCT00642018|584124663|FG001|Overall Study|Protocol Violation|1|||
161750228|NCT00642018|584124662|FG000|Overall Study|Death|0|||
161750229|NCT00642018|584124663|FG001|Overall Study|Death|3|||
161750230|NCT00642018|584124662|FG000|Overall Study|Entry Criteria Not Met|0|||
161750231|NCT00642018|584124663|FG001|Overall Study|Entry Criteria Not Met|1|||
161750232|NCT01410799|584124664|FG000|Overall Study|PI decision|13|||
161750233|NCT00617656|584124665|FG000|Overall Study|Inclusion error|4|||
161750234|NCT00617656|584124666|FG001|Overall Study|Inclusion error|4|||
161750235|NCT00617656|584124667|FG002|Overall Study|Inclusion error|0|||
161750236|NCT00617656|584124668|FG003|Overall Study|Inclusion error|0|||
161750237|NCT00617656|584124665|FG000|Overall Study|Missing data|44|||
161750238|NCT00617656|584124666|FG001|Overall Study|Missing data|30|||
161750239|NCT00617656|584124667|FG002|Overall Study|Missing data|13|||
161750240|NCT00617656|584124668|FG003|Overall Study|Missing data|6|||
161750241|NCT00617656|584124665|FG000|Overall Study|Withdrawal by Subject|0|||
161750242|NCT00617656|584124666|FG001|Overall Study|Withdrawal by Subject|2|||
161750243|NCT00617656|584124667|FG002|Overall Study|Withdrawal by Subject|0|||
161750244|NCT00617656|584124668|FG003|Overall Study|Withdrawal by Subject|0|||
161750245|NCT00509028|584126602|FG000|Overall Study|Adverse Event|2|||
161750246|NCT00509028|584126603|FG001|Overall Study|Adverse Event|0|||
161750247|NCT00509028|584126602|FG000|Overall Study|Withdrawal by Subject|4|||
161750248|NCT00509028|584126603|FG001|Overall Study|Withdrawal by Subject|3|||
161750249|NCT00509028|584126602|FG000|Overall Study|Lost to Follow-up|0|||
161750250|NCT00509028|584126603|FG001|Overall Study|Lost to Follow-up|1|||
161750251|NCT00509028|584126602|FG000|Overall Study|Protocol Violation|4|||
161750252|NCT00509028|584126603|FG001|Overall Study|Protocol Violation|2|||
161750253|NCT00509028|584126602|FG000|Overall Study|Non-compliance|2|||
161750254|NCT00509028|584126603|FG001|Overall Study|Non-compliance|1|||
161750255|NCT02996110|584126604|FG000|Pre-Treatment|Other Reasons|0|||
161750256|NCT02996110|584126605|FG001|Pre-Treatment|Other Reasons|1|||
161750257|NCT02996110|584126606|FG002|Pre-Treatment|Other Reasons|0|||
161750258|NCT02996110|584126607|FG003|Pre-Treatment|Other Reasons|0|||
161750259|NCT02996110|584126608|FG004|Pre-Treatment|Other Reasons|1|||
161750260|NCT02996110|584126604|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
161750261|NCT02996110|584126605|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
161750262|NCT02996110|584126606|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
161750263|NCT02996110|584126607|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
161750264|NCT02996110|584126608|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
161750265|NCT02996110|584126604|FG000|Track 1|Disease Progression|15|||
161750266|NCT02996110|584126605|FG001|Track 1|Disease Progression|17|||
161750267|NCT02996110|584126606|FG002|Track 1|Disease Progression|0|||
161750268|NCT02996110|584126607|FG003|Track 1|Disease Progression|0|||
161750269|NCT02996110|584126608|FG004|Track 1|Disease Progression|0|||
161843403|NCT00851318|584470084|FG003|Overall Study|Lack of Efficacy|2|||
161750270|NCT02996110|584126604|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
161750271|NCT02996110|584126605|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
161750272|NCT02996110|584126606|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
161750273|NCT02996110|584126607|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
161750274|NCT02996110|584126608|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
161750275|NCT02996110|584126604|FG000|Track 1|Study Drug Toxicity|5|||
161750276|NCT02996110|584126605|FG001|Track 1|Study Drug Toxicity|3|||
161750277|NCT02996110|584126606|FG002|Track 1|Study Drug Toxicity|0|||
161750278|NCT02996110|584126607|FG003|Track 1|Study Drug Toxicity|0|||
161750279|NCT02996110|584126608|FG004|Track 1|Study Drug Toxicity|0|||
161750280|NCT02996110|584126604|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
161750281|NCT02996110|584126605|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750282|NCT02996110|584126606|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750283|NCT02996110|584126607|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750284|NCT02996110|584126608|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750285|NCT02996110|584126604|FG000|Track 1|Administrative Reason by Sponsor|0|||
161750286|NCT02996110|584126605|FG001|Track 1|Administrative Reason by Sponsor|1|||
161750287|NCT02996110|584126606|FG002|Track 1|Administrative Reason by Sponsor|0|||
161750288|NCT02996110|584126607|FG003|Track 1|Administrative Reason by Sponsor|0|||
161750289|NCT02996110|584126608|FG004|Track 1|Administrative Reason by Sponsor|0|||
161750290|NCT02996110|584126604|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
161750291|NCT02996110|584126605|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
161750292|NCT02996110|584126606|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
161750293|NCT02996110|584126607|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
161750294|NCT02996110|584126608|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
161750295|NCT02996110|584126604|FG000|Track 2|Disease Progression|33|||
161750296|NCT02996110|584126605|FG001|Track 2|Disease Progression|26|||
161750297|NCT02996110|584126606|FG002|Track 2|Disease Progression|19|||
161750298|NCT02996110|584126607|FG003|Track 2|Disease Progression|16|||
161750299|NCT02996110|584126608|FG004|Track 2|Disease Progression|15|||
161750300|NCT02996110|584126604|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
161750301|NCT02996110|584126605|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
161750302|NCT02996110|584126606|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
161750303|NCT02996110|584126607|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
161750304|NCT02996110|584126608|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
161750305|NCT02996110|584126604|FG000|Track 2|Death|0|||
161750306|NCT02996110|584126605|FG001|Track 2|Death|0|||
161750307|NCT02996110|584126606|FG002|Track 2|Death|1|||
161750308|NCT02996110|584126607|FG003|Track 2|Death|0|||
161750309|NCT02996110|584126608|FG004|Track 2|Death|1|||
161750310|NCT02996110|584126604|FG000|Track 2|Study Drug Toxicity|4|||
161750311|NCT02996110|584126605|FG001|Track 2|Study Drug Toxicity|1|||
161750312|NCT02996110|584126606|FG002|Track 2|Study Drug Toxicity|4|||
161750313|NCT02996110|584126607|FG003|Track 2|Study Drug Toxicity|1|||
161750314|NCT02996110|584126608|FG004|Track 2|Study Drug Toxicity|0|||
161750315|NCT02996110|584126604|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
161750316|NCT02996110|584126605|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
161750317|NCT02996110|584126606|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
161750318|NCT02996110|584126607|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
161750319|NCT02996110|584126608|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
161750320|NCT02996110|584126604|FG000|Track 2|Participant Withdrew Consent|1|||
161750321|NCT02996110|584126605|FG001|Track 2|Participant Withdrew Consent|2|||
161750322|NCT02996110|584126606|FG002|Track 2|Participant Withdrew Consent|3|||
161750323|NCT02996110|584126607|FG003|Track 2|Participant Withdrew Consent|1|||
161750324|NCT02996110|584126608|FG004|Track 2|Participant Withdrew Consent|1|||
161750325|NCT02996110|584126604|FG000|Track 2|Other Reasons|0|||
161750326|NCT02996110|584126605|FG001|Track 2|Other Reasons|0|||
161750327|NCT02996110|584126606|FG002|Track 2|Other Reasons|1|||
161750328|NCT02996110|584126607|FG003|Track 2|Other Reasons|0|||
161750329|NCT02996110|584126608|FG004|Track 2|Other Reasons|1|||
161750330|NCT02436915|584126609|FG000|Overall Study|Withdrawal by Subject|0|||
161750331|NCT02436915|584126610|FG001|Overall Study|Withdrawal by Subject|1|||
161750332|NCT03805971|584126611|FG000|Overall Study|Withdrawal by Subject|1|||
161750333|NCT03805971|584126611|FG000|Overall Study|Protocol Violation|2|||
161750334|NCT01366534|584126631|FG000|Overall Study|Lost to Follow-up|1|||
161750335|NCT01366534|584126632|FG001|Overall Study|Lost to Follow-up|0|||
161750336|NCT01366534|584126633|FG002|Overall Study|Lost to Follow-up|0|||
161750337|NCT01366534|584126631|FG000|Overall Study|Migrated|1|||
161750338|NCT01366534|584126632|FG001|Overall Study|Migrated|1|||
161750339|NCT01366534|584126633|FG002|Overall Study|Migrated|0|||
161750340|NCT01366534|584126631|FG000|Overall Study|Declined challenged|0|||
161750341|NCT01366534|584126632|FG001|Overall Study|Declined challenged|1|||
161750342|NCT01366534|584126633|FG002|Overall Study|Declined challenged|0|||
161750343|NCT02939976|584126634|FG000|Overall Study|Lost to Follow-up|7|||
161750344|NCT02939976|584126635|FG001|Overall Study|Lost to Follow-up|1|||
161750345|NCT02939976|584126636|FG002|Overall Study|Lost to Follow-up|1|||
161750346|NCT02939976|584126637|FG003|Overall Study|Lost to Follow-up|2|||
161750347|NCT02939976|584126634|FG000|Overall Study|Withdrawal by Subject|4|||
161750348|NCT02939976|584126635|FG001|Overall Study|Withdrawal by Subject|0|||
161750349|NCT02939976|584126636|FG002|Overall Study|Withdrawal by Subject|2|||
161750350|NCT02939976|584126637|FG003|Overall Study|Withdrawal by Subject|4|||
161750351|NCT02939976|584126634|FG000|Overall Study|Due to early study closure|4|||
161750352|NCT02939976|584126635|FG001|Overall Study|Due to early study closure|3|||
161750353|NCT02939976|584126636|FG002|Overall Study|Due to early study closure|2|||
161750354|NCT02939976|584126637|FG003|Overall Study|Due to early study closure|3|||
161750355|NCT02640755|584126638|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
161750356|NCT02640755|584126639|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
161750357|NCT02640755|584126638|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
161750358|NCT02640755|584126639|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
161750359|NCT02640755|584126638|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
161750360|NCT02640755|584126639|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
161750361|NCT04080752|584126640|FG000|Overall Study|Adverse Event|2|||
161750362|NCT04080752|584126641|FG001|Overall Study|Adverse Event|3|||
161750363|NCT04080752|584126640|FG000|Overall Study|Lack of Efficacy|1|||
161750364|NCT04080752|584126641|FG001|Overall Study|Lack of Efficacy|0|||
161750365|NCT04080752|584126640|FG000|Overall Study|Lost to Follow-up|1|||
161750366|NCT04080752|584126641|FG001|Overall Study|Lost to Follow-up|0|||
161750367|NCT04080752|584126640|FG000|Overall Study|Pregnancy|0|||
161750368|NCT04080752|584126641|FG001|Overall Study|Pregnancy|1|||
161750369|NCT04080752|584126640|FG000|Overall Study|Withdrawal by Subject|7|||
161843404|NCT00851318|584470081|FG000|Overall Study|Non-compliance with Study Procedures|2|||
161750370|NCT04080752|584126641|FG001|Overall Study|Withdrawal by Subject|0|||
161750371|NCT04080752|584126640|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161843405|NCT00851318|584470082|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161843406|NCT00851318|584470083|FG002|Overall Study|Non-compliance with Study Procedures|1|||
161843407|NCT00851318|584470084|FG003|Overall Study|Non-compliance with Study Procedures|0|||
161843408|NCT00851318|584470081|FG000|Overall Study|Physician Decision|0|||
161843409|NCT00851318|584470082|FG001|Overall Study|Physician Decision|0|||
161750372|NCT04080752|584126641|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161843410|NCT00851318|584470083|FG002|Overall Study|Physician Decision|1|||
161843411|NCT00851318|584470084|FG003|Overall Study|Physician Decision|1|||
161750373|NCT04080752|584126640|FG000|Overall Study|Other|2|||
161750374|NCT04080752|584126641|FG001|Overall Study|Other|1|||
161750375|NCT01585168|584126646|FG000|Overall Study|Lost to Follow-up|3|||
161750376|NCT01585168|584126647|FG001|Overall Study|Lost to Follow-up|1|||
161750377|NCT01585168|584126648|FG002|Overall Study|Lost to Follow-up|1|||
161750378|NCT01585168|584126649|FG003|Overall Study|Lost to Follow-up|1|||
161750379|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
161750380|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
161750381|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
161750382|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
161750383|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
161750384|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
161750385|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
161750386|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
161750387|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
161750388|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
161750389|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
161750390|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
161750391|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161750392|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
161750393|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161750394|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161750395|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
161750396|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
161750397|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
161750398|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
161750399|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
161750400|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
161750401|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
161750402|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
161750403|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Other|0|||
161750404|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Other|1|||
161750405|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Other|0|||
161750406|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Other|0|||
161750407|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
161750408|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
161750409|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
161750410|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
161750411|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
161750412|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
161750413|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
161750414|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
161750415|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Death|0|||
161750416|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Death|1|||
161750417|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Death|0|||
161750418|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Death|0|||
161750419|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
161750420|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
161750421|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
161750422|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
161750423|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
161750424|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
161750425|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
161750426|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
161750427|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
161750428|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
161750429|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
161750430|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
161750431|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
161843412|NCT00171951|584470085|FG000|Overall Study|Adverse Event|1|||
161750432|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
161750433|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
161843413|NCT00171951|584470085|FG000|Overall Study|Abnormal Laboratory Values|2|||
161843414|NCT00171951|584470085|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161750434|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
161750435|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
161750436|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
161750437|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
161750438|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
161750439|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
161750440|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
161750441|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
161750442|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
161750443|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Other|2|||
161750444|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Other|1|||
161750445|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Other|0|||
161750446|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Other|0|||
161750447|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
161750448|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
161750449|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
161750450|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
161750451|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
161750452|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
161750453|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
161750454|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
161750455|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
161750456|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
161750457|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
161750458|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
161750459|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Death|1|||
161750460|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Death|2|||
161750461|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Death|0|||
161750462|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Death|2|||
161750463|NCT01192100|584126654|FG000|Overall Study|Withdrawal by Subject|0|||
161750464|NCT01192100|584126655|FG001|Overall Study|Withdrawal by Subject|0|||
161750465|NCT01192100|584126656|FG002|Overall Study|Withdrawal by Subject|0|||
161750466|NCT01192100|584126657|FG003|Overall Study|Withdrawal by Subject|0|||
161750467|NCT01192100|584126658|FG004|Overall Study|Withdrawal by Subject|1|||
161750468|NCT01192100|584126659|FG005|Overall Study|Withdrawal by Subject|0|||
161750469|NCT01192100|584126654|FG000|Overall Study|Protocol Violation|0|||
161750470|NCT01192100|584126655|FG001|Overall Study|Protocol Violation|0|||
161750471|NCT01192100|584126656|FG002|Overall Study|Protocol Violation|0|||
161750472|NCT01192100|584126657|FG003|Overall Study|Protocol Violation|1|||
161750473|NCT01192100|584126658|FG004|Overall Study|Protocol Violation|0|||
161750474|NCT01192100|584126659|FG005|Overall Study|Protocol Violation|0|||
161750475|NCT02057068|584126660|FG000|Overall Study|Withdrawal by Subject|2|||
161750476|NCT02057068|584126661|FG001|Overall Study|Withdrawal by Subject|2|||
161750477|NCT02057068|584126660|FG000|Overall Study|Caregiver (CG) Health|0|||
161750478|NCT02057068|584126661|FG001|Overall Study|Caregiver (CG) Health|2|||
161750479|NCT02057068|584126660|FG000|Overall Study|Carepartner (CP) Health|4|||
161750480|NCT02057068|584126661|FG001|Overall Study|Carepartner (CP) Health|2|||
161750481|NCT02057068|584126660|FG000|Overall Study|Lost to Follow-up|2|||
161750482|NCT02057068|584126661|FG001|Overall Study|Lost to Follow-up|2|||
161750483|NCT00865046|584126663|FG000|Overall Study|Lost to Follow-up|1|||
161750484|NCT00865046|584126664|FG001|Overall Study|Lost to Follow-up|4|||
161750485|NCT00865046|584126665|FG002|Overall Study|Lost to Follow-up|0|||
161750486|NCT00865046|584126663|FG000|Overall Study|Death|0|||
161750487|NCT00865046|584126664|FG001|Overall Study|Death|1|||
161750488|NCT00865046|584126665|FG002|Overall Study|Death|1|||
161750489|NCT00865046|584126663|FG000|Overall Study|Withdrawal by Subject|5|||
161750490|NCT00865046|584126664|FG001|Overall Study|Withdrawal by Subject|0|||
161750491|NCT00865046|584126665|FG002|Overall Study|Withdrawal by Subject|0|||
161750492|NCT00329784|584126671|FG000|Overall Study|Lost to Follow-up|0|||
161750493|NCT00329784|584126672|FG001|Overall Study|Lost to Follow-up|1|||
161750494|NCT00329784|584126673|FG002|Overall Study|Lost to Follow-up|0|||
161750495|NCT00329784|584126674|FG003|Overall Study|Lost to Follow-up|0|||
161750496|NCT00329784|584126671|FG000|Overall Study|Withdrawal by Subject|4|||
161750497|NCT00329784|584126672|FG001|Overall Study|Withdrawal by Subject|2|||
161750498|NCT00329784|584126673|FG002|Overall Study|Withdrawal by Subject|0|||
161750499|NCT00329784|584126674|FG003|Overall Study|Withdrawal by Subject|0|||
161750500|NCT00329784|584126671|FG000|Overall Study|Other|1|||
161750501|NCT00329784|584126672|FG001|Overall Study|Other|2|||
161750502|NCT00329784|584126673|FG002|Overall Study|Other|0|||
161750503|NCT00329784|584126674|FG003|Overall Study|Other|0|||
161750504|NCT01928082|584126679|FG000|Overall Study|Study terminated.|1|||
161750505|NCT05563714|584126680|FG000|Overall Study|Death|2|||
161750506|NCT05563714|584126681|FG001|Overall Study|Death|2|||
161750507|NCT05563714|584126682|FG002|Overall Study|Death|0|||
161750508|NCT05563714|584126683|FG003|Overall Study|Death|0|||
161750509|NCT05563714|584126680|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
161750510|NCT05563714|584126681|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
161750511|NCT05563714|584126682|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
161750512|NCT05563714|584126683|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
161750513|NCT05563714|584126680|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
161750514|NCT05563714|584126681|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
161750515|NCT05563714|584126682|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
161750516|NCT05563714|584126683|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
161750517|NCT05563714|584126680|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161750518|NCT05563714|584126681|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
161750519|NCT05563714|584126682|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161750520|NCT05563714|584126683|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161750521|NCT05563714|584126680|FG000|Overall Study|Lost to Follow-up|22|||
161750522|NCT05563714|584126681|FG001|Overall Study|Lost to Follow-up|19|||
161750523|NCT05563714|584126682|FG002|Overall Study|Lost to Follow-up|0|||
161750524|NCT05563714|584126683|FG003|Overall Study|Lost to Follow-up|0|||
161750525|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
161750526|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
161750527|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
161750528|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
161750529|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
161750530|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
161750531|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
161750532|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
161750533|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750534|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750535|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750536|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750537|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750538|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750539|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
161750540|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
161750541|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
161750542|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
161750543|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
161750544|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
161750545|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
161750546|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
161750547|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750548|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750549|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750550|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750551|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750552|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750553|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
161750554|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750555|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750556|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750557|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750558|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750559|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750560|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
161843415|NCT00171951|584470085|FG000|Overall Study|Participants Withdrew Consent|3|||
161843416|NCT00171951|584470085|FG000|Overall Study|New Cancer Therapy|5|||
161843417|NCT00171951|584470085|FG000|Overall Study|Reason not Specified|2|||
161843418|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
161843419|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
161843420|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
161843421|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
161843422|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
161843423|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
161843424|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
161843425|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
161843426|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Death|41|||
161843427|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Death|33|||
161843428|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Death|0|||
161843429|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Death|0|||
161843430|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161843431|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
161843432|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161843433|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161843434|NCT02970318|584470086|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161843435|NCT02970318|584470087|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161843436|NCT02970318|584470088|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
161843437|NCT02970318|584470089|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161843438|NCT02970318|584470086|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
161843439|NCT02970318|584470087|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
161843440|NCT02970318|584470088|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
161843441|NCT02970318|584470089|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
161843442|NCT02970318|584470086|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
161843443|NCT02970318|584470087|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
161843444|NCT02970318|584470088|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
161843445|NCT02970318|584470089|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
161843446|NCT03384654|584470090|FG000|Overall Study|Withdrawal by Subject|0|||
161843447|NCT03384654|584470091|FG001|Overall Study|Withdrawal by Subject|0|||
161843448|NCT03384654|584470092|FG002|Overall Study|Withdrawal by Subject|1|||
161843449|NCT03384654|584470093|FG003|Overall Study|Withdrawal by Subject|0|||
161843450|NCT01616953|584470094|FG000|Overall Study|Lost to Follow-up|1|||
161843451|NCT01616953|584470095|FG001|Overall Study|Lost to Follow-up|0|||
161843452|NCT01616953|584470094|FG000|Overall Study|lack of bone and soft tissue|1|||
161843453|NCT01616953|584470095|FG001|Overall Study|lack of bone and soft tissue|0|||
161843454|NCT00816361|584470097|FG000|Overall Study|Withdrawal by Subject|0|||
161843455|NCT00816361|584470098|FG001|Overall Study|Withdrawal by Subject|0|||
161843456|NCT00816361|584470099|FG002|Overall Study|Withdrawal by Subject|0|||
161843457|NCT00816361|584470100|FG003|Overall Study|Withdrawal by Subject|0|||
161843458|NCT00816361|584470101|FG004|Overall Study|Withdrawal by Subject|1|||
161843459|NCT00816361|584470102|FG005|Overall Study|Withdrawal by Subject|2|||
161843460|NCT00816361|584470103|FG006|Overall Study|Withdrawal by Subject|0|||
161843461|NCT00816361|584470104|FG007|Overall Study|Withdrawal by Subject|2|||
161843462|NCT00816361|584470105|FG008|Overall Study|Withdrawal by Subject|1|||
161843463|NCT00816361|584470097|FG000|Overall Study|Death|4|||
161843464|NCT00816361|584470098|FG001|Overall Study|Death|3|||
161843465|NCT00816361|584470099|FG002|Overall Study|Death|3|||
161843466|NCT00816361|584470100|FG003|Overall Study|Death|3|||
161843467|NCT00816361|584470101|FG004|Overall Study|Death|1|||
161843468|NCT00816361|584470102|FG005|Overall Study|Death|1|||
161843469|NCT00816361|584470103|FG006|Overall Study|Death|3|||
161843470|NCT00816361|584470104|FG007|Overall Study|Death|7|||
161843471|NCT00816361|584470105|FG008|Overall Study|Death|8|||
161843472|NCT00816361|584470097|FG000|Overall Study|Other|0|||
161843473|NCT00816361|584470098|FG001|Overall Study|Other|0|||
161843474|NCT00816361|584470099|FG002|Overall Study|Other|0|||
161843475|NCT00816361|584470100|FG003|Overall Study|Other|0|||
161843476|NCT00816361|584470101|FG004|Overall Study|Other|0|||
161843477|NCT00816361|584470102|FG005|Overall Study|Other|0|||
161843478|NCT00816361|584470103|FG006|Overall Study|Other|0|||
161843479|NCT00816361|584470104|FG007|Overall Study|Other|0|||
161843480|NCT00816361|584470105|FG008|Overall Study|Other|1|||
161843481|NCT02500641|584470106|FG000|Overall Study|Adverse Event|0|||
161843482|NCT02500641|584470107|FG001|Overall Study|Adverse Event|2|||
161843483|NCT02500641|584470106|FG000|Overall Study|Withdrawal by Subject|4|||
161843484|NCT02500641|584470107|FG001|Overall Study|Withdrawal by Subject|5|||
161843485|NCT02500641|584470106|FG000|Overall Study|Unable to follow study procedures|3|||
161843486|NCT02500641|584470107|FG001|Overall Study|Unable to follow study procedures|2|||
161843487|NCT02500641|584470106|FG000|Overall Study|Protocol Violation|1|||
161750561|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750562|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750563|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750564|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750565|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750566|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750567|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
161750568|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
161750569|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
161750570|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
161750571|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
161750572|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
161750573|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
161750574|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750575|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
161750576|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
161750577|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
161750578|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750579|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750580|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750581|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750582|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
161750583|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750584|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
161750585|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750586|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750587|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750588|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750589|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
161750590|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
161750591|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750592|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750593|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750594|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750595|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750596|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750597|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
161750598|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
161750599|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750600|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750601|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750602|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750603|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750604|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750605|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
161750606|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750607|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750608|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750609|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750610|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
161750611|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
161750612|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
161750613|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750614|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750615|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750616|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750617|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
161750618|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750619|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750620|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750621|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750622|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750623|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161750624|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
161750625|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
161750626|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161750627|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
161750628|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
161750629|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161750630|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750631|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750632|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750633|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750634|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
161750635|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750636|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750637|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750638|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
161750639|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
161750640|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750641|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
161750642|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750643|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750644|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750645|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
161750646|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
161750647|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750648|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
161750649|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750650|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750651|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750652|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
161750653|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
161750654|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750655|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
161750656|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750657|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750658|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750659|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
161750660|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
161750661|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750662|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750663|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750664|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750665|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
161750666|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
161750667|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
161750668|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
161750669|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
161750670|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
161750671|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
161750672|NCT02120352|584126689|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750673|NCT02120352|584126690|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750674|NCT02120352|584126691|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750675|NCT02120352|584126692|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750676|NCT02120352|584126693|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161843488|NCT02500641|584470107|FG001|Overall Study|Protocol Violation|2|||
161843489|NCT02500641|584470106|FG000|Overall Study|Lost to Follow-up|1|||
161843490|NCT02500641|584470107|FG001|Overall Study|Lost to Follow-up|0|||
161843491|NCT02500641|584470106|FG000|Overall Study|Sponsor decision|1|||
161843492|NCT02500641|584470107|FG001|Overall Study|Sponsor decision|0|||
161843493|NCT02500641|584470106|FG000|Overall Study|Non compliance to study drug|0|||
161843494|NCT02500641|584470107|FG001|Overall Study|Non compliance to study drug|1|||
161843495|NCT01763684|584470108|FG000|Overall Study|Study terminated early due to low enrollment|126|||
161843496|NCT01763684|584470109|FG001|Overall Study|Study terminated early due to low enrollment|127|||
161843497|NCT01763684|584470108|FG000|Overall Study|Study surgery not performed|7|||
161843498|NCT01763684|584470109|FG001|Overall Study|Study surgery not performed|6|||
161843499|NCT02196701|584470110|FG000|Overall Study|Adverse Event|1|||
161843500|NCT02196701|584470110|FG000|Overall Study|Lost to Follow-up|1|||
161843501|NCT02196701|584470110|FG000|Overall Study|Non-adherence to Protocol|1|||
161843502|NCT01408628|584470116|FG000|Consented|Withdrawal by Subject|12|||
161843503|NCT01408628|584470116|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
161843504|NCT01408628|584470116|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
161843505|NCT01408628|584470116|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
161843506|NCT04156620|584470117|FG000|Overall Study|Adverse event - TP 1|5|||
161843507|NCT04156620|584470118|FG001|Overall Study|Adverse event - TP 1|2|||
161843508|NCT04156620|584470117|FG000|Overall Study|Lost to follow-up TP 1|1|||
161843509|NCT04156620|584470118|FG001|Overall Study|Lost to follow-up TP 1|1|||
161843510|NCT04156620|584470117|FG000|Overall Study|Progressive disease - TP 1|0|||
161843511|NCT04156620|584470118|FG001|Overall Study|Progressive disease - TP 1|1|||
161843512|NCT04156620|584470117|FG000|Overall Study|Subject decision - TP 1|3|||
161843513|NCT04156620|584470118|FG001|Overall Study|Subject decision - TP 1|5|||
161843514|NCT04156620|584470117|FG000|Overall Study|Adverse event - TP 2|5|||
161843515|NCT04156620|584470118|FG001|Overall Study|Adverse event - TP 2|6|||
161843516|NCT04156620|584470117|FG000|Overall Study|Death - TP 2|1|||
161843517|NCT04156620|584470118|FG001|Overall Study|Death - TP 2|0|||
161843518|NCT04156620|584470117|FG000|Overall Study|Lost to follow-up - TP 2|5|||
161843519|NCT04156620|584470118|FG001|Overall Study|Lost to follow-up - TP 2|2|||
161843520|NCT04156620|584470117|FG000|Overall Study|Physician decision - TP 2|4|||
161843521|NCT04156620|584470118|FG001|Overall Study|Physician decision - TP 2|2|||
161843522|NCT04156620|584470117|FG000|Overall Study|Pregnancy - TP 2|1|||
161843523|NCT04156620|584470118|FG001|Overall Study|Pregnancy - TP 2|1|||
161843524|NCT04156620|584470117|FG000|Overall Study|Subject decision - TP 2|11|||
161843525|NCT04156620|584470118|FG001|Overall Study|Subject decision - TP 2|9|||
161843526|NCT04156620|584470117|FG000|Overall Study|New therapy for study indication - TP 2|1|||
161843527|NCT04156620|584470118|FG001|Overall Study|New therapy for study indication - TP 2|0|||
161843528|NCT01855074|584470119|FG000|Overall Study|Adverse Event|1|||
161843529|NCT01855074|584470119|FG000|Overall Study|Lost to Follow-up|4|||
161843530|NCT01855074|584470119|FG000|Overall Study|Withdrawal by Subject|8|||
161843531|NCT01855074|584470119|FG000|Overall Study|Started but not treated|1|||
161843532|NCT02991430|584470120|FG000|Treatment Period 1|Adverse Event|1|||
161843533|NCT02991430|584470121|FG001|Treatment Period 1|Adverse Event|0|||
161843534|NCT02991430|584470122|FG002|Treatment Period 1|Adverse Event|2|||
161843535|NCT02991430|584470120|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161843536|NCT02991430|584470121|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161843537|NCT02991430|584470122|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161843538|NCT02991430|584470120|FG000|Treatment Period 2|Study Termination|6|||
161843539|NCT02991430|584470121|FG001|Treatment Period 2|Study Termination|3|||
161843540|NCT02991430|584470122|FG002|Treatment Period 2|Study Termination|3|||
161843541|NCT02991430|584470120|FG000|Treatment Period 2|Lost to Follow-up|0|||
161843542|NCT02991430|584470121|FG001|Treatment Period 2|Lost to Follow-up|0|||
161843543|NCT02991430|584470122|FG002|Treatment Period 2|Lost to Follow-up|1|||
161843544|NCT02991430|584470120|FG000|Post-treatment Observation Period|Study Termination|3|||
161843545|NCT02991430|584470121|FG001|Post-treatment Observation Period|Study Termination|6|||
161843546|NCT02991430|584470122|FG002|Post-treatment Observation Period|Study Termination|5|||
161843547|NCT01150890|584470123|FG000|Overall Study|Other|0|||
161843548|NCT01150890|584470124|FG001|Overall Study|Other|1|||
161843549|NCT01150890|584470125|FG002|Overall Study|Other|0|||
161843550|NCT01150890|584470126|FG003|Overall Study|Other|2|||
161843551|NCT01150890|584470123|FG000|Overall Study|Pregnancy|0|||
161843552|NCT01150890|584470124|FG001|Overall Study|Pregnancy|0|||
161843553|NCT01150890|584470125|FG002|Overall Study|Pregnancy|0|||
161843554|NCT01150890|584470126|FG003|Overall Study|Pregnancy|1|||
161843555|NCT01150890|584470123|FG000|Overall Study|Administrative Decision|4|||
161843556|NCT01150890|584470124|FG001|Overall Study|Administrative Decision|4|||
161843557|NCT01150890|584470125|FG002|Overall Study|Administrative Decision|5|||
161843558|NCT01150890|584470126|FG003|Overall Study|Administrative Decision|6|||
161843559|NCT01150890|584470123|FG000|Overall Study|Ineligibility determined|0|||
161843560|NCT01150890|584470124|FG001|Overall Study|Ineligibility determined|1|||
161750677|NCT02120352|584126694|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750678|NCT02120352|584126695|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
161750679|NCT02427100|584126696|FG000|Overall Study|Lost to Follow-up|0|||
161750680|NCT02427100|584126697|FG001|Overall Study|Lost to Follow-up|2|||
161750681|NCT02186561|584126701|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
161750682|NCT02186561|584126701|FG000|Enrollment|Enrollment Cap Reached|5|||
161750683|NCT02186561|584126701|FG000|Enrollment|Insurance Denial|2|||
161750684|NCT02186561|584126701|FG000|Enrollment|Withdrawal by Subject|2|||
161750685|NCT02186561|584126701|FG000|Enrollment|Investigator Withdrew Consent|1|||
161750686|NCT02186561|584126701|FG000|30-Day Post Index Procedure Visit|Death|1|||
161750687|NCT02186561|584126701|FG000|1- Year Post Index Procedure Visit|Death|1|||
161750688|NCT02186561|584126701|FG000|1- Year Post Index Procedure Visit|Missed|1|||
161750689|NCT00842361|584126702|FG000|Overall Study|Protocol Violation|1|||
161750690|NCT00842361|584126703|FG001|Overall Study|Protocol Violation|0|||
161750691|NCT00842361|584126702|FG000|Overall Study|Unclassified|0|||
161750692|NCT00842361|584126703|FG001|Overall Study|Unclassified|2|||
161750693|NCT01072448|584126706|FG000|Overall Study|Adverse Event|9|||
161750694|NCT01072448|584126707|FG001|Overall Study|Adverse Event|10|||
161750695|NCT01072448|584126706|FG000|Overall Study|Subject withdrew consent|4|||
161750696|NCT01072448|584126707|FG001|Overall Study|Subject withdrew consent|9|||
161750697|NCT01072448|584126706|FG000|Overall Study|Protocol deviation|3|||
161750698|NCT01072448|584126707|FG001|Overall Study|Protocol deviation|4|||
161750699|NCT01072448|584126706|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161750700|NCT01072448|584126707|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161750701|NCT01072448|584126706|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161750702|NCT01072448|584126707|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161750703|NCT01072448|584126706|FG000|Overall Study|Lost to Follow-up|1|||
161750704|NCT01072448|584126707|FG001|Overall Study|Lost to Follow-up|1|||
161750705|NCT01072448|584126706|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161750706|NCT01072448|584126707|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161750707|NCT01072448|584126706|FG000|Overall Study|Death|0|||
161750708|NCT01072448|584126707|FG001|Overall Study|Death|2|||
161750709|NCT00249795|584126708|FG000|Overall Study|Not treated|16|||
161750710|NCT00249795|584126709|FG001|Overall Study|Not treated|14|||
161750711|NCT00249795|584126708|FG000|Overall Study|Symptomatic hypotension|127|||
161750712|NCT00249795|584126709|FG001|Overall Study|Symptomatic hypotension|64|||
161750713|NCT00249795|584126708|FG000|Overall Study|Other Serious Adverse Event|84|||
161750714|NCT00249795|584126709|FG001|Overall Study|Other Serious Adverse Event|93|||
161750715|NCT00249795|584126708|FG000|Overall Study|Qualifying condition not present|26|||
161750716|NCT00249795|584126709|FG001|Overall Study|Qualifying condition not present|29|||
161750717|NCT00249795|584126708|FG000|Overall Study|Withdrawal by Subject|678|||
161750718|NCT00249795|584126709|FG001|Overall Study|Withdrawal by Subject|742|||
161750719|NCT00249795|584126708|FG000|Overall Study|Thromboembolic / outcome event|39|||
161750720|NCT00249795|584126709|FG001|Overall Study|Thromboembolic / outcome event|45|||
161750721|NCT00249795|584126708|FG000|Overall Study|Oral anticoagulant required|2|||
161750722|NCT00249795|584126709|FG001|Overall Study|Oral anticoagulant required|0|||
161750723|NCT00249795|584126708|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
161750724|NCT00249795|584126709|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
161750725|NCT00249795|584126708|FG000|Overall Study|Non-compliance|71|||
161750726|NCT00249795|584126709|FG001|Overall Study|Non-compliance|69|||
161750727|NCT00249795|584126708|FG000|Overall Study|Study drug intolerance|3|||
161750728|NCT00249795|584126709|FG001|Overall Study|Study drug intolerance|3|||
161750729|NCT00249795|584126708|FG000|Overall Study|Other adverse events (non-serious)|188|||
161750730|NCT00249795|584126709|FG001|Overall Study|Other adverse events (non-serious)|159|||
161750731|NCT00249795|584126708|FG000|Overall Study|Physician withdrew consent|71|||
161750732|NCT00249795|584126709|FG001|Overall Study|Physician withdrew consent|63|||
161750733|NCT00249795|584126708|FG000|Overall Study|Surgery / procedure|4|||
161750734|NCT00249795|584126709|FG001|Overall Study|Surgery / procedure|5|||
161750735|NCT00249795|584126708|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
161750736|NCT00249795|584126709|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
161750737|NCT00249795|584126708|FG000|Overall Study|Lightheadedness / dizziness|15|||
161750738|NCT00249795|584126709|FG001|Overall Study|Lightheadedness / dizziness|11|||
161750739|NCT00249795|584126708|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
161750740|NCT00249795|584126709|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
161750741|NCT00249795|584126708|FG000|Overall Study|Other contraindicated medication|1|||
161750742|NCT00249795|584126709|FG001|Overall Study|Other contraindicated medication|1|||
161750743|NCT00249795|584126708|FG000|Overall Study|Event related to cardiac condition|17|||
161750744|NCT00249795|584126709|FG001|Overall Study|Event related to cardiac condition|16|||
161750745|NCT00249795|584126708|FG000|Overall Study|Patient not wish to continue after May08|4|||
161750746|NCT00249795|584126709|FG001|Overall Study|Patient not wish to continue after May08|6|||
161750747|NCT00249795|584126708|FG000|Overall Study|Site not agree to continue after May08|1|||
161750748|NCT00249795|584126709|FG001|Overall Study|Site not agree to continue after May08|1|||
161750749|NCT00249795|584126708|FG000|Overall Study|Lost to Follow-up|0|||
161750750|NCT00249795|584126709|FG001|Overall Study|Lost to Follow-up|2|||
161750751|NCT00249795|584126708|FG000|Overall Study|Missing|0|||
161750752|NCT00249795|584126709|FG001|Overall Study|Missing|1|||
161750753|NCT01814826|584126714|FG000|Overall Study|Other|3|||
161750754|NCT01814826|584126715|FG001|Overall Study|Other|5|||
161750755|NCT01814826|584126716|FG002|Overall Study|Other|0|||
161750756|NCT01814826|584126714|FG000|Overall Study|Death|29|||
161750757|NCT01814826|584126715|FG001|Overall Study|Death|24|||
161750758|NCT01814826|584126716|FG002|Overall Study|Death|3|||
161750759|NCT02917629|584126717|FG000|Overall Study|Withdrawal by Subject|0|||
161750760|NCT02917629|584126718|FG001|Overall Study|Withdrawal by Subject|1|||
161750761|NCT03271307|584126719|FG000|Overall Study|Lost to Follow-up|0|||
161750762|NCT03271307|584126720|FG001|Overall Study|Lost to Follow-up|0|||
161750763|NCT03271307|584126721|FG002|Overall Study|Lost to Follow-up|0|||
161750764|NCT03271307|584126722|FG003|Overall Study|Lost to Follow-up|28|||
161750765|NCT03271307|584126723|FG004|Overall Study|Lost to Follow-up|91|||
161750766|NCT01042938|584126724|FG000|Overall Study|Withdrawal by Subject|1|||
161750767|NCT01042938|584126725|FG001|Overall Study|Withdrawal by Subject|1|||
161750768|NCT01042938|584126724|FG000|Overall Study|Protocol Violation|1|||
161750769|NCT01042938|584126725|FG001|Overall Study|Protocol Violation|1|||
161750770|NCT01042938|584126724|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
161750771|NCT01042938|584126725|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
161750772|NCT03136484|584126726|FG000|Overall Study|Withdrawal by Subject|19|||
161750773|NCT03136484|584126727|FG001|Overall Study|Withdrawal by Subject|14|||
161750774|NCT03136484|584126726|FG000|Overall Study|Lost to Follow-up|7|||
161750775|NCT03136484|584126727|FG001|Overall Study|Lost to Follow-up|8|||
161750776|NCT03136484|584126726|FG000|Overall Study|Death|1|||
161750777|NCT03136484|584126727|FG001|Overall Study|Death|0|||
161750778|NCT01601470|584126730|FG000|Period 2 - LCZ696|Physician Decision|1|||
161750779|NCT03032510|584126731|FG000|Overall Study|Adverse Event|5|||
161750780|NCT03032510|584126732|FG001|Overall Study|Adverse Event|2|||
161750781|NCT03032510|584126731|FG000|Overall Study|Lost to Follow-up|8|||
161750782|NCT03032510|584126732|FG001|Overall Study|Lost to Follow-up|7|||
161750783|NCT03032510|584126731|FG000|Overall Study|Withdrawal by Subject|8|||
161750784|NCT03032510|584126732|FG001|Overall Study|Withdrawal by Subject|7|||
161750785|NCT03032510|584126731|FG000|Overall Study|Subject noncompliance|4|||
161750786|NCT03032510|584126732|FG001|Overall Study|Subject noncompliance|2|||
161750787|NCT03032510|584126731|FG000|Overall Study|Physician Decision|2|||
161750788|NCT03032510|584126732|FG001|Overall Study|Physician Decision|0|||
161750789|NCT01203787|584126733|FG000|Overall Study|Death|12|||
161750790|NCT01203787|584126734|FG001|Overall Study|Death|10|||
161750791|NCT01203787|584126733|FG000|Overall Study|Withdrawal by Subject|6|||
161750792|NCT01203787|584126734|FG001|Overall Study|Withdrawal by Subject|2|||
161750793|NCT01203787|584126733|FG000|Overall Study|Lost to Follow-up|2|||
161750794|NCT01203787|584126734|FG001|Overall Study|Lost to Follow-up|0|||
161750795|NCT01203787|584126733|FG000|Overall Study|Adverse Event|11|||
161750796|NCT01203787|584126734|FG001|Overall Study|Adverse Event|15|||
161750797|NCT00431496|584126737|FG000|Overall Study|Adverse Event|3|||
161750798|NCT00431496|584126737|FG000|Overall Study|Lost to Follow-up|1|||
161750799|NCT00431496|584126737|FG000|Overall Study|Withdrawal by Subject|2|||
161750800|NCT00431496|584126737|FG000|Overall Study|Protocol-specified criteria|5|||
161750801|NCT02999191|584126738|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
161750802|NCT02999191|584126739|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
161750803|NCT02999191|584126740|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
161750804|NCT01570309|584126741|FG000|Overall Study|Withdrawal by Subject|3|||
161750805|NCT01570309|584126742|FG001|Overall Study|Withdrawal by Subject|3|||
161750806|NCT04095793|584126743|FG000|Overall Study|Adverse Event|3|||
161750807|NCT04095793|584126743|FG000|Overall Study|Study Terminated by Sponsor|103|||
161750808|NCT04095793|584126743|FG000|Overall Study|Withdrawal by Subject|4|||
161750809|NCT03619837|584126744|FG000|Screening|received organs from HCV-negative donors|47|||
161750810|NCT03619837|584126744|FG000|Screening|died on the wait-list|2|||
161750811|NCT03619837|584126744|FG000|Screening|remained on the wait list|40|||
161750812|NCT03619837|584126744|FG000|Screening|didn't meet eligibility criteria|3|||
161750813|NCT03619837|584126744|FG000|Screening|withdrew consent|2|||
161750814|NCT03619837|584126744|FG000|Screening|never listed for HCV-viremic donor|1|||
161750815|NCT03619837|584126744|FG000|Screening|developed exclusion criteria|2|||
161750816|NCT03619837|584126744|FG000|Screening|excluded by the investigator due to non-compliance|1|||
161750817|NCT01602549|584126745|FG000|Overall Study|Protocol Violation|0|||
161750818|NCT01602549|584126746|FG001|Overall Study|Protocol Violation|1|||
161750819|NCT01602549|584126745|FG000|Overall Study|Withdrawal by Subject|1|||
161750820|NCT01602549|584126746|FG001|Overall Study|Withdrawal by Subject|0|||
161750821|NCT03627494|584126749|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
161750822|NCT03627494|584126750|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750823|NCT03627494|584126751|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
161750824|NCT03627494|584126752|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750825|NCT03627494|584126753|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750826|NCT03627494|584126754|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750827|NCT03627494|584126755|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750828|NCT03627494|584126756|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750829|NCT03627494|584126757|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750830|NCT03627494|584126758|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750831|NCT03627494|584126759|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750832|NCT03627494|584126760|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750833|NCT03627494|584126749|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750834|NCT03627494|584126750|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750835|NCT03627494|584126751|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750836|NCT03627494|584126752|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750837|NCT03627494|584126753|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750838|NCT03627494|584126754|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750839|NCT03627494|584126755|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750840|NCT03627494|584126756|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750841|NCT03627494|584126757|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
161750842|NCT03627494|584126758|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750843|NCT03627494|584126759|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750844|NCT03627494|584126760|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750845|NCT03627494|584126749|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750846|NCT03627494|584126750|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750847|NCT03627494|584126751|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750848|NCT03627494|584126752|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750849|NCT03627494|584126753|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750850|NCT03627494|584126754|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750851|NCT03627494|584126755|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750852|NCT03627494|584126756|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750853|NCT03627494|584126757|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750854|NCT03627494|584126758|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750855|NCT03627494|584126759|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
161750856|NCT03627494|584126760|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
161843561|NCT01150890|584470125|FG002|Overall Study|Ineligibility determined|0|||
161843562|NCT01150890|584470126|FG003|Overall Study|Ineligibility determined|0|||
161843563|NCT01150890|584470123|FG000|Overall Study|Adverse Event|0|||
161843564|NCT01150890|584470124|FG001|Overall Study|Adverse Event|0|||
161843565|NCT01150890|584470125|FG002|Overall Study|Adverse Event|2|||
161843566|NCT01150890|584470126|FG003|Overall Study|Adverse Event|0|||
161843567|NCT01150890|584470123|FG000|Overall Study|Withdrawal by Subject|0|||
161843568|NCT01150890|584470124|FG001|Overall Study|Withdrawal by Subject|0|||
161843569|NCT01150890|584470125|FG002|Overall Study|Withdrawal by Subject|2|||
161843570|NCT01150890|584470126|FG003|Overall Study|Withdrawal by Subject|1|||
161843571|NCT01150890|584470123|FG000|Overall Study|Disease progression|0|||
161843572|NCT01150890|584470124|FG001|Overall Study|Disease progression|7|||
161843573|NCT01150890|584470125|FG002|Overall Study|Disease progression|3|||
161843574|NCT01150890|584470126|FG003|Overall Study|Disease progression|7|||
161843575|NCT01672970|584470127|FG000|Overall Study|Lack of Efficacy|12|||
161843576|NCT01672970|584470127|FG000|Overall Study|Adverse Event|18|||
161843577|NCT01672970|584470127|FG000|Overall Study|Withdrawal by Subject|2|||
161843578|NCT01672970|584470127|FG000|Overall Study|Lost to Follow-up|5|||
161843579|NCT01672970|584470127|FG000|Overall Study|Other|9|||
161843580|NCT01672970|584470127|FG000|Overall Study|Enrolled but not treated|1|||
161843581|NCT03118570|584470128|FG000|Overall Study|Adverse Event|2|||
161843582|NCT03118570|584470129|FG001|Overall Study|Adverse Event|0|||
161843583|NCT03118570|584470130|FG002|Overall Study|Adverse Event|0|||
161843584|NCT03118570|584470131|FG003|Overall Study|Adverse Event|0|||
161843585|NCT03118570|584470132|FG004|Overall Study|Adverse Event|3|||
161843586|NCT03118570|584470128|FG000|Overall Study|Withdrawal by Subject|0|||
161843587|NCT03118570|584470129|FG001|Overall Study|Withdrawal by Subject|1|||
161843588|NCT03118570|584470130|FG002|Overall Study|Withdrawal by Subject|4|||
161843589|NCT03118570|584470131|FG003|Overall Study|Withdrawal by Subject|0|||
161843590|NCT03118570|584470132|FG004|Overall Study|Withdrawal by Subject|1|||
161843591|NCT03118570|584470128|FG000|Overall Study|Lost to Follow-up|2|||
161843592|NCT03118570|584470129|FG001|Overall Study|Lost to Follow-up|3|||
161843593|NCT03118570|584470130|FG002|Overall Study|Lost to Follow-up|1|||
161843594|NCT03118570|584470131|FG003|Overall Study|Lost to Follow-up|0|||
161843595|NCT03118570|584470132|FG004|Overall Study|Lost to Follow-up|1|||
161843596|NCT03118570|584470128|FG000|Overall Study|Other, Not Specified|1|||
161843597|NCT03118570|584470129|FG001|Overall Study|Other, Not Specified|3|||
161843598|NCT03118570|584470130|FG002|Overall Study|Other, Not Specified|0|||
161843599|NCT03118570|584470131|FG003|Overall Study|Other, Not Specified|0|||
161843600|NCT03118570|584470132|FG004|Overall Study|Other, Not Specified|0|||
161843601|NCT02132754|584470133|FG000|Overall Study|Adverse Event|0|||
161843602|NCT02132754|584470134|FG001|Overall Study|Adverse Event|0|||
161843603|NCT02132754|584470135|FG002|Overall Study|Adverse Event|0|||
161843604|NCT02132754|584470136|FG003|Overall Study|Adverse Event|0|||
161843605|NCT02132754|584470137|FG004|Overall Study|Adverse Event|0|||
161843606|NCT02132754|584470138|FG005|Overall Study|Adverse Event|0|||
161843607|NCT02132754|584470139|FG006|Overall Study|Adverse Event|0|||
161843608|NCT02132754|584470140|FG007|Overall Study|Adverse Event|0|||
161843609|NCT02132754|584470141|FG008|Overall Study|Adverse Event|0|||
161843610|NCT02132754|584470142|FG009|Overall Study|Adverse Event|0|||
161750857|NCT01432756|584128355|FG000|Overall Study|Lost to Follow-up|1|||
161750858|NCT01432756|584128356|FG001|Overall Study|Lost to Follow-up|0|||
161750859|NCT01432756|584128357|FG002|Overall Study|Lost to Follow-up|2|||
161750860|NCT01432756|584128358|FG003|Overall Study|Lost to Follow-up|1|||
161750861|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Death|3|||
161750862|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Death|0|||
161750863|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Death|0|||
161750864|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Death|0|||
161750865|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Death|0|||
161750866|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Death|0|||
161750867|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Death|0|||
161750868|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Death|0|||
161750869|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750870|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
161750871|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
161750872|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750873|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750874|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750875|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750876|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750877|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
161750878|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750879|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
161750880|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750881|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750882|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750883|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750884|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750885|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750886|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750887|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
161750888|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750889|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750890|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750891|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750892|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750893|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750894|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
161750895|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750896|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750897|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750898|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750899|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750900|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750901|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Adverse Event|0|||
161750902|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Adverse Event|0|||
161750903|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Adverse Event|0|||
161750904|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Adverse Event|0|||
161750905|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Adverse Event|1|||
161750906|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Adverse Event|0|||
161750907|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Adverse Event|0|||
161750908|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Adverse Event|2|||
161750909|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Death|1|||
161750910|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Death|0|||
161750911|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Death|0|||
161750912|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Death|0|||
161750913|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Death|0|||
161750914|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Death|0|||
161750915|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Death|1|||
161750916|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Death|0|||
161750917|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750918|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750919|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
161843611|NCT02132754|584470143|FG010|Overall Study|Adverse Event|0|||
161843612|NCT02132754|584470144|FG011|Overall Study|Adverse Event|0|||
161843613|NCT02132754|584470145|FG012|Overall Study|Adverse Event|0|||
161843614|NCT02132754|584470146|FG013|Overall Study|Adverse Event|0|||
161843615|NCT02132754|584470147|FG014|Overall Study|Adverse Event|0|||
161843616|NCT02132754|584470148|FG015|Overall Study|Adverse Event|0|||
161843617|NCT02132754|584470149|FG016|Overall Study|Adverse Event|0|||
161750920|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
161750921|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750922|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750923|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
161750924|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750925|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Physician Decision|0|||
161750926|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Physician Decision|0|||
161750927|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Physician Decision|0|||
161750928|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Physician Decision|1|||
161750929|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Physician Decision|1|||
161750930|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Physician Decision|0|||
161750931|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Physician Decision|0|||
161750932|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Physician Decision|0|||
161750933|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750934|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750935|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750936|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750937|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750938|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750939|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
161750940|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
161750941|NCT04483544|584128367|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
161750942|NCT04483544|584128367|FG000|Post-Treatment|Admitted to hospice|2|||
161750943|NCT04483544|584128367|FG000|Post-Treatment|Study terminated|3|||
161750944|NCT01131078|584128368|FG000|Overall Study|Adverse Event|22|||
161750945|NCT01131078|584128369|FG001|Overall Study|Adverse Event|12|||
161750946|NCT01131078|584128370|FG002|Overall Study|Adverse Event|17|||
161750947|NCT01131078|584128368|FG000|Overall Study|Progressive Disease|58|||
161750948|NCT01131078|584128369|FG001|Overall Study|Progressive Disease|77|||
161750949|NCT01131078|584128370|FG002|Overall Study|Progressive Disease|71|||
161750950|NCT01131078|584128368|FG000|Overall Study|Protocol Violation|1|||
161750951|NCT01131078|584128369|FG001|Overall Study|Protocol Violation|0|||
161750952|NCT01131078|584128370|FG002|Overall Study|Protocol Violation|0|||
161750953|NCT01131078|584128368|FG000|Overall Study|Lost to Follow-up|1|||
161750954|NCT01131078|584128369|FG001|Overall Study|Lost to Follow-up|1|||
161750955|NCT01131078|584128370|FG002|Overall Study|Lost to Follow-up|1|||
161750956|NCT01131078|584128368|FG000|Overall Study|Withdrawal by Subject|2|||
161750957|NCT01131078|584128369|FG001|Overall Study|Withdrawal by Subject|4|||
161750958|NCT01131078|584128370|FG002|Overall Study|Withdrawal by Subject|3|||
161750959|NCT01131078|584128368|FG000|Overall Study|Non-compliance|3|||
161750960|NCT01131078|584128369|FG001|Overall Study|Non-compliance|0|||
161750961|NCT01131078|584128370|FG002|Overall Study|Non-compliance|0|||
161750962|NCT01131078|584128368|FG000|Overall Study|Physician Decision|10|||
161750963|NCT01131078|584128369|FG001|Overall Study|Physician Decision|6|||
161750964|NCT01131078|584128370|FG002|Overall Study|Physician Decision|8|||
161750965|NCT01131078|584128368|FG000|Overall Study|Death|4|||
161750966|NCT01131078|584128369|FG001|Overall Study|Death|0|||
161750967|NCT01131078|584128370|FG002|Overall Study|Death|2|||
161750968|NCT01131078|584128368|FG000|Overall Study|Other|0|||
161750969|NCT01131078|584128369|FG001|Overall Study|Other|1|||
161750970|NCT01131078|584128370|FG002|Overall Study|Other|0|||
161750971|NCT00364351|584128371|FG000|Overall Study|Adverse Event|90|||
161750972|NCT00364351|584128372|FG001|Overall Study|Adverse Event|44|||
161750973|NCT00364351|584128371|FG000|Overall Study|Condition under investigation worsened|469|||
161750974|NCT00364351|584128372|FG001|Overall Study|Condition under investigation worsened|497|||
161750975|NCT00364351|584128371|FG000|Overall Study|Prohibited concomitant medication|0|||
161750976|NCT00364351|584128372|FG001|Overall Study|Prohibited concomitant medication|2|||
161750977|NCT00364351|584128371|FG000|Overall Study|Lost to Follow-up|1|||
161750978|NCT00364351|584128372|FG001|Overall Study|Lost to Follow-up|1|||
161750979|NCT00364351|584128371|FG000|Overall Study|Withdrawal by Subject|30|||
161750980|NCT00364351|584128372|FG001|Overall Study|Withdrawal by Subject|29|||
161843618|NCT02132754|584470150|FG017|Overall Study|Adverse Event|1|||
161750981|NCT00364351|584128371|FG000|Overall Study|Incorrect enrollment|1|||
161750982|NCT00364351|584128372|FG001|Overall Study|Incorrect enrollment|1|||
161750983|NCT00364351|584128371|FG000|Overall Study|Sponsor decision|1|||
161750984|NCT00364351|584128372|FG001|Overall Study|Sponsor decision|0|||
161750985|NCT00364351|584128371|FG000|Overall Study|Poor treatment compliance|0|||
161750986|NCT00364351|584128372|FG001|Overall Study|Poor treatment compliance|3|||
161843619|NCT02132754|584470151|FG018|Overall Study|Adverse Event|0|||
161843620|NCT02132754|584470152|FG019|Overall Study|Adverse Event|0|||
161843621|NCT02132754|584470153|FG020|Overall Study|Adverse Event|0|||
161843622|NCT02132754|584470154|FG021|Overall Study|Adverse Event|0|||
161843623|NCT02132754|584470155|FG022|Overall Study|Adverse Event|0|||
161843624|NCT02132754|584470156|FG023|Overall Study|Adverse Event|0|||
161843625|NCT02132754|584470157|FG024|Overall Study|Adverse Event|0|||
161843626|NCT02132754|584470158|FG025|Overall Study|Adverse Event|1|||
161843627|NCT02132754|584470159|FG026|Overall Study|Adverse Event|1|||
161843628|NCT02132754|584470160|FG027|Overall Study|Adverse Event|0|||
161843629|NCT02132754|584470161|FG028|Overall Study|Adverse Event|0|||
161843630|NCT02132754|584470162|FG029|Overall Study|Adverse Event|0|||
161843631|NCT02132754|584470163|FG030|Overall Study|Adverse Event|1|||
161843632|NCT02132754|584470164|FG031|Overall Study|Adverse Event|0|||
161843633|NCT02132754|584470165|FG032|Overall Study|Adverse Event|1|||
161843634|NCT02132754|584470166|FG033|Overall Study|Adverse Event|1|||
161843635|NCT02132754|584470133|FG000|Overall Study|Clinical Progression|0|||
161843636|NCT02132754|584470134|FG001|Overall Study|Clinical Progression|0|||
161843637|NCT02132754|584470135|FG002|Overall Study|Clinical Progression|0|||
161843638|NCT02132754|584470136|FG003|Overall Study|Clinical Progression|0|||
161843639|NCT02132754|584470137|FG004|Overall Study|Clinical Progression|0|||
161843640|NCT02132754|584470138|FG005|Overall Study|Clinical Progression|0|||
161843641|NCT02132754|584470139|FG006|Overall Study|Clinical Progression|0|||
161843642|NCT02132754|584470140|FG007|Overall Study|Clinical Progression|0|||
161843643|NCT02132754|584470141|FG008|Overall Study|Clinical Progression|0|||
161843644|NCT02132754|584470142|FG009|Overall Study|Clinical Progression|1|||
161843645|NCT02132754|584470143|FG010|Overall Study|Clinical Progression|0|||
161843646|NCT02132754|584470144|FG011|Overall Study|Clinical Progression|0|||
161843647|NCT02132754|584470145|FG012|Overall Study|Clinical Progression|0|||
161843648|NCT02132754|584470146|FG013|Overall Study|Clinical Progression|0|||
161843649|NCT02132754|584470147|FG014|Overall Study|Clinical Progression|0|||
161843650|NCT02132754|584470148|FG015|Overall Study|Clinical Progression|0|||
161843651|NCT02132754|584470149|FG016|Overall Study|Clinical Progression|1|||
161843652|NCT02132754|584470150|FG017|Overall Study|Clinical Progression|1|||
161843653|NCT02132754|584470151|FG018|Overall Study|Clinical Progression|0|||
161843654|NCT02132754|584470152|FG019|Overall Study|Clinical Progression|1|||
161843655|NCT02132754|584470153|FG020|Overall Study|Clinical Progression|0|||
161843656|NCT02132754|584470154|FG021|Overall Study|Clinical Progression|0|||
161843657|NCT02132754|584470155|FG022|Overall Study|Clinical Progression|1|||
161843658|NCT02132754|584470156|FG023|Overall Study|Clinical Progression|0|||
161843659|NCT02132754|584470157|FG024|Overall Study|Clinical Progression|1|||
161843660|NCT02132754|584470158|FG025|Overall Study|Clinical Progression|1|||
161843661|NCT02132754|584470159|FG026|Overall Study|Clinical Progression|0|||
161843662|NCT02132754|584470160|FG027|Overall Study|Clinical Progression|1|||
161843663|NCT02132754|584470161|FG028|Overall Study|Clinical Progression|1|||
161843664|NCT02132754|584470162|FG029|Overall Study|Clinical Progression|0|||
161843665|NCT02132754|584470163|FG030|Overall Study|Clinical Progression|1|||
161843666|NCT02132754|584470164|FG031|Overall Study|Clinical Progression|0|||
161843667|NCT02132754|584470165|FG032|Overall Study|Clinical Progression|0|||
161843668|NCT02132754|584470166|FG033|Overall Study|Clinical Progression|2|||
161843669|NCT02132754|584470133|FG000|Overall Study|Death|0|||
161843670|NCT02132754|584470134|FG001|Overall Study|Death|0|||
161843671|NCT02132754|584470135|FG002|Overall Study|Death|0|||
161843672|NCT02132754|584470136|FG003|Overall Study|Death|0|||
161843673|NCT02132754|584470137|FG004|Overall Study|Death|0|||
161843674|NCT02132754|584470138|FG005|Overall Study|Death|0|||
161843675|NCT02132754|584470139|FG006|Overall Study|Death|0|||
161843676|NCT02132754|584470140|FG007|Overall Study|Death|0|||
161843677|NCT02132754|584470141|FG008|Overall Study|Death|0|||
161843678|NCT02132754|584470142|FG009|Overall Study|Death|0|||
161843679|NCT02132754|584470143|FG010|Overall Study|Death|0|||
161843680|NCT02132754|584470144|FG011|Overall Study|Death|0|||
161843681|NCT02132754|584470145|FG012|Overall Study|Death|0|||
161843682|NCT02132754|584470146|FG013|Overall Study|Death|0|||
161843683|NCT02132754|584470147|FG014|Overall Study|Death|0|||
161843684|NCT02132754|584470148|FG015|Overall Study|Death|1|||
161843685|NCT02132754|584470149|FG016|Overall Study|Death|0|||
161843686|NCT02132754|584470150|FG017|Overall Study|Death|0|||
161843687|NCT02132754|584470151|FG018|Overall Study|Death|0|||
161843688|NCT02132754|584470152|FG019|Overall Study|Death|1|||
161843689|NCT02132754|584470153|FG020|Overall Study|Death|0|||
161843690|NCT02132754|584470154|FG021|Overall Study|Death|1|||
161843691|NCT02132754|584470155|FG022|Overall Study|Death|0|||
161843692|NCT02132754|584470156|FG023|Overall Study|Death|0|||
161843693|NCT02132754|584470157|FG024|Overall Study|Death|0|||
161843694|NCT02132754|584470158|FG025|Overall Study|Death|0|||
161843695|NCT02132754|584470159|FG026|Overall Study|Death|1|||
161843696|NCT02132754|584470160|FG027|Overall Study|Death|0|||
161843697|NCT02132754|584470161|FG028|Overall Study|Death|0|||
161843698|NCT02132754|584470162|FG029|Overall Study|Death|0|||
161843699|NCT02132754|584470163|FG030|Overall Study|Death|0|||
161843700|NCT02132754|584470164|FG031|Overall Study|Death|0|||
161843701|NCT02132754|584470165|FG032|Overall Study|Death|0|||
161843702|NCT02132754|584470166|FG033|Overall Study|Death|2|||
161843703|NCT02132754|584470133|FG000|Overall Study|Excluded Medication|0|||
161843704|NCT02132754|584470134|FG001|Overall Study|Excluded Medication|0|||
161843705|NCT02132754|584470135|FG002|Overall Study|Excluded Medication|0|||
161843706|NCT02132754|584470136|FG003|Overall Study|Excluded Medication|0|||
161843707|NCT02132754|584470137|FG004|Overall Study|Excluded Medication|0|||
161843708|NCT02132754|584470138|FG005|Overall Study|Excluded Medication|0|||
161843709|NCT02132754|584470139|FG006|Overall Study|Excluded Medication|0|||
161843710|NCT02132754|584470140|FG007|Overall Study|Excluded Medication|0|||
161843711|NCT02132754|584470141|FG008|Overall Study|Excluded Medication|0|||
161843712|NCT02132754|584470142|FG009|Overall Study|Excluded Medication|0|||
161843713|NCT02132754|584470143|FG010|Overall Study|Excluded Medication|0|||
161843714|NCT02132754|584470144|FG011|Overall Study|Excluded Medication|0|||
161843715|NCT02132754|584470145|FG012|Overall Study|Excluded Medication|0|||
161843716|NCT02132754|584470146|FG013|Overall Study|Excluded Medication|0|||
161843717|NCT02132754|584470147|FG014|Overall Study|Excluded Medication|0|||
161843718|NCT02132754|584470148|FG015|Overall Study|Excluded Medication|0|||
161843719|NCT02132754|584470149|FG016|Overall Study|Excluded Medication|0|||
161843720|NCT02132754|584470150|FG017|Overall Study|Excluded Medication|0|||
161843721|NCT02132754|584470151|FG018|Overall Study|Excluded Medication|0|||
161843722|NCT02132754|584470152|FG019|Overall Study|Excluded Medication|0|||
161843723|NCT02132754|584470153|FG020|Overall Study|Excluded Medication|1|||
161843724|NCT02132754|584470154|FG021|Overall Study|Excluded Medication|0|||
161843725|NCT02132754|584470155|FG022|Overall Study|Excluded Medication|0|||
161843726|NCT02132754|584470156|FG023|Overall Study|Excluded Medication|0|||
161843727|NCT02132754|584470157|FG024|Overall Study|Excluded Medication|0|||
161843728|NCT02132754|584470158|FG025|Overall Study|Excluded Medication|0|||
161843729|NCT02132754|584470159|FG026|Overall Study|Excluded Medication|0|||
161843730|NCT02132754|584470160|FG027|Overall Study|Excluded Medication|0|||
161843731|NCT02132754|584470161|FG028|Overall Study|Excluded Medication|0|||
161843732|NCT02132754|584470162|FG029|Overall Study|Excluded Medication|0|||
161843733|NCT02132754|584470163|FG030|Overall Study|Excluded Medication|0|||
161843734|NCT02132754|584470164|FG031|Overall Study|Excluded Medication|0|||
161843735|NCT02132754|584470165|FG032|Overall Study|Excluded Medication|0|||
161843736|NCT02132754|584470166|FG033|Overall Study|Excluded Medication|1|||
161843737|NCT02132754|584470133|FG000|Overall Study|Physician Decision|0|||
161843738|NCT02132754|584470134|FG001|Overall Study|Physician Decision|0|||
161843739|NCT02132754|584470135|FG002|Overall Study|Physician Decision|0|||
161843740|NCT02132754|584470136|FG003|Overall Study|Physician Decision|0|||
161843741|NCT02132754|584470137|FG004|Overall Study|Physician Decision|0|||
161843742|NCT02132754|584470138|FG005|Overall Study|Physician Decision|0|||
161843743|NCT02132754|584470139|FG006|Overall Study|Physician Decision|0|||
161843744|NCT02132754|584470140|FG007|Overall Study|Physician Decision|0|||
161843745|NCT02132754|584470141|FG008|Overall Study|Physician Decision|0|||
161843746|NCT02132754|584470142|FG009|Overall Study|Physician Decision|1|||
161843747|NCT02132754|584470143|FG010|Overall Study|Physician Decision|0|||
161843748|NCT02132754|584470144|FG011|Overall Study|Physician Decision|1|||
161843749|NCT02132754|584470145|FG012|Overall Study|Physician Decision|1|||
161843750|NCT02132754|584470146|FG013|Overall Study|Physician Decision|0|||
161843751|NCT02132754|584470147|FG014|Overall Study|Physician Decision|0|||
161843752|NCT02132754|584470148|FG015|Overall Study|Physician Decision|1|||
161843753|NCT02132754|584470149|FG016|Overall Study|Physician Decision|0|||
161750987|NCT00364351|584128371|FG000|Overall Study|Investigator error|0|||
161750988|NCT00364351|584128372|FG001|Overall Study|Investigator error|2|||
161750989|NCT00364351|584128371|FG000|Overall Study|Patient could not travel to site|0|||
161750990|NCT00364351|584128372|FG001|Overall Study|Patient could not travel to site|1|||
161750991|NCT00364351|584128371|FG000|Overall Study|Randomised treatment not started|0|||
161750992|NCT00364351|584128372|FG001|Overall Study|Randomised treatment not started|3|||
161750993|NCT02177786|584128373|FG000|Overall Study|Withdrew Consent|2|||
161750994|NCT02177786|584128374|FG001|Overall Study|Withdrew Consent|6|||
161750995|NCT02177786|584128375|FG002|Overall Study|Withdrew Consent|9|||
161750996|NCT02177786|584128376|FG003|Overall Study|Withdrew Consent|5|||
161750997|NCT02177786|584128373|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
161750998|NCT02177786|584128374|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
161750999|NCT02177786|584128375|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
161751000|NCT02177786|584128376|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
161751001|NCT02177786|584128373|FG000|Overall Study|Adverse Event|1|||
161751002|NCT02177786|584128374|FG001|Overall Study|Adverse Event|1|||
161751003|NCT02177786|584128375|FG002|Overall Study|Adverse Event|2|||
161751004|NCT02177786|584128376|FG003|Overall Study|Adverse Event|3|||
161751005|NCT02177786|584128373|FG000|Overall Study|Death|1|||
161751006|NCT02177786|584128374|FG001|Overall Study|Death|1|||
161751007|NCT02177786|584128375|FG002|Overall Study|Death|1|||
161751008|NCT02177786|584128376|FG003|Overall Study|Death|1|||
161751009|NCT02177786|584128373|FG000|Overall Study|Lost to Follow-up|0|||
161751010|NCT02177786|584128374|FG001|Overall Study|Lost to Follow-up|0|||
161751011|NCT02177786|584128375|FG002|Overall Study|Lost to Follow-up|2|||
161751012|NCT02177786|584128376|FG003|Overall Study|Lost to Follow-up|2|||
161751013|NCT02177786|584128373|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161751014|NCT02177786|584128374|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161751015|NCT02177786|584128375|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161751016|NCT02177786|584128376|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161751017|NCT02177786|584128373|FG000|Overall Study|Protocol Violation|0|||
161751018|NCT02177786|584128374|FG001|Overall Study|Protocol Violation|0|||
161751019|NCT02177786|584128375|FG002|Overall Study|Protocol Violation|2|||
161751020|NCT02177786|584128376|FG003|Overall Study|Protocol Violation|0|||
161751021|NCT02177786|584128373|FG000|Overall Study|Progressive Disease|0|||
161751022|NCT02177786|584128374|FG001|Overall Study|Progressive Disease|1|||
161751023|NCT02177786|584128375|FG002|Overall Study|Progressive Disease|0|||
161751024|NCT02177786|584128376|FG003|Overall Study|Progressive Disease|0|||
161751025|NCT02177786|584128373|FG000|Overall Study|Missing study completion status|0|||
161751026|NCT02177786|584128374|FG001|Overall Study|Missing study completion status|1|||
161751027|NCT02177786|584128375|FG002|Overall Study|Missing study completion status|0|||
161751028|NCT02177786|584128376|FG003|Overall Study|Missing study completion status|0|||
161751029|NCT01305941|584128377|FG000|Overall Study|Adverse Event|6|||
161751030|NCT01305941|584128377|FG000|Overall Study|Clinical decline|2|||
161751031|NCT01305941|584128377|FG000|Overall Study|Withdrawal by Subject|1|||
161751032|NCT01305941|584128377|FG000|Overall Study|Death|1|||
161751033|NCT01957215|584128379|FG000|Overall Study|Adverse Event|2|||
161751034|NCT01957215|584128380|FG001|Overall Study|Adverse Event|2|||
161751035|NCT01957215|584128379|FG000|Overall Study|Lost to Follow-up|3|||
161751036|NCT01957215|584128380|FG001|Overall Study|Lost to Follow-up|3|||
161751037|NCT01957215|584128379|FG000|Overall Study|Protocol Violation|1|||
161751038|NCT01957215|584128380|FG001|Overall Study|Protocol Violation|2|||
161751039|NCT01957215|584128379|FG000|Overall Study|Withdrawal by Subject|7|||
161751040|NCT01957215|584128380|FG001|Overall Study|Withdrawal by Subject|5|||
161751041|NCT03597503|584128384|FG000|Overall Study|Withdrawal by Subject|0|||
161751042|NCT03597503|584128385|FG001|Overall Study|Withdrawal by Subject|2|||
161751043|NCT03597503|584128384|FG000|Overall Study|Lost to Follow-up|1|||
161751044|NCT03597503|584128385|FG001|Overall Study|Lost to Follow-up|2|||
161751045|NCT03597503|584128384|FG000|Overall Study|Protocol Violation|1|||
161751046|NCT03597503|584128385|FG001|Overall Study|Protocol Violation|0|||
161751047|NCT02667236|584128388|FG000|Overall Study|Adverse Event|1|||
161751048|NCT02667236|584128389|FG001|Overall Study|Adverse Event|1|||
161751049|NCT02667236|584128388|FG000|Overall Study|Withdrawal by Subject|2|||
161751050|NCT02667236|584128389|FG001|Overall Study|Withdrawal by Subject|0|||
161751051|NCT00634751|584128390|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
161751052|NCT00634751|584128391|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161751053|NCT00634751|584128392|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161751054|NCT00634751|584128393|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161751055|NCT00634751|584128390|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161751056|NCT00634751|584128391|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
161751057|NCT00634751|584128392|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161751058|NCT00634751|584128393|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161751059|NCT00634751|584128390|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
161751060|NCT00634751|584128391|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
161751061|NCT00634751|584128392|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
161751062|NCT00634751|584128393|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
161751063|NCT00608894|584128394|FG000|Overall Study|Withdrawal by Subject|0|||
161843754|NCT02132754|584470150|FG017|Overall Study|Physician Decision|0|||
161843755|NCT02132754|584470151|FG018|Overall Study|Physician Decision|0|||
161843756|NCT02132754|584470152|FG019|Overall Study|Physician Decision|0|||
161843757|NCT02132754|584470153|FG020|Overall Study|Physician Decision|0|||
161843758|NCT02132754|584470154|FG021|Overall Study|Physician Decision|0|||
161843759|NCT02132754|584470155|FG022|Overall Study|Physician Decision|0|||
161843760|NCT02132754|584470156|FG023|Overall Study|Physician Decision|0|||
161843761|NCT02132754|584470157|FG024|Overall Study|Physician Decision|1|||
161843762|NCT02132754|584470158|FG025|Overall Study|Physician Decision|0|||
161843763|NCT02132754|584470159|FG026|Overall Study|Physician Decision|0|||
161843764|NCT02132754|584470160|FG027|Overall Study|Physician Decision|0|||
161843765|NCT02132754|584470161|FG028|Overall Study|Physician Decision|0|||
161843766|NCT02132754|584470162|FG029|Overall Study|Physician Decision|0|||
161843767|NCT02132754|584470163|FG030|Overall Study|Physician Decision|0|||
161843768|NCT02132754|584470164|FG031|Overall Study|Physician Decision|1|||
161843769|NCT02132754|584470165|FG032|Overall Study|Physician Decision|0|||
161843770|NCT02132754|584470166|FG033|Overall Study|Physician Decision|3|||
161843771|NCT02132754|584470133|FG000|Overall Study|Progressive Disease|1|||
161843772|NCT02132754|584470134|FG001|Overall Study|Progressive Disease|1|||
161843773|NCT02132754|584470135|FG002|Overall Study|Progressive Disease|1|||
161843774|NCT02132754|584470136|FG003|Overall Study|Progressive Disease|1|||
161843775|NCT02132754|584470137|FG004|Overall Study|Progressive Disease|1|||
161843776|NCT02132754|584470138|FG005|Overall Study|Progressive Disease|1|||
161843777|NCT02132754|584470139|FG006|Overall Study|Progressive Disease|1|||
161843778|NCT02132754|584470140|FG007|Overall Study|Progressive Disease|1|||
161843779|NCT02132754|584470141|FG008|Overall Study|Progressive Disease|1|||
161843780|NCT02132754|584470142|FG009|Overall Study|Progressive Disease|3|||
161843781|NCT02132754|584470143|FG010|Overall Study|Progressive Disease|3|||
161843782|NCT02132754|584470144|FG011|Overall Study|Progressive Disease|2|||
161843783|NCT02132754|584470145|FG012|Overall Study|Progressive Disease|2|||
161843784|NCT02132754|584470146|FG013|Overall Study|Progressive Disease|3|||
161843785|NCT02132754|584470147|FG014|Overall Study|Progressive Disease|2|||
161843786|NCT02132754|584470148|FG015|Overall Study|Progressive Disease|1|||
161843787|NCT02132754|584470149|FG016|Overall Study|Progressive Disease|2|||
161843788|NCT02132754|584470150|FG017|Overall Study|Progressive Disease|1|||
161843789|NCT02132754|584470151|FG018|Overall Study|Progressive Disease|3|||
161843790|NCT02132754|584470152|FG019|Overall Study|Progressive Disease|1|||
161843791|NCT02132754|584470153|FG020|Overall Study|Progressive Disease|1|||
161843792|NCT02132754|584470154|FG021|Overall Study|Progressive Disease|3|||
161843793|NCT02132754|584470155|FG022|Overall Study|Progressive Disease|2|||
161843794|NCT02132754|584470156|FG023|Overall Study|Progressive Disease|3|||
161843795|NCT02132754|584470157|FG024|Overall Study|Progressive Disease|0|||
161843796|NCT02132754|584470158|FG025|Overall Study|Progressive Disease|1|||
161843797|NCT02132754|584470159|FG026|Overall Study|Progressive Disease|2|||
161843798|NCT02132754|584470160|FG027|Overall Study|Progressive Disease|1|||
161843799|NCT02132754|584470161|FG028|Overall Study|Progressive Disease|2|||
161843800|NCT02132754|584470162|FG029|Overall Study|Progressive Disease|3|||
161843801|NCT02132754|584470163|FG030|Overall Study|Progressive Disease|1|||
161843802|NCT02132754|584470164|FG031|Overall Study|Progressive Disease|1|||
161843803|NCT02132754|584470165|FG032|Overall Study|Progressive Disease|3|||
161843804|NCT02132754|584470166|FG033|Overall Study|Progressive Disease|6|||
161843805|NCT02132754|584470133|FG000|Overall Study|Screen Failure|0|||
161843806|NCT02132754|584470134|FG001|Overall Study|Screen Failure|0|||
161843807|NCT02132754|584470135|FG002|Overall Study|Screen Failure|0|||
161843808|NCT02132754|584470136|FG003|Overall Study|Screen Failure|0|||
161843809|NCT02132754|584470137|FG004|Overall Study|Screen Failure|0|||
161843810|NCT02132754|584470138|FG005|Overall Study|Screen Failure|0|||
161843811|NCT02132754|584470139|FG006|Overall Study|Screen Failure|0|||
161843812|NCT02132754|584470140|FG007|Overall Study|Screen Failure|0|||
161843813|NCT02132754|584470141|FG008|Overall Study|Screen Failure|0|||
161843814|NCT02132754|584470142|FG009|Overall Study|Screen Failure|0|||
161843815|NCT02132754|584470143|FG010|Overall Study|Screen Failure|0|||
161843816|NCT02132754|584470144|FG011|Overall Study|Screen Failure|0|||
161843817|NCT02132754|584470145|FG012|Overall Study|Screen Failure|0|||
161843818|NCT02132754|584470146|FG013|Overall Study|Screen Failure|0|||
161843819|NCT02132754|584470147|FG014|Overall Study|Screen Failure|0|||
161843820|NCT02132754|584470148|FG015|Overall Study|Screen Failure|0|||
161843821|NCT02132754|584470149|FG016|Overall Study|Screen Failure|0|||
161843822|NCT02132754|584470150|FG017|Overall Study|Screen Failure|0|||
161843823|NCT02132754|584470151|FG018|Overall Study|Screen Failure|0|||
161843824|NCT02132754|584470152|FG019|Overall Study|Screen Failure|1|||
161843825|NCT02132754|584470153|FG020|Overall Study|Screen Failure|0|||
161843826|NCT02132754|584470154|FG021|Overall Study|Screen Failure|1|||
161843827|NCT02132754|584470155|FG022|Overall Study|Screen Failure|0|||
161843828|NCT02132754|584470156|FG023|Overall Study|Screen Failure|0|||
161843829|NCT02132754|584470157|FG024|Overall Study|Screen Failure|0|||
161843830|NCT02132754|584470158|FG025|Overall Study|Screen Failure|0|||
161843831|NCT02132754|584470159|FG026|Overall Study|Screen Failure|0|||
161843832|NCT02132754|584470160|FG027|Overall Study|Screen Failure|0|||
161843833|NCT02132754|584470161|FG028|Overall Study|Screen Failure|0|||
161843834|NCT02132754|584470162|FG029|Overall Study|Screen Failure|0|||
161843835|NCT02132754|584470163|FG030|Overall Study|Screen Failure|0|||
161843836|NCT02132754|584470164|FG031|Overall Study|Screen Failure|0|||
161843837|NCT02132754|584470165|FG032|Overall Study|Screen Failure|0|||
161843838|NCT02132754|584470166|FG033|Overall Study|Screen Failure|0|||
161843839|NCT02132754|584470133|FG000|Overall Study|Transferred to Extension Study|0|||
161843840|NCT02132754|584470134|FG001|Overall Study|Transferred to Extension Study|0|||
161843841|NCT02132754|584470135|FG002|Overall Study|Transferred to Extension Study|0|||
161843842|NCT02132754|584470136|FG003|Overall Study|Transferred to Extension Study|0|||
161843843|NCT02132754|584470137|FG004|Overall Study|Transferred to Extension Study|0|||
161843844|NCT02132754|584470138|FG005|Overall Study|Transferred to Extension Study|0|||
161843845|NCT02132754|584470139|FG006|Overall Study|Transferred to Extension Study|0|||
161843846|NCT02132754|584470140|FG007|Overall Study|Transferred to Extension Study|0|||
161843847|NCT02132754|584470141|FG008|Overall Study|Transferred to Extension Study|0|||
161843848|NCT02132754|584470142|FG009|Overall Study|Transferred to Extension Study|0|||
161843849|NCT02132754|584470143|FG010|Overall Study|Transferred to Extension Study|0|||
161843850|NCT02132754|584470144|FG011|Overall Study|Transferred to Extension Study|0|||
161843851|NCT02132754|584470145|FG012|Overall Study|Transferred to Extension Study|0|||
161843852|NCT02132754|584470146|FG013|Overall Study|Transferred to Extension Study|0|||
161843853|NCT02132754|584470147|FG014|Overall Study|Transferred to Extension Study|0|||
161843854|NCT02132754|584470148|FG015|Overall Study|Transferred to Extension Study|0|||
161843855|NCT02132754|584470149|FG016|Overall Study|Transferred to Extension Study|0|||
161843856|NCT02132754|584470150|FG017|Overall Study|Transferred to Extension Study|0|||
161843857|NCT02132754|584470151|FG018|Overall Study|Transferred to Extension Study|0|||
161843858|NCT02132754|584470152|FG019|Overall Study|Transferred to Extension Study|0|||
161843859|NCT02132754|584470153|FG020|Overall Study|Transferred to Extension Study|0|||
161843860|NCT02132754|584470154|FG021|Overall Study|Transferred to Extension Study|0|||
161843861|NCT02132754|584470155|FG022|Overall Study|Transferred to Extension Study|0|||
161843862|NCT02132754|584470156|FG023|Overall Study|Transferred to Extension Study|0|||
161843863|NCT02132754|584470157|FG024|Overall Study|Transferred to Extension Study|0|||
161843864|NCT02132754|584470158|FG025|Overall Study|Transferred to Extension Study|0|||
161843865|NCT02132754|584470159|FG026|Overall Study|Transferred to Extension Study|0|||
161843866|NCT02132754|584470160|FG027|Overall Study|Transferred to Extension Study|0|||
161843867|NCT02132754|584470161|FG028|Overall Study|Transferred to Extension Study|0|||
161843868|NCT02132754|584470162|FG029|Overall Study|Transferred to Extension Study|0|||
161843869|NCT02132754|584470163|FG030|Overall Study|Transferred to Extension Study|0|||
161843870|NCT02132754|584470164|FG031|Overall Study|Transferred to Extension Study|0|||
161843871|NCT02132754|584470165|FG032|Overall Study|Transferred to Extension Study|0|||
161843872|NCT02132754|584470166|FG033|Overall Study|Transferred to Extension Study|6|||
161843873|NCT02132754|584470133|FG000|Overall Study|Withdrawal by Subject|0|||
161843874|NCT02132754|584470134|FG001|Overall Study|Withdrawal by Subject|0|||
161843875|NCT02132754|584470135|FG002|Overall Study|Withdrawal by Subject|0|||
161843876|NCT02132754|584470136|FG003|Overall Study|Withdrawal by Subject|0|||
161843877|NCT02132754|584470137|FG004|Overall Study|Withdrawal by Subject|0|||
161843878|NCT02132754|584470138|FG005|Overall Study|Withdrawal by Subject|0|||
161843879|NCT02132754|584470139|FG006|Overall Study|Withdrawal by Subject|0|||
161843880|NCT02132754|584470140|FG007|Overall Study|Withdrawal by Subject|0|||
161843881|NCT02132754|584470141|FG008|Overall Study|Withdrawal by Subject|0|||
161843882|NCT02132754|584470142|FG009|Overall Study|Withdrawal by Subject|1|||
161843883|NCT02132754|584470143|FG010|Overall Study|Withdrawal by Subject|0|||
161843884|NCT02132754|584470144|FG011|Overall Study|Withdrawal by Subject|0|||
161843885|NCT02132754|584470145|FG012|Overall Study|Withdrawal by Subject|1|||
161843886|NCT02132754|584470146|FG013|Overall Study|Withdrawal by Subject|0|||
161843887|NCT02132754|584470147|FG014|Overall Study|Withdrawal by Subject|1|||
161843888|NCT02132754|584470148|FG015|Overall Study|Withdrawal by Subject|2|||
161843889|NCT02132754|584470149|FG016|Overall Study|Withdrawal by Subject|1|||
161843890|NCT02132754|584470150|FG017|Overall Study|Withdrawal by Subject|0|||
161843891|NCT02132754|584470151|FG018|Overall Study|Withdrawal by Subject|0|||
161843892|NCT02132754|584470152|FG019|Overall Study|Withdrawal by Subject|0|||
161843893|NCT02132754|584470153|FG020|Overall Study|Withdrawal by Subject|1|||
161843894|NCT02132754|584470154|FG021|Overall Study|Withdrawal by Subject|0|||
161843895|NCT02132754|584470155|FG022|Overall Study|Withdrawal by Subject|0|||
161843896|NCT02132754|584470156|FG023|Overall Study|Withdrawal by Subject|0|||
161843897|NCT02132754|584470157|FG024|Overall Study|Withdrawal by Subject|1|||
161843898|NCT02132754|584470158|FG025|Overall Study|Withdrawal by Subject|0|||
161843899|NCT02132754|584470159|FG026|Overall Study|Withdrawal by Subject|0|||
161843900|NCT02132754|584470160|FG027|Overall Study|Withdrawal by Subject|1|||
161843901|NCT02132754|584470161|FG028|Overall Study|Withdrawal by Subject|0|||
161843902|NCT02132754|584470162|FG029|Overall Study|Withdrawal by Subject|0|||
161843903|NCT02132754|584470163|FG030|Overall Study|Withdrawal by Subject|0|||
161843904|NCT02132754|584470164|FG031|Overall Study|Withdrawal by Subject|1|||
161843905|NCT02132754|584470165|FG032|Overall Study|Withdrawal by Subject|0|||
161843906|NCT02132754|584470166|FG033|Overall Study|Withdrawal by Subject|2|||
161843907|NCT02011386|584470173|FG000|Overall Study|Non-compliance|2|||
161843908|NCT02011386|584470173|FG000|Overall Study|Lack of Efficacy|3|||
161843909|NCT01193127|584470174|FG000|Randomized|Surgery Cancelled|0|||
161843910|NCT01193127|584470175|FG001|Randomized|Surgery Cancelled|0|||
161843911|NCT01193127|584470176|FG002|Randomized|Surgery Cancelled|0|||
161843912|NCT01193127|584470177|FG003|Randomized|Surgery Cancelled|1|||
161843913|NCT01193127|584470174|FG000|Treated|Withdrawal by Subject|0|||
161843914|NCT01193127|584470175|FG001|Treated|Withdrawal by Subject|0|||
161843915|NCT01193127|584470176|FG002|Treated|Withdrawal by Subject|0|||
161843916|NCT01193127|584470177|FG003|Treated|Withdrawal by Subject|1|||
161843917|NCT00761865|584470181|FG000|Overall Study|Lost to Follow-up|8|||
161843918|NCT00761865|584470182|FG001|Overall Study|Lost to Follow-up|7|||
161843919|NCT04555720|584470183|FG000|Overall Study|Lost to Follow-up|2|||
161843920|NCT04555720|584470184|FG001|Overall Study|Lost to Follow-up|0|||
161843921|NCT04555720|584470185|FG002|Overall Study|Lost to Follow-up|0|||
161843922|NCT04555720|584470186|FG003|Overall Study|Lost to Follow-up|0|||
161843923|NCT04555720|584470183|FG000|Overall Study|Withdrawal by Subject|4|||
161843924|NCT04555720|584470184|FG001|Overall Study|Withdrawal by Subject|6|||
161843925|NCT04555720|584470185|FG002|Overall Study|Withdrawal by Subject|0|||
161843926|NCT04555720|584470186|FG003|Overall Study|Withdrawal by Subject|0|||
161843927|NCT00321737|584470187|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
161843928|NCT00321737|584470188|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
161843929|NCT00321737|584470189|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
161843930|NCT00321737|584470187|FG000|Overall Study|Adverse Event|11|||
161843931|NCT00321737|584470188|FG001|Overall Study|Adverse Event|3|||
161843932|NCT00321737|584470189|FG002|Overall Study|Adverse Event|6|||
161843933|NCT00321737|584470187|FG000|Overall Study|Lost to Follow-up|5|||
161843934|NCT00321737|584470188|FG001|Overall Study|Lost to Follow-up|5|||
161843935|NCT00321737|584470189|FG002|Overall Study|Lost to Follow-up|6|||
161843936|NCT00321737|584470187|FG000|Overall Study|Withdrawal by Subject|19|||
161843937|NCT00321737|584470188|FG001|Overall Study|Withdrawal by Subject|12|||
161843938|NCT00321737|584470189|FG002|Overall Study|Withdrawal by Subject|17|||
161843939|NCT00321737|584470187|FG000|Overall Study|Protocol Violation|0|||
161843940|NCT00321737|584470188|FG001|Overall Study|Protocol Violation|0|||
161843941|NCT00321737|584470189|FG002|Overall Study|Protocol Violation|1|||
161843942|NCT00321737|584470187|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
161843943|NCT00321737|584470188|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161843944|NCT00321737|584470189|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161843945|NCT00321737|584470187|FG000|Overall Study|Possible Barrett's Esophagus|2|||
161843946|NCT00321737|584470188|FG001|Overall Study|Possible Barrett's Esophagus|1|||
161843947|NCT00321737|584470189|FG002|Overall Study|Possible Barrett's Esophagus|1|||
161843948|NCT00321737|584470187|FG000|Overall Study|Therapeutic Failure|6|||
161843949|NCT00321737|584470188|FG001|Overall Study|Therapeutic Failure|0|||
161843950|NCT00321737|584470189|FG002|Overall Study|Therapeutic Failure|2|||
161843951|NCT00321737|584470187|FG000|Overall Study|Pregnancy|0|||
161843952|NCT00321737|584470188|FG001|Overall Study|Pregnancy|2|||
161843953|NCT00321737|584470189|FG002|Overall Study|Pregnancy|0|||
161843954|NCT00321737|584470187|FG000|Overall Study|Noncompliance|2|||
161843955|NCT00321737|584470188|FG001|Overall Study|Noncompliance|0|||
161843956|NCT00321737|584470189|FG002|Overall Study|Noncompliance|0|||
161843957|NCT00321737|584470187|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
161843958|NCT00321737|584470188|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
161843959|NCT00321737|584470189|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
161843960|NCT02283294|584470190|FG000|Overall Study|Lost to Follow-up|1|||
161843961|NCT02283294|584470191|FG001|Overall Study|Lost to Follow-up|1|||
161843962|NCT02283294|584470190|FG000|Overall Study|Withdrawal by Subject|1|||
161843963|NCT02283294|584470191|FG001|Overall Study|Withdrawal by Subject|6|||
161843964|NCT02283294|584470190|FG000|Overall Study|Protocol Violation|1|||
161843965|NCT02283294|584470191|FG001|Overall Study|Protocol Violation|0|||
161843966|NCT02283294|584470190|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
161843967|NCT02283294|584470191|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
161843968|NCT04994483|584472280|FG000|Overall Study|Adverse Event|26|||
161843969|NCT04994483|584472281|FG001|Overall Study|Adverse Event|17|||
161843970|NCT04994483|584472280|FG000|Overall Study|Lost to Follow-up|6|||
161843971|NCT04994483|584472281|FG001|Overall Study|Lost to Follow-up|10|||
161843972|NCT04994483|584472280|FG000|Overall Study|Noncompliance with study drug|8|||
161843973|NCT04994483|584472281|FG001|Overall Study|Noncompliance with study drug|5|||
161843974|NCT04994483|584472280|FG000|Overall Study|Physician Decision|5|||
161843975|NCT04994483|584472281|FG001|Overall Study|Physician Decision|0|||
161843976|NCT04994483|584472280|FG000|Overall Study|Withdrawal by Subject|41|||
161843977|NCT04994483|584472281|FG001|Overall Study|Withdrawal by Subject|38|||
161843978|NCT04994483|584472280|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
161843979|NCT04994483|584472281|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
161843980|NCT04994483|584472280|FG000|Overall Study|Met stopping criteria|1|||
161843981|NCT04994483|584472281|FG001|Overall Study|Met stopping criteria|0|||
161843982|NCT04994483|584472280|FG000|Overall Study|Randomized in error, not treated|4|||
161843983|NCT04994483|584472281|FG001|Overall Study|Randomized in error, not treated|3|||
161843984|NCT04994483|584472280|FG000|Overall Study|Lack of a reliable study partner|0|||
161843985|NCT04994483|584472281|FG001|Overall Study|Lack of a reliable study partner|1|||
161843986|NCT04994483|584472280|FG000|Overall Study|Met MRI exclusion criteria|0|||
161843987|NCT04994483|584472281|FG001|Overall Study|Met MRI exclusion criteria|1|||
161843988|NCT02213510|584472282|FG000|Overall Study|Death|0|||
161843989|NCT02213510|584472283|FG001|Overall Study|Death|1|||
161843990|NCT02213510|584472282|FG000|Overall Study|Lost to Follow-up|1|||
161843991|NCT02213510|584472283|FG001|Overall Study|Lost to Follow-up|0|||
161843992|NCT02903030|584472284|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161843993|NCT02903030|584472285|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161843994|NCT02603393|584472291|FG000|Overall Study|Patient/guardian decision|32|||
161843995|NCT02603393|584472292|FG001|Overall Study|Patient/guardian decision|18|||
161843996|NCT02603393|584472291|FG000|Overall Study|Adverse Event|17|||
161843997|NCT02603393|584472292|FG001|Overall Study|Adverse Event|15|||
161843998|NCT02603393|584472291|FG000|Overall Study|Technical problems|4|||
161843999|NCT02603393|584472292|FG001|Overall Study|Technical problems|7|||
161844000|NCT02603393|584472291|FG000|Overall Study|Lack of Efficacy|7|||
161844001|NCT02603393|584472292|FG001|Overall Study|Lack of Efficacy|2|||
161844002|NCT02603393|584472291|FG000|Overall Study|Death|3|||
161844003|NCT02603393|584472292|FG001|Overall Study|Death|4|||
161844004|NCT02603393|584472291|FG000|Overall Study|Physician Decision|3|||
161844005|NCT02603393|584472292|FG001|Overall Study|Physician Decision|3|||
161844006|NCT02603393|584472291|FG000|Overall Study|Protocol deviation|2|||
161844007|NCT02603393|584472292|FG001|Overall Study|Protocol deviation|3|||
161844008|NCT02603393|584472291|FG000|Overall Study|Lost to Follow-up|1|||
161844009|NCT02603393|584472292|FG001|Overall Study|Lost to Follow-up|2|||
161844010|NCT02603393|584472291|FG000|Overall Study|Non-compliance with study treatment|1|||
161844011|NCT02603393|584472292|FG001|Overall Study|Non-compliance with study treatment|0|||
161844012|NCT02603393|584472291|FG000|Overall Study|Sponsor decision|1|||
161844013|NCT02603393|584472292|FG001|Overall Study|Sponsor decision|0|||
161844014|NCT04053465|584472294|FG000|Overall Study|Withdrawal by Subject|4|||
161844015|NCT04053465|584472295|FG001|Overall Study|Withdrawal by Subject|4|||
161844016|NCT02085135|584472296|FG000|Overall Study|Adverse Event|4|||
161844017|NCT02085135|584472297|FG001|Overall Study|Adverse Event|7|||
161844018|NCT02085135|584472296|FG000|Overall Study|Lost to Follow-up|2|||
161844019|NCT02085135|584472297|FG001|Overall Study|Lost to Follow-up|2|||
161844020|NCT02085135|584472296|FG000|Overall Study|Withdrawal by Subject|3|||
161844021|NCT02085135|584472297|FG001|Overall Study|Withdrawal by Subject|0|||
161844022|NCT02085135|584472296|FG000|Overall Study|Lack of Efficacy|2|||
161844023|NCT02085135|584472297|FG001|Overall Study|Lack of Efficacy|0|||
161844024|NCT01085734|584472298|FG000|Overall Study|Adverse Event|0|||
161844025|NCT01085734|584472299|FG001|Overall Study|Adverse Event|2|||
161844026|NCT01085734|584472298|FG000|Overall Study|Death|1|||
161844027|NCT01085734|584472299|FG001|Overall Study|Death|0|||
161844028|NCT01085734|584472298|FG000|Overall Study|Lost to Follow-up|0|||
161844029|NCT01085734|584472299|FG001|Overall Study|Lost to Follow-up|1|||
161844030|NCT01085734|584472298|FG000|Overall Study|Withdrawal by Subject|0|||
161844031|NCT01085734|584472299|FG001|Overall Study|Withdrawal by Subject|1|||
161844032|NCT00742924|584472302|FG000|Overall Study|Adverse Event|0|||
161844033|NCT00742924|584472303|FG001|Overall Study|Adverse Event|0|||
161844034|NCT00742924|584472304|FG002|Overall Study|Adverse Event|1|||
161844035|NCT00742924|584472305|FG003|Overall Study|Adverse Event|1|||
161844036|NCT00742924|584472302|FG000|Overall Study|Lack of Efficacy|5|||
161844037|NCT00742924|584472303|FG001|Overall Study|Lack of Efficacy|1|||
161844038|NCT00742924|584472304|FG002|Overall Study|Lack of Efficacy|2|||
161844039|NCT00742924|584472305|FG003|Overall Study|Lack of Efficacy|4|||
161844040|NCT00742924|584472302|FG000|Overall Study|Physician Decision|0|||
161844041|NCT00742924|584472303|FG001|Overall Study|Physician Decision|0|||
161844042|NCT00742924|584472304|FG002|Overall Study|Physician Decision|0|||
161844043|NCT00742924|584472305|FG003|Overall Study|Physician Decision|1|||
161844044|NCT00742924|584472302|FG000|Overall Study|Withdrawal by Subject|0|||
161844045|NCT00742924|584472303|FG001|Overall Study|Withdrawal by Subject|1|||
161844046|NCT00742924|584472304|FG002|Overall Study|Withdrawal by Subject|1|||
161844047|NCT00742924|584472305|FG003|Overall Study|Withdrawal by Subject|0|||
161844048|NCT00660400|584472306|FG000|Overall Study|Lack of insurance approval|1|||
161844049|NCT00660400|584472306|FG000|Overall Study|Suboptimal organ function|1|||
161844050|NCT00660400|584472306|FG000|Overall Study|Intracranial hemorrhage|1|||
161844051|NCT00660400|584472306|FG000|Overall Study|Withdrawal by Subject|1|||
161844052|NCT01161407|584472307|FG000|Overall Study|Protocol Violation|3|||
161844053|NCT01161407|584472308|FG001|Overall Study|Protocol Violation|1|||
161751064|NCT00608894|584128395|FG001|Overall Study|Withdrawal by Subject|2|||
161751065|NCT03654560|584128402|FG000|Overall Study|Death|3|||
161751066|NCT03654560|584128403|FG001|Overall Study|Death|1|||
161751067|NCT03654560|584128402|FG000|Overall Study|Lost to Follow-up|1|||
161751068|NCT03654560|584128403|FG001|Overall Study|Lost to Follow-up|0|||
161751069|NCT00209092|584128404|FG000|Overall Study|Progression of disease|7|||
161751070|NCT00209092|584128405|FG001|Overall Study|Progression of disease|1|||
161751071|NCT00209092|584128404|FG000|Overall Study|Adverse Event|0|||
161751072|NCT00209092|584128405|FG001|Overall Study|Adverse Event|1|||
161751073|NCT00209092|584128404|FG000|Overall Study|Withdrawal by Subject|1|||
161751074|NCT00209092|584128405|FG001|Overall Study|Withdrawal by Subject|0|||
161751075|NCT00693420|584128406|FG000|Overall Study|Adverse Event|4|||
161751076|NCT00693420|584128407|FG001|Overall Study|Adverse Event|4|||
161751077|NCT00693420|584128406|FG000|Overall Study|Lost to Follow-up|0|||
161751078|NCT00693420|584128407|FG001|Overall Study|Lost to Follow-up|3|||
161751079|NCT00693420|584128406|FG000|Overall Study|Withdrawal by Subject|1|||
161751080|NCT00693420|584128407|FG001|Overall Study|Withdrawal by Subject|0|||
161751081|NCT00693420|584128406|FG000|Overall Study|Protocol Violation|0|||
161751082|NCT00693420|584128407|FG001|Overall Study|Protocol Violation|2|||
161751083|NCT00693420|584128406|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
161751084|NCT00693420|584128407|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
161751085|NCT00693420|584128406|FG000|Overall Study|Personal Reasons|1|||
161751086|NCT00693420|584128407|FG001|Overall Study|Personal Reasons|4|||
161751087|NCT01235338|584128409|FG000|Overall Study|Adverse Event|3|||
161751088|NCT01235338|584128410|FG001|Overall Study|Adverse Event|2|||
161751089|NCT01235338|584128409|FG000|Overall Study|Protocol Violation|1|||
161751090|NCT01235338|584128410|FG001|Overall Study|Protocol Violation|1|||
161751091|NCT01235338|584128409|FG000|Overall Study|Withdrawal by Subject|5|||
161751092|NCT01235338|584128410|FG001|Overall Study|Withdrawal by Subject|0|||
161751093|NCT01235338|584128409|FG000|Overall Study|Exclusion criteria violations|1|||
161751094|NCT01235338|584128410|FG001|Overall Study|Exclusion criteria violations|1|||
161751095|NCT01235338|584128409|FG000|Overall Study|Positive drug screen|0|||
161751096|NCT01235338|584128410|FG001|Overall Study|Positive drug screen|1|||
161751097|NCT01235338|584128409|FG000|Overall Study|Prohibited meds|1|||
161751098|NCT01235338|584128410|FG001|Overall Study|Prohibited meds|0|||
161751099|NCT05283499|584128412|FG000|Overall Study|Did not receive intervention|1|||
161751100|NCT05283499|584128413|FG001|Overall Study|Did not receive intervention|2|||
161751101|NCT02828644|584128414|FG000|Overall Study|Lost to Follow-up|23|||
161751102|NCT02828644|584128415|FG001|Overall Study|Lost to Follow-up|22|||
161751103|NCT02408484|584128416|FG000|Overall Study|Withdrawal by Subject|3|||
161751104|NCT02408484|584128416|FG000|Overall Study|Not treated during study period|1|||
161751105|NCT01117181|584128420|FG000|Overall Study|Lost to Follow-up|1|||
161751106|NCT01117181|584128421|FG001|Overall Study|Lost to Follow-up|0|||
161751107|NCT01117181|584128420|FG000|Overall Study|Withdrawal by Subject|0|||
161751108|NCT01117181|584128421|FG001|Overall Study|Withdrawal by Subject|2|||
161751109|NCT00524043|584128428|FG000|Overall Study|Lack of Efficacy|15|||
161751110|NCT00524043|584128429|FG001|Overall Study|Lack of Efficacy|13|||
161751111|NCT00524043|584128430|FG002|Overall Study|Lack of Efficacy|14|||
161751112|NCT00524043|584128428|FG000|Overall Study|Withdrawal by Subject|5|||
161751113|NCT00524043|584128429|FG001|Overall Study|Withdrawal by Subject|7|||
161751114|NCT00524043|584128430|FG002|Overall Study|Withdrawal by Subject|7|||
161751115|NCT00524043|584128428|FG000|Overall Study|Adverse Event|5|||
161751116|NCT00524043|584128429|FG001|Overall Study|Adverse Event|2|||
161751117|NCT00524043|584128430|FG002|Overall Study|Adverse Event|7|||
161751118|NCT00524043|584128428|FG000|Overall Study|Lost to Follow-up|3|||
161751119|NCT00524043|584128429|FG001|Overall Study|Lost to Follow-up|5|||
161751120|NCT00524043|584128430|FG002|Overall Study|Lost to Follow-up|3|||
161751121|NCT00524043|584128428|FG000|Overall Study|Various (eg, incarceration)|2|||
161751122|NCT00524043|584128429|FG001|Overall Study|Various (eg, incarceration)|1|||
161751123|NCT00524043|584128430|FG002|Overall Study|Various (eg, incarceration)|0|||
161751124|NCT00517413|584128431|FG000|Overall Study|Adverse Event|7|||
161751125|NCT00517413|584128431|FG000|Overall Study|Death|13|||
161751126|NCT00517413|584128431|FG000|Overall Study|Protocol Violation|15|||
161751127|NCT00517413|584128431|FG000|Overall Study|Withdrawal by Subject|2|||
161751128|NCT00517413|584128431|FG000|Overall Study|Failure to return|1|||
161751129|NCT00517413|584128431|FG000|Overall Study|Other-Reasons|23|||
161751130|NCT03938636|584128432|FG000|Overall Study|Protocol Violation|0|||
161751131|NCT03938636|584128433|FG001|Overall Study|Protocol Violation|1|||
161751132|NCT03938636|584128434|FG002|Overall Study|Protocol Violation|1|||
161751133|NCT03938636|584128432|FG000|Overall Study|Subject withdrew due to death in family|0|||
161751134|NCT03938636|584128433|FG001|Overall Study|Subject withdrew due to death in family|1|||
161751135|NCT03938636|584128434|FG002|Overall Study|Subject withdrew due to death in family|0|||
161751136|NCT03938636|584128432|FG000|Overall Study|Missed visit|0|||
161844054|NCT01777620|584472309|FG000|Overall Study|Subject Withdrawal|1|||
161844055|NCT01777620|584472310|FG001|Overall Study|Subject Withdrawal|0|||
161844056|NCT04562155|584472313|FG000|Overall Study|COVID-19 pandemic|0|||
161844057|NCT04562155|584472314|FG001|Overall Study|COVID-19 pandemic|0|||
161844058|NCT04562155|584472315|FG002|Overall Study|COVID-19 pandemic|0|||
161844059|NCT04562155|584472316|FG003|Overall Study|COVID-19 pandemic|1|||
161844060|NCT04562155|584472313|FG000|Overall Study|Adverse Event|7|||
161844061|NCT04562155|584472314|FG001|Overall Study|Adverse Event|3|||
161844062|NCT04562155|584472315|FG002|Overall Study|Adverse Event|8|||
161844063|NCT04562155|584472316|FG003|Overall Study|Adverse Event|1|||
161844064|NCT04562155|584472313|FG000|Overall Study|Withdrawal by Subject|3|||
161844065|NCT04562155|584472314|FG001|Overall Study|Withdrawal by Subject|6|||
161844066|NCT04562155|584472315|FG002|Overall Study|Withdrawal by Subject|3|||
161844067|NCT04562155|584472316|FG003|Overall Study|Withdrawal by Subject|3|||
161844068|NCT04562155|584472313|FG000|Overall Study|Participant personal reason|1|||
161844069|NCT04562155|584472314|FG001|Overall Study|Participant personal reason|0|||
161844070|NCT04562155|584472315|FG002|Overall Study|Participant personal reason|2|||
161844071|NCT04562155|584472316|FG003|Overall Study|Participant personal reason|1|||
161844072|NCT01755767|584472333|FG000|Overall Study|Progressive Disease|8|||
161844073|NCT01755767|584472334|FG001|Overall Study|Progressive Disease|7|||
161844074|NCT01755767|584472335|FG002|Overall Study|Progressive Disease|91|||
161844075|NCT01755767|584472336|FG003|Overall Study|Progressive Disease|43|||
161844076|NCT01755767|584472333|FG000|Overall Study|Clinical Disease Progression|4|||
161844077|NCT01755767|584472334|FG001|Overall Study|Clinical Disease Progression|2|||
161844078|NCT01755767|584472335|FG002|Overall Study|Clinical Disease Progression|29|||
161844079|NCT01755767|584472336|FG003|Overall Study|Clinical Disease Progression|20|||
161844080|NCT01755767|584472333|FG000|Overall Study|Radiographic Disease Progression|9|||
161844081|NCT01755767|584472334|FG001|Overall Study|Radiographic Disease Progression|4|||
161844082|NCT01755767|584472335|FG002|Overall Study|Radiographic Disease Progression|44|||
161844083|NCT01755767|584472336|FG003|Overall Study|Radiographic Disease Progression|27|||
161844084|NCT01755767|584472333|FG000|Overall Study|Adverse Event|6|||
161844085|NCT01755767|584472334|FG001|Overall Study|Adverse Event|0|||
161844086|NCT01755767|584472335|FG002|Overall Study|Adverse Event|28|||
161844087|NCT01755767|584472336|FG003|Overall Study|Adverse Event|11|||
161844088|NCT01755767|584472333|FG000|Overall Study|Death|1|||
161844089|NCT01755767|584472334|FG001|Overall Study|Death|2|||
161844090|NCT01755767|584472335|FG002|Overall Study|Death|15|||
161844091|NCT01755767|584472336|FG003|Overall Study|Death|4|||
161844092|NCT01755767|584472333|FG000|Overall Study|Subject Decision|0|||
161844093|NCT01755767|584472334|FG001|Overall Study|Subject Decision|0|||
161844094|NCT01755767|584472335|FG002|Overall Study|Subject Decision|10|||
161844095|NCT01755767|584472336|FG003|Overall Study|Subject Decision|3|||
161844096|NCT01755767|584472333|FG000|Overall Study|Withdrawal by Subject|0|||
161844097|NCT01755767|584472334|FG001|Overall Study|Withdrawal by Subject|0|||
161844098|NCT01755767|584472335|FG002|Overall Study|Withdrawal by Subject|2|||
161844099|NCT01755767|584472336|FG003|Overall Study|Withdrawal by Subject|1|||
161844100|NCT01755767|584472333|FG000|Overall Study|Other|0|||
161844101|NCT01755767|584472334|FG001|Overall Study|Other|0|||
161844102|NCT01755767|584472335|FG002|Overall Study|Other|2|||
161844103|NCT01755767|584472336|FG003|Overall Study|Other|3|||
161844104|NCT01755767|584472333|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
161844105|NCT01755767|584472334|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
161844106|NCT01755767|584472335|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
161844107|NCT01755767|584472336|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
161844108|NCT02865460|584472337|FG000|Overall Study|Adverse Event|1|||
161844109|NCT02865460|584472338|FG001|Overall Study|Adverse Event|0|||
161844110|NCT02865460|584472337|FG000|Overall Study|Withdrawal by Subject|1|||
161844111|NCT02865460|584472338|FG001|Overall Study|Withdrawal by Subject|1|||
161844112|NCT02865460|584472337|FG000|Overall Study|Lost to Follow-up|7|||
161844113|NCT02865460|584472338|FG001|Overall Study|Lost to Follow-up|4|||
161844114|NCT02865460|584472337|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
161844115|NCT02865460|584472338|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
161844116|NCT00901576|584472339|FG000|Second Intervention|Withdrawal by Subject|0|||
161844117|NCT00901576|584472340|FG001|Second Intervention|Withdrawal by Subject|0|||
161844118|NCT00901576|584472341|FG002|Second Intervention|Withdrawal by Subject|0|||
161844119|NCT00901576|584472342|FG003|Second Intervention|Withdrawal by Subject|1|||
161844120|NCT00901576|584472343|FG004|Second Intervention|Withdrawal by Subject|0|||
161844121|NCT00901576|584472344|FG005|Second Intervention|Withdrawal by Subject|1|||
161844122|NCT00901576|584472339|FG000|Second Intervention|Physician Decision|1|||
161844123|NCT00901576|584472340|FG001|Second Intervention|Physician Decision|0|||
161844124|NCT00901576|584472341|FG002|Second Intervention|Physician Decision|0|||
161844125|NCT00901576|584472342|FG003|Second Intervention|Physician Decision|0|||
161844126|NCT00901576|584472343|FG004|Second Intervention|Physician Decision|0|||
161844127|NCT00901576|584472344|FG005|Second Intervention|Physician Decision|0|||
161844128|NCT01696279|584472345|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
161844129|NCT01696279|584472346|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161844130|NCT01696279|584472347|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161844131|NCT01696279|584472348|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161844132|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161844133|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
161844134|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161844135|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161844136|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161844137|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
161844138|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161844139|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161844140|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161844141|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
161844142|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161844143|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161844144|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161844145|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
161844146|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161844147|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161844148|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161844149|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
161844150|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161844151|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161844152|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161844153|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
161844154|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161844155|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161844156|NCT01696279|584472345|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161844157|NCT01696279|584472346|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161844158|NCT01696279|584472347|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
161844159|NCT01696279|584472348|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161844160|NCT01696279|584472345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161844161|NCT01696279|584472346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161844162|NCT01696279|584472347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161844163|NCT01696279|584472348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
161844164|NCT01696279|584472345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161844165|NCT01696279|584472346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161844166|NCT01696279|584472347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161844167|NCT01696279|584472348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
161844168|NCT01696279|584472345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161844169|NCT01696279|584472346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161844170|NCT01696279|584472347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161844171|NCT01696279|584472348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
161844172|NCT06077149|584472349|FG000|Overall Study|Death|1|||
161844173|NCT06077149|584472350|FG001|Overall Study|Death|0|||
161844174|NCT06077149|584472349|FG000|Overall Study|Withdrawal by Subject|2|||
161844175|NCT06077149|584472350|FG001|Overall Study|Withdrawal by Subject|0|||
161844176|NCT06077149|584472349|FG000|Overall Study|RSV infection before vaccination|3|||
161844177|NCT06077149|584472350|FG001|Overall Study|RSV infection before vaccination|0|||
161844178|NCT04658095|584472351|FG000|Overall Study|Study terminated|5|||
161844179|NCT04658095|584472352|FG001|Overall Study|Study terminated|1|||
161844180|NCT04658095|584472353|FG002|Overall Study|Study terminated|4|||
161844181|NCT04154631|584472354|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
161844182|NCT04154631|584472355|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
161844183|NCT01441947|584472356|FG000|Overall Study|Withdrawal by Subject|3|||
161844184|NCT01441947|584472357|FG001|Overall Study|Withdrawal by Subject|0|||
161844185|NCT01341782|584472359|FG000|Overall Study|Adverse Event|1|||
161844186|NCT01341782|584472360|FG001|Overall Study|Adverse Event|1|||
161844187|NCT01341782|584472359|FG000|Overall Study|Withdrawal by Subject|6|||
161844188|NCT01341782|584472360|FG001|Overall Study|Withdrawal by Subject|5|||
161844189|NCT01341782|584472359|FG000|Overall Study|Missed 3 consecutive doses|0|||
161844190|NCT01341782|584472360|FG001|Overall Study|Missed 3 consecutive doses|4|||
161844191|NCT01341782|584472359|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
161844192|NCT01341782|584472360|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
161844193|NCT01341782|584472359|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
161844194|NCT01341782|584472360|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
161844195|NCT01341782|584472359|FG000|Overall Study|Other|5|||
161844196|NCT01341782|584472360|FG001|Overall Study|Other|0|||
161844197|NCT02036775|584472361|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844198|NCT02036775|584472362|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844199|NCT02036775|584472363|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844200|NCT02036775|584472364|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844201|NCT02036775|584472365|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844202|NCT02036775|584472366|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
161844203|NCT02927366|584472368|FG000|Overall Study|Adverse Event|1|||
161844204|NCT02927366|584472369|FG001|Overall Study|Adverse Event|0|||
161844205|NCT02927366|584472368|FG000|Overall Study|Patient schedule|1|||
161844206|NCT02927366|584472369|FG001|Overall Study|Patient schedule|0|||
161844207|NCT03496610|584472372|FG000|Overall Study|Lost to Follow-up|3|||
161844208|NCT03496610|584472373|FG001|Overall Study|Lost to Follow-up|2|||
161844209|NCT03496610|584472372|FG000|Overall Study|Physician Decision|1|||
161844210|NCT03496610|584472373|FG001|Overall Study|Physician Decision|0|||
161844211|NCT03496610|584472372|FG000|Overall Study|Withdrawal by Subject|1|||
161844212|NCT03496610|584472373|FG001|Overall Study|Withdrawal by Subject|0|||
161844213|NCT00426361|584472374|FG000|Overall Study|Lost to Follow-up|3|||
161844214|NCT00426361|584472375|FG001|Overall Study|Lost to Follow-up|2|||
161844215|NCT00426361|584472376|FG002|Overall Study|Lost to Follow-up|5|||
161844216|NCT00426361|584472374|FG000|Overall Study|Withdrawal by Subject|1|||
161844217|NCT00426361|584472375|FG001|Overall Study|Withdrawal by Subject|3|||
161844218|NCT00426361|584472376|FG002|Overall Study|Withdrawal by Subject|0|||
161844219|NCT04669691|584472377|FG000|Overall Study|Death|0|||
161844220|NCT04669691|584472378|FG001|Overall Study|Death|1|||
161844221|NCT04669691|584472379|FG002|Overall Study|Death|0|||
161844222|NCT04669691|584472380|FG003|Overall Study|Death|0|||
161844223|NCT04669691|584472381|FG004|Overall Study|Death|0|||
161844224|NCT04669691|584472382|FG005|Overall Study|Death|0|||
161844225|NCT01753336|584472383|FG000|Overall Study|Patient decision|12|||
161844226|NCT01753336|584472383|FG000|Overall Study|Lost to Follow-up|3|||
161844227|NCT01753336|584472383|FG000|Overall Study|Physician Decision|2|||
161844228|NCT01753336|584472383|FG000|Overall Study|Sponsor's decision|2|||
161844229|NCT01753336|584472383|FG000|Overall Study|Withdrawal by Subject|1|||
161844230|NCT01121666|584472384|FG000|Overall Study|Protocol Violation|29|||
161844231|NCT01121666|584472385|FG001|Overall Study|Protocol Violation|10|||
161844232|NCT03201211|584472388|FG000|Overall Study|Adverse Event|1|||
161844233|NCT03201211|584472389|FG001|Overall Study|Adverse Event|0|||
161844234|NCT03201211|584472390|FG002|Overall Study|Adverse Event|0|||
161844235|NCT03201211|584472388|FG000|Overall Study|Protocol Violation|1|||
161844236|NCT03201211|584472389|FG001|Overall Study|Protocol Violation|0|||
161844237|NCT03201211|584472390|FG002|Overall Study|Protocol Violation|0|||
161844238|NCT03201211|584472388|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161844239|NCT03201211|584472389|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161844240|NCT03201211|584472390|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161844241|NCT03201211|584472388|FG000|Overall Study|OTHER unknown reasons|0|||
161844242|NCT03201211|584472389|FG001|Overall Study|OTHER unknown reasons|1|||
161844243|NCT03201211|584472390|FG002|Overall Study|OTHER unknown reasons|0|||
161844244|NCT01970865|584472391|FG000|Overall Study|Death|3|||
161844245|NCT01970865|584472392|FG001|Overall Study|Death|2|||
161844246|NCT01970865|584472393|FG002|Overall Study|Death|3|||
161844247|NCT01970865|584472394|FG003|Overall Study|Death|6|||
161844248|NCT01970865|584472395|FG004|Overall Study|Death|9|||
161844249|NCT01970865|584472396|FG005|Overall Study|Death|3|||
161844250|NCT01970865|584472397|FG006|Overall Study|Death|2|||
161844251|NCT01970865|584472398|FG007|Overall Study|Death|3|||
161844252|NCT01970865|584472399|FG008|Overall Study|Death|2|||
161844253|NCT01970865|584472400|FG009|Overall Study|Death|2|||
161844254|NCT01970865|584472401|FG010|Overall Study|Death|8|||
161844255|NCT01970865|584472402|FG011|Overall Study|Death|13|||
161844256|NCT01970865|584472403|FG012|Overall Study|Death|25|||
161844257|NCT01970865|584472404|FG013|Overall Study|Death|46|||
161844258|NCT01970865|584472405|FG014|Overall Study|Death|37|||
161844259|NCT01970865|584472406|FG015|Overall Study|Death|22|||
161844260|NCT01970865|584472407|FG016|Overall Study|Death|1|||
161844261|NCT01970865|584472408|FG017|Overall Study|Death|17|||
161844262|NCT01970865|584472391|FG000|Overall Study|Lost to Follow-up|0|||
161844263|NCT01970865|584472392|FG001|Overall Study|Lost to Follow-up|0|||
161844264|NCT01970865|584472393|FG002|Overall Study|Lost to Follow-up|0|||
161844265|NCT01970865|584472394|FG003|Overall Study|Lost to Follow-up|1|||
161844266|NCT01970865|584472395|FG004|Overall Study|Lost to Follow-up|1|||
161844267|NCT01970865|584472396|FG005|Overall Study|Lost to Follow-up|0|||
161844268|NCT01970865|584472397|FG006|Overall Study|Lost to Follow-up|0|||
161844269|NCT01970865|584472398|FG007|Overall Study|Lost to Follow-up|0|||
161844270|NCT01970865|584472399|FG008|Overall Study|Lost to Follow-up|0|||
161844271|NCT01970865|584472400|FG009|Overall Study|Lost to Follow-up|0|||
161844272|NCT01970865|584472401|FG010|Overall Study|Lost to Follow-up|1|||
161844273|NCT01970865|584472402|FG011|Overall Study|Lost to Follow-up|0|||
161844274|NCT01970865|584472403|FG012|Overall Study|Lost to Follow-up|2|||
161844275|NCT01970865|584472404|FG013|Overall Study|Lost to Follow-up|0|||
161844276|NCT01970865|584472405|FG014|Overall Study|Lost to Follow-up|1|||
161844277|NCT01970865|584472406|FG015|Overall Study|Lost to Follow-up|4|||
161844278|NCT01970865|584472407|FG016|Overall Study|Lost to Follow-up|0|||
161844279|NCT01970865|584472408|FG017|Overall Study|Lost to Follow-up|1|||
161844280|NCT01970865|584472391|FG000|Overall Study|Other|0|||
161844281|NCT01970865|584472392|FG001|Overall Study|Other|1|||
161844282|NCT01970865|584472393|FG002|Overall Study|Other|0|||
161844283|NCT01970865|584472394|FG003|Overall Study|Other|1|||
161844284|NCT01970865|584472395|FG004|Overall Study|Other|1|||
161844285|NCT01970865|584472396|FG005|Overall Study|Other|0|||
161844286|NCT01970865|584472397|FG006|Overall Study|Other|1|||
161844287|NCT01970865|584472398|FG007|Overall Study|Other|0|||
161844288|NCT01970865|584472399|FG008|Overall Study|Other|0|||
161844289|NCT01970865|584472400|FG009|Overall Study|Other|0|||
161844290|NCT01970865|584472401|FG010|Overall Study|Other|2|||
161844291|NCT01970865|584472402|FG011|Overall Study|Other|3|||
161844292|NCT01970865|584472403|FG012|Overall Study|Other|8|||
161844293|NCT01970865|584472404|FG013|Overall Study|Other|3|||
161844294|NCT01970865|584472405|FG014|Overall Study|Other|2|||
161844295|NCT01970865|584472406|FG015|Overall Study|Other|3|||
161844296|NCT01970865|584472407|FG016|Overall Study|Other|0|||
161844297|NCT01970865|584472408|FG017|Overall Study|Other|2|||
161844298|NCT01970865|584472391|FG000|Overall Study|Participant refused further follow-up|0|||
161844299|NCT01970865|584472392|FG001|Overall Study|Participant refused further follow-up|0|||
161844300|NCT01970865|584472393|FG002|Overall Study|Participant refused further follow-up|0|||
161844301|NCT01970865|584472394|FG003|Overall Study|Participant refused further follow-up|2|||
161844302|NCT01970865|584472395|FG004|Overall Study|Participant refused further follow-up|3|||
161844303|NCT01970865|584472396|FG005|Overall Study|Participant refused further follow-up|0|||
161844304|NCT01970865|584472397|FG006|Overall Study|Participant refused further follow-up|0|||
161844305|NCT01970865|584472398|FG007|Overall Study|Participant refused further follow-up|0|||
161844306|NCT01970865|584472399|FG008|Overall Study|Participant refused further follow-up|0|||
161844307|NCT01970865|584472400|FG009|Overall Study|Participant refused further follow-up|0|||
161844308|NCT01970865|584472401|FG010|Overall Study|Participant refused further follow-up|1|||
161844309|NCT01970865|584472402|FG011|Overall Study|Participant refused further follow-up|4|||
161844310|NCT01970865|584472403|FG012|Overall Study|Participant refused further follow-up|7|||
161844311|NCT01970865|584472404|FG013|Overall Study|Participant refused further follow-up|8|||
161844312|NCT01970865|584472405|FG014|Overall Study|Participant refused further follow-up|3|||
161844313|NCT01970865|584472406|FG015|Overall Study|Participant refused further follow-up|11|||
161844314|NCT01970865|584472407|FG016|Overall Study|Participant refused further follow-up|0|||
161844315|NCT01970865|584472408|FG017|Overall Study|Participant refused further follow-up|6|||
161844316|NCT01629966|584472409|FG000|Overall Study|Pregnancy|0|||
161844317|NCT01629966|584472410|FG001|Overall Study|Pregnancy|1|||
161844318|NCT01629966|584472411|FG002|Overall Study|Pregnancy|0|||
161844319|NCT01629966|584472409|FG000|Overall Study|Lost to Follow-up|10|||
161844320|NCT01629966|584472410|FG001|Overall Study|Lost to Follow-up|13|||
161844321|NCT01629966|584472411|FG002|Overall Study|Lost to Follow-up|9|||
161844322|NCT01629966|584472409|FG000|Overall Study|Withdrawal by Subject|8|||
161844323|NCT01629966|584472410|FG001|Overall Study|Withdrawal by Subject|9|||
161844324|NCT01629966|584472411|FG002|Overall Study|Withdrawal by Subject|16|||
161844325|NCT01629966|584472409|FG000|Overall Study|Protocol Violation|7|||
161844326|NCT01629966|584472410|FG001|Overall Study|Protocol Violation|9|||
161844327|NCT01629966|584472411|FG002|Overall Study|Protocol Violation|7|||
161844328|NCT01629966|584472409|FG000|Overall Study|Lack of Efficacy|5|||
161844329|NCT01629966|584472410|FG001|Overall Study|Lack of Efficacy|2|||
161844330|NCT01629966|584472411|FG002|Overall Study|Lack of Efficacy|4|||
161844331|NCT01629966|584472409|FG000|Overall Study|Adverse Event|11|||
161844332|NCT01629966|584472410|FG001|Overall Study|Adverse Event|18|||
161844333|NCT01629966|584472411|FG002|Overall Study|Adverse Event|30|||
161844334|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
161844335|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
161844336|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
161844337|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
161844338|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
161844339|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
161844340|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
161844341|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
161844342|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Other|0|||
161844343|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Other|1|||
161844344|NCT04430855|584472412|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
161844345|NCT04430855|584472413|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
161844346|NCT04430855|584472412|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
161844347|NCT04430855|584472413|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
161844348|NCT04430855|584472412|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
161844349|NCT04430855|584472413|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
161844350|NCT01770392|584472419|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
161844351|NCT03401450|584472420|FG000|Overall Study|Lost to Follow-up|4|||
161844352|NCT03401450|584472421|FG001|Overall Study|Lost to Follow-up|6|||
161844353|NCT03401450|584472420|FG000|Overall Study|Anesthesia plan changed|2|||
161844354|NCT03401450|584472421|FG001|Overall Study|Anesthesia plan changed|2|||
161844355|NCT03401450|584472420|FG000|Overall Study|Did not complete medication diary|4|||
161844356|NCT03401450|584472421|FG001|Overall Study|Did not complete medication diary|2|||
161844357|NCT03401450|584472420|FG000|Overall Study|post surgery medication change|2|||
161844358|NCT03401450|584472421|FG001|Overall Study|post surgery medication change|1|||
161844359|NCT03401450|584472420|FG000|Overall Study|Cancelled surgery|0|||
161844360|NCT03401450|584472421|FG001|Overall Study|Cancelled surgery|2|||
161844361|NCT00228423|584472422|FG000|Overall Study|Adverse Event|2|||
161844362|NCT00228423|584472423|FG001|Overall Study|Adverse Event|5|||
161844363|NCT00228423|584472422|FG000|Overall Study|Withdrawal by Subject|7|||
161844364|NCT00228423|584472423|FG001|Overall Study|Withdrawal by Subject|3|||
161844365|NCT00228423|584472422|FG000|Overall Study|Protocol Violation|1|||
161844366|NCT00228423|584472423|FG001|Overall Study|Protocol Violation|3|||
161844367|NCT00228423|584472422|FG000|Overall Study|Physician Decision|0|||
161844368|NCT00228423|584472423|FG001|Overall Study|Physician Decision|1|||
161844369|NCT00390221|584472424|FG000|Overall Study|Lost to Follow-up|0|||
161844370|NCT00390221|584472425|FG001|Overall Study|Lost to Follow-up|3|||
161844371|NCT00390221|584472426|FG002|Overall Study|Lost to Follow-up|0|||
161844372|NCT00390221|584472424|FG000|Overall Study|Adverse Event|1|||
161844373|NCT00390221|584472425|FG001|Overall Study|Adverse Event|4|||
161844374|NCT00390221|584472426|FG002|Overall Study|Adverse Event|3|||
161844375|NCT00390221|584472424|FG000|Overall Study|Investigator Decision|0|||
161844376|NCT00390221|584472425|FG001|Overall Study|Investigator Decision|0|||
161844377|NCT00390221|584472426|FG002|Overall Study|Investigator Decision|1|||
161751137|NCT03938636|584128433|FG001|Overall Study|Missed visit|1|||
161751138|NCT03938636|584128434|FG002|Overall Study|Missed visit|0|||
161844378|NCT00390221|584472424|FG000|Overall Study|Withdrawal by Subject|13|||
161844379|NCT00390221|584472425|FG001|Overall Study|Withdrawal by Subject|9|||
161844380|NCT00390221|584472426|FG002|Overall Study|Withdrawal by Subject|7|||
161844381|NCT00390221|584472424|FG000|Overall Study|Subject Non-compliance|1|||
161844382|NCT00390221|584472425|FG001|Overall Study|Subject Non-compliance|0|||
161844383|NCT00390221|584472426|FG002|Overall Study|Subject Non-compliance|2|||
161844384|NCT00390221|584472424|FG000|Overall Study|Other|3|||
161844385|NCT00390221|584472425|FG001|Overall Study|Other|4|||
161844386|NCT00390221|584472426|FG002|Overall Study|Other|2|||
161844387|NCT01709838|584472443|FG000|Overall Study|Withdrawal by Subject|21|||
161844388|NCT01709838|584472443|FG000|Overall Study|Lost to Follow-up|16|||
161844389|NCT01709838|584472443|FG000|Overall Study|Pregnancy|10|||
161844390|NCT01709838|584472443|FG000|Overall Study|Subject/guardian decision|8|||
161844391|NCT01709838|584472443|FG000|Overall Study|Adverse Event|4|||
161751139|NCT03938636|584128432|FG000|Overall Study|Adverse Event|0|||
161751140|NCT03938636|584128433|FG001|Overall Study|Adverse Event|0|||
161751141|NCT03938636|584128434|FG002|Overall Study|Adverse Event|1|||
161751142|NCT03938636|584128432|FG000|Overall Study|Lost to Follow-up|0|||
161751143|NCT03938636|584128433|FG001|Overall Study|Lost to Follow-up|0|||
161751144|NCT03938636|584128434|FG002|Overall Study|Lost to Follow-up|1|||
161751145|NCT00216086|584128435|FG000|Overall Study|Protocol Violation|1|||
161751146|NCT00216086|584128435|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
161751147|NCT00216086|584128435|FG000|Overall Study|Social Reasons|2|||
161751148|NCT01080625|584128442|FG000|Overall Study|Physician Decision|0|||
161751149|NCT01080625|584128443|FG001|Overall Study|Physician Decision|2|||
161751150|NCT01080625|584128444|FG002|Overall Study|Physician Decision|1|||
161751151|NCT01587274|584128447|FG000|Overall Study|Lost to Follow-up|4|||
161751152|NCT01587274|584128448|FG001|Overall Study|Lost to Follow-up|5|||
161751153|NCT01587274|584128449|FG002|Overall Study|Lost to Follow-up|3|||
161751154|NCT03236506|584128457|FG000|Overall Study|Death|1|||
161751155|NCT03236506|584128458|FG001|Overall Study|Death|1|||
161751156|NCT03236506|584128459|FG002|Overall Study|Death|1|||
161751157|NCT03236506|584128457|FG000|Overall Study|Withdrawal by Subject|3|||
161751158|NCT03236506|584128458|FG001|Overall Study|Withdrawal by Subject|3|||
161751159|NCT03236506|584128459|FG002|Overall Study|Withdrawal by Subject|4|||
161751160|NCT03236506|584128457|FG000|Overall Study|Did not initiate treatment|2|||
161751161|NCT03236506|584128458|FG001|Overall Study|Did not initiate treatment|1|||
161751162|NCT03236506|584128459|FG002|Overall Study|Did not initiate treatment|2|||
161751163|NCT00422669|584128468|FG000|Overall Study|The study was terminated early.|98|||
161751164|NCT00422669|584128469|FG001|Overall Study|The study was terminated early.|100|||
161751165|NCT00422669|584128470|FG002|Overall Study|The study was terminated early.|7|||
161751166|NCT02709109|584128471|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
161751167|NCT02709109|584128472|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
161751168|NCT02709109|584128473|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
161751169|NCT02709109|584128474|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
161751170|NCT02709109|584128471|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161751171|NCT02709109|584128472|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
161751172|NCT02709109|584128473|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161751173|NCT02709109|584128474|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161844392|NCT01709838|584472443|FG000|Overall Study|Physician Decision|4|||
161844393|NCT01709838|584472443|FG000|Overall Study|Death|3|||
161844394|NCT01709838|584472443|FG000|Overall Study|Protocol Violation|1|||
161751174|NCT02709109|584128471|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
161751175|NCT02709109|584128472|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161844395|NCT00620659|584472444|FG000|Treatment Period 1|Adverse Event|1|||
161844396|NCT00620659|584472445|FG001|Treatment Period 1|Adverse Event|0|||
161844397|NCT00620659|584472446|FG002|Treatment Period 1|Adverse Event|0|||
161844398|NCT00620659|584472447|FG003|Treatment Period 1|Adverse Event|3|||
161844399|NCT00620659|584472448|FG004|Treatment Period 1|Adverse Event|0|||
161844400|NCT00620659|584472449|FG005|Treatment Period 1|Adverse Event|0|||
161844401|NCT00620659|584472444|FG000|Treatment Period 1|Protocol Violation|1|||
161844402|NCT00620659|584472445|FG001|Treatment Period 1|Protocol Violation|0|||
161844403|NCT00620659|584472446|FG002|Treatment Period 1|Protocol Violation|0|||
161844404|NCT00620659|584472447|FG003|Treatment Period 1|Protocol Violation|0|||
161844405|NCT00620659|584472448|FG004|Treatment Period 1|Protocol Violation|0|||
161844406|NCT00620659|584472449|FG005|Treatment Period 1|Protocol Violation|0|||
161844407|NCT00620659|584472444|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161844408|NCT00620659|584472445|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161844409|NCT00620659|584472446|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161844410|NCT00620659|584472447|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161844411|NCT00620659|584472448|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161844412|NCT00620659|584472449|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161844413|NCT00620659|584472444|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844414|NCT00620659|584472445|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
161751176|NCT02709109|584128473|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161751177|NCT02709109|584128474|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161751178|NCT02709109|584128471|FG000|Washout Period (28 Days)|Other|2|||
161751179|NCT02709109|584128472|FG001|Washout Period (28 Days)|Other|2|||
161751180|NCT02709109|584128473|FG002|Washout Period (28 Days)|Other|3|||
161751181|NCT02709109|584128474|FG003|Washout Period (28 Days)|Other|0|||
161751182|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
161751183|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
161751184|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
161751185|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
161751186|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
161751187|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
161751188|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
161751189|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
161751190|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161751191|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161751192|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
161751193|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161844415|NCT00620659|584472446|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844416|NCT00620659|584472447|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
161751194|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Other|0|||
161751195|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Other|0|||
161751196|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Other|1|||
161751197|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Other|0|||
161751198|NCT02565615|584128476|FG000|Overall Study|Death|0|||
161751199|NCT02565615|584128477|FG001|Overall Study|Death|1|||
161751200|NCT02565615|584128478|FG002|Overall Study|Death|0|||
161751201|NCT02565615|584128479|FG003|Overall Study|Death|0|||
161751202|NCT02565615|584128480|FG004|Overall Study|Death|4|||
161751203|NCT02565615|584128476|FG000|Overall Study|Not willing to participate in study|2|||
161751204|NCT02565615|584128477|FG001|Overall Study|Not willing to participate in study|21|||
161751205|NCT02565615|584128478|FG002|Overall Study|Not willing to participate in study|0|||
161751206|NCT02565615|584128479|FG003|Overall Study|Not willing to participate in study|1|||
161751207|NCT02565615|584128480|FG004|Overall Study|Not willing to participate in study|169|||
161751208|NCT02565615|584128476|FG000|Overall Study|Lost to Follow-up|0|||
161751209|NCT02565615|584128477|FG001|Overall Study|Lost to Follow-up|4|||
161751210|NCT02565615|584128478|FG002|Overall Study|Lost to Follow-up|0|||
161751211|NCT02565615|584128479|FG003|Overall Study|Lost to Follow-up|1|||
161751212|NCT02565615|584128480|FG004|Overall Study|Lost to Follow-up|765|||
161751213|NCT02565615|584128476|FG000|Overall Study|Not meeting eligibility criteria|0|||
161751214|NCT02565615|584128477|FG001|Overall Study|Not meeting eligibility criteria|7|||
161751215|NCT02565615|584128478|FG002|Overall Study|Not meeting eligibility criteria|0|||
161751216|NCT02565615|584128479|FG003|Overall Study|Not meeting eligibility criteria|0|||
161751217|NCT02565615|584128480|FG004|Overall Study|Not meeting eligibility criteria|25|||
161751218|NCT02565615|584128476|FG000|Overall Study|Reason not defined|0|||
161751219|NCT02565615|584128477|FG001|Overall Study|Reason not defined|2|||
161751220|NCT02565615|584128478|FG002|Overall Study|Reason not defined|0|||
161751221|NCT02565615|584128479|FG003|Overall Study|Reason not defined|1|||
161751222|NCT02565615|584128480|FG004|Overall Study|Reason not defined|62|||
161751223|NCT02565615|584128476|FG000|Overall Study|Adverse Event|1|||
161751224|NCT02565615|584128477|FG001|Overall Study|Adverse Event|1|||
161751225|NCT02565615|584128478|FG002|Overall Study|Adverse Event|0|||
161751226|NCT02565615|584128479|FG003|Overall Study|Adverse Event|0|||
161751227|NCT02565615|584128480|FG004|Overall Study|Adverse Event|9|||
161751228|NCT02565615|584128476|FG000|Overall Study|Untreated|0|||
161751229|NCT02565615|584128477|FG001|Overall Study|Untreated|0|||
161751230|NCT02565615|584128478|FG002|Overall Study|Untreated|0|||
161751231|NCT02565615|584128479|FG003|Overall Study|Untreated|0|||
161751232|NCT02565615|584128480|FG004|Overall Study|Untreated|567|||
161751233|NCT01815580|584128484|FG000|Overall Study|Lost to Follow-up|4|||
161751234|NCT01815580|584128485|FG001|Overall Study|Lost to Follow-up|7|||
161751235|NCT01815580|584128484|FG000|Overall Study|Withdrawal by Subject|3|||
161751236|NCT01815580|584128485|FG001|Overall Study|Withdrawal by Subject|4|||
161751237|NCT01815580|584128484|FG000|Overall Study|Excluded from analysis|5|||
161751238|NCT01815580|584128485|FG001|Overall Study|Excluded from analysis|4|||
161751239|NCT00023712|584128488|FG000|Overall Study|Not platinum sensitive|1|||
161751240|NCT00023712|584128489|FG001|Overall Study|Not platinum sensitive|0|||
161751241|NCT00023712|584128488|FG000|Overall Study|Never treated|1|||
161751242|NCT00023712|584128489|FG001|Overall Study|Never treated|1|||
161751243|NCT00437203|584128490|FG000|Overall Study|Death|0|||
161751244|NCT00437203|584128491|FG001|Overall Study|Death|0|||
161751245|NCT00437203|584128492|FG002|Overall Study|Death|1|||
161751246|NCT00437203|584128493|FG003|Overall Study|Death|0|||
161751247|NCT00437203|584128494|FG004|Overall Study|Death|0|||
161751248|NCT00437203|584128495|FG005|Overall Study|Death|0|||
161751249|NCT00437203|584128496|FG006|Overall Study|Death|0|||
161751250|NCT00437203|584128497|FG007|Overall Study|Death|1|||
161751251|NCT00437203|584128498|FG008|Overall Study|Death|0|||
161751252|NCT00437203|584128499|FG009|Overall Study|Death|1|||
161751253|NCT00437203|584128490|FG000|Overall Study|Adverse Event|1|||
161751254|NCT00437203|584128491|FG001|Overall Study|Adverse Event|1|||
161751255|NCT00437203|584128492|FG002|Overall Study|Adverse Event|0|||
161751256|NCT00437203|584128493|FG003|Overall Study|Adverse Event|0|||
161751257|NCT00437203|584128494|FG004|Overall Study|Adverse Event|0|||
161751258|NCT00437203|584128495|FG005|Overall Study|Adverse Event|0|||
161751259|NCT00437203|584128496|FG006|Overall Study|Adverse Event|0|||
161751260|NCT00437203|584128497|FG007|Overall Study|Adverse Event|1|||
161751261|NCT00437203|584128498|FG008|Overall Study|Adverse Event|0|||
161751262|NCT00437203|584128499|FG009|Overall Study|Adverse Event|1|||
161751263|NCT00437203|584128490|FG000|Overall Study|Study terminated by sponsor|0|||
161751264|NCT00437203|584128491|FG001|Overall Study|Study terminated by sponsor|0|||
161751265|NCT00437203|584128492|FG002|Overall Study|Study terminated by sponsor|0|||
161751266|NCT00437203|584128493|FG003|Overall Study|Study terminated by sponsor|0|||
161844417|NCT00620659|584472448|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844418|NCT00620659|584472449|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844419|NCT00620659|584472444|FG000|Treatment Period 2|Adverse Event|0|||
161844420|NCT00620659|584472445|FG001|Treatment Period 2|Adverse Event|3|||
161844421|NCT00620659|584472446|FG002|Treatment Period 2|Adverse Event|0|||
161844422|NCT00620659|584472447|FG003|Treatment Period 2|Adverse Event|0|||
161844423|NCT00620659|584472448|FG004|Treatment Period 2|Adverse Event|2|||
161844424|NCT00620659|584472449|FG005|Treatment Period 2|Adverse Event|0|||
161844425|NCT00620659|584472444|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161844426|NCT00620659|584472445|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161844427|NCT00620659|584472446|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161844428|NCT00620659|584472447|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161844429|NCT00620659|584472448|FG004|Treatment Period 2|Withdrawal by Subject|3|||
161844430|NCT00620659|584472449|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161844431|NCT00620659|584472444|FG000|Placebo Washout Period 2|Adverse Event|2|||
161844432|NCT00620659|584472445|FG001|Placebo Washout Period 2|Adverse Event|0|||
161844433|NCT00620659|584472446|FG002|Placebo Washout Period 2|Adverse Event|0|||
161844434|NCT00620659|584472447|FG003|Placebo Washout Period 2|Adverse Event|0|||
161844435|NCT00620659|584472448|FG004|Placebo Washout Period 2|Adverse Event|0|||
161844436|NCT00620659|584472449|FG005|Placebo Washout Period 2|Adverse Event|0|||
161844437|NCT00620659|584472444|FG000|Treatment Period 3|Adverse Event|0|||
161844438|NCT00620659|584472445|FG001|Treatment Period 3|Adverse Event|2|||
161844439|NCT00620659|584472446|FG002|Treatment Period 3|Adverse Event|0|||
161844440|NCT00620659|584472447|FG003|Treatment Period 3|Adverse Event|0|||
161844441|NCT00620659|584472448|FG004|Treatment Period 3|Adverse Event|0|||
161844442|NCT00620659|584472449|FG005|Treatment Period 3|Adverse Event|0|||
161844443|NCT00620659|584472444|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161844444|NCT00620659|584472445|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161844445|NCT00620659|584472446|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161844446|NCT00620659|584472447|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161844447|NCT00620659|584472448|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161844448|NCT00620659|584472449|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161844449|NCT02352779|584472450|FG000|Overall Study|Personal Issues|1|||
161844450|NCT02352779|584472451|FG001|Overall Study|Personal Issues|1|||
161844451|NCT02352779|584472452|FG002|Overall Study|Personal Issues|0|||
161844452|NCT02352779|584472450|FG000|Overall Study|Too Many Forms|2|||
161844453|NCT02352779|584472451|FG001|Overall Study|Too Many Forms|0|||
161844454|NCT02352779|584472452|FG002|Overall Study|Too Many Forms|0|||
161844455|NCT02352779|584472450|FG000|Overall Study|Feeling Overwhelmed|1|||
161844456|NCT02352779|584472451|FG001|Overall Study|Feeling Overwhelmed|0|||
161844457|NCT02352779|584472452|FG002|Overall Study|Feeling Overwhelmed|0|||
161844458|NCT02352779|584472450|FG000|Overall Study|Disliked Intervention|1|||
161844459|NCT02352779|584472451|FG001|Overall Study|Disliked Intervention|0|||
161844460|NCT02352779|584472452|FG002|Overall Study|Disliked Intervention|0|||
161844461|NCT02352779|584472450|FG000|Overall Study|Changed Mind|1|||
161844462|NCT02352779|584472451|FG001|Overall Study|Changed Mind|0|||
161844463|NCT02352779|584472452|FG002|Overall Study|Changed Mind|0|||
161844464|NCT02352779|584472450|FG000|Overall Study|Study Related Symptoms|1|||
161844465|NCT02352779|584472451|FG001|Overall Study|Study Related Symptoms|0|||
161844466|NCT02352779|584472452|FG002|Overall Study|Study Related Symptoms|0|||
161844467|NCT02352779|584472450|FG000|Overall Study|Absence of Symptoms|1|||
161844468|NCT02352779|584472451|FG001|Overall Study|Absence of Symptoms|0|||
161844469|NCT02352779|584472452|FG002|Overall Study|Absence of Symptoms|0|||
161844470|NCT02352779|584472450|FG000|Overall Study|Other Medical Reason|0|||
161844471|NCT02352779|584472451|FG001|Overall Study|Other Medical Reason|0|||
161844472|NCT02352779|584472452|FG002|Overall Study|Other Medical Reason|1|||
161844473|NCT02352779|584472450|FG000|Overall Study|No Reason|0|||
161844474|NCT02352779|584472451|FG001|Overall Study|No Reason|0|||
161844475|NCT02352779|584472452|FG002|Overall Study|No Reason|1|||
161844476|NCT00968799|584472455|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
161844477|NCT00719849|584472458|FG000|Overall Study|Death|0|||
161844478|NCT00719849|584472459|FG001|Overall Study|Death|1|||
161844479|NCT00389831|584472463|FG000|Overall Study|Lack of Efficacy|0|||
161844480|NCT00389831|584472464|FG001|Overall Study|Lack of Efficacy|2|||
161844481|NCT00389831|584472463|FG000|Overall Study|Did not receive treatment.|0|||
161844482|NCT00389831|584472464|FG001|Overall Study|Did not receive treatment.|2|||
161844483|NCT00389831|584472463|FG000|Overall Study|Other reasons|0|||
161844484|NCT00389831|584472464|FG001|Overall Study|Other reasons|2|||
161751267|NCT00437203|584128494|FG004|Overall Study|Study terminated by sponsor|0|||
161751268|NCT00437203|584128495|FG005|Overall Study|Study terminated by sponsor|0|||
161751269|NCT00437203|584128496|FG006|Overall Study|Study terminated by sponsor|0|||
161751270|NCT00437203|584128497|FG007|Overall Study|Study terminated by sponsor|0|||
161751271|NCT00437203|584128498|FG008|Overall Study|Study terminated by sponsor|1|||
161751272|NCT00437203|584128499|FG009|Overall Study|Study terminated by sponsor|0|||
161751273|NCT00437203|584128490|FG000|Overall Study|Objective progression or relapse|5|||
161751274|NCT00437203|584128491|FG001|Overall Study|Objective progression or relapse|6|||
161751275|NCT00437203|584128492|FG002|Overall Study|Objective progression or relapse|2|||
161751276|NCT00437203|584128493|FG003|Overall Study|Objective progression or relapse|3|||
161751277|NCT00437203|584128494|FG004|Overall Study|Objective progression or relapse|3|||
161751278|NCT00437203|584128495|FG005|Overall Study|Objective progression or relapse|3|||
161751279|NCT00437203|584128496|FG006|Overall Study|Objective progression or relapse|6|||
161751280|NCT00437203|584128497|FG007|Overall Study|Objective progression or relapse|1|||
161751281|NCT00437203|584128498|FG008|Overall Study|Objective progression or relapse|2|||
161751282|NCT00437203|584128499|FG009|Overall Study|Objective progression or relapse|2|||
161751283|NCT00437203|584128490|FG000|Overall Study|Other|0|||
161751284|NCT00437203|584128491|FG001|Overall Study|Other|1|||
161751285|NCT00437203|584128492|FG002|Overall Study|Other|0|||
161751286|NCT00437203|584128493|FG003|Overall Study|Other|0|||
161751287|NCT00437203|584128494|FG004|Overall Study|Other|0|||
161751288|NCT00437203|584128495|FG005|Overall Study|Other|0|||
161751289|NCT00437203|584128496|FG006|Overall Study|Other|1|||
161751290|NCT00437203|584128497|FG007|Overall Study|Other|0|||
161751291|NCT00437203|584128498|FG008|Overall Study|Other|0|||
161751292|NCT00437203|584128499|FG009|Overall Study|Other|0|||
161751293|NCT03997760|584128500|FG000|Overall Study|Protocol Deviation|0|||
161751294|NCT03997760|584128501|FG001|Overall Study|Protocol Deviation|1|||
161751295|NCT03997760|584128502|FG002|Overall Study|Protocol Deviation|0|||
161751296|NCT03997760|584128503|FG003|Overall Study|Protocol Deviation|0|||
161751297|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751298|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751299|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751300|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
161751301|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751302|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751303|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751304|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751305|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
161751306|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751307|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751308|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751309|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751310|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
161751311|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751312|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751313|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751314|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751315|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
161751316|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751317|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751318|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751319|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751320|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
161751321|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751322|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
161751323|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
161751324|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
161751325|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
161751326|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
161751327|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
161751328|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
161751329|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
161751330|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
161751331|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
161751332|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
161751333|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
161751334|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
161751335|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
161751336|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
161751337|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
161751338|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161751339|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
161751340|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161751341|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161751342|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
161751343|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
161751344|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
161751345|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
161751346|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
161751347|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
161751348|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
161751349|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161751350|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161751351|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161751352|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Unclassified|7|||
161751353|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Unclassified|6|||
161751354|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Unclassified|7|||
161751355|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Unclassified|0|||
161751356|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Unclassified|0|||
161751357|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
161751358|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
161751359|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
161751360|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
161751361|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
161751362|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
161751363|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
161751364|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
161751365|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
161751366|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
161751367|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
161751368|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161751369|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
161751370|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161751371|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161751372|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161751373|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
161751374|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
161751375|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161751376|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161751377|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
161751378|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
161751379|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
161751380|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
161751381|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
161751382|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
161751383|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
161751384|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
161751385|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
161751386|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
161751387|NCT01906476|584128510|FG000|Overall Study|Lost to Follow-up|17|||
161751388|NCT01906476|584128511|FG001|Overall Study|Lost to Follow-up|16|||
161751389|NCT01993667|584128515|FG000|Overall Study|Insufficient data to analyze|16|||
161751390|NCT01993667|584128516|FG001|Overall Study|Insufficient data to analyze|16|||
161751391|NCT01993667|584128515|FG000|Overall Study|Insufficient altitude reached|3|||
161751392|NCT01993667|584128516|FG001|Overall Study|Insufficient altitude reached|1|||
161751393|NCT01993667|584128515|FG000|Overall Study|Lost to Follow-up|2|||
161751394|NCT01993667|584128516|FG001|Overall Study|Lost to Follow-up|2|||
161751395|NCT01931150|584128517|FG000|Overall Study|Withdrawal by Subject|1|||
161751396|NCT01931150|584128518|FG001|Overall Study|Withdrawal by Subject|2|||
161751397|NCT00845845|584128521|FG000|Overall Study|Lost to Follow-up|0|||
161751398|NCT00845845|584128522|FG001|Overall Study|Lost to Follow-up|4|||
161751399|NCT01685203|584128523|FG000|Overall Study|Lost to Follow-up|3|||
161751400|NCT01685203|584128524|FG001|Overall Study|Lost to Follow-up|3|||
161751401|NCT01685203|584128525|FG002|Overall Study|Lost to Follow-up|0|||
161751402|NCT01685203|584128526|FG003|Overall Study|Lost to Follow-up|1|||
161751403|NCT01685203|584128527|FG004|Overall Study|Lost to Follow-up|0|||
161751404|NCT01685203|584128528|FG005|Overall Study|Lost to Follow-up|0|||
161751405|NCT01685203|584128529|FG006|Overall Study|Lost to Follow-up|0|||
161751406|NCT01685203|584128523|FG000|Overall Study|Adverse Event|0|||
161751407|NCT01685203|584128524|FG001|Overall Study|Adverse Event|0|||
161751408|NCT01685203|584128525|FG002|Overall Study|Adverse Event|0|||
161751409|NCT01685203|584128526|FG003|Overall Study|Adverse Event|0|||
161751410|NCT01685203|584128527|FG004|Overall Study|Adverse Event|0|||
161751411|NCT01685203|584128528|FG005|Overall Study|Adverse Event|2|||
161751412|NCT01685203|584128529|FG006|Overall Study|Adverse Event|0|||
161751413|NCT01685203|584128523|FG000|Overall Study|Adverse event and withdrew consent|1|||
161751414|NCT01685203|584128524|FG001|Overall Study|Adverse event and withdrew consent|0|||
161751415|NCT01685203|584128525|FG002|Overall Study|Adverse event and withdrew consent|0|||
161751416|NCT01685203|584128526|FG003|Overall Study|Adverse event and withdrew consent|0|||
161751417|NCT01685203|584128527|FG004|Overall Study|Adverse event and withdrew consent|0|||
161751418|NCT01685203|584128528|FG005|Overall Study|Adverse event and withdrew consent|0|||
161751419|NCT01685203|584128529|FG006|Overall Study|Adverse event and withdrew consent|0|||
161751420|NCT01685203|584128523|FG000|Overall Study|Patient's decision|0|||
161751421|NCT01685203|584128524|FG001|Overall Study|Patient's decision|0|||
161751422|NCT01685203|584128525|FG002|Overall Study|Patient's decision|0|||
161751423|NCT01685203|584128526|FG003|Overall Study|Patient's decision|0|||
161751424|NCT01685203|584128527|FG004|Overall Study|Patient's decision|0|||
161751425|NCT01685203|584128528|FG005|Overall Study|Patient's decision|1|||
161751426|NCT01685203|584128529|FG006|Overall Study|Patient's decision|0|||
161751427|NCT00479167|584128530|FG000|Overall Study|Withdrawal by Subject|1|||
161751428|NCT02384993|584128531|FG000|Overall Study|Adverse Event|0|||
161751429|NCT02384993|584128532|FG001|Overall Study|Adverse Event|1|||
161751430|NCT03695471|584130867|FG000|Overall Study|Cancellation|1|||
161751431|NCT02859558|584130868|FG000|Step 1|Not Eligible|0|||
161751432|NCT02859558|584130869|FG001|Step 1|Not Eligible|0|||
161751433|NCT02859558|584130870|FG002|Step 1|Not Eligible|0|||
161751434|NCT02859558|584130871|FG003|Step 1|Not Eligible|0|||
161751435|NCT02859558|584130872|FG004|Step 1|Not Eligible|3|||
161751436|NCT02859558|584130868|FG000|Step 1|Lost to Follow-up|1|||
161751437|NCT02859558|584130869|FG001|Step 1|Lost to Follow-up|3|||
161751438|NCT02859558|584130870|FG002|Step 1|Lost to Follow-up|3|||
161751439|NCT02859558|584130871|FG003|Step 1|Lost to Follow-up|0|||
161751440|NCT02859558|584130872|FG004|Step 1|Lost to Follow-up|0|||
161751441|NCT02859558|584130868|FG000|Step 1|Did Not Return to Clinic|2|||
161751442|NCT02859558|584130869|FG001|Step 1|Did Not Return to Clinic|3|||
161751443|NCT02859558|584130870|FG002|Step 1|Did Not Return to Clinic|4|||
161751444|NCT02859558|584130871|FG003|Step 1|Did Not Return to Clinic|0|||
161751445|NCT02859558|584130872|FG004|Step 1|Did Not Return to Clinic|0|||
161751446|NCT02859558|584130868|FG000|Step 1|Moved|0|||
161751447|NCT02859558|584130869|FG001|Step 1|Moved|1|||
161751448|NCT02859558|584130870|FG002|Step 1|Moved|1|||
161751449|NCT02859558|584130871|FG003|Step 1|Moved|0|||
161751450|NCT02859558|584130872|FG004|Step 1|Moved|0|||
161751451|NCT02859558|584130868|FG000|Step 1|Withdrawal By Participant|1|||
161751452|NCT02859558|584130869|FG001|Step 1|Withdrawal By Participant|2|||
161751453|NCT02859558|584130870|FG002|Step 1|Withdrawal By Participant|1|||
161751454|NCT02859558|584130871|FG003|Step 1|Withdrawal By Participant|0|||
161751455|NCT02859558|584130872|FG004|Step 1|Withdrawal By Participant|0|||
161751456|NCT02859558|584130868|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
161751457|NCT02859558|584130869|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161751458|NCT02859558|584130870|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161751459|NCT02859558|584130871|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161751460|NCT02859558|584130872|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161844485|NCT00389831|584472463|FG000|Overall Study|Lost to Follow-up|0|||
161844486|NCT00389831|584472464|FG001|Overall Study|Lost to Follow-up|1|||
161844487|NCT00594646|584472469|FG000|Overall Study|Withdrawal by Subject|1|||
161844488|NCT00594646|584472469|FG000|Overall Study|Lost to Follow-up|15|||
161844489|NCT03907462|584472470|FG000|Overall Study|Physician Decision|1|||
161844490|NCT03907462|584472471|FG001|Overall Study|Physician Decision|3|||
161844491|NCT03907462|584472472|FG002|Overall Study|Physician Decision|1|||
161844492|NCT03907462|584472470|FG000|Overall Study|Withdrawal by Subject|6|||
161844493|NCT03907462|584472471|FG001|Overall Study|Withdrawal by Subject|3|||
161844494|NCT03907462|584472472|FG002|Overall Study|Withdrawal by Subject|3|||
161844495|NCT03907462|584472470|FG000|Overall Study|Pregnancy|4|||
161844496|NCT03907462|584472471|FG001|Overall Study|Pregnancy|2|||
161844497|NCT03907462|584472472|FG002|Overall Study|Pregnancy|6|||
161844498|NCT03907462|584472470|FG000|Overall Study|Lost to Follow-up|16|||
161844499|NCT03907462|584472471|FG001|Overall Study|Lost to Follow-up|18|||
161844500|NCT03907462|584472472|FG002|Overall Study|Lost to Follow-up|22|||
161844501|NCT00633243|584474540|FG000|Overall Study|Withdrawal by Subject|0|||
161844502|NCT00633243|584474541|FG001|Overall Study|Withdrawal by Subject|1|||
161844503|NCT00633243|584474540|FG000|Overall Study|incarceration|0|||
161844504|NCT00633243|584474541|FG001|Overall Study|incarceration|2|||
161844505|NCT00633243|584474540|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
161844506|NCT00633243|584474541|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
161844507|NCT00633243|584474540|FG000|Overall Study|Not comfortable with self-injecting|0|||
161844508|NCT00633243|584474541|FG001|Overall Study|Not comfortable with self-injecting|1|||
161844509|NCT00633243|584474540|FG000|Overall Study|Mental Health--Depression|0|||
161844510|NCT00633243|584474541|FG001|Overall Study|Mental Health--Depression|1|||
161844511|NCT00633243|584474540|FG000|Overall Study|Couldn't tolerate side-effects|1|||
161844512|NCT00633243|584474541|FG001|Overall Study|Couldn't tolerate side-effects|1|||
161844513|NCT01682863|584474542|FG000|Overall Study|Subject/guardian decision|19|||
161844514|NCT01682863|584474543|FG001|Overall Study|Subject/guardian decision|12|||
161844515|NCT01682863|584474544|FG002|Overall Study|Subject/guardian decision|10|||
161844516|NCT01682863|584474542|FG000|Overall Study|Lost to Follow-up|5|||
161844517|NCT01682863|584474543|FG001|Overall Study|Lost to Follow-up|1|||
161844518|NCT01682863|584474544|FG002|Overall Study|Lost to Follow-up|6|||
161844519|NCT01682863|584474542|FG000|Overall Study|Death|1|||
161844520|NCT01682863|584474543|FG001|Overall Study|Death|3|||
161844521|NCT01682863|584474544|FG002|Overall Study|Death|4|||
161844522|NCT01682863|584474542|FG000|Overall Study|Protocol deviation|1|||
161844523|NCT01682863|584474543|FG001|Overall Study|Protocol deviation|0|||
161844524|NCT01682863|584474544|FG002|Overall Study|Protocol deviation|1|||
161844525|NCT01682863|584474542|FG000|Overall Study|Technical problems|1|||
161844526|NCT01682863|584474543|FG001|Overall Study|Technical problems|0|||
161844527|NCT01682863|584474544|FG002|Overall Study|Technical problems|0|||
161844528|NCT01682863|584474542|FG000|Overall Study|Adverse Event|0|||
161844529|NCT01682863|584474543|FG001|Overall Study|Adverse Event|1|||
161844530|NCT01682863|584474544|FG002|Overall Study|Adverse Event|2|||
161844531|NCT01682863|584474542|FG000|Overall Study|Physician Decision|0|||
161844532|NCT01682863|584474543|FG001|Overall Study|Physician Decision|0|||
161844533|NCT01682863|584474544|FG002|Overall Study|Physician Decision|1|||
161844534|NCT00918138|584474545|FG000|Overall Study|Subject withdrew consent|1|||
161844535|NCT00918138|584474546|FG001|Overall Study|Subject withdrew consent|1|||
161844536|NCT00918138|584474545|FG000|Overall Study|Death|1|||
161844537|NCT00918138|584474546|FG001|Overall Study|Death|0|||
161844538|NCT00977379|584474547|FG000|Overall Study|Withdrawal by Subject|1|||
161844539|NCT00977379|584474548|FG001|Overall Study|Withdrawal by Subject|1|||
161844540|NCT00977379|584474547|FG000|Overall Study|Death|7|||
161844541|NCT00977379|584474548|FG001|Overall Study|Death|9|||
161844542|NCT00977379|584474547|FG000|Overall Study|Premature Study Termination|4|||
161844543|NCT00977379|584474548|FG001|Overall Study|Premature Study Termination|0|||
161844544|NCT00977379|584474547|FG000|Overall Study|Participant Moving House|0|||
161844545|NCT00977379|584474548|FG001|Overall Study|Participant Moving House|1|||
161844546|NCT00977379|584474547|FG000|Overall Study|Randomization Error|0|||
161844547|NCT00977379|584474548|FG001|Overall Study|Randomization Error|1|||
161844548|NCT03972163|584474549|FG000|Overall Study|Death|0|||
161844549|NCT03972163|584474550|FG001|Overall Study|Death|1|||
161844550|NCT01212588|584474553|FG000|Overall Study|Physician Decision|0|||
161844551|NCT01212588|584474554|FG001|Overall Study|Physician Decision|1|||
161844552|NCT01212588|584474553|FG000|Overall Study|Protocol Violation|1|||
161844553|NCT01212588|584474554|FG001|Overall Study|Protocol Violation|1|||
161844554|NCT02885181|584474555|FG000|Overall Study|Investigator's Discretion|0|||
161844555|NCT02885181|584474556|FG001|Overall Study|Investigator's Discretion|1|||
161844556|NCT02885181|584474557|FG002|Overall Study|Investigator's Discretion|0|||
161844557|NCT02885181|584474558|FG003|Overall Study|Investigator's Discretion|1|||
161844558|NCT02885181|584474555|FG000|Overall Study|Adverse Event|0|||
161844559|NCT02885181|584474556|FG001|Overall Study|Adverse Event|0|||
161844560|NCT02885181|584474557|FG002|Overall Study|Adverse Event|0|||
161844561|NCT02885181|584474558|FG003|Overall Study|Adverse Event|1|||
161844562|NCT02885181|584474555|FG000|Overall Study|Withdrawal by Subject|0|||
161844563|NCT02885181|584474556|FG001|Overall Study|Withdrawal by Subject|0|||
161844564|NCT02885181|584474557|FG002|Overall Study|Withdrawal by Subject|0|||
161844565|NCT02885181|584474558|FG003|Overall Study|Withdrawal by Subject|1|||
161844566|NCT04005352|584474567|FG000|Overall Study|Adverse Event|4|||
161844567|NCT04005352|584474568|FG001|Overall Study|Adverse Event|5|||
161844568|NCT04005352|584474567|FG000|Overall Study|Death|4|||
161844569|NCT04005352|584474568|FG001|Overall Study|Death|2|||
161844570|NCT04005352|584474567|FG000|Overall Study|Lost to Follow-up|6|||
161844571|NCT04005352|584474568|FG001|Overall Study|Lost to Follow-up|2|||
161844572|NCT04005352|584474567|FG000|Overall Study|Physician Decision|7|||
161844573|NCT04005352|584474568|FG001|Overall Study|Physician Decision|13|||
161844574|NCT04005352|584474567|FG000|Overall Study|Protocol Violation|0|||
161844575|NCT04005352|584474568|FG001|Overall Study|Protocol Violation|1|||
161844576|NCT04005352|584474567|FG000|Overall Study|Withdrawal by Subject|28|||
161844577|NCT04005352|584474568|FG001|Overall Study|Withdrawal by Subject|38|||
161844578|NCT01283035|584474569|FG000|Overall Study|Subject later found ineligible|1|||
161844579|NCT03597529|584474572|FG000|Overall Study|Lost to Follow-up|10|||
161844580|NCT03597529|584474573|FG001|Overall Study|Lost to Follow-up|12|||
161844581|NCT03597529|584474572|FG000|Overall Study|Physician Decision|3|||
161844582|NCT03597529|584474573|FG001|Overall Study|Physician Decision|1|||
161844583|NCT03597529|584474572|FG000|Overall Study|Withdrawal by Subject|6|||
161844584|NCT03597529|584474573|FG001|Overall Study|Withdrawal by Subject|3|||
161844585|NCT03597529|584474572|FG000|Overall Study|Non-compliant with study activities|1|||
161844586|NCT03597529|584474573|FG001|Overall Study|Non-compliant with study activities|2|||
161844587|NCT00191165|584474574|FG000|Overall Study|Adverse Event|2|||
161844588|NCT00191165|584474575|FG001|Overall Study|Adverse Event|0|||
161844589|NCT00191165|584474574|FG000|Overall Study|Protocol Violation|0|||
161844590|NCT00191165|584474575|FG001|Overall Study|Protocol Violation|1|||
161844591|NCT00191165|584474574|FG000|Overall Study|Participant Moved Away|0|||
161844592|NCT00191165|584474575|FG001|Overall Study|Participant Moved Away|1|||
161844593|NCT03200912|584474576|FG000|Overall Study|Adverse Event|3|||
161844594|NCT03200912|584474577|FG001|Overall Study|Adverse Event|0|||
161844595|NCT03200912|584474578|FG002|Overall Study|Adverse Event|0|||
161844596|NCT03200912|584474576|FG000|Overall Study|Withdrawal by Subject|1|||
161844597|NCT03200912|584474577|FG001|Overall Study|Withdrawal by Subject|2|||
161844598|NCT03200912|584474578|FG002|Overall Study|Withdrawal by Subject|4|||
161844599|NCT03200912|584474576|FG000|Overall Study|Non-compliance with study drug|0|||
161751461|NCT02859558|584130868|FG000|Step 1|Incarceration|0|||
161751462|NCT02859558|584130869|FG001|Step 1|Incarceration|1|||
161751463|NCT02859558|584130870|FG002|Step 1|Incarceration|0|||
161751464|NCT02859558|584130871|FG003|Step 1|Incarceration|0|||
161751465|NCT02859558|584130872|FG004|Step 1|Incarceration|0|||
161751466|NCT02859558|584130868|FG000|Step 1|Non-Adherence to Study Drug|2|||
161751467|NCT02859558|584130869|FG001|Step 1|Non-Adherence to Study Drug|0|||
161751468|NCT02859558|584130870|FG002|Step 1|Non-Adherence to Study Drug|1|||
161751469|NCT02859558|584130871|FG003|Step 1|Non-Adherence to Study Drug|0|||
161751470|NCT02859558|584130872|FG004|Step 1|Non-Adherence to Study Drug|0|||
161751471|NCT02859558|584130868|FG000|Step 1|Non-Adherence to Study Requirements|3|||
161751472|NCT02859558|584130869|FG001|Step 1|Non-Adherence to Study Requirements|1|||
161751473|NCT02859558|584130870|FG002|Step 1|Non-Adherence to Study Requirements|0|||
161751474|NCT02859558|584130871|FG003|Step 1|Non-Adherence to Study Requirements|0|||
161751475|NCT02859558|584130872|FG004|Step 1|Non-Adherence to Study Requirements|0|||
161751476|NCT02859558|584130868|FG000|Step 1|Virologic Failure|2|||
161751477|NCT02859558|584130869|FG001|Step 1|Virologic Failure|1|||
161751478|NCT02859558|584130870|FG002|Step 1|Virologic Failure|1|||
161751479|NCT02859558|584130871|FG003|Step 1|Virologic Failure|0|||
161751480|NCT02859558|584130872|FG004|Step 1|Virologic Failure|0|||
161751481|NCT02859558|584130868|FG000|Step 2|Lost to Follow-up|3|||
161751482|NCT02859558|584130869|FG001|Step 2|Lost to Follow-up|3|||
161751483|NCT02859558|584130870|FG002|Step 2|Lost to Follow-up|1|||
161751484|NCT02859558|584130871|FG003|Step 2|Lost to Follow-up|0|||
161751485|NCT02859558|584130872|FG004|Step 2|Lost to Follow-up|0|||
161751486|NCT02859558|584130868|FG000|Step 2|Withdrawal by Subject|0|||
161751487|NCT02859558|584130869|FG001|Step 2|Withdrawal by Subject|1|||
161751488|NCT02859558|584130870|FG002|Step 2|Withdrawal by Subject|1|||
161751489|NCT02859558|584130871|FG003|Step 2|Withdrawal by Subject|0|||
161751490|NCT02859558|584130872|FG004|Step 2|Withdrawal by Subject|0|||
161751491|NCT02859558|584130868|FG000|Step 2|Unexpected Closure of Site|0|||
161751492|NCT02859558|584130869|FG001|Step 2|Unexpected Closure of Site|1|||
161751493|NCT02859558|584130870|FG002|Step 2|Unexpected Closure of Site|1|||
161751494|NCT02859558|584130871|FG003|Step 2|Unexpected Closure of Site|0|||
161751495|NCT02859558|584130872|FG004|Step 2|Unexpected Closure of Site|0|||
161751496|NCT02859558|584130868|FG000|Step 2|Death|1|||
161751497|NCT02859558|584130869|FG001|Step 2|Death|0|||
161751498|NCT02859558|584130870|FG002|Step 2|Death|0|||
161751499|NCT02859558|584130871|FG003|Step 2|Death|0|||
161751500|NCT02859558|584130872|FG004|Step 2|Death|0|||
161751501|NCT02859558|584130868|FG000|Step 2|Incarceration|0|||
161751502|NCT02859558|584130869|FG001|Step 2|Incarceration|0|||
161751503|NCT02859558|584130870|FG002|Step 2|Incarceration|1|||
161751504|NCT02859558|584130871|FG003|Step 2|Incarceration|0|||
161751505|NCT02859558|584130872|FG004|Step 2|Incarceration|0|||
161751506|NCT04507360|584130873|FG000|Week 1|Lost to Follow-up|0|||
161751507|NCT04507360|584130874|FG001|Week 1|Lost to Follow-up|0|||
161751508|NCT04507360|584130875|FG002|Week 1|Lost to Follow-up|0|||
161751509|NCT04507360|584130876|FG003|Week 1|Lost to Follow-up|0|||
161751510|NCT04507360|584130877|FG004|Week 1|Lost to Follow-up|0|||
161751511|NCT04507360|584130878|FG005|Week 1|Lost to Follow-up|0|||
161751512|NCT04507360|584130879|FG006|Week 1|Lost to Follow-up|0|||
161751513|NCT04507360|584130880|FG007|Week 1|Lost to Follow-up|0|||
161751514|NCT04507360|584130881|FG008|Week 1|Lost to Follow-up|72|||
161751515|NCT04507360|584130882|FG009|Week 1|Lost to Follow-up|22|||
161751516|NCT04507360|584130883|FG010|Week 1|Lost to Follow-up|10|||
161751517|NCT04507360|584130873|FG000|Week 2|Lost to Follow-up|0|||
161751518|NCT04507360|584130874|FG001|Week 2|Lost to Follow-up|0|||
161751519|NCT04507360|584130875|FG002|Week 2|Lost to Follow-up|0|||
161751520|NCT04507360|584130876|FG003|Week 2|Lost to Follow-up|0|||
161751521|NCT04507360|584130877|FG004|Week 2|Lost to Follow-up|0|||
161751522|NCT04507360|584130878|FG005|Week 2|Lost to Follow-up|0|||
161751523|NCT04507360|584130879|FG006|Week 2|Lost to Follow-up|0|||
161751524|NCT04507360|584130880|FG007|Week 2|Lost to Follow-up|0|||
161751525|NCT04507360|584130881|FG008|Week 2|Lost to Follow-up|121|||
161751526|NCT04507360|584130882|FG009|Week 2|Lost to Follow-up|85|||
161751527|NCT04507360|584130883|FG010|Week 2|Lost to Follow-up|82|||
161751528|NCT04507360|584130873|FG000|Week 3|Lost to Follow-up|0|||
161751529|NCT04507360|584130874|FG001|Week 3|Lost to Follow-up|0|||
161751530|NCT04507360|584130875|FG002|Week 3|Lost to Follow-up|0|||
161751531|NCT04507360|584130876|FG003|Week 3|Lost to Follow-up|0|||
161751532|NCT04507360|584130877|FG004|Week 3|Lost to Follow-up|0|||
161751533|NCT04507360|584130878|FG005|Week 3|Lost to Follow-up|0|||
161751534|NCT04507360|584130879|FG006|Week 3|Lost to Follow-up|0|||
161751535|NCT04507360|584130880|FG007|Week 3|Lost to Follow-up|0|||
161751536|NCT04507360|584130881|FG008|Week 3|Lost to Follow-up|123|||
161751537|NCT04507360|584130882|FG009|Week 3|Lost to Follow-up|92|||
161751538|NCT04507360|584130883|FG010|Week 3|Lost to Follow-up|84|||
161751539|NCT04507360|584130873|FG000|Week 4|Lost to Follow-up|0|||
161751540|NCT04507360|584130874|FG001|Week 4|Lost to Follow-up|0|||
161751541|NCT04507360|584130875|FG002|Week 4|Lost to Follow-up|0|||
161751542|NCT04507360|584130876|FG003|Week 4|Lost to Follow-up|0|||
161844600|NCT03200912|584474577|FG001|Overall Study|Non-compliance with study drug|1|||
161844601|NCT03200912|584474578|FG002|Overall Study|Non-compliance with study drug|0|||
161844602|NCT03196635|584474579|FG000|Overall Study|Withdrawal by Subject|1|||
161844603|NCT00998309|584474580|FG000|Overall Study|Protocol Violation|4|||
161844604|NCT05788289|584474583|FG000|Overall Study|Death|3|||
161844605|NCT02238795|584474585|FG000|Overall Study|Patient without purpura fulminans|1|||
161844606|NCT05187013|584474586|FG000|Overall Study|Withdrawal by Subject|1|||
161844607|NCT05187013|584474587|FG001|Overall Study|Withdrawal by Subject|1|||
161844608|NCT05187013|584474588|FG002|Overall Study|Withdrawal by Subject|0|||
161844609|NCT05187013|584474586|FG000|Overall Study|Death|0|||
161844610|NCT05187013|584474587|FG001|Overall Study|Death|1|||
161844611|NCT05187013|584474588|FG002|Overall Study|Death|0|||
161844612|NCT05187013|584474586|FG000|Overall Study|Lost to Follow-up|20|||
161844613|NCT05187013|584474587|FG001|Overall Study|Lost to Follow-up|17|||
161844614|NCT05187013|584474588|FG002|Overall Study|Lost to Follow-up|0|||
161844615|NCT05187013|584474586|FG000|Overall Study|Ongoing Participants|3|||
161844616|NCT05187013|584474587|FG001|Overall Study|Ongoing Participants|5|||
161844617|NCT05187013|584474588|FG002|Overall Study|Ongoing Participants|0|||
161844618|NCT01096368|584474590|FG000|Overall Study|Death|0|||
161844619|NCT01096368|584474591|FG001|Overall Study|Death|1|||
161844620|NCT01096368|584474592|FG002|Overall Study|Death|0|||
161844621|NCT01096368|584474593|FG003|Overall Study|Death|0|||
161844622|NCT01096368|584474594|FG004|Overall Study|Death|0|||
161844623|NCT01096368|584474590|FG000|Overall Study|Physician Decision|0|||
161844624|NCT01096368|584474591|FG001|Overall Study|Physician Decision|13|||
161844625|NCT01096368|584474592|FG002|Overall Study|Physician Decision|2|||
161844626|NCT01096368|584474593|FG003|Overall Study|Physician Decision|4|||
161844627|NCT01096368|584474594|FG004|Overall Study|Physician Decision|6|||
161844628|NCT01096368|584474590|FG000|Overall Study|Withdrawal by Subject|0|||
161844629|NCT01096368|584474591|FG001|Overall Study|Withdrawal by Subject|52|||
161844630|NCT01096368|584474592|FG002|Overall Study|Withdrawal by Subject|0|||
161844631|NCT01096368|584474593|FG003|Overall Study|Withdrawal by Subject|10|||
161844632|NCT01096368|584474594|FG004|Overall Study|Withdrawal by Subject|14|||
161844633|NCT01096368|584474590|FG000|Overall Study|Ineligible|0|||
161844634|NCT01096368|584474591|FG001|Overall Study|Ineligible|3|||
161844635|NCT01096368|584474592|FG002|Overall Study|Ineligible|2|||
161844636|NCT01096368|584474593|FG003|Overall Study|Ineligible|0|||
161844637|NCT01096368|584474594|FG004|Overall Study|Ineligible|25|||
161844638|NCT01096368|584474590|FG000|Overall Study|Did not start treatment|0|||
161844639|NCT01096368|584474591|FG001|Overall Study|Did not start treatment|4|||
161844640|NCT01096368|584474592|FG002|Overall Study|Did not start treatment|4|||
161844641|NCT01096368|584474593|FG003|Overall Study|Did not start treatment|0|||
161844642|NCT01096368|584474594|FG004|Overall Study|Did not start treatment|0|||
161844643|NCT01096368|584474590|FG000|Overall Study|Progressive disease|0|||
161844644|NCT01096368|584474591|FG001|Overall Study|Progressive disease|6|||
161844645|NCT01096368|584474592|FG002|Overall Study|Progressive disease|0|||
161844646|NCT01096368|584474593|FG003|Overall Study|Progressive disease|10|||
161844647|NCT01096368|584474594|FG004|Overall Study|Progressive disease|3|||
161844648|NCT01096368|584474590|FG000|Overall Study|Other|0|||
161844649|NCT01096368|584474591|FG001|Overall Study|Other|0|||
161844650|NCT01096368|584474592|FG002|Overall Study|Other|1|||
161844651|NCT01096368|584474593|FG003|Overall Study|Other|0|||
161844652|NCT01096368|584474594|FG004|Overall Study|Other|0|||
161844653|NCT01096368|584474590|FG000|Overall Study|Treated with institutional review|0|||
161844654|NCT01096368|584474591|FG001|Overall Study|Treated with institutional review|0|||
161844655|NCT01096368|584474592|FG002|Overall Study|Treated with institutional review|0|||
161844656|NCT01096368|584474593|FG003|Overall Study|Treated with institutional review|0|||
161844657|NCT01096368|584474594|FG004|Overall Study|Treated with institutional review|1|||
161844658|NCT01568320|584474596|FG000|Overall Study|Death|20|||
161844659|NCT01568320|584474596|FG000|Overall Study|Lost to Follow-up|9|||
161844660|NCT01568320|584474596|FG000|Overall Study|Withdrawal by Subject|10|||
161844661|NCT01568320|584474596|FG000|Overall Study|Conversion to open repair|1|||
161844662|NCT01568320|584474596|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
161844663|NCT03233230|584474597|FG000|Overall Study|Adverse Event|6|||
161844664|NCT03233230|584474598|FG001|Overall Study|Adverse Event|3|||
161844665|NCT03233230|584474599|FG002|Overall Study|Adverse Event|6|||
161844666|NCT03233230|584474600|FG003|Overall Study|Adverse Event|3|||
161844667|NCT03233230|584474597|FG000|Overall Study|Protocol Violation|1|||
161844668|NCT03233230|584474598|FG001|Overall Study|Protocol Violation|2|||
161844669|NCT03233230|584474599|FG002|Overall Study|Protocol Violation|1|||
161844670|NCT03233230|584474600|FG003|Overall Study|Protocol Violation|1|||
161844671|NCT03233230|584474597|FG000|Overall Study|Lack of Efficacy|1|||
161844672|NCT03233230|584474598|FG001|Overall Study|Lack of Efficacy|0|||
161844673|NCT03233230|584474599|FG002|Overall Study|Lack of Efficacy|0|||
161844674|NCT03233230|584474600|FG003|Overall Study|Lack of Efficacy|0|||
161844675|NCT03233230|584474597|FG000|Overall Study|Other|5|||
161844676|NCT03233230|584474598|FG001|Overall Study|Other|5|||
161844677|NCT03233230|584474599|FG002|Overall Study|Other|5|||
161844678|NCT03233230|584474600|FG003|Overall Study|Other|3|||
161844679|NCT03233230|584474597|FG000|Overall Study|Withdrawal by Subject|2|||
161844680|NCT03233230|584474598|FG001|Overall Study|Withdrawal by Subject|2|||
161844681|NCT03233230|584474599|FG002|Overall Study|Withdrawal by Subject|0|||
161844682|NCT03233230|584474600|FG003|Overall Study|Withdrawal by Subject|1|||
161844683|NCT03233230|584474597|FG000|Overall Study|Lost to Follow-up|0|||
161844684|NCT03233230|584474598|FG001|Overall Study|Lost to Follow-up|3|||
161844685|NCT03233230|584474599|FG002|Overall Study|Lost to Follow-up|0|||
161844686|NCT03233230|584474600|FG003|Overall Study|Lost to Follow-up|0|||
161844687|NCT04159935|584474601|FG000|Overall Study|Study terminated due to COVID-19|1|||
161844688|NCT04159935|584474602|FG001|Overall Study|Study terminated due to COVID-19|3|||
161844689|NCT00587990|584474607|FG000|Overall Study|Death|0|||
161844690|NCT00587990|584474608|FG001|Overall Study|Death|0|||
161844691|NCT00587990|584474609|FG002|Overall Study|Death|1|||
161844692|NCT00206323|584474610|FG000|Overall Study|Lack of Efficacy|4|||
161844693|NCT00206323|584474611|FG001|Overall Study|Lack of Efficacy|1|||
161844694|NCT00206323|584474610|FG000|Overall Study|Adverse Event|1|||
161844695|NCT00206323|584474611|FG001|Overall Study|Adverse Event|1|||
161844696|NCT00206323|584474610|FG000|Overall Study|Lost to Follow-up|1|||
161844697|NCT00206323|584474611|FG001|Overall Study|Lost to Follow-up|1|||
161844698|NCT02910063|584474612|FG000|Phase 2|Withdrawal by Subject|3|||
161844699|NCT02910063|584474613|FG001|Phase 2|Withdrawal by Subject|0|||
161844700|NCT02910063|584474614|FG002|Phase 2|Withdrawal by Subject|0|||
161844701|NCT02910063|584474612|FG000|Phase 2|Lost to Follow-up|1|||
161844702|NCT02910063|584474613|FG001|Phase 2|Lost to Follow-up|0|||
161844703|NCT02910063|584474614|FG002|Phase 2|Lost to Follow-up|0|||
161844704|NCT02910063|584474612|FG000|Phase 2|Death|24|||
161844705|NCT02910063|584474613|FG001|Phase 2|Death|0|||
161844706|NCT02910063|584474614|FG002|Phase 2|Death|0|||
161844707|NCT03334617|584474617|FG000|Overall Study|Adverse Event|0|||
161844708|NCT03334617|584474618|FG001|Overall Study|Adverse Event|0|||
161844709|NCT03334617|584474619|FG002|Overall Study|Adverse Event|0|||
161844710|NCT03334617|584474620|FG003|Overall Study|Adverse Event|0|||
161844711|NCT03334617|584474621|FG004|Overall Study|Adverse Event|0|||
161844712|NCT03334617|584474622|FG005|Overall Study|Adverse Event|0|||
161844713|NCT03334617|584474623|FG006|Overall Study|Adverse Event|0|||
161844714|NCT03334617|584474624|FG007|Overall Study|Adverse Event|0|||
161844715|NCT03334617|584474625|FG008|Overall Study|Adverse Event|1|||
161751543|NCT04507360|584130877|FG004|Week 4|Lost to Follow-up|0|||
161751544|NCT04507360|584130878|FG005|Week 4|Lost to Follow-up|0|||
161751545|NCT04507360|584130879|FG006|Week 4|Lost to Follow-up|0|||
161751546|NCT04507360|584130880|FG007|Week 4|Lost to Follow-up|0|||
161751547|NCT04507360|584130881|FG008|Week 4|Lost to Follow-up|131|||
161751548|NCT04507360|584130882|FG009|Week 4|Lost to Follow-up|115|||
161844716|NCT03334617|584474626|FG009|Overall Study|Adverse Event|0|||
161844717|NCT03334617|584474627|FG010|Overall Study|Adverse Event|0|||
161844718|NCT03334617|584474628|FG011|Overall Study|Adverse Event|0|||
161844719|NCT03334617|584474629|FG012|Overall Study|Adverse Event|1|||
161844720|NCT03334617|584474630|FG013|Overall Study|Adverse Event|0|||
161844721|NCT03334617|584474631|FG014|Overall Study|Adverse Event|0|||
161751549|NCT04507360|584130883|FG010|Week 4|Lost to Follow-up|102|||
161751550|NCT04507360|584130873|FG000|Week 5|Lost to Follow-up|0|||
161751551|NCT04507360|584130874|FG001|Week 5|Lost to Follow-up|0|||
161751552|NCT04507360|584130875|FG002|Week 5|Lost to Follow-up|0|||
161751553|NCT04507360|584130876|FG003|Week 5|Lost to Follow-up|0|||
161751554|NCT04507360|584130877|FG004|Week 5|Lost to Follow-up|0|||
161751555|NCT04507360|584130878|FG005|Week 5|Lost to Follow-up|0|||
161751556|NCT04507360|584130879|FG006|Week 5|Lost to Follow-up|0|||
161751557|NCT04507360|584130880|FG007|Week 5|Lost to Follow-up|0|||
161751558|NCT04507360|584130881|FG008|Week 5|Lost to Follow-up|103|||
161751559|NCT04507360|584130882|FG009|Week 5|Lost to Follow-up|135|||
161751560|NCT04507360|584130883|FG010|Week 5|Lost to Follow-up|143|||
161751561|NCT04507360|584130873|FG000|Week 8|Lost to Follow-up|0|||
161844722|NCT03334617|584474632|FG015|Overall Study|Adverse Event|0|||
161844723|NCT03334617|584474633|FG016|Overall Study|Adverse Event|0|||
161844724|NCT03334617|584474634|FG017|Overall Study|Adverse Event|0|||
161844725|NCT03334617|584474635|FG018|Overall Study|Adverse Event|0|||
161844726|NCT03334617|584474636|FG019|Overall Study|Adverse Event|0|||
161844727|NCT03334617|584474637|FG020|Overall Study|Adverse Event|0|||
161844728|NCT03334617|584474638|FG021|Overall Study|Adverse Event|0|||
161751562|NCT04507360|584130874|FG001|Week 8|Lost to Follow-up|0|||
161751563|NCT04507360|584130875|FG002|Week 8|Lost to Follow-up|0|||
161751564|NCT04507360|584130876|FG003|Week 8|Lost to Follow-up|0|||
161751565|NCT04507360|584130877|FG004|Week 8|Lost to Follow-up|0|||
161844729|NCT03334617|584474617|FG000|Overall Study|Death|18|||
161844730|NCT03334617|584474618|FG001|Overall Study|Death|18|||
161844731|NCT03334617|584474619|FG002|Overall Study|Death|20|||
161844732|NCT03334617|584474620|FG003|Overall Study|Death|21|||
161844733|NCT03334617|584474621|FG004|Overall Study|Death|20|||
161844734|NCT03334617|584474622|FG005|Overall Study|Death|16|||
161844735|NCT03334617|584474623|FG006|Overall Study|Death|28|||
161844736|NCT03334617|584474624|FG007|Overall Study|Death|35|||
161844737|NCT03334617|584474625|FG008|Overall Study|Death|47|||
161844738|NCT03334617|584474626|FG009|Overall Study|Death|0|||
161844739|NCT03334617|584474627|FG010|Overall Study|Death|19|||
161844740|NCT03334617|584474628|FG011|Overall Study|Death|6|||
161844741|NCT03334617|584474629|FG012|Overall Study|Death|20|||
161844742|NCT03334617|584474630|FG013|Overall Study|Death|22|||
161844743|NCT03334617|584474631|FG014|Overall Study|Death|17|||
161844744|NCT03334617|584474632|FG015|Overall Study|Death|18|||
161844745|NCT03334617|584474633|FG016|Overall Study|Death|12|||
161844746|NCT03334617|584474634|FG017|Overall Study|Death|15|||
161844747|NCT03334617|584474635|FG018|Overall Study|Death|16|||
161844748|NCT03334617|584474636|FG019|Overall Study|Death|27|||
161844749|NCT03334617|584474637|FG020|Overall Study|Death|14|||
161844750|NCT03334617|584474638|FG021|Overall Study|Death|27|||
161844751|NCT03334617|584474617|FG000|Overall Study|Lost to Follow-up|0|||
161844752|NCT03334617|584474618|FG001|Overall Study|Lost to Follow-up|0|||
161844753|NCT03334617|584474619|FG002|Overall Study|Lost to Follow-up|0|||
161844754|NCT03334617|584474620|FG003|Overall Study|Lost to Follow-up|1|||
161844755|NCT03334617|584474621|FG004|Overall Study|Lost to Follow-up|0|||
161844756|NCT03334617|584474622|FG005|Overall Study|Lost to Follow-up|1|||
161844757|NCT03334617|584474623|FG006|Overall Study|Lost to Follow-up|0|||
161844758|NCT03334617|584474624|FG007|Overall Study|Lost to Follow-up|0|||
161844759|NCT03334617|584474625|FG008|Overall Study|Lost to Follow-up|1|||
161844760|NCT03334617|584474626|FG009|Overall Study|Lost to Follow-up|0|||
161844761|NCT03334617|584474627|FG010|Overall Study|Lost to Follow-up|0|||
161844762|NCT03334617|584474628|FG011|Overall Study|Lost to Follow-up|0|||
161844763|NCT03334617|584474629|FG012|Overall Study|Lost to Follow-up|0|||
161844764|NCT03334617|584474630|FG013|Overall Study|Lost to Follow-up|0|||
161844765|NCT03334617|584474631|FG014|Overall Study|Lost to Follow-up|0|||
161844766|NCT03334617|584474632|FG015|Overall Study|Lost to Follow-up|0|||
161844767|NCT03334617|584474633|FG016|Overall Study|Lost to Follow-up|0|||
161844768|NCT03334617|584474634|FG017|Overall Study|Lost to Follow-up|0|||
161844769|NCT03334617|584474635|FG018|Overall Study|Lost to Follow-up|0|||
161844770|NCT03334617|584474636|FG019|Overall Study|Lost to Follow-up|0|||
161844771|NCT03334617|584474637|FG020|Overall Study|Lost to Follow-up|0|||
161844772|NCT03334617|584474638|FG021|Overall Study|Lost to Follow-up|0|||
161844773|NCT03334617|584474617|FG000|Overall Study|Withdrawal by Subject|0|||
161844774|NCT03334617|584474618|FG001|Overall Study|Withdrawal by Subject|1|||
161844775|NCT03334617|584474619|FG002|Overall Study|Withdrawal by Subject|0|||
161844776|NCT03334617|584474620|FG003|Overall Study|Withdrawal by Subject|0|||
161844777|NCT03334617|584474621|FG004|Overall Study|Withdrawal by Subject|1|||
161844778|NCT03334617|584474622|FG005|Overall Study|Withdrawal by Subject|1|||
161844779|NCT03334617|584474623|FG006|Overall Study|Withdrawal by Subject|1|||
161844780|NCT03334617|584474624|FG007|Overall Study|Withdrawal by Subject|2|||
161844781|NCT03334617|584474625|FG008|Overall Study|Withdrawal by Subject|0|||
161844782|NCT03334617|584474626|FG009|Overall Study|Withdrawal by Subject|0|||
161844783|NCT03334617|584474627|FG010|Overall Study|Withdrawal by Subject|0|||
161844784|NCT03334617|584474628|FG011|Overall Study|Withdrawal by Subject|1|||
161844785|NCT03334617|584474629|FG012|Overall Study|Withdrawal by Subject|1|||
161844786|NCT03334617|584474630|FG013|Overall Study|Withdrawal by Subject|0|||
161844787|NCT03334617|584474631|FG014|Overall Study|Withdrawal by Subject|2|||
161844788|NCT03334617|584474632|FG015|Overall Study|Withdrawal by Subject|1|||
161844789|NCT03334617|584474633|FG016|Overall Study|Withdrawal by Subject|0|||
161844790|NCT03334617|584474634|FG017|Overall Study|Withdrawal by Subject|1|||
161844791|NCT03334617|584474635|FG018|Overall Study|Withdrawal by Subject|1|||
161844792|NCT03334617|584474636|FG019|Overall Study|Withdrawal by Subject|1|||
161844793|NCT03334617|584474637|FG020|Overall Study|Withdrawal by Subject|0|||
161844794|NCT03334617|584474638|FG021|Overall Study|Withdrawal by Subject|1|||
161844795|NCT03334617|584474617|FG000|Overall Study|Other|1|||
161844796|NCT03334617|584474618|FG001|Overall Study|Other|2|||
161844797|NCT03334617|584474619|FG002|Overall Study|Other|0|||
161844798|NCT03334617|584474620|FG003|Overall Study|Other|1|||
161844799|NCT03334617|584474621|FG004|Overall Study|Other|1|||
161844800|NCT03334617|584474622|FG005|Overall Study|Other|0|||
161844801|NCT03334617|584474623|FG006|Overall Study|Other|2|||
161844802|NCT03334617|584474624|FG007|Overall Study|Other|1|||
161844803|NCT03334617|584474625|FG008|Overall Study|Other|8|||
161844804|NCT03334617|584474626|FG009|Overall Study|Other|0|||
161844805|NCT03334617|584474627|FG010|Overall Study|Other|3|||
161844806|NCT03334617|584474628|FG011|Overall Study|Other|1|||
161844807|NCT03334617|584474629|FG012|Overall Study|Other|3|||
161844808|NCT03334617|584474630|FG013|Overall Study|Other|1|||
161844809|NCT03334617|584474631|FG014|Overall Study|Other|1|||
161751566|NCT04507360|584130878|FG005|Week 8|Lost to Follow-up|0|||
161751567|NCT04507360|584130879|FG006|Week 8|Lost to Follow-up|0|||
161751568|NCT04507360|584130880|FG007|Week 8|Lost to Follow-up|0|||
161751569|NCT04507360|584130881|FG008|Week 8|Lost to Follow-up|139|||
161751570|NCT04507360|584130882|FG009|Week 8|Lost to Follow-up|145|||
161751571|NCT04507360|584130883|FG010|Week 8|Lost to Follow-up|152|||
161751572|NCT00400946|584130884|FG000|Overall Study|Ineligible|0|||
161751573|NCT00400946|584130885|FG001|Overall Study|Ineligible|0|||
161751574|NCT00400946|584130886|FG002|Overall Study|Ineligible|0|||
161751575|NCT00400946|584130887|FG003|Overall Study|Ineligible|5|||
161751576|NCT00400946|584130888|FG004|Overall Study|Ineligible|1|||
161751577|NCT00400946|584130884|FG000|Overall Study|Induction Failure|0|||
161751578|NCT00400946|584130885|FG001|Overall Study|Induction Failure|0|||
161751579|NCT00400946|584130886|FG002|Overall Study|Induction Failure|0|||
161751580|NCT00400946|584130887|FG003|Overall Study|Induction Failure|11|||
161751581|NCT00400946|584130888|FG004|Overall Study|Induction Failure|8|||
161751582|NCT00400946|584130884|FG000|Overall Study|Induction Death|0|||
161751583|NCT00400946|584130885|FG001|Overall Study|Induction Death|0|||
161751584|NCT00400946|584130886|FG002|Overall Study|Induction Death|0|||
161751585|NCT00400946|584130887|FG003|Overall Study|Induction Death|13|||
161751586|NCT00400946|584130888|FG004|Overall Study|Induction Death|3|||
161751587|NCT00400946|584130884|FG000|Overall Study|Lost to Follow-up|1|||
161751588|NCT00400946|584130885|FG001|Overall Study|Lost to Follow-up|1|||
161751589|NCT00400946|584130886|FG002|Overall Study|Lost to Follow-up|0|||
161751590|NCT00400946|584130887|FG003|Overall Study|Lost to Follow-up|0|||
161751591|NCT00400946|584130888|FG004|Overall Study|Lost to Follow-up|1|||
161751592|NCT00400946|584130884|FG000|Overall Study|Remission Death|1|||
161751593|NCT00400946|584130885|FG001|Overall Study|Remission Death|1|||
161751594|NCT00400946|584130886|FG002|Overall Study|Remission Death|0|||
161751595|NCT00400946|584130887|FG003|Overall Study|Remission Death|0|||
161751596|NCT00400946|584130888|FG004|Overall Study|Remission Death|1|||
161751597|NCT00400946|584130884|FG000|Overall Study|Relapse|9|||
161751598|NCT00400946|584130885|FG001|Overall Study|Relapse|2|||
161751599|NCT00400946|584130886|FG002|Overall Study|Relapse|1|||
161751600|NCT00400946|584130887|FG003|Overall Study|Relapse|1|||
161751601|NCT00400946|584130888|FG004|Overall Study|Relapse|5|||
161751602|NCT00400946|584130884|FG000|Overall Study|Transplant in CR1|0|||
161751603|NCT00400946|584130885|FG001|Overall Study|Transplant in CR1|0|||
161751604|NCT00400946|584130886|FG002|Overall Study|Transplant in CR1|0|||
161751605|NCT00400946|584130887|FG003|Overall Study|Transplant in CR1|10|||
161751606|NCT00400946|584130888|FG004|Overall Study|Transplant in CR1|1|||
161751607|NCT00400946|584130884|FG000|Overall Study|Withdrawal by Subject|2|||
161751608|NCT00400946|584130885|FG001|Overall Study|Withdrawal by Subject|5|||
161751609|NCT00400946|584130886|FG002|Overall Study|Withdrawal by Subject|1|||
161751610|NCT00400946|584130887|FG003|Overall Study|Withdrawal by Subject|5|||
161751611|NCT00400946|584130888|FG004|Overall Study|Withdrawal by Subject|8|||
161751612|NCT00400946|584130884|FG000|Overall Study|Clinical|1|||
161751613|NCT00400946|584130885|FG001|Overall Study|Clinical|2|||
161751614|NCT00400946|584130886|FG002|Overall Study|Clinical|0|||
161751615|NCT00400946|584130887|FG003|Overall Study|Clinical|2|||
161751616|NCT00400946|584130888|FG004|Overall Study|Clinical|9|||
161751617|NCT00400946|584130884|FG000|Overall Study|Other|0|||
161751618|NCT00400946|584130885|FG001|Overall Study|Other|0|||
161751619|NCT00400946|584130886|FG002|Overall Study|Other|0|||
161751620|NCT00400946|584130887|FG003|Overall Study|Other|0|||
161751621|NCT00400946|584130888|FG004|Overall Study|Other|1|||
161751622|NCT03950440|584130891|FG000|Overall Study|Death|8|||
161751623|NCT03950440|584130892|FG001|Overall Study|Death|2|||
161751624|NCT03950440|584130893|FG002|Overall Study|Death|1|||
161751625|NCT02892734|584130894|FG000|Treatment on Study|Progressive Disease|2|||
161751626|NCT02892734|584130894|FG000|Follow up for 2 Years|Death|2|||
161751627|NCT02892734|584130894|FG000|Follow up for 2 Years|Study closed early|1|||
161751628|NCT00439309|584130895|FG000|Follow-Up|Death|1|||
161751629|NCT00439309|584130896|FG001|Follow-Up|Death|0|||
161751630|NCT00439309|584130895|FG000|Follow-Up|Lost to Follow-up|2|||
161751631|NCT00439309|584130896|FG001|Follow-Up|Lost to Follow-up|0|||
161751632|NCT00439309|584130895|FG000|Follow-Up|Withdrawal by Subject|0|||
161751633|NCT00439309|584130896|FG001|Follow-Up|Withdrawal by Subject|1|||
161751634|NCT00439309|584130895|FG000|Follow-Up|Late response by subject|0|||
161751635|NCT00439309|584130896|FG001|Follow-Up|Late response by subject|1|||
161751636|NCT02043509|584130897|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
161751637|NCT02043509|584130898|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
161751638|NCT02043509|584130897|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
161751639|NCT02043509|584130898|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
161751640|NCT02043509|584130897|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
161751641|NCT02043509|584130898|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
161751642|NCT02043509|584130897|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
161751643|NCT02043509|584130898|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
161751644|NCT00608244|584130903|FG000|Overall Study|Adverse Event|1|||
161751645|NCT00608244|584130903|FG000|Overall Study|Low trough levels|1|||
161751646|NCT00430027|584130904|FG000|Overall Study|Study terminated|8|||
161844810|NCT03334617|584474632|FG015|Overall Study|Other|3|||
161844811|NCT03334617|584474633|FG016|Overall Study|Other|3|||
161844812|NCT03334617|584474634|FG017|Overall Study|Other|3|||
161844813|NCT03334617|584474635|FG018|Overall Study|Other|7|||
161844814|NCT03334617|584474636|FG019|Overall Study|Other|4|||
161844815|NCT03334617|584474637|FG020|Overall Study|Other|1|||
161844816|NCT03334617|584474638|FG021|Overall Study|Other|4|||
161844817|NCT03334617|584474617|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
161844818|NCT03334617|584474618|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
161844819|NCT03334617|584474619|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
161844820|NCT03334617|584474620|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
161844821|NCT03334617|584474621|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
161844822|NCT03334617|584474622|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
161844823|NCT03334617|584474623|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
161844824|NCT03334617|584474624|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
161844825|NCT03334617|584474625|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
161844826|NCT03334617|584474626|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
161844827|NCT03334617|584474627|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
161844828|NCT03334617|584474628|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
161844829|NCT03334617|584474629|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
161844830|NCT03334617|584474630|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
161844831|NCT03334617|584474631|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
161751647|NCT01977040|584130909|FG000|Overall Study|Vasa previa not confirmed|2|||
161751648|NCT01685060|584130910|FG000|Overall Study|Rollover patients|16|||
161751649|NCT01685060|584130910|FG000|Overall Study|Adverse Event|12|||
161751650|NCT01685060|584130910|FG000|Overall Study|Progressive disease|69|||
161751651|NCT01685060|584130910|FG000|Overall Study|Physician Decision|14|||
161751652|NCT01685060|584130910|FG000|Overall Study|Subject/guardian decision|20|||
161751653|NCT01685060|584130910|FG000|Overall Study|Lost to Follow-up|1|||
161751654|NCT01685060|584130910|FG000|Overall Study|Death|8|||
161844832|NCT03334617|584474632|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
161844833|NCT03334617|584474633|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
161844834|NCT03334617|584474634|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
161844835|NCT03334617|584474635|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
161844836|NCT03334617|584474636|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
161844837|NCT03334617|584474637|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
161844838|NCT03334617|584474638|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
161844839|NCT03657342|584474640|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
161844840|NCT03657342|584474641|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
161844841|NCT03657342|584474640|FG000|Overall Study|Withdrawal by Subject|4|||
161844842|NCT03657342|584474641|FG001|Overall Study|Withdrawal by Subject|4|||
161844843|NCT03657342|584474640|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
161844844|NCT03657342|584474641|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
161844845|NCT03657342|584474640|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
161844846|NCT03657342|584474641|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
161844847|NCT00827632|584474642|FG000|Overall Study|Lost to Follow-up|8|||
161844848|NCT00827632|584474643|FG001|Overall Study|Lost to Follow-up|12|||
161844849|NCT00827632|584474642|FG000|Overall Study|Early withdrawal|14|||
161844850|NCT00827632|584474643|FG001|Overall Study|Early withdrawal|11|||
161844851|NCT00407758|584474658|FG000|Overall Study|ineligible -improper prior treatment|1|||
161844852|NCT00750308|584474671|FG000|First Treatment|Adverse Event|0|||
161844853|NCT00750308|584474672|FG001|First Treatment|Adverse Event|1|||
161844854|NCT00750308|584474673|FG002|First Treatment|Adverse Event|0|||
161844855|NCT00750308|584474674|FG003|First Treatment|Adverse Event|0|||
161844856|NCT00750308|584474675|FG004|First Treatment|Adverse Event|0|||
161844857|NCT00750308|584474676|FG005|First Treatment|Adverse Event|0|||
161844858|NCT00750308|584474677|FG006|First Treatment|Adverse Event|0|||
161751655|NCT02443155|584130913|FG000|Overall Study|Adverse Event|3|||
161751656|NCT02443155|584130914|FG001|Overall Study|Adverse Event|4|||
161751657|NCT02443155|584130915|FG002|Overall Study|Adverse Event|1|||
161844859|NCT00750308|584474678|FG007|First Treatment|Adverse Event|0|||
161751658|NCT02443155|584130916|FG003|Overall Study|Adverse Event|2|||
161751659|NCT02443155|584130913|FG000|Overall Study|Unclassified|0|||
161751660|NCT02443155|584130914|FG001|Overall Study|Unclassified|0|||
161751661|NCT02443155|584130915|FG002|Overall Study|Unclassified|2|||
161844860|NCT00750308|584474679|FG008|First Treatment|Adverse Event|0|||
161844861|NCT00750308|584474680|FG009|First Treatment|Adverse Event|0|||
161844862|NCT00750308|584474681|FG010|First Treatment|Adverse Event|1|||
161844863|NCT00750308|584474682|FG011|First Treatment|Adverse Event|1|||
161844864|NCT00750308|584474671|FG000|First Treatment|Withdrawal by Subject|0|||
161844865|NCT00750308|584474672|FG001|First Treatment|Withdrawal by Subject|0|||
161751662|NCT02443155|584130916|FG003|Overall Study|Unclassified|1|||
161751663|NCT02443155|584130913|FG000|Overall Study|Withdrawal by Subject|4|||
161751664|NCT02443155|584130914|FG001|Overall Study|Withdrawal by Subject|7|||
161751665|NCT02443155|584130915|FG002|Overall Study|Withdrawal by Subject|3|||
161751666|NCT02443155|584130916|FG003|Overall Study|Withdrawal by Subject|9|||
161751667|NCT02443155|584130913|FG000|Overall Study|Pregnancy|3|||
161751668|NCT02443155|584130914|FG001|Overall Study|Pregnancy|1|||
161751669|NCT02443155|584130915|FG002|Overall Study|Pregnancy|1|||
161751670|NCT02443155|584130916|FG003|Overall Study|Pregnancy|2|||
161751671|NCT02443155|584130913|FG000|Overall Study|Lost to Follow-up|1|||
161751672|NCT02443155|584130914|FG001|Overall Study|Lost to Follow-up|2|||
161751673|NCT02443155|584130915|FG002|Overall Study|Lost to Follow-up|0|||
161751674|NCT02443155|584130916|FG003|Overall Study|Lost to Follow-up|1|||
161751675|NCT02443155|584130913|FG000|Overall Study|Protocol Violation|1|||
161751676|NCT02443155|584130914|FG001|Overall Study|Protocol Violation|0|||
161751677|NCT02443155|584130915|FG002|Overall Study|Protocol Violation|1|||
161751678|NCT02443155|584130916|FG003|Overall Study|Protocol Violation|1|||
161751679|NCT02443155|584130913|FG000|Overall Study|Death|0|||
161751680|NCT02443155|584130914|FG001|Overall Study|Death|0|||
161751681|NCT02443155|584130915|FG002|Overall Study|Death|1|||
161751682|NCT02443155|584130916|FG003|Overall Study|Death|0|||
161751683|NCT00688623|584130917|FG000|Overall Study|Adverse Event|22|||
161751684|NCT00688623|584130917|FG000|Overall Study|abnormal lab value|1|||
161751685|NCT00688623|584130917|FG000|Overall Study|Withdrawal by Subject|4|||
161751686|NCT00688623|584130917|FG000|Overall Study|Death|3|||
161751687|NCT00688623|584130917|FG000|Overall Study|disease progression|23|||
161751688|NCT00688623|584130917|FG000|Overall Study|Protocol Violation|2|||
161751689|NCT02000219|584130918|FG000|14-Week Study Period|Physician Decision|1|||
161751690|NCT02000219|584130918|FG000|14-Week Study Period|Adverse Event|1|||
161751691|NCT02000219|584130918|FG000|14-Week Study Period|Underwent transplantation|1|||
161751692|NCT02000219|584130918|FG000|Continuation Period|Withdrawal by Subject|1|||
161751693|NCT02000219|584130918|FG000|Continuation Period|Had liver transplant|2|||
161751694|NCT02000219|584130918|FG000|Continuation Period|Non-compliance with study drug|2|||
161751695|NCT00464620|584130919|FG000|Overall Study|Physician Decision|1|||
161751696|NCT00464620|584130920|FG001|Overall Study|Physician Decision|0|||
161751697|NCT00464620|584130921|FG002|Overall Study|Physician Decision|0|||
161751698|NCT00464620|584130919|FG000|Overall Study|Withdrawal by Subject|1|||
161751699|NCT00464620|584130920|FG001|Overall Study|Withdrawal by Subject|0|||
161751700|NCT00464620|584130921|FG002|Overall Study|Withdrawal by Subject|3|||
161751701|NCT00464620|584130919|FG000|Overall Study|Ineligible sarcoma subtype|0|||
161751702|NCT00464620|584130920|FG001|Overall Study|Ineligible sarcoma subtype|2|||
161751703|NCT00464620|584130921|FG002|Overall Study|Ineligible sarcoma subtype|2|||
161751704|NCT00464620|584130919|FG000|Overall Study|Use of prohibited concomitant medication|0|||
161751705|NCT00464620|584130920|FG001|Overall Study|Use of prohibited concomitant medication|0|||
161751706|NCT00464620|584130921|FG002|Overall Study|Use of prohibited concomitant medication|2|||
161751707|NCT01998906|584130922|FG000|Overall Study|Participants ongoing in follow-up|77|||
161751708|NCT01998906|584130923|FG001|Overall Study|Participants ongoing in follow-up|60|||
161751709|NCT01998906|584130924|FG002|Overall Study|Participants ongoing in follow-up|58|||
161751710|NCT01998906|584130922|FG000|Overall Study|Death|21|||
161751711|NCT01998906|584130923|FG001|Overall Study|Death|30|||
161751712|NCT01998906|584130924|FG002|Overall Study|Death|17|||
161751713|NCT01998906|584130922|FG000|Overall Study|Lack of Efficacy|10|||
161844866|NCT00750308|584474673|FG002|First Treatment|Withdrawal by Subject|0|||
161844867|NCT00750308|584474674|FG003|First Treatment|Withdrawal by Subject|1|||
161844868|NCT00750308|584474675|FG004|First Treatment|Withdrawal by Subject|0|||
161844869|NCT00750308|584474676|FG005|First Treatment|Withdrawal by Subject|0|||
161844870|NCT00750308|584474677|FG006|First Treatment|Withdrawal by Subject|0|||
161844871|NCT00750308|584474678|FG007|First Treatment|Withdrawal by Subject|1|||
161844872|NCT00750308|584474679|FG008|First Treatment|Withdrawal by Subject|0|||
161844873|NCT00750308|584474680|FG009|First Treatment|Withdrawal by Subject|0|||
161844874|NCT00750308|584474681|FG010|First Treatment|Withdrawal by Subject|0|||
161844875|NCT00750308|584474682|FG011|First Treatment|Withdrawal by Subject|0|||
161844876|NCT00750308|584474671|FG000|Second Treatment|Adverse Event|0|||
161844877|NCT00750308|584474672|FG001|Second Treatment|Adverse Event|0|||
161844878|NCT00750308|584474673|FG002|Second Treatment|Adverse Event|0|||
161844879|NCT00750308|584474674|FG003|Second Treatment|Adverse Event|0|||
161844880|NCT00750308|584474675|FG004|Second Treatment|Adverse Event|0|||
161844881|NCT00750308|584474676|FG005|Second Treatment|Adverse Event|1|||
161844882|NCT00750308|584474677|FG006|Second Treatment|Adverse Event|0|||
161844883|NCT00750308|584474678|FG007|Second Treatment|Adverse Event|0|||
161844884|NCT00750308|584474679|FG008|Second Treatment|Adverse Event|1|||
161844885|NCT00750308|584474680|FG009|Second Treatment|Adverse Event|0|||
161844886|NCT00750308|584474681|FG010|Second Treatment|Adverse Event|0|||
161844887|NCT00750308|584474682|FG011|Second Treatment|Adverse Event|0|||
161844888|NCT00750308|584474671|FG000|Second Treatment|Withdrawal by Subject|0|||
161844889|NCT00750308|584474672|FG001|Second Treatment|Withdrawal by Subject|0|||
161844890|NCT00750308|584474673|FG002|Second Treatment|Withdrawal by Subject|0|||
161844891|NCT00750308|584474674|FG003|Second Treatment|Withdrawal by Subject|0|||
161844892|NCT00750308|584474675|FG004|Second Treatment|Withdrawal by Subject|1|||
161844893|NCT00750308|584474676|FG005|Second Treatment|Withdrawal by Subject|0|||
161844894|NCT00750308|584474677|FG006|Second Treatment|Withdrawal by Subject|0|||
161844895|NCT00750308|584474678|FG007|Second Treatment|Withdrawal by Subject|0|||
161844896|NCT00750308|584474679|FG008|Second Treatment|Withdrawal by Subject|0|||
161844897|NCT00750308|584474680|FG009|Second Treatment|Withdrawal by Subject|0|||
161844898|NCT00750308|584474681|FG010|Second Treatment|Withdrawal by Subject|0|||
161844899|NCT00750308|584474682|FG011|Second Treatment|Withdrawal by Subject|0|||
161844900|NCT00750308|584474671|FG000|Third Treatment|Withdrawal by Subject|0|||
161844901|NCT00750308|584474672|FG001|Third Treatment|Withdrawal by Subject|1|||
161844902|NCT00750308|584474673|FG002|Third Treatment|Withdrawal by Subject|0|||
161844903|NCT00750308|584474674|FG003|Third Treatment|Withdrawal by Subject|0|||
161844904|NCT00750308|584474675|FG004|Third Treatment|Withdrawal by Subject|0|||
161844905|NCT00750308|584474676|FG005|Third Treatment|Withdrawal by Subject|0|||
161844906|NCT00750308|584474677|FG006|Third Treatment|Withdrawal by Subject|0|||
161844907|NCT00750308|584474678|FG007|Third Treatment|Withdrawal by Subject|0|||
161844908|NCT00750308|584474679|FG008|Third Treatment|Withdrawal by Subject|0|||
161751714|NCT01998906|584130923|FG001|Overall Study|Lack of Efficacy|9|||
161751715|NCT01998906|584130924|FG002|Overall Study|Lack of Efficacy|8|||
161751716|NCT01998906|584130922|FG000|Overall Study|Failure to return|0|||
161751717|NCT01998906|584130923|FG001|Overall Study|Failure to return|2|||
161751718|NCT01998906|584130924|FG002|Overall Study|Failure to return|4|||
161751719|NCT01998906|584130922|FG000|Overall Study|Violation of Selection Criteria|0|||
161751720|NCT01998906|584130923|FG001|Overall Study|Violation of Selection Criteria|0|||
161751721|NCT01998906|584130924|FG002|Overall Study|Violation of Selection Criteria|1|||
161751722|NCT01998906|584130922|FG000|Overall Study|Withdrawal by Subject|1|||
161751723|NCT01998906|584130923|FG001|Overall Study|Withdrawal by Subject|4|||
161751724|NCT01998906|584130924|FG002|Overall Study|Withdrawal by Subject|3|||
161751725|NCT01998906|584130922|FG000|Overall Study|Administrative/Other|2|||
161751726|NCT01998906|584130923|FG001|Overall Study|Administrative/Other|1|||
161751727|NCT01998906|584130924|FG002|Overall Study|Administrative/Other|3|||
161751728|NCT01998906|584130922|FG000|Overall Study|Other|3|||
161751729|NCT01998906|584130923|FG001|Overall Study|Other|8|||
161751730|NCT01998906|584130924|FG002|Overall Study|Other|4|||
161751731|NCT01572844|584130925|FG000|Overall Study|Physician Decision|1|||
161751732|NCT01572844|584130926|FG001|Overall Study|Physician Decision|1|||
161751733|NCT02809118|584130929|FG000|Overall Study|Withdrawal by Subject|0|||
161751734|NCT02809118|584130930|FG001|Overall Study|Withdrawal by Subject|1|||
161751735|NCT02809118|584130931|FG002|Overall Study|Withdrawal by Subject|1|||
161751736|NCT06048809|584130940|FG000|Overall Study|Adverse Event|2|||
161751737|NCT06048809|584130941|FG001|Overall Study|Adverse Event|0|||
161751738|NCT06048809|584130940|FG000|Overall Study|Withdrawal by Subject|1|||
161751739|NCT06048809|584130941|FG001|Overall Study|Withdrawal by Subject|1|||
161751740|NCT02158728|584130942|FG000|Overall Study|no procedure according to CIP done|3|||
161751741|NCT02158728|584130942|FG000|Overall Study|no qualified dataset|24|||
161751742|NCT01156363|584130946|FG000|Overall Study|Adverse Event|6|||
161751743|NCT01156363|584130946|FG000|Overall Study|Insufficient Therapeutic Response|5|||
161751744|NCT01156363|584130946|FG000|Overall Study|Failure to Return|1|||
161751745|NCT01156363|584130946|FG000|Overall Study|Refused Treatment|4|||
161751746|NCT01156363|584130946|FG000|Overall Study|Other|6|||
161751747|NCT03135262|584130947|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
161751748|NCT03135262|584130948|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751749|NCT03135262|584130949|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751750|NCT03135262|584130950|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751751|NCT03135262|584130951|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751752|NCT03135262|584130947|FG000|Overall Study|Progression of disease|0|||
161751753|NCT03135262|584130948|FG001|Overall Study|Progression of disease|0|||
161751754|NCT03135262|584130949|FG002|Overall Study|Progression of disease|0|||
161751755|NCT03135262|584130950|FG003|Overall Study|Progression of disease|1|||
161751756|NCT03135262|584130951|FG004|Overall Study|Progression of disease|0|||
161751757|NCT03135262|584130947|FG000|Overall Study|Death|6|||
161751758|NCT03135262|584130948|FG001|Overall Study|Death|2|||
161751759|NCT03135262|584130949|FG002|Overall Study|Death|2|||
161751760|NCT03135262|584130950|FG003|Overall Study|Death|2|||
161751761|NCT03135262|584130951|FG004|Overall Study|Death|0|||
161751762|NCT03135262|584130947|FG000|Overall Study|Withdrawal by Subject|0|||
161751763|NCT03135262|584130948|FG001|Overall Study|Withdrawal by Subject|0|||
161751764|NCT03135262|584130949|FG002|Overall Study|Withdrawal by Subject|1|||
161751765|NCT03135262|584130950|FG003|Overall Study|Withdrawal by Subject|0|||
161751766|NCT03135262|584130951|FG004|Overall Study|Withdrawal by Subject|1|||
161751767|NCT03135262|584130947|FG000|Overall Study|Study terminated by sponsor|2|||
161751768|NCT03135262|584130948|FG001|Overall Study|Study terminated by sponsor|4|||
161751769|NCT03135262|584130949|FG002|Overall Study|Study terminated by sponsor|4|||
161751770|NCT03135262|584130950|FG003|Overall Study|Study terminated by sponsor|3|||
161751771|NCT03135262|584130951|FG004|Overall Study|Study terminated by sponsor|0|||
161751772|NCT03745989|584130953|FG000|Overall Study|Death|3|||
161751773|NCT03745989|584130954|FG001|Overall Study|Death|7|||
161751774|NCT03745989|584130955|FG002|Overall Study|Death|4|||
161751775|NCT03745989|584130953|FG000|Overall Study|Lost to Follow-up|0|||
161751776|NCT03745989|584130954|FG001|Overall Study|Lost to Follow-up|2|||
161751777|NCT03745989|584130955|FG002|Overall Study|Lost to Follow-up|0|||
161751778|NCT03745989|584130953|FG000|Overall Study|Sponsor Decision|0|||
161751779|NCT03745989|584130954|FG001|Overall Study|Sponsor Decision|2|||
161751780|NCT03745989|584130955|FG002|Overall Study|Sponsor Decision|8|||
161751781|NCT03745989|584130953|FG000|Overall Study|Withdrawal by Subject|0|||
161751782|NCT03745989|584130954|FG001|Overall Study|Withdrawal by Subject|1|||
161751783|NCT03745989|584130955|FG002|Overall Study|Withdrawal by Subject|3|||
161751784|NCT02728206|584130957|FG000|Overall Study|Death|1|||
161751785|NCT00735072|584130962|FG000|Overall Study|interrupted study med during ARV change|1|||
161751786|NCT00735072|584130963|FG001|Overall Study|interrupted study med during ARV change|0|||
161751787|NCT00735072|584130962|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
161751788|NCT00735072|584130963|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
161751789|NCT00911144|584130964|FG000|Overall Study|Withdrawal by Subject|16|||
161751790|NCT00911144|584130965|FG001|Overall Study|Withdrawal by Subject|5|||
161751791|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
161751792|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
161751793|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
161751794|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
161751795|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
161751796|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
161751797|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
161751798|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
161751799|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
161751800|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
161751801|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
161751802|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
161751803|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
161751804|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
161751805|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
161751806|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
161751807|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Death|1|||
161751808|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Death|0|||
161751809|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
161751810|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
161751811|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
161751812|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
161751813|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
161751814|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
161751815|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
161751816|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
161751817|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
161751818|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
161751819|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
161751820|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
161751821|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
161751822|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
161751823|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
161751824|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
161751825|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Death|1|||
161751826|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Death|0|||
161844909|NCT00750308|584474680|FG009|Third Treatment|Withdrawal by Subject|0|||
161844910|NCT00750308|584474681|FG010|Third Treatment|Withdrawal by Subject|0|||
161844911|NCT00750308|584474682|FG011|Third Treatment|Withdrawal by Subject|0|||
161751827|NCT00047008|584130970|FG000|Overall Study|Withdrawn consent|2|||
161751828|NCT00047008|584130971|FG001|Overall Study|Withdrawn consent|3|||
161751829|NCT00047008|584130970|FG000|Overall Study|Ineligible|9|||
161751830|NCT00047008|584130971|FG001|Overall Study|Ineligible|8|||
161751831|NCT00429572|584130972|FG000|Overall Study|Disease progression|1|||
161751832|NCT02773368|584130973|FG000|Overall Study|Lost to Follow-up|4|||
161751833|NCT02773368|584130974|FG001|Overall Study|Lost to Follow-up|1|||
161751834|NCT02773368|584130973|FG000|Overall Study|Withdrawal by Subject|5|||
161751835|NCT02773368|584130974|FG001|Overall Study|Withdrawal by Subject|1|||
161751836|NCT02773368|584130973|FG000|Overall Study|Unclassified|1|||
161751837|NCT02773368|584130974|FG001|Overall Study|Unclassified|1|||
161751838|NCT02773368|584130973|FG000|Overall Study|Missing|0|||
161751839|NCT02773368|584130974|FG001|Overall Study|Missing|1|||
161751840|NCT01929018|584130979|FG000|Overall Study|Lost to Follow-up|1|||
161751841|NCT01929018|584130980|FG001|Overall Study|Lost to Follow-up|0|||
161751842|NCT01929018|584130979|FG000|Overall Study|Hospitalization|0|||
161751843|NCT01929018|584130980|FG001|Overall Study|Hospitalization|1|||
161751844|NCT01047436|584130984|FG000|Overall Study|Protocol Violation|1|||
161751845|NCT01047436|584130985|FG001|Overall Study|Protocol Violation|0|||
161751846|NCT02635867|584130988|FG000|Overall Study|Lost to Follow-up|4|||
161751847|NCT02635867|584130989|FG001|Overall Study|Lost to Follow-up|3|||
161751848|NCT02635867|584130990|FG002|Overall Study|Lost to Follow-up|3|||
161751849|NCT02635867|584130991|FG003|Overall Study|Lost to Follow-up|4|||
161751850|NCT02635867|584130992|FG004|Overall Study|Lost to Follow-up|1|||
161751851|NCT02565576|584130995|FG000|Overall Study|abnormal lab value|2|||
161751852|NCT02565576|584130996|FG001|Overall Study|abnormal lab value|0|||
161751853|NCT02565576|584130995|FG000|Overall Study|subject / guardian decision|1|||
161751854|NCT02565576|584130996|FG001|Overall Study|subject / guardian decision|3|||
161751855|NCT02565576|584130995|FG000|Overall Study|Lost to Follow-up|1|||
161751856|NCT02565576|584130996|FG001|Overall Study|Lost to Follow-up|0|||
161751857|NCT02565576|584130995|FG000|Overall Study|Death|0|||
161751858|NCT02565576|584130996|FG001|Overall Study|Death|2|||
161751859|NCT02565576|584130995|FG000|Overall Study|Adverse Event|1|||
161751860|NCT02565576|584130996|FG001|Overall Study|Adverse Event|0|||
161751861|NCT00282568|584130997|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
161751862|NCT00282568|584130997|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
161751863|NCT00282568|584130997|FG000|Extended Treatment Period|Adverse Event|17|||
161751864|NCT00282568|584130997|FG000|Extended Treatment Period|Non-compliance|4|||
161751865|NCT00282568|584130997|FG000|Extended Treatment Period|Physician Decision|1|||
161751866|NCT00282568|584130997|FG000|Extended Treatment Period|Lost to Follow-up|2|||
161751867|NCT01266070|584130998|FG000|Overall Study|Adverse Event|3|||
161751868|NCT01266070|584130998|FG000|Overall Study|Protocol Violation|1|||
161751869|NCT00939341|584130999|FG000|Overall Study|Adverse Event|15|||
161751870|NCT00939341|584130999|FG000|Overall Study|Pregnancy|1|||
161751871|NCT00939341|584130999|FG000|Overall Study|Lost to Follow-up|23|||
161751872|NCT00939341|584130999|FG000|Overall Study|Withdrawal by Subject|13|||
161751873|NCT00939341|584130999|FG000|Overall Study|Protocol Violation|6|||
161751874|NCT00939341|584130999|FG000|Overall Study|Incorrect enrolment|8|||
161751875|NCT01408732|584131000|FG000|Overall Study|Withdrawal by Subject|2|||
161751876|NCT01408732|584131001|FG001|Overall Study|Withdrawal by Subject|2|||
161751877|NCT00764322|584131003|FG000|Overall Study|Withdrawal by Subject|11|||
161751878|NCT00764322|584131003|FG000|Overall Study|No CYP2D6 genotyping|9|||
161751879|NCT00796003|584131004|FG000|Overall Study|Disease Progression|2|||
161751880|NCT00796003|584131005|FG001|Overall Study|Disease Progression|13|||
161751881|NCT00796003|584131004|FG000|Overall Study|Adverse Event|1|||
161751882|NCT00796003|584131005|FG001|Overall Study|Adverse Event|7|||
161751883|NCT00796003|584131004|FG000|Overall Study|Specified organ function not met|0|||
161751884|NCT00796003|584131005|FG001|Overall Study|Specified organ function not met|1|||
161751885|NCT00796003|584131004|FG000|Overall Study|Physician Decision|0|||
161751886|NCT00796003|584131005|FG001|Overall Study|Physician Decision|4|||
161751887|NCT00796003|584131004|FG000|Overall Study|Withdrawal by Subject|0|||
161751888|NCT00796003|584131005|FG001|Overall Study|Withdrawal by Subject|1|||
161751889|NCT00796003|584131004|FG000|Overall Study|Other|0|||
161751890|NCT00796003|584131005|FG001|Overall Study|Other|1|||
161751891|NCT00796003|584131004|FG000|Overall Study|Participants Not treated|0|||
161751892|NCT00796003|584131005|FG001|Overall Study|Participants Not treated|2|||
161751893|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161751894|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161751895|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161751896|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
161751897|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
161751898|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
161751899|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
161751900|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
161751901|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
161751902|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161751903|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161751904|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161751905|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
161751906|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
161751907|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
161751908|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
161751909|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161751910|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161751911|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161751912|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
161751913|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
161751914|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
161751915|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
161751916|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
161751917|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
161751918|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
161751919|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
161751920|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
161751921|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161751922|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
161751923|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161751924|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161751925|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
161751926|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161751927|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161751928|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161751929|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
161751930|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
161751931|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
161751932|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
161751933|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
161751934|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
161751935|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
161751936|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
161751937|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
161751938|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
161751939|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
161751940|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
161751941|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
161751942|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161751943|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161751944|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161751945|NCT03447821|584131011|FG000|Overall Study|Withdrawal by Subject|1|||
161751946|NCT03447821|584131012|FG001|Overall Study|Withdrawal by Subject|1|||
161751947|NCT03447821|584131013|FG002|Overall Study|Withdrawal by Subject|0|||
161751948|NCT03447821|584131011|FG000|Overall Study|Lost to Follow-up|0|||
161751949|NCT03447821|584131012|FG001|Overall Study|Lost to Follow-up|0|||
161751950|NCT03447821|584131013|FG002|Overall Study|Lost to Follow-up|1|||
161751951|NCT02977507|584131014|FG000|Overall Study|Protocol Deviation|1|||
161751952|NCT02977507|584131015|FG001|Overall Study|Protocol Deviation|0|||
161751953|NCT02977507|584131014|FG000|Overall Study|Lost to Follow-up|1|||
161751954|NCT02977507|584131015|FG001|Overall Study|Lost to Follow-up|0|||
161751955|NCT00654420|584131016|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
161751956|NCT00654420|584131017|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
161751957|NCT00654420|584131018|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
161751958|NCT00654420|584131019|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
161751959|NCT00654420|584131016|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
161751960|NCT00654420|584131017|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
161751961|NCT00654420|584131018|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
161751962|NCT00654420|584131019|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
161751963|NCT00654420|584131016|FG000|Phase II|Adverse Event|0|||
161751964|NCT00654420|584131017|FG001|Phase II|Adverse Event|0|||
161751965|NCT00654420|584131018|FG002|Phase II|Adverse Event|3|||
161751966|NCT00654420|584131019|FG003|Phase II|Adverse Event|3|||
161751967|NCT00654420|584131016|FG000|Phase II|Lost to Follow-up|0|||
161844912|NCT02980874|584474683|FG000|Overall Study|Adverse Event|2|||
161751968|NCT00654420|584131017|FG001|Phase II|Lost to Follow-up|0|||
161751969|NCT00654420|584131018|FG002|Phase II|Lost to Follow-up|0|||
161751970|NCT00654420|584131019|FG003|Phase II|Lost to Follow-up|1|||
161751971|NCT00654420|584131016|FG000|Phase II|Physician Decision|0|||
161751972|NCT00654420|584131017|FG001|Phase II|Physician Decision|0|||
161751973|NCT00654420|584131018|FG002|Phase II|Physician Decision|0|||
161751974|NCT00654420|584131019|FG003|Phase II|Physician Decision|4|||
161751975|NCT00654420|584131016|FG000|Phase II|Progressive Disease|0|||
161751976|NCT00654420|584131017|FG001|Phase II|Progressive Disease|0|||
161751977|NCT00654420|584131018|FG002|Phase II|Progressive Disease|29|||
161751978|NCT00654420|584131019|FG003|Phase II|Progressive Disease|29|||
161751979|NCT00654420|584131016|FG000|Phase II|Withdrawal by Subject|0|||
161751980|NCT00654420|584131017|FG001|Phase II|Withdrawal by Subject|0|||
161751981|NCT00654420|584131018|FG002|Phase II|Withdrawal by Subject|4|||
161751982|NCT00654420|584131019|FG003|Phase II|Withdrawal by Subject|1|||
161751983|NCT00654420|584131016|FG000|Phase II|Missing Disposition Record|0|||
161751984|NCT00654420|584131017|FG001|Phase II|Missing Disposition Record|0|||
161751985|NCT00654420|584131018|FG002|Phase II|Missing Disposition Record|1|||
161751986|NCT00654420|584131019|FG003|Phase II|Missing Disposition Record|0|||
161751987|NCT00610207|584131024|FG000|Overall Study|Lost to Follow-up|3|||
161751988|NCT00741260|584131029|FG000|Overall Study|Disease Progression|3|||
161751989|NCT00741260|584131030|FG001|Overall Study|Disease Progression|5|||
161751990|NCT00741260|584131031|FG002|Overall Study|Disease Progression|3|||
161751991|NCT00741260|584131032|FG003|Overall Study|Disease Progression|3|||
161751992|NCT00741260|584131033|FG004|Overall Study|Disease Progression|5|||
161751993|NCT00741260|584131034|FG005|Overall Study|Disease Progression|37|||
161751994|NCT00741260|584131035|FG006|Overall Study|Disease Progression|4|||
161751995|NCT00741260|584131029|FG000|Overall Study|Death|0|||
161751996|NCT00741260|584131030|FG001|Overall Study|Death|1|||
161751997|NCT00741260|584131031|FG002|Overall Study|Death|0|||
161751998|NCT00741260|584131032|FG003|Overall Study|Death|1|||
161751999|NCT00741260|584131033|FG004|Overall Study|Death|2|||
161752000|NCT00741260|584131034|FG005|Overall Study|Death|2|||
161752001|NCT00741260|584131035|FG006|Overall Study|Death|1|||
161752002|NCT00741260|584131029|FG000|Overall Study|Withdrawal by Subject|0|||
161752003|NCT00741260|584131030|FG001|Overall Study|Withdrawal by Subject|0|||
161752004|NCT00741260|584131031|FG002|Overall Study|Withdrawal by Subject|0|||
161752005|NCT00741260|584131032|FG003|Overall Study|Withdrawal by Subject|0|||
161752006|NCT00741260|584131033|FG004|Overall Study|Withdrawal by Subject|1|||
161752007|NCT00741260|584131034|FG005|Overall Study|Withdrawal by Subject|3|||
161752008|NCT00741260|584131035|FG006|Overall Study|Withdrawal by Subject|1|||
161752009|NCT00741260|584131029|FG000|Overall Study|Physician Decision|1|||
161752010|NCT00741260|584131030|FG001|Overall Study|Physician Decision|1|||
161752011|NCT00741260|584131031|FG002|Overall Study|Physician Decision|0|||
161752012|NCT00741260|584131032|FG003|Overall Study|Physician Decision|0|||
161752013|NCT00741260|584131033|FG004|Overall Study|Physician Decision|0|||
161752014|NCT00741260|584131034|FG005|Overall Study|Physician Decision|0|||
161752015|NCT00741260|584131035|FG006|Overall Study|Physician Decision|0|||
161752016|NCT00741260|584131029|FG000|Overall Study|Other|2|||
161752017|NCT00741260|584131030|FG001|Overall Study|Other|1|||
161752018|NCT00741260|584131031|FG002|Overall Study|Other|1|||
161752019|NCT00741260|584131032|FG003|Overall Study|Other|2|||
161752020|NCT00741260|584131033|FG004|Overall Study|Other|1|||
161752021|NCT00741260|584131034|FG005|Overall Study|Other|3|||
161752022|NCT00741260|584131035|FG006|Overall Study|Other|1|||
161752023|NCT01610206|584131036|FG000|Overall Study|Adverse Event|10|||
161752024|NCT01610206|584131037|FG001|Overall Study|Adverse Event|30|||
161752025|NCT00924729|584131038|FG000|Overall Study|insufficient volume for analysis|1|||
161752026|NCT00924729|584131039|FG001|Overall Study|insufficient volume for analysis|0|||
161752027|NCT00924729|584131038|FG000|Overall Study|Protocol Violation|1|||
161752028|NCT00924729|584131039|FG001|Overall Study|Protocol Violation|0|||
161752029|NCT01576406|584131043|FG000|Overall Study|Lost to Follow-up|1|||
161752030|NCT01576406|584131044|FG001|Overall Study|Lost to Follow-up|2|||
161752031|NCT01576406|584131045|FG002|Overall Study|Lost to Follow-up|0|||
161752032|NCT01576406|584131046|FG003|Overall Study|Lost to Follow-up|0|||
161752033|NCT01576406|584131047|FG004|Overall Study|Lost to Follow-up|0|||
161752034|NCT01576406|584131048|FG005|Overall Study|Lost to Follow-up|0|||
161844913|NCT02980874|584474684|FG001|Overall Study|Adverse Event|7|||
161752035|NCT01576406|584131043|FG000|Overall Study|Death|3|||
161752036|NCT01576406|584131044|FG001|Overall Study|Death|4|||
161752037|NCT01576406|584131045|FG002|Overall Study|Death|8|||
161752038|NCT01576406|584131046|FG003|Overall Study|Death|5|||
161752039|NCT01576406|584131047|FG004|Overall Study|Death|7|||
161752040|NCT01576406|584131048|FG005|Overall Study|Death|9|||
161752041|NCT01576406|584131043|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752042|NCT01576406|584131044|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752043|NCT01576406|584131045|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
161752044|NCT01576406|584131046|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
161752045|NCT01576406|584131047|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752046|NCT01576406|584131048|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752047|NCT01576406|584131043|FG000|Overall Study|Withdrawal the consent|2|||
161752048|NCT01576406|584131044|FG001|Overall Study|Withdrawal the consent|2|||
161752049|NCT01576406|584131045|FG002|Overall Study|Withdrawal the consent|5|||
161752050|NCT01576406|584131046|FG003|Overall Study|Withdrawal the consent|1|||
161752051|NCT01576406|584131047|FG004|Overall Study|Withdrawal the consent|1|||
161752052|NCT01576406|584131048|FG005|Overall Study|Withdrawal the consent|3|||
161752053|NCT01576406|584131043|FG000|Overall Study|Other|0|||
161752054|NCT01576406|584131044|FG001|Overall Study|Other|0|||
161752055|NCT01576406|584131045|FG002|Overall Study|Other|2|||
161752056|NCT01576406|584131046|FG003|Overall Study|Other|2|||
161752057|NCT01576406|584131047|FG004|Overall Study|Other|0|||
161752058|NCT01576406|584131048|FG005|Overall Study|Other|0|||
161752059|NCT01627782|584131049|FG000|Overall Study|Adverse Event|1|||
161752060|NCT01627782|584131050|FG001|Overall Study|Adverse Event|2|||
161752061|NCT01627782|584131051|FG002|Overall Study|Adverse Event|0|||
161752062|NCT01627782|584131052|FG003|Overall Study|Adverse Event|1|||
161752063|NCT01627782|584131049|FG000|Overall Study|Lack of Efficacy|11|||
161752064|NCT01627782|584131050|FG001|Overall Study|Lack of Efficacy|1|||
161752065|NCT01627782|584131051|FG002|Overall Study|Lack of Efficacy|15|||
161752066|NCT01627782|584131052|FG003|Overall Study|Lack of Efficacy|2|||
161752067|NCT01627782|584131049|FG000|Overall Study|Protocol Violation|1|||
161752068|NCT01627782|584131050|FG001|Overall Study|Protocol Violation|0|||
161752069|NCT01627782|584131051|FG002|Overall Study|Protocol Violation|0|||
161752070|NCT01627782|584131052|FG003|Overall Study|Protocol Violation|0|||
161752071|NCT01627782|584131049|FG000|Overall Study|Withdrawal by Subject|2|||
161752072|NCT01627782|584131050|FG001|Overall Study|Withdrawal by Subject|1|||
161752073|NCT01627782|584131051|FG002|Overall Study|Withdrawal by Subject|0|||
161752074|NCT01627782|584131052|FG003|Overall Study|Withdrawal by Subject|0|||
161752075|NCT01627782|584131049|FG000|Overall Study|Other|0|||
161752076|NCT01627782|584131050|FG001|Overall Study|Other|2|||
161752077|NCT01627782|584131051|FG002|Overall Study|Other|0|||
161752078|NCT01627782|584131052|FG003|Overall Study|Other|3|||
161752079|NCT01627782|584131049|FG000|Overall Study|Randomized But Not Treated|1|||
161752080|NCT01627782|584131050|FG001|Overall Study|Randomized But Not Treated|0|||
161752081|NCT01627782|584131051|FG002|Overall Study|Randomized But Not Treated|0|||
161752082|NCT01627782|584131052|FG003|Overall Study|Randomized But Not Treated|0|||
161752083|NCT01004159|584133129|FG000|Overall Study|Adverse Event|2|||
161752084|NCT01004159|584133129|FG000|Overall Study|Disease Progression|18|||
161752085|NCT01199198|584133135|FG000|Overall Study|Adverse Event|3|||
161752086|NCT01199198|584133136|FG001|Overall Study|Adverse Event|0|||
161752087|NCT01199198|584133135|FG000|Overall Study|Lost to Follow-up|1|||
161752088|NCT01199198|584133136|FG001|Overall Study|Lost to Follow-up|5|||
161752089|NCT01199198|584133135|FG000|Overall Study|Withdrawal by Subject|1|||
161752090|NCT01199198|584133136|FG001|Overall Study|Withdrawal by Subject|2|||
161752091|NCT01199198|584133135|FG000|Overall Study|ICU Transfer|1|||
161752092|NCT01199198|584133136|FG001|Overall Study|ICU Transfer|2|||
161752093|NCT01199198|584133135|FG000|Overall Study|Hospice-care transfer|1|||
161752094|NCT01199198|584133136|FG001|Overall Study|Hospice-care transfer|2|||
161752095|NCT04315298|584133137|FG000|Overall Study|Withdrawal by Subject|0|||
161752096|NCT04315298|584133138|FG001|Overall Study|Withdrawal by Subject|0|||
161752097|NCT04315298|584133139|FG002|Overall Study|Withdrawal by Subject|0|||
161752098|NCT04315298|584133140|FG003|Overall Study|Withdrawal by Subject|2|||
161752099|NCT04315298|584133141|FG004|Overall Study|Withdrawal by Subject|2|||
161752100|NCT04315298|584133142|FG005|Overall Study|Withdrawal by Subject|2|||
161752101|NCT04315298|584133143|FG006|Overall Study|Withdrawal by Subject|0|||
161752102|NCT04315298|584133144|FG007|Overall Study|Withdrawal by Subject|1|||
161752103|NCT04315298|584133145|FG008|Overall Study|Withdrawal by Subject|1|||
161752104|NCT04315298|584133146|FG009|Overall Study|Withdrawal by Subject|1|||
161752105|NCT04315298|584133147|FG010|Overall Study|Withdrawal by Subject|0|||
161752106|NCT04315298|584133148|FG011|Overall Study|Withdrawal by Subject|0|||
161752107|NCT04315298|584133149|FG012|Overall Study|Withdrawal by Subject|0|||
161752108|NCT04315298|584133150|FG013|Overall Study|Withdrawal by Subject|0|||
161752109|NCT04315298|584133151|FG014|Overall Study|Withdrawal by Subject|0|||
161752110|NCT04315298|584133152|FG015|Overall Study|Withdrawal by Subject|0|||
161752111|NCT04315298|584133153|FG016|Overall Study|Withdrawal by Subject|0|||
161752112|NCT04315298|584133154|FG017|Overall Study|Withdrawal by Subject|0|||
161752113|NCT04315298|584133155|FG018|Overall Study|Withdrawal by Subject|0|||
161752114|NCT04315298|584133137|FG000|Overall Study|Physician Decision|0|||
161752115|NCT04315298|584133138|FG001|Overall Study|Physician Decision|0|||
161752116|NCT04315298|584133139|FG002|Overall Study|Physician Decision|0|||
161752117|NCT04315298|584133140|FG003|Overall Study|Physician Decision|0|||
161752118|NCT04315298|584133141|FG004|Overall Study|Physician Decision|1|||
161752119|NCT04315298|584133142|FG005|Overall Study|Physician Decision|0|||
161752120|NCT04315298|584133143|FG006|Overall Study|Physician Decision|0|||
161752121|NCT04315298|584133144|FG007|Overall Study|Physician Decision|0|||
161752122|NCT04315298|584133145|FG008|Overall Study|Physician Decision|0|||
161752123|NCT04315298|584133146|FG009|Overall Study|Physician Decision|0|||
161752124|NCT04315298|584133147|FG010|Overall Study|Physician Decision|0|||
161752125|NCT04315298|584133148|FG011|Overall Study|Physician Decision|0|||
161752126|NCT04315298|584133149|FG012|Overall Study|Physician Decision|0|||
161752127|NCT04315298|584133150|FG013|Overall Study|Physician Decision|0|||
161752128|NCT04315298|584133151|FG014|Overall Study|Physician Decision|0|||
161752129|NCT04315298|584133152|FG015|Overall Study|Physician Decision|0|||
161752130|NCT04315298|584133153|FG016|Overall Study|Physician Decision|0|||
161752131|NCT04315298|584133154|FG017|Overall Study|Physician Decision|0|||
161752132|NCT04315298|584133155|FG018|Overall Study|Physician Decision|0|||
161752133|NCT04315298|584133137|FG000|Overall Study|Lost to Follow-up|5|||
161752134|NCT04315298|584133138|FG001|Overall Study|Lost to Follow-up|10|||
161752135|NCT04315298|584133139|FG002|Overall Study|Lost to Follow-up|6|||
161752136|NCT04315298|584133140|FG003|Overall Study|Lost to Follow-up|8|||
161752137|NCT04315298|584133141|FG004|Overall Study|Lost to Follow-up|12|||
161752138|NCT04315298|584133142|FG005|Overall Study|Lost to Follow-up|13|||
161752139|NCT04315298|584133143|FG006|Overall Study|Lost to Follow-up|9|||
161752140|NCT04315298|584133144|FG007|Overall Study|Lost to Follow-up|16|||
161752141|NCT04315298|584133145|FG008|Overall Study|Lost to Follow-up|14|||
161752142|NCT04315298|584133146|FG009|Overall Study|Lost to Follow-up|0|||
161752143|NCT04315298|584133147|FG010|Overall Study|Lost to Follow-up|2|||
161752144|NCT04315298|584133148|FG011|Overall Study|Lost to Follow-up|1|||
161752145|NCT04315298|584133149|FG012|Overall Study|Lost to Follow-up|0|||
161752146|NCT04315298|584133150|FG013|Overall Study|Lost to Follow-up|0|||
161752147|NCT04315298|584133151|FG014|Overall Study|Lost to Follow-up|0|||
161752148|NCT04315298|584133152|FG015|Overall Study|Lost to Follow-up|2|||
161752149|NCT04315298|584133153|FG016|Overall Study|Lost to Follow-up|0|||
161752150|NCT04315298|584133154|FG017|Overall Study|Lost to Follow-up|0|||
161752151|NCT04315298|584133155|FG018|Overall Study|Lost to Follow-up|0|||
161752152|NCT04315298|584133137|FG000|Overall Study|Death|24|||
161752153|NCT04315298|584133138|FG001|Overall Study|Death|60|||
161752154|NCT04315298|584133139|FG002|Overall Study|Death|49|||
161752155|NCT04315298|584133140|FG003|Overall Study|Death|59|||
161752156|NCT04315298|584133141|FG004|Overall Study|Death|70|||
161752157|NCT04315298|584133142|FG005|Overall Study|Death|114|||
161752158|NCT04315298|584133143|FG006|Overall Study|Death|9|||
161752159|NCT04315298|584133144|FG007|Overall Study|Death|12|||
161752160|NCT04315298|584133145|FG008|Overall Study|Death|21|||
161752161|NCT04315298|584133146|FG009|Overall Study|Death|16|||
161752162|NCT04315298|584133147|FG010|Overall Study|Death|40|||
161752163|NCT04315298|584133148|FG011|Overall Study|Death|40|||
161752164|NCT04315298|584133149|FG012|Overall Study|Death|3|||
161752165|NCT04315298|584133150|FG013|Overall Study|Death|4|||
161752166|NCT04315298|584133151|FG014|Overall Study|Death|6|||
161752167|NCT04315298|584133152|FG015|Overall Study|Death|4|||
161752168|NCT04315298|584133153|FG016|Overall Study|Death|3|||
161752169|NCT04315298|584133154|FG017|Overall Study|Death|1|||
161752170|NCT04315298|584133155|FG018|Overall Study|Death|0|||
161752171|NCT00736385|584133156|FG000|Overall Study|Withdrawal by Subject|2|||
161752172|NCT00736385|584133157|FG001|Overall Study|Withdrawal by Subject|2|||
161752173|NCT00736385|584133156|FG000|Overall Study|Adverse Event|0|||
161752174|NCT00736385|584133157|FG001|Overall Study|Adverse Event|1|||
161752175|NCT00098865|584133158|FG000|Overall Study|Progressive Disease|6|||
161752176|NCT00098865|584133158|FG000|Overall Study|Adverse Event|2|||
161752177|NCT00098865|584133158|FG000|Overall Study|Alternative Therapy|1|||
161752178|NCT03267511|584133159|FG000|Overall Study|Lost to Follow-up|0|||
161752179|NCT03267511|584133160|FG001|Overall Study|Lost to Follow-up|0|||
161752180|NCT03267511|584133161|FG002|Overall Study|Lost to Follow-up|0|||
161752181|NCT03267511|584133162|FG003|Overall Study|Lost to Follow-up|1|||
161752182|NCT03050307|584133165|FG000|Overall Study|Adverse Event|4|||
161752183|NCT03050307|584133166|FG001|Overall Study|Adverse Event|2|||
161752184|NCT03050307|584133165|FG000|Overall Study|Significant Protocol Deviation|0|||
161752185|NCT03050307|584133166|FG001|Overall Study|Significant Protocol Deviation|1|||
161752186|NCT03050307|584133165|FG000|Overall Study|Lost to Follow-up|0|||
161752187|NCT03050307|584133166|FG001|Overall Study|Lost to Follow-up|1|||
161752188|NCT03050307|584133165|FG000|Overall Study|Voluntary Withdrawal|3|||
161752189|NCT03050307|584133166|FG001|Overall Study|Voluntary Withdrawal|4|||
161752190|NCT03050307|584133165|FG000|Overall Study|Reason not Specified|1|||
161752191|NCT03050307|584133166|FG001|Overall Study|Reason not Specified|1|||
161752192|NCT00653068|584133167|FG000|Overall Study|Death|9|||
161752193|NCT00653068|584133167|FG000|Overall Study|Lack of Efficacy|34|||
161752194|NCT00653068|584133167|FG000|Overall Study|Physician Decision|4|||
161752195|NCT00653068|584133167|FG000|Overall Study|Withdrawal by Subject|1|||
161752196|NCT00653068|584133167|FG000|Overall Study|Ineligible|2|||
161752197|NCT02658149|584133186|FG000|Overall Study|Physician Decision|1|||
161752198|NCT02658149|584133187|FG001|Overall Study|Physician Decision|0|||
161752199|NCT01680991|584133190|FG000|Overall Study|Adverse Event|1|||
161752200|NCT01680991|584133191|FG001|Overall Study|Adverse Event|0|||
161752201|NCT01680991|584133192|FG002|Overall Study|Adverse Event|0|||
161752202|NCT01680991|584133190|FG000|Overall Study|Death|1|||
161752203|NCT01680991|584133191|FG001|Overall Study|Death|0|||
161752204|NCT01680991|584133192|FG002|Overall Study|Death|1|||
161752205|NCT01680991|584133190|FG000|Overall Study|Protocol Violation|0|||
161752206|NCT01680991|584133191|FG001|Overall Study|Protocol Violation|1|||
161752207|NCT01680991|584133192|FG002|Overall Study|Protocol Violation|0|||
161752208|NCT01680991|584133190|FG000|Overall Study|Withdrawal by Subject|5|||
161752209|NCT01680991|584133191|FG001|Overall Study|Withdrawal by Subject|1|||
161752210|NCT01680991|584133192|FG002|Overall Study|Withdrawal by Subject|0|||
161752211|NCT01680991|584133190|FG000|Overall Study|Progressive disease (PD)|0|||
161752212|NCT01680991|584133191|FG001|Overall Study|Progressive disease (PD)|10|||
161752213|NCT01680991|584133192|FG002|Overall Study|Progressive disease (PD)|0|||
161752214|NCT01680991|584133190|FG000|Overall Study|Physician Decision|0|||
161752215|NCT01680991|584133191|FG001|Overall Study|Physician Decision|7|||
161752216|NCT01680991|584133192|FG002|Overall Study|Physician Decision|2|||
161752217|NCT01680991|584133190|FG000|Overall Study|Bad physical condition|0|||
161752218|NCT01680991|584133191|FG001|Overall Study|Bad physical condition|0|||
161752219|NCT01680991|584133192|FG002|Overall Study|Bad physical condition|1|||
161752220|NCT01680991|584133190|FG000|Overall Study|PD confirmed in other hospital|1|||
161752221|NCT01680991|584133191|FG001|Overall Study|PD confirmed in other hospital|0|||
161752222|NCT01680991|584133192|FG002|Overall Study|PD confirmed in other hospital|0|||
161752223|NCT04097028|584133193|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
161752224|NCT04097028|584133193|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
161752225|NCT04097028|584133193|FG000|Overall Study|Disease Progression prior to Surgery|2|||
161752226|NCT04097028|584133193|FG000|Overall Study|Adverse Event prior to Surgery|1|||
161752227|NCT02473289|584133194|FG000|Overall Study|Adverse Event|2|||
161752228|NCT02473289|584133195|FG001|Overall Study|Adverse Event|3|||
161752229|NCT02473289|584133194|FG000|Overall Study|Lost to Follow-up|1|||
161752230|NCT02473289|584133195|FG001|Overall Study|Lost to Follow-up|1|||
161752231|NCT02473289|584133194|FG000|Overall Study|Protocol Violation|0|||
161752232|NCT02473289|584133195|FG001|Overall Study|Protocol Violation|1|||
161752233|NCT02473289|584133194|FG000|Overall Study|Withdrawal of consent|6|||
161752234|NCT02473289|584133195|FG001|Overall Study|Withdrawal of consent|7|||
161752235|NCT02473289|584133194|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
161752236|NCT02473289|584133195|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
161752237|NCT02473289|584133194|FG000|Overall Study|Other|2|||
161752238|NCT02473289|584133195|FG001|Overall Study|Other|0|||
161752239|NCT02244619|584133196|FG000|Overall Study|Did not receive study intervention|8|||
161752240|NCT02244619|584133197|FG001|Overall Study|Did not receive study intervention|21|||
161752241|NCT03285490|584133198|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
161752242|NCT03285490|584133199|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
161844914|NCT02980874|584474683|FG000|Overall Study|Withdrawal by Subject|7|||
161752243|NCT03285490|584133198|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
161752244|NCT03285490|584133199|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
161752245|NCT00068822|584133200|FG000|First Randomized Intervention|Lost to Follow-up|1|||
161752246|NCT00068822|584133201|FG001|First Randomized Intervention|Lost to Follow-up|2|||
161752247|NCT00424099|584133202|FG000|Overall Study|Adverse Event|0|||
161752248|NCT00424099|584133203|FG001|Overall Study|Adverse Event|1|||
161752249|NCT00424099|584133204|FG002|Overall Study|Adverse Event|1|||
161752250|NCT00424099|584133205|FG003|Overall Study|Adverse Event|0|||
161752251|NCT00424099|584133202|FG000|Overall Study|Death|0|||
161752252|NCT00424099|584133203|FG001|Overall Study|Death|1|||
161752253|NCT00424099|584133204|FG002|Overall Study|Death|0|||
161752254|NCT00424099|584133205|FG003|Overall Study|Death|0|||
161752255|NCT00424099|584133202|FG000|Overall Study|Illness|2|||
161752256|NCT00424099|584133203|FG001|Overall Study|Illness|0|||
161752257|NCT00424099|584133204|FG002|Overall Study|Illness|1|||
161752258|NCT00424099|584133205|FG003|Overall Study|Illness|4|||
161752259|NCT00424099|584133202|FG000|Overall Study|Lost to Follow-up|0|||
161752260|NCT00424099|584133203|FG001|Overall Study|Lost to Follow-up|0|||
161752261|NCT00424099|584133204|FG002|Overall Study|Lost to Follow-up|3|||
161752262|NCT00424099|584133205|FG003|Overall Study|Lost to Follow-up|0|||
161752263|NCT00424099|584133202|FG000|Overall Study|Hospitalized|1|||
161752264|NCT00424099|584133203|FG001|Overall Study|Hospitalized|2|||
161752265|NCT00424099|584133204|FG002|Overall Study|Hospitalized|1|||
161752266|NCT00424099|584133205|FG003|Overall Study|Hospitalized|3|||
161752267|NCT00424099|584133202|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
161752268|NCT00424099|584133203|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
161752269|NCT00424099|584133204|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
161752270|NCT00424099|584133205|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
161752271|NCT00424099|584133202|FG000|Overall Study|Withdrawal by Subject|1|||
161752272|NCT00424099|584133203|FG001|Overall Study|Withdrawal by Subject|9|||
161752273|NCT00424099|584133204|FG002|Overall Study|Withdrawal by Subject|4|||
161752274|NCT00424099|584133205|FG003|Overall Study|Withdrawal by Subject|6|||
161752275|NCT00424099|584133202|FG000|Overall Study|Physician Decision|0|||
161752276|NCT00424099|584133203|FG001|Overall Study|Physician Decision|0|||
161752277|NCT00424099|584133204|FG002|Overall Study|Physician Decision|1|||
161752278|NCT00424099|584133205|FG003|Overall Study|Physician Decision|0|||
161752279|NCT00424099|584133202|FG000|Overall Study|Missing|0|||
161752280|NCT00424099|584133203|FG001|Overall Study|Missing|0|||
161752281|NCT00424099|584133204|FG002|Overall Study|Missing|1|||
161752282|NCT00424099|584133205|FG003|Overall Study|Missing|0|||
161752283|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
161752284|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
161752285|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161752286|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161752287|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161752288|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752289|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
161752290|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752291|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752292|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752293|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752294|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
161752295|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752296|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752297|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752298|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
161752299|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
161752300|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161752301|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161752302|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161844915|NCT02980874|584474684|FG001|Overall Study|Withdrawal by Subject|2|||
161752303|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
161752304|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
161844916|NCT02980874|584474683|FG000|Overall Study|Lost to Follow-up|5|||
161752305|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161752306|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161752307|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161752308|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
161752309|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
161752310|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161752311|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161752312|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161752313|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
161752314|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
161752315|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161752316|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161752317|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161752318|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
161752319|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
161752320|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161752321|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161752322|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161752323|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
161752324|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
161752325|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161752326|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161752327|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161752328|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
161752329|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
161752330|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161752331|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161752332|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161752333|NCT03689972|584133206|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752334|NCT03689972|584133207|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752335|NCT03689972|584133208|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
161752336|NCT03689972|584133209|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752337|NCT03689972|584133210|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752338|NCT03689972|584133206|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752339|NCT03689972|584133207|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752340|NCT03689972|584133208|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
161752341|NCT03689972|584133209|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752342|NCT03689972|584133210|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752343|NCT03689972|584133206|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752344|NCT03689972|584133207|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752345|NCT03689972|584133208|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
161752346|NCT03689972|584133209|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752347|NCT03689972|584133210|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752348|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161752349|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161752350|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161752351|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
161752352|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
161752353|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161752354|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161752355|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161752356|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
161752357|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
161752358|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161752359|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161752360|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161752361|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
161752362|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
161752363|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752364|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752365|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752366|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752367|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
161752368|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161752369|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161752370|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161752371|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
161752372|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
161752373|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752374|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752375|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752376|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752377|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
161752378|NCT01131130|584133212|FG000|Period 1 - Baseline|Pregnancy|1|||
161752379|NCT01131130|584133212|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
161752380|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
161752381|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
161752382|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
161752383|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161752384|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161752385|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
161752386|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161752387|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
161752388|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161752389|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
161752390|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161752391|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161752392|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161752393|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
161752394|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161752395|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
161752396|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
161752397|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
161752398|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
161752399|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
161752400|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
161752401|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
161752402|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
161752403|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
161752404|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
161752405|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
161752406|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
161752407|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
161752408|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
161752409|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
161752410|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Other|2|||
161752411|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Other|2|||
161752412|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Other|3|||
161752413|NCT02437162|584133220|FG000|Overall Study|Protocol Violation|0|||
161752414|NCT02437162|584133221|FG001|Overall Study|Protocol Violation|1|||
161752415|NCT02437162|584133222|FG002|Overall Study|Protocol Violation|0|||
161752416|NCT02437162|584133220|FG000|Overall Study|Randomized but not treated|0|||
161752417|NCT02437162|584133221|FG001|Overall Study|Randomized but not treated|0|||
161752418|NCT02437162|584133222|FG002|Overall Study|Randomized but not treated|1|||
161752419|NCT02437162|584133220|FG000|Overall Study|Study discontinued by Sponsor|93|||
161752420|NCT02437162|584133221|FG001|Overall Study|Study discontinued by Sponsor|98|||
161752421|NCT02437162|584133222|FG002|Overall Study|Study discontinued by Sponsor|97|||
161752422|NCT02437162|584133220|FG000|Overall Study|Withdrawal by Subject|13|||
161752423|NCT02437162|584133221|FG001|Overall Study|Withdrawal by Subject|7|||
161752424|NCT02437162|584133222|FG002|Overall Study|Withdrawal by Subject|9|||
161752425|NCT02437162|584133220|FG000|Overall Study|Adverse Event|0|||
161752426|NCT02437162|584133221|FG001|Overall Study|Adverse Event|1|||
161752427|NCT02437162|584133222|FG002|Overall Study|Adverse Event|0|||
161752428|NCT02437162|584133220|FG000|Overall Study|Lost to Follow-up|1|||
161752429|NCT02437162|584133221|FG001|Overall Study|Lost to Follow-up|0|||
161752430|NCT02437162|584133222|FG002|Overall Study|Lost to Follow-up|1|||
161752431|NCT02437162|584133220|FG000|Overall Study|Death|0|||
161752432|NCT02437162|584133221|FG001|Overall Study|Death|1|||
161752433|NCT02437162|584133222|FG002|Overall Study|Death|0|||
161752434|NCT02437162|584133220|FG000|Overall Study|Other|0|||
161752435|NCT02437162|584133221|FG001|Overall Study|Other|0|||
161752436|NCT02437162|584133222|FG002|Overall Study|Other|1|||
161752437|NCT03981744|584133223|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161752438|NCT03981744|584133224|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
161752439|NCT03981744|584133225|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161752440|NCT03981744|584133226|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161752441|NCT03981744|584133223|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161752442|NCT03981744|584133224|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161752443|NCT03981744|584133225|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
161752444|NCT03981744|584133226|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161752445|NCT03981744|584133223|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161752446|NCT03981744|584133224|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161752447|NCT03981744|584133225|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
161752448|NCT03981744|584133226|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161752449|NCT04338321|584133227|FG000|Overall Study|Adverse Event|4|||
161752450|NCT04338321|584133228|FG001|Overall Study|Adverse Event|10|||
161752451|NCT04338321|584133227|FG000|Overall Study|Death|1|||
161752452|NCT04338321|584133228|FG001|Overall Study|Death|1|||
161752453|NCT04338321|584133227|FG000|Overall Study|Lost to Follow-up|4|||
161752454|NCT04338321|584133228|FG001|Overall Study|Lost to Follow-up|9|||
161752455|NCT04338321|584133227|FG000|Overall Study|Withdrawal by Subject|45|||
161752456|NCT04338321|584133228|FG001|Overall Study|Withdrawal by Subject|69|||
161752457|NCT04338321|584133227|FG000|Overall Study|Physician Decision|5|||
161752458|NCT04338321|584133228|FG001|Overall Study|Physician Decision|9|||
161752459|NCT04338321|584133227|FG000|Overall Study|Other|3|||
161752460|NCT04338321|584133228|FG001|Overall Study|Other|10|||
161752461|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
161752462|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
161752463|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
161752464|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
161752465|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
161752466|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
161752467|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
161752468|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
161752469|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
161752470|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
161752471|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
161752472|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
161752473|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
161752474|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
161752475|NCT03321526|584133229|FG000|Follow-up Phase (2 Weeks)|Other|24|||
161752476|NCT03321526|584133230|FG001|Follow-up Phase (2 Weeks)|Other|24|||
161752477|NCT03097133|584133231|FG000|Overall Study|Lost to Follow-up|3|||
161752478|NCT03097133|584133232|FG001|Overall Study|Lost to Follow-up|2|||
161752479|NCT03097133|584133231|FG000|Overall Study|Withdrawal by Subject|2|||
161752480|NCT03097133|584133232|FG001|Overall Study|Withdrawal by Subject|5|||
161752481|NCT03097133|584133231|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
161752482|NCT03097133|584133232|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
161752483|NCT03097133|584133231|FG000|Overall Study|Other|3|||
161752484|NCT03097133|584133232|FG001|Overall Study|Other|2|||
161752485|NCT03097133|584133231|FG000|Overall Study|Adverse Event|1|||
161752486|NCT03097133|584133232|FG001|Overall Study|Adverse Event|0|||
161752487|NCT01989572|584133235|FG000|Overall Study|Lack of Efficacy|35|||
161752488|NCT01989572|584133236|FG001|Overall Study|Lack of Efficacy|48|||
161752489|NCT01989572|584133237|FG002|Overall Study|Lack of Efficacy|48|||
161752490|NCT01989572|584133238|FG003|Overall Study|Lack of Efficacy|43|||
161752491|NCT01989572|584133239|FG004|Overall Study|Lack of Efficacy|71|||
161752492|NCT01989572|584133240|FG005|Overall Study|Lack of Efficacy|79|||
161752493|NCT01989572|584133235|FG000|Overall Study|Adverse Event|2|||
161752494|NCT01989572|584133236|FG001|Overall Study|Adverse Event|1|||
161752495|NCT01989572|584133237|FG002|Overall Study|Adverse Event|3|||
161752496|NCT01989572|584133238|FG003|Overall Study|Adverse Event|0|||
161752497|NCT01989572|584133239|FG004|Overall Study|Adverse Event|3|||
161752498|NCT01989572|584133240|FG005|Overall Study|Adverse Event|0|||
161752499|NCT01989572|584133235|FG000|Overall Study|Death|0|||
161752500|NCT01989572|584133236|FG001|Overall Study|Death|0|||
161752501|NCT01989572|584133237|FG002|Overall Study|Death|0|||
161752502|NCT01989572|584133238|FG003|Overall Study|Death|0|||
161752503|NCT01989572|584133239|FG004|Overall Study|Death|1|||
161752504|NCT01989572|584133240|FG005|Overall Study|Death|0|||
161752505|NCT01989572|584133235|FG000|Overall Study|Withdrawal by Subject|4|||
161752506|NCT01989572|584133236|FG001|Overall Study|Withdrawal by Subject|1|||
161752507|NCT01989572|584133237|FG002|Overall Study|Withdrawal by Subject|5|||
161752508|NCT01989572|584133238|FG003|Overall Study|Withdrawal by Subject|1|||
161752509|NCT01989572|584133239|FG004|Overall Study|Withdrawal by Subject|12|||
161752510|NCT01989572|584133240|FG005|Overall Study|Withdrawal by Subject|4|||
161752511|NCT01989572|584133235|FG000|Overall Study|complicating disease|1|||
161752512|NCT01989572|584133236|FG001|Overall Study|complicating disease|1|||
161752513|NCT01989572|584133237|FG002|Overall Study|complicating disease|2|||
161752514|NCT01989572|584133238|FG003|Overall Study|complicating disease|0|||
161752515|NCT01989572|584133239|FG004|Overall Study|complicating disease|1|||
161752516|NCT01989572|584133240|FG005|Overall Study|complicating disease|0|||
161752517|NCT01989572|584133235|FG000|Overall Study|error|2|||
161752518|NCT01989572|584133236|FG001|Overall Study|error|1|||
161752519|NCT01989572|584133237|FG002|Overall Study|error|1|||
161752520|NCT01989572|584133238|FG003|Overall Study|error|1|||
161752521|NCT01989572|584133239|FG004|Overall Study|error|1|||
161752522|NCT01989572|584133240|FG005|Overall Study|error|1|||
161752523|NCT01989572|584133235|FG000|Overall Study|maximum dose reached|0|||
161752524|NCT01989572|584133236|FG001|Overall Study|maximum dose reached|1|||
161752525|NCT01989572|584133237|FG002|Overall Study|maximum dose reached|0|||
161752526|NCT01989572|584133238|FG003|Overall Study|maximum dose reached|0|||
161752527|NCT01989572|584133239|FG004|Overall Study|maximum dose reached|1|||
161752528|NCT01989572|584133240|FG005|Overall Study|maximum dose reached|0|||
161752529|NCT01989572|584133235|FG000|Overall Study|unknown/not specify|3|||
161752530|NCT01989572|584133236|FG001|Overall Study|unknown/not specify|4|||
161752531|NCT01989572|584133237|FG002|Overall Study|unknown/not specify|1|||
161752532|NCT01989572|584133238|FG003|Overall Study|unknown/not specify|3|||
161752533|NCT01989572|584133239|FG004|Overall Study|unknown/not specify|3|||
161752534|NCT01989572|584133240|FG005|Overall Study|unknown/not specify|5|||
161752535|NCT01989572|584133235|FG000|Overall Study|not start protocol therapy|5|||
161752536|NCT01989572|584133236|FG001|Overall Study|not start protocol therapy|1|||
161752537|NCT01989572|584133237|FG002|Overall Study|not start protocol therapy|2|||
161752538|NCT01989572|584133238|FG003|Overall Study|not start protocol therapy|3|||
161752539|NCT01989572|584133239|FG004|Overall Study|not start protocol therapy|4|||
161752540|NCT01989572|584133240|FG005|Overall Study|not start protocol therapy|18|||
161752541|NCT01989572|584133235|FG000|Overall Study|alternative therapy|3|||
161752542|NCT01989572|584133236|FG001|Overall Study|alternative therapy|0|||
161752543|NCT01989572|584133237|FG002|Overall Study|alternative therapy|0|||
161752544|NCT01989572|584133238|FG003|Overall Study|alternative therapy|0|||
161752545|NCT01989572|584133239|FG004|Overall Study|alternative therapy|1|||
161752546|NCT01989572|584133240|FG005|Overall Study|alternative therapy|3|||
161752547|NCT00732641|584133245|FG000|Overall Study|Relapse or Progressive Disease|65|||
161752548|NCT00732641|584133246|FG001|Overall Study|Relapse or Progressive Disease|101|||
161752549|NCT00732641|584133245|FG000|Overall Study|Serious Adverse Events|12|||
161752550|NCT00732641|584133246|FG001|Overall Study|Serious Adverse Events|3|||
161752551|NCT00732641|584133245|FG000|Overall Study|Physician Decision|6|||
161752552|NCT00732641|584133246|FG001|Overall Study|Physician Decision|0|||
161752553|NCT00732641|584133245|FG000|Overall Study|Withdrawal by Subject|4|||
161752554|NCT00732641|584133246|FG001|Overall Study|Withdrawal by Subject|2|||
161752555|NCT00732641|584133245|FG000|Overall Study|Unable to Complete|1|||
161752556|NCT00732641|584133246|FG001|Overall Study|Unable to Complete|1|||
161752557|NCT00732641|584133245|FG000|Overall Study|Other|18|||
161752558|NCT00732641|584133246|FG001|Overall Study|Other|5|||
161752559|NCT00732238|584133247|FG000|Overall Study|Bacteremia|4|||
161752560|NCT00732238|584133248|FG001|Overall Study|Bacteremia|1|||
161752561|NCT00732238|584133247|FG000|Overall Study|Asymptomatic bacteriuria|1|||
161752562|NCT00732238|584133248|FG001|Overall Study|Asymptomatic bacteriuria|0|||
161752563|NCT02910089|584133249|FG000|Overall Study|Lost insurance eligibility|22|||
161752564|NCT02910089|584133250|FG001|Overall Study|Lost insurance eligibility|16|||
161752565|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161752566|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
161752567|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
161752568|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
161752569|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
161752570|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
161752571|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
161752572|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
161752573|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
161752574|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
161752575|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
161752576|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
161752577|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
161752578|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
161752579|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
161752580|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
161752581|NCT03434041|584133253|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
161752582|NCT03434041|584133254|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
161752583|NCT03434041|584133253|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
161752584|NCT03434041|584133254|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
161752585|NCT03434041|584133253|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
161752586|NCT03434041|584133254|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
161752587|NCT04159701|584133255|FG000|Period 1: Treatment Period|Pregnancy|1|||
161752588|NCT04159701|584133256|FG001|Period 1: Treatment Period|Pregnancy|0|||
161752589|NCT04159701|584133255|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
161752590|NCT04159701|584133256|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
161752591|NCT04159701|584133255|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
161752592|NCT04159701|584133256|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
161752593|NCT04159701|584133255|FG000|Washout Period|site terminated by sponsor|0|||
161752594|NCT04159701|584133256|FG001|Washout Period|site terminated by sponsor|1|||
161752595|NCT04159701|584133255|FG000|Washout Period|study terminated by sponsor|10|||
161752596|NCT04159701|584133256|FG001|Washout Period|study terminated by sponsor|3|||
161752597|NCT04159701|584133255|FG000|Washout Period|Withdrawal by Subject|1|||
161752598|NCT04159701|584133256|FG001|Washout Period|Withdrawal by Subject|0|||
161752599|NCT04159701|584133255|FG000|Washout Period|Inadvertent Enrollment|1|||
161752600|NCT04159701|584133256|FG001|Washout Period|Inadvertent Enrollment|0|||
161752601|NCT04159701|584133255|FG000|Washout Period|Miscellaneous|1|||
161752602|NCT04159701|584133256|FG001|Washout Period|Miscellaneous|0|||
161752603|NCT04159701|584133255|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
161752604|NCT04159701|584133256|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
161752605|NCT04159701|584133255|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
161752606|NCT04159701|584133256|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
161752607|NCT04159701|584133255|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
161752608|NCT04159701|584133256|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
161752609|NCT04159701|584133255|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
161752610|NCT04159701|584133256|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
161752611|NCT04159701|584133255|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
161752612|NCT04159701|584133256|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
161752613|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
161752614|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161752615|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161752616|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161752617|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
161752618|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161752619|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161752620|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161752621|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
161752622|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161752623|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161752624|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161752625|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
161752626|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161752627|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161752628|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161752629|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
161752630|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161752631|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161752632|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161752633|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
161752634|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161752635|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161752636|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161752637|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
161752638|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161752639|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161752640|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161752641|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
161752642|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161752643|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161752644|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161752645|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
161752646|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161752647|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161752648|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161752649|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
161752650|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161752651|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161752652|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161752653|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
161752654|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161752655|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161752656|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161752657|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
161752658|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
161752659|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
161752660|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
161752661|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
161752662|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
161752663|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
161752664|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
161752665|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
161752666|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
161752667|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
161752668|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
161752669|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
161752670|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
161752671|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
161752672|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
161752673|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
161752674|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
161752675|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
161752676|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
161752677|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161752678|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
161752679|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161752680|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161752681|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
161752682|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
161752683|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
161752684|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
161752685|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
161752686|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
161752687|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
161752688|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
161752689|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
161844917|NCT02980874|584474684|FG001|Overall Study|Lost to Follow-up|5|||
161844918|NCT02980874|584474683|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
161752690|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
161752691|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
161752692|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
161752693|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
161752694|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
161752695|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
161752696|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
161752697|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
161752698|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
161752699|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
161752700|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
161752701|NCT01782885|584133265|FG000|Overall Study|Lost to Follow-up|4|||
161752702|NCT01782885|584133266|FG001|Overall Study|Lost to Follow-up|6|||
161752703|NCT00633360|584133267|FG000|Overall Study|Lost to Follow-up|1|||
161752704|NCT00633360|584133268|FG001|Overall Study|Lost to Follow-up|1|||
161752705|NCT00633360|584133267|FG000|Overall Study|Adverse Event|3|||
161752706|NCT00633360|584133268|FG001|Overall Study|Adverse Event|1|||
161752707|NCT00633360|584133267|FG000|Overall Study|Protocol Violation|0|||
161752708|NCT00633360|584133268|FG001|Overall Study|Protocol Violation|1|||
161752709|NCT02348840|584133274|FG000|Overall Study|Withdrawal by Subject|2|||
161752710|NCT02348840|584133275|FG001|Overall Study|Withdrawal by Subject|1|||
161752711|NCT02348840|584133276|FG002|Overall Study|Withdrawal by Subject|0|||
161752712|NCT02348840|584133277|FG003|Overall Study|Withdrawal by Subject|0|||
161752713|NCT00621244|584133278|FG000|Overall Study|Withdrawal by Subject|7|||
161752714|NCT00621244|584133279|FG001|Overall Study|Withdrawal by Subject|3|||
161752715|NCT00621244|584133280|FG002|Overall Study|Withdrawal by Subject|3|||
161752716|NCT00621244|584133281|FG003|Overall Study|Withdrawal by Subject|3|||
161752717|NCT00621244|584133278|FG000|Overall Study|Disease progression|44|||
161752718|NCT00621244|584133279|FG001|Overall Study|Disease progression|20|||
161752719|NCT00621244|584133280|FG002|Overall Study|Disease progression|20|||
161752720|NCT00621244|584133281|FG003|Overall Study|Disease progression|15|||
161752721|NCT00621244|584133278|FG000|Overall Study|Death|3|||
161752722|NCT00621244|584133279|FG001|Overall Study|Death|3|||
161752723|NCT00621244|584133280|FG002|Overall Study|Death|1|||
161752724|NCT00621244|584133281|FG003|Overall Study|Death|1|||
161752725|NCT00621244|584133278|FG000|Overall Study|Adverse Event|27|||
161752726|NCT00621244|584133279|FG001|Overall Study|Adverse Event|7|||
161752727|NCT00621244|584133280|FG002|Overall Study|Adverse Event|9|||
161752728|NCT00621244|584133281|FG003|Overall Study|Adverse Event|2|||
161752729|NCT00621244|584133278|FG000|Overall Study|Administrative problems|5|||
161752730|NCT00621244|584133279|FG001|Overall Study|Administrative problems|1|||
161752731|NCT00621244|584133280|FG002|Overall Study|Administrative problems|0|||
161752732|NCT00621244|584133281|FG003|Overall Study|Administrative problems|2|||
161752733|NCT01690988|584133282|FG000|Overall Study|Withdrawal by Subject|2|||
161752734|NCT01690988|584133283|FG001|Overall Study|Withdrawal by Subject|2|||
161752735|NCT01690988|584133284|FG002|Overall Study|Withdrawal by Subject|3|||
161752736|NCT01690988|584133282|FG000|Overall Study|Physician Decision|0|||
161752737|NCT01690988|584133283|FG001|Overall Study|Physician Decision|0|||
161752738|NCT01690988|584133284|FG002|Overall Study|Physician Decision|1|||
161752739|NCT01690988|584133282|FG000|Overall Study|Operation Cancelled|1|||
161752740|NCT01690988|584133283|FG001|Overall Study|Operation Cancelled|1|||
161752741|NCT01690988|584133284|FG002|Overall Study|Operation Cancelled|0|||
161752742|NCT01690988|584133282|FG000|Overall Study|Determined ineligible|1|||
161752743|NCT01690988|584133283|FG001|Overall Study|Determined ineligible|0|||
161752744|NCT01690988|584133284|FG002|Overall Study|Determined ineligible|0|||
161752745|NCT01690988|584133282|FG000|Overall Study|Death|1|||
161752746|NCT01690988|584133283|FG001|Overall Study|Death|1|||
161752747|NCT01690988|584133284|FG002|Overall Study|Death|1|||
161752748|NCT01690988|584133282|FG000|Overall Study|Sedated|1|||
161752749|NCT01690988|584133283|FG001|Overall Study|Sedated|1|||
161752750|NCT01690988|584133284|FG002|Overall Study|Sedated|2|||
161752751|NCT00312728|584133289|FG000|Overall Study|Progressive disease|53|||
161752752|NCT00312728|584133289|FG000|Overall Study|Adverse Event|32|||
161752753|NCT00312728|584133289|FG000|Overall Study|Withdrawal by Subject|10|||
161752754|NCT00312728|584133289|FG000|Overall Study|Required non-protocol cancer treatment|2|||
161752755|NCT00312728|584133289|FG000|Overall Study|Protocol Violation|2|||
161752756|NCT00312728|584133289|FG000|Overall Study|Other|10|||
161752757|NCT00312728|584133289|FG000|Overall Study|Other|1|||
161752758|NCT03696576|584133290|FG000|Overall Study|Soreness of throat after therapy|1|||
161752759|NCT03696576|584133291|FG001|Overall Study|Soreness of throat after therapy|1|||
161752760|NCT03696576|584133290|FG000|Overall Study|Lost to Follow-up|2|||
161752761|NCT03696576|584133291|FG001|Overall Study|Lost to Follow-up|4|||
161752762|NCT00744991|584133292|FG000|Overall Study|Progressive Disease|11|||
161752763|NCT00744991|584133292|FG000|Overall Study|Withdrawal by Subject|8|||
161752764|NCT00744991|584133292|FG000|Overall Study|Physician Decision|3|||
161752765|NCT00744991|584133292|FG000|Overall Study|Adverse Event|2|||
161752766|NCT00744991|584133292|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
161752767|NCT01662986|584133293|FG000|Overall Study|Adverse Event|5|||
161752768|NCT01662986|584133294|FG001|Overall Study|Adverse Event|4|||
161752769|NCT01662986|584133293|FG000|Overall Study|Protocol Violation|2|||
161752770|NCT01662986|584133294|FG001|Overall Study|Protocol Violation|3|||
161752771|NCT01662986|584133293|FG000|Overall Study|Lost to Follow-up|5|||
161752772|NCT01662986|584133294|FG001|Overall Study|Lost to Follow-up|4|||
161752773|NCT01662986|584133293|FG000|Overall Study|Withdrawal by Subject|2|||
161752774|NCT01662986|584133294|FG001|Overall Study|Withdrawal by Subject|2|||
161752775|NCT01662986|584133293|FG000|Overall Study|Not Treated|1|||
161752776|NCT01662986|584133294|FG001|Overall Study|Not Treated|0|||
161752777|NCT01662986|584133293|FG000|Overall Study|Other than stated above|3|||
161752778|NCT01662986|584133294|FG001|Overall Study|Other than stated above|0|||
161752779|NCT01594411|584133297|FG000|Overall Study|Lost to Follow-up|2|||
161752780|NCT01929707|584133298|FG000|Intervention Period 1|Lost to Follow-up|0|||
161752781|NCT01929707|584133299|FG001|Intervention Period 1|Lost to Follow-up|0|||
161752782|NCT01929707|584133300|FG002|Intervention Period 1|Lost to Follow-up|0|||
161752783|NCT01929707|584133301|FG003|Intervention Period 1|Lost to Follow-up|1|||
161752784|NCT01929707|584133302|FG004|Intervention Period 1|Lost to Follow-up|0|||
161752785|NCT01929707|584133303|FG005|Intervention Period 1|Lost to Follow-up|0|||
161752786|NCT01929707|584133304|FG006|Intervention Period 1|Lost to Follow-up|0|||
161752787|NCT01929707|584133305|FG007|Intervention Period 1|Lost to Follow-up|0|||
161752788|NCT01929707|584133298|FG000|Intervention Period 1|Withdrawal by Subject|0|||
161752789|NCT01929707|584133299|FG001|Intervention Period 1|Withdrawal by Subject|0|||
161752790|NCT01929707|584133300|FG002|Intervention Period 1|Withdrawal by Subject|0|||
161752791|NCT01929707|584133301|FG003|Intervention Period 1|Withdrawal by Subject|2|||
161752792|NCT01929707|584133302|FG004|Intervention Period 1|Withdrawal by Subject|0|||
161752793|NCT01929707|584133303|FG005|Intervention Period 1|Withdrawal by Subject|0|||
161752794|NCT01929707|584133304|FG006|Intervention Period 1|Withdrawal by Subject|0|||
161752795|NCT01929707|584133305|FG007|Intervention Period 1|Withdrawal by Subject|0|||
161752796|NCT01929707|584133298|FG000|Intervention Period 2|Withdrawal by Subject|0|||
161752797|NCT01929707|584133299|FG001|Intervention Period 2|Withdrawal by Subject|0|||
161752798|NCT01929707|584133300|FG002|Intervention Period 2|Withdrawal by Subject|0|||
161752799|NCT01929707|584133301|FG003|Intervention Period 2|Withdrawal by Subject|0|||
161752800|NCT01929707|584133302|FG004|Intervention Period 2|Withdrawal by Subject|0|||
161752801|NCT01929707|584133303|FG005|Intervention Period 2|Withdrawal by Subject|2|||
161752802|NCT01929707|584133304|FG006|Intervention Period 2|Withdrawal by Subject|0|||
161752803|NCT01929707|584133305|FG007|Intervention Period 2|Withdrawal by Subject|0|||
161752804|NCT02067533|584133312|FG000|Overall Study|Lost to Follow-up|4|||
161752805|NCT02067533|584133313|FG001|Overall Study|Lost to Follow-up|2|||
161752806|NCT02896192|584133317|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
161752807|NCT02896192|584133317|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
161752808|NCT02896192|584133317|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
161752809|NCT01997281|584133318|FG000|Overall Study|Withdrawal by Subject|1|||
161752810|NCT01997281|584133319|FG001|Overall Study|Withdrawal by Subject|0|||
161752811|NCT00368472|584133321|FG000|Overall Study|Adverse Event|22|||
161752812|NCT00368472|584133321|FG000|Overall Study|Medication non-compliance|4|||
161752813|NCT00368472|584133321|FG000|Overall Study|Protocol Violation|2|||
161752814|NCT00368472|584133321|FG000|Overall Study|Request of Investigator or Sponsor|3|||
161752815|NCT00368472|584133321|FG000|Overall Study|Withdrawal by Subject|40|||
161752816|NCT00368472|584133321|FG000|Overall Study|Diary non-compliance|1|||
161752817|NCT00368472|584133321|FG000|Overall Study|Other|32|||
161752818|NCT00368472|584133321|FG000|Overall Study|Missing Final Disposition Date|1|||
161752819|NCT02650895|584133323|FG000|Overall Study|Withdrawal by Subject|0|||
161752820|NCT02650895|584133324|FG001|Overall Study|Withdrawal by Subject|1|||
161752821|NCT02650895|584133325|FG002|Overall Study|Withdrawal by Subject|0|||
161752822|NCT02650895|584133326|FG003|Overall Study|Withdrawal by Subject|0|||
161752823|NCT02650895|584133327|FG004|Overall Study|Withdrawal by Subject|0|||
161752824|NCT02650895|584133328|FG005|Overall Study|Withdrawal by Subject|0|||
161752825|NCT03209362|584133329|FG000|Overall Study|Adverse Event|0|||
161752826|NCT03209362|584133330|FG001|Overall Study|Adverse Event|1|||
161752827|NCT03209362|584133329|FG000|Overall Study|Lost to Follow-up|0|||
161752828|NCT03209362|584133330|FG001|Overall Study|Lost to Follow-up|1|||
161752829|NCT03209362|584133329|FG000|Overall Study|Withdrawal by Subject|2|||
161752830|NCT03209362|584133330|FG001|Overall Study|Withdrawal by Subject|0|||
161752831|NCT03209362|584133329|FG000|Overall Study|Other|0|||
161752832|NCT03209362|584133330|FG001|Overall Study|Other|1|||
161752833|NCT00643448|584133335|FG000|Overall Study|Lack of Efficacy|2|||
161752834|NCT00643448|584133336|FG001|Overall Study|Lack of Efficacy|0|||
161752835|NCT00643448|584133337|FG002|Overall Study|Lack of Efficacy|4|||
161752836|NCT00643448|584133335|FG000|Overall Study|Adverse Event|2|||
161752837|NCT00643448|584133336|FG001|Overall Study|Adverse Event|2|||
161752838|NCT00643448|584133337|FG002|Overall Study|Adverse Event|2|||
161752839|NCT00643448|584133335|FG000|Overall Study|QTcF>550 ms|0|||
161752840|NCT00643448|584133336|FG001|Overall Study|QTcF>550 ms|3|||
161752841|NCT00643448|584133337|FG002|Overall Study|QTcF>550 ms|0|||
161752842|NCT00981682|584133338|FG000|Overall Study|Adverse Event|48|||
161752843|NCT00981682|584133338|FG000|Overall Study|Withdrawal by Subject|52|||
161752844|NCT00981682|584133338|FG000|Overall Study|Lost to Follow-up|14|||
161752845|NCT00981682|584133338|FG000|Overall Study|Lack of Efficacy|13|||
161752846|NCT00981682|584133338|FG000|Overall Study|Protocol Violation|6|||
161752847|NCT00981682|584133338|FG000|Overall Study|administrative|9|||
161752848|NCT02358863|584135565|FG000|Overall Study|Physician Decision|3|||
161752849|NCT05426460|584135570|FG000|Overall Study|Protocol Violation|1|||
161752850|NCT05426460|584135571|FG001|Overall Study|Protocol Violation|1|||
161752851|NCT05426460|584135572|FG002|Overall Study|Protocol Violation|1|||
161752852|NCT05426460|584135573|FG003|Overall Study|Protocol Violation|0|||
161752853|NCT02204410|584135574|FG000|Overall Study|Lost to Follow-up|5|||
161752854|NCT02204410|584135574|FG000|Overall Study|Physician Decision|2|||
161752855|NCT02204410|584135574|FG000|Overall Study|Protocol Violation|1|||
161752856|NCT02204410|584135574|FG000|Overall Study|Withdrawal by Subject|3|||
161752857|NCT01405027|584135577|FG000|Overall Study|Withdrawn consent|3|||
161752858|NCT01405027|584135578|FG001|Overall Study|Withdrawn consent|0|||
161752859|NCT01405027|584135577|FG000|Overall Study|Lost to Follow-up|16|||
161752860|NCT01405027|584135578|FG001|Overall Study|Lost to Follow-up|24|||
161752861|NCT01405027|584135577|FG000|Overall Study|Investigator judgement|0|||
161752862|NCT01405027|584135578|FG001|Overall Study|Investigator judgement|2|||
161752863|NCT01405027|584135577|FG000|Overall Study|Death|1|||
161752864|NCT01405027|584135578|FG001|Overall Study|Death|0|||
161752865|NCT01405027|584135577|FG000|Overall Study|Other or Unknown|12|||
161752866|NCT01405027|584135578|FG001|Overall Study|Other or Unknown|25|||
161752867|NCT01536418|584135585|FG000|Overall Study|Protocol Violation|2|||
161752868|NCT01536418|584135586|FG001|Overall Study|Protocol Violation|3|||
161752869|NCT01536418|584135585|FG000|Overall Study|Physician Decision|1|||
161752870|NCT01536418|584135586|FG001|Overall Study|Physician Decision|3|||
161752871|NCT01536418|584135585|FG000|Overall Study|Study closed/terminated|41|||
161752872|NCT01536418|584135586|FG001|Overall Study|Study closed/terminated|37|||
161752873|NCT01536418|584135585|FG000|Overall Study|Lack of Efficacy|10|||
161752874|NCT01536418|584135586|FG001|Overall Study|Lack of Efficacy|16|||
161752875|NCT01536418|584135585|FG000|Overall Study|Adverse Event|9|||
161752876|NCT01536418|584135586|FG001|Overall Study|Adverse Event|4|||
161752877|NCT01536418|584135585|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
161752878|NCT01536418|584135586|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
161752879|NCT01536418|584135585|FG000|Overall Study|Withdrawal by Subject|5|||
161752880|NCT01536418|584135586|FG001|Overall Study|Withdrawal by Subject|3|||
161752881|NCT00711412|584135591|FG000|Induction Treatment|Death|2|||
161752882|NCT00711412|584135591|FG000|Induction Treatment|Adverse Event|1|||
161752883|NCT00711412|584135591|FG000|Induction Treatment|Other|1|||
161752884|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
161752885|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Death|1|||
161752886|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
161752887|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
161752888|NCT00711412|584135591|FG000|Combination Treatment|Progressive Disease|1|||
161752889|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
161752890|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
161752891|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
161752892|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Death|1|||
161752893|NCT00711412|584135591|FG000|Survival Follow up Until Death|Other|12|||
161752894|NCT02234050|584135596|FG000|Overall Study|Lack of Efficacy|38|||
161752895|NCT02234050|584135597|FG001|Overall Study|Lack of Efficacy|22|||
161752896|NCT02234050|584135596|FG000|Overall Study|Adverse Event|13|||
161752897|NCT02234050|584135597|FG001|Overall Study|Adverse Event|1|||
161752898|NCT02234050|584135596|FG000|Overall Study|Withdrawal by Subject|4|||
161752899|NCT02234050|584135597|FG001|Overall Study|Withdrawal by Subject|2|||
161752900|NCT02234050|584135596|FG000|Overall Study|Sponsor's decision|6|||
161752901|NCT02234050|584135597|FG001|Overall Study|Sponsor's decision|0|||
161752902|NCT02498392|584135599|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
161752903|NCT02498392|584135600|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
161752904|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
161752905|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
161752906|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
161752907|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
161752908|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
161752909|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
161752910|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
161752911|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
161752912|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
161752913|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
161752914|NCT06073054|584135601|FG000|Overall Study|Withdrawal by Subject|2|||
161752915|NCT00981292|584135604|FG000|Day 1|Protocol Violation|1|||
161752916|NCT00981292|584135605|FG001|Day 1|Protocol Violation|0|||
161752917|NCT00981292|584135606|FG002|Day 1|Protocol Violation|0|||
161752918|NCT00981292|584135607|FG003|Day 1|Protocol Violation|0|||
161752919|NCT00981292|584135608|FG004|Day 1|Protocol Violation|0|||
161752920|NCT00981292|584135609|FG005|Day 1|Protocol Violation|2|||
161752921|NCT00981292|584135604|FG000|Day 2|Protocol Violation|2|||
161752922|NCT00981292|584135605|FG001|Day 2|Protocol Violation|0|||
161752923|NCT00981292|584135606|FG002|Day 2|Protocol Violation|0|||
161752924|NCT00981292|584135607|FG003|Day 2|Protocol Violation|0|||
161752925|NCT00981292|584135608|FG004|Day 2|Protocol Violation|0|||
161752926|NCT00981292|584135609|FG005|Day 2|Protocol Violation|0|||
161752927|NCT00981292|584135604|FG000|Day 3|Protocol Violation|0|||
161752928|NCT00981292|584135605|FG001|Day 3|Protocol Violation|0|||
161752929|NCT00981292|584135606|FG002|Day 3|Protocol Violation|0|||
161752930|NCT00981292|584135607|FG003|Day 3|Protocol Violation|0|||
161752931|NCT00981292|584135608|FG004|Day 3|Protocol Violation|0|||
161752932|NCT00981292|584135609|FG005|Day 3|Protocol Violation|1|||
161752933|NCT02782104|584135612|FG000|Overall Study|Other|215|||
161752934|NCT02782104|584135612|FG000|Overall Study|Induction Day 28 Non Responder|9|||
161752935|NCT02782104|584135612|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161752936|NCT02782104|584135612|FG000|Overall Study|Death|8|||
161752937|NCT02782104|584135612|FG000|Overall Study|Pregnancy|6|||
161752938|NCT02782104|584135612|FG000|Overall Study|Withdrawal by Subject|63|||
161752939|NCT02782104|584135612|FG000|Overall Study|Protocol Violation|7|||
161752940|NCT02782104|584135612|FG000|Overall Study|Lack of Efficacy|61|||
161752941|NCT02782104|584135612|FG000|Overall Study|Lost to Follow-up|23|||
161752942|NCT02782104|584135612|FG000|Overall Study|Adverse Event|74|||
161752943|NCT02438787|584135613|FG000|Overall Study|Adverse Event|1|||
161752944|NCT02438787|584135614|FG001|Overall Study|Adverse Event|0|||
161752945|NCT02438787|584135615|FG002|Overall Study|Adverse Event|2|||
161752946|NCT02438787|584135613|FG000|Overall Study|Lack of Efficacy|1|||
161752947|NCT02438787|584135614|FG001|Overall Study|Lack of Efficacy|2|||
161752948|NCT02438787|584135615|FG002|Overall Study|Lack of Efficacy|0|||
161752949|NCT02438787|584135613|FG000|Overall Study|Lost to Follow-up|0|||
161752950|NCT02438787|584135614|FG001|Overall Study|Lost to Follow-up|1|||
161752951|NCT02438787|584135615|FG002|Overall Study|Lost to Follow-up|0|||
161752952|NCT02438787|584135613|FG000|Overall Study|Protocol Violation|0|||
161752953|NCT02438787|584135614|FG001|Overall Study|Protocol Violation|0|||
161752954|NCT02438787|584135615|FG002|Overall Study|Protocol Violation|1|||
161752955|NCT02438787|584135613|FG000|Overall Study|Withdrawal by Subject|15|||
161752956|NCT02438787|584135614|FG001|Overall Study|Withdrawal by Subject|7|||
161752957|NCT02438787|584135615|FG002|Overall Study|Withdrawal by Subject|10|||
161752958|NCT02438787|584135613|FG000|Overall Study|Study discontinued by sponsor|64|||
161752959|NCT02438787|584135614|FG001|Overall Study|Study discontinued by sponsor|72|||
161752960|NCT02438787|584135615|FG002|Overall Study|Study discontinued by sponsor|69|||
161752961|NCT02438787|584135613|FG000|Overall Study|Other|0|||
161752962|NCT02438787|584135614|FG001|Overall Study|Other|1|||
161752963|NCT02438787|584135615|FG002|Overall Study|Other|0|||
161752964|NCT02438787|584135613|FG000|Overall Study|Site terminated by sponsor|0|||
161752965|NCT02438787|584135614|FG001|Overall Study|Site terminated by sponsor|0|||
161752966|NCT02438787|584135615|FG002|Overall Study|Site terminated by sponsor|1|||
161752967|NCT03412565|584135616|FG000|Overall Study|Lost to Follow-up|0|||
161752968|NCT03412565|584135617|FG001|Overall Study|Lost to Follow-up|0|||
161752969|NCT03412565|584135618|FG002|Overall Study|Lost to Follow-up|1|||
161752970|NCT03412565|584135619|FG003|Overall Study|Lost to Follow-up|0|||
161752971|NCT03412565|584135616|FG000|Overall Study|Physician Decision|0|||
161752972|NCT03412565|584135617|FG001|Overall Study|Physician Decision|0|||
161752973|NCT03412565|584135618|FG002|Overall Study|Physician Decision|0|||
161752974|NCT03412565|584135619|FG003|Overall Study|Physician Decision|1|||
161752975|NCT03412565|584135616|FG000|Overall Study|Withdrawal by Subject|0|||
161752976|NCT03412565|584135617|FG001|Overall Study|Withdrawal by Subject|4|||
161752977|NCT03412565|584135618|FG002|Overall Study|Withdrawal by Subject|5|||
161752978|NCT03412565|584135619|FG003|Overall Study|Withdrawal by Subject|5|||
161752979|NCT03412565|584135616|FG000|Overall Study|Death|1|||
161752980|NCT03412565|584135617|FG001|Overall Study|Death|3|||
161752981|NCT03412565|584135618|FG002|Overall Study|Death|4|||
161752982|NCT03412565|584135619|FG003|Overall Study|Death|5|||
161752983|NCT03412565|584135616|FG000|Overall Study|Data collection ended|0|||
161752984|NCT03412565|584135617|FG001|Overall Study|Data collection ended|41|||
161752985|NCT03412565|584135618|FG002|Overall Study|Data collection ended|41|||
161752986|NCT03412565|584135619|FG003|Overall Study|Data collection ended|40|||
161752987|NCT02280096|584135620|FG000|Overall Study|Pregnancy|1|||
161752988|NCT02280096|584135621|FG001|Overall Study|Pregnancy|0|||
161752989|NCT02280096|584135620|FG000|Overall Study|Functional neurological disorder|1|||
161752990|NCT02280096|584135621|FG001|Overall Study|Functional neurological disorder|0|||
161752991|NCT02280096|584135620|FG000|Overall Study|Lack of attachment|0|||
161752992|NCT02280096|584135621|FG001|Overall Study|Lack of attachment|1|||
161752993|NCT00246376|584135626|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
161752994|NCT00246376|584135627|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
161752995|NCT00246376|584135628|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
161752996|NCT00246376|584135629|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
161752997|NCT00246376|584135630|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
161752998|NCT00246376|584135626|FG000|Overall Study|Adverse Event|2|||
161752999|NCT00246376|584135627|FG001|Overall Study|Adverse Event|3|||
161753000|NCT00246376|584135628|FG002|Overall Study|Adverse Event|1|||
161753001|NCT00246376|584135629|FG003|Overall Study|Adverse Event|3|||
161753002|NCT00246376|584135630|FG004|Overall Study|Adverse Event|1|||
161753003|NCT00246376|584135626|FG000|Overall Study|Lost to Follow-up|2|||
161753004|NCT00246376|584135627|FG001|Overall Study|Lost to Follow-up|11|||
161753005|NCT00246376|584135628|FG002|Overall Study|Lost to Follow-up|11|||
161753006|NCT00246376|584135629|FG003|Overall Study|Lost to Follow-up|16|||
161753007|NCT00246376|584135630|FG004|Overall Study|Lost to Follow-up|13|||
161753008|NCT01872897|584135635|FG000|Overall Study|Withdrawal by Subject|1|||
161753009|NCT01872897|584135636|FG001|Overall Study|Withdrawal by Subject|0|||
161753010|NCT01849562|584135644|FG000|Overall Study|Lost to Follow-up|1|||
161753011|NCT01849562|584135645|FG001|Overall Study|Lost to Follow-up|0|||
161753012|NCT01849562|584135646|FG002|Overall Study|Lost to Follow-up|0|||
161753013|NCT01849562|584135644|FG000|Overall Study|Non-compliance with Study Drug|1|||
161753014|NCT01849562|584135645|FG001|Overall Study|Non-compliance with Study Drug|0|||
161753015|NCT01849562|584135646|FG002|Overall Study|Non-compliance with Study Drug|0|||
161753016|NCT00693693|584135650|FG000|Overall Study|Lost to Follow-up|1|||
161753017|NCT00693693|584135651|FG001|Overall Study|Lost to Follow-up|1|||
161753018|NCT00693693|584135652|FG002|Overall Study|Lost to Follow-up|2|||
161753019|NCT04599972|584135653|FG000|Overall Study|Withdrawal by Subject|6|||
161753020|NCT04599972|584135654|FG001|Overall Study|Withdrawal by Subject|1|||
161753021|NCT04599972|584135653|FG000|Overall Study|Adverse Event|1|||
161753022|NCT04599972|584135654|FG001|Overall Study|Adverse Event|1|||
161753023|NCT04599972|584135653|FG000|Overall Study|Lost to Follow-up|1|||
161753024|NCT04599972|584135654|FG001|Overall Study|Lost to Follow-up|6|||
161753025|NCT04599972|584135653|FG000|Overall Study|Protocol Violation|1|||
161753026|NCT04599972|584135654|FG001|Overall Study|Protocol Violation|0|||
161753027|NCT04599972|584135653|FG000|Overall Study|Other reason|1|||
161753028|NCT04599972|584135654|FG001|Overall Study|Other reason|0|||
161753029|NCT01025232|584135662|FG000|Overall Study|Study drug no longer available|3|||
161753030|NCT01025232|584135663|FG001|Overall Study|Study drug no longer available|6|||
161753031|NCT00373880|584135664|FG000|Overall Study|Physician Decision|3|||
161753032|NCT00373880|584135664|FG000|Overall Study|Arrested|1|||
161753033|NCT00373880|584135664|FG000|Overall Study|Protocol Violation|14|||
161753034|NCT03748420|584135665|FG000|Overall Study|No 12 month medication adherence data available|0|||
161753035|NCT03748420|584135666|FG001|Overall Study|No 12 month medication adherence data available|1|||
161753036|NCT03748420|584135665|FG000|Overall Study|Death|24|||
161753037|NCT03748420|584135666|FG001|Overall Study|Death|28|||
161753038|NCT03748420|584135665|FG000|Overall Study|Lost to Follow-up|231|||
161753039|NCT03748420|584135666|FG001|Overall Study|Lost to Follow-up|230|||
161753040|NCT01347073|584135668|FG000|Overall Study|Adverse Event|1|||
161753041|NCT01347073|584135668|FG000|Overall Study|Liver Transplant|1|||
161753042|NCT01634100|584135671|FG000|Overall Study|Withdrawal by Subject|1|||
161753043|NCT01634100|584135672|FG001|Overall Study|Withdrawal by Subject|0|||
161753044|NCT01634100|584135673|FG002|Overall Study|Withdrawal by Subject|1|||
161753045|NCT01634100|584135674|FG003|Overall Study|Withdrawal by Subject|0|||
161753046|NCT01634100|584135675|FG004|Overall Study|Withdrawal by Subject|0|||
161753047|NCT01634100|584135676|FG005|Overall Study|Withdrawal by Subject|0|||
161753048|NCT00338806|584135677|FG000|Acute Phase|Withdrawal by Subject|0|||
161753049|NCT00338806|584135678|FG001|Acute Phase|Withdrawal by Subject|1|||
161753050|NCT00338806|584135677|FG000|Follow-up|Lost to Follow-up|1|||
161753051|NCT00338806|584135678|FG001|Follow-up|Lost to Follow-up|3|||
161753052|NCT01975376|584135679|FG000|Overall Study|Adverse Event|5|||
161753053|NCT01975376|584135680|FG001|Overall Study|Adverse Event|5|||
161753054|NCT01975376|584135679|FG000|Overall Study|Death|65|||
161753055|NCT01975376|584135680|FG001|Overall Study|Death|72|||
161753056|NCT01975376|584135679|FG000|Overall Study|Lost to Follow-up|70|||
161753057|NCT01975376|584135680|FG001|Overall Study|Lost to Follow-up|66|||
161753058|NCT01975376|584135679|FG000|Overall Study|Withdrew consent|68|||
161753059|NCT01975376|584135680|FG001|Overall Study|Withdrew consent|62|||
161753060|NCT01975376|584135679|FG000|Overall Study|Other|2|||
161753061|NCT01975376|584135680|FG001|Overall Study|Other|4|||
161753062|NCT01975376|584135679|FG000|Overall Study|Randomized, Not Treated|16|||
161753063|NCT01975376|584135680|FG001|Overall Study|Randomized, Not Treated|8|||
161753064|NCT01451398|584135684|FG000|Overall Study|Adverse Event|7|||
161753065|NCT01451398|584135685|FG001|Overall Study|Adverse Event|9|||
161753066|NCT01451398|584135684|FG000|Overall Study|Protocol Violation|1|||
161753067|NCT01451398|584135685|FG001|Overall Study|Protocol Violation|2|||
161753068|NCT01451398|584135684|FG000|Overall Study|Physician Decision|1|||
161753069|NCT01451398|584135685|FG001|Overall Study|Physician Decision|1|||
161753070|NCT01451398|584135684|FG000|Overall Study|Withdrawal by Subject|10|||
161753071|NCT01451398|584135685|FG001|Overall Study|Withdrawal by Subject|14|||
161753072|NCT01451398|584135684|FG000|Overall Study|Lost to Follow-up|6|||
161753073|NCT01451398|584135685|FG001|Overall Study|Lost to Follow-up|4|||
161753074|NCT01451398|584135684|FG000|Overall Study|Non-compliance with study drug|1|||
161753075|NCT01451398|584135685|FG001|Overall Study|Non-compliance with study drug|3|||
161753076|NCT01451398|584135684|FG000|Overall Study|Non-compliance with protocol|1|||
161753077|NCT01451398|584135685|FG001|Overall Study|Non-compliance with protocol|1|||
161753078|NCT01451398|584135684|FG000|Overall Study|Moved out of country|0|||
161753079|NCT01451398|584135685|FG001|Overall Study|Moved out of country|1|||
161753080|NCT01451398|584135684|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
161753081|NCT01451398|584135685|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
161753082|NCT01451398|584135684|FG000|Overall Study|Lack of Efficacy|0|||
161753083|NCT01451398|584135685|FG001|Overall Study|Lack of Efficacy|1|||
161753084|NCT04449276|584135686|FG000|Overall Study|Adverse Event|1|||
161753085|NCT04449276|584135687|FG001|Overall Study|Adverse Event|2|||
161753086|NCT04449276|584135688|FG002|Overall Study|Adverse Event|0|||
161753087|NCT04449276|584135689|FG003|Overall Study|Adverse Event|0|||
161753088|NCT04449276|584135690|FG004|Overall Study|Adverse Event|2|||
161753089|NCT04449276|584135691|FG005|Overall Study|Adverse Event|0|||
161753090|NCT04449276|584135692|FG006|Overall Study|Adverse Event|0|||
161753091|NCT04449276|584135693|FG007|Overall Study|Adverse Event|1|||
161753092|NCT04449276|584135686|FG000|Overall Study|Withdrawal by Subject|2|||
161753093|NCT04449276|584135687|FG001|Overall Study|Withdrawal by Subject|0|||
161753094|NCT04449276|584135688|FG002|Overall Study|Withdrawal by Subject|0|||
161753095|NCT04449276|584135689|FG003|Overall Study|Withdrawal by Subject|1|||
161753096|NCT04449276|584135690|FG004|Overall Study|Withdrawal by Subject|0|||
161753097|NCT04449276|584135691|FG005|Overall Study|Withdrawal by Subject|0|||
161753098|NCT04449276|584135692|FG006|Overall Study|Withdrawal by Subject|0|||
161753099|NCT04449276|584135693|FG007|Overall Study|Withdrawal by Subject|0|||
161753100|NCT04449276|584135686|FG000|Overall Study|Other|0|||
161753101|NCT04449276|584135687|FG001|Overall Study|Other|2|||
161753102|NCT04449276|584135688|FG002|Overall Study|Other|3|||
161753103|NCT04449276|584135689|FG003|Overall Study|Other|2|||
161753104|NCT04449276|584135690|FG004|Overall Study|Other|0|||
161753105|NCT04449276|584135691|FG005|Overall Study|Other|0|||
161753106|NCT04449276|584135692|FG006|Overall Study|Other|0|||
161753107|NCT04449276|584135693|FG007|Overall Study|Other|1|||
161753108|NCT01614795|584135694|FG000|Overall Study|Adverse Event|0|||
161753109|NCT01614795|584135695|FG001|Overall Study|Adverse Event|0|||
161753110|NCT01614795|584135696|FG002|Overall Study|Adverse Event|1|||
161753111|NCT01614795|584135697|FG003|Overall Study|Adverse Event|1|||
161753112|NCT01614795|584135694|FG000|Overall Study|Lack of Efficacy|10|||
161753113|NCT01614795|584135695|FG001|Overall Study|Lack of Efficacy|10|||
161753114|NCT01614795|584135696|FG002|Overall Study|Lack of Efficacy|9|||
161753115|NCT01614795|584135697|FG003|Overall Study|Lack of Efficacy|8|||
161753116|NCT01614795|584135694|FG000|Overall Study|Physician Decision|1|||
161753117|NCT01614795|584135695|FG001|Overall Study|Physician Decision|0|||
161753118|NCT01614795|584135696|FG002|Overall Study|Physician Decision|1|||
161753119|NCT01614795|584135697|FG003|Overall Study|Physician Decision|1|||
161753120|NCT01614795|584135694|FG000|Overall Study|Withdrawal by Subject|0|||
161753121|NCT01614795|584135695|FG001|Overall Study|Withdrawal by Subject|1|||
161753122|NCT01614795|584135696|FG002|Overall Study|Withdrawal by Subject|0|||
161753123|NCT01614795|584135697|FG003|Overall Study|Withdrawal by Subject|2|||
161753124|NCT01614795|584135694|FG000|Overall Study|Ineligible|0|||
161753125|NCT01614795|584135695|FG001|Overall Study|Ineligible|1|||
161753126|NCT01614795|584135696|FG002|Overall Study|Ineligible|0|||
161753127|NCT01614795|584135697|FG003|Overall Study|Ineligible|0|||
161753128|NCT00701103|584135698|FG000|Overall Study|Adverse Event|0|||
161753129|NCT00701103|584135699|FG001|Overall Study|Adverse Event|0|||
161753130|NCT00701103|584135700|FG002|Overall Study|Adverse Event|1|||
161753131|NCT00701103|584135701|FG003|Overall Study|Adverse Event|1|||
161753132|NCT00701103|584135702|FG004|Overall Study|Adverse Event|0|||
161753133|NCT00701103|584135703|FG005|Overall Study|Adverse Event|1|||
161753134|NCT00701103|584135704|FG006|Overall Study|Adverse Event|1|||
161753135|NCT00701103|584135705|FG007|Overall Study|Adverse Event|0|||
161753136|NCT00701103|584135706|FG008|Overall Study|Adverse Event|0|||
161753137|NCT00701103|584135707|FG009|Overall Study|Adverse Event|2|||
161753138|NCT00701103|584135708|FG010|Overall Study|Adverse Event|0|||
161753139|NCT00701103|584135698|FG000|Overall Study|Progressive Disease|5|||
161753140|NCT00701103|584135699|FG001|Overall Study|Progressive Disease|2|||
161753141|NCT00701103|584135700|FG002|Overall Study|Progressive Disease|6|||
161753142|NCT00701103|584135701|FG003|Overall Study|Progressive Disease|5|||
161753143|NCT00701103|584135702|FG004|Overall Study|Progressive Disease|6|||
161753144|NCT00701103|584135703|FG005|Overall Study|Progressive Disease|5|||
161753145|NCT00701103|584135704|FG006|Overall Study|Progressive Disease|7|||
161753146|NCT00701103|584135705|FG007|Overall Study|Progressive Disease|7|||
161753147|NCT00701103|584135706|FG008|Overall Study|Progressive Disease|8|||
161753148|NCT00701103|584135707|FG009|Overall Study|Progressive Disease|8|||
161753149|NCT00701103|584135708|FG010|Overall Study|Progressive Disease|11|||
161753150|NCT00701103|584135698|FG000|Overall Study|Withdrawal by Subject|0|||
161753151|NCT00701103|584135699|FG001|Overall Study|Withdrawal by Subject|1|||
161753152|NCT00701103|584135700|FG002|Overall Study|Withdrawal by Subject|1|||
161753153|NCT00701103|584135701|FG003|Overall Study|Withdrawal by Subject|0|||
161753154|NCT00701103|584135702|FG004|Overall Study|Withdrawal by Subject|0|||
161753155|NCT00701103|584135703|FG005|Overall Study|Withdrawal by Subject|0|||
161753156|NCT00701103|584135704|FG006|Overall Study|Withdrawal by Subject|0|||
161753157|NCT00701103|584135705|FG007|Overall Study|Withdrawal by Subject|0|||
161753158|NCT00701103|584135706|FG008|Overall Study|Withdrawal by Subject|0|||
161753159|NCT00701103|584135707|FG009|Overall Study|Withdrawal by Subject|0|||
161753160|NCT00701103|584135708|FG010|Overall Study|Withdrawal by Subject|0|||
161753161|NCT00701103|584135698|FG000|Overall Study|Other|0|||
161753162|NCT00701103|584135699|FG001|Overall Study|Other|0|||
161753163|NCT00701103|584135700|FG002|Overall Study|Other|0|||
161753164|NCT00701103|584135701|FG003|Overall Study|Other|0|||
161753165|NCT00701103|584135702|FG004|Overall Study|Other|0|||
161753166|NCT00701103|584135703|FG005|Overall Study|Other|0|||
161753167|NCT00701103|584135704|FG006|Overall Study|Other|0|||
161753168|NCT00701103|584135705|FG007|Overall Study|Other|0|||
161753169|NCT00701103|584135706|FG008|Overall Study|Other|1|||
161753170|NCT00701103|584135707|FG009|Overall Study|Other|1|||
161753171|NCT00701103|584135708|FG010|Overall Study|Other|0|||
161753172|NCT00179517|584135709|FG000|Overall Study|Withdrawal by Subject|2|||
161753173|NCT00179517|584135710|FG001|Overall Study|Withdrawal by Subject|1|||
161753174|NCT01915095|584135711|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
161753175|NCT01915095|584135712|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
161753176|NCT01915095|584135713|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
161753177|NCT01915095|584135714|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
161753178|NCT01915095|584135715|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
161753179|NCT00565812|584135716|FG000|Overall Study|Death|2|||
161753180|NCT00565812|584135717|FG001|Overall Study|Death|1|||
161753181|NCT00565812|584135718|FG002|Overall Study|Death|3|||
161753182|NCT00565812|584135716|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
161753183|NCT00565812|584135717|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
161753184|NCT00565812|584135718|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
161753185|NCT00565812|584135716|FG000|Overall Study|Lost to Follow-up|10|||
161753186|NCT00565812|584135717|FG001|Overall Study|Lost to Follow-up|8|||
161753187|NCT00565812|584135718|FG002|Overall Study|Lost to Follow-up|8|||
161753188|NCT00565812|584135716|FG000|Overall Study|Withdrawal by Subject|58|||
161753189|NCT00565812|584135717|FG001|Overall Study|Withdrawal by Subject|47|||
161753190|NCT00565812|584135718|FG002|Overall Study|Withdrawal by Subject|48|||
161753191|NCT00565812|584135716|FG000|Overall Study|Work Schedule|5|||
161753192|NCT00565812|584135717|FG001|Overall Study|Work Schedule|3|||
161753193|NCT00565812|584135718|FG002|Overall Study|Work Schedule|1|||
161753194|NCT00565812|584135716|FG000|Overall Study|Protocol Violation|2|||
161753195|NCT00565812|584135717|FG001|Overall Study|Protocol Violation|6|||
161753196|NCT00565812|584135718|FG002|Overall Study|Protocol Violation|4|||
161753197|NCT00565812|584135716|FG000|Overall Study|Adverse Event|41|||
161753198|NCT00565812|584135717|FG001|Overall Study|Adverse Event|54|||
161753199|NCT00565812|584135718|FG002|Overall Study|Adverse Event|40|||
161753200|NCT00565812|584135716|FG000|Overall Study|Jury Duty|1|||
161753201|NCT00565812|584135717|FG001|Overall Study|Jury Duty|0|||
161753202|NCT00565812|584135718|FG002|Overall Study|Jury Duty|0|||
161753203|NCT00565812|584135716|FG000|Overall Study|Relocated Out of Area|5|||
161753204|NCT00565812|584135717|FG001|Overall Study|Relocated Out of Area|8|||
161753205|NCT00565812|584135718|FG002|Overall Study|Relocated Out of Area|9|||
161753206|NCT00565812|584135716|FG000|Overall Study|Sponsor Decision|1|||
161753207|NCT00565812|584135717|FG001|Overall Study|Sponsor Decision|5|||
161753208|NCT00565812|584135718|FG002|Overall Study|Sponsor Decision|1|||
161753209|NCT00565812|584135716|FG000|Overall Study|Domestic Reasons|7|||
161753210|NCT00565812|584135717|FG001|Overall Study|Domestic Reasons|1|||
161753211|NCT00565812|584135718|FG002|Overall Study|Domestic Reasons|3|||
161753212|NCT00565812|584135716|FG000|Overall Study|Research Site Closure|6|||
161753213|NCT00565812|584135717|FG001|Overall Study|Research Site Closure|1|||
161753214|NCT00565812|584135718|FG002|Overall Study|Research Site Closure|8|||
161753215|NCT00565812|584135716|FG000|Overall Study|Surgical Intervention|0|||
161753216|NCT00565812|584135717|FG001|Overall Study|Surgical Intervention|1|||
161753217|NCT00565812|584135718|FG002|Overall Study|Surgical Intervention|2|||
161753218|NCT00565812|584135716|FG000|Overall Study|Low Compliance|1|||
161753219|NCT00565812|584135717|FG001|Overall Study|Low Compliance|0|||
161753220|NCT00565812|584135718|FG002|Overall Study|Low Compliance|1|||
161753221|NCT00565812|584135716|FG000|Overall Study|Follow-up Visit Not Completed|2|||
161753222|NCT00565812|584135717|FG001|Overall Study|Follow-up Visit Not Completed|0|||
161753223|NCT00565812|584135718|FG002|Overall Study|Follow-up Visit Not Completed|1|||
161753224|NCT00565812|584135716|FG000|Overall Study|Physician Decision|2|||
161753225|NCT00565812|584135717|FG001|Overall Study|Physician Decision|0|||
161753226|NCT00565812|584135718|FG002|Overall Study|Physician Decision|0|||
161753227|NCT04857892|584135727|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
161753228|NCT04857892|584135728|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753229|NCT04857892|584135729|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753230|NCT04857892|584135730|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753231|NCT04857892|584135731|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753232|NCT04857892|584135727|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
161753233|NCT04857892|584135728|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
161753234|NCT04857892|584135729|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
161753235|NCT04857892|584135730|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
161753236|NCT04857892|584135731|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
161753237|NCT04857892|584135727|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753238|NCT04857892|584135728|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753239|NCT04857892|584135729|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753240|NCT04857892|584135730|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753241|NCT04857892|584135731|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
161753242|NCT05104749|584135732|FG000|Overall Study|Lost to Follow-up|2|||
161753243|NCT05104749|584135733|FG001|Overall Study|Lost to Follow-up|3|||
161753244|NCT00901394|584135734|FG000|Overall Study|Physician Decision|1|||
161753245|NCT00901394|584135735|FG001|Overall Study|Physician Decision|1|||
161753246|NCT00901394|584135736|FG002|Overall Study|Physician Decision|2|||
161753247|NCT04964557|584135737|FG000|Overall Study|Withdrawal by Subject|3|||
161753248|NCT04964557|584135738|FG001|Overall Study|Withdrawal by Subject|2|||
161753249|NCT04964557|584135737|FG000|Overall Study|Lost to Follow-up|1|||
161753250|NCT04964557|584135738|FG001|Overall Study|Lost to Follow-up|2|||
161753251|NCT04964557|584135737|FG000|Overall Study|Physician Decision|2|||
161753252|NCT04964557|584135738|FG001|Overall Study|Physician Decision|0|||
161753253|NCT04964557|584135737|FG000|Overall Study|Death|3|||
161753254|NCT04964557|584135738|FG001|Overall Study|Death|0|||
161753255|NCT04964557|584135737|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
161753256|NCT04964557|584135738|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
161753257|NCT00251589|584135739|FG000|Overall Study|Adverse Event|5|||
161753258|NCT00251589|584135740|FG001|Overall Study|Adverse Event|1|||
161753259|NCT00251589|584135741|FG002|Overall Study|Adverse Event|2|||
161753260|NCT00251589|584135742|FG003|Overall Study|Adverse Event|1|||
161753261|NCT00251589|584135739|FG000|Overall Study|Withdrawal by Subject|1|||
161753262|NCT00251589|584135740|FG001|Overall Study|Withdrawal by Subject|1|||
161753263|NCT00251589|584135741|FG002|Overall Study|Withdrawal by Subject|0|||
161753264|NCT00251589|584135742|FG003|Overall Study|Withdrawal by Subject|0|||
161753265|NCT00251589|584135739|FG000|Overall Study|Discontinued due to progressive disease|9|||
161753266|NCT00251589|584135740|FG001|Overall Study|Discontinued due to progressive disease|1|||
161753267|NCT00251589|584135741|FG002|Overall Study|Discontinued due to progressive disease|0|||
161753268|NCT00251589|584135742|FG003|Overall Study|Discontinued due to progressive disease|1|||
161753269|NCT02632344|584137497|FG000|Overall Study|Adverse Event|3|||
161753270|NCT02632344|584137497|FG000|Overall Study|Lack of Efficacy|3|||
161753271|NCT02632344|584137497|FG000|Overall Study|Withdrawal by Subject|2|||
161753272|NCT04984876|584137498|FG000|Overall Study|Subject decision|2|||
161753273|NCT04984876|584137499|FG001|Overall Study|Subject decision|10|||
161753274|NCT04984876|584137500|FG002|Overall Study|Subject decision|3|||
161753275|NCT04984876|584137501|FG003|Overall Study|Subject decision|3|||
161753276|NCT04984876|584137502|FG004|Overall Study|Subject decision|3|||
161753277|NCT04984876|584137503|FG005|Overall Study|Subject decision|0|||
161753278|NCT04984876|584137498|FG000|Overall Study|Guardian decision|0|||
161753279|NCT04984876|584137499|FG001|Overall Study|Guardian decision|1|||
161753280|NCT04984876|584137500|FG002|Overall Study|Guardian decision|0|||
161753281|NCT04984876|584137501|FG003|Overall Study|Guardian decision|2|||
161753282|NCT04984876|584137502|FG004|Overall Study|Guardian decision|0|||
161753283|NCT04984876|584137503|FG005|Overall Study|Guardian decision|1|||
161753284|NCT04984876|584137498|FG000|Overall Study|Lost to Follow-up|0|||
161753285|NCT04984876|584137499|FG001|Overall Study|Lost to Follow-up|0|||
161753286|NCT04984876|584137500|FG002|Overall Study|Lost to Follow-up|1|||
161753287|NCT04984876|584137501|FG003|Overall Study|Lost to Follow-up|1|||
161753288|NCT04984876|584137502|FG004|Overall Study|Lost to Follow-up|0|||
161753289|NCT04984876|584137503|FG005|Overall Study|Lost to Follow-up|0|||
161753290|NCT04984876|584137498|FG000|Overall Study|Physician Decision|1|||
161753291|NCT04984876|584137499|FG001|Overall Study|Physician Decision|0|||
161753292|NCT04984876|584137500|FG002|Overall Study|Physician Decision|0|||
161753293|NCT04984876|584137501|FG003|Overall Study|Physician Decision|1|||
161753294|NCT04984876|584137502|FG004|Overall Study|Physician Decision|0|||
161753295|NCT04984876|584137503|FG005|Overall Study|Physician Decision|0|||
161753296|NCT04984876|584137498|FG000|Overall Study|Adverse Event|0|||
161753297|NCT04984876|584137499|FG001|Overall Study|Adverse Event|0|||
161753298|NCT04984876|584137500|FG002|Overall Study|Adverse Event|1|||
161753299|NCT04984876|584137501|FG003|Overall Study|Adverse Event|0|||
161753300|NCT04984876|584137502|FG004|Overall Study|Adverse Event|0|||
161753301|NCT04984876|584137503|FG005|Overall Study|Adverse Event|0|||
161753302|NCT01077193|584137506|FG000|Overall Study|Lost to Follow-up|1|||
161753303|NCT01077193|584137506|FG000|Overall Study|Withdrawal by Subject|2|||
161753304|NCT01077193|584137506|FG000|Overall Study|Lack of Efficacy|1|||
161753305|NCT01077193|584137506|FG000|Overall Study|Study Terminated by Sponsor|40|||
161753306|NCT04960202|584137507|FG000|Overall Study|Other|5|||
161753307|NCT04960202|584137508|FG001|Overall Study|Other|0|||
161753308|NCT04960202|584137507|FG000|Overall Study|Withdrawal by Subject|37|||
161844919|NCT02980874|584474684|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
161753309|NCT04960202|584137508|FG001|Overall Study|Withdrawal by Subject|43|||
161753310|NCT04960202|584137507|FG000|Overall Study|Lost to Follow-up|20|||
161753311|NCT04960202|584137508|FG001|Overall Study|Lost to Follow-up|16|||
161753312|NCT04960202|584137507|FG000|Overall Study|Death|0|||
161753313|NCT04960202|584137508|FG001|Overall Study|Death|15|||
161753314|NCT03687827|584137512|FG000|Treatment Period 1|Death|0|||
161753315|NCT03687827|584137513|FG001|Treatment Period 1|Death|1|||
161753316|NCT03687827|584137512|FG000|Treatment Period 1|Lost to Follow-up|2|||
161753317|NCT03687827|584137513|FG001|Treatment Period 1|Lost to Follow-up|2|||
161753318|NCT03687827|584137512|FG000|Treatment Period 1|Physician Decision|5|||
161753319|NCT03687827|584137513|FG001|Treatment Period 1|Physician Decision|2|||
161753320|NCT03687827|584137512|FG000|Treatment Period 1|Withdrawal by Subject|7|||
161753321|NCT03687827|584137513|FG001|Treatment Period 1|Withdrawal by Subject|3|||
161753322|NCT03687827|584137512|FG000|Treatment Period 2|Physician Decision|4|||
161753323|NCT03687827|584137513|FG001|Treatment Period 2|Physician Decision|1|||
161753324|NCT03687827|584137512|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161753325|NCT03687827|584137513|FG001|Treatment Period 2|Withdrawal by Subject|2|||
161753326|NCT03377452|584137516|FG000|Overall Study|Refused assessment|0|||
161753327|NCT03377452|584137517|FG001|Overall Study|Refused assessment|2|||
161753328|NCT03377452|584137516|FG000|Overall Study|Lost to Follow-up|5|||
161753329|NCT03377452|584137517|FG001|Overall Study|Lost to Follow-up|4|||
161753330|NCT03464136|584137518|FG000|Overall Study|Lost to Follow-up|5|||
161753331|NCT03464136|584137519|FG001|Overall Study|Lost to Follow-up|8|||
161753332|NCT03464136|584137518|FG000|Overall Study|Withdrawal by Subject|16|||
161753333|NCT03464136|584137519|FG001|Overall Study|Withdrawal by Subject|13|||
161753334|NCT03464136|584137518|FG000|Overall Study|Death|1|||
161753335|NCT03464136|584137519|FG001|Overall Study|Death|0|||
161753336|NCT03464136|584137518|FG000|Overall Study|Other|8|||
161753337|NCT03464136|584137519|FG001|Overall Study|Other|4|||
161753338|NCT03146403|584137520|FG000|Overall Study|Withdrawal by Subject|0|||
161753339|NCT03146403|584137521|FG001|Overall Study|Withdrawal by Subject|3|||
161753340|NCT03146403|584137520|FG000|Overall Study|Lost to Follow-up|2|||
161753341|NCT03146403|584137521|FG001|Overall Study|Lost to Follow-up|0|||
161753342|NCT00481988|584137522|FG000|Overall Study|Withdrawal by Subject|1|||
161753343|NCT00481988|584137523|FG001|Overall Study|Withdrawal by Subject|1|||
161753344|NCT02182999|584137524|FG000|Overall Study|Adverse Event|4|||
161753345|NCT02182999|584137525|FG001|Overall Study|Adverse Event|3|||
161753346|NCT02182999|584137524|FG000|Overall Study|Physician Decision|1|||
161753347|NCT02182999|584137525|FG001|Overall Study|Physician Decision|0|||
161753348|NCT02252588|584137527|FG000|Overall Study|Withdrawal by Subject|4|||
161753349|NCT02252588|584137528|FG001|Overall Study|Withdrawal by Subject|0|||
161753350|NCT00638690|584137533|FG000|Overall Study|Death|655|||
161753351|NCT00638690|584137534|FG001|Overall Study|Death|335|||
161753352|NCT00638690|584137533|FG000|Overall Study|Withdrawal by Subject|22|||
161753353|NCT00638690|584137534|FG001|Overall Study|Withdrawal by Subject|5|||
161753354|NCT00638690|584137533|FG000|Overall Study|Lost to Follow-up|4|||
161753355|NCT00638690|584137534|FG001|Overall Study|Lost to Follow-up|2|||
161753356|NCT02203916|584137537|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161753357|NCT02203916|584137538|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161753358|NCT02203916|584137539|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
161753359|NCT02203916|584137537|FG000|Overall Study|Major Protocol Deviation|1|||
161753360|NCT02203916|584137538|FG001|Overall Study|Major Protocol Deviation|1|||
161753361|NCT02203916|584137539|FG002|Overall Study|Major Protocol Deviation|0|||
161753362|NCT02203916|584137537|FG000|Overall Study|Lost to Follow-up|0|||
161753363|NCT02203916|584137538|FG001|Overall Study|Lost to Follow-up|1|||
161753364|NCT02203916|584137539|FG002|Overall Study|Lost to Follow-up|0|||
161753365|NCT02203916|584137537|FG000|Overall Study|Voluntary Withdrawal|3|||
161753366|NCT02203916|584137538|FG001|Overall Study|Voluntary Withdrawal|3|||
161753367|NCT02203916|584137539|FG002|Overall Study|Voluntary Withdrawal|8|||
161753368|NCT02203916|584137537|FG000|Overall Study|Lack of Efficacy|3|||
161753369|NCT02203916|584137538|FG001|Overall Study|Lack of Efficacy|0|||
161753370|NCT02203916|584137539|FG002|Overall Study|Lack of Efficacy|0|||
161753371|NCT02203916|584137537|FG000|Overall Study|Reason Not Specified|0|||
161753372|NCT02203916|584137538|FG001|Overall Study|Reason Not Specified|2|||
161753373|NCT02203916|584137539|FG002|Overall Study|Reason Not Specified|1|||
161753374|NCT03152110|584137550|FG000|Overall Study|Withdrawal by Subject|3|||
161753375|NCT00552344|584137560|FG000|Overall Study|Lack of Efficacy|55|||
161753376|NCT00552344|584137560|FG000|Overall Study|Loss of efficacy|75|||
161753377|NCT00552344|584137560|FG000|Overall Study|Lost to Follow-up|8|||
161753378|NCT00552344|584137560|FG000|Overall Study|Withdrawal by Subject|48|||
161753379|NCT00552344|584137560|FG000|Overall Study|SAE, non-fatal|6|||
161753380|NCT00552344|584137560|FG000|Overall Study|AE, non-serious non-fatal|38|||
161753381|NCT00552344|584137560|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
161753382|NCT00552344|584137560|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
161753383|NCT00552344|584137560|FG000|Overall Study|Other Reason|22|||
161753384|NCT04247828|584137563|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
161753385|NCT03077711|584137564|FG000|Overall Study|Lost to Follow-up|2|||
161753386|NCT03077711|584137565|FG001|Overall Study|Lost to Follow-up|2|||
161753387|NCT03077711|584137564|FG000|Overall Study|noncompliant taking medication|2|||
161753388|NCT03077711|584137565|FG001|Overall Study|noncompliant taking medication|0|||
161753389|NCT01819194|584137568|FG000|Overall Study|Loss of study articles|2|||
161753390|NCT00045630|584137569|FG000|Overall Study|Adverse Event|1|||
161753391|NCT00045630|584137569|FG000|Overall Study|Refusal unrelated to adverse event|1|||
161753392|NCT00045630|584137569|FG000|Overall Study|Progression/relapse|1|||
161753393|NCT00045630|584137569|FG000|Overall Study|Death|1|||
161753394|NCT00045630|584137569|FG000|Overall Study|Ineligible|2|||
161753395|NCT01448707|584137576|FG000|Overall Study|Adverse Event|3|||
161753396|NCT01448707|584137577|FG001|Overall Study|Adverse Event|1|||
161753397|NCT01448707|584137576|FG000|Overall Study|Lost to Follow-up|2|||
161753398|NCT01448707|584137577|FG001|Overall Study|Lost to Follow-up|6|||
161753399|NCT01448707|584137576|FG000|Overall Study|Withdrawal by Subject|6|||
161753400|NCT01448707|584137577|FG001|Overall Study|Withdrawal by Subject|7|||
161753401|NCT01448707|584137576|FG000|Overall Study|Other|7|||
161753402|NCT01448707|584137577|FG001|Overall Study|Other|4|||
161753403|NCT00383708|584137581|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
161753404|NCT00383708|584137581|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
161753405|NCT00383708|584137581|FG000|Run-in Period|Protocol Violation|4|||
161753406|NCT00383708|584137581|FG000|Run-in Period|Adverse Event|2|||
161753407|NCT00383708|584137581|FG000|Run-in Period|Claustrophobia|1|||
161753408|NCT00383708|584137581|FG000|Co-administration Period|Adverse Event|5|||
161753409|NCT02033850|584137582|FG000|Overall Study|Death|1|||
161753410|NCT02033850|584137583|FG001|Overall Study|Death|0|||
161753411|NCT02033850|584137582|FG000|Overall Study|unrelated medical reason|1|||
161753412|NCT02033850|584137583|FG001|Overall Study|unrelated medical reason|1|||
161753413|NCT02820038|584137584|FG000|Overall Study|Lost to Follow-up|7|||
161753414|NCT02820038|584137585|FG001|Overall Study|Lost to Follow-up|11|||
161753415|NCT02820038|584137586|FG002|Overall Study|Lost to Follow-up|2|||
161753416|NCT02820038|584137587|FG003|Overall Study|Lost to Follow-up|9|||
161753417|NCT02820038|584137584|FG000|Overall Study|Withdrawal by Subject|3|||
161753418|NCT02820038|584137585|FG001|Overall Study|Withdrawal by Subject|14|||
161753419|NCT02820038|584137586|FG002|Overall Study|Withdrawal by Subject|3|||
161753420|NCT02820038|584137587|FG003|Overall Study|Withdrawal by Subject|13|||
161753421|NCT03215667|584137588|FG000|Overall Study|Physician Decision|4|||
161753422|NCT00333970|584137590|FG000|Overall Study|Withdrawal by Subject|13|||
161753423|NCT00333970|584137591|FG001|Overall Study|Withdrawal by Subject|7|||
161753424|NCT00560794|584137592|FG000|Overall Study|Adverse Event|2|||
161753425|NCT00560794|584137592|FG000|Overall Study|Patient was not Compliant|1|||
161753426|NCT00560794|584137592|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
161753427|NCT00560794|584137592|FG000|Overall Study|Hematological Relapse|1|||
161753428|NCT00560794|584137592|FG000|Overall Study|Received Bone Marrow Transplant|6|||
161753429|NCT00441480|584137593|FG000|Overall Study|Protocol Violation|1|||
161753430|NCT00441480|584137594|FG001|Overall Study|Protocol Violation|1|||
161753431|NCT00441480|584137593|FG000|Overall Study|Withdrawal by Subject|2|||
161753432|NCT00441480|584137594|FG001|Overall Study|Withdrawal by Subject|3|||
161753433|NCT00614991|584137595|FG000|Overall Study|Adverse Event|3|||
161753434|NCT00614991|584137596|FG001|Overall Study|Adverse Event|3|||
161753435|NCT00614991|584137597|FG002|Overall Study|Adverse Event|0|||
161753436|NCT00614991|584137598|FG003|Overall Study|Adverse Event|0|||
161753437|NCT00614991|584137599|FG004|Overall Study|Adverse Event|1|||
161753438|NCT00614991|584137600|FG005|Overall Study|Adverse Event|0|||
161753439|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
161753440|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
161753441|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
161753442|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
161753443|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
161753444|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
161753445|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
161753446|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
161753447|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
161753448|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
161753449|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
161753450|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
161753451|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
161753452|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
161753453|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
161753454|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
161753455|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
161753456|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
161753457|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
161753458|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
161753459|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
161753460|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
161753461|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
161753462|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
161753463|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
161753464|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
161753465|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
161753466|NCT01922739|584137606|FG000|Titration/Adjustment Period|Adverse Event|3|||
161753467|NCT01922739|584137606|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
161753468|NCT01922739|584137606|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
161753469|NCT01922739|584137606|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
161753470|NCT01922739|584137606|FG000|Open-label Treatment Period|Adverse Event|6|||
161753471|NCT01922739|584137606|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
161753472|NCT01922739|584137606|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
161753473|NCT01922739|584137606|FG000|Open-label Treatment Period|Protocol Violation|5|||
161753474|NCT01922739|584137606|FG000|Open-label Treatment Period|Pregnancy|1|||
161753475|NCT01922739|584137606|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
161753476|NCT01922739|584137606|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
161753477|NCT01922739|584137606|FG000|Open-label Treatment Period|Physician Decision|1|||
161753478|NCT01922739|584137606|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
161753479|NCT02963766|584137607|FG000|Double-Blind Period|Adverse Event|1|||
161753480|NCT02963766|584137608|FG001|Double-Blind Period|Adverse Event|0|||
161753481|NCT02963766|584137609|FG002|Double-Blind Period|Adverse Event|1|||
161753482|NCT02963766|584137607|FG000|Double-Blind Period|Physician Decision|1|||
161753483|NCT02963766|584137608|FG001|Double-Blind Period|Physician Decision|0|||
161753484|NCT02963766|584137609|FG002|Double-Blind Period|Physician Decision|0|||
161753485|NCT02963766|584137607|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161753486|NCT02963766|584137608|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161753487|NCT02963766|584137609|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161753488|NCT02963766|584137607|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
161753489|NCT02963766|584137608|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
161753490|NCT02963766|584137609|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
161753491|NCT02963766|584137607|FG000|Double-Blind Period|Protocol Violation|1|||
161753492|NCT02963766|584137608|FG001|Double-Blind Period|Protocol Violation|0|||
161753493|NCT02963766|584137609|FG002|Double-Blind Period|Protocol Violation|0|||
161753494|NCT02963766|584137607|FG000|Double-Blind Period|Lost to Follow-up|0|||
161753495|NCT02963766|584137608|FG001|Double-Blind Period|Lost to Follow-up|1|||
161753496|NCT02963766|584137609|FG002|Double-Blind Period|Lost to Follow-up|0|||
161753497|NCT02963766|584137607|FG000|Open Label Extension (OLE)|Physician Decision|1|||
161753498|NCT02963766|584137608|FG001|Open Label Extension (OLE)|Physician Decision|2|||
161753499|NCT02963766|584137609|FG002|Open Label Extension (OLE)|Physician Decision|2|||
161753500|NCT02963766|584137607|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
161753501|NCT02963766|584137608|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
161753502|NCT02963766|584137609|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
161753503|NCT02290340|584137612|FG000|Overall Study|Lost to Follow-up|0|||
161753504|NCT02290340|584137613|FG001|Overall Study|Lost to Follow-up|0|||
161753505|NCT02290340|584137614|FG002|Overall Study|Lost to Follow-up|0|||
161753506|NCT02290340|584137615|FG003|Overall Study|Lost to Follow-up|1|||
161753507|NCT02290340|584137612|FG000|Overall Study|Withdrawal by Subject|1|||
161753508|NCT02290340|584137613|FG001|Overall Study|Withdrawal by Subject|0|||
161753509|NCT02290340|584137614|FG002|Overall Study|Withdrawal by Subject|0|||
161753510|NCT02290340|584137615|FG003|Overall Study|Withdrawal by Subject|0|||
161753511|NCT02290340|584137612|FG000|Overall Study|Other|1|||
161753512|NCT02290340|584137613|FG001|Overall Study|Other|0|||
161753513|NCT02290340|584137614|FG002|Overall Study|Other|0|||
161753514|NCT02290340|584137615|FG003|Overall Study|Other|1|||
161753515|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Adverse Event|22|||
161753516|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Adverse Event|0|||
161753517|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
161753518|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
161753519|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
161753520|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
161753521|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
161753522|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
161753523|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
161753524|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
161753525|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
161753526|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
161753527|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Other|8|||
161753528|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Other|0|||
161753529|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
161753530|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
161753531|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
161753532|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
161753533|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
161753534|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
161753535|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
161753536|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
161753537|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
161753538|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
161753539|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
161753540|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
161753541|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
161753542|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
161753543|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Other|10|||
161753544|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Other|2|||
161753545|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
161753546|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
161753547|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
161753548|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
161753549|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
161753550|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
161753551|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
161753552|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
161753553|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
161753554|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
161753555|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
161753556|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
161753557|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
161753558|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
161753559|NCT02493868|584137621|FG000|Follow-up Phase|Lost to Follow-up|1|||
161753560|NCT02493868|584137622|FG001|Follow-up Phase|Lost to Follow-up|0|||
161753561|NCT02493868|584137621|FG000|Follow-up Phase|Withdrawal by Subject|3|||
161753562|NCT02493868|584137622|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161753563|NCT02493868|584137621|FG000|Follow-up Phase|Investigator Decision|5|||
161753564|NCT02493868|584137622|FG001|Follow-up Phase|Investigator Decision|1|||
161753565|NCT02493868|584137621|FG000|Follow-up Phase|Other|2|||
161753566|NCT02493868|584137622|FG001|Follow-up Phase|Other|1|||
161753567|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
161753568|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
161753569|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
161753570|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
161753571|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
161753572|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
161753573|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
161753574|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
161753575|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
161753576|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
161753577|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
161753578|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
161753579|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
161753580|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Death|0|||
161753581|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Death|0|||
161753582|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Death|1|||
161753583|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Death|0|||
161753584|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Death|0|||
161753585|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Death|0|||
161753586|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Death|0|||
161753587|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Death|0|||
161753588|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Death|0|||
161753589|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Death|0|||
161753590|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Death|0|||
161753591|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Death|0|||
161753592|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Death|0|||
161753593|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
161753594|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
161753595|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
161753596|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753597|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753598|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753599|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753600|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753601|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753602|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753603|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753604|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753605|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753606|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753607|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753608|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
161753609|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753610|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753611|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753612|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753613|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753614|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753615|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753616|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753617|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753618|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753619|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
161753620|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
161753621|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
161753622|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
161753623|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
161753624|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
161753625|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
161753626|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
161753627|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
161753628|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
161753629|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
161753630|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
161753631|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
161753632|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Other|2|||
161753633|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Other|1|||
161753634|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Other|5|||
161753635|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Other|0|||
161753636|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Other|0|||
161753637|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Other|0|||
161753638|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Other|0|||
161753639|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Other|0|||
161753640|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Other|0|||
161753641|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Other|0|||
161753642|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Other|0|||
161753643|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Other|0|||
161753644|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Other|0|||
161753645|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753646|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753647|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753648|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
161753649|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
161753650|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
161753651|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
161753652|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
161753653|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753654|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753655|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753656|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753657|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753658|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753659|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753660|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753661|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
161753662|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
161753663|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
161753664|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
161753665|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
161753666|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753667|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753668|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753669|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753670|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753671|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Other|0|||
161753672|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Other|0|||
161753673|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Other|0|||
161753674|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Other|5|||
161753675|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Other|7|||
161753676|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Other|8|||
161753677|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Other|4|||
161753678|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Other|6|||
161753679|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Other|0|||
161753680|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Other|0|||
161753681|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Other|0|||
161753682|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Other|0|||
161753683|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Other|0|||
161753684|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Death|0|||
161753685|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Death|0|||
161753686|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Death|0|||
161753687|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Death|0|||
161753688|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Death|0|||
161753689|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Death|0|||
161753690|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Death|0|||
161753691|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Death|1|||
161753692|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Death|0|||
161753693|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Death|0|||
161753694|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Death|0|||
161753695|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Death|0|||
161753696|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Death|0|||
161753697|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753698|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753699|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753700|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753701|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753702|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753703|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753704|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753705|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
161753706|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
161753707|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
161753708|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
161753709|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
161753710|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753711|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753712|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753713|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753714|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753715|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753716|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753717|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753718|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753719|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753720|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
161753721|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753722|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753723|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753724|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753725|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753726|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753727|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753728|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753729|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753730|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753731|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
161753732|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
161753733|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
161753734|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
161753735|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
161753736|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
161753737|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
161753738|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
161753739|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
161753740|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
161753741|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
161753742|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
161753743|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
161753744|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
161753745|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
161753746|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
161753747|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
161753748|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
161753749|NCT03039569|584137638|FG000|Overall Study|Lost to Follow-up|5|||
161753750|NCT03039569|584137639|FG001|Overall Study|Lost to Follow-up|4|||
161753751|NCT01167153|584137640|FG000|Overall Study|Non-effective therapy|1|||
161753752|NCT01167153|584137641|FG001|Overall Study|Non-effective therapy|4|||
161753753|NCT01167153|584137640|FG000|Overall Study|AE including clinical laboratory AE|2|||
161753754|NCT01167153|584137641|FG001|Overall Study|AE including clinical laboratory AE|8|||
161753755|NCT01167153|584137640|FG000|Overall Study|Hypotension|1|||
161753756|NCT01167153|584137641|FG001|Overall Study|Hypotension|0|||
161753757|NCT01167153|584137640|FG000|Overall Study|Lost to Follow-up|7|||
161753758|NCT01167153|584137641|FG001|Overall Study|Lost to Follow-up|9|||
161753759|NCT01167153|584137640|FG000|Overall Study|Non-compliance to concomitant medication|0|||
161753760|NCT01167153|584137641|FG001|Overall Study|Non-compliance to concomitant medication|2|||
161753761|NCT01167153|584137640|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
161753762|NCT01167153|584137641|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
161753763|NCT01167153|584137640|FG000|Overall Study|Withdrawal consent|1|||
161753764|NCT01167153|584137641|FG001|Overall Study|Withdrawal consent|1|||
161753765|NCT01167153|584137640|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
161753766|NCT01167153|584137641|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
161753767|NCT04888507|584139488|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
161753768|NCT00636155|584139489|FG000|Overall Study|Adverse Event|8|||
161753769|NCT00636155|584139489|FG000|Overall Study|Lack of Efficacy|1|||
161753770|NCT00636155|584139489|FG000|Overall Study|Withdrawal by Subject|3|||
161753771|NCT00636155|584139489|FG000|Overall Study|Stem cell transplant|1|||
161753772|NCT00636155|584139489|FG000|Overall Study|Physician Decision|5|||
161753773|NCT00766142|584139490|FG000|Overall Study|Protocol Violation|4|||
161753774|NCT05643170|584139496|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
161753775|NCT05643170|584139496|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
161753776|NCT00777257|584139500|FG000|Overall Study|Adverse Event|3|||
161753777|NCT00777257|584139501|FG001|Overall Study|Adverse Event|1|||
161753778|NCT00777257|584139502|FG002|Overall Study|Adverse Event|0|||
161753779|NCT00777257|584139500|FG000|Overall Study|Lost to Follow-up|3|||
161753780|NCT00777257|584139501|FG001|Overall Study|Lost to Follow-up|3|||
161753781|NCT00777257|584139502|FG002|Overall Study|Lost to Follow-up|2|||
161753782|NCT00777257|584139500|FG000|Overall Study|Protocol Violation|2|||
161753783|NCT00777257|584139501|FG001|Overall Study|Protocol Violation|2|||
161753784|NCT00777257|584139502|FG002|Overall Study|Protocol Violation|2|||
161753785|NCT00777257|584139500|FG000|Overall Study|Withdrawal by Subject|3|||
161753786|NCT00777257|584139501|FG001|Overall Study|Withdrawal by Subject|6|||
161753787|NCT00777257|584139502|FG002|Overall Study|Withdrawal by Subject|5|||
161753788|NCT01431521|584139506|FG000|Overall Study|Withdrawal by Subject|0|||
161753789|NCT01431521|584139507|FG001|Overall Study|Withdrawal by Subject|0|||
161753790|NCT01431521|584139508|FG002|Overall Study|Withdrawal by Subject|1|||
161753791|NCT01431521|584139509|FG003|Overall Study|Withdrawal by Subject|0|||
161753792|NCT02710422|584139510|FG000|Overall Study|Termination of study|9|||
161753793|NCT02710422|584139511|FG001|Overall Study|Termination of study|9|||
161753794|NCT01370499|584139512|FG000|Overall Study|Adverse Event|38|||
161753795|NCT01370499|584139513|FG001|Overall Study|Adverse Event|12|||
161753796|NCT01370499|584139512|FG000|Overall Study|Lack of Efficacy|4|||
161753797|NCT01370499|584139513|FG001|Overall Study|Lack of Efficacy|2|||
161753798|NCT01370499|584139512|FG000|Overall Study|Lost to Follow-up|2|||
161753799|NCT01370499|584139513|FG001|Overall Study|Lost to Follow-up|1|||
161753800|NCT01370499|584139512|FG000|Overall Study|Physician Decision|3|||
161753801|NCT01370499|584139513|FG001|Overall Study|Physician Decision|3|||
161753802|NCT01370499|584139512|FG000|Overall Study|Protocol Violation|5|||
161753803|NCT01370499|584139513|FG001|Overall Study|Protocol Violation|4|||
161753804|NCT01370499|584139512|FG000|Overall Study|Withdrawal by Subject|18|||
161753805|NCT01370499|584139513|FG001|Overall Study|Withdrawal by Subject|7|||
161753806|NCT01370499|584139512|FG000|Overall Study|Sponsor Decision|41|||
161753807|NCT01370499|584139513|FG001|Overall Study|Sponsor Decision|15|||
161753808|NCT02000622|584139514|FG000|Overall Study|Withdrawal by Subject|5|||
161753809|NCT02000622|584139515|FG001|Overall Study|Withdrawal by Subject|7|||
161753810|NCT02000622|584139514|FG000|Overall Study|Lost to Follow-up|4|||
161753811|NCT02000622|584139515|FG001|Overall Study|Lost to Follow-up|0|||
161753812|NCT02000622|584139514|FG000|Overall Study|Death|159|||
161753813|NCT02000622|584139515|FG001|Overall Study|Death|73|||
161753814|NCT02000622|584139514|FG000|Overall Study|Withdrawn due to site closure|1|||
161753815|NCT02000622|584139515|FG001|Overall Study|Withdrawn due to site closure|0|||
161753816|NCT01462045|584139516|FG000|Overall Study|Family matter|0|||
161753817|NCT01462045|584139517|FG001|Overall Study|Family matter|1|||
161753818|NCT01462045|584139518|FG002|Overall Study|Family matter|0|||
161753819|NCT01938391|584139519|FG000|6 Month Follow up|Withdrawal by Subject|1|||
161753820|NCT01938391|584139519|FG000|12 Month Follow up|Physician Decision|1|||
161753821|NCT01938391|584139519|FG000|12 Month Follow up|Withdrawal by Subject|1|||
161753822|NCT04924114|584139523|FG000|Overall Study|Withdrawal by Subject|0|||
161753823|NCT04924114|584139524|FG001|Overall Study|Withdrawal by Subject|2|||
161753824|NCT04924114|584139525|FG002|Overall Study|Withdrawal by Subject|2|||
161753825|NCT04924114|584139526|FG003|Overall Study|Withdrawal by Subject|0|||
161753826|NCT04924114|584139527|FG004|Overall Study|Withdrawal by Subject|2|||
161753827|NCT03558828|584139528|FG000|Overall Study|Lost to Follow-up|4|||
161753828|NCT03558828|584139529|FG001|Overall Study|Lost to Follow-up|3|||
161753829|NCT03558828|584139530|FG002|Overall Study|Lost to Follow-up|3|||
161753830|NCT03558828|584139531|FG003|Overall Study|Lost to Follow-up|5|||
161753831|NCT03558828|584139532|FG004|Overall Study|Lost to Follow-up|2|||
161753832|NCT03558828|584139533|FG005|Overall Study|Lost to Follow-up|3|||
161753833|NCT03558828|584139528|FG000|Overall Study|dropped before the intervention|1|||
161753834|NCT03558828|584139529|FG001|Overall Study|dropped before the intervention|1|||
161753835|NCT03558828|584139530|FG002|Overall Study|dropped before the intervention|0|||
161753836|NCT03558828|584139531|FG003|Overall Study|dropped before the intervention|0|||
161753837|NCT03558828|584139532|FG004|Overall Study|dropped before the intervention|0|||
161753838|NCT03558828|584139533|FG005|Overall Study|dropped before the intervention|0|||
161753839|NCT03671148|584139534|FG000|Overall Study|Adverse Event|3|||
161753840|NCT03671148|584139535|FG001|Overall Study|Adverse Event|2|||
161753841|NCT03671148|584139534|FG000|Overall Study|Withdrawal by Subject|8|||
161753842|NCT03671148|584139535|FG001|Overall Study|Withdrawal by Subject|2|||
161753843|NCT03671148|584139534|FG000|Overall Study|Lost to Follow-up|1|||
161753844|NCT03671148|584139535|FG001|Overall Study|Lost to Follow-up|2|||
161753845|NCT03671148|584139534|FG000|Overall Study|Lack of Efficacy|7|||
161753846|NCT03671148|584139535|FG001|Overall Study|Lack of Efficacy|2|||
161753847|NCT03671148|584139534|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
161753848|NCT03671148|584139535|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161753849|NCT03671148|584139534|FG000|Overall Study|Other|1|||
161753850|NCT03671148|584139535|FG001|Overall Study|Other|0|||
161753851|NCT03671148|584139534|FG000|Overall Study|Incomplete Randomization Visit|1|||
161753852|NCT03671148|584139535|FG001|Overall Study|Incomplete Randomization Visit|0|||
161753853|NCT00673816|584139536|FG000|Overall Study|Adverse Event|1|||
161753854|NCT00673816|584139536|FG000|Overall Study|Withdrawal by Subject|1|||
161753855|NCT01804842|584139540|FG000|Overall Study|Adverse Event|1|||
161753856|NCT01804842|584139541|FG001|Overall Study|Adverse Event|1|||
161753857|NCT01804842|584139542|FG002|Overall Study|Adverse Event|0|||
161753858|NCT01804842|584139540|FG000|Overall Study|Lost to Follow-up|1|||
161753859|NCT01804842|584139541|FG001|Overall Study|Lost to Follow-up|0|||
161753860|NCT01804842|584139542|FG002|Overall Study|Lost to Follow-up|0|||
161753861|NCT01804842|584139540|FG000|Overall Study|Non-Compliance|1|||
161753862|NCT01804842|584139541|FG001|Overall Study|Non-Compliance|1|||
161753863|NCT01804842|584139542|FG002|Overall Study|Non-Compliance|0|||
161753864|NCT01804842|584139540|FG000|Overall Study|Personal Reason|0|||
161753865|NCT01804842|584139541|FG001|Overall Study|Personal Reason|0|||
161753866|NCT01804842|584139542|FG002|Overall Study|Personal Reason|1|||
161753867|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
161753868|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
161753869|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
161753870|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
161753871|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
161753872|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
161753873|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
161753874|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
161753875|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
161753876|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
161753877|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
161753878|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
161753879|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
161753880|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
161753881|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
161753882|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
161753883|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
161753884|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
161753885|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
161753886|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
161753887|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
161753888|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
161753889|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
161753890|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
161753891|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
161753892|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
161753893|NCT02352090|584139547|FG000|Overall Study|general malaise|1|||
161753894|NCT02352090|584139548|FG001|Overall Study|general malaise|0|||
161753895|NCT02352090|584139549|FG002|Overall Study|general malaise|0|||
161753896|NCT02352090|584139547|FG000|Overall Study|non-specified mild side-effects|0|||
161753897|NCT02352090|584139548|FG001|Overall Study|non-specified mild side-effects|0|||
161753898|NCT02352090|584139549|FG002|Overall Study|non-specified mild side-effects|2|||
161753899|NCT00413777|584139551|FG000|Fixed-dose Period|Lost to Follow-up|1|||
161753900|NCT00413777|584139552|FG001|Fixed-dose Period|Lost to Follow-up|1|||
161753901|NCT00413777|584139551|FG000|Fixed-dose Period|Adverse Event|2|||
161753902|NCT00413777|584139552|FG001|Fixed-dose Period|Adverse Event|1|||
161753903|NCT00413777|584139551|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
161753904|NCT00413777|584139552|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
161753905|NCT00413777|584139551|FG000|Fixed-dose Period|Withdrew Consent|0|||
161753906|NCT00413777|584139552|FG001|Fixed-dose Period|Withdrew Consent|1|||
161753907|NCT01678313|584139553|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
161753908|NCT01678313|584139554|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
161753909|NCT01678313|584139553|FG000|Completed the 3-month Therapy|Physician Decision|3|||
161753910|NCT01678313|584139554|FG001|Completed the 3-month Therapy|Physician Decision|4|||
161753911|NCT01678313|584139553|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
161753912|NCT01678313|584139554|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
161753913|NCT01678313|584139553|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
161753914|NCT01678313|584139554|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
161753915|NCT05179057|584139555|FG000|Overall Study|Adverse Event|3|||
161753916|NCT05179057|584139556|FG001|Overall Study|Adverse Event|2|||
161753917|NCT05179057|584139555|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
161753918|NCT05179057|584139556|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
161753919|NCT05179057|584139555|FG000|Overall Study|Study terminated|13|||
161753920|NCT05179057|584139556|FG001|Overall Study|Study terminated|7|||
161753921|NCT05179057|584139555|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
161753922|NCT05179057|584139556|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
161753923|NCT05179057|584139555|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
161753924|NCT05179057|584139556|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
161753925|NCT03345342|584139557|FG000|Open-Label Phase|Adverse Event|30|||
161753926|NCT03345342|584139558|FG001|Open-Label Phase|Adverse Event|0|||
161753927|NCT03345342|584139559|FG002|Open-Label Phase|Adverse Event|0|||
161753928|NCT03345342|584139560|FG003|Open-Label Phase|Adverse Event|0|||
161753929|NCT03345342|584139561|FG004|Open-Label Phase|Adverse Event|0|||
161753930|NCT03345342|584139557|FG000|Open-Label Phase|Death|1|||
161753931|NCT03345342|584139558|FG001|Open-Label Phase|Death|0|||
161753932|NCT03345342|584139559|FG002|Open-Label Phase|Death|0|||
161753933|NCT03345342|584139560|FG003|Open-Label Phase|Death|0|||
161753934|NCT03345342|584139561|FG004|Open-Label Phase|Death|0|||
161753935|NCT03345342|584139557|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
161753936|NCT03345342|584139558|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
161753937|NCT03345342|584139559|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
161753938|NCT03345342|584139560|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
161753939|NCT03345342|584139561|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
161753940|NCT03345342|584139557|FG000|Open-Label Phase|Lack of Efficacy|6|||
161753941|NCT03345342|584139558|FG001|Open-Label Phase|Lack of Efficacy|0|||
161753942|NCT03345342|584139559|FG002|Open-Label Phase|Lack of Efficacy|0|||
161753943|NCT03345342|584139560|FG003|Open-Label Phase|Lack of Efficacy|0|||
161753944|NCT03345342|584139561|FG004|Open-Label Phase|Lack of Efficacy|0|||
161753945|NCT03345342|584139557|FG000|Open-Label Phase|Lost to Follow-up|9|||
161753946|NCT03345342|584139558|FG001|Open-Label Phase|Lost to Follow-up|0|||
161753947|NCT03345342|584139559|FG002|Open-Label Phase|Lost to Follow-up|0|||
161753948|NCT03345342|584139560|FG003|Open-Label Phase|Lost to Follow-up|0|||
161753949|NCT03345342|584139561|FG004|Open-Label Phase|Lost to Follow-up|0|||
161753950|NCT03345342|584139557|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
161753951|NCT03345342|584139558|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753952|NCT03345342|584139559|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753953|NCT03345342|584139560|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753954|NCT03345342|584139561|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753955|NCT03345342|584139557|FG000|Open-Label Phase|Physician Decision|4|||
161753956|NCT03345342|584139558|FG001|Open-Label Phase|Physician Decision|0|||
161753957|NCT03345342|584139559|FG002|Open-Label Phase|Physician Decision|0|||
161753958|NCT03345342|584139560|FG003|Open-Label Phase|Physician Decision|0|||
161753959|NCT03345342|584139561|FG004|Open-Label Phase|Physician Decision|0|||
161753960|NCT03345342|584139557|FG000|Open-Label Phase|Protocol Violation|8|||
161753961|NCT03345342|584139558|FG001|Open-Label Phase|Protocol Violation|0|||
161753962|NCT03345342|584139559|FG002|Open-Label Phase|Protocol Violation|0|||
161753963|NCT03345342|584139560|FG003|Open-Label Phase|Protocol Violation|0|||
161753964|NCT03345342|584139561|FG004|Open-Label Phase|Protocol Violation|0|||
161753965|NCT03345342|584139557|FG000|Open-Label Phase|Withdrawal by Subject|57|||
161753966|NCT03345342|584139558|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161753967|NCT03345342|584139559|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161753968|NCT03345342|584139560|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161753969|NCT03345342|584139561|FG004|Open-Label Phase|Withdrawal by Subject|0|||
161753970|NCT03345342|584139557|FG000|Open-Label Phase|Other|15|||
161753971|NCT03345342|584139558|FG001|Open-Label Phase|Other|0|||
161753972|NCT03345342|584139559|FG002|Open-Label Phase|Other|0|||
161753973|NCT03345342|584139560|FG003|Open-Label Phase|Other|0|||
161753974|NCT03345342|584139561|FG004|Open-Label Phase|Other|0|||
161753975|NCT03345342|584139557|FG000|Double-Blind Phase|Adverse Event|0|||
161753976|NCT03345342|584139558|FG001|Double-Blind Phase|Adverse Event|1|||
161753977|NCT03345342|584139559|FG002|Double-Blind Phase|Adverse Event|6|||
161753978|NCT03345342|584139560|FG003|Double-Blind Phase|Adverse Event|0|||
161753979|NCT03345342|584139561|FG004|Double-Blind Phase|Adverse Event|0|||
161753980|NCT03345342|584139557|FG000|Double-Blind Phase|Death|0|||
161753981|NCT03345342|584139558|FG001|Double-Blind Phase|Death|2|||
161753982|NCT03345342|584139559|FG002|Double-Blind Phase|Death|1|||
161753983|NCT03345342|584139560|FG003|Double-Blind Phase|Death|0|||
161753984|NCT03345342|584139561|FG004|Double-Blind Phase|Death|0|||
161753985|NCT03345342|584139557|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
161753986|NCT03345342|584139558|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
161753987|NCT03345342|584139559|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
161753988|NCT03345342|584139560|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
161753989|NCT03345342|584139561|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
161753990|NCT03345342|584139557|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161753991|NCT03345342|584139558|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161753992|NCT03345342|584139559|FG002|Double-Blind Phase|Lost to Follow-up|7|||
161753993|NCT03345342|584139560|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161753994|NCT03345342|584139561|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161753995|NCT03345342|584139557|FG000|Double-Blind Phase|Physician Decision|0|||
161753996|NCT03345342|584139558|FG001|Double-Blind Phase|Physician Decision|1|||
161753997|NCT03345342|584139559|FG002|Double-Blind Phase|Physician Decision|4|||
161753998|NCT03345342|584139560|FG003|Double-Blind Phase|Physician Decision|0|||
161753999|NCT03345342|584139561|FG004|Double-Blind Phase|Physician Decision|0|||
161754000|NCT03345342|584139557|FG000|Double-Blind Phase|Protocol Violation|0|||
161754001|NCT03345342|584139558|FG001|Double-Blind Phase|Protocol Violation|0|||
161754002|NCT03345342|584139559|FG002|Double-Blind Phase|Protocol Violation|1|||
161754003|NCT03345342|584139560|FG003|Double-Blind Phase|Protocol Violation|0|||
161754004|NCT03345342|584139561|FG004|Double-Blind Phase|Protocol Violation|0|||
161754005|NCT03345342|584139557|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161754006|NCT03345342|584139558|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
161754007|NCT03345342|584139559|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
161754008|NCT03345342|584139560|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161754009|NCT03345342|584139561|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161754010|NCT03345342|584139557|FG000|Double-Blind Phase|Other|0|||
161754011|NCT03345342|584139558|FG001|Double-Blind Phase|Other|1|||
161754012|NCT03345342|584139559|FG002|Double-Blind Phase|Other|3|||
161754013|NCT03345342|584139560|FG003|Double-Blind Phase|Other|0|||
161754014|NCT03345342|584139561|FG004|Double-Blind Phase|Other|0|||
161754015|NCT03345342|584139557|FG000|Follow-Up Phase|Adverse Event|0|||
161754016|NCT03345342|584139558|FG001|Follow-Up Phase|Adverse Event|0|||
161754017|NCT03345342|584139559|FG002|Follow-Up Phase|Adverse Event|0|||
161754018|NCT03345342|584139560|FG003|Follow-Up Phase|Adverse Event|0|||
161754019|NCT03345342|584139561|FG004|Follow-Up Phase|Adverse Event|4|||
161754020|NCT03345342|584139557|FG000|Follow-Up Phase|Lost to Follow-up|0|||
161754021|NCT03345342|584139558|FG001|Follow-Up Phase|Lost to Follow-up|0|||
161754022|NCT03345342|584139559|FG002|Follow-Up Phase|Lost to Follow-up|0|||
161754023|NCT03345342|584139560|FG003|Follow-Up Phase|Lost to Follow-up|0|||
161754024|NCT03345342|584139561|FG004|Follow-Up Phase|Lost to Follow-up|6|||
161754025|NCT03345342|584139557|FG000|Follow-Up Phase|Physician Decision|0|||
161754026|NCT03345342|584139558|FG001|Follow-Up Phase|Physician Decision|0|||
161754027|NCT03345342|584139559|FG002|Follow-Up Phase|Physician Decision|0|||
161754028|NCT03345342|584139560|FG003|Follow-Up Phase|Physician Decision|0|||
161754029|NCT03345342|584139561|FG004|Follow-Up Phase|Physician Decision|5|||
161754030|NCT03345342|584139557|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161754031|NCT03345342|584139558|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
161754032|NCT03345342|584139559|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
161754033|NCT03345342|584139560|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
161754034|NCT03345342|584139561|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
161754035|NCT03345342|584139557|FG000|Follow-Up Phase|Other|0|||
161754036|NCT03345342|584139558|FG001|Follow-Up Phase|Other|0|||
161754037|NCT03345342|584139559|FG002|Follow-Up Phase|Other|0|||
161754038|NCT03345342|584139560|FG003|Follow-Up Phase|Other|3|||
161754039|NCT03345342|584139561|FG004|Follow-Up Phase|Other|1|||
161754040|NCT03375203|584139562|FG000|Overall Study|Protocol Violation|0|||
161754041|NCT03375203|584139563|FG001|Overall Study|Protocol Violation|0|||
161754042|NCT03375203|584139564|FG002|Overall Study|Protocol Violation|1|||
161754043|NCT03375203|584139565|FG003|Overall Study|Protocol Violation|0|||
161754044|NCT03375203|584139566|FG004|Overall Study|Protocol Violation|0|||
161754045|NCT03375203|584139562|FG000|Overall Study|Adverse Event|2|||
161754046|NCT03375203|584139563|FG001|Overall Study|Adverse Event|3|||
161754047|NCT03375203|584139564|FG002|Overall Study|Adverse Event|0|||
161754048|NCT03375203|584139565|FG003|Overall Study|Adverse Event|2|||
161754049|NCT03375203|584139566|FG004|Overall Study|Adverse Event|2|||
161754050|NCT03375203|584139562|FG000|Overall Study|Withdrawal by Subject|3|||
161754051|NCT03375203|584139563|FG001|Overall Study|Withdrawal by Subject|0|||
161754052|NCT03375203|584139564|FG002|Overall Study|Withdrawal by Subject|1|||
161754053|NCT03375203|584139565|FG003|Overall Study|Withdrawal by Subject|0|||
161754054|NCT03375203|584139566|FG004|Overall Study|Withdrawal by Subject|2|||
161754055|NCT03375203|584139562|FG000|Overall Study|Non-compliance with study drug|1|||
161754056|NCT03375203|584139563|FG001|Overall Study|Non-compliance with study drug|0|||
161754057|NCT03375203|584139564|FG002|Overall Study|Non-compliance with study drug|0|||
161754058|NCT03375203|584139565|FG003|Overall Study|Non-compliance with study drug|0|||
161754059|NCT03375203|584139566|FG004|Overall Study|Non-compliance with study drug|0|||
161754060|NCT03375203|584139562|FG000|Overall Study|Randomized, not treated.|0|||
161754061|NCT03375203|584139563|FG001|Overall Study|Randomized, not treated.|1|||
161754062|NCT03375203|584139564|FG002|Overall Study|Randomized, not treated.|0|||
161754063|NCT03375203|584139565|FG003|Overall Study|Randomized, not treated.|0|||
161754064|NCT03375203|584139566|FG004|Overall Study|Randomized, not treated.|0|||
161754065|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
161754066|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
161754067|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161754068|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
161754069|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161754070|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
161754071|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
161754072|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
161754073|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
161754074|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
161754075|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
161754076|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
161754077|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
161754078|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
161754079|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
161754080|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
161754081|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754082|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754083|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754084|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754085|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161754086|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
161754087|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
161754088|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161754089|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161754090|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161754091|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161754092|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
161754093|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161754094|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161754095|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754096|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754097|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
161754098|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754099|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754100|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161754101|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
161754102|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
161754103|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161754104|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161754105|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
161754106|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
161754107|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
161754108|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
161754109|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
161754110|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161754111|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
161754112|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
161754113|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161754114|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161754115|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754116|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161754117|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754118|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754119|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754120|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161754121|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
161754122|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
161754123|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161754124|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161754125|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754126|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754127|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
161754128|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754129|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754130|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161754131|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
161754132|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
161754133|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161754134|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161754135|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161754136|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161754137|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161754138|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
161754139|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
161754140|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754141|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754142|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754143|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754144|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
161754145|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161754146|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161754147|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161754148|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
161754149|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
161754150|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Death|0|||
161754151|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Death|0|||
161754152|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Death|0|||
161754153|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Death|0|||
161754154|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Death|1|||
161754155|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754156|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754157|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754158|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754159|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
161754160|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161754161|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161754162|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161754163|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
161754164|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
161754165|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161754166|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161754167|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161754168|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
161754169|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
161754170|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754171|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754172|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754173|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754174|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
161754175|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754176|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754177|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754178|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
161754179|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754180|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Other|0|||
161754181|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Other|0|||
161754182|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Other|0|||
161754183|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Other|1|||
161754184|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Other|3|||
161754185|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161754186|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161754187|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161754188|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
161754189|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
161754190|NCT03277105|584139572|FG000|Overall Study|Death|129|||
161754191|NCT03277105|584139573|FG001|Overall Study|Death|124|||
161754192|NCT03277105|584139572|FG000|Overall Study|Lost to Follow-up|2|||
161754193|NCT03277105|584139573|FG001|Overall Study|Lost to Follow-up|4|||
161754194|NCT03277105|584139572|FG000|Overall Study|Withdrawal by Subject|10|||
161754195|NCT03277105|584139573|FG001|Overall Study|Withdrawal by Subject|10|||
161754196|NCT03277105|584139572|FG000|Overall Study|Other|118|||
161754197|NCT03277105|584139573|FG001|Overall Study|Other|125|||
161754198|NCT05180721|584139577|FG000|Overall Study|Lost to Follow-up|4|||
161754199|NCT02040857|584139581|FG000|Overall Study|Adverse Event|14|||
161754200|NCT02040857|584139581|FG000|Overall Study|Physician Decision|5|||
161754201|NCT02040857|584139581|FG000|Overall Study|Withdrawal by Subject|31|||
161754202|NCT02040857|584139581|FG000|Overall Study|patient non-compliance|3|||
161754203|NCT02040857|584139581|FG000|Overall Study|Lost to Follow-up|2|||
161754204|NCT02040857|584139581|FG000|Overall Study|recurrence|4|||
161754205|NCT02040857|584139581|FG000|Overall Study|ineligible|1|||
161754206|NCT00976963|584139582|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
161754207|NCT00976963|584139583|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
161754208|NCT00976963|584139582|FG000|Overall Study|administrative error|1|||
161754209|NCT00976963|584139583|FG001|Overall Study|administrative error|0|||
161754210|NCT00976963|584139582|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
161754211|NCT00976963|584139583|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
161754212|NCT00608842|584139584|FG000|Overall Study|Participant's Request|0|||
161754213|NCT00608842|584139585|FG001|Overall Study|Participant's Request|1|||
161754214|NCT00608842|584139586|FG002|Overall Study|Participant's Request|2|||
161754215|NCT00608842|584139587|FG003|Overall Study|Participant's Request|1|||
161754216|NCT00608842|584139584|FG000|Overall Study|Lost to Follow-up|1|||
161754217|NCT00608842|584139585|FG001|Overall Study|Lost to Follow-up|0|||
161754218|NCT00608842|584139586|FG002|Overall Study|Lost to Follow-up|0|||
161754219|NCT00608842|584139587|FG003|Overall Study|Lost to Follow-up|0|||
161754220|NCT01024920|584139588|FG000|Overall Study|Progressive disease|47|||
161754221|NCT01024920|584139589|FG001|Overall Study|Progressive disease|25|||
161754222|NCT01024920|584139588|FG000|Overall Study|Adverse Event|8|||
161754223|NCT01024920|584139589|FG001|Overall Study|Adverse Event|4|||
161754224|NCT01024920|584139588|FG000|Overall Study|Lost to Follow-up|0|||
161754225|NCT01024920|584139589|FG001|Overall Study|Lost to Follow-up|1|||
161754226|NCT01024920|584139588|FG000|Overall Study|Patient refusal to continue|4|||
161754227|NCT01024920|584139589|FG001|Overall Study|Patient refusal to continue|0|||
161754228|NCT01024920|584139588|FG000|Overall Study|Other than listed|5|||
161754229|NCT01024920|584139589|FG001|Overall Study|Other than listed|1|||
161754230|NCT01024920|584139588|FG000|Overall Study|Not treated|3|||
161754231|NCT01024920|584139589|FG001|Overall Study|Not treated|0|||
161754232|NCT01024920|584139588|FG000|Overall Study|Protocol Violation|0|||
161754233|NCT01024920|584139589|FG001|Overall Study|Protocol Violation|1|||
161754234|NCT03039790|584139591|FG000|Overall Study|Lost to Follow-up|2|||
161754235|NCT03039790|584139592|FG001|Overall Study|Lost to Follow-up|0|||
161754236|NCT03039790|584139593|FG002|Overall Study|Lost to Follow-up|1|||
161754237|NCT03039790|584139594|FG003|Overall Study|Lost to Follow-up|1|||
161754238|NCT03039790|584139595|FG004|Overall Study|Lost to Follow-up|0|||
161754239|NCT03039790|584139596|FG005|Overall Study|Lost to Follow-up|1|||
161754240|NCT03039790|584139597|FG006|Overall Study|Lost to Follow-up|1|||
161754241|NCT03039790|584139598|FG007|Overall Study|Lost to Follow-up|1|||
161754242|NCT03039790|584139599|FG008|Overall Study|Lost to Follow-up|0|||
161754243|NCT03039790|584139600|FG009|Overall Study|Lost to Follow-up|1|||
161754244|NCT03039790|584139601|FG010|Overall Study|Lost to Follow-up|1|||
161754245|NCT03039790|584139602|FG011|Overall Study|Lost to Follow-up|0|||
161754246|NCT03039790|584139603|FG012|Overall Study|Lost to Follow-up|1|||
161754247|NCT03039790|584139604|FG013|Overall Study|Lost to Follow-up|0|||
161754248|NCT03039790|584139605|FG014|Overall Study|Lost to Follow-up|3|||
161754249|NCT03039790|584139606|FG015|Overall Study|Lost to Follow-up|1|||
161754250|NCT03039790|584139607|FG016|Overall Study|Lost to Follow-up|2|||
161754251|NCT03039790|584139608|FG017|Overall Study|Lost to Follow-up|2|||
161754252|NCT03039790|584139609|FG018|Overall Study|Lost to Follow-up|1|||
161754253|NCT03039790|584139610|FG019|Overall Study|Lost to Follow-up|3|||
161754254|NCT03039790|584139591|FG000|Overall Study|Withdrawal of Consent|1|||
161754255|NCT03039790|584139592|FG001|Overall Study|Withdrawal of Consent|0|||
161754256|NCT03039790|584139593|FG002|Overall Study|Withdrawal of Consent|0|||
161754257|NCT03039790|584139594|FG003|Overall Study|Withdrawal of Consent|1|||
161754258|NCT03039790|584139595|FG004|Overall Study|Withdrawal of Consent|0|||
161754259|NCT03039790|584139596|FG005|Overall Study|Withdrawal of Consent|0|||
161754260|NCT03039790|584139597|FG006|Overall Study|Withdrawal of Consent|0|||
161754261|NCT03039790|584139598|FG007|Overall Study|Withdrawal of Consent|0|||
161754262|NCT03039790|584139599|FG008|Overall Study|Withdrawal of Consent|0|||
161754263|NCT03039790|584139600|FG009|Overall Study|Withdrawal of Consent|1|||
161754264|NCT03039790|584139601|FG010|Overall Study|Withdrawal of Consent|0|||
161754265|NCT03039790|584139602|FG011|Overall Study|Withdrawal of Consent|0|||
161754266|NCT03039790|584139603|FG012|Overall Study|Withdrawal of Consent|2|||
161754267|NCT03039790|584139604|FG013|Overall Study|Withdrawal of Consent|0|||
161754268|NCT03039790|584139605|FG014|Overall Study|Withdrawal of Consent|1|||
161754269|NCT03039790|584139606|FG015|Overall Study|Withdrawal of Consent|5|||
161754270|NCT03039790|584139607|FG016|Overall Study|Withdrawal of Consent|3|||
161754271|NCT03039790|584139608|FG017|Overall Study|Withdrawal of Consent|0|||
161754272|NCT03039790|584139609|FG018|Overall Study|Withdrawal of Consent|2|||
161754273|NCT03039790|584139610|FG019|Overall Study|Withdrawal of Consent|5|||
161754274|NCT03039790|584139591|FG000|Overall Study|Death|0|||
161754275|NCT03039790|584139592|FG001|Overall Study|Death|0|||
161754276|NCT03039790|584139593|FG002|Overall Study|Death|0|||
161754277|NCT03039790|584139594|FG003|Overall Study|Death|0|||
161754278|NCT03039790|584139595|FG004|Overall Study|Death|0|||
161754279|NCT03039790|584139596|FG005|Overall Study|Death|0|||
161754280|NCT03039790|584139597|FG006|Overall Study|Death|0|||
161754281|NCT03039790|584139598|FG007|Overall Study|Death|0|||
161754282|NCT03039790|584139599|FG008|Overall Study|Death|0|||
161754283|NCT03039790|584139600|FG009|Overall Study|Death|0|||
161754284|NCT03039790|584139601|FG010|Overall Study|Death|0|||
161754285|NCT03039790|584139602|FG011|Overall Study|Death|0|||
161754286|NCT03039790|584139603|FG012|Overall Study|Death|0|||
161754287|NCT03039790|584139604|FG013|Overall Study|Death|0|||
161754288|NCT03039790|584139605|FG014|Overall Study|Death|0|||
161754289|NCT03039790|584139606|FG015|Overall Study|Death|1|||
161754290|NCT03039790|584139607|FG016|Overall Study|Death|3|||
161754291|NCT03039790|584139608|FG017|Overall Study|Death|0|||
161754292|NCT03039790|584139609|FG018|Overall Study|Death|2|||
161754293|NCT03039790|584139610|FG019|Overall Study|Death|0|||
161754294|NCT03039790|584139591|FG000|Overall Study|Reason, not Specified|1|||
161754295|NCT03039790|584139592|FG001|Overall Study|Reason, not Specified|0|||
161754296|NCT03039790|584139593|FG002|Overall Study|Reason, not Specified|0|||
161754297|NCT03039790|584139594|FG003|Overall Study|Reason, not Specified|0|||
161754298|NCT03039790|584139595|FG004|Overall Study|Reason, not Specified|0|||
161754299|NCT03039790|584139596|FG005|Overall Study|Reason, not Specified|0|||
161754300|NCT03039790|584139597|FG006|Overall Study|Reason, not Specified|0|||
161754301|NCT03039790|584139598|FG007|Overall Study|Reason, not Specified|0|||
161754302|NCT03039790|584139599|FG008|Overall Study|Reason, not Specified|0|||
161754303|NCT03039790|584139600|FG009|Overall Study|Reason, not Specified|0|||
161754304|NCT03039790|584139601|FG010|Overall Study|Reason, not Specified|0|||
161754305|NCT03039790|584139602|FG011|Overall Study|Reason, not Specified|0|||
161754306|NCT03039790|584139603|FG012|Overall Study|Reason, not Specified|0|||
161754307|NCT03039790|584139604|FG013|Overall Study|Reason, not Specified|0|||
161754308|NCT03039790|584139605|FG014|Overall Study|Reason, not Specified|0|||
161754309|NCT03039790|584139606|FG015|Overall Study|Reason, not Specified|0|||
161754310|NCT03039790|584139607|FG016|Overall Study|Reason, not Specified|2|||
161754311|NCT03039790|584139608|FG017|Overall Study|Reason, not Specified|0|||
161754312|NCT03039790|584139609|FG018|Overall Study|Reason, not Specified|1|||
161754313|NCT03039790|584139610|FG019|Overall Study|Reason, not Specified|0|||
161754314|NCT02736929|584139615|FG000|Main Study|Lost to Follow-up|7|||
161754315|NCT02736929|584139616|FG001|Main Study|Lost to Follow-up|1|||
161754316|NCT02736929|584139617|FG002|Main Study|Lost to Follow-up|0|||
161754317|NCT02736929|584139615|FG000|Main Study|Withdrawal by Subject|1|||
161754318|NCT02736929|584139616|FG001|Main Study|Withdrawal by Subject|1|||
161754319|NCT02736929|584139617|FG002|Main Study|Withdrawal by Subject|0|||
161754320|NCT02736929|584139615|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
161754321|NCT02736929|584139616|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
161754322|NCT02736929|584139617|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
161754323|NCT00285649|584139618|FG000|Overall Study|Lost to Follow-up|6|||
161754324|NCT00285649|584139619|FG001|Overall Study|Lost to Follow-up|4|||
161754325|NCT00285649|584139620|FG002|Overall Study|Lost to Follow-up|4|||
161754326|NCT00285649|584139618|FG000|Overall Study|Withdrawal by Subject|3|||
161754327|NCT00285649|584139619|FG001|Overall Study|Withdrawal by Subject|2|||
161754328|NCT00285649|584139620|FG002|Overall Study|Withdrawal by Subject|2|||
161754329|NCT02972593|584139621|FG000|Overall Study|Lost to Follow-up|19|||
161754330|NCT02972593|584139622|FG001|Overall Study|Lost to Follow-up|15|||
161754331|NCT02972593|584139621|FG000|Overall Study|Protocol Violation|1|||
161754332|NCT02972593|584139622|FG001|Overall Study|Protocol Violation|0|||
161754333|NCT03934203|584139625|FG000|Overall Study|Adverse Event|0|||
161754334|NCT03934203|584139626|FG001|Overall Study|Adverse Event|0|||
161754335|NCT03934203|584139627|FG002|Overall Study|Adverse Event|1|||
161754336|NCT03934203|584139628|FG003|Overall Study|Adverse Event|0|||
161754337|NCT03934203|584139629|FG004|Overall Study|Adverse Event|1|||
161754338|NCT03934203|584139630|FG005|Overall Study|Adverse Event|0|||
161754339|NCT03934203|584139631|FG006|Overall Study|Adverse Event|2|||
161754340|NCT03934203|584139632|FG007|Overall Study|Adverse Event|0|||
161754341|NCT03934203|584139633|FG008|Overall Study|Adverse Event|0|||
161754342|NCT03934203|584139634|FG009|Overall Study|Adverse Event|0|||
161754343|NCT03934203|584139635|FG010|Overall Study|Adverse Event|0|||
161754344|NCT03934203|584139636|FG011|Overall Study|Adverse Event|0|||
161754345|NCT03934203|584139637|FG012|Overall Study|Adverse Event|0|||
161754346|NCT03934203|584139638|FG013|Overall Study|Adverse Event|1|||
161754347|NCT03934203|584139639|FG014|Overall Study|Adverse Event|0|||
161754348|NCT00044213|584139647|FG000|Overall Study|Withdrawal by Subject|50|||
161754349|NCT00044213|584139648|FG001|Overall Study|Withdrawal by Subject|65|||
161754350|NCT00044213|584139649|FG002|Overall Study|Withdrawal by Subject|91|||
161754351|NCT00044213|584139650|FG003|Overall Study|Withdrawal by Subject|83|||
161754352|NCT00044213|584139647|FG000|Overall Study|Death|42|||
161754353|NCT00044213|584139648|FG001|Overall Study|Death|42|||
161754354|NCT00044213|584139649|FG002|Overall Study|Death|42|||
161754355|NCT00044213|584139650|FG003|Overall Study|Death|49|||
161754356|NCT00044213|584139647|FG000|Overall Study|Lost to Follow-up|8|||
161754357|NCT00044213|584139648|FG001|Overall Study|Lost to Follow-up|5|||
161754358|NCT00044213|584139649|FG002|Overall Study|Lost to Follow-up|5|||
161754359|NCT00044213|584139650|FG003|Overall Study|Lost to Follow-up|4|||
161754360|NCT00422240|584139651|FG000|Overall Study|Lack of Efficacy|1|||
161754361|NCT00422240|584139652|FG001|Overall Study|Lack of Efficacy|2|||
161754362|NCT00422240|584139653|FG002|Overall Study|Lack of Efficacy|0|||
161754363|NCT00422240|584139654|FG003|Overall Study|Lack of Efficacy|1|||
161754364|NCT00422240|584139651|FG000|Overall Study|Adverse Event|11|||
161754365|NCT00422240|584139652|FG001|Overall Study|Adverse Event|4|||
161754366|NCT00422240|584139653|FG002|Overall Study|Adverse Event|5|||
161754367|NCT00422240|584139654|FG003|Overall Study|Adverse Event|2|||
161754368|NCT00422240|584139651|FG000|Overall Study|Subject request|21|||
161754369|NCT00422240|584139652|FG001|Overall Study|Subject request|17|||
161754370|NCT00422240|584139653|FG002|Overall Study|Subject request|18|||
161754371|NCT00422240|584139654|FG003|Overall Study|Subject request|30|||
161754372|NCT00422240|584139651|FG000|Overall Study|Protocol Violation|0|||
161754373|NCT00422240|584139652|FG001|Overall Study|Protocol Violation|1|||
161754374|NCT00422240|584139653|FG002|Overall Study|Protocol Violation|0|||
161754375|NCT00422240|584139654|FG003|Overall Study|Protocol Violation|1|||
161754376|NCT00422240|584139651|FG000|Overall Study|Lost to Follow-up|31|||
161754377|NCT00422240|584139652|FG001|Overall Study|Lost to Follow-up|32|||
161754378|NCT00422240|584139653|FG002|Overall Study|Lost to Follow-up|19|||
161754379|NCT00422240|584139654|FG003|Overall Study|Lost to Follow-up|34|||
161754380|NCT00422240|584139651|FG000|Overall Study|Other|1|||
161754381|NCT00422240|584139652|FG001|Overall Study|Other|0|||
161754382|NCT00422240|584139653|FG002|Overall Study|Other|0|||
161754383|NCT00422240|584139654|FG003|Overall Study|Other|1|||
161754384|NCT00422240|584139651|FG000|Overall Study|Pregnancy|3|||
161754385|NCT00422240|584139652|FG001|Overall Study|Pregnancy|1|||
161754386|NCT00422240|584139653|FG002|Overall Study|Pregnancy|1|||
161754387|NCT00422240|584139654|FG003|Overall Study|Pregnancy|2|||
161754388|NCT01927068|584139658|FG000|Overall Study|Death|37|||
161754389|NCT01927068|584139659|FG001|Overall Study|Death|3|||
161754390|NCT01927068|584139658|FG000|Overall Study|Withdrawal by Subject|50|||
161754391|NCT01927068|584139659|FG001|Overall Study|Withdrawal by Subject|3|||
161754392|NCT01927068|584139658|FG000|Overall Study|Lost to Follow-up|10|||
161754393|NCT01927068|584139659|FG001|Overall Study|Lost to Follow-up|2|||
161754394|NCT01927068|584139658|FG000|Overall Study|Physician Decision|9|||
161754395|NCT01927068|584139659|FG001|Overall Study|Physician Decision|0|||
161754396|NCT01927068|584139658|FG000|Overall Study|Missed last follow-up visit|2|||
161754397|NCT01927068|584139659|FG001|Overall Study|Missed last follow-up visit|0|||
161754398|NCT00880607|584139660|FG000|Overall Study|Physician Decision|2|||
161754399|NCT00880607|584139661|FG001|Overall Study|Physician Decision|2|||
161754400|NCT00880607|584139660|FG000|Overall Study|Protocol Violation|2|||
161754401|NCT00880607|584139661|FG001|Overall Study|Protocol Violation|1|||
161754402|NCT00880607|584139660|FG000|Overall Study|surgery did not extend past L1 level|3|||
161754403|NCT00880607|584139661|FG001|Overall Study|surgery did not extend past L1 level|0|||
161754404|NCT01624467|584139662|FG000|Overall Study|Withdrawal by Subject|2|||
161754405|NCT01624467|584139662|FG000|Overall Study|Lost to Follow-up|1|||
161754406|NCT01624467|584139662|FG000|Overall Study|Adverse Event|7|||
161754407|NCT01624467|584139662|FG000|Overall Study|Progressive Disease|19|||
161754408|NCT01624467|584139662|FG000|Overall Study|Per Sponsor Requirement|1|||
161754409|NCT01624467|584139662|FG000|Overall Study|Subject Withdrew from Treatment|1|||
161754410|NCT03964493|584139663|FG000|Overall Study|Withdrawal by Subject|4|||
161754411|NCT03964493|584139664|FG001|Overall Study|Withdrawal by Subject|1|||
161754412|NCT03964493|584139663|FG000|Overall Study|Lost to Follow-up|13|||
161754413|NCT03964493|584139664|FG001|Overall Study|Lost to Follow-up|4|||
161754414|NCT02092324|584139665|FG000|Overall Study|Adverse Event|1|||
161754415|NCT02092324|584139665|FG000|Overall Study|Lack of Efficacy|6|||
161754416|NCT02092324|584139665|FG000|Overall Study|Proceed to Transplant|3|||
161754417|NCT02092324|584139665|FG000|Overall Study|Physician Decision|7|||
161754418|NCT02092324|584139665|FG000|Overall Study|Misdiagnosis|2|||
161754419|NCT02224274|584139669|FG000|Overall Study|Death|1|||
161754420|NCT02224274|584139670|FG001|Overall Study|Death|0|||
161754421|NCT00887068|584139671|FG000|Overall Study|Withdrawal by Subject|2|||
161754422|NCT00887068|584139672|FG001|Overall Study|Withdrawal by Subject|0|||
161754423|NCT00887068|584139671|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
161754424|NCT00887068|584139672|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
161754425|NCT00499460|584139673|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
161754426|NCT00499460|584139674|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
161754427|NCT00499460|584139673|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
161754428|NCT00499460|584139674|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
161754429|NCT00499460|584139673|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
161754430|NCT00499460|584139674|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
161754431|NCT03073200|584139683|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161754432|NCT03073200|584139684|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161754433|NCT03073200|584139685|FG002|Double Blind Treatment Period|Protocol Violation|0|||
161754434|NCT03073200|584139686|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161754435|NCT03073200|584139687|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161754436|NCT03073200|584139688|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161754437|NCT03073200|584139689|FG006|Double Blind Treatment Period|Protocol Violation|0|||
161754438|NCT03073200|584139690|FG007|Double Blind Treatment Period|Protocol Violation|0|||
161754439|NCT03073200|584139691|FG008|Double Blind Treatment Period|Protocol Violation|0|||
161754440|NCT03073200|584139692|FG009|Double Blind Treatment Period|Protocol Violation|0|||
161754441|NCT03073200|584139693|FG010|Double Blind Treatment Period|Protocol Violation|0|||
161754442|NCT03073200|584139694|FG011|Double Blind Treatment Period|Protocol Violation|0|||
161754443|NCT03073200|584139695|FG012|Double Blind Treatment Period|Protocol Violation|0|||
161754444|NCT03073200|584139696|FG013|Double Blind Treatment Period|Protocol Violation|0|||
161754445|NCT03073200|584139697|FG014|Double Blind Treatment Period|Protocol Violation|0|||
161754446|NCT03073200|584139683|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754447|NCT03073200|584139684|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
161754448|NCT03073200|584139685|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754449|NCT03073200|584139686|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754450|NCT03073200|584139687|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754451|NCT03073200|584139688|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754452|NCT03073200|584139689|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754453|NCT03073200|584139690|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754454|NCT03073200|584139691|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754455|NCT03073200|584139692|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754456|NCT03073200|584139693|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754457|NCT03073200|584139694|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754458|NCT03073200|584139695|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754459|NCT03073200|584139696|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754460|NCT03073200|584139697|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754461|NCT03073200|584139683|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
161754462|NCT03073200|584139684|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754463|NCT03073200|584139685|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754464|NCT03073200|584139686|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754465|NCT03073200|584139687|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754466|NCT03073200|584139688|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754467|NCT03073200|584139689|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754468|NCT03073200|584139690|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754469|NCT03073200|584139691|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754470|NCT03073200|584139692|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754471|NCT03073200|584139693|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754472|NCT03073200|584139694|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754473|NCT03073200|584139695|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754474|NCT03073200|584139696|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754475|NCT03073200|584139697|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754476|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754477|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754478|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754479|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
161754480|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
161754481|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754482|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754483|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754484|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754485|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754486|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754487|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754488|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754489|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754490|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754491|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
161754492|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
161754493|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
161754494|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
161754495|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
161754496|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
161754497|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
161754498|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
161754499|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
161754500|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
161754501|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
161754502|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
161754503|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
161754504|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
161754505|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
161754506|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754507|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754508|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754509|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754510|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
161754511|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754512|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754513|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754514|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754515|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754516|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754517|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754518|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754519|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754520|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754521|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754522|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754523|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754524|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
161754525|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
161754526|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754527|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754528|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754529|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754530|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754531|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754532|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754533|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754534|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754535|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754536|NCT03073200|584139683|FG000|Extension Period|Lost to Follow-up|0|||
161754537|NCT03073200|584139684|FG001|Extension Period|Lost to Follow-up|0|||
161754538|NCT03073200|584139685|FG002|Extension Period|Lost to Follow-up|0|||
161754539|NCT03073200|584139686|FG003|Extension Period|Lost to Follow-up|0|||
161754540|NCT03073200|584139687|FG004|Extension Period|Lost to Follow-up|0|||
161754541|NCT03073200|584139688|FG005|Extension Period|Lost to Follow-up|0|||
161754542|NCT03073200|584139689|FG006|Extension Period|Lost to Follow-up|1|||
161754543|NCT03073200|584139690|FG007|Extension Period|Lost to Follow-up|1|||
161754544|NCT03073200|584139691|FG008|Extension Period|Lost to Follow-up|0|||
161754545|NCT03073200|584139692|FG009|Extension Period|Lost to Follow-up|0|||
161754546|NCT03073200|584139693|FG010|Extension Period|Lost to Follow-up|0|||
161754547|NCT03073200|584139694|FG011|Extension Period|Lost to Follow-up|0|||
161754548|NCT03073200|584139695|FG012|Extension Period|Lost to Follow-up|0|||
161754549|NCT03073200|584139696|FG013|Extension Period|Lost to Follow-up|0|||
161754550|NCT03073200|584139697|FG014|Extension Period|Lost to Follow-up|0|||
161754551|NCT03073200|584139683|FG000|Extension Period|Sponsor Decision|0|||
161754552|NCT03073200|584139684|FG001|Extension Period|Sponsor Decision|0|||
161754553|NCT03073200|584139685|FG002|Extension Period|Sponsor Decision|0|||
161754554|NCT03073200|584139686|FG003|Extension Period|Sponsor Decision|0|||
161754555|NCT03073200|584139687|FG004|Extension Period|Sponsor Decision|0|||
161754556|NCT03073200|584139688|FG005|Extension Period|Sponsor Decision|0|||
161754557|NCT03073200|584139689|FG006|Extension Period|Sponsor Decision|0|||
161754558|NCT03073200|584139690|FG007|Extension Period|Sponsor Decision|0|||
161754559|NCT03073200|584139691|FG008|Extension Period|Sponsor Decision|1|||
161754560|NCT03073200|584139692|FG009|Extension Period|Sponsor Decision|0|||
161754561|NCT03073200|584139693|FG010|Extension Period|Sponsor Decision|0|||
161754562|NCT03073200|584139694|FG011|Extension Period|Sponsor Decision|0|||
161754563|NCT03073200|584139695|FG012|Extension Period|Sponsor Decision|0|||
161754564|NCT03073200|584139696|FG013|Extension Period|Sponsor Decision|0|||
161754565|NCT03073200|584139697|FG014|Extension Period|Sponsor Decision|0|||
161754566|NCT03073200|584139683|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
161754567|NCT03073200|584139684|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
161754568|NCT03073200|584139685|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
161754569|NCT03073200|584139686|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
161754570|NCT03073200|584139687|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
161754571|NCT03073200|584139688|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
161754572|NCT03073200|584139689|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
161754573|NCT03073200|584139690|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
161754574|NCT03073200|584139691|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
161754575|NCT03073200|584139692|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
161754576|NCT03073200|584139693|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
161754577|NCT03073200|584139694|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
161754578|NCT03073200|584139695|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
161754579|NCT03073200|584139696|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
161754580|NCT03073200|584139697|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
161754581|NCT03073200|584139683|FG000|Extension Period|Withdrawal by Subject|0|||
161754582|NCT03073200|584139684|FG001|Extension Period|Withdrawal by Subject|0|||
161754583|NCT03073200|584139685|FG002|Extension Period|Withdrawal by Subject|0|||
161754584|NCT03073200|584139686|FG003|Extension Period|Withdrawal by Subject|0|||
161754585|NCT03073200|584139687|FG004|Extension Period|Withdrawal by Subject|0|||
161754586|NCT03073200|584139688|FG005|Extension Period|Withdrawal by Subject|0|||
161754587|NCT03073200|584139689|FG006|Extension Period|Withdrawal by Subject|1|||
161754588|NCT03073200|584139690|FG007|Extension Period|Withdrawal by Subject|2|||
161844920|NCT02980874|584474683|FG000|Overall Study|Unknown study completion status|1|||
161754589|NCT03073200|584139691|FG008|Extension Period|Withdrawal by Subject|0|||
161754590|NCT03073200|584139692|FG009|Extension Period|Withdrawal by Subject|0|||
161754591|NCT03073200|584139693|FG010|Extension Period|Withdrawal by Subject|0|||
161754592|NCT03073200|584139694|FG011|Extension Period|Withdrawal by Subject|0|||
161754593|NCT03073200|584139695|FG012|Extension Period|Withdrawal by Subject|0|||
161754594|NCT03073200|584139696|FG013|Extension Period|Withdrawal by Subject|0|||
161754595|NCT03073200|584139697|FG014|Extension Period|Withdrawal by Subject|0|||
161754596|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754597|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754598|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754599|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754600|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754601|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754602|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754603|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754604|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754605|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754606|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754607|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
161754608|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754609|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754610|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754611|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754612|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754613|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754614|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754615|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754616|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754617|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754618|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754619|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754620|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754621|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754622|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
161754623|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754624|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754625|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754626|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754627|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754628|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754629|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754630|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754631|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754632|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754633|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754634|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754635|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754636|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161754637|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161754638|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754639|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754640|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754641|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161754642|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Adverse Event|0|||
161754643|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Adverse Event|0|||
161754644|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Adverse Event|0|||
161754645|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Adverse Event|0|||
161754646|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Adverse Event|0|||
161754647|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Adverse Event|0|||
161754648|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Adverse Event|0|||
161754649|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Adverse Event|0|||
161754650|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Adverse Event|0|||
161754651|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Adverse Event|1|||
161754652|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Adverse Event|0|||
161754653|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Adverse Event|0|||
161754654|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Adverse Event|0|||
161754655|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Adverse Event|0|||
161754656|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754657|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754658|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754659|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754660|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754661|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754662|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754663|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754664|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754665|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754666|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754667|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754668|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754669|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
161754670|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754671|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754672|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754673|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754674|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754675|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754676|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754677|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754678|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754679|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754680|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754681|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754682|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754683|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754684|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161754685|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754686|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754687|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754688|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754689|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754690|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754691|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754692|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754693|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754694|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754695|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754696|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754697|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754698|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754699|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
161754700|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754701|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754702|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754703|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754704|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754705|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754706|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754707|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754708|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754709|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754710|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754711|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754712|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754713|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754714|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
161754715|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754716|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754717|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754718|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754719|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754720|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754721|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754722|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754723|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754724|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754725|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754726|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754727|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754728|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754729|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754730|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
161754731|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754732|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754733|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754734|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754735|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754736|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754737|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754738|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754739|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754740|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754741|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754742|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754743|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754744|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
161754745|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754746|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754747|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754748|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754749|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754750|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754751|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754752|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754753|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754754|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754755|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754756|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754757|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754758|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754759|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
161754760|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754761|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754762|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754763|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754764|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754765|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754766|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754767|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754768|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754769|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754770|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754771|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754772|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754773|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754774|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
161754775|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754776|NCT01474889|584139698|FG000|Overall Study|Physician Decision|1|||
161754777|NCT01474889|584139699|FG001|Overall Study|Physician Decision|0|||
161754778|NCT01474889|584139700|FG002|Overall Study|Physician Decision|0|||
161754779|NCT01474889|584139698|FG000|Overall Study|Did not meet inclusion|1|||
161754780|NCT01474889|584139699|FG001|Overall Study|Did not meet inclusion|0|||
161754781|NCT01474889|584139700|FG002|Overall Study|Did not meet inclusion|0|||
161754782|NCT01474889|584139698|FG000|Overall Study|Withdrawal by Subject|0|||
161754783|NCT01474889|584139699|FG001|Overall Study|Withdrawal by Subject|1|||
161754784|NCT01474889|584139700|FG002|Overall Study|Withdrawal by Subject|0|||
161754785|NCT02973997|584142257|FG000|Overall Study|Withdrawal by Subject|4|||
161754786|NCT02973997|584142258|FG001|Overall Study|Withdrawal by Subject|0|||
161754787|NCT02973997|584142257|FG000|Overall Study|Adverse Event|4|||
161754788|NCT02973997|584142258|FG001|Overall Study|Adverse Event|1|||
161754789|NCT02973997|584142257|FG000|Overall Study|Disease Progression|11|||
161754790|NCT02973997|584142258|FG001|Overall Study|Disease Progression|20|||
161754791|NCT02973997|584142257|FG000|Overall Study|Alternative Therapy|3|||
161754792|NCT02973997|584142258|FG001|Overall Study|Alternative Therapy|0|||
161754793|NCT02973997|584142257|FG000|Overall Study|Other complicating disease|0|||
161754794|NCT02973997|584142258|FG001|Overall Study|Other complicating disease|1|||
161754795|NCT02973997|584142257|FG000|Overall Study|Death|0|||
161754796|NCT02973997|584142258|FG001|Overall Study|Death|1|||
161754797|NCT00444951|584142259|FG000|Overall Study|Lost to Follow-up|1|||
161754798|NCT00444951|584142260|FG001|Overall Study|Lost to Follow-up|1|||
161754799|NCT00444951|584142261|FG002|Overall Study|Lost to Follow-up|0|||
161754800|NCT00444951|584142259|FG000|Overall Study|Withdrawal by Subject|4|||
161754801|NCT00444951|584142260|FG001|Overall Study|Withdrawal by Subject|5|||
161754802|NCT00444951|584142261|FG002|Overall Study|Withdrawal by Subject|3|||
161754803|NCT00887822|584142262|FG000|Overall Study|Insufficient therapeutic response|53|||
161754804|NCT00887822|584142263|FG001|Overall Study|Insufficient therapeutic response|55|||
161754805|NCT00887822|584142262|FG000|Overall Study|Adverse Event|14|||
161754806|NCT00887822|584142263|FG001|Overall Study|Adverse Event|17|||
161754807|NCT00887822|584142262|FG000|Overall Study|Failure to return|11|||
161754808|NCT00887822|584142263|FG001|Overall Study|Failure to return|11|||
161754809|NCT00887822|584142262|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
161754810|NCT00887822|584142263|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
161754811|NCT00887822|584142262|FG000|Overall Study|Administrative/Other than specified|5|||
161754812|NCT00887822|584142263|FG001|Overall Study|Administrative/Other than specified|4|||
161754813|NCT00887822|584142262|FG000|Overall Study|Death|2|||
161754814|NCT00887822|584142263|FG001|Overall Study|Death|3|||
161754815|NCT00887822|584142262|FG000|Overall Study|Protocol Violation|0|||
161754816|NCT00887822|584142263|FG001|Overall Study|Protocol Violation|1|||
161754817|NCT00887822|584142262|FG000|Overall Study|Randomized but not treated|0|||
161754818|NCT00887822|584142263|FG001|Overall Study|Randomized but not treated|1|||
161754819|NCT02045979|584142267|FG000|Overall Study|Informed Consent Withdrawn|2|||
161754820|NCT02045979|584142268|FG001|Overall Study|Informed Consent Withdrawn|0|||
161754821|NCT02045979|584142269|FG002|Overall Study|Informed Consent Withdrawn|1|||
161754822|NCT02045979|584142267|FG000|Overall Study|not specified above|0|||
161754823|NCT02045979|584142268|FG001|Overall Study|not specified above|1|||
161754824|NCT02045979|584142269|FG002|Overall Study|not specified above|0|||
161754825|NCT00378534|584142275|FG000|Overall Study|Participants did not receive transplant|3|||
161754826|NCT00378534|584142276|FG001|Overall Study|Participants did not receive transplant|0|||
161754827|NCT00425945|584142280|FG000|Overall Study|Concern about Supplement|2|||
161754828|NCT00425945|584142281|FG001|Overall Study|Concern about Supplement|0|||
161754829|NCT00425945|584142280|FG000|Overall Study|Inconvenience|0|||
161754830|NCT00425945|584142281|FG001|Overall Study|Inconvenience|2|||
161754831|NCT00425945|584142280|FG000|Overall Study|Lost to Follow-up|0|||
161754832|NCT00425945|584142281|FG001|Overall Study|Lost to Follow-up|2|||
161754833|NCT00425945|584142280|FG000|Overall Study|Began hypertension medication|1|||
161754834|NCT00425945|584142281|FG001|Overall Study|Began hypertension medication|0|||
161754835|NCT00425945|584142280|FG000|Overall Study|Began cancer treatments|1|||
161754836|NCT00425945|584142281|FG001|Overall Study|Began cancer treatments|0|||
161754837|NCT00425945|584142280|FG000|Overall Study|Moved from area|0|||
161754838|NCT00425945|584142281|FG001|Overall Study|Moved from area|1|||
161754839|NCT03878160|584142285|FG000|Overall Study|Lost to Follow-up|1|||
161754840|NCT03878160|584142286|FG001|Overall Study|Lost to Follow-up|1|||
161754841|NCT03878160|584142287|FG002|Overall Study|Lost to Follow-up|1|||
161754842|NCT03878160|584142285|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
161754843|NCT03878160|584142286|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
161754844|NCT03878160|584142287|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
161754845|NCT05618808|584142288|FG000|Overall Study|Withdrawal by Subject|3|||
161754846|NCT05618808|584142289|FG001|Overall Study|Withdrawal by Subject|1|||
161754847|NCT05618808|584142290|FG002|Overall Study|Withdrawal by Subject|3|||
161754848|NCT02365506|584142291|FG000|Overall Study|Investigator's Discretion|0|||
161754849|NCT02365506|584142292|FG001|Overall Study|Investigator's Discretion|0|||
161754850|NCT02365506|584142293|FG002|Overall Study|Investigator's Discretion|1|||
161754851|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754852|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|1|||
161754853|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|0|||
161754854|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|0|||
161754855|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754856|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754857|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|0|||
161754858|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|1|||
161754859|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|0|||
161754860|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754861|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754862|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|0|||
161754863|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|0|||
161754864|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|1|||
161754865|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754866|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754867|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|0|||
161754868|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|0|||
161754869|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|1|||
161754870|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754871|NCT03287830|584142305|FG000|Overall Study|Withdrawal by Subject|1|||
161754872|NCT03287830|584142306|FG001|Overall Study|Withdrawal by Subject|1|||
161754873|NCT03287830|584142305|FG000|Overall Study|not meeting inclusion criteria|5|||
161754874|NCT03287830|584142306|FG001|Overall Study|not meeting inclusion criteria|12|||
161754875|NCT03598140|584142309|FG000|Overall Study|enrolled but didn't start|1|||
161754876|NCT03598140|584142310|FG001|Overall Study|enrolled but didn't start|0|||
161754877|NCT02155712|584142314|FG000|Overall Study|Death|12|||
161754878|NCT02155712|584142315|FG001|Overall Study|Death|0|||
161754879|NCT02155712|584142314|FG000|Overall Study|Lost to Follow-up|37|||
161754880|NCT02155712|584142315|FG001|Overall Study|Lost to Follow-up|22|||
161754881|NCT02155712|584142314|FG000|Overall Study|Revision of device|4|||
161754882|NCT02155712|584142315|FG001|Overall Study|Revision of device|3|||
161754883|NCT02155712|584142314|FG000|Overall Study|Withdrawal by Subject|39|||
161754884|NCT02155712|584142315|FG001|Overall Study|Withdrawal by Subject|21|||
161754885|NCT02155712|584142314|FG000|Overall Study|Site termination|77|||
161754886|NCT02155712|584142315|FG001|Overall Study|Site termination|19|||
161754887|NCT02155712|584142314|FG000|Overall Study|Sponsor terminated study early|150|||
161754888|NCT02155712|584142315|FG001|Overall Study|Sponsor terminated study early|0|||
161754889|NCT02155712|584142314|FG000|Overall Study|Missed final 5-year protocol visit|0|||
161754890|NCT02155712|584142315|FG001|Overall Study|Missed final 5-year protocol visit|32|||
161754891|NCT02155712|584142314|FG000|Overall Study|Censored because surgery cancelled|6|||
161754892|NCT02155712|584142315|FG001|Overall Study|Censored because surgery cancelled|10|||
161754893|NCT02155712|584142314|FG000|Overall Study|Censored because study device was not implanted|61|||
161754894|NCT02155712|584142315|FG001|Overall Study|Censored because study device was not implanted|66|||
161754895|NCT02155712|584142314|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
161754896|NCT02155712|584142315|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
161754897|NCT02060903|584142316|FG000|Overall Study|Lost to Follow-up|4|||
161754898|NCT02060903|584142317|FG001|Overall Study|Lost to Follow-up|0|||
161754899|NCT02060903|584142316|FG000|Overall Study|Withdrawal by Subject|0|||
161754900|NCT02060903|584142317|FG001|Overall Study|Withdrawal by Subject|7|||
161754901|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
161754902|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
161754903|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
161754904|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
161754905|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
161754906|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
161754907|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
161754908|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
161754909|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
161754910|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
161754911|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
161754912|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
161754913|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
161754914|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
161754915|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
161754916|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
161754917|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
161754918|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
161754919|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Other|3|||
161754920|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Other|2|||
161754921|NCT01688999|584142322|FG000|Overall Study|Withdrawal by Subject|5|||
161754922|NCT01688999|584142323|FG001|Overall Study|Withdrawal by Subject|1|||
161754923|NCT01688999|584142324|FG002|Overall Study|Withdrawal by Subject|1|||
161754924|NCT01688999|584142322|FG000|Overall Study|Adverse Event|2|||
161754925|NCT01688999|584142323|FG001|Overall Study|Adverse Event|0|||
161754926|NCT01688999|584142324|FG002|Overall Study|Adverse Event|2|||
161754927|NCT01688999|584142322|FG000|Overall Study|Ineligible/Not treated|1|||
161754928|NCT01688999|584142323|FG001|Overall Study|Ineligible/Not treated|0|||
161754929|NCT01688999|584142324|FG002|Overall Study|Ineligible/Not treated|0|||
161754930|NCT02768103|584142325|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
161754931|NCT00498368|584142353|FG000|Overall Study|Withdrawal by Subject|3|||
161754932|NCT00498368|584142354|FG001|Overall Study|Withdrawal by Subject|2|||
161754933|NCT01855425|584142362|FG000|Overall Study|Physician Decision|20|||
161754934|NCT02148952|584142369|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
161754935|NCT02148952|584142370|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
161754936|NCT02148952|584142369|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
161754937|NCT02148952|584142370|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
161754938|NCT02148952|584142369|FG000|Follow-Up|Lost to Follow-up|219|||
161754939|NCT02148952|584142370|FG001|Follow-Up|Lost to Follow-up|231|||
161754940|NCT02148952|584142369|FG000|Follow-Up|Withdrawal by Subject|46|||
161754941|NCT02148952|584142370|FG001|Follow-Up|Withdrawal by Subject|48|||
161754942|NCT01600105|584142371|FG000|Total Participants|Withdrawal by Subject|1|||
161754943|NCT01600105|584142372|FG001|Total Participants|Withdrawal by Subject|0|||
161754944|NCT01600105|584142371|FG000|Total Participants|No images in PACS|10|||
161754945|NCT01600105|584142372|FG001|Total Participants|No images in PACS|0|||
161754946|NCT01600105|584142371|FG000|Total Participants|Insufficient image quality|30|||
161754947|NCT01600105|584142372|FG001|Total Participants|Insufficient image quality|10|||
161754948|NCT01600105|584142371|FG000|Sub Study I|Insufficient image quality|0|||
161754949|NCT01600105|584142372|FG001|Sub Study I|Insufficient image quality|10|||
161754950|NCT01600105|584142371|FG000|Sub Study II|Withdrawal by Subject|1|||
161754951|NCT01600105|584142372|FG001|Sub Study II|Withdrawal by Subject|0|||
161754952|NCT01600105|584142371|FG000|Sub Study II|No images in PACS|1|||
161754953|NCT01600105|584142372|FG001|Sub Study II|No images in PACS|0|||
161754954|NCT01600105|584142371|FG000|Sub Study II|Insufficient image quality|3|||
161754955|NCT01600105|584142372|FG001|Sub Study II|Insufficient image quality|0|||
161754956|NCT01600105|584142371|FG000|Sub Study III|Insufficient image quality|5|||
161754957|NCT01600105|584142372|FG001|Sub Study III|Insufficient image quality|0|||
161754958|NCT01600105|584142371|FG000|Sub Study V|Poor Image Quality|2|||
161754959|NCT01600105|584142372|FG001|Sub Study V|Poor Image Quality|0|||
161754960|NCT01263444|584142373|FG000|Overall Study|Adverse Event|8|||
161754961|NCT01263444|584142373|FG000|Overall Study|Withdrawal by Subject|1|||
161754962|NCT01263444|584142373|FG000|Overall Study|Protocol Violation|1|||
161754963|NCT01764022|584142374|FG000|Overall Study|Death|3|||
161754964|NCT01764022|584142375|FG001|Overall Study|Death|5|||
161754965|NCT01764022|584142374|FG000|Overall Study|Withdrawal by Subject|2|||
161754966|NCT01764022|584142375|FG001|Overall Study|Withdrawal by Subject|6|||
161754967|NCT01764022|584142374|FG000|Overall Study|Lack of Efficacy|0|||
161754968|NCT01764022|584142375|FG001|Overall Study|Lack of Efficacy|1|||
161754969|NCT01764022|584142374|FG000|Overall Study|Physician Decision|0|||
161754970|NCT01764022|584142375|FG001|Overall Study|Physician Decision|2|||
161754971|NCT01764022|584142374|FG000|Overall Study|Lost to Follow-up|2|||
161754972|NCT01764022|584142375|FG001|Overall Study|Lost to Follow-up|0|||
161754973|NCT01764022|584142374|FG000|Overall Study|Protocol Violation|1|||
161754974|NCT01764022|584142375|FG001|Overall Study|Protocol Violation|0|||
161754975|NCT01899768|584142376|FG000|Part A|Adverse Event|2|||
161754976|NCT01899768|584142376|FG000|Part A|Withdrawal by Subject|1|||
161754977|NCT01899768|584142376|FG000|Part B|Adverse Event|1|||
161754978|NCT01899768|584142376|FG000|Part B|Withdrawal by Subject|1|||
161754979|NCT04043416|584142378|FG000|Washout|Change in health condition|0|||
161754980|NCT04043416|584142379|FG001|Washout|Change in health condition|1|||
161754981|NCT00414973|584142380|FG000|Overall Study|Withdrawal by Subject|14|||
161754982|NCT00414973|584142381|FG001|Overall Study|Withdrawal by Subject|4|||
161754983|NCT00414973|584142382|FG002|Overall Study|Withdrawal by Subject|1|||
161754984|NCT00414973|584142383|FG003|Overall Study|Withdrawal by Subject|0|||
161754985|NCT00414973|584142380|FG000|Overall Study|Adverse Event|10|||
161754986|NCT00414973|584142381|FG001|Overall Study|Adverse Event|0|||
161754987|NCT00414973|584142382|FG002|Overall Study|Adverse Event|1|||
161754988|NCT00414973|584142383|FG003|Overall Study|Adverse Event|0|||
161754989|NCT00414973|584142380|FG000|Overall Study|Protocol Violation|3|||
161754990|NCT00414973|584142381|FG001|Overall Study|Protocol Violation|4|||
161754991|NCT00414973|584142382|FG002|Overall Study|Protocol Violation|0|||
161754992|NCT00414973|584142383|FG003|Overall Study|Protocol Violation|0|||
161754993|NCT00414973|584142380|FG000|Overall Study|Lost to Follow-up|0|||
161754994|NCT00414973|584142381|FG001|Overall Study|Lost to Follow-up|2|||
161754995|NCT00414973|584142382|FG002|Overall Study|Lost to Follow-up|0|||
161754996|NCT00414973|584142383|FG003|Overall Study|Lost to Follow-up|0|||
161754997|NCT00414973|584142380|FG000|Overall Study|Sponsor Decision|1|||
161754998|NCT00414973|584142381|FG001|Overall Study|Sponsor Decision|0|||
161754999|NCT00414973|584142382|FG002|Overall Study|Sponsor Decision|0|||
161755000|NCT00414973|584142383|FG003|Overall Study|Sponsor Decision|0|||
161755001|NCT00414973|584142380|FG000|Overall Study|Death|0|||
161755002|NCT00414973|584142381|FG001|Overall Study|Death|0|||
161755003|NCT00414973|584142382|FG002|Overall Study|Death|1|||
161755004|NCT00414973|584142383|FG003|Overall Study|Death|0|||
161755005|NCT01466062|584142384|FG000|Overall Study|Adverse Event|1|||
161755006|NCT01466062|584142384|FG000|Overall Study|Withdrawal by Subject|1|||
161755007|NCT00118040|584142385|FG000|Overall Study|Adverse Event|0|||
161755008|NCT00118040|584142386|FG001|Overall Study|Adverse Event|1|||
161755009|NCT00118040|584142387|FG002|Overall Study|Adverse Event|0|||
161755010|NCT00118040|584142385|FG000|Overall Study|Withdrawal by Subject|0|||
161755011|NCT00118040|584142386|FG001|Overall Study|Withdrawal by Subject|0|||
161755012|NCT00118040|584142387|FG002|Overall Study|Withdrawal by Subject|2|||
161755013|NCT00118040|584142385|FG000|Overall Study|Medical Contraindication|0|||
161755014|NCT00118040|584142386|FG001|Overall Study|Medical Contraindication|0|||
161755015|NCT00118040|584142387|FG002|Overall Study|Medical Contraindication|1|||
161755016|NCT00118040|584142385|FG000|Overall Study|Non-Compliant Participant|1|||
161755017|NCT00118040|584142386|FG001|Overall Study|Non-Compliant Participant|1|||
161755018|NCT00118040|584142387|FG002|Overall Study|Non-Compliant Participant|2|||
161755019|NCT00118040|584142385|FG000|Overall Study|Other|0|||
161755020|NCT00118040|584142386|FG001|Overall Study|Other|0|||
161755021|NCT00118040|584142387|FG002|Overall Study|Other|1|||
161755022|NCT02865928|584142388|FG000|Overall Study|Withdrawal by Subject|1|||
161755023|NCT02865928|584142389|FG001|Overall Study|Withdrawal by Subject|0|||
161755024|NCT02865928|584142388|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
161755025|NCT02865928|584142389|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
161755026|NCT02865928|584142388|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
161755027|NCT02865928|584142389|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
161755028|NCT01925014|584142390|FG000|Overall Study|Inappropriate enrollment|4|||
161755029|NCT01925014|584142391|FG001|Overall Study|Inappropriate enrollment|6|||
161755030|NCT01925014|584142390|FG000|Overall Study|Withdrawal by Subject|5|||
161755031|NCT01925014|584142391|FG001|Overall Study|Withdrawal by Subject|13|||
161755032|NCT01196091|584142395|FG000|Overall Study|Adverse Event|22|||
161755033|NCT01196091|584142396|FG001|Overall Study|Adverse Event|27|||
161755034|NCT01196091|584142397|FG002|Overall Study|Adverse Event|26|||
161755035|NCT01196091|584142395|FG000|Overall Study|Death|3|||
161755036|NCT01196091|584142396|FG001|Overall Study|Death|2|||
161755037|NCT01196091|584142397|FG002|Overall Study|Death|2|||
161755038|NCT01196091|584142395|FG000|Overall Study|Entry Criteria Not Met|11|||
161755039|NCT01196091|584142396|FG001|Overall Study|Entry Criteria Not Met|11|||
161755040|NCT01196091|584142397|FG002|Overall Study|Entry Criteria Not Met|10|||
161755041|NCT01196091|584142395|FG000|Overall Study|Lack of Efficacy|15|||
161755042|NCT01196091|584142396|FG001|Overall Study|Lack of Efficacy|12|||
161755043|NCT01196091|584142397|FG002|Overall Study|Lack of Efficacy|17|||
161755044|NCT01196091|584142395|FG000|Overall Study|Lost to Follow-up|5|||
161755045|NCT01196091|584142396|FG001|Overall Study|Lost to Follow-up|5|||
161755046|NCT01196091|584142397|FG002|Overall Study|Lost to Follow-up|6|||
161755047|NCT01196091|584142395|FG000|Overall Study|Parent/Caregiver Decision|0|||
161755048|NCT01196091|584142396|FG001|Overall Study|Parent/Caregiver Decision|0|||
161755049|NCT01196091|584142397|FG002|Overall Study|Parent/Caregiver Decision|1|||
161755050|NCT01196091|584142395|FG000|Overall Study|Withdrawal by Subject|16|||
161755051|NCT01196091|584142396|FG001|Overall Study|Withdrawal by Subject|19|||
161755052|NCT01196091|584142397|FG002|Overall Study|Withdrawal by Subject|22|||
161755053|NCT01196091|584142395|FG000|Overall Study|Physician Decision|3|||
161755054|NCT01196091|584142396|FG001|Overall Study|Physician Decision|3|||
161755055|NCT01196091|584142397|FG002|Overall Study|Physician Decision|4|||
161755056|NCT01196091|584142395|FG000|Overall Study|Protocol Violation|1|||
161755057|NCT01196091|584142396|FG001|Overall Study|Protocol Violation|3|||
161755058|NCT01196091|584142397|FG002|Overall Study|Protocol Violation|3|||
161755059|NCT01196091|584142395|FG000|Overall Study|Sponsor Decision|6|||
161755060|NCT01196091|584142396|FG001|Overall Study|Sponsor Decision|5|||
161755061|NCT01196091|584142397|FG002|Overall Study|Sponsor Decision|4|||
161755062|NCT01196091|584142395|FG000|Overall Study|Excluded Site|5|||
161755063|NCT01196091|584142396|FG001|Overall Study|Excluded Site|11|||
161755064|NCT01196091|584142397|FG002|Overall Study|Excluded Site|8|||
161755065|NCT01196091|584142395|FG000|Overall Study|Randomized, No Study Drug Received|1|||
161755066|NCT01196091|584142396|FG001|Overall Study|Randomized, No Study Drug Received|0|||
161755067|NCT01196091|584142397|FG002|Overall Study|Randomized, No Study Drug Received|1|||
161755068|NCT03733249|584142398|FG000|Overall Study|Death|7|||
161755069|NCT03733249|584142398|FG000|Overall Study|Disease relapse|16|||
161755070|NCT03733249|584142398|FG000|Overall Study|Lost to Follow-up|4|||
161755071|NCT03733249|584142398|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
161755072|NCT03733249|584142398|FG000|Overall Study|Withdrawal by Subject|1|||
161755073|NCT04476108|584142399|FG000|Overall Study|Adverse Event|4|||
161755074|NCT04476108|584142400|FG001|Overall Study|Adverse Event|1|||
161755075|NCT04476108|584142399|FG000|Overall Study|Lost to Follow-up|1|||
161755076|NCT04476108|584142400|FG001|Overall Study|Lost to Follow-up|0|||
161755077|NCT04476108|584142399|FG000|Overall Study|Inadvertent Enrollment|1|||
161755078|NCT04476108|584142400|FG001|Overall Study|Inadvertent Enrollment|0|||
161755079|NCT04476108|584142399|FG000|Overall Study|Protocol Violation|1|||
161755080|NCT04476108|584142400|FG001|Overall Study|Protocol Violation|1|||
161755081|NCT04476108|584142399|FG000|Overall Study|Withdrawal by Subject|1|||
161755082|NCT04476108|584142400|FG001|Overall Study|Withdrawal by Subject|1|||
161755083|NCT00471276|584142401|FG000|Overall Study|Death|2|||
161755084|NCT00471276|584142401|FG000|Overall Study|Adverse Event|16|||
161755085|NCT00471276|584142401|FG000|Overall Study|Protocol Violation|1|||
161755086|NCT00471276|584142401|FG000|Overall Study|Objective progression or relapse|54|||
161755087|NCT00471276|584142401|FG000|Overall Study|Global deterioration of health status|1|||
161755088|NCT00471276|584142401|FG000|Overall Study|Other|3|||
161755089|NCT00471276|584142401|FG000|Overall Study|Refused treatment|6|||
161755090|NCT01487863|584142405|FG000|Overall Study|Death|19|||
161755091|NCT01487863|584142406|FG001|Overall Study|Death|19|||
161755092|NCT02324049|584142410|FG000|Part C|Study terminated|11|||
161755093|NCT02159365|584142411|FG000|Overall Study|Disease Progression|23|||
161755094|NCT02159365|584142411|FG000|Overall Study|Other reasons|11|||
161755095|NCT02159365|584142411|FG000|Overall Study|Administrative reason by Sponsor|9|||
161755096|NCT02159365|584142411|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
161755097|NCT02159365|584142411|FG000|Overall Study|Study drug toxicity|7|||
161755098|NCT02159365|584142411|FG000|Overall Study|Maximum clinical benefit|3|||
161755099|NCT02159365|584142411|FG000|Overall Study|Subject request to discontinue treatment|3|||
161755100|NCT02159365|584142411|FG000|Overall Study|Subject withdrew consent|3|||
161755101|NCT02159365|584142411|FG000|Overall Study|Death|1|||
161755102|NCT02159365|584142411|FG000|Overall Study|Lost to Follow-up|1|||
161755103|NCT01437267|584142412|FG000|Overall Study|Withdrawal by Subject|0|||
161755104|NCT01437267|584142413|FG001|Overall Study|Withdrawal by Subject|0|||
161755105|NCT01437267|584142414|FG002|Overall Study|Withdrawal by Subject|0|||
161755106|NCT01437267|584142415|FG003|Overall Study|Withdrawal by Subject|1|||
161755107|NCT01437267|584142416|FG004|Overall Study|Withdrawal by Subject|0|||
161755108|NCT01437267|584142417|FG005|Overall Study|Withdrawal by Subject|0|||
161755109|NCT01437267|584142412|FG000|Overall Study|Protocol Violation|0|||
161755110|NCT01437267|584142413|FG001|Overall Study|Protocol Violation|1|||
161755111|NCT01437267|584142414|FG002|Overall Study|Protocol Violation|0|||
161755112|NCT01437267|584142415|FG003|Overall Study|Protocol Violation|0|||
161755113|NCT01437267|584142416|FG004|Overall Study|Protocol Violation|0|||
161755114|NCT01437267|584142417|FG005|Overall Study|Protocol Violation|0|||
161755115|NCT00033371|584142418|FG000|Overall Study|Adverse Event|1|||
161755116|NCT00033371|584142419|FG001|Overall Study|Adverse Event|5|||
161755117|NCT00033371|584142418|FG000|Overall Study|Lost to Follow-up|2|||
161755118|NCT00033371|584142419|FG001|Overall Study|Lost to Follow-up|1|||
161755119|NCT00033371|584142418|FG000|Overall Study|Withdrawal by Subject|3|||
161755120|NCT00033371|584142419|FG001|Overall Study|Withdrawal by Subject|3|||
161755121|NCT00033371|584142418|FG000|Overall Study|Disease Progression|0|||
161755122|NCT00033371|584142419|FG001|Overall Study|Disease Progression|1|||
161755123|NCT02699125|584142420|FG000|Placebo|Lost to Follow-up|2|||
161755124|NCT02699125|584142421|FG001|Placebo|Lost to Follow-up|0|||
161755125|NCT02699125|584142420|FG000|Placebo|Protocol Violation|1|||
161755126|NCT02699125|584142421|FG001|Placebo|Protocol Violation|0|||
161755127|NCT02699125|584142420|FG000|Placebo|Withdrawal by Subject|0|||
161755128|NCT02699125|584142421|FG001|Placebo|Withdrawal by Subject|4|||
161755129|NCT02699125|584142420|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
161755130|NCT02699125|584142421|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
161755131|NCT03799627|584142424|FG000|Overall Study|Adverse Event|1|||
161755132|NCT03799627|584142425|FG001|Overall Study|Adverse Event|2|||
161755133|NCT03799627|584142426|FG002|Overall Study|Adverse Event|0|||
161755134|NCT03799627|584142427|FG003|Overall Study|Adverse Event|0|||
161755135|NCT03799627|584142428|FG004|Overall Study|Adverse Event|2|||
161755136|NCT03799627|584142429|FG005|Overall Study|Adverse Event|5|||
161755137|NCT03799627|584142430|FG006|Overall Study|Adverse Event|0|||
161755138|NCT03799627|584142431|FG007|Overall Study|Adverse Event|2|||
161755139|NCT03799627|584142432|FG008|Overall Study|Adverse Event|0|||
161755140|NCT03799627|584142424|FG000|Overall Study|Physician Decision|2|||
161755141|NCT03799627|584142425|FG001|Overall Study|Physician Decision|2|||
161755142|NCT03799627|584142426|FG002|Overall Study|Physician Decision|0|||
161755143|NCT03799627|584142427|FG003|Overall Study|Physician Decision|0|||
161755144|NCT03799627|584142428|FG004|Overall Study|Physician Decision|2|||
161755145|NCT03799627|584142429|FG005|Overall Study|Physician Decision|2|||
161755146|NCT03799627|584142430|FG006|Overall Study|Physician Decision|0|||
161755147|NCT03799627|584142431|FG007|Overall Study|Physician Decision|0|||
161755148|NCT03799627|584142432|FG008|Overall Study|Physician Decision|0|||
161755149|NCT03799627|584142424|FG000|Overall Study|Withdrawal by Subject|1|||
161755150|NCT03799627|584142425|FG001|Overall Study|Withdrawal by Subject|1|||
161755151|NCT03799627|584142426|FG002|Overall Study|Withdrawal by Subject|0|||
161755152|NCT03799627|584142427|FG003|Overall Study|Withdrawal by Subject|2|||
161755153|NCT03799627|584142428|FG004|Overall Study|Withdrawal by Subject|0|||
161755154|NCT03799627|584142429|FG005|Overall Study|Withdrawal by Subject|3|||
161755155|NCT03799627|584142430|FG006|Overall Study|Withdrawal by Subject|0|||
161755156|NCT03799627|584142431|FG007|Overall Study|Withdrawal by Subject|0|||
161755157|NCT03799627|584142432|FG008|Overall Study|Withdrawal by Subject|0|||
161755158|NCT03799627|584142424|FG000|Overall Study|Lack of Efficacy|0|||
161755159|NCT03799627|584142425|FG001|Overall Study|Lack of Efficacy|0|||
161755160|NCT03799627|584142426|FG002|Overall Study|Lack of Efficacy|0|||
161755161|NCT03799627|584142427|FG003|Overall Study|Lack of Efficacy|1|||
161755162|NCT03799627|584142428|FG004|Overall Study|Lack of Efficacy|0|||
161755163|NCT03799627|584142429|FG005|Overall Study|Lack of Efficacy|0|||
161755164|NCT03799627|584142430|FG006|Overall Study|Lack of Efficacy|0|||
161755165|NCT03799627|584142431|FG007|Overall Study|Lack of Efficacy|0|||
161755166|NCT03799627|584142432|FG008|Overall Study|Lack of Efficacy|0|||
161755167|NCT03799627|584142424|FG000|Overall Study|Lost to Follow-up|0|||
161755168|NCT03799627|584142425|FG001|Overall Study|Lost to Follow-up|0|||
161755169|NCT03799627|584142426|FG002|Overall Study|Lost to Follow-up|0|||
161755170|NCT03799627|584142427|FG003|Overall Study|Lost to Follow-up|0|||
161755171|NCT03799627|584142428|FG004|Overall Study|Lost to Follow-up|0|||
161755172|NCT03799627|584142429|FG005|Overall Study|Lost to Follow-up|0|||
161755173|NCT03799627|584142430|FG006|Overall Study|Lost to Follow-up|1|||
161755174|NCT03799627|584142431|FG007|Overall Study|Lost to Follow-up|0|||
161755175|NCT03799627|584142432|FG008|Overall Study|Lost to Follow-up|1|||
161755176|NCT03799627|584142424|FG000|Overall Study|Death|0|||
161755177|NCT03799627|584142425|FG001|Overall Study|Death|0|||
161755178|NCT03799627|584142426|FG002|Overall Study|Death|0|||
161755179|NCT03799627|584142427|FG003|Overall Study|Death|1|||
161755180|NCT03799627|584142428|FG004|Overall Study|Death|0|||
161755181|NCT03799627|584142429|FG005|Overall Study|Death|0|||
161755182|NCT03799627|584142430|FG006|Overall Study|Death|0|||
161755183|NCT03799627|584142431|FG007|Overall Study|Death|0|||
161755184|NCT03799627|584142432|FG008|Overall Study|Death|0|||
161755185|NCT03799627|584142424|FG000|Overall Study|Study Drug Put on Hold|1|||
161755186|NCT03799627|584142425|FG001|Overall Study|Study Drug Put on Hold|0|||
161755187|NCT03799627|584142426|FG002|Overall Study|Study Drug Put on Hold|0|||
161755188|NCT03799627|584142427|FG003|Overall Study|Study Drug Put on Hold|0|||
161755189|NCT03799627|584142428|FG004|Overall Study|Study Drug Put on Hold|0|||
161755190|NCT03799627|584142429|FG005|Overall Study|Study Drug Put on Hold|0|||
161755191|NCT03799627|584142430|FG006|Overall Study|Study Drug Put on Hold|0|||
161755192|NCT03799627|584142431|FG007|Overall Study|Study Drug Put on Hold|0|||
161755193|NCT03799627|584142432|FG008|Overall Study|Study Drug Put on Hold|0|||
161755194|NCT03799627|584142424|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
161755195|NCT03799627|584142425|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
161755196|NCT03799627|584142426|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755197|NCT03799627|584142427|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
161755198|NCT03799627|584142428|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
161755199|NCT03799627|584142429|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755200|NCT03799627|584142430|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755201|NCT03799627|584142431|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755202|NCT03799627|584142432|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755203|NCT03799627|584142424|FG000|Overall Study|Kidney Transplantation|1|||
161755204|NCT03799627|584142425|FG001|Overall Study|Kidney Transplantation|0|||
161755205|NCT03799627|584142426|FG002|Overall Study|Kidney Transplantation|0|||
161755206|NCT03799627|584142427|FG003|Overall Study|Kidney Transplantation|1|||
161755207|NCT03799627|584142428|FG004|Overall Study|Kidney Transplantation|1|||
161755208|NCT03799627|584142429|FG005|Overall Study|Kidney Transplantation|0|||
161755209|NCT03799627|584142430|FG006|Overall Study|Kidney Transplantation|0|||
161755210|NCT03799627|584142431|FG007|Overall Study|Kidney Transplantation|0|||
161755211|NCT03799627|584142432|FG008|Overall Study|Kidney Transplantation|0|||
161755212|NCT03799627|584142424|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
161755213|NCT03799627|584142425|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
161755214|NCT03799627|584142426|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
161755215|NCT03799627|584142427|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
161755216|NCT03799627|584142428|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
161755217|NCT03799627|584142429|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
161755218|NCT03799627|584142430|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
161755219|NCT03799627|584142431|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
161755220|NCT03799627|584142432|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
161755221|NCT03799627|584142424|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755222|NCT03799627|584142425|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
161755223|NCT03799627|584142426|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755224|NCT03799627|584142427|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755225|NCT03799627|584142428|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755226|NCT03799627|584142429|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755227|NCT03799627|584142430|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755228|NCT03799627|584142431|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755229|NCT03799627|584142432|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755230|NCT03799627|584142424|FG000|Overall Study|Met Exclusion Criteria|0|||
161755231|NCT03799627|584142425|FG001|Overall Study|Met Exclusion Criteria|0|||
161755232|NCT03799627|584142426|FG002|Overall Study|Met Exclusion Criteria|0|||
161755233|NCT03799627|584142427|FG003|Overall Study|Met Exclusion Criteria|1|||
161755234|NCT03799627|584142428|FG004|Overall Study|Met Exclusion Criteria|0|||
161755235|NCT03799627|584142429|FG005|Overall Study|Met Exclusion Criteria|0|||
161844921|NCT02980874|584474684|FG001|Overall Study|Unknown study completion status|0|||
161844922|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Adverse Event|0|||
161844923|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Adverse Event|0|||
161844924|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Adverse Event|2|||
161844925|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Adverse Event|0|||
161844926|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Adverse Event|0|||
161844927|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
161844928|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
161844929|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
161844930|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
161844931|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
161755236|NCT03799627|584142430|FG006|Overall Study|Met Exclusion Criteria|0|||
161755237|NCT03799627|584142431|FG007|Overall Study|Met Exclusion Criteria|0|||
161755238|NCT03799627|584142432|FG008|Overall Study|Met Exclusion Criteria|0|||
161755239|NCT03799627|584142424|FG000|Overall Study|Investigational Product Noncompliance|0|||
161755240|NCT03799627|584142425|FG001|Overall Study|Investigational Product Noncompliance|0|||
161755241|NCT03799627|584142426|FG002|Overall Study|Investigational Product Noncompliance|0|||
161755242|NCT03799627|584142427|FG003|Overall Study|Investigational Product Noncompliance|1|||
161755243|NCT03799627|584142428|FG004|Overall Study|Investigational Product Noncompliance|0|||
161755244|NCT03799627|584142429|FG005|Overall Study|Investigational Product Noncompliance|0|||
161755245|NCT03799627|584142430|FG006|Overall Study|Investigational Product Noncompliance|0|||
161755246|NCT03799627|584142431|FG007|Overall Study|Investigational Product Noncompliance|0|||
161755247|NCT03799627|584142432|FG008|Overall Study|Investigational Product Noncompliance|0|||
161755248|NCT03799627|584142424|FG000|Overall Study|Participant Relocation|0|||
161755249|NCT03799627|584142425|FG001|Overall Study|Participant Relocation|0|||
161755250|NCT03799627|584142426|FG002|Overall Study|Participant Relocation|0|||
161755251|NCT03799627|584142427|FG003|Overall Study|Participant Relocation|1|||
161755252|NCT03799627|584142428|FG004|Overall Study|Participant Relocation|0|||
161755253|NCT03799627|584142429|FG005|Overall Study|Participant Relocation|1|||
161755254|NCT03799627|584142430|FG006|Overall Study|Participant Relocation|0|||
161755255|NCT03799627|584142431|FG007|Overall Study|Participant Relocation|0|||
161755256|NCT03799627|584142432|FG008|Overall Study|Participant Relocation|0|||
161755257|NCT03799627|584142424|FG000|Overall Study|Eurofin Issue|0|||
161755258|NCT03799627|584142425|FG001|Overall Study|Eurofin Issue|0|||
161755259|NCT03799627|584142426|FG002|Overall Study|Eurofin Issue|0|||
161755260|NCT03799627|584142427|FG003|Overall Study|Eurofin Issue|0|||
161755261|NCT03799627|584142428|FG004|Overall Study|Eurofin Issue|1|||
161755262|NCT03799627|584142429|FG005|Overall Study|Eurofin Issue|0|||
161755263|NCT03799627|584142430|FG006|Overall Study|Eurofin Issue|0|||
161755264|NCT03799627|584142431|FG007|Overall Study|Eurofin Issue|0|||
161755265|NCT03799627|584142432|FG008|Overall Study|Eurofin Issue|0|||
161755266|NCT03799627|584142424|FG000|Overall Study|Noncompliance with Site Instructions|0|||
161755267|NCT03799627|584142425|FG001|Overall Study|Noncompliance with Site Instructions|0|||
161755268|NCT03799627|584142426|FG002|Overall Study|Noncompliance with Site Instructions|0|||
161755269|NCT03799627|584142427|FG003|Overall Study|Noncompliance with Site Instructions|0|||
161755270|NCT03799627|584142428|FG004|Overall Study|Noncompliance with Site Instructions|1|||
161755271|NCT03799627|584142429|FG005|Overall Study|Noncompliance with Site Instructions|0|||
161755272|NCT03799627|584142430|FG006|Overall Study|Noncompliance with Site Instructions|0|||
161755273|NCT03799627|584142431|FG007|Overall Study|Noncompliance with Site Instructions|0|||
161755274|NCT03799627|584142432|FG008|Overall Study|Noncompliance with Site Instructions|0|||
161755275|NCT03799627|584142424|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755276|NCT03799627|584142425|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755277|NCT03799627|584142426|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755278|NCT03799627|584142427|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755279|NCT03799627|584142428|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
161755280|NCT03799627|584142429|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755281|NCT03799627|584142430|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755282|NCT03799627|584142431|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755283|NCT03799627|584142432|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755284|NCT03799627|584142424|FG000|Overall Study|Changes In Hemoglobin Values|1|||
161755285|NCT03799627|584142425|FG001|Overall Study|Changes In Hemoglobin Values|2|||
161755286|NCT03799627|584142426|FG002|Overall Study|Changes In Hemoglobin Values|1|||
161755287|NCT03799627|584142427|FG003|Overall Study|Changes In Hemoglobin Values|0|||
161755288|NCT03799627|584142428|FG004|Overall Study|Changes In Hemoglobin Values|0|||
161755289|NCT03799627|584142429|FG005|Overall Study|Changes In Hemoglobin Values|2|||
161755290|NCT03799627|584142430|FG006|Overall Study|Changes In Hemoglobin Values|1|||
161755291|NCT03799627|584142431|FG007|Overall Study|Changes In Hemoglobin Values|0|||
161755292|NCT03799627|584142432|FG008|Overall Study|Changes In Hemoglobin Values|1|||
161755293|NCT00398138|584142441|FG000|Overall Study|Adverse Event|2|||
161755294|NCT03418376|584142447|FG000|Overall Study|Musculoskeletal injury|1|||
161755295|NCT03418376|584142448|FG001|Overall Study|Musculoskeletal injury|2|||
161755296|NCT03418376|584142449|FG002|Overall Study|Musculoskeletal injury|1|||
161755297|NCT03418376|584142450|FG003|Overall Study|Musculoskeletal injury|0|||
161755298|NCT03418376|584142447|FG000|Overall Study|Personal reasons|0|||
161755299|NCT03418376|584142448|FG001|Overall Study|Personal reasons|2|||
161755300|NCT03418376|584142449|FG002|Overall Study|Personal reasons|2|||
161755301|NCT03418376|584142450|FG003|Overall Study|Personal reasons|1|||
161755302|NCT03418376|584142447|FG000|Overall Study|Exacerbation|0|||
161755303|NCT03418376|584142448|FG001|Overall Study|Exacerbation|1|||
161755304|NCT03418376|584142449|FG002|Overall Study|Exacerbation|0|||
161755305|NCT03418376|584142450|FG003|Overall Study|Exacerbation|0|||
161755306|NCT00814307|584142451|FG000|Overall Study|Randomized but not treated|1|||
161755307|NCT00814307|584142452|FG001|Overall Study|Randomized but not treated|0|||
161844932|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
161844933|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
161755308|NCT00814307|584142453|FG002|Overall Study|Randomized but not treated|0|||
161755309|NCT00814307|584142454|FG003|Overall Study|Randomized but not treated|0|||
161755310|NCT00814307|584142451|FG000|Overall Study|Adverse Event|3|||
161755311|NCT00814307|584142452|FG001|Overall Study|Adverse Event|9|||
161755312|NCT00814307|584142453|FG002|Overall Study|Adverse Event|3|||
161755313|NCT00814307|584142454|FG003|Overall Study|Adverse Event|2|||
161755314|NCT00814307|584142451|FG000|Overall Study|Lack of Efficacy|1|||
161755315|NCT00814307|584142452|FG001|Overall Study|Lack of Efficacy|1|||
161755316|NCT00814307|584142453|FG002|Overall Study|Lack of Efficacy|3|||
161755317|NCT00814307|584142454|FG003|Overall Study|Lack of Efficacy|4|||
161755318|NCT00814307|584142451|FG000|Overall Study|Other|1|||
161755319|NCT00814307|584142452|FG001|Overall Study|Other|2|||
161755320|NCT00814307|584142453|FG002|Overall Study|Other|0|||
161755321|NCT00814307|584142454|FG003|Overall Study|Other|1|||
161755322|NCT00814307|584142451|FG000|Overall Study|Protocol Violation|2|||
161755323|NCT00814307|584142452|FG001|Overall Study|Protocol Violation|8|||
161755324|NCT00814307|584142453|FG002|Overall Study|Protocol Violation|1|||
161755325|NCT00814307|584142454|FG003|Overall Study|Protocol Violation|1|||
161755326|NCT00814307|584142451|FG000|Overall Study|Withdrawal by Subject|4|||
161755327|NCT00814307|584142452|FG001|Overall Study|Withdrawal by Subject|6|||
161755328|NCT00814307|584142453|FG002|Overall Study|Withdrawal by Subject|0|||
161755329|NCT00814307|584142454|FG003|Overall Study|Withdrawal by Subject|2|||
161755330|NCT00814307|584142451|FG000|Overall Study|Death|0|||
161755331|NCT00814307|584142452|FG001|Overall Study|Death|1|||
161755332|NCT00814307|584142453|FG002|Overall Study|Death|0|||
161755333|NCT00814307|584142454|FG003|Overall Study|Death|0|||
161755334|NCT03039192|584142455|FG000|Overall Study|Lost to Follow-up|4|||
161755335|NCT03039192|584142456|FG001|Overall Study|Lost to Follow-up|4|||
161755336|NCT03039192|584142455|FG000|Overall Study|Adverse event, serious fatal|0|||
161755337|NCT03039192|584142456|FG001|Overall Study|Adverse event, serious fatal|1|||
161755338|NCT03039192|584142455|FG000|Overall Study|Adverse event, non-fatal|0|||
161755339|NCT03039192|584142456|FG001|Overall Study|Adverse event, non-fatal|2|||
161755340|NCT03039192|584142455|FG000|Overall Study|Withdrawal by Subject|6|||
161755341|NCT03039192|584142456|FG001|Overall Study|Withdrawal by Subject|9|||
161755342|NCT03039192|584142455|FG000|Overall Study|Discontinued from treatment phase|19|||
161755343|NCT03039192|584142456|FG001|Overall Study|Discontinued from treatment phase|12|||
161755344|NCT03039192|584142455|FG000|Overall Study|Other|3|||
161755345|NCT03039192|584142456|FG001|Overall Study|Other|2|||
161755346|NCT03277794|584142457|FG000|Overall Study|Lost to Follow-up|2|||
161755347|NCT03277794|584142458|FG001|Overall Study|Lost to Follow-up|4|||
161755348|NCT03277794|584142457|FG000|Overall Study|Withdrew due to high acuity|1|||
161755349|NCT03277794|584142458|FG001|Overall Study|Withdrew due to high acuity|0|||
161755350|NCT02177812|584142462|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755351|NCT02177812|584142463|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755352|NCT02177812|584142464|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755353|NCT02177812|584142465|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755354|NCT02177812|584142466|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755355|NCT02177812|584142467|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
161755356|NCT02177812|584142468|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
161755357|NCT02177812|584142469|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
161755358|NCT02177812|584142470|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755359|NCT02177812|584142462|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755360|NCT02177812|584142463|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755361|NCT02177812|584142464|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755362|NCT02177812|584142465|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755363|NCT02177812|584142466|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755364|NCT02177812|584142467|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
161755365|NCT02177812|584142468|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
161755366|NCT02177812|584142469|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755367|NCT02177812|584142470|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755368|NCT02177812|584142462|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755369|NCT02177812|584142463|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755370|NCT02177812|584142464|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755371|NCT02177812|584142465|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755372|NCT02177812|584142466|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755373|NCT02177812|584142467|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755374|NCT02177812|584142468|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
161755375|NCT02177812|584142469|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755376|NCT02177812|584142470|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755377|NCT00089999|584142471|FG000|Overall Study|Adverse Event|4|||
161755378|NCT00089999|584142472|FG001|Overall Study|Adverse Event|7|||
161755379|NCT00089999|584142471|FG000|Overall Study|Withdrawal by Subject|0|||
161755380|NCT00089999|584142472|FG001|Overall Study|Withdrawal by Subject|4|||
161755381|NCT00089999|584142471|FG000|Overall Study|Lost to Follow-up|2|||
161755382|NCT00089999|584142472|FG001|Overall Study|Lost to Follow-up|1|||
161755383|NCT00089999|584142471|FG000|Overall Study|Radiological Progression of Cancer|52|||
161844934|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
161844935|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
161844936|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
161844937|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
161844938|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
161844939|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
161844940|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
161844941|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
161844942|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
161844943|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
161844944|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
161844945|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
161844946|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
161844947|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844948|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844949|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844950|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844951|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
161844952|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844953|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844954|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844955|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844956|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
161844957|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844958|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844959|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844960|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844961|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
161844962|NCT00911807|584474690|FG000|Overall Study|Adverse Event|2|||
161844963|NCT00911807|584474691|FG001|Overall Study|Adverse Event|1|||
161844964|NCT00911807|584474692|FG002|Overall Study|Adverse Event|5|||
161844965|NCT00911807|584474690|FG000|Overall Study|Death|0|||
161844966|NCT00911807|584474691|FG001|Overall Study|Death|0|||
161844967|NCT00911807|584474692|FG002|Overall Study|Death|1|||
161844968|NCT00911807|584474690|FG000|Overall Study|Protocol Violation|6|||
161844969|NCT00911807|584474691|FG001|Overall Study|Protocol Violation|4|||
161844970|NCT00911807|584474692|FG002|Overall Study|Protocol Violation|9|||
161844971|NCT00911807|584474690|FG000|Overall Study|Withdrawal by Subject|8|||
161844972|NCT00911807|584474691|FG001|Overall Study|Withdrawal by Subject|10|||
161844973|NCT00911807|584474692|FG002|Overall Study|Withdrawal by Subject|7|||
161844974|NCT00911807|584474690|FG000|Overall Study|Organizational reasons|1|||
161844975|NCT00911807|584474691|FG001|Overall Study|Organizational reasons|3|||
161844976|NCT00911807|584474692|FG002|Overall Study|Organizational reasons|1|||
161844977|NCT00855803|584474694|FG000|Overall Study|Death|2|||
161844978|NCT00855803|584474694|FG000|Overall Study|Lost to Follow-up|2|||
161844979|NCT00855803|584474694|FG000|Overall Study|Technical inability to undergo procedure|2|||
161844980|NCT00855803|584474694|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
161844981|NCT00855803|584474694|FG000|Overall Study|Withdrawal by Subject|3|||
161844982|NCT00855803|584474694|FG000|Overall Study|Physician Decision|3|||
161844983|NCT00809159|584474695|FG000|Part 1|Adverse Event|1|||
161844984|NCT00809159|584474696|FG001|Part 1|Adverse Event|1|||
161844985|NCT00809159|584474697|FG002|Part 1|Adverse Event|0|||
161844986|NCT00809159|584474698|FG003|Part 1|Adverse Event|0|||
161844987|NCT00809159|584474699|FG004|Part 1|Adverse Event|0|||
161844988|NCT00809159|584474700|FG005|Part 1|Adverse Event|0|||
161844989|NCT00809159|584474695|FG000|Part 1|Lost to Follow-up|1|||
161844990|NCT00809159|584474696|FG001|Part 1|Lost to Follow-up|0|||
161844991|NCT00809159|584474697|FG002|Part 1|Lost to Follow-up|0|||
161844992|NCT00809159|584474698|FG003|Part 1|Lost to Follow-up|0|||
161844993|NCT00809159|584474699|FG004|Part 1|Lost to Follow-up|0|||
161844994|NCT00809159|584474700|FG005|Part 1|Lost to Follow-up|0|||
161844995|NCT00809159|584474695|FG000|Part 1|Withdrawal by Subject|3|||
161844996|NCT00809159|584474696|FG001|Part 1|Withdrawal by Subject|1|||
161844997|NCT00809159|584474697|FG002|Part 1|Withdrawal by Subject|0|||
161844998|NCT00809159|584474698|FG003|Part 1|Withdrawal by Subject|0|||
161844999|NCT00809159|584474699|FG004|Part 1|Withdrawal by Subject|0|||
161845000|NCT00809159|584474700|FG005|Part 1|Withdrawal by Subject|0|||
161845001|NCT00809159|584474695|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
161845002|NCT00809159|584474696|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
161845003|NCT00809159|584474697|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
161845004|NCT00809159|584474698|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
161845005|NCT00809159|584474699|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
161845006|NCT00809159|584474700|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
161845007|NCT00809159|584474695|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
161845008|NCT00809159|584474696|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
161845009|NCT00809159|584474697|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
161845010|NCT00809159|584474698|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
161845011|NCT00809159|584474699|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
161755384|NCT00089999|584142472|FG001|Overall Study|Radiological Progression of Cancer|44|||
161755385|NCT00089999|584142471|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
161755386|NCT00089999|584142472|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
161755387|NCT00089999|584142471|FG000|Overall Study|Death|3|||
161755388|NCT00089999|584142472|FG001|Overall Study|Death|3|||
161755389|NCT00089999|584142471|FG000|Overall Study|Poor General Condition|1|||
161755390|NCT00089999|584142472|FG001|Overall Study|Poor General Condition|0|||
161755391|NCT00089999|584142471|FG000|Overall Study|Clinical Progression|1|||
161755392|NCT00089999|584142472|FG001|Overall Study|Clinical Progression|2|||
161755393|NCT00089999|584142471|FG000|Overall Study|Physician Decision|2|||
161755394|NCT00089999|584142472|FG001|Overall Study|Physician Decision|2|||
161755395|NCT00089999|584142471|FG000|Overall Study|Patient Underwent Surgery|2|||
161755396|NCT00089999|584142472|FG001|Overall Study|Patient Underwent Surgery|0|||
161755397|NCT00089999|584142471|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
161755398|NCT00089999|584142472|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
161755399|NCT02266004|584144319|FG000|Overall Study|unrelated adverse event|1|||
161755400|NCT02266004|584144319|FG000|Overall Study|Physician Decision|1|||
161755401|NCT00537771|584144320|FG000|Overall Study|Withdrawal by Subject|6|||
161755402|NCT00537771|584144321|FG001|Overall Study|Withdrawal by Subject|23|||
161755403|NCT00537771|584144320|FG000|Overall Study|Adverse Event|8|||
161755404|NCT00537771|584144321|FG001|Overall Study|Adverse Event|15|||
161755405|NCT00537771|584144320|FG000|Overall Study|Lost to Follow-up|9|||
161755406|NCT00537771|584144321|FG001|Overall Study|Lost to Follow-up|15|||
161755407|NCT00537771|584144320|FG000|Overall Study|Protocol Violation|2|||
161755408|NCT00537771|584144321|FG001|Overall Study|Protocol Violation|6|||
161755409|NCT00537771|584144320|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161755410|NCT00537771|584144321|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161755411|NCT02465489|584144324|FG000|Overall Study|Adverse Event|5|||
161755412|NCT00850135|584144325|FG000|Overall Study|Physician Decision|1|||
161755413|NCT02253992|584144326|FG000|Overall Study|Study drug toxicity|1|||
161755414|NCT02253992|584144327|FG001|Overall Study|Study drug toxicity|0|||
161755415|NCT02253992|584144328|FG002|Overall Study|Study drug toxicity|10|||
161755416|NCT02253992|584144326|FG000|Overall Study|Disease progression|4|||
161755417|NCT02253992|584144327|FG001|Overall Study|Disease progression|3|||
161755418|NCT02253992|584144328|FG002|Overall Study|Disease progression|98|||
161755419|NCT02253992|584144326|FG000|Overall Study|Withdrawal by Subject|0|||
161755420|NCT02253992|584144327|FG001|Overall Study|Withdrawal by Subject|0|||
161755421|NCT02253992|584144328|FG002|Overall Study|Withdrawal by Subject|3|||
161755422|NCT02253992|584144326|FG000|Overall Study|Adverse Event|0|||
161755423|NCT02253992|584144327|FG001|Overall Study|Adverse Event|0|||
161755424|NCT02253992|584144328|FG002|Overall Study|Adverse Event|8|||
161755425|NCT02253992|584144326|FG000|Overall Study|Death|0|||
161755426|NCT02253992|584144327|FG001|Overall Study|Death|0|||
161755427|NCT02253992|584144328|FG002|Overall Study|Death|1|||
161755428|NCT02253992|584144326|FG000|Overall Study|Subject discontinued study drug|1|||
161755429|NCT02253992|584144327|FG001|Overall Study|Subject discontinued study drug|0|||
161755430|NCT02253992|584144328|FG002|Overall Study|Subject discontinued study drug|1|||
161755431|NCT02253992|584144326|FG000|Overall Study|Completed treatment as per protocol|0|||
161755432|NCT02253992|584144327|FG001|Overall Study|Completed treatment as per protocol|1|||
161755433|NCT02253992|584144328|FG002|Overall Study|Completed treatment as per protocol|22|||
161755434|NCT02253992|584144326|FG000|Overall Study|Other|0|||
161755435|NCT02253992|584144327|FG001|Overall Study|Other|0|||
161755436|NCT02253992|584144328|FG002|Overall Study|Other|1|||
161755437|NCT03198728|584144329|FG000|Overall Study|Adverse Event|10|||
161755438|NCT03198728|584144330|FG001|Overall Study|Adverse Event|5|||
161755439|NCT03198728|584144329|FG000|Overall Study|Lost to Follow-up|21|||
161755440|NCT03198728|584144330|FG001|Overall Study|Lost to Follow-up|7|||
161755441|NCT03198728|584144329|FG000|Overall Study|Physician Decision|7|||
161755442|NCT03198728|584144330|FG001|Overall Study|Physician Decision|2|||
161755443|NCT03198728|584144329|FG000|Overall Study|Withdrawal by Subject|14|||
161755444|NCT03198728|584144330|FG001|Overall Study|Withdrawal by Subject|10|||
161755445|NCT04051944|584144331|FG000|Overall Study|Study ending|1|||
161755446|NCT04051944|584144332|FG001|Overall Study|Study ending|1|||
161755447|NCT04051944|584144331|FG000|Overall Study|Early study termination by participant|1|||
161755448|NCT04051944|584144332|FG001|Overall Study|Early study termination by participant|0|||
161755449|NCT04051944|584144331|FG000|Overall Study|Withdrawal by Subject|2|||
161755450|NCT04051944|584144332|FG001|Overall Study|Withdrawal by Subject|2|||
161755451|NCT04051944|584144331|FG000|Overall Study|Lack of Efficacy|3|||
161755452|NCT04051944|584144332|FG001|Overall Study|Lack of Efficacy|0|||
161755453|NCT04051944|584144331|FG000|Overall Study|Adverse event, non- fatal|1|||
161755454|NCT04051944|584144332|FG001|Overall Study|Adverse event, non- fatal|1|||
161755455|NCT03083470|584144333|FG000|Overall Study|Lost to Follow-up|0|||
161845012|NCT00809159|584474700|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
161845013|NCT00809159|584474695|FG000|Part 1 and 2|Administrative problems|0|||
161755456|NCT03083470|584144334|FG001|Overall Study|Lost to Follow-up|0|||
161755457|NCT03083470|584144335|FG002|Overall Study|Lost to Follow-up|0|||
161755458|NCT03083470|584144336|FG003|Overall Study|Lost to Follow-up|0|||
161755459|NCT03083470|584144337|FG004|Overall Study|Lost to Follow-up|1|||
161755460|NCT03083470|584144333|FG000|Overall Study|Withdrawal by Subject|0|||
161755461|NCT03083470|584144334|FG001|Overall Study|Withdrawal by Subject|0|||
161755462|NCT03083470|584144335|FG002|Overall Study|Withdrawal by Subject|0|||
161755463|NCT03083470|584144336|FG003|Overall Study|Withdrawal by Subject|0|||
161755464|NCT03083470|584144337|FG004|Overall Study|Withdrawal by Subject|1|||
161755465|NCT01512693|584144338|FG000|Overall Study|Withdrawal by Subject|0|||
161755466|NCT01512693|584144339|FG001|Overall Study|Withdrawal by Subject|1|||
161755467|NCT02139280|584144340|FG000|Overall Study|No longer eligible|2|||
161755468|NCT02139280|584144341|FG001|Overall Study|No longer eligible|0|||
161755469|NCT00736450|584144348|FG000|Overall Study|Not ABC gene eligible|19|||
161755470|NCT00736450|584144348|FG000|Overall Study|Withdrawal by Subject|5|||
161755471|NCT00736450|584144348|FG000|Overall Study|Physician Decision|1|||
161755472|NCT04731922|584144352|FG000|Overall Study|Adverse Event|0|||
161755473|NCT04731922|584144353|FG001|Overall Study|Adverse Event|0|||
161755474|NCT04731922|584144354|FG002|Overall Study|Adverse Event|0|||
161755475|NCT04731922|584144355|FG003|Overall Study|Adverse Event|0|||
161755476|NCT04731922|584144356|FG004|Overall Study|Adverse Event|0|||
161755477|NCT04731922|584144357|FG005|Overall Study|Adverse Event|0|||
161755478|NCT04731922|584144358|FG006|Overall Study|Adverse Event|0|||
161755479|NCT04731922|584144359|FG007|Overall Study|Adverse Event|0|||
161755480|NCT04731922|584144360|FG008|Overall Study|Adverse Event|0|||
161755481|NCT04731922|584144361|FG009|Overall Study|Adverse Event|0|||
161755482|NCT04731922|584144362|FG010|Overall Study|Adverse Event|1|||
161755483|NCT04731922|584144363|FG011|Overall Study|Adverse Event|0|||
161755484|NCT04731922|584144364|FG012|Overall Study|Adverse Event|0|||
161755485|NCT04731922|584144365|FG013|Overall Study|Adverse Event|0|||
161755486|NCT04731922|584144366|FG014|Overall Study|Adverse Event|0|||
161755487|NCT04731922|584144367|FG015|Overall Study|Adverse Event|0|||
161755488|NCT04731922|584144368|FG016|Overall Study|Adverse Event|0|||
161755489|NCT04731922|584144352|FG000|Overall Study|Lost to Follow-up|0|||
161755490|NCT04731922|584144353|FG001|Overall Study|Lost to Follow-up|0|||
161755491|NCT04731922|584144354|FG002|Overall Study|Lost to Follow-up|0|||
161755492|NCT04731922|584144355|FG003|Overall Study|Lost to Follow-up|1|||
161755493|NCT04731922|584144356|FG004|Overall Study|Lost to Follow-up|0|||
161755494|NCT04731922|584144357|FG005|Overall Study|Lost to Follow-up|1|||
161755495|NCT04731922|584144358|FG006|Overall Study|Lost to Follow-up|0|||
161755496|NCT04731922|584144359|FG007|Overall Study|Lost to Follow-up|0|||
161755497|NCT04731922|584144360|FG008|Overall Study|Lost to Follow-up|0|||
161755498|NCT04731922|584144361|FG009|Overall Study|Lost to Follow-up|0|||
161755499|NCT04731922|584144362|FG010|Overall Study|Lost to Follow-up|0|||
161755500|NCT04731922|584144363|FG011|Overall Study|Lost to Follow-up|0|||
161755501|NCT04731922|584144364|FG012|Overall Study|Lost to Follow-up|0|||
161755502|NCT04731922|584144365|FG013|Overall Study|Lost to Follow-up|0|||
161755503|NCT04731922|584144366|FG014|Overall Study|Lost to Follow-up|0|||
161755504|NCT04731922|584144367|FG015|Overall Study|Lost to Follow-up|0|||
161755505|NCT04731922|584144368|FG016|Overall Study|Lost to Follow-up|0|||
161755506|NCT04731922|584144352|FG000|Overall Study|Withdrawal by Subject|1|||
161755507|NCT04731922|584144353|FG001|Overall Study|Withdrawal by Subject|0|||
161755508|NCT04731922|584144354|FG002|Overall Study|Withdrawal by Subject|0|||
161755509|NCT04731922|584144355|FG003|Overall Study|Withdrawal by Subject|0|||
161755510|NCT04731922|584144356|FG004|Overall Study|Withdrawal by Subject|1|||
161755511|NCT04731922|584144357|FG005|Overall Study|Withdrawal by Subject|0|||
161755512|NCT04731922|584144358|FG006|Overall Study|Withdrawal by Subject|1|||
161755513|NCT04731922|584144359|FG007|Overall Study|Withdrawal by Subject|0|||
161755514|NCT04731922|584144360|FG008|Overall Study|Withdrawal by Subject|0|||
161755515|NCT04731922|584144361|FG009|Overall Study|Withdrawal by Subject|0|||
161755516|NCT04731922|584144362|FG010|Overall Study|Withdrawal by Subject|0|||
161755517|NCT04731922|584144363|FG011|Overall Study|Withdrawal by Subject|0|||
161755518|NCT04731922|584144364|FG012|Overall Study|Withdrawal by Subject|0|||
161755519|NCT04731922|584144365|FG013|Overall Study|Withdrawal by Subject|1|||
161755520|NCT04731922|584144366|FG014|Overall Study|Withdrawal by Subject|0|||
161755521|NCT04731922|584144367|FG015|Overall Study|Withdrawal by Subject|0|||
161755522|NCT04731922|584144368|FG016|Overall Study|Withdrawal by Subject|0|||
161755523|NCT04731922|584144352|FG000|Overall Study|Other|0|||
161755524|NCT04731922|584144353|FG001|Overall Study|Other|0|||
161755525|NCT04731922|584144354|FG002|Overall Study|Other|0|||
161755526|NCT04731922|584144355|FG003|Overall Study|Other|0|||
161755527|NCT04731922|584144356|FG004|Overall Study|Other|0|||
161755528|NCT04731922|584144357|FG005|Overall Study|Other|0|||
161755529|NCT04731922|584144358|FG006|Overall Study|Other|1|||
161755530|NCT04731922|584144359|FG007|Overall Study|Other|0|||
161755531|NCT04731922|584144360|FG008|Overall Study|Other|0|||
161755532|NCT04731922|584144361|FG009|Overall Study|Other|0|||
161755533|NCT04731922|584144362|FG010|Overall Study|Other|0|||
161755534|NCT04731922|584144363|FG011|Overall Study|Other|0|||
161755535|NCT04731922|584144364|FG012|Overall Study|Other|0|||
161755536|NCT04731922|584144365|FG013|Overall Study|Other|0|||
161845014|NCT00809159|584474696|FG001|Part 1 and 2|Administrative problems|0|||
161845015|NCT00809159|584474697|FG002|Part 1 and 2|Administrative problems|0|||
161845016|NCT00809159|584474698|FG003|Part 1 and 2|Administrative problems|1|||
161845017|NCT00809159|584474699|FG004|Part 1 and 2|Administrative problems|0|||
161845018|NCT00809159|584474700|FG005|Part 1 and 2|Administrative problems|0|||
161845019|NCT00809159|584474695|FG000|Part 1 and 2|Adverse Event|0|||
161845020|NCT00809159|584474696|FG001|Part 1 and 2|Adverse Event|0|||
161845021|NCT00809159|584474697|FG002|Part 1 and 2|Adverse Event|1|||
161845022|NCT00809159|584474698|FG003|Part 1 and 2|Adverse Event|0|||
161845023|NCT00809159|584474699|FG004|Part 1 and 2|Adverse Event|1|||
161845024|NCT00809159|584474700|FG005|Part 1 and 2|Adverse Event|1|||
161845025|NCT00809159|584474695|FG000|Part 1 and 2|Lost to Follow-up|0|||
161845026|NCT00809159|584474696|FG001|Part 1 and 2|Lost to Follow-up|0|||
161845027|NCT00809159|584474697|FG002|Part 1 and 2|Lost to Follow-up|1|||
161845028|NCT00809159|584474698|FG003|Part 1 and 2|Lost to Follow-up|1|||
161845029|NCT00809159|584474699|FG004|Part 1 and 2|Lost to Follow-up|0|||
161845030|NCT00809159|584474700|FG005|Part 1 and 2|Lost to Follow-up|0|||
161845031|NCT00809159|584474695|FG000|Part 1 and 2|Withdrawal by Subject|0|||
161845032|NCT00809159|584474696|FG001|Part 1 and 2|Withdrawal by Subject|0|||
161845033|NCT00809159|584474697|FG002|Part 1 and 2|Withdrawal by Subject|4|||
161755537|NCT04731922|584144366|FG014|Overall Study|Other|0|||
161755538|NCT04731922|584144367|FG015|Overall Study|Other|0|||
161755539|NCT04731922|584144368|FG016|Overall Study|Other|0|||
161755540|NCT04157751|584144369|FG000|Overall Study|Withdrawal by Subject|12|||
161755541|NCT04157751|584144370|FG001|Overall Study|Withdrawal by Subject|17|||
161755542|NCT04157751|584144369|FG000|Overall Study|Lost to Follow-up|6|||
161755543|NCT04157751|584144370|FG001|Overall Study|Lost to Follow-up|2|||
161755544|NCT04157751|584144369|FG000|Overall Study|Adverse Event|34|||
161755545|NCT04157751|584144370|FG001|Overall Study|Adverse Event|23|||
161755546|NCT04157751|584144369|FG000|Overall Study|Not treated|1|||
161755547|NCT04157751|584144370|FG001|Overall Study|Not treated|5|||
161755548|NCT04157751|584144369|FG000|Overall Study|Other reason not stated above|10|||
161755549|NCT04157751|584144370|FG001|Overall Study|Other reason not stated above|10|||
161755550|NCT00981747|584144377|FG000|Losartan|Withdrawal by Subject|1|||
161755551|NCT00981747|584144377|FG000|Losartan|Death|1|||
161755552|NCT00981747|584144377|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
161755553|NCT01810380|584144387|FG000|Overall Study|Randomised not treated|2|||
161755554|NCT01810380|584144388|FG001|Overall Study|Randomised not treated|1|||
161755555|NCT01810380|584144389|FG002|Overall Study|Randomised not treated|1|||
161755556|NCT01810380|584144387|FG000|Overall Study|Adverse Event|11|||
161755557|NCT01810380|584144388|FG001|Overall Study|Adverse Event|14|||
161755558|NCT01810380|584144389|FG002|Overall Study|Adverse Event|4|||
161755559|NCT01810380|584144387|FG000|Overall Study|Lack of Efficacy|24|||
161755560|NCT01810380|584144388|FG001|Overall Study|Lack of Efficacy|10|||
161755561|NCT01810380|584144389|FG002|Overall Study|Lack of Efficacy|11|||
161755562|NCT01810380|584144387|FG000|Overall Study|Protocol Violation|1|||
161755563|NCT01810380|584144388|FG001|Overall Study|Protocol Violation|0|||
161755564|NCT01810380|584144389|FG002|Overall Study|Protocol Violation|1|||
161755565|NCT01810380|584144387|FG000|Overall Study|Withdrawal by Subject|6|||
161755566|NCT01810380|584144388|FG001|Overall Study|Withdrawal by Subject|0|||
161755567|NCT01810380|584144389|FG002|Overall Study|Withdrawal by Subject|6|||
161755568|NCT01810380|584144387|FG000|Overall Study|Administrative or other reasons|11|||
161755569|NCT01810380|584144388|FG001|Overall Study|Administrative or other reasons|13|||
161755570|NCT01810380|584144389|FG002|Overall Study|Administrative or other reasons|9|||
161755571|NCT01390038|584144390|FG000|Overall Study|Death|1|||
161755572|NCT01390038|584144390|FG000|Overall Study|Lost to Follow-up|1|||
161755573|NCT01390038|584144390|FG000|Overall Study|Withdrawal by Subject|4|||
161755574|NCT01390038|584144390|FG000|Overall Study|Simpliciti System Removal|2|||
161755575|NCT03148795|584144395|FG000|Overall Study|Progressive Disease|1|||
161755576|NCT00441012|584144396|FG000|Overall Study|Adverse Event|0|||
161755577|NCT00441012|584144397|FG001|Overall Study|Adverse Event|1|||
161755578|NCT00441012|584144396|FG000|Overall Study|Lost to Follow-up|3|||
161755579|NCT00441012|584144397|FG001|Overall Study|Lost to Follow-up|3|||
161755580|NCT00441012|584144396|FG000|Overall Study|Protocol Violation|10|||
161845034|NCT00809159|584474698|FG003|Part 1 and 2|Withdrawal by Subject|0|||
161845035|NCT00809159|584474699|FG004|Part 1 and 2|Withdrawal by Subject|0|||
161845036|NCT00809159|584474700|FG005|Part 1 and 2|Withdrawal by Subject|1|||
161845037|NCT03918109|584474705|FG000|Overall Study|Withdrawal by Subject|0|||
161845038|NCT03918109|584474706|FG001|Overall Study|Withdrawal by Subject|0|||
161755581|NCT00441012|584144397|FG001|Overall Study|Protocol Violation|9|||
161755582|NCT00441012|584144396|FG000|Overall Study|Withdrawal by Subject|4|||
161755583|NCT00441012|584144397|FG001|Overall Study|Withdrawal by Subject|0|||
161755584|NCT00441012|584144396|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
161755585|NCT00441012|584144397|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
161755586|NCT04489940|584144398|FG000|Overall Study|Other|2|||
161845039|NCT03918109|584474707|FG002|Overall Study|Withdrawal by Subject|2|||
161755587|NCT04489940|584144398|FG000|Overall Study|Withdrawal by Subject|2|||
161755588|NCT04489940|584144398|FG000|Overall Study|Death|5|||
161845040|NCT03918109|584474708|FG003|Overall Study|Withdrawal by Subject|1|||
161845041|NCT03918109|584474705|FG000|Overall Study|Lost to Follow-up|0|||
161845042|NCT03918109|584474706|FG001|Overall Study|Lost to Follow-up|0|||
161845043|NCT03918109|584474707|FG002|Overall Study|Lost to Follow-up|0|||
161845044|NCT03918109|584474708|FG003|Overall Study|Lost to Follow-up|1|||
161845045|NCT03050060|584474713|FG000|Overall Study|Adverse Event|7|||
161845046|NCT03050060|584474713|FG000|Overall Study|Withdrawal by Subject|1|||
161845047|NCT03050060|584474713|FG000|Overall Study|Progression|7|||
161845048|NCT04568031|584474714|FG000|Overall Study|Lost to Follow-up|1|||
161845049|NCT04568031|584474715|FG001|Overall Study|Lost to Follow-up|0|||
161845050|NCT04568031|584474716|FG002|Overall Study|Lost to Follow-up|0|||
161845051|NCT04568031|584474717|FG003|Overall Study|Lost to Follow-up|0|||
161845052|NCT04568031|584474714|FG000|Overall Study|Physician Decision|1|||
161845053|NCT04568031|584474715|FG001|Overall Study|Physician Decision|0|||
161845054|NCT04568031|584474716|FG002|Overall Study|Physician Decision|1|||
161845055|NCT04568031|584474717|FG003|Overall Study|Physician Decision|0|||
161845056|NCT04568031|584474714|FG000|Overall Study|Withdrawal by Subject|1|||
161845057|NCT04568031|584474715|FG001|Overall Study|Withdrawal by Subject|0|||
161845058|NCT04568031|584474716|FG002|Overall Study|Withdrawal by Subject|4|||
161845059|NCT04568031|584474717|FG003|Overall Study|Withdrawal by Subject|1|||
161845060|NCT02304458|584474718|FG000|Overall Study|Adverse Event|0|||
161845061|NCT02304458|584474719|FG001|Overall Study|Adverse Event|0|||
161845062|NCT02304458|584474720|FG002|Overall Study|Adverse Event|7|||
161845063|NCT02304458|584474721|FG003|Overall Study|Adverse Event|0|||
161845064|NCT02304458|584474722|FG004|Overall Study|Adverse Event|0|||
161845065|NCT02304458|584474723|FG005|Overall Study|Adverse Event|0|||
161845066|NCT02304458|584474724|FG006|Overall Study|Adverse Event|3|||
161845067|NCT02304458|584474725|FG007|Overall Study|Adverse Event|4|||
161845068|NCT02304458|584474718|FG000|Overall Study|Death|0|||
161845069|NCT02304458|584474719|FG001|Overall Study|Death|0|||
161845070|NCT02304458|584474720|FG002|Overall Study|Death|2|||
161845071|NCT02304458|584474721|FG003|Overall Study|Death|0|||
161845072|NCT02304458|584474722|FG004|Overall Study|Death|0|||
161845073|NCT02304458|584474723|FG005|Overall Study|Death|0|||
161845074|NCT02304458|584474724|FG006|Overall Study|Death|1|||
161845075|NCT02304458|584474725|FG007|Overall Study|Death|0|||
161845076|NCT02304458|584474718|FG000|Overall Study|Lack of Efficacy|4|||
161845077|NCT02304458|584474719|FG001|Overall Study|Lack of Efficacy|6|||
161845078|NCT02304458|584474720|FG002|Overall Study|Lack of Efficacy|38|||
161845079|NCT02304458|584474721|FG003|Overall Study|Lack of Efficacy|5|||
161845080|NCT02304458|584474722|FG004|Overall Study|Lack of Efficacy|6|||
161845081|NCT02304458|584474723|FG005|Overall Study|Lack of Efficacy|6|||
161845082|NCT02304458|584474724|FG006|Overall Study|Lack of Efficacy|21|||
161845083|NCT02304458|584474725|FG007|Overall Study|Lack of Efficacy|4|||
161845084|NCT02304458|584474718|FG000|Overall Study|Physician Decision|2|||
161845085|NCT02304458|584474719|FG001|Overall Study|Physician Decision|0|||
161845086|NCT02304458|584474720|FG002|Overall Study|Physician Decision|16|||
161845087|NCT02304458|584474721|FG003|Overall Study|Physician Decision|1|||
161845088|NCT02304458|584474722|FG004|Overall Study|Physician Decision|0|||
161845089|NCT02304458|584474723|FG005|Overall Study|Physician Decision|0|||
161845090|NCT02304458|584474724|FG006|Overall Study|Physician Decision|3|||
161845091|NCT02304458|584474725|FG007|Overall Study|Physician Decision|0|||
161845092|NCT02304458|584474718|FG000|Overall Study|Protocol Violation|0|||
161845093|NCT02304458|584474719|FG001|Overall Study|Protocol Violation|0|||
161845094|NCT02304458|584474720|FG002|Overall Study|Protocol Violation|1|||
161755589|NCT04489940|584144398|FG000|Overall Study|Lost to Follow-up|1|||
161755590|NCT04498468|584144399|FG000|Overall Study|Lost to Follow-up|3|||
161755591|NCT02774291|584144400|FG000|Overall Study|Lost to Follow-up|1|||
161755592|NCT00149890|584144404|FG000|Overall Study|Adverse Event|1|||
161755593|NCT00149890|584144405|FG001|Overall Study|Adverse Event|8|||
161755594|NCT00149890|584144404|FG000|Overall Study|Lack of Efficacy|8|||
161755595|NCT00149890|584144405|FG001|Overall Study|Lack of Efficacy|9|||
161755596|NCT00149890|584144404|FG000|Overall Study|Protocol Violation|1|||
161755597|NCT00149890|584144405|FG001|Overall Study|Protocol Violation|0|||
161755598|NCT00149890|584144404|FG000|Overall Study|Lost to Follow-up|1|||
161755599|NCT00149890|584144405|FG001|Overall Study|Lost to Follow-up|0|||
161755600|NCT00149890|584144404|FG000|Overall Study|Graft Loss|2|||
161755601|NCT00149890|584144405|FG001|Overall Study|Graft Loss|1|||
161755602|NCT01387594|584144406|FG000|Overall Study|Withdrawal by Subject|0|||
161755603|NCT01387594|584144407|FG001|Overall Study|Withdrawal by Subject|2|||
161755604|NCT01387594|584144406|FG000|Overall Study|Lost to Follow-up|0|||
161755605|NCT01387594|584144407|FG001|Overall Study|Lost to Follow-up|1|||
161755606|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
161755607|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
161755608|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161755609|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161755610|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161755611|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
161755612|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
161755613|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161755614|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161755615|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161755616|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
161755617|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
161755618|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161755619|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161755620|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161755621|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755622|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
161755623|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755624|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755625|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755626|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
161755627|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755628|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755629|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755630|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755631|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755632|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
161755633|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755634|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755635|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755636|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
161755637|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
161755638|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161755639|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161755640|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161755641|NCT04757376|584144410|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755642|NCT04757376|584144411|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755643|NCT04757376|584144412|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
161755644|NCT04757376|584144413|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755645|NCT04757376|584144414|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755646|NCT01307046|584144415|FG000|Overall Study|Adverse Event|3|||
161755647|NCT01307046|584144416|FG001|Overall Study|Adverse Event|3|||
161755648|NCT01307046|584144415|FG000|Overall Study|Lack of Efficacy|0|||
161755649|NCT01307046|584144416|FG001|Overall Study|Lack of Efficacy|2|||
161755650|NCT01307046|584144415|FG000|Overall Study|Physician Decision|2|||
161845095|NCT02304458|584474721|FG003|Overall Study|Protocol Violation|0|||
161845096|NCT02304458|584474722|FG004|Overall Study|Protocol Violation|0|||
161845097|NCT02304458|584474723|FG005|Overall Study|Protocol Violation|0|||
161845098|NCT02304458|584474724|FG006|Overall Study|Protocol Violation|0|||
161845099|NCT02304458|584474725|FG007|Overall Study|Protocol Violation|0|||
161845100|NCT02304458|584474718|FG000|Overall Study|Withdrawal by Subject|1|||
161845101|NCT02304458|584474719|FG001|Overall Study|Withdrawal by Subject|0|||
161845102|NCT02304458|584474720|FG002|Overall Study|Withdrawal by Subject|7|||
161845103|NCT02304458|584474721|FG003|Overall Study|Withdrawal by Subject|0|||
161845104|NCT02304458|584474722|FG004|Overall Study|Withdrawal by Subject|0|||
161845105|NCT02304458|584474723|FG005|Overall Study|Withdrawal by Subject|0|||
161845106|NCT02304458|584474724|FG006|Overall Study|Withdrawal by Subject|1|||
161845107|NCT02304458|584474725|FG007|Overall Study|Withdrawal by Subject|0|||
161845108|NCT00186043|584474726|FG000|Overall Study|Lack of Efficacy|1|||
161845109|NCT00186043|584474727|FG001|Overall Study|Lack of Efficacy|3|||
161845110|NCT00186043|584474726|FG000|Overall Study|Lost to Follow-up|4|||
161845111|NCT00186043|584474727|FG001|Overall Study|Lost to Follow-up|6|||
161845112|NCT00186043|584474726|FG000|Overall Study|Withdrawal by Subject|1|||
161845113|NCT00186043|584474727|FG001|Overall Study|Withdrawal by Subject|0|||
161845114|NCT00186043|584474726|FG000|Overall Study|Adverse Event|7|||
161845115|NCT00186043|584474727|FG001|Overall Study|Adverse Event|3|||
161845116|NCT00186043|584474726|FG000|Overall Study|Protocol Violation|2|||
161845117|NCT00186043|584474727|FG001|Overall Study|Protocol Violation|1|||
161845118|NCT04874636|584474728|FG000|Overall Study|Adverse Event|17|||
161845119|NCT04874636|584474729|FG001|Overall Study|Adverse Event|7|||
161845120|NCT04874636|584474728|FG000|Overall Study|Lost to Follow-up|1|||
161845121|NCT04874636|584474729|FG001|Overall Study|Lost to Follow-up|0|||
161845122|NCT04874636|584474728|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161845123|NCT04874636|584474729|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161845124|NCT04874636|584474728|FG000|Overall Study|Physician Decision|1|||
161845125|NCT04874636|584474729|FG001|Overall Study|Physician Decision|0|||
161845126|NCT04874636|584474728|FG000|Overall Study|Withdrawal by Subject|6|||
161845127|NCT04874636|584474729|FG001|Overall Study|Withdrawal by Subject|5|||
161845128|NCT04188301|584474732|FG000|Month 3|Lost to Follow-up|0|||
161845129|NCT04188301|584474733|FG001|Month 3|Lost to Follow-up|0|||
161845130|NCT04188301|584474734|FG002|Month 3|Lost to Follow-up|1|||
161845131|NCT04188301|584474732|FG000|Month 12|Lost to Follow-up|0|||
161845132|NCT04188301|584474733|FG001|Month 12|Lost to Follow-up|0|||
161845133|NCT04188301|584474734|FG002|Month 12|Lost to Follow-up|2|||
161845134|NCT04188301|584474732|FG000|Month 12|Death|1|||
161845135|NCT04188301|584474733|FG001|Month 12|Death|1|||
161845136|NCT04188301|584474734|FG002|Month 12|Death|0|||
161845137|NCT04188301|584474732|FG000|Month 18|Lost to Follow-up|6|||
161845138|NCT04188301|584474733|FG001|Month 18|Lost to Follow-up|0|||
161845139|NCT04188301|584474734|FG002|Month 18|Lost to Follow-up|0|||
161845140|NCT02582866|584474739|FG000|Overall Study|Death|1|||
161845141|NCT02582866|584474739|FG000|Overall Study|Lack of Efficacy|2|||
161845142|NCT02582866|584474739|FG000|Overall Study|Lost to Follow-up|2|||
161845143|NCT02582866|584474739|FG000|Overall Study|Withdrawal by Subject|7|||
161845144|NCT02582866|584474739|FG000|Overall Study|Investigator decision|5|||
161845145|NCT02582866|584474739|FG000|Overall Study|Participant wants to get pregnant|1|||
161845146|NCT02582866|584474739|FG000|Overall Study|Pregnancy|2|||
161845147|NCT02582866|584474739|FG000|Overall Study|Sponsor decision|1|||
161845148|NCT02582866|584474739|FG000|Overall Study|Withdrawal due to personal reasons|1|||
161845149|NCT03567382|584474740|FG000|Overall Study|Lost to Follow-up|1|||
161845150|NCT03567382|584474741|FG001|Overall Study|Lost to Follow-up|21|||
161845151|NCT03567382|584474742|FG002|Overall Study|Lost to Follow-up|1|||
161845152|NCT03567382|584474743|FG003|Overall Study|Lost to Follow-up|21|||
161845153|NCT03567382|584474740|FG000|Overall Study|Withdrawal by Subject|2|||
161845154|NCT03567382|584474741|FG001|Overall Study|Withdrawal by Subject|14|||
161845155|NCT03567382|584474742|FG002|Overall Study|Withdrawal by Subject|1|||
161845156|NCT03567382|584474743|FG003|Overall Study|Withdrawal by Subject|12|||
161845157|NCT03246646|584474746|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
161845158|NCT03246646|584474747|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
161845159|NCT03246646|584474746|FG000|Overall Study|Withdrawal by Subject|3|||
161845160|NCT03246646|584474747|FG001|Overall Study|Withdrawal by Subject|0|||
161845161|NCT03246646|584474746|FG000|Overall Study|Lost to Follow-up|7|||
161845162|NCT03246646|584474747|FG001|Overall Study|Lost to Follow-up|0|||
161845163|NCT00319982|584474750|FG000|Overall Study|Withdrawal by Subject|1|||
161845164|NCT00319982|584474751|FG001|Overall Study|Withdrawal by Subject|0|||
161845165|NCT00758680|584474752|FG000|Overall Study|Adverse Event|0|||
161845166|NCT00758680|584474753|FG001|Overall Study|Adverse Event|0|||
161845167|NCT00758680|584474754|FG002|Overall Study|Adverse Event|0|||
161845168|NCT00758680|584474755|FG003|Overall Study|Adverse Event|0|||
161845169|NCT00758680|584474756|FG004|Overall Study|Adverse Event|0|||
161845170|NCT00758680|584474757|FG005|Overall Study|Adverse Event|0|||
161845171|NCT00758680|584474758|FG006|Overall Study|Adverse Event|0|||
161845172|NCT00758680|584474759|FG007|Overall Study|Adverse Event|1|||
161845173|NCT00758680|584474760|FG008|Overall Study|Adverse Event|0|||
161845174|NCT00758680|584474761|FG009|Overall Study|Adverse Event|1|||
161845175|NCT00758680|584474752|FG000|Overall Study|Laboratory Adverse Event|0|||
161845176|NCT00758680|584474753|FG001|Overall Study|Laboratory Adverse Event|0|||
161845177|NCT00758680|584474754|FG002|Overall Study|Laboratory Adverse Event|0|||
161845178|NCT00758680|584474755|FG003|Overall Study|Laboratory Adverse Event|0|||
161845179|NCT00758680|584474756|FG004|Overall Study|Laboratory Adverse Event|0|||
161845180|NCT00758680|584474757|FG005|Overall Study|Laboratory Adverse Event|0|||
161845181|NCT00758680|584474758|FG006|Overall Study|Laboratory Adverse Event|0|||
161845182|NCT00758680|584474759|FG007|Overall Study|Laboratory Adverse Event|0|||
161845183|NCT00758680|584474760|FG008|Overall Study|Laboratory Adverse Event|1|||
161845184|NCT00758680|584474761|FG009|Overall Study|Laboratory Adverse Event|0|||
161845185|NCT00758680|584474752|FG000|Overall Study|Withdrawal by Subject|0|||
161845186|NCT00758680|584474753|FG001|Overall Study|Withdrawal by Subject|0|||
161845187|NCT00758680|584474754|FG002|Overall Study|Withdrawal by Subject|0|||
161845188|NCT00758680|584474755|FG003|Overall Study|Withdrawal by Subject|0|||
161845189|NCT00758680|584474756|FG004|Overall Study|Withdrawal by Subject|0|||
161845190|NCT00758680|584474757|FG005|Overall Study|Withdrawal by Subject|0|||
161845191|NCT00758680|584474758|FG006|Overall Study|Withdrawal by Subject|1|||
161845192|NCT00758680|584474759|FG007|Overall Study|Withdrawal by Subject|0|||
161845193|NCT00758680|584474760|FG008|Overall Study|Withdrawal by Subject|1|||
161845194|NCT00758680|584474761|FG009|Overall Study|Withdrawal by Subject|0|||
161845195|NCT03480386|584474762|FG000|Overall Study|Did not complete measures at 3-months|17|||
161845196|NCT03480386|584474763|FG001|Overall Study|Did not complete measures at 3-months|14|||
161845197|NCT03480386|584474762|FG000|Overall Study|No baseline measures|11|||
161845198|NCT03480386|584474763|FG001|Overall Study|No baseline measures|14|||
161845199|NCT03480386|584474762|FG000|Overall Study|Death|0|||
161845200|NCT03480386|584474763|FG001|Overall Study|Death|5|||
161845201|NCT03480386|584474762|FG000|Overall Study|Withdrawal by Subject|12|||
161845202|NCT03480386|584474763|FG001|Overall Study|Withdrawal by Subject|8|||
161845203|NCT03480386|584474762|FG000|Overall Study|Lost to Follow-up|2|||
161845204|NCT03480386|584474763|FG001|Overall Study|Lost to Follow-up|1|||
161845205|NCT03480386|584474762|FG000|Overall Study|Complicating disease|0|||
161845206|NCT03480386|584474763|FG001|Overall Study|Complicating disease|1|||
161845207|NCT03480386|584474762|FG000|Overall Study|Disease progression|3|||
161845208|NCT03480386|584474763|FG001|Overall Study|Disease progression|0|||
161845209|NCT03480386|584474762|FG000|Overall Study|Became ineligible|0|||
161845210|NCT03480386|584474763|FG001|Overall Study|Became ineligible|2|||
161845211|NCT02201290|584474764|FG000|Overall Study|Withdrawal by Subject|2|||
161845212|NCT02201290|584474764|FG000|Overall Study|Lack of Efficacy|2|||
161845213|NCT02201290|584474764|FG000|Overall Study|Adverse Event|1|||
161845214|NCT04639713|584474765|FG000|Overall Study|Protocol Noncompliance|2|||
161845215|NCT04639713|584474765|FG000|Overall Study|Withdrawal by Subject|1|||
161845216|NCT03589768|584476951|FG000|Overall Study|Death|1|||
161845217|NCT03589768|584476952|FG001|Overall Study|Death|0|||
161845218|NCT03589768|584476953|FG002|Overall Study|Death|8|||
161845219|NCT03589768|584476954|FG003|Overall Study|Death|3|||
161845220|NCT03589768|584476951|FG000|Overall Study|Withdrawal by Subject|2|||
161845221|NCT03589768|584476952|FG001|Overall Study|Withdrawal by Subject|0|||
161845222|NCT03589768|584476953|FG002|Overall Study|Withdrawal by Subject|0|||
161845223|NCT03589768|584476954|FG003|Overall Study|Withdrawal by Subject|0|||
161845224|NCT03589768|584476951|FG000|Overall Study|Protocol Violation|1|||
161845225|NCT03589768|584476952|FG001|Overall Study|Protocol Violation|0|||
161845226|NCT03589768|584476953|FG002|Overall Study|Protocol Violation|0|||
161845227|NCT03589768|584476954|FG003|Overall Study|Protocol Violation|0|||
161845228|NCT00191113|584476957|FG000|Core Study|Withdrawal by Subject|25|||
161845229|NCT00191113|584476958|FG001|Core Study|Withdrawal by Subject|9|||
161845230|NCT00191113|584476957|FG000|Core Study|Protocol Violation|6|||
161845231|NCT00191113|584476958|FG001|Core Study|Protocol Violation|2|||
161845232|NCT00191113|584476957|FG000|Core Study|Lost to Follow-up|3|||
161845233|NCT00191113|584476958|FG001|Core Study|Lost to Follow-up|0|||
161845234|NCT00191113|584476957|FG000|Core Study|Adverse Event|0|||
161845235|NCT00191113|584476958|FG001|Core Study|Adverse Event|2|||
161845236|NCT00191113|584476957|FG000|Core Study|Lack of Efficacy|0|||
161845237|NCT00191113|584476958|FG001|Core Study|Lack of Efficacy|2|||
161845238|NCT00191113|584476957|FG000|Core Study|Death|1|||
161845239|NCT00191113|584476958|FG001|Core Study|Death|0|||
161845240|NCT01555671|584476961|FG000|Overall Study|Physician Decision|20|||
161845241|NCT01555671|584476962|FG001|Overall Study|Physician Decision|25|||
161845242|NCT00631657|584476963|FG000|6-Month Treatment Period|Adverse Event|47|||
161845243|NCT00631657|584476964|FG001|6-Month Treatment Period|Adverse Event|0|||
161845244|NCT00631657|584476965|FG002|6-Month Treatment Period|Adverse Event|7|||
161845245|NCT00631657|584476963|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
161845246|NCT00631657|584476964|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
161845247|NCT00631657|584476965|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
161845248|NCT00631657|584476963|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
161845249|NCT00631657|584476964|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
161845250|NCT00631657|584476965|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
161845251|NCT00631657|584476963|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
161845252|NCT00631657|584476964|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
161845253|NCT00631657|584476965|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
161845254|NCT00631657|584476963|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
161845255|NCT00631657|584476964|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
161845256|NCT00631657|584476965|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
161845257|NCT00631657|584476963|FG000|6-Month Treatment Period|Other|16|||
161845258|NCT00631657|584476964|FG001|6-Month Treatment Period|Other|0|||
161845259|NCT00631657|584476965|FG002|6-Month Treatment Period|Other|4|||
161845260|NCT00631657|584476963|FG000|6-Month Treatment Period|Not Treated|2|||
161845261|NCT00631657|584476964|FG001|6-Month Treatment Period|Not Treated|0|||
161845262|NCT00631657|584476965|FG002|6-Month Treatment Period|Not Treated|1|||
161845263|NCT00631657|584476963|FG000|7-Day Discontinuation Period|Not Treated|1|||
161845264|NCT00631657|584476964|FG001|7-Day Discontinuation Period|Not Treated|1|||
161845265|NCT00631657|584476965|FG002|7-Day Discontinuation Period|Not Treated|1|||
161845266|NCT00631657|584476963|FG000|7-Day Discontinuation Period|Other|1|||
161845267|NCT00631657|584476964|FG001|7-Day Discontinuation Period|Other|0|||
161845268|NCT00631657|584476965|FG002|7-Day Discontinuation Period|Other|0|||
161845269|NCT04003896|584476966|FG000|Overall Study|Withdrawal by Subject|3|||
161845270|NCT04003896|584476966|FG000|Overall Study|Physician Decision|1|||
161845271|NCT03929757|584476969|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
161845272|NCT03929757|584476970|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
161845273|NCT03929757|584476971|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
161845274|NCT03929757|584476969|FG000|Main Study: Up to Day 365|Other|1|||
161845275|NCT03929757|584476970|FG001|Main Study: Up to Day 365|Other|0|||
161845276|NCT03929757|584476971|FG002|Main Study: Up to Day 365|Other|0|||
161845277|NCT03929757|584476969|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
161845278|NCT03929757|584476970|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
161845279|NCT03929757|584476971|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
161845280|NCT01154816|584476972|FG000|Overall Study|Withdrawal by Subject|1|||
161845281|NCT01154816|584476973|FG001|Overall Study|Withdrawal by Subject|0|||
161845282|NCT01154816|584476974|FG002|Overall Study|Withdrawal by Subject|0|||
161845283|NCT01154816|584476975|FG003|Overall Study|Withdrawal by Subject|1|||
161845284|NCT01154816|584476976|FG004|Overall Study|Withdrawal by Subject|0|||
161845285|NCT01154816|584476977|FG005|Overall Study|Withdrawal by Subject|0|||
161845286|NCT01154816|584476978|FG006|Overall Study|Withdrawal by Subject|0|||
161845287|NCT01154816|584476979|FG007|Overall Study|Withdrawal by Subject|0|||
161845288|NCT01154816|584476980|FG008|Overall Study|Withdrawal by Subject|1|||
161845289|NCT01154816|584476981|FG009|Overall Study|Withdrawal by Subject|3|||
161845290|NCT01154816|584476982|FG010|Overall Study|Withdrawal by Subject|0|||
161845291|NCT01154816|584476983|FG011|Overall Study|Withdrawal by Subject|0|||
161845292|NCT01154816|584476972|FG000|Overall Study|Progressive Disease|13|||
161845293|NCT01154816|584476973|FG001|Overall Study|Progressive Disease|8|||
161845294|NCT01154816|584476974|FG002|Overall Study|Progressive Disease|9|||
161845295|NCT01154816|584476975|FG003|Overall Study|Progressive Disease|9|||
161845296|NCT01154816|584476976|FG004|Overall Study|Progressive Disease|8|||
161845297|NCT01154816|584476977|FG005|Overall Study|Progressive Disease|8|||
161845298|NCT01154816|584476978|FG006|Overall Study|Progressive Disease|5|||
161845299|NCT01154816|584476979|FG007|Overall Study|Progressive Disease|6|||
161845300|NCT01154816|584476980|FG008|Overall Study|Progressive Disease|8|||
161845301|NCT01154816|584476981|FG009|Overall Study|Progressive Disease|6|||
161845302|NCT01154816|584476982|FG010|Overall Study|Progressive Disease|10|||
161845303|NCT01154816|584476983|FG011|Overall Study|Progressive Disease|3|||
161845304|NCT01154816|584476972|FG000|Overall Study|Physician Decision|1|||
161845305|NCT01154816|584476973|FG001|Overall Study|Physician Decision|0|||
161845306|NCT01154816|584476974|FG002|Overall Study|Physician Decision|1|||
161845307|NCT01154816|584476975|FG003|Overall Study|Physician Decision|0|||
161845308|NCT01154816|584476976|FG004|Overall Study|Physician Decision|2|||
161845309|NCT01154816|584476977|FG005|Overall Study|Physician Decision|0|||
161845310|NCT01154816|584476978|FG006|Overall Study|Physician Decision|0|||
161845311|NCT01154816|584476979|FG007|Overall Study|Physician Decision|0|||
161845312|NCT01154816|584476980|FG008|Overall Study|Physician Decision|0|||
161845313|NCT01154816|584476981|FG009|Overall Study|Physician Decision|1|||
161845314|NCT01154816|584476982|FG010|Overall Study|Physician Decision|1|||
161845315|NCT01154816|584476983|FG011|Overall Study|Physician Decision|1|||
161845316|NCT01154816|584476972|FG000|Overall Study|Adverse Event|5|||
161845317|NCT01154816|584476973|FG001|Overall Study|Adverse Event|2|||
161845318|NCT01154816|584476974|FG002|Overall Study|Adverse Event|0|||
161845319|NCT01154816|584476975|FG003|Overall Study|Adverse Event|0|||
161845320|NCT01154816|584476976|FG004|Overall Study|Adverse Event|0|||
161845321|NCT01154816|584476977|FG005|Overall Study|Adverse Event|0|||
161845322|NCT01154816|584476978|FG006|Overall Study|Adverse Event|1|||
161845323|NCT01154816|584476979|FG007|Overall Study|Adverse Event|1|||
161845324|NCT01154816|584476980|FG008|Overall Study|Adverse Event|0|||
161845325|NCT01154816|584476981|FG009|Overall Study|Adverse Event|0|||
161845326|NCT01154816|584476982|FG010|Overall Study|Adverse Event|0|||
161845327|NCT01154816|584476983|FG011|Overall Study|Adverse Event|0|||
161845328|NCT00806286|584476984|FG000|Overall Study|Adverse Event|5|||
161845329|NCT00806286|584476985|FG001|Overall Study|Adverse Event|2|||
161845330|NCT00806286|584476986|FG002|Overall Study|Adverse Event|0|||
161845331|NCT00806286|584476984|FG000|Overall Study|Disease progression|31|||
161845332|NCT00806286|584476985|FG001|Overall Study|Disease progression|38|||
161845333|NCT00806286|584476986|FG002|Overall Study|Disease progression|1|||
161845334|NCT00806286|584476984|FG000|Overall Study|Death|1|||
161845335|NCT00806286|584476985|FG001|Overall Study|Death|6|||
161845336|NCT00806286|584476986|FG002|Overall Study|Death|0|||
161845337|NCT00806286|584476984|FG000|Overall Study|Lost to Follow-up|0|||
161845338|NCT00806286|584476985|FG001|Overall Study|Lost to Follow-up|1|||
161845339|NCT00806286|584476986|FG002|Overall Study|Lost to Follow-up|0|||
161845340|NCT00806286|584476984|FG000|Overall Study|Withdrawal by Subject|8|||
161845341|NCT00806286|584476985|FG001|Overall Study|Withdrawal by Subject|3|||
161845342|NCT00806286|584476986|FG002|Overall Study|Withdrawal by Subject|1|||
161845343|NCT00806286|584476984|FG000|Overall Study|Physician Decision|2|||
161845344|NCT00806286|584476985|FG001|Overall Study|Physician Decision|2|||
161845345|NCT00806286|584476986|FG002|Overall Study|Physician Decision|0|||
161845346|NCT00806286|584476984|FG000|Overall Study|Due to a variety of reasons|7|||
161845347|NCT00806286|584476985|FG001|Overall Study|Due to a variety of reasons|2|||
161845348|NCT00806286|584476986|FG002|Overall Study|Due to a variety of reasons|1|||
161845349|NCT00686075|584476987|FG000|Overall Study|Withdrawal by Subject|4|||
161845350|NCT00686075|584476988|FG001|Overall Study|Withdrawal by Subject|3|||
161845351|NCT00686075|584476989|FG002|Overall Study|Withdrawal by Subject|3|||
161845352|NCT00686075|584476990|FG003|Overall Study|Withdrawal by Subject|7|||
161845353|NCT00686075|584476991|FG004|Overall Study|Withdrawal by Subject|1|||
161845354|NCT00686075|584476992|FG005|Overall Study|Withdrawal by Subject|0|||
161845355|NCT00686075|584476993|FG006|Overall Study|Withdrawal by Subject|0|||
161845356|NCT00686075|584476994|FG007|Overall Study|Withdrawal by Subject|2|||
161845357|NCT00686075|584476995|FG008|Overall Study|Withdrawal by Subject|4|||
161845358|NCT00686075|584476996|FG009|Overall Study|Withdrawal by Subject|6|||
161845359|NCT00686075|584476987|FG000|Overall Study|Lost to Follow-up|3|||
161845360|NCT00686075|584476988|FG001|Overall Study|Lost to Follow-up|6|||
161845361|NCT00686075|584476989|FG002|Overall Study|Lost to Follow-up|3|||
161845362|NCT00686075|584476990|FG003|Overall Study|Lost to Follow-up|2|||
161845363|NCT00686075|584476991|FG004|Overall Study|Lost to Follow-up|3|||
161845364|NCT00686075|584476992|FG005|Overall Study|Lost to Follow-up|3|||
161845365|NCT00686075|584476993|FG006|Overall Study|Lost to Follow-up|0|||
161845366|NCT00686075|584476994|FG007|Overall Study|Lost to Follow-up|0|||
161845367|NCT00686075|584476995|FG008|Overall Study|Lost to Follow-up|2|||
161845368|NCT00686075|584476996|FG009|Overall Study|Lost to Follow-up|3|||
161845369|NCT00686075|584476987|FG000|Overall Study|Other|1|||
161845370|NCT00686075|584476988|FG001|Overall Study|Other|1|||
161845371|NCT00686075|584476989|FG002|Overall Study|Other|0|||
161845372|NCT00686075|584476990|FG003|Overall Study|Other|0|||
161845373|NCT00686075|584476991|FG004|Overall Study|Other|0|||
161845374|NCT00686075|584476992|FG005|Overall Study|Other|0|||
161845375|NCT00686075|584476993|FG006|Overall Study|Other|0|||
161845376|NCT00686075|584476994|FG007|Overall Study|Other|0|||
161845377|NCT00686075|584476995|FG008|Overall Study|Other|0|||
161845378|NCT00686075|584476996|FG009|Overall Study|Other|1|||
161845379|NCT04713553|584476997|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
161845380|NCT04713553|584476998|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
161845381|NCT04713553|584476999|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845382|NCT04713553|584477000|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845383|NCT04713553|584477001|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
161845384|NCT04713553|584477002|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845385|NCT04713553|584477003|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845386|NCT04713553|584476997|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845387|NCT04713553|584476998|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845388|NCT04713553|584476999|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845389|NCT04713553|584477000|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
161845390|NCT04713553|584477001|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845391|NCT04713553|584477002|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845392|NCT04713553|584477003|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845393|NCT04713553|584476997|FG000|Primary Study (2 Months)|Other|1|||
161845394|NCT04713553|584476998|FG001|Primary Study (2 Months)|Other|2|||
161845395|NCT04713553|584476999|FG002|Primary Study (2 Months)|Other|0|||
161845396|NCT04713553|584477000|FG003|Primary Study (2 Months)|Other|0|||
161845397|NCT04713553|584477001|FG004|Primary Study (2 Months)|Other|1|||
161845398|NCT04713553|584477002|FG005|Primary Study (2 Months)|Other|0|||
161845399|NCT04713553|584477003|FG006|Primary Study (2 Months)|Other|0|||
161845400|NCT04713553|584476997|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
161845401|NCT04713553|584476998|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
161845402|NCT04713553|584476999|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
161845403|NCT04713553|584477000|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
161845404|NCT04713553|584477001|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
161845405|NCT04713553|584477002|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
161845406|NCT04713553|584477003|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
161845407|NCT04713553|584476997|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845408|NCT04713553|584476998|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845409|NCT04713553|584476999|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
161845410|NCT04713553|584477000|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845411|NCT04713553|584477001|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845412|NCT04713553|584477002|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845413|NCT04713553|584477003|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845414|NCT03783039|584477004|FG000|Overall Study|Death|2|||
161845415|NCT03783039|584477005|FG001|Overall Study|Death|1|||
161845416|NCT01199471|584477006|FG000|Overall Study|Protocol Violation|4|||
161845417|NCT01199471|584477006|FG000|Overall Study|Withdrawal by Subject|1|||
161845418|NCT01199471|584477006|FG000|Overall Study|Physician Decision|1|||
161845419|NCT02006693|584477007|FG000|Overall Study|No Reason Specified|6|||
161845420|NCT02006693|584477008|FG001|Overall Study|No Reason Specified|8|||
161845421|NCT02006693|584477007|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
161845422|NCT02006693|584477008|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
161845423|NCT02006693|584477007|FG000|Overall Study|XEN Implant Explantation|0|||
161845424|NCT02006693|584477008|FG001|Overall Study|XEN Implant Explantation|1|||
161845425|NCT02006693|584477007|FG000|Overall Study|Death|2|||
161845426|NCT02006693|584477008|FG001|Overall Study|Death|2|||
161845427|NCT02006693|584477007|FG000|Overall Study|Lost to Follow-up|4|||
161845428|NCT02006693|584477008|FG001|Overall Study|Lost to Follow-up|1|||
161845429|NCT02006693|584477007|FG000|Overall Study|Patient Decision|4|||
161845430|NCT02006693|584477008|FG001|Overall Study|Patient Decision|0|||
161845431|NCT03151408|584477009|FG000|Overall Study|Adverse Event|24|||
161845432|NCT03151408|584477010|FG001|Overall Study|Adverse Event|23|||
161845433|NCT03151408|584477009|FG000|Overall Study|Death|46|||
161845434|NCT03151408|584477010|FG001|Overall Study|Death|26|||
161845435|NCT03151408|584477009|FG000|Overall Study|Physician Decision|13|||
161845436|NCT03151408|584477010|FG001|Overall Study|Physician Decision|19|||
161845437|NCT03151408|584477009|FG000|Overall Study|Withdrawal by Subject|16|||
161845438|NCT03151408|584477010|FG001|Overall Study|Withdrawal by Subject|20|||
161845439|NCT03151408|584477009|FG000|Overall Study|Progressive disease|45|||
161845440|NCT03151408|584477010|FG001|Overall Study|Progressive disease|61|||
161845441|NCT03151408|584477009|FG000|Overall Study|non-compliance by patient|1|||
161845442|NCT03151408|584477010|FG001|Overall Study|non-compliance by patient|0|||
161845443|NCT03151408|584477009|FG000|Overall Study|other reasons|56|||
161845444|NCT03151408|584477010|FG001|Overall Study|other reasons|52|||
161845445|NCT03151408|584477009|FG000|Overall Study|randomized and not treated|2|||
161845446|NCT03151408|584477010|FG001|Overall Study|randomized and not treated|2|||
161845447|NCT01119508|584477011|FG000|Overall Study|Adverse Event|56|||
161845448|NCT01119508|584477011|FG000|Overall Study|Withdrawal by Subject|2|||
161845449|NCT01119508|584477011|FG000|Overall Study|Died before tumor response evaluation|1|||
161845450|NCT00265395|584477012|FG000|Overall Study|Adverse Event|3|||
161845451|NCT00265395|584477013|FG001|Overall Study|Adverse Event|6|||
161755651|NCT01307046|584144416|FG001|Overall Study|Physician Decision|0|||
161755652|NCT01307046|584144415|FG000|Overall Study|Withdrawal by Subject|1|||
161755653|NCT01307046|584144416|FG001|Overall Study|Withdrawal by Subject|1|||
161755654|NCT01307046|584144415|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
161755655|NCT01307046|584144416|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
161755656|NCT01307046|584144415|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
161755657|NCT01307046|584144416|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
161755658|NCT03898323|584144417|FG000|Overall Study|Physician Decision|1|||
161755659|NCT03954704|584144427|FG000|Overall Study|Death|1|||
161755660|NCT03954704|584144428|FG001|Overall Study|Death|1|||
161755661|NCT03954704|584144429|FG002|Overall Study|Death|1|||
161755662|NCT03954704|584144430|FG003|Overall Study|Death|3|||
161755663|NCT03954704|584144431|FG004|Overall Study|Death|2|||
161755664|NCT03954704|584144432|FG005|Overall Study|Death|2|||
161755665|NCT03954704|584144433|FG006|Overall Study|Death|0|||
161755666|NCT03954704|584144427|FG000|Overall Study|Withdrew Consent|0|||
161755667|NCT03954704|584144428|FG001|Overall Study|Withdrew Consent|0|||
161755668|NCT03954704|584144429|FG002|Overall Study|Withdrew Consent|1|||
161755669|NCT03954704|584144430|FG003|Overall Study|Withdrew Consent|0|||
161755670|NCT03954704|584144431|FG004|Overall Study|Withdrew Consent|0|||
161755671|NCT03954704|584144432|FG005|Overall Study|Withdrew Consent|1|||
161755672|NCT03954704|584144433|FG006|Overall Study|Withdrew Consent|0|||
161755673|NCT03954704|584144427|FG000|Overall Study|Lost to Follow-up|0|||
161755674|NCT03954704|584144428|FG001|Overall Study|Lost to Follow-up|0|||
161755675|NCT03954704|584144429|FG002|Overall Study|Lost to Follow-up|0|||
161755676|NCT03954704|584144430|FG003|Overall Study|Lost to Follow-up|0|||
161755677|NCT03954704|584144431|FG004|Overall Study|Lost to Follow-up|0|||
161755678|NCT03954704|584144432|FG005|Overall Study|Lost to Follow-up|0|||
161755679|NCT03954704|584144433|FG006|Overall Study|Lost to Follow-up|1|||
161755680|NCT03954704|584144427|FG000|Overall Study|Study Terminated by Sponsor|0|||
161755681|NCT03954704|584144428|FG001|Overall Study|Study Terminated by Sponsor|0|||
161755682|NCT03954704|584144429|FG002|Overall Study|Study Terminated by Sponsor|1|||
161755683|NCT03954704|584144430|FG003|Overall Study|Study Terminated by Sponsor|0|||
161755684|NCT03954704|584144431|FG004|Overall Study|Study Terminated by Sponsor|1|||
161755685|NCT03954704|584144432|FG005|Overall Study|Study Terminated by Sponsor|4|||
161755686|NCT03954704|584144433|FG006|Overall Study|Study Terminated by Sponsor|2|||
161755687|NCT03954704|584144427|FG000|Overall Study|Enrolled but not Treated|0|||
161755688|NCT03954704|584144428|FG001|Overall Study|Enrolled but not Treated|0|||
161755689|NCT03954704|584144429|FG002|Overall Study|Enrolled but not Treated|0|||
161755690|NCT03954704|584144430|FG003|Overall Study|Enrolled but not Treated|0|||
161755691|NCT03954704|584144431|FG004|Overall Study|Enrolled but not Treated|0|||
161755692|NCT03954704|584144432|FG005|Overall Study|Enrolled but not Treated|1|||
161755693|NCT03954704|584144433|FG006|Overall Study|Enrolled but not Treated|0|||
161755694|NCT00397891|584144436|FG000|Overall Study|Withdrawal by Subject|1|||
161755695|NCT00397891|584144437|FG001|Overall Study|Withdrawal by Subject|0|||
161755696|NCT00397891|584144438|FG002|Overall Study|Withdrawal by Subject|0|||
161755697|NCT00397891|584144439|FG003|Overall Study|Withdrawal by Subject|0|||
161755698|NCT00397891|584144440|FG004|Overall Study|Withdrawal by Subject|1|||
161755699|NCT02569398|584144447|FG000|Overall Study|Adverse Event|0|||
161755700|NCT02569398|584144448|FG001|Overall Study|Adverse Event|1|||
161755701|NCT02569398|584144449|FG002|Overall Study|Adverse Event|6|||
161755702|NCT02569398|584144447|FG000|Overall Study|Withdrawal by Subject|43|||
161755703|NCT02569398|584144448|FG001|Overall Study|Withdrawal by Subject|43|||
161755704|NCT02569398|584144449|FG002|Overall Study|Withdrawal by Subject|30|||
161755705|NCT02569398|584144447|FG000|Overall Study|Study terminated by sponsor|130|||
161755706|NCT02569398|584144448|FG001|Overall Study|Study terminated by sponsor|131|||
161755707|NCT02569398|584144449|FG002|Overall Study|Study terminated by sponsor|134|||
161755708|NCT02569398|584144447|FG000|Overall Study|Other|12|||
161755709|NCT02569398|584144448|FG001|Overall Study|Other|14|||
161755710|NCT02569398|584144449|FG002|Overall Study|Other|13|||
161755711|NCT02116361|584144452|FG000|Overall Study|Pregnancy|0|||
161755712|NCT02116361|584144453|FG001|Overall Study|Pregnancy|0|||
161755713|NCT02116361|584144454|FG002|Overall Study|Pregnancy|0|||
161755714|NCT02116361|584144455|FG003|Overall Study|Pregnancy|1|||
161755715|NCT02116361|584144452|FG000|Overall Study|Protocol Violation|1|||
161755716|NCT02116361|584144453|FG001|Overall Study|Protocol Violation|0|||
161755717|NCT02116361|584144454|FG002|Overall Study|Protocol Violation|0|||
161755718|NCT02116361|584144455|FG003|Overall Study|Protocol Violation|2|||
161845452|NCT00265395|584477012|FG000|Overall Study|Lost to Follow-up|2|||
161755719|NCT02116361|584144452|FG000|Overall Study|Physician Decision|2|||
161845453|NCT00265395|584477013|FG001|Overall Study|Lost to Follow-up|1|||
161755720|NCT02116361|584144453|FG001|Overall Study|Physician Decision|3|||
161755721|NCT02116361|584144454|FG002|Overall Study|Physician Decision|0|||
161755722|NCT02116361|584144455|FG003|Overall Study|Physician Decision|0|||
161755723|NCT02116361|584144452|FG000|Overall Study|Adverse Event|1|||
161755724|NCT02116361|584144453|FG001|Overall Study|Adverse Event|0|||
161845454|NCT00265395|584477012|FG000|Overall Study|Withdrawal by Subject|1|||
161755725|NCT02116361|584144454|FG002|Overall Study|Adverse Event|0|||
161755726|NCT02116361|584144455|FG003|Overall Study|Adverse Event|3|||
161755727|NCT02116361|584144452|FG000|Overall Study|Other Reasons|3|||
161755728|NCT02116361|584144453|FG001|Overall Study|Other Reasons|3|||
161755729|NCT02116361|584144454|FG002|Overall Study|Other Reasons|3|||
161755730|NCT02116361|584144455|FG003|Overall Study|Other Reasons|3|||
161755731|NCT02116361|584144452|FG000|Overall Study|Lack of Efficacy|5|||
161755732|NCT02116361|584144453|FG001|Overall Study|Lack of Efficacy|7|||
161755733|NCT02116361|584144454|FG002|Overall Study|Lack of Efficacy|4|||
161845455|NCT00265395|584477013|FG001|Overall Study|Withdrawal by Subject|6|||
161845456|NCT00265395|584477012|FG000|Overall Study|Protocol Violation|2|||
161845457|NCT00265395|584477013|FG001|Overall Study|Protocol Violation|2|||
161845458|NCT00265395|584477012|FG000|Overall Study|Lack of Efficacy|0|||
161845459|NCT00265395|584477013|FG001|Overall Study|Lack of Efficacy|1|||
161845460|NCT00265395|584477012|FG000|Overall Study|Administrative|0|||
161845461|NCT00265395|584477013|FG001|Overall Study|Administrative|1|||
161845462|NCT00837473|584477016|FG000|Overall Study|Lost to Follow-up|1|||
161845463|NCT00837473|584477016|FG000|Overall Study|Withdrawal by Subject|2|||
161845464|NCT03400943|584477017|FG000|Treatment Period 1|Adverse Event|0|||
161845465|NCT03400943|584477018|FG001|Treatment Period 1|Adverse Event|0|||
161845466|NCT03400943|584477019|FG002|Treatment Period 1|Adverse Event|0|||
161845467|NCT03400943|584477020|FG003|Treatment Period 1|Adverse Event|1|||
161845468|NCT03400943|584477017|FG000|Treatment Period 1|Lost to Follow-up|1|||
161845469|NCT03400943|584477018|FG001|Treatment Period 1|Lost to Follow-up|0|||
161845470|NCT03400943|584477019|FG002|Treatment Period 1|Lost to Follow-up|0|||
161845471|NCT03400943|584477020|FG003|Treatment Period 1|Lost to Follow-up|0|||
161845472|NCT03400943|584477017|FG000|Treatment Period 1|Protocol Violation|0|||
161845473|NCT03400943|584477018|FG001|Treatment Period 1|Protocol Violation|1|||
161845474|NCT03400943|584477019|FG002|Treatment Period 1|Protocol Violation|1|||
161845475|NCT03400943|584477020|FG003|Treatment Period 1|Protocol Violation|0|||
161845476|NCT03400943|584477017|FG000|Treatment Period 1|Study terminated by sponsor|2|||
161845477|NCT03400943|584477018|FG001|Treatment Period 1|Study terminated by sponsor|0|||
161845478|NCT03400943|584477019|FG002|Treatment Period 1|Study terminated by sponsor|0|||
161845479|NCT03400943|584477020|FG003|Treatment Period 1|Study terminated by sponsor|1|||
161845480|NCT03400943|584477017|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161845481|NCT03400943|584477018|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161845482|NCT03400943|584477019|FG002|Treatment Period 1|Withdrawal by Subject|3|||
161845483|NCT03400943|584477020|FG003|Treatment Period 1|Withdrawal by Subject|1|||
161845484|NCT03400943|584477017|FG000|Treatment Period 1|Other|2|||
161845485|NCT03400943|584477018|FG001|Treatment Period 1|Other|1|||
161845486|NCT03400943|584477019|FG002|Treatment Period 1|Other|2|||
161845487|NCT03400943|584477020|FG003|Treatment Period 1|Other|2|||
161845488|NCT03400943|584477017|FG000|Post-treatment Period 1|Adverse Event|2|||
161845489|NCT03400943|584477018|FG001|Post-treatment Period 1|Adverse Event|0|||
161845490|NCT03400943|584477019|FG002|Post-treatment Period 1|Adverse Event|0|||
161845491|NCT03400943|584477020|FG003|Post-treatment Period 1|Adverse Event|0|||
161845492|NCT03400943|584477017|FG000|Post-treatment Period 1|Protocol Violation|1|||
161845493|NCT03400943|584477018|FG001|Post-treatment Period 1|Protocol Violation|0|||
161845494|NCT03400943|584477019|FG002|Post-treatment Period 1|Protocol Violation|0|||
161845495|NCT03400943|584477020|FG003|Post-treatment Period 1|Protocol Violation|0|||
161845496|NCT03400943|584477017|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
161845497|NCT03400943|584477018|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
161845498|NCT03400943|584477019|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
161845499|NCT03400943|584477020|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
161845500|NCT03400943|584477017|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
161845501|NCT03400943|584477018|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
161845502|NCT03400943|584477019|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
161845503|NCT03400943|584477020|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
161845504|NCT03400943|584477017|FG000|Post-treatment Period 1|Other|2|||
161845505|NCT03400943|584477018|FG001|Post-treatment Period 1|Other|0|||
161845506|NCT03400943|584477019|FG002|Post-treatment Period 1|Other|4|||
161845507|NCT03400943|584477020|FG003|Post-treatment Period 1|Other|5|||
161845508|NCT03400943|584477017|FG000|Treatment Period 2|Study terminated by sponsor|0|||
161845509|NCT03400943|584477018|FG001|Treatment Period 2|Study terminated by sponsor|1|||
161845510|NCT03400943|584477019|FG002|Treatment Period 2|Study terminated by sponsor|0|||
161845511|NCT03400943|584477020|FG003|Treatment Period 2|Study terminated by sponsor|0|||
161845512|NCT03400943|584477017|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161845513|NCT03400943|584477018|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161845514|NCT03400943|584477019|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161845515|NCT03400943|584477020|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161845516|NCT03400943|584477017|FG000|Treatment Period 2|Other|1|||
161845517|NCT03400943|584477018|FG001|Treatment Period 2|Other|6|||
161845518|NCT03400943|584477019|FG002|Treatment Period 2|Other|0|||
161845519|NCT03400943|584477020|FG003|Treatment Period 2|Other|0|||
161845520|NCT03400943|584477017|FG000|Follow-up Period|Withdrawal by Subject|1|||
161845521|NCT03400943|584477018|FG001|Follow-up Period|Withdrawal by Subject|0|||
161845522|NCT03400943|584477019|FG002|Follow-up Period|Withdrawal by Subject|0|||
161845523|NCT03400943|584477020|FG003|Follow-up Period|Withdrawal by Subject|0|||
161845524|NCT02563106|584477021|FG000|Overall Study|Withdrawal by Subject|7|||
161845525|NCT02563106|584477022|FG001|Overall Study|Withdrawal by Subject|8|||
161845526|NCT02563106|584477021|FG000|Overall Study|Adverse Event|17|||
161845527|NCT02563106|584477022|FG001|Overall Study|Adverse Event|15|||
161845528|NCT02563106|584477021|FG000|Overall Study|Protocol Violation|1|||
161845529|NCT02563106|584477022|FG001|Overall Study|Protocol Violation|0|||
161845530|NCT02563106|584477021|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
161845531|NCT02563106|584477022|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
161845532|NCT02563106|584477021|FG000|Overall Study|Lost to Follow-up|3|||
161845533|NCT02563106|584477022|FG001|Overall Study|Lost to Follow-up|2|||
161845534|NCT02563106|584477021|FG000|Overall Study|Physician Decision|3|||
161845535|NCT02563106|584477022|FG001|Overall Study|Physician Decision|1|||
161845536|NCT02563106|584477021|FG000|Overall Study|Other reason - not specified|2|||
161845537|NCT02563106|584477022|FG001|Overall Study|Other reason - not specified|1|||
161845538|NCT02338193|584477023|FG000|Overall Study|Withdrawal by Subject|0|||
161845539|NCT02338193|584477024|FG001|Overall Study|Withdrawal by Subject|0|||
161845540|NCT02338193|584477025|FG002|Overall Study|Withdrawal by Subject|2|||
161845541|NCT02338193|584477023|FG000|Overall Study|Pregnancy|0|||
161845542|NCT02338193|584477024|FG001|Overall Study|Pregnancy|1|||
161845543|NCT02338193|584477025|FG002|Overall Study|Pregnancy|1|||
161845544|NCT02338193|584477023|FG000|Overall Study|Noncompliant with visits|2|||
161845545|NCT02338193|584477024|FG001|Overall Study|Noncompliant with visits|2|||
161845546|NCT02338193|584477025|FG002|Overall Study|Noncompliant with visits|7|||
161845547|NCT02338193|584477023|FG000|Overall Study|moved out of state|0|||
161845548|NCT02338193|584477024|FG001|Overall Study|moved out of state|1|||
161845549|NCT02338193|584477025|FG002|Overall Study|moved out of state|0|||
161845550|NCT02338193|584477023|FG000|Overall Study|intolerant of side effects|1|||
161845551|NCT02338193|584477024|FG001|Overall Study|intolerant of side effects|0|||
161845552|NCT02338193|584477025|FG002|Overall Study|intolerant of side effects|0|||
161845553|NCT01136967|584477030|FG000|Overall Study|Adverse Event|9|||
161755734|NCT02116361|584144455|FG003|Overall Study|Lack of Efficacy|3|||
161755735|NCT02116361|584144452|FG000|Overall Study|Lost to Follow-up|4|||
161755736|NCT02116361|584144453|FG001|Overall Study|Lost to Follow-up|5|||
161755737|NCT02116361|584144454|FG002|Overall Study|Lost to Follow-up|7|||
161755738|NCT02116361|584144455|FG003|Overall Study|Lost to Follow-up|5|||
161755739|NCT02116361|584144452|FG000|Overall Study|Personal Reasons|6|||
161755740|NCT02116361|584144453|FG001|Overall Study|Personal Reasons|6|||
161755741|NCT02116361|584144454|FG002|Overall Study|Personal Reasons|4|||
161755742|NCT02116361|584144455|FG003|Overall Study|Personal Reasons|9|||
161755743|NCT02116361|584144452|FG000|Overall Study|Investigator Decision - Relapse|9|||
161755744|NCT02116361|584144453|FG001|Overall Study|Investigator Decision - Relapse|7|||
161755745|NCT02116361|584144454|FG002|Overall Study|Investigator Decision - Relapse|8|||
161755746|NCT02116361|584144455|FG003|Overall Study|Investigator Decision - Relapse|5|||
161755747|NCT02571972|584144456|FG000|Overall Study|Protocol Violation|2|||
161755748|NCT02571972|584144456|FG000|Overall Study|Withdrawal by Subject|2|||
161755749|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
161755750|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161755751|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
161755752|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161755753|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
161755754|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
161755755|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161755756|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161755757|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
161755758|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
161755759|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
161755760|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
161755761|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161755762|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161755763|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161755764|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161755765|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161755766|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161755767|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
161755768|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161755769|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
161755770|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
161755771|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
161755772|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
161755773|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
161755774|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161755775|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
161755776|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161755777|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
161755778|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
161755779|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
161755780|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
161755781|NCT03227224|584144457|FG000|Follow-up Phase (2 Weeks)|Other|4|||
161755782|NCT03227224|584144458|FG001|Follow-up Phase (2 Weeks)|Other|4|||
161755783|NCT03227224|584144459|FG002|Follow-up Phase (2 Weeks)|Other|6|||
161755784|NCT03227224|584144460|FG003|Follow-up Phase (2 Weeks)|Other|3|||
161755785|NCT04195750|584144463|FG000|Overall Study|Death|245|||
161755786|NCT04195750|584144464|FG001|Overall Study|Death|253|||
161755787|NCT04195750|584144465|FG002|Overall Study|Death|5|||
161755788|NCT04195750|584144463|FG000|Overall Study|Physician Decision|0|||
161755789|NCT04195750|584144464|FG001|Overall Study|Physician Decision|1|||
161755790|NCT04195750|584144465|FG002|Overall Study|Physician Decision|0|||
161755791|NCT04195750|584144463|FG000|Overall Study|Withdrawal by Subject|9|||
161755792|NCT04195750|584144464|FG001|Overall Study|Withdrawal by Subject|8|||
161755793|NCT04195750|584144465|FG002|Overall Study|Withdrawal by Subject|0|||
161755794|NCT04195750|584144463|FG000|Overall Study|Ongoing|120|||
161755795|NCT04195750|584144464|FG001|Overall Study|Ongoing|110|||
161755796|NCT04195750|584144465|FG002|Overall Study|Ongoing|4|||
161755797|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755798|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
161755799|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
161755800|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755801|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755802|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755803|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755804|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
161755805|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755806|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
161755807|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755808|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755809|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755810|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755811|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
161755812|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
161755813|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
161755814|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755815|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755816|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755817|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755818|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
161755819|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755820|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
161755821|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755822|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755823|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755824|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755825|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
161755826|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
161755827|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
161755828|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
161755829|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
161755830|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
161755831|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
161755832|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
161755833|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
161755834|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
161755835|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
161755836|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
161755837|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
161755838|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
161755839|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755840|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755841|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755842|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
161755843|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
161755844|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755845|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
161755846|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161755847|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161755848|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161755849|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
161755850|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
161755851|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
161755852|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
161755853|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755854|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755855|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755856|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755857|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755858|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
161755859|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755860|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755861|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755862|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755863|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755864|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
161755865|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755866|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755867|NCT03782376|584144473|FG000|Overall Study|Lost to Follow-up|2|||
161755868|NCT03782376|584144474|FG001|Overall Study|Lost to Follow-up|2|||
161755869|NCT03782376|584144473|FG000|Overall Study|Withdrawal by Subject|7|||
161755870|NCT03782376|584144474|FG001|Overall Study|Withdrawal by Subject|11|||
161755871|NCT03782376|584144473|FG000|Overall Study|Death|1|||
161755872|NCT03782376|584144474|FG001|Overall Study|Death|0|||
161755873|NCT03782376|584144473|FG000|Overall Study|Other|16|||
161755874|NCT03782376|584144474|FG001|Overall Study|Other|17|||
161755875|NCT02659098|584144475|FG000|Overall Study|Withdrawal by Subject|7|||
161755876|NCT04363944|584144476|FG000|Overall Study|Withdrawal by Subject|2|||
161755877|NCT04363944|584144477|FG001|Overall Study|Withdrawal by Subject|0|||
161755878|NCT03559192|584144478|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
161755879|NCT03559192|584144479|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
161755880|NCT03559192|584144480|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
161755881|NCT03559192|584144478|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
161755882|NCT03559192|584144479|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
161755883|NCT03559192|584144480|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
161755884|NCT03559192|584144478|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
161755885|NCT03559192|584144479|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
161755886|NCT03559192|584144480|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
161755887|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
161755888|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
161755889|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
161755890|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
161755891|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
161755892|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
161755893|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
161755894|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
161755895|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
161755896|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
161755897|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
161755898|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
161755899|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
161755900|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
161755901|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
161755902|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
161755903|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
161755904|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
161755905|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
161755906|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
161755907|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Death|0|||
161755908|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Death|4|||
161755909|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
161755910|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
161755911|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
161755912|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
161755913|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
161755914|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
161755915|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
161755916|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
161755917|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
161755918|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
161755919|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Other|4|||
161755920|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Other|3|||
161755921|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
161755922|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
161755923|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
161755924|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
161755925|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
161755926|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
161755927|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
161755928|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
161755929|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
161755930|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
161755931|NCT02254304|584144488|FG000|Overall Study|Adverse Event|2|||
161755932|NCT02254304|584144489|FG001|Overall Study|Adverse Event|1|||
161755933|NCT02254304|584144488|FG000|Overall Study|Lost to Follow-up|2|||
161755934|NCT02254304|584144489|FG001|Overall Study|Lost to Follow-up|2|||
161755935|NCT02254304|584144488|FG000|Overall Study|Protocol Violation|1|||
161755936|NCT02254304|584144489|FG001|Overall Study|Protocol Violation|0|||
161755937|NCT02254304|584144488|FG000|Overall Study|Withdrawal by Subject|3|||
161755938|NCT02254304|584144489|FG001|Overall Study|Withdrawal by Subject|0|||
161755939|NCT02254304|584144488|FG000|Overall Study|Injection site pain and Injection fear|1|||
161755940|NCT02254304|584144489|FG001|Overall Study|Injection site pain and Injection fear|0|||
161755941|NCT02254304|584144488|FG000|Overall Study|Personal causes|4|||
161755942|NCT02254304|584144489|FG001|Overall Study|Personal causes|1|||
161755943|NCT02254304|584144488|FG000|Overall Study|Personal decision|1|||
161845554|NCT01136967|584477031|FG001|Overall Study|Adverse Event|12|||
161755944|NCT02254304|584144489|FG001|Overall Study|Personal decision|0|||
161755945|NCT00952419|584144490|FG000|Overall Study|Adverse Event|2|||
161755946|NCT00952419|584144491|FG001|Overall Study|Adverse Event|0|||
161755947|NCT00952419|584144492|FG002|Overall Study|Adverse Event|0|||
161755948|NCT00952419|584144490|FG000|Overall Study|Protocol Violation|3|||
161755949|NCT00952419|584144491|FG001|Overall Study|Protocol Violation|7|||
161755950|NCT00952419|584144492|FG002|Overall Study|Protocol Violation|0|||
161755951|NCT00952419|584144490|FG000|Overall Study|Withdrawal by Subject|1|||
161755952|NCT00952419|584144491|FG001|Overall Study|Withdrawal by Subject|3|||
161755953|NCT00952419|584144492|FG002|Overall Study|Withdrawal by Subject|0|||
161755954|NCT03573804|584144493|FG000|Overall Study|claustrophobia or MRI table problems|10|||
161755955|NCT05166603|584144497|FG000|Overall Study|Withdrawal by Subject|68|||
161755956|NCT05166603|584144498|FG001|Overall Study|Withdrawal by Subject|0|||
161755957|NCT04418427|584146188|FG000|Overall Study|Death|0|||
161755958|NCT04418427|584146189|FG001|Overall Study|Death|1|||
161755959|NCT04418427|584146190|FG002|Overall Study|Death|0|||
161755960|NCT04418427|584146188|FG000|Overall Study|Lost to Follow-up|0|||
161755961|NCT04418427|584146189|FG001|Overall Study|Lost to Follow-up|2|||
161755962|NCT04418427|584146190|FG002|Overall Study|Lost to Follow-up|2|||
161755963|NCT04418427|584146188|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
161755964|NCT04418427|584146189|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
161755965|NCT04418427|584146190|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
161755966|NCT04418427|584146188|FG000|Overall Study|Pre-existing medical condition|0|||
161755967|NCT04418427|584146189|FG001|Overall Study|Pre-existing medical condition|1|||
161755968|NCT04418427|584146190|FG002|Overall Study|Pre-existing medical condition|0|||
161755969|NCT01673373|584146193|FG000|Overall Study|Death|2|||
161755970|NCT00366444|584146195|FG000|Overall Study|Withdrawal by Subject|1|||
161755971|NCT00366444|584146196|FG001|Overall Study|Withdrawal by Subject|1|||
161755972|NCT00366444|584146195|FG000|Overall Study|Lack of Efficacy|0|||
161755973|NCT00366444|584146196|FG001|Overall Study|Lack of Efficacy|1|||
161755974|NCT01654224|584146201|FG000|Overall Study|Lost to Follow-up|2|||
161755975|NCT01654224|584146202|FG001|Overall Study|Lost to Follow-up|2|||
161755976|NCT01654224|584146201|FG000|Overall Study|Did not receive allocation|1|||
161755977|NCT01654224|584146202|FG001|Overall Study|Did not receive allocation|8|||
161755978|NCT01654224|584146201|FG000|Overall Study|Insufficient blood sample|3|||
161755979|NCT01654224|584146202|FG001|Overall Study|Insufficient blood sample|2|||
161755980|NCT00166504|584146204|FG000|Overall Study|Adverse Event|3|||
161755981|NCT00166504|584146205|FG001|Overall Study|Adverse Event|3|||
161755982|NCT00166504|584146204|FG000|Overall Study|Lost to Follow-up|1|||
161755983|NCT00166504|584146205|FG001|Overall Study|Lost to Follow-up|1|||
161755984|NCT00166504|584146204|FG000|Overall Study|Withdrawal by Subject|1|||
161755985|NCT00166504|584146205|FG001|Overall Study|Withdrawal by Subject|0|||
161755986|NCT04969900|584146206|FG000|Overall Study|Physician Decision|1|||
161755987|NCT04969900|584146207|FG001|Overall Study|Physician Decision|1|||
161755988|NCT04969900|584146206|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
161755989|NCT04969900|584146207|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
161755990|NCT03261037|584146210|FG000|Overall Study|Withdrawal by Subject|2|||
161755991|NCT03261037|584146211|FG001|Overall Study|Withdrawal by Subject|13|||
161755992|NCT03261037|584146212|FG002|Overall Study|Withdrawal by Subject|0|||
161755993|NCT03261037|584146213|FG003|Overall Study|Withdrawal by Subject|18|||
161755994|NCT03261037|584146210|FG000|Overall Study|Non-compliance with study procedures|0|||
161755995|NCT03261037|584146211|FG001|Overall Study|Non-compliance with study procedures|2|||
161755996|NCT03261037|584146212|FG002|Overall Study|Non-compliance with study procedures|0|||
161755997|NCT03261037|584146213|FG003|Overall Study|Non-compliance with study procedures|6|||
161755998|NCT03261037|584146210|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
161755999|NCT03261037|584146211|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
161756000|NCT03261037|584146212|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
161756001|NCT03261037|584146213|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
161756002|NCT03261037|584146210|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
161756003|NCT03261037|584146211|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
161756004|NCT03261037|584146212|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
161756005|NCT03261037|584146213|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
161756006|NCT03261037|584146210|FG000|Overall Study|Diagnosed but protocol deviation|1|||
161756007|NCT03261037|584146211|FG001|Overall Study|Diagnosed but protocol deviation|0|||
161756008|NCT03261037|584146212|FG002|Overall Study|Diagnosed but protocol deviation|0|||
161756009|NCT03261037|584146213|FG003|Overall Study|Diagnosed but protocol deviation|0|||
161756010|NCT03261037|584146210|FG000|Overall Study|Participant did not want to continue the study|0|||
161756011|NCT03261037|584146211|FG001|Overall Study|Participant did not want to continue the study|1|||
161756012|NCT03261037|584146212|FG002|Overall Study|Participant did not want to continue the study|0|||
161756013|NCT03261037|584146213|FG003|Overall Study|Participant did not want to continue the study|0|||
161756014|NCT03261037|584146210|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161756015|NCT03261037|584146211|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161756016|NCT03261037|584146212|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161845555|NCT01136967|584477030|FG000|Overall Study|Participant Choice|8|||
161845556|NCT01136967|584477031|FG001|Overall Study|Participant Choice|3|||
161845557|NCT01136967|584477030|FG000|Overall Study|Lost to Follow-up|0|||
161845558|NCT01136967|584477031|FG001|Overall Study|Lost to Follow-up|1|||
161845559|NCT01136967|584477030|FG000|Overall Study|Withdrawal by Subject|1|||
161845560|NCT01136967|584477031|FG001|Overall Study|Withdrawal by Subject|2|||
161845561|NCT01136967|584477030|FG000|Overall Study|Clinical Progression|3|||
161845562|NCT01136967|584477031|FG001|Overall Study|Clinical Progression|5|||
161845563|NCT01136967|584477030|FG000|Overall Study|Radiation|1|||
161845564|NCT01136967|584477031|FG001|Overall Study|Radiation|0|||
161845565|NCT01136967|584477030|FG000|Overall Study|Non-compliance|1|||
161845566|NCT01136967|584477031|FG001|Overall Study|Non-compliance|0|||
161845567|NCT01136967|584477030|FG000|Overall Study|Investigator's Choice|1|||
161845568|NCT01136967|584477031|FG001|Overall Study|Investigator's Choice|1|||
161845569|NCT01136967|584477030|FG000|Overall Study|Increase in Lesion Size|0|||
161845570|NCT01136967|584477031|FG001|Overall Study|Increase in Lesion Size|2|||
161845571|NCT01136967|584477030|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
161845572|NCT01136967|584477031|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
161845573|NCT03317834|584477032|FG000|Overall Study|Death|2|||
161845574|NCT03317834|584477032|FG000|Overall Study|Device Revision|5|||
161845575|NCT03317834|584477032|FG000|Overall Study|Withdrawal by Subject|13|||
161845576|NCT03317834|584477032|FG000|Overall Study|Lost to Follow-up|13|||
161845577|NCT03839823|584477036|FG000|Overall Study|Adverse Event|8|||
161845578|NCT03839823|584477037|FG001|Overall Study|Adverse Event|4|||
161845579|NCT03839823|584477036|FG000|Overall Study|Death|1|||
161845580|NCT03839823|584477037|FG001|Overall Study|Death|0|||
161845581|NCT03839823|584477036|FG000|Overall Study|Physician Decision|1|||
161845582|NCT03839823|584477037|FG001|Overall Study|Physician Decision|5|||
161845583|NCT03839823|584477036|FG000|Overall Study|Progressive Disease (PD)|65|||
161845584|NCT03839823|584477037|FG001|Overall Study|Progressive Disease (PD)|65|||
161845585|NCT03839823|584477036|FG000|Overall Study|Subject Decision|2|||
161845586|NCT03839823|584477037|FG001|Overall Study|Subject Decision|9|||
161845587|NCT03839823|584477036|FG000|Overall Study|Not Treated|0|||
161845588|NCT03839823|584477037|FG001|Overall Study|Not Treated|10|||
161845589|NCT01716715|584477038|FG000|Overall Study|Never Treated|2|||
161845590|NCT01716715|584477039|FG001|Overall Study|Never Treated|4|||
161845591|NCT04228783|584477040|FG000|Overall Study|Adverse Event|1|||
161845592|NCT04228783|584477041|FG001|Overall Study|Adverse Event|0|||
161845593|NCT04228783|584477042|FG002|Overall Study|Adverse Event|2|||
161845594|NCT04228783|584477043|FG003|Overall Study|Adverse Event|0|||
161845595|NCT04228783|584477044|FG004|Overall Study|Adverse Event|0|||
161845596|NCT04228783|584477045|FG005|Overall Study|Adverse Event|1|||
161845597|NCT04228783|584477040|FG000|Overall Study|Death|0|||
161845598|NCT04228783|584477041|FG001|Overall Study|Death|0|||
161845599|NCT04228783|584477042|FG002|Overall Study|Death|0|||
161845600|NCT04228783|584477043|FG003|Overall Study|Death|0|||
161845601|NCT04228783|584477044|FG004|Overall Study|Death|1|||
161845602|NCT04228783|584477045|FG005|Overall Study|Death|0|||
161845603|NCT04228783|584477040|FG000|Overall Study|Lost to Follow-up|36|||
161845604|NCT04228783|584477041|FG001|Overall Study|Lost to Follow-up|36|||
161845605|NCT04228783|584477042|FG002|Overall Study|Lost to Follow-up|28|||
161845606|NCT04228783|584477043|FG003|Overall Study|Lost to Follow-up|6|||
161845607|NCT04228783|584477044|FG004|Overall Study|Lost to Follow-up|14|||
161845608|NCT04228783|584477045|FG005|Overall Study|Lost to Follow-up|3|||
161845609|NCT04228783|584477040|FG000|Overall Study|Physician Decision|1|||
161845610|NCT04228783|584477041|FG001|Overall Study|Physician Decision|2|||
161845611|NCT04228783|584477042|FG002|Overall Study|Physician Decision|0|||
161845612|NCT04228783|584477043|FG003|Overall Study|Physician Decision|0|||
161845613|NCT04228783|584477044|FG004|Overall Study|Physician Decision|0|||
161845614|NCT04228783|584477045|FG005|Overall Study|Physician Decision|0|||
161845615|NCT04228783|584477040|FG000|Overall Study|Protocol Violation|0|||
161845616|NCT04228783|584477041|FG001|Overall Study|Protocol Violation|0|||
161845617|NCT04228783|584477042|FG002|Overall Study|Protocol Violation|0|||
161845618|NCT04228783|584477043|FG003|Overall Study|Protocol Violation|1|||
161845619|NCT04228783|584477044|FG004|Overall Study|Protocol Violation|0|||
161845620|NCT04228783|584477045|FG005|Overall Study|Protocol Violation|0|||
161845621|NCT04228783|584477040|FG000|Overall Study|Withdrawal by Subject|6|||
161845622|NCT04228783|584477041|FG001|Overall Study|Withdrawal by Subject|10|||
161756017|NCT03261037|584146213|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
161756018|NCT03261037|584146210|FG000|Overall Study|Participant presented clinical improvement|0|||
161756019|NCT03261037|584146211|FG001|Overall Study|Participant presented clinical improvement|2|||
161756020|NCT03261037|584146212|FG002|Overall Study|Participant presented clinical improvement|0|||
161756021|NCT03261037|584146213|FG003|Overall Study|Participant presented clinical improvement|0|||
161756022|NCT03261037|584146210|FG000|Overall Study|Technical difficulties|0|||
161756023|NCT03261037|584146211|FG001|Overall Study|Technical difficulties|0|||
161756024|NCT03261037|584146212|FG002|Overall Study|Technical difficulties|0|||
161756025|NCT03261037|584146213|FG003|Overall Study|Technical difficulties|1|||
161756026|NCT03261037|584146210|FG000|Overall Study|Equipment failed to work|0|||
161756027|NCT03261037|584146211|FG001|Overall Study|Equipment failed to work|0|||
161756028|NCT03261037|584146212|FG002|Overall Study|Equipment failed to work|0|||
161756029|NCT03261037|584146213|FG003|Overall Study|Equipment failed to work|1|||
161756030|NCT03261037|584146210|FG000|Overall Study|End of study for participant and no follow up|0|||
161756031|NCT03261037|584146211|FG001|Overall Study|End of study for participant and no follow up|0|||
161756032|NCT03261037|584146212|FG002|Overall Study|End of study for participant and no follow up|0|||
161756033|NCT03261037|584146213|FG003|Overall Study|End of study for participant and no follow up|1|||
161756034|NCT03261037|584146210|FG000|Overall Study|Participant was too weak to continue in study|1|||
161756035|NCT03261037|584146211|FG001|Overall Study|Participant was too weak to continue in study|0|||
161756036|NCT03261037|584146212|FG002|Overall Study|Participant was too weak to continue in study|0|||
161756037|NCT03261037|584146213|FG003|Overall Study|Participant was too weak to continue in study|0|||
161756038|NCT04423718|584146214|FG000|Main Study|Adverse Event|9|||
161756039|NCT04423718|584146215|FG001|Main Study|Adverse Event|5|||
161756040|NCT04423718|584146216|FG002|Main Study|Adverse Event|8|||
161756041|NCT04423718|584146214|FG000|Main Study|Physician Decision|3|||
161756042|NCT04423718|584146215|FG001|Main Study|Physician Decision|3|||
161756043|NCT04423718|584146216|FG002|Main Study|Physician Decision|2|||
161756044|NCT04423718|584146214|FG000|Main Study|Protocol Violation|0|||
161756045|NCT04423718|584146215|FG001|Main Study|Protocol Violation|0|||
161756046|NCT04423718|584146216|FG002|Main Study|Protocol Violation|1|||
161756047|NCT04423718|584146214|FG000|Main Study|Lost to Follow-up|3|||
161756048|NCT04423718|584146215|FG001|Main Study|Lost to Follow-up|3|||
161756049|NCT04423718|584146216|FG002|Main Study|Lost to Follow-up|4|||
161756050|NCT04423718|584146214|FG000|Main Study|Lack of Efficacy|2|||
161756051|NCT04423718|584146215|FG001|Main Study|Lack of Efficacy|1|||
161756052|NCT04423718|584146216|FG002|Main Study|Lack of Efficacy|0|||
161756053|NCT04423718|584146214|FG000|Main Study|Withdrawal by Subject|14|||
161756054|NCT04423718|584146215|FG001|Main Study|Withdrawal by Subject|20|||
161756055|NCT04423718|584146216|FG002|Main Study|Withdrawal by Subject|20|||
161756056|NCT04423718|584146214|FG000|Main Study|Death|10|||
161756057|NCT04423718|584146215|FG001|Main Study|Death|7|||
161756058|NCT04423718|584146216|FG002|Main Study|Death|7|||
161756059|NCT04423718|584146214|FG000|Main Study|COVID-19 pandemic|2|||
161756060|NCT04423718|584146215|FG001|Main Study|COVID-19 pandemic|2|||
161756061|NCT04423718|584146216|FG002|Main Study|COVID-19 pandemic|2|||
161756062|NCT04423718|584146214|FG000|Main Study|Other|7|||
161756063|NCT04423718|584146215|FG001|Main Study|Other|3|||
161756064|NCT04423718|584146216|FG002|Main Study|Other|2|||
161756065|NCT04423718|584146214|FG000|Extension Phase|Other|1|||
161756066|NCT04423718|584146215|FG001|Extension Phase|Other|0|||
161756067|NCT04423718|584146216|FG002|Extension Phase|Other|0|||
161756068|NCT04423718|584146214|FG000|Extension Phase|Logistical problems|0|||
161756069|NCT04423718|584146215|FG001|Extension Phase|Logistical problems|1|||
161756070|NCT04423718|584146216|FG002|Extension Phase|Logistical problems|1|||
161756071|NCT04423718|584146214|FG000|Extension Phase|Physician Decision|1|||
161756072|NCT04423718|584146215|FG001|Extension Phase|Physician Decision|0|||
161756073|NCT04423718|584146216|FG002|Extension Phase|Physician Decision|1|||
161756074|NCT04423718|584146214|FG000|Extension Phase|Lack of Efficacy|2|||
161756075|NCT04423718|584146215|FG001|Extension Phase|Lack of Efficacy|0|||
161756076|NCT04423718|584146216|FG002|Extension Phase|Lack of Efficacy|1|||
161756077|NCT04423718|584146214|FG000|Extension Phase|Lost to Follow-up|0|||
161756078|NCT04423718|584146215|FG001|Extension Phase|Lost to Follow-up|2|||
161756079|NCT04423718|584146216|FG002|Extension Phase|Lost to Follow-up|3|||
161756080|NCT04423718|584146214|FG000|Extension Phase|Adverse Event|2|||
161756081|NCT04423718|584146215|FG001|Extension Phase|Adverse Event|3|||
161756082|NCT04423718|584146216|FG002|Extension Phase|Adverse Event|1|||
161756083|NCT04423718|584146214|FG000|Extension Phase|Death|4|||
161845623|NCT04228783|584477042|FG002|Overall Study|Withdrawal by Subject|19|||
161756084|NCT04423718|584146215|FG001|Extension Phase|Death|7|||
161756085|NCT04423718|584146216|FG002|Extension Phase|Death|2|||
161756086|NCT04423718|584146214|FG000|Extension Phase|Withdrawal by Subject|11|||
161756087|NCT04423718|584146215|FG001|Extension Phase|Withdrawal by Subject|11|||
161756088|NCT04423718|584146216|FG002|Extension Phase|Withdrawal by Subject|7|||
161756089|NCT02881151|584146219|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
161756090|NCT00589602|584146221|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
161756091|NCT05298774|584146225|FG000|Overall Study|Physician Decision|3|||
161756092|NCT05298774|584146225|FG000|Overall Study|Withdrawal by Subject|2|||
161756093|NCT05298774|584146225|FG000|Overall Study|Lost to Follow-up|3|||
161756094|NCT05298774|584146225|FG000|Overall Study|Screen failure|1|||
161756095|NCT04992507|584146226|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
161756096|NCT04992507|584146227|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
161756097|NCT04992507|584146226|FG000|Overall Study|Death|0|||
161756098|NCT04992507|584146227|FG001|Overall Study|Death|1|||
161756099|NCT03887052|584146228|FG000|Overall Study|Adverse Event|2|||
161756100|NCT03887052|584146228|FG000|Overall Study|Physician Decision|2|||
161756101|NCT03887052|584146228|FG000|Overall Study|Withdrawal by Subject|3|||
161756102|NCT03887052|584146228|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
161756103|NCT03887052|584146228|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
161756104|NCT04517253|584146231|FG000|Primary Treatment Period|Adverse Event|1|||
161756105|NCT04517253|584146232|FG001|Primary Treatment Period|Adverse Event|0|||
161756106|NCT04517253|584146233|FG002|Primary Treatment Period|Adverse Event|0|||
161756107|NCT04517253|584146231|FG000|Primary Treatment Period|Death|0|||
161756108|NCT04517253|584146232|FG001|Primary Treatment Period|Death|1|||
161756109|NCT04517253|584146233|FG002|Primary Treatment Period|Death|0|||
161756110|NCT04517253|584146231|FG000|Maintenance Period|Withdrawal by Subject|1|||
161756111|NCT04517253|584146232|FG001|Maintenance Period|Withdrawal by Subject|0|||
161756112|NCT04517253|584146233|FG002|Maintenance Period|Withdrawal by Subject|0|||
161756113|NCT04517253|584146231|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
161756114|NCT04517253|584146232|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
161756115|NCT04517253|584146233|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
161756116|NCT01023516|584146234|FG000|Overall Study|Voluntary discontinuation|7|||
161756117|NCT01023516|584146235|FG001|Overall Study|Voluntary discontinuation|5|||
161756118|NCT01023516|584146234|FG000|Overall Study|Adverse Event|9|||
161756119|NCT01023516|584146235|FG001|Overall Study|Adverse Event|6|||
161756120|NCT01023516|584146234|FG000|Overall Study|Safety reason|0|||
161756121|NCT01023516|584146235|FG001|Overall Study|Safety reason|3|||
161756122|NCT01023516|584146234|FG000|Overall Study|Study-specific criteria|4|||
161756123|NCT01023516|584146235|FG001|Overall Study|Study-specific criteria|2|||
161756124|NCT01023516|584146234|FG000|Overall Study|Incorrect enrolment|4|||
161756125|NCT01023516|584146235|FG001|Overall Study|Incorrect enrolment|2|||
161756126|NCT01266876|584146236|FG000|Overall Study|Adverse Event|0|||
161756127|NCT01266876|584146237|FG001|Overall Study|Adverse Event|0|||
161756128|NCT01266876|584146238|FG002|Overall Study|Adverse Event|0|||
161756129|NCT01266876|584146239|FG003|Overall Study|Adverse Event|1|||
161756130|NCT01266876|584146240|FG004|Overall Study|Adverse Event|0|||
161756131|NCT01058395|584146241|FG000|Overall Study|Death|2|||
161756132|NCT01058395|584146242|FG001|Overall Study|Death|1|||
161756133|NCT01058395|584146241|FG000|Overall Study|Lost to Follow-up|1|||
161756134|NCT01058395|584146242|FG001|Overall Study|Lost to Follow-up|0|||
161756135|NCT05016037|584146244|FG000|Overall Study|Lost to Follow-up|2|||
161756136|NCT00557323|584146245|FG000|Overall Study|Death|3|||
161756137|NCT00557323|584146245|FG000|Overall Study|Withdrawal by Subject|2|||
161756138|NCT00557323|584146245|FG000|Overall Study|Administrative change|2|||
161756139|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
161756140|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
161756141|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
161756142|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
161756143|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
161756144|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
161756145|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
161756146|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
161756147|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
161756148|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
161756149|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
161756150|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
161756151|NCT04007367|584146249|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
161756152|NCT04007367|584146250|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
161756153|NCT04007367|584146251|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
161756154|NCT02010567|584146253|FG000|Overall Study|Adverse Event|0|||
161756155|NCT02010567|584146254|FG001|Overall Study|Adverse Event|0|||
161756156|NCT02010567|584146255|FG002|Overall Study|Adverse Event|1|||
161756157|NCT02010567|584146256|FG003|Overall Study|Adverse Event|0|||
161756158|NCT02010567|584146257|FG004|Overall Study|Adverse Event|1|||
161756159|NCT00372489|584146258|FG000|Overall Study|Adverse Event|18|||
161756160|NCT00372489|584146258|FG000|Overall Study|Lack of Efficacy|1|||
161756161|NCT00372489|584146258|FG000|Overall Study|Lost to Follow-up|3|||
161756162|NCT00372489|584146258|FG000|Overall Study|Physician Decision|3|||
161756163|NCT00372489|584146258|FG000|Overall Study|Withdrawal by Subject|5|||
161756164|NCT00372489|584146258|FG000|Overall Study|Patient Relocation|2|||
161756165|NCT00372489|584146258|FG000|Overall Study|Renal transplant|6|||
161756166|NCT00372489|584146258|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
161756167|NCT03323086|584146260|FG000|Overall Study|Lost to Follow-up|3|||
161756168|NCT03323086|584146261|FG001|Overall Study|Lost to Follow-up|2|||
161756169|NCT00623766|584146264|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
161756170|NCT00623766|584146265|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
161756171|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
161756172|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
161756173|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
161756174|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
161756175|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
161756176|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
161756177|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
161756178|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
161756179|NCT00796549|584146266|FG000|Overall Study|Adverse Event|11|||
161756180|NCT00796549|584146266|FG000|Overall Study|not entered|149|||
161756181|NCT00796549|584146266|FG000|Overall Study|Other|2|||
161756182|NCT00796549|584146266|FG000|Overall Study|Progressive disease|56|||
161756183|NCT00606229|584146270|FG000|Overall Study|Adverse Event|11|||
161756184|NCT00606229|584146270|FG000|Overall Study|Lack of Efficacy|1|||
161756185|NCT00606229|584146270|FG000|Overall Study|Withdrawal by Subject|4|||
161756186|NCT00606229|584146270|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
161756187|NCT00606229|584146270|FG000|Overall Study|change of residence or other commitments|2|||
161756188|NCT03523715|584146271|FG000|Overall Study|Lost to Follow-up|11|||
161756189|NCT03523715|584146272|FG001|Overall Study|Lost to Follow-up|14|||
161756190|NCT03523715|584146271|FG000|Overall Study|Did not meet inclusion criteria|1|||
161756191|NCT03523715|584146272|FG001|Overall Study|Did not meet inclusion criteria|0|||
161756192|NCT03523715|584146271|FG000|Overall Study|Internally inconsistent reporting|0|||
161756193|NCT03523715|584146272|FG001|Overall Study|Internally inconsistent reporting|2|||
161756194|NCT01526928|584146273|FG000|Overall Study|Progressive Disease|35|||
161756195|NCT01526928|584146274|FG001|Overall Study|Progressive Disease|17|||
161756196|NCT01526928|584146275|FG002|Overall Study|Progressive Disease|150|||
161756197|NCT01526928|584146276|FG003|Overall Study|Progressive Disease|182|||
161756198|NCT01526928|584146277|FG004|Overall Study|Progressive Disease|76|||
161756199|NCT01526928|584146278|FG005|Overall Study|Progressive Disease|4|||
161756200|NCT01526928|584146273|FG000|Overall Study|Adverse Event|2|||
161756201|NCT01526928|584146274|FG001|Overall Study|Adverse Event|1|||
161756202|NCT01526928|584146275|FG002|Overall Study|Adverse Event|29|||
161756203|NCT01526928|584146276|FG003|Overall Study|Adverse Event|40|||
161756204|NCT01526928|584146277|FG004|Overall Study|Adverse Event|13|||
161756205|NCT01526928|584146278|FG005|Overall Study|Adverse Event|2|||
161756206|NCT01526928|584146273|FG000|Overall Study|Death|0|||
161756207|NCT01526928|584146274|FG001|Overall Study|Death|0|||
161756208|NCT01526928|584146275|FG002|Overall Study|Death|3|||
161756209|NCT01526928|584146276|FG003|Overall Study|Death|0|||
161756210|NCT01526928|584146277|FG004|Overall Study|Death|0|||
161756211|NCT01526928|584146278|FG005|Overall Study|Death|0|||
161756212|NCT01526928|584146273|FG000|Overall Study|Withdrawal by Subject|1|||
161756213|NCT01526928|584146274|FG001|Overall Study|Withdrawal by Subject|0|||
161756214|NCT01526928|584146275|FG002|Overall Study|Withdrawal by Subject|13|||
161756215|NCT01526928|584146276|FG003|Overall Study|Withdrawal by Subject|11|||
161756216|NCT01526928|584146277|FG004|Overall Study|Withdrawal by Subject|3|||
161756217|NCT01526928|584146278|FG005|Overall Study|Withdrawal by Subject|0|||
161756218|NCT01526928|584146273|FG000|Overall Study|Physician Decision|0|||
161756219|NCT01526928|584146274|FG001|Overall Study|Physician Decision|0|||
161756220|NCT01526928|584146275|FG002|Overall Study|Physician Decision|2|||
161756221|NCT01526928|584146276|FG003|Overall Study|Physician Decision|5|||
161756222|NCT01526928|584146277|FG004|Overall Study|Physician Decision|0|||
161756223|NCT01526928|584146278|FG005|Overall Study|Physician Decision|0|||
161756224|NCT01526928|584146273|FG000|Overall Study|Other Reason|0|||
161756225|NCT01526928|584146274|FG001|Overall Study|Other Reason|1|||
161756226|NCT01526928|584146275|FG002|Overall Study|Other Reason|11|||
161756227|NCT01526928|584146276|FG003|Overall Study|Other Reason|4|||
161756228|NCT01526928|584146277|FG004|Overall Study|Other Reason|1|||
161756229|NCT01526928|584146278|FG005|Overall Study|Other Reason|0|||
161756230|NCT01526928|584146273|FG000|Overall Study|Lost to Follow-up|0|||
161756231|NCT01526928|584146274|FG001|Overall Study|Lost to Follow-up|0|||
161756232|NCT01526928|584146275|FG002|Overall Study|Lost to Follow-up|0|||
161756233|NCT01526928|584146276|FG003|Overall Study|Lost to Follow-up|1|||
161756234|NCT01526928|584146277|FG004|Overall Study|Lost to Follow-up|0|||
161756235|NCT01526928|584146278|FG005|Overall Study|Lost to Follow-up|0|||
161756236|NCT01526928|584146273|FG000|Overall Study|Protocol Deviation|0|||
161756237|NCT01526928|584146274|FG001|Overall Study|Protocol Deviation|0|||
161756238|NCT01526928|584146275|FG002|Overall Study|Protocol Deviation|0|||
161756239|NCT01526928|584146276|FG003|Overall Study|Protocol Deviation|2|||
161756240|NCT01526928|584146277|FG004|Overall Study|Protocol Deviation|0|||
161756241|NCT01526928|584146278|FG005|Overall Study|Protocol Deviation|0|||
161756242|NCT01526928|584146273|FG000|Overall Study|Missing|0|||
161756243|NCT01526928|584146274|FG001|Overall Study|Missing|0|||
161756244|NCT01526928|584146275|FG002|Overall Study|Missing|1|||
161756245|NCT01526928|584146276|FG003|Overall Study|Missing|0|||
161756246|NCT01526928|584146277|FG004|Overall Study|Missing|2|||
161756247|NCT01526928|584146278|FG005|Overall Study|Missing|0|||
161756248|NCT00942422|584146279|FG000|Overall Study|Withdrawal by Subject|1|||
161756249|NCT00942422|584146279|FG000|Overall Study|Death|1|||
161756250|NCT00942422|584146279|FG000|Overall Study|Progressive diease|1|||
161756251|NCT05559203|584146287|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
161756252|NCT01947894|584146292|FG000|Overall Study|Other|3|||
161756253|NCT01947894|584146293|FG001|Overall Study|Other|4|||
161756254|NCT01947894|584146294|FG002|Overall Study|Other|3|||
161756255|NCT01947894|584146292|FG000|Overall Study|Withdrawal by Subject|12|||
161756256|NCT01947894|584146293|FG001|Overall Study|Withdrawal by Subject|4|||
161756257|NCT01947894|584146294|FG002|Overall Study|Withdrawal by Subject|1|||
161756258|NCT01947894|584146292|FG000|Overall Study|Death|12|||
161756259|NCT01947894|584146293|FG001|Overall Study|Death|1|||
161756260|NCT01947894|584146294|FG002|Overall Study|Death|0|||
161756261|NCT01947894|584146292|FG000|Overall Study|Physician Decision|2|||
161756262|NCT01947894|584146293|FG001|Overall Study|Physician Decision|0|||
161756263|NCT01947894|584146294|FG002|Overall Study|Physician Decision|0|||
161756264|NCT01947894|584146292|FG000|Overall Study|Adverse Event|5|||
161756265|NCT01947894|584146293|FG001|Overall Study|Adverse Event|1|||
161756266|NCT01947894|584146294|FG002|Overall Study|Adverse Event|0|||
161756267|NCT01947894|584146292|FG000|Overall Study|Switched to other growth hormone brand|53|||
161756268|NCT01947894|584146293|FG001|Overall Study|Switched to other growth hormone brand|8|||
161756269|NCT01947894|584146294|FG002|Overall Study|Switched to other growth hormone brand|23|||
161756270|NCT01302691|584146295|FG000|Overall Study|Adverse Event|2|||
161756271|NCT01302691|584146296|FG001|Overall Study|Adverse Event|0|||
161756272|NCT01302691|584146295|FG000|Overall Study|Death|0|||
161756273|NCT01302691|584146296|FG001|Overall Study|Death|1|||
161756274|NCT01302691|584146295|FG000|Overall Study|Lost to Follow-up|1|||
161756275|NCT01302691|584146296|FG001|Overall Study|Lost to Follow-up|0|||
161756276|NCT01302691|584146295|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
161756277|NCT01302691|584146296|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
161756278|NCT01302691|584146295|FG000|Overall Study|Physician Decision|0|||
161756279|NCT01302691|584146296|FG001|Overall Study|Physician Decision|1|||
161756280|NCT01302691|584146295|FG000|Overall Study|Protocol Violation|1|||
161756281|NCT01302691|584146296|FG001|Overall Study|Protocol Violation|0|||
161756282|NCT02829775|584146298|FG000|Overall Study|Death|1|||
161756283|NCT02829775|584146298|FG000|Overall Study|Withdrawal by Subject|3|||
161756284|NCT02829775|584146298|FG000|Overall Study|Disease remission|1|||
161756285|NCT02725268|584146307|FG000|Overall Study|Death|58|||
161756286|NCT02725268|584146308|FG001|Overall Study|Death|59|||
161756287|NCT02725268|584146309|FG002|Overall Study|Death|30|||
161756288|NCT02725268|584146310|FG003|Overall Study|Death|16|||
161756289|NCT02725268|584146307|FG000|Overall Study|Lost to Follow-up|4|||
161756290|NCT02725268|584146308|FG001|Overall Study|Lost to Follow-up|3|||
161756291|NCT02725268|584146309|FG002|Overall Study|Lost to Follow-up|0|||
161756292|NCT02725268|584146310|FG003|Overall Study|Lost to Follow-up|1|||
161756293|NCT02725268|584146307|FG000|Overall Study|Site Terminated by Sponsor|0|||
161756294|NCT02725268|584146308|FG001|Overall Study|Site Terminated by Sponsor|1|||
161756295|NCT02725268|584146309|FG002|Overall Study|Site Terminated by Sponsor|0|||
161756296|NCT02725268|584146310|FG003|Overall Study|Site Terminated by Sponsor|0|||
161756297|NCT02725268|584146307|FG000|Overall Study|Withdrawal by Subject|8|||
161756298|NCT02725268|584146308|FG001|Overall Study|Withdrawal by Subject|6|||
161756299|NCT02725268|584146309|FG002|Overall Study|Withdrawal by Subject|8|||
161756300|NCT02725268|584146310|FG003|Overall Study|Withdrawal by Subject|1|||
161756301|NCT02725268|584146307|FG000|Overall Study|Reason not Specified|2|||
161756302|NCT02725268|584146308|FG001|Overall Study|Reason not Specified|1|||
161756303|NCT02725268|584146309|FG002|Overall Study|Reason not Specified|0|||
161756304|NCT02725268|584146310|FG003|Overall Study|Reason not Specified|0|||
161756305|NCT00262314|584146316|FG000|Overall Study|Changing physicians|38|||
161756306|NCT00262314|584146316|FG000|Overall Study|Death|12|||
161756307|NCT00262314|584146316|FG000|Overall Study|Patient's decision|92|||
161756308|NCT00262314|584146316|FG000|Overall Study|Other|95|||
161756309|NCT00262314|584146316|FG000|Overall Study|Lost to Follow-up|70|||
161756310|NCT00262314|584146316|FG000|Overall Study|Administrative withdrawal|30|||
161756311|NCT00117572|584146321|FG000|Overall Study|Site withdrew before starting treatment|2|||
161756312|NCT00117572|584146322|FG001|Overall Study|Site withdrew before starting treatment|3|||
161756313|NCT00117572|584146321|FG000|Overall Study|Withdrawal by Subject|3|||
161756314|NCT00117572|584146322|FG001|Overall Study|Withdrawal by Subject|3|||
161756315|NCT00117572|584146321|FG000|Overall Study|Protocol Violation|1|||
161756316|NCT00117572|584146322|FG001|Overall Study|Protocol Violation|0|||
161756317|NCT04973085|584146323|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
161756318|NCT04973085|584146324|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
161756319|NCT00090766|584146327|FG000|Overall Study|Nephrectomy Planned|0|||
161756320|NCT00090766|584146328|FG001|Overall Study|Nephrectomy Planned|0|||
161756321|NCT00090766|584146329|FG002|Overall Study|Nephrectomy Planned|1|||
161756322|NCT00090766|584146327|FG000|Overall Study|Death|1|||
161756323|NCT00090766|584146328|FG001|Overall Study|Death|0|||
161756324|NCT00090766|584146329|FG002|Overall Study|Death|0|||
161756325|NCT00090766|584146327|FG000|Overall Study|Admin|0|||
161756326|NCT00090766|584146328|FG001|Overall Study|Admin|2|||
161756327|NCT00090766|584146329|FG002|Overall Study|Admin|0|||
161756328|NCT00090766|584146327|FG000|Overall Study|Lost to Follow-up|2|||
161756329|NCT00090766|584146328|FG001|Overall Study|Lost to Follow-up|0|||
161756330|NCT00090766|584146329|FG002|Overall Study|Lost to Follow-up|2|||
161756331|NCT00804986|584146330|FG000|Overall Study|Adverse Event|0|||
161756332|NCT00804986|584146331|FG001|Overall Study|Adverse Event|1|||
161756333|NCT00804986|584146332|FG002|Overall Study|Adverse Event|2|||
161756334|NCT00804986|584146333|FG003|Overall Study|Adverse Event|1|||
161756335|NCT00804986|584146334|FG004|Overall Study|Adverse Event|3|||
161756336|NCT00804986|584146335|FG005|Overall Study|Adverse Event|0|||
161756337|NCT00804986|584146330|FG000|Overall Study|Lack of Efficacy|0|||
161756338|NCT00804986|584146331|FG001|Overall Study|Lack of Efficacy|0|||
161756339|NCT00804986|584146332|FG002|Overall Study|Lack of Efficacy|0|||
161756340|NCT00804986|584146333|FG003|Overall Study|Lack of Efficacy|1|||
161756341|NCT00804986|584146334|FG004|Overall Study|Lack of Efficacy|0|||
161756342|NCT00804986|584146335|FG005|Overall Study|Lack of Efficacy|3|||
161756343|NCT00804986|584146330|FG000|Overall Study|Lost to Follow-up|0|||
161756344|NCT00804986|584146331|FG001|Overall Study|Lost to Follow-up|0|||
161756345|NCT00804986|584146332|FG002|Overall Study|Lost to Follow-up|0|||
161756346|NCT00804986|584146333|FG003|Overall Study|Lost to Follow-up|1|||
161756347|NCT00804986|584146334|FG004|Overall Study|Lost to Follow-up|1|||
161756348|NCT00804986|584146335|FG005|Overall Study|Lost to Follow-up|3|||
161756349|NCT00804986|584146330|FG000|Overall Study|Protocol Violation|0|||
161756350|NCT00804986|584146331|FG001|Overall Study|Protocol Violation|1|||
161756351|NCT00804986|584146332|FG002|Overall Study|Protocol Violation|0|||
161756352|NCT00804986|584146333|FG003|Overall Study|Protocol Violation|1|||
161756353|NCT00804986|584146334|FG004|Overall Study|Protocol Violation|0|||
161756354|NCT00804986|584146335|FG005|Overall Study|Protocol Violation|0|||
161756355|NCT00804986|584146330|FG000|Overall Study|Withdrawal by Subject|0|||
161756356|NCT00804986|584146331|FG001|Overall Study|Withdrawal by Subject|3|||
161756357|NCT00804986|584146332|FG002|Overall Study|Withdrawal by Subject|0|||
161756358|NCT00804986|584146333|FG003|Overall Study|Withdrawal by Subject|3|||
161756359|NCT00804986|584146334|FG004|Overall Study|Withdrawal by Subject|5|||
161756360|NCT00804986|584146335|FG005|Overall Study|Withdrawal by Subject|3|||
161756361|NCT00804986|584146330|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161756362|NCT00804986|584146331|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
161756363|NCT00804986|584146332|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
161756364|NCT00804986|584146333|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
161756365|NCT00804986|584146334|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
161756366|NCT00804986|584146335|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
161845624|NCT04228783|584477043|FG003|Overall Study|Withdrawal by Subject|1|||
161756367|NCT00804986|584146330|FG000|Overall Study|Sponsor Decision|0|||
161756368|NCT00804986|584146331|FG001|Overall Study|Sponsor Decision|1|||
161756369|NCT00804986|584146332|FG002|Overall Study|Sponsor Decision|0|||
161756370|NCT00804986|584146333|FG003|Overall Study|Sponsor Decision|0|||
161756371|NCT00804986|584146334|FG004|Overall Study|Sponsor Decision|0|||
161756372|NCT00804986|584146335|FG005|Overall Study|Sponsor Decision|0|||
161756373|NCT00804986|584146330|FG000|Overall Study|Physician Decision|1|||
161756374|NCT00804986|584146331|FG001|Overall Study|Physician Decision|0|||
161756375|NCT00804986|584146332|FG002|Overall Study|Physician Decision|0|||
161756376|NCT00804986|584146333|FG003|Overall Study|Physician Decision|0|||
161756377|NCT00804986|584146334|FG004|Overall Study|Physician Decision|0|||
161756378|NCT00804986|584146335|FG005|Overall Study|Physician Decision|0|||
161756379|NCT04035473|584146341|FG000|Screening/Baseline|Death|0|||
161756380|NCT04035473|584146342|FG001|Screening/Baseline|Death|1|||
161756381|NCT04035473|584146341|FG000|Screening/Baseline|Adverse Event|0|||
161756382|NCT04035473|584146342|FG001|Screening/Baseline|Adverse Event|1|||
161845625|NCT04228783|584477044|FG004|Overall Study|Withdrawal by Subject|2|||
161756383|NCT04035473|584146341|FG000|Follow-up Period|Adverse Event|2|||
161756384|NCT04035473|584146342|FG001|Follow-up Period|Adverse Event|0|||
161756385|NCT00796224|584146343|FG000|Overall Study|Adverse Event|1|||
161756386|NCT00796224|584146344|FG001|Overall Study|Adverse Event|0|||
161756387|NCT00796224|584146343|FG000|Overall Study|Protocol Violation|0|||
161756388|NCT00796224|584146344|FG001|Overall Study|Protocol Violation|1|||
161756389|NCT03763942|584147847|FG000|Overall Study|Lost to Follow-up|114|||
161756390|NCT03763942|584147848|FG001|Overall Study|Lost to Follow-up|54|||
161756391|NCT03763942|584147847|FG000|Overall Study|Protocol Violation|1|||
161756392|NCT03763942|584147848|FG001|Overall Study|Protocol Violation|0|||
161756393|NCT03763942|584147847|FG000|Overall Study|Withdrawal by Subject|2|||
161756394|NCT03763942|584147848|FG001|Overall Study|Withdrawal by Subject|0|||
161756395|NCT03763942|584147847|FG000|Overall Study|Other|2|||
161756396|NCT03763942|584147848|FG001|Overall Study|Other|3|||
161756397|NCT02200510|584147849|FG000|Overall Study|Death|1|||
161756398|NCT02200510|584147850|FG001|Overall Study|Death|1|||
161756399|NCT02200510|584147849|FG000|Overall Study|Protocol Violation|0|||
161756400|NCT02200510|584147850|FG001|Overall Study|Protocol Violation|1|||
161756401|NCT02200510|584147849|FG000|Overall Study|Lost to Follow-up|7|||
161756402|NCT02200510|584147850|FG001|Overall Study|Lost to Follow-up|1|||
161756403|NCT02200510|584147849|FG000|Overall Study|potential COI - joined study team|1|||
161756404|NCT02200510|584147850|FG001|Overall Study|potential COI - joined study team|0|||
161756405|NCT04284787|584147856|FG000|Overall Study|Disease Progression|9|||
161756406|NCT04284787|584147857|FG001|Overall Study|Disease Progression|12|||
161756407|NCT04284787|584147856|FG000|Overall Study|Physician Decision|12|||
161756408|NCT04284787|584147857|FG001|Overall Study|Physician Decision|7|||
161756409|NCT04284787|584147856|FG000|Overall Study|Transplant|5|||
161756410|NCT04284787|584147857|FG001|Overall Study|Transplant|4|||
161756411|NCT04284787|584147856|FG000|Overall Study|Death|1|||
161756412|NCT04284787|584147857|FG001|Overall Study|Death|2|||
161756413|NCT04284787|584147856|FG000|Overall Study|Adverse Event|0|||
161756414|NCT04284787|584147857|FG001|Overall Study|Adverse Event|4|||
161756415|NCT04284787|584147856|FG000|Overall Study|Non-adherence|2|||
161756416|NCT04284787|584147857|FG001|Overall Study|Non-adherence|0|||
161756417|NCT04284787|584147856|FG000|Overall Study|Lack of Efficacy|2|||
161756418|NCT04284787|584147857|FG001|Overall Study|Lack of Efficacy|0|||
161756419|NCT01874353|584147858|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
161756420|NCT01874353|584147859|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161756421|NCT01874353|584147860|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161756422|NCT01874353|584147861|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161756423|NCT01874353|584147858|FG000|Overall Study|Lost to Follow-up|2|||
161756424|NCT01874353|584147859|FG001|Overall Study|Lost to Follow-up|2|||
161756425|NCT01874353|584147860|FG002|Overall Study|Lost to Follow-up|2|||
161756426|NCT01874353|584147861|FG003|Overall Study|Lost to Follow-up|0|||
161756427|NCT01874353|584147858|FG000|Overall Study|Death|110|||
161756428|NCT01874353|584147859|FG001|Overall Study|Death|60|||
161756429|NCT01874353|584147860|FG002|Overall Study|Death|13|||
161756430|NCT01874353|584147861|FG003|Overall Study|Death|7|||
161756431|NCT01874353|584147858|FG000|Overall Study|Withdrawal by Subject|13|||
161756432|NCT01874353|584147859|FG001|Overall Study|Withdrawal by Subject|11|||
161756433|NCT01874353|584147860|FG002|Overall Study|Withdrawal by Subject|0|||
161756434|NCT01874353|584147861|FG003|Overall Study|Withdrawal by Subject|0|||
161756435|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
161756436|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
161756437|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Death|1|||
161756438|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Death|1|||
161756439|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
161756440|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
161756441|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
161756442|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
161756443|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
161756444|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
161756445|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
161845626|NCT04228783|584477045|FG005|Overall Study|Withdrawal by Subject|0|||
161845627|NCT04228783|584477040|FG000|Overall Study|Other|4|||
161756446|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
161756447|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
161845628|NCT04228783|584477041|FG001|Overall Study|Other|3|||
161756448|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
161756449|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
161756450|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
161756451|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
161756452|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
161756453|NCT03728881|584147862|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
161756454|NCT03728881|584147863|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
161756455|NCT03728881|584147862|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
161756456|NCT03728881|584147863|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
161756457|NCT04651777|584147864|FG000|Overall Study|Adverse Event|1|||
161756458|NCT04651777|584147864|FG000|Overall Study|Withdrawal by Subject|2|||
161756459|NCT05505734|584147865|FG000|Overall Study|Withdrawal by Subject|51|||
161756460|NCT05505734|584147866|FG001|Overall Study|Withdrawal by Subject|64|||
161756461|NCT05505734|584147865|FG000|Overall Study|Adverse Event|6|||
161756462|NCT05505734|584147866|FG001|Overall Study|Adverse Event|20|||
161756463|NCT05505734|584147865|FG000|Overall Study|Protocol Violation|8|||
161756464|NCT05505734|584147866|FG001|Overall Study|Protocol Violation|15|||
161756465|NCT05505734|584147865|FG000|Overall Study|Lack of therapeutic response|0|||
161756466|NCT05505734|584147866|FG001|Overall Study|Lack of therapeutic response|1|||
161756467|NCT05505734|584147865|FG000|Overall Study|Lost to Follow-up|247|||
161756468|NCT05505734|584147866|FG001|Overall Study|Lost to Follow-up|237|||
161756469|NCT05505734|584147865|FG000|Overall Study|Physician Decision|22|||
161756470|NCT05505734|584147866|FG001|Overall Study|Physician Decision|13|||
161756471|NCT05505734|584147865|FG000|Overall Study|Death|2|||
161756472|NCT05505734|584147866|FG001|Overall Study|Death|1|||
161756473|NCT05505734|584147865|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161756474|NCT05505734|584147866|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161756475|NCT05505734|584147865|FG000|Overall Study|Pregnancy|1|||
161756476|NCT05505734|584147866|FG001|Overall Study|Pregnancy|0|||
161756477|NCT05505734|584147865|FG000|Overall Study|Other|17|||
161756478|NCT05505734|584147866|FG001|Overall Study|Other|13|||
161756479|NCT03575351|584147867|FG000|Overall Study|Adverse Event|1|||
161756480|NCT03575351|584147868|FG001|Overall Study|Adverse Event|0|||
161756481|NCT03575351|584147867|FG000|Overall Study|Death|2|||
161756482|NCT03575351|584147868|FG001|Overall Study|Death|2|||
161756483|NCT03575351|584147867|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
161756484|NCT03575351|584147868|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
161756485|NCT03575351|584147867|FG000|Overall Study|Lack of Efficacy|28|||
161756486|NCT03575351|584147868|FG001|Overall Study|Lack of Efficacy|0|||
161756487|NCT03575351|584147867|FG000|Overall Study|Withdrawal by Subject|1|||
161756488|NCT03575351|584147868|FG001|Overall Study|Withdrawal by Subject|1|||
161756489|NCT03575351|584147867|FG000|Overall Study|Physician Decision|3|||
161756490|NCT03575351|584147868|FG001|Overall Study|Physician Decision|0|||
161756491|NCT03575351|584147867|FG000|Overall Study|Disease relapse|15|||
161756492|NCT03575351|584147868|FG001|Overall Study|Disease relapse|6|||
161756493|NCT03575351|584147867|FG000|Overall Study|Study drug manufacturing failure|0|||
161756494|NCT03575351|584147868|FG001|Overall Study|Study drug manufacturing failure|1|||
161756495|NCT03575351|584147867|FG000|Overall Study|other reasons|5|||
161756496|NCT03575351|584147868|FG001|Overall Study|other reasons|0|||
161756497|NCT04288089|584147869|FG000|Overall Study|Ongoing Treatment|2|||
161756498|NCT04288089|584147870|FG001|Overall Study|Ongoing Treatment|1|||
161756499|NCT04288089|584147871|FG002|Overall Study|Ongoing Treatment|1|||
161756500|NCT04288089|584147872|FG003|Overall Study|Ongoing Treatment|4|||
161756501|NCT03715205|584147873|FG000|Overall Study|Death|13|||
161756502|NCT03715205|584147873|FG000|Overall Study|Lost to Follow-up|2|||
161756503|NCT03715205|584147873|FG000|Overall Study|Physician Decision|93|||
161756504|NCT03715205|584147873|FG000|Overall Study|Withdrawal by Subject|26|||
161756505|NCT00355615|584147879|FG000|Randomized Double Blind Period|Adverse Event|1|||
161756506|NCT00355615|584147880|FG001|Randomized Double Blind Period|Adverse Event|0|||
161756507|NCT00355615|584147881|FG002|Randomized Double Blind Period|Adverse Event|0|||
161756508|NCT00355615|584147882|FG003|Randomized Double Blind Period|Adverse Event|0|||
161756509|NCT00355615|584147883|FG004|Randomized Double Blind Period|Adverse Event|0|||
161756510|NCT00355615|584147879|FG000|Randomized Double Blind Period|Protocol Violation|0|||
161756511|NCT00355615|584147880|FG001|Randomized Double Blind Period|Protocol Violation|0|||
161756512|NCT00355615|584147881|FG002|Randomized Double Blind Period|Protocol Violation|1|||
161845629|NCT04228783|584477042|FG002|Overall Study|Other|2|||
161845630|NCT04228783|584477043|FG003|Overall Study|Other|1|||
161845631|NCT04228783|584477044|FG004|Overall Study|Other|0|||
161756513|NCT00355615|584147882|FG003|Randomized Double Blind Period|Protocol Violation|1|||
161756514|NCT00355615|584147883|FG004|Randomized Double Blind Period|Protocol Violation|0|||
161756515|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756516|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756517|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756518|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756519|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
161756520|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756521|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756522|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756523|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756524|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
161756525|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756526|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756527|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756528|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756529|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
161756530|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756531|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756532|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756533|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756534|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
161756535|NCT04259346|584147884|FG000|Overall Study|Lost to Follow-up|1|||
161756536|NCT04259346|584147885|FG001|Overall Study|Lost to Follow-up|3|||
161756537|NCT04259346|584147884|FG000|Overall Study|Protocol Violation|1|||
161756538|NCT04259346|584147885|FG001|Overall Study|Protocol Violation|0|||
161756539|NCT04259346|584147884|FG000|Overall Study|Withdrawal by Subject|1|||
161756540|NCT04259346|584147885|FG001|Overall Study|Withdrawal by Subject|0|||
161756541|NCT04259346|584147884|FG000|Overall Study|Adverse Event|1|||
161756542|NCT04259346|584147885|FG001|Overall Study|Adverse Event|1|||
161756543|NCT00085644|584147886|FG000|Double-Blind Period|Adverse Event|5|||
161756544|NCT00085644|584147887|FG001|Double-Blind Period|Adverse Event|2|||
161756545|NCT00085644|584147888|FG002|Double-Blind Period|Adverse Event|0|||
161756546|NCT00085644|584147886|FG000|Double-Blind Period|Withdrawal by Subject|3|||
161756547|NCT00085644|584147887|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161756548|NCT00085644|584147888|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161756549|NCT00085644|584147886|FG000|Double-Blind Period|Lost to Follow-up|2|||
161756550|NCT00085644|584147887|FG001|Double-Blind Period|Lost to Follow-up|1|||
161756551|NCT00085644|584147888|FG002|Double-Blind Period|Lost to Follow-up|0|||
161756552|NCT00085644|584147886|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
161756553|NCT00085644|584147887|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
161756554|NCT00085644|584147888|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
161756555|NCT00085644|584147886|FG000|Double-Blind Period|Contemplating pregnancy|1|||
161756556|NCT00085644|584147887|FG001|Double-Blind Period|Contemplating pregnancy|0|||
161756557|NCT00085644|584147888|FG002|Double-Blind Period|Contemplating pregnancy|0|||
161756558|NCT00085644|584147886|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
161756559|NCT00085644|584147887|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
161756560|NCT00085644|584147888|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
161756561|NCT00085644|584147886|FG000|Open-Label Period|Adverse Event|0|||
161756562|NCT00085644|584147887|FG001|Open-Label Period|Adverse Event|0|||
161756563|NCT00085644|584147888|FG002|Open-Label Period|Adverse Event|38|||
161756564|NCT00085644|584147886|FG000|Open-Label Period|Withdrawal by Subject|0|||
161756565|NCT00085644|584147887|FG001|Open-Label Period|Withdrawal by Subject|0|||
161756566|NCT00085644|584147888|FG002|Open-Label Period|Withdrawal by Subject|29|||
161756567|NCT00085644|584147886|FG000|Open-Label Period|Lost to Follow-up|0|||
161845632|NCT04228783|584477045|FG005|Overall Study|Other|0|||
161845633|NCT00626392|584477046|FG000|Run-in Period|Adverse Event|0|||
161845634|NCT00626392|584477047|FG001|Run-in Period|Adverse Event|0|||
161756568|NCT00085644|584147887|FG001|Open-Label Period|Lost to Follow-up|0|||
161756569|NCT00085644|584147888|FG002|Open-Label Period|Lost to Follow-up|13|||
161756570|NCT00085644|584147886|FG000|Open-Label Period|Lack of Efficacy|0|||
161756571|NCT00085644|584147887|FG001|Open-Label Period|Lack of Efficacy|0|||
161756572|NCT00085644|584147888|FG002|Open-Label Period|Lack of Efficacy|15|||
161756573|NCT00085644|584147886|FG000|Open-Label Period|Pregnancy|0|||
161756574|NCT00085644|584147887|FG001|Open-Label Period|Pregnancy|0|||
161756575|NCT00085644|584147888|FG002|Open-Label Period|Pregnancy|3|||
161756576|NCT00085644|584147886|FG000|Open-Label Period|Contemplating pregnancy|0|||
161756577|NCT00085644|584147887|FG001|Open-Label Period|Contemplating pregnancy|0|||
161756578|NCT00085644|584147888|FG002|Open-Label Period|Contemplating pregnancy|3|||
161756579|NCT00085644|584147886|FG000|Open-Label Period|Protocol Violation|0|||
161756580|NCT00085644|584147887|FG001|Open-Label Period|Protocol Violation|0|||
161756581|NCT00085644|584147888|FG002|Open-Label Period|Protocol Violation|4|||
161756582|NCT00085644|584147886|FG000|Open-Label Period|Personal reason|0|||
161756583|NCT00085644|584147887|FG001|Open-Label Period|Personal reason|0|||
161756584|NCT00085644|584147888|FG002|Open-Label Period|Personal reason|4|||
161756585|NCT03330106|584147896|FG000|Part A|Withdrawal by Subject|1|||
161756586|NCT03330106|584147897|FG001|Part A|Withdrawal by Subject|1|||
161756587|NCT03330106|584147898|FG002|Part A|Withdrawal by Subject|0|||
161756588|NCT03330106|584147899|FG003|Part A|Withdrawal by Subject|0|||
161756589|NCT03330106|584147896|FG000|Part A|Death|2|||
161756590|NCT03330106|584147897|FG001|Part A|Death|1|||
161756591|NCT03330106|584147898|FG002|Part A|Death|0|||
161756592|NCT03330106|584147899|FG003|Part A|Death|0|||
161756593|NCT03330106|584147896|FG000|Part A|Adverse Event|0|||
161756594|NCT03330106|584147897|FG001|Part A|Adverse Event|1|||
161845635|NCT00626392|584477048|FG002|Run-in Period|Adverse Event|1|||
161845636|NCT00626392|584477049|FG003|Run-in Period|Adverse Event|0|||
161845637|NCT00626392|584477050|FG004|Run-in Period|Adverse Event|1|||
161845638|NCT00626392|584477051|FG005|Run-in Period|Adverse Event|0|||
161845639|NCT00626392|584477046|FG000|Run-in Period|Withdrawal by Subject|0|||
161845640|NCT00626392|584477047|FG001|Run-in Period|Withdrawal by Subject|1|||
161845641|NCT00626392|584477048|FG002|Run-in Period|Withdrawal by Subject|1|||
161845642|NCT00626392|584477049|FG003|Run-in Period|Withdrawal by Subject|1|||
161845643|NCT00626392|584477050|FG004|Run-in Period|Withdrawal by Subject|3|||
161845644|NCT00626392|584477051|FG005|Run-in Period|Withdrawal by Subject|1|||
161845645|NCT00626392|584477046|FG000|Run-in Period|Noncompliance|1|||
161845646|NCT00626392|584477047|FG001|Run-in Period|Noncompliance|0|||
161845647|NCT00626392|584477048|FG002|Run-in Period|Noncompliance|1|||
161845648|NCT00626392|584477049|FG003|Run-in Period|Noncompliance|0|||
161845649|NCT00626392|584477050|FG004|Run-in Period|Noncompliance|0|||
161845650|NCT00626392|584477051|FG005|Run-in Period|Noncompliance|0|||
161845651|NCT00626392|584477046|FG000|Coadministration Period|Adverse Event|3|||
161845652|NCT00626392|584477047|FG001|Coadministration Period|Adverse Event|1|||
161845653|NCT00626392|584477048|FG002|Coadministration Period|Adverse Event|7|||
161845654|NCT00626392|584477049|FG003|Coadministration Period|Adverse Event|4|||
161845655|NCT00626392|584477050|FG004|Coadministration Period|Adverse Event|3|||
161845656|NCT00626392|584477051|FG005|Coadministration Period|Adverse Event|4|||
161845657|NCT00626392|584477046|FG000|Coadministration Period|Withdrawal by Subject|1|||
161845658|NCT00626392|584477047|FG001|Coadministration Period|Withdrawal by Subject|1|||
161845659|NCT00626392|584477048|FG002|Coadministration Period|Withdrawal by Subject|0|||
161845660|NCT00626392|584477049|FG003|Coadministration Period|Withdrawal by Subject|1|||
161845661|NCT00626392|584477050|FG004|Coadministration Period|Withdrawal by Subject|0|||
161845662|NCT00626392|584477051|FG005|Coadministration Period|Withdrawal by Subject|1|||
161845663|NCT00626392|584477046|FG000|Coadministration Period|Protocol Violation|0|||
161845664|NCT00626392|584477047|FG001|Coadministration Period|Protocol Violation|1|||
161845665|NCT00626392|584477048|FG002|Coadministration Period|Protocol Violation|0|||
161845666|NCT00626392|584477049|FG003|Coadministration Period|Protocol Violation|1|||
161845667|NCT00626392|584477050|FG004|Coadministration Period|Protocol Violation|1|||
161845668|NCT00626392|584477051|FG005|Coadministration Period|Protocol Violation|0|||
161845669|NCT00626392|584477046|FG000|Coadministration Period|Other|0|||
161845670|NCT00626392|584477047|FG001|Coadministration Period|Other|2|||
161756595|NCT03330106|584147898|FG002|Part A|Adverse Event|0|||
161756596|NCT03330106|584147899|FG003|Part A|Adverse Event|0|||
161756597|NCT03330106|584147896|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161756598|NCT03330106|584147897|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
161756599|NCT03330106|584147898|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161845671|NCT00626392|584477048|FG002|Coadministration Period|Other|3|||
161845672|NCT00626392|584477049|FG003|Coadministration Period|Other|1|||
161845673|NCT00626392|584477050|FG004|Coadministration Period|Other|1|||
161845674|NCT00626392|584477051|FG005|Coadministration Period|Other|1|||
161845675|NCT03327792|584477052|FG000|Overall Study|Adverse Event|4|||
161845676|NCT03327792|584477053|FG001|Overall Study|Adverse Event|0|||
161756600|NCT03330106|584147899|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161756601|NCT03330106|584147896|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
161756602|NCT03330106|584147897|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161756603|NCT03330106|584147898|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161756604|NCT03330106|584147899|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161756605|NCT03330106|584147896|FG000|Part A|Progressive Disease|0|||
161756606|NCT03330106|584147897|FG001|Part A|Progressive Disease|1|||
161756607|NCT03330106|584147898|FG002|Part A|Progressive Disease|0|||
161756608|NCT03330106|584147899|FG003|Part A|Progressive Disease|0|||
161756609|NCT03330106|584147896|FG000|Part B|Lost to Follow-up|0|||
161756610|NCT03330106|584147897|FG001|Part B|Lost to Follow-up|0|||
161756611|NCT03330106|584147898|FG002|Part B|Lost to Follow-up|0|||
161756612|NCT03330106|584147899|FG003|Part B|Lost to Follow-up|1|||
161756613|NCT03330106|584147896|FG000|Part B|Withdrawal by Subject|0|||
161756614|NCT03330106|584147897|FG001|Part B|Withdrawal by Subject|0|||
161756615|NCT03330106|584147898|FG002|Part B|Withdrawal by Subject|4|||
161756616|NCT03330106|584147899|FG003|Part B|Withdrawal by Subject|0|||
161756617|NCT03330106|584147896|FG000|Part B|Death|0|||
161756618|NCT03330106|584147897|FG001|Part B|Death|0|||
161756619|NCT03330106|584147898|FG002|Part B|Death|2|||
161756620|NCT03330106|584147899|FG003|Part B|Death|0|||
161756621|NCT03330106|584147896|FG000|Part B|Clinical Progression|0|||
161756622|NCT03330106|584147897|FG001|Part B|Clinical Progression|0|||
161756623|NCT03330106|584147898|FG002|Part B|Clinical Progression|1|||
161756624|NCT03330106|584147899|FG003|Part B|Clinical Progression|1|||
161756625|NCT03330106|584147896|FG000|Part B|Symptomatic Deterioration|0|||
161756626|NCT03330106|584147897|FG001|Part B|Symptomatic Deterioration|0|||
161756627|NCT03330106|584147898|FG002|Part B|Symptomatic Deterioration|0|||
161756628|NCT03330106|584147899|FG003|Part B|Symptomatic Deterioration|1|||
161756629|NCT03330106|584147896|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161756630|NCT03330106|584147897|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161756631|NCT03330106|584147898|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161756632|NCT03330106|584147899|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
161756633|NCT03330106|584147896|FG000|Part B|Progressive Disease|0|||
161756634|NCT03330106|584147897|FG001|Part B|Progressive Disease|0|||
161756635|NCT03330106|584147898|FG002|Part B|Progressive Disease|11|||
161756636|NCT03330106|584147899|FG003|Part B|Progressive Disease|4|||
161756637|NCT00486889|584147902|FG000|Overall Study|Death|3|||
161756638|NCT00486889|584147902|FG000|Overall Study|Non-compliant|2|||
161756639|NCT00486889|584147902|FG000|Overall Study|Withdrawal by Subject|6|||
161756640|NCT02750501|584147903|FG000|Overall Study|Adverse Event|4|||
161756641|NCT02750501|584147903|FG000|Overall Study|Physician Decision|1|||
161756642|NCT02750501|584147903|FG000|Overall Study|Protocol Violation|1|||
161756643|NCT02750501|584147903|FG000|Overall Study|G-tube came out|1|||
161756644|NCT02750501|584147903|FG000|Overall Study|Non-compliant use of PERT|1|||
161756645|NCT00893763|584147904|FG000|Overall Study|extubated|110|||
161756646|NCT00893763|584147905|FG001|Overall Study|extubated|110|||
161756647|NCT01738594|584147906|FG000|Registration and Treatment Start|Adverse Event|0|||
161756648|NCT01738594|584147907|FG001|Registration and Treatment Start|Adverse Event|1|||
161756649|NCT01738594|584147908|FG002|Registration and Treatment Start|Adverse Event|0|||
161756650|NCT01738594|584147909|FG003|Registration and Treatment Start|Adverse Event|0|||
161756651|NCT01738594|584147910|FG004|Registration and Treatment Start|Adverse Event|0|||
161756652|NCT01738594|584147911|FG005|Registration and Treatment Start|Adverse Event|0|||
161756653|NCT01738594|584147912|FG006|Registration and Treatment Start|Adverse Event|0|||
161756654|NCT01738594|584147913|FG007|Registration and Treatment Start|Adverse Event|0|||
161756655|NCT01738594|584147906|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756656|NCT01738594|584147907|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161845677|NCT03327792|584477052|FG000|Overall Study|Family/Personal issues|3|||
161845678|NCT03327792|584477053|FG001|Overall Study|Family/Personal issues|2|||
161845679|NCT03327792|584477052|FG000|Overall Study|Lost to Follow-up|0|||
161845680|NCT03327792|584477053|FG001|Overall Study|Lost to Follow-up|1|||
161845681|NCT04576923|584477054|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
161845682|NCT03151811|584477058|FG000|Overall Study|Randomized But Not Treated|18|||
161845683|NCT03151811|584477059|FG001|Overall Study|Randomized But Not Treated|3|||
161845684|NCT03151811|584477058|FG000|Overall Study|Progressive Disease|130|||
161845685|NCT03151811|584477059|FG001|Overall Study|Progressive Disease|170|||
161845686|NCT03151811|584477058|FG000|Overall Study|Adverse Event|49|||
161845687|NCT03151811|584477059|FG001|Overall Study|Adverse Event|40|||
161845688|NCT03151811|584477058|FG000|Overall Study|Lack of Efficacy|6|||
161845689|NCT03151811|584477059|FG001|Overall Study|Lack of Efficacy|8|||
161845690|NCT03151811|584477058|FG000|Overall Study|Physician Decision|21|||
161845691|NCT03151811|584477059|FG001|Overall Study|Physician Decision|9|||
161845692|NCT03151811|584477058|FG000|Overall Study|Withdrawal by Subject|17|||
161845693|NCT03151811|584477059|FG001|Overall Study|Withdrawal by Subject|7|||
161845694|NCT03151811|584477058|FG000|Overall Study|Lost to Follow-up|0|||
161845695|NCT03151811|584477059|FG001|Overall Study|Lost to Follow-up|1|||
161845696|NCT03151811|584477058|FG000|Overall Study|Study Terminated by Sponsor|5|||
161845697|NCT03151811|584477059|FG001|Overall Study|Study Terminated by Sponsor|11|||
161845698|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
161845699|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
161845700|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
161845701|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
161845702|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
161845703|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
161845704|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
161845705|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
161845706|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
161845707|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
161845708|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Death|1|||
161845709|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Death|0|||
161845710|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Death|0|||
161845711|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Death|0|||
161845712|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Death|0|||
161845713|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161845714|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161845715|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
161845716|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161845717|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161845718|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
161845719|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
161845720|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161845721|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
161845722|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
161845723|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
161845724|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161845725|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
161845726|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161845727|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
161845728|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
161845729|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
161845730|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
161845731|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
161845732|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161845733|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161845734|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845735|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845736|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845737|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845738|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Other|4|||
161845739|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Other|4|||
161845740|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Other|3|||
161845741|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Other|1|||
161756657|NCT01738594|584147908|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756658|NCT01738594|584147909|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756659|NCT01738594|584147910|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756660|NCT01738594|584147911|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
161756661|NCT01738594|584147912|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756662|NCT01738594|584147913|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756663|NCT01738594|584147906|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756664|NCT01738594|584147907|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
161756665|NCT01738594|584147908|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756666|NCT01738594|584147909|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756667|NCT01738594|584147910|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756668|NCT01738594|584147911|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756669|NCT01738594|584147912|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756670|NCT01738594|584147913|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756671|NCT01738594|584147906|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756672|NCT01738594|584147907|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756673|NCT01738594|584147908|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756674|NCT01738594|584147909|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756675|NCT01738594|584147910|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756676|NCT01738594|584147911|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
161756677|NCT01738594|584147912|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756678|NCT01738594|584147913|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756679|NCT01738594|584147906|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756680|NCT01738594|584147907|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756681|NCT01738594|584147908|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756682|NCT01738594|584147909|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756683|NCT01738594|584147910|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756684|NCT01738594|584147911|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
161756685|NCT01738594|584147912|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756686|NCT01738594|584147913|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756687|NCT01738594|584147906|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756688|NCT01738594|584147907|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756689|NCT01738594|584147908|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756690|NCT01738594|584147909|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756691|NCT01738594|584147910|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
161756692|NCT01738594|584147911|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756693|NCT01738594|584147912|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756694|NCT01738594|584147913|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756695|NCT01738594|584147906|FG000|Follow up for 1 Year|Death|0|||
161756696|NCT01738594|584147907|FG001|Follow up for 1 Year|Death|0|||
161756697|NCT01738594|584147908|FG002|Follow up for 1 Year|Death|0|||
161756698|NCT01738594|584147909|FG003|Follow up for 1 Year|Death|0|||
161756699|NCT01738594|584147910|FG004|Follow up for 1 Year|Death|0|||
161756700|NCT01738594|584147911|FG005|Follow up for 1 Year|Death|1|||
161756701|NCT01738594|584147912|FG006|Follow up for 1 Year|Death|0|||
161756702|NCT01738594|584147913|FG007|Follow up for 1 Year|Death|0|||
161756703|NCT01738594|584147906|FG000|Follow up for 1 Year|Other|0|||
161756704|NCT01738594|584147907|FG001|Follow up for 1 Year|Other|0|||
161756705|NCT01738594|584147908|FG002|Follow up for 1 Year|Other|0|||
161756706|NCT01738594|584147909|FG003|Follow up for 1 Year|Other|0|||
161756707|NCT01738594|584147910|FG004|Follow up for 1 Year|Other|0|||
161756708|NCT01738594|584147911|FG005|Follow up for 1 Year|Other|2|||
161756709|NCT01738594|584147912|FG006|Follow up for 1 Year|Other|0|||
161756710|NCT01738594|584147913|FG007|Follow up for 1 Year|Other|0|||
161756711|NCT04430036|584147914|FG000|Safety Run in Phase|Progression of disease|2|||
161756712|NCT04107935|584147915|FG000|Overall Study|Death|1|||
161756713|NCT04107935|584147916|FG001|Overall Study|Death|0|||
161756714|NCT01842334|584147917|FG000|Overall Study|Withdrawal by Subject|3|||
161756715|NCT01842334|584147918|FG001|Overall Study|Withdrawal by Subject|3|||
161756716|NCT01842334|584147917|FG000|Overall Study|Moved away mid-study|0|||
161756717|NCT01842334|584147918|FG001|Overall Study|Moved away mid-study|1|||
161756718|NCT00376675|584147919|FG000|Overall Study|Withdrawal by Subject|9|||
161756719|NCT00376675|584147920|FG001|Overall Study|Withdrawal by Subject|2|||
161756720|NCT00376675|584147919|FG000|Overall Study|Adverse Event|10|||
161756721|NCT00376675|584147920|FG001|Overall Study|Adverse Event|5|||
161756722|NCT00376675|584147919|FG000|Overall Study|Other Reason|1|||
161756723|NCT00376675|584147920|FG001|Overall Study|Other Reason|7|||
161756724|NCT01332851|584147923|FG000|Overall Study|Withdrawal by Subject|4|||
161756725|NCT01332851|584147924|FG001|Overall Study|Withdrawal by Subject|2|||
161756726|NCT01332851|584147923|FG000|Overall Study|Lost to Follow-up|7|||
161756727|NCT01332851|584147924|FG001|Overall Study|Lost to Follow-up|11|||
161756728|NCT00422903|584147925|FG000|Overall Study|Disease Progression|3|||
161756729|NCT00422903|584147926|FG001|Overall Study|Disease Progression|1|||
161756730|NCT00422903|584147925|FG000|Overall Study|Adverse Event|0|||
161756731|NCT00422903|584147926|FG001|Overall Study|Adverse Event|2|||
161756732|NCT00422903|584147925|FG000|Overall Study|Informed Consent Withdrawn|1|||
161756733|NCT00422903|584147926|FG001|Overall Study|Informed Consent Withdrawn|2|||
161756734|NCT03446612|584147927|FG000|Overall Study|Protocol defined stopping criteria|0|||
161756735|NCT03446612|584147928|FG001|Overall Study|Protocol defined stopping criteria|1|||
161756736|NCT01678560|584147935|FG000|Overall Study|Physician Decision|4|||
161756737|NCT01678560|584147936|FG001|Overall Study|Physician Decision|4|||
161756738|NCT01678560|584147935|FG000|Overall Study|Death|0|||
161756739|NCT01678560|584147936|FG001|Overall Study|Death|1|||
161756740|NCT01678560|584147935|FG000|Overall Study|Withdrawal by Subject|0|||
161756741|NCT01678560|584147936|FG001|Overall Study|Withdrawal by Subject|1|||
161756742|NCT02201472|584147937|FG000|Overall Study|Lack of Efficacy|2|||
161756743|NCT01300767|584147938|FG000|Overall Study|Discomfort|2|||
161756744|NCT01300767|584147938|FG000|Overall Study|Biomicroscopy|1|||
161756745|NCT01300767|584147938|FG000|Overall Study|Unacceptable fit|1|||
161756746|NCT01188811|584147943|FG000|Overall Study|Withdrawal by Subject|0|||
161756747|NCT01188811|584147944|FG001|Overall Study|Withdrawal by Subject|2|||
161756748|NCT01188811|584147943|FG000|Overall Study|Adverse Event|6|||
161756749|NCT01188811|584147944|FG001|Overall Study|Adverse Event|0|||
161756750|NCT00654368|584147945|FG000|Overall Study|Ineligibility determined|6|||
161756751|NCT00654368|584147946|FG001|Overall Study|Ineligibility determined|0|||
161756752|NCT00654368|584147947|FG002|Overall Study|Ineligibility determined|0|||
161756753|NCT00654368|584147945|FG000|Overall Study|Protocol deviation|3|||
161756754|NCT00654368|584147946|FG001|Overall Study|Protocol deviation|2|||
161756755|NCT00654368|584147947|FG002|Overall Study|Protocol deviation|1|||
161756756|NCT00654368|584147945|FG000|Overall Study|Non-compliance|2|||
161756757|NCT00654368|584147946|FG001|Overall Study|Non-compliance|1|||
161756758|NCT00654368|584147947|FG002|Overall Study|Non-compliance|2|||
161756759|NCT00654368|584147945|FG000|Overall Study|Withdrawal by Subject|5|||
161756760|NCT00654368|584147946|FG001|Overall Study|Withdrawal by Subject|2|||
161756761|NCT00654368|584147947|FG002|Overall Study|Withdrawal by Subject|2|||
161756762|NCT00654368|584147945|FG000|Overall Study|Disease progression|21|||
161756763|NCT00654368|584147946|FG001|Overall Study|Disease progression|31|||
161756764|NCT00654368|584147947|FG002|Overall Study|Disease progression|13|||
161756765|NCT00654368|584147945|FG000|Overall Study|Requirement for alternative therapy|1|||
161756766|NCT00654368|584147946|FG001|Overall Study|Requirement for alternative therapy|1|||
161756767|NCT00654368|584147947|FG002|Overall Study|Requirement for alternative therapy|1|||
161756768|NCT00654368|584147945|FG000|Overall Study|Physician Decision|0|||
161756769|NCT00654368|584147946|FG001|Overall Study|Physician Decision|0|||
161756770|NCT00654368|584147947|FG002|Overall Study|Physician Decision|2|||
161756771|NCT00654368|584147945|FG000|Overall Study|Death|1|||
161756772|NCT00654368|584147946|FG001|Overall Study|Death|0|||
161756773|NCT00654368|584147947|FG002|Overall Study|Death|0|||
161756774|NCT00654368|584147945|FG000|Overall Study|Pregnancy|0|||
161756775|NCT00654368|584147946|FG001|Overall Study|Pregnancy|0|||
161756776|NCT00654368|584147947|FG002|Overall Study|Pregnancy|2|||
161756777|NCT00654368|584147945|FG000|Overall Study|Other|0|||
161756778|NCT00654368|584147946|FG001|Overall Study|Other|2|||
161756779|NCT00654368|584147947|FG002|Overall Study|Other|3|||
161756780|NCT00654368|584147945|FG000|Overall Study|Adverse Event|14|||
161756781|NCT00654368|584147946|FG001|Overall Study|Adverse Event|9|||
161756782|NCT00654368|584147947|FG002|Overall Study|Adverse Event|6|||
161756783|NCT01602744|584147948|FG000|Overall Study|Death|17|||
161756784|NCT01602744|584147949|FG001|Overall Study|Death|15|||
161756785|NCT01602744|584147948|FG000|Overall Study|Lost to Follow-up|13|||
161756786|NCT01602744|584147949|FG001|Overall Study|Lost to Follow-up|8|||
161756787|NCT00959699|584147950|FG000|Treatment Period|Adverse Event|3|||
161756788|NCT00959699|584147951|FG001|Treatment Period|Adverse Event|13|||
161756789|NCT00959699|584147950|FG000|Treatment Period|Lack of Efficacy|15|||
161756790|NCT00959699|584147951|FG001|Treatment Period|Lack of Efficacy|6|||
161756791|NCT00959699|584147950|FG000|Treatment Period|Lost to Follow-up|0|||
161756792|NCT00959699|584147951|FG001|Treatment Period|Lost to Follow-up|1|||
161756793|NCT00959699|584147950|FG000|Treatment Period|Withdrawal by Subject|1|||
161756794|NCT00959699|584147951|FG001|Treatment Period|Withdrawal by Subject|3|||
161756795|NCT00959699|584147950|FG000|Treatment Period|Non-Compliance with Protocol|0|||
161756796|NCT00959699|584147951|FG001|Treatment Period|Non-Compliance with Protocol|1|||
161756797|NCT00959699|584147950|FG000|Treatment Period|Did not receive treatment|0|||
161756798|NCT00959699|584147951|FG001|Treatment Period|Did not receive treatment|1|||
161756799|NCT00959699|584147950|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
161756800|NCT00959699|584147951|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
161756801|NCT00959699|584147950|FG000|Follow-up Period|Lost to Follow-up|3|||
161756802|NCT00959699|584147951|FG001|Follow-up Period|Lost to Follow-up|2|||
161756803|NCT00959699|584147950|FG000|Follow-up Period|Withdrawal by Subject|3|||
161756804|NCT00959699|584147951|FG001|Follow-up Period|Withdrawal by Subject|4|||
161756805|NCT04228445|584147952|FG000|Overall Study|Lost to Follow-up|1|||
161756806|NCT04228445|584147953|FG001|Overall Study|Lost to Follow-up|1|||
161756807|NCT04228445|584147952|FG000|Overall Study|Physician Decision|1|||
161756808|NCT04228445|584147953|FG001|Overall Study|Physician Decision|2|||
161756809|NCT04228445|584147952|FG000|Overall Study|Withdrawal by Subject|0|||
161756810|NCT04228445|584147953|FG001|Overall Study|Withdrawal by Subject|1|||
161756811|NCT04228445|584147952|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
161756812|NCT04228445|584147953|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
161756813|NCT00606294|584147954|FG000|Overall Study|Withdrawal by Subject|36|||
161756814|NCT00606294|584147955|FG001|Overall Study|Withdrawal by Subject|0|||
161756815|NCT03924427|584147956|FG000|Overall Study|Adverse Event|4|||
161756816|NCT03924427|584147956|FG000|Overall Study|Lack of Efficacy|1|||
161756817|NCT03924427|584147956|FG000|Overall Study|Withdrawal by Subject|1|||
161756818|NCT00609167|584147963|FG000|Overall Study|Withdrawal by Subject|1|||
161756819|NCT00609167|584147964|FG001|Overall Study|Withdrawal by Subject|0|||
161756820|NCT00609167|584147963|FG000|Overall Study|Lack of Efficacy|1|||
161756821|NCT00609167|584147964|FG001|Overall Study|Lack of Efficacy|0|||
161756822|NCT00609167|584147963|FG000|Overall Study|Adverse Event|5|||
161756823|NCT00609167|584147964|FG001|Overall Study|Adverse Event|1|||
161756824|NCT00609167|584147963|FG000|Overall Study|Disease Progression|1|||
161756825|NCT00609167|584147964|FG001|Overall Study|Disease Progression|0|||
161756826|NCT00609167|584147963|FG000|Overall Study|Stem Cell Transplant|0|||
161756827|NCT00609167|584147964|FG001|Overall Study|Stem Cell Transplant|6|||
161756828|NCT00712270|584147965|FG000|Overall Study|Withdrawal by Subject|11|||
161756829|NCT00712270|584147965|FG000|Overall Study|Screen Failure|3|||
161756830|NCT03935594|584147966|FG000|Overall Study|Physician Decision|3|||
161756831|NCT01435122|584147967|FG000|Overall Study|Early withdrawal due to toxicity|8|||
161756832|NCT04412668|584147968|FG000|Overall Study|Death - multiple comorbidities|2|||
161756833|NCT04412668|584147969|FG001|Overall Study|Death - multiple comorbidities|0|||
161756834|NCT04412668|584147970|FG002|Overall Study|Death - multiple comorbidities|0|||
161756835|NCT04412668|584147968|FG000|Overall Study|Withdrawal by Subject|3|||
161756836|NCT04412668|584147969|FG001|Overall Study|Withdrawal by Subject|0|||
161756837|NCT04412668|584147970|FG002|Overall Study|Withdrawal by Subject|0|||
161756838|NCT04412668|584147968|FG000|Overall Study|Other than Specified|2|||
161756839|NCT04412668|584147969|FG001|Overall Study|Other than Specified|0|||
161756840|NCT04412668|584147970|FG002|Overall Study|Other than Specified|0|||
161756841|NCT03864627|584147971|FG000|Overall Study|Adverse Event|0|||
161756842|NCT03864627|584147972|FG001|Overall Study|Adverse Event|1|||
161756843|NCT03864627|584147971|FG000|Overall Study|Lack of Efficacy|0|||
161756844|NCT03864627|584147972|FG001|Overall Study|Lack of Efficacy|1|||
161756845|NCT03864627|584147971|FG000|Overall Study|Lost to Follow-up|0|||
161756846|NCT03864627|584147972|FG001|Overall Study|Lost to Follow-up|1|||
161756847|NCT03864627|584147971|FG000|Overall Study|Withdrawal by Subject|4|||
161756848|NCT03864627|584147972|FG001|Overall Study|Withdrawal by Subject|8|||
161756849|NCT03864627|584147971|FG000|Overall Study|Study terminated by sponsor|0|||
161756850|NCT03864627|584147972|FG001|Overall Study|Study terminated by sponsor|1|||
161756851|NCT01388491|584147973|FG000|Overall Study|Adverse Event|10|||
161756852|NCT01388491|584147974|FG001|Overall Study|Adverse Event|9|||
161756853|NCT01388491|584147973|FG000|Overall Study|Sponsor Request|9|||
161756854|NCT01388491|584147974|FG001|Overall Study|Sponsor Request|7|||
161756855|NCT01388491|584147973|FG000|Overall Study|Withdrawal by Subject|6|||
161756856|NCT01388491|584147974|FG001|Overall Study|Withdrawal by Subject|10|||
161756857|NCT01388491|584147973|FG000|Overall Study|Lost to Follow-up|4|||
161756858|NCT01388491|584147974|FG001|Overall Study|Lost to Follow-up|3|||
161756859|NCT01388491|584147973|FG000|Overall Study|Protocol Violation|2|||
161756860|NCT01388491|584147974|FG001|Overall Study|Protocol Violation|0|||
161756861|NCT01388491|584147973|FG000|Overall Study|Noncompliance|2|||
161756862|NCT01388491|584147974|FG001|Overall Study|Noncompliance|0|||
161756863|NCT01388491|584147973|FG000|Overall Study|Pregnancy|1|||
161756864|NCT01388491|584147974|FG001|Overall Study|Pregnancy|0|||
161756865|NCT00112840|584147975|FG000|Overall Study|Physician Decision|1|||
161756866|NCT00112840|584147976|FG001|Overall Study|Physician Decision|0|||
161756867|NCT00112840|584147977|FG002|Overall Study|Physician Decision|0|||
161756868|NCT00112840|584147975|FG000|Overall Study|Withdrawal by Subject|1|||
161756869|NCT00112840|584147976|FG001|Overall Study|Withdrawal by Subject|0|||
161756870|NCT00112840|584147977|FG002|Overall Study|Withdrawal by Subject|1|||
161756871|NCT00112840|584147975|FG000|Overall Study|Protocol Violation|0|||
161756872|NCT00112840|584147976|FG001|Overall Study|Protocol Violation|0|||
161756873|NCT00112840|584147977|FG002|Overall Study|Protocol Violation|5|||
161756874|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
161756875|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
161756876|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
161756877|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
161756878|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Other|13|||
161756879|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
161756880|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
161756881|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
161756882|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
161756883|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
161756884|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
161756885|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
161756886|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
161845742|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Other|0|||
161845743|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
161845744|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
161845745|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161845746|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161756887|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
161756888|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
161756889|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
161756890|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
161756891|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
161756892|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
161756893|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
161756894|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
161756895|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
161756896|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
161756897|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Other|1|||
161756898|NCT03128307|584147982|FG000|Overall Study|Lost to Follow-up|29|||
161756899|NCT03128307|584147982|FG000|Overall Study|Withdrawal by Subject|5|||
161756900|NCT01592773|584149601|FG000|Overall Study|Study Terminated by Sponsor|582|||
161756901|NCT01592773|584149601|FG000|Overall Study|Withdrawal by Subject|35|||
161756902|NCT01592773|584149601|FG000|Overall Study|Lost to Follow-up|19|||
161756903|NCT01592773|584149601|FG000|Overall Study|Adverse Event|17|||
161756904|NCT01592773|584149601|FG000|Overall Study|Lack of Efficacy|9|||
161756905|NCT01592773|584149601|FG000|Overall Study|Protocol Violation|2|||
161756906|NCT01592773|584149601|FG000|Overall Study|Inclusion/exclusion not meet|1|||
161756907|NCT01592773|584149601|FG000|Overall Study|Other Reason|1|||
161756908|NCT00121485|584149602|FG000|Overall Study|Not implanted|1|||
161756909|NCT00121485|584149603|FG001|Overall Study|Not implanted|5|||
161756910|NCT00121485|584149602|FG000|Overall Study|Crossover|0|||
161756911|NCT00121485|584149603|FG001|Overall Study|Crossover|2|||
161756912|NCT04124952|584149605|FG000|Overall Study|Lost to Follow-up|1|||
161756913|NCT02145429|584149606|FG000|Overall Study|Death|4|||
161756914|NCT02145429|584149607|FG001|Overall Study|Death|5|||
161756915|NCT02145429|584149606|FG000|Overall Study|Lost to Follow-up|4|||
161756916|NCT02145429|584149607|FG001|Overall Study|Lost to Follow-up|3|||
161756917|NCT02145429|584149606|FG000|Overall Study|Withdrawal by Subject|8|||
161756918|NCT02145429|584149607|FG001|Overall Study|Withdrawal by Subject|3|||
161756919|NCT00732472|584149608|FG000|Overall Study|Adverse Event|0|||
161756920|NCT00732472|584149609|FG001|Overall Study|Adverse Event|1|||
161756921|NCT00732472|584149610|FG002|Overall Study|Adverse Event|1|||
161756922|NCT00732472|584149611|FG003|Overall Study|Adverse Event|1|||
161756923|NCT00732472|584149608|FG000|Overall Study|Protocol Violation|0|||
161756924|NCT00732472|584149609|FG001|Overall Study|Protocol Violation|0|||
161756925|NCT00732472|584149610|FG002|Overall Study|Protocol Violation|0|||
161756926|NCT00732472|584149611|FG003|Overall Study|Protocol Violation|1|||
161756927|NCT00732472|584149608|FG000|Overall Study|Withdrawal by Subject|0|||
161756928|NCT00732472|584149609|FG001|Overall Study|Withdrawal by Subject|2|||
161756929|NCT00732472|584149610|FG002|Overall Study|Withdrawal by Subject|0|||
161756930|NCT00732472|584149611|FG003|Overall Study|Withdrawal by Subject|1|||
161756931|NCT02559115|584149614|FG000|Overall Study|Withdrawal by Subject|3|||
161756932|NCT02623699|584149615|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756933|NCT02623699|584149616|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
161756934|NCT02623699|584149617|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756935|NCT02623699|584149618|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756936|NCT02623699|584149619|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756937|NCT02623699|584149620|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756938|NCT02623699|584149621|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756939|NCT02623699|584149622|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756940|NCT02623699|584149623|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756941|NCT02623699|584149624|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756942|NCT02623699|584149625|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756943|NCT02623699|584149626|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756944|NCT02623699|584149615|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756945|NCT02623699|584149616|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756946|NCT02623699|584149617|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756947|NCT02623699|584149618|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756948|NCT02623699|584149619|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756949|NCT02623699|584149620|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756950|NCT02623699|584149621|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
161756951|NCT02623699|584149622|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756952|NCT02623699|584149623|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756953|NCT02623699|584149624|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756954|NCT02623699|584149625|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756955|NCT02623699|584149626|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756956|NCT02623699|584149615|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756957|NCT02623699|584149616|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756958|NCT02623699|584149617|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756959|NCT02623699|584149618|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756960|NCT02623699|584149619|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756961|NCT02623699|584149620|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
161756962|NCT02623699|584149621|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756963|NCT02623699|584149622|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756964|NCT02623699|584149623|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756965|NCT02623699|584149624|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756966|NCT02623699|584149625|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756967|NCT02623699|584149626|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756968|NCT02623699|584149615|FG000|Part B (Up to 289 Days)|Death|0|||
161756969|NCT02623699|584149616|FG001|Part B (Up to 289 Days)|Death|0|||
161756970|NCT02623699|584149617|FG002|Part B (Up to 289 Days)|Death|0|||
161756971|NCT02623699|584149618|FG003|Part B (Up to 289 Days)|Death|0|||
161756972|NCT02623699|584149619|FG004|Part B (Up to 289 Days)|Death|0|||
161756973|NCT02623699|584149620|FG005|Part B (Up to 289 Days)|Death|1|||
161756974|NCT02623699|584149621|FG006|Part B (Up to 289 Days)|Death|1|||
161756975|NCT02623699|584149622|FG007|Part B (Up to 289 Days)|Death|0|||
161756976|NCT02623699|584149623|FG008|Part B (Up to 289 Days)|Death|1|||
161756977|NCT02623699|584149624|FG009|Part B (Up to 289 Days)|Death|0|||
161756978|NCT02623699|584149625|FG010|Part B (Up to 289 Days)|Death|0|||
161756979|NCT02623699|584149626|FG011|Part B (Up to 289 Days)|Death|0|||
161756980|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
161756981|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
161756982|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
161756983|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
161756984|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
161756985|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
161756986|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
161756987|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
161756988|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
161756989|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
161756990|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
161756991|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
161756992|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756993|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161845747|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161845748|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161845749|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845750|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845751|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845752|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845753|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Death|1|||
161845754|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Death|0|||
161845755|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161845756|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Death|0|||
161845757|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Death|0|||
161845758|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
161845759|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
161845760|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161845761|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161845762|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161845763|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845764|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161845765|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845766|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845767|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845768|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161845769|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
161845770|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161845771|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161845772|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161845773|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161845774|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161845775|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161845776|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161845777|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161845778|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161845779|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
161845780|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161845781|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161845782|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161845783|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Other|4|||
161845784|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161845785|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161845786|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Other|0|||
161845787|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Other|0|||
161845788|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
161845789|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
161845790|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161845791|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161845792|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161845793|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161845794|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161845795|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161845796|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161845797|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161845798|NCT02045147|584477073|FG000|Overall Study|Withdrawal by Subject|2|||
161845799|NCT02045147|584477074|FG001|Overall Study|Withdrawal by Subject|0|||
161845800|NCT02045147|584477075|FG002|Overall Study|Withdrawal by Subject|0|||
161845801|NCT02045147|584477076|FG003|Overall Study|Withdrawal by Subject|0|||
161845802|NCT02045147|584477077|FG004|Overall Study|Withdrawal by Subject|0|||
161845803|NCT02045147|584477078|FG005|Overall Study|Withdrawal by Subject|0|||
161845804|NCT02045147|584477079|FG006|Overall Study|Withdrawal by Subject|0|||
161845805|NCT02045147|584477080|FG007|Overall Study|Withdrawal by Subject|1|||
161845806|NCT02045147|584477073|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
161845807|NCT02045147|584477074|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
161845808|NCT02045147|584477075|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
161845809|NCT02045147|584477076|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
161845810|NCT02045147|584477077|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
161756994|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756995|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756996|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756997|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756998|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756999|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161757000|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161757001|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161757002|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
161757003|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
161757004|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Death|0|||
161757005|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Death|0|||
161757006|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Death|0|||
161757007|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Death|0|||
161757008|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Death|0|||
161757009|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Death|0|||
161757010|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Death|0|||
161757011|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Death|0|||
161757012|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Death|0|||
161757013|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Death|0|||
161757014|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Death|0|||
161757015|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Death|1|||
161757016|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
161757017|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
161757018|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
161757019|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
161757020|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
161757021|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
161757022|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
161757023|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
161757024|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
161757025|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
161757026|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
161757027|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
161757028|NCT01426009|584149627|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
161757029|NCT01426009|584149627|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
161757030|NCT01426009|584149627|FG000|Washout 1|Withdrawal by Subject|1|||
161757031|NCT01426009|584149627|FG000|Washout 1|Personal Reasons|1|||
161757032|NCT01426009|584149627|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
161757033|NCT01426009|584149627|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
161757034|NCT01426009|584149627|FG000|Washout 2|electrive surgery|1|||
161757035|NCT01426009|584149627|FG000|Washout 3|personal reasons|1|||
161757036|NCT01426009|584149627|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
161757037|NCT01426009|584149627|FG000|Washout 4|Lost to Follow-up|1|||
161757038|NCT00515099|584149633|FG000|Overall Study|Lost to Follow-up|0|||
161757039|NCT00515099|584149634|FG001|Overall Study|Lost to Follow-up|4|||
161757040|NCT00515099|584149633|FG000|Overall Study|Withdrawal by Subject|2|||
161757041|NCT00515099|584149634|FG001|Overall Study|Withdrawal by Subject|0|||
161757042|NCT00515099|584149633|FG000|Overall Study|IRB Recommendation|1|||
161757043|NCT00515099|584149634|FG001|Overall Study|IRB Recommendation|0|||
161757044|NCT03342404|584149635|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
161845811|NCT02045147|584477078|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
161757045|NCT03342404|584149636|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
161757046|NCT03342404|584149635|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
161757047|NCT03342404|584149636|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
161757048|NCT03342404|584149635|FG000|Blinded Treatment Phase|Adverse Event|5|||
161757049|NCT03342404|584149636|FG001|Blinded Treatment Phase|Adverse Event|4|||
161757050|NCT03342404|584149635|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
161757051|NCT03342404|584149636|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
161757052|NCT03342404|584149635|FG000|Blinded Treatment Phase|Other reasons|1|||
161845812|NCT02045147|584477079|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
161845813|NCT02045147|584477080|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
161845814|NCT04839692|584477081|FG000|Overall Study|Withdrawal by Subject|0|||
161845815|NCT04839692|584477082|FG001|Overall Study|Withdrawal by Subject|3|||
161845816|NCT04839692|584477081|FG000|Overall Study|Physician Decision|1|||
161845817|NCT04839692|584477082|FG001|Overall Study|Physician Decision|0|||
161845818|NCT00049530|584477083|FG000|Overall Study|Lack of Efficacy|25|||
161845819|NCT00049530|584477083|FG000|Overall Study|Adverse Event|2|||
161845820|NCT00049530|584477083|FG000|Overall Study|Death|1|||
161845821|NCT00049530|584477083|FG000|Overall Study|symptomatic deterioration|1|||
161845822|NCT00049530|584477083|FG000|Overall Study|ineligible|3|||
161845823|NCT03511326|584477085|FG000|Overall Study|Withdrawal by Subject|1|||
161845824|NCT00849186|584477088|FG000|Overall Study|Adverse Event|2|||
161845825|NCT00849186|584477088|FG000|Overall Study|Withdrawal by Subject|1|||
161845826|NCT00849186|584477088|FG000|Overall Study|not treated|6|||
161845827|NCT00849186|584477088|FG000|Overall Study|Other|1|||
161845828|NCT00936897|584477091|FG000|Overall Study|Withdrawal by Subject|9|||
161845829|NCT00936897|584477092|FG001|Overall Study|Withdrawal by Subject|19|||
161845830|NCT00936897|584477091|FG000|Overall Study|Adverse Event|4|||
161845831|NCT00936897|584477092|FG001|Overall Study|Adverse Event|13|||
161845832|NCT00936897|584477091|FG000|Overall Study|Other|3|||
161845833|NCT00936897|584477092|FG001|Overall Study|Other|9|||
161845834|NCT00936897|584477091|FG000|Overall Study|Lost to Follow-up|1|||
161845835|NCT00936897|584477092|FG001|Overall Study|Lost to Follow-up|10|||
161845836|NCT00936897|584477091|FG000|Overall Study|Administrative Decision|1|||
161845837|NCT00936897|584477092|FG001|Overall Study|Administrative Decision|2|||
161845838|NCT00936897|584477091|FG000|Overall Study|Protocol Violation|1|||
161845839|NCT00936897|584477092|FG001|Overall Study|Protocol Violation|1|||
161845840|NCT00936897|584477091|FG000|Overall Study|Ineligibility Determined|0|||
161845841|NCT00936897|584477092|FG001|Overall Study|Ineligibility Determined|3|||
161845842|NCT00936897|584477091|FG000|Overall Study|Noncompliance|0|||
161845843|NCT00936897|584477092|FG001|Overall Study|Noncompliance|2|||
161845844|NCT00936897|584477091|FG000|Overall Study|Death|0|||
161845845|NCT00936897|584477092|FG001|Overall Study|Death|1|||
161845846|NCT00417170|584477093|FG000|Overall Study|Adverse Event|1|||
161845847|NCT00417170|584477094|FG001|Overall Study|Adverse Event|1|||
161845848|NCT00417170|584477093|FG000|Overall Study|Withdrawal by Subject|1|||
161845849|NCT00417170|584477094|FG001|Overall Study|Withdrawal by Subject|1|||
161845850|NCT00417170|584477093|FG000|Overall Study|Lost to Follow-up|0|||
161845851|NCT00417170|584477094|FG001|Overall Study|Lost to Follow-up|1|||
161845852|NCT04058067|584477095|FG000|Overall Study|Adverse Event|2|||
161845853|NCT04058067|584477096|FG001|Overall Study|Adverse Event|0|||
161845854|NCT04058067|584477095|FG000|Overall Study|Death|0|||
161845855|NCT04058067|584477096|FG001|Overall Study|Death|1|||
161845856|NCT04058067|584477095|FG000|Overall Study|Physician Decision|3|||
161845857|NCT04058067|584477096|FG001|Overall Study|Physician Decision|1|||
161845858|NCT04058067|584477095|FG000|Overall Study|Protocol Violation|0|||
161845859|NCT04058067|584477096|FG001|Overall Study|Protocol Violation|1|||
161845860|NCT04058067|584477095|FG000|Overall Study|Withdrawal by Subject|7|||
161845861|NCT04058067|584477096|FG001|Overall Study|Withdrawal by Subject|8|||
161845862|NCT01001988|584477099|FG000|Overall Study|Protocol Violation|84|||
161845863|NCT01001988|584477099|FG000|Overall Study|Withdrawal by Subject|18|||
161845864|NCT01001988|584477099|FG000|Overall Study|Lost to Follow-up|15|||
161845865|NCT01844856|584477100|FG000|Overall Study|Lost to Follow-up|15|||
161845866|NCT01844856|584477101|FG001|Overall Study|Lost to Follow-up|3|||
161845867|NCT01844856|584477100|FG000|Overall Study|Adverse Event|3|||
161845868|NCT01844856|584477101|FG001|Overall Study|Adverse Event|6|||
161845869|NCT01844856|584477100|FG000|Overall Study|Withdrawal by Subject|3|||
161845870|NCT01844856|584477101|FG001|Overall Study|Withdrawal by Subject|2|||
161845871|NCT01844856|584477100|FG000|Overall Study|Noncompliance|2|||
161845872|NCT01844856|584477101|FG001|Overall Study|Noncompliance|3|||
161845873|NCT01844856|584477100|FG000|Overall Study|Enterococcus Resistant|0|||
161845874|NCT01844856|584477101|FG001|Overall Study|Enterococcus Resistant|1|||
161845875|NCT01844856|584477100|FG000|Overall Study|Inadvertently Not Scheduled|1|||
161845876|NCT01844856|584477101|FG001|Overall Study|Inadvertently Not Scheduled|0|||
161845877|NCT01844856|584477100|FG000|Overall Study|Randomized but was a Screen Failure|0|||
161845878|NCT01844856|584477101|FG001|Overall Study|Randomized but was a Screen Failure|1|||
161845879|NCT01221363|584477102|FG000|Overall Study|Pregnancy|1|||
161845880|NCT01221363|584477103|FG001|Overall Study|Pregnancy|0|||
161845881|NCT01221363|584477102|FG000|Overall Study|Withdrawal by Subject|11|||
161845882|NCT01221363|584477103|FG001|Overall Study|Withdrawal by Subject|5|||
161845883|NCT04628793|584477104|FG000|Overall Study|Study terminated by sponsor|0|||
161845884|NCT04628793|584477105|FG001|Overall Study|Study terminated by sponsor|0|||
161845885|NCT04628793|584477106|FG002|Overall Study|Study terminated by sponsor|8|||
161845886|NCT04628793|584477104|FG000|Overall Study|Withdrawal by Subject|2|||
161845887|NCT04628793|584477105|FG001|Overall Study|Withdrawal by Subject|3|||
161845888|NCT04628793|584477106|FG002|Overall Study|Withdrawal by Subject|0|||
161757053|NCT03342404|584149636|FG001|Blinded Treatment Phase|Other reasons|0|||
161757054|NCT03342404|584149635|FG000|Blinded Treatment Phase|Physician Decision|1|||
161757055|NCT03342404|584149636|FG001|Blinded Treatment Phase|Physician Decision|0|||
161757056|NCT03342404|584149635|FG000|Blinded Treatment Phase|Death|1|||
161757057|NCT03342404|584149636|FG001|Blinded Treatment Phase|Death|0|||
161757058|NCT03342404|584149635|FG000|Open-Label Phase|Lost to Follow-up|0|||
161757059|NCT03342404|584149636|FG001|Open-Label Phase|Lost to Follow-up|1|||
161757060|NCT03342404|584149635|FG000|Open-Label Phase|Other reasons|0|||
161757061|NCT03342404|584149636|FG001|Open-Label Phase|Other reasons|1|||
161757062|NCT03342404|584149635|FG000|Open-Label Phase|Adverse Event|0|||
161757063|NCT03342404|584149636|FG001|Open-Label Phase|Adverse Event|3|||
161757064|NCT03342404|584149635|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161757065|NCT03342404|584149636|FG001|Open-Label Phase|Withdrawal by Subject|6|||
161757066|NCT00592072|584149637|FG000|Wash Out Period|Lost to Follow-up|1|||
161757067|NCT00592072|584149638|FG001|Wash Out Period|Lost to Follow-up|1|||
161757068|NCT05333289|584149639|FG000|Overall Study|Other|1|||
161757069|NCT05333289|584149640|FG001|Overall Study|Other|0|||
161757070|NCT05333289|584149641|FG002|Overall Study|Other|0|||
161757071|NCT05333289|584149642|FG003|Overall Study|Other|1|||
161757072|NCT05333289|584149643|FG004|Overall Study|Other|1|||
161757073|NCT05333289|584149644|FG005|Overall Study|Other|2|||
161757074|NCT05333289|584149645|FG006|Overall Study|Other|2|||
161757075|NCT05333289|584149646|FG007|Overall Study|Other|0|||
161757076|NCT05333289|584149639|FG000|Overall Study|Withdrawal by Subject|1|||
161757077|NCT05333289|584149640|FG001|Overall Study|Withdrawal by Subject|2|||
161757078|NCT05333289|584149641|FG002|Overall Study|Withdrawal by Subject|2|||
161757079|NCT05333289|584149642|FG003|Overall Study|Withdrawal by Subject|1|||
161757080|NCT05333289|584149643|FG004|Overall Study|Withdrawal by Subject|1|||
161757081|NCT05333289|584149644|FG005|Overall Study|Withdrawal by Subject|2|||
161757082|NCT05333289|584149645|FG006|Overall Study|Withdrawal by Subject|1|||
161757083|NCT05333289|584149646|FG007|Overall Study|Withdrawal by Subject|3|||
161757084|NCT05333289|584149639|FG000|Overall Study|Protocol Violation|1|||
161757085|NCT05333289|584149640|FG001|Overall Study|Protocol Violation|0|||
161757086|NCT05333289|584149641|FG002|Overall Study|Protocol Violation|0|||
161757087|NCT05333289|584149642|FG003|Overall Study|Protocol Violation|0|||
161757088|NCT05333289|584149643|FG004|Overall Study|Protocol Violation|0|||
161757089|NCT05333289|584149644|FG005|Overall Study|Protocol Violation|0|||
161757090|NCT05333289|584149645|FG006|Overall Study|Protocol Violation|0|||
161757091|NCT05333289|584149646|FG007|Overall Study|Protocol Violation|0|||
161757092|NCT05333289|584149639|FG000|Overall Study|Physician Decision|0|||
161757093|NCT05333289|584149640|FG001|Overall Study|Physician Decision|0|||
161757094|NCT05333289|584149641|FG002|Overall Study|Physician Decision|1|||
161757095|NCT05333289|584149642|FG003|Overall Study|Physician Decision|0|||
161757096|NCT05333289|584149643|FG004|Overall Study|Physician Decision|0|||
161757097|NCT05333289|584149644|FG005|Overall Study|Physician Decision|2|||
161757098|NCT05333289|584149645|FG006|Overall Study|Physician Decision|0|||
161757099|NCT05333289|584149646|FG007|Overall Study|Physician Decision|0|||
161757100|NCT05333289|584149639|FG000|Overall Study|Lost to Follow-up|6|||
161757101|NCT05333289|584149640|FG001|Overall Study|Lost to Follow-up|0|||
161757102|NCT05333289|584149641|FG002|Overall Study|Lost to Follow-up|1|||
161757103|NCT05333289|584149642|FG003|Overall Study|Lost to Follow-up|6|||
161757104|NCT05333289|584149643|FG004|Overall Study|Lost to Follow-up|3|||
161757105|NCT05333289|584149644|FG005|Overall Study|Lost to Follow-up|3|||
161757106|NCT05333289|584149645|FG006|Overall Study|Lost to Follow-up|2|||
161757107|NCT05333289|584149646|FG007|Overall Study|Lost to Follow-up|1|||
161757108|NCT05333289|584149639|FG000|Overall Study|Death|1|||
161757109|NCT05333289|584149640|FG001|Overall Study|Death|0|||
161757110|NCT05333289|584149641|FG002|Overall Study|Death|0|||
161757111|NCT05333289|584149642|FG003|Overall Study|Death|0|||
161757112|NCT05333289|584149643|FG004|Overall Study|Death|0|||
161757113|NCT05333289|584149644|FG005|Overall Study|Death|0|||
161757114|NCT05333289|584149645|FG006|Overall Study|Death|0|||
161757115|NCT05333289|584149646|FG007|Overall Study|Death|0|||
161757116|NCT00772889|584149650|FG000|Overall Study|Adverse Event|7|||
161757117|NCT00772889|584149651|FG001|Overall Study|Adverse Event|4|||
161757118|NCT00772889|584149652|FG002|Overall Study|Adverse Event|0|||
161757119|NCT00772889|584149650|FG000|Overall Study|Withdrawal by Subject|9|||
161757120|NCT00772889|584149651|FG001|Overall Study|Withdrawal by Subject|8|||
161757121|NCT00772889|584149652|FG002|Overall Study|Withdrawal by Subject|9|||
161757122|NCT00772889|584149650|FG000|Overall Study|Lost to Follow-up|6|||
161757123|NCT00772889|584149651|FG001|Overall Study|Lost to Follow-up|6|||
161757124|NCT00772889|584149652|FG002|Overall Study|Lost to Follow-up|7|||
161757125|NCT00403390|584149654|FG000|Overall Study|Withdrawal by Subject|1|||
161757126|NCT00403390|584149655|FG001|Overall Study|Withdrawal by Subject|0|||
161757127|NCT00403390|584149654|FG000|Overall Study|samples lost|1|||
161757128|NCT00403390|584149655|FG001|Overall Study|samples lost|0|||
161757129|NCT00403390|584149654|FG000|Overall Study|non-compliant|1|||
161757130|NCT00403390|584149655|FG001|Overall Study|non-compliant|0|||
161757131|NCT01878175|584149656|FG000|Overall Study|Developed contraindicated health problem|2|||
161757132|NCT01796106|584149657|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
161757133|NCT01796106|584149658|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
161757134|NCT01249157|584149661|FG000|Overall Study|Withdrawal by Subject|1|||
161757135|NCT03796195|584149662|FG000|Overall Study|Study closed early|1|||
161757136|NCT04445051|584149663|FG000|Overall Study|Adverse Event|0|||
161757137|NCT04445051|584149664|FG001|Overall Study|Adverse Event|0|||
161757138|NCT04445051|584149665|FG002|Overall Study|Adverse Event|1|||
161757139|NCT04445051|584149666|FG003|Overall Study|Adverse Event|0|||
161757140|NCT04445051|584149667|FG004|Overall Study|Adverse Event|0|||
161757141|NCT04445051|584149668|FG005|Overall Study|Adverse Event|0|||
161757142|NCT02392468|584149671|FG000|Overall Study|Adverse Event|0|||
161757143|NCT02392468|584149672|FG001|Overall Study|Adverse Event|1|||
161757144|NCT02392468|584149673|FG002|Overall Study|Adverse Event|0|||
161757145|NCT02392468|584149674|FG003|Overall Study|Adverse Event|0|||
161757146|NCT02392468|584149675|FG004|Overall Study|Adverse Event|0|||
161757147|NCT02392468|584149676|FG005|Overall Study|Adverse Event|1|||
161757148|NCT01039428|584149677|FG000|Overall Study|Protocol Violation|1|||
161757149|NCT01039428|584149678|FG001|Overall Study|Protocol Violation|0|||
161757150|NCT01039428|584149677|FG000|Overall Study|Withdrawal by Subject|1|||
161757151|NCT01039428|584149678|FG001|Overall Study|Withdrawal by Subject|0|||
161757152|NCT01313039|584149679|FG000|Overall Study|Physician Decision|1|||
161757153|NCT01313039|584149679|FG000|Overall Study|Adverse Event|1|||
161757154|NCT03630016|584149680|FG000|Overall Study|Poor Sensor Placement|1|||
161757155|NCT05083949|584149681|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
161757156|NCT05083949|584149682|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
161757157|NCT05083949|584149681|FG000|Period 1|Adverse Event|1|||
161757158|NCT05083949|584149682|FG001|Period 1|Adverse Event|1|||
161757159|NCT05083949|584149681|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
161757160|NCT05083949|584149682|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
161757161|NCT05083949|584149681|FG000|Period 2|Adverse Event|0|||
161757162|NCT05083949|584149682|FG001|Period 2|Adverse Event|2|||
161757163|NCT02470429|584149683|FG000|Overall Study|Adverse Event|1|||
161757164|NCT02470429|584149684|FG001|Overall Study|Adverse Event|0|||
161757165|NCT02470429|584149683|FG000|Overall Study|Withdrawal by Subject|1|||
161757166|NCT02470429|584149684|FG001|Overall Study|Withdrawal by Subject|0|||
161757167|NCT01976624|584149685|FG000|Overall Study|Participants contraindicated|2|||
161757168|NCT01976624|584149685|FG000|Overall Study|Participants age less than 19 years|12|||
161757169|NCT01316380|584149686|FG000|Overall Study|Adverse Event|0|||
161757170|NCT01316380|584149687|FG001|Overall Study|Adverse Event|2|||
161757171|NCT01316380|584149688|FG002|Overall Study|Adverse Event|1|||
161757172|NCT01316380|584149686|FG000|Overall Study|Protocol Violation|0|||
161757173|NCT01316380|584149687|FG001|Overall Study|Protocol Violation|0|||
161757174|NCT01316380|584149688|FG002|Overall Study|Protocol Violation|1|||
161757175|NCT01316380|584149686|FG000|Overall Study|Withdrawal by Subject|1|||
161757176|NCT01316380|584149687|FG001|Overall Study|Withdrawal by Subject|2|||
161757177|NCT01316380|584149688|FG002|Overall Study|Withdrawal by Subject|0|||
161757178|NCT01316380|584149686|FG000|Overall Study|Other|0|||
161757179|NCT01316380|584149687|FG001|Overall Study|Other|1|||
161757180|NCT01316380|584149688|FG002|Overall Study|Other|1|||
161757181|NCT01316380|584149686|FG000|Overall Study|Not treated|1|||
161757182|NCT01316380|584149687|FG001|Overall Study|Not treated|0|||
161757183|NCT01316380|584149688|FG002|Overall Study|Not treated|0|||
161757184|NCT00471315|584149690|FG000|Overall Study|Adverse Event|7|||
161757185|NCT00471315|584149690|FG000|Overall Study|Withdrawal by Subject|1|||
161757186|NCT02574520|584149694|FG000|Overall Study|Not dosed|2|||
161757187|NCT02574520|584149695|FG001|Overall Study|Not dosed|0|||
161757188|NCT02574520|584149696|FG002|Overall Study|Not dosed|5|||
161757189|NCT02574520|584149697|FG003|Overall Study|Not dosed|4|||
161757190|NCT02574520|584149694|FG000|Overall Study|Adverse Event|0|||
161757191|NCT02574520|584149695|FG001|Overall Study|Adverse Event|0|||
161757192|NCT02574520|584149696|FG002|Overall Study|Adverse Event|0|||
161757193|NCT02574520|584149697|FG003|Overall Study|Adverse Event|1|||
161757194|NCT02574520|584149694|FG000|Overall Study|Withdrawal by Subject|0|||
161845889|NCT04628793|584477104|FG000|Overall Study|Lost to Follow-up|0|||
161845890|NCT04628793|584477105|FG001|Overall Study|Lost to Follow-up|1|||
161757195|NCT02574520|584149695|FG001|Overall Study|Withdrawal by Subject|0|||
161757196|NCT02574520|584149696|FG002|Overall Study|Withdrawal by Subject|0|||
161757197|NCT02574520|584149697|FG003|Overall Study|Withdrawal by Subject|1|||
161757198|NCT02574520|584149694|FG000|Overall Study|Other|0|||
161757199|NCT02574520|584149695|FG001|Overall Study|Other|0|||
161757200|NCT02574520|584149696|FG002|Overall Study|Other|0|||
161757201|NCT02574520|584149697|FG003|Overall Study|Other|2|||
161757202|NCT01365091|584149700|FG000|Period 1|Adverse Event|1|||
161757203|NCT01365091|584149701|FG001|Period 1|Adverse Event|0|||
161757204|NCT01365091|584149702|FG002|Period 1|Adverse Event|2|||
161757205|NCT01365091|584149703|FG003|Period 1|Adverse Event|3|||
161757206|NCT01365091|584149700|FG000|Period 1|Positive test result for drugs of abuse|1|||
161757207|NCT01365091|584149701|FG001|Period 1|Positive test result for drugs of abuse|0|||
161757208|NCT01365091|584149702|FG002|Period 1|Positive test result for drugs of abuse|0|||
161757209|NCT01365091|584149703|FG003|Period 1|Positive test result for drugs of abuse|0|||
161757210|NCT01365091|584149700|FG000|Period 1|No longer met study criteria|0|||
161757211|NCT01365091|584149701|FG001|Period 1|No longer met study criteria|1|||
161757212|NCT01365091|584149702|FG002|Period 1|No longer met study criteria|0|||
161757213|NCT01365091|584149703|FG003|Period 1|No longer met study criteria|0|||
161757214|NCT01365091|584149700|FG000|Period 1|Withdrawal by Subject|0|||
161757215|NCT01365091|584149701|FG001|Period 1|Withdrawal by Subject|1|||
161757216|NCT01365091|584149702|FG002|Period 1|Withdrawal by Subject|0|||
161757217|NCT01365091|584149703|FG003|Period 1|Withdrawal by Subject|0|||
161757218|NCT01365091|584149700|FG000|Period 1|Personal reasons|0|||
161757219|NCT01365091|584149701|FG001|Period 1|Personal reasons|0|||
161757220|NCT01365091|584149702|FG002|Period 1|Personal reasons|1|||
161757221|NCT01365091|584149703|FG003|Period 1|Personal reasons|0|||
161757222|NCT01365091|584149700|FG000|Period 2|Withdrawal by Subject|1|||
161757223|NCT01365091|584149701|FG001|Period 2|Withdrawal by Subject|0|||
161757224|NCT01365091|584149702|FG002|Period 2|Withdrawal by Subject|0|||
161757225|NCT01365091|584149703|FG003|Period 2|Withdrawal by Subject|0|||
161757226|NCT01365091|584149700|FG000|Period 2|Adverse Event|0|||
161757227|NCT01365091|584149701|FG001|Period 2|Adverse Event|0|||
161757228|NCT01365091|584149702|FG002|Period 2|Adverse Event|1|||
161757229|NCT01365091|584149703|FG003|Period 2|Adverse Event|0|||
161757230|NCT05307523|584149705|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
161757231|NCT05307523|584149706|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
161757232|NCT05307523|584149705|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
161757233|NCT05307523|584149706|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
161757234|NCT05116683|584149708|FG000|Overall Study|Physician Decision|4|||
161757235|NCT00683774|584149719|FG000|Overall Study|Withdrawal by Subject|0|||
161757236|NCT00683774|584149720|FG001|Overall Study|Withdrawal by Subject|1|||
161757237|NCT00683774|584149719|FG000|Overall Study|Physician Decision|3|||
161757238|NCT00683774|584149720|FG001|Overall Study|Physician Decision|0|||
161757239|NCT02875366|584149721|FG000|Overall Study|Adverse Event|0|||
161757240|NCT02875366|584149722|FG001|Overall Study|Adverse Event|2|||
161757241|NCT02875366|584149721|FG000|Overall Study|Noncompliance|0|||
161757242|NCT02875366|584149722|FG001|Overall Study|Noncompliance|1|||
161757243|NCT03595176|584149723|FG000|Overall Study|Death|0|||
161757244|NCT03595176|584149724|FG001|Overall Study|Death|2|||
161757245|NCT03595176|584149723|FG000|Overall Study|Lost to Follow-up|0|||
161757246|NCT03595176|584149724|FG001|Overall Study|Lost to Follow-up|1|||
161757247|NCT02735044|584149726|FG000|Overall Study|Adverse Event|3|||
161757248|NCT02735044|584149727|FG001|Overall Study|Adverse Event|3|||
161757249|NCT02735044|584149726|FG000|Overall Study|Lack of Efficacy|1|||
161757250|NCT02735044|584149727|FG001|Overall Study|Lack of Efficacy|0|||
161757251|NCT02735044|584149726|FG000|Overall Study|Poor compliance to protocol|7|||
161757252|NCT02735044|584149727|FG001|Overall Study|Poor compliance to protocol|7|||
161757253|NCT02735044|584149726|FG000|Overall Study|Randomized and not treated|0|||
161757254|NCT02735044|584149727|FG001|Overall Study|Randomized and not treated|2|||
161757255|NCT02735044|584149726|FG000|Overall Study|Other, not specified above|5|||
161757256|NCT02735044|584149727|FG001|Overall Study|Other, not specified above|11|||
161757257|NCT01682759|584149729|FG000|Overall Study|Death|2|||
161757258|NCT01682759|584149730|FG001|Overall Study|Death|1|||
161757259|NCT01682759|584149729|FG000|Overall Study|Lost to Follow-up|10|||
161757260|NCT01682759|584149730|FG001|Overall Study|Lost to Follow-up|13|||
161757261|NCT01682759|584149729|FG000|Overall Study|Physician Decision|1|||
161757262|NCT01682759|584149730|FG001|Overall Study|Physician Decision|1|||
161757263|NCT01682759|584149729|FG000|Overall Study|Withdrawal by Subject|56|||
161757264|NCT01682759|584149730|FG001|Overall Study|Withdrawal by Subject|55|||
161757265|NCT00412113|584149731|FG000|Overall Study|Adverse Event|11|||
161757266|NCT00412113|584149732|FG001|Overall Study|Adverse Event|15|||
161757267|NCT00412113|584149731|FG000|Overall Study|did not receive treatment|1|||
161757268|NCT00412113|584149732|FG001|Overall Study|did not receive treatment|0|||
161757269|NCT01201967|584149733|FG000|Overall Study|Lost to Follow-up|6|||
161757270|NCT01201967|584149734|FG001|Overall Study|Lost to Follow-up|5|||
161757271|NCT01226472|584149735|FG000|Overall Study|Progressive Disease|1|||
161757272|NCT00740116|584151585|FG000|Overall Study|Withdrawal by Subject|1|||
161757273|NCT00740116|584151586|FG001|Overall Study|Withdrawal by Subject|1|||
161757274|NCT00740116|584151585|FG000|Overall Study|Protocol Violation|1|||
161757275|NCT00740116|584151586|FG001|Overall Study|Protocol Violation|4|||
161757276|NCT00621764|584151587|FG000|Overall Study|Protocol Violation|0|||
161757277|NCT00621764|584151588|FG001|Overall Study|Protocol Violation|0|||
161757278|NCT00621764|584151589|FG002|Overall Study|Protocol Violation|0|||
161757279|NCT00621764|584151590|FG003|Overall Study|Protocol Violation|1|||
161845891|NCT04628793|584477106|FG002|Overall Study|Lost to Follow-up|0|||
161845892|NCT01329549|584477113|FG000|Overall Study|Withdrawal by Subject|1|||
161845893|NCT01329549|584477113|FG000|Overall Study|Adverse Event|1|||
161845894|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
161845895|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
161845896|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
161845897|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
161845898|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
161845899|NCT02677714|584477115|FG000|Overall Study|Withdrawal by Subject|2|||
161845900|NCT02677714|584477116|FG001|Overall Study|Withdrawal by Subject|0|||
161845901|NCT03421730|584477117|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845902|NCT03421730|584477118|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
161845903|NCT03421730|584477119|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845904|NCT03421730|584477120|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845905|NCT03421730|584477121|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845906|NCT03421730|584477122|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845907|NCT03421730|584477123|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845908|NCT03421730|584477124|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845909|NCT03421730|584477125|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845910|NCT03421730|584477126|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845911|NCT03421730|584477127|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845912|NCT03421730|584477128|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845913|NCT03421730|584477117|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845914|NCT03421730|584477118|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845915|NCT03421730|584477119|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845916|NCT03421730|584477120|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845917|NCT03421730|584477121|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
161845918|NCT03421730|584477122|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845919|NCT03421730|584477123|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845920|NCT03421730|584477124|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845921|NCT03421730|584477125|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845922|NCT03421730|584477126|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845923|NCT03421730|584477127|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845924|NCT03421730|584477128|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845925|NCT01661062|584477137|FG000|Overall Study|Completed Treatment Off Study|3|||
161845926|NCT01661062|584477137|FG000|Overall Study|Withdrawal by Subject|2|||
161845927|NCT02387983|584477139|FG000|Overall Study|Adverse Event|4|||
161845928|NCT02387983|584477139|FG000|Overall Study|Protocol Violation|1|||
161845929|NCT02387983|584477139|FG000|Overall Study|Withdrawal by Subject|2|||
161845930|NCT02730351|584477140|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
161845931|NCT02730351|584477141|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
161845932|NCT02730351|584477140|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
161845933|NCT02730351|584477141|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
161845934|NCT02730351|584477140|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
161845935|NCT02730351|584477141|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
161845936|NCT02730351|584477140|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
161845937|NCT02730351|584477141|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
161845938|NCT02730351|584477140|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
161845939|NCT02730351|584477141|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
161845940|NCT00530218|584477142|FG000|Overall Study|CMV Not Detected|13|||
161845941|NCT00530218|584477142|FG000|Overall Study|Death|12|||
161845942|NCT06281171|584477147|FG000|Timepoint 2|Lost to Follow-up|6|||
161845943|NCT06281171|584477148|FG001|Timepoint 2|Lost to Follow-up|4|||
161845944|NCT06281171|584477147|FG000|Timepoint 3|Lost to Follow-up|0|||
161757280|NCT02499172|584151591|FG000|Overall Study|Financial reason|0|||
161757281|NCT02499172|584151592|FG001|Overall Study|Financial reason|0|||
161757282|NCT02499172|584151593|FG002|Overall Study|Financial reason|523|||
161757283|NCT02499172|584151594|FG003|Overall Study|Financial reason|436|||
161757284|NCT02499172|584151591|FG000|Overall Study|Lost to Follow-up|65|||
161757285|NCT02499172|584151592|FG001|Overall Study|Lost to Follow-up|64|||
161757286|NCT02499172|584151593|FG002|Overall Study|Lost to Follow-up|0|||
161757287|NCT02499172|584151594|FG003|Overall Study|Lost to Follow-up|0|||
161757288|NCT01293123|584151595|FG000|Overall Study|Lost to Follow-up|0|||
161757289|NCT01293123|584151596|FG001|Overall Study|Lost to Follow-up|1|||
161757290|NCT01888965|584151606|FG000|Overall Study|Adverse Event|5|||
161757291|NCT01888965|584151606|FG000|Overall Study|Lack of Efficacy|4|||
161757292|NCT04076579|584151607|FG000|Overall Study|Adverse Event|2|||
161757293|NCT04076579|584151608|FG001|Overall Study|Adverse Event|0|||
161757294|NCT04076579|584151607|FG000|Overall Study|discontinued due to toxicity|1|||
161757295|NCT04076579|584151608|FG001|Overall Study|discontinued due to toxicity|0|||
161757296|NCT04076579|584151607|FG000|Overall Study|Physician Decision|1|||
161757297|NCT04076579|584151608|FG001|Overall Study|Physician Decision|0|||
161757298|NCT04076579|584151607|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
161757299|NCT04076579|584151608|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
161757300|NCT04076579|584151607|FG000|Overall Study|Noncompliance|0|||
161757301|NCT04076579|584151608|FG001|Overall Study|Noncompliance|1|||
161757302|NCT04076579|584151607|FG000|Overall Study|Withdrawal by Subject|0|||
161757303|NCT04076579|584151608|FG001|Overall Study|Withdrawal by Subject|2|||
161757304|NCT00186121|584151609|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
161757305|NCT00186121|584151609|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
161757306|NCT00186121|584151609|FG000|Overall Study|Not eligible (no treatment)|1|||
161757307|NCT03650387|584151610|FG000|Overall Study|Withdrawal by Subject|13|||
161757308|NCT03650387|584151610|FG000|Overall Study|Lost to Follow-up|12|||
161757309|NCT03650387|584151610|FG000|Overall Study|Adverse Event (Not related)|1|||
161757310|NCT03650387|584151610|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
161757311|NCT00417248|584151611|FG000|Overall Study|Study Terminated|6|||
161757312|NCT00417248|584151611|FG000|Overall Study|Death|1|||
161757313|NCT00417248|584151611|FG000|Overall Study|Lack of Efficacy|1|||
161757314|NCT05815758|584151612|FG000|Overall Study|Adverse Event|6|||
161757315|NCT05815758|584151613|FG001|Overall Study|Adverse Event|2|||
161757316|NCT05815758|584151612|FG000|Overall Study|Lost to Follow-up|14|||
161757317|NCT05815758|584151613|FG001|Overall Study|Lost to Follow-up|1|||
161757318|NCT05815758|584151612|FG000|Overall Study|Withdrawal by Subject|6|||
161757319|NCT05815758|584151613|FG001|Overall Study|Withdrawal by Subject|6|||
161757320|NCT05815758|584151612|FG000|Overall Study|Protocol Violation|1|||
161757321|NCT05815758|584151613|FG001|Overall Study|Protocol Violation|1|||
161757322|NCT05815758|584151612|FG000|Overall Study|Discontinued|4|||
161757323|NCT05815758|584151613|FG001|Overall Study|Discontinued|4|||
161757324|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Adverse Event|5|||
161757325|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Adverse Event|0|||
161757326|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Adverse Event|0|||
161757327|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Adverse Event|0|||
161757328|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
161757329|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
161757330|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
161757331|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
161757332|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
161757333|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161757334|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161757335|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161757336|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
161757337|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161845945|NCT06281171|584477148|FG001|Timepoint 3|Lost to Follow-up|5|||
161845946|NCT01822275|584477149|FG000|Overall Study|Withdrawal by Subject|3|||
161845947|NCT01822275|584477149|FG000|Overall Study|Adverse Event|3|||
161845948|NCT01822275|584477149|FG000|Overall Study|Progression|14|||
161845949|NCT01822275|584477149|FG000|Overall Study|Physician Decision|2|||
161845950|NCT00513682|584477150|FG000|Washout Phase|Adverse Event|2|||
161845951|NCT03276780|584477151|FG000|Overall Study|Withdrawal by Subject|5|||
161845952|NCT03276780|584477152|FG001|Overall Study|Withdrawal by Subject|3|||
161845953|NCT03276780|584477151|FG000|Overall Study|Lost to Follow-up|3|||
161845954|NCT03276780|584477152|FG001|Overall Study|Lost to Follow-up|5|||
161845955|NCT03276780|584477151|FG000|Overall Study|Moved out of state|1|||
161845956|NCT03276780|584477152|FG001|Overall Study|Moved out of state|1|||
161845957|NCT03276780|584477151|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
161845958|NCT03276780|584477152|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
161845959|NCT03276780|584477151|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
161845960|NCT03276780|584477152|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
161845961|NCT00510289|584477153|FG000|Overall Study|Withdrawal by Subject|7|||
161845962|NCT00510289|584477153|FG000|Overall Study|Refused bone marrow biopsy|2|||
161845963|NCT00510289|584477153|FG000|Overall Study|Lost to Follow-up|1|||
161845964|NCT00510289|584477153|FG000|Overall Study|Progressed prior to starting drug|2|||
161845965|NCT03258853|584477158|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
161845966|NCT03258853|584477159|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
161845967|NCT04241315|584478924|FG000|Overall Study|Withdrawal by Subject|0|||
161845968|NCT04241315|584478925|FG001|Overall Study|Withdrawal by Subject|1|||
161845969|NCT03047330|584478926|FG000|Sleep Block 1|Withdrawal by Subject|3|||
161845970|NCT00663026|584478933|FG000|Overall Study|Lost to Follow-up|1|||
161845971|NCT00663026|584478934|FG001|Overall Study|Lost to Follow-up|0|||
161845972|NCT00663026|584478935|FG002|Overall Study|Lost to Follow-up|0|||
161845973|NCT00663026|584478933|FG000|Overall Study|Other|1|||
161845974|NCT00663026|584478934|FG001|Overall Study|Other|2|||
161845975|NCT00663026|584478935|FG002|Overall Study|Other|0|||
161845976|NCT00663026|584478933|FG000|Overall Study|Adverse Event|0|||
161845977|NCT00663026|584478934|FG001|Overall Study|Adverse Event|2|||
161845978|NCT00663026|584478935|FG002|Overall Study|Adverse Event|3|||
161845979|NCT00663026|584478933|FG000|Overall Study|Caregiver Request|0|||
161845980|NCT00663026|584478934|FG001|Overall Study|Caregiver Request|2|||
161845981|NCT00663026|584478935|FG002|Overall Study|Caregiver Request|0|||
161845982|NCT00663026|584478933|FG000|Overall Study|Withdrawal by Subject|0|||
161845983|NCT00663026|584478934|FG001|Overall Study|Withdrawal by Subject|0|||
161845984|NCT00663026|584478935|FG002|Overall Study|Withdrawal by Subject|1|||
161845985|NCT01392963|584478939|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
161845986|NCT01392963|584478940|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
161845987|NCT01392963|584478939|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
161845988|NCT01392963|584478940|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
161845989|NCT01392963|584478939|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
161845990|NCT01392963|584478940|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
161845991|NCT01735955|584478941|FG000|Overall Study|Administrative problems|1|||
161845992|NCT01735955|584478941|FG000|Overall Study|Patient/guardian decision|1|||
161845993|NCT01735955|584478941|FG000|Overall Study|Patient withdrew consent|2|||
161845994|NCT01735955|584478941|FG000|Overall Study|Physician Decision|4|||
161845995|NCT01735955|584478941|FG000|Overall Study|Disease progression|24|||
161845996|NCT01735955|584478941|FG000|Overall Study|Adverse Event|5|||
161845997|NCT01475097|584478942|FG000|Overall Study|Protocol Violation|1|||
161845998|NCT01475097|584478943|FG001|Overall Study|Protocol Violation|1|||
161845999|NCT01305044|584478944|FG000|Overall Study|Withdrawal by Subject|3|||
161846000|NCT01305044|584478945|FG001|Overall Study|Withdrawal by Subject|6|||
161846001|NCT00492024|584478946|FG000|Treatment|Adverse Event|3|||
161757338|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161757339|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161757340|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Adverse Event|0|||
161757341|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Adverse Event|1|||
161757342|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Adverse Event|0|||
161757343|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Adverse Event|0|||
161757344|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
161757345|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
161757346|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
161757347|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
161846002|NCT00492024|584478947|FG001|Treatment|Adverse Event|1|||
161846003|NCT00492024|584478946|FG000|Treatment|Lack of Efficacy|21|||
161846004|NCT00492024|584478947|FG001|Treatment|Lack of Efficacy|20|||
161846005|NCT00492024|584478946|FG000|Treatment|Lost to Follow-up|3|||
161846006|NCT00492024|584478947|FG001|Treatment|Lost to Follow-up|1|||
161846007|NCT00492024|584478946|FG000|Treatment|Withdrawal by Subject|2|||
161846008|NCT00492024|584478947|FG001|Treatment|Withdrawal by Subject|0|||
161846009|NCT00492024|584478946|FG000|Follow up|Lack of Efficacy|0|||
161846010|NCT00492024|584478947|FG001|Follow up|Lack of Efficacy|1|||
161846011|NCT00492024|584478946|FG000|Follow up|Lost to Follow-up|1|||
161846012|NCT00492024|584478947|FG001|Follow up|Lost to Follow-up|1|||
161846013|NCT03247816|584478948|FG000|Overall Study|Adverse Event|12|||
161846014|NCT03247816|584478948|FG000|Overall Study|Physician Decision|3|||
161846015|NCT03247816|584478948|FG000|Overall Study|Lack of Efficacy|1|||
161846016|NCT03247816|584478948|FG000|Overall Study|Lost to Follow-up|10|||
161846017|NCT03247816|584478948|FG000|Overall Study|Missing Feraccru stop date|3|||
161846018|NCT02861014|584478949|FG000|Primary Analysis|Adverse Event|7|||
161846019|NCT02861014|584478949|FG000|Primary Analysis|Death|1|||
161846020|NCT02861014|584478949|FG000|Primary Analysis|Lack of Efficacy|3|||
161846021|NCT02861014|584478949|FG000|Primary Analysis|Physician Decision|2|||
161846022|NCT02861014|584478949|FG000|Primary Analysis|Pregnancy|4|||
161846023|NCT02861014|584478949|FG000|Primary Analysis|Protocol Violation|2|||
161846024|NCT02861014|584478949|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
161846025|NCT02861014|584478949|FG000|Primary Analysis|Withdrawal by Subject|14|||
161846026|NCT02861014|584478949|FG000|Primary Analysis|Commercial ocrelizumab|3|||
161846027|NCT02861014|584478949|FG000|Safety Follow-up|Adverse Event|1|||
161846028|NCT02861014|584478949|FG000|Safety Follow-up|Pregnancy|1|||
161846029|NCT02861014|584478949|FG000|Safety Follow-up|Withdrawal by Subject|9|||
161846030|NCT02861014|584478949|FG000|Safety Follow-up|Study terminated by sponsor|1|||
161846031|NCT02861014|584478949|FG000|Safety Follow-up|Physician Decision|1|||
161846032|NCT02861014|584478949|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
161846033|NCT02861014|584478949|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
161846034|NCT00926783|584478952|FG000|Overall Study|Incomplete CFAE Procedures|3|||
161846035|NCT00926783|584478953|FG001|Overall Study|Incomplete CFAE Procedures|3|||
161846036|NCT01439009|584478954|FG000|Overall Study|Physician Decision|5|||
161846037|NCT01439009|584478955|FG001|Overall Study|Physician Decision|3|||
161846038|NCT01439009|584478954|FG000|Overall Study|Protocol Violation|2|||
161846039|NCT01439009|584478955|FG001|Overall Study|Protocol Violation|0|||
161846040|NCT01439009|584478954|FG000|Overall Study|Deviation of exclusion criteria|1|||
161846041|NCT01439009|584478955|FG001|Overall Study|Deviation of exclusion criteria|0|||
161846042|NCT00696787|584478957|FG000|Overall Study|Adverse Event|1|||
161846043|NCT00696787|584478958|FG001|Overall Study|Adverse Event|0|||
161846044|NCT00696787|584478959|FG002|Overall Study|Adverse Event|6|||
161846045|NCT00696787|584478957|FG000|Overall Study|Discontinuation by Sponsor|9|||
161846046|NCT00696787|584478958|FG001|Overall Study|Discontinuation by Sponsor|13|||
161846047|NCT00696787|584478959|FG002|Overall Study|Discontinuation by Sponsor|14|||
161846048|NCT00696787|584478957|FG000|Overall Study|Lack of Efficacy|0|||
161846049|NCT00696787|584478958|FG001|Overall Study|Lack of Efficacy|1|||
161846050|NCT00696787|584478959|FG002|Overall Study|Lack of Efficacy|0|||
161846051|NCT00696787|584478957|FG000|Overall Study|Lost to Follow-up|4|||
161846052|NCT00696787|584478958|FG001|Overall Study|Lost to Follow-up|0|||
161846053|NCT00696787|584478959|FG002|Overall Study|Lost to Follow-up|3|||
161846054|NCT00696787|584478957|FG000|Overall Study|Withdrawal by Subject|0|||
161846055|NCT00696787|584478958|FG001|Overall Study|Withdrawal by Subject|3|||
161846056|NCT00696787|584478959|FG002|Overall Study|Withdrawal by Subject|2|||
161846057|NCT00696787|584478957|FG000|Overall Study|Failed to return|1|||
161846058|NCT00696787|584478958|FG001|Overall Study|Failed to return|3|||
161846059|NCT00696787|584478959|FG002|Overall Study|Failed to return|1|||
161846060|NCT00867503|584478961|FG000|Overall Study|Withdrawal by Subject|1|||
161846061|NCT02704403|584478962|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
161846062|NCT02704403|584478963|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
161846063|NCT02704403|584478962|FG000|Overall Study|Administrative reasons by sponsor|1251|||
161846064|NCT02704403|584478963|FG001|Overall Study|Administrative reasons by sponsor|616|||
161846065|NCT02704403|584478962|FG000|Overall Study|Death|4|||
161846066|NCT02704403|584478963|FG001|Overall Study|Death|3|||
161846067|NCT02704403|584478962|FG000|Overall Study|Endpoint event|52|||
161846068|NCT02704403|584478963|FG001|Overall Study|Endpoint event|24|||
161846069|NCT02704403|584478962|FG000|Overall Study|Lost to Follow-up|22|||
161846070|NCT02704403|584478963|FG001|Overall Study|Lost to Follow-up|11|||
161846071|NCT02704403|584478962|FG000|Overall Study|Protocol Violation|15|||
161846072|NCT02704403|584478963|FG001|Overall Study|Protocol Violation|15|||
161846073|NCT02704403|584478962|FG000|Overall Study|Adverse Event|2|||
161846074|NCT02704403|584478963|FG001|Overall Study|Adverse Event|0|||
161846075|NCT02704403|584478962|FG000|Overall Study|Withdrawal by Subject|85|||
161846076|NCT02704403|584478963|FG001|Overall Study|Withdrawal by Subject|45|||
161846077|NCT02704403|584478962|FG000|Overall Study|Investigator decision|1|||
161846078|NCT02704403|584478963|FG001|Overall Study|Investigator decision|1|||
161846079|NCT02704403|584478962|FG000|Overall Study|Follow-up not possible|1|||
161846080|NCT02704403|584478963|FG001|Overall Study|Follow-up not possible|2|||
161846081|NCT00927394|584478972|FG000|Overall Study|Adverse Event|14|||
161846082|NCT00927394|584478973|FG001|Overall Study|Adverse Event|9|||
161757348|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161757349|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161757350|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161757351|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
161757352|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
161757353|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161757354|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161757355|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161757356|NCT02903966|584151618|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
161757357|NCT02903966|584151619|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
161757358|NCT02903966|584151618|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
161757359|NCT02903966|584151619|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
161757360|NCT02903966|584151618|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
161757361|NCT02903966|584151619|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
161757362|NCT00934791|584151620|FG000|Overall Study|Withdrawal by Subject|1|||
161757363|NCT00934791|584151621|FG001|Overall Study|Withdrawal by Subject|0|||
161757364|NCT01320033|584151623|FG000|Overall Study|Lack of Efficacy|0|||
161757365|NCT01320033|584151624|FG001|Overall Study|Lack of Efficacy|0|||
161757366|NCT01320033|584151625|FG002|Overall Study|Lack of Efficacy|1|||
161757367|NCT01320033|584151623|FG000|Overall Study|Adverse Event|9|||
161757368|NCT01320033|584151624|FG001|Overall Study|Adverse Event|7|||
161757369|NCT01320033|584151625|FG002|Overall Study|Adverse Event|8|||
161757370|NCT01320033|584151623|FG000|Overall Study|Withdrawal by Subject|22|||
161757371|NCT01320033|584151624|FG001|Overall Study|Withdrawal by Subject|23|||
161757372|NCT01320033|584151625|FG002|Overall Study|Withdrawal by Subject|23|||
161757373|NCT01320033|584151623|FG000|Overall Study|Protocol Violation|3|||
161757374|NCT01320033|584151624|FG001|Overall Study|Protocol Violation|5|||
161757375|NCT01320033|584151625|FG002|Overall Study|Protocol Violation|3|||
161757376|NCT01320033|584151623|FG000|Overall Study|Lost to Follow-up|22|||
161757377|NCT01320033|584151624|FG001|Overall Study|Lost to Follow-up|26|||
161757378|NCT01320033|584151625|FG002|Overall Study|Lost to Follow-up|17|||
161757379|NCT01320033|584151623|FG000|Overall Study|Other|2|||
161757380|NCT01320033|584151624|FG001|Overall Study|Other|3|||
161757381|NCT01320033|584151625|FG002|Overall Study|Other|1|||
161757382|NCT02425891|584151626|FG000|Overall Study|Death|333|||
161757383|NCT02425891|584151627|FG001|Overall Study|Death|314|||
161757384|NCT02425891|584151626|FG000|Overall Study|Lost to Follow-up|4|||
161757385|NCT02425891|584151627|FG001|Overall Study|Lost to Follow-up|6|||
161757386|NCT02425891|584151626|FG000|Overall Study|Non-Compliance|1|||
161757387|NCT02425891|584151627|FG001|Overall Study|Non-Compliance|1|||
161757388|NCT02425891|584151626|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
161757389|NCT02425891|584151627|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
161757390|NCT02425891|584151626|FG000|Overall Study|Physician Decision|0|||
161757391|NCT02425891|584151627|FG001|Overall Study|Physician Decision|1|||
161757392|NCT02425891|584151626|FG000|Overall Study|Protocol Violation|1|||
161757393|NCT02425891|584151627|FG001|Overall Study|Protocol Violation|1|||
161757394|NCT02425891|584151626|FG000|Overall Study|Study Terminated By Sponsor|85|||
161757395|NCT02425891|584151627|FG001|Overall Study|Study Terminated By Sponsor|95|||
161757396|NCT02425891|584151626|FG000|Overall Study|Withdrawal by Subject|27|||
161757397|NCT02425891|584151627|FG001|Overall Study|Withdrawal by Subject|32|||
161757398|NCT00963469|584151628|FG000|Overall Study|Adverse Event|15|||
161757399|NCT00963469|584151629|FG001|Overall Study|Adverse Event|11|||
161757400|NCT00963469|584151630|FG002|Overall Study|Adverse Event|1|||
161757401|NCT00963469|584151628|FG000|Overall Study|Lack of Efficacy|10|||
161757402|NCT00963469|584151629|FG001|Overall Study|Lack of Efficacy|7|||
161757403|NCT00963469|584151630|FG002|Overall Study|Lack of Efficacy|2|||
161757404|NCT00963469|584151628|FG000|Overall Study|Lost to Follow-up|1|||
161757405|NCT00963469|584151629|FG001|Overall Study|Lost to Follow-up|1|||
161757406|NCT00963469|584151630|FG002|Overall Study|Lost to Follow-up|0|||
161757407|NCT00963469|584151628|FG000|Overall Study|Protocol Violation|5|||
161757408|NCT00963469|584151629|FG001|Overall Study|Protocol Violation|5|||
161757409|NCT00963469|584151630|FG002|Overall Study|Protocol Violation|3|||
161757410|NCT00963469|584151628|FG000|Overall Study|Withdrawal by Subject|4|||
161757411|NCT00963469|584151629|FG001|Overall Study|Withdrawal by Subject|1|||
161757412|NCT00963469|584151630|FG002|Overall Study|Withdrawal by Subject|1|||
161757413|NCT00963469|584151628|FG000|Overall Study|Pre-randomization Adverse Event|1|||
161757414|NCT00963469|584151629|FG001|Overall Study|Pre-randomization Adverse Event|2|||
161757415|NCT00963469|584151630|FG002|Overall Study|Pre-randomization Adverse Event|0|||
161757416|NCT00963469|584151628|FG000|Overall Study|Moved|1|||
161757417|NCT00963469|584151629|FG001|Overall Study|Moved|0|||
161757418|NCT00963469|584151630|FG002|Overall Study|Moved|0|||
161757419|NCT00963469|584151628|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
161757420|NCT00963469|584151629|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
161757421|NCT00963469|584151630|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
161757422|NCT02943577|584151632|FG000|Overall Study|Protocol Violation|0|||
161757423|NCT02943577|584151633|FG001|Overall Study|Protocol Violation|1|||
161757424|NCT02943577|584151632|FG000|Overall Study|Adverse Event|3|||
161757425|NCT02943577|584151633|FG001|Overall Study|Adverse Event|2|||
161757426|NCT02943577|584151632|FG000|Overall Study|Lost to Follow-up|0|||
161846083|NCT00927394|584478972|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
161846084|NCT00927394|584478973|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
161846085|NCT00927394|584478972|FG000|Overall Study|Withdrawal by Subject|20|||
161846086|NCT00927394|584478973|FG001|Overall Study|Withdrawal by Subject|24|||
161846087|NCT00927394|584478972|FG000|Overall Study|Lost to Follow-up|8|||
161846088|NCT00927394|584478973|FG001|Overall Study|Lost to Follow-up|14|||
161846089|NCT00927394|584478972|FG000|Overall Study|Administrative Problem|1|||
161846090|NCT00927394|584478973|FG001|Overall Study|Administrative Problem|0|||
161846091|NCT00927394|584478972|FG000|Overall Study|Death|1|||
161846092|NCT00927394|584478973|FG001|Overall Study|Death|1|||
161846093|NCT00927394|584478972|FG000|Overall Study|Protocol deviation|16|||
161846094|NCT00927394|584478973|FG001|Overall Study|Protocol deviation|13|||
161846095|NCT00927394|584478972|FG000|Overall Study|Randomized in error|0|||
161846096|NCT00927394|584478973|FG001|Overall Study|Randomized in error|1|||
161846097|NCT04623086|584478974|FG000|Overall Study|Withdrawal by Subject|0|||
161846098|NCT04623086|584478975|FG001|Overall Study|Withdrawal by Subject|0|||
161846099|NCT04623086|584478976|FG002|Overall Study|Withdrawal by Subject|10|||
161846100|NCT03464630|584478977|FG000|Overall Study|Lost to Follow-up|62|||
161846101|NCT03464630|584478978|FG001|Overall Study|Lost to Follow-up|52|||
161846102|NCT03464630|584478977|FG000|Overall Study|Withdrawal by Subject|16|||
161846103|NCT03464630|584478978|FG001|Overall Study|Withdrawal by Subject|10|||
161846104|NCT03464630|584478977|FG000|Overall Study|Passive Disengagement|8|||
161846105|NCT03464630|584478978|FG001|Overall Study|Passive Disengagement|4|||
161846106|NCT00715624|584478979|FG000|Overall Study|Adverse Event|12|||
161846107|NCT00715624|584478980|FG001|Overall Study|Adverse Event|37|||
161757427|NCT02943577|584151633|FG001|Overall Study|Lost to Follow-up|1|||
161757428|NCT02943577|584151632|FG000|Overall Study|Withdrawal by Subject|1|||
161757429|NCT02943577|584151633|FG001|Overall Study|Withdrawal by Subject|1|||
161757430|NCT02943577|584151632|FG000|Overall Study|Pregnancy|1|||
161757431|NCT02943577|584151633|FG001|Overall Study|Pregnancy|0|||
161757432|NCT00081263|584151651|FG000|Overall Study|clerical error|1|||
161757433|NCT00081263|584151652|FG001|Overall Study|clerical error|0|||
161757434|NCT00081263|584151651|FG000|Overall Study|wrong cell type|7|||
161757435|NCT00081263|584151652|FG001|Overall Study|wrong cell type|5|||
161757436|NCT00081263|584151651|FG000|Overall Study|improper pre-protocol therapy|0|||
161757437|NCT00081263|584151652|FG001|Overall Study|improper pre-protocol therapy|1|||
161757438|NCT00081263|584151651|FG000|Overall Study|Inadequate pathology|0|||
161757439|NCT00081263|584151652|FG001|Overall Study|Inadequate pathology|1|||
161757440|NCT00081263|584151651|FG000|Overall Study|Never treated|4|||
161757441|NCT00081263|584151652|FG001|Overall Study|Never treated|5|||
161757442|NCT00081263|584151651|FG000|Overall Study|Inadequate data|5|||
161757443|NCT00081263|584151652|FG001|Overall Study|Inadequate data|10|||
161757444|NCT01852591|584151653|FG000|Overall Study|Withdrawal by Subject|2|||
161757445|NCT01852591|584151653|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
161757446|NCT01267955|584151660|FG000|Stage 1 (6 Months)|Death|3|||
161757447|NCT01267955|584151660|FG000|Stage 2 (6 Months)|Death|5|||
161757448|NCT01267955|584151660|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
161757449|NCT01263470|584151662|FG000|Overall Study|Adverse Event|2|||
161757450|NCT01263470|584151663|FG001|Overall Study|Adverse Event|2|||
161757451|NCT01263470|584151664|FG002|Overall Study|Adverse Event|1|||
161757452|NCT01263470|584151665|FG003|Overall Study|Adverse Event|1|||
161757453|NCT01263470|584151666|FG004|Overall Study|Adverse Event|2|||
161757454|NCT01263470|584151667|FG005|Overall Study|Adverse Event|2|||
161757455|NCT01263470|584151662|FG000|Overall Study|Protocol Violation|0|||
161757456|NCT01263470|584151663|FG001|Overall Study|Protocol Violation|1|||
161757457|NCT01263470|584151664|FG002|Overall Study|Protocol Violation|0|||
161757458|NCT01263470|584151665|FG003|Overall Study|Protocol Violation|0|||
161757459|NCT01263470|584151666|FG004|Overall Study|Protocol Violation|0|||
161757460|NCT01263470|584151667|FG005|Overall Study|Protocol Violation|1|||
161757461|NCT01263470|584151662|FG000|Overall Study|Withdrawal by Subject|0|||
161757462|NCT01263470|584151663|FG001|Overall Study|Withdrawal by Subject|1|||
161757463|NCT01263470|584151664|FG002|Overall Study|Withdrawal by Subject|1|||
161757464|NCT01263470|584151665|FG003|Overall Study|Withdrawal by Subject|2|||
161757465|NCT01263470|584151666|FG004|Overall Study|Withdrawal by Subject|0|||
161757466|NCT01263470|584151667|FG005|Overall Study|Withdrawal by Subject|2|||
161757467|NCT01263470|584151662|FG000|Overall Study|Lack of Efficacy|0|||
161757468|NCT01263470|584151663|FG001|Overall Study|Lack of Efficacy|0|||
161757469|NCT01263470|584151664|FG002|Overall Study|Lack of Efficacy|2|||
161757470|NCT01263470|584151665|FG003|Overall Study|Lack of Efficacy|0|||
161757471|NCT01263470|584151666|FG004|Overall Study|Lack of Efficacy|0|||
161757472|NCT01263470|584151667|FG005|Overall Study|Lack of Efficacy|0|||
161757473|NCT01263470|584151662|FG000|Overall Study|Participant Unavailability|0|||
161757474|NCT01263470|584151663|FG001|Overall Study|Participant Unavailability|1|||
161757475|NCT01263470|584151664|FG002|Overall Study|Participant Unavailability|0|||
161757476|NCT01263470|584151665|FG003|Overall Study|Participant Unavailability|0|||
161757477|NCT01263470|584151666|FG004|Overall Study|Participant Unavailability|0|||
161757478|NCT01263470|584151667|FG005|Overall Study|Participant Unavailability|0|||
161757479|NCT01263470|584151662|FG000|Overall Study|Study Drug Non-compliance|0|||
161757480|NCT01263470|584151663|FG001|Overall Study|Study Drug Non-compliance|0|||
161757481|NCT01263470|584151664|FG002|Overall Study|Study Drug Non-compliance|0|||
161757482|NCT01263470|584151665|FG003|Overall Study|Study Drug Non-compliance|0|||
161757483|NCT01263470|584151666|FG004|Overall Study|Study Drug Non-compliance|1|||
161757484|NCT01263470|584151667|FG005|Overall Study|Study Drug Non-compliance|0|||
161757485|NCT00610714|584151668|FG000|Overall Study|Adverse Event|3|||
161757486|NCT00610714|584151669|FG001|Overall Study|Adverse Event|1|||
161757487|NCT00610714|584151668|FG000|Overall Study|Death|12|||
161757488|NCT00610714|584151669|FG001|Overall Study|Death|18|||
161757489|NCT00610714|584151668|FG000|Overall Study|Withdrawal by Subject|9|||
161757490|NCT00610714|584151669|FG001|Overall Study|Withdrawal by Subject|3|||
161757491|NCT00610714|584151668|FG000|Overall Study|Study completion at 120 PFS events|2|||
161757492|NCT00610714|584151669|FG001|Overall Study|Study completion at 120 PFS events|2|||
161757493|NCT01327573|584151670|FG000|Overall Study|Physician Decision|3|||
161757494|NCT01327573|584151671|FG001|Overall Study|Physician Decision|1|||
161757495|NCT01108263|584151672|FG000|Overall Study|Adverse Event|0|||
161757496|NCT01108263|584151673|FG001|Overall Study|Adverse Event|1|||
161757497|NCT03070119|584151675|FG000|Overall Study|Adverse Event|0|||
161757498|NCT03070119|584151676|FG001|Overall Study|Adverse Event|0|||
161757499|NCT03070119|584151677|FG002|Overall Study|Adverse Event|1|||
161757500|NCT03070119|584151675|FG000|Overall Study|Lost to Follow-up|0|||
161757501|NCT03070119|584151676|FG001|Overall Study|Lost to Follow-up|1|||
161757502|NCT03070119|584151677|FG002|Overall Study|Lost to Follow-up|0|||
161757503|NCT03070119|584151675|FG000|Overall Study|Consent Withdrawn|6|||
161757504|NCT03070119|584151676|FG001|Overall Study|Consent Withdrawn|5|||
161757505|NCT03070119|584151677|FG002|Overall Study|Consent Withdrawn|3|||
161757506|NCT03070119|584151675|FG000|Overall Study|Investigator Decision|0|||
161757507|NCT03070119|584151676|FG001|Overall Study|Investigator Decision|0|||
161846108|NCT00715624|584478979|FG000|Overall Study|Lack of Efficacy|11|||
161757508|NCT03070119|584151677|FG002|Overall Study|Investigator Decision|1|||
161757509|NCT03070119|584151675|FG000|Overall Study|Death|7|||
161757510|NCT03070119|584151676|FG001|Overall Study|Death|14|||
161757511|NCT03070119|584151677|FG002|Overall Study|Death|5|||
161846109|NCT00715624|584478980|FG001|Overall Study|Lack of Efficacy|11|||
161846110|NCT00715624|584478979|FG000|Overall Study|Lost to Follow-up|1|||
161846111|NCT00715624|584478980|FG001|Overall Study|Lost to Follow-up|2|||
161846112|NCT00715624|584478979|FG000|Overall Study|Protocol Violation|1|||
161846113|NCT00715624|584478980|FG001|Overall Study|Protocol Violation|0|||
161846114|NCT00715624|584478979|FG000|Overall Study|Withdrawal by Subject|11|||
161846115|NCT00715624|584478980|FG001|Overall Study|Withdrawal by Subject|25|||
161846116|NCT00715624|584478979|FG000|Overall Study|Familial and personal reasons|10|||
161846117|NCT00715624|584478980|FG001|Overall Study|Familial and personal reasons|22|||
161846118|NCT00715624|584478979|FG000|Overall Study|Poor compliance|6|||
161846119|NCT00715624|584478980|FG001|Overall Study|Poor compliance|13|||
161846120|NCT00715624|584478979|FG000|Overall Study|Sponsor decision|0|||
161846121|NCT00715624|584478980|FG001|Overall Study|Sponsor decision|4|||
161846122|NCT00715624|584478979|FG000|Overall Study|Incorrect randomization (not treated)|0|||
161846123|NCT00715624|584478980|FG001|Overall Study|Incorrect randomization (not treated)|1|||
161846124|NCT00715624|584478979|FG000|Overall Study|Other|0|||
161846125|NCT00715624|584478980|FG001|Overall Study|Other|1|||
161846126|NCT04524364|584478984|FG000|Overall Study|Physician Decision|3|||
161846127|NCT04524364|584478985|FG001|Overall Study|Physician Decision|6|||
161846128|NCT04524364|584478984|FG000|Overall Study|Adverse Event|0|||
161846129|NCT04524364|584478985|FG001|Overall Study|Adverse Event|1|||
161846130|NCT04524364|584478984|FG000|Overall Study|Investigational device deficiency|0|||
161846131|NCT04524364|584478985|FG001|Overall Study|Investigational device deficiency|1|||
161846132|NCT04524364|584478984|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
161846133|NCT04524364|584478985|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
161846134|NCT04524364|584478984|FG000|Overall Study|Device unavailability|0|||
161846135|NCT04524364|584478985|FG001|Overall Study|Device unavailability|2|||
161846136|NCT04524364|584478984|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
161846137|NCT04524364|584478985|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
161846138|NCT04524364|584478984|FG000|Overall Study|Low International normalized ratio (INR)|1|||
161846139|NCT04524364|584478985|FG001|Overall Study|Low International normalized ratio (INR)|0|||
161846140|NCT00229723|584478986|FG000|Concomitant Phase|Adverse Event|4|||
161846141|NCT00229723|584478987|FG001|Concomitant Phase|Adverse Event|2|||
161846142|NCT00229723|584478988|FG002|Concomitant Phase|Adverse Event|5|||
161846143|NCT00229723|584478989|FG003|Concomitant Phase|Adverse Event|2|||
161846144|NCT00229723|584478990|FG004|Concomitant Phase|Adverse Event|0|||
161846145|NCT00229723|584478991|FG005|Concomitant Phase|Adverse Event|1|||
161846146|NCT00229723|584478992|FG006|Concomitant Phase|Adverse Event|2|||
161846147|NCT00229723|584478986|FG000|Concomitant Phase|Objective disease progression|0|||
161846148|NCT00229723|584478987|FG001|Concomitant Phase|Objective disease progression|0|||
161846149|NCT00229723|584478988|FG002|Concomitant Phase|Objective disease progression|0|||
161846150|NCT00229723|584478989|FG003|Concomitant Phase|Objective disease progression|0|||
161846151|NCT00229723|584478990|FG004|Concomitant Phase|Objective disease progression|0|||
161846152|NCT00229723|584478991|FG005|Concomitant Phase|Objective disease progression|0|||
161846153|NCT00229723|584478992|FG006|Concomitant Phase|Objective disease progression|0|||
161846154|NCT00229723|584478986|FG000|Concomitant Phase|Clinical progression|0|||
161846155|NCT00229723|584478987|FG001|Concomitant Phase|Clinical progression|0|||
161846156|NCT00229723|584478988|FG002|Concomitant Phase|Clinical progression|0|||
161846157|NCT00229723|584478989|FG003|Concomitant Phase|Clinical progression|0|||
161846158|NCT00229723|584478990|FG004|Concomitant Phase|Clinical progression|0|||
161846159|NCT00229723|584478991|FG005|Concomitant Phase|Clinical progression|0|||
161846160|NCT00229723|584478992|FG006|Concomitant Phase|Clinical progression|1|||
161846161|NCT00229723|584478986|FG000|Concomitant Phase|Lost to Follow-up|0|||
161846162|NCT00229723|584478987|FG001|Concomitant Phase|Lost to Follow-up|0|||
161846163|NCT00229723|584478988|FG002|Concomitant Phase|Lost to Follow-up|0|||
161846164|NCT00229723|584478989|FG003|Concomitant Phase|Lost to Follow-up|0|||
161846165|NCT00229723|584478990|FG004|Concomitant Phase|Lost to Follow-up|1|||
161846166|NCT00229723|584478991|FG005|Concomitant Phase|Lost to Follow-up|0|||
161846167|NCT00229723|584478992|FG006|Concomitant Phase|Lost to Follow-up|0|||
161846168|NCT00229723|584478986|FG000|Concomitant Phase|Informed consent withdrawn|3|||
161846169|NCT00229723|584478987|FG001|Concomitant Phase|Informed consent withdrawn|2|||
161846170|NCT00229723|584478988|FG002|Concomitant Phase|Informed consent withdrawn|0|||
161846171|NCT00229723|584478989|FG003|Concomitant Phase|Informed consent withdrawn|2|||
161846172|NCT00229723|584478990|FG004|Concomitant Phase|Informed consent withdrawn|0|||
161846173|NCT00229723|584478991|FG005|Concomitant Phase|Informed consent withdrawn|0|||
161846174|NCT00229723|584478992|FG006|Concomitant Phase|Informed consent withdrawn|0|||
161757512|NCT03070119|584151675|FG000|Overall Study|Disease Progression|5|||
161757513|NCT03070119|584151676|FG001|Overall Study|Disease Progression|7|||
161757514|NCT03070119|584151677|FG002|Overall Study|Disease Progression|7|||
161757515|NCT03070119|584151675|FG000|Overall Study|Reason not Specified|2|||
161757516|NCT03070119|584151676|FG001|Overall Study|Reason not Specified|2|||
161757517|NCT03070119|584151677|FG002|Overall Study|Reason not Specified|1|||
161757518|NCT02974621|584151678|FG000|Overall Study|Didn't receive study treatment|1|||
161757519|NCT02974621|584151679|FG001|Overall Study|Didn't receive study treatment|10|||
161757520|NCT01996865|584151680|FG000|Induction Period|Protocol Violation|1|||
161757521|NCT01996865|584151681|FG001|Induction Period|Protocol Violation|0|||
161757522|NCT01996865|584151682|FG002|Induction Period|Protocol Violation|0|||
161757523|NCT01996865|584151680|FG000|Induction Period|Progressive Disease|4|||
161757524|NCT01996865|584151681|FG001|Induction Period|Progressive Disease|0|||
161757525|NCT01996865|584151682|FG002|Induction Period|Progressive Disease|0|||
161757526|NCT01996865|584151680|FG000|Induction Period|Lost to Follow-up|10|||
161757527|NCT01996865|584151681|FG001|Induction Period|Lost to Follow-up|0|||
161757528|NCT01996865|584151682|FG002|Induction Period|Lost to Follow-up|0|||
161757529|NCT01996865|584151680|FG000|Induction Period|Other Reasons|13|||
161757530|NCT01996865|584151681|FG001|Induction Period|Other Reasons|0|||
161757531|NCT01996865|584151682|FG002|Induction Period|Other Reasons|0|||
161757532|NCT01996865|584151680|FG000|Induction Period|Adverse Event|20|||
161757533|NCT01996865|584151681|FG001|Induction Period|Adverse Event|0|||
161757534|NCT01996865|584151682|FG002|Induction Period|Adverse Event|0|||
161757535|NCT01996865|584151680|FG000|Induction Period|Withdrawal by Subject|60|||
161757536|NCT01996865|584151681|FG001|Induction Period|Withdrawal by Subject|0|||
161757537|NCT01996865|584151682|FG002|Induction Period|Withdrawal by Subject|0|||
161757538|NCT01996865|584151680|FG000|Induction Period|Death|111|||
161757539|NCT01996865|584151681|FG001|Induction Period|Death|0|||
161757540|NCT01996865|584151682|FG002|Induction Period|Death|0|||
161757541|NCT01996865|584151680|FG000|Maintenance Period|Protocol Violation|0|||
161757542|NCT01996865|584151681|FG001|Maintenance Period|Protocol Violation|1|||
161757543|NCT01996865|584151682|FG002|Maintenance Period|Protocol Violation|1|||
161757544|NCT01996865|584151680|FG000|Maintenance Period|Other reasons|0|||
161757545|NCT01996865|584151681|FG001|Maintenance Period|Other reasons|8|||
161757546|NCT01996865|584151682|FG002|Maintenance Period|Other reasons|5|||
161757547|NCT01996865|584151680|FG000|Maintenance Period|Progressive Disease|0|||
161757548|NCT01996865|584151681|FG001|Maintenance Period|Progressive Disease|6|||
161757549|NCT01996865|584151682|FG002|Maintenance Period|Progressive Disease|23|||
161757550|NCT01996865|584151680|FG000|Maintenance Period|Withdrawal by Subject|0|||
161757551|NCT01996865|584151681|FG001|Maintenance Period|Withdrawal by Subject|18|||
161757552|NCT01996865|584151682|FG002|Maintenance Period|Withdrawal by Subject|4|||
161757553|NCT01996865|584151680|FG000|Maintenance Period|Adverse Event|0|||
161757554|NCT01996865|584151681|FG001|Maintenance Period|Adverse Event|7|||
161757555|NCT01996865|584151682|FG002|Maintenance Period|Adverse Event|7|||
161757556|NCT01996865|584151680|FG000|Maintenance Period|Death|0|||
161757557|NCT01996865|584151681|FG001|Maintenance Period|Death|15|||
161757558|NCT01996865|584151682|FG002|Maintenance Period|Death|3|||
161757559|NCT01996865|584151680|FG000|Maintenance Period|Lost to Follow-up|0|||
161757560|NCT01996865|584151681|FG001|Maintenance Period|Lost to Follow-up|2|||
161757561|NCT01996865|584151682|FG002|Maintenance Period|Lost to Follow-up|0|||
161757562|NCT05304611|584151685|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757563|NCT05304611|584151686|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757564|NCT05304611|584151687|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757565|NCT05304611|584151688|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757566|NCT05304611|584151689|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757567|NCT05304611|584151690|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757568|NCT05304611|584151691|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
161757569|NCT05304611|584151692|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757570|NCT05304611|584151693|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
161757571|NCT05304611|584151694|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757572|NCT05304611|584151695|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757573|NCT05304611|584151696|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757574|NCT05304611|584151685|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
161757575|NCT05304611|584151686|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
161757576|NCT05304611|584151687|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
161757577|NCT05304611|584151688|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
161846175|NCT00229723|584478986|FG000|Concomitant Phase|Severe non-compliance|0|||
161846176|NCT00229723|584478987|FG001|Concomitant Phase|Severe non-compliance|1|||
161846177|NCT00229723|584478988|FG002|Concomitant Phase|Severe non-compliance|0|||
161846178|NCT00229723|584478989|FG003|Concomitant Phase|Severe non-compliance|0|||
161846179|NCT00229723|584478990|FG004|Concomitant Phase|Severe non-compliance|1|||
161846180|NCT00229723|584478991|FG005|Concomitant Phase|Severe non-compliance|0|||
161846181|NCT00229723|584478992|FG006|Concomitant Phase|Severe non-compliance|0|||
161846182|NCT00229723|584478986|FG000|Concomitant Phase|Other|3|||
161846183|NCT00229723|584478987|FG001|Concomitant Phase|Other|0|||
161846184|NCT00229723|584478988|FG002|Concomitant Phase|Other|1|||
161846185|NCT00229723|584478989|FG003|Concomitant Phase|Other|1|||
161846186|NCT00229723|584478990|FG004|Concomitant Phase|Other|0|||
161846187|NCT00229723|584478991|FG005|Concomitant Phase|Other|2|||
161846188|NCT00229723|584478992|FG006|Concomitant Phase|Other|0|||
161846189|NCT00229723|584478986|FG000|Maintenance Phase|Adverse Event|7|||
161846190|NCT00229723|584478987|FG001|Maintenance Phase|Adverse Event|2|||
161846191|NCT00229723|584478988|FG002|Maintenance Phase|Adverse Event|1|||
161846192|NCT00229723|584478989|FG003|Maintenance Phase|Adverse Event|4|||
161846193|NCT00229723|584478990|FG004|Maintenance Phase|Adverse Event|7|||
161846194|NCT00229723|584478991|FG005|Maintenance Phase|Adverse Event|5|||
161846195|NCT00229723|584478992|FG006|Maintenance Phase|Adverse Event|2|||
161846196|NCT00229723|584478986|FG000|Maintenance Phase|Objective disease progression|5|||
161846197|NCT00229723|584478987|FG001|Maintenance Phase|Objective disease progression|5|||
161846198|NCT00229723|584478988|FG002|Maintenance Phase|Objective disease progression|3|||
161846199|NCT00229723|584478989|FG003|Maintenance Phase|Objective disease progression|6|||
161846200|NCT00229723|584478990|FG004|Maintenance Phase|Objective disease progression|2|||
161846201|NCT00229723|584478991|FG005|Maintenance Phase|Objective disease progression|9|||
161846202|NCT00229723|584478992|FG006|Maintenance Phase|Objective disease progression|5|||
161846203|NCT00229723|584478986|FG000|Maintenance Phase|Clinical progression|4|||
161846204|NCT00229723|584478987|FG001|Maintenance Phase|Clinical progression|1|||
161846205|NCT00229723|584478988|FG002|Maintenance Phase|Clinical progression|2|||
161846206|NCT00229723|584478989|FG003|Maintenance Phase|Clinical progression|2|||
161846207|NCT00229723|584478990|FG004|Maintenance Phase|Clinical progression|1|||
161846208|NCT00229723|584478991|FG005|Maintenance Phase|Clinical progression|1|||
161846209|NCT00229723|584478992|FG006|Maintenance Phase|Clinical progression|1|||
161846210|NCT00229723|584478986|FG000|Maintenance Phase|Lost to Follow-up|0|||
161846211|NCT00229723|584478987|FG001|Maintenance Phase|Lost to Follow-up|1|||
161846212|NCT00229723|584478988|FG002|Maintenance Phase|Lost to Follow-up|2|||
161846213|NCT00229723|584478989|FG003|Maintenance Phase|Lost to Follow-up|2|||
161846214|NCT00229723|584478990|FG004|Maintenance Phase|Lost to Follow-up|0|||
161846215|NCT00229723|584478991|FG005|Maintenance Phase|Lost to Follow-up|0|||
161846216|NCT00229723|584478992|FG006|Maintenance Phase|Lost to Follow-up|1|||
161846217|NCT00229723|584478986|FG000|Maintenance Phase|Informed consent withdrawn|1|||
161846218|NCT00229723|584478987|FG001|Maintenance Phase|Informed consent withdrawn|0|||
161846219|NCT00229723|584478988|FG002|Maintenance Phase|Informed consent withdrawn|0|||
161846220|NCT00229723|584478989|FG003|Maintenance Phase|Informed consent withdrawn|1|||
161846221|NCT00229723|584478990|FG004|Maintenance Phase|Informed consent withdrawn|1|||
161846222|NCT00229723|584478991|FG005|Maintenance Phase|Informed consent withdrawn|1|||
161846223|NCT00229723|584478992|FG006|Maintenance Phase|Informed consent withdrawn|0|||
161846224|NCT00229723|584478986|FG000|Maintenance Phase|Severe non-compliance|3|||
161846225|NCT00229723|584478987|FG001|Maintenance Phase|Severe non-compliance|1|||
161846226|NCT00229723|584478988|FG002|Maintenance Phase|Severe non-compliance|0|||
161846227|NCT00229723|584478989|FG003|Maintenance Phase|Severe non-compliance|0|||
161757578|NCT05304611|584151689|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
161757579|NCT05304611|584151690|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
161757580|NCT05304611|584151691|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
161757581|NCT05304611|584151692|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
161757582|NCT05304611|584151693|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
161757583|NCT05304611|584151694|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
161757584|NCT05304611|584151695|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
161757585|NCT05304611|584151696|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
161757586|NCT05304611|584151685|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
161757587|NCT05304611|584151686|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
161757588|NCT05304611|584151687|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
161757589|NCT05304611|584151688|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
161757590|NCT05304611|584151689|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
161757591|NCT05304611|584151690|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
161757592|NCT05304611|584151691|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
161846228|NCT00229723|584478990|FG004|Maintenance Phase|Severe non-compliance|1|||
161846229|NCT00229723|584478991|FG005|Maintenance Phase|Severe non-compliance|0|||
161846230|NCT00229723|584478992|FG006|Maintenance Phase|Severe non-compliance|0|||
161846231|NCT00229723|584478986|FG000|Maintenance Phase|Other|5|||
161846232|NCT00229723|584478987|FG001|Maintenance Phase|Other|4|||
161846233|NCT00229723|584478988|FG002|Maintenance Phase|Other|1|||
161846234|NCT00229723|584478989|FG003|Maintenance Phase|Other|2|||
161846235|NCT00229723|584478990|FG004|Maintenance Phase|Other|3|||
161757593|NCT05304611|584151692|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
161757594|NCT05304611|584151693|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
161757595|NCT05304611|584151694|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
161757596|NCT05304611|584151695|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
161757597|NCT05304611|584151696|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
161757598|NCT00963820|584151701|FG000|Dose Escalation Phase|Progressive Disease|3|||
161757599|NCT00963820|584151702|FG001|Dose Escalation Phase|Progressive Disease|3|||
161757600|NCT00963820|584151703|FG002|Dose Escalation Phase|Progressive Disease|3|||
161757601|NCT00963820|584151704|FG003|Dose Escalation Phase|Progressive Disease|3|||
161757602|NCT00963820|584151705|FG004|Dose Escalation Phase|Progressive Disease|4|||
161757603|NCT00963820|584151706|FG005|Dose Escalation Phase|Progressive Disease|3|||
161757604|NCT00963820|584151707|FG006|Dose Escalation Phase|Progressive Disease|3|||
161757605|NCT00963820|584151708|FG007|Dose Escalation Phase|Progressive Disease|2|||
161757606|NCT00963820|584151709|FG008|Dose Escalation Phase|Progressive Disease|0|||
161757607|NCT00963820|584151710|FG009|Dose Escalation Phase|Progressive Disease|0|||
161757608|NCT00963820|584151711|FG010|Dose Escalation Phase|Progressive Disease|0|||
161757609|NCT00963820|584151712|FG011|Dose Escalation Phase|Progressive Disease|0|||
161757610|NCT00963820|584151701|FG000|Dose Escalation Phase|Adverse Event|0|||
161757611|NCT00963820|584151702|FG001|Dose Escalation Phase|Adverse Event|0|||
161757612|NCT00963820|584151703|FG002|Dose Escalation Phase|Adverse Event|0|||
161757613|NCT00963820|584151704|FG003|Dose Escalation Phase|Adverse Event|0|||
161757614|NCT00963820|584151705|FG004|Dose Escalation Phase|Adverse Event|0|||
161757615|NCT00963820|584151706|FG005|Dose Escalation Phase|Adverse Event|0|||
161757616|NCT00963820|584151707|FG006|Dose Escalation Phase|Adverse Event|3|||
161757617|NCT00963820|584151708|FG007|Dose Escalation Phase|Adverse Event|1|||
161757618|NCT00963820|584151709|FG008|Dose Escalation Phase|Adverse Event|0|||
161757619|NCT00963820|584151710|FG009|Dose Escalation Phase|Adverse Event|0|||
161757620|NCT00963820|584151711|FG010|Dose Escalation Phase|Adverse Event|0|||
161757621|NCT00963820|584151712|FG011|Dose Escalation Phase|Adverse Event|0|||
161757622|NCT00963820|584151701|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161757623|NCT00963820|584151702|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161757624|NCT00963820|584151703|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161757625|NCT00963820|584151704|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161757626|NCT00963820|584151705|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
161757627|NCT00963820|584151706|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
161757628|NCT00963820|584151707|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
161757629|NCT00963820|584151708|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
161757630|NCT00963820|584151709|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
161757631|NCT00963820|584151710|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
161757632|NCT00963820|584151711|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
161757633|NCT00963820|584151712|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
161757634|NCT00963820|584151701|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757635|NCT00963820|584151702|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757636|NCT00963820|584151703|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757637|NCT00963820|584151704|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757638|NCT00963820|584151705|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757639|NCT00963820|584151706|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757640|NCT00963820|584151707|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161757641|NCT00963820|584151708|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757642|NCT00963820|584151709|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757643|NCT00963820|584151710|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757644|NCT00963820|584151711|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757645|NCT00963820|584151712|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757646|NCT00963820|584151701|FG000|Expansion Phase|Progressive Disease|0|||
161757647|NCT00963820|584151702|FG001|Expansion Phase|Progressive Disease|0|||
161757648|NCT00963820|584151703|FG002|Expansion Phase|Progressive Disease|0|||
161757649|NCT00963820|584151704|FG003|Expansion Phase|Progressive Disease|0|||
161757650|NCT00963820|584151705|FG004|Expansion Phase|Progressive Disease|0|||
161757651|NCT00963820|584151706|FG005|Expansion Phase|Progressive Disease|0|||
161757652|NCT00963820|584151707|FG006|Expansion Phase|Progressive Disease|0|||
161757653|NCT00963820|584151708|FG007|Expansion Phase|Progressive Disease|0|||
161757654|NCT00963820|584151709|FG008|Expansion Phase|Progressive Disease|8|||
161757655|NCT00963820|584151710|FG009|Expansion Phase|Progressive Disease|6|||
161757656|NCT00963820|584151711|FG010|Expansion Phase|Progressive Disease|4|||
161757657|NCT00963820|584151712|FG011|Expansion Phase|Progressive Disease|2|||
161757658|NCT00963820|584151701|FG000|Expansion Phase|Adverse Event|0|||
161757659|NCT00963820|584151702|FG001|Expansion Phase|Adverse Event|0|||
161757660|NCT00963820|584151703|FG002|Expansion Phase|Adverse Event|0|||
161757661|NCT00963820|584151704|FG003|Expansion Phase|Adverse Event|0|||
161757662|NCT00963820|584151705|FG004|Expansion Phase|Adverse Event|0|||
161757663|NCT00963820|584151706|FG005|Expansion Phase|Adverse Event|0|||
161757664|NCT00963820|584151707|FG006|Expansion Phase|Adverse Event|0|||
161757665|NCT00963820|584151708|FG007|Expansion Phase|Adverse Event|0|||
161757666|NCT00963820|584151709|FG008|Expansion Phase|Adverse Event|1|||
161757667|NCT00963820|584151710|FG009|Expansion Phase|Adverse Event|3|||
161757668|NCT00963820|584151711|FG010|Expansion Phase|Adverse Event|0|||
161846236|NCT00229723|584478991|FG005|Maintenance Phase|Other|3|||
161846237|NCT00229723|584478992|FG006|Maintenance Phase|Other|1|||
161846238|NCT02309138|584478993|FG000|Overall Study|Withdrawal by Subject|44|||
161846239|NCT02309138|584478994|FG001|Overall Study|Withdrawal by Subject|15|||
161846240|NCT02309138|584478993|FG000|Overall Study|Protocol Violation|4|||
161846241|NCT02309138|584478994|FG001|Overall Study|Protocol Violation|2|||
161846242|NCT02309138|584478993|FG000|Overall Study|delivered before visit 2|0|||
161846243|NCT02309138|584478994|FG001|Overall Study|delivered before visit 2|1|||
161846244|NCT00735397|584479000|FG000|Overall Study|Adverse Event|194|||
161846245|NCT00735397|584479000|FG000|Overall Study|Lost to Follow-up|33|||
161846246|NCT00735397|584479000|FG000|Overall Study|Participant choice|252|||
161846247|NCT00735397|584479000|FG000|Overall Study|Inadequate therapeutic effect|202|||
161846248|NCT00735397|584479000|FG000|Overall Study|Administrative/Other|502|||
161846249|NCT00380744|584479001|FG000|Overall Study|Death|0|||
161846250|NCT00380744|584479002|FG001|Overall Study|Death|0|||
161846251|NCT00380744|584479003|FG002|Overall Study|Death|0|||
161846252|NCT00380744|584479004|FG003|Overall Study|Death|0|||
161846253|NCT00380744|584479005|FG004|Overall Study|Death|0|||
161846254|NCT00380744|584479006|FG005|Overall Study|Death|0|||
161846255|NCT00380744|584479007|FG006|Overall Study|Death|1|||
161846256|NCT00380744|584479001|FG000|Overall Study|Withdrawal by Subject|1|||
161846257|NCT00380744|584479002|FG001|Overall Study|Withdrawal by Subject|0|||
161846258|NCT00380744|584479003|FG002|Overall Study|Withdrawal by Subject|0|||
161846259|NCT00380744|584479004|FG003|Overall Study|Withdrawal by Subject|0|||
161846260|NCT00380744|584479005|FG004|Overall Study|Withdrawal by Subject|0|||
161846261|NCT00380744|584479006|FG005|Overall Study|Withdrawal by Subject|0|||
161846262|NCT00380744|584479007|FG006|Overall Study|Withdrawal by Subject|0|||
161846263|NCT01338870|584479012|FG000|Overall Study|Lost to Follow-up|0|||
161846264|NCT01338870|584479013|FG001|Overall Study|Lost to Follow-up|0|||
161846265|NCT01338870|584479014|FG002|Overall Study|Lost to Follow-up|1|||
161846266|NCT01338870|584479015|FG003|Overall Study|Lost to Follow-up|0|||
161846267|NCT01338870|584479016|FG004|Overall Study|Lost to Follow-up|1|||
161846268|NCT01338870|584479017|FG005|Overall Study|Lost to Follow-up|0|||
161846269|NCT01338870|584479012|FG000|Overall Study|Withdrawal by Subject|2|||
161846270|NCT01338870|584479013|FG001|Overall Study|Withdrawal by Subject|3|||
161846271|NCT01338870|584479014|FG002|Overall Study|Withdrawal by Subject|4|||
161846272|NCT01338870|584479015|FG003|Overall Study|Withdrawal by Subject|0|||
161846273|NCT01338870|584479016|FG004|Overall Study|Withdrawal by Subject|0|||
161846274|NCT01338870|584479017|FG005|Overall Study|Withdrawal by Subject|2|||
161846275|NCT01338870|584479012|FG000|Overall Study|Other|3|||
161846276|NCT01338870|584479013|FG001|Overall Study|Other|3|||
161846277|NCT01338870|584479014|FG002|Overall Study|Other|3|||
161846278|NCT01338870|584479015|FG003|Overall Study|Other|2|||
161846279|NCT01338870|584479016|FG004|Overall Study|Other|0|||
161846280|NCT01338870|584479017|FG005|Overall Study|Other|2|||
161846281|NCT01338870|584479012|FG000|Overall Study|Protocol Violation|0|||
161846282|NCT01338870|584479013|FG001|Overall Study|Protocol Violation|2|||
161846283|NCT01338870|584479014|FG002|Overall Study|Protocol Violation|2|||
161846284|NCT01338870|584479015|FG003|Overall Study|Protocol Violation|2|||
161846285|NCT01338870|584479016|FG004|Overall Study|Protocol Violation|1|||
161846286|NCT01338870|584479017|FG005|Overall Study|Protocol Violation|1|||
161846287|NCT01338870|584479012|FG000|Overall Study|Adverse Event|4|||
161846288|NCT01338870|584479013|FG001|Overall Study|Adverse Event|4|||
161846289|NCT01338870|584479014|FG002|Overall Study|Adverse Event|1|||
161846290|NCT01338870|584479015|FG003|Overall Study|Adverse Event|5|||
161846291|NCT01338870|584479016|FG004|Overall Study|Adverse Event|4|||
161846292|NCT01338870|584479017|FG005|Overall Study|Adverse Event|1|||
161846293|NCT01955083|584479018|FG000|Overall Study|Lost to Follow-up|1|||
161846294|NCT01955083|584479019|FG001|Overall Study|Lost to Follow-up|1|||
161846295|NCT01559389|584479030|FG000|Overall Study|Withdrawal by Subject|20|||
161846296|NCT01559389|584479031|FG001|Overall Study|Withdrawal by Subject|20|||
161846297|NCT02871492|584479032|FG000|Overall Study|Lost to Follow-up|6|||
161846298|NCT02871492|584479033|FG001|Overall Study|Lost to Follow-up|3|||
161846299|NCT02871492|584479034|FG002|Overall Study|Lost to Follow-up|5|||
161846300|NCT02871492|584479032|FG000|Overall Study|Withdrawal by Subject|0|||
161846301|NCT02871492|584479033|FG001|Overall Study|Withdrawal by Subject|0|||
161846302|NCT02871492|584479034|FG002|Overall Study|Withdrawal by Subject|1|||
161846303|NCT04546724|584479035|FG000|Overall Study|Withdrawal by Subject|145|||
161846304|NCT04546724|584479036|FG001|Overall Study|Withdrawal by Subject|41|||
161846305|NCT04546724|584479035|FG000|Overall Study|Adverse Event|1|||
161846306|NCT04546724|584479036|FG001|Overall Study|Adverse Event|1|||
161846307|NCT04546724|584479035|FG000|Overall Study|Lost to Follow-up|186|||
161846308|NCT04546724|584479036|FG001|Overall Study|Lost to Follow-up|63|||
161846309|NCT04546724|584479035|FG000|Overall Study|Physician Decision|8|||
161846310|NCT04546724|584479036|FG001|Overall Study|Physician Decision|2|||
161846311|NCT04546724|584479035|FG000|Overall Study|Death|2|||
161846312|NCT04546724|584479036|FG001|Overall Study|Death|1|||
161846313|NCT04546724|584479035|FG000|Overall Study|subject has been out of town|1|||
161846314|NCT04546724|584479036|FG001|Overall Study|subject has been out of town|0|||
161757669|NCT00963820|584151712|FG011|Expansion Phase|Adverse Event|0|||
161757670|NCT00963820|584151701|FG000|Expansion Phase|Withdrawal by Subject|0|||
161757671|NCT00963820|584151702|FG001|Expansion Phase|Withdrawal by Subject|0|||
161757672|NCT00963820|584151703|FG002|Expansion Phase|Withdrawal by Subject|0|||
161757673|NCT00963820|584151704|FG003|Expansion Phase|Withdrawal by Subject|0|||
161757674|NCT00963820|584151705|FG004|Expansion Phase|Withdrawal by Subject|0|||
161757675|NCT00963820|584151706|FG005|Expansion Phase|Withdrawal by Subject|0|||
161757676|NCT00963820|584151707|FG006|Expansion Phase|Withdrawal by Subject|0|||
161757677|NCT00963820|584151708|FG007|Expansion Phase|Withdrawal by Subject|0|||
161757678|NCT00963820|584151709|FG008|Expansion Phase|Withdrawal by Subject|1|||
161757679|NCT00963820|584151710|FG009|Expansion Phase|Withdrawal by Subject|0|||
161757680|NCT00963820|584151711|FG010|Expansion Phase|Withdrawal by Subject|1|||
161757681|NCT00963820|584151712|FG011|Expansion Phase|Withdrawal by Subject|1|||
161757682|NCT00963820|584151701|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757683|NCT00963820|584151702|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757684|NCT00963820|584151703|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757685|NCT00963820|584151704|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757686|NCT00963820|584151705|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757687|NCT00963820|584151706|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757688|NCT00963820|584151707|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757689|NCT00963820|584151708|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757690|NCT00963820|584151709|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757691|NCT00963820|584151710|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757692|NCT00963820|584151711|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757693|NCT00963820|584151712|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
161757694|NCT02354690|584151713|FG000|Overall Study|Physician Decision|1|||
161757695|NCT04556175|584151721|FG000|Overall Study|Study terminated due to COVID-19|8|||
161757696|NCT04556175|584151722|FG001|Overall Study|Study terminated due to COVID-19|8|||
161757697|NCT05549505|584151724|FG000|Overall Study|Lost to Follow-up|2|||
161757698|NCT05549505|584151725|FG001|Overall Study|Lost to Follow-up|0|||
161757699|NCT05549505|584151724|FG000|Overall Study|Withdrawal by Subject|3|||
161757700|NCT05549505|584151725|FG001|Overall Study|Withdrawal by Subject|3|||
161757701|NCT05549505|584151724|FG000|Overall Study|Other: Miscellaneous|3|||
161757702|NCT05549505|584151725|FG001|Overall Study|Other: Miscellaneous|6|||
161757703|NCT02756845|584151728|FG000|Overall Study|Death|12|||
161757704|NCT02756845|584151729|FG001|Overall Study|Death|2|||
161757705|NCT02756845|584151728|FG000|Overall Study|Withdrawal by Subject|1|||
161757706|NCT02756845|584151729|FG001|Overall Study|Withdrawal by Subject|0|||
161757707|NCT02005211|584151734|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757708|NCT02005211|584151735|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757709|NCT02005211|584151736|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757710|NCT02005211|584151737|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757711|NCT02005211|584151738|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
161757712|NCT02005211|584151739|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757713|NCT02005211|584151740|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757714|NCT00397631|584151743|FG000|Overall Study|Adverse Event|5|||
161757715|NCT00397631|584151744|FG001|Overall Study|Adverse Event|6|||
161757716|NCT00397631|584151743|FG000|Overall Study|Lack of Efficacy|7|||
161757717|NCT00397631|584151744|FG001|Overall Study|Lack of Efficacy|10|||
161757718|NCT00397631|584151743|FG000|Overall Study|Lost to Follow-up|8|||
161757719|NCT00397631|584151744|FG001|Overall Study|Lost to Follow-up|9|||
161757720|NCT00397631|584151743|FG000|Overall Study|Physician Decision|2|||
161757721|NCT00397631|584151744|FG001|Overall Study|Physician Decision|0|||
161757722|NCT00397631|584151743|FG000|Overall Study|Protocol Violation|0|||
161757723|NCT00397631|584151744|FG001|Overall Study|Protocol Violation|1|||
161757724|NCT00397631|584151743|FG000|Overall Study|Withdrawal by Subject|7|||
161757725|NCT00397631|584151744|FG001|Overall Study|Withdrawal by Subject|14|||
161757726|NCT00397631|584151743|FG000|Overall Study|protocol discontinuation criteria|1|||
161757727|NCT00397631|584151744|FG001|Overall Study|protocol discontinuation criteria|4|||
161757728|NCT02202161|584151745|FG000|Overall Study|Adverse Event|1|||
161757729|NCT02202161|584151746|FG001|Overall Study|Adverse Event|1|||
161757730|NCT02202161|584151747|FG002|Overall Study|Adverse Event|0|||
161757731|NCT02202161|584151748|FG003|Overall Study|Adverse Event|0|||
161757732|NCT02202161|584151749|FG004|Overall Study|Adverse Event|0|||
161757733|NCT02202161|584151750|FG005|Overall Study|Adverse Event|1|||
161757734|NCT02202161|584151751|FG006|Overall Study|Adverse Event|0|||
161757735|NCT02202161|584151752|FG007|Overall Study|Adverse Event|0|||
161757736|NCT02202161|584151745|FG000|Overall Study|Did not meet continuation criteria|0|||
161757737|NCT02202161|584151746|FG001|Overall Study|Did not meet continuation criteria|0|||
161757738|NCT02202161|584151747|FG002|Overall Study|Did not meet continuation criteria|0|||
161757739|NCT02202161|584151748|FG003|Overall Study|Did not meet continuation criteria|0|||
161757740|NCT02202161|584151749|FG004|Overall Study|Did not meet continuation criteria|0|||
161757741|NCT02202161|584151750|FG005|Overall Study|Did not meet continuation criteria|0|||
161757742|NCT02202161|584151751|FG006|Overall Study|Did not meet continuation criteria|0|||
161757743|NCT02202161|584151752|FG007|Overall Study|Did not meet continuation criteria|3|||
161846315|NCT04546724|584479035|FG000|Overall Study|subject is incarcerated|2|||
161846316|NCT04546724|584479036|FG001|Overall Study|subject is incarcerated|0|||
161757744|NCT02202161|584151745|FG000|Overall Study|Physician Decision|0|||
161757745|NCT02202161|584151746|FG001|Overall Study|Physician Decision|0|||
161757746|NCT02202161|584151747|FG002|Overall Study|Physician Decision|0|||
161757747|NCT02202161|584151748|FG003|Overall Study|Physician Decision|0|||
161757748|NCT02202161|584151749|FG004|Overall Study|Physician Decision|0|||
161757749|NCT02202161|584151750|FG005|Overall Study|Physician Decision|0|||
161757750|NCT02202161|584151751|FG006|Overall Study|Physician Decision|0|||
161757751|NCT02202161|584151752|FG007|Overall Study|Physician Decision|3|||
161846317|NCT04546724|584479035|FG000|Overall Study|subject is relocating|12|||
161846318|NCT04546724|584479036|FG001|Overall Study|subject is relocating|4|||
161846319|NCT04546724|584479035|FG000|Overall Study|Subject in another study|1|||
161846320|NCT04546724|584479036|FG001|Overall Study|Subject in another study|1|||
161846321|NCT03583086|584479037|FG000|Overall Study|Death|2|||
161846322|NCT03583086|584479038|FG001|Overall Study|Death|6|||
161846323|NCT03583086|584479039|FG002|Overall Study|Death|12|||
161846324|NCT03583086|584479040|FG003|Overall Study|Death|10|||
161846325|NCT03583086|584479041|FG004|Overall Study|Death|14|||
161846326|NCT03583086|584479042|FG005|Overall Study|Death|14|||
161846327|NCT03583086|584479043|FG006|Overall Study|Death|4|||
161846328|NCT03583086|584479037|FG000|Overall Study|Withdrawal by Subject|0|||
161846329|NCT03583086|584479038|FG001|Overall Study|Withdrawal by Subject|0|||
161846330|NCT03583086|584479039|FG002|Overall Study|Withdrawal by Subject|1|||
161846331|NCT03583086|584479040|FG003|Overall Study|Withdrawal by Subject|0|||
161846332|NCT03583086|584479041|FG004|Overall Study|Withdrawal by Subject|0|||
161846333|NCT03583086|584479042|FG005|Overall Study|Withdrawal by Subject|0|||
161846334|NCT03583086|584479043|FG006|Overall Study|Withdrawal by Subject|1|||
161846335|NCT03583086|584479037|FG000|Overall Study|Refused follow-up|0|||
161846336|NCT03583086|584479038|FG001|Overall Study|Refused follow-up|0|||
161846337|NCT03583086|584479039|FG002|Overall Study|Refused follow-up|1|||
161846338|NCT03583086|584479040|FG003|Overall Study|Refused follow-up|0|||
161846339|NCT03583086|584479041|FG004|Overall Study|Refused follow-up|1|||
161846340|NCT03583086|584479042|FG005|Overall Study|Refused follow-up|0|||
161846341|NCT03583086|584479043|FG006|Overall Study|Refused follow-up|0|||
161846342|NCT03583086|584479037|FG000|Overall Study|Declining Performance Status|0|||
161846343|NCT03583086|584479038|FG001|Overall Study|Declining Performance Status|0|||
161846344|NCT03583086|584479039|FG002|Overall Study|Declining Performance Status|1|||
161846345|NCT03583086|584479040|FG003|Overall Study|Declining Performance Status|0|||
161846346|NCT03583086|584479041|FG004|Overall Study|Declining Performance Status|0|||
161846347|NCT03583086|584479042|FG005|Overall Study|Declining Performance Status|0|||
161846348|NCT03583086|584479043|FG006|Overall Study|Declining Performance Status|0|||
161757752|NCT02202161|584151745|FG000|Overall Study|Withdrawal by Subject|0|||
161757753|NCT02202161|584151746|FG001|Overall Study|Withdrawal by Subject|0|||
161757754|NCT02202161|584151747|FG002|Overall Study|Withdrawal by Subject|0|||
161846349|NCT03583086|584479037|FG000|Overall Study|Still on study|0|||
161846350|NCT03583086|584479038|FG001|Overall Study|Still on study|0|||
161846351|NCT03583086|584479039|FG002|Overall Study|Still on study|0|||
161846352|NCT03583086|584479040|FG003|Overall Study|Still on study|1|||
161846353|NCT03583086|584479041|FG004|Overall Study|Still on study|0|||
161757755|NCT02202161|584151748|FG003|Overall Study|Withdrawal by Subject|0|||
161757756|NCT02202161|584151749|FG004|Overall Study|Withdrawal by Subject|1|||
161757757|NCT02202161|584151750|FG005|Overall Study|Withdrawal by Subject|0|||
161757758|NCT02202161|584151751|FG006|Overall Study|Withdrawal by Subject|0|||
161757759|NCT02202161|584151752|FG007|Overall Study|Withdrawal by Subject|0|||
161757760|NCT03685643|584151755|FG000|Overall Study|Lost to Follow-up|14|||
161757761|NCT03685643|584151756|FG001|Overall Study|Lost to Follow-up|22|||
161757762|NCT03797144|584151757|FG000|Enrollment|Protocol Violation|4|||
161757763|NCT03797144|584151758|FG001|Enrollment|Protocol Violation|1|||
161757764|NCT03797144|584151757|FG000|Surgery|Protocol Violation|1|||
161757765|NCT03797144|584151758|FG001|Surgery|Protocol Violation|0|||
161757766|NCT03797144|584151757|FG000|3 Month|Early termination cut-off date|2|||
161757767|NCT03797144|584151758|FG001|3 Month|Early termination cut-off date|0|||
161757768|NCT03797144|584151757|FG000|12 Month|Early termination cut-off date|8|||
161757769|NCT03797144|584151758|FG001|12 Month|Early termination cut-off date|9|||
161757770|NCT03797144|584151757|FG000|24 Month|Early termination cut-off date|1|||
161757771|NCT03797144|584151758|FG001|24 Month|Early termination cut-off date|1|||
161757772|NCT03299166|584151761|FG000|Overall Study|Adverse Event|9|||
161757773|NCT03299166|584151762|FG001|Overall Study|Adverse Event|4|||
161757774|NCT03299166|584151761|FG000|Overall Study|Withdrawal by Subject|6|||
161757775|NCT03299166|584151762|FG001|Overall Study|Withdrawal by Subject|5|||
161757776|NCT03299166|584151761|FG000|Overall Study|Physician Decision|1|||
161757777|NCT03299166|584151762|FG001|Overall Study|Physician Decision|1|||
161757778|NCT03299166|584151761|FG000|Overall Study|Sponsor Decision|3|||
161757779|NCT03299166|584151762|FG001|Overall Study|Sponsor Decision|0|||
161757780|NCT03299166|584151761|FG000|Overall Study|Lost to Follow-up|2|||
161757781|NCT03299166|584151762|FG001|Overall Study|Lost to Follow-up|4|||
161757782|NCT03299166|584151761|FG000|Overall Study|Randomization Error|0|||
161757783|NCT03299166|584151762|FG001|Overall Study|Randomization Error|1|||
161757784|NCT03299166|584151761|FG000|Overall Study|Subject unable to return due to COVID|1|||
161757785|NCT03299166|584151762|FG001|Overall Study|Subject unable to return due to COVID|0|||
161757786|NCT03299166|584151761|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
161757787|NCT03299166|584151762|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
161757788|NCT00707486|584151767|FG000|Overall Study|Withdrawal by Subject|1|||
161757789|NCT01885104|584151776|FG000|Overall Study|Withdrawal of Consent|1|||
161757790|NCT01885104|584151777|FG001|Overall Study|Withdrawal of Consent|0|||
161757791|NCT01885104|584151776|FG000|Overall Study|Lost to Follow-up|0|||
161757792|NCT01885104|584151777|FG001|Overall Study|Lost to Follow-up|1|||
161757793|NCT01885104|584151776|FG000|Overall Study|Physician Decision|1|||
161757794|NCT01885104|584151777|FG001|Overall Study|Physician Decision|0|||
161757795|NCT00126425|584151779|FG000|Overall Study|Withdrawal by Subject|17|||
161757796|NCT00126425|584151780|FG001|Overall Study|Withdrawal by Subject|1|||
161757797|NCT00126425|584151779|FG000|Overall Study|Lost to Follow-up|8|||
161757798|NCT00126425|584151780|FG001|Overall Study|Lost to Follow-up|4|||
161757799|NCT00126425|584151779|FG000|Overall Study|Protocol Violation|9|||
161757800|NCT00126425|584151780|FG001|Overall Study|Protocol Violation|6|||
161757801|NCT00126425|584151779|FG000|Overall Study|Adverse Event|1|||
161757802|NCT00126425|584151780|FG001|Overall Study|Adverse Event|0|||
161757803|NCT00126425|584151779|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
161757804|NCT00126425|584151780|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
161757805|NCT00126425|584151779|FG000|Overall Study|Other|5|||
161757806|NCT00126425|584151780|FG001|Overall Study|Other|0|||
161757807|NCT01894776|584151781|FG000|Overall Study|Withdrawal by Subject|1|||
161757808|NCT01855919|584153952|FG000|Overall Study|Adverse Event|16|||
161757809|NCT01855919|584153953|FG001|Overall Study|Adverse Event|8|||
161757810|NCT01855919|584153952|FG000|Overall Study|Lack of Efficacy|1|||
161757811|NCT01855919|584153953|FG001|Overall Study|Lack of Efficacy|3|||
161757812|NCT01855919|584153952|FG000|Overall Study|Withdrawal by Subject|4|||
161757813|NCT01855919|584153953|FG001|Overall Study|Withdrawal by Subject|10|||
161757814|NCT01855919|584153952|FG000|Overall Study|Entry Criteria Not Met|1|||
161757815|NCT01855919|584153953|FG001|Overall Study|Entry Criteria Not Met|1|||
161757816|NCT01855919|584153952|FG000|Overall Study|Protocol Violation|1|||
161757817|NCT01855919|584153953|FG001|Overall Study|Protocol Violation|4|||
161757818|NCT01625897|584153956|FG000|Overall Study|Adverse Event|27|||
161846354|NCT03583086|584479042|FG005|Overall Study|Still on study|0|||
161757819|NCT01625897|584153957|FG001|Overall Study|Adverse Event|10|||
161757820|NCT01625897|584153956|FG000|Overall Study|Physician Decision|0|||
161757821|NCT01625897|584153957|FG001|Overall Study|Physician Decision|1|||
161757822|NCT01625897|584153956|FG000|Overall Study|Withdrawal by Subject|25|||
161757823|NCT01625897|584153957|FG001|Overall Study|Withdrawal by Subject|3|||
161757824|NCT03455530|584153958|FG000|Overall Study|Withdrawal by Subject|9|||
161757825|NCT03455530|584153959|FG001|Overall Study|Withdrawal by Subject|1|||
161757826|NCT03455530|584153960|FG002|Overall Study|Withdrawal by Subject|3|||
161757827|NCT03455530|584153961|FG003|Overall Study|Withdrawal by Subject|3|||
161757828|NCT02972658|584153966|FG000|Overall Study|Adverse Event|0|||
161757829|NCT02972658|584153967|FG001|Overall Study|Adverse Event|3|||
161757830|NCT02972658|584153968|FG002|Overall Study|Adverse Event|0|||
161757831|NCT02972658|584153969|FG003|Overall Study|Adverse Event|2|||
161757832|NCT02972658|584153966|FG000|Overall Study|Other-determined by Investigator|1|||
161757833|NCT02972658|584153967|FG001|Overall Study|Other-determined by Investigator|1|||
161757834|NCT02972658|584153968|FG002|Overall Study|Other-determined by Investigator|0|||
161757835|NCT02972658|584153969|FG003|Overall Study|Other-determined by Investigator|0|||
161757836|NCT02972658|584153966|FG000|Overall Study|Death|0|||
161757837|NCT02972658|584153967|FG001|Overall Study|Death|0|||
161757838|NCT02972658|584153968|FG002|Overall Study|Death|0|||
161757839|NCT02972658|584153969|FG003|Overall Study|Death|1|||
161757840|NCT02972658|584153966|FG000|Overall Study|Lost to Follow-up|0|||
161757841|NCT02972658|584153967|FG001|Overall Study|Lost to Follow-up|1|||
161757842|NCT02972658|584153968|FG002|Overall Study|Lost to Follow-up|1|||
161757843|NCT02972658|584153969|FG003|Overall Study|Lost to Follow-up|2|||
161757844|NCT02972658|584153966|FG000|Overall Study|Progressive Disease|0|||
161757845|NCT02972658|584153967|FG001|Overall Study|Progressive Disease|1|||
161757846|NCT02972658|584153968|FG002|Overall Study|Progressive Disease|0|||
161757847|NCT02972658|584153969|FG003|Overall Study|Progressive Disease|1|||
161757848|NCT02972658|584153966|FG000|Overall Study|Withdrawal by Subject|4|||
161757849|NCT02972658|584153967|FG001|Overall Study|Withdrawal by Subject|4|||
161757850|NCT02972658|584153968|FG002|Overall Study|Withdrawal by Subject|1|||
161757851|NCT02972658|584153969|FG003|Overall Study|Withdrawal by Subject|6|||
161757852|NCT02972658|584153966|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161757853|NCT02972658|584153967|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161757854|NCT02972658|584153968|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161757855|NCT02972658|584153969|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
161757856|NCT02972658|584153966|FG000|Overall Study|Sponsor Decision|70|||
161757857|NCT02972658|584153967|FG001|Overall Study|Sponsor Decision|127|||
161757858|NCT02972658|584153968|FG002|Overall Study|Sponsor Decision|72|||
161757859|NCT02972658|584153969|FG003|Overall Study|Sponsor Decision|119|||
161757860|NCT03958149|584153974|FG000|Overall Study|Withdrawal by Subject|0|||
161757861|NCT03958149|584153975|FG001|Overall Study|Withdrawal by Subject|1|||
161757862|NCT02785588|584153978|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
161757863|NCT02785588|584153978|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
161757864|NCT03037489|584153979|FG000|Overall Study|Adverse Event|4|||
161757865|NCT03037489|584153980|FG001|Overall Study|Adverse Event|0|||
161757866|NCT03037489|584153979|FG000|Overall Study|Withdrawal by Subject|3|||
161757867|NCT03037489|584153980|FG001|Overall Study|Withdrawal by Subject|0|||
161757868|NCT00724243|584153982|FG000|Overall Study|Lack of Efficacy|10|||
161757869|NCT00724243|584153982|FG000|Overall Study|Adverse Event|5|||
161757870|NCT03031327|584153983|FG000|Overall Study|Withdrawal by Subject|0|||
161757871|NCT03031327|584153984|FG001|Overall Study|Withdrawal by Subject|1|||
161757872|NCT03031327|584153985|FG002|Overall Study|Withdrawal by Subject|1|||
161757873|NCT00669240|584153986|FG000|Overall Study|Lack of Efficacy|33|||
161757874|NCT00669240|584153986|FG000|Overall Study|Withdrawal by Subject|42|||
161757875|NCT00669240|584153986|FG000|Overall Study|Lost to Follow-up|34|||
161757876|NCT00669240|584153986|FG000|Overall Study|Adverse Event|21|||
161757877|NCT00669240|584153986|FG000|Overall Study|Other|19|||
161757878|NCT00669240|584153986|FG000|Overall Study|Enrolled but not treated|15|||
161757879|NCT00669240|584153986|FG000|Overall Study|Enrolled but no dosing record|1|||
161757880|NCT01997892|584153989|FG000|Overall Study|Physician Decision|2|||
161757881|NCT01997892|584153989|FG000|Overall Study|Lost to Follow-up|6|||
161757882|NCT01997892|584153989|FG000|Overall Study|Death|14|||
161757883|NCT01997892|584153989|FG000|Overall Study|Renal transplant|8|||
161757884|NCT01997892|584153989|FG000|Overall Study|Other|3|||
161757885|NCT01997892|584153989|FG000|Overall Study|Study completion data not recorded|35|||
161757886|NCT02531633|584153990|FG000|Part A (52 Weeks)|Sponsor request|24|||
161757887|NCT02531633|584153991|FG001|Part A (52 Weeks)|Sponsor request|24|||
161757888|NCT02531633|584153992|FG002|Part A (52 Weeks)|Sponsor request|18|||
161757889|NCT02531633|584153993|FG003|Part A (52 Weeks)|Sponsor request|18|||
161757890|NCT02531633|584153994|FG004|Part A (52 Weeks)|Sponsor request|19|||
161757891|NCT02531633|584153995|FG005|Part A (52 Weeks)|Sponsor request|0|||
161757892|NCT02531633|584153996|FG006|Part A (52 Weeks)|Sponsor request|0|||
161757893|NCT02531633|584153997|FG007|Part A (52 Weeks)|Sponsor request|0|||
161757894|NCT02531633|584153998|FG008|Part A (52 Weeks)|Sponsor request|0|||
161757895|NCT02531633|584153999|FG009|Part A (52 Weeks)|Sponsor request|0|||
161757896|NCT02531633|584153990|FG000|Part A (52 Weeks)|Protocol Violation|1|||
161757897|NCT02531633|584153991|FG001|Part A (52 Weeks)|Protocol Violation|0|||
161757898|NCT02531633|584153992|FG002|Part A (52 Weeks)|Protocol Violation|0|||
161846355|NCT03583086|584479043|FG006|Overall Study|Still on study|1|||
161846356|NCT03583086|584479037|FG000|Overall Study|Disease progression|0|||
161846357|NCT03583086|584479038|FG001|Overall Study|Disease progression|0|||
161846358|NCT03583086|584479039|FG002|Overall Study|Disease progression|0|||
161846359|NCT03583086|584479040|FG003|Overall Study|Disease progression|0|||
161846360|NCT03583086|584479041|FG004|Overall Study|Disease progression|0|||
161846361|NCT03583086|584479042|FG005|Overall Study|Disease progression|0|||
161846362|NCT03583086|584479043|FG006|Overall Study|Disease progression|1|||
161846363|NCT03583086|584479037|FG000|Overall Study|Undergoing radiation therapy|0|||
161846364|NCT03583086|584479038|FG001|Overall Study|Undergoing radiation therapy|0|||
161846365|NCT03583086|584479039|FG002|Overall Study|Undergoing radiation therapy|0|||
161846366|NCT03583086|584479040|FG003|Overall Study|Undergoing radiation therapy|0|||
161846367|NCT03583086|584479041|FG004|Overall Study|Undergoing radiation therapy|0|||
161846368|NCT03583086|584479042|FG005|Overall Study|Undergoing radiation therapy|0|||
161846369|NCT03583086|584479043|FG006|Overall Study|Undergoing radiation therapy|1|||
161846370|NCT03583086|584479037|FG000|Overall Study|Lost to Follow-up|0|||
161846371|NCT03583086|584479038|FG001|Overall Study|Lost to Follow-up|0|||
161846372|NCT03583086|584479039|FG002|Overall Study|Lost to Follow-up|0|||
161846373|NCT03583086|584479040|FG003|Overall Study|Lost to Follow-up|0|||
161846374|NCT03583086|584479041|FG004|Overall Study|Lost to Follow-up|0|||
161846375|NCT03583086|584479042|FG005|Overall Study|Lost to Follow-up|1|||
161757899|NCT02531633|584153993|FG003|Part A (52 Weeks)|Protocol Violation|0|||
161757900|NCT02531633|584153994|FG004|Part A (52 Weeks)|Protocol Violation|0|||
161757901|NCT02531633|584153995|FG005|Part A (52 Weeks)|Protocol Violation|0|||
161757902|NCT02531633|584153996|FG006|Part A (52 Weeks)|Protocol Violation|0|||
161757903|NCT02531633|584153997|FG007|Part A (52 Weeks)|Protocol Violation|0|||
161757904|NCT02531633|584153998|FG008|Part A (52 Weeks)|Protocol Violation|0|||
161757905|NCT02531633|584153999|FG009|Part A (52 Weeks)|Protocol Violation|0|||
161757906|NCT02531633|584153990|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
161757907|NCT02531633|584153991|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
161757908|NCT02531633|584153992|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
161757909|NCT02531633|584153993|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
161757910|NCT02531633|584153994|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
161757911|NCT02531633|584153995|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
161757912|NCT02531633|584153996|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
161757913|NCT02531633|584153997|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
161757914|NCT02531633|584153998|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
161757915|NCT02531633|584153999|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
161757916|NCT02531633|584153990|FG000|Part A (52 Weeks)|Physician Decision|1|||
161757917|NCT02531633|584153991|FG001|Part A (52 Weeks)|Physician Decision|4|||
161757918|NCT02531633|584153992|FG002|Part A (52 Weeks)|Physician Decision|3|||
161757919|NCT02531633|584153993|FG003|Part A (52 Weeks)|Physician Decision|1|||
161757920|NCT02531633|584153994|FG004|Part A (52 Weeks)|Physician Decision|0|||
161757921|NCT02531633|584153995|FG005|Part A (52 Weeks)|Physician Decision|0|||
161757922|NCT02531633|584153996|FG006|Part A (52 Weeks)|Physician Decision|0|||
161757923|NCT02531633|584153997|FG007|Part A (52 Weeks)|Physician Decision|0|||
161757924|NCT02531633|584153998|FG008|Part A (52 Weeks)|Physician Decision|0|||
161757925|NCT02531633|584153999|FG009|Part A (52 Weeks)|Physician Decision|0|||
161757926|NCT02531633|584153990|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
161757927|NCT02531633|584153991|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
161757928|NCT02531633|584153992|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
161757929|NCT02531633|584153993|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
161757930|NCT02531633|584153994|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
161757931|NCT02531633|584153995|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757932|NCT02531633|584153996|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757933|NCT02531633|584153997|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757934|NCT02531633|584153998|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757935|NCT02531633|584153999|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757936|NCT02531633|584153990|FG000|Part A (52 Weeks)|Other|2|||
161757937|NCT02531633|584153991|FG001|Part A (52 Weeks)|Other|0|||
161757938|NCT02531633|584153992|FG002|Part A (52 Weeks)|Other|0|||
161757939|NCT02531633|584153993|FG003|Part A (52 Weeks)|Other|0|||
161757940|NCT02531633|584153994|FG004|Part A (52 Weeks)|Other|0|||
161757941|NCT02531633|584153995|FG005|Part A (52 Weeks)|Other|0|||
161757942|NCT02531633|584153996|FG006|Part A (52 Weeks)|Other|0|||
161757943|NCT02531633|584153997|FG007|Part A (52 Weeks)|Other|0|||
161846376|NCT03583086|584479043|FG006|Overall Study|Lost to Follow-up|0|||
161846377|NCT03583086|584479037|FG000|Overall Study|Adverse Event|0|||
161846378|NCT03583086|584479038|FG001|Overall Study|Adverse Event|0|||
161846379|NCT03583086|584479039|FG002|Overall Study|Adverse Event|0|||
161846380|NCT03583086|584479040|FG003|Overall Study|Adverse Event|0|||
161846381|NCT03583086|584479041|FG004|Overall Study|Adverse Event|0|||
161757944|NCT02531633|584153998|FG008|Part A (52 Weeks)|Other|0|||
161757945|NCT02531633|584153999|FG009|Part A (52 Weeks)|Other|0|||
161757946|NCT02531633|584153990|FG000|Part B (104 Weeks)|Sponsor request|0|||
161757947|NCT02531633|584153991|FG001|Part B (104 Weeks)|Sponsor request|0|||
161757948|NCT02531633|584153992|FG002|Part B (104 Weeks)|Sponsor request|0|||
161757949|NCT02531633|584153993|FG003|Part B (104 Weeks)|Sponsor request|0|||
161757950|NCT02531633|584153994|FG004|Part B (104 Weeks)|Sponsor request|0|||
161757951|NCT02531633|584153995|FG005|Part B (104 Weeks)|Sponsor request|8|||
161757952|NCT02531633|584153996|FG006|Part B (104 Weeks)|Sponsor request|5|||
161757953|NCT02531633|584153997|FG007|Part B (104 Weeks)|Sponsor request|3|||
161757954|NCT02531633|584153998|FG008|Part B (104 Weeks)|Sponsor request|5|||
161757955|NCT02531633|584153999|FG009|Part B (104 Weeks)|Sponsor request|4|||
161757956|NCT02531633|584153990|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
161757957|NCT02531633|584153991|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
161757958|NCT02531633|584153992|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
161757959|NCT02531633|584153993|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
161757960|NCT02531633|584153994|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
161757961|NCT02531633|584153995|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
161757962|NCT02531633|584153996|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
161757963|NCT02531633|584153997|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
161757964|NCT02531633|584153998|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
161757965|NCT02531633|584153999|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
161757966|NCT04097925|584154006|FG000|Overall Study|Withdrawal by Subject|1|||
161757967|NCT02608099|584154007|FG000|Overall Study|Ablation procedure not initiated|3|||
161757968|NCT02608099|584154008|FG001|Overall Study|Ablation procedure not initiated|2|||
161757969|NCT00087594|584154013|FG000|Overall Study|Adverse Event|2|||
161757970|NCT00087594|584154014|FG001|Overall Study|Adverse Event|3|||
161757971|NCT00087594|584154013|FG000|Overall Study|Lost to Follow-up|0|||
161757972|NCT00087594|584154014|FG001|Overall Study|Lost to Follow-up|2|||
161757973|NCT00087594|584154013|FG000|Overall Study|Withdrawal by Subject|4|||
161757974|NCT00087594|584154014|FG001|Overall Study|Withdrawal by Subject|2|||
161757975|NCT00087594|584154013|FG000|Overall Study|Lack of Efficacy|2|||
161757976|NCT00087594|584154014|FG001|Overall Study|Lack of Efficacy|5|||
161757977|NCT01952041|584154018|FG000|Overall Study|Lost to Follow-up|9|||
161757978|NCT01952041|584154019|FG001|Overall Study|Lost to Follow-up|16|||
161757979|NCT01952041|584154018|FG000|Overall Study|Withdrawal by Subject|7|||
161757980|NCT01952041|584154019|FG001|Overall Study|Withdrawal by Subject|5|||
161757981|NCT01952041|584154018|FG000|Overall Study|Death|1|||
161757982|NCT01952041|584154019|FG001|Overall Study|Death|0|||
161757983|NCT01736176|584154020|FG000|Overall Study|Adverse Event|3|||
161757984|NCT01736176|584154020|FG000|Overall Study|Withdrawal by Subject|4|||
161757985|NCT01736176|584154020|FG000|Overall Study|Lack of Efficacy|3|||
161757986|NCT01736176|584154020|FG000|Overall Study|Unable to Complete PEG Placement|1|||
161757987|NCT01569568|584154021|FG000|Overall Study|Physician Decision|0|||
161757988|NCT01569568|584154022|FG001|Overall Study|Physician Decision|2|||
161757989|NCT00290355|584154027|FG000|Overall Study|Serious adverse event|7|||
161757990|NCT00290355|584154028|FG001|Overall Study|Serious adverse event|4|||
161757991|NCT00290355|584154027|FG000|Overall Study|Study product reactogenicity|1|||
161757992|NCT00290355|584154028|FG001|Overall Study|Study product reactogenicity|0|||
161846382|NCT03583086|584479042|FG005|Overall Study|Adverse Event|1|||
161757993|NCT00290355|584154027|FG000|Overall Study|Protocol Violation|1|||
161757994|NCT00290355|584154028|FG001|Overall Study|Protocol Violation|0|||
161757995|NCT00290355|584154027|FG000|Overall Study|Withdrawal by Subject|2|||
161757996|NCT00290355|584154028|FG001|Overall Study|Withdrawal by Subject|0|||
161757997|NCT00290355|584154027|FG000|Overall Study|Migrated / moved from the study area|1|||
161757998|NCT00290355|584154028|FG001|Overall Study|Migrated / moved from the study area|0|||
161846383|NCT03583086|584479043|FG006|Overall Study|Adverse Event|0|||
161846384|NCT00396812|584479047|FG000|Overall Study|Physician Decision|1|||
161846385|NCT03201445|584479049|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
161846386|NCT03201445|584479050|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
161846387|NCT03201445|584479049|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
161846388|NCT03201445|584479050|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
161846389|NCT03201445|584479049|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
161846390|NCT03201445|584479050|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
161846391|NCT03201445|584479049|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
161846392|NCT03201445|584479050|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
161846393|NCT03201445|584479049|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
161846394|NCT03201445|584479050|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
161846395|NCT03201445|584479049|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
161846396|NCT03201445|584479050|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
161846397|NCT03201445|584479049|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
161846398|NCT03201445|584479050|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
161846399|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
161846400|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
161846401|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
161846402|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
161757999|NCT00290355|584154027|FG000|Overall Study|Lost to Follow-up|3|||
161758000|NCT00290355|584154028|FG001|Overall Study|Lost to Follow-up|1|||
161758001|NCT00290355|584154027|FG000|Overall Study|Other|2|||
161758002|NCT00290355|584154028|FG001|Overall Study|Other|0|||
161758003|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
161758004|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
161758005|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
161758006|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
161758007|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
161758008|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
161758009|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
161758010|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
161758011|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161758012|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
161758013|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161758014|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161758015|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
161758016|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
161758017|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
161758018|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
161758019|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161758020|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
161758021|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161758022|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161758023|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
161758024|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
161758025|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
161758026|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
161758027|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
161758028|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
161758029|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
161758030|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
161758031|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
161758032|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
161758033|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
161758034|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
161758035|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161758036|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161758037|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161758038|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
161758039|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161758040|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161758041|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
161758042|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161758043|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
161758044|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
161758045|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
161758046|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
161758047|NCT03991936|584154033|FG000|Overall Study|Lost to Follow-up|1|||
161758048|NCT03991936|584154034|FG001|Overall Study|Lost to Follow-up|1|||
161758049|NCT03991936|584154035|FG002|Overall Study|Lost to Follow-up|1|||
161758050|NCT03991936|584154036|FG003|Overall Study|Lost to Follow-up|1|||
161758051|NCT03991936|584154037|FG004|Overall Study|Lost to Follow-up|1|||
161758052|NCT00939055|584154038|FG000|Overall Study|Discontinuation prior to procedure|4|||
161758053|NCT00939055|584154039|FG001|Overall Study|Discontinuation prior to procedure|0|||
161758054|NCT00584987|584154040|FG000|Overall Study|Protocol Violation|1|||
161846403|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
161846404|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
161846405|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
161758055|NCT00584987|584154041|FG001|Overall Study|Protocol Violation|1|||
161758056|NCT00584987|584154042|FG002|Overall Study|Protocol Violation|1|||
161758057|NCT00584987|584154043|FG003|Overall Study|Protocol Violation|0|||
161846406|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
161758058|NCT00584987|584154040|FG000|Overall Study|Adverse Event|0|||
161758059|NCT00584987|584154041|FG001|Overall Study|Adverse Event|0|||
161846407|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
161846408|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
161846409|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
161846410|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
161846411|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
161846412|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
161846413|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
161846414|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
161846415|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
161846416|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
161846417|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
161846418|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
161846419|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
161846420|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
161846421|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
161846422|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
161846423|NCT03201445|584479049|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
161846424|NCT03201445|584479050|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
161846425|NCT03201445|584479049|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
161846426|NCT03201445|584479050|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
161846427|NCT01228019|584479051|FG000|Overall Study|Dose Violation|70|||
161846428|NCT01228019|584479051|FG000|Overall Study|Duplicate enrollment|1|||
161846429|NCT01228019|584479051|FG000|Overall Study|Missing pre-treatment data|72|||
161846430|NCT01228019|584479051|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
161846431|NCT01228019|584479051|FG000|Overall Study|Violation of Entry Criterion|9|||
161846432|NCT01346293|584479054|FG000|Overall Study|Protocol Violation|30|||
161846433|NCT01346293|584479055|FG001|Overall Study|Protocol Violation|9|||
161846434|NCT01346293|584479054|FG000|Overall Study|Lost to Follow-up|21|||
161846435|NCT01346293|584479055|FG001|Overall Study|Lost to Follow-up|8|||
161846436|NCT01346293|584479054|FG000|Overall Study|Withdrawal by Subject|15|||
161846437|NCT01346293|584479055|FG001|Overall Study|Withdrawal by Subject|4|||
161758060|NCT00584987|584154042|FG002|Overall Study|Adverse Event|0|||
161758061|NCT00584987|584154043|FG003|Overall Study|Adverse Event|1|||
161758062|NCT01944462|584154047|FG000|PPPP Educational Program|Lost to Follow-up|60|||
161758063|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
161758064|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
161758065|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
161758066|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
161758067|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Other|1|||
161758068|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Other|0|||
161758069|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Other|2|||
161758070|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Other|4|||
161758071|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
161758072|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
161758073|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
161758074|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
161758075|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Adverse Event|0|||
161758076|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Adverse Event|0|||
161758077|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Adverse Event|1|||
161758078|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Adverse Event|2|||
161758079|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
161758080|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
161758081|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
161758082|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
161758083|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
161758084|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
161758085|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
161758086|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
161758087|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
161758088|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
161758089|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
161758090|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
161758091|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161758092|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161758093|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
161758094|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161758095|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
161758096|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
161758097|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
161758098|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
161758099|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
161758100|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
161758101|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
161758102|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
161758103|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
161758104|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
161758105|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
161758106|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
161758107|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
161758108|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
161758109|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
161758110|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
161758111|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161758112|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161758113|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
161758114|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161758115|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
161758116|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
161758117|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
161758118|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
161758119|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161758120|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161758121|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
161758122|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161758123|NCT00723489|584154055|FG000|Overall Study|Physician Decision|0|||
161758124|NCT00723489|584154056|FG001|Overall Study|Physician Decision|1|||
161758125|NCT00723489|584154057|FG002|Overall Study|Physician Decision|0|||
161758126|NCT00723489|584154058|FG003|Overall Study|Physician Decision|0|||
161758127|NCT00723489|584154055|FG000|Overall Study|Pregnancy|0|||
161846438|NCT01346293|584479054|FG000|Overall Study|Other|1|||
161846439|NCT01346293|584479055|FG001|Overall Study|Other|0|||
161846440|NCT01844505|584479059|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
161846441|NCT01844505|584479060|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
161846442|NCT01844505|584479061|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
161846443|NCT01844505|584479059|FG000|Treatment Period|Other Reasons|120|||
161846444|NCT01844505|584479060|FG001|Treatment Period|Other Reasons|136|||
161846445|NCT01844505|584479061|FG002|Treatment Period|Other Reasons|58|||
161846446|NCT01844505|584479059|FG000|Treatment Period|Lost to Follow-up|9|||
161846447|NCT01844505|584479060|FG001|Treatment Period|Lost to Follow-up|11|||
161846448|NCT01844505|584479061|FG002|Treatment Period|Lost to Follow-up|6|||
161846449|NCT01844505|584479059|FG000|Treatment Period|Death|175|||
161846450|NCT01844505|584479060|FG001|Treatment Period|Death|154|||
161846451|NCT01844505|584479061|FG002|Treatment Period|Death|228|||
161846452|NCT00128830|584479062|FG000|Overall Study|Adverse Event|10|||
161846453|NCT00128830|584479062|FG000|Overall Study|Withdrawal by Subject|14|||
161846454|NCT00128830|584479062|FG000|Overall Study|Lost to Follow-up|4|||
161846455|NCT00128830|584479062|FG000|Overall Study|Reached a virologic endpoint|29|||
161846456|NCT00128830|584479062|FG000|Overall Study|Non-compliant|4|||
161846457|NCT00128830|584479062|FG000|Overall Study|Discontinued or ineligible for study|2|||
161846458|NCT00128830|584479062|FG000|Overall Study|Other|9|||
161846459|NCT00311402|584479063|FG000|Overall Study|Adverse Event|118|||
161846460|NCT00311402|584479064|FG001|Overall Study|Adverse Event|105|||
161846461|NCT00311402|584479063|FG000|Overall Study|Lost to Follow-up|0|||
161846462|NCT00311402|584479064|FG001|Overall Study|Lost to Follow-up|3|||
161846463|NCT00311402|584479063|FG000|Overall Study|Withdrawal by Subject|17|||
161846464|NCT00311402|584479064|FG001|Overall Study|Withdrawal by Subject|18|||
161846465|NCT00311402|584479063|FG000|Overall Study|Lack of Efficacy|58|||
161846466|NCT00311402|584479064|FG001|Overall Study|Lack of Efficacy|42|||
161846467|NCT00311402|584479063|FG000|Overall Study|Protocol Violation|7|||
161846468|NCT00311402|584479064|FG001|Overall Study|Protocol Violation|6|||
161846469|NCT00311402|584479063|FG000|Overall Study|IRB's rejection etc.|10|||
161846470|NCT00311402|584479064|FG001|Overall Study|IRB's rejection etc.|3|||
161846471|NCT02640053|584479065|FG000|Overall Study|Withdrawal by Subject|2|||
161846472|NCT02640053|584479066|FG001|Overall Study|Withdrawal by Subject|1|||
161846473|NCT02640053|584479065|FG000|Overall Study|Adverse Event|1|||
161846474|NCT02640053|584479066|FG001|Overall Study|Adverse Event|1|||
161846475|NCT02640053|584479065|FG000|Overall Study|Alternative Therapy|1|||
161846476|NCT02640053|584479066|FG001|Overall Study|Alternative Therapy|1|||
161846477|NCT02640053|584479065|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
161846478|NCT02640053|584479066|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
161846479|NCT02754856|584479068|FG000|Overall Study|Withdrawal by Subject|1|||
161846480|NCT03477903|584479071|FG000|Overall Study|Study Terminated by Sponsor|1|||
161846481|NCT00474266|584479072|FG000|Overall Study|Withdrawal by Subject|7|||
161846482|NCT00474266|584479073|FG001|Overall Study|Withdrawal by Subject|20|||
161846483|NCT00474266|584479074|FG002|Overall Study|Withdrawal by Subject|4|||
161758128|NCT00723489|584154056|FG001|Overall Study|Pregnancy|0|||
161758129|NCT00723489|584154057|FG002|Overall Study|Pregnancy|0|||
161758130|NCT00723489|584154058|FG003|Overall Study|Pregnancy|1|||
161758131|NCT00723489|584154055|FG000|Overall Study|Withdrawal by Subject|0|||
161758132|NCT00723489|584154056|FG001|Overall Study|Withdrawal by Subject|0|||
161758133|NCT00723489|584154057|FG002|Overall Study|Withdrawal by Subject|0|||
161758134|NCT00723489|584154058|FG003|Overall Study|Withdrawal by Subject|1|||
161758135|NCT00723489|584154055|FG000|Overall Study|Seropositive at baseline|1|||
161758136|NCT00723489|584154056|FG001|Overall Study|Seropositive at baseline|0|||
161758137|NCT00723489|584154057|FG002|Overall Study|Seropositive at baseline|0|||
161758138|NCT00723489|584154058|FG003|Overall Study|Seropositive at baseline|0|||
161758139|NCT00723489|584154055|FG000|Overall Study|Prohibited Medication|0|||
161758140|NCT00723489|584154056|FG001|Overall Study|Prohibited Medication|0|||
161758141|NCT00723489|584154057|FG002|Overall Study|Prohibited Medication|0|||
161758142|NCT00723489|584154058|FG003|Overall Study|Prohibited Medication|1|||
161758143|NCT00723489|584154055|FG000|Overall Study|Samples Collected Out of Window|0|||
161758144|NCT00723489|584154056|FG001|Overall Study|Samples Collected Out of Window|3|||
161758145|NCT00723489|584154057|FG002|Overall Study|Samples Collected Out of Window|0|||
161758146|NCT00723489|584154058|FG003|Overall Study|Samples Collected Out of Window|0|||
161846484|NCT00474266|584479075|FG003|Overall Study|Withdrawal by Subject|7|||
161846485|NCT02329847|584479076|FG000|Overall Study|Death|4|||
161846486|NCT02329847|584479077|FG001|Overall Study|Death|4|||
161846487|NCT02329847|584479078|FG002|Overall Study|Death|22|||
161846488|NCT02329847|584479079|FG003|Overall Study|Death|12|||
161846489|NCT02329847|584479080|FG004|Overall Study|Death|20|||
161846490|NCT02329847|584479081|FG005|Overall Study|Death|13|||
161758147|NCT01599585|584154059|FG000|Overall Study|Withdrawal by Subject|16|||
161846491|NCT02329847|584479076|FG000|Overall Study|Lost to Follow-up|0|||
161846492|NCT02329847|584479077|FG001|Overall Study|Lost to Follow-up|0|||
161846493|NCT02329847|584479078|FG002|Overall Study|Lost to Follow-up|2|||
161846494|NCT02329847|584479079|FG003|Overall Study|Lost to Follow-up|3|||
161846495|NCT02329847|584479080|FG004|Overall Study|Lost to Follow-up|0|||
161846496|NCT02329847|584479081|FG005|Overall Study|Lost to Follow-up|1|||
161846497|NCT02329847|584479076|FG000|Overall Study|Physician Decision|0|||
161846498|NCT02329847|584479077|FG001|Overall Study|Physician Decision|0|||
161846499|NCT02329847|584479078|FG002|Overall Study|Physician Decision|0|||
161846500|NCT02329847|584479079|FG003|Overall Study|Physician Decision|0|||
161846501|NCT02329847|584479080|FG004|Overall Study|Physician Decision|1|||
161846502|NCT02329847|584479081|FG005|Overall Study|Physician Decision|0|||
161846503|NCT02329847|584479076|FG000|Overall Study|Withdrawal by Subject|2|||
161846504|NCT02329847|584479077|FG001|Overall Study|Withdrawal by Subject|1|||
161846505|NCT02329847|584479078|FG002|Overall Study|Withdrawal by Subject|5|||
161846506|NCT02329847|584479079|FG003|Overall Study|Withdrawal by Subject|7|||
161846507|NCT02329847|584479080|FG004|Overall Study|Withdrawal by Subject|8|||
161846508|NCT02329847|584479081|FG005|Overall Study|Withdrawal by Subject|3|||
161846509|NCT02329847|584479076|FG000|Overall Study|Other|1|||
161846510|NCT02329847|584479077|FG001|Overall Study|Other|2|||
161846511|NCT02329847|584479078|FG002|Overall Study|Other|6|||
161846512|NCT02329847|584479079|FG003|Overall Study|Other|13|||
161846513|NCT02329847|584479080|FG004|Overall Study|Other|10|||
161846514|NCT02329847|584479081|FG005|Overall Study|Other|3|||
161846515|NCT05330468|584479082|FG000|Overall Study|Death|6|||
161846516|NCT05330468|584479082|FG000|Overall Study|Withdrawal by Subject|4|||
161758148|NCT01599585|584154060|FG001|Overall Study|Withdrawal by Subject|9|||
161758149|NCT01599585|584154059|FG000|Overall Study|Lost to Follow-up|3|||
161758150|NCT01599585|584154060|FG001|Overall Study|Lost to Follow-up|5|||
161758151|NCT01599585|584154059|FG000|Overall Study|randomized did not start treatment|3|||
161758152|NCT01599585|584154060|FG001|Overall Study|randomized did not start treatment|3|||
161758153|NCT03657576|584154061|FG000|Overall Study|Death|0|||
161758154|NCT03657576|584154062|FG001|Overall Study|Death|1|||
161758155|NCT03657576|584154063|FG002|Overall Study|Death|1|||
161758156|NCT03657576|584154064|FG003|Overall Study|Death|0|||
161758157|NCT03657576|584154065|FG004|Overall Study|Death|0|||
161758158|NCT03657576|584154066|FG005|Overall Study|Death|0|||
161758159|NCT03657576|584154061|FG000|Overall Study|Withdrawal by Subject|0|||
161758160|NCT03657576|584154062|FG001|Overall Study|Withdrawal by Subject|0|||
161758161|NCT03657576|584154063|FG002|Overall Study|Withdrawal by Subject|0|||
161758162|NCT03657576|584154064|FG003|Overall Study|Withdrawal by Subject|1|||
161758163|NCT03657576|584154065|FG004|Overall Study|Withdrawal by Subject|0|||
161758164|NCT03657576|584154066|FG005|Overall Study|Withdrawal by Subject|0|||
161758165|NCT03657576|584154061|FG000|Overall Study|Screen Fail|0|||
161758166|NCT03657576|584154062|FG001|Overall Study|Screen Fail|0|||
161758167|NCT03657576|584154063|FG002|Overall Study|Screen Fail|0|||
161758168|NCT03657576|584154064|FG003|Overall Study|Screen Fail|0|||
161758169|NCT03657576|584154065|FG004|Overall Study|Screen Fail|0|||
161758170|NCT03657576|584154066|FG005|Overall Study|Screen Fail|5|||
161758171|NCT03657576|584154061|FG000|Overall Study|Disease Progression|1|||
161758172|NCT03657576|584154062|FG001|Overall Study|Disease Progression|1|||
161758173|NCT03657576|584154063|FG002|Overall Study|Disease Progression|0|||
161758174|NCT03657576|584154064|FG003|Overall Study|Disease Progression|5|||
161758175|NCT03657576|584154065|FG004|Overall Study|Disease Progression|0|||
161758176|NCT03657576|584154066|FG005|Overall Study|Disease Progression|0|||
161758177|NCT03657576|584154061|FG000|Overall Study|Insurance Coverage|0|||
161758178|NCT03657576|584154062|FG001|Overall Study|Insurance Coverage|0|||
161758179|NCT03657576|584154063|FG002|Overall Study|Insurance Coverage|0|||
161758180|NCT03657576|584154064|FG003|Overall Study|Insurance Coverage|1|||
161758181|NCT03657576|584154065|FG004|Overall Study|Insurance Coverage|0|||
161758182|NCT03657576|584154066|FG005|Overall Study|Insurance Coverage|0|||
161758183|NCT04437511|584154067|FG000|Overall Study|Adverse Event|50|||
161758184|NCT04437511|584154068|FG001|Overall Study|Adverse Event|21|||
161758185|NCT04437511|584154067|FG000|Overall Study|Death|15|||
161758186|NCT04437511|584154068|FG001|Overall Study|Death|10|||
161758187|NCT04437511|584154067|FG000|Overall Study|Lost to Follow-up|11|||
161758188|NCT04437511|584154068|FG001|Overall Study|Lost to Follow-up|11|||
161758189|NCT04437511|584154067|FG000|Overall Study|Physician Decision|19|||
161758190|NCT04437511|584154068|FG001|Overall Study|Physician Decision|10|||
161846517|NCT05330468|584479082|FG000|Overall Study|Lost to Follow-up|4|||
161846518|NCT02828241|584479085|FG000|Overall Study|Adverse Event|7|||
161846519|NCT02828241|584479086|FG001|Overall Study|Adverse Event|2|||
161758191|NCT04437511|584154067|FG000|Overall Study|Progressive Disease|4|||
161758192|NCT04437511|584154068|FG001|Overall Study|Progressive Disease|7|||
161758193|NCT04437511|584154067|FG000|Overall Study|Withdrawal by Subject|111|||
161758194|NCT04437511|584154068|FG001|Overall Study|Withdrawal by Subject|94|||
161758195|NCT04437511|584154067|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
161758196|NCT04437511|584154068|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
161846520|NCT02828241|584479085|FG000|Overall Study|Protocol Violation|1|||
161846521|NCT02828241|584479086|FG001|Overall Study|Protocol Violation|0|||
161846522|NCT04572893|584479087|FG000|Part A|Adverse Event|1|||
161846523|NCT04572893|584479088|FG001|Part A|Adverse Event|0|||
161846524|NCT04572893|584479089|FG002|Part A|Adverse Event|0|||
161846525|NCT04572893|584479090|FG003|Part A|Adverse Event|0|||
161846526|NCT04572893|584479091|FG004|Part A|Adverse Event|0|||
161846527|NCT04572893|584479092|FG005|Part A|Adverse Event|0|||
161846528|NCT04572893|584479093|FG006|Part A|Adverse Event|0|||
161846529|NCT04572893|584479087|FG000|Part B|Withdrawal by Subject|0|||
161846530|NCT04572893|584479088|FG001|Part B|Withdrawal by Subject|0|||
161846531|NCT04572893|584479089|FG002|Part B|Withdrawal by Subject|0|||
161846532|NCT04572893|584479090|FG003|Part B|Withdrawal by Subject|0|||
161846533|NCT04572893|584479091|FG004|Part B|Withdrawal by Subject|0|||
161846534|NCT04572893|584479092|FG005|Part B|Withdrawal by Subject|1|||
161846535|NCT04572893|584479093|FG006|Part B|Withdrawal by Subject|0|||
161846536|NCT04572893|584479087|FG000|Part B|Study terminated by sponsor|0|||
161846537|NCT04572893|584479088|FG001|Part B|Study terminated by sponsor|0|||
161846538|NCT04572893|584479089|FG002|Part B|Study terminated by sponsor|0|||
161846539|NCT04572893|584479090|FG003|Part B|Study terminated by sponsor|0|||
161846540|NCT04572893|584479091|FG004|Part B|Study terminated by sponsor|7|||
161846541|NCT04572893|584479092|FG005|Part B|Study terminated by sponsor|5|||
161846542|NCT04572893|584479093|FG006|Part B|Study terminated by sponsor|3|||
161846543|NCT04572893|584479087|FG000|Part B|Lost to Follow-up|0|||
161846544|NCT04572893|584479088|FG001|Part B|Lost to Follow-up|0|||
161846545|NCT04572893|584479089|FG002|Part B|Lost to Follow-up|0|||
161846546|NCT04572893|584479090|FG003|Part B|Lost to Follow-up|0|||
161846547|NCT04572893|584479091|FG004|Part B|Lost to Follow-up|0|||
161846548|NCT04572893|584479092|FG005|Part B|Lost to Follow-up|0|||
161846549|NCT04572893|584479093|FG006|Part B|Lost to Follow-up|1|||
161846550|NCT04572893|584479087|FG000|Part B|Adverse Event|0|||
161846551|NCT04572893|584479088|FG001|Part B|Adverse Event|0|||
161846552|NCT04572893|584479089|FG002|Part B|Adverse Event|0|||
161846553|NCT04572893|584479090|FG003|Part B|Adverse Event|0|||
161846554|NCT04572893|584479091|FG004|Part B|Adverse Event|1|||
161846555|NCT04572893|584479092|FG005|Part B|Adverse Event|1|||
161846556|NCT04572893|584479093|FG006|Part B|Adverse Event|0|||
161846557|NCT01197755|584479101|FG000|Overall Study|Adverse Event|8|||
161846558|NCT01197755|584479102|FG001|Overall Study|Adverse Event|10|||
161846559|NCT01197755|584479103|FG002|Overall Study|Adverse Event|10|||
161846560|NCT01197755|584479101|FG000|Overall Study|Study-specific discontinuation criteria|2|||
161846561|NCT01197755|584479102|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161846562|NCT01197755|584479103|FG002|Overall Study|Study-specific discontinuation criteria|0|||
161846563|NCT01197755|584479101|FG000|Overall Study|Entered the long-term extension study|18|||
161846564|NCT01197755|584479102|FG001|Overall Study|Entered the long-term extension study|21|||
161846565|NCT01197755|584479103|FG002|Overall Study|Entered the long-term extension study|35|||
161846566|NCT01197755|584479101|FG000|Overall Study|Lack of therapeutic response|0|||
161846567|NCT01197755|584479102|FG001|Overall Study|Lack of therapeutic response|7|||
161846568|NCT01197755|584479103|FG002|Overall Study|Lack of therapeutic response|4|||
161846569|NCT01197755|584479101|FG000|Overall Study|Severe non-compliance to the protocol|2|||
161846570|NCT01197755|584479102|FG001|Overall Study|Severe non-compliance to the protocol|1|||
161846571|NCT01197755|584479103|FG002|Overall Study|Severe non-compliance to the protocol|2|||
161846572|NCT01197755|584479101|FG000|Overall Study|Withdrawal by Subject|1|||
161846573|NCT01197755|584479102|FG001|Overall Study|Withdrawal by Subject|0|||
161846574|NCT01197755|584479103|FG002|Overall Study|Withdrawal by Subject|0|||
161846575|NCT01197755|584479101|FG000|Overall Study|Lost to Follow-up|0|||
161846576|NCT01197755|584479102|FG001|Overall Study|Lost to Follow-up|0|||
161846577|NCT01197755|584479103|FG002|Overall Study|Lost to Follow-up|1|||
161846578|NCT01197755|584479101|FG000|Overall Study|eg, change in circumstances|7|||
161846579|NCT01197755|584479102|FG001|Overall Study|eg, change in circumstances|3|||
161846580|NCT01197755|584479103|FG002|Overall Study|eg, change in circumstances|2|||
161846581|NCT01372774|584479107|FG000|Overall Study|Withdrawal prior to treatment|4|||
161846582|NCT01372774|584479108|FG001|Overall Study|Withdrawal prior to treatment|5|||
161846583|NCT00070499|584480306|FG000|Overall Study|Adverse Event|6|||
161846584|NCT00070499|584480307|FG001|Overall Study|Adverse Event|6|||
161846585|NCT00070499|584480308|FG002|Overall Study|Adverse Event|19|||
161846586|NCT00070499|584480309|FG003|Overall Study|Adverse Event|15|||
161846587|NCT00070499|584480306|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
161846588|NCT00070499|584480307|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
161846589|NCT00070499|584480308|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
161846590|NCT00070499|584480309|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
161846591|NCT00070499|584480306|FG000|Overall Study|Progression/relapse|4|||
161846592|NCT00070499|584480307|FG001|Overall Study|Progression/relapse|2|||
161846593|NCT00070499|584480308|FG002|Overall Study|Progression/relapse|1|||
161846594|NCT00070499|584480309|FG003|Overall Study|Progression/relapse|4|||
161846595|NCT00070499|584480306|FG000|Overall Study|Death|1|||
161846596|NCT00070499|584480307|FG001|Overall Study|Death|1|||
161846597|NCT00070499|584480308|FG002|Overall Study|Death|1|||
161846598|NCT00070499|584480309|FG003|Overall Study|Death|2|||
161846599|NCT00070499|584480306|FG000|Overall Study|Other - not protocol specified|7|||
161846600|NCT00070499|584480307|FG001|Overall Study|Other - not protocol specified|3|||
161846601|NCT00070499|584480308|FG002|Overall Study|Other - not protocol specified|12|||
161846602|NCT00070499|584480309|FG003|Overall Study|Other - not protocol specified|20|||
161846603|NCT00070499|584480306|FG000|Overall Study|Still on protocol treatment|10|||
161846604|NCT00070499|584480307|FG001|Overall Study|Still on protocol treatment|4|||
161846605|NCT00070499|584480308|FG002|Overall Study|Still on protocol treatment|79|||
161846606|NCT00070499|584480309|FG003|Overall Study|Still on protocol treatment|57|||
161846607|NCT00070499|584480306|FG000|Overall Study|Did not start treatment|1|||
161846608|NCT00070499|584480307|FG001|Overall Study|Did not start treatment|0|||
161846609|NCT00070499|584480308|FG002|Overall Study|Did not start treatment|0|||
161846610|NCT00070499|584480309|FG003|Overall Study|Did not start treatment|2|||
161846611|NCT00070499|584480306|FG000|Overall Study|Not eligible|2|||
161846612|NCT00070499|584480307|FG001|Overall Study|Not eligible|5|||
161846613|NCT00070499|584480308|FG002|Overall Study|Not eligible|3|||
161846614|NCT00070499|584480309|FG003|Overall Study|Not eligible|2|||
161846615|NCT00805467|584480310|FG000|Overall Study|Lack of Efficacy|0|||
161846616|NCT00805467|584480311|FG001|Overall Study|Lack of Efficacy|8|||
161846617|NCT00805467|584480312|FG002|Overall Study|Lack of Efficacy|13|||
161846618|NCT00805467|584480313|FG003|Overall Study|Lack of Efficacy|86|||
161846619|NCT00805467|584480310|FG000|Overall Study|Lost to Follow-up|0|||
161846620|NCT00805467|584480311|FG001|Overall Study|Lost to Follow-up|1|||
161758197|NCT04437511|584154067|FG000|Overall Study|Continuing Study|7|||
161758198|NCT04437511|584154068|FG001|Overall Study|Continuing Study|5|||
161758199|NCT03093350|584154071|FG000|Overall Study|Death|1|||
161758200|NCT03093350|584154071|FG000|Overall Study|Signed consent, never began treartment|1|||
161758201|NCT00777036|584154072|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
161758202|NCT00777036|584154073|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
161758203|NCT00777036|584154074|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
161758204|NCT00777036|584154075|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
161758205|NCT00777036|584154072|FG000|On Treatment|Administrative Reason By Sponsor|1|||
161758206|NCT00777036|584154073|FG001|On Treatment|Administrative Reason By Sponsor|0|||
161758207|NCT00777036|584154074|FG002|On Treatment|Administrative Reason By Sponsor|9|||
161758208|NCT00777036|584154075|FG003|On Treatment|Administrative Reason By Sponsor|0|||
161758209|NCT00777036|584154072|FG000|On Treatment|Failure to Meet Study Criteria|0|||
161758210|NCT00777036|584154073|FG001|On Treatment|Failure to Meet Study Criteria|1|||
161758211|NCT00777036|584154074|FG002|On Treatment|Failure to Meet Study Criteria|4|||
161758212|NCT00777036|584154075|FG003|On Treatment|Failure to Meet Study Criteria|0|||
161758213|NCT00777036|584154072|FG000|On Treatment|Pregnancy|1|||
161758214|NCT00777036|584154073|FG001|On Treatment|Pregnancy|0|||
161758215|NCT00777036|584154074|FG002|On Treatment|Pregnancy|1|||
161758216|NCT00777036|584154075|FG003|On Treatment|Pregnancy|0|||
161758217|NCT00777036|584154072|FG000|On Treatment|Non-compliance with Study Drug|1|||
161846621|NCT00805467|584480312|FG002|Overall Study|Lost to Follow-up|7|||
161846622|NCT00805467|584480313|FG003|Overall Study|Lost to Follow-up|21|||
161846623|NCT00805467|584480310|FG000|Overall Study|Withdrawal by Subject|0|||
161758218|NCT00777036|584154073|FG001|On Treatment|Non-compliance with Study Drug|0|||
161758219|NCT00777036|584154074|FG002|On Treatment|Non-compliance with Study Drug|1|||
161758220|NCT00777036|584154075|FG003|On Treatment|Non-compliance with Study Drug|0|||
161758221|NCT00777036|584154072|FG000|On Treatment|Maximum Clinical Benefit|2|||
161758222|NCT00777036|584154073|FG001|On Treatment|Maximum Clinical Benefit|0|||
161758223|NCT00777036|584154074|FG002|On Treatment|Maximum Clinical Benefit|5|||
161758224|NCT00777036|584154075|FG003|On Treatment|Maximum Clinical Benefit|0|||
161758225|NCT00777036|584154072|FG000|On Treatment|Withdrawal by Subject|0|||
161758226|NCT00777036|584154073|FG001|On Treatment|Withdrawal by Subject|2|||
161758227|NCT00777036|584154074|FG002|On Treatment|Withdrawal by Subject|2|||
161758228|NCT00777036|584154075|FG003|On Treatment|Withdrawal by Subject|0|||
161758229|NCT00777036|584154072|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
161758230|NCT00777036|584154073|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
161758231|NCT00777036|584154074|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
161758232|NCT00777036|584154075|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
161758233|NCT00777036|584154072|FG000|On Treatment|Death|0|||
161758234|NCT00777036|584154073|FG001|On Treatment|Death|2|||
161758235|NCT00777036|584154074|FG002|On Treatment|Death|0|||
161758236|NCT00777036|584154075|FG003|On Treatment|Death|0|||
161758237|NCT00777036|584154072|FG000|On Treatment|Study Drug Toxicity|1|||
161758238|NCT00777036|584154073|FG001|On Treatment|Study Drug Toxicity|0|||
161758239|NCT00777036|584154074|FG002|On Treatment|Study Drug Toxicity|4|||
161758240|NCT00777036|584154075|FG003|On Treatment|Study Drug Toxicity|0|||
161758241|NCT00777036|584154072|FG000|On Treatment|Progressive Disease|6|||
161758242|NCT00777036|584154073|FG001|On Treatment|Progressive Disease|4|||
161758243|NCT00777036|584154074|FG002|On Treatment|Progressive Disease|7|||
161758244|NCT00777036|584154075|FG003|On Treatment|Progressive Disease|0|||
161758245|NCT00777036|584154072|FG000|On Treatment|Not Reported|0|||
161758246|NCT00777036|584154073|FG001|On Treatment|Not Reported|0|||
161758247|NCT00777036|584154074|FG002|On Treatment|Not Reported|2|||
161758248|NCT00777036|584154075|FG003|On Treatment|Not Reported|0|||
161758249|NCT00777036|584154072|FG000|On Treatment|Site Closed|0|||
161758250|NCT00777036|584154073|FG001|On Treatment|Site Closed|1|||
161758251|NCT00777036|584154074|FG002|On Treatment|Site Closed|1|||
161758252|NCT00777036|584154075|FG003|On Treatment|Site Closed|0|||
161758253|NCT00777036|584154072|FG000|Follow-Up|Withdrawal by Subject|0|||
161758254|NCT00777036|584154073|FG001|Follow-Up|Withdrawal by Subject|0|||
161758255|NCT00777036|584154074|FG002|Follow-Up|Withdrawal by Subject|5|||
161758256|NCT00777036|584154075|FG003|Follow-Up|Withdrawal by Subject|0|||
161758257|NCT00777036|584154072|FG000|Follow-Up|Death|1|||
161758258|NCT00777036|584154073|FG001|Follow-Up|Death|9|||
161758259|NCT00777036|584154074|FG002|Follow-Up|Death|0|||
161758260|NCT00777036|584154075|FG003|Follow-Up|Death|0|||
161758261|NCT00777036|584154072|FG000|Follow-Up|Lost to Follow-up|3|||
161758262|NCT00777036|584154073|FG001|Follow-Up|Lost to Follow-up|0|||
161758263|NCT00777036|584154074|FG002|Follow-Up|Lost to Follow-up|0|||
161758264|NCT00777036|584154075|FG003|Follow-Up|Lost to Follow-up|0|||
161758265|NCT00777036|584154072|FG000|Follow-Up|Reason Not Specified|4|||
161758266|NCT00777036|584154073|FG001|Follow-Up|Reason Not Specified|0|||
161758267|NCT00777036|584154074|FG002|Follow-Up|Reason Not Specified|13|||
161758268|NCT00777036|584154075|FG003|Follow-Up|Reason Not Specified|0|||
161758269|NCT00777036|584154072|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
161758270|NCT00777036|584154073|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
161758271|NCT00777036|584154074|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
161758272|NCT00777036|584154075|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
161758273|NCT05564039|584154078|FG000|Overall Study|Adverse Event|1|||
161758274|NCT05564039|584154079|FG001|Overall Study|Adverse Event|0|||
161758275|NCT05564039|584154078|FG000|Overall Study|Death|1|||
161758276|NCT05564039|584154079|FG001|Overall Study|Death|1|||
161758277|NCT05564039|584154078|FG000|Overall Study|Lost to Follow-up|3|||
161758278|NCT05564039|584154079|FG001|Overall Study|Lost to Follow-up|2|||
161758279|NCT05564039|584154078|FG000|Overall Study|Withdrawal by Subject|2|||
161758280|NCT05564039|584154079|FG001|Overall Study|Withdrawal by Subject|0|||
161758281|NCT05564039|584154078|FG000|Overall Study|Inadvertent enrollment|3|||
161758282|NCT05564039|584154079|FG001|Overall Study|Inadvertent enrollment|6|||
161758283|NCT00729560|584154080|FG000|Overall Study|Withdrawal by Subject|3|||
161758284|NCT03233308|584154081|FG000|Overall Study|Adverse Event|1|||
161758285|NCT03233308|584154081|FG000|Overall Study|Protocol Violation|1|||
161758286|NCT03662789|584154082|FG000|Overall Study|Lost to Follow-up|1|||
161758287|NCT03662789|584154083|FG001|Overall Study|Lost to Follow-up|2|||
161758288|NCT03662789|584154082|FG000|Overall Study|Could not perform treadmill test|4|||
161758289|NCT03662789|584154083|FG001|Overall Study|Could not perform treadmill test|4|||
161758290|NCT03662789|584154082|FG000|Overall Study|Death|0|||
161758291|NCT03662789|584154083|FG001|Overall Study|Death|1|||
161758292|NCT02136134|584154084|FG000|Overall Study|Death|170|||
161758293|NCT02136134|584154085|FG001|Overall Study|Death|148|||
161758294|NCT02136134|584154084|FG000|Overall Study|Withdrawal by Subject|19|||
161758295|NCT02136134|584154085|FG001|Overall Study|Withdrawal by Subject|10|||
161758296|NCT02136134|584154084|FG000|Overall Study|Lost to Follow-up|3|||
161758297|NCT02136134|584154085|FG001|Overall Study|Lost to Follow-up|3|||
161758298|NCT02136134|584154084|FG000|Overall Study|Uspecified|55|||
161758299|NCT02136134|584154085|FG001|Overall Study|Uspecified|90|||
161758300|NCT00638989|584154086|FG000|Overall Study|Lost to Follow-up|0|||
161758301|NCT00638989|584154087|FG001|Overall Study|Lost to Follow-up|0|||
161758302|NCT00638989|584154088|FG002|Overall Study|Lost to Follow-up|1|||
161758303|NCT05245071|584154089|FG000|Overall Study|Progressive disease|18|||
161758304|NCT05245071|584154089|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
161758305|NCT05245071|584154089|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
161758306|NCT01602822|584154090|FG000|Overall Study|Adverse Event|11|||
161758307|NCT00853112|584154094|FG000|Overall Study|Randomized but not treated|0|||
161758308|NCT00853112|584154095|FG001|Overall Study|Randomized but not treated|1|||
161758309|NCT00853112|584154096|FG002|Overall Study|Randomized but not treated|0|||
161758310|NCT00853112|584154097|FG003|Overall Study|Randomized but not treated|2|||
161758311|NCT00853112|584154098|FG004|Overall Study|Randomized but not treated|0|||
161758312|NCT00853112|584154099|FG005|Overall Study|Randomized but not treated|0|||
161758313|NCT00853112|584154100|FG006|Overall Study|Randomized but not treated|1|||
161758314|NCT01553591|584154101|FG000|Overall Study|Voluntarily withdrew|94|||
161758315|NCT01553591|584154102|FG001|Overall Study|Voluntarily withdrew|79|||
161758316|NCT01553591|584154103|FG002|Overall Study|Voluntarily withdrew|96|||
161758317|NCT01553591|584154101|FG000|Overall Study|Adverse Event|36|||
161758318|NCT01553591|584154102|FG001|Overall Study|Adverse Event|45|||
161758319|NCT01553591|584154103|FG002|Overall Study|Adverse Event|16|||
161758320|NCT01553591|584154101|FG000|Overall Study|Lost to Follow-up|25|||
161758321|NCT01553591|584154102|FG001|Overall Study|Lost to Follow-up|23|||
161758322|NCT01553591|584154103|FG002|Overall Study|Lost to Follow-up|16|||
161758323|NCT01553591|584154101|FG000|Overall Study|Physician decision: other|11|||
161758324|NCT01553591|584154102|FG001|Overall Study|Physician decision: other|14|||
161758325|NCT01553591|584154103|FG002|Overall Study|Physician decision: other|16|||
161758326|NCT01553591|584154101|FG000|Overall Study|Physician decision: lack of efficacy|2|||
161758327|NCT01553591|584154102|FG001|Overall Study|Physician decision: lack of efficacy|3|||
161758328|NCT01553591|584154103|FG002|Overall Study|Physician decision: lack of efficacy|7|||
161758329|NCT01553591|584154101|FG000|Overall Study|Protocol Violation|3|||
161758330|NCT01553591|584154102|FG001|Overall Study|Protocol Violation|4|||
161758331|NCT01553591|584154103|FG002|Overall Study|Protocol Violation|4|||
161758332|NCT01553591|584154101|FG000|Overall Study|Sponsor decision|1|||
161758333|NCT01553591|584154102|FG001|Overall Study|Sponsor decision|0|||
161758334|NCT01553591|584154103|FG002|Overall Study|Sponsor decision|3|||
161758335|NCT01553591|584154101|FG000|Overall Study|Randomized and never dispensed drug|0|||
161758336|NCT01553591|584154102|FG001|Overall Study|Randomized and never dispensed drug|1|||
161758337|NCT01553591|584154103|FG002|Overall Study|Randomized and never dispensed drug|0|||
161758338|NCT02477800|584154104|FG000|Placebo-Controlled Period|Adverse Event|16|||
161758339|NCT02477800|584154105|FG001|Placebo-Controlled Period|Adverse Event|25|||
161758340|NCT02477800|584154106|FG002|Placebo-Controlled Period|Adverse Event|28|||
161758341|NCT02477800|584154107|FG003|Placebo-Controlled Period|Adverse Event|0|||
161758342|NCT02477800|584154108|FG004|Placebo-Controlled Period|Adverse Event|0|||
161758343|NCT02477800|584154109|FG005|Placebo-Controlled Period|Adverse Event|0|||
161758344|NCT02477800|584154110|FG006|Placebo-Controlled Period|Adverse Event|0|||
161758345|NCT02477800|584154104|FG000|Placebo-Controlled Period|Change of Treatment|1|||
161758346|NCT02477800|584154105|FG001|Placebo-Controlled Period|Change of Treatment|2|||
161758347|NCT02477800|584154106|FG002|Placebo-Controlled Period|Change of Treatment|1|||
161758348|NCT02477800|584154107|FG003|Placebo-Controlled Period|Change of Treatment|0|||
161758349|NCT02477800|584154108|FG004|Placebo-Controlled Period|Change of Treatment|0|||
161758350|NCT02477800|584154109|FG005|Placebo-Controlled Period|Change of Treatment|0|||
161758351|NCT02477800|584154110|FG006|Placebo-Controlled Period|Change of Treatment|0|||
161758352|NCT02477800|584154104|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
161758353|NCT02477800|584154105|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
161758354|NCT02477800|584154106|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
161758355|NCT02477800|584154107|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
161758356|NCT02477800|584154108|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
161758357|NCT02477800|584154109|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
161758358|NCT02477800|584154110|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
161758359|NCT02477800|584154104|FG000|Placebo-Controlled Period|Death|0|||
161758360|NCT02477800|584154105|FG001|Placebo-Controlled Period|Death|3|||
161758361|NCT02477800|584154106|FG002|Placebo-Controlled Period|Death|2|||
161758362|NCT02477800|584154107|FG003|Placebo-Controlled Period|Death|0|||
161758363|NCT02477800|584154108|FG004|Placebo-Controlled Period|Death|0|||
161758364|NCT02477800|584154109|FG005|Placebo-Controlled Period|Death|0|||
161758365|NCT02477800|584154110|FG006|Placebo-Controlled Period|Death|0|||
161758366|NCT02477800|584154104|FG000|Placebo-Controlled Period|Disease Progression|1|||
161758367|NCT02477800|584154105|FG001|Placebo-Controlled Period|Disease Progression|0|||
161758368|NCT02477800|584154106|FG002|Placebo-Controlled Period|Disease Progression|1|||
161758369|NCT02477800|584154107|FG003|Placebo-Controlled Period|Disease Progression|0|||
161758370|NCT02477800|584154108|FG004|Placebo-Controlled Period|Disease Progression|0|||
161758371|NCT02477800|584154109|FG005|Placebo-Controlled Period|Disease Progression|0|||
161758372|NCT02477800|584154110|FG006|Placebo-Controlled Period|Disease Progression|0|||
161758373|NCT02477800|584154104|FG000|Placebo-Controlled Period|Investigator Decision|3|||
161758374|NCT02477800|584154105|FG001|Placebo-Controlled Period|Investigator Decision|2|||
161758375|NCT02477800|584154106|FG002|Placebo-Controlled Period|Investigator Decision|1|||
161758376|NCT02477800|584154107|FG003|Placebo-Controlled Period|Investigator Decision|0|||
161758377|NCT02477800|584154108|FG004|Placebo-Controlled Period|Investigator Decision|0|||
161758378|NCT02477800|584154109|FG005|Placebo-Controlled Period|Investigator Decision|0|||
161758379|NCT02477800|584154110|FG006|Placebo-Controlled Period|Investigator Decision|0|||
161758380|NCT02477800|584154104|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
161758381|NCT02477800|584154105|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
161758382|NCT02477800|584154106|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
161758383|NCT02477800|584154107|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
161758384|NCT02477800|584154108|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
161758385|NCT02477800|584154109|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
161758386|NCT02477800|584154110|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
161758387|NCT02477800|584154104|FG000|Placebo-Controlled Period|Relocation|2|||
161758388|NCT02477800|584154105|FG001|Placebo-Controlled Period|Relocation|0|||
161758389|NCT02477800|584154106|FG002|Placebo-Controlled Period|Relocation|0|||
161758390|NCT02477800|584154107|FG003|Placebo-Controlled Period|Relocation|0|||
161758391|NCT02477800|584154108|FG004|Placebo-Controlled Period|Relocation|0|||
161758392|NCT02477800|584154109|FG005|Placebo-Controlled Period|Relocation|0|||
161758393|NCT02477800|584154110|FG006|Placebo-Controlled Period|Relocation|0|||
161758394|NCT02477800|584154104|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161758395|NCT02477800|584154105|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161758396|NCT02477800|584154106|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161758397|NCT02477800|584154107|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758398|NCT02477800|584154108|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758399|NCT02477800|584154109|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758400|NCT02477800|584154110|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758401|NCT02477800|584154104|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
161758402|NCT02477800|584154105|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
161758403|NCT02477800|584154106|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758404|NCT02477800|584154107|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758405|NCT02477800|584154108|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161846624|NCT00805467|584480311|FG001|Overall Study|Withdrawal by Subject|6|||
161846625|NCT00805467|584480312|FG002|Overall Study|Withdrawal by Subject|45|||
161846626|NCT00805467|584480313|FG003|Overall Study|Withdrawal by Subject|50|||
161846627|NCT00805467|584480310|FG000|Overall Study|Protocol Violation|0|||
161846628|NCT00805467|584480311|FG001|Overall Study|Protocol Violation|3|||
161846629|NCT00805467|584480312|FG002|Overall Study|Protocol Violation|0|||
161846630|NCT00805467|584480313|FG003|Overall Study|Protocol Violation|5|||
161846631|NCT00805467|584480310|FG000|Overall Study|Adverse Event|0|||
161846632|NCT00805467|584480311|FG001|Overall Study|Adverse Event|13|||
161846633|NCT00805467|584480312|FG002|Overall Study|Adverse Event|26|||
161846634|NCT00805467|584480313|FG003|Overall Study|Adverse Event|57|||
161846635|NCT00805467|584480310|FG000|Overall Study|Death|0|||
161846636|NCT00805467|584480311|FG001|Overall Study|Death|2|||
161846637|NCT00805467|584480312|FG002|Overall Study|Death|7|||
161846638|NCT00805467|584480313|FG003|Overall Study|Death|5|||
161846639|NCT00805467|584480310|FG000|Overall Study|Physician Decision|0|||
161846640|NCT00805467|584480311|FG001|Overall Study|Physician Decision|1|||
161846641|NCT00805467|584480312|FG002|Overall Study|Physician Decision|2|||
161846642|NCT00805467|584480313|FG003|Overall Study|Physician Decision|6|||
161846643|NCT00805467|584480310|FG000|Overall Study|Not reported|0|||
161846644|NCT00805467|584480311|FG001|Overall Study|Not reported|0|||
161846645|NCT00805467|584480312|FG002|Overall Study|Not reported|3|||
161846646|NCT00805467|584480313|FG003|Overall Study|Not reported|7|||
161846647|NCT04240392|584480315|FG000|Overall Study|Withdrawal by Subject|13|||
161846648|NCT04240392|584480316|FG001|Overall Study|Withdrawal by Subject|4|||
161846649|NCT04240392|584480315|FG000|Overall Study|Lost to Follow-up|11|||
161846650|NCT04240392|584480316|FG001|Overall Study|Lost to Follow-up|12|||
161846651|NCT04345601|584480329|FG000|Overall Study|Death|0|||
161846652|NCT04345601|584480330|FG001|Overall Study|Death|3|||
161846653|NCT04345601|584480331|FG002|Overall Study|Death|2|||
161846654|NCT04345601|584480329|FG000|Overall Study|Lost to Follow-up|0|||
161846655|NCT04345601|584480330|FG001|Overall Study|Lost to Follow-up|0|||
161846656|NCT04345601|584480331|FG002|Overall Study|Lost to Follow-up|2|||
161846657|NCT00660907|584480333|FG000|Overall Study|Incorrect Enrollment|1|||
161846658|NCT00660907|584480334|FG001|Overall Study|Incorrect Enrollment|1|||
161846659|NCT00660907|584480333|FG000|Overall Study|Adverse Event|33|||
161846660|NCT00660907|584480334|FG001|Overall Study|Adverse Event|19|||
161846661|NCT00660907|584480333|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
161846662|NCT00660907|584480334|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
161846663|NCT00660907|584480333|FG000|Overall Study|Withdrawal by Subject|23|||
161846664|NCT00660907|584480334|FG001|Overall Study|Withdrawal by Subject|32|||
161846665|NCT00660907|584480333|FG000|Overall Study|Lost to Follow-up|3|||
161846666|NCT00660907|584480334|FG001|Overall Study|Lost to Follow-up|3|||
161846667|NCT00660907|584480333|FG000|Overall Study|Poor/Non-Compliance|5|||
161846668|NCT00660907|584480334|FG001|Overall Study|Poor/Non-Compliance|1|||
161846669|NCT00660907|584480333|FG000|Overall Study|Safety|1|||
161846670|NCT00660907|584480334|FG001|Overall Study|Safety|0|||
161846671|NCT00660907|584480333|FG000|Overall Study|Death|1|||
161846672|NCT00660907|584480334|FG001|Overall Study|Death|3|||
161846673|NCT00660907|584480333|FG000|Overall Study|Various|11|||
161846674|NCT00660907|584480334|FG001|Overall Study|Various|8|||
161846675|NCT01908907|584480335|FG000|Overall Study|Physician Decision|1|||
161846676|NCT01908907|584480336|FG001|Overall Study|Physician Decision|0|||
161846677|NCT01908907|584480335|FG000|Overall Study|Protocol Violation|1|||
161846678|NCT01908907|584480336|FG001|Overall Study|Protocol Violation|0|||
161846679|NCT04975191|584480337|FG000|Overall Study|Protocol Violation|1|||
161846680|NCT04975191|584480338|FG001|Overall Study|Protocol Violation|2|||
161846681|NCT04975191|584480339|FG002|Overall Study|Protocol Violation|2|||
161846682|NCT04975191|584480340|FG003|Overall Study|Protocol Violation|2|||
161846683|NCT04975191|584480337|FG000|Overall Study|Lost to Follow-up|13|||
161846684|NCT04975191|584480338|FG001|Overall Study|Lost to Follow-up|3|||
161846685|NCT04975191|584480339|FG002|Overall Study|Lost to Follow-up|8|||
161846686|NCT04975191|584480340|FG003|Overall Study|Lost to Follow-up|8|||
161846687|NCT02152605|584480345|FG000|Overall Study|Adverse Event|6|||
161846688|NCT02152605|584480346|FG001|Overall Study|Adverse Event|8|||
161846689|NCT02152605|584480345|FG000|Overall Study|Lack of Efficacy|7|||
161846690|NCT02152605|584480346|FG001|Overall Study|Lack of Efficacy|4|||
161846691|NCT02152605|584480345|FG000|Overall Study|Protocol deviation|1|||
161846692|NCT02152605|584480346|FG001|Overall Study|Protocol deviation|4|||
161846693|NCT02152605|584480345|FG000|Overall Study|Lost to Follow-up|1|||
161846694|NCT02152605|584480346|FG001|Overall Study|Lost to Follow-up|0|||
161846695|NCT02152605|584480345|FG000|Overall Study|Withdrew consent|4|||
161846696|NCT02152605|584480346|FG001|Overall Study|Withdrew consent|2|||
161846697|NCT00537303|584480353|FG000|Overall Study|Adverse Event|1|||
161846698|NCT00537303|584480354|FG001|Overall Study|Adverse Event|4|||
161846699|NCT00537303|584480353|FG000|Overall Study|Lack of Efficacy|6|||
161846700|NCT00537303|584480354|FG001|Overall Study|Lack of Efficacy|7|||
161846701|NCT00537303|584480353|FG000|Overall Study|Protocol Violation|8|||
161846702|NCT00537303|584480354|FG001|Overall Study|Protocol Violation|4|||
161846703|NCT00537303|584480353|FG000|Overall Study|Withdrawal criteria|3|||
161846704|NCT00537303|584480354|FG001|Overall Study|Withdrawal criteria|3|||
161846705|NCT00537303|584480353|FG000|Overall Study|Unclassified|8|||
161846706|NCT00537303|584480354|FG001|Overall Study|Unclassified|7|||
161846707|NCT01724489|584480355|FG000|Overall Study|Adverse Event|8|||
161846708|NCT01724489|584480356|FG001|Overall Study|Adverse Event|3|||
161846709|NCT01724489|584480355|FG000|Overall Study|Surgery, medication|1|||
161846710|NCT01724489|584480356|FG001|Overall Study|Surgery, medication|1|||
161846711|NCT01724489|584480355|FG000|Overall Study|Lost to Follow-up|1|||
161846712|NCT01724489|584480356|FG001|Overall Study|Lost to Follow-up|2|||
161846713|NCT01724489|584480355|FG000|Overall Study|Withdrawal by Subject|6|||
161846714|NCT01724489|584480356|FG001|Overall Study|Withdrawal by Subject|6|||
161846715|NCT01473524|584480357|FG000|DB Phase|Adverse Event|4|||
161846716|NCT01473524|584480358|FG001|DB Phase|Adverse Event|8|||
161846717|NCT01473524|584480359|FG002|DB Phase|Adverse Event|2|||
161846718|NCT01473524|584480360|FG003|DB Phase|Adverse Event|0|||
161846719|NCT01473524|584480361|FG004|DB Phase|Adverse Event|0|||
161846720|NCT01473524|584480362|FG005|DB Phase|Adverse Event|0|||
161846721|NCT01473524|584480357|FG000|DB Phase|Death|1|||
161846722|NCT01473524|584480358|FG001|DB Phase|Death|0|||
161846723|NCT01473524|584480359|FG002|DB Phase|Death|0|||
161846724|NCT01473524|584480360|FG003|DB Phase|Death|0|||
161846725|NCT01473524|584480361|FG004|DB Phase|Death|0|||
161846726|NCT01473524|584480362|FG005|DB Phase|Death|0|||
161846727|NCT01473524|584480357|FG000|DB Phase|Withdrawal by Subject|2|||
161758406|NCT02477800|584154109|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758407|NCT02477800|584154110|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758408|NCT02477800|584154104|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
161758409|NCT02477800|584154105|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
161758410|NCT02477800|584154106|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
161758411|NCT02477800|584154107|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
161758412|NCT02477800|584154108|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
161758413|NCT02477800|584154109|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
161758414|NCT02477800|584154110|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
161758415|NCT02477800|584154104|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161758416|NCT02477800|584154105|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
161758417|NCT02477800|584154106|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
161758418|NCT02477800|584154107|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758419|NCT02477800|584154108|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758420|NCT02477800|584154109|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758421|NCT02477800|584154110|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758422|NCT02477800|584154104|FG000|Placebo-Controlled Period|Reason not Specified|161|||
161758423|NCT02477800|584154105|FG001|Placebo-Controlled Period|Reason not Specified|161|||
161758424|NCT02477800|584154106|FG002|Placebo-Controlled Period|Reason not Specified|189|||
161758425|NCT02477800|584154107|FG003|Placebo-Controlled Period|Reason not Specified|0|||
161758426|NCT02477800|584154108|FG004|Placebo-Controlled Period|Reason not Specified|0|||
161758427|NCT02477800|584154109|FG005|Placebo-Controlled Period|Reason not Specified|0|||
161758428|NCT02477800|584154110|FG006|Placebo-Controlled Period|Reason not Specified|0|||
161758429|NCT02477800|584154104|FG000|Long Term Extension Period|Adverse Event|0|||
161758430|NCT02477800|584154105|FG001|Long Term Extension Period|Adverse Event|0|||
161758431|NCT02477800|584154106|FG002|Long Term Extension Period|Adverse Event|0|||
161758432|NCT02477800|584154107|FG003|Long Term Extension Period|Adverse Event|6|||
161758433|NCT02477800|584154108|FG004|Long Term Extension Period|Adverse Event|2|||
161758434|NCT02477800|584154109|FG005|Long Term Extension Period|Adverse Event|4|||
161758435|NCT02477800|584154110|FG006|Long Term Extension Period|Adverse Event|3|||
161758436|NCT02477800|584154104|FG000|Long Term Extension Period|Death|0|||
161758437|NCT02477800|584154105|FG001|Long Term Extension Period|Death|0|||
161758438|NCT02477800|584154106|FG002|Long Term Extension Period|Death|0|||
161758439|NCT02477800|584154107|FG003|Long Term Extension Period|Death|1|||
161758440|NCT02477800|584154108|FG004|Long Term Extension Period|Death|1|||
161758441|NCT02477800|584154109|FG005|Long Term Extension Period|Death|1|||
161758442|NCT02477800|584154110|FG006|Long Term Extension Period|Death|2|||
161758443|NCT02477800|584154104|FG000|Long Term Extension Period|Consent Withdrawn|0|||
161758444|NCT02477800|584154105|FG001|Long Term Extension Period|Consent Withdrawn|0|||
161758445|NCT02477800|584154106|FG002|Long Term Extension Period|Consent Withdrawn|0|||
161758446|NCT02477800|584154107|FG003|Long Term Extension Period|Consent Withdrawn|10|||
161758447|NCT02477800|584154108|FG004|Long Term Extension Period|Consent Withdrawn|4|||
161758448|NCT02477800|584154109|FG005|Long Term Extension Period|Consent Withdrawn|13|||
161758449|NCT02477800|584154110|FG006|Long Term Extension Period|Consent Withdrawn|16|||
161758450|NCT02477800|584154104|FG000|Long Term Extension Period|Disease Progression|0|||
161758451|NCT02477800|584154105|FG001|Long Term Extension Period|Disease Progression|0|||
161758452|NCT02477800|584154106|FG002|Long Term Extension Period|Disease Progression|0|||
161758453|NCT02477800|584154107|FG003|Long Term Extension Period|Disease Progression|3|||
161758454|NCT02477800|584154108|FG004|Long Term Extension Period|Disease Progression|1|||
161758455|NCT02477800|584154109|FG005|Long Term Extension Period|Disease Progression|1|||
161758456|NCT02477800|584154110|FG006|Long Term Extension Period|Disease Progression|0|||
161846728|NCT01473524|584480358|FG001|DB Phase|Withdrawal by Subject|1|||
161846729|NCT01473524|584480359|FG002|DB Phase|Withdrawal by Subject|1|||
161846730|NCT01473524|584480360|FG003|DB Phase|Withdrawal by Subject|0|||
161846731|NCT01473524|584480361|FG004|DB Phase|Withdrawal by Subject|0|||
161846732|NCT01473524|584480362|FG005|DB Phase|Withdrawal by Subject|0|||
161846733|NCT01473524|584480357|FG000|LTSE Phase|Withdrawal by Subject|0|||
161846734|NCT01473524|584480358|FG001|LTSE Phase|Withdrawal by Subject|0|||
161846735|NCT01473524|584480359|FG002|LTSE Phase|Withdrawal by Subject|0|||
161846736|NCT01473524|584480360|FG003|LTSE Phase|Withdrawal by Subject|3|||
161846737|NCT01473524|584480361|FG004|LTSE Phase|Withdrawal by Subject|3|||
161846738|NCT01473524|584480362|FG005|LTSE Phase|Withdrawal by Subject|6|||
161846739|NCT01473524|584480357|FG000|LTSE Phase|Death|0|||
161846740|NCT01473524|584480358|FG001|LTSE Phase|Death|0|||
161846741|NCT01473524|584480359|FG002|LTSE Phase|Death|0|||
161846742|NCT01473524|584480360|FG003|LTSE Phase|Death|0|||
161846743|NCT01473524|584480361|FG004|LTSE Phase|Death|1|||
161846744|NCT01473524|584480362|FG005|LTSE Phase|Death|0|||
161846745|NCT01473524|584480357|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
161846746|NCT01473524|584480358|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
161846747|NCT01473524|584480359|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
161846748|NCT01473524|584480360|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
161846749|NCT01473524|584480361|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
161846750|NCT01473524|584480362|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
161846751|NCT01473524|584480357|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161846752|NCT01473524|584480358|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161846753|NCT01473524|584480359|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161846754|NCT01473524|584480360|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
161846755|NCT01473524|584480361|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
161846756|NCT01473524|584480362|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
161846757|NCT01473524|584480357|FG000|LTSE Phase|Lost to Follow-up|0|||
161846758|NCT01473524|584480358|FG001|LTSE Phase|Lost to Follow-up|0|||
161846759|NCT01473524|584480359|FG002|LTSE Phase|Lost to Follow-up|0|||
161846760|NCT01473524|584480360|FG003|LTSE Phase|Lost to Follow-up|1|||
161846761|NCT01473524|584480361|FG004|LTSE Phase|Lost to Follow-up|3|||
161758457|NCT02477800|584154104|FG000|Long Term Extension Period|Investigator Decision|0|||
161758458|NCT02477800|584154105|FG001|Long Term Extension Period|Investigator Decision|0|||
161758459|NCT02477800|584154106|FG002|Long Term Extension Period|Investigator Decision|0|||
161758460|NCT02477800|584154107|FG003|Long Term Extension Period|Investigator Decision|0|||
161758461|NCT02477800|584154108|FG004|Long Term Extension Period|Investigator Decision|0|||
161758462|NCT02477800|584154109|FG005|Long Term Extension Period|Investigator Decision|0|||
161758463|NCT02477800|584154110|FG006|Long Term Extension Period|Investigator Decision|2|||
161758464|NCT02477800|584154104|FG000|Long Term Extension Period|Lost to Follow-up|0|||
161758465|NCT02477800|584154105|FG001|Long Term Extension Period|Lost to Follow-up|0|||
161758466|NCT02477800|584154106|FG002|Long Term Extension Period|Lost to Follow-up|0|||
161758467|NCT02477800|584154107|FG003|Long Term Extension Period|Lost to Follow-up|0|||
161758468|NCT02477800|584154108|FG004|Long Term Extension Period|Lost to Follow-up|1|||
161758469|NCT02477800|584154109|FG005|Long Term Extension Period|Lost to Follow-up|3|||
161758470|NCT02477800|584154110|FG006|Long Term Extension Period|Lost to Follow-up|0|||
161758471|NCT02477800|584154104|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758472|NCT02477800|584154105|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758473|NCT02477800|584154106|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758474|NCT02477800|584154107|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758475|NCT02477800|584154108|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758476|NCT02477800|584154109|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
161758477|NCT02477800|584154110|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
161758478|NCT02477800|584154104|FG000|Long Term Extension Period|Study Visit Burden|0|||
161758479|NCT02477800|584154105|FG001|Long Term Extension Period|Study Visit Burden|0|||
161758480|NCT02477800|584154106|FG002|Long Term Extension Period|Study Visit Burden|0|||
161758481|NCT02477800|584154107|FG003|Long Term Extension Period|Study Visit Burden|3|||
161758482|NCT02477800|584154108|FG004|Long Term Extension Period|Study Visit Burden|0|||
161758483|NCT02477800|584154109|FG005|Long Term Extension Period|Study Visit Burden|2|||
161758484|NCT02477800|584154110|FG006|Long Term Extension Period|Study Visit Burden|2|||
161846762|NCT01473524|584480362|FG005|LTSE Phase|Lost to Follow-up|2|||
161846763|NCT01473524|584480357|FG000|LTSE Phase|Principal Investigator Decision|0|||
161846764|NCT01473524|584480358|FG001|LTSE Phase|Principal Investigator Decision|0|||
161846765|NCT01473524|584480359|FG002|LTSE Phase|Principal Investigator Decision|0|||
161846766|NCT01473524|584480360|FG003|LTSE Phase|Principal Investigator Decision|1|||
161846767|NCT01473524|584480361|FG004|LTSE Phase|Principal Investigator Decision|1|||
161846768|NCT01473524|584480362|FG005|LTSE Phase|Principal Investigator Decision|3|||
161846769|NCT01473524|584480357|FG000|LTSE Phase|Liver Transplantation|0|||
161846770|NCT01473524|584480358|FG001|LTSE Phase|Liver Transplantation|0|||
161846771|NCT01473524|584480359|FG002|LTSE Phase|Liver Transplantation|0|||
161758485|NCT02477800|584154104|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161758486|NCT02477800|584154105|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161758487|NCT02477800|584154106|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161758488|NCT02477800|584154107|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
161758489|NCT02477800|584154108|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
161758490|NCT02477800|584154109|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
161758491|NCT02477800|584154110|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
161758492|NCT02477800|584154104|FG000|Long Term Extension Period|Reason not Specified|0|||
161758493|NCT02477800|584154105|FG001|Long Term Extension Period|Reason not Specified|0|||
161758494|NCT02477800|584154106|FG002|Long Term Extension Period|Reason not Specified|0|||
161758495|NCT02477800|584154107|FG003|Long Term Extension Period|Reason not Specified|126|||
161758496|NCT02477800|584154108|FG004|Long Term Extension Period|Reason not Specified|140|||
161758497|NCT02477800|584154109|FG005|Long Term Extension Period|Reason not Specified|270|||
161758498|NCT02477800|584154110|FG006|Long Term Extension Period|Reason not Specified|224|||
161758499|NCT00423592|584154112|FG000|Overall Study|Adverse Event (through Week 12)|2|||
161758500|NCT00423592|584154112|FG000|Overall Study|Adverse Event (post Week 12)|5|||
161758501|NCT00062647|584154113|FG000|Overall Study|Death|2|||
161758502|NCT00062647|584154114|FG001|Overall Study|Death|2|||
161758503|NCT00062647|584154113|FG000|Overall Study|Adverse Event|1|||
161758504|NCT00062647|584154114|FG001|Overall Study|Adverse Event|1|||
161758505|NCT00062647|584154113|FG000|Overall Study|Withdrawal by Subject|2|||
161758506|NCT00062647|584154114|FG001|Overall Study|Withdrawal by Subject|1|||
161758507|NCT00062647|584154113|FG000|Overall Study|Protocol Violation|1|||
161758508|NCT00062647|584154114|FG001|Overall Study|Protocol Violation|0|||
161758509|NCT00062647|584154113|FG000|Overall Study|Lost to Follow-up|1|||
161758510|NCT00062647|584154114|FG001|Overall Study|Lost to Follow-up|2|||
161758511|NCT00062647|584154113|FG000|Overall Study|Failed continuation criteria|4|||
161758512|NCT00062647|584154114|FG001|Overall Study|Failed continuation criteria|2|||
161758513|NCT00062647|584154113|FG000|Overall Study|Other|4|||
161758514|NCT00062647|584154114|FG001|Overall Study|Other|4|||
161758515|NCT00062647|584154113|FG000|Overall Study|Never received study treatment|1|||
161758516|NCT00062647|584154114|FG001|Overall Study|Never received study treatment|1|||
161758517|NCT00002981|584154117|FG000|Overall Study|Inevaluable|6|||
161758518|NCT00255008|584154118|FG000|Overall Study|Adverse Event|1|||
161758519|NCT00255008|584154119|FG001|Overall Study|Adverse Event|1|||
161758520|NCT00255008|584154120|FG002|Overall Study|Adverse Event|2|||
161758521|NCT00255008|584154121|FG003|Overall Study|Adverse Event|0|||
161758522|NCT00255008|584154118|FG000|Overall Study|Lost to Follow-up|1|||
161758523|NCT00255008|584154119|FG001|Overall Study|Lost to Follow-up|0|||
161758524|NCT00255008|584154120|FG002|Overall Study|Lost to Follow-up|1|||
161758525|NCT00255008|584154121|FG003|Overall Study|Lost to Follow-up|2|||
161758526|NCT00255008|584154118|FG000|Overall Study|Did not meet viral reduction criteria|4|||
161758527|NCT00255008|584154119|FG001|Overall Study|Did not meet viral reduction criteria|5|||
161758528|NCT00255008|584154120|FG002|Overall Study|Did not meet viral reduction criteria|0|||
161758529|NCT00255008|584154121|FG003|Overall Study|Did not meet viral reduction criteria|1|||
161758530|NCT00255008|584154118|FG000|Overall Study|Withdrew consent|0|||
161758531|NCT00255008|584154119|FG001|Overall Study|Withdrew consent|0|||
161758532|NCT00255008|584154120|FG002|Overall Study|Withdrew consent|2|||
161758533|NCT00255008|584154121|FG003|Overall Study|Withdrew consent|0|||
161758534|NCT00255008|584154118|FG000|Overall Study|Sponsor request|18|||
161758535|NCT00255008|584154119|FG001|Overall Study|Sponsor request|3|||
161758536|NCT00255008|584154120|FG002|Overall Study|Sponsor request|8|||
161758537|NCT00255008|584154121|FG003|Overall Study|Sponsor request|17|||
161758538|NCT00255008|584154118|FG000|Overall Study|Adverse lab experience|1|||
161758539|NCT00255008|584154119|FG001|Overall Study|Adverse lab experience|0|||
161758540|NCT00255008|584154120|FG002|Overall Study|Adverse lab experience|0|||
161758541|NCT00255008|584154121|FG003|Overall Study|Adverse lab experience|0|||
161758542|NCT00255008|584154118|FG000|Overall Study|Other|7|||
161758543|NCT00255008|584154119|FG001|Overall Study|Other|0|||
161758544|NCT00255008|584154120|FG002|Overall Study|Other|3|||
161758545|NCT00255008|584154121|FG003|Overall Study|Other|2|||
161758546|NCT00322387|584154126|FG000|Treatment Period|Adverse Event|0|||
161758547|NCT00322387|584154127|FG001|Treatment Period|Adverse Event|1|||
161758548|NCT00322387|584154126|FG000|Follow-up Period|Final assessment not done|1|||
161758549|NCT00322387|584154127|FG001|Follow-up Period|Final assessment not done|3|||
161758550|NCT00322387|584154126|FG000|Follow-up Period|Death|1|||
161758551|NCT00322387|584154127|FG001|Follow-up Period|Death|0|||
161758552|NCT02415595|584154128|FG000|Overall Study|Administrative reason by sponsor|39|||
161758553|NCT02415595|584154129|FG001|Overall Study|Administrative reason by sponsor|40|||
161758554|NCT02415595|584154130|FG002|Overall Study|Administrative reason by sponsor|41|||
161758555|NCT02415595|584154131|FG003|Overall Study|Administrative reason by sponsor|39|||
161758556|NCT02415595|584154128|FG000|Overall Study|Adverse Event|1|||
161758557|NCT02415595|584154129|FG001|Overall Study|Adverse Event|3|||
161758558|NCT02415595|584154130|FG002|Overall Study|Adverse Event|5|||
161758559|NCT02415595|584154131|FG003|Overall Study|Adverse Event|10|||
161758560|NCT02415595|584154128|FG000|Overall Study|Lack of Efficacy|4|||
161846772|NCT01473524|584480360|FG003|LTSE Phase|Liver Transplantation|0|||
161846773|NCT01473524|584480361|FG004|LTSE Phase|Liver Transplantation|0|||
161846774|NCT01473524|584480362|FG005|LTSE Phase|Liver Transplantation|1|||
161846775|NCT01473524|584480357|FG000|LTSE Phase|Pregnancy|0|||
161846776|NCT01473524|584480358|FG001|LTSE Phase|Pregnancy|0|||
161846777|NCT01473524|584480359|FG002|LTSE Phase|Pregnancy|0|||
161846778|NCT01473524|584480360|FG003|LTSE Phase|Pregnancy|1|||
161846779|NCT01473524|584480361|FG004|LTSE Phase|Pregnancy|0|||
161846780|NCT01473524|584480362|FG005|LTSE Phase|Pregnancy|0|||
161846781|NCT01473524|584480357|FG000|LTSE Phase|Protocol Violation|0|||
161846782|NCT01473524|584480358|FG001|LTSE Phase|Protocol Violation|0|||
161846783|NCT01473524|584480359|FG002|LTSE Phase|Protocol Violation|0|||
161846784|NCT01473524|584480360|FG003|LTSE Phase|Protocol Violation|0|||
161846785|NCT01473524|584480361|FG004|LTSE Phase|Protocol Violation|0|||
161846786|NCT01473524|584480362|FG005|LTSE Phase|Protocol Violation|1|||
161846787|NCT01544179|584480363|FG000|Overall Study|Death|50|||
161846788|NCT01544179|584480364|FG001|Overall Study|Death|37|||
161846789|NCT01544179|584480363|FG000|Overall Study|Lost to Follow-up|0|||
161846790|NCT01544179|584480364|FG001|Overall Study|Lost to Follow-up|1|||
161846791|NCT01544179|584480363|FG000|Overall Study|Adverse Event|0|||
161846792|NCT01544179|584480364|FG001|Overall Study|Adverse Event|1|||
161846793|NCT01544179|584480363|FG000|Overall Study|Withdrawal by Subject|12|||
161846794|NCT01544179|584480364|FG001|Overall Study|Withdrawal by Subject|7|||
161846795|NCT01544179|584480363|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161846796|NCT01544179|584480364|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161846797|NCT03146962|584480367|FG000|Overall Study|Lost to Follow-up|1|||
161846798|NCT03146962|584480368|FG001|Overall Study|Lost to Follow-up|1|||
161846799|NCT03146962|584480369|FG002|Overall Study|Lost to Follow-up|0|||
161846800|NCT03146962|584480370|FG003|Overall Study|Lost to Follow-up|0|||
161846801|NCT03146962|584480371|FG004|Overall Study|Lost to Follow-up|0|||
161846802|NCT03146962|584480372|FG005|Overall Study|Lost to Follow-up|0|||
161846803|NCT03146962|584480373|FG006|Overall Study|Lost to Follow-up|0|||
161846804|NCT03146962|584480374|FG007|Overall Study|Lost to Follow-up|0|||
161846805|NCT03146962|584480375|FG008|Overall Study|Lost to Follow-up|0|||
161846806|NCT03146962|584480376|FG009|Overall Study|Lost to Follow-up|0|||
161846807|NCT03146962|584480367|FG000|Overall Study|Adverse Event|0|||
161846808|NCT03146962|584480368|FG001|Overall Study|Adverse Event|3|||
161846809|NCT03146962|584480369|FG002|Overall Study|Adverse Event|0|||
161846810|NCT03146962|584480370|FG003|Overall Study|Adverse Event|0|||
161846811|NCT03146962|584480371|FG004|Overall Study|Adverse Event|0|||
161846812|NCT03146962|584480372|FG005|Overall Study|Adverse Event|0|||
161846813|NCT03146962|584480373|FG006|Overall Study|Adverse Event|0|||
161846814|NCT03146962|584480374|FG007|Overall Study|Adverse Event|1|||
161846815|NCT03146962|584480375|FG008|Overall Study|Adverse Event|0|||
161846816|NCT03146962|584480376|FG009|Overall Study|Adverse Event|0|||
161846817|NCT03146962|584480367|FG000|Overall Study|Withdrawal by Subject|0|||
161846818|NCT03146962|584480368|FG001|Overall Study|Withdrawal by Subject|0|||
161846819|NCT03146962|584480369|FG002|Overall Study|Withdrawal by Subject|0|||
161846820|NCT03146962|584480370|FG003|Overall Study|Withdrawal by Subject|0|||
161846821|NCT03146962|584480371|FG004|Overall Study|Withdrawal by Subject|1|||
161846822|NCT03146962|584480372|FG005|Overall Study|Withdrawal by Subject|0|||
161846823|NCT03146962|584480373|FG006|Overall Study|Withdrawal by Subject|0|||
161846824|NCT03146962|584480374|FG007|Overall Study|Withdrawal by Subject|0|||
161846825|NCT03146962|584480375|FG008|Overall Study|Withdrawal by Subject|0|||
161846826|NCT03146962|584480376|FG009|Overall Study|Withdrawal by Subject|0|||
161846827|NCT03146962|584480367|FG000|Overall Study|Death|0|||
161846828|NCT03146962|584480368|FG001|Overall Study|Death|1|||
161846829|NCT03146962|584480369|FG002|Overall Study|Death|0|||
161846830|NCT03146962|584480370|FG003|Overall Study|Death|0|||
161846831|NCT03146962|584480371|FG004|Overall Study|Death|0|||
161846832|NCT03146962|584480372|FG005|Overall Study|Death|0|||
161846833|NCT03146962|584480373|FG006|Overall Study|Death|0|||
161846834|NCT03146962|584480374|FG007|Overall Study|Death|0|||
161846835|NCT03146962|584480375|FG008|Overall Study|Death|0|||
161846836|NCT03146962|584480376|FG009|Overall Study|Death|0|||
161846837|NCT03146962|584480367|FG000|Overall Study|COVID Precautions|1|||
161846838|NCT03146962|584480368|FG001|Overall Study|COVID Precautions|0|||
161846839|NCT03146962|584480369|FG002|Overall Study|COVID Precautions|0|||
161846840|NCT03146962|584480370|FG003|Overall Study|COVID Precautions|0|||
161846841|NCT03146962|584480371|FG004|Overall Study|COVID Precautions|0|||
161846842|NCT03146962|584480372|FG005|Overall Study|COVID Precautions|0|||
161846843|NCT03146962|584480373|FG006|Overall Study|COVID Precautions|0|||
161846844|NCT03146962|584480374|FG007|Overall Study|COVID Precautions|0|||
161846845|NCT03146962|584480375|FG008|Overall Study|COVID Precautions|0|||
161846846|NCT03146962|584480376|FG009|Overall Study|COVID Precautions|0|||
161846847|NCT03146962|584480367|FG000|Overall Study|Physician Decision|0|||
161846848|NCT03146962|584480368|FG001|Overall Study|Physician Decision|0|||
161846849|NCT03146962|584480369|FG002|Overall Study|Physician Decision|0|||
161846850|NCT03146962|584480370|FG003|Overall Study|Physician Decision|0|||
161846851|NCT03146962|584480371|FG004|Overall Study|Physician Decision|0|||
161846852|NCT03146962|584480372|FG005|Overall Study|Physician Decision|0|||
161758561|NCT02415595|584154129|FG001|Overall Study|Lack of Efficacy|4|||
161758562|NCT02415595|584154130|FG002|Overall Study|Lack of Efficacy|0|||
161758563|NCT02415595|584154131|FG003|Overall Study|Lack of Efficacy|0|||
161758564|NCT02415595|584154128|FG000|Overall Study|Lost to Follow-up|1|||
161758565|NCT02415595|584154129|FG001|Overall Study|Lost to Follow-up|3|||
161758566|NCT02415595|584154130|FG002|Overall Study|Lost to Follow-up|1|||
161758567|NCT02415595|584154131|FG003|Overall Study|Lost to Follow-up|1|||
161758568|NCT02415595|584154128|FG000|Overall Study|Poor/Non-compliance|1|||
161758569|NCT02415595|584154129|FG001|Overall Study|Poor/Non-compliance|0|||
161758570|NCT02415595|584154130|FG002|Overall Study|Poor/Non-compliance|1|||
161758571|NCT02415595|584154131|FG003|Overall Study|Poor/Non-compliance|0|||
161758572|NCT02415595|584154128|FG000|Overall Study|Reached stopping criteria|0|||
161758573|NCT02415595|584154129|FG001|Overall Study|Reached stopping criteria|1|||
161758574|NCT02415595|584154130|FG002|Overall Study|Reached stopping criteria|1|||
161758575|NCT02415595|584154131|FG003|Overall Study|Reached stopping criteria|0|||
161758576|NCT02415595|584154128|FG000|Overall Study|Withdrawal by Subject|4|||
161758577|NCT02415595|584154129|FG001|Overall Study|Withdrawal by Subject|0|||
161846853|NCT03146962|584480373|FG006|Overall Study|Physician Decision|0|||
161846854|NCT03146962|584480374|FG007|Overall Study|Physician Decision|0|||
161846855|NCT03146962|584480375|FG008|Overall Study|Physician Decision|0|||
161846856|NCT03146962|584480376|FG009|Overall Study|Physician Decision|1|||
161846857|NCT03146962|584480367|FG000|Overall Study|Started New Treatment|0|||
161846858|NCT03146962|584480368|FG001|Overall Study|Started New Treatment|1|||
161846859|NCT03146962|584480369|FG002|Overall Study|Started New Treatment|0|||
161846860|NCT03146962|584480370|FG003|Overall Study|Started New Treatment|0|||
161846861|NCT03146962|584480371|FG004|Overall Study|Started New Treatment|0|||
161846862|NCT03146962|584480372|FG005|Overall Study|Started New Treatment|0|||
161846863|NCT03146962|584480373|FG006|Overall Study|Started New Treatment|0|||
161846864|NCT03146962|584480374|FG007|Overall Study|Started New Treatment|0|||
161846865|NCT03146962|584480375|FG008|Overall Study|Started New Treatment|0|||
161846866|NCT03146962|584480376|FG009|Overall Study|Started New Treatment|0|||
161846867|NCT01635283|584480379|FG000|Overall Study|Tumor Progression|3|||
161846868|NCT01635283|584480379|FG000|Overall Study|Lost to Follow-up|1|||
161846869|NCT04516759|584480380|FG000|Overall Study|Withdrawal by Subject|1|||
161846870|NCT04516759|584480381|FG001|Overall Study|Withdrawal by Subject|1|||
161846871|NCT04516759|584480380|FG000|Overall Study|Other|0|||
161846872|NCT04516759|584480381|FG001|Overall Study|Other|1|||
161846873|NCT01268501|584480389|FG000|Overall Study|Lost to Follow-up|1|||
161846874|NCT01268501|584480389|FG000|Overall Study|Withdrawal by Subject|3|||
161846875|NCT01268501|584480389|FG000|Overall Study|Unacceptable Subjective Vision|3|||
161846876|NCT01268501|584480389|FG000|Overall Study|Handling Difficulties|2|||
161846877|NCT00724048|584480390|FG000|Overall Study|Adverse Event|1|||
161846878|NCT00724048|584480391|FG001|Overall Study|Adverse Event|1|||
161846879|NCT00724048|584480392|FG002|Overall Study|Adverse Event|1|||
161846880|NCT00724048|584480393|FG003|Overall Study|Adverse Event|0|||
161846881|NCT00724048|584480390|FG000|Overall Study|Lost to Follow-up|0|||
161846882|NCT00724048|584480391|FG001|Overall Study|Lost to Follow-up|1|||
161846883|NCT00724048|584480392|FG002|Overall Study|Lost to Follow-up|0|||
161846884|NCT00724048|584480393|FG003|Overall Study|Lost to Follow-up|0|||
161846885|NCT00724048|584480390|FG000|Overall Study|Withdrawal by Subject|1|||
161846886|NCT00724048|584480391|FG001|Overall Study|Withdrawal by Subject|2|||
161846887|NCT00724048|584480392|FG002|Overall Study|Withdrawal by Subject|1|||
161846888|NCT00724048|584480393|FG003|Overall Study|Withdrawal by Subject|2|||
161846889|NCT00724048|584480390|FG000|Overall Study|Investigator decision|0|||
161846890|NCT00724048|584480391|FG001|Overall Study|Investigator decision|0|||
161846891|NCT00724048|584480392|FG002|Overall Study|Investigator decision|1|||
161846892|NCT00724048|584480393|FG003|Overall Study|Investigator decision|0|||
161846893|NCT00724048|584480390|FG000|Overall Study|Did not tolerate study drug|0|||
161846894|NCT00724048|584480391|FG001|Overall Study|Did not tolerate study drug|0|||
161846895|NCT00724048|584480392|FG002|Overall Study|Did not tolerate study drug|0|||
161846896|NCT00724048|584480393|FG003|Overall Study|Did not tolerate study drug|1|||
161846897|NCT00724048|584480390|FG000|Overall Study|Other than specified|1|||
161758578|NCT02415595|584154130|FG002|Overall Study|Withdrawal by Subject|1|||
161758579|NCT02415595|584154131|FG003|Overall Study|Withdrawal by Subject|3|||
161758580|NCT02415595|584154128|FG000|Overall Study|Other|0|||
161758581|NCT02415595|584154129|FG001|Overall Study|Other|1|||
161758582|NCT02415595|584154130|FG002|Overall Study|Other|1|||
161846898|NCT00724048|584480391|FG001|Overall Study|Other than specified|1|||
161846899|NCT00724048|584480392|FG002|Overall Study|Other than specified|0|||
161846900|NCT00724048|584480393|FG003|Overall Study|Other than specified|0|||
161846901|NCT04874155|584480394|FG000|Overall Study|Lost to Follow-up|1|||
161846902|NCT04874155|584480395|FG001|Overall Study|Lost to Follow-up|1|||
161846903|NCT04874155|584480394|FG000|Overall Study|Withdrawal by Subject|2|||
161846904|NCT04874155|584480395|FG001|Overall Study|Withdrawal by Subject|2|||
161846905|NCT02774642|584480398|FG000|Overall Study|Lost to Follow-up|9|||
161846906|NCT02774642|584480399|FG001|Overall Study|Lost to Follow-up|7|||
161846907|NCT00477295|584480400|FG000|Overall Study|Adverse Event|31|||
161846908|NCT00477295|584480401|FG001|Overall Study|Adverse Event|35|||
161846909|NCT00477295|584480400|FG000|Overall Study|Withdrawal by Subject|35|||
161846910|NCT00477295|584480401|FG001|Overall Study|Withdrawal by Subject|24|||
161846911|NCT00477295|584480400|FG000|Overall Study|Lack of Efficacy|23|||
161846912|NCT00477295|584480401|FG001|Overall Study|Lack of Efficacy|23|||
161846913|NCT00477295|584480400|FG000|Overall Study|Protocol Violation|3|||
161846914|NCT00477295|584480401|FG001|Overall Study|Protocol Violation|8|||
161846915|NCT00477295|584480400|FG000|Overall Study|Physician Decision|4|||
161846916|NCT00477295|584480401|FG001|Overall Study|Physician Decision|5|||
161846917|NCT00477295|584480400|FG000|Overall Study|Lost to Follow-up|21|||
161846918|NCT00477295|584480401|FG001|Overall Study|Lost to Follow-up|11|||
161846919|NCT00477295|584480400|FG000|Overall Study|Other|4|||
161846920|NCT00477295|584480401|FG001|Overall Study|Other|3|||
161846921|NCT01425723|584480404|FG000|Overall Study|Lack of Efficacy|0|||
161846922|NCT01425723|584480405|FG001|Overall Study|Lack of Efficacy|1|||
161846923|NCT01425723|584480404|FG000|Overall Study|Withdrawal by Subject|1|||
161846924|NCT01425723|584480405|FG001|Overall Study|Withdrawal by Subject|4|||
161846925|NCT01425723|584480404|FG000|Overall Study|Lost to Follow-up|0|||
161846926|NCT01425723|584480405|FG001|Overall Study|Lost to Follow-up|3|||
161846927|NCT01425723|584480404|FG000|Overall Study|Physician Decision|2|||
161846928|NCT01425723|584480405|FG001|Overall Study|Physician Decision|0|||
161846929|NCT01425723|584480404|FG000|Overall Study|Other|1|||
161846930|NCT01425723|584480405|FG001|Overall Study|Other|10|||
161846931|NCT03835221|584480406|FG000|Methafilcon A|Withdrawal by Subject|1|||
161846932|NCT00861198|584480407|FG000|Overall Study|SpyGlass Failed|5|||
161846933|NCT02288182|584480408|FG000|Overall Study|Adverse Event|0|||
161846934|NCT02288182|584480409|FG001|Overall Study|Adverse Event|1|||
161846935|NCT02288182|584480408|FG000|Overall Study|Lost to Follow-up|0|||
161846936|NCT02288182|584480409|FG001|Overall Study|Lost to Follow-up|1|||
161846937|NCT04619992|584480411|FG000|Overall Study|Withdrawal by Subject|1|||
161846938|NCT04619992|584480412|FG001|Overall Study|Withdrawal by Subject|0|||
161846939|NCT03365011|584480413|FG000|Overall Study|Withdrawal by Subject|1|||
161846940|NCT03365011|584480414|FG001|Overall Study|Withdrawal by Subject|2|||
161846941|NCT03582826|584480415|FG000|Overall Study|Lost to Follow-up|39|||
161846942|NCT03582826|584480416|FG001|Overall Study|Lost to Follow-up|0|||
161846943|NCT03582826|584480415|FG000|Overall Study|Withdrawal by Subject|2|||
161846944|NCT03582826|584480416|FG001|Overall Study|Withdrawal by Subject|0|||
161846945|NCT00499174|584480417|FG000|Overall Study|Physician Decision|78|||
161846946|NCT00499174|584480418|FG001|Overall Study|Physician Decision|9|||
161846947|NCT01214915|584480419|FG000|Overall Study|Adverse Event|8|||
161846948|NCT01214915|584480419|FG000|Overall Study|Lack of Efficacy|3|||
161846949|NCT00574912|584480420|FG000|Overall Study|Could not place IV lines.|3|||
161846950|NCT00574912|584480420|FG000|Overall Study|scheduling conflicts|3|||
161846951|NCT00574912|584480420|FG000|Overall Study|Physician Decision|2|||
161846952|NCT04730349|584480429|FG000|Overall Study|Participant withdrew consent|1|||
161846953|NCT04730349|584480430|FG001|Overall Study|Participant withdrew consent|0|||
161846954|NCT04730349|584480429|FG000|Overall Study|Disease progression|6|||
161846955|NCT04730349|584480430|FG001|Overall Study|Disease progression|4|||
161846956|NCT04730349|584480429|FG000|Overall Study|Study drug toxicity|0|||
161846957|NCT04730349|584480430|FG001|Overall Study|Study drug toxicity|1|||
161846958|NCT00638027|584480431|FG000|Overall Study|Adverse Event|0|||
161846959|NCT00638027|584480432|FG001|Overall Study|Adverse Event|2|||
161846960|NCT00371397|584480433|FG000|Session 1|Withdrawal by Subject|1|||
161846961|NCT00371397|584480434|FG001|Session 1|Withdrawal by Subject|0|||
161846962|NCT00371397|584480435|FG002|Session 1|Withdrawal by Subject|0|||
161846963|NCT00371397|584480436|FG003|Session 1|Withdrawal by Subject|0|||
161846964|NCT00371397|584480437|FG004|Session 1|Withdrawal by Subject|0|||
161846965|NCT00371397|584480438|FG005|Session 1|Withdrawal by Subject|0|||
161846966|NCT00371397|584480439|FG006|Session 1|Withdrawal by Subject|0|||
161846967|NCT00371397|584480440|FG007|Session 1|Withdrawal by Subject|1|||
161846968|NCT00371397|584480441|FG008|Session 1|Withdrawal by Subject|0|||
161846969|NCT00371397|584480442|FG009|Session 1|Withdrawal by Subject|0|||
161846970|NCT00371397|584480443|FG010|Session 1|Withdrawal by Subject|0|||
161846971|NCT00371397|584480444|FG011|Session 1|Withdrawal by Subject|0|||
161846972|NCT03753763|584480445|FG000|Overall Study|Adverse Event|2|||
161846973|NCT03753763|584480446|FG001|Overall Study|Adverse Event|0|||
161846974|NCT03753763|584480445|FG000|Overall Study|Withdrawal by Subject|3|||
161846975|NCT03753763|584480446|FG001|Overall Study|Withdrawal by Subject|1|||
161846976|NCT03753763|584480445|FG000|Overall Study|clinical deterioration|1|||
161846977|NCT03753763|584480446|FG001|Overall Study|clinical deterioration|0|||
161846978|NCT01104779|584480447|FG000|Overall Study|Protocol Violation|1|||
161846979|NCT01104779|584480448|FG001|Overall Study|Protocol Violation|2|||
161758583|NCT02415595|584154131|FG003|Overall Study|Other|0|||
161758584|NCT03074318|584154134|FG000|Overall Study|Adverse Event|0|||
161758585|NCT03074318|584154135|FG001|Overall Study|Adverse Event|1|||
161758586|NCT03074318|584154136|FG002|Overall Study|Adverse Event|1|||
161758587|NCT03074318|584154137|FG003|Overall Study|Adverse Event|1|||
161758588|NCT03074318|584154134|FG000|Overall Study|Death|1|||
161758589|NCT03074318|584154135|FG001|Overall Study|Death|0|||
161758590|NCT03074318|584154136|FG002|Overall Study|Death|0|||
161758591|NCT03074318|584154137|FG003|Overall Study|Death|0|||
161758592|NCT03074318|584154134|FG000|Overall Study|Withdrawal by Subject|1|||
161758593|NCT03074318|584154135|FG001|Overall Study|Withdrawal by Subject|2|||
161758594|NCT03074318|584154136|FG002|Overall Study|Withdrawal by Subject|2|||
161758595|NCT03074318|584154137|FG003|Overall Study|Withdrawal by Subject|4|||
161758596|NCT03074318|584154134|FG000|Overall Study|Trial Closure|2|||
161758597|NCT03074318|584154135|FG001|Overall Study|Trial Closure|2|||
161758598|NCT03074318|584154136|FG002|Overall Study|Trial Closure|3|||
161758599|NCT03074318|584154137|FG003|Overall Study|Trial Closure|11|||
161758600|NCT00686699|584155354|FG000|Treatment Period 1|Adverse Event|0|||
161758601|NCT00686699|584155355|FG001|Treatment Period 1|Adverse Event|2|||
161758602|NCT00908895|584155356|FG000|Overall Study|Lost to Follow-up|1|||
161758603|NCT00908895|584155357|FG001|Overall Study|Lost to Follow-up|3|||
161758604|NCT00908895|584155356|FG000|Overall Study|algodystrophy|2|||
161758605|NCT00908895|584155357|FG001|Overall Study|algodystrophy|2|||
161758606|NCT00908895|584155356|FG000|Overall Study|Adverse Event|1|||
161758607|NCT00908895|584155357|FG001|Overall Study|Adverse Event|1|||
161758608|NCT03793010|584155358|FG000|Overall Study|Withdrawal by Subject|5|||
161758609|NCT03793010|584155359|FG001|Overall Study|Withdrawal by Subject|7|||
161758610|NCT03793010|584155358|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
161758611|NCT03793010|584155359|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
161758612|NCT03793010|584155358|FG000|Overall Study|Lost to Follow-up|1|||
161758613|NCT03793010|584155359|FG001|Overall Study|Lost to Follow-up|2|||
161758614|NCT03793010|584155358|FG000|Overall Study|Patient couldn't sit still for injection|1|||
161758615|NCT03793010|584155359|FG001|Overall Study|Patient couldn't sit still for injection|0|||
161758616|NCT03793010|584155358|FG000|Overall Study|Withdrew to pursue other treatment|1|||
161758617|NCT03793010|584155359|FG001|Overall Study|Withdrew to pursue other treatment|0|||
161758618|NCT03793010|584155358|FG000|Overall Study|Did not meet eligibility criteria|1|||
161758619|NCT03793010|584155359|FG001|Overall Study|Did not meet eligibility criteria|0|||
161758620|NCT00364611|584155362|FG000|Overall Study|Did not receive study medication|0|||
161758621|NCT00364611|584155363|FG001|Overall Study|Did not receive study medication|1|||
161758622|NCT00364611|584155362|FG000|Overall Study|Adverse Event|7|||
161758623|NCT00364611|584155363|FG001|Overall Study|Adverse Event|4|||
161758624|NCT00364611|584155362|FG000|Overall Study|Participant's Request|3|||
161758625|NCT00364611|584155363|FG001|Overall Study|Participant's Request|4|||
161758626|NCT00364611|584155362|FG000|Overall Study|Disease Progression|38|||
161758627|NCT00364611|584155363|FG001|Overall Study|Disease Progression|8|||
161758628|NCT00364611|584155362|FG000|Overall Study|Investigator decision|2|||
161758629|NCT00364611|584155363|FG001|Overall Study|Investigator decision|2|||
161758630|NCT00364611|584155362|FG000|Overall Study|Found Ineligible|1|||
161758631|NCT00364611|584155363|FG001|Overall Study|Found Ineligible|0|||
161758632|NCT00364611|584155362|FG000|Overall Study|Presumed CR on Study|0|||
161758633|NCT00364611|584155363|FG001|Overall Study|Presumed CR on Study|1|||
161758634|NCT00364611|584155362|FG000|Overall Study|Receiving Liver Ablation|0|||
161758635|NCT00364611|584155363|FG001|Overall Study|Receiving Liver Ablation|1|||
161758636|NCT02059174|584155389|FG000|Period 1|Withdrawal by Subject|0|||
161758637|NCT02059174|584155390|FG001|Period 1|Withdrawal by Subject|2|||
161758638|NCT02059174|584155389|FG000|Period 2|Withdrawal by Subject|0|||
161758639|NCT02059174|584155390|FG001|Period 2|Withdrawal by Subject|2|||
161758640|NCT02059174|584155389|FG000|Period 2|Protocol Violation|1|||
161758641|NCT02059174|584155390|FG001|Period 2|Protocol Violation|0|||
161758642|NCT02059174|584155389|FG000|Period 3|Physician Decision|1|||
161758643|NCT02059174|584155390|FG001|Period 3|Physician Decision|0|||
161758644|NCT00768040|584155391|FG000|Overall Study|Adverse Event|3|||
161758645|NCT00768040|584155392|FG001|Overall Study|Adverse Event|2|||
161758646|NCT00768040|584155391|FG000|Overall Study|Abnormal laboratory value|1|||
161758647|NCT00768040|584155392|FG001|Overall Study|Abnormal laboratory value|1|||
161758648|NCT02511106|584155397|FG000|Overall Study|Lost to Follow-up|6|||
161758649|NCT02511106|584155398|FG001|Overall Study|Lost to Follow-up|4|||
161758650|NCT02511106|584155397|FG000|Overall Study|Withdrawal by Subject|24|||
161758651|NCT02511106|584155398|FG001|Overall Study|Withdrawal by Subject|21|||
161758652|NCT02511106|584155397|FG000|Overall Study|Death|42|||
161758653|NCT02511106|584155398|FG001|Overall Study|Death|82|||
161758654|NCT02511106|584155397|FG000|Overall Study|Ongoing study at data cut-off|3|||
161758655|NCT02511106|584155398|FG001|Overall Study|Ongoing study at data cut-off|2|||
161758656|NCT02511106|584155397|FG000|Overall Study|Without specified reason|3|||
161758657|NCT02511106|584155398|FG001|Overall Study|Without specified reason|0|||
161758658|NCT01222767|584155399|FG000|Overall Study|Progressive disease|13|||
161758659|NCT01222767|584155399|FG000|Overall Study|Adverse Event|2|||
161758660|NCT01222767|584155399|FG000|Overall Study|Surgical resection|1|||
161758661|NCT01222767|584155399|FG000|Overall Study|Never treated|1|||
161758662|NCT02773849|584155400|FG000|Overall Study|Lost to Follow-up|11|||
161758663|NCT02773849|584155400|FG000|Overall Study|Death|26|||
161758664|NCT02773849|584155400|FG000|Overall Study|Withdrawal by Subject|5|||
161758665|NCT02773849|584155400|FG000|Overall Study|Withdrawal of Consent|9|||
161758666|NCT02773849|584155400|FG000|Overall Study|Other: not due to lack of tolerability|11|||
161758667|NCT02274311|584155407|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
161758668|NCT00508001|584155408|FG000|Overall Study|Adverse Event|2|||
161758669|NCT00508001|584155409|FG001|Overall Study|Adverse Event|0|||
161758670|NCT00508001|584155410|FG002|Overall Study|Adverse Event|4|||
161758671|NCT00508001|584155408|FG000|Overall Study|condition under investigation worsened|13|||
161758672|NCT00508001|584155409|FG001|Overall Study|condition under investigation worsened|7|||
161758673|NCT00508001|584155410|FG002|Overall Study|condition under investigation worsened|1|||
161758674|NCT00508001|584155408|FG000|Overall Study|Death|0|||
161758675|NCT00508001|584155409|FG001|Overall Study|Death|1|||
161758676|NCT00508001|584155410|FG002|Overall Study|Death|1|||
161758677|NCT00508001|584155408|FG000|Overall Study|Withdrawal by Subject|4|||
161758678|NCT00508001|584155409|FG001|Overall Study|Withdrawal by Subject|4|||
161758679|NCT00508001|584155410|FG002|Overall Study|Withdrawal by Subject|1|||
161758680|NCT01685372|584155411|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
161758681|NCT01685372|584155412|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
161758682|NCT01626859|584155413|FG000|Overall Study|Adverse Event|1|||
161758683|NCT01626859|584155414|FG001|Overall Study|Adverse Event|3|||
161758684|NCT01626859|584155415|FG002|Overall Study|Adverse Event|2|||
161758685|NCT01626859|584155413|FG000|Overall Study|Physician Decision|0|||
161758686|NCT01626859|584155414|FG001|Overall Study|Physician Decision|1|||
161758687|NCT01626859|584155415|FG002|Overall Study|Physician Decision|0|||
161758688|NCT01626859|584155413|FG000|Overall Study|Withdrawal by Subject|1|||
161758689|NCT01626859|584155414|FG001|Overall Study|Withdrawal by Subject|4|||
161758690|NCT01626859|584155415|FG002|Overall Study|Withdrawal by Subject|2|||
161758691|NCT03457636|584155426|FG000|Overall Study|Lost to Follow-up|2|||
161758692|NCT01828567|584155429|FG000|Overall Study|Lost to Follow-up|27|||
161758693|NCT01828567|584155430|FG001|Overall Study|Lost to Follow-up|9|||
161758694|NCT01828567|584155429|FG000|Overall Study|Excluded - did not meet criteria|4|||
161758695|NCT01828567|584155430|FG001|Overall Study|Excluded - did not meet criteria|1|||
161758696|NCT03325010|584155440|FG000|Overall Study|Adverse Event|3|||
161758697|NCT03325010|584155441|FG001|Overall Study|Adverse Event|8|||
161758698|NCT03325010|584155440|FG000|Overall Study|Protocol Violation|1|||
161758699|NCT03325010|584155441|FG001|Overall Study|Protocol Violation|8|||
161758700|NCT03325010|584155440|FG000|Overall Study|Withdrawal by Subject|1|||
161758701|NCT03325010|584155441|FG001|Overall Study|Withdrawal by Subject|3|||
161758702|NCT03325010|584155440|FG000|Overall Study|Lost to Follow-up|1|||
161758703|NCT03325010|584155441|FG001|Overall Study|Lost to Follow-up|0|||
161758704|NCT03325010|584155440|FG000|Overall Study|Physician Decision|1|||
161758705|NCT03325010|584155441|FG001|Overall Study|Physician Decision|1|||
161758706|NCT03325010|584155440|FG000|Overall Study|Lack of Efficacy|2|||
161758707|NCT03325010|584155441|FG001|Overall Study|Lack of Efficacy|0|||
161758708|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
161758709|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161758710|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
161758711|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161758712|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
161758713|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161758714|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161758715|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161758716|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
161758717|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161758718|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161758719|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161758720|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
161758721|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
161758722|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
161758723|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
161758724|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
161758725|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
161758726|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
161758727|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
161758728|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
161758729|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161758730|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161758731|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161758732|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Screen failure|0|||
161758733|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Screen failure|1|||
161758734|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Screen failure|2|||
161758735|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Screen failure|0|||
161758736|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
161758737|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161758738|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
161758739|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161758740|NCT02614261|584155442|FG000|Open-Label Extension Phase|Adverse Event|23|||
161758741|NCT02614261|584155443|FG001|Open-Label Extension Phase|Adverse Event|12|||
161758742|NCT02614261|584155444|FG002|Open-Label Extension Phase|Adverse Event|11|||
161758743|NCT02614261|584155445|FG003|Open-Label Extension Phase|Adverse Event|0|||
161758744|NCT02614261|584155442|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
161758745|NCT02614261|584155443|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
161758746|NCT02614261|584155444|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
161758747|NCT02614261|584155445|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
161758748|NCT02614261|584155442|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
161758749|NCT02614261|584155443|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
161758750|NCT02614261|584155444|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
161758751|NCT02614261|584155445|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
161758752|NCT02614261|584155442|FG000|Open-Label Extension Phase|Physician Decision|2|||
161758753|NCT02614261|584155443|FG001|Open-Label Extension Phase|Physician Decision|0|||
161758754|NCT02614261|584155444|FG002|Open-Label Extension Phase|Physician Decision|0|||
161758755|NCT02614261|584155445|FG003|Open-Label Extension Phase|Physician Decision|0|||
161758756|NCT02614261|584155442|FG000|Open-Label Extension Phase|Pregnancy|1|||
161758757|NCT02614261|584155443|FG001|Open-Label Extension Phase|Pregnancy|2|||
161758758|NCT02614261|584155444|FG002|Open-Label Extension Phase|Pregnancy|1|||
161758759|NCT02614261|584155445|FG003|Open-Label Extension Phase|Pregnancy|0|||
161758760|NCT02614261|584155442|FG000|Open-Label Extension Phase|Protocol Violation|3|||
161758761|NCT02614261|584155443|FG001|Open-Label Extension Phase|Protocol Violation|4|||
161758762|NCT02614261|584155444|FG002|Open-Label Extension Phase|Protocol Violation|1|||
161758763|NCT02614261|584155445|FG003|Open-Label Extension Phase|Protocol Violation|0|||
161758764|NCT02614261|584155442|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
161758765|NCT02614261|584155443|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
161758766|NCT02614261|584155444|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
161758767|NCT02614261|584155445|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
161758768|NCT02614261|584155442|FG000|Follow-up Phase|Adverse Event|2|||
161758769|NCT02614261|584155443|FG001|Follow-up Phase|Adverse Event|0|||
161758770|NCT02614261|584155444|FG002|Follow-up Phase|Adverse Event|1|||
161758771|NCT02614261|584155445|FG003|Follow-up Phase|Adverse Event|0|||
161758772|NCT02614261|584155442|FG000|Follow-up Phase|Lost to Follow-up|12|||
161758773|NCT02614261|584155443|FG001|Follow-up Phase|Lost to Follow-up|5|||
161758774|NCT02614261|584155444|FG002|Follow-up Phase|Lost to Follow-up|2|||
161758775|NCT02614261|584155445|FG003|Follow-up Phase|Lost to Follow-up|0|||
161758776|NCT02614261|584155442|FG000|Follow-up Phase|Physician Decision|5|||
161758777|NCT02614261|584155443|FG001|Follow-up Phase|Physician Decision|1|||
161758778|NCT02614261|584155444|FG002|Follow-up Phase|Physician Decision|0|||
161758779|NCT02614261|584155445|FG003|Follow-up Phase|Physician Decision|0|||
161758780|NCT02614261|584155442|FG000|Follow-up Phase|Pregnancy|0|||
161758781|NCT02614261|584155443|FG001|Follow-up Phase|Pregnancy|1|||
161758782|NCT02614261|584155444|FG002|Follow-up Phase|Pregnancy|0|||
161758783|NCT02614261|584155445|FG003|Follow-up Phase|Pregnancy|0|||
161758784|NCT02614261|584155442|FG000|Follow-up Phase|Protocol Violation|1|||
161758785|NCT02614261|584155443|FG001|Follow-up Phase|Protocol Violation|0|||
161758786|NCT02614261|584155444|FG002|Follow-up Phase|Protocol Violation|0|||
161758787|NCT02614261|584155445|FG003|Follow-up Phase|Protocol Violation|0|||
161758788|NCT02614261|584155442|FG000|Follow-up Phase|Withdrawal by Subject|12|||
161758789|NCT02614261|584155443|FG001|Follow-up Phase|Withdrawal by Subject|4|||
161758790|NCT02614261|584155444|FG002|Follow-up Phase|Withdrawal by Subject|11|||
161758791|NCT02614261|584155445|FG003|Follow-up Phase|Withdrawal by Subject|0|||
161758792|NCT02614261|584155442|FG000|Israel Addendum|Withdrawal by Subject|0|||
161758793|NCT02614261|584155443|FG001|Israel Addendum|Withdrawal by Subject|0|||
161758794|NCT02614261|584155444|FG002|Israel Addendum|Withdrawal by Subject|0|||
161758795|NCT02614261|584155445|FG003|Israel Addendum|Withdrawal by Subject|4|||
161758796|NCT04350372|584155447|FG000|Overall Study|Death|1|||
161758797|NCT03512275|584155449|FG000|Overall Study|Withdrawal by Subject|1|||
161758798|NCT03512275|584155450|FG001|Overall Study|Withdrawal by Subject|3|||
161758799|NCT03512275|584155449|FG000|Overall Study|Physician Decision|0|||
161758800|NCT03512275|584155450|FG001|Overall Study|Physician Decision|1|||
161758801|NCT03512275|584155449|FG000|Overall Study|Lost to Follow-up|0|||
161758802|NCT03512275|584155450|FG001|Overall Study|Lost to Follow-up|3|||
161758803|NCT03512275|584155449|FG000|Overall Study|Other|1|||
161758804|NCT03512275|584155450|FG001|Overall Study|Other|0|||
161758805|NCT00113555|584155451|FG000|Overall Study|Baseline Failure|59|||
161758806|NCT00113555|584155451|FG000|Overall Study|Permanently Explanted|7|||
161758807|NCT00113555|584155451|FG000|Overall Study|Death|1|||
161758808|NCT00113555|584155451|FG000|Overall Study|Missed Followup|4|||
161758809|NCT00113555|584155451|FG000|Overall Study|Lost to Follow-up|8|||
161758810|NCT04474366|584155452|FG000|Overall Study|Lost to Follow-up|2|||
161758811|NCT04474366|584155453|FG001|Overall Study|Lost to Follow-up|5|||
161758812|NCT01700140|584155454|FG000|Overall Study|Use of rescue drugs|3|||
161758813|NCT01700140|584155455|FG001|Overall Study|Use of rescue drugs|3|||
161758814|NCT01700140|584155456|FG002|Overall Study|Use of rescue drugs|1|||
161758815|NCT01700140|584155454|FG000|Overall Study|Discontinuation of radiotherapy|1|||
161758816|NCT01700140|584155455|FG001|Overall Study|Discontinuation of radiotherapy|0|||
161758817|NCT01700140|584155456|FG002|Overall Study|Discontinuation of radiotherapy|0|||
161758818|NCT01700140|584155454|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
161758819|NCT01700140|584155455|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
161758820|NCT01700140|584155456|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
161758821|NCT01700140|584155454|FG000|Overall Study|Aggravation of symptoms|1|||
161758822|NCT01700140|584155455|FG001|Overall Study|Aggravation of symptoms|0|||
161758823|NCT01700140|584155456|FG002|Overall Study|Aggravation of symptoms|0|||
161758824|NCT01700140|584155454|FG000|Overall Study|Adverse Event|0|||
161758825|NCT01700140|584155455|FG001|Overall Study|Adverse Event|1|||
161758826|NCT01700140|584155456|FG002|Overall Study|Adverse Event|0|||
161758827|NCT01700140|584155454|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
161758828|NCT01700140|584155455|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
161758829|NCT01700140|584155456|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
161758830|NCT01060124|584155457|FG000|Overall Study|Other|16|||
161758831|NCT01060124|584155457|FG000|Overall Study|Adverse Event|14|||
161758832|NCT01060124|584155457|FG000|Overall Study|Withdrawal by Subject|7|||
161758833|NCT00102804|584155460|FG000|Overall Study|Progressive Disease (PD)|307|||
161758834|NCT00102804|584155461|FG001|Overall Study|Progressive Disease (PD)|196|||
161758835|NCT00102804|584155460|FG000|Overall Study|Withdrawal by Subject|46|||
161758836|NCT00102804|584155461|FG001|Overall Study|Withdrawal by Subject|7|||
161758837|NCT00102804|584155460|FG000|Overall Study|Adverse Event|37|||
161758838|NCT00102804|584155461|FG001|Overall Study|Adverse Event|3|||
161758839|NCT00102804|584155460|FG000|Overall Study|Physician Decision|24|||
161758840|NCT00102804|584155461|FG001|Overall Study|Physician Decision|6|||
161758841|NCT00102804|584155460|FG000|Overall Study|Death|5|||
161758842|NCT00102804|584155461|FG001|Overall Study|Death|6|||
161758843|NCT00102804|584155460|FG000|Overall Study|Enrollment Criteria Not Met|6|||
161758844|NCT00102804|584155461|FG001|Overall Study|Enrollment Criteria Not Met|0|||
161758845|NCT00102804|584155460|FG000|Overall Study|Lost to Follow-up|4|||
161758846|NCT00102804|584155461|FG001|Overall Study|Lost to Follow-up|1|||
161758847|NCT00102804|584155460|FG000|Overall Study|Protocol Violation|2|||
161758848|NCT00102804|584155461|FG001|Overall Study|Protocol Violation|1|||
161758849|NCT00102804|584155460|FG000|Overall Study|Satisfactory Response|2|||
161758850|NCT00102804|584155461|FG001|Overall Study|Satisfactory Response|0|||
161758851|NCT00102804|584155460|FG000|Overall Study|Sponsor Decision|1|||
161758852|NCT00102804|584155461|FG001|Overall Study|Sponsor Decision|0|||
161758853|NCT00102804|584155460|FG000|Overall Study|Alive, Receiving Treatment|7|||
161758854|NCT00102804|584155461|FG001|Overall Study|Alive, Receiving Treatment|2|||
161758855|NCT03858686|584155462|FG000|Period 1|Adverse Event|1|||
161758856|NCT03858686|584155463|FG001|Period 1|Adverse Event|1|||
161758857|NCT03858686|584155462|FG000|Period 1|Lack of compliance|0|||
161758858|NCT03858686|584155463|FG001|Period 1|Lack of compliance|1|||
161758859|NCT03858686|584155462|FG000|Period 1|Adverse Event|0|||
161758860|NCT03858686|584155463|FG001|Period 1|Adverse Event|1|||
161758861|NCT03858686|584155462|FG000|Period 2|Adverse Event|0|||
161758862|NCT03858686|584155463|FG001|Period 2|Adverse Event|1|||
161758863|NCT02299206|584155470|FG000|Overall Study|Lost to Follow-up|1|||
161758864|NCT02299206|584155470|FG000|Overall Study|Withdrawal by Subject|1|||
161758865|NCT00691054|584155471|FG000|Overall Study|Withdrawal by Subject|1|||
161758866|NCT00518336|584155472|FG000|Year 7|Lost to Follow-up|2|||
161758867|NCT00518336|584155473|FG001|Year 7|Lost to Follow-up|0|||
161758868|NCT00518336|584155472|FG000|Year 7|Could not attend in time|0|||
161758869|NCT00518336|584155473|FG001|Year 7|Could not attend in time|3|||
161758870|NCT00518336|584155472|FG000|Year 8|Lost to Follow-up|1|||
161758871|NCT00518336|584155473|FG001|Year 8|Lost to Follow-up|1|||
161758872|NCT00518336|584155472|FG000|Year 8|Could not attend in time|0|||
161758873|NCT00518336|584155473|FG001|Year 8|Could not attend in time|1|||
161758874|NCT00518336|584155472|FG000|Year 9|Migrated/moved from study area|1|||
161758875|NCT00518336|584155473|FG001|Year 9|Migrated/moved from study area|1|||
161758876|NCT00518336|584155472|FG000|Year 9|Lost to Follow-up|3|||
161758877|NCT00518336|584155473|FG001|Year 9|Lost to Follow-up|0|||
161758878|NCT00518336|584155472|FG000|Year 9|Personal reasons|1|||
161758879|NCT00518336|584155473|FG001|Year 9|Personal reasons|0|||
161758880|NCT02314637|584156689|FG000|Overall Study|Adverse Event|4|||
161758881|NCT02314637|584156690|FG001|Overall Study|Adverse Event|8|||
161758882|NCT02314637|584156689|FG000|Overall Study|Lack of Efficacy|1|||
161758883|NCT02314637|584156690|FG001|Overall Study|Lack of Efficacy|0|||
161758884|NCT02314637|584156689|FG000|Overall Study|Physician Decision|5|||
161758885|NCT02314637|584156690|FG001|Overall Study|Physician Decision|2|||
161758886|NCT02314637|584156689|FG000|Overall Study|Withdrawal by Subject|5|||
161758887|NCT02314637|584156690|FG001|Overall Study|Withdrawal by Subject|4|||
161758888|NCT02314637|584156689|FG000|Overall Study|Other Reason|1|||
161758889|NCT02314637|584156690|FG001|Overall Study|Other Reason|0|||
161758890|NCT04221945|584156694|FG000|Overall Study|Death|103|||
161758891|NCT04221945|584156695|FG001|Overall Study|Death|140|||
161758892|NCT04221945|584156694|FG000|Overall Study|Lost to Follow-up|5|||
161758893|NCT04221945|584156695|FG001|Overall Study|Lost to Follow-up|8|||
161758894|NCT04221945|584156694|FG000|Overall Study|Withdrawal by Subject|21|||
161758895|NCT04221945|584156695|FG001|Overall Study|Withdrawal by Subject|11|||
161758896|NCT04221945|584156694|FG000|Overall Study|Participants Ongoing|400|||
161758897|NCT04221945|584156695|FG001|Overall Study|Participants Ongoing|372|||
161758898|NCT00974090|584156697|FG000|Period 1: Double Blind Period|Adverse Event|2|||
161758899|NCT00974090|584156698|FG001|Period 1: Double Blind Period|Adverse Event|1|||
161758900|NCT00974090|584156697|FG000|Period 1: Double Blind Period|Physician Decision|1|||
161758901|NCT00974090|584156698|FG001|Period 1: Double Blind Period|Physician Decision|0|||
161758902|NCT00974090|584156697|FG000|Period 2: Open-label Period|Adverse Event|4|||
161758903|NCT00974090|584156698|FG001|Period 2: Open-label Period|Adverse Event|6|||
161846980|NCT01104779|584480449|FG002|Overall Study|Protocol Violation|2|||
161846981|NCT01104779|584480447|FG000|Overall Study|Lack of Efficacy|26|||
161846982|NCT01104779|584480448|FG001|Overall Study|Lack of Efficacy|12|||
161846983|NCT01104779|584480449|FG002|Overall Study|Lack of Efficacy|13|||
161846984|NCT01104779|584480447|FG000|Overall Study|Adverse Event|13|||
161846985|NCT01104779|584480448|FG001|Overall Study|Adverse Event|14|||
161846986|NCT01104779|584480449|FG002|Overall Study|Adverse Event|13|||
161846987|NCT01104779|584480447|FG000|Overall Study|Did not meet inc/exc criteria|1|||
161846988|NCT01104779|584480448|FG001|Overall Study|Did not meet inc/exc criteria|1|||
161846989|NCT01104779|584480449|FG002|Overall Study|Did not meet inc/exc criteria|1|||
161846990|NCT01104779|584480447|FG000|Overall Study|Other reasons|0|||
161846991|NCT01104779|584480448|FG001|Overall Study|Other reasons|1|||
161846992|NCT01104779|584480449|FG002|Overall Study|Other reasons|0|||
161846993|NCT01104779|584480447|FG000|Overall Study|Lost to Follow-up|2|||
161846994|NCT01104779|584480448|FG001|Overall Study|Lost to Follow-up|0|||
161846995|NCT01104779|584480449|FG002|Overall Study|Lost to Follow-up|1|||
161846996|NCT01104779|584480447|FG000|Overall Study|Withdrawal by Subject|16|||
161846997|NCT01104779|584480448|FG001|Overall Study|Withdrawal by Subject|25|||
161846998|NCT01104779|584480449|FG002|Overall Study|Withdrawal by Subject|32|||
161846999|NCT02342639|584480450|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
161847000|NCT02342639|584480451|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
161847001|NCT02342639|584480450|FG000|Overall Study|Protocol Violation|0|||
161847002|NCT02342639|584480451|FG001|Overall Study|Protocol Violation|2|||
161847003|NCT00871741|584480462|FG000|Overall Study|Premature study termination|9|||
161847004|NCT00871741|584480463|FG001|Overall Study|Premature study termination|7|||
161847005|NCT01565850|584480464|FG000|Overall Study|Adverse Event|0|||
161847006|NCT01565850|584480465|FG001|Overall Study|Adverse Event|1|||
161847007|NCT01565850|584480464|FG000|Overall Study|Lost to Follow-up|12|||
161847008|NCT01565850|584480465|FG001|Overall Study|Lost to Follow-up|4|||
161847009|NCT01565850|584480464|FG000|Overall Study|Investigator's Discretion|2|||
161847010|NCT01565850|584480465|FG001|Overall Study|Investigator's Discretion|1|||
161847011|NCT01565850|584480464|FG000|Overall Study|Participant noncompliance|2|||
161847012|NCT01565850|584480465|FG001|Overall Study|Participant noncompliance|0|||
161847013|NCT01565850|584480464|FG000|Overall Study|Withdrew Consent|4|||
161847014|NCT01565850|584480465|FG001|Overall Study|Withdrew Consent|2|||
161847015|NCT03395405|584482286|FG000|Overall Study|Death|0|||
161847016|NCT03395405|584482287|FG001|Overall Study|Death|2|||
161847017|NCT03395405|584482286|FG000|Overall Study|Lost to Follow-up|0|||
161847018|NCT03395405|584482287|FG001|Overall Study|Lost to Follow-up|1|||
161847019|NCT03395405|584482286|FG000|Overall Study|Protocol Violation|0|||
161847020|NCT03395405|584482287|FG001|Overall Study|Protocol Violation|1|||
161847021|NCT03395405|584482286|FG000|Overall Study|Withdrawal by Subject|3|||
161847022|NCT03395405|584482287|FG001|Overall Study|Withdrawal by Subject|1|||
161847023|NCT03395405|584482286|FG000|Overall Study|COVID-19 Pandemic|1|||
161847024|NCT03395405|584482287|FG001|Overall Study|COVID-19 Pandemic|0|||
161847025|NCT04324073|584482288|FG000|Overall Study|withdrew consent|0|||
161847026|NCT04324073|584482289|FG001|Overall Study|withdrew consent|4|||
161847027|NCT04324073|584482290|FG002|Overall Study|withdrew consent|2|||
161847028|NCT04324073|584482291|FG003|Overall Study|withdrew consent|8|||
161847029|NCT01200069|584482297|FG000|Overall Study|Withdrawal by Subject|0|||
161847030|NCT01200069|584482298|FG001|Overall Study|Withdrawal by Subject|1|||
161847031|NCT03665441|584482301|FG000|Overall Study|survival follow up ongoing|23|||
161847032|NCT03665441|584482302|FG001|Overall Study|survival follow up ongoing|0|||
161847033|NCT03665441|584482301|FG000|Overall Study|Patients ongoing on treatment|9|||
161847034|NCT03665441|584482302|FG001|Overall Study|Patients ongoing on treatment|6|||
161847035|NCT03665441|584482301|FG000|Overall Study|Randomized but not treated|7|||
161847036|NCT03665441|584482302|FG001|Overall Study|Randomized but not treated|11|||
161847037|NCT05307510|584482303|FG000|Overall Study|Lost to Follow-up|3|||
161847038|NCT05307510|584482304|FG001|Overall Study|Lost to Follow-up|6|||
161847039|NCT05307510|584482303|FG000|Overall Study|Withdrawal by Subject|0|||
161847040|NCT05307510|584482304|FG001|Overall Study|Withdrawal by Subject|1|||
161847041|NCT03610516|584482305|FG000|Treatment Epoch|Adverse Event|3|||
161847042|NCT03610516|584482306|FG001|Treatment Epoch|Adverse Event|1|||
161847043|NCT03610516|584482305|FG000|Treatment Epoch|Death|1|||
161847044|NCT03610516|584482306|FG001|Treatment Epoch|Death|0|||
161847045|NCT03610516|584482305|FG000|Treatment Epoch|Lack of Efficacy|0|||
161847046|NCT03610516|584482306|FG001|Treatment Epoch|Lack of Efficacy|1|||
161847047|NCT03610516|584482305|FG000|Treatment Epoch|No longer requires treatment|1|||
161847048|NCT03610516|584482306|FG001|Treatment Epoch|No longer requires treatment|0|||
161847049|NCT03610516|584482305|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
161847050|NCT03610516|584482306|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
161847051|NCT03610516|584482305|FG000|Treatment Epoch|Physician Decision|8|||
161847052|NCT03610516|584482306|FG001|Treatment Epoch|Physician Decision|5|||
161847053|NCT03610516|584482305|FG000|Treatment Epoch|Protocol Deviation|1|||
161847054|NCT03610516|584482306|FG001|Treatment Epoch|Protocol Deviation|0|||
161847055|NCT03610516|584482305|FG000|Treatment Epoch|Withdrawal by Subject|3|||
161847056|NCT03610516|584482306|FG001|Treatment Epoch|Withdrawal by Subject|1|||
161847057|NCT03610516|584482305|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
161847058|NCT03610516|584482306|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
161847059|NCT03610516|584482305|FG000|Post-Treatment Follow-up|Death|1|||
161847060|NCT03610516|584482306|FG001|Post-Treatment Follow-up|Death|0|||
161847061|NCT00761657|584482309|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
161847062|NCT00761657|584482310|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
161847063|NCT00761657|584482311|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
161847064|NCT00761657|584482312|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
161847065|NCT00761657|584482313|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
161847066|NCT00761657|584482314|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
161847067|NCT00761657|584482315|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
161847068|NCT00761657|584482316|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
161847069|NCT00761657|584482317|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
161847070|NCT00761657|584482309|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847071|NCT00761657|584482310|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847072|NCT00761657|584482311|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
161847073|NCT00761657|584482312|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
161847074|NCT00761657|584482313|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847075|NCT00761657|584482314|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847076|NCT00761657|584482315|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847077|NCT00761657|584482316|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847078|NCT00761657|584482317|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847079|NCT00761657|584482309|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847080|NCT00761657|584482310|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847081|NCT00761657|584482311|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
161847082|NCT00761657|584482312|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
161847083|NCT00761657|584482313|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847084|NCT00761657|584482314|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847085|NCT00761657|584482315|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
161847086|NCT00761657|584482316|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
161847087|NCT00761657|584482317|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
161847088|NCT00761657|584482309|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
161847089|NCT00761657|584482310|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
161847090|NCT00761657|584482311|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
161847091|NCT00761657|584482312|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
161847092|NCT00761657|584482313|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
161847093|NCT00761657|584482314|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
161847094|NCT00761657|584482315|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
161847095|NCT00761657|584482316|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
161847096|NCT00761657|584482317|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
161847097|NCT00478244|584482326|FG000|Overall Study|Did not receive transplant|1|||
161847098|NCT01396512|584482330|FG000|Overall Study|Withdrawal by Subject|0|||
161847099|NCT01396512|584482331|FG001|Overall Study|Withdrawal by Subject|1|||
161847100|NCT01564537|584482332|FG000|Overall Study|Site Terminated by Sponsor|1|||
161847101|NCT01564537|584482333|FG001|Overall Study|Site Terminated by Sponsor|0|||
161847102|NCT01564537|584482332|FG000|Overall Study|Withdrawal by Subject|12|||
161847103|NCT01564537|584482333|FG001|Overall Study|Withdrawal by Subject|14|||
161847104|NCT01564537|584482332|FG000|Overall Study|Lost to Follow-up|7|||
161847105|NCT01564537|584482333|FG001|Overall Study|Lost to Follow-up|3|||
161847106|NCT01564537|584482332|FG000|Overall Study|Reason not specified|81|||
161847107|NCT01564537|584482333|FG001|Overall Study|Reason not specified|82|||
161847108|NCT05776862|584482345|FG000|Overall Study|Adverse Event|0|||
161847109|NCT05776862|584482346|FG001|Overall Study|Adverse Event|1|||
161847110|NCT05776862|584482345|FG000|Overall Study|non-compliance|1|||
161847111|NCT05776862|584482346|FG001|Overall Study|non-compliance|0|||
161847112|NCT02448706|584482347|FG000|Overall Study|Withdrawal by Subject|4|||
161847113|NCT02448706|584482348|FG001|Overall Study|Withdrawal by Subject|3|||
161847114|NCT02448706|584482347|FG000|Overall Study|Protocol Violation|1|||
161847115|NCT02448706|584482348|FG001|Overall Study|Protocol Violation|1|||
161847116|NCT01664130|584482355|FG000|Overall Study|competing secondary disease|2|||
161847117|NCT02679235|584482356|FG000|Overall Study|Withdrawal by Subject|3|||
161847118|NCT02679235|584482356|FG000|Overall Study|Adverse Event|1|||
161847119|NCT00923273|584482357|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847120|NCT00923273|584482358|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847121|NCT00923273|584482359|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847122|NCT00923273|584482360|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
161847123|NCT00923273|584482361|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847124|NCT00923273|584482357|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847125|NCT00923273|584482358|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847126|NCT00923273|584482359|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847127|NCT00923273|584482360|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
161847128|NCT00923273|584482361|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847129|NCT02383810|584482364|FG000|Overall Study|Physician Decision|1|||
161847130|NCT02383810|584482365|FG001|Overall Study|Physician Decision|1|||
161847131|NCT02383810|584482366|FG002|Overall Study|Physician Decision|0|||
161847132|NCT02383810|584482367|FG003|Overall Study|Physician Decision|0|||
161847133|NCT02383810|584482368|FG004|Overall Study|Physician Decision|0|||
161847134|NCT02383810|584482369|FG005|Overall Study|Physician Decision|0|||
161847135|NCT02383810|584482370|FG006|Overall Study|Physician Decision|0|||
161847136|NCT02383810|584482371|FG007|Overall Study|Physician Decision|0|||
161847137|NCT02383810|584482364|FG000|Overall Study|Withdrawal by Subject|2|||
161847138|NCT02383810|584482365|FG001|Overall Study|Withdrawal by Subject|3|||
161847139|NCT02383810|584482366|FG002|Overall Study|Withdrawal by Subject|3|||
161847140|NCT02383810|584482367|FG003|Overall Study|Withdrawal by Subject|3|||
161847141|NCT02383810|584482368|FG004|Overall Study|Withdrawal by Subject|0|||
161847142|NCT02383810|584482369|FG005|Overall Study|Withdrawal by Subject|0|||
161847143|NCT02383810|584482370|FG006|Overall Study|Withdrawal by Subject|0|||
161847144|NCT02383810|584482371|FG007|Overall Study|Withdrawal by Subject|0|||
161847145|NCT02383810|584482364|FG000|Overall Study|Adverse Event|0|||
161847146|NCT02383810|584482365|FG001|Overall Study|Adverse Event|2|||
161847147|NCT02383810|584482366|FG002|Overall Study|Adverse Event|4|||
161847148|NCT02383810|584482367|FG003|Overall Study|Adverse Event|5|||
161847149|NCT02383810|584482368|FG004|Overall Study|Adverse Event|0|||
161847150|NCT02383810|584482369|FG005|Overall Study|Adverse Event|1|||
161847151|NCT02383810|584482370|FG006|Overall Study|Adverse Event|1|||
161847152|NCT02383810|584482371|FG007|Overall Study|Adverse Event|0|||
161847153|NCT02383810|584482364|FG000|Overall Study|Lost to Follow-up|0|||
161847154|NCT02383810|584482365|FG001|Overall Study|Lost to Follow-up|1|||
161847155|NCT02383810|584482366|FG002|Overall Study|Lost to Follow-up|0|||
161847156|NCT02383810|584482367|FG003|Overall Study|Lost to Follow-up|1|||
161847157|NCT02383810|584482368|FG004|Overall Study|Lost to Follow-up|0|||
161847158|NCT02383810|584482369|FG005|Overall Study|Lost to Follow-up|0|||
161847159|NCT02383810|584482370|FG006|Overall Study|Lost to Follow-up|0|||
161847160|NCT02383810|584482371|FG007|Overall Study|Lost to Follow-up|0|||
161847161|NCT02383810|584482364|FG000|Overall Study|other|0|||
161847162|NCT02383810|584482365|FG001|Overall Study|other|0|||
161847163|NCT02383810|584482366|FG002|Overall Study|other|0|||
161847164|NCT02383810|584482367|FG003|Overall Study|other|2|||
161847165|NCT02383810|584482368|FG004|Overall Study|other|0|||
161847166|NCT02383810|584482369|FG005|Overall Study|other|0|||
161847167|NCT02383810|584482370|FG006|Overall Study|other|0|||
161847168|NCT02383810|584482371|FG007|Overall Study|other|0|||
161847169|NCT02383810|584482364|FG000|Overall Study|subject did not receive study treatment|0|||
161847170|NCT02383810|584482365|FG001|Overall Study|subject did not receive study treatment|1|||
161847171|NCT02383810|584482366|FG002|Overall Study|subject did not receive study treatment|0|||
161847172|NCT02383810|584482367|FG003|Overall Study|subject did not receive study treatment|0|||
161847173|NCT02383810|584482368|FG004|Overall Study|subject did not receive study treatment|0|||
161847174|NCT02383810|584482369|FG005|Overall Study|subject did not receive study treatment|0|||
161847175|NCT02383810|584482370|FG006|Overall Study|subject did not receive study treatment|0|||
161847176|NCT02383810|584482371|FG007|Overall Study|subject did not receive study treatment|0|||
161847177|NCT01438996|584482374|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
161847178|NCT01438996|584482375|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
161847179|NCT01438996|584482376|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
161847180|NCT02246114|584482377|FG000|Overall Study|miscarriage|1|||
161847181|NCT02246114|584482378|FG001|Overall Study|miscarriage|0|||
161847182|NCT02278055|584482385|FG000|Overall Study|Adverse Event|1|||
161847183|NCT02278055|584482385|FG000|Overall Study|Lost to Follow-up|1|||
161847184|NCT02278055|584482385|FG000|Overall Study|Withdrawal by Subject|2|||
161847185|NCT02278055|584482385|FG000|Overall Study|Progressive Disease|4|||
161847186|NCT01934335|584482386|FG000|Overall Study|Withdrawal by Subject|1|||
161847187|NCT01934335|584482387|FG001|Overall Study|Withdrawal by Subject|1|||
161847188|NCT01111825|584482388|FG000|Overall Study|Withdrawal by Subject|0|||
161847189|NCT01111825|584482389|FG001|Overall Study|Withdrawal by Subject|0|||
161847190|NCT01111825|584482390|FG002|Overall Study|Withdrawal by Subject|1|||
161847191|NCT01111825|584482391|FG003|Overall Study|Withdrawal by Subject|0|||
161847192|NCT01111825|584482388|FG000|Overall Study|Lost to Follow-up|0|||
161847193|NCT01111825|584482389|FG001|Overall Study|Lost to Follow-up|0|||
161847194|NCT01111825|584482390|FG002|Overall Study|Lost to Follow-up|3|||
161847195|NCT01111825|584482391|FG003|Overall Study|Lost to Follow-up|1|||
161847196|NCT01111825|584482388|FG000|Overall Study|Adverse Event|2|||
161847197|NCT01111825|584482389|FG001|Overall Study|Adverse Event|1|||
161847198|NCT01111825|584482390|FG002|Overall Study|Adverse Event|4|||
161847199|NCT01111825|584482391|FG003|Overall Study|Adverse Event|0|||
161847200|NCT01111825|584482388|FG000|Overall Study|Disease Progression|1|||
161847201|NCT01111825|584482389|FG001|Overall Study|Disease Progression|0|||
161847202|NCT01111825|584482390|FG002|Overall Study|Disease Progression|0|||
161847203|NCT01111825|584482391|FG003|Overall Study|Disease Progression|0|||
161847204|NCT01111825|584482388|FG000|Overall Study|Discontinuation by Sponsor|0|||
161847205|NCT01111825|584482389|FG001|Overall Study|Discontinuation by Sponsor|0|||
161847206|NCT01111825|584482390|FG002|Overall Study|Discontinuation by Sponsor|0|||
161847207|NCT01111825|584482391|FG003|Overall Study|Discontinuation by Sponsor|20|||
161847208|NCT00469144|584482392|FG000|Overall Study|Death|0|||
161847209|NCT00469144|584482393|FG001|Overall Study|Death|1|||
161847210|NCT00469144|584482392|FG000|Overall Study|No Response|5|||
161847211|NCT00469144|584482393|FG001|Overall Study|No Response|5|||
161847212|NCT00469144|584482392|FG000|Overall Study|Progressive Disease|1|||
161847213|NCT00469144|584482393|FG001|Overall Study|Progressive Disease|0|||
161847214|NCT01994291|584482394|FG000|Overall Study|Adverse Event|4|||
161847215|NCT01994291|584482395|FG001|Overall Study|Adverse Event|1|||
161847216|NCT01994291|584482396|FG002|Overall Study|Adverse Event|3|||
161847217|NCT01994291|584482394|FG000|Overall Study|Lost to Follow-up|1|||
161847218|NCT01994291|584482395|FG001|Overall Study|Lost to Follow-up|1|||
161847219|NCT01994291|584482396|FG002|Overall Study|Lost to Follow-up|0|||
161847220|NCT01994291|584482394|FG000|Overall Study|Does not meet entrance criteria|1|||
161847221|NCT01994291|584482395|FG001|Overall Study|Does not meet entrance criteria|0|||
161847222|NCT01994291|584482396|FG002|Overall Study|Does not meet entrance criteria|0|||
161847223|NCT01994291|584482394|FG000|Overall Study|Medication error without associated AE|1|||
161847224|NCT01994291|584482395|FG001|Overall Study|Medication error without associated AE|0|||
161847225|NCT01994291|584482396|FG002|Overall Study|Medication error without associated AE|1|||
161847226|NCT01994291|584482394|FG000|Overall Study|Protocol Violation|1|||
161847227|NCT01994291|584482395|FG001|Overall Study|Protocol Violation|0|||
161847228|NCT01994291|584482396|FG002|Overall Study|Protocol Violation|0|||
161847229|NCT01994291|584482394|FG000|Overall Study|Withdrawal by Subject|6|||
161847230|NCT01994291|584482395|FG001|Overall Study|Withdrawal by Subject|3|||
161847231|NCT01994291|584482396|FG002|Overall Study|Withdrawal by Subject|5|||
161847232|NCT01994291|584482394|FG000|Overall Study|Other|1|||
161847233|NCT01994291|584482395|FG001|Overall Study|Other|2|||
161847234|NCT01994291|584482396|FG002|Overall Study|Other|0|||
161847235|NCT01147107|584482406|FG000|Overall Study|Lack of Efficacy|5|||
161847236|NCT01147107|584482407|FG001|Overall Study|Lack of Efficacy|0|||
161847237|NCT01147107|584482406|FG000|Overall Study|Withdrawal by Subject|1|||
161847238|NCT01147107|584482407|FG001|Overall Study|Withdrawal by Subject|1|||
161847239|NCT04435184|584482408|FG000|Overall Study|follow-up blood draws missing|3|||
161847240|NCT04435184|584482409|FG001|Overall Study|follow-up blood draws missing|5|||
161847241|NCT02365558|584482413|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
161847242|NCT02365558|584482414|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
161847243|NCT02365558|584482413|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
161847244|NCT02365558|584482414|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
161847245|NCT00369317|584482415|FG000|Overall Study|Adverse Event|3|||
161847246|NCT00369317|584482415|FG000|Overall Study|Death|1|||
161847247|NCT00369317|584482415|FG000|Overall Study|Lack of Efficacy|5|||
161847248|NCT00369317|584482415|FG000|Overall Study|Physician Decision|2|||
161847249|NCT00369317|584482415|FG000|Overall Study|Withdrawal by Subject|8|||
161847250|NCT00369317|584482415|FG000|Overall Study|Ineligible|1|||
161847251|NCT02722148|584482426|FG000|Overall Study|Lost to Follow-up|2|||
161847252|NCT02722148|584482426|FG000|Overall Study|Non compliant with treatment regimen|3|||
161847253|NCT00073021|584482427|FG000|Overall Study|Protocol Violation|2|||
161847254|NCT00073021|584482428|FG001|Overall Study|Protocol Violation|1|||
161847255|NCT00073021|584482427|FG000|Overall Study|Adverse Event|4|||
161847256|NCT00073021|584482428|FG001|Overall Study|Adverse Event|4|||
161847257|NCT00073021|584482427|FG000|Overall Study|Withdrawal by Subject|6|||
161847258|NCT00073021|584482428|FG001|Overall Study|Withdrawal by Subject|5|||
161847259|NCT00073021|584482427|FG000|Overall Study|Physician Decision|3|||
161847260|NCT00073021|584482428|FG001|Overall Study|Physician Decision|1|||
161847261|NCT00073021|584482427|FG000|Overall Study|Lack of Efficacy|11|||
161847262|NCT00073021|584482428|FG001|Overall Study|Lack of Efficacy|5|||
161847263|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
161847264|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
161758904|NCT00974090|584156697|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
161758905|NCT00974090|584156698|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
161758906|NCT00974090|584156697|FG000|Period 2: Open-label Period|Physician Decision|0|||
161758907|NCT00974090|584156698|FG001|Period 2: Open-label Period|Physician Decision|3|||
161758908|NCT00974090|584156697|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
161758909|NCT00974090|584156698|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
161758910|NCT01626872|584156699|FG000|Overall Study|Physician Decision|13|||
161758911|NCT01626872|584156700|FG001|Overall Study|Physician Decision|9|||
161758912|NCT01626872|584156701|FG002|Overall Study|Physician Decision|6|||
161758913|NCT01626872|584156699|FG000|Overall Study|Withdrawal by Subject|19|||
161758914|NCT01626872|584156700|FG001|Overall Study|Withdrawal by Subject|27|||
161758915|NCT01626872|584156701|FG002|Overall Study|Withdrawal by Subject|8|||
161758916|NCT01626872|584156699|FG000|Overall Study|Adverse Event (including Death)|20|||
161758917|NCT01626872|584156700|FG001|Overall Study|Adverse Event (including Death)|28|||
161758918|NCT01626872|584156701|FG002|Overall Study|Adverse Event (including Death)|8|||
161758919|NCT01626872|584156699|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
161758920|NCT01626872|584156700|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
161758921|NCT01626872|584156701|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
161758922|NCT05626751|584156702|FG000|Overall Study|Lost to Follow-up|1|||
161758923|NCT05626751|584156703|FG001|Overall Study|Lost to Follow-up|2|||
161758924|NCT05626751|584156704|FG002|Overall Study|Lost to Follow-up|1|||
161758925|NCT05626751|584156702|FG000|Overall Study|Trial Terminated by Sponsor|39|||
161758926|NCT05626751|584156703|FG001|Overall Study|Trial Terminated by Sponsor|30|||
161758927|NCT05626751|584156704|FG002|Overall Study|Trial Terminated by Sponsor|37|||
161758928|NCT05626751|584156702|FG000|Overall Study|Withdrawal by Subject|7|||
161758929|NCT05626751|584156703|FG001|Overall Study|Withdrawal by Subject|5|||
161758930|NCT05626751|584156704|FG002|Overall Study|Withdrawal by Subject|5|||
161758931|NCT01625000|584156705|FG000|Overall Study|Physician Decision|15|||
161758932|NCT01625000|584156706|FG001|Overall Study|Physician Decision|7|||
161758933|NCT01625000|584156707|FG002|Overall Study|Physician Decision|7|||
161758934|NCT01625000|584156708|FG003|Overall Study|Physician Decision|2|||
161758935|NCT01625000|584156709|FG004|Overall Study|Physician Decision|15|||
161758936|NCT01625000|584156705|FG000|Overall Study|Protocol Violation|3|||
161758937|NCT01625000|584156706|FG001|Overall Study|Protocol Violation|10|||
161758938|NCT01625000|584156707|FG002|Overall Study|Protocol Violation|4|||
161758939|NCT01625000|584156708|FG003|Overall Study|Protocol Violation|1|||
161758940|NCT01625000|584156709|FG004|Overall Study|Protocol Violation|2|||
161758941|NCT01625000|584156705|FG000|Overall Study|Withdrawal by Subject|19|||
161758942|NCT01625000|584156706|FG001|Overall Study|Withdrawal by Subject|16|||
161758943|NCT01625000|584156707|FG002|Overall Study|Withdrawal by Subject|11|||
161758944|NCT01625000|584156708|FG003|Overall Study|Withdrawal by Subject|9|||
161758945|NCT01625000|584156709|FG004|Overall Study|Withdrawal by Subject|17|||
161758946|NCT01625000|584156705|FG000|Overall Study|Adverse Event (including Death)|15|||
161758947|NCT01625000|584156706|FG001|Overall Study|Adverse Event (including Death)|19|||
161758948|NCT01625000|584156707|FG002|Overall Study|Adverse Event (including Death)|11|||
161758949|NCT01625000|584156708|FG003|Overall Study|Adverse Event (including Death)|7|||
161758950|NCT01625000|584156709|FG004|Overall Study|Adverse Event (including Death)|21|||
161758951|NCT03912064|584156710|FG000|Overall Study|Withdrawal by Subject|2|||
161758952|NCT03912064|584156711|FG001|Overall Study|Withdrawal by Subject|0|||
161758953|NCT03912064|584156712|FG002|Overall Study|Withdrawal by Subject|0|||
161758954|NCT03912064|584156710|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
161758955|NCT03912064|584156711|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
161758956|NCT03912064|584156712|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
161758957|NCT03912064|584156710|FG000|Overall Study|Progression/Relapse|7|||
161758958|NCT03912064|584156711|FG001|Overall Study|Progression/Relapse|3|||
161758959|NCT03912064|584156712|FG002|Overall Study|Progression/Relapse|0|||
161758960|NCT03912064|584156710|FG000|Overall Study|Prolonged treatment delays|3|||
161758961|NCT03912064|584156711|FG001|Overall Study|Prolonged treatment delays|2|||
161758962|NCT03912064|584156712|FG002|Overall Study|Prolonged treatment delays|0|||
161758963|NCT03912064|584156710|FG000|Overall Study|Prohibited concomitant treatments|3|||
161758964|NCT03912064|584156711|FG001|Overall Study|Prohibited concomitant treatments|1|||
161758965|NCT03912064|584156712|FG002|Overall Study|Prohibited concomitant treatments|0|||
161758966|NCT01026194|584156713|FG000|Period 1：Double Blind Period|Adverse Event|2|||
161758967|NCT01026194|584156714|FG001|Period 1：Double Blind Period|Adverse Event|1|||
161758968|NCT01026194|584156713|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
161758969|NCT01026194|584156714|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
161758970|NCT01026194|584156713|FG000|Period 1：Double Blind Period|Physician Decision|0|||
161758971|NCT01026194|584156714|FG001|Period 1：Double Blind Period|Physician Decision|4|||
161758972|NCT01026194|584156713|FG000|Period 2：Open-label Period|Adverse Event|4|||
161758973|NCT01026194|584156714|FG001|Period 2：Open-label Period|Adverse Event|5|||
161758974|NCT01026194|584156713|FG000|Period 2：Open-label Period|Physician Decision|3|||
161758975|NCT01026194|584156714|FG001|Period 2：Open-label Period|Physician Decision|1|||
161758976|NCT01026194|584156713|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
161758977|NCT01026194|584156714|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
161758978|NCT04295759|584156715|FG000|Overall Study|Lack of Efficacy|9|||
161758979|NCT04295759|584156715|FG000|Overall Study|Death|1|||
161758980|NCT04295759|584156715|FG000|Overall Study|Withdrawal by Subject|2|||
161758981|NCT04295759|584156715|FG000|Overall Study|Deemed ineligible|1|||
161758982|NCT05740566|584156716|FG000|Overall Study|Death|151|||
161758983|NCT05740566|584156717|FG001|Overall Study|Death|111|||
161758984|NCT05740566|584156716|FG000|Overall Study|Withdrawal by Subject|2|||
161758985|NCT05740566|584156717|FG001|Overall Study|Withdrawal by Subject|0|||
161758986|NCT05740566|584156716|FG000|Overall Study|Ongoing in study|102|||
161758987|NCT05740566|584156717|FG001|Overall Study|Ongoing in study|143|||
161758988|NCT00829010|584156720|FG000|Overall Study|Adverse Event|1|||
161758989|NCT00829010|584156721|FG001|Overall Study|Adverse Event|0|||
161758990|NCT00829010|584156722|FG002|Overall Study|Adverse Event|0|||
161758991|NCT00829010|584156723|FG003|Overall Study|Adverse Event|0|||
161758992|NCT00829010|584156724|FG004|Overall Study|Adverse Event|0|||
161758993|NCT00829010|584156720|FG000|Overall Study|Withdrawal by Subject|0|||
161758994|NCT00829010|584156721|FG001|Overall Study|Withdrawal by Subject|1|||
161758995|NCT00829010|584156722|FG002|Overall Study|Withdrawal by Subject|1|||
161758996|NCT00829010|584156723|FG003|Overall Study|Withdrawal by Subject|0|||
161758997|NCT00829010|584156724|FG004|Overall Study|Withdrawal by Subject|2|||
161758998|NCT00829010|584156720|FG000|Overall Study|Lost to Follow-up|1|||
161758999|NCT00829010|584156721|FG001|Overall Study|Lost to Follow-up|0|||
161759000|NCT00829010|584156722|FG002|Overall Study|Lost to Follow-up|2|||
161759001|NCT00829010|584156723|FG003|Overall Study|Lost to Follow-up|0|||
161759002|NCT00829010|584156724|FG004|Overall Study|Lost to Follow-up|0|||
161759003|NCT00829010|584156720|FG000|Overall Study|Fatality|5|||
161759004|NCT00829010|584156721|FG001|Overall Study|Fatality|4|||
161759005|NCT00829010|584156722|FG002|Overall Study|Fatality|0|||
161759006|NCT00829010|584156723|FG003|Overall Study|Fatality|3|||
161759007|NCT00829010|584156724|FG004|Overall Study|Fatality|0|||
161759008|NCT00829010|584156720|FG000|Overall Study|Migrated/Moved from study area|3|||
161759009|NCT00829010|584156721|FG001|Overall Study|Migrated/Moved from study area|4|||
161759010|NCT00829010|584156722|FG002|Overall Study|Migrated/Moved from study area|0|||
161759011|NCT00829010|584156723|FG003|Overall Study|Migrated/Moved from study area|5|||
161759012|NCT00829010|584156724|FG004|Overall Study|Migrated/Moved from study area|0|||
161759013|NCT06210035|584156725|FG000|Overall Study|Withdrawal by Subject|3|||
161759014|NCT06210035|584156726|FG001|Overall Study|Withdrawal by Subject|0|||
161759015|NCT06210035|584156727|FG002|Overall Study|Withdrawal by Subject|0|||
161759016|NCT01029691|584156728|FG000|Continued APAP to Delivery|Death|0|||
161759017|NCT01029691|584156729|FG001|Continued APAP to Delivery|Death|0|||
161759018|NCT01029691|584156730|FG002|Continued APAP to Delivery|Death|1|||
161759019|NCT05616221|584156735|FG000|Overall Study|Withdrawal by Subject|0|||
161759020|NCT05616221|584156736|FG001|Overall Study|Withdrawal by Subject|1|||
161759021|NCT05616221|584156737|FG002|Overall Study|Withdrawal by Subject|0|||
161759022|NCT05616221|584156738|FG003|Overall Study|Withdrawal by Subject|0|||
161759023|NCT05616221|584156739|FG004|Overall Study|Withdrawal by Subject|0|||
161759024|NCT05616221|584156740|FG005|Overall Study|Withdrawal by Subject|0|||
161759025|NCT05616221|584156735|FG000|Overall Study|Adverse Event|0|||
161759026|NCT05616221|584156736|FG001|Overall Study|Adverse Event|2|||
161759027|NCT05616221|584156737|FG002|Overall Study|Adverse Event|0|||
161759028|NCT05616221|584156738|FG003|Overall Study|Adverse Event|0|||
161759029|NCT05616221|584156739|FG004|Overall Study|Adverse Event|2|||
161759030|NCT05616221|584156740|FG005|Overall Study|Adverse Event|0|||
161759031|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
161759032|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
161759033|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
161759034|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
161759035|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
161759036|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
161759037|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
161759038|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
161759039|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
161759040|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
161759041|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
161759042|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
161759043|NCT04880733|584156741|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
161759044|NCT04880733|584156742|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
161759045|NCT04880733|584156743|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
161759046|NCT00862992|584156744|FG000|Overall Study|Adverse Event|2|||
161759047|NCT00862992|584156745|FG001|Overall Study|Adverse Event|1|||
161759048|NCT00862992|584156746|FG002|Overall Study|Adverse Event|1|||
161759049|NCT00862992|584156744|FG000|Overall Study|Physician Decision|1|||
161759050|NCT00862992|584156745|FG001|Overall Study|Physician Decision|0|||
161759051|NCT00862992|584156746|FG002|Overall Study|Physician Decision|0|||
161759052|NCT00862992|584156744|FG000|Overall Study|Withdrawal by Subject|0|||
161759053|NCT00862992|584156745|FG001|Overall Study|Withdrawal by Subject|0|||
161759054|NCT00862992|584156746|FG002|Overall Study|Withdrawal by Subject|2|||
161759055|NCT05492877|584156747|FG000|Overall Study|Adverse Event|11|||
161759056|NCT05492877|584156748|FG001|Overall Study|Adverse Event|7|||
161759057|NCT05492877|584156747|FG000|Overall Study|Death|1|||
161759058|NCT05492877|584156748|FG001|Overall Study|Death|0|||
161759059|NCT05492877|584156747|FG000|Overall Study|Lost to Follow-up|1|||
161759060|NCT05492877|584156748|FG001|Overall Study|Lost to Follow-up|1|||
161759061|NCT05492877|584156747|FG000|Overall Study|Physician Decision|1|||
161759062|NCT05492877|584156748|FG001|Overall Study|Physician Decision|2|||
161759063|NCT05492877|584156747|FG000|Overall Study|Protocol Violation|1|||
161759064|NCT05492877|584156748|FG001|Overall Study|Protocol Violation|1|||
161759065|NCT05492877|584156747|FG000|Overall Study|Withdrawal by Subject|3|||
161759066|NCT05492877|584156748|FG001|Overall Study|Withdrawal by Subject|7|||
161759067|NCT05492877|584156747|FG000|Overall Study|Reason not specified|6|||
161759068|NCT05492877|584156748|FG001|Overall Study|Reason not specified|4|||
161759069|NCT00528840|584156757|FG000|Overall Study|Lost to Follow-up|10|||
161759070|NCT00528840|584156757|FG000|Overall Study|Adverse Event|1|||
161759071|NCT00528840|584156757|FG000|Overall Study|Withdrawal by Subject|17|||
161759072|NCT00528840|584156757|FG000|Overall Study|Death|2|||
161759073|NCT00528840|584156757|FG000|Overall Study|Administrative Reasons|1|||
161759074|NCT00528840|584156757|FG000|Overall Study|Other|2|||
161759075|NCT01603628|584156758|FG000|Overall Study|Personal Reasons|1|||
161759076|NCT01603628|584156759|FG001|Overall Study|Personal Reasons|1|||
161759077|NCT01603628|584156760|FG002|Overall Study|Personal Reasons|2|||
161759078|NCT01603628|584156758|FG000|Overall Study|Protocol Violation|1|||
161759079|NCT01603628|584156759|FG001|Overall Study|Protocol Violation|1|||
161759080|NCT01603628|584156760|FG002|Overall Study|Protocol Violation|0|||
161759081|NCT01603628|584156758|FG000|Overall Study|Lost to Follow-up|0|||
161759082|NCT01603628|584156759|FG001|Overall Study|Lost to Follow-up|1|||
161759083|NCT01603628|584156760|FG002|Overall Study|Lost to Follow-up|0|||
161759084|NCT01603628|584156758|FG000|Overall Study|Other Miscellaneous Reason|1|||
161759085|NCT01603628|584156759|FG001|Overall Study|Other Miscellaneous Reason|0|||
161759086|NCT01603628|584156760|FG002|Overall Study|Other Miscellaneous Reason|0|||
161759087|NCT01969565|584156761|FG000|Overall Study|Withdrawal by Subject|1|||
161759088|NCT00832091|584156762|FG000|Overall Study|Adverse Event|1|||
161759089|NCT00832091|584156763|FG001|Overall Study|Adverse Event|1|||
161759090|NCT00832091|584156762|FG000|Overall Study|Protocol Violation|1|||
161759091|NCT00832091|584156763|FG001|Overall Study|Protocol Violation|0|||
161759092|NCT00832091|584156762|FG000|Overall Study|Withdrawal by Subject|2|||
161759093|NCT00832091|584156763|FG001|Overall Study|Withdrawal by Subject|1|||
161759094|NCT00832091|584156762|FG000|Overall Study|Prohibited Medication|1|||
161759095|NCT00832091|584156763|FG001|Overall Study|Prohibited Medication|0|||
161759096|NCT02087241|584156765|FG000|Overall Study|Death|2|||
161759097|NCT02087241|584156766|FG001|Overall Study|Death|1|||
161759098|NCT02087241|584156767|FG002|Overall Study|Death|1|||
161759099|NCT02087241|584156768|FG003|Overall Study|Death|1|||
161759100|NCT02087241|584156765|FG000|Overall Study|Withdrawal by Subject|1|||
161759101|NCT02087241|584156766|FG001|Overall Study|Withdrawal by Subject|0|||
161759102|NCT02087241|584156767|FG002|Overall Study|Withdrawal by Subject|0|||
161759103|NCT02087241|584156768|FG003|Overall Study|Withdrawal by Subject|1|||
161759104|NCT02087241|584156765|FG000|Overall Study|Progressive Disease|0|||
161759105|NCT02087241|584156766|FG001|Overall Study|Progressive Disease|0|||
161759106|NCT02087241|584156767|FG002|Overall Study|Progressive Disease|0|||
161759107|NCT02087241|584156768|FG003|Overall Study|Progressive Disease|1|||
161759108|NCT02087241|584156765|FG000|Overall Study|Study Terminated by Sponsor|0|||
161759109|NCT02087241|584156766|FG001|Overall Study|Study Terminated by Sponsor|2|||
161759110|NCT02087241|584156767|FG002|Overall Study|Study Terminated by Sponsor|0|||
161759111|NCT02087241|584156768|FG003|Overall Study|Study Terminated by Sponsor|4|||
161759112|NCT01955005|584156769|FG000|Overall Study|Withdrawal by Subject|3|||
161759113|NCT01955005|584156770|FG001|Overall Study|Withdrawal by Subject|5|||
161759114|NCT00836953|584156771|FG000|Overall Study|Withdrawal by Subject|1|||
161759115|NCT00836953|584156771|FG000|Overall Study|Lost to Follow-up|1|||
161759116|NCT02943668|584156772|FG000|Overall Study|Disease Progression|1|||
161759117|NCT01200758|584156773|FG000|Stage I|Death|0|||
161759118|NCT01200758|584156774|FG001|Stage I|Death|1|||
161759119|NCT01200758|584156775|FG002|Stage I|Death|0|||
161759120|NCT01200758|584156776|FG003|Stage I|Death|0|||
161759121|NCT01200758|584156773|FG000|Stage I|Physician Decision|1|||
161759122|NCT01200758|584156774|FG001|Stage I|Physician Decision|1|||
161759123|NCT01200758|584156775|FG002|Stage I|Physician Decision|0|||
161759124|NCT01200758|584156776|FG003|Stage I|Physician Decision|0|||
161759125|NCT01200758|584156773|FG000|Stage I|Lack of Efficacy|2|||
161759126|NCT01200758|584156774|FG001|Stage I|Lack of Efficacy|1|||
161759127|NCT01200758|584156775|FG002|Stage I|Lack of Efficacy|0|||
161759128|NCT01200758|584156776|FG003|Stage I|Lack of Efficacy|0|||
161759129|NCT01200758|584156773|FG000|Stage I|Adverse Event|5|||
161759130|NCT01200758|584156774|FG001|Stage I|Adverse Event|5|||
161759131|NCT01200758|584156775|FG002|Stage I|Adverse Event|0|||
161759132|NCT01200758|584156776|FG003|Stage I|Adverse Event|0|||
161759133|NCT01200758|584156773|FG000|Stage I|Withdrawal by Subject|1|||
161759134|NCT01200758|584156774|FG001|Stage I|Withdrawal by Subject|2|||
161759135|NCT01200758|584156775|FG002|Stage I|Withdrawal by Subject|0|||
161759136|NCT01200758|584156776|FG003|Stage I|Withdrawal by Subject|0|||
161759137|NCT01200758|584156773|FG000|Stage I|Disease Progression|9|||
161759138|NCT01200758|584156774|FG001|Stage I|Disease Progression|7|||
161759139|NCT01200758|584156775|FG002|Stage I|Disease Progression|0|||
161759140|NCT01200758|584156776|FG003|Stage I|Disease Progression|0|||
161759141|NCT01200758|584156773|FG000|Stage 2|Disease Progression|0|||
161759142|NCT01200758|584156774|FG001|Stage 2|Disease Progression|0|||
161759143|NCT01200758|584156775|FG002|Stage 2|Disease Progression|16|||
161759144|NCT01200758|584156776|FG003|Stage 2|Disease Progression|21|||
161759145|NCT01200758|584156773|FG000|Stage 2|Lack of Efficacy|0|||
161759146|NCT01200758|584156774|FG001|Stage 2|Lack of Efficacy|0|||
161759147|NCT01200758|584156775|FG002|Stage 2|Lack of Efficacy|4|||
161759148|NCT01200758|584156776|FG003|Stage 2|Lack of Efficacy|2|||
161759149|NCT01200758|584156773|FG000|Stage 2|Physician Decision|0|||
161759150|NCT01200758|584156774|FG001|Stage 2|Physician Decision|0|||
161759151|NCT01200758|584156775|FG002|Stage 2|Physician Decision|5|||
161759152|NCT01200758|584156776|FG003|Stage 2|Physician Decision|7|||
161759153|NCT01200758|584156773|FG000|Stage 2|Adverse Event|0|||
161759154|NCT01200758|584156774|FG001|Stage 2|Adverse Event|0|||
161759155|NCT01200758|584156775|FG002|Stage 2|Adverse Event|5|||
161759156|NCT01200758|584156776|FG003|Stage 2|Adverse Event|9|||
161759157|NCT01200758|584156773|FG000|Stage 2|Withdrawal by Subject|0|||
161759158|NCT01200758|584156774|FG001|Stage 2|Withdrawal by Subject|0|||
161759159|NCT01200758|584156775|FG002|Stage 2|Withdrawal by Subject|4|||
161759160|NCT01200758|584156776|FG003|Stage 2|Withdrawal by Subject|1|||
161759161|NCT01200758|584156773|FG000|Stage 2|Lost to Follow-up|0|||
161759162|NCT01200758|584156774|FG001|Stage 2|Lost to Follow-up|0|||
161759163|NCT01200758|584156775|FG002|Stage 2|Lost to Follow-up|3|||
161759164|NCT01200758|584156776|FG003|Stage 2|Lost to Follow-up|1|||
161759165|NCT01200758|584156773|FG000|Stage 2|Protocol Violation|0|||
161759166|NCT01200758|584156774|FG001|Stage 2|Protocol Violation|0|||
161759167|NCT01200758|584156775|FG002|Stage 2|Protocol Violation|1|||
161759168|NCT01200758|584156776|FG003|Stage 2|Protocol Violation|4|||
161759169|NCT01200758|584156773|FG000|Stage 2|Death|0|||
161759170|NCT01200758|584156774|FG001|Stage 2|Death|0|||
161759171|NCT01200758|584156775|FG002|Stage 2|Death|3|||
161759172|NCT01200758|584156776|FG003|Stage 2|Death|5|||
161759173|NCT02711553|584156779|FG000|Overall Study|Withdrawal by Subject|2|||
161759174|NCT02711553|584156780|FG001|Overall Study|Withdrawal by Subject|1|||
161759175|NCT02711553|584156781|FG002|Overall Study|Withdrawal by Subject|1|||
161759176|NCT02711553|584156782|FG003|Overall Study|Withdrawal by Subject|0|||
161759177|NCT02711553|584156779|FG000|Overall Study|Lost to Follow-up|3|||
161759178|NCT02711553|584156780|FG001|Overall Study|Lost to Follow-up|3|||
161759179|NCT02711553|584156781|FG002|Overall Study|Lost to Follow-up|6|||
161759180|NCT02711553|584156782|FG003|Overall Study|Lost to Follow-up|3|||
161759181|NCT02711553|584156779|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
161759182|NCT02711553|584156780|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
161759183|NCT02711553|584156781|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
161759184|NCT02711553|584156782|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
161759185|NCT04048876|584156789|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
161759186|NCT04048876|584156790|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
161759187|NCT04048876|584156791|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
161759188|NCT04048876|584156792|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
161759189|NCT04048876|584156789|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
161759190|NCT04048876|584156790|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
161759191|NCT04048876|584156791|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
161759192|NCT04048876|584156792|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
161759193|NCT04048876|584156789|FG000|Placebo Controlled Phase|Adverse Event|0|||
161759194|NCT04048876|584156790|FG001|Placebo Controlled Phase|Adverse Event|1|||
161759195|NCT04048876|584156791|FG002|Placebo Controlled Phase|Adverse Event|0|||
161759196|NCT04048876|584156792|FG003|Placebo Controlled Phase|Adverse Event|0|||
161759197|NCT04048876|584156789|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
161759198|NCT04048876|584156790|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
161759199|NCT04048876|584156791|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
161759200|NCT04048876|584156792|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
161759201|NCT04063865|584156794|FG000|Overall Study|Physician Decision|1|||
161759202|NCT04063865|584156795|FG001|Overall Study|Physician Decision|3|||
161759203|NCT04063865|584156794|FG000|Overall Study|Study Closed Prior to Completion|4|||
161759204|NCT04063865|584156795|FG001|Overall Study|Study Closed Prior to Completion|4|||
161759205|NCT04063865|584156794|FG000|Overall Study|Withdrawal by Subject|1|||
161759206|NCT04063865|584156795|FG001|Overall Study|Withdrawal by Subject|1|||
161759207|NCT00320190|584156796|FG000|First 12 Months|Completed but did not enter extension|5|||
161759208|NCT00320190|584156797|FG001|First 12 Months|Completed but did not enter extension|3|||
161759209|NCT00320190|584156796|FG000|First 12 Months|Sponsor terminated study|2|||
161759210|NCT00320190|584156797|FG001|First 12 Months|Sponsor terminated study|2|||
161759211|NCT00320190|584156796|FG000|First 12 Months|Lost to Follow-up|0|||
161759212|NCT00320190|584156797|FG001|First 12 Months|Lost to Follow-up|1|||
161759213|NCT00320190|584156796|FG000|First 12 Months|Enrollment failure|0|||
161759214|NCT00320190|584156797|FG001|First 12 Months|Enrollment failure|1|||
161759215|NCT00320190|584156796|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
161759216|NCT00320190|584156797|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
161759217|NCT00320190|584156796|FG000|First 12 Months|Investigator request|0|||
161759218|NCT00320190|584156797|FG001|First 12 Months|Investigator request|1|||
161759219|NCT00320190|584156796|FG000|First 12 Months|Study drug toxicity|0|||
161759220|NCT00320190|584156797|FG001|First 12 Months|Study drug toxicity|1|||
161759221|NCT00320190|584156796|FG000|First 12 Months|Withdrawal by Subject|0|||
161759222|NCT00320190|584156797|FG001|First 12 Months|Withdrawal by Subject|1|||
161759223|NCT00320190|584156796|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
161759224|NCT00320190|584156797|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
161759225|NCT00320190|584156796|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
161759226|NCT00320190|584156797|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
161759227|NCT00320190|584156796|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
161759228|NCT00320190|584156797|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
161759229|NCT03399786|584156798|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161759230|NCT03399786|584156799|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161759231|NCT03399786|584156800|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161759232|NCT03399786|584156801|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161759233|NCT03399786|584156798|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161759234|NCT03399786|584156799|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161759235|NCT03399786|584156800|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
161759236|NCT03399786|584156801|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161759237|NCT03399786|584156798|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161759238|NCT03399786|584156799|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161759239|NCT03399786|584156800|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161759240|NCT03399786|584156801|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
161759241|NCT01004861|584158279|FG000|Overall Study|Disease progression|3|||
161759242|NCT01004861|584158280|FG001|Overall Study|Disease progression|4|||
161759243|NCT01004861|584158281|FG002|Overall Study|Disease progression|5|||
161759244|NCT01004861|584158282|FG003|Overall Study|Disease progression|4|||
161759245|NCT01004861|584158283|FG004|Overall Study|Disease progression|4|||
161759246|NCT01004861|584158284|FG005|Overall Study|Disease progression|4|||
161759247|NCT01004861|584158285|FG006|Overall Study|Disease progression|5|||
161759248|NCT01004861|584158286|FG007|Overall Study|Disease progression|1|||
161759249|NCT01004861|584158287|FG008|Overall Study|Disease progression|4|||
161759250|NCT01004861|584158288|FG009|Overall Study|Disease progression|7|||
161759251|NCT01004861|584158289|FG010|Overall Study|Disease progression|6|||
161759252|NCT01004861|584158290|FG011|Overall Study|Disease progression|3|||
161759253|NCT01004861|584158291|FG012|Overall Study|Disease progression|8|||
161759254|NCT01004861|584158279|FG000|Overall Study|Physician Decision|0|||
161759255|NCT01004861|584158280|FG001|Overall Study|Physician Decision|2|||
161759256|NCT01004861|584158281|FG002|Overall Study|Physician Decision|1|||
161759257|NCT01004861|584158282|FG003|Overall Study|Physician Decision|1|||
161759258|NCT01004861|584158283|FG004|Overall Study|Physician Decision|1|||
161759259|NCT01004861|584158284|FG005|Overall Study|Physician Decision|0|||
161759260|NCT01004861|584158285|FG006|Overall Study|Physician Decision|0|||
161759261|NCT01004861|584158286|FG007|Overall Study|Physician Decision|1|||
161759262|NCT01004861|584158287|FG008|Overall Study|Physician Decision|0|||
161759263|NCT01004861|584158288|FG009|Overall Study|Physician Decision|0|||
161759264|NCT01004861|584158289|FG010|Overall Study|Physician Decision|0|||
161759265|NCT01004861|584158290|FG011|Overall Study|Physician Decision|0|||
161759266|NCT01004861|584158291|FG012|Overall Study|Physician Decision|3|||
161759267|NCT01004861|584158279|FG000|Overall Study|Adverse Event|0|||
161759268|NCT01004861|584158280|FG001|Overall Study|Adverse Event|0|||
161759269|NCT01004861|584158281|FG002|Overall Study|Adverse Event|0|||
161759270|NCT01004861|584158282|FG003|Overall Study|Adverse Event|1|||
161759271|NCT01004861|584158283|FG004|Overall Study|Adverse Event|0|||
161759272|NCT01004861|584158284|FG005|Overall Study|Adverse Event|2|||
161759273|NCT01004861|584158285|FG006|Overall Study|Adverse Event|1|||
161759274|NCT01004861|584158286|FG007|Overall Study|Adverse Event|1|||
161759275|NCT01004861|584158287|FG008|Overall Study|Adverse Event|13|||
161759276|NCT01004861|584158288|FG009|Overall Study|Adverse Event|1|||
161759277|NCT01004861|584158289|FG010|Overall Study|Adverse Event|1|||
161759278|NCT01004861|584158290|FG011|Overall Study|Adverse Event|0|||
161759279|NCT01004861|584158291|FG012|Overall Study|Adverse Event|2|||
161759280|NCT01004861|584158279|FG000|Overall Study|Protocol Violation|0|||
161759281|NCT01004861|584158280|FG001|Overall Study|Protocol Violation|0|||
161759282|NCT01004861|584158281|FG002|Overall Study|Protocol Violation|0|||
161759283|NCT01004861|584158282|FG003|Overall Study|Protocol Violation|0|||
161759284|NCT01004861|584158283|FG004|Overall Study|Protocol Violation|1|||
161759285|NCT01004861|584158284|FG005|Overall Study|Protocol Violation|0|||
161759286|NCT01004861|584158285|FG006|Overall Study|Protocol Violation|0|||
161759287|NCT01004861|584158286|FG007|Overall Study|Protocol Violation|0|||
161759288|NCT01004861|584158287|FG008|Overall Study|Protocol Violation|0|||
161759289|NCT01004861|584158288|FG009|Overall Study|Protocol Violation|0|||
161759290|NCT01004861|584158289|FG010|Overall Study|Protocol Violation|0|||
161759291|NCT01004861|584158290|FG011|Overall Study|Protocol Violation|0|||
161759292|NCT01004861|584158291|FG012|Overall Study|Protocol Violation|0|||
161759293|NCT01004861|584158279|FG000|Overall Study|Lost to Follow-up|0|||
161759294|NCT01004861|584158280|FG001|Overall Study|Lost to Follow-up|0|||
161759295|NCT01004861|584158281|FG002|Overall Study|Lost to Follow-up|0|||
161759296|NCT01004861|584158282|FG003|Overall Study|Lost to Follow-up|0|||
161759297|NCT01004861|584158283|FG004|Overall Study|Lost to Follow-up|0|||
161759298|NCT01004861|584158284|FG005|Overall Study|Lost to Follow-up|0|||
161759299|NCT01004861|584158285|FG006|Overall Study|Lost to Follow-up|0|||
161759300|NCT01004861|584158286|FG007|Overall Study|Lost to Follow-up|1|||
161759301|NCT01004861|584158287|FG008|Overall Study|Lost to Follow-up|3|||
161759302|NCT01004861|584158288|FG009|Overall Study|Lost to Follow-up|0|||
161759303|NCT01004861|584158289|FG010|Overall Study|Lost to Follow-up|0|||
161759304|NCT01004861|584158290|FG011|Overall Study|Lost to Follow-up|1|||
161759305|NCT01004861|584158291|FG012|Overall Study|Lost to Follow-up|0|||
161759306|NCT01004861|584158279|FG000|Overall Study|Non-compliance|0|||
161759307|NCT01004861|584158280|FG001|Overall Study|Non-compliance|0|||
161759308|NCT01004861|584158281|FG002|Overall Study|Non-compliance|0|||
161759309|NCT01004861|584158282|FG003|Overall Study|Non-compliance|0|||
161759310|NCT01004861|584158283|FG004|Overall Study|Non-compliance|0|||
161759311|NCT01004861|584158284|FG005|Overall Study|Non-compliance|0|||
161759312|NCT01004861|584158285|FG006|Overall Study|Non-compliance|0|||
161759313|NCT01004861|584158286|FG007|Overall Study|Non-compliance|0|||
161759314|NCT01004861|584158287|FG008|Overall Study|Non-compliance|5|||
161759315|NCT01004861|584158288|FG009|Overall Study|Non-compliance|0|||
161759316|NCT01004861|584158289|FG010|Overall Study|Non-compliance|0|||
161759317|NCT01004861|584158290|FG011|Overall Study|Non-compliance|0|||
161759318|NCT01004861|584158291|FG012|Overall Study|Non-compliance|1|||
161759319|NCT01004861|584158279|FG000|Overall Study|Other|0|||
161759320|NCT01004861|584158280|FG001|Overall Study|Other|0|||
161759321|NCT01004861|584158281|FG002|Overall Study|Other|0|||
161759322|NCT01004861|584158282|FG003|Overall Study|Other|0|||
161759323|NCT01004861|584158283|FG004|Overall Study|Other|0|||
161759324|NCT01004861|584158284|FG005|Overall Study|Other|0|||
161759325|NCT01004861|584158285|FG006|Overall Study|Other|0|||
161759326|NCT01004861|584158286|FG007|Overall Study|Other|0|||
161759327|NCT01004861|584158287|FG008|Overall Study|Other|0|||
161759328|NCT01004861|584158288|FG009|Overall Study|Other|2|||
161759329|NCT01004861|584158289|FG010|Overall Study|Other|1|||
161759330|NCT01004861|584158290|FG011|Overall Study|Other|2|||
161759331|NCT01004861|584158291|FG012|Overall Study|Other|3|||
161759332|NCT01004861|584158279|FG000|Overall Study|Patient decision|0|||
161759333|NCT01004861|584158280|FG001|Overall Study|Patient decision|0|||
161759334|NCT01004861|584158281|FG002|Overall Study|Patient decision|0|||
161759335|NCT01004861|584158282|FG003|Overall Study|Patient decision|0|||
161759336|NCT01004861|584158283|FG004|Overall Study|Patient decision|1|||
161759337|NCT01004861|584158284|FG005|Overall Study|Patient decision|0|||
161759338|NCT01004861|584158285|FG006|Overall Study|Patient decision|1|||
161759339|NCT01004861|584158286|FG007|Overall Study|Patient decision|0|||
161759340|NCT01004861|584158287|FG008|Overall Study|Patient decision|7|||
161759341|NCT01004861|584158288|FG009|Overall Study|Patient decision|1|||
161847265|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161759342|NCT01004861|584158289|FG010|Overall Study|Patient decision|1|||
161759343|NCT01004861|584158290|FG011|Overall Study|Patient decision|2|||
161759344|NCT01004861|584158291|FG012|Overall Study|Patient decision|3|||
161759345|NCT01004861|584158279|FG000|Overall Study|Transitioned to Phase 4 study|0|||
161759346|NCT01004861|584158280|FG001|Overall Study|Transitioned to Phase 4 study|0|||
161759347|NCT01004861|584158281|FG002|Overall Study|Transitioned to Phase 4 study|0|||
161759348|NCT01004861|584158282|FG003|Overall Study|Transitioned to Phase 4 study|0|||
161759349|NCT01004861|584158283|FG004|Overall Study|Transitioned to Phase 4 study|0|||
161759350|NCT01004861|584158284|FG005|Overall Study|Transitioned to Phase 4 study|0|||
161759351|NCT01004861|584158285|FG006|Overall Study|Transitioned to Phase 4 study|0|||
161759352|NCT01004861|584158286|FG007|Overall Study|Transitioned to Phase 4 study|0|||
161759353|NCT01004861|584158287|FG008|Overall Study|Transitioned to Phase 4 study|2|||
161759354|NCT01004861|584158288|FG009|Overall Study|Transitioned to Phase 4 study|0|||
161759355|NCT01004861|584158289|FG010|Overall Study|Transitioned to Phase 4 study|0|||
161759356|NCT01004861|584158290|FG011|Overall Study|Transitioned to Phase 4 study|0|||
161759357|NCT01004861|584158291|FG012|Overall Study|Transitioned to Phase 4 study|0|||
161759358|NCT01004861|584158279|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759359|NCT01004861|584158280|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759360|NCT01004861|584158281|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759361|NCT01004861|584158282|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759362|NCT01004861|584158283|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759363|NCT01004861|584158284|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759364|NCT01004861|584158285|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759365|NCT01004861|584158286|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759366|NCT01004861|584158287|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
161759367|NCT01004861|584158288|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759368|NCT01004861|584158289|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759369|NCT01004861|584158290|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759370|NCT01004861|584158291|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759371|NCT01004861|584158279|FG000|Overall Study|Patient withdrew|0|||
161759372|NCT01004861|584158280|FG001|Overall Study|Patient withdrew|0|||
161759373|NCT01004861|584158281|FG002|Overall Study|Patient withdrew|0|||
161759374|NCT01004861|584158282|FG003|Overall Study|Patient withdrew|0|||
161759375|NCT01004861|584158283|FG004|Overall Study|Patient withdrew|0|||
161759376|NCT01004861|584158284|FG005|Overall Study|Patient withdrew|0|||
161759377|NCT01004861|584158285|FG006|Overall Study|Patient withdrew|0|||
161759378|NCT01004861|584158286|FG007|Overall Study|Patient withdrew|0|||
161759379|NCT01004861|584158287|FG008|Overall Study|Patient withdrew|1|||
161759380|NCT01004861|584158288|FG009|Overall Study|Patient withdrew|0|||
161759381|NCT01004861|584158289|FG010|Overall Study|Patient withdrew|0|||
161759382|NCT01004861|584158290|FG011|Overall Study|Patient withdrew|0|||
161759383|NCT01004861|584158291|FG012|Overall Study|Patient withdrew|0|||
161759384|NCT01004861|584158279|FG000|Overall Study|Surgical resection|0|||
161759385|NCT01004861|584158280|FG001|Overall Study|Surgical resection|0|||
161759386|NCT01004861|584158281|FG002|Overall Study|Surgical resection|0|||
161759387|NCT01004861|584158282|FG003|Overall Study|Surgical resection|0|||
161759388|NCT01004861|584158283|FG004|Overall Study|Surgical resection|0|||
161759389|NCT01004861|584158284|FG005|Overall Study|Surgical resection|0|||
161759390|NCT01004861|584158285|FG006|Overall Study|Surgical resection|0|||
161759391|NCT01004861|584158286|FG007|Overall Study|Surgical resection|0|||
161759392|NCT01004861|584158287|FG008|Overall Study|Surgical resection|1|||
161759393|NCT01004861|584158288|FG009|Overall Study|Surgical resection|0|||
161759394|NCT01004861|584158289|FG010|Overall Study|Surgical resection|0|||
161759395|NCT01004861|584158290|FG011|Overall Study|Surgical resection|0|||
161759396|NCT01004861|584158291|FG012|Overall Study|Surgical resection|0|||
161759397|NCT01004861|584158279|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759398|NCT01004861|584158280|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759399|NCT01004861|584158281|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759400|NCT01004861|584158282|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759401|NCT01004861|584158283|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759402|NCT01004861|584158284|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759403|NCT01004861|584158285|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759404|NCT01004861|584158286|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759405|NCT01004861|584158287|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
161759406|NCT01004861|584158288|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759407|NCT01004861|584158289|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759408|NCT01004861|584158290|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759409|NCT01004861|584158291|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759410|NCT01004861|584158279|FG000|Overall Study|Study termination by Sponsor|0|||
161759411|NCT01004861|584158280|FG001|Overall Study|Study termination by Sponsor|0|||
161759412|NCT01004861|584158281|FG002|Overall Study|Study termination by Sponsor|0|||
161759413|NCT01004861|584158282|FG003|Overall Study|Study termination by Sponsor|0|||
161759414|NCT01004861|584158283|FG004|Overall Study|Study termination by Sponsor|0|||
161759415|NCT01004861|584158284|FG005|Overall Study|Study termination by Sponsor|0|||
161759416|NCT01004861|584158285|FG006|Overall Study|Study termination by Sponsor|0|||
161759417|NCT01004861|584158286|FG007|Overall Study|Study termination by Sponsor|0|||
161759418|NCT01004861|584158287|FG008|Overall Study|Study termination by Sponsor|1|||
161759419|NCT01004861|584158288|FG009|Overall Study|Study termination by Sponsor|0|||
161759420|NCT01004861|584158289|FG010|Overall Study|Study termination by Sponsor|0|||
161759421|NCT01004861|584158290|FG011|Overall Study|Study termination by Sponsor|0|||
161759422|NCT01004861|584158291|FG012|Overall Study|Study termination by Sponsor|0|||
161759423|NCT04610827|584158293|FG000|Overall Study|Withdrawal by Subject|1|||
161759424|NCT04610827|584158294|FG001|Overall Study|Withdrawal by Subject|1|||
161759425|NCT04610827|584158295|FG002|Overall Study|Withdrawal by Subject|0|||
161759426|NCT01823991|584158296|FG000|Overall Study|Withdrawal by Subject|8|||
161759427|NCT01823991|584158297|FG001|Overall Study|Withdrawal by Subject|5|||
161759428|NCT00805194|584158298|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
161759429|NCT00805194|584158299|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
161759430|NCT00805194|584158298|FG000|Overall Study|Worsening or AE of underlying disease|64|||
161759431|NCT00805194|584158299|FG001|Overall Study|Worsening or AE of underlying disease|70|||
161759432|NCT00805194|584158298|FG000|Overall Study|Other AE|84|||
161759433|NCT00805194|584158299|FG001|Overall Study|Other AE|73|||
161759434|NCT00805194|584158298|FG000|Overall Study|Protocol Violation|9|||
161759435|NCT00805194|584158299|FG001|Overall Study|Protocol Violation|9|||
161759436|NCT00805194|584158298|FG000|Overall Study|Lost to Follow-up|5|||
161759437|NCT00805194|584158299|FG001|Overall Study|Lost to Follow-up|5|||
161759438|NCT00805194|584158298|FG000|Overall Study|Withdrawal by Subject|60|||
161759439|NCT00805194|584158299|FG001|Overall Study|Withdrawal by Subject|42|||
161759440|NCT00805194|584158298|FG000|Overall Study|Not treated|3|||
161759441|NCT00805194|584158299|FG001|Overall Study|Not treated|4|||
161759442|NCT00805194|584158298|FG000|Overall Study|Reasons other than stated above|20|||
161759443|NCT00805194|584158299|FG001|Overall Study|Reasons other than stated above|16|||
161759444|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
161759445|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
161759446|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
161759447|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
161759448|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
161759449|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
161759450|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
161759451|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Adverse Event|1|||
161759452|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Adverse Event|0|||
161759453|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Adverse Event|0|||
161759454|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Adverse Event|2|||
161847266|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847267|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847268|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847269|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847270|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847271|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847272|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847273|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847274|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847275|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161759455|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Adverse Event|3|||
161759456|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Adverse Event|0|||
161759457|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Adverse Event|0|||
161759458|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759459|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
161759460|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759461|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759462|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759463|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759464|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759465|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759466|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
161759467|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759468|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
161847276|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847277|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
161759469|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759470|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759471|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759472|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
161759473|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
161759474|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
161759475|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
161759476|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
161759477|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
161759478|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
161759479|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Adverse Event|0|||
161759480|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Adverse Event|0|||
161759481|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Adverse Event|0|||
161759482|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Adverse Event|0|||
161759483|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Adverse Event|0|||
161759484|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Adverse Event|1|||
161759485|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Adverse Event|4|||
161759486|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161759487|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161847278|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
161847279|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847280|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847281|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847282|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847283|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847284|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847285|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847286|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847287|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847288|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847289|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847290|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847291|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
161847292|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
161847293|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847294|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847295|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847296|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847297|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847298|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847299|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847300|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847301|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847302|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847303|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847304|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847305|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
161847306|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
161847307|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847308|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847309|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847310|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847311|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161759488|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161847312|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847313|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847314|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847315|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847316|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847317|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847318|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847319|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
161847320|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
161847321|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847322|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161759489|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161759490|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161847323|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847324|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847325|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847326|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847327|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847328|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847329|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847330|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847331|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847332|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847333|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
161847334|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
161847335|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847336|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847337|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847338|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847339|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847340|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847341|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847342|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847343|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847344|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161759491|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
161759492|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
161759493|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759494|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759495|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759496|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759497|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759498|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759499|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
161759500|NCT02094612|584158314|FG000|Overall Study|Lost to Follow-up|47|||
161759501|NCT02094612|584158315|FG001|Overall Study|Lost to Follow-up|47|||
161759502|NCT02094612|584158314|FG000|Overall Study|Never started ADHD medication|32|||
161759503|NCT02094612|584158315|FG001|Overall Study|Never started ADHD medication|23|||
161759504|NCT04167514|584158316|FG000|Overall Study|Adverse event, not serious|0|||
161759505|NCT04167514|584158317|FG001|Overall Study|Adverse event, not serious|1|||
161759506|NCT04167514|584158316|FG000|Overall Study|Lost to Follow-up|1|||
161759507|NCT04167514|584158317|FG001|Overall Study|Lost to Follow-up|0|||
161759508|NCT04167514|584158316|FG000|Overall Study|Participant Decision|2|||
161759509|NCT04167514|584158317|FG001|Overall Study|Participant Decision|4|||
161759510|NCT04167514|584158316|FG000|Overall Study|Physician Decision|3|||
161759511|NCT04167514|584158317|FG001|Overall Study|Physician Decision|2|||
161759512|NCT04167514|584158316|FG000|Overall Study|Death|14|||
161759513|NCT04167514|584158317|FG001|Overall Study|Death|18|||
161759514|NCT04167514|584158316|FG000|Overall Study|Enrolled but treatment not administered|2|||
161759515|NCT04167514|584158317|FG001|Overall Study|Enrolled but treatment not administered|0|||
161759516|NCT04167514|584158316|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
161759517|NCT04167514|584158317|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
161759518|NCT04167514|584158316|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
161759519|NCT04167514|584158317|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
161759520|NCT02646891|584158318|FG000|Overall Study|Adverse Event|0|||
161759521|NCT02646891|584158319|FG001|Overall Study|Adverse Event|1|||
161759522|NCT02646891|584158320|FG002|Overall Study|Adverse Event|0|||
161847345|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847346|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161759523|NCT02646891|584158321|FG003|Overall Study|Adverse Event|0|||
161759524|NCT02646891|584158322|FG004|Overall Study|Adverse Event|0|||
161759525|NCT02646891|584158323|FG005|Overall Study|Adverse Event|0|||
161847347|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
161847348|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
161847349|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847350|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847351|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847352|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847353|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847354|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847355|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847356|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847357|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847358|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847359|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847360|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847361|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
161847362|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
161847363|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847364|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847365|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847366|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847367|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847368|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847369|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847370|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847371|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847372|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847373|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847374|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847375|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
161847376|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
161847377|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847378|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847379|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847380|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847381|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847382|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847383|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847384|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847385|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847386|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847387|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161759526|NCT02646891|584158324|FG006|Overall Study|Adverse Event|0|||
161759527|NCT02646891|584158325|FG007|Overall Study|Adverse Event|0|||
161759528|NCT02646891|584158326|FG008|Overall Study|Adverse Event|0|||
161759529|NCT02646891|584158327|FG009|Overall Study|Adverse Event|0|||
161759530|NCT02646891|584158318|FG000|Overall Study|Lost to Follow-up|0|||
161759531|NCT02646891|584158319|FG001|Overall Study|Lost to Follow-up|0|||
161759532|NCT02646891|584158320|FG002|Overall Study|Lost to Follow-up|0|||
161759533|NCT02646891|584158321|FG003|Overall Study|Lost to Follow-up|0|||
161759534|NCT02646891|584158322|FG004|Overall Study|Lost to Follow-up|0|||
161759535|NCT02646891|584158323|FG005|Overall Study|Lost to Follow-up|0|||
161759536|NCT02646891|584158324|FG006|Overall Study|Lost to Follow-up|2|||
161759537|NCT02646891|584158325|FG007|Overall Study|Lost to Follow-up|2|||
161759538|NCT02646891|584158326|FG008|Overall Study|Lost to Follow-up|2|||
161759539|NCT02646891|584158327|FG009|Overall Study|Lost to Follow-up|2|||
161759540|NCT02646891|584158318|FG000|Overall Study|Protocol Violation|0|||
161759541|NCT02646891|584158319|FG001|Overall Study|Protocol Violation|0|||
161759542|NCT02646891|584158320|FG002|Overall Study|Protocol Violation|0|||
161759543|NCT02646891|584158321|FG003|Overall Study|Protocol Violation|0|||
161847388|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847389|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
161759544|NCT02646891|584158322|FG004|Overall Study|Protocol Violation|0|||
161759545|NCT02646891|584158323|FG005|Overall Study|Protocol Violation|0|||
161759546|NCT02646891|584158324|FG006|Overall Study|Protocol Violation|1|||
161759547|NCT02646891|584158325|FG007|Overall Study|Protocol Violation|1|||
161759548|NCT02646891|584158326|FG008|Overall Study|Protocol Violation|0|||
161759549|NCT02646891|584158327|FG009|Overall Study|Protocol Violation|0|||
161759550|NCT02646891|584158318|FG000|Overall Study|Withdrawal by Subject|2|||
161759551|NCT02646891|584158319|FG001|Overall Study|Withdrawal by Subject|0|||
161759552|NCT02646891|584158320|FG002|Overall Study|Withdrawal by Subject|1|||
161759553|NCT02646891|584158321|FG003|Overall Study|Withdrawal by Subject|0|||
161759554|NCT02646891|584158322|FG004|Overall Study|Withdrawal by Subject|0|||
161759555|NCT02646891|584158323|FG005|Overall Study|Withdrawal by Subject|0|||
161759556|NCT02646891|584158324|FG006|Overall Study|Withdrawal by Subject|5|||
161759557|NCT02646891|584158325|FG007|Overall Study|Withdrawal by Subject|9|||
161759558|NCT02646891|584158326|FG008|Overall Study|Withdrawal by Subject|7|||
161759559|NCT02646891|584158327|FG009|Overall Study|Withdrawal by Subject|3|||
161759560|NCT02646891|584158318|FG000|Overall Study|Death|0|||
161759561|NCT02646891|584158319|FG001|Overall Study|Death|0|||
161759562|NCT02646891|584158320|FG002|Overall Study|Death|0|||
161759563|NCT02646891|584158321|FG003|Overall Study|Death|0|||
161759564|NCT02646891|584158322|FG004|Overall Study|Death|0|||
161759565|NCT02646891|584158323|FG005|Overall Study|Death|0|||
161759566|NCT02646891|584158324|FG006|Overall Study|Death|1|||
161759567|NCT02646891|584158325|FG007|Overall Study|Death|1|||
161759568|NCT02646891|584158326|FG008|Overall Study|Death|1|||
161759569|NCT02646891|584158327|FG009|Overall Study|Death|0|||
161759570|NCT01542632|584158328|FG000|Overall Study|Withdrawal of Consent|0|||
161759571|NCT01542632|584158329|FG001|Overall Study|Withdrawal of Consent|0|||
161759572|NCT01542632|584158330|FG002|Overall Study|Withdrawal of Consent|0|||
161759573|NCT01542632|584158331|FG003|Overall Study|Withdrawal of Consent|2|||
161759574|NCT01542632|584158332|FG004|Overall Study|Withdrawal of Consent|3|||
161759575|NCT01542632|584158333|FG005|Overall Study|Withdrawal of Consent|0|||
161759576|NCT01542632|584158328|FG000|Overall Study|Adverse Event|0|||
161759577|NCT01542632|584158329|FG001|Overall Study|Adverse Event|0|||
161759578|NCT01542632|584158330|FG002|Overall Study|Adverse Event|1|||
161759579|NCT01542632|584158331|FG003|Overall Study|Adverse Event|0|||
161759580|NCT01542632|584158332|FG004|Overall Study|Adverse Event|0|||
161759581|NCT01542632|584158333|FG005|Overall Study|Adverse Event|0|||
161759582|NCT01542632|584158328|FG000|Overall Study|Lost to Follow-up|0|||
161759583|NCT01542632|584158329|FG001|Overall Study|Lost to Follow-up|1|||
161759584|NCT01542632|584158330|FG002|Overall Study|Lost to Follow-up|0|||
161759585|NCT01542632|584158331|FG003|Overall Study|Lost to Follow-up|0|||
161759586|NCT01542632|584158332|FG004|Overall Study|Lost to Follow-up|0|||
161759587|NCT01542632|584158333|FG005|Overall Study|Lost to Follow-up|0|||
161759588|NCT01542632|584158328|FG000|Overall Study|Sponsor/Investigator Decision|0|||
161759589|NCT01542632|584158329|FG001|Overall Study|Sponsor/Investigator Decision|0|||
161759590|NCT01542632|584158330|FG002|Overall Study|Sponsor/Investigator Decision|0|||
161759591|NCT01542632|584158331|FG003|Overall Study|Sponsor/Investigator Decision|0|||
161759592|NCT01542632|584158332|FG004|Overall Study|Sponsor/Investigator Decision|1|||
161759593|NCT01542632|584158333|FG005|Overall Study|Sponsor/Investigator Decision|0|||
161759594|NCT00033514|584158334|FG000|Overall Study|Lost to Follow-up|1|||
161759595|NCT00033514|584158335|FG001|Overall Study|Lost to Follow-up|1|||
161759596|NCT00033514|584158334|FG000|Overall Study|Withdrawal by Subject|0|||
161759597|NCT00033514|584158335|FG001|Overall Study|Withdrawal by Subject|3|||
161759598|NCT03225833|584158338|FG000|Overall Study|Adverse Event|0|||
161759599|NCT03225833|584158339|FG001|Overall Study|Adverse Event|1|||
161759600|NCT03225833|584158340|FG002|Overall Study|Adverse Event|2|||
161759601|NCT03225833|584158341|FG003|Overall Study|Adverse Event|0|||
161759602|NCT03225833|584158342|FG004|Overall Study|Adverse Event|0|||
161759603|NCT03225833|584158343|FG005|Overall Study|Adverse Event|2|||
161759604|NCT03225833|584158338|FG000|Overall Study|Withdrawal by Subject|1|||
161759605|NCT03225833|584158339|FG001|Overall Study|Withdrawal by Subject|0|||
161759606|NCT03225833|584158340|FG002|Overall Study|Withdrawal by Subject|0|||
161759607|NCT03225833|584158341|FG003|Overall Study|Withdrawal by Subject|0|||
161759608|NCT03225833|584158342|FG004|Overall Study|Withdrawal by Subject|1|||
161759609|NCT03225833|584158343|FG005|Overall Study|Withdrawal by Subject|0|||
161759610|NCT03225833|584158338|FG000|Overall Study|Termination of Study by Sponsor|4|||
161759611|NCT03225833|584158339|FG001|Overall Study|Termination of Study by Sponsor|0|||
161759612|NCT03225833|584158340|FG002|Overall Study|Termination of Study by Sponsor|0|||
161759613|NCT03225833|584158341|FG003|Overall Study|Termination of Study by Sponsor|0|||
161759614|NCT03225833|584158342|FG004|Overall Study|Termination of Study by Sponsor|0|||
161759615|NCT03225833|584158343|FG005|Overall Study|Termination of Study by Sponsor|7|||
161759616|NCT03225833|584158338|FG000|Overall Study|Sponsor Decision|0|||
161759617|NCT03225833|584158339|FG001|Overall Study|Sponsor Decision|0|||
161759618|NCT03225833|584158340|FG002|Overall Study|Sponsor Decision|0|||
161759619|NCT03225833|584158341|FG003|Overall Study|Sponsor Decision|0|||
161759620|NCT03225833|584158342|FG004|Overall Study|Sponsor Decision|0|||
161759621|NCT03225833|584158343|FG005|Overall Study|Sponsor Decision|1|||
161759622|NCT06029127|584158345|FG000|Overall Study|Withdrawal by Subject|2|||
161759623|NCT06029127|584158346|FG001|Overall Study|Withdrawal by Subject|0|||
161759624|NCT06029127|584158345|FG000|Overall Study|Lost to Follow-up|1|||
161759625|NCT06029127|584158346|FG001|Overall Study|Lost to Follow-up|0|||
161759626|NCT06029127|584158345|FG000|Overall Study|Study Closed by Sponsor|6|||
161759627|NCT06029127|584158346|FG001|Overall Study|Study Closed by Sponsor|6|||
161759628|NCT06029127|584158345|FG000|Overall Study|Death|12|||
161759629|NCT06029127|584158346|FG001|Overall Study|Death|7|||
161759630|NCT06029127|584158345|FG000|Overall Study|Declined Follow-Up Contact|0|||
161759631|NCT06029127|584158346|FG001|Overall Study|Declined Follow-Up Contact|1|||
161759632|NCT02871791|584158348|FG000|Phase 1b|Death|0|||
161759633|NCT02871791|584158349|FG001|Phase 1b|Death|1|||
161759634|NCT02871791|584158348|FG000|Phase 1b|progressive disease|6|||
161759635|NCT02871791|584158349|FG001|Phase 1b|progressive disease|2|||
161759636|NCT02871791|584158348|FG000|Phase 2|Death|1|||
161759637|NCT02871791|584158349|FG001|Phase 2|Death|0|||
161759638|NCT02871791|584158348|FG000|Phase 2|Lost to Follow-up|2|||
161759639|NCT02871791|584158349|FG001|Phase 2|Lost to Follow-up|0|||
161759640|NCT00129376|584158350|FG000|Overall Study|Adverse Event|1|||
161759641|NCT00129376|584158350|FG000|Overall Study|Lack of Efficacy|1|||
161759642|NCT03737318|584158358|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
161759643|NCT03737318|584158359|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
161759644|NCT03737318|584158360|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
161759645|NCT04554394|584158361|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
161759646|NCT04554394|584158362|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
161759647|NCT04554394|584158361|FG000|Overall Study|Withdrawal by Subject|2|||
161759648|NCT04554394|584158362|FG001|Overall Study|Withdrawal by Subject|2|||
161759649|NCT04554394|584158361|FG000|Overall Study|Lost to Follow-up|2|||
161759650|NCT04554394|584158362|FG001|Overall Study|Lost to Follow-up|2|||
161759651|NCT04554394|584158361|FG000|Overall Study|Physician Decision|1|||
161759652|NCT04554394|584158362|FG001|Overall Study|Physician Decision|1|||
161847390|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
161759653|NCT01766401|584158363|FG000|Overall Study|Adverse Event|7|||
161759654|NCT01766401|584158364|FG001|Overall Study|Adverse Event|22|||
161759655|NCT01766401|584158363|FG000|Overall Study|Lack of Efficacy|1|||
161759656|NCT01766401|584158364|FG001|Overall Study|Lack of Efficacy|2|||
161759657|NCT01766401|584158363|FG000|Overall Study|Protocol Violation|3|||
161759658|NCT01766401|584158364|FG001|Overall Study|Protocol Violation|8|||
161759659|NCT01766401|584158363|FG000|Overall Study|Withdrawal by Subject|15|||
161759660|NCT01766401|584158364|FG001|Overall Study|Withdrawal by Subject|12|||
161759661|NCT01766401|584158363|FG000|Overall Study|Lost to Follow-up|10|||
161759662|NCT01766401|584158364|FG001|Overall Study|Lost to Follow-up|11|||
161759663|NCT01766401|584158363|FG000|Overall Study|Pregnancy|1|||
161759664|NCT01766401|584158364|FG001|Overall Study|Pregnancy|1|||
161759665|NCT00886587|584158365|FG000|Overall Study|Adverse Event|2|||
161759666|NCT00886587|584158366|FG001|Overall Study|Adverse Event|1|||
161759667|NCT00886587|584158365|FG000|Overall Study|Protocol Violation|2|||
161759668|NCT00886587|584158366|FG001|Overall Study|Protocol Violation|0|||
161759669|NCT00886587|584158365|FG000|Overall Study|Withdrawal by Subject|0|||
161759670|NCT00886587|584158366|FG001|Overall Study|Withdrawal by Subject|1|||
161759671|NCT01108068|584158370|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
161759672|NCT01108068|584158371|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
161759673|NCT00398086|584158372|FG000|Overall Study|Unacceptable Toxicity|2|||
161759674|NCT00398086|584158373|FG001|Overall Study|Unacceptable Toxicity|8|||
161759675|NCT00398086|584158374|FG002|Overall Study|Unacceptable Toxicity|2|||
161759676|NCT00398086|584158372|FG000|Overall Study|Adverse Event|1|||
161759677|NCT00398086|584158373|FG001|Overall Study|Adverse Event|4|||
161759678|NCT00398086|584158374|FG002|Overall Study|Adverse Event|0|||
161759679|NCT00398086|584158372|FG000|Overall Study|Physician Decision|1|||
161759680|NCT00398086|584158373|FG001|Overall Study|Physician Decision|4|||
161759681|NCT00398086|584158374|FG002|Overall Study|Physician Decision|0|||
161759682|NCT00398086|584158372|FG000|Overall Study|Withdrawal by Subject|5|||
161759683|NCT00398086|584158373|FG001|Overall Study|Withdrawal by Subject|7|||
161759684|NCT00398086|584158374|FG002|Overall Study|Withdrawal by Subject|0|||
161759685|NCT01021553|584158375|FG000|Overall Study|Adverse Event|1|||
161759686|NCT01021553|584158376|FG001|Overall Study|Adverse Event|0|||
161759687|NCT01021553|584158377|FG002|Overall Study|Adverse Event|0|||
161759688|NCT01021553|584158375|FG000|Overall Study|Lack of Efficacy|2|||
161759689|NCT01021553|584158376|FG001|Overall Study|Lack of Efficacy|2|||
161759690|NCT01021553|584158377|FG002|Overall Study|Lack of Efficacy|0|||
161759691|NCT01021553|584158375|FG000|Overall Study|Protocol Violation|0|||
161759692|NCT01021553|584158376|FG001|Overall Study|Protocol Violation|2|||
161759693|NCT01021553|584158377|FG002|Overall Study|Protocol Violation|2|||
161759694|NCT01021553|584158375|FG000|Overall Study|Lost to Follow-up|0|||
161759695|NCT01021553|584158376|FG001|Overall Study|Lost to Follow-up|0|||
161759696|NCT01021553|584158377|FG002|Overall Study|Lost to Follow-up|1|||
161759697|NCT01021553|584158375|FG000|Overall Study|Withdrawal by Subject|1|||
161759698|NCT01021553|584158376|FG001|Overall Study|Withdrawal by Subject|1|||
161759699|NCT01021553|584158377|FG002|Overall Study|Withdrawal by Subject|0|||
161759700|NCT00696774|584158378|FG000|Period II|Adverse Event|0|||
161759701|NCT00696774|584158379|FG001|Period II|Adverse Event|0|||
161759702|NCT00696774|584158380|FG002|Period II|Adverse Event|15|||
161759703|NCT00696774|584158378|FG000|Period II|Lost to Follow-up|0|||
161759704|NCT00696774|584158379|FG001|Period II|Lost to Follow-up|0|||
161759705|NCT00696774|584158380|FG002|Period II|Lost to Follow-up|4|||
161847391|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847392|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847393|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847394|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847395|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847396|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847397|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847398|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847399|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847400|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847401|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847402|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847403|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
161847404|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
161847405|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847406|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847407|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161759706|NCT00696774|584158378|FG000|Period II|Protocol Violation|0|||
161759707|NCT00696774|584158379|FG001|Period II|Protocol Violation|0|||
161759708|NCT00696774|584158380|FG002|Period II|Protocol Violation|11|||
161759709|NCT00696774|584158378|FG000|Period II|Withdrawal by Subject|0|||
161759710|NCT00696774|584158379|FG001|Period II|Withdrawal by Subject|0|||
161847408|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847409|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847410|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161759711|NCT00696774|584158380|FG002|Period II|Withdrawal by Subject|4|||
161759712|NCT00696774|584158378|FG000|Period II|Sponsor Decision|0|||
161759713|NCT00696774|584158379|FG001|Period II|Sponsor Decision|0|||
161759714|NCT00696774|584158380|FG002|Period II|Sponsor Decision|0|||
161759715|NCT00696774|584158378|FG000|Period II|Lack of Efficacy|0|||
161759716|NCT00696774|584158379|FG001|Period II|Lack of Efficacy|0|||
161759717|NCT00696774|584158380|FG002|Period II|Lack of Efficacy|2|||
161759718|NCT00696774|584158378|FG000|Period III|Adverse Event|1|||
161759719|NCT00696774|584158379|FG001|Period III|Adverse Event|1|||
161759720|NCT00696774|584158380|FG002|Period III|Adverse Event|0|||
161759721|NCT00696774|584158378|FG000|Period III|Lost to Follow-up|2|||
161759722|NCT00696774|584158379|FG001|Period III|Lost to Follow-up|1|||
161759723|NCT00696774|584158380|FG002|Period III|Lost to Follow-up|0|||
161759724|NCT00696774|584158378|FG000|Period III|Protocol Violation|1|||
161759725|NCT00696774|584158379|FG001|Period III|Protocol Violation|1|||
161759726|NCT00696774|584158380|FG002|Period III|Protocol Violation|0|||
161759727|NCT00696774|584158378|FG000|Period III|Withdrawal by Subject|1|||
161759728|NCT00696774|584158379|FG001|Period III|Withdrawal by Subject|2|||
161759729|NCT00696774|584158380|FG002|Period III|Withdrawal by Subject|0|||
161759730|NCT00696774|584158378|FG000|Period III|Sponsor Decision|2|||
161759731|NCT00696774|584158379|FG001|Period III|Sponsor Decision|0|||
161759732|NCT00696774|584158380|FG002|Period III|Sponsor Decision|0|||
161759733|NCT00696774|584158378|FG000|Period III|Lack of Efficacy|0|||
161759734|NCT00696774|584158379|FG001|Period III|Lack of Efficacy|2|||
161759735|NCT00696774|584158380|FG002|Period III|Lack of Efficacy|0|||
161759736|NCT01950364|584158381|FG000|Overall Study|Adverse Event|3|||
161759737|NCT01950364|584158382|FG001|Overall Study|Adverse Event|0|||
161759738|NCT01950364|584158381|FG000|Overall Study|Stem Cell Transplant|2|||
161759739|NCT01950364|584158382|FG001|Overall Study|Stem Cell Transplant|6|||
161759740|NCT01950364|584158381|FG000|Overall Study|Disease Progression|5|||
161759741|NCT01950364|584158382|FG001|Overall Study|Disease Progression|2|||
161759742|NCT01950364|584158381|FG000|Overall Study|Withdrawal by Subject|0|||
161759743|NCT01950364|584158382|FG001|Overall Study|Withdrawal by Subject|1|||
161759744|NCT01950364|584158381|FG000|Overall Study|Protocol Violation|0|||
161759745|NCT01950364|584158382|FG001|Overall Study|Protocol Violation|1|||
161759746|NCT00033293|584158389|FG000|Overall Study|Death|0|||
161759747|NCT00033293|584158390|FG001|Overall Study|Death|1|||
161759748|NCT00033293|584158389|FG000|Overall Study|Lack of Efficacy|5|||
161759749|NCT00033293|584158390|FG001|Overall Study|Lack of Efficacy|8|||
161759750|NCT00033293|584158389|FG000|Overall Study|Lost to Follow-up|0|||
161759751|NCT00033293|584158390|FG001|Overall Study|Lost to Follow-up|1|||
161759752|NCT00033293|584158389|FG000|Overall Study|Physician Decision|3|||
161759753|NCT00033293|584158390|FG001|Overall Study|Physician Decision|1|||
161759754|NCT00033293|584158389|FG000|Overall Study|Withdrawal by Subject|1|||
161759755|NCT00033293|584158390|FG001|Overall Study|Withdrawal by Subject|0|||
161759756|NCT00033293|584158389|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
161759757|NCT00033293|584158390|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
161759758|NCT00033293|584158389|FG000|Overall Study|Treatment refused|0|||
161759759|NCT00033293|584158390|FG001|Overall Study|Treatment refused|6|||
161759760|NCT00935701|584158391|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
161759761|NCT02201251|584158392|FG000|Overall Study|Adverse Event|1|||
161759762|NCT02201251|584158393|FG001|Overall Study|Adverse Event|1|||
161759763|NCT02201251|584158392|FG000|Overall Study|Protocol Violation|1|||
161847411|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847412|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847413|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847414|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847415|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847416|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847417|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
161847418|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
161847419|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847420|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847421|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847422|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847423|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847424|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847425|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847426|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847427|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847428|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847429|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847430|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847431|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847432|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847433|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847434|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
161847435|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847436|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847437|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847438|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847439|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847440|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847441|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847442|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847443|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847444|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847445|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847446|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847447|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
161847448|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847449|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847450|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847451|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847452|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847453|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847454|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847455|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847456|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847457|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847458|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847459|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847460|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847461|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
161847462|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847463|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847464|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847465|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847466|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847467|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847468|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847469|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847470|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847471|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847472|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161759764|NCT02201251|584158393|FG001|Overall Study|Protocol Violation|0|||
161759765|NCT02201251|584158392|FG000|Overall Study|Noncompliance with Study Drug|0|||
161759766|NCT02201251|584158393|FG001|Overall Study|Noncompliance with Study Drug|1|||
161759767|NCT02201251|584158392|FG000|Overall Study|Withdrawal by Subject|2|||
161759768|NCT02201251|584158393|FG001|Overall Study|Withdrawal by Subject|1|||
161759769|NCT01197794|584158396|FG000|Overall Study|Adverse Event|3|||
161759770|NCT01197794|584158397|FG001|Overall Study|Adverse Event|2|||
161759771|NCT01197794|584158398|FG002|Overall Study|Adverse Event|4|||
161759772|NCT01197794|584158399|FG003|Overall Study|Adverse Event|4|||
161759773|NCT01197794|584158400|FG004|Overall Study|Adverse Event|4|||
161759774|NCT01197794|584158401|FG005|Overall Study|Adverse Event|2|||
161759775|NCT01197794|584158402|FG006|Overall Study|Adverse Event|3|||
161759776|NCT01197794|584158396|FG000|Overall Study|Protocol Violation|0|||
161759777|NCT01197794|584158397|FG001|Overall Study|Protocol Violation|0|||
161759778|NCT01197794|584158398|FG002|Overall Study|Protocol Violation|0|||
161759779|NCT01197794|584158399|FG003|Overall Study|Protocol Violation|0|||
161759780|NCT01197794|584158400|FG004|Overall Study|Protocol Violation|2|||
161759781|NCT01197794|584158401|FG005|Overall Study|Protocol Violation|0|||
161759782|NCT01197794|584158402|FG006|Overall Study|Protocol Violation|1|||
161759783|NCT01197794|584158396|FG000|Overall Study|Development of study withdrawal criteria|3|||
161759784|NCT01197794|584158397|FG001|Overall Study|Development of study withdrawal criteria|0|||
161759785|NCT01197794|584158398|FG002|Overall Study|Development of study withdrawal criteria|0|||
161759786|NCT01197794|584158399|FG003|Overall Study|Development of study withdrawal criteria|1|||
161759787|NCT01197794|584158400|FG004|Overall Study|Development of study withdrawal criteria|0|||
161759788|NCT01197794|584158401|FG005|Overall Study|Development of study withdrawal criteria|0|||
161759789|NCT01197794|584158402|FG006|Overall Study|Development of study withdrawal criteria|1|||
161759790|NCT01197794|584158396|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
161759791|NCT01197794|584158397|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
161759792|NCT01197794|584158398|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
161759793|NCT01197794|584158399|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
161759794|NCT01197794|584158400|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
161759795|NCT01197794|584158401|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
161759796|NCT01197794|584158402|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
161759797|NCT01197794|584158396|FG000|Overall Study|Withdrawal by Subject|3|||
161759798|NCT01197794|584158397|FG001|Overall Study|Withdrawal by Subject|3|||
161759799|NCT01197794|584158398|FG002|Overall Study|Withdrawal by Subject|4|||
161759800|NCT01197794|584158399|FG003|Overall Study|Withdrawal by Subject|1|||
161759801|NCT01197794|584158400|FG004|Overall Study|Withdrawal by Subject|1|||
161759802|NCT01197794|584158401|FG005|Overall Study|Withdrawal by Subject|5|||
161759803|NCT01197794|584158402|FG006|Overall Study|Withdrawal by Subject|6|||
161759804|NCT01197794|584158396|FG000|Overall Study|Lost to Follow-up|1|||
161759805|NCT01197794|584158397|FG001|Overall Study|Lost to Follow-up|1|||
161759806|NCT01197794|584158398|FG002|Overall Study|Lost to Follow-up|0|||
161759807|NCT01197794|584158399|FG003|Overall Study|Lost to Follow-up|1|||
161759808|NCT01197794|584158400|FG004|Overall Study|Lost to Follow-up|0|||
161759809|NCT01197794|584158401|FG005|Overall Study|Lost to Follow-up|1|||
161759810|NCT01197794|584158402|FG006|Overall Study|Lost to Follow-up|0|||
161759811|NCT01197794|584158396|FG000|Overall Study|Other|1|||
161759812|NCT01197794|584158397|FG001|Overall Study|Other|1|||
161759813|NCT01197794|584158398|FG002|Overall Study|Other|3|||
161759814|NCT01197794|584158399|FG003|Overall Study|Other|0|||
161759815|NCT01197794|584158400|FG004|Overall Study|Other|2|||
161759816|NCT01197794|584158401|FG005|Overall Study|Other|2|||
161759817|NCT01197794|584158402|FG006|Overall Study|Other|4|||
161759818|NCT04055844|584158403|FG000|Overall Study|Adverse Event|12|||
161759819|NCT04055844|584158403|FG000|Overall Study|Poor Performance|1|||
161759820|NCT04055844|584158403|FG000|Overall Study|Death|1|||
161759821|NCT00572728|584158404|FG000|Overall Study|Withdrawal by Subject|10|||
161759822|NCT00572728|584158404|FG000|Overall Study|Ineligible|3|||
161759823|NCT00572728|584158404|FG000|Overall Study|Enrolled under Amendment 4|5|||
161759824|NCT00572728|584158404|FG000|Overall Study|Offstudy due to complicating disease|1|||
161759825|NCT00572728|584158404|FG000|Overall Study|FLT1 not completed|4|||
161759826|NCT00572728|584158404|FG000|Overall Study|First Chemotherapy not initiated|2|||
161759827|NCT00572728|584158404|FG000|Overall Study|FLT2 not completed|5|||
161759828|NCT00572728|584158404|FG000|Overall Study|Second chemotherapy not initiated|1|||
161759829|NCT00572728|584158404|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
161759830|NCT00572728|584158404|FG000|Overall Study|Pathology missing|1|||
161759831|NCT01833806|584158411|FG000|Overall Study|Alternative treatment|2|||
161759832|NCT01833806|584158411|FG000|Overall Study|Death|5|||
161759833|NCT01833806|584158411|FG000|Overall Study|Physician Decision|1|||
161759834|NCT01833806|584158411|FG000|Overall Study|Lost to Follow-up|1|||
161759835|NCT03231228|584158418|FG000|Overall Study|Lost to Follow-up|2|||
161759836|NCT03231228|584158419|FG001|Overall Study|Lost to Follow-up|0|||
161759837|NCT03231228|584158418|FG000|Overall Study|Physician Decision|1|||
161759838|NCT03231228|584158419|FG001|Overall Study|Physician Decision|0|||
161759839|NCT01868594|584158420|FG000|Overall Study|Do not meet inclusion criteria|4|||
161759840|NCT01868594|584158421|FG001|Overall Study|Do not meet inclusion criteria|3|||
161759841|NCT04490057|584158422|FG000|Stage 1|Death|1|||
161759842|NCT04490057|584158423|FG001|Stage 1|Death|2|||
161759843|NCT04490057|584158424|FG002|Stage 1|Death|0|||
161759844|NCT04490057|584158425|FG003|Stage 1|Death|0|||
161759845|NCT04490057|584158426|FG004|Stage 1|Death|0|||
161759846|NCT04490057|584158427|FG005|Stage 1|Death|0|||
161759847|NCT04490057|584158428|FG006|Stage 1|Death|0|||
161759848|NCT04490057|584158429|FG007|Stage 1|Death|0|||
161759849|NCT04490057|584158422|FG000|Stage 1|Withdrawal by Subject|2|||
161759850|NCT04490057|584158423|FG001|Stage 1|Withdrawal by Subject|0|||
161759851|NCT04490057|584158424|FG002|Stage 1|Withdrawal by Subject|0|||
161759852|NCT04490057|584158425|FG003|Stage 1|Withdrawal by Subject|0|||
161759853|NCT04490057|584158426|FG004|Stage 1|Withdrawal by Subject|0|||
161759854|NCT04490057|584158427|FG005|Stage 1|Withdrawal by Subject|0|||
161759855|NCT04490057|584158428|FG006|Stage 1|Withdrawal by Subject|0|||
161759856|NCT04490057|584158429|FG007|Stage 1|Withdrawal by Subject|0|||
161759857|NCT04490057|584158422|FG000|Stage 2|Death|0|||
161759858|NCT04490057|584158423|FG001|Stage 2|Death|0|||
161759859|NCT04490057|584158424|FG002|Stage 2|Death|0|||
161759860|NCT04490057|584158425|FG003|Stage 2|Death|0|||
161759861|NCT04490057|584158426|FG004|Stage 2|Death|1|||
161759862|NCT04490057|584158427|FG005|Stage 2|Death|0|||
161759863|NCT04490057|584158428|FG006|Stage 2|Death|0|||
161759864|NCT04490057|584158429|FG007|Stage 2|Death|0|||
161759865|NCT04490057|584158422|FG000|Stage 2|Lost to Follow-up|0|||
161759866|NCT04490057|584158423|FG001|Stage 2|Lost to Follow-up|0|||
161759867|NCT04490057|584158424|FG002|Stage 2|Lost to Follow-up|0|||
161759868|NCT04490057|584158425|FG003|Stage 2|Lost to Follow-up|11|||
161759869|NCT04490057|584158426|FG004|Stage 2|Lost to Follow-up|17|||
161759870|NCT04490057|584158427|FG005|Stage 2|Lost to Follow-up|4|||
161759871|NCT04490057|584158428|FG006|Stage 2|Lost to Follow-up|21|||
161759872|NCT04490057|584158429|FG007|Stage 2|Lost to Follow-up|14|||
161759873|NCT02598661|584158432|FG000|Overall Study|Death|27|||
161759874|NCT02598661|584158433|FG001|Overall Study|Death|34|||
161759875|NCT02598661|584158434|FG002|Overall Study|Death|14|||
161759876|NCT02598661|584158435|FG003|Overall Study|Death|1|||
161759877|NCT02598661|584158436|FG004|Overall Study|Death|0|||
161759878|NCT02598661|584158432|FG000|Overall Study|Lost to Follow-up|2|||
161759879|NCT02598661|584158433|FG001|Overall Study|Lost to Follow-up|3|||
161759880|NCT02598661|584158434|FG002|Overall Study|Lost to Follow-up|2|||
161759881|NCT02598661|584158435|FG003|Overall Study|Lost to Follow-up|0|||
161759882|NCT02598661|584158436|FG004|Overall Study|Lost to Follow-up|0|||
161759883|NCT02598661|584158432|FG000|Overall Study|Withdrawal by Subject|13|||
161759884|NCT02598661|584158433|FG001|Overall Study|Withdrawal by Subject|24|||
161759885|NCT02598661|584158434|FG002|Overall Study|Withdrawal by Subject|14|||
161759886|NCT02598661|584158435|FG003|Overall Study|Withdrawal by Subject|1|||
161759887|NCT02598661|584158436|FG004|Overall Study|Withdrawal by Subject|1|||
161759888|NCT02598661|584158432|FG000|Overall Study|Adverse Event|0|||
161759889|NCT02598661|584158433|FG001|Overall Study|Adverse Event|0|||
161759890|NCT02598661|584158434|FG002|Overall Study|Adverse Event|1|||
161759891|NCT02598661|584158435|FG003|Overall Study|Adverse Event|0|||
161759892|NCT02598661|584158436|FG004|Overall Study|Adverse Event|0|||
161759893|NCT02598661|584158432|FG000|Overall Study|Randomized, Never Treated|0|||
161759894|NCT02598661|584158433|FG001|Overall Study|Randomized, Never Treated|0|||
161759895|NCT02598661|584158434|FG002|Overall Study|Randomized, Never Treated|0|||
161759896|NCT02598661|584158435|FG003|Overall Study|Randomized, Never Treated|0|||
161759897|NCT02598661|584158436|FG004|Overall Study|Randomized, Never Treated|1|||
161759898|NCT03053180|584160194|FG000|Overall Study|Failure to Return|1|||
161759899|NCT01465958|584160199|FG000|Run-in Phase|Protocol Violation|1|||
161759900|NCT01465958|584160200|FG001|Run-in Phase|Protocol Violation|0|||
161759901|NCT01465958|584160199|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
161759902|NCT01465958|584160200|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
161759903|NCT00211536|584160203|FG000|Overall Study|Withdrawal by Subject|2|||
161759904|NCT00211536|584160204|FG001|Overall Study|Withdrawal by Subject|2|||
161759905|NCT00211536|584160203|FG000|Overall Study|Physician Decision|0|||
161759906|NCT00211536|584160204|FG001|Overall Study|Physician Decision|5|||
161759907|NCT00211536|584160203|FG000|Overall Study|Adverse Event|2|||
161759908|NCT00211536|584160204|FG001|Overall Study|Adverse Event|0|||
161759909|NCT02583399|584160205|FG000|Overall Study|Able to be discharged|3|||
161759910|NCT02583399|584160205|FG000|Overall Study|Wanted to use a restricted medication|3|||
161759911|NCT00718887|584160206|FG000|Overall Study|Withdrawal by Subject|3|||
161759912|NCT00718887|584160207|FG001|Overall Study|Withdrawal by Subject|2|||
161759913|NCT00718887|584160206|FG000|Overall Study|Not identified|2|||
161759914|NCT00718887|584160207|FG001|Overall Study|Not identified|7|||
161759915|NCT03557801|584160210|FG000|Overall Study|Protocol Violation|1|||
161759916|NCT03557801|584160211|FG001|Overall Study|Protocol Violation|0|||
161759917|NCT03557801|584160212|FG002|Overall Study|Protocol Violation|0|||
161759918|NCT03557801|584160210|FG000|Overall Study|Withdrawal by Subject|1|||
161759919|NCT03557801|584160211|FG001|Overall Study|Withdrawal by Subject|0|||
161759920|NCT03557801|584160212|FG002|Overall Study|Withdrawal by Subject|3|||
161759921|NCT03557801|584160210|FG000|Overall Study|Lost to Follow-up|0|||
161759922|NCT03557801|584160211|FG001|Overall Study|Lost to Follow-up|1|||
161759923|NCT03557801|584160212|FG002|Overall Study|Lost to Follow-up|0|||
161759924|NCT00535236|584160213|FG000|Overall Study|Adverse Event|1|||
161759925|NCT00535236|584160214|FG001|Overall Study|Adverse Event|0|||
161759926|NCT00535236|584160215|FG002|Overall Study|Adverse Event|9|||
161759927|NCT00535236|584160216|FG003|Overall Study|Adverse Event|3|||
161759928|NCT00535236|584160217|FG004|Overall Study|Adverse Event|3|||
161759929|NCT00535236|584160218|FG005|Overall Study|Adverse Event|0|||
161759930|NCT00535236|584160219|FG006|Overall Study|Adverse Event|5|||
161759931|NCT00535236|584160220|FG007|Overall Study|Adverse Event|1|||
161759932|NCT00535236|584160221|FG008|Overall Study|Adverse Event|2|||
161759933|NCT00535236|584160222|FG009|Overall Study|Adverse Event|1|||
161759934|NCT00535236|584160213|FG000|Overall Study|Lost to Follow-up|1|||
161759935|NCT00535236|584160214|FG001|Overall Study|Lost to Follow-up|2|||
161759936|NCT00535236|584160215|FG002|Overall Study|Lost to Follow-up|0|||
161759937|NCT00535236|584160216|FG003|Overall Study|Lost to Follow-up|0|||
161759938|NCT00535236|584160217|FG004|Overall Study|Lost to Follow-up|2|||
161759939|NCT00535236|584160218|FG005|Overall Study|Lost to Follow-up|0|||
161759940|NCT00535236|584160219|FG006|Overall Study|Lost to Follow-up|0|||
161759941|NCT00535236|584160220|FG007|Overall Study|Lost to Follow-up|0|||
161759942|NCT00535236|584160221|FG008|Overall Study|Lost to Follow-up|6|||
161759943|NCT00535236|584160222|FG009|Overall Study|Lost to Follow-up|1|||
161759944|NCT00535236|584160213|FG000|Overall Study|Physician Decision|0|||
161759945|NCT00535236|584160214|FG001|Overall Study|Physician Decision|0|||
161759946|NCT00535236|584160215|FG002|Overall Study|Physician Decision|0|||
161759947|NCT00535236|584160216|FG003|Overall Study|Physician Decision|0|||
161759948|NCT00535236|584160217|FG004|Overall Study|Physician Decision|1|||
161759949|NCT00535236|584160218|FG005|Overall Study|Physician Decision|0|||
161759950|NCT00535236|584160219|FG006|Overall Study|Physician Decision|1|||
161759951|NCT00535236|584160220|FG007|Overall Study|Physician Decision|0|||
161759952|NCT00535236|584160221|FG008|Overall Study|Physician Decision|0|||
161759953|NCT00535236|584160222|FG009|Overall Study|Physician Decision|0|||
161759954|NCT00535236|584160213|FG000|Overall Study|Protocol Violation|2|||
161759955|NCT00535236|584160214|FG001|Overall Study|Protocol Violation|0|||
161759956|NCT00535236|584160215|FG002|Overall Study|Protocol Violation|1|||
161759957|NCT00535236|584160216|FG003|Overall Study|Protocol Violation|0|||
161759958|NCT00535236|584160217|FG004|Overall Study|Protocol Violation|0|||
161759959|NCT00535236|584160218|FG005|Overall Study|Protocol Violation|0|||
161759960|NCT00535236|584160219|FG006|Overall Study|Protocol Violation|0|||
161759961|NCT00535236|584160220|FG007|Overall Study|Protocol Violation|0|||
161759962|NCT00535236|584160221|FG008|Overall Study|Protocol Violation|1|||
161759963|NCT00535236|584160222|FG009|Overall Study|Protocol Violation|0|||
161759964|NCT00535236|584160213|FG000|Overall Study|Withdrawal by Subject|3|||
161759965|NCT00535236|584160214|FG001|Overall Study|Withdrawal by Subject|0|||
161759966|NCT00535236|584160215|FG002|Overall Study|Withdrawal by Subject|2|||
161759967|NCT00535236|584160216|FG003|Overall Study|Withdrawal by Subject|1|||
161759968|NCT00535236|584160217|FG004|Overall Study|Withdrawal by Subject|6|||
161759969|NCT00535236|584160218|FG005|Overall Study|Withdrawal by Subject|1|||
161759970|NCT00535236|584160219|FG006|Overall Study|Withdrawal by Subject|5|||
161759971|NCT00535236|584160220|FG007|Overall Study|Withdrawal by Subject|0|||
161759972|NCT00535236|584160221|FG008|Overall Study|Withdrawal by Subject|4|||
161759973|NCT00535236|584160222|FG009|Overall Study|Withdrawal by Subject|2|||
161759974|NCT03558503|584160223|FG000|Overall Study|Adverse Event|1|||
161759975|NCT03558503|584160223|FG000|Overall Study|Death|1|||
161759976|NCT03558503|584160223|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
161759977|NCT00561795|584160224|FG000|Overall Study|Adverse Event|3|||
161759978|NCT00561795|584160225|FG001|Overall Study|Adverse Event|3|||
161759979|NCT00561795|584160226|FG002|Overall Study|Adverse Event|0|||
161759980|NCT00561795|584160227|FG003|Overall Study|Adverse Event|0|||
161759981|NCT00561795|584160224|FG000|Overall Study|Study Closed/Terminated|0|||
161759982|NCT00561795|584160225|FG001|Overall Study|Study Closed/Terminated|3|||
161759983|NCT00561795|584160226|FG002|Overall Study|Study Closed/Terminated|0|||
161759984|NCT00561795|584160227|FG003|Overall Study|Study Closed/Terminated|0|||
161759985|NCT00561795|584160224|FG000|Overall Study|Physician Decision|1|||
161759986|NCT00561795|584160225|FG001|Overall Study|Physician Decision|0|||
161759987|NCT00561795|584160226|FG002|Overall Study|Physician Decision|0|||
161759988|NCT00561795|584160227|FG003|Overall Study|Physician Decision|0|||
161759989|NCT04564027|584160230|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
161759990|NCT04564027|584160231|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
161759991|NCT04564027|584160232|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
161759992|NCT04564027|584160233|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
161759993|NCT05827978|584160234|FG000|Overall Study|Adverse Event|1|||
161759994|NCT05827978|584160235|FG001|Overall Study|Adverse Event|0|||
161759995|NCT05827978|584160236|FG002|Overall Study|Adverse Event|0|||
161759996|NCT05827978|584160237|FG003|Overall Study|Adverse Event|1|||
161759997|NCT05827978|584160238|FG004|Overall Study|Adverse Event|0|||
161759998|NCT05827978|584160239|FG005|Overall Study|Adverse Event|0|||
161759999|NCT05827978|584160234|FG000|Overall Study|Death|1|||
161760000|NCT05827978|584160235|FG001|Overall Study|Death|5|||
161760001|NCT05827978|584160236|FG002|Overall Study|Death|2|||
161760002|NCT05827978|584160237|FG003|Overall Study|Death|3|||
161760003|NCT05827978|584160238|FG004|Overall Study|Death|1|||
161760004|NCT05827978|584160239|FG005|Overall Study|Death|3|||
161760005|NCT05827978|584160234|FG000|Overall Study|Lost to Follow-up|57|||
161760006|NCT05827978|584160235|FG001|Overall Study|Lost to Follow-up|88|||
161760007|NCT05827978|584160236|FG002|Overall Study|Lost to Follow-up|54|||
161760008|NCT05827978|584160237|FG003|Overall Study|Lost to Follow-up|47|||
161760009|NCT05827978|584160238|FG004|Overall Study|Lost to Follow-up|25|||
161760010|NCT05827978|584160239|FG005|Overall Study|Lost to Follow-up|10|||
161760011|NCT05827978|584160234|FG000|Overall Study|Noncompliance with Study Procedures|0|||
161760012|NCT05827978|584160235|FG001|Overall Study|Noncompliance with Study Procedures|1|||
161760013|NCT05827978|584160236|FG002|Overall Study|Noncompliance with Study Procedures|1|||
161760014|NCT05827978|584160237|FG003|Overall Study|Noncompliance with Study Procedures|1|||
161760015|NCT05827978|584160238|FG004|Overall Study|Noncompliance with Study Procedures|1|||
161760016|NCT05827978|584160239|FG005|Overall Study|Noncompliance with Study Procedures|0|||
161760017|NCT05827978|584160234|FG000|Overall Study|Physician Decision|2|||
161760018|NCT05827978|584160235|FG001|Overall Study|Physician Decision|0|||
161760019|NCT05827978|584160236|FG002|Overall Study|Physician Decision|1|||
161760020|NCT05827978|584160237|FG003|Overall Study|Physician Decision|2|||
161760021|NCT05827978|584160238|FG004|Overall Study|Physician Decision|1|||
161760022|NCT05827978|584160239|FG005|Overall Study|Physician Decision|1|||
161760023|NCT05827978|584160234|FG000|Overall Study|Protocol Violation|5|||
161760024|NCT05827978|584160235|FG001|Overall Study|Protocol Violation|2|||
161760025|NCT05827978|584160236|FG002|Overall Study|Protocol Violation|0|||
161760026|NCT05827978|584160237|FG003|Overall Study|Protocol Violation|0|||
161760027|NCT05827978|584160238|FG004|Overall Study|Protocol Violation|0|||
161760028|NCT05827978|584160239|FG005|Overall Study|Protocol Violation|0|||
161760029|NCT05827978|584160234|FG000|Overall Study|Withdrawal by Subject|17|||
161760030|NCT05827978|584160235|FG001|Overall Study|Withdrawal by Subject|16|||
161760031|NCT05827978|584160236|FG002|Overall Study|Withdrawal by Subject|10|||
161760032|NCT05827978|584160237|FG003|Overall Study|Withdrawal by Subject|12|||
161760033|NCT05827978|584160238|FG004|Overall Study|Withdrawal by Subject|10|||
161760034|NCT05827978|584160239|FG005|Overall Study|Withdrawal by Subject|9|||
161760035|NCT05827978|584160234|FG000|Overall Study|Other Than Specified|0|||
161760036|NCT05827978|584160235|FG001|Overall Study|Other Than Specified|0|||
161760037|NCT05827978|584160236|FG002|Overall Study|Other Than Specified|1|||
161760038|NCT05827978|584160237|FG003|Overall Study|Other Than Specified|0|||
161760039|NCT05827978|584160238|FG004|Overall Study|Other Than Specified|2|||
161760040|NCT05827978|584160239|FG005|Overall Study|Other Than Specified|0|||
161760041|NCT04566445|584160240|FG000|Overall Study|Death|4|||
161760042|NCT04566445|584160241|FG001|Overall Study|Death|1|||
161760043|NCT04566445|584160242|FG002|Overall Study|Death|1|||
161760044|NCT04566445|584160240|FG000|Overall Study|Lost to Follow-up|3|||
161760045|NCT04566445|584160241|FG001|Overall Study|Lost to Follow-up|1|||
161760046|NCT04566445|584160242|FG002|Overall Study|Lost to Follow-up|1|||
161760047|NCT04566445|584160240|FG000|Overall Study|Study terminated by sponsor|11|||
161760048|NCT04566445|584160241|FG001|Overall Study|Study terminated by sponsor|17|||
161760049|NCT04566445|584160242|FG002|Overall Study|Study terminated by sponsor|32|||
161760050|NCT04566445|584160240|FG000|Overall Study|Withdrawal by Subject|12|||
161760051|NCT04566445|584160241|FG001|Overall Study|Withdrawal by Subject|14|||
161760052|NCT04566445|584160242|FG002|Overall Study|Withdrawal by Subject|13|||
161760053|NCT04566445|584160240|FG000|Overall Study|Randomized but not treated due to AE|2|||
161760054|NCT04566445|584160241|FG001|Overall Study|Randomized but not treated due to AE|1|||
161760055|NCT04566445|584160242|FG002|Overall Study|Randomized but not treated due to AE|0|||
161760056|NCT04566445|584160240|FG000|Overall Study|Adverse Event|1|||
161760057|NCT04566445|584160241|FG001|Overall Study|Adverse Event|1|||
161760058|NCT04566445|584160242|FG002|Overall Study|Adverse Event|0|||
161760059|NCT04785144|584160243|FG000|Overall Study|Withdrawal by Subject|4|||
161760060|NCT04785144|584160244|FG001|Overall Study|Withdrawal by Subject|1|||
161760061|NCT04785144|584160245|FG002|Overall Study|Withdrawal by Subject|0|||
161760062|NCT04785144|584160246|FG003|Overall Study|Withdrawal by Subject|0|||
161760063|NCT04785144|584160247|FG004|Overall Study|Withdrawal by Subject|0|||
161760064|NCT04785144|584160248|FG005|Overall Study|Withdrawal by Subject|2|||
161760065|NCT04785144|584160249|FG006|Overall Study|Withdrawal by Subject|2|||
161760066|NCT04785144|584160250|FG007|Overall Study|Withdrawal by Subject|0|||
161760067|NCT04785144|584160251|FG008|Overall Study|Withdrawal by Subject|1|||
161760068|NCT04785144|584160252|FG009|Overall Study|Withdrawal by Subject|0|||
161760069|NCT04785144|584160243|FG000|Overall Study|Lost to Follow-up|1|||
161760070|NCT04785144|584160244|FG001|Overall Study|Lost to Follow-up|0|||
161760071|NCT04785144|584160245|FG002|Overall Study|Lost to Follow-up|0|||
161760072|NCT04785144|584160246|FG003|Overall Study|Lost to Follow-up|0|||
161760073|NCT04785144|584160247|FG004|Overall Study|Lost to Follow-up|1|||
161760074|NCT04785144|584160248|FG005|Overall Study|Lost to Follow-up|2|||
161760075|NCT04785144|584160249|FG006|Overall Study|Lost to Follow-up|1|||
161760076|NCT04785144|584160250|FG007|Overall Study|Lost to Follow-up|2|||
161760077|NCT04785144|584160251|FG008|Overall Study|Lost to Follow-up|4|||
161760078|NCT04785144|584160252|FG009|Overall Study|Lost to Follow-up|1|||
161760079|NCT04785144|584160243|FG000|Overall Study|Protocol Violation|0|||
161760080|NCT04785144|584160244|FG001|Overall Study|Protocol Violation|0|||
161760081|NCT04785144|584160245|FG002|Overall Study|Protocol Violation|0|||
161760082|NCT04785144|584160246|FG003|Overall Study|Protocol Violation|0|||
161760083|NCT04785144|584160247|FG004|Overall Study|Protocol Violation|0|||
161760084|NCT04785144|584160248|FG005|Overall Study|Protocol Violation|0|||
161760085|NCT04785144|584160249|FG006|Overall Study|Protocol Violation|1|||
161760086|NCT04785144|584160250|FG007|Overall Study|Protocol Violation|0|||
161760087|NCT04785144|584160251|FG008|Overall Study|Protocol Violation|0|||
161760088|NCT04785144|584160252|FG009|Overall Study|Protocol Violation|0|||
161760089|NCT04785144|584160243|FG000|Overall Study|Physician Decision|0|||
161760090|NCT04785144|584160244|FG001|Overall Study|Physician Decision|0|||
161760091|NCT04785144|584160245|FG002|Overall Study|Physician Decision|0|||
161760092|NCT04785144|584160246|FG003|Overall Study|Physician Decision|0|||
161760093|NCT04785144|584160247|FG004|Overall Study|Physician Decision|0|||
161760094|NCT04785144|584160248|FG005|Overall Study|Physician Decision|0|||
161760095|NCT04785144|584160249|FG006|Overall Study|Physician Decision|0|||
161760096|NCT04785144|584160250|FG007|Overall Study|Physician Decision|0|||
161760097|NCT04785144|584160251|FG008|Overall Study|Physician Decision|0|||
161760098|NCT04785144|584160252|FG009|Overall Study|Physician Decision|1|||
161760099|NCT04785144|584160243|FG000|Overall Study|Unable to continue due to work schedule|0|||
161760100|NCT04785144|584160244|FG001|Overall Study|Unable to continue due to work schedule|0|||
161760101|NCT04785144|584160245|FG002|Overall Study|Unable to continue due to work schedule|0|||
161760102|NCT04785144|584160246|FG003|Overall Study|Unable to continue due to work schedule|0|||
161760103|NCT04785144|584160247|FG004|Overall Study|Unable to continue due to work schedule|0|||
161760104|NCT04785144|584160248|FG005|Overall Study|Unable to continue due to work schedule|0|||
161760105|NCT04785144|584160249|FG006|Overall Study|Unable to continue due to work schedule|0|||
161760106|NCT04785144|584160250|FG007|Overall Study|Unable to continue due to work schedule|0|||
161760107|NCT04785144|584160251|FG008|Overall Study|Unable to continue due to work schedule|0|||
161760108|NCT04785144|584160252|FG009|Overall Study|Unable to continue due to work schedule|1|||
161760109|NCT00137267|584160255|FG000|Overall Study|Lost to Follow-up|15|||
161760110|NCT00137267|584160256|FG001|Overall Study|Lost to Follow-up|21|||
161760111|NCT02061540|584160260|FG000|Overall Study|Adverse Event|2|||
161760112|NCT02061540|584160260|FG000|Overall Study|Withdrawal by Subject|2|||
161760113|NCT04005755|584160261|FG000|Overall Study|Adverse Event|6|||
161760114|NCT04005755|584160261|FG000|Overall Study|Physician Decision|3|||
161760115|NCT04005755|584160261|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
161760116|NCT04005755|584160261|FG000|Overall Study|Withdrawal by Subject|3|||
161760117|NCT04005755|584160261|FG000|Overall Study|Lost to Follow-up|1|||
161760118|NCT02289833|584160263|FG000|Overall Study|Study discontinuation|0|||
161760119|NCT02289833|584160264|FG001|Overall Study|Study discontinuation|1|||
161760120|NCT02289833|584160263|FG000|Overall Study|Lost to Follow-up|4|||
161760121|NCT02289833|584160264|FG001|Overall Study|Lost to Follow-up|0|||
161760122|NCT02289833|584160263|FG000|Overall Study|Death|23|||
161760123|NCT02289833|584160264|FG001|Overall Study|Death|16|||
161760124|NCT02561273|584160265|FG000|Overall Study|Protocol Violation|1|||
161760125|NCT02561273|584160266|FG001|Overall Study|Protocol Violation|0|||
161760126|NCT02723019|584160267|FG000|Overall Study|Death|17|||
161760127|NCT02723019|584160268|FG001|Overall Study|Death|13|||
161760128|NCT02723019|584160267|FG000|Overall Study|Withdrawal by Subject|11|||
161760129|NCT02723019|584160268|FG001|Overall Study|Withdrawal by Subject|7|||
161760130|NCT02723019|584160267|FG000|Overall Study|Lost to Follow-up|57|||
161760131|NCT02723019|584160268|FG001|Overall Study|Lost to Follow-up|70|||
161760132|NCT00611767|584160270|FG000|Overall Study|Withdrawal by Subject|4|||
161760133|NCT00611767|584160271|FG001|Overall Study|Withdrawal by Subject|1|||
161760134|NCT00611767|584160270|FG000|Overall Study|Thiopental not available|3|||
161760135|NCT00611767|584160271|FG001|Overall Study|Thiopental not available|0|||
161760136|NCT00611767|584160270|FG000|Overall Study|didn't like the medication|1|||
161760137|NCT00611767|584160271|FG001|Overall Study|didn't like the medication|1|||
161760138|NCT00611767|584160270|FG000|Overall Study|Physician Decision|1|||
161760139|NCT00611767|584160271|FG001|Overall Study|Physician Decision|0|||
161760140|NCT01562327|584160276|FG000|Overall Study|Adverse Event|2|||
161760141|NCT01562327|584160276|FG000|Overall Study|Lack of Efficacy|1|||
161760142|NCT01562327|584160276|FG000|Overall Study|Participant drop-out|1|||
161760143|NCT01562327|584160276|FG000|Overall Study|Infusion not received at 6 month window|4|||
161760144|NCT00170846|584160277|FG000|Overall Study|Subject withdrew Informed Consent|5|||
161760145|NCT00170846|584160278|FG001|Overall Study|Subject withdrew Informed Consent|12|||
161760146|NCT00170846|584160279|FG002|Overall Study|Subject withdrew Informed Consent|8|||
161760147|NCT00170846|584160277|FG000|Overall Study|Lost to Follow-up|6|||
161760148|NCT00170846|584160278|FG001|Overall Study|Lost to Follow-up|3|||
161760149|NCT00170846|584160279|FG002|Overall Study|Lost to Follow-up|2|||
161760150|NCT00170846|584160277|FG000|Overall Study|Death|0|||
161760151|NCT00170846|584160278|FG001|Overall Study|Death|3|||
161760152|NCT00170846|584160279|FG002|Overall Study|Death|3|||
161760153|NCT00170846|584160277|FG000|Overall Study|Reason Missing|0|||
161760154|NCT00170846|584160278|FG001|Overall Study|Reason Missing|1|||
161760155|NCT00170846|584160279|FG002|Overall Study|Reason Missing|0|||
161760156|NCT02795182|584160288|FG000|Overall Study|Death|5|||
161760157|NCT02795182|584160289|FG001|Overall Study|Death|4|||
161760158|NCT02795182|584160290|FG002|Overall Study|Death|4|||
161760159|NCT02795182|584160291|FG003|Overall Study|Death|18|||
161760160|NCT02795182|584160288|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161760161|NCT02795182|584160289|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161760162|NCT02795182|584160290|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161760163|NCT02795182|584160291|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
161760164|NCT02795182|584160288|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161760165|NCT02795182|584160289|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161760166|NCT02795182|584160290|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161760167|NCT02795182|584160291|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
161760168|NCT02795182|584160288|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
161760169|NCT02795182|584160289|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
161760170|NCT02795182|584160290|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
161760171|NCT02795182|584160291|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
161760172|NCT02795182|584160288|FG000|Overall Study|Withdrawal by Subject|4|||
161760173|NCT02795182|584160289|FG001|Overall Study|Withdrawal by Subject|0|||
161760174|NCT02795182|584160290|FG002|Overall Study|Withdrawal by Subject|0|||
161760175|NCT02795182|584160291|FG003|Overall Study|Withdrawal by Subject|3|||
161760176|NCT02795182|584160288|FG000|Overall Study|Lost to Follow-up|0|||
161760177|NCT02795182|584160289|FG001|Overall Study|Lost to Follow-up|0|||
161760178|NCT02795182|584160290|FG002|Overall Study|Lost to Follow-up|1|||
161760179|NCT02795182|584160291|FG003|Overall Study|Lost to Follow-up|1|||
161760180|NCT02795182|584160288|FG000|Overall Study|Roll Over to Long Term Extension|3|||
161760181|NCT02795182|584160289|FG001|Overall Study|Roll Over to Long Term Extension|3|||
161760182|NCT02795182|584160290|FG002|Overall Study|Roll Over to Long Term Extension|2|||
161760183|NCT02795182|584160291|FG003|Overall Study|Roll Over to Long Term Extension|5|||
161760184|NCT02795182|584160288|FG000|Overall Study|Progressive Disease|0|||
161760185|NCT02795182|584160289|FG001|Overall Study|Progressive Disease|1|||
161760186|NCT02795182|584160290|FG002|Overall Study|Progressive Disease|0|||
161847473|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847474|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847475|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
161847476|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
161847477|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847478|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847479|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847480|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847481|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847482|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847483|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847484|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847485|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847486|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847487|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847488|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847489|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847490|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
161847491|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847492|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847493|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847494|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847495|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847496|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847497|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847498|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847499|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847500|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847501|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847502|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847503|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
161847504|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
161847505|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847506|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847507|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847508|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847509|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847510|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847511|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847512|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847513|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847514|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847515|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847516|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847517|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847518|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847519|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847520|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847521|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847522|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847523|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
161847524|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847525|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847526|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847527|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847528|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847529|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847530|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847531|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847532|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847533|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847534|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847535|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847536|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161760187|NCT02795182|584160291|FG003|Overall Study|Progressive Disease|4|||
161760188|NCT02795182|584160288|FG000|Overall Study|Physician Decision|0|||
161760189|NCT02795182|584160289|FG001|Overall Study|Physician Decision|0|||
161760190|NCT02795182|584160290|FG002|Overall Study|Physician Decision|0|||
161760191|NCT02795182|584160291|FG003|Overall Study|Physician Decision|1|||
161760192|NCT02724111|584160292|FG000|Overall Study|Protocol Violation|2|||
161760193|NCT02724111|584160293|FG001|Overall Study|Protocol Violation|5|||
161760194|NCT02996500|584160294|FG000|Overall Study|Adverse Event|1|||
161760195|NCT02996500|584160295|FG001|Overall Study|Adverse Event|1|||
161760196|NCT02996500|584160296|FG002|Overall Study|Adverse Event|4|||
161760197|NCT02996500|584160297|FG003|Overall Study|Adverse Event|3|||
161760198|NCT02996500|584160298|FG004|Overall Study|Adverse Event|1|||
161760199|NCT02996500|584160299|FG005|Overall Study|Adverse Event|2|||
161760200|NCT02996500|584160294|FG000|Overall Study|Lack of Efficacy|0|||
161760201|NCT02996500|584160295|FG001|Overall Study|Lack of Efficacy|0|||
161760202|NCT02996500|584160296|FG002|Overall Study|Lack of Efficacy|0|||
161760203|NCT02996500|584160297|FG003|Overall Study|Lack of Efficacy|0|||
161760204|NCT02996500|584160298|FG004|Overall Study|Lack of Efficacy|2|||
161760205|NCT02996500|584160299|FG005|Overall Study|Lack of Efficacy|0|||
161760206|NCT02996500|584160294|FG000|Overall Study|Lost to Follow-up|1|||
161760207|NCT02996500|584160295|FG001|Overall Study|Lost to Follow-up|0|||
161760208|NCT02996500|584160296|FG002|Overall Study|Lost to Follow-up|0|||
161760209|NCT02996500|584160297|FG003|Overall Study|Lost to Follow-up|0|||
161760210|NCT02996500|584160298|FG004|Overall Study|Lost to Follow-up|0|||
161760211|NCT02996500|584160299|FG005|Overall Study|Lost to Follow-up|1|||
161760212|NCT02996500|584160294|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760213|NCT02996500|584160295|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760214|NCT02996500|584160296|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
161760215|NCT02996500|584160297|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760216|NCT02996500|584160298|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760217|NCT02996500|584160299|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760218|NCT02996500|584160294|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161760219|NCT02996500|584160295|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161760220|NCT02996500|584160296|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161760221|NCT02996500|584160297|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161760222|NCT02996500|584160298|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161760223|NCT02996500|584160299|FG005|Overall Study|Non-Compliance With Study Drug|1|||
161760224|NCT02996500|584160294|FG000|Overall Study|Progressive Disease|1|||
161760225|NCT02996500|584160295|FG001|Overall Study|Progressive Disease|0|||
161760226|NCT02996500|584160296|FG002|Overall Study|Progressive Disease|0|||
161760227|NCT02996500|584160297|FG003|Overall Study|Progressive Disease|0|||
161760228|NCT02996500|584160298|FG004|Overall Study|Progressive Disease|0|||
161760229|NCT02996500|584160299|FG005|Overall Study|Progressive Disease|0|||
161760230|NCT02996500|584160294|FG000|Overall Study|Other|2|||
161760231|NCT02996500|584160295|FG001|Overall Study|Other|0|||
161760232|NCT02996500|584160296|FG002|Overall Study|Other|2|||
161760233|NCT02996500|584160297|FG003|Overall Study|Other|0|||
161760234|NCT02996500|584160298|FG004|Overall Study|Other|0|||
161760235|NCT02996500|584160299|FG005|Overall Study|Other|0|||
161760236|NCT02996500|584160294|FG000|Overall Study|Protocol Violation|0|||
161760237|NCT02996500|584160295|FG001|Overall Study|Protocol Violation|0|||
161760238|NCT02996500|584160296|FG002|Overall Study|Protocol Violation|0|||
161760239|NCT02996500|584160297|FG003|Overall Study|Protocol Violation|1|||
161760240|NCT02996500|584160298|FG004|Overall Study|Protocol Violation|0|||
161760241|NCT02996500|584160299|FG005|Overall Study|Protocol Violation|0|||
161760242|NCT02996500|584160294|FG000|Overall Study|Withdrawal by Subject|3|||
161760243|NCT02996500|584160295|FG001|Overall Study|Withdrawal by Subject|0|||
161760244|NCT02996500|584160296|FG002|Overall Study|Withdrawal by Subject|3|||
161760245|NCT02996500|584160297|FG003|Overall Study|Withdrawal by Subject|0|||
161760246|NCT02996500|584160298|FG004|Overall Study|Withdrawal by Subject|2|||
161760247|NCT02996500|584160299|FG005|Overall Study|Withdrawal by Subject|0|||
161760248|NCT02187224|584160300|FG000|Overall Study|Did not show up for test day|1|||
161760249|NCT02187224|584160301|FG001|Overall Study|Did not show up for test day|0|||
161760250|NCT01010776|584160302|FG000|Main Phase|Withdrawal by Subject|14|||
161760251|NCT01010776|584160302|FG000|Main Phase|Lack of Efficacy|8|||
161760252|NCT01010776|584160302|FG000|Main Phase|Adverse Event|7|||
161760253|NCT01010776|584160302|FG000|Main Phase|Lost to Follow-up|6|||
161760254|NCT01010776|584160302|FG000|Main Phase|Non-compliance to study medication|5|||
161760255|NCT01010776|584160302|FG000|Main Phase|Selection failure|2|||
161760256|NCT01010776|584160302|FG000|Main Phase|Inform consent withdrawal|1|||
161760257|NCT01010776|584160302|FG000|Main Phase|Other|1|||
161760258|NCT01010776|584160302|FG000|Main Phase|Did not received study medication|5|||
161760259|NCT01010776|584160302|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
161760260|NCT01010776|584160302|FG000|Extension Phase|Other|3|||
161760261|NCT02332876|584160303|FG000|Overall Study|Lost to Follow-up|1|||
161760262|NCT02332876|584160304|FG001|Overall Study|Lost to Follow-up|1|||
161760263|NCT02573012|584160308|FG000|Overall Study|Adverse Event|5|||
161760264|NCT02573012|584160309|FG001|Overall Study|Adverse Event|5|||
161760265|NCT02573012|584160308|FG000|Overall Study|Lack of Efficacy|5|||
161760266|NCT02573012|584160309|FG001|Overall Study|Lack of Efficacy|4|||
161760267|NCT02573012|584160308|FG000|Overall Study|Non-compliance|1|||
161760268|NCT02573012|584160309|FG001|Overall Study|Non-compliance|2|||
161760269|NCT02573012|584160308|FG000|Overall Study|Withdrawal by Subject|2|||
161760270|NCT02573012|584160309|FG001|Overall Study|Withdrawal by Subject|2|||
161760271|NCT02573012|584160308|FG000|Overall Study|Study Ended per Protocol|1|||
161760272|NCT02573012|584160309|FG001|Overall Study|Study Ended per Protocol|0|||
161760273|NCT02573012|584160308|FG000|Overall Study|Physician Decision|1|||
161760274|NCT02573012|584160309|FG001|Overall Study|Physician Decision|2|||
161760275|NCT00882362|584160310|FG000|Overall Study|Adverse Event|13|||
161760276|NCT00882362|584160311|FG001|Overall Study|Adverse Event|10|||
161760277|NCT00882362|584160310|FG000|Overall Study|Withdrawal by Subject|13|||
161760278|NCT00882362|584160311|FG001|Overall Study|Withdrawal by Subject|10|||
161760279|NCT00882362|584160310|FG000|Overall Study|Lack of Efficacy|3|||
161760280|NCT00882362|584160311|FG001|Overall Study|Lack of Efficacy|0|||
161760281|NCT00882362|584160310|FG000|Overall Study|Protocol Violation|7|||
161760282|NCT00882362|584160311|FG001|Overall Study|Protocol Violation|2|||
161760283|NCT00882362|584160310|FG000|Overall Study|Pregnancy|1|||
161760284|NCT00882362|584160311|FG001|Overall Study|Pregnancy|0|||
161760285|NCT00882362|584160310|FG000|Overall Study|Physician Decision|5|||
161760286|NCT00882362|584160311|FG001|Overall Study|Physician Decision|1|||
161760287|NCT00882362|584160310|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
161760288|NCT00882362|584160311|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
161760289|NCT00882362|584160310|FG000|Overall Study|change of residence or other commitments|5|||
161760290|NCT00882362|584160311|FG001|Overall Study|change of residence or other commitments|0|||
161760291|NCT02382276|584160314|FG000|Overall Study|Withdrawal by Subject|4|||
161760292|NCT02382276|584160315|FG001|Overall Study|Withdrawal by Subject|8|||
161760293|NCT02382276|584160316|FG002|Overall Study|Withdrawal by Subject|5|||
161760294|NCT02382276|584160314|FG000|Overall Study|Adverse Event|7|||
161760295|NCT02382276|584160315|FG001|Overall Study|Adverse Event|2|||
161760296|NCT02382276|584160316|FG002|Overall Study|Adverse Event|32|||
161760297|NCT02382276|584160314|FG000|Overall Study|Physician Decision|0|||
161760298|NCT02382276|584160315|FG001|Overall Study|Physician Decision|0|||
161760299|NCT02382276|584160316|FG002|Overall Study|Physician Decision|2|||
161760300|NCT01222416|584160317|FG000|Overall Study|ineligible;metastasis|3|||
161760301|NCT01222416|584160318|FG001|Overall Study|ineligible;metastasis|0|||
161760302|NCT01222416|584160317|FG000|Overall Study|Adverse Event|4|||
161760303|NCT01222416|584160318|FG001|Overall Study|Adverse Event|0|||
161760304|NCT01222416|584160317|FG000|Overall Study|Withdrawal by Subject|5|||
161760305|NCT01222416|584160318|FG001|Overall Study|Withdrawal by Subject|0|||
161760306|NCT01222416|584160317|FG000|Overall Study|scheduling|6|||
161760307|NCT01222416|584160318|FG001|Overall Study|scheduling|0|||
161760308|NCT01222416|584160317|FG000|Overall Study|missed view/scan|1|||
161760309|NCT01222416|584160318|FG001|Overall Study|missed view/scan|0|||
161760310|NCT01222416|584160317|FG000|Overall Study|Death|1|||
161760311|NCT01222416|584160318|FG001|Overall Study|Death|0|||
161760312|NCT03049852|584160332|FG000|Overall Study|Lost to Follow-up|0|||
161760313|NCT03049852|584160333|FG001|Overall Study|Lost to Follow-up|1|||
161760314|NCT03049852|584160334|FG002|Overall Study|Lost to Follow-up|0|||
161760315|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
161760316|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760317|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760318|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760319|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760320|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760321|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
161760322|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760323|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760324|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760325|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760326|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760327|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
161760328|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760329|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760330|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760331|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760332|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760333|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Other|14|||
161760334|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Other|0|||
161760335|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Other|0|||
161760336|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Other|0|||
161760337|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Other|0|||
161760338|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Other|0|||
161760339|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
161760340|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760341|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760342|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760343|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760344|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760345|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
161760346|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760347|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760348|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760349|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760350|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760351|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
161760352|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760353|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760354|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760355|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760356|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760357|NCT02141854|584160335|FG000|Treatment Period|Protocol Violation|0|||
161760358|NCT02141854|584160336|FG001|Treatment Period|Protocol Violation|1|||
161760359|NCT02141854|584160337|FG002|Treatment Period|Protocol Violation|0|||
161760360|NCT02141854|584160338|FG003|Treatment Period|Protocol Violation|2|||
161760361|NCT02141854|584160339|FG004|Treatment Period|Protocol Violation|2|||
161760362|NCT02141854|584160340|FG005|Treatment Period|Protocol Violation|1|||
161760363|NCT02141854|584160335|FG000|Treatment Period|Noncompliance|0|||
161760364|NCT02141854|584160336|FG001|Treatment Period|Noncompliance|0|||
161760365|NCT02141854|584160337|FG002|Treatment Period|Noncompliance|0|||
161760366|NCT02141854|584160338|FG003|Treatment Period|Noncompliance|1|||
161760367|NCT02141854|584160339|FG004|Treatment Period|Noncompliance|0|||
161760368|NCT02141854|584160340|FG005|Treatment Period|Noncompliance|0|||
161760369|NCT02141854|584160335|FG000|Treatment Period|Lack of Efficacy|0|||
161760370|NCT02141854|584160336|FG001|Treatment Period|Lack of Efficacy|0|||
161760371|NCT02141854|584160337|FG002|Treatment Period|Lack of Efficacy|0|||
161760372|NCT02141854|584160338|FG003|Treatment Period|Lack of Efficacy|1|||
161760373|NCT02141854|584160339|FG004|Treatment Period|Lack of Efficacy|1|||
161760374|NCT02141854|584160340|FG005|Treatment Period|Lack of Efficacy|7|||
161760375|NCT02141854|584160335|FG000|Treatment Period|Pregnancy|0|||
161760376|NCT02141854|584160336|FG001|Treatment Period|Pregnancy|1|||
161760377|NCT02141854|584160337|FG002|Treatment Period|Pregnancy|0|||
161760378|NCT02141854|584160338|FG003|Treatment Period|Pregnancy|0|||
161760379|NCT02141854|584160339|FG004|Treatment Period|Pregnancy|0|||
161760380|NCT02141854|584160340|FG005|Treatment Period|Pregnancy|0|||
161760381|NCT02141854|584160335|FG000|Treatment Period|Other|0|||
161760382|NCT02141854|584160336|FG001|Treatment Period|Other|1|||
161760383|NCT02141854|584160337|FG002|Treatment Period|Other|2|||
161760384|NCT02141854|584160338|FG003|Treatment Period|Other|0|||
161760385|NCT02141854|584160339|FG004|Treatment Period|Other|1|||
161760386|NCT02141854|584160340|FG005|Treatment Period|Other|2|||
161760387|NCT02141854|584160335|FG000|Treatment Period|Adverse Event|0|||
161760388|NCT02141854|584160336|FG001|Treatment Period|Adverse Event|2|||
161760389|NCT02141854|584160337|FG002|Treatment Period|Adverse Event|2|||
161760390|NCT02141854|584160338|FG003|Treatment Period|Adverse Event|0|||
161760391|NCT02141854|584160339|FG004|Treatment Period|Adverse Event|2|||
161760392|NCT02141854|584160340|FG005|Treatment Period|Adverse Event|2|||
161760393|NCT02141854|584160335|FG000|Treatment Period|Withdrawal by Subject|0|||
161760394|NCT02141854|584160336|FG001|Treatment Period|Withdrawal by Subject|2|||
161760395|NCT02141854|584160337|FG002|Treatment Period|Withdrawal by Subject|3|||
161760396|NCT02141854|584160338|FG003|Treatment Period|Withdrawal by Subject|3|||
161760397|NCT02141854|584160339|FG004|Treatment Period|Withdrawal by Subject|4|||
161760398|NCT02141854|584160340|FG005|Treatment Period|Withdrawal by Subject|7|||
161760399|NCT02141854|584160335|FG000|Treatment Period|Disease progression|0|||
161760400|NCT02141854|584160336|FG001|Treatment Period|Disease progression|2|||
161760401|NCT02141854|584160337|FG002|Treatment Period|Disease progression|1|||
161847537|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
161847538|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847539|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161760402|NCT02141854|584160338|FG003|Treatment Period|Disease progression|3|||
161760403|NCT02141854|584160339|FG004|Treatment Period|Disease progression|0|||
161760404|NCT02141854|584160340|FG005|Treatment Period|Disease progression|18|||
161760405|NCT02141854|584160335|FG000|Treatment Period|Lost to Follow-up|0|||
161760406|NCT02141854|584160336|FG001|Treatment Period|Lost to Follow-up|1|||
161760407|NCT02141854|584160337|FG002|Treatment Period|Lost to Follow-up|1|||
161760408|NCT02141854|584160338|FG003|Treatment Period|Lost to Follow-up|1|||
161760409|NCT02141854|584160339|FG004|Treatment Period|Lost to Follow-up|0|||
161760410|NCT02141854|584160340|FG005|Treatment Period|Lost to Follow-up|1|||
161760411|NCT03258762|584160341|FG000|Overall Study|Lost to Follow-up|0|||
161760412|NCT03258762|584160342|FG001|Overall Study|Lost to Follow-up|1|||
161760413|NCT02545049|584160343|FG000|Overall Study|Withdrawal by Subject|1|||
161760414|NCT02545049|584160344|FG001|Overall Study|Withdrawal by Subject|7|||
161760415|NCT02545049|584160343|FG000|Overall Study|Lost to Follow-up|4|||
161760416|NCT02545049|584160344|FG001|Overall Study|Lost to Follow-up|6|||
161760417|NCT02545049|584160343|FG000|Overall Study|GCP violations|37|||
161760418|NCT02545049|584160344|FG001|Overall Study|GCP violations|48|||
161760419|NCT00027027|584162201|FG000|Overall Study|Adverse Event|0|||
161760420|NCT00027027|584162202|FG001|Overall Study|Adverse Event|0|||
161760421|NCT00027027|584162203|FG002|Overall Study|Adverse Event|1|||
161760422|NCT00027027|584162204|FG003|Overall Study|Adverse Event|0|||
161760423|NCT00027027|584162205|FG004|Overall Study|Adverse Event|1|||
161760424|NCT00027027|584162201|FG000|Overall Study|Admitted for Signs of PD|0|||
161760425|NCT00027027|584162202|FG001|Overall Study|Admitted for Signs of PD|0|||
161760426|NCT00027027|584162203|FG002|Overall Study|Admitted for Signs of PD|0|||
161760427|NCT00027027|584162204|FG003|Overall Study|Admitted for Signs of PD|0|||
161760428|NCT00027027|584162205|FG004|Overall Study|Admitted for Signs of PD|1|||
161760429|NCT00027027|584162201|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
161760430|NCT00027027|584162202|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
161760431|NCT00027027|584162203|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
161760432|NCT00027027|584162204|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
161760433|NCT00027027|584162205|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
161760434|NCT00027027|584162201|FG000|Overall Study|PD Requiring Surgery|0|||
161760435|NCT00027027|584162202|FG001|Overall Study|PD Requiring Surgery|0|||
161760436|NCT00027027|584162203|FG002|Overall Study|PD Requiring Surgery|1|||
161760437|NCT00027027|584162204|FG003|Overall Study|PD Requiring Surgery|0|||
161760438|NCT00027027|584162205|FG004|Overall Study|PD Requiring Surgery|0|||
161760439|NCT00027027|584162201|FG000|Overall Study|Physician Decision Due To PD|2|||
161847540|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847541|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847542|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847543|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847544|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847545|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847546|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847547|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847548|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847549|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847550|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847551|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
161847552|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847553|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847554|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847555|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847556|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847557|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847558|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847559|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847560|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847561|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847562|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847563|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847564|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847565|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
161847566|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847567|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847568|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847569|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847570|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847571|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847572|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847573|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760440|NCT00027027|584162202|FG001|Overall Study|Physician Decision Due To PD|3|||
161760441|NCT00027027|584162203|FG002|Overall Study|Physician Decision Due To PD|2|||
161760442|NCT00027027|584162204|FG003|Overall Study|Physician Decision Due To PD|3|||
161760443|NCT00027027|584162205|FG004|Overall Study|Physician Decision Due To PD|5|||
161760444|NCT00027027|584162201|FG000|Overall Study|Withdrawal by Subject|0|||
161760445|NCT00027027|584162202|FG001|Overall Study|Withdrawal by Subject|0|||
161760446|NCT00027027|584162203|FG002|Overall Study|Withdrawal by Subject|0|||
161760447|NCT00027027|584162204|FG003|Overall Study|Withdrawal by Subject|0|||
161760448|NCT00027027|584162205|FG004|Overall Study|Withdrawal by Subject|1|||
161760449|NCT02306148|584162210|FG000|Overall Study|Adverse Event|12|||
161760450|NCT02306148|584162211|FG001|Overall Study|Adverse Event|6|||
161760451|NCT02306148|584162210|FG000|Overall Study|Lost to Follow-up|1|||
161760452|NCT02306148|584162211|FG001|Overall Study|Lost to Follow-up|4|||
161760453|NCT04397757|584162212|FG000|Overall Study|Death|3|||
161760454|NCT04397757|584162213|FG001|Overall Study|Death|11|||
161760455|NCT04397757|584162212|FG000|Overall Study|Withdrawal by Subject|2|||
161760456|NCT04397757|584162213|FG001|Overall Study|Withdrawal by Subject|0|||
161760457|NCT04397757|584162212|FG000|Overall Study|Lost to Follow-up|4|||
161760458|NCT04397757|584162213|FG001|Overall Study|Lost to Follow-up|3|||
161760459|NCT04657003|584162220|FG000|Overall Study|Adverse Event|5|||
161760460|NCT04657003|584162221|FG001|Overall Study|Adverse Event|1|||
161760461|NCT04657003|584162222|FG002|Overall Study|Adverse Event|5|||
161760462|NCT04657003|584162220|FG000|Overall Study|Death|0|||
161760463|NCT04657003|584162221|FG001|Overall Study|Death|2|||
161760464|NCT04657003|584162222|FG002|Overall Study|Death|0|||
161760465|NCT04657003|584162220|FG000|Overall Study|Lost to Follow-up|8|||
161760466|NCT04657003|584162221|FG001|Overall Study|Lost to Follow-up|4|||
161760467|NCT04657003|584162222|FG002|Overall Study|Lost to Follow-up|10|||
161760468|NCT04657003|584162220|FG000|Overall Study|Other - As Reported by Investigator|3|||
161760469|NCT04657003|584162221|FG001|Overall Study|Other - As Reported by Investigator|2|||
161760470|NCT04657003|584162222|FG002|Overall Study|Other - As Reported by Investigator|2|||
161760471|NCT04657003|584162220|FG000|Overall Study|Pregnancy|2|||
161760472|NCT04657003|584162221|FG001|Overall Study|Pregnancy|0|||
161760473|NCT04657003|584162222|FG002|Overall Study|Pregnancy|2|||
161760474|NCT04657003|584162220|FG000|Overall Study|Withdrawal by Subject|16|||
161760475|NCT04657003|584162221|FG001|Overall Study|Withdrawal by Subject|7|||
161760476|NCT04657003|584162222|FG002|Overall Study|Withdrawal by Subject|10|||
161760477|NCT05158244|584162225|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
161760478|NCT05158244|584162226|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760479|NCT05158244|584162227|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760480|NCT05158244|584162228|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760481|NCT05158244|584162229|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760482|NCT05158244|584162225|FG000|Overall Study|Withdrawal by Subject|0|||
161760483|NCT05158244|584162226|FG001|Overall Study|Withdrawal by Subject|0|||
161760484|NCT05158244|584162227|FG002|Overall Study|Withdrawal by Subject|1|||
161760485|NCT05158244|584162228|FG003|Overall Study|Withdrawal by Subject|0|||
161760486|NCT05158244|584162229|FG004|Overall Study|Withdrawal by Subject|0|||
161760487|NCT02408016|584162231|FG000|Overall Study|Death|6|||
161760488|NCT02408016|584162232|FG001|Overall Study|Death|1|||
161760489|NCT02408016|584162233|FG002|Overall Study|Death|0|||
161760490|NCT02408016|584162231|FG000|Overall Study|Physician Decision|0|||
161760491|NCT02408016|584162232|FG001|Overall Study|Physician Decision|2|||
161760492|NCT02408016|584162233|FG002|Overall Study|Physician Decision|0|||
161760493|NCT00775138|584162234|FG000|Overall Study|Withdrawal by Subject|0|||
161760494|NCT00775138|584162235|FG001|Overall Study|Withdrawal by Subject|0|||
161760495|NCT00775138|584162236|FG002|Overall Study|Withdrawal by Subject|2|||
161760496|NCT00775138|584162237|FG003|Overall Study|Withdrawal by Subject|2|||
161760497|NCT00775138|584162234|FG000|Overall Study|Adverse Event|0|||
161760498|NCT00775138|584162235|FG001|Overall Study|Adverse Event|0|||
161760499|NCT00775138|584162236|FG002|Overall Study|Adverse Event|1|||
161760500|NCT00775138|584162237|FG003|Overall Study|Adverse Event|0|||
161760501|NCT00712712|584162240|FG000|Overall Study|Protocol Violation|11|||
161760502|NCT00712712|584162240|FG000|Overall Study|Radiofrequency not done|3|||
161760503|NCT00712712|584162240|FG000|Overall Study|Death|8|||
161760504|NCT00712712|584162240|FG000|Overall Study|Withdrawal by Subject|1|||
161760505|NCT00958191|584162247|FG000|Overall Study|Death|4|||
161760506|NCT00958191|584162247|FG000|Overall Study|Lost to Follow-up|5|||
161760507|NCT00958191|584162247|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
161760508|NCT00958191|584162247|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
161760509|NCT00958191|584162247|FG000|Overall Study|Revision of study device|4|||
161760510|NCT00958191|584162247|FG000|Overall Study|Site termination|11|||
161760511|NCT00958191|584162247|FG000|Overall Study|No 5 yr x-rays|56|||
161760512|NCT01642004|584162248|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161760513|NCT01642004|584162249|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161760514|NCT01642004|584162248|FG000|Randomization|Participant withdrew consent|1|||
161760515|NCT01642004|584162249|FG001|Randomization|Participant withdrew consent|6|||
161760516|NCT01642004|584162248|FG000|Randomization|No longer meets study criteria|2|||
161760517|NCT01642004|584162249|FG001|Randomization|No longer meets study criteria|2|||
161760518|NCT01642004|584162248|FG000|Treatment|Disease progression|95|||
161760519|NCT01642004|584162249|FG001|Treatment|Disease progression|79|||
161760520|NCT01642004|584162248|FG000|Treatment|Study drug toxicity|10|||
161760521|NCT01642004|584162249|FG001|Treatment|Study drug toxicity|13|||
161760522|NCT01642004|584162248|FG000|Treatment|Death|1|||
161760523|NCT01642004|584162249|FG001|Treatment|Death|1|||
161760524|NCT01642004|584162248|FG000|Treatment|Adverse event unrelated to study drug|9|||
161760525|NCT01642004|584162249|FG001|Treatment|Adverse event unrelated to study drug|13|||
161760526|NCT01642004|584162248|FG000|Treatment|Maximum clinical benefit|1|||
161760527|NCT01642004|584162249|FG001|Treatment|Maximum clinical benefit|9|||
161760528|NCT01642004|584162248|FG000|Treatment|Poor/non-compliance|1|||
161760529|NCT01642004|584162249|FG001|Treatment|Poor/non-compliance|0|||
161760530|NCT01642004|584162248|FG000|Treatment|No longer meets study criteria|1|||
161760531|NCT01642004|584162249|FG001|Treatment|No longer meets study criteria|2|||
161760532|NCT01642004|584162248|FG000|Treatment|Other reasons|2|||
161760533|NCT01642004|584162249|FG001|Treatment|Other reasons|0|||
161760534|NCT01642004|584162248|FG000|Treatment|Not reported|0|||
161760535|NCT01642004|584162249|FG001|Treatment|Not reported|3|||
161760536|NCT01642004|584162248|FG000|Treatment|Participant request to discontinue study treatment|6|||
161760537|NCT01642004|584162249|FG001|Treatment|Participant request to discontinue study treatment|4|||
161760538|NCT01642004|584162248|FG000|Treatment|Participant withdrew consent|5|||
161760539|NCT01642004|584162249|FG001|Treatment|Participant withdrew consent|5|||
161760540|NCT02718625|584162250|FG000|Overall Study|Adverse Event|0|||
161760541|NCT02718625|584162251|FG001|Overall Study|Adverse Event|1|||
161760542|NCT02718625|584162250|FG000|Overall Study|Termination of Study by Sponsor|0|||
161760543|NCT02718625|584162251|FG001|Overall Study|Termination of Study by Sponsor|1|||
161760544|NCT01818765|584162254|FG000|Overall Study|Death|2|||
161760545|NCT00811395|584162255|FG000|Extension Treatment|Adverse Event|1|||
161760546|NCT00811395|584162256|FG001|Extension Treatment|Adverse Event|2|||
161760547|NCT00811395|584162257|FG002|Extension Treatment|Adverse Event|2|||
161760548|NCT00811395|584162258|FG003|Extension Treatment|Adverse Event|2|||
161760549|NCT00811395|584162259|FG004|Extension Treatment|Adverse Event|0|||
161760550|NCT00811395|584162260|FG005|Extension Treatment|Adverse Event|1|||
161760551|NCT00811395|584162255|FG000|Extension Treatment|Progressive disease|1|||
161760552|NCT00811395|584162256|FG001|Extension Treatment|Progressive disease|1|||
161760553|NCT00811395|584162257|FG002|Extension Treatment|Progressive disease|0|||
161760554|NCT00811395|584162258|FG003|Extension Treatment|Progressive disease|0|||
161760555|NCT00811395|584162259|FG004|Extension Treatment|Progressive disease|0|||
161760556|NCT00811395|584162260|FG005|Extension Treatment|Progressive disease|0|||
161760557|NCT00811395|584162255|FG000|Extension Treatment|Participant did not wish to continue|0|||
161760558|NCT00811395|584162256|FG001|Extension Treatment|Participant did not wish to continue|3|||
161760559|NCT00811395|584162257|FG002|Extension Treatment|Participant did not wish to continue|0|||
161760560|NCT00811395|584162258|FG003|Extension Treatment|Participant did not wish to continue|1|||
161760561|NCT00811395|584162259|FG004|Extension Treatment|Participant did not wish to continue|0|||
161760562|NCT00811395|584162260|FG005|Extension Treatment|Participant did not wish to continue|1|||
161760563|NCT00811395|584162255|FG000|Extension Treatment|Other than above|0|||
161760564|NCT00811395|584162256|FG001|Extension Treatment|Other than above|0|||
161760565|NCT00811395|584162257|FG002|Extension Treatment|Other than above|1|||
161760566|NCT00811395|584162258|FG003|Extension Treatment|Other than above|0|||
161847574|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760567|NCT00811395|584162259|FG004|Extension Treatment|Other than above|0|||
161760568|NCT00811395|584162260|FG005|Extension Treatment|Other than above|0|||
161760569|NCT01947127|584162261|FG000|Overall Study|Protocol Violation|18|||
161760570|NCT01947127|584162262|FG001|Overall Study|Protocol Violation|38|||
161760571|NCT01947127|584162261|FG000|Overall Study|Withdrawal by Subject|1|||
161760572|NCT01947127|584162262|FG001|Overall Study|Withdrawal by Subject|1|||
161760573|NCT01947127|584162261|FG000|Overall Study|Data loss|4|||
161760574|NCT01947127|584162262|FG001|Overall Study|Data loss|4|||
161760575|NCT01756833|584162265|FG000|Overall Study|Withdrawal by Subject|4|||
161760576|NCT01756833|584162266|FG001|Overall Study|Withdrawal by Subject|3|||
161760577|NCT00952588|584162267|FG000|Overall Study|Death|28|||
161760578|NCT00952588|584162268|FG001|Overall Study|Death|13|||
161760579|NCT00952588|584162267|FG000|Overall Study|Withdrawal by Subject|2|||
161760580|NCT00952588|584162268|FG001|Overall Study|Withdrawal by Subject|5|||
161760581|NCT00952588|584162267|FG000|Overall Study|Adverse Event|2|||
161760582|NCT00952588|584162268|FG001|Overall Study|Adverse Event|3|||
161760583|NCT00952588|584162267|FG000|Overall Study|Lost to Follow-up|2|||
161760584|NCT00952588|584162268|FG001|Overall Study|Lost to Follow-up|0|||
161760585|NCT00952588|584162267|FG000|Overall Study|Physician Decision|0|||
161760586|NCT00952588|584162268|FG001|Overall Study|Physician Decision|1|||
161760587|NCT00952588|584162267|FG000|Overall Study|Lack of Efficacy|2|||
161760588|NCT00952588|584162268|FG001|Overall Study|Lack of Efficacy|2|||
161760589|NCT00808132|584162269|FG000|Overall Study|Adverse Event|34|||
161760590|NCT00808132|584162270|FG001|Overall Study|Adverse Event|33|||
161760591|NCT00808132|584162271|FG002|Overall Study|Adverse Event|16|||
161760592|NCT00808132|584162272|FG003|Overall Study|Adverse Event|31|||
161760593|NCT00808132|584162273|FG004|Overall Study|Adverse Event|33|||
161760594|NCT00808132|584162269|FG000|Overall Study|Death|0|||
161760595|NCT00808132|584162270|FG001|Overall Study|Death|0|||
161760596|NCT00808132|584162271|FG002|Overall Study|Death|0|||
161760597|NCT00808132|584162272|FG003|Overall Study|Death|0|||
161760598|NCT00808132|584162273|FG004|Overall Study|Death|1|||
161760599|NCT00808132|584162269|FG000|Overall Study|Physician Decision|0|||
161760600|NCT00808132|584162270|FG001|Overall Study|Physician Decision|1|||
161760601|NCT00808132|584162271|FG002|Overall Study|Physician Decision|0|||
161760602|NCT00808132|584162272|FG003|Overall Study|Physician Decision|0|||
161760603|NCT00808132|584162273|FG004|Overall Study|Physician Decision|0|||
161760604|NCT00808132|584162269|FG000|Overall Study|Lost to Follow-up|8|||
161760605|NCT00808132|584162270|FG001|Overall Study|Lost to Follow-up|10|||
161760606|NCT00808132|584162271|FG002|Overall Study|Lost to Follow-up|11|||
161760607|NCT00808132|584162272|FG003|Overall Study|Lost to Follow-up|8|||
161760608|NCT00808132|584162273|FG004|Overall Study|Lost to Follow-up|9|||
161760609|NCT00808132|584162269|FG000|Overall Study|Protocol Violation|8|||
161760610|NCT00808132|584162270|FG001|Overall Study|Protocol Violation|9|||
161760611|NCT00808132|584162271|FG002|Overall Study|Protocol Violation|4|||
161760612|NCT00808132|584162272|FG003|Overall Study|Protocol Violation|9|||
161760613|NCT00808132|584162273|FG004|Overall Study|Protocol Violation|5|||
161760614|NCT00808132|584162269|FG000|Overall Study|Withdrawal by Subject|27|||
161760615|NCT00808132|584162270|FG001|Overall Study|Withdrawal by Subject|18|||
161760616|NCT00808132|584162271|FG002|Overall Study|Withdrawal by Subject|2|||
161760617|NCT00808132|584162272|FG003|Overall Study|Withdrawal by Subject|7|||
161760618|NCT00808132|584162273|FG004|Overall Study|Withdrawal by Subject|16|||
161760619|NCT00808132|584162269|FG000|Overall Study|Other|6|||
161760620|NCT00808132|584162270|FG001|Overall Study|Other|4|||
161760621|NCT00808132|584162271|FG002|Overall Study|Other|6|||
161760622|NCT00808132|584162272|FG003|Overall Study|Other|2|||
161760623|NCT00808132|584162273|FG004|Overall Study|Other|15|||
161760624|NCT00808132|584162269|FG000|Overall Study|Randomized, but not treated|10|||
161760625|NCT00808132|584162270|FG001|Overall Study|Randomized, but not treated|7|||
161760626|NCT00808132|584162271|FG002|Overall Study|Randomized, but not treated|9|||
161760627|NCT00808132|584162272|FG003|Overall Study|Randomized, but not treated|8|||
161760628|NCT00808132|584162273|FG004|Overall Study|Randomized, but not treated|9|||
161760629|NCT00808132|584162269|FG000|Overall Study|Unsatisfactory response|5|||
161760630|NCT00808132|584162270|FG001|Overall Study|Unsatisfactory response|6|||
161760631|NCT00808132|584162271|FG002|Overall Study|Unsatisfactory response|6|||
161760632|NCT00808132|584162272|FG003|Overall Study|Unsatisfactory response|4|||
161760633|NCT00808132|584162273|FG004|Overall Study|Unsatisfactory response|12|||
161760634|NCT00887913|584162276|FG000|Overall Study|Withdrawal by Subject|6|||
161760635|NCT01469637|584162277|FG000|First Intervention|Unacceptable behavior|0|||
161760636|NCT01469637|584162278|FG001|First Intervention|Unacceptable behavior|1|||
161760637|NCT01469637|584162277|FG000|Second Intervention|Incarcerated|1|||
161760638|NCT01469637|584162278|FG001|Second Intervention|Incarcerated|0|||
161760639|NCT01371721|584162279|FG000|Overall Study|Adverse Event|5|||
161760640|NCT01371721|584162280|FG001|Overall Study|Adverse Event|4|||
161760641|NCT01371721|584162281|FG002|Overall Study|Adverse Event|5|||
161760642|NCT01371721|584162279|FG000|Overall Study|Protocol Violation|6|||
161760643|NCT01371721|584162280|FG001|Overall Study|Protocol Violation|4|||
161760644|NCT01371721|584162281|FG002|Overall Study|Protocol Violation|5|||
161760645|NCT01371721|584162279|FG000|Overall Study|Lost to Follow-up|8|||
161760646|NCT01371721|584162280|FG001|Overall Study|Lost to Follow-up|2|||
161760647|NCT01371721|584162281|FG002|Overall Study|Lost to Follow-up|6|||
161760648|NCT01371721|584162279|FG000|Overall Study|Withdrawal by Subject|5|||
161760649|NCT01371721|584162280|FG001|Overall Study|Withdrawal by Subject|7|||
161760650|NCT01371721|584162281|FG002|Overall Study|Withdrawal by Subject|11|||
161760651|NCT01371721|584162279|FG000|Overall Study|Other|2|||
161760652|NCT01371721|584162280|FG001|Overall Study|Other|3|||
161760653|NCT01371721|584162281|FG002|Overall Study|Other|0|||
161760654|NCT01371721|584162279|FG000|Overall Study|Lack of Efficacy|2|||
161760655|NCT01371721|584162280|FG001|Overall Study|Lack of Efficacy|4|||
161760656|NCT01371721|584162281|FG002|Overall Study|Lack of Efficacy|3|||
161760657|NCT01371721|584162279|FG000|Overall Study|Randomized but not treated|1|||
161760658|NCT01371721|584162280|FG001|Overall Study|Randomized but not treated|0|||
161760659|NCT01371721|584162281|FG002|Overall Study|Randomized but not treated|0|||
161760660|NCT01055457|584162286|FG000|Overall Study|Lost to Follow-up|0|||
161760661|NCT01055457|584162287|FG001|Overall Study|Lost to Follow-up|1|||
161760662|NCT01055457|584162288|FG002|Overall Study|Lost to Follow-up|0|||
161760663|NCT01055457|584162289|FG003|Overall Study|Lost to Follow-up|0|||
161760664|NCT01055457|584162290|FG004|Overall Study|Lost to Follow-up|0|||
161760665|NCT01055457|584162291|FG005|Overall Study|Lost to Follow-up|1|||
161760666|NCT01055457|584162292|FG006|Overall Study|Lost to Follow-up|0|||
161760667|NCT01055457|584162293|FG007|Overall Study|Lost to Follow-up|0|||
161760668|NCT01055457|584162294|FG008|Overall Study|Lost to Follow-up|0|||
161760669|NCT01055457|584162295|FG009|Overall Study|Lost to Follow-up|0|||
161760670|NCT01055457|584162286|FG000|Overall Study|Protocol Violation|0|||
161760671|NCT01055457|584162287|FG001|Overall Study|Protocol Violation|0|||
161760672|NCT01055457|584162288|FG002|Overall Study|Protocol Violation|1|||
161760673|NCT01055457|584162289|FG003|Overall Study|Protocol Violation|1|||
161760674|NCT01055457|584162290|FG004|Overall Study|Protocol Violation|1|||
161760675|NCT01055457|584162291|FG005|Overall Study|Protocol Violation|2|||
161760676|NCT01055457|584162292|FG006|Overall Study|Protocol Violation|1|||
161760677|NCT01055457|584162293|FG007|Overall Study|Protocol Violation|0|||
161760678|NCT01055457|584162294|FG008|Overall Study|Protocol Violation|0|||
161760679|NCT01055457|584162295|FG009|Overall Study|Protocol Violation|1|||
161760680|NCT01055457|584162286|FG000|Overall Study|Subject Disinterest|0|||
161760681|NCT01055457|584162287|FG001|Overall Study|Subject Disinterest|0|||
161760682|NCT01055457|584162288|FG002|Overall Study|Subject Disinterest|0|||
161760683|NCT01055457|584162289|FG003|Overall Study|Subject Disinterest|0|||
161760684|NCT01055457|584162290|FG004|Overall Study|Subject Disinterest|0|||
161760685|NCT01055457|584162291|FG005|Overall Study|Subject Disinterest|0|||
161760686|NCT01055457|584162292|FG006|Overall Study|Subject Disinterest|0|||
161760687|NCT01055457|584162293|FG007|Overall Study|Subject Disinterest|1|||
161760688|NCT01055457|584162294|FG008|Overall Study|Subject Disinterest|0|||
161760689|NCT01055457|584162295|FG009|Overall Study|Subject Disinterest|0|||
161760690|NCT01055457|584162286|FG000|Overall Study|Subject Ineligible|1|||
161760691|NCT01055457|584162287|FG001|Overall Study|Subject Ineligible|0|||
161760692|NCT01055457|584162288|FG002|Overall Study|Subject Ineligible|1|||
161760693|NCT01055457|584162289|FG003|Overall Study|Subject Ineligible|0|||
161760694|NCT01055457|584162290|FG004|Overall Study|Subject Ineligible|1|||
161760695|NCT01055457|584162291|FG005|Overall Study|Subject Ineligible|0|||
161760696|NCT01055457|584162292|FG006|Overall Study|Subject Ineligible|0|||
161760697|NCT01055457|584162293|FG007|Overall Study|Subject Ineligible|0|||
161760698|NCT01055457|584162294|FG008|Overall Study|Subject Ineligible|0|||
161760699|NCT01055457|584162295|FG009|Overall Study|Subject Ineligible|0|||
161760700|NCT01055457|584162286|FG000|Overall Study|Discomfort|0|||
161760701|NCT01055457|584162287|FG001|Overall Study|Discomfort|0|||
161760702|NCT01055457|584162288|FG002|Overall Study|Discomfort|0|||
161760703|NCT01055457|584162289|FG003|Overall Study|Discomfort|0|||
161760704|NCT01055457|584162290|FG004|Overall Study|Discomfort|1|||
161760705|NCT01055457|584162291|FG005|Overall Study|Discomfort|0|||
161760706|NCT01055457|584162292|FG006|Overall Study|Discomfort|0|||
161760707|NCT01055457|584162293|FG007|Overall Study|Discomfort|0|||
161760708|NCT01055457|584162294|FG008|Overall Study|Discomfort|0|||
161760709|NCT01055457|584162295|FG009|Overall Study|Discomfort|0|||
161760710|NCT01055457|584162286|FG000|Overall Study|Pregnancy|0|||
161760711|NCT01055457|584162287|FG001|Overall Study|Pregnancy|0|||
161760712|NCT01055457|584162288|FG002|Overall Study|Pregnancy|0|||
161760713|NCT01055457|584162289|FG003|Overall Study|Pregnancy|1|||
161760714|NCT01055457|584162290|FG004|Overall Study|Pregnancy|0|||
161760715|NCT01055457|584162291|FG005|Overall Study|Pregnancy|0|||
161760716|NCT01055457|584162292|FG006|Overall Study|Pregnancy|0|||
161760717|NCT01055457|584162293|FG007|Overall Study|Pregnancy|0|||
161760718|NCT01055457|584162294|FG008|Overall Study|Pregnancy|0|||
161760719|NCT01055457|584162295|FG009|Overall Study|Pregnancy|0|||
161760720|NCT01055457|584162286|FG000|Overall Study|Adverse Event|0|||
161760721|NCT01055457|584162287|FG001|Overall Study|Adverse Event|0|||
161760722|NCT01055457|584162288|FG002|Overall Study|Adverse Event|0|||
161760723|NCT01055457|584162289|FG003|Overall Study|Adverse Event|1|||
161760724|NCT01055457|584162290|FG004|Overall Study|Adverse Event|0|||
161760725|NCT01055457|584162291|FG005|Overall Study|Adverse Event|0|||
161760726|NCT01055457|584162292|FG006|Overall Study|Adverse Event|0|||
161760727|NCT01055457|584162293|FG007|Overall Study|Adverse Event|0|||
161760728|NCT01055457|584162294|FG008|Overall Study|Adverse Event|0|||
161760729|NCT01055457|584162295|FG009|Overall Study|Adverse Event|0|||
161847575|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760730|NCT01347840|584162302|FG000|Overall Study|Withdrawal by Subject|1|||
161760731|NCT00415623|584162306|FG000|Overall Study|Adverse Event|3|||
161760732|NCT00415623|584162307|FG001|Overall Study|Adverse Event|4|||
161760733|NCT00415623|584162306|FG000|Overall Study|Death|1|||
161760734|NCT00415623|584162307|FG001|Overall Study|Death|0|||
161760735|NCT00415623|584162306|FG000|Overall Study|Withdrawal by Subject|1|||
161760736|NCT00415623|584162307|FG001|Overall Study|Withdrawal by Subject|1|||
161760737|NCT01708915|584162310|FG000|Overall Study|Adverse Event|1|||
161760738|NCT01708915|584162311|FG001|Overall Study|Adverse Event|0|||
161760739|NCT01708915|584162312|FG002|Overall Study|Adverse Event|9|||
161760740|NCT01708915|584162313|FG003|Overall Study|Adverse Event|13|||
161760741|NCT01708915|584162310|FG000|Overall Study|Lack of Efficacy|84|||
161760742|NCT01708915|584162311|FG001|Overall Study|Lack of Efficacy|60|||
161760743|NCT01708915|584162312|FG002|Overall Study|Lack of Efficacy|35|||
161760744|NCT01708915|584162313|FG003|Overall Study|Lack of Efficacy|15|||
161760745|NCT01708915|584162310|FG000|Overall Study|Protocol Violation|0|||
161760746|NCT01708915|584162311|FG001|Overall Study|Protocol Violation|0|||
161760747|NCT01708915|584162312|FG002|Overall Study|Protocol Violation|0|||
161760748|NCT01708915|584162313|FG003|Overall Study|Protocol Violation|1|||
161760749|NCT01708915|584162310|FG000|Overall Study|Withdrawal by Subject|0|||
161760750|NCT01708915|584162311|FG001|Overall Study|Withdrawal by Subject|1|||
161760751|NCT01708915|584162312|FG002|Overall Study|Withdrawal by Subject|2|||
161760752|NCT01708915|584162313|FG003|Overall Study|Withdrawal by Subject|2|||
161760753|NCT01708915|584162310|FG000|Overall Study|Other reasons than stated above|1|||
161760754|NCT01708915|584162311|FG001|Overall Study|Other reasons than stated above|1|||
161760755|NCT01708915|584162312|FG002|Overall Study|Other reasons than stated above|0|||
161760756|NCT01708915|584162313|FG003|Overall Study|Other reasons than stated above|2|||
161760757|NCT03267576|584162314|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
161760758|NCT03267576|584162315|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
161760759|NCT03267576|584162314|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
161760760|NCT03267576|584162315|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
161760761|NCT01369069|584162316|FG000|Overall Study|Lost to Follow-up|8|||
161760762|NCT01369069|584162317|FG001|Overall Study|Lost to Follow-up|9|||
161760763|NCT01369069|584162316|FG000|Overall Study|Withdrawal by Subject|9|||
161760764|NCT01369069|584162317|FG001|Overall Study|Withdrawal by Subject|7|||
161760765|NCT01268514|584162321|FG000|Overall Study|Adverse Event|20|||
161760766|NCT01268514|584162321|FG000|Overall Study|Death|8|||
161760767|NCT01268514|584162321|FG000|Overall Study|Lost to Follow-up|5|||
161760768|NCT01268514|584162321|FG000|Overall Study|Withdrawal by Subject|3|||
161760769|NCT01268514|584162321|FG000|Overall Study|Withdrawal by Surgeon|5|||
161760770|NCT02168816|584162324|FG000|Overall Study|Lost to Follow-up|2|||
161760771|NCT02168816|584162325|FG001|Overall Study|Lost to Follow-up|2|||
161760772|NCT02709889|584162328|FG000|Overall Study|Withdrawal by Subject|11|||
161760773|NCT02709889|584162329|FG001|Overall Study|Withdrawal by Subject|10|||
161760774|NCT02709889|584162330|FG002|Overall Study|Withdrawal by Subject|2|||
161760775|NCT02709889|584162331|FG003|Overall Study|Withdrawal by Subject|12|||
161760776|NCT02709889|584162328|FG000|Overall Study|Death|25|||
161760777|NCT02709889|584162329|FG001|Overall Study|Death|38|||
161760778|NCT02709889|584162330|FG002|Overall Study|Death|4|||
161760779|NCT02709889|584162331|FG003|Overall Study|Death|44|||
161760780|NCT02709889|584162328|FG000|Overall Study|Physician Decision|1|||
161760781|NCT02709889|584162329|FG001|Overall Study|Physician Decision|2|||
161760782|NCT02709889|584162330|FG002|Overall Study|Physician Decision|3|||
161760783|NCT02709889|584162331|FG003|Overall Study|Physician Decision|5|||
161760784|NCT02709889|584162328|FG000|Overall Study|Lost to Follow-up|2|||
161760785|NCT02709889|584162329|FG001|Overall Study|Lost to Follow-up|0|||
161760786|NCT02709889|584162330|FG002|Overall Study|Lost to Follow-up|0|||
161760787|NCT02709889|584162331|FG003|Overall Study|Lost to Follow-up|4|||
161760788|NCT02709889|584162328|FG000|Overall Study|Study Terminated by Sponsor|4|||
161760789|NCT02709889|584162329|FG001|Overall Study|Study Terminated by Sponsor|6|||
161760790|NCT02709889|584162330|FG002|Overall Study|Study Terminated by Sponsor|2|||
161760791|NCT02709889|584162331|FG003|Overall Study|Study Terminated by Sponsor|17|||
161760792|NCT02709889|584162328|FG000|Overall Study|Other, Not Specified|0|||
161760793|NCT02709889|584162329|FG001|Overall Study|Other, Not Specified|1|||
161760794|NCT02709889|584162330|FG002|Overall Study|Other, Not Specified|1|||
161760795|NCT02709889|584162331|FG003|Overall Study|Other, Not Specified|6|||
161760796|NCT01066546|584162332|FG000|Overall Study|Study terminated by sponsor|5|||
161760797|NCT00125268|584162337|FG000|Overall Study|Withdrawal by Subject|1|||
161760798|NCT00125268|584162338|FG001|Overall Study|Withdrawal by Subject|1|||
161760799|NCT00925522|584162339|FG000|Overall Study|study closed -- business decision|20|||
161760800|NCT02561572|584162344|FG000|Overall Study|Inadequate time before surgery|2|||
161760801|NCT02561572|584162345|FG001|Overall Study|Inadequate time before surgery|1|||
161760802|NCT02561572|584162344|FG000|Overall Study|Protocol Violation|0|||
161760803|NCT02561572|584162345|FG001|Overall Study|Protocol Violation|1|||
161760804|NCT02691468|584162346|FG000|Overall Study|Bronchial blocker use|2|||
161760805|NCT02691468|584162347|FG001|Overall Study|Bronchial blocker use|1|||
161760806|NCT02691468|584162346|FG000|Overall Study|Lost to Follow-up|2|||
161760807|NCT02691468|584162347|FG001|Overall Study|Lost to Follow-up|1|||
161760808|NCT02691468|584162346|FG000|Overall Study|Failure to advance FOB|2|||
161760809|NCT02691468|584162347|FG001|Overall Study|Failure to advance FOB|0|||
161760810|NCT01190020|584162350|FG000|Overall Study|Adverse Event|2|||
161760811|NCT01190020|584162351|FG001|Overall Study|Adverse Event|0|||
161847576|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847577|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760812|NCT01190020|584162350|FG000|Overall Study|Lost to Follow-up|2|||
161760813|NCT01190020|584162351|FG001|Overall Study|Lost to Follow-up|0|||
161760814|NCT01190020|584162350|FG000|Overall Study|Withdrawal by Subject|3|||
161760815|NCT01190020|584162351|FG001|Overall Study|Withdrawal by Subject|0|||
161760816|NCT00656799|584162356|FG000|Overall Study|Death|2|||
161760817|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
161760818|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161760819|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
161760820|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161760821|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161760822|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
161760823|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
161760824|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161760825|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
161760826|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
161760827|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
161760828|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
161760829|NCT02422186|584162357|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
161760830|NCT02422186|584162358|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
161760831|NCT02422186|584162357|FG000|Follow-up Phase (2 Weeks)|Other|3|||
161760832|NCT02422186|584162358|FG001|Follow-up Phase (2 Weeks)|Other|0|||
161760833|NCT05281094|584162359|FG000|Overall Study|Adverse Event|1|||
161760834|NCT05281094|584162360|FG001|Overall Study|Adverse Event|0|||
161760835|NCT05281094|584162359|FG000|Overall Study|Lost to Follow-up|29|||
161760836|NCT05281094|584162360|FG001|Overall Study|Lost to Follow-up|22|||
161760837|NCT05281094|584162359|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
161760838|NCT05281094|584162360|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
161760839|NCT05281094|584162359|FG000|Overall Study|Death|1|||
161760840|NCT05281094|584162360|FG001|Overall Study|Death|2|||
161760841|NCT05281094|584162359|FG000|Overall Study|Not pre-specified reason|8|||
161760842|NCT05281094|584162360|FG001|Overall Study|Not pre-specified reason|5|||
161760843|NCT04191096|584162361|FG000|Overall Study|Death|102|||
161760844|NCT04191096|584162362|FG001|Overall Study|Death|89|||
161760845|NCT04191096|584162361|FG000|Overall Study|Lost to Follow-up|1|||
161760846|NCT04191096|584162362|FG001|Overall Study|Lost to Follow-up|1|||
161760847|NCT04191096|584162361|FG000|Overall Study|Withdrawal by Subject|5|||
161760848|NCT04191096|584162362|FG001|Overall Study|Withdrawal by Subject|5|||
161760849|NCT04191096|584162361|FG000|Overall Study|Participants Ongoing|518|||
161760850|NCT04191096|584162362|FG001|Overall Study|Participants Ongoing|530|||
161760851|NCT02683668|584162366|FG000|Period 2|Withdrawal by Subject|0|||
161760852|NCT02683668|584162367|FG001|Period 2|Withdrawal by Subject|1|||
161760853|NCT02683668|584162368|FG002|Period 2|Withdrawal by Subject|0|||
161760854|NCT02390167|584164583|FG000|Overall Study|Lost to Follow-up|1|||
161760855|NCT01265719|584164585|FG000|Overall Study|Does not meet entrance criteria|0|||
161760856|NCT01265719|584164586|FG001|Overall Study|Does not meet entrance criteria|3|||
161760857|NCT01265719|584164585|FG000|Overall Study|Other reasons|2|||
161760858|NCT01265719|584164586|FG001|Overall Study|Other reasons|0|||
161760859|NCT01265719|584164585|FG000|Overall Study|Withdrawal by Subject|8|||
161760860|NCT01265719|584164586|FG001|Overall Study|Withdrawal by Subject|3|||
161760861|NCT01265719|584164585|FG000|Overall Study|Lost to Follow-up|2|||
161760862|NCT01265719|584164586|FG001|Overall Study|Lost to Follow-up|7|||
161760863|NCT01265719|584164585|FG000|Overall Study|Adverse Event|2|||
161760864|NCT01265719|584164586|FG001|Overall Study|Adverse Event|0|||
161760865|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161760866|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161760867|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161760868|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
161760869|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
161760870|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
161760871|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
161760872|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
161760873|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Death|0|||
161760874|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Death|0|||
161760875|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Death|0|||
161760876|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Death|1|||
161760877|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Death|1|||
161760878|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Death|0|||
161760879|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Death|2|||
161760880|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Death|0|||
161760881|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760882|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760883|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760884|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
161760885|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161847578|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847579|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
161760886|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760887|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760888|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760889|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760890|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760891|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760892|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
161760893|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760894|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760895|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760896|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760897|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760898|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760899|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760900|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
161760901|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760902|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
161760903|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760904|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
161760905|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760906|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760907|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760908|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
161760909|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760910|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
161760911|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
161760912|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760913|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760914|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760915|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760916|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760917|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
161760918|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760919|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
161760920|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
161760921|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760922|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760923|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760924|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760925|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
161760926|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760927|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760928|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
161760929|NCT00003389|584164595|FG000|Overall Study|Disease progression|6|||
161760930|NCT00003389|584164596|FG001|Overall Study|Disease progression|1|||
161760931|NCT00003389|584164595|FG000|Overall Study|Adverse Event|13|||
161760932|NCT00003389|584164596|FG001|Overall Study|Adverse Event|2|||
161760933|NCT00003389|584164595|FG000|Overall Study|Death|0|||
161760934|NCT00003389|584164596|FG001|Overall Study|Death|3|||
161760935|NCT00003389|584164595|FG000|Overall Study|Withdrawal by Subject|12|||
161760936|NCT00003389|584164596|FG001|Overall Study|Withdrawal by Subject|5|||
161760937|NCT00003389|584164595|FG000|Overall Study|Alternative therapy|2|||
161760938|NCT00003389|584164596|FG001|Overall Study|Alternative therapy|1|||
161760939|NCT00003389|584164595|FG000|Overall Study|Complicating disease|1|||
161760940|NCT00003389|584164596|FG001|Overall Study|Complicating disease|0|||
161760941|NCT00003389|584164595|FG000|Overall Study|Off-treatment reason missing|31|||
161760942|NCT00003389|584164596|FG001|Overall Study|Off-treatment reason missing|21|||
161760943|NCT00003389|584164595|FG000|Overall Study|Ineligible|33|||
161760944|NCT00003389|584164596|FG001|Overall Study|Ineligible|27|||
161760945|NCT02554721|584164597|FG000|Overall Study|Adverse Event|1|||
161760946|NCT02554721|584164598|FG001|Overall Study|Adverse Event|0|||
161760947|NCT02554721|584164599|FG002|Overall Study|Adverse Event|0|||
161760948|NCT02554721|584164600|FG003|Overall Study|Adverse Event|0|||
161760949|NCT02554721|584164601|FG004|Overall Study|Adverse Event|1|||
161760950|NCT02554721|584164597|FG000|Overall Study|Noncompliance|0|||
161760951|NCT02554721|584164598|FG001|Overall Study|Noncompliance|0|||
161760952|NCT02554721|584164599|FG002|Overall Study|Noncompliance|0|||
161760953|NCT02554721|584164600|FG003|Overall Study|Noncompliance|0|||
161847580|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760954|NCT02554721|584164601|FG004|Overall Study|Noncompliance|1|||
161760955|NCT01693562|584164604|FG000|Escalation Phase|Withdrawal by Subject|0|||
161760956|NCT01693562|584164605|FG001|Escalation Phase|Withdrawal by Subject|1|||
161760957|NCT01693562|584164606|FG002|Escalation Phase|Withdrawal by Subject|0|||
161760958|NCT01693562|584164607|FG003|Escalation Phase|Withdrawal by Subject|0|||
161760959|NCT01693562|584164608|FG004|Escalation Phase|Withdrawal by Subject|0|||
161760960|NCT01693562|584164609|FG005|Escalation Phase|Withdrawal by Subject|2|||
161760961|NCT01693562|584164610|FG006|Escalation Phase|Withdrawal by Subject|0|||
161760962|NCT01693562|584164611|FG007|Escalation Phase|Withdrawal by Subject|0|||
161760963|NCT01693562|584164612|FG008|Escalation Phase|Withdrawal by Subject|0|||
161760964|NCT01693562|584164613|FG009|Escalation Phase|Withdrawal by Subject|0|||
161760965|NCT01693562|584164614|FG010|Escalation Phase|Withdrawal by Subject|0|||
161760966|NCT01693562|584164615|FG011|Escalation Phase|Withdrawal by Subject|0|||
161760967|NCT01693562|584164616|FG012|Escalation Phase|Withdrawal by Subject|0|||
161760968|NCT01693562|584164617|FG013|Escalation Phase|Withdrawal by Subject|0|||
161760969|NCT01693562|584164618|FG014|Escalation Phase|Withdrawal by Subject|0|||
161760970|NCT01693562|584164619|FG015|Escalation Phase|Withdrawal by Subject|0|||
161760971|NCT01693562|584164620|FG016|Escalation Phase|Withdrawal by Subject|0|||
161760972|NCT01693562|584164621|FG017|Escalation Phase|Withdrawal by Subject|0|||
161760973|NCT01693562|584164622|FG018|Escalation Phase|Withdrawal by Subject|0|||
161760974|NCT01693562|584164623|FG019|Escalation Phase|Withdrawal by Subject|0|||
161760975|NCT01693562|584164624|FG020|Escalation Phase|Withdrawal by Subject|0|||
161760976|NCT01693562|584164625|FG021|Escalation Phase|Withdrawal by Subject|0|||
161760977|NCT01693562|584164626|FG022|Escalation Phase|Withdrawal by Subject|0|||
161760978|NCT01693562|584164604|FG000|Escalation Phase|Death|4|||
161760979|NCT01693562|584164605|FG001|Escalation Phase|Death|2|||
161760980|NCT01693562|584164606|FG002|Escalation Phase|Death|0|||
161760981|NCT01693562|584164607|FG003|Escalation Phase|Death|3|||
161760982|NCT01693562|584164608|FG004|Escalation Phase|Death|6|||
161760983|NCT01693562|584164609|FG005|Escalation Phase|Death|4|||
161760984|NCT01693562|584164610|FG006|Escalation Phase|Death|0|||
161760985|NCT01693562|584164611|FG007|Escalation Phase|Death|0|||
161760986|NCT01693562|584164612|FG008|Escalation Phase|Death|0|||
161760987|NCT01693562|584164613|FG009|Escalation Phase|Death|0|||
161760988|NCT01693562|584164614|FG010|Escalation Phase|Death|0|||
161760989|NCT01693562|584164615|FG011|Escalation Phase|Death|0|||
161760990|NCT01693562|584164616|FG012|Escalation Phase|Death|0|||
161760991|NCT01693562|584164617|FG013|Escalation Phase|Death|0|||
161760992|NCT01693562|584164618|FG014|Escalation Phase|Death|0|||
161760993|NCT01693562|584164619|FG015|Escalation Phase|Death|0|||
161760994|NCT01693562|584164620|FG016|Escalation Phase|Death|0|||
161760995|NCT01693562|584164621|FG017|Escalation Phase|Death|0|||
161760996|NCT01693562|584164622|FG018|Escalation Phase|Death|0|||
161760997|NCT01693562|584164623|FG019|Escalation Phase|Death|0|||
161760998|NCT01693562|584164624|FG020|Escalation Phase|Death|0|||
161760999|NCT01693562|584164625|FG021|Escalation Phase|Death|0|||
161761000|NCT01693562|584164626|FG022|Escalation Phase|Death|0|||
161761001|NCT01693562|584164604|FG000|Escalation Phase|Lost to Follow-up|0|||
161761002|NCT01693562|584164605|FG001|Escalation Phase|Lost to Follow-up|1|||
161761003|NCT01693562|584164606|FG002|Escalation Phase|Lost to Follow-up|1|||
161761004|NCT01693562|584164607|FG003|Escalation Phase|Lost to Follow-up|0|||
161761005|NCT01693562|584164608|FG004|Escalation Phase|Lost to Follow-up|0|||
161761006|NCT01693562|584164609|FG005|Escalation Phase|Lost to Follow-up|0|||
161761007|NCT01693562|584164610|FG006|Escalation Phase|Lost to Follow-up|0|||
161761008|NCT01693562|584164611|FG007|Escalation Phase|Lost to Follow-up|0|||
161761009|NCT01693562|584164612|FG008|Escalation Phase|Lost to Follow-up|0|||
161761010|NCT01693562|584164613|FG009|Escalation Phase|Lost to Follow-up|0|||
161761011|NCT01693562|584164614|FG010|Escalation Phase|Lost to Follow-up|0|||
161761012|NCT01693562|584164615|FG011|Escalation Phase|Lost to Follow-up|0|||
161761013|NCT01693562|584164616|FG012|Escalation Phase|Lost to Follow-up|0|||
161761014|NCT01693562|584164617|FG013|Escalation Phase|Lost to Follow-up|0|||
161761015|NCT01693562|584164618|FG014|Escalation Phase|Lost to Follow-up|0|||
161761016|NCT01693562|584164619|FG015|Escalation Phase|Lost to Follow-up|0|||
161761017|NCT01693562|584164620|FG016|Escalation Phase|Lost to Follow-up|0|||
161761018|NCT01693562|584164621|FG017|Escalation Phase|Lost to Follow-up|0|||
161761019|NCT01693562|584164622|FG018|Escalation Phase|Lost to Follow-up|0|||
161761020|NCT01693562|584164623|FG019|Escalation Phase|Lost to Follow-up|0|||
161761021|NCT01693562|584164624|FG020|Escalation Phase|Lost to Follow-up|0|||
161761022|NCT01693562|584164625|FG021|Escalation Phase|Lost to Follow-up|0|||
161761023|NCT01693562|584164626|FG022|Escalation Phase|Lost to Follow-up|0|||
161761024|NCT01693562|584164604|FG000|Escalation Phase|Other|0|||
161761025|NCT01693562|584164605|FG001|Escalation Phase|Other|0|||
161761026|NCT01693562|584164606|FG002|Escalation Phase|Other|2|||
161761027|NCT01693562|584164607|FG003|Escalation Phase|Other|0|||
161761028|NCT01693562|584164608|FG004|Escalation Phase|Other|0|||
161761029|NCT01693562|584164609|FG005|Escalation Phase|Other|1|||
161761030|NCT01693562|584164610|FG006|Escalation Phase|Other|0|||
161761031|NCT01693562|584164611|FG007|Escalation Phase|Other|0|||
161761032|NCT01693562|584164612|FG008|Escalation Phase|Other|0|||
161761033|NCT01693562|584164613|FG009|Escalation Phase|Other|0|||
161761034|NCT01693562|584164614|FG010|Escalation Phase|Other|0|||
161761035|NCT01693562|584164615|FG011|Escalation Phase|Other|0|||
161761036|NCT01693562|584164616|FG012|Escalation Phase|Other|0|||
161761037|NCT01693562|584164617|FG013|Escalation Phase|Other|0|||
161761038|NCT01693562|584164618|FG014|Escalation Phase|Other|0|||
161761039|NCT01693562|584164619|FG015|Escalation Phase|Other|0|||
161761040|NCT01693562|584164620|FG016|Escalation Phase|Other|0|||
161761041|NCT01693562|584164621|FG017|Escalation Phase|Other|0|||
161761042|NCT01693562|584164622|FG018|Escalation Phase|Other|0|||
161761043|NCT01693562|584164623|FG019|Escalation Phase|Other|0|||
161761044|NCT01693562|584164624|FG020|Escalation Phase|Other|0|||
161761045|NCT01693562|584164625|FG021|Escalation Phase|Other|0|||
161761046|NCT01693562|584164626|FG022|Escalation Phase|Other|0|||
161761047|NCT01693562|584164604|FG000|Exploration Phase|Withdrawal by Subject|0|||
161761048|NCT01693562|584164605|FG001|Exploration Phase|Withdrawal by Subject|0|||
161761049|NCT01693562|584164606|FG002|Exploration Phase|Withdrawal by Subject|0|||
161761050|NCT01693562|584164607|FG003|Exploration Phase|Withdrawal by Subject|0|||
161761051|NCT01693562|584164608|FG004|Exploration Phase|Withdrawal by Subject|0|||
161761052|NCT01693562|584164609|FG005|Exploration Phase|Withdrawal by Subject|0|||
161761053|NCT01693562|584164610|FG006|Exploration Phase|Withdrawal by Subject|2|||
161761054|NCT01693562|584164611|FG007|Exploration Phase|Withdrawal by Subject|0|||
161761055|NCT01693562|584164612|FG008|Exploration Phase|Withdrawal by Subject|0|||
161761056|NCT01693562|584164613|FG009|Exploration Phase|Withdrawal by Subject|0|||
161761057|NCT01693562|584164614|FG010|Exploration Phase|Withdrawal by Subject|0|||
161761058|NCT01693562|584164615|FG011|Exploration Phase|Withdrawal by Subject|0|||
161761059|NCT01693562|584164616|FG012|Exploration Phase|Withdrawal by Subject|0|||
161761060|NCT01693562|584164617|FG013|Exploration Phase|Withdrawal by Subject|0|||
161761061|NCT01693562|584164618|FG014|Exploration Phase|Withdrawal by Subject|0|||
161761062|NCT01693562|584164619|FG015|Exploration Phase|Withdrawal by Subject|0|||
161761063|NCT01693562|584164620|FG016|Exploration Phase|Withdrawal by Subject|0|||
161761064|NCT01693562|584164621|FG017|Exploration Phase|Withdrawal by Subject|0|||
161761065|NCT01693562|584164622|FG018|Exploration Phase|Withdrawal by Subject|0|||
161761066|NCT01693562|584164623|FG019|Exploration Phase|Withdrawal by Subject|0|||
161761067|NCT01693562|584164624|FG020|Exploration Phase|Withdrawal by Subject|0|||
161761068|NCT01693562|584164625|FG021|Exploration Phase|Withdrawal by Subject|0|||
161761069|NCT01693562|584164626|FG022|Exploration Phase|Withdrawal by Subject|0|||
161761070|NCT01693562|584164604|FG000|Exploration Phase|Death|0|||
161761071|NCT01693562|584164605|FG001|Exploration Phase|Death|0|||
161761072|NCT01693562|584164606|FG002|Exploration Phase|Death|0|||
161761073|NCT01693562|584164607|FG003|Exploration Phase|Death|0|||
161761074|NCT01693562|584164608|FG004|Exploration Phase|Death|0|||
161761075|NCT01693562|584164609|FG005|Exploration Phase|Death|0|||
161761076|NCT01693562|584164610|FG006|Exploration Phase|Death|17|||
161761077|NCT01693562|584164611|FG007|Exploration Phase|Death|0|||
161761078|NCT01693562|584164612|FG008|Exploration Phase|Death|0|||
161761079|NCT01693562|584164613|FG009|Exploration Phase|Death|0|||
161761080|NCT01693562|584164614|FG010|Exploration Phase|Death|0|||
161761081|NCT01693562|584164615|FG011|Exploration Phase|Death|0|||
161761082|NCT01693562|584164616|FG012|Exploration Phase|Death|0|||
161761083|NCT01693562|584164617|FG013|Exploration Phase|Death|0|||
161761084|NCT01693562|584164618|FG014|Exploration Phase|Death|0|||
161761085|NCT01693562|584164619|FG015|Exploration Phase|Death|0|||
161761086|NCT01693562|584164620|FG016|Exploration Phase|Death|0|||
161761087|NCT01693562|584164621|FG017|Exploration Phase|Death|0|||
161761088|NCT01693562|584164622|FG018|Exploration Phase|Death|0|||
161761089|NCT01693562|584164623|FG019|Exploration Phase|Death|0|||
161761090|NCT01693562|584164624|FG020|Exploration Phase|Death|0|||
161761091|NCT01693562|584164625|FG021|Exploration Phase|Death|0|||
161761092|NCT01693562|584164626|FG022|Exploration Phase|Death|0|||
161761093|NCT01693562|584164604|FG000|Exploration Phase|Other|0|||
161761094|NCT01693562|584164605|FG001|Exploration Phase|Other|0|||
161761095|NCT01693562|584164606|FG002|Exploration Phase|Other|0|||
161761096|NCT01693562|584164607|FG003|Exploration Phase|Other|0|||
161761097|NCT01693562|584164608|FG004|Exploration Phase|Other|0|||
161761098|NCT01693562|584164609|FG005|Exploration Phase|Other|0|||
161761099|NCT01693562|584164610|FG006|Exploration Phase|Other|2|||
161761100|NCT01693562|584164611|FG007|Exploration Phase|Other|0|||
161761101|NCT01693562|584164612|FG008|Exploration Phase|Other|0|||
161761102|NCT01693562|584164613|FG009|Exploration Phase|Other|0|||
161761103|NCT01693562|584164614|FG010|Exploration Phase|Other|0|||
161761104|NCT01693562|584164615|FG011|Exploration Phase|Other|0|||
161761105|NCT01693562|584164616|FG012|Exploration Phase|Other|0|||
161761106|NCT01693562|584164617|FG013|Exploration Phase|Other|0|||
161761107|NCT01693562|584164618|FG014|Exploration Phase|Other|0|||
161761108|NCT01693562|584164619|FG015|Exploration Phase|Other|0|||
161761109|NCT01693562|584164620|FG016|Exploration Phase|Other|0|||
161761110|NCT01693562|584164621|FG017|Exploration Phase|Other|0|||
161761111|NCT01693562|584164622|FG018|Exploration Phase|Other|0|||
161761112|NCT01693562|584164623|FG019|Exploration Phase|Other|0|||
161761113|NCT01693562|584164624|FG020|Exploration Phase|Other|0|||
161761114|NCT01693562|584164625|FG021|Exploration Phase|Other|0|||
161761115|NCT01693562|584164626|FG022|Exploration Phase|Other|0|||
161761116|NCT01693562|584164604|FG000|Expansion Phase|Withdrawal by Subject|0|||
161761117|NCT01693562|584164605|FG001|Expansion Phase|Withdrawal by Subject|0|||
161761118|NCT01693562|584164606|FG002|Expansion Phase|Withdrawal by Subject|0|||
161761119|NCT01693562|584164607|FG003|Expansion Phase|Withdrawal by Subject|0|||
161761120|NCT01693562|584164608|FG004|Expansion Phase|Withdrawal by Subject|0|||
161761121|NCT01693562|584164609|FG005|Expansion Phase|Withdrawal by Subject|0|||
161761122|NCT01693562|584164610|FG006|Expansion Phase|Withdrawal by Subject|0|||
161761123|NCT01693562|584164611|FG007|Expansion Phase|Withdrawal by Subject|16|||
161761124|NCT01693562|584164612|FG008|Expansion Phase|Withdrawal by Subject|2|||
161761125|NCT01693562|584164613|FG009|Expansion Phase|Withdrawal by Subject|54|||
161761126|NCT01693562|584164614|FG010|Expansion Phase|Withdrawal by Subject|2|||
161761127|NCT01693562|584164615|FG011|Expansion Phase|Withdrawal by Subject|2|||
161761128|NCT01693562|584164616|FG012|Expansion Phase|Withdrawal by Subject|3|||
161761129|NCT01693562|584164617|FG013|Expansion Phase|Withdrawal by Subject|5|||
161761130|NCT01693562|584164618|FG014|Expansion Phase|Withdrawal by Subject|16|||
161761131|NCT01693562|584164619|FG015|Expansion Phase|Withdrawal by Subject|7|||
161761132|NCT01693562|584164620|FG016|Expansion Phase|Withdrawal by Subject|40|||
161761133|NCT01693562|584164621|FG017|Expansion Phase|Withdrawal by Subject|4|||
161761134|NCT01693562|584164622|FG018|Expansion Phase|Withdrawal by Subject|8|||
161761135|NCT01693562|584164623|FG019|Expansion Phase|Withdrawal by Subject|3|||
161761136|NCT01693562|584164624|FG020|Expansion Phase|Withdrawal by Subject|1|||
161761137|NCT01693562|584164625|FG021|Expansion Phase|Withdrawal by Subject|8|||
161761138|NCT01693562|584164626|FG022|Expansion Phase|Withdrawal by Subject|1|||
161761139|NCT01693562|584164604|FG000|Expansion Phase|Death|0|||
161761140|NCT01693562|584164605|FG001|Expansion Phase|Death|0|||
161761141|NCT01693562|584164606|FG002|Expansion Phase|Death|0|||
161761142|NCT01693562|584164607|FG003|Expansion Phase|Death|0|||
161761143|NCT01693562|584164608|FG004|Expansion Phase|Death|0|||
161761144|NCT01693562|584164609|FG005|Expansion Phase|Death|0|||
161761145|NCT01693562|584164610|FG006|Expansion Phase|Death|0|||
161761146|NCT01693562|584164611|FG007|Expansion Phase|Death|42|||
161761147|NCT01693562|584164612|FG008|Expansion Phase|Death|17|||
161761148|NCT01693562|584164613|FG009|Expansion Phase|Death|208|||
161761149|NCT01693562|584164614|FG010|Expansion Phase|Death|30|||
161761150|NCT01693562|584164615|FG011|Expansion Phase|Death|8|||
161761151|NCT01693562|584164616|FG012|Expansion Phase|Death|19|||
161761152|NCT01693562|584164617|FG013|Expansion Phase|Death|42|||
161761153|NCT01693562|584164618|FG014|Expansion Phase|Death|23|||
161761154|NCT01693562|584164619|FG015|Expansion Phase|Death|23|||
161761155|NCT01693562|584164620|FG016|Expansion Phase|Death|128|||
161761156|NCT01693562|584164621|FG017|Expansion Phase|Death|16|||
161761157|NCT01693562|584164622|FG018|Expansion Phase|Death|36|||
161761158|NCT01693562|584164623|FG019|Expansion Phase|Death|16|||
161761159|NCT01693562|584164624|FG020|Expansion Phase|Death|17|||
161761160|NCT01693562|584164625|FG021|Expansion Phase|Death|35|||
161761161|NCT01693562|584164626|FG022|Expansion Phase|Death|7|||
161761162|NCT01693562|584164604|FG000|Expansion Phase|Lost to Follow-up|0|||
161761163|NCT01693562|584164605|FG001|Expansion Phase|Lost to Follow-up|0|||
161761164|NCT01693562|584164606|FG002|Expansion Phase|Lost to Follow-up|0|||
161761165|NCT01693562|584164607|FG003|Expansion Phase|Lost to Follow-up|0|||
161761166|NCT01693562|584164608|FG004|Expansion Phase|Lost to Follow-up|0|||
161761167|NCT01693562|584164609|FG005|Expansion Phase|Lost to Follow-up|0|||
161761168|NCT01693562|584164610|FG006|Expansion Phase|Lost to Follow-up|0|||
161761169|NCT01693562|584164611|FG007|Expansion Phase|Lost to Follow-up|1|||
161761170|NCT01693562|584164612|FG008|Expansion Phase|Lost to Follow-up|2|||
161761171|NCT01693562|584164613|FG009|Expansion Phase|Lost to Follow-up|10|||
161761172|NCT01693562|584164614|FG010|Expansion Phase|Lost to Follow-up|4|||
161761173|NCT01693562|584164615|FG011|Expansion Phase|Lost to Follow-up|4|||
161761174|NCT01693562|584164616|FG012|Expansion Phase|Lost to Follow-up|1|||
161761175|NCT01693562|584164617|FG013|Expansion Phase|Lost to Follow-up|3|||
161761176|NCT01693562|584164618|FG014|Expansion Phase|Lost to Follow-up|0|||
161761177|NCT01693562|584164619|FG015|Expansion Phase|Lost to Follow-up|1|||
161761178|NCT01693562|584164620|FG016|Expansion Phase|Lost to Follow-up|1|||
161761179|NCT01693562|584164621|FG017|Expansion Phase|Lost to Follow-up|0|||
161761180|NCT01693562|584164622|FG018|Expansion Phase|Lost to Follow-up|2|||
161761181|NCT01693562|584164623|FG019|Expansion Phase|Lost to Follow-up|1|||
161761182|NCT01693562|584164624|FG020|Expansion Phase|Lost to Follow-up|2|||
161761183|NCT01693562|584164625|FG021|Expansion Phase|Lost to Follow-up|2|||
161761184|NCT01693562|584164626|FG022|Expansion Phase|Lost to Follow-up|1|||
161761185|NCT01693562|584164604|FG000|Expansion Phase|Other|0|||
161761186|NCT01693562|584164605|FG001|Expansion Phase|Other|0|||
161761187|NCT01693562|584164606|FG002|Expansion Phase|Other|0|||
161761188|NCT01693562|584164607|FG003|Expansion Phase|Other|0|||
161761189|NCT01693562|584164608|FG004|Expansion Phase|Other|0|||
161761190|NCT01693562|584164609|FG005|Expansion Phase|Other|0|||
161761191|NCT01693562|584164610|FG006|Expansion Phase|Other|0|||
161761192|NCT01693562|584164611|FG007|Expansion Phase|Other|3|||
161761193|NCT01693562|584164612|FG008|Expansion Phase|Other|1|||
161761194|NCT01693562|584164613|FG009|Expansion Phase|Other|28|||
161761195|NCT01693562|584164614|FG010|Expansion Phase|Other|4|||
161761196|NCT01693562|584164615|FG011|Expansion Phase|Other|7|||
161761197|NCT01693562|584164616|FG012|Expansion Phase|Other|0|||
161761198|NCT01693562|584164617|FG013|Expansion Phase|Other|1|||
161761199|NCT01693562|584164618|FG014|Expansion Phase|Other|1|||
161761200|NCT01693562|584164619|FG015|Expansion Phase|Other|0|||
161761201|NCT01693562|584164620|FG016|Expansion Phase|Other|28|||
161761202|NCT01693562|584164621|FG017|Expansion Phase|Other|0|||
161761203|NCT01693562|584164622|FG018|Expansion Phase|Other|1|||
161761204|NCT01693562|584164623|FG019|Expansion Phase|Other|0|||
161761205|NCT01693562|584164624|FG020|Expansion Phase|Other|1|||
161761206|NCT01693562|584164625|FG021|Expansion Phase|Other|17|||
161761207|NCT01693562|584164626|FG022|Expansion Phase|Other|1|||
161761208|NCT05466240|584164628|FG000|Overall Study|Adverse Event|1|||
161761209|NCT05466240|584164629|FG001|Overall Study|Adverse Event|0|||
161761210|NCT05466240|584164628|FG000|Overall Study|Withdrawal by Subject|1|||
161761211|NCT05466240|584164629|FG001|Overall Study|Withdrawal by Subject|0|||
161847581|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847582|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161761212|NCT02759939|584164630|FG000|Overall Study|Missing data on first outcome assessed|11|||
161847583|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847584|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847585|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847586|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847587|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847588|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847589|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847590|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
161847591|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847592|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
161847593|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
161847594|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847595|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847596|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847597|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847598|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847599|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161761213|NCT02759939|584164631|FG001|Overall Study|Missing data on first outcome assessed|2|||
161761214|NCT02759939|584164632|FG002|Overall Study|Missing data on first outcome assessed|5|||
161761215|NCT02759939|584164633|FG003|Overall Study|Missing data on first outcome assessed|2|||
161761216|NCT02759939|584164630|FG000|Overall Study|Ineligible for T2 and T3|310|||
161761217|NCT02759939|584164631|FG001|Overall Study|Ineligible for T2 and T3|179|||
161761218|NCT02759939|584164632|FG002|Overall Study|Ineligible for T2 and T3|366|||
161761219|NCT02759939|584164633|FG003|Overall Study|Ineligible for T2 and T3|391|||
161761220|NCT02759939|584164630|FG000|Overall Study|Lost to Follow-up|735|||
161761221|NCT02759939|584164631|FG001|Overall Study|Lost to Follow-up|791|||
161761222|NCT02759939|584164632|FG002|Overall Study|Lost to Follow-up|783|||
161761223|NCT02759939|584164633|FG003|Overall Study|Lost to Follow-up|650|||
161761224|NCT04735432|584164636|FG000|Overall Study|Other - due to personal reason|1|||
161761225|NCT04735432|584164637|FG001|Overall Study|Other - due to personal reason|0|||
161761226|NCT04735432|584164636|FG000|Overall Study|Adverse Event|2|||
161761227|NCT04735432|584164637|FG001|Overall Study|Adverse Event|0|||
161761228|NCT00626327|584164638|FG000|Overall Study|Withdrawal by Subject|21|||
161761229|NCT00626327|584164639|FG001|Overall Study|Withdrawal by Subject|29|||
161761230|NCT00626327|584164640|FG002|Overall Study|Withdrawal by Subject|30|||
161761231|NCT00626327|584164638|FG000|Overall Study|Adverse Event|1|||
161761232|NCT00626327|584164639|FG001|Overall Study|Adverse Event|0|||
161761233|NCT00626327|584164640|FG002|Overall Study|Adverse Event|0|||
161761234|NCT00626327|584164638|FG000|Overall Study|Lost to Follow-up|24|||
161761235|NCT00626327|584164639|FG001|Overall Study|Lost to Follow-up|21|||
161761236|NCT00626327|584164640|FG002|Overall Study|Lost to Follow-up|23|||
161761237|NCT00626327|584164638|FG000|Overall Study|Inappropriate enrollment|4|||
161761238|NCT00626327|584164639|FG001|Overall Study|Inappropriate enrollment|5|||
161761239|NCT00626327|584164640|FG002|Overall Study|Inappropriate enrollment|3|||
161761240|NCT00626327|584164638|FG000|Overall Study|Administrative Reason|2|||
161761241|NCT00626327|584164639|FG001|Overall Study|Administrative Reason|0|||
161761242|NCT00626327|584164640|FG002|Overall Study|Administrative Reason|6|||
161761243|NCT00626327|584164638|FG000|Overall Study|Protocol Violation|26|||
161761244|NCT00626327|584164639|FG001|Overall Study|Protocol Violation|4|||
161761245|NCT00626327|584164640|FG002|Overall Study|Protocol Violation|26|||
161761246|NCT00945945|584164641|FG000|Overall Study|Adverse Event|15|||
161761247|NCT00945945|584164642|FG001|Overall Study|Adverse Event|35|||
161761248|NCT00945945|584164641|FG000|Overall Study|Withdrawal by Subject|7|||
161761249|NCT00945945|584164642|FG001|Overall Study|Withdrawal by Subject|10|||
161761250|NCT00945945|584164641|FG000|Overall Study|Lost to Follow-up|4|||
161761251|NCT00945945|584164642|FG001|Overall Study|Lost to Follow-up|5|||
161761252|NCT00945945|584164641|FG000|Overall Study|Lack of Efficacy|6|||
161761253|NCT00945945|584164642|FG001|Overall Study|Lack of Efficacy|2|||
161761254|NCT00945945|584164641|FG000|Overall Study|Protocol Violation|4|||
161761255|NCT00945945|584164642|FG001|Overall Study|Protocol Violation|2|||
161761256|NCT00945945|584164641|FG000|Overall Study|Entry Criteria Not Met|0|||
161761257|NCT00945945|584164642|FG001|Overall Study|Entry Criteria Not Met|1|||
161761258|NCT03347279|584164645|FG000|Overall Study|Withdrawal by Subject|8|||
161761259|NCT03347279|584164646|FG001|Overall Study|Withdrawal by Subject|15|||
161761260|NCT03347279|584164645|FG000|Overall Study|Death|0|||
161761261|NCT03347279|584164646|FG001|Overall Study|Death|2|||
161761262|NCT03347279|584164645|FG000|Overall Study|Lost to Follow-up|5|||
161761263|NCT03347279|584164646|FG001|Overall Study|Lost to Follow-up|2|||
161761264|NCT03347279|584164645|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
161761265|NCT03347279|584164646|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
161761266|NCT03818399|584164647|FG000|Overall Study|Lost to Follow-up|11|||
161761267|NCT03818399|584164647|FG000|Overall Study|Withdrawal by Subject|1|||
161761268|NCT03818399|584164647|FG000|Overall Study|Protocol Violation|2|||
161761269|NCT04880642|584164648|FG000|Randomization|Withdrawal by Subject|2|||
161761270|NCT04880642|584164649|FG001|Randomization|Withdrawal by Subject|3|||
161761271|NCT04880642|584164648|FG000|Treatment Period|Adverse Event|0|||
161761272|NCT04880642|584164649|FG001|Treatment Period|Adverse Event|1|||
161761273|NCT04880642|584164648|FG000|Treatment Period|Death|6|||
161761274|NCT04880642|584164649|FG001|Treatment Period|Death|6|||
161761275|NCT04880642|584164648|FG000|Treatment Period|Lost to Follow-up|1|||
161761276|NCT04880642|584164649|FG001|Treatment Period|Lost to Follow-up|0|||
161761277|NCT04880642|584164648|FG000|Treatment Period|Protocol Violation|0|||
161761278|NCT04880642|584164649|FG001|Treatment Period|Protocol Violation|1|||
161761279|NCT04880642|584164648|FG000|Treatment Period|Withdrawal by Subject|5|||
161761280|NCT04880642|584164649|FG001|Treatment Period|Withdrawal by Subject|3|||
161761281|NCT04880642|584164648|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
161761282|NCT04880642|584164649|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
161761283|NCT04880642|584164648|FG000|Follow-up|Death|4|||
161761284|NCT04880642|584164649|FG001|Follow-up|Death|3|||
161761285|NCT04880642|584164648|FG000|Follow-up|Withdrawal by Subject|1|||
161761286|NCT04880642|584164649|FG001|Follow-up|Withdrawal by Subject|0|||
161761287|NCT00141297|584164651|FG000|Overall Study|Adverse Event|0|||
161761288|NCT00141297|584164652|FG001|Overall Study|Adverse Event|0|||
161761289|NCT00141297|584164653|FG002|Overall Study|Adverse Event|1|||
161761290|NCT00141297|584164654|FG003|Overall Study|Adverse Event|0|||
161761291|NCT00141297|584164655|FG004|Overall Study|Adverse Event|1|||
161761292|NCT00141297|584164656|FG005|Overall Study|Adverse Event|1|||
161761293|NCT00141297|584164657|FG006|Overall Study|Adverse Event|0|||
161761294|NCT00141297|584164658|FG007|Overall Study|Adverse Event|1|||
161761295|NCT00141297|584164659|FG008|Overall Study|Adverse Event|1|||
161761296|NCT00141297|584164660|FG009|Overall Study|Adverse Event|0|||
161761297|NCT00141297|584164651|FG000|Overall Study|Death|1|||
161761298|NCT00141297|584164652|FG001|Overall Study|Death|0|||
161761299|NCT00141297|584164653|FG002|Overall Study|Death|0|||
161761300|NCT00141297|584164654|FG003|Overall Study|Death|0|||
161761301|NCT00141297|584164655|FG004|Overall Study|Death|0|||
161761302|NCT00141297|584164656|FG005|Overall Study|Death|0|||
161761303|NCT00141297|584164657|FG006|Overall Study|Death|0|||
161761304|NCT00141297|584164658|FG007|Overall Study|Death|0|||
161761305|NCT00141297|584164659|FG008|Overall Study|Death|1|||
161761306|NCT00141297|584164660|FG009|Overall Study|Death|0|||
161761307|NCT00141297|584164651|FG000|Overall Study|Withdrawal by Subject|0|||
161761308|NCT00141297|584164652|FG001|Overall Study|Withdrawal by Subject|0|||
161761309|NCT00141297|584164653|FG002|Overall Study|Withdrawal by Subject|0|||
161761310|NCT00141297|584164654|FG003|Overall Study|Withdrawal by Subject|0|||
161761311|NCT00141297|584164655|FG004|Overall Study|Withdrawal by Subject|0|||
161761312|NCT00141297|584164656|FG005|Overall Study|Withdrawal by Subject|0|||
161761313|NCT00141297|584164657|FG006|Overall Study|Withdrawal by Subject|0|||
161761314|NCT00141297|584164658|FG007|Overall Study|Withdrawal by Subject|0|||
161761315|NCT00141297|584164659|FG008|Overall Study|Withdrawal by Subject|1|||
161761316|NCT00141297|584164660|FG009|Overall Study|Withdrawal by Subject|0|||
161761317|NCT00141297|584164651|FG000|Overall Study|Other|0|||
161761318|NCT00141297|584164652|FG001|Overall Study|Other|0|||
161761319|NCT00141297|584164653|FG002|Overall Study|Other|0|||
161761320|NCT00141297|584164654|FG003|Overall Study|Other|1|||
161761321|NCT00141297|584164655|FG004|Overall Study|Other|5|||
161761322|NCT00141297|584164656|FG005|Overall Study|Other|0|||
161761323|NCT00141297|584164657|FG006|Overall Study|Other|0|||
161761324|NCT00141297|584164658|FG007|Overall Study|Other|0|||
161761325|NCT00141297|584164659|FG008|Overall Study|Other|2|||
161761326|NCT00141297|584164660|FG009|Overall Study|Other|0|||
161761327|NCT00141297|584164651|FG000|Overall Study|Progressive Disease|2|||
161761328|NCT00141297|584164652|FG001|Overall Study|Progressive Disease|3|||
161761329|NCT00141297|584164653|FG002|Overall Study|Progressive Disease|6|||
161761330|NCT00141297|584164654|FG003|Overall Study|Progressive Disease|2|||
161761331|NCT00141297|584164655|FG004|Overall Study|Progressive Disease|15|||
161761332|NCT00141297|584164656|FG005|Overall Study|Progressive Disease|2|||
161761333|NCT00141297|584164657|FG006|Overall Study|Progressive Disease|3|||
161761334|NCT00141297|584164658|FG007|Overall Study|Progressive Disease|3|||
161761335|NCT00141297|584164659|FG008|Overall Study|Progressive Disease|15|||
161761336|NCT00141297|584164660|FG009|Overall Study|Progressive Disease|6|||
161761337|NCT00141297|584164651|FG000|Overall Study|Transitioned|0|||
161761338|NCT00141297|584164652|FG001|Overall Study|Transitioned|0|||
161761339|NCT00141297|584164653|FG002|Overall Study|Transitioned|0|||
161761340|NCT00141297|584164654|FG003|Overall Study|Transitioned|0|||
161761341|NCT00141297|584164655|FG004|Overall Study|Transitioned|1|||
161761342|NCT00141297|584164656|FG005|Overall Study|Transitioned|0|||
161761343|NCT00141297|584164657|FG006|Overall Study|Transitioned|0|||
161761344|NCT00141297|584164658|FG007|Overall Study|Transitioned|0|||
161761345|NCT00141297|584164659|FG008|Overall Study|Transitioned|0|||
161761346|NCT00141297|584164660|FG009|Overall Study|Transitioned|0|||
161761347|NCT02987205|584164661|FG000|Overall Study|Adverse Event|1|||
161761348|NCT02987205|584164661|FG000|Overall Study|Withdrawal by Subject|3|||
161761349|NCT02807376|584164663|FG000|Overall Study|Intra-operative exclusion criteria|3|||
161761350|NCT02807376|584164664|FG001|Overall Study|Intra-operative exclusion criteria|0|||
161761351|NCT02807376|584164663|FG000|Overall Study|Lost to Follow-up|0|||
161761352|NCT02807376|584164664|FG001|Overall Study|Lost to Follow-up|1|||
161761353|NCT03228836|584164667|FG000|Overall Study|Adverse Event|3|||
161761354|NCT03228836|584164667|FG000|Overall Study|Withdrawal by Subject|1|||
161761355|NCT03228836|584164667|FG000|Overall Study|Death|1|||
161761356|NCT03228836|584164667|FG000|Overall Study|Physician Decision|1|||
161761357|NCT03228836|584164667|FG000|Overall Study|Disease Progression|7|||
161761358|NCT03228836|584164667|FG000|Overall Study|Other|4|||
161761359|NCT00948389|584164668|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
161761360|NCT00948389|584164669|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
161761361|NCT00948389|584164670|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
161761362|NCT00948389|584164671|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
161761363|NCT00948389|584164672|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
161761364|NCT00948389|584164668|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
161761365|NCT00948389|584164669|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
161761366|NCT00948389|584164670|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
161761367|NCT00948389|584164671|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
161761368|NCT00948389|584164672|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
161761369|NCT00948389|584164668|FG000|Overall Study|Both Progression and Toxicity|1|||
161761370|NCT00948389|584164669|FG001|Overall Study|Both Progression and Toxicity|0|||
161761371|NCT00948389|584164670|FG002|Overall Study|Both Progression and Toxicity|0|||
161761372|NCT00948389|584164671|FG003|Overall Study|Both Progression and Toxicity|0|||
161761373|NCT00948389|584164672|FG004|Overall Study|Both Progression and Toxicity|0|||
161761374|NCT03018340|584164685|FG000|Overall Study|Adverse Event|1|||
161761375|NCT03018340|584164686|FG001|Overall Study|Adverse Event|2|||
161761376|NCT03018340|584164685|FG000|Overall Study|Withdrawal by Subject|0|||
161761377|NCT03018340|584164686|FG001|Overall Study|Withdrawal by Subject|8|||
161761378|NCT03018340|584164685|FG000|Overall Study|Lack of Efficacy|0|||
161761379|NCT03018340|584164686|FG001|Overall Study|Lack of Efficacy|1|||
161761380|NCT03018340|584164685|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
161761381|NCT03018340|584164686|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
161761382|NCT03018340|584164685|FG000|Overall Study|Lost to Follow-up|1|||
161761383|NCT03018340|584164686|FG001|Overall Study|Lost to Follow-up|7|||
161761384|NCT03018340|584164685|FG000|Overall Study|Protocol Violation|3|||
161761385|NCT03018340|584164686|FG001|Overall Study|Protocol Violation|7|||
161761386|NCT03018340|584164685|FG000|Overall Study|Not further specified|0|||
161761387|NCT03018340|584164686|FG001|Overall Study|Not further specified|1|||
161761388|NCT04652102|584164687|FG000|Overall Study|Adverse Event|14|||
161761389|NCT04652102|584164688|FG001|Overall Study|Adverse Event|13|||
161761390|NCT04652102|584164687|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
161761391|NCT04652102|584164688|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
161761392|NCT04652102|584164687|FG000|Overall Study|Physician Decision|78|||
161761393|NCT04652102|584164688|FG001|Overall Study|Physician Decision|40|||
161761394|NCT04652102|584164687|FG000|Overall Study|Study Ended by Sponsor|64|||
161761395|NCT04652102|584164688|FG001|Overall Study|Study Ended by Sponsor|17|||
161761396|NCT04652102|584164687|FG000|Overall Study|Withdrawal by Subject|4625|||
161761397|NCT04652102|584164688|FG001|Overall Study|Withdrawal by Subject|5594|||
161761398|NCT04652102|584164687|FG000|Overall Study|Lost to Follow-up|2019|||
161761399|NCT04652102|584164688|FG001|Overall Study|Lost to Follow-up|1082|||
161761400|NCT04652102|584164687|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
161761401|NCT04652102|584164688|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
161761402|NCT04652102|584164687|FG000|Overall Study|Miscellaneous|80|||
161761403|NCT04652102|584164688|FG001|Overall Study|Miscellaneous|64|||
161761404|NCT02192190|584164689|FG000|Overall Study|Adverse Event|1|||
161761405|NCT02192190|584164690|FG001|Overall Study|Adverse Event|1|||
161761406|NCT02192190|584164691|FG002|Overall Study|Adverse Event|0|||
161761407|NCT02192190|584164692|FG003|Overall Study|Adverse Event|0|||
161761408|NCT02192190|584164693|FG004|Overall Study|Adverse Event|0|||
161761409|NCT02192190|584164694|FG005|Overall Study|Adverse Event|0|||
161761410|NCT02192190|584164689|FG000|Overall Study|Lost to Follow-up|3|||
161761411|NCT02192190|584164690|FG001|Overall Study|Lost to Follow-up|3|||
161761412|NCT02192190|584164691|FG002|Overall Study|Lost to Follow-up|2|||
161761413|NCT02192190|584164692|FG003|Overall Study|Lost to Follow-up|1|||
161761414|NCT02192190|584164693|FG004|Overall Study|Lost to Follow-up|4|||
161761415|NCT02192190|584164694|FG005|Overall Study|Lost to Follow-up|3|||
161761416|NCT02192190|584164689|FG000|Overall Study|Physician Decision|2|||
161761417|NCT02192190|584164690|FG001|Overall Study|Physician Decision|0|||
161761418|NCT02192190|584164691|FG002|Overall Study|Physician Decision|0|||
161761419|NCT02192190|584164692|FG003|Overall Study|Physician Decision|0|||
161761420|NCT02192190|584164693|FG004|Overall Study|Physician Decision|0|||
161761421|NCT02192190|584164694|FG005|Overall Study|Physician Decision|0|||
161761422|NCT02192190|584164689|FG000|Overall Study|Terminated by Sponsor|43|||
161761423|NCT02192190|584164690|FG001|Overall Study|Terminated by Sponsor|23|||
161761424|NCT02192190|584164691|FG002|Overall Study|Terminated by Sponsor|20|||
161761425|NCT02192190|584164692|FG003|Overall Study|Terminated by Sponsor|23|||
161761426|NCT02192190|584164693|FG004|Overall Study|Terminated by Sponsor|21|||
161761427|NCT02192190|584164694|FG005|Overall Study|Terminated by Sponsor|23|||
161761428|NCT02192190|584164689|FG000|Overall Study|Withdrawal by Subject|4|||
161761429|NCT02192190|584164690|FG001|Overall Study|Withdrawal by Subject|1|||
161761430|NCT02192190|584164691|FG002|Overall Study|Withdrawal by Subject|2|||
161761431|NCT02192190|584164692|FG003|Overall Study|Withdrawal by Subject|1|||
161761432|NCT02192190|584164693|FG004|Overall Study|Withdrawal by Subject|5|||
161761433|NCT02192190|584164694|FG005|Overall Study|Withdrawal by Subject|3|||
161761434|NCT02192190|584164689|FG000|Overall Study|Could not Keep Visit Schedule|1|||
161761435|NCT02192190|584164690|FG001|Overall Study|Could not Keep Visit Schedule|0|||
161761436|NCT02192190|584164691|FG002|Overall Study|Could not Keep Visit Schedule|0|||
161761437|NCT02192190|584164692|FG003|Overall Study|Could not Keep Visit Schedule|0|||
161761438|NCT02192190|584164693|FG004|Overall Study|Could not Keep Visit Schedule|0|||
161761439|NCT02192190|584164694|FG005|Overall Study|Could not Keep Visit Schedule|0|||
161761440|NCT02192190|584164689|FG000|Overall Study|Positive Drug Screen|0|||
161761441|NCT02192190|584164690|FG001|Overall Study|Positive Drug Screen|0|||
161761442|NCT02192190|584164691|FG002|Overall Study|Positive Drug Screen|0|||
161761443|NCT02192190|584164692|FG003|Overall Study|Positive Drug Screen|1|||
161761444|NCT02192190|584164693|FG004|Overall Study|Positive Drug Screen|0|||
161761445|NCT02192190|584164694|FG005|Overall Study|Positive Drug Screen|0|||
161761446|NCT02192190|584164689|FG000|Overall Study|Inadequate Pain Relief|0|||
161761447|NCT02192190|584164690|FG001|Overall Study|Inadequate Pain Relief|1|||
161761448|NCT02192190|584164691|FG002|Overall Study|Inadequate Pain Relief|1|||
161761449|NCT02192190|584164692|FG003|Overall Study|Inadequate Pain Relief|0|||
161761450|NCT02192190|584164693|FG004|Overall Study|Inadequate Pain Relief|0|||
161761451|NCT02192190|584164694|FG005|Overall Study|Inadequate Pain Relief|0|||
161761452|NCT00890201|584164695|FG000|Overall Study|Protocol Violation|5|||
161761453|NCT00890201|584164696|FG001|Overall Study|Protocol Violation|56|||
161761454|NCT01846208|584164697|FG000|Overall Study|Withdrew prior to treatment|1|||
161761455|NCT01846208|584164698|FG001|Overall Study|Withdrew prior to treatment|1|||
161761456|NCT01846208|584164699|FG002|Overall Study|Withdrew prior to treatment|1|||
161761457|NCT01846208|584164697|FG000|Overall Study|Dosing Symptoms|1|||
161761458|NCT01846208|584164698|FG001|Overall Study|Dosing Symptoms|2|||
161761459|NCT01846208|584164699|FG002|Overall Study|Dosing Symptoms|6|||
161761460|NCT01846208|584164697|FG000|Overall Study|Withdrawal by Subject|5|||
161761461|NCT01846208|584164698|FG001|Overall Study|Withdrawal by Subject|0|||
161761462|NCT01846208|584164699|FG002|Overall Study|Withdrawal by Subject|0|||
161761463|NCT01846208|584164697|FG000|Overall Study|Non-compliance|1|||
161761464|NCT01846208|584164698|FG001|Overall Study|Non-compliance|1|||
161761465|NCT01846208|584164699|FG002|Overall Study|Non-compliance|0|||
161761466|NCT01846208|584164697|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
161761467|NCT01846208|584164698|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
161761468|NCT01846208|584164699|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
161761469|NCT01846208|584164697|FG000|Overall Study|Refused SU OFC|0|||
161761470|NCT01846208|584164698|FG001|Overall Study|Refused SU OFC|0|||
161761471|NCT01846208|584164699|FG002|Overall Study|Refused SU OFC|1|||
161761472|NCT01432938|584164700|FG000|First Intervention|Protocol Violation|1|||
161761473|NCT01432938|584164701|FG001|First Intervention|Protocol Violation|0|||
161761474|NCT01432938|584164700|FG000|First Intervention|Physician Decision|1|||
161761475|NCT01432938|584164701|FG001|First Intervention|Physician Decision|0|||
161761476|NCT01432938|584164700|FG000|Second Intervention|Adverse Event|1|||
161761477|NCT01432938|584164701|FG001|Second Intervention|Adverse Event|0|||
161761478|NCT01424306|584164702|FG000|Overall Study|Protocol Violation|0|||
161761479|NCT01424306|584164703|FG001|Overall Study|Protocol Violation|0|||
161761480|NCT01424306|584164704|FG002|Overall Study|Protocol Violation|0|||
161761481|NCT01424306|584164705|FG003|Overall Study|Protocol Violation|0|||
161761482|NCT01424306|584164706|FG004|Overall Study|Protocol Violation|1|||
161761483|NCT01424306|584164707|FG005|Overall Study|Protocol Violation|0|||
161761484|NCT01875874|584164711|FG000|Overall Study|Death|3|||
161761485|NCT01601873|584164712|FG000|Overall Study|Lost to Follow-up|2|||
161761486|NCT01601873|584164713|FG001|Overall Study|Lost to Follow-up|3|||
161761487|NCT00374127|584164714|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
161761488|NCT00374127|584164714|FG000|Overall Study|Blood could not be drawn.|2|||
161761489|NCT00374127|584164714|FG000|Overall Study|Protocol Violation|5|||
161761490|NCT00374127|584164714|FG000|Overall Study|Pregnancy|1|||
161761491|NCT00281528|584164718|FG000|Overall Study|Progressive Disease|28|||
161761492|NCT00281528|584164719|FG001|Overall Study|Progressive Disease|18|||
161761493|NCT00281528|584164720|FG002|Overall Study|Progressive Disease|27|||
161761494|NCT00281528|584164718|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
161761495|NCT00281528|584164719|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
161761496|NCT00281528|584164720|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
161761497|NCT00281528|584164718|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
161761498|NCT00281528|584164719|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
161761499|NCT00281528|584164720|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
161761500|NCT00281528|584164718|FG000|Overall Study|Physician Decision|11|||
161761501|NCT00281528|584164719|FG001|Overall Study|Physician Decision|4|||
161761502|NCT00281528|584164720|FG002|Overall Study|Physician Decision|5|||
161761503|NCT00281528|584164718|FG000|Overall Study|Protocol Violation|1|||
161761504|NCT00281528|584164719|FG001|Overall Study|Protocol Violation|0|||
161761505|NCT00281528|584164720|FG002|Overall Study|Protocol Violation|1|||
161761506|NCT00281528|584164718|FG000|Overall Study|Withdrawal by Subject|5|||
161761507|NCT00281528|584164719|FG001|Overall Study|Withdrawal by Subject|5|||
161761508|NCT00281528|584164720|FG002|Overall Study|Withdrawal by Subject|7|||
161761509|NCT00281528|584164718|FG000|Overall Study|Other|6|||
161761510|NCT00281528|584164719|FG001|Overall Study|Other|3|||
161761511|NCT00281528|584164720|FG002|Overall Study|Other|5|||
161761512|NCT02520141|584164723|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
161761513|NCT00703781|584164724|FG000|Overall Study|Withdrawal by Subject|1|||
161761514|NCT00703781|584164725|FG001|Overall Study|Withdrawal by Subject|2|||
161761515|NCT00703781|584164724|FG000|Overall Study|Cancelled surgery|1|||
161761516|NCT00703781|584164725|FG001|Overall Study|Cancelled surgery|0|||
161761517|NCT01225211|584164726|FG000|Overall Study|Adverse Event|0|||
161761518|NCT01225211|584164727|FG001|Overall Study|Adverse Event|0|||
161761519|NCT01225211|584164728|FG002|Overall Study|Adverse Event|1|||
161761520|NCT01225211|584164729|FG003|Overall Study|Adverse Event|0|||
161761521|NCT01225211|584164730|FG004|Overall Study|Adverse Event|0|||
161761522|NCT01225211|584164731|FG005|Overall Study|Adverse Event|0|||
161761523|NCT01225211|584164732|FG006|Overall Study|Adverse Event|0|||
161761524|NCT01225211|584164733|FG007|Overall Study|Adverse Event|0|||
161761525|NCT01225211|584164734|FG008|Overall Study|Adverse Event|0|||
161761526|NCT01225211|584164735|FG009|Overall Study|Adverse Event|1|||
161761527|NCT01225211|584164726|FG000|Overall Study|Withdrawal by Subject|0|||
161761528|NCT01225211|584164727|FG001|Overall Study|Withdrawal by Subject|0|||
161761529|NCT01225211|584164728|FG002|Overall Study|Withdrawal by Subject|0|||
161761530|NCT01225211|584164729|FG003|Overall Study|Withdrawal by Subject|0|||
161761531|NCT01225211|584164730|FG004|Overall Study|Withdrawal by Subject|0|||
161761532|NCT01225211|584164731|FG005|Overall Study|Withdrawal by Subject|0|||
161761533|NCT01225211|584164732|FG006|Overall Study|Withdrawal by Subject|1|||
161761534|NCT01225211|584164733|FG007|Overall Study|Withdrawal by Subject|0|||
161761535|NCT01225211|584164734|FG008|Overall Study|Withdrawal by Subject|1|||
161761536|NCT01225211|584164735|FG009|Overall Study|Withdrawal by Subject|3|||
161761537|NCT01225211|584164726|FG000|Overall Study|Other|0|||
161761538|NCT01225211|584164727|FG001|Overall Study|Other|0|||
161761539|NCT01225211|584164728|FG002|Overall Study|Other|0|||
161761540|NCT01225211|584164729|FG003|Overall Study|Other|0|||
161761541|NCT01225211|584164730|FG004|Overall Study|Other|0|||
161761542|NCT01225211|584164731|FG005|Overall Study|Other|0|||
161761543|NCT01225211|584164732|FG006|Overall Study|Other|0|||
161761544|NCT01225211|584164733|FG007|Overall Study|Other|0|||
161761545|NCT01225211|584164734|FG008|Overall Study|Other|0|||
161761546|NCT01225211|584164735|FG009|Overall Study|Other|1|||
161761547|NCT01984294|584164740|FG000|Overall Study|Randomized but Never Treated|0|||
161761548|NCT01984294|584164741|FG001|Overall Study|Randomized but Never Treated|0|||
161761549|NCT01984294|584164742|FG002|Overall Study|Randomized but Never Treated|1|||
161761550|NCT01984294|584164740|FG000|Overall Study|Lack of Efficacy|4|||
161761551|NCT01984294|584164741|FG001|Overall Study|Lack of Efficacy|2|||
161761552|NCT01984294|584164742|FG002|Overall Study|Lack of Efficacy|6|||
161761553|NCT01984294|584164740|FG000|Overall Study|Adverse Event|0|||
161761554|NCT01984294|584164741|FG001|Overall Study|Adverse Event|1|||
161761555|NCT01984294|584164742|FG002|Overall Study|Adverse Event|0|||
161761556|NCT01987609|584164745|FG000|Overall Study|Adverse Event|1|||
161761557|NCT00537810|584164750|FG000|Overall Study|Withdrawal by Subject|4|||
161761558|NCT00537810|584164751|FG001|Overall Study|Withdrawal by Subject|11|||
161761559|NCT00537810|584164752|FG002|Overall Study|Withdrawal by Subject|4|||
161761560|NCT00537810|584164753|FG003|Overall Study|Withdrawal by Subject|3|||
161761561|NCT00537810|584164750|FG000|Overall Study|Medically withdrawn|2|||
161761562|NCT00537810|584164751|FG001|Overall Study|Medically withdrawn|2|||
161761563|NCT00537810|584164752|FG002|Overall Study|Medically withdrawn|0|||
161761564|NCT00537810|584164753|FG003|Overall Study|Medically withdrawn|1|||
161761565|NCT03452397|584164754|FG000|Overall Study|Adverse Event|1|||
161761566|NCT03452397|584164755|FG001|Overall Study|Adverse Event|0|||
161761567|NCT03452397|584164756|FG002|Overall Study|Adverse Event|0|||
161761568|NCT03452397|584164757|FG003|Overall Study|Adverse Event|0|||
161761569|NCT03452397|584164754|FG000|Overall Study|Administrative reason|0|||
161761570|NCT03452397|584164755|FG001|Overall Study|Administrative reason|0|||
161761571|NCT03452397|584164756|FG002|Overall Study|Administrative reason|1|||
161761572|NCT03452397|584164757|FG003|Overall Study|Administrative reason|1|||
161761573|NCT03452397|584164754|FG000|Overall Study|Withdrawal by Subject|0|||
161761574|NCT03452397|584164755|FG001|Overall Study|Withdrawal by Subject|0|||
161761575|NCT03452397|584164756|FG002|Overall Study|Withdrawal by Subject|1|||
161761576|NCT03452397|584164757|FG003|Overall Study|Withdrawal by Subject|0|||
161761577|NCT00410514|584164758|FG000|Overall Study|Adverse Event|2|||
161761578|NCT00410514|584164759|FG001|Overall Study|Adverse Event|2|||
161761579|NCT00410514|584164760|FG002|Overall Study|Adverse Event|2|||
161761580|NCT00410514|584164758|FG000|Overall Study|Protocol Violation|0|||
161761581|NCT00410514|584164759|FG001|Overall Study|Protocol Violation|1|||
161761582|NCT00410514|584164760|FG002|Overall Study|Protocol Violation|1|||
161761583|NCT00410514|584164758|FG000|Overall Study|Lost to Follow-up|0|||
161761584|NCT00410514|584164759|FG001|Overall Study|Lost to Follow-up|0|||
161761585|NCT00410514|584164760|FG002|Overall Study|Lost to Follow-up|2|||
161761586|NCT00410514|584164758|FG000|Overall Study|Non-compliant with study procedures|0|||
161761587|NCT00410514|584164759|FG001|Overall Study|Non-compliant with study procedures|0|||
161761588|NCT00410514|584164760|FG002|Overall Study|Non-compliant with study procedures|2|||
161761589|NCT02449915|584164762|FG000|Overall Study|Exclusion criteria - drug use|1|||
161761590|NCT02449915|584164763|FG001|Overall Study|Exclusion criteria - drug use|0|||
161761591|NCT02449915|584164762|FG000|Overall Study|Withdrawal by Subject|0|||
161761592|NCT02449915|584164763|FG001|Overall Study|Withdrawal by Subject|2|||
161761593|NCT02449915|584164762|FG000|Overall Study|Intraoperative surgical findings|1|||
161761594|NCT02449915|584164763|FG001|Overall Study|Intraoperative surgical findings|1|||
161761595|NCT02449915|584164762|FG000|Overall Study|Abnormal preop lab|0|||
161761596|NCT02449915|584164763|FG001|Overall Study|Abnormal preop lab|1|||
161761597|NCT01436357|584164764|FG000|Overall Study|Death|5|||
161761598|NCT01436357|584164765|FG001|Overall Study|Death|1|||
161761599|NCT01436357|584164764|FG000|Overall Study|Enrolled but not vaccinated|1|||
161761600|NCT01436357|584164765|FG001|Overall Study|Enrolled but not vaccinated|1|||
161761601|NCT01436357|584164764|FG000|Overall Study|Incarceration|18|||
161761602|NCT01436357|584164765|FG001|Overall Study|Incarceration|20|||
161761603|NCT01436357|584164764|FG000|Overall Study|Lost to Follow-up|67|||
161847600|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161761604|NCT01436357|584164765|FG001|Overall Study|Lost to Follow-up|61|||
161761605|NCT01436357|584164764|FG000|Overall Study|Protocol Violation|1|||
161847601|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847602|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847603|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847604|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161761606|NCT01436357|584164765|FG001|Overall Study|Protocol Violation|0|||
161761607|NCT01436357|584164764|FG000|Overall Study|Withdrawal by Subject|26|||
161761608|NCT01436357|584164765|FG001|Overall Study|Withdrawal by Subject|38|||
161761609|NCT01436357|584164764|FG000|Overall Study|Physician Decision|3|||
161761610|NCT01436357|584164765|FG001|Overall Study|Physician Decision|4|||
161761611|NCT01436357|584164764|FG000|Overall Study|Moved out of area|1|||
161761612|NCT01436357|584164765|FG001|Overall Study|Moved out of area|2|||
161761613|NCT01436357|584164764|FG000|Overall Study|Subject in rehab|0|||
161761614|NCT01436357|584164765|FG001|Overall Study|Subject in rehab|1|||
161761615|NCT04223778|584164776|FG000|Overall Study|Death|1|||
161761616|NCT04223778|584164777|FG001|Overall Study|Death|1|||
161761617|NCT04223778|584164776|FG000|Overall Study|Lost to Follow-up|4|||
161761618|NCT04223778|584164777|FG001|Overall Study|Lost to Follow-up|5|||
161761619|NCT04223778|584164776|FG000|Overall Study|Physician Decision|10|||
161761620|NCT04223778|584164777|FG001|Overall Study|Physician Decision|6|||
161761621|NCT04223778|584164776|FG000|Overall Study|Withdrawal by Subject|35|||
161761622|NCT04223778|584164777|FG001|Overall Study|Withdrawal by Subject|17|||
161761623|NCT04223778|584164776|FG000|Overall Study|Not Reported|7|||
161761624|NCT04223778|584164777|FG001|Overall Study|Not Reported|8|||
161761625|NCT03893630|584164780|FG000|Overall Study|Lost to Follow-up|5|||
161761626|NCT03893630|584164781|FG001|Overall Study|Lost to Follow-up|4|||
161761627|NCT03893630|584164782|FG002|Overall Study|Lost to Follow-up|2|||
161761628|NCT03893630|584164780|FG000|Overall Study|Withdrawal by Subject|3|||
161761629|NCT03893630|584164781|FG001|Overall Study|Withdrawal by Subject|6|||
161761630|NCT03893630|584164782|FG002|Overall Study|Withdrawal by Subject|3|||
161761631|NCT03893630|584164780|FG000|Overall Study|Discontinued Intervention|0|||
161761632|NCT03893630|584164781|FG001|Overall Study|Discontinued Intervention|4|||
161761633|NCT03893630|584164782|FG002|Overall Study|Discontinued Intervention|2|||
161761634|NCT00303602|584165982|FG000|Overall Study|Adverse Event|2|||
161761635|NCT00303602|584165983|FG001|Overall Study|Adverse Event|2|||
161761636|NCT00303602|584165982|FG000|Overall Study|Withdrawal by Subject|5|||
161761637|NCT00303602|584165983|FG001|Overall Study|Withdrawal by Subject|6|||
161761638|NCT00303602|584165982|FG000|Overall Study|Lost to Follow-up|5|||
161761639|NCT00303602|584165983|FG001|Overall Study|Lost to Follow-up|2|||
161761640|NCT00303602|584165982|FG000|Overall Study|Protocol entry criteria not met|2|||
161761641|NCT00303602|584165983|FG001|Overall Study|Protocol entry criteria not met|2|||
161761642|NCT00303602|584165982|FG000|Overall Study|Physician Decision|2|||
161761643|NCT00303602|584165983|FG001|Overall Study|Physician Decision|1|||
161761644|NCT00303602|584165982|FG000|Overall Study|Noncompliance|2|||
161761645|NCT00303602|584165983|FG001|Overall Study|Noncompliance|2|||
161761646|NCT00303602|584165982|FG000|Overall Study|Protocol Violation|1|||
161761647|NCT00303602|584165983|FG001|Overall Study|Protocol Violation|0|||
161761648|NCT00750867|584165990|FG000|Overall Study|Adverse Event|2|||
161761649|NCT00394654|584165991|FG000|Overall Study|Lost to Follow-up|1|||
161761650|NCT00394654|584165992|FG001|Overall Study|Lost to Follow-up|0|||
161761651|NCT00394654|584165991|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
161761652|NCT00394654|584165992|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
161761653|NCT00474539|584165993|FG000|Infant Series|Withdrawal by Subject|3|||
161761654|NCT00474539|584165994|FG001|Infant Series|Withdrawal by Subject|4|||
161761655|NCT00474539|584165993|FG000|Infant Series|Randomization error|5|||
161761656|NCT00474539|584165994|FG001|Infant Series|Randomization error|0|||
161761657|NCT00474539|584165993|FG000|Infant Series|Lost to Follow-up|2|||
161761658|NCT00474539|584165994|FG001|Infant Series|Lost to Follow-up|1|||
161761659|NCT00474539|584165993|FG000|Infant Series|Protocol Violation|0|||
161761660|NCT00474539|584165994|FG001|Infant Series|Protocol Violation|1|||
161761661|NCT00474539|584165993|FG000|After Infant Series|Lost to Follow-up|3|||
161761662|NCT00474539|584165994|FG001|After Infant Series|Lost to Follow-up|0|||
161761663|NCT00474539|584165993|FG000|After Infant Series|Withdrawal by Subject|1|||
161761664|NCT00474539|584165994|FG001|After Infant Series|Withdrawal by Subject|0|||
161761665|NCT00474539|584165993|FG000|Toddler Dose|Protocol Violation|1|||
161761666|NCT00474539|584165994|FG001|Toddler Dose|Protocol Violation|0|||
161761667|NCT03442595|584165995|FG000|Overall Study|Lost to Follow-up|94|||
161761668|NCT03442595|584165996|FG001|Overall Study|Lost to Follow-up|0|||
161761669|NCT01060150|584166001|FG000|Overall Study|Adverse Event|6|||
161761670|NCT01060150|584166001|FG000|Overall Study|Lost to Follow-up|1|||
161761671|NCT01060150|584166001|FG000|Overall Study|Protocol Violation|6|||
161761672|NCT01060150|584166001|FG000|Overall Study|Withdrawal by Subject|8|||
161761673|NCT01060150|584166001|FG000|Overall Study|Enrolled, but not treated|2|||
161761674|NCT01836549|584166002|FG000|Overall Study|Did not receive study drug|0|||
161761675|NCT01836549|584166003|FG001|Overall Study|Did not receive study drug|0|||
161761676|NCT01836549|584166004|FG002|Overall Study|Did not receive study drug|1|||
161761677|NCT01836549|584166005|FG003|Overall Study|Did not receive study drug|0|||
161761678|NCT01836549|584166006|FG004|Overall Study|Did not receive study drug|0|||
161761679|NCT01836549|584166007|FG005|Overall Study|Did not receive study drug|0|||
161761680|NCT01836549|584166008|FG006|Overall Study|Did not receive study drug|0|||
161761681|NCT01836549|584166002|FG000|Overall Study|Patient declared ineligible|0|||
161761682|NCT01836549|584166003|FG001|Overall Study|Patient declared ineligible|0|||
161761683|NCT01836549|584166004|FG002|Overall Study|Patient declared ineligible|0|||
161761684|NCT01836549|584166005|FG003|Overall Study|Patient declared ineligible|1|||
161847605|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847606|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847607|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
161847608|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847609|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847610|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847611|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847612|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847613|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847614|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847615|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847616|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847617|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847618|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
161847619|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847620|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
161847621|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
161847622|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847623|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847624|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847625|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847626|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847627|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847628|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847629|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847630|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847631|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847632|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847633|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847634|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847635|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847636|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
161847637|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
161847638|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
161847639|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
161847640|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
161847641|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847642|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847643|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847644|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161761685|NCT01836549|584166006|FG004|Overall Study|Patient declared ineligible|0|||
161761686|NCT01836549|584166007|FG005|Overall Study|Patient declared ineligible|0|||
161761687|NCT01836549|584166008|FG006|Overall Study|Patient declared ineligible|0|||
161761688|NCT01836549|584166002|FG000|Overall Study|Patient inevaluable to start therapy|0|||
161761689|NCT01836549|584166003|FG001|Overall Study|Patient inevaluable to start therapy|0|||
161761690|NCT01836549|584166004|FG002|Overall Study|Patient inevaluable to start therapy|0|||
161761691|NCT01836549|584166005|FG003|Overall Study|Patient inevaluable to start therapy|0|||
161761692|NCT01836549|584166006|FG004|Overall Study|Patient inevaluable to start therapy|0|||
161761693|NCT01836549|584166007|FG005|Overall Study|Patient inevaluable to start therapy|0|||
161761694|NCT01836549|584166008|FG006|Overall Study|Patient inevaluable to start therapy|1|||
161761695|NCT00381706|584166009|FG000|Overall Study|Never treated|7|||
161761696|NCT00381706|584166010|FG001|Overall Study|Never treated|2|||
161761697|NCT00381706|584166011|FG002|Overall Study|Never treated|1|||
161761698|NCT02364999|584166012|FG000|Overall Study|Death|136|||
161761699|NCT02364999|584166013|FG001|Overall Study|Death|138|||
161761700|NCT02364999|584166012|FG000|Overall Study|Lost to Follow-up|10|||
161761701|NCT02364999|584166013|FG001|Overall Study|Lost to Follow-up|15|||
161761702|NCT02364999|584166012|FG000|Overall Study|Protocol Violation|3|||
161761703|NCT02364999|584166013|FG001|Overall Study|Protocol Violation|2|||
161761704|NCT02364999|584166012|FG000|Overall Study|Withdrawal by Subject|14|||
161761705|NCT02364999|584166013|FG001|Overall Study|Withdrawal by Subject|14|||
161847645|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847646|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847647|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847648|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847649|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847650|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
161847651|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847652|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847653|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847654|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847655|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847656|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847657|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847658|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847659|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847660|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847661|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847662|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847663|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847664|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847665|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847666|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847667|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847668|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
161847669|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847670|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847671|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847672|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847673|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847674|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847675|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847676|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847677|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847678|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847679|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
161847680|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
161847681|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
161847682|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847683|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847684|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847685|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847686|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847687|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847688|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847689|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847690|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847691|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847692|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847693|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161761706|NCT02364999|584166012|FG000|Overall Study|Other|0|||
161761707|NCT02364999|584166013|FG001|Overall Study|Other|1|||
161761708|NCT02364999|584166012|FG000|Overall Study|Randomized but did not receive treatment|2|||
161761709|NCT02364999|584166013|FG001|Overall Study|Randomized but did not receive treatment|3|||
161761710|NCT00550615|584166014|FG000|Overall Study|Withdrawal by Subject|0|||
161761711|NCT00550615|584166015|FG001|Overall Study|Withdrawal by Subject|0|||
161761712|NCT00550615|584166016|FG002|Overall Study|Withdrawal by Subject|2|||
161761713|NCT00550615|584166017|FG003|Overall Study|Withdrawal by Subject|3|||
161761714|NCT00550615|584166014|FG000|Overall Study|Not evaluable|0|||
161761715|NCT00550615|584166015|FG001|Overall Study|Not evaluable|0|||
161761716|NCT00550615|584166016|FG002|Overall Study|Not evaluable|2|||
161761717|NCT00550615|584166017|FG003|Overall Study|Not evaluable|7|||
161761718|NCT01234337|584166018|FG000|Overall Study|Adverse Event|58|||
161761719|NCT01234337|584166019|FG001|Overall Study|Adverse Event|21|||
161761720|NCT01234337|584166018|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
161761721|NCT01234337|584166019|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
161761722|NCT01234337|584166018|FG000|Overall Study|Investi. decision not protocol driven|5|||
161761723|NCT01234337|584166019|FG001|Overall Study|Investi. decision not protocol driven|6|||
161761724|NCT01234337|584166018|FG000|Overall Study|Non-compliant with study medication|3|||
161761725|NCT01234337|584166019|FG001|Overall Study|Non-compliant with study medication|2|||
161761726|NCT01234337|584166018|FG000|Overall Study|Randomized but not treated|6|||
161761727|NCT01234337|584166019|FG001|Overall Study|Randomized but not treated|4|||
161761728|NCT01234337|584166018|FG000|Overall Study|Lost to Follow-up|0|||
161761729|NCT01234337|584166019|FG001|Overall Study|Lost to Follow-up|1|||
161761730|NCT01234337|584166018|FG000|Overall Study|Protocol Violation|2|||
161761731|NCT01234337|584166019|FG001|Overall Study|Protocol Violation|3|||
161761732|NCT01234337|584166018|FG000|Overall Study|Withdrawal by Subject|11|||
161761733|NCT01234337|584166019|FG001|Overall Study|Withdrawal by Subject|9|||
161761734|NCT01234337|584166018|FG000|Overall Study|Death|0|||
161761735|NCT01234337|584166019|FG001|Overall Study|Death|1|||
161761736|NCT01234337|584166018|FG000|Overall Study|Switch to commercial drug|0|||
161761737|NCT01234337|584166019|FG001|Overall Study|Switch to commercial drug|1|||
161761738|NCT02181504|584166023|FG000|Overall Study|Adverse Event|1|||
161761739|NCT02181504|584166024|FG001|Overall Study|Adverse Event|1|||
161761740|NCT02181504|584166025|FG002|Overall Study|Adverse Event|1|||
161761741|NCT00545584|584166032|FG000|Overall Study|Only one reason for discontinuation|62|||
161761742|NCT00545584|584166033|FG001|Overall Study|Only one reason for discontinuation|61|||
161761743|NCT00545584|584166034|FG002|Overall Study|Only one reason for discontinuation|48|||
161761744|NCT00545584|584166032|FG000|Overall Study|Two or more reasons for discontinuation|17|||
161761745|NCT00545584|584166033|FG001|Overall Study|Two or more reasons for discontinuation|19|||
161761746|NCT00545584|584166034|FG002|Overall Study|Two or more reasons for discontinuation|8|||
161761747|NCT00135694|584166040|FG000|Overall Study|Adverse Event|17|||
161761748|NCT00135694|584166041|FG001|Overall Study|Adverse Event|4|||
161761749|NCT00135694|584166042|FG002|Overall Study|Adverse Event|0|||
161761750|NCT00135694|584166040|FG000|Overall Study|Death|14|||
161761751|NCT00135694|584166041|FG001|Overall Study|Death|1|||
161761752|NCT00135694|584166042|FG002|Overall Study|Death|2|||
161761753|NCT00135694|584166040|FG000|Overall Study|Lost to Follow-up|8|||
161761754|NCT00135694|584166041|FG001|Overall Study|Lost to Follow-up|7|||
161761755|NCT00135694|584166042|FG002|Overall Study|Lost to Follow-up|1|||
161761756|NCT00135694|584166040|FG000|Overall Study|Withdrawal by Subject|41|||
161761757|NCT00135694|584166041|FG001|Overall Study|Withdrawal by Subject|7|||
161761758|NCT00135694|584166042|FG002|Overall Study|Withdrawal by Subject|4|||
161761759|NCT00135694|584166040|FG000|Overall Study|Protocol Violation|19|||
161761760|NCT00135694|584166041|FG001|Overall Study|Protocol Violation|1|||
161761761|NCT00135694|584166042|FG002|Overall Study|Protocol Violation|0|||
161761762|NCT00135694|584166040|FG000|Overall Study|Hepatitis C related reasons|39|||
161761763|NCT00135694|584166041|FG001|Overall Study|Hepatitis C related reasons|1|||
161761764|NCT00135694|584166042|FG002|Overall Study|Hepatitis C related reasons|0|||
161761765|NCT00135694|584166040|FG000|Overall Study|Ineligible for Random assignment|42|||
161761766|NCT00135694|584166041|FG001|Overall Study|Ineligible for Random assignment|0|||
161761767|NCT00135694|584166042|FG002|Overall Study|Ineligible for Random assignment|0|||
161761768|NCT02584660|584166043|FG000|Overall Study|Adverse Event|4|||
161761769|NCT02584660|584166044|FG001|Overall Study|Adverse Event|0|||
161761770|NCT02584660|584166043|FG000|Overall Study|Lost to Follow-up|3|||
161761771|NCT02584660|584166044|FG001|Overall Study|Lost to Follow-up|4|||
161761772|NCT02584660|584166043|FG000|Overall Study|Protocol Violation|0|||
161761773|NCT02584660|584166044|FG001|Overall Study|Protocol Violation|1|||
161761774|NCT02584660|584166043|FG000|Overall Study|Withdrawal by Subject|0|||
161761775|NCT02584660|584166044|FG001|Overall Study|Withdrawal by Subject|2|||
161761776|NCT02584660|584166043|FG000|Overall Study|Other|0|||
161761777|NCT02584660|584166044|FG001|Overall Study|Other|1|||
161761778|NCT00461552|584166045|FG000|Overall Study|Drug Dispensing error|0|||
161761779|NCT00461552|584166046|FG001|Overall Study|Drug Dispensing error|2|||
161761780|NCT00660816|584166047|FG000|Overall Study|Adverse Event|1|||
161761781|NCT00660816|584166048|FG001|Overall Study|Adverse Event|2|||
161761782|NCT00660816|584166047|FG000|Overall Study|Withdrawal by Subject|1|||
161761783|NCT00660816|584166048|FG001|Overall Study|Withdrawal by Subject|0|||
161761784|NCT00660816|584166047|FG000|Overall Study|Death|0|||
161761785|NCT00660816|584166048|FG001|Overall Study|Death|2|||
161761786|NCT00660816|584166047|FG000|Overall Study|Lack of Efficacy|1|||
161761787|NCT00660816|584166048|FG001|Overall Study|Lack of Efficacy|0|||
161761788|NCT00660816|584166047|FG000|Overall Study|Physician Decision|0|||
161761789|NCT00660816|584166048|FG001|Overall Study|Physician Decision|2|||
161761790|NCT00660816|584166047|FG000|Overall Study|Protocol Violation|1|||
161761791|NCT00660816|584166048|FG001|Overall Study|Protocol Violation|0|||
161761792|NCT00660816|584166047|FG000|Overall Study|Disease Progression|16|||
161761793|NCT00660816|584166048|FG001|Overall Study|Disease Progression|12|||
161761794|NCT00660816|584166047|FG000|Overall Study|Complicating Disease|0|||
161761795|NCT00660816|584166048|FG001|Overall Study|Complicating Disease|1|||
161761796|NCT00374452|584166049|FG000|Overall Study|Left clinic before intervention started|4|||
161761797|NCT00374452|584166050|FG001|Overall Study|Left clinic before intervention started|1|||
161761798|NCT00374452|584166049|FG000|Overall Study|Change in job role before intervention|0|||
161761799|NCT00374452|584166050|FG001|Overall Study|Change in job role before intervention|1|||
161761800|NCT00374452|584166049|FG000|Overall Study|Left clinic after intervention started|1|||
161761801|NCT00374452|584166050|FG001|Overall Study|Left clinic after intervention started|1|||
161761802|NCT00374452|584166049|FG000|Overall Study|Withdrawal by Subject|0|||
161761803|NCT00374452|584166050|FG001|Overall Study|Withdrawal by Subject|2|||
161761804|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761805|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
161761806|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761807|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761808|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761809|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
161761810|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761811|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761812|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761813|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761814|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761815|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761816|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761817|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
161761818|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761819|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
161761820|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761821|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761822|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
161761823|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761824|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761825|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761826|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761827|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761828|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
161761829|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
161761830|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
161761831|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
161761832|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
161761833|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
161761834|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
161761835|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761836|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761837|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761838|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761839|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761840|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
161761841|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
161761842|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
161761843|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
161761844|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
161761845|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
161761846|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
161761847|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761848|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761849|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761850|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761851|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761852|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761853|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761854|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761855|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761856|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761857|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761858|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761859|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761860|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
161761861|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761862|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161847694|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161761863|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761864|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761865|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761866|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761867|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761868|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761869|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761870|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761871|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
161761872|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
161761873|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
161761874|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
161761875|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
161761876|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761877|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761878|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761879|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761880|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761881|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761882|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761883|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161761884|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161761885|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161761886|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761887|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761888|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
161761889|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
161761890|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
161761891|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
161761892|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
161761893|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
161761894|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
161761895|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
161761896|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
161761897|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
161761898|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
161761899|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
161761900|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
161761901|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
161761902|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
161761903|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
161761904|NCT00523744|584166063|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
161761905|NCT00523744|584166063|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
161761906|NCT01289028|584166064|FG000|Overall Study|Progressive Disease|49|||
161761907|NCT01289028|584166064|FG000|Overall Study|Adverse Event|14|||
161761908|NCT01289028|584166064|FG000|Overall Study|Withdrawal by Subject|6|||
161761909|NCT01289028|584166064|FG000|Overall Study|Death|4|||
161761910|NCT01289028|584166064|FG000|Overall Study|Lack of Efficacy|2|||
161761911|NCT01289028|584166064|FG000|Overall Study|No longer required|2|||
161761912|NCT01289028|584166064|FG000|Overall Study|Lost to Follow-up|2|||
161761913|NCT01289028|584166064|FG000|Overall Study|New Cancer Therapy|2|||
161761914|NCT01289028|584166064|FG000|Overall Study|Abnormal Lab Value|1|||
161761915|NCT01289028|584166064|FG000|Overall Study|Missing reason for discon|1|||
161761916|NCT00998985|584166071|FG000|Overall Study|Withdrawal by Subject|0|||
161761917|NCT00998985|584166072|FG001|Overall Study|Withdrawal by Subject|0|||
161761918|NCT00998985|584166073|FG002|Overall Study|Withdrawal by Subject|0|||
161761919|NCT00998985|584166074|FG003|Overall Study|Withdrawal by Subject|0|||
161761920|NCT00998985|584166075|FG004|Overall Study|Withdrawal by Subject|0|||
161761921|NCT00998985|584166076|FG005|Overall Study|Withdrawal by Subject|0|||
161761922|NCT00998985|584166077|FG006|Overall Study|Withdrawal by Subject|0|||
161761923|NCT00998985|584166078|FG007|Overall Study|Withdrawal by Subject|0|||
161761924|NCT00998985|584166079|FG008|Overall Study|Withdrawal by Subject|1|||
161761925|NCT00998985|584166080|FG009|Overall Study|Withdrawal by Subject|0|||
161761926|NCT00998985|584166081|FG010|Overall Study|Withdrawal by Subject|0|||
161761927|NCT00998985|584166082|FG011|Overall Study|Withdrawal by Subject|0|||
161761928|NCT00998985|584166083|FG012|Overall Study|Withdrawal by Subject|0|||
161761929|NCT00998985|584166084|FG013|Overall Study|Withdrawal by Subject|0|||
161761930|NCT00998985|584166071|FG000|Overall Study|Protocol Violation|0|||
161761931|NCT00998985|584166072|FG001|Overall Study|Protocol Violation|0|||
161761932|NCT00998985|584166073|FG002|Overall Study|Protocol Violation|0|||
161761933|NCT00998985|584166074|FG003|Overall Study|Protocol Violation|0|||
161761934|NCT00998985|584166075|FG004|Overall Study|Protocol Violation|0|||
161761935|NCT00998985|584166076|FG005|Overall Study|Protocol Violation|1|||
161761936|NCT00998985|584166077|FG006|Overall Study|Protocol Violation|0|||
161761937|NCT00998985|584166078|FG007|Overall Study|Protocol Violation|0|||
161761938|NCT00998985|584166079|FG008|Overall Study|Protocol Violation|0|||
161761939|NCT00998985|584166080|FG009|Overall Study|Protocol Violation|0|||
161761940|NCT00998985|584166081|FG010|Overall Study|Protocol Violation|0|||
161761941|NCT00998985|584166082|FG011|Overall Study|Protocol Violation|0|||
161761942|NCT00998985|584166083|FG012|Overall Study|Protocol Violation|0|||
161761943|NCT00998985|584166084|FG013|Overall Study|Protocol Violation|0|||
161761944|NCT00542425|584166092|FG000|Initial 24 Weeks|Administrative reasons|0|||
161761945|NCT00542425|584166093|FG001|Initial 24 Weeks|Administrative reasons|0|||
161761946|NCT00542425|584166094|FG002|Initial 24 Weeks|Administrative reasons|1|||
161761947|NCT00542425|584166095|FG003|Initial 24 Weeks|Administrative reasons|1|||
161761948|NCT00542425|584166096|FG004|Initial 24 Weeks|Administrative reasons|0|||
161761949|NCT00542425|584166092|FG000|Initial 24 Weeks|Adverse Event|0|||
161761950|NCT00542425|584166093|FG001|Initial 24 Weeks|Adverse Event|1|||
161761951|NCT00542425|584166094|FG002|Initial 24 Weeks|Adverse Event|1|||
161761952|NCT00542425|584166095|FG003|Initial 24 Weeks|Adverse Event|3|||
161761953|NCT00542425|584166096|FG004|Initial 24 Weeks|Adverse Event|2|||
161761954|NCT00542425|584166092|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
161761955|NCT00542425|584166093|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
161761956|NCT00542425|584166094|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
161761957|NCT00542425|584166095|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
161761958|NCT00542425|584166096|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
161761959|NCT00542425|584166092|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
161761960|NCT00542425|584166093|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
161761961|NCT00542425|584166094|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
161761962|NCT00542425|584166095|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
161761963|NCT00542425|584166096|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
161761964|NCT00542425|584166092|FG000|Initial 24 Weeks|Non-compliance|0|||
161761965|NCT00542425|584166093|FG001|Initial 24 Weeks|Non-compliance|0|||
161761966|NCT00542425|584166094|FG002|Initial 24 Weeks|Non-compliance|0|||
161761967|NCT00542425|584166095|FG003|Initial 24 Weeks|Non-compliance|1|||
161761968|NCT00542425|584166096|FG004|Initial 24 Weeks|Non-compliance|1|||
161761969|NCT00542425|584166092|FG000|Initial 24 Weeks|Protocol Violation|0|||
161761970|NCT00542425|584166093|FG001|Initial 24 Weeks|Protocol Violation|0|||
161761971|NCT00542425|584166094|FG002|Initial 24 Weeks|Protocol Violation|0|||
161761972|NCT00542425|584166095|FG003|Initial 24 Weeks|Protocol Violation|1|||
161761973|NCT00542425|584166096|FG004|Initial 24 Weeks|Protocol Violation|0|||
161761974|NCT00542425|584166092|FG000|Initial 24 Weeks|Refusal of treatment|2|||
161761975|NCT00542425|584166093|FG001|Initial 24 Weeks|Refusal of treatment|2|||
161761976|NCT00542425|584166094|FG002|Initial 24 Weeks|Refusal of treatment|1|||
161761977|NCT00542425|584166095|FG003|Initial 24 Weeks|Refusal of treatment|4|||
161761978|NCT00542425|584166096|FG004|Initial 24 Weeks|Refusal of treatment|1|||
161761979|NCT00542425|584166092|FG000|Initial 24 Weeks|Other|0|||
161761980|NCT00542425|584166093|FG001|Initial 24 Weeks|Other|2|||
161761981|NCT00542425|584166094|FG002|Initial 24 Weeks|Other|1|||
161761982|NCT00542425|584166095|FG003|Initial 24 Weeks|Other|0|||
161761983|NCT00542425|584166096|FG004|Initial 24 Weeks|Other|0|||
161761984|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
161761985|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
161761986|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
161761987|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
161761988|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
161761989|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161761990|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161761991|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
161761992|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161761993|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161761994|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761995|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
161761996|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761997|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761998|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761999|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Other|1|||
161762000|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Other|1|||
161847695|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847696|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
161847697|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847698|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847699|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847700|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847701|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161762001|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Other|0|||
161762002|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Other|0|||
161762003|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Other|1|||
161762004|NCT02096471|584166099|FG000|Overall Study|Adverse Event|1|||
161762005|NCT02096471|584166099|FG000|Overall Study|Lack of Efficacy|7|||
161762006|NCT02096471|584166099|FG000|Overall Study|Withdrawal by Subject|3|||
161762007|NCT02096471|584166099|FG000|Overall Study|Non-Compliant|2|||
161847702|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847703|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847704|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847705|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847706|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847707|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847708|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847709|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
161847710|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
161847711|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847712|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847713|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847714|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847715|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847716|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847717|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847718|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847719|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847720|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847721|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847722|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847723|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
161847724|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847725|NCT03433755|584482443|FG000|Overall Study|Lost to Follow-up|1|||
161847726|NCT03433755|584482444|FG001|Overall Study|Lost to Follow-up|0|||
161847727|NCT03433755|584482445|FG002|Overall Study|Lost to Follow-up|0|||
161847728|NCT03433755|584482446|FG003|Overall Study|Lost to Follow-up|0|||
161847729|NCT03433755|584482443|FG000|Overall Study|Decision by Sponsor|1|||
161847730|NCT03433755|584482444|FG001|Overall Study|Decision by Sponsor|0|||
161847731|NCT03433755|584482445|FG002|Overall Study|Decision by Sponsor|0|||
161847732|NCT03433755|584482446|FG003|Overall Study|Decision by Sponsor|0|||
161847733|NCT05065567|584482448|FG000|Overall Study|Lost to Follow-up|10|||
161847734|NCT05065567|584482449|FG001|Overall Study|Lost to Follow-up|9|||
161847735|NCT05065567|584482450|FG002|Overall Study|Lost to Follow-up|6|||
161847736|NCT05323123|584482451|FG000|Overall Study|Withdrawal by Subject|2|||
161847737|NCT05323123|584482452|FG001|Overall Study|Withdrawal by Subject|1|||
161847738|NCT05323123|584482451|FG000|Overall Study|Lost to Follow-up|4|||
161847739|NCT05323123|584482452|FG001|Overall Study|Lost to Follow-up|2|||
161847740|NCT05323123|584482451|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
161847741|NCT05323123|584482452|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
161847742|NCT05529472|584482453|FG000|Overall Study|Withdrawal by Subject|1|||
161847743|NCT05529472|584482454|FG001|Overall Study|Withdrawal by Subject|1|||
161847744|NCT02886624|584484074|FG000|12-week Post Treatment Follow-up|Death|1|||
161847745|NCT02886624|584484074|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
161847746|NCT00359801|584484079|FG000|Overall Study|Lost to Follow-up|72|||
161847747|NCT00359801|584484080|FG001|Overall Study|Lost to Follow-up|58|||
161847748|NCT00359801|584484079|FG000|Overall Study|Withdrawal by Subject|143|||
161847749|NCT00359801|584484080|FG001|Overall Study|Withdrawal by Subject|96|||
161762008|NCT03344562|584166100|FG000|Overall Study|Withdrawal by Subject|2|||
161847750|NCT00359801|584484079|FG000|Overall Study|Other|66|||
161847751|NCT00359801|584484080|FG001|Overall Study|Other|46|||
161847752|NCT00359801|584484079|FG000|Overall Study|Final Status Unknown: missing data|7|||
161847753|NCT00359801|584484080|FG001|Overall Study|Final Status Unknown: missing data|4|||
161847754|NCT00359801|584484079|FG000|Overall Study|Sponsor Decision|17|||
161847755|NCT00359801|584484080|FG001|Overall Study|Sponsor Decision|16|||
161762009|NCT03344562|584166101|FG001|Overall Study|Withdrawal by Subject|0|||
161762010|NCT02736474|584166102|FG000|Overall Study|Lost to Follow-up|0|||
161762011|NCT02736474|584166103|FG001|Overall Study|Lost to Follow-up|1|||
161762012|NCT02463331|584166104|FG000|Overall Study|Adverse Event|4|||
161762013|NCT02463331|584166105|FG001|Overall Study|Adverse Event|2|||
161762014|NCT02463331|584166104|FG000|Overall Study|Lost to Follow-up|1|||
161762015|NCT02463331|584166105|FG001|Overall Study|Lost to Follow-up|1|||
161762016|NCT02463331|584166104|FG000|Overall Study|Pregnancy|2|||
161762017|NCT02463331|584166105|FG001|Overall Study|Pregnancy|3|||
161762018|NCT02463331|584166104|FG000|Overall Study|Lack of Efficacy|6|||
161762019|NCT02463331|584166105|FG001|Overall Study|Lack of Efficacy|0|||
161762020|NCT02463331|584166104|FG000|Overall Study|Physician Decision|3|||
161762021|NCT02463331|584166105|FG001|Overall Study|Physician Decision|0|||
161762022|NCT02483611|584166106|FG000|Overall Study|Protocol Violation|0|||
161762023|NCT02483611|584166107|FG001|Overall Study|Protocol Violation|0|||
161762024|NCT02483611|584166108|FG002|Overall Study|Protocol Violation|1|||
161762025|NCT02590406|584166109|FG000|Overall Study|Adverse Event|1|||
161762026|NCT02590406|584166110|FG001|Overall Study|Adverse Event|0|||
161762027|NCT02590406|584166109|FG000|Overall Study|Saturometer malfunction|0|||
161762028|NCT02590406|584166110|FG001|Overall Study|Saturometer malfunction|1|||
161762029|NCT01021293|584166113|FG000|Overall Study|Serious Adverse Event|2|||
161762030|NCT01021293|584166114|FG001|Overall Study|Serious Adverse Event|1|||
161762031|NCT01021293|584166113|FG000|Overall Study|Adverse Event|2|||
161762032|NCT01021293|584166114|FG001|Overall Study|Adverse Event|1|||
161762033|NCT01021293|584166113|FG000|Overall Study|Withdrawal by Subject|1|||
161762034|NCT01021293|584166114|FG001|Overall Study|Withdrawal by Subject|3|||
161762035|NCT01021293|584166113|FG000|Overall Study|Migrated/moved from study area|6|||
161762036|NCT01021293|584166114|FG001|Overall Study|Migrated/moved from study area|18|||
161762037|NCT01021293|584166113|FG000|Overall Study|Lost to Follow-up|1|||
161762038|NCT01021293|584166114|FG001|Overall Study|Lost to Follow-up|1|||
161762039|NCT00631969|584166115|FG000|Overall Study|Adverse Event|3|||
161762040|NCT00631969|584166116|FG001|Overall Study|Adverse Event|1|||
161762041|NCT00631969|584166115|FG000|Overall Study|Lack of Efficacy|2|||
161762042|NCT00631969|584166116|FG001|Overall Study|Lack of Efficacy|8|||
161762043|NCT00631969|584166115|FG000|Overall Study|Lost to Follow-up|2|||
161762044|NCT00631969|584166116|FG001|Overall Study|Lost to Follow-up|1|||
161762045|NCT00631969|584166115|FG000|Overall Study|Protocol Violation|1|||
161762046|NCT00631969|584166116|FG001|Overall Study|Protocol Violation|1|||
161762047|NCT00631969|584166115|FG000|Overall Study|Consent Withdrawn|5|||
161762048|NCT00631969|584166116|FG001|Overall Study|Consent Withdrawn|7|||
161762049|NCT00631969|584166115|FG000|Overall Study|Noncompliant With Study Medication|0|||
161762050|NCT00631969|584166116|FG001|Overall Study|Noncompliant With Study Medication|1|||
161762051|NCT00631969|584166115|FG000|Overall Study|No Drug Exposure|2|||
161762052|NCT00631969|584166116|FG001|Overall Study|No Drug Exposure|2|||
161762053|NCT04335929|584167833|FG000|Overall Study|Lost to Follow-up|10|||
161762054|NCT02491463|584167835|FG000|Overall Study|Withdrawal by Subject|1|||
161762055|NCT02491463|584167836|FG001|Overall Study|Withdrawal by Subject|2|||
161762056|NCT02491463|584167837|FG002|Overall Study|Withdrawal by Subject|0|||
161762057|NCT02491463|584167838|FG003|Overall Study|Withdrawal by Subject|0|||
161762058|NCT02491463|584167835|FG000|Overall Study|Migrated/moved from study area|1|||
161762059|NCT02491463|584167836|FG001|Overall Study|Migrated/moved from study area|5|||
161762060|NCT02491463|584167837|FG002|Overall Study|Migrated/moved from study area|1|||
161762061|NCT02491463|584167838|FG003|Overall Study|Migrated/moved from study area|1|||
161762062|NCT02491463|584167835|FG000|Overall Study|Lost to Follow-up|0|||
161762063|NCT02491463|584167836|FG001|Overall Study|Lost to Follow-up|3|||
161762064|NCT02491463|584167837|FG002|Overall Study|Lost to Follow-up|3|||
161762065|NCT02491463|584167838|FG003|Overall Study|Lost to Follow-up|0|||
161762066|NCT01491802|584167839|FG000|Overall Study|Adverse Event|1|||
161762067|NCT01491802|584167840|FG001|Overall Study|Adverse Event|1|||
161847756|NCT02929056|584484085|FG000|Overall Study|Lost to Follow-up|0|||
161762068|NCT01491802|584167839|FG000|Overall Study|Withdrawal by Subject|0|||
161762069|NCT01491802|584167840|FG001|Overall Study|Withdrawal by Subject|1|||
161762070|NCT01864746|584167843|FG000|Overall Study|Disease recurrence|25|||
161762071|NCT01864746|584167844|FG001|Overall Study|Disease recurrence|40|||
161762072|NCT01864746|584167843|FG000|Overall Study|Second primary invasive nonbreast|2|||
161762073|NCT01864746|584167844|FG001|Overall Study|Second primary invasive nonbreast|3|||
161762074|NCT01864746|584167843|FG000|Overall Study|Death|2|||
161762075|NCT01864746|584167844|FG001|Overall Study|Death|1|||
161762076|NCT01864746|584167843|FG000|Overall Study|Adverse Event|33|||
161762077|NCT01864746|584167844|FG001|Overall Study|Adverse Event|5|||
161762078|NCT01864746|584167843|FG000|Overall Study|Withdrawal by Subject|56|||
161762079|NCT01864746|584167844|FG001|Overall Study|Withdrawal by Subject|41|||
161762080|NCT01864746|584167843|FG000|Overall Study|Physician Decision|5|||
161762081|NCT01864746|584167844|FG001|Overall Study|Physician Decision|6|||
161762082|NCT00663208|584167845|FG000|Treatment Period|Lost to Follow-up|0|||
161762083|NCT00663208|584167846|FG001|Treatment Period|Lost to Follow-up|1|||
161762084|NCT00663208|584167847|FG002|Treatment Period|Lost to Follow-up|0|||
161762085|NCT00663208|584167848|FG003|Treatment Period|Lost to Follow-up|0|||
161762086|NCT00663208|584167849|FG004|Treatment Period|Lost to Follow-up|0|||
161762087|NCT00663208|584167850|FG005|Treatment Period|Lost to Follow-up|0|||
161762088|NCT00663208|584167851|FG006|Treatment Period|Lost to Follow-up|0|||
161762089|NCT00663208|584167845|FG000|Follow-up Period|Lost to Follow-up|2|||
161762090|NCT00663208|584167846|FG001|Follow-up Period|Lost to Follow-up|0|||
161762091|NCT00663208|584167847|FG002|Follow-up Period|Lost to Follow-up|3|||
161762092|NCT00663208|584167848|FG003|Follow-up Period|Lost to Follow-up|2|||
161762093|NCT00663208|584167849|FG004|Follow-up Period|Lost to Follow-up|0|||
161762094|NCT00663208|584167850|FG005|Follow-up Period|Lost to Follow-up|0|||
161762095|NCT00663208|584167851|FG006|Follow-up Period|Lost to Follow-up|0|||
161762096|NCT00663208|584167845|FG000|Follow-up Period|Other reason|1|||
161762097|NCT00663208|584167846|FG001|Follow-up Period|Other reason|0|||
161762098|NCT00663208|584167847|FG002|Follow-up Period|Other reason|0|||
161762099|NCT00663208|584167848|FG003|Follow-up Period|Other reason|0|||
161762100|NCT00663208|584167849|FG004|Follow-up Period|Other reason|0|||
161762101|NCT00663208|584167850|FG005|Follow-up Period|Other reason|0|||
161762102|NCT00663208|584167851|FG006|Follow-up Period|Other reason|1|||
161762103|NCT01005966|584167852|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161762104|NCT01005966|584167853|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762105|NCT01005966|584167854|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762106|NCT01005966|584167855|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762107|NCT01005966|584167856|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762108|NCT01005966|584167852|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161762109|NCT01005966|584167853|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161762110|NCT01005966|584167854|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161762111|NCT01005966|584167855|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161762112|NCT01005966|584167856|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161762113|NCT01005966|584167852|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762114|NCT01005966|584167853|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762115|NCT01005966|584167854|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762116|NCT01005966|584167855|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
161762117|NCT01005966|584167856|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762118|NCT01005966|584167852|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
161762119|NCT01005966|584167853|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
161762120|NCT01005966|584167854|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
161762121|NCT01005966|584167855|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
161762122|NCT01005966|584167856|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
161762123|NCT01005966|584167852|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762124|NCT01005966|584167853|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762125|NCT01005966|584167854|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762126|NCT01005966|584167855|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161762127|NCT01005966|584167856|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762128|NCT01005966|584167852|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762129|NCT01005966|584167853|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762130|NCT01005966|584167854|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
161762131|NCT01005966|584167855|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762132|NCT01005966|584167856|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762133|NCT01005966|584167852|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161762134|NCT01005966|584167853|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
161762135|NCT01005966|584167854|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161762136|NCT01005966|584167855|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161762137|NCT01005966|584167856|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
161762138|NCT01005966|584167852|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762139|NCT01005966|584167853|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
161762140|NCT01005966|584167854|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762141|NCT01005966|584167855|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762142|NCT01005966|584167856|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762143|NCT01005966|584167852|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
161762144|NCT01005966|584167853|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
161847757|NCT02929056|584484086|FG001|Overall Study|Lost to Follow-up|1|||
161762145|NCT01005966|584167854|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
161762146|NCT01005966|584167855|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
161762147|NCT01005966|584167856|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
161762148|NCT01451203|584167857|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
161762149|NCT01451203|584167858|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
161762150|NCT01451203|584167857|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
161762151|NCT01451203|584167858|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
161762152|NCT01451203|584167857|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
161762153|NCT01451203|584167858|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
161762154|NCT01451203|584167857|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
161762155|NCT01451203|584167858|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
161762156|NCT01451203|584167857|FG000|Double-blind Treatment Period|Adverse Event|6|||
161762157|NCT01451203|584167858|FG001|Double-blind Treatment Period|Adverse Event|9|||
161762158|NCT01451203|584167857|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
161762159|NCT01451203|584167858|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
161762160|NCT01451203|584167857|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
161762161|NCT01451203|584167858|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
161762162|NCT01451203|584167857|FG000|Double-blind Treatment Period|Investigator decision|2|||
161762163|NCT01451203|584167858|FG001|Double-blind Treatment Period|Investigator decision|0|||
161762164|NCT01451203|584167857|FG000|Post-treatment Period|Consent withdrawn|2|||
161762165|NCT01451203|584167858|FG001|Post-treatment Period|Consent withdrawn|4|||
161762166|NCT01451203|584167857|FG000|Post-treatment Period|Lack of Efficacy|12|||
161762167|NCT01451203|584167858|FG001|Post-treatment Period|Lack of Efficacy|28|||
161762168|NCT01451203|584167857|FG000|Post-treatment Period|Adverse Event|0|||
161762169|NCT01451203|584167858|FG001|Post-treatment Period|Adverse Event|1|||
161762170|NCT01451203|584167857|FG000|Post-treatment Period|Investigator decision|0|||
161762171|NCT01451203|584167858|FG001|Post-treatment Period|Investigator decision|1|||
161762172|NCT00039377|584167859|FG000|Initial Registration|Adverse Event|2|||
161762173|NCT00039377|584167860|FG001|Initial Registration|Adverse Event|0|||
161762174|NCT00039377|584167861|FG002|Initial Registration|Adverse Event|0|||
161762175|NCT00039377|584167862|FG003|Initial Registration|Adverse Event|0|||
161762176|NCT00039377|584167859|FG000|Initial Registration|Relapsed|6|||
161762177|NCT00039377|584167860|FG001|Initial Registration|Relapsed|0|||
161762178|NCT00039377|584167861|FG002|Initial Registration|Relapsed|0|||
161762179|NCT00039377|584167862|FG003|Initial Registration|Relapsed|0|||
161762180|NCT00039377|584167859|FG000|Initial Registration|Received non-protocol therapy|11|||
161762181|NCT00039377|584167860|FG001|Initial Registration|Received non-protocol therapy|0|||
161762182|NCT00039377|584167861|FG002|Initial Registration|Received non-protocol therapy|0|||
161762183|NCT00039377|584167862|FG003|Initial Registration|Received non-protocol therapy|0|||
161762184|NCT00039377|584167859|FG000|Initial Registration|Withdrawal by Subject|3|||
161762185|NCT00039377|584167860|FG001|Initial Registration|Withdrawal by Subject|0|||
161762186|NCT00039377|584167861|FG002|Initial Registration|Withdrawal by Subject|0|||
161762187|NCT00039377|584167862|FG003|Initial Registration|Withdrawal by Subject|0|||
161762188|NCT01347931|584167863|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
161762189|NCT03890731|584167864|FG000|Overall Study|Progressive disease|1|||
161762190|NCT03890731|584167864|FG000|Overall Study|Patient's decision|1|||
161762191|NCT03890731|584167864|FG000|Overall Study|Adverse Event|4|||
161762192|NCT01716585|584167865|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
161762193|NCT01716585|584167866|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
161762194|NCT01716585|584167865|FG000|Double-blind Treatment|Adverse Event|2|||
161762195|NCT01716585|584167866|FG001|Double-blind Treatment|Adverse Event|1|||
161762196|NCT01716585|584167865|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
161762197|NCT01716585|584167866|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
161762198|NCT01716585|584167865|FG000|Double-blind Treatment|Lost to Follow-up|2|||
161762199|NCT01716585|584167866|FG001|Double-blind Treatment|Lost to Follow-up|0|||
161762200|NCT01716585|584167865|FG000|Double-blind Treatment|Subject Noncompliant|1|||
161762201|NCT01716585|584167866|FG001|Double-blind Treatment|Subject Noncompliant|0|||
161762202|NCT01716585|584167865|FG000|Double-blind Treatment|Other|1|||
161762203|NCT01716585|584167866|FG001|Double-blind Treatment|Other|0|||
161762204|NCT01716585|584167865|FG000|Open-label Treatment|Adverse Event|0|||
161762205|NCT01716585|584167866|FG001|Open-label Treatment|Adverse Event|2|||
161762206|NCT01716585|584167865|FG000|Open-label Treatment|Virologic Failure|0|||
161762207|NCT01716585|584167866|FG001|Open-label Treatment|Virologic Failure|2|||
161762208|NCT01716585|584167865|FG000|Open-label Treatment|Withdrawal by Subject|0|||
161762209|NCT01716585|584167866|FG001|Open-label Treatment|Withdrawal by Subject|3|||
161762210|NCT04235959|584167867|FG000|Overall Study|Protocol Violation|0|||
161762211|NCT04235959|584167868|FG001|Overall Study|Protocol Violation|1|||
161762212|NCT04235959|584167869|FG002|Overall Study|Protocol Violation|0|||
161762213|NCT04235959|584167867|FG000|Overall Study|Adverse Event|1|||
161762214|NCT04235959|584167868|FG001|Overall Study|Adverse Event|0|||
161762215|NCT04235959|584167869|FG002|Overall Study|Adverse Event|0|||
161762216|NCT00125138|584167870|FG000|Overall Study|Adverse Event|1|||
161847758|NCT02245412|584484092|FG000|Treatment Period|Death|1|||
161847759|NCT02245412|584484093|FG001|Treatment Period|Death|1|||
161847760|NCT02245412|584484094|FG002|Treatment Period|Death|0|||
161847761|NCT02245412|584484092|FG000|Treatment Period|Physician Decision|1|||
161847762|NCT02245412|584484093|FG001|Treatment Period|Physician Decision|1|||
161847763|NCT02245412|584484094|FG002|Treatment Period|Physician Decision|0|||
161847764|NCT02245412|584484092|FG000|Treatment Period|Withdrawal by Subject|2|||
161847765|NCT02245412|584484093|FG001|Treatment Period|Withdrawal by Subject|1|||
161847766|NCT02245412|584484094|FG002|Treatment Period|Withdrawal by Subject|0|||
161847767|NCT02245412|584484092|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
161847768|NCT02245412|584484093|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
161847769|NCT02245412|584484094|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
161847770|NCT02245412|584484092|FG000|Follow-Up Period|Death|4|||
161847771|NCT02245412|584484093|FG001|Follow-Up Period|Death|2|||
161847772|NCT02245412|584484094|FG002|Follow-Up Period|Death|1|||
161847773|NCT02245412|584484092|FG000|Follow-Up Period|Physician Decision|1|||
161847774|NCT02245412|584484093|FG001|Follow-Up Period|Physician Decision|0|||
161847775|NCT02245412|584484094|FG002|Follow-Up Period|Physician Decision|0|||
161847776|NCT02245412|584484092|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
161847777|NCT02245412|584484093|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
161847778|NCT02245412|584484094|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
161847779|NCT00459043|584484095|FG000|Overall Study|Withdrawal by Subject|1|||
161847780|NCT00459043|584484096|FG001|Overall Study|Withdrawal by Subject|0|||
161847781|NCT00450801|584484099|FG000|Overall Study|Death|1|||
161847782|NCT00324649|584484100|FG000|Overall Study|Adverse Event|1|||
161847783|NCT00324649|584484101|FG001|Overall Study|Adverse Event|4|||
161847784|NCT00324649|584484100|FG000|Overall Study|Withdrawal by Subject|0|||
161847785|NCT00324649|584484101|FG001|Overall Study|Withdrawal by Subject|1|||
161847786|NCT00324649|584484100|FG000|Overall Study|Noncompliance|1|||
161847787|NCT00324649|584484101|FG001|Overall Study|Noncompliance|0|||
161847788|NCT02618759|584484102|FG000|Overall Study|Lost to Follow-up|0|||
161847789|NCT02618759|584484103|FG001|Overall Study|Lost to Follow-up|1|||
161847790|NCT02618759|584484102|FG000|Overall Study|Withdrawal by Subject|1|||
161847791|NCT02618759|584484103|FG001|Overall Study|Withdrawal by Subject|0|||
161847792|NCT02618759|584484102|FG000|Overall Study|Other Reasons|1|||
161847793|NCT02618759|584484103|FG001|Overall Study|Other Reasons|4|||
161847794|NCT02500043|584484110|FG000|Overall Study|Randomized, but not Treated|2|||
161847795|NCT02500043|584484111|FG001|Overall Study|Randomized, but not Treated|2|||
161847796|NCT02500043|584484110|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
161847797|NCT02500043|584484111|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
161847798|NCT02500043|584484110|FG000|Overall Study|Adverse Event|33|||
161847799|NCT02500043|584484111|FG001|Overall Study|Adverse Event|11|||
161847800|NCT02500043|584484110|FG000|Overall Study|Clinical Progression|54|||
161847801|NCT02500043|584484111|FG001|Overall Study|Clinical Progression|35|||
161847802|NCT02500043|584484110|FG000|Overall Study|Radiological Progression|192|||
161847803|NCT02500043|584484111|FG001|Overall Study|Radiological Progression|110|||
161847804|NCT02500043|584484110|FG000|Overall Study|Physician's Decision|11|||
161762217|NCT00125138|584167871|FG001|Overall Study|Adverse Event|0|||
161762218|NCT00125138|584167872|FG002|Overall Study|Adverse Event|3|||
161762219|NCT00125138|584167873|FG003|Overall Study|Adverse Event|2|||
161762220|NCT00125138|584167870|FG000|Overall Study|Withdrawal by Subject|2|||
161762221|NCT00125138|584167871|FG001|Overall Study|Withdrawal by Subject|3|||
161762222|NCT00125138|584167872|FG002|Overall Study|Withdrawal by Subject|1|||
161762223|NCT00125138|584167873|FG003|Overall Study|Withdrawal by Subject|1|||
161762224|NCT00125138|584167870|FG000|Overall Study|Lack of Efficacy|0|||
161762225|NCT00125138|584167871|FG001|Overall Study|Lack of Efficacy|0|||
161762226|NCT00125138|584167872|FG002|Overall Study|Lack of Efficacy|0|||
161762227|NCT00125138|584167873|FG003|Overall Study|Lack of Efficacy|1|||
161762228|NCT00125138|584167870|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
161762229|NCT00125138|584167871|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
161847805|NCT02500043|584484111|FG001|Overall Study|Physician's Decision|3|||
161847806|NCT02500043|584484110|FG000|Overall Study|Withdrawal by Subject|14|||
161847807|NCT02500043|584484111|FG001|Overall Study|Withdrawal by Subject|4|||
161847808|NCT02500043|584484110|FG000|Overall Study|Death|11|||
161847809|NCT02500043|584484111|FG001|Overall Study|Death|2|||
161847810|NCT02500043|584484110|FG000|Overall Study|Protocol Deviation|1|||
161847811|NCT02500043|584484111|FG001|Overall Study|Protocol Deviation|0|||
161847812|NCT00580788|584484112|FG000|Overall Study|Adverse Event|0|||
161847813|NCT00580788|584484113|FG001|Overall Study|Adverse Event|0|||
161847814|NCT00580788|584484114|FG002|Overall Study|Adverse Event|0|||
161847815|NCT00580788|584484115|FG003|Overall Study|Adverse Event|1|||
161762230|NCT00125138|584167872|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
161762231|NCT00125138|584167873|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
161762232|NCT00286156|584167874|FG000|Overall Study|Missed 12 month visit|0|||
161762233|NCT00286156|584167875|FG001|Overall Study|Missed 12 month visit|0|||
161762234|NCT00286156|584167876|FG002|Overall Study|Missed 12 month visit|1|||
161847816|NCT03301649|584484116|FG000|Overall Study|Need alternate therapy due to live lice|17|||
161762235|NCT00286156|584167874|FG000|Overall Study|AE: pulmonary embolus|0|||
161762236|NCT00286156|584167875|FG001|Overall Study|AE: pulmonary embolus|1|||
161762237|NCT00286156|584167876|FG002|Overall Study|AE: pulmonary embolus|0|||
161762238|NCT00286156|584167874|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
161762239|NCT00286156|584167875|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
161762240|NCT00286156|584167876|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
161762241|NCT00286156|584167874|FG000|Overall Study|AE: pneumonia|1|||
161762242|NCT00286156|584167875|FG001|Overall Study|AE: pneumonia|0|||
161762243|NCT00286156|584167876|FG002|Overall Study|AE: pneumonia|0|||
161762244|NCT02870348|584167877|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
161762245|NCT00672139|584167878|FG000|Overall Study|Death|14|||
161762246|NCT00672139|584167879|FG001|Overall Study|Death|23|||
161762247|NCT00672139|584167878|FG000|Overall Study|Withdrawal by Subject|2|||
161762248|NCT00672139|584167879|FG001|Overall Study|Withdrawal by Subject|11|||
161762249|NCT00672139|584167878|FG000|Overall Study|Adverse Event|4|||
161762250|NCT00672139|584167879|FG001|Overall Study|Adverse Event|7|||
161762251|NCT00672139|584167878|FG000|Overall Study|Physician Decision|2|||
161762252|NCT00672139|584167879|FG001|Overall Study|Physician Decision|0|||
161762253|NCT00672139|584167878|FG000|Overall Study|Lack of Efficacy|4|||
161762254|NCT00672139|584167879|FG001|Overall Study|Lack of Efficacy|1|||
161762255|NCT00672139|584167878|FG000|Overall Study|Protocol Violation|1|||
161762256|NCT00672139|584167879|FG001|Overall Study|Protocol Violation|1|||
161762257|NCT00672139|584167878|FG000|Overall Study|hospice discharge, caregiver requests|3|||
161762258|NCT00672139|584167879|FG001|Overall Study|hospice discharge, caregiver requests|2|||
161762259|NCT02381795|584167880|FG000|Overall Study|Withdrawal by Subject|1|||
161762260|NCT02381795|584167880|FG000|Overall Study|Study Terminated|2|||
161762261|NCT01488994|584167885|FG000|Overall Study|Withdrawal by Subject|0|||
161762262|NCT01488994|584167886|FG001|Overall Study|Withdrawal by Subject|1|||
161762263|NCT02908841|584167887|FG000|Overall Study|Physician Decision|4|||
161762264|NCT02908841|584167888|FG001|Overall Study|Physician Decision|0|||
161762265|NCT03798366|584167889|FG000|Overall Study|Lost to Follow-up|0|||
161762266|NCT03798366|584167890|FG001|Overall Study|Lost to Follow-up|1|||
161762267|NCT01412333|584167891|FG000|Overall Study|Adverse Event|40|||
161762268|NCT01412333|584167892|FG001|Overall Study|Adverse Event|42|||
161762269|NCT01412333|584167891|FG000|Overall Study|Death|5|||
161762270|NCT01412333|584167892|FG001|Overall Study|Death|6|||
161762271|NCT01412333|584167891|FG000|Overall Study|Lack of Efficacy|22|||
161762272|NCT01412333|584167892|FG001|Overall Study|Lack of Efficacy|10|||
161762273|NCT01412333|584167891|FG000|Overall Study|Lost to Follow-up|15|||
161762274|NCT01412333|584167892|FG001|Overall Study|Lost to Follow-up|12|||
161762275|NCT01412333|584167891|FG000|Overall Study|Non-Compliance|3|||
161762276|NCT01412333|584167892|FG001|Overall Study|Non-Compliance|7|||
161762277|NCT01412333|584167891|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161762278|NCT01412333|584167892|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161762279|NCT01412333|584167891|FG000|Overall Study|Other|30|||
161762280|NCT01412333|584167892|FG001|Overall Study|Other|33|||
161762281|NCT01412333|584167891|FG000|Overall Study|Physician Decision|11|||
161762282|NCT01412333|584167892|FG001|Overall Study|Physician Decision|16|||
161762283|NCT01412333|584167891|FG000|Overall Study|Pregnancy|6|||
161762284|NCT01412333|584167892|FG001|Overall Study|Pregnancy|4|||
161762285|NCT01412333|584167891|FG000|Overall Study|Protocol Violation|1|||
161762286|NCT01412333|584167892|FG001|Overall Study|Protocol Violation|2|||
161762287|NCT01412333|584167891|FG000|Overall Study|Study Terminated By Sponsor|3|||
161762288|NCT01412333|584167892|FG001|Overall Study|Study Terminated By Sponsor|2|||
161762289|NCT01412333|584167891|FG000|Overall Study|Withdrawal by Subject|51|||
161762290|NCT01412333|584167892|FG001|Overall Study|Withdrawal by Subject|54|||
161762291|NCT01412333|584167891|FG000|Overall Study|Missing|1|||
161762292|NCT01412333|584167892|FG001|Overall Study|Missing|3|||
161762293|NCT01117428|584167893|FG000|Overall Study|Lack of Efficacy|1|||
161762294|NCT01117428|584167894|FG001|Overall Study|Lack of Efficacy|0|||
161762295|NCT01117428|584167895|FG002|Overall Study|Lack of Efficacy|0|||
161762296|NCT01117428|584167896|FG003|Overall Study|Lack of Efficacy|0|||
161762297|NCT01117428|584167897|FG004|Overall Study|Lack of Efficacy|0|||
161762298|NCT01117428|584167898|FG005|Overall Study|Lack of Efficacy|0|||
161762299|NCT01117428|584167893|FG000|Overall Study|Adverse Event|4|||
161762300|NCT01117428|584167894|FG001|Overall Study|Adverse Event|0|||
161762301|NCT01117428|584167895|FG002|Overall Study|Adverse Event|0|||
161762302|NCT01117428|584167896|FG003|Overall Study|Adverse Event|0|||
161762303|NCT01117428|584167897|FG004|Overall Study|Adverse Event|1|||
161762304|NCT01117428|584167898|FG005|Overall Study|Adverse Event|2|||
161762305|NCT01117428|584167893|FG000|Overall Study|Death|0|||
161762306|NCT01117428|584167894|FG001|Overall Study|Death|1|||
161762307|NCT01117428|584167895|FG002|Overall Study|Death|2|||
161762308|NCT01117428|584167896|FG003|Overall Study|Death|0|||
161762309|NCT01117428|584167897|FG004|Overall Study|Death|0|||
161762310|NCT01117428|584167898|FG005|Overall Study|Death|1|||
161762311|NCT01117428|584167893|FG000|Overall Study|Physician Decision|0|||
161762312|NCT01117428|584167894|FG001|Overall Study|Physician Decision|1|||
161762313|NCT01117428|584167895|FG002|Overall Study|Physician Decision|0|||
161762314|NCT01117428|584167896|FG003|Overall Study|Physician Decision|0|||
161762315|NCT01117428|584167897|FG004|Overall Study|Physician Decision|0|||
161762316|NCT01117428|584167898|FG005|Overall Study|Physician Decision|0|||
161762317|NCT01117428|584167893|FG000|Overall Study|Withdrawal by Subject|0|||
161762318|NCT01117428|584167894|FG001|Overall Study|Withdrawal by Subject|0|||
161762319|NCT01117428|584167895|FG002|Overall Study|Withdrawal by Subject|1|||
161762320|NCT01117428|584167896|FG003|Overall Study|Withdrawal by Subject|0|||
161762321|NCT01117428|584167897|FG004|Overall Study|Withdrawal by Subject|0|||
161762322|NCT01117428|584167898|FG005|Overall Study|Withdrawal by Subject|0|||
161762323|NCT01117428|584167893|FG000|Overall Study|Progressive disease|15|||
161762324|NCT01117428|584167894|FG001|Overall Study|Progressive disease|27|||
161762325|NCT01117428|584167895|FG002|Overall Study|Progressive disease|10|||
161762326|NCT01117428|584167896|FG003|Overall Study|Progressive disease|12|||
161762327|NCT01117428|584167897|FG004|Overall Study|Progressive disease|16|||
161762328|NCT01117428|584167898|FG005|Overall Study|Progressive disease|17|||
161762329|NCT02195531|584167899|FG000|Overall Study|Withdrawal by Subject|1|||
161762330|NCT02195531|584167900|FG001|Overall Study|Withdrawal by Subject|1|||
161762331|NCT02195531|584167901|FG002|Overall Study|Withdrawal by Subject|1|||
161762332|NCT01034709|584167905|FG000|Overall Study|Protocol Violation|9|||
161762333|NCT01034709|584167906|FG001|Overall Study|Protocol Violation|16|||
161762334|NCT01657253|584167909|FG000|Overall Study|Lost to Follow-up|6|||
161762335|NCT01657253|584167910|FG001|Overall Study|Lost to Follow-up|5|||
161762336|NCT01657253|584167909|FG000|Overall Study|Withdrawal by Subject|11|||
161762337|NCT01657253|584167910|FG001|Overall Study|Withdrawal by Subject|12|||
161762338|NCT01657253|584167909|FG000|Overall Study|Adverse Event|0|||
161762339|NCT01657253|584167910|FG001|Overall Study|Adverse Event|1|||
161762340|NCT01970540|584167911|FG000|Overall Study|Non-treatment-related AE|0|||
161762341|NCT01970540|584167912|FG001|Overall Study|Non-treatment-related AE|0|||
161762342|NCT01970540|584167913|FG002|Overall Study|Non-treatment-related AE|1|||
161762343|NCT01970540|584167911|FG000|Overall Study|Progressive disease|55|||
161762344|NCT01970540|584167912|FG001|Overall Study|Progressive disease|23|||
161762345|NCT01970540|584167913|FG002|Overall Study|Progressive disease|10|||
161762346|NCT01970540|584167911|FG000|Overall Study|Treatment delay over protocol|0|||
161762347|NCT01970540|584167912|FG001|Overall Study|Treatment delay over protocol|0|||
161762348|NCT01970540|584167913|FG002|Overall Study|Treatment delay over protocol|1|||
161762349|NCT01970540|584167911|FG000|Overall Study|Physician Decision|7|||
161762350|NCT01970540|584167912|FG001|Overall Study|Physician Decision|2|||
161762351|NCT01970540|584167913|FG002|Overall Study|Physician Decision|0|||
161762352|NCT01970540|584167911|FG000|Overall Study|Clinical progression|0|||
161762353|NCT01970540|584167912|FG001|Overall Study|Clinical progression|1|||
161762354|NCT01970540|584167913|FG002|Overall Study|Clinical progression|1|||
161762355|NCT01970540|584167911|FG000|Overall Study|End of study|2|||
161762356|NCT01970540|584167912|FG001|Overall Study|End of study|0|||
161762357|NCT01970540|584167913|FG002|Overall Study|End of study|2|||
161762358|NCT01970540|584167911|FG000|Overall Study|Adverse Event|0|||
161762359|NCT01970540|584167912|FG001|Overall Study|Adverse Event|2|||
161762360|NCT01970540|584167913|FG002|Overall Study|Adverse Event|1|||
161762361|NCT01970540|584167911|FG000|Overall Study|Treatment-related AE|4|||
161762362|NCT01970540|584167912|FG001|Overall Study|Treatment-related AE|0|||
161762363|NCT01970540|584167913|FG002|Overall Study|Treatment-related AE|2|||
161762364|NCT01970540|584167911|FG000|Overall Study|Withdrawal by Subject|4|||
161762365|NCT01970540|584167912|FG001|Overall Study|Withdrawal by Subject|0|||
161762366|NCT01970540|584167913|FG002|Overall Study|Withdrawal by Subject|1|||
161762367|NCT01970540|584167911|FG000|Overall Study|Clinical deterioration|1|||
161762368|NCT01970540|584167912|FG001|Overall Study|Clinical deterioration|0|||
161762369|NCT01970540|584167913|FG002|Overall Study|Clinical deterioration|0|||
161762370|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Adverse Event|30|||
161762371|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Adverse Event|25|||
161762372|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Adverse Event|23|||
161762373|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Adverse Event|14|||
161762374|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Death|0|||
161762375|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Death|0|||
161762376|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Death|1|||
161762377|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Death|0|||
161762378|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Physician Decision|0|||
161762379|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Physician Decision|1|||
161762380|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Physician Decision|0|||
161762381|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Physician Decision|1|||
161762382|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
161762383|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
161847817|NCT03301649|584484117|FG001|Overall Study|Need alternate therapy due to live lice|25|||
161762384|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
161762385|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
161762386|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Other|6|||
161762387|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Other|1|||
161762388|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Other|0|||
161762389|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Other|2|||
161762390|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
161762391|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
161762392|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
161762393|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
161762394|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
161762395|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
161762396|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
161762397|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
161762398|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
161762399|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
161762400|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
161762401|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
161762402|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
161762403|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
161762404|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
161762405|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
161762406|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Adverse Event|2|||
161762407|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Adverse Event|3|||
161762408|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Adverse Event|5|||
161762409|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Adverse Event|2|||
161762410|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Physician Decision|1|||
161762411|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Physician Decision|1|||
161762412|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Physician Decision|0|||
161762413|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Physician Decision|0|||
161762414|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Other|24|||
161762415|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Other|24|||
161762416|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Other|9|||
161762417|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Other|11|||
161762418|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Extension not Available|17|||
161762419|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Extension not Available|21|||
161762420|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Extension not Available|8|||
161762421|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Extension not Available|7|||
161762422|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
161762423|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
161762424|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
161762425|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
161762426|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
161762427|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
161762428|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
161762429|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
161762430|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
161762431|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
161762432|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
161762433|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
161762434|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Death|0|||
161762435|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Death|0|||
161762436|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Death|0|||
161762437|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Death|1|||
161762438|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
161762439|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
161762440|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
161762441|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
161762442|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Other|3|||
161762443|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Other|5|||
161762444|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Other|4|||
161762445|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Other|3|||
161762446|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
161762447|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
161762448|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
161762449|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
161762450|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
161762451|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
161762452|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
161762453|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
161762454|NCT01057394|584167919|FG000|Overall Study|Not eligible|0|||
161762455|NCT01057394|584167920|FG001|Overall Study|Not eligible|2|||
161762456|NCT00579527|584167921|FG000|Overall Study|Death|4|||
161762457|NCT00203294|584167922|FG000|Overall Study|Withdrawal by Subject|8|||
161762458|NCT00203294|584167923|FG001|Overall Study|Withdrawal by Subject|13|||
161762459|NCT02177942|584167933|FG000|Overall Study|Adverse Event|1|||
161762460|NCT02177942|584167934|FG001|Overall Study|Adverse Event|0|||
161762461|NCT02177942|584167933|FG000|Overall Study|Lost to Follow-up|1|||
161762462|NCT02177942|584167934|FG001|Overall Study|Lost to Follow-up|1|||
161762463|NCT02177942|584167933|FG000|Overall Study|Protocol Violation|4|||
161762464|NCT02177942|584167934|FG001|Overall Study|Protocol Violation|6|||
161762465|NCT02177942|584167933|FG000|Overall Study|Withdrawal by Subject|71|||
161762466|NCT02177942|584167934|FG001|Overall Study|Withdrawal by Subject|81|||
161762467|NCT01948791|584167938|FG000|Overall Study|Adverse Event|12|||
161762468|NCT01948791|584167938|FG000|Overall Study|Lack of Efficacy|3|||
161762469|NCT01948791|584167938|FG000|Overall Study|Protocol Violation|2|||
161762470|NCT01948791|584167938|FG000|Overall Study|Withdrawal by Subject|5|||
161762471|NCT01948791|584167938|FG000|Overall Study|Lost to Follow-up|6|||
161762472|NCT01948791|584167938|FG000|Overall Study|Management issues|1|||
161762473|NCT01948791|584167938|FG000|Overall Study|Others|7|||
161762474|NCT01948791|584167938|FG000|Overall Study|Screening failure|35|||
161762475|NCT02555722|584167946|FG000|Week 2|Adverse Event|0|||
161762476|NCT02555722|584167947|FG001|Week 2|Adverse Event|1|||
161762477|NCT02555722|584167946|FG000|Week 2|Withdrawal by Subject|1|||
161762478|NCT02555722|584167947|FG001|Week 2|Withdrawal by Subject|0|||
161762479|NCT02555722|584167946|FG000|Month 1|Lens Discomfort|1|||
161762480|NCT02555722|584167947|FG001|Month 1|Lens Discomfort|0|||
161762481|NCT02555722|584167946|FG000|Month 2|Withdrawal by Subject|3|||
161762482|NCT02555722|584167947|FG001|Month 2|Withdrawal by Subject|0|||
161762483|NCT02555722|584167946|FG000|Month 2|Lost to Follow-up|1|||
161762484|NCT02555722|584167947|FG001|Month 2|Lost to Follow-up|0|||
161762485|NCT00702949|584167948|FG000|Overall Study|Refusal|3|||
161762486|NCT00702949|584167949|FG001|Overall Study|Refusal|2|||
161762487|NCT00702949|584167950|FG002|Overall Study|Refusal|2|||
161762488|NCT00702949|584167948|FG000|Overall Study|Adverse Event|1|||
161762489|NCT00702949|584167949|FG001|Overall Study|Adverse Event|6|||
161762490|NCT00702949|584167950|FG002|Overall Study|Adverse Event|3|||
161762491|NCT00702949|584167948|FG000|Overall Study|Other Medical Reason/unknown|1|||
161762492|NCT00702949|584167949|FG001|Overall Study|Other Medical Reason/unknown|1|||
161762493|NCT00702949|584167950|FG002|Overall Study|Other Medical Reason/unknown|3|||
161762494|NCT00598585|584167951|FG000|Overall Study|Lost to Follow-up|1|||
161762495|NCT00598585|584167952|FG001|Overall Study|Lost to Follow-up|0|||
161762496|NCT01040728|584167953|FG000|Overall Study|Adverse Event|4|||
161762497|NCT01040728|584167954|FG001|Overall Study|Adverse Event|8|||
161762498|NCT01040728|584167955|FG002|Overall Study|Adverse Event|0|||
161762499|NCT01040728|584167956|FG003|Overall Study|Adverse Event|4|||
161762500|NCT01040728|584167953|FG000|Overall Study|Withdrawal by Subject|0|||
161762501|NCT01040728|584167954|FG001|Overall Study|Withdrawal by Subject|1|||
161762502|NCT01040728|584167955|FG002|Overall Study|Withdrawal by Subject|1|||
161762503|NCT01040728|584167956|FG003|Overall Study|Withdrawal by Subject|0|||
161762504|NCT01040728|584167953|FG000|Overall Study|Protocol Violation|0|||
161762505|NCT01040728|584167954|FG001|Overall Study|Protocol Violation|0|||
161762506|NCT01040728|584167955|FG002|Overall Study|Protocol Violation|0|||
161762507|NCT01040728|584167956|FG003|Overall Study|Protocol Violation|1|||
161762508|NCT01040728|584167953|FG000|Overall Study|Lack of Efficacy|0|||
161762509|NCT01040728|584167954|FG001|Overall Study|Lack of Efficacy|1|||
161762510|NCT01040728|584167955|FG002|Overall Study|Lack of Efficacy|0|||
161762511|NCT01040728|584167956|FG003|Overall Study|Lack of Efficacy|1|||
161762512|NCT01040728|584167953|FG000|Overall Study|Other reasons not listed above|0|||
161762513|NCT01040728|584167954|FG001|Overall Study|Other reasons not listed above|1|||
161762514|NCT01040728|584167955|FG002|Overall Study|Other reasons not listed above|0|||
161762515|NCT01040728|584167956|FG003|Overall Study|Other reasons not listed above|0|||
161762516|NCT03196973|584167959|FG000|Overall Study|Adverse Event|1|||
161762517|NCT03196973|584167960|FG001|Overall Study|Adverse Event|1|||
161762518|NCT03196973|584167961|FG002|Overall Study|Adverse Event|2|||
161762519|NCT03196973|584167959|FG000|Overall Study|Lack of Efficacy|2|||
161762520|NCT03196973|584167960|FG001|Overall Study|Lack of Efficacy|6|||
161762521|NCT03196973|584167961|FG002|Overall Study|Lack of Efficacy|1|||
161762522|NCT03196973|584167959|FG000|Overall Study|Lost to Follow-up|4|||
161762523|NCT03196973|584167960|FG001|Overall Study|Lost to Follow-up|3|||
161762524|NCT03196973|584167961|FG002|Overall Study|Lost to Follow-up|2|||
161762525|NCT03196973|584167959|FG000|Overall Study|Consent withdrawn|2|||
161762526|NCT03196973|584167960|FG001|Overall Study|Consent withdrawn|1|||
161762527|NCT03196973|584167961|FG002|Overall Study|Consent withdrawn|0|||
161762528|NCT03196973|584167959|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
161762529|NCT03196973|584167960|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
161762530|NCT03196973|584167961|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
161847818|NCT03301649|584484118|FG002|Overall Study|Need alternate therapy due to live lice|81|||
161847819|NCT03301649|584484116|FG000|Overall Study|Lost to Follow-up|11|||
161847820|NCT03301649|584484117|FG001|Overall Study|Lost to Follow-up|11|||
161847821|NCT03301649|584484118|FG002|Overall Study|Lost to Follow-up|3|||
161847822|NCT03301649|584484116|FG000|Overall Study|Protocol Violation|0|||
161847823|NCT03301649|584484117|FG001|Overall Study|Protocol Violation|1|||
161847824|NCT03301649|584484118|FG002|Overall Study|Protocol Violation|1|||
161847825|NCT03301649|584484116|FG000|Overall Study|Withdrawal by Subject|10|||
161847826|NCT03301649|584484117|FG001|Overall Study|Withdrawal by Subject|4|||
161847827|NCT03301649|584484118|FG002|Overall Study|Withdrawal by Subject|0|||
161847828|NCT03301649|584484116|FG000|Overall Study|Other than specified|5|||
161847829|NCT03301649|584484117|FG001|Overall Study|Other than specified|3|||
161847830|NCT03301649|584484118|FG002|Overall Study|Other than specified|0|||
161847831|NCT01403051|584484119|FG000|Overall Study|Protocol Violation|2|||
161847832|NCT01403051|584484120|FG001|Overall Study|Protocol Violation|0|||
161847833|NCT01403051|584484119|FG000|Overall Study|Death|1|||
161847834|NCT01403051|584484120|FG001|Overall Study|Death|0|||
161847835|NCT01403051|584484119|FG000|Overall Study|Withdrawal by Subject|2|||
161847836|NCT01403051|584484120|FG001|Overall Study|Withdrawal by Subject|1|||
161847837|NCT01403051|584484119|FG000|Overall Study|Lost to Follow-up|5|||
161847838|NCT01403051|584484120|FG001|Overall Study|Lost to Follow-up|5|||
161847839|NCT02932306|584484133|FG000|Overall Study|Withdrawal by Subject|16|||
161847840|NCT02932306|584484134|FG001|Overall Study|Withdrawal by Subject|25|||
161847841|NCT02932306|584484133|FG000|Overall Study|Adverse Event|3|||
161847842|NCT02932306|584484134|FG001|Overall Study|Adverse Event|0|||
161847843|NCT02932306|584484133|FG000|Overall Study|Pregnancy|2|||
161847844|NCT02932306|584484134|FG001|Overall Study|Pregnancy|0|||
161847845|NCT02932306|584484133|FG000|Overall Study|Protocol Violation|1|||
161847846|NCT02932306|584484134|FG001|Overall Study|Protocol Violation|1|||
161847847|NCT02932306|584484133|FG000|Overall Study|Noncompliance with Study Drug|1|||
161847848|NCT02932306|584484134|FG001|Overall Study|Noncompliance with Study Drug|1|||
161847849|NCT02932306|584484133|FG000|Overall Study|Lost to Follow-up|36|||
161847850|NCT02932306|584484134|FG001|Overall Study|Lost to Follow-up|40|||
161847851|NCT02932306|584484133|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
161847852|NCT02932306|584484134|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
161847853|NCT02932306|584484133|FG000|Overall Study|Lack of Efficacy|0|||
161847854|NCT02932306|584484134|FG001|Overall Study|Lack of Efficacy|2|||
161847855|NCT02932306|584484133|FG000|Overall Study|Worsening condition|2|||
161847856|NCT02932306|584484134|FG001|Overall Study|Worsening condition|0|||
161847857|NCT02932306|584484133|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
161847858|NCT02932306|584484134|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
161847859|NCT02065700|584484135|FG000|Overall Study|Adverse Event|165|||
161847860|NCT02065700|584484136|FG001|Overall Study|Adverse Event|101|||
161847861|NCT02065700|584484135|FG000|Overall Study|Withdrawal by Subject|90|||
161847862|NCT02065700|584484136|FG001|Overall Study|Withdrawal by Subject|29|||
161847863|NCT02065700|584484135|FG000|Overall Study|Lost to Follow-up|12|||
161847864|NCT02065700|584484136|FG001|Overall Study|Lost to Follow-up|9|||
161847865|NCT02065700|584484135|FG000|Overall Study|Physician Decision|2|||
161847866|NCT02065700|584484136|FG001|Overall Study|Physician Decision|0|||
161847867|NCT02065700|584484135|FG000|Overall Study|Sponsor Request|38|||
161847868|NCT02065700|584484136|FG001|Overall Study|Sponsor Request|15|||
161847869|NCT02065700|584484135|FG000|Overall Study|Treatment Failure|3|||
161847870|NCT02065700|584484136|FG001|Overall Study|Treatment Failure|2|||
161847871|NCT02065700|584484135|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
161847872|NCT02065700|584484136|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
161847873|NCT02065700|584484135|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
161847874|NCT02065700|584484136|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
161847875|NCT02065700|584484135|FG000|Overall Study|Non-compliance with Study Procedures|2|||
161847876|NCT02065700|584484136|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161847877|NCT02065700|584484135|FG000|Overall Study|Not Defined|21|||
161847878|NCT02065700|584484136|FG001|Overall Study|Not Defined|3|||
161847879|NCT02315196|584484137|FG000|Overall Study|Withdrew consent|9|||
161847880|NCT01635218|584484138|FG000|Overall Study|Lost to Follow-up|3|||
161847881|NCT01635218|584484139|FG001|Overall Study|Lost to Follow-up|7|||
161847882|NCT01635218|584484140|FG002|Overall Study|Lost to Follow-up|6|||
161847883|NCT03559400|584484141|FG000|Overall Study|Lost to Follow-up|9|||
161847884|NCT03559400|584484142|FG001|Overall Study|Lost to Follow-up|7|||
161847885|NCT03559400|584484141|FG000|Overall Study|Death|0|||
161847886|NCT03559400|584484142|FG001|Overall Study|Death|2|||
161847887|NCT03262038|584484143|FG000|Overall Study|Withdrawal by Subject|0|||
161847888|NCT03262038|584484144|FG001|Overall Study|Withdrawal by Subject|1|||
161847889|NCT04933968|584484145|FG000|Overall Study|Adverse Event|0|||
161847890|NCT04933968|584484146|FG001|Overall Study|Adverse Event|0|||
161847891|NCT04933968|584484147|FG002|Overall Study|Adverse Event|1|||
161847892|NCT04933968|584484148|FG003|Overall Study|Adverse Event|1|||
161847893|NCT04933968|584484149|FG004|Overall Study|Adverse Event|0|||
161847894|NCT04933968|584484150|FG005|Overall Study|Adverse Event|0|||
161762531|NCT01610414|584167964|FG000|Study Start - Month 13|Serious Adverse Event|65|||
161762532|NCT01610414|584167965|FG001|Study Start - Month 13|Serious Adverse Event|67|||
161762533|NCT01610414|584167964|FG000|Study Start - Month 13|Adverse Event|14|||
161762534|NCT01610414|584167965|FG001|Study Start - Month 13|Adverse Event|14|||
161762535|NCT01610414|584167964|FG000|Study Start - Month 13|Protocol Violation|3|||
161762536|NCT01610414|584167965|FG001|Study Start - Month 13|Protocol Violation|1|||
161762537|NCT01610414|584167964|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
161762538|NCT01610414|584167965|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
161762539|NCT01610414|584167964|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
161762540|NCT01610414|584167965|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
161762541|NCT01610414|584167964|FG000|Study Start - Month 13|Lost to Follow-up|4|||
161762542|NCT01610414|584167965|FG001|Study Start - Month 13|Lost to Follow-up|6|||
161762543|NCT01610414|584167964|FG000|Study Start - Month 13|Suspected HZ episode|1|||
161762544|NCT01610414|584167965|FG001|Study Start - Month 13|Suspected HZ episode|3|||
161762545|NCT01610414|584167964|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
161762546|NCT01610414|584167965|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
161762547|NCT01610414|584167964|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
161762548|NCT01610414|584167965|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
161762549|NCT01610414|584167964|FG000|Month 13 - Month 25|Adverse Event|8|||
161762550|NCT01610414|584167965|FG001|Month 13 - Month 25|Adverse Event|4|||
161762551|NCT01610414|584167964|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
161762552|NCT01610414|584167965|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
161762553|NCT01610414|584167964|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
161762554|NCT01610414|584167965|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
161762555|NCT01610414|584167964|FG000|Month 13 - Month 25|Protocol Violation|0|||
161762556|NCT01610414|584167965|FG001|Month 13 - Month 25|Protocol Violation|2|||
161762557|NCT01610414|584167964|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
161762558|NCT01610414|584167965|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
161762559|NCT01610414|584167964|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
161762560|NCT01610414|584167965|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
161762561|NCT01610414|584167964|FG000|After Month 25|Study end not reached|48|||
161762562|NCT01610414|584167965|FG001|After Month 25|Study end not reached|53|||
161762563|NCT00472043|584167967|FG000|Overall Study|Withdrawal by Subject|1|||
161762564|NCT00472043|584167968|FG001|Overall Study|Withdrawal by Subject|0|||
161762565|NCT00472043|584167967|FG000|Overall Study|Death|1|||
161762566|NCT00472043|584167968|FG001|Overall Study|Death|0|||
161762567|NCT00826540|584167971|FG000|Overall Study|ineligible|3|||
161762568|NCT00826540|584167971|FG000|Overall Study|Withdrawal by Subject|1|||
161762569|NCT04009824|584167972|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
161762570|NCT04009824|584167973|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
161762571|NCT04009824|584167974|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
161762572|NCT04009824|584167975|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
161762573|NCT04009824|584167976|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
161762574|NCT01024946|584167977|FG000|Overall Study|Screen Failure|3|||
161762575|NCT01024946|584167977|FG000|Overall Study|Withdrawal by Subject|1|||
161762576|NCT01024946|584167977|FG000|Overall Study|Adverse Event|1|||
161762577|NCT03147495|584167978|FG000|Overall Study|Physician Decision|0|||
161762578|NCT03147495|584167979|FG001|Overall Study|Physician Decision|6|||
161762579|NCT02608892|584167980|FG000|Overall Study|Lost to Follow-up|1|||
161762580|NCT02608892|584167981|FG001|Overall Study|Lost to Follow-up|0|||
161762581|NCT03032523|584167982|FG000|Overall Study|Withdrawal by Subject|2|||
161762582|NCT03032523|584167983|FG001|Overall Study|Withdrawal by Subject|2|||
161762583|NCT03032523|584167982|FG000|Overall Study|Physician Decision|1|||
161762584|NCT03032523|584167983|FG001|Overall Study|Physician Decision|0|||
161762585|NCT00957723|584167984|FG000|Overall Study|Death|3|||
161762586|NCT00957723|584167984|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
161762587|NCT00957723|584167984|FG000|Overall Study|Lost to Follow-up|8|||
161762588|NCT00957723|584167984|FG000|Overall Study|Withdrawal by Subject|24|||
161762589|NCT00957723|584167984|FG000|Overall Study|Investigative Site Terminated|61|||
161762590|NCT00957723|584167984|FG000|Overall Study|Intercurrent Illness|2|||
161762591|NCT00957723|584167984|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
161762592|NCT05375838|584167985|FG000|Overall Study|Other|0|||
161762593|NCT05375838|584167986|FG001|Overall Study|Other|0|||
161762594|NCT05375838|584167987|FG002|Overall Study|Other|0|||
161762595|NCT05375838|584167988|FG003|Overall Study|Other|1|||
161762596|NCT05375838|584167989|FG004|Overall Study|Other|1|||
161762597|NCT05375838|584167990|FG005|Overall Study|Other|0|||
161762598|NCT05375838|584167985|FG000|Overall Study|Withdrawal by Subject|2|||
161762599|NCT05375838|584167986|FG001|Overall Study|Withdrawal by Subject|1|||
161762600|NCT05375838|584167987|FG002|Overall Study|Withdrawal by Subject|3|||
161762601|NCT05375838|584167988|FG003|Overall Study|Withdrawal by Subject|2|||
161762602|NCT05375838|584167989|FG004|Overall Study|Withdrawal by Subject|2|||
161847895|NCT04933968|584484145|FG000|Overall Study|Lost to Follow-up|1|||
161762603|NCT05375838|584167990|FG005|Overall Study|Withdrawal by Subject|0|||
161762604|NCT05375838|584167985|FG000|Overall Study|Protocol Violation|0|||
161762605|NCT05375838|584167986|FG001|Overall Study|Protocol Violation|0|||
161762606|NCT05375838|584167987|FG002|Overall Study|Protocol Violation|0|||
161762607|NCT05375838|584167988|FG003|Overall Study|Protocol Violation|0|||
161762608|NCT05375838|584167989|FG004|Overall Study|Protocol Violation|1|||
161762609|NCT05375838|584167990|FG005|Overall Study|Protocol Violation|0|||
161762610|NCT05375838|584167985|FG000|Overall Study|Physician Decision|0|||
161762611|NCT05375838|584167986|FG001|Overall Study|Physician Decision|1|||
161762612|NCT05375838|584167987|FG002|Overall Study|Physician Decision|0|||
161762613|NCT05375838|584167988|FG003|Overall Study|Physician Decision|0|||
161762614|NCT05375838|584167989|FG004|Overall Study|Physician Decision|0|||
161762615|NCT05375838|584167990|FG005|Overall Study|Physician Decision|1|||
161762616|NCT05375838|584167985|FG000|Overall Study|Lost to Follow-up|2|||
161762617|NCT05375838|584167986|FG001|Overall Study|Lost to Follow-up|7|||
161762618|NCT05375838|584167987|FG002|Overall Study|Lost to Follow-up|0|||
161762619|NCT05375838|584167988|FG003|Overall Study|Lost to Follow-up|4|||
161762620|NCT05375838|584167989|FG004|Overall Study|Lost to Follow-up|2|||
161762621|NCT05375838|584167990|FG005|Overall Study|Lost to Follow-up|3|||
161762622|NCT00877890|584167991|FG000|Overall Study|Adverse Event|6|||
161762623|NCT00877890|584167992|FG001|Overall Study|Adverse Event|6|||
161762624|NCT00877890|584167991|FG000|Overall Study|Lost to Follow-up|5|||
161762625|NCT00877890|584167992|FG001|Overall Study|Lost to Follow-up|5|||
161762626|NCT00877890|584167991|FG000|Overall Study|Protocol Violation|0|||
161762627|NCT00877890|584167992|FG001|Overall Study|Protocol Violation|1|||
161762628|NCT00877890|584167991|FG000|Overall Study|Withdrawal of Consent|6|||
161762629|NCT00877890|584167992|FG001|Overall Study|Withdrawal of Consent|12|||
161762630|NCT00877890|584167991|FG000|Overall Study|Investigator Decision|0|||
161762631|NCT00877890|584167992|FG001|Overall Study|Investigator Decision|2|||
161762632|NCT00877890|584167991|FG000|Overall Study|Loss of Glucose Control|3|||
161762633|NCT00877890|584167992|FG001|Overall Study|Loss of Glucose Control|4|||
161762634|NCT00984009|584167993|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
161762635|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
161762636|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
161762637|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
161762638|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
161762639|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
161762640|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
161762641|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
161762642|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
161762643|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
161762644|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
161762645|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
161762646|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161762647|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
161762648|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
161762649|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
161762650|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
161762651|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
161762652|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
161762653|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
161762654|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
161762655|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
161762656|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
161762657|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
161762658|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
161762659|NCT02036476|584168006|FG000|Overall Study|Withdrawal by Subject|2|||
161762660|NCT02036476|584168006|FG000|Overall Study|Progressive Disease|4|||
161762661|NCT02036476|584168006|FG000|Overall Study|Unacceptable Toxicity|2|||
161762662|NCT02698176|584168007|FG000|Overall Study|Progressive disease|4|||
161762663|NCT02698176|584168008|FG001|Overall Study|Progressive disease|3|||
161762664|NCT02698176|584168009|FG002|Overall Study|Progressive disease|1|||
161762665|NCT02698176|584168010|FG003|Overall Study|Progressive disease|0|||
161762666|NCT02698176|584168007|FG000|Overall Study|Adverse Event|2|||
161762667|NCT02698176|584168008|FG001|Overall Study|Adverse Event|0|||
161762668|NCT02698176|584168009|FG002|Overall Study|Adverse Event|0|||
161762669|NCT02698176|584168010|FG003|Overall Study|Adverse Event|0|||
161762670|NCT02698176|584168007|FG000|Overall Study|Clinical progression|3|||
161762671|NCT02698176|584168008|FG001|Overall Study|Clinical progression|0|||
161762672|NCT02698176|584168009|FG002|Overall Study|Clinical progression|0|||
161762673|NCT02698176|584168010|FG003|Overall Study|Clinical progression|0|||
161762674|NCT02985684|584168012|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
161762675|NCT02985684|584168012|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
161762676|NCT02985684|584168012|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
161762677|NCT01084096|584169638|FG000|Overall Study|Lost to Follow-up|1501|||
161762678|NCT01084096|584169639|FG001|Overall Study|Lost to Follow-up|1833|||
161762679|NCT01084096|584169638|FG000|Overall Study|Withdrawal by Subject|3|||
161762680|NCT01084096|584169639|FG001|Overall Study|Withdrawal by Subject|0|||
161762681|NCT01084096|584169638|FG000|Overall Study|Woman had a miscarriage|21|||
161762682|NCT01084096|584169639|FG001|Overall Study|Woman had a miscarriage|17|||
161762683|NCT00027846|584169640|FG000|Overall Study|Lost to Follow-up|0|||
161762684|NCT00027846|584169641|FG001|Overall Study|Lost to Follow-up|41|||
161762685|NCT00027846|584169642|FG002|Overall Study|Lost to Follow-up|9|||
161762686|NCT00027846|584169640|FG000|Overall Study|Withdrawal by Subject|0|||
161762687|NCT00027846|584169641|FG001|Overall Study|Withdrawal by Subject|14|||
161762688|NCT00027846|584169642|FG002|Overall Study|Withdrawal by Subject|7|||
161762689|NCT00027846|584169640|FG000|Overall Study|Ineligible for study|2|||
161762690|NCT00027846|584169641|FG001|Overall Study|Ineligible for study|6|||
161762691|NCT00027846|584169642|FG002|Overall Study|Ineligible for study|14|||
161762692|NCT00027846|584169640|FG000|Overall Study|Entry into another COG therapeutic study|0|||
161762693|NCT00027846|584169641|FG001|Overall Study|Entry into another COG therapeutic study|5|||
161762694|NCT00027846|584169642|FG002|Overall Study|Entry into another COG therapeutic study|2|||
161762695|NCT00027846|584169640|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
161762696|NCT00027846|584169641|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
161762697|NCT00027846|584169642|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
161762698|NCT02033369|584169643|FG000|Overall Study|Physician Decision|1|||
161762699|NCT02033369|584169644|FG001|Overall Study|Physician Decision|2|||
161762700|NCT02033369|584169643|FG000|Overall Study|Not a good demographic match|0|||
161762701|NCT02033369|584169644|FG001|Overall Study|Not a good demographic match|2|||
161762702|NCT02033369|584169643|FG000|Overall Study|Withdrawal by Subject|1|||
161762703|NCT02033369|584169644|FG001|Overall Study|Withdrawal by Subject|1|||
161762704|NCT02033369|584169643|FG000|Overall Study|Lost to Follow-up|1|||
161762705|NCT02033369|584169644|FG001|Overall Study|Lost to Follow-up|0|||
161762706|NCT02033369|584169643|FG000|Overall Study|Protocol Violation|2|||
161762707|NCT02033369|584169644|FG001|Overall Study|Protocol Violation|0|||
161762708|NCT01249404|584169647|FG000|Overall Study|Study treatment not received|0|||
161762709|NCT01249404|584169648|FG001|Overall Study|Study treatment not received|1|||
161762710|NCT01249404|584169649|FG002|Overall Study|Study treatment not received|2|||
161762711|NCT01249404|584169647|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
161762712|NCT01249404|584169648|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
161762713|NCT01249404|584169649|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
161762714|NCT01249404|584169647|FG000|Overall Study|Adverse Event|2|||
161762715|NCT01249404|584169648|FG001|Overall Study|Adverse Event|2|||
161762716|NCT01249404|584169649|FG002|Overall Study|Adverse Event|2|||
161762717|NCT01249404|584169647|FG000|Overall Study|Withdrawal by Subject|2|||
161762718|NCT01249404|584169648|FG001|Overall Study|Withdrawal by Subject|2|||
161762719|NCT01249404|584169649|FG002|Overall Study|Withdrawal by Subject|0|||
161762720|NCT01249404|584169647|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
161762721|NCT01249404|584169648|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
161762722|NCT01249404|584169649|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
161762723|NCT01249404|584169647|FG000|Overall Study|Non compliance to visit schedule|0|||
161762724|NCT01249404|584169648|FG001|Overall Study|Non compliance to visit schedule|1|||
161762725|NCT01249404|584169649|FG002|Overall Study|Non compliance to visit schedule|0|||
161762726|NCT03758612|584169650|FG000|Washout Period|Withdrawal by Subject|0|||
161762727|NCT03758612|584169651|FG001|Washout Period|Withdrawal by Subject|0|||
161762728|NCT03758612|584169652|FG002|Washout Period|Withdrawal by Subject|2|||
161762729|NCT03758612|584169653|FG003|Washout Period|Withdrawal by Subject|0|||
161762730|NCT03758612|584169654|FG004|Washout Period|Withdrawal by Subject|0|||
161762731|NCT03758612|584169655|FG005|Washout Period|Withdrawal by Subject|0|||
161762732|NCT03758612|584169656|FG006|Washout Period|Withdrawal by Subject|0|||
161762733|NCT03758612|584169657|FG007|Washout Period|Withdrawal by Subject|0|||
161847896|NCT04933968|584484146|FG001|Overall Study|Lost to Follow-up|0|||
161762734|NCT03758612|584169658|FG008|Washout Period|Withdrawal by Subject|0|||
161762735|NCT03758612|584169659|FG009|Washout Period|Withdrawal by Subject|0|||
161762736|NCT03758612|584169660|FG010|Washout Period|Withdrawal by Subject|0|||
161762737|NCT03758612|584169661|FG011|Washout Period|Withdrawal by Subject|0|||
161762738|NCT03758612|584169650|FG000|Period 2|Protocol Violation|0|||
161762739|NCT03758612|584169651|FG001|Period 2|Protocol Violation|0|||
161762740|NCT03758612|584169652|FG002|Period 2|Protocol Violation|0|||
161762741|NCT03758612|584169653|FG003|Period 2|Protocol Violation|0|||
161762742|NCT03758612|584169654|FG004|Period 2|Protocol Violation|1|||
161762743|NCT03758612|584169655|FG005|Period 2|Protocol Violation|0|||
161762744|NCT03758612|584169656|FG006|Period 2|Protocol Violation|0|||
161762745|NCT03758612|584169657|FG007|Period 2|Protocol Violation|0|||
161762746|NCT03758612|584169658|FG008|Period 2|Protocol Violation|0|||
161762747|NCT03758612|584169659|FG009|Period 2|Protocol Violation|0|||
161762748|NCT03758612|584169660|FG010|Period 2|Protocol Violation|0|||
161762749|NCT03758612|584169661|FG011|Period 2|Protocol Violation|0|||
161762750|NCT02500901|584169662|FG000|Overall Study|Disease ProgressionDD|2|||
161762751|NCT01191190|584169663|FG000|Overall Study|Withdrawal by Subject|1|||
161762752|NCT00348686|584169670|FG000|Overall Study|Withdrawal by Subject|45|||
161762753|NCT00348686|584169670|FG000|Overall Study|Adverse Event|5|||
161762754|NCT00348686|584169670|FG000|Overall Study|Protocol Violation|6|||
161762755|NCT00348686|584169670|FG000|Overall Study|Lost to Follow-up|2|||
161762756|NCT00348686|584169670|FG000|Overall Study|Multiple Reasons|8|||
161762757|NCT01258738|584169673|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
161762758|NCT01258738|584169674|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
161762759|NCT01258738|584169673|FG000|Double-blind Period|Withdrawal by Subject|2|||
161762760|NCT01258738|584169674|FG001|Double-blind Period|Withdrawal by Subject|2|||
161762761|NCT01258738|584169673|FG000|Double-blind Period|Protocol Violation|1|||
161762762|NCT01258738|584169674|FG001|Double-blind Period|Protocol Violation|1|||
161762763|NCT01258738|584169673|FG000|Double-blind Period|Adverse Event|3|||
161762764|NCT01258738|584169674|FG001|Double-blind Period|Adverse Event|1|||
161762765|NCT01258738|584169673|FG000|Open-label Period|Did not meet inclusion criteria|0|||
161762766|NCT01258738|584169674|FG001|Open-label Period|Did not meet inclusion criteria|1|||
161762767|NCT01258738|584169673|FG000|Open-label Period|Insufficient clinical response|5|||
161762768|NCT01258738|584169674|FG001|Open-label Period|Insufficient clinical response|3|||
161762769|NCT01258738|584169673|FG000|Open-label Period|Lost to Follow-up|0|||
161762770|NCT01258738|584169674|FG001|Open-label Period|Lost to Follow-up|2|||
161762771|NCT01258738|584169673|FG000|Open-label Period|Withdrawal by Subject|5|||
161762772|NCT01258738|584169674|FG001|Open-label Period|Withdrawal by Subject|6|||
161762773|NCT01258738|584169673|FG000|Open-label Period|Protocol Violation|2|||
161762774|NCT01258738|584169674|FG001|Open-label Period|Protocol Violation|2|||
161762775|NCT01258738|584169673|FG000|Open-label Period|Adverse Event|4|||
161762776|NCT01258738|584169674|FG001|Open-label Period|Adverse Event|5|||
161762777|NCT01258738|584169673|FG000|Open-label Period|Other Reasons|0|||
161762778|NCT01258738|584169674|FG001|Open-label Period|Other Reasons|1|||
161762779|NCT01258738|584169673|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
161762780|NCT01258738|584169674|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
161762781|NCT00689611|584169675|FG000|Overall Study|Death|6|||
161762782|NCT00689611|584169676|FG001|Overall Study|Death|9|||
161762783|NCT00689611|584169675|FG000|Overall Study|Withdrawal by Subject|8|||
161762784|NCT00689611|584169676|FG001|Overall Study|Withdrawal by Subject|9|||
161762785|NCT00689611|584169675|FG000|Overall Study|Lost to Follow-up|27|||
161762786|NCT00689611|584169676|FG001|Overall Study|Lost to Follow-up|28|||
161762787|NCT00568399|584169678|FG000|Overall Study|Death|2|||
161762788|NCT00568399|584169678|FG000|Overall Study|Adverse Event|5|||
161762789|NCT00568399|584169678|FG000|Overall Study|Withdrawal by Subject|8|||
161762790|NCT02967562|584169683|FG000|Overall Study|Consent not obtained|1|||
161762791|NCT02967562|584169684|FG001|Overall Study|Consent not obtained|0|||
161762792|NCT02967562|584169683|FG000|Overall Study|High leak precluding analysis|1|||
161762793|NCT02967562|584169684|FG001|Overall Study|High leak precluding analysis|1|||
161762794|NCT00405756|584169685|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
161762795|NCT00405756|584169686|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
161762796|NCT00405756|584169687|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
161762797|NCT00405756|584169685|FG000|Double-blind Treatment|Adverse Event|31|||
161762798|NCT00405756|584169686|FG001|Double-blind Treatment|Adverse Event|27|||
161762799|NCT00405756|584169687|FG002|Double-blind Treatment|Adverse Event|12|||
161762800|NCT00405756|584169685|FG000|Double-blind Treatment|Disease Progression|47|||
161762801|NCT00405756|584169686|FG001|Double-blind Treatment|Disease Progression|81|||
161762802|NCT00405756|584169687|FG002|Double-blind Treatment|Disease Progression|102|||
161762803|NCT00405756|584169685|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161847897|NCT04933968|584484147|FG002|Overall Study|Lost to Follow-up|1|||
161847898|NCT04933968|584484148|FG003|Overall Study|Lost to Follow-up|0|||
161847899|NCT04933968|584484149|FG004|Overall Study|Lost to Follow-up|0|||
161847900|NCT04933968|584484150|FG005|Overall Study|Lost to Follow-up|0|||
161762804|NCT00405756|584169686|FG001|Double-blind Treatment|Lack of Efficacy|4|||
161762805|NCT00405756|584169687|FG002|Double-blind Treatment|Lack of Efficacy|2|||
161762806|NCT00405756|584169685|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
161762807|NCT00405756|584169686|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
161762808|NCT00405756|584169687|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
161762809|NCT00405756|584169685|FG000|Double-blind Treatment|Lost to Follow-up|1|||
161762810|NCT00405756|584169686|FG001|Double-blind Treatment|Lost to Follow-up|0|||
161762811|NCT00405756|584169687|FG002|Double-blind Treatment|Lost to Follow-up|0|||
161762812|NCT00405756|584169685|FG000|Double-blind Treatment|Death|4|||
161762813|NCT00405756|584169686|FG001|Double-blind Treatment|Death|4|||
161762814|NCT00405756|584169687|FG002|Double-blind Treatment|Death|4|||
161762815|NCT00405756|584169685|FG000|Double-blind Treatment|Protocol Violation|1|||
161762816|NCT00405756|584169686|FG001|Double-blind Treatment|Protocol Violation|0|||
161762817|NCT00405756|584169687|FG002|Double-blind Treatment|Protocol Violation|2|||
161762818|NCT00405756|584169685|FG000|Double-blind Treatment|Other|7|||
161762819|NCT00405756|584169686|FG001|Double-blind Treatment|Other|4|||
161762820|NCT00405756|584169687|FG002|Double-blind Treatment|Other|4|||
161762821|NCT00405756|584169685|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
161762822|NCT00405756|584169686|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
161762823|NCT00405756|584169687|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
161762824|NCT00405756|584169685|FG000|Open-label Extension|Adverse Event|1|||
161762825|NCT00405756|584169686|FG001|Open-label Extension|Adverse Event|3|||
161762826|NCT00405756|584169687|FG002|Open-label Extension|Adverse Event|7|||
161762827|NCT00405756|584169685|FG000|Open-label Extension|Disease Progression|8|||
161762828|NCT00405756|584169686|FG001|Open-label Extension|Disease Progression|23|||
161762829|NCT00405756|584169687|FG002|Open-label Extension|Disease Progression|26|||
161762830|NCT00405756|584169685|FG000|Open-label Extension|Withdrawal by Subject|2|||
161762831|NCT00405756|584169686|FG001|Open-label Extension|Withdrawal by Subject|3|||
161762832|NCT00405756|584169687|FG002|Open-label Extension|Withdrawal by Subject|3|||
161762833|NCT00405756|584169685|FG000|Open-label Extension|Death|1|||
161762834|NCT00405756|584169686|FG001|Open-label Extension|Death|2|||
161762835|NCT00405756|584169687|FG002|Open-label Extension|Death|4|||
161762836|NCT00405756|584169685|FG000|Open-label Extension|Other|0|||
161762837|NCT00405756|584169686|FG001|Open-label Extension|Other|1|||
161762838|NCT00405756|584169687|FG002|Open-label Extension|Other|7|||
161762839|NCT00405756|584169685|FG000|Follow-up|Ongoing in Follow-up Period|52|||
161762840|NCT00405756|584169686|FG001|Follow-up|Ongoing in Follow-up Period|51|||
161762841|NCT00405756|584169687|FG002|Follow-up|Ongoing in Follow-up Period|60|||
161762842|NCT00405756|584169685|FG000|Follow-up|Death|21|||
161762843|NCT00405756|584169686|FG001|Follow-up|Death|31|||
161762844|NCT00405756|584169687|FG002|Follow-up|Death|24|||
161762845|NCT00405756|584169685|FG000|Follow-up|Lost to Follow-up|2|||
161762846|NCT00405756|584169686|FG001|Follow-up|Lost to Follow-up|8|||
161762847|NCT00405756|584169687|FG002|Follow-up|Lost to Follow-up|4|||
161762848|NCT01051856|584169694|FG000|Overall Study|Withdrawal by Subject|1|||
161762849|NCT01051856|584169695|FG001|Overall Study|Withdrawal by Subject|0|||
161762850|NCT02176226|584169696|FG000|Overall Study|Lost to Follow-up|3|||
161762851|NCT02176226|584169696|FG000|Overall Study|Withdrew prior to treatment|6|||
161762852|NCT01072500|584169699|FG000|Overall Study|Death|2|||
161762853|NCT01072500|584169700|FG001|Overall Study|Death|2|||
161762854|NCT01072500|584169699|FG000|Overall Study|Lost to Follow-up|5|||
161762855|NCT01072500|584169700|FG001|Overall Study|Lost to Follow-up|2|||
161762856|NCT01072500|584169699|FG000|Overall Study|Withdrawal by Subject|17|||
161762857|NCT01072500|584169700|FG001|Overall Study|Withdrawal by Subject|10|||
161762858|NCT00103207|584169701|FG000|Overall Study|Adverse Event|3|||
161762859|NCT00103207|584169701|FG000|Overall Study|Death|1|||
161762860|NCT00103207|584169701|FG000|Overall Study|Withdrawal by Subject|2|||
161762861|NCT00103207|584169701|FG000|Overall Study|Other complicating disease|1|||
161762862|NCT00103207|584169701|FG000|Overall Study|Ineligible|4|||
161762863|NCT00103207|584169701|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
161762864|NCT01611558|584169702|FG000|Induction Phase|Study drug toxicity|15|||
161762865|NCT01611558|584169702|FG000|Induction Phase|Disease progression|18|||
161762866|NCT01611558|584169702|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
161762867|NCT01611558|584169702|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
161762868|NCT01611558|584169702|FG000|Induction Phase|Death|1|||
161762869|NCT01611558|584169702|FG000|Maintenance Phase|Withdrawal by Subject|1|||
161762870|NCT01611558|584169702|FG000|Maintenance Phase|Elevated Uric acid|1|||
161762871|NCT04005885|584169717|FG000|First Intervention|Withdrawal by Subject|1|||
161762872|NCT04005885|584169718|FG001|First Intervention|Withdrawal by Subject|1|||
161762873|NCT04005885|584169717|FG000|Second Intervention|Withdrawal by Subject|0|||
161762874|NCT04005885|584169718|FG001|Second Intervention|Withdrawal by Subject|2|||
161762875|NCT01038635|584169720|FG000|Overall Study|Disease Progression|2|||
161762876|NCT01038635|584169721|FG001|Overall Study|Disease Progression|0|||
161762877|NCT01038635|584169722|FG002|Overall Study|Disease Progression|0|||
161762878|NCT01038635|584169723|FG003|Overall Study|Disease Progression|0|||
161762879|NCT01038635|584169724|FG004|Overall Study|Disease Progression|0|||
161762880|NCT01038635|584169725|FG005|Overall Study|Disease Progression|0|||
161847901|NCT04933968|584484145|FG000|Overall Study|Randomized not treated|1|||
161847902|NCT04933968|584484146|FG001|Overall Study|Randomized not treated|0|||
161847903|NCT04933968|584484147|FG002|Overall Study|Randomized not treated|0|||
161847904|NCT04933968|584484148|FG003|Overall Study|Randomized not treated|0|||
161847905|NCT04933968|584484149|FG004|Overall Study|Randomized not treated|0|||
161847906|NCT04933968|584484150|FG005|Overall Study|Randomized not treated|0|||
161847907|NCT04933968|584484145|FG000|Overall Study|Sponsor terminated study|0|||
161847908|NCT04933968|584484146|FG001|Overall Study|Sponsor terminated study|0|||
161847909|NCT04933968|584484147|FG002|Overall Study|Sponsor terminated study|0|||
161847910|NCT04933968|584484148|FG003|Overall Study|Sponsor terminated study|1|||
161847911|NCT04933968|584484149|FG004|Overall Study|Sponsor terminated study|2|||
161847912|NCT04933968|584484150|FG005|Overall Study|Sponsor terminated study|0|||
161847913|NCT04933968|584484145|FG000|Overall Study|Other|0|||
161847914|NCT04933968|584484146|FG001|Overall Study|Other|0|||
161847915|NCT04933968|584484147|FG002|Overall Study|Other|0|||
161847916|NCT04933968|584484148|FG003|Overall Study|Other|1|||
161847917|NCT04933968|584484149|FG004|Overall Study|Other|0|||
161847918|NCT04933968|584484150|FG005|Overall Study|Other|0|||
161847919|NCT04933968|584484145|FG000|Overall Study|Missing|1|||
161847920|NCT04933968|584484146|FG001|Overall Study|Missing|3|||
161847921|NCT04933968|584484147|FG002|Overall Study|Missing|2|||
161847922|NCT04933968|584484148|FG003|Overall Study|Missing|1|||
161847923|NCT04933968|584484149|FG004|Overall Study|Missing|1|||
161847924|NCT04933968|584484150|FG005|Overall Study|Missing|0|||
161847925|NCT03323437|584484153|FG000|Overall Study|Withdrawal by Subject|0|||
161847926|NCT03323437|584484154|FG001|Overall Study|Withdrawal by Subject|4|||
161847927|NCT01377987|584484157|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
161847928|NCT01377987|584484158|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161847929|NCT00168818|584484159|FG000|Overall Study|Adverse Event|23|||
161847930|NCT00168818|584484160|FG001|Overall Study|Adverse Event|29|||
161847931|NCT00168818|584484161|FG002|Overall Study|Adverse Event|31|||
161847932|NCT00168818|584484159|FG000|Overall Study|Protocol Violation|16|||
161847933|NCT00168818|584484160|FG001|Overall Study|Protocol Violation|11|||
161847934|NCT00168818|584484161|FG002|Overall Study|Protocol Violation|11|||
161847935|NCT00168818|584484159|FG000|Overall Study|Lost to Follow-up|13|||
161847936|NCT00168818|584484160|FG001|Overall Study|Lost to Follow-up|4|||
161847937|NCT00168818|584484161|FG002|Overall Study|Lost to Follow-up|15|||
161847938|NCT00168818|584484159|FG000|Overall Study|Withdrawal by Subject|43|||
161847939|NCT00168818|584484160|FG001|Overall Study|Withdrawal by Subject|41|||
161847940|NCT00168818|584484161|FG002|Overall Study|Withdrawal by Subject|37|||
161847941|NCT00168818|584484159|FG000|Overall Study|Other|22|||
161847942|NCT00168818|584484160|FG001|Overall Study|Other|24|||
161847943|NCT00168818|584484161|FG002|Overall Study|Other|30|||
161847944|NCT00168818|584484159|FG000|Treatment|Adverse Event|77|||
161847945|NCT00168818|584484160|FG001|Treatment|Adverse Event|89|||
161847946|NCT00168818|584484161|FG002|Treatment|Adverse Event|68|||
161847947|NCT00168818|584484159|FG000|Treatment|Protocol Violation|8|||
161847948|NCT00168818|584484160|FG001|Treatment|Protocol Violation|11|||
161847949|NCT00168818|584484161|FG002|Treatment|Protocol Violation|11|||
161847950|NCT00168818|584484159|FG000|Treatment|Lost to Follow-up|0|||
161847951|NCT00168818|584484160|FG001|Treatment|Lost to Follow-up|2|||
161847952|NCT00168818|584484161|FG002|Treatment|Lost to Follow-up|1|||
161847953|NCT00168818|584484159|FG000|Treatment|Withdrawal by Subject|25|||
161847954|NCT00168818|584484160|FG001|Treatment|Withdrawal by Subject|20|||
161847955|NCT00168818|584484161|FG002|Treatment|Withdrawal by Subject|22|||
161847956|NCT00168818|584484159|FG000|Treatment|Other|23|||
161847957|NCT00168818|584484160|FG001|Treatment|Other|29|||
161847958|NCT00168818|584484161|FG002|Treatment|Other|31|||
161847959|NCT01775189|584484162|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847960|NCT01775189|584484163|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
161847961|NCT01775189|584484164|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847962|NCT01775189|584484165|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847963|NCT01775189|584484166|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847964|NCT01775189|584484167|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847965|NCT01775189|584484168|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847966|NCT01775189|584484162|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847967|NCT01775189|584484163|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
161847968|NCT01775189|584484164|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847969|NCT01775189|584484165|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847970|NCT01775189|584484166|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847971|NCT01775189|584484167|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847972|NCT01775189|584484168|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847973|NCT01775189|584484162|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161762881|NCT01038635|584169726|FG006|Overall Study|Disease Progression|1|||
161762882|NCT01038635|584169727|FG007|Overall Study|Disease Progression|4|||
161762883|NCT01038635|584169728|FG008|Overall Study|Disease Progression|0|||
161762884|NCT01038635|584169720|FG000|Overall Study|Death|0|||
161762885|NCT01038635|584169721|FG001|Overall Study|Death|0|||
161762886|NCT01038635|584169722|FG002|Overall Study|Death|0|||
161762887|NCT01038635|584169723|FG003|Overall Study|Death|0|||
161762888|NCT01038635|584169724|FG004|Overall Study|Death|1|||
161762889|NCT01038635|584169725|FG005|Overall Study|Death|0|||
161762890|NCT01038635|584169726|FG006|Overall Study|Death|1|||
161762891|NCT01038635|584169727|FG007|Overall Study|Death|1|||
161762892|NCT01038635|584169728|FG008|Overall Study|Death|2|||
161762893|NCT01227252|584169729|FG000|Overall Study|Sponsor Decision|0|||
161762894|NCT01227252|584169730|FG001|Overall Study|Sponsor Decision|1|||
161762895|NCT01227252|584169731|FG002|Overall Study|Sponsor Decision|0|||
161762896|NCT01227252|584169732|FG003|Overall Study|Sponsor Decision|0|||
161762897|NCT01227252|584169729|FG000|Overall Study|Lost to Follow-up|0|||
161762898|NCT01227252|584169730|FG001|Overall Study|Lost to Follow-up|1|||
161762899|NCT01227252|584169731|FG002|Overall Study|Lost to Follow-up|0|||
161762900|NCT01227252|584169732|FG003|Overall Study|Lost to Follow-up|0|||
161762901|NCT01227252|584169729|FG000|Overall Study|Withdrawal by Subject|0|||
161762902|NCT01227252|584169730|FG001|Overall Study|Withdrawal by Subject|1|||
161762903|NCT01227252|584169731|FG002|Overall Study|Withdrawal by Subject|0|||
161762904|NCT01227252|584169732|FG003|Overall Study|Withdrawal by Subject|0|||
161762905|NCT01683058|584169733|FG000|Overall Study|Lost to Follow-up|9|||
161762906|NCT01683058|584169733|FG000|Overall Study|Adverse Event|6|||
161762907|NCT01683058|584169733|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
161762908|NCT01683058|584169733|FG000|Overall Study|Withdrawal by Subject|7|||
161762909|NCT01683058|584169733|FG000|Overall Study|Lack of Efficacy|2|||
161762910|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
161762911|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
161762912|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
161762913|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
161762914|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161762915|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161762916|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
161762917|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
161762918|NCT01195636|584169734|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
161847974|NCT01775189|584484163|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
161847975|NCT01775189|584484164|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
161847976|NCT01775189|584484165|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847977|NCT01775189|584484166|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847978|NCT01775189|584484167|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847979|NCT01775189|584484168|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847980|NCT01775189|584484162|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847981|NCT01775189|584484163|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847982|NCT01775189|584484164|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847983|NCT01775189|584484165|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847984|NCT01775189|584484166|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847985|NCT01775189|584484167|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
161847986|NCT01775189|584484168|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847987|NCT01775189|584484162|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847988|NCT01775189|584484163|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847989|NCT01775189|584484164|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847990|NCT01775189|584484165|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
161847991|NCT01775189|584484166|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847992|NCT01775189|584484167|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847993|NCT01775189|584484168|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847994|NCT01775189|584484162|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847995|NCT01775189|584484163|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847996|NCT01775189|584484164|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847997|NCT01775189|584484165|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
161847998|NCT01775189|584484166|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847999|NCT01775189|584484167|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161848000|NCT01775189|584484168|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
161848001|NCT02227446|584484169|FG000|Overall Study|not eligible post randomization|18|||
161848002|NCT02227446|584484170|FG001|Overall Study|not eligible post randomization|29|||
161848003|NCT02227446|584484169|FG000|Overall Study|Withdrawal by Subject|4|||
161848004|NCT02227446|584484170|FG001|Overall Study|Withdrawal by Subject|5|||
161848005|NCT03016975|584484178|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
161848006|NCT03016975|584484179|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
161848007|NCT03016975|584484180|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
161848008|NCT03016975|584484178|FG000|At 6 Months Follow-up|Death|2|||
161848009|NCT03016975|584484179|FG001|At 6 Months Follow-up|Death|0|||
161848010|NCT03016975|584484180|FG002|At 6 Months Follow-up|Death|0|||
161848011|NCT03016975|584484178|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
161848012|NCT03016975|584484179|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
161848013|NCT03016975|584484180|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
161848014|NCT03016975|584484178|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
161848015|NCT03016975|584484179|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
161848016|NCT03016975|584484180|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
161848017|NCT03016975|584484178|FG000|At 6 Months Follow-up|Aborted implant|1|||
161848018|NCT03016975|584484179|FG001|At 6 Months Follow-up|Aborted implant|0|||
161848019|NCT03016975|584484180|FG002|At 6 Months Follow-up|Aborted implant|0|||
161848020|NCT03016975|584484178|FG000|At 2 Year Follow-up|Death|1|||
161848021|NCT03016975|584484179|FG001|At 2 Year Follow-up|Death|0|||
161848022|NCT03016975|584484180|FG002|At 2 Year Follow-up|Death|0|||
161848023|NCT03016975|584484178|FG000|At 3 Year Follow-up|Death|1|||
161848024|NCT03016975|584484179|FG001|At 3 Year Follow-up|Death|0|||
161848025|NCT03016975|584484180|FG002|At 3 Year Follow-up|Death|0|||
161848026|NCT03016975|584484178|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
161848027|NCT03016975|584484179|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
161848028|NCT03016975|584484180|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
161848029|NCT03016975|584484178|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
161848030|NCT03016975|584484179|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
161848031|NCT03016975|584484180|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
161848032|NCT02901548|584484181|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
161848033|NCT04893018|584484182|FG000|Overall Study|Lost to Follow-up|1|||
161848034|NCT04893018|584484183|FG001|Overall Study|Lost to Follow-up|0|||
161848035|NCT04893018|584484182|FG000|Overall Study|Withdrawal by Subject|2|||
161848036|NCT04893018|584484183|FG001|Overall Study|Withdrawal by Subject|0|||
161762919|NCT01195636|584169735|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
161762920|NCT01195636|584169734|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161762921|NCT01195636|584169735|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
161762922|NCT01195636|584169734|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
161762923|NCT01195636|584169735|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
161762924|NCT01195636|584169734|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161762925|NCT01195636|584169735|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161762926|NCT01566981|584169736|FG000|Overall Study|Lost to Follow-up|5|||
161762927|NCT01566981|584169737|FG001|Overall Study|Lost to Follow-up|8|||
161762928|NCT02405091|584169738|FG000|Overall Study|Adverse Event|16|||
161762929|NCT02405091|584169739|FG001|Overall Study|Adverse Event|10|||
161762930|NCT02405091|584169740|FG002|Overall Study|Adverse Event|0|||
161762931|NCT02405091|584169738|FG000|Overall Study|Protocol Violation|1|||
161762932|NCT02405091|584169739|FG001|Overall Study|Protocol Violation|0|||
161762933|NCT02405091|584169740|FG002|Overall Study|Protocol Violation|0|||
161762934|NCT02405091|584169738|FG000|Overall Study|Noncompliance|1|||
161762935|NCT02405091|584169739|FG001|Overall Study|Noncompliance|6|||
161762936|NCT02405091|584169740|FG002|Overall Study|Noncompliance|2|||
161762937|NCT02405091|584169738|FG000|Overall Study|Withdrawal by Subject|4|||
161762938|NCT02405091|584169739|FG001|Overall Study|Withdrawal by Subject|8|||
161762939|NCT02405091|584169740|FG002|Overall Study|Withdrawal by Subject|0|||
161762940|NCT02405091|584169738|FG000|Overall Study|Death|0|||
161762941|NCT02405091|584169739|FG001|Overall Study|Death|1|||
161762942|NCT02405091|584169740|FG002|Overall Study|Death|0|||
161762943|NCT02405091|584169738|FG000|Overall Study|Lost to Follow-up|5|||
161762944|NCT02405091|584169739|FG001|Overall Study|Lost to Follow-up|6|||
161762945|NCT02405091|584169740|FG002|Overall Study|Lost to Follow-up|0|||
161762946|NCT02405091|584169738|FG000|Overall Study|Physician Decision|2|||
161762947|NCT02405091|584169739|FG001|Overall Study|Physician Decision|2|||
161762948|NCT02405091|584169740|FG002|Overall Study|Physician Decision|0|||
161762949|NCT01012037|584169750|FG000|Overall Study|Adverse Event|0|||
161762950|NCT01012037|584169751|FG001|Overall Study|Adverse Event|8|||
161762951|NCT01012037|584169752|FG002|Overall Study|Adverse Event|3|||
161762952|NCT01012037|584169750|FG000|Overall Study|Protocol Violation|0|||
161762953|NCT01012037|584169751|FG001|Overall Study|Protocol Violation|3|||
161762954|NCT01012037|584169752|FG002|Overall Study|Protocol Violation|5|||
161762955|NCT01012037|584169750|FG000|Overall Study|Withdrawal by Subject|0|||
161762956|NCT01012037|584169751|FG001|Overall Study|Withdrawal by Subject|4|||
161762957|NCT01012037|584169752|FG002|Overall Study|Withdrawal by Subject|1|||
161762958|NCT01012037|584169750|FG000|Overall Study|Other reason (not specified)|1|||
161762959|NCT01012037|584169751|FG001|Overall Study|Other reason (not specified)|1|||
161762960|NCT01012037|584169752|FG002|Overall Study|Other reason (not specified)|1|||
161762961|NCT00590031|584169756|FG000|Overall Study|Adverse Event|3|||
161762962|NCT00590031|584169756|FG000|Overall Study|Withdrawal by Subject|1|||
161762963|NCT00590031|584169756|FG000|Overall Study|Metastatic Disease|1|||
161762964|NCT00590031|584169756|FG000|Overall Study|Admin Hold|1|||
161762965|NCT01809327|584169757|FG000|Overall Study|Lost to Follow-up|5|||
161762966|NCT01809327|584169758|FG001|Overall Study|Lost to Follow-up|2|||
161762967|NCT01809327|584169759|FG002|Overall Study|Lost to Follow-up|4|||
161762968|NCT01809327|584169760|FG003|Overall Study|Lost to Follow-up|2|||
161762969|NCT01809327|584169761|FG004|Overall Study|Lost to Follow-up|3|||
161762970|NCT01809327|584169757|FG000|Overall Study|Withdrawal by Subject|6|||
161762971|NCT01809327|584169758|FG001|Overall Study|Withdrawal by Subject|4|||
161762972|NCT01809327|584169759|FG002|Overall Study|Withdrawal by Subject|4|||
161762973|NCT01809327|584169760|FG003|Overall Study|Withdrawal by Subject|2|||
161762974|NCT01809327|584169761|FG004|Overall Study|Withdrawal by Subject|5|||
161762975|NCT01809327|584169757|FG000|Overall Study|Adverse Event|4|||
161762976|NCT01809327|584169758|FG001|Overall Study|Adverse Event|3|||
161762977|NCT01809327|584169759|FG002|Overall Study|Adverse Event|7|||
161762978|NCT01809327|584169760|FG003|Overall Study|Adverse Event|4|||
161762979|NCT01809327|584169761|FG004|Overall Study|Adverse Event|8|||
161762980|NCT01809327|584169757|FG000|Overall Study|Death|1|||
161762981|NCT01809327|584169758|FG001|Overall Study|Death|0|||
161762982|NCT01809327|584169759|FG002|Overall Study|Death|0|||
161762983|NCT01809327|584169760|FG003|Overall Study|Death|0|||
161762984|NCT01809327|584169761|FG004|Overall Study|Death|0|||
161762985|NCT01809327|584169757|FG000|Overall Study|Protocol Violation|0|||
161762986|NCT01809327|584169758|FG001|Overall Study|Protocol Violation|1|||
161762987|NCT01809327|584169759|FG002|Overall Study|Protocol Violation|0|||
161762988|NCT01809327|584169760|FG003|Overall Study|Protocol Violation|0|||
161848037|NCT04893018|584484182|FG000|Overall Study|Study Terminated|1|||
161848038|NCT04893018|584484183|FG001|Overall Study|Study Terminated|2|||
161762989|NCT01809327|584169761|FG004|Overall Study|Protocol Violation|0|||
161762990|NCT01809327|584169757|FG000|Overall Study|Physician Decision|1|||
161848039|NCT03336528|584484184|FG000|Overall Study|Protocol Violation|1|||
161762991|NCT01809327|584169758|FG001|Overall Study|Physician Decision|1|||
161762992|NCT01809327|584169759|FG002|Overall Study|Physician Decision|0|||
161762993|NCT01809327|584169760|FG003|Overall Study|Physician Decision|0|||
161762994|NCT01809327|584169761|FG004|Overall Study|Physician Decision|0|||
161762995|NCT01809327|584169757|FG000|Overall Study|Pregnancy|1|||
161762996|NCT01809327|584169758|FG001|Overall Study|Pregnancy|0|||
161762997|NCT01809327|584169759|FG002|Overall Study|Pregnancy|0|||
161762998|NCT01809327|584169760|FG003|Overall Study|Pregnancy|0|||
161762999|NCT01809327|584169761|FG004|Overall Study|Pregnancy|0|||
161763000|NCT01809327|584169757|FG000|Overall Study|Other|14|||
161763001|NCT01809327|584169758|FG001|Overall Study|Other|15|||
161763002|NCT01809327|584169759|FG002|Overall Study|Other|7|||
161763003|NCT01809327|584169760|FG003|Overall Study|Other|4|||
161763004|NCT01809327|584169761|FG004|Overall Study|Other|9|||
161848040|NCT03336528|584484185|FG001|Overall Study|Protocol Violation|1|||
161848041|NCT03336528|584484184|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
161848042|NCT03336528|584484185|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
161848043|NCT03336528|584484184|FG000|Overall Study|Did not receive study medication|1|||
161848044|NCT03336528|584484185|FG001|Overall Study|Did not receive study medication|2|||
161848045|NCT00811928|584484186|FG000|Overall Study|AEs and SAEs Including Death|7|||
161848046|NCT00811928|584484187|FG001|Overall Study|AEs and SAEs Including Death|11|||
161848047|NCT00811928|584484186|FG000|Overall Study|Withdrawal by Subject|18|||
161848048|NCT00811928|584484187|FG001|Overall Study|Withdrawal by Subject|12|||
161848049|NCT00811928|584484186|FG000|Overall Study|Did Not Take Study Drug|3|||
161848050|NCT00811928|584484187|FG001|Overall Study|Did Not Take Study Drug|0|||
161848051|NCT00811928|584484186|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
161848052|NCT00811928|584484187|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
161848053|NCT00811928|584484186|FG000|Overall Study|Investigator Decision|2|||
161848054|NCT00811928|584484187|FG001|Overall Study|Investigator Decision|1|||
161848055|NCT00811928|584484186|FG000|Overall Study|Poor Compliance|2|||
161848056|NCT00811928|584484187|FG001|Overall Study|Poor Compliance|5|||
161848057|NCT01085357|584484188|FG000|Overall Study|Adverse Event|1|||
161848058|NCT01085357|584484189|FG001|Overall Study|Adverse Event|1|||
161848059|NCT01085357|584484188|FG000|Overall Study|Subject Decision|4|||
161848060|NCT01085357|584484189|FG001|Overall Study|Subject Decision|3|||
161848061|NCT01085357|584484188|FG000|Overall Study|Investigator Decision|1|||
161848062|NCT01085357|584484189|FG001|Overall Study|Investigator Decision|1|||
161848063|NCT01085357|584484188|FG000|Overall Study|Death|11|||
161848064|NCT01085357|584484189|FG001|Overall Study|Death|1|||
161848065|NCT01085357|584484188|FG000|Overall Study|Lost to Follow-up|2|||
161848066|NCT01085357|584484189|FG001|Overall Study|Lost to Follow-up|0|||
161848067|NCT00314951|584484192|FG000|Treatment|Didn't meet criteria for mITT population|16|||
161848068|NCT00314951|584484193|FG001|Treatment|Didn't meet criteria for mITT population|11|||
161848069|NCT00314951|584484192|FG000|Follow-up|mITT failure|44|||
161848070|NCT00314951|584484193|FG001|Follow-up|mITT failure|34|||
161848071|NCT02910011|584484194|FG000|Overall Study|Physician Decision|2|||
161848072|NCT00920790|584484195|FG000|Overall Study|aggravation of general condition|14|||
161848073|NCT00838435|584484196|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
161848074|NCT00838435|584484196|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
161848075|NCT00838435|584484196|FG000|Part 2 (7 Years)|Adverse Event|2|||
161848076|NCT00838435|584484196|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
161848077|NCT00838435|584484196|FG000|Part 2 (7 Years)|Physician Decision|1|||
161848078|NCT00838435|584484196|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
161848079|NCT00838435|584484196|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
161848080|NCT02348723|584484197|FG000|Overall Study|No ablation|21|||
161848081|NCT02348723|584484198|FG001|Overall Study|No ablation|20|||
161848082|NCT02348723|584484197|FG000|Overall Study|Non-compliant with Protocol|1|||
161848083|NCT02348723|584484198|FG001|Overall Study|Non-compliant with Protocol|0|||
161848084|NCT02348723|584484197|FG000|Overall Study|Lost to Follow-up|1|||
161848085|NCT02348723|584484198|FG001|Overall Study|Lost to Follow-up|1|||
161848086|NCT02348723|584484197|FG000|Overall Study|Consent withdrawn|1|||
161848087|NCT02348723|584484198|FG001|Overall Study|Consent withdrawn|3|||
161848088|NCT02348723|584484197|FG000|Overall Study|Reason other than specified|1|||
161848089|NCT02348723|584484198|FG001|Overall Study|Reason other than specified|1|||
161848090|NCT02348723|584484197|FG000|Overall Study|Adverse Event|3|||
161848091|NCT02348723|584484198|FG001|Overall Study|Adverse Event|1|||
161848092|NCT00678886|584484199|FG000|Overall Study|Withdrawal by Subject|0|||
161848093|NCT00678886|584484200|FG001|Overall Study|Withdrawal by Subject|0|||
161848094|NCT00678886|584484201|FG002|Overall Study|Withdrawal by Subject|4|||
161848095|NCT00678886|584484202|FG003|Overall Study|Withdrawal by Subject|6|||
161848096|NCT00678886|584484199|FG000|Overall Study|Physician Decision|0|||
161848097|NCT00678886|584484200|FG001|Overall Study|Physician Decision|0|||
161848098|NCT00678886|584484201|FG002|Overall Study|Physician Decision|1|||
161848099|NCT00678886|584484202|FG003|Overall Study|Physician Decision|1|||
161848100|NCT00678886|584484199|FG000|Overall Study|Lost to Follow-up|0|||
161848101|NCT00678886|584484200|FG001|Overall Study|Lost to Follow-up|0|||
161848102|NCT00678886|584484201|FG002|Overall Study|Lost to Follow-up|3|||
161848103|NCT00678886|584484202|FG003|Overall Study|Lost to Follow-up|2|||
161848104|NCT00678886|584484199|FG000|Overall Study|Other|0|||
161848105|NCT00678886|584484200|FG001|Overall Study|Other|0|||
161848106|NCT00678886|584484201|FG002|Overall Study|Other|1|||
161848107|NCT00678886|584484202|FG003|Overall Study|Other|0|||
161848108|NCT04693416|584484203|FG000|Overall Study|Lost to Follow-up|13|||
161848109|NCT04693416|584484204|FG001|Overall Study|Lost to Follow-up|0|||
161848110|NCT02290223|584484205|FG000|6 Months|Lost to Follow-up|9|||
161848111|NCT02290223|584484206|FG001|6 Months|Lost to Follow-up|6|||
161848112|NCT02290223|584484205|FG000|6 Months|Withdrawal by Subject|5|||
161763005|NCT01166386|584169763|FG000|Overall Study|Withdrawal by Subject|3|||
161763006|NCT01166386|584169764|FG001|Overall Study|Withdrawal by Subject|5|||
161763007|NCT02802735|584169765|FG000|Overall Study|Withdrawal by Subject|0|||
161763008|NCT02802735|584169766|FG001|Overall Study|Withdrawal by Subject|1|||
161763009|NCT02802735|584169767|FG002|Overall Study|Withdrawal by Subject|0|||
161763010|NCT02802735|584169768|FG003|Overall Study|Withdrawal by Subject|0|||
161763011|NCT02802735|584169769|FG004|Overall Study|Withdrawal by Subject|0|||
161763012|NCT03922711|584169772|FG000|Overall Study|Adverse Event|3|||
161763013|NCT03922711|584169773|FG001|Overall Study|Adverse Event|2|||
161763014|NCT03922711|584169774|FG002|Overall Study|Adverse Event|2|||
161763015|NCT03922711|584169772|FG000|Overall Study|Protocol Violation|1|||
161763016|NCT03922711|584169773|FG001|Overall Study|Protocol Violation|0|||
161763017|NCT03922711|584169774|FG002|Overall Study|Protocol Violation|0|||
161763018|NCT03922711|584169772|FG000|Overall Study|Withdrawal by Subject|0|||
161763019|NCT03922711|584169773|FG001|Overall Study|Withdrawal by Subject|3|||
161763020|NCT03922711|584169774|FG002|Overall Study|Withdrawal by Subject|1|||
161763021|NCT03922711|584169772|FG000|Overall Study|Not further specified|0|||
161763022|NCT03922711|584169773|FG001|Overall Study|Not further specified|0|||
161763023|NCT03922711|584169774|FG002|Overall Study|Not further specified|1|||
161763024|NCT00420212|584169777|FG000|Overall Study|Adverse Event|22|||
161763025|NCT00420212|584169778|FG001|Overall Study|Adverse Event|40|||
161763026|NCT00420212|584169779|FG002|Overall Study|Adverse Event|36|||
161763027|NCT00420212|584169777|FG000|Overall Study|Lost to Follow-up|9|||
161763028|NCT00420212|584169778|FG001|Overall Study|Lost to Follow-up|11|||
161763029|NCT00420212|584169779|FG002|Overall Study|Lost to Follow-up|11|||
161763030|NCT00420212|584169777|FG000|Overall Study|Withdrawal by Subject|31|||
161763031|NCT00420212|584169778|FG001|Overall Study|Withdrawal by Subject|22|||
161763032|NCT00420212|584169779|FG002|Overall Study|Withdrawal by Subject|19|||
161763033|NCT00420212|584169777|FG000|Overall Study|Physician Decision|4|||
161763034|NCT00420212|584169778|FG001|Overall Study|Physician Decision|4|||
161763035|NCT00420212|584169779|FG002|Overall Study|Physician Decision|3|||
161763036|NCT00420212|584169777|FG000|Overall Study|Protocol Violation|4|||
161763037|NCT00420212|584169778|FG001|Overall Study|Protocol Violation|4|||
161763038|NCT00420212|584169779|FG002|Overall Study|Protocol Violation|8|||
161763039|NCT00420212|584169777|FG000|Overall Study|Death|0|||
161763040|NCT00420212|584169778|FG001|Overall Study|Death|0|||
161763041|NCT00420212|584169779|FG002|Overall Study|Death|1|||
161763042|NCT00420212|584169777|FG000|Overall Study|Other-Unspecified|21|||
161763043|NCT00420212|584169778|FG001|Overall Study|Other-Unspecified|14|||
161763044|NCT00420212|584169779|FG002|Overall Study|Other-Unspecified|18|||
161763045|NCT02390362|584169780|FG000|Overall Study|Withdrawal by Subject|0|||
161763046|NCT02390362|584169781|FG001|Overall Study|Withdrawal by Subject|1|||
161763047|NCT02067104|584169786|FG000|Overall Study|Study termination due to low accrual|4|||
161763048|NCT02067104|584169787|FG001|Overall Study|Study termination due to low accrual|5|||
161763049|NCT02610231|584169788|FG000|Overall Study|Withdrawal by Subject|27|||
161763050|NCT02610231|584169788|FG000|Overall Study|Adverse Event|20|||
161763051|NCT02610231|584169788|FG000|Overall Study|Death|5|||
161763052|NCT02610231|584169788|FG000|Overall Study|Surgery|2|||
161763053|NCT02610231|584169788|FG000|Overall Study|Physician Decision|1|||
161763054|NCT02610231|584169788|FG000|Overall Study|Non Compliance|2|||
161763055|NCT02610231|584169788|FG000|Overall Study|Other|3|||
161763056|NCT01279954|584169791|FG000|Overall Study|Lack of Efficacy|3|||
161763057|NCT01279954|584169792|FG001|Overall Study|Lack of Efficacy|4|||
161763058|NCT02140762|584169793|FG000|Overall Study|Adverse Event|1|||
161763059|NCT02140762|584169794|FG001|Overall Study|Adverse Event|1|||
161763060|NCT02140762|584169793|FG000|Overall Study|Lost to Follow-up|9|||
161763061|NCT02140762|584169794|FG001|Overall Study|Lost to Follow-up|5|||
161763062|NCT02140762|584169793|FG000|Overall Study|Protocol Violation|1|||
161763063|NCT02140762|584169794|FG001|Overall Study|Protocol Violation|1|||
161763064|NCT02140762|584169793|FG000|Overall Study|Withdrawal by Subject|6|||
161763065|NCT02140762|584169794|FG001|Overall Study|Withdrawal by Subject|4|||
161763066|NCT02140762|584169793|FG000|Overall Study|Other|0|||
161763067|NCT02140762|584169794|FG001|Overall Study|Other|1|||
161763068|NCT01711359|584169796|FG000|Treatment Period|Withdrawal by Subject|18|||
161763069|NCT01711359|584169797|FG001|Treatment Period|Withdrawal by Subject|7|||
161763070|NCT01711359|584169798|FG002|Treatment Period|Withdrawal by Subject|13|||
161763071|NCT01711359|584169796|FG000|Treatment Period|Lack of Efficacy|13|||
161763072|NCT01711359|584169797|FG001|Treatment Period|Lack of Efficacy|2|||
161763073|NCT01711359|584169798|FG002|Treatment Period|Lack of Efficacy|2|||
161763074|NCT01711359|584169796|FG000|Treatment Period|Adverse Event|8|||
161848113|NCT02290223|584484206|FG001|6 Months|Withdrawal by Subject|0|||
161763075|NCT01711359|584169797|FG001|Treatment Period|Adverse Event|10|||
161763076|NCT01711359|584169798|FG002|Treatment Period|Adverse Event|24|||
161763077|NCT01711359|584169796|FG000|Treatment Period|Physician Decision|4|||
161763078|NCT01711359|584169797|FG001|Treatment Period|Physician Decision|3|||
161763079|NCT01711359|584169798|FG002|Treatment Period|Physician Decision|2|||
161763080|NCT01711359|584169796|FG000|Treatment Period|Death|3|||
161763081|NCT01711359|584169797|FG001|Treatment Period|Death|0|||
161763082|NCT01711359|584169798|FG002|Treatment Period|Death|0|||
161763083|NCT01711359|584169796|FG000|Treatment Period|Entry Criteria Not Met|1|||
161763084|NCT01711359|584169797|FG001|Treatment Period|Entry Criteria Not Met|0|||
161763085|NCT01711359|584169798|FG002|Treatment Period|Entry Criteria Not Met|0|||
161763086|NCT01711359|584169796|FG000|Treatment Period|Sponsor Decision|1|||
161763087|NCT01711359|584169797|FG001|Treatment Period|Sponsor Decision|0|||
161763088|NCT01711359|584169798|FG002|Treatment Period|Sponsor Decision|0|||
161763089|NCT01711359|584169796|FG000|Treatment Period|Lost to Follow-up|1|||
161763090|NCT01711359|584169797|FG001|Treatment Period|Lost to Follow-up|1|||
161763091|NCT01711359|584169798|FG002|Treatment Period|Lost to Follow-up|1|||
161763092|NCT01711359|584169796|FG000|Treatment Period|Randomized, Not Treated|3|||
161763093|NCT01711359|584169797|FG001|Treatment Period|Randomized, Not Treated|1|||
161763094|NCT01711359|584169798|FG002|Treatment Period|Randomized, Not Treated|0|||
161763095|NCT01385098|584169799|FG000|Overall Study|Adverse Event|10|||
161763096|NCT01385098|584169799|FG000|Overall Study|Lost to Follow-up|4|||
161763097|NCT00795717|584169800|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
161763098|NCT00795717|584169801|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
161763099|NCT00795717|584169800|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
161763100|NCT00795717|584169801|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
161848114|NCT02290223|584484205|FG000|6 Months|deceased (not related to study)|2|||
161763101|NCT00795717|584169800|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
161763102|NCT00795717|584169801|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
161763103|NCT00795717|584169800|FG000|Phase II|too busy|0|||
161763104|NCT00795717|584169801|FG001|Phase II|too busy|1|||
161848115|NCT02290223|584484206|FG001|6 Months|deceased (not related to study)|0|||
161848116|NCT02290223|584484205|FG000|12 Months|Lost to Follow-up|16|||
161848117|NCT02290223|584484206|FG001|12 Months|Lost to Follow-up|10|||
161848118|NCT02290223|584484205|FG000|12 Months|Refusal|0|||
161848119|NCT02290223|584484206|FG001|12 Months|Refusal|1|||
161848120|NCT05293639|584484207|FG000|Overall Study|Withdrawal by Subject|1|||
161848121|NCT05293639|584484208|FG001|Overall Study|Withdrawal by Subject|1|||
161848122|NCT05293639|584484209|FG002|Overall Study|Withdrawal by Subject|2|||
161848123|NCT05293639|584484207|FG000|Overall Study|Death|0|||
161848124|NCT05293639|584484208|FG001|Overall Study|Death|1|||
161848125|NCT05293639|584484209|FG002|Overall Study|Death|0|||
161848126|NCT05293639|584484207|FG000|Overall Study|Lost to Follow-up|0|||
161848127|NCT05293639|584484208|FG001|Overall Study|Lost to Follow-up|0|||
161848128|NCT05293639|584484209|FG002|Overall Study|Lost to Follow-up|5|||
161848129|NCT05293639|584484207|FG000|Overall Study|Other|0|||
161848130|NCT05293639|584484208|FG001|Overall Study|Other|0|||
161848131|NCT05293639|584484209|FG002|Overall Study|Other|1|||
161848132|NCT01860677|584484213|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
161848133|NCT01860677|584484214|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
161848134|NCT01671332|584484215|FG000|Overall Study|Withdrawal by Subject|1|||
161848135|NCT01671332|584484216|FG001|Overall Study|Withdrawal by Subject|1|||
161848136|NCT01458106|584484217|FG000|Overall Study|Withdrawal by Subject|2|||
161848137|NCT01458106|584484218|FG001|Overall Study|Withdrawal by Subject|0|||
161848138|NCT01458106|584484217|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
161848139|NCT01458106|584484218|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
161848140|NCT01458106|584484217|FG000|Overall Study|Withdrawn Per Protocol|0|||
161848141|NCT01458106|584484218|FG001|Overall Study|Withdrawn Per Protocol|1|||
161848142|NCT01056289|584486243|FG000|Open-label Phase|Adverse Event|29|||
161848143|NCT01056289|584486244|FG001|Open-label Phase|Adverse Event|0|||
161848144|NCT01056289|584486245|FG002|Open-label Phase|Adverse Event|0|||
161848145|NCT01056289|584486246|FG003|Open-label Phase|Adverse Event|0|||
161848146|NCT01056289|584486243|FG000|Open-label Phase|Lost to Follow-up|30|||
161848147|NCT01056289|584486244|FG001|Open-label Phase|Lost to Follow-up|0|||
161848148|NCT01056289|584486245|FG002|Open-label Phase|Lost to Follow-up|0|||
161848149|NCT01056289|584486246|FG003|Open-label Phase|Lost to Follow-up|0|||
161848150|NCT01056289|584486243|FG000|Open-label Phase|Other|9|||
161848151|NCT01056289|584486244|FG001|Open-label Phase|Other|0|||
161763105|NCT04728815|584169804|FG000|Overall Study|Lost to Follow-up|3|||
161848152|NCT01056289|584486245|FG002|Open-label Phase|Other|0|||
161763106|NCT04728815|584169805|FG001|Overall Study|Lost to Follow-up|0|||
161763107|NCT04728815|584169806|FG002|Overall Study|Lost to Follow-up|0|||
161763108|NCT04728815|584169807|FG003|Overall Study|Lost to Follow-up|1|||
161763109|NCT04728815|584169808|FG004|Overall Study|Lost to Follow-up|1|||
161763110|NCT04728815|584169809|FG005|Overall Study|Lost to Follow-up|0|||
161763111|NCT04728815|584169810|FG006|Overall Study|Lost to Follow-up|2|||
161763112|NCT04728815|584169811|FG007|Overall Study|Lost to Follow-up|0|||
161763113|NCT04728815|584169804|FG000|Overall Study|Physician Decision|0|||
161763114|NCT04728815|584169805|FG001|Overall Study|Physician Decision|0|||
161763115|NCT04728815|584169806|FG002|Overall Study|Physician Decision|1|||
161848153|NCT01056289|584486246|FG003|Open-label Phase|Other|0|||
161848154|NCT01056289|584486243|FG000|Open-label Phase|Protocol Violation|6|||
161848155|NCT01056289|584486244|FG001|Open-label Phase|Protocol Violation|0|||
161848156|NCT01056289|584486245|FG002|Open-label Phase|Protocol Violation|0|||
161848157|NCT01056289|584486246|FG003|Open-label Phase|Protocol Violation|0|||
161848158|NCT01056289|584486243|FG000|Open-label Phase|Withdrawal by Subject|26|||
161848159|NCT01056289|584486244|FG001|Open-label Phase|Withdrawal by Subject|0|||
161848160|NCT01056289|584486245|FG002|Open-label Phase|Withdrawal by Subject|0|||
161848161|NCT01056289|584486246|FG003|Open-label Phase|Withdrawal by Subject|0|||
161848162|NCT01056289|584486243|FG000|Open-label Phase|Lack of Efficacy|18|||
161848163|NCT01056289|584486244|FG001|Open-label Phase|Lack of Efficacy|0|||
161763116|NCT04728815|584169807|FG003|Overall Study|Physician Decision|0|||
161763117|NCT04728815|584169808|FG004|Overall Study|Physician Decision|0|||
161848164|NCT01056289|584486245|FG002|Open-label Phase|Lack of Efficacy|0|||
161848165|NCT01056289|584486246|FG003|Open-label Phase|Lack of Efficacy|0|||
161848166|NCT01056289|584486243|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
161848167|NCT01056289|584486244|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
161848168|NCT01056289|584486245|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
161848169|NCT01056289|584486246|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
161848170|NCT01056289|584486243|FG000|Double-blind Phase|Adverse Event|0|||
161848171|NCT01056289|584486244|FG001|Double-blind Phase|Adverse Event|1|||
161848172|NCT01056289|584486245|FG002|Double-blind Phase|Adverse Event|2|||
161848173|NCT01056289|584486246|FG003|Double-blind Phase|Adverse Event|1|||
161848174|NCT01056289|584486243|FG000|Double-blind Phase|Lost to Follow-up|0|||
161848175|NCT01056289|584486244|FG001|Double-blind Phase|Lost to Follow-up|2|||
161848176|NCT01056289|584486245|FG002|Double-blind Phase|Lost to Follow-up|2|||
161848177|NCT01056289|584486246|FG003|Double-blind Phase|Lost to Follow-up|2|||
161848178|NCT01056289|584486243|FG000|Double-blind Phase|Other|0|||
161848179|NCT01056289|584486244|FG001|Double-blind Phase|Other|0|||
161848180|NCT01056289|584486245|FG002|Double-blind Phase|Other|1|||
161848181|NCT01056289|584486246|FG003|Double-blind Phase|Other|2|||
161848182|NCT01056289|584486243|FG000|Double-blind Phase|Protocol Violation|0|||
161848183|NCT01056289|584486244|FG001|Double-blind Phase|Protocol Violation|0|||
161848184|NCT01056289|584486245|FG002|Double-blind Phase|Protocol Violation|1|||
161848185|NCT01056289|584486246|FG003|Double-blind Phase|Protocol Violation|1|||
161848186|NCT01056289|584486243|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161848187|NCT01056289|584486244|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161848188|NCT01056289|584486245|FG002|Double-blind Phase|Withdrawal by Subject|4|||
161848189|NCT01056289|584486246|FG003|Double-blind Phase|Withdrawal by Subject|2|||
161848190|NCT01056289|584486243|FG000|Double-blind Phase|Discontinuation symptom|0|||
161848191|NCT01056289|584486244|FG001|Double-blind Phase|Discontinuation symptom|1|||
161848192|NCT01056289|584486245|FG002|Double-blind Phase|Discontinuation symptom|2|||
161848193|NCT01056289|584486246|FG003|Double-blind Phase|Discontinuation symptom|2|||
161848194|NCT01056289|584486243|FG000|Double-blind Phase|Physician Decision|0|||
161848195|NCT01056289|584486244|FG001|Double-blind Phase|Physician Decision|0|||
161848196|NCT01056289|584486245|FG002|Double-blind Phase|Physician Decision|1|||
161848197|NCT01056289|584486246|FG003|Double-blind Phase|Physician Decision|0|||
161848198|NCT00270855|584486255|FG000|Overall Study|Withdrawal by Subject|8|||
161848199|NCT00270855|584486256|FG001|Overall Study|Withdrawal by Subject|8|||
161848200|NCT03156504|584486260|FG000|Overall Study|Withdrawal by Subject|1|||
161848201|NCT05048329|584486261|FG000|Overall Study|Withdrawal by Subject|1|||
161848202|NCT05048329|584486261|FG000|Overall Study|Screenfail|1|||
161848203|NCT00282919|584486262|FG000|Overall Study|Lack of Efficacy|4|||
161848204|NCT00282919|584486262|FG000|Overall Study|Withdrawal by Subject|1|||
161848205|NCT00282919|584486262|FG000|Overall Study|Asymptomatic Parasitemia|2|||
161848206|NCT03257865|584486268|FG000|Overall Study|Adverse Event|4|||
161848207|NCT03257865|584486269|FG001|Overall Study|Adverse Event|8|||
161848208|NCT03257865|584486268|FG000|Overall Study|Lack of Efficacy|1|||
161848209|NCT03257865|584486269|FG001|Overall Study|Lack of Efficacy|2|||
161848210|NCT03257865|584486268|FG000|Overall Study|Non-compliance with Study Drug|0|||
161848211|NCT03257865|584486269|FG001|Overall Study|Non-compliance with Study Drug|2|||
161848212|NCT03257865|584486268|FG000|Overall Study|Withdrawal by Subject|23|||
161848213|NCT03257865|584486269|FG001|Overall Study|Withdrawal by Subject|17|||
161848214|NCT03257865|584486268|FG000|Overall Study|Physician Decision|3|||
161848215|NCT03257865|584486269|FG001|Overall Study|Physician Decision|1|||
161848216|NCT03257865|584486268|FG000|Overall Study|Other|0|||
161848217|NCT03257865|584486269|FG001|Overall Study|Other|1|||
161848218|NCT03257865|584486268|FG000|Overall Study|Lost to Follow-up|4|||
161848219|NCT03257865|584486269|FG001|Overall Study|Lost to Follow-up|4|||
161848220|NCT02549027|584486270|FG000|Washout After Period 4|Withdrawal by Subject|0|||
161848221|NCT02549027|584486271|FG001|Washout After Period 4|Withdrawal by Subject|1|||
161848222|NCT02549027|584486272|FG002|Washout After Period 4|Withdrawal by Subject|1|||
161848223|NCT02549027|584486273|FG003|Washout After Period 4|Withdrawal by Subject|1|||
161848224|NCT02549027|584486274|FG004|Washout After Period 4|Withdrawal by Subject|0|||
161848225|NCT02549027|584486275|FG005|Washout After Period 4|Withdrawal by Subject|0|||
161848226|NCT02549027|584486270|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848227|NCT02549027|584486271|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848228|NCT02549027|584486272|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848229|NCT02549027|584486273|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848230|NCT02549027|584486274|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
161848231|NCT02549027|584486275|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848232|NCT05384171|584486281|FG000|Overall Study|Lost to Follow-up|9|||
161848233|NCT05384171|584486282|FG001|Overall Study|Lost to Follow-up|9|||
161848234|NCT05384171|584486281|FG000|Overall Study|Withdrawal by Subject|3|||
161848235|NCT05384171|584486282|FG001|Overall Study|Withdrawal by Subject|0|||
161848236|NCT01421511|584486283|FG000|Overall Study|Lost to Follow-up|11|||
161763118|NCT04728815|584169809|FG005|Overall Study|Physician Decision|0|||
161763119|NCT04728815|584169810|FG006|Overall Study|Physician Decision|0|||
161763120|NCT04728815|584169811|FG007|Overall Study|Physician Decision|0|||
161763121|NCT04728815|584169804|FG000|Overall Study|Treatment drop|0|||
161763122|NCT04728815|584169805|FG001|Overall Study|Treatment drop|2|||
161763123|NCT04728815|584169806|FG002|Overall Study|Treatment drop|1|||
161763124|NCT04728815|584169807|FG003|Overall Study|Treatment drop|0|||
161763125|NCT04728815|584169808|FG004|Overall Study|Treatment drop|3|||
161763126|NCT04728815|584169809|FG005|Overall Study|Treatment drop|1|||
161763127|NCT04728815|584169810|FG006|Overall Study|Treatment drop|3|||
161763128|NCT04728815|584169811|FG007|Overall Study|Treatment drop|0|||
161763129|NCT04728815|584169804|FG000|Overall Study|Study drop|0|||
161763130|NCT04728815|584169805|FG001|Overall Study|Study drop|3|||
161763131|NCT04728815|584169806|FG002|Overall Study|Study drop|3|||
161763132|NCT04728815|584169807|FG003|Overall Study|Study drop|0|||
161763133|NCT04728815|584169808|FG004|Overall Study|Study drop|0|||
161763134|NCT04728815|584169809|FG005|Overall Study|Study drop|0|||
161763135|NCT04728815|584169810|FG006|Overall Study|Study drop|7|||
161763136|NCT04728815|584169811|FG007|Overall Study|Study drop|0|||
161763137|NCT05315297|584169812|FG000|Overall Study|Lost to Follow-up|6|||
161763138|NCT05315297|584169813|FG001|Overall Study|Lost to Follow-up|4|||
161763139|NCT05315297|584169812|FG000|Overall Study|Withdrawal by Subject|0|||
161763140|NCT05315297|584169813|FG001|Overall Study|Withdrawal by Subject|1|||
161763141|NCT02551874|584171693|FG000|Overall Study|Lost to Follow-up|0|||
161763142|NCT02551874|584171694|FG001|Overall Study|Lost to Follow-up|2|||
161763143|NCT02551874|584171693|FG000|Overall Study|Pregnancy|0|||
161763144|NCT02551874|584171694|FG001|Overall Study|Pregnancy|1|||
161763145|NCT02551874|584171693|FG000|Overall Study|Reason not reported|10|||
161763146|NCT02551874|584171694|FG001|Overall Study|Reason not reported|4|||
161763147|NCT02551874|584171693|FG000|Overall Study|Did not receive randomized treatment|0|||
161763148|NCT02551874|584171694|FG001|Overall Study|Did not receive randomized treatment|7|||
161763149|NCT02551874|584171693|FG000|Overall Study|Did not enter long-term study|18|||
161763150|NCT02551874|584171694|FG001|Overall Study|Did not enter long-term study|25|||
161848237|NCT01421511|584486284|FG001|Overall Study|Lost to Follow-up|14|||
161848238|NCT01421511|584486283|FG000|Overall Study|Randomized but didn't receive study drug|1|||
161848239|NCT01421511|584486284|FG001|Overall Study|Randomized but didn't receive study drug|7|||
161848240|NCT01421511|584486283|FG000|Overall Study|Physician Decision|0|||
161848241|NCT01421511|584486284|FG001|Overall Study|Physician Decision|1|||
161848242|NCT01421511|584486283|FG000|Overall Study|Withdrawal by Subject|6|||
161848243|NCT01421511|584486284|FG001|Overall Study|Withdrawal by Subject|5|||
161848244|NCT01421511|584486283|FG000|Overall Study|Death|1|||
161848245|NCT01421511|584486284|FG001|Overall Study|Death|1|||
161848246|NCT02242045|584486285|FG000|Overall Study|Investigator's Discretion|1|||
161848247|NCT02242045|584486285|FG000|Overall Study|Progressive Disease|2|||
161848248|NCT02242045|584486285|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
161848249|NCT02242045|584486285|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
161848250|NCT00749892|584486286|FG000|Overall Study|Withdrawal by Subject|3|||
161848251|NCT00106964|584486288|FG000|Overall Study|Lost to Follow-up|8|||
161848252|NCT00106964|584486289|FG001|Overall Study|Lost to Follow-up|6|||
161848253|NCT00106964|584486290|FG002|Overall Study|Lost to Follow-up|2|||
161848254|NCT00106964|584486288|FG000|Overall Study|Pregnancy|2|||
161848255|NCT00106964|584486289|FG001|Overall Study|Pregnancy|3|||
161848256|NCT00106964|584486290|FG002|Overall Study|Pregnancy|2|||
161848257|NCT00106964|584486288|FG000|Overall Study|Death|1|||
161848258|NCT00106964|584486289|FG001|Overall Study|Death|1|||
161848259|NCT00106964|584486290|FG002|Overall Study|Death|0|||
161848260|NCT00106964|584486288|FG000|Overall Study|Incarceration|0|||
161848261|NCT00106964|584486289|FG001|Overall Study|Incarceration|1|||
161848262|NCT00106964|584486290|FG002|Overall Study|Incarceration|0|||
161763151|NCT04067310|584171696|FG000|Overall Study|Physician Decision|2|||
161763152|NCT04067310|584171697|FG001|Overall Study|Physician Decision|6|||
161848263|NCT00106964|584486288|FG000|Overall Study|Site Funding Terminated|0|||
161763153|NCT04067310|584171696|FG000|Overall Study|Lost to Follow-up|0|||
161763154|NCT04067310|584171697|FG001|Overall Study|Lost to Follow-up|1|||
161763155|NCT04067310|584171696|FG000|Overall Study|Withdrawal by Subject|3|||
161763156|NCT04067310|584171697|FG001|Overall Study|Withdrawal by Subject|0|||
161848264|NCT00106964|584486289|FG001|Overall Study|Site Funding Terminated|1|||
161763157|NCT01041027|584171698|FG000|Overall Study|Withdrawal by Subject|2|||
161763158|NCT01041027|584171698|FG000|Overall Study|Protocol Violation|1|||
161763159|NCT01041027|584171698|FG000|Overall Study|Delayed Radiation Therapy|1|||
161763160|NCT01041027|584171698|FG000|Overall Study|Adverse Event|4|||
161763161|NCT02493712|584171699|FG000|Overall Study|Withdrawal by Subject|1|||
161763162|NCT02493712|584171700|FG001|Overall Study|Withdrawal by Subject|0|||
161848265|NCT00106964|584486290|FG002|Overall Study|Site Funding Terminated|1|||
161848266|NCT00106964|584486288|FG000|Overall Study|Failure to adhere|2|||
161848267|NCT00106964|584486289|FG001|Overall Study|Failure to adhere|0|||
161848268|NCT00106964|584486290|FG002|Overall Study|Failure to adhere|0|||
161848269|NCT00106964|584486288|FG000|Overall Study|Did not meet eligibility criteria|0|||
161848270|NCT00106964|584486289|FG001|Overall Study|Did not meet eligibility criteria|2|||
161848271|NCT00106964|584486290|FG002|Overall Study|Did not meet eligibility criteria|2|||
161848272|NCT00106964|584486288|FG000|Overall Study|Required disallowed medication|0|||
161848273|NCT00106964|584486289|FG001|Overall Study|Required disallowed medication|1|||
161848274|NCT00106964|584486290|FG002|Overall Study|Required disallowed medication|0|||
161848275|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
161848276|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
161848277|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
161848278|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
161848279|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
161848280|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
161848281|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
161848282|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
161848283|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
161848284|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
161848285|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
161848286|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
161848287|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
161848288|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
161848289|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
161848290|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
161848291|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
161848292|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
161848293|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
161848294|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
161848295|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
161848296|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
161848297|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
161848298|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
161848299|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
161848300|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
161848301|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
161848302|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
161848303|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
161848304|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
161848305|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
161848306|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
161848307|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
161848308|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
161848309|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
161848310|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
161848311|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161848312|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
161848313|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
161763163|NCT02493712|584171701|FG002|Overall Study|Withdrawal by Subject|2|||
161763164|NCT02493712|584171699|FG000|Overall Study|Protocol Violation|0|||
161763165|NCT02493712|584171700|FG001|Overall Study|Protocol Violation|0|||
161763166|NCT02493712|584171701|FG002|Overall Study|Protocol Violation|1|||
161763167|NCT02493712|584171699|FG000|Overall Study|Lost to Follow-up|1|||
161763168|NCT02493712|584171700|FG001|Overall Study|Lost to Follow-up|0|||
161763169|NCT02493712|584171701|FG002|Overall Study|Lost to Follow-up|0|||
161763170|NCT02493712|584171699|FG000|Overall Study|Physician Decision|0|||
161763171|NCT02493712|584171700|FG001|Overall Study|Physician Decision|1|||
161763172|NCT02493712|584171701|FG002|Overall Study|Physician Decision|0|||
161763173|NCT02493712|584171699|FG000|Overall Study|Lack of Efficacy|0|||
161763174|NCT02493712|584171700|FG001|Overall Study|Lack of Efficacy|5|||
161763175|NCT02493712|584171701|FG002|Overall Study|Lack of Efficacy|3|||
161763176|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
161763177|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
161763178|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
161763179|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
161763180|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
161848314|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
161763181|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
161848315|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
161763182|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
161763183|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
161763184|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
161763185|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
161763186|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
161763187|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
161763188|NCT02528643|584171702|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
161763189|NCT02528643|584171703|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
161763190|NCT02058940|584171704|FG000|Overall Study|Discharged from Critical Care Unit|1|||
161763191|NCT04144140|584171705|FG000|Overall Study|Other|0|||
161763192|NCT04144140|584171706|FG001|Overall Study|Other|0|||
161763193|NCT04144140|584171707|FG002|Overall Study|Other|0|||
161763194|NCT04144140|584171708|FG003|Overall Study|Other|0|||
161763195|NCT04144140|584171709|FG004|Overall Study|Other|0|||
161763196|NCT04144140|584171710|FG005|Overall Study|Other|1|||
161763197|NCT04144140|584171711|FG006|Overall Study|Other|0|||
161763198|NCT02146274|584171712|FG000|Overall Study|Protocol Violation|73|||
161763199|NCT02039687|584171715|FG000|Overall Study|Adverse Event|0|||
161763200|NCT02039687|584171716|FG001|Overall Study|Adverse Event|0|||
161763201|NCT02039687|584171717|FG002|Overall Study|Adverse Event|1|||
161763202|NCT02039687|584171718|FG003|Overall Study|Adverse Event|0|||
161763203|NCT02039687|584171715|FG000|Overall Study|Withdrawal by Subject|0|||
161763204|NCT02039687|584171716|FG001|Overall Study|Withdrawal by Subject|1|||
161763205|NCT02039687|584171717|FG002|Overall Study|Withdrawal by Subject|0|||
161763206|NCT02039687|584171718|FG003|Overall Study|Withdrawal by Subject|0|||
161763207|NCT02039687|584171715|FG000|Overall Study|treatment assignment could not be confir|0|||
161763208|NCT02039687|584171716|FG001|Overall Study|treatment assignment could not be confir|0|||
161763209|NCT02039687|584171717|FG002|Overall Study|treatment assignment could not be confir|2|||
161763210|NCT02039687|584171718|FG003|Overall Study|treatment assignment could not be confir|0|||
161763211|NCT01640353|584171729|FG000|Overall Study|Withdrew prior to treatment|10|||
161763212|NCT01640353|584171729|FG000|Overall Study|Withdrawn from analysis at term site|12|||
161763213|NCT01640353|584171729|FG000|Overall Study|Withdrawal by Subject|5|||
161763214|NCT01640353|584171729|FG000|Overall Study|Death|2|||
161763215|NCT01640353|584171729|FG000|Overall Study|Early site termination|3|||
161763216|NCT01640353|584171729|FG000|Overall Study|Lost to Follow-up|12|||
161763217|NCT01640353|584171729|FG000|Overall Study|Physician Decision|1|||
161763218|NCT01967134|584171730|FG000|Overall Study|Lost to Follow-up|0|||
161763219|NCT01967134|584171731|FG001|Overall Study|Lost to Follow-up|1|||
161763220|NCT01967134|584171732|FG002|Overall Study|Lost to Follow-up|0|||
161763221|NCT00443534|584171733|FG000|Overall Study|Lack of Efficacy|67|||
161763222|NCT00443534|584171733|FG000|Overall Study|Adverse Event|16|||
161763223|NCT00443534|584171733|FG000|Overall Study|Death|9|||
161763224|NCT00443534|584171733|FG000|Overall Study|Withdrawal by Subject|8|||
161763225|NCT00443534|584171733|FG000|Overall Study|Study Terminated by Sponsor|12|||
161763226|NCT00443534|584171733|FG000|Overall Study|Other|10|||
161763227|NCT00443534|584171733|FG000|Overall Study|Enrolled, Not Treated|1|||
161763228|NCT00305773|584171735|FG000|Overall Study|Death|3|||
161763229|NCT00305773|584171736|FG001|Overall Study|Death|2|||
161763230|NCT00305773|584171735|FG000|Overall Study|Adverse Event|1|||
161763231|NCT00305773|584171736|FG001|Overall Study|Adverse Event|2|||
161763232|NCT00305773|584171735|FG000|Overall Study|Alternative Treatment|4|||
161763233|NCT00305773|584171736|FG001|Overall Study|Alternative Treatment|4|||
161763234|NCT00305773|584171735|FG000|Overall Study|Physician Decision|1|||
161763235|NCT00305773|584171736|FG001|Overall Study|Physician Decision|1|||
161763236|NCT00305773|584171735|FG000|Overall Study|Withdrawal by Subject|1|||
161763237|NCT00305773|584171736|FG001|Overall Study|Withdrawal by Subject|4|||
161763238|NCT00305773|584171735|FG000|Overall Study|Disease Progression|1|||
161763239|NCT00305773|584171736|FG001|Overall Study|Disease Progression|3|||
161763240|NCT00305773|584171735|FG000|Overall Study|All other reasons|3|||
161763241|NCT00305773|584171736|FG001|Overall Study|All other reasons|2|||
161763242|NCT02679222|584171737|FG000|Overall Study|No time for project|1|||
161763243|NCT03419741|584171738|FG000|Overall Study|Adverse Event|1|||
161763244|NCT03419741|584171739|FG001|Overall Study|Adverse Event|0|||
161763245|NCT03419741|584171738|FG000|Overall Study|Withdrawal by Subject|1|||
161763246|NCT03419741|584171739|FG001|Overall Study|Withdrawal by Subject|2|||
161763247|NCT04354870|584171740|FG000|Overall Study|Lost to Follow-up|32|||
161763248|NCT04354870|584171741|FG001|Overall Study|Lost to Follow-up|12|||
161763249|NCT04354870|584171740|FG000|Overall Study|Withdrawal by Subject|10|||
161763250|NCT04354870|584171741|FG001|Overall Study|Withdrawal by Subject|16|||
161763251|NCT04354870|584171740|FG000|Overall Study|Did not complete all study visits|6|||
161848316|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
161763252|NCT04354870|584171741|FG001|Overall Study|Did not complete all study visits|5|||
161763253|NCT03384316|584171742|FG000|Overall Study|Screen failure|0|||
161763254|NCT03384316|584171743|FG001|Overall Study|Screen failure|1|||
161848317|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
161763255|NCT00413231|584171744|FG000|0 to 30-day Post Treatment|Death|5|||
161848318|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
161848319|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
161848320|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
161848321|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
161848322|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
161848323|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
161848324|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
161848325|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
161848326|NCT03207243|584486294|FG000|Overall Study|Adverse Event|2|||
161848327|NCT03207243|584486295|FG001|Overall Study|Adverse Event|2|||
161848328|NCT03207243|584486294|FG000|Overall Study|Loss of Asthma Control|47|||
161848329|NCT03207243|584486295|FG001|Overall Study|Loss of Asthma Control|31|||
161848330|NCT03207243|584486294|FG000|Overall Study|Withdrawal by Subject|2|||
161848331|NCT03207243|584486295|FG001|Overall Study|Withdrawal by Subject|4|||
161848332|NCT03207243|584486294|FG000|Overall Study|Physician Decision|1|||
161848333|NCT03207243|584486295|FG001|Overall Study|Physician Decision|1|||
161848334|NCT03207243|584486294|FG000|Overall Study|Lost to Follow-up|0|||
161848335|NCT03207243|584486295|FG001|Overall Study|Lost to Follow-up|1|||
161848336|NCT03207243|584486294|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
161848337|NCT03207243|584486295|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
161763256|NCT00413231|584171744|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
161763257|NCT00413231|584171744|FG000|30-day to 365-day Post Treatment|Death|13|||
161763258|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Death|36|||
161763259|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
161763260|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
161763261|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
161763262|NCT04450394|584171749|FG000|Overall Study|Adverse Event|2|||
161763263|NCT04450394|584171750|FG001|Overall Study|Adverse Event|0|||
161763264|NCT04450394|584171751|FG002|Overall Study|Adverse Event|0|||
161763265|NCT04450394|584171749|FG000|Overall Study|Death|0|||
161763266|NCT04450394|584171750|FG001|Overall Study|Death|1|||
161763267|NCT04450394|584171751|FG002|Overall Study|Death|0|||
161763268|NCT04450394|584171749|FG000|Overall Study|Lost to Follow-up|0|||
161763269|NCT04450394|584171750|FG001|Overall Study|Lost to Follow-up|3|||
161763270|NCT04450394|584171751|FG002|Overall Study|Lost to Follow-up|0|||
161763271|NCT04450394|584171749|FG000|Overall Study|Physician Decision|0|||
161763272|NCT04450394|584171750|FG001|Overall Study|Physician Decision|1|||
161763273|NCT04450394|584171751|FG002|Overall Study|Physician Decision|0|||
161763274|NCT04450394|584171749|FG000|Overall Study|Protocol Violation|2|||
161763275|NCT04450394|584171750|FG001|Overall Study|Protocol Violation|0|||
161763276|NCT04450394|584171751|FG002|Overall Study|Protocol Violation|0|||
161763277|NCT04450394|584171749|FG000|Overall Study|Withdrawal by Subject|6|||
161763278|NCT04450394|584171750|FG001|Overall Study|Withdrawal by Subject|9|||
161763279|NCT04450394|584171751|FG002|Overall Study|Withdrawal by Subject|0|||
161763280|NCT01066819|584171755|FG000|Overall Study|Adverse Event|18|||
161763281|NCT01066819|584171756|FG001|Overall Study|Adverse Event|1|||
161763282|NCT01066819|584171757|FG002|Overall Study|Adverse Event|6|||
161763283|NCT01066819|584171758|FG003|Overall Study|Adverse Event|0|||
161763284|NCT01066819|584171759|FG004|Overall Study|Adverse Event|0|||
161763285|NCT01066819|584171760|FG005|Overall Study|Adverse Event|0|||
161763286|NCT01066819|584171755|FG000|Overall Study|Death|5|||
161763287|NCT01066819|584171756|FG001|Overall Study|Death|0|||
161763288|NCT01066819|584171757|FG002|Overall Study|Death|1|||
161763289|NCT01066819|584171758|FG003|Overall Study|Death|0|||
161763290|NCT01066819|584171759|FG004|Overall Study|Death|0|||
161763291|NCT01066819|584171760|FG005|Overall Study|Death|0|||
161763292|NCT01066819|584171755|FG000|Overall Study|Lack of Efficacy|22|||
161763293|NCT01066819|584171756|FG001|Overall Study|Lack of Efficacy|1|||
161763294|NCT01066819|584171757|FG002|Overall Study|Lack of Efficacy|2|||
161848338|NCT03207243|584486294|FG000|Overall Study|Protocol Violation|0|||
161848339|NCT03207243|584486295|FG001|Overall Study|Protocol Violation|3|||
161763295|NCT01066819|584171758|FG003|Overall Study|Lack of Efficacy|1|||
161763296|NCT01066819|584171759|FG004|Overall Study|Lack of Efficacy|0|||
161763297|NCT01066819|584171760|FG005|Overall Study|Lack of Efficacy|0|||
161763298|NCT01066819|584171755|FG000|Overall Study|Physician Decision|6|||
161848340|NCT00603837|584486302|FG000|Overall Study|Physician Decision|3|||
161848341|NCT00603837|584486303|FG001|Overall Study|Physician Decision|0|||
161848342|NCT01352416|584486304|FG000|Overall Study|Physician Decision|1|||
161848343|NCT01352416|584486305|FG001|Overall Study|Physician Decision|2|||
161848344|NCT01352416|584486306|FG002|Overall Study|Physician Decision|2|||
161763299|NCT01066819|584171756|FG001|Overall Study|Physician Decision|2|||
161763300|NCT01066819|584171757|FG002|Overall Study|Physician Decision|3|||
161763301|NCT01066819|584171758|FG003|Overall Study|Physician Decision|0|||
161763302|NCT01066819|584171759|FG004|Overall Study|Physician Decision|0|||
161763303|NCT01066819|584171760|FG005|Overall Study|Physician Decision|0|||
161763304|NCT01066819|584171755|FG000|Overall Study|Protocol Violation|12|||
161763305|NCT01066819|584171756|FG001|Overall Study|Protocol Violation|6|||
161763306|NCT01066819|584171757|FG002|Overall Study|Protocol Violation|0|||
161763307|NCT01066819|584171758|FG003|Overall Study|Protocol Violation|0|||
161763308|NCT01066819|584171759|FG004|Overall Study|Protocol Violation|0|||
161763309|NCT01066819|584171760|FG005|Overall Study|Protocol Violation|0|||
161763310|NCT01066819|584171755|FG000|Overall Study|Withdrawal by Subject|29|||
161763311|NCT01066819|584171756|FG001|Overall Study|Withdrawal by Subject|11|||
161763312|NCT01066819|584171757|FG002|Overall Study|Withdrawal by Subject|6|||
161763313|NCT01066819|584171758|FG003|Overall Study|Withdrawal by Subject|0|||
161763314|NCT01066819|584171759|FG004|Overall Study|Withdrawal by Subject|0|||
161763315|NCT01066819|584171760|FG005|Overall Study|Withdrawal by Subject|0|||
161763316|NCT01066819|584171755|FG000|Overall Study|Administrative|6|||
161763317|NCT01066819|584171756|FG001|Overall Study|Administrative|4|||
161763318|NCT01066819|584171757|FG002|Overall Study|Administrative|2|||
161763319|NCT01066819|584171758|FG003|Overall Study|Administrative|0|||
161763320|NCT01066819|584171759|FG004|Overall Study|Administrative|0|||
161763321|NCT01066819|584171760|FG005|Overall Study|Administrative|0|||
161763322|NCT01066819|584171755|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
161763323|NCT01066819|584171756|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
161763324|NCT01066819|584171757|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
161763325|NCT01066819|584171758|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
161763326|NCT01066819|584171759|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
161763327|NCT01066819|584171760|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
161763328|NCT01066819|584171755|FG000|Overall Study|Early termination|2|||
161763329|NCT01066819|584171756|FG001|Overall Study|Early termination|0|||
161763330|NCT01066819|584171757|FG002|Overall Study|Early termination|0|||
161763331|NCT01066819|584171758|FG003|Overall Study|Early termination|0|||
161763332|NCT01066819|584171759|FG004|Overall Study|Early termination|0|||
161763333|NCT01066819|584171760|FG005|Overall Study|Early termination|0|||
161763334|NCT01066819|584171755|FG000|Overall Study|Failed to return|298|||
161763335|NCT01066819|584171756|FG001|Overall Study|Failed to return|107|||
161763336|NCT01066819|584171757|FG002|Overall Study|Failed to return|68|||
161763337|NCT01066819|584171758|FG003|Overall Study|Failed to return|7|||
161763338|NCT01066819|584171759|FG004|Overall Study|Failed to return|2|||
161763339|NCT01066819|584171760|FG005|Overall Study|Failed to return|3|||
161763340|NCT01066819|584171755|FG000|Overall Study|Lab test not done|9|||
161763341|NCT01066819|584171756|FG001|Overall Study|Lab test not done|0|||
161763342|NCT01066819|584171757|FG002|Overall Study|Lab test not done|2|||
161763343|NCT01066819|584171758|FG003|Overall Study|Lab test not done|1|||
161763344|NCT01066819|584171759|FG004|Overall Study|Lab test not done|0|||
161763345|NCT01066819|584171760|FG005|Overall Study|Lab test not done|0|||
161763346|NCT01066819|584171755|FG000|Overall Study|Miscellaneous|28|||
161763347|NCT01066819|584171756|FG001|Overall Study|Miscellaneous|10|||
161763348|NCT01066819|584171757|FG002|Overall Study|Miscellaneous|18|||
161763349|NCT01066819|584171758|FG003|Overall Study|Miscellaneous|1|||
161763350|NCT01066819|584171759|FG004|Overall Study|Miscellaneous|0|||
161763351|NCT01066819|584171760|FG005|Overall Study|Miscellaneous|0|||
161763352|NCT01066819|584171755|FG000|Overall Study|Non responders|123|||
161763353|NCT01066819|584171756|FG001|Overall Study|Non responders|2|||
161763354|NCT01066819|584171757|FG002|Overall Study|Non responders|7|||
161763355|NCT01066819|584171758|FG003|Overall Study|Non responders|2|||
161763356|NCT01066819|584171759|FG004|Overall Study|Non responders|0|||
161763357|NCT01066819|584171760|FG005|Overall Study|Non responders|1|||
161763358|NCT01066819|584171755|FG000|Overall Study|Not categorised|9|||
161763359|NCT01066819|584171756|FG001|Overall Study|Not categorised|2|||
161763360|NCT01066819|584171757|FG002|Overall Study|Not categorised|6|||
161763361|NCT01066819|584171758|FG003|Overall Study|Not categorised|1|||
161763362|NCT01066819|584171759|FG004|Overall Study|Not categorised|0|||
161763363|NCT01066819|584171760|FG005|Overall Study|Not categorised|0|||
161763364|NCT01066819|584171755|FG000|Overall Study|Relapse|16|||
161763365|NCT01066819|584171756|FG001|Overall Study|Relapse|4|||
161763366|NCT01066819|584171757|FG002|Overall Study|Relapse|3|||
161763367|NCT01066819|584171758|FG003|Overall Study|Relapse|0|||
161763368|NCT01066819|584171759|FG004|Overall Study|Relapse|0|||
161763369|NCT01066819|584171760|FG005|Overall Study|Relapse|0|||
161763370|NCT01066819|584171755|FG000|Overall Study|Results not available|1|||
161763371|NCT01066819|584171756|FG001|Overall Study|Results not available|0|||
161763372|NCT01066819|584171757|FG002|Overall Study|Results not available|0|||
161763373|NCT01066819|584171758|FG003|Overall Study|Results not available|0|||
161763374|NCT01066819|584171759|FG004|Overall Study|Results not available|0|||
161763375|NCT01066819|584171760|FG005|Overall Study|Results not available|0|||
161763376|NCT01066819|584171755|FG000|Overall Study|Screen failure|1|||
161763377|NCT01066819|584171756|FG001|Overall Study|Screen failure|0|||
161763378|NCT01066819|584171757|FG002|Overall Study|Screen failure|0|||
161763379|NCT01066819|584171758|FG003|Overall Study|Screen failure|0|||
161763380|NCT01066819|584171759|FG004|Overall Study|Screen failure|0|||
161763381|NCT01066819|584171760|FG005|Overall Study|Screen failure|0|||
161763382|NCT01066819|584171755|FG000|Overall Study|Spontaneous cure|1|||
161763383|NCT01066819|584171756|FG001|Overall Study|Spontaneous cure|0|||
161763384|NCT01066819|584171757|FG002|Overall Study|Spontaneous cure|0|||
161763385|NCT01066819|584171758|FG003|Overall Study|Spontaneous cure|0|||
161763386|NCT01066819|584171759|FG004|Overall Study|Spontaneous cure|0|||
161763387|NCT01066819|584171760|FG005|Overall Study|Spontaneous cure|0|||
161763388|NCT01066819|584171755|FG000|Overall Study|Treatment never started|85|||
161763389|NCT01066819|584171756|FG001|Overall Study|Treatment never started|19|||
161763390|NCT01066819|584171757|FG002|Overall Study|Treatment never started|19|||
161763391|NCT01066819|584171758|FG003|Overall Study|Treatment never started|3|||
161763392|NCT01066819|584171759|FG004|Overall Study|Treatment never started|2|||
161763393|NCT01066819|584171760|FG005|Overall Study|Treatment never started|2|||
161763394|NCT01066819|584171755|FG000|Overall Study|Treatment stopped|12|||
161763395|NCT01066819|584171756|FG001|Overall Study|Treatment stopped|1|||
161763396|NCT01066819|584171757|FG002|Overall Study|Treatment stopped|2|||
161763397|NCT01066819|584171758|FG003|Overall Study|Treatment stopped|1|||
161763398|NCT01066819|584171759|FG004|Overall Study|Treatment stopped|0|||
161763399|NCT01066819|584171760|FG005|Overall Study|Treatment stopped|0|||
161763400|NCT01066819|584171755|FG000|Overall Study|Other|5|||
161763401|NCT01066819|584171756|FG001|Overall Study|Other|1|||
161763402|NCT01066819|584171757|FG002|Overall Study|Other|1|||
161763403|NCT01066819|584171758|FG003|Overall Study|Other|0|||
161763404|NCT01066819|584171759|FG004|Overall Study|Other|0|||
161763405|NCT01066819|584171760|FG005|Overall Study|Other|0|||
161763406|NCT02719028|584171761|FG000|Overall Study|Adverse Event|2|||
161763407|NCT02719028|584171762|FG001|Overall Study|Adverse Event|1|||
161763408|NCT02719028|584171763|FG002|Overall Study|Adverse Event|4|||
161848345|NCT01352416|584486307|FG003|Overall Study|Physician Decision|1|||
161848346|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
161848347|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
161848348|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848349|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848350|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848351|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848352|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848353|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848354|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848355|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848356|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848357|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
161848358|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848359|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848360|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848361|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848362|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848363|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848364|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848365|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848366|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
161848367|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
161848368|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848369|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848370|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848371|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848372|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848373|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848374|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848375|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848376|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
161848377|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
161763409|NCT02719028|584171764|FG003|Overall Study|Adverse Event|8|||
161763410|NCT02719028|584171761|FG000|Overall Study|Physician Decision|0|||
161763411|NCT02719028|584171762|FG001|Overall Study|Physician Decision|1|||
161763412|NCT02719028|584171763|FG002|Overall Study|Physician Decision|1|||
161763413|NCT02719028|584171764|FG003|Overall Study|Physician Decision|1|||
161763414|NCT02719028|584171761|FG000|Overall Study|Use of prohibited medication|0|||
161848378|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161763415|NCT02719028|584171762|FG001|Overall Study|Use of prohibited medication|0|||
161763416|NCT02719028|584171763|FG002|Overall Study|Use of prohibited medication|1|||
161763417|NCT02719028|584171764|FG003|Overall Study|Use of prohibited medication|0|||
161763418|NCT02719028|584171761|FG000|Overall Study|Protocol Violation|0|||
161848379|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848380|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848381|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848382|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848383|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848384|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848385|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848386|NCT02960490|584486308|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848387|NCT02960490|584486309|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848388|NCT02960490|584486310|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
161848389|NCT02960490|584486311|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
161848390|NCT02960490|584486312|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848391|NCT02960490|584486313|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
161848392|NCT02960490|584486314|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848393|NCT02960490|584486315|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848394|NCT02960490|584486316|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848395|NCT02960490|584486317|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848396|NCT02960490|584486308|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848397|NCT02960490|584486309|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848398|NCT02960490|584486310|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
161848399|NCT02960490|584486311|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848400|NCT02960490|584486312|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
161848401|NCT02960490|584486313|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848402|NCT02960490|584486314|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848403|NCT02960490|584486315|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848404|NCT02960490|584486316|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848405|NCT02960490|584486317|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848406|NCT02960490|584486308|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
161848407|NCT02960490|584486309|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
161848408|NCT02960490|584486310|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
161848409|NCT02960490|584486311|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
161848410|NCT02960490|584486312|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
161848411|NCT02960490|584486313|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
161848412|NCT02960490|584486314|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
161848413|NCT02960490|584486315|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
161848414|NCT02960490|584486316|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
161848415|NCT02960490|584486317|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
161848416|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848417|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848418|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848419|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848420|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848421|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848422|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
161848423|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
161848424|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
161848425|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848426|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848427|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848428|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848429|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848430|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848431|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848432|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848433|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
161848434|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848435|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848436|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848437|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848438|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848439|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848440|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848441|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848442|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
161848443|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
161848444|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
161848445|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
161848446|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848447|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848448|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848449|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848450|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848451|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848452|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
161848453|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848454|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848455|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848456|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848457|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848458|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848459|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848460|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848461|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848462|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848463|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
161848464|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848465|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848466|NCT02368314|584486318|FG000|Overall Study|Withdrawal by Subject|2|||
161848467|NCT02368314|584486319|FG001|Overall Study|Withdrawal by Subject|1|||
161848468|NCT02368314|584486318|FG000|Overall Study|Adverse Event|1|||
161848469|NCT02368314|584486319|FG001|Overall Study|Adverse Event|2|||
161848470|NCT04411914|584486320|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
161848471|NCT04411914|584486321|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
161848472|NCT04106661|584486325|FG000|Overall Study|Protocol Violation|3|||
161848473|NCT04106661|584486326|FG001|Overall Study|Protocol Violation|0|||
161848474|NCT04106661|584486325|FG000|Overall Study|Scheduling difficulties|1|||
161848475|NCT04106661|584486326|FG001|Overall Study|Scheduling difficulties|1|||
161848476|NCT00233402|584486327|FG000|Overall Study|No pathology data|12|||
161848477|NCT00233402|584486328|FG001|Overall Study|No pathology data|9|||
161848478|NCT00233402|584486327|FG000|Overall Study|No Ta/T1|89|||
161848479|NCT00233402|584486328|FG001|Overall Study|No Ta/T1|94|||
161848480|NCT00233402|584486327|FG000|Overall Study|Lost to follow up etc|3|||
161848481|NCT00233402|584486328|FG001|Overall Study|Lost to follow up etc|21|||
161848482|NCT03280381|584486329|FG000|Overall Study|Physician Decision|0|||
161848483|NCT03280381|584486330|FG001|Overall Study|Physician Decision|2|||
161848484|NCT03503864|584486331|FG000|Overall Study|Protocol Violation|6|||
161848485|NCT03503864|584486331|FG000|Overall Study|Withdrawal by Subject|7|||
161848486|NCT00423319|584486332|FG000|Overall Study|Death|2|||
161848487|NCT00423319|584486333|FG001|Overall Study|Death|0|||
161848488|NCT00423319|584486332|FG000|Overall Study|Adverse Event|93|||
161848489|NCT00423319|584486333|FG001|Overall Study|Adverse Event|112|||
161848490|NCT00423319|584486332|FG000|Overall Study|Withdrawal by Subject|86|||
161848491|NCT00423319|584486333|FG001|Overall Study|Withdrawal by Subject|99|||
161763419|NCT02719028|584171762|FG001|Overall Study|Protocol Violation|0|||
161763420|NCT02719028|584171763|FG002|Overall Study|Protocol Violation|0|||
161763421|NCT02719028|584171764|FG003|Overall Study|Protocol Violation|1|||
161763422|NCT01539720|584171768|FG000|Overall Study|Screen Fail|15|||
161763423|NCT01539720|584171769|FG001|Overall Study|Screen Fail|3|||
161763424|NCT01539720|584171768|FG000|Overall Study|Lost to Follow-up|14|||
161763425|NCT01539720|584171769|FG001|Overall Study|Lost to Follow-up|7|||
161763426|NCT00298766|584171770|FG000|Overall Study|Adverse Event|18|||
161763427|NCT00298766|584171770|FG000|Overall Study|Death|2|||
161763428|NCT00298766|584171770|FG000|Overall Study|Withdrawal by Subject|9|||
161763429|NCT00298766|584171770|FG000|Overall Study|Treatment ongoing|4|||
161763430|NCT00298766|584171770|FG000|Overall Study|Progression of amyloid markers|4|||
161763431|NCT00298766|584171770|FG000|Overall Study|Deterioration in KPS and organ function|1|||
161763432|NCT00298766|584171770|FG000|Overall Study|Subjects overall condition deterioration|4|||
161763433|NCT00298766|584171770|FG000|Overall Study|Other|4|||
161763434|NCT03287960|584171777|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
161763435|NCT03287960|584171777|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
161763436|NCT03812224|584171778|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
161763437|NCT03812224|584171779|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161763438|NCT03812224|584171778|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
161763439|NCT03812224|584171779|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
161763440|NCT03812224|584171778|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
161763441|NCT03812224|584171779|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
161763442|NCT03812224|584171778|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
161848492|NCT00423319|584486332|FG000|Overall Study|Lost to Follow-up|4|||
161848493|NCT00423319|584486333|FG001|Overall Study|Lost to Follow-up|3|||
161848494|NCT00423319|584486332|FG000|Overall Study|Poor compliance or noncompliance|1|||
161848495|NCT00423319|584486333|FG001|Overall Study|Poor compliance or noncompliance|1|||
161848496|NCT00423319|584486332|FG000|Overall Study|No longer meets study criteria|15|||
161848497|NCT00423319|584486333|FG001|Overall Study|No longer meets study criteria|15|||
161848498|NCT00423319|584486332|FG000|Overall Study|Other|23|||
161848499|NCT00423319|584486333|FG001|Overall Study|Other|22|||
161848500|NCT02639052|584486334|FG000|Overall Study|Lost to Follow-up|1|||
161848501|NCT02655666|584486337|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
161848502|NCT00895414|584486338|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
161848503|NCT00895414|584486339|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
161848504|NCT00895414|584486338|FG000|First Intervention (14 Days)|Physician Decision|0|||
161848505|NCT00895414|584486339|FG001|First Intervention (14 Days)|Physician Decision|1|||
161848506|NCT02087189|584486340|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
161848507|NCT00478426|584486345|FG000|Overall Study|Withdrawal by Subject|1|||
161848508|NCT00789737|584486346|FG000|Overall Study|Withdrawal by Subject|13|||
161848509|NCT00789737|584486347|FG001|Overall Study|Withdrawal by Subject|22|||
161848510|NCT00789737|584486346|FG000|Overall Study|Lost to Follow-up|10|||
161848511|NCT00789737|584486347|FG001|Overall Study|Lost to Follow-up|14|||
161848512|NCT00789737|584486346|FG000|Overall Study|Adverse Event|8|||
161848513|NCT00789737|584486347|FG001|Overall Study|Adverse Event|8|||
161848514|NCT00789737|584486346|FG000|Overall Study|Protocol Violation|3|||
161848515|NCT00789737|584486347|FG001|Overall Study|Protocol Violation|0|||
161848516|NCT00789737|584486346|FG000|Overall Study|Lack of Efficacy|3|||
161848517|NCT00789737|584486347|FG001|Overall Study|Lack of Efficacy|0|||
161848518|NCT00789737|584486346|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
161848519|NCT00789737|584486347|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
161848520|NCT00789737|584486346|FG000|Overall Study|Other|11|||
161848521|NCT00789737|584486347|FG001|Overall Study|Other|7|||
161848522|NCT01189487|584486348|FG000|Overall Study|Lack of Efficacy|2|||
161848523|NCT01189487|584486348|FG000|Overall Study|Adverse Event|1|||
161848524|NCT04630158|584486349|FG000|Overall Study|Adverse Event|1|||
161848525|NCT04630158|584486350|FG001|Overall Study|Adverse Event|1|||
161848526|NCT04630158|584486351|FG002|Overall Study|Adverse Event|1|||
161848527|NCT04630158|584486349|FG000|Overall Study|Physician Decision|0|||
161848528|NCT04630158|584486350|FG001|Overall Study|Physician Decision|2|||
161848529|NCT04630158|584486351|FG002|Overall Study|Physician Decision|0|||
161848530|NCT04630158|584486349|FG000|Overall Study|Protocol Violation|1|||
161848531|NCT04630158|584486350|FG001|Overall Study|Protocol Violation|0|||
161848532|NCT04630158|584486351|FG002|Overall Study|Protocol Violation|1|||
161848533|NCT04630158|584486349|FG000|Overall Study|Withdrawal by Subject|2|||
161848534|NCT04630158|584486350|FG001|Overall Study|Withdrawal by Subject|1|||
161848535|NCT04630158|584486351|FG002|Overall Study|Withdrawal by Subject|2|||
161848536|NCT03136965|584486355|FG000|Overall Study|Lost to Follow-up|0|||
161848537|NCT03136965|584486356|FG001|Overall Study|Lost to Follow-up|1|||
161848538|NCT03136965|584486357|FG002|Overall Study|Lost to Follow-up|0|||
161848539|NCT01210612|584486359|FG000|Overall Study|Withdrawal by Subject|0|||
161848540|NCT01210612|584486360|FG001|Overall Study|Withdrawal by Subject|2|||
161848541|NCT02752087|584486361|FG000|Washout|Physician Decision|1|||
161848542|NCT02752087|584486362|FG001|Washout|Physician Decision|0|||
161848543|NCT02458287|584486363|FG000|Overall Study|Adverse Event|0|||
161848544|NCT02458287|584486364|FG001|Overall Study|Adverse Event|0|||
161848545|NCT02458287|584486365|FG002|Overall Study|Adverse Event|0|||
161848546|NCT02458287|584486366|FG003|Overall Study|Adverse Event|1|||
161848547|NCT02458287|584486363|FG000|Overall Study|Lost to Follow-up|0|||
161848548|NCT02458287|584486364|FG001|Overall Study|Lost to Follow-up|1|||
161848549|NCT02458287|584486365|FG002|Overall Study|Lost to Follow-up|1|||
161848550|NCT02458287|584486366|FG003|Overall Study|Lost to Follow-up|0|||
161848551|NCT02458287|584486363|FG000|Overall Study|Protocol Violation|0|||
161848552|NCT02458287|584486364|FG001|Overall Study|Protocol Violation|1|||
161848553|NCT02458287|584486365|FG002|Overall Study|Protocol Violation|0|||
161848554|NCT02458287|584486366|FG003|Overall Study|Protocol Violation|0|||
161848555|NCT02458287|584486363|FG000|Overall Study|Withdrawal by Subject|0|||
161848556|NCT02458287|584486364|FG001|Overall Study|Withdrawal by Subject|2|||
161848557|NCT02458287|584486365|FG002|Overall Study|Withdrawal by Subject|2|||
161848558|NCT02458287|584486366|FG003|Overall Study|Withdrawal by Subject|1|||
161848559|NCT02458287|584486363|FG000|Overall Study|Relocated Out of State|0|||
161848560|NCT02458287|584486364|FG001|Overall Study|Relocated Out of State|0|||
161848561|NCT02458287|584486365|FG002|Overall Study|Relocated Out of State|0|||
161848562|NCT02458287|584486366|FG003|Overall Study|Relocated Out of State|1|||
161848563|NCT00843635|584486367|FG000|Overall Study|Adverse Event|2|||
161848564|NCT00843635|584486368|FG001|Overall Study|Adverse Event|2|||
161848565|NCT00843635|584486369|FG002|Overall Study|Adverse Event|0|||
161848566|NCT00813800|584486372|FG000|Overall Study|Screen Failure after Consent|2|||
161848567|NCT00813800|584486372|FG000|Overall Study|Adverse Event|1|||
161848568|NCT00813800|584486372|FG000|Overall Study|Worsening of depression|2|||
161848569|NCT00813800|584486372|FG000|Overall Study|Physician Decision|1|||
161848570|NCT00418821|584486379|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
161848571|NCT02823652|584486380|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
161848572|NCT02823652|584486381|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
161848573|NCT02823652|584486382|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
161848574|NCT02823652|584486380|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
161848575|NCT02823652|584486381|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
161848576|NCT02823652|584486382|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
161848577|NCT02823652|584486380|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
161848578|NCT02823652|584486381|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
161848579|NCT02823652|584486382|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
161848580|NCT02823652|584486380|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
161848581|NCT02823652|584486381|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
161848582|NCT02823652|584486382|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
161848583|NCT04428333|584486383|FG000|Overall Study|Physician Decision|5|||
161848584|NCT04428333|584486384|FG001|Overall Study|Physician Decision|6|||
161848585|NCT04428333|584486383|FG000|Overall Study|Withdrawal by Subject|1|||
161848586|NCT04428333|584486384|FG001|Overall Study|Withdrawal by Subject|3|||
161848587|NCT04428333|584486383|FG000|Overall Study|Study Terminated By Sponsor|14|||
161848588|NCT04428333|584486384|FG001|Overall Study|Study Terminated By Sponsor|16|||
161848589|NCT04853992|584486385|FG000|Treatment Period A|Adverse Event|0|||
161848590|NCT04853992|584486386|FG001|Treatment Period A|Adverse Event|1|||
161848591|NCT04853992|584486385|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
161848592|NCT04853992|584486386|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
161848593|NCT02269163|584486387|FG000|Overall Study|Lost to Follow-up|1|||
161848594|NCT02269163|584486388|FG001|Overall Study|Lost to Follow-up|0|||
161848595|NCT02269163|584486387|FG000|Overall Study|Major protocol violation|0|||
161848596|NCT02269163|584486388|FG001|Overall Study|Major protocol violation|1|||
161848597|NCT02269163|584486387|FG000|Overall Study|Other|2|||
161848598|NCT02269163|584486388|FG001|Overall Study|Other|2|||
161848599|NCT02269163|584486387|FG000|Overall Study|Withdrawal by Subject|0|||
161848600|NCT02269163|584486388|FG001|Overall Study|Withdrawal by Subject|3|||
161848601|NCT02269163|584486387|FG000|Overall Study|Physician Decision|0|||
161848602|NCT02269163|584486388|FG001|Overall Study|Physician Decision|1|||
161848603|NCT02351960|584486389|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
161848604|NCT02351960|584486390|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161848605|NCT02351960|584486389|FG000|Overall Study|Voluntary Withdrawal|5|||
161848606|NCT02351960|584486390|FG001|Overall Study|Voluntary Withdrawal|4|||
161848607|NCT02351960|584486389|FG000|Overall Study|Significant Protocol Deviation|0|||
161848608|NCT02351960|584486390|FG001|Overall Study|Significant Protocol Deviation|5|||
161848609|NCT03866902|584486391|FG000|Overall Study|Lost to Follow-up|98|||
161848610|NCT03866902|584486392|FG001|Overall Study|Lost to Follow-up|82|||
161848611|NCT03866902|584486391|FG000|Overall Study|Pregnancy|18|||
161848612|NCT03866902|584486392|FG001|Overall Study|Pregnancy|24|||
161848613|NCT02092467|584486394|FG000|Overall Study|Death|49|||
161848614|NCT02092467|584486395|FG001|Overall Study|Death|66|||
161848615|NCT02092467|584486396|FG002|Overall Study|Death|38|||
161848616|NCT02092467|584486394|FG000|Overall Study|Lost to Follow-up|38|||
161848617|NCT02092467|584486395|FG001|Overall Study|Lost to Follow-up|35|||
161848618|NCT02092467|584486396|FG002|Overall Study|Lost to Follow-up|40|||
161848619|NCT02092467|584486394|FG000|Overall Study|Global Deterioration of Health Status|1|||
161848620|NCT02092467|584486395|FG001|Overall Study|Global Deterioration of Health Status|0|||
161763443|NCT03812224|584171779|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
161763444|NCT00303719|584171782|FG000|Overall Study|Not evaluable, prior therapies|0|||
161763445|NCT00303719|584171783|FG001|Overall Study|Not evaluable, prior therapies|30|||
161763446|NCT00303719|584171782|FG000|Overall Study|Lost to Follow-up|0|||
161763447|NCT00303719|584171783|FG001|Overall Study|Lost to Follow-up|7|||
161763448|NCT01641952|584171784|FG000|Overall Study|Lost to Follow-up|28|||
161763449|NCT01641952|584171784|FG000|Overall Study|Adverse Event|6|||
161763450|NCT00656136|584171787|FG000|Overall Study|Progressive disease|177|||
161763451|NCT00656136|584171788|FG001|Overall Study|Progressive disease|322|||
161763452|NCT00656136|584171787|FG000|Overall Study|Other Adverse Event|5|||
161763453|NCT00656136|584171788|FG001|Overall Study|Other Adverse Event|51|||
161763454|NCT00656136|584171787|FG000|Overall Study|Protocol Violation|2|||
161763455|NCT00656136|584171788|FG001|Overall Study|Protocol Violation|3|||
161763456|NCT00656136|584171787|FG000|Overall Study|Patient refused to take study medication|7|||
161848621|NCT02092467|584486396|FG002|Overall Study|Global Deterioration of Health Status|0|||
161848622|NCT02092467|584486394|FG000|Overall Study|Other|32|||
161848623|NCT02092467|584486395|FG001|Overall Study|Other|30|||
161848624|NCT02092467|584486396|FG002|Overall Study|Other|24|||
161848625|NCT02092467|584486394|FG000|Overall Study|Withdrawal by Subject|282|||
161848626|NCT02092467|584486395|FG001|Overall Study|Withdrawal by Subject|327|||
161848627|NCT02092467|584486396|FG002|Overall Study|Withdrawal by Subject|289|||
161848628|NCT02092467|584486394|FG000|Overall Study|Randomized but not treated|2|||
161848629|NCT02092467|584486395|FG001|Overall Study|Randomized but not treated|1|||
161848630|NCT02092467|584486396|FG002|Overall Study|Randomized but not treated|7|||
161848631|NCT01284621|584486397|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848632|NCT01284621|584486398|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848633|NCT01284621|584486399|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848634|NCT01284621|584486400|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848635|NCT01284621|584486401|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
161848636|NCT01284621|584486402|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848637|NCT02377427|584486405|FG000|Part A (Up to Week 20)|Physician Decision|1|||
161848638|NCT02377427|584486406|FG001|Part A (Up to Week 20)|Physician Decision|0|||
161848639|NCT02377427|584486407|FG002|Part A (Up to Week 20)|Physician Decision|0|||
161848640|NCT02377427|584486408|FG003|Part A (Up to Week 20)|Physician Decision|0|||
161848641|NCT02377427|584486409|FG004|Part A (Up to Week 20)|Physician Decision|0|||
161848642|NCT02377427|584486405|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
161848643|NCT02377427|584486406|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848644|NCT02377427|584486407|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848645|NCT02377427|584486408|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848646|NCT02377427|584486409|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848647|NCT02377427|584486405|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
161848648|NCT02377427|584486406|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848649|NCT02377427|584486407|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848650|NCT02377427|584486408|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848651|NCT02377427|584486409|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848652|NCT02377427|584486405|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848653|NCT02377427|584486406|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848654|NCT02377427|584486407|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
161848655|NCT02377427|584486408|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848656|NCT02377427|584486409|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848657|NCT02293863|584486410|FG000|Overall Study|Death|4|||
161848658|NCT02293863|584486411|FG001|Overall Study|Death|6|||
161848659|NCT02293863|584486412|FG002|Overall Study|Death|4|||
161848660|NCT02293863|584486410|FG000|Overall Study|Lost to Follow-up|2|||
161848661|NCT02293863|584486411|FG001|Overall Study|Lost to Follow-up|2|||
161848662|NCT02293863|584486412|FG002|Overall Study|Lost to Follow-up|2|||
161848663|NCT02293863|584486410|FG000|Overall Study|Withdrawal by Subject|3|||
161848664|NCT02293863|584486411|FG001|Overall Study|Withdrawal by Subject|3|||
161848665|NCT02293863|584486412|FG002|Overall Study|Withdrawal by Subject|1|||
161848666|NCT02293863|584486410|FG000|Overall Study|Reason Not Specified|0|||
161848667|NCT02293863|584486411|FG001|Overall Study|Reason Not Specified|2|||
161848668|NCT02293863|584486412|FG002|Overall Study|Reason Not Specified|2|||
161848669|NCT03155945|584486413|FG000|Overall Study|Lost to Follow-up|0|||
161848670|NCT03155945|584486414|FG001|Overall Study|Lost to Follow-up|1|||
161848671|NCT03155945|584486413|FG000|Overall Study|Withdrawal by Subject|0|||
161848672|NCT03155945|584486414|FG001|Overall Study|Withdrawal by Subject|1|||
161848673|NCT03155945|584486413|FG000|Overall Study|Other Reason|0|||
161848674|NCT03155945|584486414|FG001|Overall Study|Other Reason|1|||
161848675|NCT00416884|584486415|FG000|Overall Study|Study terminated due to low accrual|1|||
161848676|NCT03408639|584488670|FG000|Overall Study|Death|5|||
161848677|NCT03408639|584488671|FG001|Overall Study|Death|5|||
161848678|NCT03408639|584488670|FG000|Overall Study|Lost to Follow-up|1|||
161848679|NCT03408639|584488671|FG001|Overall Study|Lost to Follow-up|4|||
161848680|NCT03408639|584488670|FG000|Overall Study|Withdrawal by Subject|2|||
161848681|NCT03408639|584488671|FG001|Overall Study|Withdrawal by Subject|7|||
161848682|NCT03408639|584488670|FG000|Overall Study|Physician Decision|3|||
161848683|NCT03408639|584488671|FG001|Overall Study|Physician Decision|6|||
161848684|NCT00213135|584488681|FG000|Overall Study|Adverse Event|9|||
161848685|NCT00213135|584488682|FG001|Overall Study|Adverse Event|5|||
161848686|NCT00213135|584488683|FG002|Overall Study|Adverse Event|5|||
161848687|NCT00213135|584488681|FG000|Overall Study|Lost to Follow-up|11|||
161848688|NCT00213135|584488682|FG001|Overall Study|Lost to Follow-up|8|||
161848689|NCT00213135|584488683|FG002|Overall Study|Lost to Follow-up|4|||
161848690|NCT00213135|584488681|FG000|Overall Study|Protocol Violation|4|||
161848691|NCT00213135|584488682|FG001|Overall Study|Protocol Violation|4|||
161848692|NCT00213135|584488683|FG002|Overall Study|Protocol Violation|10|||
161848693|NCT00213135|584488681|FG000|Overall Study|Death|1|||
161848694|NCT00213135|584488682|FG001|Overall Study|Death|1|||
161848695|NCT00213135|584488683|FG002|Overall Study|Death|2|||
161848696|NCT00213135|584488681|FG000|Overall Study|Disease progression|4|||
161848697|NCT00213135|584488682|FG001|Overall Study|Disease progression|5|||
161848698|NCT00213135|584488683|FG002|Overall Study|Disease progression|21|||
161848699|NCT00213135|584488681|FG000|Overall Study|Other|21|||
161848700|NCT00213135|584488682|FG001|Overall Study|Other|12|||
161848701|NCT00213135|584488683|FG002|Overall Study|Other|15|||
161848702|NCT01924754|584488688|FG000|Overall Study|Lost to Follow-up|1|||
161848703|NCT01924754|584488689|FG001|Overall Study|Lost to Follow-up|2|||
161848704|NCT01924754|584488690|FG002|Overall Study|Lost to Follow-up|1|||
161848705|NCT01924754|584488688|FG000|Overall Study|Pregnancy|0|||
161848706|NCT01924754|584488689|FG001|Overall Study|Pregnancy|1|||
161848707|NCT01924754|584488690|FG002|Overall Study|Pregnancy|2|||
161848708|NCT03132155|584488691|FG000|Overall Study|Lack of Efficacy|6|||
161848709|NCT03132155|584488691|FG000|Overall Study|Lost to Follow-up|1|||
161848710|NCT03132155|584488691|FG000|Overall Study|Withdrawal by Subject|1|||
161848711|NCT02925403|584488697|FG000|Overall Study|Lost to Follow-up|0|||
161848712|NCT02925403|584488698|FG001|Overall Study|Lost to Follow-up|1|||
161848713|NCT00402116|584488699|FG000|Overall Study|Jaw infection after surgery-other|1|||
161848714|NCT00402116|584488700|FG001|Overall Study|Jaw infection after surgery-other|0|||
161848715|NCT00402116|584488701|FG002|Overall Study|Jaw infection after surgery-other|0|||
161848716|NCT00402116|584488699|FG000|Overall Study|Withdrawal by Subject|1|||
161848717|NCT00402116|584488700|FG001|Overall Study|Withdrawal by Subject|0|||
161848718|NCT00402116|584488701|FG002|Overall Study|Withdrawal by Subject|5|||
161848719|NCT00402116|584488699|FG000|Overall Study|Treatment completed per protocol|1|||
161848720|NCT00402116|584488700|FG001|Overall Study|Treatment completed per protocol|1|||
161848721|NCT00402116|584488701|FG002|Overall Study|Treatment completed per protocol|2|||
161848722|NCT00402116|584488699|FG000|Overall Study|other complicating disease|0|||
161848723|NCT00402116|584488700|FG001|Overall Study|other complicating disease|0|||
161848724|NCT00402116|584488701|FG002|Overall Study|other complicating disease|2|||
161848725|NCT00402116|584488699|FG000|Overall Study|Disease Progression|0|||
161848726|NCT00402116|584488700|FG001|Overall Study|Disease Progression|4|||
161848727|NCT00402116|584488701|FG002|Overall Study|Disease Progression|38|||
161848728|NCT00402116|584488699|FG000|Overall Study|mistaken thrombocytopenia|0|||
161848729|NCT00402116|584488700|FG001|Overall Study|mistaken thrombocytopenia|0|||
161848730|NCT00402116|584488701|FG002|Overall Study|mistaken thrombocytopenia|1|||
161848731|NCT00402116|584488699|FG000|Overall Study|decline related hyponatremia/tumor|0|||
161848732|NCT00402116|584488700|FG001|Overall Study|decline related hyponatremia/tumor|0|||
161848733|NCT00402116|584488701|FG002|Overall Study|decline related hyponatremia/tumor|1|||
161848734|NCT00402116|584488699|FG000|Overall Study|Adverse Event|0|||
161848735|NCT00402116|584488700|FG001|Overall Study|Adverse Event|1|||
161848736|NCT00402116|584488701|FG002|Overall Study|Adverse Event|6|||
161848737|NCT02899195|584488702|FG000|Concurrent Durvalumab|Adverse Event|4|||
161848738|NCT02899195|584488702|FG000|Concurrent Durvalumab|Physician Decision|1|||
161848739|NCT02899195|584488702|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
161848740|NCT02899195|584488702|FG000|Concurrent Durvalumab|Progressive Disease|5|||
161848741|NCT02899195|584488702|FG000|Maintenance Durvalumab|Adverse Event|1|||
161848742|NCT02899195|584488702|FG000|Maintenance Durvalumab|Physician Decision|1|||
161848743|NCT02899195|584488702|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
161848744|NCT02899195|584488702|FG000|Maintenance Durvalumab|Progressive Disease|31|||
161848745|NCT04778904|584488703|FG000|Overall Study|Protocol Violation|1|||
161848746|NCT04778904|584488704|FG001|Overall Study|Protocol Violation|0|||
161848747|NCT04778904|584488705|FG002|Overall Study|Protocol Violation|0|||
161848748|NCT04778904|584488706|FG003|Overall Study|Protocol Violation|0|||
161848749|NCT04778904|584488703|FG000|Overall Study|Withdrawal by Subject|0|||
161848750|NCT04778904|584488704|FG001|Overall Study|Withdrawal by Subject|0|||
161848751|NCT04778904|584488705|FG002|Overall Study|Withdrawal by Subject|1|||
161848752|NCT04778904|584488706|FG003|Overall Study|Withdrawal by Subject|0|||
161848753|NCT03452137|584488707|FG000|Overall Study|Death|67|||
161848754|NCT03452137|584488708|FG001|Overall Study|Death|70|||
161848755|NCT03452137|584488707|FG000|Overall Study|Lost to Follow-up|4|||
161848756|NCT03452137|584488708|FG001|Overall Study|Lost to Follow-up|2|||
161848757|NCT03452137|584488707|FG000|Overall Study|Physician Decision|0|||
161848758|NCT03452137|584488708|FG001|Overall Study|Physician Decision|1|||
161848759|NCT03452137|584488707|FG000|Overall Study|Study Terminated by Sponsor|120|||
161848760|NCT03452137|584488708|FG001|Overall Study|Study Terminated by Sponsor|121|||
161848761|NCT03452137|584488707|FG000|Overall Study|Withdrawal by Subject|12|||
161848762|NCT03452137|584488708|FG001|Overall Study|Withdrawal by Subject|9|||
161848763|NCT04138043|584488709|FG000|Overall Study|Withdrawal by Subject|0|||
161848764|NCT04138043|584488710|FG001|Overall Study|Withdrawal by Subject|1|||
161848765|NCT03772717|584488711|FG000|Overall Study|Withdrawal by Subject|2|||
161848766|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161848767|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
161848768|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
161848769|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
161848770|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
161848771|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
161848772|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
161848773|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
161848774|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
161848775|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
161848776|NCT02856802|584488712|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
161848777|NCT02856802|584488713|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
161848778|NCT00587860|584488714|FG000|Overall Study|Lost to Follow-up|2|||
161848779|NCT00587860|584488715|FG001|Overall Study|Lost to Follow-up|2|||
161848780|NCT00587860|584488714|FG000|Overall Study|Withdrawal by Subject|3|||
161848781|NCT00587860|584488715|FG001|Overall Study|Withdrawal by Subject|3|||
161848782|NCT01659125|584488716|FG000|Overall Study|Withdrawal by Subject|2|||
161848783|NCT01659125|584488716|FG000|Overall Study|Lost to Follow-up|7|||
161848784|NCT01659125|584488716|FG000|Overall Study|Technical Problem|1|||
161848785|NCT01659125|584488716|FG000|Overall Study|Time Constraints|2|||
161848786|NCT01659125|584488716|FG000|Overall Study|Failed to Start Treatment|2|||
161848787|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
161848788|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
161848789|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
161848790|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
161848791|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
161848792|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
161848793|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
161848794|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
161848795|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
161848796|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
161848797|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
161848798|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
161848799|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
161848800|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
161848801|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
161848802|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
161848803|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
161848804|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
161848805|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
161848806|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
161848807|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
161848808|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
161848809|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
161848810|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
161848811|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
161848812|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
161848813|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
161848814|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
161848815|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
161848816|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
161848817|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
161848818|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
161848819|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
161848820|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
161848821|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
161848822|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
161848823|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
161763457|NCT00656136|584171788|FG001|Overall Study|Patient refused to take study medication|10|||
161763458|NCT00656136|584171787|FG000|Overall Study|Unknown and others|4|||
161763459|NCT00656136|584171788|FG001|Overall Study|Unknown and others|4|||
161763460|NCT03633461|584171798|FG000|Overall Study|Lost to Follow-up|0|||
161763461|NCT03633461|584171799|FG001|Overall Study|Lost to Follow-up|1|||
161763462|NCT02516306|584171806|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
161763463|NCT02516306|584171807|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
161763464|NCT02607865|584171810|FG000|Overall Study|Lost to Follow-up|9|||
161763465|NCT02607865|584171811|FG001|Overall Study|Lost to Follow-up|7|||
161763466|NCT02607865|584171812|FG002|Overall Study|Lost to Follow-up|7|||
161763467|NCT02607865|584171813|FG003|Overall Study|Lost to Follow-up|5|||
161763468|NCT02607865|584171810|FG000|Overall Study|Withdrawal by Subject|18|||
161763469|NCT02607865|584171811|FG001|Overall Study|Withdrawal by Subject|18|||
161763470|NCT02607865|584171812|FG002|Overall Study|Withdrawal by Subject|17|||
161763471|NCT02607865|584171813|FG003|Overall Study|Withdrawal by Subject|8|||
161763472|NCT02607865|584171810|FG000|Overall Study|Death|5|||
161763473|NCT02607865|584171811|FG001|Overall Study|Death|4|||
161763474|NCT02607865|584171812|FG002|Overall Study|Death|1|||
161763475|NCT02607865|584171813|FG003|Overall Study|Death|3|||
161763476|NCT02607865|584171810|FG000|Overall Study|Unclassified|1|||
161763477|NCT02607865|584171811|FG001|Overall Study|Unclassified|1|||
161763478|NCT02607865|584171812|FG002|Overall Study|Unclassified|2|||
161763479|NCT02607865|584171813|FG003|Overall Study|Unclassified|0|||
161763480|NCT03227692|584171814|FG000|Overall Study|Protocol Violation|1|||
161763481|NCT03227692|584171815|FG001|Overall Study|Protocol Violation|1|||
161763482|NCT03227692|584171814|FG000|Overall Study|Lost to Follow-up|4|||
161763483|NCT03227692|584171815|FG001|Overall Study|Lost to Follow-up|2|||
161763484|NCT03227692|584171814|FG000|Overall Study|Adverse Event|0|||
161763485|NCT03227692|584171815|FG001|Overall Study|Adverse Event|2|||
161763486|NCT02447952|584171816|FG000|Overall Study|Adverse Event|2|||
161763487|NCT02447952|584171816|FG000|Overall Study|Physician Decision|1|||
161763488|NCT02447952|584171816|FG000|Overall Study|Withdrawal by Subject|4|||
161763489|NCT01351415|584171820|FG000|Overall Study|Withdrawal by Subject|15|||
161763490|NCT01351415|584171821|FG001|Overall Study|Withdrawal by Subject|17|||
161763491|NCT01351415|584171820|FG000|Overall Study|Trial termination by the Sponsor|28|||
161763492|NCT01351415|584171821|FG001|Overall Study|Trial termination by the Sponsor|19|||
161763493|NCT01351415|584171820|FG000|Overall Study|Lost to Follow-up|5|||
161763494|NCT01351415|584171821|FG001|Overall Study|Lost to Follow-up|7|||
161763495|NCT01351415|584171820|FG000|Overall Study|Death|190|||
161763496|NCT01351415|584171821|FG001|Overall Study|Death|187|||
161763497|NCT01351415|584171820|FG000|Overall Study|Physician Decision|2|||
161763498|NCT01351415|584171821|FG001|Overall Study|Physician Decision|3|||
161763499|NCT01351415|584171820|FG000|Overall Study|Reason unknown|0|||
161763500|NCT01351415|584171821|FG001|Overall Study|Reason unknown|2|||
161763501|NCT01351415|584171820|FG000|Overall Study|Never Started|5|||
161763502|NCT01351415|584171821|FG001|Overall Study|Never Started|5|||
161763503|NCT00247962|584171822|FG000|Overall Study|Adverse Event|15|||
161763504|NCT00247962|584171823|FG001|Overall Study|Adverse Event|12|||
161763505|NCT00247962|584171822|FG000|Overall Study|Lost to Follow-up|3|||
161848824|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
161763506|NCT00247962|584171823|FG001|Overall Study|Lost to Follow-up|1|||
161763507|NCT00247962|584171822|FG000|Overall Study|Physician Decision|0|||
161763508|NCT00247962|584171823|FG001|Overall Study|Physician Decision|1|||
161763509|NCT00247962|584171822|FG000|Overall Study|Protocol Violation|1|||
161763510|NCT00247962|584171823|FG001|Overall Study|Protocol Violation|1|||
161763511|NCT00247962|584171822|FG000|Overall Study|Withdrawal by Subject|3|||
161763512|NCT00247962|584171823|FG001|Overall Study|Withdrawal by Subject|2|||
161763513|NCT00247962|584171822|FG000|Overall Study|Lack of Efficacy|4|||
161763514|NCT00247962|584171823|FG001|Overall Study|Lack of Efficacy|2|||
161763515|NCT03525613|584171825|FG000|Overall Study|Adverse Event|11|||
161763516|NCT03525613|584171826|FG001|Overall Study|Adverse Event|8|||
161763517|NCT03525613|584171827|FG002|Overall Study|Adverse Event|3|||
161763518|NCT03525613|584171828|FG003|Overall Study|Adverse Event|3|||
161763519|NCT03525613|584171825|FG000|Overall Study|Lost to Follow-up|4|||
161763520|NCT03525613|584171826|FG001|Overall Study|Lost to Follow-up|5|||
161763521|NCT03525613|584171827|FG002|Overall Study|Lost to Follow-up|3|||
161763522|NCT03525613|584171828|FG003|Overall Study|Lost to Follow-up|2|||
161763523|NCT03525613|584171825|FG000|Overall Study|Physician Decision|0|||
161763524|NCT03525613|584171826|FG001|Overall Study|Physician Decision|1|||
161763525|NCT03525613|584171827|FG002|Overall Study|Physician Decision|0|||
161763526|NCT03525613|584171828|FG003|Overall Study|Physician Decision|1|||
161763527|NCT03525613|584171825|FG000|Overall Study|Consent Withdrawal|25|||
161763528|NCT03525613|584171826|FG001|Overall Study|Consent Withdrawal|16|||
161763529|NCT03525613|584171827|FG002|Overall Study|Consent Withdrawal|12|||
161763530|NCT03525613|584171828|FG003|Overall Study|Consent Withdrawal|9|||
161763531|NCT03525613|584171825|FG000|Overall Study|Death|20|||
161763532|NCT03525613|584171826|FG001|Overall Study|Death|9|||
161763533|NCT03525613|584171827|FG002|Overall Study|Death|7|||
161763534|NCT03525613|584171828|FG003|Overall Study|Death|1|||
161763535|NCT03525613|584171825|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
161763536|NCT03525613|584171826|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
161763537|NCT03525613|584171827|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
161763538|NCT03525613|584171828|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
161763539|NCT03480360|584171829|FG000|Overall Study|Death|2|||
161763540|NCT03117309|584171836|FG000|Overall Study|Not meeting inclusion criteria|0|||
161763541|NCT03117309|584171837|FG001|Overall Study|Not meeting inclusion criteria|1|||
161763542|NCT02120469|584171838|FG000|Overall Study|HER-2/neu-amplified|1|||
161763543|NCT02120469|584171839|FG001|Overall Study|HER-2/neu-amplified|0|||
161763544|NCT02120469|584171840|FG002|Overall Study|HER-2/neu-amplified|1|||
161763545|NCT02583711|584171841|FG000|Overall Study|Withdrawal by Subject|0|||
161763546|NCT02583711|584171842|FG001|Overall Study|Withdrawal by Subject|10|||
161763547|NCT02583711|584171843|FG002|Overall Study|Withdrawal by Subject|0|||
161763548|NCT00392210|584171844|FG000|First Voiding Trial|Physician Decision|2|||
161763549|NCT00392210|584171845|FG001|First Voiding Trial|Physician Decision|2|||
161763550|NCT01021423|584171853|FG000|Overall Study|Study terminated|4|||
161763551|NCT01021423|584171854|FG001|Overall Study|Study terminated|5|||
161763552|NCT00122317|584171855|FG000|Overall Study|Death|3|||
161763553|NCT00122317|584171855|FG000|Overall Study|Adverse Event|4|||
161763554|NCT00122317|584171855|FG000|Overall Study|Physician Decision|2|||
161763555|NCT00122317|584171855|FG000|Overall Study|patient non-compliance|1|||
161763556|NCT00122317|584171855|FG000|Overall Study|Withdrawal by Subject|1|||
161763557|NCT03756285|584171856|FG000|Overall Study|Lost to Follow-up|0|||
161763558|NCT03756285|584171857|FG001|Overall Study|Lost to Follow-up|1|||
161763559|NCT03756285|584171856|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
161763560|NCT03756285|584171857|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
161763561|NCT03756285|584171856|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
161763562|NCT03756285|584171857|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
161763563|NCT06334055|584171858|FG000|Overall Study|Adverse Event|4|||
161763564|NCT06334055|584171858|FG000|Overall Study|Disqualified|72|||
161763565|NCT00957034|584171859|FG000|Overall Study|Adverse Event|0|||
161763566|NCT00957034|584171860|FG001|Overall Study|Adverse Event|1|||
161763567|NCT00957034|584171861|FG002|Overall Study|Adverse Event|1|||
161763568|NCT00957034|584171859|FG000|Overall Study|Sponsor Terminated Study|6|||
161763569|NCT00957034|584171860|FG001|Overall Study|Sponsor Terminated Study|1|||
161763570|NCT00957034|584171861|FG002|Overall Study|Sponsor Terminated Study|5|||
161763571|NCT00957034|584171859|FG000|Overall Study|Withdrawal by Subject|0|||
161763572|NCT00957034|584171860|FG001|Overall Study|Withdrawal by Subject|2|||
161763573|NCT00957034|584171861|FG002|Overall Study|Withdrawal by Subject|0|||
161763574|NCT01503229|584174189|FG000|Overall Study|Withdrew consent|1|||
161848825|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
161848826|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
161848827|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
161848828|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
161848829|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
161848830|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
161848831|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
161848832|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
161848833|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
161848834|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
161848835|NCT00261443|584488717|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
161848836|NCT00261443|584488718|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
161848837|NCT00261443|584488719|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
161848838|NCT00261443|584488717|FG000|3: Assessment of Relapse|Adverse Event|0|||
161848839|NCT00261443|584488718|FG001|3: Assessment of Relapse|Adverse Event|15|||
161848840|NCT00261443|584488719|FG002|3: Assessment of Relapse|Adverse Event|19|||
161848841|NCT00261443|584488717|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
161848842|NCT00261443|584488718|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
161848843|NCT00261443|584488719|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
161848844|NCT00261443|584488717|FG000|3: Assessment of Relapse|Death|0|||
161848845|NCT00261443|584488718|FG001|3: Assessment of Relapse|Death|0|||
161848846|NCT00261443|584488719|FG002|3: Assessment of Relapse|Death|1|||
161848847|NCT00261443|584488717|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
161848848|NCT00261443|584488718|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
161848849|NCT00261443|584488719|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
161848850|NCT00261443|584488717|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
161848851|NCT00261443|584488718|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
161848852|NCT00261443|584488719|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
161848853|NCT00261443|584488717|FG000|3: Assessment of Relapse|Pregnancy|0|||
161848854|NCT00261443|584488718|FG001|3: Assessment of Relapse|Pregnancy|2|||
161848855|NCT00261443|584488719|FG002|3: Assessment of Relapse|Pregnancy|1|||
161848856|NCT00261443|584488717|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
161848857|NCT00261443|584488718|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
161848858|NCT00261443|584488719|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
161848859|NCT00261443|584488717|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
161848860|NCT00261443|584488718|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
161848861|NCT00261443|584488719|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
161848862|NCT00261443|584488717|FG000|3: Assessment of Relapse|Other Reasons|0|||
161848863|NCT00261443|584488718|FG001|3: Assessment of Relapse|Other Reasons|4|||
161848864|NCT00261443|584488719|FG002|3: Assessment of Relapse|Other Reasons|3|||
161848865|NCT00261443|584488717|FG000|4: Extension Phase|Adverse Event|0|||
161848866|NCT00261443|584488718|FG001|4: Extension Phase|Adverse Event|1|||
161848867|NCT00261443|584488719|FG002|4: Extension Phase|Adverse Event|0|||
161848868|NCT00261443|584488717|FG000|4: Extension Phase|Withdrawal by Subject|0|||
161848869|NCT00261443|584488718|FG001|4: Extension Phase|Withdrawal by Subject|1|||
161848870|NCT00261443|584488719|FG002|4: Extension Phase|Withdrawal by Subject|2|||
161848871|NCT00261443|584488717|FG000|4: Extension Phase|Lost to Follow-up|0|||
161848872|NCT00261443|584488718|FG001|4: Extension Phase|Lost to Follow-up|1|||
161848873|NCT00261443|584488719|FG002|4: Extension Phase|Lost to Follow-up|0|||
161848874|NCT02755649|584488720|FG000|Overall Study|Transitioned into OLE study|99|||
161848875|NCT02755649|584488721|FG001|Overall Study|Transitioned into OLE study|98|||
161848876|NCT02755649|584488722|FG002|Overall Study|Transitioned into OLE study|100|||
161848877|NCT02755649|584488720|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
161848878|NCT02755649|584488721|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
161848879|NCT02755649|584488722|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
161848880|NCT02755649|584488720|FG000|Overall Study|Physician Decision|0|||
161848881|NCT02755649|584488721|FG001|Overall Study|Physician Decision|0|||
161848882|NCT02755649|584488722|FG002|Overall Study|Physician Decision|2|||
161848883|NCT02755649|584488720|FG000|Overall Study|Withdrawal by Subject|0|||
161848884|NCT02755649|584488721|FG001|Overall Study|Withdrawal by Subject|1|||
161848885|NCT02755649|584488722|FG002|Overall Study|Withdrawal by Subject|0|||
161848886|NCT02755649|584488720|FG000|Overall Study|Undecided|1|||
161848887|NCT02755649|584488721|FG001|Overall Study|Undecided|0|||
161848888|NCT02755649|584488722|FG002|Overall Study|Undecided|0|||
161848889|NCT01286753|584488723|FG000|Overall Study|Adverse Event|7|||
161848890|NCT01286753|584488724|FG001|Overall Study|Adverse Event|6|||
161848891|NCT01286753|584488723|FG000|Overall Study|Progression|11|||
161848892|NCT01286753|584488724|FG001|Overall Study|Progression|13|||
161848893|NCT01286753|584488723|FG000|Overall Study|Refused Treatment|1|||
161848894|NCT01286753|584488724|FG001|Overall Study|Refused Treatment|0|||
161848895|NCT01286753|584488723|FG000|Overall Study|Withdrawal of Consent|0|||
161848896|NCT01286753|584488724|FG001|Overall Study|Withdrawal of Consent|2|||
161763575|NCT01354964|584174190|FG000|Overall Study|Lost to Follow-up|2|||
161763576|NCT01354964|584174191|FG001|Overall Study|Lost to Follow-up|0|||
161763577|NCT01354964|584174190|FG000|Overall Study|IV access issues|1|||
161763578|NCT01354964|584174191|FG001|Overall Study|IV access issues|1|||
161763579|NCT01354964|584174190|FG000|Overall Study|Physician Decision|1|||
161763580|NCT01354964|584174191|FG001|Overall Study|Physician Decision|0|||
161763581|NCT00711009|584174192|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
161763582|NCT00711009|584174193|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
161763583|NCT00711009|584174192|FG000|Overall Study|Withdrawal by Subject|4|||
161763584|NCT00711009|584174193|FG001|Overall Study|Withdrawal by Subject|2|||
161763585|NCT00711009|584174192|FG000|Overall Study|Lost to Follow-up|3|||
161763586|NCT00711009|584174193|FG001|Overall Study|Lost to Follow-up|9|||
161763587|NCT00711009|584174192|FG000|Overall Study|Participant Noncompliant|0|||
161763588|NCT00711009|584174193|FG001|Overall Study|Participant Noncompliant|1|||
161763589|NCT00711009|584174192|FG000|Overall Study|Virologic Failure|2|||
161763590|NCT00711009|584174193|FG001|Overall Study|Virologic Failure|1|||
161763591|NCT00711009|584174192|FG000|Overall Study|Pregnancy|1|||
161763592|NCT00711009|584174193|FG001|Overall Study|Pregnancy|0|||
161763593|NCT00711009|584174192|FG000|Overall Study|Site closing|0|||
161763594|NCT00711009|584174193|FG001|Overall Study|Site closing|1|||
161763595|NCT00711009|584174192|FG000|Overall Study|Dose adjustment|1|||
161763596|NCT00711009|584174193|FG001|Overall Study|Dose adjustment|0|||
161763597|NCT02534324|584174194|FG000|Overall Study|Protocol Violation|4|||
161763598|NCT02534324|584174195|FG001|Overall Study|Protocol Violation|1|||
161763599|NCT02534324|584174194|FG000|Overall Study|Lost to Follow-up|20|||
161763600|NCT02534324|584174195|FG001|Overall Study|Lost to Follow-up|7|||
161763601|NCT02534324|584174194|FG000|Overall Study|Adverse Event|1|||
161763602|NCT02534324|584174195|FG001|Overall Study|Adverse Event|0|||
161763603|NCT05604781|584174196|FG000|Overall Study|Lost to Follow-up|3|||
161763604|NCT05604781|584174196|FG000|Overall Study|Adverse Event|1|||
161763605|NCT01459016|584174197|FG000|Overall Study|Withdrawal by Subject|11|||
161763606|NCT01459016|584174197|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
161763607|NCT02889861|584174198|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
161763608|NCT00959192|584174206|FG000|Overall Study|Adverse Event|1|||
161763609|NCT00959192|584174207|FG001|Overall Study|Adverse Event|1|||
161763610|NCT00959192|584174208|FG002|Overall Study|Adverse Event|1|||
161763611|NCT00959192|584174209|FG003|Overall Study|Adverse Event|0|||
161763612|NCT00959192|584174206|FG000|Overall Study|Investigator Request|1|||
161763613|NCT00959192|584174207|FG001|Overall Study|Investigator Request|0|||
161763614|NCT00959192|584174208|FG002|Overall Study|Investigator Request|0|||
161763615|NCT00959192|584174209|FG003|Overall Study|Investigator Request|0|||
161763616|NCT00959192|584174206|FG000|Overall Study|Caregiver Request|0|||
161763617|NCT00959192|584174207|FG001|Overall Study|Caregiver Request|0|||
161763618|NCT00959192|584174208|FG002|Overall Study|Caregiver Request|2|||
161763619|NCT00959192|584174209|FG003|Overall Study|Caregiver Request|1|||
161763620|NCT02194699|584174210|FG000|Randomised|Did not receive treatment|1|||
161763621|NCT02194699|584174211|FG001|Randomised|Did not receive treatment|5|||
161763622|NCT02194699|584174210|FG000|Randomised|Without potential for 52 weeks of IP|5|||
161763623|NCT02194699|584174211|FG001|Randomised|Without potential for 52 weeks of IP|5|||
161763624|NCT02194699|584174210|FG000|Randomised|Duplicate patient|2|||
161763625|NCT02194699|584174211|FG001|Randomised|Duplicate patient|1|||
161763626|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
161763627|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
161763628|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
161763629|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
161763630|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
161763631|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
161763632|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
161763633|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
161763634|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
161763635|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
161763636|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
161763637|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
161763638|NCT01667731|584174213|FG000|Overall Study|Enrolled but not treated|0|||
161763639|NCT01667731|584174214|FG001|Overall Study|Enrolled but not treated|0|||
161763640|NCT01667731|584174215|FG002|Overall Study|Enrolled but not treated|0|||
161763641|NCT01667731|584174216|FG003|Overall Study|Enrolled but not treated|0|||
161763642|NCT01667731|584174217|FG004|Overall Study|Enrolled but not treated|1|||
161763643|NCT01667731|584174213|FG000|Overall Study|Efficacy Failure|1|||
161763644|NCT01667731|584174214|FG001|Overall Study|Efficacy Failure|12|||
161763645|NCT01667731|584174215|FG002|Overall Study|Efficacy Failure|0|||
161763646|NCT01667731|584174216|FG003|Overall Study|Efficacy Failure|1|||
161763647|NCT01667731|584174217|FG004|Overall Study|Efficacy Failure|24|||
161763648|NCT01667731|584174213|FG000|Overall Study|Lost to Follow-up|2|||
161848897|NCT01286753|584488723|FG000|Overall Study|Discontinued to Join Extension Study|6|||
161848898|NCT01286753|584488724|FG001|Overall Study|Discontinued to Join Extension Study|4|||
161848899|NCT01286753|584488723|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
161848900|NCT01286753|584488724|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
161848901|NCT02126826|584488728|FG000|Overall Study|Withdrawal by Subject|0|||
161848902|NCT02126826|584488729|FG001|Overall Study|Withdrawal by Subject|0|||
161848903|NCT02126826|584488730|FG002|Overall Study|Withdrawal by Subject|0|||
161848904|NCT02126826|584488731|FG003|Overall Study|Withdrawal by Subject|1|||
161848905|NCT02126826|584488732|FG004|Overall Study|Withdrawal by Subject|0|||
161848906|NCT02126826|584488733|FG005|Overall Study|Withdrawal by Subject|0|||
161848907|NCT02126826|584488734|FG006|Overall Study|Withdrawal by Subject|0|||
161848908|NCT00887289|584488735|FG000|Overall Study|Lack of Efficacy|14|||
161848909|NCT00887289|584488735|FG000|Overall Study|Adverse Event|27|||
161848910|NCT00887289|584488735|FG000|Overall Study|Withdrawal by Subject|26|||
161848911|NCT00887289|584488735|FG000|Overall Study|Lost to Follow-up|8|||
161848912|NCT00887289|584488735|FG000|Overall Study|Other|20|||
161848913|NCT00591773|584488736|FG000|Overall Study|Adverse Event|9|||
161848914|NCT00591773|584488737|FG001|Overall Study|Adverse Event|9|||
161848915|NCT00591773|584488738|FG002|Overall Study|Adverse Event|6|||
161848916|NCT00591773|584488736|FG000|Overall Study|Protocol Violation|2|||
161848917|NCT00591773|584488737|FG001|Overall Study|Protocol Violation|3|||
161848918|NCT00591773|584488738|FG002|Overall Study|Protocol Violation|0|||
161848919|NCT00591773|584488736|FG000|Overall Study|Lost to Follow-up|1|||
161848920|NCT00591773|584488737|FG001|Overall Study|Lost to Follow-up|4|||
161848921|NCT00591773|584488738|FG002|Overall Study|Lost to Follow-up|1|||
161848922|NCT00591773|584488736|FG000|Overall Study|Withdrawal by Subject|2|||
161848923|NCT00591773|584488737|FG001|Overall Study|Withdrawal by Subject|5|||
161848924|NCT00591773|584488738|FG002|Overall Study|Withdrawal by Subject|3|||
161848925|NCT00591773|584488736|FG000|Overall Study|Lack of Efficacy|1|||
161848926|NCT00591773|584488737|FG001|Overall Study|Lack of Efficacy|2|||
161848927|NCT00591773|584488738|FG002|Overall Study|Lack of Efficacy|2|||
161848928|NCT00591773|584488736|FG000|Overall Study|Other|1|||
161848929|NCT00591773|584488737|FG001|Overall Study|Other|1|||
161848930|NCT00591773|584488738|FG002|Overall Study|Other|4|||
161848931|NCT02135614|584488739|FG000|Overall Study|Randomized but Not Treated|2|||
161848932|NCT02135614|584488740|FG001|Overall Study|Randomized but Not Treated|1|||
161848933|NCT02135614|584488739|FG000|Overall Study|Adverse Event|0|||
161848934|NCT02135614|584488740|FG001|Overall Study|Adverse Event|1|||
161848935|NCT02135614|584488739|FG000|Overall Study|Death|1|||
161848936|NCT02135614|584488740|FG001|Overall Study|Death|0|||
161848937|NCT02135614|584488739|FG000|Overall Study|Investigator's Discretion|0|||
161848938|NCT02135614|584488740|FG001|Overall Study|Investigator's Discretion|1|||
161848939|NCT02135614|584488739|FG000|Overall Study|Withdrew Consent|2|||
161848940|NCT02135614|584488740|FG001|Overall Study|Withdrew Consent|2|||
161848941|NCT02135614|584488739|FG000|Overall Study|Lost to Follow-up|3|||
161848942|NCT02135614|584488740|FG001|Overall Study|Lost to Follow-up|0|||
161848943|NCT03022084|584488741|FG000|Overall Study|Lost to Follow-up|2|||
161848944|NCT03022084|584488742|FG001|Overall Study|Lost to Follow-up|3|||
161848945|NCT00554606|584488744|FG000|Overall Study|Adverse Event|3|||
161848946|NCT00554606|584488744|FG000|Overall Study|Abnormal laboratory values|1|||
161848947|NCT00554606|584488744|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
161848948|NCT00554606|584488744|FG000|Overall Study|Subject withdrew consent|2|||
161848949|NCT00554606|584488744|FG000|Overall Study|Lost to Follow-up|2|||
161848950|NCT00554606|584488744|FG000|Overall Study|Administrative problems|60|||
161848951|NCT00554606|584488744|FG000|Overall Study|Death|1|||
161848952|NCT00554606|584488744|FG000|Overall Study|Protocol deviation|2|||
161848953|NCT00605540|584488745|FG000|Overall Study|Death|15|||
161848954|NCT00605540|584488745|FG000|Overall Study|Lost to Follow-up|23|||
161848955|NCT00509366|584488746|FG000|Overall Study|Not Treated (Screen Failure)|1|||
161848956|NCT00509366|584488747|FG001|Overall Study|Not Treated (Screen Failure)|1|||
161848957|NCT00509366|584488748|FG002|Overall Study|Not Treated (Screen Failure)|1|||
161848958|NCT00509366|584488749|FG003|Overall Study|Not Treated (Screen Failure)|0|||
161848959|NCT00509366|584488750|FG004|Overall Study|Not Treated (Screen Failure)|0|||
161848960|NCT02119819|584488753|FG000|Overall Study|Adverse Event|3|||
161848961|NCT02119819|584488754|FG001|Overall Study|Adverse Event|1|||
161848962|NCT02119819|584488755|FG002|Overall Study|Adverse Event|2|||
161848963|NCT02119819|584488756|FG003|Overall Study|Adverse Event|3|||
161848964|NCT02119819|584488757|FG004|Overall Study|Adverse Event|0|||
161848965|NCT02119819|584488758|FG005|Overall Study|Adverse Event|1|||
161848966|NCT02119819|584488753|FG000|Overall Study|Lack of Efficacy|0|||
161848967|NCT02119819|584488754|FG001|Overall Study|Lack of Efficacy|0|||
161848968|NCT02119819|584488755|FG002|Overall Study|Lack of Efficacy|0|||
161848969|NCT02119819|584488756|FG003|Overall Study|Lack of Efficacy|0|||
161848970|NCT02119819|584488757|FG004|Overall Study|Lack of Efficacy|0|||
161848971|NCT02119819|584488758|FG005|Overall Study|Lack of Efficacy|1|||
161848972|NCT02119819|584488753|FG000|Overall Study|Lost to Follow-up|0|||
161848973|NCT02119819|584488754|FG001|Overall Study|Lost to Follow-up|0|||
161848974|NCT02119819|584488755|FG002|Overall Study|Lost to Follow-up|1|||
161848975|NCT02119819|584488756|FG003|Overall Study|Lost to Follow-up|2|||
161848976|NCT02119819|584488757|FG004|Overall Study|Lost to Follow-up|1|||
161848977|NCT02119819|584488758|FG005|Overall Study|Lost to Follow-up|2|||
161763649|NCT01667731|584174214|FG001|Overall Study|Lost to Follow-up|3|||
161763650|NCT01667731|584174215|FG002|Overall Study|Lost to Follow-up|1|||
161763651|NCT01667731|584174216|FG003|Overall Study|Lost to Follow-up|1|||
161763652|NCT01667731|584174217|FG004|Overall Study|Lost to Follow-up|2|||
161763653|NCT01667731|584174213|FG000|Overall Study|Subject Withdrew Consent|2|||
161763654|NCT01667731|584174214|FG001|Overall Study|Subject Withdrew Consent|0|||
161763655|NCT01667731|584174215|FG002|Overall Study|Subject Withdrew Consent|1|||
161763656|NCT01667731|584174216|FG003|Overall Study|Subject Withdrew Consent|0|||
161763657|NCT01667731|584174217|FG004|Overall Study|Subject Withdrew Consent|1|||
161763658|NCT01667731|584174213|FG000|Overall Study|Death|0|||
161763659|NCT01667731|584174214|FG001|Overall Study|Death|1|||
161763660|NCT01667731|584174215|FG002|Overall Study|Death|0|||
161763661|NCT01667731|584174216|FG003|Overall Study|Death|0|||
161763662|NCT01667731|584174217|FG004|Overall Study|Death|0|||
161763663|NCT02516605|584174226|FG000|Overall Study|Protocol Violation|0|||
161763664|NCT02516605|584174227|FG001|Overall Study|Protocol Violation|0|||
161763665|NCT02516605|584174228|FG002|Overall Study|Protocol Violation|0|||
161763666|NCT02516605|584174229|FG003|Overall Study|Protocol Violation|0|||
161763667|NCT02516605|584174230|FG004|Overall Study|Protocol Violation|1|||
161763668|NCT02516605|584174226|FG000|Overall Study|Withdrawal by Subject|0|||
161763669|NCT02516605|584174227|FG001|Overall Study|Withdrawal by Subject|0|||
161763670|NCT02516605|584174228|FG002|Overall Study|Withdrawal by Subject|0|||
161763671|NCT02516605|584174229|FG003|Overall Study|Withdrawal by Subject|1|||
161763672|NCT02516605|584174230|FG004|Overall Study|Withdrawal by Subject|0|||
161763673|NCT02643420|584174231|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
161763674|NCT02643420|584174232|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
161763675|NCT02643420|584174231|FG000|Overall Study|Withdrawal by Subject|25|||
161763676|NCT02643420|584174232|FG001|Overall Study|Withdrawal by Subject|19|||
161763677|NCT02643420|584174231|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
161763678|NCT02643420|584174232|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
161763679|NCT02643420|584174231|FG000|Overall Study|Lost to Follow-up|6|||
161848978|NCT02119819|584488753|FG000|Overall Study|Physician Decision|1|||
161848979|NCT02119819|584488754|FG001|Overall Study|Physician Decision|1|||
161763680|NCT02643420|584174232|FG001|Overall Study|Lost to Follow-up|10|||
161848980|NCT02119819|584488755|FG002|Overall Study|Physician Decision|0|||
161763681|NCT02643420|584174231|FG000|Overall Study|Investigator Decision|2|||
161763682|NCT02643420|584174232|FG001|Overall Study|Investigator Decision|4|||
161763683|NCT02643420|584174231|FG000|Overall Study|Sponsor decision|1|||
161763684|NCT02643420|584174232|FG001|Overall Study|Sponsor decision|1|||
161763685|NCT02643420|584174231|FG000|Overall Study|Death|0|||
161763686|NCT02643420|584174232|FG001|Overall Study|Death|2|||
161763687|NCT02643420|584174231|FG000|Overall Study|Reason not Specified|8|||
161763688|NCT02643420|584174232|FG001|Overall Study|Reason not Specified|7|||
161763689|NCT02127970|584174233|FG000|Overall Study|Adverse Event|2|||
161763690|NCT02127970|584174234|FG001|Overall Study|Adverse Event|1|||
161763691|NCT02127970|584174233|FG000|Overall Study|Death|1|||
161763692|NCT02127970|584174234|FG001|Overall Study|Death|1|||
161763693|NCT02127970|584174233|FG000|Overall Study|Lost to Follow-up|14|||
161763694|NCT02127970|584174234|FG001|Overall Study|Lost to Follow-up|14|||
161763695|NCT02127970|584174233|FG000|Overall Study|Reason not Specified|4|||
161763696|NCT02127970|584174234|FG001|Overall Study|Reason not Specified|7|||
161763697|NCT02127970|584174233|FG000|Overall Study|Pregnancy|0|||
161763698|NCT02127970|584174234|FG001|Overall Study|Pregnancy|1|||
161763699|NCT02127970|584174233|FG000|Overall Study|Subject Withdrew Consent|5|||
161763700|NCT02127970|584174234|FG001|Overall Study|Subject Withdrew Consent|3|||
161763701|NCT01710709|584174235|FG000|Overall Study|Lost to Follow-up|29|||
161763702|NCT01710709|584174235|FG000|Overall Study|Adverse Event|48|||
161763703|NCT01710709|584174235|FG000|Overall Study|Participant met withdrawal criteria|33|||
161763704|NCT01710709|584174235|FG000|Overall Study|Participant withdrawn by investigator|2|||
161763705|NCT01710709|584174235|FG000|Overall Study|Withdrawal by Subject|53|||
161763706|NCT01710709|584174235|FG000|Overall Study|Protocol Violation|5|||
161763707|NCT01710709|584174235|FG000|Overall Study|Lack of Efficacy|3|||
161763708|NCT01398176|584174237|FG000|Overall Study|Lost to Follow-up|1|||
161763709|NCT01398176|584174238|FG001|Overall Study|Lost to Follow-up|3|||
161763710|NCT01398176|584174237|FG000|Overall Study|Physician Decision|2|||
161763711|NCT01398176|584174238|FG001|Overall Study|Physician Decision|3|||
161763712|NCT00542321|584174239|FG000|Overall Study|Death|0|||
161763713|NCT00542321|584174240|FG001|Overall Study|Death|1|||
161763714|NCT01871870|584174244|FG000|Overall Study|Hardware issues|7|||
161763715|NCT01871870|584174244|FG000|Overall Study|hyperglycemia|2|||
161763716|NCT00253747|584174250|FG000|Overall Study|Lost to Follow-up|13|||
161763717|NCT00253747|584174251|FG001|Overall Study|Lost to Follow-up|14|||
161763718|NCT00253747|584174250|FG000|Overall Study|Withdrawal by Subject|10|||
161763719|NCT00253747|584174251|FG001|Overall Study|Withdrawal by Subject|11|||
161763720|NCT00253747|584174250|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
161763721|NCT00253747|584174251|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
161763722|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161763723|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161763724|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161763725|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161763726|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161763727|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
161763728|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161763729|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161763730|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
161763731|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
161763732|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161763733|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161763734|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
161763735|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161763736|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161763737|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161763738|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
161763739|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161763740|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161763741|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161763742|NCT02275052|584174254|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
161763743|NCT02275052|584174255|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161763744|NCT02275052|584174256|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161763745|NCT02275052|584174257|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161763746|NCT02275052|584174254|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
161763747|NCT02275052|584174255|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161763748|NCT02275052|584174256|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161763749|NCT02275052|584174257|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161763750|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161763751|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161763752|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
161763753|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
161763754|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161763755|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161763756|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161763757|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
161848981|NCT02119819|584488756|FG003|Overall Study|Physician Decision|0|||
161848982|NCT02119819|584488757|FG004|Overall Study|Physician Decision|0|||
161848983|NCT02119819|584488758|FG005|Overall Study|Physician Decision|1|||
161848984|NCT02119819|584488753|FG000|Overall Study|Withdrawal by Subject|5|||
161848985|NCT02119819|584488754|FG001|Overall Study|Withdrawal by Subject|3|||
161848986|NCT02119819|584488755|FG002|Overall Study|Withdrawal by Subject|0|||
161848987|NCT02119819|584488756|FG003|Overall Study|Withdrawal by Subject|0|||
161848988|NCT02119819|584488757|FG004|Overall Study|Withdrawal by Subject|6|||
161848989|NCT02119819|584488758|FG005|Overall Study|Withdrawal by Subject|10|||
161848990|NCT02119819|584488753|FG000|Overall Study|Jury Duty|0|||
161848991|NCT02119819|584488754|FG001|Overall Study|Jury Duty|0|||
161848992|NCT02119819|584488755|FG002|Overall Study|Jury Duty|1|||
161848993|NCT02119819|584488756|FG003|Overall Study|Jury Duty|0|||
161848994|NCT02119819|584488757|FG004|Overall Study|Jury Duty|0|||
161848995|NCT02119819|584488758|FG005|Overall Study|Jury Duty|0|||
161848996|NCT02119819|584488753|FG000|Overall Study|Protocol Violation|0|||
161848997|NCT02119819|584488754|FG001|Overall Study|Protocol Violation|0|||
161848998|NCT02119819|584488755|FG002|Overall Study|Protocol Violation|0|||
161848999|NCT02119819|584488756|FG003|Overall Study|Protocol Violation|1|||
161849000|NCT02119819|584488757|FG004|Overall Study|Protocol Violation|0|||
161849001|NCT02119819|584488758|FG005|Overall Study|Protocol Violation|0|||
161849002|NCT02119819|584488753|FG000|Overall Study|Left the city to get a job|0|||
161849003|NCT02119819|584488754|FG001|Overall Study|Left the city to get a job|0|||
161849004|NCT02119819|584488755|FG002|Overall Study|Left the city to get a job|0|||
161849005|NCT02119819|584488756|FG003|Overall Study|Left the city to get a job|1|||
161849006|NCT02119819|584488757|FG004|Overall Study|Left the city to get a job|0|||
161849007|NCT02119819|584488758|FG005|Overall Study|Left the city to get a job|0|||
161849008|NCT04497948|584488761|FG000|Overall Study|Death|2|||
161849009|NCT04611529|584488765|FG000|2-day Follow up|Lost to Follow-up|5|||
161849010|NCT04611529|584488766|FG001|2-day Follow up|Lost to Follow-up|6|||
161849011|NCT04611529|584488767|FG002|2-day Follow up|Lost to Follow-up|3|||
161849012|NCT00856375|584488828|FG000|Overall Study|Other|0|||
161849013|NCT00856375|584488829|FG001|Overall Study|Other|1|||
161849014|NCT00856375|584488828|FG000|Overall Study|Death|32|||
161849015|NCT00856375|584488829|FG001|Overall Study|Death|30|||
161849016|NCT00856375|584488828|FG000|Overall Study|Sponsor Terminated Study|7|||
161849017|NCT00856375|584488829|FG001|Overall Study|Sponsor Terminated Study|7|||
161849018|NCT00856375|584488828|FG000|Overall Study|Withdrawal by Subject|2|||
161849019|NCT00856375|584488829|FG001|Overall Study|Withdrawal by Subject|1|||
161849020|NCT00856375|584488828|FG000|Overall Study|Lost to Follow-up|1|||
161849021|NCT00856375|584488829|FG001|Overall Study|Lost to Follow-up|2|||
161849022|NCT02121392|584488832|FG000|Prior to Intervention|Protocol Violation|40|||
161849023|NCT02121392|584488833|FG001|Prior to Intervention|Protocol Violation|35|||
161849024|NCT02121392|584488832|FG000|Prior to Intervention|Withdrawal by Subject|8|||
161849025|NCT02121392|584488833|FG001|Prior to Intervention|Withdrawal by Subject|6|||
161849026|NCT02121392|584488832|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
161849027|NCT02121392|584488833|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
161849028|NCT02121392|584488832|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
161849029|NCT02121392|584488833|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
161849030|NCT01851330|584488834|FG000|Overall Study|Lack of Efficacy|10|||
161849031|NCT01851330|584488835|FG001|Overall Study|Lack of Efficacy|9|||
161849032|NCT01851330|584488836|FG002|Overall Study|Lack of Efficacy|2|||
161849033|NCT01851330|584488834|FG000|Overall Study|Lost to Follow-up|1|||
161849034|NCT01851330|584488835|FG001|Overall Study|Lost to Follow-up|6|||
161849035|NCT01851330|584488836|FG002|Overall Study|Lost to Follow-up|9|||
161849036|NCT01851330|584488834|FG000|Overall Study|Withdrew Consent|2|||
161849037|NCT01851330|584488835|FG001|Overall Study|Withdrew Consent|1|||
161849038|NCT01851330|584488836|FG002|Overall Study|Withdrew Consent|0|||
161849039|NCT01851330|584488834|FG000|Overall Study|Investigator's Discretion|0|||
161849040|NCT01851330|584488835|FG001|Overall Study|Investigator's Discretion|0|||
161849041|NCT01851330|584488836|FG002|Overall Study|Investigator's Discretion|1|||
161849042|NCT02648932|584488837|FG000|Overall Study|No transplant|3|||
161849043|NCT02648932|584488838|FG001|Overall Study|No transplant|1|||
161849044|NCT01199016|584488839|FG000|Overall Study|No longer meets eligibility criteria|4|||
161849045|NCT01199016|584488839|FG000|Overall Study|Entrance criteria|5|||
161849046|NCT01199016|584488839|FG000|Overall Study|Protocol Violation|9|||
161849047|NCT01199016|584488839|FG000|Overall Study|Other|13|||
161849048|NCT01199016|584488839|FG000|Overall Study|Withdrawal by Subject|21|||
161849049|NCT01199016|584488839|FG000|Overall Study|Lost to Follow-up|25|||
161849050|NCT01266031|584488850|FG000|Overall Study|Not treated|0|||
161849051|NCT01266031|584488851|FG001|Overall Study|Not treated|3|||
161849052|NCT01266031|584488852|FG002|Overall Study|Not treated|2|||
161849053|NCT02842073|584488858|FG000|Overall Study|Withdrawal by Subject|1|||
161849054|NCT00195338|584488859|FG000|Overall Study|Lost to Follow-up|2|||
161849055|NCT00195338|584488859|FG000|Overall Study|Adverse Event|5|||
161849056|NCT00195338|584488859|FG000|Overall Study|Lack of Efficacy|1|||
161849057|NCT00195338|584488859|FG000|Overall Study|Early closure of the site|4|||
161849058|NCT02047734|584488862|FG000|Overall Study|Adverse Event|18|||
161763758|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161763759|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161763760|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161763761|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
161763762|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161763763|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161763764|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161763765|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
161763766|NCT05102734|584174258|FG000|Overall Study|Did not require vasopressors|1|||
161763767|NCT05102734|584174259|FG001|Overall Study|Did not require vasopressors|0|||
161763768|NCT05102734|584174258|FG000|Overall Study|Did not have functioning PA catheter|1|||
161763769|NCT05102734|584174259|FG001|Overall Study|Did not have functioning PA catheter|0|||
161763770|NCT05102734|584174258|FG000|Overall Study|Inadequate video quality|2|||
161763771|NCT05102734|584174259|FG001|Overall Study|Inadequate video quality|0|||
161763772|NCT03055806|584174265|FG000|Overall Study|Adverse Event|0|||
161763773|NCT03055806|584174266|FG001|Overall Study|Adverse Event|0|||
161763774|NCT03055806|584174267|FG002|Overall Study|Adverse Event|1|||
161763775|NCT03055806|584174268|FG003|Overall Study|Adverse Event|1|||
161763776|NCT03055806|584174265|FG000|Overall Study|Lost to Follow-up|0|||
161763777|NCT03055806|584174266|FG001|Overall Study|Lost to Follow-up|3|||
161763778|NCT03055806|584174267|FG002|Overall Study|Lost to Follow-up|6|||
161763779|NCT03055806|584174268|FG003|Overall Study|Lost to Follow-up|7|||
161763780|NCT03055806|584174265|FG000|Overall Study|Physician Decision|1|||
161763781|NCT03055806|584174266|FG001|Overall Study|Physician Decision|0|||
161763782|NCT03055806|584174267|FG002|Overall Study|Physician Decision|0|||
161763783|NCT03055806|584174268|FG003|Overall Study|Physician Decision|1|||
161763784|NCT03055806|584174265|FG000|Overall Study|Protocol Violation|1|||
161763785|NCT03055806|584174266|FG001|Overall Study|Protocol Violation|0|||
161763786|NCT03055806|584174267|FG002|Overall Study|Protocol Violation|0|||
161763787|NCT03055806|584174268|FG003|Overall Study|Protocol Violation|0|||
161763788|NCT03055806|584174265|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
161763789|NCT03055806|584174266|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
161763790|NCT03055806|584174267|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
161763791|NCT03055806|584174268|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
161763792|NCT03055806|584174265|FG000|Overall Study|Withdrawal of consent to continue study|2|||
161763793|NCT03055806|584174266|FG001|Overall Study|Withdrawal of consent to continue study|3|||
161763794|NCT03055806|584174267|FG002|Overall Study|Withdrawal of consent to continue study|4|||
161763795|NCT03055806|584174268|FG003|Overall Study|Withdrawal of consent to continue study|6|||
161763796|NCT03055806|584174265|FG000|Overall Study|Partner not willing to try intercourse|1|||
161763797|NCT03055806|584174266|FG001|Overall Study|Partner not willing to try intercourse|0|||
161763798|NCT03055806|584174267|FG002|Overall Study|Partner not willing to try intercourse|0|||
161763799|NCT03055806|584174268|FG003|Overall Study|Partner not willing to try intercourse|0|||
161763800|NCT04601194|584174269|FG000|Overall Study|Lost to Follow-up|7|||
161763801|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763802|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
161763803|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763804|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
161763805|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763806|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763807|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763808|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763809|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763810|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763811|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
161763812|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763813|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763814|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763815|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763816|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763817|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
161763818|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
161763819|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
161763820|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
161763821|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763822|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763823|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763824|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763825|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
161763826|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763827|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763828|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763829|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763830|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763831|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161849059|NCT02047734|584488863|FG001|Overall Study|Adverse Event|13|||
161849060|NCT02047734|584488864|FG002|Overall Study|Adverse Event|13|||
161849061|NCT02047734|584488862|FG000|Overall Study|Lack of Efficacy|4|||
161849062|NCT02047734|584488863|FG001|Overall Study|Lack of Efficacy|5|||
161849063|NCT02047734|584488864|FG002|Overall Study|Lack of Efficacy|1|||
161849064|NCT02047734|584488862|FG000|Overall Study|Protocol Violation|3|||
161849065|NCT02047734|584488863|FG001|Overall Study|Protocol Violation|1|||
161849066|NCT02047734|584488864|FG002|Overall Study|Protocol Violation|1|||
161849067|NCT02047734|584488862|FG000|Overall Study|Lost to Follow-up|1|||
161849068|NCT02047734|584488863|FG001|Overall Study|Lost to Follow-up|4|||
161849069|NCT02047734|584488864|FG002|Overall Study|Lost to Follow-up|0|||
161849070|NCT02047734|584488862|FG000|Overall Study|Death|0|||
161849071|NCT02047734|584488863|FG001|Overall Study|Death|1|||
161849072|NCT02047734|584488864|FG002|Overall Study|Death|0|||
161849073|NCT02047734|584488862|FG000|Overall Study|Withdrawal by Subject|30|||
161849074|NCT02047734|584488863|FG001|Overall Study|Withdrawal by Subject|31|||
161849075|NCT02047734|584488864|FG002|Overall Study|Withdrawal by Subject|19|||
161849076|NCT02047734|584488862|FG000|Overall Study|Physician Decision|7|||
161849077|NCT02047734|584488863|FG001|Overall Study|Physician Decision|6|||
161849078|NCT02047734|584488864|FG002|Overall Study|Physician Decision|5|||
161849079|NCT02047734|584488862|FG000|Overall Study|Miscellaneous|2|||
161849080|NCT02047734|584488863|FG001|Overall Study|Miscellaneous|4|||
161849081|NCT02047734|584488864|FG002|Overall Study|Miscellaneous|6|||
161849082|NCT02047734|584488862|FG000|Overall Study|Did Not Receive Study Drug|2|||
161849083|NCT02047734|584488863|FG001|Overall Study|Did Not Receive Study Drug|4|||
161849084|NCT02047734|584488864|FG002|Overall Study|Did Not Receive Study Drug|1|||
161849085|NCT01333397|584488865|FG000|Overall Study|Lost to Follow-up|1|||
161849086|NCT01333397|584488866|FG001|Overall Study|Lost to Follow-up|0|||
161849087|NCT01333397|584488867|FG002|Overall Study|Lost to Follow-up|0|||
161849088|NCT01333397|584488868|FG003|Overall Study|Lost to Follow-up|1|||
161849089|NCT01333397|584488869|FG004|Overall Study|Lost to Follow-up|0|||
161849090|NCT01994850|584488875|FG000|Overall Study|Physician Decision|1|||
161849091|NCT01994850|584488875|FG000|Overall Study|Withdrawal by Subject|1|||
161849092|NCT00182325|584488881|FG000|Overall Study|Lost to Follow-up|7|||
161849093|NCT00182325|584488882|FG001|Overall Study|Lost to Follow-up|7|||
161849094|NCT00182325|584488881|FG000|Overall Study|Miscarriage|5|||
161849095|NCT00182325|584488882|FG001|Overall Study|Miscarriage|3|||
161849096|NCT00182325|584488881|FG000|Overall Study|Did not complete survey|22|||
161849097|NCT00182325|584488882|FG001|Overall Study|Did not complete survey|43|||
161849098|NCT02015065|584488886|FG000|Overall Study|Death on study|1|||
161849099|NCT02015065|584488887|FG001|Overall Study|Death on study|2|||
161849100|NCT02015065|584488888|FG002|Overall Study|Death on study|1|||
161849101|NCT01420965|584488889|FG000|Overall Study|Withdrawal by Subject|1|||
161849102|NCT01420965|584488890|FG001|Overall Study|Withdrawal by Subject|0|||
161849103|NCT01420965|584488891|FG002|Overall Study|Withdrawal by Subject|0|||
161849104|NCT01420965|584488889|FG000|Overall Study|Adverse Event|0|||
161849105|NCT01420965|584488890|FG001|Overall Study|Adverse Event|1|||
161849106|NCT01420965|584488891|FG002|Overall Study|Adverse Event|0|||
161849107|NCT01292226|584488928|FG000|Overall Study|Adverse Event|5|||
161849108|NCT01292226|584488928|FG000|Overall Study|Death|1|||
161849109|NCT01292226|584488928|FG000|Overall Study|Graft loss|1|||
161849110|NCT01292226|584488928|FG000|Overall Study|Protocol Violation|3|||
161849111|NCT01292226|584488928|FG000|Overall Study|Withdrawal by Subject|1|||
161849112|NCT01292226|584488928|FG000|Overall Study|Other|2|||
161849113|NCT00468650|584488931|FG000|Overall Study|Lost to Follow-up|4|||
161849114|NCT00468650|584488931|FG000|Overall Study|Withdrawal by Subject|2|||
161763832|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763833|NCT02630459|584174270|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763834|NCT02630459|584174271|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763835|NCT02630459|584174272|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763836|NCT02630459|584174273|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763837|NCT02630459|584174274|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
161763838|NCT02630459|584174275|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
161763839|NCT02630459|584174276|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763840|NCT02630459|584174277|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763841|NCT02630459|584174270|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763842|NCT02630459|584174271|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763843|NCT02630459|584174272|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763844|NCT02630459|584174273|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763845|NCT02630459|584174274|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
161763846|NCT02630459|584174275|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
161763847|NCT02630459|584174276|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763848|NCT02630459|584174277|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763849|NCT02630459|584174270|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763850|NCT02630459|584174271|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763851|NCT02630459|584174272|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763852|NCT02630459|584174273|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763853|NCT02630459|584174274|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
161763854|NCT02630459|584174275|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763855|NCT02630459|584174276|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763856|NCT02630459|584174277|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763857|NCT00846027|584174278|FG000|Overall Study|Death|3|||
161763858|NCT00846027|584174278|FG000|Overall Study|Disease Progression|30|||
161763859|NCT00846027|584174278|FG000|Overall Study|Toxicity|12|||
161763860|NCT00846027|584174278|FG000|Overall Study|Patient Decision|7|||
161763861|NCT00846027|584174278|FG000|Overall Study|Investigator Discretion|29|||
161763862|NCT00846027|584174278|FG000|Overall Study|Protocol Violation|2|||
161763863|NCT00846027|584174278|FG000|Overall Study|Subject Not Treated|7|||
161763864|NCT04905563|584174281|FG000|Overall Study|Withdrawal by Subject|1|||
161763865|NCT04905563|584174282|FG001|Overall Study|Withdrawal by Subject|0|||
161763866|NCT04905563|584174281|FG000|Overall Study|Standard of care orders entered by resident|1|||
161763867|NCT04905563|584174282|FG001|Overall Study|Standard of care orders entered by resident|0|||
161763868|NCT04905563|584174281|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
161763869|NCT04905563|584174282|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
161763870|NCT04905563|584174281|FG000|Overall Study|Withdrawal by Subject|0|||
161763871|NCT04905563|584174282|FG001|Overall Study|Withdrawal by Subject|1|||
161763872|NCT01797302|584174283|FG000|Overall Study|Lost to Follow-up|16|||
161763873|NCT01797302|584174284|FG001|Overall Study|Lost to Follow-up|23|||
161763874|NCT01797302|584174285|FG002|Overall Study|Lost to Follow-up|22|||
161763875|NCT01797302|584174283|FG000|Overall Study|Withdrawal by Subject|1|||
161763876|NCT01797302|584174284|FG001|Overall Study|Withdrawal by Subject|3|||
161763877|NCT01797302|584174285|FG002|Overall Study|Withdrawal by Subject|4|||
161763878|NCT02418000|584174286|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
161763879|NCT02418000|584174287|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763880|NCT02418000|584174288|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763881|NCT02418000|584174289|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763882|NCT02418000|584174290|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763883|NCT02418000|584174286|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
161763884|NCT02418000|584174287|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763885|NCT02418000|584174288|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763886|NCT02418000|584174289|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763887|NCT02418000|584174290|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763888|NCT02418000|584174286|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
161763889|NCT02418000|584174287|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763890|NCT02418000|584174288|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763891|NCT02418000|584174289|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763892|NCT02418000|584174290|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763893|NCT02418000|584174286|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161849115|NCT00468650|584488931|FG000|Overall Study|Protocol Violation|1|||
161849116|NCT00642278|584488932|FG000|Overall Study|Adverse Event|2|||
161849117|NCT00642278|584488933|FG001|Overall Study|Adverse Event|1|||
161849118|NCT00642278|584488934|FG002|Overall Study|Adverse Event|3|||
161849119|NCT00642278|584488935|FG003|Overall Study|Adverse Event|1|||
161849120|NCT00642278|584488936|FG004|Overall Study|Adverse Event|2|||
161849121|NCT00642278|584488937|FG005|Overall Study|Adverse Event|2|||
161849122|NCT00642278|584488938|FG006|Overall Study|Adverse Event|0|||
161849123|NCT00642278|584488932|FG000|Overall Study|Lack of Efficacy|0|||
161849124|NCT00642278|584488933|FG001|Overall Study|Lack of Efficacy|1|||
161849125|NCT00642278|584488934|FG002|Overall Study|Lack of Efficacy|0|||
161849126|NCT00642278|584488935|FG003|Overall Study|Lack of Efficacy|0|||
161849127|NCT00642278|584488936|FG004|Overall Study|Lack of Efficacy|0|||
161849128|NCT00642278|584488937|FG005|Overall Study|Lack of Efficacy|0|||
161849129|NCT00642278|584488938|FG006|Overall Study|Lack of Efficacy|0|||
161849130|NCT00642278|584488932|FG000|Overall Study|Lost to Follow-up|5|||
161849131|NCT00642278|584488933|FG001|Overall Study|Lost to Follow-up|1|||
161849132|NCT00642278|584488934|FG002|Overall Study|Lost to Follow-up|0|||
161849133|NCT00642278|584488935|FG003|Overall Study|Lost to Follow-up|1|||
161849134|NCT00642278|584488936|FG004|Overall Study|Lost to Follow-up|0|||
161849135|NCT00642278|584488937|FG005|Overall Study|Lost to Follow-up|1|||
161849136|NCT00642278|584488938|FG006|Overall Study|Lost to Follow-up|1|||
161849137|NCT00642278|584488932|FG000|Overall Study|Physician Decision|0|||
161849138|NCT00642278|584488933|FG001|Overall Study|Physician Decision|0|||
161849139|NCT00642278|584488934|FG002|Overall Study|Physician Decision|0|||
161849140|NCT00642278|584488935|FG003|Overall Study|Physician Decision|1|||
161849141|NCT00642278|584488936|FG004|Overall Study|Physician Decision|0|||
161849142|NCT00642278|584488937|FG005|Overall Study|Physician Decision|0|||
161849143|NCT00642278|584488938|FG006|Overall Study|Physician Decision|0|||
161849144|NCT00642278|584488932|FG000|Overall Study|Protocol Violation|0|||
161849145|NCT00642278|584488933|FG001|Overall Study|Protocol Violation|0|||
161849146|NCT00642278|584488934|FG002|Overall Study|Protocol Violation|1|||
161849147|NCT00642278|584488935|FG003|Overall Study|Protocol Violation|1|||
161849148|NCT00642278|584488936|FG004|Overall Study|Protocol Violation|0|||
161849149|NCT00642278|584488937|FG005|Overall Study|Protocol Violation|1|||
161849150|NCT00642278|584488938|FG006|Overall Study|Protocol Violation|2|||
161849151|NCT00642278|584488932|FG000|Overall Study|Withdrawal by Subject|1|||
161849152|NCT00642278|584488933|FG001|Overall Study|Withdrawal by Subject|1|||
161849153|NCT00642278|584488934|FG002|Overall Study|Withdrawal by Subject|1|||
161849154|NCT00642278|584488935|FG003|Overall Study|Withdrawal by Subject|3|||
161849155|NCT00642278|584488936|FG004|Overall Study|Withdrawal by Subject|6|||
161849156|NCT00642278|584488937|FG005|Overall Study|Withdrawal by Subject|2|||
161849157|NCT00642278|584488938|FG006|Overall Study|Withdrawal by Subject|2|||
161849158|NCT00642278|584488932|FG000|Overall Study|Noncompliance with study drug regimen|0|||
161849159|NCT00642278|584488933|FG001|Overall Study|Noncompliance with study drug regimen|0|||
161849160|NCT00642278|584488934|FG002|Overall Study|Noncompliance with study drug regimen|0|||
161849161|NCT00642278|584488935|FG003|Overall Study|Noncompliance with study drug regimen|1|||
161849162|NCT00642278|584488936|FG004|Overall Study|Noncompliance with study drug regimen|0|||
161849163|NCT00642278|584488937|FG005|Overall Study|Noncompliance with study drug regimen|0|||
161849164|NCT00642278|584488938|FG006|Overall Study|Noncompliance with study drug regimen|0|||
161849165|NCT00642278|584488932|FG000|Overall Study|Other|2|||
161849166|NCT00642278|584488933|FG001|Overall Study|Other|1|||
161849167|NCT00642278|584488934|FG002|Overall Study|Other|0|||
161849168|NCT00642278|584488935|FG003|Overall Study|Other|1|||
161849169|NCT00642278|584488936|FG004|Overall Study|Other|0|||
161849170|NCT00642278|584488937|FG005|Overall Study|Other|1|||
161849171|NCT00642278|584488938|FG006|Overall Study|Other|0|||
161849172|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161849173|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161849174|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
161849175|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161849176|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161849177|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
161849178|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161849179|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161849180|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161849181|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161849182|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161849183|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161849184|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161849185|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
161849186|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
161849187|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161849188|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161849189|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161849190|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161849191|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161763894|NCT02418000|584174287|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
161763895|NCT02418000|584174288|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763896|NCT02418000|584174289|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763897|NCT02418000|584174290|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763898|NCT02418000|584174286|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763899|NCT02418000|584174287|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
161763900|NCT02418000|584174288|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763901|NCT02418000|584174289|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763902|NCT02418000|584174290|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763903|NCT02418000|584174286|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763904|NCT02418000|584174287|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763905|NCT02418000|584174288|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161763906|NCT02418000|584174289|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763907|NCT02418000|584174290|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763908|NCT02418000|584174286|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763909|NCT02418000|584174287|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763910|NCT02418000|584174288|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763911|NCT02418000|584174289|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161763912|NCT02418000|584174290|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763913|NCT02418000|584174286|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763914|NCT02418000|584174287|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763915|NCT02418000|584174288|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763916|NCT02418000|584174289|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763917|NCT02418000|584174290|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
161763918|NCT02418000|584174286|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763919|NCT02418000|584174287|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763920|NCT02418000|584174288|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763921|NCT02418000|584174289|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763922|NCT02418000|584174290|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161763923|NCT00490815|584174291|FG000|Overall Study|Adverse Event|2|||
161763924|NCT00490815|584174292|FG001|Overall Study|Adverse Event|3|||
161763925|NCT00490815|584174291|FG000|Overall Study|Withdrawal by Subject|4|||
161763926|NCT00490815|584174292|FG001|Overall Study|Withdrawal by Subject|0|||
161763927|NCT00490815|584174291|FG000|Overall Study|Lost to Follow-up|1|||
161763928|NCT00490815|584174292|FG001|Overall Study|Lost to Follow-up|3|||
161763929|NCT00490815|584174291|FG000|Overall Study|Death|1|||
161763930|NCT00490815|584174292|FG001|Overall Study|Death|3|||
161763931|NCT01904760|584174293|FG000|Overall Study|Protocol Violation|1|||
161763932|NCT01904760|584174294|FG001|Overall Study|Protocol Violation|0|||
161763933|NCT04249076|584174296|FG000|Overall Study|Adverse Event|1|||
161763934|NCT04249076|584174297|FG001|Overall Study|Adverse Event|1|||
161763935|NCT04249076|584174296|FG000|Overall Study|Protocol Violation|1|||
161763936|NCT04249076|584174297|FG001|Overall Study|Protocol Violation|2|||
161763937|NCT04249076|584174296|FG000|Overall Study|Lack of Efficacy|0|||
161763938|NCT04249076|584174297|FG001|Overall Study|Lack of Efficacy|1|||
161763939|NCT04249076|584174296|FG000|Overall Study|Withdrawal by Subject|0|||
161763940|NCT04249076|584174297|FG001|Overall Study|Withdrawal by Subject|1|||
161763941|NCT00783263|584174298|FG000|Overall Study|Adverse Event|3|||
161763942|NCT00783263|584174299|FG001|Overall Study|Adverse Event|0|||
161763943|NCT00783263|584174300|FG002|Overall Study|Adverse Event|2|||
161763944|NCT00783263|584174301|FG003|Overall Study|Adverse Event|1|||
161763945|NCT00783263|584174298|FG000|Overall Study|Lost to Follow-up|1|||
161763946|NCT00783263|584174299|FG001|Overall Study|Lost to Follow-up|1|||
161763947|NCT00783263|584174300|FG002|Overall Study|Lost to Follow-up|0|||
161763948|NCT00783263|584174301|FG003|Overall Study|Lost to Follow-up|0|||
161763949|NCT00783263|584174298|FG000|Overall Study|Withdrawal by Subject|0|||
161849192|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
161849193|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
161849194|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
161849195|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161849196|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161849197|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849198|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849199|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
161849200|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849201|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849202|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
161849203|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
161849204|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161849205|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161849206|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161849207|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
161849208|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
161849209|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
161849210|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
161849211|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
161849212|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161849213|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161849214|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161849215|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161849216|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161849217|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
161849218|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
161849219|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
161849220|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
161849221|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
161849222|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
161849223|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
161849224|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
161849225|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
161849226|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
161849227|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
161849228|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
161849229|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161849230|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
161849231|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
161849232|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161849233|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161849234|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161849235|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161849236|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161849237|NCT03553576|584488944|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
161849238|NCT03553576|584488945|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
161849239|NCT03553576|584488944|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
161849240|NCT03553576|584488945|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
161849241|NCT03553576|584488944|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
161849242|NCT03553576|584488945|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
161849243|NCT03553576|584488944|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
161849244|NCT03553576|584488945|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
161849245|NCT03553576|584488944|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
161849246|NCT03553576|584488945|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
161849247|NCT03553576|584488944|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
161849248|NCT03553576|584488945|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
161849249|NCT03553576|584488944|FG000|Overall Study|Physician Decision|2|||
161849250|NCT03553576|584488945|FG001|Overall Study|Physician Decision|5|||
161849251|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
161849252|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
161849253|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
161849254|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
161849255|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
161849256|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
161849257|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
161849258|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
161849259|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
161849260|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
161849261|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
161849262|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
161849263|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
161849264|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
161849265|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
161849266|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
161849267|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
161849268|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
161849269|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
161849270|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
161849271|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
161849272|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
161849273|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
161849274|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
161849275|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
161849276|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
161849277|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
161849278|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
161849279|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
161849280|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
161849281|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
161849282|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
161849283|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
161849284|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
161849285|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
161849286|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
161849287|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
161849288|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
161849289|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
161849290|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
161849291|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
161849292|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
161849293|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
161849294|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
161849295|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
161849296|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
161849297|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
161849298|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
161849299|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
161849300|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
161849301|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
161849302|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
161849303|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
161849304|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
161849305|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
161849306|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
161849307|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
161849308|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
161849309|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
161849310|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
161849311|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
161849312|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
161849313|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
161849314|NCT01094886|584488951|FG000|Overall Study|Adverse Event|2|||
161849315|NCT01094886|584488951|FG000|Overall Study|Withdrawal by Subject|5|||
161849316|NCT02013674|584488952|FG000|Overall Study|Death|0|||
161849317|NCT02013674|584488953|FG001|Overall Study|Death|1|||
161849318|NCT02013674|584488952|FG000|Overall Study|Lost to Follow-up|1|||
161849319|NCT02013674|584488953|FG001|Overall Study|Lost to Follow-up|0|||
161849320|NCT01371747|584491062|FG000|Overall Study|Adverse Event|4|||
161849321|NCT01371747|584491063|FG001|Overall Study|Adverse Event|2|||
161849322|NCT01371747|584491064|FG002|Overall Study|Adverse Event|7|||
161849323|NCT01371747|584491065|FG003|Overall Study|Adverse Event|2|||
161849324|NCT01371747|584491066|FG004|Overall Study|Adverse Event|2|||
161849325|NCT01371747|584491067|FG005|Overall Study|Adverse Event|2|||
161849326|NCT01371747|584491062|FG000|Overall Study|Death|1|||
161849327|NCT01371747|584491063|FG001|Overall Study|Death|0|||
161849328|NCT01371747|584491064|FG002|Overall Study|Death|4|||
161849329|NCT01371747|584491065|FG003|Overall Study|Death|1|||
161849330|NCT01371747|584491066|FG004|Overall Study|Death|2|||
161849331|NCT01371747|584491067|FG005|Overall Study|Death|0|||
161849332|NCT01371747|584491062|FG000|Overall Study|Abnormal Renal Function|0|||
161849333|NCT01371747|584491063|FG001|Overall Study|Abnormal Renal Function|2|||
161849334|NCT01371747|584491064|FG002|Overall Study|Abnormal Renal Function|0|||
161849335|NCT01371747|584491065|FG003|Overall Study|Abnormal Renal Function|1|||
161849336|NCT01371747|584491066|FG004|Overall Study|Abnormal Renal Function|0|||
161849337|NCT01371747|584491067|FG005|Overall Study|Abnormal Renal Function|1|||
161849338|NCT01371747|584491062|FG000|Overall Study|High Serum Potassium Results|1|||
161849339|NCT01371747|584491063|FG001|Overall Study|High Serum Potassium Results|1|||
161849340|NCT01371747|584491064|FG002|Overall Study|High Serum Potassium Results|1|||
161849341|NCT01371747|584491065|FG003|Overall Study|High Serum Potassium Results|2|||
161849342|NCT01371747|584491066|FG004|Overall Study|High Serum Potassium Results|0|||
161849343|NCT01371747|584491067|FG005|Overall Study|High Serum Potassium Results|2|||
161849344|NCT01371747|584491062|FG000|Overall Study|Low Serum Potassium Results|1|||
161849345|NCT01371747|584491063|FG001|Overall Study|Low Serum Potassium Results|1|||
161849346|NCT01371747|584491064|FG002|Overall Study|Low Serum Potassium Results|1|||
161849347|NCT01371747|584491065|FG003|Overall Study|Low Serum Potassium Results|1|||
161849348|NCT01371747|584491066|FG004|Overall Study|Low Serum Potassium Results|0|||
161849349|NCT01371747|584491067|FG005|Overall Study|Low Serum Potassium Results|3|||
161849350|NCT01371747|584491062|FG000|Overall Study|Protocol Violation|0|||
161849351|NCT01371747|584491063|FG001|Overall Study|Protocol Violation|0|||
161849352|NCT01371747|584491064|FG002|Overall Study|Protocol Violation|1|||
161849353|NCT01371747|584491065|FG003|Overall Study|Protocol Violation|0|||
161849354|NCT01371747|584491066|FG004|Overall Study|Protocol Violation|0|||
161849355|NCT01371747|584491067|FG005|Overall Study|Protocol Violation|0|||
161849356|NCT01371747|584491062|FG000|Overall Study|Non-Compliance|3|||
161849357|NCT01371747|584491063|FG001|Overall Study|Non-Compliance|4|||
161849358|NCT01371747|584491064|FG002|Overall Study|Non-Compliance|3|||
161849359|NCT01371747|584491065|FG003|Overall Study|Non-Compliance|0|||
161849360|NCT01371747|584491066|FG004|Overall Study|Non-Compliance|0|||
161849361|NCT01371747|584491067|FG005|Overall Study|Non-Compliance|1|||
161849362|NCT01371747|584491062|FG000|Overall Study|Physician Decision|0|||
161849363|NCT01371747|584491063|FG001|Overall Study|Physician Decision|0|||
161849364|NCT01371747|584491064|FG002|Overall Study|Physician Decision|0|||
161849365|NCT01371747|584491065|FG003|Overall Study|Physician Decision|0|||
161849366|NCT01371747|584491066|FG004|Overall Study|Physician Decision|1|||
161849367|NCT01371747|584491067|FG005|Overall Study|Physician Decision|0|||
161849368|NCT01371747|584491062|FG000|Overall Study|Withdrawal by Subject|6|||
161849369|NCT01371747|584491063|FG001|Overall Study|Withdrawal by Subject|12|||
161849370|NCT01371747|584491064|FG002|Overall Study|Withdrawal by Subject|5|||
161849371|NCT01371747|584491065|FG003|Overall Study|Withdrawal by Subject|2|||
161849372|NCT01371747|584491066|FG004|Overall Study|Withdrawal by Subject|2|||
161849373|NCT01371747|584491067|FG005|Overall Study|Withdrawal by Subject|4|||
161849374|NCT01371747|584491062|FG000|Overall Study|Other Reasons|2|||
161849375|NCT01371747|584491063|FG001|Overall Study|Other Reasons|1|||
161849376|NCT01371747|584491064|FG002|Overall Study|Other Reasons|2|||
161849377|NCT01371747|584491065|FG003|Overall Study|Other Reasons|0|||
161849378|NCT01371747|584491066|FG004|Overall Study|Other Reasons|0|||
161849379|NCT01371747|584491067|FG005|Overall Study|Other Reasons|1|||
161849380|NCT03092219|584491068|FG000|Overall Study|Protocol Violation|7|||
161849381|NCT03092219|584491069|FG001|Overall Study|Protocol Violation|4|||
161849382|NCT05013008|584491073|FG000|Overall Study|Exclusion from mBFAS|5|||
161849383|NCT05013008|584491074|FG001|Overall Study|Exclusion from mBFAS|25|||
161849384|NCT02094417|584491078|FG000|Overall Study|Adverse Event|0|||
161849385|NCT02094417|584491079|FG001|Overall Study|Adverse Event|0|||
161849386|NCT02094417|584491080|FG002|Overall Study|Adverse Event|0|||
161849387|NCT02094417|584491081|FG003|Overall Study|Adverse Event|1|||
161849388|NCT02094417|584491078|FG000|Overall Study|Eligibility criteria|0|||
161849389|NCT02094417|584491079|FG001|Overall Study|Eligibility criteria|1|||
161849390|NCT02094417|584491080|FG002|Overall Study|Eligibility criteria|0|||
161849391|NCT02094417|584491081|FG003|Overall Study|Eligibility criteria|0|||
161849392|NCT02094417|584491078|FG000|Overall Study|No responder|4|||
161849393|NCT02094417|584491079|FG001|Overall Study|No responder|4|||
161849394|NCT02094417|584491080|FG002|Overall Study|No responder|4|||
161849395|NCT02094417|584491081|FG003|Overall Study|No responder|3|||
161849396|NCT02094417|584491078|FG000|Overall Study|Unable to conduct observations or assess|0|||
161849397|NCT02094417|584491079|FG001|Overall Study|Unable to conduct observations or assess|1|||
161849398|NCT02094417|584491080|FG002|Overall Study|Unable to conduct observations or assess|0|||
161849399|NCT02094417|584491081|FG003|Overall Study|Unable to conduct observations or assess|0|||
161849400|NCT02094417|584491078|FG000|Overall Study|Withdrawal by Subject|1|||
161849401|NCT02094417|584491079|FG001|Overall Study|Withdrawal by Subject|2|||
161849402|NCT02094417|584491080|FG002|Overall Study|Withdrawal by Subject|1|||
161849403|NCT02094417|584491081|FG003|Overall Study|Withdrawal by Subject|3|||
161849404|NCT01443728|584491084|FG000|Overall Study|Lost to Follow-up|2|||
161849405|NCT01443728|584491085|FG001|Overall Study|Lost to Follow-up|0|||
161849406|NCT01443728|584491084|FG000|Overall Study|Withdrawal by Subject|1|||
161849407|NCT01443728|584491085|FG001|Overall Study|Withdrawal by Subject|1|||
161849408|NCT01443728|584491084|FG000|Overall Study|Adverse Event|0|||
161849409|NCT01443728|584491085|FG001|Overall Study|Adverse Event|2|||
161849410|NCT04971187|584491086|FG000|Overall Study|Screen failures|2|||
161849411|NCT04981717|584491092|FG000|Overall Study|Protocol Violation|0|||
161849412|NCT04981717|584491093|FG001|Overall Study|Protocol Violation|3|||
161849413|NCT04981717|584491092|FG000|Overall Study|Adverse Event|1|||
161849414|NCT04981717|584491093|FG001|Overall Study|Adverse Event|3|||
161849415|NCT04981717|584491092|FG000|Overall Study|Pregnancy|1|||
161849416|NCT04981717|584491093|FG001|Overall Study|Pregnancy|0|||
161849417|NCT04981717|584491092|FG000|Overall Study|Physician Decision|1|||
161849418|NCT04981717|584491093|FG001|Overall Study|Physician Decision|0|||
161849419|NCT04981717|584491092|FG000|Overall Study|Sponsor Request|157|||
161849420|NCT04981717|584491093|FG001|Overall Study|Sponsor Request|172|||
161849421|NCT04981717|584491092|FG000|Overall Study|Lost to Follow-up|4|||
161849422|NCT04981717|584491093|FG001|Overall Study|Lost to Follow-up|5|||
161849423|NCT04981717|584491092|FG000|Overall Study|Withdrawal by Subject|50|||
161849424|NCT04981717|584491093|FG001|Overall Study|Withdrawal by Subject|37|||
161849425|NCT02207634|584491094|FG000|Overall Study|Withdrawal by Subject|21|||
161849426|NCT02207634|584491095|FG001|Overall Study|Withdrawal by Subject|31|||
161849427|NCT02207634|584491094|FG000|Overall Study|Lost to Follow-up|1|||
161849428|NCT02207634|584491095|FG001|Overall Study|Lost to Follow-up|0|||
161849429|NCT01207583|584491098|FG000|Overall Study|Withdrawal by Subject|0|||
161849430|NCT01207583|584491099|FG001|Overall Study|Withdrawal by Subject|3|||
161849431|NCT01207583|584491100|FG002|Overall Study|Withdrawal by Subject|1|||
161849432|NCT01207583|584491098|FG000|Overall Study|Participant failed to return|1|||
161849433|NCT01207583|584491099|FG001|Overall Study|Participant failed to return|0|||
161849434|NCT01207583|584491100|FG002|Overall Study|Participant failed to return|0|||
161849435|NCT01207583|584491098|FG000|Overall Study|Lost to Follow-up|0|||
161849436|NCT01207583|584491099|FG001|Overall Study|Lost to Follow-up|2|||
161849437|NCT01207583|584491100|FG002|Overall Study|Lost to Follow-up|0|||
161849438|NCT01433549|584491102|FG000|Phase 2: Second Study Product|Adverse Event|0|||
161849439|NCT01433549|584491103|FG001|Phase 2: Second Study Product|Adverse Event|1|||
161849440|NCT01696058|584491105|FG000|Overall Study|Adverse Event|21|||
161849441|NCT01696058|584491106|FG001|Overall Study|Adverse Event|11|||
161849442|NCT01696058|584491105|FG000|Overall Study|Lack of Efficacy|2|||
161849443|NCT01696058|584491106|FG001|Overall Study|Lack of Efficacy|3|||
161849444|NCT01696058|584491105|FG000|Overall Study|Protocol Violation|9|||
161849445|NCT01696058|584491106|FG001|Overall Study|Protocol Violation|3|||
161849446|NCT01696058|584491105|FG000|Overall Study|Lost to Follow-up|2|||
161849447|NCT01696058|584491106|FG001|Overall Study|Lost to Follow-up|5|||
161849448|NCT01696058|584491105|FG000|Overall Study|Withdrawal by Subject|4|||
161849449|NCT01696058|584491106|FG001|Overall Study|Withdrawal by Subject|6|||
161849450|NCT01696058|584491105|FG000|Overall Study|Other reason prematurely discontinued|5|||
161849451|NCT01696058|584491106|FG001|Overall Study|Other reason prematurely discontinued|3|||
161849452|NCT02186834|584491108|FG000|Dose Escalation|Death|0|||
161849453|NCT02186834|584491109|FG001|Dose Escalation|Death|0|||
161849454|NCT02186834|584491110|FG002|Dose Escalation|Death|0|||
161849455|NCT02186834|584491111|FG003|Dose Escalation|Death|1|||
161849456|NCT02186834|584491112|FG004|Dose Escalation|Death|0|||
161849457|NCT02186834|584491113|FG005|Dose Escalation|Death|0|||
161849458|NCT02186834|584491108|FG000|Treatment at RP2D|Died prior to treatment|0|||
161849459|NCT02186834|584491109|FG001|Treatment at RP2D|Died prior to treatment|0|||
161849460|NCT02186834|584491110|FG002|Treatment at RP2D|Died prior to treatment|0|||
161849461|NCT02186834|584491111|FG003|Treatment at RP2D|Died prior to treatment|0|||
161849462|NCT02186834|584491112|FG004|Treatment at RP2D|Died prior to treatment|0|||
161849463|NCT02186834|584491113|FG005|Treatment at RP2D|Died prior to treatment|1|||
161849464|NCT04581369|584491114|FG000|Overall Study|Death|7|||
161849465|NCT04581369|584491115|FG001|Overall Study|Death|6|||
161849466|NCT04581369|584491116|FG002|Overall Study|Death|0|||
161849467|NCT04581369|584491114|FG000|Overall Study|Lost to Follow-up|7|||
161849468|NCT04581369|584491115|FG001|Overall Study|Lost to Follow-up|3|||
161849469|NCT04581369|584491116|FG002|Overall Study|Lost to Follow-up|0|||
161849470|NCT04581369|584491114|FG000|Overall Study|liver transplant|2|||
161849471|NCT04581369|584491115|FG001|Overall Study|liver transplant|2|||
161849472|NCT04581369|584491116|FG002|Overall Study|liver transplant|0|||
161849473|NCT04581369|584491114|FG000|Overall Study|transitioned to hospice care|0|||
161849474|NCT04581369|584491115|FG001|Overall Study|transitioned to hospice care|5|||
161849475|NCT04581369|584491116|FG002|Overall Study|transitioned to hospice care|0|||
161849476|NCT04746794|584491119|FG000|Overall Study|Did not complete any study assessment|50303|||
161849477|NCT04746794|584491120|FG001|Overall Study|Did not complete any study assessment|44997|||
161849478|NCT02538965|584491121|FG000|Treatment Period|Other = Death due to disease progression|1|||
161849479|NCT02538965|584491121|FG000|Treatment Period|Adverse Event|2|||
161849480|NCT02538965|584491121|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
161849481|NCT02538965|584491121|FG000|Treatment Period|Treatment Failure|9|||
161849482|NCT02538965|584491121|FG000|Treatment Period|Disease Progression|1|||
161849483|NCT02538965|584491121|FG000|Treatment Period|Physician Decision|2|||
161849484|NCT02538965|584491121|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
161849485|NCT02538965|584491121|FG000|Follow-Up Period|Withdrawal by Parent|4|||
161849486|NCT00875797|584491122|FG000|Overall Study|Protocol Violation|6|||
161849487|NCT00875797|584491123|FG001|Overall Study|Protocol Violation|3|||
161849488|NCT00253448|584491126|FG000|Overall Study|Withdrawal by Subject|1|||
161849489|NCT02564887|584491128|FG000|Overall Study|Lost to Follow-up|6|||
161849490|NCT02564887|584491129|FG001|Overall Study|Lost to Follow-up|0|||
161849491|NCT02052011|584491132|FG000|Overall Study|Lost to Follow-up|3|||
161849492|NCT02052011|584491133|FG001|Overall Study|Lost to Follow-up|0|||
161849493|NCT02052011|584491132|FG000|Overall Study|Withdrawal by Subject|1|||
161849494|NCT02052011|584491133|FG001|Overall Study|Withdrawal by Subject|2|||
161849495|NCT00000620|584491134|FG000|Overall Study|Death|86|||
161849496|NCT00000620|584491135|FG001|Overall Study|Death|67|||
161849497|NCT00000620|584491136|FG002|Overall Study|Death|112|||
161849498|NCT00000620|584491137|FG003|Overall Study|Death|126|||
161849499|NCT00000620|584491138|FG004|Overall Study|Death|64|||
161849500|NCT00000620|584491139|FG005|Overall Study|Death|77|||
161849501|NCT00000620|584491140|FG006|Overall Study|Death|91|||
161849502|NCT00000620|584491141|FG007|Overall Study|Death|95|||
161849503|NCT00000620|584491134|FG000|Overall Study|Lost to Follow-up|14|||
161849504|NCT00000620|584491135|FG001|Overall Study|Lost to Follow-up|14|||
161763950|NCT00783263|584174299|FG001|Overall Study|Withdrawal by Subject|1|||
161763951|NCT00783263|584174300|FG002|Overall Study|Withdrawal by Subject|1|||
161763952|NCT00783263|584174301|FG003|Overall Study|Withdrawal by Subject|2|||
161763953|NCT00106626|584174302|FG000|Overall Study|Adverse Event|5|||
161763954|NCT00106626|584174303|FG001|Overall Study|Adverse Event|4|||
161763955|NCT00106626|584174304|FG002|Overall Study|Adverse Event|3|||
161763956|NCT00106626|584174305|FG003|Overall Study|Adverse Event|3|||
161763957|NCT00106626|584174302|FG000|Overall Study|Progressive Disease|4|||
161763958|NCT00106626|584174303|FG001|Overall Study|Progressive Disease|1|||
161763959|NCT00106626|584174304|FG002|Overall Study|Progressive Disease|9|||
161763960|NCT00106626|584174305|FG003|Overall Study|Progressive Disease|10|||
161763961|NCT00106626|584174302|FG000|Overall Study|Received radiation on new therapy|1|||
161763962|NCT00106626|584174303|FG001|Overall Study|Received radiation on new therapy|0|||
161763963|NCT00106626|584174304|FG002|Overall Study|Received radiation on new therapy|0|||
161763964|NCT00106626|584174305|FG003|Overall Study|Received radiation on new therapy|0|||
161763965|NCT00106626|584174302|FG000|Overall Study|> 14 day delay in therapy start|0|||
161763966|NCT00106626|584174303|FG001|Overall Study|> 14 day delay in therapy start|1|||
161763967|NCT00106626|584174304|FG002|Overall Study|> 14 day delay in therapy start|0|||
161763968|NCT00106626|584174305|FG003|Overall Study|> 14 day delay in therapy start|0|||
161763969|NCT00732199|584174310|FG000|Overall Study|Withdrawal by Subject|25|||
161763970|NCT00732199|584174311|FG001|Overall Study|Withdrawal by Subject|18|||
161763971|NCT00732199|584174310|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
161763972|NCT00732199|584174311|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
161763973|NCT03018028|584174324|FG000|Overall Study|Withdrawal by Subject|3|||
161763974|NCT03018028|584174325|FG001|Overall Study|Withdrawal by Subject|0|||
161763975|NCT03018028|584174326|FG002|Overall Study|Withdrawal by Subject|1|||
161763976|NCT03018028|584174327|FG003|Overall Study|Withdrawal by Subject|2|||
161763977|NCT03018028|584174328|FG004|Overall Study|Withdrawal by Subject|0|||
161763978|NCT02519777|584174330|FG000|Overall Study|Death|1|||
161763979|NCT02519777|584174331|FG001|Overall Study|Death|0|||
161763980|NCT02519777|584174332|FG002|Overall Study|Death|0|||
161763981|NCT02519777|584174330|FG000|Overall Study|Lost to Follow-up|0|||
161763982|NCT02519777|584174331|FG001|Overall Study|Lost to Follow-up|4|||
161763983|NCT02519777|584174332|FG002|Overall Study|Lost to Follow-up|2|||
161763984|NCT02519777|584174330|FG000|Overall Study|Withdrawal by Subject|3|||
161763985|NCT02519777|584174331|FG001|Overall Study|Withdrawal by Subject|1|||
161763986|NCT02519777|584174332|FG002|Overall Study|Withdrawal by Subject|0|||
161763987|NCT02519777|584174330|FG000|Overall Study|Severe Debilitation|1|||
161763988|NCT02519777|584174331|FG001|Overall Study|Severe Debilitation|1|||
161763989|NCT02519777|584174332|FG002|Overall Study|Severe Debilitation|1|||
161763990|NCT02519777|584174330|FG000|Overall Study|Not able to get to clinic|1|||
161849505|NCT00000620|584491136|FG002|Overall Study|Lost to Follow-up|14|||
161763991|NCT02519777|584174331|FG001|Overall Study|Not able to get to clinic|2|||
161763992|NCT02519777|584174332|FG002|Overall Study|Not able to get to clinic|1|||
161763993|NCT01284127|584174334|FG000|Overall Study|Adverse Event|2|||
161763994|NCT01284127|584174334|FG000|Overall Study|Withdrawal by Subject|4|||
161763995|NCT01284127|584174334|FG000|Overall Study|Physician Decision|1|||
161763996|NCT00256204|584174336|FG000|Overall Study|Adverse Event|10|||
161763997|NCT00256204|584174337|FG001|Overall Study|Adverse Event|14|||
161763998|NCT00256204|584174338|FG002|Overall Study|Adverse Event|16|||
161763999|NCT00256204|584174339|FG003|Overall Study|Adverse Event|14|||
161764000|NCT00256204|584174336|FG000|Overall Study|Death|0|||
161764001|NCT00256204|584174337|FG001|Overall Study|Death|1|||
161764002|NCT00256204|584174338|FG002|Overall Study|Death|0|||
161764003|NCT00256204|584174339|FG003|Overall Study|Death|0|||
161764004|NCT00256204|584174336|FG000|Overall Study|Lost to Follow-up|1|||
161764005|NCT00256204|584174337|FG001|Overall Study|Lost to Follow-up|1|||
161764006|NCT00256204|584174338|FG002|Overall Study|Lost to Follow-up|1|||
161764007|NCT00256204|584174339|FG003|Overall Study|Lost to Follow-up|2|||
161764008|NCT00256204|584174336|FG000|Overall Study|Protocol Violation|1|||
161764009|NCT00256204|584174337|FG001|Overall Study|Protocol Violation|0|||
161764010|NCT00256204|584174338|FG002|Overall Study|Protocol Violation|2|||
161764011|NCT00256204|584174339|FG003|Overall Study|Protocol Violation|1|||
161764012|NCT00256204|584174336|FG000|Overall Study|Physician Decision|0|||
161764013|NCT00256204|584174337|FG001|Overall Study|Physician Decision|0|||
161764014|NCT00256204|584174338|FG002|Overall Study|Physician Decision|1|||
161764015|NCT00256204|584174339|FG003|Overall Study|Physician Decision|2|||
161764016|NCT00256204|584174336|FG000|Overall Study|Withdrawal by Subject|17|||
161764017|NCT00256204|584174337|FG001|Overall Study|Withdrawal by Subject|6|||
161764018|NCT00256204|584174338|FG002|Overall Study|Withdrawal by Subject|7|||
161764019|NCT00256204|584174339|FG003|Overall Study|Withdrawal by Subject|5|||
161764020|NCT00256204|584174336|FG000|Overall Study|Need for additional prohibited treatment|38|||
161764021|NCT00256204|584174337|FG001|Overall Study|Need for additional prohibited treatment|28|||
161764022|NCT00256204|584174338|FG002|Overall Study|Need for additional prohibited treatment|27|||
161764023|NCT00256204|584174339|FG003|Overall Study|Need for additional prohibited treatment|25|||
161764024|NCT00994890|584174345|FG000|Overall Study|Adverse Event|13|||
161764025|NCT00994890|584174346|FG001|Overall Study|Adverse Event|9|||
161764026|NCT00994890|584174347|FG002|Overall Study|Adverse Event|11|||
161764027|NCT00994890|584174345|FG000|Overall Study|Lack of Efficacy|0|||
161764028|NCT00994890|584174346|FG001|Overall Study|Lack of Efficacy|0|||
161764029|NCT00994890|584174347|FG002|Overall Study|Lack of Efficacy|1|||
161764030|NCT00994890|584174345|FG000|Overall Study|Lost to Follow-up|6|||
161764031|NCT00994890|584174346|FG001|Overall Study|Lost to Follow-up|1|||
161764032|NCT00994890|584174347|FG002|Overall Study|Lost to Follow-up|3|||
161764033|NCT00994890|584174345|FG000|Overall Study|No longer willing to participate|8|||
161764034|NCT00994890|584174346|FG001|Overall Study|No longer willing to participate|5|||
161764035|NCT00994890|584174347|FG002|Overall Study|No longer willing to participate|13|||
161764036|NCT00994890|584174345|FG000|Overall Study|Protocol Violation|2|||
161764037|NCT00994890|584174346|FG001|Overall Study|Protocol Violation|4|||
161764038|NCT00994890|584174347|FG002|Overall Study|Protocol Violation|0|||
161764039|NCT00994890|584174345|FG000|Overall Study|Study terminated by sponsor|199|||
161764040|NCT00994890|584174346|FG001|Overall Study|Study terminated by sponsor|201|||
161764041|NCT00994890|584174347|FG002|Overall Study|Study terminated by sponsor|197|||
161764042|NCT00994890|584174345|FG000|Overall Study|Randomized, but not treated|1|||
161764043|NCT00994890|584174346|FG001|Overall Study|Randomized, but not treated|0|||
161764044|NCT00994890|584174347|FG002|Overall Study|Randomized, but not treated|0|||
161764045|NCT00994890|584174345|FG000|Overall Study|Other|2|||
161764046|NCT00994890|584174346|FG001|Overall Study|Other|2|||
161764047|NCT00994890|584174347|FG002|Overall Study|Other|1|||
161764048|NCT00699582|584174348|FG000|Overall Study|Adverse Event|4|||
161764049|NCT00699582|584174349|FG001|Overall Study|Adverse Event|11|||
161764050|NCT00699582|584174350|FG002|Overall Study|Adverse Event|23|||
161849506|NCT00000620|584491137|FG003|Overall Study|Lost to Follow-up|14|||
161764051|NCT00699582|584174348|FG000|Overall Study|Withdrawal by Subject|6|||
161764052|NCT00699582|584174349|FG001|Overall Study|Withdrawal by Subject|7|||
161764053|NCT00699582|584174350|FG002|Overall Study|Withdrawal by Subject|4|||
161764054|NCT00699582|584174348|FG000|Overall Study|Lack of Efficacy|1|||
161764055|NCT00699582|584174349|FG001|Overall Study|Lack of Efficacy|0|||
161764056|NCT00699582|584174350|FG002|Overall Study|Lack of Efficacy|1|||
161764057|NCT00699582|584174348|FG000|Overall Study|Progressive Disease|1|||
161764058|NCT00699582|584174349|FG001|Overall Study|Progressive Disease|0|||
161764059|NCT00699582|584174350|FG002|Overall Study|Progressive Disease|0|||
161764060|NCT00699582|584174348|FG000|Overall Study|Administrative/Other|4|||
161764061|NCT00699582|584174349|FG001|Overall Study|Administrative/Other|3|||
161764062|NCT00699582|584174350|FG002|Overall Study|Administrative/Other|0|||
161764063|NCT00699582|584174348|FG000|Overall Study|Randomized, Not Treated|2|||
161764064|NCT00699582|584174349|FG001|Overall Study|Randomized, Not Treated|1|||
161764065|NCT00699582|584174350|FG002|Overall Study|Randomized, Not Treated|0|||
161764066|NCT01849289|584174351|FG000|Overall Study|Adverse Event|3|||
161764067|NCT01849289|584174352|FG001|Overall Study|Adverse Event|3|||
161764068|NCT01849289|584174351|FG000|Overall Study|Protocol Violation|3|||
161764069|NCT01849289|584174352|FG001|Overall Study|Protocol Violation|3|||
161764070|NCT01849289|584174351|FG000|Overall Study|Withdrawal criteria|1|||
161764071|NCT01849289|584174352|FG001|Overall Study|Withdrawal criteria|0|||
161764072|NCT01849289|584174351|FG000|Overall Study|Unclassified|25|||
161764073|NCT01849289|584174352|FG001|Overall Study|Unclassified|18|||
161764074|NCT01142791|584174363|FG000|Overall Study|Alternative Treatment|1|||
161764075|NCT01142791|584174364|FG001|Overall Study|Alternative Treatment|0|||
161764076|NCT01142791|584174363|FG000|Overall Study|Lost to Follow-up|1|||
161764077|NCT01142791|584174364|FG001|Overall Study|Lost to Follow-up|0|||
161764078|NCT01142791|584174363|FG000|Overall Study|Withdrawal by Subject|5|||
161764079|NCT01142791|584174364|FG001|Overall Study|Withdrawal by Subject|0|||
161764080|NCT01142791|584174363|FG000|Overall Study|Received only 1 sonication|0|||
161764081|NCT01142791|584174364|FG001|Overall Study|Received only 1 sonication|6|||
161764082|NCT02975206|584174366|FG000|Overall Study|Withdrawal by Subject|14|||
161764083|NCT02975206|584174367|FG001|Overall Study|Withdrawal by Subject|11|||
161764084|NCT02975206|584174368|FG002|Overall Study|Withdrawal by Subject|11|||
161764085|NCT02975206|584174366|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
161764086|NCT02975206|584174367|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
161764087|NCT02975206|584174368|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
161764088|NCT01981096|584174369|FG000|Overall Study|Parent illness|1|||
161764089|NCT01981096|584174370|FG001|Overall Study|Parent illness|0|||
161764090|NCT01981096|584174369|FG000|Overall Study|Withdrawal by Subject|0|||
161764091|NCT01981096|584174370|FG001|Overall Study|Withdrawal by Subject|1|||
161764092|NCT01981096|584174369|FG000|Overall Study|Lost to Follow-up|2|||
161764093|NCT01981096|584174370|FG001|Overall Study|Lost to Follow-up|0|||
161764094|NCT04129242|584174372|FG000|Overall Study|Physician Decision|1|||
161764095|NCT04129242|584174373|FG001|Overall Study|Physician Decision|1|||
161764096|NCT04129242|584174372|FG000|Overall Study|Protocol Violation|0|||
161764097|NCT04129242|584174373|FG001|Overall Study|Protocol Violation|1|||
161764098|NCT01899729|584174376|FG000|Overall Study|Adverse Event|1|||
161764099|NCT01899729|584174377|FG001|Overall Study|Adverse Event|0|||
161764100|NCT01899729|584174378|FG002|Overall Study|Adverse Event|0|||
161764101|NCT01899729|584174379|FG003|Overall Study|Adverse Event|0|||
161764102|NCT01899729|584174380|FG004|Overall Study|Adverse Event|1|||
161764103|NCT01899729|584174376|FG000|Overall Study|Withdrawal by Subject|1|||
161764104|NCT01899729|584174377|FG001|Overall Study|Withdrawal by Subject|2|||
161764105|NCT01899729|584174378|FG002|Overall Study|Withdrawal by Subject|0|||
161764106|NCT01899729|584174379|FG003|Overall Study|Withdrawal by Subject|0|||
161764107|NCT01899729|584174380|FG004|Overall Study|Withdrawal by Subject|0|||
161764108|NCT01899729|584174376|FG000|Overall Study|Lack of Efficacy|0|||
161764109|NCT01899729|584174377|FG001|Overall Study|Lack of Efficacy|0|||
161764110|NCT01899729|584174378|FG002|Overall Study|Lack of Efficacy|2|||
161764111|NCT01899729|584174379|FG003|Overall Study|Lack of Efficacy|0|||
161764112|NCT01899729|584174380|FG004|Overall Study|Lack of Efficacy|1|||
161764113|NCT01454531|584174381|FG000|Overall Study|Adverse Event|14|||
161764114|NCT01454531|584174381|FG000|Overall Study|Withdrawal by Subject|5|||
161764115|NCT01454531|584174381|FG000|Overall Study|Lost to Follow-up|1|||
161764116|NCT01454531|584174381|FG000|Overall Study|Physician Decision|1|||
161764117|NCT01454531|584174381|FG000|Overall Study|Delay in IMP administration|1|||
161764118|NCT01454531|584174381|FG000|Overall Study|Other|1|||
161764119|NCT03922945|584176103|FG000|Overall Study|Adverse Event|1|||
161764120|NCT03922945|584176104|FG001|Overall Study|Adverse Event|1|||
161764121|NCT03922945|584176105|FG002|Overall Study|Adverse Event|2|||
161764122|NCT03922945|584176103|FG000|Overall Study|Lost to Follow-up|13|||
161764123|NCT03922945|584176104|FG001|Overall Study|Lost to Follow-up|9|||
161764124|NCT03922945|584176105|FG002|Overall Study|Lost to Follow-up|20|||
161764125|NCT03922945|584176103|FG000|Overall Study|Lack of Efficacy|2|||
161849507|NCT00000620|584491138|FG004|Overall Study|Lost to Follow-up|15|||
161849508|NCT00000620|584491139|FG005|Overall Study|Lost to Follow-up|15|||
161849509|NCT00000620|584491140|FG006|Overall Study|Lost to Follow-up|13|||
161849510|NCT00000620|584491141|FG007|Overall Study|Lost to Follow-up|14|||
161849511|NCT00000620|584491134|FG000|Overall Study|Withdrawal by Subject|40|||
161849512|NCT00000620|584491135|FG001|Overall Study|Withdrawal by Subject|27|||
161849513|NCT00000620|584491136|FG002|Overall Study|Withdrawal by Subject|28|||
161849514|NCT00000620|584491137|FG003|Overall Study|Withdrawal by Subject|27|||
161849515|NCT00000620|584491138|FG004|Overall Study|Withdrawal by Subject|30|||
161849516|NCT00000620|584491139|FG005|Overall Study|Withdrawal by Subject|32|||
161849517|NCT00000620|584491140|FG006|Overall Study|Withdrawal by Subject|32|||
161849518|NCT00000620|584491141|FG007|Overall Study|Withdrawal by Subject|21|||
161849519|NCT00000620|584491134|FG000|Overall Study|missed closeout visit|22|||
161849520|NCT00000620|584491135|FG001|Overall Study|missed closeout visit|28|||
161849521|NCT00000620|584491136|FG002|Overall Study|missed closeout visit|16|||
161849522|NCT00000620|584491137|FG003|Overall Study|missed closeout visit|11|||
161849523|NCT00000620|584491138|FG004|Overall Study|missed closeout visit|26|||
161849524|NCT00000620|584491139|FG005|Overall Study|missed closeout visit|28|||
161849525|NCT00000620|584491140|FG006|Overall Study|missed closeout visit|13|||
161849526|NCT00000620|584491141|FG007|Overall Study|missed closeout visit|16|||
161849527|NCT01590797|584491142|FG000|Overall Study|Adverse Event|4|||
161849528|NCT01590797|584491143|FG001|Overall Study|Adverse Event|3|||
161849529|NCT01590797|584491142|FG000|Overall Study|Lack of Efficacy|0|||
161849530|NCT01590797|584491143|FG001|Overall Study|Lack of Efficacy|2|||
161849531|NCT01590797|584491142|FG000|Overall Study|Lost to Follow-up|0|||
161849532|NCT01590797|584491143|FG001|Overall Study|Lost to Follow-up|1|||
161849533|NCT01590797|584491142|FG000|Overall Study|Protocol Violation|4|||
161849534|NCT01590797|584491143|FG001|Overall Study|Protocol Violation|1|||
161849535|NCT01590797|584491142|FG000|Overall Study|Withdrawal by Subject|7|||
161849536|NCT01590797|584491143|FG001|Overall Study|Withdrawal by Subject|5|||
161849537|NCT01590797|584491142|FG000|Overall Study|Other Protocol Specified Criteria|2|||
161849538|NCT01590797|584491143|FG001|Overall Study|Other Protocol Specified Criteria|4|||
161849539|NCT03106987|584491144|FG000|Overall Study|Death|37|||
161849540|NCT03106987|584491145|FG001|Overall Study|Death|22|||
161849541|NCT03106987|584491146|FG002|Overall Study|Death|12|||
161849542|NCT03106987|584491147|FG003|Overall Study|Death|8|||
161849543|NCT03106987|584491144|FG000|Overall Study|Lost to Follow-up|2|||
161849544|NCT03106987|584491145|FG001|Overall Study|Lost to Follow-up|0|||
161849545|NCT03106987|584491146|FG002|Overall Study|Lost to Follow-up|2|||
161849546|NCT03106987|584491147|FG003|Overall Study|Lost to Follow-up|2|||
161849547|NCT03106987|584491144|FG000|Overall Study|Withdrawal by Subject|5|||
161849548|NCT03106987|584491145|FG001|Overall Study|Withdrawal by Subject|1|||
161849549|NCT03106987|584491146|FG002|Overall Study|Withdrawal by Subject|4|||
161849550|NCT03106987|584491147|FG003|Overall Study|Withdrawal by Subject|1|||
161849551|NCT01307111|584491148|FG000|IUD Insertion|Lost to Follow-up|2|||
161849552|NCT01307111|584491149|FG001|IUD Insertion|Lost to Follow-up|0|||
161849553|NCT01307111|584491148|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
161849554|NCT01307111|584491149|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
161849555|NCT02114385|584491154|FG000|Overall Study|Withdrawal by Subject|3|||
161849556|NCT02114385|584491155|FG001|Overall Study|Withdrawal by Subject|2|||
161849557|NCT02114385|584491154|FG000|Overall Study|Lost to Follow-up|0|||
161849558|NCT02114385|584491155|FG001|Overall Study|Lost to Follow-up|6|||
161849559|NCT02460679|584491156|FG000|Overall Study|Investigator Decision|1|||
161849560|NCT02460679|584491156|FG000|Overall Study|Withdrawal by Subject|4|||
161849561|NCT00339144|584491165|FG000|Overall Study|Disease progression|5|||
161849562|NCT00339144|584491166|FG001|Overall Study|Disease progression|2|||
161849563|NCT00339144|584491167|FG002|Overall Study|Disease progression|2|||
161849564|NCT00339144|584491165|FG000|Overall Study|Study drug toxicity|3|||
161849565|NCT00339144|584491166|FG001|Overall Study|Study drug toxicity|1|||
161849566|NCT00339144|584491167|FG002|Overall Study|Study drug toxicity|1|||
161849567|NCT00339144|584491165|FG000|Overall Study|Participant's request to discontinuation|1|||
161849568|NCT00339144|584491166|FG001|Overall Study|Participant's request to discontinuation|0|||
161849569|NCT00339144|584491167|FG002|Overall Study|Participant's request to discontinuation|1|||
161849570|NCT01267994|584491171|FG000|Overall Study|Adverse Event|2|||
161849571|NCT04642365|584491179|FG000|Overall Study|Death|3|||
161849572|NCT04642365|584491180|FG001|Overall Study|Death|2|||
161849573|NCT04642365|584491181|FG002|Overall Study|Death|4|||
161849574|NCT04642365|584491182|FG003|Overall Study|Death|5|||
161849575|NCT04642365|584491183|FG004|Overall Study|Death|5|||
161849576|NCT04642365|584491184|FG005|Overall Study|Death|3|||
161849577|NCT04642365|584491185|FG006|Overall Study|Death|2|||
161849578|NCT04642365|584491186|FG007|Overall Study|Death|1|||
161849579|NCT04642365|584491179|FG000|Overall Study|Physician Decision|1|||
161849580|NCT04642365|584491180|FG001|Overall Study|Physician Decision|0|||
161849581|NCT04642365|584491181|FG002|Overall Study|Physician Decision|0|||
161849582|NCT04642365|584491182|FG003|Overall Study|Physician Decision|0|||
161849583|NCT04642365|584491183|FG004|Overall Study|Physician Decision|0|||
161849584|NCT04642365|584491184|FG005|Overall Study|Physician Decision|0|||
161849585|NCT04642365|584491185|FG006|Overall Study|Physician Decision|0|||
161849586|NCT04642365|584491186|FG007|Overall Study|Physician Decision|0|||
161849587|NCT04642365|584491179|FG000|Overall Study|Progressive Disease|1|||
161849588|NCT04642365|584491180|FG001|Overall Study|Progressive Disease|1|||
161849589|NCT04642365|584491181|FG002|Overall Study|Progressive Disease|1|||
161849590|NCT04642365|584491182|FG003|Overall Study|Progressive Disease|0|||
161849591|NCT04642365|584491183|FG004|Overall Study|Progressive Disease|0|||
161849592|NCT04642365|584491184|FG005|Overall Study|Progressive Disease|0|||
161849593|NCT04642365|584491185|FG006|Overall Study|Progressive Disease|1|||
161764126|NCT03922945|584176104|FG001|Overall Study|Lack of Efficacy|0|||
161764127|NCT03922945|584176105|FG002|Overall Study|Lack of Efficacy|1|||
161764128|NCT03922945|584176103|FG000|Overall Study|Protocol Non-Compliance|0|||
161764129|NCT03922945|584176104|FG001|Overall Study|Protocol Non-Compliance|0|||
161764130|NCT03922945|584176105|FG002|Overall Study|Protocol Non-Compliance|1|||
161764131|NCT03922945|584176103|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
161764132|NCT03922945|584176104|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
161849594|NCT04642365|584491186|FG007|Overall Study|Progressive Disease|0|||
161849595|NCT04642365|584491179|FG000|Overall Study|Study Terminated By Sponsor|0|||
161849596|NCT04642365|584491180|FG001|Overall Study|Study Terminated By Sponsor|2|||
161849597|NCT04642365|584491181|FG002|Overall Study|Study Terminated By Sponsor|1|||
161849598|NCT04642365|584491182|FG003|Overall Study|Study Terminated By Sponsor|1|||
161849599|NCT04642365|584491183|FG004|Overall Study|Study Terminated By Sponsor|1|||
161849600|NCT04642365|584491184|FG005|Overall Study|Study Terminated By Sponsor|2|||
161849601|NCT04642365|584491185|FG006|Overall Study|Study Terminated By Sponsor|2|||
161849602|NCT04642365|584491186|FG007|Overall Study|Study Terminated By Sponsor|1|||
161849603|NCT04642365|584491179|FG000|Overall Study|Symptomatic Deterioration|1|||
161849604|NCT04642365|584491180|FG001|Overall Study|Symptomatic Deterioration|1|||
161849605|NCT04642365|584491181|FG002|Overall Study|Symptomatic Deterioration|0|||
161849606|NCT04642365|584491182|FG003|Overall Study|Symptomatic Deterioration|0|||
161849607|NCT04642365|584491183|FG004|Overall Study|Symptomatic Deterioration|0|||
161849608|NCT04642365|584491184|FG005|Overall Study|Symptomatic Deterioration|1|||
161849609|NCT04642365|584491185|FG006|Overall Study|Symptomatic Deterioration|0|||
161849610|NCT04642365|584491186|FG007|Overall Study|Symptomatic Deterioration|0|||
161849611|NCT04642365|584491179|FG000|Overall Study|Withdrawal by Subject|0|||
161849612|NCT04642365|584491180|FG001|Overall Study|Withdrawal by Subject|0|||
161849613|NCT04642365|584491181|FG002|Overall Study|Withdrawal by Subject|1|||
161849614|NCT04642365|584491182|FG003|Overall Study|Withdrawal by Subject|1|||
161849615|NCT04642365|584491183|FG004|Overall Study|Withdrawal by Subject|0|||
161849616|NCT04642365|584491184|FG005|Overall Study|Withdrawal by Subject|0|||
161849617|NCT04642365|584491185|FG006|Overall Study|Withdrawal by Subject|2|||
161849618|NCT04642365|584491186|FG007|Overall Study|Withdrawal by Subject|0|||
161849619|NCT04642365|584491179|FG000|Overall Study|Adverse Event|0|||
161849620|NCT04642365|584491180|FG001|Overall Study|Adverse Event|0|||
161849621|NCT04642365|584491181|FG002|Overall Study|Adverse Event|0|||
161849622|NCT04642365|584491182|FG003|Overall Study|Adverse Event|0|||
161849623|NCT04642365|584491183|FG004|Overall Study|Adverse Event|0|||
161849624|NCT04642365|584491184|FG005|Overall Study|Adverse Event|0|||
161849625|NCT04642365|584491185|FG006|Overall Study|Adverse Event|0|||
161849626|NCT04642365|584491186|FG007|Overall Study|Adverse Event|1|||
161849627|NCT01144715|584491187|FG000|Overall Study|Lost to Follow-up|2|||
161849628|NCT01144715|584491188|FG001|Overall Study|Lost to Follow-up|1|||
161849629|NCT01144715|584491187|FG000|Overall Study|Withdrawal by Subject|2|||
161849630|NCT01144715|584491188|FG001|Overall Study|Withdrawal by Subject|1|||
161849631|NCT01144715|584491187|FG000|Overall Study|Adverse Event|0|||
161849632|NCT01144715|584491188|FG001|Overall Study|Adverse Event|1|||
161764133|NCT03922945|584176105|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
161764134|NCT03922945|584176103|FG000|Overall Study|All Other Personal Reasons|1|||
161849633|NCT02728843|584491189|FG000|Overall Study|Adverse Event|0|||
161849634|NCT02728843|584491190|FG001|Overall Study|Adverse Event|2|||
161849635|NCT02728843|584491191|FG002|Overall Study|Adverse Event|3|||
161849636|NCT02728843|584491192|FG003|Overall Study|Adverse Event|1|||
161849637|NCT02728843|584491193|FG004|Overall Study|Adverse Event|2|||
161849638|NCT02728843|584491189|FG000|Overall Study|Lack of Efficacy|0|||
161849639|NCT02728843|584491190|FG001|Overall Study|Lack of Efficacy|1|||
161849640|NCT02728843|584491191|FG002|Overall Study|Lack of Efficacy|1|||
161849641|NCT02728843|584491192|FG003|Overall Study|Lack of Efficacy|0|||
161849642|NCT02728843|584491193|FG004|Overall Study|Lack of Efficacy|0|||
161849643|NCT02728843|584491189|FG000|Overall Study|Protocol Violation|2|||
161849644|NCT02728843|584491190|FG001|Overall Study|Protocol Violation|0|||
161849645|NCT02728843|584491191|FG002|Overall Study|Protocol Violation|4|||
161849646|NCT02728843|584491192|FG003|Overall Study|Protocol Violation|2|||
161849647|NCT02728843|584491193|FG004|Overall Study|Protocol Violation|2|||
161849648|NCT02728843|584491189|FG000|Overall Study|Withdrawal by Subject|1|||
161849649|NCT02728843|584491190|FG001|Overall Study|Withdrawal by Subject|0|||
161849650|NCT02728843|584491191|FG002|Overall Study|Withdrawal by Subject|0|||
161849651|NCT02728843|584491192|FG003|Overall Study|Withdrawal by Subject|1|||
161849652|NCT02728843|584491193|FG004|Overall Study|Withdrawal by Subject|0|||
161849653|NCT02728843|584491189|FG000|Overall Study|Use of rescue medication|0|||
161849654|NCT02728843|584491190|FG001|Overall Study|Use of rescue medication|2|||
161849655|NCT02728843|584491191|FG002|Overall Study|Use of rescue medication|0|||
161849656|NCT02728843|584491192|FG003|Overall Study|Use of rescue medication|2|||
161849657|NCT02728843|584491193|FG004|Overall Study|Use of rescue medication|1|||
161849658|NCT00205803|584491196|FG000|Infant Series|Lost to Follow-up|10|||
161849659|NCT00205803|584491197|FG001|Infant Series|Lost to Follow-up|4|||
161849660|NCT00205803|584491196|FG000|Infant Series|Withdrawal by Subject|2|||
161849661|NCT00205803|584491197|FG001|Infant Series|Withdrawal by Subject|5|||
161849662|NCT00205803|584491196|FG000|Infant Series|Physician Decision|3|||
161849663|NCT00205803|584491197|FG001|Infant Series|Physician Decision|1|||
161849664|NCT00205803|584491196|FG000|Infant Series|Protocol Violation|1|||
161849665|NCT00205803|584491197|FG001|Infant Series|Protocol Violation|0|||
161849666|NCT00205803|584491196|FG000|Infant Series|Lost Kaiser coverage|0|||
161849667|NCT00205803|584491197|FG001|Infant Series|Lost Kaiser coverage|1|||
161849668|NCT00205803|584491196|FG000|Infant Series|Non-compliant|1|||
161849669|NCT00205803|584491197|FG001|Infant Series|Non-compliant|0|||
161849670|NCT00205803|584491196|FG000|Infant Series|Sponsor request|1|||
161849671|NCT00205803|584491197|FG001|Infant Series|Sponsor request|0|||
161849672|NCT00205803|584491196|FG000|After Infant Series|Adverse Event|1|||
161849673|NCT00205803|584491197|FG001|After Infant Series|Adverse Event|1|||
161849674|NCT00205803|584491196|FG000|After Infant Series|Protocol Violation|1|||
161849675|NCT00205803|584491197|FG001|After Infant Series|Protocol Violation|1|||
161849676|NCT00205803|584491196|FG000|After Infant Series|Lost to Follow-up|2|||
161849677|NCT00205803|584491197|FG001|After Infant Series|Lost to Follow-up|1|||
161849678|NCT00205803|584491196|FG000|After Infant Series|Physician Decision|3|||
161849679|NCT00205803|584491197|FG001|After Infant Series|Physician Decision|2|||
161849680|NCT00205803|584491196|FG000|After Infant Series|Withdrawal by Subject|1|||
161849681|NCT00205803|584491197|FG001|After Infant Series|Withdrawal by Subject|4|||
161849682|NCT00205803|584491196|FG000|After Infant Series|Other|10|||
161849683|NCT00205803|584491197|FG001|After Infant Series|Other|4|||
161849684|NCT00205803|584491196|FG000|Toddler Dose|Lost to Follow-up|2|||
161849685|NCT00205803|584491197|FG001|Toddler Dose|Lost to Follow-up|3|||
161849686|NCT00197496|584491201|FG000|Baseline to Discharge|not interested|1|||
161849687|NCT00197496|584491202|FG001|Baseline to Discharge|not interested|0|||
161849688|NCT00197496|584491201|FG000|Baseline to Discharge|MRSA|1|||
161849689|NCT00197496|584491202|FG001|Baseline to Discharge|MRSA|0|||
161849690|NCT00197496|584491201|FG000|Baseline to Discharge|Physician Decision|0|||
161849691|NCT00197496|584491202|FG001|Baseline to Discharge|Physician Decision|1|||
161849692|NCT00197496|584491201|FG000|Baseline to Discharge|Protocol Violation|0|||
161849693|NCT00197496|584491202|FG001|Baseline to Discharge|Protocol Violation|1|||
161849694|NCT00197496|584491201|FG000|Follow-up|Lost to Follow-up|2|||
161849695|NCT00197496|584491202|FG001|Follow-up|Lost to Follow-up|1|||
161849696|NCT00857584|584491205|FG000|Overall Study|Lack of Efficacy|1|||
161849697|NCT00857584|584491206|FG001|Overall Study|Lack of Efficacy|2|||
161849698|NCT00857584|584491205|FG000|Overall Study|Adverse Event|2|||
161849699|NCT00857584|584491206|FG001|Overall Study|Adverse Event|2|||
161849700|NCT00857584|584491205|FG000|Overall Study|Physician Decision|1|||
161849701|NCT00857584|584491206|FG001|Overall Study|Physician Decision|1|||
161849702|NCT02533375|584491207|FG000|Overall Study|Lack of Efficacy|3|||
161849703|NCT02533375|584491207|FG000|Overall Study|Adverse Event|2|||
161849704|NCT00673387|584491208|FG000|Overall Study|Withdrawal by Subject|15|||
161849705|NCT00673387|584491209|FG001|Overall Study|Withdrawal by Subject|16|||
161849706|NCT00673387|584491210|FG002|Overall Study|Withdrawal by Subject|20|||
161849707|NCT00673387|584491211|FG003|Overall Study|Withdrawal by Subject|16|||
161849708|NCT00673387|584491212|FG004|Overall Study|Withdrawal by Subject|18|||
161849709|NCT00673387|584491213|FG005|Overall Study|Withdrawal by Subject|21|||
161849710|NCT00673387|584491214|FG006|Overall Study|Withdrawal by Subject|15|||
161849711|NCT00673387|584491215|FG007|Overall Study|Withdrawal by Subject|21|||
161849712|NCT00673387|584491208|FG000|Overall Study|Adverse Event|3|||
161849713|NCT00673387|584491209|FG001|Overall Study|Adverse Event|1|||
161849714|NCT00673387|584491210|FG002|Overall Study|Adverse Event|5|||
161849715|NCT00673387|584491211|FG003|Overall Study|Adverse Event|2|||
161849716|NCT00673387|584491212|FG004|Overall Study|Adverse Event|6|||
161849717|NCT00673387|584491213|FG005|Overall Study|Adverse Event|2|||
161849718|NCT00673387|584491214|FG006|Overall Study|Adverse Event|5|||
161849719|NCT00673387|584491215|FG007|Overall Study|Adverse Event|5|||
161849720|NCT00673387|584491208|FG000|Overall Study|Physician Decision|0|||
161849721|NCT00673387|584491209|FG001|Overall Study|Physician Decision|0|||
161849722|NCT00673387|584491210|FG002|Overall Study|Physician Decision|0|||
161849723|NCT00673387|584491211|FG003|Overall Study|Physician Decision|0|||
161849724|NCT00673387|584491212|FG004|Overall Study|Physician Decision|0|||
161849725|NCT00673387|584491213|FG005|Overall Study|Physician Decision|5|||
161849726|NCT00673387|584491214|FG006|Overall Study|Physician Decision|1|||
161764135|NCT03922945|584176104|FG001|Overall Study|All Other Personal Reasons|1|||
161764136|NCT03922945|584176105|FG002|Overall Study|All Other Personal Reasons|2|||
161849727|NCT00673387|584491215|FG007|Overall Study|Physician Decision|1|||
161849728|NCT00673387|584491208|FG000|Overall Study|Protocol Violation|3|||
161849729|NCT00673387|584491209|FG001|Overall Study|Protocol Violation|0|||
161849730|NCT00673387|584491210|FG002|Overall Study|Protocol Violation|1|||
161849731|NCT00673387|584491211|FG003|Overall Study|Protocol Violation|2|||
161849732|NCT00673387|584491212|FG004|Overall Study|Protocol Violation|0|||
161849733|NCT00673387|584491213|FG005|Overall Study|Protocol Violation|1|||
161849734|NCT00673387|584491214|FG006|Overall Study|Protocol Violation|1|||
161849735|NCT00673387|584491215|FG007|Overall Study|Protocol Violation|3|||
161849736|NCT00673387|584491208|FG000|Overall Study|Lost to Follow-up|8|||
161849737|NCT00673387|584491209|FG001|Overall Study|Lost to Follow-up|6|||
161849738|NCT00673387|584491210|FG002|Overall Study|Lost to Follow-up|5|||
161849739|NCT00673387|584491211|FG003|Overall Study|Lost to Follow-up|6|||
161849740|NCT00673387|584491212|FG004|Overall Study|Lost to Follow-up|6|||
161849741|NCT00673387|584491213|FG005|Overall Study|Lost to Follow-up|5|||
161849742|NCT00673387|584491214|FG006|Overall Study|Lost to Follow-up|8|||
161849743|NCT00673387|584491215|FG007|Overall Study|Lost to Follow-up|5|||
161849744|NCT00960115|584491216|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
161849745|NCT00960115|584491217|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
161849746|NCT01102374|584491218|FG000|Overall Study|Death|9|||
161849747|NCT01102374|584491219|FG001|Overall Study|Death|13|||
161849748|NCT01102374|584491218|FG000|Overall Study|Lost to Follow-up|7|||
161849749|NCT01102374|584491219|FG001|Overall Study|Lost to Follow-up|6|||
161849750|NCT02952898|584491220|FG000|Overall Study|Withdrawal by Subject|10|||
161849751|NCT02952898|584491221|FG001|Overall Study|Withdrawal by Subject|8|||
161849752|NCT02952898|584491222|FG002|Overall Study|Withdrawal by Subject|8|||
161849753|NCT02952898|584491220|FG000|Overall Study|Adverse Event|8|||
161849754|NCT02952898|584491221|FG001|Overall Study|Adverse Event|8|||
161849755|NCT02952898|584491222|FG002|Overall Study|Adverse Event|3|||
161849756|NCT02952898|584491220|FG000|Overall Study|Lost to Follow-up|3|||
161849757|NCT02952898|584491221|FG001|Overall Study|Lost to Follow-up|2|||
161849758|NCT02952898|584491222|FG002|Overall Study|Lost to Follow-up|2|||
161849759|NCT02952898|584491220|FG000|Overall Study|Non-compliance with study drug|1|||
161849760|NCT02952898|584491221|FG001|Overall Study|Non-compliance with study drug|1|||
161849761|NCT02952898|584491222|FG002|Overall Study|Non-compliance with study drug|2|||
161849762|NCT00477633|584491223|FG000|Overall Study|Did not receive treatment|23|||
161849763|NCT00477633|584491223|FG000|Overall Study|Adverse Event|143|||
161849764|NCT00477633|584491223|FG000|Overall Study|Pregnancy|23|||
161849765|NCT00477633|584491223|FG000|Overall Study|Lost to Follow-up|271|||
161849766|NCT00477633|584491223|FG000|Overall Study|Withdrawal by Subject|149|||
161849767|NCT00477633|584491223|FG000|Overall Study|Protocol Violation|25|||
161849768|NCT00477633|584491223|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
161849769|NCT02968849|584491224|FG000|Overall Study|Death|8|||
161849770|NCT02968849|584491225|FG001|Overall Study|Death|10|||
161849771|NCT02968849|584491224|FG000|Overall Study|Lost to Follow-up|31|||
161849772|NCT02968849|584491225|FG001|Overall Study|Lost to Follow-up|29|||
161849773|NCT02968849|584491224|FG000|Overall Study|Withdrawal by Subject|73|||
161849774|NCT02968849|584491225|FG001|Overall Study|Withdrawal by Subject|64|||
161849775|NCT02968849|584491224|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
161849776|NCT02968849|584491225|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
161849777|NCT02968849|584491224|FG000|Overall Study|Physician Decision|6|||
161849778|NCT02968849|584491225|FG001|Overall Study|Physician Decision|9|||
161849779|NCT02968849|584491224|FG000|Overall Study|Other|16|||
161849780|NCT02968849|584491225|FG001|Overall Study|Other|10|||
161849781|NCT02203331|584491228|FG000|Overall Study|Pregnancy|1|||
161849782|NCT02203331|584491229|FG001|Overall Study|Pregnancy|0|||
161849783|NCT02203331|584491230|FG002|Overall Study|Pregnancy|0|||
161849784|NCT02203331|584491231|FG003|Overall Study|Pregnancy|0|||
161849785|NCT02203331|584491232|FG004|Overall Study|Pregnancy|2|||
161849786|NCT02203331|584491233|FG005|Overall Study|Pregnancy|0|||
161849787|NCT02203331|584491228|FG000|Overall Study|Withdrawal by Subject|1|||
161849788|NCT02203331|584491229|FG001|Overall Study|Withdrawal by Subject|0|||
161849789|NCT02203331|584491230|FG002|Overall Study|Withdrawal by Subject|1|||
161849790|NCT02203331|584491231|FG003|Overall Study|Withdrawal by Subject|0|||
161849791|NCT02203331|584491232|FG004|Overall Study|Withdrawal by Subject|0|||
161849792|NCT02203331|584491233|FG005|Overall Study|Withdrawal by Subject|3|||
161849793|NCT02203331|584491228|FG000|Overall Study|Adverse Event|4|||
161849794|NCT02203331|584491229|FG001|Overall Study|Adverse Event|8|||
161849795|NCT02203331|584491230|FG002|Overall Study|Adverse Event|3|||
161849796|NCT02203331|584491231|FG003|Overall Study|Adverse Event|4|||
161849797|NCT02203331|584491232|FG004|Overall Study|Adverse Event|3|||
161849798|NCT02203331|584491233|FG005|Overall Study|Adverse Event|3|||
161849799|NCT02203331|584491228|FG000|Overall Study|Other Reasons|1|||
161849800|NCT02203331|584491229|FG001|Overall Study|Other Reasons|2|||
161849801|NCT02203331|584491230|FG002|Overall Study|Other Reasons|0|||
161849802|NCT02203331|584491231|FG003|Overall Study|Other Reasons|2|||
161849803|NCT02203331|584491232|FG004|Overall Study|Other Reasons|0|||
161849804|NCT02203331|584491233|FG005|Overall Study|Other Reasons|0|||
161849805|NCT02203331|584491228|FG000|Overall Study|Lack of Efficacy|0|||
161849806|NCT02203331|584491229|FG001|Overall Study|Lack of Efficacy|2|||
161849807|NCT02203331|584491230|FG002|Overall Study|Lack of Efficacy|1|||
161849808|NCT02203331|584491231|FG003|Overall Study|Lack of Efficacy|0|||
161849809|NCT02203331|584491232|FG004|Overall Study|Lack of Efficacy|0|||
161849810|NCT02203331|584491233|FG005|Overall Study|Lack of Efficacy|1|||
161849811|NCT02203331|584491228|FG000|Overall Study|Protocol Violation|0|||
161849812|NCT02203331|584491229|FG001|Overall Study|Protocol Violation|2|||
161849813|NCT02203331|584491230|FG002|Overall Study|Protocol Violation|0|||
161849814|NCT02203331|584491231|FG003|Overall Study|Protocol Violation|1|||
161849815|NCT02203331|584491232|FG004|Overall Study|Protocol Violation|1|||
161849816|NCT02203331|584491233|FG005|Overall Study|Protocol Violation|0|||
161849817|NCT02203331|584491228|FG000|Overall Study|Lost to Follow-up|0|||
161849818|NCT02203331|584491229|FG001|Overall Study|Lost to Follow-up|0|||
161849819|NCT02203331|584491230|FG002|Overall Study|Lost to Follow-up|0|||
161849820|NCT02203331|584491231|FG003|Overall Study|Lost to Follow-up|0|||
161849821|NCT02203331|584491232|FG004|Overall Study|Lost to Follow-up|1|||
161849822|NCT02203331|584491233|FG005|Overall Study|Lost to Follow-up|0|||
161849823|NCT02542605|584491234|FG000|Part B: Challenge Phase|Sponsor decision|1|||
161849824|NCT02542605|584491235|FG001|Part B: Challenge Phase|Sponsor decision|0|||
161849825|NCT02542605|584491236|FG002|Part B: Challenge Phase|Sponsor decision|0|||
161849826|NCT02542605|584491234|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
161849827|NCT02542605|584491235|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
161849828|NCT02542605|584491236|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
161849829|NCT00278889|584491237|FG000|Overall Study|Withdrawal by Subject|0|||
161849830|NCT00278889|584491238|FG001|Overall Study|Withdrawal by Subject|5|||
161849831|NCT00278889|584491239|FG002|Overall Study|Withdrawal by Subject|3|||
161849832|NCT00278889|584491237|FG000|Overall Study|Lost to Follow-up|1|||
161849833|NCT00278889|584491238|FG001|Overall Study|Lost to Follow-up|1|||
161849834|NCT00278889|584491239|FG002|Overall Study|Lost to Follow-up|0|||
161849835|NCT00278889|584491237|FG000|Overall Study|Death|24|||
161849836|NCT00278889|584491238|FG001|Overall Study|Death|21|||
161849837|NCT00278889|584491239|FG002|Overall Study|Death|17|||
161849838|NCT00704730|584491240|FG000|Overall Study|Adverse Event|35|||
161849839|NCT00704730|584491241|FG001|Overall Study|Adverse Event|9|||
161849840|NCT00704730|584491240|FG000|Overall Study|Death|11|||
161849841|NCT00704730|584491241|FG001|Overall Study|Death|5|||
161849842|NCT00704730|584491240|FG000|Overall Study|Physician Decision|2|||
161849843|NCT00704730|584491241|FG001|Overall Study|Physician Decision|0|||
161849844|NCT00704730|584491240|FG000|Overall Study|Did not receive drug|5|||
161849845|NCT00704730|584491241|FG001|Overall Study|Did not receive drug|2|||
161849846|NCT00704730|584491240|FG000|Overall Study|Disease progression per PI|58|||
161849847|NCT00704730|584491241|FG001|Overall Study|Disease progression per PI|67|||
161849848|NCT00704730|584491240|FG000|Overall Study|data unavailable|1|||
161849849|NCT00704730|584491241|FG001|Overall Study|data unavailable|0|||
161849850|NCT00704730|584491240|FG000|Overall Study|Withdrawal by Subject|9|||
161849851|NCT00704730|584491241|FG001|Overall Study|Withdrawal by Subject|13|||
161849852|NCT05833139|584492766|FG000|Study Period 2|Adverse Event|1|||
161849853|NCT03996447|584492769|FG000|First MRI Examination|Adverse Event|2|||
161849854|NCT03996447|584492770|FG001|First MRI Examination|Adverse Event|0|||
161849855|NCT03996447|584492769|FG000|First MRI Examination|Withdrawal by Subject|1|||
161849856|NCT03996447|584492770|FG001|First MRI Examination|Withdrawal by Subject|2|||
161849857|NCT03996447|584492769|FG000|First MRI Examination|Protocol Violation|0|||
161849858|NCT03996447|584492770|FG001|First MRI Examination|Protocol Violation|1|||
161849859|NCT03996447|584492769|FG000|Washout|Adverse Event|2|||
161849860|NCT03996447|584492770|FG001|Washout|Adverse Event|0|||
161849861|NCT03996447|584492769|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
161849862|NCT03996447|584492770|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
161849863|NCT03996447|584492769|FG000|Washout|Withdrawal by Subject|0|||
161849864|NCT03996447|584492770|FG001|Washout|Withdrawal by Subject|1|||
161849865|NCT03996447|584492769|FG000|Washout|Other reason|1|||
161849866|NCT03996447|584492770|FG001|Washout|Other reason|1|||
161849867|NCT00369486|584492772|FG000|4-Week Visit|Missed visit|2|||
161849868|NCT00369486|584492773|FG001|4-Week Visit|Missed visit|2|||
161849869|NCT00369486|584492774|FG002|4-Week Visit|Missed visit|0|||
161849870|NCT00369486|584492775|FG003|4-Week Visit|Missed visit|2|||
161849871|NCT00369486|584492776|FG004|4-Week Visit|Missed visit|1|||
161764137|NCT00313716|584176106|FG000|Overall Study|Death|3|||
161764138|NCT00313716|584176107|FG001|Overall Study|Death|2|||
161764139|NCT00313716|584176108|FG002|Overall Study|Death|9|||
161764140|NCT00313716|584176109|FG003|Overall Study|Death|3|||
161764141|NCT00313716|584176110|FG004|Overall Study|Death|5|||
161764142|NCT00313716|584176111|FG005|Overall Study|Death|9|||
161764143|NCT00313716|584176106|FG000|Overall Study|Lost to Follow-up|2|||
161764144|NCT00313716|584176107|FG001|Overall Study|Lost to Follow-up|5|||
161764145|NCT00313716|584176108|FG002|Overall Study|Lost to Follow-up|2|||
161764146|NCT00313716|584176109|FG003|Overall Study|Lost to Follow-up|1|||
161764147|NCT00313716|584176110|FG004|Overall Study|Lost to Follow-up|0|||
161764148|NCT00313716|584176111|FG005|Overall Study|Lost to Follow-up|4|||
161764149|NCT00313716|584176106|FG000|Overall Study|Withdrawal by Subject|0|||
161764150|NCT00313716|584176107|FG001|Overall Study|Withdrawal by Subject|1|||
161764151|NCT00313716|584176108|FG002|Overall Study|Withdrawal by Subject|1|||
161764152|NCT00313716|584176109|FG003|Overall Study|Withdrawal by Subject|0|||
161764153|NCT00313716|584176110|FG004|Overall Study|Withdrawal by Subject|1|||
161764154|NCT00313716|584176111|FG005|Overall Study|Withdrawal by Subject|0|||
161764155|NCT01603615|584176124|FG000|Overall Study|Did not Receive Treatment|7|||
161764156|NCT01603615|584176124|FG000|Overall Study|Lost to Follow-up|9|||
161764157|NCT01603615|584176124|FG000|Overall Study|Personal Reasons|17|||
161764158|NCT01603615|584176124|FG000|Overall Study|Other Miscellaneous|1|||
161764159|NCT03490734|584176139|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
161764160|NCT03490734|584176140|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
161764161|NCT03490734|584176141|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
161764162|NCT03490734|584176142|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
161764163|NCT03490734|584176139|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161764164|NCT03490734|584176140|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161764165|NCT03490734|584176141|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161764166|NCT03490734|584176142|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
161764167|NCT03490734|584176139|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161764168|NCT03490734|584176140|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161764169|NCT03490734|584176141|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161764170|NCT03490734|584176142|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
161764171|NCT03490734|584176139|FG000|Post-intervention Scan Visit|Adverse Event|2|||
161764172|NCT03490734|584176140|FG001|Post-intervention Scan Visit|Adverse Event|0|||
161764173|NCT03490734|584176141|FG002|Post-intervention Scan Visit|Adverse Event|0|||
161764174|NCT03490734|584176142|FG003|Post-intervention Scan Visit|Adverse Event|0|||
161764175|NCT03490734|584176139|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
161764176|NCT03490734|584176140|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
161764177|NCT03490734|584176141|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
161764178|NCT03490734|584176142|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
161764179|NCT03490734|584176139|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
161764180|NCT03490734|584176140|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
161764181|NCT03490734|584176141|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
161764182|NCT03490734|584176142|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
161764183|NCT04491591|584176148|FG000|Overall Study|Accidently randomized|3|||
161764184|NCT04491591|584176149|FG001|Overall Study|Accidently randomized|1|||
161764185|NCT04491591|584176150|FG002|Overall Study|Accidently randomized|0|||
161764186|NCT04491591|584176148|FG000|Overall Study|Did not complete survey|28|||
161764187|NCT04491591|584176149|FG001|Overall Study|Did not complete survey|20|||
161764188|NCT04491591|584176150|FG002|Overall Study|Did not complete survey|3|||
161764189|NCT04212221|584176153|FG000|Overall Study|Remained on Treatment|0|||
161764190|NCT04212221|584176154|FG001|Overall Study|Remained on Treatment|0|||
161764191|NCT04212221|584176155|FG002|Overall Study|Remained on Treatment|0|||
161764192|NCT04212221|584176156|FG003|Overall Study|Remained on Treatment|1|||
161764193|NCT04212221|584176157|FG004|Overall Study|Remained on Treatment|0|||
161764194|NCT04212221|584176158|FG005|Overall Study|Remained on Treatment|0|||
161764195|NCT04212221|584176159|FG006|Overall Study|Remained on Treatment|3|||
161764196|NCT04212221|584176160|FG007|Overall Study|Remained on Treatment|9|||
161764197|NCT04212221|584176153|FG000|Overall Study|Adverse Event|0|||
161764198|NCT04212221|584176154|FG001|Overall Study|Adverse Event|0|||
161764199|NCT04212221|584176155|FG002|Overall Study|Adverse Event|0|||
161764200|NCT04212221|584176156|FG003|Overall Study|Adverse Event|0|||
161764201|NCT04212221|584176157|FG004|Overall Study|Adverse Event|0|||
161764202|NCT04212221|584176158|FG005|Overall Study|Adverse Event|0|||
161764203|NCT04212221|584176159|FG006|Overall Study|Adverse Event|2|||
161764204|NCT04212221|584176160|FG007|Overall Study|Adverse Event|3|||
161764205|NCT04212221|584176153|FG000|Overall Study|Death|0|||
161764206|NCT04212221|584176154|FG001|Overall Study|Death|0|||
161764207|NCT04212221|584176155|FG002|Overall Study|Death|0|||
161764208|NCT04212221|584176156|FG003|Overall Study|Death|0|||
161764209|NCT04212221|584176157|FG004|Overall Study|Death|0|||
161764210|NCT04212221|584176158|FG005|Overall Study|Death|0|||
161764211|NCT04212221|584176159|FG006|Overall Study|Death|0|||
161764212|NCT04212221|584176160|FG007|Overall Study|Death|2|||
161764213|NCT04212221|584176153|FG000|Overall Study|Disease progression according to irRECIST|1|||
161764214|NCT04212221|584176154|FG001|Overall Study|Disease progression according to irRECIST|2|||
161764215|NCT04212221|584176155|FG002|Overall Study|Disease progression according to irRECIST|3|||
161764216|NCT04212221|584176156|FG003|Overall Study|Disease progression according to irRECIST|3|||
161764217|NCT04212221|584176157|FG004|Overall Study|Disease progression according to irRECIST|2|||
161764218|NCT04212221|584176158|FG005|Overall Study|Disease progression according to irRECIST|2|||
161764219|NCT04212221|584176159|FG006|Overall Study|Disease progression according to irRECIST|21|||
161764220|NCT04212221|584176160|FG007|Overall Study|Disease progression according to irRECIST|17|||
161764221|NCT04212221|584176153|FG000|Overall Study|Global Deterioration of Health Status|0|||
161764222|NCT04212221|584176154|FG001|Overall Study|Global Deterioration of Health Status|0|||
161849872|NCT00369486|584492772|FG000|4-Week Visit|Dropped|0|||
161849873|NCT00369486|584492773|FG001|4-Week Visit|Dropped|0|||
161849874|NCT00369486|584492774|FG002|4-Week Visit|Dropped|1|||
161849875|NCT00369486|584492775|FG003|4-Week Visit|Dropped|0|||
161849876|NCT00369486|584492776|FG004|4-Week Visit|Dropped|0|||
161849877|NCT00369486|584492772|FG000|8-Week Visit|Missed visit|0|||
161849878|NCT00369486|584492773|FG001|8-Week Visit|Missed visit|1|||
161849879|NCT00369486|584492774|FG002|8-Week Visit|Missed visit|0|||
161849880|NCT00369486|584492775|FG003|8-Week Visit|Missed visit|0|||
161849881|NCT00369486|584492776|FG004|8-Week Visit|Missed visit|1|||
161849882|NCT00369486|584492772|FG000|8-Week Visit|Dropped|0|||
161849883|NCT00369486|584492773|FG001|8-Week Visit|Dropped|0|||
161849884|NCT00369486|584492774|FG002|8-Week Visit|Dropped|0|||
161849885|NCT00369486|584492775|FG003|8-Week Visit|Dropped|1|||
161764223|NCT04212221|584176155|FG002|Overall Study|Global Deterioration of Health Status|0|||
161764224|NCT04212221|584176156|FG003|Overall Study|Global Deterioration of Health Status|0|||
161764225|NCT04212221|584176157|FG004|Overall Study|Global Deterioration of Health Status|0|||
161764226|NCT04212221|584176158|FG005|Overall Study|Global Deterioration of Health Status|0|||
161849886|NCT00369486|584492776|FG004|8-Week Visit|Dropped|0|||
161849887|NCT00369486|584492772|FG000|17-Week Visit|Missed visit|0|||
161849888|NCT00369486|584492773|FG001|17-Week Visit|Missed visit|0|||
161849889|NCT00369486|584492774|FG002|17-Week Visit|Missed visit|1|||
161849890|NCT00369486|584492775|FG003|17-Week Visit|Missed visit|1|||
161849891|NCT00369486|584492776|FG004|17-Week Visit|Missed visit|1|||
161849892|NCT00369486|584492772|FG000|34-Week Visit|Dropped|0|||
161764227|NCT04212221|584176159|FG006|Overall Study|Global Deterioration of Health Status|0|||
161764228|NCT04212221|584176160|FG007|Overall Study|Global Deterioration of Health Status|2|||
161764229|NCT04212221|584176153|FG000|Overall Study|Investigator's Decision|0|||
161764230|NCT04212221|584176154|FG001|Overall Study|Investigator's Decision|0|||
161764231|NCT04212221|584176155|FG002|Overall Study|Investigator's Decision|0|||
161764232|NCT04212221|584176156|FG003|Overall Study|Investigator's Decision|1|||
161764233|NCT04212221|584176157|FG004|Overall Study|Investigator's Decision|0|||
161764234|NCT04212221|584176158|FG005|Overall Study|Investigator's Decision|0|||
161764235|NCT04212221|584176159|FG006|Overall Study|Investigator's Decision|3|||
161764236|NCT04212221|584176160|FG007|Overall Study|Investigator's Decision|0|||
161764237|NCT04212221|584176153|FG000|Overall Study|Participant refused to continue treatment|0|||
161764238|NCT04212221|584176154|FG001|Overall Study|Participant refused to continue treatment|1|||
161764239|NCT04212221|584176155|FG002|Overall Study|Participant refused to continue treatment|0|||
161764240|NCT04212221|584176156|FG003|Overall Study|Participant refused to continue treatment|1|||
161764241|NCT04212221|584176157|FG004|Overall Study|Participant refused to continue treatment|1|||
161764242|NCT04212221|584176158|FG005|Overall Study|Participant refused to continue treatment|2|||
161764243|NCT04212221|584176159|FG006|Overall Study|Participant refused to continue treatment|4|||
161764244|NCT04212221|584176160|FG007|Overall Study|Participant refused to continue treatment|2|||
161764245|NCT04212221|584176153|FG000|Overall Study|Protocol Violation|0|||
161764246|NCT04212221|584176154|FG001|Overall Study|Protocol Violation|0|||
161764247|NCT04212221|584176155|FG002|Overall Study|Protocol Violation|0|||
161764248|NCT04212221|584176156|FG003|Overall Study|Protocol Violation|0|||
161764249|NCT04212221|584176157|FG004|Overall Study|Protocol Violation|0|||
161764250|NCT04212221|584176158|FG005|Overall Study|Protocol Violation|0|||
161849893|NCT00369486|584492773|FG001|34-Week Visit|Dropped|1|||
161849894|NCT00369486|584492774|FG002|34-Week Visit|Dropped|1|||
161849895|NCT00369486|584492775|FG003|34-Week Visit|Dropped|3|||
161849896|NCT00369486|584492776|FG004|34-Week Visit|Dropped|3|||
161849897|NCT01810302|584492783|FG000|Overall Study|Death|1|||
161849898|NCT01810302|584492784|FG001|Overall Study|Death|0|||
161849899|NCT01810302|584492783|FG000|Overall Study|Physician Decision|0|||
161849900|NCT01810302|584492784|FG001|Overall Study|Physician Decision|1|||
161849901|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1|24|||
161849902|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1|0|||
161849903|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
161849904|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
161849905|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849906|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849907|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
161849908|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
161849909|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
161849910|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
161849911|NCT03888066|584492785|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849912|NCT03888066|584492786|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849913|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849914|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849915|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
161849916|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
161849917|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849918|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849919|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
161849920|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849921|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #2|5|||
161849922|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #2|0|||
161849923|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
161849924|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
161849925|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
161849926|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
161849927|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
161849928|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
161849929|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3|11|||
161849930|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3|0|||
161849931|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
161849932|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
161849933|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
161849934|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849935|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849936|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849937|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4|3|||
161849938|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4|0|||
161849939|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
161849940|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
161849941|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
161849942|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
161849943|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
161849944|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849945|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
161849946|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
161849947|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
161849948|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849949|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
161849950|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849951|NCT03888066|584492785|FG000|Run-in Phase|AE (Adverse Event)|17|||
161849952|NCT03888066|584492786|FG001|Run-in Phase|AE (Adverse Event)|0|||
161849953|NCT03888066|584492785|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
161849954|NCT03888066|584492786|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
161849955|NCT03888066|584492785|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849956|NCT03888066|584492786|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849957|NCT03888066|584492785|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849958|NCT03888066|584492786|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849959|NCT03888066|584492785|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
161849960|NCT03888066|584492786|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849961|NCT03888066|584492785|FG000|Run-in Phase|Withdrawal by Subject|43|||
161849962|NCT03888066|584492786|FG001|Run-in Phase|Withdrawal by Subject|0|||
161849963|NCT03888066|584492785|FG000|Run-in Phase|AE; Physician Decision|1|||
161849964|NCT03888066|584492786|FG001|Run-in Phase|AE; Physician Decision|0|||
161849965|NCT03888066|584492785|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
161849966|NCT03888066|584492786|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849967|NCT03888066|584492785|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
161849968|NCT03888066|584492786|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
161849969|NCT03888066|584492785|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
161849970|NCT03888066|584492786|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849971|NCT03888066|584492785|FG000|Run-in Phase|Death|1|||
161849972|NCT03888066|584492786|FG001|Run-in Phase|Death|0|||
161849973|NCT03888066|584492785|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
161849974|NCT03888066|584492786|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
161849975|NCT03888066|584492785|FG000|Run-in Phase|Physician Decision|1|||
161849976|NCT03888066|584492786|FG001|Run-in Phase|Physician Decision|0|||
161849977|NCT03888066|584492785|FG000|Run-in Phase|Protocol Violation|13|||
161849978|NCT03888066|584492786|FG001|Run-in Phase|Protocol Violation|0|||
161849979|NCT03888066|584492785|FG000|Run-in Phase|Sponsor Request|34|||
161849980|NCT03888066|584492786|FG001|Run-in Phase|Sponsor Request|0|||
161849981|NCT03888066|584492785|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
161849982|NCT03888066|584492786|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
161849983|NCT03888066|584492785|FG000|Run-in Phase|Withdrawal Of Consent|1|||
161849984|NCT03888066|584492786|FG001|Run-in Phase|Withdrawal Of Consent|0|||
161849985|NCT03888066|584492785|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
161849986|NCT03888066|584492786|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
161849987|NCT03888066|584492785|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
161849988|NCT03888066|584492786|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
161849989|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
161849990|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
161849991|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
161849992|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
161849993|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
161849994|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
161849995|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
161849996|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
161849997|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
161849998|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
161849999|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
161850000|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
161850001|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
161850002|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
161850003|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
161850004|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
161850005|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
161850006|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
161850007|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
161850008|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
161850009|NCT03278626|584492787|FG000|Overall Study|Death|2|||
161850010|NCT03278626|584492787|FG000|Overall Study|Toxicity|1|||
161850011|NCT03278626|584492787|FG000|Overall Study|Disease Progression|2|||
161850012|NCT02856555|584492788|FG000|Overall Study|Adverse Event|1|||
161850013|NCT02856555|584492789|FG001|Overall Study|Adverse Event|0|||
161850014|NCT02856555|584492790|FG002|Overall Study|Adverse Event|0|||
161850015|NCT02856555|584492788|FG000|Overall Study|Lost to Follow-up|1|||
161850016|NCT02856555|584492789|FG001|Overall Study|Lost to Follow-up|3|||
161850017|NCT02856555|584492790|FG002|Overall Study|Lost to Follow-up|0|||
161850018|NCT02856555|584492788|FG000|Overall Study|Withdrawal by Subject|3|||
161850019|NCT02856555|584492789|FG001|Overall Study|Withdrawal by Subject|0|||
161850020|NCT02856555|584492790|FG002|Overall Study|Withdrawal by Subject|0|||
161850021|NCT02856555|584492788|FG000|Overall Study|Randomized but Never Treated|0|||
161850022|NCT02856555|584492789|FG001|Overall Study|Randomized but Never Treated|1|||
161850023|NCT02856555|584492790|FG002|Overall Study|Randomized but Never Treated|0|||
161850024|NCT03333941|584492791|FG000|Overall Study|Lost to Follow-up|10|||
161850025|NCT03333941|584492791|FG000|Overall Study|Death|2|||
161850026|NCT03333941|584492791|FG000|Overall Study|Adverse Event|1|||
161850027|NCT02077140|584492792|FG000|Overall Study|Lost to Follow-up|4|||
161850028|NCT02077140|584492793|FG001|Overall Study|Lost to Follow-up|1|||
161850029|NCT02077140|584492794|FG002|Overall Study|Lost to Follow-up|2|||
161850030|NCT02077140|584492795|FG003|Overall Study|Lost to Follow-up|2|||
161850031|NCT02077140|584492796|FG004|Overall Study|Lost to Follow-up|3|||
161850032|NCT02077140|584492792|FG000|Overall Study|Withdrawal by Subject|0|||
161850033|NCT02077140|584492793|FG001|Overall Study|Withdrawal by Subject|1|||
161850034|NCT02077140|584492794|FG002|Overall Study|Withdrawal by Subject|0|||
161850035|NCT02077140|584492795|FG003|Overall Study|Withdrawal by Subject|2|||
161850036|NCT02077140|584492796|FG004|Overall Study|Withdrawal by Subject|2|||
161850037|NCT00974922|584492797|FG000|Overall Study|study terminated|24|||
161850038|NCT00287586|584492798|FG000|Overall Study|Withdrew Consent|19|||
161850039|NCT00287586|584492799|FG001|Overall Study|Withdrew Consent|30|||
161850040|NCT00287586|584492798|FG000|Overall Study|Lost to Follow-up|5|||
161850041|NCT00287586|584492799|FG001|Overall Study|Lost to Follow-up|4|||
161850042|NCT00287586|584492798|FG000|Overall Study|Death|2|||
161850043|NCT00287586|584492799|FG001|Overall Study|Death|3|||
161850044|NCT00287586|584492798|FG000|Overall Study|Elevated Hematocrit|3|||
161850045|NCT00287586|584492799|FG001|Overall Study|Elevated Hematocrit|0|||
161850046|NCT00287586|584492798|FG000|Overall Study|Rash|3|||
161850047|NCT00287586|584492799|FG001|Overall Study|Rash|0|||
161850048|NCT00287586|584492798|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
161850049|NCT00287586|584492799|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
161850050|NCT00287586|584492798|FG000|Overall Study|Stroke|2|||
161850051|NCT00287586|584492799|FG001|Overall Study|Stroke|0|||
161850052|NCT00287586|584492798|FG000|Overall Study|Myocardial Infarction|1|||
161850053|NCT00287586|584492799|FG001|Overall Study|Myocardial Infarction|0|||
161850054|NCT00287586|584492798|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
161850055|NCT00287586|584492799|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
161850056|NCT00287586|584492798|FG000|Overall Study|Cognitive Impairment|1|||
161850057|NCT00287586|584492799|FG001|Overall Study|Cognitive Impairment|0|||
161850058|NCT00287586|584492798|FG000|Overall Study|Pancreatic Cancer|1|||
161850059|NCT00287586|584492799|FG001|Overall Study|Pancreatic Cancer|3|||
161850060|NCT00287586|584492798|FG000|Overall Study|Sleep Apnea|1|||
161850061|NCT00287586|584492799|FG001|Overall Study|Sleep Apnea|0|||
161850062|NCT00287586|584492798|FG000|Overall Study|Shoulder Pain|1|||
161850063|NCT00287586|584492799|FG001|Overall Study|Shoulder Pain|0|||
161850064|NCT00287586|584492798|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
161850065|NCT00287586|584492799|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
161850066|NCT00287586|584492798|FG000|Overall Study|Nonadherence|1|||
161850067|NCT00287586|584492799|FG001|Overall Study|Nonadherence|1|||
161850068|NCT00287586|584492798|FG000|Overall Study|Enrolled in Another Study|1|||
161850069|NCT00287586|584492799|FG001|Overall Study|Enrolled in Another Study|0|||
161850070|NCT00287586|584492798|FG000|Overall Study|Major Depression|0|||
161850071|NCT00287586|584492799|FG001|Overall Study|Major Depression|2|||
161850072|NCT00287586|584492798|FG000|Overall Study|Lung Cancer|0|||
161850073|NCT00287586|584492799|FG001|Overall Study|Lung Cancer|2|||
161850074|NCT00287586|584492798|FG000|Overall Study|Elevated IPSS Score|0|||
161850075|NCT00287586|584492799|FG001|Overall Study|Elevated IPSS Score|1|||
161850076|NCT00287586|584492798|FG000|Overall Study|Retroperitoneal Cancer|0|||
161850077|NCT00287586|584492799|FG001|Overall Study|Retroperitoneal Cancer|1|||
161850078|NCT00287586|584492798|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
161850079|NCT00287586|584492799|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
161850080|NCT00287586|584492798|FG000|Overall Study|Mood Swings and Irritability|0|||
161850081|NCT00287586|584492799|FG001|Overall Study|Mood Swings and Irritability|1|||
161850082|NCT00287586|584492798|FG000|Overall Study|Bradycardia|0|||
161850083|NCT00287586|584492799|FG001|Overall Study|Bradycardia|1|||
161850084|NCT00287586|584492798|FG000|Overall Study|Itchy Swollen Eyes|0|||
161850085|NCT00287586|584492799|FG001|Overall Study|Itchy Swollen Eyes|1|||
161850086|NCT00287586|584492798|FG000|Overall Study|Recurrent Melanoma|0|||
161850087|NCT00287586|584492799|FG001|Overall Study|Recurrent Melanoma|1|||
161850088|NCT01762800|584492801|FG000|Overall Study|Adverse Event|8|||
161850089|NCT01762800|584492802|FG001|Overall Study|Adverse Event|13|||
161850090|NCT01762800|584492801|FG000|Overall Study|Lack of Efficacy|3|||
161850091|NCT01762800|584492802|FG001|Overall Study|Lack of Efficacy|2|||
161850092|NCT01762800|584492801|FG000|Overall Study|Study Closed/Terminated|0|||
161850093|NCT01762800|584492802|FG001|Overall Study|Study Closed/Terminated|1|||
161850094|NCT01762800|584492801|FG000|Overall Study|Physician Decision|1|||
161850095|NCT01762800|584492802|FG001|Overall Study|Physician Decision|1|||
161850096|NCT01762800|584492801|FG000|Overall Study|Withdrawal by Subject|7|||
161850097|NCT01762800|584492802|FG001|Overall Study|Withdrawal by Subject|4|||
161850098|NCT02640482|584492803|FG000|Overall Study|Lost to Follow-up|3|||
161850099|NCT02640482|584492804|FG001|Overall Study|Lost to Follow-up|0|||
161850100|NCT00113763|584492805|FG000|Overall Study|Adverse Event|5|||
161850101|NCT00113763|584492806|FG001|Overall Study|Adverse Event|2|||
161850102|NCT00113763|584492805|FG000|Overall Study|Disease Progression|28|||
161850103|NCT00113763|584492806|FG001|Overall Study|Disease Progression|14|||
161850104|NCT00113763|584492805|FG000|Overall Study|Lost to Follow-up|10|||
161850105|NCT00113763|584492806|FG001|Overall Study|Lost to Follow-up|0|||
161850106|NCT00113763|584492805|FG000|Overall Study|Withdrawal by Subject|1|||
161850107|NCT00113763|584492806|FG001|Overall Study|Withdrawal by Subject|4|||
161850108|NCT00113763|584492805|FG000|Overall Study|Other|27|||
161850109|NCT00113763|584492806|FG001|Overall Study|Other|6|||
161850110|NCT00113763|584492805|FG000|Overall Study|Non-compliance|1|||
161850111|NCT00113763|584492806|FG001|Overall Study|Non-compliance|0|||
161850112|NCT00113763|584492805|FG000|Overall Study|Ongoing|1|||
161850113|NCT00113763|584492806|FG001|Overall Study|Ongoing|0|||
161850114|NCT00517881|584492807|FG000|Overall Study|Protocol Violation|2|||
161850115|NCT00517881|584492807|FG000|Overall Study|Adverse Event|1|||
161850116|NCT00517881|584492807|FG000|Overall Study|Renal transplantation|2|||
161850117|NCT03743415|584492808|FG000|Overall Study|Death|5|||
161850118|NCT03743415|584492809|FG001|Overall Study|Death|3|||
161850119|NCT03743415|584492810|FG002|Overall Study|Death|1|||
161850120|NCT03743415|584492811|FG003|Overall Study|Death|4|||
161850121|NCT03743415|584492812|FG004|Overall Study|Death|0|||
161850122|NCT03743415|584492813|FG005|Overall Study|Death|0|||
161850123|NCT03743415|584492814|FG006|Overall Study|Death|0|||
161850124|NCT03743415|584492815|FG007|Overall Study|Death|0|||
161850125|NCT03743415|584492816|FG008|Overall Study|Death|1|||
161850126|NCT03743415|584492817|FG009|Overall Study|Death|0|||
161850127|NCT03743415|584492808|FG000|Overall Study|Withdrawal by Subject|1|||
161850128|NCT03743415|584492809|FG001|Overall Study|Withdrawal by Subject|0|||
161850129|NCT03743415|584492810|FG002|Overall Study|Withdrawal by Subject|4|||
161850130|NCT03743415|584492811|FG003|Overall Study|Withdrawal by Subject|5|||
161850131|NCT03743415|584492812|FG004|Overall Study|Withdrawal by Subject|5|||
161850132|NCT03743415|584492813|FG005|Overall Study|Withdrawal by Subject|2|||
161850133|NCT03743415|584492814|FG006|Overall Study|Withdrawal by Subject|2|||
161850134|NCT03743415|584492815|FG007|Overall Study|Withdrawal by Subject|5|||
161850135|NCT03743415|584492816|FG008|Overall Study|Withdrawal by Subject|9|||
161850136|NCT03743415|584492817|FG009|Overall Study|Withdrawal by Subject|10|||
161850137|NCT03743415|584492808|FG000|Overall Study|Lost to Follow-up|2|||
161850138|NCT03743415|584492809|FG001|Overall Study|Lost to Follow-up|0|||
161850139|NCT03743415|584492810|FG002|Overall Study|Lost to Follow-up|2|||
161850140|NCT03743415|584492811|FG003|Overall Study|Lost to Follow-up|1|||
161850141|NCT03743415|584492812|FG004|Overall Study|Lost to Follow-up|1|||
161850142|NCT03743415|584492813|FG005|Overall Study|Lost to Follow-up|0|||
161850143|NCT03743415|584492814|FG006|Overall Study|Lost to Follow-up|1|||
161850144|NCT03743415|584492815|FG007|Overall Study|Lost to Follow-up|4|||
161850145|NCT03743415|584492816|FG008|Overall Study|Lost to Follow-up|13|||
161850146|NCT03743415|584492817|FG009|Overall Study|Lost to Follow-up|13|||
161850147|NCT01422187|584492818|FG000|Overall Study|Personal reason|1|||
161850148|NCT01422187|584492819|FG001|Overall Study|Personal reason|0|||
161850149|NCT01422187|584492820|FG002|Overall Study|Personal reason|0|||
161850150|NCT01422187|584492818|FG000|Overall Study|Lost to Follow-up|0|||
161850151|NCT01422187|584492819|FG001|Overall Study|Lost to Follow-up|1|||
161850152|NCT01422187|584492820|FG002|Overall Study|Lost to Follow-up|0|||
161850153|NCT00741286|584492824|FG000|Overall Study|Lost to Follow-up|15|||
161850154|NCT00741286|584492825|FG001|Overall Study|Lost to Follow-up|10|||
161850155|NCT00741286|584492824|FG000|Overall Study|Adverse Event|1|||
161850156|NCT00741286|584492825|FG001|Overall Study|Adverse Event|6|||
161850157|NCT00741286|584492824|FG000|Overall Study|Protocol Violation|3|||
161850158|NCT00741286|584492825|FG001|Overall Study|Protocol Violation|2|||
161850159|NCT00741286|584492824|FG000|Overall Study|Primary Outcome|1|||
161850160|NCT00741286|584492825|FG001|Overall Study|Primary Outcome|1|||
161850161|NCT00582010|584492829|FG000|Overall Study|Death|0|||
161850162|NCT00582010|584492830|FG001|Overall Study|Death|1|||
161850163|NCT05320887|584492833|FG000|Overall Study|Lost to Follow-up|0|||
161850164|NCT05320887|584492834|FG001|Overall Study|Lost to Follow-up|3|||
161850165|NCT05320887|584492835|FG002|Overall Study|Lost to Follow-up|0|||
161850166|NCT05320887|584492836|FG003|Overall Study|Lost to Follow-up|0|||
161850167|NCT02463357|584492837|FG000|Overall Study|Withdrawal by Subject|1|||
161850168|NCT02463357|584492838|FG001|Overall Study|Withdrawal by Subject|0|||
161850169|NCT02463357|584492839|FG002|Overall Study|Withdrawal by Subject|0|||
161850170|NCT02463357|584492840|FG003|Overall Study|Withdrawal by Subject|0|||
161850171|NCT02463357|584492841|FG004|Overall Study|Withdrawal by Subject|0|||
161850172|NCT02463357|584492837|FG000|Overall Study|Withdrawal by Subject|0|||
161850173|NCT02463357|584492838|FG001|Overall Study|Withdrawal by Subject|0|||
161850174|NCT02463357|584492839|FG002|Overall Study|Withdrawal by Subject|0|||
161850175|NCT02463357|584492840|FG003|Overall Study|Withdrawal by Subject|0|||
161850176|NCT02463357|584492841|FG004|Overall Study|Withdrawal by Subject|1|||
161850177|NCT00378573|584492843|FG000|Treatment Period|Adverse Event|9|||
161850178|NCT00378573|584492843|FG000|Treatment Period|Physician Decision|1|||
161850179|NCT00378573|584492843|FG000|Treatment Period|Withdrawal by Subject|2|||
161850180|NCT00378573|584492843|FG000|Treatment Period|Disease Progression|4|||
161850181|NCT00378573|584492843|FG000|Treatment Period|Sponsor decision to close study|1|||
161850182|NCT00378573|584492843|FG000|Follow-up|Death|12|||
161850183|NCT00378573|584492843|FG000|Follow-up|Lost to Follow-up|1|||
161850184|NCT00378573|584492843|FG000|Follow-up|Withdrawal by Subject|1|||
161850185|NCT02892149|584492844|FG000|Overall Study|Death|262|||
161850186|NCT02892149|584492845|FG001|Overall Study|Death|278|||
161850187|NCT02892149|584492844|FG000|Overall Study|Withdrawal by Subject|53|||
161850188|NCT02892149|584492845|FG001|Overall Study|Withdrawal by Subject|47|||
161850189|NCT02892149|584492844|FG000|Overall Study|Lost to Follow-up|37|||
161850190|NCT02892149|584492845|FG001|Overall Study|Lost to Follow-up|31|||
161850191|NCT00252239|584492855|FG000|Overall Study|Withdrawal by Subject|1|||
161850192|NCT00252239|584492856|FG001|Overall Study|Withdrawal by Subject|0|||
161850193|NCT00252239|584492857|FG002|Overall Study|Withdrawal by Subject|0|||
161850194|NCT00252239|584492858|FG003|Overall Study|Withdrawal by Subject|1|||
161850195|NCT00252239|584492855|FG000|Overall Study|Lost to Follow-up|0|||
161850196|NCT00252239|584492856|FG001|Overall Study|Lost to Follow-up|0|||
161850197|NCT00252239|584492857|FG002|Overall Study|Lost to Follow-up|2|||
161850198|NCT00252239|584492858|FG003|Overall Study|Lost to Follow-up|0|||
161850199|NCT02181790|584492863|FG000|Overall Study|study terminated|2|||
161850200|NCT02181790|584492864|FG001|Overall Study|study terminated|0|||
161850201|NCT03276078|584492865|FG000|Overall Study|Adverse Event|1|||
161850202|NCT02785952|584492866|FG000|Overall Study|Adverse Event|31|||
161850203|NCT02785952|584492867|FG001|Overall Study|Adverse Event|19|||
161850204|NCT02785952|584492866|FG000|Overall Study|Refusal unrelated to adverse events|10|||
161850205|NCT02785952|584492867|FG001|Overall Study|Refusal unrelated to adverse events|5|||
161850206|NCT02785952|584492866|FG000|Overall Study|Disease progression/relapse|61|||
161850207|NCT02785952|584492867|FG001|Overall Study|Disease progression/relapse|89|||
161850208|NCT02785952|584492866|FG000|Overall Study|Death|11|||
161850209|NCT02785952|584492867|FG001|Overall Study|Death|7|||
161850210|NCT02785952|584492866|FG000|Overall Study|Other- not protocol specified|6|||
161850211|NCT02785952|584492867|FG001|Overall Study|Other- not protocol specified|4|||
161850212|NCT02785952|584492866|FG000|Overall Study|On protocol treatment|6|||
161850213|NCT02785952|584492867|FG001|Overall Study|On protocol treatment|3|||
161850214|NCT00090363|584492868|FG000|Overall Study|Lost to Follow-up|1|||
161850215|NCT00090363|584492869|FG001|Overall Study|Lost to Follow-up|2|||
161850216|NCT00090363|584492870|FG002|Overall Study|Lost to Follow-up|1|||
161850217|NCT00090363|584492868|FG000|Overall Study|Withdrawal by Subject|7|||
161850218|NCT00090363|584492869|FG001|Overall Study|Withdrawal by Subject|7|||
161850219|NCT00090363|584492870|FG002|Overall Study|Withdrawal by Subject|6|||
161850220|NCT00090363|584492868|FG000|Overall Study|Study-specific discontinuation criteria|75|||
161850221|NCT00090363|584492869|FG001|Overall Study|Study-specific discontinuation criteria|74|||
161850222|NCT00090363|584492870|FG002|Overall Study|Study-specific discontinuation criteria|62|||
161850223|NCT00090363|584492868|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161850224|NCT00090363|584492869|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161850225|NCT00090363|584492870|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161850226|NCT00090363|584492868|FG000|Overall Study|Consent expired|7|||
161850227|NCT00090363|584492869|FG001|Overall Study|Consent expired|10|||
161850228|NCT00090363|584492870|FG002|Overall Study|Consent expired|9|||
161850229|NCT00090363|584492868|FG000|Overall Study|Reasons not specified|2|||
161850230|NCT00090363|584492869|FG001|Overall Study|Reasons not specified|1|||
161850231|NCT00090363|584492870|FG002|Overall Study|Reasons not specified|1|||
161850232|NCT00090363|584492868|FG000|Overall Study|Continuing on study off treatment|14|||
161850233|NCT00090363|584492869|FG001|Overall Study|Continuing on study off treatment|13|||
161850234|NCT00090363|584492870|FG002|Overall Study|Continuing on study off treatment|16|||
161850235|NCT05038800|584492872|FG000|Overall Study|Death|1|||
161850236|NCT05038800|584492873|FG001|Overall Study|Death|1|||
161850237|NCT05038800|584492874|FG002|Overall Study|Death|5|||
161850238|NCT05038800|584492875|FG003|Overall Study|Death|3|||
161850239|NCT05038800|584492876|FG004|Overall Study|Death|1|||
161850240|NCT05038800|584492872|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850241|NCT05038800|584492873|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850242|NCT05038800|584492874|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850243|NCT05038800|584492875|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850244|NCT05038800|584492876|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161850245|NCT05038800|584492872|FG000|Overall Study|Lack of Efficacy|0|||
161850246|NCT05038800|584492873|FG001|Overall Study|Lack of Efficacy|0|||
161850247|NCT05038800|584492874|FG002|Overall Study|Lack of Efficacy|0|||
161850248|NCT05038800|584492875|FG003|Overall Study|Lack of Efficacy|0|||
161850249|NCT05038800|584492876|FG004|Overall Study|Lack of Efficacy|1|||
161850250|NCT00121134|584492877|FG000|Overall Study|Progression of Disease|5|||
161850251|NCT00121134|584492878|FG001|Overall Study|Progression of Disease|3|||
161850252|NCT00121134|584492879|FG002|Overall Study|Progression of Disease|4|||
161850253|NCT00121134|584492880|FG003|Overall Study|Progression of Disease|2|||
161850254|NCT00121134|584492877|FG000|Overall Study|Toxicity|4|||
161850255|NCT00121134|584492878|FG001|Overall Study|Toxicity|7|||
161850256|NCT00121134|584492879|FG002|Overall Study|Toxicity|13|||
161850257|NCT00121134|584492880|FG003|Overall Study|Toxicity|5|||
161850258|NCT00121134|584492877|FG000|Overall Study|Physician Decision|6|||
161850259|NCT00121134|584492878|FG001|Overall Study|Physician Decision|4|||
161850260|NCT00121134|584492879|FG002|Overall Study|Physician Decision|4|||
161850261|NCT00121134|584492880|FG003|Overall Study|Physician Decision|1|||
161850262|NCT00121134|584492877|FG000|Overall Study|Treatment Delay|1|||
161850263|NCT00121134|584492878|FG001|Overall Study|Treatment Delay|0|||
161850264|NCT00121134|584492879|FG002|Overall Study|Treatment Delay|0|||
161850265|NCT00121134|584492880|FG003|Overall Study|Treatment Delay|0|||
161850266|NCT00121134|584492877|FG000|Overall Study|Intercurrent Illness|0|||
161850267|NCT00121134|584492878|FG001|Overall Study|Intercurrent Illness|0|||
161850268|NCT00121134|584492879|FG002|Overall Study|Intercurrent Illness|0|||
161764251|NCT04212221|584176159|FG006|Overall Study|Protocol Violation|0|||
161764252|NCT04212221|584176160|FG007|Overall Study|Protocol Violation|1|||
161764253|NCT02692560|584176165|FG000|Overall Study|Withdrawal by Subject|0|||
161764254|NCT02692560|584176166|FG001|Overall Study|Withdrawal by Subject|6|||
161764255|NCT00715949|584176171|FG000|Overall Study|could not finish first test|4|||
161764256|NCT01326910|584176172|FG000|Overall Study|Withdrawal by Subject|3|||
161764257|NCT01326910|584176173|FG001|Overall Study|Withdrawal by Subject|2|||
161764258|NCT01326910|584176172|FG000|Overall Study|Protocol Violation|1|||
161764259|NCT01326910|584176173|FG001|Overall Study|Protocol Violation|1|||
161764260|NCT02274766|584176176|FG000|Overall Study|Withdrawal by Subject|3|||
161764261|NCT02274766|584176177|FG001|Overall Study|Withdrawal by Subject|6|||
161764262|NCT02274766|584176176|FG000|Overall Study|Did Not Receive Study Drug|1|||
161764263|NCT02274766|584176177|FG001|Overall Study|Did Not Receive Study Drug|1|||
161764264|NCT02274766|584176176|FG000|Overall Study|Subject Unwilling to Proceed|0|||
161764265|NCT02274766|584176177|FG001|Overall Study|Subject Unwilling to Proceed|1|||
161764266|NCT02274766|584176176|FG000|Overall Study|Adverse Event|0|||
161764267|NCT02274766|584176177|FG001|Overall Study|Adverse Event|1|||
161764268|NCT00806494|584176189|FG000|Overall Study|Adverse Event|29|||
161764269|NCT00806494|584176189|FG000|Overall Study|Lack of Efficacy|6|||
161764270|NCT00806494|584176189|FG000|Overall Study|Lost to Follow-up|10|||
161764271|NCT00806494|584176189|FG000|Overall Study|Other|30|||
161764272|NCT00806494|584176189|FG000|Overall Study|Withdrawal by Subject|5|||
161764273|NCT02417935|584176190|FG000|Treatment Period|Adverse Event|12|||
161764274|NCT02417935|584176191|FG001|Treatment Period|Adverse Event|10|||
161764275|NCT02417935|584176190|FG000|Treatment Period|Lost to Follow-up|1|||
161764276|NCT02417935|584176191|FG001|Treatment Period|Lost to Follow-up|0|||
161764277|NCT02417935|584176190|FG000|Treatment Period|Entry Criteria not met|0|||
161764278|NCT02417935|584176191|FG001|Treatment Period|Entry Criteria not met|1|||
161764279|NCT02417935|584176190|FG000|Treatment Period|Protocol Violation|2|||
161764280|NCT02417935|584176191|FG001|Treatment Period|Protocol Violation|1|||
161764281|NCT02417935|584176190|FG000|Treatment Period|Withdrawal by Subject|3|||
161764282|NCT02417935|584176191|FG001|Treatment Period|Withdrawal by Subject|3|||
161764283|NCT02417935|584176190|FG000|Treatment Period|Physician Decision|3|||
161764284|NCT02417935|584176191|FG001|Treatment Period|Physician Decision|1|||
161764285|NCT02850276|584176194|FG000|Overall Study|screen failure|43|||
161764286|NCT02850276|584176194|FG000|Overall Study|Withdrawal by Subject|14|||
161764287|NCT02850276|584176194|FG000|Overall Study|Physician Decision|2|||
161764288|NCT02850276|584176194|FG000|Overall Study|Lost to Follow-up|2|||
161764289|NCT04815291|584176195|FG000|Overall Study|Lost to Follow-up|1|||
161764290|NCT04815291|584176195|FG000|Overall Study|Physician Decision|4|||
161764291|NCT04815291|584176195|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
161764292|NCT00095836|584176198|FG000|Overall Study|Lost to Follow-up|1|||
161764293|NCT00095836|584176198|FG000|Overall Study|Adverse Event|1|||
161764294|NCT00095836|584176198|FG000|Overall Study|Death|2|||
161764295|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
161764296|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
161764297|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
161764298|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161764299|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
161764300|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
161764301|NCT00989664|584176199|FG000|Long-Term Follow-Up|Death|3|||
161764302|NCT00962780|584176203|FG000|Overall Study|Death|0|||
161764303|NCT00962780|584176204|FG001|Overall Study|Death|1|||
161764304|NCT00962780|584176203|FG000|Overall Study|Protocol Violation|9|||
161764305|NCT00962780|584176204|FG001|Overall Study|Protocol Violation|4|||
161764306|NCT00962780|584176203|FG000|Overall Study|Withdrawal by Subject|1|||
161764307|NCT00962780|584176204|FG001|Overall Study|Withdrawal by Subject|8|||
161764308|NCT00962780|584176203|FG000|Overall Study|Other|0|||
161764309|NCT00962780|584176204|FG001|Overall Study|Other|1|||
161764310|NCT02646332|584176205|FG000|Overall Study|Lost to Follow-up|0|||
161764311|NCT02646332|584176206|FG001|Overall Study|Lost to Follow-up|3|||
161764312|NCT02363322|584176207|FG000|Overall Study|Lost to Follow-up|1|||
161764313|NCT02363322|584176208|FG001|Overall Study|Lost to Follow-up|0|||
161764314|NCT01775995|584176209|FG000|Overall Study|Lost to Follow-up|1|||
161764315|NCT01775995|584176210|FG001|Overall Study|Lost to Follow-up|1|||
161764316|NCT02909504|584176211|FG000|Overall Study|Adverse Event|2|||
161764317|NCT02909504|584176211|FG000|Overall Study|Lack of Efficacy|3|||
161764318|NCT02909504|584176211|FG000|Overall Study|Withdrawal by Subject|4|||
161764319|NCT02909504|584176211|FG000|Overall Study|Pregnancy|1|||
161764320|NCT02909504|584176211|FG000|Overall Study|Subject moved|1|||
161764321|NCT02909504|584176211|FG000|Overall Study|Lost to Follow-up|1|||
161764322|NCT02055976|584176212|FG000|Overall Study|Other|0|||
161764323|NCT02055976|584176213|FG001|Overall Study|Other|0|||
161764324|NCT02055976|584176214|FG002|Overall Study|Other|1|||
161764325|NCT02055976|584176215|FG003|Overall Study|Other|0|||
161764326|NCT02055976|584176216|FG004|Overall Study|Other|0|||
161764327|NCT02055976|584176217|FG005|Overall Study|Other|0|||
161764328|NCT02055976|584176218|FG006|Overall Study|Other|0|||
161764329|NCT02055976|584176219|FG007|Overall Study|Other|0|||
161764330|NCT02055976|584176220|FG008|Overall Study|Other|0|||
161764331|NCT02055976|584176212|FG000|Overall Study|Adverse Event|0|||
161764332|NCT02055976|584176213|FG001|Overall Study|Adverse Event|0|||
161764333|NCT02055976|584176214|FG002|Overall Study|Adverse Event|0|||
161764334|NCT02055976|584176215|FG003|Overall Study|Adverse Event|0|||
161764335|NCT02055976|584176216|FG004|Overall Study|Adverse Event|0|||
161764336|NCT02055976|584176217|FG005|Overall Study|Adverse Event|1|||
161764337|NCT02055976|584176218|FG006|Overall Study|Adverse Event|1|||
161764338|NCT02055976|584176219|FG007|Overall Study|Adverse Event|0|||
161764339|NCT02055976|584176220|FG008|Overall Study|Adverse Event|0|||
161764340|NCT02055976|584176212|FG000|Overall Study|Does not meet entrance criteria|0|||
161764341|NCT02055976|584176213|FG001|Overall Study|Does not meet entrance criteria|0|||
161764342|NCT02055976|584176214|FG002|Overall Study|Does not meet entrance criteria|0|||
161764343|NCT02055976|584176215|FG003|Overall Study|Does not meet entrance criteria|0|||
161764344|NCT02055976|584176216|FG004|Overall Study|Does not meet entrance criteria|0|||
161764345|NCT02055976|584176217|FG005|Overall Study|Does not meet entrance criteria|0|||
161764346|NCT02055976|584176218|FG006|Overall Study|Does not meet entrance criteria|1|||
161764347|NCT02055976|584176219|FG007|Overall Study|Does not meet entrance criteria|0|||
161764348|NCT02055976|584176220|FG008|Overall Study|Does not meet entrance criteria|0|||
161764349|NCT02055976|584176212|FG000|Overall Study|Lost to Follow-up|0|||
161764350|NCT02055976|584176213|FG001|Overall Study|Lost to Follow-up|0|||
161764351|NCT02055976|584176214|FG002|Overall Study|Lost to Follow-up|0|||
161764352|NCT02055976|584176215|FG003|Overall Study|Lost to Follow-up|1|||
161764353|NCT02055976|584176216|FG004|Overall Study|Lost to Follow-up|0|||
161764354|NCT02055976|584176217|FG005|Overall Study|Lost to Follow-up|0|||
161764355|NCT02055976|584176218|FG006|Overall Study|Lost to Follow-up|0|||
161764356|NCT02055976|584176219|FG007|Overall Study|Lost to Follow-up|0|||
161764357|NCT02055976|584176220|FG008|Overall Study|Lost to Follow-up|0|||
161764358|NCT02504424|584176223|FG000|Overall Study|Withdrawal by Subject|2|||
161764359|NCT00426842|584176225|FG000|Overall Study|Lost to Follow-up|1|||
161764360|NCT01277666|584176228|FG000|Overall Study|Adverse Event|26|||
161764361|NCT01277666|584176229|FG001|Overall Study|Adverse Event|25|||
161764362|NCT01277666|584176230|FG002|Overall Study|Adverse Event|20|||
161764363|NCT01277666|584176228|FG000|Overall Study|Lack of Efficacy|8|||
161764364|NCT01277666|584176229|FG001|Overall Study|Lack of Efficacy|20|||
161764365|NCT01277666|584176230|FG002|Overall Study|Lack of Efficacy|12|||
161764366|NCT01277666|584176228|FG000|Overall Study|Protocol Violation|2|||
161764367|NCT01277666|584176229|FG001|Overall Study|Protocol Violation|3|||
161764368|NCT01277666|584176230|FG002|Overall Study|Protocol Violation|2|||
161764369|NCT01277666|584176228|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
161764370|NCT01277666|584176229|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
161764371|NCT01277666|584176230|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
161764372|NCT01277666|584176228|FG000|Overall Study|Lost to Follow-up|1|||
161764373|NCT01277666|584176229|FG001|Overall Study|Lost to Follow-up|1|||
161764374|NCT01277666|584176230|FG002|Overall Study|Lost to Follow-up|2|||
161764375|NCT01277666|584176228|FG000|Overall Study|Withdrawal by Subject|7|||
161764376|NCT01277666|584176229|FG001|Overall Study|Withdrawal by Subject|8|||
161764377|NCT01277666|584176230|FG002|Overall Study|Withdrawal by Subject|6|||
161764378|NCT01277666|584176228|FG000|Overall Study|Death|0|||
161764379|NCT01277666|584176229|FG001|Overall Study|Death|0|||
161764380|NCT01277666|584176230|FG002|Overall Study|Death|1|||
161764381|NCT01657903|584176232|FG000|Overall Study|Lost to Follow-up|1|||
161764382|NCT01657903|584176232|FG000|Overall Study|Withdrawal by Subject|1|||
161764383|NCT00554840|584176233|FG000|Overall Study|Physician Decision|0|||
161764384|NCT00554840|584176234|FG001|Overall Study|Physician Decision|1|||
161764385|NCT02312934|584176237|FG000|Overall Study|Lost to Follow-up|1|||
161764386|NCT02312934|584176238|FG001|Overall Study|Lost to Follow-up|0|||
161764387|NCT02312934|584176237|FG000|Overall Study|Physician Decision|1|||
161764388|NCT02312934|584176238|FG001|Overall Study|Physician Decision|0|||
161764389|NCT02886338|584176239|FG000|Overall Study|Withdrawal by Subject|1|||
161764390|NCT01156012|584176241|FG000|Overall Study|Adverse Event|3|||
161764391|NCT01156012|584176242|FG001|Overall Study|Adverse Event|1|||
161764392|NCT01156012|584176241|FG000|Overall Study|Lost to Follow-up|1|||
161764393|NCT01156012|584176242|FG001|Overall Study|Lost to Follow-up|0|||
161764394|NCT01156012|584176241|FG000|Overall Study|Withdrawal by Subject|1|||
161764395|NCT01156012|584176242|FG001|Overall Study|Withdrawal by Subject|0|||
161764396|NCT01156012|584176241|FG000|Overall Study|use of commercial drug instead of study|0|||
161764397|NCT01156012|584176242|FG001|Overall Study|use of commercial drug instead of study|1|||
161764398|NCT01156012|584176241|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
161764399|NCT01156012|584176242|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
161764400|NCT03395704|584176243|FG000|Overall Study|Adverse Event|2|||
161764401|NCT03395704|584176244|FG001|Overall Study|Adverse Event|1|||
161764402|NCT03395704|584176243|FG000|Overall Study|Withdrawal by Subject|2|||
161850269|NCT00121134|584492880|FG003|Overall Study|Intercurrent Illness|1|||
161850270|NCT00121134|584492877|FG000|Overall Study|Patient Personal Reasons|0|||
161850271|NCT00121134|584492878|FG001|Overall Study|Patient Personal Reasons|1|||
161850272|NCT00121134|584492879|FG002|Overall Study|Patient Personal Reasons|0|||
161850273|NCT00121134|584492880|FG003|Overall Study|Patient Personal Reasons|0|||
161850274|NCT02478320|584492886|FG000|Overall Study|Adverse Event|2|||
161850275|NCT02478320|584492887|FG001|Overall Study|Adverse Event|0|||
161850276|NCT02478320|584492886|FG000|Overall Study|Death|1|||
161850277|NCT02478320|584492887|FG001|Overall Study|Death|0|||
161850278|NCT02478320|584492886|FG000|Overall Study|Lack of Efficacy|4|||
161850279|NCT02478320|584492887|FG001|Overall Study|Lack of Efficacy|0|||
161850280|NCT02478320|584492886|FG000|Overall Study|Withdrawal by Subject|2|||
161850281|NCT02478320|584492887|FG001|Overall Study|Withdrawal by Subject|0|||
161850282|NCT02478320|584492886|FG000|Overall Study|Screen Failure|3|||
161850283|NCT02478320|584492887|FG001|Overall Study|Screen Failure|0|||
161850284|NCT03185013|584492888|FG000|Overall Study|Withdrawal by Subject|5|||
161850285|NCT03185013|584492889|FG001|Overall Study|Withdrawal by Subject|3|||
161850286|NCT03185013|584492888|FG000|Overall Study|Adverse Event|1|||
161850287|NCT03185013|584492889|FG001|Overall Study|Adverse Event|0|||
161850288|NCT03185013|584492888|FG000|Overall Study|Progressive Disease|1|||
161850289|NCT03185013|584492889|FG001|Overall Study|Progressive Disease|0|||
161850290|NCT03185013|584492888|FG000|Overall Study|Lost to Follow-up|8|||
161850291|NCT03185013|584492889|FG001|Overall Study|Lost to Follow-up|2|||
161850292|NCT03185013|584492888|FG000|Overall Study|Physician Decision|1|||
161850293|NCT03185013|584492889|FG001|Overall Study|Physician Decision|0|||
161850294|NCT03185013|584492888|FG000|Overall Study|Protocol Deviation|2|||
161850295|NCT03185013|584492889|FG001|Overall Study|Protocol Deviation|0|||
161850296|NCT03185013|584492888|FG000|Overall Study|Reason not Specified|3|||
161850297|NCT03185013|584492889|FG001|Overall Study|Reason not Specified|2|||
161850298|NCT03185013|584492888|FG000|Overall Study|Death|1|||
161850299|NCT03185013|584492889|FG001|Overall Study|Death|0|||
161850300|NCT01104792|584492893|FG000|Overall Study|Adverse Event|77|||
161850301|NCT01104792|584492893|FG000|Overall Study|Insufficient Therapeutic Response|22|||
161850302|NCT01104792|584492893|FG000|Overall Study|Protocol Violation|45|||
161850303|NCT01104792|584492893|FG000|Overall Study|Withdrawal of Consent|179|||
161850304|NCT01104792|584492893|FG000|Overall Study|Lost to Follow-up|43|||
161850305|NCT01104792|584492893|FG000|Overall Study|Reasons Not Specified|27|||
161850306|NCT01104792|584492893|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
161850307|NCT02071849|584492895|FG000|6-month Primary Endpoint|Did not receive device|4|||
161850308|NCT02071849|584492895|FG000|6-month Primary Endpoint|Adverse Event|1|||
161850309|NCT02071849|584492895|FG000|2-year Extended Follow-up|Adverse Event|1|||
161850310|NCT03255655|584492896|FG000|Overall Study|Lost to Follow-up|7|||
161850311|NCT03255655|584492897|FG001|Overall Study|Lost to Follow-up|4|||
161850312|NCT02056392|584492903|FG000|Overall Study|Lost to Follow-up|0|||
161850313|NCT02056392|584492904|FG001|Overall Study|Lost to Follow-up|1|||
161850314|NCT02056392|584492905|FG002|Overall Study|Lost to Follow-up|2|||
161850315|NCT02056392|584492906|FG003|Overall Study|Lost to Follow-up|0|||
161850316|NCT02056392|584492907|FG004|Overall Study|Lost to Follow-up|0|||
161850317|NCT02056392|584492908|FG005|Overall Study|Lost to Follow-up|0|||
161850318|NCT02056392|584492903|FG000|Overall Study|Protocol Violation|1|||
161850319|NCT02056392|584492904|FG001|Overall Study|Protocol Violation|0|||
161850320|NCT02056392|584492905|FG002|Overall Study|Protocol Violation|1|||
161850321|NCT02056392|584492906|FG003|Overall Study|Protocol Violation|0|||
161850322|NCT02056392|584492907|FG004|Overall Study|Protocol Violation|0|||
161850323|NCT02056392|584492908|FG005|Overall Study|Protocol Violation|0|||
161850324|NCT02056392|584492903|FG000|Overall Study|Withdrawal by Subject|1|||
161850325|NCT02056392|584492904|FG001|Overall Study|Withdrawal by Subject|0|||
161850326|NCT02056392|584492905|FG002|Overall Study|Withdrawal by Subject|0|||
161850327|NCT02056392|584492906|FG003|Overall Study|Withdrawal by Subject|0|||
161850328|NCT02056392|584492907|FG004|Overall Study|Withdrawal by Subject|1|||
161850329|NCT02056392|584492908|FG005|Overall Study|Withdrawal by Subject|0|||
161850330|NCT00103610|584492909|FG000|Overall Study|Entered Rescue Procedure|10|||
161850331|NCT00103610|584492910|FG001|Overall Study|Entered Rescue Procedure|52|||
161850332|NCT00103610|584492909|FG000|Overall Study|Death|16|||
161850333|NCT00103610|584492910|FG001|Overall Study|Death|12|||
161850334|NCT00103610|584492909|FG000|Overall Study|Elective Withdrawal|4|||
161850335|NCT00103610|584492910|FG001|Overall Study|Elective Withdrawal|0|||
161850336|NCT00103610|584492909|FG000|Overall Study|Lost to Follow-up|3|||
161850337|NCT00103610|584492910|FG001|Overall Study|Lost to Follow-up|1|||
161850338|NCT00103610|584492909|FG000|Overall Study|Adverse Event|2|||
161850339|NCT00103610|584492910|FG001|Overall Study|Adverse Event|2|||
161850340|NCT00103610|584492909|FG000|Overall Study|Other|2|||
161850341|NCT00103610|584492910|FG001|Overall Study|Other|7|||
161850342|NCT00103610|584492909|FG000|Overall Study|Failed mobilization|1|||
161850343|NCT00103610|584492910|FG001|Overall Study|Failed mobilization|5|||
161850344|NCT00103610|584492909|FG000|Overall Study|Noncompliance|0|||
161850345|NCT00103610|584492910|FG001|Overall Study|Noncompliance|1|||
161850346|NCT00658021|584492911|FG000|28-Week Treatment Period|Adverse Event|3|||
161850347|NCT00658021|584492912|FG001|28-Week Treatment Period|Adverse Event|1|||
161850348|NCT00658021|584492913|FG002|28-Week Treatment Period|Adverse Event|0|||
161850349|NCT00658021|584492911|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
161850350|NCT00658021|584492912|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
161850351|NCT00658021|584492913|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
161850352|NCT00658021|584492911|FG000|28-Week Treatment Period|Protocol Violation|0|||
161850353|NCT00658021|584492912|FG001|28-Week Treatment Period|Protocol Violation|2|||
161850354|NCT00658021|584492913|FG002|28-Week Treatment Period|Protocol Violation|1|||
161850355|NCT00658021|584492911|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
161850356|NCT00658021|584492912|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
161850357|NCT00658021|584492913|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
161850358|NCT00658021|584492911|FG000|28-Week Treatment Period|Physician Decision|1|||
161850359|NCT00658021|584492912|FG001|28-Week Treatment Period|Physician Decision|2|||
161850360|NCT00658021|584492913|FG002|28-Week Treatment Period|Physician Decision|1|||
161850361|NCT00658021|584492911|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161850362|NCT00658021|584492912|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161850363|NCT00658021|584492913|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161850364|NCT00658021|584492911|FG000|28-Week Treatment Period|Loss of glucose control|1|||
161850365|NCT00658021|584492912|FG001|28-Week Treatment Period|Loss of glucose control|1|||
161850366|NCT00658021|584492913|FG002|28-Week Treatment Period|Loss of glucose control|10|||
161850367|NCT00658021|584492911|FG000|28-Week Treatment Period|Other|2|||
161850368|NCT00658021|584492912|FG001|28-Week Treatment Period|Other|3|||
161850369|NCT00658021|584492913|FG002|28-Week Treatment Period|Other|1|||
161850370|NCT00658021|584492911|FG000|28-Week Treatment Period|Did not receive treatment|2|||
161850371|NCT00658021|584492912|FG001|28-Week Treatment Period|Did not receive treatment|0|||
161850372|NCT00658021|584492913|FG002|28-Week Treatment Period|Did not receive treatment|0|||
161850373|NCT00658021|584492911|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
161850374|NCT00658021|584492912|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
161850375|NCT00658021|584492913|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
161850376|NCT00658021|584492911|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
161850377|NCT00658021|584492912|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
161850378|NCT00658021|584492913|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
161850379|NCT01806506|584492914|FG000|Overall Study|Lost to Follow-up|2|||
161850380|NCT01806506|584492915|FG001|Overall Study|Lost to Follow-up|1|||
161850381|NCT05819203|584492920|FG000|Overall Study|Protocol Violation|1|||
161850382|NCT05819203|584492921|FG001|Overall Study|Protocol Violation|2|||
161850383|NCT05819203|584492920|FG000|Overall Study|Withdrawal by Subject|1|||
161850384|NCT05819203|584492921|FG001|Overall Study|Withdrawal by Subject|0|||
161850385|NCT04844762|584492926|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850386|NCT04844762|584492927|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850387|NCT04844762|584492928|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
161850388|NCT04844762|584492929|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850389|NCT04844762|584492930|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850390|NCT04844762|584492931|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850391|NCT04844762|584492926|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161850392|NCT04844762|584492927|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161850393|NCT04844762|584492928|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161850394|NCT04844762|584492929|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161850395|NCT04844762|584492930|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161850396|NCT04844762|584492931|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161850397|NCT04844762|584492926|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850398|NCT04844762|584492927|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850399|NCT04844762|584492928|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850400|NCT04844762|584492929|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
161850401|NCT04844762|584492930|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850402|NCT04844762|584492931|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850403|NCT04844762|584492926|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850404|NCT04844762|584492927|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850405|NCT04844762|584492928|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161850406|NCT04844762|584492929|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161850407|NCT04844762|584492930|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
161850408|NCT04844762|584492931|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850409|NCT04844762|584492926|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
161850410|NCT04844762|584492927|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
161850411|NCT04844762|584492928|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850412|NCT04844762|584492929|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850413|NCT04844762|584492930|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850414|NCT04844762|584492931|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850415|NCT04844762|584492926|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850416|NCT04844762|584492927|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850417|NCT04844762|584492928|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850418|NCT04844762|584492929|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850419|NCT04844762|584492930|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850420|NCT04844762|584492931|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850421|NCT04844762|584492926|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850422|NCT04844762|584492927|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850423|NCT04844762|584492928|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850424|NCT04844762|584492929|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850425|NCT04844762|584492930|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161850426|NCT04844762|584492931|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850427|NCT04844762|584492926|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
161850428|NCT04844762|584492927|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850429|NCT04844762|584492928|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850430|NCT04844762|584492929|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850431|NCT04844762|584492930|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850432|NCT04844762|584492931|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850433|NCT04844762|584492926|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850434|NCT04844762|584492927|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850435|NCT04844762|584492928|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850436|NCT04844762|584492929|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850437|NCT04844762|584492930|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850438|NCT04844762|584492931|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850439|NCT04844762|584492926|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850440|NCT04844762|584492927|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
161850441|NCT04844762|584492928|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850442|NCT04844762|584492929|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850443|NCT04844762|584492930|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850444|NCT04844762|584492931|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850445|NCT04844762|584492926|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850446|NCT04844762|584492927|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850447|NCT04844762|584492928|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850448|NCT04844762|584492929|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
161850449|NCT04844762|584492930|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850450|NCT04844762|584492931|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850451|NCT02099682|584492932|FG000|Overall Study|Data Not Available|51|||
161850452|NCT02099682|584492932|FG000|Overall Study|Lost to Follow-up|31|||
161850453|NCT02099682|584492932|FG000|Overall Study|Other|29|||
161850454|NCT02802631|584492933|FG000|Overall Study|Withdrawal by Subject|1|||
161850455|NCT02802631|584492934|FG001|Overall Study|Withdrawal by Subject|0|||
161850456|NCT02802631|584492935|FG002|Overall Study|Withdrawal by Subject|0|||
161850457|NCT02802631|584492936|FG003|Overall Study|Withdrawal by Subject|0|||
161850458|NCT02802631|584492937|FG004|Overall Study|Withdrawal by Subject|0|||
161850459|NCT02802631|584492938|FG005|Overall Study|Withdrawal by Subject|0|||
161850460|NCT02802631|584492939|FG006|Overall Study|Withdrawal by Subject|0|||
161850461|NCT02802631|584492940|FG007|Overall Study|Withdrawal by Subject|0|||
161850462|NCT02802631|584492933|FG000|Overall Study|Physician Decision|1|||
161850463|NCT02802631|584492934|FG001|Overall Study|Physician Decision|0|||
161850464|NCT02802631|584492935|FG002|Overall Study|Physician Decision|0|||
161850465|NCT02802631|584492936|FG003|Overall Study|Physician Decision|0|||
161850466|NCT02802631|584492937|FG004|Overall Study|Physician Decision|0|||
161850467|NCT02802631|584492938|FG005|Overall Study|Physician Decision|0|||
161850468|NCT02802631|584492939|FG006|Overall Study|Physician Decision|1|||
161850469|NCT02802631|584492940|FG007|Overall Study|Physician Decision|0|||
161850470|NCT02802631|584492933|FG000|Overall Study|Adverse Event|0|||
161850471|NCT02802631|584492934|FG001|Overall Study|Adverse Event|2|||
161850472|NCT02802631|584492935|FG002|Overall Study|Adverse Event|0|||
161850473|NCT02802631|584492936|FG003|Overall Study|Adverse Event|1|||
161850474|NCT02802631|584492937|FG004|Overall Study|Adverse Event|6|||
161850475|NCT02802631|584492938|FG005|Overall Study|Adverse Event|1|||
161850476|NCT02802631|584492939|FG006|Overall Study|Adverse Event|4|||
161850477|NCT02802631|584492940|FG007|Overall Study|Adverse Event|0|||
161850478|NCT02802631|584492933|FG000|Overall Study|Sponsor Decision|0|||
161850479|NCT02802631|584492934|FG001|Overall Study|Sponsor Decision|0|||
161850480|NCT02802631|584492935|FG002|Overall Study|Sponsor Decision|6|||
161850481|NCT02802631|584492936|FG003|Overall Study|Sponsor Decision|0|||
161850482|NCT02802631|584492937|FG004|Overall Study|Sponsor Decision|2|||
161850483|NCT02802631|584492938|FG005|Overall Study|Sponsor Decision|0|||
161850484|NCT02802631|584492939|FG006|Overall Study|Sponsor Decision|0|||
161850485|NCT02802631|584492940|FG007|Overall Study|Sponsor Decision|4|||
161850486|NCT03316547|584492942|FG000|Overall Study|Death|3|||
161850487|NCT03316547|584492943|FG001|Overall Study|Death|1|||
161850488|NCT03316547|584492942|FG000|Overall Study|Lost to Follow-up|6|||
161850489|NCT03316547|584492943|FG001|Overall Study|Lost to Follow-up|6|||
161850490|NCT03316547|584492942|FG000|Overall Study|Withdrawal by Subject|3|||
161850491|NCT03316547|584492943|FG001|Overall Study|Withdrawal by Subject|2|||
161850492|NCT03316547|584492942|FG000|Overall Study|Transfer to another hospital|6|||
161850493|NCT03316547|584492943|FG001|Overall Study|Transfer to another hospital|4|||
161850494|NCT05292183|584494440|FG000|Overall Study|Adverse Event|1|||
161850495|NCT02017015|584494445|FG000|Overall Study|Adverse Event|9|||
161850496|NCT02017015|584494445|FG000|Overall Study|Withdrawal by Subject|21|||
161850497|NCT02017015|584494445|FG000|Overall Study|Death|4|||
161850498|NCT02017015|584494445|FG000|Overall Study|Progressive Disease|31|||
161850499|NCT02017015|584494445|FG000|Overall Study|Non-compliance with study drug|2|||
161850500|NCT02017015|584494445|FG000|Overall Study|Physician Decision|2|||
161850501|NCT01277601|584494446|FG000|Overall Study|Adverse Event|5|||
161850502|NCT01277601|584494447|FG001|Overall Study|Adverse Event|3|||
161850503|NCT01277601|584494448|FG002|Overall Study|Adverse Event|0|||
161850504|NCT01277601|584494449|FG003|Overall Study|Adverse Event|7|||
161850505|NCT01277601|584494446|FG000|Overall Study|Withdrawal by Subject|18|||
161850506|NCT01277601|584494447|FG001|Overall Study|Withdrawal by Subject|21|||
161850507|NCT01277601|584494448|FG002|Overall Study|Withdrawal by Subject|8|||
161850508|NCT01277601|584494449|FG003|Overall Study|Withdrawal by Subject|17|||
161850509|NCT01277601|584494446|FG000|Overall Study|Lost to Follow-up|7|||
161850510|NCT01277601|584494447|FG001|Overall Study|Lost to Follow-up|9|||
161850511|NCT01277601|584494448|FG002|Overall Study|Lost to Follow-up|4|||
161850512|NCT01277601|584494449|FG003|Overall Study|Lost to Follow-up|2|||
161850513|NCT01277601|584494446|FG000|Overall Study|Physician Decision|3|||
161850514|NCT01277601|584494447|FG001|Overall Study|Physician Decision|5|||
161850515|NCT01277601|584494448|FG002|Overall Study|Physician Decision|1|||
161850516|NCT01277601|584494449|FG003|Overall Study|Physician Decision|6|||
161850517|NCT01277601|584494446|FG000|Overall Study|Pregnancy|2|||
161850518|NCT01277601|584494447|FG001|Overall Study|Pregnancy|2|||
161850519|NCT01277601|584494448|FG002|Overall Study|Pregnancy|4|||
161850520|NCT01277601|584494449|FG003|Overall Study|Pregnancy|1|||
161850521|NCT01277601|584494446|FG000|Overall Study|Noncompliance with Study Drug|1|||
161850522|NCT01277601|584494447|FG001|Overall Study|Noncompliance with Study Drug|3|||
161850523|NCT01277601|584494448|FG002|Overall Study|Noncompliance with Study Drug|2|||
161850524|NCT01277601|584494449|FG003|Overall Study|Noncompliance with Study Drug|0|||
161850525|NCT01277601|584494446|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
161850526|NCT01277601|584494447|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
161850527|NCT01277601|584494448|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
161850528|NCT01277601|584494449|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
161850529|NCT01277601|584494446|FG000|Overall Study|Protocol Violation|0|||
161850530|NCT01277601|584494447|FG001|Overall Study|Protocol Violation|2|||
161850531|NCT01277601|584494448|FG002|Overall Study|Protocol Violation|5|||
161850532|NCT01277601|584494449|FG003|Overall Study|Protocol Violation|0|||
161850533|NCT01277601|584494446|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
161850534|NCT01277601|584494447|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
161850535|NCT01277601|584494448|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
161850536|NCT01277601|584494449|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
161850537|NCT02260570|584494451|FG000|Overall Study|Withdrawal by Subject|2|||
161850538|NCT02260570|584494452|FG001|Overall Study|Withdrawal by Subject|1|||
161850539|NCT02260570|584494451|FG000|Overall Study|Physician Decision|1|||
161850540|NCT02260570|584494452|FG001|Overall Study|Physician Decision|1|||
161850541|NCT04034927|584494453|FG000|Overall Study|Adverse Event|4|||
161850542|NCT04034927|584494454|FG001|Overall Study|Adverse Event|9|||
161850543|NCT04034927|584494453|FG000|Overall Study|Death|0|||
161850544|NCT04034927|584494454|FG001|Overall Study|Death|1|||
161850545|NCT04034927|584494453|FG000|Overall Study|Withdrawal by Subject|0|||
161850546|NCT04034927|584494454|FG001|Overall Study|Withdrawal by Subject|3|||
161850547|NCT04034927|584494453|FG000|Overall Study|Still on Treatment|2|||
161850548|NCT04034927|584494454|FG001|Overall Study|Still on Treatment|1|||
161850549|NCT04034927|584494453|FG000|Overall Study|Other|1|||
161850550|NCT04034927|584494454|FG001|Overall Study|Other|1|||
161850551|NCT00094861|584494457|FG000|Overall Study|Adverse Event|5|||
161850552|NCT00094861|584494458|FG001|Overall Study|Adverse Event|2|||
161850553|NCT00094861|584494457|FG000|Overall Study|Withdrawal by Subject|5|||
161850554|NCT00094861|584494458|FG001|Overall Study|Withdrawal by Subject|3|||
161850555|NCT00094861|584494457|FG000|Overall Study|Physician Decision|1|||
161850556|NCT00094861|584494458|FG001|Overall Study|Physician Decision|1|||
161850557|NCT00094861|584494457|FG000|Overall Study|Lost to Follow-up|0|||
161850558|NCT00094861|584494458|FG001|Overall Study|Lost to Follow-up|1|||
161850559|NCT00094861|584494457|FG000|Overall Study|Death|4|||
161850560|NCT00094861|584494458|FG001|Overall Study|Death|2|||
161850561|NCT00094861|584494457|FG000|Overall Study|Other|3|||
161850562|NCT00094861|584494458|FG001|Overall Study|Other|0|||
161850563|NCT00264550|584494459|FG000|Overall Study|Death|0|||
161850564|NCT00264550|584494460|FG001|Overall Study|Death|3|||
161850565|NCT00264550|584494461|FG002|Overall Study|Death|0|||
161850566|NCT00264550|584494462|FG003|Overall Study|Death|0|||
161850567|NCT00264550|584494459|FG000|Overall Study|Lost to Follow-up|3|||
161850568|NCT00264550|584494460|FG001|Overall Study|Lost to Follow-up|1|||
161850569|NCT00264550|584494461|FG002|Overall Study|Lost to Follow-up|1|||
161850570|NCT00264550|584494462|FG003|Overall Study|Lost to Follow-up|1|||
161850571|NCT00264550|584494459|FG000|Overall Study|Adverse Event|23|||
161850572|NCT00264550|584494460|FG001|Overall Study|Adverse Event|18|||
161850573|NCT00264550|584494461|FG002|Overall Study|Adverse Event|9|||
161850574|NCT00264550|584494462|FG003|Overall Study|Adverse Event|14|||
161850575|NCT00264550|584494459|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161850576|NCT00264550|584494460|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
161850577|NCT00264550|584494461|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
161850578|NCT00264550|584494462|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
161850579|NCT00264550|584494459|FG000|Overall Study|Discontinued oral study agent|0|||
161850580|NCT00264550|584494460|FG001|Overall Study|Discontinued oral study agent|1|||
161850581|NCT00264550|584494461|FG002|Overall Study|Discontinued oral study agent|0|||
161850582|NCT00264550|584494462|FG003|Overall Study|Discontinued oral study agent|0|||
161850583|NCT00264550|584494459|FG000|Overall Study|Other|13|||
161850584|NCT00264550|584494460|FG001|Overall Study|Other|7|||
161850585|NCT00264550|584494461|FG002|Overall Study|Other|3|||
161850586|NCT00264550|584494462|FG003|Overall Study|Other|9|||
161850587|NCT02129608|584494463|FG000|Overall Study|Lost to Follow-up|0|||
161850588|NCT02129608|584494464|FG001|Overall Study|Lost to Follow-up|1|||
161850589|NCT02129608|584494465|FG002|Overall Study|Lost to Follow-up|1|||
161850590|NCT02129608|584494463|FG000|Overall Study|Withdrawal by Subject|0|||
161850591|NCT02129608|584494464|FG001|Overall Study|Withdrawal by Subject|0|||
161850592|NCT02129608|584494465|FG002|Overall Study|Withdrawal by Subject|2|||
161850593|NCT00451204|584494466|FG000|Overall Study|Adverse Event|4|||
161850594|NCT00451204|584494467|FG001|Overall Study|Adverse Event|6|||
161850595|NCT00451204|584494466|FG000|Overall Study|Lack of Efficacy|4|||
161850596|NCT00451204|584494467|FG001|Overall Study|Lack of Efficacy|4|||
161850597|NCT00451204|584494466|FG000|Overall Study|Lost to Follow-up|4|||
161850598|NCT00451204|584494467|FG001|Overall Study|Lost to Follow-up|4|||
161850599|NCT00451204|584494466|FG000|Overall Study|Protocol Violation|1|||
161850600|NCT00451204|584494467|FG001|Overall Study|Protocol Violation|0|||
161850601|NCT00451204|584494466|FG000|Overall Study|Patient refusal|8|||
161850602|NCT00451204|584494467|FG001|Overall Study|Patient refusal|4|||
161850603|NCT00451204|584494466|FG000|Overall Study|Other|1|||
161850604|NCT00451204|584494467|FG001|Overall Study|Other|2|||
161850605|NCT00425373|584494472|FG000|Overall Study|Adverse Event|2|||
161850606|NCT00425373|584494473|FG001|Overall Study|Adverse Event|2|||
161850607|NCT00425373|584494474|FG002|Overall Study|Adverse Event|0|||
161850608|NCT00425373|584494475|FG003|Overall Study|Adverse Event|1|||
161850609|NCT00425373|584494476|FG004|Overall Study|Adverse Event|4|||
161850610|NCT00425373|584494477|FG005|Overall Study|Adverse Event|6|||
161850611|NCT00425373|584494478|FG006|Overall Study|Adverse Event|2|||
161850612|NCT00425373|584494479|FG007|Overall Study|Adverse Event|3|||
161850613|NCT00425373|584494480|FG008|Overall Study|Adverse Event|8|||
161850614|NCT00425373|584494472|FG000|Overall Study|Lost to Follow-up|0|||
161850615|NCT00425373|584494473|FG001|Overall Study|Lost to Follow-up|1|||
161850616|NCT00425373|584494474|FG002|Overall Study|Lost to Follow-up|0|||
161850617|NCT00425373|584494475|FG003|Overall Study|Lost to Follow-up|0|||
161850618|NCT00425373|584494476|FG004|Overall Study|Lost to Follow-up|1|||
161850619|NCT00425373|584494477|FG005|Overall Study|Lost to Follow-up|0|||
161850620|NCT00425373|584494478|FG006|Overall Study|Lost to Follow-up|0|||
161850621|NCT00425373|584494479|FG007|Overall Study|Lost to Follow-up|0|||
161850622|NCT00425373|584494480|FG008|Overall Study|Lost to Follow-up|0|||
161850623|NCT00425373|584494472|FG000|Overall Study|Protocol Violation|1|||
161850624|NCT00425373|584494473|FG001|Overall Study|Protocol Violation|0|||
161850625|NCT00425373|584494474|FG002|Overall Study|Protocol Violation|1|||
161850626|NCT00425373|584494475|FG003|Overall Study|Protocol Violation|0|||
161850627|NCT00425373|584494476|FG004|Overall Study|Protocol Violation|0|||
161850628|NCT00425373|584494477|FG005|Overall Study|Protocol Violation|0|||
161850629|NCT00425373|584494478|FG006|Overall Study|Protocol Violation|0|||
161850630|NCT00425373|584494479|FG007|Overall Study|Protocol Violation|5|||
161850631|NCT00425373|584494480|FG008|Overall Study|Protocol Violation|3|||
161850632|NCT00425373|584494472|FG000|Overall Study|Withdrawal by Subject|2|||
161850633|NCT00425373|584494473|FG001|Overall Study|Withdrawal by Subject|0|||
161850634|NCT00425373|584494474|FG002|Overall Study|Withdrawal by Subject|2|||
161850635|NCT00425373|584494475|FG003|Overall Study|Withdrawal by Subject|1|||
161850636|NCT00425373|584494476|FG004|Overall Study|Withdrawal by Subject|4|||
161850637|NCT00425373|584494477|FG005|Overall Study|Withdrawal by Subject|0|||
161850638|NCT00425373|584494478|FG006|Overall Study|Withdrawal by Subject|2|||
161850639|NCT00425373|584494479|FG007|Overall Study|Withdrawal by Subject|2|||
161850640|NCT00425373|584494480|FG008|Overall Study|Withdrawal by Subject|2|||
161850641|NCT00425373|584494472|FG000|Overall Study|Lack of Efficacy|0|||
161850642|NCT00425373|584494473|FG001|Overall Study|Lack of Efficacy|0|||
161850643|NCT00425373|584494474|FG002|Overall Study|Lack of Efficacy|0|||
161850644|NCT00425373|584494475|FG003|Overall Study|Lack of Efficacy|0|||
161850645|NCT00425373|584494476|FG004|Overall Study|Lack of Efficacy|1|||
161850646|NCT00425373|584494477|FG005|Overall Study|Lack of Efficacy|3|||
161850647|NCT00425373|584494478|FG006|Overall Study|Lack of Efficacy|3|||
161850648|NCT00425373|584494479|FG007|Overall Study|Lack of Efficacy|0|||
161850649|NCT00425373|584494480|FG008|Overall Study|Lack of Efficacy|5|||
161850650|NCT02620579|584494496|FG000|Overall Study|Physician Decision|0|||
161850651|NCT02620579|584494497|FG001|Overall Study|Physician Decision|0|||
161850652|NCT02620579|584494498|FG002|Overall Study|Physician Decision|0|||
161850653|NCT02620579|584494499|FG003|Overall Study|Physician Decision|1|||
161850654|NCT02620579|584494496|FG000|Overall Study|Withdrawal by Subject|0|||
161850655|NCT02620579|584494497|FG001|Overall Study|Withdrawal by Subject|1|||
161850656|NCT02620579|584494498|FG002|Overall Study|Withdrawal by Subject|1|||
161850657|NCT02620579|584494499|FG003|Overall Study|Withdrawal by Subject|0|||
161850658|NCT01721317|584494500|FG000|Overall Study|Study Closed / Terminated|2|||
161850659|NCT01721317|584494501|FG001|Overall Study|Study Closed / Terminated|2|||
161850660|NCT01721317|584494500|FG000|Overall Study|Physician Decision|0|||
161850661|NCT01721317|584494501|FG001|Overall Study|Physician Decision|1|||
161850662|NCT01721317|584494500|FG000|Overall Study|Withdrawal by Subject|0|||
161850663|NCT01721317|584494501|FG001|Overall Study|Withdrawal by Subject|1|||
161850664|NCT02661217|584494504|FG000|Overall Study|Physician Decision|12|||
161850665|NCT02661217|584494505|FG001|Overall Study|Physician Decision|15|||
161850666|NCT02661217|584494504|FG000|Overall Study|Lost to Follow-up|1|||
161850667|NCT02661217|584494505|FG001|Overall Study|Lost to Follow-up|4|||
161850668|NCT02661217|584494504|FG000|Overall Study|Protocol Deviation|0|||
161850669|NCT02661217|584494505|FG001|Overall Study|Protocol Deviation|4|||
161850670|NCT02661217|584494504|FG000|Overall Study|Non-compliance with study treatment|5|||
161850671|NCT02661217|584494505|FG001|Overall Study|Non-compliance with study treatment|5|||
161850672|NCT02661217|584494504|FG000|Overall Study|Death|21|||
161850673|NCT02661217|584494505|FG001|Overall Study|Death|15|||
161850674|NCT02661217|584494504|FG000|Overall Study|Adverse Event|10|||
161850675|NCT02661217|584494505|FG001|Overall Study|Adverse Event|8|||
161850676|NCT02661217|584494504|FG000|Overall Study|Withdrawal by Subject|15|||
161850677|NCT02661217|584494505|FG001|Overall Study|Withdrawal by Subject|19|||
161850678|NCT02661217|584494504|FG000|Overall Study|Did not enter follow-up epoch|7|||
161850679|NCT02661217|584494505|FG001|Overall Study|Did not enter follow-up epoch|10|||
161850680|NCT02661217|584494504|FG000|Overall Study|Death - no study drug received|1|||
161850681|NCT02661217|584494505|FG001|Overall Study|Death - no study drug received|2|||
161850682|NCT02661217|584494504|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
161850683|NCT02661217|584494505|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
161850684|NCT00958893|584494508|FG000|Overall Study|Study prematurely terminated|4|||
161850685|NCT03066258|584494512|FG000|Overall Study|Death|1|||
161850686|NCT03066258|584494513|FG001|Overall Study|Death|0|||
161850687|NCT03066258|584494514|FG002|Overall Study|Death|0|||
161850688|NCT03066258|584494515|FG003|Overall Study|Death|0|||
161850689|NCT03066258|584494516|FG004|Overall Study|Death|1|||
161850690|NCT02165735|584494517|FG000|Overall Study|Lost to Follow-up|12|||
161850691|NCT02165735|584494518|FG001|Overall Study|Lost to Follow-up|10|||
161850692|NCT02165735|584494517|FG000|Overall Study|Withdrawal by Subject|3|||
161850693|NCT02165735|584494518|FG001|Overall Study|Withdrawal by Subject|0|||
161850694|NCT02165735|584494517|FG000|Overall Study|Participant indicated lack of time|1|||
161850695|NCT02165735|584494518|FG001|Overall Study|Participant indicated lack of time|3|||
161850696|NCT02165735|584494517|FG000|Overall Study|Protocol Violation|0|||
161850697|NCT02165735|584494518|FG001|Overall Study|Protocol Violation|1|||
161850698|NCT02784795|584494519|FG000|Overall Study|Progressive Disease|2|||
161850699|NCT02784795|584494520|FG001|Overall Study|Progressive Disease|1|||
161850700|NCT02784795|584494521|FG002|Overall Study|Progressive Disease|1|||
161850701|NCT02784795|584494522|FG003|Overall Study|Progressive Disease|0|||
161850702|NCT02784795|584494523|FG004|Overall Study|Progressive Disease|2|||
161850703|NCT02784795|584494524|FG005|Overall Study|Progressive Disease|0|||
161850704|NCT02784795|584494525|FG006|Overall Study|Progressive Disease|2|||
161850705|NCT02784795|584494526|FG007|Overall Study|Progressive Disease|0|||
161850706|NCT02784795|584494527|FG008|Overall Study|Progressive Disease|0|||
161850707|NCT02784795|584494528|FG009|Overall Study|Progressive Disease|0|||
161850708|NCT02784795|584494529|FG010|Overall Study|Progressive Disease|1|||
161850709|NCT02784795|584494530|FG011|Overall Study|Progressive Disease|0|||
161850710|NCT02784795|584494519|FG000|Overall Study|Adverse Event|1|||
161850711|NCT02784795|584494520|FG001|Overall Study|Adverse Event|0|||
161850712|NCT02784795|584494521|FG002|Overall Study|Adverse Event|0|||
161850713|NCT02784795|584494522|FG003|Overall Study|Adverse Event|1|||
161850714|NCT02784795|584494523|FG004|Overall Study|Adverse Event|0|||
161850715|NCT02784795|584494524|FG005|Overall Study|Adverse Event|0|||
161850716|NCT02784795|584494525|FG006|Overall Study|Adverse Event|1|||
161850717|NCT02784795|584494526|FG007|Overall Study|Adverse Event|0|||
161850718|NCT02784795|584494527|FG008|Overall Study|Adverse Event|0|||
161850719|NCT02784795|584494528|FG009|Overall Study|Adverse Event|0|||
161850720|NCT02784795|584494529|FG010|Overall Study|Adverse Event|0|||
161850721|NCT02784795|584494530|FG011|Overall Study|Adverse Event|2|||
161850722|NCT02784795|584494519|FG000|Overall Study|Withdrawal by Subject|1|||
161850723|NCT02784795|584494520|FG001|Overall Study|Withdrawal by Subject|0|||
161850724|NCT02784795|584494521|FG002|Overall Study|Withdrawal by Subject|2|||
161850725|NCT02784795|584494522|FG003|Overall Study|Withdrawal by Subject|1|||
161850726|NCT02784795|584494523|FG004|Overall Study|Withdrawal by Subject|3|||
161850727|NCT02784795|584494524|FG005|Overall Study|Withdrawal by Subject|0|||
161850728|NCT02784795|584494525|FG006|Overall Study|Withdrawal by Subject|0|||
161850729|NCT02784795|584494526|FG007|Overall Study|Withdrawal by Subject|1|||
161850730|NCT02784795|584494527|FG008|Overall Study|Withdrawal by Subject|0|||
161850731|NCT02784795|584494528|FG009|Overall Study|Withdrawal by Subject|0|||
161850732|NCT02784795|584494529|FG010|Overall Study|Withdrawal by Subject|0|||
161850733|NCT02784795|584494530|FG011|Overall Study|Withdrawal by Subject|2|||
161850734|NCT02784795|584494519|FG000|Overall Study|Death|0|||
161850735|NCT02784795|584494520|FG001|Overall Study|Death|0|||
161850736|NCT02784795|584494521|FG002|Overall Study|Death|0|||
161850737|NCT02784795|584494522|FG003|Overall Study|Death|0|||
161850738|NCT02784795|584494523|FG004|Overall Study|Death|1|||
161850739|NCT02784795|584494524|FG005|Overall Study|Death|0|||
161850740|NCT02784795|584494525|FG006|Overall Study|Death|0|||
161850741|NCT02784795|584494526|FG007|Overall Study|Death|0|||
161850742|NCT02784795|584494527|FG008|Overall Study|Death|0|||
161850743|NCT02784795|584494528|FG009|Overall Study|Death|0|||
161850744|NCT02784795|584494529|FG010|Overall Study|Death|0|||
161850745|NCT02784795|584494530|FG011|Overall Study|Death|0|||
161850746|NCT02784795|584494519|FG000|Overall Study|Physician Decision|0|||
161850747|NCT02784795|584494520|FG001|Overall Study|Physician Decision|0|||
161850748|NCT02784795|584494521|FG002|Overall Study|Physician Decision|0|||
161850749|NCT02784795|584494522|FG003|Overall Study|Physician Decision|0|||
161850750|NCT02784795|584494523|FG004|Overall Study|Physician Decision|0|||
161850751|NCT02784795|584494524|FG005|Overall Study|Physician Decision|0|||
161850752|NCT02784795|584494525|FG006|Overall Study|Physician Decision|1|||
161850753|NCT02784795|584494526|FG007|Overall Study|Physician Decision|0|||
161850754|NCT02784795|584494527|FG008|Overall Study|Physician Decision|0|||
161850755|NCT02784795|584494528|FG009|Overall Study|Physician Decision|0|||
161850756|NCT02784795|584494529|FG010|Overall Study|Physician Decision|0|||
161850757|NCT02784795|584494530|FG011|Overall Study|Physician Decision|0|||
161850758|NCT00595309|584494531|FG000|Overall Study|Lost to Follow-up|1|||
161850759|NCT00595309|584494531|FG000|Overall Study|planned vaccination against yellow fever|1|||
161850760|NCT00595309|584494531|FG000|Overall Study|acute infection after V0|1|||
161850761|NCT00595309|584494531|FG000|Overall Study|personal reason|1|||
161850762|NCT00101283|584494532|FG000|Overall Study|Withdrawal by Subject|0|||
161850763|NCT00101283|584494533|FG001|Overall Study|Withdrawal by Subject|1|||
161850764|NCT00101283|584494532|FG000|Overall Study|Insurance Refusal|0|||
161850765|NCT00101283|584494533|FG001|Overall Study|Insurance Refusal|1|||
161850766|NCT00101283|584494532|FG000|Overall Study|Prostate Cancer Recurrence|0|||
161850767|NCT00101283|584494533|FG001|Overall Study|Prostate Cancer Recurrence|1|||
161850768|NCT02756208|584494536|FG000|Overall Study|Withdrawal by Subject|1|||
161850769|NCT02756208|584494537|FG001|Overall Study|Withdrawal by Subject|0|||
161850770|NCT02756208|584494538|FG002|Overall Study|Withdrawal by Subject|1|||
161850771|NCT02756208|584494539|FG003|Overall Study|Withdrawal by Subject|3|||
161850772|NCT02756208|584494536|FG000|Overall Study|Lost to Follow-up|3|||
161850773|NCT02756208|584494537|FG001|Overall Study|Lost to Follow-up|1|||
161850774|NCT02756208|584494538|FG002|Overall Study|Lost to Follow-up|1|||
161850775|NCT02756208|584494539|FG003|Overall Study|Lost to Follow-up|1|||
161850776|NCT02756208|584494536|FG000|Overall Study|Physician Decision|1|||
161850777|NCT02756208|584494537|FG001|Overall Study|Physician Decision|0|||
161850778|NCT02756208|584494538|FG002|Overall Study|Physician Decision|0|||
161850779|NCT02756208|584494539|FG003|Overall Study|Physician Decision|0|||
161850780|NCT02756208|584494536|FG000|Overall Study|Protocol Violation|0|||
161850781|NCT02756208|584494537|FG001|Overall Study|Protocol Violation|1|||
161850782|NCT02756208|584494538|FG002|Overall Study|Protocol Violation|0|||
161850783|NCT02756208|584494539|FG003|Overall Study|Protocol Violation|0|||
161850784|NCT03485365|584494540|FG000|Overall Study|Protocol Violation|0|||
161850785|NCT03485365|584494541|FG001|Overall Study|Protocol Violation|0|||
161850786|NCT03485365|584494542|FG002|Overall Study|Protocol Violation|0|||
161850787|NCT03485365|584494543|FG003|Overall Study|Protocol Violation|1|||
161850788|NCT03485365|584494544|FG004|Overall Study|Protocol Violation|0|||
161850789|NCT03485365|584494545|FG005|Overall Study|Protocol Violation|0|||
161850790|NCT03485365|584494546|FG006|Overall Study|Protocol Violation|1|||
161850791|NCT03485365|584494547|FG007|Overall Study|Protocol Violation|0|||
161850792|NCT03485365|584494548|FG008|Overall Study|Protocol Violation|0|||
161850793|NCT01275430|584494554|FG000|Overall Study|Adverse Event|1|||
161850794|NCT01275430|584494554|FG000|Overall Study|No Contrast Injection|6|||
161850795|NCT01275430|584494554|FG000|Overall Study|Device Malfunction|1|||
161850796|NCT01275430|584494554|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
161850797|NCT04988087|584494555|FG000|Overall Study|Adverse Event|4|||
161850798|NCT04988087|584494556|FG001|Overall Study|Adverse Event|0|||
161850799|NCT04988087|584494557|FG002|Overall Study|Adverse Event|0|||
161850800|NCT04988087|584494558|FG003|Overall Study|Adverse Event|0|||
161850801|NCT04988087|584494555|FG000|Overall Study|Withdrawal by Subject|1|||
161850802|NCT04988087|584494556|FG001|Overall Study|Withdrawal by Subject|1|||
161850803|NCT04988087|584494557|FG002|Overall Study|Withdrawal by Subject|0|||
161850804|NCT04988087|584494558|FG003|Overall Study|Withdrawal by Subject|0|||
161850805|NCT04988087|584494555|FG000|Overall Study|Technical problems|7|||
161850806|NCT04988087|584494556|FG001|Overall Study|Technical problems|9|||
161850807|NCT04988087|584494557|FG002|Overall Study|Technical problems|1|||
161850808|NCT04988087|584494558|FG003|Overall Study|Technical problems|2|||
161850809|NCT02613182|584494559|FG000|Overall Study|Death|6|||
161850810|NCT02613182|584494559|FG000|Overall Study|Physician Decision|1|||
161850811|NCT02613182|584494559|FG000|Overall Study|Study Terminated by Sponsor|21|||
161850812|NCT02613182|584494559|FG000|Overall Study|Withdrawal by Subject|6|||
161850813|NCT03968978|584494560|FG000|Overall Study|Adverse Event|1|||
161850814|NCT03968978|584494561|FG001|Overall Study|Adverse Event|0|||
161850815|NCT00863772|584494562|FG000|Overall Study|Adverse Event|1|||
161850816|NCT00863772|584494563|FG001|Overall Study|Adverse Event|4|||
161850817|NCT00863772|584494564|FG002|Overall Study|Adverse Event|0|||
161850818|NCT00863772|584494562|FG000|Overall Study|Lack of Efficacy|4|||
161850819|NCT00863772|584494563|FG001|Overall Study|Lack of Efficacy|2|||
161850820|NCT00863772|584494564|FG002|Overall Study|Lack of Efficacy|4|||
161850821|NCT00863772|584494562|FG000|Overall Study|Lost to Follow-up|5|||
161850822|NCT00863772|584494563|FG001|Overall Study|Lost to Follow-up|1|||
161850823|NCT00863772|584494564|FG002|Overall Study|Lost to Follow-up|1|||
161850824|NCT00863772|584494562|FG000|Overall Study|Protocol Violation|2|||
161850825|NCT00863772|584494563|FG001|Overall Study|Protocol Violation|0|||
161850826|NCT00863772|584494564|FG002|Overall Study|Protocol Violation|2|||
161850827|NCT00863772|584494562|FG000|Overall Study|Withdrawal by Subject|4|||
161850828|NCT00863772|584494563|FG001|Overall Study|Withdrawal by Subject|7|||
161850829|NCT00863772|584494564|FG002|Overall Study|Withdrawal by Subject|5|||
161850830|NCT00863772|584494562|FG000|Overall Study|Study terminated by sponsor|44|||
161850831|NCT00863772|584494563|FG001|Overall Study|Study terminated by sponsor|45|||
161850832|NCT00863772|584494564|FG002|Overall Study|Study terminated by sponsor|36|||
161850833|NCT00863772|584494562|FG000|Overall Study|Entered extension study|6|||
161850834|NCT00863772|584494563|FG001|Overall Study|Entered extension study|4|||
161850835|NCT00863772|584494564|FG002|Overall Study|Entered extension study|9|||
161850836|NCT00863772|584494562|FG000|Overall Study|Other|1|||
161850837|NCT00863772|584494563|FG001|Overall Study|Other|2|||
161850838|NCT00863772|584494564|FG002|Overall Study|Other|4|||
161850839|NCT00863772|584494562|FG000|Overall Study|Randomized but not Treated|1|||
161850840|NCT00863772|584494563|FG001|Overall Study|Randomized but not Treated|0|||
161850841|NCT00863772|584494564|FG002|Overall Study|Randomized but not Treated|0|||
161850842|NCT03014180|584494569|FG000|Overall Study|Protocol Violation|2|||
161850843|NCT04400682|584494570|FG000|Period 1|Withdrawal by Subject|1|||
161850844|NCT04400682|584494571|FG001|Period 1|Withdrawal by Subject|4|||
161850845|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
161850846|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
161850847|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850848|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850849|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850850|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850851|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850852|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850853|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850854|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850855|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
161850856|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
161850857|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850858|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850859|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850860|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850861|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850862|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850863|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850864|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850865|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850866|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
161850867|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850868|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850869|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850870|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850871|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850872|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850873|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850874|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850875|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
161850876|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850877|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850878|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850879|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850880|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850881|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850882|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850883|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850884|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850885|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
161850886|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
161850887|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850888|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850889|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850890|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850891|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850892|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850893|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850894|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850895|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
161850896|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
161850897|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850898|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850899|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850900|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850901|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850902|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850903|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850904|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850905|NCT04784533|584494572|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850906|NCT04784533|584494573|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850907|NCT04784533|584494574|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
161850908|NCT04784533|584494575|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850909|NCT04784533|584494576|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850910|NCT04784533|584494577|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850911|NCT04784533|584494578|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850912|NCT04784533|584494579|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850913|NCT04784533|584494580|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850914|NCT04784533|584494581|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850915|NCT04784533|584494572|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850916|NCT04784533|584494573|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850917|NCT04784533|584494574|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850918|NCT04784533|584494575|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850919|NCT04784533|584494576|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850920|NCT04784533|584494577|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850921|NCT04784533|584494578|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850922|NCT04784533|584494579|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850923|NCT04784533|584494580|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
161850924|NCT04784533|584494581|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850925|NCT04784533|584494572|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850926|NCT04784533|584494573|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850927|NCT04784533|584494574|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850928|NCT04784533|584494575|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850929|NCT04784533|584494576|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850930|NCT04784533|584494577|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850931|NCT04784533|584494578|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850932|NCT04784533|584494579|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850933|NCT04784533|584494580|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
161850934|NCT04784533|584494581|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
161850935|NCT02105974|584494582|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
161850936|NCT02105974|584494583|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
161850937|NCT02105974|584494584|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
161850938|NCT02105974|584494582|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
161850939|NCT02105974|584494583|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
161850940|NCT02105974|584494584|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
161850941|NCT02105974|584494582|FG000|2 Week Run-in Period|Adverse Event|6|||
161850942|NCT02105974|584494583|FG001|2 Week Run-in Period|Adverse Event|0|||
161850943|NCT02105974|584494584|FG002|2 Week Run-in Period|Adverse Event|0|||
161850944|NCT02105974|584494582|FG000|2 Week Run-in Period|Study closed/terminated|1|||
161850945|NCT02105974|584494583|FG001|2 Week Run-in Period|Study closed/terminated|0|||
161850946|NCT02105974|584494584|FG002|2 Week Run-in Period|Study closed/terminated|0|||
161850947|NCT02105974|584494582|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
161850948|NCT02105974|584494583|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
161850949|NCT02105974|584494584|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
161850950|NCT02105974|584494582|FG000|2 Week Run-in Period|Withdrew consent|23|||
161850951|NCT02105974|584494583|FG001|2 Week Run-in Period|Withdrew consent|0|||
161850952|NCT02105974|584494584|FG002|2 Week Run-in Period|Withdrew consent|0|||
161850953|NCT02105974|584494582|FG000|2 Week Run-in Period|Investigator discretion|8|||
161850954|NCT02105974|584494583|FG001|2 Week Run-in Period|Investigator discretion|0|||
161850955|NCT02105974|584494584|FG002|2 Week Run-in Period|Investigator discretion|0|||
161850956|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
161850957|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
161764403|NCT03395704|584176244|FG001|Overall Study|Withdrawal by Subject|1|||
161764404|NCT03395704|584176243|FG000|Overall Study|Physician Decision|0|||
161764405|NCT03395704|584176244|FG001|Overall Study|Physician Decision|1|||
161764406|NCT02927990|584178765|FG000|Overall Study|Protocol Violation|4|||
161764407|NCT02927990|584178765|FG000|Overall Study|Physician Decision|9|||
161764408|NCT02927990|584178765|FG000|Overall Study|Room switched and therefore no study device available|15|||
161764409|NCT02927990|584178765|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
161764410|NCT00960323|584178766|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
161764411|NCT01524900|584178772|FG000|Overall Study|Lost to Follow-up|3|||
161764412|NCT01524900|584178773|FG001|Overall Study|Lost to Follow-up|12|||
161764413|NCT01524900|584178774|FG002|Overall Study|Lost to Follow-up|1|||
161764414|NCT01524900|584178775|FG003|Overall Study|Lost to Follow-up|0|||
161764415|NCT01524900|584178776|FG004|Overall Study|Lost to Follow-up|0|||
161764416|NCT01524900|584178772|FG000|Overall Study|Other reason than stated above|1|||
161764417|NCT01524900|584178773|FG001|Overall Study|Other reason than stated above|1|||
161764418|NCT01524900|584178774|FG002|Overall Study|Other reason than stated above|0|||
161764419|NCT01524900|584178775|FG003|Overall Study|Other reason than stated above|0|||
161764420|NCT01524900|584178776|FG004|Overall Study|Other reason than stated above|0|||
161764421|NCT01524900|584178772|FG000|Overall Study|No reason documented|2|||
161764422|NCT01524900|584178773|FG001|Overall Study|No reason documented|1|||
161764423|NCT01524900|584178774|FG002|Overall Study|No reason documented|0|||
161764424|NCT01524900|584178775|FG003|Overall Study|No reason documented|1|||
161764425|NCT01524900|584178776|FG004|Overall Study|No reason documented|0|||
161764426|NCT00772031|584178777|FG000|Overall Study|Early termination of trial|12|||
161764427|NCT00772031|584178778|FG001|Overall Study|Early termination of trial|10|||
161764428|NCT00772031|584178777|FG000|Overall Study|Lost to Follow-up|20|||
161764429|NCT00772031|584178778|FG001|Overall Study|Lost to Follow-up|33|||
161764430|NCT00532441|584178779|FG000|Overall Study|Death|1|||
161764431|NCT00532441|584178780|FG001|Overall Study|Death|0|||
161764432|NCT00303329|584178781|FG000|Overall Study|Adverse Event|7|||
161764433|NCT00303329|584178782|FG001|Overall Study|Adverse Event|14|||
161764434|NCT00303329|584178781|FG000|Overall Study|Abnormal Laboratory Values|0|||
161764435|NCT00303329|584178782|FG001|Overall Study|Abnormal Laboratory Values|1|||
161764436|NCT00303329|584178781|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161764437|NCT00303329|584178782|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161764438|NCT00303329|584178781|FG000|Overall Study|Condition no longer requires study drug|0|||
161764439|NCT00303329|584178782|FG001|Overall Study|Condition no longer requires study drug|8|||
161764440|NCT00303329|584178781|FG000|Overall Study|Protocol Violation|3|||
161764441|NCT00303329|584178782|FG001|Overall Study|Protocol Violation|0|||
161764442|NCT00303329|584178781|FG000|Overall Study|Withdrawal by Subject|9|||
161764443|NCT00303329|584178782|FG001|Overall Study|Withdrawal by Subject|15|||
161764444|NCT00303329|584178781|FG000|Overall Study|Lost to Follow-up|0|||
161764445|NCT00303329|584178782|FG001|Overall Study|Lost to Follow-up|1|||
161764446|NCT00303329|584178781|FG000|Overall Study|Administrative problems|1|||
161764447|NCT00303329|584178782|FG001|Overall Study|Administrative problems|0|||
161764448|NCT00303329|584178781|FG000|Overall Study|Death|2|||
161764449|NCT00303329|584178782|FG001|Overall Study|Death|12|||
161850958|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
161850959|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
161850960|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
161850961|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
161850962|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
161850963|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
161850964|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
161850965|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
161850966|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
161850967|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
161850968|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
161850969|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
161850970|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
161850971|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
161850972|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
161850973|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
161850974|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
161850975|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
161850976|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
161850977|NCT03597464|584494592|FG000|Overall Study|Withdrawal by Subject|4|||
161850978|NCT03597464|584494593|FG001|Overall Study|Withdrawal by Subject|5|||
161850979|NCT03597464|584494592|FG000|Overall Study|Lost to Follow-up|3|||
161850980|NCT03597464|584494593|FG001|Overall Study|Lost to Follow-up|1|||
161850981|NCT03597464|584494592|FG000|Overall Study|Pregnancy|3|||
161850982|NCT03597464|584494593|FG001|Overall Study|Pregnancy|1|||
161850983|NCT03597464|584494592|FG000|Overall Study|Lack of Efficacy|2|||
161850984|NCT03597464|584494593|FG001|Overall Study|Lack of Efficacy|0|||
161850985|NCT03597464|584494592|FG000|Overall Study|Physician Decision|2|||
161850986|NCT03597464|584494593|FG001|Overall Study|Physician Decision|2|||
161850987|NCT03597464|584494592|FG000|Overall Study|Protocol Violation|1|||
161850988|NCT03597464|584494593|FG001|Overall Study|Protocol Violation|1|||
161850989|NCT03597464|584494592|FG000|Overall Study|Adverse Event|0|||
161850990|NCT03597464|584494593|FG001|Overall Study|Adverse Event|2|||
161850991|NCT03597464|584494592|FG000|Overall Study|Death|0|||
161850992|NCT03597464|584494593|FG001|Overall Study|Death|3|||
161850993|NCT02847260|584496098|FG000|Overall Study|Adverse Event|3|||
161850994|NCT02847260|584496098|FG000|Overall Study|Withdrawal by Subject|2|||
161850995|NCT02847260|584496098|FG000|Overall Study|Clinical Deterioration|1|||
161850996|NCT02847260|584496098|FG000|Overall Study|Physician Decision|1|||
161850997|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
161850998|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
161850999|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
161851000|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
161851001|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
161851002|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851003|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851004|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851005|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851006|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851007|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
161851008|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
161851009|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
161851010|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
161851011|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
161851012|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851013|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851014|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851015|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851016|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851017|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
161851018|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
161851019|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
161851020|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
161851021|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
161851022|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851023|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851024|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851025|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851026|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851027|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
161851028|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
161851029|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
161851030|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
161851031|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
161851032|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851033|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851034|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851035|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851036|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851037|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851038|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851039|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851040|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
161851041|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851042|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851043|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851044|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851045|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851046|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851047|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
161851048|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
161851049|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
161851050|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
161851051|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
161851052|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851053|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851054|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851055|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851056|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851057|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851058|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851059|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851060|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
161851061|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851062|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851063|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851064|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851065|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851066|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851067|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
161851068|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
161851069|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
161851070|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
161851071|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
161851072|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
161851073|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
161851074|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
161851075|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
161851076|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
161851077|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851078|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851079|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851080|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851081|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851082|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
161851083|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
161851084|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
161851085|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
161851086|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
161851087|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851088|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851089|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851090|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851091|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851092|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
161851093|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
161851094|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
161851095|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
161851096|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
161851097|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851098|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851099|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851100|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851101|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851102|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
161851103|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
161851104|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
161851105|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
161851106|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
161851107|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851108|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851109|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851110|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851111|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851112|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851113|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
161851114|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851115|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
161851116|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
161851117|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851118|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851119|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851120|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851121|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851122|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851123|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851124|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
161851125|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
161851126|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851127|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
161851128|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
161851129|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
161851130|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
161851131|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
161851132|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
161851133|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
161851134|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
161851135|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
161851136|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
161851137|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Other|0|||
161851138|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Other|0|||
161851139|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Other|0|||
161851140|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Other|0|||
161851141|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Other|0|||
161851142|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Other|0|||
161851143|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Other|0|||
161851144|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Other|0|||
161851145|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Other|1|||
161851146|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Other|1|||
161851147|NCT00129389|584496111|FG000|Overall Study|Adverse Event|19|||
161851148|NCT00129389|584496112|FG001|Overall Study|Adverse Event|87|||
161851149|NCT00129389|584496111|FG000|Overall Study|Death|0|||
161851150|NCT00129389|584496112|FG001|Overall Study|Death|1|||
161851151|NCT00129389|584496111|FG000|Overall Study|Lost to Follow-up|2|||
161851152|NCT00129389|584496112|FG001|Overall Study|Lost to Follow-up|1|||
161851153|NCT00129389|584496111|FG000|Overall Study|Physician Decision|0|||
161851154|NCT00129389|584496112|FG001|Overall Study|Physician Decision|4|||
161851155|NCT00129389|584496111|FG000|Overall Study|Protocol Violation|0|||
161851156|NCT00129389|584496112|FG001|Overall Study|Protocol Violation|6|||
161851157|NCT00129389|584496111|FG000|Overall Study|Withdrawal by Subject|9|||
161851158|NCT00129389|584496112|FG001|Overall Study|Withdrawal by Subject|23|||
161851159|NCT00129389|584496111|FG000|Overall Study|Relapse|1|||
161851160|NCT00129389|584496112|FG001|Overall Study|Relapse|0|||
161851161|NCT00129389|584496111|FG000|Overall Study|Not eligible|1|||
161851162|NCT00129389|584496112|FG001|Overall Study|Not eligible|2|||
161851163|NCT00129389|584496111|FG000|Overall Study|Crossed to the other arm|1|||
161851164|NCT00129389|584496112|FG001|Overall Study|Crossed to the other arm|16|||
161851165|NCT01191944|584496116|FG000|Overall Study|Adverse Event|11|||
161851166|NCT01191944|584496117|FG001|Overall Study|Adverse Event|12|||
161851167|NCT01191944|584496116|FG000|Overall Study|Protocol Violation|1|||
161851168|NCT01191944|584496117|FG001|Overall Study|Protocol Violation|2|||
161851169|NCT01191944|584496116|FG000|Overall Study|Withdrawal by Subject|4|||
161851170|NCT01191944|584496117|FG001|Overall Study|Withdrawal by Subject|2|||
161851171|NCT01191944|584496116|FG000|Overall Study|Other|1|||
161851172|NCT01191944|584496117|FG001|Overall Study|Other|3|||
161851173|NCT02794246|584496122|FG000|Overall Study|Withdrawal by Subject|2|||
161851174|NCT02794246|584496122|FG000|Overall Study|Physician Decision|4|||
161851175|NCT04602546|584496123|FG000|Overall Study|Training|2|||
161851176|NCT04602546|584496124|FG001|Overall Study|Training|2|||
161851177|NCT04602546|584496125|FG002|Overall Study|Training|1|||
161851178|NCT04602546|584496126|FG003|Overall Study|Training|2|||
161851179|NCT04602546|584496127|FG004|Overall Study|Training|0|||
161851180|NCT04602546|584496123|FG000|Overall Study|Randomized with disqualified data|2|||
161851181|NCT04602546|584496124|FG001|Overall Study|Randomized with disqualified data|0|||
161851182|NCT04602546|584496125|FG002|Overall Study|Randomized with disqualified data|2|||
161851183|NCT04602546|584496126|FG003|Overall Study|Randomized with disqualified data|5|||
161851184|NCT04602546|584496127|FG004|Overall Study|Randomized with disqualified data|3|||
161851185|NCT01831258|584496129|FG000|Overall Study|Withdrawal by Subject|2|||
161851186|NCT01831258|584496130|FG001|Overall Study|Withdrawal by Subject|1|||
161851187|NCT01831258|584496129|FG000|Overall Study|Lost to Follow-up|3|||
161851188|NCT01831258|584496130|FG001|Overall Study|Lost to Follow-up|2|||
161851189|NCT01753297|584496135|FG000|Overall Study|Lost to Follow-up|7|||
161851190|NCT01753297|584496136|FG001|Overall Study|Lost to Follow-up|2|||
161851191|NCT01753297|584496135|FG000|Overall Study|Withdrawal by Subject|26|||
161851192|NCT01753297|584496136|FG001|Overall Study|Withdrawal by Subject|23|||
161851193|NCT01753297|584496135|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
161851194|NCT01753297|584496136|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
161851195|NCT01753297|584496135|FG000|Overall Study|Death|0|||
161851196|NCT01753297|584496136|FG001|Overall Study|Death|2|||
161851197|NCT01753297|584496135|FG000|Overall Study|Did not attend end of study visit|7|||
161851198|NCT01753297|584496136|FG001|Overall Study|Did not attend end of study visit|8|||
161851199|NCT02533180|584496137|FG000|Overall Study|Death|0|||
161851200|NCT02533180|584496138|FG001|Overall Study|Death|2|||
161851201|NCT02533180|584496137|FG000|Overall Study|Lost to Follow-up|0|||
161851202|NCT02533180|584496138|FG001|Overall Study|Lost to Follow-up|1|||
161851203|NCT02533180|584496137|FG000|Overall Study|Physician Decision|0|||
161851204|NCT02533180|584496138|FG001|Overall Study|Physician Decision|1|||
161851205|NCT02533180|584496137|FG000|Overall Study|Withdrawal by Subject|2|||
161851206|NCT02533180|584496138|FG001|Overall Study|Withdrawal by Subject|5|||
161851207|NCT02533180|584496137|FG000|Overall Study|Screen Failure|37|||
161851208|NCT02533180|584496138|FG001|Overall Study|Screen Failure|0|||
161851209|NCT02533180|584496137|FG000|Overall Study|Protocol Deviation|0|||
161851210|NCT02533180|584496138|FG001|Overall Study|Protocol Deviation|1|||
161851211|NCT02533180|584496137|FG000|Overall Study|Non-compliance|0|||
161851212|NCT02533180|584496138|FG001|Overall Study|Non-compliance|1|||
161851213|NCT01174043|584496140|FG000|Overall Study|Disease progression|5|||
161851214|NCT01174043|584496140|FG000|Overall Study|Adverse Event|3|||
161851215|NCT01174043|584496140|FG000|Overall Study|Death|1|||
161851216|NCT01174043|584496140|FG000|Overall Study|Withdrawal by Subject|2|||
161851217|NCT00794339|584496145|FG000|Overall Study|Withdrawal by Subject|3|||
161851218|NCT00794339|584496145|FG000|Overall Study|Ineligible|4|||
161851219|NCT00794339|584496145|FG000|Overall Study|Tx prior to ATSM|3|||
161851220|NCT00794339|584496145|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
161851221|NCT00794339|584496145|FG000|Overall Study|Tx not per protocol|1|||
161851222|NCT01118975|584496150|FG000|Overall Study|Adverse Event|0|||
161851223|NCT01118975|584496151|FG001|Overall Study|Adverse Event|1|||
161851224|NCT01371539|584496154|FG000|Period One: One Week|Lost to Follow-up|0|||
161851225|NCT01371539|584496155|FG001|Period One: One Week|Lost to Follow-up|1|||
161851226|NCT01371539|584496154|FG000|Period Two: One Week|Lost to Follow-up|0|||
161851227|NCT01371539|584496155|FG001|Period Two: One Week|Lost to Follow-up|1|||
161851228|NCT01371539|584496154|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
161851229|NCT01371539|584496155|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
161851230|NCT01371539|584496154|FG000|Period Two: One Week|Time/job conflict|0|||
161851231|NCT01371539|584496155|FG001|Period Two: One Week|Time/job conflict|1|||
161851232|NCT01399658|584496156|FG000|Overall Study|Ineligible|1|||
161851233|NCT01399658|584496156|FG000|Overall Study|Machine Technical Issue|3|||
161851234|NCT01399658|584496156|FG000|Overall Study|Alternative therapy|1|||
161851235|NCT01399658|584496156|FG000|Overall Study|No reason given|1|||
161851236|NCT04315506|584496160|FG000|Overall Study|Lost to Follow-up|74|||
161851237|NCT04315506|584496161|FG001|Overall Study|Lost to Follow-up|82|||
161851238|NCT04315506|584496160|FG000|Overall Study|Withdrawal by Subject|8|||
161851239|NCT04315506|584496161|FG001|Overall Study|Withdrawal by Subject|8|||
161851240|NCT04315506|584496160|FG000|Overall Study|Physician Decision|0|||
161851241|NCT04315506|584496161|FG001|Overall Study|Physician Decision|1|||
161851242|NCT00704132|584496163|FG000|Overall Study|Clinical Adverse Experience|1|||
161851243|NCT00704132|584496164|FG001|Overall Study|Clinical Adverse Experience|0|||
161851244|NCT00704132|584496163|FG000|Overall Study|Lack of Efficacy|0|||
161851245|NCT00704132|584496164|FG001|Overall Study|Lack of Efficacy|1|||
161764450|NCT00303329|584178781|FG000|Overall Study|Stopped at end of core|3|||
161764451|NCT00303329|584178782|FG001|Overall Study|Stopped at end of core|9|||
161764452|NCT00303329|584178781|FG000|Overall Study|Stopped at end of extension 1|1|||
161764453|NCT00303329|584178782|FG001|Overall Study|Stopped at end of extension 1|0|||
161764454|NCT01101321|584178785|FG000|Period 1|Withdrawal by Subject|1|||
161764455|NCT01101321|584178786|FG001|Period 1|Withdrawal by Subject|1|||
161764456|NCT01101321|584178785|FG000|Period 1|Adverse Event|3|||
161764457|NCT01101321|584178786|FG001|Period 1|Adverse Event|3|||
161764458|NCT03339999|584178787|FG000|Overall Study|Adverse Event|1|||
161764459|NCT03339999|584178788|FG001|Overall Study|Adverse Event|2|||
161764460|NCT03339999|584178789|FG002|Overall Study|Adverse Event|2|||
161764461|NCT03339999|584178790|FG003|Overall Study|Adverse Event|1|||
161764462|NCT03339999|584178787|FG000|Overall Study|Lack of Efficacy|0|||
161764463|NCT03339999|584178788|FG001|Overall Study|Lack of Efficacy|1|||
161764464|NCT03339999|584178789|FG002|Overall Study|Lack of Efficacy|0|||
161764465|NCT03339999|584178790|FG003|Overall Study|Lack of Efficacy|0|||
161764466|NCT03339999|584178787|FG000|Overall Study|Lost to Follow-up|0|||
161764467|NCT03339999|584178788|FG001|Overall Study|Lost to Follow-up|0|||
161764468|NCT03339999|584178789|FG002|Overall Study|Lost to Follow-up|0|||
161764469|NCT03339999|584178790|FG003|Overall Study|Lost to Follow-up|1|||
161764470|NCT03339999|584178787|FG000|Overall Study|Study Terminated by Sponsor|6|||
161764471|NCT03339999|584178788|FG001|Overall Study|Study Terminated by Sponsor|3|||
161764472|NCT03339999|584178789|FG002|Overall Study|Study Terminated by Sponsor|4|||
161764473|NCT03339999|584178790|FG003|Overall Study|Study Terminated by Sponsor|3|||
161764474|NCT00525499|584178791|FG000|Overall Study|Lost to Follow-up|2|||
161764475|NCT00525499|584178792|FG001|Overall Study|Lost to Follow-up|4|||
161764476|NCT00525499|584178793|FG002|Overall Study|Lost to Follow-up|1|||
161764477|NCT00525499|584178794|FG003|Overall Study|Lost to Follow-up|4|||
161764478|NCT00525499|584178791|FG000|Overall Study|Adverse Event|0|||
161764479|NCT00525499|584178792|FG001|Overall Study|Adverse Event|1|||
161764480|NCT00525499|584178793|FG002|Overall Study|Adverse Event|0|||
161764481|NCT00525499|584178794|FG003|Overall Study|Adverse Event|1|||
161764482|NCT00525499|584178791|FG000|Overall Study|Withdrawal by Subject|5|||
161764483|NCT00525499|584178792|FG001|Overall Study|Withdrawal by Subject|1|||
161764484|NCT00525499|584178793|FG002|Overall Study|Withdrawal by Subject|5|||
161764485|NCT00525499|584178794|FG003|Overall Study|Withdrawal by Subject|2|||
161764486|NCT00525499|584178791|FG000|Overall Study|Protocol Violation|0|||
161764487|NCT00525499|584178792|FG001|Overall Study|Protocol Violation|1|||
161764488|NCT00525499|584178793|FG002|Overall Study|Protocol Violation|1|||
161764489|NCT00525499|584178794|FG003|Overall Study|Protocol Violation|0|||
161764490|NCT01856920|584178797|FG000|Overall Study|Disease Progression On Study|3|||
161764491|NCT01856920|584178798|FG001|Overall Study|Disease Progression On Study|4|||
161764492|NCT01856920|584178797|FG000|Overall Study|Disease Progression before Treatment|1|||
161764493|NCT01856920|584178798|FG001|Overall Study|Disease Progression before Treatment|0|||
161764494|NCT01856920|584178797|FG000|Overall Study|Ineligible|0|||
161764495|NCT01856920|584178798|FG001|Overall Study|Ineligible|1|||
161764496|NCT01856920|584178797|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
161764497|NCT01856920|584178798|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
161764498|NCT01856920|584178797|FG000|Overall Study|Refused further Treatment|5|||
161764499|NCT01856920|584178798|FG001|Overall Study|Refused further Treatment|1|||
161764500|NCT01856920|584178797|FG000|Overall Study|Other Reasons|0|||
161764501|NCT01856920|584178798|FG001|Overall Study|Other Reasons|1|||
161764502|NCT01856920|584178797|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
161764503|NCT01856920|584178798|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
161764504|NCT03287089|584178804|FG000|Overall Study|Lost to Follow-up|0|||
161764505|NCT03287089|584178805|FG001|Overall Study|Lost to Follow-up|2|||
161764506|NCT03287089|584178804|FG000|Overall Study|Physician Decision|0|||
161764507|NCT03287089|584178805|FG001|Overall Study|Physician Decision|2|||
161764508|NCT03287089|584178804|FG000|Overall Study|Withdrawal by Subject|0|||
161764509|NCT03287089|584178805|FG001|Overall Study|Withdrawal by Subject|2|||
161764510|NCT01729559|584178806|FG000|Overall Study|Protocol Violation|31|||
161764511|NCT01729559|584178807|FG001|Overall Study|Protocol Violation|28|||
161764512|NCT02452034|584178812|FG000|Overall Study|Adverse Event|0|||
161764513|NCT02452034|584178813|FG001|Overall Study|Adverse Event|0|||
161764514|NCT02452034|584178814|FG002|Overall Study|Adverse Event|0|||
161764515|NCT02452034|584178815|FG003|Overall Study|Adverse Event|0|||
161764516|NCT02452034|584178816|FG004|Overall Study|Adverse Event|0|||
161764517|NCT02452034|584178817|FG005|Overall Study|Adverse Event|1|||
161764518|NCT02452034|584178812|FG000|Overall Study|Death|0|||
161764519|NCT02452034|584178813|FG001|Overall Study|Death|0|||
161764520|NCT02452034|584178814|FG002|Overall Study|Death|0|||
161764521|NCT02452034|584178815|FG003|Overall Study|Death|0|||
161764522|NCT02452034|584178816|FG004|Overall Study|Death|1|||
161764523|NCT02452034|584178817|FG005|Overall Study|Death|1|||
161764524|NCT02452034|584178812|FG000|Overall Study|Physician Decision|0|||
161764525|NCT02452034|584178813|FG001|Overall Study|Physician Decision|1|||
161764526|NCT02452034|584178814|FG002|Overall Study|Physician Decision|1|||
161851246|NCT00704132|584496163|FG000|Overall Study|Withdrawal by Subject|0|||
161851247|NCT00704132|584496164|FG001|Overall Study|Withdrawal by Subject|1|||
161851248|NCT00442962|584496165|FG000|Overall Study|Pregnancy|1|||
161851249|NCT00442962|584496165|FG000|Overall Study|Lost to Follow-up|7|||
161851250|NCT04238650|584496166|FG000|Overall Study|Withdrawal by Subject|0|||
161851251|NCT04238650|584496167|FG001|Overall Study|Withdrawal by Subject|1|||
161851252|NCT03348163|584496168|FG000|Overall Study|Withdrawal by Subject|2|||
161851253|NCT03348163|584496169|FG001|Overall Study|Withdrawal by Subject|0|||
161851254|NCT02585778|584496170|FG000|Overall Study|Adverse Event|17|||
161851255|NCT02585778|584496171|FG001|Overall Study|Adverse Event|4|||
161851256|NCT02585778|584496170|FG000|Overall Study|Participant did not wish to continue|9|||
161851257|NCT02585778|584496171|FG001|Overall Study|Participant did not wish to continue|4|||
161851258|NCT02585778|584496170|FG000|Overall Study|Poor compliance to study protocol|0|||
161851259|NCT02585778|584496171|FG001|Overall Study|Poor compliance to study protocol|2|||
161851260|NCT02585778|584496170|FG000|Overall Study|Death|0|||
161851261|NCT02585778|584496171|FG001|Overall Study|Death|1|||
161851262|NCT02585778|584496170|FG000|Overall Study|Randomized but not treated|1|||
161851263|NCT02585778|584496171|FG001|Overall Study|Randomized but not treated|2|||
161851264|NCT02585778|584496170|FG000|Overall Study|Other than specified above|6|||
161851265|NCT02585778|584496171|FG001|Overall Study|Other than specified above|2|||
161851266|NCT03682107|584496177|FG000|Overall Study|Withdrawal by Subject|0|||
161851267|NCT03682107|584496178|FG001|Overall Study|Withdrawal by Subject|1|||
161851268|NCT03682107|584496179|FG002|Overall Study|Withdrawal by Subject|0|||
161851269|NCT03682107|584496180|FG003|Overall Study|Withdrawal by Subject|0|||
161851270|NCT03682107|584496181|FG004|Overall Study|Withdrawal by Subject|0|||
161851271|NCT05211726|584496182|FG000|Overall Study|Withdrawal by Subject|2|||
161851272|NCT05211726|584496183|FG001|Overall Study|Withdrawal by Subject|3|||
161851273|NCT05211726|584496182|FG000|Overall Study|Protocol Violation|0|||
161851274|NCT05211726|584496183|FG001|Overall Study|Protocol Violation|1|||
161851275|NCT01038297|584496184|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
161851276|NCT01038297|584496185|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
161851277|NCT01038297|584496186|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
161851278|NCT02714426|584496192|FG000|Overall Study|Withdrawal by Subject|2|||
161851279|NCT02714426|584496193|FG001|Overall Study|Withdrawal by Subject|2|||
161851280|NCT00908310|584496196|FG000|Overall Study|Death|37|||
161851281|NCT00908310|584496196|FG000|Overall Study|Withdrawal by Subject|7|||
161851282|NCT00908310|584496196|FG000|Overall Study|Lost to Follow-up|7|||
161851283|NCT00908310|584496196|FG000|Overall Study|Screening failure|5|||
161851284|NCT00908310|584496196|FG000|Overall Study|Other reasons|4|||
161851285|NCT00725205|584496199|FG000|Overall Study|Adverse Event|22|||
161764527|NCT02452034|584178815|FG003|Overall Study|Physician Decision|0|||
161764528|NCT02452034|584178816|FG004|Overall Study|Physician Decision|0|||
161764529|NCT02452034|584178817|FG005|Overall Study|Physician Decision|0|||
161764530|NCT02452034|584178812|FG000|Overall Study|Protocol Violation|0|||
161764531|NCT02452034|584178813|FG001|Overall Study|Protocol Violation|0|||
161764532|NCT02452034|584178814|FG002|Overall Study|Protocol Violation|0|||
161764533|NCT02452034|584178815|FG003|Overall Study|Protocol Violation|0|||
161764534|NCT02452034|584178816|FG004|Overall Study|Protocol Violation|0|||
161764535|NCT02452034|584178817|FG005|Overall Study|Protocol Violation|1|||
161764536|NCT02452034|584178812|FG000|Overall Study|Screen Failure|1|||
161764537|NCT02452034|584178813|FG001|Overall Study|Screen Failure|0|||
161764538|NCT02452034|584178814|FG002|Overall Study|Screen Failure|0|||
161764539|NCT02452034|584178815|FG003|Overall Study|Screen Failure|1|||
161764540|NCT02452034|584178816|FG004|Overall Study|Screen Failure|0|||
161764541|NCT02452034|584178817|FG005|Overall Study|Screen Failure|0|||
161764542|NCT02452034|584178812|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161764543|NCT02452034|584178813|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
161764544|NCT02452034|584178814|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161764545|NCT02452034|584178815|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
161764546|NCT02452034|584178816|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
161764547|NCT02452034|584178817|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
161764548|NCT01453439|584178822|FG000|Treatment Phase|Withdrawal by Subject|13|||
161764549|NCT01453439|584178823|FG001|Treatment Phase|Withdrawal by Subject|10|||
161764550|NCT01453439|584178822|FG000|Treatment Phase|Suicidal Ideation|2|||
161764551|NCT01453439|584178823|FG001|Treatment Phase|Suicidal Ideation|0|||
161764552|NCT01453439|584178822|FG000|Treatment Phase|Need for higher level of care|1|||
161764553|NCT01453439|584178823|FG001|Treatment Phase|Need for higher level of care|1|||
161851286|NCT00725205|584496199|FG000|Overall Study|Investigator Discontinued|1|||
161851287|NCT00725205|584496199|FG000|Overall Study|Non-compliance With Protocol|14|||
161851288|NCT00725205|584496199|FG000|Overall Study|Other|8|||
161851289|NCT00725205|584496199|FG000|Overall Study|Protocol Defined Clinical Event|1|||
161851290|NCT00725205|584496199|FG000|Overall Study|Treatment Failure|41|||
161851291|NCT02212379|584496203|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
161764554|NCT01453439|584178822|FG000|Treatment Phase|Therapist conflict of interest|1|||
161764555|NCT01453439|584178823|FG001|Treatment Phase|Therapist conflict of interest|0|||
161764556|NCT01453439|584178822|FG000|Follow-up|Withdrawal by Subject|0|||
161764557|NCT01453439|584178823|FG001|Follow-up|Withdrawal by Subject|1|||
161764558|NCT01453439|584178822|FG000|Follow-up|Lost to Follow-up|5|||
161764559|NCT01453439|584178823|FG001|Follow-up|Lost to Follow-up|10|||
161764560|NCT01014442|584178824|FG000|Overall Study|Adverse Event|0|||
161764561|NCT01014442|584178825|FG001|Overall Study|Adverse Event|8|||
161764562|NCT01014442|584178824|FG000|Overall Study|Withdrawal by Subject|4|||
161764563|NCT01014442|584178825|FG001|Overall Study|Withdrawal by Subject|4|||
161764564|NCT01014442|584178824|FG000|Overall Study|Protocol Violation|2|||
161764565|NCT01014442|584178825|FG001|Overall Study|Protocol Violation|5|||
161764566|NCT01014442|584178824|FG000|Overall Study|Lack of Compliance|0|||
161764567|NCT01014442|584178825|FG001|Overall Study|Lack of Compliance|1|||
161764568|NCT01014442|584178824|FG000|Overall Study|Unspecified Reason|1|||
161764569|NCT01014442|584178825|FG001|Overall Study|Unspecified Reason|1|||
161764570|NCT02074059|584178826|FG000|Overall Study|Death|0|||
161764571|NCT02074059|584178827|FG001|Overall Study|Death|0|||
161764572|NCT02074059|584178828|FG002|Overall Study|Death|0|||
161764573|NCT02074059|584178829|FG003|Overall Study|Death|0|||
161764574|NCT02074059|584178830|FG004|Overall Study|Death|1|||
161764575|NCT02074059|584178831|FG005|Overall Study|Death|1|||
161764576|NCT02764229|584178837|FG000|Overall Study|Withdrawal by Subject|15|||
161764577|NCT02764229|584178837|FG000|Overall Study|Adverse Event|9|||
161764578|NCT02764229|584178837|FG000|Overall Study|Physician Decision|5|||
161764579|NCT02764229|584178837|FG000|Overall Study|Lost to Follow-up|3|||
161764580|NCT02764229|584178837|FG000|Overall Study|Lack of Efficacy|1|||
161764581|NCT02764229|584178837|FG000|Overall Study|Study Stopped by Sponsor|69|||
161764582|NCT00672490|584178838|FG000|Overall Study|Withdrawal by Subject|8|||
161764583|NCT00672490|584178839|FG001|Overall Study|Withdrawal by Subject|8|||
161764584|NCT00672490|584178838|FG000|Overall Study|Lack of Compliance|2|||
161764585|NCT00672490|584178839|FG001|Overall Study|Lack of Compliance|7|||
161764586|NCT00672490|584178838|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
161764587|NCT00672490|584178839|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
161764588|NCT00672490|584178838|FG000|Overall Study|Adverse Event|5|||
161764589|NCT00672490|584178839|FG001|Overall Study|Adverse Event|8|||
161764590|NCT00672490|584178838|FG000|Overall Study|Violation of Concomitant Medicine|1|||
161764591|NCT00672490|584178839|FG001|Overall Study|Violation of Concomitant Medicine|0|||
161764592|NCT00672490|584178838|FG000|Overall Study|Intolerance|0|||
161764593|NCT00672490|584178839|FG001|Overall Study|Intolerance|2|||
161764594|NCT00672490|584178838|FG000|Overall Study|Lost to Follow-up|1|||
161764595|NCT00672490|584178839|FG001|Overall Study|Lost to Follow-up|5|||
161764596|NCT00672490|584178838|FG000|Overall Study|No reason was provided|6|||
161764597|NCT00672490|584178839|FG001|Overall Study|No reason was provided|2|||
161764598|NCT02242305|584178849|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
161764599|NCT02242305|584178850|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
161764600|NCT02242305|584178849|FG000|Overall Study|Adverse Event|1|||
161764601|NCT02242305|584178850|FG001|Overall Study|Adverse Event|0|||
161764602|NCT02242305|584178849|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
161764603|NCT02242305|584178850|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
161764604|NCT02242305|584178849|FG000|Overall Study|Subject withdraws inform consent|0|||
161764605|NCT02242305|584178850|FG001|Overall Study|Subject withdraws inform consent|4|||
161764606|NCT02242305|584178849|FG000|Overall Study|Lost to Follow-up|2|||
161764607|NCT02242305|584178850|FG001|Overall Study|Lost to Follow-up|0|||
161764608|NCT02543801|584178854|FG000|Overall Study|Protocol Violation|1|||
161764609|NCT02543801|584178855|FG001|Overall Study|Protocol Violation|2|||
161764610|NCT02543801|584178856|FG002|Overall Study|Protocol Violation|0|||
161764611|NCT02543801|584178857|FG003|Overall Study|Protocol Violation|0|||
161764612|NCT01756846|584178858|FG000|Overall Study|Lost to Follow-up|5|||
161764613|NCT01756846|584178859|FG001|Overall Study|Lost to Follow-up|10|||
161764614|NCT01756846|584178858|FG000|Overall Study|Withdrawal by Subject|1|||
161764615|NCT01756846|584178859|FG001|Overall Study|Withdrawal by Subject|2|||
161764616|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764617|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
161764618|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764619|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764620|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764621|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
161764622|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
161764623|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161764624|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161764625|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161764626|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
161851292|NCT02212379|584496203|FG000|From Baseline to Week 48|Adverse Event|7|||
161851293|NCT02212379|584496203|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
161851294|NCT02212379|584496203|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
161851295|NCT02212379|584496203|FG000|From Week 48 to Week 96|Adverse Event|1|||
161851296|NCT02212379|584496203|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
161851297|NCT02682927|584496212|FG000|Overall Study|Adverse Event|0|||
161851298|NCT02682927|584496213|FG001|Overall Study|Adverse Event|0|||
161851299|NCT02682927|584496214|FG002|Overall Study|Adverse Event|5|||
161851300|NCT02682927|584496215|FG003|Overall Study|Adverse Event|1|||
161851301|NCT02682927|584496216|FG004|Overall Study|Adverse Event|0|||
161851302|NCT02682927|584496217|FG005|Overall Study|Adverse Event|2|||
161851303|NCT02682927|584496212|FG000|Overall Study|Death|0|||
161851304|NCT02682927|584496213|FG001|Overall Study|Death|0|||
161851305|NCT02682927|584496214|FG002|Overall Study|Death|0|||
161851306|NCT02682927|584496215|FG003|Overall Study|Death|1|||
161851307|NCT02682927|584496216|FG004|Overall Study|Death|0|||
161851308|NCT02682927|584496217|FG005|Overall Study|Death|0|||
161851309|NCT02682927|584496212|FG000|Overall Study|Lack of Efficacy|1|||
161851310|NCT02682927|584496213|FG001|Overall Study|Lack of Efficacy|0|||
161851311|NCT02682927|584496214|FG002|Overall Study|Lack of Efficacy|0|||
161851312|NCT02682927|584496215|FG003|Overall Study|Lack of Efficacy|1|||
161851313|NCT02682927|584496216|FG004|Overall Study|Lack of Efficacy|0|||
161851314|NCT02682927|584496217|FG005|Overall Study|Lack of Efficacy|0|||
161851315|NCT02682927|584496212|FG000|Overall Study|Other|0|||
161851316|NCT02682927|584496213|FG001|Overall Study|Other|0|||
161851317|NCT02682927|584496214|FG002|Overall Study|Other|0|||
161851318|NCT02682927|584496215|FG003|Overall Study|Other|2|||
161851319|NCT02682927|584496216|FG004|Overall Study|Other|0|||
161851320|NCT02682927|584496217|FG005|Overall Study|Other|0|||
161851321|NCT02682927|584496212|FG000|Overall Study|Withdrawal by Subject|2|||
161851322|NCT02682927|584496213|FG001|Overall Study|Withdrawal by Subject|0|||
161851323|NCT02682927|584496214|FG002|Overall Study|Withdrawal by Subject|1|||
161851324|NCT02682927|584496215|FG003|Overall Study|Withdrawal by Subject|0|||
161851325|NCT02682927|584496216|FG004|Overall Study|Withdrawal by Subject|1|||
161851326|NCT02682927|584496217|FG005|Overall Study|Withdrawal by Subject|1|||
161851327|NCT03462459|584496218|FG000|Overall Study|Death|1|||
161851328|NCT03462459|584496219|FG001|Overall Study|Death|0|||
161851329|NCT03462459|584496218|FG000|Overall Study|Lack of Efficacy|2|||
161851330|NCT03462459|584496219|FG001|Overall Study|Lack of Efficacy|4|||
161851331|NCT03462459|584496218|FG000|Overall Study|Lost to Follow-up|1|||
161851332|NCT03462459|584496219|FG001|Overall Study|Lost to Follow-up|3|||
161851333|NCT03462459|584496218|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
161851334|NCT03462459|584496219|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
161851335|NCT03462459|584496218|FG000|Overall Study|Withdrawal by Subject|3|||
161851336|NCT03462459|584496219|FG001|Overall Study|Withdrawal by Subject|2|||
161851337|NCT03462459|584496218|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
161851338|NCT03462459|584496219|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
161851339|NCT01177059|584496220|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
161851340|NCT01177059|584496220|FG000|Overall Study|Withdrew consent|2|||
161851341|NCT01177059|584496220|FG000|Overall Study|Lost to Follow-up|18|||
161851342|NCT01243775|584496221|FG000|Overall Study|Withdrawal by Subject|2|||
161851343|NCT04051619|584496222|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
161851344|NCT04051619|584496223|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
161851345|NCT04051619|584496222|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
161851346|NCT04051619|584496223|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
161851347|NCT05938621|584498338|FG000|Overall Study|Lost to Follow-up|1|||
161851348|NCT05938621|584498339|FG001|Overall Study|Lost to Follow-up|5|||
161851349|NCT05938621|584498340|FG002|Overall Study|Lost to Follow-up|2|||
161851350|NCT05938621|584498341|FG003|Overall Study|Lost to Follow-up|2|||
161851351|NCT03922529|584498346|FG000|Overall Study|Withdrawal by Subject|13|||
161851352|NCT03922529|584498347|FG001|Overall Study|Withdrawal by Subject|12|||
161851353|NCT03922529|584498346|FG000|Overall Study|Death|7|||
161851354|NCT03922529|584498347|FG001|Overall Study|Death|12|||
161851355|NCT03922529|584498346|FG000|Overall Study|Lost to Follow-up|12|||
161851356|NCT03922529|584498347|FG001|Overall Study|Lost to Follow-up|19|||
161851357|NCT03922529|584498346|FG000|Overall Study|Adverse Event|1|||
161851358|NCT03922529|584498347|FG001|Overall Study|Adverse Event|0|||
161851359|NCT03922529|584498346|FG000|Overall Study|Death after withdrawal|1|||
161851360|NCT03922529|584498347|FG001|Overall Study|Death after withdrawal|0|||
161851361|NCT03922529|584498346|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
161851362|NCT03922529|584498347|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
161851363|NCT03922529|584498346|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
161851364|NCT03922529|584498347|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
161851365|NCT02731638|584498348|FG000|Overall Study|Lost to Follow-up|6|||
161851366|NCT02731638|584498349|FG001|Overall Study|Lost to Follow-up|9|||
161851367|NCT04158245|584498350|FG000|Overall Study|Lost to Follow-up|1|||
161851368|NCT01275729|584498351|FG000|Overall Study|Death|3|||
161851369|NCT01275729|584498351|FG000|Overall Study|Withdrawal by Subject|1|||
161851370|NCT00447876|584498354|FG000|Overall Study|Withdrawal by Subject|1|||
161851371|NCT00447876|584498355|FG001|Overall Study|Withdrawal by Subject|4|||
161851372|NCT00447876|584498354|FG000|Overall Study|Lost to Follow-up|1|||
161851373|NCT00447876|584498355|FG001|Overall Study|Lost to Follow-up|0|||
161851374|NCT00447876|584498354|FG000|Overall Study|Deterioration of symptomology|1|||
161851375|NCT00447876|584498355|FG001|Overall Study|Deterioration of symptomology|0|||
161851376|NCT04172597|584498356|FG000|Overall Study|Disease Progression|0|||
161851377|NCT04172597|584498357|FG001|Overall Study|Disease Progression|0|||
161851378|NCT04172597|584498358|FG002|Overall Study|Disease Progression|0|||
161851379|NCT04172597|584498359|FG003|Overall Study|Disease Progression|0|||
161851380|NCT04172597|584498360|FG004|Overall Study|Disease Progression|1|||
161851381|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|Death|0|||
161851382|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|Death|1|||
161851383|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
161851384|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
161851385|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
161851386|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
161851387|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
161851388|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
161851389|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
161851390|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
161851391|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
161851392|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
161851393|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
161851394|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
161851395|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
161851396|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
161851397|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
161851398|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
161851399|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
161851400|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
161851401|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
161851402|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
161851403|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Death|3|||
161851404|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Death|8|||
161851405|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
161851406|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
161851407|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
161851408|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
161851409|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
161851410|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
161851411|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
161851412|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
161851413|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
161851414|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
161851415|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Other|1|||
161851416|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Other|1|||
161851417|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Death|5|||
161851418|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Death|8|||
161851419|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
161851420|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
161851421|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
161851422|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
161851423|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
161851424|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
161851425|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
161851426|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
161851427|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Other|1|||
161851428|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Other|0|||
161851429|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Death|17|||
161851430|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Death|11|||
161851431|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
161851432|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
161851433|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
161851434|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
161851435|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
161851436|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
161851437|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
161851438|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
161851439|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
161851440|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
161851441|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
161851442|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
161851443|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
161851444|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
161851445|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Other|2|||
161851446|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Other|1|||
161851447|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
161851448|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
161851449|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Death|12|||
161851450|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Death|10|||
161851451|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
161851452|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
161851453|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
161851454|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
161851455|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Other|7|||
161851456|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Other|5|||
161851457|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
161851458|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
161851459|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Death|51|||
161851460|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Death|31|||
161851461|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
161851462|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
161851463|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
161851464|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
161851465|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
161851466|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
161851467|NCT00492778|584498368|FG000|Overall Study|Ineligible by Pathology Review|8|||
161851468|NCT00492778|584498369|FG001|Overall Study|Ineligible by Pathology Review|1|||
161851469|NCT03717012|584498384|FG000|Overall Study|Due to trial termination|1|||
161851470|NCT03717012|584498385|FG001|Overall Study|Due to trial termination|2|||
161851471|NCT03717012|584498384|FG000|Overall Study|Protocol Violation|0|||
161851472|NCT03717012|584498385|FG001|Overall Study|Protocol Violation|2|||
161851473|NCT03717012|584498384|FG000|Overall Study|Adverse Event|0|||
161851474|NCT03717012|584498385|FG001|Overall Study|Adverse Event|1|||
161851475|NCT03717012|584498384|FG000|Overall Study|Lung transplant|0|||
161851476|NCT03717012|584498385|FG001|Overall Study|Lung transplant|1|||
161851477|NCT00789035|584498386|FG000|Overall Study|Adverse Event|0|||
161851478|NCT00789035|584498387|FG001|Overall Study|Adverse Event|2|||
161851479|NCT00789035|584498388|FG002|Overall Study|Adverse Event|0|||
161851480|NCT00789035|584498389|FG003|Overall Study|Adverse Event|1|||
161851481|NCT00789035|584498390|FG004|Overall Study|Adverse Event|3|||
161851482|NCT00789035|584498386|FG000|Overall Study|Lack of Efficacy|3|||
161851483|NCT00789035|584498387|FG001|Overall Study|Lack of Efficacy|0|||
161851484|NCT00789035|584498388|FG002|Overall Study|Lack of Efficacy|0|||
161851485|NCT00789035|584498389|FG003|Overall Study|Lack of Efficacy|0|||
161851486|NCT00789035|584498390|FG004|Overall Study|Lack of Efficacy|2|||
161851487|NCT00789035|584498386|FG000|Overall Study|Protocol Violation|1|||
161851488|NCT00789035|584498387|FG001|Overall Study|Protocol Violation|0|||
161851489|NCT00789035|584498388|FG002|Overall Study|Protocol Violation|0|||
161851490|NCT00789035|584498389|FG003|Overall Study|Protocol Violation|0|||
161851491|NCT00789035|584498390|FG004|Overall Study|Protocol Violation|0|||
161851492|NCT00789035|584498386|FG000|Overall Study|Withdrawal by Subject|0|||
161851493|NCT00789035|584498387|FG001|Overall Study|Withdrawal by Subject|2|||
161851494|NCT00789035|584498388|FG002|Overall Study|Withdrawal by Subject|0|||
161851495|NCT00789035|584498389|FG003|Overall Study|Withdrawal by Subject|0|||
161851496|NCT00789035|584498390|FG004|Overall Study|Withdrawal by Subject|0|||
161851497|NCT00789035|584498386|FG000|Overall Study|Other reason not defined above|2|||
161851498|NCT00789035|584498387|FG001|Overall Study|Other reason not defined above|3|||
161851499|NCT00789035|584498388|FG002|Overall Study|Other reason not defined above|1|||
161851500|NCT00789035|584498389|FG003|Overall Study|Other reason not defined above|0|||
161851501|NCT00789035|584498390|FG004|Overall Study|Other reason not defined above|1|||
161851502|NCT00362336|584498391|FG000|Overall Study|Serious Adverse Event|1|||
161851503|NCT00362336|584498392|FG001|Overall Study|Serious Adverse Event|0|||
161851504|NCT00362336|584498393|FG002|Overall Study|Serious Adverse Event|1|||
161851505|NCT00362336|584498391|FG000|Overall Study|Protocol Violation|0|||
161851506|NCT00362336|584498392|FG001|Overall Study|Protocol Violation|0|||
161851507|NCT00362336|584498393|FG002|Overall Study|Protocol Violation|1|||
161851508|NCT00362336|584498391|FG000|Overall Study|Lost to Follow-up|6|||
161851509|NCT00362336|584498392|FG001|Overall Study|Lost to Follow-up|4|||
161851510|NCT00362336|584498393|FG002|Overall Study|Lost to Follow-up|0|||
161851511|NCT00362336|584498391|FG000|Overall Study|Withdrawal by Subject|3|||
161851512|NCT00362336|584498392|FG001|Overall Study|Withdrawal by Subject|3|||
161851513|NCT00362336|584498393|FG002|Overall Study|Withdrawal by Subject|1|||
161851514|NCT04414618|584498394|FG000|Overall Study|Death|3|||
161851515|NCT04414618|584498395|FG001|Overall Study|Death|3|||
161851516|NCT04414618|584498394|FG000|Overall Study|Withdrawal by Subject|2|||
161851517|NCT04414618|584498395|FG001|Overall Study|Withdrawal by Subject|1|||
161851518|NCT04414618|584498394|FG000|Overall Study|Lost to Follow-up|2|||
161851519|NCT04414618|584498395|FG001|Overall Study|Lost to Follow-up|3|||
161851520|NCT04414618|584498394|FG000|Overall Study|Physician Decision|1|||
161764627|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
161764628|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161764629|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161764630|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161764631|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
161764632|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
161764633|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161764634|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161764635|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161764636|NCT00082628|584178866|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764637|NCT00082628|584178867|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764638|NCT00082628|584178868|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764639|NCT00082628|584178869|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764640|NCT00082628|584178870|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
161764641|NCT00082628|584178866|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764642|NCT00082628|584178867|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764643|NCT00082628|584178868|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764644|NCT00082628|584178869|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
161764645|NCT00082628|584178870|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764646|NCT00082628|584178866|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
161764647|NCT00082628|584178867|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
161764648|NCT00082628|584178868|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
161764649|NCT00082628|584178869|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
161764650|NCT00082628|584178870|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
161764651|NCT03481634|584178873|FG000|Overall Study|Withdrawal by Subject|16|||
161764652|NCT03481634|584178874|FG001|Overall Study|Withdrawal by Subject|19|||
161764653|NCT03481634|584178875|FG002|Overall Study|Withdrawal by Subject|14|||
161764654|NCT03481634|584178873|FG000|Overall Study|Protocol Violation|1|||
161764655|NCT03481634|584178874|FG001|Overall Study|Protocol Violation|0|||
161764656|NCT03481634|584178875|FG002|Overall Study|Protocol Violation|1|||
161764657|NCT03481634|584178873|FG000|Overall Study|Progressive disease|0|||
161764658|NCT03481634|584178874|FG001|Overall Study|Progressive disease|1|||
161764659|NCT03481634|584178875|FG002|Overall Study|Progressive disease|0|||
161764660|NCT03481634|584178873|FG000|Overall Study|Physician Decision|3|||
161764661|NCT03481634|584178874|FG001|Overall Study|Physician Decision|0|||
161764662|NCT03481634|584178875|FG002|Overall Study|Physician Decision|1|||
161764663|NCT03481634|584178873|FG000|Overall Study|Lost to Follow-up|3|||
161764664|NCT03481634|584178874|FG001|Overall Study|Lost to Follow-up|4|||
161764665|NCT03481634|584178875|FG002|Overall Study|Lost to Follow-up|4|||
161764666|NCT03481634|584178873|FG000|Overall Study|Death|4|||
161764667|NCT03481634|584178874|FG001|Overall Study|Death|8|||
161764668|NCT03481634|584178875|FG002|Overall Study|Death|7|||
161764669|NCT03481634|584178873|FG000|Overall Study|Adverse Event|6|||
161764670|NCT03481634|584178874|FG001|Overall Study|Adverse Event|3|||
161764671|NCT03481634|584178875|FG002|Overall Study|Adverse Event|7|||
161764672|NCT00352027|584178878|FG000|Overall Study|Progressive disease|3|||
161764673|NCT04118127|584178879|FG000|Overall Study|Trial terminated by sponsor|0|||
161764674|NCT04118127|584178880|FG001|Overall Study|Trial terminated by sponsor|12|||
161764675|NCT04118127|584178879|FG000|Overall Study|Adverse Event|1|||
161764676|NCT04118127|584178880|FG001|Overall Study|Adverse Event|2|||
161764677|NCT04118127|584178879|FG000|Overall Study|Physician Decision|0|||
161764678|NCT04118127|584178880|FG001|Overall Study|Physician Decision|1|||
161764679|NCT04118127|584178879|FG000|Overall Study|Withdrawal by Subject|2|||
161764680|NCT04118127|584178880|FG001|Overall Study|Withdrawal by Subject|1|||
161764681|NCT01874288|584178881|FG000|Overall Study|Withdrawal by Subject|1|||
161764682|NCT01874288|584178882|FG001|Overall Study|Withdrawal by Subject|0|||
161764683|NCT01874288|584178883|FG002|Overall Study|Withdrawal by Subject|2|||
161764684|NCT01874288|584178884|FG003|Overall Study|Withdrawal by Subject|1|||
161851521|NCT04414618|584498395|FG001|Overall Study|Physician Decision|0|||
161851522|NCT00658879|584498396|FG000|Overall Study|Protocol Violation|1|||
161851523|NCT02640690|584498397|FG000|Overall Study|Lost to Follow-up|7|||
161851524|NCT02640690|584498398|FG001|Overall Study|Lost to Follow-up|7|||
161851525|NCT02640690|584498397|FG000|Overall Study|Withdrawal by Subject|16|||
161851526|NCT02640690|584498398|FG001|Overall Study|Withdrawal by Subject|20|||
161851527|NCT02640690|584498397|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
161851528|NCT02640690|584498398|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
161851529|NCT01520870|584498399|FG000|Overall Study|Withdrawal by Subject|2|||
161851530|NCT01645787|584498400|FG000|Washout (2 Weeks)|Adverse Event|1|||
161851531|NCT01645787|584498401|FG001|Washout (2 Weeks)|Adverse Event|0|||
161851532|NCT02289456|584498402|FG000|Induction Period|Death|2|||
161851533|NCT02289456|584498402|FG000|Induction Period|Adverse Event|11|||
161851534|NCT02289456|584498402|FG000|Induction Period|Progressive Disease (PD)|4|||
161851535|NCT02289456|584498402|FG000|Induction Period|Symptomatic Deterioration|4|||
161851536|NCT02289456|584498402|FG000|Induction Period|Withdrawal by Subject|2|||
161851537|NCT02289456|584498402|FG000|Induction Period|Miscellaneous|1|||
161851538|NCT02289456|584498402|FG000|Monotherapy Period|Death|1|||
161851539|NCT02289456|584498402|FG000|Monotherapy Period|Adverse Event|1|||
161851540|NCT02289456|584498402|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
161851541|NCT02289456|584498402|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
161851542|NCT02289456|584498402|FG000|Monotherapy Period|Withdrawal by Subject|2|||
161851543|NCT02289456|584498402|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
161851544|NCT02289456|584498402|FG000|Monotherapy Period|Miscellaneous|1|||
161851545|NCT02806024|584498404|FG000|Overall Study|Night Delivery|1|||
161851546|NCT02806024|584498405|FG001|Overall Study|Night Delivery|1|||
161851547|NCT02806024|584498404|FG000|Overall Study|DVT during antepartum admission|0|||
161851548|NCT02806024|584498405|FG001|Overall Study|DVT during antepartum admission|1|||
161851549|NCT01098474|584498406|FG000|Active Phase|Other|0|||
161851550|NCT01098474|584498407|FG001|Active Phase|Other|0|||
161851551|NCT01098474|584498408|FG002|Active Phase|Other|3|||
161851552|NCT01098474|584498409|FG003|Active Phase|Other|0|||
161851553|NCT01098474|584498410|FG004|Active Phase|Other|0|||
161851554|NCT01098474|584498411|FG005|Active Phase|Other|0|||
161851555|NCT01098474|584498406|FG000|Active Phase|Withdrawal by Subject|1|||
161851556|NCT01098474|584498407|FG001|Active Phase|Withdrawal by Subject|1|||
161851557|NCT01098474|584498408|FG002|Active Phase|Withdrawal by Subject|2|||
161851558|NCT01098474|584498409|FG003|Active Phase|Withdrawal by Subject|0|||
161851559|NCT01098474|584498410|FG004|Active Phase|Withdrawal by Subject|0|||
161851560|NCT01098474|584498411|FG005|Active Phase|Withdrawal by Subject|0|||
161851561|NCT01098474|584498406|FG000|Active Phase|Lost to Follow-up|1|||
161851562|NCT01098474|584498407|FG001|Active Phase|Lost to Follow-up|0|||
161851563|NCT01098474|584498408|FG002|Active Phase|Lost to Follow-up|0|||
161851564|NCT01098474|584498409|FG003|Active Phase|Lost to Follow-up|0|||
161851565|NCT01098474|584498410|FG004|Active Phase|Lost to Follow-up|0|||
161851566|NCT01098474|584498411|FG005|Active Phase|Lost to Follow-up|0|||
161851567|NCT01098474|584498406|FG000|Follow Up Phase|Travelled out of study area|0|||
161851568|NCT01098474|584498407|FG001|Follow Up Phase|Travelled out of study area|0|||
161851569|NCT01098474|584498408|FG002|Follow Up Phase|Travelled out of study area|0|||
161851570|NCT01098474|584498409|FG003|Follow Up Phase|Travelled out of study area|0|||
161851571|NCT01098474|584498410|FG004|Follow Up Phase|Travelled out of study area|1|||
161851572|NCT01098474|584498411|FG005|Follow Up Phase|Travelled out of study area|0|||
161851573|NCT01098474|584498406|FG000|Follow Up Phase|Other|0|||
161851574|NCT01098474|584498407|FG001|Follow Up Phase|Other|0|||
161851575|NCT01098474|584498408|FG002|Follow Up Phase|Other|0|||
161851576|NCT01098474|584498409|FG003|Follow Up Phase|Other|0|||
161851577|NCT01098474|584498410|FG004|Follow Up Phase|Other|0|||
161851578|NCT01098474|584498411|FG005|Follow Up Phase|Other|4|||
161851579|NCT01098474|584498406|FG000|Follow Up Phase|Withdrawal by Subject|0|||
161851580|NCT01098474|584498407|FG001|Follow Up Phase|Withdrawal by Subject|0|||
161851581|NCT01098474|584498408|FG002|Follow Up Phase|Withdrawal by Subject|0|||
161851582|NCT01098474|584498409|FG003|Follow Up Phase|Withdrawal by Subject|2|||
161851583|NCT01098474|584498410|FG004|Follow Up Phase|Withdrawal by Subject|0|||
161851584|NCT01098474|584498411|FG005|Follow Up Phase|Withdrawal by Subject|1|||
161851585|NCT01098474|584498406|FG000|Follow Up Phase|Lost to Follow-up|0|||
161851586|NCT01098474|584498407|FG001|Follow Up Phase|Lost to Follow-up|0|||
161851587|NCT01098474|584498408|FG002|Follow Up Phase|Lost to Follow-up|0|||
161851588|NCT01098474|584498409|FG003|Follow Up Phase|Lost to Follow-up|0|||
161851589|NCT01098474|584498410|FG004|Follow Up Phase|Lost to Follow-up|1|||
161851590|NCT01098474|584498411|FG005|Follow Up Phase|Lost to Follow-up|0|||
161851591|NCT02797171|584498412|FG000|Overall Study|Lost to Follow-up|2|||
161851592|NCT02797171|584498413|FG001|Overall Study|Lost to Follow-up|0|||
161851593|NCT02797171|584498414|FG002|Overall Study|Lost to Follow-up|2|||
161851594|NCT02797171|584498415|FG003|Overall Study|Lost to Follow-up|1|||
161851595|NCT02797171|584498416|FG004|Overall Study|Lost to Follow-up|2|||
161851596|NCT02797171|584498417|FG005|Overall Study|Lost to Follow-up|0|||
161851597|NCT02797171|584498412|FG000|Overall Study|Withdrawal by Subject|1|||
161851598|NCT02797171|584498413|FG001|Overall Study|Withdrawal by Subject|1|||
161851599|NCT02797171|584498414|FG002|Overall Study|Withdrawal by Subject|0|||
161851600|NCT02797171|584498415|FG003|Overall Study|Withdrawal by Subject|0|||
161851601|NCT02797171|584498416|FG004|Overall Study|Withdrawal by Subject|0|||
161851602|NCT02797171|584498417|FG005|Overall Study|Withdrawal by Subject|0|||
161851603|NCT02797171|584498412|FG000|Overall Study|Protocol Violation|1|||
161851604|NCT02797171|584498413|FG001|Overall Study|Protocol Violation|0|||
161851605|NCT02797171|584498414|FG002|Overall Study|Protocol Violation|0|||
161851606|NCT02797171|584498415|FG003|Overall Study|Protocol Violation|0|||
161851607|NCT02797171|584498416|FG004|Overall Study|Protocol Violation|0|||
161851608|NCT02797171|584498417|FG005|Overall Study|Protocol Violation|0|||
161851609|NCT02797171|584498412|FG000|Overall Study|Participant unable to adhere|0|||
161851610|NCT02797171|584498413|FG001|Overall Study|Participant unable to adhere|1|||
161851611|NCT02797171|584498414|FG002|Overall Study|Participant unable to adhere|0|||
161851612|NCT02797171|584498415|FG003|Overall Study|Participant unable to adhere|0|||
161851613|NCT02797171|584498416|FG004|Overall Study|Participant unable to adhere|0|||
161851614|NCT02797171|584498417|FG005|Overall Study|Participant unable to adhere|0|||
161851615|NCT02797171|584498412|FG000|Overall Study|Not Randomized|0|||
161851616|NCT02797171|584498413|FG001|Overall Study|Not Randomized|0|||
161851617|NCT02797171|584498414|FG002|Overall Study|Not Randomized|0|||
161851618|NCT02797171|584498415|FG003|Overall Study|Not Randomized|0|||
161851619|NCT02797171|584498416|FG004|Overall Study|Not Randomized|0|||
161851620|NCT02797171|584498417|FG005|Overall Study|Not Randomized|1|||
161851621|NCT00626561|584498418|FG000|Overall Study|Withdrawal by Subject|2|||
161851622|NCT00626561|584498418|FG000|Overall Study|Disease Progression|2|||
161851623|NCT01372748|584498423|FG000|Overall Study|Lost to Follow-up|16|||
161851624|NCT01372748|584498424|FG001|Overall Study|Lost to Follow-up|34|||
161851625|NCT01372748|584498423|FG000|Overall Study|Withdrawal by Subject|7|||
161851626|NCT01372748|584498424|FG001|Overall Study|Withdrawal by Subject|5|||
161851627|NCT00134901|584498425|FG000|Overall Study|Lost to Follow-up|5|||
161851628|NCT00134901|584498426|FG001|Overall Study|Lost to Follow-up|5|||
161851629|NCT00134901|584498425|FG000|Overall Study|discontinued intervention|12|||
161851630|NCT00134901|584498426|FG001|Overall Study|discontinued intervention|10|||
161851631|NCT00606632|584498427|FG000|Overall Study|Withdrawal by Subject|13|||
161851632|NCT00606632|584498427|FG000|Overall Study|Miscellaneous reasons|9|||
161851633|NCT00711880|584498428|FG000|Overall Study|Adverse Event|11|||
161851634|NCT00711880|584498429|FG001|Overall Study|Adverse Event|2|||
161851635|NCT00711880|584498428|FG000|Overall Study|Patient non-compliance|1|||
161851636|NCT00711880|584498429|FG001|Overall Study|Patient non-compliance|0|||
161851637|NCT00711880|584498428|FG000|Overall Study|Lack of Efficacy|1|||
161851638|NCT00711880|584498429|FG001|Overall Study|Lack of Efficacy|5|||
161851639|NCT03908437|584498430|FG000|Overall Study|Death|0|||
161851640|NCT03908437|584498431|FG001|Overall Study|Death|1|||
161851641|NCT03908437|584498430|FG000|Overall Study|Lost to Follow-up|31|||
161851642|NCT03908437|584498431|FG001|Overall Study|Lost to Follow-up|24|||
161851643|NCT03633825|584498432|FG000|Enrollment|Did not post on network|5066|||
161851644|NCT03633825|584498433|FG001|Enrollment|Did not post on network|5080|||
161851645|NCT03633825|584498432|FG000|Enrollment|Post not classified as crisis|13967|||
161851646|NCT03633825|584498433|FG001|Enrollment|Post not classified as crisis|13757|||
161851647|NCT03633825|584498432|FG000|Follow up|Lost to Follow-up|478|||
161851648|NCT03633825|584498433|FG001|Follow up|Lost to Follow-up|450|||
161851649|NCT04841577|584498434|FG000|Overall Study|Adverse Event|5|||
161851650|NCT04841577|584498435|FG001|Overall Study|Adverse Event|10|||
161851651|NCT04841577|584498434|FG000|Overall Study|Lost to Follow-up|8|||
161851652|NCT04841577|584498435|FG001|Overall Study|Lost to Follow-up|7|||
161851653|NCT04841577|584498434|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161851654|NCT04841577|584498435|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
161851655|NCT04841577|584498434|FG000|Overall Study|Other|0|||
161851656|NCT04841577|584498435|FG001|Overall Study|Other|1|||
161851657|NCT05246670|584498438|FG000|Overall Study|Withdrawal by Subject|2|||
161851658|NCT05246670|584498439|FG001|Overall Study|Withdrawal by Subject|3|||
161851659|NCT05246670|584498440|FG002|Overall Study|Withdrawal by Subject|0|||
161851660|NCT05246670|584498441|FG003|Overall Study|Withdrawal by Subject|1|||
161851661|NCT05246670|584498438|FG000|Overall Study|Adverse Event|0|||
161851662|NCT05246670|584498439|FG001|Overall Study|Adverse Event|0|||
161851663|NCT05246670|584498440|FG002|Overall Study|Adverse Event|1|||
161851664|NCT05246670|584498441|FG003|Overall Study|Adverse Event|0|||
161851665|NCT05246670|584498438|FG000|Overall Study|Physician Decision|1|||
161851666|NCT05246670|584498439|FG001|Overall Study|Physician Decision|0|||
161851667|NCT05246670|584498440|FG002|Overall Study|Physician Decision|0|||
161851668|NCT05246670|584498441|FG003|Overall Study|Physician Decision|0|||
161851669|NCT05246670|584498438|FG000|Overall Study|Protocol Violation|1|||
161851670|NCT05246670|584498439|FG001|Overall Study|Protocol Violation|0|||
161851671|NCT05246670|584498440|FG002|Overall Study|Protocol Violation|0|||
161851672|NCT05246670|584498441|FG003|Overall Study|Protocol Violation|0|||
161851673|NCT00356525|584498442|FG000|Overall Study|Progressive Disease|8|||
161851674|NCT00356525|584498443|FG001|Overall Study|Progressive Disease|5|||
161851675|NCT00356525|584498444|FG002|Overall Study|Progressive Disease|4|||
161851676|NCT00356525|584498445|FG003|Overall Study|Progressive Disease|2|||
161851677|NCT00356525|584498442|FG000|Overall Study|Adverse Event|1|||
161851678|NCT00356525|584498443|FG001|Overall Study|Adverse Event|3|||
161851679|NCT00356525|584498444|FG002|Overall Study|Adverse Event|1|||
161851680|NCT00356525|584498445|FG003|Overall Study|Adverse Event|1|||
161851681|NCT00356525|584498442|FG000|Overall Study|Lost to Follow-up|1|||
161851682|NCT00356525|584498443|FG001|Overall Study|Lost to Follow-up|0|||
161851683|NCT00356525|584498444|FG002|Overall Study|Lost to Follow-up|0|||
161851684|NCT00356525|584498445|FG003|Overall Study|Lost to Follow-up|0|||
161851685|NCT00356525|584498442|FG000|Overall Study|Physician Decision|2|||
161851686|NCT00356525|584498443|FG001|Overall Study|Physician Decision|2|||
161851687|NCT00356525|584498444|FG002|Overall Study|Physician Decision|2|||
161851688|NCT00356525|584498445|FG003|Overall Study|Physician Decision|1|||
161851689|NCT00356525|584498442|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
161851690|NCT00356525|584498443|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
161851691|NCT00356525|584498444|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
161851692|NCT00356525|584498445|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
161851693|NCT00356525|584498442|FG000|Overall Study|Withdrawal by Subject|1|||
161851694|NCT00356525|584498443|FG001|Overall Study|Withdrawal by Subject|1|||
161851695|NCT00356525|584498444|FG002|Overall Study|Withdrawal by Subject|0|||
161851696|NCT00356525|584498445|FG003|Overall Study|Withdrawal by Subject|3|||
161851697|NCT00356525|584498442|FG000|Overall Study|Death|0|||
161851698|NCT00356525|584498443|FG001|Overall Study|Death|0|||
161851699|NCT00356525|584498444|FG002|Overall Study|Death|0|||
161851700|NCT00356525|584498445|FG003|Overall Study|Death|1|||
161851701|NCT00356525|584498442|FG000|Overall Study|Sponsor Decision|0|||
161851702|NCT00356525|584498443|FG001|Overall Study|Sponsor Decision|0|||
161851703|NCT00356525|584498444|FG002|Overall Study|Sponsor Decision|0|||
161851704|NCT00356525|584498445|FG003|Overall Study|Sponsor Decision|1|||
161851705|NCT00652340|584498446|FG000|Overall Study|Had not progressed.|4|||
161851706|NCT00652340|584498447|FG001|Overall Study|Had not progressed.|3|||
161851707|NCT00214383|584498450|FG000|Overall Study|Lost to Follow-up|16|||
161851708|NCT00214383|584498451|FG001|Overall Study|Lost to Follow-up|26|||
161851709|NCT04152291|584498452|FG000|Overall Study|Covid-19 restrictions|27|||
161851710|NCT04152291|584498452|FG000|Overall Study|Withdrawal by Subject|3|||
161851711|NCT03597295|584498453|FG000|Overall Study|Death|70|||
161851712|NCT03597295|584498453|FG000|Overall Study|Lost to Follow-up|7|||
161851713|NCT00879411|584498454|FG000|Overall Study|lost to follow-up (non-AE)|162|||
161851714|NCT05124691|584498455|FG000|Phase II|Eligibility criteria|0|||
161851715|NCT05124691|584498456|FG001|Phase II|Eligibility criteria|1|||
161851716|NCT05124691|584498457|FG002|Phase II|Eligibility criteria|0|||
161851717|NCT05124691|584498455|FG000|Phase II|Withdrawal by Subject|6|||
161851718|NCT05124691|584498456|FG001|Phase II|Withdrawal by Subject|2|||
161851719|NCT05124691|584498457|FG002|Phase II|Withdrawal by Subject|3|||
161851720|NCT05124691|584498455|FG000|Phase III|Withdrawal by Subject|6|||
161851721|NCT05124691|584498456|FG001|Phase III|Withdrawal by Subject|4|||
161851722|NCT05124691|584498457|FG002|Phase III|Withdrawal by Subject|4|||
161851723|NCT05124691|584498455|FG000|Phase III|Lost to Follow-up|1|||
161851724|NCT05124691|584498456|FG001|Phase III|Lost to Follow-up|0|||
161851725|NCT05124691|584498457|FG002|Phase III|Lost to Follow-up|0|||
161851726|NCT00428116|584498458|FG000|Overall Study|Death|1|||
161851727|NCT00428116|584498459|FG001|Overall Study|Death|0|||
161851728|NCT00428116|584498458|FG000|Overall Study|Withdrawal by Subject|1|||
161851729|NCT00428116|584498459|FG001|Overall Study|Withdrawal by Subject|0|||
161851730|NCT00428116|584498458|FG000|Overall Study|Lost to Follow-up|1|||
161851731|NCT00428116|584498459|FG001|Overall Study|Lost to Follow-up|0|||
161851732|NCT01890434|584498460|FG000|Overall Study|Adverse Event|8|||
161851733|NCT01890434|584498460|FG000|Overall Study|PCI at external hospital|1|||
161851734|NCT01890434|584498460|FG000|Overall Study|Assessment discrepancy|1|||
161851735|NCT01890434|584498460|FG000|Overall Study|CRC didn't contact participant for FU|1|||
161851736|NCT01890434|584498460|FG000|Overall Study|Could not get whole set of images|1|||
161764685|NCT01874288|584178885|FG004|Overall Study|Withdrawal by Subject|1|||
161764686|NCT01874288|584178881|FG000|Overall Study|Physician Decision|0|||
161764687|NCT01874288|584178882|FG001|Overall Study|Physician Decision|0|||
161764688|NCT01874288|584178883|FG002|Overall Study|Physician Decision|0|||
161764689|NCT01874288|584178884|FG003|Overall Study|Physician Decision|1|||
161764690|NCT01874288|584178885|FG004|Overall Study|Physician Decision|0|||
161764691|NCT01874288|584178881|FG000|Overall Study|Progressive disease|2|||
161764692|NCT01874288|584178882|FG001|Overall Study|Progressive disease|0|||
161764693|NCT01874288|584178883|FG002|Overall Study|Progressive disease|3|||
161764694|NCT01874288|584178884|FG003|Overall Study|Progressive disease|5|||
161764695|NCT01874288|584178885|FG004|Overall Study|Progressive disease|1|||
161764696|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
161764697|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
161764698|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
161764699|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
161764700|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
161764701|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
161764702|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
161764703|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
161764704|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764705|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764706|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764707|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764708|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764709|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764710|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764711|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
161764712|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764713|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764714|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
161764715|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
161764716|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
161764717|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
161764718|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
161764719|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
161764720|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764721|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764722|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
161764723|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
161764724|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764725|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764726|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764727|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764728|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
161764729|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764730|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764731|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764732|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161764733|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161764734|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161764735|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161764736|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161764737|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161764738|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764739|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764740|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764741|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
161764742|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
161764743|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764744|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764745|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764746|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764747|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
161764748|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
161764749|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764750|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764751|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764752|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764753|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
161764754|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764755|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764756|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
161764757|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
161764758|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
161764759|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
161764760|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
161764761|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
161764762|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
161764763|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
161764764|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
161764765|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
161764766|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
161764767|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
161764768|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
161764769|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
161764770|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
161764771|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
161764772|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
161764773|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
161764774|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
161764775|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
161764776|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
161764777|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
161764778|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
161764779|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
161764780|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
161764781|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
161764782|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
161764783|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
161764784|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
161764785|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
161764786|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
161764787|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
161764788|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
161764789|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
161764790|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
161764791|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
161764792|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
161764793|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
161764794|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
161764795|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
161764796|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
161764797|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
161764798|NCT00636506|584178892|FG000|Overall Study|Lost to Follow-up|8|||
161764799|NCT00636506|584178892|FG000|Overall Study|Explanted|1|||
161764800|NCT00636506|584178892|FG000|Overall Study|Withdrawal by Subject|6|||
161764801|NCT00636506|584178892|FG000|Overall Study|Procedure aborted|1|||
161764802|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
161764803|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
161764804|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
161764805|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
161764806|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
161764807|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
161764808|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
161764809|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
161764810|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
161764811|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
161764812|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
161764813|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
161764814|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
161764815|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
161764816|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
161764817|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
161764818|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
161764819|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
161764820|NCT01624974|584178893|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
161764821|NCT01624974|584178894|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
161851737|NCT01890434|584498460|FG000|Overall Study|Decline to return for GSPECT|1|||
161851738|NCT01890434|584498460|FG000|Overall Study|GSPECT at rest was not done|1|||
161851739|NCT01890434|584498460|FG000|Overall Study|Participant didn't complete MRI|1|||
161851740|NCT01890434|584498460|FG000|Overall Study|Uncontactable by phone|1|||
161851741|NCT01890434|584498460|FG000|Overall Study|Moved out of position|1|||
161851742|NCT01890434|584498460|FG000|Overall Study|Unable to contact|1|||
161851743|NCT01890434|584498460|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
161851744|NCT02257385|584498466|FG000|Overall Study|Adverse Event|12|||
161851745|NCT02257385|584498467|FG001|Overall Study|Adverse Event|8|||
161851746|NCT02257385|584498466|FG000|Overall Study|Lack of Efficacy|1|||
161851747|NCT02257385|584498467|FG001|Overall Study|Lack of Efficacy|2|||
161851748|NCT02257385|584498466|FG000|Overall Study|Protocol Violation|5|||
161851749|NCT02257385|584498467|FG001|Overall Study|Protocol Violation|7|||
161851750|NCT02257385|584498466|FG000|Overall Study|Lost to Follow-up|0|||
161851751|NCT02257385|584498467|FG001|Overall Study|Lost to Follow-up|1|||
161851752|NCT02257385|584498466|FG000|Overall Study|Withdrawal by Subject|4|||
161851753|NCT02257385|584498467|FG001|Overall Study|Withdrawal by Subject|4|||
161851754|NCT01449370|584498474|FG000|Overall Study|Disease Progression|5|||
161851755|NCT01449370|584498475|FG001|Overall Study|Disease Progression|4|||
161851756|NCT01449370|584498476|FG002|Overall Study|Disease Progression|8|||
161851757|NCT01449370|584498477|FG003|Overall Study|Disease Progression|3|||
161851758|NCT01449370|584498478|FG004|Overall Study|Disease Progression|3|||
161851759|NCT01449370|584498479|FG005|Overall Study|Disease Progression|3|||
161851760|NCT01449370|584498480|FG006|Overall Study|Disease Progression|3|||
161851761|NCT01449370|584498481|FG007|Overall Study|Disease Progression|2|||
161851762|NCT01449370|584498482|FG008|Overall Study|Disease Progression|9|||
161851763|NCT01449370|584498483|FG009|Overall Study|Disease Progression|1|||
161851764|NCT01449370|584498484|FG010|Overall Study|Disease Progression|3|||
161851765|NCT01449370|584498485|FG011|Overall Study|Disease Progression|3|||
161851766|NCT01449370|584498486|FG012|Overall Study|Disease Progression|2|||
161851767|NCT01449370|584498487|FG013|Overall Study|Disease Progression|8|||
161851768|NCT01449370|584498488|FG014|Overall Study|Disease Progression|3|||
161851769|NCT01449370|584498489|FG015|Overall Study|Disease Progression|1|||
161851770|NCT01449370|584498490|FG016|Overall Study|Disease Progression|4|||
161851771|NCT01449370|584498491|FG017|Overall Study|Disease Progression|3|||
161851772|NCT01449370|584498492|FG018|Overall Study|Disease Progression|1|||
161851773|NCT01449370|584498493|FG019|Overall Study|Disease Progression|2|||
161851774|NCT01449370|584498494|FG020|Overall Study|Disease Progression|5|||
161851775|NCT01449370|584498495|FG021|Overall Study|Disease Progression|2|||
161851776|NCT01449370|584498496|FG022|Overall Study|Disease Progression|3|||
161851777|NCT01449370|584498497|FG023|Overall Study|Disease Progression|7|||
161851778|NCT01449370|584498498|FG024|Overall Study|Disease Progression|3|||
161851779|NCT01449370|584498474|FG000|Overall Study|Adverse Event|1|||
161851780|NCT01449370|584498475|FG001|Overall Study|Adverse Event|2|||
161851781|NCT01449370|584498476|FG002|Overall Study|Adverse Event|0|||
161851782|NCT01449370|584498477|FG003|Overall Study|Adverse Event|1|||
161851783|NCT01449370|584498478|FG004|Overall Study|Adverse Event|0|||
161851784|NCT01449370|584498479|FG005|Overall Study|Adverse Event|0|||
161851785|NCT01449370|584498480|FG006|Overall Study|Adverse Event|0|||
161851786|NCT01449370|584498481|FG007|Overall Study|Adverse Event|0|||
161851787|NCT01449370|584498482|FG008|Overall Study|Adverse Event|1|||
161851788|NCT01449370|584498483|FG009|Overall Study|Adverse Event|1|||
161851789|NCT01449370|584498484|FG010|Overall Study|Adverse Event|0|||
161851790|NCT01449370|584498485|FG011|Overall Study|Adverse Event|0|||
161851791|NCT01449370|584498486|FG012|Overall Study|Adverse Event|0|||
161851792|NCT01449370|584498487|FG013|Overall Study|Adverse Event|2|||
161851793|NCT01449370|584498488|FG014|Overall Study|Adverse Event|0|||
161851794|NCT01449370|584498489|FG015|Overall Study|Adverse Event|1|||
161851795|NCT01449370|584498490|FG016|Overall Study|Adverse Event|0|||
161851796|NCT01449370|584498491|FG017|Overall Study|Adverse Event|0|||
161851797|NCT01449370|584498492|FG018|Overall Study|Adverse Event|1|||
161851798|NCT01449370|584498493|FG019|Overall Study|Adverse Event|1|||
161851799|NCT01449370|584498494|FG020|Overall Study|Adverse Event|0|||
161851800|NCT01449370|584498495|FG021|Overall Study|Adverse Event|1|||
161851801|NCT01449370|584498496|FG022|Overall Study|Adverse Event|0|||
161851802|NCT01449370|584498497|FG023|Overall Study|Adverse Event|1|||
161851803|NCT01449370|584498498|FG024|Overall Study|Adverse Event|3|||
161851804|NCT01449370|584498474|FG000|Overall Study|Participant Decision|0|||
161851805|NCT01449370|584498475|FG001|Overall Study|Participant Decision|0|||
161851806|NCT01449370|584498476|FG002|Overall Study|Participant Decision|0|||
161851807|NCT01449370|584498477|FG003|Overall Study|Participant Decision|0|||
161851808|NCT01449370|584498478|FG004|Overall Study|Participant Decision|0|||
161851809|NCT01449370|584498479|FG005|Overall Study|Participant Decision|0|||
161851810|NCT01449370|584498480|FG006|Overall Study|Participant Decision|0|||
161851811|NCT01449370|584498481|FG007|Overall Study|Participant Decision|1|||
161851812|NCT01449370|584498482|FG008|Overall Study|Participant Decision|1|||
161851813|NCT01449370|584498483|FG009|Overall Study|Participant Decision|0|||
161851814|NCT01449370|584498484|FG010|Overall Study|Participant Decision|0|||
161851815|NCT01449370|584498485|FG011|Overall Study|Participant Decision|0|||
161851816|NCT01449370|584498486|FG012|Overall Study|Participant Decision|1|||
161851817|NCT01449370|584498487|FG013|Overall Study|Participant Decision|1|||
161851818|NCT01449370|584498488|FG014|Overall Study|Participant Decision|0|||
161851819|NCT01449370|584498489|FG015|Overall Study|Participant Decision|1|||
161851820|NCT01449370|584498490|FG016|Overall Study|Participant Decision|3|||
161851821|NCT01449370|584498491|FG017|Overall Study|Participant Decision|0|||
161851822|NCT01449370|584498492|FG018|Overall Study|Participant Decision|1|||
161851823|NCT01449370|584498493|FG019|Overall Study|Participant Decision|0|||
161851824|NCT01449370|584498494|FG020|Overall Study|Participant Decision|0|||
161851825|NCT01449370|584498495|FG021|Overall Study|Participant Decision|1|||
161851826|NCT01449370|584498496|FG022|Overall Study|Participant Decision|0|||
161851827|NCT01449370|584498497|FG023|Overall Study|Participant Decision|0|||
161851828|NCT01449370|584498498|FG024|Overall Study|Participant Decision|1|||
161851829|NCT01449370|584498474|FG000|Overall Study|Lost to Follow-up|0|||
161851830|NCT01449370|584498475|FG001|Overall Study|Lost to Follow-up|0|||
161851831|NCT01449370|584498476|FG002|Overall Study|Lost to Follow-up|0|||
161851832|NCT01449370|584498477|FG003|Overall Study|Lost to Follow-up|0|||
161851833|NCT01449370|584498478|FG004|Overall Study|Lost to Follow-up|0|||
161851834|NCT01449370|584498479|FG005|Overall Study|Lost to Follow-up|0|||
161851835|NCT01449370|584498480|FG006|Overall Study|Lost to Follow-up|0|||
161851836|NCT01449370|584498481|FG007|Overall Study|Lost to Follow-up|0|||
161851837|NCT01449370|584498482|FG008|Overall Study|Lost to Follow-up|0|||
161851838|NCT01449370|584498483|FG009|Overall Study|Lost to Follow-up|0|||
161851839|NCT01449370|584498484|FG010|Overall Study|Lost to Follow-up|0|||
161851840|NCT01449370|584498485|FG011|Overall Study|Lost to Follow-up|0|||
161851841|NCT01449370|584498486|FG012|Overall Study|Lost to Follow-up|0|||
161851842|NCT01449370|584498487|FG013|Overall Study|Lost to Follow-up|0|||
161851843|NCT01449370|584498488|FG014|Overall Study|Lost to Follow-up|0|||
161851844|NCT01449370|584498489|FG015|Overall Study|Lost to Follow-up|0|||
161851845|NCT01449370|584498490|FG016|Overall Study|Lost to Follow-up|0|||
161851846|NCT01449370|584498491|FG017|Overall Study|Lost to Follow-up|0|||
161851847|NCT01449370|584498492|FG018|Overall Study|Lost to Follow-up|0|||
161851848|NCT01449370|584498493|FG019|Overall Study|Lost to Follow-up|0|||
161851849|NCT01449370|584498494|FG020|Overall Study|Lost to Follow-up|1|||
161851850|NCT01449370|584498495|FG021|Overall Study|Lost to Follow-up|0|||
161851851|NCT01449370|584498496|FG022|Overall Study|Lost to Follow-up|0|||
161851852|NCT01449370|584498497|FG023|Overall Study|Lost to Follow-up|0|||
161851853|NCT01449370|584498498|FG024|Overall Study|Lost to Follow-up|0|||
161851854|NCT01449370|584498474|FG000|Overall Study|Other|0|||
161851855|NCT01449370|584498475|FG001|Overall Study|Other|0|||
161851856|NCT01449370|584498476|FG002|Overall Study|Other|0|||
161851857|NCT01449370|584498477|FG003|Overall Study|Other|0|||
161851858|NCT01449370|584498478|FG004|Overall Study|Other|0|||
161851859|NCT01449370|584498479|FG005|Overall Study|Other|0|||
161851860|NCT01449370|584498480|FG006|Overall Study|Other|0|||
161851861|NCT01449370|584498481|FG007|Overall Study|Other|0|||
161851862|NCT01449370|584498482|FG008|Overall Study|Other|1|||
161851863|NCT01449370|584498483|FG009|Overall Study|Other|1|||
161851864|NCT01449370|584498484|FG010|Overall Study|Other|0|||
161851865|NCT01449370|584498485|FG011|Overall Study|Other|0|||
161851866|NCT01449370|584498486|FG012|Overall Study|Other|0|||
161851867|NCT01449370|584498487|FG013|Overall Study|Other|0|||
161851868|NCT01449370|584498488|FG014|Overall Study|Other|0|||
161851869|NCT01449370|584498489|FG015|Overall Study|Other|0|||
161851870|NCT01449370|584498490|FG016|Overall Study|Other|0|||
161851871|NCT01449370|584498491|FG017|Overall Study|Other|0|||
161851872|NCT01449370|584498492|FG018|Overall Study|Other|0|||
161851873|NCT01449370|584498493|FG019|Overall Study|Other|0|||
161851874|NCT01449370|584498494|FG020|Overall Study|Other|0|||
161851875|NCT01449370|584498495|FG021|Overall Study|Other|0|||
161851876|NCT01449370|584498496|FG022|Overall Study|Other|1|||
161851877|NCT01449370|584498497|FG023|Overall Study|Other|1|||
161851878|NCT01449370|584498498|FG024|Overall Study|Other|0|||
161851879|NCT01449370|584498474|FG000|Overall Study|Medication Prohibited by Protocol|0|||
161851880|NCT01449370|584498475|FG001|Overall Study|Medication Prohibited by Protocol|0|||
161851881|NCT01449370|584498476|FG002|Overall Study|Medication Prohibited by Protocol|0|||
161851882|NCT01449370|584498477|FG003|Overall Study|Medication Prohibited by Protocol|0|||
161851883|NCT01449370|584498478|FG004|Overall Study|Medication Prohibited by Protocol|0|||
161851884|NCT01449370|584498479|FG005|Overall Study|Medication Prohibited by Protocol|0|||
161851885|NCT01449370|584498480|FG006|Overall Study|Medication Prohibited by Protocol|0|||
161851886|NCT01449370|584498481|FG007|Overall Study|Medication Prohibited by Protocol|0|||
161851887|NCT01449370|584498482|FG008|Overall Study|Medication Prohibited by Protocol|0|||
161851888|NCT01449370|584498483|FG009|Overall Study|Medication Prohibited by Protocol|0|||
161851889|NCT01449370|584498484|FG010|Overall Study|Medication Prohibited by Protocol|0|||
161851890|NCT01449370|584498485|FG011|Overall Study|Medication Prohibited by Protocol|0|||
161851891|NCT01449370|584498486|FG012|Overall Study|Medication Prohibited by Protocol|0|||
161851892|NCT01449370|584498487|FG013|Overall Study|Medication Prohibited by Protocol|0|||
161851893|NCT01449370|584498488|FG014|Overall Study|Medication Prohibited by Protocol|0|||
161851894|NCT01449370|584498489|FG015|Overall Study|Medication Prohibited by Protocol|0|||
161851895|NCT01449370|584498490|FG016|Overall Study|Medication Prohibited by Protocol|0|||
161851896|NCT01449370|584498491|FG017|Overall Study|Medication Prohibited by Protocol|0|||
161851897|NCT01449370|584498492|FG018|Overall Study|Medication Prohibited by Protocol|0|||
161851898|NCT01449370|584498493|FG019|Overall Study|Medication Prohibited by Protocol|0|||
161851899|NCT01449370|584498494|FG020|Overall Study|Medication Prohibited by Protocol|0|||
161851900|NCT01449370|584498495|FG021|Overall Study|Medication Prohibited by Protocol|0|||
161851901|NCT01449370|584498496|FG022|Overall Study|Medication Prohibited by Protocol|0|||
161851902|NCT01449370|584498497|FG023|Overall Study|Medication Prohibited by Protocol|1|||
161851903|NCT01449370|584498498|FG024|Overall Study|Medication Prohibited by Protocol|0|||
161851904|NCT01449370|584498474|FG000|Overall Study|Death|0|||
161851905|NCT01449370|584498475|FG001|Overall Study|Death|0|||
161851906|NCT01449370|584498476|FG002|Overall Study|Death|0|||
161851907|NCT01449370|584498477|FG003|Overall Study|Death|0|||
161851908|NCT01449370|584498478|FG004|Overall Study|Death|0|||
161851909|NCT01449370|584498479|FG005|Overall Study|Death|0|||
161851910|NCT01449370|584498480|FG006|Overall Study|Death|0|||
161851911|NCT01449370|584498481|FG007|Overall Study|Death|0|||
161851912|NCT01449370|584498482|FG008|Overall Study|Death|0|||
161851913|NCT01449370|584498483|FG009|Overall Study|Death|0|||
161851914|NCT01449370|584498484|FG010|Overall Study|Death|0|||
161851915|NCT01449370|584498485|FG011|Overall Study|Death|0|||
161851916|NCT01449370|584498486|FG012|Overall Study|Death|0|||
161851917|NCT01449370|584498487|FG013|Overall Study|Death|0|||
161851918|NCT01449370|584498488|FG014|Overall Study|Death|0|||
161851919|NCT01449370|584498489|FG015|Overall Study|Death|0|||
161851920|NCT01449370|584498490|FG016|Overall Study|Death|0|||
161851921|NCT01449370|584498491|FG017|Overall Study|Death|0|||
161851922|NCT01449370|584498492|FG018|Overall Study|Death|0|||
161851923|NCT01449370|584498493|FG019|Overall Study|Death|0|||
161851924|NCT01449370|584498494|FG020|Overall Study|Death|0|||
161851925|NCT01449370|584498495|FG021|Overall Study|Death|0|||
161851926|NCT01449370|584498496|FG022|Overall Study|Death|0|||
161851927|NCT01449370|584498497|FG023|Overall Study|Death|0|||
161851928|NCT01449370|584498498|FG024|Overall Study|Death|1|||
161851929|NCT00086281|584498499|FG000|Phase 1|Adverse Event|0|||
161851930|NCT00086281|584498500|FG001|Phase 1|Adverse Event|0|||
161851931|NCT00086281|584498501|FG002|Phase 1|Adverse Event|0|||
161851932|NCT00086281|584498502|FG003|Phase 1|Adverse Event|0|||
161851933|NCT00086281|584498503|FG004|Phase 1|Adverse Event|0|||
161851934|NCT00086281|584498504|FG005|Phase 1|Adverse Event|0|||
161851935|NCT00086281|584498505|FG006|Phase 1|Adverse Event|0|||
161851936|NCT00086281|584498506|FG007|Phase 1|Adverse Event|0|||
161851937|NCT00086281|584498507|FG008|Phase 1|Adverse Event|0|||
161851938|NCT00086281|584498508|FG009|Phase 1|Adverse Event|1|||
161851939|NCT00086281|584498509|FG010|Phase 1|Adverse Event|2|||
161851940|NCT00086281|584498510|FG011|Phase 1|Adverse Event|1|||
161851941|NCT00086281|584498511|FG012|Phase 1|Adverse Event|1|||
161851942|NCT00086281|584498512|FG013|Phase 1|Adverse Event|1|||
161851943|NCT00086281|584498513|FG014|Phase 1|Adverse Event|2|||
161851944|NCT00086281|584498499|FG000|Phase 1|Protocol Violation|0|||
161851945|NCT00086281|584498500|FG001|Phase 1|Protocol Violation|0|||
161851946|NCT00086281|584498501|FG002|Phase 1|Protocol Violation|0|||
161851947|NCT00086281|584498502|FG003|Phase 1|Protocol Violation|0|||
161851948|NCT00086281|584498503|FG004|Phase 1|Protocol Violation|0|||
161851949|NCT00086281|584498504|FG005|Phase 1|Protocol Violation|0|||
161851950|NCT00086281|584498505|FG006|Phase 1|Protocol Violation|0|||
161851951|NCT00086281|584498506|FG007|Phase 1|Protocol Violation|0|||
161851952|NCT00086281|584498507|FG008|Phase 1|Protocol Violation|0|||
161851953|NCT00086281|584498508|FG009|Phase 1|Protocol Violation|0|||
161851954|NCT00086281|584498509|FG010|Phase 1|Protocol Violation|1|||
161851955|NCT00086281|584498510|FG011|Phase 1|Protocol Violation|0|||
161851956|NCT00086281|584498511|FG012|Phase 1|Protocol Violation|0|||
161851957|NCT00086281|584498512|FG013|Phase 1|Protocol Violation|0|||
161851958|NCT00086281|584498513|FG014|Phase 1|Protocol Violation|0|||
161851959|NCT00086281|584498499|FG000|Phase 1|Serious Adverse Event|0|||
161851960|NCT00086281|584498500|FG001|Phase 1|Serious Adverse Event|0|||
161851961|NCT00086281|584498501|FG002|Phase 1|Serious Adverse Event|0|||
161851962|NCT00086281|584498502|FG003|Phase 1|Serious Adverse Event|0|||
161851963|NCT00086281|584498503|FG004|Phase 1|Serious Adverse Event|0|||
161851964|NCT00086281|584498504|FG005|Phase 1|Serious Adverse Event|0|||
161851965|NCT00086281|584498505|FG006|Phase 1|Serious Adverse Event|0|||
161851966|NCT00086281|584498506|FG007|Phase 1|Serious Adverse Event|0|||
161851967|NCT00086281|584498507|FG008|Phase 1|Serious Adverse Event|0|||
161851968|NCT00086281|584498508|FG009|Phase 1|Serious Adverse Event|0|||
161851969|NCT00086281|584498509|FG010|Phase 1|Serious Adverse Event|0|||
161851970|NCT00086281|584498510|FG011|Phase 1|Serious Adverse Event|0|||
161851971|NCT00086281|584498511|FG012|Phase 1|Serious Adverse Event|0|||
161851972|NCT00086281|584498512|FG013|Phase 1|Serious Adverse Event|0|||
161851973|NCT00086281|584498513|FG014|Phase 1|Serious Adverse Event|1|||
161851974|NCT00086281|584498499|FG000|Phase 2|Adverse Event|0|||
161851975|NCT00086281|584498500|FG001|Phase 2|Adverse Event|0|||
161851976|NCT00086281|584498501|FG002|Phase 2|Adverse Event|0|||
161851977|NCT00086281|584498502|FG003|Phase 2|Adverse Event|0|||
161851978|NCT00086281|584498503|FG004|Phase 2|Adverse Event|0|||
161851979|NCT00086281|584498504|FG005|Phase 2|Adverse Event|0|||
161851980|NCT00086281|584498505|FG006|Phase 2|Adverse Event|0|||
161851981|NCT00086281|584498506|FG007|Phase 2|Adverse Event|0|||
161851982|NCT00086281|584498507|FG008|Phase 2|Adverse Event|0|||
161851983|NCT00086281|584498508|FG009|Phase 2|Adverse Event|0|||
161851984|NCT00086281|584498509|FG010|Phase 2|Adverse Event|0|||
161851985|NCT00086281|584498510|FG011|Phase 2|Adverse Event|0|||
161851986|NCT00086281|584498511|FG012|Phase 2|Adverse Event|1|||
161851987|NCT00086281|584498512|FG013|Phase 2|Adverse Event|1|||
161851988|NCT00086281|584498513|FG014|Phase 2|Adverse Event|0|||
161851989|NCT03456453|584498517|FG000|Overall Study|Withdrawal by Subject|2|||
161851990|NCT03456453|584498518|FG001|Overall Study|Withdrawal by Subject|0|||
161851991|NCT03456453|584498517|FG000|Overall Study|Not released to community|1|||
161851992|NCT03456453|584498518|FG001|Overall Study|Not released to community|5|||
161851993|NCT03456453|584498517|FG000|Overall Study|Lost to Follow-up|0|||
161851994|NCT03456453|584498518|FG001|Overall Study|Lost to Follow-up|2|||
161851995|NCT00896480|584498519|FG000|Overall Study|Disease progression/recurrence|21|||
161851996|NCT01004003|584498520|FG000|Overall Study|Progressive disease|2|||
161851997|NCT01004003|584498521|FG001|Overall Study|Progressive disease|1|||
161851998|NCT01004003|584498522|FG002|Overall Study|Progressive disease|1|||
161851999|NCT01004003|584498523|FG003|Overall Study|Progressive disease|0|||
161852000|NCT01004003|584498524|FG004|Overall Study|Progressive disease|2|||
161852001|NCT01004003|584498525|FG005|Overall Study|Progressive disease|1|||
161852002|NCT01004003|584498526|FG006|Overall Study|Progressive disease|1|||
161852003|NCT01004003|584498527|FG007|Overall Study|Progressive disease|39|||
161852004|NCT01004003|584498528|FG008|Overall Study|Progressive disease|22|||
161852005|NCT01004003|584498520|FG000|Overall Study|Adverse Event|4|||
161852006|NCT01004003|584498521|FG001|Overall Study|Adverse Event|2|||
161852007|NCT01004003|584498522|FG002|Overall Study|Adverse Event|3|||
161852008|NCT01004003|584498523|FG003|Overall Study|Adverse Event|3|||
161852009|NCT01004003|584498524|FG004|Overall Study|Adverse Event|2|||
161852010|NCT01004003|584498525|FG005|Overall Study|Adverse Event|2|||
161852011|NCT01004003|584498526|FG006|Overall Study|Adverse Event|7|||
161852012|NCT01004003|584498527|FG007|Overall Study|Adverse Event|21|||
161852013|NCT01004003|584498528|FG008|Overall Study|Adverse Event|6|||
161852014|NCT01004003|584498520|FG000|Overall Study|Refused to continue taking trial med.|0|||
161852015|NCT01004003|584498521|FG001|Overall Study|Refused to continue taking trial med.|0|||
161852016|NCT01004003|584498522|FG002|Overall Study|Refused to continue taking trial med.|0|||
161852017|NCT01004003|584498523|FG003|Overall Study|Refused to continue taking trial med.|0|||
161852018|NCT01004003|584498524|FG004|Overall Study|Refused to continue taking trial med.|0|||
161764822|NCT01624974|584178893|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
161764823|NCT01624974|584178894|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
161764824|NCT01624974|584178893|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
161764825|NCT01624974|584178894|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
161764826|NCT02607735|584178895|FG000|Primary Study|Randomized but Never Treated|1|||
161764827|NCT02607735|584178896|FG001|Primary Study|Randomized but Never Treated|0|||
161764828|NCT02607735|584178897|FG002|Primary Study|Randomized but Never Treated|0|||
161764829|NCT02607735|584178895|FG000|Primary Study|Lost to Follow-up|4|||
161764830|NCT02607735|584178896|FG001|Primary Study|Lost to Follow-up|0|||
161764831|NCT02607735|584178897|FG002|Primary Study|Lost to Follow-up|0|||
161764832|NCT02607735|584178895|FG000|Primary Study|Withdrew Consent|2|||
161764833|NCT02607735|584178896|FG001|Primary Study|Withdrew Consent|0|||
161764834|NCT02607735|584178897|FG002|Primary Study|Withdrew Consent|0|||
161764835|NCT02607735|584178895|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
161764836|NCT02607735|584178896|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
161764837|NCT02607735|584178897|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
161764838|NCT02607735|584178895|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
161764839|NCT02607735|584178896|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
161764840|NCT02607735|584178897|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
161764841|NCT01376908|584178898|FG000|Overall Study|Protocol Violation|1|||
161764842|NCT01376908|584178899|FG001|Overall Study|Protocol Violation|1|||
161764843|NCT01376908|584178898|FG000|Overall Study|Withdrawal by Subject|1|||
161764844|NCT01376908|584178899|FG001|Overall Study|Withdrawal by Subject|2|||
161764845|NCT01681836|584178904|FG000|Second Intervention|Withdrawal by Subject|0|||
161764846|NCT01681836|584178905|FG001|Second Intervention|Withdrawal by Subject|1|||
161764847|NCT00742391|584178908|FG000|Overall Study|Adverse Event|2|||
161764848|NCT00742391|584178909|FG001|Overall Study|Adverse Event|1|||
161764849|NCT00742391|584178908|FG000|Overall Study|Lost to Follow-up|1|||
161764850|NCT00742391|584178909|FG001|Overall Study|Lost to Follow-up|0|||
161764851|NCT00742391|584178908|FG000|Overall Study|Protocol Violation|1|||
161764852|NCT00742391|584178909|FG001|Overall Study|Protocol Violation|0|||
161764853|NCT02394028|584178910|FG000|Induction Phase|Adverse Event|2|||
161764854|NCT02394028|584178911|FG001|Induction Phase|Adverse Event|4|||
161764855|NCT02394028|584178912|FG002|Induction Phase|Adverse Event|1|||
161764856|NCT02394028|584178913|FG003|Induction Phase|Adverse Event|2|||
161764857|NCT02394028|584178914|FG004|Induction Phase|Adverse Event|5|||
161764858|NCT02394028|584178915|FG005|Induction Phase|Adverse Event|2|||
161764859|NCT02394028|584178916|FG006|Induction Phase|Adverse Event|0|||
161764860|NCT02394028|584178917|FG007|Induction Phase|Adverse Event|0|||
161764861|NCT02394028|584178918|FG008|Induction Phase|Adverse Event|0|||
161764862|NCT02394028|584178919|FG009|Induction Phase|Adverse Event|0|||
161764863|NCT02394028|584178920|FG010|Induction Phase|Adverse Event|0|||
161764864|NCT02394028|584178910|FG000|Induction Phase|Lack of Efficacy|3|||
161764865|NCT02394028|584178911|FG001|Induction Phase|Lack of Efficacy|6|||
161764866|NCT02394028|584178912|FG002|Induction Phase|Lack of Efficacy|2|||
161764867|NCT02394028|584178913|FG003|Induction Phase|Lack of Efficacy|17|||
161764868|NCT02394028|584178914|FG004|Induction Phase|Lack of Efficacy|14|||
161764869|NCT02394028|584178915|FG005|Induction Phase|Lack of Efficacy|8|||
161764870|NCT02394028|584178916|FG006|Induction Phase|Lack of Efficacy|17|||
161764871|NCT02394028|584178917|FG007|Induction Phase|Lack of Efficacy|23|||
161764872|NCT02394028|584178918|FG008|Induction Phase|Lack of Efficacy|0|||
161764873|NCT02394028|584178919|FG009|Induction Phase|Lack of Efficacy|0|||
161764874|NCT02394028|584178920|FG010|Induction Phase|Lack of Efficacy|0|||
161764875|NCT02394028|584178910|FG000|Induction Phase|Lost to Follow-up|1|||
161764876|NCT02394028|584178911|FG001|Induction Phase|Lost to Follow-up|0|||
161764877|NCT02394028|584178912|FG002|Induction Phase|Lost to Follow-up|0|||
161764878|NCT02394028|584178913|FG003|Induction Phase|Lost to Follow-up|1|||
161764879|NCT02394028|584178914|FG004|Induction Phase|Lost to Follow-up|0|||
161764880|NCT02394028|584178915|FG005|Induction Phase|Lost to Follow-up|0|||
161764881|NCT02394028|584178916|FG006|Induction Phase|Lost to Follow-up|1|||
161764882|NCT02394028|584178917|FG007|Induction Phase|Lost to Follow-up|0|||
161764883|NCT02394028|584178918|FG008|Induction Phase|Lost to Follow-up|0|||
161764884|NCT02394028|584178919|FG009|Induction Phase|Lost to Follow-up|0|||
161764885|NCT02394028|584178920|FG010|Induction Phase|Lost to Follow-up|0|||
161764886|NCT02394028|584178910|FG000|Induction Phase|Non-compliance|0|||
161764887|NCT02394028|584178911|FG001|Induction Phase|Non-compliance|1|||
161764888|NCT02394028|584178912|FG002|Induction Phase|Non-compliance|3|||
161764889|NCT02394028|584178913|FG003|Induction Phase|Non-compliance|1|||
161764890|NCT02394028|584178914|FG004|Induction Phase|Non-compliance|3|||
161764891|NCT02394028|584178915|FG005|Induction Phase|Non-compliance|0|||
161764892|NCT02394028|584178916|FG006|Induction Phase|Non-compliance|1|||
161764893|NCT02394028|584178917|FG007|Induction Phase|Non-compliance|1|||
161764894|NCT02394028|584178918|FG008|Induction Phase|Non-compliance|0|||
161764895|NCT02394028|584178919|FG009|Induction Phase|Non-compliance|0|||
161764896|NCT02394028|584178920|FG010|Induction Phase|Non-compliance|0|||
161764897|NCT02394028|584178910|FG000|Induction Phase|Physician Decision|0|||
161764898|NCT02394028|584178911|FG001|Induction Phase|Physician Decision|0|||
161852019|NCT01004003|584498525|FG005|Overall Study|Refused to continue taking trial med.|0|||
161852020|NCT01004003|584498526|FG006|Overall Study|Refused to continue taking trial med.|0|||
161852021|NCT01004003|584498527|FG007|Overall Study|Refused to continue taking trial med.|0|||
161852022|NCT01004003|584498528|FG008|Overall Study|Refused to continue taking trial med.|2|||
161852023|NCT01004003|584498520|FG000|Overall Study|Other|0|||
161852024|NCT01004003|584498521|FG001|Overall Study|Other|0|||
161852025|NCT01004003|584498522|FG002|Overall Study|Other|0|||
161852026|NCT01004003|584498523|FG003|Overall Study|Other|0|||
161852027|NCT01004003|584498524|FG004|Overall Study|Other|0|||
161852028|NCT01004003|584498525|FG005|Overall Study|Other|1|||
161852029|NCT01004003|584498526|FG006|Overall Study|Other|0|||
161852030|NCT01004003|584498527|FG007|Overall Study|Other|0|||
161852031|NCT01004003|584498528|FG008|Overall Study|Other|0|||
161852032|NCT00351533|584498532|FG000|Overall Study|Extubated before first BAL|1|||
161852033|NCT00351533|584498533|FG001|Overall Study|Extubated before first BAL|0|||
161852034|NCT00351533|584498532|FG000|Overall Study|Lost to Follow-up|1|||
161852035|NCT00351533|584498533|FG001|Overall Study|Lost to Follow-up|3|||
161852036|NCT00351533|584498532|FG000|Overall Study|Physician Decision|0|||
161852037|NCT00351533|584498533|FG001|Overall Study|Physician Decision|1|||
161852038|NCT00351533|584498532|FG000|Overall Study|Withdrawal by Subject|0|||
161852039|NCT00351533|584498533|FG001|Overall Study|Withdrawal by Subject|1|||
161852040|NCT00315731|584498536|FG000|Overall Study|Lost to Follow-up|1|||
161852041|NCT00315731|584498536|FG000|Overall Study|Death|5|||
161852042|NCT01680497|584498538|FG000|Overall Study|Lost to Follow-up|2|||
161852043|NCT04123561|584498540|FG000|Overall Study|Lost to Follow-up|20|||
161852044|NCT04123561|584498541|FG001|Overall Study|Lost to Follow-up|12|||
161852045|NCT04123561|584498542|FG002|Overall Study|Lost to Follow-up|5|||
161852046|NCT04123561|584498540|FG000|Overall Study|Withdrawal by Subject|9|||
161852047|NCT04123561|584498541|FG001|Overall Study|Withdrawal by Subject|7|||
161852048|NCT04123561|584498542|FG002|Overall Study|Withdrawal by Subject|9|||
161852049|NCT04123561|584498540|FG000|Overall Study|Lack of Efficacy|7|||
161852050|NCT04123561|584498541|FG001|Overall Study|Lack of Efficacy|8|||
161852051|NCT04123561|584498542|FG002|Overall Study|Lack of Efficacy|6|||
161852052|NCT04123561|584498540|FG000|Overall Study|Adverse Event|5|||
161852053|NCT04123561|584498541|FG001|Overall Study|Adverse Event|2|||
161852054|NCT04123561|584498542|FG002|Overall Study|Adverse Event|3|||
161852055|NCT04123561|584498540|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
161852056|NCT04123561|584498541|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
161852057|NCT04123561|584498542|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
161852058|NCT04123561|584498540|FG000|Overall Study|Death|0|||
161852059|NCT04123561|584498541|FG001|Overall Study|Death|0|||
161852060|NCT04123561|584498542|FG002|Overall Study|Death|1|||
161852061|NCT04123561|584498540|FG000|Overall Study|Protocol Violation|0|||
161852062|NCT04123561|584498541|FG001|Overall Study|Protocol Violation|1|||
161852063|NCT04123561|584498542|FG002|Overall Study|Protocol Violation|0|||
161852064|NCT02454608|584499704|FG000|Double-Blind Period|Lack of Efficacy|0|||
161852065|NCT02454608|584499705|FG001|Double-Blind Period|Lack of Efficacy|2|||
161852066|NCT02454608|584499706|FG002|Double-Blind Period|Lack of Efficacy|0|||
161852067|NCT02454608|584499704|FG000|Open Label Period|Lost to Follow-up|0|||
161852068|NCT02454608|584499705|FG001|Open Label Period|Lost to Follow-up|0|||
161852069|NCT02454608|584499706|FG002|Open Label Period|Lost to Follow-up|11|||
161852070|NCT02454608|584499704|FG000|Open Label Period|Withdrawal by Subject|0|||
161852071|NCT02454608|584499705|FG001|Open Label Period|Withdrawal by Subject|0|||
161852072|NCT02454608|584499706|FG002|Open Label Period|Withdrawal by Subject|8|||
161852073|NCT02465398|584499707|FG000|Overall Study|Death|7|||
161852074|NCT02465398|584499707|FG000|Overall Study|Revision|7|||
161852075|NCT02465398|584499707|FG000|Overall Study|did not receive study device|1|||
161852076|NCT02465398|584499707|FG000|Overall Study|Withdrawal by Subject|1|||
161852077|NCT02465398|584499707|FG000|Overall Study|Lost to Follow-up|14|||
161852078|NCT02540850|584499708|FG000|Overall Study|Lost to Follow-up|69|||
161852079|NCT02540850|584499709|FG001|Overall Study|Lost to Follow-up|66|||
161852080|NCT02540850|584499710|FG002|Overall Study|Lost to Follow-up|34|||
161852081|NCT03760185|584499721|FG000|Overall Study|Lost to Follow-up|1|||
161852082|NCT03760185|584499722|FG001|Overall Study|Lost to Follow-up|1|||
161852083|NCT02473523|584499723|FG000|Overall Study|Death|1|||
161852084|NCT02473523|584499723|FG000|Overall Study|Lost to Follow-up|1|||
161852085|NCT02111603|584499726|FG000|Overall Study|Withdrawal by Subject|1|||
161852086|NCT00976911|584499727|FG000|Overall Study|Withdrawal by Subject|4|||
161852087|NCT00976911|584499728|FG001|Overall Study|Withdrawal by Subject|6|||
161852088|NCT00976911|584499727|FG000|Overall Study|Death|138|||
161852089|NCT00976911|584499728|FG001|Overall Study|Death|126|||
161852090|NCT00976911|584499727|FG000|Overall Study|Adverse Event|0|||
161852091|NCT00976911|584499728|FG001|Overall Study|Adverse Event|1|||
161852092|NCT00976911|584499727|FG000|Overall Study|Protocol Violation|2|||
161852093|NCT00976911|584499728|FG001|Overall Study|Protocol Violation|0|||
161852094|NCT00976911|584499727|FG000|Overall Study|Other|8|||
161852095|NCT00976911|584499728|FG001|Overall Study|Other|9|||
161852096|NCT00976911|584499727|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
161852097|NCT00976911|584499728|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
161852098|NCT02954991|584499729|FG000|Overall Study|Death|92|||
161852099|NCT02954991|584499730|FG001|Overall Study|Death|11|||
161852100|NCT02954991|584499731|FG002|Overall Study|Death|2|||
161852101|NCT02954991|584499729|FG000|Overall Study|Lost to Follow-up|3|||
161852102|NCT02954991|584499730|FG001|Overall Study|Lost to Follow-up|2|||
161852103|NCT02954991|584499731|FG002|Overall Study|Lost to Follow-up|0|||
161852104|NCT02954991|584499729|FG000|Overall Study|Withdrawal by Subject|9|||
161852105|NCT02954991|584499730|FG001|Overall Study|Withdrawal by Subject|8|||
161852106|NCT02954991|584499731|FG002|Overall Study|Withdrawal by Subject|1|||
161852107|NCT02954991|584499729|FG000|Overall Study|Study Terminated by Sponsor|18|||
161852108|NCT02954991|584499730|FG001|Overall Study|Study Terminated by Sponsor|10|||
161852109|NCT02954991|584499731|FG002|Overall Study|Study Terminated by Sponsor|1|||
161852110|NCT02954991|584499729|FG000|Overall Study|Miscellaneous|2|||
161852111|NCT02954991|584499730|FG001|Overall Study|Miscellaneous|1|||
161852112|NCT02954991|584499731|FG002|Overall Study|Miscellaneous|1|||
161852113|NCT00576316|584499732|FG000|Overall Study|Adverse Event|9|||
161852114|NCT00576316|584499732|FG000|Overall Study|Withdrawal by Subject|2|||
161852115|NCT00576316|584499732|FG000|Overall Study|Protocol Violation|9|||
161852116|NCT02552303|584499735|FG000|Allocation|Withdrawal by Subject|2|||
161852117|NCT02552303|584499736|FG001|Allocation|Withdrawal by Subject|1|||
161852118|NCT02552303|584499737|FG002|Allocation|Withdrawal by Subject|1|||
161852119|NCT02552303|584499738|FG003|Allocation|Withdrawal by Subject|1|||
161852120|NCT02552303|584499735|FG000|Allocation|ineligible|1|||
161852121|NCT02552303|584499736|FG001|Allocation|ineligible|1|||
161852122|NCT02552303|584499737|FG002|Allocation|ineligible|0|||
161852123|NCT02552303|584499738|FG003|Allocation|ineligible|0|||
161852124|NCT02552303|584499735|FG000|Follow-Up|Lost to Follow-up|0|||
161852125|NCT02552303|584499736|FG001|Follow-Up|Lost to Follow-up|0|||
161852126|NCT02552303|584499737|FG002|Follow-Up|Lost to Follow-up|1|||
161852127|NCT02552303|584499738|FG003|Follow-Up|Lost to Follow-up|0|||
161852128|NCT02552303|584499735|FG000|Follow-Up|ineligible|0|||
161852129|NCT02552303|584499736|FG001|Follow-Up|ineligible|2|||
161852130|NCT02552303|584499737|FG002|Follow-Up|ineligible|0|||
161852131|NCT02552303|584499738|FG003|Follow-Up|ineligible|0|||
161852132|NCT01582152|584499739|FG000|Overall Study|Disease Progression|4|||
161852133|NCT01582152|584499740|FG001|Overall Study|Disease Progression|5|||
161852134|NCT01582152|584499739|FG000|Overall Study|Adverse Event|2|||
161852135|NCT01582152|584499740|FG001|Overall Study|Adverse Event|1|||
161852136|NCT03055624|584499741|FG000|Overall Study|Study closed|9|||
161852137|NCT02437903|584499744|FG000|Overall Study|Adverse Event|1|||
161852138|NCT02437903|584499744|FG000|Overall Study|Withdrawal by Subject|1|||
161852139|NCT02437903|584499744|FG000|Overall Study|Lost to Follow-up|3|||
161852140|NCT00230178|584499745|FG000|Overall Study|Adverse Event|1|||
161852141|NCT00230178|584499746|FG001|Overall Study|Adverse Event|5|||
161852142|NCT00230178|584499747|FG002|Overall Study|Adverse Event|2|||
161852143|NCT00230178|584499745|FG000|Overall Study|Withdrawal by Subject|0|||
161852144|NCT00230178|584499746|FG001|Overall Study|Withdrawal by Subject|0|||
161852145|NCT00230178|584499747|FG002|Overall Study|Withdrawal by Subject|1|||
161852146|NCT00230178|584499745|FG000|Overall Study|Various other reasons|3|||
161852147|NCT00230178|584499746|FG001|Overall Study|Various other reasons|2|||
161852148|NCT00230178|584499747|FG002|Overall Study|Various other reasons|4|||
161852149|NCT02252406|584499754|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
161852150|NCT02252406|584499755|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
161852151|NCT02252406|584499754|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
161852152|NCT02252406|584499755|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
161852153|NCT02252406|584499754|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
161852154|NCT02252406|584499755|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
161852155|NCT02252406|584499754|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
161852156|NCT02252406|584499755|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
161852157|NCT02252406|584499754|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
161852158|NCT02252406|584499755|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
161852159|NCT00005957|584499756|FG000|Overall Study|No treated|3|||
161852160|NCT00005957|584499757|FG001|Overall Study|No treated|9|||
161852161|NCT00005957|584499756|FG000|Overall Study|Crossover to the other arm|5|||
161852162|NCT00005957|584499757|FG001|Overall Study|Crossover to the other arm|19|||
161852163|NCT01609023|584499758|FG000|Overall Study|Lack of Efficacy|3|||
161852164|NCT01609023|584499758|FG000|Overall Study|Withdrawal by Subject|4|||
161852165|NCT01609023|584499758|FG000|Overall Study|Lost to Follow-up|8|||
161852166|NCT01609023|584499758|FG000|Overall Study|Toxicity|3|||
161852167|NCT01609023|584499758|FG000|Overall Study|Disease progression|10|||
161852168|NCT01609023|584499758|FG000|Overall Study|Physician Decision|2|||
161852169|NCT01609023|584499758|FG000|Overall Study|Death|2|||
161852170|NCT01609023|584499758|FG000|Overall Study|Personal reasons|1|||
161852171|NCT00799825|584499759|FG000|Overall Study|Adverse Event|1|||
161852172|NCT00799825|584499759|FG000|Overall Study|Withdrawal by Subject|6|||
161852173|NCT00799825|584499759|FG000|Overall Study|Lost to Follow-up|38|||
161852174|NCT00799825|584499759|FG000|Overall Study|Pregnancy|3|||
161852175|NCT04974749|584499760|FG000|Overall Study|Withdrawal by Subject|2|||
161852176|NCT04974749|584499760|FG000|Overall Study|Gestation|1|||
161852177|NCT00796107|584499766|FG000|Overall Study|Lack of Efficacy|1|||
161852178|NCT00796107|584499766|FG000|Overall Study|Progressive Disease|5|||
161852179|NCT02681510|584499774|FG000|Overall Study|Withdrawal by Subject|1|||
161852180|NCT02681510|584499774|FG000|Overall Study|Lost to Follow-up|9|||
161852181|NCT02075515|584499775|FG000|Overall Study|Serious Adverse Event|1|||
161852182|NCT02075515|584499776|FG001|Overall Study|Serious Adverse Event|1|||
161852183|NCT02075515|584499777|FG002|Overall Study|Serious Adverse Event|1|||
161852184|NCT02075515|584499775|FG000|Overall Study|Non-Serious Adverse Event|0|||
161852185|NCT02075515|584499776|FG001|Overall Study|Non-Serious Adverse Event|1|||
161852186|NCT02075515|584499777|FG002|Overall Study|Non-Serious Adverse Event|0|||
161852187|NCT02075515|584499775|FG000|Overall Study|Withdrawal by Subject|2|||
161852188|NCT02075515|584499776|FG001|Overall Study|Withdrawal by Subject|0|||
161852189|NCT02075515|584499777|FG002|Overall Study|Withdrawal by Subject|1|||
161852190|NCT02075515|584499775|FG000|Overall Study|Lost to Follow-up|1|||
161852191|NCT02075515|584499776|FG001|Overall Study|Lost to Follow-up|3|||
161852192|NCT02075515|584499777|FG002|Overall Study|Lost to Follow-up|6|||
161852193|NCT00741338|584499788|FG000|Overall Study|Adverse Event|0|||
161852194|NCT00741338|584499789|FG001|Overall Study|Adverse Event|1|||
161852195|NCT03593395|584499790|FG000|Overall Study|Lost to Follow-up|48|||
161852196|NCT03593395|584499791|FG001|Overall Study|Lost to Follow-up|3|||
161852197|NCT03593395|584499790|FG000|Overall Study|Withdrawal by Subject|5|||
161852198|NCT03593395|584499791|FG001|Overall Study|Withdrawal by Subject|24|||
161852199|NCT03593395|584499790|FG000|Overall Study|Death|2|||
161852200|NCT03593395|584499791|FG001|Overall Study|Death|3|||
161852201|NCT03593395|584499790|FG000|Overall Study|Physician Decision|0|||
161852202|NCT03593395|584499791|FG001|Overall Study|Physician Decision|6|||
161852203|NCT03593395|584499790|FG000|Overall Study|Participant Relocated|19|||
161852204|NCT03593395|584499791|FG001|Overall Study|Participant Relocated|3|||
161852205|NCT03593395|584499790|FG000|Overall Study|No Information|1|||
161852206|NCT03593395|584499791|FG001|Overall Study|No Information|7|||
161852207|NCT02370238|584499798|FG000|Overall Study|Death|42|||
161852208|NCT02370238|584499799|FG001|Overall Study|Death|35|||
161852209|NCT02370238|584499798|FG000|Overall Study|Lost to Follow-up|1|||
161852210|NCT02370238|584499799|FG001|Overall Study|Lost to Follow-up|3|||
161852211|NCT02370238|584499798|FG000|Overall Study|Withdrawal by Subject|2|||
161852212|NCT02370238|584499799|FG001|Overall Study|Withdrawal by Subject|6|||
161852213|NCT02370238|584499798|FG000|Overall Study|Other|2|||
161852214|NCT02370238|584499799|FG001|Overall Study|Other|1|||
161852215|NCT03837743|584499805|FG000|Overall Study|Adverse Event|1|||
161852216|NCT03837743|584499805|FG000|Overall Study|Withdrawal by Subject|2|||
161852217|NCT01685840|584499808|FG000|Overall Study|Death|77|||
161852218|NCT01685840|584499809|FG001|Overall Study|Death|66|||
161852219|NCT01685840|584499808|FG000|Overall Study|Lost to Follow-up|27|||
161852220|NCT01685840|584499809|FG001|Overall Study|Lost to Follow-up|25|||
161852221|NCT01685840|584499808|FG000|Overall Study|Physician Decision|3|||
161852222|NCT01685840|584499809|FG001|Overall Study|Physician Decision|7|||
161852223|NCT01685840|584499808|FG000|Overall Study|Withdrawal by Subject|14|||
161852224|NCT01685840|584499809|FG001|Overall Study|Withdrawal by Subject|17|||
161852225|NCT01685840|584499808|FG000|Overall Study|Futility|197|||
161852226|NCT01685840|584499809|FG001|Overall Study|Futility|200|||
161852227|NCT01685840|584499808|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
161852228|NCT01685840|584499809|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
161852229|NCT00710866|584499810|FG000|Overall Study|Protocol Violation|5|||
161852230|NCT00710866|584499811|FG001|Overall Study|Protocol Violation|4|||
161852231|NCT00710866|584499810|FG000|Overall Study|Withdrawal by Subject|2|||
161852232|NCT00710866|584499811|FG001|Overall Study|Withdrawal by Subject|1|||
161852233|NCT00710866|584499810|FG000|Overall Study|Lost to Follow-up|1|||
161852234|NCT00710866|584499811|FG001|Overall Study|Lost to Follow-up|0|||
161852235|NCT00710866|584499810|FG000|Overall Study|Failed to meet eligibility|1|||
161852236|NCT00710866|584499811|FG001|Overall Study|Failed to meet eligibility|1|||
161852237|NCT03371459|584499816|FG000|Washout|Lost to Follow-up|0|||
161852238|NCT03371459|584499817|FG001|Washout|Lost to Follow-up|1|||
161852239|NCT01885195|584499820|FG000|Overall Study|Adverse Event|29|||
161852240|NCT01885195|584499820|FG000|Overall Study|Death|1|||
161852241|NCT01885195|584499820|FG000|Overall Study|Disease Progression|67|||
161852242|NCT01885195|584499820|FG000|Overall Study|Protocol Deviation|2|||
161852243|NCT01885195|584499820|FG000|Overall Study|Physician Decision|3|||
161852244|NCT01885195|584499820|FG000|Overall Study|Patient/guardian decision|8|||
161852245|NCT01589497|584499821|FG000|Overall Study|Withdrawal by Subject|0|||
161852246|NCT01589497|584499822|FG001|Overall Study|Withdrawal by Subject|1|||
161852247|NCT01589497|584499823|FG002|Overall Study|Withdrawal by Subject|0|||
161852248|NCT01589497|584499824|FG003|Overall Study|Withdrawal by Subject|1|||
161852249|NCT01589497|584499821|FG000|Overall Study|Death|1|||
161852250|NCT01589497|584499822|FG001|Overall Study|Death|0|||
161852251|NCT01589497|584499823|FG002|Overall Study|Death|0|||
161852252|NCT01589497|584499824|FG003|Overall Study|Death|0|||
161852253|NCT01589497|584499821|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161852254|NCT01589497|584499822|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161852255|NCT01589497|584499823|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
161852256|NCT01589497|584499824|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161852257|NCT03390426|584499825|FG000|Overall Study|Protocol Violation|0|||
161852258|NCT03390426|584499826|FG001|Overall Study|Protocol Violation|1|||
161852259|NCT00259272|584499827|FG000|Overall Study|Adverse Event|2|||
161852260|NCT00259272|584499828|FG001|Overall Study|Adverse Event|1|||
161852261|NCT00259272|584499829|FG002|Overall Study|Adverse Event|0|||
161852262|NCT00259272|584499830|FG003|Overall Study|Adverse Event|3|||
161852263|NCT00259272|584499827|FG000|Overall Study|Lack of Efficacy|5|||
161852264|NCT00259272|584499828|FG001|Overall Study|Lack of Efficacy|1|||
161852265|NCT00259272|584499829|FG002|Overall Study|Lack of Efficacy|2|||
161852266|NCT00259272|584499830|FG003|Overall Study|Lack of Efficacy|6|||
161852267|NCT00259272|584499827|FG000|Overall Study|Physician Decision|1|||
161852268|NCT00259272|584499828|FG001|Overall Study|Physician Decision|2|||
161852269|NCT00259272|584499829|FG002|Overall Study|Physician Decision|1|||
161852270|NCT00259272|584499830|FG003|Overall Study|Physician Decision|3|||
161852271|NCT00259272|584499827|FG000|Overall Study|Protocol Violation|2|||
161852272|NCT00259272|584499828|FG001|Overall Study|Protocol Violation|0|||
161852273|NCT00259272|584499829|FG002|Overall Study|Protocol Violation|0|||
161852274|NCT00259272|584499830|FG003|Overall Study|Protocol Violation|1|||
161852275|NCT00259272|584499827|FG000|Overall Study|Sponsor Decision|0|||
161852276|NCT00259272|584499828|FG001|Overall Study|Sponsor Decision|1|||
161852277|NCT00259272|584499829|FG002|Overall Study|Sponsor Decision|0|||
161852278|NCT00259272|584499830|FG003|Overall Study|Sponsor Decision|0|||
161852279|NCT00259272|584499827|FG000|Overall Study|Withdrawal by Subject|4|||
161852280|NCT00259272|584499828|FG001|Overall Study|Withdrawal by Subject|2|||
161852281|NCT00259272|584499829|FG002|Overall Study|Withdrawal by Subject|2|||
161852282|NCT00259272|584499830|FG003|Overall Study|Withdrawal by Subject|7|||
161852283|NCT00259272|584499827|FG000|Overall Study|Lost to Follow-up|1|||
161852284|NCT00259272|584499828|FG001|Overall Study|Lost to Follow-up|0|||
161852285|NCT00259272|584499829|FG002|Overall Study|Lost to Follow-up|0|||
161852286|NCT00259272|584499830|FG003|Overall Study|Lost to Follow-up|1|||
161852287|NCT01290302|584501764|FG000|Overall Study|Adverse Event|2|||
161852288|NCT01290302|584501765|FG001|Overall Study|Adverse Event|0|||
161852289|NCT01290302|584501764|FG000|Overall Study|Withdrawal by Subject|1|||
161852290|NCT01290302|584501765|FG001|Overall Study|Withdrawal by Subject|0|||
161852291|NCT01290302|584501764|FG000|Overall Study|Physician Decision|0|||
161852292|NCT01290302|584501765|FG001|Overall Study|Physician Decision|2|||
161852293|NCT01290302|584501764|FG000|Overall Study|Expiration of time for screening window|1|||
161852294|NCT01290302|584501765|FG001|Overall Study|Expiration of time for screening window|0|||
161852295|NCT03816878|584501768|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
161852296|NCT03816878|584501769|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
161852297|NCT03816878|584501768|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
161852298|NCT03816878|584501769|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
161852299|NCT03355469|584501770|FG000|Overall Study|COVID-19|3|||
161852300|NCT03355469|584501771|FG001|Overall Study|COVID-19|2|||
161852301|NCT03355469|584501772|FG002|Overall Study|COVID-19|3|||
161852302|NCT03355469|584501773|FG003|Overall Study|COVID-19|3|||
161852303|NCT03355469|584501770|FG000|Overall Study|Lost to Follow-up|1|||
161852304|NCT03355469|584501771|FG001|Overall Study|Lost to Follow-up|0|||
161852305|NCT03355469|584501772|FG002|Overall Study|Lost to Follow-up|1|||
161852306|NCT03355469|584501773|FG003|Overall Study|Lost to Follow-up|0|||
161852307|NCT03355469|584501770|FG000|Overall Study|Withdrawal by Subject|2|||
161852308|NCT03355469|584501771|FG001|Overall Study|Withdrawal by Subject|1|||
161852309|NCT03355469|584501772|FG002|Overall Study|Withdrawal by Subject|0|||
161852310|NCT03355469|584501773|FG003|Overall Study|Withdrawal by Subject|3|||
161852311|NCT02291510|584501774|FG000|Overall Study|Adverse Event|0|||
161852312|NCT02291510|584501775|FG001|Overall Study|Adverse Event|0|||
161852313|NCT02291510|584501776|FG002|Overall Study|Adverse Event|0|||
161852314|NCT02291510|584501777|FG003|Overall Study|Adverse Event|1|||
161852315|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
161852316|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
161852317|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
161852318|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
161852319|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
161852320|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
161852321|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
161852322|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
161852323|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
161764899|NCT02394028|584178912|FG002|Induction Phase|Physician Decision|1|||
161764900|NCT02394028|584178913|FG003|Induction Phase|Physician Decision|4|||
161764901|NCT02394028|584178914|FG004|Induction Phase|Physician Decision|0|||
161764902|NCT02394028|584178915|FG005|Induction Phase|Physician Decision|2|||
161764903|NCT02394028|584178916|FG006|Induction Phase|Physician Decision|1|||
161852324|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
161852325|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
161852326|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
161852327|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
161852328|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
161852329|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
161852330|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852331|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
161852332|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852333|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
161852334|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
161764904|NCT02394028|584178917|FG007|Induction Phase|Physician Decision|0|||
161764905|NCT02394028|584178918|FG008|Induction Phase|Physician Decision|0|||
161764906|NCT02394028|584178919|FG009|Induction Phase|Physician Decision|0|||
161764907|NCT02394028|584178920|FG010|Induction Phase|Physician Decision|0|||
161764908|NCT02394028|584178910|FG000|Induction Phase|Protocol Violation|0|||
161764909|NCT02394028|584178911|FG001|Induction Phase|Protocol Violation|2|||
161764910|NCT02394028|584178912|FG002|Induction Phase|Protocol Violation|0|||
161764911|NCT02394028|584178913|FG003|Induction Phase|Protocol Violation|3|||
161764912|NCT02394028|584178914|FG004|Induction Phase|Protocol Violation|0|||
161764913|NCT02394028|584178915|FG005|Induction Phase|Protocol Violation|1|||
161764914|NCT02394028|584178916|FG006|Induction Phase|Protocol Violation|1|||
161764915|NCT02394028|584178917|FG007|Induction Phase|Protocol Violation|0|||
161764916|NCT02394028|584178918|FG008|Induction Phase|Protocol Violation|0|||
161764917|NCT02394028|584178919|FG009|Induction Phase|Protocol Violation|0|||
161764918|NCT02394028|584178920|FG010|Induction Phase|Protocol Violation|0|||
161764919|NCT02394028|584178910|FG000|Induction Phase|Withdrawal by Subject|1|||
161764920|NCT02394028|584178911|FG001|Induction Phase|Withdrawal by Subject|2|||
161764921|NCT02394028|584178912|FG002|Induction Phase|Withdrawal by Subject|4|||
161764922|NCT02394028|584178913|FG003|Induction Phase|Withdrawal by Subject|6|||
161764923|NCT02394028|584178914|FG004|Induction Phase|Withdrawal by Subject|7|||
161764924|NCT02394028|584178915|FG005|Induction Phase|Withdrawal by Subject|4|||
161764925|NCT02394028|584178916|FG006|Induction Phase|Withdrawal by Subject|3|||
161764926|NCT02394028|584178917|FG007|Induction Phase|Withdrawal by Subject|6|||
161764927|NCT02394028|584178918|FG008|Induction Phase|Withdrawal by Subject|0|||
161764928|NCT02394028|584178919|FG009|Induction Phase|Withdrawal by Subject|0|||
161764929|NCT02394028|584178920|FG010|Induction Phase|Withdrawal by Subject|0|||
161764930|NCT02394028|584178910|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764931|NCT02394028|584178911|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764932|NCT02394028|584178912|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764933|NCT02394028|584178913|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764934|NCT02394028|584178914|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764935|NCT02394028|584178915|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764936|NCT02394028|584178916|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
161764937|NCT02394028|584178917|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764938|NCT02394028|584178918|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764939|NCT02394028|584178919|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764940|NCT02394028|584178920|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764941|NCT02394028|584178910|FG000|Induction Phase|Sponsor decision|0|||
161764942|NCT02394028|584178911|FG001|Induction Phase|Sponsor decision|1|||
161764943|NCT02394028|584178912|FG002|Induction Phase|Sponsor decision|2|||
161764944|NCT02394028|584178913|FG003|Induction Phase|Sponsor decision|0|||
161764945|NCT02394028|584178914|FG004|Induction Phase|Sponsor decision|0|||
161764946|NCT02394028|584178915|FG005|Induction Phase|Sponsor decision|0|||
161764947|NCT02394028|584178916|FG006|Induction Phase|Sponsor decision|0|||
161764948|NCT02394028|584178917|FG007|Induction Phase|Sponsor decision|0|||
161764949|NCT02394028|584178918|FG008|Induction Phase|Sponsor decision|0|||
161764950|NCT02394028|584178919|FG009|Induction Phase|Sponsor decision|0|||
161764951|NCT02394028|584178920|FG010|Induction Phase|Sponsor decision|0|||
161764952|NCT02394028|584178910|FG000|Induction Phase|Technical reason|0|||
161764953|NCT02394028|584178911|FG001|Induction Phase|Technical reason|0|||
161764954|NCT02394028|584178912|FG002|Induction Phase|Technical reason|0|||
161764955|NCT02394028|584178913|FG003|Induction Phase|Technical reason|1|||
161764956|NCT02394028|584178914|FG004|Induction Phase|Technical reason|0|||
161764957|NCT02394028|584178915|FG005|Induction Phase|Technical reason|0|||
161764958|NCT02394028|584178916|FG006|Induction Phase|Technical reason|0|||
161764959|NCT02394028|584178917|FG007|Induction Phase|Technical reason|0|||
161764960|NCT02394028|584178918|FG008|Induction Phase|Technical reason|0|||
161764961|NCT02394028|584178919|FG009|Induction Phase|Technical reason|0|||
161764962|NCT02394028|584178920|FG010|Induction Phase|Technical reason|0|||
161764963|NCT02394028|584178910|FG000|Induction Phase|:ack of calculation|0|||
161764964|NCT02394028|584178911|FG001|Induction Phase|:ack of calculation|0|||
161764965|NCT02394028|584178912|FG002|Induction Phase|:ack of calculation|0|||
161764966|NCT02394028|584178913|FG003|Induction Phase|:ack of calculation|0|||
161764967|NCT02394028|584178914|FG004|Induction Phase|:ack of calculation|0|||
161764968|NCT02394028|584178915|FG005|Induction Phase|:ack of calculation|0|||
161764969|NCT02394028|584178916|FG006|Induction Phase|:ack of calculation|0|||
161764970|NCT02394028|584178917|FG007|Induction Phase|:ack of calculation|1|||
161764971|NCT02394028|584178918|FG008|Induction Phase|:ack of calculation|0|||
161764972|NCT02394028|584178919|FG009|Induction Phase|:ack of calculation|0|||
161764973|NCT02394028|584178920|FG010|Induction Phase|:ack of calculation|0|||
161764974|NCT02394028|584178910|FG000|Maintenance Phase|Protocol Violation|0|||
161764975|NCT02394028|584178911|FG001|Maintenance Phase|Protocol Violation|0|||
161764976|NCT02394028|584178912|FG002|Maintenance Phase|Protocol Violation|0|||
161764977|NCT02394028|584178913|FG003|Maintenance Phase|Protocol Violation|0|||
161764978|NCT02394028|584178914|FG004|Maintenance Phase|Protocol Violation|0|||
161764979|NCT02394028|584178915|FG005|Maintenance Phase|Protocol Violation|0|||
161764980|NCT02394028|584178916|FG006|Maintenance Phase|Protocol Violation|0|||
161764981|NCT02394028|584178917|FG007|Maintenance Phase|Protocol Violation|0|||
161764982|NCT02394028|584178918|FG008|Maintenance Phase|Protocol Violation|0|||
161764983|NCT02394028|584178919|FG009|Maintenance Phase|Protocol Violation|0|||
161764984|NCT02394028|584178920|FG010|Maintenance Phase|Protocol Violation|1|||
161764985|NCT02394028|584178910|FG000|Maintenance Phase|Physician Decision|0|||
161764986|NCT02394028|584178911|FG001|Maintenance Phase|Physician Decision|0|||
161764987|NCT02394028|584178912|FG002|Maintenance Phase|Physician Decision|0|||
161764988|NCT02394028|584178913|FG003|Maintenance Phase|Physician Decision|0|||
161764989|NCT02394028|584178914|FG004|Maintenance Phase|Physician Decision|0|||
161764990|NCT02394028|584178915|FG005|Maintenance Phase|Physician Decision|0|||
161764991|NCT02394028|584178916|FG006|Maintenance Phase|Physician Decision|0|||
161764992|NCT02394028|584178917|FG007|Maintenance Phase|Physician Decision|0|||
161764993|NCT02394028|584178918|FG008|Maintenance Phase|Physician Decision|1|||
161764994|NCT02394028|584178919|FG009|Maintenance Phase|Physician Decision|3|||
161764995|NCT02394028|584178920|FG010|Maintenance Phase|Physician Decision|2|||
161764996|NCT02394028|584178910|FG000|Maintenance Phase|Lack of Efficacy|0|||
161764997|NCT02394028|584178911|FG001|Maintenance Phase|Lack of Efficacy|0|||
161764998|NCT02394028|584178912|FG002|Maintenance Phase|Lack of Efficacy|0|||
161764999|NCT02394028|584178913|FG003|Maintenance Phase|Lack of Efficacy|0|||
161765000|NCT02394028|584178914|FG004|Maintenance Phase|Lack of Efficacy|0|||
161765001|NCT02394028|584178915|FG005|Maintenance Phase|Lack of Efficacy|0|||
161765002|NCT02394028|584178916|FG006|Maintenance Phase|Lack of Efficacy|0|||
161765003|NCT02394028|584178917|FG007|Maintenance Phase|Lack of Efficacy|0|||
161765004|NCT02394028|584178918|FG008|Maintenance Phase|Lack of Efficacy|7|||
161765005|NCT02394028|584178919|FG009|Maintenance Phase|Lack of Efficacy|25|||
161765006|NCT02394028|584178920|FG010|Maintenance Phase|Lack of Efficacy|33|||
161765007|NCT02394028|584178910|FG000|Maintenance Phase|Death|0|||
161765008|NCT02394028|584178911|FG001|Maintenance Phase|Death|0|||
161852335|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
161852336|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
161852337|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
161765009|NCT02394028|584178912|FG002|Maintenance Phase|Death|0|||
161765010|NCT02394028|584178913|FG003|Maintenance Phase|Death|0|||
161765011|NCT02394028|584178914|FG004|Maintenance Phase|Death|0|||
161765012|NCT02394028|584178915|FG005|Maintenance Phase|Death|0|||
161765013|NCT02394028|584178916|FG006|Maintenance Phase|Death|0|||
161765014|NCT02394028|584178917|FG007|Maintenance Phase|Death|0|||
161765015|NCT02394028|584178918|FG008|Maintenance Phase|Death|0|||
161765016|NCT02394028|584178919|FG009|Maintenance Phase|Death|0|||
161765017|NCT02394028|584178920|FG010|Maintenance Phase|Death|1|||
161765018|NCT02394028|584178910|FG000|Maintenance Phase|Adverse Event|0|||
161765019|NCT02394028|584178911|FG001|Maintenance Phase|Adverse Event|0|||
161765020|NCT02394028|584178912|FG002|Maintenance Phase|Adverse Event|0|||
161765021|NCT02394028|584178913|FG003|Maintenance Phase|Adverse Event|0|||
161765022|NCT02394028|584178914|FG004|Maintenance Phase|Adverse Event|0|||
161765023|NCT02394028|584178915|FG005|Maintenance Phase|Adverse Event|0|||
161765024|NCT02394028|584178916|FG006|Maintenance Phase|Adverse Event|0|||
161765025|NCT02394028|584178917|FG007|Maintenance Phase|Adverse Event|0|||
161765026|NCT02394028|584178918|FG008|Maintenance Phase|Adverse Event|1|||
161765027|NCT02394028|584178919|FG009|Maintenance Phase|Adverse Event|1|||
161765028|NCT02394028|584178920|FG010|Maintenance Phase|Adverse Event|3|||
161765029|NCT02394028|584178910|FG000|Maintenance Phase|Site closure|0|||
161765030|NCT02394028|584178911|FG001|Maintenance Phase|Site closure|0|||
161765031|NCT02394028|584178912|FG002|Maintenance Phase|Site closure|0|||
161765032|NCT02394028|584178913|FG003|Maintenance Phase|Site closure|0|||
161765033|NCT02394028|584178914|FG004|Maintenance Phase|Site closure|0|||
161765034|NCT02394028|584178915|FG005|Maintenance Phase|Site closure|0|||
161765035|NCT02394028|584178916|FG006|Maintenance Phase|Site closure|0|||
161765036|NCT02394028|584178917|FG007|Maintenance Phase|Site closure|0|||
161765037|NCT02394028|584178918|FG008|Maintenance Phase|Site closure|0|||
161765038|NCT02394028|584178919|FG009|Maintenance Phase|Site closure|1|||
161765039|NCT02394028|584178920|FG010|Maintenance Phase|Site closure|0|||
161765040|NCT02394028|584178910|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161765041|NCT02394028|584178911|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161765042|NCT02394028|584178912|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161765043|NCT02394028|584178913|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161765044|NCT02394028|584178914|FG004|Maintenance Phase|Withdrawal by Subject|0|||
161765045|NCT02394028|584178915|FG005|Maintenance Phase|Withdrawal by Subject|0|||
161765046|NCT02394028|584178916|FG006|Maintenance Phase|Withdrawal by Subject|0|||
161765047|NCT02394028|584178917|FG007|Maintenance Phase|Withdrawal by Subject|0|||
161765048|NCT02394028|584178918|FG008|Maintenance Phase|Withdrawal by Subject|3|||
161765049|NCT02394028|584178919|FG009|Maintenance Phase|Withdrawal by Subject|12|||
161765050|NCT02394028|584178920|FG010|Maintenance Phase|Withdrawal by Subject|12|||
161765051|NCT00866606|584178923|FG000|Overall Study|Lost to Follow-up|3|||
161765052|NCT00866606|584178923|FG000|Overall Study|Adverse Event|1|||
161765053|NCT01058356|584178935|FG000|Overall Study|Adverse Event|5|||
161765054|NCT01058356|584178935|FG000|Overall Study|Administration of contraindicated drugs|12|||
161765055|NCT01058356|584178935|FG000|Overall Study|Withdrawal by Subject|21|||
161765056|NCT01058356|584178935|FG000|Overall Study|Lost to Follow-up|4|||
161765057|NCT02993783|584178936|FG000|Overall Study|Reason not Specified|6|||
161765058|NCT02993783|584178937|FG001|Overall Study|Reason not Specified|9|||
161765059|NCT00606021|584178940|FG000|Induction Phase|Death|73|||
161765060|NCT00606021|584178941|FG001|Induction Phase|Death|0|||
161765061|NCT00606021|584178942|FG002|Induction Phase|Death|0|||
161765062|NCT00606021|584178940|FG000|Induction Phase|Physician Decision|2|||
161765063|NCT00606021|584178941|FG001|Induction Phase|Physician Decision|0|||
161765064|NCT00606021|584178942|FG002|Induction Phase|Physician Decision|0|||
161765065|NCT00606021|584178940|FG000|Induction Phase|Withdrawal by Subject|2|||
161765066|NCT00606021|584178941|FG001|Induction Phase|Withdrawal by Subject|0|||
161765067|NCT00606021|584178942|FG002|Induction Phase|Withdrawal by Subject|0|||
161765068|NCT00606021|584178940|FG000|Induction Phase|Lost to Follow-up|10|||
161765069|NCT00606021|584178941|FG001|Induction Phase|Lost to Follow-up|0|||
161765070|NCT00606021|584178942|FG002|Induction Phase|Lost to Follow-up|0|||
161852338|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
161765071|NCT00606021|584178940|FG000|Maintenance Phase|Death|0|||
161765072|NCT00606021|584178941|FG001|Maintenance Phase|Death|17|||
161765073|NCT00606021|584178942|FG002|Maintenance Phase|Death|15|||
161765074|NCT00606021|584178940|FG000|Maintenance Phase|Physician Decision|0|||
161765075|NCT00606021|584178941|FG001|Maintenance Phase|Physician Decision|1|||
161765076|NCT00606021|584178942|FG002|Maintenance Phase|Physician Decision|0|||
161765077|NCT00606021|584178940|FG000|Maintenance Phase|Lost to Follow-up|0|||
161765078|NCT00606021|584178941|FG001|Maintenance Phase|Lost to Follow-up|5|||
161765079|NCT00606021|584178942|FG002|Maintenance Phase|Lost to Follow-up|2|||
161765080|NCT03480841|584178943|FG000|Overall Study|Lost to Follow-up|2|||
161765081|NCT01362049|584178944|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
161765082|NCT01362049|584178945|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
161765083|NCT01362049|584178946|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
161852339|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
161852340|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
161852341|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
161852342|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
161852343|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
161852344|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
161852345|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
161852346|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852347|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852348|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
161852349|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
161852350|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
161852351|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Other than specified|0|||
161852352|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Other than specified|0|||
161852353|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Other than specified|1|||
161852354|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161852355|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161852356|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161852357|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
161852358|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
161852359|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
161852360|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
161852361|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161852362|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
161852363|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
161852364|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
161852365|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
161852366|NCT00678210|584501786|FG000|Overall Study|Adverse Event|1|||
161852367|NCT00678210|584501787|FG001|Overall Study|Adverse Event|2|||
161852368|NCT00678210|584501788|FG002|Overall Study|Adverse Event|3|||
161852369|NCT00678210|584501789|FG003|Overall Study|Adverse Event|3|||
161852370|NCT00678210|584501786|FG000|Overall Study|Lack of Efficacy|2|||
161852371|NCT00678210|584501787|FG001|Overall Study|Lack of Efficacy|3|||
161852372|NCT00678210|584501788|FG002|Overall Study|Lack of Efficacy|1|||
161852373|NCT00678210|584501789|FG003|Overall Study|Lack of Efficacy|9|||
161852374|NCT00678210|584501786|FG000|Overall Study|Lost to Follow-up|4|||
161852375|NCT00678210|584501787|FG001|Overall Study|Lost to Follow-up|2|||
161852376|NCT00678210|584501788|FG002|Overall Study|Lost to Follow-up|0|||
161852377|NCT00678210|584501789|FG003|Overall Study|Lost to Follow-up|1|||
161852378|NCT00678210|584501786|FG000|Overall Study|Withdrawal by Subject|3|||
161852379|NCT00678210|584501787|FG001|Overall Study|Withdrawal by Subject|4|||
161852380|NCT00678210|584501788|FG002|Overall Study|Withdrawal by Subject|1|||
161852381|NCT00678210|584501789|FG003|Overall Study|Withdrawal by Subject|7|||
161852382|NCT00678210|584501786|FG000|Overall Study|Other|1|||
161852383|NCT00678210|584501787|FG001|Overall Study|Other|0|||
161852384|NCT00678210|584501788|FG002|Overall Study|Other|1|||
161852385|NCT00678210|584501789|FG003|Overall Study|Other|0|||
161852386|NCT00615199|584501790|FG000|Overall Study|Adverse Event|3|||
161852387|NCT00615199|584501791|FG001|Overall Study|Adverse Event|1|||
161852388|NCT00615199|584501792|FG002|Overall Study|Adverse Event|1|||
161852389|NCT00615199|584501793|FG003|Overall Study|Adverse Event|0|||
161852390|NCT00615199|584501790|FG000|Overall Study|Lack of Efficacy|2|||
161765084|NCT01362049|584178947|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
161765085|NCT01362049|584178944|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
161765086|NCT01362049|584178945|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
161765087|NCT01362049|584178946|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
161765088|NCT01362049|584178947|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
161765089|NCT04524663|584180452|FG000|Overall Study|Withdrawal by Subject|0|||
161765090|NCT04524663|584180453|FG001|Overall Study|Withdrawal by Subject|2|||
161765091|NCT00911508|584180454|FG000|Overall Study|Lost to Follow-up|27|||
161765092|NCT00911508|584180455|FG001|Overall Study|Lost to Follow-up|18|||
161765093|NCT00911508|584180454|FG000|Overall Study|Withdrawal by Subject|79|||
161765094|NCT00911508|584180455|FG001|Overall Study|Withdrawal by Subject|112|||
161765095|NCT04308668|584180456|FG000|Overall Study|Lost to Follow-up|32|||
161765096|NCT04308668|584180457|FG001|Overall Study|Lost to Follow-up|38|||
161765097|NCT04308668|584180456|FG000|Overall Study|Withdrawal by Subject|4|||
161765098|NCT04308668|584180457|FG001|Overall Study|Withdrawal by Subject|4|||
161765099|NCT01266967|584180458|FG000|Overall Study|Death|69|||
161765100|NCT01266967|584180459|FG001|Overall Study|Death|61|||
161852391|NCT00615199|584501791|FG001|Overall Study|Lack of Efficacy|0|||
161852392|NCT00615199|584501792|FG002|Overall Study|Lack of Efficacy|0|||
161852393|NCT00615199|584501793|FG003|Overall Study|Lack of Efficacy|1|||
161852394|NCT00615199|584501790|FG000|Overall Study|Lost to Follow-up|1|||
161852395|NCT00615199|584501791|FG001|Overall Study|Lost to Follow-up|0|||
161852396|NCT00615199|584501792|FG002|Overall Study|Lost to Follow-up|0|||
161852397|NCT00615199|584501793|FG003|Overall Study|Lost to Follow-up|0|||
161852398|NCT00615199|584501790|FG000|Overall Study|Other|0|||
161852399|NCT00615199|584501791|FG001|Overall Study|Other|0|||
161852400|NCT00615199|584501792|FG002|Overall Study|Other|0|||
161852401|NCT00615199|584501793|FG003|Overall Study|Other|1|||
161852402|NCT00615199|584501790|FG000|Overall Study|Withdrawal by Subject|2|||
161852403|NCT00615199|584501791|FG001|Overall Study|Withdrawal by Subject|1|||
161852404|NCT00615199|584501792|FG002|Overall Study|Withdrawal by Subject|0|||
161852405|NCT00615199|584501793|FG003|Overall Study|Withdrawal by Subject|0|||
161852406|NCT04825912|584501794|FG000|Overall Study|Death|3|||
161852407|NCT04825912|584501794|FG000|Overall Study|Withdrawal by Subject|1|||
161852408|NCT00459355|584501797|FG000|Overall Study|Subject no longer met inc criteria|20|||
161852409|NCT00459355|584501798|FG001|Overall Study|Subject no longer met inc criteria|18|||
161852410|NCT01009814|584501801|FG000|Overall Study|No longer met study criteria|1|||
161852411|NCT01009814|584501802|FG001|Overall Study|No longer met study criteria|1|||
161852412|NCT01009814|584501803|FG002|Overall Study|No longer met study criteria|0|||
161852413|NCT01009814|584501804|FG003|Overall Study|No longer met study criteria|0|||
161852414|NCT01009814|584501805|FG004|Overall Study|No longer met study criteria|0|||
161852415|NCT00618371|584501806|FG000|Overall Study|Withdrawal by Subject|2|||
161852416|NCT01173120|584501807|FG000|Overall Study|Lack of Efficacy|2|||
161852417|NCT01173120|584501807|FG000|Overall Study|Lost to Follow-up|1|||
161852418|NCT01173120|584501807|FG000|Overall Study|Participant Decision|2|||
161852419|NCT01173120|584501807|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
161852420|NCT01173120|584501807|FG000|Overall Study|Switch-Participant Decision|12|||
161852421|NCT01173120|584501807|FG000|Overall Study|Switch-Difficulty With Device|12|||
161852422|NCT01383707|584501811|FG000|Overall Study|Consent withdrawal|6|||
161852423|NCT01383707|584501811|FG000|Overall Study|Death|19|||
161852424|NCT01383707|584501811|FG000|Overall Study|Other|8|||
161852425|NCT01383707|584501811|FG000|Overall Study|Sponsor's decision|2|||
161852426|NCT01383707|584501811|FG000|Overall Study|Adverse Event|14|||
161852427|NCT01383707|584501811|FG000|Overall Study|Progressive disease|23|||
161852428|NCT01977417|584501815|FG000|Overall Study|Adverse Event|1|||
161852429|NCT01977417|584501816|FG001|Overall Study|Adverse Event|0|||
161852430|NCT01977417|584501815|FG000|Overall Study|Withdrawal by Subject|2|||
161852431|NCT01977417|584501816|FG001|Overall Study|Withdrawal by Subject|4|||
161852432|NCT01977417|584501815|FG000|Overall Study|Female enrollment goal met|0|||
161852433|NCT01977417|584501816|FG001|Overall Study|Female enrollment goal met|2|||
161852434|NCT02906358|584501817|FG000|Overall Study|Withdrawal by Subject|10|||
161852435|NCT02906358|584501818|FG001|Overall Study|Withdrawal by Subject|7|||
161852436|NCT02906358|584501817|FG000|Overall Study|Lost to Follow-up|12|||
161852437|NCT02906358|584501818|FG001|Overall Study|Lost to Follow-up|15|||
161852438|NCT02699684|584501819|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
161852439|NCT02699684|584501820|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
161852440|NCT01625988|584501827|FG000|Overall Study|Lost to Follow-up|5|||
161852441|NCT01625988|584501828|FG001|Overall Study|Lost to Follow-up|6|||
161852442|NCT01625988|584501827|FG000|Overall Study|Withdrawal by Subject|8|||
161852443|NCT01625988|584501828|FG001|Overall Study|Withdrawal by Subject|3|||
161852444|NCT01625988|584501827|FG000|Overall Study|Adverse Event|0|||
161852445|NCT01625988|584501828|FG001|Overall Study|Adverse Event|1|||
161852446|NCT01625988|584501827|FG000|Overall Study|Lack of Efficacy|0|||
161852447|NCT01625988|584501828|FG001|Overall Study|Lack of Efficacy|1|||
161852448|NCT01625988|584501827|FG000|Overall Study|Randomized Inappropriately|1|||
161852449|NCT01625988|584501828|FG001|Overall Study|Randomized Inappropriately|0|||
161852450|NCT01625988|584501827|FG000|Overall Study|Protocol Violation|0|||
161852451|NCT01625988|584501828|FG001|Overall Study|Protocol Violation|2|||
161852452|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
161852453|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
161852454|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
161852455|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161852456|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161852457|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
161852458|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161852459|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161852460|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161852461|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161852462|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161852463|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161852464|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161852465|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161852466|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161852467|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
161852468|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161852469|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
161852470|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161852471|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161852472|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161852473|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161852474|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161852475|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161852476|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161852477|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852478|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852479|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
161852480|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852481|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852482|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
161852483|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852484|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852485|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852486|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852487|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
161852488|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
161852489|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
161852490|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
161852491|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
161852492|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
161852493|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
161852494|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
161852495|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
161852496|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
161852497|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
161852498|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
161852499|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
161852500|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
161852501|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
161852502|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
161852503|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
161852504|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161852505|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
161852506|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161852507|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161852508|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161852509|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161852510|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161852511|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161852512|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
161852513|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852514|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852515|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852516|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852517|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Death|0|||
161852518|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Death|1|||
161852519|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Death|0|||
161852520|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Death|0|||
161852521|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Death|0|||
161852522|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852523|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161852524|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852525|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852526|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852527|NCT01524978|584501836|FG000|Overall Study|Other|16|||
161852528|NCT01524978|584501837|FG001|Overall Study|Other|2|||
161852529|NCT01524978|584501838|FG002|Overall Study|Other|1|||
161852530|NCT01524978|584501839|FG003|Overall Study|Other|2|||
161852531|NCT01524978|584501840|FG004|Overall Study|Other|1|||
161852532|NCT01524978|584501841|FG005|Overall Study|Other|3|||
161852533|NCT01524978|584501842|FG006|Overall Study|Other|17|||
161852534|NCT01524978|584501843|FG007|Overall Study|Other|1|||
161852535|NCT01524978|584501844|FG008|Overall Study|Other|2|||
161852536|NCT01524978|584501845|FG009|Overall Study|Other|2|||
161852537|NCT01524978|584501846|FG010|Overall Study|Other|5|||
161852538|NCT01524978|584501836|FG000|Overall Study|Withdrawal by Subject|12|||
161852539|NCT01524978|584501837|FG001|Overall Study|Withdrawal by Subject|0|||
161852540|NCT01524978|584501838|FG002|Overall Study|Withdrawal by Subject|1|||
161852541|NCT01524978|584501839|FG003|Overall Study|Withdrawal by Subject|1|||
161852542|NCT01524978|584501840|FG004|Overall Study|Withdrawal by Subject|3|||
161852543|NCT01524978|584501841|FG005|Overall Study|Withdrawal by Subject|1|||
161852544|NCT01524978|584501842|FG006|Overall Study|Withdrawal by Subject|6|||
161852545|NCT01524978|584501843|FG007|Overall Study|Withdrawal by Subject|2|||
161852546|NCT01524978|584501844|FG008|Overall Study|Withdrawal by Subject|4|||
161852547|NCT01524978|584501845|FG009|Overall Study|Withdrawal by Subject|0|||
161852548|NCT01524978|584501846|FG010|Overall Study|Withdrawal by Subject|5|||
161852549|NCT01524978|584501836|FG000|Overall Study|Lost to Follow-up|0|||
161852550|NCT01524978|584501837|FG001|Overall Study|Lost to Follow-up|0|||
161852551|NCT01524978|584501838|FG002|Overall Study|Lost to Follow-up|3|||
161852552|NCT01524978|584501839|FG003|Overall Study|Lost to Follow-up|0|||
161852553|NCT01524978|584501840|FG004|Overall Study|Lost to Follow-up|1|||
161852554|NCT01524978|584501841|FG005|Overall Study|Lost to Follow-up|1|||
161852555|NCT01524978|584501842|FG006|Overall Study|Lost to Follow-up|2|||
161852556|NCT01524978|584501843|FG007|Overall Study|Lost to Follow-up|0|||
161852557|NCT01524978|584501844|FG008|Overall Study|Lost to Follow-up|1|||
161852558|NCT01524978|584501845|FG009|Overall Study|Lost to Follow-up|1|||
161852559|NCT01524978|584501846|FG010|Overall Study|Lost to Follow-up|1|||
161852560|NCT01524978|584501836|FG000|Overall Study|Death|34|||
161852561|NCT01524978|584501837|FG001|Overall Study|Death|2|||
161852562|NCT01524978|584501838|FG002|Overall Study|Death|5|||
161852563|NCT01524978|584501839|FG003|Overall Study|Death|24|||
161852564|NCT01524978|584501840|FG004|Overall Study|Death|4|||
161852565|NCT01524978|584501841|FG005|Overall Study|Death|4|||
161852566|NCT01524978|584501842|FG006|Overall Study|Death|1|||
161852567|NCT01524978|584501843|FG007|Overall Study|Death|9|||
161852568|NCT01524978|584501844|FG008|Overall Study|Death|5|||
161852569|NCT01524978|584501845|FG009|Overall Study|Death|6|||
161852570|NCT01524978|584501846|FG010|Overall Study|Death|17|||
161852571|NCT03971474|584501847|FG000|Overall Study|Adverse Event|11|||
161852572|NCT03971474|584501848|FG001|Overall Study|Adverse Event|7|||
161852573|NCT03971474|584501847|FG000|Overall Study|Refusal unrelated to adverse event|5|||
161852574|NCT03971474|584501848|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161852575|NCT03971474|584501847|FG000|Overall Study|Progression/relapse|40|||
161852576|NCT03971474|584501848|FG001|Overall Study|Progression/relapse|47|||
161852577|NCT03971474|584501847|FG000|Overall Study|Death|6|||
161852578|NCT03971474|584501848|FG001|Overall Study|Death|3|||
161852579|NCT03971474|584501847|FG000|Overall Study|Other - not protocol specified|5|||
161852580|NCT03971474|584501848|FG001|Overall Study|Other - not protocol specified|4|||
161852581|NCT03971474|584501847|FG000|Overall Study|On treatment|0|||
161852582|NCT03971474|584501848|FG001|Overall Study|On treatment|7|||
161852583|NCT01023035|584501850|FG000|Treatment Period|Adverse Event|27|||
161852584|NCT01023035|584501851|FG001|Treatment Period|Adverse Event|32|||
161852585|NCT01023035|584501852|FG002|Treatment Period|Adverse Event|50|||
161852586|NCT01023035|584501850|FG000|Treatment Period|Non-Medical Reasons|19|||
161852587|NCT01023035|584501851|FG001|Treatment Period|Non-Medical Reasons|22|||
161852588|NCT01023035|584501852|FG002|Treatment Period|Non-Medical Reasons|44|||
161852589|NCT01023035|584501850|FG000|Treatment Period|Treatment Failure|26|||
161852590|NCT01023035|584501851|FG001|Treatment Period|Treatment Failure|31|||
161852591|NCT01023035|584501852|FG002|Treatment Period|Treatment Failure|24|||
161852592|NCT01023035|584501850|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
161852593|NCT01023035|584501851|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
161852594|NCT01023035|584501852|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
161852595|NCT01023035|584501850|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
161852596|NCT01023035|584501851|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
161852597|NCT01023035|584501852|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
161852598|NCT01937871|584501854|FG000|Overall Study|Adverse Event|6|||
161852599|NCT01937871|584501855|FG001|Overall Study|Adverse Event|6|||
161852600|NCT01937871|584501856|FG002|Overall Study|Adverse Event|2|||
161852601|NCT01937871|584501854|FG000|Overall Study|Lost to Follow-up|8|||
161852602|NCT01937871|584501855|FG001|Overall Study|Lost to Follow-up|2|||
161852603|NCT01937871|584501856|FG002|Overall Study|Lost to Follow-up|4|||
161852604|NCT01937871|584501854|FG000|Overall Study|Withdrawal by Subject|9|||
161852605|NCT01937871|584501855|FG001|Overall Study|Withdrawal by Subject|6|||
161852606|NCT01937871|584501856|FG002|Overall Study|Withdrawal by Subject|4|||
161852607|NCT01937871|584501854|FG000|Overall Study|Physician Decision|0|||
161852608|NCT01937871|584501855|FG001|Overall Study|Physician Decision|1|||
161852609|NCT01937871|584501856|FG002|Overall Study|Physician Decision|0|||
161852610|NCT01937871|584501854|FG000|Overall Study|Entry Criteria Not Met|1|||
161852611|NCT01937871|584501855|FG001|Overall Study|Entry Criteria Not Met|2|||
161852612|NCT01937871|584501856|FG002|Overall Study|Entry Criteria Not Met|1|||
161852613|NCT01482312|584501857|FG000|Period 1, 90 Minutes of Wear|Other|1|||
161852614|NCT01482312|584501858|FG001|Period 1, 90 Minutes of Wear|Other|0|||
161852615|NCT01482312|584501859|FG002|Period 1, 90 Minutes of Wear|Other|0|||
161852616|NCT01482312|584501857|FG000|Period 2, 90 Minutes of Wear|Other|1|||
161852617|NCT01482312|584501858|FG001|Period 2, 90 Minutes of Wear|Other|0|||
161852618|NCT01482312|584501859|FG002|Period 2, 90 Minutes of Wear|Other|0|||
161852619|NCT01295320|584501860|FG000|Overall Study|Adverse Event|2|||
161852620|NCT01295320|584501860|FG000|Overall Study|Lost to Follow-up|4|||
161852621|NCT01295320|584501860|FG000|Overall Study|Withdrawal by Subject|2|||
161852622|NCT01295320|584501860|FG000|Overall Study|Subject was bedridden|1|||
161852623|NCT01295320|584501860|FG000|Overall Study|Unable to travel|1|||
161852624|NCT00462904|584501861|FG000|Overall Study|Lost to Follow-up|1|||
161852625|NCT02652949|584501862|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
161852626|NCT02652949|584501862|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
161852627|NCT02652949|584501862|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
161852628|NCT02652949|584501862|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161852629|NCT02652949|584501862|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161852630|NCT02652949|584501862|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161852631|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161852632|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
161852633|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
161852634|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
161852635|NCT02652949|584501862|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
161852636|NCT02652949|584501862|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161852637|NCT02652949|584501862|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
161852638|NCT02652949|584501862|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161852639|NCT02652949|584501862|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161852640|NCT02652949|584501862|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
161852641|NCT02652949|584501862|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161852642|NCT01973595|584501863|FG000|Washout|Withdrawal by Subject|1|||
161852643|NCT01973595|584501864|FG001|Washout|Withdrawal by Subject|0|||
161852644|NCT01973595|584501865|FG002|Washout|Withdrawal by Subject|1|||
161852645|NCT01973595|584501866|FG003|Washout|Withdrawal by Subject|0|||
161852646|NCT02125877|584501867|FG000|Overall Study|Physician Decision|1|||
161852647|NCT02125877|584501868|FG001|Overall Study|Physician Decision|0|||
161852648|NCT02125877|584501867|FG000|Overall Study|Death|0|||
161852649|NCT02125877|584501868|FG001|Overall Study|Death|1|||
161852650|NCT02125877|584501867|FG000|Overall Study|Administrative problems|0|||
161852651|NCT02125877|584501868|FG001|Overall Study|Administrative problems|1|||
161852652|NCT02125877|584501867|FG000|Overall Study|Participant/guardian decision|0|||
161852653|NCT02125877|584501868|FG001|Overall Study|Participant/guardian decision|2|||
161852654|NCT02125877|584501867|FG000|Overall Study|Withdrawal by Subject|2|||
161852655|NCT02125877|584501868|FG001|Overall Study|Withdrawal by Subject|1|||
161852656|NCT02125877|584501867|FG000|Overall Study|Protocol deviation|4|||
161852657|NCT02125877|584501868|FG001|Overall Study|Protocol deviation|1|||
161852658|NCT02125877|584501867|FG000|Overall Study|Adverse Event|6|||
161852659|NCT02125877|584501868|FG001|Overall Study|Adverse Event|4|||
161852660|NCT01141205|584501869|FG000|Overall Study|Physician Decision|1|||
161852661|NCT01141205|584501870|FG001|Overall Study|Physician Decision|1|||
161852662|NCT01141205|584501869|FG000|Overall Study|Lost to Follow-up|1|||
161852663|NCT01141205|584501870|FG001|Overall Study|Lost to Follow-up|0|||
161852664|NCT01141205|584501869|FG000|Overall Study|Withdrawal by Subject|1|||
161852665|NCT01141205|584501870|FG001|Overall Study|Withdrawal by Subject|1|||
161852666|NCT01822366|584501871|FG000|Overall Study|Lost to Follow-up|5|||
161852667|NCT01822366|584501872|FG001|Overall Study|Lost to Follow-up|1|||
161852668|NCT01822366|584501873|FG002|Overall Study|Lost to Follow-up|5|||
161852669|NCT01822366|584501874|FG003|Overall Study|Lost to Follow-up|1|||
161852670|NCT01822366|584501871|FG000|Overall Study|Withdrawal by Subject|0|||
161852671|NCT01822366|584501872|FG001|Overall Study|Withdrawal by Subject|6|||
161852672|NCT01822366|584501873|FG002|Overall Study|Withdrawal by Subject|0|||
161852673|NCT01822366|584501874|FG003|Overall Study|Withdrawal by Subject|6|||
161852674|NCT01822366|584501871|FG000|Overall Study|Partial Intervention Completion|0|||
161852675|NCT01822366|584501872|FG001|Overall Study|Partial Intervention Completion|15|||
161852676|NCT01822366|584501873|FG002|Overall Study|Partial Intervention Completion|0|||
161852677|NCT01822366|584501874|FG003|Overall Study|Partial Intervention Completion|15|||
161852678|NCT05199090|584501875|FG000|Overall Study|Adverse Event|1|||
161852679|NCT05199090|584501876|FG001|Overall Study|Adverse Event|4|||
161852680|NCT05199090|584501877|FG002|Overall Study|Adverse Event|0|||
161852681|NCT05199090|584501878|FG003|Overall Study|Adverse Event|0|||
161852682|NCT05199090|584501879|FG004|Overall Study|Adverse Event|0|||
161852683|NCT05199090|584501880|FG005|Overall Study|Adverse Event|0|||
161852684|NCT05199090|584501875|FG000|Overall Study|Lost to Follow-up|1|||
161852685|NCT05199090|584501876|FG001|Overall Study|Lost to Follow-up|0|||
161852686|NCT05199090|584501877|FG002|Overall Study|Lost to Follow-up|1|||
161852687|NCT05199090|584501878|FG003|Overall Study|Lost to Follow-up|4|||
161852688|NCT05199090|584501879|FG004|Overall Study|Lost to Follow-up|0|||
161765101|NCT01266967|584180458|FG000|Overall Study|Study Closed/Terminated|15|||
161765102|NCT01266967|584180459|FG001|Overall Study|Study Closed/Terminated|17|||
161765103|NCT01266967|584180458|FG000|Overall Study|Lost to Follow-up|2|||
161765104|NCT01266967|584180459|FG001|Overall Study|Lost to Follow-up|1|||
161765105|NCT01266967|584180458|FG000|Overall Study|Physician Decision|0|||
161765106|NCT01266967|584180459|FG001|Overall Study|Physician Decision|1|||
161765107|NCT01266967|584180458|FG000|Overall Study|Withdrawal by Subject|3|||
161765108|NCT01266967|584180459|FG001|Overall Study|Withdrawal by Subject|3|||
161765109|NCT01519700|584180460|FG000|Overall Study|Death|1|||
161765110|NCT01519700|584180461|FG001|Overall Study|Death|0|||
161765111|NCT01519700|584180462|FG002|Overall Study|Death|0|||
161765112|NCT01519700|584180463|FG003|Overall Study|Death|0|||
161765113|NCT01519700|584180460|FG000|Overall Study|Lost to Follow-up|0|||
161765114|NCT01519700|584180461|FG001|Overall Study|Lost to Follow-up|0|||
161765115|NCT01519700|584180462|FG002|Overall Study|Lost to Follow-up|1|||
161765116|NCT01519700|584180463|FG003|Overall Study|Lost to Follow-up|1|||
161765117|NCT01519700|584180460|FG000|Overall Study|Physician Decision|1|||
161765118|NCT01519700|584180461|FG001|Overall Study|Physician Decision|1|||
161765119|NCT01519700|584180462|FG002|Overall Study|Physician Decision|3|||
161765120|NCT01519700|584180463|FG003|Overall Study|Physician Decision|0|||
161765121|NCT01519700|584180460|FG000|Overall Study|Withdrawal by Subject|5|||
161765122|NCT01519700|584180461|FG001|Overall Study|Withdrawal by Subject|3|||
161765123|NCT01519700|584180462|FG002|Overall Study|Withdrawal by Subject|3|||
161765124|NCT01519700|584180463|FG003|Overall Study|Withdrawal by Subject|2|||
161765125|NCT01519700|584180460|FG000|Overall Study|Other Reason|2|||
161765126|NCT01519700|584180461|FG001|Overall Study|Other Reason|2|||
161765127|NCT01519700|584180462|FG002|Overall Study|Other Reason|0|||
161765128|NCT01519700|584180463|FG003|Overall Study|Other Reason|4|||
161765129|NCT05111548|584180464|FG000|Overall Study|Withdrawal by Subject|2|||
161765130|NCT05111548|584180465|FG001|Overall Study|Withdrawal by Subject|1|||
161765131|NCT05111548|584180464|FG000|Overall Study|Adverse Event|1|||
161765132|NCT05111548|584180465|FG001|Overall Study|Adverse Event|0|||
161765133|NCT00561912|584180472|FG000|Overall Study|ineligible|1|||
161765134|NCT03938857|584180473|FG000|Overall Study|Physician Decision|1|||
161765135|NCT03938857|584180474|FG001|Overall Study|Physician Decision|0|||
161765136|NCT03938857|584180475|FG002|Overall Study|Physician Decision|0|||
161765137|NCT03938857|584180476|FG003|Overall Study|Physician Decision|0|||
161765138|NCT02577107|584180477|FG000|Overall Study|Protocol deviation|0|||
161765139|NCT02577107|584180478|FG001|Overall Study|Protocol deviation|1|||
161765140|NCT00577382|584180479|FG000|Overall Study|Adverse Event|0|||
161765141|NCT00577382|584180480|FG001|Overall Study|Adverse Event|6|||
161765142|NCT00577382|584180479|FG000|Overall Study|Withdrawal by Subject|0|||
161765143|NCT00577382|584180480|FG001|Overall Study|Withdrawal by Subject|1|||
161765144|NCT00577382|584180479|FG000|Overall Study|Progressive Disease|17|||
161765145|NCT00577382|584180480|FG001|Overall Study|Progressive Disease|19|||
161765146|NCT00577382|584180479|FG000|Overall Study|Intercurrent Illness|1|||
161765147|NCT00577382|584180480|FG001|Overall Study|Intercurrent Illness|2|||
161765148|NCT00577382|584180479|FG000|Overall Study|Death|1|||
161765149|NCT00577382|584180480|FG001|Overall Study|Death|1|||
161765150|NCT00577382|584180479|FG000|Overall Study|Lost to Follow-up|2|||
161765151|NCT00577382|584180480|FG001|Overall Study|Lost to Follow-up|2|||
161765152|NCT01345162|584180481|FG000|Overall Study|Protocol Violation|2|||
161765153|NCT01345162|584180482|FG001|Overall Study|Protocol Violation|4|||
161765154|NCT03007472|584180484|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
161765155|NCT03007472|584180484|FG000|Overall Study|Death|2|||
161765156|NCT03007472|584180484|FG000|Overall Study|Loss to Follow Up|1|||
161765157|NCT02988115|584180485|FG000|Overall Study|Adverse Event|6|||
161765158|NCT02988115|584180486|FG001|Overall Study|Adverse Event|1|||
161765159|NCT02988115|584180485|FG000|Overall Study|Sponsor Decision|5|||
161765160|NCT02988115|584180486|FG001|Overall Study|Sponsor Decision|2|||
161765161|NCT02988115|584180485|FG000|Overall Study|Withdrawal by Subject|1|||
161765162|NCT02988115|584180486|FG001|Overall Study|Withdrawal by Subject|1|||
161765163|NCT02988115|584180485|FG000|Overall Study|Withdrawn by Mistake|1|||
161765164|NCT02988115|584180486|FG001|Overall Study|Withdrawn by Mistake|0|||
161765165|NCT02988115|584180485|FG000|Overall Study|Lost to Follow-up|1|||
161765166|NCT02988115|584180486|FG001|Overall Study|Lost to Follow-up|0|||
161765167|NCT01731951|584180487|FG000|Overall Study|Documented Disease Progression|1|||
161765168|NCT01731951|584180488|FG001|Overall Study|Documented Disease Progression|0|||
161765169|NCT01731951|584180489|FG002|Overall Study|Documented Disease Progression|0|||
161765170|NCT01731951|584180490|FG003|Overall Study|Documented Disease Progression|0|||
161765171|NCT01731951|584180491|FG004|Overall Study|Documented Disease Progression|0|||
161765172|NCT01731951|584180492|FG005|Overall Study|Documented Disease Progression|0|||
161765173|NCT01731951|584180487|FG000|Overall Study|Lost to Follow-up|2|||
161765174|NCT01731951|584180488|FG001|Overall Study|Lost to Follow-up|0|||
161765175|NCT01731951|584180489|FG002|Overall Study|Lost to Follow-up|0|||
161765176|NCT01731951|584180490|FG003|Overall Study|Lost to Follow-up|1|||
161852689|NCT05199090|584501880|FG005|Overall Study|Lost to Follow-up|5|||
161852690|NCT05199090|584501875|FG000|Overall Study|Physician Decision|0|||
161852691|NCT05199090|584501876|FG001|Overall Study|Physician Decision|0|||
161852692|NCT05199090|584501877|FG002|Overall Study|Physician Decision|0|||
161852693|NCT05199090|584501878|FG003|Overall Study|Physician Decision|0|||
161852694|NCT05199090|584501879|FG004|Overall Study|Physician Decision|0|||
161852695|NCT05199090|584501880|FG005|Overall Study|Physician Decision|1|||
161852696|NCT05199090|584501875|FG000|Overall Study|Study terminated by sponsor|0|||
161852697|NCT05199090|584501876|FG001|Overall Study|Study terminated by sponsor|6|||
161852698|NCT05199090|584501877|FG002|Overall Study|Study terminated by sponsor|0|||
161852699|NCT05199090|584501878|FG003|Overall Study|Study terminated by sponsor|0|||
161852700|NCT05199090|584501879|FG004|Overall Study|Study terminated by sponsor|0|||
161852701|NCT05199090|584501880|FG005|Overall Study|Study terminated by sponsor|5|||
161852702|NCT05199090|584501875|FG000|Overall Study|Subject decision|0|||
161852703|NCT05199090|584501876|FG001|Overall Study|Subject decision|4|||
161852704|NCT05199090|584501877|FG002|Overall Study|Subject decision|0|||
161852705|NCT05199090|584501878|FG003|Overall Study|Subject decision|2|||
161852706|NCT05199090|584501879|FG004|Overall Study|Subject decision|5|||
161852707|NCT05199090|584501880|FG005|Overall Study|Subject decision|2|||
161852708|NCT03489109|584501881|FG000|Overall Study|Lost to Follow-up|1|||
161852709|NCT03489109|584501882|FG001|Overall Study|Lost to Follow-up|2|||
161852710|NCT04868968|584501883|FG000|Overall Study|Lost to Follow-up|1|||
161852711|NCT00384930|584501886|FG000|Overall Study|Adverse Event|5|||
161852712|NCT00384930|584501887|FG001|Overall Study|Adverse Event|4|||
161765177|NCT01731951|584180491|FG004|Overall Study|Lost to Follow-up|3|||
161765178|NCT01731951|584180492|FG005|Overall Study|Lost to Follow-up|1|||
161765179|NCT01731951|584180487|FG000|Overall Study|Withdrawal of Consent|1|||
161765180|NCT01731951|584180488|FG001|Overall Study|Withdrawal of Consent|0|||
161765181|NCT01731951|584180489|FG002|Overall Study|Withdrawal of Consent|0|||
161765182|NCT01731951|584180490|FG003|Overall Study|Withdrawal of Consent|0|||
161765183|NCT01731951|584180491|FG004|Overall Study|Withdrawal of Consent|0|||
161765184|NCT01731951|584180492|FG005|Overall Study|Withdrawal of Consent|2|||
161765185|NCT01731951|584180487|FG000|Overall Study|Death|13|||
161765186|NCT01731951|584180488|FG001|Overall Study|Death|15|||
161765187|NCT01731951|584180489|FG002|Overall Study|Death|9|||
161765188|NCT01731951|584180490|FG003|Overall Study|Death|8|||
161765189|NCT01731951|584180491|FG004|Overall Study|Death|9|||
161765190|NCT01731951|584180492|FG005|Overall Study|Death|6|||
161765191|NCT00649220|584180499|FG000|Overall Study|Adverse Event|2|||
161765192|NCT00649220|584180499|FG000|Overall Study|Withdrawal by Subject|1|||
161765193|NCT01977651|584180500|FG000|4 Month Treatment Period|Adverse Event|34|||
161765194|NCT01977651|584180500|FG000|4 Month Treatment Period|Death|3|||
161765195|NCT01977651|584180500|FG000|4 Month Treatment Period|Progressive Disease|43|||
161765196|NCT01977651|584180500|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
161765197|NCT01977651|584180500|FG000|4 Month Treatment Period|Physician Decision|4|||
161765198|NCT01977651|584180500|FG000|1 Year Extension Period|Adverse Event|14|||
161765199|NCT01977651|584180500|FG000|1 Year Extension Period|Death|10|||
161765200|NCT01977651|584180500|FG000|1 Year Extension Period|Lost to Follow-up|2|||
161765201|NCT01977651|584180500|FG000|1 Year Extension Period|Progressive Disease|86|||
161765202|NCT01977651|584180500|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
161765203|NCT01977651|584180500|FG000|1 Year Extension Period|Physician Decision|6|||
161765204|NCT01977651|584180500|FG000|1 Year Extension Period|Miscellaneous|1|||
161765205|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Adverse Event|5|||
161765206|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Death|13|||
161765207|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
161765208|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
161765209|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Physician Decision|4|||
161765210|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
161765211|NCT02906644|584180506|FG000|First 2 Weeks|Withdrawal by Subject|0|||
161765212|NCT02906644|584180507|FG001|First 2 Weeks|Withdrawal by Subject|2|||
161765213|NCT02906644|584180506|FG000|First 2 Weeks|Physician Decision|1|||
161765214|NCT02906644|584180507|FG001|First 2 Weeks|Physician Decision|1|||
161765215|NCT02906644|584180506|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
161765216|NCT02906644|584180507|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
161765217|NCT02906644|584180506|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
161765218|NCT02906644|584180507|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
161765219|NCT03672006|584180510|FG000|Overall Study|exclusion criteria met|0|||
161765220|NCT03672006|584180511|FG001|Overall Study|exclusion criteria met|1|||
161852713|NCT00384930|584501888|FG002|Overall Study|Adverse Event|12|||
161852714|NCT00384930|584501889|FG003|Overall Study|Adverse Event|11|||
161852715|NCT00384930|584501890|FG004|Overall Study|Adverse Event|14|||
161852716|NCT00384930|584501886|FG000|Overall Study|Entry Criteria Not Met|2|||
161852717|NCT00384930|584501887|FG001|Overall Study|Entry Criteria Not Met|6|||
161852718|NCT00384930|584501888|FG002|Overall Study|Entry Criteria Not Met|7|||
161765221|NCT03288987|584180512|FG000|Overall Study|Protocol Violation|10|||
161765222|NCT03288987|584180513|FG001|Overall Study|Protocol Violation|4|||
161765223|NCT00608426|584180514|FG000|Overall Study|Death|32|||
161765224|NCT00608426|584180515|FG001|Overall Study|Death|36|||
161765225|NCT00608426|584180514|FG000|Overall Study|Lost to Follow-up|485|||
161765226|NCT00608426|584180515|FG001|Overall Study|Lost to Follow-up|521|||
161765227|NCT00608426|584180514|FG000|Overall Study|refused, health issues, wrong address|319|||
161765228|NCT00608426|584180515|FG001|Overall Study|refused, health issues, wrong address|348|||
161765229|NCT00761891|584180516|FG000|Overall Study|Withdrawal by Subject|10|||
161765230|NCT00368069|584180517|FG000|Overall Study|Adverse Event|5|||
161765231|NCT00368069|584180518|FG001|Overall Study|Adverse Event|2|||
161765232|NCT00368069|584180517|FG000|Overall Study|Lack of Efficacy|0|||
161765233|NCT00368069|584180518|FG001|Overall Study|Lack of Efficacy|1|||
161765234|NCT00368069|584180517|FG000|Overall Study|Lost to Follow-up|1|||
161765235|NCT00368069|584180518|FG001|Overall Study|Lost to Follow-up|0|||
161765236|NCT00368069|584180517|FG000|Overall Study|Protocol Violation|0|||
161765237|NCT00368069|584180518|FG001|Overall Study|Protocol Violation|2|||
161765238|NCT00368069|584180517|FG000|Overall Study|Withdrawal of Consent|2|||
161765239|NCT00368069|584180518|FG001|Overall Study|Withdrawal of Consent|1|||
161765240|NCT00368069|584180517|FG000|Overall Study|no blood sampling possible|0|||
161765241|NCT00368069|584180518|FG001|Overall Study|no blood sampling possible|1|||
161765242|NCT02135848|584180531|FG000|Overall Study|Adverse Event|2|||
161765243|NCT02135848|584180532|FG001|Overall Study|Adverse Event|0|||
161765244|NCT02135848|584180531|FG000|Overall Study|Withdrawal by Subject|1|||
161765245|NCT02135848|584180532|FG001|Overall Study|Withdrawal by Subject|1|||
161765246|NCT02030067|584180533|FG000|Overall Study|Disease Progression|1|||
161765247|NCT02030067|584180534|FG001|Overall Study|Disease Progression|1|||
161765248|NCT02030067|584180535|FG002|Overall Study|Disease Progression|2|||
161765249|NCT02030067|584180536|FG003|Overall Study|Disease Progression|2|||
161765250|NCT02030067|584180537|FG004|Overall Study|Disease Progression|3|||
161765251|NCT02030067|584180538|FG005|Overall Study|Disease Progression|2|||
161765252|NCT02030067|584180539|FG006|Overall Study|Disease Progression|3|||
161852719|NCT00384930|584501889|FG003|Overall Study|Entry Criteria Not Met|8|||
161765253|NCT02030067|584180540|FG007|Overall Study|Disease Progression|3|||
161765254|NCT02030067|584180541|FG008|Overall Study|Disease Progression|4|||
161765255|NCT02030067|584180542|FG009|Overall Study|Disease Progression|3|||
161852720|NCT00384930|584501890|FG004|Overall Study|Entry Criteria Not Met|4|||
161765256|NCT02030067|584180543|FG010|Overall Study|Disease Progression|7|||
161765257|NCT02030067|584180544|FG011|Overall Study|Disease Progression|2|||
161765258|NCT02030067|584180545|FG012|Overall Study|Disease Progression|59|||
161765259|NCT02030067|584180533|FG000|Overall Study|Withdrawal by Subject|0|||
161765260|NCT02030067|584180534|FG001|Overall Study|Withdrawal by Subject|0|||
161765261|NCT02030067|584180535|FG002|Overall Study|Withdrawal by Subject|0|||
161765262|NCT02030067|584180536|FG003|Overall Study|Withdrawal by Subject|1|||
161765263|NCT02030067|584180537|FG004|Overall Study|Withdrawal by Subject|0|||
161765264|NCT02030067|584180538|FG005|Overall Study|Withdrawal by Subject|0|||
161765265|NCT02030067|584180539|FG006|Overall Study|Withdrawal by Subject|0|||
161765266|NCT02030067|584180540|FG007|Overall Study|Withdrawal by Subject|1|||
161765267|NCT02030067|584180541|FG008|Overall Study|Withdrawal by Subject|0|||
161765268|NCT02030067|584180542|FG009|Overall Study|Withdrawal by Subject|0|||
161765269|NCT02030067|584180543|FG010|Overall Study|Withdrawal by Subject|3|||
161765270|NCT02030067|584180544|FG011|Overall Study|Withdrawal by Subject|0|||
161765271|NCT02030067|584180545|FG012|Overall Study|Withdrawal by Subject|6|||
161765272|NCT02030067|584180533|FG000|Overall Study|Physician Decision|0|||
161765273|NCT02030067|584180534|FG001|Overall Study|Physician Decision|0|||
161765274|NCT02030067|584180535|FG002|Overall Study|Physician Decision|0|||
161765275|NCT02030067|584180536|FG003|Overall Study|Physician Decision|0|||
161765276|NCT02030067|584180537|FG004|Overall Study|Physician Decision|0|||
161765277|NCT02030067|584180538|FG005|Overall Study|Physician Decision|0|||
161765278|NCT02030067|584180539|FG006|Overall Study|Physician Decision|0|||
161765279|NCT02030067|584180540|FG007|Overall Study|Physician Decision|0|||
161765280|NCT02030067|584180541|FG008|Overall Study|Physician Decision|0|||
161765281|NCT02030067|584180542|FG009|Overall Study|Physician Decision|0|||
161765282|NCT02030067|584180543|FG010|Overall Study|Physician Decision|1|||
161765283|NCT02030067|584180544|FG011|Overall Study|Physician Decision|0|||
161765284|NCT02030067|584180545|FG012|Overall Study|Physician Decision|3|||
161765285|NCT02030067|584180533|FG000|Overall Study|other reasons|0|||
161765286|NCT02030067|584180534|FG001|Overall Study|other reasons|0|||
161765287|NCT02030067|584180535|FG002|Overall Study|other reasons|0|||
161765288|NCT02030067|584180536|FG003|Overall Study|other reasons|0|||
161765289|NCT02030067|584180537|FG004|Overall Study|other reasons|0|||
161765290|NCT02030067|584180538|FG005|Overall Study|other reasons|1|||
161765291|NCT02030067|584180539|FG006|Overall Study|other reasons|0|||
161765292|NCT02030067|584180540|FG007|Overall Study|other reasons|0|||
161765293|NCT02030067|584180541|FG008|Overall Study|other reasons|2|||
161765294|NCT02030067|584180542|FG009|Overall Study|other reasons|0|||
161765295|NCT02030067|584180543|FG010|Overall Study|other reasons|0|||
161765296|NCT02030067|584180544|FG011|Overall Study|other reasons|0|||
161765297|NCT02030067|584180545|FG012|Overall Study|other reasons|4|||
161765298|NCT02030067|584180533|FG000|Overall Study|Adverse Event|0|||
161765299|NCT02030067|584180534|FG001|Overall Study|Adverse Event|0|||
161765300|NCT02030067|584180535|FG002|Overall Study|Adverse Event|0|||
161765301|NCT02030067|584180536|FG003|Overall Study|Adverse Event|0|||
161765302|NCT02030067|584180537|FG004|Overall Study|Adverse Event|0|||
161852721|NCT00384930|584501886|FG000|Overall Study|Lack of Efficacy|1|||
161852722|NCT00384930|584501887|FG001|Overall Study|Lack of Efficacy|1|||
161852723|NCT00384930|584501888|FG002|Overall Study|Lack of Efficacy|2|||
161852724|NCT00384930|584501889|FG003|Overall Study|Lack of Efficacy|1|||
161852725|NCT00384930|584501890|FG004|Overall Study|Lack of Efficacy|2|||
161852726|NCT00384930|584501886|FG000|Overall Study|Lost to Follow-up|5|||
161852727|NCT00384930|584501887|FG001|Overall Study|Lost to Follow-up|3|||
161852728|NCT00384930|584501888|FG002|Overall Study|Lost to Follow-up|0|||
161852729|NCT00384930|584501889|FG003|Overall Study|Lost to Follow-up|4|||
161852730|NCT00384930|584501890|FG004|Overall Study|Lost to Follow-up|6|||
161852731|NCT00384930|584501886|FG000|Overall Study|Physician Decision|0|||
161852732|NCT00384930|584501887|FG001|Overall Study|Physician Decision|1|||
161852733|NCT00384930|584501888|FG002|Overall Study|Physician Decision|1|||
161852734|NCT00384930|584501889|FG003|Overall Study|Physician Decision|0|||
161852735|NCT00384930|584501890|FG004|Overall Study|Physician Decision|1|||
161852736|NCT00384930|584501886|FG000|Overall Study|Protocol Violation|1|||
161852737|NCT00384930|584501887|FG001|Overall Study|Protocol Violation|0|||
161852738|NCT00384930|584501888|FG002|Overall Study|Protocol Violation|1|||
161852739|NCT00384930|584501889|FG003|Overall Study|Protocol Violation|6|||
161852740|NCT00384930|584501890|FG004|Overall Study|Protocol Violation|4|||
161852741|NCT00384930|584501886|FG000|Overall Study|Sponsor Decision|3|||
161852742|NCT00384930|584501887|FG001|Overall Study|Sponsor Decision|4|||
161852743|NCT00384930|584501888|FG002|Overall Study|Sponsor Decision|0|||
161852744|NCT00384930|584501889|FG003|Overall Study|Sponsor Decision|5|||
161852745|NCT00384930|584501890|FG004|Overall Study|Sponsor Decision|0|||
161852746|NCT00384930|584501886|FG000|Overall Study|Withdrawal by Subject|9|||
161852747|NCT00384930|584501887|FG001|Overall Study|Withdrawal by Subject|7|||
161852748|NCT00384930|584501888|FG002|Overall Study|Withdrawal by Subject|7|||
161852749|NCT00384930|584501889|FG003|Overall Study|Withdrawal by Subject|6|||
161852750|NCT00384930|584501890|FG004|Overall Study|Withdrawal by Subject|16|||
161852751|NCT00384930|584501886|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
161852752|NCT00384930|584501887|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
161852753|NCT00384930|584501888|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161852754|NCT00384930|584501889|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161852755|NCT00384930|584501890|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161852756|NCT02552732|584501893|FG000|Overall Study|Lost to Follow-up|2|||
161852757|NCT02552732|584501893|FG000|Overall Study|Physician Decision|1|||
161852758|NCT02552732|584501893|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
161852759|NCT02552732|584501893|FG000|Overall Study|Withdrawal by Subject|6|||
161852760|NCT01547130|584501896|FG000|Overall Study|Lost to Follow-up|9|||
161852761|NCT01547130|584501897|FG001|Overall Study|Lost to Follow-up|5|||
161852762|NCT00025259|584501899|FG000|Overall Study|Death|1|||
161852763|NCT00025259|584501900|FG001|Overall Study|Death|3|||
161852764|NCT00025259|584501901|FG002|Overall Study|Death|0|||
161852765|NCT00025259|584501902|FG003|Overall Study|Death|3|||
161852766|NCT00025259|584501903|FG004|Overall Study|Death|0|||
161852767|NCT00025259|584501904|FG005|Overall Study|Death|1|||
161852768|NCT00025259|584501905|FG006|Overall Study|Death|2|||
161852769|NCT00025259|584501899|FG000|Overall Study|Lack of Efficacy|2|||
161852770|NCT00025259|584501900|FG001|Overall Study|Lack of Efficacy|46|||
161852771|NCT00025259|584501901|FG002|Overall Study|Lack of Efficacy|60|||
161852772|NCT00025259|584501902|FG003|Overall Study|Lack of Efficacy|78|||
161852773|NCT00025259|584501903|FG004|Overall Study|Lack of Efficacy|11|||
161852774|NCT00025259|584501904|FG005|Overall Study|Lack of Efficacy|30|||
161852775|NCT00025259|584501905|FG006|Overall Study|Lack of Efficacy|38|||
161852776|NCT00025259|584501899|FG000|Overall Study|Lost to Follow-up|2|||
161852777|NCT00025259|584501900|FG001|Overall Study|Lost to Follow-up|9|||
161852778|NCT00025259|584501901|FG002|Overall Study|Lost to Follow-up|13|||
161852779|NCT00025259|584501902|FG003|Overall Study|Lost to Follow-up|13|||
161852780|NCT00025259|584501903|FG004|Overall Study|Lost to Follow-up|1|||
161852781|NCT00025259|584501904|FG005|Overall Study|Lost to Follow-up|3|||
161852782|NCT00025259|584501905|FG006|Overall Study|Lost to Follow-up|1|||
161852783|NCT00025259|584501899|FG000|Overall Study|Physician Decision|12|||
161852784|NCT00025259|584501900|FG001|Overall Study|Physician Decision|1|||
161852785|NCT00025259|584501901|FG002|Overall Study|Physician Decision|0|||
161852786|NCT00025259|584501902|FG003|Overall Study|Physician Decision|5|||
161852787|NCT00025259|584501903|FG004|Overall Study|Physician Decision|4|||
161852788|NCT00025259|584501904|FG005|Overall Study|Physician Decision|2|||
161852789|NCT00025259|584501905|FG006|Overall Study|Physician Decision|1|||
161852790|NCT00025259|584501899|FG000|Overall Study|Protocol Violation|3|||
161852791|NCT00025259|584501900|FG001|Overall Study|Protocol Violation|2|||
161852792|NCT00025259|584501901|FG002|Overall Study|Protocol Violation|2|||
161852793|NCT00025259|584501902|FG003|Overall Study|Protocol Violation|1|||
161852794|NCT00025259|584501903|FG004|Overall Study|Protocol Violation|2|||
161852795|NCT00025259|584501904|FG005|Overall Study|Protocol Violation|1|||
161852796|NCT00025259|584501905|FG006|Overall Study|Protocol Violation|3|||
161852797|NCT00025259|584501899|FG000|Overall Study|Withdrawal by Subject|9|||
161852798|NCT00025259|584501900|FG001|Overall Study|Withdrawal by Subject|27|||
161852799|NCT00025259|584501901|FG002|Overall Study|Withdrawal by Subject|6|||
161852800|NCT00025259|584501902|FG003|Overall Study|Withdrawal by Subject|14|||
161852801|NCT00025259|584501903|FG004|Overall Study|Withdrawal by Subject|11|||
161852802|NCT00025259|584501904|FG005|Overall Study|Withdrawal by Subject|8|||
161852803|NCT00025259|584501905|FG006|Overall Study|Withdrawal by Subject|3|||
161852804|NCT00025259|584501899|FG000|Overall Study|Ineligible|14|||
161852805|NCT00025259|584501900|FG001|Overall Study|Ineligible|1|||
161852806|NCT00025259|584501901|FG002|Overall Study|Ineligible|0|||
161852807|NCT00025259|584501902|FG003|Overall Study|Ineligible|0|||
161852808|NCT00025259|584501903|FG004|Overall Study|Ineligible|6|||
161852809|NCT00025259|584501904|FG005|Overall Study|Ineligible|0|||
161852810|NCT00025259|584501905|FG006|Overall Study|Ineligible|1|||
161852811|NCT00025259|584501899|FG000|Overall Study|Randomization error|1|||
161852812|NCT00025259|584501900|FG001|Overall Study|Randomization error|0|||
161852813|NCT00025259|584501901|FG002|Overall Study|Randomization error|0|||
161852814|NCT00025259|584501902|FG003|Overall Study|Randomization error|0|||
161852815|NCT00025259|584501903|FG004|Overall Study|Randomization error|1|||
161852816|NCT00025259|584501904|FG005|Overall Study|Randomization error|7|||
161852817|NCT00025259|584501905|FG006|Overall Study|Randomization error|2|||
161852818|NCT00025259|584501899|FG000|Overall Study|Adverse Event|1|||
161852819|NCT00025259|584501900|FG001|Overall Study|Adverse Event|0|||
161852820|NCT00025259|584501901|FG002|Overall Study|Adverse Event|0|||
161852821|NCT00025259|584501902|FG003|Overall Study|Adverse Event|0|||
161852822|NCT00025259|584501903|FG004|Overall Study|Adverse Event|0|||
161852823|NCT00025259|584501904|FG005|Overall Study|Adverse Event|0|||
161852824|NCT00025259|584501905|FG006|Overall Study|Adverse Event|0|||
161852825|NCT04324021|584501909|FG000|Overall Study|Adverse Event|1|||
161852826|NCT04324021|584501910|FG001|Overall Study|Adverse Event|0|||
161852827|NCT04324021|584501911|FG002|Overall Study|Adverse Event|0|||
161852828|NCT04324021|584501909|FG000|Overall Study|Lack of Efficacy|0|||
161852829|NCT04324021|584501910|FG001|Overall Study|Lack of Efficacy|0|||
161852830|NCT04324021|584501911|FG002|Overall Study|Lack of Efficacy|1|||
161852831|NCT04324021|584501909|FG000|Overall Study|Death|1|||
161852832|NCT04324021|584501910|FG001|Overall Study|Death|1|||
161852833|NCT04324021|584501911|FG002|Overall Study|Death|0|||
161852834|NCT00246324|584501912|FG000|Overall Study|Withdrawal by Subject|1|||
161852835|NCT01098487|584501914|FG000|Overall Study|Adverse Event|22|||
161852836|NCT01098487|584501914|FG000|Overall Study|Lack of Efficacy|11|||
161852837|NCT01098487|584501914|FG000|Overall Study|Withdrawal by Subject|7|||
161852838|NCT01098487|584501914|FG000|Overall Study|Lost to Follow-up|3|||
161852839|NCT01098487|584501914|FG000|Overall Study|Physician Decision|1|||
161852840|NCT00345631|584501915|FG000|Overall Study|Withdrawal by Subject|1|||
161852841|NCT00345631|584501916|FG001|Overall Study|Withdrawal by Subject|0|||
161852842|NCT00345631|584501917|FG002|Overall Study|Withdrawal by Subject|1|||
161852843|NCT00345631|584501915|FG000|Overall Study|Adverse Event|0|||
161852844|NCT00345631|584501916|FG001|Overall Study|Adverse Event|1|||
161852845|NCT00345631|584501917|FG002|Overall Study|Adverse Event|0|||
161852846|NCT00345631|584501915|FG000|Overall Study|Lost to Follow-up|3|||
161852847|NCT00345631|584501916|FG001|Overall Study|Lost to Follow-up|7|||
161852848|NCT00345631|584501917|FG002|Overall Study|Lost to Follow-up|4|||
161852849|NCT00345631|584501915|FG000|Overall Study|Other reasons|0|||
161852850|NCT00345631|584501916|FG001|Overall Study|Other reasons|0|||
161852851|NCT00345631|584501917|FG002|Overall Study|Other reasons|1|||
161852852|NCT03301623|584501928|FG000|Overall Study|Death|3|||
161852853|NCT03301623|584501929|FG001|Overall Study|Death|1|||
161852854|NCT03301623|584501928|FG000|Overall Study|Withdrawal by Subject|11|||
161852855|NCT03301623|584501929|FG001|Overall Study|Withdrawal by Subject|13|||
161852856|NCT03301623|584501928|FG000|Overall Study|Lost to Follow-up|3|||
161852857|NCT03301623|584501929|FG001|Overall Study|Lost to Follow-up|1|||
161852858|NCT02516553|584501930|FG000|Overall Study|Progressive disease|2|||
161852859|NCT02516553|584501931|FG001|Overall Study|Progressive disease|2|||
161852860|NCT02516553|584501932|FG002|Overall Study|Progressive disease|3|||
161852861|NCT02516553|584501933|FG003|Overall Study|Progressive disease|5|||
161852862|NCT02516553|584501934|FG004|Overall Study|Progressive disease|3|||
161852863|NCT02516553|584501935|FG005|Overall Study|Progressive disease|0|||
161852864|NCT02516553|584501936|FG006|Overall Study|Progressive disease|5|||
161852865|NCT02516553|584501937|FG007|Overall Study|Progressive disease|5|||
161852866|NCT02516553|584501938|FG008|Overall Study|Progressive disease|11|||
161852867|NCT02516553|584501939|FG009|Overall Study|Progressive disease|3|||
161852868|NCT02516553|584501940|FG010|Overall Study|Progressive disease|10|||
161852869|NCT02516553|584501941|FG011|Overall Study|Progressive disease|8|||
161852870|NCT02516553|584501942|FG012|Overall Study|Progressive disease|8|||
161852871|NCT02516553|584501943|FG013|Overall Study|Progressive disease|2|||
161852872|NCT02516553|584501944|FG014|Overall Study|Progressive disease|2|||
161852873|NCT02516553|584501945|FG015|Overall Study|Progressive disease|2|||
161852874|NCT02516553|584501946|FG016|Overall Study|Progressive disease|1|||
161852875|NCT02516553|584501947|FG017|Overall Study|Progressive disease|9|||
161852876|NCT02516553|584501948|FG018|Overall Study|Progressive disease|12|||
161852877|NCT02516553|584501949|FG019|Overall Study|Progressive disease|7|||
161852878|NCT02516553|584501950|FG020|Overall Study|Progressive disease|16|||
161852879|NCT02516553|584501951|FG021|Overall Study|Progressive disease|18|||
161852880|NCT02516553|584501930|FG000|Overall Study|Dose limiting toxicity|0|||
161852881|NCT02516553|584501931|FG001|Overall Study|Dose limiting toxicity|0|||
161852882|NCT02516553|584501932|FG002|Overall Study|Dose limiting toxicity|0|||
161852883|NCT02516553|584501933|FG003|Overall Study|Dose limiting toxicity|0|||
161852884|NCT02516553|584501934|FG004|Overall Study|Dose limiting toxicity|3|||
161852885|NCT02516553|584501935|FG005|Overall Study|Dose limiting toxicity|1|||
161852886|NCT02516553|584501936|FG006|Overall Study|Dose limiting toxicity|1|||
161852887|NCT02516553|584501937|FG007|Overall Study|Dose limiting toxicity|0|||
161852888|NCT02516553|584501938|FG008|Overall Study|Dose limiting toxicity|1|||
161852889|NCT02516553|584501939|FG009|Overall Study|Dose limiting toxicity|0|||
161852890|NCT02516553|584501940|FG010|Overall Study|Dose limiting toxicity|0|||
161852891|NCT02516553|584501941|FG011|Overall Study|Dose limiting toxicity|1|||
161852892|NCT02516553|584501942|FG012|Overall Study|Dose limiting toxicity|0|||
161852893|NCT02516553|584501943|FG013|Overall Study|Dose limiting toxicity|1|||
161852894|NCT02516553|584501944|FG014|Overall Study|Dose limiting toxicity|0|||
161852895|NCT02516553|584501945|FG015|Overall Study|Dose limiting toxicity|0|||
161852896|NCT02516553|584501946|FG016|Overall Study|Dose limiting toxicity|1|||
161852897|NCT02516553|584501947|FG017|Overall Study|Dose limiting toxicity|1|||
161852898|NCT02516553|584501948|FG018|Overall Study|Dose limiting toxicity|0|||
161852899|NCT02516553|584501949|FG019|Overall Study|Dose limiting toxicity|2|||
161852900|NCT02516553|584501950|FG020|Overall Study|Dose limiting toxicity|0|||
161852901|NCT02516553|584501951|FG021|Overall Study|Dose limiting toxicity|0|||
161852902|NCT02516553|584501930|FG000|Overall Study|Other Adverse Events|0|||
161852903|NCT02516553|584501931|FG001|Overall Study|Other Adverse Events|0|||
161852904|NCT02516553|584501932|FG002|Overall Study|Other Adverse Events|0|||
161852905|NCT02516553|584501933|FG003|Overall Study|Other Adverse Events|1|||
161852906|NCT02516553|584501934|FG004|Overall Study|Other Adverse Events|0|||
161852907|NCT02516553|584501935|FG005|Overall Study|Other Adverse Events|1|||
161852908|NCT02516553|584501936|FG006|Overall Study|Other Adverse Events|0|||
161852909|NCT02516553|584501937|FG007|Overall Study|Other Adverse Events|0|||
161852910|NCT02516553|584501938|FG008|Overall Study|Other Adverse Events|0|||
161852911|NCT02516553|584501939|FG009|Overall Study|Other Adverse Events|1|||
161852912|NCT02516553|584501940|FG010|Overall Study|Other Adverse Events|3|||
161852913|NCT02516553|584501941|FG011|Overall Study|Other Adverse Events|2|||
161852914|NCT02516553|584501942|FG012|Overall Study|Other Adverse Events|0|||
161852915|NCT02516553|584501943|FG013|Overall Study|Other Adverse Events|1|||
161852916|NCT02516553|584501944|FG014|Overall Study|Other Adverse Events|0|||
161852917|NCT02516553|584501945|FG015|Overall Study|Other Adverse Events|0|||
161852918|NCT02516553|584501946|FG016|Overall Study|Other Adverse Events|0|||
161765303|NCT02030067|584180538|FG005|Overall Study|Adverse Event|0|||
161765304|NCT02030067|584180539|FG006|Overall Study|Adverse Event|0|||
161765305|NCT02030067|584180540|FG007|Overall Study|Adverse Event|0|||
161765306|NCT02030067|584180541|FG008|Overall Study|Adverse Event|0|||
161765307|NCT02030067|584180542|FG009|Overall Study|Adverse Event|0|||
161765308|NCT02030067|584180543|FG010|Overall Study|Adverse Event|0|||
161765309|NCT02030067|584180544|FG011|Overall Study|Adverse Event|1|||
161765310|NCT02030067|584180545|FG012|Overall Study|Adverse Event|8|||
161765311|NCT00265382|584180546|FG000|Overall Study|Adverse Event|21|||
161765312|NCT00265382|584180546|FG000|Overall Study|Laboratory Abnormality|1|||
161765313|NCT00265382|584180546|FG000|Overall Study|Lost to Follow-up|3|||
161765314|NCT00265382|584180546|FG000|Overall Study|Lack of Efficacy|6|||
161765315|NCT00265382|584180546|FG000|Overall Study|Miscellaneous|6|||
161765316|NCT00265382|584180546|FG000|Overall Study|Withdrawal by Subject|13|||
161765317|NCT00265382|584180546|FG000|Overall Study|Study terminated by sponsor|94|||
161765318|NCT00265382|584180546|FG000|Overall Study|Death|1|||
161765319|NCT00760994|584180553|FG000|Overall Study|Lost to Follow-up|4|||
161765320|NCT00760994|584180554|FG001|Overall Study|Lost to Follow-up|4|||
161765321|NCT00760994|584180555|FG002|Overall Study|Lost to Follow-up|3|||
161765322|NCT03258710|584180556|FG000|Overall Study|Adverse Event|1|||
161765323|NCT03258710|584180556|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161765324|NCT03258710|584180556|FG000|Overall Study|Physician Decision|1|||
161765325|NCT03451630|584180557|FG000|Overall Study|Death|15|||
161765326|NCT03451630|584180558|FG001|Overall Study|Death|16|||
161765327|NCT03451630|584180559|FG002|Overall Study|Death|11|||
161765328|NCT03451630|584180557|FG000|Overall Study|Lost to Follow-up|9|||
161765329|NCT03451630|584180558|FG001|Overall Study|Lost to Follow-up|0|||
161765330|NCT03451630|584180559|FG002|Overall Study|Lost to Follow-up|4|||
161765331|NCT03451630|584180557|FG000|Overall Study|Withdrawal by Subject|0|||
161852919|NCT02516553|584501947|FG017|Overall Study|Other Adverse Events|2|||
161852920|NCT02516553|584501948|FG018|Overall Study|Other Adverse Events|1|||
161852921|NCT02516553|584501949|FG019|Overall Study|Other Adverse Events|2|||
161852922|NCT02516553|584501950|FG020|Overall Study|Other Adverse Events|2|||
161852923|NCT02516553|584501951|FG021|Overall Study|Other Adverse Events|1|||
161852924|NCT02516553|584501930|FG000|Overall Study|Refused to continue trial medication|0|||
161852925|NCT02516553|584501931|FG001|Overall Study|Refused to continue trial medication|0|||
161852926|NCT02516553|584501932|FG002|Overall Study|Refused to continue trial medication|0|||
161852927|NCT02516553|584501933|FG003|Overall Study|Refused to continue trial medication|0|||
161852928|NCT02516553|584501934|FG004|Overall Study|Refused to continue trial medication|0|||
161852929|NCT02516553|584501935|FG005|Overall Study|Refused to continue trial medication|0|||
161852930|NCT02516553|584501936|FG006|Overall Study|Refused to continue trial medication|0|||
161852931|NCT02516553|584501937|FG007|Overall Study|Refused to continue trial medication|0|||
161852932|NCT02516553|584501938|FG008|Overall Study|Refused to continue trial medication|0|||
161852933|NCT02516553|584501939|FG009|Overall Study|Refused to continue trial medication|0|||
161852934|NCT02516553|584501940|FG010|Overall Study|Refused to continue trial medication|1|||
161852935|NCT02516553|584501941|FG011|Overall Study|Refused to continue trial medication|0|||
161852936|NCT02516553|584501942|FG012|Overall Study|Refused to continue trial medication|0|||
161852937|NCT02516553|584501943|FG013|Overall Study|Refused to continue trial medication|0|||
161852938|NCT02516553|584501944|FG014|Overall Study|Refused to continue trial medication|0|||
161852939|NCT02516553|584501945|FG015|Overall Study|Refused to continue trial medication|0|||
161852940|NCT02516553|584501946|FG016|Overall Study|Refused to continue trial medication|0|||
161852941|NCT02516553|584501947|FG017|Overall Study|Refused to continue trial medication|0|||
161852942|NCT02516553|584501948|FG018|Overall Study|Refused to continue trial medication|1|||
161852943|NCT02516553|584501949|FG019|Overall Study|Refused to continue trial medication|0|||
161852944|NCT02516553|584501950|FG020|Overall Study|Refused to continue trial medication|0|||
161852945|NCT02516553|584501951|FG021|Overall Study|Refused to continue trial medication|1|||
161852946|NCT02516553|584501930|FG000|Overall Study|other reasons than listed|0|||
161852947|NCT02516553|584501931|FG001|Overall Study|other reasons than listed|0|||
161852948|NCT02516553|584501932|FG002|Overall Study|other reasons than listed|0|||
161852949|NCT02516553|584501933|FG003|Overall Study|other reasons than listed|0|||
161852950|NCT02516553|584501934|FG004|Overall Study|other reasons than listed|0|||
161852951|NCT02516553|584501935|FG005|Overall Study|other reasons than listed|0|||
161852952|NCT02516553|584501936|FG006|Overall Study|other reasons than listed|0|||
161852953|NCT02516553|584501937|FG007|Overall Study|other reasons than listed|1|||
161852954|NCT02516553|584501938|FG008|Overall Study|other reasons than listed|1|||
161852955|NCT02516553|584501939|FG009|Overall Study|other reasons than listed|0|||
161852956|NCT02516553|584501940|FG010|Overall Study|other reasons than listed|1|||
161852957|NCT02516553|584501941|FG011|Overall Study|other reasons than listed|1|||
161852958|NCT02516553|584501942|FG012|Overall Study|other reasons than listed|0|||
161852959|NCT02516553|584501943|FG013|Overall Study|other reasons than listed|0|||
161852960|NCT02516553|584501944|FG014|Overall Study|other reasons than listed|0|||
161852961|NCT02516553|584501945|FG015|Overall Study|other reasons than listed|0|||
161852962|NCT02516553|584501946|FG016|Overall Study|other reasons than listed|0|||
161852963|NCT02516553|584501947|FG017|Overall Study|other reasons than listed|0|||
161852964|NCT02516553|584501948|FG018|Overall Study|other reasons than listed|0|||
161852965|NCT02516553|584501949|FG019|Overall Study|other reasons than listed|0|||
161852966|NCT02516553|584501950|FG020|Overall Study|other reasons than listed|2|||
161765332|NCT03451630|584180558|FG001|Overall Study|Withdrawal by Subject|3|||
161765333|NCT03451630|584180559|FG002|Overall Study|Withdrawal by Subject|0|||
161765334|NCT03451630|584180557|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
161765335|NCT03451630|584180558|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
161765336|NCT03451630|584180559|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
161765337|NCT00545740|584180561|FG000|Overall Study|Lack of Efficacy|34|||
161765338|NCT00545740|584180562|FG001|Overall Study|Lack of Efficacy|35|||
161765339|NCT00545740|584180563|FG002|Overall Study|Lack of Efficacy|47|||
161765340|NCT00545740|584180564|FG003|Overall Study|Lack of Efficacy|36|||
161765341|NCT00545740|584180561|FG000|Overall Study|Withdrawal by Subject|17|||
161765342|NCT00545740|584180562|FG001|Overall Study|Withdrawal by Subject|15|||
161765343|NCT00545740|584180563|FG002|Overall Study|Withdrawal by Subject|16|||
161765344|NCT00545740|584180564|FG003|Overall Study|Withdrawal by Subject|18|||
161765345|NCT00545740|584180561|FG000|Overall Study|Adverse Event|10|||
161765346|NCT00545740|584180562|FG001|Overall Study|Adverse Event|18|||
161765347|NCT00545740|584180563|FG002|Overall Study|Adverse Event|19|||
161852967|NCT02516553|584501951|FG021|Overall Study|other reasons than listed|2|||
161852968|NCT01374269|584501954|FG000|Overall Study|Withdrawal by Subject|4|||
161852969|NCT01374269|584501955|FG001|Overall Study|Withdrawal by Subject|0|||
161852970|NCT01374269|584501954|FG000|Overall Study|Lost to Follow-up|1|||
161852971|NCT01374269|584501955|FG001|Overall Study|Lost to Follow-up|3|||
161852972|NCT01374269|584501954|FG000|Overall Study|closed research|1|||
161852973|NCT01374269|584501955|FG001|Overall Study|closed research|2|||
161852974|NCT00708227|584501960|FG000|Overall Study|Physician Decision|0|||
161852975|NCT00708227|584501961|FG001|Overall Study|Physician Decision|3|||
161852976|NCT00708227|584501962|FG002|Overall Study|Physician Decision|1|||
161852977|NCT00708227|584501963|FG003|Overall Study|Physician Decision|2|||
161852978|NCT00708227|584501960|FG000|Overall Study|Withdrawal by Subject|1|||
161852979|NCT00708227|584501961|FG001|Overall Study|Withdrawal by Subject|2|||
161852980|NCT00708227|584501962|FG002|Overall Study|Withdrawal by Subject|0|||
161852981|NCT00708227|584501963|FG003|Overall Study|Withdrawal by Subject|1|||
161852982|NCT04007991|584501964|FG000|Overall Study|Withdrawal by Subject|1|||
161852983|NCT04007991|584501965|FG001|Overall Study|Withdrawal by Subject|1|||
161852984|NCT04007991|584501964|FG000|Overall Study|Physician Decision|1|||
161852985|NCT04007991|584501965|FG001|Overall Study|Physician Decision|1|||
161852986|NCT04007991|584501964|FG000|Overall Study|Non-compliance with Study Drug|0|||
161852987|NCT04007991|584501965|FG001|Overall Study|Non-compliance with Study Drug|1|||
161852988|NCT04007991|584501964|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
161852989|NCT04007991|584501965|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
161852990|NCT04007991|584501964|FG000|Overall Study|Adverse event, non-fatal|5|||
161852991|NCT04007991|584501965|FG001|Overall Study|Adverse event, non-fatal|0|||
161852992|NCT04007991|584501964|FG000|Overall Study|Lost to Follow-up|2|||
161852993|NCT04007991|584501965|FG001|Overall Study|Lost to Follow-up|1|||
161852994|NCT03654599|584501968|FG000|Overall Study|Lost to Follow-up|14|||
161852995|NCT03654599|584501969|FG001|Overall Study|Lost to Follow-up|12|||
161852996|NCT03654599|584501968|FG000|Overall Study|Death|8|||
161852997|NCT03654599|584501969|FG001|Overall Study|Death|6|||
161852998|NCT03654599|584501968|FG000|Overall Study|Withdrawal by Subject|6|||
161852999|NCT03654599|584501969|FG001|Overall Study|Withdrawal by Subject|4|||
161853000|NCT02551666|584501971|FG000|Overall Study|Withdrawal by Subject|1|||
161853001|NCT02551666|584501972|FG001|Overall Study|Withdrawal by Subject|3|||
161853002|NCT04559347|584503630|FG000|Overall Study|Death|1|||
161853003|NCT04559347|584503631|FG001|Overall Study|Death|0|||
161853004|NCT04559347|584503630|FG000|Overall Study|Thoracotomy conversion|1|||
161853005|NCT04559347|584503631|FG001|Overall Study|Thoracotomy conversion|1|||
161853006|NCT04559347|584503630|FG000|Overall Study|Provider unavailable|2|||
161853007|NCT04559347|584503631|FG001|Overall Study|Provider unavailable|1|||
161853008|NCT04559347|584503630|FG000|Overall Study|Other|2|||
161853009|NCT04559347|584503631|FG001|Overall Study|Other|1|||
161853010|NCT02653625|584503632|FG000|Overall Study|Adverse Event|1|||
161853011|NCT02653625|584503632|FG000|Overall Study|Non-compliance with Study Drug|1|||
161853012|NCT02653625|584503632|FG000|Overall Study|Protocol Violation|1|||
161853013|NCT02653625|584503632|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
161853014|NCT03965689|584503633|FG000|Overall Study|Too sick to get study intervention|2|||
161853015|NCT00764881|584503635|FG000|Overall Study|Adverse Event|5|||
161853016|NCT00764881|584503636|FG001|Overall Study|Adverse Event|1|||
161853017|NCT00764881|584503635|FG000|Overall Study|Withdrawal by Subject|1|||
161853018|NCT00764881|584503636|FG001|Overall Study|Withdrawal by Subject|3|||
161853019|NCT00764881|584503635|FG000|Overall Study|Protocol Violation|2|||
161853020|NCT00764881|584503636|FG001|Overall Study|Protocol Violation|2|||
161853021|NCT00764881|584503635|FG000|Overall Study|Lost to Follow-up|2|||
161853022|NCT00764881|584503636|FG001|Overall Study|Lost to Follow-up|0|||
161853023|NCT00764881|584503635|FG000|Overall Study|Noncompliant|1|||
161853024|NCT00764881|584503636|FG001|Overall Study|Noncompliant|0|||
161853025|NCT00764881|584503635|FG000|Overall Study|Accidentally discontinued study drug|1|||
161853026|NCT00764881|584503636|FG001|Overall Study|Accidentally discontinued study drug|0|||
161853027|NCT00764881|584503635|FG000|Overall Study|Wished to become pregnant|1|||
161853028|NCT00764881|584503636|FG001|Overall Study|Wished to become pregnant|0|||
161853029|NCT00764881|584503635|FG000|Overall Study|Carcinoma detected|1|||
161853030|NCT00764881|584503636|FG001|Overall Study|Carcinoma detected|0|||
161853031|NCT00764881|584503635|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
161853032|NCT00764881|584503636|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
161853033|NCT00764881|584503635|FG000|Overall Study|no treatment or no observation|2|||
161853034|NCT00764881|584503636|FG001|Overall Study|no treatment or no observation|2|||
161853035|NCT01214655|584503637|FG000|Part A|Progressive Disease|7|||
161853036|NCT01214655|584503638|FG001|Part A|Progressive Disease|0|||
161853037|NCT01214655|584503639|FG002|Part A|Progressive Disease|0|||
161853038|NCT01214655|584503637|FG000|Part A|Physician Decision|1|||
161853039|NCT01214655|584503638|FG001|Part A|Physician Decision|0|||
161853040|NCT01214655|584503639|FG002|Part A|Physician Decision|0|||
161853041|NCT01214655|584503637|FG000|Part B|Progressive disease|0|||
161853042|NCT01214655|584503638|FG001|Part B|Progressive disease|10|||
161853043|NCT01214655|584503639|FG002|Part B|Progressive disease|0|||
161853044|NCT01214655|584503637|FG000|Part B|Death|0|||
161853045|NCT01214655|584503638|FG001|Part B|Death|1|||
161853046|NCT01214655|584503639|FG002|Part B|Death|0|||
161853047|NCT01214655|584503637|FG000|Part B|Withdrawal by Subject|0|||
161853048|NCT01214655|584503638|FG001|Part B|Withdrawal by Subject|2|||
161853049|NCT01214655|584503639|FG002|Part B|Withdrawal by Subject|0|||
161853050|NCT01214655|584503637|FG000|Part C|Progressive Disease|0|||
161853051|NCT01214655|584503638|FG001|Part C|Progressive Disease|0|||
161853052|NCT01214655|584503639|FG002|Part C|Progressive Disease|5|||
161853053|NCT01214655|584503637|FG000|Part C|Death|0|||
161853054|NCT01214655|584503638|FG001|Part C|Death|0|||
161853055|NCT01214655|584503639|FG002|Part C|Death|1|||
161853056|NCT01214655|584503637|FG000|Part C|Physician Decision|0|||
161853057|NCT01214655|584503638|FG001|Part C|Physician Decision|0|||
161853058|NCT01214655|584503639|FG002|Part C|Physician Decision|1|||
161853059|NCT01611857|584503640|FG000|Overall Study|Withdrawal by Subject|0|||
161853060|NCT01611857|584503641|FG001|Overall Study|Withdrawal by Subject|2|||
161853061|NCT02439970|584503642|FG000|Overall Study|Study Terminated|2|||
161853062|NCT02439970|584503643|FG001|Overall Study|Study Terminated|3|||
161853063|NCT01121562|584503644|FG000|Overall Study|Objective progression or relapse|8|||
161853064|NCT01121562|584503644|FG000|Overall Study|Withdrawal by Subject|1|||
161853065|NCT01121562|584503644|FG000|Overall Study|Adverse Event|1|||
161853066|NCT01121562|584503644|FG000|Overall Study|Sponsor Decision|1|||
161853067|NCT01121562|584503644|FG000|Overall Study|Met study discontinuation criteria|1|||
161853068|NCT01495702|584503645|FG000|Randomized Phase|Randomized But Not Treated|1|||
161853069|NCT01495702|584503646|FG001|Randomized Phase|Randomized But Not Treated|4|||
161853070|NCT01495702|584503645|FG000|Randomized Phase|Adverse Event|2|||
161853071|NCT01495702|584503646|FG001|Randomized Phase|Adverse Event|2|||
161853072|NCT01495702|584503645|FG000|Randomized Phase|Death|1|||
161853073|NCT01495702|584503646|FG001|Randomized Phase|Death|0|||
161853074|NCT01495702|584503645|FG000|Randomized Phase|Lack of Efficacy|2|||
161853075|NCT01495702|584503646|FG001|Randomized Phase|Lack of Efficacy|0|||
161853076|NCT01495702|584503645|FG000|Randomized Phase|Investigators Discretion|2|||
161853077|NCT01495702|584503646|FG001|Randomized Phase|Investigators Discretion|0|||
161853078|NCT01495702|584503645|FG000|Randomized Phase|Withdrew Consent|10|||
161853079|NCT01495702|584503646|FG001|Randomized Phase|Withdrew Consent|18|||
161853080|NCT01495702|584503645|FG000|Randomized Phase|Lost to Follow-up|4|||
161853081|NCT01495702|584503646|FG001|Randomized Phase|Lost to Follow-up|3|||
161853082|NCT01495702|584503645|FG000|Randomized Phase|Participant Noncompliance|1|||
161853083|NCT01495702|584503646|FG001|Randomized Phase|Participant Noncompliance|0|||
161853084|NCT01495702|584503645|FG000|Randomized Phase|Protocol Violation|3|||
161853085|NCT01495702|584503646|FG001|Randomized Phase|Protocol Violation|1|||
161853086|NCT00616421|584503647|FG000|Overall Study|Withdrawal by Subject|9|||
161853087|NCT00616421|584503648|FG001|Overall Study|Withdrawal by Subject|11|||
161853088|NCT00616421|584503649|FG002|Overall Study|Withdrawal by Subject|8|||
161853089|NCT00616421|584503647|FG000|Overall Study|Lost to Follow-up|12|||
161853090|NCT00616421|584503648|FG001|Overall Study|Lost to Follow-up|26|||
161853091|NCT00616421|584503649|FG002|Overall Study|Lost to Follow-up|30|||
161853092|NCT00616421|584503647|FG000|Overall Study|Inappropriate enrollment|3|||
161853093|NCT00616421|584503648|FG001|Overall Study|Inappropriate enrollment|0|||
161853094|NCT00616421|584503649|FG002|Overall Study|Inappropriate enrollment|1|||
161853095|NCT00616421|584503647|FG000|Overall Study|Administrative reason|1|||
161853096|NCT00616421|584503648|FG001|Overall Study|Administrative reason|0|||
161853097|NCT00616421|584503649|FG002|Overall Study|Administrative reason|0|||
161853098|NCT00616421|584503647|FG000|Overall Study|Protocol Violation|0|||
161853099|NCT00616421|584503648|FG001|Overall Study|Protocol Violation|1|||
161853100|NCT00616421|584503649|FG002|Overall Study|Protocol Violation|2|||
161853101|NCT00616421|584503647|FG000|Overall Study|Unable to classify|1|||
161853102|NCT00616421|584503648|FG001|Overall Study|Unable to classify|0|||
161853103|NCT00616421|584503649|FG002|Overall Study|Unable to classify|0|||
161853104|NCT04152863|584503650|FG000|Overall Study|Death|13|||
161853105|NCT04152863|584503651|FG001|Overall Study|Death|12|||
161853106|NCT04152863|584503652|FG002|Overall Study|Death|7|||
161853107|NCT04152863|584503650|FG000|Overall Study|Physician Decision|1|||
161853108|NCT04152863|584503651|FG001|Overall Study|Physician Decision|1|||
161853109|NCT04152863|584503652|FG002|Overall Study|Physician Decision|1|||
161853110|NCT04152863|584503650|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
161853111|NCT04152863|584503651|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
161853112|NCT04152863|584503652|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
161853113|NCT04152863|584503650|FG000|Overall Study|Withdrawal by Subject|2|||
161853114|NCT04152863|584503651|FG001|Overall Study|Withdrawal by Subject|1|||
161853115|NCT04152863|584503652|FG002|Overall Study|Withdrawal by Subject|3|||
161853116|NCT01644617|584503656|FG000|Overall Study|Withdrawal by Subject|3|||
161853117|NCT01644617|584503657|FG001|Overall Study|Withdrawal by Subject|4|||
161853118|NCT01644617|584503658|FG002|Overall Study|Withdrawal by Subject|1|||
161853119|NCT01644617|584503656|FG000|Overall Study|Lost to Follow-up|0|||
161853120|NCT01644617|584503657|FG001|Overall Study|Lost to Follow-up|1|||
161853121|NCT01644617|584503658|FG002|Overall Study|Lost to Follow-up|0|||
161853122|NCT01644617|584503656|FG000|Overall Study|Adverse Event|3|||
161853123|NCT01644617|584503657|FG001|Overall Study|Adverse Event|0|||
161853124|NCT01644617|584503658|FG002|Overall Study|Adverse Event|6|||
161853125|NCT05445492|584503667|FG000|Overall Study|Physician Decision|1|||
161853126|NCT04289363|584503669|FG000|Overall Study|Lost to Follow-up|14|||
161853127|NCT04289363|584503670|FG001|Overall Study|Lost to Follow-up|0|||
161853128|NCT03790657|584503671|FG000|Overall Study|Adverse Event|1|||
161853129|NCT03790657|584503672|FG001|Overall Study|Adverse Event|1|||
161853130|NCT03790657|584503671|FG000|Overall Study|Withdrawal by Subject|1|||
161853131|NCT03790657|584503672|FG001|Overall Study|Withdrawal by Subject|1|||
161853132|NCT03126435|584503673|FG000|Overall Study|Death|90|||
161853133|NCT03126435|584503674|FG001|Overall Study|Death|84|||
161853134|NCT03126435|584503673|FG000|Overall Study|Lost to Follow-up|4|||
161853135|NCT03126435|584503674|FG001|Overall Study|Lost to Follow-up|3|||
161853136|NCT03126435|584503673|FG000|Overall Study|Physician Decision|0|||
161853137|NCT03126435|584503674|FG001|Overall Study|Physician Decision|1|||
161853138|NCT03126435|584503673|FG000|Overall Study|Withdrawal by Subject|6|||
161853139|NCT03126435|584503674|FG001|Overall Study|Withdrawal by Subject|12|||
161853140|NCT03126435|584503673|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
161853141|NCT03126435|584503674|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
161853142|NCT01807065|584503675|FG000|Overall Study|Receive no sip-T due to IV access|1|||
161853143|NCT01807065|584503676|FG001|Overall Study|Receive no sip-T due to IV access|1|||
161853144|NCT01699815|584503677|FG000|Overall Study|Protocol Violation|4|||
161853145|NCT01699815|584503678|FG001|Overall Study|Protocol Violation|7|||
161853146|NCT01699815|584503677|FG000|Overall Study|record could not be located|1|||
161853147|NCT01699815|584503678|FG001|Overall Study|record could not be located|0|||
161853148|NCT01699815|584503677|FG000|Overall Study|Adverse Event|0|||
161853149|NCT01699815|584503678|FG001|Overall Study|Adverse Event|1|||
161853150|NCT00699816|584503681|FG000|Overall Study|Protocol Violation|1|||
161853151|NCT00699816|584503682|FG001|Overall Study|Protocol Violation|3|||
161853152|NCT00560391|584503683|FG000|Overall Study|Still on treatment|0|||
161853153|NCT00560391|584503684|FG001|Overall Study|Still on treatment|0|||
161853154|NCT00560391|584503685|FG002|Overall Study|Still on treatment|0|||
161853155|NCT00560391|584503686|FG003|Overall Study|Still on treatment|1|||
161853156|NCT00560391|584503687|FG004|Overall Study|Still on treatment|2|||
161853157|NCT03668808|584503688|FG000|First Intervention|Withdrawal by Subject|2|||
161853158|NCT03668808|584503689|FG001|First Intervention|Withdrawal by Subject|2|||
161853159|NCT01895777|584503690|FG000|Overall Study|Adverse Event|1|||
161853160|NCT01895777|584503691|FG001|Overall Study|Adverse Event|2|||
161853161|NCT01895777|584503690|FG000|Overall Study|Lost to Follow-up|2|||
161853162|NCT01895777|584503691|FG001|Overall Study|Lost to Follow-up|0|||
161853163|NCT01895777|584503690|FG000|Overall Study|Not treated|1|||
161853164|NCT01895777|584503691|FG001|Overall Study|Not treated|0|||
161853165|NCT01895777|584503690|FG000|Overall Study|Other reasons|3|||
161853166|NCT01895777|584503691|FG001|Overall Study|Other reasons|2|||
161853167|NCT01895777|584503690|FG000|Overall Study|Non-compliance with the CTP|2|||
161853168|NCT01895777|584503691|FG001|Overall Study|Non-compliance with the CTP|1|||
161853169|NCT04223752|584503696|FG000|Overall Study|Participant enrolled in error|0|||
161853170|NCT04223752|584503697|FG001|Overall Study|Participant enrolled in error|0|||
161853171|NCT04223752|584503698|FG002|Overall Study|Participant enrolled in error|0|||
161765348|NCT00545740|584180564|FG003|Overall Study|Adverse Event|9|||
161765349|NCT00545740|584180561|FG000|Overall Study|Lost to Follow-up|7|||
161765350|NCT00545740|584180562|FG001|Overall Study|Lost to Follow-up|5|||
161765351|NCT00545740|584180563|FG002|Overall Study|Lost to Follow-up|5|||
161765352|NCT00545740|584180564|FG003|Overall Study|Lost to Follow-up|6|||
161765353|NCT00545740|584180561|FG000|Overall Study|Protocol Violation|1|||
161765354|NCT00545740|584180562|FG001|Overall Study|Protocol Violation|3|||
161765355|NCT00545740|584180563|FG002|Overall Study|Protocol Violation|1|||
161765356|NCT00545740|584180564|FG003|Overall Study|Protocol Violation|0|||
161765357|NCT00545740|584180561|FG000|Overall Study|Non-compliance|0|||
161765358|NCT00545740|584180562|FG001|Overall Study|Non-compliance|2|||
161765359|NCT00545740|584180563|FG002|Overall Study|Non-compliance|1|||
161765360|NCT00545740|584180564|FG003|Overall Study|Non-compliance|0|||
161765361|NCT00545740|584180561|FG000|Overall Study|Moved|2|||
161765362|NCT00545740|584180562|FG001|Overall Study|Moved|0|||
161765363|NCT00545740|584180563|FG002|Overall Study|Moved|1|||
161765364|NCT00545740|584180564|FG003|Overall Study|Moved|0|||
161765365|NCT00545740|584180561|FG000|Overall Study|Diverticulitis attack|0|||
161765366|NCT00545740|584180562|FG001|Overall Study|Diverticulitis attack|0|||
161765367|NCT00545740|584180563|FG002|Overall Study|Diverticulitis attack|1|||
161765368|NCT00545740|584180564|FG003|Overall Study|Diverticulitis attack|1|||
161765369|NCT00545740|584180561|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765370|NCT00545740|584180562|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765371|NCT00545740|584180563|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765372|NCT00545740|584180564|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765373|NCT00545740|584180561|FG000|Overall Study|Site closure|1|||
161765374|NCT00545740|584180562|FG001|Overall Study|Site closure|0|||
161765375|NCT00545740|584180563|FG002|Overall Study|Site closure|0|||
161765376|NCT00545740|584180564|FG003|Overall Study|Site closure|0|||
161765377|NCT00545740|584180561|FG000|Overall Study|Missed visit|1|||
161765378|NCT00545740|584180562|FG001|Overall Study|Missed visit|0|||
161765379|NCT00545740|584180563|FG002|Overall Study|Missed visit|0|||
161765380|NCT00545740|584180564|FG003|Overall Study|Missed visit|0|||
161765381|NCT00545740|584180561|FG000|Overall Study|Physician Decision|0|||
161765382|NCT00545740|584180562|FG001|Overall Study|Physician Decision|0|||
161765383|NCT00545740|584180563|FG002|Overall Study|Physician Decision|3|||
161765384|NCT00545740|584180564|FG003|Overall Study|Physician Decision|0|||
161765385|NCT00545740|584180561|FG000|Overall Study|Accepted only monthly telephone calls|1|||
161765386|NCT00545740|584180562|FG001|Overall Study|Accepted only monthly telephone calls|0|||
161765387|NCT00545740|584180563|FG002|Overall Study|Accepted only monthly telephone calls|0|||
161765388|NCT00545740|584180564|FG003|Overall Study|Accepted only monthly telephone calls|0|||
161765389|NCT00545740|584180561|FG000|Overall Study|Sponsor decision|0|||
161765390|NCT00545740|584180562|FG001|Overall Study|Sponsor decision|1|||
161765391|NCT00545740|584180563|FG002|Overall Study|Sponsor decision|0|||
161765392|NCT00545740|584180564|FG003|Overall Study|Sponsor decision|0|||
161765393|NCT00545740|584180561|FG000|Overall Study|Lack of time|0|||
161765394|NCT00545740|584180562|FG001|Overall Study|Lack of time|1|||
161765395|NCT00545740|584180563|FG002|Overall Study|Lack of time|0|||
161765396|NCT00545740|584180564|FG003|Overall Study|Lack of time|0|||
161765397|NCT00545740|584180561|FG000|Overall Study|Non-adherence to visits|0|||
161765398|NCT00545740|584180562|FG001|Overall Study|Non-adherence to visits|1|||
161765399|NCT00545740|584180563|FG002|Overall Study|Non-adherence to visits|0|||
161765400|NCT00545740|584180564|FG003|Overall Study|Non-adherence to visits|0|||
161765401|NCT00545740|584180561|FG000|Overall Study|Patient difficulties|0|||
161765402|NCT00545740|584180562|FG001|Overall Study|Patient difficulties|1|||
161765403|NCT00545740|584180563|FG002|Overall Study|Patient difficulties|0|||
161765404|NCT00545740|584180564|FG003|Overall Study|Patient difficulties|0|||
161765405|NCT00545740|584180561|FG000|Overall Study|Husband against study|0|||
161765406|NCT00545740|584180562|FG001|Overall Study|Husband against study|0|||
161765407|NCT00545740|584180563|FG002|Overall Study|Husband against study|1|||
161765408|NCT00545740|584180564|FG003|Overall Study|Husband against study|0|||
161765409|NCT02117024|584180565|FG000|Overall Study|Progressive Disease|26|||
161765410|NCT02117024|584180566|FG001|Overall Study|Progressive Disease|9|||
161765411|NCT02117024|584180565|FG000|Overall Study|Significant Clinical Progression|7|||
161765412|NCT02117024|584180566|FG001|Overall Study|Significant Clinical Progression|4|||
161765413|NCT02117024|584180565|FG000|Overall Study|Death|5|||
161765414|NCT02117024|584180566|FG001|Overall Study|Death|0|||
161765415|NCT02117024|584180565|FG000|Overall Study|Withdrawal by Subject|3|||
161765416|NCT02117024|584180566|FG001|Overall Study|Withdrawal by Subject|1|||
161853172|NCT04223752|584503699|FG003|Overall Study|Participant enrolled in error|0|||
161853173|NCT04223752|584503700|FG004|Overall Study|Participant enrolled in error|1|||
161853174|NCT04223752|584503696|FG000|Overall Study|Death|0|||
161853175|NCT04223752|584503697|FG001|Overall Study|Death|0|||
161853176|NCT04223752|584503698|FG002|Overall Study|Death|0|||
161853177|NCT04223752|584503699|FG003|Overall Study|Death|2|||
161765417|NCT02117024|584180565|FG000|Overall Study|Protocol Violation|1|||
161765418|NCT02117024|584180566|FG001|Overall Study|Protocol Violation|0|||
161765419|NCT02117024|584180565|FG000|Overall Study|Adverse Event|1|||
161765420|NCT02117024|584180566|FG001|Overall Study|Adverse Event|2|||
161765421|NCT02117024|584180565|FG000|Overall Study|Randomized in Error|1|||
161765422|NCT02117024|584180566|FG001|Overall Study|Randomized in Error|0|||
161765423|NCT02117024|584180565|FG000|Overall Study|Patient returned to primary oncologist|0|||
161765424|NCT02117024|584180566|FG001|Overall Study|Patient returned to primary oncologist|1|||
161765425|NCT02117024|584180565|FG000|Overall Study|Patient took treatment break|0|||
161765426|NCT02117024|584180566|FG001|Overall Study|Patient took treatment break|1|||
161765427|NCT02117024|584180565|FG000|Overall Study|Physician Decision|0|||
161765428|NCT02117024|584180566|FG001|Overall Study|Physician Decision|2|||
161765429|NCT00565721|584180567|FG000|Overall Study|Screen Failure|2|||
161765430|NCT00565721|584180567|FG000|Overall Study|Lost to Follow-up|6|||
161765431|NCT00565721|584180567|FG000|Overall Study|Technical Problems|1|||
161765432|NCT00565721|584180567|FG000|Overall Study|Physician Decision|2|||
161765433|NCT00565721|584180567|FG000|Overall Study|Other reasons|6|||
161765434|NCT02813681|584180570|FG000|Overall Study|Physician Decision|5|||
161765435|NCT02813681|584180571|FG001|Overall Study|Physician Decision|5|||
161765436|NCT02813681|584180572|FG002|Overall Study|Physician Decision|0|||
161765437|NCT02813681|584180570|FG000|Overall Study|Lost to Follow-up|0|||
161765438|NCT02813681|584180571|FG001|Overall Study|Lost to Follow-up|1|||
161765439|NCT02813681|584180572|FG002|Overall Study|Lost to Follow-up|0|||
161765440|NCT00529152|584180573|FG000|Overall Study|Adverse Event|2|||
161765441|NCT00529152|584180573|FG000|Overall Study|Withdrawal by Subject|2|||
161765442|NCT00529152|584180573|FG000|Overall Study|Lost to Follow-up|1|||
161765443|NCT04062240|584180577|FG000|Overall Study|equipment malfunction|1|||
161765444|NCT03961529|584180578|FG000|Overall Study|Adverse Event|13|||
161765445|NCT03961529|584180579|FG001|Overall Study|Adverse Event|5|||
161765446|NCT03961529|584180580|FG002|Overall Study|Adverse Event|2|||
161765447|NCT03961529|584180578|FG000|Overall Study|Withdrawal by Subject|17|||
161765448|NCT03961529|584180579|FG001|Overall Study|Withdrawal by Subject|2|||
161765449|NCT03961529|584180580|FG002|Overall Study|Withdrawal by Subject|1|||
161765450|NCT03961529|584180578|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161765451|NCT03961529|584180579|FG001|Overall Study|Withdrawal by parent/guardian|7|||
161765452|NCT03961529|584180580|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161765453|NCT03961529|584180578|FG000|Overall Study|Physician Decision|2|||
161765454|NCT03961529|584180579|FG001|Overall Study|Physician Decision|1|||
161765455|NCT03961529|584180580|FG002|Overall Study|Physician Decision|1|||
161765456|NCT03961529|584180578|FG000|Overall Study|Lost to Follow-up|2|||
161765457|NCT03961529|584180579|FG001|Overall Study|Lost to Follow-up|1|||
161765458|NCT03961529|584180580|FG002|Overall Study|Lost to Follow-up|0|||
161765459|NCT03961529|584180578|FG000|Overall Study|Lack of Efficacy|2|||
161765460|NCT03961529|584180579|FG001|Overall Study|Lack of Efficacy|0|||
161765461|NCT03961529|584180580|FG002|Overall Study|Lack of Efficacy|1|||
161765462|NCT03961529|584180578|FG000|Overall Study|Other|6|||
161765463|NCT03961529|584180579|FG001|Overall Study|Other|1|||
161765464|NCT03961529|584180580|FG002|Overall Study|Other|0|||
161765465|NCT03500419|584180581|FG000|Overall Study|Withdrawal by Subject|2|||
161765466|NCT03500419|584180582|FG001|Overall Study|Withdrawal by Subject|25|||
161765467|NCT01497899|584180583|FG000|Double-Blind Phase|Randomized but not Treated|1|||
161765468|NCT01497899|584180584|FG001|Double-Blind Phase|Randomized but not Treated|0|||
161765469|NCT01497899|584180585|FG002|Double-Blind Phase|Randomized but not Treated|0|||
161765470|NCT01497899|584180586|FG003|Double-Blind Phase|Randomized but not Treated|0|||
161765471|NCT01497899|584180583|FG000|Double-Blind Phase|Adverse Event|1|||
161765472|NCT01497899|584180584|FG001|Double-Blind Phase|Adverse Event|0|||
161765473|NCT01497899|584180585|FG002|Double-Blind Phase|Adverse Event|0|||
161765474|NCT01497899|584180586|FG003|Double-Blind Phase|Adverse Event|0|||
161765475|NCT01497899|584180583|FG000|Double-Blind Phase|Lack of Efficacy|0|||
161765476|NCT01497899|584180584|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161765477|NCT01497899|584180585|FG002|Double-Blind Phase|Lack of Efficacy|0|||
161765478|NCT01497899|584180586|FG003|Double-Blind Phase|Lack of Efficacy|0|||
161765479|NCT01497899|584180583|FG000|Double-Blind Phase|Investigator's Discretion|1|||
161765480|NCT01497899|584180584|FG001|Double-Blind Phase|Investigator's Discretion|0|||
161765481|NCT01497899|584180585|FG002|Double-Blind Phase|Investigator's Discretion|0|||
161765482|NCT01497899|584180586|FG003|Double-Blind Phase|Investigator's Discretion|0|||
161765483|NCT01497899|584180583|FG000|Double-Blind Phase|Withdrew Consent|0|||
161765484|NCT01497899|584180584|FG001|Double-Blind Phase|Withdrew Consent|1|||
161765485|NCT01497899|584180585|FG002|Double-Blind Phase|Withdrew Consent|0|||
161765486|NCT01497899|584180586|FG003|Double-Blind Phase|Withdrew Consent|0|||
161765487|NCT01497899|584180583|FG000|Double-Blind Phase|Lost to Follow-up|3|||
161765488|NCT01497899|584180584|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161765489|NCT01497899|584180585|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161765490|NCT01497899|584180586|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161765491|NCT01497899|584180583|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
161765492|NCT01497899|584180584|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
161765493|NCT01497899|584180585|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
161765494|NCT01497899|584180586|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
161765495|NCT01497899|584180583|FG000|Open-Label Extension Phase|Adverse Event|1|||
161765496|NCT01497899|584180584|FG001|Open-Label Extension Phase|Adverse Event|0|||
161765497|NCT01497899|584180585|FG002|Open-Label Extension Phase|Adverse Event|0|||
161765498|NCT01497899|584180586|FG003|Open-Label Extension Phase|Adverse Event|0|||
161765499|NCT01497899|584180583|FG000|Open-Label Extension Phase|Death|1|||
161765500|NCT01497899|584180584|FG001|Open-Label Extension Phase|Death|0|||
161765501|NCT01497899|584180585|FG002|Open-Label Extension Phase|Death|0|||
161765502|NCT01497899|584180586|FG003|Open-Label Extension Phase|Death|0|||
161765503|NCT01497899|584180583|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
161765504|NCT01497899|584180584|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
161765505|NCT01497899|584180585|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
161765506|NCT01497899|584180586|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
161765507|NCT01497899|584180583|FG000|Open-Label Extension Phase|Pregnancy|0|||
161765508|NCT01497899|584180584|FG001|Open-Label Extension Phase|Pregnancy|1|||
161765509|NCT01497899|584180585|FG002|Open-Label Extension Phase|Pregnancy|1|||
161765510|NCT01497899|584180586|FG003|Open-Label Extension Phase|Pregnancy|0|||
161765511|NCT01497899|584180583|FG000|Open-Label Extension Phase|Protocol Violation|0|||
161765512|NCT01497899|584180584|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161765513|NCT01497899|584180585|FG002|Open-Label Extension Phase|Protocol Violation|1|||
161765514|NCT01497899|584180586|FG003|Open-Label Extension Phase|Protocol Violation|0|||
161765515|NCT01497899|584180583|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
161765516|NCT01497899|584180584|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
161765517|NCT01497899|584180585|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
161765518|NCT01497899|584180586|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
161765519|NCT02142712|584180589|FG000|Overall Study|Lost to Follow-up|1|||
161765520|NCT02142712|584180590|FG001|Overall Study|Lost to Follow-up|1|||
161765521|NCT02142712|584180591|FG002|Overall Study|Lost to Follow-up|1|||
161765522|NCT02142712|584180592|FG003|Overall Study|Lost to Follow-up|0|||
161765523|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
161765524|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
161765525|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
161765526|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
161765527|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
161765528|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
161765529|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Death|5|||
161765530|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Death|5|||
161765531|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
161765532|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
161765533|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
161765534|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
161765535|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
161765536|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
161765537|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Death|5|||
161765538|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Death|16|||
161765539|NCT02828982|584180598|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161765540|NCT02828982|584180599|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161765541|NCT02475564|584180600|FG000|Overall Study|Withdrawal by Subject|1|||
161765542|NCT02475564|584180601|FG001|Overall Study|Withdrawal by Subject|0|||
161765543|NCT02475564|584180600|FG000|Overall Study|Lost to Follow-up|2|||
161765544|NCT02475564|584180601|FG001|Overall Study|Lost to Follow-up|1|||
161765545|NCT02475564|584180600|FG000|Overall Study|Intense Menstrual bleeding|1|||
161765546|NCT02475564|584180601|FG001|Overall Study|Intense Menstrual bleeding|0|||
161765547|NCT02705755|584180602|FG000|Part A (6 Days)|Adverse Event|1|||
161765548|NCT02705755|584180603|FG001|Part A (6 Days)|Adverse Event|0|||
161765549|NCT02705755|584180604|FG002|Part A (6 Days)|Adverse Event|0|||
161765550|NCT02705755|584180605|FG003|Part A (6 Days)|Adverse Event|0|||
161765551|NCT02705755|584180602|FG000|Part A (6 Days)|Physician Decision|3|||
161765552|NCT02705755|584180603|FG001|Part A (6 Days)|Physician Decision|0|||
161765553|NCT02705755|584180604|FG002|Part A (6 Days)|Physician Decision|0|||
161765554|NCT02705755|584180605|FG003|Part A (6 Days)|Physician Decision|0|||
161765555|NCT02705755|584180602|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
161765556|NCT02705755|584180603|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
161765557|NCT02705755|584180604|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
161765558|NCT02705755|584180605|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
161765559|NCT02705755|584180602|FG000|Part C (20 Weeks)|Physician Decision|0|||
161765560|NCT02705755|584180603|FG001|Part C (20 Weeks)|Physician Decision|0|||
161765561|NCT02705755|584180604|FG002|Part C (20 Weeks)|Physician Decision|0|||
161765562|NCT02705755|584180605|FG003|Part C (20 Weeks)|Physician Decision|2|||
161765563|NCT02705755|584180602|FG000|Part C (20 Weeks)|Adverse Event|0|||
161765564|NCT02705755|584180603|FG001|Part C (20 Weeks)|Adverse Event|0|||
161765565|NCT02705755|584180604|FG002|Part C (20 Weeks)|Adverse Event|0|||
161765566|NCT02705755|584180605|FG003|Part C (20 Weeks)|Adverse Event|6|||
161765567|NCT02705755|584180602|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
161765568|NCT02705755|584180603|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
161765569|NCT02705755|584180604|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
161765570|NCT02705755|584180605|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
161765571|NCT01906489|584180606|FG000|Overall Study|Adverse Event|10|||
161765572|NCT01906489|584180607|FG001|Overall Study|Adverse Event|3|||
161765573|NCT01906489|584180606|FG000|Overall Study|Worsening of CKD|6|||
161765574|NCT01906489|584180607|FG001|Overall Study|Worsening of CKD|4|||
161765575|NCT01906489|584180606|FG000|Overall Study|Withdrawal by Subject|5|||
161765576|NCT01906489|584180607|FG001|Overall Study|Withdrawal by Subject|0|||
161765577|NCT01906489|584180606|FG000|Overall Study|Worsening of Anemia|1|||
161765578|NCT01906489|584180607|FG001|Overall Study|Worsening of Anemia|0|||
161765579|NCT01906489|584180606|FG000|Overall Study|Protocol Violation|0|||
161765580|NCT01906489|584180607|FG001|Overall Study|Protocol Violation|1|||
161765581|NCT01906489|584180606|FG000|Overall Study|Non- Compliance|1|||
161765582|NCT01906489|584180607|FG001|Overall Study|Non- Compliance|0|||
161765583|NCT01906489|584180606|FG000|Overall Study|Sponsor Decision|1|||
161765584|NCT01906489|584180607|FG001|Overall Study|Sponsor Decision|0|||
161765585|NCT01906489|584180606|FG000|Overall Study|Lost to Follow-up|1|||
161765586|NCT01906489|584180607|FG001|Overall Study|Lost to Follow-up|1|||
161765587|NCT01906489|584180606|FG000|Overall Study|Other|1|||
161765588|NCT01906489|584180607|FG001|Overall Study|Other|0|||
161765589|NCT03458234|584180608|FG000|Overall Study|Withdrawal by Subject|1|||
161765590|NCT03359811|584182893|FG000|Overall Study|Protocol Violation|2|||
161765591|NCT03359811|584182894|FG001|Overall Study|Protocol Violation|0|||
161765592|NCT02528331|584182907|FG000|Overall Study|Withdrawal by Subject|2|||
161765593|NCT00386152|584182908|FG000|Overall Study|Adverse Event|6|||
161765594|NCT00386152|584182909|FG001|Overall Study|Adverse Event|5|||
161765595|NCT00386152|584182910|FG002|Overall Study|Adverse Event|4|||
161765596|NCT00386152|584182908|FG000|Overall Study|Chang from original chemo stratification|4|||
161765597|NCT00386152|584182909|FG001|Overall Study|Chang from original chemo stratification|5|||
161765598|NCT00386152|584182910|FG002|Overall Study|Chang from original chemo stratification|6|||
161765599|NCT00386152|584182908|FG000|Overall Study|Death|3|||
161765600|NCT00386152|584182909|FG001|Overall Study|Death|0|||
161765601|NCT00386152|584182910|FG002|Overall Study|Death|1|||
161765602|NCT00386152|584182908|FG000|Overall Study|Disease progression|7|||
161765603|NCT00386152|584182909|FG001|Overall Study|Disease progression|4|||
161765604|NCT00386152|584182910|FG002|Overall Study|Disease progression|5|||
161765605|NCT00386152|584182908|FG000|Overall Study|Physician Decision|13|||
161765606|NCT00386152|584182909|FG001|Overall Study|Physician Decision|10|||
161765607|NCT00386152|584182910|FG002|Overall Study|Physician Decision|4|||
161765608|NCT00386152|584182908|FG000|Overall Study|Lost to Follow-up|1|||
161765609|NCT00386152|584182909|FG001|Overall Study|Lost to Follow-up|0|||
161765610|NCT00386152|584182910|FG002|Overall Study|Lost to Follow-up|0|||
161765611|NCT00386152|584182908|FG000|Overall Study|Completed chemotherapy|4|||
161765612|NCT00386152|584182909|FG001|Overall Study|Completed chemotherapy|5|||
161765613|NCT00386152|584182910|FG002|Overall Study|Completed chemotherapy|1|||
161765614|NCT00386152|584182908|FG000|Overall Study|Protocol Violation|3|||
161765615|NCT00386152|584182909|FG001|Overall Study|Protocol Violation|5|||
161765616|NCT00386152|584182910|FG002|Overall Study|Protocol Violation|2|||
161765617|NCT00386152|584182908|FG000|Overall Study|Withdrawal by Subject|3|||
161765618|NCT00386152|584182909|FG001|Overall Study|Withdrawal by Subject|6|||
161765619|NCT00386152|584182910|FG002|Overall Study|Withdrawal by Subject|10|||
161765620|NCT03380091|584182912|FG000|Overall Study|Withdrawal by Subject|2|||
161765621|NCT03380091|584182913|FG001|Overall Study|Withdrawal by Subject|1|||
161765622|NCT04594213|584182914|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
161765623|NCT04594213|584182915|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
161765624|NCT04594213|584182916|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
161765625|NCT04594213|584182917|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161765626|NCT04594213|584182918|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161765627|NCT04594213|584182919|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161765628|NCT04594213|584182914|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765629|NCT04594213|584182915|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
161765630|NCT04594213|584182916|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765631|NCT04594213|584182917|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765632|NCT04594213|584182918|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765633|NCT04594213|584182919|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765634|NCT04594213|584182914|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161765635|NCT04594213|584182915|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765636|NCT04594213|584182916|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161765637|NCT04594213|584182917|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765638|NCT04594213|584182918|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765639|NCT04594213|584182919|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765640|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765641|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765642|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765643|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765644|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
161765645|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765646|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161765647|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161765648|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161765649|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
161765650|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
161765651|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
161765652|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765653|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765654|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765655|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765656|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765657|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
161765658|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765659|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765660|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765661|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
161765662|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765663|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765664|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765665|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765666|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765667|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
161765668|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765669|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765670|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161765671|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161765672|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161765673|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
161765674|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
161765675|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
161765676|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161765677|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161765678|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161765679|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
161765680|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
161765681|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
161765682|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
161765683|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
161765684|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
161765685|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
161765686|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
161765687|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
161765688|NCT01980056|584182921|FG000|Overall Study|Death|1|||
161765689|NCT01980056|584182922|FG001|Overall Study|Death|1|||
161765690|NCT01980056|584182923|FG002|Overall Study|Death|0|||
161765691|NCT00104299|584182924|FG000|Overall Study|Adverse Event|3|||
161765692|NCT00104299|584182925|FG001|Overall Study|Adverse Event|1|||
161765693|NCT00104299|584182924|FG000|Overall Study|Death|2|||
161765694|NCT00104299|584182925|FG001|Overall Study|Death|2|||
161765695|NCT00104299|584182924|FG000|Overall Study|Withdrawal by Subject|2|||
161765696|NCT00104299|584182925|FG001|Overall Study|Withdrawal by Subject|6|||
161765697|NCT00104299|584182924|FG000|Overall Study|Physician Decision|1|||
161765698|NCT00104299|584182925|FG001|Overall Study|Physician Decision|1|||
161765699|NCT00104299|584182924|FG000|Overall Study|To have renal transplant|1|||
161765700|NCT00104299|584182925|FG001|Overall Study|To have renal transplant|0|||
161765701|NCT01707667|584182926|FG000|Period 1|expulsion of colonic sensor catheter|1|||
161765702|NCT01707667|584182927|FG001|Period 1|expulsion of colonic sensor catheter|0|||
161765703|NCT03802331|584182928|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
161765704|NCT03802331|584182929|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
161765705|NCT03432819|584182933|FG000|Overall Study|Lost to Follow-up|2|||
161765706|NCT03432819|584182934|FG001|Overall Study|Lost to Follow-up|2|||
161765707|NCT03432819|584182933|FG000|Overall Study|Withdrawal by Subject|5|||
161765708|NCT03432819|584182934|FG001|Overall Study|Withdrawal by Subject|3|||
161765709|NCT01474993|584182935|FG000|Overall Study|Lost to Follow-up|1|||
161765710|NCT01474993|584182936|FG001|Overall Study|Lost to Follow-up|2|||
161765711|NCT01474993|584182935|FG000|Overall Study|Adverse Event|0|||
161765712|NCT01474993|584182936|FG001|Overall Study|Adverse Event|1|||
161765713|NCT02041533|584182937|FG000|Pre-Treatment Period|Disease Progression|1|||
161765714|NCT02041533|584182938|FG001|Pre-Treatment Period|Disease Progression|1|||
161765715|NCT02041533|584182937|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
161765716|NCT02041533|584182938|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
161765717|NCT02041533|584182937|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
161765718|NCT02041533|584182938|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
161765719|NCT02041533|584182937|FG000|Treatment Period|Disease progression|189|||
161765720|NCT02041533|584182938|FG001|Treatment Period|Disease progression|146|||
161765721|NCT02041533|584182937|FG000|Treatment Period|Study drug toxicity|30|||
161765722|NCT02041533|584182938|FG001|Treatment Period|Study drug toxicity|34|||
161765723|NCT02041533|584182937|FG000|Treatment Period|Death|1|||
161765724|NCT02041533|584182938|FG001|Treatment Period|Death|0|||
161765725|NCT02041533|584182937|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
161765726|NCT02041533|584182938|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
161765727|NCT02041533|584182937|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
161765728|NCT02041533|584182938|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
161765729|NCT02041533|584182937|FG000|Treatment Period|Participant withdrew consent|2|||
161765730|NCT02041533|584182938|FG001|Treatment Period|Participant withdrew consent|2|||
161765731|NCT02041533|584182937|FG000|Treatment Period|Maximum clinical benefit|0|||
161765732|NCT02041533|584182938|FG001|Treatment Period|Maximum clinical benefit|18|||
161765733|NCT02041533|584182937|FG000|Treatment Period|Poor/Non-compliance|1|||
161765734|NCT02041533|584182938|FG001|Treatment Period|Poor/Non-compliance|0|||
161765735|NCT02041533|584182937|FG000|Treatment Period|Administrative reason by sponsor|1|||
161765736|NCT02041533|584182938|FG001|Treatment Period|Administrative reason by sponsor|0|||
161765737|NCT02041533|584182937|FG000|Treatment Period|Other reasons|9|||
161765738|NCT02041533|584182938|FG001|Treatment Period|Other reasons|2|||
161765739|NCT02041533|584182937|FG000|Treatment Period|Not Reported|0|||
161765740|NCT02041533|584182938|FG001|Treatment Period|Not Reported|1|||
161765741|NCT01957111|584182939|FG000|Overall Study|Withdrawal by Subject|1|||
161765742|NCT01957111|584182940|FG001|Overall Study|Withdrawal by Subject|1|||
161765743|NCT01646255|584182941|FG000|Overall Study|Adverse Event|7|||
161765744|NCT01646255|584182942|FG001|Overall Study|Adverse Event|8|||
161765745|NCT01646255|584182941|FG000|Overall Study|Lack of Efficacy|2|||
161765746|NCT01646255|584182942|FG001|Overall Study|Lack of Efficacy|0|||
161765747|NCT01646255|584182941|FG000|Overall Study|Withdrawal by Subject|10|||
161765748|NCT01646255|584182942|FG001|Overall Study|Withdrawal by Subject|6|||
161765749|NCT01646255|584182941|FG000|Overall Study|Compliance is not well|1|||
161765750|NCT01646255|584182942|FG001|Overall Study|Compliance is not well|0|||
161765751|NCT01646255|584182941|FG000|Overall Study|Inclusion Criteria Deviation|1|||
161765752|NCT01646255|584182942|FG001|Overall Study|Inclusion Criteria Deviation|0|||
161765753|NCT01468844|584182943|FG000|Overall Study|Adverse Event|1|||
161765754|NCT01468844|584182944|FG001|Overall Study|Adverse Event|0|||
161765755|NCT01468844|584182943|FG000|Overall Study|Withdrawal by Subject|1|||
161765756|NCT01468844|584182944|FG001|Overall Study|Withdrawal by Subject|0|||
161765757|NCT01241318|584182951|FG000|Overall Study|Woman: false pregnancies|27|||
161765758|NCT01241318|584182952|FG001|Overall Study|Woman: false pregnancies|15|||
161765759|NCT01241318|584182951|FG000|Overall Study|Woman: miscarriage/abortion|46|||
161765760|NCT01241318|584182952|FG001|Overall Study|Woman: miscarriage/abortion|38|||
161765761|NCT01241318|584182951|FG000|Overall Study|Withdrawal by Subject|175|||
161765762|NCT01241318|584182952|FG001|Overall Study|Withdrawal by Subject|46|||
161765763|NCT01241318|584182951|FG000|Overall Study|Lost to Follow-up|740|||
161765764|NCT01241318|584182952|FG001|Overall Study|Lost to Follow-up|455|||
161765765|NCT01241318|584182951|FG000|Overall Study|Death|2|||
161765766|NCT01241318|584182952|FG001|Overall Study|Death|4|||
161765767|NCT01241318|584182951|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
161853178|NCT04223752|584503700|FG004|Overall Study|Death|1|||
161765768|NCT01241318|584182952|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
161765769|NCT01241318|584182951|FG000|Overall Study|Woman: Stillborn infant|129|||
161765770|NCT01241318|584182952|FG001|Overall Study|Woman: Stillborn infant|146|||
161765771|NCT02355665|584182953|FG000|Overall Study|Adverse Event|16|||
161765772|NCT02355665|584182954|FG001|Overall Study|Adverse Event|24|||
161765773|NCT02355665|584182953|FG000|Overall Study|Protocol Violation|2|||
161765774|NCT02355665|584182954|FG001|Overall Study|Protocol Violation|0|||
161853179|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Death|8|||
161853180|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Death|5|||
161853181|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Death|5|||
161853182|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Death|7|||
161853183|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
161853184|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
161853185|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
161853186|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
161853187|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
161853188|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
161853189|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
161853190|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
161853191|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
161853192|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
161853193|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
161853194|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
161853195|NCT01128543|584503708|FG000|Overall Study|Withdrawal by Subject|3|||
161853196|NCT01128543|584503708|FG000|Overall Study|Protocol Violation|1|||
161853197|NCT02374346|584503712|FG000|Overall Study|operated or discharged during weekend|48|||
161853198|NCT00396565|584503721|FG000|Overall Study|Physician Decision|3|||
161853199|NCT00396565|584503722|FG001|Overall Study|Physician Decision|1|||
161853200|NCT00396565|584503723|FG002|Overall Study|Physician Decision|2|||
161853201|NCT00396565|584503721|FG000|Overall Study|Adverse Event|5|||
161853202|NCT00396565|584503722|FG001|Overall Study|Adverse Event|13|||
161853203|NCT00396565|584503723|FG002|Overall Study|Adverse Event|3|||
161853204|NCT00396565|584503721|FG000|Overall Study|Withdrawal by Subject|8|||
161853205|NCT00396565|584503722|FG001|Overall Study|Withdrawal by Subject|13|||
161853206|NCT00396565|584503723|FG002|Overall Study|Withdrawal by Subject|1|||
161853207|NCT00396565|584503721|FG000|Overall Study|Lack of Efficacy|32|||
161853208|NCT00396565|584503722|FG001|Overall Study|Lack of Efficacy|64|||
161853209|NCT00396565|584503723|FG002|Overall Study|Lack of Efficacy|11|||
161853210|NCT04487067|584503725|FG000|Overall Study|Adverse Event|3|||
161853211|NCT04487067|584503725|FG000|Overall Study|Death Other Than Progressive Disease|60|||
161853212|NCT04487067|584503725|FG000|Overall Study|Death Due To Progressive Disease|40|||
161853213|NCT04487067|584503725|FG000|Overall Study|Lost to Follow-up|3|||
161853214|NCT04487067|584503725|FG000|Overall Study|Progressive Disease|1|||
161853215|NCT04487067|584503725|FG000|Overall Study|Protocol Violation|3|||
161853216|NCT04487067|584503725|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
161853217|NCT04487067|584503725|FG000|Overall Study|Withdrawal by Subject|15|||
161853218|NCT05299528|584503726|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853219|NCT05299528|584503727|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
161853220|NCT05299528|584503728|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853221|NCT05299528|584503729|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853222|NCT05299528|584503730|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853223|NCT05299528|584503731|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853224|NCT05299528|584503732|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853225|NCT05299528|584503726|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853226|NCT05299528|584503727|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853227|NCT05299528|584503728|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853228|NCT05299528|584503729|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161765775|NCT02355665|584182953|FG000|Overall Study|Withdrawal by Subject|90|||
161853229|NCT05299528|584503730|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853230|NCT05299528|584503731|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
161853231|NCT05299528|584503732|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853232|NCT05299528|584503726|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
161853233|NCT05299528|584503727|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
161853234|NCT05299528|584503728|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
161853235|NCT05299528|584503729|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
161853236|NCT05299528|584503730|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
161853237|NCT05299528|584503731|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
161853238|NCT05299528|584503732|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
161853239|NCT04877457|584503733|FG000|Overall Study|Early termination of study due to low enrollment|2|||
161853240|NCT04877457|584503734|FG001|Overall Study|Early termination of study due to low enrollment|1|||
161853241|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
161853242|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
161853243|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
161853244|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Death|1|||
161853245|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Death|3|||
161853246|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Death|1|||
161853247|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
161853248|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
161853249|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
161853250|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
161853251|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
161853252|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
161853253|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
161853254|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
161853255|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
161853256|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
161853257|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
161853258|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
161853259|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
161853260|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
161853261|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
161853262|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
161853263|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
161853264|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
161853265|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
161853266|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
161853267|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
161853268|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
161853269|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
161853270|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
161853271|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
161853272|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
161853273|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
161853274|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
161853275|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
161853276|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
161853277|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
161853278|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
161853279|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
161853280|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
161853281|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
161853282|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
161853283|NCT00299130|584503735|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
161853284|NCT00299130|584503736|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
161853285|NCT00299130|584503737|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
161853286|NCT00299130|584503735|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
161853287|NCT00299130|584503736|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
161853288|NCT00299130|584503737|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
161853289|NCT00299130|584503735|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
161853290|NCT00299130|584503736|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
161853291|NCT00299130|584503737|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
161853292|NCT02211417|584503738|FG000|Overall Study|Withdrawal by Subject|11|||
161853293|NCT02211417|584503739|FG001|Overall Study|Withdrawal by Subject|8|||
161853294|NCT02211417|584503738|FG000|Overall Study|Protocol Violation|1|||
161853295|NCT02211417|584503739|FG001|Overall Study|Protocol Violation|0|||
161853296|NCT02211417|584503738|FG000|Overall Study|Pregnancy|0|||
161853297|NCT02211417|584503739|FG001|Overall Study|Pregnancy|1|||
161853298|NCT02211417|584503738|FG000|Overall Study|Lost to Follow-up|2|||
161853299|NCT02211417|584503739|FG001|Overall Study|Lost to Follow-up|3|||
161853300|NCT02211417|584503738|FG000|Overall Study|Adverse Event|1|||
161853301|NCT02211417|584503739|FG001|Overall Study|Adverse Event|4|||
161853302|NCT01198132|584503740|FG000|Overall Study|Withdrawal by Subject|4|||
161853303|NCT01198132|584503741|FG001|Overall Study|Withdrawal by Subject|5|||
161853304|NCT01198132|584503740|FG000|Overall Study|Physician Decision|5|||
161853305|NCT01198132|584503741|FG001|Overall Study|Physician Decision|4|||
161853306|NCT01198132|584503740|FG000|Overall Study|Other Unspecified|3|||
161853307|NCT01198132|584503741|FG001|Overall Study|Other Unspecified|6|||
161853308|NCT01198132|584503740|FG000|Overall Study|Lack of Efficacy|2|||
161853309|NCT01198132|584503741|FG001|Overall Study|Lack of Efficacy|3|||
161853310|NCT01198132|584503740|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
161853311|NCT01198132|584503741|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
161853312|NCT01198132|584503740|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
161853313|NCT01198132|584503741|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
161853314|NCT01198132|584503740|FG000|Overall Study|Adverse Event|0|||
161853315|NCT01198132|584503741|FG001|Overall Study|Adverse Event|1|||
161853316|NCT01198132|584503740|FG000|Overall Study|Protocol Violation|1|||
161853317|NCT01198132|584503741|FG001|Overall Study|Protocol Violation|0|||
161853318|NCT01277211|584503742|FG000|Overall Study|Adverse Event|60|||
161853319|NCT01277211|584503743|FG001|Overall Study|Adverse Event|22|||
161853320|NCT01277211|584503742|FG000|Overall Study|Pregnancy|9|||
161853321|NCT01277211|584503743|FG001|Overall Study|Pregnancy|4|||
161853322|NCT01277211|584503742|FG000|Overall Study|Lost to Follow-up|14|||
161853323|NCT01277211|584503743|FG001|Overall Study|Lost to Follow-up|9|||
161853324|NCT01277211|584503742|FG000|Overall Study|Did not wish to continue|17|||
161853325|NCT01277211|584503743|FG001|Overall Study|Did not wish to continue|0|||
161853326|NCT01277211|584503742|FG000|Overall Study|Withdrew Consent|9|||
161853327|NCT01277211|584503743|FG001|Overall Study|Withdrew Consent|9|||
161853328|NCT01277211|584503742|FG000|Overall Study|Non-compliance with protocol|13|||
161853329|NCT01277211|584503743|FG001|Overall Study|Non-compliance with protocol|4|||
161853330|NCT01277211|584503742|FG000|Overall Study|Did not meet protocol eligibility|1|||
161853331|NCT01277211|584503743|FG001|Overall Study|Did not meet protocol eligibility|0|||
161853332|NCT01277211|584503742|FG000|Overall Study|Administrative|3|||
161853333|NCT01277211|584503743|FG001|Overall Study|Administrative|0|||
161853334|NCT01277211|584503742|FG000|Overall Study|Pregnancy wish|0|||
161853335|NCT01277211|584503743|FG001|Overall Study|Pregnancy wish|2|||
161853336|NCT01277211|584503742|FG000|Overall Study|Discontinued prior to treatment|24|||
161853337|NCT01277211|584503743|FG001|Overall Study|Discontinued prior to treatment|13|||
161853338|NCT04697069|584503744|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
161853339|NCT04697069|584503745|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
161853340|NCT04697069|584503744|FG000|Overall Study|Study termination|2|||
161853341|NCT04697069|584503745|FG001|Overall Study|Study termination|1|||
161853342|NCT05180227|584503746|FG000|Overall Study|Hypertension at screening|1|||
161853343|NCT05180227|584503746|FG000|Overall Study|Lost to Follow-up|1|||
161853344|NCT04614246|584503747|FG000|Overall Study|Adverse Event|0|||
161853345|NCT04614246|584503748|FG001|Overall Study|Adverse Event|1|||
161853346|NCT04614246|584503749|FG002|Overall Study|Adverse Event|1|||
161853347|NCT04614246|584503750|FG003|Overall Study|Adverse Event|2|||
161853348|NCT04614246|584503751|FG004|Overall Study|Adverse Event|1|||
161853349|NCT04614246|584503747|FG000|Overall Study|Lost to Follow-up|0|||
161853350|NCT04614246|584503748|FG001|Overall Study|Lost to Follow-up|1|||
161853351|NCT04614246|584503749|FG002|Overall Study|Lost to Follow-up|0|||
161853352|NCT04614246|584503750|FG003|Overall Study|Lost to Follow-up|1|||
161853353|NCT04614246|584503751|FG004|Overall Study|Lost to Follow-up|3|||
161853354|NCT04614246|584503747|FG000|Overall Study|Other reason|0|||
161853355|NCT04614246|584503748|FG001|Overall Study|Other reason|1|||
161853356|NCT04614246|584503749|FG002|Overall Study|Other reason|2|||
161853357|NCT04614246|584503750|FG003|Overall Study|Other reason|0|||
161853358|NCT04614246|584503751|FG004|Overall Study|Other reason|0|||
161853359|NCT04614246|584503747|FG000|Overall Study|Withdrawal by Subject|4|||
161853360|NCT04614246|584503748|FG001|Overall Study|Withdrawal by Subject|2|||
161853361|NCT04614246|584503749|FG002|Overall Study|Withdrawal by Subject|4|||
161853362|NCT04614246|584503750|FG003|Overall Study|Withdrawal by Subject|3|||
161853363|NCT04614246|584503751|FG004|Overall Study|Withdrawal by Subject|4|||
161853364|NCT04614246|584503747|FG000|Overall Study|Physician Decision|0|||
161853365|NCT04614246|584503748|FG001|Overall Study|Physician Decision|2|||
161765776|NCT02355665|584182954|FG001|Overall Study|Withdrawal by Subject|100|||
161765777|NCT02355665|584182953|FG000|Overall Study|Lost to Follow-up|131|||
161765778|NCT02355665|584182954|FG001|Overall Study|Lost to Follow-up|103|||
161765779|NCT02355665|584182953|FG000|Overall Study|Death|4|||
161765780|NCT02355665|584182954|FG001|Overall Study|Death|2|||
161765781|NCT02355665|584182953|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
161765782|NCT02355665|584182954|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
161853366|NCT04614246|584503749|FG002|Overall Study|Physician Decision|1|||
161853367|NCT04614246|584503750|FG003|Overall Study|Physician Decision|0|||
161853368|NCT04614246|584503751|FG004|Overall Study|Physician Decision|0|||
161853369|NCT04614246|584503747|FG000|Overall Study|Study terminated by sponsor|10|||
161853370|NCT04614246|584503748|FG001|Overall Study|Study terminated by sponsor|15|||
161853371|NCT04614246|584503749|FG002|Overall Study|Study terminated by sponsor|12|||
161853372|NCT04614246|584503750|FG003|Overall Study|Study terminated by sponsor|13|||
161853373|NCT04614246|584503751|FG004|Overall Study|Study terminated by sponsor|9|||
161853374|NCT04614246|584503747|FG000|Overall Study|Pregnancy|2|||
161853375|NCT04614246|584503748|FG001|Overall Study|Pregnancy|0|||
161853376|NCT04614246|584503749|FG002|Overall Study|Pregnancy|1|||
161853377|NCT04614246|584503750|FG003|Overall Study|Pregnancy|0|||
161765783|NCT02380703|584182957|FG000|Overall Study|Withdrawal by Subject|12|||
161765784|NCT02380703|584182958|FG001|Overall Study|Withdrawal by Subject|9|||
161765785|NCT02380703|584182957|FG000|Overall Study|Lost to Follow-up|12|||
161853378|NCT04614246|584503751|FG004|Overall Study|Pregnancy|0|||
161853379|NCT02185053|584503752|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
161765786|NCT02380703|584182958|FG001|Overall Study|Lost to Follow-up|12|||
161765787|NCT02380703|584182957|FG000|Overall Study|Caregiver death|1|||
161765788|NCT02380703|584182958|FG001|Overall Study|Caregiver death|0|||
161765789|NCT02380703|584182957|FG000|Overall Study|Person with dementia (PWD) death|7|||
161765790|NCT02380703|584182958|FG001|Overall Study|Person with dementia (PWD) death|8|||
161765791|NCT02380703|584182957|FG000|Overall Study|Entered Long-term Care|4|||
161765792|NCT02380703|584182958|FG001|Overall Study|Entered Long-term Care|7|||
161765793|NCT00266695|584182959|FG000|Overall Study|Adverse Event|1|||
161765794|NCT00266695|584182959|FG000|Overall Study|Death|9|||
161765795|NCT00266695|584182959|FG000|Overall Study|Physician Decision|1|||
161765796|NCT00266695|584182959|FG000|Overall Study|Lost to Follow-up|3|||
161765797|NCT00266695|584182959|FG000|Overall Study|Withdrawal by Subject|15|||
161765798|NCT03607994|584182960|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
161765799|NCT03607994|584182961|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
161765800|NCT02853318|584182968|FG000|Overall Study|Withdrawal by Subject|1|||
161765801|NCT04490499|584182971|FG000|Overall Study|Withdrawal by Subject|2|||
161765802|NCT01882439|584182977|FG000|Overall Study|Adverse event related to study drug|3|||
161765803|NCT01882439|584182978|FG001|Overall Study|Adverse event related to study drug|8|||
161765804|NCT01882439|584182979|FG002|Overall Study|Adverse event related to study drug|1|||
161765805|NCT01882439|584182980|FG003|Overall Study|Adverse event related to study drug|2|||
161765806|NCT01882439|584182977|FG000|Overall Study|Pregnancy|0|||
161765807|NCT01882439|584182978|FG001|Overall Study|Pregnancy|1|||
161765808|NCT01882439|584182979|FG002|Overall Study|Pregnancy|0|||
161765809|NCT01882439|584182980|FG003|Overall Study|Pregnancy|0|||
161765810|NCT01882439|584182977|FG000|Overall Study|Protocol Violation|2|||
161765811|NCT01882439|584182978|FG001|Overall Study|Protocol Violation|2|||
161765812|NCT01882439|584182979|FG002|Overall Study|Protocol Violation|0|||
161765813|NCT01882439|584182980|FG003|Overall Study|Protocol Violation|1|||
161765814|NCT01882439|584182977|FG000|Overall Study|No longer willing to participate|1|||
161765815|NCT01882439|584182978|FG001|Overall Study|No longer willing to participate|4|||
161765816|NCT01882439|584182979|FG002|Overall Study|No longer willing to participate|2|||
161765817|NCT01882439|584182980|FG003|Overall Study|No longer willing to participate|3|||
161765818|NCT01882439|584182977|FG000|Overall Study|Medication error with no associated AE|0|||
161765819|NCT01882439|584182978|FG001|Overall Study|Medication error with no associated AE|0|||
161765820|NCT01882439|584182979|FG002|Overall Study|Medication error with no associated AE|2|||
161765821|NCT01882439|584182980|FG003|Overall Study|Medication error with no associated AE|0|||
161765822|NCT01882439|584182977|FG000|Overall Study|Insufficient clinical response|1|||
161765823|NCT01882439|584182978|FG001|Overall Study|Insufficient clinical response|4|||
161765824|NCT01882439|584182979|FG002|Overall Study|Insufficient clinical response|4|||
161765825|NCT01882439|584182980|FG003|Overall Study|Insufficient clinical response|2|||
161765826|NCT01882439|584182977|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161765827|NCT01882439|584182978|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161765828|NCT01882439|584182979|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161765829|NCT01882439|584182980|FG003|Overall Study|Adverse event unrelated to study drug|1|||
161765830|NCT03125902|584182985|FG000|Overall Study|Adverse Event|0|||
161765831|NCT03125902|584182986|FG001|Overall Study|Adverse Event|1|||
161765832|NCT03125902|584182985|FG000|Overall Study|Death|119|||
161765833|NCT03125902|584182986|FG001|Overall Study|Death|229|||
161765834|NCT03125902|584182985|FG000|Overall Study|Lost to Follow-up|4|||
161765835|NCT03125902|584182986|FG001|Overall Study|Lost to Follow-up|13|||
161765836|NCT03125902|584182985|FG000|Overall Study|Other|0|||
161765837|NCT03125902|584182986|FG001|Overall Study|Other|4|||
161765838|NCT03125902|584182985|FG000|Overall Study|Physician Decision|2|||
161765839|NCT03125902|584182986|FG001|Overall Study|Physician Decision|1|||
161853380|NCT02185053|584503753|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
161853381|NCT02185053|584503754|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
161853382|NCT02185053|584503752|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
161853383|NCT02185053|584503753|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853384|NCT02185053|584503754|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853385|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
161853386|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
161853387|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
161853388|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
161853389|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
161853390|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
161853391|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853392|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
161853393|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853394|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
161853395|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
161853396|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
161853397|NCT02185053|584503752|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
161853398|NCT02185053|584503753|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
161853399|NCT02185053|584503754|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
161853400|NCT02185053|584503752|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
161853401|NCT02185053|584503753|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
161853402|NCT02185053|584503754|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
161853403|NCT02521376|584503762|FG000|Overall Study|Enrolled, But Not Treated|1|||
161853404|NCT02521376|584503763|FG001|Overall Study|Enrolled, But Not Treated|0|||
161853405|NCT02521376|584503764|FG002|Overall Study|Enrolled, But Not Treated|0|||
161853406|NCT02521376|584503765|FG003|Overall Study|Enrolled, But Not Treated|0|||
161853407|NCT00340678|584503766|FG000|Overall Study|Lost to Follow-up|1|||
161853408|NCT00340678|584503767|FG001|Overall Study|Lost to Follow-up|0|||
161853409|NCT00340678|584503768|FG002|Overall Study|Lost to Follow-up|0|||
161853410|NCT00340678|584503769|FG003|Overall Study|Lost to Follow-up|0|||
161853411|NCT01653912|584503770|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853412|NCT01653912|584503771|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
161853413|NCT01653912|584503772|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853414|NCT01653912|584503773|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853415|NCT01653912|584503774|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853416|NCT01653912|584503775|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853417|NCT01653912|584503770|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853418|NCT01653912|584503771|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853419|NCT01653912|584503772|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
161765840|NCT03125902|584182985|FG000|Overall Study|Progressive Disease|0|||
161765841|NCT03125902|584182986|FG001|Overall Study|Progressive Disease|3|||
161765842|NCT03125902|584182985|FG000|Overall Study|Study Terminated By Sponsor|74|||
161765843|NCT03125902|584182986|FG001|Overall Study|Study Terminated By Sponsor|143|||
161765844|NCT03125902|584182985|FG000|Overall Study|Withdrawal by Subject|21|||
161765845|NCT03125902|584182986|FG001|Overall Study|Withdrawal by Subject|37|||
161765846|NCT01997333|584182987|FG000|Randomization and Treatment|Disease Progression|70|||
161765847|NCT01997333|584182988|FG001|Randomization and Treatment|Disease Progression|159|||
161765848|NCT01997333|584182987|FG000|Randomization and Treatment|Adverse Event|10|||
161765849|NCT01997333|584182988|FG001|Randomization and Treatment|Adverse Event|32|||
161765850|NCT01997333|584182987|FG000|Randomization and Treatment|Physician Decision|0|||
161765851|NCT01997333|584182988|FG001|Randomization and Treatment|Physician Decision|4|||
161765852|NCT01997333|584182987|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
161765853|NCT01997333|584182988|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
161765854|NCT01997333|584182987|FG000|Randomization and Treatment|Did not receive treatment|17|||
161765855|NCT01997333|584182988|FG001|Randomization and Treatment|Did not receive treatment|5|||
161765856|NCT01997333|584182987|FG000|Survival Follow up|Withdrawal by Subject|15|||
161765857|NCT01997333|584182988|FG001|Survival Follow up|Withdrawal by Subject|6|||
161765858|NCT01997333|584182987|FG000|Survival Follow up|Lost to Follow-up|0|||
161765859|NCT01997333|584182988|FG001|Survival Follow up|Lost to Follow-up|6|||
161765860|NCT01997333|584182987|FG000|Survival Follow up|Various|1|||
161765861|NCT01997333|584182988|FG001|Survival Follow up|Various|2|||
161765862|NCT02269709|584182989|FG000|Time of Enrollment|Withdrawal by Subject|3|||
161765863|NCT02269709|584182989|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
161765864|NCT02269709|584182989|FG000|Six Month Follow-up|Lost to Follow-up|12|||
161765865|NCT04411472|584182992|FG000|Overall Study|Adverse Event|5|||
161765866|NCT04411472|584182993|FG001|Overall Study|Adverse Event|10|||
161765867|NCT04411472|584182994|FG002|Overall Study|Adverse Event|1|||
161765868|NCT04411472|584182995|FG003|Overall Study|Adverse Event|0|||
161765869|NCT04411472|584182996|FG004|Overall Study|Adverse Event|0|||
161765870|NCT04411472|584182997|FG005|Overall Study|Adverse Event|0|||
161765871|NCT04411472|584182992|FG000|Overall Study|Protocol Violation|1|||
161765872|NCT04411472|584182993|FG001|Overall Study|Protocol Violation|0|||
161765873|NCT04411472|584182994|FG002|Overall Study|Protocol Violation|0|||
161765874|NCT04411472|584182995|FG003|Overall Study|Protocol Violation|0|||
161765875|NCT04411472|584182996|FG004|Overall Study|Protocol Violation|0|||
161765876|NCT04411472|584182997|FG005|Overall Study|Protocol Violation|0|||
161765877|NCT04411472|584182992|FG000|Overall Study|Withdrawal by Subject|0|||
161765878|NCT04411472|584182993|FG001|Overall Study|Withdrawal by Subject|1|||
161765879|NCT04411472|584182994|FG002|Overall Study|Withdrawal by Subject|0|||
161765880|NCT04411472|584182995|FG003|Overall Study|Withdrawal by Subject|1|||
161765881|NCT04411472|584182996|FG004|Overall Study|Withdrawal by Subject|0|||
161765882|NCT04411472|584182997|FG005|Overall Study|Withdrawal by Subject|0|||
161765883|NCT04411472|584182992|FG000|Overall Study|Physician Decision|1|||
161765884|NCT04411472|584182993|FG001|Overall Study|Physician Decision|0|||
161765885|NCT04411472|584182994|FG002|Overall Study|Physician Decision|0|||
161765886|NCT04411472|584182995|FG003|Overall Study|Physician Decision|0|||
161765887|NCT04411472|584182996|FG004|Overall Study|Physician Decision|0|||
161765888|NCT04411472|584182997|FG005|Overall Study|Physician Decision|0|||
161765889|NCT04411472|584182992|FG000|Overall Study|Study terminated by sponsor|17|||
161765890|NCT04411472|584182993|FG001|Overall Study|Study terminated by sponsor|20|||
161765891|NCT04411472|584182994|FG002|Overall Study|Study terminated by sponsor|3|||
161765892|NCT04411472|584182995|FG003|Overall Study|Study terminated by sponsor|0|||
161765893|NCT04411472|584182996|FG004|Overall Study|Study terminated by sponsor|0|||
161765894|NCT04411472|584182997|FG005|Overall Study|Study terminated by sponsor|0|||
161765895|NCT00440232|584182998|FG000|Overall Study|Lost to Follow-up|1|||
161765896|NCT00440232|584182999|FG001|Overall Study|Lost to Follow-up|1|||
161765897|NCT00440232|584182998|FG000|Overall Study|Unable to treat within allowed time|0|||
161765898|NCT00440232|584182999|FG001|Overall Study|Unable to treat within allowed time|1|||
161765899|NCT00440232|584182998|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
161765900|NCT00440232|584182999|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
161765901|NCT01747655|584183000|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
161853420|NCT01653912|584503773|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853421|NCT01653912|584503774|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853422|NCT01653912|584503775|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853423|NCT01653912|584503770|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853424|NCT01653912|584503771|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853425|NCT01653912|584503772|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853426|NCT01653912|584503773|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
161853427|NCT01653912|584503774|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853428|NCT01653912|584503775|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853429|NCT01653912|584503770|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853430|NCT01653912|584503771|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853431|NCT01653912|584503772|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853432|NCT01653912|584503773|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
161853433|NCT01653912|584503774|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853434|NCT01653912|584503775|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853435|NCT01653912|584503770|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853436|NCT01653912|584503771|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853437|NCT01653912|584503772|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853438|NCT01653912|584503773|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853439|NCT01653912|584503774|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853440|NCT01653912|584503775|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
161853441|NCT01653912|584503770|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853442|NCT01653912|584503771|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853443|NCT01653912|584503772|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853444|NCT01653912|584503773|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853445|NCT01653912|584503774|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853446|NCT01653912|584503775|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
161853447|NCT01653912|584503770|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853448|NCT01653912|584503771|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853449|NCT01653912|584503772|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853450|NCT01653912|584503773|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853451|NCT01653912|584503774|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853452|NCT01653912|584503775|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
161853453|NCT01987479|584503776|FG000|Overall Study|Protocol Violation|1|||
161853454|NCT01987479|584503776|FG000|Overall Study|Physician Decision|2|||
161853455|NCT01987479|584503776|FG000|Overall Study|Participant/legal guardian decision|1|||
161853456|NCT01987479|584503776|FG000|Overall Study|Other|5|||
161853457|NCT01987479|584503776|FG000|Overall Study|Lost to Follow-up|1|||
161853458|NCT01987479|584503776|FG000|Overall Study|Adverse Event|7|||
161853459|NCT01954745|584503777|FG000|Overall Study|Radiological Progression|11|||
161853460|NCT01954745|584503777|FG000|Overall Study|Clinical Progression|5|||
161853461|NCT01954745|584503777|FG000|Overall Study|Adverse Event|2|||
161853462|NCT01954745|584503777|FG000|Overall Study|Death|1|||
161853463|NCT05314816|584503778|FG000|Overall Study|Lost to Follow-up|5|||
161853464|NCT05314816|584503779|FG001|Overall Study|Lost to Follow-up|0|||
161853465|NCT05314816|584503780|FG002|Overall Study|Lost to Follow-up|1|||
161853466|NCT05314816|584503778|FG000|Overall Study|Protocol Violation|13|||
161853467|NCT05314816|584503779|FG001|Overall Study|Protocol Violation|8|||
161853468|NCT05314816|584503780|FG002|Overall Study|Protocol Violation|0|||
161853469|NCT05422625|584503781|FG000|Overall Study|Withdrawal by Subject|1|||
161853470|NCT05422625|584503782|FG001|Overall Study|Withdrawal by Subject|0|||
161853471|NCT01059786|584506195|FG000|Overall Study|Did not receive 6 cycles.|0|||
161853472|NCT01059786|584506196|FG001|Overall Study|Did not receive 6 cycles.|0|||
161853473|NCT01059786|584506197|FG002|Overall Study|Did not receive 6 cycles.|4|||
161853474|NCT01059786|584506198|FG003|Overall Study|Did not receive 6 cycles.|1|||
161853475|NCT01059786|584506199|FG004|Overall Study|Did not receive 6 cycles.|0|||
161853476|NCT04205812|584506200|FG000|Randomized Treatment Period|Ongoing|28|||
161853477|NCT04205812|584506201|FG001|Randomized Treatment Period|Ongoing|138|||
161853478|NCT04205812|584506200|FG000|Randomized Treatment Period|Death|94|||
161853479|NCT04205812|584506201|FG001|Randomized Treatment Period|Death|226|||
161853480|NCT04205812|584506200|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
161853481|NCT04205812|584506201|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
161853482|NCT04205812|584506200|FG000|Randomized Treatment Period|Physician Decision|1|||
161853483|NCT04205812|584506201|FG001|Randomized Treatment Period|Physician Decision|4|||
161853484|NCT04205812|584506200|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
161853485|NCT04205812|584506201|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
161853486|NCT04205812|584506200|FG000|Randomized Treatment Period|Progressive Disease|0|||
161853487|NCT04205812|584506201|FG001|Randomized Treatment Period|Progressive Disease|1|||
161853488|NCT04205812|584506200|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
161853489|NCT04205812|584506201|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
161853490|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Ongoing|17|||
161853491|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Ongoing|0|||
161853492|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Death|39|||
161765902|NCT01747655|584183001|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
161765903|NCT01747655|584183000|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
161765904|NCT01747655|584183001|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
161765905|NCT01747655|584183000|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
161765906|NCT01747655|584183001|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
161765907|NCT03769753|584183002|FG000|Overall Study|Not Treated|6|||
161765908|NCT03769753|584183002|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
161765909|NCT00684073|584183003|FG000|Selection|Selection/non-selection criteria|3|||
161765910|NCT00684073|584183003|FG000|Selection|Death|1|||
161765911|NCT00684073|584183003|FG000|Selection|noncompliance|1|||
161765912|NCT00684073|584183003|FG000|Selection|Lost to Follow-up|1|||
161765913|NCT00684073|584183003|FG000|Selection|request of the sponsor|1|||
161765914|NCT00684073|584183003|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
161765915|NCT01259388|584183005|FG000|Overall Study|Adverse Event|3|||
161765916|NCT01259388|584183006|FG001|Overall Study|Adverse Event|0|||
161765917|NCT01259388|584183005|FG000|Overall Study|Withdrawal by Subject|1|||
161765918|NCT01259388|584183006|FG001|Overall Study|Withdrawal by Subject|1|||
161765919|NCT01259388|584183005|FG000|Overall Study|Physician Decision|1|||
161765920|NCT01259388|584183006|FG001|Overall Study|Physician Decision|0|||
161765921|NCT00620815|584183007|FG000|Overall Study|Adverse Event|1|||
161765922|NCT00620815|584183008|FG001|Overall Study|Adverse Event|1|||
161765923|NCT00620815|584183009|FG002|Overall Study|Adverse Event|2|||
161765924|NCT00620815|584183007|FG000|Overall Study|Withdrawal by Subject|1|||
161765925|NCT00620815|584183008|FG001|Overall Study|Withdrawal by Subject|2|||
161765926|NCT00620815|584183009|FG002|Overall Study|Withdrawal by Subject|0|||
161765927|NCT00620815|584183007|FG000|Overall Study|Lost to Follow-up|1|||
161765928|NCT00620815|584183008|FG001|Overall Study|Lost to Follow-up|6|||
161765929|NCT00620815|584183009|FG002|Overall Study|Lost to Follow-up|3|||
161765930|NCT00620815|584183007|FG000|Overall Study|Inappropriate enrolment|0|||
161765931|NCT00620815|584183008|FG001|Overall Study|Inappropriate enrolment|0|||
161765932|NCT00620815|584183009|FG002|Overall Study|Inappropriate enrolment|1|||
161765933|NCT00620815|584183007|FG000|Overall Study|Protocol Violation|1|||
161765934|NCT00620815|584183008|FG001|Overall Study|Protocol Violation|2|||
161765935|NCT00620815|584183009|FG002|Overall Study|Protocol Violation|1|||
161765936|NCT00983827|584183010|FG000|Overall Study|Withdrawal by Subject|1|||
161765937|NCT01230827|584183011|FG000|Overall Study|Lost to Follow-up|0|||
161765938|NCT01230827|584183012|FG001|Overall Study|Lost to Follow-up|0|||
161765939|NCT01230827|584183013|FG002|Overall Study|Lost to Follow-up|1|||
161765940|NCT01230827|584183014|FG003|Overall Study|Lost to Follow-up|3|||
161765941|NCT01230827|584183011|FG000|Overall Study|Withdrawal by Subject|1|||
161765942|NCT01230827|584183012|FG001|Overall Study|Withdrawal by Subject|0|||
161765943|NCT01230827|584183013|FG002|Overall Study|Withdrawal by Subject|3|||
161765944|NCT01230827|584183014|FG003|Overall Study|Withdrawal by Subject|2|||
161765945|NCT01230827|584183011|FG000|Overall Study|Lack of Efficacy|14|||
161765946|NCT01230827|584183012|FG001|Overall Study|Lack of Efficacy|1|||
161765947|NCT01230827|584183013|FG002|Overall Study|Lack of Efficacy|2|||
161765948|NCT01230827|584183014|FG003|Overall Study|Lack of Efficacy|3|||
161765949|NCT01230827|584183011|FG000|Overall Study|Adverse Event|4|||
161765950|NCT01230827|584183012|FG001|Overall Study|Adverse Event|2|||
161765951|NCT01230827|584183013|FG002|Overall Study|Adverse Event|3|||
161765952|NCT01230827|584183014|FG003|Overall Study|Adverse Event|7|||
161765953|NCT01230827|584183011|FG000|Overall Study|Recovery|0|||
161765954|NCT01230827|584183012|FG001|Overall Study|Recovery|6|||
161765955|NCT01230827|584183013|FG002|Overall Study|Recovery|0|||
161765956|NCT01230827|584183014|FG003|Overall Study|Recovery|0|||
161765957|NCT01230827|584183011|FG000|Overall Study|Study terminated by Sponsor|0|||
161765958|NCT01230827|584183012|FG001|Overall Study|Study terminated by Sponsor|2|||
161765959|NCT01230827|584183013|FG002|Overall Study|Study terminated by Sponsor|56|||
161765960|NCT01230827|584183014|FG003|Overall Study|Study terminated by Sponsor|63|||
161765961|NCT01888367|584183017|FG000|Overall Study|Physician Decision|3|||
161765962|NCT01888367|584183018|FG001|Overall Study|Physician Decision|4|||
161765963|NCT01888367|584183019|FG002|Overall Study|Physician Decision|2|||
161765964|NCT01888367|584183017|FG000|Overall Study|Death|2|||
161765965|NCT01888367|584183018|FG001|Overall Study|Death|0|||
161765966|NCT01888367|584183019|FG002|Overall Study|Death|1|||
161765967|NCT01888367|584183017|FG000|Overall Study|Withdrawal by Subject|1|||
161765968|NCT01888367|584183018|FG001|Overall Study|Withdrawal by Subject|0|||
161765969|NCT01888367|584183019|FG002|Overall Study|Withdrawal by Subject|1|||
161765970|NCT01888367|584183017|FG000|Overall Study|Lost to Follow-up|1|||
161765971|NCT01888367|584183018|FG001|Overall Study|Lost to Follow-up|1|||
161765972|NCT01888367|584183019|FG002|Overall Study|Lost to Follow-up|0|||
161765973|NCT01888367|584183017|FG000|Overall Study|Protocol Violation|0|||
161765974|NCT01888367|584183018|FG001|Overall Study|Protocol Violation|0|||
161765975|NCT01888367|584183019|FG002|Overall Study|Protocol Violation|1|||
161765976|NCT01888367|584183017|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
161765977|NCT01888367|584183018|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
161765978|NCT01888367|584183019|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
161765979|NCT02728804|584183020|FG000|Overall Study|Ineligible|3|||
161765980|NCT02728804|584183020|FG000|Overall Study|Did not complete baseline questionnaire|9|||
161765981|NCT02728804|584183020|FG000|Overall Study|Death|99|||
161765982|NCT00591786|584183021|FG000|Overall Study|Withdrawal of Informed Consent|0|||
161765983|NCT00591786|584183022|FG001|Overall Study|Withdrawal of Informed Consent|0|||
161765984|NCT00591786|584183023|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161765985|NCT00591786|584183024|FG003|Overall Study|Withdrawal of Informed Consent|0|||
161765986|NCT00591786|584183025|FG004|Overall Study|Withdrawal of Informed Consent|0|||
161765987|NCT00591786|584183026|FG005|Overall Study|Withdrawal of Informed Consent|0|||
161765988|NCT00591786|584183027|FG006|Overall Study|Withdrawal of Informed Consent|0|||
161765989|NCT00591786|584183028|FG007|Overall Study|Withdrawal of Informed Consent|0|||
161765990|NCT00591786|584183029|FG008|Overall Study|Withdrawal of Informed Consent|0|||
161765991|NCT00591786|584183030|FG009|Overall Study|Withdrawal of Informed Consent|0|||
161765992|NCT01920061|584183032|FG000|Overall Study|Death|1|||
161765993|NCT01920061|584183033|FG001|Overall Study|Death|1|||
161765994|NCT01920061|584183034|FG002|Overall Study|Death|0|||
161765995|NCT01920061|584183035|FG003|Overall Study|Death|1|||
161765996|NCT01920061|584183036|FG004|Overall Study|Death|1|||
161765997|NCT01920061|584183037|FG005|Overall Study|Death|0|||
161765998|NCT01920061|584183038|FG006|Overall Study|Death|0|||
161765999|NCT01920061|584183039|FG007|Overall Study|Death|1|||
161766000|NCT01920061|584183040|FG008|Overall Study|Death|0|||
161766001|NCT01920061|584183041|FG009|Overall Study|Death|1|||
161766002|NCT01920061|584183042|FG010|Overall Study|Death|0|||
161766003|NCT01920061|584183043|FG011|Overall Study|Death|1|||
161766004|NCT01920061|584183044|FG012|Overall Study|Death|0|||
161766005|NCT01920061|584183045|FG013|Overall Study|Death|2|||
161766006|NCT01920061|584183046|FG014|Overall Study|Death|0|||
161766007|NCT01920061|584183047|FG015|Overall Study|Death|0|||
161766008|NCT01920061|584183048|FG016|Overall Study|Death|0|||
161766009|NCT01920061|584183049|FG017|Overall Study|Death|0|||
161766010|NCT01920061|584183050|FG018|Overall Study|Death|1|||
161766011|NCT01920061|584183051|FG019|Overall Study|Death|0|||
161766012|NCT01920061|584183032|FG000|Overall Study|Lost to Follow-up|0|||
161766013|NCT01920061|584183033|FG001|Overall Study|Lost to Follow-up|2|||
161766014|NCT01920061|584183034|FG002|Overall Study|Lost to Follow-up|0|||
161766015|NCT01920061|584183035|FG003|Overall Study|Lost to Follow-up|0|||
161766016|NCT01920061|584183036|FG004|Overall Study|Lost to Follow-up|0|||
161766017|NCT01920061|584183037|FG005|Overall Study|Lost to Follow-up|0|||
161766018|NCT01920061|584183038|FG006|Overall Study|Lost to Follow-up|1|||
161766019|NCT01920061|584183039|FG007|Overall Study|Lost to Follow-up|0|||
161766020|NCT01920061|584183040|FG008|Overall Study|Lost to Follow-up|0|||
161766021|NCT01920061|584183041|FG009|Overall Study|Lost to Follow-up|0|||
161766022|NCT01920061|584183042|FG010|Overall Study|Lost to Follow-up|3|||
161766023|NCT01920061|584183043|FG011|Overall Study|Lost to Follow-up|0|||
161766024|NCT01920061|584183044|FG012|Overall Study|Lost to Follow-up|0|||
161766025|NCT01920061|584183045|FG013|Overall Study|Lost to Follow-up|0|||
161766026|NCT01920061|584183046|FG014|Overall Study|Lost to Follow-up|0|||
161766027|NCT01920061|584183047|FG015|Overall Study|Lost to Follow-up|0|||
161766028|NCT01920061|584183048|FG016|Overall Study|Lost to Follow-up|0|||
161766029|NCT01920061|584183049|FG017|Overall Study|Lost to Follow-up|1|||
161766030|NCT01920061|584183050|FG018|Overall Study|Lost to Follow-up|4|||
161766031|NCT01920061|584183051|FG019|Overall Study|Lost to Follow-up|3|||
161766032|NCT01920061|584183032|FG000|Overall Study|Other|1|||
161766033|NCT01920061|584183033|FG001|Overall Study|Other|1|||
161766034|NCT01920061|584183034|FG002|Overall Study|Other|2|||
161766035|NCT01920061|584183035|FG003|Overall Study|Other|1|||
161766036|NCT01920061|584183036|FG004|Overall Study|Other|0|||
161766037|NCT01920061|584183037|FG005|Overall Study|Other|1|||
161766038|NCT01920061|584183038|FG006|Overall Study|Other|0|||
161766039|NCT01920061|584183039|FG007|Overall Study|Other|0|||
161766040|NCT01920061|584183040|FG008|Overall Study|Other|0|||
161766041|NCT01920061|584183041|FG009|Overall Study|Other|1|||
161766042|NCT01920061|584183042|FG010|Overall Study|Other|1|||
161766043|NCT01920061|584183043|FG011|Overall Study|Other|2|||
161766044|NCT01920061|584183044|FG012|Overall Study|Other|1|||
161766045|NCT01920061|584183045|FG013|Overall Study|Other|4|||
161766046|NCT01920061|584183046|FG014|Overall Study|Other|0|||
161766047|NCT01920061|584183047|FG015|Overall Study|Other|1|||
161766048|NCT01920061|584183048|FG016|Overall Study|Other|1|||
161766049|NCT01920061|584183049|FG017|Overall Study|Other|0|||
161766050|NCT01920061|584183050|FG018|Overall Study|Other|1|||
161766051|NCT01920061|584183051|FG019|Overall Study|Other|1|||
161766052|NCT01920061|584183032|FG000|Overall Study|Participant refused further follow-up|0|||
161766053|NCT01920061|584183033|FG001|Overall Study|Participant refused further follow-up|0|||
161766054|NCT01920061|584183034|FG002|Overall Study|Participant refused further follow-up|0|||
161766055|NCT01920061|584183035|FG003|Overall Study|Participant refused further follow-up|0|||
161766056|NCT01920061|584183036|FG004|Overall Study|Participant refused further follow-up|1|||
161766057|NCT01920061|584183037|FG005|Overall Study|Participant refused further follow-up|1|||
161766058|NCT01920061|584183038|FG006|Overall Study|Participant refused further follow-up|0|||
161766059|NCT01920061|584183039|FG007|Overall Study|Participant refused further follow-up|0|||
161766060|NCT01920061|584183040|FG008|Overall Study|Participant refused further follow-up|1|||
161766061|NCT01920061|584183041|FG009|Overall Study|Participant refused further follow-up|0|||
161766062|NCT01920061|584183042|FG010|Overall Study|Participant refused further follow-up|1|||
161766063|NCT01920061|584183043|FG011|Overall Study|Participant refused further follow-up|0|||
161766064|NCT01920061|584183044|FG012|Overall Study|Participant refused further follow-up|1|||
161766065|NCT01920061|584183045|FG013|Overall Study|Participant refused further follow-up|0|||
161766066|NCT01920061|584183046|FG014|Overall Study|Participant refused further follow-up|1|||
161766067|NCT01920061|584183047|FG015|Overall Study|Participant refused further follow-up|2|||
161766068|NCT01920061|584183048|FG016|Overall Study|Participant refused further follow-up|1|||
161766069|NCT01920061|584183049|FG017|Overall Study|Participant refused further follow-up|1|||
161766070|NCT01920061|584183050|FG018|Overall Study|Participant refused further follow-up|0|||
161766071|NCT01920061|584183051|FG019|Overall Study|Participant refused further follow-up|0|||
161766072|NCT00453349|584183054|FG000|Randomized|Adverse Event|12|||
161766073|NCT00453349|584183055|FG001|Randomized|Adverse Event|11|||
161766074|NCT00453349|584183054|FG000|Randomized|Lack of Efficacy|2|||
161766075|NCT00453349|584183055|FG001|Randomized|Lack of Efficacy|1|||
161766076|NCT00453349|584183054|FG000|Randomized|Lost to Follow-up|7|||
161766077|NCT00453349|584183055|FG001|Randomized|Lost to Follow-up|5|||
161766078|NCT00453349|584183054|FG000|Randomized|Protocol Violation|1|||
161766079|NCT00453349|584183055|FG001|Randomized|Protocol Violation|1|||
161766080|NCT00453349|584183054|FG000|Randomized|Withdrawal by Subject|3|||
161766081|NCT00453349|584183055|FG001|Randomized|Withdrawal by Subject|5|||
161766082|NCT00453349|584183054|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
161766083|NCT00453349|584183055|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
161766084|NCT00453349|584183054|FG000|Completed Study|Adverse Event|12|||
161766085|NCT00453349|584183055|FG001|Completed Study|Adverse Event|11|||
161766086|NCT00453349|584183054|FG000|Completed Study|Lack of Efficacy|2|||
161766087|NCT00453349|584183055|FG001|Completed Study|Lack of Efficacy|1|||
161766088|NCT00453349|584183054|FG000|Completed Study|Lost to Follow-up|7|||
161766089|NCT00453349|584183055|FG001|Completed Study|Lost to Follow-up|5|||
161766090|NCT00453349|584183054|FG000|Completed Study|Protocol Violation|1|||
161766091|NCT00453349|584183055|FG001|Completed Study|Protocol Violation|1|||
161766092|NCT00453349|584183054|FG000|Completed Study|Withdrawal by Subject|3|||
161766093|NCT00453349|584183055|FG001|Completed Study|Withdrawal by Subject|5|||
161766094|NCT00453349|584183054|FG000|Completed Study|Lost to follow up after study treatment|2|||
161766095|NCT00453349|584183055|FG001|Completed Study|Lost to follow up after study treatment|11|||
161766096|NCT00805142|584183056|FG000|Titration Period|Adverse Event|3|||
161766097|NCT00805142|584183057|FG001|Titration Period|Adverse Event|3|||
161766098|NCT00805142|584183056|FG000|Titration Period|Lack of Efficacy|1|||
161766099|NCT00805142|584183057|FG001|Titration Period|Lack of Efficacy|1|||
161766100|NCT00805142|584183056|FG000|Titration Period|Lost to Follow-up|0|||
161766101|NCT00805142|584183057|FG001|Titration Period|Lost to Follow-up|1|||
161766102|NCT00805142|584183056|FG000|Titration Period|Disease Progression|2|||
161766103|NCT00805142|584183057|FG001|Titration Period|Disease Progression|1|||
161766104|NCT00805142|584183056|FG000|Titration Period|Withdrawal of consent|0|||
161766105|NCT00805142|584183057|FG001|Titration Period|Withdrawal of consent|1|||
161766106|NCT00805142|584183056|FG000|Titration Period|Other|0|||
161766107|NCT00805142|584183057|FG001|Titration Period|Other|3|||
161766108|NCT00805142|584183056|FG000|Maintenance Period|Adverse Event|0|||
161766109|NCT00805142|584183057|FG001|Maintenance Period|Adverse Event|1|||
161766110|NCT00805142|584183056|FG000|Maintenance Period|Other|0|||
161766111|NCT00805142|584183057|FG001|Maintenance Period|Other|1|||
161766112|NCT00422942|584183058|FG000|Overall Study|Study terminated by Sponsor|3|||
161766113|NCT04823494|584184634|FG000|Overall Study|Programming software malfunction.|1|||
161766114|NCT04823494|584184635|FG001|Overall Study|Programming software malfunction.|0|||
161766115|NCT04823494|584184634|FG000|Overall Study|Withdrawal by Subject|1|||
161766116|NCT04823494|584184635|FG001|Overall Study|Withdrawal by Subject|0|||
161766117|NCT04823494|584184634|FG000|Overall Study|Devices lost|0|||
161766118|NCT04823494|584184635|FG001|Overall Study|Devices lost|1|||
161766119|NCT03691831|584184636|FG000|Overall Study|Lost to Follow-up|16|||
161766120|NCT03691831|584184637|FG001|Overall Study|Lost to Follow-up|12|||
161766121|NCT03691831|584184636|FG000|Overall Study|Withdrawal by Subject|9|||
161766122|NCT03691831|584184637|FG001|Overall Study|Withdrawal by Subject|17|||
161766123|NCT03691831|584184636|FG000|Overall Study|Investigator Decision|2|||
161766124|NCT03691831|584184637|FG001|Overall Study|Investigator Decision|2|||
161766125|NCT01884675|584184638|FG000|Overall Study|Study closed/terminated|3|||
161766126|NCT01884675|584184639|FG001|Overall Study|Study closed/terminated|2|||
161766127|NCT01682876|584184642|FG000|Overall Study|Administrative reason|4|||
161766128|NCT01682876|584184643|FG001|Overall Study|Administrative reason|4|||
161766129|NCT01682876|584184644|FG002|Overall Study|Administrative reason|0|||
161853493|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Death|0|||
161766130|NCT01682876|584184645|FG003|Overall Study|Administrative reason|3|||
161766131|NCT01682876|584184642|FG000|Overall Study|Adverse Event|0|||
161766132|NCT01682876|584184643|FG001|Overall Study|Adverse Event|0|||
161766133|NCT01682876|584184644|FG002|Overall Study|Adverse Event|0|||
161766134|NCT01682876|584184645|FG003|Overall Study|Adverse Event|1|||
161766135|NCT01682876|584184642|FG000|Overall Study|Lost to Follow-up|11|||
161766136|NCT01682876|584184643|FG001|Overall Study|Lost to Follow-up|15|||
161766137|NCT01682876|584184644|FG002|Overall Study|Lost to Follow-up|9|||
161766138|NCT01682876|584184645|FG003|Overall Study|Lost to Follow-up|11|||
161766139|NCT01682876|584184642|FG000|Overall Study|Protocol Violation|1|||
161766140|NCT01682876|584184643|FG001|Overall Study|Protocol Violation|1|||
161766141|NCT01682876|584184644|FG002|Overall Study|Protocol Violation|1|||
161766142|NCT01682876|584184645|FG003|Overall Study|Protocol Violation|1|||
161766143|NCT01682876|584184642|FG000|Overall Study|Withdrawal by Subject|4|||
161766144|NCT01682876|584184643|FG001|Overall Study|Withdrawal by Subject|0|||
161766145|NCT01682876|584184644|FG002|Overall Study|Withdrawal by Subject|0|||
161766146|NCT01682876|584184645|FG003|Overall Study|Withdrawal by Subject|2|||
161766147|NCT01682876|584184642|FG000|Overall Study|Other|1|||
161766148|NCT01682876|584184643|FG001|Overall Study|Other|0|||
161766149|NCT01682876|584184644|FG002|Overall Study|Other|1|||
161766150|NCT01682876|584184645|FG003|Overall Study|Other|1|||
161766151|NCT04120116|584184646|FG000|Overall Study|Lost to Follow-up|0|||
161766152|NCT04120116|584184647|FG001|Overall Study|Lost to Follow-up|1|||
161766153|NCT04120116|584184648|FG002|Overall Study|Lost to Follow-up|0|||
161766154|NCT04120116|584184649|FG003|Overall Study|Lost to Follow-up|2|||
161766155|NCT04120116|584184646|FG000|Overall Study|Withdrawal by Subject|1|||
161766156|NCT04120116|584184647|FG001|Overall Study|Withdrawal by Subject|0|||
161766157|NCT04120116|584184648|FG002|Overall Study|Withdrawal by Subject|1|||
161766158|NCT04120116|584184649|FG003|Overall Study|Withdrawal by Subject|1|||
161766159|NCT04120116|584184646|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161766160|NCT04120116|584184647|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161766161|NCT04120116|584184648|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
161766162|NCT04120116|584184649|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161766163|NCT02210559|584184654|FG000|Overall Study|Progressive Disease|3|||
161766164|NCT02210559|584184655|FG001|Overall Study|Progressive Disease|2|||
161766165|NCT02210559|584184654|FG000|Overall Study|Adverse Event|2|||
161766166|NCT02210559|584184655|FG001|Overall Study|Adverse Event|2|||
161766167|NCT02210559|584184654|FG000|Overall Study|Physician Decision|1|||
161766168|NCT02210559|584184655|FG001|Overall Study|Physician Decision|0|||
161766169|NCT02210559|584184654|FG000|Overall Study|Withdrawal by Subject|0|||
161766170|NCT02210559|584184655|FG001|Overall Study|Withdrawal by Subject|1|||
161766171|NCT02210559|584184654|FG000|Overall Study|Other than specified|0|||
161766172|NCT02210559|584184655|FG001|Overall Study|Other than specified|1|||
161766173|NCT02546193|584184656|FG000|Overall Study|Withdrawal by Subject|2|||
161766174|NCT02546193|584184657|FG001|Overall Study|Withdrawal by Subject|0|||
161766175|NCT02546193|584184658|FG002|Overall Study|Withdrawal by Subject|1|||
161766176|NCT02546193|584184659|FG003|Overall Study|Withdrawal by Subject|0|||
161766177|NCT02546193|584184656|FG000|Overall Study|Not eligible at time of induction|4|||
161766178|NCT02546193|584184657|FG001|Overall Study|Not eligible at time of induction|6|||
161766179|NCT02546193|584184658|FG002|Overall Study|Not eligible at time of induction|1|||
161766180|NCT02546193|584184659|FG003|Overall Study|Not eligible at time of induction|0|||
161766181|NCT00792467|584184660|FG000|Overall Study|progression of disease|17|||
161766182|NCT00792467|584184660|FG000|Overall Study|Adverse Event|1|||
161766183|NCT00792467|584184660|FG000|Overall Study|patient request|1|||
161766184|NCT00792467|584184660|FG000|Overall Study|Lost to Follow-up|1|||
161766185|NCT00792467|584184660|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
161766186|NCT00792467|584184660|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
161766187|NCT01287403|584184664|FG000|1st Intervention (1 Day)|Adverse Event|1|||
161766188|NCT01098266|584184665|FG000|Overall Study|Physician Decision|1|||
161766189|NCT01098266|584184666|FG001|Overall Study|Physician Decision|0|||
161766190|NCT01098266|584184665|FG000|Overall Study|Death|3|||
161766191|NCT01098266|584184666|FG001|Overall Study|Death|2|||
161766192|NCT01098266|584184665|FG000|Overall Study|Withdrawal by Subject|3|||
161766193|NCT01098266|584184666|FG001|Overall Study|Withdrawal by Subject|5|||
161766194|NCT00438815|584184667|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
161766195|NCT00438815|584184667|FG000|Overall Study|3-month follow-up no longer required|12|||
161766196|NCT00438815|584184667|FG000|Overall Study|Noncompliance with protocol requirements|9|||
161766197|NCT00438815|584184667|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
161766198|NCT00438815|584184667|FG000|Overall Study|Lost to Follow-up|6|||
161766199|NCT00438815|584184667|FG000|Overall Study|Withdrawal by Subject|6|||
161766200|NCT00438815|584184667|FG000|Overall Study|Death|1|||
161766201|NCT01733758|584184668|FG000|Overall Study|Adverse Event|5|||
161766202|NCT01733758|584184669|FG001|Overall Study|Adverse Event|7|||
161766203|NCT01733758|584184670|FG002|Overall Study|Adverse Event|8|||
161766204|NCT01733758|584184671|FG003|Overall Study|Adverse Event|1|||
161766205|NCT01733758|584184668|FG000|Overall Study|Withdrawal by Subject|1|||
161766206|NCT01733758|584184669|FG001|Overall Study|Withdrawal by Subject|1|||
161766207|NCT01733758|584184670|FG002|Overall Study|Withdrawal by Subject|5|||
161766208|NCT01733758|584184671|FG003|Overall Study|Withdrawal by Subject|3|||
161766209|NCT01733758|584184668|FG000|Overall Study|Persistent Hyperglycemia|3|||
161766210|NCT01733758|584184669|FG001|Overall Study|Persistent Hyperglycemia|2|||
161766211|NCT01733758|584184670|FG002|Overall Study|Persistent Hyperglycemia|0|||
161766212|NCT01733758|584184671|FG003|Overall Study|Persistent Hyperglycemia|0|||
161766213|NCT01733758|584184668|FG000|Overall Study|Protocol Violation|0|||
161766214|NCT01733758|584184669|FG001|Overall Study|Protocol Violation|1|||
161853494|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
161853495|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
161853496|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
161853497|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
161853498|NCT00371033|584506202|FG000|Overall Study|Lost to Follow-up|3|||
161853499|NCT00371033|584506203|FG001|Overall Study|Lost to Follow-up|2|||
161853500|NCT00371033|584506202|FG000|Overall Study|No longer interested|2|||
161853501|NCT00371033|584506203|FG001|Overall Study|No longer interested|0|||
161853502|NCT00371033|584506202|FG000|Overall Study|Uknown|3|||
161853503|NCT00371033|584506203|FG001|Overall Study|Uknown|1|||
161853504|NCT03130777|584506207|FG000|Overall Study|Death|0|||
161853505|NCT03130777|584506208|FG001|Overall Study|Death|1|||
161853506|NCT03130777|584506207|FG000|Overall Study|Did not meet eligibility criteria|1|||
161853507|NCT03130777|584506208|FG001|Overall Study|Did not meet eligibility criteria|0|||
161853508|NCT05929651|584506212|FG000|Overall Study|Protocol Deviation|1|||
161853509|NCT05929651|584506212|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
161853510|NCT05026177|584506213|FG000|Overall Study|Adverse Event|33|||
161853511|NCT05026177|584506214|FG001|Overall Study|Adverse Event|33|||
161853512|NCT05026177|584506215|FG002|Overall Study|Adverse Event|17|||
161853513|NCT05026177|584506213|FG000|Overall Study|Lost to Follow-up|7|||
161853514|NCT05026177|584506214|FG001|Overall Study|Lost to Follow-up|6|||
161853515|NCT05026177|584506215|FG002|Overall Study|Lost to Follow-up|8|||
161853516|NCT05026177|584506213|FG000|Overall Study|Noncompliance with study drug|6|||
161853517|NCT05026177|584506214|FG001|Overall Study|Noncompliance with study drug|2|||
161853518|NCT05026177|584506215|FG002|Overall Study|Noncompliance with study drug|1|||
161853519|NCT05026177|584506213|FG000|Overall Study|Physician Decision|4|||
161853520|NCT05026177|584506214|FG001|Overall Study|Physician Decision|1|||
161853521|NCT05026177|584506215|FG002|Overall Study|Physician Decision|0|||
161853522|NCT05026177|584506213|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
161853523|NCT05026177|584506214|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
161853524|NCT05026177|584506215|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
161853525|NCT05026177|584506213|FG000|Overall Study|Withdrawal by Subject|53|||
161853526|NCT05026177|584506214|FG001|Overall Study|Withdrawal by Subject|51|||
161853527|NCT05026177|584506215|FG002|Overall Study|Withdrawal by Subject|55|||
161853528|NCT05026177|584506213|FG000|Overall Study|Protocol Violation|0|||
161853529|NCT05026177|584506214|FG001|Overall Study|Protocol Violation|1|||
161853530|NCT05026177|584506215|FG002|Overall Study|Protocol Violation|0|||
161853531|NCT05026177|584506213|FG000|Overall Study|Study terminated by sponsor|70|||
161853532|NCT05026177|584506214|FG001|Overall Study|Study terminated by sponsor|74|||
161853533|NCT05026177|584506215|FG002|Overall Study|Study terminated by sponsor|67|||
161853534|NCT05026177|584506213|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
161853535|NCT05026177|584506214|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
161853536|NCT05026177|584506215|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
161853537|NCT05026177|584506213|FG000|Overall Study|Starting alternative treatment|0|||
161853538|NCT05026177|584506214|FG001|Overall Study|Starting alternative treatment|1|||
161853539|NCT05026177|584506215|FG002|Overall Study|Starting alternative treatment|1|||
161853540|NCT05026177|584506213|FG000|Overall Study|Noncompliance with study procedures|0|||
161853541|NCT05026177|584506214|FG001|Overall Study|Noncompliance with study procedures|1|||
161853542|NCT05026177|584506215|FG002|Overall Study|Noncompliance with study procedures|1|||
161853543|NCT05026177|584506213|FG000|Overall Study|Met stopping criteria|0|||
161853544|NCT05026177|584506214|FG001|Overall Study|Met stopping criteria|0|||
161853545|NCT05026177|584506215|FG002|Overall Study|Met stopping criteria|1|||
161853546|NCT05026177|584506213|FG000|Overall Study|Health issues preventing continuation|0|||
161853547|NCT05026177|584506214|FG001|Overall Study|Health issues preventing continuation|0|||
161853548|NCT05026177|584506215|FG002|Overall Study|Health issues preventing continuation|1|||
161853549|NCT05026177|584506213|FG000|Overall Study|Randomized in error, not treated|0|||
161853550|NCT05026177|584506214|FG001|Overall Study|Randomized in error, not treated|0|||
161853551|NCT05026177|584506215|FG002|Overall Study|Randomized in error, not treated|2|||
161853552|NCT05109611|584506218|FG000|Overall Study|Adverse Event|13|||
161853553|NCT05109611|584506219|FG001|Overall Study|Adverse Event|10|||
161853554|NCT05109611|584506218|FG000|Overall Study|Withdrawal by Subject|1|||
161853555|NCT05109611|584506219|FG001|Overall Study|Withdrawal by Subject|0|||
161853556|NCT05109611|584506218|FG000|Overall Study|Lost to Follow-up|1|||
161853557|NCT05109611|584506219|FG001|Overall Study|Lost to Follow-up|2|||
161853558|NCT05109611|584506218|FG000|Overall Study|Protocol Violation|0|||
161853559|NCT05109611|584506219|FG001|Overall Study|Protocol Violation|4|||
161853560|NCT05109611|584506218|FG000|Overall Study|Information unavailable|1|||
161853561|NCT05109611|584506219|FG001|Overall Study|Information unavailable|1|||
161853562|NCT03203850|584506223|FG000|Overall Study|Subject/guardian decision|4|||
161766215|NCT01733758|584184670|FG002|Overall Study|Protocol Violation|2|||
161766216|NCT01733758|584184671|FG003|Overall Study|Protocol Violation|2|||
161766217|NCT01733758|584184668|FG000|Overall Study|Non-compliance|1|||
161766218|NCT01733758|584184669|FG001|Overall Study|Non-compliance|0|||
161766219|NCT01733758|584184670|FG002|Overall Study|Non-compliance|0|||
161766220|NCT01733758|584184671|FG003|Overall Study|Non-compliance|0|||
161766221|NCT01733758|584184668|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
161766222|NCT01733758|584184669|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
161766223|NCT01733758|584184670|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
161766224|NCT01733758|584184671|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
161766225|NCT01733758|584184668|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
161766226|NCT01733758|584184669|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
161766227|NCT01733758|584184670|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
161766228|NCT01733758|584184671|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
161766229|NCT02545270|584184676|FG000|Overall Study|technical difficulties|0|||
161766230|NCT02545270|584184677|FG001|Overall Study|technical difficulties|1|||
161766231|NCT02545270|584184678|FG002|Overall Study|technical difficulties|0|||
161766232|NCT02545270|584184676|FG000|Overall Study|Videos being too similar to other|0|||
161766233|NCT02545270|584184677|FG001|Overall Study|Videos being too similar to other|0|||
161766234|NCT02545270|584184678|FG002|Overall Study|Videos being too similar to other|2|||
161766235|NCT00727246|584184679|FG000|Overall Study|could not complete MRI|0|||
161853563|NCT03203850|584506224|FG001|Overall Study|Subject/guardian decision|3|||
161853564|NCT03203850|584506223|FG000|Overall Study|Adverse Event|3|||
161853565|NCT03203850|584506224|FG001|Overall Study|Adverse Event|0|||
161853566|NCT03203850|584506223|FG000|Overall Study|Death|1|||
161853567|NCT03203850|584506224|FG001|Overall Study|Death|0|||
161853568|NCT02717455|584506225|FG000|Overall Study|Adverse Event|1|||
161853569|NCT02717455|584506226|FG001|Overall Study|Adverse Event|0|||
161853570|NCT02717455|584506227|FG002|Overall Study|Adverse Event|0|||
161853571|NCT02717455|584506228|FG003|Overall Study|Adverse Event|2|||
161853572|NCT02717455|584506229|FG004|Overall Study|Adverse Event|2|||
161853573|NCT02717455|584506230|FG005|Overall Study|Adverse Event|2|||
161853574|NCT02717455|584506225|FG000|Overall Study|Withdrawal by Subject|1|||
161853575|NCT02717455|584506226|FG001|Overall Study|Withdrawal by Subject|1|||
161853576|NCT02717455|584506227|FG002|Overall Study|Withdrawal by Subject|0|||
161853577|NCT02717455|584506228|FG003|Overall Study|Withdrawal by Subject|2|||
161853578|NCT02717455|584506229|FG004|Overall Study|Withdrawal by Subject|2|||
161853579|NCT02717455|584506230|FG005|Overall Study|Withdrawal by Subject|1|||
161853580|NCT02717455|584506225|FG000|Overall Study|Death|1|||
161766236|NCT00727246|584184680|FG001|Overall Study|could not complete MRI|1|||
161766237|NCT00727246|584184681|FG002|Overall Study|could not complete MRI|0|||
161766238|NCT00727246|584184682|FG003|Overall Study|could not complete MRI|1|||
161766239|NCT00727246|584184679|FG000|Overall Study|incidental finding|0|||
161766240|NCT00727246|584184680|FG001|Overall Study|incidental finding|0|||
161766241|NCT00727246|584184681|FG002|Overall Study|incidental finding|0|||
161766242|NCT00727246|584184682|FG003|Overall Study|incidental finding|1|||
161766243|NCT00727246|584184679|FG000|Overall Study|withdrawn|0|||
161766244|NCT00727246|584184680|FG001|Overall Study|withdrawn|0|||
161766245|NCT00727246|584184681|FG002|Overall Study|withdrawn|1|||
161766246|NCT00727246|584184682|FG003|Overall Study|withdrawn|0|||
161766247|NCT00661362|584184683|FG000|Overall Study|Adverse Event|5|||
161766248|NCT00661362|584184684|FG001|Overall Study|Adverse Event|4|||
161766249|NCT00661362|584184683|FG000|Overall Study|Incorrect enrollment|2|||
161766250|NCT00661362|584184684|FG001|Overall Study|Incorrect enrollment|0|||
161766251|NCT00661362|584184683|FG000|Overall Study|Study specific discontinuation criteria|4|||
161766252|NCT00661362|584184684|FG001|Overall Study|Study specific discontinuation criteria|11|||
161766253|NCT00661362|584184683|FG000|Overall Study|Withdrawal by Subject|13|||
161766254|NCT00661362|584184684|FG001|Overall Study|Withdrawal by Subject|23|||
161766255|NCT00661362|584184683|FG000|Overall Study|Lost to Follow-up|3|||
161766256|NCT00661362|584184684|FG001|Overall Study|Lost to Follow-up|1|||
161766257|NCT00661362|584184683|FG000|Overall Study|Severe non-compliance to protocol|0|||
161766258|NCT00661362|584184684|FG001|Overall Study|Severe non-compliance to protocol|1|||
161766259|NCT00661362|584184683|FG000|Overall Study|Safety reasons|1|||
161766260|NCT00661362|584184684|FG001|Overall Study|Safety reasons|0|||
161766261|NCT00661362|584184683|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
161766262|NCT00661362|584184684|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
161766263|NCT00535262|584184687|FG000|Overall Study|No funding|3|||
161766264|NCT04382066|584184690|FG000|Overall Study|Adverse Event|1|||
161766265|NCT04382066|584184691|FG001|Overall Study|Adverse Event|0|||
161766266|NCT04382066|584184692|FG002|Overall Study|Adverse Event|0|||
161766267|NCT04382066|584184690|FG000|Overall Study|Death|1|||
161766268|NCT04382066|584184691|FG001|Overall Study|Death|0|||
161766269|NCT04382066|584184692|FG002|Overall Study|Death|1|||
161766270|NCT04738123|584184693|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
161766271|NCT04738123|584184694|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
161766272|NCT04738123|584184693|FG000|Overall Study|Progressive Disease|0|||
161766273|NCT04738123|584184694|FG001|Overall Study|Progressive Disease|4|||
161766274|NCT04738123|584184693|FG000|Overall Study|Adverse Event|8|||
161766275|NCT04738123|584184694|FG001|Overall Study|Adverse Event|7|||
161766276|NCT04738123|584184693|FG000|Overall Study|Other Reasons|0|||
161766277|NCT04738123|584184694|FG001|Overall Study|Other Reasons|1|||
161766278|NCT04738123|584184693|FG000|Overall Study|Suicidal or assaultive behavior|0|||
161853581|NCT02717455|584506226|FG001|Overall Study|Death|0|||
161766279|NCT04738123|584184694|FG001|Overall Study|Suicidal or assaultive behavior|2|||
161766280|NCT04738123|584184693|FG000|Overall Study|Protocol Violation|2|||
161853582|NCT02717455|584506227|FG002|Overall Study|Death|0|||
161853583|NCT02717455|584506228|FG003|Overall Study|Death|0|||
161853584|NCT02717455|584506229|FG004|Overall Study|Death|1|||
161853585|NCT02717455|584506230|FG005|Overall Study|Death|0|||
161853586|NCT02717455|584506225|FG000|Overall Study|Did not receive study drug|0|||
161853587|NCT02717455|584506226|FG001|Overall Study|Did not receive study drug|0|||
161766281|NCT04738123|584184694|FG001|Overall Study|Protocol Violation|2|||
161766282|NCT04738123|584184693|FG000|Overall Study|Consent Withdrawn|35|||
161766283|NCT04738123|584184694|FG001|Overall Study|Consent Withdrawn|22|||
161766284|NCT00779506|584184695|FG000|Overall Study|Screening Failed|2|||
161766285|NCT00779506|584184695|FG000|Overall Study|Adverse Event|4|||
161853588|NCT02717455|584506227|FG002|Overall Study|Did not receive study drug|0|||
161853589|NCT02717455|584506228|FG003|Overall Study|Did not receive study drug|1|||
161853590|NCT02717455|584506229|FG004|Overall Study|Did not receive study drug|0|||
161853591|NCT02717455|584506230|FG005|Overall Study|Did not receive study drug|1|||
161853592|NCT02717455|584506225|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853593|NCT02717455|584506226|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853594|NCT02717455|584506227|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853595|NCT02717455|584506228|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853596|NCT02717455|584506229|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853597|NCT02717455|584506230|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
161853598|NCT02717455|584506225|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
161853599|NCT02717455|584506226|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
161853600|NCT02717455|584506227|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
161853601|NCT02717455|584506228|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
161853602|NCT02717455|584506229|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
161853603|NCT02717455|584506230|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
161853604|NCT01433055|584506231|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
161853605|NCT01433055|584506232|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
161853606|NCT01433055|584506231|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
161853607|NCT01433055|584506232|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
161853608|NCT00733005|584506238|FG000|Overall Study|Adverse Event|0|||
161853609|NCT00733005|584506239|FG001|Overall Study|Adverse Event|1|||
161853610|NCT00733005|584506238|FG000|Overall Study|Treatment Failure|0|||
161853611|NCT00733005|584506239|FG001|Overall Study|Treatment Failure|1|||
161853612|NCT00733005|584506238|FG000|Overall Study|Withdrawal by Subject|0|||
161853613|NCT00733005|584506239|FG001|Overall Study|Withdrawal by Subject|1|||
161853614|NCT00733005|584506238|FG000|Overall Study|Protocol Violation|2|||
161853615|NCT00733005|584506239|FG001|Overall Study|Protocol Violation|0|||
161853616|NCT01769456|584506240|FG000|Overall Study|Lost to Follow-up|19|||
161853617|NCT01769456|584506240|FG000|Overall Study|Withdrawal by Subject|3|||
161853618|NCT01769456|584506240|FG000|Overall Study|Did not receive PCC intervention|6|||
161853619|NCT01769456|584506240|FG000|Overall Study|Moved out of the area|3|||
161853620|NCT01769456|584506240|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
161853621|NCT01769456|584506240|FG000|Overall Study|Parental request to youth to withdraw|1|||
161853622|NCT05244122|584506247|FG000|Overall Study|Withdrawal by Subject|318|||
161853623|NCT05377749|584506254|FG000|3 Weeks|Lost to Follow-up|2|||
161853624|NCT05377749|584506255|FG001|3 Weeks|Lost to Follow-up|4|||
161853625|NCT05377749|584506254|FG000|3 Weeks|Withdrawal by Subject|1|||
161853626|NCT05377749|584506255|FG001|3 Weeks|Withdrawal by Subject|1|||
161853627|NCT02969382|584506256|FG000|Overall Study|Adverse Event|8|||
161853628|NCT02969382|584506257|FG001|Overall Study|Adverse Event|10|||
161853629|NCT02969382|584506256|FG000|Overall Study|Lack of Efficacy|4|||
161853630|NCT02969382|584506257|FG001|Overall Study|Lack of Efficacy|5|||
161853631|NCT02969382|584506256|FG000|Overall Study|Death|0|||
161853632|NCT02969382|584506257|FG001|Overall Study|Death|1|||
161853633|NCT02969382|584506256|FG000|Overall Study|PROTOCOL DEVIATION|0|||
161853634|NCT02969382|584506257|FG001|Overall Study|PROTOCOL DEVIATION|1|||
161853635|NCT02969382|584506256|FG000|Overall Study|Withdrawal by Subject|14|||
161853636|NCT02969382|584506257|FG001|Overall Study|Withdrawal by Subject|9|||
161853637|NCT02090725|584506258|FG000|Overall Study|Withdrawal by Subject|1|||
161853638|NCT02090725|584506258|FG000|Overall Study|participants moved from area|3|||
161853639|NCT05256134|584506261|FG000|Overall Study|Study Terminated by Sponsor|11|||
161853640|NCT05256134|584506262|FG001|Overall Study|Study Terminated by Sponsor|10|||
161853641|NCT05256134|584506261|FG000|Overall Study|Withdrawal by Subject|1|||
161853642|NCT05256134|584506262|FG001|Overall Study|Withdrawal by Subject|3|||
161853643|NCT00886015|584506269|FG000|Overall Study|Death|0|||
161853644|NCT00886015|584506270|FG001|Overall Study|Death|2|||
161853645|NCT02013817|584506271|FG000|Overall Study|Adverse Event|12|||
161853646|NCT02013817|584506271|FG000|Overall Study|Withdrawal by Subject|4|||
161853647|NCT02013817|584506271|FG000|Overall Study|Death|2|||
161853648|NCT02013817|584506271|FG000|Overall Study|Other|9|||
161853649|NCT01692626|584506272|FG000|Overall Study|Death|0|||
161853650|NCT01692626|584506273|FG001|Overall Study|Death|1|||
161853651|NCT01692626|584506272|FG000|Overall Study|Adverse Event|2|||
161853652|NCT01692626|584506273|FG001|Overall Study|Adverse Event|3|||
161853653|NCT01692626|584506272|FG000|Overall Study|Protocol Violation|1|||
161853654|NCT01692626|584506273|FG001|Overall Study|Protocol Violation|2|||
161853655|NCT01692626|584506272|FG000|Overall Study|Withdrawal by Subject|1|||
161853656|NCT01692626|584506273|FG001|Overall Study|Withdrawal by Subject|0|||
161853657|NCT00855894|584506274|FG000|Overall Study|Death|31|||
161853658|NCT00855894|584506274|FG000|Overall Study|Patient's decision|1|||
161853659|NCT00855894|584506274|FG000|Overall Study|Disease progression|1|||
161853660|NCT01145508|584506275|FG000|Overall Study|Adverse Event|1|||
161853661|NCT01145508|584506276|FG001|Overall Study|Adverse Event|0|||
161853662|NCT01145508|584506275|FG000|Overall Study|Death|1|||
161853663|NCT01145508|584506276|FG001|Overall Study|Death|0|||
161853664|NCT01145508|584506275|FG000|Overall Study|Physician Decision|2|||
161853665|NCT01145508|584506276|FG001|Overall Study|Physician Decision|1|||
161853666|NCT01145508|584506275|FG000|Overall Study|Never started treatment|1|||
161853667|NCT01145508|584506276|FG001|Overall Study|Never started treatment|1|||
161853668|NCT01569295|584506289|FG000|Overall Study|Progressive Disease|75|||
161853669|NCT01569295|584506290|FG001|Overall Study|Progressive Disease|139|||
161853670|NCT01569295|584506289|FG000|Overall Study|Adverse Event|39|||
161853671|NCT01569295|584506290|FG001|Overall Study|Adverse Event|14|||
161853672|NCT01569295|584506289|FG000|Overall Study|Withdrawal by Subject|25|||
161853673|NCT01569295|584506290|FG001|Overall Study|Withdrawal by Subject|12|||
161853674|NCT01569295|584506289|FG000|Overall Study|Death|19|||
161853675|NCT01569295|584506290|FG001|Overall Study|Death|15|||
161853676|NCT01569295|584506289|FG000|Overall Study|Physician Decision|13|||
161853677|NCT01569295|584506290|FG001|Overall Study|Physician Decision|18|||
161853678|NCT01569295|584506289|FG000|Overall Study|Study Terminated by Sponsor|24|||
161853679|NCT01569295|584506290|FG001|Overall Study|Study Terminated by Sponsor|2|||
161853680|NCT01569295|584506289|FG000|Overall Study|Other Reason not Specified|3|||
161853681|NCT01569295|584506290|FG001|Overall Study|Other Reason not Specified|5|||
161853682|NCT01569295|584506289|FG000|Overall Study|Non-Compliance with Study Drug|6|||
161853683|NCT01569295|584506290|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161853684|NCT01569295|584506289|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
161853685|NCT01569295|584506290|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
161853686|NCT01569295|584506289|FG000|Overall Study|Lost to Follow-up|1|||
161853687|NCT01569295|584506290|FG001|Overall Study|Lost to Follow-up|1|||
161853688|NCT00280735|584506291|FG000|Overall Study|Adverse Event|5|||
161853689|NCT00280735|584506291|FG000|Overall Study|Lack of Efficacy|3|||
161853690|NCT00280735|584506291|FG000|Overall Study|Withdrawal by Subject|8|||
161853691|NCT00280735|584506291|FG000|Overall Study|Intercurrent Illness|2|||
161853692|NCT02064296|584506295|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
161853693|NCT02064296|584506296|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
161853694|NCT02064296|584506297|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
161853695|NCT02064296|584506295|FG000|Intervention|Withdrawal by Subject|0|||
161853696|NCT02064296|584506296|FG001|Intervention|Withdrawal by Subject|1|||
161853697|NCT02064296|584506297|FG002|Intervention|Withdrawal by Subject|2|||
161853698|NCT05061420|584506305|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
161853699|NCT05061420|584506306|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161853700|NCT05061420|584506307|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161853701|NCT05061420|584506305|FG000|Overall Study|Progressive disease|11|||
161853702|NCT05061420|584506306|FG001|Overall Study|Progressive disease|15|||
161853703|NCT05061420|584506307|FG002|Overall Study|Progressive disease|14|||
161853704|NCT05061420|584506305|FG000|Overall Study|Withdrawal by Subject|2|||
161853705|NCT05061420|584506306|FG001|Overall Study|Withdrawal by Subject|0|||
161853706|NCT05061420|584506307|FG002|Overall Study|Withdrawal by Subject|1|||
161853707|NCT05061420|584506305|FG000|Overall Study|Not related to COVID-19|2|||
161853708|NCT05061420|584506306|FG001|Overall Study|Not related to COVID-19|0|||
161853709|NCT05061420|584506307|FG002|Overall Study|Not related to COVID-19|0|||
161853710|NCT01814553|584506308|FG000|Overall Study|PD per clinical progression|6|||
161853711|NCT01814553|584506309|FG001|Overall Study|PD per clinical progression|8|||
161853712|NCT01814553|584506308|FG000|Overall Study|Other Adverse Event|4|||
161853713|NCT01814553|584506309|FG001|Overall Study|Other Adverse Event|5|||
161853714|NCT01814553|584506308|FG000|Overall Study|Withdrawal by Subject|1|||
161853715|NCT01814553|584506309|FG001|Overall Study|Withdrawal by Subject|1|||
161853716|NCT01814553|584506308|FG000|Overall Study|Other than stated|7|||
161853717|NCT01814553|584506309|FG001|Overall Study|Other than stated|8|||
161853718|NCT03138655|584506313|FG000|Overall Study|Adverse Event|2|||
161853719|NCT03138655|584506314|FG001|Overall Study|Adverse Event|1|||
161853720|NCT03138655|584506315|FG002|Overall Study|Adverse Event|2|||
161853721|NCT03138655|584506316|FG003|Overall Study|Adverse Event|1|||
161853722|NCT03138655|584506317|FG004|Overall Study|Adverse Event|1|||
161853723|NCT03138655|584506318|FG005|Overall Study|Adverse Event|4|||
161853724|NCT03138655|584506319|FG006|Overall Study|Adverse Event|2|||
161853725|NCT03138655|584506320|FG007|Overall Study|Adverse Event|2|||
161853726|NCT03138655|584506313|FG000|Overall Study|Withdrawal by Subject|0|||
161853727|NCT03138655|584506314|FG001|Overall Study|Withdrawal by Subject|1|||
161853728|NCT03138655|584506315|FG002|Overall Study|Withdrawal by Subject|0|||
161853729|NCT03138655|584506316|FG003|Overall Study|Withdrawal by Subject|0|||
161853730|NCT03138655|584506317|FG004|Overall Study|Withdrawal by Subject|0|||
161853731|NCT03138655|584506318|FG005|Overall Study|Withdrawal by Subject|0|||
161853732|NCT03138655|584506319|FG006|Overall Study|Withdrawal by Subject|1|||
161853733|NCT03138655|584506320|FG007|Overall Study|Withdrawal by Subject|0|||
161853734|NCT03138655|584506313|FG000|Overall Study|Reason not Specified|1|||
161853735|NCT03138655|584506314|FG001|Overall Study|Reason not Specified|0|||
161853736|NCT03138655|584506315|FG002|Overall Study|Reason not Specified|0|||
161853737|NCT03138655|584506316|FG003|Overall Study|Reason not Specified|2|||
161853738|NCT03138655|584506317|FG004|Overall Study|Reason not Specified|1|||
161853739|NCT03138655|584506318|FG005|Overall Study|Reason not Specified|1|||
161853740|NCT03138655|584506319|FG006|Overall Study|Reason not Specified|0|||
161853741|NCT03138655|584506320|FG007|Overall Study|Reason not Specified|0|||
161853742|NCT04036110|584506326|FG000|Overall Study|Lost to Follow-up|3|||
161853743|NCT04036110|584506327|FG001|Overall Study|Lost to Follow-up|2|||
161853744|NCT04036110|584506328|FG002|Overall Study|Lost to Follow-up|1|||
161853745|NCT04036110|584506326|FG000|Overall Study|Study Suspended|4|||
161853746|NCT04036110|584506327|FG001|Overall Study|Study Suspended|5|||
161853747|NCT04036110|584506328|FG002|Overall Study|Study Suspended|1|||
161853748|NCT00534404|584506331|FG000|Overall Study|Death|0|||
161853749|NCT00534404|584506332|FG001|Overall Study|Death|0|||
161853750|NCT00534404|584506333|FG002|Overall Study|Death|2|||
161853751|NCT00534404|584506331|FG000|Overall Study|Withdrawal by Subject|8|||
161853752|NCT00534404|584506332|FG001|Overall Study|Withdrawal by Subject|2|||
161853753|NCT00534404|584506333|FG002|Overall Study|Withdrawal by Subject|38|||
161853754|NCT00534404|584506331|FG000|Overall Study|Removed by study staff|2|||
161853755|NCT00534404|584506332|FG001|Overall Study|Removed by study staff|3|||
161853756|NCT00534404|584506333|FG002|Overall Study|Removed by study staff|1|||
161853757|NCT00534404|584506331|FG000|Overall Study|Lost to Follow-up|170|||
161853758|NCT00534404|584506332|FG001|Overall Study|Lost to Follow-up|138|||
161853759|NCT00534404|584506333|FG002|Overall Study|Lost to Follow-up|201|||
161853760|NCT04759768|584506334|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161853761|NCT04759768|584506335|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161853762|NCT04759768|584506334|FG000|Washout (7 Days)|Physician Decision|0|||
161853763|NCT04759768|584506335|FG001|Washout (7 Days)|Physician Decision|1|||
161853764|NCT02996487|584506336|FG000|Overall Study|Lost to Follow-up|1|||
161853765|NCT02996487|584506337|FG001|Overall Study|Lost to Follow-up|1|||
161853766|NCT02996487|584506338|FG002|Overall Study|Lost to Follow-up|0|||
161853767|NCT02996487|584506336|FG000|Overall Study|Death|0|||
161853768|NCT02996487|584506337|FG001|Overall Study|Death|1|||
161853769|NCT02996487|584506338|FG002|Overall Study|Death|0|||
161853770|NCT02996487|584506336|FG000|Overall Study|Withdrawal by Subject|2|||
161853771|NCT02996487|584506337|FG001|Overall Study|Withdrawal by Subject|3|||
161853772|NCT02996487|584506338|FG002|Overall Study|Withdrawal by Subject|0|||
161853773|NCT02800642|584506339|FG000|Overall Study|Death|3|||
161853774|NCT02800642|584506339|FG000|Overall Study|Other|10|||
161853775|NCT02800642|584506339|FG000|Overall Study|Physician Decision|2|||
161853776|NCT02800642|584506339|FG000|Overall Study|Adverse Event|6|||
161853777|NCT02800642|584506339|FG000|Overall Study|Withdrawal by Subject|3|||
161853778|NCT02800642|584506339|FG000|Overall Study|Lost to Follow-up|1|||
161853779|NCT02027428|584506340|FG000|Induction|Never treated|7|||
161853780|NCT02027428|584506341|FG001|Induction|Never treated|0|||
161853781|NCT02027428|584506342|FG002|Induction|Never treated|0|||
161853782|NCT02027428|584506340|FG000|Induction|Progressive disease|77|||
161853783|NCT02027428|584506341|FG001|Induction|Progressive disease|0|||
161853784|NCT02027428|584506342|FG002|Induction|Progressive disease|0|||
161853785|NCT02027428|584506340|FG000|Induction|Adverse Event|51|||
161853786|NCT02027428|584506341|FG001|Induction|Adverse Event|0|||
161853787|NCT02027428|584506342|FG002|Induction|Adverse Event|0|||
161853788|NCT02027428|584506340|FG000|Induction|Withdrawal by Subject|22|||
161853789|NCT02027428|584506341|FG001|Induction|Withdrawal by Subject|0|||
161853790|NCT02027428|584506342|FG002|Induction|Withdrawal by Subject|0|||
161853791|NCT02027428|584506340|FG000|Induction|Death|21|||
161853792|NCT02027428|584506341|FG001|Induction|Death|0|||
161853793|NCT02027428|584506342|FG002|Induction|Death|0|||
161853794|NCT02027428|584506340|FG000|Induction|Symptomatic deterioration|16|||
161853795|NCT02027428|584506341|FG001|Induction|Symptomatic deterioration|0|||
161766286|NCT00779506|584184695|FG000|Overall Study|Lack of Efficacy|11|||
161766287|NCT00779506|584184695|FG000|Overall Study|Protocol Violation|5|||
161766288|NCT00779506|584184695|FG000|Overall Study|Withdrawal by Subject|6|||
161766289|NCT00779506|584184695|FG000|Overall Study|Lost to Follow-up|1|||
161766290|NCT03982069|584184696|FG000|Overall Study|Lost to Follow-up|5|||
161766291|NCT03982069|584184697|FG001|Overall Study|Lost to Follow-up|5|||
161766292|NCT03982069|584184698|FG002|Overall Study|Lost to Follow-up|3|||
161766293|NCT03982069|584184699|FG003|Overall Study|Lost to Follow-up|5|||
161766294|NCT03982069|584184696|FG000|Overall Study|Physician Decision|0|||
161766295|NCT03982069|584184697|FG001|Overall Study|Physician Decision|1|||
161766296|NCT03982069|584184698|FG002|Overall Study|Physician Decision|0|||
161766297|NCT03982069|584184699|FG003|Overall Study|Physician Decision|0|||
161766298|NCT03982069|584184696|FG000|Overall Study|Withdrawal by Subject|2|||
161766299|NCT03982069|584184697|FG001|Overall Study|Withdrawal by Subject|1|||
161766300|NCT03982069|584184698|FG002|Overall Study|Withdrawal by Subject|5|||
161766301|NCT03982069|584184699|FG003|Overall Study|Withdrawal by Subject|2|||
161766302|NCT03982069|584184696|FG000|Overall Study|Specimen loss|3|||
161766303|NCT03982069|584184697|FG001|Overall Study|Specimen loss|3|||
161766304|NCT03982069|584184698|FG002|Overall Study|Specimen loss|1|||
161766305|NCT03982069|584184699|FG003|Overall Study|Specimen loss|1|||
161766306|NCT00787527|584184702|FG000|Overall Study|Toxicity|3|||
161766307|NCT00083616|584184703|FG000|Overall Study|Disease Progression|16|||
161766308|NCT00083616|584184703|FG000|Overall Study|Lost to Follow-up|1|||
161766309|NCT00083616|584184703|FG000|Overall Study|Physician Decision|2|||
161766310|NCT00083616|584184703|FG000|Overall Study|Withdrawal by Subject|3|||
161766311|NCT00083616|584184703|FG000|Overall Study|Ineligibility determined|2|||
161766312|NCT00083616|584184703|FG000|Overall Study|Non-compliance|1|||
161766313|NCT00083616|584184703|FG000|Overall Study|Other|6|||
161766314|NCT00914940|584184704|FG000|D0 to D100 Post-transplant|Death|2|||
161766315|NCT00914940|584184704|FG000|D101 to 2 Years Post-transplant|Death|8|||
161766316|NCT00914940|584184704|FG000|2 Years to 5 Years Post-transplant|Death|3|||
161766317|NCT01724021|584184705|FG000|Overall Study|Adverse Event|11|||
161766318|NCT01724021|584184706|FG001|Overall Study|Adverse Event|6|||
161766319|NCT01724021|584184705|FG000|Overall Study|Death|46|||
161766320|NCT01724021|584184706|FG001|Overall Study|Death|58|||
161766321|NCT01724021|584184705|FG000|Overall Study|Participant request/ Withdrew consent|18|||
161766322|NCT01724021|584184706|FG001|Overall Study|Participant request/ Withdrew consent|14|||
161766323|NCT01724021|584184705|FG000|Overall Study|Lost to Follow-up|15|||
161766324|NCT01724021|584184706|FG001|Overall Study|Lost to Follow-up|15|||
161766325|NCT01724021|584184705|FG000|Overall Study|Reason Not Specified|36|||
161766326|NCT01724021|584184706|FG001|Overall Study|Reason Not Specified|39|||
161766327|NCT01724021|584184705|FG000|Overall Study|Missing|1|||
161766328|NCT01724021|584184706|FG001|Overall Study|Missing|1|||
161766329|NCT02500706|584184709|FG000|Overall Study|Adverse Event|0|||
161766330|NCT02500706|584184710|FG001|Overall Study|Adverse Event|0|||
161766331|NCT02500706|584184711|FG002|Overall Study|Adverse Event|1|||
161766332|NCT02500706|584184709|FG000|Overall Study|Lost to Follow-up|0|||
161766333|NCT02500706|584184710|FG001|Overall Study|Lost to Follow-up|1|||
161766334|NCT02500706|584184711|FG002|Overall Study|Lost to Follow-up|1|||
161766335|NCT02500706|584184709|FG000|Overall Study|Withdrawal by Subject|4|||
161766336|NCT02500706|584184710|FG001|Overall Study|Withdrawal by Subject|6|||
161766337|NCT02500706|584184711|FG002|Overall Study|Withdrawal by Subject|4|||
161766338|NCT02500706|584184709|FG000|Overall Study|Unclassified|0|||
161766339|NCT02500706|584184710|FG001|Overall Study|Unclassified|0|||
161766340|NCT02500706|584184711|FG002|Overall Study|Unclassified|1|||
161766341|NCT03644173|584184714|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
161766342|NCT03644173|584184714|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
161766343|NCT03644173|584184714|FG000|Participants at the 1-month Follow up|Death|2|||
161766344|NCT03644173|584184714|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
161766345|NCT03323385|584184715|FG000|Overall Study|Withdrawal by Subject|1|||
161766346|NCT03323385|584184716|FG001|Overall Study|Withdrawal by Subject|2|||
161766347|NCT03323385|584184715|FG000|Overall Study|Noncompliance|0|||
161766348|NCT03323385|584184716|FG001|Overall Study|Noncompliance|1|||
161766349|NCT01000311|584184721|FG000|Overall Study|Adverse Event|2|||
161766350|NCT01000311|584184722|FG001|Overall Study|Adverse Event|5|||
161766351|NCT01000311|584184721|FG000|Overall Study|Withdrawal by Subject|16|||
161766352|NCT01000311|584184722|FG001|Overall Study|Withdrawal by Subject|24|||
161766353|NCT01000311|584184721|FG000|Overall Study|Lost to Follow-up|15|||
161766354|NCT01000311|584184722|FG001|Overall Study|Lost to Follow-up|24|||
161766355|NCT01000311|584184721|FG000|Overall Study|Protocol Violation|1|||
161766356|NCT01000311|584184722|FG001|Overall Study|Protocol Violation|2|||
161766357|NCT01000311|584184721|FG000|Overall Study|Inappropriate enrollment|2|||
161766358|NCT01000311|584184722|FG001|Overall Study|Inappropriate enrollment|0|||
161766359|NCT01000311|584184721|FG000|Overall Study|Administrative reason|9|||
161766360|NCT01000311|584184722|FG001|Overall Study|Administrative reason|15|||
161766361|NCT00819052|584184723|FG000|Overall Study|Adverse Event|0|||
161766362|NCT00819052|584184724|FG001|Overall Study|Adverse Event|5|||
161766363|NCT00819052|584184723|FG000|Overall Study|Protocol Violation|1|||
161766364|NCT00819052|584184724|FG001|Overall Study|Protocol Violation|2|||
161766365|NCT00819052|584184723|FG000|Overall Study|Lost to Follow-up|1|||
161766366|NCT00819052|584184724|FG001|Overall Study|Lost to Follow-up|2|||
161766367|NCT00819052|584184723|FG000|Overall Study|Withdrawal by Subject|1|||
161766368|NCT00819052|584184724|FG001|Overall Study|Withdrawal by Subject|2|||
161766369|NCT00819052|584184723|FG000|Overall Study|Lack of Efficacy|1|||
161766370|NCT00819052|584184724|FG001|Overall Study|Lack of Efficacy|1|||
161766371|NCT00819052|584184723|FG000|Overall Study|Pregnancy|1|||
161766372|NCT00819052|584184724|FG001|Overall Study|Pregnancy|2|||
161766373|NCT00819052|584184723|FG000|Overall Study|Death or events leading to death|1|||
161766374|NCT00819052|584184724|FG001|Overall Study|Death or events leading to death|0|||
161766375|NCT00362297|584184725|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
161766376|NCT00362297|584184726|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
161766377|NCT00982111|584184731|FG000|Overall Study|Adverse Event|1|||
161766378|NCT00982111|584184732|FG001|Overall Study|Adverse Event|1|||
161853796|NCT02027428|584506342|FG002|Induction|Symptomatic deterioration|0|||
161853797|NCT02027428|584506340|FG000|Induction|Study terminated by sponsor|12|||
161853798|NCT02027428|584506341|FG001|Induction|Study terminated by sponsor|0|||
161853799|NCT02027428|584506342|FG002|Induction|Study terminated by sponsor|0|||
161853800|NCT02027428|584506340|FG000|Induction|Protocol Violation|1|||
161853801|NCT02027428|584506341|FG001|Induction|Protocol Violation|0|||
161853802|NCT02027428|584506342|FG002|Induction|Protocol Violation|0|||
161853803|NCT02027428|584506340|FG000|Induction|Miscellaneous|14|||
161853804|NCT02027428|584506341|FG001|Induction|Miscellaneous|0|||
161853805|NCT02027428|584506342|FG002|Induction|Miscellaneous|0|||
161853806|NCT02027428|584506340|FG000|Induction|Induction Treatment Ongoing|4|||
161853807|NCT02027428|584506341|FG001|Induction|Induction Treatment Ongoing|0|||
161853808|NCT02027428|584506342|FG002|Induction|Induction Treatment Ongoing|0|||
161853809|NCT02027428|584506340|FG000|Maintenance|Death|0|||
161853810|NCT02027428|584506341|FG001|Maintenance|Death|3|||
161853811|NCT02027428|584506342|FG002|Maintenance|Death|2|||
161853812|NCT02027428|584506340|FG000|Maintenance|Adverse Event|0|||
161853813|NCT02027428|584506341|FG001|Maintenance|Adverse Event|21|||
161853814|NCT02027428|584506342|FG002|Maintenance|Adverse Event|1|||
161853815|NCT02027428|584506340|FG000|Maintenance|Progressive disease|0|||
161853816|NCT02027428|584506341|FG001|Maintenance|Progressive disease|84|||
161853817|NCT02027428|584506342|FG002|Maintenance|Progressive disease|47|||
161853818|NCT02027428|584506340|FG000|Maintenance|Symptomatic deterioration|0|||
161853819|NCT02027428|584506341|FG001|Maintenance|Symptomatic deterioration|4|||
161853820|NCT02027428|584506342|FG002|Maintenance|Symptomatic deterioration|1|||
161853821|NCT02027428|584506340|FG000|Maintenance|Withdrawal by Subject|0|||
161853822|NCT02027428|584506341|FG001|Maintenance|Withdrawal by Subject|6|||
161853823|NCT02027428|584506342|FG002|Maintenance|Withdrawal by Subject|5|||
161853824|NCT02027428|584506340|FG000|Maintenance|Protocol Violation|0|||
161853825|NCT02027428|584506341|FG001|Maintenance|Protocol Violation|0|||
161853826|NCT02027428|584506342|FG002|Maintenance|Protocol Violation|1|||
161853827|NCT02027428|584506340|FG000|Maintenance|Other|0|||
161853828|NCT02027428|584506341|FG001|Maintenance|Other|6|||
161853829|NCT02027428|584506342|FG002|Maintenance|Other|3|||
161853830|NCT02027428|584506340|FG000|Survival Follow-up|Death|0|||
161853831|NCT02027428|584506341|FG001|Survival Follow-up|Death|78|||
161853832|NCT02027428|584506342|FG002|Survival Follow-up|Death|45|||
161853833|NCT02027428|584506340|FG000|Survival Follow-up|Lost to Follow-up|0|||
161853834|NCT02027428|584506341|FG001|Survival Follow-up|Lost to Follow-up|1|||
161853835|NCT02027428|584506342|FG002|Survival Follow-up|Lost to Follow-up|1|||
161853836|NCT02859142|584506343|FG000|Overall Study|Adverse Event|1|||
161853837|NCT02859142|584506344|FG001|Overall Study|Adverse Event|2|||
161853838|NCT02859142|584506343|FG000|Overall Study|Lost to Follow-up|1|||
161853839|NCT02859142|584506344|FG001|Overall Study|Lost to Follow-up|4|||
161853840|NCT02859142|584506343|FG000|Overall Study|Withdrawal by Subject|2|||
161853841|NCT02859142|584506344|FG001|Overall Study|Withdrawal by Subject|0|||
161853842|NCT02859142|584506343|FG000|Overall Study|Scheduling difficulties|0|||
161853843|NCT02859142|584506344|FG001|Overall Study|Scheduling difficulties|3|||
161853844|NCT02676765|584506345|FG000|Overall Study|Lost to Follow-up|0|||
161853845|NCT02676765|584506346|FG001|Overall Study|Lost to Follow-up|1|||
161853846|NCT00490841|584506347|FG000|Overall Study|Death|5|||
161853847|NCT00490841|584506347|FG000|Overall Study|Withdrawal by Subject|4|||
161853848|NCT00490841|584506347|FG000|Overall Study|Lost to Follow-up|1|||
161853849|NCT00490841|584506347|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
161853850|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
161853851|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
161853852|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
161853853|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
161853854|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
161853855|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
161853856|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
161853857|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
161853858|NCT03452943|584506348|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
161853859|NCT03452943|584506349|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
161853860|NCT03452943|584506348|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
161853861|NCT03452943|584506349|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
161853862|NCT01107197|584506355|FG000|Overall Study|Death|12|||
161853863|NCT01107197|584506356|FG001|Overall Study|Death|10|||
161853864|NCT01107197|584506355|FG000|Overall Study|Lost to Follow-up|5|||
161853865|NCT01107197|584506356|FG001|Overall Study|Lost to Follow-up|8|||
161853866|NCT01107197|584506355|FG000|Overall Study|Withdrawal by Subject|3|||
161853867|NCT01107197|584506356|FG001|Overall Study|Withdrawal by Subject|5|||
161853868|NCT01301729|584506358|FG000|Overall Study|Withdrawal by Subject|2|||
161853869|NCT01301729|584506358|FG000|Overall Study|Participant did not Return for Treatment|1|||
161853870|NCT01301729|584506358|FG000|Overall Study|Violated Selection Criteria|1|||
161853871|NCT03071276|584506359|FG000|Overall Study|Adverse Event|1|||
161853872|NCT03071276|584506359|FG000|Overall Study|Lack of Efficacy|14|||
161853873|NCT05794503|584506360|FG000|Overall Study|Operation Cancelled|2|||
161853874|NCT05794503|584506361|FG001|Overall Study|Operation Cancelled|0|||
161853875|NCT05794503|584506360|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
161853876|NCT05794503|584506361|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
161853877|NCT05794503|584506360|FG000|Overall Study|Protocol Violation|1|||
161853878|NCT05794503|584506361|FG001|Overall Study|Protocol Violation|0|||
161853879|NCT00447993|584506362|FG000|Overall Study|Lost to Follow-up|0|||
161853880|NCT00447993|584506363|FG001|Overall Study|Lost to Follow-up|0|||
161853881|NCT00447993|584506364|FG002|Overall Study|Lost to Follow-up|2|||
161853882|NCT00447993|584506365|FG003|Overall Study|Lost to Follow-up|2|||
161853883|NCT00447993|584506362|FG000|Overall Study|Withdrawal by Subject|0|||
161853884|NCT00447993|584506363|FG001|Overall Study|Withdrawal by Subject|0|||
161853885|NCT00447993|584506364|FG002|Overall Study|Withdrawal by Subject|2|||
161853886|NCT00447993|584506365|FG003|Overall Study|Withdrawal by Subject|2|||
161853887|NCT02924727|584506366|FG000|Overall Study|Withdrawal by Subject|2|||
161853888|NCT02924727|584506367|FG001|Overall Study|Withdrawal by Subject|4|||
161853889|NCT02924727|584506366|FG000|Overall Study|Lost to Follow-up|2|||
161853890|NCT02924727|584506367|FG001|Overall Study|Lost to Follow-up|5|||
161853891|NCT02924727|584506366|FG000|Overall Study|Death|221|||
161853892|NCT02924727|584506367|FG001|Overall Study|Death|247|||
161766379|NCT00982111|584184731|FG000|Overall Study|Progressive Disease|46|||
161766380|NCT00982111|584184732|FG001|Overall Study|Progressive Disease|39|||
161766381|NCT00982111|584184731|FG000|Overall Study|Lost to Follow-up|9|||
161766382|NCT00982111|584184732|FG001|Overall Study|Lost to Follow-up|6|||
161766383|NCT00982111|584184731|FG000|Overall Study|New Anti-Cancer Therapy|5|||
161766384|NCT00982111|584184732|FG001|Overall Study|New Anti-Cancer Therapy|5|||
161766385|NCT00982111|584184731|FG000|Overall Study|Medical Decision|1|||
161766386|NCT00982111|584184732|FG001|Overall Study|Medical Decision|0|||
161766387|NCT00982111|584184731|FG000|Overall Study|Withdrawal by Subject|17|||
161766388|NCT00982111|584184732|FG001|Overall Study|Withdrawal by Subject|19|||
161766389|NCT00982111|584184731|FG000|Overall Study|Global Study End|0|||
161766390|NCT00982111|584184732|FG001|Overall Study|Global Study End|1|||
161766391|NCT00982111|584184731|FG000|Overall Study|Sponsor's Decision|0|||
161766392|NCT00982111|584184732|FG001|Overall Study|Sponsor's Decision|1|||
161766393|NCT01070381|584184733|FG000|Period 2, 1 Week of Wear|Handling|0|||
161766394|NCT01070381|584184734|FG001|Period 2, 1 Week of Wear|Handling|1|||
161766395|NCT01070381|584184733|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
161766396|NCT01070381|584184734|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
161766397|NCT02146352|584184740|FG000|Overall Study|Death|1|||
161766398|NCT02146352|584184740|FG000|Overall Study|Patient entered hospice care|1|||
161766399|NCT02918006|584184741|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
161766400|NCT02918006|584184742|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
161853893|NCT02924727|584506366|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
161853894|NCT02924727|584506367|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
161853895|NCT00338728|584506368|FG000|Overall Study|Screen Failure|14|||
161853896|NCT04380961|584506373|FG000|Overall Study|Lost to Follow-up|17|||
161853897|NCT04380961|584506374|FG001|Overall Study|Lost to Follow-up|11|||
161853898|NCT04380961|584506373|FG000|Overall Study|Withdrawal by Subject|3|||
161853899|NCT04380961|584506374|FG001|Overall Study|Withdrawal by Subject|0|||
161853900|NCT04380961|584506373|FG000|Overall Study|Death|22|||
161853901|NCT04380961|584506374|FG001|Overall Study|Death|16|||
161853902|NCT04380961|584506373|FG000|Overall Study|Other|1|||
161853903|NCT04380961|584506374|FG001|Overall Study|Other|0|||
161853904|NCT04380961|584506373|FG000|Overall Study|Randomized but Not Treated|1|||
161853905|NCT04380961|584506374|FG001|Overall Study|Randomized but Not Treated|2|||
161853906|NCT04803305|584506375|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
161853907|NCT04803305|584506376|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
161853908|NCT04803305|584506375|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
161853909|NCT04803305|584506376|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
161853910|NCT04803305|584506375|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
161853911|NCT04803305|584506376|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
161853912|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
161853913|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
161853914|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
161853915|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
161853916|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
161853917|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
161853918|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
161853919|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
161853920|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
161853921|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
161853922|NCT01862484|584506378|FG000|Overall Study|Lack of Efficacy|1|||
161853923|NCT01862484|584506379|FG001|Overall Study|Lack of Efficacy|1|||
161853924|NCT01862484|584506378|FG000|Overall Study|Lost to Follow-up|1|||
161853925|NCT01862484|584506379|FG001|Overall Study|Lost to Follow-up|2|||
161853926|NCT01862484|584506378|FG000|Overall Study|Protocol Violation|0|||
161853927|NCT01862484|584506379|FG001|Overall Study|Protocol Violation|2|||
161853928|NCT01862484|584506378|FG000|Overall Study|Withdrawal by Subject|0|||
161853929|NCT01862484|584506379|FG001|Overall Study|Withdrawal by Subject|3|||
161853930|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
161853931|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
161853932|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
161853933|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
161853934|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
161853935|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
161853936|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
161853937|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
161853938|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
161853939|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
161853940|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
161853941|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
161853942|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
161853943|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
161853944|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
161853945|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
161853946|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
161853947|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
161853948|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
161853949|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
161853950|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Death|1|||
161853951|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Death|0|||
161853952|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Death|0|||
161853953|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Death|0|||
161853954|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Death|0|||
161853955|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Death|1|||
161853956|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Death|0|||
161853957|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Death|0|||
161853958|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Death|0|||
161853959|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Death|0|||
161853960|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Death|0|||
161853961|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Death|0|||
161853962|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Death|0|||
161853963|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Death|0|||
161853964|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Death|0|||
161853965|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Death|0|||
161853966|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Death|0|||
161766401|NCT02918006|584184743|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
161766402|NCT02918006|584184741|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
161766403|NCT02918006|584184742|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
161766404|NCT02918006|584184743|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
161766405|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
161766406|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
161766407|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
161766408|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
161766409|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
161766410|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
161766411|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
161766412|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
161766413|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
161766414|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
161766415|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
161766416|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
161766417|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
161766418|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
161766419|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
161766420|NCT02918006|584184741|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
161766421|NCT02918006|584184742|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
161766422|NCT02918006|584184743|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
161766423|NCT02918006|584184741|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
161766424|NCT02918006|584184742|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
161766425|NCT02918006|584184743|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
161766426|NCT03969589|584184744|FG000|Overall Study|Lost to Follow-up|3|||
161766427|NCT03969589|584184745|FG001|Overall Study|Lost to Follow-up|2|||
161766428|NCT03969589|584184744|FG000|Overall Study|Declined Follow-Up|0|||
161766429|NCT03969589|584184745|FG001|Overall Study|Declined Follow-Up|1|||
161766430|NCT03091920|584184749|FG000|Overall Study|Adverse Event|0|||
161766431|NCT03091920|584184750|FG001|Overall Study|Adverse Event|1|||
161766432|NCT03091920|584184751|FG002|Overall Study|Adverse Event|0|||
161766433|NCT01513460|584184756|FG000|Overall Study|Death|0|||
161766434|NCT01513460|584184757|FG001|Overall Study|Death|0|||
161766435|NCT01513460|584184758|FG002|Overall Study|Death|1|||
161766436|NCT01513460|584184756|FG000|Overall Study|Lost to Follow-up|0|||
161766437|NCT01513460|584184757|FG001|Overall Study|Lost to Follow-up|0|||
161766438|NCT01513460|584184758|FG002|Overall Study|Lost to Follow-up|2|||
161766439|NCT01513460|584184756|FG000|Overall Study|Abnormal laboratory value|1|||
161766440|NCT01513460|584184757|FG001|Overall Study|Abnormal laboratory value|0|||
161766441|NCT01513460|584184758|FG002|Overall Study|Abnormal laboratory value|1|||
161766442|NCT01513460|584184756|FG000|Overall Study|Lack of Efficacy|1|||
161766443|NCT01513460|584184757|FG001|Overall Study|Lack of Efficacy|2|||
161766444|NCT01513460|584184758|FG002|Overall Study|Lack of Efficacy|5|||
161766445|NCT01513460|584184756|FG000|Overall Study|Protocol deviations|3|||
161766446|NCT01513460|584184757|FG001|Overall Study|Protocol deviations|4|||
161766447|NCT01513460|584184758|FG002|Overall Study|Protocol deviations|3|||
161766448|NCT01513460|584184756|FG000|Overall Study|Withdrawal by Subject|7|||
161766449|NCT01513460|584184757|FG001|Overall Study|Withdrawal by Subject|8|||
161766450|NCT01513460|584184758|FG002|Overall Study|Withdrawal by Subject|21|||
161766451|NCT01513460|584184756|FG000|Overall Study|Adverse Event|16|||
161766452|NCT01513460|584184757|FG001|Overall Study|Adverse Event|18|||
161766453|NCT01513460|584184758|FG002|Overall Study|Adverse Event|23|||
161766454|NCT01513460|584184756|FG000|Overall Study|Abnormal test procedure|1|||
161766455|NCT01513460|584184757|FG001|Overall Study|Abnormal test procedure|0|||
161766456|NCT01513460|584184758|FG002|Overall Study|Abnormal test procedure|0|||
161766457|NCT00489216|584184759|FG000|Overall Study|Adverse Event|1|||
161766458|NCT01078389|584187097|FG000|Overall Study|Adverse Event|10|||
161766459|NCT01078389|584187098|FG001|Overall Study|Adverse Event|6|||
161766460|NCT01078389|584187097|FG000|Overall Study|Major Protocol Deviation|2|||
161766461|NCT01078389|584187098|FG001|Overall Study|Major Protocol Deviation|0|||
161766462|NCT01078389|584187097|FG000|Overall Study|Lost to Follow-up|23|||
161766463|NCT01078389|584187098|FG001|Overall Study|Lost to Follow-up|23|||
161766464|NCT01078389|584187097|FG000|Overall Study|Voluntary Withdrawal|20|||
161766465|NCT01078389|584187098|FG001|Overall Study|Voluntary Withdrawal|36|||
161766466|NCT01078389|584187097|FG000|Overall Study|Other|9|||
161766467|NCT01078389|584187098|FG001|Overall Study|Other|2|||
161766468|NCT03726320|584187099|FG000|Overall Study|Lost to Follow-up|2|||
161766469|NCT03726320|584187100|FG001|Overall Study|Lost to Follow-up|4|||
161766470|NCT03726320|584187101|FG002|Overall Study|Lost to Follow-up|0|||
161766471|NCT03726320|584187099|FG000|Overall Study|Time Constraints|4|||
161766472|NCT03726320|584187100|FG001|Overall Study|Time Constraints|1|||
161766473|NCT03726320|584187101|FG002|Overall Study|Time Constraints|0|||
161766474|NCT03726320|584187099|FG000|Overall Study|Ineligible after enrollment|3|||
161766475|NCT03726320|584187100|FG001|Overall Study|Ineligible after enrollment|3|||
161766476|NCT03726320|584187101|FG002|Overall Study|Ineligible after enrollment|0|||
161766477|NCT03726320|584187099|FG000|Overall Study|Clinic / insurance issue|2|||
161766478|NCT03726320|584187100|FG001|Overall Study|Clinic / insurance issue|0|||
161766479|NCT03726320|584187101|FG002|Overall Study|Clinic / insurance issue|0|||
161766480|NCT03726320|584187099|FG000|Overall Study|Language barrier|1|||
161766481|NCT03726320|584187100|FG001|Overall Study|Language barrier|0|||
161766482|NCT03726320|584187101|FG002|Overall Study|Language barrier|0|||
161766483|NCT03726320|584187099|FG000|Overall Study|Provider left the clinic|0|||
161766484|NCT03726320|584187100|FG001|Overall Study|Provider left the clinic|0|||
161766485|NCT03726320|584187101|FG002|Overall Study|Provider left the clinic|1|||
161766486|NCT02198040|584187104|FG000|Overall Study|Work reasons|0|||
161766487|NCT02198040|584187105|FG001|Overall Study|Work reasons|1|||
161766488|NCT02198040|584187106|FG002|Overall Study|Work reasons|0|||
161766489|NCT02198040|584187104|FG000|Overall Study|Withdrawal by Subject|0|||
161766490|NCT02198040|584187105|FG001|Overall Study|Withdrawal by Subject|0|||
161766491|NCT02198040|584187106|FG002|Overall Study|Withdrawal by Subject|1|||
161766492|NCT00337935|584187107|FG000|Overall Study|Adverse Event|2|||
161766493|NCT00337935|584187108|FG001|Overall Study|Adverse Event|5|||
161766494|NCT00337935|584187107|FG000|Overall Study|Death|2|||
161766495|NCT00337935|584187108|FG001|Overall Study|Death|8|||
161766496|NCT00337935|584187107|FG000|Overall Study|Physician Decision|1|||
161766497|NCT00337935|584187108|FG001|Overall Study|Physician Decision|1|||
161766498|NCT00337935|584187107|FG000|Overall Study|Lost to Follow-up|0|||
161766499|NCT00337935|584187108|FG001|Overall Study|Lost to Follow-up|1|||
161766500|NCT00337935|584187107|FG000|Overall Study|Protocol Violation|4|||
161766501|NCT00337935|584187108|FG001|Overall Study|Protocol Violation|3|||
161766502|NCT00337935|584187107|FG000|Overall Study|Withdrawal by Subject|1|||
161766503|NCT00337935|584187108|FG001|Overall Study|Withdrawal by Subject|7|||
161766504|NCT00337935|584187107|FG000|Overall Study|Other|0|||
161766505|NCT00337935|584187108|FG001|Overall Study|Other|1|||
161766506|NCT00337935|584187107|FG000|Overall Study|Lack of Efficacy|0|||
161766507|NCT00337935|584187108|FG001|Overall Study|Lack of Efficacy|1|||
161766508|NCT02361307|584187109|FG000|Overall Study|Unstable medical condition.|0|||
161766509|NCT02361307|584187110|FG001|Overall Study|Unstable medical condition.|1|||
161766510|NCT01189201|584187115|FG000|Overall Study|Adverse Event|1|||
161766511|NCT01277757|584187116|FG000|Overall Study|Disease Progression|1|||
161766512|NCT01277757|584187116|FG000|Overall Study|Withdrawal by Subject|1|||
161766513|NCT00240331|584187122|FG000|Overall Study|Withdrawal by Subject|125|||
161766514|NCT00240331|584187123|FG001|Overall Study|Withdrawal by Subject|132|||
161766515|NCT00240331|584187122|FG000|Overall Study|Option selected by investigator|1|||
161766516|NCT00240331|584187123|FG001|Overall Study|Option selected by investigator|2|||
161766517|NCT01409382|584187124|FG000|Overall Study|Lost to Follow-up|1|||
161766518|NCT01409382|584187125|FG001|Overall Study|Lost to Follow-up|1|||
161766519|NCT01409382|584187124|FG000|Overall Study|Protocol Violation|0|||
161766520|NCT01409382|584187125|FG001|Overall Study|Protocol Violation|3|||
161766521|NCT01409382|584187124|FG000|Overall Study|Multiple pregnancy|2|||
161766522|NCT01409382|584187125|FG001|Overall Study|Multiple pregnancy|4|||
161766523|NCT01409382|584187124|FG000|Overall Study|Still pregnant when study ended|13|||
161766524|NCT01409382|584187125|FG001|Overall Study|Still pregnant when study ended|2|||
161766525|NCT01409382|584187124|FG000|Overall Study|Did not manage to get pregnant|64|||
161766526|NCT01409382|584187125|FG001|Overall Study|Did not manage to get pregnant|70|||
161766527|NCT01409382|584187124|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
161766528|NCT01409382|584187125|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
161766529|NCT01233076|584187126|FG000|Period 2, One Week|Lost to Follow-up|1|||
161766530|NCT01233076|584187127|FG001|Period 2, One Week|Lost to Follow-up|0|||
161766531|NCT04563845|584187128|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766532|NCT04563845|584187129|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766533|NCT04563845|584187130|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766534|NCT04563845|584187131|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766535|NCT04563845|584187132|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766536|NCT04563845|584187133|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766537|NCT04563845|584187134|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766538|NCT04563845|584187135|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
161766539|NCT04563845|584187136|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766540|NCT04563845|584187137|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766541|NCT04563845|584187138|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766542|NCT04563845|584187139|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766543|NCT04563845|584187140|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766544|NCT04563845|584187141|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766545|NCT04563845|584187128|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766546|NCT04563845|584187129|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766547|NCT04563845|584187130|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766548|NCT04563845|584187131|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766549|NCT04563845|584187132|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
161766550|NCT04563845|584187133|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766551|NCT04563845|584187134|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766552|NCT04563845|584187135|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766553|NCT04563845|584187136|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766554|NCT04563845|584187137|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766555|NCT04563845|584187138|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766556|NCT04563845|584187139|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766557|NCT04563845|584187140|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766558|NCT04563845|584187141|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766559|NCT00965458|584187148|FG000|Overall Study|Adverse Event|1|||
161766560|NCT00965458|584187149|FG001|Overall Study|Adverse Event|0|||
161766561|NCT00965458|584187148|FG000|Overall Study|Lost to Follow-up|1|||
161766562|NCT00965458|584187149|FG001|Overall Study|Lost to Follow-up|3|||
161766563|NCT00965458|584187148|FG000|Overall Study|Withdrawal by Subject|0|||
161766564|NCT00965458|584187149|FG001|Overall Study|Withdrawal by Subject|1|||
161766565|NCT04177862|584187151|FG000|Overall Study|Protocol Violation|2|||
161766566|NCT04177862|584187152|FG001|Overall Study|Protocol Violation|7|||
161766567|NCT01846039|584187153|FG000|Overall Study|Protocol Violation|1|||
161853967|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Death|0|||
161766568|NCT01846039|584187153|FG000|Overall Study|Subject Withdrew Consent|1|||
161766569|NCT05637515|584187154|FG000|Overall Study|Withdrawal by Subject|17|||
161766570|NCT05637515|584187155|FG001|Overall Study|Withdrawal by Subject|17|||
161766571|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Other|1|||
161766572|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Other|0|||
161766573|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Other|0|||
161766574|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Other|2|||
161766575|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Other|2|||
161766576|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Other|4|||
161766577|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Other|2|||
161766578|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Other|0|||
161766579|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766580|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161766581|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161766582|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766583|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161766584|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766585|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766586|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766587|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766588|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766589|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766590|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
161766591|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766592|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766593|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766594|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766595|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766596|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161766597|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766598|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766599|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766600|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766601|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766602|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766603|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
161766604|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
161766605|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
161766606|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
161766607|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
161766608|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
161766609|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
161766610|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
161766611|NCT04516291|584187157|FG000|Follow-up Period (12 Weeks)|Other|0|||
161766612|NCT04516291|584187158|FG001|Follow-up Period (12 Weeks)|Other|1|||
161766613|NCT04516291|584187159|FG002|Follow-up Period (12 Weeks)|Other|0|||
161766614|NCT04516291|584187160|FG003|Follow-up Period (12 Weeks)|Other|2|||
161766615|NCT04516291|584187161|FG004|Follow-up Period (12 Weeks)|Other|0|||
161766616|NCT04516291|584187162|FG005|Follow-up Period (12 Weeks)|Other|0|||
161766617|NCT04516291|584187163|FG006|Follow-up Period (12 Weeks)|Other|0|||
161766618|NCT04516291|584187164|FG007|Follow-up Period (12 Weeks)|Other|0|||
161766619|NCT04516291|584187157|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766620|NCT04516291|584187158|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766621|NCT04516291|584187159|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766622|NCT04516291|584187160|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766623|NCT04516291|584187161|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161766624|NCT04516291|584187162|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766625|NCT04516291|584187163|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766626|NCT04516291|584187164|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766627|NCT04516291|584187157|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766628|NCT04516291|584187158|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766629|NCT04516291|584187159|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
161766630|NCT04516291|584187160|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
161853968|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Death|0|||
161766631|NCT04516291|584187161|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
161766632|NCT04516291|584187162|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
161853969|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Death|0|||
161853970|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
161853971|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
161853972|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
161853973|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
161853974|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
161853975|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
161853976|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
161853977|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
161853978|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
161853979|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
161853980|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
161853981|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
161853982|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
161853983|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
161853984|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
161853985|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
161853986|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
161853987|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
161853988|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
161853989|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
161853990|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853991|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853992|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853993|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
161853994|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853995|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853996|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853997|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853998|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853999|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854000|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854001|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854002|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854003|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854004|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854005|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854006|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854007|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854008|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854009|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854010|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
161854011|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
161854012|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
161854013|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
161854014|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
161854015|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
161854016|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
161854017|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
161854018|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
161854019|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
161854020|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
161854021|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
161854022|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
161854023|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
161854024|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
161854025|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
161854026|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
161854027|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
161854028|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
161854029|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
161854030|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
161854031|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
161854032|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
161854033|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
161854034|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
161854035|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
161854036|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
161854037|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
161854038|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
161854039|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
161766633|NCT04516291|584187163|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766634|NCT04516291|584187164|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766635|NCT01855607|584187165|FG000|Overall Study|Withdrawal by Subject|1|||
161766636|NCT01855607|584187165|FG000|Overall Study|Study was terminated|11|||
161766637|NCT02181634|584187166|FG000|Overall Study|Lack of Efficacy|33|||
161766638|NCT02181634|584187166|FG000|Overall Study|Adverse Event|17|||
161766639|NCT02181634|584187166|FG000|Overall Study|Physician Decision|8|||
161766640|NCT02181634|584187166|FG000|Overall Study|Withdrawal by Subject|5|||
161766641|NCT02181634|584187166|FG000|Overall Study|Death|2|||
161766642|NCT02181634|584187166|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
161766643|NCT02181634|584187166|FG000|Overall Study|Ineligible|1|||
161766644|NCT02181634|584187166|FG000|Overall Study|Max number of dose reduction|1|||
161766645|NCT02181634|584187166|FG000|Overall Study|Symptomatic progression|1|||
161766646|NCT02181634|584187166|FG000|Overall Study|Patient opted to proceed to surgery|1|||
161766647|NCT03824704|584187172|FG000|Overall Study|Study Terminated by Sponsor|1|||
161766648|NCT02155660|584187180|FG000|Overall Study|Other Reason|8|||
161766649|NCT02155660|584187181|FG001|Overall Study|Other Reason|6|||
161766650|NCT02155660|584187182|FG002|Overall Study|Other Reason|10|||
161766651|NCT02155660|584187183|FG003|Overall Study|Other Reason|10|||
161766652|NCT02155660|584187180|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161766653|NCT02155660|584187181|FG001|Overall Study|Study-specific withdrawal criteria|1|||
161766654|NCT02155660|584187182|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161766655|NCT02155660|584187183|FG003|Overall Study|Study-specific withdrawal criteria|1|||
161766656|NCT02155660|584187180|FG000|Overall Study|Severe non-compliance|0|||
161766657|NCT02155660|584187181|FG001|Overall Study|Severe non-compliance|4|||
161766658|NCT02155660|584187182|FG002|Overall Study|Severe non-compliance|0|||
161766659|NCT02155660|584187183|FG003|Overall Study|Severe non-compliance|1|||
161766660|NCT02155660|584187180|FG000|Overall Study|Adverse Event|2|||
161766661|NCT02155660|584187181|FG001|Overall Study|Adverse Event|6|||
161766662|NCT02155660|584187182|FG002|Overall Study|Adverse Event|3|||
161766663|NCT02155660|584187183|FG003|Overall Study|Adverse Event|1|||
161766664|NCT02155660|584187180|FG000|Overall Study|Lost to Follow-up|3|||
161766665|NCT02155660|584187181|FG001|Overall Study|Lost to Follow-up|6|||
161766666|NCT02155660|584187182|FG002|Overall Study|Lost to Follow-up|5|||
161766667|NCT02155660|584187183|FG003|Overall Study|Lost to Follow-up|8|||
161766668|NCT02155660|584187180|FG000|Overall Study|Death|17|||
161766669|NCT02155660|584187181|FG001|Overall Study|Death|19|||
161766670|NCT02155660|584187182|FG002|Overall Study|Death|17|||
161766671|NCT02155660|584187183|FG003|Overall Study|Death|19|||
161766672|NCT02155660|584187180|FG000|Overall Study|Withdrawal by Subject|28|||
161766673|NCT02155660|584187181|FG001|Overall Study|Withdrawal by Subject|31|||
161766674|NCT02155660|584187182|FG002|Overall Study|Withdrawal by Subject|24|||
161766675|NCT02155660|584187183|FG003|Overall Study|Withdrawal by Subject|21|||
161766676|NCT03730987|584187184|FG000|Overall Study|Lost to Follow-up|2|||
161766677|NCT03730987|584187185|FG001|Overall Study|Lost to Follow-up|0|||
161766678|NCT03730987|584187186|FG002|Overall Study|Lost to Follow-up|2|||
161766679|NCT03730987|584187187|FG003|Overall Study|Lost to Follow-up|0|||
161766680|NCT02087085|584187188|FG000|Overall Study|Adverse Event|10|||
161766681|NCT02087085|584187189|FG001|Overall Study|Adverse Event|14|||
161766682|NCT02087085|584187188|FG000|Overall Study|Lack of Efficacy|4|||
161766683|NCT02087085|584187189|FG001|Overall Study|Lack of Efficacy|3|||
161766684|NCT02087085|584187188|FG000|Overall Study|Lost to Follow-up|6|||
161766685|NCT02087085|584187189|FG001|Overall Study|Lost to Follow-up|4|||
161766686|NCT02087085|584187188|FG000|Overall Study|Withdrawal by Subject|9|||
161766687|NCT02087085|584187189|FG001|Overall Study|Withdrawal by Subject|11|||
161766688|NCT02087085|584187188|FG000|Overall Study|Protocol Violation|1|||
161766689|NCT02087085|584187189|FG001|Overall Study|Protocol Violation|0|||
161766690|NCT02087085|584187188|FG000|Overall Study|Study Terminated by Sponsor|87|||
161766691|NCT02087085|584187189|FG001|Overall Study|Study Terminated by Sponsor|80|||
161766692|NCT02087085|584187188|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161766693|NCT02087085|584187189|FG001|Overall Study|Other Miscellaneous Reasons|4|||
161766694|NCT02505945|584187190|FG000|Overall Study|Withdrawal by Subject|13|||
161766695|NCT02505945|584187191|FG001|Overall Study|Withdrawal by Subject|2|||
161766696|NCT02505945|584187190|FG000|Overall Study|Adverse Event|1|||
161854040|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
161854041|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
161766697|NCT02505945|584187191|FG001|Overall Study|Adverse Event|0|||
161766698|NCT02505945|584187190|FG000|Overall Study|Physician Decision|2|||
161766699|NCT02505945|584187191|FG001|Overall Study|Physician Decision|1|||
161766700|NCT02505945|584187190|FG000|Overall Study|Lost to Follow-up|6|||
161766701|NCT02505945|584187191|FG001|Overall Study|Lost to Follow-up|1|||
161766702|NCT00635804|584187192|FG000|Overall Study|Adverse Event|0|||
161766703|NCT00635804|584187193|FG001|Overall Study|Adverse Event|0|||
161766704|NCT00635804|584187194|FG002|Overall Study|Adverse Event|0|||
161766705|NCT00635804|584187195|FG003|Overall Study|Adverse Event|0|||
161766706|NCT00635804|584187196|FG004|Overall Study|Adverse Event|0|||
161766707|NCT00635804|584187197|FG005|Overall Study|Adverse Event|1|||
161766708|NCT00635804|584187198|FG006|Overall Study|Adverse Event|0|||
161854042|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
161854043|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
161854044|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
161854045|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
161854046|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
161854047|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
161854048|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
161854049|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
161854050|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Death|0|||
161854051|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Death|0|||
161854052|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Death|0|||
161854053|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Death|0|||
161854054|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Death|0|||
161854055|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Death|0|||
161854056|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Death|0|||
161854057|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Death|0|||
161854058|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Death|0|||
161854059|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Death|2|||
161854060|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Death|0|||
161854061|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Death|1|||
161854062|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Death|1|||
161854063|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Death|0|||
161854064|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Death|0|||
161854065|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Death|0|||
161854066|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Death|0|||
161854067|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Death|0|||
161854068|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Death|0|||
161854069|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Death|0|||
161854070|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
161854071|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
161854072|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
161854073|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
161854074|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
161854075|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
161854076|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
161854077|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
161854078|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
161854079|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
161854080|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
161854081|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
161854082|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
161854083|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
161854084|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
161854085|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
161854086|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
161854087|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
161854088|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
161854089|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
161854090|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854091|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854092|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854093|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854094|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854095|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854096|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854097|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854098|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854099|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854100|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854101|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854102|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854103|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854104|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854105|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854106|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854107|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854108|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854109|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854110|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
161854111|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
161854112|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
161854113|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
161854114|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
161854115|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
161854116|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
161854117|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
161854118|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
161854119|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
161854120|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
161854121|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
161854122|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
161854123|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
161854124|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
161854125|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
161854126|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
161854127|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
161854128|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
161854129|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
161854130|NCT00996892|584506380|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
161854131|NCT00996892|584506381|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
161854132|NCT00996892|584506382|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
161854133|NCT00996892|584506383|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
161854134|NCT00996892|584506384|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
161854135|NCT00996892|584506385|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
161854136|NCT00996892|584506386|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
161854137|NCT00996892|584506387|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
161854138|NCT00996892|584506388|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
161854139|NCT00996892|584506389|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
161854140|NCT00996892|584506390|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
161854141|NCT00996892|584506391|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
161854142|NCT00996892|584506392|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
161854143|NCT00996892|584506393|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
161854144|NCT00996892|584506394|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
161854145|NCT00996892|584506395|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
161854146|NCT00996892|584506396|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
161854147|NCT00996892|584506397|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
161854148|NCT00996892|584506398|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
161854149|NCT00996892|584506399|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
161854150|NCT00996892|584506380|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
161854151|NCT00996892|584506381|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
161854152|NCT00996892|584506382|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
161854153|NCT00996892|584506383|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
161854154|NCT00996892|584506384|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
161854155|NCT00996892|584506385|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
161854156|NCT00996892|584506386|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
161854157|NCT00996892|584506387|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
161854158|NCT00996892|584506388|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
161854159|NCT00996892|584506389|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
161854160|NCT00996892|584506390|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
161854161|NCT00996892|584506391|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
161854162|NCT00996892|584506392|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
161854163|NCT00996892|584506393|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
161854164|NCT00996892|584506394|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
161854165|NCT00996892|584506395|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
161854166|NCT00996892|584506396|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
161854167|NCT00996892|584506397|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
161854168|NCT00996892|584506398|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
161854169|NCT00996892|584506399|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
161854170|NCT00996892|584506380|FG000|Expansion Stage 2|Adverse Event|0|||
161854171|NCT00996892|584506381|FG001|Expansion Stage 2|Adverse Event|0|||
161854172|NCT00996892|584506382|FG002|Expansion Stage 2|Adverse Event|0|||
161854173|NCT00996892|584506383|FG003|Expansion Stage 2|Adverse Event|0|||
161854174|NCT00996892|584506384|FG004|Expansion Stage 2|Adverse Event|0|||
161854175|NCT00996892|584506385|FG005|Expansion Stage 2|Adverse Event|0|||
161854176|NCT00996892|584506386|FG006|Expansion Stage 2|Adverse Event|0|||
161854177|NCT00996892|584506387|FG007|Expansion Stage 2|Adverse Event|0|||
161854178|NCT00996892|584506388|FG008|Expansion Stage 2|Adverse Event|0|||
161854179|NCT00996892|584506389|FG009|Expansion Stage 2|Adverse Event|0|||
161854180|NCT00996892|584506390|FG010|Expansion Stage 2|Adverse Event|0|||
161854181|NCT00996892|584506391|FG011|Expansion Stage 2|Adverse Event|0|||
161854182|NCT00996892|584506392|FG012|Expansion Stage 2|Adverse Event|0|||
161854183|NCT00996892|584506393|FG013|Expansion Stage 2|Adverse Event|0|||
161854184|NCT00996892|584506394|FG014|Expansion Stage 2|Adverse Event|0|||
161854185|NCT00996892|584506395|FG015|Expansion Stage 2|Adverse Event|0|||
161854186|NCT00996892|584506396|FG016|Expansion Stage 2|Adverse Event|0|||
161854187|NCT00996892|584506397|FG017|Expansion Stage 2|Adverse Event|0|||
161854188|NCT00996892|584506398|FG018|Expansion Stage 2|Adverse Event|3|||
161854189|NCT00996892|584506399|FG019|Expansion Stage 2|Adverse Event|0|||
161854190|NCT00996892|584506380|FG000|Expansion Stage 2|Death|0|||
161854191|NCT00996892|584506381|FG001|Expansion Stage 2|Death|0|||
161854192|NCT00996892|584506382|FG002|Expansion Stage 2|Death|0|||
161854193|NCT00996892|584506383|FG003|Expansion Stage 2|Death|0|||
161854194|NCT00996892|584506384|FG004|Expansion Stage 2|Death|0|||
161854195|NCT00996892|584506385|FG005|Expansion Stage 2|Death|0|||
161854196|NCT00996892|584506386|FG006|Expansion Stage 2|Death|0|||
161854197|NCT00996892|584506387|FG007|Expansion Stage 2|Death|0|||
161854198|NCT00996892|584506388|FG008|Expansion Stage 2|Death|0|||
161854199|NCT00996892|584506389|FG009|Expansion Stage 2|Death|0|||
161854200|NCT00996892|584506390|FG010|Expansion Stage 2|Death|0|||
161854201|NCT00996892|584506391|FG011|Expansion Stage 2|Death|0|||
161854202|NCT00996892|584506392|FG012|Expansion Stage 2|Death|0|||
161854203|NCT00996892|584506393|FG013|Expansion Stage 2|Death|0|||
161854204|NCT00996892|584506394|FG014|Expansion Stage 2|Death|0|||
161854205|NCT00996892|584506395|FG015|Expansion Stage 2|Death|0|||
161854206|NCT00996892|584506396|FG016|Expansion Stage 2|Death|0|||
161854207|NCT00996892|584506397|FG017|Expansion Stage 2|Death|0|||
161854208|NCT00996892|584506398|FG018|Expansion Stage 2|Death|2|||
161854209|NCT00996892|584506399|FG019|Expansion Stage 2|Death|0|||
161854210|NCT00996892|584506380|FG000|Expansion Stage 2|Physician Decision|0|||
161854211|NCT00996892|584506381|FG001|Expansion Stage 2|Physician Decision|0|||
161854212|NCT00996892|584506382|FG002|Expansion Stage 2|Physician Decision|0|||
161854213|NCT00996892|584506383|FG003|Expansion Stage 2|Physician Decision|0|||
161854214|NCT00996892|584506384|FG004|Expansion Stage 2|Physician Decision|0|||
161854215|NCT00996892|584506385|FG005|Expansion Stage 2|Physician Decision|0|||
161854216|NCT00996892|584506386|FG006|Expansion Stage 2|Physician Decision|0|||
161854217|NCT00996892|584506387|FG007|Expansion Stage 2|Physician Decision|0|||
161854218|NCT00996892|584506388|FG008|Expansion Stage 2|Physician Decision|0|||
161854219|NCT00996892|584506389|FG009|Expansion Stage 2|Physician Decision|0|||
161854220|NCT00996892|584506390|FG010|Expansion Stage 2|Physician Decision|0|||
161854221|NCT00996892|584506391|FG011|Expansion Stage 2|Physician Decision|0|||
161854222|NCT00996892|584506392|FG012|Expansion Stage 2|Physician Decision|0|||
161854223|NCT00996892|584506393|FG013|Expansion Stage 2|Physician Decision|0|||
161854224|NCT00996892|584506394|FG014|Expansion Stage 2|Physician Decision|0|||
161854225|NCT00996892|584506395|FG015|Expansion Stage 2|Physician Decision|0|||
161854226|NCT00996892|584506396|FG016|Expansion Stage 2|Physician Decision|0|||
161854227|NCT00996892|584506397|FG017|Expansion Stage 2|Physician Decision|0|||
161854228|NCT00996892|584506398|FG018|Expansion Stage 2|Physician Decision|1|||
161854229|NCT00996892|584506399|FG019|Expansion Stage 2|Physician Decision|0|||
161854230|NCT00996892|584506380|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
161854231|NCT00996892|584506381|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
161854232|NCT00996892|584506382|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
161854233|NCT00996892|584506383|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
161854234|NCT00996892|584506384|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
161854235|NCT00996892|584506385|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
161854236|NCT00996892|584506386|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
161854237|NCT00996892|584506387|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
161854238|NCT00996892|584506388|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
161854239|NCT00996892|584506389|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
161854240|NCT00996892|584506390|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
161854241|NCT00996892|584506391|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
161854242|NCT00996892|584506392|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
161854243|NCT00996892|584506393|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
161854244|NCT00996892|584506394|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
161854245|NCT00996892|584506395|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
161854246|NCT00996892|584506396|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
161854247|NCT00996892|584506397|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
161854248|NCT00996892|584506398|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
161854249|NCT00996892|584506399|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
161854250|NCT00996892|584506380|FG000|Expansion Stage 2|Disease Progression|0|||
161854251|NCT00996892|584506381|FG001|Expansion Stage 2|Disease Progression|0|||
161854252|NCT00996892|584506382|FG002|Expansion Stage 2|Disease Progression|0|||
161854253|NCT00996892|584506383|FG003|Expansion Stage 2|Disease Progression|0|||
161854254|NCT00996892|584506384|FG004|Expansion Stage 2|Disease Progression|0|||
161854255|NCT00996892|584506385|FG005|Expansion Stage 2|Disease Progression|0|||
161854256|NCT00996892|584506386|FG006|Expansion Stage 2|Disease Progression|0|||
161854257|NCT00996892|584506387|FG007|Expansion Stage 2|Disease Progression|0|||
161854258|NCT00996892|584506388|FG008|Expansion Stage 2|Disease Progression|0|||
161854259|NCT00996892|584506389|FG009|Expansion Stage 2|Disease Progression|0|||
161854260|NCT00996892|584506390|FG010|Expansion Stage 2|Disease Progression|0|||
161854261|NCT00996892|584506391|FG011|Expansion Stage 2|Disease Progression|0|||
161854262|NCT00996892|584506392|FG012|Expansion Stage 2|Disease Progression|0|||
161854263|NCT00996892|584506393|FG013|Expansion Stage 2|Disease Progression|0|||
161854264|NCT00996892|584506394|FG014|Expansion Stage 2|Disease Progression|0|||
161854265|NCT00996892|584506395|FG015|Expansion Stage 2|Disease Progression|0|||
161854266|NCT00996892|584506396|FG016|Expansion Stage 2|Disease Progression|0|||
161854267|NCT00996892|584506397|FG017|Expansion Stage 2|Disease Progression|0|||
161854268|NCT00996892|584506398|FG018|Expansion Stage 2|Disease Progression|28|||
161854269|NCT00996892|584506399|FG019|Expansion Stage 2|Disease Progression|0|||
161854270|NCT00996892|584506380|FG000|Expansion Stage 2A|Adverse Event|0|||
161854271|NCT00996892|584506381|FG001|Expansion Stage 2A|Adverse Event|0|||
161854272|NCT00996892|584506382|FG002|Expansion Stage 2A|Adverse Event|0|||
161854273|NCT00996892|584506383|FG003|Expansion Stage 2A|Adverse Event|0|||
161854274|NCT00996892|584506384|FG004|Expansion Stage 2A|Adverse Event|0|||
161854275|NCT00996892|584506385|FG005|Expansion Stage 2A|Adverse Event|0|||
161854276|NCT00996892|584506386|FG006|Expansion Stage 2A|Adverse Event|0|||
161854277|NCT00996892|584506387|FG007|Expansion Stage 2A|Adverse Event|0|||
161854278|NCT00996892|584506388|FG008|Expansion Stage 2A|Adverse Event|0|||
161854279|NCT00996892|584506389|FG009|Expansion Stage 2A|Adverse Event|0|||
161854280|NCT00996892|584506390|FG010|Expansion Stage 2A|Adverse Event|0|||
161854281|NCT00996892|584506391|FG011|Expansion Stage 2A|Adverse Event|0|||
161854282|NCT00996892|584506392|FG012|Expansion Stage 2A|Adverse Event|0|||
161854283|NCT00996892|584506393|FG013|Expansion Stage 2A|Adverse Event|0|||
161854284|NCT00996892|584506394|FG014|Expansion Stage 2A|Adverse Event|0|||
161854285|NCT00996892|584506395|FG015|Expansion Stage 2A|Adverse Event|0|||
161854286|NCT00996892|584506396|FG016|Expansion Stage 2A|Adverse Event|0|||
161854287|NCT00996892|584506397|FG017|Expansion Stage 2A|Adverse Event|0|||
161854288|NCT00996892|584506398|FG018|Expansion Stage 2A|Adverse Event|0|||
161854289|NCT00996892|584506399|FG019|Expansion Stage 2A|Adverse Event|8|||
161854290|NCT00996892|584506380|FG000|Expansion Stage 2A|Physician Decision|0|||
161854291|NCT00996892|584506381|FG001|Expansion Stage 2A|Physician Decision|0|||
161854292|NCT00996892|584506382|FG002|Expansion Stage 2A|Physician Decision|0|||
161854293|NCT00996892|584506383|FG003|Expansion Stage 2A|Physician Decision|0|||
161854294|NCT00996892|584506384|FG004|Expansion Stage 2A|Physician Decision|0|||
161854295|NCT00996892|584506385|FG005|Expansion Stage 2A|Physician Decision|0|||
161854296|NCT00996892|584506386|FG006|Expansion Stage 2A|Physician Decision|0|||
161854297|NCT00996892|584506387|FG007|Expansion Stage 2A|Physician Decision|0|||
161854298|NCT00996892|584506388|FG008|Expansion Stage 2A|Physician Decision|0|||
161854299|NCT00996892|584506389|FG009|Expansion Stage 2A|Physician Decision|0|||
161854300|NCT00996892|584506390|FG010|Expansion Stage 2A|Physician Decision|0|||
161854301|NCT00996892|584506391|FG011|Expansion Stage 2A|Physician Decision|0|||
161854302|NCT00996892|584506392|FG012|Expansion Stage 2A|Physician Decision|0|||
161854303|NCT00996892|584506393|FG013|Expansion Stage 2A|Physician Decision|0|||
161854304|NCT00996892|584506394|FG014|Expansion Stage 2A|Physician Decision|0|||
161854305|NCT00996892|584506395|FG015|Expansion Stage 2A|Physician Decision|0|||
161854306|NCT00996892|584506396|FG016|Expansion Stage 2A|Physician Decision|0|||
161854307|NCT00996892|584506397|FG017|Expansion Stage 2A|Physician Decision|0|||
161854308|NCT00996892|584506398|FG018|Expansion Stage 2A|Physician Decision|0|||
161854309|NCT00996892|584506399|FG019|Expansion Stage 2A|Physician Decision|2|||
161854310|NCT00996892|584506380|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
161854311|NCT00996892|584506381|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
161854312|NCT00996892|584506382|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
161854313|NCT00996892|584506383|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
161854314|NCT00996892|584506384|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
161854315|NCT00996892|584506385|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
161854316|NCT00996892|584506386|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
161854317|NCT00996892|584506387|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
161854318|NCT00996892|584506388|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
161854319|NCT00996892|584506389|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
161854320|NCT00996892|584506390|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
161854321|NCT00996892|584506391|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
161854322|NCT00996892|584506392|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
161854323|NCT00996892|584506393|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
161854324|NCT00996892|584506394|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
161854325|NCT00996892|584506395|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
161854326|NCT00996892|584506396|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
161854327|NCT00996892|584506397|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
161854328|NCT00996892|584506398|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
161854329|NCT00996892|584506399|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
161854330|NCT00996892|584506380|FG000|Expansion Stage 2A|Disease Progression|0|||
161854331|NCT00996892|584506381|FG001|Expansion Stage 2A|Disease Progression|0|||
161766709|NCT00635804|584187199|FG007|Overall Study|Adverse Event|0|||
161766710|NCT00635804|584187192|FG000|Overall Study|Withdrawal by Subject|1|||
161766711|NCT00635804|584187193|FG001|Overall Study|Withdrawal by Subject|0|||
161854332|NCT00996892|584506382|FG002|Expansion Stage 2A|Disease Progression|0|||
161854333|NCT00996892|584506383|FG003|Expansion Stage 2A|Disease Progression|0|||
161854334|NCT00996892|584506384|FG004|Expansion Stage 2A|Disease Progression|0|||
161854335|NCT00996892|584506385|FG005|Expansion Stage 2A|Disease Progression|0|||
161854336|NCT00996892|584506386|FG006|Expansion Stage 2A|Disease Progression|0|||
161854337|NCT00996892|584506387|FG007|Expansion Stage 2A|Disease Progression|0|||
161854338|NCT00996892|584506388|FG008|Expansion Stage 2A|Disease Progression|0|||
161854339|NCT00996892|584506389|FG009|Expansion Stage 2A|Disease Progression|0|||
161854340|NCT00996892|584506390|FG010|Expansion Stage 2A|Disease Progression|0|||
161854341|NCT00996892|584506391|FG011|Expansion Stage 2A|Disease Progression|0|||
161854342|NCT00996892|584506392|FG012|Expansion Stage 2A|Disease Progression|0|||
161854343|NCT00996892|584506393|FG013|Expansion Stage 2A|Disease Progression|0|||
161854344|NCT00996892|584506394|FG014|Expansion Stage 2A|Disease Progression|0|||
161854345|NCT00996892|584506395|FG015|Expansion Stage 2A|Disease Progression|0|||
161854346|NCT00996892|584506396|FG016|Expansion Stage 2A|Disease Progression|0|||
161854347|NCT00996892|584506397|FG017|Expansion Stage 2A|Disease Progression|0|||
161854348|NCT00996892|584506398|FG018|Expansion Stage 2A|Disease Progression|0|||
161854349|NCT00996892|584506399|FG019|Expansion Stage 2A|Disease Progression|31|||
161854350|NCT00993421|584506400|FG000|Overall Study|Adverse Event|2|||
161854351|NCT00993421|584506401|FG001|Overall Study|Adverse Event|7|||
161854352|NCT00993421|584506402|FG002|Overall Study|Adverse Event|6|||
161854353|NCT00993421|584506403|FG003|Overall Study|Adverse Event|9|||
161854354|NCT00993421|584506404|FG004|Overall Study|Adverse Event|5|||
161854355|NCT00993421|584506405|FG005|Overall Study|Adverse Event|7|||
161854356|NCT00993421|584506406|FG006|Overall Study|Adverse Event|1|||
161854357|NCT00993421|584506400|FG000|Overall Study|Sponsor Decision|36|||
161854358|NCT00993421|584506401|FG001|Overall Study|Sponsor Decision|31|||
161854359|NCT00993421|584506402|FG002|Overall Study|Sponsor Decision|28|||
161854360|NCT00993421|584506403|FG003|Overall Study|Sponsor Decision|30|||
161854361|NCT00993421|584506404|FG004|Overall Study|Sponsor Decision|38|||
161854362|NCT00993421|584506405|FG005|Overall Study|Sponsor Decision|30|||
161854363|NCT00993421|584506406|FG006|Overall Study|Sponsor Decision|29|||
161854364|NCT00993421|584506400|FG000|Overall Study|Lost to Follow-up|3|||
161854365|NCT00993421|584506401|FG001|Overall Study|Lost to Follow-up|5|||
161854366|NCT00993421|584506402|FG002|Overall Study|Lost to Follow-up|5|||
161854367|NCT00993421|584506403|FG003|Overall Study|Lost to Follow-up|0|||
161854368|NCT00993421|584506404|FG004|Overall Study|Lost to Follow-up|0|||
161854369|NCT00993421|584506405|FG005|Overall Study|Lost to Follow-up|0|||
161854370|NCT00993421|584506406|FG006|Overall Study|Lost to Follow-up|6|||
161854371|NCT00993421|584506400|FG000|Overall Study|Withdrawal by Subject|3|||
161854372|NCT00993421|584506401|FG001|Overall Study|Withdrawal by Subject|2|||
161854373|NCT00993421|584506402|FG002|Overall Study|Withdrawal by Subject|3|||
161854374|NCT00993421|584506403|FG003|Overall Study|Withdrawal by Subject|3|||
161854375|NCT00993421|584506404|FG004|Overall Study|Withdrawal by Subject|3|||
161854376|NCT00993421|584506405|FG005|Overall Study|Withdrawal by Subject|5|||
161854377|NCT00993421|584506406|FG006|Overall Study|Withdrawal by Subject|3|||
161854378|NCT00993421|584506400|FG000|Overall Study|Death|0|||
161854379|NCT00993421|584506401|FG001|Overall Study|Death|0|||
161854380|NCT00993421|584506402|FG002|Overall Study|Death|0|||
161854381|NCT00993421|584506403|FG003|Overall Study|Death|0|||
161854382|NCT00993421|584506404|FG004|Overall Study|Death|0|||
161854383|NCT00993421|584506405|FG005|Overall Study|Death|0|||
161854384|NCT00993421|584506406|FG006|Overall Study|Death|1|||
161854385|NCT00993421|584506400|FG000|Overall Study|Entry Criteria Exclusion|0|||
161854386|NCT00993421|584506401|FG001|Overall Study|Entry Criteria Exclusion|0|||
161854387|NCT00993421|584506402|FG002|Overall Study|Entry Criteria Exclusion|1|||
161854388|NCT00993421|584506403|FG003|Overall Study|Entry Criteria Exclusion|3|||
161854389|NCT00993421|584506404|FG004|Overall Study|Entry Criteria Exclusion|0|||
161854390|NCT00993421|584506405|FG005|Overall Study|Entry Criteria Exclusion|1|||
161854391|NCT00993421|584506406|FG006|Overall Study|Entry Criteria Exclusion|0|||
161854392|NCT00993421|584506400|FG000|Overall Study|Physician Decision|0|||
161854393|NCT00993421|584506401|FG001|Overall Study|Physician Decision|0|||
161854394|NCT00993421|584506402|FG002|Overall Study|Physician Decision|0|||
161854395|NCT00993421|584506403|FG003|Overall Study|Physician Decision|0|||
161854396|NCT00993421|584506404|FG004|Overall Study|Physician Decision|0|||
161854397|NCT00993421|584506405|FG005|Overall Study|Physician Decision|1|||
161854398|NCT00993421|584506406|FG006|Overall Study|Physician Decision|1|||
161854399|NCT00993421|584506400|FG000|Overall Study|Protocol Violation|0|||
161854400|NCT00993421|584506401|FG001|Overall Study|Protocol Violation|0|||
161854401|NCT00993421|584506402|FG002|Overall Study|Protocol Violation|0|||
161854402|NCT00993421|584506403|FG003|Overall Study|Protocol Violation|0|||
161854403|NCT00993421|584506404|FG004|Overall Study|Protocol Violation|0|||
161854404|NCT00993421|584506405|FG005|Overall Study|Protocol Violation|2|||
161854405|NCT00993421|584506406|FG006|Overall Study|Protocol Violation|1|||
161854406|NCT02759692|584506407|FG000|Period 1|Test article no longer available|1|||
161854407|NCT02759692|584506408|FG001|Period 1|Test article no longer available|1|||
161854408|NCT02759692|584506407|FG000|Period 1|No longer meets eligibility criteria.|1|||
161854409|NCT02759692|584506408|FG001|Period 1|No longer meets eligibility criteria.|0|||
161854410|NCT02759692|584506407|FG000|Period 1|Miss-Randomized|1|||
161854411|NCT02759692|584506408|FG001|Period 1|Miss-Randomized|1|||
161854412|NCT02759692|584506407|FG000|Period 2|Lost to Follow-up|1|||
161854413|NCT02759692|584506408|FG001|Period 2|Lost to Follow-up|0|||
161854414|NCT02759692|584506407|FG000|Period 2|Test article no longer available|0|||
161854415|NCT02759692|584506408|FG001|Period 2|Test article no longer available|1|||
161854416|NCT04042376|584506414|FG000|Overall Study|Withdrawal by Subject|1|||
161854417|NCT04042376|584506414|FG000|Overall Study|Death|3|||
161854418|NCT02514447|584508039|FG000|Overall Study|Withdrawal by Subject|3|||
161854419|NCT02514447|584508040|FG001|Overall Study|Withdrawal by Subject|1|||
161854420|NCT02514447|584508041|FG002|Overall Study|Withdrawal by Subject|1|||
161854421|NCT02514447|584508042|FG003|Overall Study|Withdrawal by Subject|0|||
161854422|NCT02514447|584508043|FG004|Overall Study|Withdrawal by Subject|0|||
161854423|NCT02514447|584508044|FG005|Overall Study|Withdrawal by Subject|0|||
161854424|NCT02514447|584508045|FG006|Overall Study|Withdrawal by Subject|0|||
161854425|NCT02514447|584508046|FG007|Overall Study|Withdrawal by Subject|1|||
161854426|NCT02514447|584508047|FG008|Overall Study|Withdrawal by Subject|1|||
161854427|NCT02514447|584508039|FG000|Overall Study|Death|24|||
161854428|NCT02514447|584508040|FG001|Overall Study|Death|28|||
161854429|NCT02514447|584508041|FG002|Overall Study|Death|29|||
161854430|NCT02514447|584508042|FG003|Overall Study|Death|0|||
161854431|NCT02514447|584508043|FG004|Overall Study|Death|3|||
161854432|NCT02514447|584508044|FG005|Overall Study|Death|4|||
161854433|NCT02514447|584508045|FG006|Overall Study|Death|8|||
161854434|NCT02514447|584508046|FG007|Overall Study|Death|6|||
161766712|NCT00635804|584187194|FG002|Overall Study|Withdrawal by Subject|0|||
161766713|NCT00635804|584187195|FG003|Overall Study|Withdrawal by Subject|0|||
161766714|NCT00635804|584187196|FG004|Overall Study|Withdrawal by Subject|0|||
161766715|NCT00635804|584187197|FG005|Overall Study|Withdrawal by Subject|0|||
161766716|NCT00635804|584187198|FG006|Overall Study|Withdrawal by Subject|0|||
161766717|NCT00635804|584187199|FG007|Overall Study|Withdrawal by Subject|0|||
161766718|NCT01425268|584187207|FG000|Overall Study|Withdrawal by Subject|2|||
161766719|NCT01425268|584187208|FG001|Overall Study|Withdrawal by Subject|0|||
161766720|NCT01425268|584187207|FG000|Overall Study|Sponsor Decision|5|||
161766721|NCT01425268|584187208|FG001|Overall Study|Sponsor Decision|0|||
161766722|NCT01425268|584187207|FG000|Overall Study|Physician Decision|1|||
161766723|NCT01425268|584187208|FG001|Overall Study|Physician Decision|0|||
161766724|NCT00719706|584187209|FG000|Overall Study|Adverse Event|5|||
161766725|NCT00719706|584187210|FG001|Overall Study|Adverse Event|4|||
161766726|NCT00719706|584187209|FG000|Overall Study|Withdrawal by Subject|1|||
161766727|NCT00719706|584187210|FG001|Overall Study|Withdrawal by Subject|2|||
161766728|NCT00719706|584187209|FG000|Overall Study|Protocol Violation|3|||
161766729|NCT00719706|584187210|FG001|Overall Study|Protocol Violation|0|||
161766730|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
161766731|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
161766732|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
161766733|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
161766734|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
161766735|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
161766736|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
161766737|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
161766738|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
161766739|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
161854435|NCT02514447|584508047|FG008|Overall Study|Death|5|||
161854436|NCT02514447|584508039|FG000|Overall Study|Lost to Follow-up|1|||
161854437|NCT02514447|584508040|FG001|Overall Study|Lost to Follow-up|0|||
161766740|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
161766741|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
161854438|NCT02514447|584508041|FG002|Overall Study|Lost to Follow-up|0|||
161766742|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
161854439|NCT02514447|584508042|FG003|Overall Study|Lost to Follow-up|0|||
161854440|NCT02514447|584508043|FG004|Overall Study|Lost to Follow-up|0|||
161766743|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
161766744|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
161766745|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Other|6|||
161766746|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Other|6|||
161766747|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Other|7|||
161766748|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
161766749|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
161766750|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
161766751|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Participant decision|7|||
161766752|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Participant decision|10|||
161766753|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Participant decision|9|||
161766754|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
161766755|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
161766756|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
161766757|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
161766758|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
161766759|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
161766760|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
161766761|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
161766762|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
161766763|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
161766764|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
161766765|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
161766766|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Other|6|||
161766767|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Other|6|||
161766768|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Other|7|||
161766769|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|No treatment given|0|||
161766770|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|No treatment given|1|||
161766771|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|No treatment given|1|||
161766772|NCT01072175|584187214|FG000|Part A (Drug-Drug Interaction)|Death|1|||
161766773|NCT01072175|584187215|FG001|Part A (Drug-Drug Interaction)|Death|0|||
161766774|NCT01072175|584187216|FG002|Part A (Drug-Drug Interaction)|Death|0|||
161766775|NCT01072175|584187217|FG003|Part A (Drug-Drug Interaction)|Death|0|||
161766776|NCT01072175|584187218|FG004|Part A (Drug-Drug Interaction)|Death|0|||
161766777|NCT01072175|584187219|FG005|Part A (Drug-Drug Interaction)|Death|0|||
161766778|NCT01072175|584187220|FG006|Part A (Drug-Drug Interaction)|Death|0|||
161766779|NCT01072175|584187221|FG007|Part A (Drug-Drug Interaction)|Death|0|||
161766780|NCT01072175|584187222|FG008|Part A (Drug-Drug Interaction)|Death|0|||
161766781|NCT01072175|584187223|FG009|Part A (Drug-Drug Interaction)|Death|0|||
161766782|NCT01072175|584187224|FG010|Part A (Drug-Drug Interaction)|Death|0|||
161766783|NCT01072175|584187225|FG011|Part A (Drug-Drug Interaction)|Death|0|||
161766784|NCT01072175|584187226|FG012|Part A (Drug-Drug Interaction)|Death|0|||
161766785|NCT01072175|584187214|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
161766786|NCT01072175|584187215|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766787|NCT01072175|584187216|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766788|NCT01072175|584187217|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766789|NCT01072175|584187218|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766790|NCT01072175|584187219|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766791|NCT01072175|584187220|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766792|NCT01072175|584187221|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766793|NCT01072175|584187222|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766794|NCT01072175|584187223|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766795|NCT01072175|584187224|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161854441|NCT02514447|584508044|FG005|Overall Study|Lost to Follow-up|0|||
161854442|NCT02514447|584508045|FG006|Overall Study|Lost to Follow-up|0|||
161854443|NCT02514447|584508046|FG007|Overall Study|Lost to Follow-up|0|||
161854444|NCT02514447|584508047|FG008|Overall Study|Lost to Follow-up|1|||
161766796|NCT01072175|584187225|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766797|NCT01072175|584187226|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766798|NCT01072175|584187214|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
161766799|NCT01072175|584187215|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766800|NCT01072175|584187216|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766801|NCT01072175|584187217|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766802|NCT01072175|584187218|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766803|NCT01072175|584187219|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766804|NCT01072175|584187220|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766805|NCT01072175|584187221|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766806|NCT01072175|584187222|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766807|NCT01072175|584187223|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766808|NCT01072175|584187224|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766809|NCT01072175|584187225|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766810|NCT01072175|584187226|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766811|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
161766812|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
161766813|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
161766814|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
161766815|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
161766816|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
161766817|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
161766818|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
161766819|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
161766820|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
161766821|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
161766822|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
161766823|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
161854445|NCT02514447|584508039|FG000|Overall Study|Sponsor Termination of Study|0|||
161854446|NCT02514447|584508040|FG001|Overall Study|Sponsor Termination of Study|1|||
161854447|NCT02514447|584508041|FG002|Overall Study|Sponsor Termination of Study|1|||
161854448|NCT02514447|584508042|FG003|Overall Study|Sponsor Termination of Study|0|||
161854449|NCT02514447|584508043|FG004|Overall Study|Sponsor Termination of Study|0|||
161854450|NCT02514447|584508044|FG005|Overall Study|Sponsor Termination of Study|0|||
161854451|NCT02514447|584508045|FG006|Overall Study|Sponsor Termination of Study|0|||
161854452|NCT02514447|584508046|FG007|Overall Study|Sponsor Termination of Study|0|||
161854453|NCT02514447|584508047|FG008|Overall Study|Sponsor Termination of Study|0|||
161854454|NCT02514447|584508039|FG000|Overall Study|Study completion per Investigator|1|||
161854455|NCT02514447|584508040|FG001|Overall Study|Study completion per Investigator|0|||
161854456|NCT02514447|584508041|FG002|Overall Study|Study completion per Investigator|1|||
161854457|NCT02514447|584508042|FG003|Overall Study|Study completion per Investigator|2|||
161854458|NCT02514447|584508043|FG004|Overall Study|Study completion per Investigator|0|||
161854459|NCT02514447|584508044|FG005|Overall Study|Study completion per Investigator|0|||
161854460|NCT02514447|584508045|FG006|Overall Study|Study completion per Investigator|0|||
161854461|NCT02514447|584508046|FG007|Overall Study|Study completion per Investigator|0|||
161854462|NCT02514447|584508047|FG008|Overall Study|Study completion per Investigator|1|||
161854463|NCT01434810|584508055|FG000|Overall Study|Did not receive treatment|11|||
161854464|NCT01434810|584508056|FG001|Overall Study|Did not receive treatment|3|||
161854465|NCT01434810|584508055|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
161854466|NCT01434810|584508056|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
161854467|NCT02794870|584508058|FG000|Overall Study|Withdrawal by Subject|2|||
161854468|NCT02794870|584508059|FG001|Overall Study|Withdrawal by Subject|0|||
161854469|NCT02540083|584508066|FG000|Overall Study|Withdrawal by Subject|16|||
161854470|NCT02301390|584508067|FG000|Overall Study|Withdrawal by Subject|3|||
161854471|NCT02301390|584508068|FG001|Overall Study|Withdrawal by Subject|5|||
161854472|NCT02301390|584508067|FG000|Overall Study|Protocol Violation|1|||
161854473|NCT02301390|584508068|FG001|Overall Study|Protocol Violation|0|||
161854474|NCT02301390|584508067|FG000|Overall Study|Physician Decision|1|||
161854475|NCT02301390|584508068|FG001|Overall Study|Physician Decision|0|||
161854476|NCT02301390|584508067|FG000|Overall Study|Lost to Follow-up|0|||
161854477|NCT02301390|584508068|FG001|Overall Study|Lost to Follow-up|1|||
161854478|NCT02301390|584508067|FG000|Overall Study|Death|2|||
161854479|NCT02301390|584508068|FG001|Overall Study|Death|2|||
161854480|NCT02301390|584508067|FG000|Overall Study|Procedure not completed|0|||
161854481|NCT02301390|584508068|FG001|Overall Study|Procedure not completed|4|||
161854482|NCT02301390|584508067|FG000|Overall Study|Missed multiple visits|1|||
161854483|NCT02301390|584508068|FG001|Overall Study|Missed multiple visits|1|||
161854484|NCT02301390|584508067|FG000|Overall Study|study terminated|2|||
161854485|NCT02301390|584508068|FG001|Overall Study|study terminated|0|||
161854486|NCT00185588|584508069|FG000|Overall Study|Adverse Event|3|||
161854487|NCT00185588|584508070|FG001|Overall Study|Adverse Event|1|||
161854488|NCT00185588|584508071|FG002|Overall Study|Adverse Event|4|||
161854489|NCT00185588|584508072|FG003|Overall Study|Adverse Event|2|||
161854490|NCT00185588|584508069|FG000|Overall Study|Lost to Follow-up|0|||
161854491|NCT00185588|584508070|FG001|Overall Study|Lost to Follow-up|0|||
161854492|NCT00185588|584508071|FG002|Overall Study|Lost to Follow-up|1|||
161854493|NCT00185588|584508072|FG003|Overall Study|Lost to Follow-up|2|||
161854494|NCT00185588|584508069|FG000|Overall Study|Withdrawal by Subject|0|||
161854495|NCT00185588|584508070|FG001|Overall Study|Withdrawal by Subject|1|||
161854496|NCT00185588|584508071|FG002|Overall Study|Withdrawal by Subject|0|||
161854497|NCT00185588|584508072|FG003|Overall Study|Withdrawal by Subject|0|||
161854498|NCT00185588|584508069|FG000|Overall Study|Physician Decision|0|||
161854499|NCT00185588|584508070|FG001|Overall Study|Physician Decision|0|||
161854500|NCT00185588|584508071|FG002|Overall Study|Physician Decision|1|||
161854501|NCT00185588|584508072|FG003|Overall Study|Physician Decision|0|||
161854502|NCT00398866|584508073|FG000|Overall Study|Adverse Event|1|||
161854503|NCT00398866|584508074|FG001|Overall Study|Adverse Event|0|||
161854504|NCT00398866|584508075|FG002|Overall Study|Adverse Event|0|||
161854505|NCT00398866|584508073|FG000|Overall Study|Lack of Efficacy|0|||
161854506|NCT00398866|584508074|FG001|Overall Study|Lack of Efficacy|0|||
161854507|NCT00398866|584508075|FG002|Overall Study|Lack of Efficacy|1|||
161854508|NCT00398866|584508073|FG000|Overall Study|Lost to Follow-up|7|||
161854509|NCT00398866|584508074|FG001|Overall Study|Lost to Follow-up|6|||
161854510|NCT00398866|584508075|FG002|Overall Study|Lost to Follow-up|4|||
161854511|NCT00398866|584508073|FG000|Overall Study|Withdrawal by Subject|5|||
161854512|NCT00398866|584508074|FG001|Overall Study|Withdrawal by Subject|1|||
161854513|NCT00398866|584508075|FG002|Overall Study|Withdrawal by Subject|2|||
161854514|NCT00398866|584508073|FG000|Overall Study|Unable to complete requirements of study|1|||
161854515|NCT00398866|584508074|FG001|Overall Study|Unable to complete requirements of study|1|||
161854516|NCT00398866|584508075|FG002|Overall Study|Unable to complete requirements of study|1|||
161854517|NCT02481869|584508080|FG000|Overall Study|Lost to Follow-up|3|||
161854518|NCT02481869|584508081|FG001|Overall Study|Lost to Follow-up|4|||
161854519|NCT02481869|584508080|FG000|Overall Study|Withdrawal by Subject|2|||
161854520|NCT02481869|584508081|FG001|Overall Study|Withdrawal by Subject|0|||
161854521|NCT01153425|584508087|FG000|Overall Study|Withdrawal by Subject|3|||
161854522|NCT01153425|584508088|FG001|Overall Study|Withdrawal by Subject|3|||
161854523|NCT03154125|584508089|FG000|Overall Study|Lost to Follow-up|11|||
161854524|NCT03154125|584508090|FG001|Overall Study|Lost to Follow-up|11|||
161854525|NCT03154125|584508091|FG002|Overall Study|Lost to Follow-up|0|||
161854526|NCT03154125|584508089|FG000|Overall Study|Withdrawal by Subject|49|||
161854527|NCT03154125|584508090|FG001|Overall Study|Withdrawal by Subject|55|||
161854528|NCT03154125|584508091|FG002|Overall Study|Withdrawal by Subject|8|||
161854529|NCT03154125|584508089|FG000|Overall Study|Physician Decision|13|||
161854530|NCT03154125|584508090|FG001|Overall Study|Physician Decision|6|||
161854531|NCT03154125|584508091|FG002|Overall Study|Physician Decision|0|||
161854532|NCT03154125|584508089|FG000|Overall Study|Protocol Violation|3|||
161854533|NCT03154125|584508090|FG001|Overall Study|Protocol Violation|5|||
161854534|NCT03154125|584508091|FG002|Overall Study|Protocol Violation|0|||
161854535|NCT00810511|584508092|FG000|Overall Study|Protocol Violation|0|||
161854536|NCT00810511|584508093|FG001|Overall Study|Protocol Violation|1|||
161854537|NCT00810511|584508092|FG000|Overall Study|Lack of Efficacy|9|||
161854538|NCT00810511|584508093|FG001|Overall Study|Lack of Efficacy|1|||
161854539|NCT00810511|584508092|FG000|Overall Study|death in the family|0|||
161854540|NCT00810511|584508093|FG001|Overall Study|death in the family|1|||
161854541|NCT00810511|584508092|FG000|Overall Study|Lost to Follow-up|1|||
161854542|NCT00810511|584508093|FG001|Overall Study|Lost to Follow-up|0|||
161854543|NCT00810511|584508092|FG000|Overall Study|deposits on contact lens|0|||
161854544|NCT00810511|584508093|FG001|Overall Study|deposits on contact lens|1|||
161854545|NCT04342819|584508095|FG000|Overall Study|Declined|4|||
161854546|NCT04342819|584508095|FG000|Overall Study|Not meeeting selection criteria|1|||
161854547|NCT00911300|584508096|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
161854548|NCT00911300|584508097|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
161854549|NCT00911300|584508096|FG000|Overall Study|Death|1|||
161854550|NCT00911300|584508097|FG001|Overall Study|Death|0|||
161854551|NCT00911300|584508096|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
161854552|NCT00911300|584508097|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
161854553|NCT00911300|584508096|FG000|Overall Study|Adverse Event|14|||
161854554|NCT00911300|584508097|FG001|Overall Study|Adverse Event|6|||
161854555|NCT00911300|584508096|FG000|Overall Study|Protocol Violation|3|||
161854556|NCT00911300|584508097|FG001|Overall Study|Protocol Violation|2|||
161854557|NCT00911300|584508096|FG000|Overall Study|Consent Withdrawn|4|||
161854558|NCT00911300|584508097|FG001|Overall Study|Consent Withdrawn|12|||
161854559|NCT00911300|584508096|FG000|Overall Study|Coronary Angiography Performed|1|||
161854560|NCT00911300|584508097|FG001|Overall Study|Coronary Angiography Performed|0|||
161854561|NCT00911300|584508096|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
161854562|NCT00911300|584508097|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
161766824|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766825|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766826|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
161766827|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766828|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
161766829|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766830|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766831|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766832|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766833|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766834|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766835|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766836|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766837|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766838|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
161766839|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766840|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
161766841|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
161766842|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766843|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766844|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766845|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766846|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161854563|NCT00911300|584508096|FG000|Overall Study|Received Commercial Treatment|1|||
161766847|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161854564|NCT00911300|584508097|FG001|Overall Study|Received Commercial Treatment|0|||
161854565|NCT00911300|584508096|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
161854566|NCT00911300|584508097|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
161854567|NCT00911300|584508096|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
161766848|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766849|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766850|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766851|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766852|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
161766853|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
161766854|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
161766855|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766856|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766857|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766858|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766859|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766860|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766861|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766862|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766863|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766864|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
161766865|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766866|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
161766867|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
161766868|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766869|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766870|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766871|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766872|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766873|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766874|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766875|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766876|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
161766877|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
161766878|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
161766879|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
161766880|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
161766881|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
161766882|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
161766883|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
161766884|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
161766885|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
161766886|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
161766887|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
161766888|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
161766889|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766890|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766891|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766892|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766893|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766894|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161766895|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161766896|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161766897|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766898|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766899|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766900|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766901|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766902|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766903|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766904|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766905|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766906|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766907|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766908|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
161766909|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
161766910|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766911|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766912|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766913|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766914|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766915|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766916|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766917|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766918|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766919|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766920|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
161766921|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
161766922|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
161766923|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766924|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766925|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766926|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766927|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766928|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766929|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766930|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766931|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766932|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766933|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
161766934|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
161766935|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766936|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766937|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766938|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766939|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766940|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766941|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766942|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766943|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766944|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766945|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766946|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766947|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766948|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766949|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
161766950|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766951|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766952|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766953|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766954|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766955|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766956|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766957|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766958|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766959|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766960|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766961|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766962|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
161766963|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766964|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766965|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766966|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766967|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766968|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766969|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766970|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766971|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766972|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766973|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766974|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766975|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
161766976|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766977|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766978|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766979|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766980|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766981|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766982|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766983|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766984|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766985|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766986|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766987|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766988|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
161766989|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766990|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766991|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766992|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766993|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Death|0|||
161766994|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Death|0|||
161766995|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Death|0|||
161766996|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Death|0|||
161766997|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Death|0|||
161766998|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Death|0|||
161766999|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Death|0|||
161767000|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Death|0|||
161767001|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Death|0|||
161767002|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Death|10|||
161767003|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Death|12|||
161767004|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Death|28|||
161767005|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Death|26|||
161767006|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
161767007|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
161767008|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
161767009|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
161767010|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
161767011|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
161767012|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
161767013|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
161767014|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
161767015|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
161767016|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
161767017|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
161767018|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
161767019|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767020|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767021|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161854568|NCT00911300|584508097|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
161854569|NCT00911300|584508096|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
161854570|NCT00911300|584508097|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
161854571|NCT00911300|584508096|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
161854572|NCT00911300|584508097|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
161854573|NCT00911300|584508096|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
161854574|NCT00911300|584508097|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
161854575|NCT00911300|584508096|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
161854576|NCT00911300|584508097|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
161854577|NCT00911300|584508096|FG000|Overall Study|International Normalized Ratio Too High|0|||
161854578|NCT00911300|584508097|FG001|Overall Study|International Normalized Ratio Too High|1|||
161854579|NCT00911300|584508096|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
161854580|NCT00911300|584508097|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
161854581|NCT00911300|584508096|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
161854582|NCT00911300|584508097|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
161854583|NCT00911300|584508096|FG000|Overall Study|Physician Decision|0|||
161854584|NCT00911300|584508097|FG001|Overall Study|Physician Decision|1|||
161854585|NCT00911300|584508096|FG000|Overall Study|Treatment Stopped by Mistake|0|||
161854586|NCT00911300|584508097|FG001|Overall Study|Treatment Stopped by Mistake|1|||
161854587|NCT00911300|584508096|FG000|Overall Study|Randomized; No Study Medication Received|0|||
161854588|NCT00911300|584508097|FG001|Overall Study|Randomized; No Study Medication Received|2|||
161854589|NCT00666328|584508101|FG000|Overall Study|Death|2|||
161854590|NCT00666328|584508101|FG000|Overall Study|Lost to Follow-up|2|||
161854591|NCT00666328|584508101|FG000|Overall Study|No longer met eligibility criteria|1|||
161854592|NCT02288325|584508102|FG000|Run-in Period|Adverse Event|48|||
161854593|NCT02288325|584508103|FG001|Run-in Period|Adverse Event|0|||
161854594|NCT02288325|584508104|FG002|Run-in Period|Adverse Event|0|||
161854595|NCT02288325|584508102|FG000|Run-in Period|Lack of Efficacy|16|||
161854596|NCT02288325|584508103|FG001|Run-in Period|Lack of Efficacy|0|||
161854597|NCT02288325|584508104|FG002|Run-in Period|Lack of Efficacy|0|||
161854598|NCT02288325|584508102|FG000|Run-in Period|Withdrawal of Consent|28|||
161854599|NCT02288325|584508103|FG001|Run-in Period|Withdrawal of Consent|0|||
161854600|NCT02288325|584508104|FG002|Run-in Period|Withdrawal of Consent|0|||
161854601|NCT02288325|584508102|FG000|Run-in Period|Lost to Follow-up|25|||
161854602|NCT02288325|584508103|FG001|Run-in Period|Lost to Follow-up|0|||
161854603|NCT02288325|584508104|FG002|Run-in Period|Lost to Follow-up|0|||
161854604|NCT02288325|584508102|FG000|Run-in Period|Protocol Violation|17|||
161854605|NCT02288325|584508103|FG001|Run-in Period|Protocol Violation|0|||
161854606|NCT02288325|584508104|FG002|Run-in Period|Protocol Violation|0|||
161854607|NCT02288325|584508102|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
161854608|NCT02288325|584508103|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
161854609|NCT02288325|584508104|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
161854610|NCT02288325|584508102|FG000|Run-in Period|Reason not Specified|8|||
161854611|NCT02288325|584508103|FG001|Run-in Period|Reason not Specified|0|||
161854612|NCT02288325|584508104|FG002|Run-in Period|Reason not Specified|0|||
161854613|NCT02288325|584508102|FG000|Stabilization Period|Adverse Event|13|||
161854614|NCT02288325|584508103|FG001|Stabilization Period|Adverse Event|0|||
161854615|NCT02288325|584508104|FG002|Stabilization Period|Adverse Event|0|||
161854616|NCT02288325|584508102|FG000|Stabilization Period|Lack of Efficacy|22|||
161854617|NCT02288325|584508103|FG001|Stabilization Period|Lack of Efficacy|0|||
161854618|NCT02288325|584508104|FG002|Stabilization Period|Lack of Efficacy|0|||
161854619|NCT02288325|584508102|FG000|Stabilization Period|Withdrawal of Consent|23|||
161854620|NCT02288325|584508103|FG001|Stabilization Period|Withdrawal of Consent|0|||
161854621|NCT02288325|584508104|FG002|Stabilization Period|Withdrawal of Consent|0|||
161854622|NCT02288325|584508102|FG000|Stabilization Period|Lost to Follow-up|12|||
161854623|NCT02288325|584508103|FG001|Stabilization Period|Lost to Follow-up|0|||
161854624|NCT02288325|584508104|FG002|Stabilization Period|Lost to Follow-up|0|||
161854625|NCT02288325|584508102|FG000|Stabilization Period|Protocol Violation|8|||
161854626|NCT02288325|584508103|FG001|Stabilization Period|Protocol Violation|0|||
161854627|NCT02288325|584508104|FG002|Stabilization Period|Protocol Violation|0|||
161854628|NCT02288325|584508102|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
161854629|NCT02288325|584508103|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
161854630|NCT02288325|584508104|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
161854631|NCT02288325|584508102|FG000|Stabilization Period|Reason not Specified|15|||
161854632|NCT02288325|584508103|FG001|Stabilization Period|Reason not Specified|0|||
161854633|NCT02288325|584508104|FG002|Stabilization Period|Reason not Specified|0|||
161854634|NCT02288325|584508102|FG000|Double-blind Treatment Period|Adverse Event|0|||
161854635|NCT02288325|584508103|FG001|Double-blind Treatment Period|Adverse Event|2|||
161854636|NCT02288325|584508104|FG002|Double-blind Treatment Period|Adverse Event|5|||
161854637|NCT02288325|584508102|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
161854638|NCT02288325|584508103|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
161854639|NCT02288325|584508104|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
161854640|NCT02288325|584508102|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161854641|NCT02288325|584508103|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
161854642|NCT02288325|584508104|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161854643|NCT02288325|584508102|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161854644|NCT02288325|584508103|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161854645|NCT02288325|584508104|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161854646|NCT02288325|584508102|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
161854647|NCT02288325|584508103|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
161854648|NCT02288325|584508104|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
161854649|NCT02288325|584508102|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
161854650|NCT02288325|584508103|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
161854651|NCT02288325|584508104|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
161854652|NCT03607487|584508108|FG000|Overall Study|Withdrawal by Subject|2|||
161854653|NCT03607487|584508109|FG001|Overall Study|Withdrawal by Subject|0|||
161854654|NCT03607487|584508110|FG002|Overall Study|Withdrawal by Subject|0|||
161854655|NCT03607487|584508111|FG003|Overall Study|Withdrawal by Subject|1|||
161854656|NCT04759703|584508113|FG000|Overall Study|Withdrawal by Subject|4|||
161854657|NCT04759703|584508114|FG001|Overall Study|Withdrawal by Subject|9|||
161854658|NCT04759703|584508113|FG000|Overall Study|Adverse Event|1|||
161854659|NCT04759703|584508114|FG001|Overall Study|Adverse Event|0|||
161854660|NCT04759703|584508113|FG000|Overall Study|Lost to Follow-up|2|||
161854661|NCT04759703|584508114|FG001|Overall Study|Lost to Follow-up|0|||
161854662|NCT04186845|584508122|FG000|Overall Study|Death|2|||
161854663|NCT04186845|584508122|FG000|Overall Study|Lost to Follow-up|1|||
161854664|NCT04186845|584508122|FG000|Overall Study|Physician Decision|1|||
161854665|NCT04186845|584508122|FG000|Overall Study|Protocol Violation|1|||
161854666|NCT04186845|584508122|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
161854667|NCT04186845|584508122|FG000|Overall Study|Biopsy ordered but not done|1|||
161854668|NCT04186845|584508122|FG000|Overall Study|It was previously confirmed|1|||
161854669|NCT04186845|584508122|FG000|Overall Study|Patient cancelled scheduled scans|2|||
161854670|NCT04186845|584508122|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
161854671|NCT04186845|584508122|FG000|Overall Study|Subject refused confirmatory imaging|1|||
161854672|NCT04186845|584508122|FG000|Overall Study|Too small to biopsy|1|||
161854673|NCT04138823|584508123|FG000|Overall Study|Clinical disease progression|0|||
161854674|NCT04138823|584508124|FG001|Overall Study|Clinical disease progression|0|||
161854675|NCT04138823|584508125|FG002|Overall Study|Clinical disease progression|1|||
161854676|NCT04138823|584508123|FG000|Overall Study|Objective disease progression|3|||
161854677|NCT04138823|584508124|FG001|Overall Study|Objective disease progression|2|||
161854678|NCT04138823|584508125|FG002|Overall Study|Objective disease progression|5|||
161854679|NCT03151304|584508126|FG000|Overall Study|Termination of study by Sponsor|23|||
161854680|NCT03151304|584508126|FG000|Overall Study|missing|3|||
161854681|NCT03151304|584508126|FG000|Overall Study|Withdrawal by Subject|8|||
161854682|NCT03151304|584508126|FG000|Overall Study|multiple reasons|30|||
161854683|NCT04868500|584508127|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
161854684|NCT04868500|584508128|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
161854685|NCT04868500|584508127|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
161854686|NCT04868500|584508128|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
161854687|NCT02466685|584508129|FG000|Overall Study|Adverse Event|5|||
161854688|NCT02466685|584508130|FG001|Overall Study|Adverse Event|2|||
161854689|NCT02466685|584508129|FG000|Overall Study|Lost to Follow-up|1|||
161854690|NCT02466685|584508130|FG001|Overall Study|Lost to Follow-up|1|||
161767022|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767023|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767024|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767025|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767026|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767027|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767028|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767029|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
161767030|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
161767031|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
161767032|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767033|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767034|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767035|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767036|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767037|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767038|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767039|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767040|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767041|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
161767042|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
161767043|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
161767044|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
161767045|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767046|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767047|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767048|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767049|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767050|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767051|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767052|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767053|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767054|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767055|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
161767056|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
161767057|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767058|NCT02839330|584187227|FG000|Overall Study|Adverse Event|0|||
161767059|NCT02839330|584187228|FG001|Overall Study|Adverse Event|1|||
161767060|NCT02839330|584187229|FG002|Overall Study|Adverse Event|2|||
161767061|NCT02839330|584187230|FG003|Overall Study|Adverse Event|2|||
161767062|NCT02839330|584187227|FG000|Overall Study|Death|4|||
161767063|NCT02839330|584187228|FG001|Overall Study|Death|6|||
161767064|NCT02839330|584187229|FG002|Overall Study|Death|1|||
161767065|NCT02839330|584187230|FG003|Overall Study|Death|1|||
161767066|NCT02839330|584187227|FG000|Overall Study|Withdrawal by Subject|27|||
161767067|NCT02839330|584187228|FG001|Overall Study|Withdrawal by Subject|19|||
161767068|NCT02839330|584187229|FG002|Overall Study|Withdrawal by Subject|11|||
161767069|NCT02839330|584187230|FG003|Overall Study|Withdrawal by Subject|13|||
161767070|NCT02839330|584187227|FG000|Overall Study|Lost to Follow-up|22|||
161767071|NCT02839330|584187228|FG001|Overall Study|Lost to Follow-up|27|||
161767072|NCT02839330|584187229|FG002|Overall Study|Lost to Follow-up|29|||
161767073|NCT02839330|584187230|FG003|Overall Study|Lost to Follow-up|25|||
161767074|NCT02839330|584187227|FG000|Overall Study|Administrative Reason|0|||
161767075|NCT02839330|584187228|FG001|Overall Study|Administrative Reason|0|||
161767076|NCT02839330|584187229|FG002|Overall Study|Administrative Reason|0|||
161767077|NCT02839330|584187230|FG003|Overall Study|Administrative Reason|1|||
161767078|NCT02839330|584187227|FG000|Overall Study|Protocol Violation|1|||
161767079|NCT02839330|584187228|FG001|Overall Study|Protocol Violation|2|||
161767080|NCT02839330|584187229|FG002|Overall Study|Protocol Violation|2|||
161767081|NCT02839330|584187230|FG003|Overall Study|Protocol Violation|3|||
161767082|NCT02839330|584187227|FG000|Overall Study|Other reason, not specified|4|||
161767083|NCT02839330|584187228|FG001|Overall Study|Other reason, not specified|3|||
161767084|NCT02839330|584187229|FG002|Overall Study|Other reason, not specified|3|||
161767085|NCT02839330|584187230|FG003|Overall Study|Other reason, not specified|6|||
161767086|NCT00682539|584187231|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
161767087|NCT00682539|584187232|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
161767088|NCT00682539|584187233|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
161767089|NCT00682539|584187231|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
161767090|NCT00682539|584187232|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
161767091|NCT00682539|584187233|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
161767092|NCT02477215|584187243|FG000|Dose Escalation Phase|Physician Decision|1|||
161767093|NCT02477215|584187244|FG001|Dose Escalation Phase|Physician Decision|2|||
161767094|NCT02477215|584187245|FG002|Dose Escalation Phase|Physician Decision|0|||
161767095|NCT02477215|584187243|FG000|Fixed Dose Phase|Physician Decision|0|||
161854691|NCT02466685|584508129|FG000|Overall Study|Withdrawal by Subject|1|||
161854692|NCT02466685|584508130|FG001|Overall Study|Withdrawal by Subject|0|||
161854693|NCT02466685|584508129|FG000|Overall Study|Physician Decision|1|||
161854694|NCT02466685|584508130|FG001|Overall Study|Physician Decision|1|||
161854695|NCT02565511|584508131|FG000|Overall Study|Study terminated by Sponsor|35|||
161854696|NCT02565511|584508132|FG001|Overall Study|Study terminated by Sponsor|22|||
161854697|NCT02565511|584508133|FG002|Overall Study|Study terminated by Sponsor|235|||
161854698|NCT02565511|584508134|FG003|Overall Study|Study terminated by Sponsor|156|||
161854699|NCT02565511|584508131|FG000|Overall Study|Withdrawal by Subject|3|||
161854700|NCT02565511|584508132|FG001|Overall Study|Withdrawal by Subject|0|||
161854701|NCT02565511|584508133|FG002|Overall Study|Withdrawal by Subject|12|||
161854702|NCT02565511|584508134|FG003|Overall Study|Withdrawal by Subject|5|||
161854703|NCT02565511|584508131|FG000|Overall Study|Adverse Event|0|||
161854704|NCT02565511|584508132|FG001|Overall Study|Adverse Event|0|||
161854705|NCT02565511|584508133|FG002|Overall Study|Adverse Event|1|||
161854706|NCT02565511|584508134|FG003|Overall Study|Adverse Event|1|||
161854707|NCT02565511|584508131|FG000|Overall Study|Lost to Follow-up|4|||
161854708|NCT02565511|584508132|FG001|Overall Study|Lost to Follow-up|1|||
161854709|NCT02565511|584508133|FG002|Overall Study|Lost to Follow-up|0|||
161854710|NCT02565511|584508134|FG003|Overall Study|Lost to Follow-up|1|||
161854711|NCT02565511|584508131|FG000|Overall Study|Physician Decision|0|||
161854712|NCT02565511|584508132|FG001|Overall Study|Physician Decision|0|||
161854713|NCT02565511|584508133|FG002|Overall Study|Physician Decision|0|||
161854714|NCT02565511|584508134|FG003|Overall Study|Physician Decision|1|||
161854715|NCT02565511|584508131|FG000|Overall Study|Protocol deviation|0|||
161854716|NCT02565511|584508132|FG001|Overall Study|Protocol deviation|0|||
161854717|NCT02565511|584508133|FG002|Overall Study|Protocol deviation|3|||
161854718|NCT02565511|584508134|FG003|Overall Study|Protocol deviation|0|||
161854719|NCT01941498|584508135|FG000|Overall Study|Relocated out of state|1|||
161854720|NCT02006732|584508136|FG000|Overall Study|Adverse Event|10|||
161854721|NCT02006732|584508137|FG001|Overall Study|Adverse Event|7|||
161854722|NCT02006732|584508138|FG002|Overall Study|Adverse Event|4|||
161854723|NCT02006732|584508139|FG003|Overall Study|Adverse Event|2|||
161854724|NCT02006732|584508136|FG000|Overall Study|Lack of Efficacy|6|||
161854725|NCT02006732|584508137|FG001|Overall Study|Lack of Efficacy|3|||
161854726|NCT02006732|584508138|FG002|Overall Study|Lack of Efficacy|1|||
161854727|NCT02006732|584508139|FG003|Overall Study|Lack of Efficacy|1|||
161854728|NCT02006732|584508136|FG000|Overall Study|Protocol Violation|1|||
161854729|NCT02006732|584508137|FG001|Overall Study|Protocol Violation|1|||
161854730|NCT02006732|584508138|FG002|Overall Study|Protocol Violation|0|||
161854731|NCT02006732|584508139|FG003|Overall Study|Protocol Violation|0|||
161854732|NCT02006732|584508136|FG000|Overall Study|Lost to Follow-up|0|||
161854733|NCT02006732|584508137|FG001|Overall Study|Lost to Follow-up|1|||
161854734|NCT02006732|584508138|FG002|Overall Study|Lost to Follow-up|0|||
161854735|NCT02006732|584508139|FG003|Overall Study|Lost to Follow-up|0|||
161854736|NCT02006732|584508136|FG000|Overall Study|Withdrawal by Subject|3|||
161854737|NCT02006732|584508137|FG001|Overall Study|Withdrawal by Subject|0|||
161854738|NCT02006732|584508138|FG002|Overall Study|Withdrawal by Subject|4|||
161854739|NCT02006732|584508139|FG003|Overall Study|Withdrawal by Subject|1|||
161854740|NCT01755091|584508140|FG000|Overall Study|Withdrawal by Subject|6|||
161854741|NCT01755091|584508141|FG001|Overall Study|Withdrawal by Subject|1|||
161854742|NCT01755091|584508142|FG002|Overall Study|Withdrawal by Subject|3|||
161854743|NCT01755091|584508140|FG000|Overall Study|Adverse Event|1|||
161854744|NCT01755091|584508141|FG001|Overall Study|Adverse Event|1|||
161854745|NCT01755091|584508142|FG002|Overall Study|Adverse Event|1|||
161854746|NCT01755091|584508140|FG000|Overall Study|Lost to Follow-up|1|||
161854747|NCT01755091|584508141|FG001|Overall Study|Lost to Follow-up|0|||
161854748|NCT01755091|584508142|FG002|Overall Study|Lost to Follow-up|1|||
161854749|NCT01755091|584508140|FG000|Overall Study|Physician Decision|1|||
161854750|NCT01755091|584508141|FG001|Overall Study|Physician Decision|1|||
161854751|NCT01755091|584508142|FG002|Overall Study|Physician Decision|2|||
161854752|NCT02969044|584508143|FG000|Overall Study|Withdrawal by Subject|2|||
161854753|NCT02969044|584508144|FG001|Overall Study|Withdrawal by Subject|6|||
161854754|NCT02969044|584508143|FG000|Overall Study|Adverse Event|3|||
161854755|NCT02969044|584508144|FG001|Overall Study|Adverse Event|0|||
161854756|NCT01330303|584508146|FG000|Period 1|Adverse Event|1|||
161854757|NCT01330303|584508147|FG001|Period 1|Adverse Event|0|||
161854758|NCT01330303|584508146|FG000|Period 1|Protocol Violation|0|||
161854759|NCT01330303|584508147|FG001|Period 1|Protocol Violation|1|||
161854760|NCT01330303|584508146|FG000|Period 1|Withdrawal by Subject|0|||
161854761|NCT01330303|584508147|FG001|Period 1|Withdrawal by Subject|1|||
161854762|NCT00796757|584508148|FG000|Overall Study|Withdrawal by Subject|14|||
161854763|NCT00796757|584508148|FG000|Overall Study|Death|61|||
161854764|NCT00796757|584508148|FG000|Overall Study|Protocol Violation|1|||
161854765|NCT00796757|584508148|FG000|Overall Study|Participant noncompliance|1|||
161854766|NCT00796757|584508148|FG000|Overall Study|Investigator's decision|2|||
161854767|NCT00796757|584508148|FG000|Overall Study|Other|7|||
161854768|NCT03516513|584508149|FG000|Overall Study|Withdrawal by Subject|2|||
161854769|NCT03516513|584508150|FG001|Overall Study|Withdrawal by Subject|2|||
161854770|NCT03516513|584508151|FG002|Overall Study|Withdrawal by Subject|0|||
161854771|NCT03516513|584508152|FG003|Overall Study|Withdrawal by Subject|0|||
161854772|NCT02593110|584508154|FG000|Overall Study|Withdrawal by Subject|0|||
161854773|NCT02593110|584508155|FG001|Overall Study|Withdrawal by Subject|3|||
161854774|NCT02593110|584508156|FG002|Overall Study|Withdrawal by Subject|3|||
161854775|NCT02593110|584508157|FG003|Overall Study|Withdrawal by Subject|2|||
161854776|NCT02593110|584508154|FG000|Overall Study|Death|0|||
161854777|NCT02593110|584508155|FG001|Overall Study|Death|0|||
161854778|NCT02593110|584508156|FG002|Overall Study|Death|1|||
161854779|NCT02593110|584508157|FG003|Overall Study|Death|0|||
161854780|NCT03548337|584508158|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
161854781|NCT03548337|584508159|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
161854782|NCT03548337|584508158|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
161854783|NCT03548337|584508159|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
161854784|NCT03548337|584508158|FG000|Infant Series|Lost to Follow-up|2|||
161854785|NCT03548337|584508159|FG001|Infant Series|Lost to Follow-up|1|||
161854786|NCT03548337|584508158|FG000|Infant Series|Adverse Event|0|||
161854787|NCT03548337|584508159|FG001|Infant Series|Adverse Event|2|||
161854788|NCT03548337|584508158|FG000|Infant Series|Randomized but Not Vaccinated|1|||
161854789|NCT03548337|584508159|FG001|Infant Series|Randomized but Not Vaccinated|0|||
161854790|NCT03548337|584508158|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
161854791|NCT03548337|584508159|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
161854792|NCT01130597|584508160|FG000|Overall Study|Protocol-specified (High K+)|1|||
161854793|NCT01130597|584508160|FG000|Overall Study|Adverse Event|4|||
161854794|NCT01130597|584508160|FG000|Overall Study|Death|1|||
161854795|NCT01130597|584508160|FG000|Overall Study|Protocol Violation|1|||
161854796|NCT03052127|584508165|FG000|Overall Study|Withdrawal by Subject|0|||
161854797|NCT03052127|584508166|FG001|Overall Study|Withdrawal by Subject|0|||
161854798|NCT03052127|584508167|FG002|Overall Study|Withdrawal by Subject|0|||
161854799|NCT03052127|584508168|FG003|Overall Study|Withdrawal by Subject|0|||
161767096|NCT02477215|584187244|FG001|Fixed Dose Phase|Physician Decision|7|||
161767097|NCT02477215|584187245|FG002|Fixed Dose Phase|Physician Decision|0|||
161767098|NCT00508872|584187246|FG000|Overall Study|Lost to Follow-up|1|||
161767099|NCT00508872|584187246|FG000|Overall Study|Physician Decision|1|||
161767100|NCT00883896|584187247|FG000|Overall Study|Lost to Follow-up|0|||
161767101|NCT00883896|584187248|FG001|Overall Study|Lost to Follow-up|0|||
161767102|NCT00883896|584187249|FG002|Overall Study|Lost to Follow-up|0|||
161767103|NCT00883896|584187250|FG003|Overall Study|Lost to Follow-up|2|||
161767104|NCT00883896|584187247|FG000|Overall Study|Withdrawal by Subject|5|||
161767105|NCT00883896|584187248|FG001|Overall Study|Withdrawal by Subject|0|||
161767106|NCT00883896|584187249|FG002|Overall Study|Withdrawal by Subject|1|||
161767107|NCT00883896|584187250|FG003|Overall Study|Withdrawal by Subject|3|||
161767108|NCT00883896|584187247|FG000|Overall Study|Lack of Efficacy|0|||
161767109|NCT00883896|584187248|FG001|Overall Study|Lack of Efficacy|0|||
161767110|NCT00883896|584187249|FG002|Overall Study|Lack of Efficacy|0|||
161767111|NCT00883896|584187250|FG003|Overall Study|Lack of Efficacy|2|||
161767112|NCT00883896|584187247|FG000|Overall Study|Other|1|||
161767113|NCT00883896|584187248|FG001|Overall Study|Other|0|||
161767114|NCT00883896|584187249|FG002|Overall Study|Other|0|||
161767115|NCT00883896|584187250|FG003|Overall Study|Other|0|||
161767116|NCT00310440|584187251|FG000|Overall Study|Lost to Follow-up|17|||
161767117|NCT00310440|584187252|FG001|Overall Study|Lost to Follow-up|8|||
161767118|NCT00310440|584187251|FG000|Overall Study|Withdrawal by Subject|2|||
161767119|NCT00310440|584187252|FG001|Overall Study|Withdrawal by Subject|1|||
161767120|NCT00310440|584187251|FG000|Overall Study|Missed 12 Month Visit|7|||
161767121|NCT00310440|584187252|FG001|Overall Study|Missed 12 Month Visit|4|||
161767122|NCT01654666|584187260|FG000|Overall Study|Protocol Violation|7|||
161767123|NCT01654666|584187261|FG001|Overall Study|Protocol Violation|4|||
161854800|NCT03052127|584508169|FG004|Overall Study|Withdrawal by Subject|0|||
161854801|NCT03052127|584508170|FG005|Overall Study|Withdrawal by Subject|0|||
161767124|NCT01654666|584187262|FG002|Overall Study|Protocol Violation|8|||
161767125|NCT01654666|584187260|FG000|Overall Study|Lost to Follow-up|4|||
161767126|NCT01654666|584187261|FG001|Overall Study|Lost to Follow-up|5|||
161767127|NCT01654666|584187262|FG002|Overall Study|Lost to Follow-up|5|||
161767128|NCT01654666|584187260|FG000|Overall Study|Withdrawal by Subject|4|||
161767129|NCT01654666|584187261|FG001|Overall Study|Withdrawal by Subject|4|||
161767130|NCT01654666|584187262|FG002|Overall Study|Withdrawal by Subject|1|||
161854802|NCT03052127|584508171|FG006|Overall Study|Withdrawal by Subject|0|||
161854803|NCT03052127|584508172|FG007|Overall Study|Withdrawal by Subject|1|||
161854804|NCT03052127|584508173|FG008|Overall Study|Withdrawal by Subject|1|||
161767131|NCT01177943|584187264|FG000|First Intervention|Withdrawal by Subject|2|||
161767132|NCT01177943|584187265|FG001|First Intervention|Withdrawal by Subject|0|||
161767133|NCT04225026|584187271|FG000|Overall Study|Withdrawal by Subject|4|||
161767134|NCT04225026|584187271|FG000|Overall Study|Adverse Event|1|||
161767135|NCT04225026|584187271|FG000|Overall Study|Other|1|||
161767136|NCT04225026|584187271|FG000|Overall Study|Death|11|||
161767137|NCT04225026|584187271|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
161767138|NCT03742271|584187283|FG000|Overall Study|Unsatisfactory Visual Response|1|||
161767139|NCT03742271|584187283|FG000|Overall Study|Withdrawal by Subject|3|||
161767140|NCT03742271|584187283|FG000|Overall Study|Lost to Follow-up|4|||
161767141|NCT03742271|584187283|FG000|Overall Study|Failed Insertion & removal|3|||
161767142|NCT03742271|584187283|FG000|Overall Study|Protocol Violation|1|||
161767143|NCT01843933|584187284|FG000|Overall Study|Data lost|6|||
161767144|NCT01843933|584187285|FG001|Overall Study|Data lost|4|||
161767145|NCT00690612|584188869|FG000|Overall Study|Adverse Event|1|||
161767146|NCT00690612|584188869|FG000|Overall Study|Withdrawal by Subject|2|||
161767147|NCT03808298|584188870|FG000|Overall Study|Adverse Event|3|||
161767148|NCT03808298|584188870|FG000|Overall Study|Physician Decision|1|||
161767149|NCT03808298|584188870|FG000|Overall Study|Withdrawal by Subject|1|||
161767150|NCT03808298|584188870|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
161767151|NCT01858701|584188873|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
161767152|NCT01858701|584188874|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
161767153|NCT01858701|584188873|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
161767154|NCT01858701|584188874|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
161767155|NCT01858701|584188873|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
161854805|NCT03052127|584508174|FG009|Overall Study|Withdrawal by Subject|1|||
161854806|NCT03052127|584508175|FG010|Overall Study|Withdrawal by Subject|0|||
161854807|NCT03052127|584508176|FG011|Overall Study|Withdrawal by Subject|0|||
161854808|NCT03052127|584508165|FG000|Overall Study|Discontinuation by Sponsor|0|||
161854809|NCT03052127|584508166|FG001|Overall Study|Discontinuation by Sponsor|0|||
161854810|NCT03052127|584508167|FG002|Overall Study|Discontinuation by Sponsor|0|||
161854811|NCT03052127|584508168|FG003|Overall Study|Discontinuation by Sponsor|0|||
161854812|NCT03052127|584508169|FG004|Overall Study|Discontinuation by Sponsor|0|||
161854813|NCT03052127|584508170|FG005|Overall Study|Discontinuation by Sponsor|0|||
161854814|NCT03052127|584508171|FG006|Overall Study|Discontinuation by Sponsor|0|||
161854815|NCT03052127|584508172|FG007|Overall Study|Discontinuation by Sponsor|0|||
161767156|NCT01858701|584188874|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
161767157|NCT01858701|584188873|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
161767158|NCT01858701|584188874|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
161767159|NCT01674010|584188875|FG000|Open Treatment Phase 1|Adverse Event|10|||
161767160|NCT01674010|584188876|FG001|Open Treatment Phase 1|Adverse Event|0|||
161767161|NCT01674010|584188877|FG002|Open Treatment Phase 1|Adverse Event|0|||
161854816|NCT03052127|584508173|FG008|Overall Study|Discontinuation by Sponsor|4|||
161854817|NCT03052127|584508174|FG009|Overall Study|Discontinuation by Sponsor|2|||
161854818|NCT03052127|584508175|FG010|Overall Study|Discontinuation by Sponsor|5|||
161854819|NCT03052127|584508176|FG011|Overall Study|Discontinuation by Sponsor|13|||
161854820|NCT03052127|584508165|FG000|Overall Study|Inability to comply with trial requirements|0|||
161854821|NCT03052127|584508166|FG001|Overall Study|Inability to comply with trial requirements|0|||
161854822|NCT03052127|584508167|FG002|Overall Study|Inability to comply with trial requirements|1|||
161854823|NCT03052127|584508168|FG003|Overall Study|Inability to comply with trial requirements|0|||
161854824|NCT03052127|584508169|FG004|Overall Study|Inability to comply with trial requirements|0|||
161854825|NCT03052127|584508170|FG005|Overall Study|Inability to comply with trial requirements|0|||
161854826|NCT03052127|584508171|FG006|Overall Study|Inability to comply with trial requirements|0|||
161854827|NCT03052127|584508172|FG007|Overall Study|Inability to comply with trial requirements|0|||
161854828|NCT03052127|584508173|FG008|Overall Study|Inability to comply with trial requirements|0|||
161854829|NCT03052127|584508174|FG009|Overall Study|Inability to comply with trial requirements|0|||
161854830|NCT03052127|584508175|FG010|Overall Study|Inability to comply with trial requirements|0|||
161854831|NCT03052127|584508176|FG011|Overall Study|Inability to comply with trial requirements|0|||
161854832|NCT03052127|584508165|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161767162|NCT01674010|584188875|FG000|Open Treatment Phase 1|Death|1|||
161767163|NCT01674010|584188876|FG001|Open Treatment Phase 1|Death|0|||
161767164|NCT01674010|584188877|FG002|Open Treatment Phase 1|Death|0|||
161767165|NCT01674010|584188875|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
161767166|NCT01674010|584188876|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
161767167|NCT01674010|584188877|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
161767168|NCT01674010|584188875|FG000|Open Treatment Phase 1|Physician Decision|9|||
161854833|NCT03052127|584508166|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854834|NCT03052127|584508167|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854835|NCT03052127|584508168|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854836|NCT03052127|584508169|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161854837|NCT03052127|584508170|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161854838|NCT03052127|584508171|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161854839|NCT03052127|584508172|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854840|NCT03052127|584508173|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854841|NCT03052127|584508174|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854842|NCT03052127|584508175|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854843|NCT03052127|584508176|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854844|NCT03694327|584508177|FG000|Overall Study|Lost to Follow-up|13|||
161854845|NCT03694327|584508178|FG001|Overall Study|Lost to Follow-up|23|||
161854846|NCT01464931|584508181|FG000|Overall Study|Withdrawal by Subject|1|||
161854847|NCT01464931|584508182|FG001|Overall Study|Withdrawal by Subject|0|||
161854848|NCT01982812|584508183|FG000|Overall Study|Death|1|||
161854849|NCT01982812|584508184|FG001|Overall Study|Death|5|||
161854850|NCT01982812|584508183|FG000|Overall Study|Adverse Event|0|||
161854851|NCT01982812|584508184|FG001|Overall Study|Adverse Event|5|||
161854852|NCT00307437|584508186|FG000|Controlled Period|Adverse Event|7|||
161854853|NCT00307437|584508187|FG001|Controlled Period|Adverse Event|2|||
161854854|NCT00307437|584508188|FG002|Controlled Period|Adverse Event|5|||
161854855|NCT00307437|584508189|FG003|Controlled Period|Adverse Event|0|||
161854856|NCT00307437|584508190|FG004|Controlled Period|Adverse Event|0|||
161854857|NCT00307437|584508191|FG005|Controlled Period|Adverse Event|0|||
161854858|NCT00307437|584508192|FG006|Controlled Period|Adverse Event|0|||
161854859|NCT00307437|584508186|FG000|Controlled Period|Death|0|||
161854860|NCT00307437|584508187|FG001|Controlled Period|Death|0|||
161854861|NCT00307437|584508188|FG002|Controlled Period|Death|1|||
161854862|NCT00307437|584508189|FG003|Controlled Period|Death|0|||
161854863|NCT00307437|584508190|FG004|Controlled Period|Death|0|||
161854864|NCT00307437|584508191|FG005|Controlled Period|Death|0|||
161854865|NCT00307437|584508192|FG006|Controlled Period|Death|0|||
161854866|NCT00307437|584508186|FG000|Controlled Period|Lack of Efficacy|2|||
161854867|NCT00307437|584508187|FG001|Controlled Period|Lack of Efficacy|0|||
161854868|NCT00307437|584508188|FG002|Controlled Period|Lack of Efficacy|0|||
161854869|NCT00307437|584508189|FG003|Controlled Period|Lack of Efficacy|0|||
161854870|NCT00307437|584508190|FG004|Controlled Period|Lack of Efficacy|0|||
161854871|NCT00307437|584508191|FG005|Controlled Period|Lack of Efficacy|0|||
161854872|NCT00307437|584508192|FG006|Controlled Period|Lack of Efficacy|0|||
161854873|NCT00307437|584508186|FG000|Controlled Period|Lost to Follow-up|2|||
161854874|NCT00307437|584508187|FG001|Controlled Period|Lost to Follow-up|3|||
161854875|NCT00307437|584508188|FG002|Controlled Period|Lost to Follow-up|0|||
161854876|NCT00307437|584508189|FG003|Controlled Period|Lost to Follow-up|0|||
161854877|NCT00307437|584508190|FG004|Controlled Period|Lost to Follow-up|0|||
161854878|NCT00307437|584508191|FG005|Controlled Period|Lost to Follow-up|0|||
161767169|NCT01674010|584188876|FG001|Open Treatment Phase 1|Physician Decision|0|||
161767170|NCT01674010|584188877|FG002|Open Treatment Phase 1|Physician Decision|0|||
161767171|NCT01674010|584188875|FG000|Open Treatment Phase 1|Protocol Violation|7|||
161767172|NCT01674010|584188876|FG001|Open Treatment Phase 1|Protocol Violation|0|||
161767173|NCT01674010|584188877|FG002|Open Treatment Phase 1|Protocol Violation|0|||
161767174|NCT01674010|584188875|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
161767175|NCT01674010|584188876|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
161767176|NCT01674010|584188877|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
161767177|NCT01674010|584188875|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
161767178|NCT01674010|584188876|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
161854879|NCT00307437|584508192|FG006|Controlled Period|Lost to Follow-up|0|||
161854880|NCT00307437|584508186|FG000|Controlled Period|Other|5|||
161854881|NCT00307437|584508187|FG001|Controlled Period|Other|1|||
161767179|NCT01674010|584188877|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
161767180|NCT01674010|584188875|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
161767181|NCT01674010|584188876|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
161767182|NCT01674010|584188877|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
161767183|NCT01674010|584188875|FG000|Randomization Phase 2|Adverse Event|0|||
161767184|NCT01674010|584188876|FG001|Randomization Phase 2|Adverse Event|1|||
161767185|NCT01674010|584188877|FG002|Randomization Phase 2|Adverse Event|1|||
161854882|NCT00307437|584508188|FG002|Controlled Period|Other|3|||
161854883|NCT00307437|584508189|FG003|Controlled Period|Other|0|||
161854884|NCT00307437|584508190|FG004|Controlled Period|Other|0|||
161854885|NCT00307437|584508191|FG005|Controlled Period|Other|0|||
161854886|NCT00307437|584508192|FG006|Controlled Period|Other|0|||
161767186|NCT01674010|584188875|FG000|Randomization Phase 2|Lost to Follow-up|0|||
161767187|NCT01674010|584188876|FG001|Randomization Phase 2|Lost to Follow-up|1|||
161767188|NCT01674010|584188877|FG002|Randomization Phase 2|Lost to Follow-up|2|||
161854887|NCT00307437|584508186|FG000|After Controlled Period|Adverse Event|0|||
161854888|NCT00307437|584508187|FG001|After Controlled Period|Adverse Event|0|||
161854889|NCT00307437|584508188|FG002|After Controlled Period|Adverse Event|0|||
161854890|NCT00307437|584508189|FG003|After Controlled Period|Adverse Event|18|||
161854891|NCT00307437|584508190|FG004|After Controlled Period|Adverse Event|16|||
161854892|NCT00307437|584508191|FG005|After Controlled Period|Adverse Event|31|||
161854893|NCT00307437|584508192|FG006|After Controlled Period|Adverse Event|40|||
161854894|NCT00307437|584508186|FG000|After Controlled Period|Death|0|||
161854895|NCT00307437|584508187|FG001|After Controlled Period|Death|0|||
161854896|NCT00307437|584508188|FG002|After Controlled Period|Death|0|||
161854897|NCT00307437|584508189|FG003|After Controlled Period|Death|3|||
161854898|NCT00307437|584508190|FG004|After Controlled Period|Death|1|||
161854899|NCT00307437|584508191|FG005|After Controlled Period|Death|1|||
161854900|NCT00307437|584508192|FG006|After Controlled Period|Death|3|||
161854901|NCT00307437|584508186|FG000|After Controlled Period|Lack of Efficacy|0|||
161854902|NCT00307437|584508187|FG001|After Controlled Period|Lack of Efficacy|0|||
161854903|NCT00307437|584508188|FG002|After Controlled Period|Lack of Efficacy|0|||
161854904|NCT00307437|584508189|FG003|After Controlled Period|Lack of Efficacy|15|||
161854905|NCT00307437|584508190|FG004|After Controlled Period|Lack of Efficacy|17|||
161854906|NCT00307437|584508191|FG005|After Controlled Period|Lack of Efficacy|37|||
161767189|NCT01674010|584188875|FG000|Randomization Phase 2|Mood episode recurrence|0|||
161767190|NCT01674010|584188876|FG001|Randomization Phase 2|Mood episode recurrence|8|||
161767191|NCT01674010|584188877|FG002|Randomization Phase 2|Mood episode recurrence|2|||
161767192|NCT01674010|584188875|FG000|Randomization Phase 2|Physician Decision|0|||
161767193|NCT01674010|584188876|FG001|Randomization Phase 2|Physician Decision|0|||
161767194|NCT01674010|584188877|FG002|Randomization Phase 2|Physician Decision|2|||
161767195|NCT01674010|584188875|FG000|Randomization Phase 2|Pregnancy|0|||
161767196|NCT01674010|584188876|FG001|Randomization Phase 2|Pregnancy|1|||
161767197|NCT01674010|584188877|FG002|Randomization Phase 2|Pregnancy|1|||
161767198|NCT01674010|584188875|FG000|Randomization Phase 2|Protocol Violation|0|||
161767199|NCT01674010|584188876|FG001|Randomization Phase 2|Protocol Violation|1|||
161767200|NCT01674010|584188877|FG002|Randomization Phase 2|Protocol Violation|1|||
161767201|NCT01674010|584188875|FG000|Randomization Phase 2|Sponsor Decision|0|||
161767202|NCT01674010|584188876|FG001|Randomization Phase 2|Sponsor Decision|42|||
161767203|NCT01674010|584188877|FG002|Randomization Phase 2|Sponsor Decision|45|||
161767204|NCT01674010|584188875|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
161767205|NCT01674010|584188876|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
161767206|NCT01674010|584188877|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
161767207|NCT01020812|584188878|FG000|Overall Study|Physician Decision|1|||
161767208|NCT01020812|584188878|FG000|Overall Study|Withdrawal by Subject|1|||
161767209|NCT01020812|584188878|FG000|Overall Study|Protocol Violation|1|||
161767210|NCT01801475|584188887|FG000|Overall Study|Withdrawal by Subject|0|||
161767211|NCT01801475|584188888|FG001|Overall Study|Withdrawal by Subject|0|||
161767212|NCT01801475|584188889|FG002|Overall Study|Withdrawal by Subject|0|||
161767213|NCT01801475|584188890|FG003|Overall Study|Withdrawal by Subject|0|||
161767214|NCT01801475|584188891|FG004|Overall Study|Withdrawal by Subject|1|||
161767215|NCT01786707|584188894|FG000|Overall Study|Lost to Follow-up|1|||
161854907|NCT00307437|584508192|FG006|After Controlled Period|Lack of Efficacy|24|||
161854908|NCT00307437|584508186|FG000|After Controlled Period|Lost to Follow-up|0|||
161854909|NCT00307437|584508187|FG001|After Controlled Period|Lost to Follow-up|0|||
161854910|NCT00307437|584508188|FG002|After Controlled Period|Lost to Follow-up|0|||
161854911|NCT00307437|584508189|FG003|After Controlled Period|Lost to Follow-up|7|||
161854912|NCT00307437|584508190|FG004|After Controlled Period|Lost to Follow-up|12|||
161854913|NCT00307437|584508191|FG005|After Controlled Period|Lost to Follow-up|13|||
161854914|NCT00307437|584508192|FG006|After Controlled Period|Lost to Follow-up|18|||
161854915|NCT00307437|584508186|FG000|After Controlled Period|Other|0|||
161854916|NCT00307437|584508187|FG001|After Controlled Period|Other|0|||
161854917|NCT00307437|584508188|FG002|After Controlled Period|Other|0|||
161854918|NCT00307437|584508189|FG003|After Controlled Period|Other|15|||
161854919|NCT00307437|584508190|FG004|After Controlled Period|Other|9|||
161767216|NCT01786707|584188895|FG001|Overall Study|Lost to Follow-up|1|||
161854920|NCT00307437|584508191|FG005|After Controlled Period|Other|40|||
161767217|NCT00421928|584188896|FG000|Overall Study|Adverse Event|61|||
161767218|NCT00421928|584188897|FG001|Overall Study|Adverse Event|140|||
161767219|NCT00421928|584188898|FG002|Overall Study|Adverse Event|22|||
161767220|NCT00421928|584188896|FG000|Overall Study|Lost to Follow-up|5|||
161767221|NCT00421928|584188897|FG001|Overall Study|Lost to Follow-up|0|||
161767222|NCT00421928|584188898|FG002|Overall Study|Lost to Follow-up|3|||
161767223|NCT00421928|584188896|FG000|Overall Study|Withdrawal by Subject|50|||
161854921|NCT00307437|584508192|FG006|After Controlled Period|Other|28|||
161854922|NCT03017612|584508196|FG000|Overall Study|Adverse Event|2|||
161854923|NCT01893346|584508197|FG000|Overall Study|Lost to Follow-up|0|||
161854924|NCT01893346|584508198|FG001|Overall Study|Lost to Follow-up|1|||
161767224|NCT00421928|584188897|FG001|Overall Study|Withdrawal by Subject|48|||
161767225|NCT00421928|584188898|FG002|Overall Study|Withdrawal by Subject|43|||
161767226|NCT00421928|584188896|FG000|Overall Study|Lack of Efficacy|15|||
161767227|NCT00421928|584188897|FG001|Overall Study|Lack of Efficacy|7|||
161767228|NCT00421928|584188898|FG002|Overall Study|Lack of Efficacy|35|||
161767229|NCT00421928|584188896|FG000|Overall Study|Study drug non-compliant|6|||
161767230|NCT00421928|584188897|FG001|Overall Study|Study drug non-compliant|7|||
161767231|NCT00421928|584188898|FG002|Overall Study|Study drug non-compliant|4|||
161767232|NCT00421928|584188896|FG000|Overall Study|All other|26|||
161767233|NCT00421928|584188897|FG001|Overall Study|All other|21|||
161767234|NCT00421928|584188898|FG002|Overall Study|All other|27|||
161767235|NCT00421928|584188896|FG000|Overall Study|Death|0|||
161767236|NCT00421928|584188897|FG001|Overall Study|Death|1|||
161767237|NCT00421928|584188898|FG002|Overall Study|Death|0|||
161767238|NCT00346775|584188905|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
161767239|NCT00346775|584188906|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
161767240|NCT00346775|584188905|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
161767241|NCT00346775|584188906|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
161767242|NCT00346775|584188905|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
161767243|NCT00346775|584188906|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
161767244|NCT02946515|584188907|FG000|Overall Study|Lost to Follow-up|2|||
161767245|NCT02946515|584188908|FG001|Overall Study|Lost to Follow-up|1|||
161767246|NCT01096017|584188918|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
161767247|NCT01096017|584188919|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
161767248|NCT01545375|584188920|FG000|Overall Study|Adverse Event|2|||
161767249|NCT01545375|584188921|FG001|Overall Study|Adverse Event|1|||
161767250|NCT01545375|584188920|FG000|Overall Study|Lost to Follow-up|34|||
161767251|NCT01545375|584188921|FG001|Overall Study|Lost to Follow-up|31|||
161767252|NCT01545375|584188920|FG000|Overall Study|Protocol Violation|3|||
161767253|NCT01545375|584188921|FG001|Overall Study|Protocol Violation|3|||
161767254|NCT01545375|584188920|FG000|Overall Study|Withdrawal by Subject|58|||
161767255|NCT01545375|584188921|FG001|Overall Study|Withdrawal by Subject|55|||
161767256|NCT00594958|584188923|FG000|Overall Study|Withdrawal by Subject|1|||
161767257|NCT00594958|584188924|FG001|Overall Study|Withdrawal by Subject|0|||
161767258|NCT00594958|584188925|FG002|Overall Study|Withdrawal by Subject|1|||
161767259|NCT00594958|584188923|FG000|Overall Study|Adverse Event|4|||
161767260|NCT00594958|584188924|FG001|Overall Study|Adverse Event|1|||
161767261|NCT00594958|584188925|FG002|Overall Study|Adverse Event|2|||
161767262|NCT00594958|584188923|FG000|Overall Study|Pregnancy|0|||
161767263|NCT00594958|584188924|FG001|Overall Study|Pregnancy|2|||
161767264|NCT00594958|584188925|FG002|Overall Study|Pregnancy|0|||
161767265|NCT00594958|584188923|FG000|Overall Study|Protocol Violation|1|||
161767266|NCT00594958|584188924|FG001|Overall Study|Protocol Violation|0|||
161767267|NCT00594958|584188925|FG002|Overall Study|Protocol Violation|2|||
161767268|NCT00594958|584188923|FG000|Overall Study|Lost to Follow-up|5|||
161767269|NCT00594958|584188924|FG001|Overall Study|Lost to Follow-up|0|||
161767270|NCT00594958|584188925|FG002|Overall Study|Lost to Follow-up|3|||
161767271|NCT00594958|584188923|FG000|Overall Study|administrative|3|||
161767272|NCT00594958|584188924|FG001|Overall Study|administrative|0|||
161767273|NCT00594958|584188925|FG002|Overall Study|administrative|2|||
161767274|NCT03233009|584188926|FG000|Overall Study|Lost to Follow-up|1|||
161767275|NCT03039686|584188927|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
161767276|NCT03039686|584188928|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
161767277|NCT03039686|584188929|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
161767278|NCT03039686|584188927|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
161767279|NCT03039686|584188928|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
161767280|NCT03039686|584188929|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
161767281|NCT03039686|584188927|FG000|Double-blind Period|Withdrawal by Subject|2|||
161767282|NCT03039686|584188928|FG001|Double-blind Period|Withdrawal by Subject|2|||
161767283|NCT03039686|584188929|FG002|Double-blind Period|Withdrawal by Subject|1|||
161767284|NCT03039686|584188927|FG000|Double-blind Period|Death|0|||
161767285|NCT03039686|584188928|FG001|Double-blind Period|Death|0|||
161767286|NCT03039686|584188929|FG002|Double-blind Period|Death|1|||
161767287|NCT03039686|584188927|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
161767288|NCT03039686|584188928|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
161767289|NCT03039686|584188929|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
161767290|NCT03039686|584188927|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
161767291|NCT03039686|584188928|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
161767292|NCT03039686|584188929|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
161767293|NCT03039686|584188927|FG000|Open Label Period|Withdrawal by Subject|0|||
161767294|NCT03039686|584188928|FG001|Open Label Period|Withdrawal by Subject|3|||
161767295|NCT03039686|584188929|FG002|Open Label Period|Withdrawal by Subject|1|||
161767296|NCT02158949|584188930|FG000|Overall Study|Withdrawal by Subject|1|||
161767297|NCT02158949|584188931|FG001|Overall Study|Withdrawal by Subject|0|||
161767298|NCT02158949|584188930|FG000|Overall Study|Lost to Follow-up|5|||
161767299|NCT02158949|584188931|FG001|Overall Study|Lost to Follow-up|11|||
161767300|NCT00475657|584188933|FG000|Overall Study|Death|1|||
161767301|NCT00475657|584188933|FG000|Overall Study|Sponsor's Decision|3|||
161767302|NCT00408408|584188934|FG000|Overall Study|No follow up data|2|||
161767303|NCT00408408|584188935|FG001|Overall Study|No follow up data|3|||
161767304|NCT00408408|584188936|FG002|Overall Study|No follow up data|0|||
161767305|NCT00408408|584188937|FG003|Overall Study|No follow up data|7|||
161767306|NCT00408408|584188938|FG004|Overall Study|No follow up data|5|||
161767307|NCT00408408|584188939|FG005|Overall Study|No follow up data|3|||
161767308|NCT02898662|584188946|FG000|Overall Study|Adverse Event|1|||
161767309|NCT02898662|584188947|FG001|Overall Study|Adverse Event|0|||
161767310|NCT02898662|584188946|FG000|Overall Study|Loss of asthma control|23|||
161767311|NCT02898662|584188947|FG001|Overall Study|Loss of asthma control|24|||
161767312|NCT02898662|584188946|FG000|Overall Study|Withdrawal by Subject|4|||
161767313|NCT02898662|584188947|FG001|Overall Study|Withdrawal by Subject|1|||
161767314|NCT02898662|584188946|FG000|Overall Study|Technical issue|0|||
161767315|NCT02898662|584188947|FG001|Overall Study|Technical issue|1|||
161767316|NCT02898662|584188946|FG000|Overall Study|Randomized in error|0|||
161767317|NCT02898662|584188947|FG001|Overall Study|Randomized in error|1|||
161767318|NCT02898662|584188946|FG000|Overall Study|Subject decision|1|||
161767319|NCT02898662|584188947|FG001|Overall Study|Subject decision|0|||
161767320|NCT02898662|584188946|FG000|Overall Study|Other|0|||
161767321|NCT02898662|584188947|FG001|Overall Study|Other|1|||
161767322|NCT00399542|584188948|FG000|Overall Study|Adverse Event|18|||
161767323|NCT00399542|584188949|FG001|Overall Study|Adverse Event|15|||
161767324|NCT00399542|584188948|FG000|Overall Study|Protocol Violation|13|||
161767325|NCT00399542|584188949|FG001|Overall Study|Protocol Violation|3|||
161767326|NCT00399542|584188948|FG000|Overall Study|Withdrawal by Subject|28|||
161767327|NCT00399542|584188949|FG001|Overall Study|Withdrawal by Subject|10|||
161767328|NCT00399542|584188948|FG000|Overall Study|Lack of Efficacy|18|||
161767329|NCT00399542|584188949|FG001|Overall Study|Lack of Efficacy|8|||
161767330|NCT00399542|584188948|FG000|Overall Study|Lost to Follow-up|6|||
161767331|NCT00399542|584188949|FG001|Overall Study|Lost to Follow-up|6|||
161767332|NCT00399542|584188948|FG000|Overall Study|Other|1|||
161767333|NCT00399542|584188949|FG001|Overall Study|Other|0|||
161767334|NCT00399542|584188948|FG000|Overall Study|Physician Decision|0|||
161767335|NCT00399542|584188949|FG001|Overall Study|Physician Decision|1|||
161767336|NCT00917553|584188950|FG000|Overall Study|Lost to Follow-up|2|||
161767337|NCT00917553|584188951|FG001|Overall Study|Lost to Follow-up|1|||
161767338|NCT01616173|584188952|FG000|Overall Study|Lost to Follow-up|0|||
161767339|NCT01616173|584188953|FG001|Overall Study|Lost to Follow-up|2|||
161767340|NCT01616173|584188954|FG002|Overall Study|Lost to Follow-up|0|||
161767341|NCT03172026|584188958|FG000|Overall Study|Withdrawal by Subject|1|||
161767342|NCT03172026|584188959|FG001|Overall Study|Withdrawal by Subject|0|||
161767343|NCT03172026|584188958|FG000|Overall Study|COVID restrictions|1|||
161767344|NCT03172026|584188959|FG001|Overall Study|COVID restrictions|0|||
161767345|NCT01430559|584188963|FG000|Overall Study|Adverse Event|7|||
161854925|NCT01893346|584508199|FG002|Overall Study|Lost to Follow-up|0|||
161854926|NCT01893346|584508200|FG003|Overall Study|Lost to Follow-up|0|||
161854927|NCT01893346|584508197|FG000|Overall Study|Protocol Violation|1|||
161854928|NCT01893346|584508198|FG001|Overall Study|Protocol Violation|0|||
161854929|NCT01893346|584508199|FG002|Overall Study|Protocol Violation|0|||
161854930|NCT01893346|584508200|FG003|Overall Study|Protocol Violation|0|||
161854931|NCT01893346|584508197|FG000|Overall Study|Withdrawal by Subject|2|||
161854932|NCT01893346|584508198|FG001|Overall Study|Withdrawal by Subject|0|||
161854933|NCT01893346|584508199|FG002|Overall Study|Withdrawal by Subject|0|||
161854934|NCT01893346|584508200|FG003|Overall Study|Withdrawal by Subject|0|||
161854935|NCT00985491|584508201|FG000|Overall Study|Adverse Event|8|||
161854936|NCT00985491|584508201|FG000|Overall Study|device migration|7|||
161854937|NCT00985491|584508201|FG000|Overall Study|Withdrawal by Subject|1|||
161854938|NCT00985491|584508201|FG000|Overall Study|implant failure|3|||
161854939|NCT02121652|584509678|FG000|Overall Study|Lost to Follow-up|2|||
161854940|NCT02121652|584509679|FG001|Overall Study|Lost to Follow-up|1|||
161854941|NCT02121652|584509678|FG000|Overall Study|Death|1|||
161854942|NCT02121652|584509679|FG001|Overall Study|Death|0|||
161854943|NCT02121652|584509678|FG000|Overall Study|Withdrawal by Subject|3|||
161854944|NCT02121652|584509679|FG001|Overall Study|Withdrawal by Subject|3|||
161854945|NCT01090414|584509680|FG000|Study 101-99|Progressive Disease|28|||
161854946|NCT01090414|584509681|FG001|Study 101-99|Progressive Disease|48|||
161767346|NCT01430559|584188964|FG001|Overall Study|Adverse Event|3|||
161767347|NCT01430559|584188963|FG000|Overall Study|Entry criteria not met|1|||
161767348|NCT01430559|584188964|FG001|Overall Study|Entry criteria not met|1|||
161767349|NCT01430559|584188963|FG000|Overall Study|Lost to Follow-up|1|||
161767350|NCT01430559|584188964|FG001|Overall Study|Lost to Follow-up|0|||
161767351|NCT01430559|584188963|FG000|Overall Study|Medication error|1|||
161767352|NCT01430559|584188964|FG001|Overall Study|Medication error|0|||
161767353|NCT01430559|584188963|FG000|Overall Study|Withdrawal by Subject|3|||
161767354|NCT01430559|584188964|FG001|Overall Study|Withdrawal by Subject|2|||
161767355|NCT01430559|584188963|FG000|Overall Study|Protocol Violation|1|||
161767356|NCT01430559|584188964|FG001|Overall Study|Protocol Violation|0|||
161767357|NCT01430559|584188963|FG000|Overall Study|Other|3|||
161767358|NCT01430559|584188964|FG001|Overall Study|Other|3|||
161767359|NCT01430559|584188963|FG000|Overall Study|Randomized, Not Treated|3|||
161767360|NCT01430559|584188964|FG001|Overall Study|Randomized, Not Treated|3|||
161767361|NCT00504595|584188965|FG000|Overall Study|Lack of Efficacy|1|||
161767362|NCT00504595|584188966|FG001|Overall Study|Lack of Efficacy|0|||
161767363|NCT00504595|584188967|FG002|Overall Study|Lack of Efficacy|0|||
161767364|NCT00504595|584188968|FG003|Overall Study|Lack of Efficacy|0|||
161767365|NCT00504595|584188965|FG000|Overall Study|Other|0|||
161767366|NCT00504595|584188966|FG001|Overall Study|Other|0|||
161767367|NCT00504595|584188967|FG002|Overall Study|Other|2|||
161767368|NCT00504595|584188968|FG003|Overall Study|Other|0|||
161767369|NCT01220024|584188969|FG000|Overall Study|Lost to Follow-up|1|||
161767370|NCT01220024|584188970|FG001|Overall Study|Lost to Follow-up|1|||
161767371|NCT00174460|584188972|FG000|Overall Study|Withdrawal by Subject|0|||
161767372|NCT00174460|584188973|FG001|Overall Study|Withdrawal by Subject|1|||
161767373|NCT00579059|584188974|FG000|Overall Study|Study Canceled at 1 Year|21|||
161767374|NCT00579059|584188975|FG001|Overall Study|Study Canceled at 1 Year|10|||
161767375|NCT00779142|584188976|FG000|Overall Study|Screen Failures|3|||
161767376|NCT04652245|584188977|FG000|Wash-Out Period|Adverse Event|0|||
161767377|NCT04652245|584188978|FG001|Wash-Out Period|Adverse Event|2|||
161767378|NCT04652245|584188977|FG000|Wash-Out Period|Withdrawal by Subject|0|||
161767379|NCT04652245|584188978|FG001|Wash-Out Period|Withdrawal by Subject|2|||
161767380|NCT03137433|584188983|FG000|Overall Study|Withdrawal by Subject|11|||
161767381|NCT03137433|584188984|FG001|Overall Study|Withdrawal by Subject|11|||
161767382|NCT03137433|584188983|FG000|Overall Study|Lost to Follow-up|5|||
161767383|NCT03137433|584188984|FG001|Overall Study|Lost to Follow-up|6|||
161767384|NCT03137433|584188983|FG000|Overall Study|Physician Decision|2|||
161767385|NCT03137433|584188984|FG001|Overall Study|Physician Decision|0|||
161767386|NCT03137433|584188983|FG000|Overall Study|Moved out of study area|1|||
161767387|NCT03137433|584188984|FG001|Overall Study|Moved out of study area|0|||
161767388|NCT03137433|584188983|FG000|Overall Study|Too far out of window due to COVID|0|||
161767389|NCT03137433|584188984|FG001|Overall Study|Too far out of window due to COVID|1|||
161767390|NCT01288911|584188985|FG000|Double-blind Period|Death|11|||
161767391|NCT01288911|584188986|FG001|Double-blind Period|Death|7|||
161767392|NCT01288911|584188985|FG000|Double-blind Period|Lost to Follow-up|0|||
161767393|NCT01288911|584188986|FG001|Double-blind Period|Lost to Follow-up|2|||
161767394|NCT01288911|584188985|FG000|Double-blind Period|Progressive Disease|75|||
161767395|NCT01288911|584188986|FG001|Double-blind Period|Progressive Disease|103|||
161767396|NCT01288911|584188985|FG000|Double-blind Period|Protocol Violation|1|||
161767397|NCT01288911|584188986|FG001|Double-blind Period|Protocol Violation|0|||
161767398|NCT01288911|584188985|FG000|Double-blind Period|Withdrawal by Subject|25|||
161767399|NCT01288911|584188986|FG001|Double-blind Period|Withdrawal by Subject|26|||
161767400|NCT01288911|584188985|FG000|Double-blind Period|Miscellaneous Reason|29|||
161767401|NCT01288911|584188986|FG001|Double-blind Period|Miscellaneous Reason|42|||
161767402|NCT01288911|584188985|FG000|Double-blind Period|Randomized but never received study drug|1|||
161767403|NCT01288911|584188986|FG001|Double-blind Period|Randomized but never received study drug|2|||
161767404|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Death|0|||
161767405|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Death|1|||
161767406|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
161767407|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
161767408|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
161767409|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
161767410|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
161767411|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
161767412|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
161767413|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
161854947|NCT01090414|584509682|FG002|Study 101-99|Progressive Disease|10|||
161854948|NCT01090414|584509683|FG003|Study 101-99|Progressive Disease|4|||
161854949|NCT01090414|584509680|FG000|Study 101-99|Adverse Event|10|||
161854950|NCT01090414|584509681|FG001|Study 101-99|Adverse Event|28|||
161767414|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
161854951|NCT01090414|584509682|FG002|Study 101-99|Adverse Event|18|||
161854952|NCT01090414|584509683|FG003|Study 101-99|Adverse Event|0|||
161854953|NCT01090414|584509680|FG000|Study 101-99|Investigator Request|1|||
161854954|NCT01090414|584509681|FG001|Study 101-99|Investigator Request|11|||
161854955|NCT01090414|584509682|FG002|Study 101-99|Investigator Request|4|||
161767415|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
161767416|NCT02543918|584188987|FG000|Overall Study|Never treated|0|||
161767417|NCT02543918|584188988|FG001|Overall Study|Never treated|1|||
161767418|NCT02543918|584188987|FG000|Overall Study|Lost to Follow-up|1|||
161854956|NCT01090414|584509683|FG003|Study 101-99|Investigator Request|0|||
161854957|NCT01090414|584509680|FG000|Study 101-99|Death|3|||
161854958|NCT01090414|584509681|FG001|Study 101-99|Death|8|||
161854959|NCT01090414|584509682|FG002|Study 101-99|Death|1|||
161854960|NCT01090414|584509683|FG003|Study 101-99|Death|0|||
161854961|NCT01090414|584509680|FG000|Study 101-99|Sponsor Discontinued Study|0|||
161767419|NCT02543918|584188988|FG001|Overall Study|Lost to Follow-up|1|||
161767420|NCT02543918|584188987|FG000|Overall Study|Withdrawal by Subject|1|||
161767421|NCT02543918|584188988|FG001|Overall Study|Withdrawal by Subject|1|||
161767422|NCT02543918|584188987|FG000|Overall Study|Adverse Event|1|||
161767423|NCT02543918|584188988|FG001|Overall Study|Adverse Event|1|||
161767424|NCT00486720|584188991|FG000|Overall Study|Adverse Event|1|||
161767425|NCT00486720|584188992|FG001|Overall Study|Adverse Event|2|||
161767426|NCT00486720|584188991|FG000|Overall Study|Lack of Efficacy|4|||
161767427|NCT00486720|584188992|FG001|Overall Study|Lack of Efficacy|6|||
161854962|NCT01090414|584509681|FG001|Study 101-99|Sponsor Discontinued Study|7|||
161854963|NCT01090414|584509682|FG002|Study 101-99|Sponsor Discontinued Study|5|||
161854964|NCT01090414|584509683|FG003|Study 101-99|Sponsor Discontinued Study|0|||
161854965|NCT01090414|584509680|FG000|Study 101-99|Other (Unknown Reasons)|3|||
161854966|NCT01090414|584509681|FG001|Study 101-99|Other (Unknown Reasons)|3|||
161854967|NCT01090414|584509682|FG002|Study 101-99|Other (Unknown Reasons)|0|||
161854968|NCT01090414|584509683|FG003|Study 101-99|Other (Unknown Reasons)|0|||
161854969|NCT01090414|584509680|FG000|Study 101-99|Withdrew Consent|0|||
161854970|NCT01090414|584509681|FG001|Study 101-99|Withdrew Consent|2|||
161854971|NCT01090414|584509682|FG002|Study 101-99|Withdrew Consent|3|||
161854972|NCT01090414|584509683|FG003|Study 101-99|Withdrew Consent|1|||
161854973|NCT01090414|584509680|FG000|Study 101-99|Participant Request|3|||
161854974|NCT01090414|584509681|FG001|Study 101-99|Participant Request|1|||
161854975|NCT01090414|584509682|FG002|Study 101-99|Participant Request|0|||
161854976|NCT01090414|584509683|FG003|Study 101-99|Participant Request|0|||
161854977|NCT03022370|584509684|FG000|Overall Study|Death|6|||
161854978|NCT03022370|584509685|FG001|Overall Study|Death|12|||
161854979|NCT03022370|584509684|FG000|Overall Study|Lost to Follow-up|174|||
161854980|NCT03022370|584509685|FG001|Overall Study|Lost to Follow-up|109|||
161854981|NCT00668317|584509686|FG000|Overall Study|Adverse Event|2|||
161854982|NCT04753216|584509687|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
161854983|NCT04753216|584509687|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
161854984|NCT04753216|584509687|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
161854985|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
161854986|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Death|1|||
161854987|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
161854988|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
161854989|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
161854990|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
161854991|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
161854992|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
161854993|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
161854994|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
161854995|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
161854996|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Other|3|||
161854997|NCT01965860|584509690|FG000|Overall Study|Pregnancy|1|||
161854998|NCT01965860|584509691|FG001|Overall Study|Pregnancy|0|||
161854999|NCT01965860|584509692|FG002|Overall Study|Pregnancy|1|||
161855000|NCT01965860|584509690|FG000|Overall Study|Logistics|1|||
161855001|NCT01965860|584509691|FG001|Overall Study|Logistics|0|||
161855002|NCT01965860|584509692|FG002|Overall Study|Logistics|0|||
161855003|NCT00769379|584509699|FG000|Overall Study|No follow up data mapped to Other.|3|||
161855004|NCT00769379|584509700|FG001|Overall Study|No follow up data mapped to Other.|13|||
161855005|NCT01884337|584509701|FG000|Treatment|Adverse Event|2|||
161855006|NCT01884337|584509702|FG001|Treatment|Adverse Event|2|||
161855007|NCT01884337|584509701|FG000|Treatment|Subj. request to discont. treatment|2|||
161855008|NCT01884337|584509702|FG001|Treatment|Subj. request to discont. treatment|0|||
161855009|NCT01884337|584509701|FG000|Follow-up Period|Lost to Follow-up|1|||
161855010|NCT01884337|584509702|FG001|Follow-up Period|Lost to Follow-up|1|||
161855011|NCT02455518|584509703|FG000|Overall Study|Protocol Violation|0|||
161855012|NCT02455518|584509704|FG001|Overall Study|Protocol Violation|1|||
161855013|NCT02455518|584509705|FG002|Overall Study|Protocol Violation|1|||
161855014|NCT02455518|584509706|FG003|Overall Study|Protocol Violation|3|||
161855015|NCT02508935|584509707|FG000|Overall Study|Withdrawal by Subject|1|||
161855016|NCT02508935|584509707|FG000|Overall Study|Withdrawal by Caregiver|8|||
161855017|NCT02508935|584509707|FG000|Overall Study|Pain Score <4|1|||
161855018|NCT02508935|584509707|FG000|Overall Study|Emesis|3|||
161855019|NCT02508935|584509707|FG000|Overall Study|Adverse Event|3|||
161855020|NCT02508935|584509707|FG000|Overall Study|Protocol Violation|1|||
161855021|NCT02508935|584509707|FG000|Overall Study|Physician Decision|1|||
161767428|NCT00486720|584188991|FG000|Overall Study|Physician Decision|1|||
161767429|NCT00486720|584188992|FG001|Overall Study|Physician Decision|2|||
161767430|NCT00486720|584188991|FG000|Overall Study|Protocol Violation|1|||
161855022|NCT02508935|584509707|FG000|Overall Study|Trial terminated by sponsor|5|||
161855023|NCT01332292|584509724|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161855024|NCT01332292|584509725|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161767431|NCT00486720|584188992|FG001|Overall Study|Protocol Violation|0|||
161767432|NCT00486720|584188991|FG000|Overall Study|Withdrawal by Subject|3|||
161767433|NCT00486720|584188992|FG001|Overall Study|Withdrawal by Subject|1|||
161767434|NCT00486720|584188991|FG000|Overall Study|Progressive Disease|0|||
161767435|NCT00486720|584188992|FG001|Overall Study|Progressive Disease|1|||
161767436|NCT02452892|584188995|FG000|Week 1 Initial Randommization|Adverse Event|1|||
161767437|NCT02452892|584188996|FG001|Week 1 Initial Randommization|Adverse Event|0|||
161767438|NCT02452892|584188997|FG002|Week 1 Initial Randommization|Adverse Event|0|||
161767439|NCT02452892|584188998|FG003|Week 1 Initial Randommization|Adverse Event|0|||
161767440|NCT02452892|584188995|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
161767441|NCT02452892|584188996|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
161767442|NCT02452892|584188997|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
161767443|NCT02452892|584188998|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
161767444|NCT02452892|584188995|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161767445|NCT02452892|584188996|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161767446|NCT02452892|584188997|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161767447|NCT02452892|584188998|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
161767448|NCT02452892|584188995|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
161767449|NCT02452892|584188996|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161767450|NCT02452892|584188997|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161767451|NCT02452892|584188998|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161767452|NCT02452892|584188995|FG000|Follow-up|Withdrawal by Subject|0|||
161767453|NCT02452892|584188996|FG001|Follow-up|Withdrawal by Subject|0|||
161767454|NCT02452892|584188997|FG002|Follow-up|Withdrawal by Subject|0|||
161767455|NCT02452892|584188998|FG003|Follow-up|Withdrawal by Subject|1|||
161767456|NCT02452892|584188995|FG000|Follow-up|Subject left town on Day 42|1|||
161767457|NCT02452892|584188996|FG001|Follow-up|Subject left town on Day 42|0|||
161767458|NCT02452892|584188997|FG002|Follow-up|Subject left town on Day 42|0|||
161767459|NCT02452892|584188998|FG003|Follow-up|Subject left town on Day 42|0|||
161767460|NCT03137173|584189001|FG000|Overall Study|Withdrawal by Subject|8|||
161767461|NCT03137173|584189002|FG001|Overall Study|Withdrawal by Subject|13|||
161767462|NCT03137173|584189001|FG000|Overall Study|Death|1|||
161767463|NCT03137173|584189002|FG001|Overall Study|Death|3|||
161767464|NCT03137173|584189001|FG000|Overall Study|Physician Decision|1|||
161855025|NCT01332292|584509724|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161855026|NCT01332292|584509725|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161855027|NCT01332292|584509724|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
161855028|NCT01332292|584509725|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
161855029|NCT00104572|584509726|FG000|Overall Study|Withdrawal by Subject|3|||
161767465|NCT03137173|584189002|FG001|Overall Study|Physician Decision|0|||
161767466|NCT03137173|584189001|FG000|Overall Study|Lost to Follow-up|13|||
161767467|NCT03137173|584189002|FG001|Overall Study|Lost to Follow-up|18|||
161767468|NCT03137173|584189001|FG000|Overall Study|Other reasons|3|||
161767469|NCT03137173|584189002|FG001|Overall Study|Other reasons|2|||
161767470|NCT05060003|584189003|FG000|Overall Study|ctDNA negative|7|||
161767471|NCT01373294|584189004|FG000|Overall Study|Adverse Event|1|||
161767472|NCT01373294|584189005|FG001|Overall Study|Adverse Event|0|||
161767473|NCT00423267|584189006|FG000|Period A|Withdrawal by Subject|0|||
161767474|NCT00423267|584189007|FG001|Period A|Withdrawal by Subject|1|||
161767475|NCT00423267|584189006|FG000|Period A|Non-compliance with protocol|1|||
161767476|NCT00423267|584189007|FG001|Period A|Non-compliance with protocol|0|||
161767477|NCT00423267|584189006|FG000|Period A|Administrative|1|||
161767478|NCT00423267|584189007|FG001|Period A|Administrative|0|||
161767479|NCT01333865|584189008|FG000|Overall Study|Adverse Event|2|||
161767480|NCT03512028|584189009|FG000|Overall Study|Withdrawal by Subject|2|||
161855030|NCT00104572|584509727|FG001|Overall Study|Withdrawal by Subject|3|||
161855031|NCT00104572|584509728|FG002|Overall Study|Withdrawal by Subject|0|||
161855032|NCT00098774|584509729|FG000|Overall Study|Adverse Event|2|||
161855033|NCT00098774|584509729|FG000|Overall Study|Disease Progression|9|||
161767481|NCT03512028|584189010|FG001|Overall Study|Withdrawal by Subject|0|||
161767482|NCT03512028|584189009|FG000|Overall Study|Protocol Violation|2|||
161767483|NCT03512028|584189010|FG001|Overall Study|Protocol Violation|0|||
161767484|NCT00554229|584189015|FG000|Overall Study|Lost to Follow-up|3|||
161767485|NCT00554229|584189016|FG001|Overall Study|Lost to Follow-up|6|||
161767486|NCT00554229|584189015|FG000|Overall Study|Withdrawal by Subject|29|||
161767487|NCT00554229|584189016|FG001|Overall Study|Withdrawal by Subject|37|||
161767488|NCT00554229|584189015|FG000|Overall Study|Adverse Event|71|||
161767489|NCT00554229|584189016|FG001|Overall Study|Adverse Event|39|||
161767490|NCT00554229|584189015|FG000|Overall Study|Protocol Violation|3|||
161767491|NCT00554229|584189016|FG001|Overall Study|Protocol Violation|3|||
161767492|NCT00554229|584189015|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
161767493|NCT00554229|584189016|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
161767494|NCT00554229|584189015|FG000|Overall Study|Randomised but no treatment received|1|||
161767495|NCT00554229|584189016|FG001|Overall Study|Randomised but no treatment received|0|||
161767496|NCT00517634|584189017|FG000|Second Treatment Period|Withdrawal by Subject|0|||
161767497|NCT00517634|584189018|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161767498|NCT00517634|584189019|FG002|Second Treatment Period|Withdrawal by Subject|0|||
161767499|NCT00517634|584189020|FG003|Second Treatment Period|Withdrawal by Subject|0|||
161767500|NCT00517634|584189021|FG004|Second Treatment Period|Withdrawal by Subject|1|||
161767501|NCT00517634|584189022|FG005|Second Treatment Period|Withdrawal by Subject|0|||
161767502|NCT03143855|584189023|FG000|Overall Study|Withdrawal by Subject|4|||
161767503|NCT03143855|584189024|FG001|Overall Study|Withdrawal by Subject|3|||
161767504|NCT03143855|584189023|FG000|Overall Study|Protocol Violation|1|||
161767505|NCT03143855|584189024|FG001|Overall Study|Protocol Violation|0|||
161767506|NCT03143855|584189023|FG000|Overall Study|Participant experienced withdrawal|0|||
161767507|NCT03143855|584189024|FG001|Overall Study|Participant experienced withdrawal|1|||
161767508|NCT00701064|584189027|FG000|Overall Study|Protocol Violation|1|||
161767509|NCT00701064|584189028|FG001|Overall Study|Protocol Violation|1|||
161767510|NCT00701064|584189027|FG000|Overall Study|Withdrawal by Subject|1|||
161767511|NCT00701064|584189028|FG001|Overall Study|Withdrawal by Subject|1|||
161767512|NCT00701064|584189027|FG000|Overall Study|initiated other PTSD treatment|2|||
161767513|NCT00701064|584189028|FG001|Overall Study|initiated other PTSD treatment|2|||
161767514|NCT02098733|584189029|FG000|Overall Study|Data Not Available|5|||
161767515|NCT02098733|584189029|FG000|Overall Study|Lost to Follow-up|5|||
161767516|NCT00939094|584189030|FG000|Overall Study|Adverse Event|9|||
161767517|NCT00939094|584189031|FG001|Overall Study|Adverse Event|0|||
161767518|NCT00939094|584189030|FG000|Overall Study|Withdrawal by Subject|1|||
161767519|NCT00939094|584189031|FG001|Overall Study|Withdrawal by Subject|6|||
161767520|NCT00939094|584189030|FG000|Overall Study|Lost to Follow-up|1|||
161767521|NCT00939094|584189031|FG001|Overall Study|Lost to Follow-up|1|||
161767522|NCT00939094|584189030|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161767523|NCT00939094|584189031|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161767524|NCT00939094|584189030|FG000|Overall Study|Severe non-compliance to protocol|0|||
161767525|NCT00939094|584189031|FG001|Overall Study|Severe non-compliance to protocol|1|||
161767526|NCT00939094|584189030|FG000|Overall Study|Study stopped by sponsor|0|||
161767527|NCT00939094|584189031|FG001|Overall Study|Study stopped by sponsor|2|||
161767528|NCT00939094|584189030|FG000|Overall Study|Abnormal ECG findings|1|||
161767529|NCT00939094|584189031|FG001|Overall Study|Abnormal ECG findings|0|||
161767530|NCT01002573|584190664|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
161767531|NCT01002573|584190665|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
161767532|NCT02713490|584190669|FG000|Overall Study|Withdrawal by Subject|2|||
161767533|NCT02713490|584190670|FG001|Overall Study|Withdrawal by Subject|1|||
161767534|NCT02713490|584190669|FG000|Overall Study|Did not receive study drug|1|||
161767535|NCT02713490|584190670|FG001|Overall Study|Did not receive study drug|0|||
161767536|NCT02713490|584190669|FG000|Overall Study|Met exclusion criteria|0|||
161767537|NCT02713490|584190670|FG001|Overall Study|Met exclusion criteria|1|||
161767538|NCT00134563|584190676|FG000|Overall Study|Not treated due to protocol violation|0|||
161767539|NCT00134563|584190677|FG001|Overall Study|Not treated due to protocol violation|1|||
161767540|NCT00134563|584190678|FG002|Overall Study|Not treated due to protocol violation|1|||
161767541|NCT00134563|584190676|FG000|Overall Study|Adverse Event|29|||
161767542|NCT00134563|584190677|FG001|Overall Study|Adverse Event|37|||
161767543|NCT00134563|584190678|FG002|Overall Study|Adverse Event|38|||
161767544|NCT00134563|584190676|FG000|Overall Study|Lack of Efficacy|24|||
161767545|NCT00134563|584190677|FG001|Overall Study|Lack of Efficacy|14|||
161767546|NCT00134563|584190678|FG002|Overall Study|Lack of Efficacy|17|||
161767547|NCT00134563|584190676|FG000|Overall Study|Protocol Violation|3|||
161767548|NCT00134563|584190677|FG001|Overall Study|Protocol Violation|2|||
161767549|NCT00134563|584190678|FG002|Overall Study|Protocol Violation|5|||
161767550|NCT00134563|584190676|FG000|Overall Study|Lost to Follow-up|4|||
161767551|NCT00134563|584190677|FG001|Overall Study|Lost to Follow-up|0|||
161767552|NCT00134563|584190678|FG002|Overall Study|Lost to Follow-up|2|||
161767553|NCT00134563|584190676|FG000|Overall Study|progressive disease|11|||
161767554|NCT00134563|584190677|FG001|Overall Study|progressive disease|4|||
161767555|NCT00134563|584190678|FG002|Overall Study|progressive disease|2|||
161767556|NCT00134563|584190676|FG000|Overall Study|did not wish to continue|33|||
161767557|NCT00134563|584190677|FG001|Overall Study|did not wish to continue|32|||
161767558|NCT00134563|584190678|FG002|Overall Study|did not wish to continue|26|||
161767559|NCT00134563|584190676|FG000|Overall Study|Reason other than above|0|||
161767560|NCT00134563|584190677|FG001|Overall Study|Reason other than above|2|||
161767561|NCT00134563|584190678|FG002|Overall Study|Reason other than above|5|||
161767562|NCT03382639|584190679|FG000|Overall Study|Adverse Event|2|||
161767563|NCT03382639|584190680|FG001|Overall Study|Adverse Event|0|||
161767564|NCT03382639|584190681|FG002|Overall Study|Adverse Event|1|||
161767565|NCT03382639|584190682|FG003|Overall Study|Adverse Event|1|||
161767566|NCT03382639|584190679|FG000|Overall Study|Lost to Follow-up|1|||
161767567|NCT03382639|584190680|FG001|Overall Study|Lost to Follow-up|0|||
161767568|NCT03382639|584190681|FG002|Overall Study|Lost to Follow-up|0|||
161767569|NCT03382639|584190682|FG003|Overall Study|Lost to Follow-up|0|||
161767570|NCT03382639|584190679|FG000|Overall Study|Withdrawal by Subject|4|||
161767571|NCT03382639|584190680|FG001|Overall Study|Withdrawal by Subject|3|||
161767572|NCT03382639|584190681|FG002|Overall Study|Withdrawal by Subject|2|||
161767573|NCT03382639|584190682|FG003|Overall Study|Withdrawal by Subject|3|||
161767574|NCT03382639|584190679|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161767575|NCT03382639|584190680|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
161767576|NCT03382639|584190681|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
161767577|NCT03382639|584190682|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
161767578|NCT03382639|584190679|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
161767579|NCT03382639|584190680|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
161767580|NCT03382639|584190681|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
161767581|NCT03382639|584190682|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
161767582|NCT03382639|584190679|FG000|Overall Study|Other|2|||
161767583|NCT03382639|584190680|FG001|Overall Study|Other|0|||
161767584|NCT03382639|584190681|FG002|Overall Study|Other|0|||
161767585|NCT03382639|584190682|FG003|Overall Study|Other|3|||
161767586|NCT02406586|584190683|FG000|Overall Study|Lost to Follow-up|0|||
161767587|NCT02406586|584190684|FG001|Overall Study|Lost to Follow-up|4|||
161767588|NCT02406586|584190685|FG002|Overall Study|Lost to Follow-up|2|||
161767589|NCT02406586|584190683|FG000|Overall Study|Withdrawal by Subject|1|||
161767590|NCT02406586|584190684|FG001|Overall Study|Withdrawal by Subject|0|||
161767591|NCT02406586|584190685|FG002|Overall Study|Withdrawal by Subject|0|||
161767592|NCT00285857|584190688|FG000|Overall Study|Withdrawal by Subject|2|||
161767593|NCT00285857|584190688|FG000|Overall Study|Inadequate initial breast cytology|1|||
161767594|NCT00285857|584190688|FG000|Overall Study|Adverse Event|1|||
161767595|NCT06104423|584190693|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
161767596|NCT06104423|584190694|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
161767597|NCT06104423|584190695|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
161767598|NCT06104423|584190693|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
161767599|NCT06104423|584190694|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
161767600|NCT06104423|584190695|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
161767601|NCT00351611|584190700|FG000|Overall Study|Adverse Event|11|||
161767602|NCT00351611|584190701|FG001|Overall Study|Adverse Event|3|||
161767603|NCT00351611|584190700|FG000|Overall Study|Death|1|||
161767604|NCT00351611|584190701|FG001|Overall Study|Death|0|||
161767605|NCT00351611|584190700|FG000|Overall Study|Lost to Follow-up|1|||
161767606|NCT00351611|584190701|FG001|Overall Study|Lost to Follow-up|0|||
161767607|NCT00351611|584190700|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
161767608|NCT00351611|584190701|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
161767609|NCT00351611|584190700|FG000|Overall Study|Other|1|||
161767610|NCT00351611|584190701|FG001|Overall Study|Other|0|||
161767611|NCT00351611|584190700|FG000|Overall Study|Protocol Violation|0|||
161767612|NCT00351611|584190701|FG001|Overall Study|Protocol Violation|2|||
161767613|NCT01589185|584190702|FG000|Overall Study|Death|1|||
161855034|NCT00098774|584509729|FG000|Overall Study|Withdrawal by Subject|1|||
161767614|NCT01589185|584190703|FG001|Overall Study|Death|2|||
161767615|NCT01589185|584190704|FG002|Overall Study|Death|2|||
161767616|NCT01589185|584190705|FG003|Overall Study|Death|0|||
161767617|NCT01589185|584190706|FG004|Overall Study|Death|1|||
161767618|NCT01589185|584190702|FG000|Overall Study|Lost to Follow-up|1|||
161767619|NCT01589185|584190703|FG001|Overall Study|Lost to Follow-up|0|||
161767620|NCT01589185|584190704|FG002|Overall Study|Lost to Follow-up|2|||
161767621|NCT01589185|584190705|FG003|Overall Study|Lost to Follow-up|3|||
161767622|NCT01589185|584190706|FG004|Overall Study|Lost to Follow-up|0|||
161767623|NCT02708524|584190707|FG000|Overall Study|Adverse Event|0|||
161767624|NCT02708524|584190708|FG001|Overall Study|Adverse Event|1|||
161767625|NCT02708524|584190709|FG002|Overall Study|Adverse Event|0|||
161767626|NCT02708524|584190710|FG003|Overall Study|Adverse Event|0|||
161767627|NCT02708524|584190707|FG000|Overall Study|Lens Discomfort|1|||
161767628|NCT02708524|584190708|FG001|Overall Study|Lens Discomfort|0|||
161767629|NCT02708524|584190709|FG002|Overall Study|Lens Discomfort|1|||
161767630|NCT02708524|584190710|FG003|Overall Study|Lens Discomfort|0|||
161767631|NCT02708524|584190707|FG000|Overall Study|Lost to Follow-up|1|||
161767632|NCT02708524|584190708|FG001|Overall Study|Lost to Follow-up|1|||
161767633|NCT02708524|584190709|FG002|Overall Study|Lost to Follow-up|1|||
161767634|NCT02708524|584190710|FG003|Overall Study|Lost to Follow-up|0|||
161767635|NCT02708524|584190707|FG000|Overall Study|Protocol Violation|0|||
161767636|NCT02708524|584190708|FG001|Overall Study|Protocol Violation|1|||
161767637|NCT02708524|584190709|FG002|Overall Study|Protocol Violation|0|||
161767638|NCT02708524|584190710|FG003|Overall Study|Protocol Violation|0|||
161767639|NCT02708524|584190707|FG000|Overall Study|Withdrawal by Subject|1|||
161767640|NCT02708524|584190708|FG001|Overall Study|Withdrawal by Subject|1|||
161767641|NCT02708524|584190709|FG002|Overall Study|Withdrawal by Subject|0|||
161767642|NCT02708524|584190710|FG003|Overall Study|Withdrawal by Subject|0|||
161767643|NCT02708524|584190707|FG000|Overall Study|Dispensed incorrect study lens|0|||
161767644|NCT02708524|584190708|FG001|Overall Study|Dispensed incorrect study lens|1|||
161767645|NCT02708524|584190709|FG002|Overall Study|Dispensed incorrect study lens|1|||
161767646|NCT02708524|584190710|FG003|Overall Study|Dispensed incorrect study lens|0|||
161767647|NCT02708524|584190707|FG000|Overall Study|Did not wear lens at final visit|0|||
161767648|NCT02708524|584190708|FG001|Overall Study|Did not wear lens at final visit|1|||
161767649|NCT02708524|584190709|FG002|Overall Study|Did not wear lens at final visit|0|||
161767650|NCT02708524|584190710|FG003|Overall Study|Did not wear lens at final visit|0|||
161767651|NCT02708524|584190707|FG000|Overall Study|Subject lost study lens|1|||
161767652|NCT02708524|584190708|FG001|Overall Study|Subject lost study lens|0|||
161767653|NCT02708524|584190709|FG002|Overall Study|Subject lost study lens|0|||
161767654|NCT02708524|584190710|FG003|Overall Study|Subject lost study lens|0|||
161767655|NCT03781167|584190716|FG000|Overall Study|Adverse Event|23|||
161767656|NCT03781167|584190717|FG001|Overall Study|Adverse Event|25|||
161767657|NCT03781167|584190716|FG000|Overall Study|Withdrew consent|16|||
161767658|NCT03781167|584190717|FG001|Overall Study|Withdrew consent|12|||
161767659|NCT03781167|584190716|FG000|Overall Study|Lost to Follow-up|0|||
161767660|NCT03781167|584190717|FG001|Overall Study|Lost to Follow-up|1|||
161767661|NCT03781167|584190716|FG000|Overall Study|Lack of Efficacy|4|||
161767662|NCT03781167|584190717|FG001|Overall Study|Lack of Efficacy|5|||
161767663|NCT03781167|584190716|FG000|Overall Study|Difficulty with drug delivery system|2|||
161767664|NCT03781167|584190717|FG001|Overall Study|Difficulty with drug delivery system|3|||
161767665|NCT03781167|584190716|FG000|Overall Study|Other, not specified|2|||
161767666|NCT03781167|584190717|FG001|Overall Study|Other, not specified|2|||
161767667|NCT00462501|584190718|FG000|Overall Study|Not treated|3|||
161767668|NCT00462501|584190718|FG000|Overall Study|Adverse Event|2|||
161767669|NCT00679354|584190723|FG000|Overall Study|Death|3|||
161767670|NCT00679354|584190723|FG000|Overall Study|Lack of Efficacy|22|||
161767671|NCT00679354|584190723|FG000|Overall Study|Physician Decision|4|||
161767672|NCT00679354|584190723|FG000|Overall Study|Ineligible|1|||
161767673|NCT01258803|584190724|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161767674|NCT01258803|584190725|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161767675|NCT01258803|584190726|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161767676|NCT01258803|584190727|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161767677|NCT01258803|584190728|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161767678|NCT01258803|584190729|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161767679|NCT01258803|584190724|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767680|NCT01258803|584190725|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
161767681|NCT01258803|584190726|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767682|NCT01258803|584190727|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767683|NCT01258803|584190728|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767684|NCT01258803|584190729|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767685|NCT01258803|584190724|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767686|NCT01258803|584190725|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767687|NCT01258803|584190726|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
161767688|NCT01258803|584190727|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767689|NCT01258803|584190728|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767690|NCT01258803|584190729|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767691|NCT01552408|584190730|FG000|Overall Study|Lost to Follow-up|2|||
161767692|NCT01552408|584190731|FG001|Overall Study|Lost to Follow-up|0|||
161767693|NCT01552408|584190730|FG000|Overall Study|Relocation|0|||
161767694|NCT01552408|584190731|FG001|Overall Study|Relocation|1|||
161767695|NCT01552408|584190730|FG000|Overall Study|Withdrawal by Subject|2|||
161767696|NCT01552408|584190731|FG001|Overall Study|Withdrawal by Subject|1|||
161767697|NCT01016912|584190735|FG000|End of Treatment Period|Lack of Efficacy|0|||
161767698|NCT01016912|584190736|FG001|End of Treatment Period|Lack of Efficacy|1|||
161767699|NCT01016912|584190737|FG002|End of Treatment Period|Lack of Efficacy|0|||
161767700|NCT01016912|584190738|FG003|End of Treatment Period|Lack of Efficacy|4|||
161767701|NCT01016912|584190739|FG004|End of Treatment Period|Lack of Efficacy|4|||
161767702|NCT01016912|584190735|FG000|End of Treatment Period|Adverse Event|0|||
161767703|NCT01016912|584190736|FG001|End of Treatment Period|Adverse Event|1|||
161767704|NCT01016912|584190737|FG002|End of Treatment Period|Adverse Event|1|||
161767705|NCT01016912|584190738|FG003|End of Treatment Period|Adverse Event|0|||
161767706|NCT01016912|584190739|FG004|End of Treatment Period|Adverse Event|0|||
161767707|NCT01016912|584190735|FG000|End of Treatment Period|Completed double-blind period only|0|||
161767708|NCT01016912|584190736|FG001|End of Treatment Period|Completed double-blind period only|1|||
161767709|NCT01016912|584190737|FG002|End of Treatment Period|Completed double-blind period only|0|||
161767710|NCT01016912|584190738|FG003|End of Treatment Period|Completed double-blind period only|0|||
161767711|NCT01016912|584190739|FG004|End of Treatment Period|Completed double-blind period only|0|||
161767712|NCT01016912|584190735|FG000|Follow-up Period|Other reason|0|||
161767713|NCT01016912|584190736|FG001|Follow-up Period|Other reason|0|||
161767714|NCT01016912|584190737|FG002|Follow-up Period|Other reason|1|||
161767715|NCT01016912|584190738|FG003|Follow-up Period|Other reason|1|||
161767716|NCT01016912|584190739|FG004|Follow-up Period|Other reason|0|||
161767717|NCT01853397|584190742|FG000|Overall Study|Withdrawal by Subject|0|||
161767718|NCT01853397|584190743|FG001|Overall Study|Withdrawal by Subject|0|||
161767719|NCT01853397|584190744|FG002|Overall Study|Withdrawal by Subject|0|||
161767720|NCT01853397|584190745|FG003|Overall Study|Withdrawal by Subject|1|||
161767721|NCT01853397|584190742|FG000|Overall Study|Subject Noncompliance|0|||
161767722|NCT01853397|584190743|FG001|Overall Study|Subject Noncompliance|0|||
161767723|NCT01853397|584190744|FG002|Overall Study|Subject Noncompliance|0|||
161767724|NCT01853397|584190745|FG003|Overall Study|Subject Noncompliance|1|||
161767725|NCT01632345|584190746|FG000|Treatment: Part I|Adverse Event|1|||
161767726|NCT01632345|584190747|FG001|Treatment: Part I|Adverse Event|4|||
161767727|NCT01632345|584190748|FG002|Treatment: Part I|Adverse Event|2|||
161767728|NCT01632345|584190749|FG003|Treatment: Part I|Adverse Event|1|||
161767729|NCT01632345|584190750|FG004|Treatment: Part I|Adverse Event|3|||
161767730|NCT01632345|584190751|FG005|Treatment: Part I|Adverse Event|0|||
161767731|NCT01632345|584190752|FG006|Treatment: Part I|Adverse Event|0|||
161767732|NCT01632345|584190746|FG000|Treatment: Part I|Lack of Efficacy|0|||
161767733|NCT01632345|584190747|FG001|Treatment: Part I|Lack of Efficacy|1|||
161767734|NCT01632345|584190748|FG002|Treatment: Part I|Lack of Efficacy|0|||
161767735|NCT01632345|584190749|FG003|Treatment: Part I|Lack of Efficacy|1|||
161767736|NCT01632345|584190750|FG004|Treatment: Part I|Lack of Efficacy|1|||
161767737|NCT01632345|584190751|FG005|Treatment: Part I|Lack of Efficacy|0|||
161767738|NCT01632345|584190752|FG006|Treatment: Part I|Lack of Efficacy|0|||
161767739|NCT01632345|584190746|FG000|Treatment: Part I|Lost to Follow-up|3|||
161767740|NCT01632345|584190747|FG001|Treatment: Part I|Lost to Follow-up|2|||
161767741|NCT01632345|584190748|FG002|Treatment: Part I|Lost to Follow-up|1|||
161767742|NCT01632345|584190749|FG003|Treatment: Part I|Lost to Follow-up|3|||
161767743|NCT01632345|584190750|FG004|Treatment: Part I|Lost to Follow-up|4|||
161767744|NCT01632345|584190751|FG005|Treatment: Part I|Lost to Follow-up|0|||
161767745|NCT01632345|584190752|FG006|Treatment: Part I|Lost to Follow-up|0|||
161767746|NCT01632345|584190746|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
161767747|NCT01632345|584190747|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
161767748|NCT01632345|584190748|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
161767749|NCT01632345|584190749|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
161767750|NCT01632345|584190750|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
161767751|NCT01632345|584190751|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
161767752|NCT01632345|584190752|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
161767753|NCT01632345|584190746|FG000|Treatment: Part I|Physician Decision|2|||
161767754|NCT01632345|584190747|FG001|Treatment: Part I|Physician Decision|1|||
161767755|NCT01632345|584190748|FG002|Treatment: Part I|Physician Decision|0|||
161767756|NCT01632345|584190749|FG003|Treatment: Part I|Physician Decision|0|||
161767757|NCT01632345|584190750|FG004|Treatment: Part I|Physician Decision|1|||
161767758|NCT01632345|584190751|FG005|Treatment: Part I|Physician Decision|0|||
161767759|NCT01632345|584190752|FG006|Treatment: Part I|Physician Decision|0|||
161767760|NCT01632345|584190746|FG000|Treatment: Part I|Pregnancy|0|||
161767761|NCT01632345|584190747|FG001|Treatment: Part I|Pregnancy|1|||
161767762|NCT01632345|584190748|FG002|Treatment: Part I|Pregnancy|0|||
161767763|NCT01632345|584190749|FG003|Treatment: Part I|Pregnancy|0|||
161767764|NCT01632345|584190750|FG004|Treatment: Part I|Pregnancy|0|||
161767765|NCT01632345|584190751|FG005|Treatment: Part I|Pregnancy|0|||
161767766|NCT01632345|584190752|FG006|Treatment: Part I|Pregnancy|0|||
161767767|NCT01632345|584190746|FG000|Treatment: Part I|Protocol Deviation|0|||
161767768|NCT01632345|584190747|FG001|Treatment: Part I|Protocol Deviation|0|||
161767769|NCT01632345|584190748|FG002|Treatment: Part I|Protocol Deviation|1|||
161767770|NCT01632345|584190749|FG003|Treatment: Part I|Protocol Deviation|1|||
161767771|NCT01632345|584190750|FG004|Treatment: Part I|Protocol Deviation|0|||
161767772|NCT01632345|584190751|FG005|Treatment: Part I|Protocol Deviation|0|||
161767773|NCT01632345|584190752|FG006|Treatment: Part I|Protocol Deviation|0|||
161767774|NCT01632345|584190746|FG000|Treatment: Part I|Withdrawal by Subject|3|||
161767775|NCT01632345|584190747|FG001|Treatment: Part I|Withdrawal by Subject|4|||
161767776|NCT01632345|584190748|FG002|Treatment: Part I|Withdrawal by Subject|4|||
161767777|NCT01632345|584190749|FG003|Treatment: Part I|Withdrawal by Subject|1|||
161767778|NCT01632345|584190750|FG004|Treatment: Part I|Withdrawal by Subject|4|||
161767779|NCT01632345|584190751|FG005|Treatment: Part I|Withdrawal by Subject|0|||
161767780|NCT01632345|584190752|FG006|Treatment: Part I|Withdrawal by Subject|0|||
161767781|NCT01632345|584190746|FG000|Treatment: Part II|Adverse Event|0|||
161767782|NCT01632345|584190747|FG001|Treatment: Part II|Adverse Event|0|||
161767783|NCT01632345|584190748|FG002|Treatment: Part II|Adverse Event|0|||
161767784|NCT01632345|584190749|FG003|Treatment: Part II|Adverse Event|0|||
161767785|NCT01632345|584190750|FG004|Treatment: Part II|Adverse Event|0|||
161767786|NCT01632345|584190751|FG005|Treatment: Part II|Adverse Event|3|||
161767787|NCT01632345|584190752|FG006|Treatment: Part II|Adverse Event|8|||
161767788|NCT01632345|584190746|FG000|Treatment: Part II|Lost to Follow-up|0|||
161767789|NCT01632345|584190747|FG001|Treatment: Part II|Lost to Follow-up|0|||
161767790|NCT01632345|584190748|FG002|Treatment: Part II|Lost to Follow-up|0|||
161767791|NCT01632345|584190749|FG003|Treatment: Part II|Lost to Follow-up|0|||
161767792|NCT01632345|584190750|FG004|Treatment: Part II|Lost to Follow-up|0|||
161767793|NCT01632345|584190751|FG005|Treatment: Part II|Lost to Follow-up|3|||
161767794|NCT01632345|584190752|FG006|Treatment: Part II|Lost to Follow-up|1|||
161767795|NCT01632345|584190746|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767796|NCT01632345|584190747|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767797|NCT01632345|584190748|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767798|NCT01632345|584190749|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767799|NCT01632345|584190750|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767800|NCT01632345|584190751|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
161767801|NCT01632345|584190752|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767802|NCT01632345|584190746|FG000|Treatment: Part II|Withdrawal by Subject|0|||
161767803|NCT01632345|584190747|FG001|Treatment: Part II|Withdrawal by Subject|0|||
161767804|NCT01632345|584190748|FG002|Treatment: Part II|Withdrawal by Subject|0|||
161767805|NCT01632345|584190749|FG003|Treatment: Part II|Withdrawal by Subject|0|||
161767806|NCT01632345|584190750|FG004|Treatment: Part II|Withdrawal by Subject|0|||
161767807|NCT01632345|584190751|FG005|Treatment: Part II|Withdrawal by Subject|2|||
161767808|NCT01632345|584190752|FG006|Treatment: Part II|Withdrawal by Subject|2|||
161767809|NCT00089505|584190753|FG000|Overall Study|Death|4|||
161767810|NCT00089505|584190754|FG001|Overall Study|Death|1|||
161767811|NCT00089505|584190755|FG002|Overall Study|Death|5|||
161767812|NCT00089505|584190756|FG003|Overall Study|Death|8|||
161767813|NCT00089505|584190753|FG000|Overall Study|Withdrawal by Subject|3|||
161767814|NCT00089505|584190754|FG001|Overall Study|Withdrawal by Subject|0|||
161767815|NCT00089505|584190755|FG002|Overall Study|Withdrawal by Subject|6|||
161767816|NCT00089505|584190756|FG003|Overall Study|Withdrawal by Subject|6|||
161767817|NCT00089505|584190753|FG000|Overall Study|Lost to Follow-up|1|||
161767818|NCT00089505|584190754|FG001|Overall Study|Lost to Follow-up|1|||
161767819|NCT00089505|584190755|FG002|Overall Study|Lost to Follow-up|9|||
161767820|NCT00089505|584190756|FG003|Overall Study|Lost to Follow-up|7|||
161767821|NCT00089505|584190753|FG000|Overall Study|Physician Decision|1|||
161767822|NCT00089505|584190754|FG001|Overall Study|Physician Decision|0|||
161767823|NCT00089505|584190755|FG002|Overall Study|Physician Decision|0|||
161767824|NCT00089505|584190756|FG003|Overall Study|Physician Decision|0|||
161767825|NCT00089505|584190753|FG000|Overall Study|Protocol Violation|0|||
161767826|NCT00089505|584190754|FG001|Overall Study|Protocol Violation|0|||
161767827|NCT00089505|584190755|FG002|Overall Study|Protocol Violation|1|||
161767828|NCT00089505|584190756|FG003|Overall Study|Protocol Violation|0|||
161767829|NCT02431559|584190757|FG000|Overall Study|Adverse Event|0|||
161767830|NCT02431559|584190758|FG001|Overall Study|Adverse Event|1|||
161767831|NCT02431559|584190759|FG002|Overall Study|Adverse Event|0|||
161767832|NCT02431559|584190760|FG003|Overall Study|Adverse Event|4|||
161767833|NCT02431559|584190757|FG000|Overall Study|Progressive disease|2|||
161767834|NCT02431559|584190758|FG001|Overall Study|Progressive disease|1|||
161767835|NCT02431559|584190759|FG002|Overall Study|Progressive disease|4|||
161767836|NCT02431559|584190760|FG003|Overall Study|Progressive disease|22|||
161767837|NCT02431559|584190757|FG000|Overall Study|Withdrawal by Subject|0|||
161767838|NCT02431559|584190758|FG001|Overall Study|Withdrawal by Subject|1|||
161767839|NCT02431559|584190759|FG002|Overall Study|Withdrawal by Subject|0|||
161767840|NCT02431559|584190760|FG003|Overall Study|Withdrawal by Subject|4|||
161767841|NCT02431559|584190757|FG000|Overall Study|Physician Decision|0|||
161767842|NCT02431559|584190758|FG001|Overall Study|Physician Decision|0|||
161767843|NCT02431559|584190759|FG002|Overall Study|Physician Decision|0|||
161767844|NCT02431559|584190760|FG003|Overall Study|Physician Decision|1|||
161767845|NCT01005875|584190766|FG000|Overall Study|Death|3|||
161767846|NCT00606931|584190767|FG000|Overall Study|Withdrawal by Subject|3|||
161767847|NCT05047601|584190768|FG000|Overall Study|Lost to Follow-up|9|||
161767848|NCT05047601|584190769|FG001|Overall Study|Lost to Follow-up|11|||
161767849|NCT05047601|584190770|FG002|Overall Study|Lost to Follow-up|7|||
161767850|NCT05047601|584190768|FG000|Overall Study|Withdrawal by Subject|25|||
161767851|NCT05047601|584190769|FG001|Overall Study|Withdrawal by Subject|36|||
161767852|NCT05047601|584190770|FG002|Overall Study|Withdrawal by Subject|23|||
161767853|NCT05047601|584190768|FG000|Overall Study|Other|10|||
161767854|NCT05047601|584190769|FG001|Overall Study|Other|6|||
161767855|NCT05047601|584190770|FG002|Overall Study|Other|5|||
161767856|NCT00286234|584190771|FG000|Overall Study|Protocol Violation|1|||
161767857|NCT00286234|584190772|FG001|Overall Study|Protocol Violation|2|||
161767858|NCT00286234|584190773|FG002|Overall Study|Protocol Violation|0|||
161767859|NCT00286234|584190774|FG003|Overall Study|Protocol Violation|1|||
161767860|NCT00286234|584190771|FG000|Overall Study|Physician Decision|1|||
161767861|NCT00286234|584190772|FG001|Overall Study|Physician Decision|0|||
161767862|NCT00286234|584190773|FG002|Overall Study|Physician Decision|0|||
161767863|NCT00286234|584190774|FG003|Overall Study|Physician Decision|1|||
161767864|NCT00286234|584190771|FG000|Overall Study|Adverse Event|0|||
161767865|NCT00286234|584190772|FG001|Overall Study|Adverse Event|0|||
161767866|NCT00286234|584190773|FG002|Overall Study|Adverse Event|0|||
161767867|NCT00286234|584190774|FG003|Overall Study|Adverse Event|1|||
161767868|NCT00286234|584190771|FG000|Overall Study|Adverse Event|0|||
161767869|NCT00286234|584190772|FG001|Overall Study|Adverse Event|0|||
161767870|NCT00286234|584190773|FG002|Overall Study|Adverse Event|0|||
161767871|NCT00286234|584190774|FG003|Overall Study|Adverse Event|1|||
161767872|NCT02924129|584190785|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
161767873|NCT02924129|584190786|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
161767874|NCT02924129|584190785|FG000|Overall Study|Withdrawal by Subject|2|||
161767875|NCT02924129|584190786|FG001|Overall Study|Withdrawal by Subject|2|||
161767876|NCT02924129|584190785|FG000|Overall Study|Physician Decision|1|||
161767877|NCT02924129|584190786|FG001|Overall Study|Physician Decision|0|||
161767878|NCT02924129|584190785|FG000|Overall Study|Missed Visit|0|||
161767879|NCT02924129|584190786|FG001|Overall Study|Missed Visit|1|||
161767880|NCT00302731|584190790|FG000|Overall Study|Lost to Follow-up|1|||
161767881|NCT00302731|584190791|FG001|Overall Study|Lost to Follow-up|2|||
161767882|NCT00302731|584190792|FG002|Overall Study|Lost to Follow-up|0|||
161767883|NCT00302731|584190793|FG003|Overall Study|Lost to Follow-up|0|||
161767884|NCT00302731|584190790|FG000|Overall Study|Adverse Event|0|||
161767885|NCT00302731|584190791|FG001|Overall Study|Adverse Event|2|||
161767886|NCT00302731|584190792|FG002|Overall Study|Adverse Event|2|||
161767887|NCT00302731|584190793|FG003|Overall Study|Adverse Event|0|||
161767888|NCT00302731|584190790|FG000|Overall Study|Withdrawal by Subject|1|||
161767889|NCT00302731|584190791|FG001|Overall Study|Withdrawal by Subject|1|||
161767890|NCT00302731|584190792|FG002|Overall Study|Withdrawal by Subject|0|||
161767891|NCT00302731|584190793|FG003|Overall Study|Withdrawal by Subject|0|||
161767892|NCT00302731|584190790|FG000|Overall Study|Protocol Violation|1|||
161767893|NCT00302731|584190791|FG001|Overall Study|Protocol Violation|0|||
161767894|NCT00302731|584190792|FG002|Overall Study|Protocol Violation|0|||
161767895|NCT00302731|584190793|FG003|Overall Study|Protocol Violation|0|||
161767896|NCT00302731|584190790|FG000|Overall Study|cancer unrelated to study discovered|1|||
161767897|NCT00302731|584190791|FG001|Overall Study|cancer unrelated to study discovered|0|||
161767898|NCT00302731|584190792|FG002|Overall Study|cancer unrelated to study discovered|1|||
161767899|NCT00302731|584190793|FG003|Overall Study|cancer unrelated to study discovered|0|||
161767900|NCT01610752|584190796|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
161767901|NCT01610752|584190797|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
161767902|NCT01610752|584190798|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
161767903|NCT00283062|584190799|FG000|Overall Study|Did not receive any study medication|5|||
161767904|NCT00283062|584190800|FG001|Overall Study|Did not receive any study medication|4|||
161767905|NCT00283062|584190801|FG002|Overall Study|Did not receive any study medication|36|||
161767906|NCT00283062|584190802|FG003|Overall Study|Did not receive any study medication|45|||
161767907|NCT00283062|584190799|FG000|Overall Study|Adverse Event|2|||
161767908|NCT00283062|584190800|FG001|Overall Study|Adverse Event|0|||
161767909|NCT00283062|584190801|FG002|Overall Study|Adverse Event|1|||
161767910|NCT00283062|584190802|FG003|Overall Study|Adverse Event|0|||
161767911|NCT00283062|584190799|FG000|Overall Study|Lost to Follow-up|1|||
161767912|NCT00283062|584190800|FG001|Overall Study|Lost to Follow-up|0|||
161767913|NCT00283062|584190801|FG002|Overall Study|Lost to Follow-up|1|||
161767914|NCT00283062|584190802|FG003|Overall Study|Lost to Follow-up|0|||
161767915|NCT00283062|584190799|FG000|Overall Study|Progressive disease|0|||
161767916|NCT00283062|584190800|FG001|Overall Study|Progressive disease|0|||
161767917|NCT00283062|584190801|FG002|Overall Study|Progressive disease|1|||
161767918|NCT00283062|584190802|FG003|Overall Study|Progressive disease|0|||
161767919|NCT00283062|584190799|FG000|Overall Study|Participant did not wish to continue|3|||
161767920|NCT00283062|584190800|FG001|Overall Study|Participant did not wish to continue|2|||
161767921|NCT00283062|584190801|FG002|Overall Study|Participant did not wish to continue|1|||
161767922|NCT00283062|584190802|FG003|Overall Study|Participant did not wish to continue|0|||
161767923|NCT00283062|584190799|FG000|Overall Study|Undefined|0|||
161767924|NCT00283062|584190800|FG001|Overall Study|Undefined|1|||
161767925|NCT00283062|584190801|FG002|Overall Study|Undefined|1|||
161767926|NCT00283062|584190802|FG003|Overall Study|Undefined|4|||
161767927|NCT00283062|584190799|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
161767928|NCT00283062|584190800|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
161767929|NCT00283062|584190801|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
161767930|NCT00283062|584190802|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
161767931|NCT00252499|584190805|FG000|Overall Study|Lost to Follow-up|1|||
161767932|NCT00252499|584190806|FG001|Overall Study|Lost to Follow-up|0|||
161767933|NCT00252499|584190807|FG002|Overall Study|Lost to Follow-up|0|||
161767934|NCT01535638|584190808|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767935|NCT01535638|584190809|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767936|NCT01535638|584190810|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
161855035|NCT00098774|584509729|FG000|Overall Study|Failed (to respond) during induction|4|||
161855036|NCT00098774|584509729|FG000|Overall Study|Physician Decision|2|||
161855037|NCT03097991|584509730|FG000|Overall Study|Didn't meet study criteria|8|||
161855038|NCT03097991|584509731|FG001|Overall Study|Didn't meet study criteria|0|||
161855039|NCT03097991|584509730|FG000|Overall Study|Withdrawal by Subject|12|||
161855040|NCT03097991|584509731|FG001|Overall Study|Withdrawal by Subject|6|||
161855041|NCT03097991|584509730|FG000|Overall Study|Death of Baby|3|||
161855042|NCT03097991|584509731|FG001|Overall Study|Death of Baby|1|||
161855043|NCT03097991|584509730|FG000|Overall Study|Lost to Follow-up|24|||
161855044|NCT03097991|584509731|FG001|Overall Study|Lost to Follow-up|38|||
161855045|NCT03097991|584509730|FG000|Overall Study|Adverse Event|3|||
161855046|NCT03097991|584509731|FG001|Overall Study|Adverse Event|5|||
161855047|NCT04502212|584509732|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
161855048|NCT04502212|584509732|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
161855049|NCT01320150|584509735|FG000|Overall Study|Protocol Violation|15|||
161855050|NCT01320150|584509735|FG000|Overall Study|Withdrawal by Subject|5|||
161855051|NCT01320150|584509735|FG000|Overall Study|Death|2|||
161855052|NCT01320150|584509735|FG000|Overall Study|Lost to Follow-up|44|||
161855053|NCT00919854|584509736|FG000|Overall Study|Adverse Event|1|||
161855054|NCT00143247|584509743|FG000|Overall Study|Death|8|||
161855055|NCT00143247|584509743|FG000|Overall Study|Adverse Event|19|||
161855056|NCT00143247|584509743|FG000|Overall Study|Lack of Efficacy|3|||
161855057|NCT00143247|584509743|FG000|Overall Study|Withdrawal by Subject|55|||
161855058|NCT00143247|584509743|FG000|Overall Study|Study terminated by sponsor|31|||
161855059|NCT00143247|584509743|FG000|Overall Study|Protocol Violation|15|||
161855060|NCT00143247|584509743|FG000|Overall Study|Lost to Follow-up|12|||
161855061|NCT00143247|584509743|FG000|Overall Study|following inaccurate lab adverse event|1|||
161855062|NCT00143247|584509743|FG000|Overall Study|Other|12|||
161855063|NCT00489827|584509744|FG000|Overall Study|Intraoperative exclusion criteria|1|||
161855064|NCT00489827|584509745|FG001|Overall Study|Intraoperative exclusion criteria|1|||
161855065|NCT00489827|584509744|FG000|Overall Study|Intraoperative exclusion criteria|1|||
161855066|NCT00489827|584509745|FG001|Overall Study|Intraoperative exclusion criteria|1|||
161855067|NCT02766283|584509746|FG000|Overall Study|Lost to Follow-up|27|||
161855068|NCT00721227|584509747|FG000|Overall Study|Lost to Follow-up|3|||
161855069|NCT00721227|584509748|FG001|Overall Study|Lost to Follow-up|0|||
161855070|NCT00721227|584509747|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
161855071|NCT00721227|584509748|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
161855072|NCT01632280|584509762|FG000|Overall Study|Withdrawal by Subject|1|||
161855073|NCT01632280|584509763|FG001|Overall Study|Withdrawal by Subject|0|||
161855074|NCT03086551|584509764|FG000|First Intervention|Failure to meet inclusion criterion|1|||
161855075|NCT03086551|584509765|FG001|First Intervention|Failure to meet inclusion criterion|0|||
161855076|NCT03086551|584509764|FG000|First Intervention|Lost to Follow-up|0|||
161855077|NCT03086551|584509765|FG001|First Intervention|Lost to Follow-up|1|||
161855078|NCT03086551|584509764|FG000|Washout|Lost to Follow-up|1|||
161855079|NCT03086551|584509765|FG001|Washout|Lost to Follow-up|2|||
161855080|NCT03086551|584509764|FG000|Washout|Withdrawal by Subject|2|||
161855081|NCT03086551|584509765|FG001|Washout|Withdrawal by Subject|1|||
161855082|NCT03736031|584509769|FG000|Overall Study|Death|2|||
161855083|NCT03736031|584509770|FG001|Overall Study|Death|4|||
161855084|NCT03736031|584509769|FG000|Overall Study|Lost to Follow-up|21|||
161855085|NCT03736031|584509770|FG001|Overall Study|Lost to Follow-up|2|||
161855086|NCT03736031|584509769|FG000|Overall Study|Withdrawal by Subject|9|||
161855087|NCT03736031|584509770|FG001|Overall Study|Withdrawal by Subject|0|||
161855088|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
161855089|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
161855090|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
161855091|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
161767937|NCT01535638|584190811|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767938|NCT01535638|584190812|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767939|NCT01535638|584190813|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
161767940|NCT01535638|584190808|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767941|NCT01535638|584190809|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767942|NCT01535638|584190810|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767943|NCT01535638|584190811|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
161767944|NCT01535638|584190812|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767945|NCT01535638|584190813|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767946|NCT03524664|584190814|FG000|Overall Study|Withdrawal by Subject|1|||
161767947|NCT03524664|584190815|FG001|Overall Study|Withdrawal by Subject|2|||
161767948|NCT03524664|584190814|FG000|Overall Study|Lost to Follow-up|4|||
161767949|NCT03524664|584190815|FG001|Overall Study|Lost to Follow-up|13|||
161767950|NCT01482598|584190816|FG000|Overall Study|Death|7|||
161767951|NCT01482598|584190817|FG001|Overall Study|Death|10|||
161767952|NCT01482598|584190816|FG000|Overall Study|Physician Decision|0|||
161767953|NCT01482598|584190817|FG001|Overall Study|Physician Decision|3|||
161767954|NCT01482598|584190816|FG000|Overall Study|Withdrawal by Subject|4|||
161767955|NCT01482598|584190817|FG001|Overall Study|Withdrawal by Subject|5|||
161767956|NCT01482598|584190816|FG000|Overall Study|Lost to Follow-up|5|||
161767957|NCT01482598|584190817|FG001|Overall Study|Lost to Follow-up|4|||
161767958|NCT02694562|584190818|FG000|Overall Study|Death|8|||
161767959|NCT02694562|584190818|FG000|Overall Study|Protocol Violation|4|||
161767960|NCT02694562|584190818|FG000|Overall Study|Lost to Follow-up|3|||
161767961|NCT02694562|584190818|FG000|Overall Study|Screen Failure|2|||
161767962|NCT02694562|584190818|FG000|Overall Study|Physician Decision|1|||
161767963|NCT03702166|584190819|FG000|Overall Study|Lost to Follow-up|1|||
161767964|NCT03702166|584190819|FG000|Overall Study|Withdrawal by Subject|1|||
161767965|NCT00827112|584190820|FG000|Overall Study|Adverse Event|2|||
161767966|NCT00827112|584190821|FG001|Overall Study|Adverse Event|0|||
161767967|NCT00827112|584190820|FG000|Overall Study|Lack of Efficacy|2|||
161767968|NCT00827112|584190821|FG001|Overall Study|Lack of Efficacy|0|||
161767969|NCT00827112|584190820|FG000|Overall Study|Lost to Follow-up|3|||
161767970|NCT00827112|584190821|FG001|Overall Study|Lost to Follow-up|2|||
161767971|NCT00827112|584190820|FG000|Overall Study|Pregnancy|0|||
161767972|NCT00827112|584190821|FG001|Overall Study|Pregnancy|1|||
161767973|NCT00827112|584190820|FG000|Overall Study|Protocol Violation|0|||
161767974|NCT00827112|584190821|FG001|Overall Study|Protocol Violation|2|||
161767975|NCT00827112|584190820|FG000|Overall Study|Withdrawal by Subject|2|||
161767976|NCT00827112|584190821|FG001|Overall Study|Withdrawal by Subject|1|||
161767977|NCT00827112|584190820|FG000|Overall Study|Randomized but not treated|5|||
161767978|NCT00827112|584190821|FG001|Overall Study|Randomized but not treated|3|||
161767979|NCT00827112|584190820|FG000|Overall Study|Other|1|||
161767980|NCT00827112|584190821|FG001|Overall Study|Other|3|||
161767981|NCT03529162|584190826|FG000|Overall Study|Lost to Follow-up|2|||
161767982|NCT03529162|584190827|FG001|Overall Study|Lost to Follow-up|2|||
161767983|NCT00784836|584190828|FG000|Overall Study|Early Study Termination|3|||
161767984|NCT02613910|584190829|FG000|Overall Study|Termination of study|1|||
161767985|NCT03077646|584190830|FG000|Overall Study|Lost to Follow-up|29|||
161767986|NCT03077646|584190831|FG001|Overall Study|Lost to Follow-up|30|||
161767987|NCT03077646|584190832|FG002|Overall Study|Lost to Follow-up|31|||
161767988|NCT00765726|584190833|FG000|Overall Study|Withdrawal by Subject|1|||
161767989|NCT00765726|584190833|FG000|Overall Study|Discontinuation of study by sponsor|8|||
161767990|NCT02993731|584190834|FG000|Overall Study|Study Termination|101|||
161767991|NCT02993731|584190835|FG001|Overall Study|Study Termination|105|||
161767992|NCT02028182|584192520|FG000|Overall Study|Protocol Violation|2|||
161767993|NCT01684930|584192521|FG000|Overall Study|Withdrawal by Subject|3|||
161767994|NCT01684930|584192522|FG001|Overall Study|Withdrawal by Subject|1|||
161767995|NCT01945866|584192523|FG000|Overall Study|Eyes did not complete or were dropped|2|||
161767996|NCT01945866|584192524|FG001|Overall Study|Eyes did not complete or were dropped|0|||
161767997|NCT01336647|584192525|FG000|Overall Study|Lost to Follow-up|4|||
161767998|NCT01336647|584192526|FG001|Overall Study|Lost to Follow-up|1|||
161767999|NCT01336647|584192527|FG002|Overall Study|Lost to Follow-up|3|||
161768000|NCT01018680|584192528|FG000|Overall Study|Adverse Event|23|||
161768001|NCT01018680|584192529|FG001|Overall Study|Adverse Event|40|||
161768002|NCT01018680|584192528|FG000|Overall Study|Withdrawal by Subject|10|||
161768003|NCT01018680|584192529|FG001|Overall Study|Withdrawal by Subject|10|||
161768004|NCT01018680|584192528|FG000|Overall Study|Protocol Violation|5|||
161768005|NCT01018680|584192529|FG001|Overall Study|Protocol Violation|8|||
161768006|NCT01018680|584192528|FG000|Overall Study|Sponsor Decision|6|||
161768007|NCT01018680|584192529|FG001|Overall Study|Sponsor Decision|7|||
161768008|NCT01018680|584192528|FG000|Overall Study|Lack of Efficacy|8|||
161768009|NCT01018680|584192529|FG001|Overall Study|Lack of Efficacy|2|||
161768010|NCT01018680|584192528|FG000|Overall Study|Lost to Follow-up|5|||
161768011|NCT01018680|584192529|FG001|Overall Study|Lost to Follow-up|3|||
161768012|NCT01018680|584192528|FG000|Overall Study|Entry Criteria Not Met|1|||
161768013|NCT01018680|584192529|FG001|Overall Study|Entry Criteria Not Met|4|||
161768014|NCT01018680|584192528|FG000|Overall Study|Physician Decision|3|||
161768015|NCT01018680|584192529|FG001|Overall Study|Physician Decision|1|||
161768016|NCT02930889|584192530|FG000|Overall Study|Lost to Follow-up|2|||
161768017|NCT02930889|584192530|FG000|Overall Study|Withdrawal by Subject|6|||
161768018|NCT02930889|584192530|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
161768019|NCT04398030|584192531|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
161768020|NCT04398030|584192532|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
161768021|NCT04398030|584192531|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
161768022|NCT04398030|584192532|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
161768023|NCT05056311|584192533|FG000|Overall Study|Lost to Follow-up|14|||
161768024|NCT05056311|584192533|FG000|Overall Study|Withdrawal by Subject|1|||
161768025|NCT05056311|584192533|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
161768026|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
161768027|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
161768028|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
161768029|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
161768030|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Adverse Event|0|||
161768031|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Adverse Event|1|||
161768032|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Adverse Event|0|||
161768033|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Adverse Event|0|||
161768034|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
161768035|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
161768036|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
161768037|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
161768038|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
161768039|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
161768040|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
161768041|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
161768042|NCT01714726|584192534|FG000|Open-Label Period|Other|0|||
161768043|NCT01714726|584192535|FG001|Open-Label Period|Other|0|||
161768044|NCT01714726|584192536|FG002|Open-Label Period|Other|1|||
161768045|NCT01714726|584192537|FG003|Open-Label Period|Other|3|||
161768046|NCT01714726|584192534|FG000|Open-Label Period|Adverse Event|0|||
161768047|NCT01714726|584192535|FG001|Open-Label Period|Adverse Event|0|||
161768048|NCT01714726|584192536|FG002|Open-Label Period|Adverse Event|1|||
161768049|NCT01714726|584192537|FG003|Open-Label Period|Adverse Event|0|||
161768050|NCT01714726|584192534|FG000|Open-Label Period|Withdrawal by Subject|0|||
161768051|NCT01714726|584192535|FG001|Open-Label Period|Withdrawal by Subject|0|||
161768052|NCT01714726|584192536|FG002|Open-Label Period|Withdrawal by Subject|9|||
161768053|NCT01714726|584192537|FG003|Open-Label Period|Withdrawal by Subject|19|||
161768054|NCT01714726|584192534|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
161768055|NCT01714726|584192535|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
161768056|NCT01714726|584192536|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
161768057|NCT01714726|584192537|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
161768058|NCT01714726|584192534|FG000|Open-Label Period|Lost to Follow-up|0|||
161768059|NCT01714726|584192535|FG001|Open-Label Period|Lost to Follow-up|0|||
161768060|NCT01714726|584192536|FG002|Open-Label Period|Lost to Follow-up|3|||
161768061|NCT01714726|584192537|FG003|Open-Label Period|Lost to Follow-up|4|||
161768062|NCT00548340|584192539|FG000|Overall Study|Protocol Violation|2|||
161768063|NCT00548340|584192540|FG001|Overall Study|Protocol Violation|3|||
161768064|NCT00548340|584192541|FG002|Overall Study|Protocol Violation|3|||
161768065|NCT00548340|584192539|FG000|Overall Study|Adverse Event|2|||
161768066|NCT00548340|584192540|FG001|Overall Study|Adverse Event|2|||
161768067|NCT00548340|584192541|FG002|Overall Study|Adverse Event|2|||
161768068|NCT00548340|584192539|FG000|Overall Study|Lost to Follow-up|1|||
161768069|NCT00548340|584192540|FG001|Overall Study|Lost to Follow-up|1|||
161768070|NCT00548340|584192541|FG002|Overall Study|Lost to Follow-up|0|||
161768071|NCT00548340|584192539|FG000|Overall Study|Withdrawal by Subject|2|||
161768072|NCT00548340|584192540|FG001|Overall Study|Withdrawal by Subject|4|||
161768073|NCT00548340|584192541|FG002|Overall Study|Withdrawal by Subject|3|||
161768074|NCT00548340|584192539|FG000|Overall Study|Other|1|||
161768075|NCT00548340|584192540|FG001|Overall Study|Other|1|||
161768076|NCT00548340|584192541|FG002|Overall Study|Other|1|||
161768077|NCT02600559|584192542|FG000|Overall Study|Withdrawal by Subject|3|||
161768078|NCT02600559|584192542|FG000|Overall Study|Lost to Follow-up|20|||
161768079|NCT00679042|584192551|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
161768080|NCT00679042|584192551|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
161768081|NCT00679042|584192551|FG000|5-Year Follow Up|Death|1|||
161768082|NCT00679042|584192551|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
161768083|NCT00679042|584192551|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
161768084|NCT02392078|584192552|FG000|Overall Study|Did not have procedure|32|||
161768085|NCT02392078|584192553|FG001|Overall Study|Did not have procedure|43|||
161768086|NCT02392078|584192554|FG002|Overall Study|Did not have procedure|20|||
161768087|NCT02392078|584192555|FG003|Overall Study|Did not have procedure|1|||
161768088|NCT02079077|584192556|FG000|Overall Study|Lost to Follow-up|5|||
161768089|NCT02079077|584192557|FG001|Overall Study|Lost to Follow-up|7|||
161768090|NCT02079077|584192556|FG000|Overall Study|Became STIs Positive|1|||
161768091|NCT02079077|584192557|FG001|Overall Study|Became STIs Positive|2|||
161768092|NCT03868410|584192558|FG000|Overall Study|Physician Decision|0|||
161768093|NCT03868410|584192559|FG001|Overall Study|Physician Decision|1|||
161768094|NCT02624713|584192566|FG000|Overall Study|Lost to Follow-up|14|||
161768095|NCT02624713|584192567|FG001|Overall Study|Lost to Follow-up|0|||
161768096|NCT00148109|584192568|FG000|Overall Study|Lack of Efficacy|10|||
161768097|NCT00148109|584192569|FG001|Overall Study|Lack of Efficacy|18|||
161768098|NCT00148109|584192568|FG000|Overall Study|Adverse Event|0|||
161768099|NCT00148109|584192569|FG001|Overall Study|Adverse Event|2|||
161768100|NCT00148109|584192568|FG000|Overall Study|Withdrawal by Subject|2|||
161768101|NCT00148109|584192569|FG001|Overall Study|Withdrawal by Subject|0|||
161768102|NCT04047472|584192580|FG000|Overall Study|Adverse Event|3|||
161768103|NCT04047472|584192581|FG001|Overall Study|Adverse Event|3|||
161768104|NCT04047472|584192580|FG000|Overall Study|Death|0|||
161768105|NCT04047472|584192581|FG001|Overall Study|Death|1|||
161768106|NCT04047472|584192580|FG000|Overall Study|Lost to Follow-up|1|||
161768107|NCT04047472|584192581|FG001|Overall Study|Lost to Follow-up|0|||
161768108|NCT04047472|584192580|FG000|Overall Study|Physician Decision|1|||
161768109|NCT04047472|584192581|FG001|Overall Study|Physician Decision|2|||
161768110|NCT04047472|584192580|FG000|Overall Study|Protocol Violation|1|||
161768111|NCT04047472|584192581|FG001|Overall Study|Protocol Violation|0|||
161768112|NCT04047472|584192580|FG000|Overall Study|Withdrawal by Subject|10|||
161768113|NCT04047472|584192581|FG001|Overall Study|Withdrawal by Subject|10|||
161768114|NCT01218477|584192582|FG000|Overall Study|Disease progression|2|||
161768115|NCT01218477|584192583|FG001|Overall Study|Disease progression|3|||
161768116|NCT01218477|584192584|FG002|Overall Study|Disease progression|6|||
161768117|NCT01218477|584192585|FG003|Overall Study|Disease progression|2|||
161768118|NCT01218477|584192582|FG000|Overall Study|Study drug toxicity|0|||
161768119|NCT01218477|584192583|FG001|Overall Study|Study drug toxicity|2|||
161768120|NCT01218477|584192584|FG002|Overall Study|Study drug toxicity|5|||
161768121|NCT01218477|584192585|FG003|Overall Study|Study drug toxicity|0|||
161768122|NCT01218477|584192582|FG000|Overall Study|No longer meets study criteria|1|||
161768123|NCT01218477|584192583|FG001|Overall Study|No longer meets study criteria|0|||
161768124|NCT01218477|584192584|FG002|Overall Study|No longer meets study criteria|0|||
161768125|NCT01218477|584192585|FG003|Overall Study|No longer meets study criteria|0|||
161768126|NCT01218477|584192582|FG000|Overall Study|Withdrawal by Subject|0|||
161768127|NCT01218477|584192583|FG001|Overall Study|Withdrawal by Subject|0|||
161768128|NCT01218477|584192584|FG002|Overall Study|Withdrawal by Subject|1|||
161768129|NCT01218477|584192585|FG003|Overall Study|Withdrawal by Subject|0|||
161768130|NCT01218477|584192582|FG000|Overall Study|Prepared for cell transplantation|0|||
161768131|NCT01218477|584192583|FG001|Overall Study|Prepared for cell transplantation|1|||
161768132|NCT01218477|584192584|FG002|Overall Study|Prepared for cell transplantation|1|||
161768133|NCT01218477|584192585|FG003|Overall Study|Prepared for cell transplantation|0|||
161768134|NCT01218477|584192582|FG000|Overall Study|Administrative reason by sponsor|0|||
161768135|NCT01218477|584192583|FG001|Overall Study|Administrative reason by sponsor|0|||
161768136|NCT01218477|584192584|FG002|Overall Study|Administrative reason by sponsor|1|||
161768137|NCT01218477|584192585|FG003|Overall Study|Administrative reason by sponsor|0|||
161768138|NCT01218477|584192582|FG000|Overall Study|Maximum clinical benefit|0|||
161768139|NCT01218477|584192583|FG001|Overall Study|Maximum clinical benefit|2|||
161768140|NCT01218477|584192584|FG002|Overall Study|Maximum clinical benefit|0|||
161768141|NCT01218477|584192585|FG003|Overall Study|Maximum clinical benefit|0|||
161768142|NCT01303159|584192589|FG000|Overall Study|Death|16|||
161768143|NCT01303159|584192589|FG000|Overall Study|Study Termination|7|||
161768144|NCT00496782|584192595|FG000|Overall Study|Protocol Violation|1|||
161768145|NCT00496782|584192596|FG001|Overall Study|Protocol Violation|2|||
161768146|NCT02132312|584192598|FG000|Overall Study|Adverse Event|2|||
161768147|NCT02132312|584192599|FG001|Overall Study|Adverse Event|0|||
161768148|NCT02132312|584192598|FG000|Overall Study|Physician Decision|1|||
161768149|NCT02132312|584192599|FG001|Overall Study|Physician Decision|1|||
161768150|NCT02132312|584192598|FG000|Overall Study|Protocol Violation|0|||
161768151|NCT02132312|584192599|FG001|Overall Study|Protocol Violation|1|||
161768152|NCT02132312|584192598|FG000|Overall Study|Withdrawal by Subject|1|||
161768153|NCT02132312|584192599|FG001|Overall Study|Withdrawal by Subject|0|||
161768154|NCT02132312|584192598|FG000|Overall Study|Lost to Follow-up|2|||
161768155|NCT02132312|584192599|FG001|Overall Study|Lost to Follow-up|1|||
161768156|NCT01348828|584192602|FG000|Overall Study|Death|20|||
161768157|NCT01348828|584192602|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
161768158|NCT01348828|584192602|FG000|Overall Study|Conversion|2|||
161768159|NCT01348828|584192602|FG000|Overall Study|missed visit|1|||
161768160|NCT04246996|584192603|FG000|Overall Study|Physician Decision|1|||
161768161|NCT04246996|584192604|FG001|Overall Study|Physician Decision|1|||
161768162|NCT04246996|584192603|FG000|Overall Study|Did not meet eligibility criteria|1|||
161768163|NCT04246996|584192604|FG001|Overall Study|Did not meet eligibility criteria|4|||
161768164|NCT02442284|584192607|FG000|Overall Study|Adverse Event|1|||
161768165|NCT02442284|584192607|FG000|Overall Study|Withdrew Consent|2|||
161768166|NCT02442284|584192607|FG000|Overall Study|Lost to Follow-up|3|||
161768167|NCT02442284|584192607|FG000|Overall Study|Other|1|||
161768168|NCT01365468|584192611|FG000|Overall Study|Physician Decision|1|||
161768169|NCT01365468|584192612|FG001|Overall Study|Physician Decision|0|||
161768170|NCT01365468|584192611|FG000|Overall Study|Disease progression|1|||
161768171|NCT01365468|584192612|FG001|Overall Study|Disease progression|0|||
161768172|NCT01365468|584192611|FG000|Overall Study|Lost to Follow-up|2|||
161768173|NCT01365468|584192612|FG001|Overall Study|Lost to Follow-up|0|||
161768174|NCT01521494|584192615|FG000|Overall Study|Adverse Event|1|||
161768175|NCT01521494|584192616|FG001|Overall Study|Adverse Event|2|||
161768176|NCT01521494|584192617|FG002|Overall Study|Adverse Event|9|||
161768177|NCT01521494|584192618|FG003|Overall Study|Adverse Event|6|||
161768178|NCT01521494|584192619|FG004|Overall Study|Adverse Event|2|||
161768179|NCT01521494|584192615|FG000|Overall Study|Lack of Efficacy|0|||
161768180|NCT01521494|584192616|FG001|Overall Study|Lack of Efficacy|0|||
161768181|NCT01521494|584192617|FG002|Overall Study|Lack of Efficacy|0|||
161768182|NCT01521494|584192618|FG003|Overall Study|Lack of Efficacy|0|||
161768183|NCT01521494|584192619|FG004|Overall Study|Lack of Efficacy|2|||
161768184|NCT01521494|584192615|FG000|Overall Study|Withdrawal by Subject|1|||
161768185|NCT01521494|584192616|FG001|Overall Study|Withdrawal by Subject|1|||
161768186|NCT01521494|584192617|FG002|Overall Study|Withdrawal by Subject|0|||
161768187|NCT01521494|584192618|FG003|Overall Study|Withdrawal by Subject|2|||
161768188|NCT01521494|584192619|FG004|Overall Study|Withdrawal by Subject|0|||
161768189|NCT01521494|584192615|FG000|Overall Study|Decrease in serum phosphate|0|||
161768190|NCT01521494|584192616|FG001|Overall Study|Decrease in serum phosphate|2|||
161768191|NCT01521494|584192617|FG002|Overall Study|Decrease in serum phosphate|3|||
161768192|NCT01521494|584192618|FG003|Overall Study|Decrease in serum phosphate|12|||
161768193|NCT01521494|584192619|FG004|Overall Study|Decrease in serum phosphate|0|||
161768194|NCT01521494|584192615|FG000|Overall Study|Decrease in serum calcium|0|||
161768195|NCT01521494|584192616|FG001|Overall Study|Decrease in serum calcium|0|||
161768196|NCT01521494|584192617|FG002|Overall Study|Decrease in serum calcium|0|||
161768197|NCT01521494|584192618|FG003|Overall Study|Decrease in serum calcium|1|||
161768198|NCT01521494|584192619|FG004|Overall Study|Decrease in serum calcium|1|||
161768199|NCT01521494|584192615|FG000|Overall Study|Physician Decision|0|||
161768200|NCT01521494|584192616|FG001|Overall Study|Physician Decision|0|||
161768201|NCT01521494|584192617|FG002|Overall Study|Physician Decision|0|||
161768202|NCT01521494|584192618|FG003|Overall Study|Physician Decision|0|||
161768203|NCT01521494|584192619|FG004|Overall Study|Physician Decision|2|||
161768204|NCT00877929|584192620|FG000|Overall Study|Adverse Event|11|||
161768205|NCT00877929|584192621|FG001|Overall Study|Adverse Event|20|||
161768206|NCT00877929|584192620|FG000|Overall Study|Protocol Violation|3|||
161768207|NCT00877929|584192621|FG001|Overall Study|Protocol Violation|3|||
161768208|NCT00877929|584192620|FG000|Overall Study|Lost to Follow-up|0|||
161768209|NCT00877929|584192621|FG001|Overall Study|Lost to Follow-up|1|||
161768210|NCT00877929|584192620|FG000|Overall Study|Withdrawal by Subject|4|||
161768211|NCT00877929|584192621|FG001|Overall Study|Withdrawal by Subject|4|||
161768212|NCT00877929|584192620|FG000|Overall Study|Lack of Efficacy|0|||
161768213|NCT00877929|584192621|FG001|Overall Study|Lack of Efficacy|1|||
161768214|NCT00877929|584192620|FG000|Overall Study|Other reason (not specified)|2|||
161768215|NCT00877929|584192621|FG001|Overall Study|Other reason (not specified)|6|||
161768216|NCT01140646|584192622|FG000|Overall Study|Adverse Event|4|||
161768217|NCT01140646|584192622|FG000|Overall Study|Refused Further Treatment|5|||
161768218|NCT00689728|584192626|FG000|Double-Blind Treatment|Adverse Event|1|||
161768219|NCT00689728|584192627|FG001|Double-Blind Treatment|Adverse Event|0|||
161768220|NCT00689728|584192628|FG002|Double-Blind Treatment|Adverse Event|0|||
161768221|NCT00689728|584192626|FG000|Double-Blind Treatment|Protocol Violation|0|||
161768222|NCT00689728|584192627|FG001|Double-Blind Treatment|Protocol Violation|0|||
161768223|NCT00689728|584192628|FG002|Double-Blind Treatment|Protocol Violation|1|||
161855092|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
161855093|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
161855094|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
161768224|NCT00689728|584192626|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
161768225|NCT00689728|584192627|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
161768226|NCT00689728|584192628|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
161768227|NCT00689728|584192626|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
161768228|NCT00689728|584192627|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
161768229|NCT00689728|584192628|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
161768230|NCT00689728|584192626|FG000|Rescue|Adverse Event|0|||
161768231|NCT00689728|584192627|FG001|Rescue|Adverse Event|1|||
161768232|NCT00689728|584192628|FG002|Rescue|Adverse Event|0|||
161768233|NCT00689728|584192626|FG000|Rescue|Withdrawal by Subject|1|||
161768234|NCT00689728|584192627|FG001|Rescue|Withdrawal by Subject|1|||
161768235|NCT00689728|584192628|FG002|Rescue|Withdrawal by Subject|1|||
161768236|NCT00689728|584192626|FG000|Optional Follow-Up|Adverse Event|1|||
161768237|NCT00689728|584192627|FG001|Optional Follow-Up|Adverse Event|0|||
161768238|NCT00689728|584192628|FG002|Optional Follow-Up|Adverse Event|0|||
161768239|NCT00689728|584192626|FG000|Optional Follow-Up|Lack of Efficacy|0|||
161768240|NCT00689728|584192627|FG001|Optional Follow-Up|Lack of Efficacy|1|||
161768241|NCT00689728|584192628|FG002|Optional Follow-Up|Lack of Efficacy|1|||
161768242|NCT00689728|584192626|FG000|Optional Follow-Up|Lost to Follow-up|0|||
161768243|NCT00689728|584192627|FG001|Optional Follow-Up|Lost to Follow-up|1|||
161768244|NCT00689728|584192628|FG002|Optional Follow-Up|Lost to Follow-up|1|||
161768245|NCT00689728|584192626|FG000|Optional Follow-Up|Protocol Violation|0|||
161768246|NCT00689728|584192627|FG001|Optional Follow-Up|Protocol Violation|0|||
161768247|NCT00689728|584192628|FG002|Optional Follow-Up|Protocol Violation|1|||
161768248|NCT00689728|584192626|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
161768249|NCT00689728|584192627|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
161768250|NCT00689728|584192628|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
161768251|NCT00842829|584192631|FG000|Dose Titration Period|Adverse Event|11|||
161768252|NCT00842829|584192632|FG001|Dose Titration Period|Adverse Event|10|||
161768253|NCT00842829|584192633|FG002|Dose Titration Period|Adverse Event|0|||
161768254|NCT00842829|584192631|FG000|Dose Titration Period|Lack of Efficacy|4|||
161768255|NCT00842829|584192632|FG001|Dose Titration Period|Lack of Efficacy|1|||
161768256|NCT00842829|584192633|FG002|Dose Titration Period|Lack of Efficacy|0|||
161768257|NCT00842829|584192631|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
161768258|NCT00842829|584192632|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
161768259|NCT00842829|584192633|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
161768260|NCT00842829|584192631|FG000|Dose Titration Period|Withdrawal by Subject|2|||
161768261|NCT00842829|584192632|FG001|Dose Titration Period|Withdrawal by Subject|6|||
161768262|NCT00842829|584192633|FG002|Dose Titration Period|Withdrawal by Subject|0|||
161768263|NCT00842829|584192631|FG000|Dose Titration Period|Other|5|||
161768264|NCT00842829|584192632|FG001|Dose Titration Period|Other|4|||
161768265|NCT00842829|584192633|FG002|Dose Titration Period|Other|0|||
161768266|NCT00842829|584192631|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
161768267|NCT00842829|584192632|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
161768268|NCT00842829|584192633|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
161768269|NCT00842829|584192631|FG000|Dose Titration Period|Non-compliance to study drug|2|||
161768270|NCT00842829|584192632|FG001|Dose Titration Period|Non-compliance to study drug|1|||
161768271|NCT00842829|584192633|FG002|Dose Titration Period|Non-compliance to study drug|0|||
161768272|NCT00842829|584192631|FG000|Treatment Period|Adverse Event|0|||
161768273|NCT00842829|584192632|FG001|Treatment Period|Adverse Event|0|||
161768274|NCT00842829|584192633|FG002|Treatment Period|Adverse Event|15|||
161768275|NCT00842829|584192631|FG000|Treatment Period|Lack of Efficacy|0|||
161768276|NCT00842829|584192632|FG001|Treatment Period|Lack of Efficacy|0|||
161768277|NCT00842829|584192633|FG002|Treatment Period|Lack of Efficacy|6|||
161768278|NCT00842829|584192631|FG000|Treatment Period|Unstable persistent cancer pain|0|||
161768279|NCT00842829|584192632|FG001|Treatment Period|Unstable persistent cancer pain|0|||
161768280|NCT00842829|584192633|FG002|Treatment Period|Unstable persistent cancer pain|5|||
161768281|NCT00842829|584192631|FG000|Treatment Period|Withdrawal by Subject|0|||
161768282|NCT00842829|584192632|FG001|Treatment Period|Withdrawal by Subject|0|||
161768283|NCT00842829|584192633|FG002|Treatment Period|Withdrawal by Subject|11|||
161768284|NCT00842829|584192631|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
161855095|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
161855096|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
161855097|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
161768285|NCT00842829|584192632|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
161768286|NCT00842829|584192633|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
161768287|NCT00842829|584192631|FG000|Treatment Period|Protocol Violation|0|||
161768288|NCT00842829|584192632|FG001|Treatment Period|Protocol Violation|0|||
161768289|NCT00842829|584192633|FG002|Treatment Period|Protocol Violation|2|||
161768290|NCT00842829|584192631|FG000|Treatment Period|Other|0|||
161768291|NCT00842829|584192632|FG001|Treatment Period|Other|0|||
161855098|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
161855099|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
161855100|NCT00451178|584509771|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
161855101|NCT00451178|584509772|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
161855102|NCT00451178|584509771|FG000|Prior to Maintenance Therapy|PD|2|||
161855103|NCT00451178|584509772|FG001|Prior to Maintenance Therapy|PD|0|||
161855104|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
161855105|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
161855106|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
161855107|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
161855108|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
161855109|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
161855110|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
161855111|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
161855112|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
161855113|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
161855114|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
161855115|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
161855116|NCT00451178|584509771|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
161855117|NCT00451178|584509772|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
161855118|NCT00352417|584509775|FG000|Overall Study|Adverse Event|1|||
161855119|NCT00352417|584509776|FG001|Overall Study|Adverse Event|0|||
161855120|NCT00352417|584509775|FG000|Overall Study|Protocol Violation|0|||
161855121|NCT00352417|584509776|FG001|Overall Study|Protocol Violation|2|||
161855122|NCT00352417|584509775|FG000|Overall Study|Withdrawal by Subject|1|||
161855123|NCT00352417|584509776|FG001|Overall Study|Withdrawal by Subject|2|||
161855124|NCT00352417|584509775|FG000|Overall Study|Lost to Follow-up|1|||
161855125|NCT00352417|584509776|FG001|Overall Study|Lost to Follow-up|0|||
161855126|NCT00352417|584509775|FG000|Overall Study|Schedule Change|2|||
161855127|NCT00352417|584509776|FG001|Overall Study|Schedule Change|1|||
161855128|NCT00912912|584509777|FG000|Overall Study|Withdrawal by Subject|1|||
161855129|NCT00912912|584509777|FG000|Overall Study|Disease Progression|3|||
161855130|NCT02447744|584509778|FG000|Overall Study|Withdrawal by Subject|3|||
161768292|NCT00842829|584192633|FG002|Treatment Period|Other|18|||
161768293|NCT00842829|584192631|FG000|Treatment Period|Non-compliance to study procedures|0|||
161768294|NCT00842829|584192632|FG001|Treatment Period|Non-compliance to study procedures|0|||
161768295|NCT00842829|584192633|FG002|Treatment Period|Non-compliance to study procedures|4|||
161768296|NCT00842829|584192631|FG000|Treatment Period|Unclear completion status|0|||
161768297|NCT00842829|584192632|FG001|Treatment Period|Unclear completion status|0|||
161768298|NCT00842829|584192633|FG002|Treatment Period|Unclear completion status|1|||
161855131|NCT02447744|584509779|FG001|Overall Study|Withdrawal by Subject|1|||
161768299|NCT00842829|584192631|FG000|Continuation Period|Adverse Event|0|||
161768300|NCT00842829|584192632|FG001|Continuation Period|Adverse Event|0|||
161768301|NCT00842829|584192633|FG002|Continuation Period|Adverse Event|32|||
161768302|NCT00842829|584192631|FG000|Continuation Period|Lack of Efficacy|0|||
161768303|NCT00842829|584192632|FG001|Continuation Period|Lack of Efficacy|0|||
161768304|NCT00842829|584192633|FG002|Continuation Period|Lack of Efficacy|6|||
161768305|NCT00842829|584192631|FG000|Continuation Period|Unstable persistent cancer pain|0|||
161768306|NCT00842829|584192632|FG001|Continuation Period|Unstable persistent cancer pain|0|||
161768307|NCT00842829|584192633|FG002|Continuation Period|Unstable persistent cancer pain|3|||
161768308|NCT00842829|584192631|FG000|Continuation Period|Withdrawal by Subject|0|||
161768309|NCT00842829|584192632|FG001|Continuation Period|Withdrawal by Subject|0|||
161768310|NCT00842829|584192633|FG002|Continuation Period|Withdrawal by Subject|10|||
161768311|NCT00842829|584192631|FG000|Continuation Period|Other|0|||
161768312|NCT00842829|584192632|FG001|Continuation Period|Other|0|||
161768313|NCT00842829|584192633|FG002|Continuation Period|Other|7|||
161768314|NCT00842829|584192631|FG000|Continuation Period|Non-compliance to study procedures|0|||
161768315|NCT00842829|584192632|FG001|Continuation Period|Non-compliance to study procedures|0|||
161768316|NCT00842829|584192633|FG002|Continuation Period|Non-compliance to study procedures|2|||
161855132|NCT02447744|584509778|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
161855133|NCT02447744|584509779|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
161855134|NCT00306995|584509780|FG000|Study Part I|Withdrawal by Subject|0|||
161855135|NCT00306995|584509781|FG001|Study Part I|Withdrawal by Subject|0|||
161855136|NCT00306995|584509782|FG002|Study Part I|Withdrawal by Subject|0|||
161768317|NCT00842829|584192631|FG000|Continuation Period|Non-compliance to study drug|0|||
161768318|NCT00842829|584192632|FG001|Continuation Period|Non-compliance to study drug|0|||
161768319|NCT00842829|584192633|FG002|Continuation Period|Non-compliance to study drug|1|||
161768320|NCT00660829|584192639|FG000|Overall Study|Adverse Event|3|||
161768321|NCT00660829|584192640|FG001|Overall Study|Adverse Event|4|||
161768322|NCT00660829|584192639|FG000|Overall Study|Lack of Efficacy|2|||
161768323|NCT00660829|584192640|FG001|Overall Study|Lack of Efficacy|3|||
161768324|NCT00660829|584192639|FG000|Overall Study|Non-Compliance|0|||
161855137|NCT00306995|584509783|FG003|Study Part I|Withdrawal by Subject|0|||
161855138|NCT00306995|584509784|FG004|Study Part I|Withdrawal by Subject|0|||
161855139|NCT00306995|584509785|FG005|Study Part I|Withdrawal by Subject|0|||
161855140|NCT00306995|584509786|FG006|Study Part I|Withdrawal by Subject|1|||
161855141|NCT00306995|584509780|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
161855142|NCT00306995|584509781|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
161855143|NCT00306995|584509782|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
161855144|NCT00306995|584509783|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
161855145|NCT00306995|584509784|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
161855146|NCT00306995|584509785|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
161855147|NCT00306995|584509786|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
161855148|NCT06419907|584512269|FG000|Overall Study|Protocol Violation|0|||
161855149|NCT06419907|584512270|FG001|Overall Study|Protocol Violation|3|||
161855150|NCT06419907|584512271|FG002|Overall Study|Protocol Violation|0|||
161855151|NCT06419907|584512272|FG003|Overall Study|Protocol Violation|1|||
161855152|NCT06419907|584512269|FG000|Overall Study|Lost to Follow-up|0|||
161855153|NCT06419907|584512270|FG001|Overall Study|Lost to Follow-up|0|||
161855154|NCT06419907|584512271|FG002|Overall Study|Lost to Follow-up|2|||
161855155|NCT06419907|584512272|FG003|Overall Study|Lost to Follow-up|1|||
161855156|NCT02586688|584512273|FG000|Overall Study|Lost to Follow-up|2|||
161855157|NCT02586688|584512274|FG001|Overall Study|Lost to Follow-up|1|||
161768325|NCT00660829|584192640|FG001|Overall Study|Non-Compliance|4|||
161768326|NCT00660829|584192639|FG000|Overall Study|Withdrawal by Subject|1|||
161768327|NCT00660829|584192640|FG001|Overall Study|Withdrawal by Subject|2|||
161768328|NCT00660829|584192639|FG000|Overall Study|Lost to Follow-up|3|||
161768329|NCT00660829|584192640|FG001|Overall Study|Lost to Follow-up|2|||
161768330|NCT00660829|584192639|FG000|Overall Study|Other|9|||
161768331|NCT00660829|584192640|FG001|Overall Study|Other|4|||
161768332|NCT02127931|584192643|FG000|Overall Study|Glitch in Game|1|||
161855158|NCT02586688|584512273|FG000|Overall Study|Withdrawal by Subject|1|||
161855159|NCT02586688|584512274|FG001|Overall Study|Withdrawal by Subject|1|||
161855160|NCT02586688|584512273|FG000|Overall Study|Adverse Event|3|||
161855161|NCT02586688|584512274|FG001|Overall Study|Adverse Event|1|||
161855162|NCT04856917|584512275|FG000|Overall Study|Withdrawal by Subject|4|||
161855163|NCT04856917|584512276|FG001|Overall Study|Withdrawal by Subject|3|||
161855164|NCT04856917|584512277|FG002|Overall Study|Withdrawal by Subject|1|||
161855165|NCT04856917|584512275|FG000|Overall Study|Lost to Follow-up|3|||
161855166|NCT04856917|584512276|FG001|Overall Study|Lost to Follow-up|1|||
161855167|NCT04856917|584512277|FG002|Overall Study|Lost to Follow-up|1|||
161855168|NCT04856917|584512275|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
161768333|NCT03417999|584192644|FG000|Overall Study|Withdrawal by Subject|1|||
161768334|NCT03417999|584192645|FG001|Overall Study|Withdrawal by Subject|0|||
161768335|NCT03417999|584192646|FG002|Overall Study|Withdrawal by Subject|0|||
161768336|NCT03417999|584192644|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
161768337|NCT03417999|584192645|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
161855169|NCT04856917|584512276|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
161855170|NCT04856917|584512277|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
161855171|NCT04856917|584512275|FG000|Overall Study|Other|1|||
161855172|NCT04856917|584512276|FG001|Overall Study|Other|1|||
161855173|NCT04856917|584512277|FG002|Overall Study|Other|0|||
161855174|NCT03573830|584512280|FG000|Overall Study|Dropped without completing treatment|0|||
161855175|NCT03573830|584512281|FG001|Overall Study|Dropped without completing treatment|7|||
161855176|NCT03573830|584512280|FG000|Overall Study|Lost to Follow-up|4|||
161768338|NCT03417999|584192646|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
161768339|NCT03417999|584192644|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
161768340|NCT03417999|584192645|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
161768341|NCT03417999|584192646|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
161768342|NCT03417999|584192644|FG000|Overall Study|Inadequate study staff available to process samples|0|||
161768343|NCT03417999|584192645|FG001|Overall Study|Inadequate study staff available to process samples|0|||
161768344|NCT03417999|584192646|FG002|Overall Study|Inadequate study staff available to process samples|1|||
161768345|NCT02612194|584192651|FG000|Overall Study|Death|5|||
161768346|NCT02612194|584192652|FG001|Overall Study|Death|0|||
161768347|NCT02612194|584192653|FG002|Overall Study|Death|2|||
161768348|NCT02612194|584192651|FG000|Overall Study|Early Study Termination|1|||
161768349|NCT02612194|584192652|FG001|Overall Study|Early Study Termination|0|||
161768350|NCT02612194|584192653|FG002|Overall Study|Early Study Termination|0|||
161768351|NCT02539160|584192654|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
161768352|NCT02539160|584192655|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
161855177|NCT03573830|584512281|FG001|Overall Study|Lost to Follow-up|0|||
161855178|NCT00266630|584512282|FG000|Overall Study|Adverse Event|8|||
161855179|NCT00266630|584512283|FG001|Overall Study|Adverse Event|6|||
161855180|NCT00266630|584512282|FG000|Overall Study|Lack of Efficacy|1|||
161855181|NCT00266630|584512283|FG001|Overall Study|Lack of Efficacy|4|||
161855182|NCT00266630|584512282|FG000|Overall Study|Entry Criteria not met|1|||
161855183|NCT00266630|584512283|FG001|Overall Study|Entry Criteria not met|0|||
161855184|NCT00266630|584512282|FG000|Overall Study|Protocol Violation|1|||
161855185|NCT00266630|584512283|FG001|Overall Study|Protocol Violation|3|||
161855186|NCT00266630|584512282|FG000|Overall Study|Physician Decision|1|||
161855187|NCT00266630|584512283|FG001|Overall Study|Physician Decision|2|||
161855188|NCT00266630|584512282|FG000|Overall Study|Withdrawal by Subject|10|||
161855189|NCT00266630|584512283|FG001|Overall Study|Withdrawal by Subject|2|||
161855190|NCT00266630|584512282|FG000|Overall Study|Lost to Follow-up|1|||
161855191|NCT00266630|584512283|FG001|Overall Study|Lost to Follow-up|0|||
161855192|NCT00266630|584512282|FG000|Overall Study|Other|19|||
161855193|NCT00266630|584512283|FG001|Overall Study|Other|11|||
161768353|NCT02539160|584192656|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
161768354|NCT02539160|584192657|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
161768355|NCT02539160|584192654|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
161768356|NCT02539160|584192655|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
161768357|NCT02539160|584192656|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
161768358|NCT02539160|584192657|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
161768359|NCT02539160|584192654|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
161768360|NCT02539160|584192655|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
161768361|NCT02539160|584192656|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
161768362|NCT02539160|584192657|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
161768363|NCT00372905|584192658|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
161768364|NCT00372905|584192659|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161768365|NCT00372905|584192660|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161768366|NCT00372905|584192661|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161768367|NCT00372905|584192658|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161768368|NCT00372905|584192659|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161768369|NCT00372905|584192660|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
161768370|NCT00372905|584192661|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161768371|NCT00372905|584192658|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161768372|NCT00372905|584192659|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161768373|NCT00372905|584192660|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
161768374|NCT00372905|584192661|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161768375|NCT00372905|584192658|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161768376|NCT00372905|584192659|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161768377|NCT00372905|584192660|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161768378|NCT00372905|584192661|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
161768379|NCT00372905|584192658|FG000|Follow up Until Relapse or Progression|Study closed|0|||
161768380|NCT00372905|584192659|FG001|Follow up Until Relapse or Progression|Study closed|0|||
161855194|NCT03284723|584512288|FG000|Overall Study|Death|0|||
161855195|NCT03284723|584512289|FG001|Overall Study|Death|0|||
161768381|NCT00372905|584192660|FG002|Follow up Until Relapse or Progression|Study closed|0|||
161768382|NCT00372905|584192661|FG003|Follow up Until Relapse or Progression|Study closed|3|||
161768383|NCT00372905|584192658|FG000|Follow up Until Relapse or Progression|Other|0|||
161768384|NCT00372905|584192659|FG001|Follow up Until Relapse or Progression|Other|1|||
161768385|NCT00372905|584192660|FG002|Follow up Until Relapse or Progression|Other|0|||
161768386|NCT00372905|584192661|FG003|Follow up Until Relapse or Progression|Other|0|||
161768387|NCT01728454|584192662|FG000|Stage 1 and 2|Pregnancy|1|||
161768388|NCT01728454|584192663|FG001|Stage 1 and 2|Pregnancy|0|||
161768389|NCT01728454|584192664|FG002|Stage 1 and 2|Pregnancy|0|||
161768390|NCT01728454|584192662|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
161768391|NCT01728454|584192663|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
161768392|NCT01728454|584192664|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
161768393|NCT01728454|584192662|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
161768394|NCT01728454|584192663|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
161768395|NCT01728454|584192664|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
161768396|NCT01728454|584192662|FG000|Stage 1 and 2|Lost to Follow-up|1|||
161768397|NCT01728454|584192663|FG001|Stage 1 and 2|Lost to Follow-up|1|||
161768398|NCT01728454|584192664|FG002|Stage 1 and 2|Lost to Follow-up|0|||
161768399|NCT01728454|584192662|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
161768400|NCT01728454|584192663|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
161768401|NCT01728454|584192664|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
161768402|NCT01728454|584192662|FG000|Stage 3|Reason Missing|0|||
161768403|NCT01728454|584192663|FG001|Stage 3|Reason Missing|0|||
161768404|NCT01728454|584192664|FG002|Stage 3|Reason Missing|1|||
161768405|NCT01728454|584192662|FG000|Stage 3|Subject Required Other Treatment|0|||
161768406|NCT01728454|584192663|FG001|Stage 3|Subject Required Other Treatment|1|||
161768407|NCT01728454|584192664|FG002|Stage 3|Subject Required Other Treatment|0|||
161768408|NCT01728454|584192662|FG000|Stage 3|Pregnancy|1|||
161768409|NCT01728454|584192663|FG001|Stage 3|Pregnancy|0|||
161768410|NCT01728454|584192664|FG002|Stage 3|Pregnancy|0|||
161768411|NCT01728454|584192662|FG000|Stage 3|Withdrew Consent|1|||
161768412|NCT01728454|584192663|FG001|Stage 3|Withdrew Consent|0|||
161768413|NCT01728454|584192664|FG002|Stage 3|Withdrew Consent|1|||
161768414|NCT01728454|584192662|FG000|Stage 3|Non-compliance with Protocol|0|||
161768415|NCT01728454|584192663|FG001|Stage 3|Non-compliance with Protocol|0|||
161768416|NCT01728454|584192664|FG002|Stage 3|Non-compliance with Protocol|1|||
161768417|NCT01728454|584192662|FG000|Stage 3|Lost to Follow-up|0|||
161768418|NCT01728454|584192663|FG001|Stage 3|Lost to Follow-up|3|||
161768419|NCT01728454|584192664|FG002|Stage 3|Lost to Follow-up|1|||
161768420|NCT01728454|584192662|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
161768421|NCT01728454|584192663|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
161768422|NCT01728454|584192664|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
161768423|NCT01362062|584192669|FG000|Overall Study|Adverse Event|1|||
161768424|NCT01362062|584192670|FG001|Overall Study|Adverse Event|0|||
161768425|NCT01362062|584192669|FG000|Overall Study|Lost to Follow-up|11|||
161768426|NCT01362062|584192670|FG001|Overall Study|Lost to Follow-up|0|||
161768427|NCT01362062|584192669|FG000|Overall Study|Withdrawal by Subject|2|||
161768428|NCT01362062|584192670|FG001|Overall Study|Withdrawal by Subject|0|||
161768429|NCT01362062|584192669|FG000|Overall Study|Non-compliant participant|2|||
161768430|NCT01362062|584192670|FG001|Overall Study|Non-compliant participant|0|||
161768431|NCT01362062|584192669|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
161768432|NCT01362062|584192670|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
161768433|NCT01362062|584192669|FG000|Overall Study|Had significant improvement|9|||
161768434|NCT01362062|584192670|FG001|Overall Study|Had significant improvement|0|||
161768435|NCT02545504|584192673|FG000|Overall Study|Death|174|||
161768436|NCT02545504|584192674|FG001|Overall Study|Death|168|||
161768437|NCT02545504|584192673|FG000|Overall Study|Unknown reason|30|||
161768438|NCT02545504|584192674|FG001|Overall Study|Unknown reason|32|||
161768439|NCT02545504|584192673|FG000|Overall Study|Withdrew consent|9|||
161768440|NCT02545504|584192674|FG001|Overall Study|Withdrew consent|11|||
161768441|NCT02545504|584192673|FG000|Overall Study|Investigator's discretion|3|||
161768442|NCT02545504|584192674|FG001|Overall Study|Investigator's discretion|1|||
161768443|NCT02545504|584192673|FG000|Overall Study|Lost to Follow-up|2|||
161768444|NCT02545504|584192674|FG001|Overall Study|Lost to Follow-up|2|||
161768445|NCT00434876|584192675|FG000|Overall Study|Lost to Follow-up|1|||
161768446|NCT00434876|584192676|FG001|Overall Study|Lost to Follow-up|1|||
161768447|NCT00758394|584192677|FG000|2nd Intervention Order|Lost to Follow-up|0|||
161768448|NCT00758394|584192678|FG001|2nd Intervention Order|Lost to Follow-up|1|||
161768449|NCT00758394|584192679|FG002|2nd Intervention Order|Lost to Follow-up|0|||
161768450|NCT00758394|584192680|FG003|2nd Intervention Order|Lost to Follow-up|0|||
161855196|NCT03284723|584512290|FG002|Overall Study|Death|0|||
161768451|NCT00758394|584192677|FG000|3rd Intervention|Lost to Follow-up|1|||
161768452|NCT00758394|584192678|FG001|3rd Intervention|Lost to Follow-up|0|||
161768453|NCT00758394|584192679|FG002|3rd Intervention|Lost to Follow-up|0|||
161768454|NCT00758394|584192680|FG003|3rd Intervention|Lost to Follow-up|1|||
161768455|NCT02926833|584194482|FG000|Overall Study|Death|1|||
161768456|NCT02926833|584194483|FG001|Overall Study|Death|1|||
161768457|NCT02926833|584194484|FG002|Overall Study|Death|2|||
161768458|NCT02926833|584194485|FG003|Overall Study|Death|13|||
161768459|NCT02926833|584194482|FG000|Overall Study|Lost to Follow-up|1|||
161768460|NCT02926833|584194483|FG001|Overall Study|Lost to Follow-up|2|||
161768461|NCT02926833|584194484|FG002|Overall Study|Lost to Follow-up|0|||
161768462|NCT02926833|584194485|FG003|Overall Study|Lost to Follow-up|3|||
161768463|NCT02926833|584194482|FG000|Overall Study|Full Consent Withdrawal|0|||
161855197|NCT03284723|584512291|FG003|Overall Study|Death|1|||
161855198|NCT03284723|584512292|FG004|Overall Study|Death|0|||
161855199|NCT03284723|584512293|FG005|Overall Study|Death|0|||
161855200|NCT03284723|584512294|FG006|Overall Study|Death|1|||
161855201|NCT03284723|584512295|FG007|Overall Study|Death|0|||
161855202|NCT03284723|584512296|FG008|Overall Study|Death|0|||
161855203|NCT03284723|584512297|FG009|Overall Study|Death|2|||
161855204|NCT03284723|584512298|FG010|Overall Study|Death|1|||
161855205|NCT03284723|584512299|FG011|Overall Study|Death|0|||
161855206|NCT03284723|584512288|FG000|Overall Study|Lost to Follow-up|0|||
161855207|NCT03284723|584512289|FG001|Overall Study|Lost to Follow-up|0|||
161855208|NCT03284723|584512290|FG002|Overall Study|Lost to Follow-up|0|||
161855209|NCT03284723|584512291|FG003|Overall Study|Lost to Follow-up|0|||
161855210|NCT03284723|584512292|FG004|Overall Study|Lost to Follow-up|0|||
161855211|NCT03284723|584512293|FG005|Overall Study|Lost to Follow-up|2|||
161855212|NCT03284723|584512294|FG006|Overall Study|Lost to Follow-up|1|||
161855213|NCT03284723|584512295|FG007|Overall Study|Lost to Follow-up|0|||
161855214|NCT03284723|584512296|FG008|Overall Study|Lost to Follow-up|0|||
161855215|NCT03284723|584512297|FG009|Overall Study|Lost to Follow-up|2|||
161855216|NCT03284723|584512298|FG010|Overall Study|Lost to Follow-up|0|||
161855217|NCT03284723|584512299|FG011|Overall Study|Lost to Follow-up|0|||
161855218|NCT03284723|584512288|FG000|Overall Study|Study Terminated By Sponsor|0|||
161855219|NCT03284723|584512289|FG001|Overall Study|Study Terminated By Sponsor|0|||
161855220|NCT03284723|584512290|FG002|Overall Study|Study Terminated By Sponsor|0|||
161855221|NCT03284723|584512291|FG003|Overall Study|Study Terminated By Sponsor|0|||
161855222|NCT03284723|584512292|FG004|Overall Study|Study Terminated By Sponsor|1|||
161855223|NCT03284723|584512293|FG005|Overall Study|Study Terminated By Sponsor|0|||
161855224|NCT03284723|584512294|FG006|Overall Study|Study Terminated By Sponsor|0|||
161855225|NCT03284723|584512295|FG007|Overall Study|Study Terminated By Sponsor|0|||
161855226|NCT03284723|584512296|FG008|Overall Study|Study Terminated By Sponsor|1|||
161855227|NCT03284723|584512297|FG009|Overall Study|Study Terminated By Sponsor|1|||
161855228|NCT03284723|584512298|FG010|Overall Study|Study Terminated By Sponsor|1|||
161855229|NCT03284723|584512299|FG011|Overall Study|Study Terminated By Sponsor|1|||
161855230|NCT03284723|584512288|FG000|Overall Study|Withdrawal by Subject|0|||
161855231|NCT03284723|584512289|FG001|Overall Study|Withdrawal by Subject|0|||
161855232|NCT03284723|584512290|FG002|Overall Study|Withdrawal by Subject|0|||
161855233|NCT03284723|584512291|FG003|Overall Study|Withdrawal by Subject|0|||
161855234|NCT03284723|584512292|FG004|Overall Study|Withdrawal by Subject|5|||
161855235|NCT03284723|584512293|FG005|Overall Study|Withdrawal by Subject|3|||
161855236|NCT03284723|584512294|FG006|Overall Study|Withdrawal by Subject|1|||
161855237|NCT03284723|584512295|FG007|Overall Study|Withdrawal by Subject|0|||
161855238|NCT03284723|584512296|FG008|Overall Study|Withdrawal by Subject|6|||
161855239|NCT03284723|584512297|FG009|Overall Study|Withdrawal by Subject|0|||
161855240|NCT03284723|584512298|FG010|Overall Study|Withdrawal by Subject|3|||
161768464|NCT02926833|584194483|FG001|Overall Study|Full Consent Withdrawal|0|||
161768465|NCT02926833|584194484|FG002|Overall Study|Full Consent Withdrawal|0|||
161855241|NCT03284723|584512299|FG011|Overall Study|Withdrawal by Subject|1|||
161855242|NCT03284723|584512288|FG000|Overall Study|Other|1|||
161855243|NCT03284723|584512289|FG001|Overall Study|Other|0|||
161855244|NCT03284723|584512290|FG002|Overall Study|Other|1|||
161855245|NCT03284723|584512291|FG003|Overall Study|Other|0|||
161855246|NCT03284723|584512292|FG004|Overall Study|Other|1|||
161855247|NCT03284723|584512293|FG005|Overall Study|Other|0|||
161855248|NCT03284723|584512294|FG006|Overall Study|Other|0|||
161855249|NCT03284723|584512295|FG007|Overall Study|Other|0|||
161855250|NCT03284723|584512296|FG008|Overall Study|Other|0|||
161855251|NCT03284723|584512297|FG009|Overall Study|Other|0|||
161855252|NCT03284723|584512298|FG010|Overall Study|Other|1|||
161855253|NCT03284723|584512299|FG011|Overall Study|Other|0|||
161855254|NCT03284723|584512288|FG000|Overall Study|Adverse Event|0|||
161768466|NCT02926833|584194485|FG003|Overall Study|Full Consent Withdrawal|2|||
161768467|NCT02926833|584194482|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
161768468|NCT02926833|584194483|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
161855255|NCT03284723|584512289|FG001|Overall Study|Adverse Event|0|||
161855256|NCT03284723|584512290|FG002|Overall Study|Adverse Event|0|||
161855257|NCT03284723|584512291|FG003|Overall Study|Adverse Event|0|||
161855258|NCT03284723|584512292|FG004|Overall Study|Adverse Event|0|||
161855259|NCT03284723|584512293|FG005|Overall Study|Adverse Event|0|||
161855260|NCT03284723|584512294|FG006|Overall Study|Adverse Event|0|||
161855261|NCT03284723|584512295|FG007|Overall Study|Adverse Event|0|||
161855262|NCT03284723|584512296|FG008|Overall Study|Adverse Event|1|||
161855263|NCT03284723|584512297|FG009|Overall Study|Adverse Event|0|||
161855264|NCT03284723|584512298|FG010|Overall Study|Adverse Event|0|||
161855265|NCT03284723|584512299|FG011|Overall Study|Adverse Event|0|||
161855266|NCT00064987|584512304|FG000|Overall Study|Physician Decision|3|||
161855267|NCT00064987|584512305|FG001|Overall Study|Physician Decision|0|||
161855268|NCT01499095|584512306|FG000|Overall Study|Randomized But Not Treated|1|||
161855269|NCT01499095|584512307|FG001|Overall Study|Randomized But Not Treated|1|||
161855270|NCT01499095|584512306|FG000|Overall Study|Adverse Event|12|||
161855271|NCT01499095|584512307|FG001|Overall Study|Adverse Event|7|||
161855272|NCT01499095|584512306|FG000|Overall Study|Lack of Efficacy|2|||
161855273|NCT01499095|584512307|FG001|Overall Study|Lack of Efficacy|1|||
161855274|NCT01499095|584512306|FG000|Overall Study|Protocol Violation|6|||
161855275|NCT01499095|584512307|FG001|Overall Study|Protocol Violation|7|||
161855276|NCT01499095|584512306|FG000|Overall Study|Received Rescue Therapy|32|||
161855277|NCT01499095|584512307|FG001|Overall Study|Received Rescue Therapy|40|||
161855278|NCT01499095|584512306|FG000|Overall Study|Diverse Reasons|22|||
161855279|NCT01499095|584512307|FG001|Overall Study|Diverse Reasons|25|||
161855280|NCT01499095|584512306|FG000|Overall Study|Lost to Follow-up|6|||
161855281|NCT01499095|584512307|FG001|Overall Study|Lost to Follow-up|4|||
161855282|NCT01499095|584512306|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
161855283|NCT01499095|584512307|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
161855284|NCT01499095|584512306|FG000|Overall Study|Hypoglycemia|3|||
161855285|NCT01499095|584512307|FG001|Overall Study|Hypoglycemia|1|||
161855286|NCT01499095|584512306|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
161855287|NCT01499095|584512307|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
161855288|NCT01499095|584512306|FG000|Overall Study|Change in Injection Schedule|2|||
161855289|NCT01499095|584512307|FG001|Overall Study|Change in Injection Schedule|0|||
161855290|NCT01499095|584512306|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161855291|NCT01499095|584512307|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161855292|NCT01368497|584512308|FG000|Overall Study|Lost to Follow-up|2|||
161855293|NCT00443729|584512312|FG000|Overall Study|Never Treated|0|||
161855294|NCT00443729|584512313|FG001|Overall Study|Never Treated|1|||
161855295|NCT00443729|584512312|FG000|Overall Study|Lack of Efficacy|4|||
161855296|NCT00443729|584512313|FG001|Overall Study|Lack of Efficacy|2|||
161855297|NCT00443729|584512312|FG000|Overall Study|Lost to Follow-up|0|||
161855298|NCT00443729|584512313|FG001|Overall Study|Lost to Follow-up|1|||
161855299|NCT00443729|584512312|FG000|Overall Study|Physician Decision|2|||
161855300|NCT00443729|584512313|FG001|Overall Study|Physician Decision|1|||
161855301|NCT00443729|584512312|FG000|Overall Study|Protocol Violation|1|||
161855302|NCT00443729|584512313|FG001|Overall Study|Protocol Violation|1|||
161855303|NCT00443729|584512312|FG000|Overall Study|Withdrawal by Subject|3|||
161855304|NCT00443729|584512313|FG001|Overall Study|Withdrawal by Subject|1|||
161855305|NCT00782626|584512317|FG000|Overall Study|Adverse Event|1|||
161855306|NCT00782626|584512317|FG000|Overall Study|Progressive Disease|5|||
161855307|NCT00782626|584512317|FG000|Overall Study|Other Complicating Disease|1|||
161855308|NCT00077207|584512320|FG000|Overall Study|Adverse Event|5|||
161855309|NCT00077207|584512320|FG000|Overall Study|Lack of Efficacy|12|||
161855310|NCT00077207|584512320|FG000|Overall Study|Physician Decision|6|||
161855311|NCT00077207|584512320|FG000|Overall Study|Withdrawal by Subject|6|||
161855312|NCT00077207|584512320|FG000|Overall Study|Ineligible|1|||
161855313|NCT03052751|584512323|FG000|Dosing Period 1|Adverse Event|0|||
161855314|NCT03052751|584512324|FG001|Dosing Period 1|Adverse Event|1|||
161855315|NCT03052751|584512325|FG002|Dosing Period 1|Adverse Event|0|||
161855316|NCT03052751|584512326|FG003|Dosing Period 1|Adverse Event|0|||
161855317|NCT03052751|584512327|FG004|Dosing Period 1|Adverse Event|0|||
161855318|NCT03052751|584512328|FG005|Dosing Period 1|Adverse Event|0|||
161855319|NCT03052751|584512323|FG000|Dosing Period 2|Adverse Event|0|||
161855320|NCT03052751|584512324|FG001|Dosing Period 2|Adverse Event|0|||
161855321|NCT03052751|584512325|FG002|Dosing Period 2|Adverse Event|3|||
161855322|NCT03052751|584512326|FG003|Dosing Period 2|Adverse Event|0|||
161855323|NCT03052751|584512327|FG004|Dosing Period 2|Adverse Event|0|||
161855324|NCT03052751|584512328|FG005|Dosing Period 2|Adverse Event|0|||
161855325|NCT03052751|584512323|FG000|Observation Period|Adverse Event|0|||
161855326|NCT03052751|584512324|FG001|Observation Period|Adverse Event|0|||
161855327|NCT03052751|584512325|FG002|Observation Period|Adverse Event|0|||
161855328|NCT03052751|584512326|FG003|Observation Period|Adverse Event|0|||
161855329|NCT03052751|584512327|FG004|Observation Period|Adverse Event|1|||
161855330|NCT03052751|584512328|FG005|Observation Period|Adverse Event|0|||
161855331|NCT01427608|584512339|FG000|Overall Study|Death|1|||
161855332|NCT01427608|584512340|FG001|Overall Study|Death|0|||
161855333|NCT01427608|584512339|FG000|Overall Study|Withdrawal by Subject|7|||
161855334|NCT01427608|584512340|FG001|Overall Study|Withdrawal by Subject|3|||
161855335|NCT01427608|584512339|FG000|Overall Study|Relapsed-all cause|13|||
161855336|NCT01427608|584512340|FG001|Overall Study|Relapsed-all cause|34|||
161855337|NCT01427608|584512339|FG000|Overall Study|Events not attributed to study meds|0|||
161855338|NCT01427608|584512340|FG001|Overall Study|Events not attributed to study meds|1|||
161855339|NCT01473407|584512341|FG000|Overall Study|Physician Decision|1|||
161855340|NCT01473407|584512342|FG001|Overall Study|Physician Decision|4|||
161855341|NCT01473407|584512341|FG000|Overall Study|Lost to Follow-up|10|||
161768469|NCT02926833|584194484|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
161768470|NCT02926833|584194485|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
161768471|NCT02926833|584194482|FG000|Overall Study|Investigator Decision|0|||
161768472|NCT02926833|584194483|FG001|Overall Study|Investigator Decision|1|||
161768473|NCT02926833|584194484|FG002|Overall Study|Investigator Decision|0|||
161768474|NCT02926833|584194485|FG003|Overall Study|Investigator Decision|0|||
161768475|NCT02926833|584194482|FG000|Overall Study|Adverse Event|0|||
161855342|NCT01473407|584512342|FG001|Overall Study|Lost to Follow-up|4|||
161855343|NCT01473407|584512341|FG000|Overall Study|Adverse Event|8|||
161855344|NCT01473407|584512342|FG001|Overall Study|Adverse Event|8|||
161855345|NCT01473407|584512341|FG000|Overall Study|Randomization Error|3|||
161855346|NCT01473407|584512342|FG001|Overall Study|Randomization Error|1|||
161855347|NCT01473407|584512341|FG000|Overall Study|Withdrawal by Subject|4|||
161855348|NCT01473407|584512342|FG001|Overall Study|Withdrawal by Subject|7|||
161855349|NCT01473407|584512341|FG000|Overall Study|Kidney Transplant|7|||
161855350|NCT01473407|584512342|FG001|Overall Study|Kidney Transplant|6|||
161855351|NCT01473407|584512341|FG000|Overall Study|Vacation/Travel|1|||
161855352|NCT01473407|584512342|FG001|Overall Study|Vacation/Travel|1|||
161855353|NCT01473407|584512341|FG000|Overall Study|Elevated Hemoglobin|1|||
161855354|NCT01473407|584512342|FG001|Overall Study|Elevated Hemoglobin|0|||
161855355|NCT01473407|584512341|FG000|Overall Study|Patient Received Aranesp|1|||
161855356|NCT01473407|584512342|FG001|Overall Study|Patient Received Aranesp|0|||
161855357|NCT01473407|584512341|FG000|Overall Study|Patient Lost Green Card Status|1|||
161855358|NCT01473407|584512342|FG001|Overall Study|Patient Lost Green Card Status|0|||
161855359|NCT01473407|584512341|FG000|Overall Study|Temperature Excursion|2|||
161855360|NCT01473407|584512342|FG001|Overall Study|Temperature Excursion|3|||
161855361|NCT01473407|584512341|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
161855362|NCT01473407|584512342|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
161855363|NCT01473407|584512341|FG000|Overall Study|Sponsor's Decision|10|||
161855364|NCT01473407|584512342|FG001|Overall Study|Sponsor's Decision|10|||
161855365|NCT01473407|584512341|FG000|Overall Study|Site Closure|1|||
161855366|NCT01473407|584512342|FG001|Overall Study|Site Closure|0|||
161855367|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
161855368|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
161855369|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
161855370|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
161855371|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
161855372|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
161855373|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161855374|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161855375|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
161855376|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
161855377|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
161855378|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
161855379|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
161855380|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
161855381|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
161855382|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
161855383|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
161855384|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
161855385|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
161855386|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
161855387|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
161855388|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
161855389|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
161855390|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
161855391|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
161855392|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
161768476|NCT02926833|584194483|FG001|Overall Study|Adverse Event|0|||
161855393|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161855394|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
161855395|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
161855396|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
161855397|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
161855398|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
161855399|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
161855400|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
161768477|NCT02926833|584194484|FG002|Overall Study|Adverse Event|1|||
161768478|NCT02926833|584194485|FG003|Overall Study|Adverse Event|0|||
161768479|NCT02926833|584194482|FG000|Overall Study|Partial Withdrawal of Consent|0|||
161768480|NCT02926833|584194483|FG001|Overall Study|Partial Withdrawal of Consent|0|||
161768481|NCT02926833|584194484|FG002|Overall Study|Partial Withdrawal of Consent|0|||
161768482|NCT02926833|584194485|FG003|Overall Study|Partial Withdrawal of Consent|1|||
161768483|NCT01004822|584194486|FG000|Overall Study|Objective progression or relapse|3|||
161768484|NCT01004822|584194487|FG001|Overall Study|Objective progression or relapse|3|||
161768485|NCT01004822|584194488|FG002|Overall Study|Objective progression or relapse|0|||
161768486|NCT01004822|584194489|FG003|Overall Study|Objective progression or relapse|1|||
161768487|NCT01004822|584194490|FG004|Overall Study|Objective progression or relapse|2|||
161768488|NCT01004822|584194491|FG005|Overall Study|Objective progression or relapse|2|||
161768489|NCT01004822|584194492|FG006|Overall Study|Objective progression or relapse|1|||
161768490|NCT01004822|584194493|FG007|Overall Study|Objective progression or relapse|4|||
161768491|NCT01004822|584194486|FG000|Overall Study|Global deterioration of health status|0|||
161768492|NCT01004822|584194487|FG001|Overall Study|Global deterioration of health status|0|||
161768493|NCT01004822|584194488|FG002|Overall Study|Global deterioration of health status|0|||
161768494|NCT01004822|584194489|FG003|Overall Study|Global deterioration of health status|1|||
161768495|NCT01004822|584194490|FG004|Overall Study|Global deterioration of health status|0|||
161768496|NCT01004822|584194491|FG005|Overall Study|Global deterioration of health status|0|||
161768497|NCT01004822|584194492|FG006|Overall Study|Global deterioration of health status|1|||
161768498|NCT01004822|584194493|FG007|Overall Study|Global deterioration of health status|0|||
161768499|NCT01004822|584194486|FG000|Overall Study|No longer willing to continue|0|||
161768500|NCT01004822|584194487|FG001|Overall Study|No longer willing to continue|0|||
161768501|NCT01004822|584194488|FG002|Overall Study|No longer willing to continue|0|||
161768502|NCT01004822|584194489|FG003|Overall Study|No longer willing to continue|1|||
161768503|NCT01004822|584194490|FG004|Overall Study|No longer willing to continue|2|||
161768504|NCT01004822|584194491|FG005|Overall Study|No longer willing to continue|1|||
161768505|NCT01004822|584194492|FG006|Overall Study|No longer willing to continue|1|||
161768506|NCT01004822|584194493|FG007|Overall Study|No longer willing to continue|0|||
161768507|NCT01004822|584194486|FG000|Overall Study|Adverse Event|0|||
161768508|NCT01004822|584194487|FG001|Overall Study|Adverse Event|0|||
161768509|NCT01004822|584194488|FG002|Overall Study|Adverse Event|0|||
161768510|NCT01004822|584194489|FG003|Overall Study|Adverse Event|0|||
161768511|NCT01004822|584194490|FG004|Overall Study|Adverse Event|0|||
161768512|NCT01004822|584194491|FG005|Overall Study|Adverse Event|0|||
161768513|NCT01004822|584194492|FG006|Overall Study|Adverse Event|1|||
161768514|NCT01004822|584194493|FG007|Overall Study|Adverse Event|1|||
161768515|NCT01004822|584194486|FG000|Overall Study|Other|0|||
161768516|NCT01004822|584194487|FG001|Overall Study|Other|0|||
161768517|NCT01004822|584194488|FG002|Overall Study|Other|4|||
161768518|NCT01004822|584194489|FG003|Overall Study|Other|1|||
161768519|NCT01004822|584194490|FG004|Overall Study|Other|0|||
161768520|NCT01004822|584194491|FG005|Overall Study|Other|1|||
161768521|NCT01004822|584194492|FG006|Overall Study|Other|0|||
161768522|NCT01004822|584194493|FG007|Overall Study|Other|0|||
161768523|NCT03159455|584194496|FG000|Overall Study|Adverse Event|0|||
161768524|NCT03159455|584194497|FG001|Overall Study|Adverse Event|0|||
161768525|NCT03159455|584194498|FG002|Overall Study|Adverse Event|0|||
161768526|NCT03159455|584194499|FG003|Overall Study|Adverse Event|0|||
161768527|NCT03159455|584194500|FG004|Overall Study|Adverse Event|0|||
161768528|NCT03159455|584194501|FG005|Overall Study|Adverse Event|1|||
161768529|NCT03799198|584194507|FG000|Overall Study|Lost to Follow-up|4|||
161768530|NCT03799198|584194508|FG001|Overall Study|Lost to Follow-up|8|||
161768531|NCT03799198|584194507|FG000|Overall Study|Death|0|||
161768532|NCT03799198|584194508|FG001|Overall Study|Death|1|||
161768533|NCT00960869|584194510|FG000|Overall Study|Adverse Event|17|||
161768534|NCT00960869|584194511|FG001|Overall Study|Adverse Event|26|||
161768535|NCT00960869|584194510|FG000|Overall Study|Withdrawal by Subject|16|||
161768536|NCT00960869|584194511|FG001|Overall Study|Withdrawal by Subject|14|||
161768537|NCT00960869|584194510|FG000|Overall Study|Lost to Follow-up|1|||
161768538|NCT00960869|584194511|FG001|Overall Study|Lost to Follow-up|4|||
161768539|NCT00960869|584194510|FG000|Overall Study|Misc|19|||
161768540|NCT00960869|584194511|FG001|Overall Study|Misc|18|||
161768541|NCT02501642|584194512|FG000|Overall Study|Lost to Follow-up|7|||
161768542|NCT02501642|584194513|FG001|Overall Study|Lost to Follow-up|11|||
161768543|NCT01153971|584194517|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
161768544|NCT01153971|584194517|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
161768545|NCT01153971|584194517|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
161768546|NCT01153971|584194517|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
161768547|NCT01153971|584194517|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
161768548|NCT01153971|584194517|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
161768549|NCT01153971|584194517|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
161768550|NCT03410693|584194518|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
161768551|NCT03410693|584194519|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
161768552|NCT03410693|584194518|FG000|Overall Study|Disc trt: Lost to follow up|0|||
161768553|NCT03410693|584194519|FG001|Overall Study|Disc trt: Lost to follow up|1|||
161768554|NCT03410693|584194518|FG000|Overall Study|Disc trt: radiological progression|58|||
161768555|NCT03410693|584194519|FG001|Overall Study|Disc trt: radiological progression|50|||
161768556|NCT03410693|584194518|FG000|Overall Study|Disc trt: Other|1|||
161768557|NCT03410693|584194519|FG001|Overall Study|Disc trt: Other|0|||
161768558|NCT03410693|584194518|FG000|Overall Study|Study drug never administered|1|||
161768559|NCT03410693|584194519|FG001|Overall Study|Study drug never administered|6|||
161768560|NCT03410693|584194518|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
161768561|NCT03410693|584194519|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
161768562|NCT03410693|584194518|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
161768563|NCT03410693|584194519|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
161768564|NCT03410693|584194518|FG000|Overall Study|Disc trt: Physician decision|0|||
161768565|NCT03410693|584194519|FG001|Overall Study|Disc trt: Physician decision|5|||
161768566|NCT03410693|584194518|FG000|Overall Study|Disc trt: clinical progression|1|||
161768567|NCT03410693|584194519|FG001|Overall Study|Disc trt: clinical progression|5|||
161768568|NCT03410693|584194518|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
161768569|NCT03410693|584194519|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
161768570|NCT00953576|584194520|FG000|Overall Study|Adverse Event|0|||
161768571|NCT00953576|584194521|FG001|Overall Study|Adverse Event|1|||
161768572|NCT00953576|584194520|FG000|Overall Study|Ineligible after Consent|2|||
161768573|NCT00953576|584194521|FG001|Overall Study|Ineligible after Consent|0|||
161768574|NCT00501969|584194522|FG000|Overall Study|Major Protocol Violation|4|||
161768575|NCT00501969|584194522|FG000|Overall Study|Lack of Efficacy|29|||
161768576|NCT00501969|584194522|FG000|Overall Study|Adverse Event|76|||
161768577|NCT00501969|584194522|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
161768578|NCT00501969|584194522|FG000|Overall Study|Subject withdrew consent|51|||
161768579|NCT00501969|584194522|FG000|Overall Study|Lost to Follow-up|4|||
161768580|NCT00501969|584194522|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
161768581|NCT00501969|584194522|FG000|Overall Study|Other: Sponsors Request|10|||
161768582|NCT00501969|584194522|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
161768583|NCT00501969|584194522|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
161768584|NCT00501969|584194522|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
161768585|NCT00501969|584194522|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
161768586|NCT00501969|584194522|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
161768587|NCT00501969|584194522|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
161768588|NCT00501969|584194522|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
161768589|NCT00501969|584194522|FG000|Overall Study|Other: As Required by Local EC|2|||
161768590|NCT00501969|584194522|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
161768591|NCT00501969|584194522|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
161768592|NCT00665366|584194523|FG000|Overall Study|Lack of Efficacy|11|||
161768593|NCT00665366|584194524|FG001|Overall Study|Lack of Efficacy|10|||
161768594|NCT00665366|584194523|FG000|Overall Study|Adverse Event|25|||
161768595|NCT00665366|584194524|FG001|Overall Study|Adverse Event|23|||
161768596|NCT00665366|584194523|FG000|Overall Study|Withdrawal by Subject|11|||
161768597|NCT00665366|584194524|FG001|Overall Study|Withdrawal by Subject|14|||
161768598|NCT00665366|584194523|FG000|Overall Study|Lost to Follow-up|3|||
161768599|NCT00665366|584194524|FG001|Overall Study|Lost to Follow-up|5|||
161768600|NCT00665366|584194523|FG000|Overall Study|Poor compliance/noncompliance|3|||
161768601|NCT00665366|584194524|FG001|Overall Study|Poor compliance/noncompliance|5|||
161768602|NCT00665366|584194523|FG000|Overall Study|Pregnancy|1|||
161768603|NCT00665366|584194524|FG001|Overall Study|Pregnancy|0|||
161768604|NCT00665366|584194523|FG000|Overall Study|No longer meets study criteria|0|||
161768605|NCT00665366|584194524|FG001|Overall Study|No longer meets study criteria|1|||
161768606|NCT00665366|584194523|FG000|Overall Study|Other reasons|4|||
161768607|NCT00665366|584194524|FG001|Overall Study|Other reasons|1|||
161768608|NCT03628781|584194525|FG000|Overall Study|Lost to Follow-up|16|||
161768609|NCT03628781|584194526|FG001|Overall Study|Lost to Follow-up|8|||
161768610|NCT03628781|584194525|FG000|Overall Study|Withdrawal by Subject|16|||
161768611|NCT03628781|584194526|FG001|Overall Study|Withdrawal by Subject|1|||
161768612|NCT03778021|584194527|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
161768613|NCT03778021|584194528|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
161768614|NCT02687815|584194529|FG000|Overall Study|Lost to Follow-up|2|||
161768615|NCT02687815|584194530|FG001|Overall Study|Lost to Follow-up|4|||
161768616|NCT02687815|584194529|FG000|Overall Study|Withdrawal by Subject|2|||
161768617|NCT02687815|584194530|FG001|Overall Study|Withdrawal by Subject|4|||
161768618|NCT00379639|584194531|FG000|Overall Study|Disease Progression|3|||
161768619|NCT00379639|584194532|FG001|Overall Study|Disease Progression|3|||
161768620|NCT00379639|584194533|FG002|Overall Study|Disease Progression|3|||
161768621|NCT00379639|584194534|FG003|Overall Study|Disease Progression|4|||
161768622|NCT00379639|584194535|FG004|Overall Study|Disease Progression|4|||
161768623|NCT00379639|584194531|FG000|Overall Study|Physician Decision|0|||
161768624|NCT00379639|584194532|FG001|Overall Study|Physician Decision|2|||
161768625|NCT00379639|584194533|FG002|Overall Study|Physician Decision|1|||
161768626|NCT00379639|584194534|FG003|Overall Study|Physician Decision|1|||
161768627|NCT00379639|584194535|FG004|Overall Study|Physician Decision|0|||
161768628|NCT00379639|584194531|FG000|Overall Study|Symptomatic Deterioration|0|||
161768629|NCT00379639|584194532|FG001|Overall Study|Symptomatic Deterioration|0|||
161768630|NCT00379639|584194533|FG002|Overall Study|Symptomatic Deterioration|1|||
161768631|NCT00379639|584194534|FG003|Overall Study|Symptomatic Deterioration|0|||
161768632|NCT00379639|584194535|FG004|Overall Study|Symptomatic Deterioration|1|||
161768633|NCT00379639|584194531|FG000|Overall Study|Adverse Event|0|||
161768634|NCT00379639|584194532|FG001|Overall Study|Adverse Event|0|||
161768635|NCT00379639|584194533|FG002|Overall Study|Adverse Event|1|||
161768636|NCT00379639|584194534|FG003|Overall Study|Adverse Event|0|||
161768637|NCT00379639|584194535|FG004|Overall Study|Adverse Event|1|||
161768638|NCT00379639|584194531|FG000|Overall Study|Lost to Follow-up|0|||
161768639|NCT00379639|584194532|FG001|Overall Study|Lost to Follow-up|0|||
161768640|NCT00379639|584194533|FG002|Overall Study|Lost to Follow-up|0|||
161768641|NCT00379639|584194534|FG003|Overall Study|Lost to Follow-up|1|||
161768642|NCT00379639|584194535|FG004|Overall Study|Lost to Follow-up|0|||
161768643|NCT00379639|584194531|FG000|Overall Study|Other|0|||
161768644|NCT00379639|584194532|FG001|Overall Study|Other|0|||
161768645|NCT00379639|584194533|FG002|Overall Study|Other|3|||
161768646|NCT00379639|584194534|FG003|Overall Study|Other|0|||
161768647|NCT00379639|584194535|FG004|Overall Study|Other|0|||
161768648|NCT01238861|584194540|FG000|Overall Study|Lost to Follow-up|4|||
161768649|NCT01238861|584194541|FG001|Overall Study|Lost to Follow-up|2|||
161768650|NCT01238861|584194542|FG002|Overall Study|Lost to Follow-up|3|||
161768651|NCT01238861|584194543|FG003|Overall Study|Lost to Follow-up|1|||
161768652|NCT01238861|584194544|FG004|Overall Study|Lost to Follow-up|1|||
161768653|NCT01238861|584194545|FG005|Overall Study|Lost to Follow-up|2|||
161768654|NCT01238861|584194540|FG000|Overall Study|Unplanned surgery|1|||
161768655|NCT01238861|584194541|FG001|Overall Study|Unplanned surgery|0|||
161768656|NCT01238861|584194542|FG002|Overall Study|Unplanned surgery|0|||
161768657|NCT01238861|584194543|FG003|Overall Study|Unplanned surgery|0|||
161768658|NCT01238861|584194544|FG004|Overall Study|Unplanned surgery|0|||
161768659|NCT01238861|584194545|FG005|Overall Study|Unplanned surgery|0|||
161768660|NCT01238861|584194540|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161768661|NCT01238861|584194541|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161768662|NCT01238861|584194542|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161768663|NCT01238861|584194543|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161768664|NCT01238861|584194544|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161768665|NCT01238861|584194545|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161768666|NCT01238861|584194540|FG000|Overall Study|Incorrect enrollment/randomization|0|||
161768667|NCT01238861|584194541|FG001|Overall Study|Incorrect enrollment/randomization|0|||
161768668|NCT01238861|584194542|FG002|Overall Study|Incorrect enrollment/randomization|1|||
161768669|NCT01238861|584194543|FG003|Overall Study|Incorrect enrollment/randomization|0|||
161768670|NCT01238861|584194544|FG004|Overall Study|Incorrect enrollment/randomization|1|||
161768671|NCT01238861|584194545|FG005|Overall Study|Incorrect enrollment/randomization|0|||
161768672|NCT01238861|584194540|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768673|NCT01238861|584194541|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768674|NCT01238861|584194542|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
161768675|NCT01238861|584194543|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768676|NCT01238861|584194544|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768677|NCT01238861|584194545|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768678|NCT01238861|584194540|FG000|Overall Study|Subject moved out of state/area|0|||
161768679|NCT01238861|584194541|FG001|Overall Study|Subject moved out of state/area|0|||
161768680|NCT01238861|584194542|FG002|Overall Study|Subject moved out of state/area|1|||
161768681|NCT01238861|584194543|FG003|Overall Study|Subject moved out of state/area|1|||
161768682|NCT01238861|584194544|FG004|Overall Study|Subject moved out of state/area|0|||
161768683|NCT01238861|584194545|FG005|Overall Study|Subject moved out of state/area|0|||
161768684|NCT01238861|584194540|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768685|NCT01238861|584194541|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768686|NCT01238861|584194542|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
161855401|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
161855402|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
161855403|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
161855404|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
161768687|NCT01238861|584194543|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
161768688|NCT01238861|584194544|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768689|NCT01238861|584194545|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768690|NCT01238861|584194540|FG000|Overall Study|Personal problems|0|||
161768691|NCT01238861|584194541|FG001|Overall Study|Personal problems|0|||
161768692|NCT01238861|584194542|FG002|Overall Study|Personal problems|0|||
161768693|NCT01238861|584194543|FG003|Overall Study|Personal problems|1|||
161768694|NCT01238861|584194544|FG004|Overall Study|Personal problems|0|||
161768695|NCT01238861|584194545|FG005|Overall Study|Personal problems|0|||
161768696|NCT01238861|584194540|FG000|Overall Study|Unable to continue visits|0|||
161768697|NCT01238861|584194541|FG001|Overall Study|Unable to continue visits|0|||
161768698|NCT01238861|584194542|FG002|Overall Study|Unable to continue visits|0|||
161768699|NCT01238861|584194543|FG003|Overall Study|Unable to continue visits|1|||
161768700|NCT01238861|584194544|FG004|Overall Study|Unable to continue visits|0|||
161768701|NCT01238861|584194545|FG005|Overall Study|Unable to continue visits|1|||
161768702|NCT01238861|584194540|FG000|Overall Study|Serious adverse event|0|||
161768703|NCT01238861|584194541|FG001|Overall Study|Serious adverse event|0|||
161768704|NCT01238861|584194542|FG002|Overall Study|Serious adverse event|0|||
161768705|NCT01238861|584194543|FG003|Overall Study|Serious adverse event|0|||
161768706|NCT01238861|584194544|FG004|Overall Study|Serious adverse event|0|||
161768707|NCT01238861|584194545|FG005|Overall Study|Serious adverse event|1|||
161768708|NCT01238861|584194540|FG000|Overall Study|Lack of compliance|0|||
161768709|NCT01238861|584194541|FG001|Overall Study|Lack of compliance|0|||
161768710|NCT01238861|584194542|FG002|Overall Study|Lack of compliance|0|||
161768711|NCT01238861|584194543|FG003|Overall Study|Lack of compliance|0|||
161768712|NCT01238861|584194544|FG004|Overall Study|Lack of compliance|0|||
161768713|NCT01238861|584194545|FG005|Overall Study|Lack of compliance|1|||
161768714|NCT01238861|584194540|FG000|Overall Study|Adverse Event|0|||
161768715|NCT01238861|584194541|FG001|Overall Study|Adverse Event|1|||
161768716|NCT01238861|584194542|FG002|Overall Study|Adverse Event|0|||
161768717|NCT01238861|584194543|FG003|Overall Study|Adverse Event|0|||
161768718|NCT01238861|584194544|FG004|Overall Study|Adverse Event|0|||
161855405|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
161768719|NCT01238861|584194545|FG005|Overall Study|Adverse Event|0|||
161768720|NCT01238861|584194540|FG000|Overall Study|Withdrawal by Subject|6|||
161768721|NCT01238861|584194541|FG001|Overall Study|Withdrawal by Subject|5|||
161768722|NCT01238861|584194542|FG002|Overall Study|Withdrawal by Subject|4|||
161768723|NCT01238861|584194543|FG003|Overall Study|Withdrawal by Subject|8|||
161768724|NCT01238861|584194544|FG004|Overall Study|Withdrawal by Subject|10|||
161768725|NCT01238861|584194545|FG005|Overall Study|Withdrawal by Subject|9|||
161768726|NCT01928758|584194547|FG000|Overall Study|Lost to Follow-up|14|||
161768727|NCT01928758|584194548|FG001|Overall Study|Lost to Follow-up|9|||
161768728|NCT01928758|584194547|FG000|Overall Study|Withdrawal by Subject|5|||
161768729|NCT01928758|584194548|FG001|Overall Study|Withdrawal by Subject|2|||
161768730|NCT01928758|584194547|FG000|Overall Study|Adverse Event|3|||
161768731|NCT01928758|584194548|FG001|Overall Study|Adverse Event|5|||
161768732|NCT01928758|584194547|FG000|Overall Study|Protocol Violation|3|||
161768733|NCT01928758|584194548|FG001|Overall Study|Protocol Violation|4|||
161768734|NCT02718131|584194549|FG000|Overall Study|Withdrawal by Subject|1|||
161768735|NCT02718131|584194550|FG001|Overall Study|Withdrawal by Subject|0|||
161768736|NCT02718131|584194549|FG000|Overall Study|Adverse Event|1|||
161768737|NCT02718131|584194550|FG001|Overall Study|Adverse Event|0|||
161768738|NCT02718131|584194549|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
161768739|NCT02718131|584194550|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
161768740|NCT02452320|584194551|FG000|Overall Study|Adverse Event|0|||
161768741|NCT02452320|584194552|FG001|Overall Study|Adverse Event|1|||
161768742|NCT03198559|584194553|FG000|Overall Study|Adverse Event|2|||
161768743|NCT03737812|584194554|FG000|Overall Study|Withdrawal by Subject|1|||
161768744|NCT03737812|584194555|FG001|Overall Study|Withdrawal by Subject|2|||
161768745|NCT03737812|584194556|FG002|Overall Study|Withdrawal by Subject|1|||
161768746|NCT03737812|584194554|FG000|Overall Study|Sponsor Discontinued the Study|4|||
161768747|NCT03737812|584194555|FG001|Overall Study|Sponsor Discontinued the Study|3|||
161768748|NCT03737812|584194556|FG002|Overall Study|Sponsor Discontinued the Study|2|||
161768749|NCT03737812|584194554|FG000|Overall Study|Adverse Event|0|||
161768750|NCT03737812|584194555|FG001|Overall Study|Adverse Event|1|||
161768751|NCT03737812|584194556|FG002|Overall Study|Adverse Event|0|||
161768752|NCT03737812|584194554|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
161768753|NCT03737812|584194555|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
161768754|NCT03737812|584194556|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
161768755|NCT01474291|584194560|FG000|Overall Study|Not Evaluable for Efficacy|26|||
161768756|NCT01474291|584194560|FG000|Overall Study|Lack of Treatment Efficacy|88|||
161768757|NCT01474291|584194560|FG000|Overall Study|Adverse Event|53|||
161768758|NCT01474291|584194560|FG000|Overall Study|Lost to Follow-up|29|||
161768759|NCT01474291|584194560|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
161768760|NCT01474291|584194560|FG000|Overall Study|No Reason Reported|10|||
161768761|NCT01474291|584194560|FG000|Overall Study|Death|2|||
161768762|NCT03471507|584194561|FG000|Overall Study|Lost to Follow-up|1|||
161768763|NCT03471507|584194562|FG001|Overall Study|Lost to Follow-up|3|||
161768764|NCT03471507|584194561|FG000|Overall Study|Physician Decision|0|||
161768765|NCT03471507|584194562|FG001|Overall Study|Physician Decision|1|||
161768766|NCT03471507|584194561|FG000|Overall Study|Withdrawal by Subject|2|||
161768767|NCT03471507|584194562|FG001|Overall Study|Withdrawal by Subject|1|||
161768768|NCT01399619|584194564|FG000|Overall Study|Adverse Event|10|||
161768769|NCT01399619|584194565|FG001|Overall Study|Adverse Event|0|||
161768770|NCT01399619|584194566|FG002|Overall Study|Adverse Event|4|||
161768771|NCT01399619|584194567|FG003|Overall Study|Adverse Event|10|||
161855406|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
161855407|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
161855408|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
161855409|NCT04071405|584512345|FG000|Overall Study|Protocol Violation|3|||
161768772|NCT01399619|584194564|FG000|Overall Study|Lack of Efficacy|9|||
161768773|NCT01399619|584194565|FG001|Overall Study|Lack of Efficacy|0|||
161768774|NCT01399619|584194566|FG002|Overall Study|Lack of Efficacy|5|||
161768775|NCT01399619|584194567|FG003|Overall Study|Lack of Efficacy|0|||
161768776|NCT01399619|584194564|FG000|Overall Study|Withdrawal by Subject|6|||
161768777|NCT01399619|584194565|FG001|Overall Study|Withdrawal by Subject|0|||
161768778|NCT01399619|584194566|FG002|Overall Study|Withdrawal by Subject|3|||
161855410|NCT01027702|584512350|FG000|Overall Study|Received subsequent therapy|1|||
161768779|NCT01399619|584194567|FG003|Overall Study|Withdrawal by Subject|4|||
161768780|NCT01399619|584194564|FG000|Overall Study|Protocol Violation|0|||
161768781|NCT01399619|584194565|FG001|Overall Study|Protocol Violation|0|||
161768782|NCT01399619|584194566|FG002|Overall Study|Protocol Violation|0|||
161768783|NCT01399619|584194567|FG003|Overall Study|Protocol Violation|1|||
161768784|NCT01399619|584194564|FG000|Overall Study|Not treated|0|||
161768785|NCT01399619|584194565|FG001|Overall Study|Not treated|0|||
161768786|NCT01399619|584194566|FG002|Overall Study|Not treated|0|||
161768787|NCT01399619|584194567|FG003|Overall Study|Not treated|2|||
161768788|NCT02557308|584194570|FG000|Overall Study|Withdrawal by Subject|11|||
161768789|NCT02557308|584194571|FG001|Overall Study|Withdrawal by Subject|3|||
161768790|NCT02557308|584194572|FG002|Overall Study|Withdrawal by Subject|2|||
161768791|NCT02557308|584194573|FG003|Overall Study|Withdrawal by Subject|0|||
161768792|NCT02557308|584194574|FG004|Overall Study|Withdrawal by Subject|1|||
161768793|NCT02557308|584194575|FG005|Overall Study|Withdrawal by Subject|0|||
161768794|NCT02557308|584194576|FG006|Overall Study|Withdrawal by Subject|10|||
161768795|NCT02557308|584194577|FG007|Overall Study|Withdrawal by Subject|1|||
161855411|NCT01027702|584512351|FG001|Overall Study|Received subsequent therapy|2|||
161768796|NCT02557308|584194570|FG000|Overall Study|Disease Progression|0|||
161768797|NCT02557308|584194571|FG001|Overall Study|Disease Progression|1|||
161768798|NCT02557308|584194572|FG002|Overall Study|Disease Progression|0|||
161768799|NCT02557308|584194573|FG003|Overall Study|Disease Progression|0|||
161768800|NCT02557308|584194574|FG004|Overall Study|Disease Progression|0|||
161768801|NCT02557308|584194575|FG005|Overall Study|Disease Progression|0|||
161768802|NCT02557308|584194576|FG006|Overall Study|Disease Progression|0|||
161768803|NCT02557308|584194577|FG007|Overall Study|Disease Progression|0|||
161768804|NCT02557308|584194570|FG000|Overall Study|Lack of Efficacy|3|||
161768805|NCT02557308|584194571|FG001|Overall Study|Lack of Efficacy|0|||
161768806|NCT02557308|584194572|FG002|Overall Study|Lack of Efficacy|0|||
161768807|NCT02557308|584194573|FG003|Overall Study|Lack of Efficacy|0|||
161768808|NCT02557308|584194574|FG004|Overall Study|Lack of Efficacy|0|||
161768809|NCT02557308|584194575|FG005|Overall Study|Lack of Efficacy|0|||
161768810|NCT02557308|584194576|FG006|Overall Study|Lack of Efficacy|1|||
161768811|NCT02557308|584194577|FG007|Overall Study|Lack of Efficacy|0|||
161768812|NCT02557308|584194570|FG000|Overall Study|Adverse Event|4|||
161768813|NCT02557308|584194571|FG001|Overall Study|Adverse Event|1|||
161768814|NCT02557308|584194572|FG002|Overall Study|Adverse Event|2|||
161768815|NCT02557308|584194573|FG003|Overall Study|Adverse Event|0|||
161768816|NCT02557308|584194574|FG004|Overall Study|Adverse Event|0|||
161768817|NCT02557308|584194575|FG005|Overall Study|Adverse Event|0|||
161768818|NCT02557308|584194576|FG006|Overall Study|Adverse Event|4|||
161768819|NCT02557308|584194577|FG007|Overall Study|Adverse Event|1|||
161768820|NCT02557308|584194570|FG000|Overall Study|Lost to Follow-up|2|||
161768821|NCT02557308|584194571|FG001|Overall Study|Lost to Follow-up|0|||
161768822|NCT02557308|584194572|FG002|Overall Study|Lost to Follow-up|1|||
161768823|NCT02557308|584194573|FG003|Overall Study|Lost to Follow-up|0|||
161768824|NCT02557308|584194574|FG004|Overall Study|Lost to Follow-up|0|||
161768825|NCT02557308|584194575|FG005|Overall Study|Lost to Follow-up|0|||
161768826|NCT02557308|584194576|FG006|Overall Study|Lost to Follow-up|2|||
161768827|NCT02557308|584194577|FG007|Overall Study|Lost to Follow-up|0|||
161768828|NCT02557308|584194570|FG000|Overall Study|Death|1|||
161768829|NCT02557308|584194571|FG001|Overall Study|Death|0|||
161768830|NCT02557308|584194572|FG002|Overall Study|Death|0|||
161768831|NCT02557308|584194573|FG003|Overall Study|Death|0|||
161768832|NCT02557308|584194574|FG004|Overall Study|Death|0|||
161768833|NCT02557308|584194575|FG005|Overall Study|Death|0|||
161768834|NCT02557308|584194576|FG006|Overall Study|Death|0|||
161768835|NCT02557308|584194577|FG007|Overall Study|Death|0|||
161768836|NCT02557308|584194570|FG000|Overall Study|Study Close|98|||
161768837|NCT02557308|584194571|FG001|Overall Study|Study Close|18|||
161768838|NCT02557308|584194572|FG002|Overall Study|Study Close|5|||
161768839|NCT02557308|584194573|FG003|Overall Study|Study Close|3|||
161768840|NCT02557308|584194574|FG004|Overall Study|Study Close|1|||
161768841|NCT02557308|584194575|FG005|Overall Study|Study Close|0|||
161768842|NCT02557308|584194576|FG006|Overall Study|Study Close|123|||
161768843|NCT02557308|584194577|FG007|Overall Study|Study Close|5|||
161768844|NCT02557308|584194570|FG000|Overall Study|Except for study close|5|||
161768845|NCT02557308|584194571|FG001|Overall Study|Except for study close|0|||
161768846|NCT02557308|584194572|FG002|Overall Study|Except for study close|0|||
161768847|NCT02557308|584194573|FG003|Overall Study|Except for study close|0|||
161768848|NCT02557308|584194574|FG004|Overall Study|Except for study close|3|||
161768849|NCT02557308|584194575|FG005|Overall Study|Except for study close|0|||
161768850|NCT02557308|584194576|FG006|Overall Study|Except for study close|6|||
161768851|NCT02557308|584194577|FG007|Overall Study|Except for study close|10|||
161768852|NCT03911401|584194578|FG000|Overall Study|Adverse Event|1|||
161768853|NCT03911401|584194579|FG001|Overall Study|Adverse Event|2|||
161768854|NCT03911401|584194580|FG002|Overall Study|Adverse Event|5|||
161768855|NCT03911401|584194578|FG000|Overall Study|Lack of Efficacy|1|||
161768856|NCT03911401|584194579|FG001|Overall Study|Lack of Efficacy|1|||
161768857|NCT03911401|584194580|FG002|Overall Study|Lack of Efficacy|8|||
161768858|NCT03911401|584194578|FG000|Overall Study|Physician Decision|0|||
161768859|NCT03911401|584194579|FG001|Overall Study|Physician Decision|0|||
161768860|NCT03911401|584194580|FG002|Overall Study|Physician Decision|1|||
161768861|NCT03911401|584194578|FG000|Overall Study|Withdrawal by Subject|1|||
161768862|NCT03911401|584194579|FG001|Overall Study|Withdrawal by Subject|2|||
161768863|NCT03911401|584194580|FG002|Overall Study|Withdrawal by Subject|0|||
161768864|NCT03911401|584194578|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161768865|NCT03911401|584194579|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161768866|NCT03911401|584194580|FG002|Overall Study|Withdrawal by parent/guardian|11|||
161768867|NCT03417245|584194584|FG000|Overall Study|Adverse Event|1|||
161768868|NCT03417245|584194585|FG001|Overall Study|Adverse Event|0|||
161768869|NCT03417245|584194584|FG000|Overall Study|Protocol Violation|1|||
161768870|NCT03417245|584194585|FG001|Overall Study|Protocol Violation|0|||
161768871|NCT03417245|584194584|FG000|Overall Study|Withdrawal by Subject|1|||
161768872|NCT03417245|584194585|FG001|Overall Study|Withdrawal by Subject|1|||
161768873|NCT02046993|584194586|FG000|Overall Study|Withdrawal by Subject|2|||
161768874|NCT02046993|584194587|FG001|Overall Study|Withdrawal by Subject|10|||
161768875|NCT02046993|584194586|FG000|Overall Study|Lost to Follow-up|1|||
161768876|NCT02046993|584194587|FG001|Overall Study|Lost to Follow-up|1|||
161768877|NCT01590628|584194595|FG000|Overall Study|Death|2|||
161768878|NCT01590628|584194596|FG001|Overall Study|Death|0|||
161768879|NCT00761735|584194597|FG000|Overall Study|Lost to Follow-up|6|||
161768880|NCT00761735|584194597|FG000|Overall Study|Withdrawal by Subject|6|||
161768881|NCT00761735|584194597|FG000|Overall Study|Non-compliance with protocol|1|||
161768882|NCT00761735|584194597|FG000|Overall Study|Administrative|1|||
161768883|NCT00267202|584194598|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
161768884|NCT00267202|584194599|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161768885|NCT00267202|584194598|FG000|Overall Study|Withdrawal by Subject|12|||
161768886|NCT00267202|584194599|FG001|Overall Study|Withdrawal by Subject|15|||
161768887|NCT00267202|584194598|FG000|Overall Study|Adverse Event|13|||
161768888|NCT00267202|584194599|FG001|Overall Study|Adverse Event|7|||
161768889|NCT00267202|584194598|FG000|Overall Study|Protocol Violation|2|||
161768890|NCT00267202|584194599|FG001|Overall Study|Protocol Violation|3|||
161768891|NCT00267202|584194598|FG000|Overall Study|Administrative problems|2|||
161768892|NCT00267202|584194599|FG001|Overall Study|Administrative problems|1|||
161768893|NCT00267202|584194598|FG000|Overall Study|Lost to Follow-up|3|||
161768894|NCT00267202|584194599|FG001|Overall Study|Lost to Follow-up|0|||
161768895|NCT03326323|584194600|FG000|Overall Study|Unable to receive ANH protocol|3|||
161768896|NCT00920582|584194601|FG000|Overall Study|Lost to Follow-up|5|||
161768897|NCT00920582|584194602|FG001|Overall Study|Lost to Follow-up|1|||
161768898|NCT00920582|584194603|FG002|Overall Study|Lost to Follow-up|2|||
161768899|NCT00920582|584194604|FG003|Overall Study|Lost to Follow-up|0|||
161768900|NCT00920582|584194601|FG000|Overall Study|Withdrawal by Subject|5|||
161768901|NCT00920582|584194602|FG001|Overall Study|Withdrawal by Subject|4|||
161768902|NCT00920582|584194603|FG002|Overall Study|Withdrawal by Subject|6|||
161768903|NCT00920582|584194604|FG003|Overall Study|Withdrawal by Subject|3|||
161768904|NCT00920582|584194601|FG000|Overall Study|Protocol Violation|1|||
161768905|NCT00920582|584194602|FG001|Overall Study|Protocol Violation|0|||
161768906|NCT00920582|584194603|FG002|Overall Study|Protocol Violation|0|||
161768907|NCT00920582|584194604|FG003|Overall Study|Protocol Violation|0|||
161768908|NCT00920582|584194601|FG000|Overall Study|Other|2|||
161768909|NCT00920582|584194602|FG001|Overall Study|Other|1|||
161768910|NCT00920582|584194603|FG002|Overall Study|Other|3|||
161768911|NCT00920582|584194604|FG003|Overall Study|Other|2|||
161768912|NCT00851721|584194609|FG000|Overall Study|planned surgery|1|||
161768913|NCT00851721|584194610|FG001|Overall Study|planned surgery|0|||
161768914|NCT00851721|584194609|FG000|Overall Study|Death|1|||
161768915|NCT00851721|584194610|FG001|Overall Study|Death|0|||
161768916|NCT00851721|584194609|FG000|Overall Study|Adverse Event|0|||
161768917|NCT00851721|584194610|FG001|Overall Study|Adverse Event|1|||
161768918|NCT01333501|584194611|FG000|Overall Study|Adverse Event|3|||
161768919|NCT01333501|584194612|FG001|Overall Study|Adverse Event|1|||
161768920|NCT01333501|584194611|FG000|Overall Study|Abnormal laboratory value|2|||
161768921|NCT01333501|584194612|FG001|Overall Study|Abnormal laboratory value|1|||
161768922|NCT01333501|584194611|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161768923|NCT01333501|584194612|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
161768924|NCT01333501|584194611|FG000|Overall Study|Withdrawn consent|3|||
161768925|NCT01333501|584194612|FG001|Overall Study|Withdrawn consent|12|||
161768926|NCT00955682|584194613|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
161768927|NCT00955682|584194614|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
161768928|NCT04034225|584194615|FG000|Overall Study|Death|3|||
161768929|NCT04034225|584194615|FG000|Overall Study|Withdrawal by Subject|2|||
161768930|NCT04034225|584194615|FG000|Overall Study|Study termination by Sponsor|18|||
161768931|NCT04034225|584194615|FG000|Overall Study|Physician Decision|1|||
161768932|NCT04034225|584194615|FG000|Overall Study|Lack of Efficacy|1|||
161768933|NCT01681004|584194621|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
161768934|NCT01681004|584194622|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
161768935|NCT01681004|584194621|FG000|Study Completion|Lost to Follow-up|8|||
161768936|NCT01681004|584194622|FG001|Study Completion|Lost to Follow-up|3|||
161768937|NCT01681004|584194621|FG000|Study Completion|Physician Decision|1|||
161768938|NCT01681004|584194622|FG001|Study Completion|Physician Decision|3|||
161768939|NCT01681004|584194621|FG000|Study Completion|Site Termination|2|||
161768940|NCT01681004|584194622|FG001|Study Completion|Site Termination|1|||
161768941|NCT01681004|584194621|FG000|Study Completion|Death|1|||
161768942|NCT01681004|584194622|FG001|Study Completion|Death|1|||
161768943|NCT00689299|584194625|FG000|Overall Study|Adverse Event|2|||
161768944|NCT00689299|584194626|FG001|Overall Study|Adverse Event|1|||
161768945|NCT00689299|584194627|FG002|Overall Study|Adverse Event|1|||
161768946|NCT00689299|584194625|FG000|Overall Study|Lost to Follow-up|0|||
161768947|NCT00689299|584194626|FG001|Overall Study|Lost to Follow-up|1|||
161768948|NCT00689299|584194627|FG002|Overall Study|Lost to Follow-up|1|||
161768949|NCT00689299|584194625|FG000|Overall Study|Withdrawal by Subject|4|||
161768950|NCT00689299|584194626|FG001|Overall Study|Withdrawal by Subject|1|||
161768951|NCT00689299|584194627|FG002|Overall Study|Withdrawal by Subject|3|||
161768952|NCT00689299|584194625|FG000|Overall Study|Protocol Violation|1|||
161768953|NCT00689299|584194626|FG001|Overall Study|Protocol Violation|0|||
161768954|NCT00689299|584194627|FG002|Overall Study|Protocol Violation|0|||
161768955|NCT01190839|584194630|FG000|Overall Study|Adverse Event|32|||
161768956|NCT01190839|584194631|FG001|Overall Study|Adverse Event|41|||
161768957|NCT01190839|584194630|FG000|Overall Study|Protocol Violation|2|||
161768958|NCT01190839|584194631|FG001|Overall Study|Protocol Violation|2|||
161768959|NCT01190839|584194630|FG000|Overall Study|Lost to Follow-up|7|||
161768960|NCT01190839|584194631|FG001|Overall Study|Lost to Follow-up|1|||
161768961|NCT01190839|584194630|FG000|Overall Study|Death|1|||
161768962|NCT01190839|584194631|FG001|Overall Study|Death|0|||
161768963|NCT01190839|584194630|FG000|Overall Study|Trial stopped by Sponsor|71|||
161768964|NCT01190839|584194631|FG001|Overall Study|Trial stopped by Sponsor|68|||
161768965|NCT01190839|584194630|FG000|Overall Study|Undefined|35|||
161768966|NCT01190839|584194631|FG001|Overall Study|Undefined|31|||
161768967|NCT01190839|584194630|FG000|Overall Study|Randomized but not treated|2|||
161768968|NCT01190839|584194631|FG001|Overall Study|Randomized but not treated|4|||
161768969|NCT00695318|584194635|FG000|Overall Study|Lost to Follow-up|1|||
161768970|NCT00695318|584194636|FG001|Overall Study|Lost to Follow-up|0|||
161768971|NCT00695318|584194635|FG000|Overall Study|Withdrawal by Subject|2|||
161768972|NCT00695318|584194636|FG001|Overall Study|Withdrawal by Subject|0|||
161768973|NCT00695318|584194635|FG000|Overall Study|Death|1|||
161768974|NCT00695318|584194636|FG001|Overall Study|Death|1|||
161768975|NCT00695318|584194635|FG000|Overall Study|Study Terminated|1|||
161768976|NCT00695318|584194636|FG001|Overall Study|Study Terminated|0|||
161768977|NCT02058966|584194637|FG000|Open-Label Methamphetamine|Adverse Event|1|||
161768978|NCT02058966|584194637|FG000|First Intervention|Withdrawal by Subject|1|||
161768979|NCT01265511|584194638|FG000|Overall Study|Lack of Efficacy|2|||
161768980|NCT01265511|584194639|FG001|Overall Study|Lack of Efficacy|1|||
161768981|NCT01265511|584194638|FG000|Overall Study|Met stopping rules|0|||
161768982|NCT01265511|584194639|FG001|Overall Study|Met stopping rules|2|||
161768983|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
161768984|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
161768985|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
161768986|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161768987|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
161768988|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
161768989|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
161768990|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
161768991|NCT00950755|584194643|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
161768992|NCT00950755|584194643|FG000|Long-Term Follow-Up|Death|8|||
161768993|NCT00508820|584194644|FG000|Overall Study|Adverse Event|6|||
161768994|NCT00508820|584194645|FG001|Overall Study|Adverse Event|10|||
161768995|NCT00508820|584194644|FG000|Overall Study|Death|6|||
161768996|NCT00508820|584194645|FG001|Overall Study|Death|8|||
161768997|NCT00508820|584194644|FG000|Overall Study|Lost to Follow-up|1|||
161768998|NCT00508820|584194645|FG001|Overall Study|Lost to Follow-up|1|||
161768999|NCT00508820|584194644|FG000|Overall Study|Physician Decision|8|||
161769000|NCT00508820|584194645|FG001|Overall Study|Physician Decision|2|||
161769001|NCT00508820|584194644|FG000|Overall Study|Pregnancy|0|||
161769002|NCT00508820|584194645|FG001|Overall Study|Pregnancy|2|||
161769003|NCT00508820|584194644|FG000|Overall Study|Protocol Violation|2|||
161769004|NCT00508820|584194645|FG001|Overall Study|Protocol Violation|0|||
161769005|NCT00508820|584194644|FG000|Overall Study|Withdrawal by Subject|10|||
161769006|NCT00508820|584194645|FG001|Overall Study|Withdrawal by Subject|12|||
161769007|NCT00508820|584194644|FG000|Overall Study|Other|11|||
161769008|NCT00508820|584194645|FG001|Overall Study|Other|2|||
161769009|NCT00508820|584194644|FG000|Overall Study|Noncompliance|1|||
161769010|NCT00508820|584194645|FG001|Overall Study|Noncompliance|0|||
161769011|NCT00508820|584194644|FG000|Overall Study|Requirement for alternative therapy|7|||
161855412|NCT01027702|584512352|FG002|Overall Study|Received subsequent therapy|0|||
161855413|NCT01027702|584512353|FG003|Overall Study|Received subsequent therapy|4|||
161855414|NCT01027702|584512354|FG004|Overall Study|Received subsequent therapy|1|||
161855415|NCT01027702|584512355|FG005|Overall Study|Received subsequent therapy|0|||
161855416|NCT01027702|584512356|FG006|Overall Study|Received subsequent therapy|1|||
161855417|NCT01027702|584512350|FG000|Overall Study|Death|0|||
161855418|NCT01027702|584512351|FG001|Overall Study|Death|0|||
161855419|NCT01027702|584512352|FG002|Overall Study|Death|1|||
161855420|NCT01027702|584512353|FG003|Overall Study|Death|0|||
161855421|NCT01027702|584512354|FG004|Overall Study|Death|0|||
161855422|NCT01027702|584512355|FG005|Overall Study|Death|0|||
161855423|NCT01027702|584512356|FG006|Overall Study|Death|0|||
161855424|NCT00403585|584512357|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
161855425|NCT00403585|584512357|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
161855426|NCT00403585|584512357|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
161855427|NCT02604407|584512358|FG000|Overall Study|Adverse Event|0|||
161855428|NCT02604407|584512359|FG001|Overall Study|Adverse Event|7|||
161855429|NCT02604407|584512360|FG002|Overall Study|Adverse Event|5|||
161855430|NCT02604407|584512358|FG000|Overall Study|Protocol Violation|2|||
161855431|NCT02604407|584512359|FG001|Overall Study|Protocol Violation|0|||
161855432|NCT02604407|584512360|FG002|Overall Study|Protocol Violation|0|||
161855433|NCT02604407|584512358|FG000|Overall Study|Withdrawal by Subject|3|||
161855434|NCT02604407|584512359|FG001|Overall Study|Withdrawal by Subject|3|||
161855435|NCT02604407|584512360|FG002|Overall Study|Withdrawal by Subject|5|||
161855436|NCT02604407|584512358|FG000|Overall Study|Lost to Follow-up|2|||
161855437|NCT02604407|584512359|FG001|Overall Study|Lost to Follow-up|1|||
161855438|NCT02604407|584512360|FG002|Overall Study|Lost to Follow-up|2|||
161855439|NCT02604407|584512358|FG000|Overall Study|Lack of Efficacy|1|||
161855440|NCT02604407|584512359|FG001|Overall Study|Lack of Efficacy|0|||
161855441|NCT02604407|584512360|FG002|Overall Study|Lack of Efficacy|0|||
161855442|NCT02604407|584512358|FG000|Overall Study|Other|3|||
161855443|NCT02604407|584512359|FG001|Overall Study|Other|1|||
161855444|NCT02604407|584512360|FG002|Overall Study|Other|4|||
161855445|NCT02862730|584512363|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855446|NCT02862730|584512364|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855447|NCT02862730|584512365|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
161855448|NCT02862730|584512366|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855449|NCT02862730|584512367|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855450|NCT02862730|584512368|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855451|NCT02862730|584512369|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855452|NCT02862730|584512363|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
161855453|NCT02862730|584512364|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855454|NCT02862730|584512365|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855455|NCT02862730|584512366|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855456|NCT02862730|584512367|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855457|NCT02862730|584512368|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855458|NCT02862730|584512369|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855459|NCT02862730|584512363|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855460|NCT02862730|584512364|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855461|NCT02862730|584512365|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
161855462|NCT02862730|584512366|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855463|NCT02862730|584512367|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
161855464|NCT02862730|584512368|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855465|NCT02862730|584512369|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855466|NCT02862730|584512363|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855467|NCT02862730|584512364|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855468|NCT02862730|584512365|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855469|NCT02862730|584512366|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
161855470|NCT02862730|584512367|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855471|NCT02862730|584512368|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855472|NCT02862730|584512369|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855473|NCT00191191|584512370|FG000|Overall Study|Entry Criteria Exclusion|2|||
161855474|NCT00191191|584512371|FG001|Overall Study|Entry Criteria Exclusion|0|||
161855475|NCT00191191|584512370|FG000|Overall Study|Treated with Another Systemic Agent|1|||
161855476|NCT00191191|584512371|FG001|Overall Study|Treated with Another Systemic Agent|1|||
161855477|NCT00191191|584512370|FG000|Overall Study|Adverse Event|11|||
161855478|NCT00191191|584512371|FG001|Overall Study|Adverse Event|21|||
161855479|NCT00191191|584512370|FG000|Overall Study|Progressive Disease|84|||
161855480|NCT00191191|584512371|FG001|Overall Study|Progressive Disease|72|||
161855481|NCT00191191|584512370|FG000|Overall Study|Toxicity After Dose Reduction|7|||
161855482|NCT00191191|584512371|FG001|Overall Study|Toxicity After Dose Reduction|8|||
161855483|NCT00191191|584512370|FG000|Overall Study|Family/Caregiver Decision|5|||
161855484|NCT00191191|584512371|FG001|Overall Study|Family/Caregiver Decision|7|||
161855485|NCT00191191|584512370|FG000|Overall Study|Lost to Follow-up|1|||
161855486|NCT00191191|584512371|FG001|Overall Study|Lost to Follow-up|0|||
161855487|NCT00191191|584512370|FG000|Overall Study|Physician Decision|3|||
161855488|NCT00191191|584512371|FG001|Overall Study|Physician Decision|2|||
161855489|NCT00191191|584512370|FG000|Overall Study|Good Clinical Practice Violation|0|||
161855490|NCT00191191|584512371|FG001|Overall Study|Good Clinical Practice Violation|1|||
161855491|NCT03685344|584512372|FG000|Overall Study|Withdrawal by Subject|1|||
161855492|NCT03685344|584512373|FG001|Overall Study|Withdrawal by Subject|1|||
161855493|NCT03685344|584512374|FG002|Overall Study|Withdrawal by Subject|2|||
161855494|NCT03685344|584512375|FG003|Overall Study|Withdrawal by Subject|0|||
161855495|NCT03685344|584512372|FG000|Overall Study|Physician Decision|1|||
161855496|NCT03685344|584512373|FG001|Overall Study|Physician Decision|1|||
161855497|NCT03685344|584512374|FG002|Overall Study|Physician Decision|5|||
161855498|NCT03685344|584512375|FG003|Overall Study|Physician Decision|0|||
161855499|NCT03685344|584512372|FG000|Overall Study|Death|1|||
161855500|NCT03685344|584512373|FG001|Overall Study|Death|1|||
161855501|NCT03685344|584512374|FG002|Overall Study|Death|0|||
161855502|NCT03685344|584512375|FG003|Overall Study|Death|0|||
161855503|NCT02276807|584512378|FG000|Overall Study|Withdrawal by Subject|8|||
161855504|NCT02276807|584512379|FG001|Overall Study|Withdrawal by Subject|7|||
161855505|NCT02276807|584512378|FG000|Overall Study|Lost to Follow-up|10|||
161855506|NCT02276807|584512379|FG001|Overall Study|Lost to Follow-up|10|||
161855507|NCT00261950|584512381|FG000|Overall Study|Lost to Follow-up|2|||
161855508|NCT00261950|584512381|FG000|Overall Study|Death|6|||
161855509|NCT00261950|584512381|FG000|Overall Study|Withdrawal by Subject|5|||
161855510|NCT00261950|584512381|FG000|Overall Study|Other|1|||
161855511|NCT00261950|584512381|FG000|Overall Study|Physician Decision|1|||
161855512|NCT00261950|584512381|FG000|Overall Study|Protocol specified Criteria|11|||
161855513|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
161855514|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
161855515|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
161855516|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
161855517|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161769012|NCT00508820|584194645|FG001|Overall Study|Requirement for alternative therapy|15|||
161769013|NCT00508820|584194644|FG000|Overall Study|Protocol-specified Criteria|3|||
161769014|NCT00508820|584194645|FG001|Overall Study|Protocol-specified Criteria|12|||
161769015|NCT01789476|584196027|FG000|Overall Study|Lack of Efficacy|6|||
161769016|NCT01789476|584196028|FG001|Overall Study|Lack of Efficacy|2|||
161769017|NCT01789476|584196027|FG000|Overall Study|Adverse Event|1|||
161769018|NCT01789476|584196028|FG001|Overall Study|Adverse Event|0|||
161769019|NCT01789476|584196027|FG000|Overall Study|Unable to get IV access|1|||
161769020|NCT01789476|584196028|FG001|Overall Study|Unable to get IV access|0|||
161769021|NCT03053102|584196029|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
161769022|NCT03053102|584196029|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
161769023|NCT01798056|584196030|FG000|Overall Study|Serious Adverse Event|13|||
161769024|NCT01798056|584196031|FG001|Overall Study|Serious Adverse Event|12|||
161769025|NCT01798056|584196030|FG000|Overall Study|Withdrawal by Subject|12|||
161769026|NCT01798056|584196031|FG001|Overall Study|Withdrawal by Subject|9|||
161769027|NCT01798056|584196030|FG000|Overall Study|Migrated/moved from study area|1|||
161769028|NCT01798056|584196031|FG001|Overall Study|Migrated/moved from study area|1|||
161769029|NCT01798056|584196030|FG000|Overall Study|Lost to Follow-up|1|||
161769030|NCT01798056|584196031|FG001|Overall Study|Lost to Follow-up|1|||
161769031|NCT01798056|584196030|FG000|Overall Study|Other|0|||
161769032|NCT01798056|584196031|FG001|Overall Study|Other|2|||
161769033|NCT01269346|584196034|FG000|Treatment Phase|Disease progression|3|||
161769034|NCT01269346|584196034|FG000|Treatment Phase|Adverse Event|3|||
161769035|NCT01269346|584196034|FG000|Treatment Phase|Withdrawal by Subject|1|||
161769036|NCT01269346|584196034|FG000|Treatment Phase|Other|2|||
161769037|NCT01269346|584196034|FG000|Extension Phase|Adverse Event|6|||
161769038|NCT01269346|584196034|FG000|Extension Phase|Withdrawal by Subject|4|||
161769039|NCT01269346|584196034|FG000|Extension Phase|Disease progression|22|||
161769040|NCT01269346|584196034|FG000|Extension Phase|Physician decision or participant choice|9|||
161769041|NCT01269346|584196034|FG000|Extension Phase|Clinical progression|1|||
161769042|NCT01269346|584196034|FG000|Extension Phase|Started a prohibited con med|1|||
161769043|NCT00247416|584196035|FG000|Overall Study|3 patients were found to be ineligible|1|||
161769044|NCT00247416|584196036|FG001|Overall Study|3 patients were found to be ineligible|2|||
161769045|NCT02660489|584196045|FG000|Overall Study|Lost to Follow-up|1|||
161769046|NCT02660489|584196046|FG001|Overall Study|Lost to Follow-up|1|||
161769047|NCT02660489|584196045|FG000|Overall Study|Adverse Event|1|||
161769048|NCT02660489|584196046|FG001|Overall Study|Adverse Event|3|||
161769049|NCT02660489|584196045|FG000|Overall Study|no rhinovirus infection|4|||
161769050|NCT02660489|584196046|FG001|Overall Study|no rhinovirus infection|4|||
161769051|NCT02322866|584196047|FG000|Overall Study|Adverse Event|6|||
161769052|NCT02322866|584196048|FG001|Overall Study|Adverse Event|11|||
161769053|NCT02322866|584196047|FG000|Overall Study|Withdrawal of Consent|16|||
161769054|NCT02322866|584196048|FG001|Overall Study|Withdrawal of Consent|25|||
161769055|NCT02322866|584196047|FG000|Overall Study|Lost to Follow-up|36|||
161769056|NCT02322866|584196048|FG001|Overall Study|Lost to Follow-up|39|||
161769057|NCT02322866|584196047|FG000|Overall Study|Protocol Violation|1|||
161769058|NCT02322866|584196048|FG001|Overall Study|Protocol Violation|0|||
161769059|NCT02322866|584196047|FG000|Overall Study|Noncompliance with Treatment|3|||
161769060|NCT02322866|584196048|FG001|Overall Study|Noncompliance with Treatment|4|||
161769061|NCT02322866|584196047|FG000|Overall Study|Lack of Efficacy|3|||
161769062|NCT02322866|584196048|FG001|Overall Study|Lack of Efficacy|1|||
161769063|NCT02322866|584196047|FG000|Overall Study|Other Miscellaneous Reasons|6|||
161769064|NCT02322866|584196048|FG001|Overall Study|Other Miscellaneous Reasons|6|||
161769065|NCT03735680|584196051|FG000|Overall Study|Withdrawal by Subject|0|||
161769066|NCT03735680|584196052|FG001|Overall Study|Withdrawal by Subject|1|||
161769067|NCT03735680|584196053|FG002|Overall Study|Withdrawal by Subject|0|||
161769068|NCT03735680|584196054|FG003|Overall Study|Withdrawal by Subject|0|||
161769069|NCT03735680|584196055|FG004|Overall Study|Withdrawal by Subject|0|||
161769070|NCT03735680|584196056|FG005|Overall Study|Withdrawal by Subject|1|||
161769071|NCT03735680|584196051|FG000|Overall Study|Patient unable or unwilling to continue|0|||
161769072|NCT03735680|584196052|FG001|Overall Study|Patient unable or unwilling to continue|0|||
161769073|NCT03735680|584196053|FG002|Overall Study|Patient unable or unwilling to continue|1|||
161769074|NCT03735680|584196054|FG003|Overall Study|Patient unable or unwilling to continue|0|||
161769075|NCT03735680|584196055|FG004|Overall Study|Patient unable or unwilling to continue|0|||
161769076|NCT03735680|584196056|FG005|Overall Study|Patient unable or unwilling to continue|0|||
161769077|NCT03472586|584196073|FG000|Overall Study|Physician Decision|6|||
161769078|NCT03472586|584196073|FG000|Overall Study|Death|6|||
161769079|NCT03472586|584196073|FG000|Overall Study|Adverse Event|1|||
161769080|NCT05064436|584196075|FG000|Overall Study|Other Reasons|1|||
161769081|NCT05064436|584196076|FG001|Overall Study|Other Reasons|0|||
161769082|NCT01342445|584196077|FG000|Overall Study|Experienced side effects|0|||
161769083|NCT01342445|584196078|FG001|Overall Study|Experienced side effects|2|||
161769084|NCT02957149|584196081|FG000|Overall Study|Withdrawal by Subject|5|||
161769085|NCT06045026|584196082|FG000|Overall Study|Lost to Follow-up|60|||
161769086|NCT06045026|584196082|FG000|Overall Study|Adverse Event|12|||
161855518|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161855519|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
161855520|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161855521|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
161855522|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
161855523|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
161855524|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
161855525|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
161855526|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
161855527|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
161855528|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
161855529|NCT00445432|584512386|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161855530|NCT00445432|584512387|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161855531|NCT00445432|584512388|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161855532|NCT00445432|584512389|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
161855533|NCT00445432|584512386|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161855534|NCT00445432|584512387|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161855535|NCT00445432|584512388|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161855536|NCT00445432|584512389|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
161855537|NCT00445432|584512386|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
161855538|NCT00445432|584512387|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
161855539|NCT00445432|584512388|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
161855540|NCT00445432|584512389|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
161855541|NCT02789137|584512390|FG000|Overall Study|Dropped out/Died|58|||
161855542|NCT00799058|584512397|FG000|Overall Study|Withdrawal by Subject|2|||
161855543|NCT00799058|584512398|FG001|Overall Study|Withdrawal by Subject|2|||
161855544|NCT00799058|584512399|FG002|Overall Study|Withdrawal by Subject|2|||
161855545|NCT00799058|584512397|FG000|Overall Study|Lost to Follow-up|1|||
161855546|NCT00799058|584512398|FG001|Overall Study|Lost to Follow-up|2|||
161855547|NCT00799058|584512399|FG002|Overall Study|Lost to Follow-up|1|||
161855548|NCT00799058|584512397|FG000|Overall Study|Adverse Event|0|||
161855549|NCT00799058|584512398|FG001|Overall Study|Adverse Event|2|||
161855550|NCT00799058|584512399|FG002|Overall Study|Adverse Event|0|||
161855551|NCT00799058|584512397|FG000|Overall Study|Pregnancy|1|||
161855552|NCT00799058|584512398|FG001|Overall Study|Pregnancy|0|||
161855553|NCT00799058|584512399|FG002|Overall Study|Pregnancy|0|||
161855554|NCT00799058|584512397|FG000|Overall Study|Not adherent|3|||
161855555|NCT00799058|584512398|FG001|Overall Study|Not adherent|2|||
161855556|NCT00799058|584512399|FG002|Overall Study|Not adherent|1|||
161855557|NCT00799058|584512397|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
161855558|NCT00799058|584512398|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
161855559|NCT00799058|584512399|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
161855560|NCT00799058|584512397|FG000|Overall Study|IP dispensing error|1|||
161855561|NCT00799058|584512398|FG001|Overall Study|IP dispensing error|0|||
161855562|NCT00799058|584512399|FG002|Overall Study|IP dispensing error|0|||
161855563|NCT00799058|584512397|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
161855564|NCT00799058|584512398|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
161855565|NCT00799058|584512399|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
161855566|NCT00799058|584512397|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
161855567|NCT00799058|584512398|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
161855568|NCT00799058|584512399|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
161855569|NCT00799058|584512397|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
161855570|NCT00799058|584512398|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
161855571|NCT00799058|584512399|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
161855572|NCT00799058|584512397|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
161855573|NCT00799058|584512398|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
161855574|NCT00799058|584512399|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
161855575|NCT02088697|584512406|FG000|Period I|Physician Decision|1|||
161855576|NCT02088697|584512407|FG001|Period I|Physician Decision|4|||
161855577|NCT02088697|584512406|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
161855578|NCT02088697|584512407|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
161855579|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Other|34|||
161855580|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Other|0|||
161855581|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Other|0|||
161855582|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Other|0|||
161855583|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Death|14|||
161855584|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Death|0|||
161855585|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Death|0|||
161855586|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Death|0|||
161855587|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
161855588|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
161855589|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
161855590|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
161855591|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
161855592|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161855593|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161855594|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161855595|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
161855596|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
161769087|NCT06045026|584196082|FG000|Overall Study|Withdrawal by Subject|3|||
161769088|NCT06045026|584196082|FG000|Overall Study|Enrollment closed|1|||
161769089|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
161769090|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
161769091|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
161769092|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
161769093|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
161769094|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
161769095|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
161769096|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
161769097|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
161769098|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
161769099|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
161769100|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
161769101|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
161769102|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
161769103|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769104|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769105|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769106|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769107|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769108|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769109|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769110|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769111|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769112|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769113|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
161769114|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769115|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769116|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769117|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769118|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769119|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769120|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769121|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161855597|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
161855598|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
161855599|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
161855600|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161855601|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161855602|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161855603|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
161855604|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161855605|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161855606|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161855607|NCT01995513|584512408|FG000|Period 1: Second Open Label Treatment|Other|0|||
161855608|NCT01995513|584512409|FG001|Period 1: Second Open Label Treatment|Other|2|||
161855609|NCT01995513|584512410|FG002|Period 1: Second Open Label Treatment|Other|0|||
161855610|NCT01995513|584512411|FG003|Period 1: Second Open Label Treatment|Other|0|||
161855611|NCT01995513|584512408|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
161855612|NCT01995513|584512409|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
161855613|NCT01995513|584512410|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
161855614|NCT01995513|584512411|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
161855615|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Death|0|||
161855616|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Death|0|||
161855617|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Death|0|||
161855618|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Death|1|||
161855619|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Other|0|||
161855620|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Other|0|||
161855621|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Other|3|||
161855622|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Other|3|||
161855623|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
161855624|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
161855625|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
161855626|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
161855627|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
161855628|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
161855629|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
161855630|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
161855631|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
161855632|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
161855633|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
161855634|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
161855635|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161855636|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161855637|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161855638|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
161855639|NCT01232452|584512412|FG000|Overall Study|Adverse Event|17|||
161855640|NCT01232452|584512413|FG001|Overall Study|Adverse Event|15|||
161855641|NCT01232452|584512412|FG000|Overall Study|Withdrawal by Subject|11|||
161855642|NCT01232452|584512413|FG001|Overall Study|Withdrawal by Subject|8|||
161855643|NCT01232452|584512412|FG000|Overall Study|Physician Decision|8|||
161855644|NCT01232452|584512413|FG001|Overall Study|Physician Decision|12|||
161855645|NCT01232452|584512412|FG000|Overall Study|Protocol entry criterion not met|0|||
161855646|NCT01232452|584512413|FG001|Overall Study|Protocol entry criterion not met|2|||
161855647|NCT01232452|584512412|FG000|Overall Study|Sponsor Decision|3|||
161855648|NCT01232452|584512413|FG001|Overall Study|Sponsor Decision|1|||
161855649|NCT01232452|584512412|FG000|Overall Study|Protocol Violation|0|||
161855650|NCT01232452|584512413|FG001|Overall Study|Protocol Violation|1|||
161855651|NCT00247676|584512418|FG000|Overall Study|Death|5|||
161855652|NCT00247676|584512418|FG000|Overall Study|Adverse Event|11|||
161855653|NCT00247676|584512418|FG000|Overall Study|Lack of Efficacy|15|||
161855654|NCT00247676|584512418|FG000|Overall Study|Other|3|||
161855655|NCT00247676|584512418|FG000|Overall Study|Withdrawal by Subject|2|||
161855656|NCT03594071|584512419|FG000|Overall Study|Re-operation|3|||
161855657|NCT03594071|584512419|FG000|Overall Study|Missed visit|2|||
161855658|NCT05219448|584512420|FG000|Overall Study|Lost to Follow-up|9|||
161855659|NCT05219448|584512421|FG001|Overall Study|Lost to Follow-up|0|||
161855660|NCT01750190|584512422|FG000|Overall Study|Adverse Event|47|||
161855661|NCT01750190|584512423|FG001|Overall Study|Adverse Event|19|||
161855662|NCT01750190|584512422|FG000|Overall Study|Death|38|||
161855663|NCT01750190|584512423|FG001|Overall Study|Death|11|||
161855664|NCT01750190|584512422|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
161855665|NCT01750190|584512423|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
161855666|NCT01750190|584512422|FG000|Overall Study|Lost to Follow-up|28|||
161855667|NCT01750190|584512423|FG001|Overall Study|Lost to Follow-up|7|||
161855668|NCT01750190|584512422|FG000|Overall Study|Physician Decision|16|||
161855669|NCT01750190|584512423|FG001|Overall Study|Physician Decision|17|||
161855670|NCT01750190|584512422|FG000|Overall Study|Protocol Violation|6|||
161855671|NCT01750190|584512423|FG001|Overall Study|Protocol Violation|5|||
161855672|NCT01750190|584512422|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
161855673|NCT01750190|584512423|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
161855674|NCT01750190|584512422|FG000|Overall Study|Withdrawal by Subject|83|||
161855675|NCT01750190|584512423|FG001|Overall Study|Withdrawal by Subject|89|||
161855676|NCT01750190|584512422|FG000|Overall Study|Kidney Transplant|8|||
161855677|NCT01750190|584512423|FG001|Overall Study|Kidney Transplant|4|||
161855678|NCT01750190|584512422|FG000|Overall Study|Dialysis|22|||
161855679|NCT01750190|584512423|FG001|Overall Study|Dialysis|8|||
161855680|NCT01750190|584512422|FG000|Overall Study|Other than Specified|13|||
161855681|NCT01750190|584512423|FG001|Overall Study|Other than Specified|4|||
161855682|NCT02287922|584512424|FG000|Overall Study|Adverse Event|1|||
161855683|NCT02287922|584512425|FG001|Overall Study|Adverse Event|1|||
161855684|NCT02287922|584512426|FG002|Overall Study|Adverse Event|3|||
161855685|NCT02287922|584512427|FG003|Overall Study|Adverse Event|4|||
161855686|NCT02287922|584512424|FG000|Overall Study|Withdrawal by Subject|1|||
161855687|NCT02287922|584512425|FG001|Overall Study|Withdrawal by Subject|1|||
161855688|NCT02287922|584512426|FG002|Overall Study|Withdrawal by Subject|1|||
161855689|NCT02287922|584512427|FG003|Overall Study|Withdrawal by Subject|2|||
161855690|NCT02287922|584512424|FG000|Overall Study|Lost to Follow-up|0|||
161855691|NCT02287922|584512425|FG001|Overall Study|Lost to Follow-up|0|||
161855692|NCT02287922|584512426|FG002|Overall Study|Lost to Follow-up|1|||
161855693|NCT02287922|584512427|FG003|Overall Study|Lost to Follow-up|0|||
161855694|NCT02287922|584512424|FG000|Overall Study|Sponsor's decision|0|||
161855695|NCT02287922|584512425|FG001|Overall Study|Sponsor's decision|0|||
161855696|NCT02287922|584512426|FG002|Overall Study|Sponsor's decision|0|||
161855697|NCT02287922|584512427|FG003|Overall Study|Sponsor's decision|1|||
161855698|NCT02287922|584512424|FG000|Overall Study|Other|1|||
161855699|NCT02287922|584512425|FG001|Overall Study|Other|0|||
161855700|NCT02287922|584512426|FG002|Overall Study|Other|2|||
161855701|NCT02287922|584512427|FG003|Overall Study|Other|0|||
161855702|NCT01526655|584512430|FG000|Overall Study|Withdrawal by Subject|0|||
161855703|NCT01526655|584512431|FG001|Overall Study|Withdrawal by Subject|1|||
161855704|NCT03571828|584512436|FG000|Overall Study|Withdrawal by Subject|1|||
161855705|NCT03571828|584512437|FG001|Overall Study|Withdrawal by Subject|0|||
161855706|NCT03571828|584512436|FG000|Overall Study|Decision by sponsor|5|||
161855707|NCT03571828|584512437|FG001|Overall Study|Decision by sponsor|1|||
161855708|NCT03571828|584512436|FG000|Overall Study|Death|2|||
161855709|NCT03571828|584512437|FG001|Overall Study|Death|0|||
161855710|NCT02232984|584512438|FG000|Overall Study|Withdrawal by Subject|5|||
161855711|NCT02232984|584512438|FG000|Overall Study|Death|1|||
161855712|NCT02232984|584512438|FG000|Overall Study|Investigator withdrawal|10|||
161855713|NCT02232984|584512438|FG000|Overall Study|Device implant unsuccessful|53|||
161855714|NCT02232984|584512438|FG000|Overall Study|not disclosed by site|7|||
161855715|NCT02232984|584512438|FG000|Overall Study|Protocol Violation|1|||
161855716|NCT03762239|584512441|FG000|Overall Study|Appointment to the doctor|1|||
161855717|NCT03762239|584512442|FG001|Overall Study|Appointment to the doctor|1|||
161855718|NCT00548093|584512446|FG000|Overall Study|Death|33|||
161855719|NCT00548093|584512447|FG001|Overall Study|Death|13|||
161855720|NCT00548093|584512446|FG000|Overall Study|Lost to Follow-up|3|||
161855721|NCT00548093|584512447|FG001|Overall Study|Lost to Follow-up|1|||
161855722|NCT00548093|584512446|FG000|Overall Study|Objective progression or relapse|1|||
161855723|NCT00548093|584512447|FG001|Overall Study|Objective progression or relapse|1|||
161855724|NCT00548093|584512446|FG000|Overall Study|Other|11|||
161855725|NCT00548093|584512447|FG001|Overall Study|Other|1|||
161855726|NCT00548093|584512446|FG000|Overall Study|Withdrawal by Subject|1|||
161855727|NCT00548093|584512447|FG001|Overall Study|Withdrawal by Subject|0|||
161855728|NCT00548093|584512446|FG000|Overall Study|Completed post-treatment follow-up|1|||
161855729|NCT00548093|584512447|FG001|Overall Study|Completed post-treatment follow-up|0|||
161855730|NCT02359994|584512449|FG000|Overall Population Study|Adverse Event|1|||
161855731|NCT02359994|584512450|FG001|Overall Population Study|Adverse Event|1|||
161855732|NCT02359994|584512449|FG000|Overall Population Study|Death|1|||
161855733|NCT02359994|584512450|FG001|Overall Population Study|Death|5|||
161855734|NCT02359994|584512449|FG000|Overall Population Study|Lost to Follow-up|1|||
161855735|NCT02359994|584512450|FG001|Overall Population Study|Lost to Follow-up|1|||
161855736|NCT02359994|584512449|FG000|Overall Population Study|Withdrawal by Subject|1|||
161855737|NCT02359994|584512450|FG001|Overall Population Study|Withdrawal by Subject|0|||
161855738|NCT02359994|584512449|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
161855739|NCT02359994|584512450|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
161855740|NCT02359994|584512449|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
161855741|NCT02359994|584512450|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
161855742|NCT02359994|584512449|FG000|Extended Oncology 24-Month Survival|Death|19|||
161855743|NCT02359994|584512450|FG001|Extended Oncology 24-Month Survival|Death|21|||
161855744|NCT02359994|584512449|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
161855745|NCT02359994|584512450|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
161855746|NCT02933255|584512453|FG000|Overall Study|Discontinued due to study closure.|1|||
161855747|NCT02933255|584512454|FG001|Overall Study|Discontinued due to study closure.|0|||
161855748|NCT02215967|584512459|FG000|Overall Study|Patient became ineligible for treatment|0|||
161855749|NCT02215967|584512460|FG001|Overall Study|Patient became ineligible for treatment|0|||
161855750|NCT02215967|584512461|FG002|Overall Study|Patient became ineligible for treatment|0|||
161855751|NCT02215967|584512462|FG003|Overall Study|Patient became ineligible for treatment|3|||
161855752|NCT02215967|584512459|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
161855753|NCT02215967|584512460|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
161855754|NCT02215967|584512461|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
161855755|NCT02215967|584512462|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
161855756|NCT03207867|584512463|FG000|Overall Study|Adverse Event|1|||
161855757|NCT03207867|584512464|FG001|Overall Study|Adverse Event|0|||
161855758|NCT03207867|584512465|FG002|Overall Study|Adverse Event|1|||
161855759|NCT03207867|584512466|FG003|Overall Study|Adverse Event|0|||
161855760|NCT03207867|584512467|FG004|Overall Study|Adverse Event|0|||
161855761|NCT03207867|584512468|FG005|Overall Study|Adverse Event|2|||
161855762|NCT03207867|584512469|FG006|Overall Study|Adverse Event|1|||
161855763|NCT03207867|584512470|FG007|Overall Study|Adverse Event|1|||
161855764|NCT03207867|584512471|FG008|Overall Study|Adverse Event|2|||
161855765|NCT03207867|584512472|FG009|Overall Study|Adverse Event|2|||
161855766|NCT03207867|584512473|FG010|Overall Study|Adverse Event|0|||
161855767|NCT03207867|584512474|FG011|Overall Study|Adverse Event|0|||
161855768|NCT03207867|584512475|FG012|Overall Study|Adverse Event|0|||
161855769|NCT03207867|584512476|FG013|Overall Study|Adverse Event|0|||
161855770|NCT03207867|584512477|FG014|Overall Study|Adverse Event|0|||
161855771|NCT03207867|584512478|FG015|Overall Study|Adverse Event|0|||
161855772|NCT03207867|584512479|FG016|Overall Study|Adverse Event|3|||
161855773|NCT03207867|584512480|FG017|Overall Study|Adverse Event|1|||
161855774|NCT03207867|584512481|FG018|Overall Study|Adverse Event|2|||
161855775|NCT03207867|584512482|FG019|Overall Study|Adverse Event|1|||
161855776|NCT03207867|584512483|FG020|Overall Study|Adverse Event|0|||
161855777|NCT03207867|584512484|FG021|Overall Study|Adverse Event|0|||
161855778|NCT03207867|584512485|FG022|Overall Study|Adverse Event|0|||
161855779|NCT03207867|584512486|FG023|Overall Study|Adverse Event|0|||
161855780|NCT03207867|584512463|FG000|Overall Study|Death|0|||
161855781|NCT03207867|584512464|FG001|Overall Study|Death|0|||
161855782|NCT03207867|584512465|FG002|Overall Study|Death|0|||
161855783|NCT03207867|584512466|FG003|Overall Study|Death|0|||
161855784|NCT03207867|584512467|FG004|Overall Study|Death|0|||
161855785|NCT03207867|584512468|FG005|Overall Study|Death|1|||
161855786|NCT03207867|584512469|FG006|Overall Study|Death|0|||
161855787|NCT03207867|584512470|FG007|Overall Study|Death|3|||
161855788|NCT03207867|584512471|FG008|Overall Study|Death|1|||
161855789|NCT03207867|584512472|FG009|Overall Study|Death|2|||
161855790|NCT03207867|584512473|FG010|Overall Study|Death|0|||
161855791|NCT03207867|584512474|FG011|Overall Study|Death|1|||
161855792|NCT03207867|584512475|FG012|Overall Study|Death|0|||
161855793|NCT03207867|584512476|FG013|Overall Study|Death|1|||
161855794|NCT03207867|584512477|FG014|Overall Study|Death|0|||
161855795|NCT03207867|584512478|FG015|Overall Study|Death|0|||
161855796|NCT03207867|584512479|FG016|Overall Study|Death|0|||
161855797|NCT03207867|584512480|FG017|Overall Study|Death|2|||
161855798|NCT03207867|584512481|FG018|Overall Study|Death|0|||
161855799|NCT03207867|584512482|FG019|Overall Study|Death|1|||
161855800|NCT03207867|584512483|FG020|Overall Study|Death|0|||
161855801|NCT03207867|584512484|FG021|Overall Study|Death|0|||
161855802|NCT03207867|584512485|FG022|Overall Study|Death|0|||
161855803|NCT03207867|584512486|FG023|Overall Study|Death|0|||
161855804|NCT03207867|584512463|FG000|Overall Study|Physician Decision|3|||
161855805|NCT03207867|584512464|FG001|Overall Study|Physician Decision|5|||
161855806|NCT03207867|584512465|FG002|Overall Study|Physician Decision|0|||
161855807|NCT03207867|584512466|FG003|Overall Study|Physician Decision|3|||
161855808|NCT03207867|584512467|FG004|Overall Study|Physician Decision|2|||
161855809|NCT03207867|584512468|FG005|Overall Study|Physician Decision|0|||
161855810|NCT03207867|584512469|FG006|Overall Study|Physician Decision|0|||
161855811|NCT03207867|584512470|FG007|Overall Study|Physician Decision|0|||
161855812|NCT03207867|584512471|FG008|Overall Study|Physician Decision|4|||
161855813|NCT03207867|584512472|FG009|Overall Study|Physician Decision|2|||
161855814|NCT03207867|584512473|FG010|Overall Study|Physician Decision|0|||
161855815|NCT03207867|584512474|FG011|Overall Study|Physician Decision|4|||
161855816|NCT03207867|584512475|FG012|Overall Study|Physician Decision|0|||
161855817|NCT03207867|584512476|FG013|Overall Study|Physician Decision|0|||
161855818|NCT03207867|584512477|FG014|Overall Study|Physician Decision|2|||
161855819|NCT03207867|584512478|FG015|Overall Study|Physician Decision|1|||
161855820|NCT03207867|584512479|FG016|Overall Study|Physician Decision|1|||
161855821|NCT03207867|584512480|FG017|Overall Study|Physician Decision|2|||
161855822|NCT03207867|584512481|FG018|Overall Study|Physician Decision|1|||
161855823|NCT03207867|584512482|FG019|Overall Study|Physician Decision|3|||
161855824|NCT03207867|584512483|FG020|Overall Study|Physician Decision|0|||
161855825|NCT03207867|584512484|FG021|Overall Study|Physician Decision|0|||
161855826|NCT03207867|584512485|FG022|Overall Study|Physician Decision|0|||
161855827|NCT03207867|584512486|FG023|Overall Study|Physician Decision|0|||
161855828|NCT03207867|584512463|FG000|Overall Study|Progressive Disease|7|||
161855829|NCT03207867|584512464|FG001|Overall Study|Progressive Disease|7|||
161855830|NCT03207867|584512465|FG002|Overall Study|Progressive Disease|9|||
161855831|NCT03207867|584512466|FG003|Overall Study|Progressive Disease|10|||
161855832|NCT03207867|584512467|FG004|Overall Study|Progressive Disease|11|||
161855833|NCT03207867|584512468|FG005|Overall Study|Progressive Disease|10|||
161855834|NCT03207867|584512469|FG006|Overall Study|Progressive Disease|9|||
161855835|NCT03207867|584512470|FG007|Overall Study|Progressive Disease|8|||
161855836|NCT03207867|584512471|FG008|Overall Study|Progressive Disease|19|||
161855837|NCT03207867|584512472|FG009|Overall Study|Progressive Disease|23|||
161855838|NCT03207867|584512473|FG010|Overall Study|Progressive Disease|2|||
161855839|NCT03207867|584512474|FG011|Overall Study|Progressive Disease|24|||
161855840|NCT03207867|584512475|FG012|Overall Study|Progressive Disease|3|||
161855841|NCT03207867|584512476|FG013|Overall Study|Progressive Disease|11|||
161855842|NCT03207867|584512477|FG014|Overall Study|Progressive Disease|9|||
161855843|NCT03207867|584512478|FG015|Overall Study|Progressive Disease|5|||
161855844|NCT03207867|584512479|FG016|Overall Study|Progressive Disease|10|||
161855845|NCT03207867|584512480|FG017|Overall Study|Progressive Disease|14|||
161855846|NCT03207867|584512481|FG018|Overall Study|Progressive Disease|13|||
161855847|NCT03207867|584512482|FG019|Overall Study|Progressive Disease|14|||
161855848|NCT03207867|584512483|FG020|Overall Study|Progressive Disease|6|||
161855849|NCT03207867|584512484|FG021|Overall Study|Progressive Disease|3|||
161855850|NCT03207867|584512485|FG022|Overall Study|Progressive Disease|3|||
161855851|NCT03207867|584512486|FG023|Overall Study|Progressive Disease|3|||
161855852|NCT03207867|584512463|FG000|Overall Study|Patient/guardian Decision|0|||
161855853|NCT03207867|584512464|FG001|Overall Study|Patient/guardian Decision|0|||
161855854|NCT03207867|584512465|FG002|Overall Study|Patient/guardian Decision|1|||
161855855|NCT03207867|584512466|FG003|Overall Study|Patient/guardian Decision|1|||
161855856|NCT03207867|584512467|FG004|Overall Study|Patient/guardian Decision|1|||
161855857|NCT03207867|584512468|FG005|Overall Study|Patient/guardian Decision|2|||
161855858|NCT03207867|584512469|FG006|Overall Study|Patient/guardian Decision|1|||
161855859|NCT03207867|584512470|FG007|Overall Study|Patient/guardian Decision|0|||
161855860|NCT03207867|584512471|FG008|Overall Study|Patient/guardian Decision|1|||
161855861|NCT03207867|584512472|FG009|Overall Study|Patient/guardian Decision|0|||
161855862|NCT03207867|584512473|FG010|Overall Study|Patient/guardian Decision|0|||
161855863|NCT03207867|584512474|FG011|Overall Study|Patient/guardian Decision|1|||
161855864|NCT03207867|584512475|FG012|Overall Study|Patient/guardian Decision|0|||
161855865|NCT03207867|584512476|FG013|Overall Study|Patient/guardian Decision|1|||
161855866|NCT03207867|584512477|FG014|Overall Study|Patient/guardian Decision|2|||
161855867|NCT03207867|584512478|FG015|Overall Study|Patient/guardian Decision|0|||
161855868|NCT03207867|584512479|FG016|Overall Study|Patient/guardian Decision|1|||
161855869|NCT03207867|584512480|FG017|Overall Study|Patient/guardian Decision|3|||
161855870|NCT03207867|584512481|FG018|Overall Study|Patient/guardian Decision|4|||
161855871|NCT03207867|584512482|FG019|Overall Study|Patient/guardian Decision|1|||
161855872|NCT03207867|584512483|FG020|Overall Study|Patient/guardian Decision|0|||
161855873|NCT03207867|584512484|FG021|Overall Study|Patient/guardian Decision|0|||
161855874|NCT03207867|584512485|FG022|Overall Study|Patient/guardian Decision|0|||
161855875|NCT03207867|584512486|FG023|Overall Study|Patient/guardian Decision|0|||
161855876|NCT06473519|584514535|FG000|Overall Study|Lost to Follow-up|2|||
161855877|NCT06473519|584514536|FG001|Overall Study|Lost to Follow-up|5|||
161855878|NCT06473519|584514535|FG000|Overall Study|Withdrawal by Subject|1|||
161855879|NCT06473519|584514536|FG001|Overall Study|Withdrawal by Subject|4|||
161855880|NCT06473519|584514535|FG000|Overall Study|Randomized but not vaccinated|1|||
161855881|NCT06473519|584514536|FG001|Overall Study|Randomized but not vaccinated|2|||
161855882|NCT03560037|584514538|FG000|Overall Study|Protocol Violation|1|||
161855883|NCT03560037|584514539|FG001|Overall Study|Protocol Violation|0|||
161855884|NCT03560037|584514538|FG000|Overall Study|Physician Decision|0|||
161855885|NCT03560037|584514539|FG001|Overall Study|Physician Decision|1|||
161855886|NCT03620708|584514540|FG000|Overall Study|Lost to Follow-up|1|||
161855887|NCT03620708|584514541|FG001|Overall Study|Lost to Follow-up|1|||
161855888|NCT03620708|584514542|FG002|Overall Study|Lost to Follow-up|2|||
161855889|NCT03620708|584514540|FG000|Overall Study|Withdrawal by Subject|0|||
161855890|NCT03620708|584514541|FG001|Overall Study|Withdrawal by Subject|0|||
161855891|NCT03620708|584514542|FG002|Overall Study|Withdrawal by Subject|1|||
161855892|NCT02498613|584514543|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
161855893|NCT02498613|584514544|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
161855894|NCT02498613|584514545|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
161855895|NCT02498613|584514546|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
161855896|NCT02498613|584514543|FG000|Overall Study|Withdrawal by Subject|3|||
161855897|NCT02498613|584514544|FG001|Overall Study|Withdrawal by Subject|1|||
161855898|NCT02498613|584514545|FG002|Overall Study|Withdrawal by Subject|0|||
161855899|NCT02498613|584514546|FG003|Overall Study|Withdrawal by Subject|0|||
161855900|NCT05168202|584514547|FG000|Overall Study|Progressive Disease|4|||
161855901|NCT05168202|584514548|FG001|Overall Study|Progressive Disease|4|||
161855902|NCT05168202|584514549|FG002|Overall Study|Progressive Disease|2|||
161855903|NCT05168202|584514550|FG003|Overall Study|Progressive Disease|3|||
161855904|NCT05168202|584514551|FG004|Overall Study|Progressive Disease|2|||
161855905|NCT05168202|584514552|FG005|Overall Study|Progressive Disease|3|||
161855906|NCT05168202|584514553|FG006|Overall Study|Progressive Disease|2|||
161855907|NCT05168202|584514547|FG000|Overall Study|Adverse Event|2|||
161855908|NCT05168202|584514548|FG001|Overall Study|Adverse Event|1|||
161855909|NCT05168202|584514549|FG002|Overall Study|Adverse Event|4|||
161855910|NCT05168202|584514550|FG003|Overall Study|Adverse Event|4|||
161855911|NCT05168202|584514551|FG004|Overall Study|Adverse Event|3|||
161855912|NCT05168202|584514552|FG005|Overall Study|Adverse Event|2|||
161855913|NCT05168202|584514553|FG006|Overall Study|Adverse Event|0|||
161855914|NCT05168202|584514547|FG000|Overall Study|Lack of Efficacy|0|||
161855915|NCT05168202|584514548|FG001|Overall Study|Lack of Efficacy|1|||
161855916|NCT05168202|584514549|FG002|Overall Study|Lack of Efficacy|1|||
161855917|NCT05168202|584514550|FG003|Overall Study|Lack of Efficacy|0|||
161855918|NCT05168202|584514551|FG004|Overall Study|Lack of Efficacy|1|||
161855919|NCT05168202|584514552|FG005|Overall Study|Lack of Efficacy|2|||
161855920|NCT05168202|584514553|FG006|Overall Study|Lack of Efficacy|2|||
161855921|NCT05168202|584514547|FG000|Overall Study|Withdrawal by Subject|0|||
161855922|NCT05168202|584514548|FG001|Overall Study|Withdrawal by Subject|0|||
161855923|NCT05168202|584514549|FG002|Overall Study|Withdrawal by Subject|1|||
161855924|NCT05168202|584514550|FG003|Overall Study|Withdrawal by Subject|1|||
161855925|NCT05168202|584514551|FG004|Overall Study|Withdrawal by Subject|1|||
161855926|NCT05168202|584514552|FG005|Overall Study|Withdrawal by Subject|1|||
161855927|NCT05168202|584514553|FG006|Overall Study|Withdrawal by Subject|0|||
161855928|NCT05168202|584514547|FG000|Overall Study|Disease Relapse|0|||
161855929|NCT05168202|584514548|FG001|Overall Study|Disease Relapse|1|||
161855930|NCT05168202|584514549|FG002|Overall Study|Disease Relapse|0|||
161855931|NCT05168202|584514550|FG003|Overall Study|Disease Relapse|1|||
161855932|NCT05168202|584514551|FG004|Overall Study|Disease Relapse|1|||
161855933|NCT05168202|584514552|FG005|Overall Study|Disease Relapse|0|||
161855934|NCT05168202|584514553|FG006|Overall Study|Disease Relapse|0|||
161855935|NCT05168202|584514547|FG000|Overall Study|Other Reasons|0|||
161855936|NCT05168202|584514548|FG001|Overall Study|Other Reasons|0|||
161855937|NCT05168202|584514549|FG002|Overall Study|Other Reasons|0|||
161855938|NCT05168202|584514550|FG003|Overall Study|Other Reasons|0|||
161855939|NCT05168202|584514551|FG004|Overall Study|Other Reasons|0|||
161855940|NCT05168202|584514552|FG005|Overall Study|Other Reasons|2|||
161855941|NCT05168202|584514553|FG006|Overall Study|Other Reasons|1|||
161855942|NCT05168202|584514547|FG000|Overall Study|Physician Decision|0|||
161855943|NCT05168202|584514548|FG001|Overall Study|Physician Decision|1|||
161855944|NCT05168202|584514549|FG002|Overall Study|Physician Decision|1|||
161855945|NCT05168202|584514550|FG003|Overall Study|Physician Decision|0|||
161855946|NCT05168202|584514551|FG004|Overall Study|Physician Decision|0|||
161855947|NCT05168202|584514552|FG005|Overall Study|Physician Decision|0|||
161855948|NCT05168202|584514553|FG006|Overall Study|Physician Decision|0|||
161855949|NCT05168202|584514547|FG000|Overall Study|Study Terminated by Sponsor|0|||
161855950|NCT05168202|584514548|FG001|Overall Study|Study Terminated by Sponsor|0|||
161855951|NCT05168202|584514549|FG002|Overall Study|Study Terminated by Sponsor|0|||
161855952|NCT05168202|584514550|FG003|Overall Study|Study Terminated by Sponsor|1|||
161855953|NCT05168202|584514551|FG004|Overall Study|Study Terminated by Sponsor|0|||
161855954|NCT05168202|584514552|FG005|Overall Study|Study Terminated by Sponsor|0|||
161855955|NCT05168202|584514553|FG006|Overall Study|Study Terminated by Sponsor|0|||
161855956|NCT04011722|584514557|FG000|30 Days|Death|5|||
161855957|NCT04011722|584514558|FG001|30 Days|Death|1|||
161855958|NCT04011722|584514557|FG000|1 Year|Death|13|||
161855959|NCT04011722|584514558|FG001|1 Year|Death|5|||
161855960|NCT04011722|584514557|FG000|1 Year|Withdrawal by Subject|8|||
161855961|NCT04011722|584514558|FG001|1 Year|Withdrawal by Subject|2|||
161855962|NCT04011722|584514557|FG000|1 Year|Missed Visit|6|||
161855963|NCT04011722|584514558|FG001|1 Year|Missed Visit|1|||
161855964|NCT04011722|584514557|FG000|1 Year|Pending Visit|0|||
161855965|NCT04011722|584514558|FG001|1 Year|Pending Visit|11|||
161855966|NCT04011722|584514557|FG000|1 Year|Not Yet Due|0|||
161855967|NCT04011722|584514558|FG001|1 Year|Not Yet Due|9|||
161855968|NCT04011722|584514557|FG000|2 Year|Death|16|||
161855969|NCT04011722|584514558|FG001|2 Year|Death|1|||
161855970|NCT04011722|584514557|FG000|2 Year|Withdrawal by Subject|10|||
161855971|NCT04011722|584514558|FG001|2 Year|Withdrawal by Subject|1|||
161855972|NCT04011722|584514557|FG000|2 Year|Missed Visit|9|||
161855973|NCT04011722|584514558|FG001|2 Year|Missed Visit|0|||
161855974|NCT04011722|584514557|FG000|2 Year|Visit Pending|1|||
161855975|NCT04011722|584514558|FG001|2 Year|Visit Pending|3|||
161855976|NCT04011722|584514557|FG000|2 Year|Not Yet Due|43|||
161855977|NCT04011722|584514558|FG001|2 Year|Not Yet Due|54|||
161855978|NCT04011722|584514557|FG000|3 Year|Death|10|||
161855979|NCT04011722|584514558|FG001|3 Year|Death|0|||
161855980|NCT04011722|584514557|FG000|3 Year|Withdrawal by Subject|2|||
161855981|NCT04011722|584514558|FG001|3 Year|Withdrawal by Subject|0|||
161855982|NCT04011722|584514557|FG000|3 Year|Missed Visit|2|||
161855983|NCT04011722|584514558|FG001|3 Year|Missed Visit|0|||
161855984|NCT04011722|584514557|FG000|3 Year|Pending Visit|34|||
161855985|NCT04011722|584514558|FG001|3 Year|Pending Visit|0|||
161855986|NCT04011722|584514557|FG000|3 Year|Not Yet Due|99|||
161855987|NCT04011722|584514558|FG001|3 Year|Not Yet Due|0|||
161855988|NCT05626231|584514561|FG000|Provider Enrollment|Worked part-time|4|||
161855989|NCT05626231|584514561|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
161855990|NCT05626231|584514561|FG000|Provider Enrollment|Non-clinical employee|1|||
161855991|NCT05626231|584514561|FG000|Provider Enrollment|Provider does not see clients|3|||
161855992|NCT05626231|584514561|FG000|Provider Enrollment|Other|5|||
161855993|NCT06195930|584514562|FG000|Overall Study|Adverse Event|4|||
161855994|NCT00233948|584514569|FG000|Overall Study|Adverse Event|1|||
161855995|NCT00233948|584514570|FG001|Overall Study|Adverse Event|0|||
161855996|NCT00233948|584514571|FG002|Overall Study|Adverse Event|0|||
161855997|NCT00233948|584514572|FG003|Overall Study|Adverse Event|0|||
161855998|NCT00233948|584514573|FG004|Overall Study|Adverse Event|0|||
161855999|NCT00233948|584514574|FG005|Overall Study|Adverse Event|0|||
161856000|NCT01567462|584514575|FG000|Overall Study|Withdrawal by Subject|4|||
161856001|NCT01567462|584514576|FG001|Overall Study|Withdrawal by Subject|7|||
161856002|NCT02548156|584514577|FG000|Washout Period 1|Lost to Follow-up|0|||
161856003|NCT02548156|584514578|FG001|Washout Period 1|Lost to Follow-up|0|||
161856004|NCT02548156|584514579|FG002|Washout Period 1|Lost to Follow-up|0|||
161856005|NCT02548156|584514580|FG003|Washout Period 1|Lost to Follow-up|0|||
161856006|NCT02548156|584514581|FG004|Washout Period 1|Lost to Follow-up|1|||
161856007|NCT02548156|584514582|FG005|Washout Period 1|Lost to Follow-up|0|||
161856008|NCT00444587|584514583|FG000|Overall Study|Death|2|||
161856009|NCT00444587|584514584|FG001|Overall Study|Death|1|||
161856010|NCT00444587|584514583|FG000|Overall Study|Progression of the disease|73|||
161856011|NCT00444587|584514584|FG001|Overall Study|Progression of the disease|8|||
161856012|NCT00444587|584514583|FG000|Overall Study|Refused treatment/did not cooperate|4|||
161856013|NCT00444587|584514584|FG001|Overall Study|Refused treatment/did not cooperate|1|||
161856014|NCT00444587|584514583|FG000|Overall Study|Investigator decision|3|||
161856015|NCT00444587|584514584|FG001|Overall Study|Investigator decision|0|||
161856016|NCT00444587|584514583|FG000|Overall Study|Protocol Violation|1|||
161856017|NCT00444587|584514584|FG001|Overall Study|Protocol Violation|0|||
161856018|NCT00444587|584514583|FG000|Overall Study|Missing|0|||
161856019|NCT00444587|584514584|FG001|Overall Study|Missing|5|||
161856020|NCT00196326|584514585|FG000|Overall Study|Did not meet protocol requirements|64|||
161856021|NCT00196326|584514585|FG000|Overall Study|Non-compliance with the protocol|81|||
161856022|NCT00196326|584514585|FG000|Overall Study|Physician Decision|3|||
161856023|NCT00196326|584514585|FG000|Overall Study|Withdrawal by Subject|225|||
161856024|NCT00196326|584514585|FG000|Overall Study|Adverse Event|253|||
161856025|NCT00196326|584514585|FG000|Overall Study|Pregnancy|34|||
161856026|NCT00196326|584514585|FG000|Overall Study|Lost to Follow-up|304|||
161856027|NCT00196326|584514585|FG000|Overall Study|Other|22|||
161856028|NCT01720225|584514594|FG000|Overall Study|Withdrawal by Subject|0|||
161856029|NCT01720225|584514595|FG001|Overall Study|Withdrawal by Subject|1|||
161856030|NCT01720225|584514594|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
161856031|NCT01720225|584514595|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
161856032|NCT05223920|584514596|FG000|Overall Study|Adverse Event|6|||
161856033|NCT05223920|584514597|FG001|Overall Study|Adverse Event|3|||
161856034|NCT05223920|584514596|FG000|Overall Study|Death|2|||
161856035|NCT05223920|584514597|FG001|Overall Study|Death|0|||
161856036|NCT05223920|584514596|FG000|Overall Study|Disease Progression|1|||
161856037|NCT05223920|584514597|FG001|Overall Study|Disease Progression|2|||
161856038|NCT05223920|584514596|FG000|Overall Study|Physician Decision|1|||
161856039|NCT05223920|584514597|FG001|Overall Study|Physician Decision|2|||
161856040|NCT05223920|584514596|FG000|Overall Study|Sponsor decision|11|||
161856041|NCT05223920|584514597|FG001|Overall Study|Sponsor decision|9|||
161856042|NCT05223920|584514596|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
161856043|NCT05223920|584514597|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
161856044|NCT05223920|584514596|FG000|Overall Study|Subject decision|1|||
161856045|NCT05223920|584514597|FG001|Overall Study|Subject decision|0|||
161856046|NCT05223920|584514596|FG000|Overall Study|Withdrawal by Subject|1|||
161856047|NCT05223920|584514597|FG001|Overall Study|Withdrawal by Subject|6|||
161856048|NCT00369941|584514598|FG000|Overall Study|Never Treated|1|||
161856049|NCT00369941|584514599|FG001|Overall Study|Never Treated|2|||
161856050|NCT00369941|584514598|FG000|Overall Study|Adverse Event|14|||
161856051|NCT00369941|584514599|FG001|Overall Study|Adverse Event|28|||
161856052|NCT00369941|584514598|FG000|Overall Study|Lack of Efficacy|6|||
161856053|NCT00369941|584514599|FG001|Overall Study|Lack of Efficacy|10|||
161856054|NCT00369941|584514598|FG000|Overall Study|Lost to Follow-up|12|||
161856055|NCT00369941|584514599|FG001|Overall Study|Lost to Follow-up|22|||
161856056|NCT00369941|584514598|FG000|Overall Study|Protocol Violation|5|||
161856057|NCT00369941|584514599|FG001|Overall Study|Protocol Violation|3|||
161856058|NCT00369941|584514598|FG000|Overall Study|Withdrawal by Subject|5|||
161856059|NCT00369941|584514599|FG001|Overall Study|Withdrawal by Subject|18|||
161856060|NCT00369941|584514598|FG000|Overall Study|Pregnancy|4|||
161856061|NCT00369941|584514599|FG001|Overall Study|Pregnancy|2|||
161856062|NCT00369941|584514598|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
161856063|NCT00369941|584514599|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
161856064|NCT00369941|584514598|FG000|Overall Study|Moved|11|||
161856065|NCT00369941|584514599|FG001|Overall Study|Moved|5|||
161856066|NCT00369941|584514598|FG000|Overall Study|Treatment with Prohibited Medication|3|||
161856067|NCT00369941|584514599|FG001|Overall Study|Treatment with Prohibited Medication|1|||
161856068|NCT00369941|584514598|FG000|Overall Study|Employment Interfered with Study Visits|1|||
161856069|NCT00369941|584514599|FG001|Overall Study|Employment Interfered with Study Visits|0|||
161856070|NCT00369941|584514598|FG000|Overall Study|Study Site Terminated|2|||
161856071|NCT00369941|584514599|FG001|Overall Study|Study Site Terminated|0|||
161856072|NCT00369941|584514598|FG000|Overall Study|Miscellaneous|3|||
161856073|NCT00369941|584514599|FG001|Overall Study|Miscellaneous|3|||
161856074|NCT00661193|584514600|FG000|Overall Study|Adverse Event|2|||
161856075|NCT00661193|584514601|FG001|Overall Study|Adverse Event|1|||
161856076|NCT00661193|584514600|FG000|Overall Study|Withdrawal by Subject|3|||
161856077|NCT00661193|584514601|FG001|Overall Study|Withdrawal by Subject|1|||
161856078|NCT00661193|584514600|FG000|Overall Study|Progression|27|||
161856079|NCT00661193|584514601|FG001|Overall Study|Progression|24|||
161856080|NCT00661193|584514600|FG000|Overall Study|Not protocol specified|1|||
161856081|NCT00661193|584514601|FG001|Overall Study|Not protocol specified|0|||
161856082|NCT02964312|584514602|FG000|Overall Study|Lost to Follow-up|28|||
161856083|NCT02964312|584514602|FG000|Overall Study|Withdrawal by Subject|11|||
161856084|NCT02964312|584514602|FG000|Overall Study|Lack of Efficacy|10|||
161856085|NCT02964312|584514602|FG000|Overall Study|Did not consent to long-term FU|14|||
161856086|NCT02964312|584514602|FG000|Overall Study|Death|1|||
161856087|NCT03288714|584514609|FG000|Overall Study|Lost to Follow-up|2|||
161856088|NCT03288714|584514610|FG001|Overall Study|Lost to Follow-up|1|||
161856089|NCT03288714|584514609|FG000|Overall Study|Non-compliance with study schedule|2|||
161856090|NCT03288714|584514610|FG001|Overall Study|Non-compliance with study schedule|0|||
161856091|NCT03288714|584514609|FG000|Overall Study|Withdrawal by Subject|3|||
161856092|NCT03288714|584514610|FG001|Overall Study|Withdrawal by Subject|1|||
161856093|NCT03288714|584514609|FG000|Overall Study|Clinical Worsening|2|||
161856094|NCT03288714|584514610|FG001|Overall Study|Clinical Worsening|1|||
161856095|NCT03288714|584514609|FG000|Overall Study|Adverse Event|1|||
161856096|NCT03288714|584514610|FG001|Overall Study|Adverse Event|0|||
161856097|NCT03280264|584514611|FG000|Overall Study|Adverse Event|1|||
161856098|NCT03280264|584514611|FG000|Overall Study|Physician Decision|1|||
161856099|NCT03280264|584514611|FG000|Overall Study|Withdrawal by Subject|1|||
161856100|NCT00524420|584514619|FG000|Overall Study|Lack of Efficacy|1|||
161856101|NCT00524420|584514620|FG001|Overall Study|Lack of Efficacy|0|||
161856102|NCT00577863|584514621|FG000|Overall Study|Adverse Event|4|||
161856103|NCT00577863|584514622|FG001|Overall Study|Adverse Event|2|||
161856104|NCT00577863|584514621|FG000|Overall Study|Death|1|||
161856105|NCT00577863|584514622|FG001|Overall Study|Death|0|||
161856106|NCT00577863|584514621|FG000|Overall Study|Lost to Follow-up|2|||
161856107|NCT00577863|584514622|FG001|Overall Study|Lost to Follow-up|2|||
161856108|NCT00577863|584514621|FG000|Overall Study|Entry Criteria Exclusion|1|||
161856109|NCT00577863|584514622|FG001|Overall Study|Entry Criteria Exclusion|0|||
161856110|NCT00577863|584514621|FG000|Overall Study|Withdrawal by Subject|0|||
161856111|NCT00577863|584514622|FG001|Overall Study|Withdrawal by Subject|2|||
161856112|NCT00577863|584514621|FG000|Overall Study|Sponsor Decision|2|||
161856113|NCT00577863|584514622|FG001|Overall Study|Sponsor Decision|7|||
161856114|NCT00577863|584514621|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
161856115|NCT00577863|584514622|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
161856116|NCT02738138|584514626|FG000|Overall Study|Adverse Event|0|||
161856117|NCT02738138|584514627|FG001|Overall Study|Adverse Event|1|||
161856118|NCT02738138|584514626|FG000|Overall Study|Lost to Follow-up|2|||
161856119|NCT02738138|584514627|FG001|Overall Study|Lost to Follow-up|0|||
161856120|NCT02738138|584514626|FG000|Overall Study|Other - not further specified|1|||
161856121|NCT02738138|584514627|FG001|Overall Study|Other - not further specified|0|||
161856122|NCT01960257|584514631|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
161856123|NCT01960257|584514632|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
161856124|NCT01960257|584514633|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
161856125|NCT01960257|584514631|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
161856126|NCT01960257|584514632|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
161856127|NCT01960257|584514633|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
161856128|NCT01960257|584514631|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
161856129|NCT01960257|584514632|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
161856130|NCT01960257|584514633|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
161856131|NCT02038010|584514634|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161856132|NCT02038010|584514635|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
161856133|NCT02038010|584514636|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161856134|NCT02038010|584514637|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161856135|NCT02038010|584514634|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
161856136|NCT02038010|584514635|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161856137|NCT02038010|584514636|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161856138|NCT02038010|584514637|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161856139|NCT02038010|584514634|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161856140|NCT02038010|584514635|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
161856141|NCT02038010|584514636|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161856142|NCT02038010|584514637|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161856143|NCT02038010|584514634|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
161856144|NCT02038010|584514635|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
161856145|NCT02038010|584514636|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
161856146|NCT02038010|584514637|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
161856147|NCT02038010|584514634|FG000|Follow Up|Death|4|||
161856148|NCT02038010|584514635|FG001|Follow Up|Death|3|||
161856149|NCT02038010|584514636|FG002|Follow Up|Death|0|||
161856150|NCT02038010|584514637|FG003|Follow Up|Death|0|||
161856151|NCT02038010|584514634|FG000|Follow Up|Other|3|||
161856152|NCT02038010|584514635|FG001|Follow Up|Other|0|||
161856153|NCT02038010|584514636|FG002|Follow Up|Other|0|||
161856154|NCT02038010|584514637|FG003|Follow Up|Other|0|||
161856155|NCT00958828|584514643|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
161856156|NCT00958828|584514644|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
161856157|NCT00958828|584514643|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
161856158|NCT00958828|584514644|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
161856159|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
161856160|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
161856161|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
161856162|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
161856163|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
161856164|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
161856165|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
161856166|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
161856167|NCT00535405|584514657|FG000|Overall Study|Adverse Event|6|||
161856168|NCT00535405|584514658|FG001|Overall Study|Adverse Event|8|||
161856169|NCT00535405|584514659|FG002|Overall Study|Adverse Event|3|||
161856170|NCT00535405|584514660|FG003|Overall Study|Adverse Event|8|||
161856171|NCT00535405|584514661|FG004|Overall Study|Adverse Event|6|||
161856172|NCT00535405|584514657|FG000|Overall Study|Lost to Follow-up|1|||
161856173|NCT00535405|584514658|FG001|Overall Study|Lost to Follow-up|3|||
161856174|NCT00535405|584514659|FG002|Overall Study|Lost to Follow-up|3|||
161856175|NCT00535405|584514660|FG003|Overall Study|Lost to Follow-up|2|||
161856176|NCT00535405|584514661|FG004|Overall Study|Lost to Follow-up|1|||
161856177|NCT00535405|584514657|FG000|Overall Study|Physician Decision|3|||
161856178|NCT00535405|584514658|FG001|Overall Study|Physician Decision|2|||
161856179|NCT00535405|584514659|FG002|Overall Study|Physician Decision|0|||
161856180|NCT00535405|584514660|FG003|Overall Study|Physician Decision|1|||
161856181|NCT00535405|584514661|FG004|Overall Study|Physician Decision|1|||
161856182|NCT00535405|584514657|FG000|Overall Study|Protocol Violation|2|||
161856183|NCT00535405|584514658|FG001|Overall Study|Protocol Violation|2|||
161856184|NCT00535405|584514659|FG002|Overall Study|Protocol Violation|2|||
161856185|NCT00535405|584514660|FG003|Overall Study|Protocol Violation|1|||
161856186|NCT00535405|584514661|FG004|Overall Study|Protocol Violation|0|||
161856187|NCT00535405|584514657|FG000|Overall Study|Withdrawal by Subject|5|||
161856188|NCT00535405|584514658|FG001|Overall Study|Withdrawal by Subject|11|||
161856189|NCT00535405|584514659|FG002|Overall Study|Withdrawal by Subject|10|||
161856190|NCT00535405|584514660|FG003|Overall Study|Withdrawal by Subject|10|||
161856191|NCT00535405|584514661|FG004|Overall Study|Withdrawal by Subject|8|||
161856192|NCT03910673|584514665|FG000|Overall Study|Adverse Event|0|||
161856193|NCT03910673|584514666|FG001|Overall Study|Adverse Event|0|||
161856194|NCT03910673|584514667|FG002|Overall Study|Adverse Event|0|||
161856195|NCT03910673|584514668|FG003|Overall Study|Adverse Event|2|||
161856196|NCT03910673|584514669|FG004|Overall Study|Adverse Event|0|||
161856197|NCT04650204|584514685|FG000|Overall Study|Study was Terminated|2|||
161856198|NCT04650204|584514686|FG001|Overall Study|Study was Terminated|1|||
161856199|NCT03164616|584514687|FG000|Overall Study|Death|250|||
161856200|NCT03164616|584514688|FG001|Overall Study|Death|264|||
161856201|NCT03164616|584514689|FG002|Overall Study|Death|279|||
161856202|NCT03164616|584514687|FG000|Overall Study|Lost to Follow-up|2|||
161856203|NCT03164616|584514688|FG001|Overall Study|Lost to Follow-up|2|||
161856204|NCT03164616|584514689|FG002|Overall Study|Lost to Follow-up|2|||
161856205|NCT03164616|584514687|FG000|Overall Study|Withdrawal by Subject|6|||
161856206|NCT03164616|584514688|FG001|Overall Study|Withdrawal by Subject|7|||
161856207|NCT03164616|584514689|FG002|Overall Study|Withdrawal by Subject|16|||
161856208|NCT01911273|584514691|FG000|Overall Study|Progression of Disease|1|||
161856209|NCT01911273|584514692|FG001|Overall Study|Progression of Disease|0|||
161856210|NCT01911273|584514691|FG000|Overall Study|Withdrawal by Subject|0|||
161856211|NCT01911273|584514692|FG001|Overall Study|Withdrawal by Subject|2|||
161856212|NCT02503787|584514697|FG000|Enrollment|Withdrawal by Subject|6|||
161856213|NCT02503787|584514697|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
161856214|NCT02503787|584514697|FG000|Enrollment|Physician Decision|2|||
161856215|NCT02503787|584514697|FG000|Enrollment|Insurance issue|2|||
161856216|NCT02503787|584514697|FG000|Enrollment|Lost to Follow-up|1|||
161856217|NCT02503787|584514697|FG000|Enrollment|Study closure|1|||
161856218|NCT02503787|584514697|FG000|Enrollment|Adverse Event|1|||
161856219|NCT02503787|584514697|FG000|Enrollment|Protocol Violation|1|||
161856220|NCT02503787|584514697|FG000|Enrollment|Inability to implant system|1|||
161856221|NCT02503787|584514697|FG000|Enrollment|Unable to be programmed|1|||
161856222|NCT02503787|584514697|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
161856223|NCT02503787|584514697|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
161856224|NCT02503787|584514697|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
161856225|NCT02503787|584514697|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
161856226|NCT02503787|584514697|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
161856227|NCT02503787|584514697|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
161856228|NCT04787627|584514698|FG000|Overall Study|Withdrawal by Subject|3|||
161856229|NCT04787627|584514699|FG001|Overall Study|Withdrawal by Subject|0|||
161856230|NCT04787627|584514698|FG000|Overall Study|Physician Decision|2|||
161856231|NCT04787627|584514699|FG001|Overall Study|Physician Decision|0|||
161856232|NCT04787627|584514698|FG000|Overall Study|Excluded|0|||
161856233|NCT04787627|584514699|FG001|Overall Study|Excluded|1|||
161856234|NCT00174954|584514702|FG000|Overall Study|Adverse Event|2|||
161856235|NCT00174954|584514702|FG000|Overall Study|No tophi found in MRI|1|||
161856236|NCT00174954|584514702|FG000|Overall Study|Physician Decision|1|||
161856237|NCT00839254|584514703|FG000|Overall Study|Protocol Violation|0|||
161856238|NCT00839254|584514704|FG001|Overall Study|Protocol Violation|1|||
161856239|NCT00839254|584514705|FG002|Overall Study|Protocol Violation|1|||
161856240|NCT00839254|584514706|FG003|Overall Study|Protocol Violation|1|||
161856241|NCT00839254|584514707|FG004|Overall Study|Protocol Violation|0|||
161856242|NCT00839254|584514708|FG005|Overall Study|Protocol Violation|0|||
161856243|NCT00839254|584514709|FG006|Overall Study|Protocol Violation|1|||
161856244|NCT00839254|584514710|FG007|Overall Study|Protocol Violation|2|||
161856245|NCT00839254|584514703|FG000|Overall Study|Physician Decision|0|||
161856246|NCT00839254|584514704|FG001|Overall Study|Physician Decision|1|||
161856247|NCT00839254|584514705|FG002|Overall Study|Physician Decision|0|||
161856248|NCT00839254|584514706|FG003|Overall Study|Physician Decision|0|||
161856249|NCT00839254|584514707|FG004|Overall Study|Physician Decision|0|||
161856250|NCT00839254|584514708|FG005|Overall Study|Physician Decision|0|||
161856251|NCT00839254|584514709|FG006|Overall Study|Physician Decision|0|||
161856252|NCT00839254|584514710|FG007|Overall Study|Physician Decision|1|||
161856253|NCT00839254|584514703|FG000|Overall Study|Wrong treatment number allocation|0|||
161856254|NCT00839254|584514704|FG001|Overall Study|Wrong treatment number allocation|1|||
161856255|NCT00839254|584514705|FG002|Overall Study|Wrong treatment number allocation|0|||
161856256|NCT00839254|584514706|FG003|Overall Study|Wrong treatment number allocation|0|||
161856257|NCT00839254|584514707|FG004|Overall Study|Wrong treatment number allocation|0|||
161856258|NCT00839254|584514708|FG005|Overall Study|Wrong treatment number allocation|1|||
161856259|NCT00839254|584514709|FG006|Overall Study|Wrong treatment number allocation|0|||
161856260|NCT00839254|584514710|FG007|Overall Study|Wrong treatment number allocation|0|||
161856261|NCT00839254|584514703|FG000|Overall Study|Adverse Event|12|||
161856262|NCT00839254|584514704|FG001|Overall Study|Adverse Event|6|||
161856263|NCT00839254|584514705|FG002|Overall Study|Adverse Event|3|||
161856264|NCT00839254|584514706|FG003|Overall Study|Adverse Event|5|||
161856265|NCT00839254|584514707|FG004|Overall Study|Adverse Event|2|||
161856266|NCT00839254|584514708|FG005|Overall Study|Adverse Event|1|||
161856267|NCT00839254|584514709|FG006|Overall Study|Adverse Event|0|||
161856268|NCT00839254|584514710|FG007|Overall Study|Adverse Event|1|||
161856269|NCT00839254|584514703|FG000|Overall Study|Withdrawal by Subject|87|||
161856270|NCT00839254|584514704|FG001|Overall Study|Withdrawal by Subject|53|||
161856271|NCT00839254|584514705|FG002|Overall Study|Withdrawal by Subject|54|||
161856272|NCT00839254|584514706|FG003|Overall Study|Withdrawal by Subject|32|||
161856273|NCT00839254|584514707|FG004|Overall Study|Withdrawal by Subject|27|||
161856274|NCT00839254|584514708|FG005|Overall Study|Withdrawal by Subject|15|||
161856275|NCT00839254|584514709|FG006|Overall Study|Withdrawal by Subject|22|||
161856276|NCT00839254|584514710|FG007|Overall Study|Withdrawal by Subject|9|||
161856277|NCT00839254|584514703|FG000|Overall Study|Wrong group allocation|0|||
161856278|NCT00839254|584514704|FG001|Overall Study|Wrong group allocation|0|||
161856279|NCT00839254|584514705|FG002|Overall Study|Wrong group allocation|0|||
161856280|NCT00839254|584514706|FG003|Overall Study|Wrong group allocation|0|||
161856281|NCT00839254|584514707|FG004|Overall Study|Wrong group allocation|0|||
161856282|NCT00839254|584514708|FG005|Overall Study|Wrong group allocation|0|||
161856283|NCT00839254|584514709|FG006|Overall Study|Wrong group allocation|1|||
161856284|NCT00839254|584514710|FG007|Overall Study|Wrong group allocation|0|||
161856285|NCT00839254|584514703|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
161856286|NCT00839254|584514704|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856287|NCT00839254|584514705|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856288|NCT00839254|584514706|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856289|NCT00839254|584514707|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856290|NCT00839254|584514708|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
161856291|NCT00839254|584514709|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856292|NCT00839254|584514710|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856293|NCT00839254|584514703|FG000|Overall Study|Withdrawn due to non-compliance|2|||
161856294|NCT00839254|584514704|FG001|Overall Study|Withdrawn due to non-compliance|0|||
161856295|NCT00839254|584514705|FG002|Overall Study|Withdrawn due to non-compliance|0|||
161856296|NCT00839254|584514706|FG003|Overall Study|Withdrawn due to non-compliance|0|||
161856297|NCT00839254|584514707|FG004|Overall Study|Withdrawn due to non-compliance|0|||
161856298|NCT00839254|584514708|FG005|Overall Study|Withdrawn due to non-compliance|0|||
161856299|NCT00839254|584514709|FG006|Overall Study|Withdrawn due to non-compliance|0|||
161856300|NCT00839254|584514710|FG007|Overall Study|Withdrawn due to non-compliance|0|||
161856301|NCT00839254|584514703|FG000|Overall Study|Lost to Follow-up|51|||
161856302|NCT00839254|584514704|FG001|Overall Study|Lost to Follow-up|30|||
161856303|NCT00839254|584514705|FG002|Overall Study|Lost to Follow-up|32|||
161856304|NCT00839254|584514706|FG003|Overall Study|Lost to Follow-up|24|||
161856305|NCT00839254|584514707|FG004|Overall Study|Lost to Follow-up|8|||
161856306|NCT00839254|584514708|FG005|Overall Study|Lost to Follow-up|8|||
161856307|NCT00839254|584514709|FG006|Overall Study|Lost to Follow-up|4|||
161856308|NCT00839254|584514710|FG007|Overall Study|Lost to Follow-up|2|||
161856309|NCT04597632|584514711|FG000|Overall Study|Withdrawal by Subject|10|||
161856310|NCT04597632|584514711|FG000|Overall Study|Lost to Follow-up|1|||
161856311|NCT04597632|584514711|FG000|Overall Study|Death|1|||
161856312|NCT04597632|584514711|FG000|Overall Study|Adverse Event|5|||
161856313|NCT01823835|584514712|FG000|Overall Study|Adverse Event|0|||
161856314|NCT01823835|584514713|FG001|Overall Study|Adverse Event|0|||
161856315|NCT01823835|584514714|FG002|Overall Study|Adverse Event|0|||
161856316|NCT01823835|584514715|FG003|Overall Study|Adverse Event|0|||
161856317|NCT01823835|584514716|FG004|Overall Study|Adverse Event|1|||
161856318|NCT01823835|584514717|FG005|Overall Study|Adverse Event|0|||
161856319|NCT01823835|584514718|FG006|Overall Study|Adverse Event|1|||
161856320|NCT01823835|584514719|FG007|Overall Study|Adverse Event|0|||
161856321|NCT01823835|584514720|FG008|Overall Study|Adverse Event|0|||
161856322|NCT01823835|584514721|FG009|Overall Study|Adverse Event|0|||
161856323|NCT01823835|584514722|FG010|Overall Study|Adverse Event|1|||
161856324|NCT01823835|584514723|FG011|Overall Study|Adverse Event|2|||
161856325|NCT01823835|584514724|FG012|Overall Study|Adverse Event|0|||
161856326|NCT01823835|584514725|FG013|Overall Study|Adverse Event|0|||
161856327|NCT01823835|584514726|FG014|Overall Study|Adverse Event|0|||
161856328|NCT01823835|584514712|FG000|Overall Study|Physician Decision|0|||
161856329|NCT01823835|584514713|FG001|Overall Study|Physician Decision|0|||
161856330|NCT01823835|584514714|FG002|Overall Study|Physician Decision|0|||
161856331|NCT01823835|584514715|FG003|Overall Study|Physician Decision|0|||
161856332|NCT01823835|584514716|FG004|Overall Study|Physician Decision|0|||
161856333|NCT01823835|584514717|FG005|Overall Study|Physician Decision|0|||
161856334|NCT01823835|584514718|FG006|Overall Study|Physician Decision|0|||
161856335|NCT01823835|584514719|FG007|Overall Study|Physician Decision|0|||
161856336|NCT01823835|584514720|FG008|Overall Study|Physician Decision|0|||
161856337|NCT01823835|584514721|FG009|Overall Study|Physician Decision|0|||
161856338|NCT01823835|584514722|FG010|Overall Study|Physician Decision|0|||
161856339|NCT01823835|584514723|FG011|Overall Study|Physician Decision|2|||
161856340|NCT01823835|584514724|FG012|Overall Study|Physician Decision|0|||
161856341|NCT01823835|584514725|FG013|Overall Study|Physician Decision|0|||
161856342|NCT01823835|584514726|FG014|Overall Study|Physician Decision|0|||
161856343|NCT01823835|584514712|FG000|Overall Study|Progressive Disease|3|||
161856344|NCT01823835|584514713|FG001|Overall Study|Progressive Disease|4|||
161856345|NCT01823835|584514714|FG002|Overall Study|Progressive Disease|3|||
161856346|NCT01823835|584514715|FG003|Overall Study|Progressive Disease|6|||
161856347|NCT01823835|584514716|FG004|Overall Study|Progressive Disease|4|||
161856348|NCT01823835|584514717|FG005|Overall Study|Progressive Disease|6|||
161856349|NCT01823835|584514718|FG006|Overall Study|Progressive Disease|5|||
161856350|NCT01823835|584514719|FG007|Overall Study|Progressive Disease|3|||
161856351|NCT01823835|584514720|FG008|Overall Study|Progressive Disease|3|||
161856352|NCT01823835|584514721|FG009|Overall Study|Progressive Disease|18|||
161856353|NCT01823835|584514722|FG010|Overall Study|Progressive Disease|8|||
161856354|NCT01823835|584514723|FG011|Overall Study|Progressive Disease|46|||
161856355|NCT01823835|584514724|FG012|Overall Study|Progressive Disease|18|||
161856356|NCT01823835|584514725|FG013|Overall Study|Progressive Disease|4|||
161856357|NCT01823835|584514726|FG014|Overall Study|Progressive Disease|6|||
161856358|NCT01823835|584514712|FG000|Overall Study|Study Termination|0|||
161856359|NCT01823835|584514713|FG001|Overall Study|Study Termination|0|||
161856360|NCT01823835|584514714|FG002|Overall Study|Study Termination|0|||
161856361|NCT01823835|584514715|FG003|Overall Study|Study Termination|0|||
161856362|NCT01823835|584514716|FG004|Overall Study|Study Termination|1|||
161856363|NCT01823835|584514717|FG005|Overall Study|Study Termination|0|||
161856364|NCT01823835|584514718|FG006|Overall Study|Study Termination|0|||
161856365|NCT01823835|584514719|FG007|Overall Study|Study Termination|0|||
161856366|NCT01823835|584514720|FG008|Overall Study|Study Termination|0|||
161856367|NCT01823835|584514721|FG009|Overall Study|Study Termination|0|||
161856368|NCT01823835|584514722|FG010|Overall Study|Study Termination|0|||
161856369|NCT01823835|584514723|FG011|Overall Study|Study Termination|1|||
161856370|NCT01823835|584514724|FG012|Overall Study|Study Termination|0|||
161856371|NCT01823835|584514725|FG013|Overall Study|Study Termination|0|||
161856372|NCT01823835|584514726|FG014|Overall Study|Study Termination|0|||
161856373|NCT01823835|584514712|FG000|Overall Study|Withdrawal by Subject|0|||
161856374|NCT01823835|584514713|FG001|Overall Study|Withdrawal by Subject|0|||
161856375|NCT01823835|584514714|FG002|Overall Study|Withdrawal by Subject|1|||
161856376|NCT01823835|584514715|FG003|Overall Study|Withdrawal by Subject|0|||
161856377|NCT01823835|584514716|FG004|Overall Study|Withdrawal by Subject|0|||
161856378|NCT01823835|584514717|FG005|Overall Study|Withdrawal by Subject|0|||
161856379|NCT01823835|584514718|FG006|Overall Study|Withdrawal by Subject|0|||
161856380|NCT01823835|584514719|FG007|Overall Study|Withdrawal by Subject|0|||
161856381|NCT01823835|584514720|FG008|Overall Study|Withdrawal by Subject|0|||
161856382|NCT01823835|584514721|FG009|Overall Study|Withdrawal by Subject|1|||
161856383|NCT01823835|584514722|FG010|Overall Study|Withdrawal by Subject|1|||
161856384|NCT01823835|584514723|FG011|Overall Study|Withdrawal by Subject|2|||
161856385|NCT01823835|584514724|FG012|Overall Study|Withdrawal by Subject|1|||
161856386|NCT01823835|584514725|FG013|Overall Study|Withdrawal by Subject|0|||
161856387|NCT01823835|584514726|FG014|Overall Study|Withdrawal by Subject|0|||
161856388|NCT00509795|584514727|FG000|Overall Study|Adverse Event|4|||
161856389|NCT00509795|584514728|FG001|Overall Study|Adverse Event|3|||
161856390|NCT00509795|584514729|FG002|Overall Study|Adverse Event|5|||
161856391|NCT00509795|584514730|FG003|Overall Study|Adverse Event|4|||
161856392|NCT00509795|584514727|FG000|Overall Study|Death|3|||
161769122|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769123|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769124|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769125|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Other|1|||
161769126|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Other|0|||
161769127|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Other|0|||
161769128|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Other|0|||
161769129|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Other|0|||
161769130|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Other|0|||
161769131|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Other|0|||
161769132|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Other|0|||
161769133|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Other|0|||
161769134|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Other|0|||
161769135|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Other|0|||
161769136|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Other|0|||
161769137|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769138|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
161769139|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769140|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769141|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769142|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769143|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769144|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769145|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769146|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769147|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769148|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769149|NCT05602818|584196086|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
161769150|NCT05602818|584196087|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
161769151|NCT05602818|584196088|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
161769152|NCT05602818|584196089|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
161769153|NCT05602818|584196090|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
161769154|NCT05602818|584196091|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
161769155|NCT05602818|584196092|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
161769156|NCT05602818|584196093|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
161769157|NCT05602818|584196094|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
161769158|NCT05602818|584196095|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
161769159|NCT05602818|584196096|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
161769160|NCT05602818|584196097|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
161769161|NCT05602818|584196086|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769162|NCT05602818|584196087|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769163|NCT05602818|584196088|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769164|NCT05602818|584196089|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769165|NCT05602818|584196090|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769166|NCT05602818|584196091|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769167|NCT05602818|584196092|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769168|NCT05602818|584196093|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769169|NCT05602818|584196094|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769170|NCT05602818|584196095|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769171|NCT05602818|584196096|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
161769172|NCT05602818|584196097|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
161769173|NCT05602818|584196086|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
161769174|NCT05602818|584196087|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
161769175|NCT05602818|584196088|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
161769176|NCT05602818|584196089|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
161769177|NCT05602818|584196090|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
161769178|NCT05602818|584196091|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
161769179|NCT05602818|584196092|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
161769180|NCT05602818|584196093|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
161769181|NCT05602818|584196094|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
161856393|NCT00509795|584514728|FG001|Overall Study|Death|1|||
161856394|NCT00509795|584514729|FG002|Overall Study|Death|2|||
161856395|NCT00509795|584514730|FG003|Overall Study|Death|7|||
161856396|NCT00509795|584514727|FG000|Overall Study|Lack of Efficacy|0|||
161856397|NCT00509795|584514728|FG001|Overall Study|Lack of Efficacy|0|||
161856398|NCT00509795|584514729|FG002|Overall Study|Lack of Efficacy|2|||
161856399|NCT00509795|584514730|FG003|Overall Study|Lack of Efficacy|2|||
161856400|NCT00509795|584514727|FG000|Overall Study|Lost to Follow-up|1|||
161856401|NCT00509795|584514728|FG001|Overall Study|Lost to Follow-up|2|||
161856402|NCT00509795|584514729|FG002|Overall Study|Lost to Follow-up|4|||
161856403|NCT00509795|584514730|FG003|Overall Study|Lost to Follow-up|4|||
161856404|NCT00509795|584514727|FG000|Overall Study|OTHER|1|||
161856405|NCT00509795|584514728|FG001|Overall Study|OTHER|0|||
161856406|NCT00509795|584514729|FG002|Overall Study|OTHER|4|||
161856407|NCT00509795|584514730|FG003|Overall Study|OTHER|1|||
161856408|NCT00509795|584514727|FG000|Overall Study|Protocol Violation|3|||
161856409|NCT00509795|584514728|FG001|Overall Study|Protocol Violation|0|||
161856410|NCT00509795|584514729|FG002|Overall Study|Protocol Violation|3|||
161856411|NCT00509795|584514730|FG003|Overall Study|Protocol Violation|1|||
161856412|NCT00509795|584514727|FG000|Overall Study|Withdrawal by Subject|10|||
161856413|NCT00509795|584514728|FG001|Overall Study|Withdrawal by Subject|5|||
161856414|NCT00509795|584514729|FG002|Overall Study|Withdrawal by Subject|7|||
161856415|NCT00509795|584514730|FG003|Overall Study|Withdrawal by Subject|8|||
161856416|NCT04895982|584514731|FG000|Overall Study|Withdrawal by Subject|0|||
161856417|NCT04895982|584514732|FG001|Overall Study|Withdrawal by Subject|0|||
161856418|NCT04895982|584514733|FG002|Overall Study|Withdrawal by Subject|0|||
161856419|NCT04895982|584514734|FG003|Overall Study|Withdrawal by Subject|0|||
161856420|NCT04895982|584514735|FG004|Overall Study|Withdrawal by Subject|0|||
161856421|NCT04895982|584514736|FG005|Overall Study|Withdrawal by Subject|1|||
161856422|NCT04895982|584514737|FG006|Overall Study|Withdrawal by Subject|1|||
161856423|NCT04895982|584514738|FG007|Overall Study|Withdrawal by Subject|0|||
161856424|NCT04895982|584514739|FG008|Overall Study|Withdrawal by Subject|0|||
161856425|NCT04895982|584514740|FG009|Overall Study|Withdrawal by Subject|1|||
161856426|NCT04895982|584514741|FG010|Overall Study|Withdrawal by Subject|0|||
161856427|NCT04895982|584514742|FG011|Overall Study|Withdrawal by Subject|1|||
161856428|NCT04895982|584514731|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161856429|NCT04895982|584514732|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161856430|NCT04895982|584514733|FG002|Overall Study|Withdrawal by parent/guardian|3|||
161856431|NCT04895982|584514734|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161856432|NCT04895982|584514735|FG004|Overall Study|Withdrawal by parent/guardian|3|||
161856433|NCT04895982|584514736|FG005|Overall Study|Withdrawal by parent/guardian|2|||
161856434|NCT04895982|584514737|FG006|Overall Study|Withdrawal by parent/guardian|1|||
161856435|NCT04895982|584514738|FG007|Overall Study|Withdrawal by parent/guardian|0|||
161856436|NCT04895982|584514739|FG008|Overall Study|Withdrawal by parent/guardian|3|||
161856437|NCT04895982|584514740|FG009|Overall Study|Withdrawal by parent/guardian|0|||
161856438|NCT04895982|584514741|FG010|Overall Study|Withdrawal by parent/guardian|0|||
161856439|NCT04895982|584514742|FG011|Overall Study|Withdrawal by parent/guardian|0|||
161856440|NCT04895982|584514731|FG000|Overall Study|Other|0|||
161856441|NCT04895982|584514732|FG001|Overall Study|Other|0|||
161856442|NCT04895982|584514733|FG002|Overall Study|Other|1|||
161856443|NCT04895982|584514734|FG003|Overall Study|Other|1|||
161856444|NCT04895982|584514735|FG004|Overall Study|Other|0|||
161856445|NCT04895982|584514736|FG005|Overall Study|Other|0|||
161856446|NCT04895982|584514737|FG006|Overall Study|Other|0|||
161856447|NCT04895982|584514738|FG007|Overall Study|Other|0|||
161856448|NCT04895982|584514739|FG008|Overall Study|Other|0|||
161856449|NCT04895982|584514740|FG009|Overall Study|Other|1|||
161856450|NCT04895982|584514741|FG010|Overall Study|Other|0|||
161856451|NCT04895982|584514742|FG011|Overall Study|Other|0|||
161856452|NCT04895982|584514731|FG000|Overall Study|Protocol Violation|0|||
161856453|NCT04895982|584514732|FG001|Overall Study|Protocol Violation|0|||
161856454|NCT04895982|584514733|FG002|Overall Study|Protocol Violation|1|||
161856455|NCT04895982|584514734|FG003|Overall Study|Protocol Violation|1|||
161856456|NCT04895982|584514735|FG004|Overall Study|Protocol Violation|1|||
161856457|NCT04895982|584514736|FG005|Overall Study|Protocol Violation|0|||
161856458|NCT04895982|584514737|FG006|Overall Study|Protocol Violation|0|||
161856459|NCT04895982|584514738|FG007|Overall Study|Protocol Violation|1|||
161856460|NCT04895982|584514739|FG008|Overall Study|Protocol Violation|0|||
161856461|NCT04895982|584514740|FG009|Overall Study|Protocol Violation|0|||
161856462|NCT04895982|584514741|FG010|Overall Study|Protocol Violation|0|||
161856463|NCT04895982|584514742|FG011|Overall Study|Protocol Violation|0|||
161856464|NCT04895982|584514731|FG000|Overall Study|Lost to Follow-up|0|||
161856465|NCT04895982|584514732|FG001|Overall Study|Lost to Follow-up|0|||
161856466|NCT04895982|584514733|FG002|Overall Study|Lost to Follow-up|1|||
161856467|NCT04895982|584514734|FG003|Overall Study|Lost to Follow-up|0|||
161856468|NCT04895982|584514735|FG004|Overall Study|Lost to Follow-up|0|||
161856469|NCT04895982|584514736|FG005|Overall Study|Lost to Follow-up|1|||
161856470|NCT04895982|584514737|FG006|Overall Study|Lost to Follow-up|0|||
161856471|NCT04895982|584514738|FG007|Overall Study|Lost to Follow-up|0|||
161856472|NCT04895982|584514739|FG008|Overall Study|Lost to Follow-up|1|||
161856473|NCT04895982|584514740|FG009|Overall Study|Lost to Follow-up|0|||
161856474|NCT04895982|584514741|FG010|Overall Study|Lost to Follow-up|0|||
161856475|NCT04895982|584514742|FG011|Overall Study|Lost to Follow-up|0|||
161856476|NCT04895982|584514731|FG000|Overall Study|Refused further study procedures|0|||
161856477|NCT04895982|584514732|FG001|Overall Study|Refused further study procedures|0|||
161856478|NCT04895982|584514733|FG002|Overall Study|Refused further study procedures|1|||
161856479|NCT04895982|584514734|FG003|Overall Study|Refused further study procedures|0|||
161769182|NCT05602818|584196095|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
161769183|NCT05602818|584196096|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
161769184|NCT05602818|584196097|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
161769185|NCT03814499|584196098|FG000|Overall Study|Lost to Follow-up|3|||
161769186|NCT00598442|584196102|FG000|Overall Study|Adverse Event|3|||
161769187|NCT00598442|584196103|FG001|Overall Study|Adverse Event|0|||
161769188|NCT00598442|584196104|FG002|Overall Study|Adverse Event|0|||
161769189|NCT00598442|584196102|FG000|Overall Study|Death|19|||
161769190|NCT00598442|584196103|FG001|Overall Study|Death|11|||
161769191|NCT00598442|584196104|FG002|Overall Study|Death|11|||
161769192|NCT00598442|584196102|FG000|Overall Study|Lost to Follow-up|4|||
161769193|NCT00598442|584196103|FG001|Overall Study|Lost to Follow-up|3|||
161769194|NCT00598442|584196104|FG002|Overall Study|Lost to Follow-up|3|||
161769195|NCT00598442|584196102|FG000|Overall Study|Physician Decision|2|||
161769196|NCT00598442|584196103|FG001|Overall Study|Physician Decision|1|||
161769197|NCT00598442|584196104|FG002|Overall Study|Physician Decision|1|||
161769198|NCT00598442|584196102|FG000|Overall Study|Withdrawal by Subject|8|||
161769199|NCT00598442|584196103|FG001|Overall Study|Withdrawal by Subject|16|||
161769200|NCT00598442|584196104|FG002|Overall Study|Withdrawal by Subject|6|||
161769201|NCT00598442|584196102|FG000|Overall Study|Noncompliance|0|||
161769202|NCT00598442|584196103|FG001|Overall Study|Noncompliance|2|||
161769203|NCT00598442|584196104|FG002|Overall Study|Noncompliance|1|||
161769204|NCT00598442|584196102|FG000|Overall Study|Relocation|1|||
161769205|NCT00598442|584196103|FG001|Overall Study|Relocation|4|||
161769206|NCT00598442|584196104|FG002|Overall Study|Relocation|0|||
161769207|NCT00598442|584196102|FG000|Overall Study|Renal transplant|0|||
161769208|NCT00598442|584196103|FG001|Overall Study|Renal transplant|0|||
161769209|NCT00598442|584196104|FG002|Overall Study|Renal transplant|1|||
161769210|NCT00598442|584196102|FG000|Overall Study|Site closed by sponsor|5|||
161769211|NCT00598442|584196103|FG001|Overall Study|Site closed by sponsor|2|||
161769212|NCT00598442|584196104|FG002|Overall Study|Site closed by sponsor|1|||
161769213|NCT00598442|584196102|FG000|Overall Study|Started dialysis|1|||
161769214|NCT00598442|584196103|FG001|Overall Study|Started dialysis|0|||
161769215|NCT00598442|584196104|FG002|Overall Study|Started dialysis|0|||
161769216|NCT00229931|584196117|FG000|Overall Study|Death|1|||
161769217|NCT00229931|584196118|FG001|Overall Study|Death|0|||
161769218|NCT00229931|584196117|FG000|Overall Study|Lost to Follow-up|3|||
161769219|NCT00229931|584196118|FG001|Overall Study|Lost to Follow-up|2|||
161769220|NCT02992743|584196119|FG000|Overall Study|Withdrawal by Subject|1|||
161769221|NCT02992743|584196120|FG001|Overall Study|Withdrawal by Subject|1|||
161769222|NCT02992743|584196119|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
161769223|NCT02992743|584196120|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
161769224|NCT02992743|584196119|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
161769225|NCT02992743|584196120|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
161769226|NCT02992743|584196119|FG000|Overall Study|No measurable disease|1|||
161769227|NCT02992743|584196120|FG001|Overall Study|No measurable disease|0|||
161769228|NCT02992743|584196119|FG000|Overall Study|Lost to Follow-up|0|||
161769229|NCT02992743|584196120|FG001|Overall Study|Lost to Follow-up|1|||
161769230|NCT00381680|584196121|FG000|Overall Study|Adverse Event|9|||
161769231|NCT00381680|584196122|FG001|Overall Study|Adverse Event|3|||
161769232|NCT00381680|584196121|FG000|Overall Study|Death|10|||
161769233|NCT00381680|584196122|FG001|Overall Study|Death|7|||
161769234|NCT00381680|584196121|FG000|Overall Study|Lost to Follow-up|3|||
161769235|NCT00381680|584196122|FG001|Overall Study|Lost to Follow-up|2|||
161769236|NCT00381680|584196121|FG000|Overall Study|Physician Decision|25|||
161769237|NCT00381680|584196122|FG001|Overall Study|Physician Decision|6|||
161769238|NCT00381680|584196121|FG000|Overall Study|Withdrawal by Subject|3|||
161769239|NCT00381680|584196122|FG001|Overall Study|Withdrawal by Subject|1|||
161769240|NCT00381680|584196121|FG000|Overall Study|Entry onto another COG Trial|1|||
161769241|NCT00381680|584196122|FG001|Overall Study|Entry onto another COG Trial|2|||
161769242|NCT00381680|584196121|FG000|Overall Study|Alternative Therapy|11|||
161769243|NCT00381680|584196122|FG001|Overall Study|Alternative Therapy|5|||
161769244|NCT00381680|584196121|FG000|Overall Study|Secondary Malignancy|3|||
161856480|NCT04895982|584514735|FG004|Overall Study|Refused further study procedures|0|||
161856481|NCT04895982|584514736|FG005|Overall Study|Refused further study procedures|0|||
161856482|NCT04895982|584514737|FG006|Overall Study|Refused further study procedures|0|||
161856483|NCT04895982|584514738|FG007|Overall Study|Refused further study procedures|0|||
161856484|NCT04895982|584514739|FG008|Overall Study|Refused further study procedures|0|||
161856485|NCT04895982|584514740|FG009|Overall Study|Refused further study procedures|0|||
161856486|NCT04895982|584514741|FG010|Overall Study|Refused further study procedures|0|||
161856487|NCT04895982|584514742|FG011|Overall Study|Refused further study procedures|0|||
161856488|NCT02517463|584514748|FG000|Overall Study|Lost to Follow-up|5|||
161856489|NCT02517463|584514749|FG001|Overall Study|Lost to Follow-up|2|||
161856490|NCT02296931|584514756|FG000|Overall Study|Protocol Violation|0|||
161856491|NCT02296931|584514757|FG001|Overall Study|Protocol Violation|2|||
161856492|NCT02603146|584517097|FG000|Overall Study|Lost to Follow-up|5|||
161856493|NCT02603146|584517098|FG001|Overall Study|Lost to Follow-up|6|||
161856494|NCT02603146|584517097|FG000|Overall Study|Withdrawal by Subject|8|||
161856495|NCT02603146|584517098|FG001|Overall Study|Withdrawal by Subject|10|||
161856496|NCT02603146|584517097|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
161856497|NCT02603146|584517098|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
161856498|NCT02603146|584517097|FG000|Overall Study|Participant moved|2|||
161856499|NCT02603146|584517098|FG001|Overall Study|Participant moved|0|||
161856500|NCT02603146|584517097|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
161856501|NCT02603146|584517098|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
161856502|NCT05221320|584517102|FG000|Overall Study|Lack of Efficacy|3|||
161856503|NCT05221320|584517103|FG001|Overall Study|Lack of Efficacy|7|||
161856504|NCT05221320|584517104|FG002|Overall Study|Lack of Efficacy|10|||
161856505|NCT05221320|584517105|FG003|Overall Study|Lack of Efficacy|1|||
161856506|NCT05221320|584517106|FG004|Overall Study|Lack of Efficacy|0|||
161856507|NCT05221320|584517107|FG005|Overall Study|Lack of Efficacy|0|||
161856508|NCT05221320|584517102|FG000|Overall Study|Physician Decision|1|||
161856509|NCT05221320|584517103|FG001|Overall Study|Physician Decision|0|||
161856510|NCT05221320|584517104|FG002|Overall Study|Physician Decision|3|||
161856511|NCT05221320|584517105|FG003|Overall Study|Physician Decision|1|||
161856512|NCT05221320|584517106|FG004|Overall Study|Physician Decision|0|||
161856513|NCT05221320|584517107|FG005|Overall Study|Physician Decision|0|||
161856514|NCT05221320|584517102|FG000|Overall Study|Withdrawal by Subject|0|||
161856515|NCT05221320|584517103|FG001|Overall Study|Withdrawal by Subject|3|||
161856516|NCT05221320|584517104|FG002|Overall Study|Withdrawal by Subject|1|||
161856517|NCT05221320|584517105|FG003|Overall Study|Withdrawal by Subject|0|||
161856518|NCT05221320|584517106|FG004|Overall Study|Withdrawal by Subject|0|||
161856519|NCT05221320|584517107|FG005|Overall Study|Withdrawal by Subject|0|||
161856520|NCT05221320|584517102|FG000|Overall Study|Death|0|||
161856521|NCT05221320|584517103|FG001|Overall Study|Death|5|||
161856522|NCT05221320|584517104|FG002|Overall Study|Death|6|||
161856523|NCT05221320|584517105|FG003|Overall Study|Death|0|||
161856524|NCT05221320|584517106|FG004|Overall Study|Death|1|||
161856525|NCT05221320|584517107|FG005|Overall Study|Death|0|||
161856526|NCT05016960|584517108|FG000|Overall Study|Withdrawal by Subject|1|||
161856527|NCT05016960|584517109|FG001|Overall Study|Withdrawal by Subject|9|||
161856528|NCT03300817|584517115|FG000|Overall Study|Withdrawal by Subject|1|||
161856529|NCT03300817|584517115|FG000|Overall Study|Adverse Event|1|||
161856530|NCT03300817|584517115|FG000|Overall Study|Subject Found to be Ineligible|2|||
161856531|NCT03729596|584517118|FG000|Overall Study|Death|3|||
161856532|NCT03729596|584517119|FG001|Overall Study|Death|5|||
161856533|NCT03729596|584517120|FG002|Overall Study|Death|4|||
161856534|NCT03729596|584517121|FG003|Overall Study|Death|1|||
161856535|NCT03729596|584517122|FG004|Overall Study|Death|0|||
161856536|NCT03729596|584517123|FG005|Overall Study|Death|34|||
161856537|NCT03729596|584517124|FG006|Overall Study|Death|18|||
161856538|NCT03729596|584517125|FG007|Overall Study|Death|14|||
161856539|NCT03729596|584517126|FG008|Overall Study|Death|19|||
161856540|NCT03729596|584517127|FG009|Overall Study|Death|9|||
161856541|NCT03729596|584517118|FG000|Overall Study|Lost to Follow-up|0|||
161856542|NCT03729596|584517119|FG001|Overall Study|Lost to Follow-up|0|||
161856543|NCT03729596|584517120|FG002|Overall Study|Lost to Follow-up|0|||
161856544|NCT03729596|584517121|FG003|Overall Study|Lost to Follow-up|0|||
161856545|NCT03729596|584517122|FG004|Overall Study|Lost to Follow-up|0|||
161856546|NCT03729596|584517123|FG005|Overall Study|Lost to Follow-up|0|||
161856547|NCT03729596|584517124|FG006|Overall Study|Lost to Follow-up|1|||
161856548|NCT03729596|584517125|FG007|Overall Study|Lost to Follow-up|0|||
161856549|NCT03729596|584517126|FG008|Overall Study|Lost to Follow-up|0|||
161856550|NCT03729596|584517127|FG009|Overall Study|Lost to Follow-up|1|||
161856551|NCT03729596|584517118|FG000|Overall Study|protocol amendment|0|||
161856552|NCT03729596|584517119|FG001|Overall Study|protocol amendment|1|||
161856553|NCT03729596|584517120|FG002|Overall Study|protocol amendment|3|||
161856554|NCT03729596|584517121|FG003|Overall Study|protocol amendment|6|||
161856555|NCT03729596|584517122|FG004|Overall Study|protocol amendment|5|||
161856556|NCT03729596|584517123|FG005|Overall Study|protocol amendment|0|||
161856557|NCT03729596|584517124|FG006|Overall Study|protocol amendment|0|||
161856558|NCT03729596|584517125|FG007|Overall Study|protocol amendment|0|||
161769245|NCT00381680|584196122|FG001|Overall Study|Secondary Malignancy|0|||
161769246|NCT00381680|584196121|FG000|Overall Study|Delay initiation|1|||
161769247|NCT00381680|584196122|FG001|Overall Study|Delay initiation|0|||
161769248|NCT00381680|584196121|FG000|Overall Study|Stem Cell Transplant|26|||
161769249|NCT00381680|584196122|FG001|Overall Study|Stem Cell Transplant|10|||
161769250|NCT00381680|584196121|FG000|Overall Study|Relapse|18|||
161769251|NCT00381680|584196122|FG001|Overall Study|Relapse|9|||
161769252|NCT00381680|584196121|FG000|Overall Study|Induction Failure|4|||
161769253|NCT00381680|584196122|FG001|Overall Study|Induction Failure|1|||
161769254|NCT00381680|584196121|FG000|Overall Study|Progression|1|||
161769255|NCT00381680|584196122|FG001|Overall Study|Progression|1|||
161769256|NCT00381680|584196121|FG000|Overall Study|Other not otherwise specified|7|||
161769257|NCT00381680|584196122|FG001|Overall Study|Other not otherwise specified|2|||
161769258|NCT00381680|584196121|FG000|Overall Study|Ineligible|3|||
161769259|NCT00381680|584196122|FG001|Overall Study|Ineligible|1|||
161769260|NCT03290131|584196125|FG000|Overall Study|Adverse Event|22|||
161769261|NCT03290131|584196126|FG001|Overall Study|Adverse Event|57|||
161769262|NCT03290131|584196127|FG002|Overall Study|Adverse Event|11|||
161769263|NCT03290131|584196125|FG000|Overall Study|Withdrawal by Subject|18|||
161769264|NCT03290131|584196126|FG001|Overall Study|Withdrawal by Subject|13|||
161769265|NCT03290131|584196127|FG002|Overall Study|Withdrawal by Subject|8|||
161769266|NCT03290131|584196125|FG000|Overall Study|MS Relapse|2|||
161769267|NCT03290131|584196126|FG001|Overall Study|MS Relapse|1|||
161769268|NCT03290131|584196127|FG002|Overall Study|MS Relapse|0|||
161769269|NCT03290131|584196125|FG000|Overall Study|Unknown reason|0|||
161769270|NCT03290131|584196126|FG001|Overall Study|Unknown reason|1|||
161769271|NCT03290131|584196127|FG002|Overall Study|Unknown reason|0|||
161769272|NCT03099096|584196128|FG000|Overall Study|Adverse Event|1|||
161769273|NCT03099096|584196128|FG000|Overall Study|Physician Decision|1|||
161769274|NCT00361504|584196131|FG000|Overall Study|Withdrawal by Subject|94|||
161769275|NCT00361504|584196132|FG001|Overall Study|Withdrawal by Subject|31|||
161769276|NCT00361504|584196131|FG000|Overall Study|Lost to Follow-up|40|||
161769277|NCT00361504|584196132|FG001|Overall Study|Lost to Follow-up|7|||
161769278|NCT00361504|584196131|FG000|Overall Study|Adverse Event|203|||
161769279|NCT00361504|584196132|FG001|Overall Study|Adverse Event|82|||
161769280|NCT00361504|584196131|FG000|Overall Study|Lack of Efficacy|72|||
161769281|NCT00361504|584196132|FG001|Overall Study|Lack of Efficacy|7|||
161769282|NCT00361504|584196131|FG000|Overall Study|Resolution of Pain|2|||
161769283|NCT00361504|584196132|FG001|Overall Study|Resolution of Pain|0|||
161769284|NCT00361504|584196131|FG000|Overall Study|Study medication non compliant|42|||
161769285|NCT00361504|584196132|FG001|Overall Study|Study medication non compliant|15|||
161769286|NCT00361504|584196131|FG000|Overall Study|All other|28|||
161769287|NCT00361504|584196132|FG001|Overall Study|All other|3|||
161769288|NCT03764813|584196134|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
161769289|NCT03764813|584196135|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
161769290|NCT03764813|584196136|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
161769291|NCT03764813|584196137|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
161769292|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
161769293|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
161769294|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
161769295|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
161769296|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
161769297|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
161769298|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
161769299|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
161769300|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
161769301|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
161769302|NCT01374516|584196139|FG000|Surveillance Expansion Period|Protocol Violation|386|||
161769303|NCT01374516|584196140|FG001|Surveillance Expansion Period|Protocol Violation|217|||
161769304|NCT01374516|584196139|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
161769305|NCT01374516|584196140|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
161769306|NCT01374516|584196139|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
161769307|NCT01374516|584196140|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
161856559|NCT03729596|584517126|FG008|Overall Study|protocol amendment|0|||
161856560|NCT03729596|584517127|FG009|Overall Study|protocol amendment|0|||
161856561|NCT03729596|584517118|FG000|Overall Study|Withdrawal by Subject|0|||
161856562|NCT03729596|584517119|FG001|Overall Study|Withdrawal by Subject|0|||
161856563|NCT03729596|584517120|FG002|Overall Study|Withdrawal by Subject|0|||
161856564|NCT03729596|584517121|FG003|Overall Study|Withdrawal by Subject|0|||
161856565|NCT03729596|584517122|FG004|Overall Study|Withdrawal by Subject|0|||
161856566|NCT03729596|584517123|FG005|Overall Study|Withdrawal by Subject|4|||
161856567|NCT03729596|584517124|FG006|Overall Study|Withdrawal by Subject|2|||
161856568|NCT03729596|584517125|FG007|Overall Study|Withdrawal by Subject|3|||
161856569|NCT03729596|584517126|FG008|Overall Study|Withdrawal by Subject|2|||
161856570|NCT03729596|584517127|FG009|Overall Study|Withdrawal by Subject|3|||
161856571|NCT03729596|584517118|FG000|Overall Study|study terminated by sponsor|0|||
161856572|NCT03729596|584517119|FG001|Overall Study|study terminated by sponsor|0|||
161856573|NCT03729596|584517120|FG002|Overall Study|study terminated by sponsor|0|||
161856574|NCT03729596|584517121|FG003|Overall Study|study terminated by sponsor|0|||
161856575|NCT03729596|584517122|FG004|Overall Study|study terminated by sponsor|1|||
161856576|NCT03729596|584517123|FG005|Overall Study|study terminated by sponsor|3|||
161856577|NCT03729596|584517124|FG006|Overall Study|study terminated by sponsor|0|||
161856578|NCT03729596|584517125|FG007|Overall Study|study terminated by sponsor|1|||
161856579|NCT03729596|584517126|FG008|Overall Study|study terminated by sponsor|0|||
161856580|NCT03729596|584517127|FG009|Overall Study|study terminated by sponsor|0|||
161856581|NCT03713593|584517128|FG000|Overall Study|Sponsor Decision|73|||
161856582|NCT03713593|584517129|FG001|Overall Study|Sponsor Decision|41|||
161856583|NCT03713593|584517128|FG000|Overall Study|Lost to Follow-up|2|||
161856584|NCT03713593|584517129|FG001|Overall Study|Lost to Follow-up|1|||
161856585|NCT03713593|584517128|FG000|Overall Study|Death|314|||
161856586|NCT03713593|584517129|FG001|Overall Study|Death|349|||
161856587|NCT03713593|584517128|FG000|Overall Study|Withdrawal by Subject|6|||
161856588|NCT03713593|584517129|FG001|Overall Study|Withdrawal by Subject|8|||
161856589|NCT05126693|584517130|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
161856590|NCT05126693|584517131|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
161856591|NCT05126693|584517130|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
161856592|NCT05126693|584517131|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
161769308|NCT01374516|584196139|FG000|Surveillance Expansion Period|Serious adverse event|20|||
161769309|NCT01374516|584196140|FG001|Surveillance Expansion Period|Serious adverse event|5|||
161769310|NCT00450814|584196148|FG000|Overall Study|Failed to complete the initial therapy|0|||
161769311|NCT00450814|584196149|FG001|Overall Study|Failed to complete the initial therapy|0|||
161769312|NCT00450814|584196150|FG002|Overall Study|Failed to complete the initial therapy|0|||
161769313|NCT00450814|584196151|FG003|Overall Study|Failed to complete the initial therapy|1|||
161769314|NCT00450814|584196152|FG004|Overall Study|Failed to complete the initial therapy|1|||
161769315|NCT00450814|584196153|FG005|Overall Study|Failed to complete the initial therapy|1|||
161769316|NCT00450814|584196154|FG006|Overall Study|Failed to complete the initial therapy|0|||
161769317|NCT00450814|584196155|FG007|Overall Study|Failed to complete the initial therapy|0|||
161769318|NCT00450814|584196156|FG008|Overall Study|Failed to complete the initial therapy|0|||
161769319|NCT00450814|584196157|FG009|Overall Study|Failed to complete the initial therapy|0|||
161769320|NCT00450814|584196158|FG010|Overall Study|Failed to complete the initial therapy|0|||
161769321|NCT00450814|584196148|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
161769322|NCT00450814|584196149|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
161769323|NCT00450814|584196150|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
161769324|NCT00450814|584196151|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
161769325|NCT00450814|584196152|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
161769326|NCT00450814|584196153|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
161769327|NCT00450814|584196154|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
161769328|NCT00450814|584196155|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
161769329|NCT00450814|584196156|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
161769330|NCT00450814|584196157|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
161769331|NCT00450814|584196158|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
161769332|NCT03602976|584196163|FG000|Overall Study|Withdrawal by Subject|1|||
161769333|NCT04837807|584196164|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
161769334|NCT04837807|584196165|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
161769335|NCT04629534|584196166|FG000|Overall Study|Physician Decision|1|||
161769336|NCT04629534|584196167|FG001|Overall Study|Physician Decision|0|||
161769337|NCT04629534|584196166|FG000|Overall Study|Protocol Violation|0|||
161769338|NCT04629534|584196167|FG001|Overall Study|Protocol Violation|2|||
161769339|NCT01757821|584196170|FG000|Overall Study|Adverse Event|1|||
161769340|NCT00334893|584196171|FG000|Overall Study|Not Treated|1|||
161769341|NCT00334893|584196172|FG001|Overall Study|Not Treated|0|||
161769342|NCT03556202|584196173|FG000|Extension Treatment Period|Adverse Event|18|||
161769343|NCT03556202|584196174|FG001|Extension Treatment Period|Adverse Event|14|||
161769344|NCT03556202|584196175|FG002|Extension Treatment Period|Adverse Event|9|||
161769345|NCT03556202|584196173|FG000|Extension Treatment Period|Death|2|||
161769346|NCT03556202|584196174|FG001|Extension Treatment Period|Death|6|||
161769347|NCT03556202|584196175|FG002|Extension Treatment Period|Death|0|||
161769348|NCT03556202|584196173|FG000|Extension Treatment Period|Lack of Efficacy|5|||
161769349|NCT03556202|584196174|FG001|Extension Treatment Period|Lack of Efficacy|12|||
161769350|NCT03556202|584196175|FG002|Extension Treatment Period|Lack of Efficacy|18|||
161769351|NCT03556202|584196173|FG000|Extension Treatment Period|Lost to Follow-up|9|||
161769352|NCT03556202|584196174|FG001|Extension Treatment Period|Lost to Follow-up|20|||
161769353|NCT03556202|584196175|FG002|Extension Treatment Period|Lost to Follow-up|2|||
161769354|NCT03556202|584196173|FG000|Extension Treatment Period|Pregnancy|2|||
161769355|NCT03556202|584196174|FG001|Extension Treatment Period|Pregnancy|4|||
161769356|NCT03556202|584196175|FG002|Extension Treatment Period|Pregnancy|3|||
161769357|NCT03556202|584196173|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
161769358|NCT03556202|584196174|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
161769359|NCT03556202|584196175|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
161769360|NCT03556202|584196173|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
161769361|NCT03556202|584196174|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
161769362|NCT03556202|584196175|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
161769363|NCT03556202|584196173|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
161769364|NCT03556202|584196174|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
161769365|NCT03556202|584196175|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
161769366|NCT03556202|584196173|FG000|Extension Treatment Period|Physician Decision|0|||
161769367|NCT03556202|584196174|FG001|Extension Treatment Period|Physician Decision|8|||
161769368|NCT03556202|584196175|FG002|Extension Treatment Period|Physician Decision|2|||
161769369|NCT03556202|584196173|FG000|Extension Treatment Period|Protocol Violation|0|||
161769370|NCT03556202|584196174|FG001|Extension Treatment Period|Protocol Violation|1|||
161769371|NCT03556202|584196175|FG002|Extension Treatment Period|Protocol Violation|1|||
161769372|NCT03556202|584196173|FG000|Extension Treatment Period|Sponsor Decision|0|||
161856593|NCT05126693|584517130|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
161856594|NCT05126693|584517131|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
161856595|NCT03631199|584517136|FG000|Overall Study|Progressive disease|9|||
161856596|NCT03631199|584517137|FG001|Overall Study|Progressive disease|5|||
161856597|NCT03631199|584517138|FG002|Overall Study|Progressive disease|5|||
161856598|NCT03631199|584517139|FG003|Overall Study|Progressive disease|149|||
161856599|NCT03631199|584517140|FG004|Overall Study|Progressive disease|148|||
161856600|NCT03631199|584517136|FG000|Overall Study|Physician Decision|0|||
161856601|NCT03631199|584517137|FG001|Overall Study|Physician Decision|2|||
161856602|NCT03631199|584517138|FG002|Overall Study|Physician Decision|3|||
161856603|NCT03631199|584517139|FG003|Overall Study|Physician Decision|19|||
161856604|NCT03631199|584517140|FG004|Overall Study|Physician Decision|13|||
161856605|NCT03631199|584517136|FG000|Overall Study|Adverse Event|1|||
161856606|NCT03631199|584517137|FG001|Overall Study|Adverse Event|1|||
161856607|NCT03631199|584517138|FG002|Overall Study|Adverse Event|0|||
161856608|NCT03631199|584517139|FG003|Overall Study|Adverse Event|28|||
161856609|NCT03631199|584517140|FG004|Overall Study|Adverse Event|29|||
161856610|NCT03631199|584517136|FG000|Overall Study|Death|0|||
161856611|NCT03631199|584517137|FG001|Overall Study|Death|1|||
161856612|NCT03631199|584517138|FG002|Overall Study|Death|0|||
161856613|NCT03631199|584517139|FG003|Overall Study|Death|35|||
161856614|NCT03631199|584517140|FG004|Overall Study|Death|48|||
161856615|NCT03631199|584517136|FG000|Overall Study|Subject decision|0|||
161856616|NCT03631199|584517137|FG001|Overall Study|Subject decision|1|||
161856617|NCT03631199|584517138|FG002|Overall Study|Subject decision|0|||
161856618|NCT03631199|584517139|FG003|Overall Study|Subject decision|12|||
161856619|NCT03631199|584517140|FG004|Overall Study|Subject decision|12|||
161856620|NCT03631199|584517136|FG000|Overall Study|No treated|0|||
161856621|NCT03631199|584517137|FG001|Overall Study|No treated|0|||
161856622|NCT03631199|584517138|FG002|Overall Study|No treated|0|||
161856623|NCT03631199|584517139|FG003|Overall Study|No treated|0|||
161856624|NCT03631199|584517140|FG004|Overall Study|No treated|1|||
161856625|NCT03631199|584517136|FG000|Overall Study|Treatment ongoing|0|||
161856626|NCT03631199|584517137|FG001|Overall Study|Treatment ongoing|1|||
161856627|NCT03631199|584517138|FG002|Overall Study|Treatment ongoing|1|||
161856628|NCT03631199|584517139|FG003|Overall Study|Treatment ongoing|76|||
161856629|NCT03631199|584517140|FG004|Overall Study|Treatment ongoing|71|||
161856630|NCT03631199|584517136|FG000|Overall Study|Guardian decision|0|||
161856631|NCT03631199|584517137|FG001|Overall Study|Guardian decision|0|||
161856632|NCT03631199|584517138|FG002|Overall Study|Guardian decision|0|||
161856633|NCT03631199|584517139|FG003|Overall Study|Guardian decision|1|||
161856634|NCT03631199|584517140|FG004|Overall Study|Guardian decision|1|||
161856635|NCT03999996|584517141|FG000|Prior to Booster|Adverse Event|2|||
161856636|NCT03999996|584517142|FG001|Prior to Booster|Adverse Event|0|||
161856637|NCT03999996|584517143|FG002|Prior to Booster|Adverse Event|0|||
161856638|NCT03999996|584517144|FG003|Prior to Booster|Adverse Event|0|||
161856639|NCT03999996|584517141|FG000|Prior to Booster|Lost to Follow-up|17|||
161856640|NCT03999996|584517142|FG001|Prior to Booster|Lost to Follow-up|22|||
161856641|NCT03999996|584517143|FG002|Prior to Booster|Lost to Follow-up|0|||
161856642|NCT03999996|584517144|FG003|Prior to Booster|Lost to Follow-up|0|||
161856643|NCT03999996|584517141|FG000|Prior to Booster|Withdrawal of Consent|51|||
161856644|NCT03999996|584517142|FG001|Prior to Booster|Withdrawal of Consent|8|||
161856645|NCT03999996|584517143|FG002|Prior to Booster|Withdrawal of Consent|0|||
161856646|NCT03999996|584517144|FG003|Prior to Booster|Withdrawal of Consent|0|||
161856647|NCT03999996|584517141|FG000|Prior to Booster|Death|0|||
161856648|NCT03999996|584517142|FG001|Prior to Booster|Death|1|||
161856649|NCT03999996|584517143|FG002|Prior to Booster|Death|0|||
161856650|NCT03999996|584517144|FG003|Prior to Booster|Death|0|||
161856651|NCT03999996|584517141|FG000|Prior to Booster|Reason Not Specified|27|||
161856652|NCT03999996|584517142|FG001|Prior to Booster|Reason Not Specified|4|||
161856653|NCT03999996|584517143|FG002|Prior to Booster|Reason Not Specified|0|||
161856654|NCT03999996|584517144|FG003|Prior to Booster|Reason Not Specified|0|||
161856655|NCT03999996|584517141|FG000|Booster Phase|Lost to Follow-up|0|||
161856656|NCT03999996|584517142|FG001|Booster Phase|Lost to Follow-up|0|||
161856657|NCT03999996|584517143|FG002|Booster Phase|Lost to Follow-up|3|||
161856658|NCT03999996|584517144|FG003|Booster Phase|Lost to Follow-up|3|||
161856659|NCT03999996|584517141|FG000|Booster Phase|Withdrawal of Consent|0|||
161856660|NCT03999996|584517142|FG001|Booster Phase|Withdrawal of Consent|0|||
161856661|NCT03999996|584517143|FG002|Booster Phase|Withdrawal of Consent|0|||
161856662|NCT03999996|584517144|FG003|Booster Phase|Withdrawal of Consent|1|||
161856663|NCT03999996|584517141|FG000|Booster Phase|Reason Not Specified|0|||
161856664|NCT03999996|584517142|FG001|Booster Phase|Reason Not Specified|0|||
161856665|NCT03999996|584517143|FG002|Booster Phase|Reason Not Specified|0|||
161856666|NCT03999996|584517144|FG003|Booster Phase|Reason Not Specified|1|||
161856667|NCT03690388|584517145|FG000|Overall Study|Adverse Event|8|||
161856668|NCT03690388|584517146|FG001|Overall Study|Adverse Event|1|||
161856669|NCT03690388|584517145|FG000|Overall Study|Radiographic Progression|14|||
161856670|NCT03690388|584517146|FG001|Overall Study|Radiographic Progression|29|||
161856671|NCT03690388|584517145|FG000|Overall Study|Clinical deterioration|10|||
161856672|NCT03690388|584517146|FG001|Overall Study|Clinical deterioration|6|||
161856673|NCT03690388|584517145|FG000|Overall Study|Withdrawal by Subject|2|||
161856674|NCT03690388|584517146|FG001|Overall Study|Withdrawal by Subject|0|||
161856675|NCT03690388|584517145|FG000|Overall Study|Lack of Efficacy|1|||
161856676|NCT03690388|584517146|FG001|Overall Study|Lack of Efficacy|0|||
161856677|NCT03690388|584517145|FG000|Overall Study|Lost to Follow-up|1|||
161856678|NCT03690388|584517146|FG001|Overall Study|Lost to Follow-up|0|||
161856679|NCT03765788|584517147|FG000|Overall Study|Subject decision|2|||
161856680|NCT03765788|584517148|FG001|Overall Study|Subject decision|3|||
161856681|NCT03765788|584517147|FG000|Overall Study|Physician Decision|2|||
161856682|NCT03765788|584517148|FG001|Overall Study|Physician Decision|4|||
161856683|NCT03765788|584517147|FG000|Overall Study|Death|0|||
161856684|NCT03765788|584517148|FG001|Overall Study|Death|1|||
161856685|NCT03765788|584517147|FG000|Overall Study|Lost to Follow-up|1|||
161856686|NCT03765788|584517148|FG001|Overall Study|Lost to Follow-up|0|||
161856687|NCT00001521|584517149|FG000|Overall Study|Withdrawal by Subject|3|||
161856688|NCT00001521|584517150|FG001|Overall Study|Withdrawal by Subject|3|||
161856689|NCT00001521|584517149|FG000|Overall Study|Physician Decision|1|||
161856690|NCT00001521|584517150|FG001|Overall Study|Physician Decision|1|||
161856691|NCT00001521|584517149|FG000|Overall Study|Noncompliant|6|||
161856692|NCT00001521|584517150|FG001|Overall Study|Noncompliant|3|||
161856693|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
161856694|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
161856695|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
161856696|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
161856697|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
161856698|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
161856699|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
161856700|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
161856701|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
161856702|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
161856703|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
161856704|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
161856705|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
161856706|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
161856707|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
161856708|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
161856709|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
161856710|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
161856711|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
161856712|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
161856713|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
161856714|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
161856715|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
161856716|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
161856717|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
161856718|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
161856719|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
161856720|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
161856721|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
161856722|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
161856723|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
161856724|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
161856725|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161856726|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161856727|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161856728|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
161856729|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161856730|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161856731|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161856732|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
161856733|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161856734|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161856735|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161856736|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
161856737|NCT02656303|584517158|FG000|Overall Study|Adverse Event|3|||
161856738|NCT02656303|584517159|FG001|Overall Study|Adverse Event|2|||
161856739|NCT02656303|584517160|FG002|Overall Study|Adverse Event|0|||
161856740|NCT02656303|584517158|FG000|Overall Study|Death|12|||
161856741|NCT02656303|584517159|FG001|Overall Study|Death|4|||
161856742|NCT02656303|584517160|FG002|Overall Study|Death|1|||
161856743|NCT02656303|584517158|FG000|Overall Study|Lack of Efficacy|1|||
161856744|NCT02656303|584517159|FG001|Overall Study|Lack of Efficacy|0|||
161856745|NCT02656303|584517160|FG002|Overall Study|Lack of Efficacy|0|||
161856746|NCT02656303|584517158|FG000|Overall Study|Non-Compliance with Study|1|||
161856747|NCT02656303|584517159|FG001|Overall Study|Non-Compliance with Study|1|||
161856748|NCT02656303|584517160|FG002|Overall Study|Non-Compliance with Study|0|||
161856749|NCT02656303|584517158|FG000|Overall Study|Investigator Decision|2|||
161856750|NCT02656303|584517159|FG001|Overall Study|Investigator Decision|1|||
161856751|NCT02656303|584517160|FG002|Overall Study|Investigator Decision|0|||
161856752|NCT02656303|584517158|FG000|Overall Study|Progressive Disease|25|||
161856753|NCT02656303|584517159|FG001|Overall Study|Progressive Disease|14|||
161856754|NCT02656303|584517160|FG002|Overall Study|Progressive Disease|10|||
161856755|NCT02656303|584517158|FG000|Overall Study|Study Terminated by Sponsor|20|||
161856756|NCT02656303|584517159|FG001|Overall Study|Study Terminated by Sponsor|7|||
161856757|NCT02656303|584517160|FG002|Overall Study|Study Terminated by Sponsor|5|||
161856758|NCT02656303|584517158|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
161856759|NCT02656303|584517159|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
161856760|NCT02656303|584517160|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
161856761|NCT02656303|584517158|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
161856762|NCT02656303|584517159|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
161856763|NCT02656303|584517160|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
161856764|NCT02656303|584517158|FG000|Overall Study|Reason not Specified|1|||
161856765|NCT02656303|584517159|FG001|Overall Study|Reason not Specified|1|||
161856766|NCT02656303|584517160|FG002|Overall Study|Reason not Specified|2|||
161856767|NCT03041311|584517163|FG000|Overall Study|Death|39|||
161856768|NCT03041311|584517164|FG001|Overall Study|Death|42|||
161856769|NCT03041311|584517163|FG000|Overall Study|Lost to Follow-up|0|||
161856770|NCT03041311|584517164|FG001|Overall Study|Lost to Follow-up|1|||
161856771|NCT03041311|584517163|FG000|Overall Study|Withdrawal by Subject|8|||
161856772|NCT03041311|584517164|FG001|Overall Study|Withdrawal by Subject|5|||
161856773|NCT03041311|584517163|FG000|Overall Study|Sponsor Terminated Study|2|||
161856774|NCT03041311|584517164|FG001|Overall Study|Sponsor Terminated Study|4|||
161856775|NCT03041311|584517163|FG000|Overall Study|Disease Progression|3|||
161856776|NCT03041311|584517164|FG001|Overall Study|Disease Progression|1|||
161856777|NCT03041311|584517163|FG000|Overall Study|Randomized in error, did not receive drug|2|||
161856778|NCT03041311|584517164|FG001|Overall Study|Randomized in error, did not receive drug|0|||
161856779|NCT01842438|584517165|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
161856780|NCT01842438|584517166|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
161856781|NCT01842438|584517165|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
161856782|NCT01842438|584517166|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
161856783|NCT01842438|584517165|FG000|T2: 6month Follow-up|Death|0|||
161856784|NCT01842438|584517166|FG001|T2: 6month Follow-up|Death|1|||
161856785|NCT04909853|584517167|FG000|Part 1|Assigned but not treated|0|||
161856786|NCT04909853|584517168|FG001|Part 1|Assigned but not treated|0|||
161856787|NCT04909853|584517169|FG002|Part 1|Assigned but not treated|1|||
161856788|NCT04909853|584517170|FG003|Part 1|Assigned but not treated|0|||
161856789|NCT04909853|584517167|FG000|Part 2|Adverse Event|0|||
161856790|NCT04909853|584517168|FG001|Part 2|Adverse Event|0|||
161856791|NCT04909853|584517169|FG002|Part 2|Adverse Event|0|||
161769373|NCT03556202|584196174|FG001|Extension Treatment Period|Sponsor Decision|1|||
161769374|NCT03556202|584196175|FG002|Extension Treatment Period|Sponsor Decision|0|||
161769375|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
161769376|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
161769377|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
161769378|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Death|1|||
161769379|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Death|0|||
161769380|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Death|0|||
161769381|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
161769382|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
161769383|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
161769384|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
161769385|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
161769386|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
161769387|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
161769388|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
161769389|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
161769390|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
161769391|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
161769392|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
161769393|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
161769394|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
161769395|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
161769396|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
161769397|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
161769398|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
161769399|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
161769400|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
161769401|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
161769402|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
161769403|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
161769404|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
161769405|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
161769406|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
161769407|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
161769408|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
161769409|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
161769410|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
161769411|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
161769412|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
161769413|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
161769414|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
161769415|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
161769416|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
161769417|NCT03319160|584196176|FG000|Overall Study|Data not available.|7|||
161769418|NCT00665002|584196177|FG000|Overall Study|Progression/relapse during treatment|11|||
161769419|NCT00665002|584196177|FG000|Overall Study|Cytogenetic resistance|1|||
161769420|NCT03604159|584196178|FG000|Overall Study|Lost to Follow-up|6|||
161769421|NCT03604159|584196179|FG001|Overall Study|Lost to Follow-up|7|||
161769422|NCT04533204|584196180|FG000|Overall Study|Unable to understand training instructions|1|||
161769423|NCT04533204|584196181|FG001|Overall Study|Unable to understand training instructions|1|||
161769424|NCT02260791|584196185|FG000|Overall Study|Lost to Follow-up|4|||
161769425|NCT02260791|584196186|FG001|Overall Study|Lost to Follow-up|4|||
161769426|NCT02260791|584196185|FG000|Overall Study|Lack of Efficacy|2|||
161769427|NCT02260791|584196186|FG001|Overall Study|Lack of Efficacy|1|||
161769428|NCT02260791|584196185|FG000|Overall Study|Adverse Event|13|||
161769429|NCT02260791|584196186|FG001|Overall Study|Adverse Event|9|||
161769430|NCT02260791|584196185|FG000|Overall Study|Death|1|||
161769431|NCT02260791|584196186|FG001|Overall Study|Death|0|||
161856792|NCT04909853|584517170|FG003|Part 2|Adverse Event|1|||
161856793|NCT04882241|584517178|FG000|Overall Study|Ongoing in study|46|||
161856794|NCT04882241|584517179|FG001|Overall Study|Ongoing in study|48|||
161856795|NCT04882241|584517180|FG002|Overall Study|Ongoing in study|0|||
161856796|NCT04882241|584517181|FG003|Overall Study|Ongoing in study|0|||
161856797|NCT04882241|584517178|FG000|Overall Study|Death|13|||
161856798|NCT04882241|584517179|FG001|Overall Study|Death|13|||
161856799|NCT04882241|584517180|FG002|Overall Study|Death|0|||
161856800|NCT04882241|584517181|FG003|Overall Study|Death|0|||
161856801|NCT03639779|584517187|FG000|Overall Study|Lost to Follow-up|1|||
161856802|NCT02413229|584517190|FG000|Overall Study|Adverse Event|0|||
161856803|NCT02413229|584517191|FG001|Overall Study|Adverse Event|0|||
161856804|NCT02413229|584517192|FG002|Overall Study|Adverse Event|0|||
161856805|NCT02413229|584517193|FG003|Overall Study|Adverse Event|1|||
161856806|NCT02413229|584517194|FG004|Overall Study|Adverse Event|0|||
161856807|NCT02413229|584517195|FG005|Overall Study|Adverse Event|0|||
161856808|NCT02413229|584517196|FG006|Overall Study|Adverse Event|0|||
161856809|NCT02413229|584517197|FG007|Overall Study|Adverse Event|1|||
161856810|NCT02413229|584517190|FG000|Overall Study|Lost to Follow-up|0|||
161856811|NCT02413229|584517191|FG001|Overall Study|Lost to Follow-up|0|||
161856812|NCT02413229|584517192|FG002|Overall Study|Lost to Follow-up|1|||
161856813|NCT02413229|584517193|FG003|Overall Study|Lost to Follow-up|0|||
161856814|NCT02413229|584517194|FG004|Overall Study|Lost to Follow-up|2|||
161856815|NCT02413229|584517195|FG005|Overall Study|Lost to Follow-up|0|||
161856816|NCT02413229|584517196|FG006|Overall Study|Lost to Follow-up|0|||
161856817|NCT02413229|584517197|FG007|Overall Study|Lost to Follow-up|0|||
161856818|NCT02413229|584517190|FG000|Overall Study|Withdrawal by Subject|1|||
161856819|NCT02413229|584517191|FG001|Overall Study|Withdrawal by Subject|1|||
161856820|NCT02413229|584517192|FG002|Overall Study|Withdrawal by Subject|0|||
161856821|NCT02413229|584517193|FG003|Overall Study|Withdrawal by Subject|0|||
161856822|NCT02413229|584517194|FG004|Overall Study|Withdrawal by Subject|1|||
161856823|NCT02413229|584517195|FG005|Overall Study|Withdrawal by Subject|0|||
161856824|NCT02413229|584517196|FG006|Overall Study|Withdrawal by Subject|0|||
161856825|NCT02413229|584517197|FG007|Overall Study|Withdrawal by Subject|2|||
161856826|NCT02413229|584517190|FG000|Overall Study|Progressive Disease|0|||
161856827|NCT02413229|584517191|FG001|Overall Study|Progressive Disease|0|||
161856828|NCT02413229|584517192|FG002|Overall Study|Progressive Disease|0|||
161856829|NCT02413229|584517193|FG003|Overall Study|Progressive Disease|0|||
161856830|NCT02413229|584517194|FG004|Overall Study|Progressive Disease|0|||
161856831|NCT02413229|584517195|FG005|Overall Study|Progressive Disease|0|||
161856832|NCT02413229|584517196|FG006|Overall Study|Progressive Disease|0|||
161856833|NCT02413229|584517197|FG007|Overall Study|Progressive Disease|1|||
161856834|NCT02932462|584517198|FG000|Overall Study|Adverse Event|1|||
161856835|NCT02932462|584517199|FG001|Overall Study|Adverse Event|2|||
161856836|NCT02932462|584517198|FG000|Overall Study|Lost to Follow-up|4|||
161856837|NCT02932462|584517199|FG001|Overall Study|Lost to Follow-up|1|||
161856838|NCT02932462|584517198|FG000|Overall Study|Protocol Violation|0|||
161856839|NCT02932462|584517199|FG001|Overall Study|Protocol Violation|5|||
161856840|NCT02932462|584517198|FG000|Overall Study|Withdrawal by Subject|1|||
161856841|NCT02932462|584517199|FG001|Overall Study|Withdrawal by Subject|4|||
161856842|NCT02932462|584517198|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161856843|NCT02932462|584517199|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161856844|NCT02932462|584517198|FG000|Overall Study|Progressive Disease|1|||
161856845|NCT02932462|584517199|FG001|Overall Study|Progressive Disease|0|||
161856846|NCT05024747|584517203|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
161856847|NCT05024747|584517204|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
161856848|NCT05024747|584517203|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
161856849|NCT05024747|584517204|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
161856850|NCT05024747|584517203|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
161856851|NCT05024747|584517204|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
161856852|NCT00662649|584517206|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
161856853|NCT00662649|584517207|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
161856854|NCT00662649|584517208|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
161856855|NCT00662649|584517209|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
161856856|NCT00662649|584517210|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
161856857|NCT00662649|584517206|FG000|Core Study (24 Months)|Adverse Event|22|||
161856858|NCT00662649|584517207|FG001|Core Study (24 Months)|Adverse Event|13|||
161856859|NCT00662649|584517208|FG002|Core Study (24 Months)|Adverse Event|18|||
161856860|NCT00662649|584517209|FG003|Core Study (24 Months)|Adverse Event|0|||
161856861|NCT00662649|584517210|FG004|Core Study (24 Months)|Adverse Event|0|||
161856862|NCT00662649|584517206|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
161856863|NCT00662649|584517207|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
161856864|NCT00662649|584517208|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
161856865|NCT00662649|584517209|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
161856866|NCT00662649|584517210|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
161856867|NCT00662649|584517206|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
161856868|NCT00662649|584517207|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
161856869|NCT00662649|584517208|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
161856870|NCT00662649|584517209|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
161856871|NCT00662649|584517210|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
161856872|NCT00662649|584517206|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
161856873|NCT00662649|584517207|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
161856874|NCT00662649|584517208|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
161856875|NCT00662649|584517209|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
161856876|NCT00662649|584517210|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
161856877|NCT00662649|584517206|FG000|Core Study (24 Months)|Protocol Violation|5|||
161856878|NCT00662649|584517207|FG001|Core Study (24 Months)|Protocol Violation|5|||
161856879|NCT00662649|584517208|FG002|Core Study (24 Months)|Protocol Violation|4|||
161856880|NCT00662649|584517209|FG003|Core Study (24 Months)|Protocol Violation|0|||
161856881|NCT00662649|584517210|FG004|Core Study (24 Months)|Protocol Violation|0|||
161856882|NCT00662649|584517206|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
161856883|NCT00662649|584517207|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
161856884|NCT00662649|584517208|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
161856885|NCT00662649|584517209|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
161856886|NCT00662649|584517210|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
161856887|NCT00662649|584517206|FG000|Core Study (24 Months)|Death|1|||
161856888|NCT00662649|584517207|FG001|Core Study (24 Months)|Death|0|||
161856889|NCT00662649|584517208|FG002|Core Study (24 Months)|Death|2|||
161856890|NCT00662649|584517209|FG003|Core Study (24 Months)|Death|0|||
161856891|NCT00662649|584517210|FG004|Core Study (24 Months)|Death|0|||
161856892|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
161856893|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
161856894|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
161856895|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
161856896|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
161856897|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
161856898|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
161856899|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
161856900|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
161856901|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
161856902|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856903|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856904|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856905|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
161856906|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856907|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
161856908|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
161856909|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
161856910|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
161856911|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
161856912|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
161856913|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
161856914|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
161856915|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
161856916|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
161856917|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
161856918|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
161856919|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161856920|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161856921|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161856922|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
161856923|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
161856924|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
161856925|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
161856926|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
161856927|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856928|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
161856929|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856930|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856931|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856932|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
161856933|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
161856934|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
161856935|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
161856936|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
161856937|NCT02009722|584517217|FG000|Overall Study|Protocol Violation|1|||
161856938|NCT02009722|584517218|FG001|Overall Study|Protocol Violation|2|||
161856939|NCT02009722|584517217|FG000|Overall Study|Did not receive intervention|0|||
161856940|NCT02009722|584517218|FG001|Overall Study|Did not receive intervention|1|||
161856941|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
161856942|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
161856943|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
161856944|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
161856945|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
161856946|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
161856947|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Other|3|||
161856948|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Other|2|||
161856949|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Adverse Event|11|||
161856950|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Adverse Event|7|||
161856951|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
161856952|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
161856953|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
161856954|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
161856955|NCT02955212|584517219|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
161856956|NCT02955212|584517220|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
161856957|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Other|2|||
161856958|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Other|4|||
161856959|NCT02454933|584517227|FG000|Overall Study|Progressive disease|10|||
161856960|NCT02454933|584517228|FG001|Overall Study|Progressive disease|7|||
161856961|NCT02454933|584517227|FG000|Overall Study|Adverse Event|1|||
161856962|NCT02454933|584517228|FG001|Overall Study|Adverse Event|1|||
161856963|NCT02454933|584517227|FG000|Overall Study|Withdrawal by Subject|0|||
161856964|NCT02454933|584517228|FG001|Overall Study|Withdrawal by Subject|3|||
161856965|NCT02454933|584517227|FG000|Overall Study|Lost to Follow-up|1|||
161856966|NCT02454933|584517228|FG001|Overall Study|Lost to Follow-up|0|||
161856967|NCT02071225|584517234|FG000|Overall Study|Withdrawal of Consent|2|||
161856968|NCT02071225|584517234|FG000|Overall Study|Protocol Deviation|1|||
161856969|NCT02071225|584517234|FG000|Overall Study|Lost to Follow-up|2|||
161856970|NCT02071225|584517234|FG000|Overall Study|Death|25|||
161856971|NCT01342081|584517237|FG000|Overall Study|Did not receive allocated intervention|0|||
161856972|NCT01342081|584517238|FG001|Overall Study|Did not receive allocated intervention|0|||
161856973|NCT01342081|584517239|FG002|Overall Study|Did not receive allocated intervention|1|||
161856974|NCT01342081|584517237|FG000|Overall Study|Adverse Event|1|||
161856975|NCT01342081|584517238|FG001|Overall Study|Adverse Event|0|||
161856976|NCT01342081|584517239|FG002|Overall Study|Adverse Event|0|||
161856977|NCT01342081|584517237|FG000|Overall Study|Physician Decision|0|||
161856978|NCT01342081|584517238|FG001|Overall Study|Physician Decision|1|||
161856979|NCT01342081|584517239|FG002|Overall Study|Physician Decision|0|||
161856980|NCT01342081|584517237|FG000|Overall Study|Withdrawal by Subject|1|||
161856981|NCT01342081|584517238|FG001|Overall Study|Withdrawal by Subject|1|||
161856982|NCT01342081|584517239|FG002|Overall Study|Withdrawal by Subject|0|||
161856983|NCT04720053|584517244|FG000|Overall Study|Lost to Follow-up|12|||
161856984|NCT01942993|584517245|FG000|Overall Study|Lost to Follow-up|1|||
161856985|NCT01942993|584517245|FG000|Overall Study|Physician Decision|1|||
161856986|NCT02906670|584517249|FG000|Cohort 1, QW|Radiological Progression|1|||
161856987|NCT02906670|584517250|FG001|Cohort 1, QW|Radiological Progression|0|||
161856988|NCT02906670|584517251|FG002|Cohort 1, QW|Radiological Progression|0|||
161856989|NCT02906670|584517252|FG003|Cohort 1, QW|Radiological Progression|0|||
161856990|NCT02906670|584517253|FG004|Cohort 1, QW|Radiological Progression|0|||
161856991|NCT02906670|584517254|FG005|Cohort 1, QW|Radiological Progression|0|||
161856992|NCT02906670|584517255|FG006|Cohort 1, QW|Radiological Progression|0|||
161856993|NCT02906670|584517256|FG007|Cohort 1, QW|Radiological Progression|0|||
161856994|NCT02906670|584517257|FG008|Cohort 1, QW|Radiological Progression|0|||
161856995|NCT02906670|584517258|FG009|Cohort 1, QW|Radiological Progression|0|||
161856996|NCT02906670|584517249|FG000|Cohort 2, QW|Radiological Progression|0|||
161856997|NCT02906670|584517250|FG001|Cohort 2, QW|Radiological Progression|1|||
161856998|NCT02906670|584517251|FG002|Cohort 2, QW|Radiological Progression|0|||
161856999|NCT02906670|584517252|FG003|Cohort 2, QW|Radiological Progression|0|||
161857000|NCT02906670|584517253|FG004|Cohort 2, QW|Radiological Progression|0|||
161857001|NCT02906670|584517254|FG005|Cohort 2, QW|Radiological Progression|0|||
161769432|NCT02260791|584196185|FG000|Overall Study|Withdrawal by Subject|11|||
161769433|NCT02260791|584196186|FG001|Overall Study|Withdrawal by Subject|16|||
161769434|NCT02260791|584196185|FG000|Overall Study|Screen failure|0|||
161769435|NCT02260791|584196186|FG001|Overall Study|Screen failure|1|||
161769436|NCT02260791|584196185|FG000|Overall Study|Protocol deviation|2|||
161769437|NCT02260791|584196186|FG001|Overall Study|Protocol deviation|3|||
161769438|NCT01411917|584196187|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
161769439|NCT01411917|584196188|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
161769440|NCT02354599|584196191|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161769441|NCT02354599|584196192|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161769442|NCT02354599|584196193|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161769443|NCT02354599|584196194|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
161769444|NCT02354599|584196195|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161769445|NCT02354599|584196196|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
161769446|NCT02354599|584196191|FG000|Overall Study|Withdrawal by Subject|1|||
161769447|NCT02354599|584196192|FG001|Overall Study|Withdrawal by Subject|1|||
161769448|NCT02354599|584196193|FG002|Overall Study|Withdrawal by Subject|0|||
161769449|NCT02354599|584196194|FG003|Overall Study|Withdrawal by Subject|0|||
161769450|NCT02354599|584196195|FG004|Overall Study|Withdrawal by Subject|0|||
161769451|NCT02354599|584196196|FG005|Overall Study|Withdrawal by Subject|0|||
161769452|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Death|2|||
161769453|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Death|0|||
161769454|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Adverse Event|33|||
161769455|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Adverse Event|31|||
161769456|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
161769457|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
161769458|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
161769459|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
161769460|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
161769461|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
161769462|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Other|7|||
161769463|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Other|8|||
161769464|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
161769465|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
161769466|NCT00495794|584196201|FG000|Overall Study|Pharmacist did not activate patient|522|||
161769467|NCT00495794|584196202|FG001|Overall Study|Pharmacist did not activate patient|0|||
161769468|NCT00198107|584198458|FG000|Double-Blind Period|Adverse Event|1|||
161769469|NCT00198107|584198459|FG001|Double-Blind Period|Adverse Event|1|||
161769470|NCT00198107|584198460|FG002|Double-Blind Period|Adverse Event|0|||
161769471|NCT00198107|584198458|FG000|Double-Blind Period|Lack of Efficacy|2|||
161769472|NCT00198107|584198459|FG001|Double-Blind Period|Lack of Efficacy|0|||
161769473|NCT00198107|584198460|FG002|Double-Blind Period|Lack of Efficacy|0|||
161769474|NCT00198107|584198458|FG000|Double-Blind Period|Lost to Follow-up|2|||
161769475|NCT00198107|584198459|FG001|Double-Blind Period|Lost to Follow-up|1|||
161769476|NCT00198107|584198460|FG002|Double-Blind Period|Lost to Follow-up|0|||
161769477|NCT00198107|584198458|FG000|Double-Blind Period|Physician Decision|1|||
161769478|NCT00198107|584198459|FG001|Double-Blind Period|Physician Decision|0|||
161769479|NCT00198107|584198460|FG002|Double-Blind Period|Physician Decision|0|||
161769480|NCT00198107|584198458|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161769481|NCT00198107|584198459|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161769482|NCT00198107|584198460|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161769483|NCT00198107|584198458|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
161769484|NCT00198107|584198459|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
161769485|NCT00198107|584198460|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
161769486|NCT02513732|584198461|FG000|Overall Study|Lost to Follow-up|11|||
161769487|NCT02513732|584198461|FG000|Overall Study|Death|9|||
161769488|NCT02513732|584198461|FG000|Overall Study|Changing hospital|2|||
161769489|NCT00467051|584198462|FG000|Overall Study|Adverse Event|2|||
161769490|NCT00934661|584198463|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
161769491|NCT00934661|584198464|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
161769492|NCT01846442|584198469|FG000|Overall Study|Adverse Event|2|||
161769493|NCT01846442|584198470|FG001|Overall Study|Adverse Event|4|||
161769494|NCT01846442|584198471|FG002|Overall Study|Adverse Event|2|||
161769495|NCT01846442|584198472|FG003|Overall Study|Adverse Event|1|||
161769496|NCT01846442|584198469|FG000|Overall Study|Lost to Follow-up|0|||
161769497|NCT01846442|584198470|FG001|Overall Study|Lost to Follow-up|0|||
161769498|NCT01846442|584198471|FG002|Overall Study|Lost to Follow-up|1|||
161769499|NCT01846442|584198472|FG003|Overall Study|Lost to Follow-up|0|||
161857002|NCT02906670|584517255|FG006|Cohort 2, QW|Radiological Progression|0|||
161857003|NCT02906670|584517256|FG007|Cohort 2, QW|Radiological Progression|0|||
161857004|NCT02906670|584517257|FG008|Cohort 2, QW|Radiological Progression|0|||
161857005|NCT02906670|584517258|FG009|Cohort 2, QW|Radiological Progression|0|||
161857006|NCT02906670|584517249|FG000|Cohort 3, QW|Radiological Progression|0|||
161857007|NCT02906670|584517250|FG001|Cohort 3, QW|Radiological Progression|0|||
161857008|NCT02906670|584517251|FG002|Cohort 3, QW|Radiological Progression|2|||
161857009|NCT02906670|584517252|FG003|Cohort 3, QW|Radiological Progression|0|||
161857010|NCT02906670|584517253|FG004|Cohort 3, QW|Radiological Progression|0|||
161857011|NCT02906670|584517254|FG005|Cohort 3, QW|Radiological Progression|0|||
161857012|NCT02906670|584517255|FG006|Cohort 3, QW|Radiological Progression|0|||
161857013|NCT02906670|584517256|FG007|Cohort 3, QW|Radiological Progression|0|||
161857014|NCT02906670|584517257|FG008|Cohort 3, QW|Radiological Progression|0|||
161857015|NCT02906670|584517258|FG009|Cohort 3, QW|Radiological Progression|0|||
161857016|NCT02906670|584517249|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857017|NCT02906670|584517250|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857018|NCT02906670|584517251|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
161857019|NCT02906670|584517252|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857020|NCT02906670|584517253|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857021|NCT02906670|584517254|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857022|NCT02906670|584517255|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857023|NCT02906670|584517256|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857024|NCT02906670|584517257|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857025|NCT02906670|584517258|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857026|NCT02906670|584517249|FG000|Cohort 4, Q2W|Radiological Progression|0|||
161857027|NCT02906670|584517250|FG001|Cohort 4, Q2W|Radiological Progression|0|||
161857028|NCT02906670|584517251|FG002|Cohort 4, Q2W|Radiological Progression|0|||
161857029|NCT02906670|584517252|FG003|Cohort 4, Q2W|Radiological Progression|0|||
161857030|NCT02906670|584517253|FG004|Cohort 4, Q2W|Radiological Progression|0|||
161857031|NCT02906670|584517254|FG005|Cohort 4, Q2W|Radiological Progression|1|||
161769500|NCT01846442|584198469|FG000|Overall Study|Withdrawal by Subject|3|||
161769501|NCT01846442|584198470|FG001|Overall Study|Withdrawal by Subject|2|||
161769502|NCT01846442|584198471|FG002|Overall Study|Withdrawal by Subject|0|||
161769503|NCT01846442|584198472|FG003|Overall Study|Withdrawal by Subject|1|||
161769504|NCT01846442|584198469|FG000|Overall Study|Left the city/Lost medication|1|||
161769505|NCT01846442|584198470|FG001|Overall Study|Left the city/Lost medication|0|||
161769506|NCT01846442|584198471|FG002|Overall Study|Left the city/Lost medication|1|||
161769507|NCT01846442|584198472|FG003|Overall Study|Left the city/Lost medication|1|||
161769508|NCT02777554|584198475|FG000|Overall Study|Adverse Event|4|||
161769509|NCT02777554|584198476|FG001|Overall Study|Adverse Event|4|||
161769510|NCT02777554|584198477|FG002|Overall Study|Adverse Event|0|||
161769511|NCT02777554|584198478|FG003|Overall Study|Adverse Event|1|||
161769512|NCT02777554|584198479|FG004|Overall Study|Adverse Event|0|||
161769513|NCT02777554|584198480|FG005|Overall Study|Adverse Event|0|||
161769514|NCT02777554|584198475|FG000|Overall Study|Withdrawal by Subject|3|||
161769515|NCT02777554|584198476|FG001|Overall Study|Withdrawal by Subject|1|||
161769516|NCT02777554|584198477|FG002|Overall Study|Withdrawal by Subject|1|||
161769517|NCT02777554|584198478|FG003|Overall Study|Withdrawal by Subject|0|||
161769518|NCT02777554|584198479|FG004|Overall Study|Withdrawal by Subject|0|||
161769519|NCT02777554|584198480|FG005|Overall Study|Withdrawal by Subject|0|||
161769520|NCT02777554|584198475|FG000|Overall Study|Discharged early due to hurricane|22|||
161857032|NCT02906670|584517255|FG006|Cohort 4, Q2W|Radiological Progression|0|||
161857033|NCT02906670|584517256|FG007|Cohort 4, Q2W|Radiological Progression|0|||
161857034|NCT02906670|584517257|FG008|Cohort 4, Q2W|Radiological Progression|0|||
161857035|NCT02906670|584517258|FG009|Cohort 4, Q2W|Radiological Progression|0|||
161857036|NCT02906670|584517249|FG000|Cohort 4, Q2W|Clinical Progression|0|||
161857037|NCT02906670|584517250|FG001|Cohort 4, Q2W|Clinical Progression|0|||
161857038|NCT02906670|584517251|FG002|Cohort 4, Q2W|Clinical Progression|0|||
161857039|NCT02906670|584517252|FG003|Cohort 4, Q2W|Clinical Progression|0|||
161857040|NCT02906670|584517253|FG004|Cohort 4, Q2W|Clinical Progression|0|||
161857041|NCT02906670|584517254|FG005|Cohort 4, Q2W|Clinical Progression|2|||
161857042|NCT02906670|584517255|FG006|Cohort 4, Q2W|Clinical Progression|0|||
161857043|NCT02906670|584517256|FG007|Cohort 4, Q2W|Clinical Progression|0|||
161857044|NCT02906670|584517257|FG008|Cohort 4, Q2W|Clinical Progression|0|||
161857045|NCT02906670|584517258|FG009|Cohort 4, Q2W|Clinical Progression|0|||
161857046|NCT02906670|584517249|FG000|Cohort 5, Q2W|Radiological Progression|0|||
161857047|NCT02906670|584517250|FG001|Cohort 5, Q2W|Radiological Progression|0|||
161857048|NCT02906670|584517251|FG002|Cohort 5, Q2W|Radiological Progression|0|||
161857049|NCT02906670|584517252|FG003|Cohort 5, Q2W|Radiological Progression|0|||
161857050|NCT02906670|584517253|FG004|Cohort 5, Q2W|Radiological Progression|0|||
161769521|NCT02777554|584198476|FG001|Overall Study|Discharged early due to hurricane|20|||
161769522|NCT02777554|584198477|FG002|Overall Study|Discharged early due to hurricane|0|||
161857051|NCT02906670|584517254|FG005|Cohort 5, Q2W|Radiological Progression|0|||
161857052|NCT02906670|584517255|FG006|Cohort 5, Q2W|Radiological Progression|4|||
161857053|NCT02906670|584517256|FG007|Cohort 5, Q2W|Radiological Progression|0|||
161857054|NCT02906670|584517257|FG008|Cohort 5, Q2W|Radiological Progression|0|||
161857055|NCT02906670|584517258|FG009|Cohort 5, Q2W|Radiological Progression|0|||
161857056|NCT02906670|584517249|FG000|Cohort 5, Q2W|Clinical Progression|0|||
161857057|NCT02906670|584517250|FG001|Cohort 5, Q2W|Clinical Progression|0|||
161857058|NCT02906670|584517251|FG002|Cohort 5, Q2W|Clinical Progression|0|||
161857059|NCT02906670|584517252|FG003|Cohort 5, Q2W|Clinical Progression|0|||
161857060|NCT02906670|584517253|FG004|Cohort 5, Q2W|Clinical Progression|0|||
161857061|NCT02906670|584517254|FG005|Cohort 5, Q2W|Clinical Progression|0|||
161857062|NCT02906670|584517255|FG006|Cohort 5, Q2W|Clinical Progression|1|||
161857063|NCT02906670|584517256|FG007|Cohort 5, Q2W|Clinical Progression|0|||
161857064|NCT02906670|584517257|FG008|Cohort 5, Q2W|Clinical Progression|0|||
161857065|NCT02906670|584517258|FG009|Cohort 5, Q2W|Clinical Progression|0|||
161857066|NCT02906670|584517249|FG000|Cohort 5, Q2W|Adverse Event|0|||
161857067|NCT02906670|584517250|FG001|Cohort 5, Q2W|Adverse Event|0|||
161857068|NCT02906670|584517251|FG002|Cohort 5, Q2W|Adverse Event|0|||
161857069|NCT02906670|584517252|FG003|Cohort 5, Q2W|Adverse Event|0|||
161857070|NCT02906670|584517253|FG004|Cohort 5, Q2W|Adverse Event|0|||
161857071|NCT02906670|584517254|FG005|Cohort 5, Q2W|Adverse Event|0|||
161857072|NCT02906670|584517255|FG006|Cohort 5, Q2W|Adverse Event|1|||
161857073|NCT02906670|584517256|FG007|Cohort 5, Q2W|Adverse Event|0|||
161857074|NCT02906670|584517257|FG008|Cohort 5, Q2W|Adverse Event|0|||
161857075|NCT02906670|584517258|FG009|Cohort 5, Q2W|Adverse Event|0|||
161857076|NCT02906670|584517249|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857077|NCT02906670|584517250|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857078|NCT02906670|584517251|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857079|NCT02906670|584517252|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857080|NCT02906670|584517253|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857081|NCT02906670|584517254|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857082|NCT02906670|584517255|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
161857083|NCT02906670|584517256|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857084|NCT02906670|584517257|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857085|NCT02906670|584517258|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857086|NCT02906670|584517249|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
161857087|NCT02906670|584517250|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
161857088|NCT02906670|584517251|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
161857089|NCT02906670|584517252|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
161857090|NCT02906670|584517253|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
161857091|NCT02906670|584517254|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
161857092|NCT02906670|584517255|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
161857093|NCT02906670|584517256|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
161857094|NCT02906670|584517257|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
161857095|NCT02906670|584517258|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
161857096|NCT02906670|584517249|FG000|Cohort 5P, Q2W|Adverse Event|0|||
161857097|NCT02906670|584517250|FG001|Cohort 5P, Q2W|Adverse Event|0|||
161857098|NCT02906670|584517251|FG002|Cohort 5P, Q2W|Adverse Event|0|||
161857099|NCT02906670|584517252|FG003|Cohort 5P, Q2W|Adverse Event|0|||
161857100|NCT02906670|584517253|FG004|Cohort 5P, Q2W|Adverse Event|0|||
161857101|NCT02906670|584517254|FG005|Cohort 5P, Q2W|Adverse Event|0|||
161857102|NCT02906670|584517255|FG006|Cohort 5P, Q2W|Adverse Event|0|||
161857103|NCT02906670|584517256|FG007|Cohort 5P, Q2W|Adverse Event|1|||
161857104|NCT02906670|584517257|FG008|Cohort 5P, Q2W|Adverse Event|0|||
161857105|NCT02906670|584517258|FG009|Cohort 5P, Q2W|Adverse Event|0|||
161857106|NCT02906670|584517249|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
161857107|NCT02906670|584517250|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
161857108|NCT02906670|584517251|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
161857109|NCT02906670|584517252|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
161857110|NCT02906670|584517253|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
161857111|NCT02906670|584517254|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
161857112|NCT02906670|584517255|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
161857113|NCT02906670|584517256|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
161857114|NCT02906670|584517257|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
161857115|NCT02906670|584517258|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
161857116|NCT02906670|584517249|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
161857117|NCT02906670|584517250|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
161857118|NCT02906670|584517251|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
161857119|NCT02906670|584517252|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
161857120|NCT02906670|584517253|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
161857121|NCT02906670|584517254|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
161857122|NCT02906670|584517255|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
161857123|NCT02906670|584517256|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
161857124|NCT02906670|584517257|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
161857125|NCT02906670|584517258|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
161857126|NCT02906670|584517249|FG000|Cohort 4P, QW|Radiological Progression|0|||
161857127|NCT02906670|584517250|FG001|Cohort 4P, QW|Radiological Progression|0|||
161857128|NCT02906670|584517251|FG002|Cohort 4P, QW|Radiological Progression|0|||
161857129|NCT02906670|584517252|FG003|Cohort 4P, QW|Radiological Progression|3|||
161857130|NCT02906670|584517253|FG004|Cohort 4P, QW|Radiological Progression|0|||
161857131|NCT02906670|584517254|FG005|Cohort 4P, QW|Radiological Progression|0|||
161857132|NCT02906670|584517255|FG006|Cohort 4P, QW|Radiological Progression|0|||
161857133|NCT02906670|584517256|FG007|Cohort 4P, QW|Radiological Progression|0|||
161857134|NCT02906670|584517257|FG008|Cohort 4P, QW|Radiological Progression|0|||
161857135|NCT02906670|584517258|FG009|Cohort 4P, QW|Radiological Progression|0|||
161857136|NCT02906670|584517249|FG000|Cohort 7P, Q2W|Adverse Event|0|||
161857137|NCT02906670|584517250|FG001|Cohort 7P, Q2W|Adverse Event|0|||
161857138|NCT02906670|584517251|FG002|Cohort 7P, Q2W|Adverse Event|0|||
161857139|NCT02906670|584517252|FG003|Cohort 7P, Q2W|Adverse Event|0|||
161857140|NCT02906670|584517253|FG004|Cohort 7P, Q2W|Adverse Event|0|||
161857141|NCT02906670|584517254|FG005|Cohort 7P, Q2W|Adverse Event|0|||
161857142|NCT02906670|584517255|FG006|Cohort 7P, Q2W|Adverse Event|0|||
161857143|NCT02906670|584517256|FG007|Cohort 7P, Q2W|Adverse Event|0|||
161857144|NCT02906670|584517257|FG008|Cohort 7P, Q2W|Adverse Event|0|||
161857145|NCT02906670|584517258|FG009|Cohort 7P, Q2W|Adverse Event|1|||
161857146|NCT02906670|584517249|FG000|Cohort 7P, Q2W|Physician Decision|0|||
161857147|NCT02906670|584517250|FG001|Cohort 7P, Q2W|Physician Decision|0|||
161857148|NCT02906670|584517251|FG002|Cohort 7P, Q2W|Physician Decision|0|||
161857149|NCT02906670|584517252|FG003|Cohort 7P, Q2W|Physician Decision|0|||
161857150|NCT02906670|584517253|FG004|Cohort 7P, Q2W|Physician Decision|0|||
161857151|NCT02906670|584517254|FG005|Cohort 7P, Q2W|Physician Decision|0|||
161857152|NCT02906670|584517255|FG006|Cohort 7P, Q2W|Physician Decision|0|||
161857153|NCT02906670|584517256|FG007|Cohort 7P, Q2W|Physician Decision|0|||
161857154|NCT02906670|584517257|FG008|Cohort 7P, Q2W|Physician Decision|0|||
161857155|NCT02906670|584517258|FG009|Cohort 7P, Q2W|Physician Decision|1|||
161857156|NCT02906670|584517249|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857157|NCT02906670|584517250|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857158|NCT02906670|584517251|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857159|NCT02906670|584517252|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857160|NCT02906670|584517253|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857161|NCT02906670|584517254|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857162|NCT02906670|584517255|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857163|NCT02906670|584517256|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857164|NCT02906670|584517257|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857165|NCT02906670|584517258|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
161857166|NCT02906670|584517249|FG000|Cohort 5P, QW|Radiological Progression|0|||
161857167|NCT02906670|584517250|FG001|Cohort 5P, QW|Radiological Progression|0|||
161857168|NCT02906670|584517251|FG002|Cohort 5P, QW|Radiological Progression|0|||
161857169|NCT02906670|584517252|FG003|Cohort 5P, QW|Radiological Progression|0|||
161857170|NCT02906670|584517253|FG004|Cohort 5P, QW|Radiological Progression|3|||
161857171|NCT02906670|584517254|FG005|Cohort 5P, QW|Radiological Progression|0|||
161857172|NCT02906670|584517255|FG006|Cohort 5P, QW|Radiological Progression|0|||
161857173|NCT02906670|584517256|FG007|Cohort 5P, QW|Radiological Progression|0|||
161857174|NCT02906670|584517257|FG008|Cohort 5P, QW|Radiological Progression|0|||
161857175|NCT02906670|584517258|FG009|Cohort 5P, QW|Radiological Progression|0|||
161857176|NCT01349192|584517259|FG000|Overall Study|Protocol Violation|0|||
161857177|NCT01349192|584517260|FG001|Overall Study|Protocol Violation|1|||
161857178|NCT01349192|584517259|FG000|Overall Study|Withdrawal by Subject|0|||
161857179|NCT01349192|584517260|FG001|Overall Study|Withdrawal by Subject|2|||
161857180|NCT01349192|584517259|FG000|Overall Study|Lost to Follow-up|1|||
161857181|NCT01349192|584517260|FG001|Overall Study|Lost to Follow-up|3|||
161857182|NCT01349192|584517259|FG000|Overall Study|Failure to adhere to Protocol|2|||
161857183|NCT01349192|584517260|FG001|Overall Study|Failure to adhere to Protocol|0|||
161857184|NCT03749330|584517261|FG000|Overall Study|Clinicians left work in the CICU|0|||
161857185|NCT03749330|584517262|FG001|Overall Study|Clinicians left work in the CICU|2|||
161857186|NCT03749330|584517263|FG002|Overall Study|Clinicians left work in the CICU|0|||
161857187|NCT03749330|584517264|FG003|Overall Study|Clinicians left work in the CICU|0|||
161857188|NCT03749330|584517265|FG004|Overall Study|Clinicians left work in the CICU|0|||
161857189|NCT03749330|584517266|FG005|Overall Study|Clinicians left work in the CICU|0|||
161857190|NCT02105467|584517269|FG000|Period 1|Lost to Follow-up|1|||
161857191|NCT02105467|584517270|FG001|Period 1|Lost to Follow-up|0|||
161857192|NCT02105467|584517269|FG000|Period 1|Death|1|||
161857193|NCT02105467|584517270|FG001|Period 1|Death|0|||
161857194|NCT02105467|584517269|FG000|Period 2|Lost to Follow-up|1|||
161857195|NCT02105467|584517270|FG001|Period 2|Lost to Follow-up|0|||
161857196|NCT02105467|584517269|FG000|Period 2|Death|1|||
161857197|NCT02105467|584517270|FG001|Period 2|Death|0|||
161857198|NCT02105467|584517269|FG000|Period 2|Withdrawal by Subject|0|||
161857199|NCT02105467|584517270|FG001|Period 2|Withdrawal by Subject|2|||
161857200|NCT02105467|584517269|FG000|Period 3|Lost to Follow-up|0|||
161857201|NCT02105467|584517270|FG001|Period 3|Lost to Follow-up|1|||
161857202|NCT03908125|584517271|FG000|Overall Study|Withdrawal by Subject|92|||
161857203|NCT03908125|584517271|FG000|Overall Study|Lost to Follow-up|8|||
161857204|NCT02262325|584517272|FG000|Overall Study|Death|16|||
161857205|NCT02262325|584517272|FG000|Overall Study|Lost to Follow-up|1|||
161857206|NCT02815995|584517273|FG000|Overall Study|Disease Progression|3|||
161857207|NCT02815995|584517274|FG001|Overall Study|Disease Progression|7|||
161857208|NCT02815995|584517275|FG002|Overall Study|Disease Progression|2|||
161857209|NCT02815995|584517276|FG003|Overall Study|Disease Progression|4|||
161857210|NCT02815995|584517277|FG004|Overall Study|Disease Progression|3|||
161857211|NCT02815995|584517278|FG005|Overall Study|Disease Progression|9|||
161857212|NCT02815995|584517279|FG006|Overall Study|Disease Progression|3|||
161857213|NCT02815995|584517280|FG007|Overall Study|Disease Progression|1|||
161857214|NCT02815995|584517273|FG000|Overall Study|Adverse Event|1|||
161857215|NCT02815995|584517274|FG001|Overall Study|Adverse Event|2|||
161857216|NCT02815995|584517275|FG002|Overall Study|Adverse Event|2|||
161857217|NCT02815995|584517276|FG003|Overall Study|Adverse Event|0|||
161857218|NCT02815995|584517277|FG004|Overall Study|Adverse Event|0|||
161857219|NCT02815995|584517278|FG005|Overall Study|Adverse Event|1|||
161857220|NCT02815995|584517279|FG006|Overall Study|Adverse Event|0|||
161857221|NCT02815995|584517280|FG007|Overall Study|Adverse Event|0|||
161857222|NCT02815995|584517273|FG000|Overall Study|Pregnancy|0|||
161857223|NCT02815995|584517274|FG001|Overall Study|Pregnancy|0|||
161857224|NCT02815995|584517275|FG002|Overall Study|Pregnancy|0|||
161857225|NCT02815995|584517276|FG003|Overall Study|Pregnancy|0|||
161857226|NCT02815995|584517277|FG004|Overall Study|Pregnancy|0|||
161857227|NCT02815995|584517278|FG005|Overall Study|Pregnancy|0|||
161857228|NCT02815995|584517279|FG006|Overall Study|Pregnancy|1|||
161857229|NCT02815995|584517280|FG007|Overall Study|Pregnancy|0|||
161857230|NCT01071915|584517284|FG000|Overall Study|Adverse Event|3|||
161857231|NCT01071915|584517284|FG000|Overall Study|Physician Decision|2|||
161857232|NCT01071915|584517284|FG000|Overall Study|Withdrawal by Subject|2|||
161857233|NCT01071915|584517284|FG000|Overall Study|Miscellaneous Reasons|2|||
161857234|NCT02016183|584517285|FG000|Overall Study|Case Report Forms Uncollected|13|||
161857235|NCT02016183|584517285|FG000|Overall Study|Protocol Violation|52|||
161857236|NCT00770328|584517286|FG000|Overall Study|Adverse Event|11|||
161857237|NCT00770328|584517287|FG001|Overall Study|Adverse Event|2|||
161857238|NCT00770328|584517286|FG000|Overall Study|Lost to Follow-up|2|||
161857239|NCT00770328|584517287|FG001|Overall Study|Lost to Follow-up|2|||
161857240|NCT02286843|584517290|FG000|Overall Study|Not Treated|4|||
161857241|NCT02286843|584517290|FG000|Overall Study|Protocol Violation|1|||
161857242|NCT02286843|584517290|FG000|Overall Study|Withdrawal by Subject|1|||
161857243|NCT02536846|584517291|FG000|Overall Study|Withdrawal by Subject|1|||
161857244|NCT04388553|584517292|FG000|Overall Study|Protocol Violation|1|||
161857245|NCT04388553|584517293|FG001|Overall Study|Protocol Violation|0|||
161857246|NCT04604795|584517294|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
161857247|NCT04604795|584517295|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
161857248|NCT04604795|584517296|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857249|NCT04604795|584517297|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857250|NCT04604795|584517298|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857251|NCT04604795|584517299|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857252|NCT04604795|584517300|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857253|NCT04604795|584517301|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857254|NCT04604795|584517302|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857255|NCT04604795|584517303|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857256|NCT04604795|584517294|FG000|Part B: Up to Day 14|Adverse Event|0|||
161857257|NCT04604795|584517295|FG001|Part B: Up to Day 14|Adverse Event|0|||
161857258|NCT04604795|584517296|FG002|Part B: Up to Day 14|Adverse Event|0|||
161857259|NCT04604795|584517297|FG003|Part B: Up to Day 14|Adverse Event|0|||
161857260|NCT04604795|584517298|FG004|Part B: Up to Day 14|Adverse Event|2|||
161857261|NCT04604795|584517299|FG005|Part B: Up to Day 14|Adverse Event|1|||
161857262|NCT04604795|584517300|FG006|Part B: Up to Day 14|Adverse Event|0|||
161857263|NCT04604795|584517301|FG007|Part B: Up to Day 14|Adverse Event|0|||
161857264|NCT04604795|584517302|FG008|Part B: Up to Day 14|Adverse Event|0|||
161857265|NCT04604795|584517303|FG009|Part B: Up to Day 14|Adverse Event|0|||
161857266|NCT04604795|584517294|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857267|NCT04604795|584517295|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857268|NCT04604795|584517296|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857269|NCT04604795|584517297|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857270|NCT04604795|584517298|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857271|NCT04604795|584517299|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857272|NCT04604795|584517300|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857273|NCT04604795|584517301|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857274|NCT04604795|584517302|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161769523|NCT02777554|584198478|FG003|Overall Study|Discharged early due to hurricane|0|||
161769524|NCT02777554|584198479|FG004|Overall Study|Discharged early due to hurricane|0|||
161769525|NCT02777554|584198480|FG005|Overall Study|Discharged early due to hurricane|0|||
161769526|NCT02777554|584198475|FG000|Overall Study|Other - Miscellaneous|1|||
161769527|NCT02777554|584198476|FG001|Overall Study|Other - Miscellaneous|0|||
161769528|NCT02777554|584198477|FG002|Overall Study|Other - Miscellaneous|0|||
161769529|NCT02777554|584198478|FG003|Overall Study|Other - Miscellaneous|0|||
161769530|NCT02777554|584198479|FG004|Overall Study|Other - Miscellaneous|0|||
161769531|NCT02777554|584198480|FG005|Overall Study|Other - Miscellaneous|0|||
161769532|NCT02147132|584198481|FG000|Overall Study|Lost to Follow-up|1|||
161769533|NCT02147132|584198482|FG001|Overall Study|Lost to Follow-up|0|||
161769534|NCT02147132|584198483|FG002|Overall Study|Lost to Follow-up|0|||
161769535|NCT02147132|584198484|FG003|Overall Study|Lost to Follow-up|0|||
161769536|NCT01013207|584198485|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
161769537|NCT01541644|584198490|FG000|Overall Study|Withdrawal by Subject|3|||
161769538|NCT01458535|584198493|FG000|Overall Study|Other|0|||
161769539|NCT01458535|584198494|FG001|Overall Study|Other|0|||
161769540|NCT01458535|584198495|FG002|Overall Study|Other|0|||
161769541|NCT01458535|584198496|FG003|Overall Study|Other|0|||
161769542|NCT01458535|584198497|FG004|Overall Study|Other|1|||
161769543|NCT01458535|584198498|FG005|Overall Study|Other|1|||
161769544|NCT01458535|584198493|FG000|Overall Study|Withdrawal by Subject|0|||
161769545|NCT01458535|584198494|FG001|Overall Study|Withdrawal by Subject|0|||
161769546|NCT01458535|584198495|FG002|Overall Study|Withdrawal by Subject|2|||
161769547|NCT01458535|584198496|FG003|Overall Study|Withdrawal by Subject|0|||
161769548|NCT01458535|584198497|FG004|Overall Study|Withdrawal by Subject|1|||
161769549|NCT01458535|584198498|FG005|Overall Study|Withdrawal by Subject|1|||
161769550|NCT01458535|584198493|FG000|Overall Study|Lost to Follow-up|0|||
161769551|NCT01458535|584198494|FG001|Overall Study|Lost to Follow-up|2|||
161769552|NCT01458535|584198495|FG002|Overall Study|Lost to Follow-up|0|||
161769553|NCT01458535|584198496|FG003|Overall Study|Lost to Follow-up|3|||
161769554|NCT01458535|584198497|FG004|Overall Study|Lost to Follow-up|2|||
161769555|NCT01458535|584198498|FG005|Overall Study|Lost to Follow-up|2|||
161769556|NCT01458535|584198493|FG000|Overall Study|Adverse Event|0|||
161769557|NCT01458535|584198494|FG001|Overall Study|Adverse Event|0|||
161769558|NCT01458535|584198495|FG002|Overall Study|Adverse Event|0|||
161769559|NCT01458535|584198496|FG003|Overall Study|Adverse Event|1|||
161769560|NCT01458535|584198497|FG004|Overall Study|Adverse Event|0|||
161769561|NCT01458535|584198498|FG005|Overall Study|Adverse Event|0|||
161769562|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
161769563|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
161769564|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769565|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769566|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769567|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769568|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769569|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769570|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769571|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769572|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769573|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769574|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161769575|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769576|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769577|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769578|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769579|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769580|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161769581|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769582|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769583|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769584|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161769585|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769586|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769587|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
161769588|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769589|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769590|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769591|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769592|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769593|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769594|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769595|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769596|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769597|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769598|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
161769599|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
161769600|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
161769601|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
161769602|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
161769603|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
161769604|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
161769605|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
161769606|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
161769607|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
161769608|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
161769609|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
161769610|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769611|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769612|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769613|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769614|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769615|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
161769616|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769617|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769618|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769619|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769620|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769621|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769622|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769623|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769624|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769625|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769626|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769627|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
161769628|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769629|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769630|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769631|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769632|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769633|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769634|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769635|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769636|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769637|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769638|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769639|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769640|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
161769641|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769642|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769643|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769644|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769645|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769646|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769647|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769648|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769649|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769650|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769651|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
161769652|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769653|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769654|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769655|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769656|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769657|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769658|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
161769659|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
161857275|NCT04604795|584517303|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
161857276|NCT04604795|584517294|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857277|NCT04604795|584517295|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857278|NCT04604795|584517296|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857279|NCT04604795|584517297|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857280|NCT04604795|584517298|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857281|NCT04604795|584517299|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857282|NCT04604795|584517300|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857283|NCT04604795|584517301|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857284|NCT04604795|584517302|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
161857285|NCT04604795|584517303|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857286|NCT04604795|584517294|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857287|NCT04604795|584517295|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857288|NCT04604795|584517296|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857289|NCT04604795|584517297|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857290|NCT04604795|584517298|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857291|NCT04604795|584517299|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857292|NCT04604795|584517300|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857293|NCT04604795|584517301|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857294|NCT04604795|584517302|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
161857295|NCT04604795|584517303|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857296|NCT04604795|584517294|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857297|NCT04604795|584517295|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857298|NCT04604795|584517296|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857299|NCT04604795|584517297|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857300|NCT04604795|584517298|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857301|NCT04604795|584517299|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857302|NCT04604795|584517300|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857303|NCT04604795|584517301|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857304|NCT04604795|584517302|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
161857305|NCT04604795|584517303|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857306|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|3|||
161857307|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|2|||
161857308|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|1|||
161857309|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|1|||
161857310|NCT04386616|584517307|FG000|Overall Study|Death|22|||
161857311|NCT04386616|584517308|FG001|Overall Study|Death|22|||
161857312|NCT04386616|584517309|FG002|Overall Study|Death|21|||
161857313|NCT04386616|584517307|FG000|Overall Study|Lost to Follow-up|5|||
161857314|NCT04386616|584517308|FG001|Overall Study|Lost to Follow-up|8|||
161857315|NCT04386616|584517309|FG002|Overall Study|Lost to Follow-up|6|||
161857316|NCT04386616|584517307|FG000|Overall Study|Withdrawal by Subject|2|||
161857317|NCT04386616|584517308|FG001|Overall Study|Withdrawal by Subject|4|||
161857318|NCT04386616|584517309|FG002|Overall Study|Withdrawal by Subject|1|||
161857319|NCT04386616|584517307|FG000|Overall Study|Adverse Event|1|||
161857320|NCT04386616|584517308|FG001|Overall Study|Adverse Event|1|||
161857321|NCT04386616|584517309|FG002|Overall Study|Adverse Event|0|||
161857322|NCT01377012|584517310|FG000|Core Study|Study terminated by Sponsor|47|||
161857323|NCT01377012|584517311|FG001|Core Study|Study terminated by Sponsor|54|||
161857324|NCT01377012|584517312|FG002|Core Study|Study terminated by Sponsor|46|||
161857325|NCT01377012|584517310|FG000|Core Study|Technical problems|1|||
161857326|NCT01377012|584517311|FG001|Core Study|Technical problems|0|||
161857327|NCT01377012|584517312|FG002|Core Study|Technical problems|0|||
161857328|NCT01377012|584517310|FG000|Core Study|Withdrawal by Subject|15|||
161857329|NCT01377012|584517311|FG001|Core Study|Withdrawal by Subject|23|||
161857330|NCT01377012|584517312|FG002|Core Study|Withdrawal by Subject|18|||
161857331|NCT01377012|584517310|FG000|Core Study|Protocol Violation|7|||
161857332|NCT01377012|584517311|FG001|Core Study|Protocol Violation|3|||
161857333|NCT01377012|584517312|FG002|Core Study|Protocol Violation|2|||
161857334|NCT01377012|584517310|FG000|Core Study|Pregnancy|0|||
161857335|NCT01377012|584517311|FG001|Core Study|Pregnancy|0|||
161857336|NCT01377012|584517312|FG002|Core Study|Pregnancy|1|||
161857337|NCT01377012|584517310|FG000|Core Study|Physician Decision|5|||
161857338|NCT01377012|584517311|FG001|Core Study|Physician Decision|4|||
161857339|NCT01377012|584517312|FG002|Core Study|Physician Decision|10|||
161857340|NCT01377012|584517310|FG000|Core Study|Non-Compliant with study treatment|0|||
161857341|NCT01377012|584517311|FG001|Core Study|Non-Compliant with study treatment|0|||
161857342|NCT01377012|584517312|FG002|Core Study|Non-Compliant with study treatment|1|||
161857343|NCT01377012|584517310|FG000|Core Study|No Longer require treatment|0|||
161857344|NCT01377012|584517311|FG001|Core Study|No Longer require treatment|0|||
161857345|NCT01377012|584517312|FG002|Core Study|No Longer require treatment|1|||
161857346|NCT01377012|584517310|FG000|Core Study|Lost to Follow-up|7|||
161857347|NCT01377012|584517311|FG001|Core Study|Lost to Follow-up|5|||
161857348|NCT01377012|584517312|FG002|Core Study|Lost to Follow-up|4|||
161857349|NCT01377012|584517310|FG000|Core Study|Lack of Efficacy|41|||
161857350|NCT01377012|584517311|FG001|Core Study|Lack of Efficacy|28|||
161857351|NCT01377012|584517312|FG002|Core Study|Lack of Efficacy|37|||
161857352|NCT01377012|584517310|FG000|Core Study|Death|1|||
161857353|NCT01377012|584517311|FG001|Core Study|Death|1|||
161857354|NCT01377012|584517312|FG002|Core Study|Death|1|||
161857355|NCT01377012|584517310|FG000|Core Study|Adverse Event|10|||
161857356|NCT01377012|584517311|FG001|Core Study|Adverse Event|14|||
161857357|NCT01377012|584517312|FG002|Core Study|Adverse Event|13|||
161857358|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
161857359|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
161857360|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
161857361|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
161857362|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
161857363|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
161857364|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
161857365|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
161857366|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
161857367|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
161857368|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
161857369|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
161857370|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
161857371|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
161857372|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
161857373|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
161857374|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
161857375|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
161857376|NCT00805961|584517313|FG000|Modality Therapy|Withdrawal by Subject|1|||
161857377|NCT00805961|584517313|FG000|Modality Therapy|Adverse Event|1|||
161857378|NCT00805961|584517313|FG000|Modality Therapy|Disease Progression|2|||
161857379|NCT00805961|584517313|FG000|Treatment-Free Interval|Adverse Event|3|||
161857380|NCT00805961|584517313|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
161857381|NCT00805961|584517313|FG000|Treatment-Free Interval|Physician Decision|1|||
161857382|NCT00805961|584517313|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
161857383|NCT00805961|584517313|FG000|Maintenance Treatment|Lack of Efficacy|13|||
161857384|NCT00805961|584517313|FG000|Maintenance Treatment|Intercurrent Illness|7|||
161857385|NCT00805961|584517313|FG000|Maintenance Treatment|Adverse Event|6|||
161857386|NCT00805961|584517313|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
161857387|NCT00805961|584517313|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
161857388|NCT00805961|584517313|FG000|Maintenance Treatment|Withdrawn Consent|1|||
161857389|NCT05061134|584518990|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
161857390|NCT05061134|584518991|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
161857391|NCT05061134|584518992|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
161857392|NCT05061134|584518990|FG000|Overall Study|Subject not treated|0|||
161857393|NCT05061134|584518991|FG001|Overall Study|Subject not treated|0|||
161857394|NCT05061134|584518992|FG002|Overall Study|Subject not treated|2|||
161857395|NCT05061134|584518990|FG000|Overall Study|Other|0|||
161857396|NCT05061134|584518991|FG001|Overall Study|Other|0|||
161857397|NCT05061134|584518992|FG002|Overall Study|Other|9|||
161857398|NCT05061134|584518990|FG000|Overall Study|Withdrawal by Subject|9|||
161857399|NCT05061134|584518991|FG001|Overall Study|Withdrawal by Subject|8|||
161857400|NCT05061134|584518992|FG002|Overall Study|Withdrawal by Subject|5|||
161857401|NCT05061134|584518990|FG000|Overall Study|Study Terminated by Sponsor|22|||
161857402|NCT05061134|584518991|FG001|Overall Study|Study Terminated by Sponsor|14|||
161857403|NCT05061134|584518992|FG002|Overall Study|Study Terminated by Sponsor|7|||
161857404|NCT05061134|584518990|FG000|Overall Study|Progressive Disease|1|||
161857405|NCT05061134|584518991|FG001|Overall Study|Progressive Disease|2|||
161857406|NCT05061134|584518992|FG002|Overall Study|Progressive Disease|0|||
161857407|NCT05061134|584518990|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
161857408|NCT05061134|584518991|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
161857409|NCT05061134|584518992|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
161857410|NCT05061134|584518990|FG000|Overall Study|Lost to Follow-up|1|||
161857411|NCT05061134|584518991|FG001|Overall Study|Lost to Follow-up|0|||
161857412|NCT05061134|584518992|FG002|Overall Study|Lost to Follow-up|0|||
161857413|NCT05061134|584518990|FG000|Overall Study|Physician Decision|1|||
161857414|NCT05061134|584518991|FG001|Overall Study|Physician Decision|1|||
161857415|NCT05061134|584518992|FG002|Overall Study|Physician Decision|0|||
161857416|NCT05061134|584518990|FG000|Overall Study|Disease progression|1|||
161857417|NCT05061134|584518991|FG001|Overall Study|Disease progression|0|||
161769660|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
161769661|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
161769662|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
161769663|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
161769664|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
161769665|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
161769666|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
161769667|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
161769668|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
161769669|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
161769670|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769671|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769672|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769673|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769674|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769675|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769676|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
161769677|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769678|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769679|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769680|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769681|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769682|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769683|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769684|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
161769685|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769686|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769687|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769688|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769689|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769690|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769691|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769692|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769693|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769694|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769695|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161857418|NCT05061134|584518992|FG002|Overall Study|Disease progression|0|||
161857419|NCT05061134|584518990|FG000|Overall Study|Death|43|||
161857420|NCT05061134|584518991|FG001|Overall Study|Death|23|||
161857421|NCT05061134|584518992|FG002|Overall Study|Death|14|||
161857422|NCT05061134|584518990|FG000|Overall Study|Database lock|2|||
161857423|NCT05061134|584518991|FG001|Overall Study|Database lock|0|||
161857424|NCT05061134|584518992|FG002|Overall Study|Database lock|0|||
161857425|NCT03176134|584518993|FG000|Overall Study|Lost to Follow-up|0|||
161857426|NCT03176134|584518994|FG001|Overall Study|Lost to Follow-up|2|||
161857427|NCT03176134|584518995|FG002|Overall Study|Lost to Follow-up|0|||
161857428|NCT03176134|584518996|FG003|Overall Study|Lost to Follow-up|0|||
161857429|NCT03176134|584518997|FG004|Overall Study|Lost to Follow-up|0|||
161857430|NCT03176134|584518998|FG005|Overall Study|Lost to Follow-up|0|||
161857431|NCT03176134|584518999|FG006|Overall Study|Lost to Follow-up|0|||
161857432|NCT03176134|584519000|FG007|Overall Study|Lost to Follow-up|0|||
161857433|NCT03176134|584518993|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161857434|NCT03176134|584518994|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161857435|NCT03176134|584518995|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161857436|NCT03176134|584518996|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161857437|NCT03176134|584518997|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161857438|NCT03176134|584518998|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161857439|NCT03176134|584518999|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161857440|NCT03176134|584519000|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
161857441|NCT03410056|584519005|FG000|Overall Study|Decision by Sponsor|0|||
161857442|NCT03410056|584519006|FG001|Overall Study|Decision by Sponsor|0|||
161857443|NCT03410056|584519007|FG002|Overall Study|Decision by Sponsor|3|||
161857444|NCT03410056|584519008|FG003|Overall Study|Decision by Sponsor|0|||
161857445|NCT03410056|584519009|FG004|Overall Study|Decision by Sponsor|0|||
161857446|NCT03410056|584519010|FG005|Overall Study|Decision by Sponsor|0|||
161857447|NCT03410056|584519011|FG006|Overall Study|Decision by Sponsor|0|||
161857448|NCT03410056|584519005|FG000|Overall Study|Withdrawal by Subject|0|||
161857449|NCT03410056|584519006|FG001|Overall Study|Withdrawal by Subject|2|||
161857450|NCT03410056|584519007|FG002|Overall Study|Withdrawal by Subject|5|||
161857451|NCT03410056|584519008|FG003|Overall Study|Withdrawal by Subject|5|||
161857452|NCT03410056|584519009|FG004|Overall Study|Withdrawal by Subject|0|||
161857453|NCT03410056|584519010|FG005|Overall Study|Withdrawal by Subject|0|||
161857454|NCT03410056|584519011|FG006|Overall Study|Withdrawal by Subject|0|||
161857455|NCT02762929|584519012|FG000|Overall Study|Adverse Event|0|||
161857456|NCT02762929|584519013|FG001|Overall Study|Adverse Event|0|||
161857457|NCT02762929|584519014|FG002|Overall Study|Adverse Event|0|||
161857458|NCT02762929|584519015|FG003|Overall Study|Adverse Event|1|||
161857459|NCT02762929|584519016|FG004|Overall Study|Adverse Event|0|||
161857460|NCT02762929|584519017|FG005|Overall Study|Adverse Event|0|||
161857461|NCT02762929|584519012|FG000|Overall Study|Lost to Follow-up|1|||
161857462|NCT02762929|584519013|FG001|Overall Study|Lost to Follow-up|2|||
161857463|NCT02762929|584519014|FG002|Overall Study|Lost to Follow-up|0|||
161857464|NCT02762929|584519015|FG003|Overall Study|Lost to Follow-up|1|||
161857465|NCT02762929|584519016|FG004|Overall Study|Lost to Follow-up|0|||
161857466|NCT02762929|584519017|FG005|Overall Study|Lost to Follow-up|0|||
161857467|NCT02762929|584519012|FG000|Overall Study|Withdrawal by Subject|0|||
161857468|NCT02762929|584519013|FG001|Overall Study|Withdrawal by Subject|1|||
161857469|NCT02762929|584519014|FG002|Overall Study|Withdrawal by Subject|0|||
161857470|NCT02762929|584519015|FG003|Overall Study|Withdrawal by Subject|0|||
161857471|NCT02762929|584519016|FG004|Overall Study|Withdrawal by Subject|0|||
161857472|NCT02762929|584519017|FG005|Overall Study|Withdrawal by Subject|0|||
161857473|NCT02762929|584519012|FG000|Overall Study|exclusionary medication disclosed late|0|||
161857474|NCT02762929|584519013|FG001|Overall Study|exclusionary medication disclosed late|0|||
161857475|NCT02762929|584519014|FG002|Overall Study|exclusionary medication disclosed late|0|||
161857476|NCT02762929|584519015|FG003|Overall Study|exclusionary medication disclosed late|1|||
161857477|NCT02762929|584519016|FG004|Overall Study|exclusionary medication disclosed late|0|||
161857478|NCT02762929|584519017|FG005|Overall Study|exclusionary medication disclosed late|0|||
161857479|NCT02366689|584519024|FG000|Overall Study|Withdrawal by Subject|1|||
161857480|NCT02366689|584519025|FG001|Overall Study|Withdrawal by Subject|0|||
161857481|NCT02366689|584519026|FG002|Overall Study|Withdrawal by Subject|1|||
161857482|NCT02366689|584519024|FG000|Overall Study|Lost to Follow-up|3|||
161857483|NCT02366689|584519025|FG001|Overall Study|Lost to Follow-up|2|||
161857484|NCT02366689|584519026|FG002|Overall Study|Lost to Follow-up|0|||
161857485|NCT02366689|584519024|FG000|Overall Study|Pregnancy|0|||
161857486|NCT02366689|584519025|FG001|Overall Study|Pregnancy|1|||
161857487|NCT02366689|584519026|FG002|Overall Study|Pregnancy|1|||
161857488|NCT03718832|584519027|FG000|Analysis Sample|Withdrawal by Subject|18|||
161857489|NCT03718832|584519028|FG001|Analysis Sample|Withdrawal by Subject|15|||
161857490|NCT03718832|584519027|FG000|Analysis Sample|Legal hold on data|1|||
161857491|NCT03718832|584519028|FG001|Analysis Sample|Legal hold on data|0|||
161857492|NCT03718832|584519027|FG000|Analysis Sample|Participant from treated household|0|||
161857493|NCT03718832|584519028|FG001|Analysis Sample|Participant from treated household|1|||
161857494|NCT03718832|584519027|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
161857495|NCT03718832|584519028|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
161857496|NCT01996241|584519029|FG000|Overall Study|Lost to Follow-up|252|||
161857497|NCT01996241|584519030|FG001|Overall Study|Lost to Follow-up|235|||
161857498|NCT01068262|584519034|FG000|Overall Study|Adverse Event|2|||
161857499|NCT01068262|584519035|FG001|Overall Study|Adverse Event|0|||
161857500|NCT01068262|584519036|FG002|Overall Study|Adverse Event|1|||
161857501|NCT01068262|584519037|FG003|Overall Study|Adverse Event|0|||
161857502|NCT01068262|584519034|FG000|Overall Study|Protocol Violation|1|||
161857503|NCT01068262|584519035|FG001|Overall Study|Protocol Violation|0|||
161857504|NCT01068262|584519036|FG002|Overall Study|Protocol Violation|0|||
161857505|NCT01068262|584519037|FG003|Overall Study|Protocol Violation|0|||
161857506|NCT01068262|584519034|FG000|Overall Study|Withdrawal by Subject|0|||
161857507|NCT01068262|584519035|FG001|Overall Study|Withdrawal by Subject|1|||
161857508|NCT01068262|584519036|FG002|Overall Study|Withdrawal by Subject|0|||
161857509|NCT01068262|584519037|FG003|Overall Study|Withdrawal by Subject|0|||
161857510|NCT04182490|584519038|FG000|Overall Study|Withdrawal by Subject|3|||
161857511|NCT04182490|584519039|FG001|Overall Study|Withdrawal by Subject|3|||
161857512|NCT04182490|584519038|FG000|Overall Study|Lost to Follow-up|0|||
161857513|NCT04182490|584519039|FG001|Overall Study|Lost to Follow-up|1|||
161857514|NCT04182490|584519038|FG000|Overall Study|Physician Decision|0|||
161857515|NCT04182490|584519039|FG001|Overall Study|Physician Decision|1|||
161857516|NCT01811472|584519045|FG000|Overall Study|Adverse Event|1|||
161857517|NCT01811472|584519046|FG001|Overall Study|Adverse Event|0|||
161857518|NCT01811472|584519047|FG002|Overall Study|Adverse Event|4|||
161857519|NCT01811472|584519045|FG000|Overall Study|Lost to Follow-up|0|||
161857520|NCT01811472|584519046|FG001|Overall Study|Lost to Follow-up|0|||
161857521|NCT01811472|584519047|FG002|Overall Study|Lost to Follow-up|1|||
161857522|NCT01811472|584519045|FG000|Overall Study|Subject/guardian decision|1|||
161857523|NCT01811472|584519046|FG001|Overall Study|Subject/guardian decision|0|||
161857524|NCT01811472|584519047|FG002|Overall Study|Subject/guardian decision|0|||
161857525|NCT01350271|584519056|FG000|Overall Study|Lost to Follow-up|21|||
161857526|NCT01350271|584519057|FG001|Overall Study|Lost to Follow-up|17|||
161857527|NCT01350271|584519058|FG002|Overall Study|Lost to Follow-up|26|||
161857528|NCT01973439|584519059|FG000|Overall Study|Lost samples from one PK Day|2|||
161857529|NCT01973439|584519059|FG000|Overall Study|Vomiting after commencing once daily|1|||
161857530|NCT01973439|584519059|FG000|Overall Study|PK curve incomplete|2|||
161857531|NCT00344448|584519060|FG000|Screening|Withdrawal by Subject|0|||
161857532|NCT00344448|584519061|FG001|Screening|Withdrawal by Subject|1|||
161769696|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
161769697|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769698|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769699|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769700|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769701|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769702|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769703|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769704|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769705|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769706|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769707|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769708|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769709|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769710|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769711|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769712|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769713|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769714|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769715|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769716|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769717|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
161769718|NCT00151775|584198499|FG000|Period 4: Open Label|Increased blood pressure|0|||
161769719|NCT00151775|584198500|FG001|Period 4: Open Label|Increased blood pressure|0|||
161769720|NCT00151775|584198501|FG002|Period 4: Open Label|Increased blood pressure|0|||
161769721|NCT00151775|584198502|FG003|Period 4: Open Label|Increased blood pressure|0|||
161769722|NCT00151775|584198503|FG004|Period 4: Open Label|Increased blood pressure|1|||
161769723|NCT00151775|584198504|FG005|Period 4: Open Label|Increased blood pressure|0|||
161769724|NCT00151775|584198505|FG006|Period 4: Open Label|Increased blood pressure|0|||
161769725|NCT00151775|584198506|FG007|Period 4: Open Label|Increased blood pressure|0|||
161769726|NCT00151775|584198507|FG008|Period 4: Open Label|Increased blood pressure|0|||
161769727|NCT00151775|584198508|FG009|Period 4: Open Label|Increased blood pressure|1|||
161769728|NCT00151775|584198509|FG010|Period 4: Open Label|Increased blood pressure|0|||
161769729|NCT00151775|584198510|FG011|Period 4: Open Label|Increased blood pressure|0|||
161769730|NCT00151775|584198499|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
161769731|NCT00151775|584198500|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
161769732|NCT00151775|584198501|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
161769733|NCT00151775|584198502|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
161769734|NCT00151775|584198503|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
161769735|NCT00151775|584198504|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
161769736|NCT00151775|584198505|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
161769737|NCT00151775|584198506|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
161769738|NCT00151775|584198507|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
161769739|NCT00151775|584198508|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
161769740|NCT00151775|584198509|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
161769741|NCT00151775|584198510|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
161769742|NCT00151775|584198499|FG000|Period 4: Open Label|Adverse Event|0|||
161769743|NCT00151775|584198500|FG001|Period 4: Open Label|Adverse Event|0|||
161769744|NCT00151775|584198501|FG002|Period 4: Open Label|Adverse Event|0|||
161769745|NCT00151775|584198502|FG003|Period 4: Open Label|Adverse Event|0|||
161769746|NCT00151775|584198503|FG004|Period 4: Open Label|Adverse Event|1|||
161769747|NCT00151775|584198504|FG005|Period 4: Open Label|Adverse Event|0|||
161769748|NCT00151775|584198505|FG006|Period 4: Open Label|Adverse Event|0|||
161769749|NCT00151775|584198506|FG007|Period 4: Open Label|Adverse Event|0|||
161769750|NCT00151775|584198507|FG008|Period 4: Open Label|Adverse Event|0|||
161769751|NCT00151775|584198508|FG009|Period 4: Open Label|Adverse Event|2|||
161769752|NCT00151775|584198509|FG010|Period 4: Open Label|Adverse Event|0|||
161769753|NCT00151775|584198510|FG011|Period 4: Open Label|Adverse Event|0|||
161769754|NCT00151775|584198499|FG000|Period 4: Open Label|Lost to Follow-up|0|||
161769755|NCT00151775|584198500|FG001|Period 4: Open Label|Lost to Follow-up|0|||
161769756|NCT00151775|584198501|FG002|Period 4: Open Label|Lost to Follow-up|0|||
161769757|NCT00151775|584198502|FG003|Period 4: Open Label|Lost to Follow-up|0|||
161769758|NCT00151775|584198503|FG004|Period 4: Open Label|Lost to Follow-up|17|||
161769759|NCT00151775|584198504|FG005|Period 4: Open Label|Lost to Follow-up|0|||
161769760|NCT00151775|584198505|FG006|Period 4: Open Label|Lost to Follow-up|0|||
161769761|NCT00151775|584198506|FG007|Period 4: Open Label|Lost to Follow-up|0|||
161769762|NCT00151775|584198507|FG008|Period 4: Open Label|Lost to Follow-up|0|||
161769763|NCT00151775|584198508|FG009|Period 4: Open Label|Lost to Follow-up|7|||
161769764|NCT00151775|584198509|FG010|Period 4: Open Label|Lost to Follow-up|0|||
161769765|NCT00151775|584198510|FG011|Period 4: Open Label|Lost to Follow-up|0|||
161769766|NCT00151775|584198499|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
161769767|NCT00151775|584198500|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
161769768|NCT00151775|584198501|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
161769769|NCT00151775|584198502|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
161769770|NCT00151775|584198503|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
161769771|NCT00151775|584198504|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
161769772|NCT00151775|584198505|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
161769773|NCT00151775|584198506|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
161769774|NCT00151775|584198507|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
161769775|NCT00151775|584198508|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
161769776|NCT00151775|584198509|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
161769777|NCT00151775|584198510|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
161769778|NCT00151775|584198499|FG000|Period 4: Open Label|Other|0|||
161769779|NCT00151775|584198500|FG001|Period 4: Open Label|Other|0|||
161769780|NCT00151775|584198501|FG002|Period 4: Open Label|Other|0|||
161769781|NCT00151775|584198502|FG003|Period 4: Open Label|Other|0|||
161769782|NCT00151775|584198503|FG004|Period 4: Open Label|Other|1|||
161769783|NCT00151775|584198504|FG005|Period 4: Open Label|Other|0|||
161769784|NCT00151775|584198505|FG006|Period 4: Open Label|Other|0|||
161769785|NCT00151775|584198506|FG007|Period 4: Open Label|Other|0|||
161769786|NCT00151775|584198507|FG008|Period 4: Open Label|Other|0|||
161769787|NCT00151775|584198508|FG009|Period 4: Open Label|Other|3|||
161769788|NCT00151775|584198509|FG010|Period 4: Open Label|Other|0|||
161769789|NCT00151775|584198510|FG011|Period 4: Open Label|Other|0|||
161769790|NCT00151775|584198499|FG000|Period 4: Open Label|Physician Decision|0|||
161769791|NCT00151775|584198500|FG001|Period 4: Open Label|Physician Decision|0|||
161769792|NCT00151775|584198501|FG002|Period 4: Open Label|Physician Decision|0|||
161769793|NCT00151775|584198502|FG003|Period 4: Open Label|Physician Decision|0|||
161769794|NCT00151775|584198503|FG004|Period 4: Open Label|Physician Decision|0|||
161769795|NCT00151775|584198504|FG005|Period 4: Open Label|Physician Decision|0|||
161769796|NCT00151775|584198505|FG006|Period 4: Open Label|Physician Decision|0|||
161769797|NCT00151775|584198506|FG007|Period 4: Open Label|Physician Decision|0|||
161769798|NCT00151775|584198507|FG008|Period 4: Open Label|Physician Decision|0|||
161769799|NCT00151775|584198508|FG009|Period 4: Open Label|Physician Decision|2|||
161769800|NCT00151775|584198509|FG010|Period 4: Open Label|Physician Decision|0|||
161769801|NCT00151775|584198510|FG011|Period 4: Open Label|Physician Decision|0|||
161769802|NCT00151775|584198499|FG000|Period 4: Open Label|Protocol Violation|0|||
161769803|NCT00151775|584198500|FG001|Period 4: Open Label|Protocol Violation|0|||
161769804|NCT00151775|584198501|FG002|Period 4: Open Label|Protocol Violation|0|||
161769805|NCT00151775|584198502|FG003|Period 4: Open Label|Protocol Violation|0|||
161769806|NCT00151775|584198503|FG004|Period 4: Open Label|Protocol Violation|1|||
161769807|NCT00151775|584198504|FG005|Period 4: Open Label|Protocol Violation|0|||
161769808|NCT00151775|584198505|FG006|Period 4: Open Label|Protocol Violation|0|||
161769809|NCT00151775|584198506|FG007|Period 4: Open Label|Protocol Violation|0|||
161769810|NCT00151775|584198507|FG008|Period 4: Open Label|Protocol Violation|0|||
161769811|NCT00151775|584198508|FG009|Period 4: Open Label|Protocol Violation|0|||
161769812|NCT00151775|584198509|FG010|Period 4: Open Label|Protocol Violation|0|||
161769813|NCT00151775|584198510|FG011|Period 4: Open Label|Protocol Violation|0|||
161769814|NCT00474994|584198511|FG000|Overall Study|Patient Not treated|1|||
161769815|NCT00474994|584198511|FG000|Overall Study|Patient evaluable for toxicity only|3|||
161769816|NCT00474994|584198511|FG000|Overall Study|Patient found to be ineligible|1|||
161769817|NCT00278473|584198512|FG000|Overall Study|drop out|4|||
161769818|NCT00278473|584198513|FG001|Overall Study|drop out|3|||
161769819|NCT00761761|584198514|FG000|Overall Study|Lost to Follow-up|3|||
161769820|NCT00761761|584198515|FG001|Overall Study|Lost to Follow-up|1|||
161769821|NCT00761761|584198514|FG000|Overall Study|Withdrawal by Subject|3|||
161769822|NCT00761761|584198515|FG001|Overall Study|Withdrawal by Subject|0|||
161769823|NCT04001790|584198516|FG000|Overall Study|Withdrawal by Subject|1|||
161769824|NCT04001790|584198517|FG001|Overall Study|Withdrawal by Subject|2|||
161769825|NCT01711736|584198518|FG000|Overall Study|Lost to Follow-up|4|||
161769826|NCT01711736|584198519|FG001|Overall Study|Lost to Follow-up|1|||
161769827|NCT01711736|584198518|FG000|Overall Study|Withdrawal by Subject|6|||
161769828|NCT01711736|584198519|FG001|Overall Study|Withdrawal by Subject|6|||
161769829|NCT01711736|584198518|FG000|Overall Study|Migrated/moved from study area|2|||
161769830|NCT01711736|584198519|FG001|Overall Study|Migrated/moved from study area|1|||
161769831|NCT02706327|584198520|FG000|Overall Study|Lost to Follow-up|1|||
161769832|NCT02706327|584198521|FG001|Overall Study|Lost to Follow-up|1|||
161769833|NCT02706327|584198522|FG002|Overall Study|Lost to Follow-up|2|||
161769834|NCT02652793|584198525|FG000|Overall Study|Adverse Event|1|||
161769835|NCT02652793|584198525|FG000|Overall Study|Lost to Follow-up|2|||
161857533|NCT00344448|584519060|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
161857534|NCT00344448|584519061|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
161857535|NCT00344448|584519060|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
161857536|NCT00344448|584519061|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
161857537|NCT00344448|584519060|FG000|Open Label|Withdrawal by Subject|1|||
161857538|NCT00344448|584519061|FG001|Open Label|Withdrawal by Subject|1|||
161857539|NCT00344448|584519060|FG000|Open Label|Study terminated|1|||
161857540|NCT00344448|584519061|FG001|Open Label|Study terminated|0|||
161857541|NCT03519087|584519064|FG000|Clinic Evaluation|Physician Decision|15|||
161857542|NCT03519087|584519065|FG001|Clinic Evaluation|Physician Decision|18|||
161857543|NCT03519087|584519066|FG002|Clinic Evaluation|Physician Decision|0|||
161857544|NCT03519087|584519067|FG003|Clinic Evaluation|Physician Decision|0|||
161857545|NCT03519087|584519068|FG004|Clinic Evaluation|Physician Decision|0|||
161857546|NCT03519087|584519064|FG000|Clinic Evaluation|Protocol Violation|1|||
161857547|NCT03519087|584519065|FG001|Clinic Evaluation|Protocol Violation|0|||
161857548|NCT03519087|584519066|FG002|Clinic Evaluation|Protocol Violation|0|||
161857549|NCT03519087|584519067|FG003|Clinic Evaluation|Protocol Violation|0|||
161857550|NCT03519087|584519068|FG004|Clinic Evaluation|Protocol Violation|0|||
161857551|NCT03519087|584519064|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
161857552|NCT03519087|584519065|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
161857553|NCT03519087|584519066|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
161857554|NCT03519087|584519067|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
161857555|NCT03519087|584519068|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
161857556|NCT03519087|584519064|FG000|Re-randomization for Treatment|Not appropriate|2|||
161857557|NCT03519087|584519065|FG001|Re-randomization for Treatment|Not appropriate|3|||
161857558|NCT03519087|584519066|FG002|Re-randomization for Treatment|Not appropriate|0|||
161857559|NCT03519087|584519067|FG003|Re-randomization for Treatment|Not appropriate|0|||
161857560|NCT03519087|584519068|FG004|Re-randomization for Treatment|Not appropriate|0|||
161857561|NCT03519087|584519064|FG000|Laboratory Testing|Lost to Follow-up|0|||
161857562|NCT03519087|584519065|FG001|Laboratory Testing|Lost to Follow-up|0|||
161857563|NCT03519087|584519066|FG002|Laboratory Testing|Lost to Follow-up|2|||
161857564|NCT03519087|584519067|FG003|Laboratory Testing|Lost to Follow-up|3|||
161857565|NCT03519087|584519068|FG004|Laboratory Testing|Lost to Follow-up|6|||
161857566|NCT03519087|584519064|FG000|Laboratory Testing|Protocol Violation|0|||
161857567|NCT03519087|584519065|FG001|Laboratory Testing|Protocol Violation|0|||
161857568|NCT03519087|584519066|FG002|Laboratory Testing|Protocol Violation|0|||
161857569|NCT03519087|584519067|FG003|Laboratory Testing|Protocol Violation|1|||
161857570|NCT03519087|584519068|FG004|Laboratory Testing|Protocol Violation|0|||
161857571|NCT01137071|584519069|FG000|Overall Study|Disease Progression|11|||
161857572|NCT01137071|584519069|FG000|Overall Study|Withdrawal by Subject|2|||
161857573|NCT01137071|584519069|FG000|Overall Study|Wrongly Included|1|||
161857574|NCT04807400|584519070|FG000|Overall Study|Adverse Event|2|||
161857575|NCT04807400|584519071|FG001|Overall Study|Adverse Event|3|||
161857576|NCT04807400|584519072|FG002|Overall Study|Adverse Event|3|||
161857577|NCT04807400|584519070|FG000|Overall Study|Death|2|||
161857578|NCT04807400|584519071|FG001|Overall Study|Death|0|||
161857579|NCT04807400|584519072|FG002|Overall Study|Death|0|||
161857580|NCT04807400|584519070|FG000|Overall Study|Lost to Follow-up|8|||
161857581|NCT04807400|584519071|FG001|Overall Study|Lost to Follow-up|6|||
161857582|NCT04807400|584519072|FG002|Overall Study|Lost to Follow-up|6|||
161857583|NCT04807400|584519070|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161857584|NCT04807400|584519071|FG001|Overall Study|Non-Compliance With Study Drug|4|||
161857585|NCT04807400|584519072|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161769836|NCT02652793|584198525|FG000|Overall Study|Withdrawal by Subject|1|||
161769837|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
161769838|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
161769839|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
161769840|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
161769841|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
161769842|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
161769843|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
161769844|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
161769845|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
161769846|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
161769847|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
161857586|NCT04807400|584519070|FG000|Overall Study|Participant Decision|20|||
161857587|NCT04807400|584519071|FG001|Overall Study|Participant Decision|19|||
161857588|NCT04807400|584519072|FG002|Overall Study|Participant Decision|26|||
161857589|NCT04807400|584519070|FG000|Overall Study|Physician Decision|0|||
161857590|NCT04807400|584519071|FG001|Overall Study|Physician Decision|1|||
161857591|NCT04807400|584519072|FG002|Overall Study|Physician Decision|0|||
161857592|NCT04807400|584519070|FG000|Overall Study|Protocol Violation|4|||
161857593|NCT04807400|584519071|FG001|Overall Study|Protocol Violation|3|||
161857594|NCT04807400|584519072|FG002|Overall Study|Protocol Violation|7|||
161857595|NCT04807400|584519070|FG000|Overall Study|Withdrawal by Subject|13|||
161857596|NCT04807400|584519071|FG001|Overall Study|Withdrawal by Subject|9|||
161857597|NCT04807400|584519072|FG002|Overall Study|Withdrawal by Subject|20|||
161857598|NCT04807400|584519070|FG000|Overall Study|Mis-randomized|1|||
161857599|NCT04807400|584519071|FG001|Overall Study|Mis-randomized|0|||
161857600|NCT04807400|584519072|FG002|Overall Study|Mis-randomized|0|||
161857601|NCT04194645|584519075|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857602|NCT04194645|584519076|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857603|NCT04194645|584519077|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857604|NCT04194645|584519078|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857605|NCT04194645|584519079|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857606|NCT04194645|584519080|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857607|NCT04194645|584519081|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857608|NCT04194645|584519082|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857609|NCT04194645|584519083|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857610|NCT04194645|584519084|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
161857611|NCT04194645|584519085|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857612|NCT04194645|584519086|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857613|NCT04194645|584519087|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857614|NCT04194645|584519088|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857615|NCT04194645|584519089|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857616|NCT03656744|584519090|FG000|Overall Study|Adverse Event|1|||
161857617|NCT03656744|584519091|FG001|Overall Study|Adverse Event|4|||
161857618|NCT03656744|584519092|FG002|Overall Study|Adverse Event|1|||
161857619|NCT03656744|584519090|FG000|Overall Study|Protocol Violation|1|||
161857620|NCT03656744|584519091|FG001|Overall Study|Protocol Violation|0|||
161857621|NCT03656744|584519092|FG002|Overall Study|Protocol Violation|0|||
161857622|NCT03656744|584519090|FG000|Overall Study|Lost to Follow-up|2|||
161857623|NCT03656744|584519091|FG001|Overall Study|Lost to Follow-up|2|||
161857624|NCT03656744|584519092|FG002|Overall Study|Lost to Follow-up|0|||
161857625|NCT03656744|584519090|FG000|Overall Study|Withdrawal by Subject|0|||
161857626|NCT03656744|584519091|FG001|Overall Study|Withdrawal by Subject|1|||
161857627|NCT03656744|584519092|FG002|Overall Study|Withdrawal by Subject|0|||
161857628|NCT03656744|584519090|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
161857629|NCT03656744|584519091|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
161857630|NCT03656744|584519092|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
161857631|NCT03076775|584519093|FG000|Overall Study|Lost to Follow-up|1|||
161857632|NCT03076775|584519094|FG001|Overall Study|Lost to Follow-up|0|||
161857633|NCT01783886|584519095|FG000|Overall Study|Lost to Follow-up|0|||
161857634|NCT01783886|584519096|FG001|Overall Study|Lost to Follow-up|3|||
161857635|NCT01783886|584519097|FG002|Overall Study|Lost to Follow-up|0|||
161857636|NCT01783886|584519095|FG000|Overall Study|Protocol deviation|0|||
161857637|NCT01783886|584519096|FG001|Overall Study|Protocol deviation|0|||
161857638|NCT01783886|584519097|FG002|Overall Study|Protocol deviation|2|||
161857639|NCT01783886|584519095|FG000|Overall Study|Withdrawal of consent by participant|1|||
161857640|NCT01783886|584519096|FG001|Overall Study|Withdrawal of consent by participant|3|||
161857641|NCT01783886|584519097|FG002|Overall Study|Withdrawal of consent by participant|4|||
161857642|NCT01783886|584519095|FG000|Overall Study|Adverse Event|4|||
161857643|NCT01783886|584519096|FG001|Overall Study|Adverse Event|5|||
161857644|NCT01783886|584519097|FG002|Overall Study|Adverse Event|4|||
161857645|NCT00940316|584519098|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
161857646|NCT00940316|584519099|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
161857647|NCT00940316|584519100|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
161857648|NCT00940316|584519098|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
161857649|NCT00940316|584519099|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
161857650|NCT00940316|584519100|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
161857651|NCT00940316|584519098|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
161857652|NCT00940316|584519099|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
161857653|NCT00940316|584519100|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
161857654|NCT00940316|584519098|FG000|Treated After Cycle 5|Adverse Event|0|||
161857655|NCT00940316|584519099|FG001|Treated After Cycle 5|Adverse Event|0|||
161857656|NCT00940316|584519100|FG002|Treated After Cycle 5|Adverse Event|1|||
161857657|NCT00940316|584519098|FG000|Treated After Cycle 5|Progressive disease|0|||
161857658|NCT00940316|584519099|FG001|Treated After Cycle 5|Progressive disease|1|||
161857659|NCT00940316|584519100|FG002|Treated After Cycle 5|Progressive disease|0|||
161857660|NCT02290405|584519101|FG000|Overall Study|Withdrawal by Subject|1|||
161857661|NCT02290405|584519102|FG001|Overall Study|Withdrawal by Subject|0|||
161857662|NCT00996489|584519103|FG000|Overall Study|Device failure|45|||
161857663|NCT00996489|584519103|FG000|Overall Study|Discontinued|116|||
161857664|NCT03142191|584519104|FG000|Placebo Controlled Period|Death|0|||
161857665|NCT03142191|584519105|FG001|Placebo Controlled Period|Death|1|||
161857666|NCT03142191|584519106|FG002|Placebo Controlled Period|Death|1|||
161857667|NCT03142191|584519107|FG003|Placebo Controlled Period|Death|0|||
161857668|NCT03142191|584519108|FG004|Placebo Controlled Period|Death|0|||
161857669|NCT03142191|584519104|FG000|Placebo Controlled Period|Adverse Event|4|||
161857670|NCT03142191|584519105|FG001|Placebo Controlled Period|Adverse Event|5|||
161857671|NCT03142191|584519106|FG002|Placebo Controlled Period|Adverse Event|1|||
161857672|NCT03142191|584519107|FG003|Placebo Controlled Period|Adverse Event|0|||
161857673|NCT03142191|584519108|FG004|Placebo Controlled Period|Adverse Event|0|||
161857674|NCT03142191|584519104|FG000|Placebo Controlled Period|Progressive Disease|1|||
161857675|NCT03142191|584519105|FG001|Placebo Controlled Period|Progressive Disease|0|||
161857676|NCT03142191|584519106|FG002|Placebo Controlled Period|Progressive Disease|1|||
161857677|NCT03142191|584519107|FG003|Placebo Controlled Period|Progressive Disease|0|||
161857678|NCT03142191|584519108|FG004|Placebo Controlled Period|Progressive Disease|0|||
161857679|NCT03142191|584519104|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
161857680|NCT03142191|584519105|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
161857681|NCT03142191|584519106|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
161857682|NCT03142191|584519107|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
161857683|NCT03142191|584519108|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
161857684|NCT03142191|584519104|FG000|Placebo Controlled Period|Other Reasons|1|||
161857685|NCT03142191|584519105|FG001|Placebo Controlled Period|Other Reasons|0|||
161857686|NCT03142191|584519106|FG002|Placebo Controlled Period|Other Reasons|0|||
161857687|NCT03142191|584519107|FG003|Placebo Controlled Period|Other Reasons|0|||
161857688|NCT03142191|584519108|FG004|Placebo Controlled Period|Other Reasons|0|||
161857689|NCT03142191|584519104|FG000|Active Treatment Extension Period|Death|2|||
161857690|NCT03142191|584519105|FG001|Active Treatment Extension Period|Death|1|||
161857691|NCT03142191|584519106|FG002|Active Treatment Extension Period|Death|1|||
161857692|NCT03142191|584519107|FG003|Active Treatment Extension Period|Death|1|||
161857693|NCT03142191|584519108|FG004|Active Treatment Extension Period|Death|0|||
161857694|NCT03142191|584519104|FG000|Active Treatment Extension Period|Adverse Event|6|||
161857695|NCT03142191|584519105|FG001|Active Treatment Extension Period|Adverse Event|5|||
161857696|NCT03142191|584519106|FG002|Active Treatment Extension Period|Adverse Event|4|||
161857697|NCT03142191|584519107|FG003|Active Treatment Extension Period|Adverse Event|1|||
161857698|NCT03142191|584519108|FG004|Active Treatment Extension Period|Adverse Event|0|||
161857699|NCT03142191|584519104|FG000|Active Treatment Extension Period|Progressive Disease|10|||
161857700|NCT03142191|584519105|FG001|Active Treatment Extension Period|Progressive Disease|5|||
161857701|NCT03142191|584519106|FG002|Active Treatment Extension Period|Progressive Disease|4|||
161857702|NCT03142191|584519107|FG003|Active Treatment Extension Period|Progressive Disease|1|||
161857703|NCT03142191|584519108|FG004|Active Treatment Extension Period|Progressive Disease|2|||
161857704|NCT03142191|584519104|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
161857705|NCT03142191|584519105|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
161857706|NCT03142191|584519106|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
161857707|NCT03142191|584519107|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
161857708|NCT03142191|584519108|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
161857709|NCT03142191|584519104|FG000|Active Treatment Extension Period|Physician Decision|2|||
161857710|NCT03142191|584519105|FG001|Active Treatment Extension Period|Physician Decision|0|||
161857711|NCT03142191|584519106|FG002|Active Treatment Extension Period|Physician Decision|0|||
161857712|NCT03142191|584519107|FG003|Active Treatment Extension Period|Physician Decision|0|||
161857713|NCT03142191|584519108|FG004|Active Treatment Extension Period|Physician Decision|0|||
161857714|NCT03142191|584519104|FG000|Active Treatment Extension Period|Other Reasons|3|||
161857715|NCT03142191|584519105|FG001|Active Treatment Extension Period|Other Reasons|3|||
161857716|NCT03142191|584519106|FG002|Active Treatment Extension Period|Other Reasons|3|||
161857717|NCT03142191|584519107|FG003|Active Treatment Extension Period|Other Reasons|8|||
161857718|NCT03142191|584519108|FG004|Active Treatment Extension Period|Other Reasons|3|||
161857719|NCT03142191|584519104|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
161857720|NCT03142191|584519105|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
161857721|NCT03142191|584519106|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
161857722|NCT03142191|584519107|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
161857723|NCT03142191|584519108|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
161857724|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
161857725|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
161857726|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
161857727|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
161857728|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
161857729|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
161857730|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
161857731|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
161857732|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
161857733|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
161857734|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
161857735|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
161857736|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
161857737|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
161857738|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
161857739|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
161857740|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
161857741|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
161857742|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
161857743|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
161857744|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
161857745|NCT01130493|584519113|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
161857746|NCT01130493|584519114|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
161857747|NCT01130493|584519115|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
161857748|NCT01130493|584519113|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
161857749|NCT01130493|584519114|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
161857750|NCT01130493|584519115|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
161857751|NCT01130493|584519113|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
161857752|NCT01130493|584519114|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
161857753|NCT01130493|584519115|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
161857754|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
161857755|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
161857756|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
161857757|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
161857758|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
161857759|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
161857760|NCT01130493|584519113|FG000|Part 2: OLE|Adverse Event|0|||
161857761|NCT01130493|584519114|FG001|Part 2: OLE|Adverse Event|2|||
161857762|NCT01130493|584519115|FG002|Part 2: OLE|Adverse Event|1|||
161857763|NCT01130493|584519113|FG000|Part 2: OLE|Withdrawal by Subject|0|||
161857764|NCT01130493|584519114|FG001|Part 2: OLE|Withdrawal by Subject|1|||
161857765|NCT01130493|584519115|FG002|Part 2: OLE|Withdrawal by Subject|4|||
161857766|NCT03541317|584519118|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
161857767|NCT03541317|584519119|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857768|NCT03541317|584519120|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857769|NCT03541317|584519121|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857770|NCT03541317|584519122|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857771|NCT03541317|584519123|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857772|NCT00879086|584519124|FG000|Overall Study|Adverse Event|3|||
161857773|NCT00879086|584519125|FG001|Overall Study|Adverse Event|15|||
161857774|NCT00879086|584519124|FG000|Overall Study|Participant choice|2|||
161857775|NCT00879086|584519125|FG001|Overall Study|Participant choice|2|||
161857776|NCT00879086|584519124|FG000|Overall Study|Progression of disease|40|||
161857777|NCT00879086|584519125|FG001|Overall Study|Progression of disease|26|||
161857778|NCT00879086|584519124|FG000|Overall Study|Withdrawal of consent|2|||
161857779|NCT00879086|584519125|FG001|Overall Study|Withdrawal of consent|1|||
161857780|NCT00879086|584519124|FG000|Overall Study|Other|4|||
161857781|NCT00879086|584519125|FG001|Overall Study|Other|6|||
161857782|NCT00879086|584519124|FG000|Overall Study|Death|1|||
161857783|NCT00879086|584519125|FG001|Overall Study|Death|2|||
161857784|NCT04728802|584519128|FG000|Overall Study|Withdrawal by Subject|4|||
161857785|NCT04728802|584519129|FG001|Overall Study|Withdrawal by Subject|20|||
161857786|NCT04728802|584519128|FG000|Overall Study|Physician Decision|7|||
161857787|NCT04728802|584519129|FG001|Overall Study|Physician Decision|7|||
161857788|NCT04728802|584519128|FG000|Overall Study|Protocol Violation|10|||
161857789|NCT04728802|584519129|FG001|Overall Study|Protocol Violation|4|||
161857790|NCT04728802|584519128|FG000|Overall Study|Transfer|1|||
161857791|NCT04728802|584519129|FG001|Overall Study|Transfer|0|||
161857792|NCT04728802|584519128|FG000|Overall Study|Death|4|||
161857793|NCT04728802|584519129|FG001|Overall Study|Death|5|||
161857794|NCT04728802|584519128|FG000|Overall Study|Other|3|||
161857795|NCT04728802|584519129|FG001|Overall Study|Other|0|||
161857796|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
161857797|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Off-label use|283|||
161857798|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
161857799|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
161857800|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
161857801|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
161857802|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
161857803|NCT01070953|584519132|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
161857804|NCT01070953|584519132|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
161857805|NCT01070953|584519132|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
161857806|NCT04700137|584519133|FG000|Overall Study|Lost to Follow-up|1|||
161857807|NCT04700137|584519134|FG001|Overall Study|Lost to Follow-up|6|||
161857808|NCT04700137|584519135|FG002|Overall Study|Lost to Follow-up|1|||
161857809|NCT04700137|584519136|FG003|Overall Study|Lost to Follow-up|1|||
161857810|NCT04700137|584519133|FG000|Overall Study|Withdrawal by Subject|0|||
161857811|NCT04700137|584519134|FG001|Overall Study|Withdrawal by Subject|0|||
161857812|NCT04700137|584519135|FG002|Overall Study|Withdrawal by Subject|1|||
161857813|NCT04700137|584519136|FG003|Overall Study|Withdrawal by Subject|0|||
161857814|NCT04700137|584519133|FG000|Overall Study|Death|0|||
161857815|NCT04700137|584519134|FG001|Overall Study|Death|0|||
161857816|NCT04700137|584519135|FG002|Overall Study|Death|1|||
161857817|NCT04700137|584519136|FG003|Overall Study|Death|0|||
161857818|NCT03449446|584519139|FG000|Overall Study|Randomized but Never Treated|0|||
161857819|NCT03449446|584519140|FG001|Overall Study|Randomized but Never Treated|0|||
161857820|NCT03449446|584519141|FG002|Overall Study|Randomized but Never Treated|1|||
161857821|NCT03449446|584519142|FG003|Overall Study|Randomized but Never Treated|1|||
161857822|NCT03449446|584519143|FG004|Overall Study|Randomized but Never Treated|1|||
161857823|NCT03449446|584519144|FG005|Overall Study|Randomized but Never Treated|0|||
161857824|NCT03449446|584519145|FG006|Overall Study|Randomized but Never Treated|0|||
161857825|NCT03449446|584519139|FG000|Overall Study|Unknown Reason|33|||
161857826|NCT03449446|584519140|FG001|Overall Study|Unknown Reason|1|||
161857827|NCT03449446|584519141|FG002|Overall Study|Unknown Reason|1|||
161857828|NCT03449446|584519142|FG003|Overall Study|Unknown Reason|1|||
161857829|NCT03449446|584519143|FG004|Overall Study|Unknown Reason|2|||
161857830|NCT03449446|584519144|FG005|Overall Study|Unknown Reason|2|||
161857831|NCT03449446|584519145|FG006|Overall Study|Unknown Reason|0|||
161857832|NCT03449446|584519139|FG000|Overall Study|Withdrew Consent|1|||
161857833|NCT03449446|584519140|FG001|Overall Study|Withdrew Consent|3|||
161857834|NCT03449446|584519141|FG002|Overall Study|Withdrew Consent|1|||
161857835|NCT03449446|584519142|FG003|Overall Study|Withdrew Consent|4|||
161857836|NCT03449446|584519143|FG004|Overall Study|Withdrew Consent|4|||
161857837|NCT03449446|584519144|FG005|Overall Study|Withdrew Consent|4|||
161857838|NCT03449446|584519145|FG006|Overall Study|Withdrew Consent|1|||
161857839|NCT03449446|584519139|FG000|Overall Study|Adverse Event|1|||
161857840|NCT03449446|584519140|FG001|Overall Study|Adverse Event|2|||
161857841|NCT03449446|584519141|FG002|Overall Study|Adverse Event|1|||
161857842|NCT03449446|584519142|FG003|Overall Study|Adverse Event|0|||
161857843|NCT03449446|584519143|FG004|Overall Study|Adverse Event|0|||
161857844|NCT03449446|584519144|FG005|Overall Study|Adverse Event|2|||
161857845|NCT03449446|584519145|FG006|Overall Study|Adverse Event|0|||
161857846|NCT03449446|584519139|FG000|Overall Study|Lost to Follow-up|0|||
161857847|NCT03449446|584519140|FG001|Overall Study|Lost to Follow-up|0|||
161857848|NCT03449446|584519141|FG002|Overall Study|Lost to Follow-up|2|||
161857849|NCT03449446|584519142|FG003|Overall Study|Lost to Follow-up|1|||
161857850|NCT03449446|584519143|FG004|Overall Study|Lost to Follow-up|3|||
161857851|NCT03449446|584519144|FG005|Overall Study|Lost to Follow-up|0|||
161857852|NCT03449446|584519145|FG006|Overall Study|Lost to Follow-up|0|||
161857853|NCT03449446|584519139|FG000|Overall Study|Investigator's Discretion|0|||
161857854|NCT03449446|584519140|FG001|Overall Study|Investigator's Discretion|1|||
161857855|NCT03449446|584519141|FG002|Overall Study|Investigator's Discretion|1|||
161857856|NCT03449446|584519142|FG003|Overall Study|Investigator's Discretion|2|||
161857857|NCT03449446|584519143|FG004|Overall Study|Investigator's Discretion|0|||
161857858|NCT03449446|584519144|FG005|Overall Study|Investigator's Discretion|0|||
161857859|NCT03449446|584519145|FG006|Overall Study|Investigator's Discretion|0|||
161857860|NCT03449446|584519139|FG000|Overall Study|Non Compliance with Study Drug|1|||
161857861|NCT03449446|584519140|FG001|Overall Study|Non Compliance with Study Drug|0|||
161857862|NCT03449446|584519141|FG002|Overall Study|Non Compliance with Study Drug|0|||
161857863|NCT03449446|584519142|FG003|Overall Study|Non Compliance with Study Drug|0|||
161857864|NCT03449446|584519143|FG004|Overall Study|Non Compliance with Study Drug|0|||
161857865|NCT03449446|584519144|FG005|Overall Study|Non Compliance with Study Drug|0|||
161857866|NCT03449446|584519145|FG006|Overall Study|Non Compliance with Study Drug|0|||
161857867|NCT03449446|584519139|FG000|Overall Study|Protocol Violation|0|||
161857868|NCT03449446|584519140|FG001|Overall Study|Protocol Violation|0|||
161857869|NCT03449446|584519141|FG002|Overall Study|Protocol Violation|0|||
161857870|NCT03449446|584519142|FG003|Overall Study|Protocol Violation|0|||
161857871|NCT03449446|584519143|FG004|Overall Study|Protocol Violation|1|||
161857872|NCT03449446|584519144|FG005|Overall Study|Protocol Violation|1|||
161857873|NCT03449446|584519145|FG006|Overall Study|Protocol Violation|0|||
161857874|NCT03449446|584519139|FG000|Overall Study|Death|0|||
161857875|NCT03449446|584519140|FG001|Overall Study|Death|0|||
161857876|NCT03449446|584519141|FG002|Overall Study|Death|0|||
161857877|NCT03449446|584519142|FG003|Overall Study|Death|0|||
161857878|NCT03449446|584519143|FG004|Overall Study|Death|1|||
161857879|NCT03449446|584519144|FG005|Overall Study|Death|0|||
161857880|NCT03449446|584519145|FG006|Overall Study|Death|0|||
161857881|NCT03180645|584519158|FG000|Overall Study|Adverse Event|0|||
161857882|NCT03180645|584519159|FG001|Overall Study|Adverse Event|1|||
161857883|NCT03180645|584519160|FG002|Overall Study|Adverse Event|2|||
161857884|NCT04208750|584519161|FG000|Overall Study|Lost to Follow-up|16|||
161857885|NCT04208750|584519162|FG001|Overall Study|Lost to Follow-up|15|||
161857886|NCT02201277|584519163|FG000|Overall Study|Death|3|||
161857887|NCT02201277|584519164|FG001|Overall Study|Death|4|||
161857888|NCT02201277|584519163|FG000|Overall Study|Lost to Follow-up|2|||
161857889|NCT02201277|584519164|FG001|Overall Study|Lost to Follow-up|1|||
161857890|NCT02201277|584519163|FG000|Overall Study|Failed retrieval|1|||
161857891|NCT02201277|584519164|FG001|Overall Study|Failed retrieval|0|||
161857892|NCT02201277|584519163|FG000|Overall Study|Physician Decision|1|||
161857893|NCT02201277|584519164|FG001|Overall Study|Physician Decision|0|||
161857894|NCT05022212|584519167|FG000|Overall Study|Lost to Follow-up|0|||
161857895|NCT05022212|584519168|FG001|Overall Study|Lost to Follow-up|2|||
161857896|NCT02905032|584519169|FG000|Overall Study|Withdrawal by Subject|2|||
161857897|NCT02905032|584519170|FG001|Overall Study|Withdrawal by Subject|0|||
161857898|NCT02905032|584519171|FG002|Overall Study|Withdrawal by Subject|0|||
161857899|NCT02905032|584519169|FG000|Overall Study|Protocol Violation|6|||
161857900|NCT02905032|584519170|FG001|Overall Study|Protocol Violation|12|||
161857901|NCT02905032|584519171|FG002|Overall Study|Protocol Violation|0|||
161857902|NCT00739063|584519172|FG000|Overall Study|Screen failures|8|||
161857903|NCT01625091|584519173|FG000|Intervention|Death|1|||
161857904|NCT01625091|584519174|FG001|Intervention|Death|1|||
161857905|NCT01625091|584519173|FG000|Intervention|Withdrawal by Subject|4|||
161857906|NCT01625091|584519174|FG001|Intervention|Withdrawal by Subject|1|||
161857907|NCT01625091|584519173|FG000|Intervention|Adverse Event|0|||
161857908|NCT01625091|584519174|FG001|Intervention|Adverse Event|2|||
161857909|NCT01625091|584519173|FG000|Intervention|Lost to Follow-up|4|||
161857910|NCT01625091|584519174|FG001|Intervention|Lost to Follow-up|4|||
161857911|NCT01625091|584519173|FG000|Intervention|Study termination|2|||
161857912|NCT01625091|584519174|FG001|Intervention|Study termination|3|||
161857913|NCT01625091|584519173|FG000|Post-intervention|Death|0|||
161857914|NCT01625091|584519174|FG001|Post-intervention|Death|1|||
161857915|NCT01625091|584519173|FG000|Post-intervention|Lost to Follow-up|2|||
161857916|NCT01625091|584519174|FG001|Post-intervention|Lost to Follow-up|0|||
161857917|NCT01625091|584519173|FG000|Post-intervention|Study termination|2|||
161857918|NCT01625091|584519174|FG001|Post-intervention|Study termination|1|||
161857919|NCT02163057|584519175|FG000|Overall Study|Participant Refusal to Continue|2|||
161857920|NCT02163057|584519176|FG001|Overall Study|Participant Refusal to Continue|2|||
161857921|NCT02163057|584519175|FG000|Overall Study|Participant Significant Noncompliance|0|||
161857922|NCT02163057|584519176|FG001|Overall Study|Participant Significant Noncompliance|1|||
161857923|NCT02163057|584519175|FG000|Overall Study|Progression of Disease|1|||
161857924|NCT02163057|584519176|FG001|Overall Study|Progression of Disease|2|||
161857925|NCT01547390|584519177|FG000|Overall Study|Withdrawal by Subject|10|||
161857926|NCT01547390|584519178|FG001|Overall Study|Withdrawal by Subject|7|||
161857927|NCT01547390|584519177|FG000|Overall Study|termination of pregnancy|0|||
161857928|NCT01547390|584519178|FG001|Overall Study|termination of pregnancy|1|||
161857929|NCT01547390|584519177|FG000|Overall Study|Lost to Follow-up|0|||
161857930|NCT01547390|584519178|FG001|Overall Study|Lost to Follow-up|2|||
161857931|NCT01547390|584519177|FG000|Overall Study|Adverse Event|3|||
161857932|NCT01547390|584519178|FG001|Overall Study|Adverse Event|0|||
161769848|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
161769849|NCT04963231|584198526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
161769850|NCT04963231|584198527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
161769851|NCT04963231|584198528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
161769852|NCT04963231|584198526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
161769853|NCT04963231|584198527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
161769854|NCT04963231|584198528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
161769855|NCT04963231|584198526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
161769856|NCT04963231|584198527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
161769857|NCT04963231|584198528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
161769858|NCT01059175|584198529|FG000|Overall Study|Death|17|||
161769859|NCT01059175|584198530|FG001|Overall Study|Death|17|||
161769860|NCT01059175|584198529|FG000|Overall Study|Adverse Event|4|||
161769861|NCT01059175|584198530|FG001|Overall Study|Adverse Event|2|||
161769862|NCT01059175|584198529|FG000|Overall Study|Lost to Follow-up|0|||
161769863|NCT01059175|584198530|FG001|Overall Study|Lost to Follow-up|1|||
161769864|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Adverse Event|4|||
161769865|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Adverse Event|3|||
161769866|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Adverse Event|0|||
161769867|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Adverse Event|0|||
161769868|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Death|24|||
161769869|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Death|9|||
161769870|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Death|0|||
161769871|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Death|0|||
161769872|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
161769873|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
161769874|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
161769875|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
161769876|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Physician Decision|4|||
161769877|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Physician Decision|1|||
161769878|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Physician Decision|0|||
161769879|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Physician Decision|0|||
161769880|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Progressive disease|1|||
161769881|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Progressive disease|0|||
161769882|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Progressive disease|0|||
161769883|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Progressive disease|0|||
161769884|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
161769885|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
161769886|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
161769887|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
161769888|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
161769889|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161769890|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161769891|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161769892|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
161769893|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
161769894|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
161769895|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
161769896|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Other|2|||
161769897|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Other|0|||
161769898|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Other|0|||
161769899|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Other|0|||
161769900|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161769901|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161769902|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
161769903|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161769904|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
161769905|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
161769906|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
161769907|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
161769908|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
161769909|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
161769910|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
161857933|NCT01260701|584519179|FG000|Overall Study|Adverse Event|9|||
161857934|NCT01260701|584519179|FG000|Overall Study|Withdrawal by Subject|2|||
161857935|NCT01260701|584519179|FG000|Overall Study|Progression|53|||
161857936|NCT01260701|584519179|FG000|Overall Study|Death|2|||
161857937|NCT01260701|584519179|FG000|Overall Study|Not protocol specified|3|||
161857938|NCT01260701|584519179|FG000|Overall Study|Under review|1|||
161857939|NCT01260701|584519179|FG000|Overall Study|Ineligible|4|||
161857940|NCT01260701|584519179|FG000|Overall Study|Did not begin protocol therapy|1|||
161857941|NCT04108299|584520690|FG000|Overall Study|Not interested in participating|2|||
161857942|NCT04108299|584520691|FG001|Overall Study|Not interested in participating|1|||
161857943|NCT04108299|584520692|FG002|Overall Study|Not interested in participating|2|||
161857944|NCT04108299|584520693|FG003|Overall Study|Not interested in participating|1|||
161857945|NCT02515331|584520702|FG000|Overall Study|Withdrawal by Subject|0|||
161857946|NCT02515331|584520703|FG001|Overall Study|Withdrawal by Subject|0|||
161857947|NCT02515331|584520704|FG002|Overall Study|Withdrawal by Subject|1|||
161857948|NCT02515331|584520702|FG000|Overall Study|Protocol deviation|0|||
161857949|NCT02515331|584520703|FG001|Overall Study|Protocol deviation|0|||
161857950|NCT02515331|584520704|FG002|Overall Study|Protocol deviation|3|||
161857951|NCT02515331|584520702|FG000|Overall Study|Adverse Event|2|||
161857952|NCT02515331|584520703|FG001|Overall Study|Adverse Event|0|||
161857953|NCT02515331|584520704|FG002|Overall Study|Adverse Event|0|||
161857954|NCT00124748|584520705|FG000|Overall Study|Adverse Event|8|||
161857955|NCT00124748|584520706|FG001|Overall Study|Adverse Event|39|||
161857956|NCT00124748|584520705|FG000|Overall Study|Abnormal laboratory Value|2|||
161857957|NCT00124748|584520706|FG001|Overall Study|Abnormal laboratory Value|2|||
161857958|NCT00124748|584520705|FG000|Overall Study|Abnormal Procedure|0|||
161857959|NCT00124748|584520706|FG001|Overall Study|Abnormal Procedure|1|||
161857960|NCT00124748|584520705|FG000|Overall Study|Lack of Efficacy|20|||
161857961|NCT00124748|584520706|FG001|Overall Study|Lack of Efficacy|41|||
161857962|NCT00124748|584520705|FG000|Overall Study|No longer requires study drug|1|||
161857963|NCT00124748|584520706|FG001|Overall Study|No longer requires study drug|1|||
161857964|NCT00124748|584520705|FG000|Overall Study|Protocol Violation|3|||
161857965|NCT00124748|584520706|FG001|Overall Study|Protocol Violation|1|||
161857966|NCT00124748|584520705|FG000|Overall Study|Withdrawal by Subject|5|||
161857967|NCT00124748|584520706|FG001|Overall Study|Withdrawal by Subject|15|||
161857968|NCT00124748|584520705|FG000|Overall Study|Lost to Follow-up|2|||
161857969|NCT00124748|584520706|FG001|Overall Study|Lost to Follow-up|7|||
161857970|NCT00124748|584520705|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
161857971|NCT00124748|584520706|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
161857972|NCT00124748|584520705|FG000|Overall Study|Death|1|||
161857973|NCT00124748|584520706|FG001|Overall Study|Death|3|||
161857974|NCT00322712|584520707|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
161857975|NCT04176250|584520710|FG000|Overall Study|Adverse Event|0|||
161857976|NCT04176250|584520711|FG001|Overall Study|Adverse Event|1|||
161857977|NCT04176250|584520712|FG002|Overall Study|Adverse Event|0|||
161857978|NCT04176250|584520713|FG003|Overall Study|Adverse Event|1|||
161857979|NCT04176250|584520714|FG004|Overall Study|Adverse Event|0|||
161857980|NCT04176250|584520715|FG005|Overall Study|Adverse Event|1|||
161857981|NCT04176250|584520710|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857982|NCT04176250|584520711|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857983|NCT04176250|584520712|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
161857984|NCT04176250|584520713|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
161857985|NCT04176250|584520714|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857986|NCT04176250|584520715|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857987|NCT04176250|584520710|FG000|Overall Study|Withdrawal by Subject|0|||
161857988|NCT04176250|584520711|FG001|Overall Study|Withdrawal by Subject|0|||
161857989|NCT04176250|584520712|FG002|Overall Study|Withdrawal by Subject|0|||
161857990|NCT04176250|584520713|FG003|Overall Study|Withdrawal by Subject|0|||
161857991|NCT04176250|584520714|FG004|Overall Study|Withdrawal by Subject|0|||
161857992|NCT04176250|584520715|FG005|Overall Study|Withdrawal by Subject|1|||
161857993|NCT04176250|584520710|FG000|Overall Study|Randomized in error|0|||
161857994|NCT04176250|584520711|FG001|Overall Study|Randomized in error|0|||
161857995|NCT04176250|584520712|FG002|Overall Study|Randomized in error|0|||
161857996|NCT04176250|584520713|FG003|Overall Study|Randomized in error|0|||
161857997|NCT04176250|584520714|FG004|Overall Study|Randomized in error|1|||
161857998|NCT04176250|584520715|FG005|Overall Study|Randomized in error|0|||
161857999|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
161858000|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
161858001|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
161858002|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858003|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
161858004|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
161858005|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858006|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858007|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858008|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858009|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858010|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858011|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858012|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858013|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858014|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858015|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858016|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161858017|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858018|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
161858019|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161858020|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
161858021|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161858022|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858023|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858024|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858025|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858026|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858027|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858028|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858029|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858030|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858031|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858032|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858033|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
161858034|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161858035|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161858036|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
161858037|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
161858038|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161858039|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858040|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858041|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858042|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858043|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858044|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858045|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858046|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858047|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858048|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858049|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858050|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858051|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
161858052|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
161858053|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858054|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
161858055|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
161858056|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858057|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858058|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858059|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858060|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858061|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858062|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858063|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858064|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858065|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858066|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858067|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858068|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858069|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
161858070|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
161858071|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858072|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858073|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858074|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858075|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858076|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858077|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858078|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858079|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858080|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858081|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858082|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858083|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858084|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858085|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858086|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858087|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858088|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
161858089|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858090|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858091|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858092|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858093|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858094|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858095|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858096|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858097|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858098|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858099|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858100|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858101|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858102|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
161858103|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858104|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858105|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858106|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858107|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858108|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858109|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858110|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858111|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858112|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858113|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858114|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858115|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858116|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858117|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858118|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858119|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
161858120|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858121|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858122|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858123|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858124|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858125|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858126|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858127|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858128|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858129|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858130|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858131|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858132|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858133|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858134|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858135|NCT00758524|584520716|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858136|NCT00758524|584520717|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858137|NCT00758524|584520718|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858138|NCT00758524|584520719|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858139|NCT00758524|584520720|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858140|NCT00758524|584520721|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858141|NCT00758524|584520722|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858142|NCT00758524|584520723|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858143|NCT00758524|584520724|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
161858144|NCT00758524|584520725|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858145|NCT00758524|584520726|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858146|NCT00758524|584520727|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858147|NCT00758524|584520728|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858148|NCT00758524|584520729|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858149|NCT00758524|584520730|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858150|NCT00758524|584520731|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858151|NCT00758524|584520732|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858152|NCT00758524|584520716|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858153|NCT00758524|584520717|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858154|NCT00758524|584520718|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858155|NCT00758524|584520719|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858156|NCT00758524|584520720|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858157|NCT00758524|584520721|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858158|NCT00758524|584520722|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
161858159|NCT00758524|584520723|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858160|NCT00758524|584520724|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858161|NCT00758524|584520725|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858162|NCT00758524|584520726|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858163|NCT00758524|584520727|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858164|NCT00758524|584520728|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858165|NCT00758524|584520729|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858166|NCT00758524|584520730|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858167|NCT00758524|584520731|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858168|NCT00758524|584520732|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858169|NCT04688671|584520733|FG000|Overall Study|Adverse Event|3|||
161858170|NCT04688671|584520734|FG001|Overall Study|Adverse Event|1|||
161858171|NCT04688671|584520733|FG000|Overall Study|Withdrawal by Subject|3|||
161858172|NCT04688671|584520734|FG001|Overall Study|Withdrawal by Subject|1|||
161858173|NCT04688671|584520733|FG000|Overall Study|Lack of Efficacy|1|||
161858174|NCT04688671|584520734|FG001|Overall Study|Lack of Efficacy|1|||
161858175|NCT04688671|584520733|FG000|Overall Study|Protocol Violation|1|||
161858176|NCT04688671|584520734|FG001|Overall Study|Protocol Violation|0|||
161858177|NCT04688671|584520733|FG000|Overall Study|Lost to Follow-up|0|||
161858178|NCT04688671|584520734|FG001|Overall Study|Lost to Follow-up|1|||
161858179|NCT02676882|584520739|FG000|Overall Study|Adverse Event|1|||
161858180|NCT02676882|584520740|FG001|Overall Study|Adverse Event|0|||
161858181|NCT02676882|584520739|FG000|Overall Study|Lost to Follow-up|1|||
161858182|NCT02676882|584520740|FG001|Overall Study|Lost to Follow-up|0|||
161858183|NCT02676882|584520739|FG000|Overall Study|Withdrawal by Subject|1|||
161858184|NCT02676882|584520740|FG001|Overall Study|Withdrawal by Subject|2|||
161858185|NCT00811733|584520742|FG000|Overall Study|Investigator Discretion|10|||
161858186|NCT00811733|584520743|FG001|Overall Study|Investigator Discretion|8|||
161858187|NCT00811733|584520742|FG000|Overall Study|Withdrawal by Subject|1|||
161858188|NCT00811733|584520743|FG001|Overall Study|Withdrawal by Subject|2|||
161858189|NCT00793871|584520744|FG000|Overall Study|Death|50|||
161858190|NCT00793871|584520744|FG000|Overall Study|Lost to Follow-up|3|||
161858191|NCT00793871|584520744|FG000|Overall Study|Study terminated by the Sponsor|7|||
161858192|NCT02500589|584520745|FG000|Overall Study|Withdrawal by Subject|11|||
161858193|NCT02500589|584520746|FG001|Overall Study|Withdrawal by Subject|14|||
161858194|NCT02500589|584520745|FG000|Overall Study|Lost to Follow-up|10|||
161858195|NCT02500589|584520746|FG001|Overall Study|Lost to Follow-up|12|||
161858196|NCT02500589|584520745|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
161858197|NCT02500589|584520746|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
161858198|NCT02500589|584520745|FG000|Overall Study|Death|7|||
161858199|NCT02500589|584520746|FG001|Overall Study|Death|5|||
161858200|NCT00245466|584520747|FG000|Overall Study|Adverse Event|2|||
161858201|NCT00245466|584520748|FG001|Overall Study|Adverse Event|8|||
161858202|NCT00245466|584520749|FG002|Overall Study|Adverse Event|4|||
161858203|NCT00245466|584520747|FG000|Overall Study|Low prostate specific antigen suppr|16|||
161858204|NCT00245466|584520748|FG001|Overall Study|Low prostate specific antigen suppr|14|||
161858205|NCT00245466|584520749|FG002|Overall Study|Low prostate specific antigen suppr|5|||
161858206|NCT00245466|584520747|FG000|Overall Study|Insufficient testosterone suppr|12|||
161858207|NCT00245466|584520748|FG001|Overall Study|Insufficient testosterone suppr|12|||
161858208|NCT00245466|584520749|FG002|Overall Study|Insufficient testosterone suppr|21|||
161858209|NCT00245466|584520747|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
161858210|NCT00245466|584520748|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
161858211|NCT00245466|584520749|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
161858212|NCT00245466|584520747|FG000|Overall Study|Withdrawal by Subject|2|||
161858213|NCT00245466|584520748|FG001|Overall Study|Withdrawal by Subject|2|||
161858214|NCT00245466|584520749|FG002|Overall Study|Withdrawal by Subject|1|||
161858215|NCT00245466|584520747|FG000|Overall Study|Lost to Follow-up|3|||
161858216|NCT00245466|584520748|FG001|Overall Study|Lost to Follow-up|0|||
161858217|NCT00245466|584520749|FG002|Overall Study|Lost to Follow-up|0|||
161858218|NCT00245466|584520747|FG000|Overall Study|Disease progression|0|||
161858219|NCT00245466|584520748|FG001|Overall Study|Disease progression|3|||
161858220|NCT00245466|584520749|FG002|Overall Study|Disease progression|1|||
161858221|NCT00245466|584520747|FG000|Overall Study|Protocol Violation|1|||
161858222|NCT00245466|584520748|FG001|Overall Study|Protocol Violation|2|||
161858223|NCT00245466|584520749|FG002|Overall Study|Protocol Violation|2|||
161858224|NCT00245466|584520747|FG000|Overall Study|Death|0|||
161858225|NCT00245466|584520748|FG001|Overall Study|Death|2|||
161858226|NCT00245466|584520749|FG002|Overall Study|Death|0|||
161858227|NCT00245466|584520747|FG000|Overall Study|Administrative reasons|0|||
161858228|NCT00245466|584520748|FG001|Overall Study|Administrative reasons|1|||
161858229|NCT00245466|584520749|FG002|Overall Study|Administrative reasons|0|||
161858230|NCT03885661|584520750|FG000|Overall Study|Withdrawal by Subject|0|||
161858231|NCT03885661|584520751|FG001|Overall Study|Withdrawal by Subject|1|||
161858232|NCT03885661|584520750|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
161858233|NCT03885661|584520751|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
161858234|NCT00856193|584520752|FG000|Period 2|Abnormal test procedure results|0|||
161858235|NCT00856193|584520753|FG001|Period 2|Abnormal test procedure results|1|||
161858236|NCT00856193|584520752|FG000|Period 2|Lost to Follow-up|0|||
161858237|NCT00856193|584520753|FG001|Period 2|Lost to Follow-up|1|||
161858238|NCT05064397|584520754|FG000|Overall Study|Adverse Event|4|||
161858239|NCT05064397|584520754|FG000|Overall Study|Lack of Efficacy|12|||
161858240|NCT05064397|584520754|FG000|Overall Study|Withdrawal by Subject|3|||
161858241|NCT05064397|584520754|FG000|Overall Study|Lost to Follow-up|1|||
161858242|NCT05064397|584520754|FG000|Overall Study|Other reasons|3|||
161858243|NCT02324582|584520757|FG000|Overall Study|Screen Failures|0|||
161858244|NCT02324582|584520758|FG001|Overall Study|Screen Failures|5|||
161858245|NCT00129545|584520762|FG000|Overall Study|Death|5|||
161858246|NCT00129545|584520763|FG001|Overall Study|Death|60|||
161858247|NCT00129545|584520764|FG002|Overall Study|Death|44|||
161858248|NCT00129545|584520762|FG000|Overall Study|Withdrawal by Subject|3|||
161858249|NCT00129545|584520763|FG001|Overall Study|Withdrawal by Subject|18|||
161858250|NCT00129545|584520764|FG002|Overall Study|Withdrawal by Subject|44|||
161858251|NCT00129545|584520762|FG000|Overall Study|Lost to Follow-up|2|||
161858252|NCT00129545|584520763|FG001|Overall Study|Lost to Follow-up|22|||
161858253|NCT00129545|584520764|FG002|Overall Study|Lost to Follow-up|13|||
161858254|NCT00129545|584520762|FG000|Overall Study|Physician Decision|0|||
161858255|NCT00129545|584520763|FG001|Overall Study|Physician Decision|3|||
161858256|NCT00129545|584520764|FG002|Overall Study|Physician Decision|10|||
161858257|NCT00129545|584520762|FG000|Overall Study|Device not implanted|16|||
161858258|NCT00129545|584520763|FG001|Overall Study|Device not implanted|61|||
161858259|NCT00129545|584520764|FG002|Overall Study|Device not implanted|0|||
161858260|NCT04660331|584520765|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
161858261|NCT04660331|584520766|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
161858262|NCT04660331|584520767|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
161858263|NCT00111241|584520776|FG000|Overall Study|Lost to Follow-up|1|||
161858264|NCT00111241|584520777|FG001|Overall Study|Lost to Follow-up|0|||
161858265|NCT00111241|584520776|FG000|Overall Study|Withdrawal by Subject|4|||
161858266|NCT00111241|584520777|FG001|Overall Study|Withdrawal by Subject|0|||
161858267|NCT00111241|584520776|FG000|Overall Study|Protocol Violation|9|||
161858268|NCT00111241|584520777|FG001|Overall Study|Protocol Violation|8|||
161858269|NCT00111241|584520776|FG000|Overall Study|Adverse Event|1|||
161858270|NCT00111241|584520777|FG001|Overall Study|Adverse Event|0|||
161858271|NCT02096744|584520788|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
161858272|NCT02096744|584520789|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
161858273|NCT02096744|584520788|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
161858274|NCT02096744|584520789|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
161858275|NCT02096744|584520788|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
161858276|NCT02096744|584520789|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
161858277|NCT05724589|584520795|FG000|Overall Study|Lost to Follow-up|1|||
161858278|NCT00786409|584520796|FG000|Overall Study|Withdrawal by Subject|2|||
161858279|NCT00786409|584520796|FG000|Overall Study|Adverse Event|2|||
161858280|NCT00786409|584520796|FG000|Overall Study|Pregnancy|2|||
161858281|NCT00786409|584520796|FG000|Overall Study|Lost to Follow-up|1|||
161858282|NCT00610129|584520797|FG000|Overall Study|Not treated since patients ineligible|3|||
161858283|NCT01957176|584520806|FG000|Overall Study|Adverse Event|2|||
161858284|NCT01957176|584520807|FG001|Overall Study|Adverse Event|0|||
161858285|NCT01957176|584520806|FG000|Overall Study|Physician Decision|2|||
161858286|NCT01957176|584520807|FG001|Overall Study|Physician Decision|1|||
161858287|NCT01957176|584520806|FG000|Overall Study|Withdrawal by Subject|1|||
161858288|NCT01957176|584520807|FG001|Overall Study|Withdrawal by Subject|0|||
161858289|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
161858290|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
161858291|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
161858292|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
161858293|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
161858294|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161858295|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161858296|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161858297|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
161858298|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161858299|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161858300|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161858301|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
161858302|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
161858303|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
161858304|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
161858305|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
161858306|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
161858307|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
161858308|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
161858309|NCT00866359|584520809|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
161858310|NCT00866359|584520810|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
161858311|NCT00866359|584520811|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
161858312|NCT00866359|584520812|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
161858313|NCT04917861|584520823|FG000|Main Study (196 Days)|Adverse Event|0|||
161858314|NCT04917861|584520824|FG001|Main Study (196 Days)|Adverse Event|1|||
161858315|NCT04917861|584520825|FG002|Main Study (196 Days)|Adverse Event|0|||
161858316|NCT04917861|584520826|FG003|Main Study (196 Days)|Adverse Event|0|||
161858317|NCT04917861|584520823|FG000|Main Study (196 Days)|Death|0|||
161858318|NCT04917861|584520824|FG001|Main Study (196 Days)|Death|0|||
161858319|NCT04917861|584520825|FG002|Main Study (196 Days)|Death|0|||
161858320|NCT04917861|584520826|FG003|Main Study (196 Days)|Death|1|||
161858321|NCT04917861|584520823|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
161858322|NCT04917861|584520824|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
161858323|NCT04917861|584520825|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
161858324|NCT04917861|584520826|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
161858325|NCT04917861|584520823|FG000|Main Study (196 Days)|Physician Decision|0|||
161858326|NCT04917861|584520824|FG001|Main Study (196 Days)|Physician Decision|0|||
161858327|NCT04917861|584520825|FG002|Main Study (196 Days)|Physician Decision|0|||
161858328|NCT04917861|584520826|FG003|Main Study (196 Days)|Physician Decision|1|||
161858329|NCT04917861|584520823|FG000|Main Study (196 Days)|Pregnancy|1|||
161858330|NCT04917861|584520824|FG001|Main Study (196 Days)|Pregnancy|1|||
161858331|NCT04917861|584520825|FG002|Main Study (196 Days)|Pregnancy|0|||
161858332|NCT04917861|584520826|FG003|Main Study (196 Days)|Pregnancy|0|||
161858333|NCT04917861|584520823|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
161858334|NCT04917861|584520824|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
161858335|NCT04917861|584520825|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
161858336|NCT04917861|584520826|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
161858337|NCT04917861|584520823|FG000|Main Study (196 Days)|Other Than Specified|1|||
161858338|NCT04917861|584520824|FG001|Main Study (196 Days)|Other Than Specified|0|||
161858339|NCT04917861|584520825|FG002|Main Study (196 Days)|Other Than Specified|1|||
161858340|NCT04917861|584520826|FG003|Main Study (196 Days)|Other Than Specified|2|||
161858341|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
161858342|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
161858343|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
161858344|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
161858345|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161858346|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
161858347|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161858348|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161858349|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161858350|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
161858351|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161858352|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161858353|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
161858354|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
161858355|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
161858356|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
161858357|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161858358|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
161858359|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161858360|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161858361|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
161858362|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
161858363|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
161858364|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
161858365|NCT00720382|584520828|FG000|Overall Study|Adverse Event|54|||
161858366|NCT00720382|584520829|FG001|Overall Study|Adverse Event|17|||
161858367|NCT00720382|584520828|FG000|Overall Study|Lack of Efficacy|18|||
161858368|NCT00720382|584520829|FG001|Overall Study|Lack of Efficacy|7|||
161858369|NCT00720382|584520828|FG000|Overall Study|Non-Compliance|15|||
161858370|NCT00720382|584520829|FG001|Overall Study|Non-Compliance|5|||
161858371|NCT00720382|584520828|FG000|Overall Study|Withdrawal by Subject|47|||
161858372|NCT00720382|584520829|FG001|Overall Study|Withdrawal by Subject|11|||
161858373|NCT00720382|584520828|FG000|Overall Study|Lost to Follow-up|28|||
161858374|NCT00720382|584520829|FG001|Overall Study|Lost to Follow-up|14|||
161858375|NCT00720382|584520828|FG000|Overall Study|administrative|14|||
161858376|NCT00720382|584520829|FG001|Overall Study|administrative|5|||
161858377|NCT05192889|584520830|FG000|Block 1: All Eligible Patients|Death|2|||
161858378|NCT05192889|584520831|FG001|Block 1: All Eligible Patients|Death|0|||
161858379|NCT05192889|584520832|FG002|Block 1: All Eligible Patients|Death|0|||
161858380|NCT05192889|584520830|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
161858381|NCT05192889|584520831|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
161858382|NCT05192889|584520832|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
161858383|NCT05192889|584520830|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
161858384|NCT05192889|584520831|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
161858385|NCT05192889|584520832|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
161858386|NCT04075487|584522807|FG000|Overall Study|Withdrawal by Subject|1|||
161858387|NCT00265759|584522810|FG000|Overall Study|Withdrawal by Subject|0|||
161858388|NCT00265759|584522811|FG001|Overall Study|Withdrawal by Subject|1|||
161858389|NCT00265759|584522812|FG002|Overall Study|Withdrawal by Subject|2|||
161858390|NCT00265759|584522813|FG003|Overall Study|Withdrawal by Subject|2|||
161858391|NCT00265759|584522810|FG000|Overall Study|Cancel|0|||
161858392|NCT00265759|584522811|FG001|Overall Study|Cancel|0|||
161858393|NCT00265759|584522812|FG002|Overall Study|Cancel|0|||
161858394|NCT00265759|584522813|FG003|Overall Study|Cancel|3|||
161858395|NCT00265759|584522810|FG000|Overall Study|Ineligible|0|||
161858396|NCT00265759|584522811|FG001|Overall Study|Ineligible|0|||
161858397|NCT00265759|584522812|FG002|Overall Study|Ineligible|0|||
161858398|NCT00265759|584522813|FG003|Overall Study|Ineligible|1|||
161858399|NCT00265759|584522810|FG000|Overall Study|Bilateral disease|0|||
161858400|NCT00265759|584522811|FG001|Overall Study|Bilateral disease|0|||
161858401|NCT00265759|584522812|FG002|Overall Study|Bilateral disease|0|||
161858402|NCT00265759|584522813|FG003|Overall Study|Bilateral disease|2|||
161858403|NCT00265759|584522810|FG000|Overall Study|Discontinued due to intolerability|0|||
161858404|NCT00265759|584522811|FG001|Overall Study|Discontinued due to intolerability|0|||
161858405|NCT00265759|584522812|FG002|Overall Study|Discontinued due to intolerability|0|||
161858406|NCT00265759|584522813|FG003|Overall Study|Discontinued due to intolerability|1|||
161858407|NCT04467840|584522814|FG000|Overall Study|Death|35|||
161858408|NCT04467840|584522815|FG001|Overall Study|Death|39|||
161858409|NCT04467840|584522814|FG000|Overall Study|Withdrawal by Subject|8|||
161858410|NCT04467840|584522815|FG001|Overall Study|Withdrawal by Subject|4|||
161858411|NCT04467840|584522814|FG000|Overall Study|Adverse Event|2|||
161858412|NCT04467840|584522815|FG001|Overall Study|Adverse Event|0|||
161858413|NCT04467840|584522814|FG000|Overall Study|Lost to Follow-up|1|||
161858414|NCT04467840|584522815|FG001|Overall Study|Lost to Follow-up|3|||
161858415|NCT04467840|584522814|FG000|Overall Study|Physician Decision|1|||
161858416|NCT04467840|584522815|FG001|Overall Study|Physician Decision|0|||
161858417|NCT04467840|584522814|FG000|Overall Study|Other|1|||
161858418|NCT04467840|584522815|FG001|Overall Study|Other|5|||
161858419|NCT04467840|584522814|FG000|Overall Study|Missing study completion status|3|||
161858420|NCT04467840|584522815|FG001|Overall Study|Missing study completion status|1|||
161858421|NCT06082843|584522822|FG000|Overall Study|Withdrawal by Subject|0|||
161858422|NCT06082843|584522823|FG001|Overall Study|Withdrawal by Subject|2|||
161858423|NCT06082843|584522822|FG000|Overall Study|Study terminated by sponsor|12|||
161858424|NCT06082843|584522823|FG001|Overall Study|Study terminated by sponsor|8|||
161858425|NCT00696423|584522826|FG000|Overall Study|Lost to Follow-up|0|||
161858426|NCT00696423|584522827|FG001|Overall Study|Lost to Follow-up|5|||
161858427|NCT03989102|584522828|FG000|Year 1|Withdrawal by Subject|6|||
161858428|NCT03989102|584522829|FG001|Year 1|Withdrawal by Subject|2|||
161858429|NCT03989102|584522830|FG002|Year 1|Withdrawal by Subject|7|||
161858430|NCT03989102|584522828|FG000|Year 1|Lost to Follow-up|5|||
161858431|NCT03989102|584522829|FG001|Year 1|Lost to Follow-up|2|||
161858432|NCT03989102|584522830|FG002|Year 1|Lost to Follow-up|5|||
161858433|NCT03989102|584522828|FG000|Year 1|Subject met withdrawal criteria|1|||
161858434|NCT03989102|584522829|FG001|Year 1|Subject met withdrawal criteria|0|||
161858435|NCT03989102|584522830|FG002|Year 1|Subject met withdrawal criteria|1|||
161858436|NCT03989102|584522828|FG000|Year 2|Lost to Follow-up|7|||
161858437|NCT03989102|584522829|FG001|Year 2|Lost to Follow-up|3|||
161858438|NCT03989102|584522830|FG002|Year 2|Lost to Follow-up|4|||
161858439|NCT03989102|584522828|FG000|Year 2|Withdrawal by Subject|3|||
161858440|NCT03989102|584522829|FG001|Year 2|Withdrawal by Subject|1|||
161858441|NCT03989102|584522830|FG002|Year 2|Withdrawal by Subject|2|||
161858442|NCT03989102|584522828|FG000|Year 2|Subject non-compliant|3|||
161858443|NCT03989102|584522829|FG001|Year 2|Subject non-compliant|2|||
161858444|NCT03989102|584522830|FG002|Year 2|Subject non-compliant|0|||
161858445|NCT03989102|584522828|FG000|Year 2|Travel|1|||
161858446|NCT03989102|584522829|FG001|Year 2|Travel|0|||
161858447|NCT03989102|584522830|FG002|Year 2|Travel|1|||
161858448|NCT03989102|584522828|FG000|Year 2|P16 missing|4|||
161858449|NCT03989102|584522829|FG001|Year 2|P16 missing|2|||
161858450|NCT03989102|584522830|FG002|Year 2|P16 missing|1|||
161858451|NCT03989102|584522828|FG000|Year 2|P11 missing|1|||
161858452|NCT03989102|584522829|FG001|Year 2|P11 missing|3|||
161858453|NCT03989102|584522830|FG002|Year 2|P11 missing|7|||
161858454|NCT03989102|584522828|FG000|Year 2|Definitive displacement outside the study site|0|||
161858455|NCT03989102|584522829|FG001|Year 2|Definitive displacement outside the study site|1|||
161858456|NCT03989102|584522830|FG002|Year 2|Definitive displacement outside the study site|0|||
161858457|NCT03989102|584522828|FG000|Year 2|Subject missed last study visit|0|||
161858458|NCT03989102|584522829|FG001|Year 2|Subject missed last study visit|1|||
161858459|NCT03989102|584522830|FG002|Year 2|Subject missed last study visit|0|||
161858460|NCT03989102|584522828|FG000|Year 2|Death|0|||
161858461|NCT03989102|584522829|FG001|Year 2|Death|1|||
161858462|NCT03989102|584522830|FG002|Year 2|Death|0|||
161858463|NCT03989102|584522828|FG000|Year 2|Subject not reachable|0|||
161858464|NCT03989102|584522829|FG001|Year 2|Subject not reachable|0|||
161858465|NCT03989102|584522830|FG002|Year 2|Subject not reachable|1|||
161858466|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
161858467|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
161769911|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
161769912|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
161769913|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
161769914|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
161769915|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
161769916|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
161769917|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
161769918|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
161769919|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
161769920|NCT05450198|584198535|FG000|Overall Study|Withdrawal by Subject|1|||
161769921|NCT05450198|584198536|FG001|Overall Study|Withdrawal by Subject|1|||
161769922|NCT05450198|584198537|FG002|Overall Study|Withdrawal by Subject|2|||
161858468|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
161769923|NCT05450198|584198538|FG003|Overall Study|Withdrawal by Subject|0|||
161858469|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161858470|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161858471|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161858472|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
161858473|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
161858474|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
161858475|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
161858476|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
161858477|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
161858478|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
161858479|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
161858480|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
161858481|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
161858482|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
161858483|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
161858484|NCT04054765|584522831|FG000|Baseline|Withdrawal by Subject|5|||
161858485|NCT04054765|584522832|FG001|Baseline|Withdrawal by Subject|3|||
161858486|NCT04054765|584522831|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
161858487|NCT04054765|584522832|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
161858488|NCT04054765|584522831|FG000|3-month Follow up|Withdrawal by Subject|0|||
161858489|NCT04054765|584522832|FG001|3-month Follow up|Withdrawal by Subject|3|||
161858490|NCT04054765|584522831|FG000|6-month Follow up|Lost to Follow-up|32|||
161858491|NCT04054765|584522832|FG001|6-month Follow up|Lost to Follow-up|32|||
161858492|NCT01290068|584522833|FG000|Overall Study|Adverse Event|1|||
161858493|NCT01290068|584522834|FG001|Overall Study|Adverse Event|3|||
161858494|NCT01290068|584522833|FG000|Overall Study|Lost to Follow-up|3|||
161858495|NCT01290068|584522834|FG001|Overall Study|Lost to Follow-up|0|||
161858496|NCT01290068|584522833|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
161769924|NCT05450198|584198535|FG000|Overall Study|Lost to Follow-up|1|||
161769925|NCT05450198|584198536|FG001|Overall Study|Lost to Follow-up|0|||
161769926|NCT05450198|584198537|FG002|Overall Study|Lost to Follow-up|2|||
161769927|NCT05450198|584198538|FG003|Overall Study|Lost to Follow-up|1|||
161769928|NCT01982942|584198544|FG000|Overall Study|Adverse Event|10|||
161769929|NCT01982942|584198545|FG001|Overall Study|Adverse Event|5|||
161769930|NCT01982942|584198544|FG000|Overall Study|Lost to Follow-up|4|||
161769931|NCT01982942|584198545|FG001|Overall Study|Lost to Follow-up|3|||
161769932|NCT01982942|584198544|FG000|Overall Study|Multiple sclerosis progression|3|||
161769933|NCT01982942|584198545|FG001|Overall Study|Multiple sclerosis progression|2|||
161769934|NCT01982942|584198544|FG000|Overall Study|Wanted to try therapy not permitted|1|||
161769935|NCT01982942|584198545|FG001|Overall Study|Wanted to try therapy not permitted|0|||
161769936|NCT01982942|584198544|FG000|Overall Study|Subject declined future visits|0|||
161769937|NCT01982942|584198545|FG001|Overall Study|Subject declined future visits|1|||
161769938|NCT01982942|584198544|FG000|Overall Study|Left geographical area|2|||
161769939|NCT01982942|584198545|FG001|Overall Study|Left geographical area|0|||
161769940|NCT01982942|584198544|FG000|Overall Study|Too many pills|1|||
161769941|NCT01982942|584198545|FG001|Overall Study|Too many pills|0|||
161769942|NCT01982942|584198544|FG000|Overall Study|MS Relapse|0|||
161769943|NCT01982942|584198545|FG001|Overall Study|MS Relapse|1|||
161769944|NCT01982942|584198544|FG000|Overall Study|Chose to join a stem cell trial|0|||
161769945|NCT01982942|584198545|FG001|Overall Study|Chose to join a stem cell trial|1|||
161769946|NCT01982942|584198544|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
161769947|NCT01982942|584198545|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
161769948|NCT04511533|584198546|FG000|Treatment|Other|2|||
161769949|NCT04511533|584198546|FG000|Treatment|Withdrawal by Subject|11|||
161769950|NCT04511533|584198546|FG000|Treatment|Death|5|||
161769951|NCT04511533|584198546|FG000|Treatment|Physician Decision|1|||
161769952|NCT04511533|584198546|FG000|Treatment|Progressive Disease|61|||
161769953|NCT04511533|584198546|FG000|Follow-Up|Other|7|||
161769954|NCT04511533|584198546|FG000|Follow-Up|Withdrawal by Subject|5|||
161769955|NCT04511533|584198546|FG000|Follow-Up|Lost to Follow-up|2|||
161769956|NCT04511533|584198546|FG000|Follow-Up|Death|4|||
161769957|NCT01224171|584198547|FG000|Overall Study|Adverse Event|8|||
161769958|NCT01224171|584198548|FG001|Overall Study|Adverse Event|4|||
161769959|NCT01224171|584198547|FG000|Overall Study|Protocol Violation|0|||
161769960|NCT01224171|584198548|FG001|Overall Study|Protocol Violation|1|||
161769961|NCT01224171|584198547|FG000|Overall Study|Lack of Efficacy|5|||
161769962|NCT01224171|584198548|FG001|Overall Study|Lack of Efficacy|1|||
161769963|NCT01224171|584198547|FG000|Overall Study|Withdrawal of Consent|2|||
161769964|NCT01224171|584198548|FG001|Overall Study|Withdrawal of Consent|4|||
161769965|NCT01224171|584198547|FG000|Overall Study|Lost to Follow-up|0|||
161769966|NCT01224171|584198548|FG001|Overall Study|Lost to Follow-up|3|||
161769967|NCT01097057|584198549|FG000|Overall Study|Physician Decision|3|||
161769968|NCT01270139|584198552|FG000|Overall Study|Adverse Event|8|||
161769969|NCT01270139|584198553|FG001|Overall Study|Adverse Event|17|||
161769970|NCT01270139|584198554|FG002|Overall Study|Adverse Event|18|||
161769971|NCT01270139|584198552|FG000|Overall Study|Lost to Follow-up|10|||
161769972|NCT01270139|584198553|FG001|Overall Study|Lost to Follow-up|9|||
161769973|NCT01270139|584198554|FG002|Overall Study|Lost to Follow-up|2|||
161769974|NCT01161173|584198560|FG000|Overall Study|Protocol Violation|13|||
161769975|NCT01161173|584198560|FG000|Overall Study|Lost to Follow-up|7|||
161769976|NCT01161173|584198560|FG000|Overall Study|Progressive Disease|82|||
161769977|NCT01161173|584198560|FG000|Overall Study|Withdrawal of Consent|5|||
161769978|NCT01161173|584198560|FG000|Overall Study|Unacceptable Toxicity|21|||
161769979|NCT01161173|584198560|FG000|Overall Study|Death|194|||
161769980|NCT01161173|584198560|FG000|Overall Study|End of Study|2|||
161769981|NCT01161173|584198560|FG000|Overall Study|Reasons Not Specified|23|||
161769982|NCT01911546|584198561|FG000|Overall Study|Lost to Follow-up|1|||
161769983|NCT01911546|584198561|FG000|Overall Study|Everolimus was discontinued|5|||
161769984|NCT02213666|584198563|FG000|Overall Study|Withdrawal by Subject|1|||
161769985|NCT01319422|584198564|FG000|Overall Study|Withdrawal by Subject|1|||
161769986|NCT01319422|584198565|FG001|Overall Study|Withdrawal by Subject|0|||
161769987|NCT02918968|584198566|FG000|1st Line AAT|Progressive disease|9|||
161769988|NCT02918968|584198567|FG001|1st Line AAT|Progressive disease|4|||
161769989|NCT02918968|584198566|FG000|1st Line AAT|Adverse Event|12|||
161769990|NCT02918968|584198567|FG001|1st Line AAT|Adverse Event|3|||
161769991|NCT02918968|584198566|FG000|1st Line AAT|Physician Decision|4|||
161769992|NCT02918968|584198567|FG001|1st Line AAT|Physician Decision|2|||
161769993|NCT02918968|584198566|FG000|1st Line AAT|Withdrawal by Subject|2|||
161769994|NCT02918968|584198567|FG001|1st Line AAT|Withdrawal by Subject|1|||
161769995|NCT02918968|584198566|FG000|1st Line AAT|Lost to Follow-up|0|||
161769996|NCT02918968|584198567|FG001|1st Line AAT|Lost to Follow-up|1|||
161769997|NCT02918968|584198566|FG000|1st Line AAT|Death|1|||
161769998|NCT02918968|584198567|FG001|1st Line AAT|Death|0|||
161769999|NCT02918968|584198566|FG000|1st Line AAT|Miscellaneous|1|||
161770000|NCT02918968|584198567|FG001|1st Line AAT|Miscellaneous|0|||
161770001|NCT02918968|584198566|FG000|2nd Line AAT|Progressive disease|21|||
161770002|NCT02918968|584198567|FG001|2nd Line AAT|Progressive disease|3|||
161770003|NCT02918968|584198566|FG000|2nd Line AAT|Adverse Event|2|||
161770004|NCT02918968|584198567|FG001|2nd Line AAT|Adverse Event|5|||
161770005|NCT02918968|584198566|FG000|2nd Line AAT|Physician Decision|0|||
161770006|NCT02918968|584198567|FG001|2nd Line AAT|Physician Decision|1|||
161770007|NCT02918968|584198566|FG000|2nd Line AAT|Withdrawal by Subject|2|||
161770008|NCT02918968|584198567|FG001|2nd Line AAT|Withdrawal by Subject|2|||
161770009|NCT02918968|584198566|FG000|2nd Line AAT|Death|0|||
161770010|NCT02918968|584198567|FG001|2nd Line AAT|Death|1|||
161770011|NCT00750061|584198568|FG000|Overall Study|Adverse Event|2|||
161770012|NCT00750061|584198569|FG001|Overall Study|Adverse Event|0|||
161770013|NCT00750061|584198568|FG000|Overall Study|Withdrawal by Subject|0|||
161770014|NCT00750061|584198569|FG001|Overall Study|Withdrawal by Subject|1|||
161770015|NCT00750061|584198568|FG000|Overall Study|Physician Decision|0|||
161770016|NCT00750061|584198569|FG001|Overall Study|Physician Decision|1|||
161770017|NCT03732534|584198572|FG000|Overall Study|Study terminated by Sponsor|6|||
161770018|NCT02190604|584198573|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770019|NCT02190604|584198574|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770020|NCT02190604|584198575|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770021|NCT02190604|584198576|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770022|NCT02190604|584198577|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770023|NCT02190604|584198578|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770024|NCT02190604|584198579|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770025|NCT02190604|584198580|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770026|NCT02190604|584198581|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770027|NCT02190604|584198582|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770028|NCT02190604|584198583|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770029|NCT02190604|584198584|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770030|NCT02190604|584198585|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770031|NCT02190604|584198586|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770032|NCT02190604|584198587|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
161770033|NCT02190604|584198588|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770034|NCT02190604|584198589|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770035|NCT02190604|584198590|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770036|NCT02190604|584198591|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770037|NCT02190604|584198573|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770038|NCT02190604|584198574|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770039|NCT02190604|584198575|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770040|NCT02190604|584198576|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770041|NCT02190604|584198577|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770042|NCT02190604|584198578|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770043|NCT02190604|584198579|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770044|NCT02190604|584198580|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770045|NCT02190604|584198581|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770046|NCT02190604|584198582|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770047|NCT02190604|584198583|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770048|NCT02190604|584198584|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770049|NCT02190604|584198585|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770050|NCT02190604|584198586|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
161770051|NCT02190604|584198587|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770052|NCT02190604|584198588|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770053|NCT02190604|584198589|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770054|NCT02190604|584198590|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770055|NCT02190604|584198591|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770056|NCT02797951|584198592|FG000|Overall Study|Adverse Event|4|||
161770057|NCT02797951|584198592|FG000|Overall Study|Death|1|||
161770058|NCT02797951|584198592|FG000|Overall Study|Lack of Efficacy|19|||
161770059|NCT02797951|584198592|FG000|Overall Study|Lost to Follow-up|4|||
161770060|NCT02797951|584198592|FG000|Overall Study|Physician Decision|6|||
161770061|NCT02797951|584198592|FG000|Overall Study|Withdrawal by Subject|15|||
161770062|NCT01901393|584198593|FG000|Overall Study|Adverse Event|1|||
161770063|NCT01901393|584198594|FG001|Overall Study|Adverse Event|0|||
161770064|NCT03125382|584198595|FG000|Randomization|screening failure|1|||
161770065|NCT03125382|584198596|FG001|Randomization|screening failure|4|||
161770066|NCT03125382|584198597|FG002|Randomization|screening failure|2|||
161770067|NCT03125382|584198598|FG003|Randomization|screening failure|0|||
161770068|NCT03125382|584198595|FG000|Follow-up|Death|1|||
161770069|NCT03125382|584198596|FG001|Follow-up|Death|2|||
161770070|NCT03125382|584198597|FG002|Follow-up|Death|1|||
161770071|NCT03125382|584198598|FG003|Follow-up|Death|2|||
161770072|NCT03125382|584198595|FG000|Follow-up|Lost to Follow-up|1|||
161770073|NCT03125382|584198596|FG001|Follow-up|Lost to Follow-up|4|||
161770074|NCT03125382|584198597|FG002|Follow-up|Lost to Follow-up|3|||
161770075|NCT03125382|584198598|FG003|Follow-up|Lost to Follow-up|1|||
161770076|NCT03907072|584198599|FG000|Overall Study|Study Terminated by Sponsor|2|||
161770077|NCT03907072|584198600|FG001|Overall Study|Study Terminated by Sponsor|2|||
161770078|NCT03907072|584198601|FG002|Overall Study|Study Terminated by Sponsor|2|||
161770079|NCT00612456|584198602|FG000|Overall Study|Adverse Event|1|||
161770080|NCT00612456|584198603|FG001|Overall Study|Adverse Event|0|||
161770081|NCT00612456|584198604|FG002|Overall Study|Adverse Event|0|||
161770082|NCT00612456|584198602|FG000|Overall Study|Lack of Efficacy|1|||
161770083|NCT00612456|584198603|FG001|Overall Study|Lack of Efficacy|1|||
161770084|NCT00612456|584198604|FG002|Overall Study|Lack of Efficacy|0|||
161770085|NCT00612456|584198602|FG000|Overall Study|Withdrawal by Subject|0|||
161770086|NCT00612456|584198603|FG001|Overall Study|Withdrawal by Subject|1|||
161770087|NCT00612456|584198604|FG002|Overall Study|Withdrawal by Subject|0|||
161770088|NCT00265109|584198607|FG000|Overall Study|Withdrawal by Subject|5|||
161770089|NCT00265109|584198607|FG000|Overall Study|Adverse Event|1|||
161770090|NCT02463097|584198608|FG000|Overall Study|Withdrawal by Subject|1|||
161770091|NCT00808665|584198609|FG000|Overall Study|Withdrawal by Subject|1|||
161770092|NCT00808665|584198610|FG001|Overall Study|Withdrawal by Subject|0|||
161770093|NCT00808665|584198609|FG000|Overall Study|only required minimally invasive surgery|1|||
161770094|NCT00808665|584198610|FG001|Overall Study|only required minimally invasive surgery|0|||
161770095|NCT00808665|584198609|FG000|Overall Study|surgery cancelled|1|||
161770096|NCT00808665|584198610|FG001|Overall Study|surgery cancelled|0|||
161770097|NCT00808665|584198609|FG000|Overall Study|required an additional procedure|0|||
161770098|NCT00808665|584198610|FG001|Overall Study|required an additional procedure|1|||
161770099|NCT00808665|584198609|FG000|Overall Study|Physician Decision|3|||
161770100|NCT00808665|584198610|FG001|Overall Study|Physician Decision|1|||
161770101|NCT00808665|584198609|FG000|Overall Study|Medication stopped by resident|0|||
161770102|NCT00808665|584198610|FG001|Overall Study|Medication stopped by resident|1|||
161770103|NCT03831282|584198611|FG000|Overall Study|Could not place sensor|1|||
161770104|NCT00678652|584198618|FG000|Overall Study|Protocol Violation|2|||
161858497|NCT01290068|584522834|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
161858498|NCT01290068|584522833|FG000|Overall Study|Other|3|||
161858499|NCT01290068|584522834|FG001|Overall Study|Other|1|||
161858500|NCT02719184|584522837|FG000|Overall Study|Other than listed|1|||
161858501|NCT02719184|584522838|FG001|Overall Study|Other than listed|12|||
161858502|NCT02719184|584522839|FG002|Overall Study|Other than listed|13|||
161858503|NCT02719184|584522840|FG003|Overall Study|Other than listed|22|||
161858504|NCT02719184|584522841|FG004|Overall Study|Other than listed|9|||
161858505|NCT02719184|584522837|FG000|Overall Study|Withdrawal by Subject|5|||
161858506|NCT02719184|584522838|FG001|Overall Study|Withdrawal by Subject|3|||
161858507|NCT02719184|584522839|FG002|Overall Study|Withdrawal by Subject|6|||
161858508|NCT02719184|584522840|FG003|Overall Study|Withdrawal by Subject|6|||
161858509|NCT02719184|584522841|FG004|Overall Study|Withdrawal by Subject|0|||
161858510|NCT02719184|584522837|FG000|Overall Study|Lost to Follow-up|0|||
161858511|NCT02719184|584522838|FG001|Overall Study|Lost to Follow-up|4|||
161858512|NCT02719184|584522839|FG002|Overall Study|Lost to Follow-up|1|||
161858513|NCT02719184|584522840|FG003|Overall Study|Lost to Follow-up|3|||
161858514|NCT02719184|584522841|FG004|Overall Study|Lost to Follow-up|0|||
161858515|NCT02719184|584522837|FG000|Overall Study|Protocol Violation|0|||
161858516|NCT02719184|584522838|FG001|Overall Study|Protocol Violation|3|||
161858517|NCT02719184|584522839|FG002|Overall Study|Protocol Violation|0|||
161858518|NCT02719184|584522840|FG003|Overall Study|Protocol Violation|2|||
161858519|NCT02719184|584522841|FG004|Overall Study|Protocol Violation|0|||
161858520|NCT02719184|584522837|FG000|Overall Study|Adverse Event|0|||
161858521|NCT02719184|584522838|FG001|Overall Study|Adverse Event|0|||
161858522|NCT02719184|584522839|FG002|Overall Study|Adverse Event|0|||
161858523|NCT02719184|584522840|FG003|Overall Study|Adverse Event|3|||
161858524|NCT02719184|584522841|FG004|Overall Study|Adverse Event|0|||
161858525|NCT04428034|584522844|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
161858526|NCT02556801|584522847|FG000|Overall Study|Lost to Follow-up|1|||
161858527|NCT02556801|584522848|FG001|Overall Study|Lost to Follow-up|0|||
161858528|NCT02556801|584522849|FG002|Overall Study|Lost to Follow-up|2|||
161858529|NCT02556801|584522850|FG003|Overall Study|Lost to Follow-up|0|||
161858530|NCT02556801|584522847|FG000|Overall Study|Withdrawal by Subject|1|||
161858531|NCT02556801|584522848|FG001|Overall Study|Withdrawal by Subject|1|||
161858532|NCT02556801|584522849|FG002|Overall Study|Withdrawal by Subject|1|||
161858533|NCT02556801|584522850|FG003|Overall Study|Withdrawal by Subject|0|||
161858534|NCT02556801|584522847|FG000|Overall Study|Protocol Violation|0|||
161858535|NCT02556801|584522848|FG001|Overall Study|Protocol Violation|3|||
161858536|NCT02556801|584522849|FG002|Overall Study|Protocol Violation|1|||
161858537|NCT02556801|584522850|FG003|Overall Study|Protocol Violation|1|||
161858538|NCT02556801|584522847|FG000|Overall Study|Adverse Event|0|||
161858539|NCT02556801|584522848|FG001|Overall Study|Adverse Event|2|||
161858540|NCT02556801|584522849|FG002|Overall Study|Adverse Event|0|||
161858541|NCT02556801|584522850|FG003|Overall Study|Adverse Event|3|||
161858542|NCT02556801|584522847|FG000|Overall Study|Pregnancy|0|||
161858543|NCT02556801|584522848|FG001|Overall Study|Pregnancy|1|||
161858544|NCT02556801|584522849|FG002|Overall Study|Pregnancy|0|||
161858545|NCT02556801|584522850|FG003|Overall Study|Pregnancy|0|||
161858546|NCT02556801|584522847|FG000|Overall Study|Personal reasons patient|0|||
161858547|NCT02556801|584522848|FG001|Overall Study|Personal reasons patient|0|||
161858548|NCT02556801|584522849|FG002|Overall Study|Personal reasons patient|0|||
161858549|NCT02556801|584522850|FG003|Overall Study|Personal reasons patient|1|||
161858550|NCT01431079|584522860|FG000|Overall Study|Lost to Follow-up|35|||
161858551|NCT01431079|584522861|FG001|Overall Study|Lost to Follow-up|39|||
161858552|NCT01202175|584522862|FG000|Overall Study|Lost to Follow-up|2|||
161858553|NCT01202175|584522862|FG000|Overall Study|Withdrawal by Subject|1|||
161858554|NCT01202175|584522862|FG000|Overall Study|Adverse Event|2|||
161858555|NCT02790437|584522863|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
161858556|NCT02790437|584522864|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
161858557|NCT02790437|584522863|FG000|Overall Study|Adverse Event|1|||
161858558|NCT02790437|584522864|FG001|Overall Study|Adverse Event|0|||
161858559|NCT02790437|584522863|FG000|Overall Study|Withdrawal by Subject|1|||
161858560|NCT02790437|584522864|FG001|Overall Study|Withdrawal by Subject|0|||
161858561|NCT04747470|584522865|FG000|Overall Study|Death|0|||
161858562|NCT04747470|584522866|FG001|Overall Study|Death|3|||
161858563|NCT04747470|584522867|FG002|Overall Study|Death|2|||
161858564|NCT04747470|584522868|FG003|Overall Study|Death|2|||
161858565|NCT04747470|584522869|FG004|Overall Study|Death|2|||
161858566|NCT04747470|584522870|FG005|Overall Study|Death|0|||
161858567|NCT04747470|584522871|FG006|Overall Study|Death|0|||
161858568|NCT04747470|584522872|FG007|Overall Study|Death|0|||
161858569|NCT04747470|584522873|FG008|Overall Study|Death|0|||
161858570|NCT04747470|584522874|FG009|Overall Study|Death|0|||
161858571|NCT04747470|584522875|FG010|Overall Study|Death|0|||
161858572|NCT04747470|584522865|FG000|Overall Study|Withdrew Consent|0|||
161858573|NCT04747470|584522866|FG001|Overall Study|Withdrew Consent|0|||
161858574|NCT04747470|584522867|FG002|Overall Study|Withdrew Consent|0|||
161858575|NCT04747470|584522868|FG003|Overall Study|Withdrew Consent|1|||
161770105|NCT00678652|584198619|FG001|Overall Study|Protocol Violation|0|||
161770106|NCT00678652|584198620|FG002|Overall Study|Protocol Violation|0|||
161770107|NCT00678652|584198621|FG003|Overall Study|Protocol Violation|0|||
161770108|NCT00678652|584198618|FG000|Overall Study|Pregnancy|0|||
161770109|NCT00678652|584198619|FG001|Overall Study|Pregnancy|0|||
161770110|NCT00678652|584198620|FG002|Overall Study|Pregnancy|1|||
161770111|NCT00678652|584198621|FG003|Overall Study|Pregnancy|0|||
161770112|NCT00678652|584198618|FG000|Overall Study|Relocation|1|||
161770113|NCT00678652|584198619|FG001|Overall Study|Relocation|0|||
161770114|NCT00678652|584198620|FG002|Overall Study|Relocation|0|||
161770115|NCT00678652|584198621|FG003|Overall Study|Relocation|0|||
161770116|NCT05146999|584198622|FG000|Overall Study|Withdrew consent|6|||
161770117|NCT05146999|584198623|FG001|Overall Study|Withdrew consent|1|||
161770118|NCT05146999|584198622|FG000|Overall Study|Lost to Follow-up|3|||
161770119|NCT05146999|584198623|FG001|Overall Study|Lost to Follow-up|2|||
161770120|NCT05146999|584198622|FG000|Overall Study|Other|1|||
161770121|NCT05146999|584198623|FG001|Overall Study|Other|3|||
161770122|NCT00383292|584198626|FG000|Overall Study|Adverse Event|4|||
161770123|NCT00383292|584198627|FG001|Overall Study|Adverse Event|1|||
161770124|NCT00383292|584198628|FG002|Overall Study|Adverse Event|2|||
161770125|NCT00383292|584198626|FG000|Overall Study|Death|3|||
161770126|NCT00383292|584198627|FG001|Overall Study|Death|3|||
161770127|NCT00383292|584198628|FG002|Overall Study|Death|3|||
161770128|NCT00383292|584198626|FG000|Overall Study|Physician Decision|4|||
161770129|NCT00383292|584198627|FG001|Overall Study|Physician Decision|0|||
161770130|NCT00383292|584198628|FG002|Overall Study|Physician Decision|1|||
161770131|NCT00383292|584198626|FG000|Overall Study|Withdrawal by Subject|3|||
161770132|NCT00383292|584198627|FG001|Overall Study|Withdrawal by Subject|2|||
161770133|NCT00383292|584198628|FG002|Overall Study|Withdrawal by Subject|2|||
161770134|NCT00383292|584198626|FG000|Overall Study|Other|1|||
161770135|NCT00383292|584198627|FG001|Overall Study|Other|0|||
161770136|NCT00383292|584198628|FG002|Overall Study|Other|0|||
161770137|NCT00697255|584198629|FG000|Stage 1a|Insufficient ovarian response|1|||
161770138|NCT00697255|584198630|FG001|Stage 1a|Insufficient ovarian response|0|||
161770139|NCT00697255|584198629|FG000|Stage 1a|Multifollicular growth|1|||
161770140|NCT00697255|584198630|FG001|Stage 1a|Multifollicular growth|0|||
161770141|NCT00697255|584198629|FG000|Stage 1a|Not growing of dominant follicle|1|||
161770142|NCT00697255|584198630|FG001|Stage 1a|Not growing of dominant follicle|0|||
161770143|NCT00697255|584198629|FG000|Stage 1b|Not growing of dominant follicle|0|||
161770144|NCT00697255|584198630|FG001|Stage 1b|Not growing of dominant follicle|1|||
161770145|NCT00697255|584198629|FG000|Stage 1b|Insufficient ovarian response|0|||
161770146|NCT00697255|584198630|FG001|Stage 1b|Insufficient ovarian response|1|||
161770147|NCT05664672|584198633|FG000|Overall Study|Adverse Event|0|||
161770148|NCT05664672|584198634|FG001|Overall Study|Adverse Event|0|||
161770149|NCT05664672|584198635|FG002|Overall Study|Adverse Event|0|||
161770150|NCT05664672|584198636|FG003|Overall Study|Adverse Event|0|||
161770151|NCT05664672|584198637|FG004|Overall Study|Adverse Event|0|||
161770152|NCT05664672|584198638|FG005|Overall Study|Adverse Event|1|||
161770153|NCT05664672|584198633|FG000|Overall Study|Withdrawal by Subject|0|||
161770154|NCT05664672|584198634|FG001|Overall Study|Withdrawal by Subject|1|||
161770155|NCT05664672|584198635|FG002|Overall Study|Withdrawal by Subject|3|||
161770156|NCT05664672|584198636|FG003|Overall Study|Withdrawal by Subject|0|||
161770157|NCT05664672|584198637|FG004|Overall Study|Withdrawal by Subject|5|||
161770158|NCT05664672|584198638|FG005|Overall Study|Withdrawal by Subject|6|||
161770159|NCT05664672|584198633|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
161770160|NCT05664672|584198634|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161770161|NCT05664672|584198635|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161770162|NCT05664672|584198636|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
161770163|NCT05664672|584198637|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161770164|NCT05664672|584198638|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
161770165|NCT05664672|584198633|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
161770166|NCT05664672|584198634|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770167|NCT05664672|584198635|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770168|NCT05664672|584198636|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770169|NCT05664672|584198637|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770170|NCT05664672|584198638|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770171|NCT02815670|584198643|FG000|Overall Study|Prematurely discontinued of the trial|1|||
161770172|NCT01815099|584198646|FG000|Overall Study|Lack of Efficacy|1|||
161770173|NCT01815099|584198646|FG000|Overall Study|unable to attend study visits|1|||
161858576|NCT04747470|584522869|FG004|Overall Study|Withdrew Consent|0|||
161858577|NCT04747470|584522870|FG005|Overall Study|Withdrew Consent|0|||
161858578|NCT04747470|584522871|FG006|Overall Study|Withdrew Consent|0|||
161858579|NCT04747470|584522872|FG007|Overall Study|Withdrew Consent|0|||
161858580|NCT04747470|584522873|FG008|Overall Study|Withdrew Consent|0|||
161858581|NCT04747470|584522874|FG009|Overall Study|Withdrew Consent|0|||
161858582|NCT04747470|584522875|FG010|Overall Study|Withdrew Consent|0|||
161858583|NCT04747470|584522865|FG000|Overall Study|Study Terminated by Sponsor|0|||
161858584|NCT04747470|584522866|FG001|Overall Study|Study Terminated by Sponsor|0|||
161858585|NCT04747470|584522867|FG002|Overall Study|Study Terminated by Sponsor|1|||
161858586|NCT04747470|584522868|FG003|Overall Study|Study Terminated by Sponsor|0|||
161858587|NCT04747470|584522869|FG004|Overall Study|Study Terminated by Sponsor|2|||
161858588|NCT04747470|584522870|FG005|Overall Study|Study Terminated by Sponsor|0|||
161858589|NCT04747470|584522871|FG006|Overall Study|Study Terminated by Sponsor|0|||
161858590|NCT04747470|584522872|FG007|Overall Study|Study Terminated by Sponsor|0|||
161858591|NCT04747470|584522873|FG008|Overall Study|Study Terminated by Sponsor|0|||
161858592|NCT04747470|584522874|FG009|Overall Study|Study Terminated by Sponsor|0|||
161858593|NCT04747470|584522875|FG010|Overall Study|Study Terminated by Sponsor|0|||
161858594|NCT01626690|584522878|FG000|Overall Study|Protocol Violation|1|||
161858595|NCT01626690|584522879|FG001|Overall Study|Protocol Violation|0|||
161858596|NCT01626690|584522878|FG000|Overall Study|Adverse Event|1|||
161858597|NCT01626690|584522879|FG001|Overall Study|Adverse Event|0|||
161858598|NCT01125189|584522880|FG000|Treatment Period|Lack of Efficacy|15|||
161858599|NCT01125189|584522881|FG001|Treatment Period|Lack of Efficacy|18|||
161858600|NCT01125189|584522882|FG002|Treatment Period|Lack of Efficacy|25|||
161858601|NCT01125189|584522880|FG000|Treatment Period|Adverse Event|7|||
161858602|NCT01125189|584522881|FG001|Treatment Period|Adverse Event|8|||
161858603|NCT01125189|584522882|FG002|Treatment Period|Adverse Event|8|||
161858604|NCT01125189|584522880|FG000|Treatment Period|Withdrawal by Subject|3|||
161858605|NCT01125189|584522881|FG001|Treatment Period|Withdrawal by Subject|1|||
161858606|NCT01125189|584522882|FG002|Treatment Period|Withdrawal by Subject|1|||
161858607|NCT01125189|584522880|FG000|Treatment Period|Death|1|||
161858608|NCT01125189|584522881|FG001|Treatment Period|Death|0|||
161858609|NCT01125189|584522882|FG002|Treatment Period|Death|0|||
161858610|NCT01125189|584522880|FG000|Treatment Period|Lost to Follow-up|1|||
161858611|NCT01125189|584522881|FG001|Treatment Period|Lost to Follow-up|2|||
161858612|NCT01125189|584522882|FG002|Treatment Period|Lost to Follow-up|1|||
161858613|NCT01125189|584522880|FG000|Treatment Period|Poor compliance/noncompliance|0|||
161858614|NCT01125189|584522881|FG001|Treatment Period|Poor compliance/noncompliance|1|||
161858615|NCT01125189|584522882|FG002|Treatment Period|Poor compliance/noncompliance|0|||
161858616|NCT01125189|584522880|FG000|Treatment Period|Participants requested to discontinue|1|||
161858617|NCT01125189|584522881|FG001|Treatment Period|Participants requested to discontinue|3|||
161858618|NCT01125189|584522882|FG002|Treatment Period|Participants requested to discontinue|4|||
161858619|NCT01125189|584522880|FG000|Treatment Period|Other reasons|1|||
161858620|NCT01125189|584522881|FG001|Treatment Period|Other reasons|1|||
161858621|NCT01125189|584522882|FG002|Treatment Period|Other reasons|0|||
161858622|NCT01125189|584522880|FG000|Treatment Period|Completed 24 week treatment period only|2|||
161858623|NCT01125189|584522881|FG001|Treatment Period|Completed 24 week treatment period only|1|||
161858624|NCT01125189|584522882|FG002|Treatment Period|Completed 24 week treatment period only|2|||
161858625|NCT01125189|584522880|FG000|Follow up Period|Withdrawal by Subject|3|||
161858626|NCT01125189|584522881|FG001|Follow up Period|Withdrawal by Subject|2|||
161858627|NCT01125189|584522882|FG002|Follow up Period|Withdrawal by Subject|5|||
161858628|NCT01125189|584522880|FG000|Follow up Period|Death|1|||
161858629|NCT01125189|584522881|FG001|Follow up Period|Death|0|||
161858630|NCT01125189|584522882|FG002|Follow up Period|Death|0|||
161858631|NCT01125189|584522880|FG000|Follow up Period|Lost to Follow-up|12|||
161858632|NCT01125189|584522881|FG001|Follow up Period|Lost to Follow-up|9|||
161858633|NCT01125189|584522882|FG002|Follow up Period|Lost to Follow-up|6|||
161858634|NCT01125189|584522880|FG000|Follow up Period|Other reasons|4|||
161858635|NCT01125189|584522881|FG001|Follow up Period|Other reasons|4|||
161858636|NCT01125189|584522882|FG002|Follow up Period|Other reasons|5|||
161858637|NCT00114140|584522883|FG000|Overall Study|Protocol Violation|7|||
161858638|NCT00110396|584522888|FG000|Overall Study|Adverse Event|15|||
161858639|NCT00110396|584522888|FG000|Overall Study|Lost to Follow-up|1|||
161858640|NCT00110396|584522888|FG000|Overall Study|Administration of plasmapheresis|1|||
161858641|NCT00110396|584522888|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
161858642|NCT00110396|584522888|FG000|Overall Study|Lack of Efficacy|1|||
161858643|NCT00110396|584522888|FG000|Overall Study|Decided not to continue treatment|1|||
161858644|NCT00110396|584522888|FG000|Overall Study|Patient non-compliance|1|||
161858645|NCT00110396|584522888|FG000|Overall Study|Patient refused to continue|1|||
161858646|NCT00110396|584522888|FG000|Overall Study|Patient refused to participate|1|||
161858647|NCT00110396|584522888|FG000|Overall Study|Patient will|1|||
161858648|NCT00110396|584522888|FG000|Overall Study|Patient's decision|1|||
161858649|NCT00110396|584522888|FG000|Overall Study|Participation in MS vaccine study|1|||
161770174|NCT01475214|584198647|FG000|Overall Study|Lost to Follow-up|1|||
161770175|NCT01475214|584198648|FG001|Overall Study|Lost to Follow-up|0|||
161770176|NCT01475214|584198649|FG002|Overall Study|Lost to Follow-up|1|||
161770177|NCT01475214|584198647|FG000|Overall Study|Physician Decision|2|||
161770178|NCT01475214|584198648|FG001|Overall Study|Physician Decision|0|||
161770179|NCT01475214|584198649|FG002|Overall Study|Physician Decision|0|||
161770180|NCT01475214|584198647|FG000|Overall Study|Withdrawal by Subject|2|||
161770181|NCT01475214|584198648|FG001|Overall Study|Withdrawal by Subject|4|||
161770182|NCT01475214|584198649|FG002|Overall Study|Withdrawal by Subject|1|||
161770183|NCT00643851|584198650|FG000|Overall Study|Death|0|||
161770184|NCT00643851|584198651|FG001|Overall Study|Death|1|||
161770185|NCT00643851|584198652|FG002|Overall Study|Death|0|||
161770186|NCT00643851|584198650|FG000|Overall Study|Lack of Efficacy|0|||
161770187|NCT00643851|584198651|FG001|Overall Study|Lack of Efficacy|1|||
161770188|NCT00643851|584198652|FG002|Overall Study|Lack of Efficacy|0|||
161770189|NCT00643851|584198650|FG000|Overall Study|Adverse Event|2|||
161770190|NCT00643851|584198651|FG001|Overall Study|Adverse Event|6|||
161770191|NCT00643851|584198652|FG002|Overall Study|Adverse Event|6|||
161770192|NCT00643851|584198650|FG000|Overall Study|Lost to Follow-up|4|||
161770193|NCT00643851|584198651|FG001|Overall Study|Lost to Follow-up|6|||
161770194|NCT00643851|584198652|FG002|Overall Study|Lost to Follow-up|9|||
161770195|NCT00643851|584198650|FG000|Overall Study|Withdrawal by Subject|8|||
161770196|NCT00643851|584198651|FG001|Overall Study|Withdrawal by Subject|15|||
161770197|NCT00643851|584198652|FG002|Overall Study|Withdrawal by Subject|9|||
161770198|NCT00643851|584198650|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
161770199|NCT00643851|584198651|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
161770200|NCT00643851|584198652|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
161770201|NCT01977573|584198653|FG000|Overall Study|Adverse Event|7|||
161770202|NCT01977573|584198654|FG001|Overall Study|Adverse Event|0|||
161770203|NCT01977573|584198655|FG002|Overall Study|Adverse Event|2|||
161770204|NCT01977573|584198656|FG003|Overall Study|Adverse Event|1|||
161770205|NCT01977573|584198653|FG000|Overall Study|Lost to Follow-up|1|||
161770206|NCT01977573|584198654|FG001|Overall Study|Lost to Follow-up|0|||
161770207|NCT01977573|584198655|FG002|Overall Study|Lost to Follow-up|0|||
161770208|NCT01977573|584198656|FG003|Overall Study|Lost to Follow-up|1|||
161770209|NCT01977573|584198653|FG000|Overall Study|Physician Decision|1|||
161770210|NCT01977573|584198654|FG001|Overall Study|Physician Decision|0|||
161770211|NCT01977573|584198655|FG002|Overall Study|Physician Decision|0|||
161770212|NCT01977573|584198656|FG003|Overall Study|Physician Decision|0|||
161770213|NCT01977573|584198653|FG000|Overall Study|Protocol Violation|3|||
161770214|NCT01977573|584198654|FG001|Overall Study|Protocol Violation|1|||
161770215|NCT01977573|584198655|FG002|Overall Study|Protocol Violation|0|||
161770216|NCT01977573|584198656|FG003|Overall Study|Protocol Violation|0|||
161770217|NCT01977573|584198653|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
161770218|NCT01977573|584198654|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
161770219|NCT01977573|584198655|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
161770220|NCT01977573|584198656|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
161770221|NCT01977573|584198653|FG000|Overall Study|Withdrawal by Subject|6|||
161770222|NCT01977573|584198654|FG001|Overall Study|Withdrawal by Subject|1|||
161770223|NCT01977573|584198655|FG002|Overall Study|Withdrawal by Subject|1|||
161770224|NCT01977573|584198656|FG003|Overall Study|Withdrawal by Subject|1|||
161770225|NCT00323479|584198657|FG000|Overall Study|Adverse Event|2|||
161770226|NCT00323479|584198657|FG000|Overall Study|Withdrawal by Subject|2|||
161770227|NCT00323479|584198657|FG000|Overall Study|Protocol Violation|3|||
161770228|NCT00323479|584198657|FG000|Overall Study|house moving|1|||
161770229|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
161770230|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
161770231|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
161770232|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
161770233|NCT03044730|584198660|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
161770234|NCT03044730|584198660|FG000|Cycles 4 and Beyond|Adverse Event|1|||
161858650|NCT00110396|584522888|FG000|Overall Study|Pregnancy|1|||
161858651|NCT00110396|584522888|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
161858652|NCT00110396|584522888|FG000|Overall Study|Protocol Violation|2|||
161858653|NCT00110396|584522888|FG000|Overall Study|Patient refused to come back|1|||
161858654|NCT00110396|584522888|FG000|Overall Study|The patient has refused|2|||
161858655|NCT00110396|584522888|FG000|Overall Study|The patient has refused to visit site|1|||
161858656|NCT00110396|584522888|FG000|Overall Study|Patient is to be administered copaxone|1|||
161858657|NCT02414958|584522889|FG000|Overall Study|Adverse Event|6|||
161858658|NCT02414958|584522890|FG001|Overall Study|Adverse Event|6|||
161858659|NCT02414958|584522891|FG002|Overall Study|Adverse Event|3|||
161858660|NCT02414958|584522889|FG000|Overall Study|Protocol Violation|10|||
161858661|NCT02414958|584522890|FG001|Overall Study|Protocol Violation|3|||
161858662|NCT02414958|584522891|FG002|Overall Study|Protocol Violation|1|||
161858663|NCT02414958|584522889|FG000|Overall Study|Lost to Follow-up|7|||
161858664|NCT02414958|584522890|FG001|Overall Study|Lost to Follow-up|4|||
161858665|NCT02414958|584522891|FG002|Overall Study|Lost to Follow-up|0|||
161858666|NCT02414958|584522889|FG000|Overall Study|Withdrawal by Subject|5|||
161858667|NCT02414958|584522890|FG001|Overall Study|Withdrawal by Subject|3|||
161858668|NCT02414958|584522891|FG002|Overall Study|Withdrawal by Subject|5|||
161858669|NCT02414958|584522889|FG000|Overall Study|Other than specified|4|||
161858670|NCT02414958|584522890|FG001|Overall Study|Other than specified|4|||
161858671|NCT02414958|584522891|FG002|Overall Study|Other than specified|5|||
161858672|NCT01269918|584522892|FG000|Overall Study|Did not receive study drug|0|||
161858673|NCT01269918|584522893|FG001|Overall Study|Did not receive study drug|3|||
161858674|NCT04542057|584522897|FG000|Overall Study|Death|3|||
161858675|NCT04542057|584522898|FG001|Overall Study|Death|1|||
161858676|NCT04542057|584522897|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
161858677|NCT04542057|584522898|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
161858678|NCT04542057|584522897|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
161858679|NCT04542057|584522898|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
161858680|NCT04542057|584522897|FG000|Overall Study|Adverse Event|15|||
161858681|NCT04542057|584522898|FG001|Overall Study|Adverse Event|6|||
161858682|NCT04542057|584522897|FG000|Overall Study|COVID-19 adverse event|6|||
161858683|NCT04542057|584522898|FG001|Overall Study|COVID-19 adverse event|4|||
161858684|NCT04542057|584522897|FG000|Overall Study|Lack of Efficacy|2|||
161858685|NCT04542057|584522898|FG001|Overall Study|Lack of Efficacy|5|||
161858686|NCT04542057|584522897|FG000|Overall Study|Study terminated by sponsor|1|||
161858687|NCT04542057|584522898|FG001|Overall Study|Study terminated by sponsor|0|||
161858688|NCT04542057|584522897|FG000|Overall Study|Investigator discretion|2|||
161858689|NCT04542057|584522898|FG001|Overall Study|Investigator discretion|1|||
161858690|NCT04542057|584522897|FG000|Overall Study|Withdrawal by Subject|52|||
161858691|NCT04542057|584522898|FG001|Overall Study|Withdrawal by Subject|30|||
161858692|NCT04542057|584522897|FG000|Overall Study|Lost to Follow-up|8|||
161858693|NCT04542057|584522898|FG001|Overall Study|Lost to Follow-up|11|||
161858694|NCT04542057|584522897|FG000|Overall Study|Other|2|||
161858695|NCT04542057|584522898|FG001|Overall Study|Other|2|||
161858696|NCT00838526|584522899|FG000|Overall Study|Adverse Event|3|||
161858697|NCT00838526|584522900|FG001|Overall Study|Adverse Event|12|||
161858698|NCT00838526|584522899|FG000|Overall Study|Lost to Follow-up|4|||
161858699|NCT00838526|584522900|FG001|Overall Study|Lost to Follow-up|12|||
161858700|NCT00838526|584522899|FG000|Overall Study|Withdrawal by Subject|4|||
161858701|NCT00838526|584522900|FG001|Overall Study|Withdrawal by Subject|5|||
161858702|NCT00838526|584522899|FG000|Overall Study|Lack of Efficacy|2|||
161858703|NCT00838526|584522900|FG001|Overall Study|Lack of Efficacy|3|||
161858704|NCT00838526|584522899|FG000|Overall Study|Other|11|||
161858705|NCT00838526|584522900|FG001|Overall Study|Other|7|||
161858706|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
161858707|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
161858708|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
161858709|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
161858710|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
161858711|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
161858712|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
161858713|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
161858714|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
161858715|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
161858716|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
161858717|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
161770235|NCT03044730|584198660|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
161770236|NCT03044730|584198660|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
161770237|NCT03044730|584198660|FG000|On Follow-up for 2 Years|Death|17|||
161770238|NCT01302366|584200168|FG000|Overall Study|patient choice or noncompliance|5|||
161770239|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770240|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
161770241|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770242|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770243|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
161770244|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
161770245|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770246|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770247|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
161770248|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770249|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
161770250|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770251|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770252|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770253|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
161770254|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
161770255|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
161770256|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
161770257|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
161770258|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
161770259|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
161770260|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770261|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
161770262|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770263|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770264|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770265|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770266|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770267|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770268|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
161770269|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770270|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770271|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770272|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770273|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
161770274|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
161770275|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
161770276|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
161770277|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
161770278|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
161770279|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
161770280|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
161770281|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770282|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
161770283|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770284|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770285|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
161858718|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
161858719|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
161858720|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
161858721|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
161858722|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
161858723|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
161858724|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
161858725|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
161858726|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
161858727|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
161858728|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
161858729|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
161858730|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
161858731|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
161858732|NCT04338022|584522901|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
161858733|NCT04338022|584522902|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
161858734|NCT02273388|584522903|FG000|Overall Study|Adverse Event|0|||
161858735|NCT02273388|584522904|FG001|Overall Study|Adverse Event|0|||
161858736|NCT02273388|584522905|FG002|Overall Study|Adverse Event|0|||
161858737|NCT02273388|584522906|FG003|Overall Study|Adverse Event|0|||
161858738|NCT02273388|584522907|FG004|Overall Study|Adverse Event|0|||
161858739|NCT02273388|584522908|FG005|Overall Study|Adverse Event|0|||
161858740|NCT02273388|584522909|FG006|Overall Study|Adverse Event|1|||
161858741|NCT02273388|584522910|FG007|Overall Study|Adverse Event|2|||
161858742|NCT02273388|584522911|FG008|Overall Study|Adverse Event|0|||
161858743|NCT02273388|584522912|FG009|Overall Study|Adverse Event|0|||
161858744|NCT02273388|584522913|FG010|Overall Study|Adverse Event|0|||
161858745|NCT02273388|584522914|FG011|Overall Study|Adverse Event|0|||
161858746|NCT02273388|584522903|FG000|Overall Study|Adverse Event study disease worse|4|||
161858747|NCT02273388|584522904|FG001|Overall Study|Adverse Event study disease worse|3|||
161858748|NCT02273388|584522905|FG002|Overall Study|Adverse Event study disease worse|3|||
161858749|NCT02273388|584522906|FG003|Overall Study|Adverse Event study disease worse|2|||
161858750|NCT02273388|584522907|FG004|Overall Study|Adverse Event study disease worse|4|||
161858751|NCT02273388|584522908|FG005|Overall Study|Adverse Event study disease worse|3|||
161858752|NCT02273388|584522909|FG006|Overall Study|Adverse Event study disease worse|14|||
161858753|NCT02273388|584522910|FG007|Overall Study|Adverse Event study disease worse|6|||
161858754|NCT02273388|584522911|FG008|Overall Study|Adverse Event study disease worse|6|||
161858755|NCT02273388|584522912|FG009|Overall Study|Adverse Event study disease worse|5|||
161858756|NCT02273388|584522913|FG010|Overall Study|Adverse Event study disease worse|10|||
161858757|NCT02273388|584522914|FG011|Overall Study|Adverse Event study disease worse|1|||
161858758|NCT02273388|584522903|FG000|Overall Study|Sponsor decision|0|||
161858759|NCT02273388|584522904|FG001|Overall Study|Sponsor decision|0|||
161858760|NCT02273388|584522905|FG002|Overall Study|Sponsor decision|0|||
161858761|NCT02273388|584522906|FG003|Overall Study|Sponsor decision|0|||
161858762|NCT02273388|584522907|FG004|Overall Study|Sponsor decision|0|||
161858763|NCT02273388|584522908|FG005|Overall Study|Sponsor decision|0|||
161858764|NCT02273388|584522909|FG006|Overall Study|Sponsor decision|0|||
161858765|NCT02273388|584522910|FG007|Overall Study|Sponsor decision|0|||
161858766|NCT02273388|584522911|FG008|Overall Study|Sponsor decision|0|||
161858767|NCT02273388|584522912|FG009|Overall Study|Sponsor decision|0|||
161858768|NCT02273388|584522913|FG010|Overall Study|Sponsor decision|0|||
161858769|NCT02273388|584522914|FG011|Overall Study|Sponsor decision|1|||
161858770|NCT04331808|584522915|FG000|Overall Study|Withdrew consent|1|||
161858771|NCT04331808|584522916|FG001|Overall Study|Withdrew consent|0|||
161858772|NCT04331808|584522917|FG002|Overall Study|Withdrew consent|2|||
161858773|NCT04331808|584522918|FG003|Overall Study|Withdrew consent|3|||
161858774|NCT02445963|584522919|FG000|Overall Study|Lost to Follow-up|1|||
161858775|NCT02445963|584522920|FG001|Overall Study|Lost to Follow-up|0|||
161858776|NCT02445963|584522921|FG002|Overall Study|Lost to Follow-up|0|||
161858777|NCT02445963|584522922|FG003|Overall Study|Lost to Follow-up|0|||
161858778|NCT02445963|584522919|FG000|Overall Study|Change in employment|1|||
161858779|NCT02445963|584522920|FG001|Overall Study|Change in employment|0|||
161858780|NCT02445963|584522921|FG002|Overall Study|Change in employment|0|||
161858781|NCT02445963|584522922|FG003|Overall Study|Change in employment|0|||
161858782|NCT02445963|584522919|FG000|Overall Study|Symptoms post-vaccination|0|||
161858783|NCT02445963|584522920|FG001|Overall Study|Symptoms post-vaccination|0|||
161858784|NCT02445963|584522921|FG002|Overall Study|Symptoms post-vaccination|1|||
161858785|NCT02445963|584522922|FG003|Overall Study|Symptoms post-vaccination|0|||
161858786|NCT00952731|584522923|FG000|Overall Study|Drug supply expired|1|||
161858787|NCT00952731|584522924|FG001|Overall Study|Drug supply expired|0|||
161858788|NCT01449812|584522925|FG000|Overall Study|Migrated/moved from study area|1|||
161858789|NCT01449812|584522926|FG001|Overall Study|Migrated/moved from study area|0|||
161858790|NCT01449812|584522927|FG002|Overall Study|Migrated/moved from study area|0|||
161858791|NCT01449812|584522925|FG000|Overall Study|Withdrawal by Subject|0|||
161858792|NCT01449812|584522926|FG001|Overall Study|Withdrawal by Subject|0|||
161858793|NCT01449812|584522927|FG002|Overall Study|Withdrawal by Subject|1|||
161858794|NCT01449812|584522925|FG000|Overall Study|Lost to Follow-up|1|||
161858795|NCT01449812|584522926|FG001|Overall Study|Lost to Follow-up|0|||
161858796|NCT01449812|584522927|FG002|Overall Study|Lost to Follow-up|0|||
161858797|NCT00625872|584522928|FG000|Overall Study|Withdrawal by Subject|1|||
161858798|NCT00625872|584522929|FG001|Overall Study|Withdrawal by Subject|0|||
161858799|NCT00625872|584522928|FG000|Overall Study|Does not meet inclusion criteria|1|||
161858800|NCT00625872|584522929|FG001|Overall Study|Does not meet inclusion criteria|0|||
161858801|NCT00625872|584522928|FG000|Overall Study|Terminated by sponsor|2|||
161858802|NCT00625872|584522929|FG001|Overall Study|Terminated by sponsor|5|||
161858803|NCT00625872|584522928|FG000|Overall Study|Randomized but not treated|0|||
161858804|NCT00625872|584522929|FG001|Overall Study|Randomized but not treated|1|||
161858805|NCT01512160|584522933|FG000|Overall Study|Lost to Follow-up|1|||
161858806|NCT01512160|584522934|FG001|Overall Study|Lost to Follow-up|0|||
161858807|NCT01512160|584522935|FG002|Overall Study|Lost to Follow-up|0|||
161858808|NCT01512160|584522936|FG003|Overall Study|Lost to Follow-up|0|||
161858809|NCT01512160|584522933|FG000|Overall Study|Withdrawal by Subject|1|||
161858810|NCT01512160|584522934|FG001|Overall Study|Withdrawal by Subject|0|||
161858811|NCT01512160|584522935|FG002|Overall Study|Withdrawal by Subject|0|||
161858812|NCT01512160|584522936|FG003|Overall Study|Withdrawal by Subject|1|||
161858813|NCT02729909|584522937|FG000|Overall Study|Lost to Follow-up|0|||
161858814|NCT02729909|584522938|FG001|Overall Study|Lost to Follow-up|1|||
161858815|NCT02729909|584522937|FG000|Overall Study|Lack of Efficacy|0|||
161858816|NCT02729909|584522938|FG001|Overall Study|Lack of Efficacy|2|||
161858817|NCT02729909|584522937|FG000|Overall Study|Significant Protocol Deviation|0|||
161858818|NCT02729909|584522938|FG001|Overall Study|Significant Protocol Deviation|2|||
161858819|NCT02729909|584522937|FG000|Overall Study|Voluntary Withdrawal|1|||
161858820|NCT02729909|584522938|FG001|Overall Study|Voluntary Withdrawal|0|||
161858821|NCT01128179|584522939|FG000|Overall Study|Death|1|||
161858822|NCT01128179|584522940|FG001|Overall Study|Death|0|||
161858823|NCT01128179|584522939|FG000|Overall Study|Protocol Violation|1|||
161858824|NCT01128179|584522940|FG001|Overall Study|Protocol Violation|0|||
161858825|NCT04358081|584525178|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
161858826|NCT04358081|584525179|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
161770286|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770287|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770288|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770289|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770290|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770291|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
161770292|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
161770293|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770294|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770295|NCT04585906|584200178|FG000|Overall Study|Lost to Follow-up|8|||
161770296|NCT04585906|584200179|FG001|Overall Study|Lost to Follow-up|5|||
161770297|NCT04626947|584200180|FG000|Overall Study|Study terminated|14|||
161770298|NCT01428882|584200191|FG000|Overall Study|Lack of Efficacy|2|||
161770299|NCT01428882|584200192|FG001|Overall Study|Lack of Efficacy|7|||
161770300|NCT01428882|584200191|FG000|Overall Study|Protocol Violation|4|||
161770301|NCT01428882|584200192|FG001|Overall Study|Protocol Violation|3|||
161770302|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
161770303|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
161770304|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
161770305|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
161770306|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
161770307|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
161770308|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
161770309|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
161770310|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
161770311|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
161770312|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
161770313|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
161770314|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
161770315|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
161770316|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
161770317|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
161770318|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
161770319|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
161770320|NCT01694849|584200199|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
161770321|NCT01694849|584200200|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
161770322|NCT01694849|584200201|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
161770323|NCT01694849|584200199|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
161770324|NCT01694849|584200200|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
161770325|NCT01694849|584200201|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
161770326|NCT01326312|584200202|FG000|Overall Study|Adverse Event|11|||
161770327|NCT01326312|584200203|FG001|Overall Study|Adverse Event|11|||
161770328|NCT01326312|584200204|FG002|Overall Study|Adverse Event|1|||
161770329|NCT01326312|584200202|FG000|Overall Study|Withdrawal by Subject|1|||
161770330|NCT01326312|584200203|FG001|Overall Study|Withdrawal by Subject|2|||
161770331|NCT01326312|584200204|FG002|Overall Study|Withdrawal by Subject|1|||
161770332|NCT01326312|584200202|FG000|Overall Study|Protocol Violation|0|||
161770333|NCT01326312|584200203|FG001|Overall Study|Protocol Violation|1|||
161770334|NCT01326312|584200204|FG002|Overall Study|Protocol Violation|0|||
161770335|NCT01326312|584200202|FG000|Overall Study|Lack of Efficacy|13|||
161770336|NCT01326312|584200203|FG001|Overall Study|Lack of Efficacy|7|||
161770337|NCT01326312|584200204|FG002|Overall Study|Lack of Efficacy|1|||
161770338|NCT01326312|584200202|FG000|Overall Study|Death|1|||
161770339|NCT01326312|584200203|FG001|Overall Study|Death|0|||
161770340|NCT01326312|584200204|FG002|Overall Study|Death|1|||
161770341|NCT01326312|584200202|FG000|Overall Study|progressive disease|0|||
161770342|NCT01326312|584200203|FG001|Overall Study|progressive disease|1|||
161770343|NCT01326312|584200204|FG002|Overall Study|progressive disease|1|||
161770344|NCT01326312|584200202|FG000|Overall Study|Study terminated by Sponsor|8|||
161770345|NCT01326312|584200203|FG001|Overall Study|Study terminated by Sponsor|32|||
161770346|NCT01326312|584200204|FG002|Overall Study|Study terminated by Sponsor|46|||
161770347|NCT01326312|584200202|FG000|Overall Study|Treatment arm terminated|19|||
161770348|NCT01326312|584200203|FG001|Overall Study|Treatment arm terminated|0|||
161770349|NCT01326312|584200204|FG002|Overall Study|Treatment arm terminated|0|||
161770350|NCT01326312|584200202|FG000|Overall Study|QTc > 500|0|||
161770351|NCT01326312|584200203|FG001|Overall Study|QTc > 500|1|||
161770352|NCT01326312|584200204|FG002|Overall Study|QTc > 500|0|||
161770353|NCT02243306|584200214|FG000|Overall Study|Adverse Event|0|||
161770354|NCT02243306|584200215|FG001|Overall Study|Adverse Event|1|||
161858827|NCT04358081|584525180|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
161858828|NCT04358081|584525178|FG000|Treatment Phase of Study|Adverse Event|1|||
161858829|NCT04358081|584525179|FG001|Treatment Phase of Study|Adverse Event|0|||
161858830|NCT04358081|584525180|FG002|Treatment Phase of Study|Adverse Event|1|||
161858831|NCT04358081|584525178|FG000|Treatment Phase of Study|Physician Decision|2|||
161858832|NCT04358081|584525179|FG001|Treatment Phase of Study|Physician Decision|0|||
161858833|NCT04358081|584525180|FG002|Treatment Phase of Study|Physician Decision|1|||
161858834|NCT04358081|584525178|FG000|Treatment Phase of Study|Protocol Violation|1|||
161858835|NCT04358081|584525179|FG001|Treatment Phase of Study|Protocol Violation|0|||
161858836|NCT04358081|584525180|FG002|Treatment Phase of Study|Protocol Violation|0|||
161858837|NCT04358081|584525178|FG000|Study Completion Phase|Death|0|||
161858838|NCT04358081|584525179|FG001|Study Completion Phase|Death|0|||
161858839|NCT04358081|584525180|FG002|Study Completion Phase|Death|1|||
161858840|NCT04358081|584525178|FG000|Study Completion Phase|Lost to Follow-up|1|||
161858841|NCT04358081|584525179|FG001|Study Completion Phase|Lost to Follow-up|0|||
161858842|NCT04358081|584525180|FG002|Study Completion Phase|Lost to Follow-up|1|||
161858843|NCT03283566|584525181|FG000|Overall Study|Lost to Follow-up|1|||
161858844|NCT03283566|584525182|FG001|Overall Study|Lost to Follow-up|2|||
161858845|NCT04515147|584525183|FG000|Overall Study|Withdrawal by Subject|1|||
161858846|NCT04515147|584525184|FG001|Overall Study|Withdrawal by Subject|0|||
161858847|NCT04515147|584525185|FG002|Overall Study|Withdrawal by Subject|10|||
161858848|NCT04515147|584525186|FG003|Overall Study|Withdrawal by Subject|18|||
161858849|NCT04515147|584525187|FG004|Overall Study|Withdrawal by Subject|1|||
161858850|NCT04515147|584525188|FG005|Overall Study|Withdrawal by Subject|8|||
161858851|NCT04515147|584525183|FG000|Overall Study|Lost to Follow-up|0|||
161858852|NCT04515147|584525184|FG001|Overall Study|Lost to Follow-up|1|||
161858853|NCT04515147|584525185|FG002|Overall Study|Lost to Follow-up|5|||
161858854|NCT04515147|584525186|FG003|Overall Study|Lost to Follow-up|6|||
161858855|NCT04515147|584525187|FG004|Overall Study|Lost to Follow-up|2|||
161858856|NCT04515147|584525188|FG005|Overall Study|Lost to Follow-up|1|||
161858857|NCT04515147|584525183|FG000|Overall Study|Adverse Event|0|||
161858858|NCT04515147|584525184|FG001|Overall Study|Adverse Event|0|||
161858859|NCT04515147|584525185|FG002|Overall Study|Adverse Event|0|||
161858860|NCT04515147|584525186|FG003|Overall Study|Adverse Event|2|||
161858861|NCT04515147|584525187|FG004|Overall Study|Adverse Event|0|||
161858862|NCT04515147|584525188|FG005|Overall Study|Adverse Event|0|||
161858863|NCT04515147|584525183|FG000|Overall Study|Miscellaneous|0|||
161858864|NCT04515147|584525184|FG001|Overall Study|Miscellaneous|0|||
161858865|NCT04515147|584525185|FG002|Overall Study|Miscellaneous|0|||
161858866|NCT04515147|584525186|FG003|Overall Study|Miscellaneous|1|||
161858867|NCT04515147|584525187|FG004|Overall Study|Miscellaneous|0|||
161858868|NCT04515147|584525188|FG005|Overall Study|Miscellaneous|1|||
161858869|NCT04123405|584525189|FG000|Overall Study|Adverse Event|1|||
161858870|NCT04123405|584525190|FG001|Overall Study|Adverse Event|2|||
161858871|NCT04123405|584525191|FG002|Overall Study|Adverse Event|3|||
161858872|NCT04123405|584525192|FG003|Overall Study|Adverse Event|3|||
161858873|NCT04123405|584525189|FG000|Overall Study|Exclusion criteria met|1|||
161858874|NCT04123405|584525190|FG001|Overall Study|Exclusion criteria met|2|||
161858875|NCT04123405|584525191|FG002|Overall Study|Exclusion criteria met|0|||
161858876|NCT04123405|584525192|FG003|Overall Study|Exclusion criteria met|2|||
161858877|NCT04123405|584525189|FG000|Overall Study|Withdrawal by Subject|1|||
161858878|NCT04123405|584525190|FG001|Overall Study|Withdrawal by Subject|3|||
161858879|NCT04123405|584525191|FG002|Overall Study|Withdrawal by Subject|0|||
161858880|NCT04123405|584525192|FG003|Overall Study|Withdrawal by Subject|2|||
161858881|NCT04123405|584525189|FG000|Overall Study|Contact to subject lost|0|||
161858882|NCT04123405|584525190|FG001|Overall Study|Contact to subject lost|0|||
161858883|NCT04123405|584525191|FG002|Overall Study|Contact to subject lost|0|||
161858884|NCT04123405|584525192|FG003|Overall Study|Contact to subject lost|1|||
161858885|NCT04123405|584525189|FG000|Overall Study|screening failure|1|||
161858886|NCT04123405|584525190|FG001|Overall Study|screening failure|0|||
161858887|NCT04123405|584525191|FG002|Overall Study|screening failure|0|||
161858888|NCT04123405|584525192|FG003|Overall Study|screening failure|0|||
161858889|NCT01050530|584525193|FG000|Overall Study|Adverse Event|6|||
161858890|NCT01050530|584525194|FG001|Overall Study|Adverse Event|3|||
161858891|NCT01050530|584525193|FG000|Overall Study|Lack of Efficacy|1|||
161858892|NCT01050530|584525194|FG001|Overall Study|Lack of Efficacy|4|||
161858893|NCT01050530|584525193|FG000|Overall Study|Withdrawal by Subject|0|||
161858894|NCT01050530|584525194|FG001|Overall Study|Withdrawal by Subject|3|||
161858895|NCT01050530|584525193|FG000|Overall Study|Protocol Violation|1|||
161858896|NCT01050530|584525194|FG001|Overall Study|Protocol Violation|0|||
161858897|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Physician Decision|3|||
161858898|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
161858899|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Disease Progression|1|||
161858900|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
161858901|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
161858902|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
161858903|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
161858904|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
161858905|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
161858906|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Death|2|||
161858907|NCT00116779|584525196|FG000|Overall Study|Adverse Event|4|||
161858908|NCT00116779|584525197|FG001|Overall Study|Adverse Event|2|||
161858909|NCT00116779|584525196|FG000|Overall Study|Protocol Violation|1|||
161858910|NCT00116779|584525197|FG001|Overall Study|Protocol Violation|4|||
161858911|NCT00116779|584525196|FG000|Overall Study|Withdrawal by Subject|4|||
161858912|NCT00116779|584525197|FG001|Overall Study|Withdrawal by Subject|1|||
161858913|NCT00116779|584525196|FG000|Overall Study|Inadequate testosterone suppression|7|||
161858914|NCT00116779|584525197|FG001|Overall Study|Inadequate testosterone suppression|9|||
161858915|NCT00116779|584525196|FG000|Overall Study|Physician Decision|3|||
161858916|NCT00116779|584525197|FG001|Overall Study|Physician Decision|1|||
161858917|NCT00116779|584525196|FG000|Overall Study|Elevated PSA levels|2|||
161858918|NCT00116779|584525197|FG001|Overall Study|Elevated PSA levels|2|||
161858919|NCT03934541|584525209|FG000|Overall Study|Study Terminated by Sponsor|0|||
161858920|NCT03934541|584525210|FG001|Overall Study|Study Terminated by Sponsor|1|||
161858921|NCT03934541|584525211|FG002|Overall Study|Study Terminated by Sponsor|0|||
161858922|NCT03934541|584525212|FG003|Overall Study|Study Terminated by Sponsor|0|||
161858923|NCT01928472|584525215|FG000|Overall Study|Death|0|||
161858924|NCT01928472|584525216|FG001|Overall Study|Death|0|||
161858925|NCT01928472|584525217|FG002|Overall Study|Death|1|||
161858926|NCT01928472|584525218|FG003|Overall Study|Death|0|||
161858927|NCT01928472|584525215|FG000|Overall Study|Withdrawal by Subject|4|||
161858928|NCT01928472|584525216|FG001|Overall Study|Withdrawal by Subject|4|||
161858929|NCT01928472|584525217|FG002|Overall Study|Withdrawal by Subject|1|||
161858930|NCT01928472|584525218|FG003|Overall Study|Withdrawal by Subject|2|||
161858931|NCT01928472|584525215|FG000|Overall Study|Lost to Follow-up|2|||
161858932|NCT01928472|584525216|FG001|Overall Study|Lost to Follow-up|3|||
161858933|NCT01928472|584525217|FG002|Overall Study|Lost to Follow-up|4|||
161858934|NCT01928472|584525218|FG003|Overall Study|Lost to Follow-up|0|||
161858935|NCT01928472|584525215|FG000|Overall Study|Administrative Reason|2|||
161858936|NCT01928472|584525216|FG001|Overall Study|Administrative Reason|1|||
161858937|NCT01928472|584525217|FG002|Overall Study|Administrative Reason|0|||
161858938|NCT01928472|584525218|FG003|Overall Study|Administrative Reason|0|||
161858939|NCT01928472|584525215|FG000|Overall Study|Unclassified|0|||
161858940|NCT01928472|584525216|FG001|Overall Study|Unclassified|0|||
161858941|NCT01928472|584525217|FG002|Overall Study|Unclassified|1|||
161858942|NCT01928472|584525218|FG003|Overall Study|Unclassified|0|||
161858943|NCT03624192|584525220|FG000|Overall Study|Lost to Follow-up|1|||
161858944|NCT03624192|584525221|FG001|Overall Study|Lost to Follow-up|1|||
161858945|NCT01640249|584525222|FG000|Period 1|Withdrawal by Subject|1|||
161858946|NCT01640249|584525223|FG001|Period 1|Withdrawal by Subject|0|||
161858947|NCT01640249|584525224|FG002|Period 1|Withdrawal by Subject|0|||
161858948|NCT01640249|584525225|FG003|Period 1|Withdrawal by Subject|0|||
161858949|NCT01640249|584525226|FG004|Period 1|Withdrawal by Subject|0|||
161858950|NCT01640249|584525227|FG005|Period 1|Withdrawal by Subject|1|||
161858951|NCT01640249|584525228|FG006|Period 1|Withdrawal by Subject|0|||
161858952|NCT00065156|584525229|FG000|Overall Study|Adverse Event|37|||
161858953|NCT00065156|584525229|FG000|Overall Study|Lack of Efficacy|52|||
161858954|NCT00065156|584525229|FG000|Overall Study|Withdrawal by Subject|8|||
161858955|NCT00065156|584525229|FG000|Overall Study|Lost to Follow-up|1|||
161858956|NCT00065156|584525229|FG000|Overall Study|Death|11|||
161858957|NCT00065156|584525229|FG000|Overall Study|Study Closed by Sponsor|2|||
161858958|NCT00065156|584525229|FG000|Overall Study|Disease Progression|7|||
161858959|NCT00065156|584525229|FG000|Overall Study|Investigator Decision|2|||
161858960|NCT00065156|584525229|FG000|Overall Study|Non-Compliance|2|||
161858961|NCT00065156|584525229|FG000|Overall Study|Loss of Response|1|||
161858962|NCT00065156|584525229|FG000|Overall Study|Secondary Malign Disease|1|||
161858963|NCT00312338|584525230|FG000|Overall Study|Adverse Event|7|||
161858964|NCT00312338|584525231|FG001|Overall Study|Adverse Event|2|||
161858965|NCT00312338|584525230|FG000|Overall Study|Lost to Follow-up|9|||
161858966|NCT00312338|584525231|FG001|Overall Study|Lost to Follow-up|1|||
161858967|NCT00312338|584525230|FG000|Overall Study|Withdrawal by Subject|4|||
161858968|NCT00312338|584525231|FG001|Overall Study|Withdrawal by Subject|0|||
161858969|NCT00312338|584525230|FG000|Overall Study|Subsequent infection|2|||
161858970|NCT00312338|584525231|FG001|Overall Study|Subsequent infection|0|||
161858971|NCT00100828|584525232|FG000|Overall Study|Physician Decision|6|||
161858972|NCT04583735|584525233|FG000|Double-masked Treatment Period|Adverse Event|0|||
161858973|NCT04583735|584525234|FG001|Double-masked Treatment Period|Adverse Event|1|||
161858974|NCT04583735|584525233|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
161858975|NCT04583735|584525234|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
161858976|NCT04583735|584525233|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
161858977|NCT04583735|584525234|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
161858978|NCT04583735|584525233|FG000|Open-label Treatment Period|Adverse Event|1|||
161858979|NCT04583735|584525234|FG001|Open-label Treatment Period|Adverse Event|1|||
161858980|NCT04583735|584525233|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
161858981|NCT04583735|584525234|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161858982|NCT04583735|584525233|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161858983|NCT04583735|584525234|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
161858984|NCT01176513|584525235|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
161858985|NCT01215136|584525236|FG000|Overall Study|Adverse Event|2|||
161858986|NCT01215136|584525237|FG001|Overall Study|Adverse Event|9|||
161858987|NCT01215136|584525236|FG000|Overall Study|Disease Progression|3|||
161858988|NCT01215136|584525237|FG001|Overall Study|Disease Progression|14|||
161858989|NCT01215136|584525236|FG000|Overall Study|Symptomatic Deterioration|1|||
161858990|NCT01215136|584525237|FG001|Overall Study|Symptomatic Deterioration|1|||
161858991|NCT01215136|584525236|FG000|Overall Study|Death|0|||
161858992|NCT01215136|584525237|FG001|Overall Study|Death|2|||
161858993|NCT01215136|584525236|FG000|Overall Study|Withdrawal by Subject|0|||
161858994|NCT01215136|584525237|FG001|Overall Study|Withdrawal by Subject|1|||
161858995|NCT01125917|584525242|FG000|Overall Study|Adverse Event|43|||
161858996|NCT01125917|584525242|FG000|Overall Study|Lost to Follow-up|23|||
161858997|NCT01125917|584525242|FG000|Overall Study|Withdrawal by Subject|31|||
161858998|NCT01125917|584525242|FG000|Overall Study|Administrative|223|||
161858999|NCT01125917|584525242|FG000|Overall Study|Lack of Efficacy|19|||
161859000|NCT04421131|584525244|FG000|Overall Study|Lost to Follow-up|1|||
161859001|NCT04421131|584525244|FG000|Overall Study|Protocol Violation|2|||
161859002|NCT04421131|584525244|FG000|Overall Study|App crashed|5|||
161859003|NCT02308124|584525245|FG000|Overall Study|Lost to Follow-up|6|||
161859004|NCT02308124|584525246|FG001|Overall Study|Lost to Follow-up|6|||
161859005|NCT02308124|584525247|FG002|Overall Study|Lost to Follow-up|6|||
161859006|NCT02308124|584525245|FG000|Overall Study|Adverse Event|0|||
161859007|NCT02308124|584525246|FG001|Overall Study|Adverse Event|2|||
161859008|NCT02308124|584525247|FG002|Overall Study|Adverse Event|2|||
161859009|NCT02501928|584525252|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161859010|NCT02501928|584525253|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161859011|NCT02501928|584525254|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
161859012|NCT02501928|584525255|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
161859013|NCT02501928|584525256|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
161859014|NCT02501928|584525257|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
161859015|NCT01197911|584525258|FG000|Overall Study|Adverse Event|0|||
161859016|NCT01197911|584525259|FG001|Overall Study|Adverse Event|0|||
161859017|NCT01197911|584525260|FG002|Overall Study|Adverse Event|1|||
161859018|NCT01526057|584525264|FG000|Overall Study|Withdrawal by Subject|3|||
161859019|NCT01526057|584525265|FG001|Overall Study|Withdrawal by Subject|2|||
161859020|NCT01526057|584525266|FG002|Overall Study|Withdrawal by Subject|2|||
161859021|NCT01526057|584525264|FG000|Overall Study|Adverse Event|3|||
161859022|NCT01526057|584525265|FG001|Overall Study|Adverse Event|1|||
161859023|NCT01526057|584525266|FG002|Overall Study|Adverse Event|1|||
161859024|NCT01526057|584525264|FG000|Overall Study|Death|1|||
161859025|NCT01526057|584525265|FG001|Overall Study|Death|0|||
161859026|NCT01526057|584525266|FG002|Overall Study|Death|0|||
161859027|NCT01526057|584525264|FG000|Overall Study|Lost to Follow-up|1|||
161859028|NCT01526057|584525265|FG001|Overall Study|Lost to Follow-up|0|||
161859029|NCT01526057|584525266|FG002|Overall Study|Lost to Follow-up|1|||
161859030|NCT01526057|584525264|FG000|Overall Study|Other|1|||
161859031|NCT01526057|584525265|FG001|Overall Study|Other|0|||
161859032|NCT01526057|584525266|FG002|Overall Study|Other|1|||
161859033|NCT01526057|584525264|FG000|Overall Study|Protocol Violation|0|||
161859034|NCT01526057|584525265|FG001|Overall Study|Protocol Violation|0|||
161859035|NCT01526057|584525266|FG002|Overall Study|Protocol Violation|1|||
161859036|NCT02123446|584525267|FG000|Washout Period (1 Day)|Physician Decision|1|||
161859037|NCT02123446|584525268|FG001|Washout Period (1 Day)|Physician Decision|0|||
161859038|NCT02553772|584525270|FG000|Overall Study|Adverse Event|2|||
161859039|NCT02553772|584525271|FG001|Overall Study|Adverse Event|3|||
161859040|NCT02553772|584525270|FG000|Overall Study|Lost to Follow-up|2|||
161859041|NCT02553772|584525271|FG001|Overall Study|Lost to Follow-up|1|||
161859042|NCT02553772|584525270|FG000|Overall Study|Withdrawal of Consent|1|||
161859043|NCT02553772|584525271|FG001|Overall Study|Withdrawal of Consent|1|||
161859044|NCT02553772|584525270|FG000|Overall Study|Lack of Efficacy|1|||
161859045|NCT02553772|584525271|FG001|Overall Study|Lack of Efficacy|0|||
161859046|NCT02553772|584525270|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161859047|NCT02553772|584525271|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161859048|NCT02860546|584525272|FG000|Overall Study|Clinical Progression|6|||
161859049|NCT02860546|584525272|FG000|Overall Study|Radiological Progression|12|||
161859050|NCT02466321|584525273|FG000|Overall Study|Death|26|||
161859051|NCT02466321|584525273|FG000|Overall Study|Revision|6|||
161859052|NCT02466321|584525273|FG000|Overall Study|Lost to Follow-up|60|||
161859053|NCT02466321|584525273|FG000|Overall Study|Did not receive study device|1|||
161859054|NCT01184079|584525283|FG000|Overall Study|Lost to Follow-up|14|||
161859055|NCT01184079|584525284|FG001|Overall Study|Lost to Follow-up|2|||
161859056|NCT03172494|584525285|FG000|Overall Study|Adverse Event|5|||
161770355|NCT02243306|584200214|FG000|Overall Study|Other: Reached stopping criteria|0|||
161770356|NCT02243306|584200215|FG001|Overall Study|Other: Reached stopping criteria|1|||
161770357|NCT02243306|584200214|FG000|Overall Study|Physician Decision|0|||
161770358|NCT02243306|584200215|FG001|Overall Study|Physician Decision|1|||
161770359|NCT02221882|584200216|FG000|Overall Study|Withdrawal by Subject|0|||
161770360|NCT02221882|584200217|FG001|Overall Study|Withdrawal by Subject|0|||
161770361|NCT02221882|584200218|FG002|Overall Study|Withdrawal by Subject|4|||
161770362|NCT02221882|584200219|FG003|Overall Study|Withdrawal by Subject|2|||
161770363|NCT02221882|584200220|FG004|Overall Study|Withdrawal by Subject|2|||
161770364|NCT02221882|584200221|FG005|Overall Study|Withdrawal by Subject|2|||
161770365|NCT02221882|584200216|FG000|Overall Study|Death|0|||
161770366|NCT02221882|584200217|FG001|Overall Study|Death|1|||
161770367|NCT02221882|584200218|FG002|Overall Study|Death|0|||
161770368|NCT02221882|584200219|FG003|Overall Study|Death|0|||
161770369|NCT02221882|584200220|FG004|Overall Study|Death|0|||
161770370|NCT02221882|584200221|FG005|Overall Study|Death|0|||
161770371|NCT04095039|584200224|FG000|Overall Study|Withdrawal by Subject|2|||
161770372|NCT04095039|584200225|FG001|Overall Study|Withdrawal by Subject|16|||
161770373|NCT04095039|584200224|FG000|Overall Study|Transplanted|21|||
161770374|NCT04095039|584200225|FG001|Overall Study|Transplanted|24|||
161770375|NCT04095039|584200224|FG000|Overall Study|Transferred to Non-study Facility|47|||
161770376|NCT04095039|584200225|FG001|Overall Study|Transferred to Non-study Facility|44|||
161770377|NCT04095039|584200224|FG000|Overall Study|Withdrawal from internvention target|0|||
161770378|NCT04095039|584200225|FG001|Overall Study|Withdrawal from internvention target|2|||
161770379|NCT04095039|584200224|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
161770380|NCT04095039|584200225|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
161770381|NCT04095039|584200224|FG000|Overall Study|Cacliphylaxis|0|||
161770382|NCT04095039|584200225|FG001|Overall Study|Cacliphylaxis|1|||
161770383|NCT04095039|584200224|FG000|Overall Study|Pregnancy|1|||
161770384|NCT04095039|584200225|FG001|Overall Study|Pregnancy|0|||
161770385|NCT04768881|584200226|FG000|Overall Study|Completed Study Follow-up|0|||
161770386|NCT04768881|584200227|FG001|Overall Study|Completed Study Follow-up|2|||
161770387|NCT04768881|584200226|FG000|Overall Study|Death|3|||
161770388|NCT04768881|584200227|FG001|Overall Study|Death|2|||
161770389|NCT04768881|584200226|FG000|Overall Study|Study Terminated by Sponsor|2|||
161770390|NCT04768881|584200227|FG001|Overall Study|Study Terminated by Sponsor|2|||
161770391|NCT04768881|584200226|FG000|Overall Study|Withdrawal by Subject|2|||
161770392|NCT04768881|584200227|FG001|Overall Study|Withdrawal by Subject|0|||
161770393|NCT04768881|584200226|FG000|Overall Study|Other|2|||
161859057|NCT03172494|584525286|FG001|Overall Study|Adverse Event|1|||
161859058|NCT03172494|584525287|FG002|Overall Study|Adverse Event|15|||
161859059|NCT03172494|584525285|FG000|Overall Study|Protocol Violation|3|||
161859060|NCT03172494|584525286|FG001|Overall Study|Protocol Violation|2|||
161859061|NCT03172494|584525287|FG002|Overall Study|Protocol Violation|1|||
161770394|NCT04768881|584200227|FG001|Overall Study|Other|0|||
161859062|NCT03172494|584525285|FG000|Overall Study|Lack of Efficacy|0|||
161859063|NCT03172494|584525286|FG001|Overall Study|Lack of Efficacy|0|||
161859064|NCT03172494|584525287|FG002|Overall Study|Lack of Efficacy|4|||
161859065|NCT03172494|584525285|FG000|Overall Study|Pregnancy|0|||
161859066|NCT03172494|584525286|FG001|Overall Study|Pregnancy|1|||
161859067|NCT03172494|584525287|FG002|Overall Study|Pregnancy|0|||
161859068|NCT03172494|584525285|FG000|Overall Study|Withdrawal by Subject|10|||
161859069|NCT03172494|584525286|FG001|Overall Study|Withdrawal by Subject|8|||
161859070|NCT03172494|584525287|FG002|Overall Study|Withdrawal by Subject|8|||
161859071|NCT03172494|584525285|FG000|Overall Study|Severe hypoglycaemic episode|0|||
161859072|NCT03172494|584525286|FG001|Overall Study|Severe hypoglycaemic episode|0|||
161859073|NCT03172494|584525287|FG002|Overall Study|Severe hypoglycaemic episode|1|||
161859074|NCT03172494|584525285|FG000|Overall Study|Non-compliance towards treatment|2|||
161859075|NCT03172494|584525286|FG001|Overall Study|Non-compliance towards treatment|0|||
161859076|NCT03172494|584525287|FG002|Overall Study|Non-compliance towards treatment|0|||
161859077|NCT04233073|584525288|FG000|Overall Study|Death|5|||
161859078|NCT00243412|584525289|FG000|Overall Study|Death|0|||
161859079|NCT00243412|584525290|FG001|Overall Study|Death|1|||
161859080|NCT00243412|584525289|FG000|Overall Study|Adverse Event|4|||
161859081|NCT00243412|584525290|FG001|Overall Study|Adverse Event|2|||
161859082|NCT00243412|584525289|FG000|Overall Study|Lost to Follow-up|0|||
161859083|NCT00243412|584525290|FG001|Overall Study|Lost to Follow-up|1|||
161859084|NCT00243412|584525289|FG000|Overall Study|Physician Decision|1|||
161859085|NCT00243412|584525290|FG001|Overall Study|Physician Decision|1|||
161859086|NCT00243412|584525289|FG000|Overall Study|Withdrawal by Subject|4|||
161859087|NCT00243412|584525290|FG001|Overall Study|Withdrawal by Subject|5|||
161859088|NCT00243412|584525289|FG000|Overall Study|Other|1|||
161859089|NCT00243412|584525290|FG001|Overall Study|Other|1|||
161859090|NCT00143390|584525291|FG000|Overall Study|Death|2|||
161859091|NCT00143390|584525292|FG001|Overall Study|Death|0|||
161859092|NCT00143390|584525291|FG000|Overall Study|Not meeting entry criteria|2|||
161859093|NCT00143390|584525292|FG001|Overall Study|Not meeting entry criteria|5|||
161859094|NCT00143390|584525291|FG000|Overall Study|Withdrawal by Subject|4|||
161859095|NCT00143390|584525292|FG001|Overall Study|Withdrawal by Subject|4|||
161859096|NCT00143390|584525291|FG000|Overall Study|Progressive disease|119|||
161859097|NCT00143390|584525292|FG001|Overall Study|Progressive disease|115|||
161859098|NCT00143390|584525291|FG000|Overall Study|Protocol Violation|2|||
161859099|NCT00143390|584525292|FG001|Overall Study|Protocol Violation|0|||
161859100|NCT00143390|584525291|FG000|Overall Study|Study termination|10|||
161859101|NCT00143390|584525292|FG001|Overall Study|Study termination|15|||
161859102|NCT00143390|584525291|FG000|Overall Study|Adverse Event|9|||
161859103|NCT00143390|584525292|FG001|Overall Study|Adverse Event|8|||
161859104|NCT00143390|584525291|FG000|Overall Study|Other|1|||
161859105|NCT00143390|584525292|FG001|Overall Study|Other|2|||
161859106|NCT00041132|584525294|FG000|Overall Study|Adverse Event|19|||
161859107|NCT00041132|584525294|FG000|Overall Study|Death|1|||
161859108|NCT00041132|584525294|FG000|Overall Study|Not Eligible|7|||
161859109|NCT00041132|584525294|FG000|Overall Study|Withdrawal by Subject|1|||
161859110|NCT00041132|584525294|FG000|Overall Study|Physician Decision|2|||
161859111|NCT02764151|584525298|FG000|Overall Study|Subject refused further follow-up|0|||
161859112|NCT02764151|584525299|FG001|Overall Study|Subject refused further follow-up|0|||
161859113|NCT02764151|584525300|FG002|Overall Study|Subject refused further follow-up|0|||
161859114|NCT02764151|584525301|FG003|Overall Study|Subject refused further follow-up|1|||
161859115|NCT02764151|584525298|FG000|Overall Study|Other|0|||
161859116|NCT02764151|584525299|FG001|Overall Study|Other|0|||
161859117|NCT02764151|584525300|FG002|Overall Study|Other|0|||
161859118|NCT02764151|584525301|FG003|Overall Study|Other|2|||
161859119|NCT01450683|584525302|FG000|Overall Study|Adverse Event|2|||
161859120|NCT05101343|584525307|FG000|Overall Study|Withdrawal by Subject|2|||
161859121|NCT05101343|584525308|FG001|Overall Study|Withdrawal by Subject|1|||
161859122|NCT04779879|584525309|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859123|NCT04779879|584525310|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859124|NCT04779879|584525311|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859125|NCT04779879|584525312|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
161859126|NCT04779879|584525313|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859127|NCT04779879|584525314|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859128|NCT04779879|584525309|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859129|NCT04779879|584525310|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859130|NCT04779879|584525311|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859131|NCT04779879|584525312|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
161859132|NCT04779879|584525313|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859133|NCT04779879|584525314|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859134|NCT04779879|584525309|FG000|Part C: Up to Week 36|Death|0|||
161859135|NCT04779879|584525310|FG001|Part C: Up to Week 36|Death|0|||
161859136|NCT04779879|584525311|FG002|Part C: Up to Week 36|Death|0|||
161859137|NCT04779879|584525312|FG003|Part C: Up to Week 36|Death|0|||
161859138|NCT04779879|584525313|FG004|Part C: Up to Week 36|Death|0|||
161859139|NCT04779879|584525314|FG005|Part C: Up to Week 36|Death|1|||
161859140|NCT04779879|584525309|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
161859141|NCT04779879|584525310|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
161859142|NCT04779879|584525311|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
161859143|NCT04779879|584525312|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
161770395|NCT02370173|584200230|FG000|Overall Study|Protocol Violation|1|||
161770396|NCT02370173|584200231|FG001|Overall Study|Protocol Violation|1|||
161770397|NCT02370173|584200230|FG000|Overall Study|Withdrawal by Subject|2|||
161770398|NCT02370173|584200231|FG001|Overall Study|Withdrawal by Subject|2|||
161770399|NCT04236986|584200232|FG000|Overall Study|Withdrawal by Subject|3|||
161770400|NCT04236986|584200233|FG001|Overall Study|Withdrawal by Subject|1|||
161770401|NCT00307736|584200236|FG000|Overall Study|Adverse Event|0|||
161770402|NCT00307736|584200237|FG001|Overall Study|Adverse Event|0|||
161770403|NCT00307736|584200238|FG002|Overall Study|Adverse Event|1|||
161770404|NCT00307736|584200239|FG003|Overall Study|Adverse Event|3|||
161770405|NCT00307736|584200236|FG000|Overall Study|Withdrawal by Subject|0|||
161770406|NCT00307736|584200237|FG001|Overall Study|Withdrawal by Subject|0|||
161770407|NCT00307736|584200238|FG002|Overall Study|Withdrawal by Subject|2|||
161770408|NCT00307736|584200239|FG003|Overall Study|Withdrawal by Subject|0|||
161770409|NCT01365182|584200246|FG000|Overall Study|Withdrawal by Subject|10|||
161770410|NCT01365182|584200247|FG001|Overall Study|Withdrawal by Subject|13|||
161770411|NCT01365182|584200248|FG002|Overall Study|Withdrawal by Subject|12|||
161770412|NCT00736840|584200249|FG000|Overall Study|Lost to Follow-up|13|||
161770413|NCT01728194|584200252|FG000|Overall Study|Lost to Follow-up|4|||
161770414|NCT01728194|584200253|FG001|Overall Study|Lost to Follow-up|3|||
161770415|NCT01728194|584200252|FG000|Overall Study|Physician Decision|4|||
161770416|NCT01728194|584200253|FG001|Overall Study|Physician Decision|0|||
161770417|NCT01728194|584200252|FG000|Overall Study|Withdrawal by Subject|7|||
161770418|NCT01728194|584200253|FG001|Overall Study|Withdrawal by Subject|3|||
161770419|NCT01728194|584200252|FG000|Overall Study|Perceived Medication Side Effects|4|||
161770420|NCT01728194|584200253|FG001|Overall Study|Perceived Medication Side Effects|0|||
161770421|NCT01728194|584200252|FG000|Overall Study|Family Member Request|1|||
161770422|NCT01728194|584200253|FG001|Overall Study|Family Member Request|0|||
161770423|NCT02309372|584200254|FG000|Overall Study|Lost to Follow-up|3|||
161770424|NCT02309372|584200255|FG001|Overall Study|Lost to Follow-up|2|||
161770425|NCT03289676|584200260|FG000|Overall Study|Withdrawal by Subject|2|||
161770426|NCT03289676|584200261|FG001|Overall Study|Withdrawal by Subject|0|||
161770427|NCT03289676|584200260|FG000|Overall Study|Protocol Violation|2|||
161770428|NCT03289676|584200261|FG001|Overall Study|Protocol Violation|0|||
161770429|NCT03289676|584200260|FG000|Overall Study|Lost to Follow-up|0|||
161770430|NCT03289676|584200261|FG001|Overall Study|Lost to Follow-up|1|||
161770431|NCT02576652|584200264|FG000|Overall Study|Withdrawal by Subject|2|||
161770432|NCT04806334|584200265|FG000|Overall Study|Withdrawal by Subject|1|||
161770433|NCT02811640|584200266|FG000|Overall Study|Technology malfunction|2|||
161770434|NCT00553319|584200277|FG000|Overall Study|Lost to Follow-up|10|||
161770435|NCT00553319|584200278|FG001|Overall Study|Lost to Follow-up|9|||
161770436|NCT00553319|584200279|FG002|Overall Study|Lost to Follow-up|5|||
161770437|NCT00553319|584200277|FG000|Overall Study|wanted treatment elsewhere|2|||
161770438|NCT00553319|584200278|FG001|Overall Study|wanted treatment elsewhere|1|||
161770439|NCT00553319|584200279|FG002|Overall Study|wanted treatment elsewhere|1|||
161770440|NCT00553319|584200277|FG000|Overall Study|non-compliance|0|||
161770441|NCT00553319|584200278|FG001|Overall Study|non-compliance|0|||
161770442|NCT00553319|584200279|FG002|Overall Study|non-compliance|2|||
161770443|NCT00553319|584200277|FG000|Overall Study|incarceration|1|||
161770444|NCT00553319|584200278|FG001|Overall Study|incarceration|0|||
161770445|NCT00553319|584200279|FG002|Overall Study|incarceration|0|||
161770446|NCT00553319|584200277|FG000|Overall Study|moved|1|||
161770447|NCT00553319|584200278|FG001|Overall Study|moved|0|||
161770448|NCT00553319|584200279|FG002|Overall Study|moved|1|||
161770449|NCT04369742|584200284|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
161770450|NCT04369742|584200285|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
161770451|NCT04369742|584200284|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
161770452|NCT04369742|584200285|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
161770453|NCT00465894|584200286|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
161770454|NCT00465894|584200287|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
161770455|NCT00465894|584200286|FG000|Treatment For 12 Weeks|Family Issues|1|||
161770456|NCT00465894|584200287|FG001|Treatment For 12 Weeks|Family Issues|1|||
161770457|NCT00465894|584200286|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
161770458|NCT00465894|584200287|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
161770459|NCT01636076|584200288|FG000|Overall Study|Terminated by sponsor|1|||
161770460|NCT01636076|584200289|FG001|Overall Study|Terminated by sponsor|1|||
161770461|NCT01636076|584200288|FG000|Overall Study|Lack of Efficacy|0|||
161770462|NCT01636076|584200289|FG001|Overall Study|Lack of Efficacy|1|||
161770463|NCT01636076|584200288|FG000|Overall Study|Lost to Follow-up|1|||
161770464|NCT01636076|584200289|FG001|Overall Study|Lost to Follow-up|0|||
161770465|NCT01636076|584200288|FG000|Overall Study|Physician Decision|1|||
161770466|NCT01636076|584200289|FG001|Overall Study|Physician Decision|1|||
161770467|NCT01636076|584200288|FG000|Overall Study|Non-compliance with study treatment|1|||
161770468|NCT01636076|584200289|FG001|Overall Study|Non-compliance with study treatment|1|||
161770469|NCT01636076|584200288|FG000|Overall Study|Adverse Event|6|||
161770470|NCT01636076|584200289|FG001|Overall Study|Adverse Event|11|||
161770471|NCT01636076|584200288|FG000|Overall Study|Withdrawal by Subject|7|||
161770472|NCT01636076|584200289|FG001|Overall Study|Withdrawal by Subject|10|||
161859144|NCT04779879|584525313|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
161859145|NCT04779879|584525314|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
161859146|NCT02854527|584525315|FG000|Overall Study|Adverse Event|0|||
161859147|NCT02854527|584525316|FG001|Overall Study|Adverse Event|0|||
161859148|NCT02854527|584525317|FG002|Overall Study|Adverse Event|0|||
161859149|NCT02854527|584525318|FG003|Overall Study|Adverse Event|0|||
161859150|NCT02854527|584525319|FG004|Overall Study|Adverse Event|1|||
161859151|NCT02854527|584525320|FG005|Overall Study|Adverse Event|0|||
161859152|NCT02854527|584525321|FG006|Overall Study|Adverse Event|0|||
161859153|NCT02854527|584525322|FG007|Overall Study|Adverse Event|0|||
161859154|NCT02854527|584525323|FG008|Overall Study|Adverse Event|0|||
161859155|NCT02854527|584525324|FG009|Overall Study|Adverse Event|0|||
161859156|NCT02854527|584525315|FG000|Overall Study|Lost to Follow-up|0|||
161859157|NCT02854527|584525316|FG001|Overall Study|Lost to Follow-up|0|||
161859158|NCT02854527|584525317|FG002|Overall Study|Lost to Follow-up|0|||
161859159|NCT02854527|584525318|FG003|Overall Study|Lost to Follow-up|1|||
161859160|NCT02854527|584525319|FG004|Overall Study|Lost to Follow-up|0|||
161859161|NCT02854527|584525320|FG005|Overall Study|Lost to Follow-up|0|||
161859162|NCT02854527|584525321|FG006|Overall Study|Lost to Follow-up|0|||
161859163|NCT02854527|584525322|FG007|Overall Study|Lost to Follow-up|0|||
161859164|NCT02854527|584525323|FG008|Overall Study|Lost to Follow-up|0|||
161859165|NCT02854527|584525324|FG009|Overall Study|Lost to Follow-up|0|||
161859166|NCT01959295|584525325|FG000|Overall Study|Adverse Event|2|||
161859167|NCT01959295|584525326|FG001|Overall Study|Adverse Event|0|||
161859168|NCT01959295|584525325|FG000|Overall Study|Lost to Follow-up|0|||
161859169|NCT01959295|584525326|FG001|Overall Study|Lost to Follow-up|2|||
161859170|NCT01959295|584525325|FG000|Overall Study|Physician Decision|2|||
161859171|NCT01959295|584525326|FG001|Overall Study|Physician Decision|3|||
161859172|NCT01959295|584525325|FG000|Overall Study|Protocol Violation|16|||
161859173|NCT01959295|584525326|FG001|Overall Study|Protocol Violation|5|||
161859174|NCT01959295|584525325|FG000|Overall Study|Withdrawal by Subject|3|||
161859175|NCT01959295|584525326|FG001|Overall Study|Withdrawal by Subject|1|||
161859176|NCT01959295|584525325|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
161859177|NCT01959295|584525326|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
161859178|NCT01682811|584525328|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859179|NCT01682811|584525329|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859180|NCT01682811|584525330|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859181|NCT01682811|584525331|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859182|NCT01682811|584525332|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
161859183|NCT01682811|584525333|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859184|NCT01682811|584525334|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859185|NCT01682811|584525328|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
161859186|NCT01682811|584525329|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
161859187|NCT01682811|584525330|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
161859188|NCT01682811|584525331|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
161859189|NCT01682811|584525332|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
161859190|NCT01682811|584525333|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
161859191|NCT01682811|584525334|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
161859192|NCT01682811|584525328|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859193|NCT01682811|584525329|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859194|NCT01682811|584525330|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859195|NCT01682811|584525331|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859196|NCT01682811|584525332|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
161859197|NCT01682811|584525333|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859198|NCT01682811|584525334|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859199|NCT01682811|584525328|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859200|NCT01682811|584525329|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859201|NCT01682811|584525330|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859202|NCT01682811|584525331|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859203|NCT01682811|584525332|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859204|NCT01682811|584525333|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
161859205|NCT01682811|584525334|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859206|NCT02694328|584525338|FG000|Overall Study|Adverse Event|27|||
161859207|NCT02694328|584525339|FG001|Overall Study|Adverse Event|33|||
161859208|NCT02694328|584525338|FG000|Overall Study|Withdrawal by Subject|27|||
161859209|NCT02694328|584525339|FG001|Overall Study|Withdrawal by Subject|23|||
161859210|NCT02694328|584525338|FG000|Overall Study|Lost to Follow-up|26|||
161859211|NCT02694328|584525339|FG001|Overall Study|Lost to Follow-up|22|||
161859212|NCT02694328|584525338|FG000|Overall Study|Noncompliant with study drug|11|||
161859213|NCT02694328|584525339|FG001|Overall Study|Noncompliant with study drug|8|||
161859214|NCT02694328|584525338|FG000|Overall Study|Incarceration|1|||
161859215|NCT02694328|584525339|FG001|Overall Study|Incarceration|1|||
161859216|NCT02694328|584525338|FG000|Overall Study|Lack of Efficacy|1|||
161859217|NCT02694328|584525339|FG001|Overall Study|Lack of Efficacy|2|||
161859218|NCT02694328|584525338|FG000|Overall Study|Pregnancy|1|||
161859219|NCT02694328|584525339|FG001|Overall Study|Pregnancy|1|||
161859220|NCT02694328|584525338|FG000|Overall Study|Protocol Violation|6|||
161859221|NCT02694328|584525339|FG001|Overall Study|Protocol Violation|5|||
161859222|NCT02694328|584525338|FG000|Overall Study|Abnormal Laboratory Value|0|||
161859223|NCT02694328|584525339|FG001|Overall Study|Abnormal Laboratory Value|3|||
161859224|NCT04653454|584527537|FG000|Overall Study|Withdrawal by Subject|1|||
161859225|NCT04653454|584527537|FG000|Overall Study|Physician Decision|40|||
161859226|NCT05525520|584527538|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
161859227|NCT05525520|584527539|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
161859228|NCT05525520|584527538|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
161859229|NCT05525520|584527539|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
161859230|NCT05878093|584527540|FG000|Overall Study|Withdrawal by Subject|3|||
161859231|NCT05878093|584527541|FG001|Overall Study|Withdrawal by Subject|1|||
161859232|NCT02721732|584527542|FG000|Overall Study|Adverse Event|2|||
161859233|NCT02721732|584527543|FG001|Overall Study|Adverse Event|0|||
161859234|NCT02721732|584527544|FG002|Overall Study|Adverse Event|2|||
161859235|NCT02721732|584527545|FG003|Overall Study|Adverse Event|0|||
161859236|NCT02721732|584527546|FG004|Overall Study|Adverse Event|1|||
161859237|NCT02721732|584527547|FG005|Overall Study|Adverse Event|0|||
161859238|NCT02721732|584527548|FG006|Overall Study|Adverse Event|1|||
161859239|NCT02721732|584527549|FG007|Overall Study|Adverse Event|0|||
161859240|NCT02721732|584527550|FG008|Overall Study|Adverse Event|1|||
161859241|NCT02721732|584527551|FG009|Overall Study|Adverse Event|1|||
161859242|NCT02721732|584527542|FG000|Overall Study|Death|0|||
161859243|NCT02721732|584527543|FG001|Overall Study|Death|0|||
161859244|NCT02721732|584527544|FG002|Overall Study|Death|0|||
161859245|NCT02721732|584527545|FG003|Overall Study|Death|0|||
161859246|NCT02721732|584527546|FG004|Overall Study|Death|1|||
161859247|NCT02721732|584527547|FG005|Overall Study|Death|0|||
161859248|NCT02721732|584527548|FG006|Overall Study|Death|1|||
161859249|NCT02721732|584527549|FG007|Overall Study|Death|0|||
161859250|NCT02721732|584527550|FG008|Overall Study|Death|0|||
161859251|NCT02721732|584527551|FG009|Overall Study|Death|1|||
161859252|NCT02721732|584527542|FG000|Overall Study|Lack of Efficacy|12|||
161859253|NCT02721732|584527543|FG001|Overall Study|Lack of Efficacy|11|||
161859254|NCT02721732|584527544|FG002|Overall Study|Lack of Efficacy|18|||
161859255|NCT02721732|584527545|FG003|Overall Study|Lack of Efficacy|5|||
161859256|NCT02721732|584527546|FG004|Overall Study|Lack of Efficacy|21|||
161859257|NCT02721732|584527547|FG005|Overall Study|Lack of Efficacy|2|||
161859258|NCT02721732|584527548|FG006|Overall Study|Lack of Efficacy|8|||
161859259|NCT02721732|584527549|FG007|Overall Study|Lack of Efficacy|11|||
161859260|NCT02721732|584527550|FG008|Overall Study|Lack of Efficacy|10|||
161859261|NCT02721732|584527551|FG009|Overall Study|Lack of Efficacy|20|||
161859262|NCT02721732|584527542|FG000|Overall Study|Physician Decision|0|||
161859263|NCT02721732|584527543|FG001|Overall Study|Physician Decision|0|||
161859264|NCT02721732|584527544|FG002|Overall Study|Physician Decision|1|||
161859265|NCT02721732|584527545|FG003|Overall Study|Physician Decision|0|||
161859266|NCT02721732|584527546|FG004|Overall Study|Physician Decision|0|||
161859267|NCT02721732|584527547|FG005|Overall Study|Physician Decision|0|||
161859268|NCT02721732|584527548|FG006|Overall Study|Physician Decision|0|||
161859269|NCT02721732|584527549|FG007|Overall Study|Physician Decision|0|||
161859270|NCT02721732|584527550|FG008|Overall Study|Physician Decision|0|||
161859271|NCT02721732|584527551|FG009|Overall Study|Physician Decision|0|||
161859272|NCT02721732|584527542|FG000|Overall Study|Withdrawal by Subject|1|||
161859273|NCT02721732|584527543|FG001|Overall Study|Withdrawal by Subject|0|||
161859274|NCT02721732|584527544|FG002|Overall Study|Withdrawal by Subject|0|||
161859275|NCT02721732|584527545|FG003|Overall Study|Withdrawal by Subject|0|||
161859276|NCT02721732|584527546|FG004|Overall Study|Withdrawal by Subject|3|||
161859277|NCT02721732|584527547|FG005|Overall Study|Withdrawal by Subject|0|||
161859278|NCT02721732|584527548|FG006|Overall Study|Withdrawal by Subject|1|||
161859279|NCT02721732|584527549|FG007|Overall Study|Withdrawal by Subject|1|||
161859280|NCT02721732|584527550|FG008|Overall Study|Withdrawal by Subject|0|||
161859281|NCT02721732|584527551|FG009|Overall Study|Withdrawal by Subject|1|||
161859282|NCT02721732|584527542|FG000|Overall Study|Participant Choice|1|||
161859283|NCT02721732|584527543|FG001|Overall Study|Participant Choice|0|||
161859284|NCT02721732|584527544|FG002|Overall Study|Participant Choice|0|||
161859285|NCT02721732|584527545|FG003|Overall Study|Participant Choice|0|||
161859286|NCT02721732|584527546|FG004|Overall Study|Participant Choice|0|||
161859287|NCT02721732|584527547|FG005|Overall Study|Participant Choice|0|||
161859288|NCT02721732|584527548|FG006|Overall Study|Participant Choice|0|||
161859289|NCT02721732|584527549|FG007|Overall Study|Participant Choice|0|||
161859290|NCT02721732|584527550|FG008|Overall Study|Participant Choice|0|||
161859291|NCT02721732|584527551|FG009|Overall Study|Participant Choice|1|||
161859292|NCT02721732|584527542|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859293|NCT02721732|584527543|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859294|NCT02721732|584527544|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
161859295|NCT02721732|584527545|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859296|NCT02721732|584527546|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859297|NCT02721732|584527547|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859298|NCT02721732|584527548|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859299|NCT02721732|584527549|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859300|NCT02721732|584527550|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859301|NCT02721732|584527551|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859302|NCT02721732|584527542|FG000|Overall Study|Progression and withdrew consent|1|||
161859303|NCT02721732|584527543|FG001|Overall Study|Progression and withdrew consent|1|||
161859304|NCT02721732|584527544|FG002|Overall Study|Progression and withdrew consent|0|||
161859305|NCT02721732|584527545|FG003|Overall Study|Progression and withdrew consent|0|||
161859306|NCT02721732|584527546|FG004|Overall Study|Progression and withdrew consent|0|||
161859307|NCT02721732|584527547|FG005|Overall Study|Progression and withdrew consent|0|||
161859308|NCT02721732|584527548|FG006|Overall Study|Progression and withdrew consent|0|||
161859309|NCT02721732|584527549|FG007|Overall Study|Progression and withdrew consent|0|||
161859310|NCT02721732|584527550|FG008|Overall Study|Progression and withdrew consent|0|||
161859311|NCT02721732|584527551|FG009|Overall Study|Progression and withdrew consent|1|||
161859312|NCT02721732|584527542|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
161859313|NCT02721732|584527543|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
161859314|NCT02721732|584527544|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
161859315|NCT02721732|584527545|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
161859316|NCT02721732|584527546|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
161859317|NCT02721732|584527547|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
161859318|NCT02721732|584527548|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
161859319|NCT02721732|584527549|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
161859320|NCT02721732|584527550|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
161859321|NCT02721732|584527551|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
161859322|NCT04100018|584527552|FG000|Pre-Treatment Period|Not Reported|0|||
161859323|NCT04100018|584527553|FG001|Pre-Treatment Period|Not Reported|4|||
161859324|NCT04100018|584527552|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
161859325|NCT04100018|584527553|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
161859326|NCT04100018|584527552|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
161859327|NCT04100018|584527553|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
161859328|NCT04100018|584527552|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
161859329|NCT04100018|584527553|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161859330|NCT04100018|584527552|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161859331|NCT04100018|584527553|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
161859332|NCT04100018|584527552|FG000|Treatment Period|Ongoing Treatment|1|||
161859333|NCT04100018|584527553|FG001|Treatment Period|Ongoing Treatment|0|||
161859334|NCT04100018|584527552|FG000|Treatment Period|Other Reason|26|||
161859335|NCT04100018|584527553|FG001|Treatment Period|Other Reason|37|||
161859336|NCT04100018|584527552|FG000|Treatment Period|Completed treatment as per protocol|1|||
161859337|NCT04100018|584527553|FG001|Treatment Period|Completed treatment as per protocol|2|||
161859338|NCT04100018|584527552|FG000|Treatment Period|Maximum clinical benefit|3|||
161859339|NCT04100018|584527553|FG001|Treatment Period|Maximum clinical benefit|0|||
161859340|NCT04100018|584527552|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
161859341|NCT04100018|584527553|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
161859342|NCT04100018|584527552|FG000|Treatment Period|Study drug toxicity|67|||
161859343|NCT04100018|584527553|FG001|Treatment Period|Study drug toxicity|28|||
161859344|NCT04100018|584527552|FG000|Treatment Period|Disease Progression|284|||
161859345|NCT04100018|584527553|FG001|Treatment Period|Disease Progression|327|||
161859346|NCT04100018|584527552|FG000|Treatment Period|Administrative reasons by sponsor|16|||
161859347|NCT04100018|584527553|FG001|Treatment Period|Administrative reasons by sponsor|30|||
161859348|NCT04100018|584527552|FG000|Treatment Period|Poor/Non-Compliance|1|||
161859349|NCT04100018|584527553|FG001|Treatment Period|Poor/Non-Compliance|0|||
161859350|NCT04100018|584527552|FG000|Treatment Period|Lost to Follow-up|2|||
161859351|NCT04100018|584527553|FG001|Treatment Period|Lost to Follow-up|2|||
161859352|NCT04100018|584527552|FG000|Treatment Period|Death|16|||
161859353|NCT04100018|584527553|FG001|Treatment Period|Death|11|||
161859354|NCT04100018|584527552|FG000|Treatment Period|Participant withdrew consent|10|||
161859355|NCT04100018|584527553|FG001|Treatment Period|Participant withdrew consent|10|||
161859356|NCT04100018|584527552|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
161859357|NCT04100018|584527553|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
161859358|NCT04100018|584527552|FG000|Treatment Period|Adverse Event|14|||
161859359|NCT04100018|584527553|FG001|Treatment Period|Adverse Event|6|||
161859360|NCT04100018|584527552|FG000|Treatment Period|Lack of Efficacy|4|||
161859361|NCT04100018|584527553|FG001|Treatment Period|Lack of Efficacy|2|||
161859362|NCT02848001|584527554|FG000|Overall Study|other reasons|0|||
161859363|NCT02848001|584527555|FG001|Overall Study|other reasons|0|||
161859364|NCT02848001|584527556|FG002|Overall Study|other reasons|1|||
161859365|NCT02848001|584527557|FG003|Overall Study|other reasons|0|||
161859366|NCT02848001|584527558|FG004|Overall Study|other reasons|4|||
161859367|NCT02848001|584527559|FG005|Overall Study|other reasons|1|||
161859368|NCT02848001|584527560|FG006|Overall Study|other reasons|0|||
161859369|NCT02848001|584527561|FG007|Overall Study|other reasons|2|||
161859370|NCT02848001|584527562|FG008|Overall Study|other reasons|2|||
161859371|NCT02848001|584527563|FG009|Overall Study|other reasons|3|||
161859372|NCT02848001|584527564|FG010|Overall Study|other reasons|0|||
161859373|NCT02848001|584527565|FG011|Overall Study|other reasons|1|||
161859374|NCT02848001|584527566|FG012|Overall Study|other reasons|1|||
161859375|NCT02848001|584527567|FG013|Overall Study|other reasons|0|||
161859376|NCT02848001|584527568|FG014|Overall Study|other reasons|0|||
161859377|NCT02848001|584527569|FG015|Overall Study|other reasons|2|||
161859378|NCT02848001|584527570|FG016|Overall Study|other reasons|1|||
161859379|NCT02848001|584527554|FG000|Overall Study|Lack of Efficacy|0|||
161859380|NCT02848001|584527555|FG001|Overall Study|Lack of Efficacy|1|||
161859381|NCT02848001|584527556|FG002|Overall Study|Lack of Efficacy|1|||
161770473|NCT01130831|584200290|FG000|Overall Study|Withdrawal by Subject|7|||
161770474|NCT01130831|584200290|FG000|Overall Study|Death|4|||
161770475|NCT01130831|584200290|FG000|Overall Study|Information was missing|3|||
161770476|NCT01159665|584200291|FG000|Overall Study|Withdrawal by Subject|0|||
161770477|NCT01159665|584200292|FG001|Overall Study|Withdrawal by Subject|1|||
161770478|NCT01159665|584200293|FG002|Overall Study|Withdrawal by Subject|0|||
161770479|NCT01159665|584200294|FG003|Overall Study|Withdrawal by Subject|0|||
161770480|NCT01159665|584200295|FG004|Overall Study|Withdrawal by Subject|0|||
161770481|NCT01159665|584200296|FG005|Overall Study|Withdrawal by Subject|0|||
161770482|NCT00951912|584200297|FG000|Overall Study|Lack of Efficacy|1|||
161770483|NCT00951912|584200298|FG001|Overall Study|Lack of Efficacy|0|||
161770484|NCT00951912|584200299|FG002|Overall Study|Lack of Efficacy|0|||
161770485|NCT00951912|584200297|FG000|Overall Study|Adverse Event|0|||
161770486|NCT00951912|584200298|FG001|Overall Study|Adverse Event|1|||
161770487|NCT00951912|584200299|FG002|Overall Study|Adverse Event|1|||
161770488|NCT00951912|584200297|FG000|Overall Study|Lost to Follow-up|2|||
161770489|NCT00951912|584200298|FG001|Overall Study|Lost to Follow-up|2|||
161770490|NCT00951912|584200299|FG002|Overall Study|Lost to Follow-up|0|||
161770491|NCT00951912|584200297|FG000|Overall Study|Physician Decision|1|||
161770492|NCT00951912|584200298|FG001|Overall Study|Physician Decision|0|||
161770493|NCT00951912|584200299|FG002|Overall Study|Physician Decision|1|||
161770494|NCT00951912|584200297|FG000|Overall Study|Withdrawal by Subject|1|||
161770495|NCT00951912|584200298|FG001|Overall Study|Withdrawal by Subject|1|||
161770496|NCT00951912|584200299|FG002|Overall Study|Withdrawal by Subject|0|||
161770497|NCT00951912|584200297|FG000|Overall Study|Other:Depression|1|||
161770498|NCT00951912|584200298|FG001|Overall Study|Other:Depression|0|||
161770499|NCT00951912|584200299|FG002|Overall Study|Other:Depression|0|||
161770500|NCT00951912|584200297|FG000|Overall Study|Other: Colon cancer|1|||
161770501|NCT00951912|584200298|FG001|Overall Study|Other: Colon cancer|0|||
161770502|NCT00951912|584200299|FG002|Overall Study|Other: Colon cancer|0|||
161770503|NCT00951912|584200297|FG000|Overall Study|Other: Stroke|0|||
161770504|NCT00951912|584200298|FG001|Overall Study|Other: Stroke|1|||
161770505|NCT00951912|584200299|FG002|Overall Study|Other: Stroke|0|||
161770506|NCT02173158|584200301|FG000|Efficacy Phase|Adverse Event|1|||
161770507|NCT01377194|584200302|FG000|Overall Study|Adverse Event|3|||
161770508|NCT01377194|584200303|FG001|Overall Study|Adverse Event|12|||
161770509|NCT01377194|584200304|FG002|Overall Study|Adverse Event|19|||
161770510|NCT01377194|584200302|FG000|Overall Study|Lack of Efficacy|3|||
161770511|NCT01377194|584200303|FG001|Overall Study|Lack of Efficacy|3|||
161770512|NCT01377194|584200304|FG002|Overall Study|Lack of Efficacy|3|||
161770513|NCT01377194|584200302|FG000|Overall Study|Protocol Violation|4|||
161770514|NCT01377194|584200303|FG001|Overall Study|Protocol Violation|10|||
161770515|NCT01377194|584200304|FG002|Overall Study|Protocol Violation|6|||
161770516|NCT01377194|584200302|FG000|Overall Study|Withdrawal by Subject|8|||
161770517|NCT01377194|584200303|FG001|Overall Study|Withdrawal by Subject|10|||
161770518|NCT01377194|584200304|FG002|Overall Study|Withdrawal by Subject|7|||
161770519|NCT01377194|584200302|FG000|Overall Study|Lost to Follow-up|14|||
161770520|NCT01377194|584200303|FG001|Overall Study|Lost to Follow-up|8|||
161770521|NCT01377194|584200304|FG002|Overall Study|Lost to Follow-up|11|||
161770522|NCT01207427|584200305|FG000|Double-blind Treatment Period|Adverse Event|0|||
161770523|NCT01207427|584200306|FG001|Double-blind Treatment Period|Adverse Event|1|||
161770524|NCT01207427|584200307|FG002|Double-blind Treatment Period|Adverse Event|0|||
161770525|NCT01207427|584200305|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161770526|NCT01207427|584200306|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161770527|NCT01207427|584200307|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161770528|NCT01207427|584200305|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161770529|NCT01207427|584200306|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161770530|NCT01207427|584200307|FG002|Double-blind Treatment Period|Protocol Violation|1|||
161770531|NCT01207427|584200305|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161770532|NCT01207427|584200306|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161770533|NCT01207427|584200307|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161770534|NCT00422227|584200308|FG000|Overall Study|Adverse Event|3|||
161770535|NCT00422227|584200309|FG001|Overall Study|Adverse Event|8|||
161770536|NCT00422227|584200308|FG000|Overall Study|Lost to Follow-up|1|||
161770537|NCT00422227|584200309|FG001|Overall Study|Lost to Follow-up|3|||
161770538|NCT00422227|584200308|FG000|Overall Study|Withdrawal by Subject|0|||
161770539|NCT00422227|584200309|FG001|Overall Study|Withdrawal by Subject|4|||
161770540|NCT00967343|584200313|FG000|Overall Study|Study termination by sponsor|12|||
161770541|NCT00967343|584200313|FG000|Overall Study|Death|24|||
161770542|NCT00967343|584200313|FG000|Overall Study|Relapse|1|||
161770543|NCT00967343|584200313|FG000|Overall Study|Lost to Follow-up|1|||
161770544|NCT03996694|584202150|FG000|First Washout (7 Days)|positive urine drug screen|0|||
161770545|NCT03996694|584202151|FG001|First Washout (7 Days)|positive urine drug screen|0|||
161770546|NCT03996694|584202152|FG002|First Washout (7 Days)|positive urine drug screen|1|||
161770547|NCT03996694|584202153|FG003|First Washout (7 Days)|positive urine drug screen|0|||
161770548|NCT03996694|584202154|FG004|First Washout (7 Days)|positive urine drug screen|0|||
161770549|NCT03996694|584202155|FG005|First Washout (7 Days)|positive urine drug screen|0|||
161859382|NCT02848001|584527557|FG003|Overall Study|Lack of Efficacy|2|||
161859383|NCT02848001|584527558|FG004|Overall Study|Lack of Efficacy|3|||
161859384|NCT02848001|584527559|FG005|Overall Study|Lack of Efficacy|0|||
161859385|NCT02848001|584527560|FG006|Overall Study|Lack of Efficacy|1|||
161859386|NCT02848001|584527561|FG007|Overall Study|Lack of Efficacy|0|||
161859387|NCT02848001|584527562|FG008|Overall Study|Lack of Efficacy|0|||
161859388|NCT02848001|584527563|FG009|Overall Study|Lack of Efficacy|1|||
161859389|NCT02848001|584527564|FG010|Overall Study|Lack of Efficacy|0|||
161859390|NCT02848001|584527565|FG011|Overall Study|Lack of Efficacy|2|||
161859391|NCT02848001|584527566|FG012|Overall Study|Lack of Efficacy|0|||
161859392|NCT02848001|584527567|FG013|Overall Study|Lack of Efficacy|2|||
161859393|NCT02848001|584527568|FG014|Overall Study|Lack of Efficacy|2|||
161859394|NCT02848001|584527569|FG015|Overall Study|Lack of Efficacy|0|||
161859395|NCT02848001|584527570|FG016|Overall Study|Lack of Efficacy|0|||
161859396|NCT02848001|584527554|FG000|Overall Study|Progressive Disease|2|||
161859397|NCT02848001|584527555|FG001|Overall Study|Progressive Disease|1|||
161859398|NCT02848001|584527556|FG002|Overall Study|Progressive Disease|0|||
161859399|NCT02848001|584527557|FG003|Overall Study|Progressive Disease|4|||
161859400|NCT02848001|584527558|FG004|Overall Study|Progressive Disease|3|||
161859401|NCT02848001|584527559|FG005|Overall Study|Progressive Disease|0|||
161859402|NCT02848001|584527560|FG006|Overall Study|Progressive Disease|4|||
161859403|NCT02848001|584527561|FG007|Overall Study|Progressive Disease|1|||
161859404|NCT02848001|584527562|FG008|Overall Study|Progressive Disease|0|||
161859405|NCT02848001|584527563|FG009|Overall Study|Progressive Disease|2|||
161859406|NCT02848001|584527564|FG010|Overall Study|Progressive Disease|3|||
161859407|NCT02848001|584527565|FG011|Overall Study|Progressive Disease|2|||
161859408|NCT02848001|584527566|FG012|Overall Study|Progressive Disease|1|||
161859409|NCT02848001|584527567|FG013|Overall Study|Progressive Disease|0|||
161859410|NCT02848001|584527568|FG014|Overall Study|Progressive Disease|2|||
161859411|NCT02848001|584527569|FG015|Overall Study|Progressive Disease|4|||
161859412|NCT02848001|584527570|FG016|Overall Study|Progressive Disease|0|||
161859413|NCT02848001|584527554|FG000|Overall Study|Adverse Event|0|||
161770550|NCT03996694|584202150|FG000|First Washout (7 Days)|Adverse Event|0|||
161770551|NCT03996694|584202151|FG001|First Washout (7 Days)|Adverse Event|1|||
161770552|NCT03996694|584202152|FG002|First Washout (7 Days)|Adverse Event|0|||
161770553|NCT03996694|584202153|FG003|First Washout (7 Days)|Adverse Event|0|||
161770554|NCT03996694|584202154|FG004|First Washout (7 Days)|Adverse Event|0|||
161770555|NCT03996694|584202155|FG005|First Washout (7 Days)|Adverse Event|0|||
161770556|NCT03996694|584202150|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
161770557|NCT03996694|584202151|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
161770558|NCT03996694|584202152|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
161770559|NCT03996694|584202153|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
161770560|NCT03996694|584202154|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
161770561|NCT03996694|584202155|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
161770562|NCT03996694|584202150|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770563|NCT03996694|584202151|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770564|NCT03996694|584202152|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770565|NCT03996694|584202153|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770566|NCT03996694|584202154|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
161770567|NCT03996694|584202155|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770568|NCT03323034|584202164|FG000|Overall Study|Lack of Efficacy|5|||
161770569|NCT03323034|584202165|FG001|Overall Study|Lack of Efficacy|5|||
161770570|NCT03323034|584202166|FG002|Overall Study|Lack of Efficacy|6|||
161770571|NCT03323034|584202167|FG003|Overall Study|Lack of Efficacy|5|||
161770572|NCT03323034|584202168|FG004|Overall Study|Lack of Efficacy|5|||
161770573|NCT03323034|584202164|FG000|Overall Study|Physician Decision|0|||
161770574|NCT03323034|584202165|FG001|Overall Study|Physician Decision|0|||
161770575|NCT03323034|584202166|FG002|Overall Study|Physician Decision|0|||
161770576|NCT03323034|584202167|FG003|Overall Study|Physician Decision|0|||
161770577|NCT03323034|584202168|FG004|Overall Study|Physician Decision|1|||
161770578|NCT03323034|584202164|FG000|Overall Study|Withdrawal by Subject|1|||
161770579|NCT03323034|584202165|FG001|Overall Study|Withdrawal by Subject|1|||
161770580|NCT03323034|584202166|FG002|Overall Study|Withdrawal by Subject|0|||
161770581|NCT03323034|584202167|FG003|Overall Study|Withdrawal by Subject|1|||
161770582|NCT03323034|584202168|FG004|Overall Study|Withdrawal by Subject|0|||
161770583|NCT02646566|584202170|FG000|Overall Study|Lost to Follow-up|5|||
161770584|NCT02646566|584202171|FG001|Overall Study|Lost to Follow-up|4|||
161770585|NCT02646566|584202172|FG002|Overall Study|Lost to Follow-up|5|||
161770586|NCT02646566|584202170|FG000|Overall Study|Treatment failure|1|||
161770587|NCT02646566|584202171|FG001|Overall Study|Treatment failure|0|||
161770588|NCT02646566|584202172|FG002|Overall Study|Treatment failure|0|||
161770589|NCT04576702|584202180|FG000|Overall Study|Death|1|||
161770590|NCT04576702|584202181|FG001|Overall Study|Death|0|||
161770591|NCT04576702|584202182|FG002|Overall Study|Death|0|||
161770592|NCT04576702|584202183|FG003|Overall Study|Death|0|||
161770593|NCT04576702|584202180|FG000|Overall Study|Withdrawal by Subject|0|||
161770594|NCT04576702|584202181|FG001|Overall Study|Withdrawal by Subject|2|||
161770595|NCT04576702|584202182|FG002|Overall Study|Withdrawal by Subject|1|||
161770596|NCT04576702|584202183|FG003|Overall Study|Withdrawal by Subject|0|||
161770597|NCT04576702|584202180|FG000|Overall Study|Lost to Follow-up|3|||
161770598|NCT04576702|584202181|FG001|Overall Study|Lost to Follow-up|3|||
161770599|NCT04576702|584202182|FG002|Overall Study|Lost to Follow-up|3|||
161770600|NCT04576702|584202183|FG003|Overall Study|Lost to Follow-up|4|||
161770601|NCT01151085|584202184|FG000|Overall Study|Lost to Follow-up|31|||
161770602|NCT01151085|584202184|FG000|Overall Study|Protocol Violation|25|||
161770603|NCT00003526|584202185|FG000|Overall Study|Not evaluable|6|||
161770604|NCT02059265|584202186|FG000|Overall Study|Ineligible|4|||
161770605|NCT00998166|584202187|FG000|Overall Study|Early Study Termination|8|||
161770606|NCT02985996|584202191|FG000|Overall Study|Withdrawal by Subject|0|||
161770607|NCT02985996|584202192|FG001|Overall Study|Withdrawal by Subject|0|||
161770608|NCT02985996|584202193|FG002|Overall Study|Withdrawal by Subject|1|||
161770609|NCT02985996|584202194|FG003|Overall Study|Withdrawal by Subject|0|||
161770610|NCT02985996|584202195|FG004|Overall Study|Withdrawal by Subject|0|||
161770611|NCT02985996|584202191|FG000|Overall Study|Protocol Violation|0|||
161770612|NCT02985996|584202192|FG001|Overall Study|Protocol Violation|1|||
161770613|NCT02985996|584202193|FG002|Overall Study|Protocol Violation|0|||
161770614|NCT02985996|584202194|FG003|Overall Study|Protocol Violation|0|||
161770615|NCT02985996|584202195|FG004|Overall Study|Protocol Violation|0|||
161770616|NCT00401726|584202196|FG000|Overall Study|Adverse Event|34|||
161770617|NCT00401726|584202197|FG001|Overall Study|Adverse Event|45|||
161770618|NCT00401726|584202196|FG000|Overall Study|Death|0|||
161770619|NCT00401726|584202197|FG001|Overall Study|Death|3|||
161859414|NCT02848001|584527555|FG001|Overall Study|Adverse Event|0|||
161859415|NCT02848001|584527556|FG002|Overall Study|Adverse Event|0|||
161859416|NCT02848001|584527557|FG003|Overall Study|Adverse Event|0|||
161859417|NCT02848001|584527558|FG004|Overall Study|Adverse Event|2|||
161859418|NCT02848001|584527559|FG005|Overall Study|Adverse Event|0|||
161859419|NCT02848001|584527560|FG006|Overall Study|Adverse Event|0|||
161859420|NCT02848001|584527561|FG007|Overall Study|Adverse Event|0|||
161859421|NCT02848001|584527562|FG008|Overall Study|Adverse Event|0|||
161859422|NCT02848001|584527563|FG009|Overall Study|Adverse Event|1|||
161859423|NCT02848001|584527564|FG010|Overall Study|Adverse Event|0|||
161859424|NCT02848001|584527565|FG011|Overall Study|Adverse Event|1|||
161859425|NCT02848001|584527566|FG012|Overall Study|Adverse Event|1|||
161859426|NCT02848001|584527567|FG013|Overall Study|Adverse Event|0|||
161859427|NCT02848001|584527568|FG014|Overall Study|Adverse Event|2|||
161859428|NCT02848001|584527569|FG015|Overall Study|Adverse Event|0|||
161859429|NCT02848001|584527570|FG016|Overall Study|Adverse Event|0|||
161859430|NCT02848001|584527554|FG000|Overall Study|Death|0|||
161859431|NCT02848001|584527555|FG001|Overall Study|Death|0|||
161859432|NCT02848001|584527556|FG002|Overall Study|Death|0|||
161859433|NCT02848001|584527557|FG003|Overall Study|Death|1|||
161859434|NCT02848001|584527558|FG004|Overall Study|Death|3|||
161859435|NCT02848001|584527559|FG005|Overall Study|Death|1|||
161859436|NCT02848001|584527560|FG006|Overall Study|Death|2|||
161859437|NCT02848001|584527561|FG007|Overall Study|Death|3|||
161859438|NCT02848001|584527562|FG008|Overall Study|Death|4|||
161859439|NCT02848001|584527563|FG009|Overall Study|Death|1|||
161859440|NCT02848001|584527564|FG010|Overall Study|Death|0|||
161859441|NCT02848001|584527565|FG011|Overall Study|Death|1|||
161859442|NCT02848001|584527566|FG012|Overall Study|Death|3|||
161859443|NCT02848001|584527567|FG013|Overall Study|Death|0|||
161859444|NCT02848001|584527568|FG014|Overall Study|Death|2|||
161859445|NCT02848001|584527569|FG015|Overall Study|Death|3|||
161859446|NCT02848001|584527570|FG016|Overall Study|Death|0|||
161859447|NCT02848001|584527554|FG000|Overall Study|Physician Decision|0|||
161859448|NCT02848001|584527555|FG001|Overall Study|Physician Decision|0|||
161859449|NCT02848001|584527556|FG002|Overall Study|Physician Decision|0|||
161859450|NCT02848001|584527557|FG003|Overall Study|Physician Decision|0|||
161859451|NCT02848001|584527558|FG004|Overall Study|Physician Decision|0|||
161859452|NCT02848001|584527559|FG005|Overall Study|Physician Decision|0|||
161859453|NCT02848001|584527560|FG006|Overall Study|Physician Decision|0|||
161859454|NCT02848001|584527561|FG007|Overall Study|Physician Decision|0|||
161859455|NCT02848001|584527562|FG008|Overall Study|Physician Decision|1|||
161859456|NCT02848001|584527563|FG009|Overall Study|Physician Decision|1|||
161859457|NCT02848001|584527564|FG010|Overall Study|Physician Decision|0|||
161859458|NCT02848001|584527565|FG011|Overall Study|Physician Decision|0|||
161859459|NCT02848001|584527566|FG012|Overall Study|Physician Decision|2|||
161859460|NCT02848001|584527567|FG013|Overall Study|Physician Decision|0|||
161859461|NCT02848001|584527568|FG014|Overall Study|Physician Decision|0|||
161859462|NCT02848001|584527569|FG015|Overall Study|Physician Decision|0|||
161859463|NCT02848001|584527570|FG016|Overall Study|Physician Decision|0|||
161859464|NCT02848001|584527554|FG000|Overall Study|Withdrawal by Subject|0|||
161859465|NCT02848001|584527555|FG001|Overall Study|Withdrawal by Subject|0|||
161859466|NCT02848001|584527556|FG002|Overall Study|Withdrawal by Subject|0|||
161859467|NCT02848001|584527557|FG003|Overall Study|Withdrawal by Subject|0|||
161859468|NCT02848001|584527558|FG004|Overall Study|Withdrawal by Subject|0|||
161859469|NCT02848001|584527559|FG005|Overall Study|Withdrawal by Subject|1|||
161859470|NCT02848001|584527560|FG006|Overall Study|Withdrawal by Subject|1|||
161859471|NCT02848001|584527561|FG007|Overall Study|Withdrawal by Subject|1|||
161859472|NCT02848001|584527562|FG008|Overall Study|Withdrawal by Subject|0|||
161859473|NCT02848001|584527563|FG009|Overall Study|Withdrawal by Subject|0|||
161859474|NCT02848001|584527564|FG010|Overall Study|Withdrawal by Subject|0|||
161859475|NCT02848001|584527565|FG011|Overall Study|Withdrawal by Subject|0|||
161859476|NCT02848001|584527566|FG012|Overall Study|Withdrawal by Subject|0|||
161859477|NCT02848001|584527567|FG013|Overall Study|Withdrawal by Subject|0|||
161859478|NCT02848001|584527568|FG014|Overall Study|Withdrawal by Subject|0|||
161859479|NCT02848001|584527569|FG015|Overall Study|Withdrawal by Subject|0|||
161859480|NCT02848001|584527570|FG016|Overall Study|Withdrawal by Subject|0|||
161859481|NCT00725283|584527571|FG000|Overall Study|Missing Code|3|||
161859482|NCT00725283|584527571|FG000|Overall Study|Death|5|||
161859483|NCT00725283|584527571|FG000|Overall Study|Other|6|||
161859484|NCT00725283|584527571|FG000|Overall Study|Withdrawal by Subject|10|||
161859485|NCT03103087|584527575|FG000|Overall Study|Did not receive any study drug|1|||
161859486|NCT03103087|584527576|FG001|Overall Study|Did not receive any study drug|0|||
161859487|NCT03103087|584527577|FG002|Overall Study|Did not receive any study drug|0|||
161859488|NCT03103087|584527575|FG000|Overall Study|Protocol Violation|1|||
161859489|NCT03103087|584527576|FG001|Overall Study|Protocol Violation|2|||
161859490|NCT03103087|584527577|FG002|Overall Study|Protocol Violation|1|||
161859491|NCT03103087|584527575|FG000|Overall Study|Lack of Efficacy|2|||
161859492|NCT03103087|584527576|FG001|Overall Study|Lack of Efficacy|1|||
161770620|NCT00401726|584202196|FG000|Overall Study|Sponsor Request|0|||
161770621|NCT00401726|584202197|FG001|Overall Study|Sponsor Request|1|||
161770622|NCT00401726|584202196|FG000|Overall Study|Physician Decision|3|||
161770623|NCT00401726|584202197|FG001|Overall Study|Physician Decision|6|||
161770624|NCT00401726|584202196|FG000|Overall Study|Lost to Follow-up|23|||
161770625|NCT00401726|584202197|FG001|Overall Study|Lost to Follow-up|20|||
161770626|NCT00401726|584202196|FG000|Overall Study|Protocol Violation|6|||
161770627|NCT00401726|584202197|FG001|Overall Study|Protocol Violation|3|||
161770628|NCT00401726|584202196|FG000|Overall Study|Withdrawal by Subject|18|||
161770629|NCT00401726|584202197|FG001|Overall Study|Withdrawal by Subject|24|||
161770630|NCT00401726|584202196|FG000|Overall Study|Lack of Efficacy|4|||
161770631|NCT00401726|584202197|FG001|Overall Study|Lack of Efficacy|6|||
161770632|NCT00401726|584202196|FG000|Overall Study|Protocol Deviation|9|||
161770633|NCT00401726|584202197|FG001|Overall Study|Protocol Deviation|4|||
161770634|NCT00814502|584202200|FG000|Overall Study|Adverse Event|1|||
161770635|NCT00814502|584202201|FG001|Overall Study|Adverse Event|0|||
161770636|NCT00814502|584202200|FG000|Overall Study|Withdrawal by Subject|0|||
161770637|NCT00814502|584202201|FG001|Overall Study|Withdrawal by Subject|2|||
161770638|NCT03735849|584202203|FG000|Overall Study|Lost to Follow-up|1|||
161770639|NCT03735849|584202204|FG001|Overall Study|Lost to Follow-up|0|||
161770640|NCT03735849|584202205|FG002|Overall Study|Lost to Follow-up|0|||
161770641|NCT03735849|584202203|FG000|Overall Study|Participant unable to adhere to visit|1|||
161770642|NCT03735849|584202204|FG001|Overall Study|Participant unable to adhere to visit|0|||
161770643|NCT03735849|584202205|FG002|Overall Study|Participant unable to adhere to visit|0|||
161770644|NCT03735849|584202203|FG000|Overall Study|Not Randomized|0|||
161770645|NCT03735849|584202204|FG001|Overall Study|Not Randomized|0|||
161770646|NCT03735849|584202205|FG002|Overall Study|Not Randomized|4|||
161770647|NCT01050998|584202208|FG000|Overall Study|Adverse Event|1|||
161770648|NCT01050998|584202209|FG001|Overall Study|Adverse Event|0|||
161770649|NCT01050998|584202210|FG002|Overall Study|Adverse Event|1|||
161770650|NCT01050998|584202211|FG003|Overall Study|Adverse Event|0|||
161770651|NCT01050998|584202212|FG004|Overall Study|Adverse Event|2|||
161770652|NCT01050998|584202208|FG000|Overall Study|Withdrawal by Subject|0|||
161770653|NCT01050998|584202209|FG001|Overall Study|Withdrawal by Subject|0|||
161770654|NCT01050998|584202210|FG002|Overall Study|Withdrawal by Subject|0|||
161770655|NCT01050998|584202211|FG003|Overall Study|Withdrawal by Subject|1|||
161770656|NCT01050998|584202212|FG004|Overall Study|Withdrawal by Subject|3|||
161770657|NCT01050998|584202208|FG000|Overall Study|Other|3|||
161770658|NCT01050998|584202209|FG001|Overall Study|Other|2|||
161770659|NCT01050998|584202210|FG002|Overall Study|Other|1|||
161770660|NCT01050998|584202211|FG003|Overall Study|Other|1|||
161770661|NCT01050998|584202212|FG004|Overall Study|Other|5|||
161770662|NCT01050998|584202208|FG000|Overall Study|Data integrity issues|0|||
161770663|NCT01050998|584202209|FG001|Overall Study|Data integrity issues|0|||
161770664|NCT01050998|584202210|FG002|Overall Study|Data integrity issues|1|||
161770665|NCT01050998|584202211|FG003|Overall Study|Data integrity issues|1|||
161770666|NCT01050998|584202212|FG004|Overall Study|Data integrity issues|4|||
161770667|NCT04246593|584202215|FG000|Overall Study|Withdrawal by Subject|14|||
161770668|NCT04246593|584202216|FG001|Overall Study|Withdrawal by Subject|13|||
161770669|NCT04246593|584202215|FG000|Overall Study|Lost to Follow-up|124|||
161770670|NCT04246593|584202216|FG001|Overall Study|Lost to Follow-up|71|||
161770671|NCT04246593|584202215|FG000|Overall Study|Moved out of area/became ineligible|3|||
161770672|NCT04246593|584202216|FG001|Overall Study|Moved out of area/became ineligible|1|||
161770673|NCT04246593|584202215|FG000|Overall Study|Reason unknown|4|||
161770674|NCT04246593|584202216|FG001|Overall Study|Reason unknown|2|||
161770675|NCT01012765|584202219|FG000|Treatment Period 1|Adverse Event|1|||
161770676|NCT01012765|584202220|FG001|Treatment Period 1|Adverse Event|0|||
161770677|NCT01012765|584202221|FG002|Treatment Period 1|Adverse Event|1|||
161770678|NCT01012765|584202222|FG003|Treatment Period 1|Adverse Event|0|||
161770679|NCT01012765|584202223|FG004|Treatment Period 1|Adverse Event|0|||
161770680|NCT01012765|584202224|FG005|Treatment Period 1|Adverse Event|0|||
161770681|NCT01012765|584202219|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161770682|NCT01012765|584202220|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161770683|NCT01012765|584202221|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161770684|NCT01012765|584202222|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161770685|NCT01012765|584202223|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161770686|NCT01012765|584202224|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161770687|NCT01012765|584202219|FG000|Treatment Period 1|Administrative problems|0|||
161770688|NCT01012765|584202220|FG001|Treatment Period 1|Administrative problems|0|||
161770689|NCT01012765|584202221|FG002|Treatment Period 1|Administrative problems|1|||
161770690|NCT01012765|584202222|FG003|Treatment Period 1|Administrative problems|1|||
161770691|NCT01012765|584202223|FG004|Treatment Period 1|Administrative problems|1|||
161770692|NCT01012765|584202224|FG005|Treatment Period 1|Administrative problems|0|||
161770693|NCT01012765|584202219|FG000|Treatment Period 1|Protocol Violation|0|||
161859493|NCT03103087|584527577|FG002|Overall Study|Lack of Efficacy|1|||
161859494|NCT03103087|584527575|FG000|Overall Study|Pregnancy|0|||
161859495|NCT03103087|584527576|FG001|Overall Study|Pregnancy|0|||
161859496|NCT03103087|584527577|FG002|Overall Study|Pregnancy|1|||
161859497|NCT03103087|584527575|FG000|Overall Study|Adverse Event|2|||
161859498|NCT03103087|584527576|FG001|Overall Study|Adverse Event|15|||
161859499|NCT03103087|584527577|FG002|Overall Study|Adverse Event|6|||
161859500|NCT03103087|584527575|FG000|Overall Study|Withdrawal by Subject|13|||
161859501|NCT03103087|584527576|FG001|Overall Study|Withdrawal by Subject|6|||
161859502|NCT03103087|584527577|FG002|Overall Study|Withdrawal by Subject|6|||
161859503|NCT03103087|584527575|FG000|Overall Study|Lost to Follow-up|4|||
161859504|NCT03103087|584527576|FG001|Overall Study|Lost to Follow-up|2|||
161859505|NCT03103087|584527577|FG002|Overall Study|Lost to Follow-up|7|||
161859506|NCT03103087|584527575|FG000|Overall Study|Other reason not reported|1|||
161859507|NCT03103087|584527576|FG001|Overall Study|Other reason not reported|3|||
161859508|NCT03103087|584527577|FG002|Overall Study|Other reason not reported|5|||
161859509|NCT00118157|584527578|FG000|Overall Study|Adverse Event|2|||
161859510|NCT00118157|584527578|FG000|Overall Study|Death|8|||
161859511|NCT00118157|584527578|FG000|Overall Study|Withdrawal by Subject|2|||
161859512|NCT02760004|584527579|FG000|Overall Study|Lost to Follow-up|13|||
161859513|NCT02760004|584527580|FG001|Overall Study|Lost to Follow-up|22|||
161859514|NCT01495000|584527581|FG000|Overall Study|Lost to Follow-up|2|||
161859515|NCT01495000|584527582|FG001|Overall Study|Lost to Follow-up|2|||
161859516|NCT01495000|584527581|FG000|Overall Study|Protocol Violation|1|||
161859517|NCT01495000|584527582|FG001|Overall Study|Protocol Violation|0|||
161859518|NCT01495000|584527581|FG000|Overall Study|Withdrawal by Subject|10|||
161859519|NCT01495000|584527582|FG001|Overall Study|Withdrawal by Subject|10|||
161859520|NCT02070965|584527583|FG000|Overall Study|Lost to Follow-up|0|||
161859521|NCT02070965|584527584|FG001|Overall Study|Lost to Follow-up|1|||
161859522|NCT02070965|584527585|FG002|Overall Study|Lost to Follow-up|0|||
161859523|NCT02070965|584527583|FG000|Overall Study|Withdrawal by Subject|1|||
161859524|NCT02070965|584527584|FG001|Overall Study|Withdrawal by Subject|1|||
161859525|NCT02070965|584527585|FG002|Overall Study|Withdrawal by Subject|1|||
161859526|NCT02070965|584527583|FG000|Overall Study|Subject moved|1|||
161859527|NCT02070965|584527584|FG001|Overall Study|Subject moved|0|||
161859528|NCT02070965|584527585|FG002|Overall Study|Subject moved|0|||
161859529|NCT03889886|584527587|FG000|Overall Study|Other|0|||
161859530|NCT03889886|584527588|FG001|Overall Study|Other|1|||
161859531|NCT03889886|584527589|FG002|Overall Study|Other|0|||
161859532|NCT03889886|584527590|FG003|Overall Study|Other|1|||
161859533|NCT03889886|584527587|FG000|Overall Study|Withdrawal by Subject|0|||
161859534|NCT03889886|584527588|FG001|Overall Study|Withdrawal by Subject|0|||
161859535|NCT03889886|584527589|FG002|Overall Study|Withdrawal by Subject|1|||
161859536|NCT03889886|584527590|FG003|Overall Study|Withdrawal by Subject|0|||
161859537|NCT03889886|584527587|FG000|Overall Study|Adverse Event|0|||
161859538|NCT03889886|584527588|FG001|Overall Study|Adverse Event|0|||
161859539|NCT03889886|584527589|FG002|Overall Study|Adverse Event|0|||
161859540|NCT03889886|584527590|FG003|Overall Study|Adverse Event|6|||
161859541|NCT00276484|584527591|FG000|Overall Study|Adverse Event|4|||
161859542|NCT00276484|584527592|FG001|Overall Study|Adverse Event|7|||
161859543|NCT00276484|584527591|FG000|Overall Study|Lost to Follow-up|1|||
161859544|NCT00276484|584527592|FG001|Overall Study|Lost to Follow-up|1|||
161859545|NCT00276484|584527591|FG000|Overall Study|Protocol Violation|0|||
161859546|NCT00276484|584527592|FG001|Overall Study|Protocol Violation|1|||
161859547|NCT00276484|584527591|FG000|Overall Study|Withdrawal by Subject|4|||
161859548|NCT00276484|584527592|FG001|Overall Study|Withdrawal by Subject|3|||
161859549|NCT00276484|584527591|FG000|Overall Study|Could not take time off work|0|||
161859550|NCT00276484|584527592|FG001|Overall Study|Could not take time off work|1|||
161859551|NCT00942357|584527606|FG000|Overall Study|Ineligible|37|||
161859552|NCT00942357|584527607|FG001|Overall Study|Ineligible|40|||
161859553|NCT03347110|584527608|FG000|Overall Study|Other (Participant is incarcerated)|1|||
161859554|NCT03347110|584527608|FG000|Overall Study|Withdrawal by Subject|9|||
161859555|NCT03347110|584527608|FG000|Overall Study|Lost to Follow-up|1|||
161859556|NCT03347110|584527608|FG000|Overall Study|Lack of Efficacy|2|||
161859557|NCT03347110|584527608|FG000|Overall Study|Adverse Event, non-fatal|9|||
161859558|NCT01321879|584527609|FG000|Overall Study|Lack of Efficacy|5|||
161859559|NCT01321879|584527609|FG000|Overall Study|Adverse Event|5|||
161859560|NCT01321879|584527609|FG000|Overall Study|Death|3|||
161859561|NCT01321879|584527609|FG000|Overall Study|Withdrawal by Subject|1|||
161859562|NCT02687451|584527610|FG000|Overall Study|Withdrawal by Subject|1|||
161859563|NCT02687451|584527611|FG001|Overall Study|Withdrawal by Subject|0|||
161859564|NCT02687451|584527612|FG002|Overall Study|Withdrawal by Subject|0|||
161859565|NCT02687451|584527613|FG003|Overall Study|Withdrawal by Subject|0|||
161859566|NCT02687451|584527614|FG004|Overall Study|Withdrawal by Subject|0|||
161859567|NCT02687451|584527615|FG005|Overall Study|Withdrawal by Subject|1|||
161859568|NCT00707239|584527616|FG000|Overall Study|Adverse Event|5|||
161859569|NCT00707239|584527617|FG001|Overall Study|Adverse Event|3|||
161859570|NCT00707239|584527618|FG002|Overall Study|Adverse Event|2|||
161859571|NCT00707239|584527616|FG000|Overall Study|Death|3|||
161859572|NCT00707239|584527617|FG001|Overall Study|Death|1|||
161859573|NCT00707239|584527618|FG002|Overall Study|Death|3|||
161859574|NCT00707239|584527616|FG000|Overall Study|Physician Decision|1|||
161859575|NCT00707239|584527617|FG001|Overall Study|Physician Decision|1|||
161859576|NCT00707239|584527618|FG002|Overall Study|Physician Decision|2|||
161859577|NCT00707239|584527616|FG000|Overall Study|Protocol Violation|0|||
161859578|NCT00707239|584527617|FG001|Overall Study|Protocol Violation|0|||
161859579|NCT00707239|584527618|FG002|Overall Study|Protocol Violation|1|||
161859580|NCT00707239|584527616|FG000|Overall Study|Lack of Efficacy|1|||
161859581|NCT00707239|584527617|FG001|Overall Study|Lack of Efficacy|2|||
161859582|NCT00707239|584527618|FG002|Overall Study|Lack of Efficacy|0|||
161859583|NCT00707239|584527616|FG000|Overall Study|Randomized, but not treated|1|||
161859584|NCT00707239|584527617|FG001|Overall Study|Randomized, but not treated|1|||
161859585|NCT00707239|584527618|FG002|Overall Study|Randomized, but not treated|1|||
161859586|NCT00707239|584527616|FG000|Overall Study|Other|8|||
161859587|NCT00707239|584527617|FG001|Overall Study|Other|3|||
161859588|NCT00707239|584527618|FG002|Overall Study|Other|5|||
161859589|NCT01518322|584527619|FG000|Overall Study|FeNO measurement was missing|13|||
161859590|NCT03652051|584527620|FG000|Stage 1|Adverse Event|0|||
161859591|NCT03652051|584527621|FG001|Stage 1|Adverse Event|5|||
161859592|NCT03652051|584527622|FG002|Stage 1|Adverse Event|7|||
161859593|NCT03652051|584527623|FG003|Stage 1|Adverse Event|1|||
161859594|NCT03652051|584527620|FG000|Stage 1|Withdrawal by Subject|0|||
161859595|NCT03652051|584527621|FG001|Stage 1|Withdrawal by Subject|0|||
161859596|NCT03652051|584527622|FG002|Stage 1|Withdrawal by Subject|1|||
161859597|NCT03652051|584527623|FG003|Stage 1|Withdrawal by Subject|0|||
161859598|NCT03652051|584527620|FG000|Stage 2|Adverse Event|0|||
161859599|NCT03652051|584527621|FG001|Stage 2|Adverse Event|2|||
161859600|NCT03652051|584527622|FG002|Stage 2|Adverse Event|1|||
161859601|NCT03652051|584527623|FG003|Stage 2|Adverse Event|0|||
161859602|NCT03652051|584527620|FG000|Stage 2|Protocol Violation|0|||
161859603|NCT03652051|584527621|FG001|Stage 2|Protocol Violation|1|||
161859604|NCT03652051|584527622|FG002|Stage 2|Protocol Violation|6|||
161859605|NCT03652051|584527623|FG003|Stage 2|Protocol Violation|0|||
161859606|NCT03652051|584527620|FG000|Stage 2|Lost to Follow-up|0|||
161859607|NCT03652051|584527621|FG001|Stage 2|Lost to Follow-up|2|||
161859608|NCT03652051|584527622|FG002|Stage 2|Lost to Follow-up|0|||
161859609|NCT03652051|584527623|FG003|Stage 2|Lost to Follow-up|3|||
161859610|NCT03652051|584527620|FG000|Stage 2|Withdrawal by Subject|0|||
161859611|NCT03652051|584527621|FG001|Stage 2|Withdrawal by Subject|11|||
161859612|NCT03652051|584527622|FG002|Stage 2|Withdrawal by Subject|9|||
161859613|NCT03652051|584527623|FG003|Stage 2|Withdrawal by Subject|3|||
161859614|NCT01930162|584527624|FG000|Overall Study|Abnormal test procedure result(s)|4|||
161859615|NCT01930162|584527624|FG000|Overall Study|Death|1|||
161859616|NCT01958437|584527625|FG000|Overall Study|Incidental MRI findings|0|||
161859617|NCT01958437|584527626|FG001|Overall Study|Incidental MRI findings|0|||
161859618|NCT01958437|584527627|FG002|Overall Study|Incidental MRI findings|1|||
161859619|NCT01958437|584527628|FG003|Overall Study|Incidental MRI findings|1|||
161859620|NCT02394600|584527631|FG000|Overall Study|Adverse Event|3|||
161859621|NCT02394600|584527632|FG001|Overall Study|Adverse Event|0|||
161859622|NCT02394600|584527631|FG000|Overall Study|Lost to Follow-up|0|||
161859623|NCT02394600|584527632|FG001|Overall Study|Lost to Follow-up|1|||
161859624|NCT02394600|584527631|FG000|Overall Study|Withdrawal by Subject|0|||
161859625|NCT02394600|584527632|FG001|Overall Study|Withdrawal by Subject|1|||
161859626|NCT02394600|584527631|FG000|Overall Study|Protocol Violation|1|||
161859627|NCT02394600|584527632|FG001|Overall Study|Protocol Violation|0|||
161859628|NCT02569801|584527633|FG000|Overall Study|Withdrawal by Subject|9|||
161859629|NCT02569801|584527634|FG001|Overall Study|Withdrawal by Subject|9|||
161859630|NCT02569801|584527633|FG000|Overall Study|Sponsor Decision|13|||
161859631|NCT02569801|584527634|FG001|Overall Study|Sponsor Decision|14|||
161859632|NCT02569801|584527633|FG000|Overall Study|Progressive Disease|2|||
161859633|NCT02569801|584527634|FG001|Overall Study|Progressive Disease|7|||
161859634|NCT02569801|584527633|FG000|Overall Study|Lost to Follow-up|0|||
161859635|NCT02569801|584527634|FG001|Overall Study|Lost to Follow-up|1|||
161859636|NCT02569801|584527633|FG000|Overall Study|Death|12|||
161859637|NCT02569801|584527634|FG001|Overall Study|Death|4|||
161859638|NCT03442751|584527638|FG000|Overall Study|Withdrawal by Subject|3|||
161859639|NCT03442751|584527639|FG001|Overall Study|Withdrawal by Subject|1|||
161859640|NCT03442751|584527638|FG000|Overall Study|Lost to Follow-up|3|||
161859641|NCT03442751|584527639|FG001|Overall Study|Lost to Follow-up|0|||
161770694|NCT01012765|584202220|FG001|Treatment Period 1|Protocol Violation|0|||
161770695|NCT01012765|584202221|FG002|Treatment Period 1|Protocol Violation|0|||
161770696|NCT01012765|584202222|FG003|Treatment Period 1|Protocol Violation|2|||
161770697|NCT01012765|584202223|FG004|Treatment Period 1|Protocol Violation|1|||
161770698|NCT01012765|584202224|FG005|Treatment Period 1|Protocol Violation|0|||
161770699|NCT01012765|584202219|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770700|NCT01012765|584202220|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770701|NCT01012765|584202221|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770702|NCT01012765|584202222|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770703|NCT01012765|584202223|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
161859642|NCT02603887|584527641|FG000|Stage 1|Adverse Event|4|||
161859643|NCT02603887|584527641|FG000|Stage 1|Disease progression|1|||
161770704|NCT01012765|584202224|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770705|NCT01012765|584202219|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161770706|NCT01012765|584202220|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161770707|NCT01012765|584202221|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161770708|NCT01012765|584202222|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161770709|NCT01012765|584202223|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161770710|NCT01012765|584202224|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161770711|NCT01012765|584202219|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770712|NCT01012765|584202220|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770713|NCT01012765|584202221|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770714|NCT01012765|584202222|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770715|NCT01012765|584202223|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770716|NCT01012765|584202224|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
161770717|NCT01012765|584202219|FG000|Treatment Period 2|Adverse Event|0|||
161770718|NCT01012765|584202220|FG001|Treatment Period 2|Adverse Event|1|||
161770719|NCT01012765|584202221|FG002|Treatment Period 2|Adverse Event|1|||
161770720|NCT01012765|584202222|FG003|Treatment Period 2|Adverse Event|0|||
161770721|NCT01012765|584202223|FG004|Treatment Period 2|Adverse Event|0|||
161770722|NCT01012765|584202224|FG005|Treatment Period 2|Adverse Event|0|||
161770723|NCT01012765|584202219|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770724|NCT01012765|584202220|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
161770725|NCT01012765|584202221|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
161770726|NCT01012765|584202222|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770727|NCT01012765|584202223|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770728|NCT01012765|584202224|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770729|NCT04668157|584202232|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
161770730|NCT04668157|584202233|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161770731|NCT04668157|584202232|FG000|Treatment Period (52 Weeks)|Other|0|||
161770732|NCT04668157|584202233|FG001|Treatment Period (52 Weeks)|Other|2|||
161770733|NCT02283411|584202238|FG000|Overall Study|Withdrawal by Subject|3|||
161770734|NCT02283411|584202238|FG000|Overall Study|Screen Failed|28|||
161770735|NCT05437211|584202239|FG000|Overall Study|Patient's decision|1|||
161770736|NCT05437211|584202240|FG001|Overall Study|Patient's decision|1|||
161770737|NCT03282123|584202242|FG000|Overall Study|Withdrawal by Subject|5|||
161770738|NCT03457701|584202243|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161770739|NCT03457701|584202244|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161770740|NCT03457701|584202243|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
161859644|NCT02603887|584527641|FG000|Stage 2|FDA guidance|1|||
161770741|NCT03457701|584202244|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161770742|NCT03329404|584202245|FG000|Overall Study|The study was suspended.|1|||
161859645|NCT01308424|584527644|FG000|Baseline Eligibility|Screen Failures|71|||
161859646|NCT01308424|584527645|FG001|Baseline Eligibility|Screen Failures|0|||
161859647|NCT01308424|584527646|FG002|Baseline Eligibility|Screen Failures|0|||
161859648|NCT01308424|584527644|FG000|Randomization|Adverse Event|0|||
161859649|NCT01308424|584527645|FG001|Randomization|Adverse Event|1|||
161859650|NCT01308424|584527646|FG002|Randomization|Adverse Event|1|||
161859651|NCT01308424|584527644|FG000|Randomization|Lost to Follow-up|0|||
161859652|NCT01308424|584527645|FG001|Randomization|Lost to Follow-up|1|||
161859653|NCT01308424|584527646|FG002|Randomization|Lost to Follow-up|0|||
161859654|NCT01308424|584527644|FG000|Randomization|Physician Decision|0|||
161859655|NCT01308424|584527645|FG001|Randomization|Physician Decision|1|||
161859656|NCT01308424|584527646|FG002|Randomization|Physician Decision|1|||
161859657|NCT00948155|584527647|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
161859658|NCT00948155|584527648|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
161859659|NCT00948155|584527647|FG000|Washout 14 Days|Lost to Follow-up|1|||
161859660|NCT00948155|584527648|FG001|Washout 14 Days|Lost to Follow-up|2|||
161859661|NCT04620746|584527649|FG000|Overall Study|Adverse Event|2|||
161859662|NCT04620746|584527650|FG001|Overall Study|Adverse Event|0|||
161859663|NCT04620746|584527649|FG000|Overall Study|Uniterpretable skin test|1|||
161859664|NCT04620746|584527650|FG001|Overall Study|Uniterpretable skin test|0|||
161859665|NCT04620746|584527649|FG000|Overall Study|Withdrawal by Subject|0|||
161859666|NCT04620746|584527650|FG001|Overall Study|Withdrawal by Subject|1|||
161859667|NCT05767905|584527655|FG000|Overall Study|Adverse Event|0|||
161859668|NCT05767905|584527656|FG001|Overall Study|Adverse Event|0|||
161859669|NCT05767905|584527657|FG002|Overall Study|Adverse Event|1|||
161859670|NCT03404674|584527663|FG000|Overall Study|Inability to Attend Future Visits|0|||
161859671|NCT03404674|584527664|FG001|Overall Study|Inability to Attend Future Visits|1|||
161859672|NCT03404674|584527665|FG002|Overall Study|Inability to Attend Future Visits|1|||
161859673|NCT03404674|584527666|FG003|Overall Study|Inability to Attend Future Visits|0|||
161859674|NCT03404674|584527667|FG004|Overall Study|Inability to Attend Future Visits|0|||
161859675|NCT03404674|584527668|FG005|Overall Study|Inability to Attend Future Visits|0|||
161859676|NCT03404674|584527663|FG000|Overall Study|Behavioral Problems|0|||
161859677|NCT03404674|584527664|FG001|Overall Study|Behavioral Problems|0|||
161859678|NCT03404674|584527665|FG002|Overall Study|Behavioral Problems|1|||
161859679|NCT03404674|584527666|FG003|Overall Study|Behavioral Problems|0|||
161859680|NCT03404674|584527667|FG004|Overall Study|Behavioral Problems|0|||
161859681|NCT03404674|584527668|FG005|Overall Study|Behavioral Problems|0|||
161859682|NCT03404674|584527663|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859683|NCT03404674|584527664|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859684|NCT03404674|584527665|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859685|NCT03404674|584527666|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
161859686|NCT03404674|584527667|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859687|NCT03404674|584527668|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
161859688|NCT01841593|584527673|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
161859689|NCT01841593|584527674|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
161859690|NCT01841593|584527673|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
161859691|NCT01841593|584527674|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
161859692|NCT02635984|584527675|FG000|Overall Study|Lost to Follow-up|2|||
161859693|NCT02635984|584527676|FG001|Overall Study|Lost to Follow-up|4|||
161859694|NCT02635984|584527675|FG000|Overall Study|Study Arm Closed|1|||
161859695|NCT02635984|584527676|FG001|Overall Study|Study Arm Closed|0|||
161859696|NCT00307086|584527677|FG000|Overall Study|ineligible|5|||
161859697|NCT01487525|584527680|FG000|Overall Study|Withdrawal by Subject|0|||
161859698|NCT01487525|584527681|FG001|Overall Study|Withdrawal by Subject|1|||
161859699|NCT03518008|584527682|FG000|Period 2, Second Week of Wear|Family emergency|0|||
161859700|NCT03518008|584527683|FG001|Period 2, Second Week of Wear|Family emergency|1|||
161859701|NCT01329900|584527684|FG000|Overall Study|Elevated creatinine/renal function|1|||
161859702|NCT01855828|584527685|FG000|Overall Study|Adverse Event|1|||
161859703|NCT01855828|584527685|FG000|Overall Study|Withdrawal by Subject|1|||
161859704|NCT01866098|584527690|FG000|Overall Study|Lost to Follow-up|11|||
161859705|NCT01866098|584527691|FG001|Overall Study|Lost to Follow-up|18|||
161859706|NCT01866098|584527692|FG002|Overall Study|Lost to Follow-up|13|||
161859707|NCT01866098|584527690|FG000|Overall Study|Physician Decision|0|||
161859708|NCT01866098|584527691|FG001|Overall Study|Physician Decision|1|||
161859709|NCT01866098|584527692|FG002|Overall Study|Physician Decision|2|||
161859710|NCT01866098|584527690|FG000|Overall Study|Adverse Event|1|||
161859711|NCT01866098|584527691|FG001|Overall Study|Adverse Event|5|||
161859712|NCT01866098|584527692|FG002|Overall Study|Adverse Event|4|||
161859713|NCT01866098|584527690|FG000|Overall Study|Protocol Violation|1|||
161859714|NCT01866098|584527691|FG001|Overall Study|Protocol Violation|0|||
161859715|NCT01866098|584527692|FG002|Overall Study|Protocol Violation|0|||
161859716|NCT01866098|584527690|FG000|Overall Study|Withdrawal by Subject|1|||
161859717|NCT01866098|584527691|FG001|Overall Study|Withdrawal by Subject|2|||
161859718|NCT01866098|584527692|FG002|Overall Study|Withdrawal by Subject|0|||
161859719|NCT01866098|584527690|FG000|Overall Study|Unrelated Hospitalization|2|||
161859720|NCT01866098|584527691|FG001|Overall Study|Unrelated Hospitalization|0|||
161859721|NCT01866098|584527692|FG002|Overall Study|Unrelated Hospitalization|1|||
161859722|NCT01866098|584527690|FG000|Overall Study|Non-compliance|1|||
161859723|NCT01866098|584527691|FG001|Overall Study|Non-compliance|0|||
161859724|NCT01866098|584527692|FG002|Overall Study|Non-compliance|1|||
161859725|NCT01866098|584527690|FG000|Overall Study|Pregnancy|2|||
161859726|NCT01866098|584527691|FG001|Overall Study|Pregnancy|0|||
161859727|NCT01866098|584527692|FG002|Overall Study|Pregnancy|0|||
161859728|NCT01866098|584527690|FG000|Overall Study|Death|0|||
161770743|NCT03329404|584202246|FG001|Overall Study|The study was suspended.|4|||
161770744|NCT00796367|584202250|FG000|Overall Study|Adverse Event|6|||
161770745|NCT00796367|584202251|FG001|Overall Study|Adverse Event|4|||
161770746|NCT00796367|584202252|FG002|Overall Study|Adverse Event|7|||
161770747|NCT00796367|584202250|FG000|Overall Study|Lost to Follow-up|5|||
161770748|NCT00796367|584202251|FG001|Overall Study|Lost to Follow-up|4|||
161770749|NCT00796367|584202252|FG002|Overall Study|Lost to Follow-up|21|||
161770750|NCT00796367|584202250|FG000|Overall Study|Withdrawal by Subject|9|||
161770751|NCT00796367|584202251|FG001|Overall Study|Withdrawal by Subject|11|||
161770752|NCT00796367|584202252|FG002|Overall Study|Withdrawal by Subject|12|||
161770753|NCT00796367|584202250|FG000|Overall Study|Lack of Efficacy|2|||
161770754|NCT00796367|584202251|FG001|Overall Study|Lack of Efficacy|1|||
161770755|NCT00796367|584202252|FG002|Overall Study|Lack of Efficacy|0|||
161770756|NCT00796367|584202250|FG000|Overall Study|non compliance|3|||
161770757|NCT00796367|584202251|FG001|Overall Study|non compliance|1|||
161770758|NCT00796367|584202252|FG002|Overall Study|non compliance|1|||
161770759|NCT00796367|584202250|FG000|Overall Study|Pregnancy|1|||
161770760|NCT00796367|584202251|FG001|Overall Study|Pregnancy|0|||
161770761|NCT00796367|584202252|FG002|Overall Study|Pregnancy|1|||
161770762|NCT00796367|584202250|FG000|Overall Study|Requirement for restricted medication|2|||
161770763|NCT00796367|584202251|FG001|Overall Study|Requirement for restricted medication|0|||
161770764|NCT00796367|584202252|FG002|Overall Study|Requirement for restricted medication|2|||
161770765|NCT00796367|584202250|FG000|Overall Study|other|2|||
161770766|NCT00796367|584202251|FG001|Overall Study|other|4|||
161770767|NCT00796367|584202252|FG002|Overall Study|other|3|||
161770768|NCT01463631|584202253|FG000|Overall Study|Withdrawal by Subject|0|||
161770769|NCT01463631|584202254|FG001|Overall Study|Withdrawal by Subject|0|||
161770770|NCT01463631|584202255|FG002|Overall Study|Withdrawal by Subject|0|||
161770771|NCT01463631|584202256|FG003|Overall Study|Withdrawal by Subject|1|||
161770772|NCT01463631|584202253|FG000|Overall Study|Death|0|||
161770773|NCT01463631|584202254|FG001|Overall Study|Death|0|||
161770774|NCT01463631|584202255|FG002|Overall Study|Death|1|||
161770775|NCT01463631|584202256|FG003|Overall Study|Death|0|||
161770776|NCT01463631|584202253|FG000|Overall Study|Progressive Disease|0|||
161770777|NCT01463631|584202254|FG001|Overall Study|Progressive Disease|0|||
161770778|NCT01463631|584202255|FG002|Overall Study|Progressive Disease|0|||
161770779|NCT01463631|584202256|FG003|Overall Study|Progressive Disease|5|||
161770780|NCT04604015|584202265|FG000|Overall Study|Incomplete Data Collection|33|||
161770781|NCT01314261|584202266|FG000|Overall Study|Adverse Event|1|||
161770782|NCT01314261|584202267|FG001|Overall Study|Adverse Event|0|||
161770783|NCT01314261|584202268|FG002|Overall Study|Adverse Event|0|||
161770784|NCT01314261|584202269|FG003|Overall Study|Adverse Event|0|||
161770785|NCT01314261|584202266|FG000|Overall Study|Withdrawal by Subject|0|||
161770786|NCT01314261|584202267|FG001|Overall Study|Withdrawal by Subject|3|||
161770787|NCT01314261|584202268|FG002|Overall Study|Withdrawal by Subject|1|||
161770788|NCT01314261|584202269|FG003|Overall Study|Withdrawal by Subject|0|||
161770789|NCT01314261|584202266|FG000|Overall Study|Lost to Follow-up|1|||
161770790|NCT01314261|584202267|FG001|Overall Study|Lost to Follow-up|0|||
161770791|NCT01314261|584202268|FG002|Overall Study|Lost to Follow-up|2|||
161770792|NCT01314261|584202269|FG003|Overall Study|Lost to Follow-up|2|||
161770793|NCT01314261|584202266|FG000|Overall Study|Virologic Failure|0|||
161859729|NCT01866098|584527691|FG001|Overall Study|Death|1|||
161770794|NCT01314261|584202267|FG001|Overall Study|Virologic Failure|1|||
161770795|NCT01314261|584202268|FG002|Overall Study|Virologic Failure|0|||
161770796|NCT01314261|584202269|FG003|Overall Study|Virologic Failure|1|||
161770797|NCT02129192|584202270|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
161859730|NCT01866098|584527692|FG002|Overall Study|Death|0|||
161859731|NCT04239027|584527696|FG000|Overall Study|Adverse Event|4|||
161859732|NCT04239027|584527696|FG000|Overall Study|Withdrawal by Subject|9|||
161770798|NCT02129192|584202271|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
161859733|NCT04239027|584527696|FG000|Overall Study|Death|1|||
161770799|NCT01231620|584202272|FG000|Overall Study|Physician Decision|3|||
161770800|NCT01231620|584202273|FG001|Overall Study|Physician Decision|5|||
161770801|NCT01231620|584202274|FG002|Overall Study|Physician Decision|10|||
161770802|NCT01231620|584202272|FG000|Overall Study|Death|12|||
161770803|NCT01231620|584202273|FG001|Overall Study|Death|14|||
161770804|NCT01231620|584202274|FG002|Overall Study|Death|11|||
161770805|NCT01231620|584202272|FG000|Overall Study|Adverse Event|2|||
161770806|NCT01231620|584202273|FG001|Overall Study|Adverse Event|2|||
161770807|NCT01231620|584202274|FG002|Overall Study|Adverse Event|1|||
161770808|NCT01231620|584202272|FG000|Overall Study|Withdrawal by Subject|6|||
161770809|NCT01231620|584202273|FG001|Overall Study|Withdrawal by Subject|6|||
161770810|NCT01231620|584202274|FG002|Overall Study|Withdrawal by Subject|8|||
161770811|NCT01231620|584202272|FG000|Overall Study|Lost to Follow-up|3|||
161770812|NCT01231620|584202273|FG001|Overall Study|Lost to Follow-up|4|||
161770813|NCT01231620|584202274|FG002|Overall Study|Lost to Follow-up|9|||
161770814|NCT04557189|584202288|FG000|Overall Study|Adverse Event|0|||
161770815|NCT04557189|584202289|FG001|Overall Study|Adverse Event|1|||
161770816|NCT04557189|584202288|FG000|Overall Study|Lost to Follow-up|1|||
161770817|NCT04557189|584202289|FG001|Overall Study|Lost to Follow-up|1|||
161770818|NCT04557189|584202288|FG000|Overall Study|Withdrawal by Subject|2|||
161770819|NCT04557189|584202289|FG001|Overall Study|Withdrawal by Subject|1|||
161770820|NCT04557189|584202288|FG000|Overall Study|Reason not Specified|3|||
161770821|NCT04557189|584202289|FG001|Overall Study|Reason not Specified|6|||
161770822|NCT03590613|584202290|FG000|Period 2, 4 Days|Physician Decision|0|||
161770823|NCT03590613|584202291|FG001|Period 2, 4 Days|Physician Decision|0|||
161770824|NCT03590613|584202292|FG002|Period 2, 4 Days|Physician Decision|0|||
161770825|NCT03590613|584202293|FG003|Period 2, 4 Days|Physician Decision|1|||
161770826|NCT03575975|584202295|FG000|Overall Study|Lost to Follow-up|1|||
161770827|NCT03575975|584202296|FG001|Overall Study|Lost to Follow-up|0|||
161770828|NCT03575975|584202297|FG002|Overall Study|Lost to Follow-up|0|||
161770829|NCT02441517|584202298|FG000|Overall Study|Lost to Follow-up|1|||
161770830|NCT02441517|584202298|FG000|Overall Study|Withdrawal by Subject|2|||
161770831|NCT02441517|584202298|FG000|Overall Study|Study Terminated by Sponsor|1|||
161770832|NCT00129220|584202300|FG000|Study Period II|Adverse Event|9|||
161770833|NCT00129220|584202301|FG001|Study Period II|Adverse Event|5|||
161770834|NCT00129220|584202302|FG002|Study Period II|Adverse Event|7|||
161770835|NCT00129220|584202300|FG000|Study Period II|Lack of Efficacy|15|||
161770836|NCT00129220|584202301|FG001|Study Period II|Lack of Efficacy|1|||
161770837|NCT00129220|584202302|FG002|Study Period II|Lack of Efficacy|28|||
161770838|NCT00129220|584202300|FG000|Study Period II|Entry Criteria Not Met|2|||
161770839|NCT00129220|584202301|FG001|Study Period II|Entry Criteria Not Met|0|||
161770840|NCT00129220|584202302|FG002|Study Period II|Entry Criteria Not Met|2|||
161770841|NCT00129220|584202300|FG000|Study Period II|Protocol Violation|4|||
161770842|NCT00129220|584202301|FG001|Study Period II|Protocol Violation|2|||
161770843|NCT00129220|584202302|FG002|Study Period II|Protocol Violation|1|||
161770844|NCT00129220|584202300|FG000|Study Period II|Physician Decision|0|||
161770845|NCT00129220|584202301|FG001|Study Period II|Physician Decision|1|||
161770846|NCT00129220|584202302|FG002|Study Period II|Physician Decision|0|||
161770847|NCT00129220|584202300|FG000|Study Period II|Withdrawal by Subject|1|||
161770848|NCT00129220|584202301|FG001|Study Period II|Withdrawal by Subject|3|||
161770849|NCT00129220|584202302|FG002|Study Period II|Withdrawal by Subject|4|||
161770850|NCT00129220|584202300|FG000|Study Period II|Reason Not Specified|2|||
161770851|NCT00129220|584202301|FG001|Study Period II|Reason Not Specified|0|||
161770852|NCT00129220|584202302|FG002|Study Period II|Reason Not Specified|5|||
161770853|NCT00129220|584202300|FG000|Study Period III|Adverse Event|1|||
161770854|NCT00129220|584202301|FG001|Study Period III|Adverse Event|0|||
161770855|NCT00129220|584202302|FG002|Study Period III|Adverse Event|3|||
161770856|NCT00129220|584202300|FG000|Study Period III|Protocol Violation|1|||
161770857|NCT00129220|584202301|FG001|Study Period III|Protocol Violation|1|||
161770858|NCT00129220|584202302|FG002|Study Period III|Protocol Violation|2|||
161770859|NCT00129220|584202300|FG000|Study Period III|Withdrawal by Subject|1|||
161770860|NCT00129220|584202301|FG001|Study Period III|Withdrawal by Subject|0|||
161770861|NCT00129220|584202302|FG002|Study Period III|Withdrawal by Subject|3|||
161770862|NCT00129220|584202300|FG000|Study Period III|Sponsor Decision|1|||
161770863|NCT00129220|584202301|FG001|Study Period III|Sponsor Decision|0|||
161770864|NCT00129220|584202302|FG002|Study Period III|Sponsor Decision|0|||
161770865|NCT00129220|584202300|FG000|Study Period III|Reason Not Specified|9|||
161770866|NCT00129220|584202301|FG001|Study Period III|Reason Not Specified|0|||
161770867|NCT00129220|584202302|FG002|Study Period III|Reason Not Specified|2|||
161770868|NCT00686894|584202304|FG000|Overall Study|Relapse|2|||
161770869|NCT00686894|584202304|FG000|Overall Study|Protocol Violation|4|||
161770870|NCT01230489|584202305|FG000|Overall Study|Death|2|||
161770871|NCT01230489|584202305|FG000|Overall Study|Adverse Event|2|||
161770872|NCT01230489|584202305|FG000|Overall Study|Treatment modality changed|1|||
161770873|NCT00869362|584204148|FG000|Overall Study|Death|0|||
161770874|NCT00869362|584204149|FG001|Overall Study|Death|2|||
161770875|NCT00869362|584204148|FG000|Overall Study|Lost to Follow-up|1|||
161770876|NCT00869362|584204149|FG001|Overall Study|Lost to Follow-up|3|||
161770877|NCT02815540|584204152|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
161770878|NCT04887922|584204160|FG000|1st Randomization|Decided not to have surgery|0|||
161770879|NCT04887922|584204161|FG001|1st Randomization|Decided not to have surgery|1|||
161770880|NCT04887922|584204162|FG002|1st Randomization|Decided not to have surgery|0|||
161770881|NCT04887922|584204163|FG003|1st Randomization|Decided not to have surgery|0|||
161770882|NCT04887922|584204164|FG004|1st Randomization|Decided not to have surgery|0|||
161770883|NCT00953017|584204165|FG000|Overall Study|DId not show up for colonoscopy|4|||
161770884|NCT00953017|584204166|FG001|Overall Study|DId not show up for colonoscopy|4|||
161770885|NCT00953017|584204167|FG002|Overall Study|DId not show up for colonoscopy|5|||
161770886|NCT00953017|584204168|FG003|Overall Study|DId not show up for colonoscopy|4|||
161770887|NCT00953017|584204165|FG000|Overall Study|Incomplete data|1|||
161770888|NCT00953017|584204166|FG001|Overall Study|Incomplete data|1|||
161770889|NCT00953017|584204167|FG002|Overall Study|Incomplete data|0|||
161770890|NCT00953017|584204168|FG003|Overall Study|Incomplete data|0|||
161770891|NCT00953017|584204165|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
161770892|NCT00953017|584204166|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
161770893|NCT00953017|584204167|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
161770894|NCT00953017|584204168|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
161770895|NCT00953017|584204165|FG000|Overall Study|Brown stool prior to procedure|0|||
161770896|NCT00953017|584204166|FG001|Overall Study|Brown stool prior to procedure|0|||
161770897|NCT00953017|584204167|FG002|Overall Study|Brown stool prior to procedure|1|||
161770898|NCT00953017|584204168|FG003|Overall Study|Brown stool prior to procedure|0|||
161770899|NCT00798161|584204171|FG000|Overall Study|Adverse Event|3|||
161770900|NCT00798161|584204172|FG001|Overall Study|Adverse Event|4|||
161770901|NCT00798161|584204173|FG002|Overall Study|Adverse Event|6|||
161770902|NCT00798161|584204174|FG003|Overall Study|Adverse Event|6|||
161770903|NCT00798161|584204175|FG004|Overall Study|Adverse Event|5|||
161770904|NCT00798161|584204176|FG005|Overall Study|Adverse Event|2|||
161770905|NCT00798161|584204177|FG006|Overall Study|Adverse Event|4|||
161770906|NCT00798161|584204171|FG000|Overall Study|Protocol Violation|2|||
161770907|NCT00798161|584204172|FG001|Overall Study|Protocol Violation|1|||
161770908|NCT00798161|584204173|FG002|Overall Study|Protocol Violation|3|||
161770909|NCT00798161|584204174|FG003|Overall Study|Protocol Violation|3|||
161770910|NCT00798161|584204175|FG004|Overall Study|Protocol Violation|3|||
161770911|NCT00798161|584204176|FG005|Overall Study|Protocol Violation|2|||
161770912|NCT00798161|584204177|FG006|Overall Study|Protocol Violation|0|||
161770913|NCT00798161|584204171|FG000|Overall Study|Lost to Follow-up|1|||
161770914|NCT00798161|584204172|FG001|Overall Study|Lost to Follow-up|3|||
161770915|NCT00798161|584204173|FG002|Overall Study|Lost to Follow-up|4|||
161770916|NCT00798161|584204174|FG003|Overall Study|Lost to Follow-up|3|||
161770917|NCT00798161|584204175|FG004|Overall Study|Lost to Follow-up|4|||
161770918|NCT00798161|584204176|FG005|Overall Study|Lost to Follow-up|0|||
161770919|NCT00798161|584204177|FG006|Overall Study|Lost to Follow-up|0|||
161770920|NCT00798161|584204171|FG000|Overall Study|Withdrawal by Subject|5|||
161770921|NCT00798161|584204172|FG001|Overall Study|Withdrawal by Subject|4|||
161770922|NCT00798161|584204173|FG002|Overall Study|Withdrawal by Subject|5|||
161770923|NCT00798161|584204174|FG003|Overall Study|Withdrawal by Subject|4|||
161770924|NCT00798161|584204175|FG004|Overall Study|Withdrawal by Subject|2|||
161770925|NCT00798161|584204176|FG005|Overall Study|Withdrawal by Subject|3|||
161770926|NCT00798161|584204177|FG006|Overall Study|Withdrawal by Subject|1|||
161770927|NCT00798161|584204171|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
161770928|NCT00798161|584204172|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
161770929|NCT00798161|584204173|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
161770930|NCT00798161|584204174|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
161770931|NCT00798161|584204175|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
161770932|NCT00798161|584204176|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
161770933|NCT00798161|584204177|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
161770934|NCT00594568|584204178|FG000|Initial Treatment|Adverse Event|51|||
161770935|NCT00594568|584204179|FG001|Initial Treatment|Adverse Event|121|||
161770936|NCT00594568|584204180|FG002|Initial Treatment|Adverse Event|144|||
161770937|NCT00594568|584204178|FG000|Initial Treatment|Death|6|||
161770938|NCT00594568|584204179|FG001|Initial Treatment|Death|11|||
161770939|NCT00594568|584204180|FG002|Initial Treatment|Death|15|||
161770940|NCT00594568|584204178|FG000|Initial Treatment|Lost to Follow-up|4|||
161770941|NCT00594568|584204179|FG001|Initial Treatment|Lost to Follow-up|1|||
161770942|NCT00594568|584204180|FG002|Initial Treatment|Lost to Follow-up|4|||
161770943|NCT00594568|584204178|FG000|Initial Treatment|Physician Decision|3|||
161770944|NCT00594568|584204179|FG001|Initial Treatment|Physician Decision|2|||
161770945|NCT00594568|584204180|FG002|Initial Treatment|Physician Decision|4|||
161770946|NCT00594568|584204178|FG000|Initial Treatment|Protocol Violation|2|||
161770947|NCT00594568|584204179|FG001|Initial Treatment|Protocol Violation|2|||
161770948|NCT00594568|584204180|FG002|Initial Treatment|Protocol Violation|5|||
161770949|NCT00594568|584204178|FG000|Initial Treatment|Withdrawal by Subject|25|||
161770950|NCT00594568|584204179|FG001|Initial Treatment|Withdrawal by Subject|31|||
161770951|NCT00594568|584204180|FG002|Initial Treatment|Withdrawal by Subject|46|||
161770952|NCT00594568|584204178|FG000|Initial Treatment|Sponsor decision|193|||
161770953|NCT00594568|584204179|FG001|Initial Treatment|Sponsor decision|142|||
161770954|NCT00594568|584204180|FG002|Initial Treatment|Sponsor decision|147|||
161770955|NCT00594568|584204178|FG000|Initial Treatment|Caregiver decision|21|||
161770956|NCT00594568|584204179|FG001|Initial Treatment|Caregiver decision|36|||
161859734|NCT04239027|584527696|FG000|Overall Study|Physician Decision|9|||
161859735|NCT04239027|584527696|FG000|Overall Study|Lost to Follow-up|2|||
161859736|NCT04239027|584527696|FG000|Overall Study|Lack of Efficacy|1|||
161859737|NCT01256502|584527707|FG000|Overall Study|Had scaffold removed|4|||
161859738|NCT01256502|584527707|FG000|Overall Study|Personal reasons|5|||
161859739|NCT01256502|584527707|FG000|Overall Study|Protocol deviation|1|||
161859740|NCT01523002|584527708|FG000|Period 1|Withdrawal by Subject|1|||
161859741|NCT01523002|584527709|FG001|Period 1|Withdrawal by Subject|3|||
161859742|NCT01523002|584527708|FG000|Period 1|Lost to Follow-up|1|||
161770957|NCT00594568|584204180|FG002|Initial Treatment|Caregiver decision|36|||
161770958|NCT00594568|584204178|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
161770959|NCT00594568|584204179|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
161770960|NCT00594568|584204180|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
161770961|NCT00594568|584204178|FG000|Initial Treatment|Entry criteria exclusion|0|||
161770962|NCT00594568|584204179|FG001|Initial Treatment|Entry criteria exclusion|1|||
161770963|NCT00594568|584204180|FG002|Initial Treatment|Entry criteria exclusion|1|||
161770964|NCT00594568|584204178|FG000|Delayed Start|Death|0|||
161770965|NCT00594568|584204179|FG001|Delayed Start|Death|0|||
161770966|NCT00594568|584204180|FG002|Delayed Start|Death|1|||
161770967|NCT00594568|584204178|FG000|Delayed Start|Adverse Event|12|||
161770968|NCT00594568|584204179|FG001|Delayed Start|Adverse Event|2|||
161770969|NCT00594568|584204180|FG002|Delayed Start|Adverse Event|2|||
161770970|NCT00594568|584204178|FG000|Delayed Start|Withdrawal by Subject|4|||
161770971|NCT00594568|584204179|FG001|Delayed Start|Withdrawal by Subject|3|||
161770972|NCT00594568|584204180|FG002|Delayed Start|Withdrawal by Subject|0|||
161770973|NCT00594568|584204178|FG000|Delayed Start|Physician Decision|0|||
161770974|NCT00594568|584204179|FG001|Delayed Start|Physician Decision|0|||
161770975|NCT00594568|584204180|FG002|Delayed Start|Physician Decision|1|||
161770976|NCT00594568|584204178|FG000|Delayed Start|Lost to Follow-up|0|||
161770977|NCT00594568|584204179|FG001|Delayed Start|Lost to Follow-up|0|||
161770978|NCT00594568|584204180|FG002|Delayed Start|Lost to Follow-up|1|||
161770979|NCT00594568|584204178|FG000|Delayed Start|Caregiver Decision|5|||
161770980|NCT00594568|584204179|FG001|Delayed Start|Caregiver Decision|6|||
161770981|NCT00594568|584204180|FG002|Delayed Start|Caregiver Decision|2|||
161770982|NCT00594568|584204178|FG000|Delayed Start|Sponsor Decision|77|||
161770983|NCT00594568|584204179|FG001|Delayed Start|Sponsor Decision|66|||
161770984|NCT00594568|584204180|FG002|Delayed Start|Sponsor Decision|59|||
161770985|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
161770986|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
161770987|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
161770988|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
161770989|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161770990|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161770991|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
161770992|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
161770993|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
161859743|NCT01523002|584527709|FG001|Period 1|Lost to Follow-up|0|||
161859744|NCT01523002|584527708|FG000|Period 1|Adverse Event|0|||
161859745|NCT01523002|584527709|FG001|Period 1|Adverse Event|8|||
161859746|NCT01523002|584527708|FG000|Period 2|Withdrawal by Subject|4|||
161859747|NCT01523002|584527709|FG001|Period 2|Withdrawal by Subject|1|||
161859748|NCT01523002|584527708|FG000|Period 2|Adverse Event|2|||
161859749|NCT01523002|584527709|FG001|Period 2|Adverse Event|5|||
161859750|NCT01523002|584527708|FG000|Period 3|Withdrawal by Subject|1|||
161859751|NCT01523002|584527709|FG001|Period 3|Withdrawal by Subject|0|||
161859752|NCT01523002|584527708|FG000|Period 3|Adverse Event|3|||
161859753|NCT01523002|584527709|FG001|Period 3|Adverse Event|0|||
161859754|NCT03953612|584527710|FG000|Overall Study|Randomized but did not start|1|||
161859755|NCT03953612|584527711|FG001|Overall Study|Randomized but did not start|1|||
161859756|NCT03953612|584527712|FG002|Overall Study|Randomized but did not start|1|||
161859757|NCT03953612|584527710|FG000|Overall Study|Withdrawal by Subject|2|||
161859758|NCT03953612|584527711|FG001|Overall Study|Withdrawal by Subject|1|||
161859759|NCT03953612|584527712|FG002|Overall Study|Withdrawal by Subject|0|||
161859760|NCT00489255|584527713|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
161859761|NCT00489255|584527714|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
161859762|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
161859763|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
161859764|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
161859765|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
161859766|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
161859767|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
161859768|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
161859769|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
161859770|NCT00489255|584527713|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
161859771|NCT00489255|584527714|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
161859772|NCT00489255|584527713|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
161859773|NCT00489255|584527714|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
161859774|NCT00489255|584527713|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
161859775|NCT00489255|584527714|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
161859776|NCT00489255|584527713|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
161859777|NCT00489255|584527714|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
161859778|NCT00489255|584527713|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
161859779|NCT00489255|584527714|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
161859780|NCT03485352|584527715|FG000|Overall Study|Lost to Follow-up|9|||
161859781|NCT01982955|584527717|FG000|Overall Study|Randomized but not treated|0|||
161859782|NCT01982955|584527718|FG001|Overall Study|Randomized but not treated|0|||
161859783|NCT01982955|584527719|FG002|Overall Study|Randomized but not treated|0|||
161859784|NCT01982955|584527720|FG003|Overall Study|Randomized but not treated|1|||
161859785|NCT01982955|584527721|FG004|Overall Study|Randomized but not treated|0|||
161859786|NCT02548143|584527726|FG000|Overall Study|Adverse Event|1|||
161859787|NCT02548143|584527727|FG001|Overall Study|Adverse Event|0|||
161859788|NCT02548143|584527726|FG000|Overall Study|Withdrawal by Subject|0|||
161859789|NCT02548143|584527727|FG001|Overall Study|Withdrawal by Subject|1|||
161859790|NCT05655546|584529564|FG000|Overall Study|Withdrawal by Subject|2|||
161859791|NCT05655546|584529565|FG001|Overall Study|Withdrawal by Subject|4|||
161859792|NCT03493685|584529566|FG000|Overall Study|Death|4|||
161859793|NCT03493685|584529567|FG001|Overall Study|Death|3|||
161859794|NCT03493685|584529566|FG000|Overall Study|Lost to Follow-up|3|||
161859795|NCT03493685|584529567|FG001|Overall Study|Lost to Follow-up|2|||
161859796|NCT03493685|584529566|FG000|Overall Study|Physician Decision|2|||
161859797|NCT03493685|584529567|FG001|Overall Study|Physician Decision|0|||
161859798|NCT03493685|584529566|FG000|Overall Study|Withdrawal by Subject|7|||
161859799|NCT03493685|584529567|FG001|Overall Study|Withdrawal by Subject|11|||
161859800|NCT04452669|584529568|FG000|Overall Study|Death|1|||
161859801|NCT04452669|584529569|FG001|Overall Study|Death|4|||
161859802|NCT04576507|584529573|FG000|Overall Study|Adverse Event|4|||
161859803|NCT04576507|584529573|FG000|Overall Study|Withdrawal by Subject|1|||
161859804|NCT00413699|584529574|FG000|Initial Period|Death|25|||
161859805|NCT00413699|584529575|FG001|Initial Period|Death|30|||
161859806|NCT00413699|584529576|FG002|Initial Period|Death|0|||
161859807|NCT00413699|584529574|FG000|Initial Period|Lack of Efficacy|59|||
161859808|NCT00413699|584529575|FG001|Initial Period|Lack of Efficacy|115|||
161859809|NCT00413699|584529576|FG002|Initial Period|Lack of Efficacy|0|||
161859810|NCT00413699|584529574|FG000|Initial Period|Lost to Follow-up|31|||
161859811|NCT00413699|584529575|FG001|Initial Period|Lost to Follow-up|101|||
161859812|NCT00413699|584529576|FG002|Initial Period|Lost to Follow-up|0|||
161859813|NCT00413699|584529574|FG000|Initial Period|Protocol Violation|38|||
161859814|NCT00413699|584529575|FG001|Initial Period|Protocol Violation|89|||
161859815|NCT00413699|584529576|FG002|Initial Period|Protocol Violation|0|||
161859816|NCT00413699|584529574|FG000|Initial Period|Pregnancy|10|||
161770994|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
161770995|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
161770996|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
161770997|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
161770998|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
161770999|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
161771000|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
161771001|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
161771002|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
161771003|NCT01366846|584204184|FG000|Overall Study|Withdrawal by Subject|2|||
161771004|NCT01366846|584204185|FG001|Overall Study|Withdrawal by Subject|0|||
161771005|NCT01366846|584204186|FG002|Overall Study|Withdrawal by Subject|0|||
161771006|NCT01366846|584204187|FG003|Overall Study|Withdrawal by Subject|0|||
161771007|NCT01366846|584204184|FG000|Overall Study|Communication Difficulties|1|||
161771008|NCT01366846|584204185|FG001|Overall Study|Communication Difficulties|4|||
161771009|NCT01366846|584204186|FG002|Overall Study|Communication Difficulties|0|||
161771010|NCT01366846|584204187|FG003|Overall Study|Communication Difficulties|1|||
161771011|NCT01366846|584204184|FG000|Overall Study|Scheduling Conflicts|0|||
161771012|NCT01366846|584204185|FG001|Overall Study|Scheduling Conflicts|0|||
161771013|NCT01366846|584204186|FG002|Overall Study|Scheduling Conflicts|1|||
161771014|NCT01366846|584204187|FG003|Overall Study|Scheduling Conflicts|0|||
161771015|NCT00290511|584204188|FG000|Overall Study|Adverse Event|1|||
161771016|NCT00290511|584204188|FG000|Overall Study|Death|1|||
161771017|NCT00290511|584204188|FG000|Overall Study|Physician Decision|1|||
161771018|NCT00290511|584204188|FG000|Overall Study|Withdrawal by Subject|1|||
161771019|NCT04341727|584204193|FG000|Overall Study|Withdrawal by Subject|0|||
161771020|NCT04341727|584204194|FG001|Overall Study|Withdrawal by Subject|0|||
161771021|NCT04341727|584204195|FG002|Overall Study|Withdrawal by Subject|1|||
161771022|NCT04341727|584204196|FG003|Overall Study|Withdrawal by Subject|0|||
161771023|NCT04341727|584204193|FG000|Overall Study|Lost to Follow-up|0|||
161771024|NCT04341727|584204194|FG001|Overall Study|Lost to Follow-up|0|||
161771025|NCT04341727|584204195|FG002|Overall Study|Lost to Follow-up|0|||
161771026|NCT04341727|584204196|FG003|Overall Study|Lost to Follow-up|1|||
161771027|NCT00447265|584204197|FG000|Overall Study|Physician Decision|1|||
161771028|NCT00447265|584204198|FG001|Overall Study|Physician Decision|0|||
161771029|NCT00503035|584204199|FG000|Overall Study|Lost to Follow-up|2|||
161771030|NCT00503035|584204199|FG000|Overall Study|Physician Decision|3|||
161771031|NCT00503035|584204199|FG000|Overall Study|Ineligible|15|||
161771032|NCT04311411|584204202|FG000|Overall Study|Adverse Event|2|||
161771033|NCT04311411|584204203|FG001|Overall Study|Adverse Event|3|||
161771034|NCT04311411|584204204|FG002|Overall Study|Adverse Event|2|||
161771035|NCT04311411|584204202|FG000|Overall Study|Withdrawal by Subject|3|||
161771036|NCT04311411|584204203|FG001|Overall Study|Withdrawal by Subject|3|||
161771037|NCT04311411|584204204|FG002|Overall Study|Withdrawal by Subject|0|||
161771038|NCT01976663|584204208|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
161771039|NCT01976663|584204208|FG000|Overall Study|Personal Reasons|6|||
161771040|NCT01976663|584204208|FG000|Overall Study|Withdrawal by Subject|4|||
161771041|NCT01976663|584204208|FG000|Overall Study|Screen Failure|3|||
161771042|NCT01976663|584204208|FG000|Overall Study|Adverse Event|2|||
161771043|NCT01976663|584204208|FG000|Overall Study|Lost to Follow-up|3|||
161771044|NCT05028816|584204209|FG000|Overall Study|Lost to Follow-up|5|||
161771045|NCT05028816|584204210|FG001|Overall Study|Lost to Follow-up|3|||
161771046|NCT05028816|584204209|FG000|Overall Study|Withdrawal by Subject|4|||
161771047|NCT05028816|584204210|FG001|Overall Study|Withdrawal by Subject|1|||
161771048|NCT05028816|584204209|FG000|Overall Study|Physician Decision|1|||
161771049|NCT05028816|584204210|FG001|Overall Study|Physician Decision|0|||
161771050|NCT04780776|584204216|FG000|Titration Week 1-5|Lost to Follow-up|2|||
161771051|NCT04780776|584204217|FG001|Titration Week 1-5|Lost to Follow-up|8|||
161771052|NCT04780776|584204216|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
161771053|NCT04780776|584204217|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
161771054|NCT04780776|584204216|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
161771055|NCT04780776|584204217|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
161771056|NCT03113760|584204219|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
161771057|NCT03113760|584204220|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161771058|NCT03113760|584204221|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161771059|NCT03113760|584204222|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161771060|NCT03113760|584204219|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
161771061|NCT03113760|584204220|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161771062|NCT03113760|584204221|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161771063|NCT03113760|584204222|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161771064|NCT03113760|584204219|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
161771065|NCT03113760|584204220|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
161771066|NCT03113760|584204221|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
161771067|NCT03113760|584204222|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
161859817|NCT00413699|584529575|FG001|Initial Period|Pregnancy|8|||
161859818|NCT00413699|584529576|FG002|Initial Period|Pregnancy|0|||
161859819|NCT00413699|584529574|FG000|Initial Period|Did not meet entrance criteria|2|||
161859820|NCT00413699|584529575|FG001|Initial Period|Did not meet entrance criteria|2|||
161859821|NCT00413699|584529576|FG002|Initial Period|Did not meet entrance criteria|0|||
161859822|NCT00413699|584529574|FG000|Initial Period|Medication error without adverse event|0|||
161859823|NCT00413699|584529575|FG001|Initial Period|Medication error without adverse event|1|||
161859824|NCT00413699|584529576|FG002|Initial Period|Medication error without adverse event|0|||
161859825|NCT00413699|584529574|FG000|Initial Period|Study terminated by Sponsor|0|||
161859826|NCT00413699|584529575|FG001|Initial Period|Study terminated by Sponsor|1|||
161859827|NCT00413699|584529576|FG002|Initial Period|Study terminated by Sponsor|0|||
161859828|NCT00413699|584529574|FG000|Initial Period|Other|67|||
161859829|NCT00413699|584529575|FG001|Initial Period|Other|211|||
161859830|NCT00413699|584529576|FG002|Initial Period|Other|0|||
161859831|NCT00413699|584529574|FG000|Initial Period|Adverse event related to study drug|178|||
161859832|NCT00413699|584529575|FG001|Initial Period|Adverse event related to study drug|527|||
161859833|NCT00413699|584529576|FG002|Initial Period|Adverse event related to study drug|0|||
161859834|NCT00413699|584529574|FG000|Initial Period|Adverse event not related to study drug|113|||
161859835|NCT00413699|584529575|FG001|Initial Period|Adverse event not related to study drug|248|||
161859836|NCT00413699|584529576|FG002|Initial Period|Adverse event not related to study drug|0|||
161859837|NCT00413699|584529574|FG000|Initial Period|Missing end of study page|0|||
161859838|NCT00413699|584529575|FG001|Initial Period|Missing end of study page|4|||
161859839|NCT00413699|584529576|FG002|Initial Period|Missing end of study page|0|||
161859840|NCT00413699|584529574|FG000|Initial Period|No longer willing to participate|116|||
161859841|NCT00413699|584529575|FG001|Initial Period|No longer willing to participate|368|||
161859842|NCT00413699|584529576|FG002|Initial Period|No longer willing to participate|0|||
161859843|NCT00413699|584529574|FG000|Extension Period|No Longer Willing to Participate|0|||
161859844|NCT00413699|584529575|FG001|Extension Period|No Longer Willing to Participate|0|||
161859845|NCT00413699|584529576|FG002|Extension Period|No Longer Willing to Participate|2|||
161859846|NCT00413699|584529574|FG000|Extension Period|Protocol Violation|0|||
161859847|NCT00413699|584529575|FG001|Extension Period|Protocol Violation|0|||
161859848|NCT00413699|584529576|FG002|Extension Period|Protocol Violation|1|||
161859849|NCT00413699|584529574|FG000|Extension Period|Adverse Event|0|||
161859850|NCT00413699|584529575|FG001|Extension Period|Adverse Event|0|||
161859851|NCT00413699|584529576|FG002|Extension Period|Adverse Event|2|||
161859852|NCT02115269|584529578|FG000|Overall Study|Lost to Follow-up|43|||
161859853|NCT02115269|584529578|FG000|Overall Study|Did not complete patient diary|3|||
161859854|NCT02115269|584529578|FG000|Overall Study|Moved to another city|7|||
161859855|NCT02115269|584529578|FG000|Overall Study|Withdrawal by Subject|2|||
161859856|NCT02115269|584529578|FG000|Overall Study|Didn't take study drug|2|||
161859857|NCT05989672|584529579|FG000|Overall Study|Adverse Event|3|||
161859858|NCT05989672|584529580|FG001|Overall Study|Adverse Event|0|||
161859859|NCT05989672|584529581|FG002|Overall Study|Adverse Event|0|||
161859860|NCT03511105|584529582|FG000|Overall Study|Adverse Event|1|||
161859861|NCT03511105|584529583|FG001|Overall Study|Adverse Event|0|||
161859862|NCT03511105|584529582|FG000|Overall Study|Withdrew consent|1|||
161859863|NCT03511105|584529583|FG001|Overall Study|Withdrew consent|0|||
161859864|NCT02810457|584529584|FG000|Overall Study|Randomised but no treatment received|2|||
161859865|NCT02810457|584529585|FG001|Overall Study|Randomised but no treatment received|1|||
161859866|NCT02810457|584529584|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
161859867|NCT02810457|584529585|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
161859868|NCT02810457|584529584|FG000|Overall Study|Adverse Event|37|||
161859869|NCT02810457|584529585|FG001|Overall Study|Adverse Event|43|||
161859870|NCT02810457|584529584|FG000|Overall Study|Patient decision|31|||
161859871|NCT02810457|584529585|FG001|Overall Study|Patient decision|35|||
161859872|NCT02810457|584529584|FG000|Overall Study|Patient lost to follow-up|2|||
161859873|NCT02810457|584529585|FG001|Overall Study|Patient lost to follow-up|2|||
161859874|NCT02810457|584529584|FG000|Overall Study|Death|39|||
161859875|NCT02810457|584529585|FG001|Overall Study|Death|28|||
161859876|NCT02810457|584529584|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
161859877|NCT02810457|584529585|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
161859878|NCT02810457|584529584|FG000|Overall Study|Clinical progression|15|||
161859879|NCT02810457|584529585|FG001|Overall Study|Clinical progression|16|||
161859880|NCT02810457|584529584|FG000|Overall Study|Investigator decision|3|||
161859881|NCT02810457|584529585|FG001|Overall Study|Investigator decision|2|||
161859882|NCT02810457|584529584|FG000|Overall Study|Patient ineligibility|3|||
161859883|NCT02810457|584529585|FG001|Overall Study|Patient ineligibility|0|||
161859884|NCT02810457|584529584|FG000|Overall Study|Miscalculated PD|1|||
161859885|NCT02810457|584529585|FG001|Overall Study|Miscalculated PD|0|||
161859886|NCT02810457|584529584|FG000|Overall Study|Physician Decision|0|||
161859887|NCT02810457|584529585|FG001|Overall Study|Physician Decision|1|||
161859888|NCT01962103|584529586|FG000|Phase 1|Adverse Event|4|||
161859889|NCT01962103|584529587|FG001|Phase 1|Adverse Event|0|||
161859890|NCT01962103|584529588|FG002|Phase 1|Adverse Event|2|||
161859891|NCT01962103|584529589|FG003|Phase 1|Adverse Event|1|||
161859892|NCT01962103|584529590|FG004|Phase 1|Adverse Event|2|||
161859893|NCT01962103|584529591|FG005|Phase 1|Adverse Event|2|||
161859894|NCT01962103|584529592|FG006|Phase 1|Adverse Event|0|||
161859895|NCT01962103|584529593|FG007|Phase 1|Adverse Event|0|||
161859896|NCT01962103|584529594|FG008|Phase 1|Adverse Event|0|||
161859897|NCT01962103|584529586|FG000|Phase 1|Progressive Disease|8|||
161859898|NCT01962103|584529587|FG001|Phase 1|Progressive Disease|6|||
161859899|NCT01962103|584529588|FG002|Phase 1|Progressive Disease|8|||
161859900|NCT01962103|584529589|FG003|Phase 1|Progressive Disease|4|||
161859901|NCT01962103|584529590|FG004|Phase 1|Progressive Disease|5|||
161859902|NCT01962103|584529591|FG005|Phase 1|Progressive Disease|4|||
161859903|NCT01962103|584529592|FG006|Phase 1|Progressive Disease|0|||
161859904|NCT01962103|584529593|FG007|Phase 1|Progressive Disease|0|||
161859905|NCT01962103|584529594|FG008|Phase 1|Progressive Disease|0|||
161859906|NCT01962103|584529586|FG000|Phase 1|Withdrawal by Subject|0|||
161859907|NCT01962103|584529587|FG001|Phase 1|Withdrawal by Subject|0|||
161859908|NCT01962103|584529588|FG002|Phase 1|Withdrawal by Subject|0|||
161859909|NCT01962103|584529589|FG003|Phase 1|Withdrawal by Subject|2|||
161859910|NCT01962103|584529590|FG004|Phase 1|Withdrawal by Subject|0|||
161859911|NCT01962103|584529591|FG005|Phase 1|Withdrawal by Subject|0|||
161859912|NCT01962103|584529592|FG006|Phase 1|Withdrawal by Subject|0|||
161859913|NCT01962103|584529593|FG007|Phase 1|Withdrawal by Subject|0|||
161859914|NCT01962103|584529594|FG008|Phase 1|Withdrawal by Subject|0|||
161859915|NCT01962103|584529586|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
161859916|NCT01962103|584529587|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
161859917|NCT01962103|584529588|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
161859918|NCT01962103|584529589|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
161859919|NCT01962103|584529590|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
161859920|NCT01962103|584529591|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
161859921|NCT01962103|584529592|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
161859922|NCT01962103|584529593|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
161859923|NCT01962103|584529594|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
161859924|NCT01962103|584529586|FG000|Phase 1|Physician Decision|0|||
161859925|NCT01962103|584529587|FG001|Phase 1|Physician Decision|0|||
161859926|NCT01962103|584529588|FG002|Phase 1|Physician Decision|0|||
161859927|NCT01962103|584529589|FG003|Phase 1|Physician Decision|1|||
161859928|NCT01962103|584529590|FG004|Phase 1|Physician Decision|0|||
161859929|NCT01962103|584529591|FG005|Phase 1|Physician Decision|0|||
161859930|NCT01962103|584529592|FG006|Phase 1|Physician Decision|0|||
161859931|NCT01962103|584529593|FG007|Phase 1|Physician Decision|0|||
161859932|NCT01962103|584529594|FG008|Phase 1|Physician Decision|0|||
161859933|NCT01962103|584529586|FG000|Phase 1|Symptomatic Deterioration|3|||
161859934|NCT01962103|584529587|FG001|Phase 1|Symptomatic Deterioration|2|||
161859935|NCT01962103|584529588|FG002|Phase 1|Symptomatic Deterioration|2|||
161859936|NCT01962103|584529589|FG003|Phase 1|Symptomatic Deterioration|2|||
161859937|NCT01962103|584529590|FG004|Phase 1|Symptomatic Deterioration|1|||
161859938|NCT01962103|584529591|FG005|Phase 1|Symptomatic Deterioration|1|||
161859939|NCT01962103|584529592|FG006|Phase 1|Symptomatic Deterioration|0|||
161859940|NCT01962103|584529593|FG007|Phase 1|Symptomatic Deterioration|0|||
161859941|NCT01962103|584529594|FG008|Phase 1|Symptomatic Deterioration|0|||
161859942|NCT01962103|584529586|FG000|Phase 1|Miscellaneous|1|||
161859943|NCT01962103|584529587|FG001|Phase 1|Miscellaneous|0|||
161859944|NCT01962103|584529588|FG002|Phase 1|Miscellaneous|0|||
161859945|NCT01962103|584529589|FG003|Phase 1|Miscellaneous|0|||
161859946|NCT01962103|584529590|FG004|Phase 1|Miscellaneous|0|||
161859947|NCT01962103|584529591|FG005|Phase 1|Miscellaneous|0|||
161859948|NCT01962103|584529592|FG006|Phase 1|Miscellaneous|0|||
161859949|NCT01962103|584529593|FG007|Phase 1|Miscellaneous|0|||
161859950|NCT01962103|584529594|FG008|Phase 1|Miscellaneous|0|||
161859951|NCT01962103|584529586|FG000|Phase 2|Adverse Event|0|||
161859952|NCT01962103|584529587|FG001|Phase 2|Adverse Event|0|||
161859953|NCT01962103|584529588|FG002|Phase 2|Adverse Event|0|||
161859954|NCT01962103|584529589|FG003|Phase 2|Adverse Event|0|||
161859955|NCT01962103|584529590|FG004|Phase 2|Adverse Event|0|||
161859956|NCT01962103|584529591|FG005|Phase 2|Adverse Event|0|||
161859957|NCT01962103|584529592|FG006|Phase 2|Adverse Event|1|||
161859958|NCT01962103|584529593|FG007|Phase 2|Adverse Event|0|||
161859959|NCT01962103|584529594|FG008|Phase 2|Adverse Event|3|||
161859960|NCT01962103|584529586|FG000|Phase 2|Progressive Disease|0|||
161859961|NCT01962103|584529587|FG001|Phase 2|Progressive Disease|0|||
161859962|NCT01962103|584529588|FG002|Phase 2|Progressive Disease|0|||
161859963|NCT01962103|584529589|FG003|Phase 2|Progressive Disease|0|||
161859964|NCT01962103|584529590|FG004|Phase 2|Progressive Disease|0|||
161859965|NCT01962103|584529591|FG005|Phase 2|Progressive Disease|0|||
161859966|NCT01962103|584529592|FG006|Phase 2|Progressive Disease|11|||
161859967|NCT01962103|584529593|FG007|Phase 2|Progressive Disease|12|||
161859968|NCT01962103|584529594|FG008|Phase 2|Progressive Disease|11|||
161859969|NCT01962103|584529586|FG000|Phase 2|Symptomatic Deterioration|0|||
161859970|NCT01962103|584529587|FG001|Phase 2|Symptomatic Deterioration|0|||
161859971|NCT01962103|584529588|FG002|Phase 2|Symptomatic Deterioration|0|||
161859972|NCT01962103|584529589|FG003|Phase 2|Symptomatic Deterioration|0|||
161859973|NCT01962103|584529590|FG004|Phase 2|Symptomatic Deterioration|0|||
161859974|NCT01962103|584529591|FG005|Phase 2|Symptomatic Deterioration|0|||
161859975|NCT01962103|584529592|FG006|Phase 2|Symptomatic Deterioration|2|||
161859976|NCT01962103|584529593|FG007|Phase 2|Symptomatic Deterioration|2|||
161859977|NCT01962103|584529594|FG008|Phase 2|Symptomatic Deterioration|0|||
161859978|NCT04179838|584529595|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161859979|NCT04179838|584529596|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
161859980|NCT04179838|584529595|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
161859981|NCT04179838|584529596|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
161859982|NCT02750618|584529597|FG000|Overall Study|Withdrawal by Subject|1|||
161859983|NCT02763046|584529604|FG000|Overall Study|Adverse Event|5|||
161859984|NCT02763046|584529605|FG001|Overall Study|Adverse Event|4|||
161859985|NCT02763046|584529606|FG002|Overall Study|Adverse Event|0|||
161859986|NCT02763046|584529604|FG000|Overall Study|Lack of Efficacy|1|||
161859987|NCT02763046|584529605|FG001|Overall Study|Lack of Efficacy|1|||
161859988|NCT02763046|584529606|FG002|Overall Study|Lack of Efficacy|3|||
161859989|NCT02763046|584529604|FG000|Overall Study|Physician Decision|1|||
161859990|NCT02763046|584529605|FG001|Overall Study|Physician Decision|0|||
161859991|NCT02763046|584529606|FG002|Overall Study|Physician Decision|1|||
161859992|NCT02763046|584529604|FG000|Overall Study|Subject/guardian decision|2|||
161859993|NCT02763046|584529605|FG001|Overall Study|Subject/guardian decision|0|||
161859994|NCT02763046|584529606|FG002|Overall Study|Subject/guardian decision|4|||
161859995|NCT00818766|584529611|FG000|Overall Study|Could not be Contacted on Day 28|11|||
161859996|NCT00818766|584529612|FG001|Overall Study|Could not be Contacted on Day 28|10|||
161859997|NCT00818766|584529611|FG000|Overall Study|Death|1|||
161859998|NCT00818766|584529612|FG001|Overall Study|Death|0|||
161859999|NCT00818766|584529611|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
161860000|NCT00818766|584529612|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
161860001|NCT00086684|584529613|FG000|Overall Study|Adverse Event|12|||
161860002|NCT00086684|584529614|FG001|Overall Study|Adverse Event|17|||
161860003|NCT00086684|584529615|FG002|Overall Study|Adverse Event|14|||
161860004|NCT00086684|584529613|FG000|Overall Study|Lack of Efficacy|6|||
161860005|NCT00086684|584529614|FG001|Overall Study|Lack of Efficacy|6|||
161860006|NCT00086684|584529615|FG002|Overall Study|Lack of Efficacy|5|||
161860007|NCT00086684|584529613|FG000|Overall Study|Lost to Follow-up|15|||
161860008|NCT00086684|584529614|FG001|Overall Study|Lost to Follow-up|8|||
161860009|NCT00086684|584529615|FG002|Overall Study|Lost to Follow-up|10|||
161860010|NCT00086684|584529613|FG000|Overall Study|Protocol Violation|8|||
161860011|NCT00086684|584529614|FG001|Overall Study|Protocol Violation|3|||
161860012|NCT00086684|584529615|FG002|Overall Study|Protocol Violation|0|||
161860013|NCT00086684|584529613|FG000|Overall Study|Withdrawal by Subject|0|||
161860014|NCT00086684|584529614|FG001|Overall Study|Withdrawal by Subject|4|||
161860015|NCT00086684|584529615|FG002|Overall Study|Withdrawal by Subject|10|||
161860016|NCT00086684|584529613|FG000|Overall Study|NONCOMPLIANCE|5|||
161860017|NCT00086684|584529614|FG001|Overall Study|NONCOMPLIANCE|7|||
161860018|NCT00086684|584529615|FG002|Overall Study|NONCOMPLIANCE|6|||
161860019|NCT00086684|584529613|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161860020|NCT00086684|584529614|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
161860021|NCT00086684|584529615|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161860022|NCT00086684|584529613|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
161860023|NCT00086684|584529614|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
161860024|NCT00086684|584529615|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
161860025|NCT00086684|584529613|FG000|Overall Study|Other|4|||
161860026|NCT00086684|584529614|FG001|Overall Study|Other|2|||
161860027|NCT00086684|584529615|FG002|Overall Study|Other|3|||
161860028|NCT01103180|584529618|FG000|Overall Study|Withdrawal by Subject|8|||
161860029|NCT01103180|584529619|FG001|Overall Study|Withdrawal by Subject|13|||
161860030|NCT01103180|584529618|FG000|Overall Study|Lost to Follow-up|13|||
161860031|NCT01103180|584529619|FG001|Overall Study|Lost to Follow-up|7|||
161860032|NCT01103180|584529618|FG000|Overall Study|Physician Decision|1|||
161860033|NCT01103180|584529619|FG001|Overall Study|Physician Decision|0|||
161860034|NCT01103180|584529618|FG000|Overall Study|Protocol Violation|0|||
161860035|NCT01103180|584529619|FG001|Overall Study|Protocol Violation|1|||
161860036|NCT01067105|584529620|FG000|Overall Study|Adverse Event|14|||
161860037|NCT01067105|584529620|FG000|Overall Study|Protocol Violation|48|||
161860038|NCT01067105|584529620|FG000|Overall Study|Withdrawal by Subject|36|||
161860039|NCT01067105|584529620|FG000|Overall Study|Lost to Follow-up|6|||
161860040|NCT01067105|584529620|FG000|Overall Study|Physician Decision|6|||
161860041|NCT01067105|584529620|FG000|Overall Study|Other|31|||
161860042|NCT02439216|584529623|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
161860043|NCT02439216|584529624|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860044|NCT02439216|584529625|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860045|NCT02439216|584529626|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860046|NCT02439216|584529627|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860047|NCT02439216|584529628|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860048|NCT02439216|584529629|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860049|NCT02439216|584529630|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860050|NCT02439216|584529631|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860051|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860052|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860053|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860054|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860055|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860056|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161771068|NCT00465101|584204223|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
161771069|NCT00465101|584204223|FG000|Overall Study|Change in health precluded follow up|4|||
161771070|NCT00465101|584204223|FG000|Overall Study|Did not meet study criteria|4|||
161771071|NCT00465101|584204223|FG000|Overall Study|Lost to Follow-up|5|||
161771072|NCT00465101|584204223|FG000|Overall Study|Other|6|||
161771073|NCT00465101|584204223|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
161771074|NCT00465101|584204223|FG000|Overall Study|Patient postponed procedure|1|||
161771075|NCT00465101|584204223|FG000|Overall Study|Site closed due to IRB expiration|1|||
161771076|NCT00465101|584204223|FG000|Overall Study|Unable to obtain IRB approval|1|||
161771077|NCT00465101|584204223|FG000|Overall Study|Death|3|||
161771078|NCT00465101|584204223|FG000|Overall Study|Withdrawal by Subject|25|||
161771079|NCT00465101|584204223|FG000|Overall Study|Physician Decision|1|||
161771080|NCT00465101|584204223|FG000|Overall Study|Withdrew consent prior to procedure|3|||
161771081|NCT00933543|584204225|FG000|Overall Study|Adverse Event|2|||
161771082|NCT00933543|584204226|FG001|Overall Study|Adverse Event|1|||
161771083|NCT00933543|584204225|FG000|Overall Study|Lost to Follow-up|0|||
161771084|NCT00933543|584204226|FG001|Overall Study|Lost to Follow-up|1|||
161771085|NCT00933543|584204225|FG000|Overall Study|Withdrawal by Subject|0|||
161771086|NCT00933543|584204226|FG001|Overall Study|Withdrawal by Subject|1|||
161771087|NCT00933543|584204225|FG000|Overall Study|Lack of Efficacy|0|||
161771088|NCT00933543|584204226|FG001|Overall Study|Lack of Efficacy|3|||
161771089|NCT00933543|584204225|FG000|Overall Study|Other|1|||
161771090|NCT00933543|584204226|FG001|Overall Study|Other|1|||
161771091|NCT04988035|584204228|FG000|Overall Study|Death|19|||
161771092|NCT04988035|584204229|FG001|Overall Study|Death|13|||
161771093|NCT04988035|584204228|FG000|Overall Study|Lost to Follow-up|12|||
161771094|NCT04988035|584204229|FG001|Overall Study|Lost to Follow-up|6|||
161771095|NCT04988035|584204228|FG000|Overall Study|Protocol Violation|0|||
161771096|NCT04988035|584204229|FG001|Overall Study|Protocol Violation|1|||
161771097|NCT04988035|584204228|FG000|Overall Study|Withdrawal by Subject|2|||
161771098|NCT04988035|584204229|FG001|Overall Study|Withdrawal by Subject|4|||
161771099|NCT04988035|584204228|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
161771100|NCT04988035|584204229|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
161771101|NCT04113746|584204232|FG000|Overall Study|Lost to Follow-up|4|||
161771102|NCT04113746|584204233|FG001|Overall Study|Lost to Follow-up|4|||
161771103|NCT00499694|584204234|FG000|Overall Study|Patient never received treatment.|1|||
161771104|NCT03958045|584204235|FG000|Overall Study|Withdrawal by Subject|1|||
161771105|NCT00674440|584204236|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
161771106|NCT00674440|584204236|FG000|Overall Study|did not have surgery, so unevaluable|7|||
161771107|NCT00674440|584204236|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
161771108|NCT04409262|584204248|FG000|Overall Study|Adverse Event|0|||
161771109|NCT04409262|584204249|FG001|Overall Study|Adverse Event|2|||
161771110|NCT04409262|584204248|FG000|Overall Study|Death|55|||
161771111|NCT04409262|584204249|FG001|Overall Study|Death|97|||
161771112|NCT04409262|584204248|FG000|Overall Study|Lost to Follow-up|12|||
161771113|NCT04409262|584204249|FG001|Overall Study|Lost to Follow-up|23|||
161771114|NCT04409262|584204248|FG000|Overall Study|Lack of Staff|0|||
161771115|NCT04409262|584204249|FG001|Overall Study|Lack of Staff|1|||
161771116|NCT04409262|584204248|FG000|Overall Study|Protocol Violation|3|||
161771117|NCT04409262|584204249|FG001|Overall Study|Protocol Violation|1|||
161771118|NCT04409262|584204248|FG000|Overall Study|Withdrawal by Subject|5|||
161771119|NCT04409262|584204249|FG001|Overall Study|Withdrawal by Subject|10|||
161771120|NCT04794491|584204253|FG000|Overall Study|Adverse Event|1|||
161771121|NCT04794491|584204253|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
161771122|NCT04794491|584204253|FG000|Overall Study|Noncompliance With Study Intervention|1|||
161771123|NCT04794491|584204253|FG000|Overall Study|Withdrawal by Subject|2|||
161771124|NCT01326481|584204254|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
161771125|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Death|1|||
161771126|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Death|0|||
161771127|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Death|0|||
161771128|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Death|0|||
161771129|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Death|2|||
161771130|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Death|1|||
161771131|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Death|2|||
161771132|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Death|1|||
161771133|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
161771134|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
161771135|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
161771136|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
161771137|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161771138|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
161771139|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161771140|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161860057|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860058|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
161860059|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860060|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860061|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860062|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860063|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860064|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860065|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860066|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860067|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
161860068|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
161860069|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860070|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860071|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860072|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860073|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860074|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860075|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860076|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860077|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
161860078|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860079|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860080|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860081|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860082|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860083|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860084|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860085|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
161860086|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
161860087|NCT00470535|584529639|FG000|Overall Study|Disease Progression|13|||
161860088|NCT00470535|584529639|FG000|Overall Study|Withdrawal by Subject|1|||
161860089|NCT00470535|584529639|FG000|Overall Study|Adverse Event|1|||
161860090|NCT00470535|584529639|FG000|Overall Study|Death|1|||
161860091|NCT00470535|584529639|FG000|Overall Study|Other|2|||
161860092|NCT02094300|584529640|FG000|Overall Study|Death|7|||
161860093|NCT02094300|584529640|FG000|Overall Study|Lost to Follow-up|10|||
161860094|NCT02094300|584529640|FG000|Overall Study|Still be eligible for follow-up|3|||
161860095|NCT00725491|584529643|FG000|Overall Study|Adverse Event|3|||
161860096|NCT00725491|584529644|FG001|Overall Study|Adverse Event|2|||
161860097|NCT00725491|584529643|FG000|Overall Study|Pregnancy|0|||
161860098|NCT00725491|584529644|FG001|Overall Study|Pregnancy|3|||
161860099|NCT00725491|584529643|FG000|Overall Study|Risk for hyperstimulation|2|||
161860100|NCT00725491|584529644|FG001|Overall Study|Risk for hyperstimulation|9|||
161860101|NCT00725491|584529643|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
161860102|NCT00725491|584529644|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
161860103|NCT00725491|584529643|FG000|Overall Study|Fertilization failure|0|||
161860104|NCT00725491|584529644|FG001|Overall Study|Fertilization failure|1|||
161860105|NCT00725491|584529643|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
161860106|NCT00725491|584529644|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
161860107|NCT01641640|584529647|FG000|Overall Study|Enrolled but not treated|1|||
161860108|NCT01641640|584529647|FG000|Overall Study|Efficacy failure|29|||
161860109|NCT01641640|584529647|FG000|Overall Study|Lost to Follow-up|3|||
161860110|NCT01641640|584529647|FG000|Overall Study|Withdrawal by Subject|2|||
161860111|NCT01641640|584529647|FG000|Overall Study|Adverse Event|1|||
161860112|NCT01778530|584529651|FG000|Overall Study|Progression on study|1|||
161860113|NCT01778530|584529651|FG000|Overall Study|Adverse event/side effect|1|||
161860114|NCT01199939|584529652|FG000|Overall Study|Adverse Event|4|||
161860115|NCT01199939|584529652|FG000|Overall Study|Protocol Violation|3|||
161860116|NCT01199939|584529652|FG000|Overall Study|Lost to Follow-up|2|||
161860117|NCT01199939|584529652|FG000|Overall Study|Reached a virologic endpoint|4|||
161860118|NCT03472014|584529653|FG000|Overall Study|Lost to Follow-up|4|||
161860119|NCT02792517|584529661|FG000|Overall Study|Withdrawal by Subject|10|||
161860120|NCT02792517|584529661|FG000|Overall Study|Decision by Sponsor|7|||
161860121|NCT02792517|584529661|FG000|Overall Study|Lost to Follow-up|3|||
161860122|NCT00882518|584529662|FG000|Overall Study|Adverse Event|9|||
161860123|NCT00882518|584529663|FG001|Overall Study|Adverse Event|18|||
161860124|NCT00882518|584529662|FG000|Overall Study|Withdrawal by Subject|9|||
161860125|NCT00882518|584529663|FG001|Overall Study|Withdrawal by Subject|13|||
161860126|NCT00882518|584529662|FG000|Overall Study|Lack of Efficacy|12|||
161860127|NCT00882518|584529663|FG001|Overall Study|Lack of Efficacy|9|||
161860128|NCT00882518|584529662|FG000|Overall Study|Severe non-compliance to protocol|3|||
161860129|NCT00882518|584529663|FG001|Overall Study|Severe non-compliance to protocol|1|||
161860130|NCT00882518|584529662|FG000|Overall Study|Incorrect enrolment|4|||
161860131|NCT00882518|584529663|FG001|Overall Study|Incorrect enrolment|2|||
161860132|NCT00882518|584529662|FG000|Overall Study|Central lab closure for National day|1|||
161860133|NCT00882518|584529663|FG001|Overall Study|Central lab closure for National day|0|||
161860134|NCT00882518|584529662|FG000|Overall Study|Allocating random number by mistake|0|||
161860135|NCT00882518|584529663|FG001|Overall Study|Allocating random number by mistake|1|||
161860136|NCT03238651|584529664|FG000|Overall Study|Other|0|||
161860137|NCT03238651|584529665|FG001|Overall Study|Other|0|||
161860138|NCT03238651|584529666|FG002|Overall Study|Other|0|||
161860139|NCT03238651|584529667|FG003|Overall Study|Other|0|||
161860140|NCT03238651|584529668|FG004|Overall Study|Other|1|||
161860141|NCT03238651|584529664|FG000|Overall Study|Progressive Disease|2|||
161860142|NCT03238651|584529665|FG001|Overall Study|Progressive Disease|2|||
161860143|NCT03238651|584529666|FG002|Overall Study|Progressive Disease|2|||
161860144|NCT03238651|584529667|FG003|Overall Study|Progressive Disease|2|||
161860145|NCT03238651|584529668|FG004|Overall Study|Progressive Disease|0|||
161860146|NCT03238651|584529664|FG000|Overall Study|Withdrawal by Subject|0|||
161860147|NCT03238651|584529665|FG001|Overall Study|Withdrawal by Subject|1|||
161860148|NCT03238651|584529666|FG002|Overall Study|Withdrawal by Subject|0|||
161860149|NCT03238651|584529667|FG003|Overall Study|Withdrawal by Subject|1|||
161860150|NCT03238651|584529668|FG004|Overall Study|Withdrawal by Subject|0|||
161860151|NCT03238651|584529664|FG000|Overall Study|Adverse Event|1|||
161860152|NCT03238651|584529665|FG001|Overall Study|Adverse Event|3|||
161860153|NCT03238651|584529666|FG002|Overall Study|Adverse Event|2|||
161860154|NCT03238651|584529667|FG003|Overall Study|Adverse Event|0|||
161860155|NCT03238651|584529668|FG004|Overall Study|Adverse Event|0|||
161860156|NCT00711087|584529669|FG000|Overall Study|Lost to Follow-up|1|||
161860157|NCT00711087|584529670|FG001|Overall Study|Lost to Follow-up|0|||
161860158|NCT03535740|584529671|FG000|Overall Study|Death|44|||
161860159|NCT03535740|584529671|FG000|Overall Study|Lost to Follow-up|1|||
161860160|NCT03535740|584529671|FG000|Overall Study|Withdrawal by Subject|13|||
161860161|NCT03535740|584529671|FG000|Overall Study|Site terminated by Sponsor|45|||
161860162|NCT01870778|584529675|FG000|Overall Study|Withdrawal by Subject|8|||
161860163|NCT01870778|584529676|FG001|Overall Study|Withdrawal by Subject|7|||
161860164|NCT01870778|584529675|FG000|Overall Study|Lost to Follow-up|0|||
161860165|NCT01870778|584529676|FG001|Overall Study|Lost to Follow-up|2|||
161860166|NCT01169350|584529683|FG000|Overall Study|Physician Decision|3|||
161860167|NCT01169350|584529683|FG000|Overall Study|Lost to Follow-up|2|||
161860168|NCT04870710|584529685|FG000|Overall Study|Lost to Follow-up|3|||
161860169|NCT01876446|584529686|FG000|Overall Study|Death|0|||
161860170|NCT01876446|584529687|FG001|Overall Study|Death|1|||
161860171|NCT01876446|584529686|FG000|Overall Study|Withdrawal by Subject|1|||
161860172|NCT01876446|584529687|FG001|Overall Study|Withdrawal by Subject|2|||
161860173|NCT01876446|584529686|FG000|Overall Study|Physician Decision|1|||
161860174|NCT01876446|584529687|FG001|Overall Study|Physician Decision|3|||
161860175|NCT02108912|584529688|FG000|Overall Study|Lost to Follow-up|1|||
161860176|NCT02108912|584529689|FG001|Overall Study|Lost to Follow-up|1|||
161860177|NCT02108912|584529688|FG000|Overall Study|lack of transportation|1|||
161860178|NCT02108912|584529689|FG001|Overall Study|lack of transportation|0|||
161860179|NCT02108912|584529688|FG000|Overall Study|high blood pressure|1|||
161860180|NCT02108912|584529689|FG001|Overall Study|high blood pressure|0|||
161860181|NCT01808573|584529690|FG000|Overall Study|Death|212|||
161860182|NCT01808573|584529691|FG001|Overall Study|Death|240|||
161860183|NCT01808573|584529690|FG000|Overall Study|Withdrawal by Subject|12|||
161860184|NCT01808573|584529691|FG001|Overall Study|Withdrawal by Subject|10|||
161860185|NCT01808573|584529690|FG000|Overall Study|Lost to Follow-up|3|||
161860186|NCT01808573|584529691|FG001|Overall Study|Lost to Follow-up|0|||
161860187|NCT01808573|584529690|FG000|Overall Study|Discontinuation of study by sponsor|79|||
161860188|NCT01808573|584529691|FG001|Overall Study|Discontinuation of study by sponsor|64|||
161860189|NCT01808573|584529690|FG000|Overall Study|Randomized in Error|1|||
161860190|NCT01808573|584529691|FG001|Overall Study|Randomized in Error|0|||
161860191|NCT00852202|584529702|FG000|Overall Study|Adverse Event|2|||
161860192|NCT00852202|584529703|FG001|Overall Study|Adverse Event|3|||
161860193|NCT00852202|584529704|FG002|Overall Study|Adverse Event|7|||
161860194|NCT00852202|584529702|FG000|Overall Study|Lack of Efficacy|4|||
161860195|NCT00852202|584529703|FG001|Overall Study|Lack of Efficacy|1|||
161860196|NCT00852202|584529704|FG002|Overall Study|Lack of Efficacy|2|||
161860197|NCT00852202|584529702|FG000|Overall Study|Protocol Violation|2|||
161860198|NCT00852202|584529703|FG001|Overall Study|Protocol Violation|2|||
161860199|NCT00852202|584529704|FG002|Overall Study|Protocol Violation|7|||
161860200|NCT00852202|584529702|FG000|Overall Study|Withdrawal by Subject|3|||
161860201|NCT00852202|584529703|FG001|Overall Study|Withdrawal by Subject|1|||
161860202|NCT00852202|584529704|FG002|Overall Study|Withdrawal by Subject|2|||
161860203|NCT00852202|584529702|FG000|Overall Study|Lost to Follow-up|5|||
161860204|NCT00852202|584529703|FG001|Overall Study|Lost to Follow-up|5|||
161860205|NCT00852202|584529704|FG002|Overall Study|Lost to Follow-up|6|||
161860206|NCT00852202|584529702|FG000|Overall Study|pregnancy,moving away and surgery|1|||
161860207|NCT00852202|584529703|FG001|Overall Study|pregnancy,moving away and surgery|0|||
161860208|NCT00852202|584529704|FG002|Overall Study|pregnancy,moving away and surgery|2|||
161860209|NCT02552121|584529710|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
161860210|NCT02552121|584529711|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860211|NCT02552121|584529712|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860212|NCT02552121|584529713|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860213|NCT02552121|584529714|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860214|NCT02552121|584529715|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860215|NCT02552121|584529716|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860216|NCT02552121|584529717|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860217|NCT02552121|584529710|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
161860218|NCT02552121|584529711|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860219|NCT02552121|584529712|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860220|NCT02552121|584529713|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860221|NCT02552121|584529714|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860222|NCT02552121|584529715|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860223|NCT02552121|584529716|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860224|NCT02552121|584529717|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860225|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860226|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
161860227|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860228|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860229|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860230|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860231|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860232|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860233|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860234|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
161860235|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860236|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860237|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860238|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860239|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860240|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860241|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860242|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
161860243|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860244|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860245|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860246|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860247|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860248|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161771141|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
161860249|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860250|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
161860251|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860252|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860253|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860254|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860255|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860256|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860257|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
161860258|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
161860259|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
161860260|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
161860261|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
161860262|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
161860263|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
161860264|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
161860265|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
161860266|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
161860267|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
161860268|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
161860269|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
161860270|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
161860271|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
161860272|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
161860273|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
161860274|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
161860275|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
161860276|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
161860277|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
161860278|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
161860279|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
161860280|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
161860281|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Death|0|||
161860282|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Death|0|||
161860283|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Death|1|||
161860284|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Death|0|||
161860285|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Death|0|||
161860286|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Death|0|||
161860287|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Death|0|||
161860288|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Death|0|||
161860289|NCT03629184|584529718|FG000|Overall Study|Withdrawal by Subject|2|||
161860290|NCT03629184|584529719|FG001|Overall Study|Withdrawal by Subject|1|||
161860291|NCT03629184|584529718|FG000|Overall Study|Physician Decision|1|||
161860292|NCT03629184|584529719|FG001|Overall Study|Physician Decision|0|||
161860293|NCT01461538|584529720|FG000|Overall Study|Death|15|||
161860294|NCT01461538|584529721|FG001|Overall Study|Death|6|||
161860295|NCT01461538|584529722|FG002|Overall Study|Death|2|||
161860296|NCT01461538|584529720|FG000|Overall Study|Study Stopped by Sponsor|2|||
161860297|NCT01461538|584529721|FG001|Overall Study|Study Stopped by Sponsor|1|||
161860298|NCT01461538|584529722|FG002|Overall Study|Study Stopped by Sponsor|0|||
161860299|NCT01461538|584529720|FG000|Overall Study|Withdrawal by Subject|1|||
161860300|NCT01461538|584529721|FG001|Overall Study|Withdrawal by Subject|1|||
161860301|NCT01461538|584529722|FG002|Overall Study|Withdrawal by Subject|0|||
161860302|NCT00141778|584529724|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
161860303|NCT00141778|584529725|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
161860304|NCT00141778|584529726|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
161860305|NCT00141778|584529724|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
161860306|NCT00141778|584529725|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
161860307|NCT00141778|584529726|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
161860308|NCT00141778|584529724|FG000|Started Study Medication|Withdrawal by Subject|0|||
161860309|NCT00141778|584529725|FG001|Started Study Medication|Withdrawal by Subject|2|||
161860310|NCT00141778|584529726|FG002|Started Study Medication|Withdrawal by Subject|0|||
161860311|NCT00141778|584529724|FG000|Started Study Medication|Difficulty Swallowing|0|||
161860312|NCT00141778|584529725|FG001|Started Study Medication|Difficulty Swallowing|1|||
161860313|NCT00141778|584529726|FG002|Started Study Medication|Difficulty Swallowing|0|||
161860314|NCT00141778|584529724|FG000|Started Study Medication|Chest Discomfort|0|||
161860315|NCT00141778|584529725|FG001|Started Study Medication|Chest Discomfort|0|||
161860316|NCT00141778|584529726|FG002|Started Study Medication|Chest Discomfort|1|||
161860317|NCT04211831|584529727|FG000|Overall Study|Withdrawal by Subject|4|||
161860318|NCT04211831|584529728|FG001|Overall Study|Withdrawal by Subject|1|||
161860319|NCT04211831|584529729|FG002|Overall Study|Withdrawal by Subject|1|||
161860320|NCT04211831|584529727|FG000|Overall Study|Protocol Violation|0|||
161860321|NCT04211831|584529728|FG001|Overall Study|Protocol Violation|0|||
161860322|NCT04211831|584529729|FG002|Overall Study|Protocol Violation|1|||
161860323|NCT04211831|584529727|FG000|Overall Study|Adverse Event|0|||
161860324|NCT04211831|584529728|FG001|Overall Study|Adverse Event|1|||
161860325|NCT04211831|584529729|FG002|Overall Study|Adverse Event|0|||
161860326|NCT04211831|584529727|FG000|Overall Study|Lack of Efficacy|0|||
161860327|NCT04211831|584529728|FG001|Overall Study|Lack of Efficacy|0|||
161860328|NCT04211831|584529729|FG002|Overall Study|Lack of Efficacy|1|||
161860329|NCT04211831|584529727|FG000|Overall Study|Lost to Follow-up|0|||
161860330|NCT04211831|584529728|FG001|Overall Study|Lost to Follow-up|0|||
161860331|NCT04211831|584529729|FG002|Overall Study|Lost to Follow-up|2|||
161860332|NCT04211831|584529727|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
161860333|NCT04211831|584529728|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
161860334|NCT04211831|584529729|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
161860335|NCT04211831|584529727|FG000|Overall Study|Other|0|||
161860336|NCT04211831|584529728|FG001|Overall Study|Other|1|||
161860337|NCT04211831|584529729|FG002|Overall Study|Other|0|||
161860338|NCT04796961|584531098|FG000|Overall Study|Lost to Follow-up|10|||
161860339|NCT04796961|584531098|FG000|Overall Study|Withdrawal by Subject|3|||
161860340|NCT04796961|584531098|FG000|Overall Study|Left Organization|10|||
161771142|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
161771143|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
161771144|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
161771145|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161771146|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161771147|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
161771148|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161771149|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
161771150|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
161860341|NCT01557504|584531103|FG000|Overall Study|Physician Decision|1|||
161860342|NCT01557504|584531104|FG001|Overall Study|Physician Decision|0|||
161860343|NCT01321749|584531110|FG000|Overall Study|Lost to Follow-up|4|||
161860344|NCT01321749|584531111|FG001|Overall Study|Lost to Follow-up|11|||
161860345|NCT01321749|584531110|FG000|Overall Study|Protocol Violation|4|||
161860346|NCT01321749|584531111|FG001|Overall Study|Protocol Violation|7|||
161860347|NCT01321749|584531110|FG000|Overall Study|Withdrawal by Subject|5|||
161860348|NCT01321749|584531111|FG001|Overall Study|Withdrawal by Subject|4|||
161860349|NCT01173523|584531115|FG000|Overall Study|Clinical Progression|1|||
161860350|NCT01173523|584531116|FG001|Overall Study|Clinical Progression|1|||
161860351|NCT01173523|584531115|FG000|Overall Study|Progressive Disease|10|||
161860352|NCT01173523|584531116|FG001|Overall Study|Progressive Disease|8|||
161860353|NCT01173523|584531115|FG000|Overall Study|Other|2|||
161860354|NCT01173523|584531116|FG001|Overall Study|Other|3|||
161860355|NCT00853099|584531117|FG000|Double-blind Period|Adverse Event|7|||
161860356|NCT00853099|584531118|FG001|Double-blind Period|Adverse Event|9|||
161860357|NCT00853099|584531119|FG002|Double-blind Period|Adverse Event|13|||
161860358|NCT00853099|584531120|FG003|Double-blind Period|Adverse Event|0|||
161860359|NCT00853099|584531117|FG000|Double-blind Period|Withdrawal by Subject|2|||
161860360|NCT00853099|584531118|FG001|Double-blind Period|Withdrawal by Subject|3|||
161860361|NCT00853099|584531119|FG002|Double-blind Period|Withdrawal by Subject|0|||
161860362|NCT00853099|584531120|FG003|Double-blind Period|Withdrawal by Subject|0|||
161860363|NCT00853099|584531117|FG000|Double-blind Period|Lack of Efficacy|14|||
161860364|NCT00853099|584531118|FG001|Double-blind Period|Lack of Efficacy|17|||
161860365|NCT00853099|584531119|FG002|Double-blind Period|Lack of Efficacy|16|||
161860366|NCT00853099|584531120|FG003|Double-blind Period|Lack of Efficacy|0|||
161860367|NCT00853099|584531117|FG000|Double-blind Period|Other|0|||
161860368|NCT00853099|584531118|FG001|Double-blind Period|Other|0|||
161860369|NCT00853099|584531119|FG002|Double-blind Period|Other|1|||
161860370|NCT00853099|584531120|FG003|Double-blind Period|Other|0|||
161860371|NCT00853099|584531117|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
161860372|NCT00853099|584531118|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
161860373|NCT00853099|584531119|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
161860374|NCT00853099|584531120|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
161860375|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161860376|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161860377|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161860378|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
161860379|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
161860380|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
161860381|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
161860382|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
161860383|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161860384|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161860385|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161860386|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
161860387|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Other|0|||
161860388|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Other|0|||
161860389|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Other|0|||
161860390|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Other|6|||
161860391|NCT00970593|584531122|FG000|Overall Study|Adverse Event|1|||
161860392|NCT00970593|584531123|FG001|Overall Study|Adverse Event|1|||
161860393|NCT00970593|584531124|FG002|Overall Study|Adverse Event|0|||
161860394|NCT00970593|584531125|FG003|Overall Study|Adverse Event|0|||
161860395|NCT00970593|584531126|FG004|Overall Study|Adverse Event|0|||
161860396|NCT00970593|584531127|FG005|Overall Study|Adverse Event|0|||
161860397|NCT00970593|584531128|FG006|Overall Study|Adverse Event|0|||
161860398|NCT00970593|584531122|FG000|Overall Study|Discontinuation of study by sponsor|0|||
161860399|NCT00970593|584531123|FG001|Overall Study|Discontinuation of study by sponsor|0|||
161860400|NCT00970593|584531124|FG002|Overall Study|Discontinuation of study by sponsor|5|||
161860401|NCT00970593|584531125|FG003|Overall Study|Discontinuation of study by sponsor|0|||
161860402|NCT00970593|584531126|FG004|Overall Study|Discontinuation of study by sponsor|0|||
161860403|NCT00970593|584531127|FG005|Overall Study|Discontinuation of study by sponsor|0|||
161860404|NCT00970593|584531128|FG006|Overall Study|Discontinuation of study by sponsor|2|||
161860405|NCT00970593|584531122|FG000|Overall Study|Withdrawal by Subject|0|||
161860406|NCT00970593|584531123|FG001|Overall Study|Withdrawal by Subject|0|||
161860407|NCT00970593|584531124|FG002|Overall Study|Withdrawal by Subject|1|||
161860408|NCT00970593|584531125|FG003|Overall Study|Withdrawal by Subject|0|||
161860409|NCT00970593|584531126|FG004|Overall Study|Withdrawal by Subject|0|||
161860410|NCT00970593|584531127|FG005|Overall Study|Withdrawal by Subject|0|||
161860411|NCT00970593|584531128|FG006|Overall Study|Withdrawal by Subject|0|||
161860412|NCT02203357|584531129|FG000|Overall Study|Lost to Follow-up|58|||
161860413|NCT02203357|584531130|FG001|Overall Study|Lost to Follow-up|66|||
161860414|NCT02203357|584531131|FG002|Overall Study|Lost to Follow-up|70|||
161860415|NCT02968576|584531132|FG000|Overall Study|Pregnancy|0|||
161860416|NCT02968576|584531133|FG001|Overall Study|Pregnancy|1|||
161860417|NCT02002221|584531134|FG000|Overall Study|Adverse Event|2|||
161860418|NCT02002221|584531135|FG001|Overall Study|Adverse Event|1|||
161860419|NCT02002221|584531134|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161860420|NCT02002221|584531135|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161860421|NCT02002221|584531134|FG000|Overall Study|Patient withdrew consent|0|||
161860422|NCT02002221|584531135|FG001|Overall Study|Patient withdrew consent|1|||
161860423|NCT01998919|584531136|FG000|Overall Study|Death|2|||
161860424|NCT01998919|584531137|FG001|Overall Study|Death|2|||
161860425|NCT01998919|584531136|FG000|Overall Study|Adverse Event|0|||
161860426|NCT01998919|584531137|FG001|Overall Study|Adverse Event|5|||
161860427|NCT01998919|584531136|FG000|Overall Study|Disease progression|31|||
161860428|NCT01998919|584531137|FG001|Overall Study|Disease progression|22|||
161860429|NCT01998919|584531136|FG000|Overall Study|Withdrawal by Subject|2|||
161860430|NCT01998919|584531137|FG001|Overall Study|Withdrawal by Subject|4|||
161860431|NCT01998919|584531136|FG000|Overall Study|Lost to Follow-up|2|||
161860432|NCT01998919|584531137|FG001|Overall Study|Lost to Follow-up|0|||
161860433|NCT01998919|584531136|FG000|Overall Study|Other|5|||
161860434|NCT01998919|584531137|FG001|Overall Study|Other|2|||
161860435|NCT00897715|584531141|FG000|Overall Study|Lost to Follow-up|0|||
161860436|NCT00897715|584531142|FG001|Overall Study|Lost to Follow-up|1|||
161860437|NCT00897715|584531141|FG000|Overall Study|Physician Decision|1|||
161860438|NCT00897715|584531142|FG001|Overall Study|Physician Decision|0|||
161860439|NCT00897715|584531141|FG000|Overall Study|increased risk of infection|1|||
161860440|NCT00897715|584531142|FG001|Overall Study|increased risk of infection|0|||
161860441|NCT00927589|584531144|FG000|Overall Study|Death|1|||
161860442|NCT00927589|584531144|FG000|Overall Study|Physician Decision|1|||
161860443|NCT00927589|584531144|FG000|Overall Study|Withdrawal by Subject|3|||
161860444|NCT00927589|584531144|FG000|Overall Study|Adverse Event|2|||
161860445|NCT00927589|584531144|FG000|Overall Study|Disease Progression|8|||
161860446|NCT00927589|584531144|FG000|Overall Study|Non-compliance|1|||
161860447|NCT03875508|584531145|FG000|Overall Study|Adverse Event|1|||
161860448|NCT03875508|584531145|FG000|Overall Study|Lost to Follow-up|8|||
161860449|NCT03875508|584531145|FG000|Overall Study|Lack of Efficacy|1|||
161860450|NCT03875508|584531145|FG000|Overall Study|Other, not specified|2|||
161860451|NCT03743051|584531146|FG000|Overall Study|Adverse Event|5|||
161860452|NCT03743051|584531147|FG001|Overall Study|Adverse Event|9|||
161860453|NCT03743051|584531146|FG000|Overall Study|Death|27|||
161860454|NCT03743051|584531147|FG001|Overall Study|Death|26|||
161860455|NCT03743051|584531146|FG000|Overall Study|Lost to Follow-up|4|||
161860456|NCT03743051|584531147|FG001|Overall Study|Lost to Follow-up|8|||
161860457|NCT03743051|584531146|FG000|Overall Study|Withdrawal by Subject|32|||
161860458|NCT03743051|584531147|FG001|Overall Study|Withdrawal by Subject|19|||
161860459|NCT03743051|584531146|FG000|Overall Study|Physician Decision|10|||
161860460|NCT03743051|584531147|FG001|Overall Study|Physician Decision|15|||
161860461|NCT03743051|584531146|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
161860462|NCT03743051|584531147|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
161860463|NCT02137252|584531148|FG000|Overall Study|trial terminated early|2|||
161860464|NCT02137252|584531149|FG001|Overall Study|trial terminated early|1|||
161860465|NCT02550561|584531153|FG000|Overall Study|Lost to Follow-up|5|||
161771151|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
161771152|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
161771153|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
161771154|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
161771155|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
161771156|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
161771157|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161771158|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
161771159|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
161771160|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
161771161|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161771162|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
161771163|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161860466|NCT02550561|584531153|FG000|Overall Study|Withdrawal by Subject|1|||
161860467|NCT00428246|584531154|FG000|Overall Study|Withdrawal by Subject|0|||
161860468|NCT00428246|584531155|FG001|Overall Study|Withdrawal by Subject|0|||
161860469|NCT00428246|584531156|FG002|Overall Study|Withdrawal by Subject|1|||
161860470|NCT00428246|584531154|FG000|Overall Study|Adverse Event|1|||
161860471|NCT00428246|584531155|FG001|Overall Study|Adverse Event|0|||
161860472|NCT00428246|584531156|FG002|Overall Study|Adverse Event|0|||
161860473|NCT05198518|584531158|FG000|Screening Visit|Deemed unable to participate|58|||
161771164|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161771165|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Death|0|||
161771166|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Death|2|||
161771167|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Death|2|||
161771168|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Death|0|||
161771169|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Death|0|||
161771170|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Death|1|||
161771171|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Death|0|||
161771172|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Death|0|||
161771173|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161771174|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771175|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161771176|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161771177|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771178|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771179|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771180|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771181|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
161771182|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771183|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
161771184|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771185|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
161771186|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771187|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771188|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771189|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771190|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771191|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
161771192|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771193|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771194|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
161771195|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771196|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771197|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771198|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771199|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771200|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
161771201|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771202|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771203|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771204|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771205|NCT00945815|584204263|FG000|Overall Study|Death|3|||
161771206|NCT00945815|584204263|FG000|Overall Study|Not protocol specified|1|||
161771207|NCT00945815|584204263|FG000|Overall Study|Ineligible|3|||
161771208|NCT00945815|584204263|FG000|Overall Study|Did not begin protocol therapy|1|||
161771209|NCT01990339|584204268|FG000|Overall Study|Data Not Available|49|||
161771210|NCT01990339|584204268|FG000|Overall Study|Voluntary Withdrawal|1402|||
161771211|NCT01990339|584204268|FG000|Overall Study|Lost to Follow-up|861|||
161771212|NCT01038609|584204269|FG000|Overall Study|Adverse Event|0|||
161771213|NCT01038609|584204270|FG001|Overall Study|Adverse Event|0|||
161771214|NCT01038609|584204271|FG002|Overall Study|Adverse Event|1|||
161771215|NCT01038609|584204272|FG003|Overall Study|Adverse Event|0|||
161771216|NCT01038609|584204273|FG004|Overall Study|Adverse Event|0|||
161771217|NCT01038609|584204269|FG000|Overall Study|Dosing Error|0|||
161771218|NCT01038609|584204270|FG001|Overall Study|Dosing Error|0|||
161771219|NCT01038609|584204271|FG002|Overall Study|Dosing Error|0|||
161771220|NCT01038609|584204272|FG003|Overall Study|Dosing Error|1|||
161771221|NCT01038609|584204273|FG004|Overall Study|Dosing Error|1|||
161771222|NCT01038609|584204269|FG000|Overall Study|Death in the Family|1|||
161771223|NCT01038609|584204270|FG001|Overall Study|Death in the Family|0|||
161771224|NCT01038609|584204271|FG002|Overall Study|Death in the Family|0|||
161771225|NCT01038609|584204272|FG003|Overall Study|Death in the Family|0|||
161771226|NCT01038609|584204273|FG004|Overall Study|Death in the Family|0|||
161771227|NCT01038609|584204269|FG000|Overall Study|Refusal of Blood Draws|0|||
161771228|NCT01038609|584204270|FG001|Overall Study|Refusal of Blood Draws|1|||
161771229|NCT01038609|584204271|FG002|Overall Study|Refusal of Blood Draws|0|||
161771230|NCT01038609|584204272|FG003|Overall Study|Refusal of Blood Draws|0|||
161771231|NCT01038609|584204273|FG004|Overall Study|Refusal of Blood Draws|0|||
161771232|NCT00242658|584204276|FG000|Overall Study|Lost to Follow-up|22|||
161771233|NCT00242658|584204277|FG001|Overall Study|Lost to Follow-up|19|||
161771234|NCT01590810|584204278|FG000|Overall Study|Physician Decision|0|||
161771235|NCT01590810|584204279|FG001|Overall Study|Physician Decision|1|||
161771236|NCT01590810|584204280|FG002|Overall Study|Physician Decision|1|||
161771237|NCT01590810|584204281|FG003|Overall Study|Physician Decision|0|||
161771238|NCT01590810|584204282|FG004|Overall Study|Physician Decision|0|||
161771239|NCT01087944|584204283|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
161771240|NCT01087944|584204284|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
161771241|NCT01087944|584204283|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
161771242|NCT01087944|584204284|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
161771243|NCT01731600|584204285|FG000|Overall Study|Adverse Event|2|||
161771244|NCT01731600|584204286|FG001|Overall Study|Adverse Event|0|||
161771245|NCT01731600|584204285|FG000|Overall Study|Withdrawal criteria|1|||
161771246|NCT01731600|584204286|FG001|Overall Study|Withdrawal criteria|0|||
161771247|NCT01731600|584204285|FG000|Overall Study|Other reasons|3|||
161771248|NCT01731600|584204286|FG001|Overall Study|Other reasons|0|||
161771249|NCT00540228|584204287|FG000|Overall Study|Adverse Event|2|||
161771250|NCT00540228|584204288|FG001|Overall Study|Adverse Event|0|||
161771251|NCT00540228|584204289|FG002|Overall Study|Adverse Event|0|||
161771252|NCT00540228|584204290|FG003|Overall Study|Adverse Event|0|||
161771253|NCT00540228|584204291|FG004|Overall Study|Adverse Event|0|||
161771254|NCT00540228|584204287|FG000|Overall Study|Lost to Follow-up|1|||
161771255|NCT00540228|584204288|FG001|Overall Study|Lost to Follow-up|1|||
161771256|NCT00540228|584204289|FG002|Overall Study|Lost to Follow-up|0|||
161771257|NCT00540228|584204290|FG003|Overall Study|Lost to Follow-up|0|||
161771258|NCT00540228|584204291|FG004|Overall Study|Lost to Follow-up|0|||
161771259|NCT01883362|584204292|FG000|Treatment|Adverse Event|1|||
161771260|NCT01883362|584204293|FG001|Treatment|Adverse Event|8|||
161771261|NCT01883362|584204292|FG000|Treatment|Withdrawal by Subject|6|||
161771262|NCT01883362|584204293|FG001|Treatment|Withdrawal by Subject|2|||
161771263|NCT01883362|584204292|FG000|Treatment|Administrative problems|4|||
161771264|NCT01883362|584204293|FG001|Treatment|Administrative problems|1|||
161771265|NCT01883362|584204292|FG000|Treatment|Relapse|4|||
161771266|NCT01883362|584204293|FG001|Treatment|Relapse|2|||
161771267|NCT01883362|584204292|FG000|Treatment|Randomized, not treated|1|||
161771268|NCT01883362|584204293|FG001|Treatment|Randomized, not treated|1|||
161771269|NCT01883362|584204292|FG000|Post Treatment Follow-up|Protocol Violation|0|||
161771270|NCT01883362|584204293|FG001|Post Treatment Follow-up|Protocol Violation|1|||
161771271|NCT01883362|584204292|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
161771272|NCT01883362|584204293|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
161771273|NCT01883362|584204292|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
161771274|NCT01883362|584204293|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
161771275|NCT01883362|584204292|FG000|Post Treatment Follow-up|Administrative problems|2|||
161771276|NCT01883362|584204293|FG001|Post Treatment Follow-up|Administrative problems|0|||
161771277|NCT01883362|584204292|FG000|Post Treatment Follow-up|Death|8|||
161771278|NCT01883362|584204293|FG001|Post Treatment Follow-up|Death|4|||
161771279|NCT01883362|584204292|FG000|Post Treatment Follow-up|Relapse|1|||
161771280|NCT01883362|584204293|FG001|Post Treatment Follow-up|Relapse|2|||
161771281|NCT01383317|584204294|FG000|Overall Study|Lost to Follow-up|2|||
161771282|NCT01383317|584204295|FG001|Overall Study|Lost to Follow-up|1|||
161771283|NCT01383317|584204294|FG000|Overall Study|Death|1|||
161771284|NCT01383317|584204295|FG001|Overall Study|Death|0|||
161771285|NCT01383317|584204294|FG000|Overall Study|Adverse Event|0|||
161771286|NCT01383317|584204295|FG001|Overall Study|Adverse Event|1|||
161771287|NCT01349816|584204296|FG000|Overall Study|Withdrawal by Subject|4|||
161771288|NCT01349816|584204296|FG000|Overall Study|Physician Decision|1|||
161771289|NCT01349816|584204296|FG000|Overall Study|Adverse Event|14|||
161771290|NCT01349816|584204296|FG000|Overall Study|Lost to Follow-up|2|||
161771291|NCT01349816|584204296|FG000|Overall Study|Protocol Violation|1|||
161771292|NCT01349816|584204296|FG000|Overall Study|Protocol-specified criteria|8|||
161771293|NCT02569996|584204299|FG000|Overall Study|Adverse Event|6|||
161771294|NCT02569996|584204299|FG000|Overall Study|Physician Decision|3|||
161771295|NCT02569996|584204299|FG000|Overall Study|Progression of the disease|18|||
161771296|NCT02569996|584204299|FG000|Overall Study|New anti-lymphoma treatment|1|||
161771297|NCT02569996|584204299|FG000|Overall Study|Non-compliance|9|||
161771298|NCT02569996|584204299|FG000|Overall Study|Withdrawal by Subject|5|||
161771299|NCT02569996|584204299|FG000|Overall Study|Lost to Follow-up|5|||
161771300|NCT02569996|584204299|FG000|Overall Study|Complete remission|7|||
161771301|NCT02569996|584204299|FG000|Overall Study|Unknown reason|1|||
161771302|NCT02911285|584204300|FG000|Overall Study|Lost to Follow-up|8|||
161771303|NCT02911285|584204301|FG001|Overall Study|Lost to Follow-up|5|||
161771304|NCT02911285|584204300|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
161771305|NCT02911285|584204301|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
161771306|NCT02451137|584204303|FG000|Overall Study|Randomized but not treated|19|||
161771307|NCT02451137|584204304|FG001|Overall Study|Randomized but not treated|27|||
161771308|NCT02451137|584204303|FG000|Overall Study|Adverse Event|43|||
161771309|NCT02451137|584204304|FG001|Overall Study|Adverse Event|42|||
161771310|NCT02451137|584204303|FG000|Overall Study|Lack of Efficacy|4|||
161771311|NCT02451137|584204304|FG001|Overall Study|Lack of Efficacy|9|||
161771312|NCT02451137|584204303|FG000|Overall Study|Participant decision:discontinue insulin|41|||
161771313|NCT02451137|584204304|FG001|Overall Study|Participant decision:discontinue insulin|43|||
161771314|NCT02451137|584204303|FG000|Overall Study|Hypoglycemia|2|||
161771315|NCT02451137|584204304|FG001|Overall Study|Hypoglycemia|1|||
161771316|NCT02451137|584204303|FG000|Overall Study|Investigator's decision|23|||
161771317|NCT02451137|584204304|FG001|Overall Study|Investigator's decision|19|||
161771318|NCT02451137|584204303|FG000|Overall Study|Lost to Follow-up|53|||
161771319|NCT02451137|584204304|FG001|Overall Study|Lost to Follow-up|61|||
161771320|NCT02451137|584204303|FG000|Overall Study|Physician Decision|6|||
161771321|NCT02451137|584204304|FG001|Overall Study|Physician Decision|5|||
161771322|NCT02451137|584204303|FG000|Overall Study|Sponsor decision|13|||
161771323|NCT02451137|584204304|FG001|Overall Study|Sponsor decision|25|||
161771324|NCT02451137|584204303|FG000|Overall Study|Withdrawal by Subject|40|||
161771325|NCT02451137|584204304|FG001|Overall Study|Withdrawal by Subject|63|||
161771326|NCT02451137|584204303|FG000|Overall Study|Other than specified above|2|||
161771327|NCT02451137|584204304|FG001|Overall Study|Other than specified above|3|||
161771328|NCT02842736|584206250|FG000|Overall Study|Lost to Follow-up|13|||
161771329|NCT02842736|584206250|FG000|Overall Study|Intervention for menstrual bleeding|17|||
161771330|NCT02842736|584206250|FG000|Overall Study|Withdrawal by Subject|4|||
161771331|NCT02842736|584206250|FG000|Overall Study|Pregnancy|3|||
161771332|NCT02842736|584206250|FG000|Overall Study|Hysterectomy for fibroids|2|||
161771333|NCT02842736|584206250|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
161771334|NCT02842736|584206250|FG000|Overall Study|IUD: Mirena|1|||
161771335|NCT02389621|584206252|FG000|Treatment Period|Withdrawal by Subject|1|||
161771336|NCT02389621|584206253|FG001|Treatment Period|Withdrawal by Subject|1|||
161771337|NCT02389621|584206252|FG000|Posttreatment Period|Adverse Event|3|||
161771338|NCT02389621|584206253|FG001|Posttreatment Period|Adverse Event|1|||
161771339|NCT02389621|584206252|FG000|Posttreatment Period|Withdrawal by Subject|3|||
161771340|NCT02389621|584206253|FG001|Posttreatment Period|Withdrawal by Subject|2|||
161771341|NCT02389621|584206252|FG000|Posttreatment Period|Lost to Follow-up|1|||
161771342|NCT02389621|584206253|FG001|Posttreatment Period|Lost to Follow-up|1|||
161771343|NCT02389621|584206252|FG000|Posttreatment Period|Other - Miscellaneous|2|||
161771344|NCT02389621|584206253|FG001|Posttreatment Period|Other - Miscellaneous|0|||
161860474|NCT05198518|584531159|FG001|Screening Visit|Deemed unable to participate|0|||
161860475|NCT05198518|584531160|FG002|Screening Visit|Deemed unable to participate|0|||
161771345|NCT00726882|584206258|FG000|Overall Study|Withdrawal by Subject|5|||
161771346|NCT00726882|584206258|FG000|Overall Study|Lost to Follow-up|7|||
161771347|NCT00726882|584206258|FG000|Overall Study|Other|10|||
161771348|NCT00344968|584206259|FG000|Overall Study|Adverse Event|5|||
161771349|NCT00344968|584206260|FG001|Overall Study|Adverse Event|4|||
161771350|NCT00344968|584206261|FG002|Overall Study|Adverse Event|15|||
161771351|NCT00344968|584206259|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161771352|NCT00344968|584206260|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161771353|NCT00344968|584206261|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161771354|NCT00344968|584206259|FG000|Overall Study|Protocol Violation|2|||
161771355|NCT00344968|584206260|FG001|Overall Study|Protocol Violation|2|||
161771356|NCT00344968|584206261|FG002|Overall Study|Protocol Violation|5|||
161771357|NCT00344968|584206259|FG000|Overall Study|Withdrawal by Subject|14|||
161771358|NCT00344968|584206260|FG001|Overall Study|Withdrawal by Subject|31|||
161771359|NCT00344968|584206261|FG002|Overall Study|Withdrawal by Subject|27|||
161771360|NCT00344968|584206259|FG000|Overall Study|Lost to Follow-up|24|||
161771361|NCT00344968|584206260|FG001|Overall Study|Lost to Follow-up|37|||
161771362|NCT00344968|584206261|FG002|Overall Study|Lost to Follow-up|37|||
161771363|NCT00344968|584206259|FG000|Overall Study|Death|11|||
161771364|NCT00344968|584206260|FG001|Overall Study|Death|27|||
161771365|NCT00344968|584206261|FG002|Overall Study|Death|31|||
161771366|NCT00344968|584206259|FG000|Overall Study|Other|0|||
161771367|NCT00344968|584206260|FG001|Overall Study|Other|1|||
161771368|NCT00344968|584206261|FG002|Overall Study|Other|0|||
161771369|NCT02526017|584206262|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771370|NCT02526017|584206263|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771371|NCT02526017|584206264|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771372|NCT02526017|584206265|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771373|NCT02526017|584206266|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
161771374|NCT02526017|584206267|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771375|NCT02526017|584206268|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771376|NCT02526017|584206269|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771377|NCT02526017|584206270|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771378|NCT01548573|584206271|FG000|Overall Study|Death|3|||
161771379|NCT01548573|584206271|FG000|Overall Study|Withdrawal by Subject|2|||
161771380|NCT03246152|584206284|FG000|Overall Study|Lost to Follow-up|2|||
161771381|NCT03246152|584206284|FG000|Overall Study|Protocol Violation|1|||
161771382|NCT00423137|584206285|FG000|Overall Study|Lost to Follow-up|0|||
161771383|NCT00423137|584206286|FG001|Overall Study|Lost to Follow-up|0|||
161771384|NCT00423137|584206287|FG002|Overall Study|Lost to Follow-up|1|||
161771385|NCT00423137|584206288|FG003|Overall Study|Lost to Follow-up|0|||
161771386|NCT00423137|584206285|FG000|Overall Study|Protocol Violation|0|||
161771387|NCT00423137|584206286|FG001|Overall Study|Protocol Violation|0|||
161771388|NCT00423137|584206287|FG002|Overall Study|Protocol Violation|0|||
161771389|NCT00423137|584206288|FG003|Overall Study|Protocol Violation|1|||
161771390|NCT00423137|584206285|FG000|Overall Study|Adverse Event Study disease worse|1|||
161771391|NCT00423137|584206286|FG001|Overall Study|Adverse Event Study disease worse|0|||
161771392|NCT00423137|584206287|FG002|Overall Study|Adverse Event Study disease worse|3|||
161771393|NCT00423137|584206288|FG003|Overall Study|Adverse Event Study disease worse|1|||
161771394|NCT00423137|584206285|FG000|Overall Study|Adverse Event Other|0|||
161771395|NCT00423137|584206286|FG001|Overall Study|Adverse Event Other|0|||
161771396|NCT00423137|584206287|FG002|Overall Study|Adverse Event Other|2|||
161771397|NCT00423137|584206288|FG003|Overall Study|Adverse Event Other|0|||
161771398|NCT04196023|584206292|FG000|Overall Study|Withdrawal by Subject|0|||
161771399|NCT04196023|584206293|FG001|Overall Study|Withdrawal by Subject|1|||
161771400|NCT04196023|584206292|FG000|Overall Study|Adverse Event|3|||
161771401|NCT04196023|584206293|FG001|Overall Study|Adverse Event|1|||
161771402|NCT04196023|584206292|FG000|Overall Study|Lost to Follow-up|0|||
161771403|NCT04196023|584206293|FG001|Overall Study|Lost to Follow-up|1|||
161771404|NCT04359758|584206298|FG000|Overall Study|Protocol Violation|3|||
161771405|NCT04359758|584206299|FG001|Overall Study|Protocol Violation|2|||
161771406|NCT03358407|584206303|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771407|NCT03358407|584206304|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771408|NCT03358407|584206305|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
161771409|NCT03358407|584206306|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771410|NCT03358407|584206307|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771411|NCT03358407|584206308|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771412|NCT03358407|584206309|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771413|NCT03358407|584206310|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771414|NCT03358407|584206311|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771415|NCT03358407|584206312|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771416|NCT03358407|584206303|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771417|NCT03358407|584206304|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771418|NCT03358407|584206305|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771419|NCT03358407|584206306|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771420|NCT03358407|584206307|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161771421|NCT03358407|584206308|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771422|NCT03358407|584206309|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771423|NCT03358407|584206310|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771424|NCT03358407|584206311|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771425|NCT03358407|584206312|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771426|NCT03358407|584206303|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771427|NCT03358407|584206304|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771428|NCT03358407|584206305|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771429|NCT03358407|584206306|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771430|NCT03358407|584206307|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771431|NCT03358407|584206308|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
161771432|NCT03358407|584206309|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771433|NCT03358407|584206310|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
161771434|NCT03358407|584206311|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771435|NCT03358407|584206312|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771436|NCT03358407|584206303|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771437|NCT03358407|584206304|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771438|NCT03358407|584206305|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771439|NCT03358407|584206306|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771440|NCT03358407|584206307|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771441|NCT03358407|584206308|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
161771442|NCT03358407|584206309|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771443|NCT03358407|584206310|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
161771444|NCT03358407|584206311|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771445|NCT03358407|584206312|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771446|NCT03358407|584206303|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771447|NCT03358407|584206304|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771448|NCT03358407|584206305|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771449|NCT03358407|584206306|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771450|NCT03358407|584206307|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771451|NCT03358407|584206308|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161771452|NCT03358407|584206309|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161771453|NCT03358407|584206310|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771454|NCT03358407|584206311|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771455|NCT03358407|584206312|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771456|NCT03358407|584206303|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771457|NCT03358407|584206304|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771458|NCT03358407|584206305|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771459|NCT03358407|584206306|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771460|NCT03358407|584206307|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771461|NCT03358407|584206308|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
161771462|NCT03358407|584206309|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
161771463|NCT03358407|584206310|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
161771464|NCT03358407|584206311|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771465|NCT03358407|584206312|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771466|NCT00483574|584206313|FG000|Overall Study|Adverse Event|6|||
161771467|NCT00483574|584206314|FG001|Overall Study|Adverse Event|0|||
161771468|NCT00483574|584206313|FG000|Overall Study|Protocol Violation|28|||
161771469|NCT00483574|584206314|FG001|Overall Study|Protocol Violation|9|||
161771470|NCT00483574|584206313|FG000|Overall Study|Lost to Follow-up|16|||
161771471|NCT00483574|584206314|FG001|Overall Study|Lost to Follow-up|4|||
161771472|NCT00483574|584206313|FG000|Overall Study|Withdrawal by Subject|52|||
161771473|NCT00483574|584206314|FG001|Overall Study|Withdrawal by Subject|0|||
161771474|NCT03605758|584206315|FG000|Overall Study|Lost to Follow-up|2|||
161771475|NCT03605758|584206316|FG001|Overall Study|Lost to Follow-up|1|||
161771476|NCT03605758|584206315|FG000|Overall Study|Illness|0|||
161771477|NCT03605758|584206316|FG001|Overall Study|Illness|1|||
161771478|NCT03605758|584206315|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
161771479|NCT03605758|584206316|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
161771480|NCT04753606|584206319|FG000|Overall Study|Adverse Event|1|||
161771481|NCT04753606|584206320|FG001|Overall Study|Adverse Event|0|||
161771482|NCT04753606|584206321|FG002|Overall Study|Adverse Event|0|||
161771483|NCT00489411|584206322|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
161771484|NCT00489411|584206323|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
161771485|NCT00489411|584206322|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
161771486|NCT00489411|584206323|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
161771487|NCT00489411|584206322|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
161771488|NCT00489411|584206323|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
161771489|NCT00489411|584206322|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
161771490|NCT00489411|584206323|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
161771491|NCT00489411|584206322|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
161771492|NCT00489411|584206323|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
161771493|NCT01748162|584206325|FG000|Overall Study|no additional croup episodes to evaluate|2|||
161771494|NCT01748162|584206326|FG001|Overall Study|no additional croup episodes to evaluate|2|||
161771495|NCT01748162|584206325|FG000|Overall Study|participant consented but did not begin|0|||
161771496|NCT01748162|584206326|FG001|Overall Study|participant consented but did not begin|1|||
161771497|NCT01748162|584206325|FG000|Overall Study|reasons not available|3|||
161771498|NCT01748162|584206326|FG001|Overall Study|reasons not available|2|||
161771499|NCT03219372|584206327|FG000|Overall Study|Withdrawal by Subject|1|||
161771500|NCT03219372|584206328|FG001|Overall Study|Withdrawal by Subject|0|||
161771501|NCT03841331|584206329|FG000|Overall Study|Withdrawal by Subject|4|||
161771502|NCT03841331|584206330|FG001|Overall Study|Withdrawal by Subject|9|||
161771503|NCT03841331|584206329|FG000|Overall Study|Lost to Follow-up|5|||
161771504|NCT03841331|584206330|FG001|Overall Study|Lost to Follow-up|1|||
161771505|NCT04145531|584206331|FG000|Part A|Adverse Event|2|||
161771506|NCT04145531|584206332|FG001|Part A|Adverse Event|12|||
161771507|NCT04145531|584206333|FG002|Part A|Adverse Event|6|||
161771508|NCT04145531|584206334|FG003|Part A|Adverse Event|0|||
161771509|NCT04145531|584206331|FG000|Part A|Death|1|||
161771510|NCT04145531|584206332|FG001|Part A|Death|2|||
161771511|NCT04145531|584206333|FG002|Part A|Death|0|||
161771512|NCT04145531|584206334|FG003|Part A|Death|0|||
161771513|NCT04145531|584206331|FG000|Part A|Physician Decision|2|||
161771514|NCT04145531|584206332|FG001|Part A|Physician Decision|5|||
161771515|NCT04145531|584206333|FG002|Part A|Physician Decision|2|||
161771516|NCT04145531|584206334|FG003|Part A|Physician Decision|0|||
161771517|NCT04145531|584206331|FG000|Part A|Progressive disease|0|||
161771518|NCT04145531|584206332|FG001|Part A|Progressive disease|2|||
161771519|NCT04145531|584206333|FG002|Part A|Progressive disease|1|||
161771520|NCT04145531|584206334|FG003|Part A|Progressive disease|0|||
161771521|NCT04145531|584206331|FG000|Part A|Protocol deviation|0|||
161771522|NCT04145531|584206332|FG001|Part A|Protocol deviation|0|||
161771523|NCT04145531|584206333|FG002|Part A|Protocol deviation|1|||
161771524|NCT04145531|584206334|FG003|Part A|Protocol deviation|0|||
161771525|NCT04145531|584206331|FG000|Part A|Withdrawal by parent or guardian|1|||
161771526|NCT04145531|584206332|FG001|Part A|Withdrawal by parent or guardian|0|||
161771527|NCT04145531|584206333|FG002|Part A|Withdrawal by parent or guardian|0|||
161771528|NCT04145531|584206334|FG003|Part A|Withdrawal by parent or guardian|0|||
161771529|NCT04145531|584206331|FG000|Part A|Withdrawal by participant|0|||
161771530|NCT04145531|584206332|FG001|Part A|Withdrawal by participant|0|||
161771531|NCT04145531|584206333|FG002|Part A|Withdrawal by participant|1|||
161771532|NCT04145531|584206334|FG003|Part A|Withdrawal by participant|0|||
161771533|NCT04145531|584206331|FG000|Part A|Other|0|||
161771534|NCT04145531|584206332|FG001|Part A|Other|0|||
161771535|NCT04145531|584206333|FG002|Part A|Other|1|||
161771536|NCT04145531|584206334|FG003|Part A|Other|0|||
161771537|NCT04145531|584206331|FG000|Part B|Adverse Event|0|||
161771538|NCT04145531|584206332|FG001|Part B|Adverse Event|0|||
161771539|NCT04145531|584206333|FG002|Part B|Adverse Event|0|||
161771540|NCT04145531|584206334|FG003|Part B|Adverse Event|21|||
161771541|NCT04145531|584206331|FG000|Part B|Physician Decision|0|||
161771542|NCT04145531|584206332|FG001|Part B|Physician Decision|0|||
161771543|NCT04145531|584206333|FG002|Part B|Physician Decision|0|||
161771544|NCT04145531|584206334|FG003|Part B|Physician Decision|7|||
161771545|NCT04145531|584206331|FG000|Part B|Progressive disease|0|||
161771546|NCT04145531|584206332|FG001|Part B|Progressive disease|0|||
161771547|NCT04145531|584206333|FG002|Part B|Progressive disease|0|||
161771548|NCT04145531|584206334|FG003|Part B|Progressive disease|1|||
161771549|NCT04145531|584206331|FG000|Part B|Recurrent disease|0|||
161771550|NCT04145531|584206332|FG001|Part B|Recurrent disease|0|||
161771551|NCT04145531|584206333|FG002|Part B|Recurrent disease|0|||
161771552|NCT04145531|584206334|FG003|Part B|Recurrent disease|1|||
161771553|NCT04145531|584206331|FG000|Part B|Withdrawal by parent or guardian|0|||
161771554|NCT04145531|584206332|FG001|Part B|Withdrawal by parent or guardian|0|||
161771555|NCT04145531|584206333|FG002|Part B|Withdrawal by parent or guardian|0|||
161771556|NCT04145531|584206334|FG003|Part B|Withdrawal by parent or guardian|3|||
161771557|NCT04145531|584206331|FG000|Part B|Withdrawal by participant|0|||
161771558|NCT04145531|584206332|FG001|Part B|Withdrawal by participant|0|||
161771559|NCT04145531|584206333|FG002|Part B|Withdrawal by participant|0|||
161771560|NCT04145531|584206334|FG003|Part B|Withdrawal by participant|1|||
161771561|NCT04145531|584206331|FG000|Part B|Other|0|||
161771562|NCT04145531|584206332|FG001|Part B|Other|0|||
161771563|NCT04145531|584206333|FG002|Part B|Other|0|||
161771564|NCT04145531|584206334|FG003|Part B|Other|1|||
161771565|NCT02067728|584206335|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
161771566|NCT02067728|584206336|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
161771567|NCT02067728|584206335|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
161771568|NCT02067728|584206336|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
161771569|NCT02067728|584206335|FG000|6 Month Measurements|Unable to attend|114|||
161771570|NCT02067728|584206336|FG001|6 Month Measurements|Unable to attend|97|||
161771571|NCT00442572|584206342|FG000|Overall Study|Relapse|8|||
161771572|NCT00442572|584206343|FG001|Overall Study|Relapse|1|||
161771573|NCT00442572|584206342|FG000|Overall Study|Lost to Follow-up|0|||
161771574|NCT00442572|584206343|FG001|Overall Study|Lost to Follow-up|1|||
161771575|NCT00442572|584206342|FG000|Overall Study|Withdrawal by Subject|0|||
161771576|NCT00442572|584206343|FG001|Overall Study|Withdrawal by Subject|1|||
161771577|NCT03532048|584206344|FG000|Overall Study|Lost to Follow-up|12|||
161771578|NCT03532048|584206345|FG001|Overall Study|Lost to Follow-up|17|||
161771579|NCT03532048|584206344|FG000|Overall Study|Withdrawal by Subject|7|||
161771580|NCT03532048|584206345|FG001|Overall Study|Withdrawal by Subject|0|||
161771581|NCT04366258|584206346|FG000|Baseline Assessments|Screen Failure|21|||
161771582|NCT04366258|584206346|FG000|Baseline Assessments|Early Termination|3|||
161771583|NCT03557775|584206348|FG000|Overall Study|Withdrawal by Subject|1|||
161771584|NCT03557775|584206349|FG001|Overall Study|Withdrawal by Subject|2|||
161771585|NCT03557775|584206350|FG002|Overall Study|Withdrawal by Subject|4|||
161771586|NCT03557775|584206348|FG000|Overall Study|Physician Decision|0|||
161771587|NCT03557775|584206349|FG001|Overall Study|Physician Decision|1|||
161771588|NCT03557775|584206350|FG002|Overall Study|Physician Decision|0|||
161771589|NCT00308555|584206355|FG000|Overall Study|Withdrawal by Subject|1|||
161771590|NCT00308555|584206356|FG001|Overall Study|Withdrawal by Subject|0|||
161771591|NCT00308555|584206355|FG000|Overall Study|Physician Decision|2|||
161771592|NCT00308555|584206356|FG001|Overall Study|Physician Decision|0|||
161771593|NCT00276458|584206357|FG000|Overall Study|Adverse Event|0|||
161771594|NCT00276458|584206358|FG001|Overall Study|Adverse Event|2|||
161771595|NCT00276458|584206357|FG000|Overall Study|Lost to Follow-up|2|||
161771596|NCT00276458|584206358|FG001|Overall Study|Lost to Follow-up|2|||
161771597|NCT00276458|584206357|FG000|Overall Study|Protocol Violation|4|||
161771598|NCT00276458|584206358|FG001|Overall Study|Protocol Violation|3|||
161771599|NCT01977625|584206367|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
161771600|NCT01977625|584206368|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161771601|NCT01977625|584206367|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161771602|NCT01977625|584206368|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161771603|NCT00429026|584206370|FG000|Overall Study|Inevaluable for response.|40|||
161771604|NCT04338685|584206375|FG000|Overall Study|Death|3|||
161771605|NCT04338685|584206376|FG001|Overall Study|Death|4|||
161771606|NCT04338685|584206377|FG002|Overall Study|Death|2|||
161771607|NCT04338685|584206378|FG003|Overall Study|Death|4|||
161771608|NCT04338685|584206379|FG004|Overall Study|Death|4|||
161771609|NCT04338685|584206380|FG005|Overall Study|Death|8|||
161771610|NCT04338685|584206381|FG006|Overall Study|Death|1|||
161771611|NCT04338685|584206382|FG007|Overall Study|Death|0|||
161771612|NCT04338685|584206383|FG008|Overall Study|Death|0|||
161771613|NCT04338685|584206375|FG000|Overall Study|Study terminated by Sponsor|0|||
161771614|NCT04338685|584206376|FG001|Overall Study|Study terminated by Sponsor|0|||
161771615|NCT04338685|584206377|FG002|Overall Study|Study terminated by Sponsor|1|||
161771616|NCT04338685|584206378|FG003|Overall Study|Study terminated by Sponsor|4|||
161771617|NCT04338685|584206379|FG004|Overall Study|Study terminated by Sponsor|0|||
161771618|NCT04338685|584206380|FG005|Overall Study|Study terminated by Sponsor|5|||
161771619|NCT04338685|584206381|FG006|Overall Study|Study terminated by Sponsor|2|||
161771620|NCT04338685|584206382|FG007|Overall Study|Study terminated by Sponsor|4|||
161771621|NCT04338685|584206383|FG008|Overall Study|Study terminated by Sponsor|1|||
161771622|NCT04338685|584206375|FG000|Overall Study|Withdrawal by Subject|1|||
161771623|NCT04338685|584206376|FG001|Overall Study|Withdrawal by Subject|2|||
161771624|NCT04338685|584206377|FG002|Overall Study|Withdrawal by Subject|0|||
161771625|NCT04338685|584206378|FG003|Overall Study|Withdrawal by Subject|2|||
161771626|NCT04338685|584206379|FG004|Overall Study|Withdrawal by Subject|0|||
161771627|NCT04338685|584206380|FG005|Overall Study|Withdrawal by Subject|5|||
161771628|NCT04338685|584206381|FG006|Overall Study|Withdrawal by Subject|1|||
161771629|NCT04338685|584206382|FG007|Overall Study|Withdrawal by Subject|1|||
161771630|NCT04338685|584206383|FG008|Overall Study|Withdrawal by Subject|0|||
161771631|NCT00234533|584206384|FG000|Overall Study|Withdrawal by Subject|6|||
161771632|NCT00234533|584206384|FG000|Overall Study|Adverse Event|2|||
161771633|NCT00234533|584206384|FG000|Overall Study|Enrolled but not treated|3|||
161771634|NCT02967055|584206385|FG000|Overall Study|Excluded|40|||
161771635|NCT02967055|584206385|FG000|Overall Study|Screen fail|3|||
161771636|NCT02967055|584206385|FG000|Overall Study|Lost to Follow-up|2|||
161771637|NCT02967055|584206385|FG000|Overall Study|Stopped due to side effects|3|||
161771638|NCT02967055|584206385|FG000|Overall Study|Stopped due to drug cost|1|||
161771639|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
161771640|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
161771641|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
161771642|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
161771643|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
161771644|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
161771645|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
161771646|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
161771647|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
161771648|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
161771649|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
161771650|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
161771651|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
161771652|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
161771653|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
161771654|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
161771655|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
161771656|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
161771657|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
161771658|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
161771659|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
161771660|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161771661|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
161771662|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
161771663|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
161771664|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
161771665|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
161771666|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
161771667|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
161771668|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
161771669|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
161771670|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
161771671|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
161771672|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
161771673|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
161771674|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
161771675|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161771676|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
161771677|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161771678|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
161771679|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
161771680|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
161771681|NCT00976989|584206389|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161771682|NCT00976989|584206390|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161771683|NCT00976989|584206391|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
161771684|NCT00976989|584206389|FG000|Overall Study|Death|5|||
161771685|NCT00976989|584206390|FG001|Overall Study|Death|7|||
161771686|NCT00976989|584206391|FG002|Overall Study|Death|10|||
161771687|NCT00976989|584206389|FG000|Overall Study|Refused Treatment|4|||
161771688|NCT00976989|584206390|FG001|Overall Study|Refused Treatment|3|||
161771689|NCT00976989|584206391|FG002|Overall Study|Refused Treatment|5|||
161771690|NCT00976989|584206389|FG000|Overall Study|Failure to Return|2|||
161771691|NCT00976989|584206390|FG001|Overall Study|Failure to Return|1|||
161771692|NCT00976989|584206391|FG002|Overall Study|Failure to Return|0|||
161771693|NCT00976989|584206389|FG000|Overall Study|Recurrence of Disease|0|||
161771694|NCT00976989|584206390|FG001|Overall Study|Recurrence of Disease|1|||
161771695|NCT00976989|584206391|FG002|Overall Study|Recurrence of Disease|0|||
161771696|NCT00976989|584206389|FG000|Overall Study|Other|1|||
161771697|NCT00976989|584206390|FG001|Overall Study|Other|0|||
161771698|NCT00976989|584206391|FG002|Overall Study|Other|1|||
161771699|NCT00908375|584206392|FG000|Overall Study|Withdrawal by Subject|2|||
161771700|NCT00908375|584206393|FG001|Overall Study|Withdrawal by Subject|4|||
161771701|NCT00908375|584206392|FG000|Overall Study|Lost to Follow-up|8|||
161771702|NCT00908375|584206393|FG001|Overall Study|Lost to Follow-up|6|||
161771703|NCT00903357|584206394|FG000|First Intervention|Withdrawal by Subject|5|||
161771704|NCT00903357|584206395|FG001|First Intervention|Withdrawal by Subject|3|||
161771705|NCT00903357|584206394|FG000|First Intervention|Flu|0|||
161771706|NCT00903357|584206395|FG001|First Intervention|Flu|1|||
161771707|NCT00903357|584206394|FG000|Wash Out Period of 2 Weeks|Flu|0|||
161771708|NCT00903357|584206395|FG001|Wash Out Period of 2 Weeks|Flu|1|||
161771709|NCT00903357|584206394|FG000|Second Intervention|Lost to Follow-up|1|||
161771710|NCT00903357|584206395|FG001|Second Intervention|Lost to Follow-up|0|||
161771711|NCT02279888|584206397|FG000|Overall Study|Death|326|||
161771712|NCT02279888|584206397|FG000|Overall Study|Withdrawal by Subject|38|||
161771713|NCT02279888|584206397|FG000|Overall Study|Lost to Follow-up|21|||
161771714|NCT02279888|584206397|FG000|Overall Study|Physician Decision|62|||
161860476|NCT05317312|584531167|FG000|Overall Study|Withdrawal by Subject|0|||
161860477|NCT05317312|584531168|FG001|Overall Study|Withdrawal by Subject|1|||
161771715|NCT02279888|584206397|FG000|Overall Study|Subject Non-compliance|43|||
161771716|NCT02279888|584206397|FG000|Overall Study|Not implanted|14|||
161771717|NCT02279888|584206397|FG000|Overall Study|Visit not performed|26|||
161771718|NCT00752206|584206398|FG000|Overall Study|Disease progression|8|||
161771719|NCT00752206|584206399|FG001|Overall Study|Disease progression|11|||
161771720|NCT00752206|584206398|FG000|Overall Study|Pregnancy|1|||
161771721|NCT00752206|584206399|FG001|Overall Study|Pregnancy|0|||
161771722|NCT01484691|584206400|FG000|Overall Study|Withdrawal by Subject|1|||
161771723|NCT01484691|584206401|FG001|Overall Study|Withdrawal by Subject|1|||
161771724|NCT01484691|584206402|FG002|Overall Study|Withdrawal by Subject|1|||
161771725|NCT01484691|584206400|FG000|Overall Study|Physician Decision|0|||
161771726|NCT01484691|584206401|FG001|Overall Study|Physician Decision|2|||
161771727|NCT01484691|584206402|FG002|Overall Study|Physician Decision|1|||
161771728|NCT03480243|584206405|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
161771729|NCT03480243|584206405|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
161771730|NCT04365387|584206406|FG000|Overall Study|Adverse Event|4|||
161771731|NCT04365387|584206407|FG001|Overall Study|Adverse Event|2|||
161771732|NCT04365387|584206406|FG000|Overall Study|Participants request|14|||
161771733|NCT04365387|584206407|FG001|Overall Study|Participants request|14|||
161771734|NCT04365387|584206406|FG000|Overall Study|Lost to Follow-up|8|||
161771735|NCT04365387|584206407|FG001|Overall Study|Lost to Follow-up|5|||
161771736|NCT04365387|584206406|FG000|Overall Study|Protocol deviation|3|||
161771737|NCT04365387|584206407|FG001|Overall Study|Protocol deviation|4|||
161771738|NCT04365387|584206406|FG000|Overall Study|Participant compliance with visit schedule|1|||
161771739|NCT04365387|584206407|FG001|Overall Study|Participant compliance with visit schedule|0|||
161771740|NCT04365387|584206406|FG000|Overall Study|Participant incarcerated|1|||
161771741|NCT04365387|584206407|FG001|Overall Study|Participant incarcerated|0|||
161771742|NCT04365387|584206406|FG000|Overall Study|Participant moved out of town (relocated)|0|||
161771743|NCT04365387|584206407|FG001|Overall Study|Participant moved out of town (relocated)|1|||
161771744|NCT04365387|584206406|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
161771745|NCT04365387|584206407|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
161771746|NCT04365387|584206406|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
161771747|NCT04365387|584206407|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
161771748|NCT01683565|584206410|FG000|Overall Study|Lost to Follow-up|2|||
161771749|NCT01683565|584206411|FG001|Overall Study|Lost to Follow-up|0|||
161771750|NCT01683565|584206410|FG000|Overall Study|Discontinued Intervention|1|||
161771751|NCT01683565|584206411|FG001|Overall Study|Discontinued Intervention|1|||
161771752|NCT00764465|584206412|FG000|Overall Study|Adverse Event|2|||
161771753|NCT00764465|584206413|FG001|Overall Study|Adverse Event|0|||
161771754|NCT00764465|584206414|FG002|Overall Study|Adverse Event|0|||
161771755|NCT00764465|584206415|FG003|Overall Study|Adverse Event|1|||
161771756|NCT00764465|584206416|FG004|Overall Study|Adverse Event|1|||
161771757|NCT00764465|584206417|FG005|Overall Study|Adverse Event|1|||
161771758|NCT00764465|584206412|FG000|Overall Study|Withdrawal by Subject|0|||
161771759|NCT00764465|584206413|FG001|Overall Study|Withdrawal by Subject|1|||
161771760|NCT00764465|584206414|FG002|Overall Study|Withdrawal by Subject|1|||
161771761|NCT00764465|584206415|FG003|Overall Study|Withdrawal by Subject|0|||
161771762|NCT00764465|584206416|FG004|Overall Study|Withdrawal by Subject|0|||
161771763|NCT00764465|584206417|FG005|Overall Study|Withdrawal by Subject|0|||
161771764|NCT01195662|584206418|FG000|Double Blind Treatment Period|Adverse Event|4|||
161771765|NCT01195662|584206419|FG001|Double Blind Treatment Period|Adverse Event|1|||
161771766|NCT01195662|584206420|FG002|Double Blind Treatment Period|Adverse Event|2|||
161771767|NCT01195662|584206418|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
161771768|NCT01195662|584206419|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
161771769|NCT01195662|584206420|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
161771770|NCT01195662|584206418|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
161771771|NCT01195662|584206419|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
161771772|NCT01195662|584206420|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
161771773|NCT01195662|584206418|FG000|Double Blind Treatment Period|Administrative reason|2|||
161771774|NCT01195662|584206419|FG001|Double Blind Treatment Period|Administrative reason|1|||
161771775|NCT01195662|584206420|FG002|Double Blind Treatment Period|Administrative reason|1|||
161860478|NCT05317312|584531169|FG002|Overall Study|Withdrawal by Subject|0|||
161860479|NCT05317312|584531170|FG003|Overall Study|Withdrawal by Subject|0|||
161860480|NCT05317312|584531167|FG000|Overall Study|Lost to Follow-up|0|||
161771776|NCT01195662|584206418|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
161771777|NCT01195662|584206419|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
161771778|NCT01195662|584206420|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
161771779|NCT01195662|584206418|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
161771780|NCT01195662|584206419|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
161771781|NCT01195662|584206420|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
161771782|NCT01195662|584206418|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
161771783|NCT01195662|584206419|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161771784|NCT01195662|584206420|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161771785|NCT01195662|584206418|FG000|Double Blind Treatment Period|Non-specified|3|||
161771786|NCT01195662|584206419|FG001|Double Blind Treatment Period|Non-specified|0|||
161771787|NCT01195662|584206420|FG002|Double Blind Treatment Period|Non-specified|0|||
161771788|NCT01195662|584206418|FG000|Double Blind Treatment Period|Missing disposition information|0|||
161771789|NCT01195662|584206419|FG001|Double Blind Treatment Period|Missing disposition information|1|||
161771790|NCT01195662|584206420|FG002|Double Blind Treatment Period|Missing disposition information|1|||
161771791|NCT01195662|584206418|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
161771792|NCT01195662|584206419|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
161771793|NCT01195662|584206420|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
161771794|NCT01195662|584206418|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
161771795|NCT01195662|584206419|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
161771796|NCT01195662|584206420|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
161771797|NCT02161380|584206421|FG000|Overall Study|Lost to Follow-up|0|||
161771798|NCT02161380|584206422|FG001|Overall Study|Lost to Follow-up|1|||
161771799|NCT02161380|584206423|FG002|Overall Study|Lost to Follow-up|0|||
161771800|NCT02161380|584206424|FG003|Overall Study|Lost to Follow-up|0|||
161771801|NCT01393444|584206435|FG000|Overall Study|Withdrawal by Subject|1|||
161771802|NCT01393444|584206435|FG000|Overall Study|Determined ineligible during screening.|2|||
161771803|NCT03039699|584206436|FG000|Overall Study|Incorrect inclusion|5|||
161771804|NCT03039699|584206437|FG001|Overall Study|Incorrect inclusion|4|||
161771805|NCT03039699|584206436|FG000|Overall Study|Lack of data to assess study endpoint|5|||
161771806|NCT03039699|584206437|FG001|Overall Study|Lack of data to assess study endpoint|3|||
161771807|NCT03039699|584206436|FG000|Overall Study|Bacterial infection|12|||
161771808|NCT03039699|584206437|FG001|Overall Study|Bacterial infection|28|||
161771809|NCT01397409|584206438|FG000|Stage 2|Adverse Event|0|||
161771810|NCT01397409|584206439|FG001|Stage 2|Adverse Event|0|||
161771811|NCT01397409|584206440|FG002|Stage 2|Adverse Event|0|||
161771812|NCT01397409|584206441|FG003|Stage 2|Adverse Event|0|||
161771813|NCT01397409|584206442|FG004|Stage 2|Adverse Event|6|||
161771814|NCT01397409|584206443|FG005|Stage 2|Adverse Event|3|||
161771815|NCT01397409|584206444|FG006|Stage 2|Adverse Event|0|||
161771816|NCT01397409|584206445|FG007|Stage 2|Adverse Event|0|||
161771817|NCT01397409|584206446|FG008|Stage 2|Adverse Event|0|||
161771818|NCT01397409|584206447|FG009|Stage 2|Adverse Event|0|||
161771819|NCT01397409|584206438|FG000|Stage 2|Personal Reasons|0|||
161771820|NCT01397409|584206439|FG001|Stage 2|Personal Reasons|0|||
161771821|NCT01397409|584206440|FG002|Stage 2|Personal Reasons|0|||
161771822|NCT01397409|584206441|FG003|Stage 2|Personal Reasons|0|||
161771823|NCT01397409|584206442|FG004|Stage 2|Personal Reasons|1|||
161771824|NCT01397409|584206443|FG005|Stage 2|Personal Reasons|0|||
161771825|NCT01397409|584206444|FG006|Stage 2|Personal Reasons|0|||
161771826|NCT01397409|584206445|FG007|Stage 2|Personal Reasons|0|||
161771827|NCT01397409|584206446|FG008|Stage 2|Personal Reasons|0|||
161771828|NCT01397409|584206447|FG009|Stage 2|Personal Reasons|0|||
161771829|NCT01397409|584206438|FG000|Stage 2|Other Miscellaneous Reasons|0|||
161771830|NCT01397409|584206439|FG001|Stage 2|Other Miscellaneous Reasons|0|||
161771831|NCT01397409|584206440|FG002|Stage 2|Other Miscellaneous Reasons|0|||
161771832|NCT01397409|584206441|FG003|Stage 2|Other Miscellaneous Reasons|0|||
161771833|NCT01397409|584206442|FG004|Stage 2|Other Miscellaneous Reasons|1|||
161771834|NCT01397409|584206443|FG005|Stage 2|Other Miscellaneous Reasons|1|||
161771835|NCT01397409|584206444|FG006|Stage 2|Other Miscellaneous Reasons|0|||
161771836|NCT01397409|584206445|FG007|Stage 2|Other Miscellaneous Reasons|0|||
161771837|NCT01397409|584206446|FG008|Stage 2|Other Miscellaneous Reasons|0|||
161771838|NCT01397409|584206447|FG009|Stage 2|Other Miscellaneous Reasons|0|||
161771839|NCT01397409|584206438|FG000|Stage 3|Adverse Event|0|||
161771840|NCT01397409|584206439|FG001|Stage 3|Adverse Event|0|||
161771841|NCT01397409|584206440|FG002|Stage 3|Adverse Event|0|||
161771842|NCT01397409|584206441|FG003|Stage 3|Adverse Event|0|||
161771843|NCT01397409|584206442|FG004|Stage 3|Adverse Event|0|||
161771844|NCT01397409|584206443|FG005|Stage 3|Adverse Event|0|||
161771845|NCT01397409|584206444|FG006|Stage 3|Adverse Event|0|||
161771846|NCT01397409|584206445|FG007|Stage 3|Adverse Event|1|||
161771847|NCT01397409|584206446|FG008|Stage 3|Adverse Event|0|||
161771848|NCT01397409|584206447|FG009|Stage 3|Adverse Event|0|||
161771849|NCT01397409|584206438|FG000|Stage 3|Other Miscellaneous Reasons|0|||
161771850|NCT01397409|584206439|FG001|Stage 3|Other Miscellaneous Reasons|0|||
161771851|NCT01397409|584206440|FG002|Stage 3|Other Miscellaneous Reasons|0|||
161771852|NCT01397409|584206441|FG003|Stage 3|Other Miscellaneous Reasons|0|||
161771853|NCT01397409|584206442|FG004|Stage 3|Other Miscellaneous Reasons|0|||
161771854|NCT01397409|584206443|FG005|Stage 3|Other Miscellaneous Reasons|0|||
161771855|NCT01397409|584206444|FG006|Stage 3|Other Miscellaneous Reasons|0|||
161771856|NCT01397409|584206445|FG007|Stage 3|Other Miscellaneous Reasons|1|||
161771857|NCT01397409|584206446|FG008|Stage 3|Other Miscellaneous Reasons|0|||
161771858|NCT01397409|584206447|FG009|Stage 3|Other Miscellaneous Reasons|0|||
161771859|NCT03418727|584206448|FG000|Overall Study|Adverse Event|1|||
161771860|NCT03418727|584206449|FG001|Overall Study|Adverse Event|2|||
161771861|NCT03418727|584206450|FG002|Overall Study|Adverse Event|0|||
161771862|NCT03418727|584206448|FG000|Overall Study|Withdrawal by Subject|0|||
161771863|NCT03418727|584206449|FG001|Overall Study|Withdrawal by Subject|0|||
161771864|NCT03418727|584206450|FG002|Overall Study|Withdrawal by Subject|2|||
161771865|NCT01740297|584208188|FG000|Overall Study|Withdrawal by Subject|4|||
161771866|NCT01740297|584208189|FG001|Overall Study|Withdrawal by Subject|16|||
161771867|NCT01740297|584208190|FG002|Overall Study|Withdrawal by Subject|17|||
161771868|NCT01740297|584208188|FG000|Overall Study|Death|8|||
161771869|NCT01740297|584208189|FG001|Overall Study|Death|46|||
161771870|NCT01740297|584208190|FG002|Overall Study|Death|40|||
161771871|NCT01740297|584208188|FG000|Overall Study|Lost to Follow-up|1|||
161771872|NCT01740297|584208189|FG001|Overall Study|Lost to Follow-up|2|||
161771873|NCT01740297|584208190|FG002|Overall Study|Lost to Follow-up|4|||
161771874|NCT03280628|584208195|FG000|Overall Study|Lost to Follow-up|8|||
161771875|NCT03280628|584208196|FG001|Overall Study|Lost to Follow-up|6|||
161771876|NCT03280628|584208197|FG002|Overall Study|Lost to Follow-up|11|||
161771877|NCT00761462|584208198|FG000|Treatment|Subjects never received study medication|23|||
161771878|NCT00761462|584208199|FG001|Treatment|Subjects never received study medication|12|||
161771879|NCT00761462|584208198|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
161771880|NCT00761462|584208199|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
161771881|NCT00761462|584208198|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
161771882|NCT00761462|584208199|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
161771883|NCT00761462|584208198|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
161771884|NCT00761462|584208199|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
161771885|NCT02163759|584208206|FG000|Overall Study|Withdrawal by Subject|1|||
161771886|NCT02163759|584208207|FG001|Overall Study|Withdrawal by Subject|5|||
161771887|NCT02163759|584208208|FG002|Overall Study|Withdrawal by Subject|1|||
161771888|NCT02163759|584208206|FG000|Overall Study|Adverse Event|0|||
161771889|NCT02163759|584208207|FG001|Overall Study|Adverse Event|0|||
161771890|NCT02163759|584208208|FG002|Overall Study|Adverse Event|1|||
161771891|NCT02163759|584208206|FG000|Overall Study|Death|0|||
161771892|NCT02163759|584208207|FG001|Overall Study|Death|0|||
161771893|NCT02163759|584208208|FG002|Overall Study|Death|1|||
161771894|NCT01479777|584208214|FG000|Overall Study|Physician Decision|2|||
161771895|NCT00451191|584208218|FG000|Overall Study|withdrawal or received alternate tx|15|||
161771896|NCT00451191|584208219|FG001|Overall Study|withdrawal or received alternate tx|11|||
161771897|NCT00656669|584208227|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
161771898|NCT00656669|584208227|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
161771899|NCT00656669|584208227|FG000|AC (Cycles 6-9)|Adverse Event|1|||
161771900|NCT00656669|584208227|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
161771901|NCT03575806|584208232|FG000|Overall Study|Withdrawal by Subject|0|||
161771902|NCT03575806|584208233|FG001|Overall Study|Withdrawal by Subject|2|||
161771903|NCT03575806|584208232|FG000|Overall Study|Protocol Violation|0|||
161771904|NCT03575806|584208233|FG001|Overall Study|Protocol Violation|2|||
161771905|NCT00219349|584208234|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
161771906|NCT00219349|584208234|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
161771907|NCT00219349|584208234|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
161771908|NCT00219349|584208234|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
161771909|NCT01241591|584208236|FG000|Overall Study|Lack of Efficacy|5|||
161771910|NCT01241591|584208237|FG001|Overall Study|Lack of Efficacy|2|||
161771911|NCT01241591|584208238|FG002|Overall Study|Lack of Efficacy|2|||
161771912|NCT01241591|584208239|FG003|Overall Study|Lack of Efficacy|3|||
161771913|NCT01241591|584208236|FG000|Overall Study|Protocol Violation|5|||
161771914|NCT01241591|584208237|FG001|Overall Study|Protocol Violation|2|||
161771915|NCT01241591|584208238|FG002|Overall Study|Protocol Violation|3|||
161771916|NCT01241591|584208239|FG003|Overall Study|Protocol Violation|0|||
161771917|NCT01241591|584208236|FG000|Overall Study|Lost to Follow-up|1|||
161771918|NCT01241591|584208237|FG001|Overall Study|Lost to Follow-up|2|||
161771919|NCT01241591|584208238|FG002|Overall Study|Lost to Follow-up|2|||
161860481|NCT05317312|584531168|FG001|Overall Study|Lost to Follow-up|0|||
161860482|NCT05317312|584531169|FG002|Overall Study|Lost to Follow-up|0|||
161860483|NCT05317312|584531170|FG003|Overall Study|Lost to Follow-up|1|||
161771920|NCT01241591|584208239|FG003|Overall Study|Lost to Follow-up|2|||
161771921|NCT01241591|584208236|FG000|Overall Study|Screen Failure|3|||
161771922|NCT01241591|584208237|FG001|Overall Study|Screen Failure|2|||
161771923|NCT01241591|584208238|FG002|Overall Study|Screen Failure|1|||
161771924|NCT01241591|584208239|FG003|Overall Study|Screen Failure|0|||
161771925|NCT01241591|584208236|FG000|Overall Study|Withdrawal by Subject|6|||
161771926|NCT01241591|584208237|FG001|Overall Study|Withdrawal by Subject|4|||
161771927|NCT01241591|584208238|FG002|Overall Study|Withdrawal by Subject|2|||
161771928|NCT01241591|584208239|FG003|Overall Study|Withdrawal by Subject|2|||
161771929|NCT01241591|584208236|FG000|Overall Study|Other|0|||
161771930|NCT01241591|584208237|FG001|Overall Study|Other|1|||
161771931|NCT01241591|584208238|FG002|Overall Study|Other|0|||
161771932|NCT01241591|584208239|FG003|Overall Study|Other|1|||
161771933|NCT01241591|584208236|FG000|Overall Study|Adverse Event|3|||
161771934|NCT01241591|584208237|FG001|Overall Study|Adverse Event|11|||
161771935|NCT01241591|584208238|FG002|Overall Study|Adverse Event|12|||
161771936|NCT01241591|584208239|FG003|Overall Study|Adverse Event|4|||
161771937|NCT01945034|584208240|FG000|Overall Study|Medication Error|0|||
161771938|NCT01945034|584208241|FG001|Overall Study|Medication Error|1|||
161771939|NCT01945034|584208242|FG002|Overall Study|Medication Error|0|||
161771940|NCT01945034|584208240|FG000|Overall Study|Withdrawal by Subject|0|||
161771941|NCT01945034|584208241|FG001|Overall Study|Withdrawal by Subject|3|||
161771942|NCT01945034|584208242|FG002|Overall Study|Withdrawal by Subject|1|||
161771943|NCT01945034|584208240|FG000|Overall Study|Other|0|||
161771944|NCT01945034|584208241|FG001|Overall Study|Other|1|||
161771945|NCT01945034|584208242|FG002|Overall Study|Other|3|||
161771946|NCT01945034|584208240|FG000|Overall Study|Lost to Follow-up|0|||
161771947|NCT01945034|584208241|FG001|Overall Study|Lost to Follow-up|0|||
161771948|NCT01945034|584208242|FG002|Overall Study|Lost to Follow-up|2|||
161771949|NCT01945034|584208240|FG000|Overall Study|Protocol Violation|1|||
161771950|NCT01945034|584208241|FG001|Overall Study|Protocol Violation|0|||
161771951|NCT01945034|584208242|FG002|Overall Study|Protocol Violation|1|||
161771952|NCT00700115|584208245|FG000|Overall Study|Withdrawal by Subject|1|||
161771953|NCT00700115|584208246|FG001|Overall Study|Withdrawal by Subject|0|||
161771954|NCT00700115|584208245|FG000|Overall Study|Lost to Follow-up|0|||
161771955|NCT00700115|584208246|FG001|Overall Study|Lost to Follow-up|1|||
161771956|NCT01300741|584208252|FG000|Overall Study|Lens deposits|1|||
161771957|NCT01300741|584208252|FG000|Overall Study|Lost to Follow-up|1|||
161771958|NCT01300741|584208252|FG000|Overall Study|Discomfort|1|||
161771959|NCT04854421|584208253|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
161771960|NCT04854421|584208254|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
161771961|NCT00718809|584208256|FG000|Overall Study|Disease progression|9|||
161771962|NCT00718809|584208257|FG001|Overall Study|Disease progression|7|||
161771963|NCT00718809|584208256|FG000|Overall Study|Adverse Event|1|||
161771964|NCT00718809|584208257|FG001|Overall Study|Adverse Event|1|||
161771965|NCT00718809|584208256|FG000|Overall Study|Withdrawal by Subject|0|||
161771966|NCT00718809|584208257|FG001|Overall Study|Withdrawal by Subject|1|||
161771967|NCT00718809|584208256|FG000|Overall Study|Lost to Follow-up|1|||
161771968|NCT00718809|584208257|FG001|Overall Study|Lost to Follow-up|0|||
161771969|NCT00718809|584208256|FG000|Overall Study|Noncompliance|1|||
161771970|NCT00718809|584208257|FG001|Overall Study|Noncompliance|0|||
161771971|NCT00463385|584208258|FG000|Overall Study|Other|4|||
161771972|NCT00463385|584208259|FG001|Overall Study|Other|3|||
161771973|NCT00463385|584208260|FG002|Overall Study|Other|6|||
161771974|NCT00463385|584208261|FG003|Overall Study|Other|4|||
161771975|NCT00463385|584208258|FG000|Overall Study|Adverse Event|5|||
161771976|NCT00463385|584208259|FG001|Overall Study|Adverse Event|8|||
161771977|NCT00463385|584208260|FG002|Overall Study|Adverse Event|4|||
161771978|NCT00463385|584208261|FG003|Overall Study|Adverse Event|2|||
161771979|NCT00463385|584208258|FG000|Overall Study|Lack of Efficacy|6|||
161771980|NCT00463385|584208259|FG001|Overall Study|Lack of Efficacy|6|||
161771981|NCT00463385|584208260|FG002|Overall Study|Lack of Efficacy|7|||
161771982|NCT00463385|584208261|FG003|Overall Study|Lack of Efficacy|9|||
161771983|NCT00463385|584208258|FG000|Overall Study|Withdrawal by Subject|3|||
161771984|NCT00463385|584208259|FG001|Overall Study|Withdrawal by Subject|3|||
161771985|NCT00463385|584208260|FG002|Overall Study|Withdrawal by Subject|3|||
161771986|NCT00463385|584208261|FG003|Overall Study|Withdrawal by Subject|4|||
161771987|NCT00463385|584208258|FG000|Overall Study|Lost to Follow-up|0|||
161771988|NCT00463385|584208259|FG001|Overall Study|Lost to Follow-up|0|||
161771989|NCT00463385|584208260|FG002|Overall Study|Lost to Follow-up|0|||
161771990|NCT00463385|584208261|FG003|Overall Study|Lost to Follow-up|1|||
161771991|NCT00463385|584208258|FG000|Overall Study|Death|2|||
161771992|NCT00463385|584208259|FG001|Overall Study|Death|1|||
161771993|NCT00463385|584208260|FG002|Overall Study|Death|2|||
161771994|NCT00463385|584208261|FG003|Overall Study|Death|0|||
161771995|NCT00463385|584208258|FG000|Overall Study|Missing|2|||
161771996|NCT00463385|584208259|FG001|Overall Study|Missing|0|||
161771997|NCT00463385|584208260|FG002|Overall Study|Missing|0|||
161771998|NCT00463385|584208261|FG003|Overall Study|Missing|2|||
161771999|NCT00463385|584208258|FG000|Overall Study|1 participant received commercial drug|0|||
161772000|NCT00463385|584208259|FG001|Overall Study|1 participant received commercial drug|1|||
161772001|NCT00463385|584208260|FG002|Overall Study|1 participant received commercial drug|0|||
161772002|NCT00463385|584208261|FG003|Overall Study|1 participant received commercial drug|0|||
161772003|NCT00536991|584208263|FG000|Overall Study|Withdrawal by Subject|10|||
161772004|NCT00536991|584208263|FG000|Overall Study|Physician Decision|1|||
161772005|NCT00536991|584208263|FG000|Overall Study|patient ineligible|2|||
161772006|NCT00054639|584208264|FG000|Overall Study|Lack of Efficacy|1|||
161772007|NCT00054639|584208264|FG000|Overall Study|Physician Decision|1|||
161772008|NCT01600755|584208265|FG000|Overall Study|Withdrawal by Subject|6|||
161772009|NCT00938392|584208270|FG000|Overall Study|Adverse Event|0|||
161772010|NCT00938392|584208271|FG001|Overall Study|Adverse Event|1|||
161772011|NCT00938392|584208270|FG000|Overall Study|Withdrawal by Subject|0|||
161772012|NCT00938392|584208271|FG001|Overall Study|Withdrawal by Subject|1|||
161772013|NCT00938392|584208270|FG000|Overall Study|Lost to Follow-up|2|||
161772014|NCT00938392|584208271|FG001|Overall Study|Lost to Follow-up|2|||
161772015|NCT00122954|584208272|FG000|Overall Study|Withdrawal by Subject|2|||
161772016|NCT00122954|584208273|FG001|Overall Study|Withdrawal by Subject|2|||
161772017|NCT00122954|584208272|FG000|Overall Study|Protocol Violation|0|||
161772018|NCT00122954|584208273|FG001|Overall Study|Protocol Violation|1|||
161772019|NCT00494234|584208279|FG000|Overall Study|Withdrawal by Subject|1|||
161772020|NCT00494234|584208280|FG001|Overall Study|Withdrawal by Subject|0|||
161772021|NCT00494234|584208279|FG000|Overall Study|Disease progression|11|||
161772022|NCT00494234|584208280|FG001|Overall Study|Disease progression|8|||
161772023|NCT00494234|584208279|FG000|Overall Study|Death|2|||
161772024|NCT00494234|584208280|FG001|Overall Study|Death|1|||
161772025|NCT02743117|584208284|FG000|Overall Study|Lost to Follow-up|0|||
161772026|NCT02743117|584208285|FG001|Overall Study|Lost to Follow-up|1|||
161772027|NCT02743117|584208284|FG000|Overall Study|Other|1|||
161772028|NCT02743117|584208285|FG001|Overall Study|Other|0|||
161772029|NCT00779857|584208286|FG000|Overall Study|Death|1|||
161772030|NCT00779857|584208286|FG000|Overall Study|Withdrawal by Subject|3|||
161772031|NCT00779857|584208286|FG000|Overall Study|Missed Visit|2|||
161772032|NCT04640168|584208287|FG000|Overall Study|Withdrawal by Subject|8|||
161772033|NCT04640168|584208288|FG001|Overall Study|Withdrawal by Subject|7|||
161772034|NCT04640168|584208287|FG000|Overall Study|Lost to Follow-up|1|||
161772035|NCT04640168|584208288|FG001|Overall Study|Lost to Follow-up|0|||
161772036|NCT04640168|584208287|FG000|Overall Study|Enrolled but not treated|12|||
161772037|NCT04640168|584208288|FG001|Overall Study|Enrolled but not treated|12|||
161772038|NCT00978120|584208292|FG000|Overall Study|Death|0|||
161772039|NCT00978120|584208293|FG001|Overall Study|Death|0|||
161772040|NCT00978120|584208294|FG002|Overall Study|Death|0|||
161772041|NCT00978120|584208295|FG003|Overall Study|Death|1|||
161772042|NCT00978120|584208292|FG000|Overall Study|Lost to Follow-up|0|||
161772043|NCT00978120|584208293|FG001|Overall Study|Lost to Follow-up|0|||
161772044|NCT00978120|584208294|FG002|Overall Study|Lost to Follow-up|3|||
161772045|NCT00978120|584208295|FG003|Overall Study|Lost to Follow-up|0|||
161772046|NCT00978120|584208292|FG000|Overall Study|Withdrawal by Subject|2|||
161772047|NCT00978120|584208293|FG001|Overall Study|Withdrawal by Subject|0|||
161772048|NCT00978120|584208294|FG002|Overall Study|Withdrawal by Subject|0|||
161772049|NCT00978120|584208295|FG003|Overall Study|Withdrawal by Subject|0|||
161772050|NCT00978120|584208292|FG000|Overall Study|Moved out of state|0|||
161772051|NCT00978120|584208293|FG001|Overall Study|Moved out of state|0|||
161772052|NCT00978120|584208294|FG002|Overall Study|Moved out of state|0|||
161772053|NCT00978120|584208295|FG003|Overall Study|Moved out of state|1|||
161772054|NCT01023815|584208297|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
161772055|NCT01023815|584208298|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161772056|NCT01023815|584208299|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161772057|NCT01023815|584208300|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161772058|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
161772059|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
161772060|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
161772061|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
161772062|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
161772063|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
161772064|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
161772065|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
161772066|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
161772067|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
161772068|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
161772069|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
161772070|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161772071|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
161772072|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161772073|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161772074|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
161772075|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
161772076|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
161772077|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
161772078|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
161772079|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Death|1|||
161772080|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Death|0|||
161772081|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Death|0|||
161772082|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Death|0|||
161772083|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Death|0|||
161772084|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
161772085|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
161772086|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
161772087|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
161772088|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
161772089|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
161772090|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
161772091|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
161772092|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
161772093|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
161772094|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161772095|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
161772096|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
161772097|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161772098|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161772099|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161772100|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
161772101|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
161772102|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161772103|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161772104|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
161772105|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
161772106|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161772107|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161772108|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161772109|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Other|1|||
161772110|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Other|8|||
161772111|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Other|5|||
161772112|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Other|0|||
161772113|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Other|0|||
161772114|NCT00634933|584208302|FG000|Between Part A and Part B|Physician Decision|0|||
161772115|NCT00634933|584208303|FG001|Between Part A and Part B|Physician Decision|1|||
161772116|NCT00634933|584208304|FG002|Between Part A and Part B|Physician Decision|0|||
161772117|NCT00634933|584208305|FG003|Between Part A and Part B|Physician Decision|0|||
161772118|NCT00634933|584208306|FG004|Between Part A and Part B|Physician Decision|0|||
161772119|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
161772120|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
161772121|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
161772122|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
161772123|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
161860484|NCT05317312|584531167|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
161860485|NCT05317312|584531168|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
161860486|NCT05317312|584531169|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
161772124|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
161772125|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
161772126|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
161772127|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
161772128|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
161772129|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
161772130|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
161772131|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
161772132|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
161772133|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
161772134|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772135|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772136|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772137|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772138|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
161772139|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161772140|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161772141|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161772142|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
161772143|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
161772144|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161772145|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
161772146|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
161772147|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161772148|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161772149|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Other|0|||
161772150|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Other|0|||
161860487|NCT05317312|584531170|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
161860488|NCT00262028|584531171|FG000|Overall Study|Withdrawal by Subject|6|||
161860489|NCT00262028|584531172|FG001|Overall Study|Withdrawal by Subject|3|||
161860490|NCT00262028|584531173|FG002|Overall Study|Withdrawal by Subject|6|||
161860491|NCT00262028|584531174|FG003|Overall Study|Withdrawal by Subject|5|||
161860492|NCT00262028|584531175|FG004|Overall Study|Withdrawal by Subject|2|||
161860493|NCT00262028|584531176|FG005|Overall Study|Withdrawal by Subject|3|||
161860494|NCT00262028|584531177|FG006|Overall Study|Withdrawal by Subject|5|||
161860495|NCT00262028|584531178|FG007|Overall Study|Withdrawal by Subject|7|||
161860496|NCT00262028|584531179|FG008|Overall Study|Withdrawal by Subject|2|||
161860497|NCT00262028|584531171|FG000|Overall Study|Lost to Follow-up|7|||
161860498|NCT00262028|584531172|FG001|Overall Study|Lost to Follow-up|7|||
161860499|NCT00262028|584531173|FG002|Overall Study|Lost to Follow-up|5|||
161860500|NCT00262028|584531174|FG003|Overall Study|Lost to Follow-up|5|||
161860501|NCT00262028|584531175|FG004|Overall Study|Lost to Follow-up|4|||
161860502|NCT00262028|584531176|FG005|Overall Study|Lost to Follow-up|3|||
161860503|NCT00262028|584531177|FG006|Overall Study|Lost to Follow-up|3|||
161860504|NCT00262028|584531178|FG007|Overall Study|Lost to Follow-up|5|||
161860505|NCT00262028|584531179|FG008|Overall Study|Lost to Follow-up|6|||
161860506|NCT00262028|584531171|FG000|Overall Study|Administrative Reason|11|||
161860507|NCT00262028|584531172|FG001|Overall Study|Administrative Reason|14|||
161860508|NCT00262028|584531173|FG002|Overall Study|Administrative Reason|9|||
161860509|NCT00262028|584531174|FG003|Overall Study|Administrative Reason|12|||
161860510|NCT00262028|584531175|FG004|Overall Study|Administrative Reason|6|||
161860511|NCT00262028|584531176|FG005|Overall Study|Administrative Reason|7|||
161860512|NCT00262028|584531177|FG006|Overall Study|Administrative Reason|4|||
161860513|NCT00262028|584531178|FG007|Overall Study|Administrative Reason|6|||
161860514|NCT00262028|584531179|FG008|Overall Study|Administrative Reason|10|||
161860515|NCT00262028|584531171|FG000|Overall Study|Protocol Violation|0|||
161860516|NCT00262028|584531172|FG001|Overall Study|Protocol Violation|0|||
161860517|NCT00262028|584531173|FG002|Overall Study|Protocol Violation|0|||
161860518|NCT00262028|584531174|FG003|Overall Study|Protocol Violation|1|||
161860519|NCT00262028|584531175|FG004|Overall Study|Protocol Violation|0|||
161860520|NCT00262028|584531176|FG005|Overall Study|Protocol Violation|0|||
161860521|NCT00262028|584531177|FG006|Overall Study|Protocol Violation|0|||
161860522|NCT00262028|584531178|FG007|Overall Study|Protocol Violation|0|||
161860523|NCT00262028|584531179|FG008|Overall Study|Protocol Violation|0|||
161860524|NCT00262028|584531171|FG000|Overall Study|Unable to classify|0|||
161860525|NCT00262028|584531172|FG001|Overall Study|Unable to classify|3|||
161860526|NCT00262028|584531173|FG002|Overall Study|Unable to classify|0|||
161860527|NCT00262028|584531174|FG003|Overall Study|Unable to classify|0|||
161860528|NCT00262028|584531175|FG004|Overall Study|Unable to classify|0|||
161860529|NCT00262028|584531176|FG005|Overall Study|Unable to classify|0|||
161772151|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Other|5|||
161860530|NCT00262028|584531177|FG006|Overall Study|Unable to classify|0|||
161860531|NCT00262028|584531178|FG007|Overall Study|Unable to classify|0|||
161860532|NCT00262028|584531179|FG008|Overall Study|Unable to classify|1|||
161860533|NCT00124917|584531180|FG000|Overall Study|Physician Decision|3|||
161860534|NCT03164551|584531181|FG000|Overall Study|Imaging discontinued prior completion|8|||
161772152|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Other|0|||
161772153|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Other|1|||
161860535|NCT03164551|584531182|FG001|Overall Study|Imaging discontinued prior completion|0|||
161860536|NCT03164551|584531181|FG000|Overall Study|Participant was non-compliant|1|||
161860537|NCT03164551|584531182|FG001|Overall Study|Participant was non-compliant|0|||
161860538|NCT03164551|584531181|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
161860539|NCT03164551|584531182|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
161860540|NCT03164551|584531181|FG000|Overall Study|Other|8|||
161860541|NCT03164551|584531182|FG001|Overall Study|Other|2|||
161860542|NCT01515423|584531183|FG000|Open Label Phase|Adverse Event|57|||
161860543|NCT01515423|584531184|FG001|Open Label Phase|Adverse Event|0|||
161860544|NCT01515423|584531185|FG002|Open Label Phase|Adverse Event|0|||
161860545|NCT01515423|584531183|FG000|Open Label Phase|Death|2|||
161860546|NCT01515423|584531184|FG001|Open Label Phase|Death|0|||
161860547|NCT01515423|584531185|FG002|Open Label Phase|Death|0|||
161860548|NCT01515423|584531183|FG000|Open Label Phase|Lack of Efficacy|117|||
161860549|NCT01515423|584531184|FG001|Open Label Phase|Lack of Efficacy|0|||
161860550|NCT01515423|584531185|FG002|Open Label Phase|Lack of Efficacy|0|||
161860551|NCT01515423|584531183|FG000|Open Label Phase|Lost to Follow-up|21|||
161860552|NCT01515423|584531184|FG001|Open Label Phase|Lost to Follow-up|0|||
161860553|NCT01515423|584531185|FG002|Open Label Phase|Lost to Follow-up|0|||
161860554|NCT01515423|584531183|FG000|Open Label Phase|Withdrawal by Subject|118|||
161860555|NCT01515423|584531184|FG001|Open Label Phase|Withdrawal by Subject|0|||
161860556|NCT01515423|584531185|FG002|Open Label Phase|Withdrawal by Subject|0|||
161860557|NCT01515423|584531183|FG000|Open Label Phase|excluded from DB Phase|70|||
161860558|NCT01515423|584531184|FG001|Open Label Phase|excluded from DB Phase|0|||
161860559|NCT01515423|584531185|FG002|Open Label Phase|excluded from DB Phase|0|||
161860560|NCT01515423|584531183|FG000|Open Label Phase|Other|28|||
161860561|NCT01515423|584531184|FG001|Open Label Phase|Other|0|||
161860562|NCT01515423|584531185|FG002|Open Label Phase|Other|0|||
161860563|NCT01515423|584531183|FG000|DOUBLE BLIND|Adverse Event|0|||
161860564|NCT01515423|584531184|FG001|DOUBLE BLIND|Adverse Event|15|||
161860565|NCT01515423|584531185|FG002|DOUBLE BLIND|Adverse Event|13|||
161860566|NCT01515423|584531183|FG000|DOUBLE BLIND|Death|0|||
161860567|NCT01515423|584531184|FG001|DOUBLE BLIND|Death|1|||
161860568|NCT01515423|584531185|FG002|DOUBLE BLIND|Death|2|||
161860569|NCT01515423|584531183|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
161860570|NCT01515423|584531184|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
161860571|NCT01515423|584531185|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
161860572|NCT01515423|584531183|FG000|DOUBLE BLIND|Pregnancy|0|||
161860573|NCT01515423|584531184|FG001|DOUBLE BLIND|Pregnancy|2|||
161860574|NCT01515423|584531185|FG002|DOUBLE BLIND|Pregnancy|0|||
161860575|NCT01515423|584531183|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
161860576|NCT01515423|584531184|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
161860577|NCT01515423|584531185|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
161860578|NCT01515423|584531183|FG000|DOUBLE BLIND|Other|0|||
161860579|NCT01515423|584531184|FG001|DOUBLE BLIND|Other|6|||
161860580|NCT01515423|584531185|FG002|DOUBLE BLIND|Other|12|||
161860581|NCT01515423|584531183|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
161860582|NCT01515423|584531184|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
161860583|NCT01515423|584531185|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
161860584|NCT01422213|584531190|FG000|Overall Study|Adverse Event|8|||
161860585|NCT01422213|584531191|FG001|Overall Study|Adverse Event|7|||
161860586|NCT01422213|584531192|FG002|Overall Study|Adverse Event|11|||
161860587|NCT01422213|584531190|FG000|Overall Study|Lack of Efficacy|10|||
161860588|NCT01422213|584531191|FG001|Overall Study|Lack of Efficacy|2|||
161860589|NCT01422213|584531192|FG002|Overall Study|Lack of Efficacy|2|||
161860590|NCT01422213|584531190|FG000|Overall Study|Non-compliance with study drug|0|||
161860591|NCT01422213|584531191|FG001|Overall Study|Non-compliance with study drug|1|||
161860592|NCT01422213|584531192|FG002|Overall Study|Non-compliance with study drug|0|||
161860593|NCT01422213|584531190|FG000|Overall Study|Protocol Violation|0|||
161860594|NCT01422213|584531191|FG001|Overall Study|Protocol Violation|2|||
161860595|NCT01422213|584531192|FG002|Overall Study|Protocol Violation|4|||
161860596|NCT01422213|584531190|FG000|Overall Study|Withdrawal of Consent|7|||
161860597|NCT01422213|584531191|FG001|Overall Study|Withdrawal of Consent|3|||
161860598|NCT01422213|584531192|FG002|Overall Study|Withdrawal of Consent|5|||
161860599|NCT01422213|584531190|FG000|Overall Study|Lost to Follow-up|3|||
161860600|NCT01422213|584531191|FG001|Overall Study|Lost to Follow-up|3|||
161860601|NCT01422213|584531192|FG002|Overall Study|Lost to Follow-up|5|||
161860602|NCT01422213|584531190|FG000|Overall Study|Administrative or Other Reason(s)|5|||
161860603|NCT01422213|584531191|FG001|Overall Study|Administrative or Other Reason(s)|4|||
161860604|NCT01422213|584531192|FG002|Overall Study|Administrative or Other Reason(s)|2|||
161860605|NCT00613171|584531193|FG000|Overall Study|Adverse Event|7|||
161860606|NCT00613171|584531193|FG000|Overall Study|Withdrawal by Subject|3|||
161860607|NCT00613171|584531193|FG000|Overall Study|Reason not Specified|4|||
161860608|NCT00951496|584531198|FG000|Overall Study|Did not initiate study treatment|10|||
161860609|NCT00951496|584531199|FG001|Overall Study|Did not initiate study treatment|8|||
161860610|NCT00951496|584531200|FG002|Overall Study|Did not initiate study treatment|13|||
161860611|NCT01042093|584531201|FG000|Overall Study|Protocol Violation|2|||
161860612|NCT01042093|584531202|FG001|Overall Study|Protocol Violation|2|||
161860613|NCT01042093|584531203|FG002|Overall Study|Protocol Violation|2|||
161860614|NCT01042093|584531204|FG003|Overall Study|Protocol Violation|3|||
161860615|NCT01042093|584531201|FG000|Overall Study|Withdrawal by Subject|0|||
161860616|NCT01042093|584531202|FG001|Overall Study|Withdrawal by Subject|0|||
161860617|NCT01042093|584531203|FG002|Overall Study|Withdrawal by Subject|0|||
161860618|NCT01042093|584531204|FG003|Overall Study|Withdrawal by Subject|1|||
161860619|NCT00995774|584531207|FG000|Training Period 2|Withdrawal by Subject|2|||
161860620|NCT00995774|584531208|FG001|Training Period 2|Withdrawal by Subject|0|||
161860621|NCT01998841|584531215|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
161860622|NCT01998841|584531216|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
161860623|NCT01998841|584531217|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
161860624|NCT01998841|584531218|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860625|NCT01998841|584531219|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860626|NCT01998841|584531215|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860627|NCT01998841|584531216|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860628|NCT01998841|584531217|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860629|NCT01998841|584531218|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
161860630|NCT01998841|584531219|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
161860631|NCT00972595|584531220|FG000|Period 1|Adverse Event|1|||
161860632|NCT00972595|584531221|FG001|Period 1|Adverse Event|0|||
161860633|NCT01406574|584531223|FG000|Overall Study|Adverse Event|0|||
161860634|NCT01406574|584531224|FG001|Overall Study|Adverse Event|0|||
161860635|NCT01406574|584531225|FG002|Overall Study|Adverse Event|1|||
161860636|NCT01406574|584531226|FG003|Overall Study|Adverse Event|3|||
161860637|NCT01406574|584531223|FG000|Overall Study|Physician Decision|0|||
161860638|NCT01406574|584531224|FG001|Overall Study|Physician Decision|0|||
161860639|NCT01406574|584531225|FG002|Overall Study|Physician Decision|0|||
161860640|NCT01406574|584531226|FG003|Overall Study|Physician Decision|1|||
161860641|NCT01406574|584531223|FG000|Overall Study|Withdrawal by Subject|0|||
161860642|NCT01406574|584531224|FG001|Overall Study|Withdrawal by Subject|1|||
161860643|NCT01406574|584531225|FG002|Overall Study|Withdrawal by Subject|0|||
161860644|NCT01406574|584531226|FG003|Overall Study|Withdrawal by Subject|0|||
161860645|NCT01406574|584531223|FG000|Overall Study|Definite progression of primary disease|1|||
161860646|NCT01406574|584531224|FG001|Overall Study|Definite progression of primary disease|0|||
161860647|NCT01406574|584531225|FG002|Overall Study|Definite progression of primary disease|0|||
161860648|NCT01406574|584531226|FG003|Overall Study|Definite progression of primary disease|0|||
161860649|NCT03447743|584531227|FG000|Overall Study|Withdrawal by Subject|2|||
161860650|NCT03447743|584531227|FG000|Overall Study|Lost to Follow-up|3|||
161860651|NCT03447743|584531227|FG000|Overall Study|Adverse Event|1|||
161860652|NCT03447743|584531227|FG000|Overall Study|Did not meet criteria to continue|1|||
161860653|NCT01112059|584531228|FG000|Overall Study|Withdrawal by Subject|1|||
161860654|NCT01112059|584531229|FG001|Overall Study|Withdrawal by Subject|0|||
161860655|NCT01245283|584531230|FG000|Overall Study|Lost to Follow-up|14|||
161860656|NCT01245283|584531231|FG001|Overall Study|Lost to Follow-up|11|||
161860657|NCT01245283|584531232|FG002|Overall Study|Lost to Follow-up|11|||
161860658|NCT03567980|584531243|FG000|Overall Study|Adverse Event|1|||
161860659|NCT01610492|584531244|FG000|Overall Study|Adverse Event|1|||
161860660|NCT01610492|584531244|FG000|Overall Study|Lack of Efficacy|3|||
161860661|NCT01610492|584531244|FG000|Overall Study|Other: Reached stopping criteria|1|||
161860662|NCT01610492|584531244|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
161860663|NCT02575833|584531248|FG000|Overall Study|Withdrawal by Subject|0|||
161860664|NCT02575833|584531249|FG001|Overall Study|Withdrawal by Subject|1|||
161860665|NCT02575833|584531248|FG000|Overall Study|Lost to Follow-up|1|||
161860666|NCT02575833|584531249|FG001|Overall Study|Lost to Follow-up|0|||
161860667|NCT01757275|584531250|FG000|Overall Study|Lost to Follow-up|1|||
161860668|NCT01757275|584531251|FG001|Overall Study|Lost to Follow-up|2|||
161860669|NCT01757275|584531250|FG000|Overall Study|Adverse Event|3|||
161860670|NCT01757275|584531251|FG001|Overall Study|Adverse Event|3|||
161860671|NCT01757275|584531250|FG000|Overall Study|Withdrawal by Subject|2|||
161860672|NCT01757275|584531251|FG001|Overall Study|Withdrawal by Subject|4|||
161860673|NCT01757275|584531250|FG000|Overall Study|Not treated|3|||
161860674|NCT01757275|584531251|FG001|Overall Study|Not treated|4|||
161860675|NCT03093259|584531252|FG000|Overall Study|Adverse Event|1|||
161860676|NCT03093259|584531253|FG001|Overall Study|Adverse Event|0|||
161860677|NCT03093259|584531252|FG000|Overall Study|Withdrawal by Subject|1|||
161860678|NCT03093259|584531253|FG001|Overall Study|Withdrawal by Subject|0|||
161860679|NCT01821807|584531254|FG000|Overall Study|Lost to Follow-up|3|||
161860680|NCT01821807|584531255|FG001|Overall Study|Lost to Follow-up|1|||
161860681|NCT00768248|584531256|FG000|Overall Study|Research coordinator didn't collect data|1|||
161860682|NCT00768248|584531257|FG001|Overall Study|Research coordinator didn't collect data|1|||
161860683|NCT00967330|584531258|FG000|Overall Study|Protocol Violation|3|||
161860684|NCT00967330|584531259|FG001|Overall Study|Protocol Violation|4|||
161772154|NCT02304484|584208307|FG000|Overall Study|Death|9|||
161772155|NCT02304484|584208307|FG000|Overall Study|Withdrawal by Subject|14|||
161772156|NCT02304484|584208307|FG000|Overall Study|Lost to Follow-up|2|||
161772157|NCT03522506|584208308|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161772158|NCT03522506|584208309|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161772159|NCT03522506|584208310|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161772160|NCT03522506|584208311|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161772161|NCT03522506|584208308|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161772162|NCT03522506|584208309|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161772163|NCT03522506|584208310|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161772164|NCT03522506|584208311|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
161772165|NCT05770401|584208312|FG000|Overall Study|Lost to Follow-up|5|||
161772166|NCT05770401|584208313|FG001|Overall Study|Lost to Follow-up|4|||
161772167|NCT01298323|584208315|FG000|Overall Study|Adverse Event|2|||
161772168|NCT01298323|584208316|FG001|Overall Study|Adverse Event|4|||
161772169|NCT01298323|584208315|FG000|Overall Study|Death|11|||
161772170|NCT01298323|584208316|FG001|Overall Study|Death|16|||
161772171|NCT01298323|584208315|FG000|Overall Study|Lost to Follow-up|1|||
161772172|NCT01298323|584208316|FG001|Overall Study|Lost to Follow-up|0|||
161772173|NCT01298323|584208315|FG000|Overall Study|Withdrawal by Subject|6|||
161772174|NCT01298323|584208316|FG001|Overall Study|Withdrawal by Subject|3|||
161772175|NCT01298323|584208315|FG000|Overall Study|Protocol Violation|1|||
161772176|NCT01298323|584208316|FG001|Overall Study|Protocol Violation|0|||
161772177|NCT01298323|584208315|FG000|Overall Study|Other|10|||
161772178|NCT01298323|584208316|FG001|Overall Study|Other|9|||
161772179|NCT01298323|584208315|FG000|Overall Study|Ongoing|55|||
161772180|NCT01298323|584208316|FG001|Overall Study|Ongoing|55|||
161772181|NCT01298323|584208315|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161772182|NCT01298323|584208316|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161772183|NCT01761565|584208317|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
161772184|NCT04524507|584208319|FG000|Overall Study|Lost to Follow-up|2|||
161772185|NCT04524507|584208320|FG001|Overall Study|Lost to Follow-up|4|||
161772186|NCT04524507|584208319|FG000|Overall Study|Withdrawal by Subject|2|||
161772187|NCT04524507|584208320|FG001|Overall Study|Withdrawal by Subject|9|||
161772188|NCT04524507|584208319|FG000|Overall Study|Death|2|||
161772189|NCT04524507|584208320|FG001|Overall Study|Death|10|||
161772190|NCT03655951|584208321|FG000|Overall Study|Lost to Follow-up|39|||
161772191|NCT03655951|584208322|FG001|Overall Study|Lost to Follow-up|20|||
161772192|NCT03655951|584208321|FG000|Overall Study|Withdrawal by Subject|0|||
161772193|NCT03655951|584208322|FG001|Overall Study|Withdrawal by Subject|1|||
161772194|NCT01078974|584208327|FG000|Overall Study|Adverse Event|3|||
161772195|NCT01791543|584208329|FG000|Overall Study|Lost to Follow-up|1|||
161772196|NCT01791543|584208329|FG000|Overall Study|Adverse Event|1|||
161772197|NCT01361308|584209726|FG000|Overall Study|Withdrawal by Subject|9|||
161772198|NCT01361308|584209727|FG001|Overall Study|Withdrawal by Subject|13|||
161772199|NCT01361308|584209726|FG000|Overall Study|Physician Decision|3|||
161772200|NCT01361308|584209727|FG001|Overall Study|Physician Decision|3|||
161772201|NCT01361308|584209726|FG000|Overall Study|Lack of Efficacy|2|||
161772202|NCT01361308|584209727|FG001|Overall Study|Lack of Efficacy|0|||
161772203|NCT01361308|584209726|FG000|Overall Study|Protocol Violation|1|||
161772204|NCT01361308|584209727|FG001|Overall Study|Protocol Violation|0|||
161772205|NCT01361308|584209726|FG000|Overall Study|Lost to Follow-up|5|||
161772206|NCT01361308|584209727|FG001|Overall Study|Lost to Follow-up|4|||
161772207|NCT01361308|584209726|FG000|Overall Study|Adverse Event|8|||
161772208|NCT01361308|584209727|FG001|Overall Study|Adverse Event|4|||
161772209|NCT01361308|584209726|FG000|Overall Study|Eligibility Criteria Not Met|2|||
161772210|NCT01361308|584209727|FG001|Overall Study|Eligibility Criteria Not Met|3|||
161772211|NCT01361308|584209726|FG000|Overall Study|Failed C-SSRS|5|||
161772212|NCT01361308|584209727|FG001|Overall Study|Failed C-SSRS|2|||
161772213|NCT01361308|584209726|FG000|Overall Study|Other|0|||
161772214|NCT01361308|584209727|FG001|Overall Study|Other|1|||
161772215|NCT03839693|584209732|FG000|Overall Study|Lost to Follow-up|0|||
161772216|NCT03839693|584209733|FG001|Overall Study|Lost to Follow-up|2|||
161772217|NCT03839693|584209734|FG002|Overall Study|Lost to Follow-up|2|||
161772218|NCT03839693|584209732|FG000|Overall Study|Withdrawal by Subject|1|||
161772219|NCT03839693|584209733|FG001|Overall Study|Withdrawal by Subject|0|||
161772220|NCT03839693|584209734|FG002|Overall Study|Withdrawal by Subject|2|||
161772221|NCT03839693|584209732|FG000|Overall Study|subject moved out of the area|1|||
161772222|NCT03839693|584209733|FG001|Overall Study|subject moved out of the area|0|||
161772223|NCT03839693|584209734|FG002|Overall Study|subject moved out of the area|0|||
161772224|NCT00270205|584209743|FG000|Overall Study|Lost to Follow-up|1|||
161772225|NCT00270205|584209744|FG001|Overall Study|Lost to Follow-up|0|||
161772226|NCT00270205|584209745|FG002|Overall Study|Lost to Follow-up|0|||
161772227|NCT00270205|584209746|FG003|Overall Study|Lost to Follow-up|1|||
161772228|NCT00066573|584209747|FG000|Overall Study|Did not received protocol treatment|28|||
161772229|NCT00066573|584209748|FG001|Overall Study|Did not received protocol treatment|28|||
161860685|NCT00967330|584531258|FG000|Overall Study|Regular|10|||
161860686|NCT00967330|584531259|FG001|Overall Study|Regular|3|||
161860687|NCT00967330|584531258|FG000|Overall Study|Withdrawal by Subject|6|||
161860688|NCT00967330|584531259|FG001|Overall Study|Withdrawal by Subject|0|||
161860689|NCT00967330|584531258|FG000|Overall Study|Lost to Follow-up|1|||
161860690|NCT00967330|584531259|FG001|Overall Study|Lost to Follow-up|1|||
161860691|NCT00967330|584531258|FG000|Overall Study|Death|102|||
161860692|NCT00967330|584531259|FG001|Overall Study|Death|51|||
161860693|NCT00967330|584531258|FG000|Overall Study|Severe protocol deviation|0|||
161860694|NCT00967330|584531259|FG001|Overall Study|Severe protocol deviation|1|||
161860695|NCT04563754|584533166|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
161860696|NCT04563754|584533167|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
161860697|NCT04563754|584533168|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
161860698|NCT04563754|584533166|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
161860699|NCT04563754|584533167|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
161860700|NCT04563754|584533168|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
161860701|NCT04563754|584533166|FG000|Follow up|Lost to Follow-up|61|||
161860702|NCT04563754|584533167|FG001|Follow up|Lost to Follow-up|23|||
161860703|NCT04563754|584533168|FG002|Follow up|Lost to Follow-up|5|||
161860704|NCT04563754|584533166|FG000|Follow up|Death|0|||
161860705|NCT04563754|584533167|FG001|Follow up|Death|2|||
161860706|NCT04563754|584533168|FG002|Follow up|Death|0|||
161860707|NCT04563754|584533166|FG000|Follow up|Ongoing|0|||
161860708|NCT04563754|584533167|FG001|Follow up|Ongoing|28|||
161860709|NCT04563754|584533168|FG002|Follow up|Ongoing|0|||
161860710|NCT00070564|584533169|FG000|Overall Study|Progression|2|||
161860711|NCT00070564|584533170|FG001|Overall Study|Progression|4|||
161860712|NCT00070564|584533171|FG002|Overall Study|Progression|7|||
161860713|NCT00070564|584533172|FG003|Overall Study|Progression|7|||
161860714|NCT00070564|584533173|FG004|Overall Study|Progression|1|||
161860715|NCT00070564|584533174|FG005|Overall Study|Progression|0|||
161860716|NCT00070564|584533169|FG000|Overall Study|Delinquent|1|||
161860717|NCT00070564|584533170|FG001|Overall Study|Delinquent|4|||
161860718|NCT00070564|584533171|FG002|Overall Study|Delinquent|2|||
161860719|NCT00070564|584533172|FG003|Overall Study|Delinquent|0|||
161860720|NCT00070564|584533173|FG004|Overall Study|Delinquent|0|||
161860721|NCT00070564|584533174|FG005|Overall Study|Delinquent|0|||
161860722|NCT00070564|584533169|FG000|Overall Study|Adverse Event|150|||
161860723|NCT00070564|584533170|FG001|Overall Study|Adverse Event|142|||
161860724|NCT00070564|584533171|FG002|Overall Study|Adverse Event|120|||
161860725|NCT00070564|584533172|FG003|Overall Study|Adverse Event|108|||
161860726|NCT00070564|584533173|FG004|Overall Study|Adverse Event|63|||
161860727|NCT00070564|584533174|FG005|Overall Study|Adverse Event|36|||
161860728|NCT00070564|584533169|FG000|Overall Study|Death|4|||
161860729|NCT00070564|584533170|FG001|Overall Study|Death|1|||
161860730|NCT00070564|584533171|FG002|Overall Study|Death|5|||
161860731|NCT00070564|584533172|FG003|Overall Study|Death|3|||
161860732|NCT00070564|584533173|FG004|Overall Study|Death|0|||
161860733|NCT00070564|584533174|FG005|Overall Study|Death|1|||
161860734|NCT00070564|584533169|FG000|Overall Study|Other, not protocol specified|17|||
161860735|NCT00070564|584533170|FG001|Overall Study|Other, not protocol specified|15|||
161860736|NCT00070564|584533171|FG002|Overall Study|Other, not protocol specified|14|||
161860737|NCT00070564|584533172|FG003|Overall Study|Other, not protocol specified|19|||
161860738|NCT00070564|584533173|FG004|Overall Study|Other, not protocol specified|6|||
161860739|NCT00070564|584533174|FG005|Overall Study|Other, not protocol specified|7|||
161860740|NCT00070564|584533169|FG000|Overall Study|Withdrawal by Subject|26|||
161860741|NCT00070564|584533170|FG001|Overall Study|Withdrawal by Subject|37|||
161860742|NCT00070564|584533171|FG002|Overall Study|Withdrawal by Subject|23|||
161860743|NCT00070564|584533172|FG003|Overall Study|Withdrawal by Subject|30|||
161860744|NCT00070564|584533173|FG004|Overall Study|Withdrawal by Subject|8|||
161860745|NCT00070564|584533174|FG005|Overall Study|Withdrawal by Subject|8|||
161860746|NCT00070564|584533169|FG000|Overall Study|Not reported|0|||
161860747|NCT00070564|584533170|FG001|Overall Study|Not reported|0|||
161860748|NCT00070564|584533171|FG002|Overall Study|Not reported|0|||
161860749|NCT00070564|584533172|FG003|Overall Study|Not reported|0|||
161860750|NCT00070564|584533173|FG004|Overall Study|Not reported|1|||
161860751|NCT00070564|584533174|FG005|Overall Study|Not reported|0|||
161860752|NCT01490086|584533177|FG000|Overall Study|Consent withdrawn|4|||
161860753|NCT01490086|584533178|FG001|Overall Study|Consent withdrawn|4|||
161860754|NCT01490086|584533179|FG002|Overall Study|Consent withdrawn|3|||
161860755|NCT01490086|584533180|FG003|Overall Study|Consent withdrawn|0|||
161860756|NCT01490086|584533181|FG004|Overall Study|Consent withdrawn|1|||
161860757|NCT01490086|584533177|FG000|Overall Study|Non-compliance|0|||
161860758|NCT01490086|584533178|FG001|Overall Study|Non-compliance|1|||
161860759|NCT01490086|584533179|FG002|Overall Study|Non-compliance|0|||
161860760|NCT01490086|584533180|FG003|Overall Study|Non-compliance|0|||
161860761|NCT01490086|584533181|FG004|Overall Study|Non-compliance|0|||
161860762|NCT01490086|584533177|FG000|Overall Study|Abnormal laboratory findings|1|||
161772230|NCT01646268|584209752|FG000|Overall Study|Adverse Event|6|||
161772231|NCT01646268|584209753|FG001|Overall Study|Adverse Event|7|||
161772232|NCT01646268|584209752|FG000|Overall Study|Lack of Efficacy|1|||
161772233|NCT01646268|584209753|FG001|Overall Study|Lack of Efficacy|3|||
161772234|NCT01646268|584209752|FG000|Overall Study|Protocol Violation|0|||
161772235|NCT01646268|584209753|FG001|Overall Study|Protocol Violation|1|||
161772236|NCT01646268|584209752|FG000|Overall Study|Withdrawal by Subject|2|||
161772237|NCT01646268|584209753|FG001|Overall Study|Withdrawal by Subject|5|||
161772238|NCT01646268|584209752|FG000|Overall Study|Other|2|||
161772239|NCT01646268|584209753|FG001|Overall Study|Other|0|||
161772240|NCT02222246|584209754|FG000|Overall Study|No Emergency Department Visits|27|||
161772241|NCT02222246|584209755|FG001|Overall Study|No Emergency Department Visits|26|||
161772242|NCT02222246|584209754|FG000|Overall Study|Physician Decision|0|||
161772243|NCT02222246|584209755|FG001|Overall Study|Physician Decision|1|||
161772244|NCT01473602|584209758|FG000|Overall Study|Adverse Event|1|||
161772245|NCT01473602|584209759|FG001|Overall Study|Adverse Event|2|||
161772246|NCT01473602|584209758|FG000|Overall Study|Death|0|||
161772247|NCT01473602|584209759|FG001|Overall Study|Death|1|||
161772248|NCT01473602|584209758|FG000|Overall Study|Lost to Follow-up|1|||
161772249|NCT01473602|584209759|FG001|Overall Study|Lost to Follow-up|1|||
161772250|NCT01473602|584209758|FG000|Overall Study|Withdrawal by Subject|5|||
161772251|NCT01473602|584209759|FG001|Overall Study|Withdrawal by Subject|4|||
161772252|NCT01473602|584209758|FG000|Overall Study|Physician Decision|1|||
161772253|NCT01473602|584209759|FG001|Overall Study|Physician Decision|0|||
161772254|NCT00449761|584209761|FG000|Overall Study|Disease progression|12|||
161772255|NCT00449761|584209761|FG000|Overall Study|Death|5|||
161772256|NCT00449761|584209761|FG000|Overall Study|New cancer therapy|1|||
161772257|NCT00560573|584209762|FG000|Overall Study|Death|4|||
161772258|NCT00560573|584209763|FG001|Overall Study|Death|1|||
161772259|NCT00560573|584209764|FG002|Overall Study|Death|4|||
161772260|NCT00560573|584209765|FG003|Overall Study|Death|5|||
161772261|NCT00560573|584209766|FG004|Overall Study|Death|1|||
161772262|NCT00560573|584209767|FG005|Overall Study|Death|10|||
161772263|NCT00560573|584209762|FG000|Overall Study|Lost to Follow-up|0|||
161772264|NCT00560573|584209763|FG001|Overall Study|Lost to Follow-up|0|||
161772265|NCT00560573|584209764|FG002|Overall Study|Lost to Follow-up|0|||
161772266|NCT00560573|584209765|FG003|Overall Study|Lost to Follow-up|1|||
161772267|NCT00560573|584209766|FG004|Overall Study|Lost to Follow-up|1|||
161772268|NCT00560573|584209767|FG005|Overall Study|Lost to Follow-up|0|||
161772269|NCT00560573|584209762|FG000|Overall Study|Withdrawal by Subject|0|||
161772270|NCT00560573|584209763|FG001|Overall Study|Withdrawal by Subject|0|||
161772271|NCT00560573|584209764|FG002|Overall Study|Withdrawal by Subject|0|||
161772272|NCT00560573|584209765|FG003|Overall Study|Withdrawal by Subject|1|||
161772273|NCT00560573|584209766|FG004|Overall Study|Withdrawal by Subject|1|||
161772274|NCT00560573|584209767|FG005|Overall Study|Withdrawal by Subject|0|||
161772275|NCT00560573|584209762|FG000|Overall Study|Other|2|||
161772276|NCT00560573|584209763|FG001|Overall Study|Other|2|||
161772277|NCT00560573|584209764|FG002|Overall Study|Other|2|||
161772278|NCT00560573|584209765|FG003|Overall Study|Other|3|||
161772279|NCT00560573|584209766|FG004|Overall Study|Other|3|||
161772280|NCT00560573|584209767|FG005|Overall Study|Other|3|||
161772281|NCT00560573|584209762|FG000|Overall Study|Enrolled, not treated|0|||
161772282|NCT00560573|584209763|FG001|Overall Study|Enrolled, not treated|0|||
161772283|NCT00560573|584209764|FG002|Overall Study|Enrolled, not treated|0|||
161772284|NCT00560573|584209765|FG003|Overall Study|Enrolled, not treated|0|||
161772285|NCT00560573|584209766|FG004|Overall Study|Enrolled, not treated|1|||
161772286|NCT00560573|584209767|FG005|Overall Study|Enrolled, not treated|0|||
161772287|NCT01422876|584209771|FG000|Week 24|Lost to Follow-up|1|||
161772288|NCT01422876|584209772|FG001|Week 24|Lost to Follow-up|1|||
161772289|NCT01422876|584209773|FG002|Week 24|Lost to Follow-up|2|||
161772290|NCT01422876|584209774|FG003|Week 24|Lost to Follow-up|4|||
161772291|NCT01422876|584209775|FG004|Week 24|Lost to Follow-up|2|||
161772292|NCT01422876|584209776|FG005|Week 24|Lost to Follow-up|0|||
161772293|NCT01422876|584209777|FG006|Week 24|Lost to Follow-up|1|||
161772294|NCT01422876|584209778|FG007|Week 24|Lost to Follow-up|3|||
161772295|NCT01422876|584209779|FG008|Week 24|Lost to Follow-up|3|||
161772296|NCT01422876|584209780|FG009|Week 24|Lost to Follow-up|4|||
161772297|NCT01422876|584209771|FG000|Week 24|Consent withdrawn|5|||
161772298|NCT01422876|584209772|FG001|Week 24|Consent withdrawn|1|||
161772299|NCT01422876|584209773|FG002|Week 24|Consent withdrawn|3|||
161772300|NCT01422876|584209774|FG003|Week 24|Consent withdrawn|4|||
161772301|NCT01422876|584209775|FG004|Week 24|Consent withdrawn|5|||
161772302|NCT01422876|584209776|FG005|Week 24|Consent withdrawn|6|||
161772303|NCT01422876|584209777|FG006|Week 24|Consent withdrawn|5|||
161772304|NCT01422876|584209778|FG007|Week 24|Consent withdrawn|4|||
161772305|NCT01422876|584209779|FG008|Week 24|Consent withdrawn|3|||
161772306|NCT01422876|584209780|FG009|Week 24|Consent withdrawn|6|||
161772307|NCT01422876|584209771|FG000|Week 24|Death|0|||
161772308|NCT01422876|584209772|FG001|Week 24|Death|1|||
161860763|NCT01490086|584533178|FG001|Overall Study|Abnormal laboratory findings|0|||
161860764|NCT01490086|584533179|FG002|Overall Study|Abnormal laboratory findings|0|||
161860765|NCT01490086|584533180|FG003|Overall Study|Abnormal laboratory findings|0|||
161860766|NCT01490086|584533181|FG004|Overall Study|Abnormal laboratory findings|0|||
161860767|NCT01490086|584533177|FG000|Overall Study|Lost to Follow-up|0|||
161860768|NCT01490086|584533178|FG001|Overall Study|Lost to Follow-up|0|||
161860769|NCT01490086|584533179|FG002|Overall Study|Lost to Follow-up|0|||
161860770|NCT01490086|584533180|FG003|Overall Study|Lost to Follow-up|0|||
161860771|NCT01490086|584533181|FG004|Overall Study|Lost to Follow-up|1|||
161860772|NCT01490086|584533177|FG000|Overall Study|Physician Decision|3|||
161860773|NCT01490086|584533178|FG001|Overall Study|Physician Decision|4|||
161860774|NCT01490086|584533179|FG002|Overall Study|Physician Decision|2|||
161860775|NCT01490086|584533180|FG003|Overall Study|Physician Decision|3|||
161860776|NCT01490086|584533181|FG004|Overall Study|Physician Decision|1|||
161860777|NCT01490086|584533177|FG000|Overall Study|Adverse Event|0|||
161860778|NCT01490086|584533178|FG001|Overall Study|Adverse Event|0|||
161860779|NCT01490086|584533179|FG002|Overall Study|Adverse Event|1|||
161860780|NCT01490086|584533180|FG003|Overall Study|Adverse Event|2|||
161860781|NCT01490086|584533181|FG004|Overall Study|Adverse Event|0|||
161860782|NCT01490086|584533177|FG000|Overall Study|Lack of Efficacy|0|||
161860783|NCT01490086|584533178|FG001|Overall Study|Lack of Efficacy|3|||
161860784|NCT01490086|584533179|FG002|Overall Study|Lack of Efficacy|1|||
161860785|NCT01490086|584533180|FG003|Overall Study|Lack of Efficacy|0|||
161860786|NCT01490086|584533181|FG004|Overall Study|Lack of Efficacy|8|||
161860787|NCT01490086|584533177|FG000|Overall Study|Worsening of symptoms|0|||
161860788|NCT01490086|584533178|FG001|Overall Study|Worsening of symptoms|1|||
161860789|NCT01490086|584533179|FG002|Overall Study|Worsening of symptoms|0|||
161860790|NCT01490086|584533180|FG003|Overall Study|Worsening of symptoms|1|||
161860791|NCT01490086|584533181|FG004|Overall Study|Worsening of symptoms|0|||
161860792|NCT01490086|584533177|FG000|Overall Study|Subject uncontrollable and abusive|0|||
161860793|NCT01490086|584533178|FG001|Overall Study|Subject uncontrollable and abusive|1|||
161860794|NCT01490086|584533179|FG002|Overall Study|Subject uncontrollable and abusive|0|||
161860795|NCT01490086|584533180|FG003|Overall Study|Subject uncontrollable and abusive|0|||
161772309|NCT01422876|584209773|FG002|Week 24|Death|0|||
161772310|NCT01422876|584209774|FG003|Week 24|Death|0|||
161772311|NCT01422876|584209775|FG004|Week 24|Death|0|||
161772312|NCT01422876|584209776|FG005|Week 24|Death|0|||
161772313|NCT01422876|584209777|FG006|Week 24|Death|0|||
161772314|NCT01422876|584209778|FG007|Week 24|Death|0|||
161772315|NCT01422876|584209779|FG008|Week 24|Death|0|||
161772316|NCT01422876|584209780|FG009|Week 24|Death|0|||
161772317|NCT01422876|584209771|FG000|Week 52|Lost to Follow-up|3|||
161772318|NCT01422876|584209772|FG001|Week 52|Lost to Follow-up|5|||
161772319|NCT01422876|584209773|FG002|Week 52|Lost to Follow-up|7|||
161772320|NCT01422876|584209774|FG003|Week 52|Lost to Follow-up|5|||
161772321|NCT01422876|584209775|FG004|Week 52|Lost to Follow-up|8|||
161772322|NCT01422876|584209776|FG005|Week 52|Lost to Follow-up|5|||
161772323|NCT01422876|584209777|FG006|Week 52|Lost to Follow-up|5|||
161772324|NCT01422876|584209778|FG007|Week 52|Lost to Follow-up|8|||
161772325|NCT01422876|584209779|FG008|Week 52|Lost to Follow-up|7|||
161772326|NCT01422876|584209780|FG009|Week 52|Lost to Follow-up|8|||
161772327|NCT01422876|584209771|FG000|Week 52|Consent withdrawn|9|||
161772328|NCT01422876|584209772|FG001|Week 52|Consent withdrawn|4|||
161772329|NCT01422876|584209773|FG002|Week 52|Consent withdrawn|6|||
161772330|NCT01422876|584209774|FG003|Week 52|Consent withdrawn|12|||
161772331|NCT01422876|584209775|FG004|Week 52|Consent withdrawn|7|||
161772332|NCT01422876|584209776|FG005|Week 52|Consent withdrawn|12|||
161772333|NCT01422876|584209777|FG006|Week 52|Consent withdrawn|10|||
161772334|NCT01422876|584209778|FG007|Week 52|Consent withdrawn|12|||
161772335|NCT01422876|584209779|FG008|Week 52|Consent withdrawn|13|||
161772336|NCT01422876|584209780|FG009|Week 52|Consent withdrawn|9|||
161772337|NCT01422876|584209771|FG000|Week 52|Death|0|||
161772338|NCT01422876|584209772|FG001|Week 52|Death|1|||
161772339|NCT01422876|584209773|FG002|Week 52|Death|0|||
161772340|NCT01422876|584209774|FG003|Week 52|Death|1|||
161772341|NCT01422876|584209775|FG004|Week 52|Death|0|||
161772342|NCT01422876|584209776|FG005|Week 52|Death|0|||
161772343|NCT01422876|584209777|FG006|Week 52|Death|1|||
161772344|NCT01422876|584209778|FG007|Week 52|Death|3|||
161772345|NCT01422876|584209779|FG008|Week 52|Death|1|||
161772346|NCT01422876|584209780|FG009|Week 52|Death|0|||
161772347|NCT00558831|584209781|FG000|Overall Study|Lost to Follow-up|1|||
161772348|NCT02204449|584209782|FG000|Overall Study|Lost to Follow-up|7|||
161772349|NCT02204449|584209783|FG001|Overall Study|Lost to Follow-up|9|||
161772350|NCT02204449|584209782|FG000|Overall Study|Death|0|||
161772351|NCT02204449|584209783|FG001|Overall Study|Death|1|||
161772352|NCT02204449|584209782|FG000|Overall Study|Withdrawal by Subject|0|||
161772353|NCT02204449|584209783|FG001|Overall Study|Withdrawal by Subject|1|||
161772354|NCT02856282|584209784|FG000|Overall Study|Withdrawal by Subject|1|||
161772355|NCT00057330|584209785|FG000|Overall Study|Adverse Event|9|||
161772356|NCT00057330|584209786|FG001|Overall Study|Adverse Event|12|||
161772357|NCT00057330|584209785|FG000|Overall Study|Death|1|||
161772358|NCT00057330|584209786|FG001|Overall Study|Death|0|||
161772359|NCT00057330|584209785|FG000|Overall Study|Protocol Violation|1|||
161860796|NCT01490086|584533181|FG004|Overall Study|Subject uncontrollable and abusive|0|||
161860797|NCT01490086|584533177|FG000|Overall Study|Subject left hospital|0|||
161860798|NCT01490086|584533178|FG001|Overall Study|Subject left hospital|1|||
161860799|NCT01490086|584533179|FG002|Overall Study|Subject left hospital|0|||
161860800|NCT01490086|584533180|FG003|Overall Study|Subject left hospital|1|||
161860801|NCT01490086|584533181|FG004|Overall Study|Subject left hospital|0|||
161860802|NCT04510090|584533184|FG000|FE-HS|Withdrawal by Subject|0|||
161860803|NCT04510090|584533185|FG001|FE-HS|Withdrawal by Subject|0|||
161860804|NCT04510090|584533186|FG002|FE-HS|Withdrawal by Subject|0|||
161860805|NCT04510090|584533187|FG003|FE-HS|Withdrawal by Subject|0|||
161860806|NCT04510090|584533188|FG004|FE-HS|Withdrawal by Subject|1|||
161860807|NCT04510090|584533189|FG005|FE-HS|Withdrawal by Subject|0|||
161860808|NCT04510090|584533190|FG006|FE-HS|Withdrawal by Subject|0|||
161860809|NCT04510090|584533191|FG007|FE-HS|Withdrawal by Subject|0|||
161860810|NCT05825404|584533192|FG000|First Intervention (Weeks 2-5)|Death|0|||
161860811|NCT05825404|584533193|FG001|First Intervention (Weeks 2-5)|Death|1|||
161860812|NCT05825404|584533192|FG000|Second Intervention (Weeks 8-11)|Death|0|||
161860813|NCT05825404|584533193|FG001|Second Intervention (Weeks 8-11)|Death|1|||
161860814|NCT01127256|584533194|FG000|Overall Study|Adverse Event|13|||
161860815|NCT01127256|584533195|FG001|Overall Study|Adverse Event|13|||
161860816|NCT01127256|584533194|FG000|Overall Study|Lack of Efficacy|4|||
161860817|NCT01127256|584533195|FG001|Overall Study|Lack of Efficacy|0|||
161860818|NCT01127256|584533194|FG000|Overall Study|Lost to Follow-up|16|||
161860819|NCT01127256|584533195|FG001|Overall Study|Lost to Follow-up|17|||
161860820|NCT01127256|584533194|FG000|Overall Study|Withdrawal by Subject|5|||
161860821|NCT01127256|584533195|FG001|Overall Study|Withdrawal by Subject|9|||
161860822|NCT01127256|584533194|FG000|Overall Study|Protocol Violation|1|||
161860823|NCT01127256|584533195|FG001|Overall Study|Protocol Violation|0|||
161860824|NCT00679211|584533196|FG000|Overall Study|Progressive disease|82|||
161860825|NCT00679211|584533196|FG000|Overall Study|Adverse Event|7|||
161860826|NCT00679211|584533196|FG000|Overall Study|Withdrawal by Subject|2|||
161860827|NCT00679211|584533196|FG000|Overall Study|Physician Decision|5|||
161860828|NCT00679211|584533196|FG000|Overall Study|Refused to undergo protocol procedures|1|||
161860829|NCT00679211|584533196|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
161860830|NCT00679211|584533196|FG000|Overall Study|Other|1|||
161860831|NCT01922037|584533197|FG000|Overall Study|Withdrawal by Subject|2|||
161860832|NCT01922037|584533198|FG001|Overall Study|Withdrawal by Subject|44|||
161860833|NCT01922037|584533197|FG000|Overall Study|Adverse Event|1|||
161860834|NCT01922037|584533198|FG001|Overall Study|Adverse Event|7|||
161860835|NCT01922037|584533197|FG000|Overall Study|Death|0|||
161860836|NCT01922037|584533198|FG001|Overall Study|Death|5|||
161860837|NCT01922037|584533197|FG000|Overall Study|Pregnancy|0|||
161860838|NCT01922037|584533198|FG001|Overall Study|Pregnancy|2|||
161860839|NCT01922037|584533197|FG000|Overall Study|Participant non-compliance|4|||
161860840|NCT01922037|584533198|FG001|Overall Study|Participant non-compliance|46|||
161860841|NCT01922037|584533197|FG000|Overall Study|Investigator/Sponsor decision|1|||
161860842|NCT01922037|584533198|FG001|Overall Study|Investigator/Sponsor decision|4|||
161860843|NCT01922037|584533197|FG000|Overall Study|Other unspecified|2|||
161860844|NCT01922037|584533198|FG001|Overall Study|Other unspecified|66|||
161860845|NCT00931528|584533199|FG000|Overall Study|Protocol Violation|9|||
161860846|NCT00931528|584533200|FG001|Overall Study|Protocol Violation|12|||
161860847|NCT00931528|584533199|FG000|Overall Study|Withdrawal by Subject|4|||
161860848|NCT00931528|584533200|FG001|Overall Study|Withdrawal by Subject|12|||
161860849|NCT00931528|584533199|FG000|Overall Study|Lost to Follow-up|6|||
161860850|NCT00931528|584533200|FG001|Overall Study|Lost to Follow-up|13|||
161860851|NCT00931528|584533199|FG000|Overall Study|Assessment outside of Time Frame|22|||
161860852|NCT00931528|584533200|FG001|Overall Study|Assessment outside of Time Frame|23|||
161860853|NCT01470248|584533201|FG000|Overall Study|Withdrawal by Subject|1|||
161860854|NCT02243605|584533204|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
161860855|NCT02243605|584533205|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
161860856|NCT02243605|584533204|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
161860857|NCT02243605|584533205|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
161860858|NCT02243605|584533204|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
161860859|NCT02243605|584533205|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
161860860|NCT02243605|584533204|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
161860861|NCT02243605|584533205|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
161860862|NCT02243605|584533204|FG000|Stage 2 - Final Analysis Population|Progression|0|||
161860863|NCT02243605|584533205|FG001|Stage 2 - Final Analysis Population|Progression|1|||
161860864|NCT05842967|584533206|FG000|Period 1: SSA|Adverse Event|1|||
161860865|NCT05842967|584533207|FG001|Period 1: SSA|Adverse Event|1|||
161860866|NCT05842967|584533208|FG002|Period 1: SSA|Adverse Event|0|||
161860867|NCT05842967|584533209|FG003|Period 1: SSA|Adverse Event|0|||
161860868|NCT05842967|584533206|FG000|Period 1: SSA|Death|1|||
161860869|NCT05842967|584533207|FG001|Period 1: SSA|Death|0|||
161860870|NCT05842967|584533208|FG002|Period 1: SSA|Death|0|||
161860871|NCT05842967|584533209|FG003|Period 1: SSA|Death|0|||
161860872|NCT05842967|584533206|FG000|Period 1: SSA|Lost to Follow-up|16|||
161860873|NCT05842967|584533207|FG001|Period 1: SSA|Lost to Follow-up|4|||
161860874|NCT05842967|584533208|FG002|Period 1: SSA|Lost to Follow-up|0|||
161860875|NCT05842967|584533209|FG003|Period 1: SSA|Lost to Follow-up|0|||
161860876|NCT05842967|584533206|FG000|Period 1: SSA|Physician Decision|1|||
161860877|NCT05842967|584533207|FG001|Period 1: SSA|Physician Decision|0|||
161860878|NCT05842967|584533208|FG002|Period 1: SSA|Physician Decision|0|||
161860879|NCT05842967|584533209|FG003|Period 1: SSA|Physician Decision|0|||
161860880|NCT05842967|584533206|FG000|Period 1: SSA|Withdrawal by Subject|2|||
161860881|NCT05842967|584533207|FG001|Period 1: SSA|Withdrawal by Subject|2|||
161860882|NCT05842967|584533208|FG002|Period 1: SSA|Withdrawal by Subject|0|||
161860883|NCT05842967|584533209|FG003|Period 1: SSA|Withdrawal by Subject|0|||
161860884|NCT05842967|584533206|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
161860885|NCT05842967|584533207|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
161860886|NCT05842967|584533208|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
161860887|NCT05842967|584533209|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
161860888|NCT05842967|584533206|FG000|Period 2: SSB|Adverse Event|0|||
161860889|NCT05842967|584533207|FG001|Period 2: SSB|Adverse Event|0|||
161860890|NCT05842967|584533208|FG002|Period 2: SSB|Adverse Event|2|||
161860891|NCT05842967|584533209|FG003|Period 2: SSB|Adverse Event|0|||
161860892|NCT05842967|584533206|FG000|Period 2: SSB|Lost to Follow-up|0|||
161860893|NCT05842967|584533207|FG001|Period 2: SSB|Lost to Follow-up|0|||
161860894|NCT05842967|584533208|FG002|Period 2: SSB|Lost to Follow-up|4|||
161860895|NCT05842967|584533209|FG003|Period 2: SSB|Lost to Follow-up|3|||
161860896|NCT05842967|584533206|FG000|Period 2: SSB|Withdrawal by Subject|0|||
161860897|NCT05842967|584533207|FG001|Period 2: SSB|Withdrawal by Subject|0|||
161860898|NCT05842967|584533208|FG002|Period 2: SSB|Withdrawal by Subject|1|||
161860899|NCT05842967|584533209|FG003|Period 2: SSB|Withdrawal by Subject|0|||
161860900|NCT05842967|584533206|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
161860901|NCT05842967|584533207|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
161860902|NCT05842967|584533208|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
161860903|NCT05842967|584533209|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
161860904|NCT05842967|584533206|FG000|Period 2: SSB|Protocol Violation|0|||
161860905|NCT05842967|584533207|FG001|Period 2: SSB|Protocol Violation|0|||
161860906|NCT05842967|584533208|FG002|Period 2: SSB|Protocol Violation|0|||
161860907|NCT05842967|584533209|FG003|Period 2: SSB|Protocol Violation|1|||
161860908|NCT01866826|584533221|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
161860909|NCT01866826|584533222|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
161860910|NCT01866826|584533221|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
161860911|NCT01866826|584533222|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
161860912|NCT01866826|584533221|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
161860913|NCT01866826|584533222|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
161860914|NCT02288312|584533223|FG000|Overall Study|Pregnancy|1|||
161860915|NCT02288312|584533224|FG001|Overall Study|Pregnancy|0|||
161860916|NCT02288312|584533225|FG002|Overall Study|Pregnancy|0|||
161860917|NCT01276041|584533226|FG000|Overall Study|Adverse Event|2|||
161860918|NCT01276041|584533226|FG000|Overall Study|Protocol Violation|1|||
161860919|NCT02058069|584533229|FG000|Overall Study|Exclusion due to implant size|5|||
161860920|NCT02058069|584533229|FG000|Overall Study|Withdrawal by Subject|6|||
161860921|NCT02222922|584533230|FG000|Overall Study|Death|0|||
161860922|NCT02222922|584533231|FG001|Overall Study|Death|0|||
161860923|NCT02222922|584533232|FG002|Overall Study|Death|0|||
161860924|NCT02222922|584533233|FG003|Overall Study|Death|0|||
161860925|NCT02222922|584533234|FG004|Overall Study|Death|13|||
161860926|NCT02222922|584533235|FG005|Overall Study|Death|0|||
161860927|NCT02222922|584533236|FG006|Overall Study|Death|0|||
161860928|NCT02222922|584533237|FG007|Overall Study|Death|0|||
161860929|NCT02222922|584533238|FG008|Overall Study|Death|2|||
161860930|NCT02222922|584533230|FG000|Overall Study|Lost to Follow-up|0|||
161860931|NCT02222922|584533231|FG001|Overall Study|Lost to Follow-up|0|||
161860932|NCT02222922|584533232|FG002|Overall Study|Lost to Follow-up|1|||
161860933|NCT02222922|584533233|FG003|Overall Study|Lost to Follow-up|0|||
161860934|NCT02222922|584533234|FG004|Overall Study|Lost to Follow-up|9|||
161860935|NCT02222922|584533235|FG005|Overall Study|Lost to Follow-up|1|||
161860936|NCT02222922|584533236|FG006|Overall Study|Lost to Follow-up|0|||
161860937|NCT02222922|584533237|FG007|Overall Study|Lost to Follow-up|0|||
161860938|NCT02222922|584533238|FG008|Overall Study|Lost to Follow-up|0|||
161860939|NCT02222922|584533230|FG000|Overall Study|Other|0|||
161860940|NCT02222922|584533231|FG001|Overall Study|Other|0|||
161860941|NCT02222922|584533232|FG002|Overall Study|Other|0|||
161860942|NCT02222922|584533233|FG003|Overall Study|Other|2|||
161860943|NCT02222922|584533234|FG004|Overall Study|Other|10|||
161860944|NCT02222922|584533235|FG005|Overall Study|Other|2|||
161860945|NCT02222922|584533236|FG006|Overall Study|Other|2|||
161860946|NCT02222922|584533237|FG007|Overall Study|Other|4|||
161860947|NCT02222922|584533238|FG008|Overall Study|Other|1|||
161860948|NCT02222922|584533230|FG000|Overall Study|Participant refused further follow-up|1|||
161860949|NCT02222922|584533231|FG001|Overall Study|Participant refused further follow-up|0|||
161860950|NCT02222922|584533232|FG002|Overall Study|Participant refused further follow-up|0|||
161860951|NCT02222922|584533233|FG003|Overall Study|Participant refused further follow-up|1|||
161860952|NCT02222922|584533234|FG004|Overall Study|Participant refused further follow-up|6|||
161860953|NCT02222922|584533235|FG005|Overall Study|Participant refused further follow-up|0|||
161860954|NCT02222922|584533236|FG006|Overall Study|Participant refused further follow-up|0|||
161860955|NCT02222922|584533237|FG007|Overall Study|Participant refused further follow-up|0|||
161860956|NCT02222922|584533238|FG008|Overall Study|Participant refused further follow-up|3|||
161860957|NCT01068860|584533239|FG000|Overall Study|Withdrawal by Subject|0|||
161860958|NCT01068860|584533240|FG001|Overall Study|Withdrawal by Subject|0|||
161860959|NCT01068860|584533241|FG002|Overall Study|Withdrawal by Subject|0|||
161860960|NCT01068860|584533242|FG003|Overall Study|Withdrawal by Subject|0|||
161860961|NCT01068860|584533243|FG004|Overall Study|Withdrawal by Subject|0|||
161860962|NCT01068860|584533244|FG005|Overall Study|Withdrawal by Subject|2|||
161860963|NCT01068860|584533245|FG006|Overall Study|Withdrawal by Subject|0|||
161860964|NCT01068860|584533246|FG007|Overall Study|Withdrawal by Subject|0|||
161860965|NCT01068860|584533247|FG008|Overall Study|Withdrawal by Subject|0|||
161860966|NCT01068860|584533248|FG009|Overall Study|Withdrawal by Subject|3|||
161860967|NCT01068860|584533239|FG000|Overall Study|Administrative problems; misrandomized|0|||
161860968|NCT01068860|584533240|FG001|Overall Study|Administrative problems; misrandomized|0|||
161860969|NCT01068860|584533241|FG002|Overall Study|Administrative problems; misrandomized|0|||
161860970|NCT01068860|584533242|FG003|Overall Study|Administrative problems; misrandomized|1|||
161860971|NCT01068860|584533243|FG004|Overall Study|Administrative problems; misrandomized|0|||
161860972|NCT01068860|584533244|FG005|Overall Study|Administrative problems; misrandomized|0|||
161860973|NCT01068860|584533245|FG006|Overall Study|Administrative problems; misrandomized|0|||
161860974|NCT01068860|584533246|FG007|Overall Study|Administrative problems; misrandomized|0|||
161860975|NCT01068860|584533247|FG008|Overall Study|Administrative problems; misrandomized|0|||
161860976|NCT01068860|584533248|FG009|Overall Study|Administrative problems; misrandomized|1|||
161860977|NCT01068860|584533239|FG000|Overall Study|Lost to Follow-up|0|||
161860978|NCT01068860|584533240|FG001|Overall Study|Lost to Follow-up|1|||
161860979|NCT01068860|584533241|FG002|Overall Study|Lost to Follow-up|0|||
161860980|NCT01068860|584533242|FG003|Overall Study|Lost to Follow-up|0|||
161860981|NCT01068860|584533243|FG004|Overall Study|Lost to Follow-up|0|||
161860982|NCT01068860|584533244|FG005|Overall Study|Lost to Follow-up|0|||
161860983|NCT01068860|584533245|FG006|Overall Study|Lost to Follow-up|0|||
161860984|NCT01068860|584533246|FG007|Overall Study|Lost to Follow-up|0|||
161860985|NCT01068860|584533247|FG008|Overall Study|Lost to Follow-up|0|||
161860986|NCT01068860|584533248|FG009|Overall Study|Lost to Follow-up|0|||
161860987|NCT02568072|584533249|FG000|Overall Study|Unavailable for appointment|23|||
161860988|NCT02568072|584533249|FG000|Overall Study|Unable to contact|3|||
161860989|NCT02568072|584533249|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
161860990|NCT02568072|584533249|FG000|Overall Study|Withdrawal by Subject|1|||
161860991|NCT02568072|584533249|FG000|Overall Study|Sustained injury, marathon not run|24|||
161860992|NCT05263908|584533250|FG000|Overall Study|No informed consent for publication of study results|397|||
161860993|NCT05263908|584533250|FG000|Overall Study|CRF not collected|1|||
161860994|NCT02714218|584533251|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161860995|NCT02714218|584533252|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161860996|NCT02714218|584533253|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161860997|NCT02714218|584533251|FG000|Pre-Treatment Period|Other reasons|0|||
161860998|NCT02714218|584533252|FG001|Pre-Treatment Period|Other reasons|1|||
161860999|NCT02714218|584533253|FG002|Pre-Treatment Period|Other reasons|0|||
161861000|NCT02714218|584533251|FG000|Treatment Period|Disease Progression|55|||
161861001|NCT02714218|584533252|FG001|Treatment Period|Disease Progression|52|||
161861002|NCT02714218|584533253|FG002|Treatment Period|Disease Progression|14|||
161861003|NCT02714218|584533251|FG000|Treatment Period|Study drug toxicity|46|||
161861004|NCT02714218|584533252|FG001|Treatment Period|Study drug toxicity|70|||
161861005|NCT02714218|584533253|FG002|Treatment Period|Study drug toxicity|6|||
161861006|NCT02714218|584533251|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
161861007|NCT02714218|584533252|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
161861008|NCT02714218|584533253|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
161861009|NCT02714218|584533251|FG000|Treatment Period|Request to discontinue treatment|1|||
161861010|NCT02714218|584533252|FG001|Treatment Period|Request to discontinue treatment|4|||
161861011|NCT02714218|584533253|FG002|Treatment Period|Request to discontinue treatment|1|||
161861012|NCT02714218|584533251|FG000|Treatment Period|Participant withdrew consent|2|||
161772360|NCT00057330|584209786|FG001|Overall Study|Protocol Violation|1|||
161772361|NCT00057330|584209785|FG000|Overall Study|Withdrawal by Subject|115|||
161772362|NCT00057330|584209786|FG001|Overall Study|Withdrawal by Subject|84|||
161772363|NCT00057330|584209785|FG000|Overall Study|Lost to Follow-up|745|||
161772364|NCT00057330|584209786|FG001|Overall Study|Lost to Follow-up|617|||
161772365|NCT00057330|584209785|FG000|Overall Study|Physician Decision|1|||
161772366|NCT00057330|584209786|FG001|Overall Study|Physician Decision|0|||
161772367|NCT00057330|584209785|FG000|Overall Study|Other|260|||
161772368|NCT00057330|584209786|FG001|Overall Study|Other|206|||
161772369|NCT01491737|584209787|FG000|Overall Study|Withdrawal by Subject|20|||
161772370|NCT01491737|584209788|FG001|Overall Study|Withdrawal by Subject|17|||
161772371|NCT01491737|584209787|FG000|Overall Study|Lost to Follow-up|2|||
161772372|NCT01491737|584209788|FG001|Overall Study|Lost to Follow-up|10|||
161772373|NCT01491737|584209787|FG000|Overall Study|Death|63|||
161772374|NCT01491737|584209788|FG001|Overall Study|Death|57|||
161772375|NCT01491737|584209787|FG000|Overall Study|Study Termination by Sponsor|36|||
161772376|NCT01491737|584209788|FG001|Overall Study|Study Termination by Sponsor|36|||
161772377|NCT01491737|584209787|FG000|Overall Study|Reason Not Specified|8|||
161772378|NCT01491737|584209788|FG001|Overall Study|Reason Not Specified|9|||
161772379|NCT01308476|584209789|FG000|Overall Study|Lost to Follow-up|2|||
161772380|NCT01308476|584209790|FG001|Overall Study|Lost to Follow-up|2|||
161772381|NCT01308476|584209789|FG000|Overall Study|Other|1|||
161772382|NCT01308476|584209790|FG001|Overall Study|Other|0|||
161772383|NCT03772574|584209791|FG000|Overall Study|Protocol Violation|2|||
161772384|NCT03772574|584209792|FG001|Overall Study|Protocol Violation|0|||
161772385|NCT03772574|584209793|FG002|Overall Study|Protocol Violation|0|||
161772386|NCT03772574|584209791|FG000|Overall Study|Discomfort|0|||
161772387|NCT03772574|584209792|FG001|Overall Study|Discomfort|5|||
161772388|NCT03772574|584209793|FG002|Overall Study|Discomfort|4|||
161772389|NCT02696382|584209796|FG000|Overall Study|Death|7|||
161772390|NCT02696382|584209797|FG001|Overall Study|Death|2|||
161772391|NCT02696382|584209796|FG000|Overall Study|Withdrawal by Subject|5|||
161772392|NCT02696382|584209797|FG001|Overall Study|Withdrawal by Subject|12|||
161772393|NCT02696382|584209796|FG000|Overall Study|Lost to Follow-up|4|||
161772394|NCT02696382|584209797|FG001|Overall Study|Lost to Follow-up|7|||
161772395|NCT00761969|584209798|FG000|Overall Study|Death|112|||
161772396|NCT00761969|584209799|FG001|Overall Study|Death|47|||
161772397|NCT00761969|584209798|FG000|Overall Study|Lost to Follow-up|88|||
161772398|NCT00761969|584209799|FG001|Overall Study|Lost to Follow-up|93|||
161772399|NCT01725217|584209800|FG000|Overall Study|Withdrawal by Subject|1|||
161772400|NCT01725217|584209801|FG001|Overall Study|Withdrawal by Subject|0|||
161772401|NCT01725217|584209802|FG002|Overall Study|Withdrawal by Subject|0|||
161772402|NCT00585468|584209803|FG000|First Intervention|Withdrawal by Subject|1|||
161772403|NCT00585468|584209804|FG001|First Intervention|Withdrawal by Subject|1|||
161772404|NCT02940392|584209809|FG000|Overall Study|Lost to Follow-up|3|||
161772405|NCT02940392|584209809|FG000|Overall Study|Retreatment|3|||
161772406|NCT02940392|584209809|FG000|Overall Study|Death|2|||
161772407|NCT03205046|584209810|FG000|Overall Study|Death|10|||
161772408|NCT03205046|584209811|FG001|Overall Study|Death|6|||
161772409|NCT03205046|584209810|FG000|Overall Study|Withdrawal by Subject|1|||
161772410|NCT03205046|584209811|FG001|Overall Study|Withdrawal by Subject|2|||
161772411|NCT03205046|584209810|FG000|Overall Study|Lost to Follow-up|0|||
161772412|NCT03205046|584209811|FG001|Overall Study|Lost to Follow-up|1|||
161772413|NCT03205046|584209810|FG000|Overall Study|Study terminated by sponsor|2|||
161772414|NCT03205046|584209811|FG001|Overall Study|Study terminated by sponsor|1|||
161772415|NCT00762073|584209812|FG000|Overall Study|Lack of Efficacy|1|||
161772416|NCT00762073|584209813|FG001|Overall Study|Lack of Efficacy|1|||
161772417|NCT00762073|584209814|FG002|Overall Study|Lack of Efficacy|0|||
161772418|NCT00762073|584209815|FG003|Overall Study|Lack of Efficacy|0|||
161772419|NCT00762073|584209812|FG000|Overall Study|Adverse Event|1|||
161772420|NCT00762073|584209813|FG001|Overall Study|Adverse Event|0|||
161772421|NCT00762073|584209814|FG002|Overall Study|Adverse Event|1|||
161772422|NCT00762073|584209815|FG003|Overall Study|Adverse Event|1|||
161772423|NCT00762073|584209812|FG000|Overall Study|Significant Subject Noncompliance|0|||
161772424|NCT00762073|584209813|FG001|Overall Study|Significant Subject Noncompliance|1|||
161772425|NCT00762073|584209814|FG002|Overall Study|Significant Subject Noncompliance|0|||
161772426|NCT00762073|584209815|FG003|Overall Study|Significant Subject Noncompliance|1|||
161772427|NCT00762073|584209812|FG000|Overall Study|Withdrawal by Subject|1|||
161772428|NCT00762073|584209813|FG001|Overall Study|Withdrawal by Subject|2|||
161772429|NCT00762073|584209814|FG002|Overall Study|Withdrawal by Subject|1|||
161772430|NCT00762073|584209815|FG003|Overall Study|Withdrawal by Subject|1|||
161772431|NCT00762073|584209812|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
161772432|NCT00762073|584209813|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
161772433|NCT00762073|584209814|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
161772434|NCT00762073|584209815|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
161772435|NCT01068418|584209818|FG000|Overall Study|Physician Decision|12|||
161772436|NCT02319642|584209819|FG000|Overall Study|Adverse Event|2|||
161772437|NCT02319642|584209820|FG001|Overall Study|Adverse Event|4|||
161772438|NCT02319642|584209819|FG000|Overall Study|Lack of Efficacy|1|||
161861013|NCT02714218|584533252|FG001|Treatment Period|Participant withdrew consent|2|||
161861014|NCT02714218|584533253|FG002|Treatment Period|Participant withdrew consent|0|||
161861015|NCT02714218|584533251|FG000|Treatment Period|Maximum clinical benefit|4|||
161861016|NCT02714218|584533252|FG001|Treatment Period|Maximum clinical benefit|2|||
161861017|NCT02714218|584533253|FG002|Treatment Period|Maximum clinical benefit|0|||
161861018|NCT02714218|584533251|FG000|Treatment Period|Administrative reason by sponsor|2|||
161861019|NCT02714218|584533252|FG001|Treatment Period|Administrative reason by sponsor|1|||
161861020|NCT02714218|584533253|FG002|Treatment Period|Administrative reason by sponsor|0|||
161861021|NCT02714218|584533251|FG000|Treatment Period|Other reasons|6|||
161861022|NCT02714218|584533252|FG001|Treatment Period|Other reasons|6|||
161861023|NCT02714218|584533253|FG002|Treatment Period|Other reasons|0|||
161861024|NCT02714218|584533251|FG000|Treatment Period|Completed treatment as per protocol|36|||
161861025|NCT02714218|584533252|FG001|Treatment Period|Completed treatment as per protocol|27|||
161861026|NCT02714218|584533253|FG002|Treatment Period|Completed treatment as per protocol|3|||
161861027|NCT02714218|584533251|FG000|Treatment Period|Not reported|9|||
161861028|NCT02714218|584533252|FG001|Treatment Period|Not reported|6|||
161861029|NCT02714218|584533253|FG002|Treatment Period|Not reported|0|||
161861030|NCT00840749|584533254|FG000|Overall Study|Death|1|||
161861031|NCT00840749|584533255|FG001|Overall Study|Death|2|||
161861032|NCT00840749|584533254|FG000|Overall Study|not treated on study arm|11|||
161861033|NCT00840749|584533255|FG001|Overall Study|not treated on study arm|11|||
161861034|NCT00840749|584533254|FG000|Overall Study|study closed|19|||
161861035|NCT00840749|584533255|FG001|Overall Study|study closed|14|||
161861036|NCT01113892|584533256|FG000|Overall Study|Lost to Follow-up|2|||
161861037|NCT01113892|584533257|FG001|Overall Study|Lost to Follow-up|2|||
161861038|NCT01113892|584533256|FG000|Overall Study|Withdrawal by Subject|1|||
161861039|NCT01113892|584533257|FG001|Overall Study|Withdrawal by Subject|1|||
161772439|NCT02319642|584209820|FG001|Overall Study|Lack of Efficacy|1|||
161772440|NCT02319642|584209819|FG000|Overall Study|Withdrawal by Subject|1|||
161772441|NCT02319642|584209820|FG001|Overall Study|Withdrawal by Subject|1|||
161772442|NCT01265875|584209821|FG000|Overall Study|Uncooperative/unreliable|1|||
161772443|NCT00145795|584209824|FG000|Overall Study|Adverse Event|1|||
161772444|NCT00145795|584209825|FG001|Overall Study|Adverse Event|0|||
161772445|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Adverse Event|6|||
161772446|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Adverse Event|6|||
161772447|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Death|14|||
161772448|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Death|11|||
161772449|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
161772450|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
161772451|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
161772452|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
161772453|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
161772454|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
161772455|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Disease Progression|1|||
161772456|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Disease Progression|0|||
161772457|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
161772458|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
161772459|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
161772460|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
161772461|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Participant Decision|4|||
161772462|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Participant Decision|3|||
161772463|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
161772464|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
161772465|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Death|4|||
161772466|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Death|6|||
161772467|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
161861040|NCT01113892|584533256|FG000|Overall Study|Death|2|||
161861041|NCT01113892|584533257|FG001|Overall Study|Death|4|||
161861042|NCT01113892|584533256|FG000|Overall Study|Graft no longer evaluable|9|||
161861043|NCT01113892|584533257|FG001|Overall Study|Graft no longer evaluable|9|||
161861044|NCT00789854|584533264|FG000|Overall Study|Adverse Event|28|||
161861045|NCT00789854|584533265|FG001|Overall Study|Adverse Event|23|||
161861046|NCT00789854|584533266|FG002|Overall Study|Adverse Event|18|||
161861047|NCT00789854|584533264|FG000|Overall Study|Lost to Follow-up|1|||
161861048|NCT00789854|584533265|FG001|Overall Study|Lost to Follow-up|1|||
161861049|NCT00789854|584533266|FG002|Overall Study|Lost to Follow-up|4|||
161861050|NCT00789854|584533264|FG000|Overall Study|Withdrawal by Subject|9|||
161861051|NCT00789854|584533265|FG001|Overall Study|Withdrawal by Subject|6|||
161861052|NCT00789854|584533266|FG002|Overall Study|Withdrawal by Subject|17|||
161772468|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
161772469|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
161772470|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
161772471|NCT01539512|584209828|FG000|Overall Study|Adverse Event|9|||
161772472|NCT01539512|584209829|FG001|Overall Study|Adverse Event|7|||
161772473|NCT01539512|584209828|FG000|Overall Study|Physician Decision|1|||
161772474|NCT01539512|584209829|FG001|Overall Study|Physician Decision|1|||
161772475|NCT01539512|584209828|FG000|Overall Study|Withdrawal by Subject|12|||
161772476|NCT01539512|584209829|FG001|Overall Study|Withdrawal by Subject|5|||
161772477|NCT01539512|584209828|FG000|Overall Study|Richter's Transformation|1|||
161772478|NCT01539512|584209829|FG001|Overall Study|Richter's Transformation|0|||
161772479|NCT01015118|584209830|FG000|Overall Study|Protocol Violation|5|||
161772480|NCT01015118|584209831|FG001|Overall Study|Protocol Violation|6|||
161772481|NCT01015118|584209830|FG000|Overall Study|Withdrawal by Subject|103|||
161772482|NCT01015118|584209831|FG001|Overall Study|Withdrawal by Subject|27|||
161772483|NCT01015118|584209830|FG000|Overall Study|Other Adverse Event (AE)|141|||
161772484|NCT01015118|584209831|FG001|Overall Study|Other Adverse Event (AE)|33|||
161772485|NCT01015118|584209830|FG000|Overall Study|Worsening or AE of underlying disease|5|||
161772486|NCT01015118|584209831|FG001|Overall Study|Worsening or AE of underlying disease|4|||
161772487|NCT01015118|584209830|FG000|Overall Study|Progressive disease|364|||
161772488|NCT01015118|584209831|FG001|Overall Study|Progressive disease|229|||
161772489|NCT01015118|584209830|FG000|Overall Study|Not treated|9|||
161772490|NCT01015118|584209831|FG001|Overall Study|Not treated|5|||
161772491|NCT01015118|584209830|FG000|Overall Study|Other than stated above|42|||
161772492|NCT01015118|584209831|FG001|Overall Study|Other than stated above|23|||
161772493|NCT02388906|584209832|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161772494|NCT02388906|584209833|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161772495|NCT02388906|584209832|FG000|Treatment Period|Disease progression|121|||
161772496|NCT02388906|584209833|FG001|Treatment Period|Disease progression|100|||
161772497|NCT02388906|584209832|FG000|Treatment Period|Study drug toxicity|41|||
161772498|NCT02388906|584209833|FG001|Treatment Period|Study drug toxicity|208|||
161772499|NCT02388906|584209832|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
161772500|NCT02388906|584209833|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
161772501|NCT02388906|584209832|FG000|Treatment Period|Participant request to stop treatment|5|||
161772502|NCT02388906|584209833|FG001|Treatment Period|Participant request to stop treatment|9|||
161772503|NCT02388906|584209832|FG000|Treatment Period|Participant withdrew consent|2|||
161772504|NCT02388906|584209833|FG001|Treatment Period|Participant withdrew consent|3|||
161772505|NCT02388906|584209832|FG000|Treatment Period|Poor/non-compliance|0|||
161772506|NCT02388906|584209833|FG001|Treatment Period|Poor/non-compliance|1|||
161772507|NCT02388906|584209832|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161772508|NCT02388906|584209833|FG001|Treatment Period|Participant no longer meets study criteria|1|||
161772509|NCT02388906|584209832|FG000|Treatment Period|Other reasons|3|||
161772510|NCT02388906|584209833|FG001|Treatment Period|Other reasons|3|||
161772511|NCT01250418|584209834|FG000|Overall Study|monitor data failure|1|||
161772512|NCT01250418|584209835|FG001|Overall Study|monitor data failure|1|||
161772513|NCT02400281|584209837|FG000|Overall Study|Adverse Event|0|||
161772514|NCT02400281|584209838|FG001|Overall Study|Adverse Event|0|||
161772515|NCT02400281|584209839|FG002|Overall Study|Adverse Event|1|||
161772516|NCT02400281|584209840|FG003|Overall Study|Adverse Event|0|||
161772517|NCT02400281|584209841|FG004|Overall Study|Adverse Event|1|||
161772518|NCT02400281|584209842|FG005|Overall Study|Adverse Event|0|||
161772519|NCT02400281|584209837|FG000|Overall Study|Physician Decision|0|||
161772520|NCT02400281|584209838|FG001|Overall Study|Physician Decision|0|||
161772521|NCT02400281|584209839|FG002|Overall Study|Physician Decision|1|||
161772522|NCT02400281|584209840|FG003|Overall Study|Physician Decision|0|||
161772523|NCT02400281|584209841|FG004|Overall Study|Physician Decision|0|||
161772524|NCT02400281|584209842|FG005|Overall Study|Physician Decision|0|||
161772525|NCT00412360|584209843|FG000|Overall Study|Lost to Follow-up|0|||
161772526|NCT00412360|584209844|FG001|Overall Study|Lost to Follow-up|1|||
161772527|NCT00412360|584209843|FG000|Overall Study|Not Transplanted|1|||
161772528|NCT00412360|584209844|FG001|Overall Study|Not Transplanted|2|||
161772529|NCT03145207|584209846|FG000|Overall Study|volunteer started taking allergy shots|1|||
161772530|NCT03145207|584209846|FG000|Overall Study|baseline blood pressure high|1|||
161772531|NCT01790633|584209847|FG000|Overall Study|Protocol Violation|1|||
161772532|NCT01790633|584209848|FG001|Overall Study|Protocol Violation|2|||
161772533|NCT01790633|584209847|FG000|Overall Study|Did not have serology performed|47|||
161772534|NCT01790633|584209848|FG001|Overall Study|Did not have serology performed|0|||
161772535|NCT01790633|584209847|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
161772536|NCT01790633|584209848|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
161772537|NCT01396434|584209850|FG000|Overall Study|Lost to Follow-up|1|||
161772538|NCT01396434|584209851|FG001|Overall Study|Lost to Follow-up|0|||
161772539|NCT01396434|584209852|FG002|Overall Study|Lost to Follow-up|0|||
161772540|NCT01396434|584209850|FG000|Overall Study|Other|10|||
161772541|NCT01396434|584209851|FG001|Overall Study|Other|0|||
161772542|NCT01396434|584209852|FG002|Overall Study|Other|0|||
161772543|NCT04678557|584209853|FG000|Overall Study|Withdrawal by Subject|1|||
161772544|NCT04678557|584209854|FG001|Overall Study|Withdrawal by Subject|0|||
161772545|NCT04678557|584209853|FG000|Overall Study|Lack of Efficacy|0|||
161772546|NCT04678557|584209854|FG001|Overall Study|Lack of Efficacy|13|||
161772547|NCT04678557|584209853|FG000|Overall Study|Safety Evaluation|0|||
161772548|NCT04678557|584209854|FG001|Overall Study|Safety Evaluation|1|||
161861053|NCT00789854|584533264|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161861054|NCT00789854|584533265|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
161861055|NCT00789854|584533266|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161861056|NCT00789854|584533264|FG000|Overall Study|Severe non-compliance to the protocol|3|||
161861057|NCT00789854|584533265|FG001|Overall Study|Severe non-compliance to the protocol|0|||
161861058|NCT00789854|584533266|FG002|Overall Study|Severe non-compliance to the protocol|0|||
161861059|NCT00789854|584533264|FG000|Overall Study|Safety reasons|0|||
161861060|NCT00789854|584533265|FG001|Overall Study|Safety reasons|0|||
161861061|NCT00789854|584533266|FG002|Overall Study|Safety reasons|2|||
161861062|NCT00789854|584533264|FG000|Overall Study|Other|6|||
161861063|NCT00789854|584533265|FG001|Overall Study|Other|0|||
161861064|NCT00789854|584533266|FG002|Overall Study|Other|5|||
161861065|NCT03473925|584533267|FG000|Overall Study|Death|48|||
161861066|NCT03473925|584533268|FG001|Overall Study|Death|44|||
161861067|NCT03473925|584533267|FG000|Overall Study|Sponsor Decision|2|||
161861068|NCT03473925|584533268|FG001|Overall Study|Sponsor Decision|7|||
161861069|NCT03473925|584533267|FG000|Overall Study|Withdrawal by Subject|1|||
161861070|NCT03473925|584533268|FG001|Overall Study|Withdrawal by Subject|3|||
161861071|NCT03473925|584533267|FG000|Overall Study|Not Treated|1|||
161861072|NCT03473925|584533268|FG001|Overall Study|Not Treated|1|||
161861073|NCT03411863|584533269|FG000|Overall Study|Withdrawal by Subject|3|||
161861074|NCT03411863|584533270|FG001|Overall Study|Withdrawal by Subject|1|||
161861075|NCT03411863|584533269|FG000|Overall Study|Physician Decision|0|||
161861076|NCT03411863|584533270|FG001|Overall Study|Physician Decision|1|||
161861077|NCT02766335|584533272|FG000|Initial Registration|Adverse Event|6|||
161861078|NCT02766335|584533273|FG001|Initial Registration|Adverse Event|3|||
161861079|NCT02766335|584533274|FG002|Initial Registration|Adverse Event|0|||
161861080|NCT02766335|584533272|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
161861081|NCT02766335|584533273|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
161861082|NCT02766335|584533274|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
161861083|NCT02766335|584533272|FG000|Initial Registration|Progression/relapse|49|||
161861084|NCT02766335|584533273|FG001|Initial Registration|Progression/relapse|15|||
161861085|NCT02766335|584533274|FG002|Initial Registration|Progression/relapse|0|||
161861086|NCT02766335|584533272|FG000|Initial Registration|Death|1|||
161861087|NCT02766335|584533273|FG001|Initial Registration|Death|3|||
161861088|NCT02766335|584533274|FG002|Initial Registration|Death|0|||
161861089|NCT02766335|584533272|FG000|Initial Registration|not protocol specified|1|||
161861090|NCT02766335|584533273|FG001|Initial Registration|not protocol specified|9|||
161861091|NCT02766335|584533274|FG002|Initial Registration|not protocol specified|0|||
161861092|NCT02766335|584533272|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
161861093|NCT02766335|584533273|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
161861094|NCT02766335|584533274|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
161861095|NCT02766335|584533272|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
161861096|NCT02766335|584533273|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
161861097|NCT02766335|584533274|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
161861098|NCT02756611|584533276|FG000|Overall Study|Death|70|||
161861099|NCT02756611|584533276|FG000|Overall Study|Withdrawal by Subject|2|||
161861100|NCT02756611|584533276|FG000|Overall Study|Lost to Follow-up|3|||
161861101|NCT02756611|584533276|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
161861102|NCT02756611|584533276|FG000|Overall Study|Other|10|||
161861103|NCT03125798|584533278|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
161861104|NCT03125798|584533279|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
161861105|NCT03125798|584533278|FG000|Overall Study|Conversion to thoracotomy|7|||
161861106|NCT03125798|584533279|FG001|Overall Study|Conversion to thoracotomy|7|||
161861107|NCT00476190|584533294|FG000|Overall Study|Ineligible|1|||
161861108|NCT00476190|584533295|FG001|Overall Study|Ineligible|1|||
161861109|NCT00476190|584533294|FG000|Overall Study|Induction Death|2|||
161861110|NCT00476190|584533295|FG001|Overall Study|Induction Death|0|||
161861111|NCT00476190|584533294|FG000|Overall Study|Induction Failure|2|||
161861112|NCT00476190|584533295|FG001|Overall Study|Induction Failure|4|||
161861113|NCT00476190|584533294|FG000|Overall Study|Lost to Follow-up|1|||
161861114|NCT00476190|584533295|FG001|Overall Study|Lost to Follow-up|0|||
161861115|NCT00476190|584533294|FG000|Overall Study|Relapse/Progression|5|||
161861116|NCT00476190|584533295|FG001|Overall Study|Relapse/Progression|2|||
161861117|NCT00476190|584533294|FG000|Overall Study|Remission Death|0|||
161861118|NCT00476190|584533295|FG001|Overall Study|Remission Death|1|||
161861119|NCT00476190|584533294|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
161861120|NCT00476190|584533295|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
161861121|NCT00476190|584533294|FG000|Overall Study|Withdrawal by Subject|6|||
161861122|NCT00476190|584533295|FG001|Overall Study|Withdrawal by Subject|2|||
161861123|NCT00476190|584533294|FG000|Overall Study|Other|9|||
161861124|NCT00476190|584533295|FG001|Overall Study|Other|10|||
161861125|NCT04782076|584533296|FG000|Overall Study|Family Emergency|1|||
161861126|NCT02189837|584533300|FG000|Overall Study|Withdrawal by Subject|2|||
161861127|NCT02189837|584533301|FG001|Overall Study|Withdrawal by Subject|1|||
161861128|NCT02189837|584533302|FG002|Overall Study|Withdrawal by Subject|3|||
161861129|NCT02189837|584533303|FG003|Overall Study|Withdrawal by Subject|1|||
161861130|NCT02189837|584533300|FG000|Overall Study|Sponsor Decision|0|||
161861131|NCT02189837|584533301|FG001|Overall Study|Sponsor Decision|0|||
161861132|NCT02189837|584533302|FG002|Overall Study|Sponsor Decision|0|||
161861133|NCT02189837|584533303|FG003|Overall Study|Sponsor Decision|1|||
161861134|NCT04052620|584533304|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
161861135|NCT04052620|584533305|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
161861136|NCT04052620|584533304|FG000|Overall Study|Withdrawal by Subject|1|||
161861137|NCT04052620|584533305|FG001|Overall Study|Withdrawal by Subject|0|||
161861138|NCT04052620|584533304|FG000|Overall Study|Lost to Follow-up|1|||
161861139|NCT04052620|584533305|FG001|Overall Study|Lost to Follow-up|1|||
161861140|NCT04052620|584533304|FG000|Overall Study|Adverse Event|1|||
161861141|NCT04052620|584533305|FG001|Overall Study|Adverse Event|0|||
161861142|NCT04052620|584533304|FG000|Overall Study|Subject did not meet study Criteria|0|||
161861143|NCT04052620|584533305|FG001|Overall Study|Subject did not meet study Criteria|1|||
161861144|NCT04052620|584533304|FG000|Overall Study|Screened failure, randomized by mistake|0|||
161861145|NCT04052620|584533305|FG001|Overall Study|Screened failure, randomized by mistake|1|||
161861146|NCT04052620|584533304|FG000|Overall Study|Personal reasons|2|||
161861147|NCT04052620|584533305|FG001|Overall Study|Personal reasons|4|||
161861148|NCT04052620|584533304|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
161861149|NCT04052620|584533305|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
161861150|NCT03552380|584533307|FG000|Study Treatment|Disease Progression|3|||
161861151|NCT03552380|584533308|FG001|Study Treatment|Disease Progression|4|||
161861152|NCT03552380|584533307|FG000|Study Treatment|Adverse Event|2|||
161861153|NCT03552380|584533308|FG001|Study Treatment|Adverse Event|2|||
161861154|NCT03552380|584533307|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
161861155|NCT03552380|584533308|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
161861156|NCT03552380|584533307|FG000|Follow up|Death|3|||
161861157|NCT03552380|584533308|FG001|Follow up|Death|4|||
161861158|NCT03552380|584533307|FG000|Follow up|Site IRB terminated|0|||
161861159|NCT03552380|584533308|FG001|Follow up|Site IRB terminated|1|||
161861160|NCT02633787|584533311|FG000|Overall Study|Withdrawal by Subject|1|||
161861161|NCT00550459|584533312|FG000|Overall Study|Adverse Event|0|||
161861162|NCT00550459|584533313|FG001|Overall Study|Adverse Event|2|||
161861163|NCT00550459|584533312|FG000|Overall Study|Withdrawal by Subject|1|||
161861164|NCT00550459|584533313|FG001|Overall Study|Withdrawal by Subject|1|||
161861165|NCT01401452|584533314|FG000|Overall Study|Adverse reaction|9|||
161861166|NCT01401452|584533314|FG000|Overall Study|Lost to Follow-up|12|||
161861167|NCT01401452|584533314|FG000|Overall Study|Lack of Efficacy|30|||
161861168|NCT01401452|584533314|FG000|Overall Study|Participant developed breast cancer|1|||
161861169|NCT01401452|584533314|FG000|Overall Study|Tx stopped due to financial reasons|1|||
161861170|NCT01401452|584533314|FG000|Overall Study|Tx stopped by psychiatrist|1|||
161861171|NCT01401452|584533314|FG000|Overall Study|No more visits within the 36 wk followup|4|||
161861172|NCT01401452|584533314|FG000|Overall Study|Subject did not come to follow up visits|2|||
161861173|NCT01401452|584533314|FG000|Overall Study|Subject didn't return for routine visits|1|||
161861174|NCT01401452|584533314|FG000|Overall Study|Subject moved to another city|1|||
161861175|NCT01401452|584533314|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
161861176|NCT01401452|584533314|FG000|Overall Study|Psoriatic arthritis|1|||
161861177|NCT01401452|584533314|FG000|Overall Study|Participant stopped Tx|2|||
161861178|NCT01401452|584533314|FG000|Overall Study|Discontinuation for personal reasons|1|||
161861179|NCT01401452|584533314|FG000|Overall Study|Treatment failure|1|||
161861180|NCT01401452|584533314|FG000|Overall Study|Unsatisfactory output|1|||
161861181|NCT01401452|584533314|FG000|Overall Study|Subject withdrew because of Tx success|1|||
161861182|NCT01401452|584533314|FG000|Overall Study|Subject chose to discontinue treatment|1|||
161861183|NCT01401452|584533314|FG000|Overall Study|Participant withdrew consent|1|||
161861184|NCT00584454|584533315|FG000|Overall Study|Adverse Event|1|||
161861185|NCT00584454|584533315|FG000|Overall Study|Relocation|1|||
161861186|NCT00584454|584533315|FG000|Overall Study|Clinical Hold|2|||
161861187|NCT02404805|584533316|FG000|Overall Study|Withdrawal by Subject|1|||
161861188|NCT02404805|584533317|FG001|Overall Study|Withdrawal by Subject|0|||
161861189|NCT02404805|584533318|FG002|Overall Study|Withdrawal by Subject|0|||
161861190|NCT02404805|584533319|FG003|Overall Study|Withdrawal by Subject|0|||
161861191|NCT02404805|584533320|FG004|Overall Study|Withdrawal by Subject|0|||
161861192|NCT02404805|584533321|FG005|Overall Study|Withdrawal by Subject|0|||
161861193|NCT01742897|584533322|FG000|Overall Study|Adverse Event|3|||
161861194|NCT01742897|584533322|FG000|Overall Study|Withdrawal by Subject|1|||
161861195|NCT01742897|584533322|FG000|Overall Study|Other|1|||
161861196|NCT01459783|584533326|FG000|Baseline to 6 Months|Death|1|||
161861197|NCT01459783|584533327|FG001|Baseline to 6 Months|Death|0|||
161861198|NCT01459783|584533326|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
161861199|NCT01459783|584533327|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
161861200|NCT01459783|584533326|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
161861201|NCT01459783|584533327|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
161861202|NCT01459783|584533326|FG000|6 Months to 12 Months|Death|0|||
161861203|NCT01459783|584533327|FG001|6 Months to 12 Months|Death|1|||
161861204|NCT01459783|584533326|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
161861205|NCT01459783|584533327|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
161861206|NCT01459783|584533326|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
161861207|NCT01459783|584533327|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
161861208|NCT01459783|584533326|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
161861209|NCT01459783|584533327|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
161861210|NCT02601014|584533328|FG000|Overall Study|Adverse Event|3|||
161861211|NCT02601014|584533329|FG001|Overall Study|Adverse Event|3|||
161861212|NCT02601014|584533328|FG000|Overall Study|Death|3|||
161861213|NCT02601014|584533329|FG001|Overall Study|Death|1|||
161861214|NCT02601014|584533328|FG000|Overall Study|Disease progression|4|||
161861215|NCT02601014|584533329|FG001|Overall Study|Disease progression|8|||
161861216|NCT02698163|584533330|FG000|Overall Study|Lost to Follow-up|0|||
161861217|NCT02698163|584533331|FG001|Overall Study|Lost to Follow-up|1|||
161861218|NCT01133067|584533332|FG000|Overall Study|Death|136|||
161861219|NCT01133067|584533332|FG000|Overall Study|Lost to Follow-up|3|||
161861220|NCT00752128|584533333|FG000|Overall Study|Withdrawal by Subject|4|||
161861221|NCT00349973|584533334|FG000|Overall Study|Adverse Event|3|||
161861222|NCT00349973|584533335|FG001|Overall Study|Adverse Event|3|||
161861223|NCT00349973|584533334|FG000|Overall Study|Withdrawal by Subject|1|||
161861224|NCT00349973|584533335|FG001|Overall Study|Withdrawal by Subject|0|||
161861225|NCT04135937|584533336|FG000|Overall Study|Lost to Follow-up|2|||
161861226|NCT04135937|584533336|FG000|Overall Study|Withdrawal by Subject|1|||
161861227|NCT05620082|584533337|FG000|Overall Study|Discharged before study end|1|||
161861228|NCT05620082|584533338|FG001|Overall Study|Discharged before study end|4|||
161861229|NCT05620082|584533339|FG002|Overall Study|Discharged before study end|0|||
161861230|NCT05620082|584533337|FG000|Overall Study|Moved to a different ward|1|||
161861231|NCT05620082|584533338|FG001|Overall Study|Moved to a different ward|0|||
161861232|NCT05620082|584533339|FG002|Overall Study|Moved to a different ward|0|||
161861233|NCT05620082|584533337|FG000|Overall Study|Feeling too unwell|1|||
161861234|NCT05620082|584533338|FG001|Overall Study|Feeling too unwell|0|||
161861235|NCT05620082|584533339|FG002|Overall Study|Feeling too unwell|0|||
161861236|NCT04199104|584535882|FG000|Overall Study|Death|148|||
161861237|NCT04199104|584535883|FG001|Overall Study|Death|134|||
161861238|NCT04199104|584535882|FG000|Overall Study|Lost to Follow-up|1|||
161861239|NCT04199104|584535883|FG001|Overall Study|Lost to Follow-up|1|||
161861240|NCT04199104|584535882|FG000|Overall Study|Withdrawal by Subject|4|||
161861241|NCT04199104|584535883|FG001|Overall Study|Withdrawal by Subject|4|||
161861242|NCT04199104|584535882|FG000|Overall Study|Participants Ongoing|103|||
161861243|NCT04199104|584535883|FG001|Overall Study|Participants Ongoing|116|||
161861244|NCT04023396|584535884|FG000|Overall Study|Adverse Event|16|||
161861245|NCT04023396|584535884|FG000|Overall Study|Death|1|||
161861246|NCT04023396|584535884|FG000|Overall Study|Lost to Follow-up|1|||
161861247|NCT04023396|584535884|FG000|Overall Study|Withdrawal by Subject|14|||
161861248|NCT04023396|584535884|FG000|Overall Study|Pregnancy|4|||
161861249|NCT04023396|584535884|FG000|Overall Study|Lack of Efficacy|3|||
161861250|NCT04023396|584535884|FG000|Overall Study|Physician Decision|4|||
161861251|NCT04023396|584535884|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
161861252|NCT02325973|584535887|FG000|Overall Study|Death|5|||
161861253|NCT02325973|584535887|FG000|Overall Study|Withdrawal by subject or investigator|16|||
161861254|NCT04075825|584535888|FG000|Overall Study|Withdrawal by Subject|6|||
161861255|NCT04075825|584535889|FG001|Overall Study|Withdrawal by Subject|8|||
161861256|NCT04075825|584535888|FG000|Overall Study|Physician Decision|3|||
161861257|NCT04075825|584535889|FG001|Overall Study|Physician Decision|1|||
161861258|NCT04075825|584535888|FG000|Overall Study|Lost to Follow-up|5|||
161861259|NCT04075825|584535889|FG001|Overall Study|Lost to Follow-up|1|||
161861260|NCT04075825|584535888|FG000|Overall Study|Participation in New Clinical Trial|1|||
161861261|NCT04075825|584535889|FG001|Overall Study|Participation in New Clinical Trial|1|||
161861262|NCT04075825|584535888|FG000|Overall Study|Reason Not Specified|2|||
161861263|NCT04075825|584535889|FG001|Overall Study|Reason Not Specified|2|||
161861264|NCT01168232|584535890|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
161861265|NCT01168232|584535890|FG000|Overall Study|Ineligible- Wrong cell type|6|||
161861266|NCT01168232|584535890|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
161861267|NCT03879135|584535895|FG000|Overall Study|Physician Decision|0|||
161861268|NCT03879135|584535896|FG001|Overall Study|Physician Decision|0|||
161861269|NCT03879135|584535897|FG002|Overall Study|Physician Decision|0|||
161861270|NCT03879135|584535898|FG003|Overall Study|Physician Decision|1|||
161861271|NCT03879135|584535899|FG004|Overall Study|Physician Decision|0|||
161861272|NCT03879135|584535900|FG005|Overall Study|Physician Decision|0|||
161861273|NCT03879135|584535895|FG000|Overall Study|Withdrawal by Subject|0|||
161861274|NCT03879135|584535896|FG001|Overall Study|Withdrawal by Subject|0|||
161861275|NCT03879135|584535897|FG002|Overall Study|Withdrawal by Subject|0|||
161861276|NCT03879135|584535898|FG003|Overall Study|Withdrawal by Subject|0|||
161861277|NCT03879135|584535899|FG004|Overall Study|Withdrawal by Subject|0|||
161861278|NCT03879135|584535900|FG005|Overall Study|Withdrawal by Subject|1|||
161861279|NCT03879135|584535895|FG000|Overall Study|Site Closed by Sponsor|0|||
161861280|NCT03879135|584535896|FG001|Overall Study|Site Closed by Sponsor|0|||
161861281|NCT03879135|584535897|FG002|Overall Study|Site Closed by Sponsor|0|||
161861282|NCT03879135|584535898|FG003|Overall Study|Site Closed by Sponsor|1|||
161861283|NCT03879135|584535899|FG004|Overall Study|Site Closed by Sponsor|1|||
161861284|NCT03879135|584535900|FG005|Overall Study|Site Closed by Sponsor|0|||
161861285|NCT05201794|584535901|FG000|Overall Study|Withdrawal by Subject|13|||
161861286|NCT05201794|584535902|FG001|Overall Study|Withdrawal by Subject|12|||
161861287|NCT05201794|584535903|FG002|Overall Study|Withdrawal by Subject|14|||
161861288|NCT05201794|584535904|FG003|Overall Study|Withdrawal by Subject|0|||
161861289|NCT05201794|584535901|FG000|Overall Study|Adverse Event|5|||
161861290|NCT05201794|584535902|FG001|Overall Study|Adverse Event|5|||
161861291|NCT05201794|584535903|FG002|Overall Study|Adverse Event|4|||
161861292|NCT05201794|584535904|FG003|Overall Study|Adverse Event|0|||
161861293|NCT05201794|584535901|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
161861294|NCT05201794|584535902|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161861295|NCT05201794|584535903|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
161861296|NCT05201794|584535904|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161861297|NCT05201794|584535901|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161861298|NCT05201794|584535902|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161861299|NCT05201794|584535903|FG002|Overall Study|Non-Compliance With Study Drug|3|||
161861300|NCT05201794|584535904|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161861301|NCT05201794|584535901|FG000|Overall Study|Physician Decision|1|||
161861302|NCT05201794|584535902|FG001|Overall Study|Physician Decision|3|||
161861303|NCT05201794|584535903|FG002|Overall Study|Physician Decision|2|||
161861304|NCT05201794|584535904|FG003|Overall Study|Physician Decision|0|||
161861305|NCT05201794|584535901|FG000|Overall Study|Lost to Follow-up|2|||
161861306|NCT05201794|584535902|FG001|Overall Study|Lost to Follow-up|2|||
161861307|NCT05201794|584535903|FG002|Overall Study|Lost to Follow-up|0|||
161861308|NCT05201794|584535904|FG003|Overall Study|Lost to Follow-up|0|||
161861309|NCT05201794|584535901|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
161861310|NCT05201794|584535902|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
161861311|NCT05201794|584535903|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
161861312|NCT05201794|584535904|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
161861313|NCT05201794|584535901|FG000|Overall Study|Protocol Violation|2|||
161861314|NCT05201794|584535902|FG001|Overall Study|Protocol Violation|0|||
161861315|NCT05201794|584535903|FG002|Overall Study|Protocol Violation|1|||
161861316|NCT05201794|584535904|FG003|Overall Study|Protocol Violation|0|||
161861317|NCT05201794|584535901|FG000|Overall Study|Death|1|||
161861318|NCT05201794|584535902|FG001|Overall Study|Death|0|||
161861319|NCT05201794|584535903|FG002|Overall Study|Death|0|||
161861320|NCT05201794|584535904|FG003|Overall Study|Death|0|||
161861321|NCT05201794|584535901|FG000|Overall Study|Site Terminated By Sponsor|0|||
161861322|NCT05201794|584535902|FG001|Overall Study|Site Terminated By Sponsor|1|||
161861323|NCT05201794|584535903|FG002|Overall Study|Site Terminated By Sponsor|0|||
161861324|NCT05201794|584535904|FG003|Overall Study|Site Terminated By Sponsor|0|||
161861325|NCT05201794|584535901|FG000|Overall Study|Other|3|||
161861326|NCT05201794|584535902|FG001|Overall Study|Other|3|||
161861327|NCT05201794|584535903|FG002|Overall Study|Other|3|||
161861328|NCT05201794|584535904|FG003|Overall Study|Other|0|||
161861329|NCT05201794|584535901|FG000|Overall Study|Randomized But Not Treated|1|||
161861330|NCT05201794|584535902|FG001|Overall Study|Randomized But Not Treated|2|||
161861331|NCT05201794|584535903|FG002|Overall Study|Randomized But Not Treated|1|||
161861332|NCT05201794|584535904|FG003|Overall Study|Randomized But Not Treated|0|||
161861333|NCT03428958|584535905|FG000|Overall Study|Adverse Event|0|||
161861334|NCT03428958|584535906|FG001|Overall Study|Adverse Event|0|||
161861335|NCT03428958|584535907|FG002|Overall Study|Adverse Event|0|||
161861336|NCT03428958|584535908|FG003|Overall Study|Adverse Event|1|||
161861337|NCT03428958|584535909|FG004|Overall Study|Adverse Event|0|||
161861338|NCT03428958|584535910|FG005|Overall Study|Adverse Event|2|||
161861339|NCT03428958|584535911|FG006|Overall Study|Adverse Event|1|||
161861340|NCT03428958|584535912|FG007|Overall Study|Adverse Event|0|||
161861341|NCT03428958|584535913|FG008|Overall Study|Adverse Event|0|||
161861342|NCT03428958|584535914|FG009|Overall Study|Adverse Event|0|||
161861343|NCT03428958|584535915|FG010|Overall Study|Adverse Event|0|||
161861344|NCT03428958|584535916|FG011|Overall Study|Adverse Event|0|||
161861345|NCT03428958|584535917|FG012|Overall Study|Adverse Event|0|||
161861346|NCT03428958|584535918|FG013|Overall Study|Adverse Event|0|||
161861347|NCT03428958|584535919|FG014|Overall Study|Adverse Event|0|||
161861348|NCT03428958|584535920|FG015|Overall Study|Adverse Event|0|||
161861349|NCT03428958|584535921|FG016|Overall Study|Adverse Event|0|||
161861350|NCT03428958|584535905|FG000|Overall Study|Clinical Progression|2|||
161861351|NCT03428958|584535906|FG001|Overall Study|Clinical Progression|3|||
161861352|NCT03428958|584535907|FG002|Overall Study|Clinical Progression|2|||
161861353|NCT03428958|584535908|FG003|Overall Study|Clinical Progression|1|||
161861354|NCT03428958|584535909|FG004|Overall Study|Clinical Progression|0|||
161861355|NCT03428958|584535910|FG005|Overall Study|Clinical Progression|2|||
161861356|NCT03428958|584535911|FG006|Overall Study|Clinical Progression|0|||
161861357|NCT03428958|584535912|FG007|Overall Study|Clinical Progression|0|||
161861358|NCT03428958|584535913|FG008|Overall Study|Clinical Progression|0|||
161861359|NCT03428958|584535914|FG009|Overall Study|Clinical Progression|0|||
161861360|NCT03428958|584535915|FG010|Overall Study|Clinical Progression|0|||
161861361|NCT03428958|584535916|FG011|Overall Study|Clinical Progression|0|||
161861362|NCT03428958|584535917|FG012|Overall Study|Clinical Progression|0|||
161861363|NCT03428958|584535918|FG013|Overall Study|Clinical Progression|0|||
161861364|NCT03428958|584535919|FG014|Overall Study|Clinical Progression|0|||
161861365|NCT03428958|584535920|FG015|Overall Study|Clinical Progression|0|||
161861366|NCT03428958|584535921|FG016|Overall Study|Clinical Progression|0|||
161861367|NCT03428958|584535905|FG000|Overall Study|Progression per RECIST|6|||
161861368|NCT03428958|584535906|FG001|Overall Study|Progression per RECIST|6|||
161861369|NCT03428958|584535907|FG002|Overall Study|Progression per RECIST|7|||
161861370|NCT03428958|584535908|FG003|Overall Study|Progression per RECIST|4|||
161861371|NCT03428958|584535909|FG004|Overall Study|Progression per RECIST|0|||
161861372|NCT03428958|584535910|FG005|Overall Study|Progression per RECIST|7|||
161861373|NCT03428958|584535911|FG006|Overall Study|Progression per RECIST|8|||
161861374|NCT03428958|584535912|FG007|Overall Study|Progression per RECIST|0|||
161861375|NCT03428958|584535913|FG008|Overall Study|Progression per RECIST|0|||
161861376|NCT03428958|584535914|FG009|Overall Study|Progression per RECIST|0|||
161861377|NCT03428958|584535915|FG010|Overall Study|Progression per RECIST|0|||
161861378|NCT03428958|584535916|FG011|Overall Study|Progression per RECIST|0|||
161861379|NCT03428958|584535917|FG012|Overall Study|Progression per RECIST|1|||
161861380|NCT03428958|584535918|FG013|Overall Study|Progression per RECIST|0|||
161861381|NCT03428958|584535919|FG014|Overall Study|Progression per RECIST|0|||
161861382|NCT03428958|584535920|FG015|Overall Study|Progression per RECIST|0|||
161861383|NCT03428958|584535921|FG016|Overall Study|Progression per RECIST|0|||
161861384|NCT03428958|584535905|FG000|Overall Study|Death|2|||
161861385|NCT03428958|584535906|FG001|Overall Study|Death|2|||
161861386|NCT03428958|584535907|FG002|Overall Study|Death|0|||
161861387|NCT03428958|584535908|FG003|Overall Study|Death|0|||
161861388|NCT03428958|584535909|FG004|Overall Study|Death|0|||
161861389|NCT03428958|584535910|FG005|Overall Study|Death|7|||
161861390|NCT03428958|584535911|FG006|Overall Study|Death|9|||
161861391|NCT03428958|584535912|FG007|Overall Study|Death|6|||
161861392|NCT03428958|584535913|FG008|Overall Study|Death|0|||
161861393|NCT03428958|584535914|FG009|Overall Study|Death|0|||
161861394|NCT03428958|584535915|FG010|Overall Study|Death|3|||
161861395|NCT03428958|584535916|FG011|Overall Study|Death|0|||
161861396|NCT03428958|584535917|FG012|Overall Study|Death|4|||
161861397|NCT03428958|584535918|FG013|Overall Study|Death|0|||
161861398|NCT03428958|584535919|FG014|Overall Study|Death|0|||
161861399|NCT03428958|584535920|FG015|Overall Study|Death|0|||
161861400|NCT03428958|584535921|FG016|Overall Study|Death|0|||
161861401|NCT03428958|584535905|FG000|Overall Study|Lost to Follow-up|0|||
161861402|NCT03428958|584535906|FG001|Overall Study|Lost to Follow-up|0|||
161861403|NCT03428958|584535907|FG002|Overall Study|Lost to Follow-up|0|||
161861404|NCT03428958|584535908|FG003|Overall Study|Lost to Follow-up|0|||
161861405|NCT03428958|584535909|FG004|Overall Study|Lost to Follow-up|0|||
161861406|NCT03428958|584535910|FG005|Overall Study|Lost to Follow-up|1|||
161861407|NCT03428958|584535911|FG006|Overall Study|Lost to Follow-up|1|||
161861408|NCT03428958|584535912|FG007|Overall Study|Lost to Follow-up|0|||
161861409|NCT03428958|584535913|FG008|Overall Study|Lost to Follow-up|0|||
161861410|NCT03428958|584535914|FG009|Overall Study|Lost to Follow-up|0|||
161861411|NCT03428958|584535915|FG010|Overall Study|Lost to Follow-up|0|||
161861412|NCT03428958|584535916|FG011|Overall Study|Lost to Follow-up|0|||
161861413|NCT03428958|584535917|FG012|Overall Study|Lost to Follow-up|0|||
161861414|NCT03428958|584535918|FG013|Overall Study|Lost to Follow-up|0|||
161861415|NCT03428958|584535919|FG014|Overall Study|Lost to Follow-up|0|||
161861416|NCT03428958|584535920|FG015|Overall Study|Lost to Follow-up|0|||
161861417|NCT03428958|584535921|FG016|Overall Study|Lost to Follow-up|0|||
161861418|NCT03428958|584535905|FG000|Overall Study|Physician/Sponsor Decision|1|||
161861419|NCT03428958|584535906|FG001|Overall Study|Physician/Sponsor Decision|0|||
161861420|NCT03428958|584535907|FG002|Overall Study|Physician/Sponsor Decision|1|||
161861421|NCT03428958|584535908|FG003|Overall Study|Physician/Sponsor Decision|0|||
161861422|NCT03428958|584535909|FG004|Overall Study|Physician/Sponsor Decision|0|||
161861423|NCT03428958|584535910|FG005|Overall Study|Physician/Sponsor Decision|2|||
161861424|NCT03428958|584535911|FG006|Overall Study|Physician/Sponsor Decision|2|||
161861425|NCT03428958|584535912|FG007|Overall Study|Physician/Sponsor Decision|2|||
161861426|NCT03428958|584535913|FG008|Overall Study|Physician/Sponsor Decision|0|||
161861427|NCT03428958|584535914|FG009|Overall Study|Physician/Sponsor Decision|0|||
161861428|NCT03428958|584535915|FG010|Overall Study|Physician/Sponsor Decision|2|||
161861429|NCT03428958|584535916|FG011|Overall Study|Physician/Sponsor Decision|0|||
161861430|NCT03428958|584535917|FG012|Overall Study|Physician/Sponsor Decision|4|||
161861431|NCT03428958|584535918|FG013|Overall Study|Physician/Sponsor Decision|0|||
161861432|NCT03428958|584535919|FG014|Overall Study|Physician/Sponsor Decision|0|||
161861433|NCT03428958|584535920|FG015|Overall Study|Physician/Sponsor Decision|0|||
161861434|NCT03428958|584535921|FG016|Overall Study|Physician/Sponsor Decision|0|||
161861435|NCT03428958|584535905|FG000|Overall Study|Withdrawal by Subject|0|||
161861436|NCT03428958|584535906|FG001|Overall Study|Withdrawal by Subject|0|||
161861437|NCT03428958|584535907|FG002|Overall Study|Withdrawal by Subject|2|||
161861438|NCT03428958|584535908|FG003|Overall Study|Withdrawal by Subject|0|||
161861439|NCT03428958|584535909|FG004|Overall Study|Withdrawal by Subject|0|||
161861440|NCT03428958|584535910|FG005|Overall Study|Withdrawal by Subject|2|||
161861441|NCT03428958|584535911|FG006|Overall Study|Withdrawal by Subject|4|||
161861442|NCT03428958|584535912|FG007|Overall Study|Withdrawal by Subject|1|||
161861443|NCT03428958|584535913|FG008|Overall Study|Withdrawal by Subject|0|||
161861444|NCT03428958|584535914|FG009|Overall Study|Withdrawal by Subject|0|||
161861445|NCT03428958|584535915|FG010|Overall Study|Withdrawal by Subject|0|||
161861446|NCT03428958|584535916|FG011|Overall Study|Withdrawal by Subject|0|||
161861447|NCT03428958|584535917|FG012|Overall Study|Withdrawal by Subject|0|||
161861448|NCT03428958|584535918|FG013|Overall Study|Withdrawal by Subject|0|||
161861449|NCT03428958|584535919|FG014|Overall Study|Withdrawal by Subject|0|||
161861450|NCT03428958|584535920|FG015|Overall Study|Withdrawal by Subject|0|||
161861451|NCT03428958|584535921|FG016|Overall Study|Withdrawal by Subject|0|||
161861452|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
161861453|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
161861454|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
161861455|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
161861456|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161861457|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161861458|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
161861459|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
161861460|NCT03874117|584535922|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161861461|NCT03874117|584535923|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161861462|NCT03657797|584535925|FG000|Overall Study|Lost to Follow-up|0|||
161861463|NCT03657797|584535926|FG001|Overall Study|Lost to Follow-up|1|||
161861464|NCT03657797|584535927|FG002|Overall Study|Lost to Follow-up|1|||
161861465|NCT03657797|584535928|FG003|Overall Study|Lost to Follow-up|0|||
161861466|NCT03657797|584535925|FG000|Overall Study|Physician Decision|0|||
161861467|NCT03657797|584535926|FG001|Overall Study|Physician Decision|1|||
161861468|NCT03657797|584535927|FG002|Overall Study|Physician Decision|0|||
161861469|NCT03657797|584535928|FG003|Overall Study|Physician Decision|0|||
161861470|NCT03657797|584535925|FG000|Overall Study|Withdrawal by Subject|0|||
161861471|NCT03657797|584535926|FG001|Overall Study|Withdrawal by Subject|1|||
161861472|NCT03657797|584535927|FG002|Overall Study|Withdrawal by Subject|2|||
161861473|NCT03657797|584535928|FG003|Overall Study|Withdrawal by Subject|0|||
161861474|NCT03657797|584535925|FG000|Overall Study|Adverse Event|0|||
161861475|NCT03657797|584535926|FG001|Overall Study|Adverse Event|0|||
161861476|NCT03657797|584535927|FG002|Overall Study|Adverse Event|2|||
161861477|NCT03657797|584535928|FG003|Overall Study|Adverse Event|0|||
161861478|NCT00711243|584535931|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
161861479|NCT00711243|584535932|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
161861480|NCT00711243|584535933|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
161861481|NCT00711243|584535934|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
161861482|NCT00711243|584535935|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
161861483|NCT00711243|584535936|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
161861484|NCT00711243|584535931|FG000|Reached First Response/4 Cycles|Death|0|||
161861485|NCT00711243|584535932|FG001|Reached First Response/4 Cycles|Death|0|||
161861486|NCT00711243|584535933|FG002|Reached First Response/4 Cycles|Death|0|||
161861487|NCT00711243|584535934|FG003|Reached First Response/4 Cycles|Death|0|||
161861488|NCT00711243|584535935|FG004|Reached First Response/4 Cycles|Death|0|||
161861489|NCT00711243|584535936|FG005|Reached First Response/4 Cycles|Death|2|||
161861490|NCT00711243|584535931|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
161861491|NCT00711243|584535932|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
161861492|NCT00711243|584535933|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
161861493|NCT00711243|584535934|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
161861494|NCT00711243|584535935|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
161861495|NCT00711243|584535936|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
161861496|NCT00711243|584535931|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
161861497|NCT00711243|584535932|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
161861498|NCT00711243|584535933|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
161861499|NCT00711243|584535934|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
161861500|NCT00711243|584535935|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
161861501|NCT00711243|584535936|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
161861502|NCT00711243|584535931|FG000|Treated Cycle 5 After First Response|Death|0|||
161861503|NCT00711243|584535932|FG001|Treated Cycle 5 After First Response|Death|0|||
161861504|NCT00711243|584535933|FG002|Treated Cycle 5 After First Response|Death|0|||
161861505|NCT00711243|584535934|FG003|Treated Cycle 5 After First Response|Death|0|||
161861506|NCT00711243|584535935|FG004|Treated Cycle 5 After First Response|Death|0|||
161861507|NCT00711243|584535936|FG005|Treated Cycle 5 After First Response|Death|2|||
161861508|NCT00711243|584535931|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861509|NCT00711243|584535932|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861510|NCT00711243|584535933|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861511|NCT00711243|584535934|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861512|NCT00711243|584535935|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861513|NCT00711243|584535936|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
161861514|NCT00711243|584535931|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861515|NCT00711243|584535932|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861516|NCT00711243|584535933|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861517|NCT00711243|584535934|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861518|NCT00711243|584535935|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861519|NCT00711243|584535936|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
161861520|NCT01402570|584535939|FG000|Overall Study|Adverse Event|1|||
161861521|NCT03642262|584535940|FG000|Period 1|Withdrawal by Subject|1|||
161861522|NCT03642262|584535941|FG001|Period 1|Withdrawal by Subject|1|||
161861523|NCT03642262|584535940|FG000|Period 1|Adverse Event|0|||
161861524|NCT03642262|584535941|FG001|Period 1|Adverse Event|1|||
161861525|NCT02572570|584535942|FG000|Overall Study|Study Terminated|27|||
161861526|NCT02019472|584535943|FG000|Overall Study|Adverse Event|14|||
161861527|NCT02019472|584535944|FG001|Overall Study|Adverse Event|23|||
161861528|NCT02019472|584535945|FG002|Overall Study|Adverse Event|17|||
161861529|NCT02019472|584535943|FG000|Overall Study|Death|0|||
161861530|NCT02019472|584535944|FG001|Overall Study|Death|1|||
161861531|NCT02019472|584535945|FG002|Overall Study|Death|1|||
161861532|NCT02019472|584535943|FG000|Overall Study|Lack of Efficacy|7|||
161861533|NCT02019472|584535944|FG001|Overall Study|Lack of Efficacy|4|||
161861534|NCT02019472|584535945|FG002|Overall Study|Lack of Efficacy|4|||
161861535|NCT02019472|584535943|FG000|Overall Study|Lost to Follow-up|0|||
161861536|NCT02019472|584535944|FG001|Overall Study|Lost to Follow-up|2|||
161861537|NCT02019472|584535945|FG002|Overall Study|Lost to Follow-up|1|||
161772549|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
161772550|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772551|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772552|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772553|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161772554|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161772555|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161772556|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772557|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
161772558|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772559|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161772560|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772561|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
161772562|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161772563|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772564|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772565|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
161772566|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161772567|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
161772568|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161772569|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
161772570|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
161772571|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
161772572|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161772573|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
161772574|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
161772575|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161772576|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
161772577|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772578|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772579|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772580|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772581|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772582|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772583|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
161772584|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772585|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772586|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772587|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772588|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772589|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772590|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772591|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772592|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
161772593|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
161772594|NCT02985541|584211412|FG000|Overall Study|Withdrawal by Subject|33|||
161772595|NCT02985541|584211412|FG000|Overall Study|Lost to Follow-up|26|||
161772596|NCT02985541|584211412|FG000|Overall Study|Adverse Event|27|||
161772597|NCT02985541|584211412|FG000|Overall Study|Physician Decision|2|||
161772598|NCT02985541|584211412|FG000|Overall Study|Pregnancy|2|||
161772599|NCT02985541|584211412|FG000|Overall Study|Wish for pregnancy|44|||
161772600|NCT02985541|584211412|FG000|Overall Study|Other reason|5|||
161772601|NCT02985541|584211412|FG000|Overall Study|Not valid for analysis|2|||
161772602|NCT02383966|584211413|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
161772603|NCT02383966|584211414|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
161772604|NCT02383966|584211413|FG000|Overall Study|Randomized, but not treated|1|||
161772605|NCT02383966|584211414|FG001|Overall Study|Randomized, but not treated|3|||
161772606|NCT02503215|584211415|FG000|Overall Study|Unable to wear compression stockings|1|||
161772607|NCT02503215|584211415|FG000|Overall Study|Unable to use positive airway pressure|2|||
161772608|NCT02983305|584211420|FG000|Overall Study|incomplete data|2|||
161772609|NCT02983305|584211421|FG001|Overall Study|incomplete data|0|||
161772610|NCT00706901|584211422|FG000|Overall Study|Lost to Follow-up|2|||
161772611|NCT00706901|584211423|FG001|Overall Study|Lost to Follow-up|3|||
161861538|NCT02019472|584535943|FG000|Overall Study|Physician Decision|1|||
161861539|NCT02019472|584535944|FG001|Overall Study|Physician Decision|2|||
161861540|NCT02019472|584535945|FG002|Overall Study|Physician Decision|0|||
161772612|NCT00706901|584211424|FG002|Overall Study|Lost to Follow-up|2|||
161772613|NCT00706901|584211422|FG000|Overall Study|Withdrawal by Subject|4|||
161772614|NCT00706901|584211423|FG001|Overall Study|Withdrawal by Subject|2|||
161772615|NCT00706901|584211424|FG002|Overall Study|Withdrawal by Subject|5|||
161772616|NCT00706901|584211422|FG000|Overall Study|In Jail|1|||
161772617|NCT00706901|584211423|FG001|Overall Study|In Jail|0|||
161772618|NCT00706901|584211424|FG002|Overall Study|In Jail|1|||
161772619|NCT00706901|584211422|FG000|Overall Study|Death|1|||
161772620|NCT00706901|584211423|FG001|Overall Study|Death|0|||
161772621|NCT00706901|584211424|FG002|Overall Study|Death|0|||
161772622|NCT00822237|584211425|FG000|Dose 1 Vaccination|Not vaccinated|3|||
161772623|NCT00822237|584211426|FG001|Dose 1 Vaccination|Not vaccinated|0|||
161772624|NCT00822237|584211425|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
161772625|NCT00822237|584211426|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
161772626|NCT00822237|584211425|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
161772627|NCT00822237|584211426|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
161772628|NCT00822237|584211425|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
161772629|NCT00822237|584211426|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
161772630|NCT00822237|584211425|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
161772631|NCT00822237|584211426|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
161772632|NCT03433482|584211427|FG000|Overall Study|Lost to Follow-up|1|||
161772633|NCT03433482|584211428|FG001|Overall Study|Lost to Follow-up|0|||
161772634|NCT03433482|584211429|FG002|Overall Study|Lost to Follow-up|1|||
161772635|NCT03433482|584211430|FG003|Overall Study|Lost to Follow-up|1|||
161772636|NCT03433482|584211427|FG000|Overall Study|Withdrawal by Subject|0|||
161772637|NCT03433482|584211428|FG001|Overall Study|Withdrawal by Subject|0|||
161772638|NCT03433482|584211429|FG002|Overall Study|Withdrawal by Subject|1|||
161772639|NCT03433482|584211430|FG003|Overall Study|Withdrawal by Subject|0|||
161772640|NCT03433482|584211427|FG000|Overall Study|Unknown reason|0|||
161772641|NCT03433482|584211428|FG001|Overall Study|Unknown reason|0|||
161772642|NCT03433482|584211429|FG002|Overall Study|Unknown reason|2|||
161772643|NCT03433482|584211430|FG003|Overall Study|Unknown reason|0|||
161772644|NCT00437294|584211431|FG000|Overall Study|Adverse Event|5|||
161772645|NCT00437294|584211432|FG001|Overall Study|Adverse Event|4|||
161772646|NCT00437294|584211431|FG000|Overall Study|Death|5|||
161772647|NCT00437294|584211432|FG001|Overall Study|Death|2|||
161772648|NCT00437294|584211431|FG000|Overall Study|Physician Decision|0|||
161772649|NCT00437294|584211432|FG001|Overall Study|Physician Decision|3|||
161772650|NCT00437294|584211431|FG000|Overall Study|Withdrawal by Subject|5|||
161772651|NCT00437294|584211432|FG001|Overall Study|Withdrawal by Subject|0|||
161772652|NCT00437294|584211431|FG000|Overall Study|Progressive Disease|19|||
161772653|NCT00437294|584211432|FG001|Overall Study|Progressive Disease|23|||
161772654|NCT00437294|584211431|FG000|Overall Study|Sponsor Decision|8|||
161772655|NCT00437294|584211432|FG001|Overall Study|Sponsor Decision|9|||
161772656|NCT00437294|584211431|FG000|Overall Study|Protocol Violation|0|||
161772657|NCT00437294|584211432|FG001|Overall Study|Protocol Violation|1|||
161772658|NCT00437294|584211431|FG000|Overall Study|Entry criteria not met|1|||
161772659|NCT00437294|584211432|FG001|Overall Study|Entry criteria not met|1|||
161772660|NCT02064231|584211436|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
161772661|NCT02064231|584211437|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
161772662|NCT02064231|584211438|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
161772663|NCT02064231|584211439|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
161772664|NCT02064231|584211436|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
161772665|NCT02064231|584211437|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
161772666|NCT02064231|584211438|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
161772667|NCT02064231|584211439|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
161772668|NCT02064231|584211436|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
161772669|NCT02064231|584211437|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
161772670|NCT02064231|584211438|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
161772671|NCT02064231|584211439|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
161772672|NCT02064231|584211436|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
161772673|NCT02064231|584211437|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
161772674|NCT02064231|584211438|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
161772675|NCT02064231|584211439|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
161772676|NCT01339273|584211441|FG000|Overall Study|Lost to Follow-up|8|||
161772677|NCT01339273|584211442|FG001|Overall Study|Lost to Follow-up|8|||
161772678|NCT04478994|584211443|FG000|Overall Study|Withdrawal by Subject|1|||
161772679|NCT04478994|584211444|FG001|Overall Study|Withdrawal by Subject|1|||
161772680|NCT00518531|584211445|FG000|Treatment Period 1|Adverse Event|5|||
161772681|NCT00518531|584211446|FG001|Treatment Period 1|Adverse Event|0|||
161772682|NCT00518531|584211445|FG000|Treatment Period 1|Lost to Follow-up|5|||
161861541|NCT02019472|584535943|FG000|Overall Study|Pregnancy|1|||
161861542|NCT02019472|584535944|FG001|Overall Study|Pregnancy|2|||
161861543|NCT02019472|584535945|FG002|Overall Study|Pregnancy|2|||
161861544|NCT02019472|584535943|FG000|Overall Study|Withdrawal by Subject|11|||
161861545|NCT02019472|584535944|FG001|Overall Study|Withdrawal by Subject|10|||
161861546|NCT02019472|584535945|FG002|Overall Study|Withdrawal by Subject|11|||
161861547|NCT02019472|584535943|FG000|Overall Study|Other|3|||
161861548|NCT02019472|584535944|FG001|Overall Study|Other|8|||
161861549|NCT02019472|584535945|FG002|Overall Study|Other|6|||
161861550|NCT00513695|584535948|FG000|Overall Study|Discontinued therapy|2|||
161861551|NCT00513695|584535948|FG000|Overall Study|Progression prior to surgery|3|||
161861552|NCT02157935|584535949|FG000|Overall Study|Withdrawal by Subject|25|||
161861553|NCT02157935|584535950|FG001|Overall Study|Withdrawal by Subject|39|||
161861554|NCT02157935|584535949|FG000|Overall Study|Screen failure|1|||
161861555|NCT02157935|584535950|FG001|Overall Study|Screen failure|2|||
161861556|NCT02157935|584535949|FG000|Overall Study|Protocol Violation|1|||
161861557|NCT02157935|584535950|FG001|Overall Study|Protocol Violation|0|||
161861558|NCT02157935|584535949|FG000|Overall Study|Progressive disease|0|||
161861559|NCT02157935|584535950|FG001|Overall Study|Progressive disease|2|||
161861560|NCT02157935|584535949|FG000|Overall Study|Other|5|||
161861561|NCT02157935|584535950|FG001|Overall Study|Other|12|||
161861562|NCT02157935|584535949|FG000|Overall Study|Lack of Efficacy|0|||
161861563|NCT02157935|584535950|FG001|Overall Study|Lack of Efficacy|1|||
161861564|NCT02157935|584535949|FG000|Overall Study|Death|4|||
161861565|NCT02157935|584535950|FG001|Overall Study|Death|4|||
161861566|NCT02157935|584535949|FG000|Overall Study|Adverse Event|3|||
161861567|NCT02157935|584535950|FG001|Overall Study|Adverse Event|5|||
161861568|NCT01417156|584535951|FG000|Overall Study|Adverse Event|12|||
161861569|NCT01417156|584535951|FG000|Overall Study|Protocol Violation|2|||
161861570|NCT03192488|584535952|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
161861571|NCT03192488|584535953|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
161861572|NCT03192488|584535954|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
161861573|NCT03192488|584535955|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
161861574|NCT03192488|584535956|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
161861575|NCT03192488|584535957|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
161861576|NCT03192488|584535952|FG000|Third Intervention (d1)|Adverse Event|0|||
161861577|NCT03192488|584535953|FG001|Third Intervention (d1)|Adverse Event|0|||
161861578|NCT03192488|584535954|FG002|Third Intervention (d1)|Adverse Event|0|||
161861579|NCT03192488|584535955|FG003|Third Intervention (d1)|Adverse Event|0|||
161861580|NCT03192488|584535956|FG004|Third Intervention (d1)|Adverse Event|1|||
161861581|NCT03192488|584535957|FG005|Third Intervention (d1)|Adverse Event|0|||
161861582|NCT00611923|584535959|FG000|Overall Study|Withdrawal by Subject|2|||
161861583|NCT00611923|584535960|FG001|Overall Study|Withdrawal by Subject|2|||
161861584|NCT02302833|584535974|FG000|Overall Study|Lost to Follow-up|3|||
161861585|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
161861586|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
161861587|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861588|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861589|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861590|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861591|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
161861592|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
161861593|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
161861594|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
161861595|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
161861596|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
161861597|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
161861598|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
161861599|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
161861600|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161861601|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161861602|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161861603|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
161861604|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
161861605|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
161861606|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161861607|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161861608|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161861609|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
161861610|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
161861611|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
161861612|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161861613|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161861614|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161861615|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Death|9|||
161861616|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Death|18|||
161861617|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Death|5|||
161772683|NCT00518531|584211446|FG001|Treatment Period 1|Lost to Follow-up|3|||
161772684|NCT00518531|584211445|FG000|Treatment Period 1|Physician Decision|1|||
161772685|NCT00518531|584211446|FG001|Treatment Period 1|Physician Decision|0|||
161772686|NCT00518531|584211445|FG000|Treatment Period 1|Protocol Violation|2|||
161772687|NCT00518531|584211446|FG001|Treatment Period 1|Protocol Violation|0|||
161772688|NCT00518531|584211445|FG000|Treatment Period 1|Withdrawal by Subject|4|||
161772689|NCT00518531|584211446|FG001|Treatment Period 1|Withdrawal by Subject|6|||
161772690|NCT00518531|584211445|FG000|Treatment Period 1|Early crossover|1|||
161772691|NCT00518531|584211446|FG001|Treatment Period 1|Early crossover|3|||
161772692|NCT00518531|584211445|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161772693|NCT00518531|584211446|FG001|Treatment Period 2|Withdrawal by Subject|8|||
161772694|NCT00518531|584211445|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
161772695|NCT00518531|584211446|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
161772696|NCT00518531|584211445|FG000|Treatment Period 2|Adverse Event|1|||
161772697|NCT00518531|584211446|FG001|Treatment Period 2|Adverse Event|7|||
161772698|NCT00518531|584211445|FG000|Treatment Period 2|Protocol-specified criteria|0|||
161772699|NCT00518531|584211446|FG001|Treatment Period 2|Protocol-specified criteria|1|||
161772700|NCT00518531|584211445|FG000|Treatment Period 2|Non-compliance|1|||
161861618|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Death|0|||
161861619|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Death|0|||
161861620|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Death|0|||
161861621|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861622|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861623|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861624|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
161861625|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861626|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861627|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161861628|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161861629|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161861630|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161861631|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161861632|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161861633|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861634|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861635|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861636|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861637|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
161861638|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
161861639|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161861640|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161861641|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161861642|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
161861643|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
161861644|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
161861645|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161861646|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161861647|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161861648|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
161772701|NCT00518531|584211446|FG001|Treatment Period 2|Non-compliance|2|||
161861649|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
161861650|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
161861651|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161772702|NCT00457249|584211447|FG000|Overall Study|Lost to Follow-up|3|||
161772703|NCT00457249|584211448|FG001|Overall Study|Lost to Follow-up|0|||
161772704|NCT00457249|584211447|FG000|Overall Study|Protocol Violation|4|||
161772705|NCT00457249|584211448|FG001|Overall Study|Protocol Violation|1|||
161772706|NCT00457249|584211447|FG000|Overall Study|Withdrawal by Subject|3|||
161861652|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161861653|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161861654|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
161861655|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
161861656|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
161861657|NCT05516108|584535981|FG000|Overall Study|Time Commitment|3|||
161861658|NCT05516108|584535982|FG001|Overall Study|Time Commitment|1|||
161861659|NCT05516108|584535981|FG000|Overall Study|Reason Unknown|2|||
161861660|NCT05516108|584535982|FG001|Overall Study|Reason Unknown|4|||
161861661|NCT03664232|584535983|FG000|Overall Study|Withdrawal by Subject|0|||
161861662|NCT03664232|584535984|FG001|Overall Study|Withdrawal by Subject|1|||
161861663|NCT03664232|584535985|FG002|Overall Study|Withdrawal by Subject|0|||
161861664|NCT03664232|584535986|FG003|Overall Study|Withdrawal by Subject|1|||
161861665|NCT03664232|584535983|FG000|Overall Study|Adverse Event|0|||
161861666|NCT03664232|584535984|FG001|Overall Study|Adverse Event|0|||
161861667|NCT03664232|584535985|FG002|Overall Study|Adverse Event|1|||
161861668|NCT03664232|584535986|FG003|Overall Study|Adverse Event|0|||
161861669|NCT03664232|584535983|FG000|Overall Study|Other-Non-compliance with study drug|0|||
161861670|NCT03664232|584535984|FG001|Overall Study|Other-Non-compliance with study drug|1|||
161861671|NCT03664232|584535985|FG002|Overall Study|Other-Non-compliance with study drug|0|||
161861672|NCT03664232|584535986|FG003|Overall Study|Other-Non-compliance with study drug|2|||
161861673|NCT03664232|584535983|FG000|Overall Study|Other-Unspecified|0|||
161861674|NCT03664232|584535984|FG001|Overall Study|Other-Unspecified|3|||
161861675|NCT03664232|584535985|FG002|Overall Study|Other-Unspecified|0|||
161861676|NCT03664232|584535986|FG003|Overall Study|Other-Unspecified|1|||
161861677|NCT03664232|584535983|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
161861678|NCT03664232|584535984|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
161861679|NCT03664232|584535985|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
161861680|NCT03664232|584535986|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
161861681|NCT02717507|584535987|FG000|Overall Study|Lost to Follow-up|5|||
161861682|NCT02717507|584535988|FG001|Overall Study|Lost to Follow-up|8|||
161861683|NCT02717507|584535987|FG000|Overall Study|Pregnancy|1|||
161861684|NCT02717507|584535988|FG001|Overall Study|Pregnancy|1|||
161861685|NCT02717507|584535987|FG000|Overall Study|Protocol Violation|2|||
161861686|NCT02717507|584535988|FG001|Overall Study|Protocol Violation|2|||
161861687|NCT02717507|584535987|FG000|Overall Study|Withdrawal by Subject|20|||
161861688|NCT02717507|584535988|FG001|Overall Study|Withdrawal by Subject|20|||
161861689|NCT02717507|584535987|FG000|Overall Study|Relapse|1|||
161861690|NCT02717507|584535988|FG001|Overall Study|Relapse|1|||
161861691|NCT02717507|584535987|FG000|Overall Study|Cardiac Event|2|||
161861692|NCT02717507|584535988|FG001|Overall Study|Cardiac Event|6|||
161861693|NCT05017246|584535989|FG000|Overall Study|Withdrawal by Subject|5|||
161861694|NCT05017246|584535990|FG001|Overall Study|Withdrawal by Subject|3|||
161861695|NCT05017246|584535989|FG000|Overall Study|Determined to be ineligible|0|||
161861696|NCT05017246|584535990|FG001|Overall Study|Determined to be ineligible|1|||
161861697|NCT05017246|584535989|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
161861698|NCT05017246|584535990|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
161861699|NCT05017246|584535989|FG000|Overall Study|Technical failure|1|||
161861700|NCT05017246|584535990|FG001|Overall Study|Technical failure|3|||
161861701|NCT02493660|584535993|FG000|Overall Study|Physician Decision|0|||
161861702|NCT02493660|584535994|FG001|Overall Study|Physician Decision|1|||
161861703|NCT02493660|584535993|FG000|Overall Study|Adverse Event|4|||
161861704|NCT02493660|584535994|FG001|Overall Study|Adverse Event|2|||
161861705|NCT02493660|584535993|FG000|Overall Study|Withdrawal by Subject|2|||
161861706|NCT02493660|584535994|FG001|Overall Study|Withdrawal by Subject|3|||
161861707|NCT02493660|584535993|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
161861708|NCT02493660|584535994|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
161861709|NCT02493660|584535993|FG000|Overall Study|Protocol Violation|0|||
161861710|NCT02493660|584535994|FG001|Overall Study|Protocol Violation|1|||
161861711|NCT02493660|584535993|FG000|Overall Study|Death|0|||
161861712|NCT02493660|584535994|FG001|Overall Study|Death|1|||
161861713|NCT02493660|584535993|FG000|Overall Study|Lost to Follow-up|2|||
161861714|NCT02493660|584535994|FG001|Overall Study|Lost to Follow-up|4|||
161861715|NCT00709995|584535995|FG000|Overall Study|Adverse Event|4|||
161861716|NCT00709995|584535996|FG001|Overall Study|Adverse Event|2|||
161861717|NCT00709995|584535995|FG000|Overall Study|Withdrawal by Subject|1|||
161861718|NCT00709995|584535996|FG001|Overall Study|Withdrawal by Subject|3|||
161861719|NCT00638508|584535997|FG000|Overall Study|Physician Decision|5|||
161861720|NCT00638508|584535998|FG001|Overall Study|Physician Decision|2|||
161861721|NCT03500198|584535999|FG000|Overall Study|Lost to Follow-up|0|||
161861722|NCT03500198|584536000|FG001|Overall Study|Lost to Follow-up|1|||
161861723|NCT00654095|584536001|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
161861724|NCT00654095|584536001|FG000|Overall Study|Elevated triglyceride level (2)|1|||
161861725|NCT00654095|584536001|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
161861726|NCT00654095|584536001|FG000|Overall Study|Adverse Event|11|||
161861727|NCT00654095|584536001|FG000|Overall Study|Withdrawal by Subject|5|||
161861728|NCT00654095|584536001|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
161861729|NCT00654095|584536001|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
161861730|NCT00654095|584536001|FG000|Overall Study|Did not meet inclusion criteria|1|||
161861731|NCT00595621|584536007|FG000|Open Label Run in|Adverse Event|1|||
161861732|NCT00595621|584536008|FG001|Open Label Run in|Adverse Event|0|||
161861733|NCT00595621|584536007|FG000|Open Label Run in|Physician Decision|1|||
161861734|NCT00595621|584536008|FG001|Open Label Run in|Physician Decision|0|||
161861735|NCT00595621|584536007|FG000|Open Label Run in|Withdrawal by Subject|1|||
161861736|NCT00595621|584536008|FG001|Open Label Run in|Withdrawal by Subject|0|||
161861737|NCT00595621|584536007|FG000|Randomization and Study|Adverse Event|2|||
161861738|NCT00595621|584536008|FG001|Randomization and Study|Adverse Event|0|||
161861739|NCT00595621|584536007|FG000|Randomization and Study|Withdrawal by Subject|0|||
161861740|NCT00595621|584536008|FG001|Randomization and Study|Withdrawal by Subject|1|||
161861741|NCT02440464|584536009|FG000|Overall Study|Withdrawal by Subject|3|||
161861742|NCT02440464|584536010|FG001|Overall Study|Withdrawal by Subject|2|||
161861743|NCT00324987|584536011|FG000|Overall Study|Adverse Event|2|||
161861744|NCT00324987|584536012|FG001|Overall Study|Adverse Event|1|||
161861745|NCT00324987|584536011|FG000|Overall Study|Withdrawal by Subject|1|||
161861746|NCT00324987|584536012|FG001|Overall Study|Withdrawal by Subject|1|||
161861747|NCT00324987|584536011|FG000|Overall Study|Progression|1|||
161861748|NCT00324987|584536012|FG001|Overall Study|Progression|1|||
161861749|NCT00324987|584536011|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
161861750|NCT00324987|584536012|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
161861751|NCT03565900|584536014|FG000|Overall Study|Disposition Unknown|4|||
161861752|NCT03565900|584536015|FG001|Overall Study|Disposition Unknown|1|||
161861753|NCT03565900|584536014|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161861754|NCT03565900|584536015|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
161861755|NCT03565900|584536014|FG000|Overall Study|Withdrawal by Subject|4|||
161861756|NCT03565900|584536015|FG001|Overall Study|Withdrawal by Subject|5|||
161861757|NCT03565900|584536014|FG000|Overall Study|Randomized By Mistake|0|||
161861758|NCT03565900|584536015|FG001|Overall Study|Randomized By Mistake|2|||
161861759|NCT03565900|584536014|FG000|Overall Study|Physician Decision|7|||
161861760|NCT03565900|584536015|FG001|Overall Study|Physician Decision|11|||
161861761|NCT03565900|584536014|FG000|Overall Study|Death|9|||
161861762|NCT03565900|584536015|FG001|Overall Study|Death|7|||
161861763|NCT01254643|584536016|FG000|Overall Study|Withdrawal by Subject|1|||
161861764|NCT03359850|584536019|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
161861765|NCT03359850|584536020|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
161861766|NCT03359850|584536019|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
161861767|NCT03359850|584536020|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
161861768|NCT03359850|584536019|FG000|Extension Phase (Up to 28 Months)|Death|2|||
161861769|NCT03359850|584536020|FG001|Extension Phase (Up to 28 Months)|Death|4|||
161861770|NCT03359850|584536019|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
161861771|NCT03359850|584536020|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
161861772|NCT03359850|584536019|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
161861773|NCT03359850|584536020|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
161861774|NCT01037218|584536034|FG000|Overall Study|Adverse Event|4|||
161861775|NCT01037218|584536035|FG001|Overall Study|Adverse Event|2|||
161861776|NCT01037218|584536036|FG002|Overall Study|Adverse Event|2|||
161861777|NCT01037218|584536037|FG003|Overall Study|Adverse Event|1|||
161861778|NCT01037218|584536034|FG000|Overall Study|Lack of Efficacy|0|||
161861779|NCT01037218|584536035|FG001|Overall Study|Lack of Efficacy|2|||
161861780|NCT01037218|584536036|FG002|Overall Study|Lack of Efficacy|1|||
161861781|NCT01037218|584536037|FG003|Overall Study|Lack of Efficacy|5|||
161861782|NCT01037218|584536034|FG000|Overall Study|Lost to Follow-up|3|||
161861783|NCT01037218|584536035|FG001|Overall Study|Lost to Follow-up|5|||
161861784|NCT01037218|584536036|FG002|Overall Study|Lost to Follow-up|4|||
161861785|NCT01037218|584536037|FG003|Overall Study|Lost to Follow-up|2|||
161861786|NCT01037218|584536034|FG000|Overall Study|Withdrawal by Subject|6|||
161861787|NCT01037218|584536035|FG001|Overall Study|Withdrawal by Subject|7|||
161861788|NCT01037218|584536036|FG002|Overall Study|Withdrawal by Subject|7|||
161861789|NCT01037218|584536037|FG003|Overall Study|Withdrawal by Subject|4|||
161861790|NCT01037218|584536034|FG000|Overall Study|Partner Withdrew Consent|0|||
161861791|NCT01037218|584536035|FG001|Overall Study|Partner Withdrew Consent|3|||
161861792|NCT01037218|584536036|FG002|Overall Study|Partner Withdrew Consent|2|||
161861793|NCT01037218|584536037|FG003|Overall Study|Partner Withdrew Consent|1|||
161861794|NCT01037218|584536034|FG000|Overall Study|Protocol Violation|0|||
161861795|NCT01037218|584536035|FG001|Overall Study|Protocol Violation|0|||
161861796|NCT01037218|584536036|FG002|Overall Study|Protocol Violation|2|||
161861797|NCT01037218|584536037|FG003|Overall Study|Protocol Violation|2|||
161861798|NCT01037218|584536034|FG000|Overall Study|Various|3|||
161861799|NCT01037218|584536035|FG001|Overall Study|Various|2|||
161861800|NCT01037218|584536036|FG002|Overall Study|Various|3|||
161861801|NCT01037218|584536037|FG003|Overall Study|Various|1|||
161861802|NCT00513240|584536039|FG000|Overall Study|Did not have intended surgery|3|||
161861803|NCT00513240|584536040|FG001|Overall Study|Did not have intended surgery|0|||
161861804|NCT00513240|584536039|FG000|Overall Study|Death|3|||
161861805|NCT00513240|584536040|FG001|Overall Study|Death|3|||
161861806|NCT00513240|584536039|FG000|Overall Study|Withdrawal by Subject|7|||
161861807|NCT00513240|584536040|FG001|Overall Study|Withdrawal by Subject|4|||
161861808|NCT00729937|584536045|FG000|Overall Study|Lost to Follow-up|49|||
161861809|NCT00729937|584536046|FG001|Overall Study|Lost to Follow-up|58|||
161861810|NCT00729937|584536047|FG002|Overall Study|Lost to Follow-up|18|||
161861811|NCT00729937|584536048|FG003|Overall Study|Lost to Follow-up|33|||
161861812|NCT00729937|584536049|FG004|Overall Study|Lost to Follow-up|18|||
161861813|NCT00729937|584536050|FG005|Overall Study|Lost to Follow-up|23|||
161861814|NCT00729937|584536045|FG000|Overall Study|Physician Decision|7|||
161861815|NCT00729937|584536046|FG001|Overall Study|Physician Decision|16|||
161861816|NCT00729937|584536047|FG002|Overall Study|Physician Decision|2|||
161861817|NCT00729937|584536048|FG003|Overall Study|Physician Decision|0|||
161861818|NCT00729937|584536049|FG004|Overall Study|Physician Decision|5|||
161861819|NCT00729937|584536050|FG005|Overall Study|Physician Decision|8|||
161861820|NCT00729937|584536045|FG000|Overall Study|Death|1|||
161861821|NCT00729937|584536046|FG001|Overall Study|Death|0|||
161861822|NCT00729937|584536047|FG002|Overall Study|Death|1|||
161861823|NCT00729937|584536048|FG003|Overall Study|Death|0|||
161861824|NCT00729937|584536049|FG004|Overall Study|Death|0|||
161861825|NCT00729937|584536050|FG005|Overall Study|Death|1|||
161861826|NCT00729937|584536045|FG000|Overall Study|Withdrawal by Subject|3|||
161861827|NCT00729937|584536046|FG001|Overall Study|Withdrawal by Subject|5|||
161861828|NCT00729937|584536047|FG002|Overall Study|Withdrawal by Subject|6|||
161861829|NCT00729937|584536048|FG003|Overall Study|Withdrawal by Subject|0|||
161861830|NCT00729937|584536049|FG004|Overall Study|Withdrawal by Subject|4|||
161861831|NCT00729937|584536050|FG005|Overall Study|Withdrawal by Subject|2|||
161861832|NCT00729937|584536045|FG000|Overall Study|Randomized but not treated|12|||
161861833|NCT00729937|584536046|FG001|Overall Study|Randomized but not treated|6|||
161861834|NCT00729937|584536047|FG002|Overall Study|Randomized but not treated|1|||
161861835|NCT00729937|584536048|FG003|Overall Study|Randomized but not treated|0|||
161861836|NCT00729937|584536049|FG004|Overall Study|Randomized but not treated|1|||
161861837|NCT00729937|584536050|FG005|Overall Study|Randomized but not treated|3|||
161861838|NCT00729937|584536045|FG000|Overall Study|Did not meet eligibility criteria|2|||
161861839|NCT00729937|584536046|FG001|Overall Study|Did not meet eligibility criteria|1|||
161861840|NCT00729937|584536047|FG002|Overall Study|Did not meet eligibility criteria|0|||
161861841|NCT00729937|584536048|FG003|Overall Study|Did not meet eligibility criteria|0|||
161861842|NCT00729937|584536049|FG004|Overall Study|Did not meet eligibility criteria|0|||
161861843|NCT00729937|584536050|FG005|Overall Study|Did not meet eligibility criteria|0|||
161861844|NCT00729937|584536045|FG000|Overall Study|Incarcerated|0|||
161861845|NCT00729937|584536046|FG001|Overall Study|Incarcerated|2|||
161861846|NCT00729937|584536047|FG002|Overall Study|Incarcerated|1|||
161861847|NCT00729937|584536048|FG003|Overall Study|Incarcerated|1|||
161861848|NCT00729937|584536049|FG004|Overall Study|Incarcerated|0|||
161861849|NCT00729937|584536050|FG005|Overall Study|Incarcerated|0|||
161861850|NCT02198963|584536054|FG000|Overall Study|Adverse Event|1|||
161861851|NCT02198963|584536054|FG000|Overall Study|Withdrawal by Subject|6|||
161861852|NCT00683657|584536055|FG000|Overall Study|Adverse Event|0|||
161861853|NCT00683657|584536056|FG001|Overall Study|Adverse Event|1|||
161861854|NCT00683657|584536055|FG000|Overall Study|Subject Withdrew Consent|1|||
161861855|NCT00683657|584536056|FG001|Overall Study|Subject Withdrew Consent|0|||
161861856|NCT02586155|584536060|FG000|Overall Study|Adverse Event|2|||
161861857|NCT02586155|584536061|FG001|Overall Study|Adverse Event|3|||
161861858|NCT02586155|584536060|FG000|Overall Study|Withdrawal by Subject|31|||
161861859|NCT02586155|584536061|FG001|Overall Study|Withdrawal by Subject|24|||
161861860|NCT02586155|584536060|FG000|Overall Study|Lost to Follow-up|7|||
161861861|NCT02586155|584536061|FG001|Overall Study|Lost to Follow-up|13|||
161861862|NCT02586155|584536060|FG000|Overall Study|Death|61|||
161861863|NCT02586155|584536061|FG001|Overall Study|Death|72|||
161861864|NCT02586155|584536060|FG000|Overall Study|Other reasons|26|||
161861865|NCT02586155|584536061|FG001|Overall Study|Other reasons|15|||
161861866|NCT02461160|584536062|FG000|Overall Study|Lost to Follow-up|0|||
161861867|NCT02461160|584536063|FG001|Overall Study|Lost to Follow-up|0|||
161861868|NCT02461160|584536064|FG002|Overall Study|Lost to Follow-up|0|||
161861869|NCT02461160|584536065|FG003|Overall Study|Lost to Follow-up|0|||
161861870|NCT02461160|584536066|FG004|Overall Study|Lost to Follow-up|0|||
161861871|NCT02461160|584536067|FG005|Overall Study|Lost to Follow-up|0|||
161861872|NCT02461160|584536068|FG006|Overall Study|Lost to Follow-up|0|||
161861873|NCT02461160|584536069|FG007|Overall Study|Lost to Follow-up|1|||
161861874|NCT02461160|584536070|FG008|Overall Study|Lost to Follow-up|0|||
161861875|NCT02461160|584536071|FG009|Overall Study|Lost to Follow-up|0|||
161861876|NCT02461160|584536072|FG010|Overall Study|Lost to Follow-up|0|||
161861877|NCT02461160|584536073|FG011|Overall Study|Lost to Follow-up|0|||
161861878|NCT02461160|584536074|FG012|Overall Study|Lost to Follow-up|0|||
161861879|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
161861880|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
161861881|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Physician Decision|2|||
161861882|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Adverse Event|2|||
161861883|NCT00193050|584536075|FG000|Adjuvant|Physician Decision|5|||
161861884|NCT00193050|584536075|FG000|Adjuvant|Intercurrent Hospitalization|3|||
161861885|NCT00193050|584536075|FG000|Adjuvant|Lack of Efficacy|2|||
161861886|NCT00916383|584536076|FG000|Overall Study|Adverse Event|1|||
161861887|NCT00916383|584536076|FG000|Overall Study|Death|1|||
161861888|NCT00916383|584536076|FG000|Overall Study|Protocol Violation|1|||
161861889|NCT00258960|584536077|FG000|Overall Study|Death|2|||
161861890|NCT00258960|584536077|FG000|Overall Study|Disease Progression|7|||
161861891|NCT00258960|584536077|FG000|Overall Study|Adverse Event|4|||
161861892|NCT00258960|584536077|FG000|Overall Study|Physician Decision|1|||
161861893|NCT00258960|584536077|FG000|Overall Study|Withdrawal by Subject|1|||
161861894|NCT00258960|584536077|FG000|Overall Study|Mistake|2|||
161861895|NCT02899962|584536078|FG000|Open-label Phase|Adverse Event|2|||
161861896|NCT02899962|584536079|FG001|Open-label Phase|Adverse Event|0|||
161861897|NCT02899962|584536080|FG002|Open-label Phase|Adverse Event|0|||
161861898|NCT02899962|584536078|FG000|Open-label Phase|Lost to Follow-up|9|||
161861899|NCT02899962|584536079|FG001|Open-label Phase|Lost to Follow-up|0|||
161861900|NCT02899962|584536080|FG002|Open-label Phase|Lost to Follow-up|0|||
161861901|NCT02899962|584536078|FG000|Open-label Phase|Other reasons|9|||
161861902|NCT02899962|584536079|FG001|Open-label Phase|Other reasons|0|||
161861903|NCT02899962|584536080|FG002|Open-label Phase|Other reasons|0|||
161861904|NCT02899962|584536078|FG000|Open-label Phase|Withdrawal by Subject|7|||
161861905|NCT02899962|584536079|FG001|Open-label Phase|Withdrawal by Subject|0|||
161861906|NCT02899962|584536080|FG002|Open-label Phase|Withdrawal by Subject|0|||
161861907|NCT02899962|584536078|FG000|Maintenance Phase|Adverse Event|0|||
161861908|NCT02899962|584536079|FG001|Maintenance Phase|Adverse Event|2|||
161861909|NCT02899962|584536080|FG002|Maintenance Phase|Adverse Event|1|||
161861910|NCT02899962|584536078|FG000|Maintenance Phase|Death|0|||
161861911|NCT02899962|584536079|FG001|Maintenance Phase|Death|0|||
161861912|NCT02899962|584536080|FG002|Maintenance Phase|Death|1|||
161861913|NCT02899962|584536078|FG000|Maintenance Phase|Lack of Efficacy|0|||
161861914|NCT02899962|584536079|FG001|Maintenance Phase|Lack of Efficacy|20|||
161861915|NCT02899962|584536080|FG002|Maintenance Phase|Lack of Efficacy|16|||
161861916|NCT02899962|584536078|FG000|Maintenance Phase|Lost to Follow-up|0|||
161861917|NCT02899962|584536079|FG001|Maintenance Phase|Lost to Follow-up|12|||
161861918|NCT02899962|584536080|FG002|Maintenance Phase|Lost to Follow-up|14|||
161861919|NCT02899962|584536078|FG000|Maintenance Phase|Other reasons|0|||
161861920|NCT02899962|584536079|FG001|Maintenance Phase|Other reasons|9|||
161861921|NCT02899962|584536080|FG002|Maintenance Phase|Other reasons|13|||
161861922|NCT02899962|584536078|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
161861923|NCT02899962|584536079|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
161861924|NCT02899962|584536080|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
161861925|NCT02899962|584536078|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
161861926|NCT02899962|584536079|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
161861927|NCT02899962|584536080|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
161861928|NCT02899962|584536078|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161861929|NCT02899962|584536079|FG001|Maintenance Phase|Withdrawal by Subject|30|||
161861930|NCT02899962|584536080|FG002|Maintenance Phase|Withdrawal by Subject|36|||
161861931|NCT00473590|584536081|FG000|Overall Study|Adverse Event|3|||
161861932|NCT00473590|584536082|FG001|Overall Study|Adverse Event|3|||
161861933|NCT00473590|584536081|FG000|Overall Study|Death|4|||
161861934|NCT00473590|584536082|FG001|Overall Study|Death|2|||
161861935|NCT00473590|584536081|FG000|Overall Study|Progression not resulting in death|24|||
161861936|NCT00473590|584536082|FG001|Overall Study|Progression not resulting in death|20|||
161861937|NCT00473590|584536081|FG000|Overall Study|Non-protocol-specified therapy|7|||
161861938|NCT00473590|584536082|FG001|Overall Study|Non-protocol-specified therapy|5|||
161861939|NCT00473590|584536081|FG000|Overall Study|Physician Decision|2|||
161861940|NCT00473590|584536082|FG001|Overall Study|Physician Decision|4|||
161861941|NCT00473590|584536081|FG000|Overall Study|Withdrawal by Subject|5|||
161861942|NCT00473590|584536082|FG001|Overall Study|Withdrawal by Subject|3|||
161861943|NCT00473590|584536081|FG000|Overall Study|Other|0|||
161861944|NCT00473590|584536082|FG001|Overall Study|Other|1|||
161861945|NCT03367819|584536086|FG000|Overall Study|Adverse Event|4|||
161861946|NCT03367819|584536087|FG001|Overall Study|Adverse Event|4|||
161861947|NCT03367819|584536086|FG000|Overall Study|Progressive Disease|15|||
161861948|NCT03367819|584536087|FG001|Overall Study|Progressive Disease|13|||
161861949|NCT03367819|584536086|FG000|Overall Study|Withdrawal by Subject|1|||
161861950|NCT03367819|584536087|FG001|Overall Study|Withdrawal by Subject|0|||
161861951|NCT03367819|584536086|FG000|Overall Study|Other|4|||
161861952|NCT03367819|584536087|FG001|Overall Study|Other|2|||
161861953|NCT00445146|584536091|FG000|Overall Study|Withdrew Consent|29|||
161861954|NCT00445146|584536091|FG000|Overall Study|Lack of Efficacy|28|||
161861955|NCT00445146|584536091|FG000|Overall Study|Investigator's Discretion|22|||
161861956|NCT00445146|584536091|FG000|Overall Study|Adverse Event|13|||
161861957|NCT00445146|584536091|FG000|Overall Study|Lost to Follow-up|13|||
161861958|NCT00445146|584536091|FG000|Overall Study|Death|9|||
161861959|NCT00445146|584536091|FG000|Overall Study|Protocol Violation|4|||
161861960|NCT00445146|584536091|FG000|Overall Study|Pregnancy|1|||
161861961|NCT02623725|584536092|FG000|Overall Study|Non compliance with protocol|9|||
161861962|NCT02623725|584536093|FG001|Overall Study|Non compliance with protocol|3|||
161861963|NCT02623725|584536092|FG000|Overall Study|Serious adverse event|0|||
161861964|NCT02623725|584536093|FG001|Overall Study|Serious adverse event|2|||
161861965|NCT02623725|584536092|FG000|Overall Study|Withdrawal by Subject|7|||
161861966|NCT02623725|584536093|FG001|Overall Study|Withdrawal by Subject|1|||
161861967|NCT03918629|584536094|FG000|Overall Study|Adverse Event|19|||
161861968|NCT03918629|584536095|FG001|Overall Study|Adverse Event|20|||
161861969|NCT03918629|584536094|FG000|Overall Study|Death|14|||
161861970|NCT03918629|584536095|FG001|Overall Study|Death|7|||
161861971|NCT03918629|584536094|FG000|Overall Study|Lost to Follow-up|36|||
161861972|NCT03918629|584536095|FG001|Overall Study|Lost to Follow-up|28|||
161861973|NCT03918629|584536094|FG000|Overall Study|Physician Decision|1|||
161861974|NCT03918629|584536095|FG001|Overall Study|Physician Decision|0|||
161861975|NCT03918629|584536094|FG000|Overall Study|Protocol Violation|7|||
161861976|NCT03918629|584536095|FG001|Overall Study|Protocol Violation|4|||
161861977|NCT03918629|584536094|FG000|Overall Study|Withdrawal by Subject|47|||
161861978|NCT03918629|584536095|FG001|Overall Study|Withdrawal by Subject|47|||
161861979|NCT03918629|584536094|FG000|Overall Study|Other|7|||
161861980|NCT03918629|584536095|FG001|Overall Study|Other|11|||
161861981|NCT03918629|584536094|FG000|Overall Study|Randomized but not vaccinated|2|||
161861982|NCT03918629|584536095|FG001|Overall Study|Randomized but not vaccinated|1|||
161861983|NCT02456740|584536097|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161861984|NCT02456740|584536098|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161861985|NCT02456740|584536099|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161861986|NCT02456740|584536100|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861987|NCT02456740|584536101|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861988|NCT02456740|584536102|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861989|NCT02456740|584536103|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861990|NCT02456740|584536104|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861991|NCT02456740|584536105|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861992|NCT02456740|584536097|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
161861993|NCT02456740|584536098|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
161861994|NCT02456740|584536099|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
161861995|NCT02456740|584536100|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861996|NCT02456740|584536101|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861997|NCT02456740|584536102|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861998|NCT02456740|584536103|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861999|NCT02456740|584536104|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161862000|NCT02456740|584536105|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161862001|NCT02456740|584536097|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
161862002|NCT02456740|584536098|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
161862003|NCT02456740|584536099|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
161862004|NCT02456740|584536100|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862005|NCT02456740|584536101|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862006|NCT02456740|584536102|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862007|NCT02456740|584536103|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862008|NCT02456740|584536104|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862009|NCT02456740|584536105|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862010|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862011|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862012|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862013|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
161862014|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
161862015|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862016|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862017|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862018|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
161862019|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161862020|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161862021|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161862022|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
161862023|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
161862024|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
161862025|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
161862026|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
161862027|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
161862028|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862029|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862030|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862031|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862032|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862033|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862034|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862035|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
161862036|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862037|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161862038|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161862039|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161862040|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
161862041|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
161862042|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
161862043|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
161862044|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
161862045|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
161862046|NCT01891864|584536109|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
161862047|NCT01891864|584536110|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
161862048|NCT01891864|584536111|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862049|NCT01891864|584536112|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862050|NCT01891864|584536113|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862051|NCT01891864|584536114|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862052|NCT01891864|584536109|FG000|Treatment Period 1|Physician Decision|0|||
161862053|NCT01891864|584536110|FG001|Treatment Period 1|Physician Decision|1|||
161862054|NCT01891864|584536111|FG002|Treatment Period 1|Physician Decision|0|||
161862055|NCT01891864|584536112|FG003|Treatment Period 1|Physician Decision|0|||
161862056|NCT01891864|584536113|FG004|Treatment Period 1|Physician Decision|0|||
161862057|NCT01891864|584536114|FG005|Treatment Period 1|Physician Decision|0|||
161862058|NCT01891864|584536109|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862059|NCT01891864|584536110|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
161862060|NCT01891864|584536111|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862061|NCT01891864|584536112|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862062|NCT01891864|584536113|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862063|NCT01891864|584536114|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862064|NCT01891864|584536109|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
161862065|NCT01891864|584536110|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
161862066|NCT01891864|584536111|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862067|NCT01891864|584536112|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862068|NCT01891864|584536113|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862069|NCT01891864|584536114|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862070|NCT01891864|584536109|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161862071|NCT01891864|584536110|FG001|Treatment Period 1|Withdrawal by Subject|5|||
161862072|NCT01891864|584536111|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161862073|NCT01891864|584536112|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161862074|NCT01891864|584536113|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161862075|NCT01891864|584536114|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161862076|NCT01891864|584536109|FG000|Treatment Period 1|Lost to Follow-up|1|||
161772707|NCT00457249|584211448|FG001|Overall Study|Withdrawal by Subject|1|||
161772708|NCT00457249|584211447|FG000|Overall Study|Serious Adverse Events|2|||
161772709|NCT00457249|584211448|FG001|Overall Study|Serious Adverse Events|0|||
161772710|NCT04621227|584211451|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
161772711|NCT04621227|584211451|FG000|Period 3 (29 Days)|Adverse Event|1|||
161772712|NCT04621227|584211451|FG000|Period 8 (2 Days)|Adverse Event|1|||
161772713|NCT02916056|584211452|FG000|Overall Study|Adverse Event|6|||
161772714|NCT02916056|584211452|FG000|Overall Study|Lost to Follow-up|1|||
161772715|NCT02916056|584211452|FG000|Overall Study|Other|12|||
161772716|NCT02916056|584211452|FG000|Overall Study|Protocol Violation|1|||
161772717|NCT02916056|584211452|FG000|Overall Study|Withdrawal by Subject|8|||
161772718|NCT02916056|584211452|FG000|Overall Study|Study Terminated by Sponsor|269|||
161772719|NCT00124709|584211453|FG000|Overall Study|Randomized but did not take medication|3|||
161772720|NCT00124709|584211454|FG001|Overall Study|Randomized but did not take medication|1|||
161772721|NCT00124709|584211453|FG000|Overall Study|Adverse Event|3|||
161772722|NCT00124709|584211454|FG001|Overall Study|Adverse Event|0|||
161772723|NCT00124709|584211453|FG000|Overall Study|Lack of Efficacy|5|||
161772724|NCT00124709|584211454|FG001|Overall Study|Lack of Efficacy|10|||
161772725|NCT00124709|584211453|FG000|Overall Study|Protocol Violation|3|||
161772726|NCT00124709|584211454|FG001|Overall Study|Protocol Violation|5|||
161772727|NCT00124709|584211453|FG000|Overall Study|Withdrawal by Subject|127|||
161772728|NCT00124709|584211454|FG001|Overall Study|Withdrawal by Subject|136|||
161772729|NCT00124709|584211453|FG000|Overall Study|Lost to Follow-up|114|||
161772730|NCT00124709|584211454|FG001|Overall Study|Lost to Follow-up|120|||
161772731|NCT01728376|584211455|FG000|Overall Study|Adverse Event|1|||
161772732|NCT01728376|584211456|FG001|Overall Study|Adverse Event|1|||
161772733|NCT01728376|584211457|FG002|Overall Study|Adverse Event|1|||
161772734|NCT01728376|584211458|FG003|Overall Study|Adverse Event|1|||
161772735|NCT01728376|584211459|FG004|Overall Study|Adverse Event|1|||
161772736|NCT01728376|584211460|FG005|Overall Study|Adverse Event|0|||
161772737|NCT01728376|584211455|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
161772738|NCT01728376|584211456|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
161772739|NCT01728376|584211457|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
161772740|NCT01728376|584211458|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
161772741|NCT01728376|584211459|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
161772742|NCT01728376|584211460|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
161772743|NCT01728376|584211455|FG000|Overall Study|No relevant bacteria|2|||
161772744|NCT01728376|584211456|FG001|Overall Study|No relevant bacteria|0|||
161772745|NCT01728376|584211457|FG002|Overall Study|No relevant bacteria|0|||
161772746|NCT01728376|584211458|FG003|Overall Study|No relevant bacteria|0|||
161772747|NCT01728376|584211459|FG004|Overall Study|No relevant bacteria|1|||
161772748|NCT01728376|584211460|FG005|Overall Study|No relevant bacteria|1|||
161772749|NCT01728376|584211455|FG000|Overall Study|Did not receive treatment|0|||
161772750|NCT01728376|584211456|FG001|Overall Study|Did not receive treatment|1|||
161772751|NCT01728376|584211457|FG002|Overall Study|Did not receive treatment|0|||
161772752|NCT01728376|584211458|FG003|Overall Study|Did not receive treatment|0|||
161772753|NCT01728376|584211459|FG004|Overall Study|Did not receive treatment|0|||
161772754|NCT01728376|584211460|FG005|Overall Study|Did not receive treatment|0|||
161772755|NCT01728376|584211455|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772756|NCT01728376|584211456|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772757|NCT01728376|584211457|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772758|NCT01728376|584211458|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
161772759|NCT01728376|584211459|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772760|NCT01728376|584211460|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
161772761|NCT02094573|584211462|FG000|Overall Study|Adverse Event|4|||
161772762|NCT02094573|584211463|FG001|Overall Study|Adverse Event|14|||
161772763|NCT02094573|584211462|FG000|Overall Study|Clinical Progressive Disease|9|||
161772764|NCT02094573|584211463|FG001|Overall Study|Clinical Progressive Disease|13|||
161772765|NCT02094573|584211462|FG000|Overall Study|Death|11|||
161772766|NCT02094573|584211463|FG001|Overall Study|Death|3|||
161772767|NCT02094573|584211462|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
161772768|NCT02094573|584211463|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
161772769|NCT02094573|584211462|FG000|Overall Study|Non-compliance with Study Drug|1|||
161772770|NCT02094573|584211463|FG001|Overall Study|Non-compliance with Study Drug|1|||
161772771|NCT02094573|584211462|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
161772772|NCT02094573|584211463|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
161772773|NCT02094573|584211462|FG000|Overall Study|Physician Decision|4|||
161772774|NCT02094573|584211463|FG001|Overall Study|Physician Decision|4|||
161772775|NCT02094573|584211462|FG000|Overall Study|Site Terminated by Sponsor|10|||
161772776|NCT02094573|584211463|FG001|Overall Study|Site Terminated by Sponsor|17|||
161772777|NCT02094573|584211462|FG000|Overall Study|Withdrawal by Subject|6|||
161772778|NCT02094573|584211463|FG001|Overall Study|Withdrawal by Subject|8|||
161772779|NCT02094573|584211462|FG000|Overall Study|Randomized but not Treated|3|||
161862077|NCT01891864|584536110|FG001|Treatment Period 1|Lost to Follow-up|0|||
161862078|NCT01891864|584536111|FG002|Treatment Period 1|Lost to Follow-up|0|||
161862079|NCT01891864|584536112|FG003|Treatment Period 1|Lost to Follow-up|0|||
161862080|NCT01891864|584536113|FG004|Treatment Period 1|Lost to Follow-up|0|||
161862081|NCT01891864|584536114|FG005|Treatment Period 1|Lost to Follow-up|0|||
161862082|NCT01891864|584536109|FG000|Treatment Period 2|Protocol Violation|0|||
161862083|NCT01891864|584536110|FG001|Treatment Period 2|Protocol Violation|0|||
161862084|NCT01891864|584536111|FG002|Treatment Period 2|Protocol Violation|0|||
161862085|NCT01891864|584536112|FG003|Treatment Period 2|Protocol Violation|1|||
161772780|NCT02094573|584211463|FG001|Overall Study|Randomized but not Treated|0|||
161772781|NCT02411110|584211464|FG000|Treatment Period 1|Adverse Event|4|||
161772782|NCT02411110|584211465|FG001|Treatment Period 1|Adverse Event|2|||
161772783|NCT02411110|584211464|FG000|Treatment Period 1|Lost to Follow-up|1|||
161772784|NCT02411110|584211465|FG001|Treatment Period 1|Lost to Follow-up|0|||
161772785|NCT02411110|584211464|FG000|Treatment Period 1|Personal Reasons|2|||
161772786|NCT02411110|584211465|FG001|Treatment Period 1|Personal Reasons|5|||
161772787|NCT02411110|584211464|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
161772788|NCT02411110|584211465|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
161772789|NCT02411110|584211464|FG000|Treatment Period 2|Adverse Event|1|||
161772790|NCT02411110|584211465|FG001|Treatment Period 2|Adverse Event|0|||
161772791|NCT02411110|584211464|FG000|Treatment Period 2|Lost to Follow-up|0|||
161772792|NCT02411110|584211465|FG001|Treatment Period 2|Lost to Follow-up|2|||
161772793|NCT02411110|584211464|FG000|Treatment Period 2|Personal Reasons|0|||
161772794|NCT02411110|584211465|FG001|Treatment Period 2|Personal Reasons|2|||
161772795|NCT00812968|584211466|FG000|Overall Study|Relapse after erythroid response|6|||
161772796|NCT00812968|584211466|FG000|Overall Study|Disease progression|1|||
161772797|NCT00812968|584211466|FG000|Overall Study|No further treatment required|1|||
161772798|NCT00812968|584211466|FG000|Overall Study|Study closed due to marketing approval|3|||
161772799|NCT00505765|584211472|FG000|Overall Study|Withdrawal by Subject|1|||
161772800|NCT00505765|584211473|FG001|Overall Study|Withdrawal by Subject|0|||
161772801|NCT00505765|584211474|FG002|Overall Study|Withdrawal by Subject|0|||
161772802|NCT00505765|584211472|FG000|Overall Study|Adverse Event|1|||
161772803|NCT00505765|584211473|FG001|Overall Study|Adverse Event|2|||
161772804|NCT00505765|584211474|FG002|Overall Study|Adverse Event|0|||
161772805|NCT00505765|584211472|FG000|Overall Study|Noncompliance|0|||
161772806|NCT00505765|584211473|FG001|Overall Study|Noncompliance|1|||
161772807|NCT00505765|584211474|FG002|Overall Study|Noncompliance|3|||
161772808|NCT01207219|584211476|FG000|Overall Study|changed diagnosis during study period|5|||
161772809|NCT01207219|584211477|FG001|Overall Study|changed diagnosis during study period|3|||
161772810|NCT01207219|584211478|FG002|Overall Study|changed diagnosis during study period|1|||
161772811|NCT01207219|584211476|FG000|Overall Study|Lost to Follow-up|6|||
161772812|NCT01207219|584211477|FG001|Overall Study|Lost to Follow-up|8|||
161772813|NCT01207219|584211478|FG002|Overall Study|Lost to Follow-up|6|||
161772814|NCT01012609|584211479|FG000|Overall Study|Withdrawal by Subject|1|||
161772815|NCT01012609|584211480|FG001|Overall Study|Withdrawal by Subject|1|||
161772816|NCT01453296|584211481|FG000|Treatment Period 1|Adverse Event|0|||
161772817|NCT01453296|584211482|FG001|Treatment Period 1|Adverse Event|1|||
161772818|NCT01453296|584211481|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
161772819|NCT01453296|584211482|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
161772820|NCT01453296|584211481|FG000|Treatment Period 2|Adverse Event|1|||
161772821|NCT01453296|584211482|FG001|Treatment Period 2|Adverse Event|0|||
161772822|NCT01453296|584211481|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161772823|NCT01453296|584211482|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161772824|NCT00620776|584211483|FG000|Overall Study|Did not receive treatment|3|||
161772825|NCT00620776|584211484|FG001|Overall Study|Did not receive treatment|5|||
161772826|NCT00620776|584211483|FG000|Overall Study|Adverse Event|2|||
161772827|NCT00620776|584211484|FG001|Overall Study|Adverse Event|3|||
161772828|NCT00620776|584211483|FG000|Overall Study|Lack of Efficacy|2|||
161772829|NCT00620776|584211484|FG001|Overall Study|Lack of Efficacy|1|||
161772830|NCT00620776|584211483|FG000|Overall Study|Lost to Follow-up|2|||
161772831|NCT00620776|584211484|FG001|Overall Study|Lost to Follow-up|5|||
161772832|NCT00620776|584211483|FG000|Overall Study|Withdrawal by Subject|3|||
161772833|NCT00620776|584211484|FG001|Overall Study|Withdrawal by Subject|2|||
161772834|NCT00924820|584211485|FG000|Overall Study|Death|2|||
161772835|NCT00924820|584211485|FG000|Overall Study|Ineligible, Screen Failure|5|||
161772836|NCT04983589|584211486|FG000|Overall Study|Withdrawal by Subject|0|||
161772837|NCT04983589|584211487|FG001|Overall Study|Withdrawal by Subject|3|||
161772838|NCT04983589|584211486|FG000|Overall Study|COVID-19 Infection|1|||
161772839|NCT04983589|584211487|FG001|Overall Study|COVID-19 Infection|0|||
161772840|NCT04983589|584211486|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
161772841|NCT04983589|584211487|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
161772842|NCT01049360|584211490|FG000|Period 1|Adverse Event|0|||
161772843|NCT01049360|584211491|FG001|Period 1|Adverse Event|1|||
161772844|NCT01049360|584211492|FG002|Period 1|Adverse Event|0|||
161772845|NCT01049360|584211493|FG003|Period 1|Adverse Event|1|||
161862086|NCT01891864|584536113|FG004|Treatment Period 2|Protocol Violation|0|||
161862087|NCT01891864|584536114|FG005|Treatment Period 2|Protocol Violation|0|||
161862088|NCT01891864|584536109|FG000|Treatment Period 2|Physician Decision|0|||
161862089|NCT01891864|584536110|FG001|Treatment Period 2|Physician Decision|0|||
161862090|NCT01891864|584536111|FG002|Treatment Period 2|Physician Decision|1|||
161862091|NCT01891864|584536112|FG003|Treatment Period 2|Physician Decision|0|||
161862092|NCT01891864|584536113|FG004|Treatment Period 2|Physician Decision|0|||
161862093|NCT01891864|584536114|FG005|Treatment Period 2|Physician Decision|0|||
161862094|NCT01891864|584536109|FG000|Treatment Period 2|Site Termination|0|||
161862095|NCT01891864|584536110|FG001|Treatment Period 2|Site Termination|0|||
161862096|NCT01891864|584536111|FG002|Treatment Period 2|Site Termination|1|||
161862097|NCT01891864|584536112|FG003|Treatment Period 2|Site Termination|2|||
161862098|NCT01891864|584536113|FG004|Treatment Period 2|Site Termination|0|||
161862099|NCT01891864|584536114|FG005|Treatment Period 2|Site Termination|0|||
161862100|NCT01891864|584536109|FG000|Treatment Period 2|Lack of Efficacy|0|||
161862101|NCT01891864|584536110|FG001|Treatment Period 2|Lack of Efficacy|0|||
161862102|NCT01891864|584536111|FG002|Treatment Period 2|Lack of Efficacy|1|||
161862103|NCT01891864|584536112|FG003|Treatment Period 2|Lack of Efficacy|0|||
161862104|NCT01891864|584536113|FG004|Treatment Period 2|Lack of Efficacy|1|||
161862105|NCT01891864|584536114|FG005|Treatment Period 2|Lack of Efficacy|0|||
161862106|NCT01891864|584536109|FG000|Treatment Period 2|Adverse Event|0|||
161862107|NCT01891864|584536110|FG001|Treatment Period 2|Adverse Event|0|||
161862108|NCT01891864|584536111|FG002|Treatment Period 2|Adverse Event|1|||
161862109|NCT01891864|584536112|FG003|Treatment Period 2|Adverse Event|2|||
161862110|NCT01891864|584536113|FG004|Treatment Period 2|Adverse Event|0|||
161862111|NCT01891864|584536114|FG005|Treatment Period 2|Adverse Event|4|||
161862112|NCT01891864|584536109|FG000|Treatment Period 2|Termination of Site|0|||
161862113|NCT01891864|584536110|FG001|Treatment Period 2|Termination of Site|0|||
161862114|NCT01891864|584536111|FG002|Treatment Period 2|Termination of Site|0|||
161862115|NCT01891864|584536112|FG003|Treatment Period 2|Termination of Site|0|||
161862116|NCT01891864|584536113|FG004|Treatment Period 2|Termination of Site|2|||
161862117|NCT01891864|584536114|FG005|Treatment Period 2|Termination of Site|0|||
161862118|NCT01891864|584536109|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161862119|NCT01891864|584536110|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161862120|NCT01891864|584536111|FG002|Treatment Period 2|Withdrawal by Subject|3|||
161862121|NCT01891864|584536112|FG003|Treatment Period 2|Withdrawal by Subject|4|||
161862122|NCT01891864|584536113|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161862123|NCT01891864|584536114|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161862124|NCT01891864|584536109|FG000|Extension Period|Lack of Efficacy|0|||
161862125|NCT01891864|584536110|FG001|Extension Period|Lack of Efficacy|0|||
161862126|NCT01891864|584536111|FG002|Extension Period|Lack of Efficacy|0|||
161862127|NCT01891864|584536112|FG003|Extension Period|Lack of Efficacy|1|||
161862128|NCT01891864|584536113|FG004|Extension Period|Lack of Efficacy|1|||
161862129|NCT01891864|584536114|FG005|Extension Period|Lack of Efficacy|0|||
161862130|NCT01891864|584536109|FG000|Extension Period|Pregnancy|0|||
161862131|NCT01891864|584536110|FG001|Extension Period|Pregnancy|0|||
161862132|NCT01891864|584536111|FG002|Extension Period|Pregnancy|1|||
161862133|NCT01891864|584536112|FG003|Extension Period|Pregnancy|0|||
161862134|NCT01891864|584536113|FG004|Extension Period|Pregnancy|0|||
161862135|NCT01891864|584536114|FG005|Extension Period|Pregnancy|0|||
161862136|NCT01891864|584536109|FG000|Extension Period|Adverse Event|0|||
161862137|NCT01891864|584536110|FG001|Extension Period|Adverse Event|0|||
161862138|NCT01891864|584536111|FG002|Extension Period|Adverse Event|4|||
161862139|NCT01891864|584536112|FG003|Extension Period|Adverse Event|2|||
161862140|NCT01891864|584536113|FG004|Extension Period|Adverse Event|2|||
161862141|NCT01891864|584536114|FG005|Extension Period|Adverse Event|0|||
161862142|NCT01891864|584536109|FG000|Extension Period|Withdrawal by Subject|0|||
161862143|NCT01891864|584536110|FG001|Extension Period|Withdrawal by Subject|0|||
161862144|NCT01891864|584536111|FG002|Extension Period|Withdrawal by Subject|1|||
161862145|NCT01891864|584536112|FG003|Extension Period|Withdrawal by Subject|2|||
161862146|NCT01891864|584536113|FG004|Extension Period|Withdrawal by Subject|4|||
161862147|NCT01891864|584536114|FG005|Extension Period|Withdrawal by Subject|0|||
161862148|NCT01891864|584536109|FG000|Extension Period|Lost to Follow-up|0|||
161862149|NCT01891864|584536110|FG001|Extension Period|Lost to Follow-up|0|||
161862150|NCT01891864|584536111|FG002|Extension Period|Lost to Follow-up|2|||
161862151|NCT01891864|584536112|FG003|Extension Period|Lost to Follow-up|0|||
161862152|NCT01891864|584536113|FG004|Extension Period|Lost to Follow-up|0|||
161862153|NCT01891864|584536114|FG005|Extension Period|Lost to Follow-up|0|||
161862154|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
161862155|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161862156|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161862157|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161862158|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
161862159|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161862160|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161862161|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161862162|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
161862163|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161862164|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161862165|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161862166|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
161862167|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161862168|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161862169|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161862170|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
161862171|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161862172|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161862173|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161862174|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
161862175|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161862176|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161862177|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161862178|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
161862179|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161862180|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161862181|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161862182|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
161862183|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
161862184|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
161862185|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
161862186|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
161862187|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161862188|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161862189|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161862190|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
161862191|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161862192|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161862193|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161862194|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
161862195|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161862196|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161862197|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161862198|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161862199|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
161862200|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161862201|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161862202|NCT04581824|584537941|FG000|Overall Study|Lost to Follow-up|1|||
161862203|NCT04581824|584537942|FG001|Overall Study|Lost to Follow-up|0|||
161862204|NCT04581824|584537941|FG000|Overall Study|Withdrawal by Subject|2|||
161862205|NCT04581824|584537942|FG001|Overall Study|Withdrawal by Subject|7|||
161862206|NCT04581824|584537941|FG000|Overall Study|Study terminated by sponsor|37|||
161862207|NCT04581824|584537942|FG001|Overall Study|Study terminated by sponsor|23|||
161862208|NCT05012098|584537943|FG000|Overall Study|Disease progression|5|||
161862209|NCT05012098|584537944|FG001|Overall Study|Disease progression|2|||
161862210|NCT05012098|584537943|FG000|Overall Study|Adverse Event|1|||
161862211|NCT05012098|584537944|FG001|Overall Study|Adverse Event|0|||
161862212|NCT05012098|584537943|FG000|Overall Study|Withdrawal by Subject|1|||
161862213|NCT05012098|584537944|FG001|Overall Study|Withdrawal by Subject|0|||
161862214|NCT05012098|584537943|FG000|Overall Study|Discontinuation per protocol|1|||
161862215|NCT05012098|584537944|FG001|Overall Study|Discontinuation per protocol|0|||
161862216|NCT01749826|584537947|FG000|Overall Study|Study Terminated|20|||
161862217|NCT01749826|584537948|FG001|Overall Study|Study Terminated|0|||
161862218|NCT00813150|584537949|FG000|Treatment Period|Adverse Event|16|||
161862219|NCT00813150|584537950|FG001|Treatment Period|Adverse Event|15|||
161862220|NCT00813150|584537949|FG000|Treatment Period|Death|2|||
161862221|NCT00813150|584537950|FG001|Treatment Period|Death|0|||
161862222|NCT00813150|584537949|FG000|Treatment Period|Progressive disease|1|||
161862223|NCT00813150|584537950|FG001|Treatment Period|Progressive disease|0|||
161862224|NCT00813150|584537949|FG000|Treatment Period|Complete response|0|||
161862225|NCT00813150|584537950|FG001|Treatment Period|Complete response|1|||
161862226|NCT00813150|584537949|FG000|Treatment Period|Stable disease|1|||
161862227|NCT00813150|584537950|FG001|Treatment Period|Stable disease|2|||
161862228|NCT00813150|584537949|FG000|Treatment Period|Protocol Violation|3|||
161862229|NCT00813150|584537950|FG001|Treatment Period|Protocol Violation|4|||
161862230|NCT00813150|584537949|FG000|Treatment Period|Withdrawal by Subject|5|||
161862231|NCT00813150|584537950|FG001|Treatment Period|Withdrawal by Subject|3|||
161862232|NCT00813150|584537949|FG000|Treatment Period|Non compliance|0|||
161862233|NCT00813150|584537950|FG001|Treatment Period|Non compliance|1|||
161862234|NCT00813150|584537949|FG000|Treatment Period|Reason not specified|3|||
161862235|NCT00813150|584537950|FG001|Treatment Period|Reason not specified|4|||
161862236|NCT00813150|584537949|FG000|Treatment Period|Data not available|1|||
161862237|NCT00813150|584537950|FG001|Treatment Period|Data not available|2|||
161862238|NCT00813150|584537949|FG000|Long Term Follow-up|Death|0|||
161862239|NCT00813150|584537950|FG001|Long Term Follow-up|Death|4|||
161862240|NCT00813150|584537949|FG000|Long Term Follow-up|Other|0|||
161862241|NCT00813150|584537950|FG001|Long Term Follow-up|Other|3|||
161862242|NCT00813150|584537949|FG000|Long Term Follow-up|Lost to Follow-up|2|||
161862243|NCT00813150|584537950|FG001|Long Term Follow-up|Lost to Follow-up|0|||
161862244|NCT00813150|584537949|FG000|Long Term Follow-up|Progression/Relapse|22|||
161862245|NCT00813150|584537950|FG001|Long Term Follow-up|Progression/Relapse|24|||
161862246|NCT05085834|584537951|FG000|Overall Study|Lost to Follow-up|9|||
161862247|NCT05085834|584537952|FG001|Overall Study|Lost to Follow-up|2|||
161862248|NCT05085834|584537951|FG000|Overall Study|Adverse Event|6|||
161862249|NCT05085834|584537952|FG001|Overall Study|Adverse Event|0|||
161862250|NCT05085834|584537951|FG000|Overall Study|Death|1|||
161862251|NCT05085834|584537952|FG001|Overall Study|Death|0|||
161862252|NCT05085834|584537951|FG000|Overall Study|Inability to swallow the pill|0|||
161862253|NCT05085834|584537952|FG001|Overall Study|Inability to swallow the pill|1|||
161862254|NCT01823328|584537957|FG000|Overall Study|Withdrawal by Subject|8|||
161862255|NCT01823328|584537958|FG001|Overall Study|Withdrawal by Subject|6|||
161862256|NCT04565145|584537959|FG000|Overall Study|Withdrawal by Subject|1|||
161862257|NCT04565145|584537960|FG001|Overall Study|Withdrawal by Subject|1|||
161862258|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
161862259|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
161862260|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
161862261|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
161862262|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
161862263|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
161862264|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
161862265|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
161862266|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
161862267|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
161862268|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
161862269|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
161772846|NCT01049360|584211494|FG004|Period 1|Adverse Event|0|||
161772847|NCT01049360|584211495|FG005|Period 1|Adverse Event|0|||
161772848|NCT01049360|584211496|FG006|Period 1|Adverse Event|0|||
161772849|NCT01049360|584211497|FG007|Period 1|Adverse Event|1|||
161772850|NCT01049360|584211498|FG008|Period 1|Adverse Event|0|||
161772851|NCT01049360|584211499|FG009|Period 1|Adverse Event|0|||
161772852|NCT01049360|584211500|FG010|Period 1|Adverse Event|0|||
161772853|NCT01049360|584211501|FG011|Period 1|Adverse Event|0|||
161772854|NCT01049360|584211502|FG012|Period 1|Adverse Event|1|||
161772855|NCT01049360|584211503|FG013|Period 1|Adverse Event|1|||
161772856|NCT01049360|584211504|FG014|Period 1|Adverse Event|0|||
161772857|NCT01049360|584211505|FG015|Period 1|Adverse Event|0|||
161772858|NCT01049360|584211506|FG016|Period 1|Adverse Event|1|||
161772859|NCT01049360|584211507|FG017|Period 1|Adverse Event|0|||
161772860|NCT01049360|584211508|FG018|Period 1|Adverse Event|1|||
161862270|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
161772861|NCT01049360|584211509|FG019|Period 1|Adverse Event|0|||
161772862|NCT01049360|584211490|FG000|Period 1|Did not meet inc/exc criteria|0|||
161772863|NCT01049360|584211491|FG001|Period 1|Did not meet inc/exc criteria|0|||
161772864|NCT01049360|584211492|FG002|Period 1|Did not meet inc/exc criteria|0|||
161772865|NCT01049360|584211493|FG003|Period 1|Did not meet inc/exc criteria|0|||
161862271|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
161862272|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
161862273|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
161862274|NCT00742209|584537975|FG000|Overall Study|Adverse Event|11|||
161862275|NCT00742209|584537976|FG001|Overall Study|Adverse Event|4|||
161862276|NCT00742209|584537977|FG002|Overall Study|Adverse Event|17|||
161862277|NCT00742209|584537978|FG003|Overall Study|Adverse Event|16|||
161862278|NCT00742209|584537979|FG004|Overall Study|Adverse Event|13|||
161862279|NCT00742209|584537975|FG000|Overall Study|Participant Withdrew Consent|8|||
161862280|NCT00742209|584537976|FG001|Overall Study|Participant Withdrew Consent|4|||
161862281|NCT00742209|584537977|FG002|Overall Study|Participant Withdrew Consent|14|||
161862282|NCT00742209|584537978|FG003|Overall Study|Participant Withdrew Consent|7|||
161862283|NCT00742209|584537979|FG004|Overall Study|Participant Withdrew Consent|4|||
161862284|NCT00742209|584537975|FG000|Overall Study|Protocol Violation|6|||
161862285|NCT00742209|584537976|FG001|Overall Study|Protocol Violation|5|||
161862286|NCT00742209|584537977|FG002|Overall Study|Protocol Violation|4|||
161862287|NCT00742209|584537978|FG003|Overall Study|Protocol Violation|5|||
161862288|NCT00742209|584537979|FG004|Overall Study|Protocol Violation|3|||
161862289|NCT00742209|584537975|FG000|Overall Study|Lost to Follow-up|3|||
161862290|NCT00742209|584537976|FG001|Overall Study|Lost to Follow-up|4|||
161862291|NCT00742209|584537977|FG002|Overall Study|Lost to Follow-up|5|||
161862292|NCT00742209|584537978|FG003|Overall Study|Lost to Follow-up|5|||
161862293|NCT00742209|584537979|FG004|Overall Study|Lost to Follow-up|3|||
161862294|NCT00742209|584537975|FG000|Overall Study|Lack of Efficacy|6|||
161862295|NCT00742209|584537976|FG001|Overall Study|Lack of Efficacy|1|||
161862296|NCT00742209|584537977|FG002|Overall Study|Lack of Efficacy|1|||
161862297|NCT00742209|584537978|FG003|Overall Study|Lack of Efficacy|3|||
161862298|NCT00742209|584537979|FG004|Overall Study|Lack of Efficacy|1|||
161862299|NCT00742209|584537975|FG000|Overall Study|Investigator Discretion|0|||
161862300|NCT00742209|584537976|FG001|Overall Study|Investigator Discretion|0|||
161862301|NCT00742209|584537977|FG002|Overall Study|Investigator Discretion|5|||
161862302|NCT00742209|584537978|FG003|Overall Study|Investigator Discretion|1|||
161862303|NCT00742209|584537979|FG004|Overall Study|Investigator Discretion|1|||
161862304|NCT02003209|584537980|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
161862305|NCT02003209|584537981|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
161862306|NCT00485264|584537984|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
161862307|NCT00485264|584537985|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
161862308|NCT00485264|584537986|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
161862309|NCT00485264|584537987|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
161862310|NCT00485264|584537988|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
161862311|NCT00485264|584537989|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
161862312|NCT00485264|584537984|FG000|Overall Study|Death|1|||
161862313|NCT00485264|584537985|FG001|Overall Study|Death|0|||
161862314|NCT00485264|584537986|FG002|Overall Study|Death|0|||
161862315|NCT00485264|584537987|FG003|Overall Study|Death|0|||
161862316|NCT00485264|584537988|FG004|Overall Study|Death|1|||
161862317|NCT00485264|584537989|FG005|Overall Study|Death|0|||
161862318|NCT00485264|584537984|FG000|Overall Study|Adverse Event|1|||
161862319|NCT00485264|584537985|FG001|Overall Study|Adverse Event|0|||
161862320|NCT00485264|584537986|FG002|Overall Study|Adverse Event|2|||
161862321|NCT00485264|584537987|FG003|Overall Study|Adverse Event|3|||
161862322|NCT00485264|584537988|FG004|Overall Study|Adverse Event|1|||
161862323|NCT00485264|584537989|FG005|Overall Study|Adverse Event|3|||
161862324|NCT00485264|584537984|FG000|Overall Study|Pregnancy|4|||
161862325|NCT00485264|584537985|FG001|Overall Study|Pregnancy|0|||
161862326|NCT00485264|584537986|FG002|Overall Study|Pregnancy|0|||
161862327|NCT00485264|584537987|FG003|Overall Study|Pregnancy|0|||
161862328|NCT00485264|584537988|FG004|Overall Study|Pregnancy|0|||
161862329|NCT00485264|584537989|FG005|Overall Study|Pregnancy|0|||
161862330|NCT00485264|584537984|FG000|Overall Study|Disallowed Medication|0|||
161862331|NCT00485264|584537985|FG001|Overall Study|Disallowed Medication|0|||
161862332|NCT00485264|584537986|FG002|Overall Study|Disallowed Medication|0|||
161862333|NCT00485264|584537987|FG003|Overall Study|Disallowed Medication|0|||
161862334|NCT00485264|584537988|FG004|Overall Study|Disallowed Medication|0|||
161862335|NCT00485264|584537989|FG005|Overall Study|Disallowed Medication|1|||
161862336|NCT00485264|584537984|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
161862337|NCT00485264|584537985|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
161862338|NCT00485264|584537986|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
161862339|NCT00485264|584537987|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
161862340|NCT00485264|584537988|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
161862341|NCT00485264|584537989|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
161862342|NCT00485264|584537984|FG000|Overall Study|Lack of Efficacy|0|||
161862343|NCT00485264|584537985|FG001|Overall Study|Lack of Efficacy|1|||
161862344|NCT00485264|584537986|FG002|Overall Study|Lack of Efficacy|0|||
161862345|NCT00485264|584537987|FG003|Overall Study|Lack of Efficacy|0|||
161862346|NCT00485264|584537988|FG004|Overall Study|Lack of Efficacy|0|||
161862347|NCT00485264|584537989|FG005|Overall Study|Lack of Efficacy|0|||
161862348|NCT00485264|584537984|FG000|Overall Study|Guardian Consent Withdrawn|1|||
161862349|NCT00485264|584537985|FG001|Overall Study|Guardian Consent Withdrawn|0|||
161862350|NCT00485264|584537986|FG002|Overall Study|Guardian Consent Withdrawn|0|||
161862351|NCT00485264|584537987|FG003|Overall Study|Guardian Consent Withdrawn|0|||
161862352|NCT00485264|584537988|FG004|Overall Study|Guardian Consent Withdrawn|1|||
161862353|NCT00485264|584537989|FG005|Overall Study|Guardian Consent Withdrawn|0|||
161862354|NCT00485264|584537984|FG000|Overall Study|Physician Decision|0|||
161862355|NCT00485264|584537985|FG001|Overall Study|Physician Decision|2|||
161862356|NCT00485264|584537986|FG002|Overall Study|Physician Decision|0|||
161862357|NCT00485264|584537987|FG003|Overall Study|Physician Decision|0|||
161862358|NCT00485264|584537988|FG004|Overall Study|Physician Decision|0|||
161862359|NCT00485264|584537989|FG005|Overall Study|Physician Decision|0|||
161862360|NCT00485264|584537984|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862361|NCT00485264|584537985|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862362|NCT00485264|584537986|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
161862363|NCT00485264|584537987|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862364|NCT00485264|584537988|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862365|NCT00485264|584537989|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862366|NCT00485264|584537984|FG000|Overall Study|Not Able to Attend Clinic|5|||
161862367|NCT00485264|584537985|FG001|Overall Study|Not Able to Attend Clinic|0|||
161862368|NCT00485264|584537986|FG002|Overall Study|Not Able to Attend Clinic|0|||
161862369|NCT00485264|584537987|FG003|Overall Study|Not Able to Attend Clinic|1|||
161862370|NCT00485264|584537988|FG004|Overall Study|Not Able to Attend Clinic|1|||
161862371|NCT00485264|584537989|FG005|Overall Study|Not Able to Attend Clinic|2|||
161862372|NCT00485264|584537984|FG000|Overall Study|Non-Compliant|17|||
161862373|NCT00485264|584537985|FG001|Overall Study|Non-Compliant|2|||
161862374|NCT00485264|584537986|FG002|Overall Study|Non-Compliant|1|||
161862375|NCT00485264|584537987|FG003|Overall Study|Non-Compliant|0|||
161862376|NCT00485264|584537988|FG004|Overall Study|Non-Compliant|1|||
161862377|NCT00485264|584537989|FG005|Overall Study|Non-Compliant|0|||
161862378|NCT00485264|584537984|FG000|Overall Study|Lost to Follow-up|2|||
161862379|NCT00485264|584537985|FG001|Overall Study|Lost to Follow-up|1|||
161862380|NCT00485264|584537986|FG002|Overall Study|Lost to Follow-up|1|||
161862381|NCT00485264|584537987|FG003|Overall Study|Lost to Follow-up|0|||
161862382|NCT00485264|584537988|FG004|Overall Study|Lost to Follow-up|0|||
161862383|NCT00485264|584537989|FG005|Overall Study|Lost to Follow-up|1|||
161862384|NCT00485264|584537984|FG000|Overall Study|Other Reason|3|||
161862385|NCT00485264|584537985|FG001|Overall Study|Other Reason|0|||
161862386|NCT00485264|584537986|FG002|Overall Study|Other Reason|0|||
161862387|NCT00485264|584537987|FG003|Overall Study|Other Reason|0|||
161862388|NCT00485264|584537988|FG004|Overall Study|Other Reason|0|||
161862389|NCT00485264|584537989|FG005|Overall Study|Other Reason|0|||
161862390|NCT01514461|584537990|FG000|Overall Study|Adverse Event|2|||
161862391|NCT01514461|584537991|FG001|Overall Study|Adverse Event|1|||
161862392|NCT01514461|584537992|FG002|Overall Study|Adverse Event|3|||
161862393|NCT01514461|584537990|FG000|Overall Study|Physician Decision|1|||
161862394|NCT01514461|584537991|FG001|Overall Study|Physician Decision|1|||
161862395|NCT01514461|584537992|FG002|Overall Study|Physician Decision|0|||
161862396|NCT01514461|584537990|FG000|Overall Study|Patient/guardian decision|1|||
161862397|NCT01514461|584537991|FG001|Overall Study|Patient/guardian decision|1|||
161862398|NCT01514461|584537992|FG002|Overall Study|Patient/guardian decision|1|||
161862399|NCT01514461|584537990|FG000|Overall Study|Death|1|||
161862400|NCT01514461|584537991|FG001|Overall Study|Death|0|||
161862401|NCT01514461|584537992|FG002|Overall Study|Death|0|||
161862402|NCT02548832|584537993|FG000|Overall Study|Lost to Follow-up|2|||
161862403|NCT02548832|584537994|FG001|Overall Study|Lost to Follow-up|2|||
161862404|NCT02548832|584537995|FG002|Overall Study|Lost to Follow-up|2|||
161862405|NCT03817125|584538003|FG000|Overall Study|Adverse Event|1|||
161862406|NCT03817125|584538004|FG001|Overall Study|Adverse Event|0|||
161862407|NCT03817125|584538003|FG000|Overall Study|Physician Decision|0|||
161862408|NCT03817125|584538004|FG001|Overall Study|Physician Decision|1|||
161862409|NCT03817125|584538003|FG000|Overall Study|Lack of Efficacy|1|||
161862410|NCT03817125|584538004|FG001|Overall Study|Lack of Efficacy|5|||
161862411|NCT00942084|584538005|FG000|Overall Study|Death|2|||
161862412|NCT01062425|584538006|FG000|Overall Study|Protocol Violation|3|||
161862413|NCT01062425|584538007|FG001|Overall Study|Protocol Violation|6|||
161862414|NCT02088177|584538010|FG000|Overall Study|Lost to Follow-up|3|||
161862415|NCT01234350|584538011|FG000|Overall Study|Adverse Event|277|||
161862416|NCT01234350|584538012|FG001|Overall Study|Adverse Event|92|||
161862417|NCT01234350|584538011|FG000|Overall Study|Withdrawal by Subject|61|||
161862418|NCT01234350|584538012|FG001|Overall Study|Withdrawal by Subject|36|||
161862419|NCT01234350|584538011|FG000|Overall Study|Lost to Follow-up|115|||
161862420|NCT01234350|584538012|FG001|Overall Study|Lost to Follow-up|47|||
161862421|NCT01234350|584538011|FG000|Overall Study|Covers a diverse set of reasons|234|||
161862422|NCT01234350|584538012|FG001|Overall Study|Covers a diverse set of reasons|92|||
161862423|NCT00289848|584538013|FG000|Overall Study|Adverse Event|6|||
161862424|NCT00289848|584538014|FG001|Overall Study|Adverse Event|4|||
161862425|NCT00289848|584538013|FG000|Overall Study|Death|1|||
161862426|NCT00289848|584538014|FG001|Overall Study|Death|0|||
161862427|NCT00289848|584538013|FG000|Overall Study|Lack of Efficacy|20|||
161862428|NCT00289848|584538014|FG001|Overall Study|Lack of Efficacy|24|||
161862429|NCT00289848|584538013|FG000|Overall Study|Lost to Follow-up|3|||
161862430|NCT00289848|584538014|FG001|Overall Study|Lost to Follow-up|1|||
161862431|NCT00289848|584538013|FG000|Overall Study|Protocol Violation|5|||
161862432|NCT00289848|584538014|FG001|Overall Study|Protocol Violation|2|||
161862433|NCT00289848|584538013|FG000|Overall Study|Withdrawal by Subject|5|||
161862434|NCT00289848|584538014|FG001|Overall Study|Withdrawal by Subject|11|||
161862435|NCT00289848|584538013|FG000|Overall Study|Patient Moved|6|||
161862436|NCT00289848|584538014|FG001|Overall Study|Patient Moved|2|||
161862437|NCT00289848|584538013|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
161862438|NCT00289848|584538014|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
161862439|NCT03428152|584538021|FG000|Overall Study|Physician Decision|4|||
161862440|NCT03428152|584538022|FG001|Overall Study|Physician Decision|2|||
161862441|NCT03428152|584538021|FG000|Overall Study|Protocol Violation|3|||
161862442|NCT03428152|584538022|FG001|Overall Study|Protocol Violation|5|||
161862443|NCT03428152|584538021|FG000|Overall Study|Lack of Efficacy|0|||
161862444|NCT03428152|584538022|FG001|Overall Study|Lack of Efficacy|4|||
161862445|NCT01686373|584538023|FG000|Overall Study|Lost to Follow-up|3|||
161862446|NCT01686373|584538024|FG001|Overall Study|Lost to Follow-up|0|||
161862447|NCT01686373|584538023|FG000|Overall Study|Withdrawal by Subject|0|||
161862448|NCT01686373|584538024|FG001|Overall Study|Withdrawal by Subject|1|||
161862449|NCT01686373|584538023|FG000|Overall Study|Adverse Event|0|||
161862450|NCT01686373|584538024|FG001|Overall Study|Adverse Event|1|||
161862451|NCT05366010|584538031|FG000|Overall Study|Withdrawal by Subject|1|||
161862452|NCT05366010|584538031|FG000|Overall Study|Protocol Violation|1|||
161862453|NCT05366010|584538031|FG000|Overall Study|Lost to Follow-up|2|||
161862454|NCT05366010|584538031|FG000|Overall Study|Screen Failure|2|||
161862455|NCT02857816|584538034|FG000|Overall Study|Screen Failure|33|||
161862456|NCT02857816|584538034|FG000|Overall Study|Withdrawal by Subject|4|||
161862457|NCT02857816|584538034|FG000|Overall Study|Lost to Follow-up|1|||
161862458|NCT01949662|584538035|FG000|Overall Study|Death|9|||
161862459|NCT01949662|584538036|FG001|Overall Study|Death|7|||
161862460|NCT01949662|584538035|FG000|Overall Study|Discharged before an agitation event|8|||
161862461|NCT01949662|584538036|FG001|Overall Study|Discharged before an agitation event|3|||
161862462|NCT01949662|584538035|FG000|Overall Study|Dropped out|1|||
161862463|NCT01949662|584538036|FG001|Overall Study|Dropped out|3|||
161862464|NCT01949662|584538035|FG000|Overall Study|Ineligible|0|||
161862465|NCT01949662|584538036|FG001|Overall Study|Ineligible|1|||
161862466|NCT02291237|584538037|FG000|Overall Study|Study Terminated by Sponsor|72|||
161862467|NCT02291237|584538038|FG001|Overall Study|Study Terminated by Sponsor|67|||
161862468|NCT02291237|584538037|FG000|Overall Study|Adverse Event|1|||
161862469|NCT02291237|584538038|FG001|Overall Study|Adverse Event|3|||
161862470|NCT02291237|584538037|FG000|Overall Study|Investigator's Discretion|0|||
161862471|NCT02291237|584538038|FG001|Overall Study|Investigator's Discretion|3|||
161862472|NCT02291237|584538037|FG000|Overall Study|Withdrew Consent|11|||
161862473|NCT02291237|584538038|FG001|Overall Study|Withdrew Consent|11|||
161862474|NCT02291237|584538037|FG000|Overall Study|Lost to Follow-up|0|||
161862475|NCT02291237|584538038|FG001|Overall Study|Lost to Follow-up|2|||
161862476|NCT02291237|584538037|FG000|Overall Study|Subject Required Prohibited Medication|2|||
161862477|NCT02291237|584538038|FG001|Overall Study|Subject Required Prohibited Medication|0|||
161862478|NCT00281957|584538039|FG000|Overall Study|Adverse Event|7|||
161862479|NCT00281957|584538040|FG001|Overall Study|Adverse Event|2|||
161862480|NCT00281957|584538039|FG000|Overall Study|Death|1|||
161862481|NCT00281957|584538040|FG001|Overall Study|Death|0|||
161862482|NCT00281957|584538039|FG000|Overall Study|Progression/relapse|47|||
161862483|NCT00281957|584538040|FG001|Overall Study|Progression/relapse|35|||
161862484|NCT00281957|584538039|FG000|Overall Study|Not protocol specified|8|||
161862485|NCT00281957|584538040|FG001|Overall Study|Not protocol specified|1|||
161862486|NCT00281957|584538039|FG000|Overall Study|Not eligible|1|||
161862487|NCT00281957|584538040|FG001|Overall Study|Not eligible|2|||
161862488|NCT00281957|584538039|FG000|Overall Study|Did not start treatment|3|||
161862489|NCT00281957|584538040|FG001|Overall Study|Did not start treatment|1|||
161862490|NCT00281957|584538039|FG000|Overall Study|Refusal unrelated to adverse events|0|||
161862491|NCT00281957|584538040|FG001|Overall Study|Refusal unrelated to adverse events|1|||
161862492|NCT03281876|584538049|FG000|Overall Study|Adverse Event|4|||
161862493|NCT03281876|584538050|FG001|Overall Study|Adverse Event|15|||
161862494|NCT03281876|584538049|FG000|Overall Study|Lost to Follow-up|1|||
161862495|NCT03281876|584538050|FG001|Overall Study|Lost to Follow-up|4|||
161862496|NCT03281876|584538049|FG000|Overall Study|Withdrawal by Subject|11|||
161862497|NCT03281876|584538050|FG001|Overall Study|Withdrawal by Subject|15|||
161862498|NCT03281876|584538049|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161862499|NCT03281876|584538050|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161862500|NCT03281876|584538049|FG000|Overall Study|OTHER|5|||
161862501|NCT03281876|584538050|FG001|Overall Study|OTHER|5|||
161862502|NCT02208089|584538051|FG000|Overall Study|Withdrawal by Subject|1|||
161862503|NCT02208089|584538052|FG001|Overall Study|Withdrawal by Subject|0|||
161862504|NCT02208089|584538051|FG000|Overall Study|Lost to Follow-up|6|||
161862505|NCT02208089|584538052|FG001|Overall Study|Lost to Follow-up|0|||
161862506|NCT00456300|584538053|FG000|Overall Study|Adverse Event|1|||
161862507|NCT00456300|584538054|FG001|Overall Study|Adverse Event|0|||
161862508|NCT01478373|584538056|FG000|Treatment Phase|Protocol Violation|1|||
161862509|NCT01478373|584538056|FG000|Survival Phase|Adverse Event|8|||
161862510|NCT01478373|584538056|FG000|Survival Phase|Protocol Violation|1|||
161862511|NCT01478373|584538056|FG000|Survival Phase|crossover to another study|2|||
161862512|NCT01478373|584538056|FG000|Survival Phase|Progressive Disease|27|||
161772866|NCT01049360|584211494|FG004|Period 1|Did not meet inc/exc criteria|0|||
161772867|NCT01049360|584211495|FG005|Period 1|Did not meet inc/exc criteria|0|||
161772868|NCT01049360|584211496|FG006|Period 1|Did not meet inc/exc criteria|0|||
161772869|NCT01049360|584211497|FG007|Period 1|Did not meet inc/exc criteria|1|||
161772870|NCT01049360|584211498|FG008|Period 1|Did not meet inc/exc criteria|1|||
161772871|NCT01049360|584211499|FG009|Period 1|Did not meet inc/exc criteria|0|||
161772872|NCT01049360|584211500|FG010|Period 1|Did not meet inc/exc criteria|0|||
161772873|NCT01049360|584211501|FG011|Period 1|Did not meet inc/exc criteria|0|||
161772874|NCT01049360|584211502|FG012|Period 1|Did not meet inc/exc criteria|0|||
161772875|NCT01049360|584211503|FG013|Period 1|Did not meet inc/exc criteria|0|||
161772876|NCT01049360|584211504|FG014|Period 1|Did not meet inc/exc criteria|0|||
161772877|NCT01049360|584211505|FG015|Period 1|Did not meet inc/exc criteria|0|||
161772878|NCT01049360|584211506|FG016|Period 1|Did not meet inc/exc criteria|0|||
161772879|NCT01049360|584211507|FG017|Period 1|Did not meet inc/exc criteria|0|||
161772880|NCT01049360|584211508|FG018|Period 1|Did not meet inc/exc criteria|0|||
161772881|NCT01049360|584211509|FG019|Period 1|Did not meet inc/exc criteria|0|||
161772882|NCT01049360|584211490|FG000|Period 1|Withdrawal by Subject|0|||
161772883|NCT01049360|584211491|FG001|Period 1|Withdrawal by Subject|0|||
161772884|NCT01049360|584211492|FG002|Period 1|Withdrawal by Subject|0|||
161772885|NCT01049360|584211493|FG003|Period 1|Withdrawal by Subject|0|||
161772886|NCT01049360|584211494|FG004|Period 1|Withdrawal by Subject|0|||
161772887|NCT01049360|584211495|FG005|Period 1|Withdrawal by Subject|0|||
161772888|NCT01049360|584211496|FG006|Period 1|Withdrawal by Subject|0|||
161772889|NCT01049360|584211497|FG007|Period 1|Withdrawal by Subject|0|||
161772890|NCT01049360|584211498|FG008|Period 1|Withdrawal by Subject|1|||
161772891|NCT01049360|584211499|FG009|Period 1|Withdrawal by Subject|0|||
161772892|NCT01049360|584211500|FG010|Period 1|Withdrawal by Subject|1|||
161772893|NCT01049360|584211501|FG011|Period 1|Withdrawal by Subject|0|||
161772894|NCT01049360|584211502|FG012|Period 1|Withdrawal by Subject|1|||
161772895|NCT01049360|584211503|FG013|Period 1|Withdrawal by Subject|0|||
161772896|NCT01049360|584211504|FG014|Period 1|Withdrawal by Subject|0|||
161772897|NCT01049360|584211505|FG015|Period 1|Withdrawal by Subject|0|||
161772898|NCT01049360|584211506|FG016|Period 1|Withdrawal by Subject|0|||
161772899|NCT01049360|584211507|FG017|Period 1|Withdrawal by Subject|0|||
161772900|NCT01049360|584211508|FG018|Period 1|Withdrawal by Subject|0|||
161772901|NCT01049360|584211509|FG019|Period 1|Withdrawal by Subject|0|||
161772902|NCT01049360|584211490|FG000|Period 2|Protocol Violation|0|||
161862513|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
161862514|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862515|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862516|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862517|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862518|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
161862519|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862520|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862521|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862522|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862523|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
161862524|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862525|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862526|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862527|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862528|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
161862529|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862530|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862531|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862532|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862533|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161862534|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
161862535|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
161862536|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161862537|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161862538|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161862539|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
161862540|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
161862541|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161862542|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161862543|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161862544|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
161862545|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
161862546|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161862547|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161862548|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862549|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
161862550|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862551|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862552|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862553|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161862554|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
161862555|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
161862556|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161862557|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161862558|NCT01074944|584538065|FG000|Long Term Treatment|Adverse Event|0|||
161862559|NCT01074944|584538066|FG001|Long Term Treatment|Adverse Event|0|||
161862560|NCT01074944|584538067|FG002|Long Term Treatment|Adverse Event|0|||
161862561|NCT01074944|584538068|FG003|Long Term Treatment|Adverse Event|3|||
161862562|NCT01074944|584538069|FG004|Long Term Treatment|Adverse Event|0|||
161862563|NCT01074944|584538065|FG000|Long Term Treatment|Lost to Follow-up|0|||
161862564|NCT01074944|584538066|FG001|Long Term Treatment|Lost to Follow-up|0|||
161862565|NCT01074944|584538067|FG002|Long Term Treatment|Lost to Follow-up|0|||
161862566|NCT01074944|584538068|FG003|Long Term Treatment|Lost to Follow-up|2|||
161862567|NCT01074944|584538069|FG004|Long Term Treatment|Lost to Follow-up|0|||
161862568|NCT01074944|584538065|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862569|NCT01074944|584538066|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862570|NCT01074944|584538067|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862571|NCT01074944|584538068|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
161862572|NCT01074944|584538069|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862573|NCT01074944|584538065|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862574|NCT01074944|584538066|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862575|NCT01074944|584538067|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862576|NCT01074944|584538068|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
161862577|NCT01074944|584538069|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862578|NCT01074944|584538065|FG000|Long Term Treatment|Withdrawal by Subject|0|||
161862579|NCT01074944|584538066|FG001|Long Term Treatment|Withdrawal by Subject|0|||
161862580|NCT01074944|584538067|FG002|Long Term Treatment|Withdrawal by Subject|0|||
161862581|NCT01074944|584538068|FG003|Long Term Treatment|Withdrawal by Subject|2|||
161862582|NCT01074944|584538069|FG004|Long Term Treatment|Withdrawal by Subject|0|||
161862583|NCT01074944|584538065|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862584|NCT01074944|584538066|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862585|NCT01074944|584538067|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862586|NCT01074944|584538068|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862587|NCT01074944|584538069|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
161862588|NCT01074944|584538065|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862589|NCT01074944|584538066|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862590|NCT01074944|584538067|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862591|NCT01074944|584538068|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862592|NCT01074944|584538069|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
161862593|NCT03200717|584538075|FG000|Overall Study|Progressive disease|24|||
161862594|NCT03200717|584538076|FG001|Overall Study|Progressive disease|5|||
161862595|NCT03200717|584538075|FG000|Overall Study|Adverse Event|11|||
161862596|NCT03200717|584538076|FG001|Overall Study|Adverse Event|8|||
161862597|NCT03200717|584538075|FG000|Overall Study|Physician Decision|3|||
161862598|NCT03200717|584538076|FG001|Overall Study|Physician Decision|2|||
161862599|NCT03200717|584538075|FG000|Overall Study|Death|2|||
161862600|NCT03200717|584538076|FG001|Overall Study|Death|0|||
161862601|NCT03200717|584538075|FG000|Overall Study|Subject/Guardian Decision|1|||
161862602|NCT03200717|584538076|FG001|Overall Study|Subject/Guardian Decision|0|||
161862603|NCT01522456|584538077|FG000|Overall Study|Adverse Event|2|||
161862604|NCT01522456|584538077|FG000|Overall Study|Lost to Follow-up|2|||
161862605|NCT01522456|584538077|FG000|Overall Study|Withdrawal by Subject|2|||
161862606|NCT01522456|584538077|FG000|Overall Study|Pregnancy|1|||
161862607|NCT01522456|584538077|FG000|Overall Study|Tolerability Assessment|1|||
161862608|NCT02201784|584538078|FG000|Overall Study|Failure to achieve adequate block|2|||
161862609|NCT02201784|584538079|FG001|Overall Study|Failure to achieve adequate block|0|||
161862610|NCT02046603|584538080|FG000|Overall Study|Other|11|||
161862611|NCT02046603|584538081|FG001|Overall Study|Other|66|||
161862612|NCT02046603|584538080|FG000|Overall Study|Protocol Violation|0|||
161862613|NCT02046603|584538081|FG001|Overall Study|Protocol Violation|1|||
161862614|NCT02046603|584538080|FG000|Overall Study|Participant/legal guardian decision|1|||
161862615|NCT02046603|584538081|FG001|Overall Study|Participant/legal guardian decision|3|||
161862616|NCT02046603|584538080|FG000|Overall Study|Physician Decision|2|||
161862617|NCT02046603|584538081|FG001|Overall Study|Physician Decision|1|||
161862618|NCT02046603|584538080|FG000|Overall Study|Lost to Follow-up|1|||
161862619|NCT02046603|584538081|FG001|Overall Study|Lost to Follow-up|2|||
161862620|NCT02046603|584538080|FG000|Overall Study|Death|0|||
161862621|NCT02046603|584538081|FG001|Overall Study|Death|1|||
161862622|NCT02046603|584538080|FG000|Overall Study|Adverse Event|0|||
161862623|NCT02046603|584538081|FG001|Overall Study|Adverse Event|1|||
161862624|NCT02072980|584538082|FG000|Period 2, Second Wear|Adverse Event|0|||
161862625|NCT02072980|584538083|FG001|Period 2, Second Wear|Adverse Event|1|||
161862626|NCT02431364|584538084|FG000|Overall Study|Adverse Event|0|||
161862627|NCT02431364|584538085|FG001|Overall Study|Adverse Event|1|||
161862628|NCT02431364|584538086|FG002|Overall Study|Adverse Event|0|||
161862629|NCT02431364|584538087|FG003|Overall Study|Adverse Event|0|||
161862630|NCT02431364|584538088|FG004|Overall Study|Adverse Event|0|||
161862631|NCT02431364|584538084|FG000|Overall Study|Randomized but never treated|0|||
161862632|NCT02431364|584538085|FG001|Overall Study|Randomized but never treated|0|||
161862633|NCT02431364|584538086|FG002|Overall Study|Randomized but never treated|0|||
161862634|NCT02431364|584538087|FG003|Overall Study|Randomized but never treated|1|||
161862635|NCT02431364|584538088|FG004|Overall Study|Randomized but never treated|0|||
161862636|NCT00061932|584538089|FG000|Overall Study|Withdrawal by Subject|13|||
161862637|NCT00061932|584538090|FG001|Overall Study|Withdrawal by Subject|4|||
161862638|NCT04720105|584538093|FG000|Overall Study|Lack of Efficacy|1|||
161862639|NCT04720105|584538093|FG000|Overall Study|Lost to Follow-up|1|||
161862640|NCT04720105|584538093|FG000|Overall Study|Withdrawal by Subject|3|||
161862641|NCT00625820|584538095|FG000|Overall Study|Withdrawal by Subject|1|||
161862642|NCT02141438|584540183|FG000|Overall Study|Death|1308|||
161862643|NCT02141438|584540183|FG000|Overall Study|Lost to Follow-up|84|||
161862644|NCT02141438|584540183|FG000|Overall Study|Withdrawal by Subject|52|||
161862645|NCT02141438|584540183|FG000|Overall Study|Physician Decision|1|||
161862646|NCT02141438|584540183|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
161862647|NCT02546986|584540186|FG000|Treatment Period|Progressive Disease|20|||
161772903|NCT01049360|584211491|FG001|Period 2|Protocol Violation|0|||
161772904|NCT01049360|584211492|FG002|Period 2|Protocol Violation|0|||
161772905|NCT01049360|584211493|FG003|Period 2|Protocol Violation|1|||
161772906|NCT01049360|584211494|FG004|Period 2|Protocol Violation|0|||
161772907|NCT01049360|584211495|FG005|Period 2|Protocol Violation|0|||
161772908|NCT01049360|584211496|FG006|Period 2|Protocol Violation|0|||
161772909|NCT01049360|584211497|FG007|Period 2|Protocol Violation|0|||
161772910|NCT01049360|584211498|FG008|Period 2|Protocol Violation|0|||
161772911|NCT01049360|584211499|FG009|Period 2|Protocol Violation|0|||
161772912|NCT01049360|584211500|FG010|Period 2|Protocol Violation|0|||
161772913|NCT01049360|584211501|FG011|Period 2|Protocol Violation|0|||
161772914|NCT01049360|584211502|FG012|Period 2|Protocol Violation|0|||
161772915|NCT01049360|584211503|FG013|Period 2|Protocol Violation|0|||
161772916|NCT01049360|584211504|FG014|Period 2|Protocol Violation|1|||
161772917|NCT01049360|584211505|FG015|Period 2|Protocol Violation|1|||
161772918|NCT01049360|584211506|FG016|Period 2|Protocol Violation|0|||
161772919|NCT01049360|584211507|FG017|Period 2|Protocol Violation|0|||
161772920|NCT01049360|584211508|FG018|Period 2|Protocol Violation|0|||
161772921|NCT01049360|584211509|FG019|Period 2|Protocol Violation|0|||
161772922|NCT01049360|584211490|FG000|Period 2|Adverse Event|0|||
161772923|NCT01049360|584211491|FG001|Period 2|Adverse Event|1|||
161772924|NCT01049360|584211492|FG002|Period 2|Adverse Event|0|||
161772925|NCT01049360|584211493|FG003|Period 2|Adverse Event|0|||
161772926|NCT01049360|584211494|FG004|Period 2|Adverse Event|0|||
161772927|NCT01049360|584211495|FG005|Period 2|Adverse Event|0|||
161772928|NCT01049360|584211496|FG006|Period 2|Adverse Event|0|||
161772929|NCT01049360|584211497|FG007|Period 2|Adverse Event|0|||
161772930|NCT01049360|584211498|FG008|Period 2|Adverse Event|1|||
161772931|NCT01049360|584211499|FG009|Period 2|Adverse Event|0|||
161772932|NCT01049360|584211500|FG010|Period 2|Adverse Event|0|||
161772933|NCT01049360|584211501|FG011|Period 2|Adverse Event|0|||
161772934|NCT01049360|584211502|FG012|Period 2|Adverse Event|0|||
161772935|NCT01049360|584211503|FG013|Period 2|Adverse Event|0|||
161772936|NCT01049360|584211504|FG014|Period 2|Adverse Event|0|||
161772937|NCT01049360|584211505|FG015|Period 2|Adverse Event|0|||
161772938|NCT01049360|584211506|FG016|Period 2|Adverse Event|0|||
161772939|NCT01049360|584211507|FG017|Period 2|Adverse Event|0|||
161772940|NCT01049360|584211508|FG018|Period 2|Adverse Event|0|||
161772941|NCT01049360|584211509|FG019|Period 2|Adverse Event|1|||
161772942|NCT01049360|584211490|FG000|Period 2|Withdrawal by Subject|0|||
161772943|NCT01049360|584211491|FG001|Period 2|Withdrawal by Subject|0|||
161772944|NCT01049360|584211492|FG002|Period 2|Withdrawal by Subject|0|||
161772945|NCT01049360|584211493|FG003|Period 2|Withdrawal by Subject|1|||
161772946|NCT01049360|584211494|FG004|Period 2|Withdrawal by Subject|0|||
161772947|NCT01049360|584211495|FG005|Period 2|Withdrawal by Subject|0|||
161772948|NCT01049360|584211496|FG006|Period 2|Withdrawal by Subject|0|||
161772949|NCT01049360|584211497|FG007|Period 2|Withdrawal by Subject|0|||
161772950|NCT01049360|584211498|FG008|Period 2|Withdrawal by Subject|0|||
161772951|NCT01049360|584211499|FG009|Period 2|Withdrawal by Subject|0|||
161772952|NCT01049360|584211500|FG010|Period 2|Withdrawal by Subject|0|||
161772953|NCT01049360|584211501|FG011|Period 2|Withdrawal by Subject|0|||
161772954|NCT01049360|584211502|FG012|Period 2|Withdrawal by Subject|0|||
161772955|NCT01049360|584211503|FG013|Period 2|Withdrawal by Subject|0|||
161772956|NCT01049360|584211504|FG014|Period 2|Withdrawal by Subject|1|||
161772957|NCT01049360|584211505|FG015|Period 2|Withdrawal by Subject|0|||
161772958|NCT01049360|584211506|FG016|Period 2|Withdrawal by Subject|0|||
161772959|NCT01049360|584211507|FG017|Period 2|Withdrawal by Subject|0|||
161772960|NCT01049360|584211508|FG018|Period 2|Withdrawal by Subject|0|||
161772961|NCT01049360|584211509|FG019|Period 2|Withdrawal by Subject|1|||
161772962|NCT01049360|584211490|FG000|Period 2|Lack of Efficacy|0|||
161772963|NCT01049360|584211491|FG001|Period 2|Lack of Efficacy|0|||
161772964|NCT01049360|584211492|FG002|Period 2|Lack of Efficacy|0|||
161772965|NCT01049360|584211493|FG003|Period 2|Lack of Efficacy|0|||
161772966|NCT01049360|584211494|FG004|Period 2|Lack of Efficacy|0|||
161772967|NCT01049360|584211495|FG005|Period 2|Lack of Efficacy|1|||
161772968|NCT01049360|584211496|FG006|Period 2|Lack of Efficacy|0|||
161772969|NCT01049360|584211497|FG007|Period 2|Lack of Efficacy|0|||
161772970|NCT01049360|584211498|FG008|Period 2|Lack of Efficacy|0|||
161772971|NCT01049360|584211499|FG009|Period 2|Lack of Efficacy|0|||
161862648|NCT02546986|584540187|FG001|Treatment Period|Progressive Disease|22|||
161862649|NCT02546986|584540186|FG000|Treatment Period|Adverse Event|14|||
161772972|NCT01049360|584211500|FG010|Period 2|Lack of Efficacy|0|||
161772973|NCT01049360|584211501|FG011|Period 2|Lack of Efficacy|0|||
161772974|NCT01049360|584211502|FG012|Period 2|Lack of Efficacy|0|||
161772975|NCT01049360|584211503|FG013|Period 2|Lack of Efficacy|0|||
161772976|NCT01049360|584211504|FG014|Period 2|Lack of Efficacy|0|||
161772977|NCT01049360|584211505|FG015|Period 2|Lack of Efficacy|0|||
161772978|NCT01049360|584211506|FG016|Period 2|Lack of Efficacy|0|||
161772979|NCT01049360|584211507|FG017|Period 2|Lack of Efficacy|0|||
161772980|NCT01049360|584211508|FG018|Period 2|Lack of Efficacy|0|||
161772981|NCT01049360|584211509|FG019|Period 2|Lack of Efficacy|0|||
161772982|NCT01049360|584211490|FG000|Period 4|Protocol Violation|0|||
161772983|NCT01049360|584211491|FG001|Period 4|Protocol Violation|0|||
161772984|NCT01049360|584211492|FG002|Period 4|Protocol Violation|0|||
161862650|NCT02546986|584540187|FG001|Treatment Period|Adverse Event|6|||
161862651|NCT02546986|584540186|FG000|Treatment Period|Symptomatic Deterioration|4|||
161862652|NCT02546986|584540187|FG001|Treatment Period|Symptomatic Deterioration|3|||
161862653|NCT02546986|584540186|FG000|Treatment Period|Death|3|||
161862654|NCT02546986|584540187|FG001|Treatment Period|Death|4|||
161862655|NCT02546986|584540186|FG000|Treatment Period|Physician Decision|1|||
161862656|NCT02546986|584540187|FG001|Treatment Period|Physician Decision|2|||
161862657|NCT02546986|584540186|FG000|Treatment Period|Protocol Violation|1|||
161862658|NCT02546986|584540187|FG001|Treatment Period|Protocol Violation|0|||
161862659|NCT02546986|584540186|FG000|Treatment Period|Withdrawal by Subject|1|||
161862660|NCT02546986|584540187|FG001|Treatment Period|Withdrawal by Subject|1|||
161862661|NCT02546986|584540186|FG000|Treatment Period|Non-compliance with Study Drug|0|||
161862662|NCT02546986|584540187|FG001|Treatment Period|Non-compliance with Study Drug|1|||
161862663|NCT02546986|584540186|FG000|Treatment Period|Study Terminated by Sponsor|0|||
161862664|NCT02546986|584540187|FG001|Treatment Period|Study Terminated by Sponsor|1|||
161862665|NCT02546986|584540186|FG000|Treatment Period|Miscellaneous|7|||
161862666|NCT02546986|584540187|FG001|Treatment Period|Miscellaneous|9|||
161862667|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Missing Status|3|||
161862668|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Missing Status|5|||
161862669|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Death|18|||
161862670|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Death|12|||
161862671|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Alive|13|||
161862672|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Alive|16|||
161862673|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
161862674|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
161862675|NCT04021914|584540190|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
161862676|NCT02844543|584540194|FG000|Overall Study|Withdrawal by Subject|4|||
161862677|NCT02844543|584540194|FG000|Overall Study|Did not meet eligibility criteria|1|||
161862678|NCT03349060|584540195|FG000|Overall Study|Adverse Event|9|||
161862679|NCT03349060|584540196|FG001|Overall Study|Adverse Event|9|||
161862680|NCT03349060|584540197|FG002|Overall Study|Adverse Event|7|||
161862681|NCT03349060|584540195|FG000|Overall Study|Lack of Efficacy|1|||
161862682|NCT03349060|584540196|FG001|Overall Study|Lack of Efficacy|0|||
161862683|NCT03349060|584540197|FG002|Overall Study|Lack of Efficacy|2|||
161862684|NCT03349060|584540195|FG000|Overall Study|Lost to Follow-up|2|||
161862685|NCT03349060|584540196|FG001|Overall Study|Lost to Follow-up|1|||
161862686|NCT03349060|584540197|FG002|Overall Study|Lost to Follow-up|1|||
161862687|NCT03349060|584540195|FG000|Overall Study|Protocol Violation|2|||
161862688|NCT03349060|584540196|FG001|Overall Study|Protocol Violation|2|||
161862689|NCT03349060|584540197|FG002|Overall Study|Protocol Violation|1|||
161862690|NCT03349060|584540195|FG000|Overall Study|Withdrawal by Subject|5|||
161862691|NCT03349060|584540196|FG001|Overall Study|Withdrawal by Subject|3|||
161862692|NCT03349060|584540197|FG002|Overall Study|Withdrawal by Subject|4|||
161862693|NCT03349060|584540195|FG000|Overall Study|Medication error,no linked adverse event|0|||
161862694|NCT03349060|584540196|FG001|Overall Study|Medication error,no linked adverse event|0|||
161862695|NCT03349060|584540197|FG002|Overall Study|Medication error,no linked adverse event|1|||
161862696|NCT03349060|584540195|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161862697|NCT03349060|584540196|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
161862698|NCT03349060|584540197|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
161862699|NCT03349060|584540195|FG000|Overall Study|Other|2|||
161862700|NCT03349060|584540196|FG001|Overall Study|Other|1|||
161862701|NCT03349060|584540197|FG002|Overall Study|Other|0|||
161862702|NCT02861586|584540198|FG000|Overall Study|Withdrawal by Subject|1|||
161862703|NCT02861586|584540199|FG001|Overall Study|Withdrawal by Subject|2|||
161862704|NCT02861586|584540200|FG002|Overall Study|Withdrawal by Subject|0|||
161862705|NCT02861586|584540201|FG003|Overall Study|Withdrawal by Subject|0|||
161862706|NCT02861586|584540202|FG004|Overall Study|Withdrawal by Subject|0|||
161862707|NCT02861586|584540203|FG005|Overall Study|Withdrawal by Subject|1|||
161862708|NCT02861586|584540204|FG006|Overall Study|Withdrawal by Subject|1|||
161862709|NCT02861586|584540205|FG007|Overall Study|Withdrawal by Subject|0|||
161862710|NCT02861586|584540198|FG000|Overall Study|Lost to Follow-up|3|||
161862711|NCT02861586|584540199|FG001|Overall Study|Lost to Follow-up|1|||
161862712|NCT02861586|584540200|FG002|Overall Study|Lost to Follow-up|1|||
161862713|NCT02861586|584540201|FG003|Overall Study|Lost to Follow-up|0|||
161862714|NCT02861586|584540202|FG004|Overall Study|Lost to Follow-up|0|||
161862715|NCT02861586|584540203|FG005|Overall Study|Lost to Follow-up|3|||
161862716|NCT02861586|584540204|FG006|Overall Study|Lost to Follow-up|0|||
161862717|NCT02861586|584540205|FG007|Overall Study|Lost to Follow-up|0|||
161862718|NCT02861586|584540198|FG000|Overall Study|Adverse Event|0|||
161862719|NCT02861586|584540199|FG001|Overall Study|Adverse Event|0|||
161862720|NCT02861586|584540200|FG002|Overall Study|Adverse Event|0|||
161862721|NCT02861586|584540201|FG003|Overall Study|Adverse Event|0|||
161862722|NCT02861586|584540202|FG004|Overall Study|Adverse Event|0|||
161862723|NCT02861586|584540203|FG005|Overall Study|Adverse Event|1|||
161862724|NCT02861586|584540204|FG006|Overall Study|Adverse Event|0|||
161862725|NCT02861586|584540205|FG007|Overall Study|Adverse Event|0|||
161862726|NCT00803790|584540206|FG000|Period 1|Adverse Event|0|||
161772985|NCT01049360|584211493|FG003|Period 4|Protocol Violation|0|||
161772986|NCT01049360|584211494|FG004|Period 4|Protocol Violation|0|||
161772987|NCT01049360|584211495|FG005|Period 4|Protocol Violation|0|||
161772988|NCT01049360|584211496|FG006|Period 4|Protocol Violation|0|||
161772989|NCT01049360|584211497|FG007|Period 4|Protocol Violation|0|||
161772990|NCT01049360|584211498|FG008|Period 4|Protocol Violation|0|||
161772991|NCT01049360|584211499|FG009|Period 4|Protocol Violation|0|||
161772992|NCT01049360|584211500|FG010|Period 4|Protocol Violation|0|||
161772993|NCT01049360|584211501|FG011|Period 4|Protocol Violation|0|||
161772994|NCT01049360|584211502|FG012|Period 4|Protocol Violation|0|||
161772995|NCT01049360|584211503|FG013|Period 4|Protocol Violation|0|||
161772996|NCT01049360|584211504|FG014|Period 4|Protocol Violation|0|||
161772997|NCT01049360|584211505|FG015|Period 4|Protocol Violation|0|||
161772998|NCT01049360|584211506|FG016|Period 4|Protocol Violation|0|||
161772999|NCT01049360|584211507|FG017|Period 4|Protocol Violation|1|||
161773000|NCT01049360|584211508|FG018|Period 4|Protocol Violation|0|||
161773001|NCT01049360|584211509|FG019|Period 4|Protocol Violation|0|||
161773002|NCT01049360|584211490|FG000|Period 4|Withdrawal by Subject|0|||
161773003|NCT01049360|584211491|FG001|Period 4|Withdrawal by Subject|0|||
161773004|NCT01049360|584211492|FG002|Period 4|Withdrawal by Subject|0|||
161773005|NCT01049360|584211493|FG003|Period 4|Withdrawal by Subject|1|||
161773006|NCT01049360|584211494|FG004|Period 4|Withdrawal by Subject|0|||
161773007|NCT01049360|584211495|FG005|Period 4|Withdrawal by Subject|0|||
161773008|NCT01049360|584211496|FG006|Period 4|Withdrawal by Subject|0|||
161773009|NCT01049360|584211497|FG007|Period 4|Withdrawal by Subject|0|||
161773010|NCT01049360|584211498|FG008|Period 4|Withdrawal by Subject|0|||
161773011|NCT01049360|584211499|FG009|Period 4|Withdrawal by Subject|0|||
161773012|NCT01049360|584211500|FG010|Period 4|Withdrawal by Subject|0|||
161773013|NCT01049360|584211501|FG011|Period 4|Withdrawal by Subject|0|||
161773014|NCT01049360|584211502|FG012|Period 4|Withdrawal by Subject|0|||
161773015|NCT01049360|584211503|FG013|Period 4|Withdrawal by Subject|0|||
161773016|NCT01049360|584211504|FG014|Period 4|Withdrawal by Subject|0|||
161773017|NCT01049360|584211505|FG015|Period 4|Withdrawal by Subject|0|||
161773018|NCT01049360|584211506|FG016|Period 4|Withdrawal by Subject|0|||
161773019|NCT01049360|584211507|FG017|Period 4|Withdrawal by Subject|0|||
161773020|NCT01049360|584211508|FG018|Period 4|Withdrawal by Subject|0|||
161773021|NCT01049360|584211509|FG019|Period 4|Withdrawal by Subject|0|||
161773022|NCT05147311|584211512|FG000|Overall Study|Did not complete survey|2|||
161773023|NCT05147311|584211513|FG001|Overall Study|Did not complete survey|1|||
161773024|NCT05147311|584211512|FG000|Overall Study|Patient too sick|1|||
161773025|NCT05147311|584211513|FG001|Overall Study|Patient too sick|2|||
161773026|NCT05147311|584211512|FG000|Overall Study|Death|0|||
161773027|NCT05147311|584211513|FG001|Overall Study|Death|1|||
161773028|NCT05147311|584211512|FG000|Overall Study|Declined survey|1|||
161773029|NCT05147311|584211513|FG001|Overall Study|Declined survey|0|||
161773030|NCT00402298|584211529|FG000|Overall Study|Withdrawal by Subject|1|||
161773031|NCT00402298|584211530|FG001|Overall Study|Withdrawal by Subject|0|||
161773032|NCT00480077|584211531|FG000|Overall Study|Death|19|||
161773033|NCT00480077|584211532|FG001|Overall Study|Death|15|||
161773034|NCT00480077|584211531|FG000|Overall Study|early exit|12|||
161773035|NCT00480077|584211532|FG001|Overall Study|early exit|11|||
161773036|NCT00262119|584211535|FG000|Overall Study|Lost to Follow-up|38|||
161773037|NCT00262119|584211536|FG001|Overall Study|Lost to Follow-up|51|||
161773038|NCT00262119|584211537|FG002|Overall Study|Lost to Follow-up|42|||
161773039|NCT00262119|584211535|FG000|Overall Study|Death|20|||
161773040|NCT00262119|584211536|FG001|Overall Study|Death|19|||
161773041|NCT00262119|584211537|FG002|Overall Study|Death|16|||
161773042|NCT00071006|584211538|FG000|Overall Study|Lack of Efficacy|7|||
161773043|NCT00071006|584211538|FG000|Overall Study|Adverse Event|1|||
161773044|NCT00071006|584211538|FG000|Overall Study|Withdrawal by Subject|1|||
161773045|NCT00071006|584211538|FG000|Overall Study|Other|3|||
161773046|NCT00938366|584211540|FG000|Overall Study|Withdrawal by Subject|1|||
161773047|NCT00938366|584211541|FG001|Overall Study|Withdrawal by Subject|0|||
161773048|NCT01215968|584211542|FG000|Overall Study|Adverse Event|0|||
161773049|NCT01215968|584211543|FG001|Overall Study|Adverse Event|2|||
161773050|NCT01215968|584211542|FG000|Overall Study|Protocol Violation|2|||
161773051|NCT01215968|584211543|FG001|Overall Study|Protocol Violation|4|||
161773052|NCT01215968|584211542|FG000|Overall Study|Not received study drug|0|||
161773053|NCT01215968|584211543|FG001|Overall Study|Not received study drug|1|||
161773054|NCT05966129|584211544|FG000|Overall Study|Death|1|||
161773055|NCT05966129|584211545|FG001|Overall Study|Death|2|||
161773056|NCT05966129|584211544|FG000|Overall Study|Lost to Follow-up|63|||
161773057|NCT05966129|584211545|FG001|Overall Study|Lost to Follow-up|66|||
161773058|NCT05966129|584211544|FG000|Overall Study|Protocol Violation|1|||
161773059|NCT05966129|584211545|FG001|Overall Study|Protocol Violation|0|||
161773060|NCT05966129|584211544|FG000|Overall Study|Withdrawal by Subject|26|||
161773061|NCT05966129|584211545|FG001|Overall Study|Withdrawal by Subject|25|||
161773062|NCT05966129|584211544|FG000|Overall Study|Surgery not completed|63|||
161773063|NCT05966129|584211545|FG001|Overall Study|Surgery not completed|69|||
161862727|NCT00803790|584540207|FG001|Period 1|Adverse Event|1|||
161862728|NCT00803790|584540208|FG002|Period 1|Adverse Event|0|||
161862729|NCT00803790|584540209|FG003|Period 1|Adverse Event|0|||
161862730|NCT00803790|584540206|FG000|Period 1|Lost to Follow-up|1|||
161862731|NCT00803790|584540207|FG001|Period 1|Lost to Follow-up|2|||
161862732|NCT00803790|584540208|FG002|Period 1|Lost to Follow-up|0|||
161862733|NCT00803790|584540209|FG003|Period 1|Lost to Follow-up|0|||
161862734|NCT00803790|584540206|FG000|Period 1|Withdrawal by Subject|8|||
161862735|NCT00803790|584540207|FG001|Period 1|Withdrawal by Subject|6|||
161862736|NCT00803790|584540208|FG002|Period 1|Withdrawal by Subject|0|||
161862737|NCT00803790|584540209|FG003|Period 1|Withdrawal by Subject|0|||
161862738|NCT00803790|584540206|FG000|Period 1|positive drug screen or personal reasons|0|||
161862739|NCT00803790|584540207|FG001|Period 1|positive drug screen or personal reasons|3|||
161862740|NCT00803790|584540208|FG002|Period 1|positive drug screen or personal reasons|0|||
161862741|NCT00803790|584540209|FG003|Period 1|positive drug screen or personal reasons|4|||
161862742|NCT00803790|584540206|FG000|Period 1|Protocol Violation|0|||
161862743|NCT00803790|584540207|FG001|Period 1|Protocol Violation|0|||
161862744|NCT00803790|584540208|FG002|Period 1|Protocol Violation|1|||
161862745|NCT00803790|584540209|FG003|Period 1|Protocol Violation|0|||
161862746|NCT00803790|584540206|FG000|Period 2|Adverse Event|0|||
161862747|NCT00803790|584540207|FG001|Period 2|Adverse Event|0|||
161862748|NCT00803790|584540208|FG002|Period 2|Adverse Event|1|||
161862749|NCT00803790|584540209|FG003|Period 2|Adverse Event|1|||
161862750|NCT00803790|584540206|FG000|Period 2|Withdrawal by Subject|1|||
161862751|NCT00803790|584540207|FG001|Period 2|Withdrawal by Subject|0|||
161862752|NCT00803790|584540208|FG002|Period 2|Withdrawal by Subject|0|||
161862753|NCT00803790|584540209|FG003|Period 2|Withdrawal by Subject|0|||
161862754|NCT00803790|584540206|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
161862755|NCT00803790|584540207|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
161862756|NCT00803790|584540208|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
161862757|NCT00803790|584540209|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
161862758|NCT04710576|584540210|FG000|Overall Study|Participants still in the study|73|||
161862759|NCT04710576|584540211|FG001|Overall Study|Participants still in the study|70|||
161862760|NCT04710576|584540212|FG002|Overall Study|Participants still in the study|60|||
161862761|NCT04710576|584540210|FG000|Overall Study|Death|2|||
161862762|NCT04710576|584540211|FG001|Overall Study|Death|7|||
161862763|NCT04710576|584540212|FG002|Overall Study|Death|12|||
161862764|NCT04710576|584540210|FG000|Overall Study|Withdrawal by Subject|4|||
161862765|NCT04710576|584540211|FG001|Overall Study|Withdrawal by Subject|3|||
161862766|NCT04710576|584540212|FG002|Overall Study|Withdrawal by Subject|7|||
161862767|NCT04710576|584540210|FG000|Overall Study|Sponsor decision|1|||
161862768|NCT04710576|584540211|FG001|Overall Study|Sponsor decision|0|||
161862769|NCT04710576|584540212|FG002|Overall Study|Sponsor decision|0|||
161862770|NCT04796909|584540213|FG000|Overall Study|Withdrawal by Subject|1|||
161862771|NCT04796909|584540214|FG001|Overall Study|Withdrawal by Subject|1|||
161862772|NCT00437021|584540215|FG000|Overall Study|Adverse Event|0|||
161862773|NCT00437021|584540216|FG001|Overall Study|Adverse Event|0|||
161862774|NCT00437021|584540217|FG002|Overall Study|Adverse Event|0|||
161862775|NCT00437021|584540218|FG003|Overall Study|Adverse Event|0|||
161862776|NCT00437021|584540219|FG004|Overall Study|Adverse Event|0|||
161862777|NCT00437021|584540220|FG005|Overall Study|Adverse Event|0|||
161862778|NCT00437021|584540221|FG006|Overall Study|Adverse Event|1|||
161862779|NCT00437021|584540222|FG007|Overall Study|Adverse Event|0|||
161862780|NCT00437021|584540223|FG008|Overall Study|Adverse Event|0|||
161862781|NCT00437021|584540224|FG009|Overall Study|Adverse Event|0|||
161862782|NCT00437021|584540225|FG010|Overall Study|Adverse Event|0|||
161862783|NCT00437021|584540226|FG011|Overall Study|Adverse Event|0|||
161862784|NCT00437021|584540215|FG000|Overall Study|Lost to Follow-up|0|||
161862785|NCT00437021|584540216|FG001|Overall Study|Lost to Follow-up|3|||
161862786|NCT00437021|584540217|FG002|Overall Study|Lost to Follow-up|0|||
161862787|NCT00437021|584540218|FG003|Overall Study|Lost to Follow-up|0|||
161862788|NCT00437021|584540219|FG004|Overall Study|Lost to Follow-up|0|||
161862789|NCT00437021|584540220|FG005|Overall Study|Lost to Follow-up|2|||
161862790|NCT00437021|584540221|FG006|Overall Study|Lost to Follow-up|0|||
161862791|NCT00437021|584540222|FG007|Overall Study|Lost to Follow-up|1|||
161862792|NCT00437021|584540223|FG008|Overall Study|Lost to Follow-up|0|||
161862793|NCT00437021|584540224|FG009|Overall Study|Lost to Follow-up|0|||
161862794|NCT00437021|584540225|FG010|Overall Study|Lost to Follow-up|0|||
161862795|NCT00437021|584540226|FG011|Overall Study|Lost to Follow-up|0|||
161862796|NCT00437021|584540215|FG000|Overall Study|Withdrawal by Subject|2|||
161862797|NCT00437021|584540216|FG001|Overall Study|Withdrawal by Subject|1|||
161862798|NCT00437021|584540217|FG002|Overall Study|Withdrawal by Subject|0|||
161862799|NCT00437021|584540218|FG003|Overall Study|Withdrawal by Subject|0|||
161862800|NCT00437021|584540219|FG004|Overall Study|Withdrawal by Subject|0|||
161862801|NCT00437021|584540220|FG005|Overall Study|Withdrawal by Subject|0|||
161862802|NCT00437021|584540221|FG006|Overall Study|Withdrawal by Subject|0|||
161862803|NCT00437021|584540222|FG007|Overall Study|Withdrawal by Subject|0|||
161862804|NCT00437021|584540223|FG008|Overall Study|Withdrawal by Subject|0|||
161862805|NCT00437021|584540224|FG009|Overall Study|Withdrawal by Subject|0|||
161862806|NCT00437021|584540225|FG010|Overall Study|Withdrawal by Subject|0|||
161862807|NCT00437021|584540226|FG011|Overall Study|Withdrawal by Subject|0|||
161862808|NCT04162847|584540227|FG000|Overall Study|Withdrawal by Subject|7|||
161862809|NCT04162847|584540228|FG001|Overall Study|Withdrawal by Subject|1|||
161862810|NCT03985800|584540229|FG000|Overall Study|Death|1|||
161862811|NCT03985800|584540230|FG001|Overall Study|Death|2|||
161862812|NCT03985800|584540229|FG000|Overall Study|Withdrawal by Subject|3|||
161862813|NCT03985800|584540230|FG001|Overall Study|Withdrawal by Subject|6|||
161862814|NCT03985800|584540229|FG000|Overall Study|Protocol Violation|2|||
161862815|NCT03985800|584540230|FG001|Overall Study|Protocol Violation|0|||
161862816|NCT05258773|584540231|FG000|Overall Study|Screen Failure|1|||
161862817|NCT05258773|584540232|FG001|Overall Study|Screen Failure|1|||
161862818|NCT05258773|584540231|FG000|Overall Study|Adverse Event|1|||
161862819|NCT05258773|584540232|FG001|Overall Study|Adverse Event|0|||
161862820|NCT05258773|584540231|FG000|Overall Study|Withdrawal by Subject|0|||
161862821|NCT05258773|584540232|FG001|Overall Study|Withdrawal by Subject|1|||
161862822|NCT03018288|584540235|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
161862823|NCT03018288|584540236|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
161862824|NCT03018288|584540237|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
161862825|NCT03018288|584540238|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
161862826|NCT03018288|584540235|FG000|Overall Study|Participant withdrew consent.|0|||
161862827|NCT03018288|584540236|FG001|Overall Study|Participant withdrew consent.|0|||
161862828|NCT03018288|584540237|FG002|Overall Study|Participant withdrew consent.|1|||
161862829|NCT03018288|584540238|FG003|Overall Study|Participant withdrew consent.|0|||
161862830|NCT03018288|584540235|FG000|Overall Study|Switched to alternative treatment.|0|||
161862831|NCT03018288|584540236|FG001|Overall Study|Switched to alternative treatment.|0|||
161862832|NCT03018288|584540237|FG002|Overall Study|Switched to alternative treatment.|1|||
161862833|NCT03018288|584540238|FG003|Overall Study|Switched to alternative treatment.|0|||
161862834|NCT03018288|584540235|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
161862835|NCT03018288|584540236|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
161862836|NCT03018288|584540237|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
161862837|NCT03018288|584540238|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
161862838|NCT03018288|584540235|FG000|Overall Study|Screen failures|0|||
161862839|NCT03018288|584540236|FG001|Overall Study|Screen failures|0|||
161862840|NCT03018288|584540237|FG002|Overall Study|Screen failures|0|||
161862841|NCT03018288|584540238|FG003|Overall Study|Screen failures|51|||
161862842|NCT03018288|584540235|FG000|Overall Study|Chose treatment outside of UNC|0|||
161862843|NCT03018288|584540236|FG001|Overall Study|Chose treatment outside of UNC|0|||
161862844|NCT03018288|584540237|FG002|Overall Study|Chose treatment outside of UNC|0|||
161862845|NCT03018288|584540238|FG003|Overall Study|Chose treatment outside of UNC|1|||
161862846|NCT03018288|584540235|FG000|Overall Study|Unable to comply with protocol requirements|1|||
161862847|NCT03018288|584540236|FG001|Overall Study|Unable to comply with protocol requirements|1|||
161862848|NCT03018288|584540237|FG002|Overall Study|Unable to comply with protocol requirements|0|||
161862849|NCT03018288|584540238|FG003|Overall Study|Unable to comply with protocol requirements|1|||
161862850|NCT03018288|584540235|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161862851|NCT03018288|584540236|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
161862852|NCT03018288|584540237|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
161862853|NCT03018288|584540238|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
161862854|NCT03018288|584540235|FG000|Overall Study|Physician Decision|0|||
161862855|NCT03018288|584540236|FG001|Overall Study|Physician Decision|0|||
161862856|NCT03018288|584540237|FG002|Overall Study|Physician Decision|0|||
161862857|NCT03018288|584540238|FG003|Overall Study|Physician Decision|1|||
161862858|NCT05573464|584540239|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
161862859|NCT05573464|584540240|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
161862860|NCT05573464|584540239|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
161862861|NCT05573464|584540240|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
161862862|NCT05573464|584540239|FG000|12-week Treatment Period|Protocol Violation|3|||
161862863|NCT05573464|584540240|FG001|12-week Treatment Period|Protocol Violation|1|||
161862864|NCT05573464|584540239|FG000|12-week Treatment Period|Physician Decision|1|||
161862865|NCT05573464|584540240|FG001|12-week Treatment Period|Physician Decision|2|||
161862866|NCT05573464|584540239|FG000|12-week Treatment Period|Lost to Follow-up|2|||
161862867|NCT05573464|584540240|FG001|12-week Treatment Period|Lost to Follow-up|0|||
161862868|NCT05573464|584540239|FG000|12-week Treatment Period|Adverse Event|20|||
161862869|NCT05573464|584540240|FG001|12-week Treatment Period|Adverse Event|9|||
161862870|NCT05573464|584540239|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
161862871|NCT05573464|584540240|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
161862872|NCT05573464|584540239|FG000|12-week Treatment Period|Randomised, not treated|0|||
161773064|NCT05966129|584211544|FG000|Overall Study|Surgery logistics issue|2|||
161773065|NCT05966129|584211545|FG001|Overall Study|Surgery logistics issue|1|||
161773066|NCT05182840|584211546|FG000|Run-in Period|Not treated|0|||
161773067|NCT05182840|584211547|FG001|Run-in Period|Not treated|1|||
161773068|NCT05182840|584211548|FG002|Run-in Period|Not treated|0|||
161773069|NCT05182840|584211549|FG003|Run-in Period|Not treated|0|||
161773070|NCT05182840|584211550|FG004|Run-in Period|Not treated|0|||
161773071|NCT05182840|584211551|FG005|Run-in Period|Not treated|0|||
161773072|NCT05182840|584211552|FG006|Run-in Period|Not treated|0|||
161773073|NCT05182840|584211553|FG007|Run-in Period|Not treated|0|||
161773074|NCT05182840|584211554|FG008|Run-in Period|Not treated|0|||
161773075|NCT05182840|584211555|FG009|Run-in Period|Not treated|0|||
161773076|NCT05182840|584211546|FG000|Run-in Period|Other reason but not sponsor termination|14|||
161773077|NCT05182840|584211547|FG001|Run-in Period|Other reason but not sponsor termination|18|||
161773078|NCT05182840|584211548|FG002|Run-in Period|Other reason but not sponsor termination|0|||
161773079|NCT05182840|584211549|FG003|Run-in Period|Other reason but not sponsor termination|0|||
161773080|NCT05182840|584211550|FG004|Run-in Period|Other reason but not sponsor termination|0|||
161773081|NCT05182840|584211551|FG005|Run-in Period|Other reason but not sponsor termination|0|||
161773082|NCT05182840|584211552|FG006|Run-in Period|Other reason but not sponsor termination|0|||
161773083|NCT05182840|584211553|FG007|Run-in Period|Other reason but not sponsor termination|0|||
161773084|NCT05182840|584211554|FG008|Run-in Period|Other reason but not sponsor termination|0|||
161773085|NCT05182840|584211555|FG009|Run-in Period|Other reason but not sponsor termination|0|||
161773086|NCT05182840|584211546|FG000|Run-in Period|No reason available|2|||
161773087|NCT05182840|584211547|FG001|Run-in Period|No reason available|2|||
161773088|NCT05182840|584211548|FG002|Run-in Period|No reason available|0|||
161773089|NCT05182840|584211549|FG003|Run-in Period|No reason available|0|||
161773090|NCT05182840|584211550|FG004|Run-in Period|No reason available|0|||
161773091|NCT05182840|584211551|FG005|Run-in Period|No reason available|0|||
161773092|NCT05182840|584211552|FG006|Run-in Period|No reason available|0|||
161773093|NCT05182840|584211553|FG007|Run-in Period|No reason available|0|||
161773094|NCT05182840|584211554|FG008|Run-in Period|No reason available|0|||
161773095|NCT05182840|584211555|FG009|Run-in Period|No reason available|0|||
161773096|NCT05182840|584211546|FG000|Run-in Period|Burden of study procedures|2|||
161773097|NCT05182840|584211547|FG001|Run-in Period|Burden of study procedures|2|||
161773098|NCT05182840|584211548|FG002|Run-in Period|Burden of study procedures|0|||
161773099|NCT05182840|584211549|FG003|Run-in Period|Burden of study procedures|0|||
161773100|NCT05182840|584211550|FG004|Run-in Period|Burden of study procedures|0|||
161773101|NCT05182840|584211551|FG005|Run-in Period|Burden of study procedures|0|||
161773102|NCT05182840|584211552|FG006|Run-in Period|Burden of study procedures|0|||
161773103|NCT05182840|584211553|FG007|Run-in Period|Burden of study procedures|0|||
161773104|NCT05182840|584211554|FG008|Run-in Period|Burden of study procedures|0|||
161773105|NCT05182840|584211555|FG009|Run-in Period|Burden of study procedures|0|||
161773106|NCT05182840|584211546|FG000|Run-in Period|Change of residence|1|||
161773107|NCT05182840|584211547|FG001|Run-in Period|Change of residence|0|||
161773108|NCT05182840|584211548|FG002|Run-in Period|Change of residence|0|||
161773109|NCT05182840|584211549|FG003|Run-in Period|Change of residence|0|||
161773110|NCT05182840|584211550|FG004|Run-in Period|Change of residence|0|||
161773111|NCT05182840|584211551|FG005|Run-in Period|Change of residence|0|||
161773112|NCT05182840|584211552|FG006|Run-in Period|Change of residence|0|||
161773113|NCT05182840|584211553|FG007|Run-in Period|Change of residence|0|||
161773114|NCT05182840|584211554|FG008|Run-in Period|Change of residence|0|||
161773115|NCT05182840|584211555|FG009|Run-in Period|Change of residence|0|||
161773116|NCT05182840|584211546|FG000|Run-in Period|Adverse Event|5|||
161773117|NCT05182840|584211547|FG001|Run-in Period|Adverse Event|5|||
161773118|NCT05182840|584211548|FG002|Run-in Period|Adverse Event|0|||
161773119|NCT05182840|584211549|FG003|Run-in Period|Adverse Event|0|||
161773120|NCT05182840|584211550|FG004|Run-in Period|Adverse Event|0|||
161773121|NCT05182840|584211551|FG005|Run-in Period|Adverse Event|0|||
161773122|NCT05182840|584211552|FG006|Run-in Period|Adverse Event|0|||
161773123|NCT05182840|584211553|FG007|Run-in Period|Adverse Event|0|||
161773124|NCT05182840|584211554|FG008|Run-in Period|Adverse Event|0|||
161773125|NCT05182840|584211555|FG009|Run-in Period|Adverse Event|0|||
161773126|NCT05182840|584211546|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
161773127|NCT05182840|584211547|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
161773128|NCT05182840|584211548|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773129|NCT05182840|584211549|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773130|NCT05182840|584211550|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773131|NCT05182840|584211551|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773132|NCT05182840|584211552|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773133|NCT05182840|584211553|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773134|NCT05182840|584211554|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161862873|NCT05573464|584540240|FG001|12-week Treatment Period|Randomised, not treated|1|||
161862874|NCT05573464|584540239|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
161862875|NCT05573464|584540240|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
161862876|NCT05573464|584540239|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
161862877|NCT05573464|584540240|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
161862878|NCT05573464|584540239|FG000|52-week Treatment Period|Protocol Violation|1|||
161862879|NCT05573464|584540240|FG001|52-week Treatment Period|Protocol Violation|1|||
161862880|NCT05573464|584540239|FG000|52-week Treatment Period|Physician Decision|2|||
161862881|NCT05573464|584540240|FG001|52-week Treatment Period|Physician Decision|2|||
161862882|NCT05573464|584540239|FG000|52-week Treatment Period|Lost to Follow-up|1|||
161862883|NCT05573464|584540240|FG001|52-week Treatment Period|Lost to Follow-up|1|||
161862884|NCT05573464|584540239|FG000|52-week Treatment Period|Adverse Event|11|||
161862885|NCT05573464|584540240|FG001|52-week Treatment Period|Adverse Event|8|||
161862886|NCT05573464|584540239|FG000|52-week Treatment Period|Death|1|||
161862887|NCT05573464|584540240|FG001|52-week Treatment Period|Death|1|||
161862888|NCT05734157|584540241|FG000|Overall Study|Death|3|||
161862889|NCT05734157|584540241|FG000|Overall Study|Withdrawal by Subject|2|||
161862890|NCT05734157|584540241|FG000|Overall Study|Lost to Follow-up|1|||
161862891|NCT05734157|584540241|FG000|Overall Study|Telephone call|3|||
161773135|NCT05182840|584211555|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773136|NCT05182840|584211546|FG000|Treatment Period|Reason missing|0|||
161773137|NCT05182840|584211547|FG001|Treatment Period|Reason missing|0|||
161773138|NCT05182840|584211548|FG002|Treatment Period|Reason missing|1|||
161773139|NCT05182840|584211549|FG003|Treatment Period|Reason missing|0|||
161773140|NCT05182840|584211550|FG004|Treatment Period|Reason missing|0|||
161773141|NCT05182840|584211551|FG005|Treatment Period|Reason missing|0|||
161773142|NCT05182840|584211552|FG006|Treatment Period|Reason missing|0|||
161773143|NCT05182840|584211553|FG007|Treatment Period|Reason missing|0|||
161773144|NCT05182840|584211554|FG008|Treatment Period|Reason missing|0|||
161773145|NCT05182840|584211555|FG009|Treatment Period|Reason missing|0|||
161773146|NCT05182840|584211546|FG000|Treatment Period|Other but not sponsor termination|0|||
161773147|NCT05182840|584211547|FG001|Treatment Period|Other but not sponsor termination|0|||
161773148|NCT05182840|584211548|FG002|Treatment Period|Other but not sponsor termination|8|||
161773149|NCT05182840|584211549|FG003|Treatment Period|Other but not sponsor termination|6|||
161773150|NCT05182840|584211550|FG004|Treatment Period|Other but not sponsor termination|6|||
161773151|NCT05182840|584211551|FG005|Treatment Period|Other but not sponsor termination|7|||
161773152|NCT05182840|584211552|FG006|Treatment Period|Other but not sponsor termination|5|||
161773153|NCT05182840|584211553|FG007|Treatment Period|Other but not sponsor termination|8|||
161773154|NCT05182840|584211554|FG008|Treatment Period|Other but not sponsor termination|7|||
161773155|NCT05182840|584211555|FG009|Treatment Period|Other but not sponsor termination|2|||
161773156|NCT05182840|584211546|FG000|Treatment Period|Protocol deviation|0|||
161773157|NCT05182840|584211547|FG001|Treatment Period|Protocol deviation|0|||
161773158|NCT05182840|584211548|FG002|Treatment Period|Protocol deviation|0|||
161773159|NCT05182840|584211549|FG003|Treatment Period|Protocol deviation|0|||
161773160|NCT05182840|584211550|FG004|Treatment Period|Protocol deviation|0|||
161773161|NCT05182840|584211551|FG005|Treatment Period|Protocol deviation|0|||
161773162|NCT05182840|584211552|FG006|Treatment Period|Protocol deviation|0|||
161773163|NCT05182840|584211553|FG007|Treatment Period|Protocol deviation|0|||
161773164|NCT05182840|584211554|FG008|Treatment Period|Protocol deviation|1|||
161773165|NCT05182840|584211555|FG009|Treatment Period|Protocol deviation|0|||
161773166|NCT05182840|584211546|FG000|Treatment Period|No reason available|0|||
161773167|NCT05182840|584211547|FG001|Treatment Period|No reason available|0|||
161773168|NCT05182840|584211548|FG002|Treatment Period|No reason available|0|||
161773169|NCT05182840|584211549|FG003|Treatment Period|No reason available|1|||
161773170|NCT05182840|584211550|FG004|Treatment Period|No reason available|0|||
161862892|NCT04815083|584540242|FG000|Overall Study|Physician Decision|1|||
161862893|NCT04815083|584540242|FG000|Overall Study|Study pause|2|||
161862894|NCT04815083|584540242|FG000|Overall Study|Screening failure|4|||
161862895|NCT06025721|584540243|FG000|Overall Study|Physician Decision|1|||
161862896|NCT06025721|584540243|FG000|Overall Study|Protocol Violation|1|||
161773171|NCT05182840|584211551|FG005|Treatment Period|No reason available|2|||
161773172|NCT05182840|584211552|FG006|Treatment Period|No reason available|0|||
161773173|NCT05182840|584211553|FG007|Treatment Period|No reason available|1|||
161862897|NCT06025721|584540243|FG000|Overall Study|Incarceration|1|||
161862898|NCT01730053|584540246|FG000|Overall Study|Participant moved|0|||
161862899|NCT01730053|584540247|FG001|Overall Study|Participant moved|0|||
161862900|NCT01730053|584540248|FG002|Overall Study|Participant moved|1|||
161862901|NCT01730053|584540249|FG003|Overall Study|Participant moved|0|||
161862902|NCT01730053|584540250|FG004|Overall Study|Participant moved|0|||
161862903|NCT01730053|584540251|FG005|Overall Study|Participant moved|0|||
161862904|NCT01730053|584540246|FG000|Overall Study|Physician Decision|0|||
161862905|NCT01730053|584540247|FG001|Overall Study|Physician Decision|0|||
161862906|NCT01730053|584540248|FG002|Overall Study|Physician Decision|0|||
161862907|NCT01730053|584540249|FG003|Overall Study|Physician Decision|1|||
161862908|NCT01730053|584540250|FG004|Overall Study|Physician Decision|0|||
161862909|NCT01730053|584540251|FG005|Overall Study|Physician Decision|0|||
161862910|NCT01730053|584540246|FG000|Overall Study|Adverse Event|2|||
161862911|NCT01730053|584540247|FG001|Overall Study|Adverse Event|6|||
161862912|NCT01730053|584540248|FG002|Overall Study|Adverse Event|3|||
161862913|NCT01730053|584540249|FG003|Overall Study|Adverse Event|3|||
161862914|NCT01730053|584540250|FG004|Overall Study|Adverse Event|2|||
161862915|NCT01730053|584540251|FG005|Overall Study|Adverse Event|2|||
161862916|NCT01730053|584540246|FG000|Overall Study|Poor compliance to protocol|1|||
161862917|NCT01730053|584540247|FG001|Overall Study|Poor compliance to protocol|2|||
161862918|NCT01730053|584540248|FG002|Overall Study|Poor compliance to protocol|2|||
161862919|NCT01730053|584540249|FG003|Overall Study|Poor compliance to protocol|0|||
161862920|NCT01730053|584540250|FG004|Overall Study|Poor compliance to protocol|0|||
161862921|NCT01730053|584540251|FG005|Overall Study|Poor compliance to protocol|2|||
161862922|NCT01730053|584540246|FG000|Overall Study|Other than specified|2|||
161862923|NCT01730053|584540247|FG001|Overall Study|Other than specified|6|||
161862924|NCT01730053|584540248|FG002|Overall Study|Other than specified|5|||
161862925|NCT01730053|584540249|FG003|Overall Study|Other than specified|4|||
161862926|NCT01730053|584540250|FG004|Overall Study|Other than specified|7|||
161862927|NCT01730053|584540251|FG005|Overall Study|Other than specified|9|||
161862928|NCT02068508|584540252|FG000|Overall Study|Case report forms uncollected|27|||
161773174|NCT05182840|584211554|FG008|Treatment Period|No reason available|0|||
161773175|NCT05182840|584211555|FG009|Treatment Period|No reason available|0|||
161773176|NCT05182840|584211546|FG000|Treatment Period|Burden of study procedures|0|||
161773177|NCT05182840|584211547|FG001|Treatment Period|Burden of study procedures|0|||
161773178|NCT05182840|584211548|FG002|Treatment Period|Burden of study procedures|0|||
161773179|NCT05182840|584211549|FG003|Treatment Period|Burden of study procedures|0|||
161773180|NCT05182840|584211550|FG004|Treatment Period|Burden of study procedures|1|||
161773181|NCT05182840|584211551|FG005|Treatment Period|Burden of study procedures|0|||
161773182|NCT05182840|584211552|FG006|Treatment Period|Burden of study procedures|0|||
161773183|NCT05182840|584211553|FG007|Treatment Period|Burden of study procedures|0|||
161773184|NCT05182840|584211554|FG008|Treatment Period|Burden of study procedures|0|||
161773185|NCT05182840|584211555|FG009|Treatment Period|Burden of study procedures|0|||
161773186|NCT05182840|584211546|FG000|Treatment Period|Change of residence|0|||
161773187|NCT05182840|584211547|FG001|Treatment Period|Change of residence|0|||
161773188|NCT05182840|584211548|FG002|Treatment Period|Change of residence|0|||
161773189|NCT05182840|584211549|FG003|Treatment Period|Change of residence|0|||
161773190|NCT05182840|584211550|FG004|Treatment Period|Change of residence|0|||
161773191|NCT05182840|584211551|FG005|Treatment Period|Change of residence|1|||
161773192|NCT05182840|584211552|FG006|Treatment Period|Change of residence|0|||
161773193|NCT05182840|584211553|FG007|Treatment Period|Change of residence|0|||
161773194|NCT05182840|584211554|FG008|Treatment Period|Change of residence|0|||
161773195|NCT05182840|584211555|FG009|Treatment Period|Change of residence|0|||
161773196|NCT05182840|584211546|FG000|Treatment Period|Adverse Event|0|||
161773197|NCT05182840|584211547|FG001|Treatment Period|Adverse Event|0|||
161773198|NCT05182840|584211548|FG002|Treatment Period|Adverse Event|4|||
161773199|NCT05182840|584211549|FG003|Treatment Period|Adverse Event|16|||
161773200|NCT05182840|584211550|FG004|Treatment Period|Adverse Event|12|||
161773201|NCT05182840|584211551|FG005|Treatment Period|Adverse Event|6|||
161773202|NCT05182840|584211552|FG006|Treatment Period|Adverse Event|4|||
161773203|NCT05182840|584211553|FG007|Treatment Period|Adverse Event|8|||
161773204|NCT05182840|584211554|FG008|Treatment Period|Adverse Event|16|||
161773205|NCT05182840|584211555|FG009|Treatment Period|Adverse Event|5|||
161862929|NCT02068508|584540252|FG000|Overall Study|Patient did not visit the study site|1|||
161862930|NCT02068508|584540252|FG000|Overall Study|Protocol Violation|4|||
161862931|NCT00075816|584540260|FG000|Overall Study|Did not undergo transplantation|14|||
161862932|NCT00075816|584540261|FG001|Overall Study|Did not undergo transplantation|11|||
161862933|NCT04173507|584540262|FG000|Overall Study|On Treatment|3|||
161773206|NCT05182840|584211546|FG000|Treatment Period|Not treated with study drug|0|||
161862934|NCT04173507|584540262|FG000|Overall Study|Adverse Event|3|||
161862935|NCT04173507|584540262|FG000|Overall Study|Progression/Relapse|34|||
161862936|NCT04173507|584540262|FG000|Overall Study|Death|2|||
161862937|NCT02832687|584540263|FG000|Overall Study|Adverse Event|0|||
161862938|NCT02832687|584540264|FG001|Overall Study|Adverse Event|2|||
161862939|NCT04231825|584540265|FG000|Overall Study|Protocol Violation|3|||
161862940|NCT04231825|584540266|FG001|Overall Study|Protocol Violation|3|||
161862941|NCT04231825|584540265|FG000|Overall Study|Lost to Follow-up|0|||
161862942|NCT04231825|584540266|FG001|Overall Study|Lost to Follow-up|1|||
161862943|NCT01662635|584540267|FG000|Overall Study|scarce samples for evaluation|30|||
161862944|NCT01217112|584540268|FG000|Overall Study|Adverse Event|0|||
161862945|NCT01217112|584540269|FG001|Overall Study|Adverse Event|2|||
161862946|NCT01217112|584540270|FG002|Overall Study|Adverse Event|0|||
161862947|NCT01217112|584540271|FG003|Overall Study|Adverse Event|2|||
161862948|NCT01217112|584540272|FG004|Overall Study|Adverse Event|0|||
161862949|NCT01217112|584540268|FG000|Overall Study|Withdrawal by Subject|0|||
161862950|NCT01217112|584540269|FG001|Overall Study|Withdrawal by Subject|0|||
161862951|NCT01217112|584540270|FG002|Overall Study|Withdrawal by Subject|1|||
161862952|NCT01217112|584540271|FG003|Overall Study|Withdrawal by Subject|0|||
161862953|NCT01217112|584540272|FG004|Overall Study|Withdrawal by Subject|0|||
161862954|NCT01217112|584540268|FG000|Overall Study|Physician Decision|0|||
161862955|NCT01217112|584540269|FG001|Overall Study|Physician Decision|0|||
161862956|NCT01217112|584540270|FG002|Overall Study|Physician Decision|0|||
161862957|NCT01217112|584540271|FG003|Overall Study|Physician Decision|0|||
161862958|NCT01217112|584540272|FG004|Overall Study|Physician Decision|1|||
161862959|NCT01401361|584540273|FG000|Overall Study|Withdrawal by Subject|16|||
161862960|NCT01401361|584540273|FG000|Overall Study|Lack of Efficacy|6|||
161862961|NCT01401361|584540273|FG000|Overall Study|Physician Decision|1|||
161862962|NCT01401361|584540273|FG000|Overall Study|Lost to Follow-up|3|||
161862963|NCT01401361|584540273|FG000|Overall Study|Subject/family decision post procedure|2|||
161862964|NCT00595920|584540276|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
161862965|NCT00351468|584540277|FG000|Overall Study|Adverse Event|42|||
161862966|NCT00351468|584540277|FG000|Overall Study|Withdrawal by Subject|39|||
161862967|NCT00351468|584540277|FG000|Overall Study|Various -follow up w clinical team|39|||
161862968|NCT00351468|584540277|FG000|Overall Study|Lack of Efficacy|32|||
161862969|NCT00351468|584540277|FG000|Overall Study|Non-compliance|8|||
161862970|NCT00351468|584540277|FG000|Overall Study|Lost to Follow-up|4|||
161862971|NCT00351468|584540277|FG000|Overall Study|Protocol Violation|3|||
161862972|NCT03588910|584540278|FG000|Overall Study|Withdrawal by Subject|1|||
161862973|NCT03588910|584540279|FG001|Overall Study|Withdrawal by Subject|0|||
161862974|NCT03588910|584540278|FG000|Overall Study|Allergy|2|||
161862975|NCT03588910|584540279|FG001|Overall Study|Allergy|0|||
161862976|NCT03588910|584540278|FG000|Overall Study|Protocol Violation|0|||
161862977|NCT03588910|584540279|FG001|Overall Study|Protocol Violation|3|||
161862978|NCT03588910|584540278|FG000|Overall Study|Did not complete Day 1 Survey|5|||
161862979|NCT03588910|584540279|FG001|Overall Study|Did not complete Day 1 Survey|10|||
161862980|NCT03588910|584540278|FG000|Overall Study|Did not complete Day 7 Survey|5|||
161862981|NCT03588910|584540279|FG001|Overall Study|Did not complete Day 7 Survey|2|||
161862982|NCT03096314|584540280|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
161862983|NCT03096314|584540281|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
161862984|NCT00471822|584540282|FG000|Overall Study|Protocol Violation|2|||
161862985|NCT03318861|584540283|FG000|Overall Study|Death|2|||
161862986|NCT03318861|584540284|FG001|Overall Study|Death|3|||
161862987|NCT03318861|584540285|FG002|Overall Study|Death|3|||
161862988|NCT03318861|584540286|FG003|Overall Study|Death|2|||
161862989|NCT03318861|584540287|FG004|Overall Study|Death|2|||
161862990|NCT03318861|584540283|FG000|Overall Study|Enrolled But Never Treated|0|||
161862991|NCT03318861|584540284|FG001|Overall Study|Enrolled But Never Treated|1|||
161862992|NCT03318861|584540285|FG002|Overall Study|Enrolled But Never Treated|0|||
161862993|NCT03318861|584540286|FG003|Overall Study|Enrolled But Never Treated|1|||
161862994|NCT03318861|584540287|FG004|Overall Study|Enrolled But Never Treated|1|||
161862995|NCT03318861|584540283|FG000|Overall Study|Informed Consent Withdraw|0|||
161862996|NCT03318861|584540284|FG001|Overall Study|Informed Consent Withdraw|0|||
161862997|NCT03318861|584540285|FG002|Overall Study|Informed Consent Withdraw|0|||
161862998|NCT03318861|584540286|FG003|Overall Study|Informed Consent Withdraw|1|||
161862999|NCT03318861|584540287|FG004|Overall Study|Informed Consent Withdraw|0|||
161863000|NCT03318861|584540283|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
161863001|NCT03318861|584540284|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863002|NCT03318861|584540285|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863003|NCT03318861|584540286|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863004|NCT03318861|584540287|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863005|NCT02844933|584540288|FG000|Overall Study|Discontinued due to premature termination of study|3|||
161863006|NCT02844933|584540289|FG001|Overall Study|Discontinued due to premature termination of study|2|||
161863007|NCT01479465|584540290|FG000|Overall Study|Disease Progression|9|||
161863008|NCT01479465|584540291|FG001|Overall Study|Disease Progression|61|||
161863009|NCT01479465|584540292|FG002|Overall Study|Disease Progression|65|||
161863010|NCT01479465|584540293|FG003|Overall Study|Disease Progression|70|||
161863011|NCT01479465|584540290|FG000|Overall Study|Study Discontinued by Sponsor|0|||
161863012|NCT01479465|584540291|FG001|Overall Study|Study Discontinued by Sponsor|7|||
161863013|NCT01479465|584540292|FG002|Overall Study|Study Discontinued by Sponsor|5|||
161863014|NCT01479465|584540293|FG003|Overall Study|Study Discontinued by Sponsor|3|||
161863015|NCT01479465|584540290|FG000|Overall Study|Adverse Event|0|||
161863016|NCT01479465|584540291|FG001|Overall Study|Adverse Event|3|||
161863017|NCT01479465|584540292|FG002|Overall Study|Adverse Event|6|||
161863018|NCT01479465|584540293|FG003|Overall Study|Adverse Event|4|||
161863019|NCT01479465|584540290|FG000|Overall Study|Investigator Discretion|1|||
161863020|NCT01479465|584540291|FG001|Overall Study|Investigator Discretion|4|||
161863021|NCT01479465|584540292|FG002|Overall Study|Investigator Discretion|2|||
161863022|NCT01479465|584540293|FG003|Overall Study|Investigator Discretion|4|||
161863023|NCT01479465|584540290|FG000|Overall Study|Subject Request|1|||
161863024|NCT01479465|584540291|FG001|Overall Study|Subject Request|3|||
161863025|NCT01479465|584540292|FG002|Overall Study|Subject Request|4|||
161863026|NCT01479465|584540293|FG003|Overall Study|Subject Request|2|||
161863027|NCT01479465|584540290|FG000|Overall Study|Subject Withdrew Consent|0|||
161863028|NCT01479465|584540291|FG001|Overall Study|Subject Withdrew Consent|5|||
161863029|NCT01479465|584540292|FG002|Overall Study|Subject Withdrew Consent|2|||
161863030|NCT01479465|584540293|FG003|Overall Study|Subject Withdrew Consent|1|||
161863031|NCT01479465|584540290|FG000|Overall Study|Protocol Violation|0|||
161863032|NCT01479465|584540291|FG001|Overall Study|Protocol Violation|1|||
161863033|NCT01479465|584540292|FG002|Overall Study|Protocol Violation|1|||
161863034|NCT01479465|584540293|FG003|Overall Study|Protocol Violation|0|||
161863035|NCT01479465|584540290|FG000|Overall Study|Death|0|||
161863036|NCT01479465|584540291|FG001|Overall Study|Death|0|||
161863037|NCT01479465|584540292|FG002|Overall Study|Death|0|||
161863038|NCT01479465|584540293|FG003|Overall Study|Death|1|||
161863039|NCT01479465|584540290|FG000|Overall Study|Lost to Follow-up|0|||
161863040|NCT01479465|584540291|FG001|Overall Study|Lost to Follow-up|0|||
161863041|NCT01479465|584540292|FG002|Overall Study|Lost to Follow-up|1|||
161863042|NCT01479465|584540293|FG003|Overall Study|Lost to Follow-up|0|||
161863043|NCT01892501|584540294|FG000|Overall Study|Protocol Violation|2|||
161863044|NCT01892501|584540294|FG000|Overall Study|Puncture not carried out|9|||
161863045|NCT01892501|584540294|FG000|Overall Study|Radiological monitoring not carried out|5|||
161863046|NCT01892501|584540294|FG000|Overall Study|Non-contributory histological result|12|||
161863047|NCT04335123|584540298|FG000|Overall Study|Withdrawal by Subject|2|||
161863048|NCT04335123|584540299|FG001|Overall Study|Withdrawal by Subject|0|||
161863049|NCT04335123|584540298|FG000|Overall Study|Physician Decision|2|||
161863050|NCT04335123|584540299|FG001|Overall Study|Physician Decision|0|||
161863051|NCT01439802|584540300|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
161863052|NCT01439802|584540300|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
161863053|NCT01433471|584540304|FG000|Overall Study|Withdrawal by Subject|0|||
161863054|NCT01433471|584540305|FG001|Overall Study|Withdrawal by Subject|1|||
161863055|NCT00395629|584540306|FG000|Core Study|Adverse Event|0|||
161863056|NCT00395629|584540307|FG001|Core Study|Adverse Event|3|||
161863057|NCT00395629|584540308|FG002|Core Study|Adverse Event|4|||
161863058|NCT00395629|584540306|FG000|Core Study|Abnormal laboratory value(s)|0|||
161863059|NCT00395629|584540307|FG001|Core Study|Abnormal laboratory value(s)|0|||
161863060|NCT00395629|584540308|FG002|Core Study|Abnormal laboratory value(s)|1|||
161863061|NCT00395629|584540306|FG000|Core Study|Protocol Violation|1|||
161863062|NCT00395629|584540307|FG001|Core Study|Protocol Violation|0|||
161863063|NCT00395629|584540308|FG002|Core Study|Protocol Violation|0|||
161863064|NCT00395629|584540306|FG000|Core Study|Withdrawal by Subject|0|||
161863065|NCT00395629|584540307|FG001|Core Study|Withdrawal by Subject|1|||
161863066|NCT00395629|584540308|FG002|Core Study|Withdrawal by Subject|1|||
161863067|NCT00395629|584540306|FG000|Core Study|Lost to Follow-up|0|||
161863068|NCT00395629|584540307|FG001|Core Study|Lost to Follow-up|0|||
161863069|NCT00395629|584540308|FG002|Core Study|Lost to Follow-up|1|||
161863070|NCT00395629|584540306|FG000|Extension Study|Adverse Event|0|||
161863071|NCT00395629|584540307|FG001|Extension Study|Adverse Event|0|||
161863072|NCT00395629|584540308|FG002|Extension Study|Adverse Event|2|||
161863073|NCT00395629|584540306|FG000|Extension Study|Administrative problems|0|||
161863074|NCT00395629|584540307|FG001|Extension Study|Administrative problems|0|||
161863075|NCT00395629|584540308|FG002|Extension Study|Administrative problems|1|||
161863076|NCT01836471|584540309|FG000|Overall Study|Pregnancy|1|||
161863077|NCT01836471|584540310|FG001|Overall Study|Pregnancy|0|||
161863078|NCT01836471|584540311|FG002|Overall Study|Pregnancy|0|||
161863079|NCT01836471|584540312|FG003|Overall Study|Pregnancy|0|||
161863080|NCT01836471|584540313|FG004|Overall Study|Pregnancy|0|||
161863081|NCT01836471|584540309|FG000|Overall Study|Withdrawal by Subject|3|||
161863082|NCT01836471|584540310|FG001|Overall Study|Withdrawal by Subject|4|||
161863083|NCT01836471|584540311|FG002|Overall Study|Withdrawal by Subject|1|||
161863084|NCT01836471|584540312|FG003|Overall Study|Withdrawal by Subject|0|||
161863085|NCT01836471|584540313|FG004|Overall Study|Withdrawal by Subject|2|||
161863086|NCT01836471|584540309|FG000|Overall Study|Physician Decision|0|||
161863087|NCT01836471|584540310|FG001|Overall Study|Physician Decision|1|||
161863088|NCT01836471|584540311|FG002|Overall Study|Physician Decision|0|||
161863089|NCT01836471|584540312|FG003|Overall Study|Physician Decision|0|||
161863090|NCT01836471|584540313|FG004|Overall Study|Physician Decision|0|||
161863091|NCT01836471|584540309|FG000|Overall Study|Lost to Follow-up|0|||
161863092|NCT01836471|584540310|FG001|Overall Study|Lost to Follow-up|0|||
161863093|NCT01836471|584540311|FG002|Overall Study|Lost to Follow-up|0|||
161863094|NCT01836471|584540312|FG003|Overall Study|Lost to Follow-up|1|||
161863095|NCT01836471|584540313|FG004|Overall Study|Lost to Follow-up|1|||
161863096|NCT01836471|584540309|FG000|Overall Study|Adverse Event|6|||
161863097|NCT01836471|584540310|FG001|Overall Study|Adverse Event|3|||
161863098|NCT01836471|584540311|FG002|Overall Study|Adverse Event|1|||
161863099|NCT01836471|584540312|FG003|Overall Study|Adverse Event|1|||
161863100|NCT01836471|584540313|FG004|Overall Study|Adverse Event|2|||
161863101|NCT01836471|584540309|FG000|Overall Study|Non compliance with tx|1|||
161863102|NCT01836471|584540310|FG001|Overall Study|Non compliance with tx|1|||
161863103|NCT01836471|584540311|FG002|Overall Study|Non compliance with tx|0|||
161863104|NCT01836471|584540312|FG003|Overall Study|Non compliance with tx|0|||
161863105|NCT01836471|584540313|FG004|Overall Study|Non compliance with tx|0|||
161863106|NCT01960413|584540317|FG000|Overall Study|Withdrawal by Subject|1|||
161863107|NCT01960413|584540318|FG001|Overall Study|Withdrawal by Subject|1|||
161863108|NCT01960413|584540317|FG000|Overall Study|Physician Decision|1|||
161863109|NCT01960413|584540318|FG001|Overall Study|Physician Decision|0|||
161863110|NCT01960413|584540317|FG000|Overall Study|Lost to Follow-up|2|||
161863111|NCT01960413|584540318|FG001|Overall Study|Lost to Follow-up|0|||
161863112|NCT02285361|584540319|FG000|Overall Study|Protocol Violation|43|||
161863113|NCT02285361|584540319|FG000|Overall Study|Lost to Follow-up|5|||
161863114|NCT02285361|584540319|FG000|Overall Study|Not taken GIOTRIF|2|||
161863115|NCT02285361|584540319|FG000|Overall Study|Consented prior to the contract date|1|||
161863116|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
161863117|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
161863118|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
161863119|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
161863120|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
161863121|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
161863122|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
161863123|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
161863124|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
161863125|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
161863126|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
161863127|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
161863128|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
161863129|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
161863130|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
161863131|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
161773207|NCT05182840|584211547|FG001|Treatment Period|Not treated with study drug|0|||
161773208|NCT05182840|584211548|FG002|Treatment Period|Not treated with study drug|0|||
161773209|NCT05182840|584211549|FG003|Treatment Period|Not treated with study drug|1|||
161773210|NCT05182840|584211550|FG004|Treatment Period|Not treated with study drug|0|||
161773211|NCT05182840|584211551|FG005|Treatment Period|Not treated with study drug|0|||
161773212|NCT05182840|584211552|FG006|Treatment Period|Not treated with study drug|1|||
161773213|NCT05182840|584211553|FG007|Treatment Period|Not treated with study drug|1|||
161773214|NCT05182840|584211554|FG008|Treatment Period|Not treated with study drug|0|||
161773215|NCT05182840|584211555|FG009|Treatment Period|Not treated with study drug|0|||
161773216|NCT02396849|584211559|FG000|Overall Study|Lost to Follow-up|1|||
161773217|NCT02396849|584211560|FG001|Overall Study|Lost to Follow-up|1|||
161773218|NCT02396849|584211559|FG000|Overall Study|Did not tolerate intervention|1|||
161773219|NCT02396849|584211560|FG001|Overall Study|Did not tolerate intervention|1|||
161773220|NCT03328325|584211561|FG000|Overall Study|Lost to Follow-up|4|||
161773221|NCT03328325|584211561|FG000|Overall Study|Physician Decision|1|||
161773222|NCT03328325|584211561|FG000|Overall Study|Withdrawal by Subject|3|||
161773223|NCT03328325|584211561|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
161773224|NCT00157157|584211569|FG000|Overall Study|Withdrawal by Subject|6|||
161773225|NCT00157157|584211569|FG000|Overall Study|Physician Decision|1|||
161773226|NCT00157157|584211569|FG000|Overall Study|Lost to Follow-up|1|||
161773227|NCT00157157|584211569|FG000|Overall Study|Enrolled in another study|1|||
161773228|NCT00157157|584211569|FG000|Overall Study|Met exclusion criteria|1|||
161863132|NCT00191477|584540322|FG000|Overall Study|Tumor Recurrence|49|||
161863133|NCT00191477|584540323|FG001|Overall Study|Tumor Recurrence|48|||
161863134|NCT00191477|584540322|FG000|Overall Study|Death, Study Disease|1|||
161863135|NCT00191477|584540323|FG001|Overall Study|Death, Study Disease|1|||
161863136|NCT00191477|584540322|FG000|Overall Study|Death, Other Cause|3|||
161863137|NCT00191477|584540323|FG001|Overall Study|Death, Other Cause|6|||
161863138|NCT00191477|584540322|FG000|Overall Study|Lost to Follow-up|23|||
161863139|NCT00191477|584540323|FG001|Overall Study|Lost to Follow-up|21|||
161863140|NCT00191477|584540322|FG000|Overall Study|Protocol Violation|1|||
161863141|NCT00191477|584540323|FG001|Overall Study|Protocol Violation|1|||
161863142|NCT00191477|584540322|FG000|Overall Study|Treatment Change|2|||
161863143|NCT00191477|584540323|FG001|Overall Study|Treatment Change|0|||
161863144|NCT00191477|584540322|FG000|Overall Study|Withdrawal by Subject|2|||
161863145|NCT00191477|584540323|FG001|Overall Study|Withdrawal by Subject|0|||
161863146|NCT00191477|584540322|FG000|Overall Study|Other|2|||
161863147|NCT00191477|584540323|FG001|Overall Study|Other|0|||
161863148|NCT00191477|584540322|FG000|Overall Study|Not Eligible|41|||
161863149|NCT00191477|584540323|FG001|Overall Study|Not Eligible|38|||
161863150|NCT00191477|584540322|FG000|Overall Study|Pathological Specimen Lost|1|||
161863151|NCT00191477|584540323|FG001|Overall Study|Pathological Specimen Lost|0|||
161863152|NCT00191477|584540322|FG000|Overall Study|Discontinued Prior to Instillation|13|||
161863153|NCT00191477|584540323|FG001|Overall Study|Discontinued Prior to Instillation|14|||
161863154|NCT02411656|584540324|FG000|Overall Study|Adverse Event|4|||
161863155|NCT02411656|584540324|FG000|Overall Study|Clinical Progression|33|||
161863156|NCT06481709|584540325|FG000|Overall Study|Withdrawal by Subject|0|||
161863157|NCT06481709|584540326|FG001|Overall Study|Withdrawal by Subject|0|||
161863158|NCT06481709|584540327|FG002|Overall Study|Withdrawal by Subject|2|||
161863159|NCT06481709|584540328|FG003|Overall Study|Withdrawal by Subject|0|||
161863160|NCT02224157|584540330|FG000|Overall Study|Severe non-compliance to protocol|2|||
161863161|NCT02224157|584540331|FG001|Overall Study|Severe non-compliance to protocol|2|||
161863162|NCT02224157|584540330|FG000|Overall Study|Other|13|||
161773229|NCT00157157|584211569|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
161773230|NCT02260804|584211570|FG000|Induction Study Period|Protocol Violation|2|||
161773231|NCT02260804|584211571|FG001|Induction Study Period|Protocol Violation|0|||
161773232|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
161863163|NCT02224157|584540331|FG001|Overall Study|Other|10|||
161863164|NCT02224157|584540330|FG000|Overall Study|Subject decision|58|||
161863165|NCT02224157|584540331|FG001|Overall Study|Subject decision|50|||
161863166|NCT02224157|584540330|FG000|Overall Study|Prematurely closed site|4|||
161863167|NCT02224157|584540331|FG001|Overall Study|Prematurely closed site|2|||
161863168|NCT02224157|584540330|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
161863169|NCT02224157|584540331|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
161863170|NCT02224157|584540330|FG000|Overall Study|Lost to Follow-up|27|||
161863171|NCT02224157|584540331|FG001|Overall Study|Lost to Follow-up|35|||
161863172|NCT02224157|584540330|FG000|Overall Study|Death|1|||
161863173|NCT02224157|584540331|FG001|Overall Study|Death|1|||
161863174|NCT02224157|584540330|FG000|Overall Study|Adverse Event|1|||
161863175|NCT02224157|584540331|FG001|Overall Study|Adverse Event|3|||
161863176|NCT05906628|584540332|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
161863177|NCT05906628|584540333|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
161863178|NCT05906628|584540332|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
161863179|NCT05906628|584540333|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
161863180|NCT05906628|584540332|FG000|16-Week DBVC Period|Protocol Violation|4|||
161863181|NCT05906628|584540333|FG001|16-Week DBVC Period|Protocol Violation|2|||
161863182|NCT05906628|584540332|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
161863183|NCT05906628|584540333|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
161863184|NCT05906628|584540332|FG000|16-Week OLE Period|Death|1|||
161863185|NCT05906628|584540333|FG001|16-Week OLE Period|Death|0|||
161863186|NCT05906628|584540332|FG000|16-Week OLE Period|Lost to Follow-up|1|||
161863187|NCT05906628|584540333|FG001|16-Week OLE Period|Lost to Follow-up|1|||
161863188|NCT05906628|584540332|FG000|16-Week OLE Period|Protocol Violation|0|||
161863189|NCT05906628|584540333|FG001|16-Week OLE Period|Protocol Violation|1|||
161863190|NCT05906628|584540332|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
161863191|NCT05906628|584540333|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
161863192|NCT01108718|584540334|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
161863193|NCT01108718|584540335|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
161863194|NCT02443740|584540336|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863195|NCT02443740|584540337|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863196|NCT02443740|584540338|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863197|NCT02443740|584540339|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863198|NCT02443740|584540340|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863199|NCT02443740|584540341|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
161863200|NCT02443740|584540342|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863201|NCT02443740|584540343|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863202|NCT02443740|584540344|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863203|NCT02443740|584540345|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863204|NCT02443740|584540346|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863205|NCT02443740|584540336|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
161863206|NCT02443740|584540337|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863207|NCT02443740|584540338|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863208|NCT02443740|584540339|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863209|NCT02443740|584540340|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863210|NCT02443740|584540341|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863211|NCT02443740|584540342|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
161863212|NCT02443740|584540343|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863213|NCT02443740|584540344|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863214|NCT02443740|584540345|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863215|NCT02443740|584540346|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863216|NCT02443740|584540336|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863217|NCT02443740|584540337|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863218|NCT02443740|584540338|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863219|NCT02443740|584540339|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863220|NCT02443740|584540340|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863221|NCT02443740|584540341|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
161863222|NCT02443740|584540342|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863223|NCT02443740|584540343|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863224|NCT02443740|584540344|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863225|NCT02443740|584540345|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863226|NCT02443740|584540346|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863227|NCT05373108|584540347|FG000|Overall Study|Withdrawal by Subject|2|||
161863228|NCT02892331|584540348|FG000|Overall Study|Withdrawal by Subject|0|||
161863229|NCT02892331|584540349|FG001|Overall Study|Withdrawal by Subject|1|||
161863230|NCT02892331|584540350|FG002|Overall Study|Withdrawal by Subject|1|||
161863231|NCT02892331|584540348|FG000|Overall Study|Sick family member|0|||
161863232|NCT02892331|584540349|FG001|Overall Study|Sick family member|0|||
161863233|NCT02892331|584540350|FG002|Overall Study|Sick family member|1|||
161863234|NCT02892331|584540348|FG000|Overall Study|Corona virus pandemic|1|||
161863235|NCT02892331|584540349|FG001|Overall Study|Corona virus pandemic|0|||
161863236|NCT02892331|584540350|FG002|Overall Study|Corona virus pandemic|1|||
161863237|NCT02892331|584540348|FG000|Overall Study|Lost to Follow-up|1|||
161863238|NCT02892331|584540349|FG001|Overall Study|Lost to Follow-up|0|||
161863239|NCT02892331|584540350|FG002|Overall Study|Lost to Follow-up|1|||
161863240|NCT02892331|584540348|FG000|Overall Study|Blood pressure was too elevated|0|||
161863241|NCT02892331|584540349|FG001|Overall Study|Blood pressure was too elevated|1|||
161863242|NCT02892331|584540350|FG002|Overall Study|Blood pressure was too elevated|0|||
161863243|NCT02892331|584540348|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
161863244|NCT02892331|584540349|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
161863245|NCT02892331|584540350|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
161863246|NCT04871776|584540351|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
161863247|NCT04871776|584540352|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
161863248|NCT04871776|584540353|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
161863249|NCT04871776|584540351|FG000|Overall Study|Did not meet eligibility criteria|1|||
161863250|NCT04871776|584540352|FG001|Overall Study|Did not meet eligibility criteria|1|||
161863251|NCT04871776|584540353|FG002|Overall Study|Did not meet eligibility criteria|1|||
161863252|NCT00370552|584542177|FG000|Overall Study|Adverse Event|2|||
161863253|NCT00370552|584542178|FG001|Overall Study|Adverse Event|2|||
161863254|NCT00370552|584542179|FG002|Overall Study|Adverse Event|2|||
161863255|NCT00370552|584542177|FG000|Overall Study|Disease progression|23|||
161863256|NCT00370552|584542178|FG001|Overall Study|Disease progression|23|||
161863257|NCT00370552|584542179|FG002|Overall Study|Disease progression|15|||
161863258|NCT00370552|584542177|FG000|Overall Study|Maximum clinical benefit|3|||
161863259|NCT00370552|584542178|FG001|Overall Study|Maximum clinical benefit|5|||
161863260|NCT00370552|584542179|FG002|Overall Study|Maximum clinical benefit|5|||
161863261|NCT00370552|584542177|FG000|Overall Study|Poor or noncompliance|0|||
161863262|NCT00370552|584542178|FG001|Overall Study|Poor or noncompliance|0|||
161863263|NCT00370552|584542179|FG002|Overall Study|Poor or noncompliance|1|||
161863264|NCT00370552|584542177|FG000|Overall Study|Study drug toxicity|11|||
161863265|NCT00370552|584542178|FG001|Overall Study|Study drug toxicity|8|||
161863266|NCT00370552|584542179|FG002|Overall Study|Study drug toxicity|6|||
161863267|NCT00370552|584542177|FG000|Overall Study|Withdrawal by Subject|2|||
161863268|NCT00370552|584542178|FG001|Overall Study|Withdrawal by Subject|0|||
161863269|NCT00370552|584542179|FG002|Overall Study|Withdrawal by Subject|1|||
161863270|NCT00370552|584542177|FG000|Overall Study|Still on treatment|1|||
161863271|NCT00370552|584542178|FG001|Overall Study|Still on treatment|3|||
161863272|NCT00370552|584542179|FG002|Overall Study|Still on treatment|2|||
161863273|NCT00370552|584542177|FG000|Overall Study|Never treated|1|||
161863274|NCT00370552|584542178|FG001|Overall Study|Never treated|0|||
161863275|NCT00370552|584542179|FG002|Overall Study|Never treated|0|||
161863276|NCT00370552|584542177|FG000|Overall Study|Physician Decision|1|||
161863277|NCT00370552|584542178|FG001|Overall Study|Physician Decision|1|||
161863278|NCT00370552|584542179|FG002|Overall Study|Physician Decision|0|||
161863279|NCT00370552|584542177|FG000|Overall Study|Investigator decision|2|||
161863280|NCT00370552|584542178|FG001|Overall Study|Investigator decision|1|||
161863281|NCT00370552|584542179|FG002|Overall Study|Investigator decision|0|||
161863282|NCT00370552|584542177|FG000|Overall Study|High risk of allergic reaction|0|||
161863283|NCT00370552|584542178|FG001|Overall Study|High risk of allergic reaction|1|||
161863284|NCT00370552|584542179|FG002|Overall Study|High risk of allergic reaction|0|||
161863285|NCT00370552|584542177|FG000|Overall Study|Planned radiation for palliation|0|||
161863286|NCT00370552|584542178|FG001|Overall Study|Planned radiation for palliation|1|||
161863287|NCT00370552|584542179|FG002|Overall Study|Planned radiation for palliation|0|||
161863288|NCT03499067|584542180|FG000|First Intervention|Physician Decision|2|||
161863289|NCT03499067|584542181|FG001|First Intervention|Physician Decision|1|||
161863290|NCT03499067|584542180|FG000|First Intervention|Withdrawal by Subject|3|||
161863291|NCT03499067|584542181|FG001|First Intervention|Withdrawal by Subject|6|||
161863292|NCT02392481|584542182|FG000|Overall Study|Adverse Event|0|||
161863293|NCT02392481|584542183|FG001|Overall Study|Adverse Event|0|||
161863294|NCT02392481|584542184|FG002|Overall Study|Adverse Event|1|||
161773233|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
161773234|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
161773235|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
161773236|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
161773237|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
161773238|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
161773239|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
161773240|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
161773241|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
161773242|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
161773243|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
161773244|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
161773245|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
161773246|NCT02260804|584211570|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
161773247|NCT02260804|584211571|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
161773248|NCT02260804|584211570|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
161773249|NCT02260804|584211571|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
161773250|NCT02260804|584211570|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
161773251|NCT02260804|584211571|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
161773252|NCT00509223|584214245|FG000|Overall Study|Lost to Follow-up|1|||
161773253|NCT00509223|584214246|FG001|Overall Study|Lost to Follow-up|1|||
161773254|NCT00509223|584214245|FG000|Overall Study|Adverse Event|1|||
161773255|NCT00509223|584214246|FG001|Overall Study|Adverse Event|1|||
161773256|NCT00509223|584214245|FG000|Overall Study|Withdrawal by Subject|25|||
161773257|NCT00509223|584214246|FG001|Overall Study|Withdrawal by Subject|6|||
161773258|NCT00509223|584214245|FG000|Overall Study|Including: subject change of address|5|||
161773259|NCT00509223|584214246|FG001|Overall Study|Including: subject change of address|2|||
161773260|NCT00509223|584214245|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
161773261|NCT00509223|584214246|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
161773262|NCT04888377|584214249|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
161863295|NCT02392481|584542185|FG003|Overall Study|Adverse Event|2|||
161863296|NCT02392481|584542182|FG000|Overall Study|Withdrawal by Subject|0|||
161773263|NCT04888377|584214250|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
161773264|NCT04888377|584214249|FG000|Overall Study|Physician Decision|6|||
161863297|NCT02392481|584542183|FG001|Overall Study|Withdrawal by Subject|0|||
161863298|NCT02392481|584542184|FG002|Overall Study|Withdrawal by Subject|1|||
161863299|NCT02392481|584542185|FG003|Overall Study|Withdrawal by Subject|0|||
161863300|NCT02502149|584542186|FG000|Intermediate|Discontinued prematurely|1|||
161863301|NCT02502149|584542187|FG001|Intermediate|Discontinued prematurely|0|||
161863302|NCT02502149|584542188|FG002|Intermediate|Discontinued prematurely|0|||
161863303|NCT02502149|584542189|FG003|Intermediate|Discontinued prematurely|0|||
161863304|NCT02502149|584542190|FG004|Intermediate|Discontinued prematurely|0|||
161863305|NCT02383017|584542207|FG000|Overall Study|Injury Sustained Outside Study|1|||
161863306|NCT02383017|584542208|FG001|Overall Study|Injury Sustained Outside Study|0|||
161863307|NCT02383017|584542207|FG000|Overall Study|Compliance|3|||
161863308|NCT02383017|584542208|FG001|Overall Study|Compliance|2|||
161863309|NCT02383017|584542207|FG000|Overall Study|Found to be Hypogonadal|1|||
161863310|NCT02383017|584542208|FG001|Overall Study|Found to be Hypogonadal|0|||
161863311|NCT03871543|584542212|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
161863312|NCT03871543|584542212|FG000|Period 1|Investigator Error|1|||
161863313|NCT03871543|584542212|FG000|Period 1|Protocol Violation|2|||
161863314|NCT03871543|584542212|FG000|Period 1|COVID-19 Related|1|||
161863315|NCT03871543|584542212|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
161863316|NCT03871543|584542212|FG000|Period 1|Withdrawal by Subject|10|||
161863317|NCT03871543|584542212|FG000|Period 2|Adverse Event|1|||
161863318|NCT03871543|584542212|FG000|Period 2|Withdrawal by Subject|1|||
161863319|NCT01894919|584542213|FG000|Overall Study|Withdrawal by Subject|1|||
161863320|NCT01894919|584542214|FG001|Overall Study|Withdrawal by Subject|0|||
161863321|NCT01894919|584542215|FG002|Overall Study|Withdrawal by Subject|0|||
161863322|NCT01894919|584542216|FG003|Overall Study|Withdrawal by Subject|0|||
161863323|NCT01894919|584542217|FG004|Overall Study|Withdrawal by Subject|1|||
161863324|NCT01894919|584542218|FG005|Overall Study|Withdrawal by Subject|0|||
161863325|NCT01894919|584542219|FG006|Overall Study|Withdrawal by Subject|0|||
161863326|NCT01894919|584542220|FG007|Overall Study|Withdrawal by Subject|0|||
161863327|NCT01894919|584542221|FG008|Overall Study|Withdrawal by Subject|0|||
161863328|NCT01894919|584542222|FG009|Overall Study|Withdrawal by Subject|1|||
161863329|NCT01894919|584542223|FG010|Overall Study|Withdrawal by Subject|1|||
161863330|NCT01894919|584542224|FG011|Overall Study|Withdrawal by Subject|0|||
161863331|NCT01894919|584542225|FG012|Overall Study|Withdrawal by Subject|0|||
161863332|NCT01894919|584542213|FG000|Overall Study|Adverse Event|0|||
161863333|NCT01894919|584542214|FG001|Overall Study|Adverse Event|0|||
161863334|NCT01894919|584542215|FG002|Overall Study|Adverse Event|0|||
161863335|NCT01894919|584542216|FG003|Overall Study|Adverse Event|0|||
161863336|NCT01894919|584542217|FG004|Overall Study|Adverse Event|0|||
161863337|NCT01894919|584542218|FG005|Overall Study|Adverse Event|0|||
161863338|NCT01894919|584542219|FG006|Overall Study|Adverse Event|0|||
161863339|NCT01894919|584542220|FG007|Overall Study|Adverse Event|0|||
161863340|NCT01894919|584542221|FG008|Overall Study|Adverse Event|0|||
161863341|NCT01894919|584542222|FG009|Overall Study|Adverse Event|0|||
161863342|NCT01894919|584542223|FG010|Overall Study|Adverse Event|1|||
161863343|NCT01894919|584542224|FG011|Overall Study|Adverse Event|0|||
161863344|NCT01894919|584542225|FG012|Overall Study|Adverse Event|0|||
161863345|NCT01894919|584542213|FG000|Overall Study|Other-Unspecified|1|||
161863346|NCT01894919|584542214|FG001|Overall Study|Other-Unspecified|0|||
161863347|NCT01894919|584542215|FG002|Overall Study|Other-Unspecified|0|||
161863348|NCT01894919|584542216|FG003|Overall Study|Other-Unspecified|0|||
161863349|NCT01894919|584542217|FG004|Overall Study|Other-Unspecified|0|||
161863350|NCT01894919|584542218|FG005|Overall Study|Other-Unspecified|0|||
161863351|NCT01894919|584542219|FG006|Overall Study|Other-Unspecified|0|||
161863352|NCT01894919|584542220|FG007|Overall Study|Other-Unspecified|0|||
161863353|NCT01894919|584542221|FG008|Overall Study|Other-Unspecified|0|||
161863354|NCT01894919|584542222|FG009|Overall Study|Other-Unspecified|0|||
161863355|NCT01894919|584542223|FG010|Overall Study|Other-Unspecified|0|||
161863356|NCT01894919|584542224|FG011|Overall Study|Other-Unspecified|0|||
161863357|NCT01894919|584542225|FG012|Overall Study|Other-Unspecified|0|||
161863358|NCT01894919|584542213|FG000|Overall Study|Lost to Follow-up|0|||
161863359|NCT01894919|584542214|FG001|Overall Study|Lost to Follow-up|0|||
161863360|NCT01894919|584542215|FG002|Overall Study|Lost to Follow-up|0|||
161863361|NCT01894919|584542216|FG003|Overall Study|Lost to Follow-up|0|||
161863362|NCT01894919|584542217|FG004|Overall Study|Lost to Follow-up|2|||
161863363|NCT01894919|584542218|FG005|Overall Study|Lost to Follow-up|0|||
161863364|NCT01894919|584542219|FG006|Overall Study|Lost to Follow-up|0|||
161863365|NCT01894919|584542220|FG007|Overall Study|Lost to Follow-up|0|||
161863366|NCT01894919|584542221|FG008|Overall Study|Lost to Follow-up|0|||
161863367|NCT01894919|584542222|FG009|Overall Study|Lost to Follow-up|0|||
161863368|NCT01894919|584542223|FG010|Overall Study|Lost to Follow-up|0|||
161863369|NCT01894919|584542224|FG011|Overall Study|Lost to Follow-up|0|||
161863370|NCT01894919|584542225|FG012|Overall Study|Lost to Follow-up|0|||
161863371|NCT03711188|584542226|FG000|Overall Study|Disease progression|11|||
161863372|NCT03711188|584542226|FG000|Overall Study|Adverse Event|1|||
161863373|NCT04341363|584542229|FG000|Overall Study|Adverse Event|1|||
161863374|NCT04341363|584542229|FG000|Overall Study|Withdrawal by Subject|1|||
161863375|NCT00063934|584542230|FG000|Overall Study|Ineligible|1|||
161863376|NCT03534687|584542231|FG000|Overall Study|Lost to Follow-up|7|||
161863377|NCT03534687|584542232|FG001|Overall Study|Lost to Follow-up|2|||
161863378|NCT02570308|584542235|FG000|Overall Study|Death|1|||
161863379|NCT02570308|584542236|FG001|Overall Study|Death|5|||
161863380|NCT02570308|584542237|FG002|Overall Study|Death|4|||
161863381|NCT02570308|584542238|FG003|Overall Study|Death|4|||
161863382|NCT02570308|584542239|FG004|Overall Study|Death|69|||
161863383|NCT02570308|584542235|FG000|Overall Study|Lost to Follow-up|0|||
161863384|NCT02570308|584542236|FG001|Overall Study|Lost to Follow-up|0|||
161863385|NCT02570308|584542237|FG002|Overall Study|Lost to Follow-up|0|||
161863386|NCT02570308|584542238|FG003|Overall Study|Lost to Follow-up|0|||
161863387|NCT02570308|584542239|FG004|Overall Study|Lost to Follow-up|2|||
161863388|NCT02570308|584542235|FG000|Overall Study|Withdrawal by Subject|0|||
161863389|NCT02570308|584542236|FG001|Overall Study|Withdrawal by Subject|0|||
161863390|NCT02570308|584542237|FG002|Overall Study|Withdrawal by Subject|0|||
161863391|NCT02570308|584542238|FG003|Overall Study|Withdrawal by Subject|0|||
161863392|NCT02570308|584542239|FG004|Overall Study|Withdrawal by Subject|1|||
161863393|NCT02570308|584542235|FG000|Overall Study|Other|0|||
161863394|NCT02570308|584542236|FG001|Overall Study|Other|0|||
161863395|NCT02570308|584542237|FG002|Overall Study|Other|0|||
161863396|NCT02570308|584542238|FG003|Overall Study|Other|0|||
161863397|NCT02570308|584542239|FG004|Overall Study|Other|2|||
161863398|NCT00314340|584542241|FG000|Overall Study|lost interest|1|||
161863399|NCT02069015|584542242|FG000|Overall Study|Lost to Follow-up|39|||
161863400|NCT02069015|584542243|FG001|Overall Study|Lost to Follow-up|32|||
161863401|NCT02069015|584542242|FG000|Overall Study|Withdrawal by Subject|1|||
161863402|NCT02069015|584542243|FG001|Overall Study|Withdrawal by Subject|1|||
161863403|NCT01283464|584542244|FG000|Overall Study|Lost to Follow-up|0|||
161863404|NCT01283464|584542245|FG001|Overall Study|Lost to Follow-up|1|||
161863405|NCT01283464|584542244|FG000|Overall Study|Withdrawal by Subject|1|||
161863406|NCT01283464|584542245|FG001|Overall Study|Withdrawal by Subject|0|||
161863407|NCT01283464|584542244|FG000|Overall Study|Physician Decision|1|||
161863408|NCT01283464|584542245|FG001|Overall Study|Physician Decision|0|||
161863409|NCT03051100|584542246|FG000|Overall Study|Withdrawal by Subject|1|||
161863410|NCT03051100|584542247|FG001|Overall Study|Withdrawal by Subject|0|||
161863411|NCT01286467|584542254|FG000|Overall Study|Death|1|||
161863412|NCT01286467|584542255|FG001|Overall Study|Death|1|||
161863413|NCT01286467|584542256|FG002|Overall Study|Death|1|||
161863414|NCT01286467|584542257|FG003|Overall Study|Death|0|||
161863415|NCT01286467|584542254|FG000|Overall Study|Lost to Follow-up|0|||
161863416|NCT01286467|584542255|FG001|Overall Study|Lost to Follow-up|0|||
161863417|NCT01286467|584542256|FG002|Overall Study|Lost to Follow-up|0|||
161863418|NCT01286467|584542257|FG003|Overall Study|Lost to Follow-up|1|||
161863419|NCT01286467|584542254|FG000|Overall Study|Withdrawal by Subject|0|||
161863420|NCT01286467|584542255|FG001|Overall Study|Withdrawal by Subject|0|||
161863421|NCT01286467|584542256|FG002|Overall Study|Withdrawal by Subject|1|||
161863422|NCT01286467|584542257|FG003|Overall Study|Withdrawal by Subject|0|||
161863423|NCT01286467|584542254|FG000|Overall Study|Physician Decision|0|||
161863424|NCT01286467|584542255|FG001|Overall Study|Physician Decision|0|||
161773265|NCT04888377|584214250|FG001|Overall Study|Physician Decision|6|||
161773266|NCT04888377|584214249|FG000|Overall Study|Withdrawal by Subject|7|||
161773267|NCT04888377|584214250|FG001|Overall Study|Withdrawal by Subject|3|||
161773268|NCT00526162|584214251|FG000|Overall Study|Device not implanted|3|||
161773269|NCT05279807|584214252|FG000|Overall Study|Withdrawal by Subject|1|||
161773270|NCT05279807|584214253|FG001|Overall Study|Withdrawal by Subject|0|||
161773271|NCT05279807|584214252|FG000|Overall Study|Adverse Event|0|||
161773272|NCT05279807|584214253|FG001|Overall Study|Adverse Event|1|||
161773273|NCT05279807|584214252|FG000|Overall Study|Laboratory Abnormal Results|1|||
161773274|NCT05279807|584214253|FG001|Overall Study|Laboratory Abnormal Results|0|||
161773275|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
161773276|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
161773277|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Other|2|||
161773278|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Other|0|||
161773279|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
161773280|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
161773281|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
161773282|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
161773283|NCT05299359|584214258|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
161773284|NCT05299359|584214259|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
161773285|NCT05299359|584214258|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
161773286|NCT05299359|584214259|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
161773287|NCT05299359|584214258|FG000|Extension Part: Day 1 to Day 366|Other|0|||
161773288|NCT05299359|584214259|FG001|Extension Part: Day 1 to Day 366|Other|1|||
161773289|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161773290|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
161773291|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
161773292|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773293|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773294|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773295|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773296|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773297|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
161773298|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
161773299|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161863425|NCT01286467|584542256|FG002|Overall Study|Physician Decision|0|||
161863426|NCT01286467|584542257|FG003|Overall Study|Physician Decision|1|||
161863427|NCT01286467|584542254|FG000|Overall Study|Disease progression|3|||
161863428|NCT01286467|584542255|FG001|Overall Study|Disease progression|2|||
161863429|NCT01286467|584542256|FG002|Overall Study|Disease progression|2|||
161863430|NCT01286467|584542257|FG003|Overall Study|Disease progression|3|||
161773300|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773301|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773302|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773303|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
161773304|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
161773305|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
161773306|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773307|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773308|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773309|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773310|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
161773311|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
161773312|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
161773313|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773314|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773315|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773316|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773317|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
161773318|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773319|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773320|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773321|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773322|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773323|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773324|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773325|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773326|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
161773327|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773328|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773329|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773330|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773331|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773332|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773333|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
161773334|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773335|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773336|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773337|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773338|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773339|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
161773340|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
161773341|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773342|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773343|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773344|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773345|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773346|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773347|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773348|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
161773349|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
161773350|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
161773351|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
161773352|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773353|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773354|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773355|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
161773356|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
161773357|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
161773358|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
161773359|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773360|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161863431|NCT01286467|584542254|FG000|Overall Study|Adverse Event|0|||
161863432|NCT01286467|584542255|FG001|Overall Study|Adverse Event|1|||
161863433|NCT01286467|584542256|FG002|Overall Study|Adverse Event|2|||
161863434|NCT01286467|584542257|FG003|Overall Study|Adverse Event|3|||
161863435|NCT01286467|584542254|FG000|Overall Study|Study drug stop longer than 14 days|0|||
161863436|NCT01286467|584542255|FG001|Overall Study|Study drug stop longer than 14 days|0|||
161863437|NCT01286467|584542256|FG002|Overall Study|Study drug stop longer than 14 days|1|||
161863438|NCT01286467|584542257|FG003|Overall Study|Study drug stop longer than 14 days|0|||
161863439|NCT03335475|584542258|FG000|Overall Study|Did not wear accelerometer|4|||
161863440|NCT03335475|584542259|FG001|Overall Study|Did not wear accelerometer|0|||
161863441|NCT03335475|584542258|FG000|Overall Study|Withdrawal by Subject|0|||
161863442|NCT03335475|584542259|FG001|Overall Study|Withdrawal by Subject|1|||
161863443|NCT04886596|584542260|FG000|Overall Study|Adverse Event|442|||
161863444|NCT04886596|584542261|FG001|Overall Study|Adverse Event|441|||
161863445|NCT04886596|584542260|FG000|Overall Study|Lost to Follow-up|448|||
161863446|NCT04886596|584542261|FG001|Overall Study|Lost to Follow-up|465|||
161863447|NCT04886596|584542260|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
161863448|NCT04886596|584542261|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
161863449|NCT04886596|584542260|FG000|Overall Study|Migrated/moved from the study area|201|||
161863450|NCT04886596|584542261|FG001|Overall Study|Migrated/moved from the study area|184|||
161863451|NCT04886596|584542260|FG000|Overall Study|Other|298|||
161863452|NCT04886596|584542261|FG001|Overall Study|Other|326|||
161863453|NCT03751098|584542264|FG000|Overall Study|Withdrawal by Subject|0|||
161863454|NCT03751098|584542265|FG001|Overall Study|Withdrawal by Subject|1|||
161863455|NCT05921903|584542266|FG000|Overall Study|Unsolicited non-SAE|0|||
161863456|NCT05921903|584542267|FG001|Overall Study|Unsolicited non-SAE|1|||
161863457|NCT05921903|584542268|FG002|Overall Study|Unsolicited non-SAE|0|||
161863458|NCT05921903|584542266|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
161863459|NCT05921903|584542267|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
161863460|NCT05921903|584542268|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
161863461|NCT05921903|584542266|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
161863462|NCT05921903|584542267|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
161863463|NCT05921903|584542268|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
161863464|NCT03305848|584542269|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
161863465|NCT03305848|584542269|FG000|Overall Study|Physician Decision|2|||
161863466|NCT01060072|584542273|FG000|Overall Study|Adverse Event|1|||
161863467|NCT01060072|584542274|FG001|Overall Study|Adverse Event|1|||
161863468|NCT01060072|584542273|FG000|Overall Study|Physician Decision|0|||
161863469|NCT01060072|584542274|FG001|Overall Study|Physician Decision|2|||
161863470|NCT01060072|584542273|FG000|Overall Study|Protocol Violation|0|||
161863471|NCT01060072|584542274|FG001|Overall Study|Protocol Violation|1|||
161863472|NCT01060072|584542273|FG000|Overall Study|Acute cholecystitis|1|||
161863473|NCT01060072|584542274|FG001|Overall Study|Acute cholecystitis|0|||
161863474|NCT01060072|584542273|FG000|Overall Study|Excluded Medications|0|||
161863475|NCT01060072|584542274|FG001|Overall Study|Excluded Medications|1|||
161863476|NCT02301169|584542275|FG000|Overall Study|Adverse Event|1|||
161863477|NCT02301169|584542276|FG001|Overall Study|Adverse Event|0|||
161863478|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
161863479|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
161863480|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
161863481|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
161863482|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
161863483|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
161863484|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
161863485|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
161863486|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
161863487|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
161863488|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Other|0|||
161863489|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Other|1|||
161863490|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
161863491|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
161863492|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
161863493|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
161863494|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
161863495|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
161863496|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
161863497|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
161863498|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
161863499|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
161863500|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
161863501|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
161863502|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
161863503|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
161863504|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
161863505|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
161863506|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Other|1|||
161863507|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Other|0|||
161863508|NCT00765102|584542279|FG000|Overall Study|Progressive disease|18|||
161863509|NCT00765102|584542279|FG000|Overall Study|Adverse Event|6|||
161863510|NCT00765102|584542279|FG000|Overall Study|Physician Decision|4|||
161863511|NCT00765102|584542279|FG000|Overall Study|Withdrawal by Subject|2|||
161863512|NCT00765102|584542279|FG000|Overall Study|Protocol Violation|1|||
161863513|NCT02289729|584542283|FG000|Overall Study|Lack of Efficacy|3|||
161863514|NCT02289729|584542283|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
161863515|NCT02289729|584542283|FG000|Overall Study|Withdrawal by Subject|1|||
161863516|NCT02289729|584542283|FG000|Overall Study|Death|1|||
161863517|NCT00470470|584542284|FG000|Overall Study|Adverse Event|2|||
161863518|NCT00470470|584542284|FG000|Overall Study|Death|2|||
161863519|NCT00470470|584542284|FG000|Overall Study|Not treated|1|||
161863520|NCT01149863|584542296|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
161863521|NCT03326193|584542298|FG000|Overall Study|Sponsor decision|35|||
161773361|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773362|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161863522|NCT00822692|584542301|FG000|Overall Study|Lost to Follow-up|17|||
161863523|NCT00822692|584542302|FG001|Overall Study|Lost to Follow-up|25|||
161863524|NCT01964976|584542303|FG000|Overall Study|Protocol Violation|31|||
161863525|NCT02452476|584542304|FG000|Overall Study|Death|4|||
161863526|NCT02452476|584542305|FG001|Overall Study|Death|7|||
161863527|NCT02452476|584542304|FG000|Overall Study|Lost to Follow-up|1|||
161863528|NCT02452476|584542305|FG001|Overall Study|Lost to Follow-up|1|||
161863529|NCT02452476|584542304|FG000|Overall Study|Physician Decision|1|||
161863530|NCT02452476|584542305|FG001|Overall Study|Physician Decision|1|||
161863531|NCT02452476|584542304|FG000|Overall Study|Not treated|5|||
161863532|NCT02452476|584542305|FG001|Overall Study|Not treated|1|||
161863533|NCT02348112|584542306|FG000|Overall Study|Withdrawal by Subject|32|||
161863534|NCT02348112|584542307|FG001|Overall Study|Withdrawal by Subject|29|||
161863535|NCT02348112|584542306|FG000|Overall Study|Lost to Follow-up|24|||
161863536|NCT02348112|584542307|FG001|Overall Study|Lost to Follow-up|20|||
161863537|NCT02348112|584542306|FG000|Overall Study|Physician Decision|17|||
161863538|NCT02348112|584542307|FG001|Overall Study|Physician Decision|15|||
161863539|NCT02348112|584542306|FG000|Overall Study|Site closed due to PI leaving|0|||
161863540|NCT02348112|584542307|FG001|Overall Study|Site closed due to PI leaving|30|||
161863541|NCT02348112|584542306|FG000|Overall Study|Sponsor withdrawal|0|||
161863542|NCT02348112|584542307|FG001|Overall Study|Sponsor withdrawal|7|||
161863543|NCT02348112|584542306|FG000|Overall Study|Death|0|||
161773363|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161863544|NCT02348112|584542307|FG001|Overall Study|Death|1|||
161863545|NCT01408043|584542308|FG000|Overall Study|unable to collect cells|1|||
161863546|NCT00946920|584542310|FG000|Overall Study|Withdrawal by Subject|28|||
161863547|NCT00946920|584542311|FG001|Overall Study|Withdrawal by Subject|15|||
161863548|NCT00946920|584542310|FG000|Overall Study|Lost to Follow-up|2|||
161863549|NCT00946920|584542311|FG001|Overall Study|Lost to Follow-up|2|||
161863550|NCT00946920|584542310|FG000|Overall Study|Physician Decision|5|||
161863551|NCT00946920|584542311|FG001|Overall Study|Physician Decision|2|||
161863552|NCT00946920|584542310|FG000|Overall Study|Adverse Event|41|||
161863553|NCT00946920|584542311|FG001|Overall Study|Adverse Event|14|||
161863554|NCT00946920|584542310|FG000|Overall Study|Protocol Violation|16|||
161863555|NCT00946920|584542311|FG001|Overall Study|Protocol Violation|8|||
161863556|NCT00946920|584542310|FG000|Overall Study|Miscellaneous reasons|18|||
161863557|NCT00946920|584542311|FG001|Overall Study|Miscellaneous reasons|3|||
161863558|NCT00397514|584542312|FG000|Overall Study|Withdrawal by Subject|1|||
161863559|NCT00397514|584542312|FG000|Overall Study|Pacing wire malfunction|1|||
161863560|NCT00397514|584542312|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
161863561|NCT00397514|584542312|FG000|Overall Study|early extubation|2|||
161863562|NCT00397514|584542312|FG000|Overall Study|poor echocardiographic windows|1|||
161863563|NCT01530464|584542313|FG000|Washout (24h)|Withdrawal by Subject|1|||
161863564|NCT01530464|584542314|FG001|Washout (24h)|Withdrawal by Subject|0|||
161863565|NCT01530464|584542313|FG000|Washout (24h)|Withdrawal by Subject|0|||
161863566|NCT01530464|584542314|FG001|Washout (24h)|Withdrawal by Subject|1|||
161863567|NCT01709500|584542315|FG000|Overall Study|Randomized but not treated|0|||
161863568|NCT01709500|584542316|FG001|Overall Study|Randomized but not treated|1|||
161863569|NCT01709500|584542315|FG000|Overall Study|Adverse Event|5|||
161863570|NCT01709500|584542316|FG001|Overall Study|Adverse Event|1|||
161863571|NCT01709500|584542315|FG000|Overall Study|Poor compliance to protocol|2|||
161863572|NCT01709500|584542316|FG001|Overall Study|Poor compliance to protocol|1|||
161863573|NCT01709500|584542315|FG000|Overall Study|Other|3|||
161863574|NCT01709500|584542316|FG001|Overall Study|Other|1|||
161863575|NCT01709500|584542315|FG000|Overall Study|Related to IMP administration|1|||
161863576|NCT01709500|584542316|FG001|Overall Study|Related to IMP administration|0|||
161863577|NCT01709500|584542315|FG000|Overall Study|Treatment ongoing|156|||
161863578|NCT01709500|584542316|FG001|Overall Study|Treatment ongoing|78|||
161863579|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
161863580|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
161863581|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
161863582|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161863583|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161863584|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161863585|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161863586|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161863587|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161863588|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Other|1|||
161863589|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Other|0|||
161863590|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Other|4|||
161863591|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161863592|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161863593|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
161863594|NCT06389487|584542326|FG000|Overall Study|Lost to Follow-up|9|||
161863595|NCT06389487|584542327|FG001|Overall Study|Lost to Follow-up|5|||
161863596|NCT06389487|584542328|FG002|Overall Study|Lost to Follow-up|13|||
161863597|NCT06389487|584542326|FG000|Overall Study|Protocol Violation|0|||
161863598|NCT06389487|584542327|FG001|Overall Study|Protocol Violation|0|||
161863599|NCT06389487|584542328|FG002|Overall Study|Protocol Violation|2|||
161863600|NCT06389487|584542326|FG000|Overall Study|Withdrawal by Subject|2|||
161863601|NCT06389487|584542327|FG001|Overall Study|Withdrawal by Subject|2|||
161863602|NCT06389487|584542328|FG002|Overall Study|Withdrawal by Subject|1|||
161863603|NCT06389487|584542326|FG000|Overall Study|Other|1|||
161863604|NCT06389487|584542327|FG001|Overall Study|Other|0|||
161863605|NCT06389487|584542328|FG002|Overall Study|Other|1|||
161863606|NCT00955409|584544028|FG000|Overall Study|Lack of Efficacy|1|||
161863607|NCT00955409|584544029|FG001|Overall Study|Lack of Efficacy|0|||
161863608|NCT00955409|584544030|FG002|Overall Study|Lack of Efficacy|0|||
161863609|NCT00955409|584544031|FG003|Overall Study|Lack of Efficacy|0|||
161863610|NCT00955409|584544032|FG004|Overall Study|Lack of Efficacy|0|||
161863611|NCT00955409|584544033|FG005|Overall Study|Lack of Efficacy|0|||
161863612|NCT00955409|584544034|FG006|Overall Study|Lack of Efficacy|0|||
161863613|NCT00955409|584544035|FG007|Overall Study|Lack of Efficacy|0|||
161863614|NCT00955409|584544036|FG008|Overall Study|Lack of Efficacy|0|||
161863615|NCT00955409|584544037|FG009|Overall Study|Lack of Efficacy|0|||
161863616|NCT00955409|584544028|FG000|Overall Study|Withdrawal by Subject|1|||
161863617|NCT00955409|584544029|FG001|Overall Study|Withdrawal by Subject|0|||
161863618|NCT00955409|584544030|FG002|Overall Study|Withdrawal by Subject|5|||
161863619|NCT00955409|584544031|FG003|Overall Study|Withdrawal by Subject|2|||
161863620|NCT00955409|584544032|FG004|Overall Study|Withdrawal by Subject|0|||
161863621|NCT00955409|584544033|FG005|Overall Study|Withdrawal by Subject|0|||
161863622|NCT00955409|584544034|FG006|Overall Study|Withdrawal by Subject|2|||
161773364|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161773365|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161773366|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161773367|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161773368|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161773369|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161773370|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
161773371|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161773372|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161773373|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161773374|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161773375|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161773376|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
161773377|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
161773378|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
161773379|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
161773380|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773381|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773382|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773383|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
161773384|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773385|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773386|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773387|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773388|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773389|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773390|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773391|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
161773392|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773393|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773394|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773395|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773396|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773397|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773398|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
161773399|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773400|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773401|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773402|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773403|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773404|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773405|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
161773406|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773407|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773408|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773409|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773410|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773411|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773412|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
161773413|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773414|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773415|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773416|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773417|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773418|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773419|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
161773420|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773421|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773422|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773423|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773424|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773425|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773426|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773427|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
161773428|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773429|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773430|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773431|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773432|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773433|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773434|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
161773435|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773436|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773437|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773438|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773439|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773440|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773441|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773442|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
161773443|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773444|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773445|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773446|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773447|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773448|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773449|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
161773450|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773451|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773452|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773453|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773454|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773455|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773456|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
161773457|NCT03587116|584214267|FG000|Overall Study|Lost to Follow-up|0|||
161773458|NCT03587116|584214268|FG001|Overall Study|Lost to Follow-up|1|||
161773459|NCT03587116|584214267|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
161773460|NCT03587116|584214268|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
161773461|NCT03587116|584214267|FG000|Overall Study|Withdrawal by Subject|4|||
161773462|NCT03587116|584214268|FG001|Overall Study|Withdrawal by Subject|0|||
161773463|NCT05993299|584214271|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
161773464|NCT05993299|584214271|FG000|Overall Study|Ongoing|4|||
161773465|NCT05644756|584214272|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
161773466|NCT05644756|584214272|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
161773467|NCT03110107|584214273|FG000|Treatment Period|Disease Progression|3|||
161773468|NCT03110107|584214274|FG001|Treatment Period|Disease Progression|9|||
161773469|NCT03110107|584214275|FG002|Treatment Period|Disease Progression|8|||
161773470|NCT03110107|584214276|FG003|Treatment Period|Disease Progression|11|||
161773471|NCT03110107|584214277|FG004|Treatment Period|Disease Progression|8|||
161773472|NCT03110107|584214278|FG005|Treatment Period|Disease Progression|4|||
161773473|NCT03110107|584214279|FG006|Treatment Period|Disease Progression|6|||
161773474|NCT03110107|584214280|FG007|Treatment Period|Disease Progression|7|||
161773475|NCT03110107|584214281|FG008|Treatment Period|Disease Progression|2|||
161773476|NCT03110107|584214282|FG009|Treatment Period|Disease Progression|10|||
161773477|NCT03110107|584214283|FG010|Treatment Period|Disease Progression|5|||
161773478|NCT03110107|584214284|FG011|Treatment Period|Disease Progression|2|||
161773479|NCT03110107|584214285|FG012|Treatment Period|Disease Progression|0|||
161773480|NCT03110107|584214286|FG013|Treatment Period|Disease Progression|5|||
161773481|NCT03110107|584214287|FG014|Treatment Period|Disease Progression|14|||
161773482|NCT03110107|584214288|FG015|Treatment Period|Disease Progression|14|||
161773483|NCT03110107|584214289|FG016|Treatment Period|Disease Progression|4|||
161773484|NCT03110107|584214290|FG017|Treatment Period|Disease Progression|3|||
161773485|NCT03110107|584214291|FG018|Treatment Period|Disease Progression|16|||
161773486|NCT03110107|584214292|FG019|Treatment Period|Disease Progression|14|||
161773487|NCT03110107|584214293|FG020|Treatment Period|Disease Progression|12|||
161773488|NCT03110107|584214294|FG021|Treatment Period|Disease Progression|16|||
161773489|NCT03110107|584214295|FG022|Treatment Period|Disease Progression|18|||
161773490|NCT03110107|584214296|FG023|Treatment Period|Disease Progression|13|||
161773491|NCT03110107|584214297|FG024|Treatment Period|Disease Progression|16|||
161773492|NCT03110107|584214298|FG025|Treatment Period|Disease Progression|31|||
161773493|NCT03110107|584214273|FG000|Treatment Period|Study drug toxicity|1|||
161863623|NCT00955409|584544035|FG007|Overall Study|Withdrawal by Subject|0|||
161773494|NCT03110107|584214274|FG001|Treatment Period|Study drug toxicity|0|||
161773495|NCT03110107|584214275|FG002|Treatment Period|Study drug toxicity|1|||
161773496|NCT03110107|584214276|FG003|Treatment Period|Study drug toxicity|2|||
161773497|NCT03110107|584214277|FG004|Treatment Period|Study drug toxicity|0|||
161773498|NCT03110107|584214278|FG005|Treatment Period|Study drug toxicity|3|||
161773499|NCT03110107|584214279|FG006|Treatment Period|Study drug toxicity|1|||
161773500|NCT03110107|584214280|FG007|Treatment Period|Study drug toxicity|1|||
161773501|NCT03110107|584214281|FG008|Treatment Period|Study drug toxicity|3|||
161773502|NCT03110107|584214282|FG009|Treatment Period|Study drug toxicity|2|||
161773503|NCT03110107|584214283|FG010|Treatment Period|Study drug toxicity|0|||
161773504|NCT03110107|584214284|FG011|Treatment Period|Study drug toxicity|2|||
161773505|NCT03110107|584214285|FG012|Treatment Period|Study drug toxicity|0|||
161773506|NCT03110107|584214286|FG013|Treatment Period|Study drug toxicity|0|||
161773507|NCT03110107|584214287|FG014|Treatment Period|Study drug toxicity|2|||
161773508|NCT03110107|584214288|FG015|Treatment Period|Study drug toxicity|3|||
161773509|NCT03110107|584214289|FG016|Treatment Period|Study drug toxicity|3|||
161773510|NCT03110107|584214290|FG017|Treatment Period|Study drug toxicity|3|||
161773511|NCT03110107|584214291|FG018|Treatment Period|Study drug toxicity|1|||
161773512|NCT03110107|584214292|FG019|Treatment Period|Study drug toxicity|2|||
161773513|NCT03110107|584214293|FG020|Treatment Period|Study drug toxicity|2|||
161773514|NCT03110107|584214294|FG021|Treatment Period|Study drug toxicity|0|||
161773515|NCT03110107|584214295|FG022|Treatment Period|Study drug toxicity|2|||
161773516|NCT03110107|584214296|FG023|Treatment Period|Study drug toxicity|6|||
161773517|NCT03110107|584214297|FG024|Treatment Period|Study drug toxicity|7|||
161773518|NCT03110107|584214298|FG025|Treatment Period|Study drug toxicity|6|||
161773519|NCT03110107|584214273|FG000|Treatment Period|Death|0|||
161773520|NCT03110107|584214274|FG001|Treatment Period|Death|0|||
161773521|NCT03110107|584214275|FG002|Treatment Period|Death|0|||
161773522|NCT03110107|584214276|FG003|Treatment Period|Death|0|||
161773523|NCT03110107|584214277|FG004|Treatment Period|Death|0|||
161773524|NCT03110107|584214278|FG005|Treatment Period|Death|0|||
161863624|NCT00955409|584544036|FG008|Overall Study|Withdrawal by Subject|1|||
161863625|NCT00955409|584544037|FG009|Overall Study|Withdrawal by Subject|0|||
161863626|NCT00955409|584544028|FG000|Overall Study|Caregiver Request|2|||
161863627|NCT00955409|584544029|FG001|Overall Study|Caregiver Request|0|||
161863628|NCT00955409|584544030|FG002|Overall Study|Caregiver Request|6|||
161863629|NCT00955409|584544031|FG003|Overall Study|Caregiver Request|5|||
161863630|NCT00955409|584544032|FG004|Overall Study|Caregiver Request|0|||
161863631|NCT00955409|584544033|FG005|Overall Study|Caregiver Request|2|||
161863632|NCT00955409|584544034|FG006|Overall Study|Caregiver Request|3|||
161863633|NCT00955409|584544035|FG007|Overall Study|Caregiver Request|1|||
161863634|NCT00955409|584544036|FG008|Overall Study|Caregiver Request|3|||
161863635|NCT00955409|584544037|FG009|Overall Study|Caregiver Request|0|||
161863636|NCT00955409|584544028|FG000|Overall Study|Investigator Request|0|||
161863637|NCT00955409|584544029|FG001|Overall Study|Investigator Request|0|||
161863638|NCT00955409|584544030|FG002|Overall Study|Investigator Request|1|||
161863639|NCT00955409|584544031|FG003|Overall Study|Investigator Request|0|||
161863640|NCT00955409|584544032|FG004|Overall Study|Investigator Request|0|||
161863641|NCT00955409|584544033|FG005|Overall Study|Investigator Request|0|||
161863642|NCT00955409|584544034|FG006|Overall Study|Investigator Request|0|||
161863643|NCT00955409|584544035|FG007|Overall Study|Investigator Request|0|||
161863644|NCT00955409|584544036|FG008|Overall Study|Investigator Request|0|||
161863645|NCT00955409|584544037|FG009|Overall Study|Investigator Request|0|||
161863646|NCT00955409|584544028|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161863647|NCT00955409|584544029|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161863648|NCT00955409|584544030|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161863649|NCT00955409|584544031|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161863650|NCT00955409|584544032|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161863651|NCT00955409|584544033|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161863652|NCT00955409|584544034|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
161863653|NCT00955409|584544035|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
161863654|NCT00955409|584544036|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
161863655|NCT00955409|584544037|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
161863656|NCT00955409|584544028|FG000|Overall Study|Lost to Follow-up|0|||
161863657|NCT00955409|584544029|FG001|Overall Study|Lost to Follow-up|0|||
161863658|NCT00955409|584544030|FG002|Overall Study|Lost to Follow-up|1|||
161863659|NCT00955409|584544031|FG003|Overall Study|Lost to Follow-up|0|||
161863660|NCT00955409|584544032|FG004|Overall Study|Lost to Follow-up|0|||
161863661|NCT00955409|584544033|FG005|Overall Study|Lost to Follow-up|0|||
161863662|NCT00955409|584544034|FG006|Overall Study|Lost to Follow-up|1|||
161863663|NCT00955409|584544035|FG007|Overall Study|Lost to Follow-up|0|||
161773525|NCT03110107|584214279|FG006|Treatment Period|Death|0|||
161773526|NCT03110107|584214280|FG007|Treatment Period|Death|0|||
161773527|NCT03110107|584214281|FG008|Treatment Period|Death|0|||
161773528|NCT03110107|584214282|FG009|Treatment Period|Death|0|||
161773529|NCT03110107|584214283|FG010|Treatment Period|Death|0|||
161773530|NCT03110107|584214284|FG011|Treatment Period|Death|0|||
161773531|NCT03110107|584214285|FG012|Treatment Period|Death|1|||
161773532|NCT03110107|584214286|FG013|Treatment Period|Death|0|||
161773533|NCT03110107|584214287|FG014|Treatment Period|Death|0|||
161773534|NCT03110107|584214288|FG015|Treatment Period|Death|0|||
161773535|NCT03110107|584214289|FG016|Treatment Period|Death|0|||
161773536|NCT03110107|584214290|FG017|Treatment Period|Death|0|||
161773537|NCT03110107|584214291|FG018|Treatment Period|Death|0|||
161773538|NCT03110107|584214292|FG019|Treatment Period|Death|0|||
161773539|NCT03110107|584214293|FG020|Treatment Period|Death|0|||
161863664|NCT00955409|584544036|FG008|Overall Study|Lost to Follow-up|0|||
161863665|NCT00955409|584544037|FG009|Overall Study|Lost to Follow-up|0|||
161773540|NCT03110107|584214294|FG021|Treatment Period|Death|0|||
161773541|NCT03110107|584214295|FG022|Treatment Period|Death|0|||
161773542|NCT03110107|584214296|FG023|Treatment Period|Death|0|||
161773543|NCT03110107|584214297|FG024|Treatment Period|Death|0|||
161773544|NCT03110107|584214298|FG025|Treatment Period|Death|0|||
161773545|NCT03110107|584214273|FG000|Treatment Period|Adverse Event|0|||
161773546|NCT03110107|584214274|FG001|Treatment Period|Adverse Event|0|||
161773547|NCT03110107|584214275|FG002|Treatment Period|Adverse Event|1|||
161773548|NCT03110107|584214276|FG003|Treatment Period|Adverse Event|0|||
161773549|NCT03110107|584214277|FG004|Treatment Period|Adverse Event|0|||
161773550|NCT03110107|584214278|FG005|Treatment Period|Adverse Event|2|||
161773551|NCT03110107|584214279|FG006|Treatment Period|Adverse Event|0|||
161773552|NCT03110107|584214280|FG007|Treatment Period|Adverse Event|2|||
161773553|NCT03110107|584214281|FG008|Treatment Period|Adverse Event|0|||
161773554|NCT03110107|584214282|FG009|Treatment Period|Adverse Event|1|||
161773555|NCT03110107|584214283|FG010|Treatment Period|Adverse Event|0|||
161773556|NCT03110107|584214284|FG011|Treatment Period|Adverse Event|0|||
161773557|NCT03110107|584214285|FG012|Treatment Period|Adverse Event|0|||
161773558|NCT03110107|584214286|FG013|Treatment Period|Adverse Event|0|||
161773559|NCT03110107|584214287|FG014|Treatment Period|Adverse Event|0|||
161773560|NCT03110107|584214288|FG015|Treatment Period|Adverse Event|2|||
161773561|NCT03110107|584214289|FG016|Treatment Period|Adverse Event|0|||
161773562|NCT03110107|584214290|FG017|Treatment Period|Adverse Event|1|||
161773563|NCT03110107|584214291|FG018|Treatment Period|Adverse Event|2|||
161773564|NCT03110107|584214292|FG019|Treatment Period|Adverse Event|1|||
161773565|NCT03110107|584214293|FG020|Treatment Period|Adverse Event|4|||
161773566|NCT03110107|584214294|FG021|Treatment Period|Adverse Event|2|||
161773567|NCT03110107|584214295|FG022|Treatment Period|Adverse Event|2|||
161773568|NCT03110107|584214296|FG023|Treatment Period|Adverse Event|2|||
161773569|NCT03110107|584214297|FG024|Treatment Period|Adverse Event|2|||
161773570|NCT03110107|584214298|FG025|Treatment Period|Adverse Event|4|||
161773571|NCT03110107|584214273|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
161773572|NCT03110107|584214274|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
161773573|NCT03110107|584214275|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
161773574|NCT03110107|584214276|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
161773575|NCT03110107|584214277|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
161773576|NCT03110107|584214278|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
161773577|NCT03110107|584214279|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
161773578|NCT03110107|584214280|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
161773579|NCT03110107|584214281|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
161773580|NCT03110107|584214282|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
161773581|NCT03110107|584214283|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
161773582|NCT03110107|584214284|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
161773583|NCT03110107|584214285|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
161773584|NCT03110107|584214286|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
161773585|NCT03110107|584214287|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
161773586|NCT03110107|584214288|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
161773587|NCT03110107|584214289|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
161773588|NCT03110107|584214290|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
161773589|NCT03110107|584214291|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
161773590|NCT03110107|584214292|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
161773591|NCT03110107|584214293|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
161773592|NCT03110107|584214294|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
161773593|NCT03110107|584214295|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
161773594|NCT03110107|584214296|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
161773595|NCT03110107|584214297|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
161773596|NCT03110107|584214298|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
161773597|NCT03110107|584214273|FG000|Treatment Period|Participant withdrew consent|0|||
161773598|NCT03110107|584214274|FG001|Treatment Period|Participant withdrew consent|0|||
161773599|NCT03110107|584214275|FG002|Treatment Period|Participant withdrew consent|1|||
161773600|NCT03110107|584214276|FG003|Treatment Period|Participant withdrew consent|0|||
161773601|NCT03110107|584214277|FG004|Treatment Period|Participant withdrew consent|4|||
161773602|NCT03110107|584214278|FG005|Treatment Period|Participant withdrew consent|3|||
161863666|NCT00955409|584544028|FG000|Overall Study|Failed to Return|2|||
161863667|NCT00955409|584544029|FG001|Overall Study|Failed to Return|0|||
161863668|NCT00955409|584544030|FG002|Overall Study|Failed to Return|0|||
161863669|NCT00955409|584544031|FG003|Overall Study|Failed to Return|0|||
161863670|NCT00955409|584544032|FG004|Overall Study|Failed to Return|0|||
161863671|NCT00955409|584544033|FG005|Overall Study|Failed to Return|0|||
161863672|NCT00955409|584544034|FG006|Overall Study|Failed to Return|0|||
161863673|NCT00955409|584544035|FG007|Overall Study|Failed to Return|2|||
161863674|NCT00955409|584544036|FG008|Overall Study|Failed to Return|0|||
161863675|NCT00955409|584544037|FG009|Overall Study|Failed to Return|0|||
161863676|NCT00955409|584544028|FG000|Overall Study|Adverse Event (AE)|2|||
161863677|NCT00955409|584544029|FG001|Overall Study|Adverse Event (AE)|0|||
161863678|NCT00955409|584544030|FG002|Overall Study|Adverse Event (AE)|0|||
161863679|NCT00955409|584544031|FG003|Overall Study|Adverse Event (AE)|0|||
161863680|NCT00955409|584544032|FG004|Overall Study|Adverse Event (AE)|0|||
161863681|NCT00955409|584544033|FG005|Overall Study|Adverse Event (AE)|1|||
161863682|NCT00955409|584544034|FG006|Overall Study|Adverse Event (AE)|2|||
161863683|NCT00955409|584544035|FG007|Overall Study|Adverse Event (AE)|0|||
161863684|NCT00955409|584544036|FG008|Overall Study|Adverse Event (AE)|2|||
161863685|NCT00955409|584544037|FG009|Overall Study|Adverse Event (AE)|0|||
161863686|NCT00955409|584544028|FG000|Overall Study|Reason not Specified|2|||
161863687|NCT00955409|584544029|FG001|Overall Study|Reason not Specified|1|||
161863688|NCT00955409|584544030|FG002|Overall Study|Reason not Specified|13|||
161863689|NCT00955409|584544031|FG003|Overall Study|Reason not Specified|1|||
161863690|NCT00955409|584544032|FG004|Overall Study|Reason not Specified|2|||
161863691|NCT00955409|584544033|FG005|Overall Study|Reason not Specified|0|||
161863692|NCT00955409|584544034|FG006|Overall Study|Reason not Specified|16|||
161863693|NCT00955409|584544035|FG007|Overall Study|Reason not Specified|0|||
161863694|NCT00955409|584544036|FG008|Overall Study|Reason not Specified|8|||
161863695|NCT00955409|584544037|FG009|Overall Study|Reason not Specified|1|||
161863696|NCT00485732|584544038|FG000|Overall Study|Protocol Violation|1|||
161863697|NCT00485732|584544039|FG001|Overall Study|Protocol Violation|3|||
161863698|NCT00485732|584544038|FG000|Overall Study|Withdrawal by Subject|5|||
161863699|NCT00485732|584544039|FG001|Overall Study|Withdrawal by Subject|4|||
161863700|NCT00485732|584544038|FG000|Overall Study|Lost to Follow-up|2|||
161863701|NCT00485732|584544039|FG001|Overall Study|Lost to Follow-up|2|||
161863702|NCT05423093|584544041|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
161863703|NCT05423093|584544041|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
161863704|NCT05423093|584544041|FG000|Attended Intervention Session|Lost to Follow-up|3|||
161863705|NCT05423093|584544041|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
161863706|NCT05423093|584544041|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
161863707|NCT03593525|584544042|FG000|Overall Study|Withdrawal by Subject|1|||
161863708|NCT03593525|584544043|FG001|Overall Study|Withdrawal by Subject|0|||
161863709|NCT03593525|584544042|FG000|Overall Study|Lost to Follow-up|7|||
161863710|NCT03593525|584544043|FG001|Overall Study|Lost to Follow-up|5|||
161863711|NCT00210210|584544051|FG000|Overall Study|Withdrawal by Subject|3|||
161863712|NCT00210210|584544052|FG001|Overall Study|Withdrawal by Subject|2|||
161863713|NCT00210210|584544051|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
161863714|NCT00210210|584544052|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
161863715|NCT02445248|584544057|FG000|Overall Study|Death|45|||
161863716|NCT02445248|584544058|FG001|Overall Study|Death|12|||
161863717|NCT02445248|584544057|FG000|Overall Study|Progressive disease|13|||
161863718|NCT02445248|584544058|FG001|Overall Study|Progressive disease|1|||
161863719|NCT02445248|584544057|FG000|Overall Study|Subject decision|8|||
161863720|NCT02445248|584544058|FG001|Overall Study|Subject decision|0|||
161863721|NCT02445248|584544057|FG000|Overall Study|Physician Decision|5|||
161863722|NCT02445248|584544058|FG001|Overall Study|Physician Decision|0|||
161863723|NCT02445248|584544057|FG000|Overall Study|Adverse Event|1|||
161863724|NCT02445248|584544058|FG001|Overall Study|Adverse Event|0|||
161863725|NCT02445248|584544057|FG000|Overall Study|Lost to Follow-up|1|||
161863726|NCT02445248|584544058|FG001|Overall Study|Lost to Follow-up|0|||
161863727|NCT01120184|584544059|FG000|Overall Study|Adverse Event|0|||
161863728|NCT01120184|584544060|FG001|Overall Study|Adverse Event|1|||
161863729|NCT01120184|584544061|FG002|Overall Study|Adverse Event|0|||
161863730|NCT01120184|584544059|FG000|Overall Study|Lost to Follow-up|13|||
161863731|NCT01120184|584544060|FG001|Overall Study|Lost to Follow-up|13|||
161863732|NCT01120184|584544061|FG002|Overall Study|Lost to Follow-up|11|||
161863733|NCT01120184|584544059|FG000|Overall Study|Physician Decision|9|||
161863734|NCT01120184|584544060|FG001|Overall Study|Physician Decision|1|||
161863735|NCT01120184|584544061|FG002|Overall Study|Physician Decision|3|||
161863736|NCT01120184|584544059|FG000|Overall Study|Reason not Specified|8|||
161863737|NCT01120184|584544060|FG001|Overall Study|Reason not Specified|3|||
161863738|NCT01120184|584544061|FG002|Overall Study|Reason not Specified|12|||
161863739|NCT01120184|584544059|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
161863740|NCT01120184|584544060|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
161863741|NCT01120184|584544061|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
161863742|NCT01120184|584544059|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
161863743|NCT01120184|584544060|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
161863744|NCT01120184|584544061|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
161863745|NCT01120184|584544059|FG000|Overall Study|Death|170|||
161863746|NCT01120184|584544060|FG001|Overall Study|Death|176|||
161863747|NCT01120184|584544061|FG002|Overall Study|Death|169|||
161863748|NCT02596971|584544064|FG000|Overall Study|Death|5|||
161863749|NCT02596971|584544065|FG001|Overall Study|Death|1|||
161863750|NCT02596971|584544066|FG002|Overall Study|Death|5|||
161863751|NCT02596971|584544064|FG000|Overall Study|Withdrawal by Subject|5|||
161863752|NCT02596971|584544065|FG001|Overall Study|Withdrawal by Subject|1|||
161863753|NCT02596971|584544066|FG002|Overall Study|Withdrawal by Subject|4|||
161863754|NCT00824772|584544067|FG000|Overall Study|Withdrawal by Subject|8|||
161863755|NCT02764762|584544071|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161863756|NCT02764762|584544071|FG000|Overall Study|Lost to Follow-up|4|||
161863757|NCT02764762|584544071|FG000|Overall Study|Voluntary Withdrawal|8|||
161863758|NCT02764762|584544071|FG000|Overall Study|Site Termination|1|||
161863759|NCT02764762|584544071|FG000|Overall Study|Lack of Efficacy|16|||
161863760|NCT02764762|584544071|FG000|Overall Study|Reason not Specified|1|||
161863761|NCT01002989|584544072|FG000|Overall Study|exclusion criteria, no consent|5|||
161863762|NCT02954601|584544073|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
161863763|NCT02954601|584544074|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
161863764|NCT02954601|584544075|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
161863765|NCT02954601|584544076|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
161863766|NCT00318474|584544077|FG000|Overall Study|Adverse Event|1|||
161863767|NCT00318474|584544078|FG001|Overall Study|Adverse Event|1|||
161863768|NCT00318474|584544077|FG000|Overall Study|Lost to Follow-up|0|||
161863769|NCT00318474|584544078|FG001|Overall Study|Lost to Follow-up|1|||
161863770|NCT00318474|584544077|FG000|Overall Study|Pregnancy|0|||
161863771|NCT00318474|584544078|FG001|Overall Study|Pregnancy|2|||
161863772|NCT00318474|584544077|FG000|Overall Study|Protocol Violation|1|||
161863773|NCT00318474|584544078|FG001|Overall Study|Protocol Violation|0|||
161863774|NCT00318474|584544077|FG000|Overall Study|Withdrawal by Subject|3|||
161863775|NCT00318474|584544078|FG001|Overall Study|Withdrawal by Subject|2|||
161863776|NCT00318474|584544077|FG000|Overall Study|Fall in GFR|3|||
161863777|NCT00318474|584544078|FG001|Overall Study|Fall in GFR|3|||
161863778|NCT00318474|584544077|FG000|Overall Study|Post-therapy hyperflycemia|0|||
161863779|NCT00318474|584544078|FG001|Overall Study|Post-therapy hyperflycemia|1|||
161863780|NCT00318474|584544077|FG000|Overall Study|Trial terminated|10|||
161863781|NCT00318474|584544078|FG001|Overall Study|Trial terminated|7|||
161863782|NCT00917852|584544082|FG000|Overall Study|Death|6|||
161863783|NCT00471081|584544083|FG000|Active Phase|Protocol Violation|1|||
161863784|NCT00471081|584544084|FG001|Active Phase|Protocol Violation|1|||
161863785|NCT00471081|584544083|FG000|Active Phase|Withdrawal by Subject|0|||
161863786|NCT00471081|584544084|FG001|Active Phase|Withdrawal by Subject|3|||
161863787|NCT00471081|584544083|FG000|Active Phase|Lost to Follow-up|0|||
161863788|NCT00471081|584544084|FG001|Active Phase|Lost to Follow-up|1|||
161863789|NCT00471081|584544083|FG000|Active Phase|Lost health plan/insurance|1|||
161863790|NCT00471081|584544084|FG001|Active Phase|Lost health plan/insurance|8|||
161863791|NCT00471081|584544083|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
161863792|NCT00471081|584544084|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
161863793|NCT00471081|584544083|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
161863794|NCT00471081|584544084|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
161863795|NCT00471081|584544083|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
161863796|NCT00471081|584544084|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
161863797|NCT02393950|584544089|FG000|Overall Study|Adverse Event|1|||
161863798|NCT02393950|584544090|FG001|Overall Study|Adverse Event|0|||
161863799|NCT02393950|584544089|FG000|Overall Study|Withdrawal by Subject|0|||
161863800|NCT02393950|584544090|FG001|Overall Study|Withdrawal by Subject|1|||
161863801|NCT05486091|584544091|FG000|Overall Study|Withdrawal by Subject|1|||
161863802|NCT05486091|584544091|FG000|Overall Study|Lost to Follow-up|2|||
161863803|NCT04067050|584544092|FG000|One Month|Lost to Follow-up|4|||
161863804|NCT04067050|584544093|FG001|One Month|Lost to Follow-up|0|||
161773603|NCT03110107|584214279|FG006|Treatment Period|Participant withdrew consent|0|||
161773604|NCT03110107|584214280|FG007|Treatment Period|Participant withdrew consent|0|||
161773605|NCT03110107|584214281|FG008|Treatment Period|Participant withdrew consent|0|||
161773606|NCT03110107|584214282|FG009|Treatment Period|Participant withdrew consent|1|||
161773607|NCT03110107|584214283|FG010|Treatment Period|Participant withdrew consent|0|||
161773608|NCT03110107|584214284|FG011|Treatment Period|Participant withdrew consent|0|||
161773609|NCT03110107|584214285|FG012|Treatment Period|Participant withdrew consent|0|||
161863805|NCT04067050|584544092|FG000|Two Month|Lost to Follow-up|1|||
161863806|NCT04067050|584544093|FG001|Two Month|Lost to Follow-up|0|||
161863807|NCT04067050|584544092|FG000|Two Month|Adverse Event|1|||
161863808|NCT04067050|584544093|FG001|Two Month|Adverse Event|0|||
161863809|NCT00957801|584544098|FG000|Overall Study|Withdrawal by Subject|0|||
161863810|NCT00957801|584544099|FG001|Overall Study|Withdrawal by Subject|0|||
161863811|NCT00957801|584544100|FG002|Overall Study|Withdrawal by Subject|0|||
161863812|NCT00957801|584544101|FG003|Overall Study|Withdrawal by Subject|1|||
161863813|NCT02626026|584544103|FG000|Overall Study|Randomized but Never Treated|0|||
161863814|NCT02626026|584544104|FG001|Overall Study|Randomized but Never Treated|0|||
161863815|NCT02626026|584544105|FG002|Overall Study|Randomized but Never Treated|0|||
161863816|NCT02626026|584544106|FG003|Overall Study|Randomized but Never Treated|0|||
161863817|NCT02626026|584544107|FG004|Overall Study|Randomized but Never Treated|1|||
161863818|NCT02626026|584544108|FG005|Overall Study|Randomized but Never Treated|0|||
161863819|NCT01778855|584544109|FG000|Overall Study|Death|0|||
161863820|NCT01778855|584544110|FG001|Overall Study|Death|1|||
161863821|NCT00923013|584544113|FG000|Overall Study|Refused further treatment|0|||
161863822|NCT00923013|584544114|FG001|Overall Study|Refused further treatment|1|||
161863823|NCT00923013|584544115|FG002|Overall Study|Refused further treatment|2|||
161863824|NCT00923013|584544116|FG003|Overall Study|Refused further treatment|0|||
161863825|NCT00923013|584544117|FG004|Overall Study|Refused further treatment|0|||
161863826|NCT00923013|584544118|FG005|Overall Study|Refused further treatment|0|||
161863827|NCT00923013|584544113|FG000|Overall Study|Switched to alternative treatment|0|||
161863828|NCT00923013|584544114|FG001|Overall Study|Switched to alternative treatment|1|||
161863829|NCT00923013|584544115|FG002|Overall Study|Switched to alternative treatment|0|||
161863830|NCT00923013|584544116|FG003|Overall Study|Switched to alternative treatment|0|||
161863831|NCT00923013|584544117|FG004|Overall Study|Switched to alternative treatment|0|||
161863832|NCT00923013|584544118|FG005|Overall Study|Switched to alternative treatment|0|||
161863833|NCT00923013|584544113|FG000|Overall Study|Death on study|2|||
161863834|NCT00923013|584544114|FG001|Overall Study|Death on study|2|||
161863835|NCT00923013|584544115|FG002|Overall Study|Death on study|0|||
161863836|NCT00923013|584544116|FG003|Overall Study|Death on study|1|||
161863837|NCT00923013|584544117|FG004|Overall Study|Death on study|0|||
161863838|NCT00923013|584544118|FG005|Overall Study|Death on study|0|||
161863839|NCT01168427|584544119|FG000|Overall Study|Patient exited prior to implant|1|||
161863840|NCT01256879|584544120|FG000|Overall Study|Withdrawal by Subject|1|||
161863841|NCT00640315|584544121|FG000|Overall Study|Withdrawal by Subject|0|||
161863842|NCT00640315|584544122|FG001|Overall Study|Withdrawal by Subject|1|||
161863843|NCT02964247|584544123|FG000|Overall Study|Lost to Follow-up|2|||
161863844|NCT02964247|584544124|FG001|Overall Study|Lost to Follow-up|0|||
161863845|NCT02964247|584544123|FG000|Overall Study|Withdrawal by Subject|1|||
161863846|NCT02964247|584544124|FG001|Overall Study|Withdrawal by Subject|2|||
161863847|NCT00725920|584544125|FG000|Overall Study|Lack of Efficacy|3|||
161863848|NCT00725920|584544126|FG001|Overall Study|Lack of Efficacy|6|||
161863849|NCT02107131|584544127|FG000|Overall Study|Lost to Follow-up|4|||
161863850|NCT02107131|584544128|FG001|Overall Study|Lost to Follow-up|4|||
161863851|NCT02107131|584544127|FG000|Overall Study|Physician Decision|1|||
161863852|NCT02107131|584544128|FG001|Overall Study|Physician Decision|0|||
161863853|NCT02107131|584544127|FG000|Overall Study|Withdrawal by Subject|2|||
161863854|NCT02107131|584544128|FG001|Overall Study|Withdrawal by Subject|0|||
161863855|NCT02107131|584544127|FG000|Overall Study|mental instability|1|||
161863856|NCT02107131|584544128|FG001|Overall Study|mental instability|0|||
161863857|NCT02107131|584544127|FG000|Overall Study|Death|0|||
161863858|NCT02107131|584544128|FG001|Overall Study|Death|1|||
161863859|NCT02107131|584544127|FG000|Overall Study|Protocol Violation|0|||
161863860|NCT02107131|584544128|FG001|Overall Study|Protocol Violation|4|||
161863861|NCT02286713|584544129|FG000|One Week Follow-Up|Death|1|||
161863862|NCT02286713|584544130|FG001|One Week Follow-Up|Death|0|||
161863863|NCT02286713|584544129|FG000|One Week Follow-Up|Lost to Follow-up|17|||
161863864|NCT02286713|584544130|FG001|One Week Follow-Up|Lost to Follow-up|21|||
161863865|NCT02286713|584544129|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
161863866|NCT02286713|584544130|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
161863867|NCT02286713|584544129|FG000|Three Month Follow-Up|Death|1|||
161773610|NCT03110107|584214286|FG013|Treatment Period|Participant withdrew consent|0|||
161773611|NCT03110107|584214287|FG014|Treatment Period|Participant withdrew consent|0|||
161773612|NCT03110107|584214288|FG015|Treatment Period|Participant withdrew consent|0|||
161773613|NCT03110107|584214289|FG016|Treatment Period|Participant withdrew consent|0|||
161773614|NCT03110107|584214290|FG017|Treatment Period|Participant withdrew consent|0|||
161773615|NCT03110107|584214291|FG018|Treatment Period|Participant withdrew consent|0|||
161773616|NCT03110107|584214292|FG019|Treatment Period|Participant withdrew consent|1|||
161773617|NCT03110107|584214293|FG020|Treatment Period|Participant withdrew consent|0|||
161773618|NCT03110107|584214294|FG021|Treatment Period|Participant withdrew consent|2|||
161773619|NCT03110107|584214295|FG022|Treatment Period|Participant withdrew consent|0|||
161773620|NCT03110107|584214296|FG023|Treatment Period|Participant withdrew consent|0|||
161773621|NCT03110107|584214297|FG024|Treatment Period|Participant withdrew consent|0|||
161773622|NCT03110107|584214298|FG025|Treatment Period|Participant withdrew consent|2|||
161773623|NCT03110107|584214273|FG000|Treatment Period|Participants no longer meets study criteria|0|||
161773624|NCT03110107|584214274|FG001|Treatment Period|Participants no longer meets study criteria|0|||
161773625|NCT03110107|584214275|FG002|Treatment Period|Participants no longer meets study criteria|0|||
161773626|NCT03110107|584214276|FG003|Treatment Period|Participants no longer meets study criteria|0|||
161773627|NCT03110107|584214277|FG004|Treatment Period|Participants no longer meets study criteria|0|||
161773628|NCT03110107|584214278|FG005|Treatment Period|Participants no longer meets study criteria|0|||
161773629|NCT03110107|584214279|FG006|Treatment Period|Participants no longer meets study criteria|0|||
161773630|NCT03110107|584214280|FG007|Treatment Period|Participants no longer meets study criteria|0|||
161773631|NCT03110107|584214281|FG008|Treatment Period|Participants no longer meets study criteria|0|||
161773632|NCT03110107|584214282|FG009|Treatment Period|Participants no longer meets study criteria|0|||
161773633|NCT03110107|584214283|FG010|Treatment Period|Participants no longer meets study criteria|0|||
161773634|NCT03110107|584214284|FG011|Treatment Period|Participants no longer meets study criteria|0|||
161773635|NCT03110107|584214285|FG012|Treatment Period|Participants no longer meets study criteria|0|||
161773636|NCT03110107|584214286|FG013|Treatment Period|Participants no longer meets study criteria|0|||
161773637|NCT03110107|584214287|FG014|Treatment Period|Participants no longer meets study criteria|0|||
161773638|NCT03110107|584214288|FG015|Treatment Period|Participants no longer meets study criteria|0|||
161773639|NCT03110107|584214289|FG016|Treatment Period|Participants no longer meets study criteria|0|||
161773640|NCT03110107|584214290|FG017|Treatment Period|Participants no longer meets study criteria|0|||
161773641|NCT03110107|584214291|FG018|Treatment Period|Participants no longer meets study criteria|0|||
161773642|NCT03110107|584214292|FG019|Treatment Period|Participants no longer meets study criteria|0|||
161773643|NCT03110107|584214293|FG020|Treatment Period|Participants no longer meets study criteria|0|||
161773644|NCT03110107|584214294|FG021|Treatment Period|Participants no longer meets study criteria|0|||
161773645|NCT03110107|584214295|FG022|Treatment Period|Participants no longer meets study criteria|0|||
161773646|NCT03110107|584214296|FG023|Treatment Period|Participants no longer meets study criteria|1|||
161773647|NCT03110107|584214297|FG024|Treatment Period|Participants no longer meets study criteria|0|||
161773648|NCT03110107|584214298|FG025|Treatment Period|Participants no longer meets study criteria|0|||
161773649|NCT03110107|584214273|FG000|Treatment Period|Other Reasons|0|||
161773650|NCT03110107|584214274|FG001|Treatment Period|Other Reasons|0|||
161773651|NCT03110107|584214275|FG002|Treatment Period|Other Reasons|1|||
161773652|NCT03110107|584214276|FG003|Treatment Period|Other Reasons|1|||
161773653|NCT03110107|584214277|FG004|Treatment Period|Other Reasons|0|||
161773654|NCT03110107|584214278|FG005|Treatment Period|Other Reasons|1|||
161773655|NCT03110107|584214279|FG006|Treatment Period|Other Reasons|0|||
161773656|NCT03110107|584214280|FG007|Treatment Period|Other Reasons|0|||
161773657|NCT03110107|584214281|FG008|Treatment Period|Other Reasons|0|||
161773658|NCT03110107|584214282|FG009|Treatment Period|Other Reasons|0|||
161773659|NCT03110107|584214283|FG010|Treatment Period|Other Reasons|0|||
161773660|NCT03110107|584214284|FG011|Treatment Period|Other Reasons|0|||
161773661|NCT03110107|584214285|FG012|Treatment Period|Other Reasons|0|||
161773662|NCT03110107|584214286|FG013|Treatment Period|Other Reasons|0|||
161773663|NCT03110107|584214287|FG014|Treatment Period|Other Reasons|0|||
161773664|NCT03110107|584214288|FG015|Treatment Period|Other Reasons|0|||
161773665|NCT03110107|584214289|FG016|Treatment Period|Other Reasons|0|||
161773666|NCT03110107|584214290|FG017|Treatment Period|Other Reasons|0|||
161773667|NCT03110107|584214291|FG018|Treatment Period|Other Reasons|0|||
161773668|NCT03110107|584214292|FG019|Treatment Period|Other Reasons|0|||
161773669|NCT03110107|584214293|FG020|Treatment Period|Other Reasons|0|||
161773670|NCT03110107|584214294|FG021|Treatment Period|Other Reasons|0|||
161773671|NCT03110107|584214295|FG022|Treatment Period|Other Reasons|0|||
161773672|NCT03110107|584214296|FG023|Treatment Period|Other Reasons|0|||
161773673|NCT03110107|584214297|FG024|Treatment Period|Other Reasons|1|||
161773674|NCT03110107|584214298|FG025|Treatment Period|Other Reasons|0|||
161773675|NCT03985982|584214302|FG000|Double-Blind Phase|Lost to Follow-up|4|||
161773676|NCT03985982|584214303|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161773677|NCT03985982|584214304|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161773678|NCT03985982|584214302|FG000|Double-Blind Phase|Physician Decision|1|||
161773679|NCT03985982|584214303|FG001|Double-Blind Phase|Physician Decision|0|||
161773680|NCT03985982|584214304|FG002|Double-Blind Phase|Physician Decision|0|||
161773681|NCT03985982|584214302|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
161773682|NCT03985982|584214303|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161773683|NCT03985982|584214304|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161773684|NCT03985982|584214302|FG000|Double-Blind Phase|COVID-19|1|||
161773685|NCT03985982|584214303|FG001|Double-Blind Phase|COVID-19|0|||
161773686|NCT03985982|584214304|FG002|Double-Blind Phase|COVID-19|0|||
161773687|NCT03985982|584214302|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
161773688|NCT03985982|584214303|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
161773689|NCT03985982|584214304|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
161773690|NCT03985982|584214302|FG000|Open-Label Phase|Lost to Follow-up|0|||
161773691|NCT03985982|584214303|FG001|Open-Label Phase|Lost to Follow-up|0|||
161773692|NCT03985982|584214304|FG002|Open-Label Phase|Lost to Follow-up|13|||
161863868|NCT02286713|584544130|FG001|Three Month Follow-Up|Death|1|||
161863869|NCT02286713|584544129|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
161863870|NCT02286713|584544130|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
161863871|NCT02286713|584544129|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
161863872|NCT02286713|584544130|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
161863873|NCT02286713|584544129|FG000|Six Month Follow-Up|Death|2|||
161863874|NCT02286713|584544130|FG001|Six Month Follow-Up|Death|0|||
161863875|NCT02286713|584544129|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
161863876|NCT02286713|584544130|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
161863877|NCT04314037|584544131|FG000|Treatment Period 2|Adverse Event|1|||
161863878|NCT04314037|584544132|FG001|Treatment Period 2|Adverse Event|0|||
161863879|NCT04314037|584544131|FG000|Treatment Period 3|Protocol Violation|1|||
161863880|NCT04314037|584544132|FG001|Treatment Period 3|Protocol Violation|0|||
161863881|NCT04314037|584544131|FG000|Treatment Period 3|Adverse Event|0|||
161863882|NCT04314037|584544132|FG001|Treatment Period 3|Adverse Event|1|||
161863883|NCT00856492|584544135|FG000|Overall Study|Ineligible or withdrew consent|1|||
161863884|NCT00856492|584544136|FG001|Overall Study|Ineligible or withdrew consent|1|||
161863885|NCT00856492|584544137|FG002|Overall Study|Ineligible or withdrew consent|2|||
161863886|NCT06018129|584544138|FG000|Overall Study|Death|1|||
161863887|NCT06018129|584544139|FG001|Overall Study|Death|1|||
161863888|NCT06018129|584544140|FG002|Overall Study|Death|2|||
161863889|NCT06018129|584544138|FG000|Overall Study|Sponsor Decision|2|||
161863890|NCT06018129|584544139|FG001|Overall Study|Sponsor Decision|2|||
161863891|NCT06018129|584544140|FG002|Overall Study|Sponsor Decision|1|||
161863892|NCT03832686|584544141|FG000|Overall Study|Lost to Follow-up|6|||
161863893|NCT03832686|584544142|FG001|Overall Study|Lost to Follow-up|9|||
161863894|NCT03832686|584544141|FG000|Overall Study|Discontinued Intervention|5|||
161863895|NCT03832686|584544142|FG001|Overall Study|Discontinued Intervention|4|||
161863896|NCT03323398|584544143|FG000|Overall Study|Other than Specified|0|||
161863897|NCT03323398|584544144|FG001|Overall Study|Other than Specified|1|||
161863898|NCT03323398|584544145|FG002|Overall Study|Other than Specified|2|||
161863899|NCT03323398|584544146|FG003|Overall Study|Other than Specified|0|||
161863900|NCT03323398|584544147|FG004|Overall Study|Other than Specified|0|||
161863901|NCT03323398|584544148|FG005|Overall Study|Other than Specified|0|||
161863902|NCT03323398|584544149|FG006|Overall Study|Other than Specified|1|||
161863903|NCT03323398|584544150|FG007|Overall Study|Other than Specified|0|||
161863904|NCT03323398|584544151|FG008|Overall Study|Other than Specified|2|||
161863905|NCT03323398|584544143|FG000|Overall Study|Lost to Follow-up|1|||
161863906|NCT03323398|584544144|FG001|Overall Study|Lost to Follow-up|2|||
161863907|NCT03323398|584544145|FG002|Overall Study|Lost to Follow-up|1|||
161863908|NCT03323398|584544146|FG003|Overall Study|Lost to Follow-up|0|||
161863909|NCT03323398|584544147|FG004|Overall Study|Lost to Follow-up|0|||
161863910|NCT03323398|584544148|FG005|Overall Study|Lost to Follow-up|0|||
161863911|NCT03323398|584544149|FG006|Overall Study|Lost to Follow-up|0|||
161863912|NCT03323398|584544150|FG007|Overall Study|Lost to Follow-up|0|||
161863913|NCT03323398|584544151|FG008|Overall Study|Lost to Follow-up|0|||
161863914|NCT03323398|584544143|FG000|Overall Study|Death|4|||
161863915|NCT03323398|584544144|FG001|Overall Study|Death|6|||
161863916|NCT03323398|584544145|FG002|Overall Study|Death|2|||
161863917|NCT03323398|584544146|FG003|Overall Study|Death|2|||
161863918|NCT03323398|584544147|FG004|Overall Study|Death|1|||
161863919|NCT03323398|584544148|FG005|Overall Study|Death|2|||
161863920|NCT03323398|584544149|FG006|Overall Study|Death|0|||
161863921|NCT03323398|584544150|FG007|Overall Study|Death|0|||
161863922|NCT03323398|584544151|FG008|Overall Study|Death|6|||
161863923|NCT03323398|584544143|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
161863924|NCT03323398|584544144|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
161863925|NCT03323398|584544145|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
161863926|NCT03323398|584544146|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
161863927|NCT03323398|584544147|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
161863928|NCT03323398|584544148|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
161863929|NCT03323398|584544149|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
161863930|NCT03323398|584544150|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
161863931|NCT03323398|584544151|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
161863932|NCT03323398|584544143|FG000|Overall Study|Withdrawal by Subject|2|||
161863933|NCT03323398|584544144|FG001|Overall Study|Withdrawal by Subject|1|||
161863934|NCT03323398|584544145|FG002|Overall Study|Withdrawal by Subject|3|||
161863935|NCT03323398|584544146|FG003|Overall Study|Withdrawal by Subject|0|||
161863936|NCT03323398|584544147|FG004|Overall Study|Withdrawal by Subject|0|||
161863937|NCT03323398|584544148|FG005|Overall Study|Withdrawal by Subject|1|||
161863938|NCT03323398|584544149|FG006|Overall Study|Withdrawal by Subject|0|||
161863939|NCT03323398|584544150|FG007|Overall Study|Withdrawal by Subject|0|||
161863940|NCT03323398|584544151|FG008|Overall Study|Withdrawal by Subject|0|||
161863941|NCT03323398|584544143|FG000|Overall Study|Participant was Put on Hospice|0|||
161863942|NCT03323398|584544144|FG001|Overall Study|Participant was Put on Hospice|0|||
161863943|NCT03323398|584544145|FG002|Overall Study|Participant was Put on Hospice|0|||
161863944|NCT03323398|584544146|FG003|Overall Study|Participant was Put on Hospice|0|||
161863945|NCT03323398|584544147|FG004|Overall Study|Participant was Put on Hospice|0|||
161863946|NCT03323398|584544148|FG005|Overall Study|Participant was Put on Hospice|0|||
161863947|NCT03323398|584544149|FG006|Overall Study|Participant was Put on Hospice|1|||
161863948|NCT03323398|584544150|FG007|Overall Study|Participant was Put on Hospice|0|||
161863949|NCT03323398|584544151|FG008|Overall Study|Participant was Put on Hospice|0|||
161863950|NCT03323398|584544143|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
161863951|NCT03323398|584544144|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
161863952|NCT03323398|584544145|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
161863953|NCT03323398|584544146|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
161863954|NCT03323398|584544147|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
161863955|NCT03323398|584544148|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
161863956|NCT03323398|584544149|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
161863957|NCT03323398|584544150|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
161863958|NCT03323398|584544151|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
161863959|NCT02235454|584544152|FG000|Overall Study|Withdrawal by Subject|2|||
161863960|NCT03641469|584544153|FG000|Overall Study|Ineligible|2|||
161863961|NCT03641469|584544153|FG000|Overall Study|Withdrawal by Subject|5|||
161863962|NCT03641469|584544153|FG000|Overall Study|Physician Decision|1|||
161863963|NCT03641469|584544153|FG000|Overall Study|Protocol Violation|1|||
161863964|NCT03641469|584544153|FG000|Overall Study|Lost to Follow-up|2|||
161863965|NCT01415518|584545543|FG000|Overall Study|Withdrawal by Subject|2|||
161863966|NCT01415518|584545544|FG001|Overall Study|Withdrawal by Subject|12|||
161863967|NCT01415518|584545543|FG000|Overall Study|Protocol Violation|6|||
161863968|NCT01415518|584545544|FG001|Overall Study|Protocol Violation|8|||
161863969|NCT01415518|584545543|FG000|Overall Study|Lost to Follow-up|3|||
161863970|NCT01415518|584545544|FG001|Overall Study|Lost to Follow-up|5|||
161863971|NCT01415518|584545543|FG000|Overall Study|Adverse Event|3|||
161863972|NCT01415518|584545544|FG001|Overall Study|Adverse Event|4|||
161863973|NCT01415518|584545543|FG000|Overall Study|Death|1|||
161863974|NCT01415518|584545544|FG001|Overall Study|Death|1|||
161863975|NCT01415518|584545543|FG000|Overall Study|Condition under Investigation Worsened|1|||
161863976|NCT01415518|584545544|FG001|Overall Study|Condition under Investigation Worsened|1|||
161863977|NCT05364931|584545548|FG000|Overall Study|Adverse Event|0|||
161863978|NCT05364931|584545549|FG001|Overall Study|Adverse Event|2|||
161863979|NCT05364931|584545550|FG002|Overall Study|Adverse Event|1|||
161863980|NCT05364931|584545551|FG003|Overall Study|Adverse Event|0|||
161863981|NCT05364931|584545548|FG000|Overall Study|Lost to Follow-up|1|||
161863982|NCT05364931|584545549|FG001|Overall Study|Lost to Follow-up|0|||
161863983|NCT05364931|584545550|FG002|Overall Study|Lost to Follow-up|0|||
161863984|NCT05364931|584545551|FG003|Overall Study|Lost to Follow-up|0|||
161863985|NCT05364931|584545548|FG000|Overall Study|Withdrawal by Subject|1|||
161863986|NCT05364931|584545549|FG001|Overall Study|Withdrawal by Subject|1|||
161863987|NCT05364931|584545550|FG002|Overall Study|Withdrawal by Subject|3|||
161863988|NCT05364931|584545551|FG003|Overall Study|Withdrawal by Subject|2|||
161863989|NCT05364931|584545548|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161863990|NCT05364931|584545549|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
161863991|NCT05364931|584545550|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161863992|NCT05364931|584545551|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161863993|NCT05364931|584545548|FG000|Overall Study|Discontinued|1|||
161863994|NCT05364931|584545549|FG001|Overall Study|Discontinued|0|||
161863995|NCT05364931|584545550|FG002|Overall Study|Discontinued|0|||
161863996|NCT05364931|584545551|FG003|Overall Study|Discontinued|0|||
161863997|NCT03976362|584545552|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
161863998|NCT03976362|584545553|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161863999|NCT03976362|584545554|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161864000|NCT03976362|584545552|FG000|Induction Phase|Death|62|||
161864001|NCT03976362|584545553|FG001|Induction Phase|Death|0|||
161864002|NCT03976362|584545554|FG002|Induction Phase|Death|0|||
161864003|NCT03976362|584545552|FG000|Maintenance Phase|Participants Ongoing|0|||
161864004|NCT03976362|584545553|FG001|Maintenance Phase|Participants Ongoing|106|||
161864005|NCT03976362|584545554|FG002|Maintenance Phase|Participants Ongoing|103|||
161864006|NCT03976362|584545552|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161864007|NCT03976362|584545553|FG001|Maintenance Phase|Withdrawal by Subject|4|||
161864008|NCT03976362|584545554|FG002|Maintenance Phase|Withdrawal by Subject|4|||
161864009|NCT03976362|584545552|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
161864010|NCT03976362|584545553|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
161864011|NCT03976362|584545554|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
161864012|NCT03976362|584545552|FG000|Maintenance Phase|Death|0|||
161864013|NCT03976362|584545553|FG001|Maintenance Phase|Death|186|||
161864014|NCT03976362|584545554|FG002|Maintenance Phase|Death|187|||
161864015|NCT04846569|584545555|FG000|Overall Study|Withdrawal by Subject|3|||
161864016|NCT04846569|584545556|FG001|Overall Study|Withdrawal by Subject|1|||
161864017|NCT02525783|584545558|FG000|Overall Study|Lost to Follow-up|10|||
161864018|NCT04570670|584545561|FG000|Overall Study|Withdrawal by Subject|1|||
161864019|NCT04570670|584545562|FG001|Overall Study|Withdrawal by Subject|0|||
161864020|NCT00683618|584545563|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
161864021|NCT00683618|584545564|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
161864022|NCT00683618|584545565|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
161864023|NCT00683618|584545563|FG000|Randomised Treatment Period|Protocol Violation|0|||
161864024|NCT00683618|584545564|FG001|Randomised Treatment Period|Protocol Violation|1|||
161864025|NCT00683618|584545565|FG002|Randomised Treatment Period|Protocol Violation|0|||
161864026|NCT00683618|584545563|FG000|Randomised Treatment Period|Adverse Event|2|||
161864027|NCT00683618|584545564|FG001|Randomised Treatment Period|Adverse Event|0|||
161864028|NCT00683618|584545565|FG002|Randomised Treatment Period|Adverse Event|2|||
161864029|NCT00683618|584545563|FG000|Randomised Treatment Period|Reason not provided|0|||
161864030|NCT00683618|584545564|FG001|Randomised Treatment Period|Reason not provided|0|||
161864031|NCT00683618|584545565|FG002|Randomised Treatment Period|Reason not provided|2|||
161864032|NCT00683618|584545563|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
161864033|NCT00683618|584545564|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161864034|NCT00683618|584545565|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161864035|NCT00683618|584545563|FG000|Extension Treatment Period|Adverse Event|1|||
161864036|NCT00683618|584545564|FG001|Extension Treatment Period|Adverse Event|0|||
161864037|NCT00683618|584545565|FG002|Extension Treatment Period|Adverse Event|0|||
161864038|NCT00683618|584545563|FG000|Extension Treatment Period|Protocol Violation|1|||
161864039|NCT00683618|584545564|FG001|Extension Treatment Period|Protocol Violation|0|||
161864040|NCT00683618|584545565|FG002|Extension Treatment Period|Protocol Violation|0|||
161864041|NCT03776357|584545566|FG000|Overall Study|Lost to Follow-up|3|||
161864042|NCT00777296|584545568|FG000|Overall Study|Adverse Event|0|||
161864043|NCT00777296|584545569|FG001|Overall Study|Adverse Event|1|||
161864044|NCT00777296|584545570|FG002|Overall Study|Adverse Event|0|||
161864045|NCT00777296|584545571|FG003|Overall Study|Adverse Event|1|||
161864046|NCT00777296|584545568|FG000|Overall Study|Withdrawal by Subject|1|||
161864047|NCT00777296|584545569|FG001|Overall Study|Withdrawal by Subject|0|||
161864048|NCT00777296|584545570|FG002|Overall Study|Withdrawal by Subject|0|||
161864049|NCT00777296|584545571|FG003|Overall Study|Withdrawal by Subject|0|||
161864050|NCT00777296|584545568|FG000|Overall Study|CRF form not completed|0|||
161864051|NCT00777296|584545569|FG001|Overall Study|CRF form not completed|0|||
161864052|NCT00777296|584545570|FG002|Overall Study|CRF form not completed|2|||
161864053|NCT00777296|584545571|FG003|Overall Study|CRF form not completed|0|||
161864054|NCT02211209|584545572|FG000|Overall Study|Investigator judgment|0|||
161864055|NCT02211209|584545573|FG001|Overall Study|Investigator judgment|1|||
161864056|NCT02211209|584545572|FG000|Overall Study|Voluntary withdrawal|1|||
161864057|NCT02211209|584545573|FG001|Overall Study|Voluntary withdrawal|4|||
161864058|NCT02211209|584545572|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161864059|NCT02211209|584545573|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
161864060|NCT02211209|584545572|FG000|Overall Study|Reason Not Specified|1|||
161864061|NCT02211209|584545573|FG001|Overall Study|Reason Not Specified|0|||
161864062|NCT00658723|584545577|FG000|Overall Study|Lost to Follow-up|0|||
161864063|NCT00658723|584545578|FG001|Overall Study|Lost to Follow-up|2|||
161864064|NCT00658723|584545579|FG002|Overall Study|Lost to Follow-up|2|||
161864065|NCT00658723|584545577|FG000|Overall Study|Death|2|||
161864066|NCT00658723|584545578|FG001|Overall Study|Death|1|||
161864067|NCT00658723|584545579|FG002|Overall Study|Death|4|||
161864068|NCT00658723|584545577|FG000|Overall Study|Scheduling Issue|1|||
161864069|NCT00658723|584545578|FG001|Overall Study|Scheduling Issue|1|||
161864070|NCT00658723|584545579|FG002|Overall Study|Scheduling Issue|0|||
161864071|NCT00658723|584545577|FG000|Overall Study|Withdrawal by Subject|1|||
161864072|NCT00658723|584545578|FG001|Overall Study|Withdrawal by Subject|0|||
161864073|NCT00658723|584545579|FG002|Overall Study|Withdrawal by Subject|1|||
161864074|NCT03876743|584545580|FG000|Overall Study|Lost to Follow-up|6|||
161864075|NCT03876743|584545581|FG001|Overall Study|Lost to Follow-up|4|||
161864076|NCT03876743|584545582|FG002|Overall Study|Lost to Follow-up|4|||
161864077|NCT03876743|584545583|FG003|Overall Study|Lost to Follow-up|7|||
161864078|NCT03889418|584545584|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
161864079|NCT03889418|584545585|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864080|NCT03889418|584545586|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864081|NCT03889418|584545587|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864082|NCT03889418|584545588|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864083|NCT03889418|584545589|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864084|NCT03889418|584545590|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864085|NCT03889418|584545591|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864086|NCT03889418|584545592|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864087|NCT03889418|584545593|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864088|NCT03889418|584545584|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864089|NCT03889418|584545585|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
161864090|NCT03889418|584545586|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
161864091|NCT03889418|584545587|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864092|NCT03889418|584545588|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864093|NCT03889418|584545589|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864094|NCT03889418|584545590|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864095|NCT03889418|584545591|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864096|NCT03889418|584545592|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864097|NCT03889418|584545593|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864098|NCT03889418|584545584|FG000|October-December 2019 (Month 7-9)|Death|0|||
161864099|NCT03889418|584545585|FG001|October-December 2019 (Month 7-9)|Death|0|||
161864100|NCT03889418|584545586|FG002|October-December 2019 (Month 7-9)|Death|0|||
161864101|NCT03889418|584545587|FG003|October-December 2019 (Month 7-9)|Death|0|||
161864102|NCT03889418|584545588|FG004|October-December 2019 (Month 7-9)|Death|0|||
161864103|NCT03889418|584545589|FG005|October-December 2019 (Month 7-9)|Death|0|||
161864104|NCT03889418|584545590|FG006|October-December 2019 (Month 7-9)|Death|0|||
161864105|NCT03889418|584545591|FG007|October-December 2019 (Month 7-9)|Death|0|||
161864106|NCT03889418|584545592|FG008|October-December 2019 (Month 7-9)|Death|1|||
161864107|NCT03889418|584545593|FG009|October-December 2019 (Month 7-9)|Death|0|||
161864108|NCT03889418|584545584|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864109|NCT03889418|584545585|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864110|NCT03889418|584545586|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864111|NCT03889418|584545587|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
161864112|NCT03889418|584545588|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864113|NCT03889418|584545589|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864114|NCT03889418|584545590|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864115|NCT03889418|584545591|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
161864116|NCT03889418|584545592|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864117|NCT03889418|584545593|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864118|NCT03889418|584545584|FG000|April - June 2020 (Month 13-15)|Death|0|||
161864119|NCT03889418|584545585|FG001|April - June 2020 (Month 13-15)|Death|1|||
161864120|NCT03889418|584545586|FG002|April - June 2020 (Month 13-15)|Death|0|||
161864121|NCT03889418|584545587|FG003|April - June 2020 (Month 13-15)|Death|0|||
161864122|NCT03889418|584545588|FG004|April - June 2020 (Month 13-15)|Death|0|||
161864123|NCT03889418|584545589|FG005|April - June 2020 (Month 13-15)|Death|0|||
161864124|NCT03889418|584545590|FG006|April - June 2020 (Month 13-15)|Death|0|||
161864125|NCT03889418|584545591|FG007|April - June 2020 (Month 13-15)|Death|0|||
161864126|NCT03889418|584545592|FG008|April - June 2020 (Month 13-15)|Death|0|||
161864127|NCT03889418|584545593|FG009|April - June 2020 (Month 13-15)|Death|0|||
161864128|NCT03889418|584545584|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864129|NCT03889418|584545585|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864130|NCT03889418|584545586|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864131|NCT03889418|584545587|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
161864132|NCT03889418|584545588|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864133|NCT03889418|584545589|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864134|NCT03889418|584545590|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864135|NCT03889418|584545591|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864136|NCT03889418|584545592|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864137|NCT03889418|584545593|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864138|NCT03889418|584545584|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
161864139|NCT03889418|584545585|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864140|NCT03889418|584545586|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
161864141|NCT03889418|584545587|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
161864142|NCT03889418|584545588|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864143|NCT03889418|584545589|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864144|NCT03889418|584545590|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864145|NCT03889418|584545591|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
161864146|NCT03889418|584545592|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864147|NCT03889418|584545593|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864148|NCT03889418|584545584|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864149|NCT03889418|584545585|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
161864150|NCT03889418|584545586|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
161864151|NCT03889418|584545587|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
161864152|NCT03889418|584545588|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864153|NCT03889418|584545589|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864154|NCT03889418|584545590|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864155|NCT03889418|584545591|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
161864156|NCT03889418|584545592|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864157|NCT03889418|584545593|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
161864158|NCT00092118|584545595|FG000|Overall Study|Adverse Event|35|||
161864159|NCT00092118|584545596|FG001|Overall Study|Adverse Event|32|||
161864160|NCT00092118|584545595|FG000|Overall Study|Lack of Efficacy|12|||
161773693|NCT03985982|584214302|FG000|Open-Label Phase|Physician Decision|0|||
161773694|NCT03985982|584214303|FG001|Open-Label Phase|Physician Decision|0|||
161773695|NCT03985982|584214304|FG002|Open-Label Phase|Physician Decision|2|||
161773696|NCT03985982|584214302|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161773697|NCT03985982|584214303|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161773698|NCT03985982|584214304|FG002|Open-Label Phase|Withdrawal by Subject|11|||
161773699|NCT03526549|584214306|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
161773700|NCT03526549|584214307|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
161773701|NCT03526549|584214306|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
161773702|NCT03526549|584214307|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
161773703|NCT03526549|584214306|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
161773704|NCT03526549|584214307|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
161773705|NCT03526549|584214306|FG000|Open-label Phase|Adverse Event|4|||
161773706|NCT03526549|584214307|FG001|Open-label Phase|Adverse Event|0|||
161773707|NCT03526549|584214306|FG000|Open-label Phase|Withdrawal by Subject|54|||
161773708|NCT03526549|584214307|FG001|Open-label Phase|Withdrawal by Subject|0|||
161773709|NCT03526549|584214306|FG000|Open-label Phase|Lost to Follow-up|35|||
161773710|NCT03526549|584214307|FG001|Open-label Phase|Lost to Follow-up|0|||
161773711|NCT03526549|584214306|FG000|Open-label Phase|Other than Specified|5|||
161773712|NCT03526549|584214307|FG001|Open-label Phase|Other than Specified|0|||
161773713|NCT05981365|584214308|FG000|Period 1|Adverse Event|1|||
161773714|NCT05981365|584214309|FG001|Period 1|Adverse Event|0|||
161773715|NCT03927989|584214312|FG000|Overall Study|Withdrawal by Subject|0|||
161773716|NCT03927989|584214313|FG001|Overall Study|Withdrawal by Subject|1|||
161773717|NCT02593175|584214314|FG000|Overall Study|Adverse Event|5|||
161773718|NCT02593175|584214314|FG000|Overall Study|Disease progression|4|||
161773719|NCT00478933|584214318|FG000|Overall Study|Protocol Violation|22|||
161773720|NCT00478933|584214318|FG000|Overall Study|Informed consent not verified|3|||
161773721|NCT00478933|584214318|FG000|Overall Study|Inadequate data available|53|||
161773722|NCT00643006|584214320|FG000|Overall Study|Lost to Follow-up|5|||
161773723|NCT00643006|584214321|FG001|Overall Study|Lost to Follow-up|4|||
161773724|NCT02506101|584214322|FG000|Overall Study|Transportation issues|1|||
161773725|NCT02506101|584214323|FG001|Overall Study|Transportation issues|0|||
161773726|NCT02506101|584214322|FG000|Overall Study|No enrollment and staff unavailability|1|||
161773727|NCT02506101|584214323|FG001|Overall Study|No enrollment and staff unavailability|0|||
161773728|NCT01471197|584214324|FG000|Overall Study|Disease Progression|4|||
161773729|NCT01471197|584214325|FG001|Overall Study|Disease Progression|2|||
161773730|NCT01471197|584214324|FG000|Overall Study|Death|1|||
161773731|NCT01471197|584214325|FG001|Overall Study|Death|0|||
161773732|NCT01471197|584214324|FG000|Overall Study|Study Drug Toxicity|1|||
161773733|NCT01471197|584214325|FG001|Overall Study|Study Drug Toxicity|0|||
161773734|NCT01353586|584214329|FG000|Overall Study|Procedure terminated prior to ablation|3|||
161773735|NCT01353586|584214330|FG001|Overall Study|Procedure terminated prior to ablation|0|||
161773736|NCT01353586|584214329|FG000|Overall Study|Never had insertion of study catheter|4|||
161773737|NCT01353586|584214330|FG001|Overall Study|Never had insertion of study catheter|1|||
161773738|NCT01353586|584214329|FG000|Overall Study|Neurological exam not done|0|||
161773739|NCT01353586|584214330|FG001|Overall Study|Neurological exam not done|1|||
161773740|NCT03253809|584214331|FG000|Overall Study|Unable to obtain study related data|14|||
161773741|NCT03992456|584214332|FG000|Overall Study|Withdrawal by Subject|1|||
161773742|NCT03992456|584214333|FG001|Overall Study|Withdrawal by Subject|0|||
161773743|NCT03992456|584214332|FG000|Overall Study|Disease progression|4|||
161773744|NCT03992456|584214333|FG001|Overall Study|Disease progression|5|||
161773745|NCT03992456|584214332|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
161773746|NCT03992456|584214333|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
161773747|NCT03155269|584214334|FG000|Overall Study|Withdrawal by Subject|4|||
161773748|NCT03155269|584214335|FG001|Overall Study|Withdrawal by Subject|5|||
161773749|NCT03155269|584214334|FG000|Overall Study|Lost to Follow-up|1|||
161864161|NCT00092118|584545596|FG001|Overall Study|Lack of Efficacy|14|||
161864162|NCT00092118|584545595|FG000|Overall Study|Lost to Follow-up|4|||
161773750|NCT03155269|584214335|FG001|Overall Study|Lost to Follow-up|2|||
161773751|NCT00910000|584214338|FG000|Overall Study|Adverse Event|0|||
161773752|NCT00910000|584214339|FG001|Overall Study|Adverse Event|3|||
161864163|NCT00092118|584545596|FG001|Overall Study|Lost to Follow-up|3|||
161773753|NCT00910000|584214340|FG002|Overall Study|Adverse Event|2|||
161773754|NCT00910000|584214341|FG003|Overall Study|Adverse Event|2|||
161773755|NCT00910000|584214342|FG004|Overall Study|Adverse Event|0|||
161773756|NCT00910000|584214343|FG005|Overall Study|Adverse Event|1|||
161773757|NCT00910000|584214338|FG000|Overall Study|Withdrawal by Subject|0|||
161773758|NCT00910000|584214339|FG001|Overall Study|Withdrawal by Subject|0|||
161773759|NCT00910000|584214340|FG002|Overall Study|Withdrawal by Subject|1|||
161773760|NCT00910000|584214341|FG003|Overall Study|Withdrawal by Subject|0|||
161773761|NCT00910000|584214342|FG004|Overall Study|Withdrawal by Subject|1|||
161773762|NCT00910000|584214343|FG005|Overall Study|Withdrawal by Subject|0|||
161773763|NCT04637815|584214344|FG000|Overall Study|Death|1|||
161773764|NCT04637815|584214345|FG001|Overall Study|Death|0|||
161773765|NCT04637815|584214344|FG000|Overall Study|Lost to Follow-up|5|||
161773766|NCT04637815|584214345|FG001|Overall Study|Lost to Follow-up|2|||
161773767|NCT00483119|584214348|FG000|Overall Study|Adverse Event|0|||
161773768|NCT00483119|584214349|FG001|Overall Study|Adverse Event|1|||
161773769|NCT00483119|584214348|FG000|Overall Study|Physician Decision|1|||
161773770|NCT00483119|584214349|FG001|Overall Study|Physician Decision|0|||
161773771|NCT02369874|584214350|FG000|Overall Study|Lost to Follow-up|2|||
161773772|NCT02369874|584214351|FG001|Overall Study|Lost to Follow-up|2|||
161773773|NCT02369874|584214352|FG002|Overall Study|Lost to Follow-up|2|||
161773774|NCT02369874|584214350|FG000|Overall Study|Withdrawal by Subject|7|||
161773775|NCT02369874|584214351|FG001|Overall Study|Withdrawal by Subject|9|||
161773776|NCT02369874|584214352|FG002|Overall Study|Withdrawal by Subject|27|||
161773777|NCT02369874|584214350|FG000|Overall Study|Miscellaneous|1|||
161773778|NCT02369874|584214351|FG001|Overall Study|Miscellaneous|1|||
161773779|NCT02369874|584214352|FG002|Overall Study|Miscellaneous|0|||
161773780|NCT02369874|584214350|FG000|Overall Study|On Treatment/Off Study|34|||
161773781|NCT02369874|584214351|FG001|Overall Study|On Treatment/Off Study|45|||
161773782|NCT02369874|584214352|FG002|Overall Study|On Treatment/Off Study|32|||
161773783|NCT02058849|584214353|FG000|Overall Study|Hospitalization|1|||
161773784|NCT02058849|584214354|FG001|Overall Study|Hospitalization|1|||
161773785|NCT02058849|584214353|FG000|Overall Study|Death|1|||
161773786|NCT02058849|584214354|FG001|Overall Study|Death|0|||
161773787|NCT02058849|584214353|FG000|Overall Study|Lost to Follow-up|1|||
161773788|NCT02058849|584214354|FG001|Overall Study|Lost to Follow-up|0|||
161773789|NCT02058849|584214353|FG000|Overall Study|Withdrawal by Subject|4|||
161773790|NCT02058849|584214354|FG001|Overall Study|Withdrawal by Subject|0|||
161773791|NCT02331680|584214355|FG000|Overall Study|Adverse Event|3|||
161773792|NCT02331680|584214356|FG001|Overall Study|Adverse Event|0|||
161773793|NCT02331680|584214357|FG002|Overall Study|Adverse Event|2|||
161773794|NCT02331680|584214355|FG000|Overall Study|Physician Decision|1|||
161773795|NCT02331680|584214356|FG001|Overall Study|Physician Decision|1|||
161773796|NCT02331680|584214357|FG002|Overall Study|Physician Decision|2|||
161773797|NCT02331680|584214355|FG000|Overall Study|Withdrawal by Subject|0|||
161773798|NCT02331680|584214356|FG001|Overall Study|Withdrawal by Subject|1|||
161773799|NCT02331680|584214357|FG002|Overall Study|Withdrawal by Subject|2|||
161773800|NCT02331680|584214355|FG000|Overall Study|Met withdrawal criteria|2|||
161773801|NCT02331680|584214356|FG001|Overall Study|Met withdrawal criteria|2|||
161773802|NCT02331680|584214357|FG002|Overall Study|Met withdrawal criteria|5|||
161773803|NCT02331680|584214355|FG000|Overall Study|Non-compliance with study drug|0|||
161864164|NCT00092118|584545595|FG000|Overall Study|Protocol Violation|23|||
161773804|NCT02331680|584214356|FG001|Overall Study|Non-compliance with study drug|0|||
161773805|NCT02331680|584214357|FG002|Overall Study|Non-compliance with study drug|1|||
161773806|NCT02331680|584214355|FG000|Overall Study|Protocol Violation|0|||
161773807|NCT02331680|584214356|FG001|Overall Study|Protocol Violation|0|||
161773808|NCT02331680|584214357|FG002|Overall Study|Protocol Violation|3|||
161773809|NCT02219477|584214358|FG000|Overall Study|Adverse Event|0|||
161773810|NCT02219477|584214359|FG001|Overall Study|Adverse Event|1|||
161773811|NCT02219477|584214360|FG002|Overall Study|Adverse Event|1|||
161773812|NCT02219477|584214358|FG000|Overall Study|Withdrawal by Subject|0|||
161773813|NCT02219477|584214359|FG001|Overall Study|Withdrawal by Subject|1|||
161773814|NCT02219477|584214360|FG002|Overall Study|Withdrawal by Subject|0|||
161773815|NCT00596466|584214361|FG000|Overall Study|Lack of Efficacy|5|||
161773816|NCT00596466|584214361|FG000|Overall Study|Adverse Event|4|||
161773817|NCT00596466|584214361|FG000|Overall Study|Withdrawal by Subject|2|||
161773818|NCT00596466|584214361|FG000|Overall Study|Protocol Violation|2|||
161773819|NCT00596466|584214361|FG000|Overall Study|Unpecified|2|||
161773820|NCT00596466|584214361|FG000|Overall Study|Enrolled, not treated|2|||
161773821|NCT04505592|584214362|FG000|Overall Study|Death|2|||
161773822|NCT04505592|584214363|FG001|Overall Study|Death|1|||
161773823|NCT01891669|584214365|FG000|Overall Study|Death|0|||
161773824|NCT01891669|584214366|FG001|Overall Study|Death|0|||
161773825|NCT01891669|584214367|FG002|Overall Study|Death|0|||
161773826|NCT01891669|584214368|FG003|Overall Study|Death|0|||
161773827|NCT01891669|584214369|FG004|Overall Study|Death|0|||
161773828|NCT01891669|584214370|FG005|Overall Study|Death|0|||
161773829|NCT01891669|584214371|FG006|Overall Study|Death|0|||
161773830|NCT01891669|584214372|FG007|Overall Study|Death|1|||
161773831|NCT01891669|584214373|FG008|Overall Study|Death|0|||
161773832|NCT01891669|584214374|FG009|Overall Study|Death|1|||
161773833|NCT01891669|584214365|FG000|Overall Study|Withdrawal by Subject|1|||
161773834|NCT01891669|584214366|FG001|Overall Study|Withdrawal by Subject|1|||
161773835|NCT01891669|584214367|FG002|Overall Study|Withdrawal by Subject|0|||
161773836|NCT01891669|584214368|FG003|Overall Study|Withdrawal by Subject|0|||
161773837|NCT01891669|584214369|FG004|Overall Study|Withdrawal by Subject|0|||
161773838|NCT01891669|584214370|FG005|Overall Study|Withdrawal by Subject|0|||
161773839|NCT01891669|584214371|FG006|Overall Study|Withdrawal by Subject|1|||
161773840|NCT01891669|584214372|FG007|Overall Study|Withdrawal by Subject|2|||
161773841|NCT01891669|584214373|FG008|Overall Study|Withdrawal by Subject|1|||
161773842|NCT01891669|584214374|FG009|Overall Study|Withdrawal by Subject|1|||
161773843|NCT01891669|584214365|FG000|Overall Study|Other|1|||
161773844|NCT01891669|584214366|FG001|Overall Study|Other|0|||
161773845|NCT01891669|584214367|FG002|Overall Study|Other|0|||
161773846|NCT01891669|584214368|FG003|Overall Study|Other|0|||
161773847|NCT01891669|584214369|FG004|Overall Study|Other|0|||
161773848|NCT01891669|584214370|FG005|Overall Study|Other|0|||
161773849|NCT01891669|584214371|FG006|Overall Study|Other|0|||
161773850|NCT01891669|584214372|FG007|Overall Study|Other|1|||
161773851|NCT01891669|584214373|FG008|Overall Study|Other|0|||
161773852|NCT01891669|584214374|FG009|Overall Study|Other|0|||
161773853|NCT04298229|584214379|FG000|Overall Study|Physician Decision|1|||
161773854|NCT04298229|584214380|FG001|Overall Study|Physician Decision|1|||
161773855|NCT04298229|584214379|FG000|Overall Study|Withdrawal by Subject|1|||
161773856|NCT04298229|584214380|FG001|Overall Study|Withdrawal by Subject|1|||
161773857|NCT04298229|584214379|FG000|Overall Study|Did not receive IV loop diuretics|2|||
161773858|NCT04298229|584214380|FG001|Overall Study|Did not receive IV loop diuretics|0|||
161773859|NCT00859313|584214381|FG000|Overall Study|Lack of Efficacy|2|||
161773860|NCT00859313|584214381|FG000|Overall Study|Adverse Event|1|||
161773861|NCT00859313|584214381|FG000|Overall Study|staff error|1|||
161773862|NCT05261126|584214386|FG000|Overall Study|Death|0|||
161773863|NCT05261126|584214387|FG001|Overall Study|Death|0|||
161773864|NCT05261126|584214388|FG002|Overall Study|Death|1|||
161773865|NCT05261126|584214389|FG003|Overall Study|Death|0|||
161773866|NCT05261126|584214390|FG004|Overall Study|Death|0|||
161773867|NCT05261126|584214386|FG000|Overall Study|Lost to Follow-up|0|||
161773868|NCT05261126|584214387|FG001|Overall Study|Lost to Follow-up|0|||
161773869|NCT05261126|584214388|FG002|Overall Study|Lost to Follow-up|0|||
161773870|NCT05261126|584214389|FG003|Overall Study|Lost to Follow-up|0|||
161773871|NCT05261126|584214390|FG004|Overall Study|Lost to Follow-up|1|||
161773872|NCT05261126|584214386|FG000|Overall Study|Physician Decision|1|||
161773873|NCT05261126|584214387|FG001|Overall Study|Physician Decision|0|||
161773874|NCT05261126|584214388|FG002|Overall Study|Physician Decision|0|||
161773875|NCT05261126|584214389|FG003|Overall Study|Physician Decision|0|||
161773876|NCT05261126|584214390|FG004|Overall Study|Physician Decision|0|||
161773877|NCT05261126|584214386|FG000|Overall Study|Screen Failure|0|||
161773878|NCT05261126|584214387|FG001|Overall Study|Screen Failure|0|||
161773879|NCT05261126|584214388|FG002|Overall Study|Screen Failure|0|||
161773880|NCT05261126|584214389|FG003|Overall Study|Screen Failure|0|||
161773881|NCT05261126|584214390|FG004|Overall Study|Screen Failure|1|||
161773882|NCT05261126|584214386|FG000|Overall Study|Withdrawal by Subject|1|||
161773883|NCT05261126|584214387|FG001|Overall Study|Withdrawal by Subject|0|||
161773884|NCT05261126|584214388|FG002|Overall Study|Withdrawal by Subject|1|||
161773885|NCT05261126|584214389|FG003|Overall Study|Withdrawal by Subject|1|||
161773886|NCT05261126|584214390|FG004|Overall Study|Withdrawal by Subject|0|||
161773887|NCT05261126|584214386|FG000|Overall Study|Not Recorded|0|||
161773888|NCT05261126|584214387|FG001|Overall Study|Not Recorded|0|||
161773889|NCT05261126|584214388|FG002|Overall Study|Not Recorded|0|||
161773890|NCT05261126|584214389|FG003|Overall Study|Not Recorded|1|||
161773891|NCT05261126|584214390|FG004|Overall Study|Not Recorded|0|||
161773892|NCT05939388|584214391|FG000|Overall Study|Lost to Follow-up|1|||
161773893|NCT03901274|584214392|FG000|Overall Study|Lost to Follow-up|120|||
161773894|NCT03901274|584214393|FG001|Overall Study|Lost to Follow-up|124|||
161773895|NCT03901274|584214392|FG000|Overall Study|Withdrawal by Subject|0|||
161773896|NCT03901274|584214393|FG001|Overall Study|Withdrawal by Subject|6|||
161773897|NCT05570604|584214394|FG000|Overall Study|Lost to Follow-up|1|||
161773898|NCT05570604|584214395|FG001|Overall Study|Lost to Follow-up|5|||
161773899|NCT05570604|584214394|FG000|Overall Study|Illness|2|||
161773900|NCT05570604|584214395|FG001|Overall Study|Illness|2|||
161773901|NCT04527380|584214402|FG000|Overall Study|Lack of Efficacy|0|||
161773902|NCT04527380|584214403|FG001|Overall Study|Lack of Efficacy|1|||
161773903|NCT04527380|584214402|FG000|Overall Study|Withdrawal by Subject|1|||
161773904|NCT04527380|584214403|FG001|Overall Study|Withdrawal by Subject|0|||
161773905|NCT04479358|584214404|FG000|Overall Study|Withdrawal by Subject|0|||
161773906|NCT04479358|584214405|FG001|Overall Study|Withdrawal by Subject|0|||
161773907|NCT04479358|584214406|FG002|Overall Study|Withdrawal by Subject|1|||
161773908|NCT04479358|584214407|FG003|Overall Study|Withdrawal by Subject|0|||
161773909|NCT04479358|584214408|FG004|Overall Study|Withdrawal by Subject|0|||
161773910|NCT04479358|584214409|FG005|Overall Study|Withdrawal by Subject|1|||
161773911|NCT05116241|584214424|FG000|Study|Withdrawal by Subject|5|||
161773912|NCT05116241|584214425|FG001|Study|Withdrawal by Subject|2|||
161773913|NCT05116241|584214426|FG002|Study|Withdrawal by Subject|1|||
161773914|NCT05116241|584214424|FG000|Study|Lost to Follow-up|0|||
161773915|NCT05116241|584214425|FG001|Study|Lost to Follow-up|2|||
161773916|NCT05116241|584214426|FG002|Study|Lost to Follow-up|2|||
161773917|NCT04410991|584214431|FG000|Overall Study|Poor compliance to protocol|5|||
161773918|NCT04410991|584214432|FG001|Overall Study|Poor compliance to protocol|4|||
161773919|NCT04410991|584214431|FG000|Overall Study|Withdrawal by Subject|59|||
161773920|NCT04410991|584214432|FG001|Overall Study|Withdrawal by Subject|55|||
161773921|NCT04410991|584214431|FG000|Overall Study|Other|10|||
161773922|NCT04410991|584214432|FG001|Overall Study|Other|4|||
161773923|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161773924|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161773925|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
161773926|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773927|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773928|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773929|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773930|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773931|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773932|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
161773933|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161864165|NCT00092118|584545596|FG001|Overall Study|Protocol Violation|25|||
161773934|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773935|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773936|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773937|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
161773938|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773939|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
161773940|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773941|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773942|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773943|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773944|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
161773945|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773946|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
161773947|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773948|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773949|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773950|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773951|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
161773952|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
161773953|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
161773954|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773955|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773956|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773957|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773958|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161864166|NCT00092118|584545595|FG000|Overall Study|Withdrawal by Subject|4|||
161864167|NCT00092118|584545596|FG001|Overall Study|Withdrawal by Subject|10|||
161864168|NCT00092118|584545595|FG000|Overall Study|Other|6|||
161864169|NCT00092118|584545596|FG001|Overall Study|Other|5|||
161864170|NCT01139125|584545600|FG000|Overall Study|Withdrawal by Subject|1|||
161864171|NCT00837148|584545601|FG000|Overall Study|Adverse Event|1|||
161864172|NCT00837148|584545601|FG000|Overall Study|Death|1|||
161864173|NCT00931411|584545604|FG000|First Intervention - 42 Days|Adverse Event|2|||
161864174|NCT00931411|584545605|FG001|First Intervention - 42 Days|Adverse Event|3|||
161864175|NCT00931411|584545604|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
161864176|NCT00931411|584545605|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
161864177|NCT00931411|584545604|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
161864178|NCT00931411|584545605|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
161864179|NCT01827111|584545606|FG000|Overall Study|Disease Progression|1|||
161864180|NCT03181633|584545609|FG000|Overall Study|Withdrawal by Subject|1|||
161864181|NCT03181633|584545609|FG000|Overall Study|Missing follow-up visit|1|||
161864182|NCT04383327|584545616|FG000|Overall Study|Lost to Follow-up|112|||
161864183|NCT04383327|584545617|FG001|Overall Study|Lost to Follow-up|14|||
161864184|NCT04383327|584545618|FG002|Overall Study|Lost to Follow-up|78|||
161864185|NCT04383327|584545619|FG003|Overall Study|Lost to Follow-up|13|||
161864186|NCT04383327|584545620|FG004|Overall Study|Lost to Follow-up|110|||
161864187|NCT04383327|584545621|FG005|Overall Study|Lost to Follow-up|13|||
161864188|NCT04383327|584545622|FG006|Overall Study|Lost to Follow-up|74|||
161864189|NCT04383327|584545623|FG007|Overall Study|Lost to Follow-up|13|||
161864190|NCT04383327|584545624|FG008|Overall Study|Lost to Follow-up|78|||
161864191|NCT04383327|584545625|FG009|Overall Study|Lost to Follow-up|10|||
161864192|NCT04383327|584545626|FG010|Overall Study|Lost to Follow-up|160|||
161864193|NCT04383327|584545627|FG011|Overall Study|Lost to Follow-up|13|||
161864194|NCT04837196|584545628|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161864195|NCT04837196|584545629|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
161773959|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773960|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
161773961|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773962|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773963|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773964|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161864196|NCT04837196|584545630|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161864197|NCT04837196|584545631|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161864198|NCT04837196|584545632|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
161864199|NCT04837196|584545628|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161864200|NCT04837196|584545629|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
161864201|NCT04837196|584545630|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
161864202|NCT04837196|584545631|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161864203|NCT04837196|584545632|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161864204|NCT04837196|584545628|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864205|NCT04837196|584545629|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
161864206|NCT04837196|584545630|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864207|NCT04837196|584545631|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864208|NCT04837196|584545632|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864209|NCT04837196|584545628|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864210|NCT04837196|584545629|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864211|NCT04837196|584545630|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
161864212|NCT04837196|584545631|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864213|NCT04837196|584545632|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864214|NCT04837196|584545628|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864215|NCT04837196|584545629|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864216|NCT04837196|584545630|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
161864217|NCT04837196|584545631|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864218|NCT04837196|584545632|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864219|NCT00991887|584545633|FG000|Overall Study|Lost to Follow-up|2|||
161864220|NCT00991887|584545634|FG001|Overall Study|Lost to Follow-up|1|||
161864221|NCT01306305|584545635|FG000|Overall Study|Lost to Follow-up|1|||
161864222|NCT01306305|584545636|FG001|Overall Study|Lost to Follow-up|0|||
161864223|NCT01306305|584545635|FG000|Overall Study|Withdrew consent|1|||
161864224|NCT01306305|584545636|FG001|Overall Study|Withdrew consent|0|||
161864225|NCT04030299|584545637|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
161864226|NCT04030299|584545637|FG000|Overall Study|Withdrawal by Subject|3|||
161864227|NCT00699998|584545638|FG000|Overall Study|Withdrawal by Subject|194|||
161864228|NCT00699998|584545639|FG001|Overall Study|Withdrawal by Subject|83|||
161864229|NCT00699998|584545640|FG002|Overall Study|Withdrawal by Subject|202|||
161864230|NCT00699998|584545641|FG003|Overall Study|Withdrawal by Subject|80|||
161864231|NCT00699998|584545638|FG000|Overall Study|Physician Decision|3|||
161864232|NCT00699998|584545639|FG001|Overall Study|Physician Decision|2|||
161864233|NCT00699998|584545640|FG002|Overall Study|Physician Decision|1|||
161864234|NCT00699998|584545641|FG003|Overall Study|Physician Decision|1|||
161864235|NCT00699998|584545638|FG000|Overall Study|Lost to Follow-up|2|||
161864236|NCT00699998|584545639|FG001|Overall Study|Lost to Follow-up|1|||
161864237|NCT00699998|584545640|FG002|Overall Study|Lost to Follow-up|3|||
161864238|NCT00699998|584545641|FG003|Overall Study|Lost to Follow-up|1|||
161864239|NCT04616612|584545648|FG000|Overall Study|Lost to Follow-up|6|||
161864240|NCT04616612|584545649|FG001|Overall Study|Lost to Follow-up|3|||
161864241|NCT04740918|584545651|FG000|Overall Study|Study Terminated by Sponsor|41|||
161864242|NCT04740918|584545652|FG001|Overall Study|Study Terminated by Sponsor|32|||
161864243|NCT04740918|584545651|FG000|Overall Study|Death|3|||
161864244|NCT04740918|584545652|FG001|Overall Study|Death|6|||
161864245|NCT04740918|584545651|FG000|Overall Study|Withdrawal by Subject|5|||
161864246|NCT04740918|584545652|FG001|Overall Study|Withdrawal by Subject|4|||
161864247|NCT04740918|584545651|FG000|Overall Study|Lost to Follow-up|1|||
161864248|NCT04740918|584545652|FG001|Overall Study|Lost to Follow-up|3|||
161864249|NCT04740918|584545651|FG000|Overall Study|Progressive disease|0|||
161864250|NCT04740918|584545652|FG001|Overall Study|Progressive disease|1|||
161864251|NCT00359424|584545656|FG000|Overall Study|Death|99|||
161864252|NCT00359424|584545657|FG001|Overall Study|Death|58|||
161864253|NCT00359424|584545656|FG000|Overall Study|Lost to Follow-up|19|||
161864254|NCT00359424|584545657|FG001|Overall Study|Lost to Follow-up|7|||
161864255|NCT00359424|584545656|FG000|Overall Study|Withdrawal by Subject|10|||
161864256|NCT00359424|584545657|FG001|Overall Study|Withdrawal by Subject|2|||
161864257|NCT00359424|584545656|FG000|Overall Study|follow up not conducted|2|||
161864258|NCT00359424|584545657|FG001|Overall Study|follow up not conducted|0|||
161864259|NCT02208362|584545658|FG000|Overall Study|Participant did not complete treatment|0|||
161864260|NCT02208362|584545659|FG001|Overall Study|Participant did not complete treatment|1|||
161864261|NCT02208362|584545660|FG002|Overall Study|Participant did not complete treatment|0|||
161864262|NCT02208362|584545661|FG003|Overall Study|Participant did not complete treatment|0|||
161864263|NCT02208362|584545662|FG004|Overall Study|Participant did not complete treatment|0|||
161864264|NCT02208362|584545663|FG005|Overall Study|Participant did not complete treatment|0|||
161864265|NCT02208362|584545664|FG006|Overall Study|Participant did not complete treatment|1|||
161864266|NCT02208362|584545665|FG007|Overall Study|Participant did not complete treatment|1|||
161864267|NCT02208362|584545666|FG008|Overall Study|Participant did not complete treatment|2|||
161864268|NCT02208362|584545667|FG009|Overall Study|Participant did not complete treatment|0|||
161864269|NCT02208362|584545668|FG010|Overall Study|Participant did not complete treatment|1|||
161864270|NCT02208362|584545669|FG011|Overall Study|Participant did not complete treatment|0|||
161864271|NCT02208362|584545658|FG000|Overall Study|Participant received disallowed treatment|0|||
161864272|NCT02208362|584545659|FG001|Overall Study|Participant received disallowed treatment|0|||
161864273|NCT02208362|584545660|FG002|Overall Study|Participant received disallowed treatment|0|||
161864274|NCT02208362|584545661|FG003|Overall Study|Participant received disallowed treatment|0|||
161864275|NCT02208362|584545662|FG004|Overall Study|Participant received disallowed treatment|0|||
161864276|NCT02208362|584545663|FG005|Overall Study|Participant received disallowed treatment|0|||
161864277|NCT02208362|584545664|FG006|Overall Study|Participant received disallowed treatment|0|||
161864278|NCT02208362|584545665|FG007|Overall Study|Participant received disallowed treatment|0|||
161864279|NCT02208362|584545666|FG008|Overall Study|Participant received disallowed treatment|1|||
161864280|NCT02208362|584545667|FG009|Overall Study|Participant received disallowed treatment|0|||
161864281|NCT02208362|584545668|FG010|Overall Study|Participant received disallowed treatment|0|||
161864282|NCT02208362|584545669|FG011|Overall Study|Participant received disallowed treatment|0|||
161864283|NCT05479435|584545672|FG000|Overall Study|Withdrawal by Subject|1|||
161864284|NCT05479435|584545673|FG001|Overall Study|Withdrawal by Subject|0|||
161864285|NCT05479435|584545674|FG002|Overall Study|Withdrawal by Subject|0|||
161864286|NCT05479435|584545672|FG000|Overall Study|Covid 19|0|||
161864287|NCT05479435|584545673|FG001|Overall Study|Covid 19|0|||
161864288|NCT05479435|584545674|FG002|Overall Study|Covid 19|2|||
161864289|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
161864290|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
161864291|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
161864292|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
161864293|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
161864294|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
161864295|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
161864296|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
161864297|NCT01609790|584545681|FG000|Overall Study|Protocol Violation|1|||
161864298|NCT01609790|584545682|FG001|Overall Study|Protocol Violation|7|||
161864299|NCT01609790|584545683|FG002|Overall Study|Protocol Violation|8|||
161864300|NCT00858273|584545684|FG000|Overall Study|Protocol Violation|3|||
161864301|NCT00858273|584545685|FG001|Overall Study|Protocol Violation|5|||
161864302|NCT00982657|584545686|FG000|Overall Study|Death|1|||
161864303|NCT00982657|584545687|FG001|Overall Study|Death|0|||
161864304|NCT00982657|584545688|FG002|Overall Study|Death|1|||
161864305|NCT00982657|584545689|FG003|Overall Study|Death|1|||
161864306|NCT00982657|584545686|FG000|Overall Study|Withdrawal by Subject|0|||
161864307|NCT00982657|584545687|FG001|Overall Study|Withdrawal by Subject|0|||
161864308|NCT00982657|584545688|FG002|Overall Study|Withdrawal by Subject|1|||
161864309|NCT00982657|584545689|FG003|Overall Study|Withdrawal by Subject|3|||
161864310|NCT00982657|584545686|FG000|Overall Study|Other|0|||
161864311|NCT00982657|584545687|FG001|Overall Study|Other|0|||
161864312|NCT00982657|584545688|FG002|Overall Study|Other|0|||
161864313|NCT00982657|584545689|FG003|Overall Study|Other|4|||
161864314|NCT00982657|584545686|FG000|Overall Study|On going at date of cut-off|0|||
161864315|NCT00982657|584545687|FG001|Overall Study|On going at date of cut-off|0|||
161864316|NCT00982657|584545688|FG002|Overall Study|On going at date of cut-off|0|||
161864317|NCT00982657|584545689|FG003|Overall Study|On going at date of cut-off|1|||
161864318|NCT03760744|584547674|FG000|Overall Study|Lost to Follow-up|3|||
161864319|NCT03760744|584547675|FG001|Overall Study|Lost to Follow-up|0|||
161864320|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Adverse Event|7|||
161864321|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
161864322|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Non-compliance|3|||
161864323|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Other|17|||
161864324|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Physician Decision|2|||
161864325|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Pregnancy|1|||
161864326|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
161864327|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
161864328|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
161864329|NCT05207865|584547676|FG000|Follow-up Phase|Lost to Follow-up|1|||
161864330|NCT05207865|584547676|FG000|Follow-up Phase|Non-compliance|1|||
161864331|NCT05207865|584547676|FG000|Follow-up Phase|Not reported|2|||
161864332|NCT05207865|584547676|FG000|Follow-up Phase|Not collected|11|||
161864333|NCT00739882|584547681|FG000|Double-blind Period|Adverse Event|1|||
161864334|NCT00739882|584547682|FG001|Double-blind Period|Adverse Event|2|||
161864335|NCT00739882|584547681|FG000|Double-blind Period|Protocol Violation|1|||
161864336|NCT00739882|584547682|FG001|Double-blind Period|Protocol Violation|0|||
161864337|NCT00739882|584547681|FG000|Double-blind Period|Lack of Efficacy|1|||
161864338|NCT00739882|584547682|FG001|Double-blind Period|Lack of Efficacy|1|||
161864339|NCT00739882|584547681|FG000|Double-blind Period|Other|16|||
161864340|NCT00739882|584547682|FG001|Double-blind Period|Other|8|||
161864341|NCT00739882|584547681|FG000|Open-label Period|Adverse Event|1|||
161864342|NCT00739882|584547682|FG001|Open-label Period|Adverse Event|0|||
161864343|NCT00739882|584547681|FG000|Open-label Period|Other|9|||
161864344|NCT00739882|584547682|FG001|Open-label Period|Other|5|||
161864345|NCT03055338|584547685|FG000|Overall Study|Lost to Follow-up|9|||
161864346|NCT03055338|584547686|FG001|Overall Study|Lost to Follow-up|2|||
161864347|NCT03055338|584547687|FG002|Overall Study|Lost to Follow-up|3|||
161864348|NCT03055338|584547685|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
161864349|NCT03055338|584547686|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
161864350|NCT03055338|584547687|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
161864351|NCT03055338|584547685|FG000|Overall Study|Physician Decision|0|||
161864352|NCT03055338|584547686|FG001|Overall Study|Physician Decision|0|||
161864353|NCT03055338|584547687|FG002|Overall Study|Physician Decision|2|||
161864354|NCT03055338|584547685|FG000|Overall Study|Withdrawal by Subject|9|||
161864355|NCT03055338|584547686|FG001|Overall Study|Withdrawal by Subject|8|||
161864356|NCT03055338|584547687|FG002|Overall Study|Withdrawal by Subject|7|||
161864357|NCT00975611|584547688|FG000|Overall Study|Screen Fail|16|||
161864358|NCT00975611|584547688|FG000|Overall Study|Physician Decision|1|||
161864359|NCT03058705|584547689|FG000|Overall Study|Withdrawal by Subject|2|||
161864360|NCT03058705|584547689|FG000|Overall Study|Physician Decision|2|||
161864361|NCT01880554|584547690|FG000|Overall Study|Protocol Violation|14|||
161864362|NCT01880554|584547690|FG000|Overall Study|Simon's design requirements|2|||
161864363|NCT01102257|584547695|FG000|Overall Study|Adverse Event|1|||
161864364|NCT01102257|584547696|FG001|Overall Study|Adverse Event|0|||
161864365|NCT01102257|584547695|FG000|Overall Study|Adverse Event|1|||
161864366|NCT01102257|584547696|FG001|Overall Study|Adverse Event|0|||
161864367|NCT03752970|584547697|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
161864368|NCT03752970|584547698|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
161864369|NCT03752970|584547699|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
161864370|NCT03752970|584547697|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
161864371|NCT03752970|584547698|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
161864372|NCT03752970|584547699|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
161864373|NCT03752970|584547697|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
161864374|NCT03752970|584547698|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
161864375|NCT03752970|584547699|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
161864376|NCT03752970|584547697|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
161864377|NCT03752970|584547698|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
161864378|NCT03752970|584547699|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
161864379|NCT03752970|584547697|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
161864380|NCT03752970|584547698|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
161864381|NCT03752970|584547699|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
161864382|NCT04767282|584547700|FG000|Overall Study|Refused or did not begin surveys|6|||
161864383|NCT04767282|584547701|FG001|Overall Study|Refused or did not begin surveys|2|||
161864384|NCT04767282|584547702|FG002|Overall Study|Refused or did not begin surveys|2|||
161864385|NCT04767282|584547700|FG000|Overall Study|Duplicate household previously enrolled|2|||
161864386|NCT04767282|584547701|FG001|Overall Study|Duplicate household previously enrolled|0|||
161864387|NCT04767282|584547702|FG002|Overall Study|Duplicate household previously enrolled|8|||
161864388|NCT04767282|584547700|FG000|Overall Study|Unable to confirm legal guardian|0|||
161864389|NCT04767282|584547701|FG001|Overall Study|Unable to confirm legal guardian|2|||
161864390|NCT04767282|584547702|FG002|Overall Study|Unable to confirm legal guardian|8|||
161864391|NCT04767282|584547700|FG000|Overall Study|Withdrawal by Subject|0|||
161864392|NCT04767282|584547701|FG001|Overall Study|Withdrawal by Subject|0|||
161864393|NCT04767282|584547702|FG002|Overall Study|Withdrawal by Subject|6|||
161864394|NCT04767282|584547700|FG000|Overall Study|Survey comprehension challenges|4|||
161864395|NCT04767282|584547701|FG001|Overall Study|Survey comprehension challenges|0|||
161864396|NCT04767282|584547702|FG002|Overall Study|Survey comprehension challenges|0|||
161864397|NCT01467713|584547704|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
161864398|NCT01467713|584547705|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161864399|NCT01467713|584547706|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161864400|NCT01467713|584547707|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
161864401|NCT01467713|584547704|FG000|Overall Study|Major Protocol Deviation|2|||
161864402|NCT01467713|584547705|FG001|Overall Study|Major Protocol Deviation|4|||
161864403|NCT01467713|584547706|FG002|Overall Study|Major Protocol Deviation|4|||
161864404|NCT01467713|584547707|FG003|Overall Study|Major Protocol Deviation|1|||
161864405|NCT01467713|584547704|FG000|Overall Study|Lost to Follow-up|9|||
161864406|NCT01467713|584547705|FG001|Overall Study|Lost to Follow-up|12|||
161864407|NCT01467713|584547706|FG002|Overall Study|Lost to Follow-up|6|||
161864408|NCT01467713|584547707|FG003|Overall Study|Lost to Follow-up|9|||
161864409|NCT01467713|584547704|FG000|Overall Study|Voluntary Withdrawal|18|||
161864410|NCT01467713|584547705|FG001|Overall Study|Voluntary Withdrawal|14|||
161864411|NCT01467713|584547706|FG002|Overall Study|Voluntary Withdrawal|21|||
161864412|NCT01467713|584547707|FG003|Overall Study|Voluntary Withdrawal|20|||
161864413|NCT01467713|584547704|FG000|Overall Study|Study Termination|23|||
161864414|NCT01467713|584547705|FG001|Overall Study|Study Termination|33|||
161864415|NCT01467713|584547706|FG002|Overall Study|Study Termination|28|||
161864416|NCT01467713|584547707|FG003|Overall Study|Study Termination|29|||
161864417|NCT01467713|584547704|FG000|Overall Study|Pregnancy|0|||
161864418|NCT01467713|584547705|FG001|Overall Study|Pregnancy|1|||
161864419|NCT01467713|584547706|FG002|Overall Study|Pregnancy|1|||
161864420|NCT01467713|584547707|FG003|Overall Study|Pregnancy|3|||
161864421|NCT01467713|584547704|FG000|Overall Study|Relapse|35|||
161864422|NCT01467713|584547705|FG001|Overall Study|Relapse|25|||
161864423|NCT01467713|584547706|FG002|Overall Study|Relapse|28|||
161864424|NCT01467713|584547707|FG003|Overall Study|Relapse|35|||
161864425|NCT01467713|584547704|FG000|Overall Study|Reason not Specified|6|||
161864426|NCT01467713|584547705|FG001|Overall Study|Reason not Specified|11|||
161864427|NCT01467713|584547706|FG002|Overall Study|Reason not Specified|8|||
161864428|NCT01467713|584547707|FG003|Overall Study|Reason not Specified|7|||
161864429|NCT02512302|584547710|FG000|Period 1|Adverse Event|0|||
161864430|NCT02512302|584547711|FG001|Period 1|Adverse Event|1|||
161864431|NCT02512302|584547712|FG002|Period 1|Adverse Event|0|||
161864432|NCT02512302|584547713|FG003|Period 1|Adverse Event|0|||
161864433|NCT02512302|584547714|FG004|Period 1|Adverse Event|0|||
161864434|NCT02512302|584547715|FG005|Period 1|Adverse Event|0|||
161864435|NCT02512302|584547716|FG006|Period 1|Adverse Event|0|||
161864436|NCT02512302|584547717|FG007|Period 1|Adverse Event|0|||
161864437|NCT02512302|584547718|FG008|Period 1|Adverse Event|0|||
161864438|NCT02512302|584547719|FG009|Period 1|Adverse Event|0|||
161864439|NCT02512302|584547710|FG000|Period 2|Adverse Event|0|||
161864440|NCT02512302|584547711|FG001|Period 2|Adverse Event|0|||
161864441|NCT02512302|584547712|FG002|Period 2|Adverse Event|0|||
161864442|NCT02512302|584547713|FG003|Period 2|Adverse Event|0|||
161864443|NCT02512302|584547714|FG004|Period 2|Adverse Event|0|||
161864444|NCT02512302|584547715|FG005|Period 2|Adverse Event|0|||
161864445|NCT02512302|584547716|FG006|Period 2|Adverse Event|0|||
161864446|NCT02512302|584547717|FG007|Period 2|Adverse Event|0|||
161864447|NCT02512302|584547718|FG008|Period 2|Adverse Event|0|||
161864448|NCT02512302|584547719|FG009|Period 2|Adverse Event|1|||
161864449|NCT02512302|584547710|FG000|Period 3|Lost to Follow-up|0|||
161864450|NCT02512302|584547711|FG001|Period 3|Lost to Follow-up|0|||
161864451|NCT02512302|584547712|FG002|Period 3|Lost to Follow-up|1|||
161864452|NCT02512302|584547713|FG003|Period 3|Lost to Follow-up|0|||
161864453|NCT02512302|584547714|FG004|Period 3|Lost to Follow-up|0|||
161864454|NCT02512302|584547715|FG005|Period 3|Lost to Follow-up|0|||
161864455|NCT02512302|584547716|FG006|Period 3|Lost to Follow-up|0|||
161864456|NCT02512302|584547717|FG007|Period 3|Lost to Follow-up|0|||
161864457|NCT02512302|584547718|FG008|Period 3|Lost to Follow-up|0|||
161864458|NCT02512302|584547719|FG009|Period 3|Lost to Follow-up|0|||
161864459|NCT02512302|584547710|FG000|Period 4|Adverse Event|0|||
161864460|NCT02512302|584547711|FG001|Period 4|Adverse Event|0|||
161864461|NCT02512302|584547712|FG002|Period 4|Adverse Event|0|||
161864462|NCT02512302|584547713|FG003|Period 4|Adverse Event|0|||
161864463|NCT02512302|584547714|FG004|Period 4|Adverse Event|0|||
161864464|NCT02512302|584547715|FG005|Period 4|Adverse Event|0|||
161864465|NCT02512302|584547716|FG006|Period 4|Adverse Event|1|||
161864466|NCT02512302|584547717|FG007|Period 4|Adverse Event|0|||
161864467|NCT02512302|584547718|FG008|Period 4|Adverse Event|0|||
161864468|NCT02512302|584547719|FG009|Period 4|Adverse Event|0|||
161864469|NCT01735916|584547728|FG000|Overall Study|Subject not eligible to be randomized|11|||
161864470|NCT01735916|584547729|FG001|Overall Study|Subject not eligible to be randomized|0|||
161864471|NCT01735916|584547730|FG002|Overall Study|Subject not eligible to be randomized|0|||
161864472|NCT01735916|584547728|FG000|Overall Study|Early termination of study by sponsor|4|||
161864473|NCT01735916|584547729|FG001|Overall Study|Early termination of study by sponsor|19|||
161864474|NCT01735916|584547730|FG002|Overall Study|Early termination of study by sponsor|7|||
161864475|NCT01735916|584547728|FG000|Overall Study|Withdrawal by Subject|3|||
161864476|NCT01735916|584547729|FG001|Overall Study|Withdrawal by Subject|0|||
161864477|NCT01735916|584547730|FG002|Overall Study|Withdrawal by Subject|0|||
161864478|NCT05177484|584547736|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
161864479|NCT05177484|584547737|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
161864480|NCT05177484|584547736|FG000|Overall Study|Inadvertently withdrawn|3|||
161864481|NCT05177484|584547737|FG001|Overall Study|Inadvertently withdrawn|1|||
161864482|NCT05177484|584547736|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
161864483|NCT05177484|584547737|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
161864484|NCT01379768|584547738|FG000|Overall Study|Adverse Event|1|||
161864485|NCT01379768|584547739|FG001|Overall Study|Adverse Event|1|||
161864486|NCT01379768|584547740|FG002|Overall Study|Adverse Event|0|||
161864487|NCT01379768|584547738|FG000|Overall Study|Lost to Follow-up|2|||
161864488|NCT01379768|584547739|FG001|Overall Study|Lost to Follow-up|0|||
161864489|NCT01379768|584547740|FG002|Overall Study|Lost to Follow-up|0|||
161864490|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
161864491|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
161864492|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
161864493|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
161864494|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
161864495|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864496|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864497|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864498|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161773965|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773966|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773967|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
161773968|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773969|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773970|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773971|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773972|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773973|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
161773974|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
161773975|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773976|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773977|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773978|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773979|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773980|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773981|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773982|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773983|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
161773984|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
161773985|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
161773986|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773987|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773988|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773989|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773990|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
161773991|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
161773992|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
161773993|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773994|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773995|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773996|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773997|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773998|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161773999|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161774000|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161774001|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161774002|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161774003|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161774004|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161774005|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
161774006|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161774007|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161774008|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161774009|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161774010|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
161774011|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
161774012|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
161774013|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
161774014|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774015|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774016|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774017|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774018|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
161774019|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774020|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774021|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774022|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774023|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774024|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774025|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774026|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
161774027|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774028|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774029|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774030|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774031|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774032|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774033|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
161774034|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
161774035|NCT01958619|584214450|FG000|Overall Study|Protocol Violation|2|||
161774036|NCT01958619|584214451|FG001|Overall Study|Protocol Violation|0|||
161774037|NCT01958619|584214452|FG002|Overall Study|Protocol Violation|1|||
161774038|NCT01958619|584214453|FG003|Overall Study|Protocol Violation|0|||
161774039|NCT00931515|584214454|FG000|Overall Study|Lost to Follow-up|2|||
161774040|NCT00931515|584214455|FG001|Overall Study|Lost to Follow-up|5|||
161774041|NCT01054443|584214456|FG000|Overall Study|Withdrawal by Subject|0|||
161774042|NCT01054443|584214457|FG001|Overall Study|Withdrawal by Subject|0|||
161774043|NCT01054443|584214458|FG002|Overall Study|Withdrawal by Subject|0|||
161774044|NCT01054443|584214459|FG003|Overall Study|Withdrawal by Subject|1|||
161774045|NCT00985114|584214461|FG000|Overall Study|Adverse Event|1|||
161864499|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864500|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864501|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864502|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864503|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864504|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864505|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
161864506|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
161864507|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
161864508|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
161864509|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
161864510|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864511|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864512|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864513|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864514|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864515|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864516|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864517|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864518|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864519|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864520|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
161864521|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
161864522|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
161864523|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
161864524|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
161864525|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864526|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864527|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864528|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864529|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864530|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864531|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864532|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864533|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161774046|NCT00985114|584214462|FG001|Overall Study|Adverse Event|0|||
161774047|NCT00985114|584214461|FG000|Overall Study|Withdrawal by Subject|0|||
161864534|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864535|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
161864536|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
161864537|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
161864538|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
161864539|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
161864540|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864541|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864542|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864543|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864544|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864545|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864546|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864547|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864548|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864549|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864550|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
161864551|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864552|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
161864553|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
161864554|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
161864555|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864556|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864557|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864558|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864559|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864560|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864561|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864562|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864563|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864564|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864565|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864566|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864567|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864568|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
161864569|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864570|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864571|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864572|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
161774048|NCT00985114|584214462|FG001|Overall Study|Withdrawal by Subject|2|||
161774049|NCT02950831|584214463|FG000|Overall Study|Lost to Follow-up|1|||
161774050|NCT02950831|584214463|FG000|Overall Study|Withdrawal by Subject|3|||
161774051|NCT02950831|584214463|FG000|Overall Study|stimulation trail failure|5|||
161774052|NCT01119118|584214464|FG000|Overall Study|Adverse Event|1|||
161864573|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864574|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864575|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864576|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864577|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864578|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864579|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864580|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864581|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
161864582|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
161864583|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
161864584|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
161864585|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864586|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864587|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864588|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864589|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864590|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864591|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864592|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864593|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864594|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864595|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864596|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864597|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864598|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864599|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864600|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161864601|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
161864602|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161864603|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
161864604|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
161864605|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161864606|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
161864607|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
161864608|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
161864609|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
161864610|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864611|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864612|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864613|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864614|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864615|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
161864616|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
161864617|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
161864618|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
161864619|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
161864620|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
161864621|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
161864622|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
161864623|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
161864624|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
161864625|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864626|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864627|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864628|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864629|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864630|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
161864631|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
161864632|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
161864633|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
161864634|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
161774053|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
161774054|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
161774055|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
161774056|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
161774057|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
161774058|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
161774059|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
161774060|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
161774061|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
161774062|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Death|1|||
161864635|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
161864636|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
161864637|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864638|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
161864639|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
161864640|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864641|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864642|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864643|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864644|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864645|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
161864646|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
161864647|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161864648|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161864649|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
161864650|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
161864651|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
161864652|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161864653|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
161864654|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
161864655|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864656|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864657|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864658|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864659|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864660|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864661|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
161864662|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
161864663|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
161864664|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161864665|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161864666|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161864667|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864668|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
161864669|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
161864670|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864671|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864672|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864673|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864674|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864675|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864676|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864677|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864678|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864679|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864680|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864681|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
161864682|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864683|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
161864684|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864685|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864686|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864687|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864688|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864689|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864690|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
161864691|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864692|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864693|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864694|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864695|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864696|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864697|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864698|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864699|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
161864700|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864701|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864702|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864703|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864704|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864705|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864706|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864707|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864708|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864709|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
161864710|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864711|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864712|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864713|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864714|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864715|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864716|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864717|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864718|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864719|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864720|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864721|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864722|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864723|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864724|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864725|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864726|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864727|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864728|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
161864729|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
161864730|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864731|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864732|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864733|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864734|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864735|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161864736|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864737|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864738|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864739|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864740|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161864741|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864742|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864743|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864744|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161864745|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864746|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864747|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864748|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864749|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864750|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864751|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864752|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864753|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864754|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864755|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864756|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
161864757|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864758|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864759|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864760|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864761|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864762|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864763|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864764|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864765|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864766|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864767|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864768|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864769|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864770|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864771|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161864772|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864773|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161864774|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161864775|NCT03922321|584547760|FG000|Overall Study|Participant Moved|1|||
161864776|NCT03922321|584547760|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
161864777|NCT02342678|584547764|FG000|Overall Study|Lost to Follow-up|0|||
161864778|NCT02342678|584547765|FG001|Overall Study|Lost to Follow-up|1|||
161864779|NCT02342678|584547764|FG000|Overall Study|Too busy to complete study|0|||
161864780|NCT02342678|584547765|FG001|Overall Study|Too busy to complete study|2|||
161864781|NCT02342678|584547764|FG000|Overall Study|Family illness/emergency|0|||
161864782|NCT02342678|584547765|FG001|Overall Study|Family illness/emergency|1|||
161864783|NCT02342678|584547764|FG000|Overall Study|Illness/medical reason|1|||
161864784|NCT02342678|584547765|FG001|Overall Study|Illness/medical reason|1|||
161864785|NCT00460603|584547766|FG000|Phase 1|Death|1|||
161864786|NCT00460603|584547767|FG001|Phase 1|Death|0|||
161864787|NCT00460603|584547768|FG002|Phase 1|Death|0|||
161864788|NCT00460603|584547769|FG003|Phase 1|Death|2|||
161864789|NCT00460603|584547770|FG004|Phase 1|Death|0|||
161864790|NCT00460603|584547771|FG005|Phase 1|Death|0|||
161864791|NCT00460603|584547772|FG006|Phase 1|Death|0|||
161864792|NCT00460603|584547773|FG007|Phase 1|Death|0|||
161864793|NCT00460603|584547774|FG008|Phase 1|Death|1|||
161864794|NCT00460603|584547775|FG009|Phase 1|Death|0|||
161864795|NCT00460603|584547776|FG010|Phase 1|Death|0|||
161864796|NCT00460603|584547777|FG011|Phase 1|Death|0|||
161864797|NCT00460603|584547766|FG000|Phase 1|Adverse Event|3|||
161864798|NCT00460603|584547767|FG001|Phase 1|Adverse Event|1|||
161864799|NCT00460603|584547768|FG002|Phase 1|Adverse Event|1|||
161864800|NCT00460603|584547769|FG003|Phase 1|Adverse Event|2|||
161864801|NCT00460603|584547770|FG004|Phase 1|Adverse Event|0|||
161864802|NCT00460603|584547771|FG005|Phase 1|Adverse Event|0|||
161864803|NCT00460603|584547772|FG006|Phase 1|Adverse Event|3|||
161864804|NCT00460603|584547773|FG007|Phase 1|Adverse Event|0|||
161864805|NCT00460603|584547774|FG008|Phase 1|Adverse Event|4|||
161864806|NCT00460603|584547775|FG009|Phase 1|Adverse Event|0|||
161864807|NCT00460603|584547776|FG010|Phase 1|Adverse Event|0|||
161864808|NCT00460603|584547777|FG011|Phase 1|Adverse Event|0|||
161864809|NCT00460603|584547766|FG000|Phase 1|Lack of Efficacy|1|||
161864810|NCT00460603|584547767|FG001|Phase 1|Lack of Efficacy|0|||
161864811|NCT00460603|584547768|FG002|Phase 1|Lack of Efficacy|1|||
161864812|NCT00460603|584547769|FG003|Phase 1|Lack of Efficacy|2|||
161864813|NCT00460603|584547770|FG004|Phase 1|Lack of Efficacy|2|||
161864814|NCT00460603|584547771|FG005|Phase 1|Lack of Efficacy|2|||
161864815|NCT00460603|584547772|FG006|Phase 1|Lack of Efficacy|2|||
161864816|NCT00460603|584547773|FG007|Phase 1|Lack of Efficacy|2|||
161864817|NCT00460603|584547774|FG008|Phase 1|Lack of Efficacy|11|||
161864818|NCT00460603|584547775|FG009|Phase 1|Lack of Efficacy|0|||
161864819|NCT00460603|584547776|FG010|Phase 1|Lack of Efficacy|0|||
161864820|NCT00460603|584547777|FG011|Phase 1|Lack of Efficacy|0|||
161864821|NCT00460603|584547766|FG000|Phase 1|Withdrawal by Subject|1|||
161864822|NCT00460603|584547767|FG001|Phase 1|Withdrawal by Subject|2|||
161864823|NCT00460603|584547768|FG002|Phase 1|Withdrawal by Subject|1|||
161864824|NCT00460603|584547769|FG003|Phase 1|Withdrawal by Subject|1|||
161864825|NCT00460603|584547770|FG004|Phase 1|Withdrawal by Subject|3|||
161864826|NCT00460603|584547771|FG005|Phase 1|Withdrawal by Subject|0|||
161864827|NCT00460603|584547772|FG006|Phase 1|Withdrawal by Subject|1|||
161864828|NCT00460603|584547773|FG007|Phase 1|Withdrawal by Subject|0|||
161864829|NCT00460603|584547774|FG008|Phase 1|Withdrawal by Subject|2|||
161864830|NCT00460603|584547775|FG009|Phase 1|Withdrawal by Subject|0|||
161864831|NCT00460603|584547776|FG010|Phase 1|Withdrawal by Subject|0|||
161864832|NCT00460603|584547777|FG011|Phase 1|Withdrawal by Subject|0|||
161864833|NCT00460603|584547766|FG000|Phase 1|Other|0|||
161864834|NCT00460603|584547767|FG001|Phase 1|Other|3|||
161864835|NCT00460603|584547768|FG002|Phase 1|Other|1|||
161864836|NCT00460603|584547769|FG003|Phase 1|Other|1|||
161864837|NCT00460603|584547770|FG004|Phase 1|Other|1|||
161864838|NCT00460603|584547771|FG005|Phase 1|Other|2|||
161864839|NCT00460603|584547772|FG006|Phase 1|Other|0|||
161864840|NCT00460603|584547773|FG007|Phase 1|Other|1|||
161864841|NCT00460603|584547774|FG008|Phase 1|Other|0|||
161864842|NCT00460603|584547775|FG009|Phase 1|Other|0|||
161864843|NCT00460603|584547776|FG010|Phase 1|Other|0|||
161864844|NCT00460603|584547777|FG011|Phase 1|Other|0|||
161864845|NCT00460603|584547766|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864846|NCT00460603|584547767|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864847|NCT00460603|584547768|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864848|NCT00460603|584547769|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864849|NCT00460603|584547770|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864850|NCT00460603|584547771|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864851|NCT00460603|584547772|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864852|NCT00460603|584547773|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864853|NCT00460603|584547774|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864854|NCT00460603|584547775|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
161864855|NCT00460603|584547776|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864856|NCT00460603|584547777|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864857|NCT00460603|584547766|FG000|Phase 2|Adverse Event|0|||
161864858|NCT00460603|584547767|FG001|Phase 2|Adverse Event|0|||
161864859|NCT00460603|584547768|FG002|Phase 2|Adverse Event|0|||
161864860|NCT00460603|584547769|FG003|Phase 2|Adverse Event|0|||
161864861|NCT00460603|584547770|FG004|Phase 2|Adverse Event|0|||
161864862|NCT00460603|584547771|FG005|Phase 2|Adverse Event|0|||
161864863|NCT00460603|584547772|FG006|Phase 2|Adverse Event|0|||
161864864|NCT00460603|584547773|FG007|Phase 2|Adverse Event|0|||
161864865|NCT00460603|584547774|FG008|Phase 2|Adverse Event|0|||
161864866|NCT00460603|584547775|FG009|Phase 2|Adverse Event|12|||
161864867|NCT00460603|584547776|FG010|Phase 2|Adverse Event|9|||
161864868|NCT00460603|584547777|FG011|Phase 2|Adverse Event|10|||
161864869|NCT00460603|584547766|FG000|Phase 2|Death|0|||
161864870|NCT00460603|584547767|FG001|Phase 2|Death|0|||
161864871|NCT00460603|584547768|FG002|Phase 2|Death|0|||
161864872|NCT00460603|584547769|FG003|Phase 2|Death|0|||
161864873|NCT00460603|584547770|FG004|Phase 2|Death|0|||
161864874|NCT00460603|584547771|FG005|Phase 2|Death|0|||
161864875|NCT00460603|584547772|FG006|Phase 2|Death|0|||
161864876|NCT00460603|584547773|FG007|Phase 2|Death|0|||
161864877|NCT00460603|584547774|FG008|Phase 2|Death|0|||
161864878|NCT00460603|584547775|FG009|Phase 2|Death|4|||
161864879|NCT00460603|584547776|FG010|Phase 2|Death|2|||
161864880|NCT00460603|584547777|FG011|Phase 2|Death|2|||
161864881|NCT00460603|584547766|FG000|Phase 2|Protocol Violation|0|||
161864882|NCT00460603|584547767|FG001|Phase 2|Protocol Violation|0|||
161864883|NCT00460603|584547768|FG002|Phase 2|Protocol Violation|0|||
161864884|NCT00460603|584547769|FG003|Phase 2|Protocol Violation|0|||
161864885|NCT00460603|584547770|FG004|Phase 2|Protocol Violation|0|||
161864886|NCT00460603|584547771|FG005|Phase 2|Protocol Violation|0|||
161864887|NCT00460603|584547772|FG006|Phase 2|Protocol Violation|0|||
161864888|NCT00460603|584547773|FG007|Phase 2|Protocol Violation|0|||
161864889|NCT00460603|584547774|FG008|Phase 2|Protocol Violation|0|||
161864890|NCT00460603|584547775|FG009|Phase 2|Protocol Violation|1|||
161864891|NCT00460603|584547776|FG010|Phase 2|Protocol Violation|1|||
161864892|NCT00460603|584547777|FG011|Phase 2|Protocol Violation|0|||
161864893|NCT00460603|584547766|FG000|Phase 2|Lost to Follow-up|0|||
161864894|NCT00460603|584547767|FG001|Phase 2|Lost to Follow-up|0|||
161864895|NCT00460603|584547768|FG002|Phase 2|Lost to Follow-up|0|||
161864896|NCT00460603|584547769|FG003|Phase 2|Lost to Follow-up|0|||
161864897|NCT00460603|584547770|FG004|Phase 2|Lost to Follow-up|0|||
161864898|NCT00460603|584547771|FG005|Phase 2|Lost to Follow-up|0|||
161864899|NCT00460603|584547772|FG006|Phase 2|Lost to Follow-up|0|||
161864900|NCT00460603|584547773|FG007|Phase 2|Lost to Follow-up|0|||
161864901|NCT00460603|584547774|FG008|Phase 2|Lost to Follow-up|0|||
161864902|NCT00460603|584547775|FG009|Phase 2|Lost to Follow-up|1|||
161864903|NCT00460603|584547776|FG010|Phase 2|Lost to Follow-up|0|||
161864904|NCT00460603|584547777|FG011|Phase 2|Lost to Follow-up|0|||
161864905|NCT00460603|584547766|FG000|Phase 2|Other|0|||
161864906|NCT00460603|584547767|FG001|Phase 2|Other|0|||
161864907|NCT00460603|584547768|FG002|Phase 2|Other|0|||
161864908|NCT00460603|584547769|FG003|Phase 2|Other|0|||
161864909|NCT00460603|584547770|FG004|Phase 2|Other|0|||
161864910|NCT00460603|584547771|FG005|Phase 2|Other|0|||
161864911|NCT00460603|584547772|FG006|Phase 2|Other|0|||
161864912|NCT00460603|584547773|FG007|Phase 2|Other|0|||
161864913|NCT00460603|584547774|FG008|Phase 2|Other|0|||
161864914|NCT00460603|584547775|FG009|Phase 2|Other|6|||
161864915|NCT00460603|584547776|FG010|Phase 2|Other|16|||
161864916|NCT00460603|584547777|FG011|Phase 2|Other|7|||
161864917|NCT00460603|584547766|FG000|Phase 2|Objective Progression or Relapse|0|||
161864918|NCT00460603|584547767|FG001|Phase 2|Objective Progression or Relapse|0|||
161864919|NCT00460603|584547768|FG002|Phase 2|Objective Progression or Relapse|0|||
161864920|NCT00460603|584547769|FG003|Phase 2|Objective Progression or Relapse|0|||
161864921|NCT00460603|584547770|FG004|Phase 2|Objective Progression or Relapse|0|||
161864922|NCT00460603|584547771|FG005|Phase 2|Objective Progression or Relapse|0|||
161864923|NCT00460603|584547772|FG006|Phase 2|Objective Progression or Relapse|0|||
161864924|NCT00460603|584547773|FG007|Phase 2|Objective Progression or Relapse|0|||
161864925|NCT00460603|584547774|FG008|Phase 2|Objective Progression or Relapse|0|||
161864926|NCT00460603|584547775|FG009|Phase 2|Objective Progression or Relapse|9|||
161864927|NCT00460603|584547776|FG010|Phase 2|Objective Progression or Relapse|10|||
161864928|NCT00460603|584547777|FG011|Phase 2|Objective Progression or Relapse|17|||
161864929|NCT00460603|584547766|FG000|Phase 2|Global Deterioration of Health Status|0|||
161864930|NCT00460603|584547767|FG001|Phase 2|Global Deterioration of Health Status|0|||
161864931|NCT00460603|584547768|FG002|Phase 2|Global Deterioration of Health Status|0|||
161864932|NCT00460603|584547769|FG003|Phase 2|Global Deterioration of Health Status|0|||
161864933|NCT00460603|584547770|FG004|Phase 2|Global Deterioration of Health Status|0|||
161864934|NCT00460603|584547771|FG005|Phase 2|Global Deterioration of Health Status|0|||
161864935|NCT00460603|584547772|FG006|Phase 2|Global Deterioration of Health Status|0|||
161864936|NCT00460603|584547773|FG007|Phase 2|Global Deterioration of Health Status|0|||
161864937|NCT00460603|584547774|FG008|Phase 2|Global Deterioration of Health Status|0|||
161864938|NCT00460603|584547775|FG009|Phase 2|Global Deterioration of Health Status|0|||
161864939|NCT00460603|584547776|FG010|Phase 2|Global Deterioration of Health Status|1|||
161864940|NCT00460603|584547777|FG011|Phase 2|Global Deterioration of Health Status|0|||
161864941|NCT00460603|584547766|FG000|Phase 2|Withdrawal by Subject|0|||
161864942|NCT00460603|584547767|FG001|Phase 2|Withdrawal by Subject|0|||
161864943|NCT00460603|584547768|FG002|Phase 2|Withdrawal by Subject|0|||
161864944|NCT00460603|584547769|FG003|Phase 2|Withdrawal by Subject|0|||
161864945|NCT00460603|584547770|FG004|Phase 2|Withdrawal by Subject|0|||
161864946|NCT00460603|584547771|FG005|Phase 2|Withdrawal by Subject|0|||
161864947|NCT00460603|584547772|FG006|Phase 2|Withdrawal by Subject|0|||
161864948|NCT00460603|584547773|FG007|Phase 2|Withdrawal by Subject|0|||
161864949|NCT00460603|584547774|FG008|Phase 2|Withdrawal by Subject|0|||
161864950|NCT00460603|584547775|FG009|Phase 2|Withdrawal by Subject|5|||
161864951|NCT00460603|584547776|FG010|Phase 2|Withdrawal by Subject|4|||
161864952|NCT00460603|584547777|FG011|Phase 2|Withdrawal by Subject|5|||
161864953|NCT00460603|584547766|FG000|Phase 2|Randomized, but not treated|0|||
161864954|NCT00460603|584547767|FG001|Phase 2|Randomized, but not treated|0|||
161864955|NCT00460603|584547768|FG002|Phase 2|Randomized, but not treated|0|||
161864956|NCT00460603|584547769|FG003|Phase 2|Randomized, but not treated|0|||
161864957|NCT00460603|584547770|FG004|Phase 2|Randomized, but not treated|0|||
161864958|NCT00460603|584547771|FG005|Phase 2|Randomized, but not treated|0|||
161864959|NCT00460603|584547772|FG006|Phase 2|Randomized, but not treated|0|||
161864960|NCT00460603|584547773|FG007|Phase 2|Randomized, but not treated|0|||
161864961|NCT00460603|584547774|FG008|Phase 2|Randomized, but not treated|0|||
161864962|NCT00460603|584547775|FG009|Phase 2|Randomized, but not treated|3|||
161864963|NCT00460603|584547776|FG010|Phase 2|Randomized, but not treated|0|||
161864964|NCT00460603|584547777|FG011|Phase 2|Randomized, but not treated|0|||
161864965|NCT01651117|584547781|FG000|Overall Study|Death|2|||
161864966|NCT01651117|584547782|FG001|Overall Study|Death|3|||
161864967|NCT01651117|584547783|FG002|Overall Study|Death|2|||
161864968|NCT01651117|584547784|FG003|Overall Study|Death|2|||
161864969|NCT02075203|584547786|FG000|Overall Study|Withdrawal by Subject|1|||
161864970|NCT02075203|584547787|FG001|Overall Study|Withdrawal by Subject|0|||
161864971|NCT02075203|584547788|FG002|Overall Study|Withdrawal by Subject|1|||
161864972|NCT02075203|584547786|FG000|Overall Study|Adverse Event|1|||
161864973|NCT02075203|584547787|FG001|Overall Study|Adverse Event|0|||
161864974|NCT02075203|584547788|FG002|Overall Study|Adverse Event|0|||
161864975|NCT02075203|584547786|FG000|Overall Study|participant refused to use contraception|1|||
161864976|NCT02075203|584547787|FG001|Overall Study|participant refused to use contraception|0|||
161864977|NCT02075203|584547788|FG002|Overall Study|participant refused to use contraception|0|||
161864978|NCT00350207|584547789|FG000|Overall Study|Adverse Event|5|||
161864979|NCT00350207|584547790|FG001|Overall Study|Adverse Event|2|||
161864980|NCT00350207|584547791|FG002|Overall Study|Adverse Event|2|||
161864981|NCT00350207|584547789|FG000|Overall Study|Lack of Efficacy|1|||
161864982|NCT00350207|584547790|FG001|Overall Study|Lack of Efficacy|0|||
161864983|NCT00350207|584547791|FG002|Overall Study|Lack of Efficacy|2|||
161864984|NCT00350207|584547789|FG000|Overall Study|Lost to Follow-up|1|||
161864985|NCT00350207|584547790|FG001|Overall Study|Lost to Follow-up|0|||
161864986|NCT00350207|584547791|FG002|Overall Study|Lost to Follow-up|1|||
161864987|NCT00350207|584547789|FG000|Overall Study|Withdrawal by Subject|0|||
161864988|NCT00350207|584547790|FG001|Overall Study|Withdrawal by Subject|1|||
161864989|NCT00350207|584547791|FG002|Overall Study|Withdrawal by Subject|1|||
161864990|NCT00350207|584547789|FG000|Overall Study|Other|1|||
161864991|NCT00350207|584547790|FG001|Overall Study|Other|3|||
161864992|NCT00350207|584547791|FG002|Overall Study|Other|1|||
161864993|NCT03802825|584547792|FG000|Overall Study|Lost to follow-up for intervention|12|||
161864994|NCT03802825|584547793|FG001|Overall Study|Lost to follow-up for intervention|3|||
161864995|NCT03802825|584547792|FG000|Overall Study|Received only 1 component of intervention|0|||
161864996|NCT03802825|584547793|FG001|Overall Study|Received only 1 component of intervention|13|||
161864997|NCT00568451|584547797|FG000|Overall Study|Disease Progression|0|||
161864998|NCT00568451|584547798|FG001|Overall Study|Disease Progression|0|||
161864999|NCT00568451|584547799|FG002|Overall Study|Disease Progression|2|||
161865000|NCT00568451|584547800|FG003|Overall Study|Disease Progression|7|||
161865001|NCT01293695|584547802|FG000|Overall Study|Withdrawal by Subject|7|||
161865002|NCT01293695|584547803|FG001|Overall Study|Withdrawal by Subject|1|||
161865003|NCT01293695|584547802|FG000|Overall Study|Lost to Follow-up|8|||
161865004|NCT01293695|584547803|FG001|Overall Study|Lost to Follow-up|6|||
161865005|NCT01082328|584547807|FG000|Overall Study|Adverse Event|1|||
161865006|NCT00791778|584547808|FG000|Double-blind Treatment|Adverse Event|49|||
161865007|NCT00791778|584547809|FG001|Double-blind Treatment|Adverse Event|9|||
161865008|NCT00791778|584547808|FG000|Double-blind Treatment|Physician Decision|6|||
161865009|NCT00791778|584547809|FG001|Double-blind Treatment|Physician Decision|26|||
161865010|NCT00791778|584547808|FG000|Double-blind Treatment|Protocol Violation|0|||
161865011|NCT00791778|584547809|FG001|Double-blind Treatment|Protocol Violation|4|||
161865012|NCT00791778|584547808|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
161865013|NCT00791778|584547809|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
161865014|NCT00791778|584547808|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
161865015|NCT00791778|584547809|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
161865016|NCT00791778|584547808|FG000|Follow-up|Withdrawal by Subject|3|||
161865017|NCT00791778|584547809|FG001|Follow-up|Withdrawal by Subject|0|||
161865018|NCT00791778|584547808|FG000|Follow-up|Lost to Follow-up|2|||
161865019|NCT00791778|584547809|FG001|Follow-up|Lost to Follow-up|1|||
161865020|NCT00031590|584547810|FG000|Overall Study|Adverse Event|1|||
161865021|NCT00031590|584547810|FG000|Overall Study|Withdrawal by parents|2|||
161865022|NCT05506046|584547811|FG000|Overall Study|Lost to Follow-up|89|||
161865023|NCT05506046|584547812|FG001|Overall Study|Lost to Follow-up|101|||
161865024|NCT05506046|584547813|FG002|Overall Study|Lost to Follow-up|102|||
161865025|NCT05506046|584547814|FG003|Overall Study|Lost to Follow-up|99|||
161865026|NCT03313180|584547819|FG000|Overall Study|Adverse Event|120|||
161865027|NCT03313180|584547819|FG000|Overall Study|Lost to Follow-up|3|||
161865028|NCT03313180|584547819|FG000|Overall Study|Withdrawal by Subject|39|||
161865029|NCT03313180|584547819|FG000|Overall Study|Other than listed above|15|||
161865030|NCT03313180|584547819|FG000|Overall Study|Covid-19 related|2|||
161865031|NCT01058642|584547822|FG000|Treatment Period 1|Adverse Event|0|||
161865032|NCT01058642|584547823|FG001|Treatment Period 1|Adverse Event|1|||
161865033|NCT01058642|584547824|FG002|Treatment Period 1|Adverse Event|1|||
161865034|NCT01058642|584547825|FG003|Treatment Period 1|Adverse Event|0|||
161865035|NCT01058642|584547822|FG000|Treatment Period 1|Physician Decision|0|||
161865036|NCT01058642|584547823|FG001|Treatment Period 1|Physician Decision|0|||
161865037|NCT01058642|584547824|FG002|Treatment Period 1|Physician Decision|1|||
161865038|NCT01058642|584547825|FG003|Treatment Period 1|Physician Decision|0|||
161865039|NCT01058642|584547822|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161865040|NCT01058642|584547823|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161865041|NCT01058642|584547824|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161865042|NCT01058642|584547825|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161865043|NCT01058642|584547822|FG000|Treatment Period 1|Lack of Efficacy|0|||
161865044|NCT01058642|584547823|FG001|Treatment Period 1|Lack of Efficacy|0|||
161865045|NCT01058642|584547824|FG002|Treatment Period 1|Lack of Efficacy|0|||
161865046|NCT01058642|584547825|FG003|Treatment Period 1|Lack of Efficacy|1|||
161865047|NCT01058642|584547822|FG000|Treatment Period 1|Protocol Violation|0|||
161865048|NCT01058642|584547823|FG001|Treatment Period 1|Protocol Violation|0|||
161865049|NCT01058642|584547824|FG002|Treatment Period 1|Protocol Violation|0|||
161865050|NCT01058642|584547825|FG003|Treatment Period 1|Protocol Violation|1|||
161865051|NCT01058642|584547822|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
161865052|NCT01058642|584547823|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161865053|NCT01058642|584547824|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161865054|NCT01058642|584547825|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161865055|NCT03267212|584547826|FG000|First Intervention|Lost to Follow-up|0|||
161865056|NCT03267212|584547827|FG001|First Intervention|Lost to Follow-up|2|||
161865057|NCT03267212|584547826|FG000|First Intervention|Withdrawal by Subject|1|||
161865058|NCT03267212|584547827|FG001|First Intervention|Withdrawal by Subject|1|||
161865059|NCT03267212|584547826|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
161865060|NCT03267212|584547827|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
161865061|NCT03759392|584547828|FG000|Overall Study|Adverse Event|12|||
161865062|NCT03759392|584547829|FG001|Overall Study|Adverse Event|4|||
161865063|NCT03759392|584547828|FG000|Overall Study|Death|2|||
161865064|NCT03759392|584547829|FG001|Overall Study|Death|1|||
161865065|NCT03759392|584547828|FG000|Overall Study|Withdrawal by Subject|2|||
161865066|NCT03759392|584547829|FG001|Overall Study|Withdrawal by Subject|0|||
161865067|NCT03759392|584547828|FG000|Overall Study|Protocol Violation|2|||
161865068|NCT03759392|584547829|FG001|Overall Study|Protocol Violation|0|||
161865069|NCT03759392|584547828|FG000|Overall Study|Physician Decision|0|||
161865070|NCT03759392|584547829|FG001|Overall Study|Physician Decision|1|||
161865071|NCT03759392|584547828|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
161865072|NCT03759392|584547829|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
161865073|NCT03759392|584547828|FG000|Overall Study|No longer able to take medicines|1|||
161865074|NCT03759392|584547829|FG001|Overall Study|No longer able to take medicines|0|||
161865075|NCT03759392|584547828|FG000|Overall Study|Stopped taking study drug|1|||
161865076|NCT03759392|584547829|FG001|Overall Study|Stopped taking study drug|0|||
161865077|NCT01288079|584547830|FG000|Overall Study|Withdrawal by Subject|2|||
161865078|NCT01288079|584547831|FG001|Overall Study|Withdrawal by Subject|4|||
161865079|NCT01288079|584547832|FG002|Overall Study|Withdrawal by Subject|1|||
161865080|NCT01288079|584547833|FG003|Overall Study|Withdrawal by Subject|0|||
161865081|NCT01288079|584547830|FG000|Overall Study|Adverse Event|2|||
161865082|NCT01288079|584547831|FG001|Overall Study|Adverse Event|1|||
161865083|NCT01288079|584547832|FG002|Overall Study|Adverse Event|2|||
161865084|NCT01288079|584547833|FG003|Overall Study|Adverse Event|3|||
161865085|NCT01288079|584547830|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
161865086|NCT01288079|584547831|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
161865087|NCT01288079|584547832|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161865088|NCT01288079|584547833|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
161865089|NCT01288079|584547830|FG000|Overall Study|Condition under Investigation Worsened|0|||
161865090|NCT01288079|584547831|FG001|Overall Study|Condition under Investigation Worsened|0|||
161865091|NCT01288079|584547832|FG002|Overall Study|Condition under Investigation Worsened|0|||
161865092|NCT01288079|584547833|FG003|Overall Study|Condition under Investigation Worsened|1|||
161865093|NCT01288079|584547830|FG000|Overall Study|Lack of Efficacy|2|||
161865094|NCT01288079|584547831|FG001|Overall Study|Lack of Efficacy|2|||
161865095|NCT01288079|584547832|FG002|Overall Study|Lack of Efficacy|0|||
161865096|NCT01288079|584547833|FG003|Overall Study|Lack of Efficacy|2|||
161865097|NCT01288079|584547830|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
161865098|NCT01288079|584547831|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161865099|NCT01288079|584547832|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
161865100|NCT01288079|584547833|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
161865101|NCT01288079|584547830|FG000|Overall Study|Lost to Follow-up|1|||
161865102|NCT01288079|584547831|FG001|Overall Study|Lost to Follow-up|1|||
161865103|NCT01288079|584547832|FG002|Overall Study|Lost to Follow-up|1|||
161865104|NCT01288079|584547833|FG003|Overall Study|Lost to Follow-up|0|||
161865105|NCT01288079|584547830|FG000|Overall Study|Other or Study Termination|11|||
161865106|NCT01288079|584547831|FG001|Overall Study|Other or Study Termination|15|||
161865107|NCT01288079|584547832|FG002|Overall Study|Other or Study Termination|14|||
161865108|NCT01288079|584547833|FG003|Overall Study|Other or Study Termination|8|||
161865109|NCT02387840|584547834|FG000|Overall Study|Death|0|||
161865110|NCT02387840|584547835|FG001|Overall Study|Death|0|||
161865111|NCT02387840|584547836|FG002|Overall Study|Death|0|||
161865112|NCT02387840|584547837|FG003|Overall Study|Death|0|||
161865113|NCT02387840|584547838|FG004|Overall Study|Death|0|||
161865114|NCT02387840|584547839|FG005|Overall Study|Death|1|||
161865115|NCT03170544|584547840|FG000|Part 1|Lost to Follow-up|1|||
161865116|NCT03170544|584547841|FG001|Part 1|Lost to Follow-up|0|||
161865117|NCT03170544|584547842|FG002|Part 1|Lost to Follow-up|0|||
161865118|NCT03170544|584547843|FG003|Part 1|Lost to Follow-up|0|||
161865119|NCT03170544|584547844|FG004|Part 1|Lost to Follow-up|0|||
161865120|NCT03170544|584547845|FG005|Part 1|Lost to Follow-up|0|||
161865121|NCT03170544|584547846|FG006|Part 1|Lost to Follow-up|0|||
161865122|NCT03170544|584547847|FG007|Part 1|Lost to Follow-up|0|||
161865123|NCT03170544|584547848|FG008|Part 1|Lost to Follow-up|0|||
161865124|NCT03170544|584547849|FG009|Part 1|Lost to Follow-up|0|||
161865125|NCT03170544|584547850|FG010|Part 1|Lost to Follow-up|0|||
161865126|NCT03170544|584547851|FG011|Part 1|Lost to Follow-up|0|||
161865127|NCT03170544|584547840|FG000|Part 1|Not treated|0|||
161865128|NCT03170544|584547841|FG001|Part 1|Not treated|0|||
161865129|NCT03170544|584547842|FG002|Part 1|Not treated|0|||
161865130|NCT03170544|584547843|FG003|Part 1|Not treated|1|||
161865131|NCT03170544|584547844|FG004|Part 1|Not treated|0|||
161865132|NCT03170544|584547845|FG005|Part 1|Not treated|0|||
161865133|NCT03170544|584547846|FG006|Part 1|Not treated|0|||
161865134|NCT03170544|584547847|FG007|Part 1|Not treated|0|||
161865135|NCT03170544|584547848|FG008|Part 1|Not treated|0|||
161865136|NCT03170544|584547849|FG009|Part 1|Not treated|0|||
161865137|NCT03170544|584547850|FG010|Part 1|Not treated|0|||
161865138|NCT03170544|584547851|FG011|Part 1|Not treated|0|||
161865139|NCT01213966|584547852|FG000|Overall Study|Protocol Violation|1|||
161865140|NCT01213966|584547853|FG001|Overall Study|Protocol Violation|0|||
161865141|NCT01213966|584547854|FG002|Overall Study|Protocol Violation|3|||
161865142|NCT01213966|584547855|FG003|Overall Study|Protocol Violation|1|||
161865143|NCT05161481|584549447|FG000|Overall Study|Withdrawal of consent|0|||
161865144|NCT05161481|584549448|FG001|Overall Study|Withdrawal of consent|1|||
161865145|NCT05161481|584549449|FG002|Overall Study|Withdrawal of consent|1|||
161865146|NCT05161481|584549447|FG000|Overall Study|Study terminated by sponsor|3|||
161865147|NCT05161481|584549448|FG001|Overall Study|Study terminated by sponsor|3|||
161865148|NCT05161481|584549449|FG002|Overall Study|Study terminated by sponsor|2|||
161865149|NCT05161481|584549447|FG000|Overall Study|Adverse Event|3|||
161865150|NCT05161481|584549448|FG001|Overall Study|Adverse Event|0|||
161865151|NCT05161481|584549449|FG002|Overall Study|Adverse Event|6|||
161865152|NCT05161481|584549447|FG000|Overall Study|Randomised in error and was not treated|1|||
161865153|NCT05161481|584549448|FG001|Overall Study|Randomised in error and was not treated|0|||
161865154|NCT05161481|584549449|FG002|Overall Study|Randomised in error and was not treated|0|||
161865155|NCT05161481|584549447|FG000|Overall Study|Subject decision|0|||
161865156|NCT05161481|584549448|FG001|Overall Study|Subject decision|0|||
161865157|NCT05161481|584549449|FG002|Overall Study|Subject decision|1|||
161865158|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
161865159|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
161865160|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
161865161|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
161865162|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
161865163|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
161865164|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
161865165|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
161865166|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
161865167|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
161865168|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
161865169|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
161865170|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161865171|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161865172|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
161865173|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161865174|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
161865175|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
161865176|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
161865177|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
161865178|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
161865179|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
161865180|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
161865181|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
161865182|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
161865183|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
161865184|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
161865185|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
161865186|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
161865187|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
161865188|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
161865189|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
161865190|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161865191|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
161774063|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
161774064|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
161774065|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Other|1|||
161774066|NCT03099265|584215930|FG000|Overall Study|Adverse Event|1|||
161774067|NCT00396318|584215938|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
161774068|NCT00602927|584215939|FG000|Period 1: 13 Days|Protocol Violation|2|||
161774069|NCT00602927|584215940|FG001|Period 1: 13 Days|Protocol Violation|4|||
161774070|NCT00602927|584215939|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
161774071|NCT00602927|584215940|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
161774072|NCT00602927|584215939|FG000|Period 1: 13 Days|Time|1|||
161774073|NCT00602927|584215940|FG001|Period 1: 13 Days|Time|0|||
161774074|NCT00602927|584215939|FG000|Period 1: 13 Days|Claustrophobia|0|||
161774075|NCT00602927|584215940|FG001|Period 1: 13 Days|Claustrophobia|1|||
161774076|NCT00602927|584215939|FG000|Period 2: 14 Days|Protocol Violation|0|||
161774077|NCT00602927|584215940|FG001|Period 2: 14 Days|Protocol Violation|2|||
161774078|NCT00602927|584215939|FG000|Period 3: 13 Days|Protocol Violation|0|||
161774079|NCT00602927|584215940|FG001|Period 3: 13 Days|Protocol Violation|1|||
161774080|NCT00602927|584215939|FG000|Period 3: 13 Days|MRI data quality|2|||
161774081|NCT00602927|584215940|FG001|Period 3: 13 Days|MRI data quality|2|||
161774082|NCT01741259|584215947|FG000|Overall Study|Protocol Violation|6|||
161774083|NCT01741259|584215948|FG001|Overall Study|Protocol Violation|4|||
161774084|NCT01741259|584215947|FG000|Overall Study|Withdrawal by Subject|0|||
161774085|NCT01741259|584215948|FG001|Overall Study|Withdrawal by Subject|2|||
161774086|NCT05604521|584215954|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
161774087|NCT05604521|584215955|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
161774088|NCT05604521|584215954|FG000|Overall Study|Adverse Event|1|||
161774089|NCT05604521|584215955|FG001|Overall Study|Adverse Event|0|||
161774090|NCT02875340|584215956|FG000|Overall Study|Death|2|||
161774091|NCT02875340|584215956|FG000|Overall Study|Withdrawal by Subject|2|||
161774092|NCT02875340|584215956|FG000|Overall Study|Physician Decision|3|||
161774093|NCT02875340|584215956|FG000|Overall Study|Adverse Event|1|||
161774094|NCT01160770|584215959|FG000|Overall Study|Adverse Event|10|||
161774095|NCT01160770|584215959|FG000|Overall Study|Protocol Violation|2|||
161774096|NCT01160770|584215959|FG000|Overall Study|Subject/parent/caregiver request|33|||
161774097|NCT01160770|584215959|FG000|Overall Study|Physician Decision|1|||
161774098|NCT01160770|584215959|FG000|Overall Study|Lost to Follow-up|7|||
161774099|NCT01160770|584215959|FG000|Overall Study|Study termination or sponsor request|1|||
161774100|NCT01160770|584215959|FG000|Overall Study|Death|9|||
161774101|NCT01160770|584215959|FG000|Overall Study|Lack of Efficacy|15|||
161774102|NCT01160770|584215959|FG000|Overall Study|Other Reasons|1|||
161774103|NCT00630994|584215960|FG000|Overall Study|Adverse Event|1|||
161774104|NCT00630994|584215960|FG000|Overall Study|Disease Progression|1|||
161774105|NCT00630994|584215960|FG000|Overall Study|Lack of Efficacy|1|||
161774106|NCT00630994|584215960|FG000|Overall Study|Other|1|||
161774107|NCT03586427|584215964|FG000|Overall Study|Lost to Follow-up|0|||
161774108|NCT03586427|584215965|FG001|Overall Study|Lost to Follow-up|3|||
161774109|NCT03586427|584215966|FG002|Overall Study|Lost to Follow-up|1|||
161774110|NCT03586427|584215967|FG003|Overall Study|Lost to Follow-up|3|||
161774111|NCT03586427|584215968|FG004|Overall Study|Lost to Follow-up|3|||
161774112|NCT03586427|584215964|FG000|Overall Study|Withdrawal by Subject|0|||
161774113|NCT03586427|584215965|FG001|Overall Study|Withdrawal by Subject|1|||
161774114|NCT03586427|584215966|FG002|Overall Study|Withdrawal by Subject|2|||
161774115|NCT03586427|584215967|FG003|Overall Study|Withdrawal by Subject|1|||
161774116|NCT03586427|584215968|FG004|Overall Study|Withdrawal by Subject|1|||
161774117|NCT03586427|584215964|FG000|Overall Study|Adverse Event|0|||
161774118|NCT03586427|584215965|FG001|Overall Study|Adverse Event|0|||
161774119|NCT03586427|584215966|FG002|Overall Study|Adverse Event|1|||
161774120|NCT03586427|584215967|FG003|Overall Study|Adverse Event|0|||
161774121|NCT03586427|584215968|FG004|Overall Study|Adverse Event|0|||
161774122|NCT03586427|584215964|FG000|Overall Study|Protocol Violation|0|||
161774123|NCT03586427|584215965|FG001|Overall Study|Protocol Violation|0|||
161774124|NCT03586427|584215966|FG002|Overall Study|Protocol Violation|1|||
161774125|NCT03586427|584215967|FG003|Overall Study|Protocol Violation|0|||
161774126|NCT03586427|584215968|FG004|Overall Study|Protocol Violation|1|||
161774127|NCT03586427|584215964|FG000|Overall Study|Noncompliance with study drug|0|||
161774128|NCT03586427|584215965|FG001|Overall Study|Noncompliance with study drug|0|||
161774129|NCT03586427|584215966|FG002|Overall Study|Noncompliance with study drug|1|||
161774130|NCT03586427|584215967|FG003|Overall Study|Noncompliance with study drug|0|||
161774131|NCT03586427|584215968|FG004|Overall Study|Noncompliance with study drug|0|||
161774132|NCT03193996|584215971|FG000|Overall Study|Withdrawal by Subject|4|||
161774133|NCT03193996|584215971|FG000|Overall Study|Lost to Follow-up|4|||
161774134|NCT03193996|584215971|FG000|Overall Study|Physician Decision|2|||
161774135|NCT03193996|584215971|FG000|Overall Study|Pregnancy|1|||
161774136|NCT03193996|584215971|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
161774137|NCT03193996|584215971|FG000|Overall Study|Complicating disease|1|||
161774138|NCT00593385|584215974|FG000|Overall Study|Death|14|||
161865192|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161865193|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161865194|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161865195|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161865196|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161865197|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
161865198|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
161865199|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161865200|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161865201|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161865202|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
161865203|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161865204|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
161865205|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
161865206|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161865207|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161865208|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
161865209|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161865210|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Site closed|0|||
161865211|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Site closed|0|||
161865212|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Site closed|1|||
161865213|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Site closed|0|||
161865214|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
161865215|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161865216|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161865217|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161865218|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
161865219|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
161865220|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
161865221|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
161865222|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
161865223|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161865224|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161865225|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161865226|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
161865227|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161865228|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
161865229|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
161865230|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161865231|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
161865232|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
161865233|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
161865234|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
161865235|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
161865236|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
161865237|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
161865238|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
161865239|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
161865240|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
161865241|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
161865242|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
161865243|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
161865244|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
161865245|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
161865246|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865247|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865248|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865249|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865250|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
161865251|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161865252|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
161865253|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161865254|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161865255|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
161865256|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161865257|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161865258|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161865259|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
161865260|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161865261|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161865262|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161865263|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161865264|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161865265|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
161865266|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Missing|1|||
161865267|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Missing|2|||
161865268|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Missing|1|||
161865269|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Missing|1|||
161865270|NCT01894841|584549454|FG000|Overall Study|Withdrawal by Subject|9|||
161865271|NCT01894841|584549455|FG001|Overall Study|Withdrawal by Subject|4|||
161865272|NCT01894841|584549454|FG000|Overall Study|Withdrawn by investigator|2|||
161865273|NCT01894841|584549455|FG001|Overall Study|Withdrawn by investigator|2|||
161865274|NCT01894841|584549454|FG000|Overall Study|Lost to Follow-up|7|||
161865275|NCT01894841|584549455|FG001|Overall Study|Lost to Follow-up|3|||
161865276|NCT01100086|584549456|FG000|Period 1|Withdrawal by Subject|1|||
161865277|NCT01100086|584549457|FG001|Period 1|Withdrawal by Subject|0|||
161865278|NCT00495391|584549460|FG000|Overall Study|Lack of Efficacy|34|||
161865279|NCT00495391|584549461|FG001|Overall Study|Lack of Efficacy|18|||
161865280|NCT00495391|584549460|FG000|Overall Study|Withdrawal by Subject|2|||
161865281|NCT00495391|584549461|FG001|Overall Study|Withdrawal by Subject|3|||
161865282|NCT03214224|584549462|FG000|Overall Study|Protocol Violation|1|||
161865283|NCT03214224|584549462|FG000|Overall Study|Withdrawal by Subject|2|||
161865284|NCT03214224|584549462|FG000|Overall Study|Practice controls or therapists|6|||
161865285|NCT02712320|584549471|FG000|Overall Study|Lost to Follow-up|1|||
161865286|NCT02712320|584549471|FG000|Overall Study|Withdrawal by Subject|1|||
161865287|NCT02712320|584549471|FG000|Overall Study|Transferred to another facility|1|||
161865288|NCT02712320|584549471|FG000|Overall Study|Treating with the prohibited medications|2|||
161865289|NCT05266053|584549472|FG000|Overall Study|Withdrawal by Subject|8|||
161865290|NCT05266053|584549473|FG001|Overall Study|Withdrawal by Subject|4|||
161865291|NCT05344560|584549474|FG000|Period 1|Subject out of visit window|1|||
161865292|NCT05344560|584549475|FG001|Period 1|Subject out of visit window|1|||
161865293|NCT05344560|584549474|FG000|Period 2|Covid-19 Related|1|||
161865294|NCT05344560|584549475|FG001|Period 2|Covid-19 Related|0|||
161865295|NCT05344560|584549474|FG000|Period 2|Adverse Event|1|||
161865296|NCT05344560|584549475|FG001|Period 2|Adverse Event|0|||
161865297|NCT05344560|584549474|FG000|Period 2|Subject out of visit window|1|||
161865298|NCT05344560|584549475|FG001|Period 2|Subject out of visit window|1|||
161865299|NCT05344560|584549474|FG000|Period 3|Subject out of visit window|1|||
161865300|NCT05344560|584549475|FG001|Period 3|Subject out of visit window|0|||
161865301|NCT01051960|584549479|FG000|Overall Study|Adverse Event|1|||
161865302|NCT02996968|584549480|FG000|Overall Study|Withdrawal by Subject|1|||
161865303|NCT02996968|584549481|FG001|Overall Study|Withdrawal by Subject|0|||
161865304|NCT04177095|584549495|FG000|Overall Study|Withdrawal by Subject|3|||
161865305|NCT04177095|584549495|FG000|Overall Study|Screen Failure|3|||
161865306|NCT04177095|584549495|FG000|Overall Study|Problems with the Trugraf assay|1|||
161865307|NCT02275819|584549496|FG000|Overall Study|Adverse Event|0|||
161865308|NCT02275819|584549497|FG001|Overall Study|Adverse Event|1|||
161865309|NCT01346059|584549498|FG000|Overall Study|Withdrawal by Subject|1|||
161865310|NCT01346059|584549499|FG001|Overall Study|Withdrawal by Subject|0|||
161865311|NCT02556775|584549500|FG000|Overall Study|Withdrawal by Subject|1|||
161865312|NCT02556775|584549501|FG001|Overall Study|Withdrawal by Subject|0|||
161865313|NCT02556775|584549502|FG002|Overall Study|Withdrawal by Subject|1|||
161865314|NCT02556775|584549503|FG003|Overall Study|Withdrawal by Subject|0|||
161865315|NCT02556775|584549500|FG000|Overall Study|Lost to Follow-up|1|||
161865316|NCT02556775|584549501|FG001|Overall Study|Lost to Follow-up|0|||
161865317|NCT02556775|584549502|FG002|Overall Study|Lost to Follow-up|0|||
161865318|NCT02556775|584549503|FG003|Overall Study|Lost to Follow-up|0|||
161865319|NCT02025725|584549504|FG000|Overall Study|Adverse Event|5|||
161865320|NCT02025725|584549505|FG001|Overall Study|Adverse Event|0|||
161865321|NCT02025725|584549504|FG000|Overall Study|Lost to Follow-up|2|||
161865322|NCT02025725|584549505|FG001|Overall Study|Lost to Follow-up|0|||
161865323|NCT02025725|584549504|FG000|Overall Study|Protocol Violation|1|||
161865324|NCT02025725|584549505|FG001|Overall Study|Protocol Violation|1|||
161865325|NCT02025725|584549504|FG000|Overall Study|Withdrawal by Subject|3|||
161865326|NCT02025725|584549505|FG001|Overall Study|Withdrawal by Subject|2|||
161865327|NCT02025725|584549504|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
161865328|NCT02025725|584549505|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
161865329|NCT01592786|584549506|FG000|Overall Study|Adverse Event|60|||
161865330|NCT01592786|584549506|FG000|Overall Study|Lack of Efficacy|19|||
161865331|NCT01592786|584549506|FG000|Overall Study|Protocol Violation|14|||
161865332|NCT01592786|584549506|FG000|Overall Study|Withdrawal by Subject|23|||
161865333|NCT01592786|584549506|FG000|Overall Study|Lost to Follow-up|19|||
161865334|NCT01592786|584549506|FG000|Overall Study|Other|3|||
161865335|NCT02172664|584549514|FG000|Overall Study|Lost to Follow-up|4|||
161865336|NCT02172664|584549515|FG001|Overall Study|Lost to Follow-up|4|||
161865337|NCT02172664|584549514|FG000|Overall Study|Death|1|||
161865338|NCT02172664|584549515|FG001|Overall Study|Death|1|||
161865339|NCT02172664|584549514|FG000|Overall Study|Moved out of area|1|||
161865340|NCT02172664|584549515|FG001|Overall Study|Moved out of area|1|||
161865341|NCT01909934|584549516|FG000|Overall Study|Withdrawal by Subject|3|||
161865342|NCT01909934|584549516|FG000|Overall Study|Lost to Follow-up|1|||
161865343|NCT01909934|584549516|FG000|Overall Study|Death|25|||
161865344|NCT01909934|584549516|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161865345|NCT01909934|584549516|FG000|Overall Study|Reason Not Specified|1|||
161865346|NCT03810092|584549517|FG000|Overall Study|no ground support|17|||
161865347|NCT03810092|584549517|FG000|Overall Study|ADL not done at J0|16|||
161865348|NCT03810092|584549517|FG000|Overall Study|No hemoglobin measure at J5|27|||
161865349|NCT04578535|584549519|FG000|Overall Study|Lost to Follow-up|1|||
161865350|NCT04578535|584549520|FG001|Overall Study|Lost to Follow-up|0|||
161865351|NCT04578535|584549521|FG002|Overall Study|Lost to Follow-up|0|||
161865352|NCT04578535|584549522|FG003|Overall Study|Lost to Follow-up|1|||
161865353|NCT04578535|584549523|FG004|Overall Study|Lost to Follow-up|0|||
161865354|NCT04578535|584549524|FG005|Overall Study|Lost to Follow-up|2|||
161865355|NCT04578535|584549519|FG000|Overall Study|Pregnancy|1|||
161865356|NCT04578535|584549520|FG001|Overall Study|Pregnancy|0|||
161865357|NCT04578535|584549521|FG002|Overall Study|Pregnancy|0|||
161865358|NCT04578535|584549522|FG003|Overall Study|Pregnancy|0|||
161865359|NCT04578535|584549523|FG004|Overall Study|Pregnancy|0|||
161865360|NCT04578535|584549524|FG005|Overall Study|Pregnancy|0|||
161865361|NCT04578535|584549519|FG000|Overall Study|Withdrawal by Subject|0|||
161865362|NCT04578535|584549520|FG001|Overall Study|Withdrawal by Subject|0|||
161865363|NCT04578535|584549521|FG002|Overall Study|Withdrawal by Subject|0|||
161865364|NCT04578535|584549522|FG003|Overall Study|Withdrawal by Subject|1|||
161865365|NCT04578535|584549523|FG004|Overall Study|Withdrawal by Subject|1|||
161865366|NCT04578535|584549524|FG005|Overall Study|Withdrawal by Subject|5|||
161865367|NCT04578535|584549519|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
161865368|NCT04578535|584549520|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
161865369|NCT04578535|584549521|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
161865370|NCT04578535|584549522|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
161865371|NCT04578535|584549523|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
161865372|NCT04578535|584549524|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
161865373|NCT00235755|584549525|FG000|4-Week Titration Phase|Adverse Event|6|||
161865374|NCT00235755|584549526|FG001|4-Week Titration Phase|Adverse Event|14|||
161865375|NCT00235755|584549527|FG002|4-Week Titration Phase|Adverse Event|20|||
161865376|NCT00235755|584549525|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
161865377|NCT00235755|584549526|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
161865378|NCT00235755|584549527|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
161865379|NCT00235755|584549525|FG000|4-Week Titration Phase|Protocol Violation|2|||
161865380|NCT00235755|584549526|FG001|4-Week Titration Phase|Protocol Violation|2|||
161865381|NCT00235755|584549527|FG002|4-Week Titration Phase|Protocol Violation|1|||
161865382|NCT00235755|584549525|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
161865383|NCT00235755|584549526|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
161865384|NCT00235755|584549527|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
161865385|NCT00235755|584549525|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161865386|NCT00235755|584549526|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161865387|NCT00235755|584549527|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
161865388|NCT00235755|584549525|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
161865389|NCT00235755|584549526|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
161865390|NCT00235755|584549527|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
161865391|NCT00235755|584549525|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
161865392|NCT00235755|584549526|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
161865393|NCT00235755|584549527|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
161865394|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Adverse Event|8|||
161865395|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Adverse Event|12|||
161865396|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Adverse Event|26|||
161865397|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
161865398|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
161865399|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
161865400|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
161865401|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
161865402|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
161865403|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
161865404|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
161865405|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
161865406|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
161865407|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
161865408|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
161865409|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
161865410|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
161865411|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
161865412|NCT00806403|584549532|FG000|Overall Study|Death|4|||
161865413|NCT00806403|584549533|FG001|Overall Study|Death|3|||
161865414|NCT01320293|584549536|FG000|Overall Study|Lack of Efficacy|1|||
161865415|NCT01320293|584549536|FG000|Overall Study|Adverse Event|1|||
161865416|NCT01787292|584549539|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
161865417|NCT01787292|584549540|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
161865418|NCT01787292|584549539|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
161865419|NCT01787292|584549540|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
161865420|NCT01532934|584549541|FG000|Overall Study|Lost to Follow-up|11|||
161865421|NCT01532934|584549542|FG001|Overall Study|Lost to Follow-up|11|||
161865422|NCT01532934|584549541|FG000|Overall Study|In controlled environment|3|||
161865423|NCT01532934|584549542|FG001|Overall Study|In controlled environment|2|||
161865424|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
161865425|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865426|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865427|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865428|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865429|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
161865430|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865431|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
161865432|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
161865433|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
161865434|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
161865435|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
161865436|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
161865437|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
161865438|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865439|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
161865440|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865441|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865442|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865443|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
161865444|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865445|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Other|0|||
161865446|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Other|3|||
161865447|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Other|3|||
161865448|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Other|0|||
161865449|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Other|1|||
161865450|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Other|0|||
161865451|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Other|0|||
161865452|NCT01147068|584549543|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161865453|NCT01147068|584549544|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865454|NCT01147068|584549545|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865455|NCT01147068|584549546|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865456|NCT01147068|584549547|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865457|NCT01147068|584549548|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161865458|NCT01147068|584549549|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161865459|NCT01147068|584549543|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865460|NCT01147068|584549544|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865461|NCT01147068|584549545|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865462|NCT01147068|584549546|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
161865463|NCT01147068|584549547|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865464|NCT01147068|584549548|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865465|NCT01147068|584549549|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865466|NCT01147068|584549543|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865467|NCT01147068|584549544|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
161865468|NCT01147068|584549545|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865469|NCT01147068|584549546|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865470|NCT01147068|584549547|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865471|NCT01147068|584549548|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865472|NCT01147068|584549549|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865473|NCT02962648|584549551|FG000|Overall Study|Withdrawal by Subject|3|||
161865474|NCT02962648|584549551|FG000|Overall Study|Lost to Follow-up|3|||
161865475|NCT02962648|584549551|FG000|Overall Study|Physician Decision|1|||
161865476|NCT02962648|584549551|FG000|Overall Study|Subject had problems with transportation|2|||
161865477|NCT01597778|584549552|FG000|Overall Study|Death|7|||
161865478|NCT01597778|584549553|FG001|Overall Study|Death|10|||
161865479|NCT01597778|584549552|FG000|Overall Study|Withdrawal by Subject|3|||
161865480|NCT01597778|584549553|FG001|Overall Study|Withdrawal by Subject|4|||
161865481|NCT01597778|584549552|FG000|Overall Study|Adverse Event|1|||
161865482|NCT01597778|584549553|FG001|Overall Study|Adverse Event|1|||
161865483|NCT01597778|584549552|FG000|Overall Study|Protocol Violation|1|||
161865484|NCT01597778|584549553|FG001|Overall Study|Protocol Violation|11|||
161865485|NCT01597778|584549552|FG000|Overall Study|Transplanted off protocol|2|||
161865486|NCT01597778|584549553|FG001|Overall Study|Transplanted off protocol|3|||
161865487|NCT05691712|584549555|FG000|Overall Study|Adverse Event|0|||
161865488|NCT05691712|584549556|FG001|Overall Study|Adverse Event|1|||
161865489|NCT05691712|584549557|FG002|Overall Study|Adverse Event|2|||
161865490|NCT05691712|584549558|FG003|Overall Study|Adverse Event|1|||
161865491|NCT05691712|584549555|FG000|Overall Study|Withdrawal by Subject|2|||
161865492|NCT05691712|584549556|FG001|Overall Study|Withdrawal by Subject|3|||
161865493|NCT05691712|584549557|FG002|Overall Study|Withdrawal by Subject|3|||
161865494|NCT05691712|584549558|FG003|Overall Study|Withdrawal by Subject|1|||
161865495|NCT05691712|584549555|FG000|Overall Study|Death|1|||
161865496|NCT05691712|584549556|FG001|Overall Study|Death|0|||
161865497|NCT05691712|584549557|FG002|Overall Study|Death|0|||
161865498|NCT05691712|584549558|FG003|Overall Study|Death|0|||
161865499|NCT05691712|584549555|FG000|Overall Study|Pregnancy|0|||
161865500|NCT05691712|584549556|FG001|Overall Study|Pregnancy|1|||
161865501|NCT05691712|584549557|FG002|Overall Study|Pregnancy|0|||
161865502|NCT05691712|584549558|FG003|Overall Study|Pregnancy|0|||
161865503|NCT05691712|584549555|FG000|Overall Study|Assigned Treatment by Mistake|1|||
161865504|NCT05691712|584549556|FG001|Overall Study|Assigned Treatment by Mistake|0|||
161865505|NCT05691712|584549557|FG002|Overall Study|Assigned Treatment by Mistake|0|||
161865506|NCT05691712|584549558|FG003|Overall Study|Assigned Treatment by Mistake|1|||
161865507|NCT05303194|584549559|FG000|Overall Study|Lost to Follow-up|1|||
161865508|NCT05303194|584549560|FG001|Overall Study|Lost to Follow-up|1|||
161865509|NCT05303194|584549559|FG000|Overall Study|Withdrawal by Subject|0|||
161865510|NCT05303194|584549560|FG001|Overall Study|Withdrawal by Subject|1|||
161865511|NCT01289678|584549570|FG000|Overall Study|Physician Decision|6|||
161865512|NCT00226499|584549571|FG000|Overall Study|Adverse Event|10|||
161865513|NCT00226499|584549572|FG001|Overall Study|Adverse Event|6|||
161865514|NCT00226499|584549573|FG002|Overall Study|Adverse Event|3|||
161865515|NCT00226499|584549571|FG000|Overall Study|Others|1064|||
161865516|NCT00226499|584549572|FG001|Overall Study|Others|1066|||
161865517|NCT00226499|584549573|FG002|Overall Study|Others|356|||
161865518|NCT00468819|584549574|FG000|Overall Study|Withdrawal by Subject|4|||
161865519|NCT00468819|584549575|FG001|Overall Study|Withdrawal by Subject|0|||
161865520|NCT00468819|584549576|FG002|Overall Study|Withdrawal by Subject|1|||
161865521|NCT00468819|584549574|FG000|Overall Study|Lost to Follow-up|0|||
161865522|NCT00468819|584549575|FG001|Overall Study|Lost to Follow-up|0|||
161865523|NCT00468819|584549576|FG002|Overall Study|Lost to Follow-up|1|||
161865524|NCT00468819|584549574|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
161865525|NCT00468819|584549575|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
161865526|NCT00468819|584549576|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
161865527|NCT02723344|584549579|FG000|Overall Study|Lost to Follow-up|0|||
161865528|NCT02723344|584549580|FG001|Overall Study|Lost to Follow-up|4|||
161865529|NCT02524847|584549582|FG000|Overall Study|Adverse Event|4|||
161865530|NCT02524847|584549582|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161865531|NCT02524847|584549582|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
161865532|NCT02524847|584549582|FG000|Overall Study|Death|1|||
161865533|NCT02524847|584549582|FG000|Overall Study|Reason not Specified|1|||
161865534|NCT04352101|584549583|FG000|Overall Study|Physician Decision|2|||
161865535|NCT04352101|584549584|FG001|Overall Study|Physician Decision|1|||
161865536|NCT03539302|584549593|FG000|Overall Study|Spontaneous cardio version|0|||
161865537|NCT03539302|584549594|FG001|Overall Study|Spontaneous cardio version|0|||
161865538|NCT03539302|584549595|FG002|Overall Study|Spontaneous cardio version|0|||
161865539|NCT03539302|584549596|FG003|Overall Study|Spontaneous cardio version|0|||
161865540|NCT03539302|584549597|FG004|Overall Study|Spontaneous cardio version|0|||
161865541|NCT03539302|584549598|FG005|Overall Study|Spontaneous cardio version|1|||
161865542|NCT03539302|584549599|FG006|Overall Study|Spontaneous cardio version|1|||
161865543|NCT04564092|584549601|FG000|Overall Study|Withdrawal by Subject|1|||
161774139|NCT00593385|584215974|FG000|Overall Study|Lost to Follow-up|17|||
161774140|NCT00593385|584215974|FG000|Overall Study|Withdrawal by Subject|9|||
161774141|NCT00924313|584215979|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
161774142|NCT01298362|584215980|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
161774143|NCT01298362|584215981|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
161774144|NCT02871921|584215986|FG000|Overall Study|Withdrawal by Subject|34|||
161774145|NCT02871921|584215987|FG001|Overall Study|Withdrawal by Subject|27|||
161774146|NCT02871921|584215988|FG002|Overall Study|Withdrawal by Subject|27|||
161774147|NCT02871921|584215989|FG003|Overall Study|Withdrawal by Subject|30|||
161774148|NCT00326625|584215994|FG000|Overall Study|Adverse Event|20|||
161774149|NCT00326625|584215995|FG001|Overall Study|Adverse Event|9|||
161774150|NCT00326625|584215994|FG000|Overall Study|Withdrawal by Subject|15|||
161774151|NCT00326625|584215995|FG001|Overall Study|Withdrawal by Subject|12|||
161774152|NCT00326625|584215994|FG000|Overall Study|Death|18|||
161774153|NCT00326625|584215995|FG001|Overall Study|Death|16|||
161774154|NCT00326625|584215994|FG000|Overall Study|Lost to Follow-up|1|||
161774155|NCT00326625|584215995|FG001|Overall Study|Lost to Follow-up|0|||
161774156|NCT00326625|584215994|FG000|Overall Study|prescheduled medical intervention|0|||
161774157|NCT00326625|584215995|FG001|Overall Study|prescheduled medical intervention|1|||
161774158|NCT02594384|584215996|FG000|Overall Study|Disease Progression|3|||
161774159|NCT02594384|584215997|FG001|Overall Study|Disease Progression|7|||
161774160|NCT02594384|584215998|FG002|Overall Study|Disease Progression|0|||
161774161|NCT02594384|584215999|FG003|Overall Study|Disease Progression|2|||
161774162|NCT02594384|584216000|FG004|Overall Study|Disease Progression|2|||
161774163|NCT02594384|584216001|FG005|Overall Study|Disease Progression|12|||
161774164|NCT02594384|584216002|FG006|Overall Study|Disease Progression|5|||
161774165|NCT02594384|584216003|FG007|Overall Study|Disease Progression|5|||
161774166|NCT02594384|584215996|FG000|Overall Study|Adverse Event|0|||
161774167|NCT02594384|584215997|FG001|Overall Study|Adverse Event|1|||
161774168|NCT02594384|584215998|FG002|Overall Study|Adverse Event|4|||
161774169|NCT02594384|584215999|FG003|Overall Study|Adverse Event|1|||
161774170|NCT02594384|584216000|FG004|Overall Study|Adverse Event|0|||
161774171|NCT02594384|584216001|FG005|Overall Study|Adverse Event|6|||
161774172|NCT02594384|584216002|FG006|Overall Study|Adverse Event|1|||
161774173|NCT02594384|584216003|FG007|Overall Study|Adverse Event|1|||
161774174|NCT02594384|584215996|FG000|Overall Study|Withdrawal by Subject|0|||
161774175|NCT02594384|584215997|FG001|Overall Study|Withdrawal by Subject|0|||
161774176|NCT02594384|584215998|FG002|Overall Study|Withdrawal by Subject|0|||
161774177|NCT02594384|584215999|FG003|Overall Study|Withdrawal by Subject|1|||
161774178|NCT02594384|584216000|FG004|Overall Study|Withdrawal by Subject|0|||
161774179|NCT02594384|584216001|FG005|Overall Study|Withdrawal by Subject|0|||
161774180|NCT02594384|584216002|FG006|Overall Study|Withdrawal by Subject|0|||
161774181|NCT02594384|584216003|FG007|Overall Study|Withdrawal by Subject|1|||
161774182|NCT02594384|584215996|FG000|Overall Study|Physician Decision|0|||
161774183|NCT02594384|584215997|FG001|Overall Study|Physician Decision|0|||
161774184|NCT02594384|584215998|FG002|Overall Study|Physician Decision|0|||
161774185|NCT02594384|584215999|FG003|Overall Study|Physician Decision|0|||
161774186|NCT02594384|584216000|FG004|Overall Study|Physician Decision|0|||
161774187|NCT02594384|584216001|FG005|Overall Study|Physician Decision|1|||
161774188|NCT02594384|584216002|FG006|Overall Study|Physician Decision|2|||
161774189|NCT02594384|584216003|FG007|Overall Study|Physician Decision|0|||
161774190|NCT02594384|584215996|FG000|Overall Study|Progressive Leukocytosis|0|||
161774191|NCT02594384|584215997|FG001|Overall Study|Progressive Leukocytosis|0|||
161774192|NCT02594384|584215998|FG002|Overall Study|Progressive Leukocytosis|1|||
161774193|NCT02594384|584215999|FG003|Overall Study|Progressive Leukocytosis|0|||
161774194|NCT02594384|584216000|FG004|Overall Study|Progressive Leukocytosis|0|||
161774195|NCT02594384|584216001|FG005|Overall Study|Progressive Leukocytosis|0|||
161774196|NCT02594384|584216002|FG006|Overall Study|Progressive Leukocytosis|0|||
161774197|NCT02594384|584216003|FG007|Overall Study|Progressive Leukocytosis|0|||
161774198|NCT02594384|584215996|FG000|Overall Study|Lack of Efficacy|0|||
161774199|NCT02594384|584215997|FG001|Overall Study|Lack of Efficacy|0|||
161774200|NCT02594384|584215998|FG002|Overall Study|Lack of Efficacy|0|||
161774201|NCT02594384|584215999|FG003|Overall Study|Lack of Efficacy|0|||
161774202|NCT02594384|584216000|FG004|Overall Study|Lack of Efficacy|1|||
161774203|NCT02594384|584216001|FG005|Overall Study|Lack of Efficacy|0|||
161774204|NCT02594384|584216002|FG006|Overall Study|Lack of Efficacy|0|||
161774205|NCT02594384|584216003|FG007|Overall Study|Lack of Efficacy|0|||
161774206|NCT02594384|584215996|FG000|Overall Study|Substantial noncompliance|0|||
161774207|NCT02594384|584215997|FG001|Overall Study|Substantial noncompliance|0|||
161774208|NCT02594384|584215998|FG002|Overall Study|Substantial noncompliance|0|||
161774209|NCT02594384|584215999|FG003|Overall Study|Substantial noncompliance|0|||
161774210|NCT02594384|584216000|FG004|Overall Study|Substantial noncompliance|0|||
161774211|NCT02594384|584216001|FG005|Overall Study|Substantial noncompliance|0|||
161774212|NCT02594384|584216002|FG006|Overall Study|Substantial noncompliance|1|||
161774213|NCT02594384|584216003|FG007|Overall Study|Substantial noncompliance|0|||
161774214|NCT03919669|584216006|FG000|Overall Study|Withdrawal by Subject|1|||
161774215|NCT03919669|584216007|FG001|Overall Study|Withdrawal by Subject|0|||
161774216|NCT03919669|584216008|FG002|Overall Study|Withdrawal by Subject|0|||
161865544|NCT00420420|584549604|FG000|Overall Study|Adverse Event|5|||
161865545|NCT00420420|584549605|FG001|Overall Study|Adverse Event|3|||
161865546|NCT00420420|584549604|FG000|Overall Study|Protocol Violation|1|||
161865547|NCT00420420|584549605|FG001|Overall Study|Protocol Violation|1|||
161865548|NCT00420420|584549604|FG000|Overall Study|Withdrawal by Subject|1|||
161865549|NCT00420420|584549605|FG001|Overall Study|Withdrawal by Subject|0|||
161865550|NCT00420420|584549604|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
161865551|NCT00420420|584549605|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
161865552|NCT00273182|584549606|FG000|Overall Study|Death|450|||
161865553|NCT00273182|584549606|FG000|Overall Study|Lost to Follow-up|88|||
161865554|NCT00273182|584549606|FG000|Overall Study|Withdrawal by Subject|257|||
161865555|NCT00273182|584549606|FG000|Overall Study|Device/System Explant|154|||
161865556|NCT00273182|584549606|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
161865557|NCT04762160|584549607|FG000|Overall Study|Study terminated early due to business reasons|5|||
161865558|NCT04146012|584549609|FG000|Overall Study|Study Terminated|30|||
161865559|NCT04146012|584549610|FG001|Overall Study|Study Terminated|15|||
161865560|NCT03817190|584549611|FG000|Overall Study|Early Termination|13|||
161865561|NCT03817190|584549612|FG001|Overall Study|Early Termination|20|||
161865562|NCT03817190|584549611|FG000|Overall Study|Adverse Event|10|||
161865563|NCT03817190|584549612|FG001|Overall Study|Adverse Event|17|||
161865564|NCT03817190|584549611|FG000|Overall Study|Withdrawal by Subject|12|||
161865565|NCT03817190|584549612|FG001|Overall Study|Withdrawal by Subject|8|||
161865566|NCT03817190|584549611|FG000|Overall Study|Lost to Follow-up|11|||
161865567|NCT03817190|584549612|FG001|Overall Study|Lost to Follow-up|7|||
161865568|NCT03817190|584549611|FG000|Overall Study|Lack of Efficacy|7|||
161865569|NCT03817190|584549612|FG001|Overall Study|Lack of Efficacy|5|||
161865570|NCT03817190|584549611|FG000|Overall Study|Investigator Decision|5|||
161865571|NCT03817190|584549612|FG001|Overall Study|Investigator Decision|1|||
161865572|NCT03817190|584549611|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
161865573|NCT03817190|584549612|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
161865574|NCT03817190|584549611|FG000|Overall Study|Lack of Contact|1|||
161865575|NCT03817190|584549612|FG001|Overall Study|Lack of Contact|0|||
161865576|NCT03817190|584549611|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
161865577|NCT03817190|584549612|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
161865578|NCT00868530|584549615|FG000|Overall Study|Adverse Event|3|||
161865579|NCT00868530|584549615|FG000|Overall Study|Lost to Follow-up|1|||
161865580|NCT05795153|584551613|FG000|Overall Study|Adverse Event|2|||
161865581|NCT05795153|584551613|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161865582|NCT05795153|584551613|FG000|Overall Study|Lost to Follow-up|1|||
161865583|NCT05795153|584551613|FG000|Overall Study|Subject decision|2|||
161865584|NCT03668119|584551614|FG000|Pre-treatment|Disease Progression|1|||
161865585|NCT03668119|584551615|FG001|Pre-treatment|Disease Progression|0|||
161865586|NCT03668119|584551614|FG000|Treatment|Disease Progression|76|||
161865587|NCT03668119|584551615|FG001|Treatment|Disease Progression|57|||
161865588|NCT03668119|584551614|FG000|Treatment|Study drug toxicity|19|||
161865589|NCT03668119|584551615|FG001|Treatment|Study drug toxicity|1|||
161865590|NCT03668119|584551614|FG000|Treatment|Death|3|||
161865591|NCT03668119|584551615|FG001|Treatment|Death|0|||
161865592|NCT03668119|584551614|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
161865593|NCT03668119|584551615|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
161865594|NCT03668119|584551614|FG000|Treatment|Withdrawal by Subject|1|||
161865595|NCT03668119|584551615|FG001|Treatment|Withdrawal by Subject|1|||
161865596|NCT03668119|584551614|FG000|Treatment|Participant request to discontinue study treatment|3|||
161865597|NCT03668119|584551615|FG001|Treatment|Participant request to discontinue study treatment|1|||
161865598|NCT03668119|584551614|FG000|Treatment|Maximum Clinical Benefit|0|||
161865599|NCT03668119|584551615|FG001|Treatment|Maximum Clinical Benefit|1|||
161865600|NCT03668119|584551614|FG000|Treatment|Participants completed treatment|27|||
161865601|NCT03668119|584551615|FG001|Treatment|Participants completed treatment|11|||
161865602|NCT03668119|584551614|FG000|Treatment|Other reasons|2|||
161865603|NCT03668119|584551615|FG001|Treatment|Other reasons|1|||
161865604|NCT03769168|584551616|FG000|Overall Study|Adverse Event|0|||
161865605|NCT03769168|584551617|FG001|Overall Study|Adverse Event|1|||
161865606|NCT03769168|584551616|FG000|Overall Study|Lack of Efficacy|2|||
161865607|NCT03769168|584551617|FG001|Overall Study|Lack of Efficacy|4|||
161865608|NCT03769168|584551616|FG000|Overall Study|Post study access to treatment|3|||
161865609|NCT03769168|584551617|FG001|Overall Study|Post study access to treatment|11|||
161865610|NCT03769168|584551616|FG000|Overall Study|Physician Decision|1|||
161865611|NCT03769168|584551617|FG001|Overall Study|Physician Decision|4|||
161865612|NCT03769168|584551616|FG000|Overall Study|Subject Decision|2|||
161865613|NCT03769168|584551617|FG001|Overall Study|Subject Decision|4|||
161865614|NCT03769168|584551616|FG000|Overall Study|Guardian decision|1|||
161865615|NCT03769168|584551617|FG001|Overall Study|Guardian decision|0|||
161865616|NCT05142722|584551618|FG000|Overall Study|Lost to Follow-up|16|||
161865617|NCT05142722|584551619|FG001|Overall Study|Lost to Follow-up|38|||
161865618|NCT05142722|584551618|FG000|Overall Study|Withdrawal by Subject|20|||
161865619|NCT05142722|584551619|FG001|Overall Study|Withdrawal by Subject|27|||
161865620|NCT05142722|584551618|FG000|Overall Study|Death|11|||
161865621|NCT05142722|584551619|FG001|Overall Study|Death|17|||
161865622|NCT05142722|584551618|FG000|Overall Study|Physician Decision|0|||
161865623|NCT05142722|584551619|FG001|Overall Study|Physician Decision|1|||
161865624|NCT05142722|584551618|FG000|Overall Study|Participant Moved Away|0|||
161865625|NCT05142722|584551619|FG001|Overall Study|Participant Moved Away|2|||
161865626|NCT05142722|584551618|FG000|Overall Study|Adverse Event|2|||
161865627|NCT05142722|584551619|FG001|Overall Study|Adverse Event|1|||
161865628|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161865629|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865630|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161865631|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865632|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161865633|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865634|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865635|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865636|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865637|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865638|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
161865639|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865640|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865641|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
161865642|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865643|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865644|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865645|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865646|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161865647|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865648|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865649|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161865650|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865651|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161865652|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865653|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865654|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865655|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865656|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865657|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865658|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865659|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865660|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865661|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865662|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
161865663|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865664|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865665|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865666|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
161865667|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865668|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865669|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865670|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
161865671|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865672|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865673|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
161865674|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865675|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
161865676|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
161865677|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
161865678|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865679|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865680|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865681|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865682|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865683|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865684|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865685|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
161865686|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865687|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865688|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865689|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865690|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865691|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865692|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865693|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865694|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865695|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865696|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
161865697|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865698|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865699|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865700|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865701|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865702|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865703|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865704|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865705|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
161865706|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865707|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865708|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865709|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865710|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865711|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865712|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865713|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
161865714|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
161865715|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865716|NCT05400655|584551630|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
161865717|NCT05400655|584551631|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
161865718|NCT05400655|584551632|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
161865719|NCT05400655|584551633|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
161865720|NCT05400655|584551634|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
161865721|NCT05400655|584551635|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
161865722|NCT05400655|584551636|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
161865723|NCT05400655|584551637|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
161865724|NCT05400655|584551638|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
161865725|NCT05400655|584551639|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
161865726|NCT05400655|584551640|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
161865727|NCT05400655|584551641|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
161865728|NCT05400655|584551642|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
161865729|NCT05400655|584551643|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
161865730|NCT05400655|584551644|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
161865731|NCT05400655|584551645|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
161865732|NCT05400655|584551646|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
161865733|NCT05400655|584551647|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
161865734|NCT05400655|584551648|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
161865735|NCT05400655|584551649|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
161865736|NCT05400655|584551650|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
161865737|NCT05400655|584551651|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
161865738|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865739|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865740|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865741|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865742|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865743|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865744|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865745|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865746|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865747|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865748|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865749|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865750|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161865751|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865752|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865753|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865754|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161865755|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865756|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161865757|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
161865758|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865759|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865760|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865761|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865762|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865763|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865764|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865765|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865766|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865767|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865768|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865769|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865770|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865771|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865772|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865773|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
161865774|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865775|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865776|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
161865777|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865778|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
161865779|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865780|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865781|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865782|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865783|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865784|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865785|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865786|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865787|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865788|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865789|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865790|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865791|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865792|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865793|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865794|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865795|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865796|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865797|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865798|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161865799|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161865800|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
161865801|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865802|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
161865803|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161865804|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865805|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865806|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865807|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865808|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865809|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865810|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865811|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865812|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865813|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865814|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865815|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865816|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865817|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865818|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865819|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865820|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865821|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
161865822|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
161865823|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865824|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865825|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865826|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865827|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865828|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865829|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865830|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865831|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865832|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865833|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865834|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865835|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865836|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865837|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865838|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865839|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865840|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865841|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865842|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161865843|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865844|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161865845|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
161865846|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161865847|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
161865848|NCT01068678|584551660|FG000|Overall Study|Lack of Efficacy|3|||
161865849|NCT01068678|584551661|FG001|Overall Study|Lack of Efficacy|2|||
161865850|NCT01068678|584551660|FG000|Overall Study|Protocol Violation|5|||
161865851|NCT01068678|584551661|FG001|Overall Study|Protocol Violation|1|||
161865852|NCT01068678|584551660|FG000|Overall Study|Withdrawal criteria|12|||
161865853|NCT01068678|584551661|FG001|Overall Study|Withdrawal criteria|6|||
161865854|NCT01068678|584551660|FG000|Overall Study|Unclassified|18|||
161865855|NCT01068678|584551661|FG001|Overall Study|Unclassified|15|||
161865856|NCT00536939|584551662|FG000|Overall Study|Withdrawal by Subject|1|||
161865857|NCT00536939|584551663|FG001|Overall Study|Withdrawal by Subject|0|||
161865858|NCT00536939|584551662|FG000|Overall Study|Other Complicating Disease|1|||
161865859|NCT00536939|584551663|FG001|Overall Study|Other Complicating Disease|0|||
161865860|NCT01611935|584551664|FG000|Overall Study|Family Declined Participation|1|||
161865861|NCT01611935|584551665|FG001|Overall Study|Family Declined Participation|0|||
161865862|NCT04227197|584551666|FG000|Randomization|Protocol Violation|1|||
161865863|NCT04227197|584551667|FG001|Randomization|Protocol Violation|0|||
161865864|NCT04227197|584551666|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
161865865|NCT04227197|584551667|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
161865866|NCT04227197|584551666|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
161865867|NCT04227197|584551667|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
161865868|NCT04227197|584551666|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
161865869|NCT04227197|584551667|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
161865870|NCT04227197|584551666|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
161865871|NCT04227197|584551667|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
161865872|NCT04227197|584551666|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
161865873|NCT04227197|584551667|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
161865874|NCT04227197|584551666|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
161865875|NCT04227197|584551667|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
161865876|NCT02549859|584551672|FG000|Long-term 60 Hz DBS|Study Closed|1|||
161865877|NCT01209949|584551680|FG000|Overall Study|Lost to Follow-up|3|||
161865878|NCT00729612|584551681|FG000|Overall Study|Non evaluable for response|10|||
161865879|NCT00708552|584551682|FG000|Overall Study|Adverse Event|10|||
161865880|NCT00708552|584551683|FG001|Overall Study|Adverse Event|3|||
161865881|NCT00708552|584551684|FG002|Overall Study|Adverse Event|4|||
161865882|NCT00708552|584551685|FG003|Overall Study|Adverse Event|6|||
161865883|NCT00708552|584551682|FG000|Overall Study|Lack of Efficacy|0|||
161865884|NCT00708552|584551683|FG001|Overall Study|Lack of Efficacy|4|||
161865885|NCT00708552|584551684|FG002|Overall Study|Lack of Efficacy|1|||
161865886|NCT00708552|584551685|FG003|Overall Study|Lack of Efficacy|0|||
161865887|NCT00708552|584551682|FG000|Overall Study|Protocol Violation|0|||
161865888|NCT00708552|584551683|FG001|Overall Study|Protocol Violation|0|||
161865889|NCT00708552|584551684|FG002|Overall Study|Protocol Violation|2|||
161865890|NCT00708552|584551685|FG003|Overall Study|Protocol Violation|4|||
161865891|NCT00708552|584551682|FG000|Overall Study|Lost to Follow-up|4|||
161865892|NCT00708552|584551683|FG001|Overall Study|Lost to Follow-up|2|||
161865893|NCT00708552|584551684|FG002|Overall Study|Lost to Follow-up|0|||
161865894|NCT00708552|584551685|FG003|Overall Study|Lost to Follow-up|1|||
161865895|NCT00708552|584551682|FG000|Overall Study|Physician Decision|1|||
161865896|NCT00708552|584551683|FG001|Overall Study|Physician Decision|2|||
161865897|NCT00708552|584551684|FG002|Overall Study|Physician Decision|0|||
161865898|NCT00708552|584551685|FG003|Overall Study|Physician Decision|0|||
161865899|NCT00708552|584551682|FG000|Overall Study|Withdrawal by Subject|12|||
161865900|NCT00708552|584551683|FG001|Overall Study|Withdrawal by Subject|7|||
161865901|NCT00708552|584551684|FG002|Overall Study|Withdrawal by Subject|8|||
161865902|NCT00708552|584551685|FG003|Overall Study|Withdrawal by Subject|10|||
161865903|NCT02309411|584551686|FG000|Overall Study|Physician Decision|1|||
161865904|NCT02309411|584551687|FG001|Overall Study|Physician Decision|0|||
161865905|NCT02309411|584551688|FG002|Overall Study|Physician Decision|0|||
161865906|NCT02309411|584551686|FG000|Overall Study|Withdrawal by Subject|1|||
161865907|NCT02309411|584551687|FG001|Overall Study|Withdrawal by Subject|1|||
161865908|NCT02309411|584551688|FG002|Overall Study|Withdrawal by Subject|0|||
161865909|NCT04878432|584551690|FG000|Overall Study|Adverse Event|1|||
161865910|NCT04878432|584551690|FG000|Overall Study|Death|2|||
161865911|NCT04878432|584551690|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161865912|NCT04878432|584551690|FG000|Overall Study|Withdrawal by Subject|6|||
161865913|NCT04878432|584551690|FG000|Overall Study|Progressive Disease|7|||
161865914|NCT04878432|584551690|FG000|Overall Study|New Therapy for Study Indication|7|||
161865915|NCT04878432|584551690|FG000|Overall Study|Physician Decision|11|||
161865916|NCT03971071|584551691|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865917|NCT03971071|584551692|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
161865918|NCT03971071|584551693|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865919|NCT03971071|584551694|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865920|NCT03971071|584551695|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865921|NCT03971071|584551691|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
161865922|NCT03971071|584551692|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
161865923|NCT03971071|584551693|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
161865924|NCT03971071|584551694|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161865925|NCT03971071|584551695|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161865926|NCT03971071|584551691|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
161865927|NCT03971071|584551692|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
161865928|NCT03971071|584551693|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
161865929|NCT03971071|584551694|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
161865930|NCT03971071|584551695|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
161865931|NCT03971071|584551691|FG000|Open-label Treatment Period|Sponsor decision|0|||
161865932|NCT03971071|584551692|FG001|Open-label Treatment Period|Sponsor decision|0|||
161865933|NCT03971071|584551693|FG002|Open-label Treatment Period|Sponsor decision|0|||
161865934|NCT03971071|584551694|FG003|Open-label Treatment Period|Sponsor decision|0|||
161865935|NCT03971071|584551695|FG004|Open-label Treatment Period|Sponsor decision|1|||
161865936|NCT03971071|584551691|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161865937|NCT03971071|584551692|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161865938|NCT03971071|584551693|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161865939|NCT03971071|584551694|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
161865940|NCT03971071|584551695|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
161865941|NCT03971071|584551691|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161865942|NCT03971071|584551692|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161865943|NCT03971071|584551693|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161865944|NCT03971071|584551694|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161865945|NCT03971071|584551695|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
161865946|NCT00360282|584551696|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
161865947|NCT00360282|584551697|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
161865948|NCT00360282|584551698|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
161865949|NCT00360282|584551699|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
161865950|NCT00360282|584551696|FG000|Second Intervention|Adverse Event|0|||
161865951|NCT00360282|584551697|FG001|Second Intervention|Adverse Event|1|||
161865952|NCT00360282|584551698|FG002|Second Intervention|Adverse Event|0|||
161865953|NCT00360282|584551699|FG003|Second Intervention|Adverse Event|0|||
161865954|NCT04537078|584551702|FG000|Overall Study|Protocol Violation|3|||
161865955|NCT04537078|584551703|FG001|Overall Study|Protocol Violation|2|||
161865956|NCT04537078|584551702|FG000|Overall Study|Lost to Follow-up|1|||
161865957|NCT04537078|584551703|FG001|Overall Study|Lost to Follow-up|0|||
161865958|NCT04537078|584551702|FG000|Overall Study|Withdrawal by Subject|0|||
161865959|NCT04537078|584551703|FG001|Overall Study|Withdrawal by Subject|1|||
161865960|NCT03207815|584551704|FG000|Overall Study|Protocol Violation|3|||
161865961|NCT03207815|584551705|FG001|Overall Study|Protocol Violation|1|||
161865962|NCT03207815|584551704|FG000|Overall Study|Adverse Event|1|||
161865963|NCT03207815|584551705|FG001|Overall Study|Adverse Event|2|||
161865964|NCT03207815|584551704|FG000|Overall Study|Lost to Follow-up|1|||
161865965|NCT03207815|584551705|FG001|Overall Study|Lost to Follow-up|2|||
161865966|NCT03207815|584551704|FG000|Overall Study|Investigator's Discretion|1|||
161865967|NCT03207815|584551705|FG001|Overall Study|Investigator's Discretion|1|||
161865968|NCT03207815|584551704|FG000|Overall Study|Lack of Efficacy|0|||
161865969|NCT03207815|584551705|FG001|Overall Study|Lack of Efficacy|1|||
161865970|NCT03207815|584551704|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
161865971|NCT03207815|584551705|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
161865972|NCT03207815|584551704|FG000|Overall Study|Withdrew Consent|1|||
161865973|NCT03207815|584551705|FG001|Overall Study|Withdrew Consent|0|||
161865974|NCT03817853|584551706|FG000|Induction Phase|Adverse Event|5|||
161865975|NCT03817853|584551707|FG001|Induction Phase|Adverse Event|0|||
161865976|NCT03817853|584551708|FG002|Induction Phase|Adverse Event|0|||
161865977|NCT03817853|584551706|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
161865978|NCT03817853|584551707|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
161865979|NCT03817853|584551708|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
161865980|NCT03817853|584551706|FG000|Induction Phase|Physician Decision|2|||
161865981|NCT03817853|584551707|FG001|Induction Phase|Physician Decision|0|||
161865982|NCT03817853|584551708|FG002|Induction Phase|Physician Decision|0|||
161865983|NCT03817853|584551706|FG000|Induction Phase|Progressive Disease|6|||
161865984|NCT03817853|584551707|FG001|Induction Phase|Progressive Disease|0|||
161865985|NCT03817853|584551708|FG002|Induction Phase|Progressive Disease|0|||
161865986|NCT03817853|584551706|FG000|Induction Phase|Withdrawal by Subject|4|||
161865987|NCT03817853|584551707|FG001|Induction Phase|Withdrawal by Subject|0|||
161865988|NCT03817853|584551708|FG002|Induction Phase|Withdrawal by Subject|0|||
161865989|NCT03817853|584551706|FG000|Maintenance Phase|Adverse Event|0|||
161865990|NCT03817853|584551707|FG001|Maintenance Phase|Adverse Event|8|||
161774217|NCT00625846|584216009|FG000|Overall Study|Withdrawal by Subject|2|||
161774218|NCT00625846|584216010|FG001|Overall Study|Withdrawal by Subject|0|||
161774219|NCT00625846|584216011|FG002|Overall Study|Withdrawal by Subject|1|||
161774220|NCT00625846|584216012|FG003|Overall Study|Withdrawal by Subject|2|||
161774221|NCT02686749|584216023|FG000|Overall Study|terminated for poor enrollment|2|||
161774222|NCT02686749|584216024|FG001|Overall Study|terminated for poor enrollment|2|||
161774223|NCT04409509|584216028|FG000|Overall Study|Failure to meet randomization requirement|1|||
161774224|NCT04409509|584216029|FG001|Overall Study|Failure to meet randomization requirement|0|||
161774225|NCT04409509|584216028|FG000|Overall Study|Adverse Event|0|||
161774226|NCT04409509|584216029|FG001|Overall Study|Adverse Event|1|||
161774227|NCT04409509|584216028|FG000|Overall Study|Death|11|||
161774228|NCT04409509|584216029|FG001|Overall Study|Death|10|||
161774229|NCT04409509|584216028|FG000|Overall Study|Non-compliance with study drug|0|||
161774230|NCT04409509|584216029|FG001|Overall Study|Non-compliance with study drug|1|||
161774231|NCT04409509|584216028|FG000|Overall Study|Lost to Follow-up|0|||
161774232|NCT04409509|584216029|FG001|Overall Study|Lost to Follow-up|3|||
161774233|NCT04409509|584216028|FG000|Overall Study|Withdrawal by Subject|0|||
161774234|NCT04409509|584216029|FG001|Overall Study|Withdrawal by Subject|3|||
161774235|NCT04409509|584216028|FG000|Overall Study|Randomized by mistake|0|||
161774236|NCT04409509|584216029|FG001|Overall Study|Randomized by mistake|1|||
161774237|NCT04409509|584216028|FG000|Overall Study|Other|1|||
161774238|NCT04409509|584216029|FG001|Overall Study|Other|1|||
161774239|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Adverse Event|0|||
161774240|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Adverse Event|0|||
161774241|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Adverse Event|0|||
161774242|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Adverse Event|0|||
161774243|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Adverse Event|0|||
161774244|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Adverse Event|0|||
161774245|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Adverse Event|0|||
161774246|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Adverse Event|0|||
161774247|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Adverse Event|0|||
161774248|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Adverse Event|0|||
161774249|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Adverse Event|0|||
161774250|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Adverse Event|1|||
161774251|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Adverse Event|1|||
161774252|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Adverse Event|0|||
161774253|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Adverse Event|0|||
161774254|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Adverse Event|0|||
161774255|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Adverse Event|0|||
161774256|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Adverse Event|0|||
161774257|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Adverse Event|0|||
161774258|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774259|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774260|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
161774261|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774262|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774263|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774264|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774265|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774266|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774267|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774268|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774269|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774270|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774271|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774272|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774273|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774274|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774275|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774276|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774277|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Other|0|||
161774278|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Other|0|||
161774279|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Other|0|||
161774280|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Other|0|||
161774281|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Other|0|||
161774282|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Other|0|||
161774283|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Other|0|||
161774284|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Other|0|||
161774285|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Other|0|||
161774286|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Other|0|||
161774287|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Other|0|||
161774288|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Other|1|||
161774289|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Other|0|||
161774290|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Other|0|||
161774291|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Other|0|||
161774292|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Other|0|||
161865991|NCT03817853|584551708|FG002|Maintenance Phase|Adverse Event|0|||
161865992|NCT03817853|584551706|FG000|Maintenance Phase|Death|0|||
161865993|NCT03817853|584551707|FG001|Maintenance Phase|Death|5|||
161865994|NCT03817853|584551708|FG002|Maintenance Phase|Death|0|||
161865995|NCT03817853|584551706|FG000|Maintenance Phase|Progressive Disease|0|||
161865996|NCT03817853|584551707|FG001|Maintenance Phase|Progressive Disease|7|||
161865997|NCT03817853|584551708|FG002|Maintenance Phase|Progressive Disease|0|||
161865998|NCT03817853|584551706|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161865999|NCT03817853|584551707|FG001|Maintenance Phase|Withdrawal by Subject|2|||
161866000|NCT03817853|584551708|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161866001|NCT03817853|584551706|FG000|Maintenance Phase|Physician Decision|0|||
161866002|NCT03817853|584551707|FG001|Maintenance Phase|Physician Decision|1|||
161866003|NCT03817853|584551708|FG002|Maintenance Phase|Physician Decision|0|||
161866004|NCT03817853|584551706|FG000|Maintenance Phase|Various reasons|0|||
161866005|NCT03817853|584551707|FG001|Maintenance Phase|Various reasons|4|||
161866006|NCT03817853|584551708|FG002|Maintenance Phase|Various reasons|0|||
161866007|NCT03817853|584551706|FG000|Maintenance Phase|Protocol Deviation|0|||
161866008|NCT03817853|584551707|FG001|Maintenance Phase|Protocol Deviation|1|||
161866009|NCT03817853|584551708|FG002|Maintenance Phase|Protocol Deviation|0|||
161866010|NCT03817853|584551706|FG000|Follow-up Phase|Adverse Event|0|||
161866011|NCT03817853|584551707|FG001|Follow-up Phase|Adverse Event|0|||
161866012|NCT03817853|584551708|FG002|Follow-up Phase|Adverse Event|2|||
161866013|NCT03817853|584551706|FG000|Follow-up Phase|Death|0|||
161866014|NCT03817853|584551707|FG001|Follow-up Phase|Death|0|||
161866015|NCT03817853|584551708|FG002|Follow-up Phase|Death|1|||
161866016|NCT03817853|584551706|FG000|Follow-up Phase|Progressive Disease|0|||
161866017|NCT03817853|584551707|FG001|Follow-up Phase|Progressive Disease|0|||
161866018|NCT03817853|584551708|FG002|Follow-up Phase|Progressive Disease|3|||
161866019|NCT03817853|584551706|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161866020|NCT03817853|584551707|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161866021|NCT03817853|584551708|FG002|Follow-up Phase|Withdrawal by Subject|1|||
161866022|NCT00391768|584551709|FG000|Overall Study|Withdrawal by Subject|0|||
161866023|NCT00391768|584551710|FG001|Overall Study|Withdrawal by Subject|0|||
161866024|NCT00391768|584551711|FG002|Overall Study|Withdrawal by Subject|1|||
161866025|NCT00391768|584551712|FG003|Overall Study|Withdrawal by Subject|0|||
161866026|NCT00391768|584551713|FG004|Overall Study|Withdrawal by Subject|0|||
161866027|NCT00391768|584551714|FG005|Overall Study|Withdrawal by Subject|1|||
161866028|NCT00391768|584551715|FG006|Overall Study|Withdrawal by Subject|1|||
161866029|NCT00391768|584551709|FG000|Overall Study|Lost to Follow-up|0|||
161866030|NCT00391768|584551710|FG001|Overall Study|Lost to Follow-up|0|||
161866031|NCT00391768|584551711|FG002|Overall Study|Lost to Follow-up|0|||
161866032|NCT00391768|584551712|FG003|Overall Study|Lost to Follow-up|1|||
161866033|NCT00391768|584551713|FG004|Overall Study|Lost to Follow-up|2|||
161866034|NCT00391768|584551714|FG005|Overall Study|Lost to Follow-up|2|||
161866035|NCT00391768|584551715|FG006|Overall Study|Lost to Follow-up|3|||
161866036|NCT01620138|584551716|FG000|Overall Study|Withdrawal by Subject|3|||
161866037|NCT01620138|584551717|FG001|Overall Study|Withdrawal by Subject|0|||
161866038|NCT01620138|584551716|FG000|Overall Study|Lack of Efficacy|1|||
161866039|NCT01620138|584551717|FG001|Overall Study|Lack of Efficacy|0|||
161866040|NCT01620138|584551716|FG000|Overall Study|Adverse Event|2|||
161866041|NCT01620138|584551717|FG001|Overall Study|Adverse Event|0|||
161866042|NCT00444535|584551720|FG000|Overall Study|Withdrawal by Subject|5|||
161866043|NCT00444535|584551720|FG000|Overall Study|Physician Decision|5|||
161866044|NCT00444535|584551720|FG000|Overall Study|progressive disease|1|||
161866045|NCT00444535|584551720|FG000|Overall Study|Adverse Event|2|||
161866046|NCT01568892|584551721|FG000|Open-label Phase|Adverse Event|2|||
161866047|NCT01568892|584551722|FG001|Open-label Phase|Adverse Event|0|||
161866048|NCT01568892|584551721|FG000|Open-label Phase|Lack of Efficacy|4|||
161866049|NCT01568892|584551722|FG001|Open-label Phase|Lack of Efficacy|2|||
161866050|NCT01568892|584551721|FG000|Open-label Phase|Lost to Follow-up|0|||
161866051|NCT01568892|584551722|FG001|Open-label Phase|Lost to Follow-up|1|||
161866052|NCT01697748|584551730|FG000|Overall Study|ineligible skin incision|1|||
161866053|NCT01697748|584551731|FG001|Overall Study|ineligible skin incision|2|||
161866054|NCT01697748|584551730|FG000|Overall Study|ineligible uterine incision|4|||
161866055|NCT01697748|584551731|FG001|Overall Study|ineligible uterine incision|1|||
161866056|NCT01697748|584551730|FG000|Overall Study|Lost to Follow-up|53|||
161866057|NCT01697748|584551731|FG001|Overall Study|Lost to Follow-up|65|||
161866058|NCT01256450|584551734|FG000|Open-label Titration|Adverse Event|39|||
161866059|NCT01256450|584551735|FG001|Open-label Titration|Adverse Event|0|||
161866060|NCT01256450|584551736|FG002|Open-label Titration|Adverse Event|0|||
161866061|NCT01256450|584551734|FG000|Open-label Titration|Lost to Follow-up|7|||
161866062|NCT01256450|584551735|FG001|Open-label Titration|Lost to Follow-up|0|||
161866063|NCT01256450|584551736|FG002|Open-label Titration|Lost to Follow-up|0|||
161866064|NCT01256450|584551734|FG000|Open-label Titration|Lack of analgesic effect|30|||
161866065|NCT01256450|584551735|FG001|Open-label Titration|Lack of analgesic effect|0|||
161866066|NCT01256450|584551736|FG002|Open-label Titration|Lack of analgesic effect|0|||
161866067|NCT01256450|584551734|FG000|Open-label Titration|Non-compliance|9|||
161866068|NCT01256450|584551735|FG001|Open-label Titration|Non-compliance|0|||
161866069|NCT01256450|584551736|FG002|Open-label Titration|Non-compliance|0|||
161866070|NCT01256450|584551734|FG000|Open-label Titration|Screen failure|1|||
161866071|NCT01256450|584551735|FG001|Open-label Titration|Screen failure|0|||
161866072|NCT01256450|584551736|FG002|Open-label Titration|Screen failure|0|||
161866073|NCT01256450|584551734|FG000|Open-label Titration|Other|13|||
161866074|NCT01256450|584551735|FG001|Open-label Titration|Other|0|||
161866075|NCT01256450|584551736|FG002|Open-label Titration|Other|0|||
161866076|NCT01256450|584551734|FG000|Double-blind Treatment|Adverse Event|0|||
161866077|NCT01256450|584551735|FG001|Double-blind Treatment|Adverse Event|8|||
161866078|NCT01256450|584551736|FG002|Double-blind Treatment|Adverse Event|6|||
161866079|NCT01256450|584551734|FG000|Double-blind Treatment|Lost to Follow-up|0|||
161866080|NCT01256450|584551735|FG001|Double-blind Treatment|Lost to Follow-up|1|||
161866081|NCT01256450|584551736|FG002|Double-blind Treatment|Lost to Follow-up|7|||
161866082|NCT01256450|584551734|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
161866083|NCT01256450|584551735|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
161866084|NCT01256450|584551736|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
161866085|NCT01256450|584551734|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
161866086|NCT01256450|584551735|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
161866087|NCT01256450|584551736|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
161866088|NCT01256450|584551734|FG000|Double-blind Treatment|Non-compliance|0|||
161866089|NCT01256450|584551735|FG001|Double-blind Treatment|Non-compliance|5|||
161866090|NCT01256450|584551736|FG002|Double-blind Treatment|Non-compliance|4|||
161866091|NCT01256450|584551734|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
161866092|NCT01256450|584551735|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
161866093|NCT01256450|584551736|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
161866094|NCT01256450|584551734|FG000|Double-blind Treatment|Other|0|||
161866095|NCT01256450|584551735|FG001|Double-blind Treatment|Other|9|||
161866096|NCT01256450|584551736|FG002|Double-blind Treatment|Other|12|||
161866097|NCT01704495|584551737|FG000|Subjects Randomized|Other Reason|3|||
161866098|NCT01704495|584551738|FG001|Subjects Randomized|Other Reason|2|||
161866099|NCT01704495|584551739|FG002|Subjects Randomized|Other Reason|3|||
161866100|NCT01704495|584551740|FG003|Subjects Randomized|Other Reason|2|||
161866101|NCT01704495|584551737|FG000|Subjects Randomized|Discontinuation criteria met|4|||
161866102|NCT01704495|584551738|FG001|Subjects Randomized|Discontinuation criteria met|2|||
161866103|NCT01704495|584551739|FG002|Subjects Randomized|Discontinuation criteria met|2|||
161866104|NCT01704495|584551740|FG003|Subjects Randomized|Discontinuation criteria met|0|||
161866105|NCT01704495|584551737|FG000|Subjects Randomized|Adverse Event|8|||
161866106|NCT01704495|584551738|FG001|Subjects Randomized|Adverse Event|2|||
161866107|NCT01704495|584551739|FG002|Subjects Randomized|Adverse Event|0|||
161866108|NCT01704495|584551740|FG003|Subjects Randomized|Adverse Event|7|||
161866109|NCT01704495|584551737|FG000|Subjects Randomized|Withdrawal by Subject|5|||
161866110|NCT01704495|584551738|FG001|Subjects Randomized|Withdrawal by Subject|5|||
161866111|NCT01704495|584551739|FG002|Subjects Randomized|Withdrawal by Subject|5|||
161866112|NCT01704495|584551740|FG003|Subjects Randomized|Withdrawal by Subject|5|||
161866113|NCT01704495|584551737|FG000|Subjects Randomized|Protocol Violation|1|||
161866114|NCT01704495|584551738|FG001|Subjects Randomized|Protocol Violation|1|||
161866115|NCT01704495|584551739|FG002|Subjects Randomized|Protocol Violation|2|||
161866116|NCT01704495|584551740|FG003|Subjects Randomized|Protocol Violation|0|||
161866117|NCT01704495|584551737|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
161866118|NCT01704495|584551738|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
161866119|NCT01704495|584551739|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
161866120|NCT01704495|584551740|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
161866121|NCT01704495|584551737|FG000|Optional Safety Extension|Adverse Event|0|||
161866122|NCT01704495|584551738|FG001|Optional Safety Extension|Adverse Event|4|||
161866123|NCT01704495|584551739|FG002|Optional Safety Extension|Adverse Event|0|||
161866124|NCT01704495|584551740|FG003|Optional Safety Extension|Adverse Event|1|||
161866125|NCT01704495|584551737|FG000|Optional Safety Extension|Other reason|27|||
161866126|NCT01704495|584551738|FG001|Optional Safety Extension|Other reason|29|||
161866127|NCT01704495|584551739|FG002|Optional Safety Extension|Other reason|30|||
161866128|NCT01704495|584551740|FG003|Optional Safety Extension|Other reason|28|||
161866129|NCT01704495|584551737|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
161866130|NCT01704495|584551738|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
161866131|NCT01704495|584551739|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
161866132|NCT01704495|584551740|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
161866133|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
161866134|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
161866135|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
161866136|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161866137|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161866138|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161866139|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
161866140|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
161866141|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
161866142|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
161866143|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
161866144|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
161866145|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
161866146|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
161866147|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
161866148|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
161866149|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
161866150|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
161866151|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
161866152|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
161866153|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
161866154|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
161866155|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
161866156|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
161866157|NCT00891020|584551745|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
161866158|NCT00891020|584551746|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
161866159|NCT00891020|584551747|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
161866160|NCT00891020|584551745|FG000|24 Week Treatment Period|Death|0|||
161866161|NCT00891020|584551746|FG001|24 Week Treatment Period|Death|2|||
161866162|NCT00891020|584551747|FG002|24 Week Treatment Period|Death|0|||
161866163|NCT00891020|584551745|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
161866164|NCT00891020|584551746|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
161866165|NCT00891020|584551747|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
161866166|NCT00891020|584551745|FG000|24 Week Treatment Period|Failure to return|4|||
161866167|NCT00891020|584551746|FG001|24 Week Treatment Period|Failure to return|5|||
161866168|NCT00891020|584551747|FG002|24 Week Treatment Period|Failure to return|5|||
161866169|NCT00891020|584551745|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
161866170|NCT00891020|584551746|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
161866171|NCT00891020|584551747|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
161866172|NCT00891020|584551745|FG000|24 Week Treatment Period|Other protocol violation|1|||
161866173|NCT00891020|584551746|FG001|24 Week Treatment Period|Other protocol violation|1|||
161866174|NCT00891020|584551747|FG002|24 Week Treatment Period|Other protocol violation|2|||
161866175|NCT00891020|584551745|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
161866176|NCT00891020|584551746|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
161866177|NCT00891020|584551747|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
161866178|NCT00891020|584551745|FG000|24 Week Treatment Period|Withdrew consent|6|||
161866179|NCT00891020|584551746|FG001|24 Week Treatment Period|Withdrew consent|3|||
161866180|NCT00891020|584551747|FG002|24 Week Treatment Period|Withdrew consent|15|||
161866181|NCT00891020|584551745|FG000|24 Week Treatment Period|Administrative/Other|5|||
161866182|NCT00891020|584551746|FG001|24 Week Treatment Period|Administrative/Other|6|||
161866183|NCT00891020|584551747|FG002|24 Week Treatment Period|Administrative/Other|1|||
161866184|NCT00891020|584551745|FG000|Long-term Extension Period|Adverse Event|1|||
161866185|NCT00891020|584551746|FG001|Long-term Extension Period|Adverse Event|11|||
161866186|NCT00891020|584551747|FG002|Long-term Extension Period|Adverse Event|10|||
161866187|NCT00891020|584551745|FG000|Long-term Extension Period|Death|0|||
161866188|NCT00891020|584551746|FG001|Long-term Extension Period|Death|0|||
161866189|NCT00891020|584551747|FG002|Long-term Extension Period|Death|1|||
161866190|NCT00891020|584551745|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
161866191|NCT00891020|584551746|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
161866192|NCT00891020|584551747|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
161866193|NCT00891020|584551745|FG000|Long-term Extension Period|Protocol Violation|0|||
161866194|NCT00891020|584551746|FG001|Long-term Extension Period|Protocol Violation|1|||
161866195|NCT00891020|584551747|FG002|Long-term Extension Period|Protocol Violation|1|||
161866196|NCT00891020|584551745|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
161866197|NCT00891020|584551746|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
161866198|NCT00891020|584551747|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
161866199|NCT00891020|584551745|FG000|Long-term Extension Period|Failure to return|0|||
161866200|NCT00891020|584551746|FG001|Long-term Extension Period|Failure to return|2|||
161866201|NCT00891020|584551747|FG002|Long-term Extension Period|Failure to return|3|||
161866202|NCT00891020|584551745|FG000|Long-term Extension Period|Administrative|1|||
161866203|NCT00891020|584551746|FG001|Long-term Extension Period|Administrative|2|||
161866204|NCT00891020|584551747|FG002|Long-term Extension Period|Administrative|2|||
161866205|NCT00320710|584551749|FG000|Overall Study|Disease progression|24|||
161866206|NCT00320710|584551750|FG001|Overall Study|Disease progression|19|||
161866207|NCT00320710|584551751|FG002|Overall Study|Disease progression|2|||
161866208|NCT00320710|584551749|FG000|Overall Study|Death|10|||
161866209|NCT00320710|584551750|FG001|Overall Study|Death|7|||
161866210|NCT00320710|584551751|FG002|Overall Study|Death|1|||
161866211|NCT00320710|584551749|FG000|Overall Study|Administrative problems|1|||
161866212|NCT00320710|584551750|FG001|Overall Study|Administrative problems|2|||
161866213|NCT00320710|584551751|FG002|Overall Study|Administrative problems|0|||
161866214|NCT00320710|584551749|FG000|Overall Study|Withdrawal by Subject|20|||
161866215|NCT00320710|584551750|FG001|Overall Study|Withdrawal by Subject|26|||
161866216|NCT00320710|584551751|FG002|Overall Study|Withdrawal by Subject|1|||
161866217|NCT00320710|584551749|FG000|Overall Study|Protocol Violation|6|||
161866218|NCT00320710|584551750|FG001|Overall Study|Protocol Violation|5|||
161866219|NCT00320710|584551751|FG002|Overall Study|Protocol Violation|0|||
161866220|NCT00320710|584551749|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161866221|NCT00320710|584551750|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161866222|NCT00320710|584551751|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161866223|NCT00320710|584551749|FG000|Overall Study|Abnormal laboratory value(s)|12|||
161866224|NCT00320710|584551750|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161866225|NCT00320710|584551751|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161866226|NCT00320710|584551749|FG000|Overall Study|Adverse Event|18|||
161866227|NCT00320710|584551750|FG001|Overall Study|Adverse Event|14|||
161866228|NCT00320710|584551751|FG002|Overall Study|Adverse Event|1|||
161866229|NCT00320710|584551749|FG000|Overall Study|Lost to Follow-up|1|||
161866230|NCT00320710|584551750|FG001|Overall Study|Lost to Follow-up|0|||
161866231|NCT00320710|584551751|FG002|Overall Study|Lost to Follow-up|0|||
161866232|NCT03866512|584551752|FG000|Overall Study|Lost to Follow-up|1|||
161866233|NCT03866512|584551753|FG001|Overall Study|Lost to Follow-up|2|||
161866234|NCT03866512|584551754|FG002|Overall Study|Lost to Follow-up|1|||
161866235|NCT03866512|584551752|FG000|Overall Study|Cannulation issues|0|||
161866236|NCT03866512|584551753|FG001|Overall Study|Cannulation issues|1|||
161866237|NCT03866512|584551754|FG002|Overall Study|Cannulation issues|2|||
161866238|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
161866239|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866240|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866241|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866242|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
161866243|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161866244|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161866245|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161866246|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
161866247|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161866248|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161866249|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161866250|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
161866251|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866252|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866253|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866254|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
161866255|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866256|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866257|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866258|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
161866259|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866260|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866261|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866262|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
161866263|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161866264|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161866265|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161866266|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
161866267|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161866268|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161866269|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161866270|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
161866271|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866272|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866273|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866274|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
161866275|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
161866276|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
161866277|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
161866278|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
161866279|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
161866280|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
161866281|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
161866282|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
161866283|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
161866284|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
161866285|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
161866286|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
161866287|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
161866288|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
161866289|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
161866290|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
161866291|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
161866292|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
161866293|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
161866294|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
161866295|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
161866296|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
161866297|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
161866298|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
161866299|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
161866300|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
161866301|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
161866302|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161866303|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161866304|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
161866305|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161866306|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161866307|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161866308|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161866309|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
161866310|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866311|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866312|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866313|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
161866314|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866315|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866316|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866317|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
161866318|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866319|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866320|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866321|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
161866322|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866323|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866324|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866325|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
161866326|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866327|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866328|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866329|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
161866330|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161866331|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161866332|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161866333|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
161866334|NCT00997373|584551764|FG000|Overall Study|Withdrawal by Subject|5|||
161866335|NCT00997373|584551765|FG001|Overall Study|Withdrawal by Subject|0|||
161866336|NCT00997373|584551764|FG000|Overall Study|wrong tumor type|4|||
161866337|NCT00997373|584551765|FG001|Overall Study|wrong tumor type|0|||
161866338|NCT00997373|584551764|FG000|Overall Study|could not have hysterectomy|6|||
161866339|NCT00997373|584551765|FG001|Overall Study|could not have hysterectomy|0|||
161866340|NCT00832455|584551766|FG000|Overall Study|Adverse Event|13|||
161866341|NCT00832455|584551766|FG000|Overall Study|Lost to Follow-up|26|||
161866342|NCT00832455|584551766|FG000|Overall Study|Protocol Violation|4|||
161866343|NCT00832455|584551766|FG000|Overall Study|Withdrawal by Subject|17|||
161866344|NCT00832455|584551766|FG000|Overall Study|Screening Failure|2|||
161866345|NCT00832455|584551766|FG000|Overall Study|Stopped Medication|4|||
161866346|NCT00832455|584551766|FG000|Overall Study|Parent misunderstood study|1|||
161866347|NCT00832455|584551766|FG000|Overall Study|Parent dissatisfied|1|||
161866348|NCT00832455|584551766|FG000|Overall Study|No improvement|3|||
161866349|NCT00832455|584551766|FG000|Overall Study|Patient moved|1|||
161866350|NCT04578457|584551767|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
161866351|NCT04578457|584551767|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
161866352|NCT04578457|584551767|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
161866353|NCT04578457|584551767|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
161866354|NCT00739661|584551769|FG000|Overall Study|Adverse Event|2|||
161866355|NCT00739661|584551770|FG001|Overall Study|Adverse Event|0|||
161866356|NCT00739661|584551769|FG000|Overall Study|Physician decision to withdraw patient|1|||
161866357|NCT00739661|584551770|FG001|Overall Study|Physician decision to withdraw patient|0|||
161866358|NCT00739661|584551769|FG000|Overall Study|Patient decision to withdraw|9|||
161866359|NCT00739661|584551770|FG001|Overall Study|Patient decision to withdraw|4|||
161866360|NCT00739661|584551769|FG000|Overall Study|Disease progression, radiographic|33|||
161866361|NCT00739661|584551770|FG001|Overall Study|Disease progression, radiographic|37|||
161866362|NCT00739661|584551769|FG000|Overall Study|Reason for discontinuation not available|1|||
161866363|NCT00739661|584551770|FG001|Overall Study|Reason for discontinuation not available|1|||
161866364|NCT02883062|584551773|FG000|Overall Study|Withdrawal by Subject|6|||
161866365|NCT02883062|584551774|FG001|Overall Study|Withdrawal by Subject|0|||
161866366|NCT03839628|584551775|FG000|Overall Study|Withdrawal by Subject|1|||
161866367|NCT00380874|584551776|FG000|Overall Study|Adverse Event|7|||
161866368|NCT00380874|584551777|FG001|Overall Study|Adverse Event|7|||
161866369|NCT00380874|584551776|FG000|Overall Study|Death|1|||
161866370|NCT00380874|584551777|FG001|Overall Study|Death|0|||
161866371|NCT00380874|584551776|FG000|Overall Study|Withdrawal by Subject|2|||
161866372|NCT00380874|584551777|FG001|Overall Study|Withdrawal by Subject|1|||
161866373|NCT00380874|584551776|FG000|Overall Study|Not related to study drug|3|||
161866374|NCT00380874|584551777|FG001|Overall Study|Not related to study drug|2|||
161866375|NCT03380429|584551778|FG000|Overall Study|Physician Decision|0|||
161866376|NCT03380429|584551779|FG001|Overall Study|Physician Decision|1|||
161866377|NCT03380429|584551780|FG002|Overall Study|Physician Decision|0|||
161866378|NCT03380429|584551781|FG003|Overall Study|Physician Decision|1|||
161866379|NCT03380429|584551782|FG004|Overall Study|Physician Decision|1|||
161866380|NCT03380429|584551778|FG000|Overall Study|Withdrawal by Subject|3|||
161866381|NCT03380429|584551779|FG001|Overall Study|Withdrawal by Subject|3|||
161866382|NCT03380429|584551780|FG002|Overall Study|Withdrawal by Subject|5|||
161866383|NCT03380429|584551781|FG003|Overall Study|Withdrawal by Subject|2|||
161866384|NCT03380429|584551782|FG004|Overall Study|Withdrawal by Subject|1|||
161866385|NCT03380429|584551778|FG000|Overall Study|Lost to Follow-up|0|||
161866386|NCT03380429|584551779|FG001|Overall Study|Lost to Follow-up|2|||
161866387|NCT03380429|584551780|FG002|Overall Study|Lost to Follow-up|4|||
161866388|NCT03380429|584551781|FG003|Overall Study|Lost to Follow-up|3|||
161866389|NCT03380429|584551782|FG004|Overall Study|Lost to Follow-up|1|||
161866390|NCT03380429|584551778|FG000|Overall Study|Protocol Violation|1|||
161866391|NCT03380429|584551779|FG001|Overall Study|Protocol Violation|0|||
161866392|NCT03380429|584551780|FG002|Overall Study|Protocol Violation|1|||
161866393|NCT03380429|584551781|FG003|Overall Study|Protocol Violation|0|||
161866394|NCT03380429|584551782|FG004|Overall Study|Protocol Violation|1|||
161866395|NCT03380429|584551778|FG000|Overall Study|Lack of Efficacy|0|||
161866396|NCT03380429|584551779|FG001|Overall Study|Lack of Efficacy|0|||
161866397|NCT03380429|584551780|FG002|Overall Study|Lack of Efficacy|0|||
161866398|NCT03380429|584551781|FG003|Overall Study|Lack of Efficacy|2|||
161866399|NCT03380429|584551782|FG004|Overall Study|Lack of Efficacy|1|||
161866400|NCT03380429|584551778|FG000|Overall Study|Adverse Event|1|||
161866401|NCT03380429|584551779|FG001|Overall Study|Adverse Event|1|||
161866402|NCT03380429|584551780|FG002|Overall Study|Adverse Event|1|||
161866403|NCT03380429|584551781|FG003|Overall Study|Adverse Event|2|||
161866404|NCT03380429|584551782|FG004|Overall Study|Adverse Event|0|||
161866405|NCT01707290|584551787|FG000|Overall Study|Adverse event (AE)|1|||
161866406|NCT01707290|584551788|FG001|Overall Study|Adverse event (AE)|0|||
161866407|NCT01707290|584551787|FG000|Overall Study|Physician Decision|1|||
161866408|NCT01707290|584551788|FG001|Overall Study|Physician Decision|0|||
161866409|NCT01707290|584551787|FG000|Overall Study|Lost to Follow-up|3|||
161866410|NCT01707290|584551788|FG001|Overall Study|Lost to Follow-up|0|||
161866411|NCT01707290|584551787|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
161866412|NCT01707290|584551788|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
161866413|NCT01707290|584551787|FG000|Overall Study|Commercial drug available|60|||
161866414|NCT01707290|584551788|FG001|Overall Study|Commercial drug available|1|||
161866415|NCT01707290|584551787|FG000|Overall Study|Other unspecified|17|||
161866416|NCT01707290|584551788|FG001|Overall Study|Other unspecified|0|||
161866417|NCT02314026|584551789|FG000|Overall Study|Protocol Violation|28|||
161866418|NCT01139775|584551790|FG000|Overall Study|Adverse Event|0|||
161866419|NCT01139775|584551791|FG001|Overall Study|Adverse Event|6|||
161866420|NCT01139775|584551792|FG002|Overall Study|Adverse Event|2|||
161866421|NCT01139775|584551790|FG000|Overall Study|Protocol Violation|0|||
161866422|NCT01139775|584551791|FG001|Overall Study|Protocol Violation|5|||
161866423|NCT01139775|584551792|FG002|Overall Study|Protocol Violation|0|||
161866424|NCT01139775|584551790|FG000|Overall Study|Withdrawal by Subject|1|||
161866425|NCT01139775|584551791|FG001|Overall Study|Withdrawal by Subject|0|||
161866426|NCT01139775|584551792|FG002|Overall Study|Withdrawal by Subject|2|||
161866427|NCT01139775|584551790|FG000|Overall Study|Physician Decision|0|||
161866428|NCT01139775|584551791|FG001|Overall Study|Physician Decision|2|||
161866429|NCT01139775|584551792|FG002|Overall Study|Physician Decision|2|||
161866430|NCT01882985|584551795|FG000|Overall Study|Lost to Follow-up|1|||
161866431|NCT01882985|584551795|FG000|Overall Study|Withdrawal by Subject|1|||
161866432|NCT03193853|584551802|FG000|Overall Study|Death|6|||
161866433|NCT04129125|584551803|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
161866434|NCT04129125|584551803|FG000|Overall Study|Study device was not used|3|||
161866435|NCT02362360|584551814|FG000|Period 1|Lack of Efficacy|1|||
161866436|NCT02362360|584551815|FG001|Period 1|Lack of Efficacy|0|||
161866437|NCT02362360|584551814|FG000|Period 1|Withdrawal by Subject|2|||
161866438|NCT02362360|584551815|FG001|Period 1|Withdrawal by Subject|1|||
161866439|NCT01546025|584551816|FG000|Overall Study|Lost to Follow-up|0|||
161866440|NCT01546025|584551817|FG001|Overall Study|Lost to Follow-up|1|||
161866441|NCT04955691|584553504|FG000|Period 2|Discontinued intervention|1|||
161866442|NCT04955691|584553505|FG001|Period 2|Discontinued intervention|2|||
161866443|NCT05336227|584553506|FG000|Overall Study|Adverse Event|1|||
161866444|NCT05336227|584553507|FG001|Overall Study|Adverse Event|0|||
161866445|NCT05336227|584553506|FG000|Overall Study|Lost to Follow-up|2|||
161866446|NCT05336227|584553507|FG001|Overall Study|Lost to Follow-up|0|||
161866447|NCT05336227|584553506|FG000|Overall Study|Withdrawal by Subject|1|||
161866448|NCT05336227|584553507|FG001|Overall Study|Withdrawal by Subject|0|||
161866449|NCT05086744|584553508|FG000|Part A|Adverse Event|0|||
161866450|NCT05086744|584553509|FG001|Part A|Adverse Event|1|||
161866451|NCT05086744|584553508|FG000|Part A|Lack of Efficacy|3|||
161866452|NCT05086744|584553509|FG001|Part A|Lack of Efficacy|0|||
161866453|NCT05086744|584553508|FG000|Part A|Protocol deviation|1|||
161866454|NCT05086744|584553509|FG001|Part A|Protocol deviation|0|||
161866455|NCT05086744|584553508|FG000|Part A|Subject decision|1|||
161866456|NCT05086744|584553509|FG001|Part A|Subject decision|0|||
161866457|NCT05086744|584553508|FG000|Part B|Adverse Event|0|||
161866458|NCT05086744|584553509|FG001|Part B|Adverse Event|1|||
161866459|NCT05086744|584553508|FG000|Part B|Lack of Efficacy|0|||
161866460|NCT05086744|584553509|FG001|Part B|Lack of Efficacy|1|||
161866461|NCT05086744|584553508|FG000|Part B|Study terminated by sponsor|1|||
161866462|NCT05086744|584553509|FG001|Part B|Study terminated by sponsor|6|||
161866463|NCT04053868|584553512|FG000|Overall Study|Withdrawal by Subject|1|||
161866464|NCT04053868|584553513|FG001|Overall Study|Withdrawal by Subject|0|||
161866465|NCT05731700|584553514|FG000|Overall Study|Death|1|||
161866466|NCT05468164|584553515|FG000|Treatment Period 4|Adverse Event|0|||
161866467|NCT05468164|584553516|FG001|Treatment Period 4|Adverse Event|0|||
161866468|NCT05468164|584553517|FG002|Treatment Period 4|Adverse Event|0|||
161866469|NCT05468164|584553518|FG003|Treatment Period 4|Adverse Event|1|||
161866470|NCT04225715|584553519|FG000|Overall Study|Reason not Specified|1|||
161866471|NCT04225715|584553520|FG001|Overall Study|Reason not Specified|0|||
161866472|NCT04225715|584553521|FG002|Overall Study|Reason not Specified|0|||
161866473|NCT04225715|584553522|FG003|Overall Study|Reason not Specified|0|||
161866474|NCT04225715|584553523|FG004|Overall Study|Reason not Specified|0|||
161866475|NCT04225715|584553524|FG005|Overall Study|Reason not Specified|0|||
161866476|NCT04225715|584553525|FG006|Overall Study|Reason not Specified|0|||
161866477|NCT04225715|584553526|FG007|Overall Study|Reason not Specified|0|||
161866478|NCT04225715|584553527|FG008|Overall Study|Reason not Specified|0|||
161866479|NCT04225715|584553519|FG000|Overall Study|Protocol Violation|1|||
161866480|NCT04225715|584553520|FG001|Overall Study|Protocol Violation|0|||
161866481|NCT04225715|584553521|FG002|Overall Study|Protocol Violation|0|||
161866482|NCT04225715|584553522|FG003|Overall Study|Protocol Violation|0|||
161866483|NCT04225715|584553523|FG004|Overall Study|Protocol Violation|0|||
161866484|NCT04225715|584553524|FG005|Overall Study|Protocol Violation|9|||
161866485|NCT04225715|584553525|FG006|Overall Study|Protocol Violation|0|||
161866486|NCT04225715|584553526|FG007|Overall Study|Protocol Violation|0|||
161866487|NCT04225715|584553527|FG008|Overall Study|Protocol Violation|0|||
161866488|NCT04225715|584553519|FG000|Overall Study|Withdrawal by Subject|4|||
161866489|NCT04225715|584553520|FG001|Overall Study|Withdrawal by Subject|1|||
161866490|NCT04225715|584553521|FG002|Overall Study|Withdrawal by Subject|1|||
161866491|NCT04225715|584553522|FG003|Overall Study|Withdrawal by Subject|0|||
161866492|NCT04225715|584553523|FG004|Overall Study|Withdrawal by Subject|3|||
161866493|NCT04225715|584553524|FG005|Overall Study|Withdrawal by Subject|1|||
161866494|NCT04225715|584553525|FG006|Overall Study|Withdrawal by Subject|1|||
161866495|NCT04225715|584553526|FG007|Overall Study|Withdrawal by Subject|1|||
161866496|NCT04225715|584553527|FG008|Overall Study|Withdrawal by Subject|0|||
161866497|NCT04225715|584553519|FG000|Overall Study|Adverse Event|0|||
161866498|NCT04225715|584553520|FG001|Overall Study|Adverse Event|0|||
161866499|NCT04225715|584553521|FG002|Overall Study|Adverse Event|0|||
161866500|NCT04225715|584553522|FG003|Overall Study|Adverse Event|0|||
161866501|NCT04225715|584553523|FG004|Overall Study|Adverse Event|0|||
161866502|NCT04225715|584553524|FG005|Overall Study|Adverse Event|0|||
161866503|NCT04225715|584553525|FG006|Overall Study|Adverse Event|0|||
161866504|NCT04225715|584553526|FG007|Overall Study|Adverse Event|0|||
161866505|NCT04225715|584553527|FG008|Overall Study|Adverse Event|1|||
161866506|NCT04225715|584553519|FG000|Overall Study|Arm Terminated By Sponsor|0|||
161866507|NCT04225715|584553520|FG001|Overall Study|Arm Terminated By Sponsor|0|||
161866508|NCT04225715|584553521|FG002|Overall Study|Arm Terminated By Sponsor|0|||
161866509|NCT04225715|584553522|FG003|Overall Study|Arm Terminated By Sponsor|0|||
161866510|NCT04225715|584553523|FG004|Overall Study|Arm Terminated By Sponsor|0|||
161866511|NCT04225715|584553524|FG005|Overall Study|Arm Terminated By Sponsor|0|||
161866512|NCT04225715|584553525|FG006|Overall Study|Arm Terminated By Sponsor|0|||
161866513|NCT04225715|584553526|FG007|Overall Study|Arm Terminated By Sponsor|17|||
161866514|NCT04225715|584553527|FG008|Overall Study|Arm Terminated By Sponsor|18|||
161866515|NCT04168112|584553528|FG000|Overall Study|Lost to Follow-up|1|||
161866516|NCT04168112|584553529|FG001|Overall Study|Lost to Follow-up|0|||
161866517|NCT04168112|584553528|FG000|Overall Study|Withdrawal by Subject|1|||
161866518|NCT04168112|584553529|FG001|Overall Study|Withdrawal by Subject|0|||
161866519|NCT02275546|584553532|FG000|Treatment Period 2|Withdrawal by Subject|2|||
161866520|NCT02275546|584553533|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161866521|NCT02275546|584553532|FG000|Treatment Period 2|Protocol Violation|0|||
161866522|NCT02275546|584553533|FG001|Treatment Period 2|Protocol Violation|1|||
161866523|NCT00570141|584553543|FG000|Overall Study|Adverse Event|1|||
161866524|NCT00570141|584553543|FG000|Overall Study|Missed visits|1|||
161866525|NCT00570141|584553543|FG000|Overall Study|Lost to Follow-up|1|||
161866526|NCT00925704|584553544|FG000|First Intervention|Withdrew consent|0|||
161866527|NCT00925704|584553545|FG001|First Intervention|Withdrew consent|0|||
161866528|NCT00925704|584553546|FG002|First Intervention|Withdrew consent|0|||
161866529|NCT00925704|584553547|FG003|First Intervention|Withdrew consent|1|||
161866530|NCT00925704|584553548|FG004|First Intervention|Withdrew consent|1|||
161866531|NCT00925704|584553549|FG005|First Intervention|Withdrew consent|0|||
161866532|NCT00925704|584553544|FG000|Second Intervention|Withdrawal by Subject|1|||
161866533|NCT00925704|584553545|FG001|Second Intervention|Withdrawal by Subject|0|||
161866534|NCT00925704|584553546|FG002|Second Intervention|Withdrawal by Subject|0|||
161866535|NCT00925704|584553547|FG003|Second Intervention|Withdrawal by Subject|0|||
161866536|NCT00925704|584553548|FG004|Second Intervention|Withdrawal by Subject|1|||
161866537|NCT00925704|584553549|FG005|Second Intervention|Withdrawal by Subject|0|||
161866538|NCT00925704|584553544|FG000|Third Intervention|Withdrew consent|0|||
161866539|NCT00925704|584553545|FG001|Third Intervention|Withdrew consent|0|||
161866540|NCT00925704|584553546|FG002|Third Intervention|Withdrew consent|0|||
161866541|NCT00925704|584553547|FG003|Third Intervention|Withdrew consent|0|||
161866542|NCT00925704|584553548|FG004|Third Intervention|Withdrew consent|0|||
161866543|NCT00925704|584553549|FG005|Third Intervention|Withdrew consent|1|||
161866544|NCT03922308|584553550|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
161866545|NCT03922308|584553551|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
161866546|NCT03922308|584553552|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
161866547|NCT03922308|584553550|FG000|Overall Study|Lost to Follow-up|1|||
161866548|NCT03922308|584553551|FG001|Overall Study|Lost to Follow-up|0|||
161866549|NCT03922308|584553552|FG002|Overall Study|Lost to Follow-up|0|||
161866550|NCT03922308|584553550|FG000|Overall Study|Reason not Specified|0|||
161866551|NCT03922308|584553551|FG001|Overall Study|Reason not Specified|2|||
161866552|NCT03922308|584553552|FG002|Overall Study|Reason not Specified|1|||
161866553|NCT05005507|584553553|FG000|Overall Study|Premature termination of study|1|||
161866554|NCT02841995|584553554|FG000|Overall Study|Disease progression|5|||
161866555|NCT02841995|584553555|FG001|Overall Study|Disease progression|11|||
161866556|NCT02841995|584553556|FG002|Overall Study|Disease progression|8|||
161866557|NCT02841995|584553554|FG000|Overall Study|Withdrawal by Subject|2|||
161866558|NCT02841995|584553555|FG001|Overall Study|Withdrawal by Subject|4|||
161866559|NCT02841995|584553556|FG002|Overall Study|Withdrawal by Subject|4|||
161866560|NCT02841995|584553554|FG000|Overall Study|Adverse Event|2|||
161866561|NCT02841995|584553555|FG001|Overall Study|Adverse Event|0|||
161866562|NCT02841995|584553556|FG002|Overall Study|Adverse Event|1|||
161866563|NCT02841995|584553554|FG000|Overall Study|Investigator decision|2|||
161866564|NCT02841995|584553555|FG001|Overall Study|Investigator decision|0|||
161866565|NCT02841995|584553556|FG002|Overall Study|Investigator decision|1|||
161866566|NCT02841995|584553554|FG000|Overall Study|Death|0|||
161866567|NCT02841995|584553555|FG001|Overall Study|Death|0|||
161866568|NCT02841995|584553556|FG002|Overall Study|Death|2|||
161866569|NCT02841995|584553554|FG000|Overall Study|Noncompliance to protocol|1|||
161866570|NCT02841995|584553555|FG001|Overall Study|Noncompliance to protocol|0|||
161866571|NCT02841995|584553556|FG002|Overall Study|Noncompliance to protocol|0|||
161866572|NCT02841995|584553554|FG000|Overall Study|Sponsor decision|1|||
161866573|NCT02841995|584553555|FG001|Overall Study|Sponsor decision|0|||
161866574|NCT02841995|584553556|FG002|Overall Study|Sponsor decision|0|||
161866575|NCT02841995|584553554|FG000|Overall Study|Other|4|||
161866576|NCT02841995|584553555|FG001|Overall Study|Other|1|||
161866577|NCT02841995|584553556|FG002|Overall Study|Other|5|||
161866578|NCT02755103|584553564|FG000|Overall Study|Lost to Follow-up|17|||
161866579|NCT02755103|584553565|FG001|Overall Study|Lost to Follow-up|15|||
161866580|NCT02755103|584553564|FG000|Overall Study|Death|0|||
161866581|NCT02755103|584553565|FG001|Overall Study|Death|1|||
161866582|NCT02755103|584553564|FG000|Overall Study|Physician Decision|0|||
161866583|NCT02755103|584553565|FG001|Overall Study|Physician Decision|1|||
161866584|NCT02755103|584553564|FG000|Overall Study|Pregnancy|0|||
161866585|NCT02755103|584553565|FG001|Overall Study|Pregnancy|1|||
161866586|NCT02755103|584553564|FG000|Overall Study|Withdrawal by Subject|3|||
161866587|NCT02755103|584553565|FG001|Overall Study|Withdrawal by Subject|0|||
161866588|NCT02198664|584553571|FG000|Overall Study|Adverse Event|2|||
161866589|NCT02198664|584553572|FG001|Overall Study|Adverse Event|0|||
161866590|NCT02198664|584553571|FG000|Overall Study|Withdrawal by Subject|11|||
161866591|NCT02198664|584553572|FG001|Overall Study|Withdrawal by Subject|8|||
161866592|NCT02198664|584553571|FG000|Overall Study|Failure to tolerate|2|||
161866593|NCT02198664|584553572|FG001|Overall Study|Failure to tolerate|0|||
161866594|NCT02198664|584553571|FG000|Overall Study|Not stated|1|||
161866595|NCT02198664|584553572|FG001|Overall Study|Not stated|0|||
161866596|NCT02632409|584553573|FG000|Randomized|AE unrelated to study Drug|0|||
161866597|NCT02632409|584553574|FG001|Randomized|AE unrelated to study Drug|1|||
161866598|NCT02632409|584553573|FG000|Randomized|Participant withdrew consent|2|||
161866599|NCT02632409|584553574|FG001|Randomized|Participant withdrew consent|1|||
161866600|NCT02632409|584553573|FG000|Randomized|No Longer meets study criteria|5|||
161866601|NCT02632409|584553574|FG001|Randomized|No Longer meets study criteria|0|||
161866602|NCT02632409|584553573|FG000|Randomized|other reasons|1|||
161866603|NCT02632409|584553574|FG001|Randomized|other reasons|0|||
161866604|NCT02632409|584553573|FG000|Treatment Period|Ongoing Treatment|20|||
161866605|NCT02632409|584553574|FG001|Treatment Period|Ongoing Treatment|21|||
161866606|NCT02632409|584553573|FG000|Treatment Period|Disease Recurrence|147|||
161866607|NCT02632409|584553574|FG001|Treatment Period|Disease Recurrence|90|||
161866608|NCT02632409|584553573|FG000|Treatment Period|Study Drug Toxicity|8|||
161866609|NCT02632409|584553574|FG001|Treatment Period|Study Drug Toxicity|49|||
161866610|NCT02632409|584553573|FG000|Treatment Period|Death|1|||
161866611|NCT02632409|584553574|FG001|Treatment Period|Death|0|||
161866612|NCT02632409|584553573|FG000|Treatment Period|AE unrelated to study drug|15|||
161866613|NCT02632409|584553574|FG001|Treatment Period|AE unrelated to study drug|16|||
161866614|NCT02632409|584553573|FG000|Treatment Period|Request to discontinue treatment|4|||
161866615|NCT02632409|584553574|FG001|Treatment Period|Request to discontinue treatment|19|||
161866616|NCT02632409|584553573|FG000|Treatment Period|Participant withdrew consent|7|||
161866617|NCT02632409|584553574|FG001|Treatment Period|Participant withdrew consent|5|||
161866618|NCT02632409|584553573|FG000|Treatment Period|Lost to Follow-up|0|||
161866619|NCT02632409|584553574|FG001|Treatment Period|Lost to Follow-up|1|||
161866620|NCT02632409|584553573|FG000|Treatment Period|Maximum clinical benefit|1|||
161866621|NCT02632409|584553574|FG001|Treatment Period|Maximum clinical benefit|0|||
161866622|NCT02632409|584553573|FG000|Treatment Period|No longer meets study criteria|3|||
161866623|NCT02632409|584553574|FG001|Treatment Period|No longer meets study criteria|0|||
161866624|NCT02632409|584553573|FG000|Treatment Period|Administrative Reason by sponsor|0|||
161866625|NCT02632409|584553574|FG001|Treatment Period|Administrative Reason by sponsor|1|||
161866626|NCT02632409|584553573|FG000|Treatment Period|Other Reasons|10|||
161866627|NCT02632409|584553574|FG001|Treatment Period|Other Reasons|6|||
161866628|NCT01198470|584553575|FG000|Overall Study|Adverse Event|2|||
161866629|NCT01924689|584553576|FG000|Overall Study|Death|0|||
161866630|NCT01924689|584553577|FG001|Overall Study|Death|1|||
161866631|NCT01924689|584553578|FG002|Overall Study|Death|0|||
161866632|NCT01924689|584553579|FG003|Overall Study|Death|1|||
161866633|NCT01924689|584553580|FG004|Overall Study|Death|0|||
161866634|NCT01924689|584553581|FG005|Overall Study|Death|0|||
161866635|NCT01924689|584553576|FG000|Overall Study|Disease progression|0|||
161866636|NCT01924689|584553577|FG001|Overall Study|Disease progression|0|||
161866637|NCT01924689|584553578|FG002|Overall Study|Disease progression|2|||
161866638|NCT01924689|584553579|FG003|Overall Study|Disease progression|0|||
161866639|NCT01924689|584553580|FG004|Overall Study|Disease progression|3|||
161866640|NCT01924689|584553581|FG005|Overall Study|Disease progression|2|||
161866641|NCT01924689|584553576|FG000|Overall Study|New therapy or study|3|||
161866642|NCT01924689|584553577|FG001|Overall Study|New therapy or study|2|||
161866643|NCT01924689|584553578|FG002|Overall Study|New therapy or study|1|||
161866644|NCT01924689|584553579|FG003|Overall Study|New therapy or study|4|||
161866645|NCT01924689|584553580|FG004|Overall Study|New therapy or study|2|||
161866646|NCT01924689|584553581|FG005|Overall Study|New therapy or study|0|||
161866647|NCT01924689|584553576|FG000|Overall Study|Withdrawal of consent|0|||
161866648|NCT01924689|584553577|FG001|Overall Study|Withdrawal of consent|0|||
161866649|NCT01924689|584553578|FG002|Overall Study|Withdrawal of consent|1|||
161866650|NCT01924689|584553579|FG003|Overall Study|Withdrawal of consent|1|||
161866651|NCT01924689|584553580|FG004|Overall Study|Withdrawal of consent|0|||
161866652|NCT01924689|584553581|FG005|Overall Study|Withdrawal of consent|0|||
161866653|NCT01924689|584553576|FG000|Overall Study|Other|0|||
161866654|NCT01924689|584553577|FG001|Overall Study|Other|0|||
161866655|NCT01924689|584553578|FG002|Overall Study|Other|0|||
161866656|NCT01924689|584553579|FG003|Overall Study|Other|0|||
161866657|NCT01924689|584553580|FG004|Overall Study|Other|1|||
161866658|NCT01924689|584553581|FG005|Overall Study|Other|0|||
161866659|NCT05271175|584553583|FG000|One Week Follow up|Lost to Follow-up|10|||
161866660|NCT05271175|584553584|FG001|One Week Follow up|Lost to Follow-up|7|||
161866661|NCT05271175|584553585|FG002|One Week Follow up|Lost to Follow-up|5|||
161866662|NCT05271175|584553583|FG000|One Month Follow up|Lost to Follow-up|12|||
161866663|NCT05271175|584553584|FG001|One Month Follow up|Lost to Follow-up|7|||
161866664|NCT05271175|584553585|FG002|One Month Follow up|Lost to Follow-up|9|||
161866665|NCT05271175|584553583|FG000|Six Months Follow up|Lost to Follow-up|8|||
161866666|NCT05271175|584553584|FG001|Six Months Follow up|Lost to Follow-up|2|||
161866667|NCT05271175|584553585|FG002|Six Months Follow up|Lost to Follow-up|2|||
161866668|NCT02492867|584553586|FG000|Overall Study|Alternate therapy|1|||
161866669|NCT02492867|584553586|FG000|Overall Study|Withdrawal by Subject|2|||
161866670|NCT02492867|584553586|FG000|Overall Study|Disease progression after treatment started|1|||
161866671|NCT02492867|584553586|FG000|Overall Study|Death|1|||
161866672|NCT03296527|584553587|FG000|Overall Study|Adverse Event|15|||
161866673|NCT03296527|584553588|FG001|Overall Study|Adverse Event|33|||
161866674|NCT03296527|584553587|FG000|Overall Study|Protocol Deviation|4|||
161866675|NCT03296527|584553588|FG001|Overall Study|Protocol Deviation|0|||
161866676|NCT03296527|584553587|FG000|Overall Study|Participant withdrew consent|3|||
161866677|NCT03296527|584553588|FG001|Overall Study|Participant withdrew consent|1|||
161866678|NCT03296527|584553587|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
161866679|NCT03296527|584553588|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
161866680|NCT03296527|584553587|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
161866681|NCT03296527|584553588|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
161866682|NCT03296527|584553587|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
161866683|NCT03296527|584553588|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
161866684|NCT03296527|584553587|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
161866685|NCT03296527|584553588|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
161866686|NCT03296527|584553587|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
161866687|NCT03296527|584553588|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
161866688|NCT01597973|584553589|FG000|Overall Study|Found ineligible before study medication started|4|||
161866689|NCT01597973|584553590|FG001|Overall Study|Found ineligible before study medication started|2|||
161866690|NCT01597973|584553589|FG000|Overall Study|Eligible pathogen not confirmed|14|||
161866691|NCT01597973|584553590|FG001|Overall Study|Eligible pathogen not confirmed|15|||
161866692|NCT01597973|584553589|FG000|Overall Study|LAR not authorized to consent|0|||
161866693|NCT01597973|584553590|FG001|Overall Study|LAR not authorized to consent|1|||
161866694|NCT01597973|584553589|FG000|Overall Study|Ineligible due to early seizures|1|||
161866695|NCT01597973|584553590|FG001|Overall Study|Ineligible due to early seizures|0|||
161866696|NCT01597973|584553589|FG000|Overall Study|Ineligible due to non-target infection|1|||
161866697|NCT01597973|584553590|FG001|Overall Study|Ineligible due to non-target infection|1|||
161866698|NCT01326845|584553591|FG000|Overall Study|Administrative Problems|5|||
161866699|NCT01326845|584553592|FG001|Overall Study|Administrative Problems|2|||
161866700|NCT01326845|584553591|FG000|Overall Study|Adverse Event|1|||
161866701|NCT01326845|584553592|FG001|Overall Study|Adverse Event|0|||
161866702|NCT01326845|584553591|FG000|Overall Study|Misisng|1|||
161866703|NCT01326845|584553592|FG001|Overall Study|Misisng|3|||
161866704|NCT00740636|584553596|FG000|Overall Study|Adverse Event|0|||
161866705|NCT00740636|584553597|FG001|Overall Study|Adverse Event|2|||
161866706|NCT00740636|584553596|FG000|Overall Study|Patient Ineligible|0|||
161866707|NCT00740636|584553597|FG001|Overall Study|Patient Ineligible|1|||
161866708|NCT00740636|584553596|FG000|Overall Study|Patient Not Treated|0|||
161866709|NCT00740636|584553597|FG001|Overall Study|Patient Not Treated|1|||
161866710|NCT00740636|584553596|FG000|Overall Study|Progressive Disease|1|||
161866711|NCT00740636|584553597|FG001|Overall Study|Progressive Disease|0|||
161866712|NCT00740636|584553596|FG000|Overall Study|Death|1|||
161866713|NCT00740636|584553597|FG001|Overall Study|Death|0|||
161866714|NCT02174627|584553602|FG000|Overall Study|Missing|0|||
161866715|NCT02174627|584553603|FG001|Overall Study|Missing|1|||
161866716|NCT02174627|584553602|FG000|Overall Study|Incorrect enrolment before randomization|0|||
161866717|NCT02174627|584553603|FG001|Overall Study|Incorrect enrolment before randomization|1|||
161866718|NCT02174627|584553602|FG000|Overall Study|Participant decision|84|||
161866719|NCT02174627|584553603|FG001|Overall Study|Participant decision|128|||
161866720|NCT02166333|584553604|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
161866721|NCT02166333|584553605|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161866722|NCT02166333|584553606|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161866723|NCT02166333|584553607|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161866724|NCT02166333|584553608|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
161866725|NCT02166333|584553609|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
161866726|NCT02166333|584553604|FG000|Stage 1|Death|4|||
161866727|NCT02166333|584553605|FG001|Stage 1|Death|0|||
161866728|NCT02166333|584553606|FG002|Stage 1|Death|2|||
161866729|NCT02166333|584553607|FG003|Stage 1|Death|0|||
161866730|NCT02166333|584553608|FG004|Stage 1|Death|3|||
161866731|NCT02166333|584553609|FG005|Stage 1|Death|2|||
161866732|NCT02166333|584553604|FG000|Stage 1|Lost to Follow-up|12|||
161866733|NCT02166333|584553605|FG001|Stage 1|Lost to Follow-up|0|||
161866734|NCT02166333|584553606|FG002|Stage 1|Lost to Follow-up|6|||
161866735|NCT02166333|584553607|FG003|Stage 1|Lost to Follow-up|0|||
161866736|NCT02166333|584553608|FG004|Stage 1|Lost to Follow-up|3|||
161866737|NCT02166333|584553609|FG005|Stage 1|Lost to Follow-up|3|||
161866738|NCT02166333|584553604|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
161866739|NCT02166333|584553605|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
161866740|NCT02166333|584553606|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
161866741|NCT02166333|584553607|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
161866742|NCT02166333|584553608|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
161866743|NCT02166333|584553609|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
161866744|NCT02166333|584553604|FG000|Stage 2|Death|4|||
161866745|NCT02166333|584553605|FG001|Stage 2|Death|2|||
161866746|NCT02166333|584553606|FG002|Stage 2|Death|1|||
161866747|NCT02166333|584553607|FG003|Stage 2|Death|0|||
161866748|NCT02166333|584553608|FG004|Stage 2|Death|0|||
161866749|NCT02166333|584553609|FG005|Stage 2|Death|1|||
161866750|NCT02166333|584553604|FG000|Stage 2|Lost to Follow-up|23|||
161866751|NCT02166333|584553605|FG001|Stage 2|Lost to Follow-up|4|||
161866752|NCT02166333|584553606|FG002|Stage 2|Lost to Follow-up|11|||
161866753|NCT02166333|584553607|FG003|Stage 2|Lost to Follow-up|9|||
161866754|NCT02166333|584553608|FG004|Stage 2|Lost to Follow-up|3|||
161866755|NCT02166333|584553609|FG005|Stage 2|Lost to Follow-up|6|||
161866756|NCT02269098|584553610|FG000|Overall Study|Lost to Follow-up|14|||
161866757|NCT02269098|584553611|FG001|Overall Study|Lost to Follow-up|9|||
161866758|NCT00503698|584553612|FG000|Overall Study|Protocol Violation|5|||
161866759|NCT00503698|584553613|FG001|Overall Study|Protocol Violation|6|||
161866760|NCT00503698|584553612|FG000|Overall Study|Adverse Event|52|||
161866761|NCT00503698|584553613|FG001|Overall Study|Adverse Event|41|||
161866762|NCT00503698|584553612|FG000|Overall Study|Death|1|||
161866763|NCT00503698|584553613|FG001|Overall Study|Death|0|||
161866764|NCT00503698|584553612|FG000|Overall Study|Lack of Efficacy|3|||
161866765|NCT00503698|584553613|FG001|Overall Study|Lack of Efficacy|4|||
161866766|NCT00503698|584553612|FG000|Overall Study|Trial terminated|216|||
161866767|NCT00503698|584553613|FG001|Overall Study|Trial terminated|253|||
161866768|NCT00503698|584553612|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
161866769|NCT00503698|584553613|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
161866770|NCT00503698|584553612|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
161866771|NCT00503698|584553613|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
161866772|NCT00503698|584553612|FG000|Overall Study|Any condition in exclusion criteria|4|||
161866773|NCT00503698|584553613|FG001|Overall Study|Any condition in exclusion criteria|6|||
161866774|NCT00503698|584553612|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
161866775|NCT00503698|584553613|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
161866776|NCT00503698|584553612|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
161866777|NCT00503698|584553613|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
161866778|NCT00503698|584553612|FG000|Overall Study|Critically ill|2|||
161866779|NCT00503698|584553613|FG001|Overall Study|Critically ill|0|||
161866780|NCT00503698|584553612|FG000|Overall Study|Unclassified|48|||
161866781|NCT00503698|584553613|FG001|Overall Study|Unclassified|32|||
161866782|NCT00503698|584553612|FG000|Overall Study|Not exposed to trial drug|11|||
161866783|NCT00503698|584553613|FG001|Overall Study|Not exposed to trial drug|6|||
161866784|NCT00682786|584553619|FG000|Overall Study|Withdrawal by Subject|2|||
161866785|NCT00682786|584553620|FG001|Overall Study|Withdrawal by Subject|2|||
161866786|NCT00682786|584553619|FG000|Overall Study|Did not receive irinotecan|0|||
161866787|NCT00682786|584553620|FG001|Overall Study|Did not receive irinotecan|1|||
161866788|NCT03644342|584553621|FG000|Overall Study|Adverse Event|2|||
161866789|NCT03644342|584553622|FG001|Overall Study|Adverse Event|0|||
161866790|NCT03644342|584553621|FG000|Overall Study|Protocol Violation|0|||
161866791|NCT03644342|584553622|FG001|Overall Study|Protocol Violation|1|||
161866792|NCT02462603|584553625|FG000|Overall Study|Investigator Decision|1|||
161866793|NCT02462603|584553625|FG000|Overall Study|Non-Compliance|1|||
161866794|NCT02462603|584553625|FG000|Overall Study|Withdrawal by Subject|2|||
161866795|NCT01591096|584553626|FG000|Overall Study|Adverse Event|1|||
161866796|NCT01831635|584553627|FG000|Overall Study|Withdrawal by Subject|0|||
161866797|NCT01831635|584553628|FG001|Overall Study|Withdrawal by Subject|2|||
161866798|NCT01831635|584553629|FG002|Overall Study|Withdrawal by Subject|0|||
161866799|NCT03655405|584553632|FG000|Overall Study|Death after initial data collection|4|||
161866800|NCT03655405|584553633|FG001|Overall Study|Death after initial data collection|2|||
161866801|NCT03655405|584553632|FG000|Overall Study|Died before initial data collection|1|||
161866802|NCT03655405|584553633|FG001|Overall Study|Died before initial data collection|2|||
161866803|NCT03655405|584553632|FG000|Overall Study|Protocol Violation|0|||
161866804|NCT03655405|584553633|FG001|Overall Study|Protocol Violation|1|||
161774293|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Other|0|||
161774294|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Other|0|||
161774295|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Other|0|||
161774296|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774297|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774298|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774299|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774300|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774301|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774302|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774303|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774304|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774305|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774306|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774307|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774308|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
161774309|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774310|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774311|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
161774312|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774313|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774314|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774315|NCT04668066|584216030|FG000|Part 1: Follow-Up|Adverse Event|0|||
161774316|NCT04668066|584216031|FG001|Part 1: Follow-Up|Adverse Event|0|||
161774317|NCT04668066|584216032|FG002|Part 1: Follow-Up|Adverse Event|0|||
161774318|NCT04668066|584216033|FG003|Part 1: Follow-Up|Adverse Event|0|||
161774319|NCT04668066|584216034|FG004|Part 1: Follow-Up|Adverse Event|0|||
161774320|NCT04668066|584216035|FG005|Part 1: Follow-Up|Adverse Event|0|||
161774321|NCT04668066|584216036|FG006|Part 1: Follow-Up|Adverse Event|0|||
161774322|NCT04668066|584216037|FG007|Part 1: Follow-Up|Adverse Event|0|||
161774323|NCT04668066|584216038|FG008|Part 1: Follow-Up|Adverse Event|0|||
161774324|NCT04668066|584216039|FG009|Part 1: Follow-Up|Adverse Event|0|||
161774325|NCT04668066|584216040|FG010|Part 1: Follow-Up|Adverse Event|0|||
161774326|NCT04668066|584216041|FG011|Part 1: Follow-Up|Adverse Event|1|||
161774327|NCT04668066|584216042|FG012|Part 1: Follow-Up|Adverse Event|0|||
161774328|NCT04668066|584216043|FG013|Part 1: Follow-Up|Adverse Event|0|||
161774329|NCT04668066|584216044|FG014|Part 1: Follow-Up|Adverse Event|0|||
161774330|NCT04668066|584216045|FG015|Part 1: Follow-Up|Adverse Event|0|||
161774331|NCT04668066|584216046|FG016|Part 1: Follow-Up|Adverse Event|0|||
161774332|NCT04668066|584216047|FG017|Part 1: Follow-Up|Adverse Event|0|||
161866805|NCT01991743|584553634|FG000|Overall Study|external cephalic version not performed|0|||
161866806|NCT01991743|584553635|FG001|Overall Study|external cephalic version not performed|0|||
161866807|NCT01991743|584553636|FG002|Overall Study|external cephalic version not performed|1|||
161866808|NCT01991743|584553637|FG003|Overall Study|external cephalic version not performed|0|||
161866809|NCT04050462|584555579|FG000|Overall Study|Withdrawal by Subject|1|||
161866810|NCT04050462|584555580|FG001|Overall Study|Withdrawal by Subject|0|||
161866811|NCT04050462|584555581|FG002|Overall Study|Withdrawal by Subject|0|||
161866812|NCT05151744|584555582|FG000|Overall Study|Adverse Event|6|||
161866813|NCT05151744|584555583|FG001|Overall Study|Adverse Event|2|||
161866814|NCT05151744|584555582|FG000|Overall Study|Death|1|||
161866815|NCT05151744|584555583|FG001|Overall Study|Death|2|||
161866816|NCT05151744|584555582|FG000|Overall Study|Lack of Efficacy|1|||
161866817|NCT05151744|584555583|FG001|Overall Study|Lack of Efficacy|1|||
161866818|NCT05151744|584555582|FG000|Overall Study|Lost to Follow-up|2|||
161866819|NCT05151744|584555583|FG001|Overall Study|Lost to Follow-up|2|||
161866820|NCT05151744|584555582|FG000|Overall Study|Need for Rescue Treatment|0|||
161866821|NCT05151744|584555583|FG001|Overall Study|Need for Rescue Treatment|1|||
161866822|NCT05151744|584555582|FG000|Overall Study|Non-compliance with Study Drug|0|||
161866823|NCT05151744|584555583|FG001|Overall Study|Non-compliance with Study Drug|1|||
161866824|NCT05151744|584555582|FG000|Overall Study|Reason not Specified|10|||
161866825|NCT05151744|584555583|FG001|Overall Study|Reason not Specified|0|||
161866826|NCT05151744|584555582|FG000|Overall Study|Physician Decision|2|||
161866827|NCT05151744|584555583|FG001|Overall Study|Physician Decision|1|||
161866828|NCT05151744|584555582|FG000|Overall Study|Protocol Violation|1|||
161866829|NCT05151744|584555583|FG001|Overall Study|Protocol Violation|0|||
161866830|NCT05151744|584555582|FG000|Overall Study|Withdrawal by Subject|6|||
161866831|NCT05151744|584555583|FG001|Overall Study|Withdrawal by Subject|3|||
161866832|NCT01682226|584555586|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
161866833|NCT01682226|584555586|FG000|Overall Study|Participants did not receive treatment|2|||
161866834|NCT01682226|584555586|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
161866835|NCT03771898|584555595|FG000|Overall Study|Adverse Event|1|||
161866836|NCT03771898|584555596|FG001|Overall Study|Adverse Event|0|||
161866837|NCT03771898|584555597|FG002|Overall Study|Adverse Event|0|||
161866838|NCT03771898|584555598|FG003|Overall Study|Adverse Event|0|||
161866839|NCT03771898|584555599|FG004|Overall Study|Adverse Event|0|||
161866840|NCT03771898|584555595|FG000|Overall Study|Lost to Follow-up|1|||
161866841|NCT03771898|584555596|FG001|Overall Study|Lost to Follow-up|1|||
161866842|NCT03771898|584555597|FG002|Overall Study|Lost to Follow-up|1|||
161866843|NCT03771898|584555598|FG003|Overall Study|Lost to Follow-up|0|||
161866844|NCT03771898|584555599|FG004|Overall Study|Lost to Follow-up|0|||
161866845|NCT03771898|584555595|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161866846|NCT03771898|584555596|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161866847|NCT03771898|584555597|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161866848|NCT03771898|584555598|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161866849|NCT03771898|584555599|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161866850|NCT03771898|584555595|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866851|NCT03771898|584555596|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866852|NCT03771898|584555597|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866853|NCT03771898|584555598|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866854|NCT03771898|584555599|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
161866855|NCT03123120|584555600|FG000|Overall Study|Lost to Follow-up|0|||
161866856|NCT03123120|584555601|FG001|Overall Study|Lost to Follow-up|1|||
161866857|NCT03123120|584555600|FG000|Overall Study|Withdrawal by Subject|0|||
161866858|NCT03123120|584555601|FG001|Overall Study|Withdrawal by Subject|1|||
161866859|NCT03135548|584555605|FG000|Overall Study|Lost to Follow-up|3|||
161866860|NCT03135548|584555606|FG001|Overall Study|Lost to Follow-up|0|||
161866861|NCT03135548|584555607|FG002|Overall Study|Lost to Follow-up|0|||
161866862|NCT03135548|584555605|FG000|Overall Study|Withdrawal by Subject|2|||
161866863|NCT03135548|584555606|FG001|Overall Study|Withdrawal by Subject|2|||
161866864|NCT03135548|584555607|FG002|Overall Study|Withdrawal by Subject|1|||
161866865|NCT03135548|584555605|FG000|Overall Study|Other than listed|0|||
161866866|NCT03135548|584555606|FG001|Overall Study|Other than listed|2|||
161866867|NCT03135548|584555607|FG002|Overall Study|Other than listed|2|||
161866868|NCT02632175|584555608|FG000|Overall Study|Withdrawal by Subject|6|||
161866869|NCT02632175|584555608|FG000|Overall Study|Lost to Follow-up|1|||
161866870|NCT02632175|584555608|FG000|Overall Study|Lack of Efficacy|18|||
161866871|NCT02632175|584555608|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
161866872|NCT02632175|584555608|FG000|Overall Study|Subject noncompliance|3|||
161866873|NCT02632175|584555608|FG000|Overall Study|other|2|||
161866874|NCT02088554|584555609|FG000|Overall Study|Exited before procedure|130|||
161866875|NCT02088554|584555609|FG000|Overall Study|Attempted but not implanted|31|||
161866876|NCT02088554|584555609|FG000|Overall Study|Implant not attempted|19|||
161866877|NCT02088554|584555609|FG000|Overall Study|Pending next visit|532|||
161866878|NCT02088554|584555609|FG000|Overall Study|Death|170|||
161866879|NCT02088554|584555609|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
161866880|NCT02088554|584555609|FG000|Overall Study|Lost to Follow-up|23|||
161866881|NCT02088554|584555609|FG000|Overall Study|Explanted|32|||
161866882|NCT02088554|584555609|FG000|Overall Study|Any other reason not covered by previous categories|11|||
161866883|NCT04623216|584555610|FG000|Overall Study|Death|5|||
161866884|NCT04623216|584555611|FG001|Overall Study|Death|2|||
161866885|NCT04623216|584555612|FG002|Overall Study|Death|0|||
161866886|NCT04623216|584555613|FG003|Overall Study|Death|0|||
161866887|NCT04623216|584555610|FG000|Overall Study|Terminated by Sponsor|3|||
161866888|NCT04623216|584555611|FG001|Overall Study|Terminated by Sponsor|2|||
161866889|NCT04623216|584555612|FG002|Overall Study|Terminated by Sponsor|2|||
161866890|NCT04623216|584555613|FG003|Overall Study|Terminated by Sponsor|0|||
161866891|NCT04623216|584555610|FG000|Overall Study|Physician Decision|1|||
161866892|NCT04623216|584555611|FG001|Overall Study|Physician Decision|0|||
161866893|NCT04623216|584555612|FG002|Overall Study|Physician Decision|0|||
161866894|NCT04623216|584555613|FG003|Overall Study|Physician Decision|0|||
161866895|NCT03521154|584555616|FG000|Overall Study|Ongoing study at data cut-off|111|||
161866896|NCT03521154|584555617|FG001|Overall Study|Ongoing study at data cut-off|52|||
161866897|NCT04632927|584555618|FG000|Overall Study|Adverse Event|0|||
161866898|NCT04632927|584555619|FG001|Overall Study|Adverse Event|1|||
161866899|NCT04632927|584555618|FG000|Overall Study|Lack of Efficacy|0|||
161866900|NCT04632927|584555619|FG001|Overall Study|Lack of Efficacy|4|||
161866901|NCT04632927|584555618|FG000|Overall Study|Loss of efficacy|0|||
161866902|NCT04632927|584555619|FG001|Overall Study|Loss of efficacy|1|||
161866903|NCT04632927|584555618|FG000|Overall Study|Non-compliance with study drug|0|||
161866904|NCT04632927|584555619|FG001|Overall Study|Non-compliance with study drug|1|||
161866905|NCT04632927|584555618|FG000|Overall Study|Physician Decision|0|||
161866906|NCT04632927|584555619|FG001|Overall Study|Physician Decision|1|||
161866907|NCT04632927|584555618|FG000|Overall Study|Subject decision|0|||
161866908|NCT04632927|584555619|FG001|Overall Study|Subject decision|1|||
161866909|NCT04632927|584555618|FG000|Overall Study|Withdrawal by Subject|0|||
161866910|NCT04632927|584555619|FG001|Overall Study|Withdrawal by Subject|1|||
161866911|NCT03827291|584555620|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
161866912|NCT03827291|584555621|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
161866913|NCT04795466|584555622|FG000|Overall Study|Adverse Event|3|||
161866914|NCT04795466|584555623|FG001|Overall Study|Adverse Event|1|||
161866915|NCT04795466|584555622|FG000|Overall Study|Physician Decision|1|||
161866916|NCT04795466|584555623|FG001|Overall Study|Physician Decision|0|||
161866917|NCT04795466|584555622|FG000|Overall Study|Withdrawal by Subject|2|||
161866918|NCT04795466|584555623|FG001|Overall Study|Withdrawal by Subject|1|||
161866919|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
161866920|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
161866921|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
161866922|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
161866923|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
161866924|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
161866925|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Death|0|||
161866926|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Death|0|||
161866927|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Death|0|||
161866928|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Death|0|||
161866929|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Death|0|||
161866930|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Death|2|||
161866931|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866932|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866933|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866934|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866935|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866936|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
161866937|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866938|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866939|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866940|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866941|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
161866942|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866943|NCT00866281|584555641|FG000|Overall Study|Adverse Event|1|||
161866944|NCT00866281|584555642|FG001|Overall Study|Adverse Event|0|||
161866945|NCT00866281|584555641|FG000|Overall Study|Withdrawal by participants|3|||
161866946|NCT00866281|584555642|FG001|Overall Study|Withdrawal by participants|0|||
161866947|NCT00866281|584555641|FG000|Overall Study|Disease progression|3|||
161866948|NCT00866281|584555642|FG001|Overall Study|Disease progression|11|||
161866949|NCT00866281|584555641|FG000|Overall Study|New cancer therapy|0|||
161866950|NCT00866281|584555642|FG001|Overall Study|New cancer therapy|4|||
161866951|NCT00529087|584555645|FG000|Overall Study|Adverse Event|10|||
161866952|NCT00529087|584555646|FG001|Overall Study|Adverse Event|13|||
161866953|NCT00529087|584555647|FG002|Overall Study|Adverse Event|4|||
161866954|NCT00529087|584555645|FG000|Overall Study|Lost to Follow-up|6|||
161866955|NCT00529087|584555646|FG001|Overall Study|Lost to Follow-up|4|||
161866956|NCT00529087|584555647|FG002|Overall Study|Lost to Follow-up|1|||
161866957|NCT00529087|584555645|FG000|Overall Study|Protocol Violation|8|||
161866958|NCT00529087|584555646|FG001|Overall Study|Protocol Violation|7|||
161866959|NCT00529087|584555647|FG002|Overall Study|Protocol Violation|6|||
161866960|NCT00529087|584555645|FG000|Overall Study|Withdrawal by Subject|3|||
161866961|NCT00529087|584555646|FG001|Overall Study|Withdrawal by Subject|3|||
161866962|NCT00529087|584555647|FG002|Overall Study|Withdrawal by Subject|3|||
161866963|NCT00529087|584555645|FG000|Overall Study|Protocol deviation|1|||
161866964|NCT00529087|584555646|FG001|Overall Study|Protocol deviation|1|||
161866965|NCT00529087|584555647|FG002|Overall Study|Protocol deviation|2|||
161866966|NCT02955355|584555653|FG000|Overall Study|Adverse Event|4|||
161866967|NCT02955355|584555653|FG000|Overall Study|Death|1|||
161866968|NCT02955355|584555653|FG000|Overall Study|Physician Decision|21|||
161866969|NCT02955355|584555653|FG000|Overall Study|Site Terminated by Sponsor|35|||
161866970|NCT02955355|584555653|FG000|Overall Study|Withdrawal by Subject|19|||
161866971|NCT02955355|584555653|FG000|Overall Study|Reason Not Specified|5|||
161866972|NCT02612623|584555654|FG000|Overall Study|Withdrawal by Subject|0|||
161866973|NCT02612623|584555655|FG001|Overall Study|Withdrawal by Subject|1|||
161866974|NCT02612623|584555656|FG002|Overall Study|Withdrawal by Subject|0|||
161866975|NCT02612623|584555657|FG003|Overall Study|Withdrawal by Subject|0|||
161866976|NCT02612623|584555654|FG000|Overall Study|Adverse Event|1|||
161866977|NCT02612623|584555655|FG001|Overall Study|Adverse Event|0|||
161866978|NCT02612623|584555656|FG002|Overall Study|Adverse Event|1|||
161866979|NCT02612623|584555657|FG003|Overall Study|Adverse Event|0|||
161866980|NCT03168711|584555659|FG000|Overall Study|Adverse Event|2|||
161866981|NCT03168711|584555660|FG001|Overall Study|Adverse Event|0|||
161866982|NCT03168711|584555659|FG000|Overall Study|Withdrawal by Subject|0|||
161866983|NCT03168711|584555660|FG001|Overall Study|Withdrawal by Subject|1|||
161866984|NCT03168711|584555659|FG000|Overall Study|Death|0|||
161866985|NCT03168711|584555660|FG001|Overall Study|Death|1|||
161866986|NCT01671007|584555665|FG000|Overall Study|Other reasons than listed|166|||
161866987|NCT01671007|584555666|FG001|Overall Study|Other reasons than listed|373|||
161866988|NCT01671007|584555667|FG002|Overall Study|Other reasons than listed|197|||
161866989|NCT01671007|584555668|FG003|Overall Study|Other reasons than listed|228|||
161866990|NCT01671007|584555669|FG004|Overall Study|Other reasons than listed|14|||
161866991|NCT01671007|584555670|FG005|Overall Study|Other reasons than listed|71|||
161866992|NCT01671007|584555671|FG006|Overall Study|Other reasons than listed|17|||
161866993|NCT01671007|584555672|FG007|Overall Study|Other reasons than listed|66|||
161866994|NCT01671007|584555673|FG008|Overall Study|Other reasons than listed|0|||
161866995|NCT01671007|584555665|FG000|Overall Study|Withdrawal by Subject|36|||
161866996|NCT01671007|584555666|FG001|Overall Study|Withdrawal by Subject|59|||
161866997|NCT01671007|584555667|FG002|Overall Study|Withdrawal by Subject|53|||
161866998|NCT01671007|584555668|FG003|Overall Study|Withdrawal by Subject|58|||
161866999|NCT01671007|584555669|FG004|Overall Study|Withdrawal by Subject|4|||
161867000|NCT01671007|584555670|FG005|Overall Study|Withdrawal by Subject|15|||
161867001|NCT01671007|584555671|FG006|Overall Study|Withdrawal by Subject|1|||
161867002|NCT01671007|584555672|FG007|Overall Study|Withdrawal by Subject|19|||
161867003|NCT01671007|584555673|FG008|Overall Study|Withdrawal by Subject|0|||
161867004|NCT01671007|584555665|FG000|Overall Study|Lost to Follow-up|93|||
161867005|NCT01671007|584555666|FG001|Overall Study|Lost to Follow-up|142|||
161867006|NCT01671007|584555667|FG002|Overall Study|Lost to Follow-up|91|||
161867007|NCT01671007|584555668|FG003|Overall Study|Lost to Follow-up|63|||
161867008|NCT01671007|584555669|FG004|Overall Study|Lost to Follow-up|7|||
161867009|NCT01671007|584555670|FG005|Overall Study|Lost to Follow-up|20|||
161867010|NCT01671007|584555671|FG006|Overall Study|Lost to Follow-up|2|||
161867011|NCT01671007|584555672|FG007|Overall Study|Lost to Follow-up|28|||
161867012|NCT01671007|584555673|FG008|Overall Study|Lost to Follow-up|0|||
161867013|NCT01671007|584555665|FG000|Overall Study|No end of study case report form|3|||
161867014|NCT01671007|584555666|FG001|Overall Study|No end of study case report form|1|||
161867015|NCT01671007|584555667|FG002|Overall Study|No end of study case report form|0|||
161867016|NCT01671007|584555668|FG003|Overall Study|No end of study case report form|2|||
161867017|NCT01671007|584555669|FG004|Overall Study|No end of study case report form|0|||
161867018|NCT01671007|584555670|FG005|Overall Study|No end of study case report form|0|||
161867019|NCT01671007|584555671|FG006|Overall Study|No end of study case report form|0|||
161867020|NCT01671007|584555672|FG007|Overall Study|No end of study case report form|0|||
161867021|NCT01671007|584555673|FG008|Overall Study|No end of study case report form|0|||
161867022|NCT01671007|584555665|FG000|Overall Study|Not eligible|23|||
161867023|NCT01671007|584555666|FG001|Overall Study|Not eligible|76|||
161867024|NCT01671007|584555667|FG002|Overall Study|Not eligible|25|||
161867025|NCT01671007|584555668|FG003|Overall Study|Not eligible|17|||
161867026|NCT01671007|584555669|FG004|Overall Study|Not eligible|0|||
161867027|NCT01671007|584555670|FG005|Overall Study|Not eligible|6|||
161867028|NCT01671007|584555671|FG006|Overall Study|Not eligible|1|||
161867029|NCT01671007|584555672|FG007|Overall Study|Not eligible|19|||
161867030|NCT01671007|584555673|FG008|Overall Study|Not eligible|0|||
161867031|NCT03877068|584555674|FG000|Overall Study|Physician Decision|9|||
161867032|NCT03877068|584555675|FG001|Overall Study|Physician Decision|3|||
161867033|NCT00449865|584555676|FG000|Overall Study|Withdrawal by Subject|110|||
161867034|NCT00449865|584555677|FG001|Overall Study|Withdrawal by Subject|110|||
161867035|NCT00449865|584555676|FG000|Overall Study|Lost to Follow-up|36|||
161867036|NCT00449865|584555677|FG001|Overall Study|Lost to Follow-up|37|||
161867037|NCT00449865|584555676|FG000|Overall Study|Physician Decision|13|||
161867038|NCT00449865|584555677|FG001|Overall Study|Physician Decision|12|||
161867039|NCT00449865|584555676|FG000|Overall Study|Death|31|||
161867040|NCT00449865|584555677|FG001|Overall Study|Death|40|||
161867041|NCT00449865|584555676|FG000|Overall Study|Protocol Violation|8|||
161867042|NCT00449865|584555677|FG001|Overall Study|Protocol Violation|7|||
161867043|NCT00449865|584555676|FG000|Overall Study|Study was stopped|324|||
161867044|NCT00449865|584555677|FG001|Overall Study|Study was stopped|328|||
161867045|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
161867046|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161867047|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
161867048|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
161867049|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
161867050|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
161867051|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
161867052|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
161867053|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
161867054|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
161867055|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
161867056|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
161867057|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
161867058|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
161867059|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
161867060|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
161867061|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
161867062|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
161867063|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
161867064|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
161867065|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
161867066|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
161867067|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
161867068|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
161774333|NCT04668066|584216048|FG018|Part 1: Follow-Up|Adverse Event|0|||
161774334|NCT04668066|584216030|FG000|Part 1: Follow-Up|Other|0|||
161774335|NCT04668066|584216031|FG001|Part 1: Follow-Up|Other|0|||
161774336|NCT04668066|584216032|FG002|Part 1: Follow-Up|Other|0|||
161774337|NCT04668066|584216033|FG003|Part 1: Follow-Up|Other|0|||
161774338|NCT04668066|584216034|FG004|Part 1: Follow-Up|Other|0|||
161774339|NCT04668066|584216035|FG005|Part 1: Follow-Up|Other|0|||
161774340|NCT04668066|584216036|FG006|Part 1: Follow-Up|Other|0|||
161774341|NCT04668066|584216037|FG007|Part 1: Follow-Up|Other|0|||
161774342|NCT04668066|584216038|FG008|Part 1: Follow-Up|Other|0|||
161774343|NCT04668066|584216039|FG009|Part 1: Follow-Up|Other|0|||
161774344|NCT04668066|584216040|FG010|Part 1: Follow-Up|Other|0|||
161774345|NCT04668066|584216041|FG011|Part 1: Follow-Up|Other|1|||
161774346|NCT04668066|584216042|FG012|Part 1: Follow-Up|Other|1|||
161774347|NCT04668066|584216043|FG013|Part 1: Follow-Up|Other|0|||
161774348|NCT04668066|584216044|FG014|Part 1: Follow-Up|Other|0|||
161774349|NCT04668066|584216045|FG015|Part 1: Follow-Up|Other|0|||
161774350|NCT04668066|584216046|FG016|Part 1: Follow-Up|Other|0|||
161774351|NCT04668066|584216047|FG017|Part 1: Follow-Up|Other|0|||
161774352|NCT04668066|584216048|FG018|Part 1: Follow-Up|Other|0|||
161774353|NCT04668066|584216030|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774354|NCT04668066|584216031|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774355|NCT04668066|584216032|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774356|NCT04668066|584216033|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774357|NCT04668066|584216034|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774358|NCT04668066|584216035|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774359|NCT04668066|584216036|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774360|NCT04668066|584216037|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774361|NCT04668066|584216038|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774362|NCT04668066|584216039|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774363|NCT04668066|584216040|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774364|NCT04668066|584216041|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774365|NCT04668066|584216042|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
161774366|NCT04668066|584216043|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774367|NCT04668066|584216044|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774368|NCT04668066|584216045|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
161774369|NCT04668066|584216046|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774370|NCT04668066|584216047|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774371|NCT04668066|584216048|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774372|NCT04668066|584216030|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774373|NCT04668066|584216031|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774374|NCT04668066|584216032|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774375|NCT04668066|584216033|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774376|NCT04668066|584216034|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774377|NCT04668066|584216035|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774378|NCT04668066|584216036|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774379|NCT04668066|584216037|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774380|NCT04668066|584216038|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774381|NCT04668066|584216039|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774382|NCT04668066|584216040|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774383|NCT04668066|584216041|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774384|NCT04668066|584216042|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774385|NCT04668066|584216043|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774386|NCT04668066|584216044|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774387|NCT04668066|584216045|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774388|NCT04668066|584216046|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774389|NCT04668066|584216047|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774390|NCT04668066|584216048|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
161774391|NCT04668066|584216030|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774392|NCT04668066|584216031|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774393|NCT04668066|584216032|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774394|NCT04668066|584216033|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774395|NCT04668066|584216034|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774396|NCT04668066|584216035|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774397|NCT04668066|584216036|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774398|NCT04668066|584216037|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774399|NCT04668066|584216038|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774400|NCT04668066|584216039|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774401|NCT04668066|584216040|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774402|NCT04668066|584216041|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774403|NCT04668066|584216042|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774404|NCT04668066|584216043|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774405|NCT04668066|584216044|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774406|NCT04668066|584216045|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774407|NCT04668066|584216046|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774408|NCT04668066|584216047|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774409|NCT04668066|584216048|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
161867069|NCT03252535|584555680|FG000|Overall Study|Withdrawal by Subject|1|||
161867070|NCT03252535|584555681|FG001|Overall Study|Withdrawal by Subject|0|||
161867071|NCT03252535|584555682|FG002|Overall Study|Withdrawal by Subject|0|||
161867072|NCT03252535|584555680|FG000|Overall Study|Physician Decision|0|||
161867073|NCT03252535|584555681|FG001|Overall Study|Physician Decision|1|||
161867074|NCT03252535|584555682|FG002|Overall Study|Physician Decision|0|||
161867075|NCT03252535|584555680|FG000|Overall Study|Met discontinuation criteria|0|||
161867076|NCT03252535|584555681|FG001|Overall Study|Met discontinuation criteria|1|||
161867077|NCT03252535|584555682|FG002|Overall Study|Met discontinuation criteria|0|||
161867078|NCT04426006|584555683|FG000|Inclusion|Protocol Violation|1|||
161867079|NCT04426006|584555683|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
161867080|NCT04426006|584555683|FG000|Inclusion|Blood sample at inclusion not done|1|||
161867081|NCT04426006|584555683|FG000|3 Months|Lost to Follow-up|17|||
161867082|NCT04426006|584555683|FG000|12 Months|Lost to Follow-up|38|||
161867083|NCT01262872|584555686|FG000|Step 2|Death|0|||
161867084|NCT01262872|584555687|FG001|Step 2|Death|0|||
161867085|NCT01262872|584555688|FG002|Step 2|Death|0|||
161867086|NCT01262872|584555689|FG003|Step 2|Death|1|||
161867087|NCT01262872|584555690|FG004|Step 2|Death|0|||
161867088|NCT01262872|584555691|FG005|Step 2|Death|2|||
161867089|NCT01262872|584555692|FG006|Step 2|Death|2|||
161867090|NCT01262872|584555693|FG007|Step 2|Death|1|||
161867091|NCT01262872|584555686|FG000|Step 2|Protocol Violation|0|||
161867092|NCT01262872|584555687|FG001|Step 2|Protocol Violation|0|||
161867093|NCT01262872|584555688|FG002|Step 2|Protocol Violation|1|||
161867094|NCT01262872|584555689|FG003|Step 2|Protocol Violation|0|||
161867095|NCT01262872|584555690|FG004|Step 2|Protocol Violation|0|||
161867096|NCT01262872|584555691|FG005|Step 2|Protocol Violation|0|||
161867097|NCT01262872|584555692|FG006|Step 2|Protocol Violation|3|||
161867098|NCT01262872|584555693|FG007|Step 2|Protocol Violation|1|||
161867099|NCT01262872|584555686|FG000|Step 2|Withdrawal by Subject|0|||
161867100|NCT01262872|584555687|FG001|Step 2|Withdrawal by Subject|0|||
161867101|NCT01262872|584555688|FG002|Step 2|Withdrawal by Subject|4|||
161867102|NCT01262872|584555689|FG003|Step 2|Withdrawal by Subject|6|||
161867103|NCT01262872|584555690|FG004|Step 2|Withdrawal by Subject|3|||
161867104|NCT01262872|584555691|FG005|Step 2|Withdrawal by Subject|1|||
161867105|NCT01262872|584555692|FG006|Step 2|Withdrawal by Subject|2|||
161867106|NCT01262872|584555693|FG007|Step 2|Withdrawal by Subject|1|||
161867107|NCT01262872|584555686|FG000|Step 2|Migrated/moved from study area|0|||
161867108|NCT01262872|584555687|FG001|Step 2|Migrated/moved from study area|0|||
161867109|NCT01262872|584555688|FG002|Step 2|Migrated/moved from study area|4|||
161867110|NCT01262872|584555689|FG003|Step 2|Migrated/moved from study area|3|||
161867111|NCT01262872|584555690|FG004|Step 2|Migrated/moved from study area|2|||
161867112|NCT01262872|584555691|FG005|Step 2|Migrated/moved from study area|6|||
161867113|NCT01262872|584555692|FG006|Step 2|Migrated/moved from study area|2|||
161867114|NCT01262872|584555693|FG007|Step 2|Migrated/moved from study area|3|||
161867115|NCT01000155|584555696|FG000|Overall Study|Withdrawal by Subject|1|||
161867116|NCT01000155|584555696|FG000|Overall Study|Adverse Event|1|||
161867117|NCT00720213|584555699|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
161867118|NCT00720213|584555700|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
161867119|NCT00720213|584555701|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
161867120|NCT01808066|584555705|FG000|Overall Study|Withdrawal by Subject|15|||
161867121|NCT02949973|584555710|FG000|Overall Study|Physician Decision|1|||
161867122|NCT01252095|584555711|FG000|Overall Study|Disease progression|1|||
161867123|NCT01252095|584555712|FG001|Overall Study|Disease progression|0|||
161867124|NCT01420068|584555713|FG000|Overall Study|Administrative problems|1|||
161867125|NCT01420068|584555714|FG001|Overall Study|Administrative problems|3|||
161867126|NCT01420068|584555713|FG000|Overall Study|Withdrawal by Subject|1|||
161867127|NCT01420068|584555714|FG001|Overall Study|Withdrawal by Subject|2|||
161867128|NCT00365794|584555715|FG000|Overall Study|Withdrawal by Subject|2|||
161867129|NCT00586703|584555716|FG000|Overall Study|Death|12|||
161867130|NCT04760626|584555717|FG000|Overall Study|Withdrawal by Subject|24|||
161867131|NCT04760626|584555718|FG001|Overall Study|Withdrawal by Subject|20|||
161867132|NCT04760626|584555717|FG000|Overall Study|Lost to Follow-up|14|||
161867133|NCT04760626|584555718|FG001|Overall Study|Lost to Follow-up|19|||
161867134|NCT04760626|584555717|FG000|Overall Study|Physician Decision|3|||
161867135|NCT04760626|584555718|FG001|Overall Study|Physician Decision|5|||
161867136|NCT04760626|584555717|FG000|Overall Study|Death|3|||
161867137|NCT04760626|584555718|FG001|Overall Study|Death|6|||
161867138|NCT04760626|584555717|FG000|Overall Study|Site closure|1|||
161867139|NCT04760626|584555718|FG001|Overall Study|Site closure|0|||
161867140|NCT02554682|584555721|FG000|Overall Study|Lost to Follow-up|11|||
161867141|NCT02554682|584555722|FG001|Overall Study|Lost to Follow-up|9|||
161867142|NCT02554682|584555723|FG002|Overall Study|Lost to Follow-up|4|||
161867143|NCT02554682|584555724|FG003|Overall Study|Lost to Follow-up|3|||
161867144|NCT02554682|584555725|FG004|Overall Study|Lost to Follow-up|2|||
161867145|NCT02554682|584555726|FG005|Overall Study|Lost to Follow-up|1|||
161867146|NCT02554682|584555727|FG006|Overall Study|Lost to Follow-up|6|||
161867147|NCT02554682|584555728|FG007|Overall Study|Lost to Follow-up|6|||
161867148|NCT02554682|584555729|FG008|Overall Study|Lost to Follow-up|2|||
161867149|NCT02554682|584555730|FG009|Overall Study|Lost to Follow-up|2|||
161867150|NCT02554682|584555721|FG000|Overall Study|Withdrawal by Subject|2|||
161867151|NCT02554682|584555722|FG001|Overall Study|Withdrawal by Subject|1|||
161867152|NCT02554682|584555723|FG002|Overall Study|Withdrawal by Subject|0|||
161867153|NCT02554682|584555724|FG003|Overall Study|Withdrawal by Subject|0|||
161867154|NCT02554682|584555725|FG004|Overall Study|Withdrawal by Subject|0|||
161867155|NCT02554682|584555726|FG005|Overall Study|Withdrawal by Subject|0|||
161867156|NCT02554682|584555727|FG006|Overall Study|Withdrawal by Subject|0|||
161867157|NCT02554682|584555728|FG007|Overall Study|Withdrawal by Subject|0|||
161867158|NCT02554682|584555729|FG008|Overall Study|Withdrawal by Subject|0|||
161867159|NCT02554682|584555730|FG009|Overall Study|Withdrawal by Subject|0|||
161867160|NCT02554682|584555721|FG000|Overall Study|Physician Decision|2|||
161867161|NCT02554682|584555722|FG001|Overall Study|Physician Decision|2|||
161867162|NCT02554682|584555723|FG002|Overall Study|Physician Decision|0|||
161867163|NCT02554682|584555724|FG003|Overall Study|Physician Decision|0|||
161867164|NCT02554682|584555725|FG004|Overall Study|Physician Decision|0|||
161867165|NCT02554682|584555726|FG005|Overall Study|Physician Decision|0|||
161867166|NCT02554682|584555727|FG006|Overall Study|Physician Decision|0|||
161867167|NCT02554682|584555728|FG007|Overall Study|Physician Decision|0|||
161867168|NCT02554682|584555729|FG008|Overall Study|Physician Decision|0|||
161867169|NCT02554682|584555730|FG009|Overall Study|Physician Decision|0|||
161867170|NCT00884117|584555733|FG000|Overall Study|Adverse Event|2|||
161867171|NCT00884117|584555733|FG000|Overall Study|Withdrawal by Subject|89|||
161867172|NCT00884117|584555733|FG000|Overall Study|Death|3|||
161867173|NCT00884117|584555733|FG000|Overall Study|Lost to Follow-up|143|||
161867174|NCT00884117|584555733|FG000|Overall Study|Other|12|||
161867175|NCT02946463|584555734|FG000|Primary Evaluation Period|Physician Decision|0|||
161867176|NCT02946463|584555735|FG001|Primary Evaluation Period|Physician Decision|1|||
161867177|NCT02946463|584555736|FG002|Primary Evaluation Period|Physician Decision|0|||
161867178|NCT02946463|584555737|FG003|Primary Evaluation Period|Physician Decision|0|||
161867179|NCT02946463|584555734|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
161867180|NCT02946463|584555735|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
161867181|NCT02946463|584555736|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
161867182|NCT02946463|584555737|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
161867183|NCT02946463|584555734|FG000|Extension Period|Death|4|||
161867184|NCT02946463|584555735|FG001|Extension Period|Death|4|||
161867185|NCT02946463|584555736|FG002|Extension Period|Death|0|||
161867186|NCT02946463|584555737|FG003|Extension Period|Death|0|||
161867187|NCT02946463|584555734|FG000|Extension Period|Withdrawal by Subject|4|||
161867188|NCT02946463|584555735|FG001|Extension Period|Withdrawal by Subject|3|||
161867189|NCT02946463|584555736|FG002|Extension Period|Withdrawal by Subject|0|||
161867190|NCT02946463|584555737|FG003|Extension Period|Withdrawal by Subject|0|||
161867191|NCT02946463|584555734|FG000|Extension Period|Other than specified|2|||
161867192|NCT02946463|584555735|FG001|Extension Period|Other than specified|3|||
161867193|NCT02946463|584555736|FG002|Extension Period|Other than specified|2|||
161867194|NCT02946463|584555737|FG003|Extension Period|Other than specified|0|||
161867195|NCT02946463|584555734|FG000|Extension Period|Physician Decision|1|||
161867196|NCT02946463|584555735|FG001|Extension Period|Physician Decision|4|||
161867197|NCT02946463|584555736|FG002|Extension Period|Physician Decision|0|||
161867198|NCT02946463|584555737|FG003|Extension Period|Physician Decision|0|||
161867199|NCT02946463|584555734|FG000|Extension Period|Pregnancy|3|||
161867200|NCT02946463|584555735|FG001|Extension Period|Pregnancy|1|||
161867201|NCT02946463|584555736|FG002|Extension Period|Pregnancy|0|||
161867202|NCT02946463|584555737|FG003|Extension Period|Pregnancy|0|||
161867203|NCT02946463|584555734|FG000|Extension Period|Adverse Event|1|||
161867204|NCT02946463|584555735|FG001|Extension Period|Adverse Event|2|||
161867205|NCT02946463|584555736|FG002|Extension Period|Adverse Event|0|||
161867206|NCT02946463|584555737|FG003|Extension Period|Adverse Event|0|||
161867207|NCT02946463|584555734|FG000|Extension Period|Lost to Follow-up|1|||
161867208|NCT02946463|584555735|FG001|Extension Period|Lost to Follow-up|0|||
161867209|NCT02946463|584555736|FG002|Extension Period|Lost to Follow-up|0|||
161867210|NCT02946463|584555737|FG003|Extension Period|Lost to Follow-up|0|||
161867211|NCT02022202|584555738|FG000|Overall Study|Withdrawal by Subject|2|||
161867212|NCT02022202|584555738|FG000|Overall Study|Disease Progression|3|||
161867213|NCT02022202|584555738|FG000|Overall Study|Desire go to immediately to surgery|3|||
161867214|NCT01565889|584555740|FG000|Part A|Withdrawal by Subject|1|||
161867215|NCT01565889|584555741|FG001|Part A|Withdrawal by Subject|0|||
161867216|NCT01565889|584555742|FG002|Part A|Withdrawal by Subject|0|||
161867217|NCT01565889|584555743|FG003|Part A|Withdrawal by Subject|0|||
161867218|NCT01565889|584555744|FG004|Part A|Withdrawal by Subject|0|||
161867219|NCT01565889|584555745|FG005|Part A|Withdrawal by Subject|0|||
161867220|NCT01565889|584555740|FG000|Part B|Withdrawal by Subject|0|||
161867221|NCT01565889|584555741|FG001|Part B|Withdrawal by Subject|0|||
161867222|NCT01565889|584555742|FG002|Part B|Withdrawal by Subject|0|||
161867223|NCT01565889|584555743|FG003|Part B|Withdrawal by Subject|0|||
161867224|NCT01565889|584555744|FG004|Part B|Withdrawal by Subject|0|||
161867225|NCT01565889|584555745|FG005|Part B|Withdrawal by Subject|1|||
161867226|NCT01565889|584555740|FG000|Part B|Lack of Efficacy|0|||
161867227|NCT01565889|584555741|FG001|Part B|Lack of Efficacy|0|||
161867228|NCT01565889|584555742|FG002|Part B|Lack of Efficacy|0|||
161867229|NCT01565889|584555743|FG003|Part B|Lack of Efficacy|0|||
161867230|NCT01565889|584555744|FG004|Part B|Lack of Efficacy|0|||
161867231|NCT01565889|584555745|FG005|Part B|Lack of Efficacy|2|||
161867232|NCT01565889|584555740|FG000|Part B|Lost to Follow-up|0|||
161867233|NCT01565889|584555741|FG001|Part B|Lost to Follow-up|0|||
161867234|NCT01565889|584555742|FG002|Part B|Lost to Follow-up|0|||
161867235|NCT01565889|584555743|FG003|Part B|Lost to Follow-up|0|||
161867236|NCT01565889|584555744|FG004|Part B|Lost to Follow-up|0|||
161867237|NCT01565889|584555745|FG005|Part B|Lost to Follow-up|1|||
161867238|NCT00122382|584555746|FG000|Double-Blind Study|Adverse Event|9|||
161867239|NCT00122382|584555747|FG001|Double-Blind Study|Adverse Event|11|||
161867240|NCT00122382|584555748|FG002|Double-Blind Study|Adverse Event|0|||
161867241|NCT00122382|584555746|FG000|Double-Blind Study|Death|2|||
161867242|NCT00122382|584555747|FG001|Double-Blind Study|Death|2|||
161867243|NCT00122382|584555748|FG002|Double-Blind Study|Death|0|||
161867244|NCT00122382|584555746|FG000|Double-Blind Study|Lack of Efficacy|0|||
161867245|NCT00122382|584555747|FG001|Double-Blind Study|Lack of Efficacy|8|||
161867246|NCT00122382|584555748|FG002|Double-Blind Study|Lack of Efficacy|0|||
161867247|NCT00122382|584555746|FG000|Double-Blind Study|Lost to Follow-up|2|||
161867248|NCT00122382|584555747|FG001|Double-Blind Study|Lost to Follow-up|1|||
161867249|NCT00122382|584555748|FG002|Double-Blind Study|Lost to Follow-up|0|||
161867250|NCT00122382|584555746|FG000|Double-Blind Study|Pregnancy|2|||
161867251|NCT00122382|584555747|FG001|Double-Blind Study|Pregnancy|0|||
161867252|NCT00122382|584555748|FG002|Double-Blind Study|Pregnancy|0|||
161867253|NCT00122382|584555746|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
161867254|NCT00122382|584555747|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
161867255|NCT00122382|584555748|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
161867256|NCT00122382|584555746|FG000|Double-Blind Study|Withdrawal of Consent|7|||
161867257|NCT00122382|584555747|FG001|Double-Blind Study|Withdrawal of Consent|3|||
161867258|NCT00122382|584555748|FG002|Double-Blind Study|Withdrawal of Consent|0|||
161867259|NCT00122382|584555746|FG000|Double-Blind Study|Protocol Violation|1|||
161867260|NCT00122382|584555747|FG001|Double-Blind Study|Protocol Violation|0|||
161867261|NCT00122382|584555748|FG002|Double-Blind Study|Protocol Violation|0|||
161867262|NCT00122382|584555746|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
161867263|NCT00122382|584555747|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
161867264|NCT00122382|584555748|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
161867265|NCT00122382|584555746|FG000|Double-Blind Study|Randomized but not treated|0|||
161867266|NCT00122382|584555747|FG001|Double-Blind Study|Randomized but not treated|2|||
161867267|NCT00122382|584555748|FG002|Double-Blind Study|Randomized but not treated|0|||
161867268|NCT00122382|584555746|FG000|Open-Label Study|Adverse Event|0|||
161867269|NCT00122382|584555747|FG001|Open-Label Study|Adverse Event|0|||
161867270|NCT00122382|584555748|FG002|Open-Label Study|Adverse Event|11|||
161867271|NCT00122382|584555746|FG000|Open-Label Study|Death|0|||
161867272|NCT00122382|584555747|FG001|Open-Label Study|Death|0|||
161867273|NCT00122382|584555748|FG002|Open-Label Study|Death|2|||
161867274|NCT00122382|584555746|FG000|Open-Label Study|Lack of Efficacy|0|||
161867275|NCT00122382|584555747|FG001|Open-Label Study|Lack of Efficacy|0|||
161867276|NCT00122382|584555748|FG002|Open-Label Study|Lack of Efficacy|3|||
161867277|NCT00122382|584555746|FG000|Open-Label Study|Lost to Follow-up|0|||
161867278|NCT00122382|584555747|FG001|Open-Label Study|Lost to Follow-up|0|||
161867279|NCT00122382|584555748|FG002|Open-Label Study|Lost to Follow-up|3|||
161867280|NCT00122382|584555746|FG000|Open-Label Study|Pregnancy|0|||
161867281|NCT00122382|584555747|FG001|Open-Label Study|Pregnancy|0|||
161867282|NCT00122382|584555748|FG002|Open-Label Study|Pregnancy|2|||
161867283|NCT00122382|584555746|FG000|Open-Label Study|Poor/Non-Compliance|0|||
161867284|NCT00122382|584555747|FG001|Open-Label Study|Poor/Non-Compliance|0|||
161867285|NCT00122382|584555748|FG002|Open-Label Study|Poor/Non-Compliance|1|||
161867286|NCT00122382|584555746|FG000|Open-Label Study|Withdrawal of Consent|0|||
161867287|NCT00122382|584555747|FG001|Open-Label Study|Withdrawal of Consent|0|||
161867288|NCT00122382|584555748|FG002|Open-Label Study|Withdrawal of Consent|4|||
161867289|NCT02040805|584555749|FG000|Overall Study|Lost to Follow-up|14|||
161867290|NCT02040805|584555750|FG001|Overall Study|Lost to Follow-up|9|||
161867291|NCT02040805|584555749|FG000|Overall Study|Withdrawal by Subject|28|||
161867292|NCT02040805|584555750|FG001|Overall Study|Withdrawal by Subject|41|||
161867293|NCT00908544|584555751|FG000|Overall Study|Withdrawal by Subject|2|||
161867294|NCT00908544|584555752|FG001|Overall Study|Withdrawal by Subject|4|||
161867295|NCT00908544|584555751|FG000|Overall Study|Lack of Efficacy|0|||
161867296|NCT00908544|584555752|FG001|Overall Study|Lack of Efficacy|1|||
161867297|NCT00908544|584555751|FG000|Overall Study|Pregnancy|1|||
161867298|NCT00908544|584555752|FG001|Overall Study|Pregnancy|0|||
161867299|NCT00908544|584555751|FG000|Overall Study|Relocation abroad|1|||
161867300|NCT00908544|584555752|FG001|Overall Study|Relocation abroad|1|||
161867301|NCT00908544|584555751|FG000|Overall Study|Unable to visit sutdy center|1|||
161867302|NCT00908544|584555752|FG001|Overall Study|Unable to visit sutdy center|0|||
161867303|NCT02259010|584555753|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
161867304|NCT01662492|584555754|FG000|Overall Study|Other miscellaneous reasons.|1|||
161867305|NCT01662492|584555755|FG001|Overall Study|Other miscellaneous reasons.|0|||
161867306|NCT01662492|584555756|FG002|Overall Study|Other miscellaneous reasons.|1|||
161867307|NCT01662492|584555754|FG000|Overall Study|Withdrawal by Subject|0|||
161867308|NCT01662492|584555755|FG001|Overall Study|Withdrawal by Subject|0|||
161867309|NCT01662492|584555756|FG002|Overall Study|Withdrawal by Subject|1|||
161867310|NCT01662492|584555754|FG000|Overall Study|Protocol Violation|1|||
161867311|NCT01662492|584555755|FG001|Overall Study|Protocol Violation|0|||
161867312|NCT01662492|584555756|FG002|Overall Study|Protocol Violation|0|||
161867313|NCT01662492|584555754|FG000|Overall Study|Lost to Follow-up|0|||
161867314|NCT01662492|584555755|FG001|Overall Study|Lost to Follow-up|0|||
161867315|NCT01662492|584555756|FG002|Overall Study|Lost to Follow-up|2|||
161867316|NCT01662492|584555754|FG000|Overall Study|Lack of Efficacy|1|||
161867317|NCT01662492|584555755|FG001|Overall Study|Lack of Efficacy|1|||
161867318|NCT01662492|584555756|FG002|Overall Study|Lack of Efficacy|2|||
161867319|NCT02859337|584555758|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
161867320|NCT02859337|584555759|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
161867321|NCT02859337|584555760|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
161867322|NCT02859337|584555758|FG000|Overall Study|Withdrawal by Subject|3|||
161867323|NCT02859337|584555759|FG001|Overall Study|Withdrawal by Subject|1|||
161867324|NCT02859337|584555760|FG002|Overall Study|Withdrawal by Subject|0|||
161867325|NCT02859337|584555758|FG000|Overall Study|Lost to Follow-up|1|||
161867326|NCT02859337|584555759|FG001|Overall Study|Lost to Follow-up|0|||
161867327|NCT02859337|584555760|FG002|Overall Study|Lost to Follow-up|0|||
161867328|NCT00848718|584555761|FG000|Overall Study|Adverse Event|2|||
161867329|NCT00848718|584555762|FG001|Overall Study|Adverse Event|2|||
161867330|NCT00848718|584555763|FG002|Overall Study|Adverse Event|1|||
161867331|NCT00848718|584555764|FG003|Overall Study|Adverse Event|1|||
161867332|NCT00848718|584555765|FG004|Overall Study|Adverse Event|1|||
161774410|NCT04668066|584216030|FG000|Part 2: Treatment Phase|Other|0|||
161774411|NCT04668066|584216031|FG001|Part 2: Treatment Phase|Other|0|||
161774412|NCT04668066|584216032|FG002|Part 2: Treatment Phase|Other|0|||
161774413|NCT04668066|584216033|FG003|Part 2: Treatment Phase|Other|0|||
161774414|NCT04668066|584216034|FG004|Part 2: Treatment Phase|Other|0|||
161774415|NCT04668066|584216035|FG005|Part 2: Treatment Phase|Other|0|||
161774416|NCT04668066|584216036|FG006|Part 2: Treatment Phase|Other|0|||
161774417|NCT04668066|584216037|FG007|Part 2: Treatment Phase|Other|0|||
161774418|NCT04668066|584216038|FG008|Part 2: Treatment Phase|Other|0|||
161774419|NCT04668066|584216039|FG009|Part 2: Treatment Phase|Other|0|||
161774420|NCT04668066|584216040|FG010|Part 2: Treatment Phase|Other|0|||
161774421|NCT04668066|584216041|FG011|Part 2: Treatment Phase|Other|0|||
161774422|NCT04668066|584216042|FG012|Part 2: Treatment Phase|Other|0|||
161774423|NCT04668066|584216043|FG013|Part 2: Treatment Phase|Other|0|||
161774424|NCT04668066|584216044|FG014|Part 2: Treatment Phase|Other|0|||
161774425|NCT04668066|584216045|FG015|Part 2: Treatment Phase|Other|0|||
161774426|NCT04668066|584216046|FG016|Part 2: Treatment Phase|Other|0|||
161774427|NCT04668066|584216047|FG017|Part 2: Treatment Phase|Other|0|||
161774428|NCT04668066|584216048|FG018|Part 2: Treatment Phase|Other|1|||
161774429|NCT04668066|584216030|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774430|NCT04668066|584216031|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774431|NCT04668066|584216032|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774432|NCT04668066|584216033|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774433|NCT04668066|584216034|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774434|NCT04668066|584216035|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774435|NCT04668066|584216036|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774436|NCT04668066|584216037|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774437|NCT04668066|584216038|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774438|NCT04668066|584216039|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774439|NCT04668066|584216040|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774440|NCT04668066|584216041|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774441|NCT04668066|584216042|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774442|NCT04668066|584216043|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774443|NCT04668066|584216044|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774444|NCT04668066|584216045|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774445|NCT04668066|584216046|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774446|NCT04668066|584216047|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774447|NCT04668066|584216048|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
161774448|NCT02060188|584216049|FG000|Overall Study|Disease Progression|36|||
161774449|NCT02060188|584216050|FG001|Overall Study|Disease Progression|42|||
161774450|NCT02060188|584216051|FG002|Overall Study|Disease Progression|8|||
161774451|NCT02060188|584216052|FG003|Overall Study|Disease Progression|5|||
161774452|NCT02060188|584216053|FG004|Overall Study|Disease Progression|6|||
161774453|NCT02060188|584216054|FG005|Overall Study|Disease Progression|3|||
161774454|NCT02060188|584216055|FG006|Overall Study|Disease Progression|23|||
161774455|NCT02060188|584216056|FG007|Overall Study|Disease Progression|20|||
161774456|NCT02060188|584216057|FG008|Overall Study|Disease Progression|43|||
161774457|NCT02060188|584216049|FG000|Overall Study|Study Drug Toxicity|10|||
161774458|NCT02060188|584216050|FG001|Overall Study|Study Drug Toxicity|18|||
161774459|NCT02060188|584216051|FG002|Overall Study|Study Drug Toxicity|7|||
161774460|NCT02060188|584216052|FG003|Overall Study|Study Drug Toxicity|4|||
161774461|NCT02060188|584216053|FG004|Overall Study|Study Drug Toxicity|3|||
161774462|NCT02060188|584216054|FG005|Overall Study|Study Drug Toxicity|0|||
161774463|NCT02060188|584216055|FG006|Overall Study|Study Drug Toxicity|2|||
161774464|NCT02060188|584216056|FG007|Overall Study|Study Drug Toxicity|5|||
161774465|NCT02060188|584216057|FG008|Overall Study|Study Drug Toxicity|0|||
161774466|NCT02060188|584216049|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161867333|NCT00848718|584555766|FG005|Overall Study|Adverse Event|0|||
161867334|NCT00848718|584555767|FG006|Overall Study|Adverse Event|0|||
161867335|NCT00848718|584555768|FG007|Overall Study|Adverse Event|1|||
161867336|NCT00848718|584555769|FG008|Overall Study|Adverse Event|1|||
161867337|NCT00848718|584555770|FG009|Overall Study|Adverse Event|0|||
161867338|NCT00848718|584555771|FG010|Overall Study|Adverse Event|0|||
161867339|NCT00848718|584555772|FG011|Overall Study|Adverse Event|0|||
161867340|NCT00848718|584555773|FG012|Overall Study|Adverse Event|2|||
161867341|NCT00848718|584555761|FG000|Overall Study|Lack of Efficacy|0|||
161867342|NCT00848718|584555762|FG001|Overall Study|Lack of Efficacy|0|||
161867343|NCT00848718|584555763|FG002|Overall Study|Lack of Efficacy|1|||
161867344|NCT00848718|584555764|FG003|Overall Study|Lack of Efficacy|0|||
161867345|NCT00848718|584555765|FG004|Overall Study|Lack of Efficacy|0|||
161867346|NCT00848718|584555766|FG005|Overall Study|Lack of Efficacy|0|||
161867347|NCT00848718|584555767|FG006|Overall Study|Lack of Efficacy|1|||
161867348|NCT00848718|584555768|FG007|Overall Study|Lack of Efficacy|0|||
161867349|NCT00848718|584555769|FG008|Overall Study|Lack of Efficacy|0|||
161867350|NCT00848718|584555770|FG009|Overall Study|Lack of Efficacy|0|||
161867351|NCT00848718|584555771|FG010|Overall Study|Lack of Efficacy|0|||
161867352|NCT00848718|584555772|FG011|Overall Study|Lack of Efficacy|0|||
161867353|NCT00848718|584555773|FG012|Overall Study|Lack of Efficacy|0|||
161867354|NCT00848718|584555761|FG000|Overall Study|Physician Decision|0|||
161867355|NCT00848718|584555762|FG001|Overall Study|Physician Decision|1|||
161867356|NCT00848718|584555763|FG002|Overall Study|Physician Decision|0|||
161867357|NCT00848718|584555764|FG003|Overall Study|Physician Decision|0|||
161867358|NCT00848718|584555765|FG004|Overall Study|Physician Decision|1|||
161867359|NCT00848718|584555766|FG005|Overall Study|Physician Decision|1|||
161867360|NCT00848718|584555767|FG006|Overall Study|Physician Decision|0|||
161867361|NCT00848718|584555768|FG007|Overall Study|Physician Decision|0|||
161867362|NCT00848718|584555769|FG008|Overall Study|Physician Decision|1|||
161867363|NCT00848718|584555770|FG009|Overall Study|Physician Decision|2|||
161867364|NCT00848718|584555771|FG010|Overall Study|Physician Decision|0|||
161867365|NCT00848718|584555772|FG011|Overall Study|Physician Decision|0|||
161867366|NCT00848718|584555773|FG012|Overall Study|Physician Decision|1|||
161867367|NCT00848718|584555761|FG000|Overall Study|Progressive disease before treatment|1|||
161867368|NCT00848718|584555762|FG001|Overall Study|Progressive disease before treatment|5|||
161867369|NCT00848718|584555763|FG002|Overall Study|Progressive disease before treatment|1|||
161867370|NCT00848718|584555764|FG003|Overall Study|Progressive disease before treatment|3|||
161867371|NCT00848718|584555765|FG004|Overall Study|Progressive disease before treatment|4|||
161867372|NCT00848718|584555766|FG005|Overall Study|Progressive disease before treatment|4|||
161867373|NCT00848718|584555767|FG006|Overall Study|Progressive disease before treatment|2|||
161867374|NCT00848718|584555768|FG007|Overall Study|Progressive disease before treatment|1|||
161867375|NCT00848718|584555769|FG008|Overall Study|Progressive disease before treatment|2|||
161867376|NCT00848718|584555770|FG009|Overall Study|Progressive disease before treatment|7|||
161867377|NCT00848718|584555771|FG010|Overall Study|Progressive disease before treatment|3|||
161867378|NCT00848718|584555772|FG011|Overall Study|Progressive disease before treatment|6|||
161867379|NCT00848718|584555773|FG012|Overall Study|Progressive disease before treatment|2|||
161867380|NCT00848718|584555761|FG000|Overall Study|Protocol Violation|0|||
161867381|NCT00848718|584555762|FG001|Overall Study|Protocol Violation|1|||
161867382|NCT00848718|584555763|FG002|Overall Study|Protocol Violation|0|||
161867383|NCT00848718|584555764|FG003|Overall Study|Protocol Violation|0|||
161867384|NCT00848718|584555765|FG004|Overall Study|Protocol Violation|0|||
161867385|NCT00848718|584555766|FG005|Overall Study|Protocol Violation|0|||
161867386|NCT00848718|584555767|FG006|Overall Study|Protocol Violation|0|||
161867387|NCT00848718|584555768|FG007|Overall Study|Protocol Violation|1|||
161867388|NCT00848718|584555769|FG008|Overall Study|Protocol Violation|0|||
161867389|NCT00848718|584555770|FG009|Overall Study|Protocol Violation|0|||
161867390|NCT00848718|584555771|FG010|Overall Study|Protocol Violation|0|||
161867391|NCT00848718|584555772|FG011|Overall Study|Protocol Violation|0|||
161867392|NCT00848718|584555773|FG012|Overall Study|Protocol Violation|1|||
161867393|NCT00848718|584555761|FG000|Overall Study|Withdrawal by Subject|1|||
161867394|NCT00848718|584555762|FG001|Overall Study|Withdrawal by Subject|0|||
161867395|NCT00848718|584555763|FG002|Overall Study|Withdrawal by Subject|0|||
161867396|NCT00848718|584555764|FG003|Overall Study|Withdrawal by Subject|1|||
161867397|NCT00848718|584555765|FG004|Overall Study|Withdrawal by Subject|0|||
161867398|NCT00848718|584555766|FG005|Overall Study|Withdrawal by Subject|0|||
161867399|NCT00848718|584555767|FG006|Overall Study|Withdrawal by Subject|0|||
161867400|NCT00848718|584555768|FG007|Overall Study|Withdrawal by Subject|0|||
161867401|NCT00848718|584555769|FG008|Overall Study|Withdrawal by Subject|0|||
161867402|NCT00848718|584555770|FG009|Overall Study|Withdrawal by Subject|0|||
161867403|NCT00848718|584555771|FG010|Overall Study|Withdrawal by Subject|1|||
161867404|NCT00848718|584555772|FG011|Overall Study|Withdrawal by Subject|0|||
161867405|NCT00848718|584555773|FG012|Overall Study|Withdrawal by Subject|0|||
161867406|NCT00848718|584555761|FG000|Overall Study|Progressive disease during treatment|3|||
161867407|NCT00848718|584555762|FG001|Overall Study|Progressive disease during treatment|0|||
161867408|NCT00848718|584555763|FG002|Overall Study|Progressive disease during treatment|3|||
161867409|NCT00848718|584555764|FG003|Overall Study|Progressive disease during treatment|0|||
161867410|NCT00848718|584555765|FG004|Overall Study|Progressive disease during treatment|0|||
161867411|NCT00848718|584555766|FG005|Overall Study|Progressive disease during treatment|0|||
161867412|NCT00848718|584555767|FG006|Overall Study|Progressive disease during treatment|0|||
161867413|NCT00848718|584555768|FG007|Overall Study|Progressive disease during treatment|2|||
161867414|NCT00848718|584555769|FG008|Overall Study|Progressive disease during treatment|0|||
161867415|NCT00848718|584555770|FG009|Overall Study|Progressive disease during treatment|0|||
161867416|NCT00848718|584555771|FG010|Overall Study|Progressive disease during treatment|0|||
161867417|NCT00848718|584555772|FG011|Overall Study|Progressive disease during treatment|0|||
161867418|NCT00848718|584555773|FG012|Overall Study|Progressive disease during treatment|2|||
161867419|NCT02389829|584555774|FG000|Overall Study|Lost to Follow-up|0|||
161867420|NCT02389829|584555775|FG001|Overall Study|Lost to Follow-up|1|||
161867421|NCT05271370|584557597|FG000|Overall Study|Study early termination|8|||
161867422|NCT05271370|584557598|FG001|Overall Study|Study early termination|16|||
161867423|NCT05271370|584557599|FG002|Overall Study|Study early termination|29|||
161867424|NCT02283268|584557606|FG000|Overall Study|Withdrawal by Subject|1|||
161867425|NCT00333983|584557607|FG000|Overall Study|Lost to Follow-up|2|||
161867426|NCT00333983|584557608|FG001|Overall Study|Lost to Follow-up|1|||
161867427|NCT00333983|584557609|FG002|Overall Study|Lost to Follow-up|0|||
161867428|NCT00333983|584557607|FG000|Overall Study|Adverse Event|1|||
161867429|NCT00333983|584557608|FG001|Overall Study|Adverse Event|1|||
161867430|NCT00333983|584557609|FG002|Overall Study|Adverse Event|1|||
161867431|NCT00333983|584557607|FG000|Overall Study|Withdrawal by Subject|0|||
161867432|NCT00333983|584557608|FG001|Overall Study|Withdrawal by Subject|3|||
161867433|NCT00333983|584557609|FG002|Overall Study|Withdrawal by Subject|1|||
161867434|NCT00833105|584557610|FG000|Overall Study|Withdrawal by Subject|1|||
161867435|NCT00833105|584557610|FG000|Overall Study|Adverse Event|2|||
161867436|NCT02898597|584557611|FG000|Overall Study|Protocol Violation|4|||
161867437|NCT02898597|584557612|FG001|Overall Study|Protocol Violation|2|||
161867438|NCT02898597|584557611|FG000|Overall Study|Lost to Follow-up|0|||
161867439|NCT02898597|584557612|FG001|Overall Study|Lost to Follow-up|9|||
161867440|NCT02898597|584557611|FG000|Overall Study|Death|0|||
161867441|NCT02898597|584557612|FG001|Overall Study|Death|1|||
161867442|NCT03656068|584557613|FG000|Overall Study|Withdrawal by Subject|4|||
161867443|NCT03656068|584557613|FG000|Overall Study|Adverse Event|1|||
161867444|NCT01436370|584557615|FG000|Overall Study|Lost to Follow-up|0|||
161867445|NCT01436370|584557616|FG001|Overall Study|Lost to Follow-up|0|||
161867446|NCT01436370|584557617|FG002|Overall Study|Lost to Follow-up|0|||
161867447|NCT01436370|584557618|FG003|Overall Study|Lost to Follow-up|0|||
161867448|NCT01436370|584557619|FG004|Overall Study|Lost to Follow-up|1|||
161867449|NCT01436370|584557620|FG005|Overall Study|Lost to Follow-up|0|||
161867450|NCT01436370|584557621|FG006|Overall Study|Lost to Follow-up|0|||
161867451|NCT01436370|584557622|FG007|Overall Study|Lost to Follow-up|0|||
161867452|NCT02770170|584557629|FG000|Overall Study|Withdrawal by Subject|0|||
161867453|NCT02770170|584557630|FG001|Overall Study|Withdrawal by Subject|0|||
161867454|NCT02770170|584557631|FG002|Overall Study|Withdrawal by Subject|0|||
161867455|NCT02770170|584557632|FG003|Overall Study|Withdrawal by Subject|2|||
161867456|NCT02770170|584557629|FG000|Overall Study|due to pregnancy|1|||
161867457|NCT02770170|584557630|FG001|Overall Study|due to pregnancy|0|||
161867458|NCT02770170|584557631|FG002|Overall Study|due to pregnancy|0|||
161867459|NCT02770170|584557632|FG003|Overall Study|due to pregnancy|0|||
161867460|NCT02770170|584557629|FG000|Overall Study|Lack of Efficacy|2|||
161867461|NCT02770170|584557630|FG001|Overall Study|Lack of Efficacy|0|||
161867462|NCT02770170|584557631|FG002|Overall Study|Lack of Efficacy|0|||
161867463|NCT02770170|584557632|FG003|Overall Study|Lack of Efficacy|1|||
161867464|NCT02770170|584557629|FG000|Overall Study|Adverse Event|4|||
161867465|NCT02770170|584557630|FG001|Overall Study|Adverse Event|3|||
161867466|NCT02770170|584557631|FG002|Overall Study|Adverse Event|5|||
161867467|NCT02770170|584557632|FG003|Overall Study|Adverse Event|3|||
161867468|NCT02770170|584557629|FG000|Overall Study|due to disease worsening|0|||
161867469|NCT02770170|584557630|FG001|Overall Study|due to disease worsening|0|||
161867470|NCT02770170|584557631|FG002|Overall Study|due to disease worsening|0|||
161867471|NCT02770170|584557632|FG003|Overall Study|due to disease worsening|1|||
161867472|NCT03270657|584557633|FG000|Overall Study|Withdrawal by Subject|1|||
161867473|NCT00162981|584557634|FG000|Overall Study|Adverse Event|2|||
161867474|NCT00162981|584557635|FG001|Overall Study|Adverse Event|5|||
161867475|NCT00162981|584557634|FG000|Overall Study|Withdrawal by Subject|1|||
161867476|NCT00162981|584557635|FG001|Overall Study|Withdrawal by Subject|1|||
161867477|NCT00162981|584557634|FG000|Overall Study|Physician Decision|1|||
161867478|NCT00162981|584557635|FG001|Overall Study|Physician Decision|0|||
161867479|NCT00171210|584557641|FG000|Overall Study|Adverse Event|16|||
161867480|NCT00171210|584557642|FG001|Overall Study|Adverse Event|27|||
161867481|NCT00171210|584557641|FG000|Overall Study|Abnormal laboratory value(s)|6|||
161867482|NCT00171210|584557642|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161867483|NCT00171210|584557641|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161867484|NCT00171210|584557642|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161867485|NCT00171210|584557641|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
161774467|NCT02060188|584216050|FG001|Overall Study|Adverse event unrelated to study drug|5|||
161774468|NCT02060188|584216051|FG002|Overall Study|Adverse event unrelated to study drug|6|||
161774469|NCT02060188|584216052|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161774470|NCT02060188|584216053|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161774471|NCT02060188|584216054|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161774472|NCT02060188|584216055|FG006|Overall Study|Adverse event unrelated to study drug|4|||
161774473|NCT02060188|584216056|FG007|Overall Study|Adverse event unrelated to study drug|4|||
161774474|NCT02060188|584216057|FG008|Overall Study|Adverse event unrelated to study drug|1|||
161774475|NCT02060188|584216049|FG000|Overall Study|Participant request to discontinue study treatment|7|||
161774476|NCT02060188|584216050|FG001|Overall Study|Participant request to discontinue study treatment|7|||
161774477|NCT02060188|584216051|FG002|Overall Study|Participant request to discontinue study treatment|4|||
161774478|NCT02060188|584216052|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161774479|NCT02060188|584216053|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161774480|NCT02060188|584216054|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161774481|NCT02060188|584216055|FG006|Overall Study|Participant request to discontinue study treatment|1|||
161774482|NCT02060188|584216056|FG007|Overall Study|Participant request to discontinue study treatment|1|||
161774483|NCT02060188|584216057|FG008|Overall Study|Participant request to discontinue study treatment|0|||
161774484|NCT02060188|584216049|FG000|Overall Study|Participant withdrew consent|3|||
161774485|NCT02060188|584216050|FG001|Overall Study|Participant withdrew consent|0|||
161774486|NCT02060188|584216051|FG002|Overall Study|Participant withdrew consent|0|||
161774487|NCT02060188|584216052|FG003|Overall Study|Participant withdrew consent|0|||
161774488|NCT02060188|584216053|FG004|Overall Study|Participant withdrew consent|0|||
161774489|NCT02060188|584216054|FG005|Overall Study|Participant withdrew consent|0|||
161774490|NCT02060188|584216055|FG006|Overall Study|Participant withdrew consent|0|||
161774491|NCT02060188|584216056|FG007|Overall Study|Participant withdrew consent|0|||
161774492|NCT02060188|584216057|FG008|Overall Study|Participant withdrew consent|0|||
161774493|NCT02060188|584216049|FG000|Overall Study|Maximum clinical benefit|13|||
161774494|NCT02060188|584216050|FG001|Overall Study|Maximum clinical benefit|38|||
161774495|NCT02060188|584216051|FG002|Overall Study|Maximum clinical benefit|19|||
161774496|NCT02060188|584216052|FG003|Overall Study|Maximum clinical benefit|0|||
161774497|NCT02060188|584216053|FG004|Overall Study|Maximum clinical benefit|0|||
161774498|NCT02060188|584216054|FG005|Overall Study|Maximum clinical benefit|0|||
161774499|NCT02060188|584216055|FG006|Overall Study|Maximum clinical benefit|0|||
161774500|NCT02060188|584216056|FG007|Overall Study|Maximum clinical benefit|10|||
161774501|NCT02060188|584216057|FG008|Overall Study|Maximum clinical benefit|0|||
161774502|NCT02060188|584216049|FG000|Overall Study|Other reason|3|||
161774503|NCT02060188|584216050|FG001|Overall Study|Other reason|7|||
161774504|NCT02060188|584216051|FG002|Overall Study|Other reason|0|||
161774505|NCT02060188|584216052|FG003|Overall Study|Other reason|1|||
161774506|NCT02060188|584216053|FG004|Overall Study|Other reason|0|||
161774507|NCT02060188|584216054|FG005|Overall Study|Other reason|0|||
161774508|NCT02060188|584216055|FG006|Overall Study|Other reason|0|||
161774509|NCT02060188|584216056|FG007|Overall Study|Other reason|9|||
161774510|NCT02060188|584216057|FG008|Overall Study|Other reason|0|||
161774511|NCT02060188|584216049|FG000|Overall Study|Death|0|||
161774512|NCT02060188|584216050|FG001|Overall Study|Death|1|||
161774513|NCT02060188|584216051|FG002|Overall Study|Death|0|||
161774514|NCT02060188|584216052|FG003|Overall Study|Death|0|||
161774515|NCT02060188|584216053|FG004|Overall Study|Death|0|||
161774516|NCT02060188|584216054|FG005|Overall Study|Death|0|||
161774517|NCT02060188|584216055|FG006|Overall Study|Death|0|||
161774518|NCT02060188|584216056|FG007|Overall Study|Death|1|||
161774519|NCT02060188|584216057|FG008|Overall Study|Death|0|||
161774520|NCT02060188|584216049|FG000|Overall Study|Administrative reasons by sponsor|0|||
161774521|NCT02060188|584216050|FG001|Overall Study|Administrative reasons by sponsor|1|||
161774522|NCT02060188|584216051|FG002|Overall Study|Administrative reasons by sponsor|0|||
161774523|NCT02060188|584216052|FG003|Overall Study|Administrative reasons by sponsor|0|||
161774524|NCT02060188|584216053|FG004|Overall Study|Administrative reasons by sponsor|0|||
161774525|NCT02060188|584216054|FG005|Overall Study|Administrative reasons by sponsor|0|||
161774526|NCT02060188|584216055|FG006|Overall Study|Administrative reasons by sponsor|0|||
161774527|NCT02060188|584216056|FG007|Overall Study|Administrative reasons by sponsor|0|||
161774528|NCT02060188|584216057|FG008|Overall Study|Administrative reasons by sponsor|0|||
161774529|NCT02060188|584216049|FG000|Overall Study|Lost to Follow-up|0|||
161774530|NCT02060188|584216050|FG001|Overall Study|Lost to Follow-up|0|||
161774531|NCT02060188|584216051|FG002|Overall Study|Lost to Follow-up|1|||
161774532|NCT02060188|584216052|FG003|Overall Study|Lost to Follow-up|0|||
161774533|NCT02060188|584216053|FG004|Overall Study|Lost to Follow-up|0|||
161774534|NCT02060188|584216054|FG005|Overall Study|Lost to Follow-up|0|||
161774535|NCT02060188|584216055|FG006|Overall Study|Lost to Follow-up|0|||
161774536|NCT02060188|584216056|FG007|Overall Study|Lost to Follow-up|0|||
161774537|NCT02060188|584216057|FG008|Overall Study|Lost to Follow-up|0|||
161774538|NCT03205605|584216068|FG000|Overall Study|Withdrawal by Subject|1|||
161867486|NCT00171210|584557642|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
161867487|NCT00171210|584557641|FG000|Overall Study|Protocol Violation|0|||
161867488|NCT00171210|584557642|FG001|Overall Study|Protocol Violation|2|||
161867489|NCT00171210|584557641|FG000|Overall Study|Withdrawal by Subject|32|||
161867490|NCT00171210|584557642|FG001|Overall Study|Withdrawal by Subject|30|||
161867491|NCT00171210|584557641|FG000|Overall Study|Lost to Follow-up|1|||
161867492|NCT00171210|584557642|FG001|Overall Study|Lost to Follow-up|0|||
161867493|NCT00171210|584557641|FG000|Overall Study|Administrative problems|1|||
161867494|NCT00171210|584557642|FG001|Overall Study|Administrative problems|1|||
161867495|NCT00171210|584557641|FG000|Overall Study|Death|2|||
161867496|NCT00171210|584557642|FG001|Overall Study|Death|3|||
161867497|NCT00171210|584557641|FG000|Overall Study|Stopped at end of core|0|||
161867498|NCT00171210|584557642|FG001|Overall Study|Stopped at end of core|32|||
161867499|NCT00171210|584557641|FG000|Overall Study|Stopped at end of extension 1|0|||
161867500|NCT00171210|584557642|FG001|Overall Study|Stopped at end of extension 1|1|||
161867501|NCT03187301|584557645|FG000|Titration Period|Adverse Event|0|||
161867502|NCT03187301|584557646|FG001|Titration Period|Adverse Event|0|||
161867503|NCT03187301|584557647|FG002|Titration Period|Adverse Event|0|||
161867504|NCT03187301|584557648|FG003|Titration Period|Adverse Event|0|||
161867505|NCT03187301|584557649|FG004|Titration Period|Adverse Event|0|||
161867506|NCT03187301|584557650|FG005|Titration Period|Adverse Event|0|||
161867507|NCT03187301|584557651|FG006|Titration Period|Adverse Event|5|||
161867508|NCT03187301|584557645|FG000|Titration Period|Withdrawal by Subject|0|||
161867509|NCT03187301|584557646|FG001|Titration Period|Withdrawal by Subject|0|||
161867510|NCT03187301|584557647|FG002|Titration Period|Withdrawal by Subject|0|||
161867511|NCT03187301|584557648|FG003|Titration Period|Withdrawal by Subject|0|||
161867512|NCT03187301|584557649|FG004|Titration Period|Withdrawal by Subject|0|||
161867513|NCT03187301|584557650|FG005|Titration Period|Withdrawal by Subject|0|||
161867514|NCT03187301|584557651|FG006|Titration Period|Withdrawal by Subject|1|||
161867515|NCT03187301|584557645|FG000|Titration Period|Exclusion Criteria Met|0|||
161867516|NCT03187301|584557646|FG001|Titration Period|Exclusion Criteria Met|0|||
161867517|NCT03187301|584557647|FG002|Titration Period|Exclusion Criteria Met|0|||
161867518|NCT03187301|584557648|FG003|Titration Period|Exclusion Criteria Met|0|||
161867519|NCT03187301|584557649|FG004|Titration Period|Exclusion Criteria Met|0|||
161867520|NCT03187301|584557650|FG005|Titration Period|Exclusion Criteria Met|0|||
161867521|NCT03187301|584557651|FG006|Titration Period|Exclusion Criteria Met|1|||
161867522|NCT03187301|584557645|FG000|Pre-Intervention|Withdrawal by Subject|1|||
161867523|NCT03187301|584557646|FG001|Pre-Intervention|Withdrawal by Subject|0|||
161867524|NCT03187301|584557647|FG002|Pre-Intervention|Withdrawal by Subject|0|||
161867525|NCT03187301|584557648|FG003|Pre-Intervention|Withdrawal by Subject|0|||
161867526|NCT03187301|584557649|FG004|Pre-Intervention|Withdrawal by Subject|0|||
161867527|NCT03187301|584557650|FG005|Pre-Intervention|Withdrawal by Subject|0|||
161867528|NCT03187301|584557651|FG006|Pre-Intervention|Withdrawal by Subject|0|||
161867529|NCT01966120|584557657|FG000|Overall Study|Withdrawal by Subject|0|||
161867530|NCT01966120|584557658|FG001|Overall Study|Withdrawal by Subject|5|||
161867531|NCT01966120|584557657|FG000|Overall Study|Lost to Follow-up|1|||
161867532|NCT01966120|584557658|FG001|Overall Study|Lost to Follow-up|1|||
161867533|NCT00461630|584557659|FG000|Overall Study|Death|798|||
161774539|NCT03795233|584216069|FG000|Overall Study|Withdrawal by Subject|2|||
161774540|NCT03795233|584216070|FG001|Overall Study|Withdrawal by Subject|1|||
161774541|NCT03795233|584216069|FG000|Overall Study|Lost to Follow-up|1|||
161774542|NCT03795233|584216070|FG001|Overall Study|Lost to Follow-up|0|||
161774543|NCT03795233|584216069|FG000|Overall Study|Death|1|||
161774544|NCT03795233|584216070|FG001|Overall Study|Death|0|||
161774545|NCT02756182|584216071|FG000|Overall Study|StudyTechnical Difficulties|4|||
161774546|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
161774547|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
161774548|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
161774549|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
161774550|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161774551|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
161774552|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161774553|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161774554|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
161774555|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161774556|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161774557|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161774558|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
161774559|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
161774560|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
161774561|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
161774562|NCT01965600|584216075|FG000|Second Intervention|Study terminated by Sponsor|0|||
161774563|NCT01965600|584216076|FG001|Second Intervention|Study terminated by Sponsor|0|||
161774564|NCT01965600|584216077|FG002|Second Intervention|Study terminated by Sponsor|2|||
161774565|NCT01965600|584216078|FG003|Second Intervention|Study terminated by Sponsor|2|||
161774566|NCT02711306|584216086|FG000|Overall Study|Withdrawal by Subject|2|||
161774567|NCT02711306|584216087|FG001|Overall Study|Withdrawal by Subject|2|||
161774568|NCT00242567|584217284|FG000|Overall Study|Adverse Event|70|||
161774569|NCT00242567|584217285|FG001|Overall Study|Adverse Event|43|||
161774570|NCT00242567|584217284|FG000|Overall Study|Disease Progression|17|||
161774571|NCT00242567|584217285|FG001|Overall Study|Disease Progression|22|||
161774572|NCT00242567|584217284|FG000|Overall Study|Symptomatic deterioration|9|||
161774573|NCT00242567|584217285|FG001|Overall Study|Symptomatic deterioration|3|||
161774574|NCT00242567|584217284|FG000|Overall Study|Lack of Efficacy|2|||
161774575|NCT00242567|584217285|FG001|Overall Study|Lack of Efficacy|2|||
161774576|NCT00242567|584217284|FG000|Overall Study|Lost to Follow-up|9|||
161774577|NCT00242567|584217285|FG001|Overall Study|Lost to Follow-up|19|||
161774578|NCT00242567|584217284|FG000|Overall Study|Withdrawal by Subject|33|||
161774579|NCT00242567|584217285|FG001|Overall Study|Withdrawal by Subject|28|||
161774580|NCT00242567|584217284|FG000|Overall Study|Protocol Violation|12|||
161774581|NCT00242567|584217285|FG001|Overall Study|Protocol Violation|12|||
161774582|NCT00242567|584217284|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
161774583|NCT00242567|584217285|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
161774584|NCT00242567|584217284|FG000|Overall Study|Other|14|||
161774585|NCT00242567|584217285|FG001|Overall Study|Other|9|||
161774586|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
161774587|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
161774588|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
161774589|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
161774590|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
161774591|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
161774592|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
161774593|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
161774594|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161774595|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161774596|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161774597|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
161774598|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
161774599|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
161774600|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
161774601|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
161774602|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
161774603|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
161774604|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
161867534|NCT00461630|584557660|FG001|Overall Study|Death|732|||
161867535|NCT00461630|584557659|FG000|Overall Study|Lost to Follow-up|108|||
161867536|NCT00461630|584557660|FG001|Overall Study|Lost to Follow-up|95|||
161867537|NCT02588612|584557664|FG000|Overall Study|Physician Decision|1|||
161867538|NCT02588612|584557664|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
161867539|NCT02588612|584557664|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
161867540|NCT02588612|584557664|FG000|Overall Study|Death prior to T-cell infusion|1|||
161867541|NCT03809663|584557665|FG000|Overall Study|Decision by sponsor|24|||
161867542|NCT03809663|584557666|FG001|Overall Study|Decision by sponsor|18|||
161867543|NCT03809663|584557667|FG002|Overall Study|Decision by sponsor|20|||
161867544|NCT03809663|584557668|FG003|Overall Study|Decision by sponsor|20|||
161867545|NCT03809663|584557669|FG004|Overall Study|Decision by sponsor|0|||
161867546|NCT03809663|584557670|FG005|Overall Study|Decision by sponsor|0|||
161867547|NCT03809663|584557665|FG000|Overall Study|Withdrawal by Subject|26|||
161867548|NCT03809663|584557666|FG001|Overall Study|Withdrawal by Subject|22|||
161867549|NCT03809663|584557667|FG002|Overall Study|Withdrawal by Subject|27|||
161867550|NCT03809663|584557668|FG003|Overall Study|Withdrawal by Subject|26|||
161867551|NCT03809663|584557669|FG004|Overall Study|Withdrawal by Subject|0|||
161867552|NCT03809663|584557670|FG005|Overall Study|Withdrawal by Subject|0|||
161867553|NCT03809663|584557665|FG000|Overall Study|Lost to Follow-up|1|||
161867554|NCT03809663|584557666|FG001|Overall Study|Lost to Follow-up|4|||
161867555|NCT03809663|584557667|FG002|Overall Study|Lost to Follow-up|1|||
161867556|NCT03809663|584557668|FG003|Overall Study|Lost to Follow-up|1|||
161867557|NCT03809663|584557669|FG004|Overall Study|Lost to Follow-up|0|||
161867558|NCT03809663|584557670|FG005|Overall Study|Lost to Follow-up|0|||
161867559|NCT03376789|584557671|FG000|Overall Study|Withdrawal by Subject|3|||
161867560|NCT03376789|584557672|FG001|Overall Study|Withdrawal by Subject|5|||
161867561|NCT03376789|584557671|FG000|Overall Study|Protocol Violation|0|||
161867562|NCT03376789|584557672|FG001|Overall Study|Protocol Violation|1|||
161867563|NCT03376789|584557671|FG000|Overall Study|Adverse Event|0|||
161867564|NCT03376789|584557672|FG001|Overall Study|Adverse Event|1|||
161867565|NCT03376789|584557671|FG000|Overall Study|Lost to Follow-up|1|||
161867566|NCT03376789|584557672|FG001|Overall Study|Lost to Follow-up|1|||
161867567|NCT03376789|584557671|FG000|Overall Study|Per sponsor due to noncompliance|1|||
161867568|NCT03376789|584557672|FG001|Overall Study|Per sponsor due to noncompliance|0|||
161867569|NCT03376789|584557671|FG000|Overall Study|Subject off study medication|0|||
161867570|NCT03376789|584557672|FG001|Overall Study|Subject off study medication|1|||
161867571|NCT01703260|584557673|FG000|Overall Study|Adverse Event|1|||
161867572|NCT01703260|584557674|FG001|Overall Study|Adverse Event|2|||
161867573|NCT01703260|584557675|FG002|Overall Study|Adverse Event|2|||
161867574|NCT01703260|584557673|FG000|Overall Study|Lost to Follow-up|1|||
161867575|NCT01703260|584557674|FG001|Overall Study|Lost to Follow-up|0|||
161867576|NCT01703260|584557675|FG002|Overall Study|Lost to Follow-up|0|||
161867577|NCT01703260|584557673|FG000|Overall Study|Withdrawal by Subject|0|||
161867578|NCT01703260|584557674|FG001|Overall Study|Withdrawal by Subject|0|||
161867579|NCT01703260|584557675|FG002|Overall Study|Withdrawal by Subject|1|||
161867580|NCT01703260|584557673|FG000|Overall Study|Study Termination|1|||
161867581|NCT01703260|584557674|FG001|Overall Study|Study Termination|2|||
161867582|NCT01703260|584557675|FG002|Overall Study|Study Termination|0|||
161867583|NCT02042014|584557676|FG000|Overall Study|Adverse Event|1|||
161867584|NCT02042014|584557676|FG000|Overall Study|Physician Decision|7|||
161867585|NCT02792062|584557680|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
161867586|NCT02792062|584557681|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867587|NCT02792062|584557682|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867588|NCT02792062|584557683|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867589|NCT02792062|584557684|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867590|NCT02792062|584557685|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867591|NCT03309943|584557688|FG000|Overall Study|Withdrawal by Subject|0|||
161867592|NCT03309943|584557689|FG001|Overall Study|Withdrawal by Subject|1|||
161867593|NCT03309943|584557688|FG000|Overall Study|Inappropriate behavior towards staff|0|||
161867594|NCT03309943|584557689|FG001|Overall Study|Inappropriate behavior towards staff|1|||
161867595|NCT03123393|584557690|FG000|Overall Study|Study Terminated by Sponsor|6|||
161867596|NCT03123393|584557691|FG001|Overall Study|Study Terminated by Sponsor|9|||
161867597|NCT03123393|584557690|FG000|Overall Study|Withdrawal by Subject|2|||
161867598|NCT03123393|584557691|FG001|Overall Study|Withdrawal by Subject|1|||
161867599|NCT03123393|584557690|FG000|Overall Study|Reason not Specified|13|||
161867600|NCT03123393|584557691|FG001|Overall Study|Reason not Specified|13|||
161867601|NCT02230904|584557693|FG000|Overall Study|Safety follow up could not take place|0|||
161867602|NCT02230904|584557694|FG001|Overall Study|Safety follow up could not take place|1|||
161867603|NCT01464424|584557695|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
161867604|NCT01464424|584557696|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
161867605|NCT05047211|584557700|FG000|Overall Study|Lost to Follow-up|8|||
161867606|NCT05047211|584557701|FG001|Overall Study|Lost to Follow-up|5|||
161867607|NCT00561392|584557702|FG000|Overall Study|Adverse Event|38|||
161867608|NCT00561392|584557702|FG000|Overall Study|Lack of Efficacy|2|||
161867609|NCT00561392|584557702|FG000|Overall Study|Protocol Violation|1|||
161867610|NCT00561392|584557702|FG000|Overall Study|Withdrawal by Subject|8|||
161867611|NCT00561392|584557702|FG000|Overall Study|Administrative problems|4|||
161867612|NCT03822468|584557703|FG000|Treatment Period|Progressive disease|98|||
161867613|NCT03822468|584557704|FG001|Treatment Period|Progressive disease|94|||
161867614|NCT03822468|584557703|FG000|Treatment Period|Adverse Event|21|||
161867615|NCT03822468|584557704|FG001|Treatment Period|Adverse Event|24|||
161867616|NCT03822468|584557703|FG000|Treatment Period|Withdrawal by Subject|9|||
161867617|NCT03822468|584557704|FG001|Treatment Period|Withdrawal by Subject|5|||
161867618|NCT03822468|584557703|FG000|Treatment Period|Physician Decision|9|||
161867619|NCT03822468|584557704|FG001|Treatment Period|Physician Decision|7|||
161867620|NCT03822468|584557703|FG000|Treatment Period|Protocol Violation|2|||
161867621|NCT03822468|584557704|FG001|Treatment Period|Protocol Violation|1|||
161867622|NCT03822468|584557703|FG000|Treatment Period|Death|2|||
161867623|NCT03822468|584557704|FG001|Treatment Period|Death|3|||
161867624|NCT03822468|584557703|FG000|Treatment Period|Lost to Follow-up|1|||
161867625|NCT03822468|584557704|FG001|Treatment Period|Lost to Follow-up|1|||
161867626|NCT03822468|584557703|FG000|Treatment Period|Sponsor decision|46|||
161867627|NCT03822468|584557704|FG001|Treatment Period|Sponsor decision|53|||
161867628|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
161867629|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
161867630|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
161867631|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
161867632|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Death|1|||
161867633|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161867634|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161867635|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161867636|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161867637|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161867638|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
161867639|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161867640|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
161867641|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
161867642|NCT03331796|584557705|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
161867643|NCT03331796|584557706|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
161867644|NCT03331796|584557707|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
161867645|NCT03331796|584557705|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
161867646|NCT03331796|584557706|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
161867647|NCT03331796|584557707|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
161867648|NCT03331796|584557705|FG000|Extended Follow-up|Adverse Event|1|||
161867649|NCT03331796|584557706|FG001|Extended Follow-up|Adverse Event|0|||
161867650|NCT03331796|584557707|FG002|Extended Follow-up|Adverse Event|1|||
161867651|NCT03331796|584557705|FG000|Extended Follow-up|Lost to Follow-up|0|||
161867652|NCT03331796|584557706|FG001|Extended Follow-up|Lost to Follow-up|0|||
161867653|NCT03331796|584557707|FG002|Extended Follow-up|Lost to Follow-up|1|||
161867654|NCT03331796|584557705|FG000|Extended Follow-up|Withdrawal by Subject|1|||
161867655|NCT03331796|584557706|FG001|Extended Follow-up|Withdrawal by Subject|0|||
161867656|NCT03331796|584557707|FG002|Extended Follow-up|Withdrawal by Subject|0|||
161867657|NCT03331796|584557705|FG000|Extended Follow-up|Termination of Funding|0|||
161867658|NCT03331796|584557706|FG001|Extended Follow-up|Termination of Funding|1|||
161867659|NCT03331796|584557707|FG002|Extended Follow-up|Termination of Funding|0|||
161867660|NCT01786993|584557709|FG000|Overall Study|Death|6|||
161867661|NCT01786993|584557710|FG001|Overall Study|Death|7|||
161867662|NCT01786993|584557709|FG000|Overall Study|Withdrawal by Subject|3|||
161867663|NCT01786993|584557710|FG001|Overall Study|Withdrawal by Subject|2|||
161867664|NCT01786993|584557709|FG000|Overall Study|Lost to Follow-up|0|||
161867665|NCT01786993|584557710|FG001|Overall Study|Lost to Follow-up|1|||
161867666|NCT01786993|584557709|FG000|Overall Study|Subject Non-Compliance|1|||
161867667|NCT01786993|584557710|FG001|Overall Study|Subject Non-Compliance|0|||
161867668|NCT01786993|584557709|FG000|Overall Study|System Explant|1|||
161867669|NCT01786993|584557710|FG001|Overall Study|System Explant|0|||
161867670|NCT01786993|584557709|FG000|Overall Study|Hospice Admission|1|||
161867671|NCT01786993|584557710|FG001|Overall Study|Hospice Admission|0|||
161867672|NCT00450437|584557711|FG000|Overall Study|Withdrawal by Subject|10|||
161867673|NCT00450437|584557712|FG001|Overall Study|Withdrawal by Subject|2|||
161867674|NCT00450437|584557713|FG002|Overall Study|Withdrawal by Subject|0|||
161867675|NCT00450437|584557714|FG003|Overall Study|Withdrawal by Subject|1|||
161867676|NCT00450437|584557711|FG000|Overall Study|Lost to Follow-up|31|||
161867677|NCT00450437|584557712|FG001|Overall Study|Lost to Follow-up|12|||
161867678|NCT00450437|584557713|FG002|Overall Study|Lost to Follow-up|19|||
161867679|NCT00450437|584557714|FG003|Overall Study|Lost to Follow-up|9|||
161867680|NCT00450437|584557711|FG000|Overall Study|Protocol Violation|0|||
161867681|NCT00450437|584557712|FG001|Overall Study|Protocol Violation|1|||
161867682|NCT00450437|584557713|FG002|Overall Study|Protocol Violation|0|||
161867683|NCT00450437|584557714|FG003|Overall Study|Protocol Violation|1|||
161867684|NCT00450437|584557711|FG000|Overall Study|Inappropriate enrollment|4|||
161867685|NCT00450437|584557712|FG001|Overall Study|Inappropriate enrollment|1|||
161867686|NCT00450437|584557713|FG002|Overall Study|Inappropriate enrollment|3|||
161867687|NCT00450437|584557714|FG003|Overall Study|Inappropriate enrollment|0|||
161867688|NCT00450437|584557711|FG000|Overall Study|Administrative reason|0|||
161867689|NCT00450437|584557712|FG001|Overall Study|Administrative reason|0|||
161867690|NCT00450437|584557713|FG002|Overall Study|Administrative reason|1|||
161867691|NCT00450437|584557714|FG003|Overall Study|Administrative reason|0|||
161867692|NCT00450437|584557711|FG000|Overall Study|Unable to Classify|1|||
161867693|NCT00450437|584557712|FG001|Overall Study|Unable to Classify|0|||
161867694|NCT00450437|584557713|FG002|Overall Study|Unable to Classify|1|||
161867695|NCT00450437|584557714|FG003|Overall Study|Unable to Classify|0|||
161867696|NCT01890122|584557715|FG000|Overall Study|Adverse Event|1|||
161867697|NCT01890122|584557716|FG001|Overall Study|Adverse Event|1|||
161867698|NCT01890122|584557717|FG002|Overall Study|Adverse Event|1|||
161867699|NCT01890122|584557718|FG003|Overall Study|Adverse Event|2|||
161867700|NCT01890122|584557715|FG000|Overall Study|Major Protocol Deviation|3|||
161867701|NCT01890122|584557716|FG001|Overall Study|Major Protocol Deviation|1|||
161867702|NCT01890122|584557717|FG002|Overall Study|Major Protocol Deviation|0|||
161867703|NCT01890122|584557718|FG003|Overall Study|Major Protocol Deviation|1|||
161867704|NCT01890122|584557715|FG000|Overall Study|Lost to Follow-up|0|||
161867705|NCT01890122|584557716|FG001|Overall Study|Lost to Follow-up|1|||
161867706|NCT01890122|584557717|FG002|Overall Study|Lost to Follow-up|2|||
161867707|NCT01890122|584557718|FG003|Overall Study|Lost to Follow-up|2|||
161867708|NCT01890122|584557715|FG000|Overall Study|Voluntary Withdrawal|8|||
161867709|NCT01890122|584557716|FG001|Overall Study|Voluntary Withdrawal|8|||
161867710|NCT01890122|584557717|FG002|Overall Study|Voluntary Withdrawal|2|||
161867711|NCT01890122|584557718|FG003|Overall Study|Voluntary Withdrawal|11|||
161867712|NCT01890122|584557715|FG000|Overall Study|Lack of Efficacy|14|||
161867713|NCT01890122|584557716|FG001|Overall Study|Lack of Efficacy|24|||
161867714|NCT01890122|584557717|FG002|Overall Study|Lack of Efficacy|7|||
161867715|NCT01890122|584557718|FG003|Overall Study|Lack of Efficacy|41|||
161867716|NCT01890122|584557715|FG000|Overall Study|Reason not Specified|0|||
161867717|NCT01890122|584557716|FG001|Overall Study|Reason not Specified|1|||
161867718|NCT01890122|584557717|FG002|Overall Study|Reason not Specified|1|||
161867719|NCT01890122|584557718|FG003|Overall Study|Reason not Specified|2|||
161867720|NCT01890122|584557715|FG000|Overall Study|Randomized but not Treated|1|||
161867721|NCT01890122|584557716|FG001|Overall Study|Randomized but not Treated|1|||
161867722|NCT01890122|584557717|FG002|Overall Study|Randomized but not Treated|0|||
161867723|NCT01890122|584557718|FG003|Overall Study|Randomized but not Treated|0|||
161867724|NCT04025879|584557719|FG000|Randomization|Participant withdrew consent|0|||
161867725|NCT04025879|584557720|FG001|Randomization|Participant withdrew consent|1|||
161867726|NCT04025879|584557719|FG000|Randomization|Participant no longer met study criteria|1|||
161867727|NCT04025879|584557720|FG001|Randomization|Participant no longer met study criteria|1|||
161867728|NCT04025879|584557719|FG000|Treatment|Ongoing treatment|10|||
161867729|NCT04025879|584557720|FG001|Treatment|Ongoing treatment|8|||
161867730|NCT04025879|584557719|FG000|Treatment|Disease progression/recurrence|36|||
161867731|NCT04025879|584557720|FG001|Treatment|Disease progression/recurrence|72|||
161867732|NCT04025879|584557719|FG000|Treatment|Study drug toxicity|36|||
161867733|NCT04025879|584557720|FG001|Treatment|Study drug toxicity|13|||
161867734|NCT04025879|584557719|FG000|Treatment|Death|2|||
161867735|NCT04025879|584557720|FG001|Treatment|Death|0|||
161867736|NCT04025879|584557719|FG000|Treatment|Adverse event unrelated to study drug|21|||
161867737|NCT04025879|584557720|FG001|Treatment|Adverse event unrelated to study drug|14|||
161867738|NCT04025879|584557719|FG000|Treatment|Participant request to discontinue study treatment|16|||
161867739|NCT04025879|584557720|FG001|Treatment|Participant request to discontinue study treatment|8|||
161867740|NCT04025879|584557719|FG000|Treatment|Participant withdrew consent|1|||
161867741|NCT04025879|584557720|FG001|Treatment|Participant withdrew consent|3|||
161867742|NCT04025879|584557719|FG000|Treatment|Participant no longer meets study criteria|3|||
161867743|NCT04025879|584557720|FG001|Treatment|Participant no longer meets study criteria|2|||
161867744|NCT04025879|584557719|FG000|Treatment|Lost to Follow-up|1|||
161867745|NCT04025879|584557720|FG001|Treatment|Lost to Follow-up|0|||
161867746|NCT04025879|584557719|FG000|Treatment|Other reasons|15|||
161867747|NCT04025879|584557720|FG001|Treatment|Other reasons|17|||
161867748|NCT04025879|584557719|FG000|Treatment|Administrative reason by sponsor|0|||
161867749|NCT04025879|584557720|FG001|Treatment|Administrative reason by sponsor|1|||
161867750|NCT04025879|584557719|FG000|Treatment|Not reported|2|||
161867751|NCT04025879|584557720|FG001|Treatment|Not reported|0|||
161867752|NCT00071110|584557725|FG000|Overall Study|Protocol Violation|0|||
161867753|NCT00071110|584557726|FG001|Overall Study|Protocol Violation|4|||
161867754|NCT02640664|584557733|FG000|Epoch 1|Withdrawal of informed consent|1|||
161867755|NCT02640664|584557734|FG001|Epoch 1|Withdrawal of informed consent|0|||
161867756|NCT02640664|584557735|FG002|Epoch 1|Withdrawal of informed consent|0|||
161867757|NCT02640664|584557733|FG000|Epoch 1|Death|0|||
161867758|NCT02640664|584557734|FG001|Epoch 1|Death|0|||
161867759|NCT02640664|584557735|FG002|Epoch 1|Death|1|||
161867760|NCT02640664|584557733|FG000|Epoch 2|Withdrawal of informed consent|3|||
161867761|NCT02640664|584557734|FG001|Epoch 2|Withdrawal of informed consent|4|||
161867762|NCT02640664|584557735|FG002|Epoch 2|Withdrawal of informed consent|2|||
161867763|NCT02640664|584557733|FG000|Epoch 2|Subject/guardian decision|0|||
161867764|NCT02640664|584557734|FG001|Epoch 2|Subject/guardian decision|2|||
161867765|NCT02640664|584557735|FG002|Epoch 2|Subject/guardian decision|2|||
161867766|NCT02640664|584557733|FG000|Epoch 2|Lost to Follow-up|3|||
161867767|NCT02640664|584557734|FG001|Epoch 2|Lost to Follow-up|4|||
161867768|NCT02640664|584557735|FG002|Epoch 2|Lost to Follow-up|1|||
161867769|NCT02640664|584557733|FG000|Epoch 2|Death|0|||
161867770|NCT02640664|584557734|FG001|Epoch 2|Death|0|||
161867771|NCT02640664|584557735|FG002|Epoch 2|Death|1|||
161867772|NCT05514873|584557740|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
161867773|NCT05514873|584557740|FG000|Main Treatment Period|Adverse Event|2|||
161867774|NCT05514873|584557740|FG000|Extension Treatment Period|Lost to Follow-up|3|||
161867775|NCT02729025|584557741|FG000|Overall Study|Sponsor Decision|0|||
161867776|NCT02729025|584557742|FG001|Overall Study|Sponsor Decision|1|||
161867777|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
161867778|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
161867779|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
161867780|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
161867781|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
161867782|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
161867783|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
161867784|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161867785|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161867786|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161867787|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
161867788|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
161867789|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
161867790|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
161867791|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
161867792|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
161867793|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
161867794|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
161867795|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
161867796|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
161867797|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
161867798|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
161867799|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
161867800|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
161867801|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
161867802|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
161867803|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
161867804|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161867805|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161867806|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161867807|NCT05343000|584558985|FG000|Overall Study|Physician Decision|2|||
161867808|NCT04432831|584558986|FG000|Overall Study|Withdrawal by Subject|24|||
161867809|NCT04432831|584558987|FG001|Overall Study|Withdrawal by Subject|28|||
161867810|NCT04432831|584558988|FG002|Overall Study|Withdrawal by Subject|21|||
161867811|NCT04432831|584558986|FG000|Overall Study|Death|23|||
161867812|NCT04432831|584558987|FG001|Overall Study|Death|23|||
161867813|NCT04432831|584558988|FG002|Overall Study|Death|17|||
161867814|NCT04432831|584558986|FG000|Overall Study|Lost to Follow-up|15|||
161867815|NCT04432831|584558987|FG001|Overall Study|Lost to Follow-up|15|||
161867816|NCT04432831|584558988|FG002|Overall Study|Lost to Follow-up|12|||
161867817|NCT04432831|584558986|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
161867818|NCT04432831|584558987|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
161867819|NCT04432831|584558988|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
161867820|NCT04432831|584558986|FG000|Overall Study|Reason Not Specified|7|||
161867821|NCT04432831|584558987|FG001|Overall Study|Reason Not Specified|11|||
161867822|NCT04432831|584558988|FG002|Overall Study|Reason Not Specified|9|||
161867823|NCT04432831|584558986|FG000|Overall Study|Adverse Event|7|||
161867824|NCT04432831|584558987|FG001|Overall Study|Adverse Event|7|||
161867825|NCT04432831|584558988|FG002|Overall Study|Adverse Event|7|||
161867826|NCT04432831|584558986|FG000|Overall Study|Physician Decision|1|||
161867827|NCT04432831|584558987|FG001|Overall Study|Physician Decision|3|||
161867828|NCT04432831|584558988|FG002|Overall Study|Physician Decision|6|||
161867829|NCT04432831|584558986|FG000|Overall Study|Protocol Violation|1|||
161867830|NCT04432831|584558987|FG001|Overall Study|Protocol Violation|0|||
161867831|NCT04432831|584558988|FG002|Overall Study|Protocol Violation|2|||
161867832|NCT04432831|584558986|FG000|Overall Study|Pregnancy|0|||
161867833|NCT04432831|584558987|FG001|Overall Study|Pregnancy|1|||
161867834|NCT04432831|584558988|FG002|Overall Study|Pregnancy|0|||
161867835|NCT04432831|584558986|FG000|Overall Study|Lack of Efficacy|0|||
161867836|NCT04432831|584558987|FG001|Overall Study|Lack of Efficacy|0|||
161867837|NCT04432831|584558988|FG002|Overall Study|Lack of Efficacy|2|||
161867838|NCT03782792|584558989|FG000|Overall Study|Patient left the country|0|||
161867839|NCT03782792|584558990|FG001|Overall Study|Patient left the country|1|||
161867840|NCT03782792|584558989|FG000|Overall Study|Withdrawal by Subject|1|||
161867841|NCT03782792|584558990|FG001|Overall Study|Withdrawal by Subject|2|||
161867842|NCT00617890|584558991|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
161867843|NCT00617890|584558992|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
161867844|NCT00617890|584558993|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
161867845|NCT00617890|584558994|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
161867846|NCT00617890|584558991|FG000|Overall Study|Lack of Efficacy|23|||
161867847|NCT00617890|584558992|FG001|Overall Study|Lack of Efficacy|26|||
161867848|NCT00617890|584558993|FG002|Overall Study|Lack of Efficacy|30|||
161867849|NCT00617890|584558994|FG003|Overall Study|Lack of Efficacy|97|||
161867850|NCT00617890|584558991|FG000|Overall Study|Lost to Follow-up|0|||
161867851|NCT00617890|584558992|FG001|Overall Study|Lost to Follow-up|0|||
161867852|NCT00617890|584558993|FG002|Overall Study|Lost to Follow-up|1|||
161867853|NCT00617890|584558994|FG003|Overall Study|Lost to Follow-up|2|||
161867854|NCT00617890|584558991|FG000|Overall Study|Withdrawal by Subject|4|||
161867855|NCT00617890|584558992|FG001|Overall Study|Withdrawal by Subject|1|||
161867856|NCT00617890|584558993|FG002|Overall Study|Withdrawal by Subject|0|||
161867857|NCT00617890|584558994|FG003|Overall Study|Withdrawal by Subject|2|||
161867858|NCT00617890|584558991|FG000|Overall Study|Protocol Violation|2|||
161867859|NCT00617890|584558992|FG001|Overall Study|Protocol Violation|1|||
161867860|NCT00617890|584558993|FG002|Overall Study|Protocol Violation|0|||
161867861|NCT00617890|584558994|FG003|Overall Study|Protocol Violation|0|||
161867862|NCT00617890|584558991|FG000|Overall Study|Adverse Event|1|||
161867863|NCT00617890|584558992|FG001|Overall Study|Adverse Event|0|||
161867864|NCT00617890|584558993|FG002|Overall Study|Adverse Event|3|||
161867865|NCT00617890|584558994|FG003|Overall Study|Adverse Event|8|||
161867866|NCT00617890|584558991|FG000|Overall Study|Not treated|1|||
161867867|NCT00617890|584558992|FG001|Overall Study|Not treated|0|||
161867868|NCT00617890|584558993|FG002|Overall Study|Not treated|1|||
161867869|NCT00617890|584558994|FG003|Overall Study|Not treated|1|||
161867870|NCT00154284|584558998|FG000|Overall Study|Adverse Event|6|||
161867871|NCT00154284|584558999|FG001|Overall Study|Adverse Event|9|||
161867872|NCT00154284|584558998|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161867873|NCT00154284|584558999|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161867874|NCT00154284|584558998|FG000|Overall Study|Lack of Efficacy|1|||
161867875|NCT00154284|584558999|FG001|Overall Study|Lack of Efficacy|2|||
161867876|NCT00154284|584558998|FG000|Overall Study|Protocol Violation|0|||
161867877|NCT00154284|584558999|FG001|Overall Study|Protocol Violation|1|||
161867878|NCT00427648|584559003|FG000|Overall Study|Protocol Violation|1|||
161867879|NCT00427648|584559004|FG001|Overall Study|Protocol Violation|2|||
161867880|NCT00427648|584559003|FG000|Overall Study|Adverse Event|0|||
161867881|NCT00427648|584559004|FG001|Overall Study|Adverse Event|1|||
161867882|NCT01609296|584559005|FG000|Overall Study|Death|253|||
161867883|NCT01609296|584559005|FG000|Overall Study|Withdrawal by Subject|151|||
161867884|NCT01609296|584559005|FG000|Overall Study|Lost to Follow-up|21|||
161867885|NCT01609296|584559005|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
161867886|NCT01609296|584559005|FG000|Overall Study|missed visit but known to be alive|28|||
161867887|NCT01681212|584559008|FG000|Overall Study|No longer met study criteria|5|||
161867888|NCT01681212|584559008|FG000|Overall Study|Administrative reason by sponsor|1|||
161867889|NCT01464333|584559009|FG000|Overall Study|Adverse Event|34|||
161867890|NCT01464333|584559009|FG000|Overall Study|Lack of Efficacy|72|||
161867891|NCT01464333|584559009|FG000|Overall Study|Withdrawal by Subject|11|||
161867892|NCT01464333|584559009|FG000|Overall Study|Other|4|||
161867893|NCT01464333|584559009|FG000|Overall Study|No Hospital Visit|42|||
161867894|NCT03321968|584559013|FG000|Overall Study|Withdrawal by Subject|1|||
161867895|NCT03321968|584559014|FG001|Overall Study|Withdrawal by Subject|2|||
161867896|NCT03321968|584559015|FG002|Overall Study|Withdrawal by Subject|1|||
161867897|NCT03321968|584559013|FG000|Overall Study|Lost to Follow-up|2|||
161867898|NCT03321968|584559014|FG001|Overall Study|Lost to Follow-up|0|||
161867899|NCT03321968|584559015|FG002|Overall Study|Lost to Follow-up|1|||
161867900|NCT03321968|584559013|FG000|Overall Study|Other than specified|0|||
161867901|NCT03321968|584559014|FG001|Overall Study|Other than specified|0|||
161867902|NCT03321968|584559015|FG002|Overall Study|Other than specified|1|||
161867903|NCT02282813|584559018|FG000|Overall Study|Withdrawal by Subject|4|||
161867904|NCT02282813|584559019|FG001|Overall Study|Withdrawal by Subject|5|||
161867905|NCT02282813|584559020|FG002|Overall Study|Withdrawal by Subject|0|||
161867906|NCT02282813|584559018|FG000|Overall Study|Adverse Event|3|||
161867907|NCT02282813|584559019|FG001|Overall Study|Adverse Event|10|||
161867908|NCT02282813|584559020|FG002|Overall Study|Adverse Event|1|||
161867909|NCT02282813|584559018|FG000|Overall Study|Subject non-compliance|1|||
161867910|NCT02282813|584559019|FG001|Overall Study|Subject non-compliance|4|||
161867911|NCT02282813|584559020|FG002|Overall Study|Subject non-compliance|0|||
161867912|NCT02282813|584559018|FG000|Overall Study|Physician Decision|0|||
161867913|NCT02282813|584559019|FG001|Overall Study|Physician Decision|3|||
161867914|NCT02282813|584559020|FG002|Overall Study|Physician Decision|1|||
161867915|NCT02282813|584559018|FG000|Overall Study|Lost to Follow-up|2|||
161867916|NCT02282813|584559019|FG001|Overall Study|Lost to Follow-up|0|||
161867917|NCT02282813|584559020|FG002|Overall Study|Lost to Follow-up|1|||
161867918|NCT02282813|584559018|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
161867919|NCT02282813|584559019|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
161867920|NCT02282813|584559020|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
161867921|NCT02282813|584559018|FG000|Overall Study|Lack of Efficacy|1|||
161867922|NCT02282813|584559019|FG001|Overall Study|Lack of Efficacy|0|||
161867923|NCT02282813|584559020|FG002|Overall Study|Lack of Efficacy|0|||
161867924|NCT02282813|584559018|FG000|Overall Study|Administrative reasons|0|||
161867925|NCT02282813|584559019|FG001|Overall Study|Administrative reasons|1|||
161867926|NCT02282813|584559020|FG002|Overall Study|Administrative reasons|0|||
161867927|NCT00529308|584559021|FG000|Overall Study|Withdrawal by Subject|1|||
161867928|NCT00529308|584559022|FG001|Overall Study|Withdrawal by Subject|1|||
161867929|NCT06509438|584559023|FG000|Overall Study|Adverse Event|1|||
161867930|NCT06509438|584559023|FG000|Overall Study|Lost to Follow-up|3|||
161867931|NCT00745901|584559025|FG000|Overall Study|Adverse Event|3|||
161867932|NCT00745901|584559026|FG001|Overall Study|Adverse Event|4|||
161867933|NCT00745901|584559025|FG000|Overall Study|Protocol Violation|0|||
161867934|NCT00745901|584559026|FG001|Overall Study|Protocol Violation|1|||
161867935|NCT00745901|584559025|FG000|Overall Study|Withdrawal by Subject|1|||
161867936|NCT00745901|584559026|FG001|Overall Study|Withdrawal by Subject|0|||
161867937|NCT00745901|584559025|FG000|Overall Study|Lost to Follow-up|7|||
161867938|NCT00745901|584559026|FG001|Overall Study|Lost to Follow-up|4|||
161867939|NCT00745901|584559025|FG000|Overall Study|Pregnancy|2|||
161867940|NCT00745901|584559026|FG001|Overall Study|Pregnancy|4|||
161867941|NCT00745901|584559025|FG000|Overall Study|Lack of compliance|2|||
161867942|NCT00745901|584559026|FG001|Overall Study|Lack of compliance|2|||
161867943|NCT00745901|584559025|FG000|Overall Study|Patient's next menses did not start with|1|||
161867944|NCT00745901|584559026|FG001|Overall Study|Patient's next menses did not start with|0|||
161867945|NCT00745901|584559025|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
161867946|NCT00745901|584559026|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
161867947|NCT00745901|584559025|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
161867948|NCT00745901|584559026|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
161867949|NCT00745901|584559025|FG000|Overall Study|Patient didn't take any study medication|7|||
161867950|NCT00745901|584559026|FG001|Overall Study|Patient didn't take any study medication|3|||
161867951|NCT01753310|584559028|FG000|Overall Study|Entered into open label extension study|25|||
161867952|NCT01753310|584559029|FG001|Overall Study|Entered into open label extension study|22|||
161867953|NCT01753310|584559028|FG000|Overall Study|Adverse Event|1|||
161867954|NCT01753310|584559029|FG001|Overall Study|Adverse Event|0|||
161867955|NCT01753310|584559028|FG000|Overall Study|Lost to Follow-up|2|||
161867956|NCT01753310|584559029|FG001|Overall Study|Lost to Follow-up|0|||
161867957|NCT01753310|584559028|FG000|Overall Study|Subject decision|2|||
161867958|NCT01753310|584559029|FG001|Overall Study|Subject decision|2|||
161867959|NCT01753310|584559028|FG000|Overall Study|Sponsor decision|1|||
161867960|NCT01753310|584559029|FG001|Overall Study|Sponsor decision|0|||
161867961|NCT01753310|584559028|FG000|Overall Study|Withdrawal by Subject|1|||
161867962|NCT01753310|584559029|FG001|Overall Study|Withdrawal by Subject|0|||
161867963|NCT05581641|584559030|FG000|Overall Study|Withdrawal by Subject|0|||
161867964|NCT05581641|584559031|FG001|Overall Study|Withdrawal by Subject|1|||
161867965|NCT05581641|584559032|FG002|Overall Study|Withdrawal by Subject|3|||
161867966|NCT05581641|584559033|FG003|Overall Study|Withdrawal by Subject|1|||
161867967|NCT05581641|584559030|FG000|Overall Study|Lost to Follow-up|0|||
161867968|NCT05581641|584559031|FG001|Overall Study|Lost to Follow-up|1|||
161867969|NCT05581641|584559032|FG002|Overall Study|Lost to Follow-up|0|||
161867970|NCT05581641|584559033|FG003|Overall Study|Lost to Follow-up|1|||
161867971|NCT05581641|584559030|FG000|Overall Study|Protocol Violation|1|||
161867972|NCT05581641|584559031|FG001|Overall Study|Protocol Violation|0|||
161867973|NCT05581641|584559032|FG002|Overall Study|Protocol Violation|0|||
161867974|NCT05581641|584559033|FG003|Overall Study|Protocol Violation|0|||
161867975|NCT05581641|584559030|FG000|Overall Study|Other|1|||
161867976|NCT05581641|584559031|FG001|Overall Study|Other|0|||
161867977|NCT05581641|584559032|FG002|Overall Study|Other|2|||
161867978|NCT05581641|584559033|FG003|Overall Study|Other|1|||
161867979|NCT04390763|584559034|FG000|Safety run-in Part|Adverse Event|4|||
161867980|NCT04390763|584559035|FG001|Safety run-in Part|Adverse Event|0|||
161867981|NCT04390763|584559036|FG002|Safety run-in Part|Adverse Event|0|||
161867982|NCT04390763|584559037|FG003|Safety run-in Part|Adverse Event|0|||
161867983|NCT04390763|584559034|FG000|Safety run-in Part|Physician Decision|1|||
161867984|NCT04390763|584559035|FG001|Safety run-in Part|Physician Decision|0|||
161867985|NCT04390763|584559036|FG002|Safety run-in Part|Physician Decision|0|||
161867986|NCT04390763|584559037|FG003|Safety run-in Part|Physician Decision|0|||
161867987|NCT04390763|584559034|FG000|Safety run-in Part|Progressive Disease|6|||
161867988|NCT04390763|584559035|FG001|Safety run-in Part|Progressive Disease|0|||
161867989|NCT04390763|584559036|FG002|Safety run-in Part|Progressive Disease|0|||
161867990|NCT04390763|584559037|FG003|Safety run-in Part|Progressive Disease|0|||
161867991|NCT04390763|584559034|FG000|Randomized Part|Adverse Event|0|||
161867992|NCT04390763|584559035|FG001|Randomized Part|Adverse Event|11|||
161867993|NCT04390763|584559036|FG002|Randomized Part|Adverse Event|5|||
161867994|NCT04390763|584559037|FG003|Randomized Part|Adverse Event|5|||
161867995|NCT04390763|584559034|FG000|Randomized Part|Death|0|||
161867996|NCT04390763|584559035|FG001|Randomized Part|Death|3|||
161867997|NCT04390763|584559036|FG002|Randomized Part|Death|4|||
161867998|NCT04390763|584559037|FG003|Randomized Part|Death|2|||
161867999|NCT04390763|584559034|FG000|Randomized Part|Physician Decision|0|||
161868000|NCT04390763|584559035|FG001|Randomized Part|Physician Decision|2|||
161868001|NCT04390763|584559036|FG002|Randomized Part|Physician Decision|2|||
161868002|NCT04390763|584559037|FG003|Randomized Part|Physician Decision|9|||
161868003|NCT04390763|584559034|FG000|Randomized Part|Progressive Disease|0|||
161868004|NCT04390763|584559035|FG001|Randomized Part|Progressive Disease|24|||
161868005|NCT04390763|584559036|FG002|Randomized Part|Progressive Disease|31|||
161868006|NCT04390763|584559037|FG003|Randomized Part|Progressive Disease|23|||
161868007|NCT04390763|584559034|FG000|Randomized Part|Study terminated by sponsor|0|||
161868008|NCT04390763|584559035|FG001|Randomized Part|Study terminated by sponsor|1|||
161868009|NCT04390763|584559036|FG002|Randomized Part|Study terminated by sponsor|0|||
161868010|NCT04390763|584559037|FG003|Randomized Part|Study terminated by sponsor|0|||
161868011|NCT04390763|584559034|FG000|Randomized Part|Participant Decision|0|||
161868012|NCT04390763|584559035|FG001|Randomized Part|Participant Decision|5|||
161868013|NCT04390763|584559036|FG002|Randomized Part|Participant Decision|7|||
161868014|NCT04390763|584559037|FG003|Randomized Part|Participant Decision|6|||
161868015|NCT04390763|584559034|FG000|Randomized Part|Not treated|0|||
161868016|NCT04390763|584559035|FG001|Randomized Part|Not treated|4|||
161868017|NCT04390763|584559036|FG002|Randomized Part|Not treated|2|||
161868018|NCT04390763|584559037|FG003|Randomized Part|Not treated|7|||
161868019|NCT01956773|584559042|FG000|Overall Study|Lost to Follow-up|628|||
161868020|NCT01956773|584559043|FG001|Overall Study|Lost to Follow-up|1|||
161868021|NCT01383174|584559046|FG000|3 Month Assessment|Death|0|||
161868022|NCT01383174|584559047|FG001|3 Month Assessment|Death|1|||
161868023|NCT01383174|584559046|FG000|3 Month Assessment|Lost to Follow-up|2|||
161868024|NCT01383174|584559047|FG001|3 Month Assessment|Lost to Follow-up|0|||
161868025|NCT01383174|584559046|FG000|3 Month Assessment|Refused to complete|4|||
161868026|NCT01383174|584559047|FG001|3 Month Assessment|Refused to complete|0|||
161868027|NCT01383174|584559046|FG000|6 Month Assessment|Lost to Follow-up|1|||
161868028|NCT01383174|584559047|FG001|6 Month Assessment|Lost to Follow-up|1|||
161868029|NCT01383174|584559046|FG000|6 Month Assessment|Refused to complete|4|||
161868030|NCT01383174|584559047|FG001|6 Month Assessment|Refused to complete|0|||
161868031|NCT01153815|584559048|FG000|Overall Study|Adverse Event|3|||
161868032|NCT01153815|584559049|FG001|Overall Study|Adverse Event|1|||
161868033|NCT01153815|584559048|FG000|Overall Study|Withdrawal by Subject|6|||
161868034|NCT01153815|584559049|FG001|Overall Study|Withdrawal by Subject|4|||
161868035|NCT02169271|584559052|FG000|Overall Study|Protocol Violation|1|||
161868036|NCT02169271|584559053|FG001|Overall Study|Protocol Violation|2|||
161868037|NCT03591874|584559054|FG000|Overall Study|Adverse Event|4|||
161868038|NCT03591874|584559055|FG001|Overall Study|Adverse Event|0|||
161868039|NCT03591874|584559054|FG000|Overall Study|Withdrawal by Subject|2|||
161868040|NCT03591874|584559055|FG001|Overall Study|Withdrawal by Subject|1|||
161868041|NCT03591874|584559054|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
161868042|NCT03591874|584559055|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
161868043|NCT03591874|584559054|FG000|Overall Study|On Study at Time of Study Termination|12|||
161868044|NCT03591874|584559055|FG001|Overall Study|On Study at Time of Study Termination|6|||
161868045|NCT03194542|584559058|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
161868046|NCT03194542|584559059|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161868047|NCT03194542|584559060|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161868048|NCT03194542|584559061|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161868049|NCT03194542|584559058|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
161868050|NCT03194542|584559059|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
161868051|NCT03194542|584559060|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
161868052|NCT03194542|584559061|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
161868053|NCT03194542|584559058|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
161868054|NCT03194542|584559059|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
161868055|NCT03194542|584559060|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
161868056|NCT03194542|584559061|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
161868057|NCT03194542|584559058|FG000|Overall Study|Loss of Response|4|||
161868058|NCT03194542|584559059|FG001|Overall Study|Loss of Response|2|||
161868059|NCT03194542|584559060|FG002|Overall Study|Loss of Response|3|||
161868060|NCT03194542|584559061|FG003|Overall Study|Loss of Response|4|||
161868061|NCT03194542|584559058|FG000|Overall Study|Physician Decision|0|||
161868062|NCT03194542|584559059|FG001|Overall Study|Physician Decision|1|||
161868063|NCT03194542|584559060|FG002|Overall Study|Physician Decision|0|||
161868064|NCT03194542|584559061|FG003|Overall Study|Physician Decision|0|||
161868065|NCT03194542|584559058|FG000|Overall Study|Lack of Efficacy|2|||
161868066|NCT03194542|584559059|FG001|Overall Study|Lack of Efficacy|2|||
161868067|NCT03194542|584559060|FG002|Overall Study|Lack of Efficacy|2|||
161868068|NCT03194542|584559061|FG003|Overall Study|Lack of Efficacy|6|||
161868069|NCT03194542|584559058|FG000|Overall Study|Withdrawal by Subject|2|||
161868070|NCT03194542|584559059|FG001|Overall Study|Withdrawal by Subject|1|||
161868071|NCT03194542|584559060|FG002|Overall Study|Withdrawal by Subject|5|||
161868072|NCT03194542|584559061|FG003|Overall Study|Withdrawal by Subject|4|||
161868073|NCT03194542|584559058|FG000|Overall Study|Progressive Disease|1|||
161868074|NCT03194542|584559059|FG001|Overall Study|Progressive Disease|0|||
161868075|NCT03194542|584559060|FG002|Overall Study|Progressive Disease|1|||
161868076|NCT03194542|584559061|FG003|Overall Study|Progressive Disease|1|||
161868077|NCT03194542|584559058|FG000|Overall Study|Adverse Event|1|||
161868078|NCT03194542|584559059|FG001|Overall Study|Adverse Event|2|||
161868079|NCT03194542|584559060|FG002|Overall Study|Adverse Event|0|||
161868080|NCT03194542|584559061|FG003|Overall Study|Adverse Event|5|||
161868081|NCT03194542|584559058|FG000|Overall Study|Death|1|||
161868082|NCT03194542|584559059|FG001|Overall Study|Death|2|||
161868083|NCT03194542|584559060|FG002|Overall Study|Death|0|||
161868084|NCT03194542|584559061|FG003|Overall Study|Death|5|||
161868085|NCT03194542|584559058|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
161868086|NCT03194542|584559059|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
161868087|NCT03194542|584559060|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
161868088|NCT03194542|584559061|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
161868089|NCT03859427|584559065|FG000|Overall Study|Withdrawal by Subject|4|||
161868090|NCT03859427|584559066|FG001|Overall Study|Withdrawal by Subject|7|||
161868091|NCT03859427|584559065|FG000|Overall Study|Decision by sponsor|0|||
161868092|NCT03859427|584559066|FG001|Overall Study|Decision by sponsor|3|||
161868093|NCT03859427|584559065|FG000|Overall Study|Lost to Follow-up|3|||
161868094|NCT03859427|584559066|FG001|Overall Study|Lost to Follow-up|2|||
161868095|NCT03859427|584559065|FG000|Overall Study|Death|22|||
161868096|NCT03859427|584559066|FG001|Overall Study|Death|25|||
161868097|NCT00722137|584559067|FG000|Overall Study|Overt Disease Progression|5|||
161868098|NCT00722137|584559068|FG001|Overall Study|Overt Disease Progression|4|||
161868099|NCT00722137|584559067|FG000|Overall Study|Adverse Event|17|||
161868100|NCT00722137|584559068|FG001|Overall Study|Adverse Event|21|||
161868101|NCT00722137|584559067|FG000|Overall Study|Death|12|||
161868102|NCT00722137|584559068|FG001|Overall Study|Death|7|||
161868103|NCT00722137|584559067|FG000|Overall Study|Withdrawal by Subject|6|||
161868104|NCT00722137|584559068|FG001|Overall Study|Withdrawal by Subject|9|||
161868105|NCT00722137|584559067|FG000|Overall Study|Other Reason Unknown|3|||
161868106|NCT00722137|584559068|FG001|Overall Study|Other Reason Unknown|4|||
161868107|NCT00722137|584559067|FG000|Overall Study|Randomized But Not Treated|2|||
161868108|NCT00722137|584559068|FG001|Overall Study|Randomized But Not Treated|3|||
161868109|NCT01295671|584560614|FG000|Overall Study|Lost to Follow-up|4|||
161868110|NCT01295671|584560615|FG001|Overall Study|Lost to Follow-up|6|||
161868111|NCT01295671|584560616|FG002|Overall Study|Lost to Follow-up|3|||
161868112|NCT01295671|584560614|FG000|Overall Study|Withdrawal by Subject|3|||
161868113|NCT01295671|584560615|FG001|Overall Study|Withdrawal by Subject|1|||
161868114|NCT01295671|584560616|FG002|Overall Study|Withdrawal by Subject|0|||
161868115|NCT02395848|584560619|FG000|Overall Study|Lost to Follow-up|2|||
161868116|NCT02276560|584560620|FG000|Overall Study|Adverse Event|1|||
161868117|NCT02276560|584560621|FG001|Overall Study|Adverse Event|0|||
161868118|NCT02276560|584560622|FG002|Overall Study|Adverse Event|0|||
161868119|NCT02058537|584560623|FG000|Overall Study|Withdrawal by Subject|1|||
161868120|NCT02126579|584560624|FG000|Overall Study|disease progression|0|||
161868121|NCT02126579|584560625|FG001|Overall Study|disease progression|0|||
161868122|NCT02126579|584560626|FG002|Overall Study|disease progression|0|||
161868123|NCT02126579|584560627|FG003|Overall Study|disease progression|1|||
161868124|NCT02126579|584560628|FG004|Overall Study|disease progression|0|||
161868125|NCT02126579|584560629|FG005|Overall Study|disease progression|0|||
161868126|NCT02126579|584560630|FG006|Overall Study|disease progression|1|||
161868127|NCT01780038|584560633|FG000|Overall Study|Lost to Follow-up|4|||
161868128|NCT01780038|584560634|FG001|Overall Study|Lost to Follow-up|1|||
161868129|NCT01609010|584560637|FG000|Overall Study|Stable disease (SD)|22|||
161868130|NCT01609010|584560638|FG001|Overall Study|Stable disease (SD)|16|||
161868131|NCT01609010|584560637|FG000|Overall Study|Progressive disease (PD)|8|||
161868132|NCT01609010|584560638|FG001|Overall Study|Progressive disease (PD)|10|||
161868133|NCT01609010|584560637|FG000|Overall Study|Adverse Event|3|||
161868134|NCT01609010|584560638|FG001|Overall Study|Adverse Event|6|||
161868135|NCT01609010|584560637|FG000|Overall Study|Withdrawal by Subject|2|||
161868136|NCT01609010|584560638|FG001|Overall Study|Withdrawal by Subject|2|||
161868137|NCT01609010|584560637|FG000|Overall Study|Other|2|||
161868138|NCT01609010|584560638|FG001|Overall Study|Other|0|||
161868139|NCT01609010|584560637|FG000|Overall Study|Other malignancy|1|||
161868140|NCT01609010|584560638|FG001|Overall Study|Other malignancy|0|||
161868141|NCT01609010|584560637|FG000|Overall Study|Pathology review|2|||
161868142|NCT01609010|584560638|FG001|Overall Study|Pathology review|1|||
161868143|NCT01609010|584560637|FG000|Overall Study|Protocol Violation|1|||
161868144|NCT01609010|584560638|FG001|Overall Study|Protocol Violation|1|||
161868145|NCT01609010|584560637|FG000|Overall Study|New cancer|1|||
161868146|NCT01609010|584560638|FG001|Overall Study|New cancer|0|||
161868147|NCT01609010|584560637|FG000|Overall Study|Lost to Follow-up|1|||
161868148|NCT01609010|584560638|FG001|Overall Study|Lost to Follow-up|1|||
161868149|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
161868150|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
161868151|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
161868152|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
161868153|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
161868154|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
161868155|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
161868156|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
161868157|NCT01134107|584560639|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
161868158|NCT01134107|584560640|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
161868159|NCT01134107|584560639|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
161868160|NCT01134107|584560640|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
161868161|NCT01134107|584560639|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
161868162|NCT01134107|584560640|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
161868163|NCT04541589|584560646|FG000|Treatment Period|Adverse Event|8|||
161868164|NCT04541589|584560647|FG001|Treatment Period|Adverse Event|2|||
161868165|NCT04541589|584560646|FG000|Treatment Period|Physician Decision|3|||
161868166|NCT04541589|584560647|FG001|Treatment Period|Physician Decision|1|||
161868167|NCT04541589|584560646|FG000|Treatment Period|Subject decision|7|||
161868168|NCT04541589|584560647|FG001|Treatment Period|Subject decision|4|||
161868169|NCT04541589|584560646|FG000|Treatment Period|Withdrawal by Subject|1|||
161868170|NCT04541589|584560647|FG001|Treatment Period|Withdrawal by Subject|0|||
161868171|NCT04541589|584560646|FG000|Safety Follow-up Period|Adverse Event|2|||
161868172|NCT04541589|584560647|FG001|Safety Follow-up Period|Adverse Event|1|||
161868173|NCT04541589|584560646|FG000|Safety Follow-up Period|Physician Decision|1|||
161868174|NCT04541589|584560647|FG001|Safety Follow-up Period|Physician Decision|0|||
161868175|NCT04541589|584560646|FG000|Safety Follow-up Period|Subject decision|5|||
161868176|NCT04541589|584560647|FG001|Safety Follow-up Period|Subject decision|3|||
161868177|NCT04541589|584560646|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
161868178|NCT04541589|584560647|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
161868179|NCT03581123|584560650|FG000|2-month Follow-up|Withdrawal by Subject|5|||
161868180|NCT03581123|584560651|FG001|2-month Follow-up|Withdrawal by Subject|4|||
161868181|NCT03581123|584560652|FG002|2-month Follow-up|Withdrawal by Subject|6|||
161868182|NCT03581123|584560653|FG003|2-month Follow-up|Withdrawal by Subject|4|||
161868183|NCT03581123|584560650|FG000|2-month Follow-up|Lost to Follow-up|8|||
161868184|NCT03581123|584560651|FG001|2-month Follow-up|Lost to Follow-up|1|||
161868185|NCT03581123|584560652|FG002|2-month Follow-up|Lost to Follow-up|2|||
161868186|NCT03581123|584560653|FG003|2-month Follow-up|Lost to Follow-up|2|||
161868187|NCT03581123|584560650|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
161868188|NCT03581123|584560651|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
161868189|NCT03581123|584560652|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
161868190|NCT03581123|584560653|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
161868191|NCT03581123|584560650|FG000|6-Month Follow-up|Lost to Follow-up|3|||
161868192|NCT03581123|584560651|FG001|6-Month Follow-up|Lost to Follow-up|3|||
161868193|NCT03581123|584560652|FG002|6-Month Follow-up|Lost to Follow-up|1|||
161868194|NCT03581123|584560653|FG003|6-Month Follow-up|Lost to Follow-up|1|||
161868195|NCT03581123|584560650|FG000|12-Month Follow-up|Lost to Follow-up|4|||
161868196|NCT03581123|584560651|FG001|12-Month Follow-up|Lost to Follow-up|3|||
161868197|NCT03581123|584560652|FG002|12-Month Follow-up|Lost to Follow-up|4|||
161868198|NCT03581123|584560653|FG003|12-Month Follow-up|Lost to Follow-up|5|||
161868199|NCT04195685|584560654|FG000|Overall Study|Withdrawal by Subject|6|||
161868200|NCT04195685|584560655|FG001|Overall Study|Withdrawal by Subject|2|||
161868201|NCT04195685|584560654|FG000|Overall Study|Lost to Follow-up|1|||
161868202|NCT04195685|584560655|FG001|Overall Study|Lost to Follow-up|4|||
161868203|NCT00455403|584560657|FG000|Overall Study|Lost to Follow-up|2|||
161868204|NCT00455403|584560658|FG001|Overall Study|Lost to Follow-up|1|||
161868205|NCT00455403|584560657|FG000|Overall Study|Withdrawal by Subject|1|||
161868206|NCT00455403|584560658|FG001|Overall Study|Withdrawal by Subject|3|||
161868207|NCT00455403|584560657|FG000|Overall Study|Protocol Violation|0|||
161868208|NCT00455403|584560658|FG001|Overall Study|Protocol Violation|2|||
161868209|NCT01812109|584560659|FG000|Overall Study|research personnel delay|16|||
161868210|NCT01812109|584560659|FG000|Overall Study|NIRS Unattainable|17|||
161868211|NCT04630002|584560660|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
161868212|NCT04630002|584560661|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868213|NCT04630002|584560662|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868214|NCT04630002|584560660|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
161868215|NCT04630002|584560661|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868216|NCT04630002|584560662|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868217|NCT04630002|584560660|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
161868218|NCT04630002|584560661|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868219|NCT04630002|584560662|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868220|NCT04630002|584560660|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868221|NCT04630002|584560661|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
161868222|NCT04630002|584560662|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868223|NCT04630002|584560660|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868224|NCT04630002|584560661|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
161868225|NCT04630002|584560662|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868226|NCT04630002|584560660|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868227|NCT04630002|584560661|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
161868228|NCT04630002|584560662|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868229|NCT04630002|584560660|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
161868230|NCT04630002|584560661|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
161868231|NCT04630002|584560662|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
161868232|NCT04630002|584560660|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
161868233|NCT04630002|584560661|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
161868234|NCT04630002|584560662|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
161868235|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
161868236|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
161868237|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Death|0|||
161868238|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Death|1|||
161868239|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
161868240|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
161868241|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
161868242|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
161868243|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
161868244|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
161868245|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
161868246|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
161868247|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
161868248|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
161868249|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
161868250|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
161868251|NCT04498182|584560666|FG000|Overall Study|Adverse Event|2|||
161868252|NCT04498182|584560667|FG001|Overall Study|Adverse Event|3|||
161868253|NCT04498182|584560668|FG002|Overall Study|Adverse Event|2|||
161868254|NCT04498182|584560666|FG000|Overall Study|Withdrawal of Consent|3|||
161868255|NCT04498182|584560667|FG001|Overall Study|Withdrawal of Consent|4|||
161868256|NCT04498182|584560668|FG002|Overall Study|Withdrawal of Consent|3|||
161868257|NCT04498182|584560666|FG000|Overall Study|Non-Compliant|1|||
161868258|NCT04498182|584560667|FG001|Overall Study|Non-Compliant|0|||
161868259|NCT04498182|584560668|FG002|Overall Study|Non-Compliant|1|||
161868260|NCT04498182|584560666|FG000|Overall Study|Lost to Follow-up|0|||
161868261|NCT04498182|584560667|FG001|Overall Study|Lost to Follow-up|0|||
161868262|NCT04498182|584560668|FG002|Overall Study|Lost to Follow-up|1|||
161868263|NCT04498182|584560666|FG000|Overall Study|Investigator Decision|0|||
161868264|NCT04498182|584560667|FG001|Overall Study|Investigator Decision|0|||
161868265|NCT04498182|584560668|FG002|Overall Study|Investigator Decision|1|||
161868266|NCT04498182|584560666|FG000|Overall Study|Protocol Violation|1|||
161868267|NCT04498182|584560667|FG001|Overall Study|Protocol Violation|0|||
161868268|NCT04498182|584560668|FG002|Overall Study|Protocol Violation|2|||
161868269|NCT01372618|584560678|FG000|Overall Study|PI Died. Study Terminated|9|||
161868270|NCT03448419|584560679|FG000|Overall Study|Adverse Event|10|||
161868271|NCT03448419|584560680|FG001|Overall Study|Adverse Event|9|||
161868272|NCT03448419|584560679|FG000|Overall Study|Lost to Follow-up|0|||
161868273|NCT03448419|584560680|FG001|Overall Study|Lost to Follow-up|2|||
161868274|NCT03448419|584560679|FG000|Overall Study|Withdrawal by Subject|3|||
161868275|NCT03448419|584560680|FG001|Overall Study|Withdrawal by Subject|1|||
161868276|NCT03448419|584560679|FG000|Overall Study|Not treated|0|||
161868277|NCT03448419|584560680|FG001|Overall Study|Not treated|1|||
161868278|NCT03448419|584560679|FG000|Overall Study|Patient did not attend all visits|0|||
161868279|NCT03448419|584560680|FG001|Overall Study|Patient did not attend all visits|2|||
161868280|NCT03448419|584560679|FG000|Overall Study|Withdrawn by Sponsor|0|||
161868281|NCT03448419|584560680|FG001|Overall Study|Withdrawn by Sponsor|1|||
161868282|NCT04548193|584560691|FG000|Overall Study|Lost to Follow-up|0|||
161868283|NCT04548193|584560692|FG001|Overall Study|Lost to Follow-up|1|||
161868284|NCT04548193|584560691|FG000|Overall Study|Death|0|||
161868285|NCT04548193|584560692|FG001|Overall Study|Death|1|||
161868286|NCT04548193|584560691|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
161868287|NCT04548193|584560692|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
161868288|NCT04548193|584560691|FG000|Overall Study|Withdrawal by Subject|2|||
161868289|NCT04548193|584560692|FG001|Overall Study|Withdrawal by Subject|2|||
161868290|NCT00630825|584560693|FG000|Overall Study|Adverse Event|4|||
161868291|NCT00630825|584560694|FG001|Overall Study|Adverse Event|4|||
161868292|NCT00630825|584560695|FG002|Overall Study|Adverse Event|3|||
161868293|NCT00630825|584560696|FG003|Overall Study|Adverse Event|1|||
161868294|NCT00630825|584560693|FG000|Overall Study|Entry Criteria Not Met|1|||
161868295|NCT00630825|584560694|FG001|Overall Study|Entry Criteria Not Met|0|||
161868296|NCT00630825|584560695|FG002|Overall Study|Entry Criteria Not Met|2|||
161868297|NCT00630825|584560696|FG003|Overall Study|Entry Criteria Not Met|1|||
161868298|NCT00630825|584560693|FG000|Overall Study|Lost to Follow-up|1|||
161868299|NCT00630825|584560694|FG001|Overall Study|Lost to Follow-up|1|||
161868300|NCT00630825|584560695|FG002|Overall Study|Lost to Follow-up|1|||
161868301|NCT00630825|584560696|FG003|Overall Study|Lost to Follow-up|1|||
161774605|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
161774606|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161774607|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161774608|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
161774609|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161774610|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
161774611|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
161774612|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
161774613|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
161774614|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
161774615|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
161774616|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
161774617|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
161774618|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
161774619|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
161774620|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
161774621|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
161774622|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
161774623|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
161774624|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
161774625|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
161774626|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
161774627|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
161774628|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
161774629|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
161868302|NCT00630825|584560693|FG000|Overall Study|Physician Decision|1|||
161868303|NCT00630825|584560694|FG001|Overall Study|Physician Decision|0|||
161868304|NCT00630825|584560695|FG002|Overall Study|Physician Decision|0|||
161868305|NCT00630825|584560696|FG003|Overall Study|Physician Decision|0|||
161868306|NCT00630825|584560693|FG000|Overall Study|Withdrawal by Subject|2|||
161868307|NCT00630825|584560694|FG001|Overall Study|Withdrawal by Subject|2|||
161868308|NCT00630825|584560695|FG002|Overall Study|Withdrawal by Subject|2|||
161868309|NCT00630825|584560696|FG003|Overall Study|Withdrawal by Subject|3|||
161868310|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
161868311|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
161868312|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
161868313|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
161868314|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
161868315|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
161868316|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
161868317|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
161868318|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Adverse Event|14|||
161868319|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Adverse Event|11|||
161868320|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Death|1|||
161868321|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Death|1|||
161868322|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
161868323|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
161868324|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
161868325|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
161868326|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Pregnancy|1|||
161868327|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Pregnancy|0|||
161868328|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
161868329|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
161868330|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
161868331|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
161868332|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Other|0|||
161868333|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Other|1|||
161868334|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Ineligibility|3|||
161868335|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Ineligibility|4|||
161868336|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
161868337|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
161868338|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Patient Moved|2|||
161868339|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Patient Moved|2|||
161868340|NCT00558701|584560701|FG000|Overall Study|Protocol Deviations|1|||
161868341|NCT00558701|584560702|FG001|Overall Study|Protocol Deviations|4|||
161868342|NCT02187198|584560703|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
161868343|NCT02187198|584560704|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
161868344|NCT02187198|584560703|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
161868345|NCT02187198|584560704|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
161868346|NCT00546377|584560705|FG000|Overall Study|Deemed ineligible|1|||
161868347|NCT00546377|584560705|FG000|Overall Study|Adverse Event|6|||
161868348|NCT01532518|584560706|FG000|Overall Study|Withdrawal by Subject|0|||
161868349|NCT01532518|584560707|FG001|Overall Study|Withdrawal by Subject|0|||
161868350|NCT01532518|584560708|FG002|Overall Study|Withdrawal by Subject|1|||
161868351|NCT01575834|584560709|FG000|Overall Study|Withdrawal by Subject|352|||
161868352|NCT01575834|584560710|FG001|Overall Study|Withdrawal by Subject|390|||
161868353|NCT01575834|584560709|FG000|Overall Study|Death|81|||
161868354|NCT01575834|584560710|FG001|Overall Study|Death|74|||
161868355|NCT01575834|584560709|FG000|Overall Study|Other|70|||
161868356|NCT01575834|584560710|FG001|Overall Study|Other|70|||
161868357|NCT01575834|584560709|FG000|Overall Study|Adverse Event|63|||
161868358|NCT01575834|584560710|FG001|Overall Study|Adverse Event|61|||
161868359|NCT01575834|584560709|FG000|Overall Study|Lost to Follow-up|55|||
161868360|NCT01575834|584560710|FG001|Overall Study|Lost to Follow-up|68|||
161868361|NCT01575834|584560709|FG000|Overall Study|Noncompliance|52|||
161868362|NCT01575834|584560710|FG001|Overall Study|Noncompliance|27|||
161868363|NCT01575834|584560709|FG000|Overall Study|Administrative decision|15|||
161868364|NCT01575834|584560710|FG001|Overall Study|Administrative decision|33|||
161868365|NCT01575834|584560709|FG000|Overall Study|Ineligibility Determined|5|||
161868366|NCT01575834|584560710|FG001|Overall Study|Ineligibility Determined|8|||
161868367|NCT01575834|584560709|FG000|Overall Study|Protocol Deviation|4|||
161868368|NCT01575834|584560710|FG001|Overall Study|Protocol Deviation|3|||
161868369|NCT01575834|584560709|FG000|Overall Study|Requirement for Alternative Therapy|2|||
161868370|NCT01575834|584560710|FG001|Overall Study|Requirement for Alternative Therapy|4|||
161868371|NCT00488644|584560712|FG000|Overall Study|Not Eligible|1|||
161774630|NCT05553600|584217288|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
161774631|NCT05553600|584217289|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
161774632|NCT05553600|584217290|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
161774633|NCT05553600|584217291|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
161774634|NCT05027958|584217293|FG000|Overall Study|Lost to Follow-up|1|||
161774635|NCT05027958|584217294|FG001|Overall Study|Lost to Follow-up|1|||
161774636|NCT05027958|584217293|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
161774637|NCT05027958|584217294|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
161774638|NCT05027958|584217293|FG000|Overall Study|Physician Decision|1|||
161774639|NCT05027958|584217294|FG001|Overall Study|Physician Decision|4|||
161774640|NCT05027958|584217293|FG000|Overall Study|Adverse Event|0|||
161774641|NCT05027958|584217294|FG001|Overall Study|Adverse Event|1|||
161774642|NCT00890409|584217298|FG000|Overall Study|Lost to Follow-up|20|||
161774643|NCT00890409|584217299|FG001|Overall Study|Lost to Follow-up|21|||
161774644|NCT00455923|584217300|FG000|Overall Study|Pregnancy|0|||
161774645|NCT00455923|584217301|FG001|Overall Study|Pregnancy|2|||
161774646|NCT00455923|584217300|FG000|Overall Study|Other|3|||
161774647|NCT00455923|584217301|FG001|Overall Study|Other|1|||
161774648|NCT02353572|584217302|FG000|Overall Study|Withdrawal by Subject|1|||
161774649|NCT02353572|584217302|FG000|Overall Study|Study terminated|2|||
161774650|NCT01244516|584217303|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
161774651|NCT01244516|584217304|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
161774652|NCT01244516|584217305|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
161774653|NCT01244516|584217303|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
161774654|NCT01244516|584217304|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
161774655|NCT01244516|584217305|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
161774656|NCT01244516|584217303|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
161774657|NCT01244516|584217304|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
161774658|NCT01244516|584217305|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
161774659|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
161774660|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
161774661|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
161774662|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
161774663|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
161774664|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
161774665|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
161774666|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
161774667|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
161774668|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
161774669|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
161774670|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
161774671|NCT04456998|584217310|FG000|Overall Study|Adverse Event|0|||
161774672|NCT04456998|584217311|FG001|Overall Study|Adverse Event|4|||
161774673|NCT04456998|584217310|FG000|Overall Study|Protocol Deviation|0|||
161774674|NCT04456998|584217311|FG001|Overall Study|Protocol Deviation|1|||
161774675|NCT04456998|584217310|FG000|Overall Study|Withdrawal by Subject|0|||
161774676|NCT04456998|584217311|FG001|Overall Study|Withdrawal by Subject|1|||
161774677|NCT03707145|584217315|FG000|Overall Study|Lost to Follow-up|0|||
161774678|NCT03707145|584217316|FG001|Overall Study|Lost to Follow-up|1|||
161774679|NCT03707145|584217317|FG002|Overall Study|Lost to Follow-up|1|||
161774680|NCT03707145|584217318|FG003|Overall Study|Lost to Follow-up|0|||
161774681|NCT04221477|584217319|FG000|Overall Study|Adverse Event|1|||
161774682|NCT04221477|584217320|FG001|Overall Study|Adverse Event|1|||
161774683|NCT04221477|584217319|FG000|Overall Study|Death|5|||
161774684|NCT04221477|584217320|FG001|Overall Study|Death|4|||
161868372|NCT00488644|584560712|FG000|Overall Study|Not Evaluable|1|||
161868373|NCT02503540|584560717|FG000|Overall Study|Death|2|||
161868374|NCT02503540|584560717|FG000|Overall Study|Withdrawal by Subject|1|||
161868375|NCT00564850|584560718|FG000|Overall Study|Protocol Violation|2|||
161868376|NCT00979654|584560719|FG000|Overall Study|Lost to Follow-up|1|||
161868377|NCT00979654|584560719|FG000|Overall Study|Withdrawal by Subject|22|||
161868378|NCT00979654|584560719|FG000|Overall Study|Death|1|||
161868379|NCT00979654|584560719|FG000|Overall Study|Lack of Efficacy|6|||
161868380|NCT00979654|584560719|FG000|Overall Study|Adverse Event|1|||
161868381|NCT00979654|584560719|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
161868382|NCT00979654|584560719|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
161868383|NCT00979654|584560719|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
161868384|NCT00979654|584560719|FG000|Overall Study|Serious Adverse Event|1|||
161868385|NCT00979654|584560719|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
161868386|NCT01804946|584560722|FG000|Overall Study|Protocol Violation|1|||
161868387|NCT01804946|584560723|FG001|Overall Study|Protocol Violation|0|||
161868388|NCT01804946|584560722|FG000|Overall Study|Adverse Event|0|||
161868389|NCT01804946|584560723|FG001|Overall Study|Adverse Event|1|||
161868390|NCT01804946|584560722|FG000|Overall Study|Insufficient data available|0|||
161868391|NCT01804946|584560723|FG001|Overall Study|Insufficient data available|1|||
161868392|NCT01804946|584560722|FG000|Overall Study|Do not meet inclusion criteria|1|||
161868393|NCT01804946|584560723|FG001|Overall Study|Do not meet inclusion criteria|2|||
161868394|NCT03830333|584560726|FG000|Overall Study|Death|0|||
161868395|NCT03830333|584560727|FG001|Overall Study|Death|1|||
161868396|NCT03830333|584560726|FG000|Overall Study|Withdrawal by Subject|5|||
161868397|NCT03830333|584560727|FG001|Overall Study|Withdrawal by Subject|1|||
161868398|NCT03830333|584560726|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
161868399|NCT03830333|584560727|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
161774685|NCT04221477|584217319|FG000|Overall Study|Lack of Efficacy|1|||
161774686|NCT04221477|584217320|FG001|Overall Study|Lack of Efficacy|2|||
161774687|NCT04221477|584217319|FG000|Overall Study|Lost to Follow-up|1|||
161774688|NCT04221477|584217320|FG001|Overall Study|Lost to Follow-up|2|||
161774689|NCT04221477|584217319|FG000|Overall Study|Non-compliance with Study Drug|1|||
161774690|NCT04221477|584217320|FG001|Overall Study|Non-compliance with Study Drug|0|||
161774691|NCT04221477|584217319|FG000|Overall Study|Reason not Specified|0|||
161774692|NCT04221477|584217320|FG001|Overall Study|Reason not Specified|5|||
161774693|NCT04221477|584217319|FG000|Overall Study|Physician Decision|0|||
161774694|NCT04221477|584217320|FG001|Overall Study|Physician Decision|6|||
161774695|NCT04221477|584217319|FG000|Overall Study|Withdrawal by Subject|10|||
161774696|NCT04221477|584217320|FG001|Overall Study|Withdrawal by Subject|14|||
161774697|NCT04221477|584217319|FG000|Overall Study|Ongoing in the Study|116|||
161774698|NCT04221477|584217320|FG001|Overall Study|Ongoing in the Study|102|||
161774699|NCT02242942|584217321|FG000|Overall Study|Death|17|||
161774700|NCT02242942|584217322|FG001|Overall Study|Death|20|||
161774701|NCT02242942|584217323|FG002|Overall Study|Death|2|||
161774702|NCT02242942|584217321|FG000|Overall Study|Physician Decision|1|||
161774703|NCT02242942|584217322|FG001|Overall Study|Physician Decision|0|||
161774704|NCT02242942|584217323|FG002|Overall Study|Physician Decision|0|||
161774705|NCT02242942|584217321|FG000|Overall Study|Withdrawal by Subject|8|||
161774706|NCT02242942|584217322|FG001|Overall Study|Withdrawal by Subject|10|||
161774707|NCT02242942|584217323|FG002|Overall Study|Withdrawal by Subject|0|||
161774708|NCT02242942|584217321|FG000|Overall Study|On-going in Study|190|||
161774709|NCT02242942|584217322|FG001|Overall Study|On-going in Study|186|||
161774710|NCT02242942|584217323|FG002|Overall Study|On-going in Study|11|||
161774711|NCT04784455|584217324|FG000|Overall Study|Death|4|||
161774712|NCT04882085|584217325|FG000|Overall Study|Death|6|||
161774713|NCT04882085|584217326|FG001|Overall Study|Death|9|||
161774714|NCT04882085|584217325|FG000|Overall Study|Withdrawal by Subject|0|||
161774715|NCT04882085|584217326|FG001|Overall Study|Withdrawal by Subject|3|||
161774716|NCT04882085|584217325|FG000|Overall Study|Randomized not treated|1|||
161774717|NCT04882085|584217326|FG001|Overall Study|Randomized not treated|0|||
161774718|NCT04455620|584217330|FG000|Overall Study|Withdrawal by Subject|0|||
161774719|NCT04455620|584217331|FG001|Overall Study|Withdrawal by Subject|0|||
161774720|NCT04455620|584217332|FG002|Overall Study|Withdrawal by Subject|2|||
161774721|NCT04455620|584217333|FG003|Overall Study|Withdrawal by Subject|0|||
161774722|NCT04455620|584217334|FG004|Overall Study|Withdrawal by Subject|1|||
161774723|NCT04455620|584217330|FG000|Overall Study|Lost to Follow-up|0|||
161774724|NCT04455620|584217331|FG001|Overall Study|Lost to Follow-up|0|||
161774725|NCT04455620|584217332|FG002|Overall Study|Lost to Follow-up|1|||
161774726|NCT04455620|584217333|FG003|Overall Study|Lost to Follow-up|1|||
161774727|NCT04455620|584217334|FG004|Overall Study|Lost to Follow-up|0|||
161774728|NCT04455620|584217330|FG000|Overall Study|Death|1|||
161774729|NCT04455620|584217331|FG001|Overall Study|Death|6|||
161774730|NCT04455620|584217332|FG002|Overall Study|Death|20|||
161774731|NCT04455620|584217333|FG003|Overall Study|Death|1|||
161774732|NCT04455620|584217334|FG004|Overall Study|Death|7|||
161774733|NCT04455620|584217330|FG000|Overall Study|Study Termination|0|||
161774734|NCT04455620|584217331|FG001|Overall Study|Study Termination|2|||
161774735|NCT04455620|584217332|FG002|Overall Study|Study Termination|1|||
161774736|NCT04455620|584217333|FG003|Overall Study|Study Termination|0|||
161774737|NCT04455620|584217334|FG004|Overall Study|Study Termination|6|||
161774738|NCT00965562|584217335|FG000|Overall Study|Lost to Follow-up|1|||
161774739|NCT00965562|584217336|FG001|Overall Study|Lost to Follow-up|2|||
161774740|NCT00965562|584217337|FG002|Overall Study|Lost to Follow-up|3|||
161774741|NCT00965562|584217335|FG000|Overall Study|Withdrawal by Subject|2|||
161774742|NCT00965562|584217336|FG001|Overall Study|Withdrawal by Subject|2|||
161774743|NCT00965562|584217337|FG002|Overall Study|Withdrawal by Subject|0|||
161774744|NCT05681715|584217338|FG000|Training Period (6-weeks)|Adverse Event|3|||
161774745|NCT05681715|584217339|FG001|Training Period (6-weeks)|Adverse Event|0|||
161774746|NCT05681715|584217340|FG002|Training Period (6-weeks)|Adverse Event|0|||
161774747|NCT05681715|584217338|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
161774748|NCT05681715|584217339|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774749|NCT05681715|584217340|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774750|NCT05681715|584217338|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
161774751|NCT05681715|584217339|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
161774752|NCT05681715|584217340|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
161774753|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
161774754|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
161774755|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
161774756|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774757|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774758|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
161774759|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
161774760|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
161774761|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
161774762|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
161774763|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
161774764|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
161868400|NCT01129557|584560728|FG000|Overall Study|Adverse Event|1|||
161868401|NCT01129557|584560729|FG001|Overall Study|Adverse Event|2|||
161868402|NCT01129557|584560730|FG002|Overall Study|Adverse Event|2|||
161868403|NCT01129557|584560728|FG000|Overall Study|Novartis terminated study early|3|||
161868404|NCT01129557|584560729|FG001|Overall Study|Novartis terminated study early|3|||
161868405|NCT01129557|584560730|FG002|Overall Study|Novartis terminated study early|2|||
161868406|NCT01486446|584560731|FG000|Overall Study|Adverse Event|1|||
161868407|NCT01486446|584560732|FG001|Overall Study|Adverse Event|0|||
161868408|NCT04390113|584560733|FG000|Overall Study|Not Treated|0|||
161868409|NCT04390113|584560734|FG001|Overall Study|Not Treated|1|||
161868410|NCT04390113|584560733|FG000|Overall Study|Adverse Event|1|||
161868411|NCT04390113|584560734|FG001|Overall Study|Adverse Event|0|||
161868412|NCT04390113|584560733|FG000|Overall Study|Death|2|||
161868413|NCT04390113|584560734|FG001|Overall Study|Death|1|||
161868414|NCT04390113|584560733|FG000|Overall Study|Physician Decision|1|||
161868415|NCT04390113|584560734|FG001|Overall Study|Physician Decision|3|||
161868416|NCT04390113|584560733|FG000|Overall Study|Study Terminated by Sponsor|5|||
161868417|NCT04390113|584560734|FG001|Overall Study|Study Terminated by Sponsor|3|||
161868418|NCT04390113|584560733|FG000|Overall Study|Withdrawal by Subject|10|||
161868419|NCT04390113|584560734|FG001|Overall Study|Withdrawal by Subject|5|||
161868420|NCT04390113|584560733|FG000|Overall Study|Other|1|||
161868421|NCT04390113|584560734|FG001|Overall Study|Other|0|||
161868422|NCT04390113|584560733|FG000|Overall Study|Missing|0|||
161868423|NCT04390113|584560734|FG001|Overall Study|Missing|1|||
161868424|NCT04031846|584560738|FG000|Overall Study|Lost to Follow-up|4|||
161868425|NCT04031846|584560739|FG001|Overall Study|Lost to Follow-up|4|||
161868426|NCT04031846|584560738|FG000|Overall Study|Physician Decision|0|||
161868427|NCT04031846|584560739|FG001|Overall Study|Physician Decision|1|||
161868428|NCT04031846|584560738|FG000|Overall Study|Protocol Violation|1|||
161868429|NCT04031846|584560739|FG001|Overall Study|Protocol Violation|1|||
161868430|NCT04031846|584560738|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
161868431|NCT04031846|584560739|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
161868432|NCT02431676|584560740|FG000|Overall Study|no lab obtained|0|||
161868433|NCT02431676|584560741|FG001|Overall Study|no lab obtained|1|||
161868434|NCT02431676|584560742|FG002|Overall Study|no lab obtained|2|||
161868435|NCT00571727|584560743|FG000|Overall Study|Did not enter in this study|1|||
161868436|NCT00571727|584560743|FG000|Overall Study|Non-compliance|4|||
161868437|NCT00571727|584560743|FG000|Overall Study|Lost to Follow-up|30|||
161868438|NCT00571727|584560743|FG000|Overall Study|Poor growth|1|||
161868439|NCT00571727|584560743|FG000|Overall Study|Parent/patient decision|2|||
161868440|NCT00571727|584560743|FG000|Overall Study|Participant transferred to commercial drug|14|||
161868441|NCT00571727|584560743|FG000|Overall Study|Unable to provide study drug|6|||
161868442|NCT00571727|584560743|FG000|Overall Study|On-treatment at end of study|8|||
161868443|NCT01622673|584560744|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161868444|NCT01622673|584560745|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161868445|NCT01622673|584560746|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161868446|NCT01622673|584560747|FG003|Treatment Period 1|Withdrawal by Subject|1|||
161868447|NCT01622673|584560748|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161868448|NCT01622673|584560749|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161868449|NCT01622673|584560744|FG000|Treatment Period 1|Protocol Violation|0|||
161868450|NCT01622673|584560745|FG001|Treatment Period 1|Protocol Violation|1|||
161868451|NCT01622673|584560746|FG002|Treatment Period 1|Protocol Violation|0|||
161868452|NCT01622673|584560747|FG003|Treatment Period 1|Protocol Violation|0|||
161868453|NCT01622673|584560748|FG004|Treatment Period 1|Protocol Violation|0|||
161868454|NCT01622673|584560749|FG005|Treatment Period 1|Protocol Violation|0|||
161868455|NCT01622673|584560744|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161868456|NCT01622673|584560745|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161868457|NCT01622673|584560746|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161868458|NCT01622673|584560747|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161868459|NCT01622673|584560748|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161868460|NCT01622673|584560749|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161868461|NCT01622673|584560744|FG000|Treatment Period 3|Protocol Violation|0|||
161868462|NCT01622673|584560745|FG001|Treatment Period 3|Protocol Violation|1|||
161868463|NCT01622673|584560746|FG002|Treatment Period 3|Protocol Violation|0|||
161868464|NCT01622673|584560747|FG003|Treatment Period 3|Protocol Violation|0|||
161868465|NCT01622673|584560748|FG004|Treatment Period 3|Protocol Violation|0|||
161868466|NCT01622673|584560749|FG005|Treatment Period 3|Protocol Violation|0|||
161868467|NCT01540487|584563007|FG000|Overall Study|Protocol Violation|1|||
161868468|NCT01540487|584563008|FG001|Overall Study|Protocol Violation|0|||
161868469|NCT03503370|584563009|FG000|Overall Study|Death|3|||
161868470|NCT03503370|584563010|FG001|Overall Study|Death|1|||
161868471|NCT03483961|584563011|FG000|Overall Study|Lost to Follow-up|7|||
161868472|NCT03483961|584563012|FG001|Overall Study|Lost to Follow-up|6|||
161868473|NCT03483961|584563013|FG002|Overall Study|Lost to Follow-up|6|||
161868474|NCT03483961|584563014|FG003|Overall Study|Lost to Follow-up|6|||
161868475|NCT03483961|584563015|FG004|Overall Study|Lost to Follow-up|6|||
161868476|NCT03483961|584563016|FG005|Overall Study|Lost to Follow-up|4|||
161868477|NCT03483961|584563017|FG006|Overall Study|Lost to Follow-up|4|||
161868478|NCT03483961|584563018|FG007|Overall Study|Lost to Follow-up|11|||
161868479|NCT03483961|584563019|FG008|Overall Study|Lost to Follow-up|1|||
161868480|NCT03483961|584563020|FG009|Overall Study|Lost to Follow-up|0|||
161868481|NCT03483961|584563011|FG000|Overall Study|Withdrawal by Subject|3|||
161868482|NCT03483961|584563012|FG001|Overall Study|Withdrawal by Subject|4|||
161868483|NCT03483961|584563013|FG002|Overall Study|Withdrawal by Subject|5|||
161868484|NCT03483961|584563014|FG003|Overall Study|Withdrawal by Subject|3|||
161868485|NCT03483961|584563015|FG004|Overall Study|Withdrawal by Subject|4|||
161868486|NCT03483961|584563016|FG005|Overall Study|Withdrawal by Subject|2|||
161868487|NCT03483961|584563017|FG006|Overall Study|Withdrawal by Subject|1|||
161868488|NCT03483961|584563018|FG007|Overall Study|Withdrawal by Subject|2|||
161868489|NCT03483961|584563019|FG008|Overall Study|Withdrawal by Subject|1|||
161868490|NCT03483961|584563020|FG009|Overall Study|Withdrawal by Subject|0|||
161868491|NCT03483961|584563011|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
161868492|NCT03483961|584563012|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868493|NCT03483961|584563013|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868494|NCT03483961|584563014|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868495|NCT03483961|584563015|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868496|NCT03483961|584563016|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868497|NCT03483961|584563017|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868498|NCT03483961|584563018|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868499|NCT03483961|584563019|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868500|NCT03483961|584563020|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868501|NCT03483961|584563011|FG000|Overall Study|Adverse Event|0|||
161868502|NCT03483961|584563012|FG001|Overall Study|Adverse Event|0|||
161868503|NCT03483961|584563013|FG002|Overall Study|Adverse Event|1|||
161868504|NCT03483961|584563014|FG003|Overall Study|Adverse Event|0|||
161868505|NCT03483961|584563015|FG004|Overall Study|Adverse Event|0|||
161868506|NCT03483961|584563016|FG005|Overall Study|Adverse Event|0|||
161868507|NCT03483961|584563017|FG006|Overall Study|Adverse Event|0|||
161868508|NCT03483961|584563018|FG007|Overall Study|Adverse Event|0|||
161868509|NCT03483961|584563019|FG008|Overall Study|Adverse Event|0|||
161774765|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
161774766|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
161774767|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
161774768|NCT05455684|584217341|FG000|Overall Study|Withdrawal by Subject|7|||
161774769|NCT05455684|584217342|FG001|Overall Study|Withdrawal by Subject|4|||
161774770|NCT05455684|584217341|FG000|Overall Study|Lost to Follow-up|3|||
161774771|NCT05455684|584217342|FG001|Overall Study|Lost to Follow-up|3|||
161774772|NCT05455684|584217341|FG000|Overall Study|Adverse Event|2|||
161774773|NCT05455684|584217342|FG001|Overall Study|Adverse Event|3|||
161774774|NCT05455684|584217341|FG000|Overall Study|Protocol Violation|1|||
161774775|NCT05455684|584217342|FG001|Overall Study|Protocol Violation|1|||
161774776|NCT05455684|584217341|FG000|Overall Study|Non-Compliant with study drug|0|||
161774777|NCT05455684|584217342|FG001|Overall Study|Non-Compliant with study drug|1|||
161774778|NCT05455684|584217341|FG000|Overall Study|Other|1|||
161774779|NCT05455684|584217342|FG001|Overall Study|Other|2|||
161774780|NCT05455684|584217341|FG000|Overall Study|Randomized but not treated|1|||
161774781|NCT05455684|584217342|FG001|Overall Study|Randomized but not treated|0|||
161774782|NCT05204563|584217343|FG000|Overall Study|Other than Specified|2|||
161774783|NCT05204563|584217344|FG001|Overall Study|Other than Specified|1|||
161774784|NCT05204563|584217343|FG000|Overall Study|Death|18|||
161774785|NCT05204563|584217344|FG001|Overall Study|Death|4|||
161774786|NCT05204563|584217343|FG000|Overall Study|Lost to Follow-up|6|||
161774787|NCT05204563|584217344|FG001|Overall Study|Lost to Follow-up|3|||
161774788|NCT05204563|584217343|FG000|Overall Study|Withdrawal by Subject|12|||
161774789|NCT05204563|584217344|FG001|Overall Study|Withdrawal by Subject|3|||
161774790|NCT05204563|584217343|FG000|Overall Study|Enrolled, Not Treated|1|||
161868510|NCT03483961|584563020|FG009|Overall Study|Adverse Event|0|||
161868511|NCT02366637|584563026|FG000|First Intervention Period|Adverse Event|0|||
161868512|NCT02366637|584563027|FG001|First Intervention Period|Adverse Event|1|||
161868513|NCT02366637|584563026|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
161868514|NCT02366637|584563027|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
161868515|NCT02366637|584563026|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
161868516|NCT02366637|584563027|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
161868517|NCT02609607|584563033|FG000|Overall Study|Lost to Follow-up|0|||
161868518|NCT02609607|584563034|FG001|Overall Study|Lost to Follow-up|1|||
161868519|NCT03691207|584563035|FG000|Overall Study|Death|41|||
161868520|NCT03691207|584563036|FG001|Overall Study|Death|26|||
161868521|NCT03691207|584563035|FG000|Overall Study|Lost to Follow-up|1|||
161868522|NCT03691207|584563036|FG001|Overall Study|Lost to Follow-up|1|||
161868523|NCT03691207|584563035|FG000|Overall Study|Withdrawal by Subject|2|||
161868524|NCT03691207|584563036|FG001|Overall Study|Withdrawal by Subject|8|||
161868525|NCT03691207|584563035|FG000|Overall Study|Sponsor decision|1|||
161868526|NCT03691207|584563036|FG001|Overall Study|Sponsor decision|7|||
161868527|NCT00651261|584563037|FG000|Overall Study|Adverse Event|32|||
161868528|NCT00651261|584563038|FG001|Overall Study|Adverse Event|22|||
161868529|NCT00651261|584563037|FG000|Overall Study|Death|18|||
161868530|NCT00651261|584563038|FG001|Overall Study|Death|18|||
161868531|NCT00651261|584563037|FG000|Overall Study|Withdrawal by Subject|22|||
161868532|NCT00651261|584563038|FG001|Overall Study|Withdrawal by Subject|40|||
161868533|NCT00651261|584563037|FG000|Overall Study|Induction failure|24|||
161868534|NCT00651261|584563038|FG001|Overall Study|Induction failure|35|||
161868535|NCT00651261|584563037|FG000|Overall Study|Disease progression|58|||
161868536|NCT00651261|584563038|FG001|Overall Study|Disease progression|58|||
161868537|NCT00651261|584563037|FG000|Overall Study|Alternative therapy|109|||
161868538|NCT00651261|584563038|FG001|Overall Study|Alternative therapy|107|||
161868539|NCT00651261|584563037|FG000|Overall Study|Other disease or participant decisions|23|||
161868540|NCT00651261|584563038|FG001|Overall Study|Other disease or participant decisions|23|||
161868541|NCT00651261|584563037|FG000|Overall Study|Never treated|5|||
161868542|NCT00651261|584563038|FG001|Overall Study|Never treated|3|||
161868543|NCT04509076|584563044|FG000|Overall Study|Withdrawal by Subject|1|||
161868544|NCT04509076|584563045|FG001|Overall Study|Withdrawal by Subject|2|||
161868545|NCT04509076|584563044|FG000|Overall Study|Lost to Follow-up|1|||
161868546|NCT04509076|584563045|FG001|Overall Study|Lost to Follow-up|2|||
161868547|NCT03351608|584563046|FG000|Overall Study|Lost to Follow-up|0|||
161868548|NCT03351608|584563047|FG001|Overall Study|Lost to Follow-up|1|||
161868549|NCT03351608|584563048|FG002|Overall Study|Lost to Follow-up|1|||
161868550|NCT03351608|584563049|FG003|Overall Study|Lost to Follow-up|1|||
161868551|NCT03351608|584563050|FG004|Overall Study|Lost to Follow-up|1|||
161868552|NCT03351608|584563046|FG000|Overall Study|Physician Decision|1|||
161868553|NCT03351608|584563047|FG001|Overall Study|Physician Decision|0|||
161868554|NCT03351608|584563048|FG002|Overall Study|Physician Decision|0|||
161868555|NCT03351608|584563049|FG003|Overall Study|Physician Decision|2|||
161868556|NCT03351608|584563050|FG004|Overall Study|Physician Decision|1|||
161868557|NCT03351608|584563046|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
161868558|NCT03351608|584563047|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
161868559|NCT03351608|584563048|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
161868560|NCT03351608|584563049|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
161868561|NCT03351608|584563050|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
161868562|NCT03351608|584563046|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161868563|NCT03351608|584563047|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161868564|NCT03351608|584563048|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161868565|NCT03351608|584563049|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161868566|NCT03351608|584563050|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161868567|NCT03351608|584563046|FG000|Overall Study|Other|0|||
161868568|NCT03351608|584563047|FG001|Overall Study|Other|1|||
161868569|NCT03351608|584563048|FG002|Overall Study|Other|1|||
161868570|NCT03351608|584563049|FG003|Overall Study|Other|3|||
161868571|NCT03351608|584563050|FG004|Overall Study|Other|0|||
161868572|NCT02877004|584563051|FG000|Overall Study|Pregnancy|0|||
161868573|NCT02877004|584563052|FG001|Overall Study|Pregnancy|0|||
161868574|NCT02877004|584563053|FG002|Overall Study|Pregnancy|1|||
161868575|NCT02727478|584563054|FG000|Overall Study|Withdrawal by Subject|8|||
161868576|NCT02727478|584563055|FG001|Overall Study|Withdrawal by Subject|10|||
161868577|NCT02633293|584563056|FG000|Overall Study|Death|56|||
161868578|NCT02633293|584563056|FG000|Overall Study|Progressive Disease|12|||
161868579|NCT02633293|584563056|FG000|Overall Study|Adverse Event|29|||
161868580|NCT02633293|584563056|FG000|Overall Study|Withdrawal by Subject|41|||
161868581|NCT02633293|584563056|FG000|Overall Study|Protocol Violation|1|||
161868582|NCT02633293|584563056|FG000|Overall Study|Lost to Follow-up|1|||
161868583|NCT02633293|584563056|FG000|Overall Study|Study Terminated by Sponsor|24|||
161868584|NCT02633293|584563056|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
161868585|NCT02633293|584563056|FG000|Overall Study|Lung Transplant|5|||
161868586|NCT02633293|584563056|FG000|Overall Study|Lack of Efficacy|2|||
161868587|NCT02633293|584563056|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
161868588|NCT01343043|584563057|FG000|Overall Study|Disease progression before treatment|1|||
161868589|NCT01343043|584563058|FG001|Overall Study|Disease progression before treatment|0|||
161868590|NCT01343043|584563059|FG002|Overall Study|Disease progression before treatment|0|||
161868591|NCT01343043|584563060|FG003|Overall Study|Disease progression before treatment|0|||
161868592|NCT01343043|584563057|FG000|Overall Study|Withdrawal by Subject|1|||
161868593|NCT01343043|584563058|FG001|Overall Study|Withdrawal by Subject|0|||
161868594|NCT01343043|584563059|FG002|Overall Study|Withdrawal by Subject|0|||
161868595|NCT01343043|584563060|FG003|Overall Study|Withdrawal by Subject|0|||
161868596|NCT01343043|584563057|FG000|Overall Study|Death|1|||
161868597|NCT01343043|584563058|FG001|Overall Study|Death|1|||
161868598|NCT01343043|584563059|FG002|Overall Study|Death|0|||
161868599|NCT01343043|584563060|FG003|Overall Study|Death|1|||
161868600|NCT00502242|584563063|FG000|Overall Study|Lack of Efficacy|1|||
161868601|NCT00502242|584563064|FG001|Overall Study|Lack of Efficacy|11|||
161868602|NCT00502242|584563063|FG000|Overall Study|Adverse Event|31|||
161868603|NCT00502242|584563064|FG001|Overall Study|Adverse Event|20|||
161868604|NCT00502242|584563063|FG000|Overall Study|Physician Decision|2|||
161868605|NCT00502242|584563064|FG001|Overall Study|Physician Decision|3|||
161868606|NCT00502242|584563063|FG000|Overall Study|Other - Unspecified|8|||
161868607|NCT00502242|584563064|FG001|Overall Study|Other - Unspecified|14|||
161868608|NCT00502242|584563063|FG000|Overall Study|Protocol Violation|3|||
161868609|NCT00502242|584563064|FG001|Overall Study|Protocol Violation|1|||
161868610|NCT00502242|584563063|FG000|Overall Study|Withdrawal by Subject|6|||
161868611|NCT00502242|584563064|FG001|Overall Study|Withdrawal by Subject|7|||
161868612|NCT00778817|584563065|FG000|Overall Study|Adverse Event|2|||
161868613|NCT00778817|584563065|FG000|Overall Study|Withdrawal by Subject|2|||
161868614|NCT02509507|584563066|FG000|Overall Study|Death|21|||
161868615|NCT02509507|584563067|FG001|Overall Study|Death|3|||
161868616|NCT02509507|584563068|FG002|Overall Study|Death|22|||
161868617|NCT02509507|584563069|FG003|Overall Study|Death|14|||
161868618|NCT02509507|584563070|FG004|Overall Study|Death|8|||
161868619|NCT02509507|584563071|FG005|Overall Study|Death|12|||
161868620|NCT02509507|584563072|FG006|Overall Study|Death|5|||
161868621|NCT02509507|584563073|FG007|Overall Study|Death|4|||
161868622|NCT02509507|584563074|FG008|Overall Study|Death|8|||
161868623|NCT02509507|584563066|FG000|Overall Study|Lost to Follow-up|0|||
161868624|NCT02509507|584563067|FG001|Overall Study|Lost to Follow-up|1|||
161868625|NCT02509507|584563068|FG002|Overall Study|Lost to Follow-up|0|||
161868626|NCT02509507|584563069|FG003|Overall Study|Lost to Follow-up|0|||
161868627|NCT02509507|584563070|FG004|Overall Study|Lost to Follow-up|0|||
161868628|NCT02509507|584563071|FG005|Overall Study|Lost to Follow-up|2|||
161868629|NCT02509507|584563072|FG006|Overall Study|Lost to Follow-up|0|||
161868630|NCT02509507|584563073|FG007|Overall Study|Lost to Follow-up|0|||
161868631|NCT02509507|584563074|FG008|Overall Study|Lost to Follow-up|0|||
161868632|NCT02509507|584563066|FG000|Overall Study|Withdrawal by Subject|2|||
161868633|NCT02509507|584563067|FG001|Overall Study|Withdrawal by Subject|0|||
161868634|NCT02509507|584563068|FG002|Overall Study|Withdrawal by Subject|1|||
161868635|NCT02509507|584563069|FG003|Overall Study|Withdrawal by Subject|4|||
161868636|NCT02509507|584563070|FG004|Overall Study|Withdrawal by Subject|1|||
161868637|NCT02509507|584563071|FG005|Overall Study|Withdrawal by Subject|3|||
161868638|NCT02509507|584563072|FG006|Overall Study|Withdrawal by Subject|4|||
161868639|NCT02509507|584563073|FG007|Overall Study|Withdrawal by Subject|0|||
161868640|NCT02509507|584563074|FG008|Overall Study|Withdrawal by Subject|1|||
161868641|NCT02356588|584563075|FG000|Overall Study|Lack of Efficacy|4|||
161868642|NCT02356588|584563076|FG001|Overall Study|Lack of Efficacy|10|||
161868643|NCT02356588|584563075|FG000|Overall Study|Adverse Event|0|||
161868644|NCT02356588|584563076|FG001|Overall Study|Adverse Event|2|||
161868645|NCT02356588|584563075|FG000|Overall Study|Withdrawal by Subject|1|||
161868646|NCT02356588|584563076|FG001|Overall Study|Withdrawal by Subject|0|||
161868647|NCT02356588|584563075|FG000|Overall Study|Protocol Violation|0|||
161868648|NCT02356588|584563076|FG001|Overall Study|Protocol Violation|1|||
161868649|NCT01418378|584563077|FG000|Overall Study|Death|1|||
161868650|NCT01418378|584563078|FG001|Overall Study|Death|2|||
161868651|NCT01418378|584563077|FG000|Overall Study|Physician Decision|0|||
161868652|NCT01418378|584563078|FG001|Overall Study|Physician Decision|1|||
161868653|NCT01418378|584563077|FG000|Overall Study|ligament imbalance|0|||
161868654|NCT01418378|584563078|FG001|Overall Study|ligament imbalance|1|||
161868655|NCT01418378|584563077|FG000|Overall Study|developed chronic myopathy|0|||
161868656|NCT01418378|584563078|FG001|Overall Study|developed chronic myopathy|1|||
161868657|NCT01346696|584563083|FG000|Overall Study|Death|1|||
161868658|NCT02182843|584563084|FG000|Overall Study|Withdrawal by Subject|7|||
161868659|NCT02182843|584563084|FG000|Overall Study|Lost to Follow-up|2|||
161868660|NCT02182843|584563084|FG000|Overall Study|Adverse Event|1|||
161868661|NCT01051791|584563092|FG000|Overall Study|Failed screening|3|||
161868662|NCT01051791|584563092|FG000|Overall Study|Withdrawal by Subject|1|||
161868663|NCT00288626|584563095|FG000|Overall Study|Death|3|||
161868664|NCT00288626|584563095|FG000|Overall Study|Withdrawal by Subject|4|||
161868665|NCT04610346|584563096|FG000|Overall Study|Withdrawal by Subject|1|||
161868666|NCT04610346|584563097|FG001|Overall Study|Withdrawal by Subject|1|||
161868667|NCT04610346|584563096|FG000|Overall Study|did not complete shelter onboarding|2|||
161868668|NCT04610346|584563097|FG001|Overall Study|did not complete shelter onboarding|1|||
161868669|NCT00558467|584563098|FG000|Overall Study|Adverse Event|1|||
161868670|NCT00558467|584563099|FG001|Overall Study|Adverse Event|2|||
161868671|NCT00558467|584563098|FG000|Overall Study|Lack of Efficacy|0|||
161868672|NCT00558467|584563099|FG001|Overall Study|Lack of Efficacy|1|||
161868673|NCT00558467|584563098|FG000|Overall Study|Patient moving out of state|0|||
161868674|NCT00558467|584563099|FG001|Overall Study|Patient moving out of state|1|||
161868675|NCT00931255|584563100|FG000|Overall Study|Follow up biopsy not done|2|||
161868676|NCT00931255|584563101|FG001|Overall Study|Follow up biopsy not done|3|||
161868677|NCT02019264|584563102|FG000|Overall Study|Not treated|6|||
161868678|NCT02019264|584563103|FG001|Overall Study|Not treated|4|||
161868679|NCT02019264|584563102|FG000|Overall Study|Lost to Follow-up|50|||
161868680|NCT02019264|584563103|FG001|Overall Study|Lost to Follow-up|47|||
161868681|NCT02019264|584563102|FG000|Overall Study|Withdrawal by Subject|142|||
161868682|NCT02019264|584563103|FG001|Overall Study|Withdrawal by Subject|117|||
161868683|NCT02019264|584563102|FG000|Overall Study|Administrative reason|36|||
161868684|NCT02019264|584563103|FG001|Overall Study|Administrative reason|28|||
161868685|NCT02019264|584563102|FG000|Overall Study|Missing|14|||
161868686|NCT02019264|584563103|FG001|Overall Study|Missing|11|||
161868687|NCT00869999|584563115|FG000|Overall Study|Withdrawal by Subject|1|||
161868688|NCT00869999|584563115|FG000|Overall Study|removed prior to starting therapy|1|||
161868689|NCT03674112|584563119|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
161868690|NCT03674112|584563120|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
161868691|NCT03674112|584563119|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
161868692|NCT03674112|584563120|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
161868693|NCT03674112|584563119|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
161868694|NCT03674112|584563120|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
161868695|NCT03674112|584563119|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
161868696|NCT03674112|584563120|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
161868697|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
161868698|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
161868699|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
161868700|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
161868701|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Death|2|||
161868702|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Death|0|||
161868703|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
161868704|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
161868705|NCT04157348|584563121|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
161868706|NCT04157348|584563122|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
161868707|NCT04157348|584563121|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161868708|NCT04157348|584563122|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161868709|NCT04157348|584563121|FG000|Double-blind Treatment Period|Adverse Event|0|||
161868710|NCT04157348|584563122|FG001|Double-blind Treatment Period|Adverse Event|1|||
161868711|NCT04157348|584563121|FG000|Open-label Extension Period|Adverse Event|1|||
161868712|NCT04157348|584563122|FG001|Open-label Extension Period|Adverse Event|1|||
161868713|NCT04157348|584563121|FG000|Open-label Extension Period|Death|0|||
161868714|NCT04157348|584563122|FG001|Open-label Extension Period|Death|1|||
161868715|NCT04157348|584563121|FG000|Open-label Extension Period|Lack of Efficacy|2|||
161868716|NCT04157348|584563122|FG001|Open-label Extension Period|Lack of Efficacy|2|||
161868717|NCT04157348|584563121|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
161868718|NCT04157348|584563122|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161868719|NCT04157348|584563121|FG000|Open-label Extension Period|Ongoing|60|||
161868720|NCT04157348|584563122|FG001|Open-label Extension Period|Ongoing|57|||
161868721|NCT04157348|584563121|FG000|Open-label Extension Period|other reasons|1|||
161868722|NCT04157348|584563122|FG001|Open-label Extension Period|other reasons|1|||
161868723|NCT02220764|584563125|FG000|Overall Study|Lost to Follow-up|3|||
161868724|NCT02220764|584563126|FG001|Overall Study|Lost to Follow-up|1|||
161868725|NCT02220764|584563125|FG000|Overall Study|Death|1|||
161868726|NCT02220764|584563126|FG001|Overall Study|Death|0|||
161868727|NCT04526288|584563130|FG000|Overall Study|Disease Progression|1|||
161868728|NCT04526288|584563131|FG001|Overall Study|Disease Progression|0|||
161868729|NCT00952068|584563132|FG000|Overall Study|Adverse Event|3|||
161868730|NCT00952068|584563132|FG000|Overall Study|Withdrawal by Subject|4|||
161868731|NCT04926831|584563133|FG000|Overall Study|Withdrawal by Subject|2|||
161868732|NCT04926831|584563133|FG000|Overall Study|Adverse Event|2|||
161868733|NCT02712554|584563134|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
161868734|NCT02712554|584563135|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
161868735|NCT02712554|584563134|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
161868736|NCT02712554|584563135|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
161868737|NCT02712554|584563134|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
161868738|NCT02712554|584563135|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
161868739|NCT02712554|584563134|FG000|Part B: Qualification Phase|Adverse Event|0|||
161868740|NCT02712554|584563135|FG001|Part B: Qualification Phase|Adverse Event|1|||
161868741|NCT02712554|584563134|FG000|Part B: Treatment Phase|Adverse Event|0|||
161868742|NCT02712554|584563135|FG001|Part B: Treatment Phase|Adverse Event|1|||
161868743|NCT02712554|584563134|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
161868744|NCT02712554|584563135|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
161868745|NCT02712554|584563134|FG000|Part B: Treatment Phase|Other|0|||
161868746|NCT02712554|584563135|FG001|Part B: Treatment Phase|Other|1|||
161868747|NCT01445730|584563136|FG000|Overall Study|Adverse Event|1|||
161774791|NCT05204563|584217344|FG001|Overall Study|Enrolled, Not Treated|0|||
161774792|NCT05643573|584217345|FG000|Overall Study|Adverse Event|117|||
161774793|NCT05643573|584217346|FG001|Overall Study|Adverse Event|90|||
161774794|NCT05643573|584217345|FG000|Overall Study|Death|53|||
161774795|NCT05643573|584217346|FG001|Overall Study|Death|57|||
161774796|NCT05643573|584217345|FG000|Overall Study|Lost to Follow-up|6|||
161774797|NCT05643573|584217346|FG001|Overall Study|Lost to Follow-up|3|||
161774798|NCT05643573|584217345|FG000|Overall Study|Other|18|||
161774799|NCT05643573|584217346|FG001|Overall Study|Other|15|||
161774800|NCT05643573|584217345|FG000|Overall Study|Outcome event|64|||
161774801|NCT05643573|584217346|FG001|Overall Study|Outcome event|36|||
161774802|NCT05643573|584217345|FG000|Overall Study|Physician Decision|33|||
161774803|NCT05643573|584217346|FG001|Overall Study|Physician Decision|19|||
161774804|NCT05643573|584217345|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
161774805|NCT05643573|584217346|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
161774806|NCT05643573|584217345|FG000|Overall Study|Site terminated by sponsor|10|||
161774807|NCT05643573|584217346|FG001|Overall Study|Site terminated by sponsor|10|||
161774808|NCT05643573|584217345|FG000|Overall Study|Study terminated by sponsor|1|||
161774809|NCT05643573|584217346|FG001|Overall Study|Study terminated by sponsor|0|||
161774810|NCT05643573|584217345|FG000|Overall Study|Withdrawal by Subject|178|||
161774811|NCT05643573|584217346|FG001|Overall Study|Withdrawal by Subject|130|||
161774812|NCT02268214|584217350|FG000|Overall Study|Subject no longer meets study criteria|0|||
161774813|NCT02268214|584217351|FG001|Overall Study|Subject no longer meets study criteria|2|||
161774814|NCT02268214|584217352|FG002|Overall Study|Subject no longer meets study criteria|0|||
161774815|NCT02268214|584217350|FG000|Overall Study|Pregnancy|2|||
161774816|NCT02268214|584217351|FG001|Overall Study|Pregnancy|2|||
161774817|NCT02268214|584217352|FG002|Overall Study|Pregnancy|1|||
161774818|NCT02268214|584217350|FG000|Overall Study|Lost to Follow-up|3|||
161774819|NCT02268214|584217351|FG001|Overall Study|Lost to Follow-up|3|||
161774820|NCT02268214|584217352|FG002|Overall Study|Lost to Follow-up|4|||
161774821|NCT02268214|584217350|FG000|Overall Study|Lack of Efficacy|1|||
161774822|NCT02268214|584217351|FG001|Overall Study|Lack of Efficacy|0|||
161774823|NCT02268214|584217352|FG002|Overall Study|Lack of Efficacy|2|||
161774824|NCT02268214|584217350|FG000|Overall Study|Adverse Event|11|||
161774825|NCT02268214|584217351|FG001|Overall Study|Adverse Event|14|||
161774826|NCT02268214|584217352|FG002|Overall Study|Adverse Event|9|||
161774827|NCT02268214|584217350|FG000|Overall Study|Withdrawal by Subject|4|||
161868748|NCT01445730|584563136|FG000|Overall Study|For the advice of a dentist|1|||
161774828|NCT02268214|584217351|FG001|Overall Study|Withdrawal by Subject|5|||
161774829|NCT02268214|584217352|FG002|Overall Study|Withdrawal by Subject|10|||
161774830|NCT02268214|584217350|FG000|Overall Study|Subject request to discontinue treatment|10|||
161774831|NCT02268214|584217351|FG001|Overall Study|Subject request to discontinue treatment|8|||
161774832|NCT02268214|584217352|FG002|Overall Study|Subject request to discontinue treatment|6|||
161774833|NCT02268214|584217350|FG000|Overall Study|Poor/non-compliance|2|||
161774834|NCT02268214|584217351|FG001|Overall Study|Poor/non-compliance|1|||
161868749|NCT01445730|584563136|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
161868750|NCT01367886|584563137|FG000|Overall Study|Lost to Follow-up|4|||
161868751|NCT01367886|584563137|FG000|Overall Study|Lack of Efficacy|2|||
161868752|NCT01367886|584563137|FG000|Overall Study|Death|1|||
161868753|NCT01167140|584563142|FG000|Overall Study|Withdrawal by Subject|1|||
161868754|NCT00985504|584563147|FG000|Acute Treatment Period|Adverse Event|3|||
161868755|NCT00985504|584563148|FG001|Acute Treatment Period|Adverse Event|4|||
161868756|NCT00985504|584563147|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
161868757|NCT00985504|584563148|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
161868758|NCT00985504|584563147|FG000|Acute Treatment Period|Protocol Violation|2|||
161868759|NCT00985504|584563148|FG001|Acute Treatment Period|Protocol Violation|0|||
161868760|NCT00985504|584563147|FG000|Acute Treatment Period|Sponsor Decision|0|||
161868761|NCT00985504|584563148|FG001|Acute Treatment Period|Sponsor Decision|1|||
161868762|NCT00985504|584563147|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
161868763|NCT00985504|584563148|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
161868764|NCT00985504|584563147|FG000|Optimization Period|Adverse Event|7|||
161868765|NCT00985504|584563148|FG001|Optimization Period|Adverse Event|9|||
161868766|NCT00985504|584563147|FG000|Optimization Period|Death|0|||
161868767|NCT00985504|584563148|FG001|Optimization Period|Death|1|||
161868768|NCT00985504|584563147|FG000|Optimization Period|Lack of Efficacy|5|||
161868769|NCT00985504|584563148|FG001|Optimization Period|Lack of Efficacy|3|||
161868770|NCT00985504|584563147|FG000|Optimization Period|Lost to Follow-up|0|||
161868771|NCT00985504|584563148|FG001|Optimization Period|Lost to Follow-up|1|||
161868772|NCT00985504|584563147|FG000|Optimization Period|Physician Decision|1|||
161868773|NCT00985504|584563148|FG001|Optimization Period|Physician Decision|0|||
161868774|NCT00985504|584563147|FG000|Optimization Period|Protocol Violation|3|||
161868775|NCT00985504|584563148|FG001|Optimization Period|Protocol Violation|1|||
161868776|NCT00985504|584563147|FG000|Optimization Period|Withdrawal by Subject|10|||
161868777|NCT00985504|584563148|FG001|Optimization Period|Withdrawal by Subject|8|||
161868778|NCT03805412|584563149|FG000|Overall Study|Lost to Follow-up|0|||
161868779|NCT03805412|584563150|FG001|Overall Study|Lost to Follow-up|1|||
161868780|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
161868781|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
161868782|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
161868783|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
161868784|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
161868785|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
161868786|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
161868787|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
161868788|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
161868789|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
161868790|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
161868791|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
161868792|NCT00669669|584563159|FG000|Overall Study|To late to start treatment|1|||
161868793|NCT01611883|584563160|FG000|Overall Study|Adverse Event|1|||
161868794|NCT01611883|584563161|FG001|Overall Study|Adverse Event|1|||
161868795|NCT03379727|584563163|FG000|Overall Study|Lack of Efficacy|73|||
161868796|NCT03379727|584563163|FG000|Overall Study|Adverse Event|32|||
161868797|NCT03379727|584563163|FG000|Overall Study|Death|18|||
161868798|NCT03379727|584563163|FG000|Overall Study|Patient/guardian decision|17|||
161868799|NCT03379727|584563163|FG000|Overall Study|Physician Decision|104|||
161868800|NCT03379727|584563163|FG000|Overall Study|Protocol Violation|4|||
161868801|NCT03379727|584563163|FG000|Overall Study|Lost to Follow-up|1|||
161868802|NCT00030901|584563166|FG000|Initial Registration|Ineligible|167|||
161868803|NCT00030901|584563167|FG001|Initial Registration|Ineligible|0|||
161868804|NCT00030901|584563168|FG002|Initial Registration|Ineligible|0|||
161868805|NCT00030901|584563166|FG000|Randomization|Adverse Event|0|||
161868806|NCT00030901|584563167|FG001|Randomization|Adverse Event|11|||
161868807|NCT00030901|584563168|FG002|Randomization|Adverse Event|7|||
161868808|NCT00030901|584563166|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
161868809|NCT00030901|584563167|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
161868810|NCT00030901|584563168|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
161868811|NCT00030901|584563166|FG000|Randomization|Progression/Relapse|0|||
161868812|NCT00030901|584563167|FG001|Randomization|Progression/Relapse|22|||
161868813|NCT00030901|584563168|FG002|Randomization|Progression/Relapse|21|||
161868814|NCT00030901|584563166|FG000|Randomization|Death|0|||
161868815|NCT00030901|584563167|FG001|Randomization|Death|1|||
161868816|NCT00030901|584563168|FG002|Randomization|Death|3|||
161868817|NCT00030901|584563166|FG000|Randomization|Other|0|||
161868818|NCT00030901|584563167|FG001|Randomization|Other|36|||
161868819|NCT00030901|584563168|FG002|Randomization|Other|33|||
161868820|NCT00030901|584563166|FG000|Randomization|Ineligible|0|||
161868821|NCT00030901|584563167|FG001|Randomization|Ineligible|15|||
161868822|NCT00030901|584563168|FG002|Randomization|Ineligible|14|||
161868823|NCT02576847|584563169|FG000|Overall Study|Adverse Event|27|||
161868824|NCT02576847|584563169|FG000|Overall Study|Lost to Follow-up|22|||
161868825|NCT02576847|584563169|FG000|Overall Study|Physician Decision|1|||
161868826|NCT02576847|584563169|FG000|Overall Study|Pregnancy|1|||
161868827|NCT02576847|584563169|FG000|Overall Study|Protocol Violation|3|||
161868828|NCT02576847|584563169|FG000|Overall Study|Withdrawal by Subject|78|||
161868829|NCT02576847|584563169|FG000|Overall Study|Other|5|||
161868830|NCT01806051|584563170|FG000|Overall Study|Withdrawal by Subject|6|||
161868831|NCT01205776|584563173|FG000|Overall Study|Lost to Follow-up|53|||
161868832|NCT01205776|584563174|FG001|Overall Study|Lost to Follow-up|61|||
161868833|NCT01205776|584563173|FG000|Overall Study|Withdrawal by Subject|11|||
161868834|NCT01205776|584563174|FG001|Overall Study|Withdrawal by Subject|34|||
161868835|NCT02418182|584563175|FG000|Overall Study|Unable to re-consent|18|||
161868836|NCT02418182|584563176|FG001|Overall Study|Unable to re-consent|15|||
161868837|NCT02418182|584563175|FG000|Overall Study|Lost to Follow-up|0|||
161868838|NCT02418182|584563176|FG001|Overall Study|Lost to Follow-up|2|||
161868839|NCT00734994|584563177|FG000|Overall Study|Withdrawal by Subject|1|||
161868840|NCT02747108|584563183|FG000|Overall Study|Death|2|||
161868841|NCT02747108|584563184|FG001|Overall Study|Death|2|||
161868842|NCT02747108|584563183|FG000|Overall Study|Withdrawal by Subject|1|||
161868843|NCT02747108|584563184|FG001|Overall Study|Withdrawal by Subject|0|||
161868844|NCT02747108|584563183|FG000|Overall Study|Protocol Violation|2|||
161868845|NCT02747108|584563184|FG001|Overall Study|Protocol Violation|0|||
161868846|NCT03103152|584563185|FG000|Overall Study|Physician Decision|5|||
161868847|NCT03103152|584563186|FG001|Overall Study|Physician Decision|2|||
161868848|NCT03103152|584563187|FG002|Overall Study|Physician Decision|6|||
161868849|NCT03103152|584563188|FG003|Overall Study|Physician Decision|3|||
161868850|NCT03103152|584563189|FG004|Overall Study|Physician Decision|3|||
161868851|NCT03103152|584563190|FG005|Overall Study|Physician Decision|1|||
161868852|NCT03103152|584563185|FG000|Overall Study|Protocol Violation|2|||
161868853|NCT03103152|584563186|FG001|Overall Study|Protocol Violation|2|||
161868854|NCT03103152|584563187|FG002|Overall Study|Protocol Violation|1|||
161868855|NCT03103152|584563188|FG003|Overall Study|Protocol Violation|2|||
161868856|NCT03103152|584563189|FG004|Overall Study|Protocol Violation|1|||
161868857|NCT03103152|584563190|FG005|Overall Study|Protocol Violation|1|||
161868858|NCT03103152|584563185|FG000|Overall Study|Inter-current illness|0|||
161868859|NCT03103152|584563186|FG001|Overall Study|Inter-current illness|0|||
161868860|NCT03103152|584563187|FG002|Overall Study|Inter-current illness|1|||
161868861|NCT03103152|584563188|FG003|Overall Study|Inter-current illness|0|||
161868862|NCT03103152|584563189|FG004|Overall Study|Inter-current illness|0|||
161868863|NCT03103152|584563190|FG005|Overall Study|Inter-current illness|0|||
161868864|NCT03103152|584563185|FG000|Overall Study|Death|0|||
161868865|NCT03103152|584563186|FG001|Overall Study|Death|1|||
161868866|NCT03103152|584563187|FG002|Overall Study|Death|0|||
161868867|NCT03103152|584563188|FG003|Overall Study|Death|0|||
161868868|NCT03103152|584563189|FG004|Overall Study|Death|0|||
161868869|NCT03103152|584563190|FG005|Overall Study|Death|0|||
161868870|NCT03103152|584563185|FG000|Overall Study|Adverse Event|0|||
161868871|NCT03103152|584563186|FG001|Overall Study|Adverse Event|0|||
161868872|NCT03103152|584563187|FG002|Overall Study|Adverse Event|1|||
161868873|NCT03103152|584563188|FG003|Overall Study|Adverse Event|0|||
161868874|NCT03103152|584563189|FG004|Overall Study|Adverse Event|0|||
161868875|NCT03103152|584563190|FG005|Overall Study|Adverse Event|1|||
161868876|NCT03103152|584563185|FG000|Overall Study|Withdrawal by Subject|1|||
161868877|NCT03103152|584563186|FG001|Overall Study|Withdrawal by Subject|0|||
161868878|NCT03103152|584563187|FG002|Overall Study|Withdrawal by Subject|1|||
161868879|NCT03103152|584563188|FG003|Overall Study|Withdrawal by Subject|1|||
161868880|NCT03103152|584563189|FG004|Overall Study|Withdrawal by Subject|1|||
161868881|NCT03103152|584563190|FG005|Overall Study|Withdrawal by Subject|1|||
161868882|NCT03103152|584563185|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
161868883|NCT03103152|584563186|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
161868884|NCT03103152|584563187|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
161868885|NCT03103152|584563188|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
161868886|NCT03103152|584563189|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
161868887|NCT03103152|584563190|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
161868888|NCT03103152|584563185|FG000|Overall Study|Unacceptable side effects|0|||
161868889|NCT03103152|584563186|FG001|Overall Study|Unacceptable side effects|0|||
161868890|NCT03103152|584563187|FG002|Overall Study|Unacceptable side effects|0|||
161868891|NCT03103152|584563188|FG003|Overall Study|Unacceptable side effects|0|||
161868892|NCT03103152|584563189|FG004|Overall Study|Unacceptable side effects|0|||
161868893|NCT03103152|584563190|FG005|Overall Study|Unacceptable side effects|1|||
161868894|NCT03103152|584563185|FG000|Overall Study|Lost to Follow-up|0|||
161868895|NCT03103152|584563186|FG001|Overall Study|Lost to Follow-up|1|||
161868896|NCT03103152|584563187|FG002|Overall Study|Lost to Follow-up|0|||
161868897|NCT03103152|584563188|FG003|Overall Study|Lost to Follow-up|1|||
161868898|NCT03103152|584563189|FG004|Overall Study|Lost to Follow-up|0|||
161868899|NCT03103152|584563190|FG005|Overall Study|Lost to Follow-up|1|||
161868900|NCT03103152|584563185|FG000|Overall Study|Testicular pain|0|||
161868901|NCT03103152|584563186|FG001|Overall Study|Testicular pain|0|||
161868902|NCT03103152|584563187|FG002|Overall Study|Testicular pain|0|||
161868903|NCT03103152|584563188|FG003|Overall Study|Testicular pain|1|||
161868904|NCT03103152|584563189|FG004|Overall Study|Testicular pain|0|||
161868905|NCT03103152|584563190|FG005|Overall Study|Testicular pain|0|||
161868906|NCT05966584|584563191|FG000|Overall Study|Lost to Follow-up|1|||
161868907|NCT06360588|584564910|FG000|Overall Study|Adverse Event|3|||
161868908|NCT06360588|584564910|FG000|Overall Study|Death|2|||
161868909|NCT06360588|584564910|FG000|Overall Study|Disease Progression|14|||
161868910|NCT06360588|584564910|FG000|Overall Study|Withdrawal by Subject|1|||
161868911|NCT06360588|584564910|FG000|Overall Study|Lack of Efficacy|1|||
161868912|NCT06360588|584564910|FG000|Overall Study|Ineligible|1|||
161868913|NCT04010240|584564911|FG000|Overall Study|IHC not performed|2299|||
161868914|NCT01481766|584564912|FG000|4 months|Lost to Follow-up|3|||
161868915|NCT01481766|584564913|FG001|4 months|Lost to Follow-up|2|||
161868916|NCT01481766|584564914|FG002|4 months|Lost to Follow-up|1|||
161868917|NCT01481766|584564915|FG003|4 months|Lost to Follow-up|5|||
161868918|NCT01481766|584564912|FG000|12 months|Lost to Follow-up|7|||
161868919|NCT01481766|584564913|FG001|12 months|Lost to Follow-up|8|||
161868920|NCT01481766|584564914|FG002|12 months|Lost to Follow-up|5|||
161868921|NCT01481766|584564915|FG003|12 months|Lost to Follow-up|3|||
161868922|NCT00347958|584564916|FG000|Overall Study|Adverse Event|1|||
161868923|NCT00347958|584564916|FG000|Overall Study|Protocol Violation|2|||
161868924|NCT00347958|584564916|FG000|Overall Study|Withdrawal by Subject|1|||
161868925|NCT00754234|584564917|FG000|Overall Study|Withdrawal by Subject|3|||
161868926|NCT00570687|584564918|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868927|NCT00570687|584564919|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868928|NCT00570687|584564920|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868929|NCT00570687|584564921|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868930|NCT00570687|584564922|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868931|NCT00570687|584564923|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868932|NCT00570687|584564924|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
161868933|NCT00570687|584564925|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868934|NCT00570687|584564926|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
161868935|NCT00570687|584564927|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868936|NCT00570687|584564918|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868937|NCT00570687|584564919|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868938|NCT00570687|584564920|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868939|NCT00570687|584564921|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868940|NCT00570687|584564922|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868941|NCT00570687|584564923|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868942|NCT00570687|584564924|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868943|NCT00570687|584564925|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868944|NCT00570687|584564926|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
161868945|NCT00570687|584564927|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868946|NCT00570687|584564918|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868947|NCT00570687|584564919|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868948|NCT00570687|584564920|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868949|NCT00570687|584564921|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868950|NCT00570687|584564922|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868951|NCT00570687|584564923|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868952|NCT00570687|584564924|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
161868953|NCT00570687|584564925|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868954|NCT00570687|584564926|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868955|NCT00570687|584564927|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868956|NCT03263936|584564928|FG000|Overall Study|Adverse Event|0|||
161868957|NCT03263936|584564929|FG001|Overall Study|Adverse Event|1|||
161868958|NCT03263936|584564930|FG002|Overall Study|Adverse Event|0|||
161868959|NCT03263936|584564928|FG000|Overall Study|Death|0|||
161868960|NCT03263936|584564929|FG001|Overall Study|Death|1|||
161868961|NCT03263936|584564930|FG002|Overall Study|Death|0|||
161868962|NCT00298272|584564932|FG000|Double-blind Phase|Adverse Event|2|||
161868963|NCT00298272|584564933|FG001|Double-blind Phase|Adverse Event|0|||
161868964|NCT00298272|584564932|FG000|Double-blind Phase|Failure to Return|2|||
161868965|NCT00298272|584564933|FG001|Double-blind Phase|Failure to Return|0|||
161868966|NCT00298272|584564932|FG000|Double-blind Phase|Protocol Violation|2|||
161868967|NCT00298272|584564933|FG001|Double-blind Phase|Protocol Violation|0|||
161868968|NCT00298272|584564932|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161868969|NCT00298272|584564933|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161868970|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Adverse Event|1|||
161868971|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Adverse Event|2|||
161868972|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
161868973|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
161868974|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Failure to Return|1|||
161868975|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Failure to Return|0|||
161868976|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
161868977|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
161868978|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
161868979|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
161868980|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
161868981|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
161868982|NCT00298272|584564932|FG000|Safety Follow-up Phase|Failure to Return|1|||
161868983|NCT00298272|584564933|FG001|Safety Follow-up Phase|Failure to Return|1|||
161868984|NCT00298272|584564932|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
161868985|NCT00298272|584564933|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
161868986|NCT00298272|584564932|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
161868987|NCT00298272|584564933|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
161868988|NCT00326716|584564934|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
161868989|NCT00326716|584564935|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
161868990|NCT00326716|584564936|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
161868991|NCT00326716|584564937|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
161868992|NCT00684411|584564938|FG000|Overall Study|New Primary Cancer|1|||
161868993|NCT00684411|584564938|FG000|Overall Study|Disease Progression|10|||
161868994|NCT00684411|584564938|FG000|Overall Study|Adverse Event|1|||
161868995|NCT00734162|584564939|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
161868996|NCT00734162|584564940|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
161868997|NCT00734162|584564941|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
161868998|NCT00734162|584564942|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
161868999|NCT00734162|584564939|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161869000|NCT00734162|584564940|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161869001|NCT00734162|584564941|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161869002|NCT00734162|584564942|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
161869003|NCT00734162|584564939|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
161869004|NCT00734162|584564940|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161869005|NCT00734162|584564941|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161869006|NCT00734162|584564942|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161869007|NCT00734162|584564939|FG000|Open-Label Phase|Withdrew Consent|1|||
161869008|NCT00734162|584564940|FG001|Open-Label Phase|Withdrew Consent|0|||
161869009|NCT00734162|584564941|FG002|Open-Label Phase|Withdrew Consent|1|||
161869010|NCT00734162|584564942|FG003|Open-Label Phase|Withdrew Consent|1|||
161869011|NCT00734162|584564939|FG000|Open-Label Phase|Lost to Follow-up|1|||
161869012|NCT00734162|584564940|FG001|Open-Label Phase|Lost to Follow-up|2|||
161869013|NCT00734162|584564941|FG002|Open-Label Phase|Lost to Follow-up|0|||
161869014|NCT00734162|584564942|FG003|Open-Label Phase|Lost to Follow-up|1|||
161869015|NCT00734162|584564939|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161869016|NCT00734162|584564940|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161869017|NCT00734162|584564941|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161869018|NCT00734162|584564942|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
161869019|NCT05253573|584564943|FG000|Overall Study|Death|1|||
161869020|NCT05253573|584564944|FG001|Overall Study|Death|0|||
161869021|NCT01344824|584564945|FG000|Overall Study|Adverse Event|15|||
161869022|NCT01344824|584564945|FG000|Overall Study|Withdrawal by Subject|6|||
161869023|NCT01344824|584564945|FG000|Overall Study|Other complicating disease|1|||
161869024|NCT01344824|584564945|FG000|Overall Study|Progression|15|||
161869025|NCT00566020|584564946|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
161869026|NCT00566020|584564947|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
161869027|NCT00566020|584564946|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
161869028|NCT00566020|584564947|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
161869029|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
161869030|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
161869031|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
161869032|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
161869033|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
161869034|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
161869035|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
161869036|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
161869037|NCT01754129|584564948|FG000|Overall Study|Death|13|||
161869038|NCT01754129|584564948|FG000|Overall Study|Duodopa discontinuation|9|||
161869039|NCT01754129|584564948|FG000|Overall Study|Lost to Follow-up|7|||
161869040|NCT01754129|584564948|FG000|Overall Study|Withdrew consent|1|||
161869041|NCT01754129|584564948|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
161774835|NCT02268214|584217352|FG002|Overall Study|Poor/non-compliance|2|||
161774836|NCT02268214|584217350|FG000|Overall Study|Other reasons|7|||
161774837|NCT02268214|584217351|FG001|Overall Study|Other reasons|3|||
161774838|NCT02268214|584217352|FG002|Overall Study|Other reasons|3|||
161774839|NCT02268214|584217350|FG000|Overall Study|Not entering long-term period|2|||
161774840|NCT02268214|584217351|FG001|Overall Study|Not entering long-term period|3|||
161774841|NCT02268214|584217352|FG002|Overall Study|Not entering long-term period|5|||
161774842|NCT02951130|584217353|FG000|Overall Study|Protocol Violation|1|||
161774843|NCT02951130|584217354|FG001|Overall Study|Protocol Violation|1|||
161774844|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
161774845|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
161774846|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
161774847|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
161774848|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
161774849|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
161774850|NCT04584294|584217355|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
161774851|NCT04584294|584217356|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
161774852|NCT04584294|584217355|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
161774853|NCT04584294|584217356|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
161774854|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
161774855|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
161774856|NCT02500732|584217358|FG000|Overall Study|Physician Decision|0|||
161774857|NCT02500732|584217359|FG001|Overall Study|Physician Decision|1|||
161774858|NCT01233284|584217369|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161774859|NCT01233284|584217370|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774860|NCT01233284|584217371|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774861|NCT01233284|584217372|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774862|NCT01233284|584217373|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774863|NCT01233284|584217369|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774864|NCT01233284|584217370|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
161774865|NCT01233284|584217371|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774866|NCT01233284|584217372|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774867|NCT01233284|584217373|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774868|NCT01233284|584217369|FG000|Period 1 (4 Weeks)|Other|0|||
161774869|NCT01233284|584217370|FG001|Period 1 (4 Weeks)|Other|0|||
161869042|NCT01085630|584564949|FG000|Overall Study|Insufficient data|1|||
161869043|NCT01085630|584564950|FG001|Overall Study|Insufficient data|0|||
161869044|NCT01085630|584564949|FG000|Overall Study|Ineligible|3|||
161869045|NCT01085630|584564950|FG001|Overall Study|Ineligible|0|||
161869046|NCT02027545|584564951|FG000|Overall Study|Failed to sign HIPAA|0|||
161869047|NCT02027545|584564952|FG001|Overall Study|Failed to sign HIPAA|2|||
161869048|NCT02027545|584564951|FG000|Overall Study|Failed to attend study visit|2|||
161869049|NCT02027545|584564952|FG001|Overall Study|Failed to attend study visit|0|||
161869050|NCT02027545|584564951|FG000|Overall Study|Protocol Violation|1|||
161869051|NCT02027545|584564952|FG001|Overall Study|Protocol Violation|0|||
161869052|NCT01017874|584564953|FG000|Overall Study|Withdrawal by Subject|23|||
161869053|NCT01017874|584564954|FG001|Overall Study|Withdrawal by Subject|20|||
161869054|NCT01017874|584564953|FG000|Overall Study|Sponsor decision|3|||
161869055|NCT01017874|584564954|FG001|Overall Study|Sponsor decision|1|||
161869056|NCT01017874|584564953|FG000|Overall Study|Lost to Follow-up|3|||
161869057|NCT01017874|584564954|FG001|Overall Study|Lost to Follow-up|2|||
161869058|NCT01017874|584564953|FG000|Overall Study|Physician Decision|1|||
161869059|NCT01017874|584564954|FG001|Overall Study|Physician Decision|3|||
161869060|NCT01790984|584564959|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
161869061|NCT01790984|584564960|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
161869062|NCT01790984|584564961|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
161869063|NCT01790984|584564962|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
161869064|NCT01163851|584564970|FG000|Overall Study|Site Closure|0|||
161869065|NCT01163851|584564971|FG001|Overall Study|Site Closure|1|||
161869066|NCT01163851|584564970|FG000|Overall Study|Enrolled but not treated|1|||
161869067|NCT01163851|584564971|FG001|Overall Study|Enrolled but not treated|0|||
161869068|NCT00789373|584564975|FG000|Induction|Adverse Event|64|||
161869069|NCT00789373|584564976|FG001|Induction|Adverse Event|0|||
161869070|NCT00789373|584564977|FG002|Induction|Adverse Event|0|||
161869071|NCT00789373|584564975|FG000|Induction|Death Due to study disease|24|||
161869072|NCT00789373|584564976|FG001|Induction|Death Due to study disease|0|||
161869073|NCT00789373|584564977|FG002|Induction|Death Due to study disease|0|||
161869074|NCT00789373|584564975|FG000|Induction|Death due to adverse event|19|||
161869075|NCT00789373|584564976|FG001|Induction|Death due to adverse event|0|||
161869076|NCT00789373|584564977|FG002|Induction|Death due to adverse event|0|||
161869077|NCT00789373|584564975|FG000|Induction|Death due to toxicity|11|||
161869078|NCT00789373|584564976|FG001|Induction|Death due to toxicity|0|||
161869079|NCT00789373|584564977|FG002|Induction|Death due to toxicity|0|||
161869080|NCT00789373|584564975|FG000|Induction|Death due to procedure|1|||
161869081|NCT00789373|584564976|FG001|Induction|Death due to procedure|0|||
161869082|NCT00789373|584564977|FG002|Induction|Death due to procedure|0|||
161869083|NCT00789373|584564975|FG000|Induction|Investigator decision|7|||
161869084|NCT00789373|584564976|FG001|Induction|Investigator decision|0|||
161869085|NCT00789373|584564977|FG002|Induction|Investigator decision|0|||
161869086|NCT00789373|584564975|FG000|Induction|Protocol entry criteria not met|9|||
161869087|NCT00789373|584564976|FG001|Induction|Protocol entry criteria not met|0|||
161869088|NCT00789373|584564977|FG002|Induction|Protocol entry criteria not met|0|||
161869089|NCT00789373|584564975|FG000|Induction|Lost to Follow-up|6|||
161869090|NCT00789373|584564976|FG001|Induction|Lost to Follow-up|0|||
161869091|NCT00789373|584564977|FG002|Induction|Lost to Follow-up|0|||
161869092|NCT00789373|584564975|FG000|Induction|Protocol Violation|1|||
161869093|NCT00789373|584564976|FG001|Induction|Protocol Violation|0|||
161869094|NCT00789373|584564977|FG002|Induction|Protocol Violation|0|||
161869095|NCT00789373|584564975|FG000|Induction|Progressive Disease|220|||
161869096|NCT00789373|584564976|FG001|Induction|Progressive Disease|0|||
161869097|NCT00789373|584564977|FG002|Induction|Progressive Disease|0|||
161869098|NCT00789373|584564975|FG000|Induction|Withdrawal by Subject|37|||
161869099|NCT00789373|584564976|FG001|Induction|Withdrawal by Subject|0|||
161869100|NCT00789373|584564977|FG002|Induction|Withdrawal by Subject|0|||
161869101|NCT00789373|584564975|FG000|Maintenance|Adverse Event|0|||
161869102|NCT00789373|584564976|FG001|Maintenance|Adverse Event|65|||
161869103|NCT00789373|584564977|FG002|Maintenance|Adverse Event|12|||
161869104|NCT00789373|584564975|FG000|Maintenance|Death due to study disease|0|||
161869105|NCT00789373|584564976|FG001|Maintenance|Death due to study disease|3|||
161869106|NCT00789373|584564977|FG002|Maintenance|Death due to study disease|1|||
161869107|NCT00789373|584564975|FG000|Maintenance|Death due to adverse event|0|||
161869108|NCT00789373|584564976|FG001|Maintenance|Death due to adverse event|4|||
161869109|NCT00789373|584564977|FG002|Maintenance|Death due to adverse event|1|||
161869110|NCT00789373|584564975|FG000|Maintenance|Death due to toxicity|0|||
161869111|NCT00789373|584564976|FG001|Maintenance|Death due to toxicity|1|||
161869112|NCT00789373|584564977|FG002|Maintenance|Death due to toxicity|2|||
161869113|NCT00789373|584564975|FG000|Maintenance|Investigator Decision|0|||
161869114|NCT00789373|584564976|FG001|Maintenance|Investigator Decision|4|||
161869115|NCT00789373|584564977|FG002|Maintenance|Investigator Decision|2|||
161869116|NCT00789373|584564975|FG000|Maintenance|Protocol entry criteria not met|0|||
161869117|NCT00789373|584564976|FG001|Maintenance|Protocol entry criteria not met|2|||
161869118|NCT00789373|584564977|FG002|Maintenance|Protocol entry criteria not met|0|||
161869119|NCT00789373|584564975|FG000|Maintenance|Lost to Follow-up|0|||
161869120|NCT00789373|584564976|FG001|Maintenance|Lost to Follow-up|2|||
161869121|NCT00789373|584564977|FG002|Maintenance|Lost to Follow-up|0|||
161869122|NCT00789373|584564975|FG000|Maintenance|Progressive Disease|0|||
161869123|NCT00789373|584564976|FG001|Maintenance|Progressive Disease|253|||
161869124|NCT00789373|584564977|FG002|Maintenance|Progressive Disease|152|||
161869125|NCT00789373|584564975|FG000|Maintenance|Withdrawal by Subject|0|||
161869126|NCT00789373|584564976|FG001|Maintenance|Withdrawal by Subject|21|||
161869127|NCT00789373|584564977|FG002|Maintenance|Withdrawal by Subject|8|||
161869128|NCT00789373|584564975|FG000|Maintenance|Sponsor Decision|0|||
161869129|NCT00789373|584564976|FG001|Maintenance|Sponsor Decision|0|||
161869130|NCT00789373|584564977|FG002|Maintenance|Sponsor Decision|2|||
161869131|NCT00789373|584564975|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
161869132|NCT00789373|584564976|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
161869133|NCT00789373|584564977|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
161869134|NCT01684423|584564987|FG000|Overall Study|Withdrawal by Subject|0|||
161869135|NCT01684423|584564988|FG001|Overall Study|Withdrawal by Subject|0|||
161869136|NCT01684423|584564989|FG002|Overall Study|Withdrawal by Subject|1|||
161869137|NCT01684423|584564990|FG003|Overall Study|Withdrawal by Subject|0|||
161869138|NCT01684423|584564991|FG004|Overall Study|Withdrawal by Subject|0|||
161869139|NCT02155283|584564992|FG000|Overall Study|Lost to Follow-up|3|||
161869140|NCT02155283|584564992|FG000|Overall Study|Withdrawal by Subject|1|||
161869141|NCT02155283|584564992|FG000|Overall Study|Protocol Violation|3|||
161869142|NCT01741688|584564996|FG000|Overall Study|Lack of insurance coverage|2|||
161869143|NCT01741688|584564996|FG000|Overall Study|Withdrawal by Subject|1|||
161869144|NCT03850496|584565001|FG000|Overall Study|Withdrawal by Subject|1|||
161869145|NCT03850496|584565002|FG001|Overall Study|Withdrawal by Subject|0|||
161869146|NCT03850496|584565003|FG002|Overall Study|Withdrawal by Subject|0|||
161869147|NCT03850496|584565001|FG000|Overall Study|Lost to Follow-up|0|||
161869148|NCT03850496|584565002|FG001|Overall Study|Lost to Follow-up|1|||
161869149|NCT03850496|584565003|FG002|Overall Study|Lost to Follow-up|4|||
161869150|NCT03020992|584565004|FG000|Overall Study|Adverse Event|5|||
161869151|NCT03020992|584565004|FG000|Overall Study|Withdrawal by Subject|1|||
161869152|NCT05000164|584565005|FG000|Overall Study|Adverse Event|1|||
161869153|NCT05000164|584565005|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161869154|NCT05000164|584565005|FG000|Overall Study|Lens Discomfort|3|||
161869155|NCT05000164|584565005|FG000|Overall Study|Withdrew Consent during Study|2|||
161869156|NCT05000164|584565005|FG000|Overall Study|Subject Withdrawn by PI|2|||
161869157|NCT05000164|584565005|FG000|Overall Study|Other Fractured Test Article|1|||
161869158|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
161869159|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
161869160|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
161869161|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
161869162|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Pregnancy|0|||
161869163|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Pregnancy|1|||
161869164|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
161869165|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
161869166|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
161869167|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
161869168|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
161869169|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
161869170|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Other|3|||
161869171|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Other|0|||
161869172|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Adverse Event|0|||
161869173|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Adverse Event|4|||
161869174|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
161869175|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
161869176|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
161869177|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
161869178|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161869179|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
161869180|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161869181|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
161869182|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Death|0|||
161869183|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Death|1|||
161869184|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
161869185|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
161869186|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
161869187|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
161869188|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
161869189|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
161869190|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
161869191|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
161869192|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
161869193|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
161869194|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
161869195|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
161869196|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
161869197|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
161869198|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
161869199|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
161869200|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
161869201|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
161869202|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
161869203|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
161869204|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
161869205|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
161869206|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
161869207|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
161869208|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
161869209|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
161869210|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
161869211|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
161869212|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
161869213|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
161869214|NCT03493854|584565008|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
161869215|NCT03493854|584565009|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
161869216|NCT03493854|584565008|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
161869217|NCT03493854|584565009|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
161869218|NCT03493854|584565008|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
161869219|NCT03493854|584565009|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
161869220|NCT00410813|584565012|FG000|Overall Study|Adverse Event|6|||
161869221|NCT00410813|584565013|FG001|Overall Study|Adverse Event|11|||
161869222|NCT00410813|584565012|FG000|Overall Study|Progression|32|||
161869223|NCT00410813|584565013|FG001|Overall Study|Progression|21|||
161869224|NCT00410813|584565012|FG000|Overall Study|Not protocol specified|3|||
161869225|NCT00410813|584565013|FG001|Overall Study|Not protocol specified|4|||
161869226|NCT00410813|584565012|FG000|Overall Study|Ineligible|2|||
161869227|NCT00410813|584565013|FG001|Overall Study|Ineligible|4|||
161869228|NCT00410813|584565012|FG000|Overall Study|Death|0|||
161869229|NCT00410813|584565013|FG001|Overall Study|Death|2|||
161869230|NCT02268916|584565025|FG000|Overall Study|Lost to Follow-up|1|||
161869231|NCT02268916|584565026|FG001|Overall Study|Lost to Follow-up|1|||
161869232|NCT02268916|584565025|FG000|Overall Study|Withdrawal by Subject|6|||
161869233|NCT02268916|584565026|FG001|Overall Study|Withdrawal by Subject|5|||
161869234|NCT02268916|584565025|FG000|Overall Study|Participant did not have diabetes|1|||
161869235|NCT02268916|584565026|FG001|Overall Study|Participant did not have diabetes|0|||
161869236|NCT02268916|584565025|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
161869237|NCT02268916|584565026|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
161869238|NCT00594165|584565029|FG000|Overall Study|Major protocol violation|1|||
161869239|NCT00594165|584565029|FG000|Overall Study|Lack of Efficacy|12|||
161869240|NCT00594165|584565029|FG000|Overall Study|Adverse Event|52|||
161869241|NCT00594165|584565029|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
161869242|NCT00594165|584565029|FG000|Overall Study|Subject withdrew consent|27|||
161774870|NCT01233284|584217371|FG002|Period 1 (4 Weeks)|Other|1|||
161774871|NCT01233284|584217372|FG003|Period 1 (4 Weeks)|Other|0|||
161774872|NCT01233284|584217373|FG004|Period 1 (4 Weeks)|Other|0|||
161774873|NCT01233284|584217369|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774874|NCT01233284|584217370|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774875|NCT01233284|584217371|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
161774876|NCT01233284|584217372|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774877|NCT01233284|584217373|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774878|NCT01233284|584217369|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774879|NCT01233284|584217370|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774880|NCT01233284|584217371|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
161774881|NCT01233284|584217372|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774882|NCT01233284|584217373|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774883|NCT01233284|584217369|FG000|Period 3 (4 Weeks)|Other|0|||
161774884|NCT01233284|584217370|FG001|Period 3 (4 Weeks)|Other|0|||
161774885|NCT01233284|584217371|FG002|Period 3 (4 Weeks)|Other|0|||
161774886|NCT01233284|584217372|FG003|Period 3 (4 Weeks)|Other|1|||
161774887|NCT01233284|584217373|FG004|Period 3 (4 Weeks)|Other|0|||
161774888|NCT01233284|584217369|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
161774889|NCT01233284|584217370|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
161774890|NCT01233284|584217371|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
161774891|NCT01233284|584217372|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
161774892|NCT01233284|584217373|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
161774893|NCT01233284|584217369|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774894|NCT01233284|584217370|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774895|NCT01233284|584217371|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774896|NCT01233284|584217372|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
161774897|NCT01233284|584217373|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774898|NCT03759340|584217374|FG000|Overall Study|Adverse Event|2|||
161774899|NCT03759340|584217374|FG000|Overall Study|Lost to Follow-up|1|||
161774900|NCT03759340|584217374|FG000|Overall Study|Withdrawal by Subject|15|||
161774901|NCT03759340|584217374|FG000|Overall Study|Study Terminated by Sponsor|38|||
161774902|NCT04814654|584217375|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
161774903|NCT04814654|584217376|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
161774904|NCT04814654|584217377|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
161774905|NCT00157820|584217383|FG000|Randomized|Physician Decision|4|||
161774906|NCT00157820|584217384|FG001|Randomized|Physician Decision|2|||
161774907|NCT00157820|584217385|FG002|Randomized|Physician Decision|3|||
161774908|NCT00157820|584217383|FG000|Randomized|Withdrawal by Subject|1|||
161774909|NCT00157820|584217384|FG001|Randomized|Withdrawal by Subject|2|||
161774910|NCT00157820|584217385|FG002|Randomized|Withdrawal by Subject|3|||
161774911|NCT00157820|584217383|FG000|Randomized|Protocol Violation|2|||
161774912|NCT00157820|584217384|FG001|Randomized|Protocol Violation|1|||
161774913|NCT00157820|584217385|FG002|Randomized|Protocol Violation|2|||
161774914|NCT00157820|584217383|FG000|1st 8 Month|Death|7|||
161774915|NCT00157820|584217384|FG001|1st 8 Month|Death|8|||
161774916|NCT00157820|584217385|FG002|1st 8 Month|Death|3|||
161774917|NCT00157820|584217383|FG000|1st 8 Month|Lost to Follow-up|1|||
161774918|NCT00157820|584217384|FG001|1st 8 Month|Lost to Follow-up|2|||
161774919|NCT00157820|584217385|FG002|1st 8 Month|Lost to Follow-up|1|||
161774920|NCT00157820|584217383|FG000|1st 8 Month|Premature cross-over|0|||
161774921|NCT00157820|584217384|FG001|1st 8 Month|Premature cross-over|2|||
161774922|NCT00157820|584217385|FG002|1st 8 Month|Premature cross-over|2|||
161774923|NCT00157820|584217383|FG000|2nd 8 Months|Death|3|||
161774924|NCT00157820|584217384|FG001|2nd 8 Months|Death|1|||
161774925|NCT00157820|584217385|FG002|2nd 8 Months|Death|3|||
161774926|NCT00157820|584217383|FG000|2nd 8 Months|Lost to Follow-up|1|||
161774927|NCT00157820|584217384|FG001|2nd 8 Months|Lost to Follow-up|5|||
161774928|NCT00157820|584217385|FG002|2nd 8 Months|Lost to Follow-up|2|||
161774929|NCT00157820|584217383|FG000|2nd 8 Months|Premature cross-over|1|||
161774930|NCT00157820|584217384|FG001|2nd 8 Months|Premature cross-over|7|||
161774931|NCT00157820|584217385|FG002|2nd 8 Months|Premature cross-over|9|||
161774932|NCT01676818|584217386|FG000|Overall Study|Physician Decision|1|||
161774933|NCT01676818|584217386|FG000|Overall Study|Withdrawal by Subject|1|||
161869243|NCT00594165|584565029|FG000|Overall Study|Study ended per sponsor|102|||
161869244|NCT00594165|584565029|FG000|Overall Study|Lost to Follow-up|4|||
161869245|NCT00594165|584565029|FG000|Overall Study|Other: PI discretion|5|||
161869246|NCT00594165|584565029|FG000|Overall Study|Other: Subject moving|3|||
161869247|NCT00594165|584565029|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
161869248|NCT00594165|584565029|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
161869249|NCT00594165|584565029|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
161869250|NCT00594165|584565029|FG000|Overall Study|Other: Site terminated participation|2|||
161869251|NCT04830969|584565030|FG000|Overall Study|Withdrawal by Subject|6|||
161869252|NCT04830969|584565031|FG001|Overall Study|Withdrawal by Subject|2|||
161869253|NCT04830969|584565030|FG000|Overall Study|Protocol Violation|3|||
161869254|NCT04830969|584565031|FG001|Overall Study|Protocol Violation|9|||
161869255|NCT04830969|584565030|FG000|Overall Study|Lost to Follow-up|4|||
161869256|NCT04830969|584565031|FG001|Overall Study|Lost to Follow-up|4|||
161869257|NCT00996125|584565032|FG000|Overall Study|Adverse Event|0|||
161869258|NCT00996125|584565033|FG001|Overall Study|Adverse Event|2|||
161869259|NCT00996125|584565032|FG000|Overall Study|Lost to Follow-up|1|||
161869260|NCT00996125|584565033|FG001|Overall Study|Lost to Follow-up|6|||
161869261|NCT00996125|584565032|FG000|Overall Study|Withdrawal by Subject|4|||
161869262|NCT00996125|584565033|FG001|Overall Study|Withdrawal by Subject|3|||
161869263|NCT05236764|584565034|FG000|Overall Study|In follow up (ongoing)|1|||
161869264|NCT05236764|584565034|FG000|Overall Study|Taken off study - secondary graft failure|1|||
161869265|NCT05236764|584565034|FG000|Overall Study|Death|1|||
161869266|NCT02062450|584565043|FG000|Overall Study|No follow-up visit|124|||
161869267|NCT04495829|584565044|FG000|Overall Study|Lost to Follow-up|2|||
161869268|NCT04495829|584565044|FG000|Overall Study|Inclusion criterion not met|3|||
161869269|NCT01205269|584565053|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869270|NCT01205269|584565054|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869271|NCT01205269|584565055|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869272|NCT01205269|584565056|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
161869273|NCT01205269|584565057|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869274|NCT01205269|584565058|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869275|NCT00987337|584565059|FG000|Overall Study|Adverse Event|10|||
161869276|NCT00987337|584565060|FG001|Overall Study|Adverse Event|9|||
161869277|NCT00987337|584565061|FG002|Overall Study|Adverse Event|8|||
161869278|NCT00987337|584565059|FG000|Overall Study|Insufficient Virologic Response|10|||
161869279|NCT00987337|584565060|FG001|Overall Study|Insufficient Virologic Response|7|||
161869280|NCT00987337|584565061|FG002|Overall Study|Insufficient Virologic Response|12|||
161869281|NCT00987337|584565059|FG000|Overall Study|Virologic Breakthrough|2|||
161869282|NCT00987337|584565060|FG001|Overall Study|Virologic Breakthrough|2|||
161869283|NCT00987337|584565061|FG002|Overall Study|Virologic Breakthrough|8|||
161869284|NCT00987337|584565059|FG000|Overall Study|Lost to Follow-up|10|||
161869285|NCT00987337|584565060|FG001|Overall Study|Lost to Follow-up|6|||
161869286|NCT00987337|584565061|FG002|Overall Study|Lost to Follow-up|2|||
161869287|NCT00987337|584565059|FG000|Overall Study|Withdrawal by Subject|6|||
161869288|NCT00987337|584565060|FG001|Overall Study|Withdrawal by Subject|9|||
161869289|NCT00987337|584565061|FG002|Overall Study|Withdrawal by Subject|9|||
161869290|NCT00987337|584565059|FG000|Overall Study|Other|0|||
161869291|NCT00987337|584565060|FG001|Overall Study|Other|2|||
161869292|NCT00987337|584565061|FG002|Overall Study|Other|5|||
161869293|NCT00987337|584565059|FG000|Overall Study|Protocol Violation|1|||
161869294|NCT00987337|584565060|FG001|Overall Study|Protocol Violation|0|||
161869295|NCT00987337|584565061|FG002|Overall Study|Protocol Violation|2|||
161869296|NCT00987337|584565059|FG000|Overall Study|Participant Relapsed|18|||
161869297|NCT00987337|584565060|FG001|Overall Study|Participant Relapsed|20|||
161869298|NCT00987337|584565061|FG002|Overall Study|Participant Relapsed|5|||
161869299|NCT03100903|584566685|FG000|Overall Study|Withdrawal by Subject|0|||
161869300|NCT03100903|584566686|FG001|Overall Study|Withdrawal by Subject|0|||
161869301|NCT03100903|584566687|FG002|Overall Study|Withdrawal by Subject|1|||
161869302|NCT04659993|584566688|FG000|Overall Study|Withdrawal by Subject|2|||
161869303|NCT04659993|584566688|FG000|Overall Study|Lost to Follow-up|2|||
161869304|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
161869305|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
161869306|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
161869307|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
161869308|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
161869309|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
161869310|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
161869311|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
161869312|NCT03868930|584566692|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
161869313|NCT03868930|584566693|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
161869314|NCT02151851|584566696|FG000|Overall Study|Lack of Efficacy|67|||
161869315|NCT02151851|584566697|FG001|Overall Study|Lack of Efficacy|94|||
161869316|NCT02151851|584566696|FG000|Overall Study|Protocol Violation|0|||
161869317|NCT02151851|584566697|FG001|Overall Study|Protocol Violation|1|||
161869318|NCT02151851|584566696|FG000|Overall Study|Withdrawal by Subject|2|||
161869319|NCT02151851|584566697|FG001|Overall Study|Withdrawal by Subject|5|||
161869320|NCT02151851|584566696|FG000|Overall Study|Medical impairment|1|||
161869321|NCT02151851|584566697|FG001|Overall Study|Medical impairment|0|||
161869322|NCT02151851|584566696|FG000|Overall Study|Low compliance to study visits|0|||
161869323|NCT02151851|584566697|FG001|Overall Study|Low compliance to study visits|1|||
161869324|NCT02151851|584566696|FG000|Overall Study|Subject entered into study in error|0|||
161869325|NCT02151851|584566697|FG001|Overall Study|Subject entered into study in error|1|||
161869326|NCT02151851|584566696|FG000|Overall Study|Adverse Event|6|||
161869327|NCT02151851|584566697|FG001|Overall Study|Adverse Event|28|||
161869328|NCT02159053|584566698|FG000|Overall Study|Death|2|||
161869329|NCT02159053|584566699|FG001|Overall Study|Death|0|||
161869330|NCT02159053|584566700|FG002|Overall Study|Death|1|||
161869331|NCT02159053|584566698|FG000|Overall Study|Physician Decision|0|||
161869332|NCT02159053|584566699|FG001|Overall Study|Physician Decision|1|||
161869333|NCT02159053|584566700|FG002|Overall Study|Physician Decision|1|||
161869334|NCT02159053|584566698|FG000|Overall Study|Lack of Efficacy|3|||
161869335|NCT02159053|584566699|FG001|Overall Study|Lack of Efficacy|4|||
161869336|NCT02159053|584566700|FG002|Overall Study|Lack of Efficacy|7|||
161869337|NCT02159053|584566698|FG000|Overall Study|Adverse Event|7|||
161869338|NCT02159053|584566699|FG001|Overall Study|Adverse Event|6|||
161869339|NCT02159053|584566700|FG002|Overall Study|Adverse Event|5|||
161869340|NCT02159053|584566698|FG000|Overall Study|Participants/guardian decision|8|||
161869341|NCT02159053|584566699|FG001|Overall Study|Participants/guardian decision|10|||
161869342|NCT02159053|584566700|FG002|Overall Study|Participants/guardian decision|6|||
161869343|NCT02640950|584566701|FG000|Overall Study|Adverse Event|1|||
161869344|NCT02640950|584566701|FG000|Overall Study|Withdrawal by Subject|1|||
161869345|NCT04545489|584566702|FG000|Overall Study|Withdrawal by Subject|12|||
161869346|NCT04545489|584566703|FG001|Overall Study|Withdrawal by Subject|4|||
161869347|NCT04545489|584566702|FG000|Overall Study|Lost to Follow-up|17|||
161869348|NCT04545489|584566703|FG001|Overall Study|Lost to Follow-up|18|||
161869349|NCT04545489|584566702|FG000|Overall Study|12month BP not collected|4|||
161869350|NCT04545489|584566703|FG001|Overall Study|12month BP not collected|4|||
161869351|NCT00652626|584566704|FG000|Initial Treatment Phase|Adverse Event|0|||
161869352|NCT00652626|584566705|FG001|Initial Treatment Phase|Adverse Event|0|||
161869353|NCT00652626|584566706|FG002|Initial Treatment Phase|Adverse Event|0|||
161869354|NCT00652626|584566707|FG003|Initial Treatment Phase|Adverse Event|0|||
161869355|NCT00652626|584566708|FG004|Initial Treatment Phase|Adverse Event|1|||
161869356|NCT00652626|584566709|FG005|Initial Treatment Phase|Adverse Event|0|||
161869357|NCT00652626|584566710|FG006|Initial Treatment Phase|Adverse Event|0|||
161869358|NCT00652626|584566704|FG000|Initial Treatment Phase|Protocol Violation|0|||
161869359|NCT00652626|584566705|FG001|Initial Treatment Phase|Protocol Violation|0|||
161869360|NCT00652626|584566706|FG002|Initial Treatment Phase|Protocol Violation|0|||
161869361|NCT00652626|584566707|FG003|Initial Treatment Phase|Protocol Violation|1|||
161869362|NCT00652626|584566708|FG004|Initial Treatment Phase|Protocol Violation|0|||
161869363|NCT00652626|584566709|FG005|Initial Treatment Phase|Protocol Violation|0|||
161869364|NCT00652626|584566710|FG006|Initial Treatment Phase|Protocol Violation|0|||
161869365|NCT00652626|584566704|FG000|Initial Treatment Phase|Physician Decision|0|||
161869366|NCT00652626|584566705|FG001|Initial Treatment Phase|Physician Decision|0|||
161869367|NCT00652626|584566706|FG002|Initial Treatment Phase|Physician Decision|0|||
161869368|NCT00652626|584566707|FG003|Initial Treatment Phase|Physician Decision|0|||
161869369|NCT00652626|584566708|FG004|Initial Treatment Phase|Physician Decision|1|||
161869370|NCT00652626|584566709|FG005|Initial Treatment Phase|Physician Decision|0|||
161869371|NCT00652626|584566710|FG006|Initial Treatment Phase|Physician Decision|0|||
161869372|NCT00652626|584566704|FG000|Initial Treatment Phase|Sponsor Request|0|||
161869373|NCT00652626|584566705|FG001|Initial Treatment Phase|Sponsor Request|0|||
161869374|NCT00652626|584566706|FG002|Initial Treatment Phase|Sponsor Request|1|||
161869375|NCT00652626|584566707|FG003|Initial Treatment Phase|Sponsor Request|0|||
161869376|NCT00652626|584566708|FG004|Initial Treatment Phase|Sponsor Request|0|||
161869377|NCT00652626|584566709|FG005|Initial Treatment Phase|Sponsor Request|0|||
161869378|NCT00652626|584566710|FG006|Initial Treatment Phase|Sponsor Request|0|||
161869379|NCT00652626|584566704|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
161869380|NCT00652626|584566705|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
161869381|NCT00652626|584566706|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
161869382|NCT00652626|584566707|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
161869383|NCT00652626|584566708|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
161869384|NCT00652626|584566709|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
161869385|NCT00652626|584566710|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
161869386|NCT00652626|584566704|FG000|Extension Phase|Withdrawal by Subject|0|||
161869387|NCT00652626|584566705|FG001|Extension Phase|Withdrawal by Subject|0|||
161869388|NCT00652626|584566706|FG002|Extension Phase|Withdrawal by Subject|0|||
161869389|NCT00652626|584566707|FG003|Extension Phase|Withdrawal by Subject|0|||
161869390|NCT00652626|584566708|FG004|Extension Phase|Withdrawal by Subject|0|||
161869391|NCT00652626|584566709|FG005|Extension Phase|Withdrawal by Subject|2|||
161869392|NCT00652626|584566710|FG006|Extension Phase|Withdrawal by Subject|0|||
161869393|NCT00652626|584566704|FG000|Extension Phase|Adverse Event|0|||
161869394|NCT00652626|584566705|FG001|Extension Phase|Adverse Event|0|||
161869395|NCT00652626|584566706|FG002|Extension Phase|Adverse Event|0|||
161869396|NCT00652626|584566707|FG003|Extension Phase|Adverse Event|0|||
161869397|NCT00652626|584566708|FG004|Extension Phase|Adverse Event|0|||
161869398|NCT00652626|584566709|FG005|Extension Phase|Adverse Event|2|||
161869399|NCT00652626|584566710|FG006|Extension Phase|Adverse Event|1|||
161869400|NCT00652626|584566704|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869401|NCT00652626|584566705|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869402|NCT00652626|584566706|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869403|NCT00652626|584566707|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869404|NCT00652626|584566708|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869405|NCT00652626|584566709|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
161869406|NCT00652626|584566710|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869407|NCT00652626|584566704|FG000|Extension Phase|Physician Decision|0|||
161869408|NCT00652626|584566705|FG001|Extension Phase|Physician Decision|0|||
161869409|NCT00652626|584566706|FG002|Extension Phase|Physician Decision|0|||
161869410|NCT00652626|584566707|FG003|Extension Phase|Physician Decision|0|||
161869411|NCT00652626|584566708|FG004|Extension Phase|Physician Decision|0|||
161869412|NCT00652626|584566709|FG005|Extension Phase|Physician Decision|1|||
161869413|NCT00652626|584566710|FG006|Extension Phase|Physician Decision|1|||
161869414|NCT00652626|584566704|FG000|Extension Phase|Death|0|||
161869415|NCT00652626|584566705|FG001|Extension Phase|Death|0|||
161869416|NCT00652626|584566706|FG002|Extension Phase|Death|0|||
161869417|NCT00652626|584566707|FG003|Extension Phase|Death|0|||
161869418|NCT00652626|584566708|FG004|Extension Phase|Death|0|||
161869419|NCT00652626|584566709|FG005|Extension Phase|Death|1|||
161869420|NCT00652626|584566710|FG006|Extension Phase|Death|1|||
161869421|NCT04003636|584566711|FG000|Overall Study|Death|409|||
161869422|NCT04003636|584566712|FG001|Overall Study|Death|443|||
161869423|NCT04003636|584566711|FG000|Overall Study|Lost to Follow-up|0|||
161869424|NCT04003636|584566712|FG001|Overall Study|Lost to Follow-up|1|||
161869425|NCT04003636|584566711|FG000|Overall Study|Withdrawal by Subject|5|||
161869426|NCT04003636|584566712|FG001|Overall Study|Withdrawal by Subject|2|||
161869427|NCT04003636|584566711|FG000|Overall Study|Participant On-going|119|||
161869428|NCT04003636|584566712|FG001|Overall Study|Participant On-going|90|||
161869429|NCT03048747|584566713|FG000|Overall Study|Adverse Event|2|||
161869430|NCT03048747|584566713|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
161869431|NCT03048747|584566713|FG000|Overall Study|Physician Decision|1|||
161869432|NCT00915018|584566716|FG000|Overall Study|Death|75|||
161869433|NCT00915018|584566717|FG001|Overall Study|Death|70|||
161869434|NCT00915018|584566716|FG000|Overall Study|Lost to Follow-up|10|||
161869435|NCT00915018|584566717|FG001|Overall Study|Lost to Follow-up|5|||
161869436|NCT00915018|584566716|FG000|Overall Study|Withdrawal by Subject|38|||
161869437|NCT00915018|584566717|FG001|Overall Study|Withdrawal by Subject|27|||
161869438|NCT00915018|584566716|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
161869439|NCT00915018|584566717|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
161869440|NCT00457002|584566718|FG000|Overall Study|Death|40|||
161869441|NCT00457002|584566719|FG001|Overall Study|Death|47|||
161869442|NCT00457002|584566718|FG000|Overall Study|Adverse Event|284|||
161869443|NCT00457002|584566719|FG001|Overall Study|Adverse Event|260|||
161869444|NCT00457002|584566718|FG000|Overall Study|Withdrawal by Subject|299|||
161869445|NCT00457002|584566719|FG001|Overall Study|Withdrawal by Subject|271|||
161869446|NCT00457002|584566718|FG000|Overall Study|Lost to Follow-up|72|||
161869447|NCT00457002|584566719|FG001|Overall Study|Lost to Follow-up|71|||
161869448|NCT00457002|584566718|FG000|Overall Study|Poor/Non-compliance|46|||
161869449|NCT00457002|584566719|FG001|Overall Study|Poor/Non-compliance|33|||
161869450|NCT00457002|584566718|FG000|Overall Study|No longer met criteria|41|||
161869451|NCT00457002|584566719|FG001|Overall Study|No longer met criteria|37|||
161869452|NCT00457002|584566718|FG000|Overall Study|Administrative reason by Sponsor|1|||
161869453|NCT00457002|584566719|FG001|Overall Study|Administrative reason by Sponsor|0|||
161869454|NCT00457002|584566718|FG000|Overall Study|non-specified|29|||
161869455|NCT00457002|584566719|FG001|Overall Study|non-specified|38|||
161869456|NCT00457002|584566718|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
161869457|NCT00457002|584566719|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
161869458|NCT01623310|584566720|FG000|Overall Study|Adverse Event|21|||
161869459|NCT01623310|584566720|FG000|Overall Study|Lost to Follow-up|18|||
161869460|NCT01623310|584566720|FG000|Overall Study|Lack of Efficacy|6|||
161869461|NCT01623310|584566720|FG000|Overall Study|Protocol Violation|6|||
161869462|NCT01623310|584566720|FG000|Overall Study|Withdrawal by Subject|25|||
161869463|NCT01623310|584566720|FG000|Overall Study|Became potentially child-bearing|1|||
161869464|NCT01623310|584566720|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
161869465|NCT01623310|584566720|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
161869466|NCT00454246|584566721|FG000|Overall Study|Adverse Event|2|||
161869467|NCT00454246|584566722|FG001|Overall Study|Adverse Event|2|||
161869468|NCT00454246|584566723|FG002|Overall Study|Adverse Event|0|||
161869469|NCT00454246|584566721|FG000|Overall Study|Violation of selection criteria at entry|6|||
161869470|NCT00454246|584566722|FG001|Overall Study|Violation of selection criteria at entry|0|||
161869471|NCT00454246|584566723|FG002|Overall Study|Violation of selection criteria at entry|0|||
161869472|NCT00454246|584566721|FG000|Overall Study|Protocol Violation|1|||
161869473|NCT00454246|584566722|FG001|Overall Study|Protocol Violation|0|||
161869474|NCT00454246|584566723|FG002|Overall Study|Protocol Violation|0|||
161869475|NCT00454246|584566721|FG000|Overall Study|Refused Treatment|1|||
161869476|NCT00454246|584566722|FG001|Overall Study|Refused Treatment|1|||
161869477|NCT00454246|584566723|FG002|Overall Study|Refused Treatment|0|||
161869478|NCT00454246|584566721|FG000|Overall Study|Failure to return|1|||
161869479|NCT00454246|584566722|FG001|Overall Study|Failure to return|0|||
161869480|NCT00454246|584566723|FG002|Overall Study|Failure to return|0|||
161869481|NCT00454246|584566721|FG000|Overall Study|Early termination of study|62|||
161869482|NCT00454246|584566722|FG001|Overall Study|Early termination of study|26|||
161869483|NCT00454246|584566723|FG002|Overall Study|Early termination of study|9|||
161869484|NCT00356603|584566724|FG000|Overall Study|Other|6|||
161869485|NCT00356603|584566725|FG001|Overall Study|Other|3|||
161869486|NCT05326529|584566726|FG000|Overall Study|Lack of Efficacy|0|||
161869487|NCT05326529|584566727|FG001|Overall Study|Lack of Efficacy|1|||
161869488|NCT05326529|584566728|FG002|Overall Study|Lack of Efficacy|0|||
161869489|NCT05326529|584566726|FG000|Overall Study|Physician Decision|0|||
161869490|NCT05326529|584566727|FG001|Overall Study|Physician Decision|0|||
161869491|NCT05326529|584566728|FG002|Overall Study|Physician Decision|2|||
161869492|NCT01262287|584566730|FG000|Overall Study|Lost to Follow-up|2|||
161869493|NCT01262287|584566731|FG001|Overall Study|Lost to Follow-up|1|||
161869494|NCT00932373|584566732|FG000|Overall Study|Progressive disease|3|||
161869495|NCT00932373|584566733|FG001|Overall Study|Progressive disease|1|||
161869496|NCT00932373|584566734|FG002|Overall Study|Progressive disease|0|||
161869497|NCT00932373|584566735|FG003|Overall Study|Progressive disease|0|||
161869498|NCT00932373|584566736|FG004|Overall Study|Progressive disease|10|||
161869499|NCT00932373|584566737|FG005|Overall Study|Progressive disease|1|||
161869500|NCT00932373|584566738|FG006|Overall Study|Progressive disease|0|||
161869501|NCT00932373|584566739|FG007|Overall Study|Progressive disease|2|||
161869502|NCT00932373|584566740|FG008|Overall Study|Progressive disease|1|||
161869503|NCT00932373|584566741|FG009|Overall Study|Progressive disease|9|||
161869504|NCT00932373|584566742|FG010|Overall Study|Progressive disease|2|||
161869505|NCT00932373|584566732|FG000|Overall Study|Adverse Event|0|||
161869506|NCT00932373|584566733|FG001|Overall Study|Adverse Event|0|||
161869507|NCT00932373|584566734|FG002|Overall Study|Adverse Event|0|||
161869508|NCT00932373|584566735|FG003|Overall Study|Adverse Event|0|||
161869509|NCT00932373|584566736|FG004|Overall Study|Adverse Event|2|||
161869510|NCT00932373|584566737|FG005|Overall Study|Adverse Event|1|||
161869511|NCT00932373|584566738|FG006|Overall Study|Adverse Event|0|||
161869512|NCT00932373|584566739|FG007|Overall Study|Adverse Event|1|||
161869513|NCT00932373|584566740|FG008|Overall Study|Adverse Event|0|||
161869514|NCT00932373|584566741|FG009|Overall Study|Adverse Event|2|||
161869515|NCT00932373|584566742|FG010|Overall Study|Adverse Event|1|||
161869516|NCT00932373|584566732|FG000|Overall Study|Physician Decision|0|||
161869517|NCT00932373|584566733|FG001|Overall Study|Physician Decision|0|||
161869518|NCT00932373|584566734|FG002|Overall Study|Physician Decision|1|||
161869519|NCT00932373|584566735|FG003|Overall Study|Physician Decision|0|||
161869520|NCT00932373|584566736|FG004|Overall Study|Physician Decision|2|||
161869521|NCT00932373|584566737|FG005|Overall Study|Physician Decision|0|||
161869522|NCT00932373|584566738|FG006|Overall Study|Physician Decision|0|||
161869523|NCT00932373|584566739|FG007|Overall Study|Physician Decision|0|||
161869524|NCT00932373|584566740|FG008|Overall Study|Physician Decision|0|||
161869525|NCT00932373|584566741|FG009|Overall Study|Physician Decision|1|||
161869526|NCT00932373|584566742|FG010|Overall Study|Physician Decision|0|||
161869527|NCT00932373|584566732|FG000|Overall Study|Dose limiting toxicity|0|||
161869528|NCT00932373|584566733|FG001|Overall Study|Dose limiting toxicity|0|||
161869529|NCT00932373|584566734|FG002|Overall Study|Dose limiting toxicity|0|||
161774934|NCT02207413|584217394|FG000|Overall Study|Withdrawal by Subject|1|||
161774935|NCT02207413|584217395|FG001|Overall Study|Withdrawal by Subject|0|||
161774936|NCT02207413|584217396|FG002|Overall Study|Withdrawal by Subject|0|||
161774937|NCT02207413|584217397|FG003|Overall Study|Withdrawal by Subject|0|||
161774938|NCT02207413|584217398|FG004|Overall Study|Withdrawal by Subject|3|||
161774939|NCT02207413|584217399|FG005|Overall Study|Withdrawal by Subject|7|||
161774940|NCT02207413|584217394|FG000|Overall Study|Lost to Follow-up|0|||
161774941|NCT02207413|584217395|FG001|Overall Study|Lost to Follow-up|0|||
161774942|NCT02207413|584217396|FG002|Overall Study|Lost to Follow-up|0|||
161774943|NCT02207413|584217397|FG003|Overall Study|Lost to Follow-up|1|||
161774944|NCT02207413|584217398|FG004|Overall Study|Lost to Follow-up|1|||
161774945|NCT02207413|584217399|FG005|Overall Study|Lost to Follow-up|5|||
161774946|NCT02207413|584217394|FG000|Overall Study|Adverse Event|0|||
161774947|NCT02207413|584217395|FG001|Overall Study|Adverse Event|0|||
161774948|NCT02207413|584217396|FG002|Overall Study|Adverse Event|0|||
161774949|NCT02207413|584217397|FG003|Overall Study|Adverse Event|0|||
161774950|NCT02207413|584217398|FG004|Overall Study|Adverse Event|2|||
161774951|NCT02207413|584217399|FG005|Overall Study|Adverse Event|1|||
161774952|NCT02207413|584217394|FG000|Overall Study|Migrated/moved from study area|0|||
161774953|NCT02207413|584217395|FG001|Overall Study|Migrated/moved from study area|0|||
161774954|NCT02207413|584217396|FG002|Overall Study|Migrated/moved from study area|0|||
161774955|NCT02207413|584217397|FG003|Overall Study|Migrated/moved from study area|0|||
161774956|NCT02207413|584217398|FG004|Overall Study|Migrated/moved from study area|1|||
161774957|NCT02207413|584217399|FG005|Overall Study|Migrated/moved from study area|0|||
161774958|NCT01100073|584219331|FG000|Overall Study|Lack of Efficacy|4|||
161774959|NCT01100073|584219331|FG000|Overall Study|Insufficient Tolerability|21|||
161774960|NCT01100073|584219331|FG000|Overall Study|Withdrawal by Subject|13|||
161774961|NCT01100073|584219331|FG000|Overall Study|Lost to Follow-up|39|||
161774962|NCT01100073|584219331|FG000|Overall Study|Lack of effect + patient's wish|2|||
161774963|NCT01100073|584219331|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
161774964|NCT01100073|584219331|FG000|Overall Study|Other|8|||
161774965|NCT01100073|584219331|FG000|Overall Study|Missing|5|||
161774966|NCT00299546|584219332|FG000|Overall Study|Death|3|||
161774967|NCT00299546|584219333|FG001|Overall Study|Death|2|||
161774968|NCT00299546|584219334|FG002|Overall Study|Death|0|||
161774969|NCT00299546|584219332|FG000|Overall Study|Lost to Follow-up|2|||
161774970|NCT00299546|584219333|FG001|Overall Study|Lost to Follow-up|2|||
161774971|NCT00299546|584219334|FG002|Overall Study|Lost to Follow-up|5|||
161774972|NCT00299546|584219332|FG000|Overall Study|Adverse Event|37|||
161774973|NCT00299546|584219333|FG001|Overall Study|Adverse Event|22|||
161774974|NCT00299546|584219334|FG002|Overall Study|Adverse Event|27|||
161774975|NCT00299546|584219332|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
161774976|NCT00299546|584219333|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
161774977|NCT00299546|584219334|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
161774978|NCT00299546|584219332|FG000|Overall Study|Other|24|||
161774979|NCT00299546|584219333|FG001|Overall Study|Other|26|||
161774980|NCT00299546|584219334|FG002|Overall Study|Other|19|||
161774981|NCT00299546|584219332|FG000|Overall Study|Not treated|0|||
161774982|NCT00299546|584219333|FG001|Overall Study|Not treated|1|||
161774983|NCT00299546|584219334|FG002|Overall Study|Not treated|1|||
161774984|NCT01656850|584219335|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
161774985|NCT01656850|584219336|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
161774986|NCT00968539|584219337|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
161774987|NCT00968539|584219338|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161774988|NCT00326118|584219339|FG000|Active Phase|Withdrawal by Subject|4|||
161774989|NCT00326118|584219340|FG001|Active Phase|Withdrawal by Subject|1|||
161774990|NCT02525627|584219347|FG000|Overall Study|Revision|1|||
161774991|NCT02525627|584219348|FG001|Overall Study|Revision|1|||
161774992|NCT02525627|584219347|FG000|Overall Study|Withdrawal by Subject|1|||
161774993|NCT02525627|584219348|FG001|Overall Study|Withdrawal by Subject|2|||
161774994|NCT02525627|584219347|FG000|Overall Study|Death|1|||
161774995|NCT02525627|584219348|FG001|Overall Study|Death|0|||
161774996|NCT02525627|584219347|FG000|Overall Study|Site terminated|11|||
161774997|NCT02525627|584219348|FG001|Overall Study|Site terminated|10|||
161774998|NCT03710824|584219351|FG000|Overall Study|Withdrawal by Subject|1|||
161774999|NCT03710824|584219351|FG000|Overall Study|Lost to Follow-up|3|||
161775000|NCT03710824|584219351|FG000|Overall Study|Adverse Event|25|||
161775001|NCT03710824|584219351|FG000|Overall Study|Treatment discontinuation|2|||
161775002|NCT02329834|584219352|FG000|Overall Study|Physician Decision|1|||
161775003|NCT02329834|584219353|FG001|Overall Study|Physician Decision|0|||
161775004|NCT00578448|584219354|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
161775005|NCT00578448|584219354|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
161775006|NCT00578448|584219354|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
161775007|NCT00578448|584219354|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
161775008|NCT01301625|584219367|FG000|Overall Study|Death|5|||
161775009|NCT01301625|584219367|FG000|Overall Study|Not Due|21|||
161775010|NCT01301625|584219367|FG000|Overall Study|Expected|8|||
161775011|NCT01301625|584219367|FG000|Overall Study|Lost to Follow-up|1|||
161775012|NCT05102162|584219373|FG000|Overall Study|Withdrawal by Subject|3|||
161775013|NCT05102162|584219374|FG001|Overall Study|Withdrawal by Subject|0|||
161775014|NCT05102162|584219373|FG000|Overall Study|Baseline cultures negative|4|||
161775015|NCT05102162|584219374|FG001|Overall Study|Baseline cultures negative|2|||
161775016|NCT05102162|584219373|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
161775017|NCT05102162|584219374|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
161775018|NCT05102162|584219373|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
161775019|NCT05102162|584219374|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
161775020|NCT02181673|584219377|FG000|Up to Week 24|Adverse Event|2|||
161775021|NCT02181673|584219378|FG001|Up to Week 24|Adverse Event|0|||
161775022|NCT02181673|584219379|FG002|Up to Week 24|Adverse Event|3|||
161775023|NCT02181673|584219377|FG000|Up to Week 24|Death|1|||
161775024|NCT02181673|584219378|FG001|Up to Week 24|Death|0|||
161775025|NCT02181673|584219379|FG002|Up to Week 24|Death|0|||
161775026|NCT02181673|584219377|FG000|Up to Week 24|Lack of Efficacy|1|||
161775027|NCT02181673|584219378|FG001|Up to Week 24|Lack of Efficacy|0|||
161775028|NCT02181673|584219379|FG002|Up to Week 24|Lack of Efficacy|0|||
161775029|NCT02181673|584219377|FG000|Up to Week 24|Lost to Follow-up|1|||
161775030|NCT02181673|584219378|FG001|Up to Week 24|Lost to Follow-up|0|||
161775031|NCT02181673|584219379|FG002|Up to Week 24|Lost to Follow-up|0|||
161775032|NCT02181673|584219377|FG000|Up to Week 24|Physician Decision|0|||
161775033|NCT02181673|584219378|FG001|Up to Week 24|Physician Decision|0|||
161775034|NCT02181673|584219379|FG002|Up to Week 24|Physician Decision|3|||
161775035|NCT02181673|584219377|FG000|Up to Week 24|Withdrawal by Subject|10|||
161775036|NCT02181673|584219378|FG001|Up to Week 24|Withdrawal by Subject|0|||
161775037|NCT02181673|584219379|FG002|Up to Week 24|Withdrawal by Subject|1|||
161775038|NCT02181673|584219377|FG000|Up to Week 24|Other|2|||
161775039|NCT02181673|584219378|FG001|Up to Week 24|Other|0|||
161775040|NCT02181673|584219379|FG002|Up to Week 24|Other|3|||
161775041|NCT02181673|584219377|FG000|Up to Week 24|Randomized not Treated|0|||
161775042|NCT02181673|584219378|FG001|Up to Week 24|Randomized not Treated|0|||
161775043|NCT02181673|584219379|FG002|Up to Week 24|Randomized not Treated|1|||
161775044|NCT02181673|584219377|FG000|Week 24-Week 60|Adverse Event|0|||
161775045|NCT02181673|584219378|FG001|Week 24-Week 60|Adverse Event|4|||
161775046|NCT02181673|584219379|FG002|Week 24-Week 60|Adverse Event|10|||
161775047|NCT02181673|584219377|FG000|Week 24-Week 60|Other|0|||
161775048|NCT02181673|584219378|FG001|Week 24-Week 60|Other|2|||
161775049|NCT02181673|584219379|FG002|Week 24-Week 60|Other|1|||
161775050|NCT02181673|584219377|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
161775051|NCT02181673|584219378|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
161775052|NCT02181673|584219379|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
161775053|NCT02181673|584219377|FG000|Week 24-Week 60|Pregnancy|0|||
161775054|NCT02181673|584219378|FG001|Week 24-Week 60|Pregnancy|0|||
161775055|NCT02181673|584219379|FG002|Week 24-Week 60|Pregnancy|1|||
161775056|NCT02181673|584219377|FG000|Week 24-Week 60|Lack of Efficacy|0|||
161775057|NCT02181673|584219378|FG001|Week 24-Week 60|Lack of Efficacy|0|||
161775058|NCT02181673|584219379|FG002|Week 24-Week 60|Lack of Efficacy|1|||
161775059|NCT02181673|584219377|FG000|Week 24-Week 60|Lost to Follow-up|0|||
161775060|NCT02181673|584219378|FG001|Week 24-Week 60|Lost to Follow-up|0|||
161775061|NCT02181673|584219379|FG002|Week 24-Week 60|Lost to Follow-up|1|||
161775062|NCT02181673|584219377|FG000|Week 24-Week 60|Physician Decision|0|||
161775063|NCT02181673|584219378|FG001|Week 24-Week 60|Physician Decision|0|||
161775064|NCT02181673|584219379|FG002|Week 24-Week 60|Physician Decision|1|||
161775065|NCT00433771|584219380|FG000|Overall Study|screen fail|14|||
161775066|NCT00433771|584219380|FG000|Overall Study|Treated and later found to be ineligible|2|||
161775067|NCT00433771|584219380|FG000|Overall Study|Death|2|||
161775068|NCT00433771|584219380|FG000|Overall Study|Failure to deploy stent|1|||
161775069|NCT00138658|584219381|FG000|Overall Study|Adverse Event|23|||
161775070|NCT00138658|584219381|FG000|Overall Study|Death|1|||
161775071|NCT00138658|584219381|FG000|Overall Study|Disease Progression|21|||
161775072|NCT00138658|584219381|FG000|Overall Study|Physician Decision|11|||
161869530|NCT00932373|584566735|FG003|Overall Study|Dose limiting toxicity|0|||
161869531|NCT00932373|584566736|FG004|Overall Study|Dose limiting toxicity|0|||
161869532|NCT00932373|584566737|FG005|Overall Study|Dose limiting toxicity|1|||
161869533|NCT00932373|584566738|FG006|Overall Study|Dose limiting toxicity|0|||
161869534|NCT00932373|584566739|FG007|Overall Study|Dose limiting toxicity|0|||
161869535|NCT00932373|584566740|FG008|Overall Study|Dose limiting toxicity|0|||
161869536|NCT00932373|584566741|FG009|Overall Study|Dose limiting toxicity|0|||
161869537|NCT00932373|584566742|FG010|Overall Study|Dose limiting toxicity|0|||
161869538|NCT00932373|584566732|FG000|Overall Study|Withdrawal by Subject|0|||
161869539|NCT00932373|584566733|FG001|Overall Study|Withdrawal by Subject|0|||
161869540|NCT00932373|584566734|FG002|Overall Study|Withdrawal by Subject|0|||
161869541|NCT00932373|584566735|FG003|Overall Study|Withdrawal by Subject|0|||
161869542|NCT00932373|584566736|FG004|Overall Study|Withdrawal by Subject|0|||
161869543|NCT00932373|584566737|FG005|Overall Study|Withdrawal by Subject|0|||
161869544|NCT00932373|584566738|FG006|Overall Study|Withdrawal by Subject|0|||
161869545|NCT00932373|584566739|FG007|Overall Study|Withdrawal by Subject|0|||
161869546|NCT00932373|584566740|FG008|Overall Study|Withdrawal by Subject|1|||
161869547|NCT00932373|584566741|FG009|Overall Study|Withdrawal by Subject|0|||
161869548|NCT00932373|584566742|FG010|Overall Study|Withdrawal by Subject|0|||
161869549|NCT00932373|584566732|FG000|Overall Study|Clinical progression|0|||
161869550|NCT00932373|584566733|FG001|Overall Study|Clinical progression|0|||
161869551|NCT00932373|584566734|FG002|Overall Study|Clinical progression|0|||
161869552|NCT00932373|584566735|FG003|Overall Study|Clinical progression|0|||
161869553|NCT00932373|584566736|FG004|Overall Study|Clinical progression|0|||
161869554|NCT00932373|584566737|FG005|Overall Study|Clinical progression|0|||
161869555|NCT00932373|584566738|FG006|Overall Study|Clinical progression|1|||
161869556|NCT00932373|584566739|FG007|Overall Study|Clinical progression|0|||
161869557|NCT00932373|584566740|FG008|Overall Study|Clinical progression|0|||
161869558|NCT00932373|584566741|FG009|Overall Study|Clinical progression|0|||
161869559|NCT00932373|584566742|FG010|Overall Study|Clinical progression|0|||
161869560|NCT00932373|584566732|FG000|Overall Study|Lack of Efficacy|0|||
161869561|NCT00932373|584566733|FG001|Overall Study|Lack of Efficacy|0|||
161869562|NCT00932373|584566734|FG002|Overall Study|Lack of Efficacy|0|||
161869563|NCT00932373|584566735|FG003|Overall Study|Lack of Efficacy|0|||
161869564|NCT00932373|584566736|FG004|Overall Study|Lack of Efficacy|0|||
161869565|NCT00932373|584566737|FG005|Overall Study|Lack of Efficacy|0|||
161869566|NCT00932373|584566738|FG006|Overall Study|Lack of Efficacy|0|||
161869567|NCT00932373|584566739|FG007|Overall Study|Lack of Efficacy|0|||
161869568|NCT00932373|584566740|FG008|Overall Study|Lack of Efficacy|0|||
161869569|NCT00932373|584566741|FG009|Overall Study|Lack of Efficacy|1|||
161869570|NCT00932373|584566742|FG010|Overall Study|Lack of Efficacy|0|||
161869571|NCT04134767|584566745|FG000|Overall Study|Death|0|||
161869572|NCT04134767|584566746|FG001|Overall Study|Death|1|||
161869573|NCT04134767|584566745|FG000|Overall Study|Removed for harassing staff|0|||
161869574|NCT04134767|584566746|FG001|Overall Study|Removed for harassing staff|1|||
161869575|NCT04134767|584566745|FG000|Overall Study|Lost to Follow-up|44|||
161869576|NCT04134767|584566746|FG001|Overall Study|Lost to Follow-up|40|||
161869577|NCT02582242|584566747|FG000|Overall Study|Adverse Event|4|||
161869578|NCT02582242|584566748|FG001|Overall Study|Adverse Event|3|||
161869579|NCT02582242|584566747|FG000|Overall Study|Protocol Violation|3|||
161869580|NCT02582242|584566748|FG001|Overall Study|Protocol Violation|1|||
161869581|NCT02582242|584566747|FG000|Overall Study|Lost to Follow-up|0|||
161869582|NCT02582242|584566748|FG001|Overall Study|Lost to Follow-up|1|||
161869583|NCT02582242|584566747|FG000|Overall Study|Withdrawal by Subject|11|||
161869584|NCT02582242|584566748|FG001|Overall Study|Withdrawal by Subject|11|||
161869585|NCT02582242|584566747|FG000|Overall Study|Unclassified|2|||
161869586|NCT02582242|584566748|FG001|Overall Study|Unclassified|1|||
161869587|NCT02101736|584566749|FG000|Overall Study|Protocol Violation|3|||
161869588|NCT02101736|584566750|FG001|Overall Study|Protocol Violation|0|||
161869589|NCT02101736|584566749|FG000|Overall Study|Withdrawal by Subject|1|||
161869590|NCT02101736|584566750|FG001|Overall Study|Withdrawal by Subject|1|||
161869591|NCT03150719|584566755|FG000|Overall Study|Adverse Event|0|||
161869592|NCT03150719|584566756|FG001|Overall Study|Adverse Event|1|||
161869593|NCT03150719|584566755|FG000|Overall Study|Death|0|||
161869594|NCT03150719|584566756|FG001|Overall Study|Death|1|||
161869595|NCT03150719|584566755|FG000|Overall Study|Other|1|||
161869596|NCT03150719|584566756|FG001|Overall Study|Other|0|||
161869597|NCT04938180|584566757|FG000|Overall Study|Adverse Event|1|||
161869598|NCT01964222|584566758|FG000|Overall Study|Lost to Follow-up|7|||
161869599|NCT01964222|584566759|FG001|Overall Study|Lost to Follow-up|5|||
161869600|NCT01964222|584566758|FG000|Overall Study|Withdrawal by Subject|6|||
161869601|NCT01964222|584566759|FG001|Overall Study|Withdrawal by Subject|6|||
161869602|NCT01964222|584566758|FG000|Overall Study|Screening Failure|2|||
161869603|NCT01964222|584566759|FG001|Overall Study|Screening Failure|0|||
161869604|NCT01019694|584566764|FG000|Overall Study|Adverse Event|12|||
161869605|NCT01019694|584566765|FG001|Overall Study|Adverse Event|16|||
161869606|NCT01019694|584566766|FG002|Overall Study|Adverse Event|19|||
161869607|NCT01019694|584566764|FG000|Overall Study|Protocol Violation|2|||
161869608|NCT01019694|584566765|FG001|Overall Study|Protocol Violation|6|||
161869609|NCT01019694|584566766|FG002|Overall Study|Protocol Violation|4|||
161869610|NCT01019694|584566764|FG000|Overall Study|Lost to Follow-up|5|||
161869611|NCT01019694|584566765|FG001|Overall Study|Lost to Follow-up|3|||
161869612|NCT01019694|584566766|FG002|Overall Study|Lost to Follow-up|3|||
161869613|NCT01019694|584566764|FG000|Overall Study|Withdrawal by Subject|4|||
161869614|NCT01019694|584566765|FG001|Overall Study|Withdrawal by Subject|6|||
161869615|NCT01019694|584566766|FG002|Overall Study|Withdrawal by Subject|12|||
161869616|NCT01019694|584566764|FG000|Overall Study|Not treated|0|||
161869617|NCT01019694|584566765|FG001|Overall Study|Not treated|2|||
161869618|NCT01019694|584566766|FG002|Overall Study|Not treated|3|||
161869619|NCT01019694|584566764|FG000|Overall Study|Other reason (not specified)|1|||
161869620|NCT01019694|584566765|FG001|Overall Study|Other reason (not specified)|5|||
161869621|NCT01019694|584566766|FG002|Overall Study|Other reason (not specified)|6|||
161869622|NCT00441129|584566769|FG000|Overall Study|Withdrawal by Subject|6|||
161869623|NCT00441129|584566770|FG001|Overall Study|Withdrawal by Subject|14|||
161869624|NCT04278417|584566780|FG000|Overall Study|Withdrawal by Subject|20|||
161869625|NCT04278417|584566781|FG001|Overall Study|Withdrawal by Subject|20|||
161869626|NCT04278417|584566780|FG000|Overall Study|Progressive disease|0|||
161869627|NCT04278417|584566781|FG001|Overall Study|Progressive disease|2|||
161869628|NCT04278417|584566780|FG000|Overall Study|Physician Decision|4|||
161869629|NCT04278417|584566781|FG001|Overall Study|Physician Decision|6|||
161869630|NCT04278417|584566780|FG000|Overall Study|Lost to Follow-up|11|||
161869631|NCT04278417|584566781|FG001|Overall Study|Lost to Follow-up|13|||
161869632|NCT04278417|584566780|FG000|Overall Study|Death|8|||
161869633|NCT04278417|584566781|FG001|Overall Study|Death|9|||
161869634|NCT04278417|584566780|FG000|Overall Study|Adverse Event|3|||
161869635|NCT04278417|584566781|FG001|Overall Study|Adverse Event|5|||
161869636|NCT02097745|584566787|FG000|Overall Study|Adverse Event|25|||
161869637|NCT02097745|584566787|FG000|Overall Study|Death|16|||
161869638|NCT02097745|584566787|FG000|Overall Study|Failure to Return|14|||
161869639|NCT02097745|584566787|FG000|Overall Study|Administrative/Other|27|||
161869640|NCT02097745|584566787|FG000|Overall Study|Reason Not Specified|96|||
161869641|NCT02748356|584566788|FG000|Overall Study|Withdrawal by Subject|1|||
161869642|NCT00425750|584566789|FG000|Overall Study|Death|1|||
161869643|NCT00425750|584566789|FG000|Overall Study|Withdrawal by Subject|3|||
161869644|NCT00425750|584566789|FG000|Overall Study|Adverse Event|3|||
161869645|NCT00425750|584566789|FG000|Overall Study|Progression of disease|18|||
161869646|NCT04331067|584566790|FG000|Overall Study|Adverse Event|1|||
161869647|NCT04331067|584566791|FG001|Overall Study|Adverse Event|3|||
161869648|NCT04331067|584566792|FG002|Overall Study|Adverse Event|1|||
161869649|NCT04331067|584566790|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
161869650|NCT04331067|584566791|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
161869651|NCT04331067|584566792|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
161869652|NCT00347009|584566793|FG000|Overall Study|Death|1|||
161869653|NCT00347009|584566793|FG000|Overall Study|Adverse Event|6|||
161869654|NCT00347009|584566793|FG000|Overall Study|Withdrawal by Subject|3|||
161869655|NCT00347009|584566793|FG000|Overall Study|Physician Decision|5|||
161869656|NCT00347009|584566793|FG000|Overall Study|Lost to Follow-up|4|||
161869657|NCT00347009|584566793|FG000|Overall Study|Protocol Violation|2|||
161869658|NCT00347009|584566793|FG000|Overall Study|Adverse Laboratory Experience|1|||
161869659|NCT00347009|584566793|FG000|Overall Study|Insufficient Viral Suppression|3|||
161869660|NCT00347009|584566793|FG000|Overall Study|Increased ALT/HBV DNA|1|||
161869661|NCT00347009|584566793|FG000|Overall Study|Serious Adverse Event|1|||
161869662|NCT02907177|584566794|FG000|Overall Study|Death|0|||
161869663|NCT02907177|584566795|FG001|Overall Study|Death|1|||
161869664|NCT02907177|584566794|FG000|Overall Study|Physician Decision|3|||
161869665|NCT02907177|584566795|FG001|Overall Study|Physician Decision|3|||
161869666|NCT02907177|584566794|FG000|Overall Study|Withdrawal by Subject|15|||
161869667|NCT02907177|584566795|FG001|Overall Study|Withdrawal by Subject|7|||
161869668|NCT02907177|584566794|FG000|Overall Study|Sponsor's Decision|50|||
161869669|NCT02907177|584566795|FG001|Overall Study|Sponsor's Decision|57|||
161869670|NCT01796392|584566796|FG000|Overall Study|Withdrawal by Subject|2|||
161869671|NCT01796392|584566797|FG001|Overall Study|Withdrawal by Subject|0|||
161869672|NCT01796392|584566796|FG000|Overall Study|Death|5|||
161869673|NCT01796392|584566797|FG001|Overall Study|Death|1|||
161869674|NCT01796392|584566796|FG000|Overall Study|Excluded for medical reasons|1|||
161869675|NCT01796392|584566797|FG001|Overall Study|Excluded for medical reasons|2|||
161869676|NCT01796392|584566796|FG000|Overall Study|Lost to Follow-up|1|||
161869677|NCT01796392|584566797|FG001|Overall Study|Lost to Follow-up|0|||
161869678|NCT03482635|584566798|FG000|Overall Study|Lack of Efficacy|0|||
161869679|NCT03482635|584566799|FG001|Overall Study|Lack of Efficacy|0|||
161869680|NCT03482635|584566800|FG002|Overall Study|Lack of Efficacy|1|||
161869681|NCT03482635|584566801|FG003|Overall Study|Lack of Efficacy|3|||
161869682|NCT03482635|584566798|FG000|Overall Study|Adverse Event|2|||
161869683|NCT03482635|584566799|FG001|Overall Study|Adverse Event|2|||
161869684|NCT03482635|584566800|FG002|Overall Study|Adverse Event|0|||
161869685|NCT03482635|584566801|FG003|Overall Study|Adverse Event|3|||
161869686|NCT03482635|584566798|FG000|Overall Study|Withdrawal by Subject|2|||
161869687|NCT03482635|584566799|FG001|Overall Study|Withdrawal by Subject|1|||
161869688|NCT03482635|584566800|FG002|Overall Study|Withdrawal by Subject|0|||
161869689|NCT03482635|584566801|FG003|Overall Study|Withdrawal by Subject|1|||
161869690|NCT03482635|584566798|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
161869691|NCT03482635|584566799|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
161869692|NCT03482635|584566800|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
161869693|NCT03482635|584566801|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
161869694|NCT03482635|584566798|FG000|Overall Study|Not treated|0|||
161869695|NCT03482635|584566799|FG001|Overall Study|Not treated|0|||
161869696|NCT03482635|584566800|FG002|Overall Study|Not treated|0|||
161869697|NCT03482635|584566801|FG003|Overall Study|Not treated|1|||
161869698|NCT04639219|584566802|FG000|Overall Study|Withdrawal by Subject|8|||
161869699|NCT04639219|584566802|FG000|Overall Study|Lost to Follow-up|6|||
161869700|NCT04639219|584566802|FG000|Overall Study|Death|55|||
161869701|NCT04681066|584566803|FG000|Overall Study|Lost to Follow-up|3|||
161869702|NCT04681066|584566804|FG001|Overall Study|Lost to Follow-up|1|||
161869703|NCT04681066|584566805|FG002|Overall Study|Lost to Follow-up|2|||
161869704|NCT04681066|584566806|FG003|Overall Study|Lost to Follow-up|1|||
161869705|NCT04681066|584566803|FG000|Overall Study|Withdrawal by Subject|2|||
161869706|NCT04681066|584566804|FG001|Overall Study|Withdrawal by Subject|1|||
161869707|NCT04681066|584566805|FG002|Overall Study|Withdrawal by Subject|0|||
161869708|NCT04681066|584566806|FG003|Overall Study|Withdrawal by Subject|3|||
161869709|NCT04681066|584566803|FG000|Overall Study|Death|0|||
161869710|NCT04681066|584566804|FG001|Overall Study|Death|1|||
161869711|NCT04681066|584566805|FG002|Overall Study|Death|0|||
161869712|NCT04681066|584566806|FG003|Overall Study|Death|0|||
161869713|NCT03474965|584566807|FG000|Overall Study|Pregnancy|1|||
161869714|NCT03474965|584566808|FG001|Overall Study|Pregnancy|0|||
161869715|NCT03474965|584566809|FG002|Overall Study|Pregnancy|0|||
161869716|NCT03474965|584566810|FG003|Overall Study|Pregnancy|0|||
161869717|NCT03474965|584566807|FG000|Overall Study|Lost to Follow-up|0|||
161869718|NCT03474965|584566808|FG001|Overall Study|Lost to Follow-up|0|||
161869719|NCT03474965|584566809|FG002|Overall Study|Lost to Follow-up|1|||
161869720|NCT03474965|584566810|FG003|Overall Study|Lost to Follow-up|0|||
161869721|NCT03474965|584566807|FG000|Overall Study|Death|1|||
161869722|NCT03474965|584566808|FG001|Overall Study|Death|0|||
161869723|NCT03474965|584566809|FG002|Overall Study|Death|0|||
161869724|NCT03474965|584566810|FG003|Overall Study|Death|0|||
161869725|NCT03474965|584566807|FG000|Overall Study|Adverse Event|1|||
161869726|NCT03474965|584566808|FG001|Overall Study|Adverse Event|0|||
161869727|NCT03474965|584566809|FG002|Overall Study|Adverse Event|0|||
161869728|NCT03474965|584566810|FG003|Overall Study|Adverse Event|1|||
161869729|NCT03474965|584566807|FG000|Overall Study|Physician Decision|3|||
161869730|NCT03474965|584566808|FG001|Overall Study|Physician Decision|1|||
161869731|NCT03474965|584566809|FG002|Overall Study|Physician Decision|2|||
161869732|NCT03474965|584566810|FG003|Overall Study|Physician Decision|0|||
161869733|NCT03474965|584566807|FG000|Overall Study|Participant Decision|7|||
161869734|NCT03474965|584566808|FG001|Overall Study|Participant Decision|0|||
161869735|NCT03474965|584566809|FG002|Overall Study|Participant Decision|1|||
161869736|NCT03474965|584566810|FG003|Overall Study|Participant Decision|0|||
161869737|NCT03474965|584566807|FG000|Overall Study|Guardian Decision|4|||
161869738|NCT03474965|584566808|FG001|Overall Study|Guardian Decision|2|||
161869739|NCT03474965|584566809|FG002|Overall Study|Guardian Decision|7|||
161869740|NCT03474965|584566810|FG003|Overall Study|Guardian Decision|2|||
161869741|NCT00300885|584568412|FG000|Treatment|Adverse Event|134|||
161869742|NCT00300885|584568413|FG001|Treatment|Adverse Event|82|||
161869743|NCT00300885|584568412|FG000|Treatment|Death|20|||
161869744|NCT00300885|584568413|FG001|Treatment|Death|7|||
161869745|NCT00300885|584568412|FG000|Treatment|Lack of Efficacy|1|||
161869746|NCT00300885|584568413|FG001|Treatment|Lack of Efficacy|1|||
161869747|NCT00300885|584568412|FG000|Treatment|Lost to Follow-up|3|||
161869748|NCT00300885|584568413|FG001|Treatment|Lost to Follow-up|2|||
161869749|NCT00300885|584568412|FG000|Treatment|Physician Decision|4|||
161869750|NCT00300885|584568413|FG001|Treatment|Physician Decision|5|||
161869751|NCT00300885|584568412|FG000|Treatment|Protocol Violation|11|||
161869752|NCT00300885|584568413|FG001|Treatment|Protocol Violation|11|||
161869753|NCT00300885|584568412|FG000|Treatment|Withdrawal by Subject|26|||
161869754|NCT00300885|584568413|FG001|Treatment|Withdrawal by Subject|23|||
161869755|NCT00300885|584568412|FG000|Treatment|Disease progression|171|||
161869756|NCT00300885|584568413|FG001|Treatment|Disease progression|238|||
161869757|NCT00300885|584568412|FG000|Treatment|Random code broken (subject died)|0|||
161869758|NCT00300885|584568413|FG001|Treatment|Random code broken (subject died)|1|||
161869759|NCT00300885|584568412|FG000|Treatment|Non-compliant with study medication|3|||
161869760|NCT00300885|584568413|FG001|Treatment|Non-compliant with study medication|4|||
161869761|NCT00300885|584568412|FG000|Follow-up|Death|141|||
161869762|NCT00300885|584568413|FG001|Follow-up|Death|163|||
161869763|NCT00300885|584568412|FG000|Follow-up|Lost to Follow-up|11|||
161869764|NCT00300885|584568413|FG001|Follow-up|Lost to Follow-up|7|||
161869765|NCT00300885|584568412|FG000|Follow-up|Withdrawal by Subject|26|||
161869766|NCT00300885|584568413|FG001|Follow-up|Withdrawal by Subject|25|||
161869767|NCT01637922|584568414|FG000|Overall Study|Adverse Event|0|||
161869768|NCT01637922|584568415|FG001|Overall Study|Adverse Event|1|||
161869769|NCT01637922|584568414|FG000|Overall Study|Protocol Violation|0|||
161869770|NCT01637922|584568415|FG001|Overall Study|Protocol Violation|1|||
161869771|NCT01637922|584568414|FG000|Overall Study|Withdrawal by Subject|0|||
161869772|NCT01637922|584568415|FG001|Overall Study|Withdrawal by Subject|3|||
161869773|NCT01637922|584568414|FG000|Overall Study|Lost to Follow-up|2|||
161869774|NCT01637922|584568415|FG001|Overall Study|Lost to Follow-up|0|||
161869775|NCT00638404|584568416|FG000|Overall Study|Physician Decision|8|||
161869776|NCT00638404|584568417|FG001|Overall Study|Physician Decision|0|||
161869777|NCT02492984|584568421|FG000|Overall Study|Adverse Event|1|||
161869778|NCT02492984|584568422|FG001|Overall Study|Adverse Event|0|||
161869779|NCT02492984|584568421|FG000|Overall Study|Protocol Violation|1|||
161869780|NCT02492984|584568422|FG001|Overall Study|Protocol Violation|0|||
161869781|NCT02492984|584568421|FG000|Overall Study|Withdrawal by Subject|1|||
161869782|NCT02492984|584568422|FG001|Overall Study|Withdrawal by Subject|0|||
161869783|NCT02282631|584568423|FG000|Overall Study|Lost to Follow-up|2|||
161869784|NCT02282631|584568424|FG001|Overall Study|Lost to Follow-up|0|||
161869785|NCT00459290|584568425|FG000|Overall Study|Adverse Event|3|||
161869786|NCT00459290|584568425|FG000|Overall Study|Ineligible|2|||
161869787|NCT00687271|584568426|FG000|Overall Study|Adverse Event|1|||
161869788|NCT00687271|584568427|FG001|Overall Study|Adverse Event|3|||
161869789|NCT00687271|584568428|FG002|Overall Study|Adverse Event|1|||
161869790|NCT00687271|584568429|FG003|Overall Study|Adverse Event|0|||
161869791|NCT00687271|584568426|FG000|Overall Study|Lost to Follow-up|0|||
161869792|NCT00687271|584568427|FG001|Overall Study|Lost to Follow-up|1|||
161869793|NCT00687271|584568428|FG002|Overall Study|Lost to Follow-up|0|||
161869794|NCT00687271|584568429|FG003|Overall Study|Lost to Follow-up|0|||
161869795|NCT00687271|584568426|FG000|Overall Study|Protocol Violation|2|||
161869796|NCT00687271|584568427|FG001|Overall Study|Protocol Violation|1|||
161869797|NCT00687271|584568428|FG002|Overall Study|Protocol Violation|1|||
161869798|NCT00687271|584568429|FG003|Overall Study|Protocol Violation|0|||
161869799|NCT00687271|584568426|FG000|Overall Study|Withdrawal by Subject|0|||
161869800|NCT00687271|584568427|FG001|Overall Study|Withdrawal by Subject|1|||
161869801|NCT00687271|584568428|FG002|Overall Study|Withdrawal by Subject|3|||
161869802|NCT00687271|584568429|FG003|Overall Study|Withdrawal by Subject|0|||
161869803|NCT02453334|584568430|FG000|Overall Study|Death|15|||
161869804|NCT02453334|584568431|FG001|Overall Study|Death|13|||
161869805|NCT02453334|584568430|FG000|Overall Study|Adverse Event|2|||
161869806|NCT02453334|584568431|FG001|Overall Study|Adverse Event|1|||
161869807|NCT02453334|584568430|FG000|Overall Study|Lost to Follow-up|5|||
161869808|NCT02453334|584568431|FG001|Overall Study|Lost to Follow-up|9|||
161869809|NCT02453334|584568430|FG000|Overall Study|Physician Decision|1|||
161869810|NCT02453334|584568431|FG001|Overall Study|Physician Decision|0|||
161869811|NCT02453334|584568430|FG000|Overall Study|Withdrawal by Subject|17|||
161869812|NCT02453334|584568431|FG001|Overall Study|Withdrawal by Subject|13|||
161869813|NCT02453334|584568430|FG000|Overall Study|Other reason|1|||
161869814|NCT02453334|584568431|FG001|Overall Study|Other reason|4|||
161869815|NCT01841762|584568432|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
161869816|NCT01841762|584568432|FG000|Treatment Period|Adverse Event|16|||
161869817|NCT01841762|584568432|FG000|Treatment Period|Death|1|||
161869818|NCT01841762|584568432|FG000|Treatment Period|Withdrawal by Subject|7|||
161869819|NCT01841762|584568432|FG000|Treatment Period|Lost to Follow-up|1|||
161869820|NCT01841762|584568432|FG000|Treatment Period|Physician Decision|2|||
161869821|NCT01841762|584568432|FG000|Treatment Period|Other, including non-compliance|5|||
161869822|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
161869823|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
161869824|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
161869825|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
161869826|NCT05483686|584568436|FG000|Overall Study|Lost to Follow-up|5|||
161869827|NCT05483686|584568437|FG001|Overall Study|Lost to Follow-up|7|||
161869828|NCT03981900|584568438|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
161869829|NCT03981900|584568438|FG000|Overall Study|Adverse Event|5|||
161869830|NCT03981900|584568438|FG000|Overall Study|Protocol Violation|1|||
161869831|NCT03981900|584568438|FG000|Overall Study|Withdrawal by Subject|7|||
161869832|NCT03981900|584568438|FG000|Overall Study|Lost to Follow-up|46|||
161869833|NCT03981900|584568438|FG000|Overall Study|Decision of the researcher|3|||
161869834|NCT03981900|584568438|FG000|Overall Study|Death|3|||
161869835|NCT03981900|584568438|FG000|Overall Study|Other|5|||
161869836|NCT02693106|584568440|FG000|Overall Study|No time|3|||
161869837|NCT06152224|584568447|FG000|Overall Study|Withdrawal by Subject|1|||
161869838|NCT06152224|584568448|FG001|Overall Study|Withdrawal by Subject|0|||
161869839|NCT06152224|584568447|FG000|Overall Study|Lost to Follow-up|0|||
161869840|NCT06152224|584568448|FG001|Overall Study|Lost to Follow-up|1|||
161869841|NCT06152224|584568447|FG000|Overall Study|On Follow Up|18|||
161869842|NCT06152224|584568448|FG001|Overall Study|On Follow Up|18|||
161869843|NCT05780983|584568449|FG000|Overall Study|Withdrawal by Subject|1|||
161869844|NCT06028438|584568453|FG000|Overall Study|Adverse Event|3|||
161869845|NCT06028438|584568454|FG001|Overall Study|Adverse Event|9|||
161869846|NCT06028438|584568453|FG000|Overall Study|Lack of Efficacy|1|||
161869847|NCT06028438|584568454|FG001|Overall Study|Lack of Efficacy|1|||
161869848|NCT06028438|584568453|FG000|Overall Study|Lost to Follow-up|1|||
161869849|NCT06028438|584568454|FG001|Overall Study|Lost to Follow-up|0|||
161869850|NCT06028438|584568453|FG000|Overall Study|Withdrawal by Subject|1|||
161869851|NCT06028438|584568454|FG001|Overall Study|Withdrawal by Subject|0|||
161869852|NCT06028438|584568453|FG000|Overall Study|Other|3|||
161869853|NCT06028438|584568454|FG001|Overall Study|Other|3|||
161869854|NCT05625802|584568455|FG000|Overall Study|Lost to Follow-up|1|||
161869855|NCT05625802|584568456|FG001|Overall Study|Lost to Follow-up|0|||
161869856|NCT00808210|584568458|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
161869857|NCT00808210|584568459|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
161869858|NCT00808210|584568458|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
161869859|NCT00808210|584568459|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
161869860|NCT00808210|584568458|FG000|Double-Blind TX Period|Adverse Event|0|||
161869861|NCT00808210|584568459|FG001|Double-Blind TX Period|Adverse Event|1|||
161869862|NCT00808210|584568458|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
161869863|NCT00808210|584568459|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
161869864|NCT00808210|584568458|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
161869865|NCT00808210|584568459|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
161869866|NCT00808210|584568458|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
161869867|NCT00808210|584568459|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
161869868|NCT02044302|584568460|FG000|Overall Study|study terminated|2|||
161869869|NCT02044302|584568461|FG001|Overall Study|study terminated|0|||
161869870|NCT01954056|584568463|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
161869871|NCT01954056|584568464|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
161869872|NCT03337113|584568476|FG000|Overall Study|Adverse Event|1|||
161869873|NCT03337113|584568477|FG001|Overall Study|Adverse Event|1|||
161869874|NCT03337113|584568478|FG002|Overall Study|Adverse Event|0|||
161869875|NCT03337113|584568479|FG003|Overall Study|Adverse Event|1|||
161869876|NCT03337113|584568476|FG000|Overall Study|Physician Decision|0|||
161869877|NCT03337113|584568477|FG001|Overall Study|Physician Decision|2|||
161869878|NCT03337113|584568478|FG002|Overall Study|Physician Decision|0|||
161869879|NCT03337113|584568479|FG003|Overall Study|Physician Decision|1|||
161869880|NCT03337113|584568476|FG000|Overall Study|Withdrawal by Subject|0|||
161869881|NCT03337113|584568477|FG001|Overall Study|Withdrawal by Subject|0|||
161869882|NCT03337113|584568478|FG002|Overall Study|Withdrawal by Subject|1|||
161869883|NCT03337113|584568479|FG003|Overall Study|Withdrawal by Subject|0|||
161869884|NCT01164579|584568480|FG000|Overall Study|Lack of Efficacy|0|||
161869885|NCT01164579|584568481|FG001|Overall Study|Lack of Efficacy|0|||
161869886|NCT01164579|584568482|FG002|Overall Study|Lack of Efficacy|6|||
161869887|NCT01164579|584568480|FG000|Overall Study|Lost to Follow-up|1|||
161869888|NCT01164579|584568481|FG001|Overall Study|Lost to Follow-up|1|||
161869889|NCT01164579|584568482|FG002|Overall Study|Lost to Follow-up|0|||
161869890|NCT01164579|584568480|FG000|Overall Study|Withdrawal by Subject|2|||
161869891|NCT01164579|584568481|FG001|Overall Study|Withdrawal by Subject|5|||
161869892|NCT01164579|584568482|FG002|Overall Study|Withdrawal by Subject|3|||
161869893|NCT01164579|584568480|FG000|Overall Study|Protocol Violation|0|||
161869894|NCT01164579|584568481|FG001|Overall Study|Protocol Violation|1|||
161869895|NCT01164579|584568482|FG002|Overall Study|Protocol Violation|2|||
161869896|NCT01164579|584568480|FG000|Overall Study|Adverse Event|4|||
161869897|NCT01164579|584568481|FG001|Overall Study|Adverse Event|2|||
161869898|NCT01164579|584568482|FG002|Overall Study|Adverse Event|5|||
161869899|NCT01164579|584568480|FG000|Overall Study|Reason not specified|1|||
161869900|NCT01164579|584568481|FG001|Overall Study|Reason not specified|0|||
161869901|NCT01164579|584568482|FG002|Overall Study|Reason not specified|0|||
161869902|NCT01372995|584568491|FG000|Overall Study|Spouse withdrew participant from study|0|||
161869903|NCT01372995|584568492|FG001|Overall Study|Spouse withdrew participant from study|1|||
161869904|NCT01372995|584568493|FG002|Overall Study|Spouse withdrew participant from study|0|||
161869905|NCT01372995|584568491|FG000|Overall Study|Physician Decision|0|||
161869906|NCT01372995|584568492|FG001|Overall Study|Physician Decision|0|||
161869907|NCT01372995|584568493|FG002|Overall Study|Physician Decision|1|||
161869908|NCT01297517|584568498|FG000|Overall Study|Adverse Event|21|||
161869909|NCT01297517|584568499|FG001|Overall Study|Adverse Event|7|||
161869910|NCT01297517|584568500|FG002|Overall Study|Adverse Event|16|||
161869911|NCT01297517|584568498|FG000|Overall Study|Lost to Follow-up|1|||
161869912|NCT01297517|584568499|FG001|Overall Study|Lost to Follow-up|0|||
161869913|NCT01297517|584568500|FG002|Overall Study|Lost to Follow-up|1|||
161869914|NCT01297517|584568498|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
161869915|NCT01297517|584568499|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
161869916|NCT01297517|584568500|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
161869917|NCT01297517|584568498|FG000|Overall Study|Noncompliance|1|||
161869918|NCT01297517|584568499|FG001|Overall Study|Noncompliance|0|||
161869919|NCT01297517|584568500|FG002|Overall Study|Noncompliance|0|||
161869920|NCT01297517|584568498|FG000|Overall Study|Protocol Violation|1|||
161869921|NCT01297517|584568499|FG001|Overall Study|Protocol Violation|1|||
161869922|NCT01297517|584568500|FG002|Overall Study|Protocol Violation|1|||
161869923|NCT01297517|584568498|FG000|Overall Study|Inadequate Control of IOP|1|||
161869924|NCT01297517|584568499|FG001|Overall Study|Inadequate Control of IOP|1|||
161869925|NCT01297517|584568500|FG002|Overall Study|Inadequate Control of IOP|2|||
161869926|NCT02914613|584568501|FG000|Overall Study|Withdrawal by Subject|1|||
161869927|NCT02914613|584568502|FG001|Overall Study|Withdrawal by Subject|2|||
161869928|NCT02914613|584568501|FG000|Overall Study|Adverse Event|1|||
161869929|NCT02914613|584568502|FG001|Overall Study|Adverse Event|0|||
161869930|NCT01737710|584568503|FG000|Overall Study|Lost to Follow-up|0|||
161869931|NCT01737710|584568504|FG001|Overall Study|Lost to Follow-up|2|||
161869932|NCT01737710|584568505|FG002|Overall Study|Lost to Follow-up|2|||
161869933|NCT01737710|584568506|FG003|Overall Study|Lost to Follow-up|0|||
161869934|NCT01737710|584568507|FG004|Overall Study|Lost to Follow-up|0|||
161869935|NCT01737710|584568503|FG000|Overall Study|Withdrawal by Subject|1|||
161869936|NCT01737710|584568504|FG001|Overall Study|Withdrawal by Subject|1|||
161869937|NCT01737710|584568505|FG002|Overall Study|Withdrawal by Subject|1|||
161869938|NCT01737710|584568506|FG003|Overall Study|Withdrawal by Subject|0|||
161869939|NCT01737710|584568507|FG004|Overall Study|Withdrawal by Subject|0|||
161869940|NCT01737710|584568503|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
161869941|NCT01737710|584568504|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
161869942|NCT01737710|584568505|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
161869943|NCT01737710|584568506|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
161869944|NCT01737710|584568507|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
161869945|NCT00758485|584568513|FG000|Overall Study|Lost to Follow-up|0|||
161869946|NCT00758485|584568514|FG001|Overall Study|Lost to Follow-up|1|||
161869947|NCT00758485|584568513|FG000|Overall Study|Not Treated|1|||
161869948|NCT00758485|584568514|FG001|Overall Study|Not Treated|2|||
161869949|NCT00921557|584568515|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
161869950|NCT00921557|584568516|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
161869951|NCT00921557|584568517|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
161869952|NCT00921557|584568515|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
161869953|NCT00921557|584568516|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
161869954|NCT00921557|584568517|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
161869955|NCT00921557|584568515|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
161869956|NCT00921557|584568516|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
161869957|NCT00921557|584568517|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
161869958|NCT00921557|584568515|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
161869959|NCT00921557|584568516|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
161869960|NCT00921557|584568517|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
161869961|NCT00921557|584568515|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
161869962|NCT00921557|584568516|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
161869963|NCT00921557|584568517|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
161869964|NCT03259425|584568518|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
161869965|NCT00463047|584568519|FG000|Titration Period 1|Adverse Event|10|||
161869966|NCT00463047|584568520|FG001|Titration Period 1|Adverse Event|8|||
161869967|NCT00463047|584568519|FG000|Titration Period 1|Lack of Efficacy|10|||
161869968|NCT00463047|584568520|FG001|Titration Period 1|Lack of Efficacy|4|||
161869969|NCT00463047|584568519|FG000|Titration Period 1|Lost to Follow-up|2|||
161869970|NCT00463047|584568520|FG001|Titration Period 1|Lost to Follow-up|0|||
161869971|NCT00463047|584568519|FG000|Titration Period 1|Non-compliance with study medication|3|||
161869972|NCT00463047|584568520|FG001|Titration Period 1|Non-compliance with study medication|5|||
161869973|NCT00463047|584568519|FG000|Titration Period 1|Protocol Violation|5|||
161869974|NCT00463047|584568520|FG001|Titration Period 1|Protocol Violation|5|||
161869975|NCT00463047|584568519|FG000|Titration Period 1|Withdrawal by Subject|3|||
161869976|NCT00463047|584568520|FG001|Titration Period 1|Withdrawal by Subject|5|||
161869977|NCT00463047|584568519|FG000|Titration Period 1|Non-compliance procedures|4|||
161869978|NCT00463047|584568520|FG001|Titration Period 1|Non-compliance procedures|10|||
161869979|NCT00463047|584568519|FG000|Titration Period 1|Other|0|||
161869980|NCT00463047|584568520|FG001|Titration Period 1|Other|2|||
161869981|NCT00463047|584568519|FG000|Titration Period 2|Adverse Event|9|||
161869982|NCT00463047|584568520|FG001|Titration Period 2|Adverse Event|9|||
161869983|NCT00463047|584568519|FG000|Titration Period 2|Lack of Efficacy|6|||
161869984|NCT00463047|584568520|FG001|Titration Period 2|Lack of Efficacy|4|||
161869985|NCT00463047|584568519|FG000|Titration Period 2|Withdrawal by Subject|1|||
161869986|NCT00463047|584568520|FG001|Titration Period 2|Withdrawal by Subject|0|||
161869987|NCT00463047|584568519|FG000|Titration Period 2|Protocol Violation|2|||
161869988|NCT00463047|584568520|FG001|Titration Period 2|Protocol Violation|3|||
161869989|NCT00463047|584568519|FG000|Titration Period 2|Lost to Follow-up|1|||
161869990|NCT00463047|584568520|FG001|Titration Period 2|Lost to Follow-up|2|||
161869991|NCT00463047|584568519|FG000|Titration Period 2|Non-compliance study medication|4|||
161869992|NCT00463047|584568520|FG001|Titration Period 2|Non-compliance study medication|2|||
161869993|NCT00463047|584568519|FG000|Titration Period 2|Non-compliance procedures|4|||
161869994|NCT00463047|584568520|FG001|Titration Period 2|Non-compliance procedures|1|||
161869995|NCT00463047|584568519|FG000|Titration Period 2|Other|3|||
161869996|NCT00463047|584568520|FG001|Titration Period 2|Other|2|||
161869997|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
161869998|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
161869999|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
161870000|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
161870001|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
161870002|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
161870003|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Other|1|||
161870004|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Other|0|||
161870005|NCT00463047|584568519|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
161870006|NCT00463047|584568520|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
161870007|NCT00463047|584568519|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161870008|NCT00463047|584568520|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
161870009|NCT00463047|584568519|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
161870010|NCT00463047|584568520|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
161870011|NCT01732458|584568526|FG000|Overall Study|Lost to Follow-up|0|||
161870012|NCT01732458|584568527|FG001|Overall Study|Lost to Follow-up|2|||
161870013|NCT01732458|584568528|FG002|Overall Study|Lost to Follow-up|0|||
161870014|NCT01732458|584568529|FG003|Overall Study|Lost to Follow-up|0|||
161870015|NCT01732458|584568526|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161870016|NCT01732458|584568527|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161870017|NCT01732458|584568528|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161870018|NCT01732458|584568529|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161870019|NCT01732458|584568526|FG000|Overall Study|Physician Decision|1|||
161870020|NCT01732458|584568527|FG001|Overall Study|Physician Decision|2|||
161870021|NCT01732458|584568528|FG002|Overall Study|Physician Decision|2|||
161870022|NCT01732458|584568529|FG003|Overall Study|Physician Decision|0|||
161870023|NCT01732458|584568526|FG000|Overall Study|Protocol Violation|2|||
161870024|NCT01732458|584568527|FG001|Overall Study|Protocol Violation|0|||
161870025|NCT01732458|584568528|FG002|Overall Study|Protocol Violation|0|||
161870026|NCT01732458|584568529|FG003|Overall Study|Protocol Violation|2|||
161870027|NCT01732458|584568526|FG000|Overall Study|Screen Failure|0|||
161870028|NCT01732458|584568527|FG001|Overall Study|Screen Failure|1|||
161870029|NCT01732458|584568528|FG002|Overall Study|Screen Failure|0|||
161870030|NCT01732458|584568529|FG003|Overall Study|Screen Failure|0|||
161870031|NCT05870371|584568530|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
161870032|NCT05870371|584568531|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
161870033|NCT02203721|584568532|FG000|Overall Study|Lost to Follow-up|1|||
161870034|NCT02203721|584568533|FG001|Overall Study|Lost to Follow-up|0|||
161870035|NCT02203721|584568532|FG000|Overall Study|Death|0|||
161870036|NCT02203721|584568533|FG001|Overall Study|Death|2|||
161870037|NCT02203721|584568532|FG000|Overall Study|Illness|0|||
161870038|NCT02203721|584568533|FG001|Overall Study|Illness|1|||
161870039|NCT00703157|584568534|FG000|Overall Study|Lost to Follow-up|0|||
161870040|NCT00703157|584568535|FG001|Overall Study|Lost to Follow-up|1|||
161870041|NCT00703157|584568534|FG000|Overall Study|source data permanently lost/ other|4|||
161870042|NCT00703157|584568535|FG001|Overall Study|source data permanently lost/ other|1|||
161870043|NCT02522884|584568538|FG000|Overall Study|Withdrawal by Subject|6|||
161870044|NCT02522884|584568538|FG000|Overall Study|Death|3|||
161870045|NCT02522884|584568538|FG000|Overall Study|Missed 12-month Follow-up|9|||
161870046|NCT04495751|584568539|FG000|Overall Study|Withdrawal by Subject|1|||
161870047|NCT04495751|584568540|FG001|Overall Study|Withdrawal by Subject|0|||
161870048|NCT04495751|584568539|FG000|Overall Study|Lost to Follow-up|1|||
161870049|NCT04495751|584568540|FG001|Overall Study|Lost to Follow-up|0|||
161870050|NCT03289754|584568541|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
161870051|NCT04873934|584568542|FG000|Overall Study|Adverse Event|0|||
161870052|NCT04873934|584568543|FG001|Overall Study|Adverse Event|1|||
161870053|NCT04873934|584568542|FG000|Overall Study|Death|0|||
161870054|NCT04873934|584568543|FG001|Overall Study|Death|2|||
161870055|NCT04873934|584568542|FG000|Overall Study|Lost to Follow-up|13|||
161870056|NCT04873934|584568543|FG001|Overall Study|Lost to Follow-up|9|||
161870057|NCT04873934|584568542|FG000|Overall Study|Physician Decision|1|||
161870058|NCT04873934|584568543|FG001|Overall Study|Physician Decision|1|||
161870059|NCT04873934|584568542|FG000|Overall Study|Protocol deviation|2|||
161870060|NCT04873934|584568543|FG001|Overall Study|Protocol deviation|1|||
161870061|NCT04873934|584568542|FG000|Overall Study|Subject decision|1|||
161870062|NCT04873934|584568543|FG001|Overall Study|Subject decision|8|||
161870063|NCT04873934|584568542|FG000|Overall Study|Withdrew consent|0|||
161870064|NCT04873934|584568543|FG001|Overall Study|Withdrew consent|4|||
161870065|NCT04873934|584568542|FG000|Overall Study|Missing|1|||
161870066|NCT04873934|584568543|FG001|Overall Study|Missing|0|||
161870067|NCT00708461|584568544|FG000|Overall Study|Lost to Follow-up|18|||
161870068|NCT00708461|584568545|FG001|Overall Study|Lost to Follow-up|11|||
161870069|NCT00708461|584568544|FG000|Overall Study|Withdrawal by Subject|8|||
161870070|NCT00708461|584568545|FG001|Overall Study|Withdrawal by Subject|9|||
161870071|NCT00708461|584568544|FG000|Overall Study|left workforce|115|||
161870072|NCT00708461|584568545|FG001|Overall Study|left workforce|180|||
161870073|NCT03584854|584568547|FG000|Overall Study|Primary outcome not measured|1|||
161870074|NCT03584854|584568548|FG001|Overall Study|Primary outcome not measured|2|||
161870075|NCT02968173|584568549|FG000|Overall Study|Withdrawal by Subject|1|||
161870076|NCT00314327|584568553|FG000|Overall Study|Withdrawal by Subject|1|||
161870077|NCT01207687|584568554|FG000|Overall Study|Adverse Event|1|||
161870078|NCT01207687|584568554|FG000|Overall Study|Withdrawal by Subject|1|||
161870079|NCT01801865|584568555|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
161870080|NCT01801865|584568555|FG000|Overall Study|Physician Decision|7|||
161870081|NCT01500382|584568556|FG000|Washout Period|Study site went out of business|0|||
161870082|NCT01500382|584568557|FG001|Washout Period|Study site went out of business|0|||
161870083|NCT01500382|584568558|FG002|Washout Period|Study site went out of business|1|||
161870084|NCT01500382|584568559|FG003|Washout Period|Study site went out of business|0|||
161870085|NCT02134015|584568560|FG000|Overall Study|Protocol Violation|0|||
161870086|NCT02134015|584568561|FG001|Overall Study|Protocol Violation|1|||
161870087|NCT02134015|584568560|FG000|Overall Study|Death|2|||
161870088|NCT02134015|584568561|FG001|Overall Study|Death|1|||
161870089|NCT02134015|584568560|FG000|Overall Study|Reason not provided|1|||
161870090|NCT02134015|584568561|FG001|Overall Study|Reason not provided|2|||
161870091|NCT02134015|584568560|FG000|Overall Study|Clinical progression|14|||
161870092|NCT02134015|584568561|FG001|Overall Study|Clinical progression|7|||
161870093|NCT02134015|584568560|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
161870094|NCT02134015|584568561|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
161870095|NCT02134015|584568560|FG000|Overall Study|Study terminated by sponsor|2|||
161870096|NCT02134015|584568561|FG001|Overall Study|Study terminated by sponsor|3|||
161870097|NCT02134015|584568560|FG000|Overall Study|Adverse Event|9|||
161870098|NCT02134015|584568561|FG001|Overall Study|Adverse Event|10|||
161870099|NCT02134015|584568560|FG000|Overall Study|Withdrawal by Subject|3|||
161870100|NCT02134015|584568561|FG001|Overall Study|Withdrawal by Subject|7|||
161870101|NCT01515865|584570093|FG000|Part A (Open-label)|Other|3|||
161870102|NCT01515865|584570094|FG001|Part A (Open-label)|Other|0|||
161870103|NCT01515865|584570095|FG002|Part A (Open-label)|Other|0|||
161870104|NCT01515865|584570093|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
161870105|NCT01515865|584570094|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
161870106|NCT01515865|584570095|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
161870107|NCT01515865|584570093|FG000|Part B (Open-label)|Other|1|||
161870108|NCT01515865|584570094|FG001|Part B (Open-label)|Other|0|||
161870109|NCT01515865|584570095|FG002|Part B (Open-label)|Other|0|||
161870110|NCT02510664|584570100|FG000|Overall Study|Transferred Care|9|||
161870111|NCT02510664|584570101|FG001|Overall Study|Transferred Care|9|||
161870112|NCT02510664|584570102|FG002|Overall Study|Transferred Care|0|||
161870113|NCT02510664|584570100|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
161870114|NCT02510664|584570101|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
161870115|NCT02510664|584570102|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
161870116|NCT02510664|584570100|FG000|Overall Study|Time Constraints|1|||
161870117|NCT02510664|584570101|FG001|Overall Study|Time Constraints|1|||
161870118|NCT02510664|584570102|FG002|Overall Study|Time Constraints|0|||
161870119|NCT04090060|584570104|FG000|Overall Study|Lost to Follow-up|76|||
161870120|NCT04090060|584570105|FG001|Overall Study|Lost to Follow-up|77|||
161870121|NCT00507455|584570109|FG000|Overall Study|Adverse Event|3|||
161870122|NCT00507455|584570110|FG001|Overall Study|Adverse Event|3|||
161870123|NCT00507455|584570111|FG002|Overall Study|Adverse Event|6|||
161870124|NCT00507455|584570109|FG000|Overall Study|Withdrawal by Subject|2|||
161870125|NCT00507455|584570110|FG001|Overall Study|Withdrawal by Subject|1|||
161870126|NCT00507455|584570111|FG002|Overall Study|Withdrawal by Subject|2|||
161870127|NCT00507455|584570109|FG000|Overall Study|Protocol Violation|4|||
161870128|NCT00507455|584570110|FG001|Overall Study|Protocol Violation|1|||
161870129|NCT00507455|584570111|FG002|Overall Study|Protocol Violation|1|||
161870130|NCT00507455|584570109|FG000|Overall Study|Lost to Follow-up|2|||
161870131|NCT00507455|584570110|FG001|Overall Study|Lost to Follow-up|0|||
161870132|NCT00507455|584570111|FG002|Overall Study|Lost to Follow-up|2|||
161870133|NCT00507455|584570109|FG000|Overall Study|Lack of Efficacy|0|||
161870134|NCT00507455|584570110|FG001|Overall Study|Lack of Efficacy|1|||
161870135|NCT00507455|584570111|FG002|Overall Study|Lack of Efficacy|0|||
161870136|NCT00507455|584570109|FG000|Overall Study|Other - miscellaneous reason|1|||
161870137|NCT00507455|584570110|FG001|Overall Study|Other - miscellaneous reason|0|||
161870138|NCT00507455|584570111|FG002|Overall Study|Other - miscellaneous reason|1|||
161870139|NCT02176655|584570112|FG000|Overall Study|Subjects did not treat|6|||
161870140|NCT06110494|584570118|FG000|Overall Study|Protocol Violation|2|||
161870141|NCT06110494|584570119|FG001|Overall Study|Protocol Violation|0|||
161870142|NCT06110494|584570120|FG002|Overall Study|Protocol Violation|1|||
161870143|NCT06110494|584570118|FG000|Overall Study|Dixon's test for outlier analysis|1|||
161870144|NCT06110494|584570119|FG001|Overall Study|Dixon's test for outlier analysis|1|||
161870145|NCT06110494|584570120|FG002|Overall Study|Dixon's test for outlier analysis|0|||
161870146|NCT00105079|584570121|FG000|Overall Study|Adverse Event|5|||
161870147|NCT00105079|584570122|FG001|Overall Study|Adverse Event|12|||
161870148|NCT00105079|584570121|FG000|Overall Study|Death|3|||
161870149|NCT00105079|584570122|FG001|Overall Study|Death|1|||
161870150|NCT00105079|584570121|FG000|Overall Study|Lost to Follow-up|12|||
161870151|NCT00105079|584570122|FG001|Overall Study|Lost to Follow-up|12|||
161870152|NCT00105079|584570121|FG000|Overall Study|Lack of Efficacy|9|||
161870153|NCT00105079|584570122|FG001|Overall Study|Lack of Efficacy|3|||
161870154|NCT00105079|584570121|FG000|Overall Study|Refused treatment|6|||
161870155|NCT00105079|584570122|FG001|Overall Study|Refused treatment|4|||
161870156|NCT00105079|584570121|FG000|Overall Study|Violation of selection criteria at entry|0|||
161870157|NCT00105079|584570122|FG001|Overall Study|Violation of selection criteria at entry|2|||
161870158|NCT00105079|584570121|FG000|Overall Study|Protocol Violation|1|||
161870159|NCT00105079|584570122|FG001|Overall Study|Protocol Violation|0|||
161870160|NCT00105079|584570121|FG000|Overall Study|Other|3|||
161775073|NCT00138658|584219381|FG000|Overall Study|Withdrawal by Subject|5|||
161775074|NCT00320801|584219386|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
161775075|NCT00320801|584219387|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161775076|NCT00320801|584219388|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161775077|NCT00320801|584219389|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
161775078|NCT00320801|584219386|FG000|Open-label Run-in Period|Adverse Event|33|||
161775079|NCT00320801|584219387|FG001|Open-label Run-in Period|Adverse Event|0|||
161775080|NCT00320801|584219388|FG002|Open-label Run-in Period|Adverse Event|0|||
161775081|NCT00320801|584219389|FG003|Open-label Run-in Period|Adverse Event|0|||
161775082|NCT00320801|584219386|FG000|Open-label Run-in Period|Administrative|10|||
161775083|NCT00320801|584219387|FG001|Open-label Run-in Period|Administrative|0|||
161775084|NCT00320801|584219388|FG002|Open-label Run-in Period|Administrative|0|||
161775085|NCT00320801|584219389|FG003|Open-label Run-in Period|Administrative|0|||
161775086|NCT00320801|584219386|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
161775087|NCT00320801|584219387|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161775088|NCT00320801|584219388|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161775089|NCT00320801|584219389|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
161775090|NCT00320801|584219386|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
161775091|NCT00320801|584219387|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161775092|NCT00320801|584219388|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161775093|NCT00320801|584219389|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
161775094|NCT00320801|584219386|FG000|Open-label Run-in Period|Did not qualify|1|||
161775095|NCT00320801|584219387|FG001|Open-label Run-in Period|Did not qualify|0|||
161775096|NCT00320801|584219388|FG002|Open-label Run-in Period|Did not qualify|0|||
161775097|NCT00320801|584219389|FG003|Open-label Run-in Period|Did not qualify|0|||
161775098|NCT00320801|584219386|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161775099|NCT00320801|584219387|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161775100|NCT00320801|584219388|FG002|Double-blind Phase|Withdrawal by Subject|1|||
161775101|NCT00320801|584219389|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161775102|NCT00320801|584219386|FG000|Double-blind Phase|Adverse Event|0|||
161775103|NCT00320801|584219387|FG001|Double-blind Phase|Adverse Event|2|||
161775104|NCT00320801|584219388|FG002|Double-blind Phase|Adverse Event|8|||
161775105|NCT00320801|584219389|FG003|Double-blind Phase|Adverse Event|0|||
161775106|NCT00320801|584219386|FG000|Double-blind Phase|Administrative|0|||
161775107|NCT00320801|584219387|FG001|Double-blind Phase|Administrative|0|||
161775108|NCT00320801|584219388|FG002|Double-blind Phase|Administrative|4|||
161775109|NCT00320801|584219389|FG003|Double-blind Phase|Administrative|0|||
161775110|NCT00320801|584219386|FG000|Double-blind Phase|Lack of Efficacy|0|||
161775111|NCT00320801|584219387|FG001|Double-blind Phase|Lack of Efficacy|9|||
161775112|NCT00320801|584219388|FG002|Double-blind Phase|Lack of Efficacy|1|||
161775113|NCT00320801|584219389|FG003|Double-blind Phase|Lack of Efficacy|0|||
161775114|NCT00320801|584219386|FG000|Extension Phase|Withdrawal by Subject|0|||
161775115|NCT00320801|584219387|FG001|Extension Phase|Withdrawal by Subject|0|||
161775116|NCT00320801|584219388|FG002|Extension Phase|Withdrawal by Subject|0|||
161775117|NCT00320801|584219389|FG003|Extension Phase|Withdrawal by Subject|6|||
161775118|NCT00320801|584219386|FG000|Extension Phase|Adverse Event|0|||
161775119|NCT00320801|584219387|FG001|Extension Phase|Adverse Event|0|||
161775120|NCT00320801|584219388|FG002|Extension Phase|Adverse Event|0|||
161775121|NCT00320801|584219389|FG003|Extension Phase|Adverse Event|8|||
161775122|NCT00320801|584219386|FG000|Extension Phase|Administrative|0|||
161775123|NCT00320801|584219387|FG001|Extension Phase|Administrative|0|||
161775124|NCT00320801|584219388|FG002|Extension Phase|Administrative|0|||
161775125|NCT00320801|584219389|FG003|Extension Phase|Administrative|29|||
161775126|NCT00320801|584219386|FG000|Extension Phase|Lack of Efficacy|0|||
161775127|NCT00320801|584219387|FG001|Extension Phase|Lack of Efficacy|0|||
161775128|NCT00320801|584219388|FG002|Extension Phase|Lack of Efficacy|0|||
161775129|NCT00320801|584219389|FG003|Extension Phase|Lack of Efficacy|2|||
161775130|NCT00320801|584219386|FG000|Extension Phase|Lost to Follow-up|0|||
161775131|NCT00320801|584219387|FG001|Extension Phase|Lost to Follow-up|0|||
161775132|NCT00320801|584219388|FG002|Extension Phase|Lost to Follow-up|0|||
161775133|NCT00320801|584219389|FG003|Extension Phase|Lost to Follow-up|3|||
161775134|NCT00337727|584219390|FG000|Overall Study|Adverse Event|5|||
161775135|NCT00337727|584219391|FG001|Overall Study|Adverse Event|3|||
161775136|NCT00337727|584219390|FG000|Overall Study|Lost to Follow-up|5|||
161775137|NCT00337727|584219391|FG001|Overall Study|Lost to Follow-up|4|||
161775138|NCT00337727|584219390|FG000|Overall Study|Physician Decision|1|||
161775139|NCT00337727|584219391|FG001|Overall Study|Physician Decision|0|||
161775140|NCT00337727|584219390|FG000|Overall Study|Protocol Violation|4|||
161775141|NCT00337727|584219391|FG001|Overall Study|Protocol Violation|0|||
161775142|NCT00337727|584219390|FG000|Overall Study|Withdrawal by Subject|3|||
161870161|NCT00105079|584570122|FG001|Overall Study|Other|1|||
161870162|NCT01464593|584570123|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
161870163|NCT02490371|584570126|FG000|Overall Study|Lost to Follow-up|1|||
161870164|NCT02490371|584570127|FG001|Overall Study|Lost to Follow-up|1|||
161870165|NCT00656292|584570130|FG000|Overall Study|Withdrawal by Subject|2|||
161870166|NCT00656292|584570131|FG001|Overall Study|Withdrawal by Subject|3|||
161870167|NCT00656292|584570130|FG000|Overall Study|Screen failure|1|||
161870168|NCT00656292|584570131|FG001|Overall Study|Screen failure|2|||
161870169|NCT03363776|584570132|FG000|Overall Study|Progressive disease|2|||
161870170|NCT03363776|584570133|FG001|Overall Study|Progressive disease|3|||
161870171|NCT03363776|584570134|FG002|Overall Study|Progressive disease|1|||
161870172|NCT03363776|584570132|FG000|Overall Study|Study drug toxicity|0|||
161870173|NCT03363776|584570133|FG001|Overall Study|Study drug toxicity|0|||
161870174|NCT03363776|584570134|FG002|Overall Study|Study drug toxicity|1|||
161870175|NCT03363776|584570132|FG000|Overall Study|Death|1|||
161870176|NCT03363776|584570133|FG001|Overall Study|Death|0|||
161870177|NCT03363776|584570134|FG002|Overall Study|Death|0|||
161870178|NCT02993250|584570142|FG000|Overall Study|Lost to Follow-up|0|||
161870179|NCT02993250|584570143|FG001|Overall Study|Lost to Follow-up|1|||
161870180|NCT02527434|584570145|FG000|Overall Study|Lost to Follow-up|2|||
161870181|NCT02527434|584570146|FG001|Overall Study|Lost to Follow-up|2|||
161870182|NCT02527434|584570147|FG002|Overall Study|Lost to Follow-up|0|||
161870183|NCT02527434|584570145|FG000|Overall Study|Death|19|||
161870184|NCT02527434|584570146|FG001|Overall Study|Death|6|||
161870185|NCT02527434|584570147|FG002|Overall Study|Death|17|||
161870186|NCT02527434|584570145|FG000|Overall Study|Withdrawal by Subject|5|||
161870187|NCT02527434|584570146|FG001|Overall Study|Withdrawal by Subject|3|||
161870188|NCT02527434|584570147|FG002|Overall Study|Withdrawal by Subject|3|||
161870189|NCT02527434|584570145|FG000|Overall Study|Reason Not Specified|1|||
161870190|NCT02527434|584570146|FG001|Overall Study|Reason Not Specified|0|||
161870191|NCT02527434|584570147|FG002|Overall Study|Reason Not Specified|0|||
161870192|NCT02527434|584570145|FG000|Overall Study|Site closure|1|||
161870193|NCT02527434|584570146|FG001|Overall Study|Site closure|0|||
161870194|NCT02527434|584570147|FG002|Overall Study|Site closure|0|||
161870195|NCT02861807|584570148|FG000|Overall Study|Lost to Follow-up|7|||
161870196|NCT02861807|584570149|FG001|Overall Study|Lost to Follow-up|6|||
161870197|NCT02861807|584570148|FG000|Overall Study|Withdrawal by Subject|5|||
161870198|NCT02861807|584570149|FG001|Overall Study|Withdrawal by Subject|8|||
161870199|NCT00568061|584570154|FG000|Overall Study|Inclusion / exclusion criteria|5|||
161870200|NCT00568061|584570155|FG001|Overall Study|Inclusion / exclusion criteria|1|||
161870201|NCT00568061|584570154|FG000|Overall Study|Adverse Event|0|||
161870202|NCT00568061|584570155|FG001|Overall Study|Adverse Event|1|||
161870203|NCT05027451|584570156|FG000|Overall Study|Lost to Follow-up|1|||
161870204|NCT05027451|584570157|FG001|Overall Study|Lost to Follow-up|1|||
161870205|NCT00356148|584570158|FG000|Overall Study|Reoperation within 30 days|2|||
161870206|NCT00356148|584570159|FG001|Overall Study|Reoperation within 30 days|1|||
161870207|NCT02693002|584570161|FG000|Overall Study|Withdrawal by Subject|1|||
161870208|NCT02693002|584570162|FG001|Overall Study|Withdrawal by Subject|0|||
161870209|NCT00812981|584570163|FG000|Overall Study|Other|0|||
161870210|NCT00812981|584570164|FG001|Overall Study|Other|1|||
161870211|NCT04666259|584570166|FG000|Treatment Phase|Physician Decision|9|||
161870212|NCT04666259|584570167|FG001|Treatment Phase|Physician Decision|3|||
161870213|NCT04666259|584570168|FG002|Treatment Phase|Physician Decision|3|||
161870214|NCT04666259|584570166|FG000|Treatment Phase|Adverse Event|3|||
161870215|NCT04666259|584570167|FG001|Treatment Phase|Adverse Event|1|||
161870216|NCT04666259|584570168|FG002|Treatment Phase|Adverse Event|0|||
161870217|NCT04666259|584570166|FG000|Treatment Phase|Subject decision|1|||
161870218|NCT04666259|584570167|FG001|Treatment Phase|Subject decision|2|||
161870219|NCT04666259|584570168|FG002|Treatment Phase|Subject decision|0|||
161870220|NCT04666259|584570166|FG000|Treatment Phase|Progressive disease|0|||
161870221|NCT04666259|584570167|FG001|Treatment Phase|Progressive disease|1|||
161870222|NCT04666259|584570168|FG002|Treatment Phase|Progressive disease|0|||
161870223|NCT04666259|584570166|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
161870224|NCT04666259|584570167|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
161870225|NCT04666259|584570168|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
161870226|NCT04666259|584570166|FG000|Safety Follow-up Phase|Physician Decision|2|||
161870227|NCT04666259|584570167|FG001|Safety Follow-up Phase|Physician Decision|0|||
161870228|NCT04666259|584570168|FG002|Safety Follow-up Phase|Physician Decision|0|||
161870229|NCT04666259|584570166|FG000|Safety Follow-up Phase|Subject decision|1|||
161870230|NCT04666259|584570167|FG001|Safety Follow-up Phase|Subject decision|0|||
161870231|NCT04666259|584570168|FG002|Safety Follow-up Phase|Subject decision|0|||
161870232|NCT04666259|584570166|FG000|Safety Follow-up Phase|Death|0|||
161870233|NCT04666259|584570167|FG001|Safety Follow-up Phase|Death|1|||
161870234|NCT04666259|584570168|FG002|Safety Follow-up Phase|Death|0|||
161870235|NCT04178122|584570169|FG000|Overall Study|Withdrawal by Subject|1|||
161870236|NCT04178122|584570170|FG001|Overall Study|Withdrawal by Subject|1|||
161870237|NCT04178122|584570169|FG000|Overall Study|Death|2|||
161870238|NCT04178122|584570170|FG001|Overall Study|Death|0|||
161870239|NCT04178122|584570169|FG000|Overall Study|Did not complete testing|3|||
161870240|NCT04178122|584570170|FG001|Overall Study|Did not complete testing|13|||
161870241|NCT03124407|584570175|FG000|Overall Study|Lost to Follow-up|1|||
161870242|NCT03124407|584570176|FG001|Overall Study|Lost to Follow-up|0|||
161870243|NCT03124407|584570177|FG002|Overall Study|Lost to Follow-up|0|||
161775143|NCT00337727|584219391|FG001|Overall Study|Withdrawal by Subject|5|||
161775144|NCT00491322|584219393|FG000|Overall Study|Protocol Violation|1|||
161775145|NCT00491322|584219394|FG001|Overall Study|Protocol Violation|0|||
161775146|NCT00491322|584219393|FG000|Overall Study|Pregnancy|0|||
161775147|NCT00491322|584219394|FG001|Overall Study|Pregnancy|1|||
161775148|NCT06067191|584219400|FG000|Overall Study|Withdrawal by Subject|0|||
161775149|NCT06067191|584219401|FG001|Overall Study|Withdrawal by Subject|1|||
161775150|NCT01870921|584219404|FG000|Overall Study|Subject decision|80|||
161775151|NCT01870921|584219404|FG000|Overall Study|Severe non-compliance to protocol|7|||
161775152|NCT01870921|584219404|FG000|Overall Study|Subject Lost to Follow up|2|||
161775153|NCT01870921|584219404|FG000|Overall Study|Other|1|||
161775154|NCT00806416|584219405|FG000|Period 1 - Part I|Adverse Event|0|||
161775155|NCT00806416|584219406|FG001|Period 1 - Part I|Adverse Event|1|||
161775156|NCT00806416|584219407|FG002|Period 1 - Part I|Adverse Event|0|||
161775157|NCT00806416|584219408|FG003|Period 1 - Part I|Adverse Event|0|||
161775158|NCT00806416|584219405|FG000|Period 1 - Part I|Lost to Follow-up|0|||
161775159|NCT00806416|584219406|FG001|Period 1 - Part I|Lost to Follow-up|2|||
161775160|NCT00806416|584219407|FG002|Period 1 - Part I|Lost to Follow-up|0|||
161775161|NCT00806416|584219408|FG003|Period 1 - Part I|Lost to Follow-up|0|||
161775162|NCT00806416|584219405|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
161775163|NCT00806416|584219406|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
161775164|NCT00806416|584219407|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
161775165|NCT00806416|584219408|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
161775166|NCT00806416|584219405|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
161775167|NCT00806416|584219406|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
161775168|NCT00806416|584219407|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
161775169|NCT00806416|584219408|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
161775170|NCT01102972|584219414|FG000|Overall Study|Adverse Event|8|||
161775171|NCT01102972|584219415|FG001|Overall Study|Adverse Event|2|||
161775172|NCT01102972|584219414|FG000|Overall Study|Lack of Efficacy|2|||
161775173|NCT01102972|584219415|FG001|Overall Study|Lack of Efficacy|1|||
161775174|NCT01102972|584219414|FG000|Overall Study|Protocol Violation|1|||
161775175|NCT01102972|584219415|FG001|Overall Study|Protocol Violation|0|||
161775176|NCT01102972|584219414|FG000|Overall Study|Lost to Follow-up|10|||
161775177|NCT01102972|584219415|FG001|Overall Study|Lost to Follow-up|5|||
161775178|NCT01102972|584219414|FG000|Overall Study|Investigator Discretion|2|||
161775179|NCT01102972|584219415|FG001|Overall Study|Investigator Discretion|0|||
161775180|NCT01102972|584219414|FG000|Overall Study|Withdrawal by Subject|6|||
161775181|NCT01102972|584219415|FG001|Overall Study|Withdrawal by Subject|6|||
161775182|NCT03664024|584219419|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
161775183|NCT03664024|584219419|FG000|Overall Study|Lost to Follow-up|2|||
161775184|NCT03664024|584219419|FG000|Overall Study|Withdrawal by Subject|2|||
161775185|NCT03664024|584219419|FG000|Overall Study|Death|80|||
161775186|NCT01157065|584219420|FG000|Overall Study|Death|0|||
161870244|NCT03124407|584570178|FG003|Overall Study|Lost to Follow-up|0|||
161870245|NCT03124407|584570175|FG000|Overall Study|Adverse Event|0|||
161870246|NCT03124407|584570176|FG001|Overall Study|Adverse Event|0|||
161870247|NCT03124407|584570177|FG002|Overall Study|Adverse Event|1|||
161870248|NCT03124407|584570178|FG003|Overall Study|Adverse Event|0|||
161870249|NCT05343364|584570179|FG000|Overall Study|Miscellaneous|0|||
161870250|NCT05343364|584570180|FG001|Overall Study|Miscellaneous|1|||
161870251|NCT01791894|584570181|FG000|Overall Study|Adverse Event|1|||
161870252|NCT00984542|584570184|FG000|Overall Study|disease progression|19|||
161870253|NCT00984542|584570184|FG000|Overall Study|toxicity|7|||
161870254|NCT00984542|584570184|FG000|Overall Study|Death|7|||
161870255|NCT00984542|584570184|FG000|Overall Study|complicating disease|3|||
161870256|NCT00984542|584570184|FG000|Overall Study|Withdrawal by Subject|3|||
161870257|NCT00984542|584570184|FG000|Overall Study|clinical deterioration|2|||
161870258|NCT01422889|584570185|FG000|Overall Study|No Data Entered for Study Stent|9|||
161870259|NCT01276756|584570194|FG000|Overall Study|Lost to Follow-up|2|||
161870260|NCT01276756|584570195|FG001|Overall Study|Lost to Follow-up|0|||
161870261|NCT01276756|584570194|FG000|Overall Study|Adverse Event|3|||
161870262|NCT01276756|584570195|FG001|Overall Study|Adverse Event|2|||
161870263|NCT02589639|584570196|FG000|Overall Study|Lost to Follow-up|1|||
161870264|NCT02589639|584570197|FG001|Overall Study|Lost to Follow-up|0|||
161870265|NCT02589639|584570198|FG002|Overall Study|Lost to Follow-up|0|||
161870266|NCT02589639|584570196|FG000|Overall Study|Protocol Violation|1|||
161870267|NCT02589639|584570197|FG001|Overall Study|Protocol Violation|0|||
161870268|NCT02589639|584570198|FG002|Overall Study|Protocol Violation|0|||
161870269|NCT02589639|584570196|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
161870270|NCT02589639|584570197|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
161870271|NCT02589639|584570198|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
161870272|NCT02589639|584570196|FG000|Overall Study|Adverse Event|4|||
161870273|NCT02589639|584570197|FG001|Overall Study|Adverse Event|5|||
161870274|NCT02589639|584570198|FG002|Overall Study|Adverse Event|3|||
161870275|NCT02589639|584570196|FG000|Overall Study|Other reason than specified above|1|||
161870276|NCT02589639|584570197|FG001|Overall Study|Other reason than specified above|2|||
161870277|NCT02589639|584570198|FG002|Overall Study|Other reason than specified above|1|||
161870278|NCT02589639|584570196|FG000|Overall Study|Not Treated|0|||
161870279|NCT02589639|584570197|FG001|Overall Study|Not Treated|3|||
161870280|NCT02589639|584570198|FG002|Overall Study|Not Treated|0|||
161870281|NCT02630251|584570201|FG000|Overall Study|Physician Decision|0|||
161870282|NCT02630251|584570202|FG001|Overall Study|Physician Decision|0|||
161870283|NCT02630251|584570203|FG002|Overall Study|Physician Decision|1|||
161870284|NCT02630251|584570204|FG003|Overall Study|Physician Decision|0|||
161870285|NCT00153179|584570210|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
161870286|NCT00153179|584570211|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
161870287|NCT00153179|584570212|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
161870288|NCT00153179|584570213|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
161870289|NCT03517540|584570214|FG000|Overall Study|Protocol Violation|2|||
161870290|NCT03517540|584570215|FG001|Overall Study|Protocol Violation|0|||
161870291|NCT03517540|584570216|FG002|Overall Study|Protocol Violation|0|||
161870292|NCT03517540|584570217|FG003|Overall Study|Protocol Violation|1|||
161870293|NCT03517540|584570214|FG000|Overall Study|Adverse Event|9|||
161870294|NCT03517540|584570215|FG001|Overall Study|Adverse Event|3|||
161870295|NCT03517540|584570216|FG002|Overall Study|Adverse Event|8|||
161870296|NCT03517540|584570217|FG003|Overall Study|Adverse Event|1|||
161870297|NCT03517540|584570214|FG000|Overall Study|Withdrawal by Subject|3|||
161870298|NCT03517540|584570215|FG001|Overall Study|Withdrawal by Subject|4|||
161870299|NCT03517540|584570216|FG002|Overall Study|Withdrawal by Subject|1|||
161870300|NCT03517540|584570217|FG003|Overall Study|Withdrawal by Subject|3|||
161870301|NCT05763875|584570226|FG000|Overall Study|Subject decision|5|||
161870302|NCT05763875|584570227|FG001|Overall Study|Subject decision|2|||
161870303|NCT05763875|584570228|FG002|Overall Study|Subject decision|1|||
161870304|NCT05763875|584570226|FG000|Overall Study|Lost to Follow-up|4|||
161870305|NCT05763875|584570227|FG001|Overall Study|Lost to Follow-up|1|||
161870306|NCT05763875|584570228|FG002|Overall Study|Lost to Follow-up|2|||
161870307|NCT05763875|584570226|FG000|Overall Study|Adverse Event|1|||
161870308|NCT05763875|584570227|FG001|Overall Study|Adverse Event|0|||
161870309|NCT05763875|584570228|FG002|Overall Study|Adverse Event|0|||
161870310|NCT01777282|584570229|FG000|Overall Study|Persistent Hyperglycemia|0|||
161870311|NCT01777282|584570230|FG001|Overall Study|Persistent Hyperglycemia|0|||
161870312|NCT01777282|584570231|FG002|Overall Study|Persistent Hyperglycemia|1|||
161870313|NCT01777282|584570232|FG003|Overall Study|Persistent Hyperglycemia|0|||
161870314|NCT01777282|584570233|FG004|Overall Study|Persistent Hyperglycemia|0|||
161870315|NCT01777282|584570229|FG000|Overall Study|New Antidiabetic Medication|0|||
161870316|NCT01777282|584570230|FG001|Overall Study|New Antidiabetic Medication|0|||
161870317|NCT01777282|584570231|FG002|Overall Study|New Antidiabetic Medication|1|||
161870318|NCT01777282|584570232|FG003|Overall Study|New Antidiabetic Medication|0|||
161870319|NCT01777282|584570233|FG004|Overall Study|New Antidiabetic Medication|0|||
161870320|NCT01777282|584570229|FG000|Overall Study|Adverse Event|4|||
161870321|NCT01777282|584570230|FG001|Overall Study|Adverse Event|4|||
161870322|NCT01777282|584570231|FG002|Overall Study|Adverse Event|2|||
161870323|NCT01777282|584570232|FG003|Overall Study|Adverse Event|1|||
161870324|NCT01777282|584570233|FG004|Overall Study|Adverse Event|3|||
161870325|NCT01777282|584570229|FG000|Overall Study|Withdrawal by Subject|4|||
161870326|NCT01777282|584570230|FG001|Overall Study|Withdrawal by Subject|0|||
161870327|NCT01777282|584570231|FG002|Overall Study|Withdrawal by Subject|0|||
161870328|NCT01777282|584570232|FG003|Overall Study|Withdrawal by Subject|1|||
161870329|NCT01777282|584570233|FG004|Overall Study|Withdrawal by Subject|2|||
161870330|NCT01777282|584570229|FG000|Overall Study|Protocol Violation|2|||
161870331|NCT01777282|584570230|FG001|Overall Study|Protocol Violation|0|||
161870332|NCT01777282|584570231|FG002|Overall Study|Protocol Violation|1|||
161870333|NCT01777282|584570232|FG003|Overall Study|Protocol Violation|0|||
161870334|NCT01777282|584570233|FG004|Overall Study|Protocol Violation|2|||
161870335|NCT01777282|584570229|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
161870336|NCT01777282|584570230|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161870337|NCT01777282|584570231|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
161870338|NCT01777282|584570232|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161870339|NCT01777282|584570233|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161870340|NCT04015518|584570234|FG000|Overall Study|Adverse Event|6|||
161870341|NCT04015518|584570235|FG001|Overall Study|Adverse Event|1|||
161870342|NCT04015518|584570236|FG002|Overall Study|Adverse Event|1|||
161870343|NCT04015518|584570237|FG003|Overall Study|Adverse Event|3|||
161870344|NCT04015518|584570238|FG004|Overall Study|Adverse Event|3|||
161870345|NCT04015518|584570234|FG000|Overall Study|Lack of Efficacy|1|||
161870346|NCT04015518|584570235|FG001|Overall Study|Lack of Efficacy|0|||
161870347|NCT04015518|584570236|FG002|Overall Study|Lack of Efficacy|1|||
161870348|NCT04015518|584570237|FG003|Overall Study|Lack of Efficacy|0|||
161870349|NCT04015518|584570238|FG004|Overall Study|Lack of Efficacy|4|||
161870350|NCT04015518|584570234|FG000|Overall Study|Lost to Follow-up|0|||
161870351|NCT04015518|584570235|FG001|Overall Study|Lost to Follow-up|0|||
161870352|NCT04015518|584570236|FG002|Overall Study|Lost to Follow-up|0|||
161870353|NCT04015518|584570237|FG003|Overall Study|Lost to Follow-up|0|||
161870354|NCT04015518|584570238|FG004|Overall Study|Lost to Follow-up|1|||
161870355|NCT04015518|584570234|FG000|Overall Study|Withdrawal by Subject|0|||
161870356|NCT04015518|584570235|FG001|Overall Study|Withdrawal by Subject|1|||
161870357|NCT04015518|584570236|FG002|Overall Study|Withdrawal by Subject|0|||
161870358|NCT04015518|584570237|FG003|Overall Study|Withdrawal by Subject|1|||
161870359|NCT04015518|584570238|FG004|Overall Study|Withdrawal by Subject|1|||
161870360|NCT04015518|584570234|FG000|Overall Study|Patient did not come for consecutive visits|0|||
161870361|NCT04015518|584570235|FG001|Overall Study|Patient did not come for consecutive visits|1|||
161870362|NCT04015518|584570236|FG002|Overall Study|Patient did not come for consecutive visits|0|||
161870363|NCT04015518|584570237|FG003|Overall Study|Patient did not come for consecutive visits|0|||
161870364|NCT04015518|584570238|FG004|Overall Study|Patient did not come for consecutive visits|0|||
161870365|NCT04015518|584570234|FG000|Overall Study|not willing to travel due to Covid-19|0|||
161870366|NCT04015518|584570235|FG001|Overall Study|not willing to travel due to Covid-19|0|||
161870367|NCT04015518|584570236|FG002|Overall Study|not willing to travel due to Covid-19|1|||
161870368|NCT04015518|584570237|FG003|Overall Study|not willing to travel due to Covid-19|0|||
161870369|NCT04015518|584570238|FG004|Overall Study|not willing to travel due to Covid-19|0|||
161870370|NCT04015518|584570234|FG000|Overall Study|Patient wants to discontinue treatment|0|||
161870371|NCT04015518|584570235|FG001|Overall Study|Patient wants to discontinue treatment|0|||
161870372|NCT04015518|584570236|FG002|Overall Study|Patient wants to discontinue treatment|0|||
161870373|NCT04015518|584570237|FG003|Overall Study|Patient wants to discontinue treatment|1|||
161870374|NCT04015518|584570238|FG004|Overall Study|Patient wants to discontinue treatment|0|||
161870375|NCT04015518|584570234|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
161870376|NCT04015518|584570235|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
161870377|NCT04015518|584570236|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
161870378|NCT04015518|584570237|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
161870379|NCT04015518|584570238|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
161870380|NCT04015518|584570234|FG000|Overall Study|Pregnancy|0|||
161870381|NCT04015518|584570235|FG001|Overall Study|Pregnancy|0|||
161870382|NCT04015518|584570236|FG002|Overall Study|Pregnancy|0|||
161870383|NCT04015518|584570237|FG003|Overall Study|Pregnancy|0|||
161870384|NCT04015518|584570238|FG004|Overall Study|Pregnancy|1|||
161870385|NCT04015518|584570234|FG000|Overall Study|Personal reasons|1|||
161870386|NCT04015518|584570235|FG001|Overall Study|Personal reasons|0|||
161870387|NCT04015518|584570236|FG002|Overall Study|Personal reasons|0|||
161870388|NCT04015518|584570237|FG003|Overall Study|Personal reasons|0|||
161870389|NCT04015518|584570238|FG004|Overall Study|Personal reasons|1|||
161870390|NCT04015518|584570234|FG000|Overall Study|Withdrew consent|1|||
161870391|NCT04015518|584570235|FG001|Overall Study|Withdrew consent|0|||
161870392|NCT04015518|584570236|FG002|Overall Study|Withdrew consent|0|||
161870393|NCT04015518|584570237|FG003|Overall Study|Withdrew consent|0|||
161870394|NCT04015518|584570238|FG004|Overall Study|Withdrew consent|0|||
161870395|NCT04015518|584570234|FG000|Overall Study|Prostate carcinoma|1|||
161775187|NCT01157065|584219421|FG001|Overall Study|Death|1|||
161775188|NCT03426995|584219424|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775189|NCT03426995|584219425|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775190|NCT03426995|584219426|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
161775191|NCT03426995|584219427|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775192|NCT03426995|584219428|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775193|NCT03426995|584219429|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775194|NCT03426995|584219430|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775195|NCT03426995|584219431|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775196|NCT03426995|584219432|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775197|NCT03426995|584219433|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775198|NCT03426995|584219434|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775199|NCT03426995|584219435|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775200|NCT03426995|584219436|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775201|NCT03426995|584219437|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775202|NCT03426995|584219438|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775203|NCT03426995|584219439|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775204|NCT03426995|584219440|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775205|NCT03426995|584219441|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775206|NCT03426995|584219442|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775207|NCT03426995|584219424|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775208|NCT03426995|584219425|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775209|NCT03426995|584219426|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775210|NCT03426995|584219427|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775211|NCT03426995|584219428|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775212|NCT03426995|584219429|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
161775213|NCT03426995|584219430|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775214|NCT03426995|584219431|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775215|NCT03426995|584219432|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775216|NCT03426995|584219433|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775217|NCT03426995|584219434|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775218|NCT03426995|584219435|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775219|NCT03426995|584219436|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775220|NCT03426995|584219437|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775221|NCT03426995|584219438|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775222|NCT03426995|584219439|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775223|NCT03426995|584219440|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775224|NCT03426995|584219441|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775225|NCT03426995|584219442|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775226|NCT03426995|584219424|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775227|NCT03426995|584219425|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775228|NCT03426995|584219426|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775229|NCT03426995|584219427|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775230|NCT03426995|584219428|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
161775231|NCT03426995|584219429|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
161775232|NCT03426995|584219430|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775233|NCT03426995|584219431|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775234|NCT03426995|584219432|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775235|NCT03426995|584219433|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775236|NCT03426995|584219434|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775237|NCT03426995|584219435|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775238|NCT03426995|584219436|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775239|NCT03426995|584219437|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775240|NCT03426995|584219438|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775241|NCT03426995|584219439|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775242|NCT03426995|584219440|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775243|NCT03426995|584219441|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775244|NCT03426995|584219442|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775245|NCT03426995|584219424|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775246|NCT03426995|584219425|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775247|NCT03426995|584219426|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775248|NCT03426995|584219427|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775249|NCT03426995|584219428|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775250|NCT03426995|584219429|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161870396|NCT04015518|584570235|FG001|Overall Study|Prostate carcinoma|0|||
161775251|NCT03426995|584219430|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775252|NCT03426995|584219431|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775253|NCT03426995|584219432|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775254|NCT03426995|584219433|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775255|NCT03426995|584219434|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
161775256|NCT03426995|584219435|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775257|NCT03426995|584219436|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775258|NCT03426995|584219437|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775259|NCT03426995|584219438|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775260|NCT03426995|584219439|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775261|NCT03426995|584219440|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775262|NCT03426995|584219441|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775263|NCT03426995|584219442|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775264|NCT03426995|584219424|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775265|NCT03426995|584219425|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775266|NCT03426995|584219426|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775267|NCT03426995|584219427|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775268|NCT03426995|584219428|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775269|NCT03426995|584219429|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775270|NCT03426995|584219430|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775271|NCT03426995|584219431|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
161775272|NCT03426995|584219432|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775273|NCT03426995|584219433|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775274|NCT03426995|584219434|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775275|NCT03426995|584219435|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775276|NCT03426995|584219436|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775277|NCT03426995|584219437|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775278|NCT03426995|584219438|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775279|NCT03426995|584219439|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775280|NCT03426995|584219440|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775281|NCT03426995|584219441|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775282|NCT03426995|584219442|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775283|NCT03426995|584219424|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775284|NCT03426995|584219425|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775285|NCT03426995|584219426|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775286|NCT03426995|584219427|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775287|NCT03426995|584219428|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775288|NCT03426995|584219429|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775289|NCT03426995|584219430|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775290|NCT03426995|584219431|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775291|NCT03426995|584219432|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775292|NCT03426995|584219433|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775293|NCT03426995|584219434|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775294|NCT03426995|584219435|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775295|NCT03426995|584219436|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775296|NCT03426995|584219437|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775297|NCT03426995|584219438|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
161775298|NCT03426995|584219439|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
161775299|NCT03426995|584219440|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775300|NCT03426995|584219441|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775301|NCT03426995|584219442|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775302|NCT03426995|584219424|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775303|NCT03426995|584219425|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775304|NCT03426995|584219426|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775305|NCT03426995|584219427|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775306|NCT03426995|584219428|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775307|NCT03426995|584219429|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775308|NCT03426995|584219430|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775309|NCT03426995|584219431|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775310|NCT03426995|584219432|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775311|NCT03426995|584219433|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775312|NCT03426995|584219434|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775313|NCT03426995|584219435|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775314|NCT03426995|584219436|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775315|NCT03426995|584219437|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161870397|NCT04015518|584570236|FG002|Overall Study|Prostate carcinoma|0|||
161775316|NCT03426995|584219438|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
161870398|NCT04015518|584570237|FG003|Overall Study|Prostate carcinoma|0|||
161870399|NCT04015518|584570238|FG004|Overall Study|Prostate carcinoma|0|||
161870400|NCT04015518|584570234|FG000|Overall Study|Could not keep appointments due to work|1|||
161870401|NCT04015518|584570235|FG001|Overall Study|Could not keep appointments due to work|0|||
161870402|NCT04015518|584570236|FG002|Overall Study|Could not keep appointments due to work|0|||
161870403|NCT04015518|584570237|FG003|Overall Study|Could not keep appointments due to work|0|||
161870404|NCT04015518|584570238|FG004|Overall Study|Could not keep appointments due to work|0|||
161870405|NCT00550745|584570239|FG000|Overall Study|Death|20|||
161870406|NCT00550745|584570240|FG001|Overall Study|Death|16|||
161870407|NCT00550745|584570239|FG000|Overall Study|Lost to Follow-up|45|||
161870408|NCT00550745|584570240|FG001|Overall Study|Lost to Follow-up|30|||
161870409|NCT00550745|584570239|FG000|Overall Study|Physician Decision|0|||
161870410|NCT00550745|584570240|FG001|Overall Study|Physician Decision|2|||
161870411|NCT00550745|584570239|FG000|Overall Study|Protocol Violation|4|||
161870412|NCT00550745|584570240|FG001|Overall Study|Protocol Violation|2|||
161870413|NCT00550745|584570239|FG000|Overall Study|Withdrawal by Subject|17|||
161870414|NCT00550745|584570240|FG001|Overall Study|Withdrawal by Subject|10|||
161870415|NCT00550745|584570239|FG000|Overall Study|Screen failure|1|||
161870416|NCT00550745|584570240|FG001|Overall Study|Screen failure|0|||
161870417|NCT00764660|584570241|FG000|Overall Study|Adverse Event|6|||
161870418|NCT00764660|584570242|FG001|Overall Study|Adverse Event|3|||
161870419|NCT00764660|584570241|FG000|Overall Study|Lost to Follow-up|3|||
161870420|NCT00764660|584570242|FG001|Overall Study|Lost to Follow-up|4|||
161870421|NCT00764660|584570241|FG000|Overall Study|Withdrawal by Subject|7|||
161870422|NCT00764660|584570242|FG001|Overall Study|Withdrawal by Subject|3|||
161870423|NCT00764660|584570241|FG000|Overall Study|Noncompliance With Protocol|5|||
161870424|NCT00764660|584570242|FG001|Overall Study|Noncompliance With Protocol|1|||
161870425|NCT00764660|584570241|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
161870426|NCT00764660|584570242|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161870427|NCT01131455|584570243|FG000|Overall Study|Death of PI|6|||
161870428|NCT01131455|584570244|FG001|Overall Study|Death of PI|4|||
161870429|NCT01131455|584570245|FG002|Overall Study|Death of PI|0|||
161870430|NCT02186873|584571635|FG000|Overall Study|Adverse Event|1|||
161870431|NCT02186873|584571636|FG001|Overall Study|Adverse Event|3|||
161870432|NCT02186873|584571635|FG000|Overall Study|Lack of Efficacy|0|||
161870433|NCT02186873|584571636|FG001|Overall Study|Lack of Efficacy|1|||
161870434|NCT02186873|584571635|FG000|Overall Study|Lost to Follow-up|1|||
161870435|NCT02186873|584571636|FG001|Overall Study|Lost to Follow-up|2|||
161870436|NCT02186873|584571635|FG000|Overall Study|Withdrawal by Subject|7|||
161870437|NCT02186873|584571636|FG001|Overall Study|Withdrawal by Subject|2|||
161870438|NCT03694002|584571637|FG000|Overall Study|Progression|4|||
161870439|NCT03694002|584571638|FG001|Overall Study|Progression|2|||
161870440|NCT03694002|584571637|FG000|Overall Study|Adverse Event|2|||
161870441|NCT03694002|584571638|FG001|Overall Study|Adverse Event|0|||
161870442|NCT03694002|584571637|FG000|Overall Study|Other not protocol specified|1|||
161870443|NCT03694002|584571638|FG001|Overall Study|Other not protocol specified|0|||
161870444|NCT03694002|584571637|FG000|Overall Study|Ineligible|0|||
161870445|NCT03694002|584571638|FG001|Overall Study|Ineligible|1|||
161870446|NCT03694002|584571637|FG000|Overall Study|Withdrew consent before starting treatment|0|||
161870447|NCT03694002|584571638|FG001|Overall Study|Withdrew consent before starting treatment|3|||
161870448|NCT01760655|584571639|FG000|Overall Study|Death|18|||
161870449|NCT01760655|584571639|FG000|Overall Study|Physician Decision|1|||
161870450|NCT00068393|584571644|FG000|Overall Study|Adverse Event|2|||
161870451|NCT00068393|584571644|FG000|Overall Study|Death|3|||
161870452|NCT00068393|584571644|FG000|Overall Study|Withdrawal by Subject|3|||
161870453|NCT00068393|584571644|FG000|Overall Study|Alternative treatment|1|||
161870454|NCT00068393|584571644|FG000|Overall Study|Quality of life worsening|1|||
161870455|NCT01399047|584571645|FG000|Overall Study|Withdrawal by Subject|0|||
161870456|NCT01399047|584571646|FG001|Overall Study|Withdrawal by Subject|1|||
161870457|NCT03300505|584571652|FG000|Overall Study|Death|0|||
161870458|NCT03300505|584571653|FG001|Overall Study|Death|1|||
161870459|NCT03300505|584571654|FG002|Overall Study|Death|0|||
161870460|NCT03300505|584571652|FG000|Overall Study|Withdrawal by Subject|0|||
161870461|NCT03300505|584571653|FG001|Overall Study|Withdrawal by Subject|1|||
161870462|NCT03300505|584571654|FG002|Overall Study|Withdrawal by Subject|1|||
161870463|NCT03300505|584571652|FG000|Overall Study|Sponsor Termination|0|||
161870464|NCT03300505|584571653|FG001|Overall Study|Sponsor Termination|1|||
161870465|NCT03300505|584571654|FG002|Overall Study|Sponsor Termination|0|||
161870466|NCT03300505|584571652|FG000|Overall Study|Adverse Event|0|||
161870467|NCT03300505|584571653|FG001|Overall Study|Adverse Event|0|||
161870468|NCT03300505|584571654|FG002|Overall Study|Adverse Event|2|||
161870469|NCT01108341|584571658|FG000|Overall Study|Death|2|||
161870470|NCT01108341|584571658|FG000|Overall Study|Withdrawal by Subject|1|||
161870471|NCT01108341|584571658|FG000|Overall Study|Lost to Follow-up|1|||
161870472|NCT01108341|584571658|FG000|Overall Study|Other|1|||
161870473|NCT00386360|584571659|FG000|Overall Study|Adverse Event|4|||
161870474|NCT00386360|584571660|FG001|Overall Study|Adverse Event|2|||
161870475|NCT00386360|584571659|FG000|Overall Study|Physician Decision|2|||
161870476|NCT00386360|584571660|FG001|Overall Study|Physician Decision|2|||
161870477|NCT00386360|584571659|FG000|Overall Study|Lost to Follow-up|0|||
161870478|NCT00386360|584571660|FG001|Overall Study|Lost to Follow-up|2|||
161870479|NCT00386360|584571659|FG000|Overall Study|Protocol Violation|0|||
161870480|NCT00386360|584571660|FG001|Overall Study|Protocol Violation|3|||
161870481|NCT00386360|584571659|FG000|Overall Study|Withdrawal by Subject|3|||
161870482|NCT00386360|584571660|FG001|Overall Study|Withdrawal by Subject|6|||
161870483|NCT00386360|584571659|FG000|Overall Study|Did not take any study medication|0|||
161870484|NCT00386360|584571660|FG001|Overall Study|Did not take any study medication|2|||
161870485|NCT01073605|584571665|FG000|Overall Study|Ongoing at Cutoff Date|1|||
161870486|NCT01073605|584571666|FG001|Overall Study|Ongoing at Cutoff Date|1|||
161870487|NCT01073605|584571667|FG002|Overall Study|Ongoing at Cutoff Date|0|||
161870488|NCT01073605|584571665|FG000|Overall Study|Adverse Event|2|||
161870489|NCT01073605|584571666|FG001|Overall Study|Adverse Event|1|||
161870490|NCT01073605|584571667|FG002|Overall Study|Adverse Event|0|||
161870491|NCT01073605|584571665|FG000|Overall Study|Lost to Follow-up|3|||
161870492|NCT01073605|584571666|FG001|Overall Study|Lost to Follow-up|4|||
161870493|NCT01073605|584571667|FG002|Overall Study|Lost to Follow-up|9|||
161870494|NCT01073605|584571665|FG000|Overall Study|Other|25|||
161870495|NCT01073605|584571666|FG001|Overall Study|Other|21|||
161870496|NCT01073605|584571667|FG002|Overall Study|Other|29|||
161870497|NCT01073605|584571665|FG000|Overall Study|Withdrawal by Subject|31|||
161870498|NCT01073605|584571666|FG001|Overall Study|Withdrawal by Subject|39|||
161870499|NCT01073605|584571667|FG002|Overall Study|Withdrawal by Subject|22|||
161870500|NCT01073605|584571665|FG000|Overall Study|Randomized But Not Treated|0|||
161870501|NCT01073605|584571666|FG001|Overall Study|Randomized But Not Treated|1|||
161870502|NCT01073605|584571667|FG002|Overall Study|Randomized But Not Treated|1|||
161870503|NCT03491462|584571668|FG000|Overall Study|Lost to Follow-up|2|||
161870504|NCT03491462|584571669|FG001|Overall Study|Lost to Follow-up|0|||
161870505|NCT03491462|584571668|FG000|Overall Study|Adverse Event|11|||
161870506|NCT03491462|584571669|FG001|Overall Study|Adverse Event|1|||
161870507|NCT03491462|584571668|FG000|Overall Study|Physician Decision|3|||
161870508|NCT03491462|584571669|FG001|Overall Study|Physician Decision|0|||
161870509|NCT03491462|584571668|FG000|Overall Study|Withdrawal by Subject|22|||
161870510|NCT03491462|584571669|FG001|Overall Study|Withdrawal by Subject|15|||
161870511|NCT03018080|584571670|FG000|Overall Study|Death|12|||
161870512|NCT03018080|584571671|FG001|Overall Study|Death|19|||
161870513|NCT00740792|584571672|FG000|Overall Study|Adverse Event|3|||
161870514|NCT00740792|584571673|FG001|Overall Study|Adverse Event|1|||
161870515|NCT00740792|584571674|FG002|Overall Study|Adverse Event|1|||
161870516|NCT00740792|584571675|FG003|Overall Study|Adverse Event|3|||
161870517|NCT00740792|584571672|FG000|Overall Study|Lack of Efficacy|1|||
161870518|NCT00740792|584571673|FG001|Overall Study|Lack of Efficacy|1|||
161870519|NCT00740792|584571674|FG002|Overall Study|Lack of Efficacy|0|||
161870520|NCT00740792|584571675|FG003|Overall Study|Lack of Efficacy|3|||
161870521|NCT00740792|584571672|FG000|Overall Study|Lost to Follow-up|2|||
161870522|NCT00740792|584571673|FG001|Overall Study|Lost to Follow-up|1|||
161870523|NCT00740792|584571674|FG002|Overall Study|Lost to Follow-up|0|||
161870524|NCT00740792|584571675|FG003|Overall Study|Lost to Follow-up|0|||
161870525|NCT00740792|584571672|FG000|Overall Study|Protocol Violation|0|||
161870526|NCT00740792|584571673|FG001|Overall Study|Protocol Violation|1|||
161870527|NCT00740792|584571674|FG002|Overall Study|Protocol Violation|0|||
161870528|NCT00740792|584571675|FG003|Overall Study|Protocol Violation|2|||
161870529|NCT00740792|584571672|FG000|Overall Study|Withdrawal by Subject|1|||
161870530|NCT00740792|584571673|FG001|Overall Study|Withdrawal by Subject|1|||
161870531|NCT00740792|584571674|FG002|Overall Study|Withdrawal by Subject|0|||
161870532|NCT00740792|584571675|FG003|Overall Study|Withdrawal by Subject|0|||
161870533|NCT00740792|584571672|FG000|Overall Study|administrative|3|||
161870534|NCT00740792|584571673|FG001|Overall Study|administrative|3|||
161870535|NCT00740792|584571674|FG002|Overall Study|administrative|8|||
161870536|NCT00740792|584571675|FG003|Overall Study|administrative|2|||
161870537|NCT00026494|584571678|FG000|Overall Study|Withdrawal by Subject|1|||
161870538|NCT00026494|584571679|FG001|Overall Study|Withdrawal by Subject|0|||
161870539|NCT00026494|584571680|FG002|Overall Study|Withdrawal by Subject|1|||
161870540|NCT00026494|584571681|FG003|Overall Study|Withdrawal by Subject|0|||
161870541|NCT00026494|584571678|FG000|Overall Study|Patient non-compliance|1|||
161870542|NCT00026494|584571679|FG001|Overall Study|Patient non-compliance|0|||
161870543|NCT00026494|584571680|FG002|Overall Study|Patient non-compliance|0|||
161870544|NCT00026494|584571681|FG003|Overall Study|Patient non-compliance|0|||
161870545|NCT00026494|584571678|FG000|Overall Study|Patient not treated|0|||
161870546|NCT00026494|584571679|FG001|Overall Study|Patient not treated|0|||
161870547|NCT00026494|584571680|FG002|Overall Study|Patient not treated|2|||
161870548|NCT00026494|584571681|FG003|Overall Study|Patient not treated|0|||
161870549|NCT00026494|584571678|FG000|Overall Study|Clinical progression|0|||
161870550|NCT00026494|584571679|FG001|Overall Study|Clinical progression|0|||
161870551|NCT00026494|584571680|FG002|Overall Study|Clinical progression|3|||
161870552|NCT00026494|584571681|FG003|Overall Study|Clinical progression|0|||
161870553|NCT01455597|584571682|FG000|Overall Study|Adverse Event|7|||
161870554|NCT01455597|584571683|FG001|Overall Study|Adverse Event|0|||
161870555|NCT01455597|584571684|FG002|Overall Study|Adverse Event|5|||
161870556|NCT01455597|584571685|FG003|Overall Study|Adverse Event|1|||
161870557|NCT01455597|584571682|FG000|Overall Study|Lack of Efficacy|0|||
161870558|NCT01455597|584571683|FG001|Overall Study|Lack of Efficacy|1|||
161870559|NCT01455597|584571684|FG002|Overall Study|Lack of Efficacy|2|||
161870560|NCT01455597|584571685|FG003|Overall Study|Lack of Efficacy|0|||
161870561|NCT01455597|584571682|FG000|Overall Study|Lost to Follow-up|3|||
161870562|NCT01455597|584571683|FG001|Overall Study|Lost to Follow-up|0|||
161870563|NCT01455597|584571684|FG002|Overall Study|Lost to Follow-up|2|||
161870564|NCT01455597|584571685|FG003|Overall Study|Lost to Follow-up|1|||
161870565|NCT01455597|584571682|FG000|Overall Study|Withdrew Consent|6|||
161870566|NCT01455597|584571683|FG001|Overall Study|Withdrew Consent|5|||
161870567|NCT01455597|584571684|FG002|Overall Study|Withdrew Consent|8|||
161870568|NCT01455597|584571685|FG003|Overall Study|Withdrew Consent|5|||
161870569|NCT01455597|584571682|FG000|Overall Study|Reason not Specified|1|||
161870570|NCT01455597|584571683|FG001|Overall Study|Reason not Specified|2|||
161870571|NCT01455597|584571684|FG002|Overall Study|Reason not Specified|3|||
161870572|NCT01455597|584571685|FG003|Overall Study|Reason not Specified|3|||
161870573|NCT03412734|584571689|FG000|Overall Study|Incorrect labeling of samples|2|||
161870574|NCT03412734|584571690|FG001|Overall Study|Incorrect labeling of samples|0|||
161870575|NCT03412734|584571689|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
161870576|NCT03412734|584571690|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
161870577|NCT00423332|584571691|FG000|Overall Study|Adverse Event|6|||
161870578|NCT00423332|584571692|FG001|Overall Study|Adverse Event|2|||
161870579|NCT00423332|584571691|FG000|Overall Study|Withdrawal by Subject|1|||
161870580|NCT00423332|584571692|FG001|Overall Study|Withdrawal by Subject|0|||
161870581|NCT00423332|584571691|FG000|Overall Study|Condition under investigation worsened|1|||
161870582|NCT00423332|584571692|FG001|Overall Study|Condition under investigation worsened|1|||
161870583|NCT00423332|584571691|FG000|Overall Study|Progressive at Week 6|0|||
161870584|NCT00423332|584571692|FG001|Overall Study|Progressive at Week 6|1|||
161870585|NCT00423332|584571691|FG000|Overall Study|Unblinded before 12 weeks|1|||
161870586|NCT00423332|584571692|FG001|Overall Study|Unblinded before 12 weeks|3|||
161870587|NCT00179660|584571701|FG000|Overall Study|Adverse Event|7|||
161870588|NCT00179660|584571701|FG000|Overall Study|Lack of therapeutic effect|28|||
161870589|NCT00179660|584571701|FG000|Overall Study|Withdrawal by Subject|2|||
161870590|NCT00179660|584571701|FG000|Overall Study|Lost to Follow-up|1|||
161870591|NCT00179660|584571701|FG000|Overall Study|Death|3|||
161870592|NCT00179660|584571701|FG000|Overall Study|Other - Unspecified|9|||
161870593|NCT03777436|584571702|FG000|Placebo-controlled Phase|Adverse Event|8|||
161870594|NCT03777436|584571703|FG001|Placebo-controlled Phase|Adverse Event|10|||
161870595|NCT03777436|584571704|FG002|Placebo-controlled Phase|Adverse Event|0|||
161870596|NCT03777436|584571702|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
161870597|NCT03777436|584571703|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
161870598|NCT03777436|584571704|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161870599|NCT03777436|584571702|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
161870600|NCT03777436|584571703|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
161870601|NCT03777436|584571704|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161870602|NCT03777436|584571702|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
161870603|NCT03777436|584571703|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
161870604|NCT03777436|584571704|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
161870605|NCT03777436|584571702|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
161870606|NCT03777436|584571703|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
161870607|NCT03777436|584571704|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161870608|NCT03777436|584571702|FG000|Placebo-controlled Phase|Physician Decision|0|||
161870609|NCT03777436|584571703|FG001|Placebo-controlled Phase|Physician Decision|1|||
161870610|NCT03777436|584571704|FG002|Placebo-controlled Phase|Physician Decision|0|||
161870611|NCT03777436|584571702|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
161870612|NCT03777436|584571703|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
161870613|NCT03777436|584571704|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
161870614|NCT03777436|584571702|FG000|Apremilast Extension Phase|Adverse Event|0|||
161870615|NCT03777436|584571703|FG001|Apremilast Extension Phase|Adverse Event|0|||
161870616|NCT03777436|584571704|FG002|Apremilast Extension Phase|Adverse Event|6|||
161870617|NCT03777436|584571702|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161870618|NCT03777436|584571703|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161870619|NCT03777436|584571704|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
161870620|NCT03777436|584571702|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161870621|NCT03777436|584571703|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161870622|NCT03777436|584571704|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
161870623|NCT03777436|584571702|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161870624|NCT03777436|584571703|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161870625|NCT03777436|584571704|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
161870626|NCT03777436|584571702|FG000|Apremilast Extension Phase|Miscellaneous|0|||
161870627|NCT03777436|584571703|FG001|Apremilast Extension Phase|Miscellaneous|0|||
161870628|NCT03777436|584571704|FG002|Apremilast Extension Phase|Miscellaneous|1|||
161870629|NCT02035202|584571705|FG000|Overall Study|Lost to Follow-up|8|||
161870630|NCT02035202|584571706|FG001|Overall Study|Lost to Follow-up|16|||
161870631|NCT02035202|584571707|FG002|Overall Study|Lost to Follow-up|2|||
161870632|NCT00685399|584571709|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161870633|NCT00685399|584571710|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161870634|NCT00685399|584571711|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161870635|NCT00685399|584571712|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161870636|NCT00685399|584571713|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161870637|NCT00685399|584571714|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161870638|NCT00685399|584571715|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161870639|NCT00685399|584571716|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161870640|NCT00685399|584571709|FG000|Treatment Period 1|Protocol Violation|1|||
161870641|NCT00685399|584571710|FG001|Treatment Period 1|Protocol Violation|0|||
161870642|NCT00685399|584571711|FG002|Treatment Period 1|Protocol Violation|0|||
161870643|NCT00685399|584571712|FG003|Treatment Period 1|Protocol Violation|0|||
161870644|NCT00685399|584571713|FG004|Treatment Period 1|Protocol Violation|0|||
161870645|NCT00685399|584571714|FG005|Treatment Period 1|Protocol Violation|0|||
161870646|NCT00685399|584571715|FG006|Treatment Period 1|Protocol Violation|0|||
161870647|NCT00685399|584571716|FG007|Treatment Period 1|Protocol Violation|0|||
161870648|NCT00685399|584571709|FG000|Treatment Period 1|Administrative|2|||
161870649|NCT00685399|584571710|FG001|Treatment Period 1|Administrative|0|||
161870650|NCT00685399|584571711|FG002|Treatment Period 1|Administrative|0|||
161870651|NCT00685399|584571712|FG003|Treatment Period 1|Administrative|0|||
161870652|NCT00685399|584571713|FG004|Treatment Period 1|Administrative|0|||
161870653|NCT00685399|584571714|FG005|Treatment Period 1|Administrative|0|||
161870654|NCT00685399|584571715|FG006|Treatment Period 1|Administrative|0|||
161870655|NCT00685399|584571716|FG007|Treatment Period 1|Administrative|0|||
161870656|NCT00685399|584571709|FG000|Treatment Period 1|Lack of Efficacy|1|||
161870657|NCT00685399|584571710|FG001|Treatment Period 1|Lack of Efficacy|0|||
161870658|NCT00685399|584571711|FG002|Treatment Period 1|Lack of Efficacy|0|||
161870659|NCT00685399|584571712|FG003|Treatment Period 1|Lack of Efficacy|0|||
161870660|NCT00685399|584571713|FG004|Treatment Period 1|Lack of Efficacy|0|||
161870661|NCT00685399|584571714|FG005|Treatment Period 1|Lack of Efficacy|0|||
161870662|NCT00685399|584571715|FG006|Treatment Period 1|Lack of Efficacy|0|||
161870663|NCT00685399|584571716|FG007|Treatment Period 1|Lack of Efficacy|0|||
161870664|NCT00685399|584571709|FG000|Treatment Period 2|Administrative Problems|0|||
161870665|NCT00685399|584571710|FG001|Treatment Period 2|Administrative Problems|2|||
161870666|NCT00685399|584571711|FG002|Treatment Period 2|Administrative Problems|1|||
161870667|NCT00685399|584571712|FG003|Treatment Period 2|Administrative Problems|0|||
161870668|NCT00685399|584571713|FG004|Treatment Period 2|Administrative Problems|0|||
161870669|NCT00685399|584571714|FG005|Treatment Period 2|Administrative Problems|0|||
161870670|NCT00685399|584571715|FG006|Treatment Period 2|Administrative Problems|0|||
161870671|NCT00685399|584571716|FG007|Treatment Period 2|Administrative Problems|0|||
161870672|NCT00685399|584571709|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161870673|NCT00685399|584571710|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161870674|NCT00685399|584571711|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161870675|NCT00685399|584571712|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161870676|NCT00685399|584571713|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161870677|NCT00685399|584571714|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161870678|NCT00685399|584571715|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161870679|NCT00685399|584571716|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161870680|NCT00685399|584571709|FG000|Treatment Period 2|Adverse Event|0|||
161870681|NCT00685399|584571710|FG001|Treatment Period 2|Adverse Event|0|||
161870682|NCT00685399|584571711|FG002|Treatment Period 2|Adverse Event|0|||
161870683|NCT00685399|584571712|FG003|Treatment Period 2|Adverse Event|0|||
161870684|NCT00685399|584571713|FG004|Treatment Period 2|Adverse Event|0|||
161870685|NCT00685399|584571714|FG005|Treatment Period 2|Adverse Event|1|||
161870686|NCT00685399|584571715|FG006|Treatment Period 2|Adverse Event|0|||
161870687|NCT00685399|584571716|FG007|Treatment Period 2|Adverse Event|0|||
161870688|NCT00685399|584571709|FG000|Treatment Period 2|Lack of Efficacy|0|||
161870689|NCT00685399|584571710|FG001|Treatment Period 2|Lack of Efficacy|10|||
161870690|NCT00685399|584571711|FG002|Treatment Period 2|Lack of Efficacy|2|||
161870691|NCT00685399|584571712|FG003|Treatment Period 2|Lack of Efficacy|0|||
161870692|NCT00685399|584571713|FG004|Treatment Period 2|Lack of Efficacy|0|||
161870693|NCT00685399|584571714|FG005|Treatment Period 2|Lack of Efficacy|1|||
161870694|NCT00685399|584571715|FG006|Treatment Period 2|Lack of Efficacy|0|||
161870695|NCT00685399|584571716|FG007|Treatment Period 2|Lack of Efficacy|0|||
161870696|NCT00685399|584571709|FG000|Extension|Administrative Issues|0|||
161870697|NCT00685399|584571710|FG001|Extension|Administrative Issues|0|||
161870698|NCT00685399|584571711|FG002|Extension|Administrative Issues|0|||
161870699|NCT00685399|584571712|FG003|Extension|Administrative Issues|1|||
161870700|NCT00685399|584571713|FG004|Extension|Administrative Issues|0|||
161870701|NCT00685399|584571714|FG005|Extension|Administrative Issues|0|||
161870702|NCT00685399|584571715|FG006|Extension|Administrative Issues|0|||
161870703|NCT00685399|584571716|FG007|Extension|Administrative Issues|0|||
161870704|NCT00685399|584571709|FG000|Extension|Withdrawal by Subject|0|||
161870705|NCT00685399|584571710|FG001|Extension|Withdrawal by Subject|0|||
161870706|NCT00685399|584571711|FG002|Extension|Withdrawal by Subject|0|||
161870707|NCT00685399|584571712|FG003|Extension|Withdrawal by Subject|1|||
161870708|NCT00685399|584571713|FG004|Extension|Withdrawal by Subject|0|||
161870709|NCT00685399|584571714|FG005|Extension|Withdrawal by Subject|0|||
161870710|NCT00685399|584571715|FG006|Extension|Withdrawal by Subject|0|||
161870711|NCT00685399|584571716|FG007|Extension|Withdrawal by Subject|0|||
161870712|NCT00685399|584571709|FG000|Extension|Protocol Violation|0|||
161870713|NCT00685399|584571710|FG001|Extension|Protocol Violation|0|||
161870714|NCT00685399|584571711|FG002|Extension|Protocol Violation|0|||
161870715|NCT00685399|584571712|FG003|Extension|Protocol Violation|1|||
161870716|NCT00685399|584571713|FG004|Extension|Protocol Violation|0|||
161870717|NCT00685399|584571714|FG005|Extension|Protocol Violation|0|||
161870718|NCT00685399|584571715|FG006|Extension|Protocol Violation|0|||
161870719|NCT00685399|584571716|FG007|Extension|Protocol Violation|0|||
161870720|NCT00685399|584571709|FG000|Extension|Lack of Efficacy|0|||
161870721|NCT00685399|584571710|FG001|Extension|Lack of Efficacy|0|||
161870722|NCT00685399|584571711|FG002|Extension|Lack of Efficacy|0|||
161870723|NCT00685399|584571712|FG003|Extension|Lack of Efficacy|2|||
161870724|NCT00685399|584571713|FG004|Extension|Lack of Efficacy|0|||
161870725|NCT00685399|584571714|FG005|Extension|Lack of Efficacy|0|||
161870726|NCT00685399|584571715|FG006|Extension|Lack of Efficacy|0|||
161870727|NCT00685399|584571716|FG007|Extension|Lack of Efficacy|0|||
161870728|NCT00685399|584571709|FG000|Extension|Adverse Event|0|||
161870729|NCT00685399|584571710|FG001|Extension|Adverse Event|0|||
161870730|NCT00685399|584571711|FG002|Extension|Adverse Event|0|||
161870731|NCT00685399|584571712|FG003|Extension|Adverse Event|2|||
161870732|NCT00685399|584571713|FG004|Extension|Adverse Event|0|||
161870733|NCT00685399|584571714|FG005|Extension|Adverse Event|0|||
161870734|NCT00685399|584571715|FG006|Extension|Adverse Event|0|||
161870735|NCT00685399|584571716|FG007|Extension|Adverse Event|0|||
161870736|NCT04478695|584571717|FG000|Overall Study|Death|1|||
161870737|NCT04478695|584571718|FG001|Overall Study|Death|0|||
161870738|NCT00644917|584571719|FG000|Overall Study|Withdrawal by Subject|2|||
161870739|NCT01136356|584571720|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
161870740|NCT01136356|584571721|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
161870741|NCT01136356|584571720|FG000|First 18-day Withdrawal|Physician Decision|1|||
161870742|NCT01136356|584571721|FG001|First 18-day Withdrawal|Physician Decision|0|||
161870743|NCT01136356|584571720|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
161870744|NCT01136356|584571721|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
161870745|NCT00402688|584571722|FG000|Overall Study|Adverse Event|12|||
161870746|NCT00402688|584571723|FG001|Overall Study|Adverse Event|9|||
161870747|NCT00402688|584571724|FG002|Overall Study|Adverse Event|3|||
161870748|NCT00402688|584571722|FG000|Overall Study|Withdrawal by Subject|3|||
161870749|NCT00402688|584571723|FG001|Overall Study|Withdrawal by Subject|1|||
161870750|NCT00402688|584571724|FG002|Overall Study|Withdrawal by Subject|1|||
161870751|NCT00402688|584571722|FG000|Overall Study|Physician Decision|0|||
161870752|NCT00402688|584571723|FG001|Overall Study|Physician Decision|0|||
161870753|NCT00402688|584571724|FG002|Overall Study|Physician Decision|1|||
161870754|NCT00402688|584571722|FG000|Overall Study|Lack of Efficacy|4|||
161870755|NCT00402688|584571723|FG001|Overall Study|Lack of Efficacy|4|||
161870756|NCT00402688|584571724|FG002|Overall Study|Lack of Efficacy|5|||
161870757|NCT00402688|584571722|FG000|Overall Study|Protocol Violation|1|||
161870758|NCT00402688|584571723|FG001|Overall Study|Protocol Violation|1|||
161870759|NCT00402688|584571724|FG002|Overall Study|Protocol Violation|1|||
161870760|NCT00402688|584571722|FG000|Overall Study|Lost to Follow-up|1|||
161870761|NCT00402688|584571723|FG001|Overall Study|Lost to Follow-up|0|||
161870762|NCT00402688|584571724|FG002|Overall Study|Lost to Follow-up|2|||
161870763|NCT00402688|584571722|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
161870764|NCT00402688|584571723|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
161870765|NCT00402688|584571724|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
161870766|NCT00402688|584571722|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
161870767|NCT00402688|584571723|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
161870768|NCT00402688|584571724|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
161870769|NCT00402688|584571722|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
161870770|NCT00402688|584571723|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
161870771|NCT00402688|584571724|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
161870772|NCT00178685|584571725|FG000|Overall Study|Death|3|||
161870773|NCT00178685|584571726|FG001|Overall Study|Death|3|||
161870774|NCT00178685|584571727|FG002|Overall Study|Death|6|||
161870775|NCT00178685|584571725|FG000|Overall Study|Lost to Follow-up|100|||
161870776|NCT00178685|584571726|FG001|Overall Study|Lost to Follow-up|187|||
161870777|NCT00178685|584571727|FG002|Overall Study|Lost to Follow-up|183|||
161870778|NCT00178685|584571725|FG000|Overall Study|Withdrawal by Subject|8|||
161870779|NCT00178685|584571726|FG001|Overall Study|Withdrawal by Subject|14|||
161870780|NCT00178685|584571727|FG002|Overall Study|Withdrawal by Subject|7|||
161870781|NCT00927862|584571728|FG000|Overall Study|Missing data needed for endpt analyses|27|||
161870782|NCT00927862|584571729|FG001|Overall Study|Missing data needed for endpt analyses|45|||
161870783|NCT00820248|584571730|FG000|Overall Study|No treated|4|||
161870784|NCT00820248|584571731|FG001|Overall Study|No treated|1|||
161870785|NCT04157296|584571741|FG000|Overall Study|Withdrawal by Subject|0|||
161870786|NCT04157296|584571742|FG001|Overall Study|Withdrawal by Subject|1|||
161870787|NCT04157296|584571741|FG000|Overall Study|Did not obtain second fMRI.|0|||
161870788|NCT04157296|584571742|FG001|Overall Study|Did not obtain second fMRI.|1|||
161870789|NCT04157296|584571741|FG000|Overall Study|MRI failed/no second fMRI|0|||
161870790|NCT04157296|584571742|FG001|Overall Study|MRI failed/no second fMRI|1|||
161870791|NCT02088905|584571749|FG000|Overall Study|Withdrawal by Subject|5|||
161870792|NCT02088905|584571750|FG001|Overall Study|Withdrawal by Subject|1|||
161870793|NCT01562782|584571756|FG000|Overall Study|Withdrawal by Subject|3|||
161870794|NCT01562782|584571757|FG001|Overall Study|Withdrawal by Subject|3|||
161870795|NCT01562782|584571756|FG000|Overall Study|screen failure|1|||
161870796|NCT01562782|584571757|FG001|Overall Study|screen failure|2|||
161870797|NCT02308540|584571758|FG000|Overall Study|Lost to Follow-up|0|||
161870798|NCT02308540|584571759|FG001|Overall Study|Lost to Follow-up|0|||
161870799|NCT02308540|584571760|FG002|Overall Study|Lost to Follow-up|0|||
161870800|NCT02308540|584571761|FG003|Overall Study|Lost to Follow-up|0|||
161870801|NCT02308540|584571762|FG004|Overall Study|Lost to Follow-up|0|||
161870802|NCT02308540|584571763|FG005|Overall Study|Lost to Follow-up|1|||
161870803|NCT04109391|584571764|FG000|Overall Study|Adverse Event|2|||
161870804|NCT04109391|584571765|FG001|Overall Study|Adverse Event|2|||
161870805|NCT04109391|584571766|FG002|Overall Study|Adverse Event|0|||
161870806|NCT04109391|584571764|FG000|Overall Study|Withdrawal by Subject|2|||
161870807|NCT04109391|584571765|FG001|Overall Study|Withdrawal by Subject|0|||
161870808|NCT04109391|584571766|FG002|Overall Study|Withdrawal by Subject|0|||
161870809|NCT04109391|584571764|FG000|Overall Study|Pregnancy|1|||
161870810|NCT04109391|584571765|FG001|Overall Study|Pregnancy|0|||
161870811|NCT04109391|584571766|FG002|Overall Study|Pregnancy|0|||
161870812|NCT04109391|584571764|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
161870813|NCT04109391|584571765|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
161870814|NCT04109391|584571766|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
161870815|NCT04109391|584571764|FG000|Overall Study|Lost to Follow-up|0|||
161870816|NCT04109391|584571765|FG001|Overall Study|Lost to Follow-up|0|||
161870817|NCT04109391|584571766|FG002|Overall Study|Lost to Follow-up|1|||
161870818|NCT04109391|584571764|FG000|Overall Study|Lack of Efficacy|2|||
161870819|NCT04109391|584571765|FG001|Overall Study|Lack of Efficacy|2|||
161870820|NCT04109391|584571766|FG002|Overall Study|Lack of Efficacy|3|||
161870821|NCT02649439|584571767|FG000|Overall Study|Switched to alternative treatment|6|||
161870822|NCT02649439|584571768|FG001|Overall Study|Switched to alternative treatment|4|||
161870823|NCT02649439|584571767|FG000|Overall Study|Patient decision|1|||
161870824|NCT02649439|584571768|FG001|Overall Study|Patient decision|0|||
161870825|NCT02649439|584571767|FG000|Overall Study|Patient going out of country|1|||
161870826|NCT02649439|584571768|FG001|Overall Study|Patient going out of country|0|||
161870827|NCT02649439|584571767|FG000|Overall Study|To start finasteride|1|||
161870828|NCT02649439|584571768|FG001|Overall Study|To start finasteride|0|||
161870829|NCT02649439|584571767|FG000|Overall Study|Physician Decision|1|||
161870830|NCT02649439|584571768|FG001|Overall Study|Physician Decision|0|||
161870831|NCT02649439|584571767|FG000|Overall Study|Disease progression on study|12|||
161870832|NCT02649439|584571768|FG001|Overall Study|Disease progression on study|13|||
161870833|NCT02649439|584571767|FG000|Overall Study|Refused further treatment|1|||
161870834|NCT02649439|584571768|FG001|Overall Study|Refused further treatment|0|||
161870835|NCT02649439|584571767|FG000|Overall Study|Refused further follow up|2|||
161870836|NCT02649439|584571768|FG001|Overall Study|Refused further follow up|7|||
161870837|NCT02649439|584571767|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
161870838|NCT02649439|584571768|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
161870839|NCT02649439|584571767|FG000|Overall Study|No treatment, per protocol|1|||
161870840|NCT02649439|584571768|FG001|Overall Study|No treatment, per protocol|0|||
161870841|NCT02649439|584571767|FG000|Overall Study|PSA DT makes ineligible|0|||
161870842|NCT02649439|584571768|FG001|Overall Study|PSA DT makes ineligible|1|||
161870843|NCT02649439|584571767|FG000|Overall Study|Rising PSA No Mets|0|||
161870844|NCT02649439|584571768|FG001|Overall Study|Rising PSA No Mets|1|||
161870845|NCT02649439|584571767|FG000|Overall Study|Rising PSA|0|||
161870846|NCT02649439|584571768|FG001|Overall Study|Rising PSA|1|||
161870847|NCT02649439|584571767|FG000|Overall Study|Signed follow up protocol|0|||
161870848|NCT02649439|584571768|FG001|Overall Study|Signed follow up protocol|1|||
161870849|NCT02097238|584571769|FG000|Overall Study|Death|1|||
161870850|NCT02097238|584571769|FG000|Overall Study|Physician Decision|1|||
161870851|NCT02097238|584571769|FG000|Overall Study|Progressive Disease|17|||
161870852|NCT01282372|584571780|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
161870853|NCT01282372|584571780|FG000|Overall Study|Lost to Follow-up|23|||
161870854|NCT01282372|584571780|FG000|Overall Study|Withdrawal by Subject|11|||
161870855|NCT01282372|584571780|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
161870856|NCT01282372|584571780|FG000|Overall Study|Death|1|||
161870857|NCT01282372|584571780|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
161870858|NCT01282372|584571780|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
161870859|NCT01282372|584571780|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
161870860|NCT01282372|584571780|FG000|Overall Study|Adverse Event|12|||
161870861|NCT02737930|584571781|FG000|Overall Study|Withdrawal by Subject|0|||
161870862|NCT02737930|584571782|FG001|Overall Study|Withdrawal by Subject|1|||
161870863|NCT04468347|584571787|FG000|Overall Study|Withdrawal by Subject|0|||
161870864|NCT04468347|584571788|FG001|Overall Study|Withdrawal by Subject|1|||
161870865|NCT04468347|584571789|FG002|Overall Study|Withdrawal by Subject|3|||
161870866|NCT04468347|584571790|FG003|Overall Study|Withdrawal by Subject|3|||
161870867|NCT04468347|584571787|FG000|Overall Study|Lost to Follow-up|0|||
161870868|NCT04468347|584571788|FG001|Overall Study|Lost to Follow-up|0|||
161870869|NCT04468347|584571789|FG002|Overall Study|Lost to Follow-up|1|||
161870870|NCT04468347|584571790|FG003|Overall Study|Lost to Follow-up|1|||
161870871|NCT04468347|584571787|FG000|Overall Study|Physician Decision|1|||
161870872|NCT04468347|584571788|FG001|Overall Study|Physician Decision|0|||
161870873|NCT04468347|584571789|FG002|Overall Study|Physician Decision|2|||
161870874|NCT04468347|584571790|FG003|Overall Study|Physician Decision|0|||
161870875|NCT04468347|584571787|FG000|Overall Study|Protocol Violation|1|||
161870876|NCT04468347|584571788|FG001|Overall Study|Protocol Violation|0|||
161870877|NCT04468347|584571789|FG002|Overall Study|Protocol Violation|0|||
161870878|NCT04468347|584571790|FG003|Overall Study|Protocol Violation|0|||
161870879|NCT00994461|584571792|FG000|Overall Study|Adverse Event|2|||
161870880|NCT00994461|584571793|FG001|Overall Study|Adverse Event|1|||
161870881|NCT00994461|584571794|FG002|Overall Study|Adverse Event|0|||
161870882|NCT04339062|584571795|FG000|Overall Study|Death|0|||
161870883|NCT04339062|584571796|FG001|Overall Study|Death|1|||
161870884|NCT05868577|584571797|FG000|Overall Study|Lost to Follow-up|5|||
161870885|NCT05868577|584571798|FG001|Overall Study|Lost to Follow-up|5|||
161870886|NCT02505217|584571799|FG000|Overall Study|Withdrawal by Subject|1|||
161870887|NCT02505217|584571800|FG001|Overall Study|Withdrawal by Subject|2|||
161870888|NCT00615550|584571805|FG000|Overall Study|Lost to Follow-up|6|||
161870889|NCT00615550|584571806|FG001|Overall Study|Lost to Follow-up|1|||
161870890|NCT01408303|584571807|FG000|Overall Study|Adverse Event|3|||
161870891|NCT01408303|584571808|FG001|Overall Study|Adverse Event|7|||
161870892|NCT01408303|584571809|FG002|Overall Study|Adverse Event|2|||
161870893|NCT01408303|584571807|FG000|Overall Study|Lost to Follow-up|0|||
161870894|NCT01408303|584571808|FG001|Overall Study|Lost to Follow-up|1|||
161870895|NCT01408303|584571809|FG002|Overall Study|Lost to Follow-up|2|||
161870896|NCT01408303|584571807|FG000|Overall Study|Withdrawal by Subject|2|||
161870897|NCT01408303|584571808|FG001|Overall Study|Withdrawal by Subject|3|||
161870898|NCT01408303|584571809|FG002|Overall Study|Withdrawal by Subject|1|||
161870899|NCT01408303|584571807|FG000|Overall Study|Protocol Violation|0|||
161870900|NCT01408303|584571808|FG001|Overall Study|Protocol Violation|1|||
161870901|NCT01408303|584571809|FG002|Overall Study|Protocol Violation|0|||
161870902|NCT01408303|584571807|FG000|Overall Study|Noncompliance|1|||
161870903|NCT01408303|584571808|FG001|Overall Study|Noncompliance|0|||
161870904|NCT01408303|584571809|FG002|Overall Study|Noncompliance|1|||
161870905|NCT02644668|584571810|FG000|Overall Study|Adverse Event|2|||
161870906|NCT02644668|584571811|FG001|Overall Study|Adverse Event|0|||
161870907|NCT02644668|584571812|FG002|Overall Study|Adverse Event|1|||
161870908|NCT02644668|584571810|FG000|Overall Study|Protocol Violation|0|||
161870909|NCT02644668|584571811|FG001|Overall Study|Protocol Violation|0|||
161870910|NCT02644668|584571812|FG002|Overall Study|Protocol Violation|1|||
161870911|NCT02644668|584571810|FG000|Overall Study|Withdrawal by Subject|0|||
161870912|NCT02644668|584571811|FG001|Overall Study|Withdrawal by Subject|0|||
161870913|NCT02644668|584571812|FG002|Overall Study|Withdrawal by Subject|1|||
161870914|NCT05119595|584573606|FG000|Overall Study|Death|1|||
161870915|NCT05119595|584573606|FG000|Overall Study|Lost to Follow-up|7|||
161870916|NCT01806961|584573607|FG000|Overall Study|sponsor decision|16|||
161870917|NCT03056638|584573614|FG000|Overall Study|Death|1|||
161870918|NCT03056638|584573615|FG001|Overall Study|Death|0|||
161870919|NCT02530125|584573616|FG000|Completed Treatment|Early termination of study|1|||
161870920|NCT02530125|584573616|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
161870921|NCT00468481|584573617|FG000|Overall Study|Adverse Event|13|||
161870922|NCT00468481|584573618|FG001|Overall Study|Adverse Event|3|||
161870923|NCT00468481|584573617|FG000|Overall Study|Lost to Follow-up|25|||
161870924|NCT00468481|584573618|FG001|Overall Study|Lost to Follow-up|8|||
161870925|NCT00468481|584573617|FG000|Overall Study|Pregnancy|2|||
161870926|NCT00468481|584573618|FG001|Overall Study|Pregnancy|0|||
161870927|NCT00468481|584573617|FG000|Overall Study|Protocol Violation|18|||
161870928|NCT00468481|584573618|FG001|Overall Study|Protocol Violation|8|||
161870929|NCT00468481|584573617|FG000|Overall Study|Withdrawal by Subject|12|||
161870930|NCT00468481|584573618|FG001|Overall Study|Withdrawal by Subject|3|||
161870931|NCT00468481|584573617|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
161870932|NCT00468481|584573618|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
161870933|NCT00468481|584573617|FG000|Overall Study|Prohibited Medication|1|||
161870934|NCT00468481|584573618|FG001|Overall Study|Prohibited Medication|1|||
161870935|NCT00468481|584573617|FG000|Overall Study|Egg Donor|1|||
161870936|NCT00468481|584573618|FG001|Overall Study|Egg Donor|0|||
161870937|NCT00468481|584573617|FG000|Overall Study|Moved out of area|4|||
161870938|NCT00468481|584573618|FG001|Overall Study|Moved out of area|1|||
161870939|NCT00468481|584573617|FG000|Overall Study|Non-Compliance|5|||
161870940|NCT00468481|584573618|FG001|Overall Study|Non-Compliance|0|||
161870941|NCT00468481|584573617|FG000|Overall Study|Other|6|||
161870942|NCT00468481|584573618|FG001|Overall Study|Other|0|||
161870943|NCT01568034|584573619|FG000|Overall Study|Withdrawal by Subject|1|||
161870944|NCT01568034|584573620|FG001|Overall Study|Withdrawal by Subject|0|||
161870945|NCT01568034|584573621|FG002|Overall Study|Withdrawal by Subject|0|||
161870946|NCT01568034|584573622|FG003|Overall Study|Withdrawal by Subject|0|||
161870947|NCT00728468|584573623|FG000|Overall Study|Enrolled but not treated|1|||
161870948|NCT00728468|584573623|FG000|Overall Study|Death|1|||
161870949|NCT00728468|584573623|FG000|Overall Study|Protocol Violation|4|||
161870950|NCT00728468|584573623|FG000|Overall Study|Objective progression or relapse|9|||
161870951|NCT00728468|584573623|FG000|Overall Study|Study terminated by sponsor|1|||
161870952|NCT00596687|584573624|FG000|Overall Study|< 24 hours of insulin treatment|8|||
161870953|NCT00596687|584573625|FG001|Overall Study|< 24 hours of insulin treatment|6|||
161870954|NCT00596687|584573624|FG000|Overall Study|continuous insulin infusion during TPN|2|||
161870955|NCT00596687|584573625|FG001|Overall Study|continuous insulin infusion during TPN|1|||
161870956|NCT00596687|584573624|FG000|Overall Study|Withdrawal by Subject|3|||
161870957|NCT00596687|584573625|FG001|Overall Study|Withdrawal by Subject|1|||
161870958|NCT00596687|584573624|FG000|Overall Study|cancelled surgery|1|||
161870959|NCT00596687|584573625|FG001|Overall Study|cancelled surgery|1|||
161870960|NCT03831113|584573626|FG000|Overall Study|Withdrawal by Subject|0|||
161870961|NCT03831113|584573627|FG001|Overall Study|Withdrawal by Subject|2|||
161870962|NCT03831113|584573626|FG000|Overall Study|Protocol Violation|0|||
161870963|NCT03831113|584573627|FG001|Overall Study|Protocol Violation|9|||
161870964|NCT01068730|584573628|FG000|Period 3|Personal reason|1|||
161870965|NCT01068730|584573629|FG001|Period 3|Personal reason|0|||
161870966|NCT01068730|584573630|FG002|Period 3|Personal reason|0|||
161870967|NCT01068730|584573631|FG003|Period 3|Personal reason|0|||
161870968|NCT01068730|584573628|FG000|Period 4|Family emergency|0|||
161870969|NCT01068730|584573629|FG001|Period 4|Family emergency|1|||
161870970|NCT01068730|584573630|FG002|Period 4|Family emergency|0|||
161870971|NCT01068730|584573631|FG003|Period 4|Family emergency|0|||
161870972|NCT03508726|584573632|FG000|Overall Study|Withdrawal by Subject|0|||
161870973|NCT03508726|584573633|FG001|Overall Study|Withdrawal by Subject|1|||
161870974|NCT02498444|584573637|FG000|Overall Study|Withdrawal by Subject|3|||
161870975|NCT02498444|584573638|FG001|Overall Study|Withdrawal by Subject|0|||
161870976|NCT02498444|584573637|FG000|Overall Study|Physician Decision|1|||
161870977|NCT02498444|584573638|FG001|Overall Study|Physician Decision|0|||
161870978|NCT03656692|584573639|FG000|Overall Study|Worsening of disease activity|2|||
161870979|NCT03656692|584573639|FG000|Overall Study|Physician Decision|1|||
161870980|NCT03233529|584573640|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
161870981|NCT03233529|584573640|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
161870982|NCT01177293|584573641|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
161870983|NCT01177293|584573642|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
161870984|NCT00594100|584573643|FG000|Procedure|Technical Failure|9|||
161870985|NCT00594100|584573643|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
161870986|NCT00594100|584573643|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
161870987|NCT00594100|584573643|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
161870988|NCT02448537|584573644|FG000|Overall Study|Withdrawal by Subject|1|||
161870989|NCT02448537|584573645|FG001|Overall Study|Withdrawal by Subject|1|||
161870990|NCT02448537|584573646|FG002|Overall Study|Withdrawal by Subject|1|||
161775317|NCT03426995|584219439|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
161775318|NCT03426995|584219440|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775319|NCT03426995|584219441|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775320|NCT03426995|584219442|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775321|NCT01886105|584219443|FG000|Overall Study|Lack of Efficacy|3|||
161775322|NCT01360021|584219446|FG000|Overall Study|Eligibility criteria + other|2|||
161775323|NCT01360021|584219447|FG001|Overall Study|Eligibility criteria + other|1|||
161775324|NCT01360021|584219448|FG002|Overall Study|Eligibility criteria + other|1|||
161775325|NCT01360021|584219446|FG000|Overall Study|Protocol Violation|0|||
161775326|NCT01360021|584219447|FG001|Overall Study|Protocol Violation|0|||
161775327|NCT01360021|584219448|FG002|Overall Study|Protocol Violation|1|||
161775328|NCT01360021|584219446|FG000|Overall Study|Withdrawal by Subject|4|||
161775329|NCT01360021|584219447|FG001|Overall Study|Withdrawal by Subject|0|||
161775330|NCT01360021|584219448|FG002|Overall Study|Withdrawal by Subject|2|||
161775331|NCT01360021|584219446|FG000|Overall Study|Adverse Event|2|||
161775332|NCT01360021|584219447|FG001|Overall Study|Adverse Event|3|||
161775333|NCT01360021|584219448|FG002|Overall Study|Adverse Event|3|||
161775334|NCT03075826|584219451|FG000|Overall Study|Withdrawal by Subject|1|||
161775335|NCT03075826|584219451|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
161775336|NCT00650806|584219453|FG000|Overall Study|Adverse Event|0|||
161775337|NCT00650806|584219454|FG001|Overall Study|Adverse Event|5|||
161775338|NCT00650806|584219455|FG002|Overall Study|Adverse Event|3|||
161775339|NCT00650806|584219456|FG003|Overall Study|Adverse Event|4|||
161775340|NCT00650806|584219453|FG000|Overall Study|Lost to Follow-up|7|||
161775341|NCT00650806|584219454|FG001|Overall Study|Lost to Follow-up|6|||
161775342|NCT00650806|584219455|FG002|Overall Study|Lost to Follow-up|11|||
161775343|NCT00650806|584219456|FG003|Overall Study|Lost to Follow-up|10|||
161775344|NCT00650806|584219453|FG000|Overall Study|Protocol Violation|0|||
161775345|NCT00650806|584219454|FG001|Overall Study|Protocol Violation|0|||
161775346|NCT00650806|584219455|FG002|Overall Study|Protocol Violation|0|||
161775347|NCT00650806|584219456|FG003|Overall Study|Protocol Violation|1|||
161775348|NCT00650806|584219453|FG000|Overall Study|Pregnancy|0|||
161775349|NCT00650806|584219454|FG001|Overall Study|Pregnancy|0|||
161775350|NCT00650806|584219455|FG002|Overall Study|Pregnancy|0|||
161775351|NCT00650806|584219456|FG003|Overall Study|Pregnancy|1|||
161775352|NCT00650806|584219453|FG000|Overall Study|Withdrawal by Subject|7|||
161775353|NCT00650806|584219454|FG001|Overall Study|Withdrawal by Subject|5|||
161775354|NCT00650806|584219455|FG002|Overall Study|Withdrawal by Subject|8|||
161775355|NCT00650806|584219456|FG003|Overall Study|Withdrawal by Subject|6|||
161775356|NCT00650806|584219453|FG000|Overall Study|Noncompliance with study drug regimen|1|||
161870991|NCT01106911|584573659|FG000|Overall Study|Physician Decision|2|||
161870992|NCT01106911|584573659|FG000|Overall Study|deemed ineligible after screening|3|||
161870993|NCT01814696|584573661|FG000|Overall Study|Withdrawal by Subject|1|||
161870994|NCT01814696|584573662|FG001|Overall Study|Withdrawal by Subject|0|||
161870995|NCT01814696|584573661|FG000|Overall Study|Randomized to wrong group|1|||
161870996|NCT01814696|584573662|FG001|Overall Study|Randomized to wrong group|0|||
161870997|NCT05708976|584573673|FG000|Overall Study|Withdrawal by Subject|0|||
161870998|NCT05708976|584573674|FG001|Overall Study|Withdrawal by Subject|1|||
161870999|NCT05310071|584573675|FG000|Overall Study|Death|0|||
161871000|NCT05310071|584573676|FG001|Overall Study|Death|3|||
161871001|NCT05310071|584573675|FG000|Overall Study|Adverse Event|4|||
161871002|NCT05310071|584573676|FG001|Overall Study|Adverse Event|31|||
161871003|NCT05310071|584573675|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
161871004|NCT05310071|584573676|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
161871005|NCT05310071|584573675|FG000|Overall Study|Protocol Deviation|2|||
161871006|NCT05310071|584573676|FG001|Overall Study|Protocol Deviation|0|||
161871007|NCT05310071|584573675|FG000|Overall Study|Randomized by Mistake|0|||
161871008|NCT05310071|584573676|FG001|Overall Study|Randomized by Mistake|1|||
161871009|NCT05310071|584573675|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
161871010|NCT05310071|584573676|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161871011|NCT05310071|584573675|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161871012|NCT05310071|584573676|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161871013|NCT05310071|584573675|FG000|Overall Study|Site Terminated by Sponsor|0|||
161871014|NCT05310071|584573676|FG001|Overall Study|Site Terminated by Sponsor|2|||
161871015|NCT05310071|584573675|FG000|Overall Study|Study Terminated by Sponsor|282|||
161871016|NCT05310071|584573676|FG001|Overall Study|Study Terminated by Sponsor|559|||
161871017|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
161871018|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
161871019|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
161871020|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
161871021|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
161871022|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
161871023|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
161871024|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
161871025|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Other|25|||
161871026|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Other|30|||
161871027|NCT05310071|584573675|FG000|Overall Study|Lost to Follow-up|2|||
161871028|NCT05310071|584573676|FG001|Overall Study|Lost to Follow-up|4|||
161871029|NCT05310071|584573675|FG000|Overall Study|Reason Not Specified|1|||
161871030|NCT05310071|584573676|FG001|Overall Study|Reason Not Specified|3|||
161871031|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
161871032|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871033|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871034|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871035|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871036|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871037|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
161871038|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
161871039|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871040|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871041|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871042|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871043|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
161871044|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
161871045|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871046|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871047|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871048|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871049|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161871050|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161871051|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871052|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871053|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871054|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871055|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
161871056|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
161871057|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871058|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871059|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871060|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871061|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871062|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
161871063|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871064|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871065|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871066|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871067|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871068|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871069|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
161871070|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
161871071|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871072|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871073|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871074|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871075|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
161871076|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
161871077|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871078|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871079|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871080|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871081|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
161871082|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
161871083|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161775357|NCT00650806|584219454|FG001|Overall Study|Noncompliance with study drug regimen|1|||
161775358|NCT00650806|584219455|FG002|Overall Study|Noncompliance with study drug regimen|0|||
161775359|NCT00650806|584219456|FG003|Overall Study|Noncompliance with study drug regimen|0|||
161871084|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871085|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871086|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871087|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
161871088|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161871089|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871090|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871091|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871092|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871093|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
161871094|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871095|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871096|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871097|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871098|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871099|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871100|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
161871101|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871102|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871103|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871104|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871105|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
161871106|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871107|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871108|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871109|NCT02105987|584573677|FG000|Continuation Phase|Protocol Violation|0|||
161871110|NCT02105987|584573678|FG001|Continuation Phase|Protocol Violation|0|||
161871111|NCT02105987|584573679|FG002|Continuation Phase|Protocol Violation|0|||
161871112|NCT02105987|584573680|FG003|Continuation Phase|Protocol Violation|0|||
161871113|NCT02105987|584573681|FG004|Continuation Phase|Protocol Violation|1|||
161871114|NCT02105987|584573682|FG005|Continuation Phase|Protocol Violation|0|||
161871115|NCT02418949|584573689|FG000|Overall Study|Withdrawal by Subject|1|||
161871116|NCT02418949|584573690|FG001|Overall Study|Withdrawal by Subject|0|||
161871117|NCT02418949|584573691|FG002|Overall Study|Withdrawal by Subject|1|||
161871118|NCT02418949|584573692|FG003|Overall Study|Withdrawal by Subject|1|||
161871119|NCT02418949|584573689|FG000|Overall Study|Lost to Follow-up|1|||
161871120|NCT02418949|584573690|FG001|Overall Study|Lost to Follow-up|0|||
161871121|NCT02418949|584573691|FG002|Overall Study|Lost to Follow-up|1|||
161871122|NCT02418949|584573692|FG003|Overall Study|Lost to Follow-up|0|||
161871123|NCT02418949|584573689|FG000|Overall Study|Physician Decision|1|||
161871124|NCT02418949|584573690|FG001|Overall Study|Physician Decision|1|||
161871125|NCT02418949|584573691|FG002|Overall Study|Physician Decision|1|||
161871126|NCT02418949|584573692|FG003|Overall Study|Physician Decision|0|||
161871127|NCT00396656|584573698|FG000|First Treatment Period|Withdrawal by Subject|0|||
161871128|NCT00396656|584573699|FG001|First Treatment Period|Withdrawal by Subject|2|||
161871129|NCT00396656|584573698|FG000|Second Treatment Period|Adverse Event|0|||
161871130|NCT00396656|584573699|FG001|Second Treatment Period|Adverse Event|1|||
161871131|NCT02343939|584573700|FG000|Overall Study|Death|0|||
161871132|NCT02343939|584573701|FG001|Overall Study|Death|15|||
161871133|NCT02343939|584573702|FG002|Overall Study|Death|4|||
161871134|NCT02343939|584573703|FG003|Overall Study|Death|2|||
161871135|NCT02343939|584573704|FG004|Overall Study|Death|5|||
161871136|NCT02343939|584573705|FG005|Overall Study|Death|11|||
161871137|NCT02343939|584573706|FG006|Overall Study|Death|8|||
161871138|NCT02343939|584573707|FG007|Overall Study|Death|22|||
161871139|NCT02343939|584573708|FG008|Overall Study|Death|1|||
161871140|NCT02343939|584573700|FG000|Overall Study|Study terminated by sponsor|0|||
161871141|NCT02343939|584573701|FG001|Overall Study|Study terminated by sponsor|27|||
161871142|NCT02343939|584573702|FG002|Overall Study|Study terminated by sponsor|0|||
161871143|NCT02343939|584573703|FG003|Overall Study|Study terminated by sponsor|1|||
161871144|NCT02343939|584573704|FG004|Overall Study|Study terminated by sponsor|1|||
161871145|NCT02343939|584573705|FG005|Overall Study|Study terminated by sponsor|5|||
161871146|NCT02343939|584573706|FG006|Overall Study|Study terminated by sponsor|3|||
161871147|NCT02343939|584573707|FG007|Overall Study|Study terminated by sponsor|4|||
161871148|NCT02343939|584573708|FG008|Overall Study|Study terminated by sponsor|0|||
161871149|NCT02343939|584573700|FG000|Overall Study|Withdrew consent|3|||
161871150|NCT02343939|584573701|FG001|Overall Study|Withdrew consent|6|||
161871151|NCT02343939|584573702|FG002|Overall Study|Withdrew consent|1|||
161871152|NCT02343939|584573703|FG003|Overall Study|Withdrew consent|2|||
161871153|NCT02343939|584573704|FG004|Overall Study|Withdrew consent|2|||
161871154|NCT02343939|584573705|FG005|Overall Study|Withdrew consent|0|||
161871155|NCT02343939|584573706|FG006|Overall Study|Withdrew consent|0|||
161871156|NCT02343939|584573707|FG007|Overall Study|Withdrew consent|8|||
161871157|NCT02343939|584573708|FG008|Overall Study|Withdrew consent|6|||
161871158|NCT02343939|584573700|FG000|Overall Study|Treatment failure|0|||
161871159|NCT02343939|584573701|FG001|Overall Study|Treatment failure|0|||
161871160|NCT02343939|584573702|FG002|Overall Study|Treatment failure|0|||
161871161|NCT02343939|584573703|FG003|Overall Study|Treatment failure|0|||
161871162|NCT02343939|584573704|FG004|Overall Study|Treatment failure|0|||
161871163|NCT02343939|584573705|FG005|Overall Study|Treatment failure|0|||
161871164|NCT02343939|584573706|FG006|Overall Study|Treatment failure|2|||
161871165|NCT02343939|584573707|FG007|Overall Study|Treatment failure|1|||
161871166|NCT02343939|584573708|FG008|Overall Study|Treatment failure|0|||
161871167|NCT02343939|584573700|FG000|Overall Study|Investigator's discretion|0|||
161871168|NCT02343939|584573701|FG001|Overall Study|Investigator's discretion|0|||
161871169|NCT02343939|584573702|FG002|Overall Study|Investigator's discretion|0|||
161871170|NCT02343939|584573703|FG003|Overall Study|Investigator's discretion|1|||
161871171|NCT02343939|584573704|FG004|Overall Study|Investigator's discretion|0|||
161871172|NCT02343939|584573705|FG005|Overall Study|Investigator's discretion|0|||
161871173|NCT02343939|584573706|FG006|Overall Study|Investigator's discretion|1|||
161871174|NCT02343939|584573707|FG007|Overall Study|Investigator's discretion|0|||
161871175|NCT02343939|584573708|FG008|Overall Study|Investigator's discretion|0|||
161871176|NCT02343939|584573700|FG000|Overall Study|Adverse Event|0|||
161871177|NCT02343939|584573701|FG001|Overall Study|Adverse Event|0|||
161871178|NCT02343939|584573702|FG002|Overall Study|Adverse Event|0|||
161871179|NCT02343939|584573703|FG003|Overall Study|Adverse Event|0|||
161871180|NCT02343939|584573704|FG004|Overall Study|Adverse Event|0|||
161871181|NCT02343939|584573705|FG005|Overall Study|Adverse Event|1|||
161871182|NCT02343939|584573706|FG006|Overall Study|Adverse Event|0|||
161871183|NCT02343939|584573707|FG007|Overall Study|Adverse Event|0|||
161871184|NCT02343939|584573708|FG008|Overall Study|Adverse Event|0|||
161871185|NCT02343939|584573700|FG000|Overall Study|Never Treated With ENTO|0|||
161871186|NCT02343939|584573701|FG001|Overall Study|Never Treated With ENTO|0|||
161871187|NCT02343939|584573702|FG002|Overall Study|Never Treated With ENTO|0|||
161871188|NCT02343939|584573703|FG003|Overall Study|Never Treated With ENTO|0|||
161871189|NCT02343939|584573704|FG004|Overall Study|Never Treated With ENTO|0|||
161871190|NCT02343939|584573705|FG005|Overall Study|Never Treated With ENTO|0|||
161871191|NCT02343939|584573706|FG006|Overall Study|Never Treated With ENTO|1|||
161871192|NCT02343939|584573707|FG007|Overall Study|Never Treated With ENTO|2|||
161871193|NCT02343939|584573708|FG008|Overall Study|Never Treated With ENTO|0|||
161871194|NCT01303172|584573709|FG000|Overall Study|Physician Decision|9|||
161871195|NCT01303172|584573710|FG001|Overall Study|Physician Decision|6|||
161871196|NCT01303172|584573709|FG000|Overall Study|Adverse Event|5|||
161871197|NCT01303172|584573710|FG001|Overall Study|Adverse Event|2|||
161871198|NCT01303172|584573709|FG000|Overall Study|Withdrawal by Subject|4|||
161871199|NCT01303172|584573710|FG001|Overall Study|Withdrawal by Subject|2|||
161871200|NCT01303172|584573709|FG000|Overall Study|Death|20|||
161871201|NCT01303172|584573710|FG001|Overall Study|Death|7|||
161871202|NCT01303172|584573709|FG000|Overall Study|Lack of Efficacy|25|||
161871203|NCT01303172|584573710|FG001|Overall Study|Lack of Efficacy|17|||
161871204|NCT02684097|584573711|FG000|Overall Study|Lack of Efficacy|13|||
161871205|NCT02684097|584573712|FG001|Overall Study|Lack of Efficacy|6|||
161871206|NCT00462709|584573713|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
161871207|NCT00462709|584573713|FG000|Overall Study|Lost to Follow-up|10|||
161871208|NCT00462709|584573713|FG000|Overall Study|Withdrawal by Subject|8|||
161871209|NCT00462709|584573713|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
161871210|NCT00462709|584573713|FG000|Overall Study|Death|2|||
161871211|NCT00462709|584573713|FG000|Overall Study|Logistical reasons|2|||
161871212|NCT00462709|584573713|FG000|Overall Study|Physician Decision|1|||
161871213|NCT00462709|584573713|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
161871214|NCT02099110|584573718|FG000|Overall Study|Protocol Violation|2|||
161871215|NCT02099110|584573719|FG001|Overall Study|Protocol Violation|1|||
161871216|NCT02099110|584573720|FG002|Overall Study|Protocol Violation|0|||
161871217|NCT02099110|584573721|FG003|Overall Study|Protocol Violation|3|||
161871218|NCT02099110|584573722|FG004|Overall Study|Protocol Violation|1|||
161871219|NCT02099110|584573718|FG000|Overall Study|Participant moved|1|||
161871220|NCT02099110|584573719|FG001|Overall Study|Participant moved|1|||
161871221|NCT02099110|584573720|FG002|Overall Study|Participant moved|1|||
161871222|NCT02099110|584573721|FG003|Overall Study|Participant moved|0|||
161871223|NCT02099110|584573722|FG004|Overall Study|Participant moved|2|||
161871224|NCT02099110|584573718|FG000|Overall Study|Withdrawal by Subject|7|||
161871225|NCT02099110|584573719|FG001|Overall Study|Withdrawal by Subject|11|||
161871226|NCT02099110|584573720|FG002|Overall Study|Withdrawal by Subject|13|||
161871227|NCT02099110|584573721|FG003|Overall Study|Withdrawal by Subject|9|||
161871228|NCT02099110|584573722|FG004|Overall Study|Withdrawal by Subject|13|||
161871229|NCT02099110|584573718|FG000|Overall Study|Adverse Event|3|||
161871230|NCT02099110|584573719|FG001|Overall Study|Adverse Event|5|||
161871231|NCT02099110|584573720|FG002|Overall Study|Adverse Event|2|||
161871232|NCT02099110|584573721|FG003|Overall Study|Adverse Event|3|||
161871233|NCT02099110|584573722|FG004|Overall Study|Adverse Event|2|||
161871234|NCT02099110|584573718|FG000|Overall Study|Lost to Follow-up|6|||
161871235|NCT02099110|584573719|FG001|Overall Study|Lost to Follow-up|12|||
161871236|NCT02099110|584573720|FG002|Overall Study|Lost to Follow-up|11|||
161871237|NCT02099110|584573721|FG003|Overall Study|Lost to Follow-up|5|||
161871238|NCT02099110|584573722|FG004|Overall Study|Lost to Follow-up|6|||
161871239|NCT02099110|584573718|FG000|Overall Study|Death|0|||
161871240|NCT02099110|584573719|FG001|Overall Study|Death|1|||
161871241|NCT02099110|584573720|FG002|Overall Study|Death|0|||
161871242|NCT02099110|584573721|FG003|Overall Study|Death|0|||
161871243|NCT02099110|584573722|FG004|Overall Study|Death|0|||
161871244|NCT02099110|584573718|FG000|Overall Study|Screen failure|0|||
161871245|NCT02099110|584573719|FG001|Overall Study|Screen failure|0|||
161871246|NCT02099110|584573720|FG002|Overall Study|Screen failure|0|||
161871247|NCT02099110|584573721|FG003|Overall Study|Screen failure|0|||
161871248|NCT02099110|584573722|FG004|Overall Study|Screen failure|1|||
161871249|NCT02099110|584573718|FG000|Overall Study|Non-compliance with study drug|2|||
161871250|NCT02099110|584573719|FG001|Overall Study|Non-compliance with study drug|0|||
161871251|NCT02099110|584573720|FG002|Overall Study|Non-compliance with study drug|0|||
161871252|NCT02099110|584573721|FG003|Overall Study|Non-compliance with study drug|0|||
161871253|NCT02099110|584573722|FG004|Overall Study|Non-compliance with study drug|1|||
161871254|NCT02099110|584573718|FG000|Overall Study|Physician Decision|3|||
161871255|NCT02099110|584573719|FG001|Overall Study|Physician Decision|0|||
161871256|NCT02099110|584573720|FG002|Overall Study|Physician Decision|1|||
161871257|NCT02099110|584573721|FG003|Overall Study|Physician Decision|2|||
161871258|NCT02099110|584573722|FG004|Overall Study|Physician Decision|1|||
161871259|NCT02064816|584573723|FG000|Overall Study|Adverse Event|3|||
161871260|NCT02064816|584573724|FG001|Overall Study|Adverse Event|2|||
161871261|NCT02064816|584573723|FG000|Overall Study|Withdrawal by Subject|2|||
161871262|NCT02064816|584573724|FG001|Overall Study|Withdrawal by Subject|1|||
161871263|NCT02064816|584573723|FG000|Overall Study|Lost to Follow-up|2|||
161871264|NCT02064816|584573724|FG001|Overall Study|Lost to Follow-up|1|||
161871265|NCT02064816|584573723|FG000|Overall Study|Therapeutic failure|0|||
161871266|NCT02064816|584573724|FG001|Overall Study|Therapeutic failure|1|||
161871267|NCT02064816|584573723|FG000|Overall Study|Other|1|||
161871268|NCT02064816|584573724|FG001|Overall Study|Other|3|||
161871269|NCT01757184|584573731|FG000|Double-blind Period|Adverse Event|1|||
161871270|NCT01757184|584573732|FG001|Double-blind Period|Adverse Event|0|||
161871271|NCT01757184|584573733|FG002|Double-blind Period|Adverse Event|0|||
161871272|NCT01757184|584573734|FG003|Double-blind Period|Adverse Event|0|||
161871273|NCT01757184|584573731|FG000|Open-label Period|Lost to Follow-up|0|||
161871274|NCT01757184|584573732|FG001|Open-label Period|Lost to Follow-up|0|||
161871275|NCT01757184|584573733|FG002|Open-label Period|Lost to Follow-up|2|||
161871276|NCT01757184|584573734|FG003|Open-label Period|Lost to Follow-up|0|||
161871277|NCT01757184|584573731|FG000|Open-label Period|Withdrawal by Subject|0|||
161871278|NCT01757184|584573732|FG001|Open-label Period|Withdrawal by Subject|0|||
161871279|NCT01757184|584573733|FG002|Open-label Period|Withdrawal by Subject|1|||
161871280|NCT01757184|584573734|FG003|Open-label Period|Withdrawal by Subject|1|||
161871281|NCT01757184|584573731|FG000|Open-label Period|Discontinued by Sponsor|0|||
161871282|NCT01757184|584573732|FG001|Open-label Period|Discontinued by Sponsor|0|||
161871283|NCT01757184|584573733|FG002|Open-label Period|Discontinued by Sponsor|1|||
161871284|NCT01757184|584573734|FG003|Open-label Period|Discontinued by Sponsor|2|||
161871285|NCT00237458|584573735|FG000|Overall Study|Lack of Efficacy|1|||
161871286|NCT00237458|584573735|FG000|Overall Study|Adverse Event|1|||
161871287|NCT00237458|584573735|FG000|Overall Study|Withdrawal by Subject|1|||
161871288|NCT05107492|584573736|FG000|Overall Study|Lost to Follow-up|1|||
161871289|NCT05107492|584573737|FG001|Overall Study|Lost to Follow-up|0|||
161871290|NCT03218826|584573738|FG000|Overall Study|Non-compliance with protocol|1|||
161871291|NCT03218826|584573739|FG001|Overall Study|Non-compliance with protocol|0|||
161871292|NCT03218826|584573740|FG002|Overall Study|Non-compliance with protocol|2|||
161871293|NCT03218826|584573741|FG003|Overall Study|Non-compliance with protocol|1|||
161871294|NCT03218826|584573742|FG004|Overall Study|Non-compliance with protocol|1|||
161871295|NCT04586244|584573749|FG000|Overall Study|Lost to Follow-up|1|||
161871296|NCT04586244|584573750|FG001|Overall Study|Lost to Follow-up|0|||
161871297|NCT04586244|584573751|FG002|Overall Study|Lost to Follow-up|0|||
161871298|NCT04586244|584573752|FG003|Overall Study|Lost to Follow-up|1|||
161871299|NCT04586244|584573753|FG004|Overall Study|Lost to Follow-up|0|||
161871300|NCT04586244|584573749|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871301|NCT04586244|584573750|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
161871302|NCT04586244|584573751|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871303|NCT04586244|584573752|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871304|NCT04586244|584573753|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871305|NCT03564119|584573754|FG000|Overall Study|Adverse Event|4|||
161871306|NCT03564119|584573755|FG001|Overall Study|Adverse Event|0|||
161775360|NCT00650806|584219453|FG000|Overall Study|Study terminated by sponsor|2|||
161775361|NCT00650806|584219454|FG001|Overall Study|Study terminated by sponsor|3|||
161775362|NCT00650806|584219455|FG002|Overall Study|Study terminated by sponsor|5|||
161775363|NCT00650806|584219456|FG003|Overall Study|Study terminated by sponsor|4|||
161775364|NCT00650806|584219453|FG000|Overall Study|Other|1|||
161871307|NCT03564119|584573754|FG000|Overall Study|Lost to Follow-up|1|||
161871308|NCT03564119|584573755|FG001|Overall Study|Lost to Follow-up|4|||
161871309|NCT03564119|584573754|FG000|Overall Study|Protocol Violation|1|||
161871310|NCT03564119|584573755|FG001|Overall Study|Protocol Violation|0|||
161871311|NCT03564119|584573754|FG000|Overall Study|Withdrawal by Subject|9|||
161871312|NCT03564119|584573755|FG001|Overall Study|Withdrawal by Subject|4|||
161871313|NCT03564119|584573754|FG000|Overall Study|Other Than Specified|0|||
161871314|NCT03564119|584573755|FG001|Overall Study|Other Than Specified|1|||
161871315|NCT00634036|584573756|FG000|Overall Study|Lost to Follow-up|1|||
161871316|NCT00634036|584573757|FG001|Overall Study|Lost to Follow-up|1|||
161871317|NCT00634036|584573756|FG000|Overall Study|Withdrawal by Subject|1|||
161775365|NCT00650806|584219454|FG001|Overall Study|Other|1|||
161775366|NCT00650806|584219455|FG002|Overall Study|Other|2|||
161775367|NCT00650806|584219456|FG003|Overall Study|Other|0|||
161775368|NCT04228107|584219457|FG000|Overall Study|Protocol Violation|1|||
161775369|NCT04228107|584219458|FG001|Overall Study|Protocol Violation|0|||
161775370|NCT04228107|584219457|FG000|Overall Study|Withdrawal by Subject|6|||
161775371|NCT04228107|584219458|FG001|Overall Study|Withdrawal by Subject|0|||
161775372|NCT04228107|584219457|FG000|Overall Study|Lost to Follow-up|18|||
161775373|NCT04228107|584219458|FG001|Overall Study|Lost to Follow-up|0|||
161775374|NCT04228107|584219457|FG000|Overall Study|No controller use data|1|||
161775375|NCT04228107|584219458|FG001|Overall Study|No controller use data|0|||
161775376|NCT04228107|584219457|FG000|Overall Study|No medication data collected|1|||
161775377|NCT04228107|584219458|FG001|Overall Study|No medication data collected|0|||
161775378|NCT03792633|584219459|FG000|Overall Study|Alternative Treatment|17|||
161775379|NCT03792633|584219460|FG001|Overall Study|Alternative Treatment|19|||
161775380|NCT03792633|584219459|FG000|Overall Study|Death|2|||
161775381|NCT03792633|584219460|FG001|Overall Study|Death|0|||
161775382|NCT03792633|584219459|FG000|Overall Study|Disease progression|8|||
161775383|NCT03792633|584219460|FG001|Overall Study|Disease progression|9|||
161775384|NCT03792633|584219459|FG000|Overall Study|Lost to Follow-up|1|||
161775385|NCT03792633|584219460|FG001|Overall Study|Lost to Follow-up|1|||
161775386|NCT03792633|584219459|FG000|Overall Study|Screen fail|1|||
161775387|NCT03792633|584219460|FG001|Overall Study|Screen fail|0|||
161775388|NCT03792633|584219459|FG000|Overall Study|Second malignancy|0|||
161775389|NCT03792633|584219460|FG001|Overall Study|Second malignancy|1|||
161775390|NCT00145119|584219461|FG000|Overall Study|Death|45|||
161775391|NCT04411641|584219462|FG000|DB Period|Other|7|||
161775392|NCT04411641|584219463|FG001|DB Period|Other|27|||
161775393|NCT04411641|584219464|FG002|DB Period|Other|0|||
161775394|NCT04411641|584219465|FG003|DB Period|Other|0|||
161775395|NCT04411641|584219462|FG000|DB Period|Withdrawal by Subject|67|||
161775396|NCT04411641|584219463|FG001|DB Period|Withdrawal by Subject|122|||
161775397|NCT04411641|584219464|FG002|DB Period|Withdrawal by Subject|0|||
161775398|NCT04411641|584219465|FG003|DB Period|Withdrawal by Subject|0|||
161775399|NCT04411641|584219462|FG000|DB Period|Progressive disease|76|||
161775400|NCT04411641|584219463|FG001|DB Period|Progressive disease|116|||
161775401|NCT04411641|584219464|FG002|DB Period|Progressive disease|0|||
161775402|NCT04411641|584219465|FG003|DB Period|Progressive disease|0|||
161775403|NCT04411641|584219462|FG000|DB Period|Poor compliance to protocol|1|||
161775404|NCT04411641|584219463|FG001|DB Period|Poor compliance to protocol|5|||
161775405|NCT04411641|584219464|FG002|DB Period|Poor compliance to protocol|0|||
161775406|NCT04411641|584219465|FG003|DB Period|Poor compliance to protocol|0|||
161775407|NCT04411641|584219462|FG000|DB Period|Lack of Efficacy|19|||
161775408|NCT04411641|584219463|FG001|DB Period|Lack of Efficacy|19|||
161775409|NCT04411641|584219464|FG002|DB Period|Lack of Efficacy|0|||
161775410|NCT04411641|584219465|FG003|DB Period|Lack of Efficacy|0|||
161775411|NCT04411641|584219462|FG000|DB Period|Adverse Event|13|||
161775412|NCT04411641|584219463|FG001|DB Period|Adverse Event|29|||
161775413|NCT04411641|584219464|FG002|DB Period|Adverse Event|0|||
161775414|NCT04411641|584219465|FG003|DB Period|Adverse Event|0|||
161775415|NCT04411641|584219462|FG000|DB Period|Randomized and not treated|2|||
161775416|NCT04411641|584219463|FG001|DB Period|Randomized and not treated|2|||
161775417|NCT04411641|584219464|FG002|DB Period|Randomized and not treated|0|||
161775418|NCT04411641|584219465|FG003|DB Period|Randomized and not treated|0|||
161775419|NCT04411641|584219462|FG000|OL|Withdrawal by Subject|0|||
161775420|NCT04411641|584219463|FG001|OL|Withdrawal by Subject|0|||
161775421|NCT04411641|584219464|FG002|OL|Withdrawal by Subject|6|||
161775422|NCT04411641|584219465|FG003|OL|Withdrawal by Subject|17|||
161775423|NCT04411641|584219462|FG000|OL|Progressive disease|0|||
161775424|NCT04411641|584219463|FG001|OL|Progressive disease|0|||
161775425|NCT04411641|584219464|FG002|OL|Progressive disease|1|||
161775426|NCT04411641|584219465|FG003|OL|Progressive disease|2|||
161775427|NCT04411641|584219462|FG000|OL|Poor compliance to protocol|0|||
161775428|NCT04411641|584219463|FG001|OL|Poor compliance to protocol|0|||
161775429|NCT04411641|584219464|FG002|OL|Poor compliance to protocol|1|||
161775430|NCT04411641|584219465|FG003|OL|Poor compliance to protocol|0|||
161775431|NCT04411641|584219462|FG000|OL|Adverse Event|0|||
161775432|NCT04411641|584219463|FG001|OL|Adverse Event|0|||
161871318|NCT00634036|584573757|FG001|Overall Study|Withdrawal by Subject|1|||
161871319|NCT03896022|584573758|FG000|Overall Study|Withdrawal by Subject|1|||
161871320|NCT03896022|584573759|FG001|Overall Study|Withdrawal by Subject|0|||
161871321|NCT03896022|584573760|FG002|Overall Study|Withdrawal by Subject|0|||
161871322|NCT03896022|584573758|FG000|Overall Study|Did not have procedure|3|||
161871323|NCT03896022|584573759|FG001|Overall Study|Did not have procedure|0|||
161871324|NCT03896022|584573760|FG002|Overall Study|Did not have procedure|0|||
161871325|NCT02741076|584573761|FG000|Overall Study|Adverse Event|0|||
161871326|NCT02741076|584573762|FG001|Overall Study|Adverse Event|1|||
161871327|NCT02741076|584573763|FG002|Overall Study|Adverse Event|1|||
161871328|NCT02741076|584573764|FG003|Overall Study|Adverse Event|0|||
161871329|NCT02741076|584573761|FG000|Overall Study|Lack of Efficacy|1|||
161871330|NCT02741076|584573762|FG001|Overall Study|Lack of Efficacy|0|||
161775433|NCT04411641|584219464|FG002|OL|Adverse Event|1|||
161775434|NCT04411641|584219465|FG003|OL|Adverse Event|0|||
161775435|NCT04411641|584219462|FG000|OL|Other|0|||
161775436|NCT04411641|584219463|FG001|OL|Other|0|||
161775437|NCT04411641|584219464|FG002|OL|Other|0|||
161775438|NCT04411641|584219465|FG003|OL|Other|6|||
161775439|NCT04342390|584219466|FG000|Overall Study|Lost to Follow-up|3|||
161775440|NCT04342390|584219467|FG001|Overall Study|Lost to Follow-up|0|||
161775441|NCT01003691|584219472|FG000|Overall Study|Adverse Event|0|||
161775442|NCT01003691|584219473|FG001|Overall Study|Adverse Event|0|||
161775443|NCT01003691|584219474|FG002|Overall Study|Adverse Event|0|||
161775444|NCT01003691|584219475|FG003|Overall Study|Adverse Event|1|||
161775445|NCT01869959|584219479|FG000|Randomization Period|Physician Decision|0|||
161775446|NCT01869959|584219480|FG001|Randomization Period|Physician Decision|0|||
161775447|NCT01869959|584219481|FG002|Randomization Period|Physician Decision|0|||
161775448|NCT01869959|584219482|FG003|Randomization Period|Physician Decision|0|||
161775449|NCT01869959|584219483|FG004|Randomization Period|Physician Decision|1|||
161775450|NCT01869959|584219479|FG000|Treatment Period|Adverse Event|1|||
161775451|NCT01869959|584219480|FG001|Treatment Period|Adverse Event|0|||
161775452|NCT01869959|584219481|FG002|Treatment Period|Adverse Event|3|||
161775453|NCT01869959|584219482|FG003|Treatment Period|Adverse Event|1|||
161775454|NCT01869959|584219483|FG004|Treatment Period|Adverse Event|0|||
161775455|NCT01869959|584219479|FG000|Treatment Period|Sponsor decision|0|||
161775456|NCT01869959|584219480|FG001|Treatment Period|Sponsor decision|1|||
161775457|NCT01869959|584219481|FG002|Treatment Period|Sponsor decision|0|||
161775458|NCT01869959|584219482|FG003|Treatment Period|Sponsor decision|1|||
161775459|NCT01869959|584219483|FG004|Treatment Period|Sponsor decision|0|||
161775460|NCT01869959|584219479|FG000|Treatment Period|Withdrawal by Subject|0|||
161775461|NCT01869959|584219480|FG001|Treatment Period|Withdrawal by Subject|1|||
161775462|NCT01869959|584219481|FG002|Treatment Period|Withdrawal by Subject|0|||
161775463|NCT01869959|584219482|FG003|Treatment Period|Withdrawal by Subject|0|||
161775464|NCT01869959|584219483|FG004|Treatment Period|Withdrawal by Subject|0|||
161775465|NCT04075656|584219488|FG000|Overall Study|Withdrawal by Subject|5|||
161775466|NCT04075656|584219489|FG001|Overall Study|Withdrawal by Subject|5|||
161775467|NCT01519635|584221183|FG000|Overall Study|Withdrawal by Subject|0|||
161775468|NCT01519635|584221184|FG001|Overall Study|Withdrawal by Subject|1|||
161775469|NCT01519635|584221183|FG000|Overall Study|No possibility to put a catheter|1|||
161775470|NCT01519635|584221184|FG001|Overall Study|No possibility to put a catheter|2|||
161775471|NCT00347776|584221185|FG000|1.5 Month Follow-up|Death|2|||
161775472|NCT00347776|584221186|FG001|1.5 Month Follow-up|Death|0|||
161775473|NCT00347776|584221187|FG002|1.5 Month Follow-up|Death|0|||
161775474|NCT00347776|584221185|FG000|1.5 Month Follow-up|reached the endpoint|12|||
161775475|NCT00347776|584221186|FG001|1.5 Month Follow-up|reached the endpoint|8|||
161775476|NCT00347776|584221187|FG002|1.5 Month Follow-up|reached the endpoint|12|||
161775477|NCT00347776|584221185|FG000|6 Month Follow-up|Death|2|||
161775478|NCT00347776|584221186|FG001|6 Month Follow-up|Death|1|||
161775479|NCT00347776|584221187|FG002|6 Month Follow-up|Death|3|||
161871331|NCT02741076|584573763|FG002|Overall Study|Lack of Efficacy|0|||
161871332|NCT02741076|584573764|FG003|Overall Study|Lack of Efficacy|0|||
161871333|NCT02741076|584573761|FG000|Overall Study|Withdrawal by Subject|0|||
161871334|NCT02741076|584573762|FG001|Overall Study|Withdrawal by Subject|1|||
161871335|NCT02741076|584573763|FG002|Overall Study|Withdrawal by Subject|0|||
161871336|NCT02741076|584573764|FG003|Overall Study|Withdrawal by Subject|0|||
161871337|NCT02741076|584573761|FG000|Overall Study|Sponsor Request|2|||
161871338|NCT02741076|584573762|FG001|Overall Study|Sponsor Request|3|||
161871339|NCT02741076|584573763|FG002|Overall Study|Sponsor Request|0|||
161871340|NCT02741076|584573764|FG003|Overall Study|Sponsor Request|1|||
161871341|NCT02741076|584573761|FG000|Overall Study|No additional information available|0|||
161871342|NCT02741076|584573762|FG001|Overall Study|No additional information available|0|||
161871343|NCT02741076|584573763|FG002|Overall Study|No additional information available|1|||
161871344|NCT02741076|584573764|FG003|Overall Study|No additional information available|1|||
161871345|NCT01779440|584573765|FG000|Overall Study|Withdrawal by Subject|3|||
161871346|NCT01779440|584573766|FG001|Overall Study|Withdrawal by Subject|5|||
161871347|NCT01190410|584575111|FG000|Overall Study|Adverse Event|0|||
161871348|NCT01190410|584575112|FG001|Overall Study|Adverse Event|3|||
161871349|NCT01190410|584575111|FG000|Overall Study|Lack of Efficacy|0|||
161871350|NCT01190410|584575112|FG001|Overall Study|Lack of Efficacy|2|||
161871351|NCT01190410|584575111|FG000|Overall Study|Withdrawal by Subject|0|||
161871352|NCT01190410|584575112|FG001|Overall Study|Withdrawal by Subject|2|||
161871353|NCT01190410|584575111|FG000|Overall Study|Administrative decision|1|||
161871354|NCT01190410|584575112|FG001|Overall Study|Administrative decision|0|||
161871355|NCT01190410|584575111|FG000|Overall Study|PI discretion|0|||
161871356|NCT01190410|584575112|FG001|Overall Study|PI discretion|2|||
161871357|NCT01283334|584575114|FG000|Overall Study|Withdrawal by Subject|1|||
161871358|NCT01283334|584575114|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
161871359|NCT01283334|584575114|FG000|Overall Study|Adverse Event|4|||
161871360|NCT01283334|584575114|FG000|Overall Study|Physician Decision|1|||
161871361|NCT03467217|584575115|FG000|Overall Study|Trial stopped early|5|||
161871362|NCT03467217|584575116|FG001|Overall Study|Trial stopped early|2|||
161871363|NCT03467217|584575115|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
161871364|NCT03467217|584575116|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
161871365|NCT03467217|584575115|FG000|Overall Study|Lost to Follow-up|0|||
161871366|NCT03467217|584575116|FG001|Overall Study|Lost to Follow-up|2|||
161871367|NCT00769067|584575117|FG000|Overall Study|Death|89|||
161871368|NCT00769067|584575118|FG001|Overall Study|Death|86|||
161871369|NCT00769067|584575117|FG000|Overall Study|Lost to Follow-up|3|||
161871370|NCT00769067|584575118|FG001|Overall Study|Lost to Follow-up|1|||
161871371|NCT00769067|584575117|FG000|Overall Study|Study terminated by sponsor|1|||
161871372|NCT00769067|584575118|FG001|Overall Study|Study terminated by sponsor|3|||
161871373|NCT00769067|584575117|FG000|Overall Study|Other|1|||
161871374|NCT00769067|584575118|FG001|Overall Study|Other|3|||
161871375|NCT00769067|584575117|FG000|Overall Study|Withdrawal by Subject|0|||
161871376|NCT00769067|584575118|FG001|Overall Study|Withdrawal by Subject|1|||
161871377|NCT04981470|584575121|FG000|Overall Study|Device failure in all 4 patients|4|||
161871378|NCT04402138|584575122|FG000|Overall Study|Progressive Disease|2|||
161871379|NCT04402138|584575122|FG000|Overall Study|Adverse Event|1|||
161871380|NCT00784238|584575123|FG000|Overall Study|Adverse Event|14|||
161871381|NCT00784238|584575123|FG000|Overall Study|Death|2|||
161871382|NCT00784238|584575123|FG000|Overall Study|Lack of Efficacy|33|||
161871383|NCT00784238|584575123|FG000|Overall Study|Lost to Follow-up|29|||
161871384|NCT00784238|584575123|FG000|Overall Study|Pregnancy|1|||
161871385|NCT00784238|584575123|FG000|Overall Study|Withdrawal by Subject|26|||
161871386|NCT00784238|584575123|FG000|Overall Study|Other|14|||
161871387|NCT04390503|584575125|FG000|Overall Study|Physician Decision|2|||
161871388|NCT04390503|584575126|FG001|Overall Study|Physician Decision|1|||
161871389|NCT04390503|584575125|FG000|Overall Study|Adverse Event|1|||
161871390|NCT04390503|584575126|FG001|Overall Study|Adverse Event|0|||
161871391|NCT00078767|584575127|FG000|Overall Study|Withdrawal by Subject|1|||
161871392|NCT00078767|584575128|FG001|Overall Study|Withdrawal by Subject|1|||
161871393|NCT06098339|584575129|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
161871394|NCT06098339|584575130|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
161871395|NCT06098339|584575129|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
161871396|NCT06098339|584575130|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
161871397|NCT03528369|584575133|FG000|Overall Study|Withdrawal by Subject|2|||
161871398|NCT03528369|584575134|FG001|Overall Study|Withdrawal by Subject|0|||
161871399|NCT03528369|584575135|FG002|Overall Study|Withdrawal by Subject|0|||
161871400|NCT03528369|584575133|FG000|Overall Study|Lost to Follow-up|1|||
161871401|NCT03528369|584575134|FG001|Overall Study|Lost to Follow-up|0|||
161871402|NCT03528369|584575135|FG002|Overall Study|Lost to Follow-up|0|||
161871403|NCT03528369|584575133|FG000|Overall Study|Adverse Event|0|||
161871404|NCT03528369|584575134|FG001|Overall Study|Adverse Event|1|||
161871405|NCT03528369|584575135|FG002|Overall Study|Adverse Event|0|||
161871406|NCT04725812|584575136|FG000|Overall Study|Withdrawal by Subject|1|||
161871407|NCT05656534|584575138|FG000|Overall Study|Withdrawal by Subject|1|||
161871408|NCT05656534|584575139|FG001|Overall Study|Withdrawal by Subject|1|||
161871409|NCT05656534|584575140|FG002|Overall Study|Withdrawal by Subject|0|||
161871410|NCT05656534|584575141|FG003|Overall Study|Withdrawal by Subject|0|||
161871411|NCT05656534|584575138|FG000|Overall Study|Physician Decision|1|||
161871412|NCT05656534|584575139|FG001|Overall Study|Physician Decision|1|||
161871413|NCT05656534|584575140|FG002|Overall Study|Physician Decision|0|||
161871414|NCT05656534|584575141|FG003|Overall Study|Physician Decision|0|||
161871415|NCT00839800|584575146|FG000|Overall Study|Adverse Event|8|||
161871416|NCT00839800|584575147|FG001|Overall Study|Adverse Event|12|||
161871417|NCT00839800|584575146|FG000|Overall Study|Lost to Follow-up|31|||
161871418|NCT00839800|584575147|FG001|Overall Study|Lost to Follow-up|26|||
161871419|NCT00839800|584575146|FG000|Overall Study|Withdrawal by Subject|28|||
161871420|NCT00839800|584575147|FG001|Overall Study|Withdrawal by Subject|34|||
161871421|NCT00839800|584575146|FG000|Overall Study|Incorrect Enrolment|3|||
161871422|NCT00839800|584575147|FG001|Overall Study|Incorrect Enrolment|3|||
161871423|NCT00839800|584575146|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
161871424|NCT00839800|584575147|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
161871425|NCT00839800|584575146|FG000|Overall Study|Safety Reasons|2|||
161871426|NCT00839800|584575147|FG001|Overall Study|Safety Reasons|1|||
161871427|NCT00839800|584575146|FG000|Overall Study|Other|8|||
161871428|NCT00839800|584575147|FG001|Overall Study|Other|14|||
161871429|NCT00839800|584575146|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
161871430|NCT00839800|584575147|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
161871431|NCT02801617|584575148|FG000|Overall Study|Protocol Violation|2|||
161871432|NCT02801617|584575149|FG001|Overall Study|Protocol Violation|6|||
161871433|NCT00302328|584575150|FG000|Overall Study|Physician Decision|0|||
161871434|NCT00302328|584575151|FG001|Overall Study|Physician Decision|1|||
161871435|NCT00302328|584575152|FG002|Overall Study|Physician Decision|0|||
161871436|NCT01718535|584575155|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
161871437|NCT01718535|584575156|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
161871438|NCT01718535|584575157|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
161871439|NCT01718535|584575158|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
161871440|NCT01718535|584575159|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
161871441|NCT01718535|584575160|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
161871442|NCT01718535|584575161|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
161871443|NCT01718535|584575162|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
161871444|NCT01718535|584575163|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
161871445|NCT01718535|584575164|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
161871446|NCT02476578|584575165|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
161871447|NCT02476578|584575166|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
161871448|NCT02476578|584575165|FG000|Overall Study|Lost to Follow-up|6|||
161871449|NCT02476578|584575166|FG001|Overall Study|Lost to Follow-up|13|||
161871450|NCT00912743|584575173|FG000|Overall Study|Adverse Event|3|||
161871451|NCT00912743|584575174|FG001|Overall Study|Adverse Event|1|||
161871452|NCT00912743|584575173|FG000|Overall Study|Lack of Efficacy|9|||
161775480|NCT00347776|584221185|FG000|6 Month Follow-up|reached endpont|20|||
161775481|NCT00347776|584221186|FG001|6 Month Follow-up|reached endpont|12|||
161775482|NCT00347776|584221187|FG002|6 Month Follow-up|reached endpont|15|||
161775483|NCT00347776|584221185|FG000|12 Month Follow-up|Lost to Follow-up|7|||
161775484|NCT00347776|584221186|FG001|12 Month Follow-up|Lost to Follow-up|6|||
161775485|NCT00347776|584221187|FG002|12 Month Follow-up|Lost to Follow-up|6|||
161775486|NCT00347776|584221185|FG000|12 Month Follow-up|Death|3|||
161775487|NCT00347776|584221186|FG001|12 Month Follow-up|Death|4|||
161775488|NCT00347776|584221187|FG002|12 Month Follow-up|Death|4|||
161775489|NCT00347776|584221185|FG000|12 Month Follow-up|Reached endpoint|13|||
161775490|NCT00347776|584221186|FG001|12 Month Follow-up|Reached endpoint|6|||
161775491|NCT00347776|584221187|FG002|12 Month Follow-up|Reached endpoint|9|||
161775492|NCT02074982|584221188|FG000|Overall Study|Adverse Event|15|||
161775493|NCT02074982|584221189|FG001|Overall Study|Adverse Event|7|||
161775494|NCT02074982|584221188|FG000|Overall Study|Lack of Efficacy|6|||
161775495|NCT02074982|584221189|FG001|Overall Study|Lack of Efficacy|1|||
161775496|NCT02074982|584221188|FG000|Overall Study|Lost to Follow-up|9|||
161775497|NCT02074982|584221189|FG001|Overall Study|Lost to Follow-up|10|||
161775498|NCT02074982|584221188|FG000|Overall Study|Non-compliance with study treatment|0|||
161775499|NCT02074982|584221189|FG001|Overall Study|Non-compliance with study treatment|2|||
161775500|NCT02074982|584221188|FG000|Overall Study|Physician Decision|1|||
161775501|NCT02074982|584221189|FG001|Overall Study|Physician Decision|1|||
161775502|NCT02074982|584221188|FG000|Overall Study|Pregnancy|1|||
161775503|NCT02074982|584221189|FG001|Overall Study|Pregnancy|2|||
161775504|NCT02074982|584221188|FG000|Overall Study|Protocol deviation|4|||
161775505|NCT02074982|584221189|FG001|Overall Study|Protocol deviation|3|||
161775506|NCT02074982|584221188|FG000|Overall Study|Technical problems|0|||
161775507|NCT02074982|584221189|FG001|Overall Study|Technical problems|2|||
161775508|NCT02074982|584221188|FG000|Overall Study|Subject/guardian decision|15|||
161775509|NCT02074982|584221189|FG001|Overall Study|Subject/guardian decision|24|||
161775510|NCT02074982|584221188|FG000|Overall Study|Death|0|||
161775511|NCT02074982|584221189|FG001|Overall Study|Death|2|||
161775512|NCT02116309|584221206|FG000|Overall Study|Lost to Follow-up|0|||
161775513|NCT02116309|584221207|FG001|Overall Study|Lost to Follow-up|1|||
161775514|NCT03292731|584221208|FG000|Overall Study|Protocol Violation|4|||
161775515|NCT03292731|584221209|FG001|Overall Study|Protocol Violation|11|||
161775516|NCT03292731|584221210|FG002|Overall Study|Protocol Violation|1|||
161775517|NCT00471237|584221211|FG000|Overall Study|Adverse Event|6|||
161775518|NCT00471237|584221212|FG001|Overall Study|Adverse Event|5|||
161775519|NCT00471237|584221213|FG002|Overall Study|Adverse Event|4|||
161775520|NCT00471237|584221214|FG003|Overall Study|Adverse Event|8|||
161775521|NCT00471237|584221215|FG004|Overall Study|Adverse Event|7|||
161775522|NCT00471237|584221216|FG005|Overall Study|Adverse Event|5|||
161775523|NCT00471237|584221217|FG006|Overall Study|Adverse Event|0|||
161775524|NCT00471237|584221211|FG000|Overall Study|Lost to Follow-up|1|||
161775525|NCT00471237|584221212|FG001|Overall Study|Lost to Follow-up|1|||
161775526|NCT00471237|584221213|FG002|Overall Study|Lost to Follow-up|0|||
161775527|NCT00471237|584221214|FG003|Overall Study|Lost to Follow-up|2|||
161775528|NCT00471237|584221215|FG004|Overall Study|Lost to Follow-up|3|||
161775529|NCT00471237|584221216|FG005|Overall Study|Lost to Follow-up|0|||
161775530|NCT00471237|584221217|FG006|Overall Study|Lost to Follow-up|0|||
161775531|NCT00471237|584221211|FG000|Overall Study|Protocol Violation|3|||
161775532|NCT00471237|584221212|FG001|Overall Study|Protocol Violation|6|||
161775533|NCT00471237|584221213|FG002|Overall Study|Protocol Violation|3|||
161775534|NCT00471237|584221214|FG003|Overall Study|Protocol Violation|2|||
161775535|NCT00471237|584221215|FG004|Overall Study|Protocol Violation|2|||
161775536|NCT00471237|584221216|FG005|Overall Study|Protocol Violation|4|||
161775537|NCT00471237|584221217|FG006|Overall Study|Protocol Violation|1|||
161775538|NCT00471237|584221211|FG000|Overall Study|Withdrawal by Subject|8|||
161775539|NCT00471237|584221212|FG001|Overall Study|Withdrawal by Subject|6|||
161775540|NCT00471237|584221213|FG002|Overall Study|Withdrawal by Subject|5|||
161775541|NCT00471237|584221214|FG003|Overall Study|Withdrawal by Subject|8|||
161775542|NCT00471237|584221215|FG004|Overall Study|Withdrawal by Subject|7|||
161775543|NCT00471237|584221216|FG005|Overall Study|Withdrawal by Subject|4|||
161775544|NCT00471237|584221217|FG006|Overall Study|Withdrawal by Subject|2|||
161775545|NCT00471237|584221211|FG000|Overall Study|Sponsor terminated study|20|||
161775546|NCT00471237|584221212|FG001|Overall Study|Sponsor terminated study|23|||
161775547|NCT00471237|584221213|FG002|Overall Study|Sponsor terminated study|19|||
161775548|NCT00471237|584221214|FG003|Overall Study|Sponsor terminated study|22|||
161775549|NCT00471237|584221215|FG004|Overall Study|Sponsor terminated study|18|||
161775550|NCT00471237|584221216|FG005|Overall Study|Sponsor terminated study|24|||
161775551|NCT00471237|584221217|FG006|Overall Study|Sponsor terminated study|0|||
161775552|NCT00471237|584221211|FG000|Overall Study|Non-compliance|0|||
161775553|NCT00471237|584221212|FG001|Overall Study|Non-compliance|1|||
161775554|NCT00471237|584221213|FG002|Overall Study|Non-compliance|0|||
161775555|NCT00471237|584221214|FG003|Overall Study|Non-compliance|1|||
161775556|NCT00471237|584221215|FG004|Overall Study|Non-compliance|0|||
161775557|NCT00471237|584221216|FG005|Overall Study|Non-compliance|0|||
161775558|NCT00471237|584221217|FG006|Overall Study|Non-compliance|0|||
161775559|NCT00471237|584221211|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
161775560|NCT00471237|584221212|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775561|NCT00471237|584221213|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
161775562|NCT00471237|584221214|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
161871453|NCT00912743|584575174|FG001|Overall Study|Lack of Efficacy|18|||
161871454|NCT00912743|584575173|FG000|Overall Study|Toxicity|0|||
161871455|NCT00912743|584575174|FG001|Overall Study|Toxicity|1|||
161871456|NCT00912743|584575173|FG000|Overall Study|End of treatment form was not collected|1|||
161871457|NCT00912743|584575174|FG001|Overall Study|End of treatment form was not collected|0|||
161871458|NCT04747886|584575175|FG000|Overall Study|Withdrawal by Subject|1|||
161871459|NCT04747886|584575176|FG001|Overall Study|Withdrawal by Subject|4|||
161871460|NCT02237196|584575177|FG000|Overall Study|Adverse Event|0|||
161871461|NCT02237196|584575178|FG001|Overall Study|Adverse Event|1|||
161871462|NCT02237196|584575179|FG002|Overall Study|Adverse Event|1|||
161871463|NCT02237196|584575180|FG003|Overall Study|Adverse Event|0|||
161871464|NCT02237196|584575177|FG000|Overall Study|Lost to Follow-up|4|||
161871465|NCT02237196|584575178|FG001|Overall Study|Lost to Follow-up|2|||
161871466|NCT02237196|584575179|FG002|Overall Study|Lost to Follow-up|4|||
161871467|NCT02237196|584575180|FG003|Overall Study|Lost to Follow-up|6|||
161871468|NCT02237196|584575177|FG000|Overall Study|Physician Decision|2|||
161871469|NCT02237196|584575178|FG001|Overall Study|Physician Decision|0|||
161871470|NCT02237196|584575179|FG002|Overall Study|Physician Decision|0|||
161871471|NCT02237196|584575180|FG003|Overall Study|Physician Decision|1|||
161871472|NCT02237196|584575177|FG000|Overall Study|Pregnancy|0|||
161871473|NCT02237196|584575178|FG001|Overall Study|Pregnancy|0|||
161871474|NCT02237196|584575179|FG002|Overall Study|Pregnancy|1|||
161871475|NCT02237196|584575180|FG003|Overall Study|Pregnancy|1|||
161871476|NCT02237196|584575177|FG000|Overall Study|Withdrawal by Subject|1|||
161871477|NCT02237196|584575178|FG001|Overall Study|Withdrawal by Subject|1|||
161871478|NCT02237196|584575179|FG002|Overall Study|Withdrawal by Subject|4|||
161871479|NCT02237196|584575180|FG003|Overall Study|Withdrawal by Subject|1|||
161871480|NCT02237196|584575177|FG000|Overall Study|Site Error|1|||
161871481|NCT02237196|584575178|FG001|Overall Study|Site Error|2|||
161871482|NCT02237196|584575179|FG002|Overall Study|Site Error|0|||
161871483|NCT02237196|584575180|FG003|Overall Study|Site Error|2|||
161871484|NCT01057810|584575181|FG000|Overall Study|Disease progression|156|||
161871485|NCT01057810|584575182|FG001|Overall Study|Disease progression|197|||
161871486|NCT01057810|584575181|FG000|Overall Study|Study drug toxicity|5|||
161871487|NCT01057810|584575182|FG001|Overall Study|Study drug toxicity|114|||
161871488|NCT01057810|584575181|FG000|Overall Study|Adverse event unrelated to study drug|13|||
161871489|NCT01057810|584575182|FG001|Overall Study|Adverse event unrelated to study drug|29|||
161871490|NCT01057810|584575181|FG000|Overall Study|Withdrawal by Subject|10|||
161871491|NCT01057810|584575182|FG001|Overall Study|Withdrawal by Subject|25|||
161871492|NCT01057810|584575181|FG000|Overall Study|Death|2|||
161871493|NCT01057810|584575182|FG001|Overall Study|Death|12|||
161871494|NCT01057810|584575181|FG000|Overall Study|Maximum clinical benefit|5|||
161871495|NCT01057810|584575182|FG001|Overall Study|Maximum clinical benefit|5|||
161871496|NCT01057810|584575181|FG000|Overall Study|Poor/non-compliance|0|||
161871497|NCT01057810|584575182|FG001|Overall Study|Poor/non-compliance|1|||
161871498|NCT01057810|584575181|FG000|Overall Study|No longer met study criteria|0|||
161871499|NCT01057810|584575182|FG001|Overall Study|No longer met study criteria|1|||
161871500|NCT01057810|584575181|FG000|Overall Study|Other|7|||
161871501|NCT01057810|584575182|FG001|Overall Study|Other|14|||
161871502|NCT00267969|584575183|FG000|Controlled Period|Adverse Event|6|||
161871503|NCT00267969|584575184|FG001|Controlled Period|Adverse Event|0|||
161871504|NCT00267969|584575185|FG002|Controlled Period|Adverse Event|2|||
161871505|NCT00267969|584575186|FG003|Controlled Period|Adverse Event|0|||
161871506|NCT00267969|584575187|FG004|Controlled Period|Adverse Event|0|||
161871507|NCT00267969|584575188|FG005|Controlled Period|Adverse Event|0|||
161871508|NCT00267969|584575189|FG006|Controlled Period|Adverse Event|0|||
161871509|NCT00267969|584575183|FG000|Controlled Period|Lack of Efficacy|3|||
161871510|NCT00267969|584575184|FG001|Controlled Period|Lack of Efficacy|0|||
161871511|NCT00267969|584575185|FG002|Controlled Period|Lack of Efficacy|1|||
161871512|NCT00267969|584575186|FG003|Controlled Period|Lack of Efficacy|0|||
161871513|NCT00267969|584575187|FG004|Controlled Period|Lack of Efficacy|0|||
161871514|NCT00267969|584575188|FG005|Controlled Period|Lack of Efficacy|0|||
161871515|NCT00267969|584575189|FG006|Controlled Period|Lack of Efficacy|0|||
161871516|NCT00267969|584575183|FG000|Controlled Period|Lost to Follow-up|1|||
161871517|NCT00267969|584575184|FG001|Controlled Period|Lost to Follow-up|0|||
161871518|NCT00267969|584575185|FG002|Controlled Period|Lost to Follow-up|1|||
161871519|NCT00267969|584575186|FG003|Controlled Period|Lost to Follow-up|0|||
161871520|NCT00267969|584575187|FG004|Controlled Period|Lost to Follow-up|0|||
161871521|NCT00267969|584575188|FG005|Controlled Period|Lost to Follow-up|0|||
161871522|NCT00267969|584575189|FG006|Controlled Period|Lost to Follow-up|0|||
161871523|NCT00267969|584575183|FG000|Controlled Period|Randomized but not treated|0|||
161871524|NCT00267969|584575184|FG001|Controlled Period|Randomized but not treated|0|||
161871525|NCT00267969|584575185|FG002|Controlled Period|Randomized but not treated|1|||
161871526|NCT00267969|584575186|FG003|Controlled Period|Randomized but not treated|0|||
161871527|NCT00267969|584575187|FG004|Controlled Period|Randomized but not treated|0|||
161871528|NCT00267969|584575188|FG005|Controlled Period|Randomized but not treated|0|||
161871529|NCT00267969|584575189|FG006|Controlled Period|Randomized but not treated|0|||
161775563|NCT00471237|584221215|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775564|NCT00471237|584221216|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775565|NCT00471237|584221217|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775566|NCT00471237|584221211|FG000|Overall Study|Early stopping due to non-efficacy|1|||
161775567|NCT00471237|584221212|FG001|Overall Study|Early stopping due to non-efficacy|0|||
161775568|NCT00471237|584221213|FG002|Overall Study|Early stopping due to non-efficacy|0|||
161775569|NCT00471237|584221214|FG003|Overall Study|Early stopping due to non-efficacy|0|||
161775570|NCT00471237|584221215|FG004|Overall Study|Early stopping due to non-efficacy|1|||
161775571|NCT00471237|584221216|FG005|Overall Study|Early stopping due to non-efficacy|0|||
161775572|NCT00471237|584221217|FG006|Overall Study|Early stopping due to non-efficacy|0|||
161775573|NCT00471237|584221211|FG000|Overall Study|Participant planned to travel to abraod|1|||
161775574|NCT00471237|584221212|FG001|Overall Study|Participant planned to travel to abraod|0|||
161775575|NCT00471237|584221213|FG002|Overall Study|Participant planned to travel to abraod|0|||
161871530|NCT00267969|584575183|FG000|Controlled Period|Other|2|||
161871531|NCT00267969|584575184|FG001|Controlled Period|Other|1|||
161871532|NCT00267969|584575185|FG002|Controlled Period|Other|6|||
161871533|NCT00267969|584575186|FG003|Controlled Period|Other|0|||
161871534|NCT00267969|584575187|FG004|Controlled Period|Other|0|||
161871535|NCT00267969|584575188|FG005|Controlled Period|Other|0|||
161871536|NCT00267969|584575189|FG006|Controlled Period|Other|0|||
161871537|NCT00267969|584575183|FG000|After Controlled Period|Adverse Event|0|||
161871538|NCT00267969|584575184|FG001|After Controlled Period|Adverse Event|0|||
161871539|NCT00267969|584575185|FG002|After Controlled Period|Adverse Event|0|||
161871540|NCT00267969|584575186|FG003|After Controlled Period|Adverse Event|7|||
161871541|NCT00267969|584575187|FG004|After Controlled Period|Adverse Event|8|||
161871542|NCT00267969|584575188|FG005|After Controlled Period|Adverse Event|23|||
161871543|NCT00267969|584575189|FG006|After Controlled Period|Adverse Event|21|||
161871544|NCT00267969|584575183|FG000|After Controlled Period|Death|0|||
161871545|NCT00267969|584575184|FG001|After Controlled Period|Death|0|||
161871546|NCT00267969|584575185|FG002|After Controlled Period|Death|0|||
161871547|NCT00267969|584575186|FG003|After Controlled Period|Death|1|||
161871548|NCT00267969|584575187|FG004|After Controlled Period|Death|2|||
161871549|NCT00267969|584575188|FG005|After Controlled Period|Death|0|||
161871550|NCT00267969|584575189|FG006|After Controlled Period|Death|1|||
161871551|NCT00267969|584575183|FG000|After Controlled Period|Lack of Efficacy|0|||
161871552|NCT00267969|584575184|FG001|After Controlled Period|Lack of Efficacy|0|||
161871553|NCT00267969|584575185|FG002|After Controlled Period|Lack of Efficacy|0|||
161871554|NCT00267969|584575186|FG003|After Controlled Period|Lack of Efficacy|10|||
161871555|NCT00267969|584575187|FG004|After Controlled Period|Lack of Efficacy|6|||
161871556|NCT00267969|584575188|FG005|After Controlled Period|Lack of Efficacy|28|||
161871557|NCT00267969|584575189|FG006|After Controlled Period|Lack of Efficacy|15|||
161871558|NCT00267969|584575183|FG000|After Controlled Period|Lost to Follow-up|0|||
161871559|NCT00267969|584575184|FG001|After Controlled Period|Lost to Follow-up|0|||
161871560|NCT00267969|584575185|FG002|After Controlled Period|Lost to Follow-up|0|||
161871561|NCT00267969|584575186|FG003|After Controlled Period|Lost to Follow-up|5|||
161871562|NCT00267969|584575187|FG004|After Controlled Period|Lost to Follow-up|8|||
161871563|NCT00267969|584575188|FG005|After Controlled Period|Lost to Follow-up|9|||
161871564|NCT00267969|584575189|FG006|After Controlled Period|Lost to Follow-up|10|||
161871565|NCT00267969|584575183|FG000|After Controlled Period|Other|0|||
161871566|NCT00267969|584575184|FG001|After Controlled Period|Other|0|||
161871567|NCT00267969|584575185|FG002|After Controlled Period|Other|0|||
161871568|NCT00267969|584575186|FG003|After Controlled Period|Other|13|||
161871569|NCT00267969|584575187|FG004|After Controlled Period|Other|11|||
161871570|NCT00267969|584575188|FG005|After Controlled Period|Other|22|||
161871571|NCT00267969|584575189|FG006|After Controlled Period|Other|25|||
161871572|NCT00862823|584575190|FG000|First Intervention|Withdrawal by Subject|1|||
161871573|NCT00862823|584575191|FG001|First Intervention|Withdrawal by Subject|1|||
161871574|NCT00887315|584575192|FG000|Overall Study|Study termination|7|||
161871575|NCT00887315|584575193|FG001|Overall Study|Study termination|4|||
161871576|NCT00619892|584575195|FG000|Overall Study|Adverse Event|3|||
161871577|NCT00619892|584575196|FG001|Overall Study|Adverse Event|0|||
161871578|NCT00619892|584575195|FG000|Overall Study|Lost to Follow-up|0|||
161871579|NCT00619892|584575196|FG001|Overall Study|Lost to Follow-up|1|||
161871580|NCT00619892|584575195|FG000|Overall Study|Intercurrent illness|0|||
161871581|NCT00619892|584575196|FG001|Overall Study|Intercurrent illness|1|||
161871582|NCT00857896|584575205|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
161871583|NCT01091662|584575207|FG000|Overall Study|Adverse Event|1|||
161871584|NCT01091662|584575208|FG001|Overall Study|Adverse Event|9|||
161871585|NCT01091662|584575207|FG000|Overall Study|Physician Decision|1|||
161871586|NCT01091662|584575208|FG001|Overall Study|Physician Decision|1|||
161871587|NCT01091662|584575207|FG000|Overall Study|Withdrawal by Subject|7|||
161871588|NCT01091662|584575208|FG001|Overall Study|Withdrawal by Subject|6|||
161871589|NCT01091662|584575207|FG000|Overall Study|met exit criteria|7|||
161871590|NCT01091662|584575208|FG001|Overall Study|met exit criteria|13|||
161871591|NCT01091662|584575207|FG000|Overall Study|met exclusion criteria|1|||
161871592|NCT01091662|584575208|FG001|Overall Study|met exclusion criteria|0|||
161871593|NCT01091662|584575207|FG000|Overall Study|Lost to Follow-up|0|||
161871594|NCT01091662|584575208|FG001|Overall Study|Lost to Follow-up|1|||
161871595|NCT01091662|584575207|FG000|Overall Study|Pregnancy|0|||
161871596|NCT01091662|584575208|FG001|Overall Study|Pregnancy|1|||
161871597|NCT01091662|584575207|FG000|Overall Study|Protocol Violation|0|||
161871598|NCT01091662|584575208|FG001|Overall Study|Protocol Violation|2|||
161871599|NCT01091662|584575207|FG000|Overall Study|unable to swallow capsule|0|||
161871600|NCT01091662|584575208|FG001|Overall Study|unable to swallow capsule|1|||
161871601|NCT02285166|584575209|FG000|Overall Study|Case Report Forms Uncollected|564|||
161871602|NCT02285166|584575209|FG000|Overall Study|Protocol Deviation|402|||
161871603|NCT00443079|584575214|FG000|Overall Study|Lost to Follow-up|0|||
161871604|NCT00443079|584575215|FG001|Overall Study|Lost to Follow-up|1|||
161871605|NCT01421225|584575216|FG000|Overall Study|Withdrawal by Subject|0|||
161871606|NCT01421225|584575217|FG001|Overall Study|Withdrawal by Subject|1|||
161871607|NCT02049814|584575218|FG000|Overall Study|Reason not Specified|4|||
161871608|NCT02049814|584575219|FG001|Overall Study|Reason not Specified|3|||
161871609|NCT02049814|584575218|FG000|Overall Study|Pregnancy|1|||
161871610|NCT02049814|584575219|FG001|Overall Study|Pregnancy|0|||
161871611|NCT02049814|584575218|FG000|Overall Study|Lost to Follow-up|2|||
161871612|NCT02049814|584575219|FG001|Overall Study|Lost to Follow-up|3|||
161871613|NCT02049814|584575218|FG000|Overall Study|Serious Protocol Violation|5|||
161871614|NCT02049814|584575219|FG001|Overall Study|Serious Protocol Violation|7|||
161871615|NCT02049814|584575218|FG000|Overall Study|Study Termination|0|||
161871616|NCT02049814|584575219|FG001|Overall Study|Study Termination|1|||
161871617|NCT02049814|584575218|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
161871618|NCT02049814|584575219|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
161871619|NCT02049814|584575218|FG000|Overall Study|Voluntary withdrawal|9|||
161871620|NCT02049814|584575219|FG001|Overall Study|Voluntary withdrawal|8|||
161871621|NCT02714595|584575220|FG000|Overall Study|Lost to Follow-up|1|||
161871622|NCT02714595|584575221|FG001|Overall Study|Lost to Follow-up|0|||
161871623|NCT02714595|584575220|FG000|Overall Study|Withdrawal by Subject|1|||
161871624|NCT02714595|584575221|FG001|Overall Study|Withdrawal by Subject|2|||
161871625|NCT02714595|584575220|FG000|Overall Study|Lack of Efficacy|0|||
161871626|NCT02714595|584575221|FG001|Overall Study|Lack of Efficacy|1|||
161871627|NCT02714595|584575220|FG000|Overall Study|Death|30|||
161871628|NCT02714595|584575221|FG001|Overall Study|Death|9|||
161871629|NCT02714595|584575220|FG000|Overall Study|Other-Miscellaneous|0|||
161871630|NCT02714595|584575221|FG001|Overall Study|Other-Miscellaneous|1|||
161871631|NCT00713258|584575222|FG000|Overall Study|Adverse Event|2|||
161871632|NCT00713258|584575223|FG001|Overall Study|Adverse Event|4|||
161871633|NCT00713258|584575222|FG000|Overall Study|Non-Compliance|2|||
161871634|NCT00713258|584575223|FG001|Overall Study|Non-Compliance|1|||
161871635|NCT00713258|584575222|FG000|Overall Study|Other|1|||
161871636|NCT00713258|584575223|FG001|Overall Study|Other|1|||
161871637|NCT03515811|584575236|FG000|Overall Study|Lost to Follow-up|2|||
161871638|NCT03515811|584575237|FG001|Overall Study|Lost to Follow-up|1|||
161871639|NCT03515811|584575236|FG000|Overall Study|Protocol Violation|1|||
161871640|NCT03515811|584575237|FG001|Overall Study|Protocol Violation|1|||
161871641|NCT03515811|584575236|FG000|Overall Study|Death|1|||
161871642|NCT03515811|584575237|FG001|Overall Study|Death|1|||
161871643|NCT03515811|584575236|FG000|Overall Study|Withdrawal by Subject|0|||
161871644|NCT03515811|584575237|FG001|Overall Study|Withdrawal by Subject|2|||
161871645|NCT03515811|584575236|FG000|Overall Study|Technical Problems|1|||
161871646|NCT03515811|584575237|FG001|Overall Study|Technical Problems|0|||
161871647|NCT03515811|584575236|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
161871648|NCT03515811|584575237|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
161871649|NCT03515811|584575236|FG000|Overall Study|COVID-19|0|||
161871650|NCT03515811|584575237|FG001|Overall Study|COVID-19|1|||
161871651|NCT01197534|584575238|FG000|Overall Study|Not reported|16|||
161871652|NCT01197534|584575239|FG001|Overall Study|Not reported|10|||
161871653|NCT01197534|584575240|FG002|Overall Study|Not reported|16|||
161871654|NCT01197534|584575238|FG000|Overall Study|Enrolment in long term extension|57|||
161871655|NCT01197534|584575239|FG001|Overall Study|Enrolment in long term extension|66|||
161871656|NCT01197534|584575240|FG002|Overall Study|Enrolment in long term extension|119|||
161871657|NCT01197534|584575238|FG000|Overall Study|Severe non-compliance to protocol|3|||
161871658|NCT01197534|584575239|FG001|Overall Study|Severe non-compliance to protocol|4|||
161871659|NCT01197534|584575240|FG002|Overall Study|Severe non-compliance to protocol|1|||
161871660|NCT01197534|584575238|FG000|Overall Study|Lack of therapeutic response|9|||
161871661|NCT01197534|584575239|FG001|Overall Study|Lack of therapeutic response|4|||
161871662|NCT01197534|584575240|FG002|Overall Study|Lack of therapeutic response|9|||
161871663|NCT01197534|584575238|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
161871664|NCT01197534|584575239|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
161871665|NCT01197534|584575240|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
161871666|NCT01197534|584575238|FG000|Overall Study|Lost to Follow-up|1|||
161871667|NCT01197534|584575239|FG001|Overall Study|Lost to Follow-up|4|||
161871668|NCT01197534|584575240|FG002|Overall Study|Lost to Follow-up|2|||
161871669|NCT01197534|584575238|FG000|Overall Study|Adverse Event|35|||
161871670|NCT01197534|584575239|FG001|Overall Study|Adverse Event|36|||
161871671|NCT01197534|584575240|FG002|Overall Study|Adverse Event|24|||
161871672|NCT02593097|584575241|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
161871673|NCT02593097|584575242|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
161871674|NCT02593097|584575241|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161871675|NCT02593097|584575242|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161871676|NCT02593097|584575241|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
161871677|NCT02593097|584575242|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
161871678|NCT02593097|584575241|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
161871679|NCT02593097|584575242|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
161871680|NCT02593097|584575241|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
161871681|NCT02593097|584575242|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
161871682|NCT02858583|584575243|FG000|Overall Study|Declined consent|1|||
161871683|NCT02858583|584575244|FG001|Overall Study|Declined consent|1|||
161871684|NCT03627546|584575249|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
161871685|NCT03627546|584575250|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
161871686|NCT03627546|584575251|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
161871687|NCT03627546|584575249|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
161871688|NCT03627546|584575250|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
161871689|NCT03627546|584575251|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
161871690|NCT00961350|584575254|FG000|Overall Study|Adverse Event|18|||
161871691|NCT00961350|584575255|FG001|Overall Study|Adverse Event|33|||
161871692|NCT00961350|584575254|FG000|Overall Study|Withdrawal by Subject|10|||
161871693|NCT00961350|584575255|FG001|Overall Study|Withdrawal by Subject|10|||
161871694|NCT00961350|584575254|FG000|Overall Study|Lost to Follow-up|3|||
161871695|NCT00961350|584575255|FG001|Overall Study|Lost to Follow-up|3|||
161871696|NCT00961350|584575254|FG000|Overall Study|Misc|16|||
161871697|NCT00961350|584575255|FG001|Overall Study|Misc|21|||
161871698|NCT03291431|584575257|FG000|Overall Study|Protocol Violation|2|||
161871699|NCT03291431|584575258|FG001|Overall Study|Protocol Violation|1|||
161871700|NCT03291431|584575257|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
161871701|NCT03291431|584575258|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
161871702|NCT03291431|584575257|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
161871703|NCT03291431|584575258|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
161871704|NCT06868654|584575259|FG000|Overall Study|Death|4|||
161871705|NCT06868654|584575260|FG001|Overall Study|Death|14|||
161871706|NCT06868654|584575259|FG000|Overall Study|Lost to Follow-up|0|||
161871707|NCT06868654|584575260|FG001|Overall Study|Lost to Follow-up|1|||
161871708|NCT06868654|584575259|FG000|Overall Study|Withdrawal by Subject|5|||
161871709|NCT06868654|584575260|FG001|Overall Study|Withdrawal by Subject|3|||
161871710|NCT06868654|584575259|FG000|Overall Study|Physician Decision|0|||
161871711|NCT06868654|584575260|FG001|Overall Study|Physician Decision|1|||
161871712|NCT06868654|584575259|FG000|Overall Study|Ongoing|23|||
161871713|NCT06868654|584575260|FG001|Overall Study|Ongoing|21|||
161871714|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
161871715|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
161871716|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
161871717|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
161871718|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
161871719|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
161871720|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
161871721|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
161871722|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
161871723|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
161871724|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Adverse Event|5|||
161871725|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Adverse Event|11|||
161871726|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
161871727|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
161871728|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Physician Decision|6|||
161871729|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Physician Decision|3|||
161871730|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Pregnancy|2|||
161871731|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Pregnancy|2|||
161871732|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
161871733|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
161871734|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
161871735|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
161871736|NCT03867201|584575261|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
161871737|NCT03867201|584575262|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
161871738|NCT03867201|584575261|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
161871739|NCT03867201|584575262|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
161871740|NCT03260244|584576950|FG000|Overall Study|Death|19|||
161871741|NCT03260244|584576950|FG000|Overall Study|Lost to Follow-up|60|||
161871742|NCT03260244|584576950|FG000|Overall Study|Withdrawal by Subject|48|||
161871743|NCT03260244|584576950|FG000|Overall Study|Procedure Not Performed|21|||
161871744|NCT03260244|584576950|FG000|Overall Study|Enrollment Criteria Not Met|31|||
161871745|NCT03260244|584576950|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
161871746|NCT03260244|584576950|FG000|Overall Study|Subject Noncompliance|6|||
161775576|NCT00471237|584221214|FG003|Overall Study|Participant planned to travel to abraod|0|||
161775577|NCT00471237|584221215|FG004|Overall Study|Participant planned to travel to abraod|0|||
161775578|NCT00471237|584221216|FG005|Overall Study|Participant planned to travel to abraod|1|||
161775579|NCT00471237|584221217|FG006|Overall Study|Participant planned to travel to abraod|0|||
161775580|NCT00471237|584221211|FG000|Overall Study|High parathyroid hormone|0|||
161775581|NCT00471237|584221212|FG001|Overall Study|High parathyroid hormone|0|||
161775582|NCT00471237|584221213|FG002|Overall Study|High parathyroid hormone|1|||
161775583|NCT00471237|584221214|FG003|Overall Study|High parathyroid hormone|0|||
161775584|NCT00471237|584221215|FG004|Overall Study|High parathyroid hormone|0|||
161775585|NCT00471237|584221216|FG005|Overall Study|High parathyroid hormone|0|||
161775586|NCT00471237|584221217|FG006|Overall Study|High parathyroid hormone|0|||
161775587|NCT00471237|584221211|FG000|Overall Study|Participant lost medication|0|||
161775588|NCT00471237|584221212|FG001|Overall Study|Participant lost medication|0|||
161775589|NCT00471237|584221213|FG002|Overall Study|Participant lost medication|0|||
161775590|NCT00471237|584221214|FG003|Overall Study|Participant lost medication|0|||
161775591|NCT00471237|584221215|FG004|Overall Study|Participant lost medication|1|||
161775592|NCT00471237|584221216|FG005|Overall Study|Participant lost medication|0|||
161775593|NCT00471237|584221217|FG006|Overall Study|Participant lost medication|0|||
161775594|NCT00471237|584221211|FG000|Overall Study|Administration of prohibited medicine|0|||
161871747|NCT03260244|584576950|FG000|Overall Study|No inducible Arrhythmia|2|||
161871748|NCT03260244|584576950|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
161871749|NCT03260244|584576950|FG000|Overall Study|Screen Failure|2|||
161871750|NCT03260244|584576950|FG000|Overall Study|Treated Off Label|69|||
161871751|NCT03260244|584576950|FG000|Overall Study|No Radiofrequency Ablation|14|||
161871752|NCT01288937|584576954|FG000|Overall Study|Adverse Event|1|||
161871753|NCT01288937|584576955|FG001|Overall Study|Adverse Event|0|||
161871754|NCT01750697|584576961|FG000|Overall Study|Transferred Back to Local Hospital|1|||
161871755|NCT01750697|584576961|FG000|Overall Study|Physician and Family Decision|1|||
161871756|NCT01750697|584576961|FG000|Overall Study|Transferred to Adult Services|5|||
161871757|NCT01750697|584576961|FG000|Overall Study|Physician Decision|1|||
161871758|NCT01750697|584576961|FG000|Overall Study|Withdrawal by Subject|1|||
161871759|NCT00384839|584576966|FG000|Overall Study|Adverse Event|4|||
161871760|NCT00384839|584576966|FG000|Overall Study|Investigator Request|1|||
161871761|NCT00384839|584576966|FG000|Overall Study|Patient Request|1|||
161871762|NCT00384839|584576966|FG000|Overall Study|Ineligible|2|||
161871763|NCT01431716|584576969|FG000|Overall Study|Withdrawal of consent|1|||
161871764|NCT02484456|584576972|FG000|Washout Period|Withdrawal by Subject|0|||
161871765|NCT02484456|584576973|FG001|Washout Period|Withdrawal by Subject|1|||
161871766|NCT02484456|584576972|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
161871767|NCT02484456|584576973|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
161871768|NCT02484456|584576972|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
161871769|NCT02484456|584576973|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
161871770|NCT02484456|584576972|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
161871771|NCT02484456|584576973|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
161871772|NCT00708214|584576974|FG000|Overall Study|Other Adverse Event|3|||
161871773|NCT00708214|584576975|FG001|Overall Study|Other Adverse Event|6|||
161871774|NCT00708214|584576976|FG002|Overall Study|Other Adverse Event|2|||
161871775|NCT00708214|584576974|FG000|Overall Study|Other|0|||
161871776|NCT00708214|584576975|FG001|Overall Study|Other|1|||
161871777|NCT00708214|584576976|FG002|Overall Study|Other|1|||
161871778|NCT00708214|584576974|FG000|Overall Study|Progressive Disease|4|||
161871779|NCT00708214|584576975|FG001|Overall Study|Progressive Disease|6|||
161871780|NCT00708214|584576976|FG002|Overall Study|Progressive Disease|5|||
161871781|NCT02199795|584576977|FG000|Overall Study|no longer met inclusion criteria|1|||
161871782|NCT02199795|584576978|FG001|Overall Study|no longer met inclusion criteria|0|||
161871783|NCT02199795|584576977|FG000|Overall Study|withdrew due to shoulder pain|1|||
161871784|NCT02199795|584576978|FG001|Overall Study|withdrew due to shoulder pain|0|||
161871785|NCT01908829|584576982|FG000|Overall Study|Adverse Event|13|||
161871786|NCT01908829|584576983|FG001|Overall Study|Adverse Event|11|||
161871787|NCT01908829|584576984|FG002|Overall Study|Adverse Event|13|||
161871788|NCT01908829|584576982|FG000|Overall Study|Lost to Follow-up|4|||
161871789|NCT01908829|584576983|FG001|Overall Study|Lost to Follow-up|2|||
161871790|NCT01908829|584576984|FG002|Overall Study|Lost to Follow-up|1|||
161871791|NCT01908829|584576982|FG000|Overall Study|Randomized no double-blind drug received|1|||
161871792|NCT01908829|584576983|FG001|Overall Study|Randomized no double-blind drug received|0|||
161871793|NCT01908829|584576984|FG002|Overall Study|Randomized no double-blind drug received|1|||
161871794|NCT01908829|584576982|FG000|Overall Study|Discontinued (no EoT page)|2|||
161871795|NCT01908829|584576983|FG001|Overall Study|Discontinued (no EoT page)|0|||
161871796|NCT01908829|584576984|FG002|Overall Study|Discontinued (no EoT page)|0|||
161871797|NCT01908829|584576982|FG000|Overall Study|Miscellaneous|0|||
161871798|NCT01908829|584576983|FG001|Overall Study|Miscellaneous|2|||
161871799|NCT01908829|584576984|FG002|Overall Study|Miscellaneous|0|||
161871800|NCT01908829|584576982|FG000|Overall Study|Protocol Violation|2|||
161871801|NCT01908829|584576983|FG001|Overall Study|Protocol Violation|2|||
161871802|NCT01908829|584576984|FG002|Overall Study|Protocol Violation|0|||
161871803|NCT01908829|584576982|FG000|Overall Study|Lack of Efficacy|1|||
161871804|NCT01908829|584576983|FG001|Overall Study|Lack of Efficacy|3|||
161871805|NCT01908829|584576984|FG002|Overall Study|Lack of Efficacy|2|||
161871806|NCT01908829|584576982|FG000|Overall Study|Withdrawal by Subject|26|||
161871807|NCT01908829|584576983|FG001|Overall Study|Withdrawal by Subject|29|||
161871808|NCT01908829|584576984|FG002|Overall Study|Withdrawal by Subject|22|||
161871809|NCT02792192|584576985|FG000|Overall Study|Death|1|||
161871810|NCT02792192|584576986|FG001|Overall Study|Death|0|||
161871811|NCT02792192|584576987|FG002|Overall Study|Death|0|||
161871812|NCT02792192|584576988|FG003|Overall Study|Death|0|||
161871813|NCT02792192|584576985|FG000|Overall Study|Informed Consent Withdrawn|4|||
161871814|NCT02792192|584576986|FG001|Overall Study|Informed Consent Withdrawn|0|||
161871815|NCT02792192|584576987|FG002|Overall Study|Informed Consent Withdrawn|0|||
161871816|NCT02792192|584576988|FG003|Overall Study|Informed Consent Withdrawn|0|||
161871817|NCT02792192|584576985|FG000|Overall Study|Physician Decision|1|||
161871818|NCT02792192|584576986|FG001|Overall Study|Physician Decision|0|||
161871819|NCT02792192|584576987|FG002|Overall Study|Physician Decision|0|||
161871820|NCT02792192|584576988|FG003|Overall Study|Physician Decision|0|||
161871821|NCT02792192|584576985|FG000|Overall Study|Progressive Disease|0|||
161871822|NCT02792192|584576986|FG001|Overall Study|Progressive Disease|1|||
161871823|NCT02792192|584576987|FG002|Overall Study|Progressive Disease|0|||
161871824|NCT02792192|584576988|FG003|Overall Study|Progressive Disease|0|||
161871825|NCT02792192|584576985|FG000|Overall Study|Study Terminated By Sponsor|6|||
161871826|NCT02792192|584576986|FG001|Overall Study|Study Terminated By Sponsor|10|||
161871827|NCT02792192|584576987|FG002|Overall Study|Study Terminated By Sponsor|0|||
161871828|NCT02792192|584576988|FG003|Overall Study|Study Terminated By Sponsor|0|||
161871829|NCT01339923|584576989|FG000|Overall Study|Adverse Event|1|||
161871830|NCT01339923|584576990|FG001|Overall Study|Adverse Event|1|||
161871831|NCT01339923|584576991|FG002|Overall Study|Adverse Event|1|||
161871832|NCT01339923|584576992|FG003|Overall Study|Adverse Event|0|||
161871833|NCT01339923|584576993|FG004|Overall Study|Adverse Event|0|||
161871834|NCT01339923|584576994|FG005|Overall Study|Adverse Event|0|||
161871835|NCT01339923|584576995|FG006|Overall Study|Adverse Event|1|||
161871836|NCT01339923|584576989|FG000|Overall Study|Inappropriate Enrollment|1|||
161871837|NCT01339923|584576990|FG001|Overall Study|Inappropriate Enrollment|0|||
161871838|NCT01339923|584576991|FG002|Overall Study|Inappropriate Enrollment|0|||
161871839|NCT01339923|584576992|FG003|Overall Study|Inappropriate Enrollment|0|||
161871840|NCT01339923|584576993|FG004|Overall Study|Inappropriate Enrollment|0|||
161871841|NCT01339923|584576994|FG005|Overall Study|Inappropriate Enrollment|1|||
161871842|NCT01339923|584576995|FG006|Overall Study|Inappropriate Enrollment|0|||
161871843|NCT01339923|584576989|FG000|Overall Study|Lost to Follow-up|4|||
161871844|NCT01339923|584576990|FG001|Overall Study|Lost to Follow-up|4|||
161871845|NCT01339923|584576991|FG002|Overall Study|Lost to Follow-up|0|||
161871846|NCT01339923|584576992|FG003|Overall Study|Lost to Follow-up|3|||
161871847|NCT01339923|584576993|FG004|Overall Study|Lost to Follow-up|1|||
161871848|NCT01339923|584576994|FG005|Overall Study|Lost to Follow-up|1|||
161871849|NCT01339923|584576995|FG006|Overall Study|Lost to Follow-up|5|||
161871850|NCT01339923|584576989|FG000|Overall Study|Protocol Violation|0|||
161871851|NCT01339923|584576990|FG001|Overall Study|Protocol Violation|0|||
161871852|NCT01339923|584576991|FG002|Overall Study|Protocol Violation|0|||
161871853|NCT01339923|584576992|FG003|Overall Study|Protocol Violation|0|||
161871854|NCT01339923|584576993|FG004|Overall Study|Protocol Violation|0|||
161871855|NCT01339923|584576994|FG005|Overall Study|Protocol Violation|3|||
161871856|NCT01339923|584576995|FG006|Overall Study|Protocol Violation|1|||
161871857|NCT01339923|584576989|FG000|Overall Study|Unable to Classify|1|||
161871858|NCT01339923|584576990|FG001|Overall Study|Unable to Classify|0|||
161871859|NCT01339923|584576991|FG002|Overall Study|Unable to Classify|1|||
161871860|NCT01339923|584576992|FG003|Overall Study|Unable to Classify|0|||
161871861|NCT01339923|584576993|FG004|Overall Study|Unable to Classify|0|||
161871862|NCT01339923|584576994|FG005|Overall Study|Unable to Classify|1|||
161871863|NCT01339923|584576995|FG006|Overall Study|Unable to Classify|5|||
161871864|NCT01339923|584576989|FG000|Overall Study|Withdrawal by Subject|7|||
161871865|NCT01339923|584576990|FG001|Overall Study|Withdrawal by Subject|11|||
161871866|NCT01339923|584576991|FG002|Overall Study|Withdrawal by Subject|6|||
161871867|NCT01339923|584576992|FG003|Overall Study|Withdrawal by Subject|1|||
161871868|NCT01339923|584576993|FG004|Overall Study|Withdrawal by Subject|4|||
161871869|NCT01339923|584576994|FG005|Overall Study|Withdrawal by Subject|3|||
161871870|NCT01339923|584576995|FG006|Overall Study|Withdrawal by Subject|2|||
161871871|NCT01430403|584576998|FG000|Overall Study|Lost to Follow-up|5|||
161871872|NCT01430403|584576999|FG001|Overall Study|Lost to Follow-up|5|||
161871873|NCT01430403|584577000|FG002|Overall Study|Lost to Follow-up|3|||
161871874|NCT01430403|584576998|FG000|Overall Study|Physician Decision|1|||
161871875|NCT01430403|584576999|FG001|Overall Study|Physician Decision|0|||
161871876|NCT01430403|584577000|FG002|Overall Study|Physician Decision|0|||
161871877|NCT01430403|584576998|FG000|Overall Study|Protocol Violation|2|||
161871878|NCT01430403|584576999|FG001|Overall Study|Protocol Violation|3|||
161871879|NCT01430403|584577000|FG002|Overall Study|Protocol Violation|2|||
161871880|NCT01430403|584576998|FG000|Overall Study|Withdrawal by Subject|9|||
161871881|NCT01430403|584576999|FG001|Overall Study|Withdrawal by Subject|1|||
161871882|NCT01430403|584577000|FG002|Overall Study|Withdrawal by Subject|3|||
161871883|NCT02677922|584577001|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161871884|NCT02677922|584577002|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
161871885|NCT02677922|584577003|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
161871886|NCT02677922|584577004|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
161871887|NCT02677922|584577005|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
161871888|NCT02677922|584577006|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
161871889|NCT02677922|584577001|FG000|Treatment Period|Adverse Event|0|||
161871890|NCT02677922|584577002|FG001|Treatment Period|Adverse Event|0|||
161871891|NCT02677922|584577003|FG002|Treatment Period|Adverse Event|1|||
161871892|NCT02677922|584577004|FG003|Treatment Period|Adverse Event|3|||
161871893|NCT02677922|584577005|FG004|Treatment Period|Adverse Event|5|||
161871894|NCT02677922|584577006|FG005|Treatment Period|Adverse Event|2|||
161871895|NCT02677922|584577001|FG000|Treatment Period|Progressive Disease|1|||
161871896|NCT02677922|584577002|FG001|Treatment Period|Progressive Disease|1|||
161871897|NCT02677922|584577003|FG002|Treatment Period|Progressive Disease|0|||
161871898|NCT02677922|584577004|FG003|Treatment Period|Progressive Disease|0|||
161871899|NCT02677922|584577005|FG004|Treatment Period|Progressive Disease|8|||
161871900|NCT02677922|584577006|FG005|Treatment Period|Progressive Disease|7|||
161871901|NCT02677922|584577001|FG000|Treatment Period|Lack of Efficacy|0|||
161871902|NCT02677922|584577002|FG001|Treatment Period|Lack of Efficacy|0|||
161871903|NCT02677922|584577003|FG002|Treatment Period|Lack of Efficacy|0|||
161871904|NCT02677922|584577004|FG003|Treatment Period|Lack of Efficacy|1|||
161871905|NCT02677922|584577005|FG004|Treatment Period|Lack of Efficacy|1|||
161871906|NCT02677922|584577006|FG005|Treatment Period|Lack of Efficacy|6|||
161871907|NCT02677922|584577001|FG000|Treatment Period|Withdrawal by Subject|0|||
161871908|NCT02677922|584577002|FG001|Treatment Period|Withdrawal by Subject|0|||
161871909|NCT02677922|584577003|FG002|Treatment Period|Withdrawal by Subject|1|||
161871910|NCT02677922|584577004|FG003|Treatment Period|Withdrawal by Subject|3|||
161871911|NCT02677922|584577005|FG004|Treatment Period|Withdrawal by Subject|5|||
161871912|NCT02677922|584577006|FG005|Treatment Period|Withdrawal by Subject|5|||
161871913|NCT02677922|584577001|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
161871914|NCT02677922|584577002|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
161871915|NCT02677922|584577003|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
161871916|NCT02677922|584577004|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
161871917|NCT02677922|584577005|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
161871918|NCT02677922|584577006|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
161871919|NCT02677922|584577001|FG000|Treatment Period|Disease Relapse|0|||
161871920|NCT02677922|584577002|FG001|Treatment Period|Disease Relapse|0|||
161871921|NCT02677922|584577003|FG002|Treatment Period|Disease Relapse|0|||
161871922|NCT02677922|584577004|FG003|Treatment Period|Disease Relapse|3|||
161871923|NCT02677922|584577005|FG004|Treatment Period|Disease Relapse|6|||
161871924|NCT02677922|584577006|FG005|Treatment Period|Disease Relapse|1|||
161871925|NCT02677922|584577001|FG000|Treatment Period|Allogeneic HSCT|1|||
161871926|NCT02677922|584577002|FG001|Treatment Period|Allogeneic HSCT|0|||
161871927|NCT02677922|584577003|FG002|Treatment Period|Allogeneic HSCT|0|||
161871928|NCT02677922|584577004|FG003|Treatment Period|Allogeneic HSCT|1|||
161871929|NCT02677922|584577005|FG004|Treatment Period|Allogeneic HSCT|4|||
161871930|NCT02677922|584577006|FG005|Treatment Period|Allogeneic HSCT|1|||
161871931|NCT02677922|584577001|FG000|Treatment Period|Other Reasons|0|||
161871932|NCT02677922|584577002|FG001|Treatment Period|Other Reasons|0|||
161871933|NCT02677922|584577003|FG002|Treatment Period|Other Reasons|0|||
161871934|NCT02677922|584577004|FG003|Treatment Period|Other Reasons|1|||
161871935|NCT02677922|584577005|FG004|Treatment Period|Other Reasons|3|||
161871936|NCT02677922|584577006|FG005|Treatment Period|Other Reasons|5|||
161871937|NCT02677922|584577001|FG000|Treatment Period|Death|0|||
161871938|NCT02677922|584577002|FG001|Treatment Period|Death|0|||
161871939|NCT02677922|584577003|FG002|Treatment Period|Death|0|||
161871940|NCT02677922|584577004|FG003|Treatment Period|Death|0|||
161871941|NCT02677922|584577005|FG004|Treatment Period|Death|12|||
161871942|NCT02677922|584577006|FG005|Treatment Period|Death|1|||
161871943|NCT02677922|584577001|FG000|Treatment Period|Non-compliance with Study Drug|0|||
161871944|NCT02677922|584577002|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161871945|NCT02677922|584577003|FG002|Treatment Period|Non-compliance with Study Drug|0|||
161871946|NCT02677922|584577004|FG003|Treatment Period|Non-compliance with Study Drug|0|||
161871947|NCT02677922|584577005|FG004|Treatment Period|Non-compliance with Study Drug|1|||
161871948|NCT02677922|584577006|FG005|Treatment Period|Non-compliance with Study Drug|0|||
161871949|NCT02677922|584577001|FG000|Treatment Period|Physician Decision|0|||
161871950|NCT02677922|584577002|FG001|Treatment Period|Physician Decision|0|||
161871951|NCT02677922|584577003|FG002|Treatment Period|Physician Decision|0|||
161871952|NCT02677922|584577004|FG003|Treatment Period|Physician Decision|0|||
161871953|NCT02677922|584577005|FG004|Treatment Period|Physician Decision|0|||
161871954|NCT02677922|584577006|FG005|Treatment Period|Physician Decision|1|||
161871955|NCT02677922|584577001|FG000|Treatment Period|Symptomatic Deterioration|0|||
161871956|NCT02677922|584577002|FG001|Treatment Period|Symptomatic Deterioration|0|||
161871957|NCT02677922|584577003|FG002|Treatment Period|Symptomatic Deterioration|0|||
161871958|NCT02677922|584577004|FG003|Treatment Period|Symptomatic Deterioration|0|||
161871959|NCT02677922|584577005|FG004|Treatment Period|Symptomatic Deterioration|1|||
161871960|NCT02677922|584577006|FG005|Treatment Period|Symptomatic Deterioration|0|||
161775595|NCT00471237|584221212|FG001|Overall Study|Administration of prohibited medicine|0|||
161775596|NCT00471237|584221213|FG002|Overall Study|Administration of prohibited medicine|0|||
161775597|NCT00471237|584221214|FG003|Overall Study|Administration of prohibited medicine|0|||
161871961|NCT00637000|584577007|FG000|Overall Study|Withdrawal by Subject|4|||
161871962|NCT00637000|584577008|FG001|Overall Study|Withdrawal by Subject|3|||
161871963|NCT00183885|584577031|FG000|Overall Study|Adverse Event|11|||
161871964|NCT00183885|584577031|FG000|Overall Study|Death|1|||
161871965|NCT00183885|584577031|FG000|Overall Study|Lost to Follow-up|3|||
161871966|NCT00183885|584577031|FG000|Overall Study|Physician Decision|6|||
161871967|NCT00183885|584577031|FG000|Overall Study|Withdrawal by Subject|5|||
161871968|NCT00183885|584577031|FG000|Overall Study|Switched to alternative treatment|8|||
161775598|NCT00471237|584221215|FG004|Overall Study|Administration of prohibited medicine|1|||
161775599|NCT00471237|584221216|FG005|Overall Study|Administration of prohibited medicine|0|||
161775600|NCT00471237|584221217|FG006|Overall Study|Administration of prohibited medicine|0|||
161775601|NCT00471237|584221211|FG000|Overall Study|Participant shifted residence|0|||
161775602|NCT00471237|584221212|FG001|Overall Study|Participant shifted residence|0|||
161775603|NCT00471237|584221213|FG002|Overall Study|Participant shifted residence|0|||
161775604|NCT00471237|584221214|FG003|Overall Study|Participant shifted residence|0|||
161775605|NCT00471237|584221215|FG004|Overall Study|Participant shifted residence|1|||
161775606|NCT00471237|584221216|FG005|Overall Study|Participant shifted residence|0|||
161775607|NCT00471237|584221217|FG006|Overall Study|Participant shifted residence|0|||
161775608|NCT00471237|584221211|FG000|Overall Study|Participant's decision|0|||
161775609|NCT00471237|584221212|FG001|Overall Study|Participant's decision|0|||
161775610|NCT00471237|584221213|FG002|Overall Study|Participant's decision|0|||
161775611|NCT00471237|584221214|FG003|Overall Study|Participant's decision|0|||
161775612|NCT00471237|584221215|FG004|Overall Study|Participant's decision|0|||
161775613|NCT00471237|584221216|FG005|Overall Study|Participant's decision|1|||
161775614|NCT00471237|584221217|FG006|Overall Study|Participant's decision|0|||
161775615|NCT00848965|584221218|FG000|Overall Study|Adverse Event|1|||
161775616|NCT00848965|584221218|FG000|Overall Study|Withdrawal by Subject|1|||
161775617|NCT00348348|584221219|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
161775618|NCT00348348|584221220|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
161775619|NCT00348348|584221219|FG000|Overall Study|Lack of Efficacy|1|||
161775620|NCT00348348|584221220|FG001|Overall Study|Lack of Efficacy|1|||
161775621|NCT00348348|584221219|FG000|Overall Study|Lost to Follow-up|8|||
161775622|NCT00348348|584221220|FG001|Overall Study|Lost to Follow-up|10|||
161775623|NCT00348348|584221219|FG000|Overall Study|Withdrawal by Subject|4|||
161775624|NCT00348348|584221220|FG001|Overall Study|Withdrawal by Subject|1|||
161775625|NCT00348348|584221219|FG000|Overall Study|Other|7|||
161775626|NCT00348348|584221220|FG001|Overall Study|Other|4|||
161775627|NCT00348348|584221219|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
161775628|NCT00348348|584221220|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
161775629|NCT00348348|584221219|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
161775630|NCT00348348|584221220|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
161775631|NCT00348348|584221219|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
161775632|NCT00348348|584221220|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
161775633|NCT00348348|584221219|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
161775634|NCT00348348|584221220|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
161871969|NCT00183885|584577031|FG000|Overall Study|Treatment delayed too long|4|||
161871970|NCT00183885|584577031|FG000|Overall Study|Developed second malignancy|1|||
161871971|NCT00014495|584577034|FG000|Overall Study|Death|0|||
161871972|NCT00014495|584577035|FG001|Overall Study|Death|0|||
161871973|NCT00014495|584577036|FG002|Overall Study|Death|1|||
161871974|NCT00014495|584577037|FG003|Overall Study|Death|0|||
161871975|NCT00014495|584577034|FG000|Overall Study|Clinical deterioration|0|||
161871976|NCT00014495|584577035|FG001|Overall Study|Clinical deterioration|0|||
161871977|NCT00014495|584577036|FG002|Overall Study|Clinical deterioration|0|||
161871978|NCT00014495|584577037|FG003|Overall Study|Clinical deterioration|1|||
161871979|NCT00828568|584577038|FG000|Randomized|Withdrawal by Subject|1|||
161871980|NCT00828568|584577039|FG001|Randomized|Withdrawal by Subject|0|||
161871981|NCT00828568|584577040|FG002|Randomized|Withdrawal by Subject|2|||
161871982|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
161871983|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
161871984|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
161871985|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
161871986|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
161871987|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
161871988|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
161871989|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
161871990|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
161871991|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
161871992|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
161871993|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
161871994|NCT00460811|584577042|FG000|Overall Study|Adverse Event|4|||
161871995|NCT00460811|584577043|FG001|Overall Study|Adverse Event|6|||
161871996|NCT00460811|584577044|FG002|Overall Study|Adverse Event|3|||
161871997|NCT00460811|584577045|FG003|Overall Study|Adverse Event|10|||
161871998|NCT00460811|584577046|FG004|Overall Study|Adverse Event|2|||
161871999|NCT00460811|584577042|FG000|Overall Study|Noncompliance|1|||
161872000|NCT00460811|584577043|FG001|Overall Study|Noncompliance|0|||
161872001|NCT00460811|584577044|FG002|Overall Study|Noncompliance|0|||
161872002|NCT00460811|584577045|FG003|Overall Study|Noncompliance|2|||
161872003|NCT00460811|584577046|FG004|Overall Study|Noncompliance|1|||
161872004|NCT00460811|584577042|FG000|Overall Study|Withdrawal by Subject|7|||
161872005|NCT00460811|584577043|FG001|Overall Study|Withdrawal by Subject|7|||
161872006|NCT00460811|584577044|FG002|Overall Study|Withdrawal by Subject|6|||
161872007|NCT00460811|584577045|FG003|Overall Study|Withdrawal by Subject|3|||
161872008|NCT00460811|584577046|FG004|Overall Study|Withdrawal by Subject|11|||
161872009|NCT00460811|584577042|FG000|Overall Study|Physician Decision|1|||
161872010|NCT00460811|584577043|FG001|Overall Study|Physician Decision|0|||
161872011|NCT00460811|584577044|FG002|Overall Study|Physician Decision|0|||
161872012|NCT00460811|584577045|FG003|Overall Study|Physician Decision|0|||
161872013|NCT00460811|584577046|FG004|Overall Study|Physician Decision|0|||
161872014|NCT00460811|584577042|FG000|Overall Study|Lost to Follow-up|3|||
161872015|NCT00460811|584577043|FG001|Overall Study|Lost to Follow-up|2|||
161872016|NCT00460811|584577044|FG002|Overall Study|Lost to Follow-up|5|||
161872017|NCT00460811|584577045|FG003|Overall Study|Lost to Follow-up|3|||
161872018|NCT00460811|584577046|FG004|Overall Study|Lost to Follow-up|6|||
161872019|NCT02821754|584577047|FG000|Overall Study|Procedure not required prior to amendment change|13|||
161872020|NCT02821754|584577048|FG001|Overall Study|Procedure not required prior to amendment change|11|||
161872021|NCT02821754|584577049|FG002|Overall Study|Procedure not required prior to amendment change|0|||
161872022|NCT02821754|584577047|FG000|Overall Study|Participant's Clinical status|2|||
161872023|NCT02821754|584577048|FG001|Overall Study|Participant's Clinical status|0|||
161872024|NCT02821754|584577049|FG002|Overall Study|Participant's Clinical status|0|||
161872025|NCT02821754|584577047|FG000|Overall Study|Participant removed for noncompliance|1|||
161872026|NCT02821754|584577048|FG001|Overall Study|Participant removed for noncompliance|0|||
161872027|NCT02821754|584577049|FG002|Overall Study|Participant removed for noncompliance|0|||
161872028|NCT02821754|584577047|FG000|Overall Study|Drug not available.|0|||
161872029|NCT02821754|584577048|FG001|Overall Study|Drug not available.|0|||
161872030|NCT02821754|584577049|FG002|Overall Study|Drug not available.|1|||
161872031|NCT02821754|584577047|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
161872032|NCT02821754|584577048|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
161872033|NCT02821754|584577049|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
161872034|NCT01355575|584577050|FG000|Overall Study|Withdrawal by Subject|2|||
161872035|NCT01166438|584577051|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
161872036|NCT01166438|584577052|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
161872037|NCT01166438|584577051|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
161872038|NCT01166438|584577052|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
161872039|NCT01166438|584577051|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
161872040|NCT01166438|584577052|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
161872041|NCT01166438|584577051|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
161872042|NCT01166438|584577052|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
161872043|NCT01166438|584577051|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
161872044|NCT01166438|584577052|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
161872045|NCT01166438|584577051|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
161872046|NCT01166438|584577052|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
161872047|NCT03759587|584577063|FG000|Overall Study|Adverse Event|5|||
161872048|NCT03759587|584577063|FG000|Overall Study|Progressive Disease|10|||
161872049|NCT03759587|584577063|FG000|Overall Study|Site Terminated by Sponsor|3|||
161872050|NCT03759587|584577063|FG000|Overall Study|Withdrawal by Subject|1|||
161872051|NCT00591565|584577064|FG000|Overall Study|lost follow up, withdrawn|5|||
161872052|NCT00454363|584577065|FG000|Overall Study|Adverse Event|1|||
161872053|NCT00454363|584577066|FG001|Overall Study|Adverse Event|2|||
161872054|NCT00454363|584577065|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
161872055|NCT00454363|584577066|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
161872056|NCT01554527|584577068|FG000|Overall Study|Withdrawal by Subject|1|||
161872057|NCT01554527|584577069|FG001|Overall Study|Withdrawal by Subject|0|||
161872058|NCT01554527|584577070|FG002|Overall Study|Withdrawal by Subject|3|||
161872059|NCT01554527|584577068|FG000|Overall Study|Lost to Follow-up|0|||
161872060|NCT01554527|584577069|FG001|Overall Study|Lost to Follow-up|0|||
161872061|NCT01554527|584577070|FG002|Overall Study|Lost to Follow-up|4|||
161872062|NCT01554527|584577068|FG000|Overall Study|Physician Decision|0|||
161872063|NCT01554527|584577069|FG001|Overall Study|Physician Decision|0|||
161872064|NCT01554527|584577070|FG002|Overall Study|Physician Decision|1|||
161872065|NCT01863667|584577077|FG000|Overall Study|Adverse Event|1|||
161872066|NCT01863667|584577078|FG001|Overall Study|Adverse Event|0|||
161872067|NCT01863667|584577077|FG000|Overall Study|Study terminated by Sponsor|30|||
161872068|NCT01863667|584577078|FG001|Overall Study|Study terminated by Sponsor|30|||
161872069|NCT01863667|584577077|FG000|Overall Study|Withdrawal by Subject|2|||
161872070|NCT01863667|584577078|FG001|Overall Study|Withdrawal by Subject|2|||
161872071|NCT01537042|584577082|FG000|Overall Study|Adverse Event|0|||
161872072|NCT01537042|584577083|FG001|Overall Study|Adverse Event|2|||
161872073|NCT01537042|584577082|FG000|Overall Study|Lack of Efficacy|0|||
161872074|NCT01537042|584577083|FG001|Overall Study|Lack of Efficacy|1|||
161872075|NCT01537042|584577082|FG000|Overall Study|Protocol Violation|0|||
161872076|NCT01537042|584577083|FG001|Overall Study|Protocol Violation|1|||
161872077|NCT01537042|584577082|FG000|Overall Study|Other|0|||
161872078|NCT01537042|584577083|FG001|Overall Study|Other|1|||
161775635|NCT00348348|584221219|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
161775636|NCT00348348|584221220|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
161775637|NCT00348348|584221219|FG000|Overall Study|Adverse event probably related to study|1|||
161775638|NCT00348348|584221220|FG001|Overall Study|Adverse event probably related to study|0|||
161775639|NCT01605370|584221223|FG000|Overall Study|Adverse Event|1|||
161775640|NCT01605370|584221224|FG001|Overall Study|Adverse Event|0|||
161775641|NCT01976104|584221225|FG000|Overall Study|Adverse Event|0|||
161775642|NCT01976104|584221226|FG001|Overall Study|Adverse Event|0|||
161775643|NCT01976104|584221227|FG002|Overall Study|Adverse Event|1|||
161775644|NCT01976104|584221228|FG003|Overall Study|Adverse Event|0|||
161775645|NCT01976104|584221225|FG000|Overall Study|Lost to Follow-up|3|||
161775646|NCT01976104|584221226|FG001|Overall Study|Lost to Follow-up|0|||
161775647|NCT01976104|584221227|FG002|Overall Study|Lost to Follow-up|1|||
161775648|NCT01976104|584221228|FG003|Overall Study|Lost to Follow-up|1|||
161775649|NCT01976104|584221225|FG000|Overall Study|Subject Choice|0|||
161775650|NCT01976104|584221226|FG001|Overall Study|Subject Choice|1|||
161872079|NCT02837731|584577084|FG000|Allocation|Admitted to General Floor|3|||
161872080|NCT02837731|584577085|FG001|Allocation|Admitted to General Floor|4|||
161872081|NCT02837731|584577084|FG000|Allocation|Immediate surgery/withdrew|2|||
161872082|NCT02837731|584577085|FG001|Allocation|Immediate surgery/withdrew|0|||
161872083|NCT02837731|584577084|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
161872084|NCT02837731|584577085|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
161872085|NCT02837731|584577084|FG000|Allocation|Withdrawal by Subject|2|||
161872086|NCT02837731|584577085|FG001|Allocation|Withdrawal by Subject|0|||
161775651|NCT01976104|584221227|FG002|Overall Study|Subject Choice|0|||
161872087|NCT02837731|584577084|FG000|Allocation|Device not available|1|||
161872088|NCT02837731|584577085|FG001|Allocation|Device not available|0|||
161872089|NCT02837731|584577084|FG000|Allocation|Protocol not implemented|7|||
161872090|NCT02837731|584577085|FG001|Allocation|Protocol not implemented|0|||
161872091|NCT02837731|584577084|FG000|Allocation|Moribund/Do not resuscitate|2|||
161872092|NCT02837731|584577085|FG001|Allocation|Moribund/Do not resuscitate|0|||
161775652|NCT01976104|584221228|FG003|Overall Study|Subject Choice|1|||
161775653|NCT01976104|584221225|FG000|Overall Study|Withdrawal by Subject|3|||
161775654|NCT01976104|584221226|FG001|Overall Study|Withdrawal by Subject|0|||
161775655|NCT01976104|584221227|FG002|Overall Study|Withdrawal by Subject|0|||
161775656|NCT01976104|584221228|FG003|Overall Study|Withdrawal by Subject|1|||
161775657|NCT01976104|584221225|FG000|Overall Study|Other|0|||
161775658|NCT01976104|584221226|FG001|Overall Study|Other|1|||
161872093|NCT02837731|584577084|FG000|Allocation|Did not meet sepsis criteria|1|||
161775659|NCT01976104|584221227|FG002|Overall Study|Other|0|||
161775660|NCT01976104|584221228|FG003|Overall Study|Other|0|||
161775661|NCT01317199|584221229|FG000|Dose-escalation Phase 1|Physician Decision|5|||
161775662|NCT01317199|584221230|FG001|Dose-escalation Phase 1|Physician Decision|0|||
161775663|NCT01317199|584221231|FG002|Dose-escalation Phase 1|Physician Decision|0|||
161872094|NCT02837731|584577085|FG001|Allocation|Did not meet sepsis criteria|2|||
161872095|NCT02837731|584577084|FG000|Allocation|Known aortic abnormalities|0|||
161775664|NCT01317199|584221232|FG003|Dose-escalation Phase 1|Physician Decision|0|||
161872096|NCT02837731|584577085|FG001|Allocation|Known aortic abnormalities|1|||
161872097|NCT02965573|584577087|FG000|Overall Study|Lack of Efficacy|1|||
161872098|NCT02965573|584577088|FG001|Overall Study|Lack of Efficacy|0|||
161872099|NCT00315458|584577089|FG000|Overall Study|Administrative|0|||
161872100|NCT00315458|584577090|FG001|Overall Study|Administrative|3|||
161872101|NCT00315458|584577091|FG002|Overall Study|Administrative|8|||
161872102|NCT00315458|584577092|FG003|Overall Study|Administrative|21|||
161872103|NCT00315458|584577089|FG000|Overall Study|Adverse Event|2|||
161872104|NCT00315458|584577090|FG001|Overall Study|Adverse Event|4|||
161872105|NCT00315458|584577091|FG002|Overall Study|Adverse Event|23|||
161872106|NCT00315458|584577092|FG003|Overall Study|Adverse Event|3|||
161872107|NCT00315458|584577089|FG000|Overall Study|Lost to Follow-up|1|||
161872108|NCT00315458|584577090|FG001|Overall Study|Lost to Follow-up|2|||
161872109|NCT00315458|584577091|FG002|Overall Study|Lost to Follow-up|0|||
161872110|NCT00315458|584577092|FG003|Overall Study|Lost to Follow-up|2|||
161872111|NCT00315458|584577089|FG000|Overall Study|Withdrawal by Subject|0|||
161872112|NCT00315458|584577090|FG001|Overall Study|Withdrawal by Subject|3|||
161872113|NCT00315458|584577091|FG002|Overall Study|Withdrawal by Subject|0|||
161872114|NCT00315458|584577092|FG003|Overall Study|Withdrawal by Subject|2|||
161872115|NCT00315458|584577089|FG000|Overall Study|Lack of Efficacy|0|||
161872116|NCT00315458|584577090|FG001|Overall Study|Lack of Efficacy|0|||
161872117|NCT00315458|584577091|FG002|Overall Study|Lack of Efficacy|20|||
161872118|NCT00315458|584577092|FG003|Overall Study|Lack of Efficacy|1|||
161872119|NCT00315458|584577089|FG000|Overall Study|Did not qualify|0|||
161872120|NCT00315458|584577090|FG001|Overall Study|Did not qualify|0|||
161872121|NCT00315458|584577091|FG002|Overall Study|Did not qualify|1|||
161872122|NCT00315458|584577092|FG003|Overall Study|Did not qualify|0|||
161872123|NCT00523848|584577094|FG000|Overall Study|Adverse Event|11|||
161872124|NCT00523848|584577094|FG000|Overall Study|Withdrawal by Subject|2|||
161872125|NCT00523848|584577094|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
161872126|NCT00523848|584577094|FG000|Overall Study|Disease Progression|5|||
161872127|NCT00523848|584577094|FG000|Overall Study|Other, unspecified|4|||
161872128|NCT00086619|584577096|FG000|Overall Study|Withdrawal by Subject|6|||
161872129|NCT00086619|584577097|FG001|Overall Study|Withdrawal by Subject|6|||
161872130|NCT00086619|584577096|FG000|Overall Study|Adverse Event|8|||
161872131|NCT00086619|584577097|FG001|Overall Study|Adverse Event|10|||
161872132|NCT00086619|584577096|FG000|Overall Study|Protocol Violation|1|||
161872133|NCT00086619|584577097|FG001|Overall Study|Protocol Violation|1|||
161872134|NCT00489918|584577098|FG000|Overall Study|Withdrawal by Subject|2|||
161872135|NCT00489918|584577099|FG001|Overall Study|Withdrawal by Subject|1|||
161872136|NCT00489918|584577100|FG002|Overall Study|Withdrawal by Subject|1|||
161872137|NCT00489918|584577101|FG003|Overall Study|Withdrawal by Subject|0|||
161872138|NCT00489918|584577102|FG004|Overall Study|Withdrawal by Subject|1|||
161872139|NCT00489918|584577098|FG000|Overall Study|Adverse Event|0|||
161872140|NCT00489918|584577099|FG001|Overall Study|Adverse Event|1|||
161872141|NCT00489918|584577100|FG002|Overall Study|Adverse Event|1|||
161872142|NCT00489918|584577101|FG003|Overall Study|Adverse Event|0|||
161872143|NCT00489918|584577102|FG004|Overall Study|Adverse Event|0|||
161872144|NCT00489918|584577098|FG000|Overall Study|Lost to Follow-up|0|||
161872145|NCT00489918|584577099|FG001|Overall Study|Lost to Follow-up|0|||
161872146|NCT00489918|584577100|FG002|Overall Study|Lost to Follow-up|1|||
161872147|NCT00489918|584577101|FG003|Overall Study|Lost to Follow-up|1|||
161872148|NCT00489918|584577102|FG004|Overall Study|Lost to Follow-up|0|||
161872149|NCT00489918|584577098|FG000|Overall Study|Physician Decision|0|||
161872150|NCT00489918|584577099|FG001|Overall Study|Physician Decision|0|||
161872151|NCT00489918|584577100|FG002|Overall Study|Physician Decision|1|||
161872152|NCT00489918|584577101|FG003|Overall Study|Physician Decision|0|||
161872153|NCT00489918|584577102|FG004|Overall Study|Physician Decision|0|||
161872154|NCT02748213|584577103|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
161872155|NCT02748213|584577104|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
161872156|NCT02748213|584577103|FG000|Overall Study|Abnormal Laboratory Test|1|||
161872157|NCT02748213|584577104|FG001|Overall Study|Abnormal Laboratory Test|0|||
161872158|NCT02748213|584577103|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
161872159|NCT02748213|584577104|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
161872160|NCT02748213|584577103|FG000|Overall Study|Death|5|||
161872161|NCT02748213|584577104|FG001|Overall Study|Death|3|||
161872162|NCT02748213|584577103|FG000|Overall Study|Insufficient Therapeutic Response|56|||
161872163|NCT02748213|584577104|FG001|Overall Study|Insufficient Therapeutic Response|57|||
161872164|NCT02748213|584577103|FG000|Overall Study|Violation of Selection Criteria|2|||
161872165|NCT02748213|584577104|FG001|Overall Study|Violation of Selection Criteria|0|||
161872166|NCT02748213|584577103|FG000|Overall Study|Protocol Violation|6|||
161872167|NCT02748213|584577104|FG001|Overall Study|Protocol Violation|4|||
161872168|NCT02748213|584577103|FG000|Overall Study|Refused Treatment*|6|||
161872169|NCT02748213|584577104|FG001|Overall Study|Refused Treatment*|6|||
161872170|NCT02748213|584577103|FG000|Overall Study|Failure to Return|1|||
161872171|NCT02748213|584577104|FG001|Overall Study|Failure to Return|0|||
161872172|NCT02748213|584577103|FG000|Overall Study|Other|30|||
161872173|NCT02748213|584577104|FG001|Overall Study|Other|29|||
161872174|NCT01209520|584577108|FG000|Overall Study|Withdrawal by Subject|3|||
161872175|NCT03850483|584577109|FG000|Treatment for Stage 1|Adverse Event|1|||
161872176|NCT03850483|584577110|FG001|Treatment for Stage 1|Adverse Event|1|||
161872177|NCT03850483|584577111|FG002|Treatment for Stage 1|Adverse Event|3|||
161872178|NCT03850483|584577112|FG003|Treatment for Stage 1|Adverse Event|0|||
161872179|NCT03850483|584577113|FG004|Treatment for Stage 1|Adverse Event|2|||
161872180|NCT03850483|584577114|FG005|Treatment for Stage 1|Adverse Event|0|||
161872181|NCT03850483|584577115|FG006|Treatment for Stage 1|Adverse Event|2|||
161872182|NCT03850483|584577116|FG007|Treatment for Stage 1|Adverse Event|2|||
161872183|NCT03850483|584577117|FG008|Treatment for Stage 1|Adverse Event|0|||
161872184|NCT03850483|584577118|FG009|Treatment for Stage 1|Adverse Event|0|||
161872185|NCT03850483|584577109|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
161872186|NCT03850483|584577110|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
161872187|NCT03850483|584577111|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
161872188|NCT03850483|584577112|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
161872189|NCT03850483|584577113|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
161872190|NCT03850483|584577114|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
161872191|NCT03850483|584577115|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
161872192|NCT03850483|584577116|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
161872193|NCT03850483|584577117|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
161872194|NCT03850483|584577118|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
161872195|NCT03850483|584577109|FG000|Treatment for Stage 1|Protocol Violation|1|||
161872196|NCT03850483|584577110|FG001|Treatment for Stage 1|Protocol Violation|0|||
161872197|NCT03850483|584577111|FG002|Treatment for Stage 1|Protocol Violation|0|||
161872198|NCT03850483|584577112|FG003|Treatment for Stage 1|Protocol Violation|0|||
161872199|NCT03850483|584577113|FG004|Treatment for Stage 1|Protocol Violation|0|||
161872200|NCT03850483|584577114|FG005|Treatment for Stage 1|Protocol Violation|0|||
161872201|NCT03850483|584577115|FG006|Treatment for Stage 1|Protocol Violation|1|||
161872202|NCT03850483|584577116|FG007|Treatment for Stage 1|Protocol Violation|0|||
161872203|NCT03850483|584577117|FG008|Treatment for Stage 1|Protocol Violation|0|||
161872204|NCT03850483|584577118|FG009|Treatment for Stage 1|Protocol Violation|0|||
161872205|NCT03850483|584577109|FG000|Treatment for Stage 1|Physician Decision|0|||
161872206|NCT03850483|584577110|FG001|Treatment for Stage 1|Physician Decision|0|||
161872207|NCT03850483|584577111|FG002|Treatment for Stage 1|Physician Decision|0|||
161872208|NCT03850483|584577112|FG003|Treatment for Stage 1|Physician Decision|0|||
161872209|NCT03850483|584577113|FG004|Treatment for Stage 1|Physician Decision|0|||
161872210|NCT03850483|584577114|FG005|Treatment for Stage 1|Physician Decision|1|||
161872211|NCT03850483|584577115|FG006|Treatment for Stage 1|Physician Decision|0|||
161872212|NCT03850483|584577116|FG007|Treatment for Stage 1|Physician Decision|0|||
161872213|NCT03850483|584577117|FG008|Treatment for Stage 1|Physician Decision|0|||
161872214|NCT03850483|584577118|FG009|Treatment for Stage 1|Physician Decision|0|||
161872215|NCT03850483|584577109|FG000|Treatment for Stage 1|Other|0|||
161872216|NCT03850483|584577110|FG001|Treatment for Stage 1|Other|0|||
161872217|NCT03850483|584577111|FG002|Treatment for Stage 1|Other|0|||
161872218|NCT03850483|584577112|FG003|Treatment for Stage 1|Other|0|||
161872219|NCT03850483|584577113|FG004|Treatment for Stage 1|Other|2|||
161872220|NCT03850483|584577114|FG005|Treatment for Stage 1|Other|1|||
161872221|NCT03850483|584577115|FG006|Treatment for Stage 1|Other|0|||
161872222|NCT03850483|584577116|FG007|Treatment for Stage 1|Other|0|||
161872223|NCT03850483|584577117|FG008|Treatment for Stage 1|Other|0|||
161872224|NCT03850483|584577118|FG009|Treatment for Stage 1|Other|0|||
161872225|NCT03850483|584577109|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872226|NCT03850483|584577110|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872227|NCT03850483|584577111|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
161872228|NCT03850483|584577112|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872229|NCT03850483|584577113|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872230|NCT03850483|584577114|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872231|NCT03850483|584577115|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872232|NCT03850483|584577116|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872233|NCT03850483|584577117|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872234|NCT03850483|584577118|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872235|NCT03850483|584577109|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872236|NCT03850483|584577110|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872237|NCT03850483|584577111|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872238|NCT03850483|584577112|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872239|NCT03850483|584577113|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872240|NCT03850483|584577114|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
161872241|NCT03850483|584577115|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872242|NCT03850483|584577116|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872243|NCT03850483|584577117|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872244|NCT03850483|584577118|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872245|NCT03850483|584577109|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
161872246|NCT03850483|584577110|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
161872247|NCT03850483|584577111|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
161872248|NCT03850483|584577112|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
161872249|NCT03850483|584577113|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
161872250|NCT03850483|584577114|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
161872251|NCT03850483|584577115|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
161872252|NCT03850483|584577116|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
161872253|NCT03850483|584577117|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
161872254|NCT03850483|584577118|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
161872255|NCT03850483|584577109|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
161872256|NCT03850483|584577110|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
161872257|NCT03850483|584577111|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
161872258|NCT03850483|584577112|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
161872259|NCT03850483|584577113|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
161872260|NCT03850483|584577114|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
161872261|NCT03850483|584577115|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
161872262|NCT03850483|584577116|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
161872263|NCT03850483|584577117|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
161872264|NCT03850483|584577118|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
161872265|NCT03850483|584577109|FG000|Treatment for Stage 1|Death|0|||
161872266|NCT03850483|584577110|FG001|Treatment for Stage 1|Death|0|||
161872267|NCT03850483|584577111|FG002|Treatment for Stage 1|Death|0|||
161872268|NCT03850483|584577112|FG003|Treatment for Stage 1|Death|0|||
161872269|NCT03850483|584577113|FG004|Treatment for Stage 1|Death|0|||
161872270|NCT03850483|584577114|FG005|Treatment for Stage 1|Death|1|||
161872271|NCT03850483|584577115|FG006|Treatment for Stage 1|Death|0|||
161872272|NCT03850483|584577116|FG007|Treatment for Stage 1|Death|0|||
161872273|NCT03850483|584577117|FG008|Treatment for Stage 1|Death|0|||
161872274|NCT03850483|584577118|FG009|Treatment for Stage 1|Death|0|||
161872275|NCT03850483|584577109|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
161872276|NCT03850483|584577110|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
161872277|NCT03850483|584577111|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
161872278|NCT03850483|584577112|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
161872279|NCT03850483|584577113|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
161872280|NCT03850483|584577114|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
161872281|NCT03850483|584577115|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
161872282|NCT03850483|584577116|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
161872283|NCT03850483|584577117|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
161872284|NCT03850483|584577118|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
161872285|NCT03850483|584577109|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
161872286|NCT03850483|584577110|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
161872287|NCT03850483|584577111|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
161872288|NCT03850483|584577112|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
161872289|NCT03850483|584577113|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
161872290|NCT03850483|584577114|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
161872291|NCT03850483|584577115|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
161872292|NCT03850483|584577116|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
161872293|NCT03850483|584577117|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
161872294|NCT03850483|584577118|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
161872295|NCT03850483|584577109|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872296|NCT03850483|584577110|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872297|NCT03850483|584577111|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872298|NCT03850483|584577112|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872299|NCT03850483|584577113|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872300|NCT03850483|584577114|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872301|NCT03850483|584577115|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
161872302|NCT03850483|584577116|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
161872303|NCT03850483|584577117|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872304|NCT03850483|584577118|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872305|NCT03850483|584577109|FG000|Follow-up for Stage 1|Physician Decision|0|||
161872306|NCT03850483|584577110|FG001|Follow-up for Stage 1|Physician Decision|0|||
161872307|NCT03850483|584577111|FG002|Follow-up for Stage 1|Physician Decision|0|||
161872308|NCT03850483|584577112|FG003|Follow-up for Stage 1|Physician Decision|0|||
161872309|NCT03850483|584577113|FG004|Follow-up for Stage 1|Physician Decision|1|||
161872310|NCT03850483|584577114|FG005|Follow-up for Stage 1|Physician Decision|0|||
161872311|NCT03850483|584577115|FG006|Follow-up for Stage 1|Physician Decision|1|||
161872312|NCT03850483|584577116|FG007|Follow-up for Stage 1|Physician Decision|0|||
161872313|NCT03850483|584577117|FG008|Follow-up for Stage 1|Physician Decision|0|||
161872314|NCT03850483|584577118|FG009|Follow-up for Stage 1|Physician Decision|0|||
161872315|NCT03850483|584577109|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
161872316|NCT03850483|584577110|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
161872317|NCT03850483|584577111|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
161872318|NCT03850483|584577112|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
161872319|NCT03850483|584577113|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
161872320|NCT03850483|584577114|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
161872321|NCT03850483|584577115|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
161872322|NCT03850483|584577116|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
161872323|NCT03850483|584577117|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
161872324|NCT03850483|584577118|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
161872325|NCT03850483|584577109|FG000|Follow-up for Stage 1|Adverse Event|0|||
161872326|NCT03850483|584577110|FG001|Follow-up for Stage 1|Adverse Event|0|||
161872327|NCT03850483|584577111|FG002|Follow-up for Stage 1|Adverse Event|1|||
161872328|NCT03850483|584577112|FG003|Follow-up for Stage 1|Adverse Event|0|||
161872329|NCT03850483|584577113|FG004|Follow-up for Stage 1|Adverse Event|0|||
161872330|NCT03850483|584577114|FG005|Follow-up for Stage 1|Adverse Event|1|||
161872331|NCT03850483|584577115|FG006|Follow-up for Stage 1|Adverse Event|0|||
161872332|NCT03850483|584577116|FG007|Follow-up for Stage 1|Adverse Event|0|||
161872333|NCT03850483|584577117|FG008|Follow-up for Stage 1|Adverse Event|0|||
161872334|NCT03850483|584577118|FG009|Follow-up for Stage 1|Adverse Event|0|||
161872335|NCT03850483|584577109|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872336|NCT03850483|584577110|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
161872337|NCT03850483|584577111|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872338|NCT03850483|584577112|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872339|NCT03850483|584577113|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
161872340|NCT03850483|584577114|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
161872341|NCT03850483|584577115|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872342|NCT03850483|584577116|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872343|NCT03850483|584577117|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872344|NCT03850483|584577118|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872345|NCT03850483|584577109|FG000|Follow-up for Stage 1|Other|0|||
161872346|NCT03850483|584577110|FG001|Follow-up for Stage 1|Other|2|||
161872347|NCT03850483|584577111|FG002|Follow-up for Stage 1|Other|0|||
161872348|NCT03850483|584577112|FG003|Follow-up for Stage 1|Other|2|||
161872349|NCT03850483|584577113|FG004|Follow-up for Stage 1|Other|0|||
161872350|NCT03850483|584577114|FG005|Follow-up for Stage 1|Other|1|||
161872351|NCT03850483|584577115|FG006|Follow-up for Stage 1|Other|0|||
161872352|NCT03850483|584577116|FG007|Follow-up for Stage 1|Other|0|||
161872353|NCT03850483|584577117|FG008|Follow-up for Stage 1|Other|0|||
161872354|NCT03850483|584577118|FG009|Follow-up for Stage 1|Other|0|||
161872355|NCT03850483|584577109|FG000|Treatment for Stage 2|Adverse Event|0|||
161872356|NCT03850483|584577110|FG001|Treatment for Stage 2|Adverse Event|0|||
161872357|NCT03850483|584577111|FG002|Treatment for Stage 2|Adverse Event|0|||
161872358|NCT03850483|584577112|FG003|Treatment for Stage 2|Adverse Event|0|||
161872359|NCT03850483|584577113|FG004|Treatment for Stage 2|Adverse Event|0|||
161872360|NCT03850483|584577114|FG005|Treatment for Stage 2|Adverse Event|0|||
161872361|NCT03850483|584577115|FG006|Treatment for Stage 2|Adverse Event|0|||
161872362|NCT03850483|584577116|FG007|Treatment for Stage 2|Adverse Event|0|||
161872363|NCT03850483|584577117|FG008|Treatment for Stage 2|Adverse Event|0|||
161872364|NCT03850483|584577118|FG009|Treatment for Stage 2|Adverse Event|1|||
161872365|NCT03850483|584577109|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
161872366|NCT03850483|584577110|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
161872367|NCT03850483|584577111|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
161872368|NCT03850483|584577112|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
161872369|NCT03850483|584577113|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
161872370|NCT03850483|584577114|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
161872371|NCT03850483|584577115|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
161872372|NCT03850483|584577116|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
161872373|NCT03850483|584577117|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
161872374|NCT03850483|584577118|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
161872375|NCT03850483|584577109|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
161872376|NCT03850483|584577110|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
161872377|NCT03850483|584577111|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
161872378|NCT03850483|584577112|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
161872379|NCT03850483|584577113|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
161872380|NCT03850483|584577114|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
161872381|NCT03850483|584577115|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
161872382|NCT03850483|584577116|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
161872383|NCT03850483|584577117|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
161872384|NCT03850483|584577118|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
161872385|NCT03850483|584577109|FG000|Treatment for Stage 2|Physician Decision|0|||
161872386|NCT03850483|584577110|FG001|Treatment for Stage 2|Physician Decision|0|||
161872387|NCT03850483|584577111|FG002|Treatment for Stage 2|Physician Decision|0|||
161872388|NCT03850483|584577112|FG003|Treatment for Stage 2|Physician Decision|0|||
161872389|NCT03850483|584577113|FG004|Treatment for Stage 2|Physician Decision|0|||
161872390|NCT03850483|584577114|FG005|Treatment for Stage 2|Physician Decision|0|||
161872391|NCT03850483|584577115|FG006|Treatment for Stage 2|Physician Decision|0|||
161872392|NCT03850483|584577116|FG007|Treatment for Stage 2|Physician Decision|0|||
161872393|NCT03850483|584577117|FG008|Treatment for Stage 2|Physician Decision|0|||
161872394|NCT03850483|584577118|FG009|Treatment for Stage 2|Physician Decision|1|||
161872395|NCT03850483|584577109|FG000|Treatment for Stage 2|Protocol Violation|0|||
161872396|NCT03850483|584577110|FG001|Treatment for Stage 2|Protocol Violation|0|||
161872397|NCT03850483|584577111|FG002|Treatment for Stage 2|Protocol Violation|0|||
161872398|NCT03850483|584577112|FG003|Treatment for Stage 2|Protocol Violation|0|||
161872399|NCT03850483|584577113|FG004|Treatment for Stage 2|Protocol Violation|0|||
161872400|NCT03850483|584577114|FG005|Treatment for Stage 2|Protocol Violation|0|||
161872401|NCT03850483|584577115|FG006|Treatment for Stage 2|Protocol Violation|0|||
161872402|NCT03850483|584577116|FG007|Treatment for Stage 2|Protocol Violation|0|||
161872403|NCT03850483|584577117|FG008|Treatment for Stage 2|Protocol Violation|1|||
161872404|NCT03850483|584577118|FG009|Treatment for Stage 2|Protocol Violation|0|||
161872405|NCT03850483|584577109|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
161872406|NCT03850483|584577110|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
161872407|NCT03850483|584577111|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
161872408|NCT03850483|584577112|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
161872409|NCT03850483|584577113|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
161872410|NCT03850483|584577114|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
161872411|NCT03850483|584577115|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
161872412|NCT03850483|584577116|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
161872413|NCT03850483|584577117|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
161872414|NCT03850483|584577118|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
161872415|NCT03850483|584577109|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872416|NCT03850483|584577110|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872417|NCT03850483|584577111|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872418|NCT03850483|584577112|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872419|NCT03850483|584577113|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872420|NCT03850483|584577114|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872421|NCT03850483|584577115|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872422|NCT03850483|584577116|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872423|NCT03850483|584577117|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872424|NCT03850483|584577118|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
161872425|NCT03850483|584577109|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
161872426|NCT03850483|584577110|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
161872427|NCT03850483|584577111|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
161872428|NCT03850483|584577112|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
161872429|NCT03850483|584577113|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
161872430|NCT03850483|584577114|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
161872431|NCT03850483|584577115|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
161872432|NCT03850483|584577116|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
161872433|NCT03850483|584577117|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
161872434|NCT03850483|584577118|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
161872435|NCT03850483|584577109|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
161872436|NCT03850483|584577110|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
161872437|NCT03850483|584577111|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
161872438|NCT03850483|584577112|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
161872439|NCT03850483|584577113|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
161872440|NCT03850483|584577114|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
161872441|NCT03850483|584577115|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
161872442|NCT03850483|584577116|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
161872443|NCT03850483|584577117|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
161872444|NCT03850483|584577118|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
161872445|NCT03850483|584577109|FG000|Follow-up For Stage 2|Other|0|||
161872446|NCT03850483|584577110|FG001|Follow-up For Stage 2|Other|0|||
161872447|NCT03850483|584577111|FG002|Follow-up For Stage 2|Other|0|||
161872448|NCT03850483|584577112|FG003|Follow-up For Stage 2|Other|0|||
161872449|NCT03850483|584577113|FG004|Follow-up For Stage 2|Other|0|||
161872450|NCT03850483|584577114|FG005|Follow-up For Stage 2|Other|0|||
161872451|NCT03850483|584577115|FG006|Follow-up For Stage 2|Other|0|||
161872452|NCT03850483|584577116|FG007|Follow-up For Stage 2|Other|0|||
161872453|NCT03850483|584577117|FG008|Follow-up For Stage 2|Other|0|||
161872454|NCT03850483|584577118|FG009|Follow-up For Stage 2|Other|1|||
161872455|NCT03232931|584578537|FG000|Overall Study|Physician Decision|1|||
161872456|NCT03232931|584578538|FG001|Overall Study|Physician Decision|1|||
161872457|NCT03232931|584578537|FG000|Overall Study|Withdrawal by Subject|6|||
161872458|NCT03232931|584578538|FG001|Overall Study|Withdrawal by Subject|0|||
161872459|NCT03232931|584578537|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
161872460|NCT03232931|584578538|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
161872461|NCT03232931|584578537|FG000|Overall Study|Parent did not record voice|1|||
161872462|NCT03232931|584578538|FG001|Overall Study|Parent did not record voice|2|||
161872463|NCT03232931|584578537|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
161872464|NCT03232931|584578538|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
161872465|NCT04925557|584578539|FG000|Overall Study|Study closed|5|||
161872466|NCT04925557|584578540|FG001|Overall Study|Study closed|3|||
161872467|NCT01270464|584578544|FG000|Overall Study|Protocol Violation|4|||
161872468|NCT01270464|584578545|FG001|Overall Study|Protocol Violation|3|||
161872469|NCT01270464|584578546|FG002|Overall Study|Protocol Violation|2|||
161872470|NCT01270464|584578544|FG000|Overall Study|Lack of Efficacy|2|||
161872471|NCT01270464|584578545|FG001|Overall Study|Lack of Efficacy|3|||
161872472|NCT01270464|584578546|FG002|Overall Study|Lack of Efficacy|1|||
161872473|NCT01270464|584578544|FG000|Overall Study|Adverse Event|9|||
161872474|NCT01270464|584578545|FG001|Overall Study|Adverse Event|1|||
161872475|NCT01270464|584578546|FG002|Overall Study|Adverse Event|7|||
161872476|NCT01270464|584578544|FG000|Overall Study|Withdrawal by Subject|2|||
161872477|NCT01270464|584578545|FG001|Overall Study|Withdrawal by Subject|1|||
161872478|NCT01270464|584578546|FG002|Overall Study|Withdrawal by Subject|4|||
161872479|NCT01270464|584578544|FG000|Overall Study|Lost to Follow-up|2|||
161872480|NCT01270464|584578545|FG001|Overall Study|Lost to Follow-up|3|||
161872481|NCT01270464|584578546|FG002|Overall Study|Lost to Follow-up|1|||
161872482|NCT01270464|584578544|FG000|Overall Study|Other|1|||
161872483|NCT01270464|584578545|FG001|Overall Study|Other|1|||
161872484|NCT01270464|584578546|FG002|Overall Study|Other|3|||
161872485|NCT00076752|584578547|FG000|Overall Study|Death|2|||
161872486|NCT00076752|584578547|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
161872487|NCT00892151|584578548|FG000|Overall Study|Protocol Violation|1|||
161872488|NCT01222520|584578553|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
161872489|NCT01222520|584578554|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
161872490|NCT01222520|584578553|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
161872491|NCT01222520|584578554|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
161872492|NCT01222520|584578553|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
161872493|NCT01222520|584578554|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
161872494|NCT01222520|584578553|FG000|Double-blind Period|Adverse Event|0|||
161872495|NCT01222520|584578554|FG001|Double-blind Period|Adverse Event|1|||
161872496|NCT01222520|584578553|FG000|Double-blind Period|Lack of Efficacy|0|||
161872497|NCT01222520|584578554|FG001|Double-blind Period|Lack of Efficacy|1|||
161872498|NCT01222520|584578553|FG000|Double-blind Period|Study medication stolen|1|||
161872499|NCT01222520|584578554|FG001|Double-blind Period|Study medication stolen|0|||
161872500|NCT01322490|584578557|FG000|Treatment Period|Adverse Event|12|||
161872501|NCT01322490|584578558|FG001|Treatment Period|Adverse Event|18|||
161872502|NCT01322490|584578559|FG002|Treatment Period|Adverse Event|15|||
161872503|NCT01322490|584578557|FG000|Treatment Period|Death|5|||
161872504|NCT01322490|584578558|FG001|Treatment Period|Death|7|||
161872505|NCT01322490|584578559|FG002|Treatment Period|Death|3|||
161872506|NCT01322490|584578557|FG000|Treatment Period|Lack of Efficacy|89|||
161872507|NCT01322490|584578558|FG001|Treatment Period|Lack of Efficacy|100|||
161872508|NCT01322490|584578559|FG002|Treatment Period|Lack of Efficacy|112|||
161872509|NCT01322490|584578557|FG000|Treatment Period|Physician Decision|0|||
161872510|NCT01322490|584578558|FG001|Treatment Period|Physician Decision|2|||
161872511|NCT01322490|584578559|FG002|Treatment Period|Physician Decision|1|||
161872512|NCT01322490|584578557|FG000|Treatment Period|Protocol Violation|7|||
161872513|NCT01322490|584578558|FG001|Treatment Period|Protocol Violation|5|||
161872514|NCT01322490|584578559|FG002|Treatment Period|Protocol Violation|4|||
161872515|NCT01322490|584578557|FG000|Treatment Period|Withdrawal by Subject|14|||
161872516|NCT01322490|584578558|FG001|Treatment Period|Withdrawal by Subject|16|||
161872517|NCT01322490|584578559|FG002|Treatment Period|Withdrawal by Subject|11|||
161872518|NCT01322490|584578557|FG000|Treatment Period|Non-compliance with study drug|0|||
161872519|NCT01322490|584578558|FG001|Treatment Period|Non-compliance with study drug|0|||
161872520|NCT01322490|584578559|FG002|Treatment Period|Non-compliance with study drug|1|||
161872521|NCT01322490|584578557|FG000|Treatment Period|Other per report|2|||
161872522|NCT01322490|584578558|FG001|Treatment Period|Other per report|2|||
161872523|NCT01322490|584578559|FG002|Treatment Period|Other per report|1|||
161872524|NCT01322490|584578557|FG000|Treatment Period|Randomized but Not Treated|3|||
161872525|NCT01322490|584578558|FG001|Treatment Period|Randomized but Not Treated|3|||
161872526|NCT01322490|584578559|FG002|Treatment Period|Randomized but Not Treated|5|||
161872527|NCT01322490|584578557|FG000|Long Term Follow-up Period|Death|235|||
161872528|NCT01322490|584578558|FG001|Long Term Follow-up Period|Death|239|||
161872529|NCT01322490|584578559|FG002|Long Term Follow-up Period|Death|236|||
161872530|NCT01322490|584578557|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
161872531|NCT01322490|584578558|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
161872532|NCT01322490|584578559|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
161872533|NCT01322490|584578557|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
161872534|NCT01322490|584578558|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
161872535|NCT01322490|584578559|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
161872536|NCT01322490|584578557|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
161872537|NCT01322490|584578558|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
161872538|NCT01322490|584578559|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
161872539|NCT01322490|584578557|FG000|Long Term Follow-up Period|Other per report|3|||
161872540|NCT01322490|584578558|FG001|Long Term Follow-up Period|Other per report|2|||
161872541|NCT01322490|584578559|FG002|Long Term Follow-up Period|Other per report|2|||
161872542|NCT01322490|584578557|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
161872543|NCT01322490|584578558|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
161872544|NCT01322490|584578559|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
161872545|NCT02257489|584578562|FG000|Overall Study|Withdrawal by Subject|0|||
161872546|NCT02257489|584578563|FG001|Overall Study|Withdrawal by Subject|0|||
161872547|NCT02257489|584578564|FG002|Overall Study|Withdrawal by Subject|0|||
161872548|NCT02257489|584578565|FG003|Overall Study|Withdrawal by Subject|1|||
161872549|NCT02257489|584578566|FG004|Overall Study|Withdrawal by Subject|0|||
161872550|NCT02257489|584578567|FG005|Overall Study|Withdrawal by Subject|0|||
161872551|NCT02257489|584578568|FG006|Overall Study|Withdrawal by Subject|0|||
161872552|NCT02257489|584578569|FG007|Overall Study|Withdrawal by Subject|0|||
161872553|NCT02257489|584578570|FG008|Overall Study|Withdrawal by Subject|0|||
161872554|NCT04606394|584578571|FG000|Overall Study|Withdrawal by Subject|3|||
161872555|NCT04606394|584578571|FG000|Overall Study|Exclusion criteria screen failure|12|||
161872556|NCT01896128|584578572|FG000|Overall Study|Withdrawal by Subject|3|||
161872557|NCT01896128|584578573|FG001|Overall Study|Withdrawal by Subject|3|||
161872558|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
161775665|NCT01317199|584221229|FG000|Dose-escalation Phase 1|Disease progression|1|||
161775666|NCT01317199|584221230|FG001|Dose-escalation Phase 1|Disease progression|0|||
161775667|NCT01317199|584221231|FG002|Dose-escalation Phase 1|Disease progression|0|||
161775668|NCT01317199|584221232|FG003|Dose-escalation Phase 1|Disease progression|0|||
161775669|NCT01317199|584221229|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
161775670|NCT01317199|584221230|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161775671|NCT01317199|584221231|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161775672|NCT01317199|584221232|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161775673|NCT01317199|584221229|FG000|Randomized Phase 2|Disease progression|0|||
161775674|NCT01317199|584221230|FG001|Randomized Phase 2|Disease progression|3|||
161775675|NCT01317199|584221231|FG002|Randomized Phase 2|Disease progression|7|||
161775676|NCT01317199|584221232|FG003|Randomized Phase 2|Disease progression|5|||
161775677|NCT01317199|584221229|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
161775678|NCT01317199|584221230|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
161775679|NCT01317199|584221231|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
161775680|NCT01317199|584221232|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
161775681|NCT01317199|584221229|FG000|Randomized Phase 2|Adverse Event|0|||
161775682|NCT01317199|584221230|FG001|Randomized Phase 2|Adverse Event|0|||
161775683|NCT01317199|584221231|FG002|Randomized Phase 2|Adverse Event|0|||
161775684|NCT01317199|584221232|FG003|Randomized Phase 2|Adverse Event|1|||
161775685|NCT01317199|584221229|FG000|Randomized Phase 2|Comorbidities|0|||
161775686|NCT01317199|584221230|FG001|Randomized Phase 2|Comorbidities|2|||
161775687|NCT01317199|584221231|FG002|Randomized Phase 2|Comorbidities|2|||
161775688|NCT01317199|584221232|FG003|Randomized Phase 2|Comorbidities|2|||
161775689|NCT01317199|584221229|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
161775690|NCT01317199|584221230|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
161775691|NCT01317199|584221231|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
161775692|NCT01317199|584221232|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
161775693|NCT01317199|584221229|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
161775694|NCT01317199|584221230|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
161775695|NCT01317199|584221231|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
161775696|NCT01317199|584221232|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
161775697|NCT01317199|584221229|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
161775698|NCT01317199|584221230|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
161775699|NCT01317199|584221231|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
161775700|NCT01317199|584221232|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
161775701|NCT01317199|584221229|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
161775702|NCT01317199|584221230|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
161775703|NCT01317199|584221231|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
161775704|NCT01317199|584221232|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
161775705|NCT01353209|584221233|FG000|Overall Study|Adverse Event|1|||
161775706|NCT01353209|584221234|FG001|Overall Study|Adverse Event|1|||
161775707|NCT01283009|584221235|FG000|Overall Study|Death|83|||
161775708|NCT01283009|584221236|FG001|Overall Study|Death|78|||
161775709|NCT01283009|584221235|FG000|Overall Study|Study ended early|23|||
161775710|NCT01283009|584221236|FG001|Overall Study|Study ended early|26|||
161775711|NCT01283009|584221235|FG000|Overall Study|Withdrawal by Subject|10|||
161775712|NCT01283009|584221236|FG001|Overall Study|Withdrawal by Subject|8|||
161775713|NCT01283009|584221235|FG000|Overall Study|Physician Decision|1|||
161775714|NCT01283009|584221236|FG001|Overall Study|Physician Decision|1|||
161775715|NCT01283009|584221235|FG000|Overall Study|Lost to Follow-up|1|||
161775716|NCT01283009|584221236|FG001|Overall Study|Lost to Follow-up|0|||
161775717|NCT01283009|584221235|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
161775718|NCT01283009|584221236|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
161775719|NCT03237325|584221240|FG000|Overall Study|Lost to Follow-up|3|||
161775720|NCT03237325|584221241|FG001|Overall Study|Lost to Follow-up|5|||
161775721|NCT03237325|584221240|FG000|Overall Study|Physician Decision|2|||
161775722|NCT03237325|584221241|FG001|Overall Study|Physician Decision|4|||
161775723|NCT03237325|584221240|FG000|Overall Study|Withdrawal by Subject|9|||
161775724|NCT03237325|584221241|FG001|Overall Study|Withdrawal by Subject|12|||
161775725|NCT03237325|584221240|FG000|Overall Study|Noncompliance with Study Procedures|1|||
161775726|NCT03237325|584221241|FG001|Overall Study|Noncompliance with Study Procedures|1|||
161775727|NCT03237325|584221240|FG000|Overall Study|Termination by Sponsor|0|||
161775728|NCT03237325|584221241|FG001|Overall Study|Termination by Sponsor|1|||
161775729|NCT03237325|584221240|FG000|Overall Study|Reason other than described|0|||
161775730|NCT03237325|584221241|FG001|Overall Study|Reason other than described|2|||
161775731|NCT02684370|584221242|FG000|Part A|Adverse Event|2|||
161775732|NCT02684370|584221243|FG001|Part A|Adverse Event|0|||
161775733|NCT02684370|584221244|FG002|Part A|Adverse Event|1|||
161775734|NCT02684370|584221245|FG003|Part A|Adverse Event|0|||
161775735|NCT02684370|584221246|FG004|Part A|Adverse Event|0|||
161775736|NCT02684370|584221247|FG005|Part A|Adverse Event|0|||
161775737|NCT02684370|584221242|FG000|Part A|Lost to Follow-up|1|||
161775738|NCT02684370|584221243|FG001|Part A|Lost to Follow-up|1|||
161775739|NCT02684370|584221244|FG002|Part A|Lost to Follow-up|0|||
161775740|NCT02684370|584221245|FG003|Part A|Lost to Follow-up|0|||
161775741|NCT02684370|584221246|FG004|Part A|Lost to Follow-up|0|||
161775742|NCT02684370|584221247|FG005|Part A|Lost to Follow-up|0|||
161775743|NCT02684370|584221242|FG000|Part A|Subject Withdrawal|1|||
161775744|NCT02684370|584221243|FG001|Part A|Subject Withdrawal|0|||
161775745|NCT02684370|584221244|FG002|Part A|Subject Withdrawal|3|||
161775746|NCT02684370|584221245|FG003|Part A|Subject Withdrawal|0|||
161775747|NCT02684370|584221246|FG004|Part A|Subject Withdrawal|0|||
161775748|NCT02684370|584221247|FG005|Part A|Subject Withdrawal|0|||
161775749|NCT02684370|584221242|FG000|Part A|Other|0|||
161775750|NCT02684370|584221243|FG001|Part A|Other|0|||
161775751|NCT02684370|584221244|FG002|Part A|Other|1|||
161775752|NCT02684370|584221245|FG003|Part A|Other|0|||
161775753|NCT02684370|584221246|FG004|Part A|Other|0|||
161775754|NCT02684370|584221247|FG005|Part A|Other|0|||
161775755|NCT02684370|584221242|FG000|Part B|Adverse Event|0|||
161775756|NCT02684370|584221243|FG001|Part B|Adverse Event|0|||
161775757|NCT02684370|584221244|FG002|Part B|Adverse Event|0|||
161775758|NCT02684370|584221245|FG003|Part B|Adverse Event|0|||
161775759|NCT02684370|584221246|FG004|Part B|Adverse Event|2|||
161775760|NCT02684370|584221247|FG005|Part B|Adverse Event|1|||
161775761|NCT02684370|584221242|FG000|Part B|Lost to Follow-up|0|||
161775762|NCT02684370|584221243|FG001|Part B|Lost to Follow-up|0|||
161775763|NCT02684370|584221244|FG002|Part B|Lost to Follow-up|0|||
161775764|NCT02684370|584221245|FG003|Part B|Lost to Follow-up|1|||
161775765|NCT02684370|584221246|FG004|Part B|Lost to Follow-up|2|||
161775766|NCT02684370|584221247|FG005|Part B|Lost to Follow-up|5|||
161775767|NCT02684370|584221242|FG000|Part B|Subject Withdrawal|0|||
161775768|NCT02684370|584221243|FG001|Part B|Subject Withdrawal|0|||
161775769|NCT02684370|584221244|FG002|Part B|Subject Withdrawal|0|||
161775770|NCT02684370|584221245|FG003|Part B|Subject Withdrawal|1|||
161775771|NCT02684370|584221246|FG004|Part B|Subject Withdrawal|1|||
161775772|NCT02684370|584221247|FG005|Part B|Subject Withdrawal|2|||
161775773|NCT00627094|584221249|FG000|Overall Study|Adverse Event|8|||
161775774|NCT00627094|584221250|FG001|Overall Study|Adverse Event|7|||
161775775|NCT00627094|584221249|FG000|Overall Study|Lost to Follow-up|1|||
161775776|NCT00627094|584221250|FG001|Overall Study|Lost to Follow-up|0|||
161775777|NCT00627094|584221249|FG000|Overall Study|Withdrawal by Subject|1|||
161775778|NCT00627094|584221250|FG001|Overall Study|Withdrawal by Subject|1|||
161775779|NCT00627094|584221249|FG000|Overall Study|ulcer healed|1|||
161775780|NCT00627094|584221250|FG001|Overall Study|ulcer healed|7|||
161775781|NCT00627094|584221249|FG000|Overall Study|Other reason|1|||
161775782|NCT00627094|584221250|FG001|Overall Study|Other reason|0|||
161872559|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
161872560|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
161872561|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
161872562|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
161872563|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
161872564|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
161872565|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
161872566|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
161872567|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
161872568|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
161872569|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
161872570|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
161872571|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
161872572|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872573|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872574|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872575|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872576|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
161872577|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
161872578|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
161872579|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
161872580|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
161872581|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
161872582|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
161872583|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
161872584|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
161872585|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
161872586|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
161872587|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
161872588|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
161872589|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
161872590|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872591|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872592|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872593|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872594|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
161872595|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
161872596|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872597|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872598|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872599|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872600|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872601|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872602|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872603|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872604|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872605|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
161872606|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
161872607|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
161872608|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
161872609|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
161872610|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
161872611|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
161872612|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
161872613|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
161872614|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
161872615|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
161872616|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
161872617|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
161872618|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Death|0|||
161872619|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Death|0|||
161872620|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Death|0|||
161872621|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Death|0|||
161872622|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Death|0|||
161872623|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Death|1|||
161872624|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
161872625|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
161872626|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
161872627|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
161872628|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
161872629|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
161872630|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
161872631|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
161872632|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
161872633|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
161872634|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
161872635|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
161872636|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872637|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872638|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
161872639|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872640|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872641|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
161872642|NCT02016105|584578574|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
161872643|NCT02016105|584578575|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
161872644|NCT02016105|584578576|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
161872645|NCT02016105|584578577|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
161872646|NCT02016105|584578578|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
161872647|NCT02016105|584578579|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
161872648|NCT02016105|584578574|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
161872649|NCT02016105|584578575|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
161872650|NCT02016105|584578576|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
161872651|NCT02016105|584578577|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
161872652|NCT02016105|584578578|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
161872653|NCT02016105|584578579|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
161872654|NCT02016105|584578574|FG000|EXTENSION PERIOD|Adverse Event|0|||
161872655|NCT02016105|584578575|FG001|EXTENSION PERIOD|Adverse Event|0|||
161872656|NCT02016105|584578576|FG002|EXTENSION PERIOD|Adverse Event|2|||
161872657|NCT02016105|584578577|FG003|EXTENSION PERIOD|Adverse Event|0|||
161872658|NCT02016105|584578578|FG004|EXTENSION PERIOD|Adverse Event|1|||
161872659|NCT02016105|584578579|FG005|EXTENSION PERIOD|Adverse Event|0|||
161872660|NCT02016105|584578574|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
161872661|NCT02016105|584578575|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
161872662|NCT02016105|584578576|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872663|NCT02016105|584578577|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872664|NCT02016105|584578578|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872665|NCT02016105|584578579|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872666|NCT02016105|584578574|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872667|NCT02016105|584578575|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872668|NCT02016105|584578576|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872669|NCT02016105|584578577|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872670|NCT02016105|584578578|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
161872671|NCT02016105|584578579|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872672|NCT02016105|584578574|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
161872673|NCT02016105|584578575|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
161872674|NCT02016105|584578576|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
161872675|NCT02016105|584578577|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
161872676|NCT02016105|584578578|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
161872677|NCT02016105|584578579|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
161872678|NCT00090493|584578580|FG000|Overall Study|Physician Decision|2|||
161872679|NCT02865499|584578581|FG000|Baseline|Adverse Event|1|||
161872680|NCT02865499|584578581|FG000|Baseline|Withdrawal by Subject|1|||
161872681|NCT02320058|584578582|FG000|Overall Study|Death|25|||
161872682|NCT02320058|584578583|FG001|Overall Study|Death|10|||
161872683|NCT02320058|584578582|FG000|Overall Study|Lost to Follow-up|4|||
161872684|NCT02320058|584578583|FG001|Overall Study|Lost to Follow-up|0|||
161872685|NCT02320058|584578582|FG000|Overall Study|Other reasons|4|||
161872686|NCT02320058|584578583|FG001|Overall Study|Other reasons|1|||
161872687|NCT02320058|584578582|FG000|Overall Study|Withdrawal by Subject|8|||
161872688|NCT02320058|584578583|FG001|Overall Study|Withdrawal by Subject|2|||
161872689|NCT02320058|584578582|FG000|Overall Study|Not reported|1|||
161872690|NCT02320058|584578583|FG001|Overall Study|Not reported|0|||
161872691|NCT00661609|584578584|FG000|Overall Study|Adverse Event|4|||
161872692|NCT00661609|584578584|FG000|Overall Study|Death|20|||
161872693|NCT00661609|584578584|FG000|Overall Study|Withdrawal by Subject|2|||
161872694|NCT00661609|584578584|FG000|Overall Study|PI Decision|1|||
161872695|NCT00661609|584578584|FG000|Overall Study|Survival follow up stage discontinued|11|||
161872696|NCT00661609|584578584|FG000|Overall Study|Disease progression|3|||
161872697|NCT01769508|584578585|FG000|Overall Study|Death|3|||
161872698|NCT01769508|584578585|FG000|Overall Study|Withdrawal by Subject|1|||
161872699|NCT01769508|584578585|FG000|Overall Study|Adverse Event|1|||
161872700|NCT01769508|584578585|FG000|Overall Study|Lost to Follow-up|1|||
161872701|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
161872702|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
161872703|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
161872704|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
161872705|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
161872706|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
161872707|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
161775783|NCT00183170|584221252|FG000|First Intervention|Did not complete study|1|||
161775784|NCT00183170|584221253|FG001|First Intervention|Did not complete study|0|||
161775785|NCT00183170|584221252|FG000|First Intervention|Did not meet targeted BrAC|1|||
161775786|NCT00183170|584221253|FG001|First Intervention|Did not meet targeted BrAC|0|||
161775787|NCT00183170|584221252|FG000|Washout 1 Week|Did not complete study|6|||
161775788|NCT00183170|584221253|FG001|Washout 1 Week|Did not complete study|8|||
161775789|NCT00183170|584221252|FG000|Second Intervention|Did not complete study|1|||
161775790|NCT00183170|584221253|FG001|Second Intervention|Did not complete study|0|||
161775791|NCT00183170|584221252|FG000|Second Intervention|Did not meet targeted BrAC|0|||
161775792|NCT00183170|584221253|FG001|Second Intervention|Did not meet targeted BrAC|2|||
161775793|NCT01165424|584221254|FG000|Overall Study|Clinical adverse experiences|1|||
161775794|NCT01165424|584221254|FG000|Overall Study|Laboratory adverse experiences|1|||
161775795|NCT01165424|584221254|FG000|Overall Study|Did not meet entry criteria|1|||
161775796|NCT01165424|584221254|FG000|Overall Study|Participant moved (relocated)|1|||
161775797|NCT02050373|584221260|FG000|Overall Study|Adverse Event|4|||
161775798|NCT02050373|584221261|FG001|Overall Study|Adverse Event|7|||
161775799|NCT02050373|584221260|FG000|Overall Study|Death|3|||
161775800|NCT02050373|584221261|FG001|Overall Study|Death|3|||
161775801|NCT00807040|584221265|FG000|Overall Study|Death|24|||
161775802|NCT00807040|584221266|FG001|Overall Study|Death|29|||
161775803|NCT00807040|584221265|FG000|Overall Study|Withdrawal by Subject|8|||
161775804|NCT00807040|584221266|FG001|Overall Study|Withdrawal by Subject|6|||
161775805|NCT00807040|584221265|FG000|Overall Study|Lost to Follow-up|4|||
161775806|NCT00807040|584221266|FG001|Overall Study|Lost to Follow-up|6|||
161775807|NCT01067339|584221267|FG000|Overall Study|Withdrawal by Subject|6|||
161775808|NCT01067339|584221268|FG001|Overall Study|Withdrawal by Subject|5|||
161775809|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
161775810|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
161775811|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
161775812|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
161775813|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
161775814|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
161775815|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
161775816|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
161775817|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
161775818|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
161775819|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Other|66|||
161775820|NCT00572910|584221274|FG000|Overall Study|Adverse Event|1|||
161775821|NCT00572910|584221275|FG001|Overall Study|Adverse Event|2|||
161775822|NCT00572910|584221276|FG002|Overall Study|Adverse Event|0|||
161775823|NCT00572910|584221277|FG003|Overall Study|Adverse Event|2|||
161775824|NCT00572910|584221278|FG004|Overall Study|Adverse Event|0|||
161775825|NCT00572910|584221279|FG005|Overall Study|Adverse Event|0|||
161775826|NCT00572910|584221280|FG006|Overall Study|Adverse Event|4|||
161775827|NCT00572910|584221281|FG007|Overall Study|Adverse Event|2|||
161775828|NCT00572910|584221282|FG008|Overall Study|Adverse Event|1|||
161775829|NCT00572910|584221283|FG009|Overall Study|Adverse Event|3|||
161775830|NCT00572910|584221284|FG010|Overall Study|Adverse Event|2|||
161775831|NCT00572910|584221274|FG000|Overall Study|Lost to Follow-up|0|||
161775832|NCT00572910|584221275|FG001|Overall Study|Lost to Follow-up|1|||
161775833|NCT00572910|584221276|FG002|Overall Study|Lost to Follow-up|1|||
161775834|NCT00572910|584221277|FG003|Overall Study|Lost to Follow-up|2|||
161775835|NCT00572910|584221278|FG004|Overall Study|Lost to Follow-up|1|||
161775836|NCT00572910|584221279|FG005|Overall Study|Lost to Follow-up|0|||
161775837|NCT00572910|584221280|FG006|Overall Study|Lost to Follow-up|0|||
161775838|NCT00572910|584221281|FG007|Overall Study|Lost to Follow-up|0|||
161775839|NCT00572910|584221282|FG008|Overall Study|Lost to Follow-up|0|||
161775840|NCT00572910|584221283|FG009|Overall Study|Lost to Follow-up|1|||
161775841|NCT00572910|584221284|FG010|Overall Study|Lost to Follow-up|0|||
161775842|NCT00572910|584221274|FG000|Overall Study|Withdrawal by Subject|3|||
161775843|NCT00572910|584221275|FG001|Overall Study|Withdrawal by Subject|0|||
161775844|NCT00572910|584221276|FG002|Overall Study|Withdrawal by Subject|1|||
161775845|NCT00572910|584221277|FG003|Overall Study|Withdrawal by Subject|0|||
161775846|NCT00572910|584221278|FG004|Overall Study|Withdrawal by Subject|1|||
161775847|NCT00572910|584221279|FG005|Overall Study|Withdrawal by Subject|3|||
161775848|NCT00572910|584221280|FG006|Overall Study|Withdrawal by Subject|0|||
161775849|NCT00572910|584221281|FG007|Overall Study|Withdrawal by Subject|2|||
161775850|NCT00572910|584221282|FG008|Overall Study|Withdrawal by Subject|2|||
161775851|NCT00572910|584221283|FG009|Overall Study|Withdrawal by Subject|2|||
161775852|NCT00572910|584221284|FG010|Overall Study|Withdrawal by Subject|1|||
161775853|NCT01833897|584221290|FG000|Overall Study|Lack of Efficacy|1|||
161775854|NCT05275673|584221291|FG000|Overall Study|Study Termination by Sponsor|2|||
161775855|NCT05275673|584221292|FG001|Overall Study|Study Termination by Sponsor|3|||
161775856|NCT05275673|584221291|FG000|Overall Study|Death|1|||
161775857|NCT05275673|584221292|FG001|Overall Study|Death|0|||
161775858|NCT05275673|584221291|FG000|Overall Study|Withdrawal by Subject|1|||
161872708|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
161872709|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
161872710|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
161872711|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
161872712|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
161872713|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
161872714|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
161872715|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
161872716|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
161872717|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
161872718|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
161872719|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
161872720|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
161872721|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
161872722|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
161872723|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
161872724|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
161872725|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
161872726|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
161872727|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
161872728|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
161872729|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161872730|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161872731|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
161872732|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
161872733|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
161872734|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
161872735|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
161872736|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
161872737|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161872738|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
161872739|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161872740|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
161872741|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
161872742|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
161872743|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
161872744|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
161872745|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
161872746|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
161872747|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
161872748|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
161872749|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
161872750|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
161872751|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161872752|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
161872753|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
161872754|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
161872755|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
161872756|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
161872757|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
161872758|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
161872759|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
161872760|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
161872761|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
161872762|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
161872763|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
161872764|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
161872765|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
161872766|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
161872767|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
161872768|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
161872769|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
161775859|NCT05275673|584221292|FG001|Overall Study|Withdrawal by Subject|0|||
161775860|NCT02325739|584221293|FG000|Phase I Part|Adverse Event|1|||
161775861|NCT02325739|584221294|FG001|Phase I Part|Adverse Event|0|||
161872770|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
161872771|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
161872772|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
161872773|NCT02751450|584578589|FG000|Overall Study|Adverse Event|1|||
161872774|NCT02751450|584578590|FG001|Overall Study|Adverse Event|0|||
161872775|NCT02587598|584578591|FG000|Overall Study|Death|4|||
161872776|NCT02587598|584578592|FG001|Overall Study|Death|8|||
161872777|NCT02587598|584578593|FG002|Overall Study|Death|4|||
161872778|NCT02587598|584578594|FG003|Overall Study|Death|16|||
161872779|NCT02587598|584578595|FG004|Overall Study|Death|9|||
161872780|NCT02587598|584578596|FG005|Overall Study|Death|4|||
161872781|NCT02587598|584578597|FG006|Overall Study|Death|6|||
161872782|NCT02587598|584578598|FG007|Overall Study|Death|7|||
161872783|NCT02587598|584578599|FG008|Overall Study|Death|9|||
161872784|NCT02587598|584578600|FG009|Overall Study|Death|1|||
161872785|NCT02587598|584578601|FG010|Overall Study|Death|3|||
161872786|NCT02587598|584578591|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161872787|NCT02587598|584578592|FG001|Overall Study|Study Terminated by the Sponsor|1|||
161872788|NCT02587598|584578593|FG002|Overall Study|Study Terminated by the Sponsor|0|||
161872789|NCT02587598|584578594|FG003|Overall Study|Study Terminated by the Sponsor|3|||
161872790|NCT02587598|584578595|FG004|Overall Study|Study Terminated by the Sponsor|0|||
161872791|NCT02587598|584578596|FG005|Overall Study|Study Terminated by the Sponsor|1|||
161872792|NCT02587598|584578597|FG006|Overall Study|Study Terminated by the Sponsor|0|||
161872793|NCT02587598|584578598|FG007|Overall Study|Study Terminated by the Sponsor|0|||
161872794|NCT02587598|584578599|FG008|Overall Study|Study Terminated by the Sponsor|0|||
161872795|NCT02587598|584578600|FG009|Overall Study|Study Terminated by the Sponsor|1|||
161872796|NCT02587598|584578601|FG010|Overall Study|Study Terminated by the Sponsor|6|||
161872797|NCT02587598|584578591|FG000|Overall Study|Reason for study withdrawal not specified|0|||
161872798|NCT02587598|584578592|FG001|Overall Study|Reason for study withdrawal not specified|1|||
161872799|NCT02587598|584578593|FG002|Overall Study|Reason for study withdrawal not specified|0|||
161872800|NCT02587598|584578594|FG003|Overall Study|Reason for study withdrawal not specified|0|||
161872801|NCT02587598|584578595|FG004|Overall Study|Reason for study withdrawal not specified|0|||
161872802|NCT02587598|584578596|FG005|Overall Study|Reason for study withdrawal not specified|0|||
161872803|NCT02587598|584578597|FG006|Overall Study|Reason for study withdrawal not specified|0|||
161872804|NCT02587598|584578598|FG007|Overall Study|Reason for study withdrawal not specified|0|||
161872805|NCT02587598|584578599|FG008|Overall Study|Reason for study withdrawal not specified|0|||
161872806|NCT02587598|584578600|FG009|Overall Study|Reason for study withdrawal not specified|0|||
161872807|NCT02587598|584578601|FG010|Overall Study|Reason for study withdrawal not specified|0|||
161872808|NCT02587598|584578591|FG000|Overall Study|Withdrawal by Subject|0|||
161872809|NCT02587598|584578592|FG001|Overall Study|Withdrawal by Subject|1|||
161872810|NCT02587598|584578593|FG002|Overall Study|Withdrawal by Subject|0|||
161872811|NCT02587598|584578594|FG003|Overall Study|Withdrawal by Subject|2|||
161872812|NCT02587598|584578595|FG004|Overall Study|Withdrawal by Subject|3|||
161872813|NCT02587598|584578596|FG005|Overall Study|Withdrawal by Subject|1|||
161872814|NCT02587598|584578597|FG006|Overall Study|Withdrawal by Subject|0|||
161872815|NCT02587598|584578598|FG007|Overall Study|Withdrawal by Subject|0|||
161872816|NCT02587598|584578599|FG008|Overall Study|Withdrawal by Subject|0|||
161872817|NCT02587598|584578600|FG009|Overall Study|Withdrawal by Subject|1|||
161872818|NCT02587598|584578601|FG010|Overall Study|Withdrawal by Subject|2|||
161872819|NCT02587598|584578591|FG000|Overall Study|Physician Decision|0|||
161872820|NCT02587598|584578592|FG001|Overall Study|Physician Decision|0|||
161872821|NCT02587598|584578593|FG002|Overall Study|Physician Decision|0|||
161872822|NCT02587598|584578594|FG003|Overall Study|Physician Decision|0|||
161872823|NCT02587598|584578595|FG004|Overall Study|Physician Decision|0|||
161872824|NCT02587598|584578596|FG005|Overall Study|Physician Decision|0|||
161872825|NCT02587598|584578597|FG006|Overall Study|Physician Decision|0|||
161872826|NCT02587598|584578598|FG007|Overall Study|Physician Decision|0|||
161872827|NCT02587598|584578599|FG008|Overall Study|Physician Decision|0|||
161872828|NCT02587598|584578600|FG009|Overall Study|Physician Decision|0|||
161872829|NCT02587598|584578601|FG010|Overall Study|Physician Decision|3|||
161872830|NCT00679289|584578602|FG000|Overall Study|Progressive disease|4|||
161872831|NCT00679289|584578603|FG001|Overall Study|Progressive disease|5|||
161872832|NCT00679289|584578604|FG002|Overall Study|Progressive disease|18|||
161872833|NCT00679289|584578602|FG000|Overall Study|Withdrawal by Subject|0|||
161872834|NCT00679289|584578603|FG001|Overall Study|Withdrawal by Subject|1|||
161872835|NCT00679289|584578604|FG002|Overall Study|Withdrawal by Subject|1|||
161872836|NCT00679289|584578602|FG000|Overall Study|Adverse Event|0|||
161872837|NCT00679289|584578603|FG001|Overall Study|Adverse Event|0|||
161872838|NCT00679289|584578604|FG002|Overall Study|Adverse Event|3|||
161872839|NCT00679289|584578602|FG000|Overall Study|Physician Decision|1|||
161872840|NCT00679289|584578603|FG001|Overall Study|Physician Decision|0|||
161872841|NCT00679289|584578604|FG002|Overall Study|Physician Decision|1|||
161872842|NCT00937040|584578605|FG000|Overall Study|Adverse Event|5|||
161872843|NCT00937040|584578606|FG001|Overall Study|Adverse Event|8|||
161872844|NCT00937040|584578605|FG000|Overall Study|Lost to Follow-up|12|||
161872845|NCT00937040|584578606|FG001|Overall Study|Lost to Follow-up|12|||
161872846|NCT00937040|584578605|FG000|Overall Study|Protocol Violation|3|||
161872847|NCT00937040|584578606|FG001|Overall Study|Protocol Violation|0|||
161872848|NCT00937040|584578605|FG000|Overall Study|Withdrawal by Subject|13|||
161872849|NCT00937040|584578606|FG001|Overall Study|Withdrawal by Subject|7|||
161872850|NCT00937040|584578605|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
161872851|NCT00937040|584578606|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
161872852|NCT00937040|584578605|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
161872853|NCT00937040|584578606|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
161872854|NCT02477826|584578607|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872855|NCT02477826|584578608|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
161872856|NCT02477826|584578609|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
161872857|NCT02477826|584578610|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
161872858|NCT02477826|584578611|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872859|NCT02477826|584578612|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872860|NCT02477826|584578613|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
161872861|NCT02477826|584578614|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
161872862|NCT02477826|584578615|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872863|NCT02477826|584578616|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872864|NCT02477826|584578607|FG000|Pre-Treatment|Other reasons|4|||
161872865|NCT02477826|584578608|FG001|Pre-Treatment|Other reasons|1|||
161872866|NCT02477826|584578609|FG002|Pre-Treatment|Other reasons|4|||
161872867|NCT02477826|584578610|FG003|Pre-Treatment|Other reasons|1|||
161872868|NCT02477826|584578611|FG004|Pre-Treatment|Other reasons|4|||
161872869|NCT02477826|584578612|FG005|Pre-Treatment|Other reasons|2|||
161872870|NCT02477826|584578613|FG006|Pre-Treatment|Other reasons|0|||
161872871|NCT02477826|584578614|FG007|Pre-Treatment|Other reasons|0|||
161872872|NCT02477826|584578615|FG008|Pre-Treatment|Other reasons|0|||
161872873|NCT02477826|584578616|FG009|Pre-Treatment|Other reasons|0|||
161872874|NCT02477826|584578607|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
161872875|NCT02477826|584578608|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
161872876|NCT02477826|584578609|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
161872877|NCT02477826|584578610|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
161872878|NCT02477826|584578611|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
161872879|NCT02477826|584578612|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
161872880|NCT02477826|584578613|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
161872881|NCT02477826|584578614|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
161872882|NCT02477826|584578615|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
161872883|NCT02477826|584578616|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
161872884|NCT02477826|584578607|FG000|Pre-Treatment|Subject withdrew consent|0|||
161872885|NCT02477826|584578608|FG001|Pre-Treatment|Subject withdrew consent|0|||
161872886|NCT02477826|584578609|FG002|Pre-Treatment|Subject withdrew consent|3|||
161872887|NCT02477826|584578610|FG003|Pre-Treatment|Subject withdrew consent|0|||
161872888|NCT02477826|584578611|FG004|Pre-Treatment|Subject withdrew consent|0|||
161872889|NCT02477826|584578612|FG005|Pre-Treatment|Subject withdrew consent|1|||
161872890|NCT02477826|584578613|FG006|Pre-Treatment|Subject withdrew consent|0|||
161872891|NCT02477826|584578614|FG007|Pre-Treatment|Subject withdrew consent|1|||
161872892|NCT02477826|584578615|FG008|Pre-Treatment|Subject withdrew consent|0|||
161872893|NCT02477826|584578616|FG009|Pre-Treatment|Subject withdrew consent|3|||
161872894|NCT02477826|584578607|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872895|NCT02477826|584578608|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
161872896|NCT02477826|584578609|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872897|NCT02477826|584578610|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872898|NCT02477826|584578611|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872899|NCT02477826|584578612|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872900|NCT02477826|584578613|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872901|NCT02477826|584578614|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872902|NCT02477826|584578615|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872903|NCT02477826|584578616|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
161872904|NCT02477826|584578607|FG000|Pre-Treatment|Death|0|||
161872905|NCT02477826|584578608|FG001|Pre-Treatment|Death|0|||
161872906|NCT02477826|584578609|FG002|Pre-Treatment|Death|0|||
161872907|NCT02477826|584578610|FG003|Pre-Treatment|Death|0|||
161872908|NCT02477826|584578611|FG004|Pre-Treatment|Death|0|||
161872909|NCT02477826|584578612|FG005|Pre-Treatment|Death|0|||
161872910|NCT02477826|584578613|FG006|Pre-Treatment|Death|1|||
161872911|NCT02477826|584578614|FG007|Pre-Treatment|Death|0|||
161872912|NCT02477826|584578615|FG008|Pre-Treatment|Death|0|||
161872913|NCT02477826|584578616|FG009|Pre-Treatment|Death|0|||
161872914|NCT02477826|584578607|FG000|Treatment Period|Not reported|8|||
161872915|NCT02477826|584578608|FG001|Treatment Period|Not reported|6|||
161872916|NCT02477826|584578609|FG002|Treatment Period|Not reported|4|||
161872917|NCT02477826|584578610|FG003|Treatment Period|Not reported|4|||
161872918|NCT02477826|584578611|FG004|Treatment Period|Not reported|2|||
161872919|NCT02477826|584578612|FG005|Treatment Period|Not reported|1|||
161872920|NCT02477826|584578613|FG006|Treatment Period|Not reported|14|||
161872921|NCT02477826|584578614|FG007|Treatment Period|Not reported|8|||
161872922|NCT02477826|584578615|FG008|Treatment Period|Not reported|5|||
161872923|NCT02477826|584578616|FG009|Treatment Period|Not reported|2|||
161872924|NCT02477826|584578607|FG000|Treatment Period|Other reasons|5|||
161872925|NCT02477826|584578608|FG001|Treatment Period|Other reasons|6|||
161872926|NCT02477826|584578609|FG002|Treatment Period|Other reasons|12|||
161872927|NCT02477826|584578610|FG003|Treatment Period|Other reasons|7|||
161872928|NCT02477826|584578611|FG004|Treatment Period|Other reasons|5|||
161872929|NCT02477826|584578612|FG005|Treatment Period|Other reasons|1|||
161872930|NCT02477826|584578613|FG006|Treatment Period|Other reasons|8|||
161872931|NCT02477826|584578614|FG007|Treatment Period|Other reasons|8|||
161775862|NCT02325739|584221295|FG002|Phase I Part|Adverse Event|1|||
161775863|NCT02325739|584221296|FG003|Phase I Part|Adverse Event|2|||
161775864|NCT02325739|584221297|FG004|Phase I Part|Adverse Event|3|||
161775865|NCT02325739|584221298|FG005|Phase I Part|Adverse Event|1|||
161775866|NCT02325739|584221299|FG006|Phase I Part|Adverse Event|0|||
161775867|NCT02325739|584221300|FG007|Phase I Part|Adverse Event|2|||
161775868|NCT02325739|584221301|FG008|Phase I Part|Adverse Event|0|||
161775869|NCT02325739|584221302|FG009|Phase I Part|Adverse Event|0|||
161775870|NCT02325739|584221303|FG010|Phase I Part|Adverse Event|0|||
161775871|NCT02325739|584221293|FG000|Phase I Part|Progressive disease|9|||
161775872|NCT02325739|584221294|FG001|Phase I Part|Progressive disease|6|||
161775873|NCT02325739|584221295|FG002|Phase I Part|Progressive disease|3|||
161775874|NCT02325739|584221296|FG003|Phase I Part|Progressive disease|23|||
161775875|NCT02325739|584221297|FG004|Phase I Part|Progressive disease|14|||
161775876|NCT02325739|584221298|FG005|Phase I Part|Progressive disease|6|||
161872932|NCT02477826|584578615|FG008|Treatment Period|Other reasons|21|||
161872933|NCT02477826|584578616|FG009|Treatment Period|Other reasons|1|||
161872934|NCT02477826|584578607|FG000|Treatment Period|Administrative reason by sponsor|0|||
161775877|NCT02325739|584221299|FG006|Phase I Part|Progressive disease|6|||
161775878|NCT02325739|584221300|FG007|Phase I Part|Progressive disease|3|||
161775879|NCT02325739|584221301|FG008|Phase I Part|Progressive disease|0|||
161775880|NCT02325739|584221302|FG009|Phase I Part|Progressive disease|0|||
161775881|NCT02325739|584221303|FG010|Phase I Part|Progressive disease|0|||
161775882|NCT02325739|584221293|FG000|Phase I Part|Subject/guardian decision|1|||
161775883|NCT02325739|584221294|FG001|Phase I Part|Subject/guardian decision|0|||
161775884|NCT02325739|584221295|FG002|Phase I Part|Subject/guardian decision|1|||
161775885|NCT02325739|584221296|FG003|Phase I Part|Subject/guardian decision|1|||
161775886|NCT02325739|584221297|FG004|Phase I Part|Subject/guardian decision|0|||
161775887|NCT02325739|584221298|FG005|Phase I Part|Subject/guardian decision|0|||
161775888|NCT02325739|584221299|FG006|Phase I Part|Subject/guardian decision|0|||
161775889|NCT02325739|584221300|FG007|Phase I Part|Subject/guardian decision|1|||
161872935|NCT02477826|584578608|FG001|Treatment Period|Administrative reason by sponsor|3|||
161872936|NCT02477826|584578609|FG002|Treatment Period|Administrative reason by sponsor|0|||
161872937|NCT02477826|584578610|FG003|Treatment Period|Administrative reason by sponsor|0|||
161872938|NCT02477826|584578611|FG004|Treatment Period|Administrative reason by sponsor|0|||
161872939|NCT02477826|584578612|FG005|Treatment Period|Administrative reason by sponsor|0|||
161872940|NCT02477826|584578613|FG006|Treatment Period|Administrative reason by sponsor|0|||
161872941|NCT02477826|584578614|FG007|Treatment Period|Administrative reason by sponsor|0|||
161872942|NCT02477826|584578615|FG008|Treatment Period|Administrative reason by sponsor|0|||
161872943|NCT02477826|584578616|FG009|Treatment Period|Administrative reason by sponsor|0|||
161872944|NCT02477826|584578607|FG000|Treatment Period|Participant meet no longer study criteria|1|||
161872945|NCT02477826|584578608|FG001|Treatment Period|Participant meet no longer study criteria|1|||
161872946|NCT02477826|584578609|FG002|Treatment Period|Participant meet no longer study criteria|0|||
161872947|NCT02477826|584578610|FG003|Treatment Period|Participant meet no longer study criteria|0|||
161872948|NCT02477826|584578611|FG004|Treatment Period|Participant meet no longer study criteria|1|||
161872949|NCT02477826|584578612|FG005|Treatment Period|Participant meet no longer study criteria|1|||
161872950|NCT02477826|584578613|FG006|Treatment Period|Participant meet no longer study criteria|0|||
161872951|NCT02477826|584578614|FG007|Treatment Period|Participant meet no longer study criteria|1|||
161872952|NCT02477826|584578615|FG008|Treatment Period|Participant meet no longer study criteria|0|||
161872953|NCT02477826|584578616|FG009|Treatment Period|Participant meet no longer study criteria|0|||
161872954|NCT02477826|584578607|FG000|Treatment Period|Poor/Non Compliance|1|||
161872955|NCT02477826|584578608|FG001|Treatment Period|Poor/Non Compliance|0|||
161872956|NCT02477826|584578609|FG002|Treatment Period|Poor/Non Compliance|2|||
161872957|NCT02477826|584578610|FG003|Treatment Period|Poor/Non Compliance|0|||
161872958|NCT02477826|584578611|FG004|Treatment Period|Poor/Non Compliance|0|||
161872959|NCT02477826|584578612|FG005|Treatment Period|Poor/Non Compliance|1|||
161872960|NCT02477826|584578613|FG006|Treatment Period|Poor/Non Compliance|1|||
161872961|NCT02477826|584578614|FG007|Treatment Period|Poor/Non Compliance|0|||
161872962|NCT02477826|584578615|FG008|Treatment Period|Poor/Non Compliance|0|||
161872963|NCT02477826|584578616|FG009|Treatment Period|Poor/Non Compliance|1|||
161872964|NCT02477826|584578607|FG000|Treatment Period|Maximum Clinical Benefit|3|||
161872965|NCT02477826|584578608|FG001|Treatment Period|Maximum Clinical Benefit|3|||
161872966|NCT02477826|584578609|FG002|Treatment Period|Maximum Clinical Benefit|1|||
161872967|NCT02477826|584578610|FG003|Treatment Period|Maximum Clinical Benefit|1|||
161872968|NCT02477826|584578611|FG004|Treatment Period|Maximum Clinical Benefit|3|||
161872969|NCT02477826|584578612|FG005|Treatment Period|Maximum Clinical Benefit|0|||
161872970|NCT02477826|584578613|FG006|Treatment Period|Maximum Clinical Benefit|3|||
161872971|NCT02477826|584578614|FG007|Treatment Period|Maximum Clinical Benefit|2|||
161872972|NCT02477826|584578615|FG008|Treatment Period|Maximum Clinical Benefit|2|||
161872973|NCT02477826|584578616|FG009|Treatment Period|Maximum Clinical Benefit|2|||
161872974|NCT02477826|584578607|FG000|Treatment Period|Lost to Follow-up|0|||
161872975|NCT02477826|584578608|FG001|Treatment Period|Lost to Follow-up|0|||
161872976|NCT02477826|584578609|FG002|Treatment Period|Lost to Follow-up|1|||
161872977|NCT02477826|584578610|FG003|Treatment Period|Lost to Follow-up|1|||
161872978|NCT02477826|584578611|FG004|Treatment Period|Lost to Follow-up|0|||
161872979|NCT02477826|584578612|FG005|Treatment Period|Lost to Follow-up|0|||
161872980|NCT02477826|584578613|FG006|Treatment Period|Lost to Follow-up|2|||
161872981|NCT02477826|584578614|FG007|Treatment Period|Lost to Follow-up|2|||
161872982|NCT02477826|584578615|FG008|Treatment Period|Lost to Follow-up|0|||
161872983|NCT02477826|584578616|FG009|Treatment Period|Lost to Follow-up|0|||
161872984|NCT02477826|584578607|FG000|Treatment Period|Participant withdrew Consent|5|||
161872985|NCT02477826|584578608|FG001|Treatment Period|Participant withdrew Consent|5|||
161872986|NCT02477826|584578609|FG002|Treatment Period|Participant withdrew Consent|3|||
161872987|NCT02477826|584578610|FG003|Treatment Period|Participant withdrew Consent|3|||
161872988|NCT02477826|584578611|FG004|Treatment Period|Participant withdrew Consent|1|||
161872989|NCT02477826|584578612|FG005|Treatment Period|Participant withdrew Consent|3|||
161872990|NCT02477826|584578613|FG006|Treatment Period|Participant withdrew Consent|3|||
161872991|NCT02477826|584578614|FG007|Treatment Period|Participant withdrew Consent|3|||
161872992|NCT02477826|584578615|FG008|Treatment Period|Participant withdrew Consent|2|||
161872993|NCT02477826|584578616|FG009|Treatment Period|Participant withdrew Consent|3|||
161872994|NCT02477826|584578607|FG000|Treatment Period|Participant request to discontinue treatment|5|||
161872995|NCT02477826|584578608|FG001|Treatment Period|Participant request to discontinue treatment|3|||
161872996|NCT02477826|584578609|FG002|Treatment Period|Participant request to discontinue treatment|15|||
161872997|NCT02477826|584578610|FG003|Treatment Period|Participant request to discontinue treatment|5|||
161872998|NCT02477826|584578611|FG004|Treatment Period|Participant request to discontinue treatment|3|||
161872999|NCT02477826|584578612|FG005|Treatment Period|Participant request to discontinue treatment|6|||
161873000|NCT02477826|584578613|FG006|Treatment Period|Participant request to discontinue treatment|13|||
161873001|NCT02477826|584578614|FG007|Treatment Period|Participant request to discontinue treatment|15|||
161775890|NCT02325739|584221301|FG008|Phase I Part|Subject/guardian decision|0|||
161775891|NCT02325739|584221302|FG009|Phase I Part|Subject/guardian decision|0|||
161775892|NCT02325739|584221303|FG010|Phase I Part|Subject/guardian decision|0|||
161775893|NCT02325739|584221293|FG000|Phase I Part|Death|0|||
161775894|NCT02325739|584221294|FG001|Phase I Part|Death|0|||
161775895|NCT02325739|584221295|FG002|Phase I Part|Death|0|||
161775896|NCT02325739|584221296|FG003|Phase I Part|Death|0|||
161775897|NCT02325739|584221297|FG004|Phase I Part|Death|2|||
161775898|NCT02325739|584221298|FG005|Phase I Part|Death|0|||
161775899|NCT02325739|584221299|FG006|Phase I Part|Death|0|||
161775900|NCT02325739|584221300|FG007|Phase I Part|Death|0|||
161775901|NCT02325739|584221301|FG008|Phase I Part|Death|0|||
161775902|NCT02325739|584221302|FG009|Phase I Part|Death|0|||
161775903|NCT02325739|584221303|FG010|Phase I Part|Death|0|||
161873002|NCT02477826|584578615|FG008|Treatment Period|Participant request to discontinue treatment|4|||
161775904|NCT02325739|584221293|FG000|Phase II Part|Adverse Event|0|||
161775905|NCT02325739|584221294|FG001|Phase II Part|Adverse Event|0|||
161873003|NCT02477826|584578616|FG009|Treatment Period|Participant request to discontinue treatment|18|||
161873004|NCT02477826|584578607|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
161873005|NCT02477826|584578608|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
161873006|NCT02477826|584578609|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
161873007|NCT02477826|584578610|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
161873008|NCT02477826|584578611|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
161873009|NCT02477826|584578612|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
161873010|NCT02477826|584578613|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
161873011|NCT02477826|584578614|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
161873012|NCT02477826|584578615|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
161873013|NCT02477826|584578616|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
161873014|NCT02477826|584578607|FG000|Treatment Period|Death|4|||
161873015|NCT02477826|584578608|FG001|Treatment Period|Death|7|||
161873016|NCT02477826|584578609|FG002|Treatment Period|Death|0|||
161873017|NCT02477826|584578610|FG003|Treatment Period|Death|0|||
161873018|NCT02477826|584578611|FG004|Treatment Period|Death|1|||
161873019|NCT02477826|584578612|FG005|Treatment Period|Death|2|||
161873020|NCT02477826|584578613|FG006|Treatment Period|Death|6|||
161873021|NCT02477826|584578614|FG007|Treatment Period|Death|5|||
161873022|NCT02477826|584578615|FG008|Treatment Period|Death|9|||
161873023|NCT02477826|584578616|FG009|Treatment Period|Death|0|||
161873024|NCT02477826|584578607|FG000|Treatment Period|Study Drug Toxicity|79|||
161873025|NCT02477826|584578608|FG001|Treatment Period|Study Drug Toxicity|51|||
161873026|NCT02477826|584578609|FG002|Treatment Period|Study Drug Toxicity|31|||
161873027|NCT02477826|584578610|FG003|Treatment Period|Study Drug Toxicity|39|||
161873028|NCT02477826|584578611|FG004|Treatment Period|Study Drug Toxicity|12|||
161873029|NCT02477826|584578612|FG005|Treatment Period|Study Drug Toxicity|25|||
161873030|NCT02477826|584578613|FG006|Treatment Period|Study Drug Toxicity|52|||
161873031|NCT02477826|584578614|FG007|Treatment Period|Study Drug Toxicity|30|||
161873032|NCT02477826|584578615|FG008|Treatment Period|Study Drug Toxicity|20|||
161873033|NCT02477826|584578616|FG009|Treatment Period|Study Drug Toxicity|9|||
161873034|NCT02477826|584578607|FG000|Treatment Period|Disease progression|212|||
161873035|NCT02477826|584578608|FG001|Treatment Period|Disease progression|240|||
161873036|NCT02477826|584578609|FG002|Treatment Period|Disease progression|202|||
161873037|NCT02477826|584578610|FG003|Treatment Period|Disease progression|93|||
161873038|NCT02477826|584578611|FG004|Treatment Period|Disease progression|113|||
161873039|NCT02477826|584578612|FG005|Treatment Period|Disease progression|96|||
161873040|NCT02477826|584578613|FG006|Treatment Period|Disease progression|208|||
161873041|NCT02477826|584578614|FG007|Treatment Period|Disease progression|195|||
161873042|NCT02477826|584578615|FG008|Treatment Period|Disease progression|59|||
161873043|NCT02477826|584578616|FG009|Treatment Period|Disease progression|46|||
161873044|NCT02477826|584578607|FG000|Treatment Period|Pregnancy|0|||
161873045|NCT02477826|584578608|FG001|Treatment Period|Pregnancy|0|||
161873046|NCT02477826|584578609|FG002|Treatment Period|Pregnancy|0|||
161873047|NCT02477826|584578610|FG003|Treatment Period|Pregnancy|0|||
161873048|NCT02477826|584578611|FG004|Treatment Period|Pregnancy|0|||
161873049|NCT02477826|584578612|FG005|Treatment Period|Pregnancy|0|||
161873050|NCT02477826|584578613|FG006|Treatment Period|Pregnancy|0|||
161873051|NCT02477826|584578614|FG007|Treatment Period|Pregnancy|0|||
161873052|NCT02477826|584578615|FG008|Treatment Period|Pregnancy|0|||
161873053|NCT02477826|584578616|FG009|Treatment Period|Pregnancy|1|||
161873054|NCT02477826|584578607|FG000|Treatment Period|Other|0|||
161873055|NCT02477826|584578608|FG001|Treatment Period|Other|0|||
161873056|NCT02477826|584578609|FG002|Treatment Period|Other|0|||
161873057|NCT02477826|584578610|FG003|Treatment Period|Other|0|||
161873058|NCT02477826|584578611|FG004|Treatment Period|Other|0|||
161873059|NCT02477826|584578612|FG005|Treatment Period|Other|0|||
161873060|NCT02477826|584578613|FG006|Treatment Period|Other|0|||
161873061|NCT02477826|584578614|FG007|Treatment Period|Other|0|||
161873062|NCT02477826|584578615|FG008|Treatment Period|Other|0|||
161873063|NCT02477826|584578616|FG009|Treatment Period|Other|1|||
161873064|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
161873065|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
161873066|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
161873067|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
161873068|NCT00403481|584578650|FG000|Olm 40 mg|Adverse Event|2|||
161873069|NCT00403481|584578650|FG000|Olm 40 mg|Protocol Violation|1|||
161873070|NCT00403481|584578650|FG000|Olm 40 mg|Withdrawal by Subject|1|||
161873071|NCT00403481|584578650|FG000|Olm 40 mg|Other|1|||
161873072|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
161873073|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
161873074|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
161873075|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
161873076|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
161873077|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
161873078|NCT02929589|584578652|FG000|Overall Study|Withdrawal by Subject|1|||
161775906|NCT02325739|584221295|FG002|Phase II Part|Adverse Event|0|||
161775907|NCT02325739|584221296|FG003|Phase II Part|Adverse Event|0|||
161775908|NCT02325739|584221297|FG004|Phase II Part|Adverse Event|0|||
161775909|NCT02325739|584221298|FG005|Phase II Part|Adverse Event|0|||
161775910|NCT02325739|584221299|FG006|Phase II Part|Adverse Event|0|||
161775911|NCT02325739|584221300|FG007|Phase II Part|Adverse Event|0|||
161873079|NCT02929589|584578653|FG001|Overall Study|Withdrawal by Subject|0|||
161873080|NCT02929589|584578654|FG002|Overall Study|Withdrawal by Subject|0|||
161873081|NCT02929589|584578655|FG003|Overall Study|Withdrawal by Subject|0|||
161873082|NCT02929589|584578652|FG000|Overall Study|Physician Decision|2|||
161873083|NCT02929589|584578653|FG001|Overall Study|Physician Decision|0|||
161873084|NCT02929589|584578654|FG002|Overall Study|Physician Decision|0|||
161873085|NCT02929589|584578655|FG003|Overall Study|Physician Decision|0|||
161873086|NCT02091089|584578656|FG000|Overall Study|Lost to Follow-up|2|||
161873087|NCT00766636|584578667|FG000|Overall Study|Withdrawal by Subject|1|||
161873088|NCT00766636|584578668|FG001|Overall Study|Withdrawal by Subject|1|||
161873089|NCT00766636|584578667|FG000|Overall Study|Incomplete Treatment|0|||
161873090|NCT00766636|584578668|FG001|Overall Study|Incomplete Treatment|1|||
161873091|NCT00766636|584578667|FG000|Overall Study|Adverse Event|1|||
161873092|NCT00766636|584578668|FG001|Overall Study|Adverse Event|0|||
161873093|NCT00766636|584578667|FG000|Overall Study|Disease Progression|1|||
161873094|NCT00766636|584578668|FG001|Overall Study|Disease Progression|0|||
161873095|NCT02477332|584578671|FG000|Overall Study|Adverse Event|0|||
161873096|NCT02477332|584578672|FG001|Overall Study|Adverse Event|1|||
161873097|NCT02477332|584578673|FG002|Overall Study|Adverse Event|1|||
161873098|NCT02477332|584578674|FG003|Overall Study|Adverse Event|2|||
161873099|NCT02477332|584578675|FG004|Overall Study|Adverse Event|1|||
161873100|NCT02477332|584578676|FG005|Overall Study|Adverse Event|2|||
161873101|NCT02477332|584578671|FG000|Overall Study|Lack of Efficacy|1|||
161873102|NCT02477332|584578672|FG001|Overall Study|Lack of Efficacy|2|||
161873103|NCT02477332|584578673|FG002|Overall Study|Lack of Efficacy|1|||
161873104|NCT02477332|584578674|FG003|Overall Study|Lack of Efficacy|2|||
161873105|NCT02477332|584578675|FG004|Overall Study|Lack of Efficacy|1|||
161873106|NCT02477332|584578676|FG005|Overall Study|Lack of Efficacy|1|||
161873107|NCT02477332|584578671|FG000|Overall Study|Non-compliance with study treatment|0|||
161873108|NCT02477332|584578672|FG001|Overall Study|Non-compliance with study treatment|1|||
161873109|NCT02477332|584578673|FG002|Overall Study|Non-compliance with study treatment|2|||
161873110|NCT02477332|584578674|FG003|Overall Study|Non-compliance with study treatment|0|||
161873111|NCT02477332|584578675|FG004|Overall Study|Non-compliance with study treatment|0|||
161873112|NCT02477332|584578676|FG005|Overall Study|Non-compliance with study treatment|0|||
161873113|NCT02477332|584578671|FG000|Overall Study|Pregnancy|0|||
161873114|NCT02477332|584578672|FG001|Overall Study|Pregnancy|0|||
161873115|NCT02477332|584578673|FG002|Overall Study|Pregnancy|0|||
161873116|NCT02477332|584578674|FG003|Overall Study|Pregnancy|1|||
161873117|NCT02477332|584578675|FG004|Overall Study|Pregnancy|0|||
161873118|NCT02477332|584578676|FG005|Overall Study|Pregnancy|0|||
161873119|NCT02477332|584578671|FG000|Overall Study|Protocol Violation|2|||
161873120|NCT02477332|584578672|FG001|Overall Study|Protocol Violation|0|||
161873121|NCT02477332|584578673|FG002|Overall Study|Protocol Violation|3|||
161873122|NCT02477332|584578674|FG003|Overall Study|Protocol Violation|3|||
161873123|NCT02477332|584578675|FG004|Overall Study|Protocol Violation|1|||
161873124|NCT02477332|584578676|FG005|Overall Study|Protocol Violation|1|||
161873125|NCT02477332|584578671|FG000|Overall Study|Technical problems|0|||
161873126|NCT02477332|584578672|FG001|Overall Study|Technical problems|0|||
161873127|NCT02477332|584578673|FG002|Overall Study|Technical problems|1|||
161873128|NCT02477332|584578674|FG003|Overall Study|Technical problems|0|||
161873129|NCT02477332|584578675|FG004|Overall Study|Technical problems|0|||
161873130|NCT02477332|584578676|FG005|Overall Study|Technical problems|0|||
161873131|NCT02477332|584578671|FG000|Overall Study|Lost to Follow-up|0|||
161873132|NCT02477332|584578672|FG001|Overall Study|Lost to Follow-up|0|||
161873133|NCT02477332|584578673|FG002|Overall Study|Lost to Follow-up|2|||
161873134|NCT02477332|584578674|FG003|Overall Study|Lost to Follow-up|0|||
161873135|NCT02477332|584578675|FG004|Overall Study|Lost to Follow-up|0|||
161873136|NCT02477332|584578676|FG005|Overall Study|Lost to Follow-up|0|||
161873137|NCT02477332|584578671|FG000|Overall Study|Physician Decision|0|||
161873138|NCT02477332|584578672|FG001|Overall Study|Physician Decision|0|||
161873139|NCT02477332|584578673|FG002|Overall Study|Physician Decision|1|||
161873140|NCT02477332|584578674|FG003|Overall Study|Physician Decision|3|||
161873141|NCT02477332|584578675|FG004|Overall Study|Physician Decision|0|||
161873142|NCT02477332|584578676|FG005|Overall Study|Physician Decision|1|||
161873143|NCT02477332|584578671|FG000|Overall Study|Withdrawal by Subject|0|||
161873144|NCT02477332|584578672|FG001|Overall Study|Withdrawal by Subject|3|||
161873145|NCT02477332|584578673|FG002|Overall Study|Withdrawal by Subject|1|||
161873146|NCT02477332|584578674|FG003|Overall Study|Withdrawal by Subject|2|||
161873147|NCT02477332|584578675|FG004|Overall Study|Withdrawal by Subject|1|||
161873148|NCT02477332|584578676|FG005|Overall Study|Withdrawal by Subject|0|||
161873149|NCT04657198|584578677|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
161873150|NCT04657198|584578678|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161873151|NCT04657198|584578679|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161873152|NCT02977572|584578682|FG000|Overall Study|Exclusion criterion|2|||
161873153|NCT02977572|584578683|FG001|Overall Study|Exclusion criterion|2|||
161873154|NCT01075256|584578686|FG000|Overall Study|Withdrawal by Subject|1|||
161873155|NCT01075256|584578687|FG001|Overall Study|Withdrawal by Subject|0|||
161873156|NCT01075256|584578688|FG002|Overall Study|Withdrawal by Subject|0|||
161873157|NCT03502070|584578689|FG000|Overall Study|Withdrawal by Subject|1|||
161873158|NCT03502070|584578689|FG000|Overall Study|Screen Failure|1|||
161873159|NCT01218087|584578701|FG000|Overall Study|Death|2|||
161873160|NCT01218087|584578702|FG001|Overall Study|Death|1|||
161873161|NCT01218087|584578701|FG000|Overall Study|Withdrawal by Subject|5|||
161873162|NCT01218087|584578702|FG001|Overall Study|Withdrawal by Subject|0|||
161873163|NCT01218087|584578701|FG000|Overall Study|Transferred|8|||
161873164|NCT01218087|584578702|FG001|Overall Study|Transferred|5|||
161873165|NCT03170362|584578703|FG000|Overall Study|Death|2|||
161873166|NCT03170362|584578704|FG001|Overall Study|Death|2|||
161873167|NCT03170362|584578703|FG000|Overall Study|Withdrawal by Subject|23|||
161873168|NCT03170362|584578704|FG001|Overall Study|Withdrawal by Subject|22|||
161873169|NCT03170362|584578703|FG000|Overall Study|Lost to Follow-up|187|||
161873170|NCT03170362|584578704|FG001|Overall Study|Lost to Follow-up|167|||
161873171|NCT00552396|584578705|FG000|Overall Study|protocol withdrawal criteria|3|||
161873172|NCT00552396|584578706|FG001|Overall Study|protocol withdrawal criteria|3|||
161873173|NCT00552396|584578707|FG002|Overall Study|protocol withdrawal criteria|3|||
161873174|NCT00552396|584578708|FG003|Overall Study|protocol withdrawal criteria|6|||
161873175|NCT00552396|584578709|FG004|Overall Study|protocol withdrawal criteria|3|||
161873176|NCT00552396|584578710|FG005|Overall Study|protocol withdrawal criteria|3|||
161873177|NCT00552396|584578711|FG006|Overall Study|protocol withdrawal criteria|9|||
161873178|NCT03340454|584578712|FG000|Overall Study|Lost to Follow-up|0|||
161873179|NCT03340454|584578713|FG001|Overall Study|Lost to Follow-up|4|||
161873180|NCT03307252|584578719|FG000|Part 2, Period 1|Treatment not received|0|||
161873181|NCT03307252|584578720|FG001|Part 2, Period 1|Treatment not received|0|||
161873182|NCT03307252|584578721|FG002|Part 2, Period 1|Treatment not received|0|||
161873183|NCT03307252|584578722|FG003|Part 2, Period 1|Treatment not received|0|||
161873184|NCT03307252|584578723|FG004|Part 2, Period 1|Treatment not received|0|||
161873185|NCT03307252|584578724|FG005|Part 2, Period 1|Treatment not received|1|||
161873186|NCT03307252|584578725|FG006|Part 2, Period 1|Treatment not received|0|||
161873187|NCT03307252|584578726|FG007|Part 2, Period 1|Treatment not received|0|||
161873188|NCT03307252|584578727|FG008|Part 2, Period 1|Treatment not received|0|||
161873189|NCT03307252|584578728|FG009|Part 2, Period 1|Treatment not received|0|||
161873190|NCT03307252|584578729|FG010|Part 2, Period 1|Treatment not received|0|||
161873191|NCT03307252|584578719|FG000|Part 2, Period 3|Other than listed|0|||
161873192|NCT03307252|584578720|FG001|Part 2, Period 3|Other than listed|0|||
161873193|NCT03307252|584578721|FG002|Part 2, Period 3|Other than listed|0|||
161873194|NCT03307252|584578722|FG003|Part 2, Period 3|Other than listed|0|||
161873195|NCT03307252|584578723|FG004|Part 2, Period 3|Other than listed|1|||
161873196|NCT03307252|584578724|FG005|Part 2, Period 3|Other than listed|0|||
161873197|NCT03307252|584578725|FG006|Part 2, Period 3|Other than listed|0|||
161873198|NCT03307252|584578726|FG007|Part 2, Period 3|Other than listed|0|||
161873199|NCT03307252|584578727|FG008|Part 2, Period 3|Other than listed|0|||
161873200|NCT03307252|584578728|FG009|Part 2, Period 3|Other than listed|0|||
161873201|NCT03307252|584578729|FG010|Part 2, Period 3|Other than listed|0|||
161873202|NCT03307252|584578719|FG000|Part 2, Period 4|Other than listed|0|||
161873203|NCT03307252|584578720|FG001|Part 2, Period 4|Other than listed|0|||
161873204|NCT03307252|584578721|FG002|Part 2, Period 4|Other than listed|0|||
161873205|NCT03307252|584578722|FG003|Part 2, Period 4|Other than listed|0|||
161873206|NCT03307252|584578723|FG004|Part 2, Period 4|Other than listed|0|||
161873207|NCT03307252|584578724|FG005|Part 2, Period 4|Other than listed|0|||
161873208|NCT03307252|584578725|FG006|Part 2, Period 4|Other than listed|1|||
161873209|NCT03307252|584578726|FG007|Part 2, Period 4|Other than listed|0|||
161873210|NCT03307252|584578727|FG008|Part 2, Period 4|Other than listed|0|||
161873211|NCT03307252|584578728|FG009|Part 2, Period 4|Other than listed|0|||
161873212|NCT03307252|584578729|FG010|Part 2, Period 4|Other than listed|0|||
161873213|NCT03307252|584578719|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873214|NCT03307252|584578720|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873215|NCT03307252|584578721|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873216|NCT03307252|584578722|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873217|NCT03307252|584578723|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873218|NCT03307252|584578724|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873219|NCT03307252|584578725|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873220|NCT03307252|584578726|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873221|NCT03307252|584578727|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873222|NCT03307252|584578728|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873223|NCT03307252|584578729|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
161873224|NCT01052480|584578730|FG000|Overall Study|Lost to Follow-up|3|||
161873225|NCT01052480|584578731|FG001|Overall Study|Lost to Follow-up|3|||
161873226|NCT01052480|584578730|FG000|Overall Study|Protocol Violation|1|||
161873227|NCT01052480|584578731|FG001|Overall Study|Protocol Violation|0|||
161873228|NCT01052480|584578730|FG000|Overall Study|Withdrawal by Subject|3|||
161873229|NCT01052480|584578731|FG001|Overall Study|Withdrawal by Subject|7|||
161873230|NCT01052480|584578730|FG000|Overall Study|Physician Decision|0|||
161873231|NCT01052480|584578731|FG001|Overall Study|Physician Decision|2|||
161873232|NCT01052480|584578730|FG000|Overall Study|Death|1|||
161873233|NCT01052480|584578731|FG001|Overall Study|Death|5|||
161873234|NCT04185220|584578736|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
161873235|NCT04185220|584578737|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
161873236|NCT04185220|584578736|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
161873237|NCT04185220|584578737|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
161873238|NCT03225105|584578744|FG000|Overall Study|Withdrawal by Subject|1|||
161873239|NCT03225105|584578745|FG001|Overall Study|Withdrawal by Subject|0|||
161873240|NCT03225105|584578746|FG002|Overall Study|Withdrawal by Subject|0|||
161873241|NCT03225105|584578747|FG003|Overall Study|Withdrawal by Subject|0|||
161873242|NCT03225105|584578744|FG000|Overall Study|Death|0|||
161873243|NCT03225105|584578745|FG001|Overall Study|Death|4|||
161873244|NCT03225105|584578746|FG002|Overall Study|Death|2|||
161873245|NCT03225105|584578747|FG003|Overall Study|Death|0|||
161873246|NCT03225105|584578744|FG000|Overall Study|Study termination per Sponsor Decision|2|||
161873247|NCT03225105|584578745|FG001|Overall Study|Study termination per Sponsor Decision|0|||
161873248|NCT03225105|584578746|FG002|Overall Study|Study termination per Sponsor Decision|3|||
161873249|NCT03225105|584578747|FG003|Overall Study|Study termination per Sponsor Decision|3|||
161873250|NCT05488470|584580523|FG000|Overall Study|Physician Decision|2|||
161873251|NCT05488470|584580523|FG000|Overall Study|Withdrawal by Subject|1|||
161873252|NCT05488470|584580523|FG000|Overall Study|Death|1|||
161873253|NCT01736397|584580524|FG000|Overall Study|Lack of Efficacy|1|||
161873254|NCT01736397|584580525|FG001|Overall Study|Lack of Efficacy|11|||
161873255|NCT01736397|584580524|FG000|Overall Study|Withdrawal by Subject|6|||
161873256|NCT01736397|584580525|FG001|Overall Study|Withdrawal by Subject|5|||
161873257|NCT01736397|584580524|FG000|Overall Study|Lost to Follow-up|0|||
161873258|NCT01736397|584580525|FG001|Overall Study|Lost to Follow-up|1|||
161873259|NCT01736397|584580524|FG000|Overall Study|Adverse Event|6|||
161873260|NCT01736397|584580525|FG001|Overall Study|Adverse Event|3|||
161873261|NCT01736397|584580524|FG000|Overall Study|Not stated|1|||
161873262|NCT01736397|584580525|FG001|Overall Study|Not stated|4|||
161873263|NCT01868438|584580526|FG000|First Intervention|Withdrawal by Subject|5|||
161873264|NCT01868438|584580527|FG001|First Intervention|Withdrawal by Subject|1|||
161873265|NCT01868438|584580526|FG000|First Intervention|Lost to Follow-up|2|||
161873266|NCT01868438|584580527|FG001|First Intervention|Lost to Follow-up|3|||
161873267|NCT01868438|584580526|FG000|First Intervention|Meeting the non-redosing criteria|0|||
161873268|NCT01868438|584580527|FG001|First Intervention|Meeting the non-redosing criteria|1|||
161873269|NCT01868438|584580526|FG000|Second Intervention|Adverse Event|3|||
161873270|NCT01868438|584580527|FG001|Second Intervention|Adverse Event|3|||
161873271|NCT02028767|584580528|FG000|Treatment Period 2|Non compliant with protocol|1|||
161873272|NCT02028767|584580529|FG001|Treatment Period 2|Non compliant with protocol|0|||
161873273|NCT02028767|584580528|FG000|Treatment Period 2|Reason other than those specified above|1|||
161873274|NCT02028767|584580529|FG001|Treatment Period 2|Reason other than those specified above|0|||
161873275|NCT01284348|584580530|FG000|Overall Study|Death|1|||
161873276|NCT01284348|584580531|FG001|Overall Study|Death|1|||
161873277|NCT01284348|584580530|FG000|Overall Study|Withdrew consent|0|||
161873278|NCT01284348|584580531|FG001|Overall Study|Withdrew consent|1|||
161873279|NCT01284348|584580530|FG000|Overall Study|Status not recorded|9|||
161873280|NCT01284348|584580531|FG001|Overall Study|Status not recorded|10|||
161873281|NCT02875613|584580534|FG000|Overall Study|Withdrawal by Subject|1|||
161873282|NCT02875613|584580534|FG000|Overall Study|Screen Failure|1|||
161873283|NCT02347774|584580535|FG000|Study Participation|Lost to Follow-up|3|||
161873284|NCT02347774|584580536|FG001|Study Participation|Lost to Follow-up|6|||
161873285|NCT02347774|584580537|FG002|Study Participation|Lost to Follow-up|2|||
161873286|NCT02347774|584580535|FG000|Study Participation|Withdrawal by Subject|8|||
161873287|NCT02347774|584580536|FG001|Study Participation|Withdrawal by Subject|9|||
161873288|NCT02347774|584580537|FG002|Study Participation|Withdrawal by Subject|15|||
161873289|NCT02347774|584580535|FG000|Study Participation|Adverse Event|1|||
161873290|NCT02347774|584580536|FG001|Study Participation|Adverse Event|4|||
161873291|NCT02347774|584580537|FG002|Study Participation|Adverse Event|6|||
161873292|NCT02347774|584580535|FG000|Study Participation|withdrew consent|1|||
161873293|NCT02347774|584580536|FG001|Study Participation|withdrew consent|1|||
161873294|NCT02347774|584580537|FG002|Study Participation|withdrew consent|1|||
161873295|NCT02347774|584580535|FG000|Study Participation|Met Prolonged QT criteria|1|||
161873296|NCT02347774|584580536|FG001|Study Participation|Met Prolonged QT criteria|0|||
161873297|NCT02347774|584580537|FG002|Study Participation|Met Prolonged QT criteria|0|||
161873298|NCT02347774|584580535|FG000|Study Participation|non-compliance with study drug|0|||
161873299|NCT02347774|584580536|FG001|Study Participation|non-compliance with study drug|1|||
161873300|NCT02347774|584580537|FG002|Study Participation|non-compliance with study drug|0|||
161873301|NCT02347774|584580535|FG000|Study Participation|incarceration|1|||
161873302|NCT02347774|584580536|FG001|Study Participation|incarceration|0|||
161873303|NCT02347774|584580537|FG002|Study Participation|incarceration|0|||
161873304|NCT02347774|584580535|FG000|Study Participation|randomized in error|0|||
161873305|NCT02347774|584580536|FG001|Study Participation|randomized in error|0|||
161873306|NCT02347774|584580537|FG002|Study Participation|randomized in error|1|||
161873307|NCT02347774|584580535|FG000|On Study Treatment|Adverse Event|9|||
161873308|NCT02347774|584580536|FG001|On Study Treatment|Adverse Event|15|||
161873309|NCT02347774|584580537|FG002|On Study Treatment|Adverse Event|19|||
161873310|NCT02347774|584580535|FG000|On Study Treatment|Lack of Efficacy|3|||
161873311|NCT02347774|584580536|FG001|On Study Treatment|Lack of Efficacy|0|||
161873312|NCT02347774|584580537|FG002|On Study Treatment|Lack of Efficacy|2|||
161873313|NCT02347774|584580535|FG000|On Study Treatment|non-complicance with study medication|0|||
161873314|NCT02347774|584580536|FG001|On Study Treatment|non-complicance with study medication|2|||
161873315|NCT02347774|584580537|FG002|On Study Treatment|non-complicance with study medication|0|||
161873316|NCT02347774|584580535|FG000|On Study Treatment|Protocol Violation|0|||
161873317|NCT02347774|584580536|FG001|On Study Treatment|Protocol Violation|0|||
161873318|NCT02347774|584580537|FG002|On Study Treatment|Protocol Violation|1|||
161873319|NCT02347774|584580535|FG000|On Study Treatment|withdrew consent|9|||
161873320|NCT02347774|584580536|FG001|On Study Treatment|withdrew consent|8|||
161873321|NCT02347774|584580537|FG002|On Study Treatment|withdrew consent|12|||
161873322|NCT02347774|584580535|FG000|On Study Treatment|Lost to Follow-up|2|||
161873323|NCT02347774|584580536|FG001|On Study Treatment|Lost to Follow-up|6|||
161873324|NCT02347774|584580537|FG002|On Study Treatment|Lost to Follow-up|1|||
161873325|NCT02347774|584580535|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
161873326|NCT02347774|584580536|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
161873327|NCT02347774|584580537|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
161873328|NCT02347774|584580535|FG000|On Study Treatment|ranomized in error|0|||
161873329|NCT02347774|584580536|FG001|On Study Treatment|ranomized in error|0|||
161873330|NCT02347774|584580537|FG002|On Study Treatment|ranomized in error|1|||
161873331|NCT04112043|584580539|FG000|Overall Study|Withdrawal by Subject|1|||
161873332|NCT04112043|584580540|FG001|Overall Study|Withdrawal by Subject|1|||
161873333|NCT04112043|584580541|FG002|Overall Study|Withdrawal by Subject|1|||
161873334|NCT04112043|584580539|FG000|Overall Study|Taking NR supplement|1|||
161873335|NCT04112043|584580540|FG001|Overall Study|Taking NR supplement|0|||
161873336|NCT04112043|584580541|FG002|Overall Study|Taking NR supplement|0|||
161873337|NCT04112043|584580539|FG000|Overall Study|Adverse Event|0|||
161873338|NCT04112043|584580540|FG001|Overall Study|Adverse Event|1|||
161873339|NCT04112043|584580541|FG002|Overall Study|Adverse Event|0|||
161873340|NCT00954941|584580544|FG000|Overall Study|Received treatment at home|1|||
161873341|NCT00954941|584580545|FG001|Overall Study|Received treatment at home|0|||
161873342|NCT00954941|584580544|FG000|Overall Study|Withdrawal by Subject|1|||
161873343|NCT00954941|584580545|FG001|Overall Study|Withdrawal by Subject|0|||
161873344|NCT00954941|584580544|FG000|Overall Study|Insurance Denial|2|||
161775912|NCT02325739|584221301|FG008|Phase II Part|Adverse Event|4|||
161775913|NCT02325739|584221302|FG009|Phase II Part|Adverse Event|5|||
161775914|NCT02325739|584221303|FG010|Phase II Part|Adverse Event|1|||
161775915|NCT02325739|584221293|FG000|Phase II Part|Physician Decision|0|||
161775916|NCT02325739|584221294|FG001|Phase II Part|Physician Decision|0|||
161775917|NCT02325739|584221295|FG002|Phase II Part|Physician Decision|0|||
161775918|NCT02325739|584221296|FG003|Phase II Part|Physician Decision|0|||
161775919|NCT02325739|584221297|FG004|Phase II Part|Physician Decision|0|||
161775920|NCT02325739|584221298|FG005|Phase II Part|Physician Decision|0|||
161775921|NCT02325739|584221299|FG006|Phase II Part|Physician Decision|0|||
161775922|NCT02325739|584221300|FG007|Phase II Part|Physician Decision|0|||
161775923|NCT02325739|584221301|FG008|Phase II Part|Physician Decision|0|||
161775924|NCT02325739|584221302|FG009|Phase II Part|Physician Decision|1|||
161775925|NCT02325739|584221303|FG010|Phase II Part|Physician Decision|0|||
161775926|NCT02325739|584221293|FG000|Phase II Part|Progressive disease|0|||
161775927|NCT02325739|584221294|FG001|Phase II Part|Progressive disease|0|||
161775928|NCT02325739|584221295|FG002|Phase II Part|Progressive disease|0|||
161775929|NCT02325739|584221296|FG003|Phase II Part|Progressive disease|0|||
161775930|NCT02325739|584221297|FG004|Phase II Part|Progressive disease|0|||
161775931|NCT02325739|584221298|FG005|Phase II Part|Progressive disease|0|||
161775932|NCT02325739|584221299|FG006|Phase II Part|Progressive disease|0|||
161775933|NCT02325739|584221300|FG007|Phase II Part|Progressive disease|0|||
161775934|NCT02325739|584221301|FG008|Phase II Part|Progressive disease|22|||
161775935|NCT02325739|584221302|FG009|Phase II Part|Progressive disease|29|||
161775936|NCT02325739|584221303|FG010|Phase II Part|Progressive disease|18|||
161775937|NCT02325739|584221293|FG000|Phase II Part|Subject/guardian decision|0|||
161775938|NCT02325739|584221294|FG001|Phase II Part|Subject/guardian decision|0|||
161775939|NCT02325739|584221295|FG002|Phase II Part|Subject/guardian decision|0|||
161775940|NCT02325739|584221296|FG003|Phase II Part|Subject/guardian decision|0|||
161775941|NCT02325739|584221297|FG004|Phase II Part|Subject/guardian decision|0|||
161775942|NCT02325739|584221298|FG005|Phase II Part|Subject/guardian decision|0|||
161775943|NCT02325739|584221299|FG006|Phase II Part|Subject/guardian decision|0|||
161775944|NCT02325739|584221300|FG007|Phase II Part|Subject/guardian decision|0|||
161775945|NCT02325739|584221301|FG008|Phase II Part|Subject/guardian decision|4|||
161775946|NCT02325739|584221302|FG009|Phase II Part|Subject/guardian decision|1|||
161775947|NCT02325739|584221303|FG010|Phase II Part|Subject/guardian decision|1|||
161775948|NCT00227591|584221304|FG000|Overall Study|Withdrawal by Subject|1|||
161775949|NCT02335411|584221305|FG000|Overall Study|Death|223|||
161775950|NCT02335411|584221306|FG001|Overall Study|Death|22|||
161775951|NCT02335411|584221307|FG002|Overall Study|Death|26|||
161775952|NCT02335411|584221305|FG000|Overall Study|Physician Decision|3|||
161775953|NCT02335411|584221306|FG001|Overall Study|Physician Decision|0|||
161775954|NCT02335411|584221307|FG002|Overall Study|Physician Decision|0|||
161775955|NCT02335411|584221305|FG000|Overall Study|Protocol Violation|1|||
161775956|NCT02335411|584221306|FG001|Overall Study|Protocol Violation|0|||
161775957|NCT02335411|584221307|FG002|Overall Study|Protocol Violation|0|||
161775958|NCT02335411|584221305|FG000|Overall Study|Withdrawal by Subject|11|||
161775959|NCT02335411|584221306|FG001|Overall Study|Withdrawal by Subject|0|||
161775960|NCT02335411|584221307|FG002|Overall Study|Withdrawal by Subject|3|||
161775961|NCT02335411|584221305|FG000|Overall Study|Sponsor Decision|12|||
161775962|NCT02335411|584221306|FG001|Overall Study|Sponsor Decision|3|||
161775963|NCT02335411|584221307|FG002|Overall Study|Sponsor Decision|2|||
161775964|NCT02335411|584221305|FG000|Overall Study|Adverse Event|9|||
161775965|NCT02335411|584221306|FG001|Overall Study|Adverse Event|0|||
161775966|NCT02335411|584221307|FG002|Overall Study|Adverse Event|0|||
161775967|NCT02596009|584221310|FG000|Overall Study|Administrative problems|0|||
161775968|NCT02596009|584221311|FG001|Overall Study|Administrative problems|1|||
161775969|NCT02596009|584221312|FG002|Overall Study|Administrative problems|0|||
161775970|NCT02596009|584221313|FG003|Overall Study|Administrative problems|0|||
161775971|NCT02596009|584221314|FG004|Overall Study|Administrative problems|0|||
161775972|NCT02596009|584221315|FG005|Overall Study|Administrative problems|0|||
161775973|NCT04755283|584221319|FG000|Overall Study|Withdrawal by Subject|14|||
161775974|NCT04755283|584221320|FG001|Overall Study|Withdrawal by Subject|3|||
161775975|NCT04755283|584221321|FG002|Overall Study|Withdrawal by Subject|6|||
161775976|NCT04755283|584221319|FG000|Overall Study|Lost to Follow-up|0|||
161775977|NCT04755283|584221320|FG001|Overall Study|Lost to Follow-up|0|||
161775978|NCT04755283|584221321|FG002|Overall Study|Lost to Follow-up|1|||
161775979|NCT04755283|584221319|FG000|Overall Study|Death|31|||
161775980|NCT04755283|584221320|FG001|Overall Study|Death|36|||
161775981|NCT04755283|584221321|FG002|Overall Study|Death|34|||
161775982|NCT04410978|584221330|FG000|Overall Study|Poor compliance to protocol|2|||
161775983|NCT04410978|584221331|FG001|Overall Study|Poor compliance to protocol|4|||
161775984|NCT04410978|584221330|FG000|Overall Study|Withdrawal by Subject|64|||
161775985|NCT04410978|584221331|FG001|Overall Study|Withdrawal by Subject|66|||
161775986|NCT04410978|584221330|FG000|Overall Study|Other|6|||
161775987|NCT04410978|584221331|FG001|Overall Study|Other|7|||
161775988|NCT04410978|584221330|FG000|Overall Study|Missing study status|1|||
161775989|NCT04410978|584221331|FG001|Overall Study|Missing study status|0|||
161775990|NCT05153629|584221332|FG000|Overall Study|Withdrawal by Subject|0|||
161775991|NCT05153629|584221333|FG001|Overall Study|Withdrawal by Subject|2|||
161775992|NCT04089566|584221336|FG000|Overall Study|Death|0|||
161775993|NCT04089566|584221337|FG001|Overall Study|Death|6|||
161775994|NCT04089566|584221338|FG002|Overall Study|Death|10|||
161775995|NCT04089566|584221339|FG003|Overall Study|Death|0|||
161775996|NCT04089566|584221340|FG004|Overall Study|Death|0|||
161775997|NCT04089566|584221341|FG005|Overall Study|Death|0|||
161775998|NCT04089566|584221336|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
161775999|NCT04089566|584221337|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
161776000|NCT04089566|584221338|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
161776001|NCT04089566|584221339|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
161776002|NCT04089566|584221340|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
161776003|NCT04089566|584221341|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
161776004|NCT04089566|584221336|FG000|Overall Study|Reason not Specified|0|||
161776005|NCT04089566|584221337|FG001|Overall Study|Reason not Specified|4|||
161776006|NCT04089566|584221338|FG002|Overall Study|Reason not Specified|4|||
161776007|NCT04089566|584221339|FG003|Overall Study|Reason not Specified|1|||
161776008|NCT04089566|584221340|FG004|Overall Study|Reason not Specified|0|||
161776009|NCT04089566|584221341|FG005|Overall Study|Reason not Specified|0|||
161776010|NCT01083121|584221342|FG000|Overall Study|Use of Humira outside the approved label|81|||
161776011|NCT05403502|584221344|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
161776012|NCT05403502|584221344|FG000|Humalog Lead-In Period|Physician Decision|2|||
161776013|NCT05403502|584221344|FG000|Humalog Lead-In Period|Protocol Violation|1|||
161873345|NCT00954941|584580545|FG001|Overall Study|Insurance Denial|2|||
161873346|NCT00954941|584580544|FG000|Overall Study|Physician Decision|2|||
161873347|NCT00954941|584580545|FG001|Overall Study|Physician Decision|2|||
161873348|NCT00954941|584580544|FG000|Overall Study|Ineligible|2|||
161873349|NCT00954941|584580545|FG001|Overall Study|Ineligible|2|||
161873350|NCT00954941|584580544|FG000|Overall Study|Adverse Event|0|||
161873351|NCT00954941|584580545|FG001|Overall Study|Adverse Event|1|||
161873352|NCT00955955|584580546|FG000|Overall Study|Lost to Follow-up|2|||
161873353|NCT00955955|584580547|FG001|Overall Study|Lost to Follow-up|0|||
161873354|NCT00955955|584580548|FG002|Overall Study|Lost to Follow-up|0|||
161873355|NCT01996254|584580552|FG000|Overall Study|Change in Eligibility|0|||
161873356|NCT01996254|584580553|FG001|Overall Study|Change in Eligibility|2|||
161873357|NCT01996254|584580554|FG002|Overall Study|Change in Eligibility|0|||
161873358|NCT01996254|584580552|FG000|Overall Study|Withdrawal by Subject|0|||
161873359|NCT01996254|584580553|FG001|Overall Study|Withdrawal by Subject|3|||
161873360|NCT01996254|584580554|FG002|Overall Study|Withdrawal by Subject|4|||
161873361|NCT01996254|584580552|FG000|Overall Study|Lost to Follow-up|1|||
161873362|NCT01996254|584580553|FG001|Overall Study|Lost to Follow-up|0|||
161873363|NCT01996254|584580554|FG002|Overall Study|Lost to Follow-up|4|||
161873364|NCT02920008|584580555|FG000|Overall Study|Death|117|||
161873365|NCT02920008|584580556|FG001|Overall Study|Death|127|||
161873366|NCT02920008|584580555|FG000|Overall Study|Withdrawal by Subject|3|||
161873367|NCT02920008|584580556|FG001|Overall Study|Withdrawal by Subject|6|||
161873368|NCT02920008|584580555|FG000|Overall Study|Lost to Follow-up|0|||
161873369|NCT02920008|584580556|FG001|Overall Study|Lost to Follow-up|1|||
161873370|NCT01053663|584580557|FG000|Overall Study|Death|2|||
161873371|NCT01053663|584580557|FG000|Overall Study|Lost to Follow-up|1|||
161873372|NCT01053663|584580557|FG000|Overall Study|Poor IV Access|1|||
161873373|NCT01053663|584580557|FG000|Overall Study|Transferred to Another Hospital|1|||
161873374|NCT01053663|584580557|FG000|Overall Study|Negative Influenza Diagnosis|1|||
161873375|NCT03533114|584580560|FG000|Overall|Adverse Event|16|||
161873376|NCT03533114|584580561|FG001|Overall|Adverse Event|11|||
161873377|NCT03533114|584580560|FG000|Overall|Consent Withdrawal by Participant|7|||
161873378|NCT03533114|584580561|FG001|Overall|Consent Withdrawal by Participant|6|||
161873379|NCT03533114|584580560|FG000|Overall|Lack of Efficacy|5|||
161873380|NCT03533114|584580561|FG001|Overall|Lack of Efficacy|3|||
161873381|NCT03533114|584580560|FG000|Overall|Lost to Follow-up|1|||
161873382|NCT03533114|584580561|FG001|Overall|Lost to Follow-up|1|||
161873383|NCT03533114|584580560|FG000|Overall|Physician Decision|0|||
161873384|NCT03533114|584580561|FG001|Overall|Physician Decision|2|||
161873385|NCT03533114|584580560|FG000|Overall|Protocol deviation|1|||
161873386|NCT03533114|584580561|FG001|Overall|Protocol deviation|1|||
161873387|NCT03533114|584580560|FG000|Overall|Failure to meet randomization criteria|1|||
161873388|NCT03533114|584580561|FG001|Overall|Failure to meet randomization criteria|2|||
161873389|NCT03533114|584580560|FG000|Overall|Non-Compliance with study drug|0|||
161873390|NCT03533114|584580561|FG001|Overall|Non-Compliance with study drug|1|||
161873391|NCT03533114|584580560|FG000|Overall|Other|0|||
161873392|NCT03533114|584580561|FG001|Overall|Other|1|||
161873393|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Adverse Event|11|||
161873394|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Adverse Event|8|||
161873395|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
161873396|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
161873397|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
161873398|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
161873399|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
161873400|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
161873401|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
161873402|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
161873403|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
161873404|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
161873405|NCT03533114|584580560|FG000|Stable Dose|Adverse Event|0|||
161873406|NCT03533114|584580561|FG001|Stable Dose|Adverse Event|2|||
161873407|NCT03533114|584580560|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
161873408|NCT03533114|584580561|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
161873409|NCT03533114|584580560|FG000|Stable Dose|Lack of Efficacy|1|||
161873410|NCT03533114|584580561|FG001|Stable Dose|Lack of Efficacy|0|||
161873411|NCT03533114|584580560|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
161873412|NCT03533114|584580561|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
161873413|NCT03533114|584580560|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
161873414|NCT03533114|584580561|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
161873415|NCT03533114|584580560|FG000|Open-Label Safety Extension|Adverse Event|3|||
161873416|NCT03533114|584580561|FG001|Open-Label Safety Extension|Adverse Event|0|||
161873417|NCT03533114|584580560|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
161873418|NCT03533114|584580561|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
161873419|NCT03533114|584580560|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
161873420|NCT03533114|584580561|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
161873421|NCT03533114|584580560|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
161873422|NCT03533114|584580561|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
161873423|NCT03533114|584580560|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
161873424|NCT03533114|584580561|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
161873425|NCT03852264|584580562|FG000|Third Research Visit|Lost to Follow-up|1|||
161873426|NCT03852264|584580563|FG001|Third Research Visit|Lost to Follow-up|0|||
161873427|NCT01862250|584580564|FG000|Overall Study|Adverse Event|4|||
161873428|NCT02411396|584580568|FG000|Overall Study|Lost to Follow-up|31|||
161873429|NCT02411396|584580568|FG000|Overall Study|Death|10|||
161873430|NCT03575793|584580577|FG000|Overall Study|Withdrawal by Subject|0|||
161873431|NCT03575793|584580578|FG001|Overall Study|Withdrawal by Subject|1|||
161873432|NCT03575793|584580577|FG000|Overall Study|Never Treated|0|||
161873433|NCT03575793|584580578|FG001|Overall Study|Never Treated|2|||
161873434|NCT03521115|584580581|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
161873435|NCT03521115|584580582|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
161873436|NCT03521115|584580581|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
161873437|NCT03521115|584580582|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
161873438|NCT02295020|584580592|FG000|Overall Study|Adverse Event|0|||
161873439|NCT02295020|584580593|FG001|Overall Study|Adverse Event|1|||
161873440|NCT02295020|584580592|FG000|Overall Study|Withdrawal by Subject|3|||
161873441|NCT02295020|584580593|FG001|Overall Study|Withdrawal by Subject|2|||
161873442|NCT00562302|584580594|FG000|Overall Study|Lost to Follow-up|3|||
161873443|NCT00562302|584580595|FG001|Overall Study|Lost to Follow-up|3|||
161873444|NCT00562302|584580594|FG000|Overall Study|Adverse Event|0|||
161873445|NCT00562302|584580595|FG001|Overall Study|Adverse Event|6|||
161873446|NCT00562302|584580594|FG000|Overall Study|Non-compliance|1|||
161873447|NCT00562302|584580595|FG001|Overall Study|Non-compliance|2|||
161873448|NCT00562302|584580594|FG000|Overall Study|Withdrawal by Subject|7|||
161873449|NCT00562302|584580595|FG001|Overall Study|Withdrawal by Subject|8|||
161873450|NCT00562302|584580594|FG000|Overall Study|Death|1|||
161873451|NCT00562302|584580595|FG001|Overall Study|Death|2|||
161873452|NCT00562302|584580594|FG000|Overall Study|Lung resection prior to study completion|7|||
161873453|NCT00562302|584580595|FG001|Overall Study|Lung resection prior to study completion|7|||
161873454|NCT00562302|584580594|FG000|Overall Study|Not stated|1|||
161873455|NCT00562302|584580595|FG001|Overall Study|Not stated|4|||
161873456|NCT01855243|584580596|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
161873457|NCT01855243|584580597|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
161873458|NCT01855243|584580598|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
161873459|NCT03615144|584580599|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
161873460|NCT03615144|584580600|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
161873461|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
161873462|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
161873463|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
161873464|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
161873465|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873466|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873467|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873468|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873469|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873470|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873471|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873472|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
161873473|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873474|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
161873475|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
161873476|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873477|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873478|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873479|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873480|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873481|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873482|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873483|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
161873484|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
161873485|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
161873486|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
161873487|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873488|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873489|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873490|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873491|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873492|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873493|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873494|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
161873495|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
161873496|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
161873497|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
161873498|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873499|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873500|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873501|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873502|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873503|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873504|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873505|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873506|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873507|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873508|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
161873509|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873510|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873511|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873512|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873513|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873514|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873515|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873516|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873517|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873518|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873519|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873520|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
161873521|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
161873522|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
161873523|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873524|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873525|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873526|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
161873527|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873528|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873529|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873530|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873531|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873532|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873533|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873534|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161776014|NCT05403502|584221344|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
161776015|NCT05403502|584221344|FG000|Lyumjev Treatment Period|Physician Decision|2|||
161776016|NCT01593761|584221345|FG000|Overall Study|Lost to Follow-up|1|||
161776017|NCT01593761|584221345|FG000|Overall Study|culture negative for MRSA at baseline|5|||
161776018|NCT01593761|584221345|FG000|Overall Study|positive for hepatitis C virus|1|||
161776019|NCT01593761|584221345|FG000|Overall Study|secondary cellulitis|1|||
161776020|NCT02576951|584221346|FG000|Overall Study|Lost to Follow-up|0|||
161776021|NCT02576951|584221347|FG001|Overall Study|Lost to Follow-up|0|||
161776022|NCT02576951|584221348|FG002|Overall Study|Lost to Follow-up|2|||
161776023|NCT02576951|584221349|FG003|Overall Study|Lost to Follow-up|2|||
161776024|NCT02576951|584221346|FG000|Overall Study|Withdrawal by Subject|1|||
161776025|NCT02576951|584221347|FG001|Overall Study|Withdrawal by Subject|0|||
161776026|NCT02576951|584221348|FG002|Overall Study|Withdrawal by Subject|0|||
161776027|NCT02576951|584221349|FG003|Overall Study|Withdrawal by Subject|2|||
161776028|NCT02576951|584221346|FG000|Overall Study|Protocol Violation|0|||
161776029|NCT02576951|584221347|FG001|Overall Study|Protocol Violation|0|||
161776030|NCT02576951|584221348|FG002|Overall Study|Protocol Violation|0|||
161776031|NCT02576951|584221349|FG003|Overall Study|Protocol Violation|1|||
161776032|NCT00223990|584221350|FG000|Overall Study|Moved from area|2|||
161776033|NCT00223990|584221351|FG001|Overall Study|Moved from area|1|||
161776034|NCT00223990|584221350|FG000|Overall Study|Withdrawal by Subject|4|||
161776035|NCT00223990|584221351|FG001|Overall Study|Withdrawal by Subject|8|||
161776036|NCT00223990|584221350|FG000|Overall Study|Lost to Follow-up|1|||
161873535|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873536|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
161873537|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873538|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873539|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873540|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873541|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873542|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
161873543|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
161873544|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
161873545|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873546|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
161873547|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
161873548|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
161873549|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873550|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873551|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873552|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873553|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
161873554|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
161873555|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
161873556|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
161873557|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
161873558|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
161873559|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
161873560|NCT01704651|584580616|FG000|Overall Study|Pre-op withdrawal by subject|1|||
161873561|NCT01704651|584580617|FG001|Overall Study|Pre-op withdrawal by subject|1|||
161873562|NCT01704651|584580616|FG000|Overall Study|Pre-op change in treatment plan|1|||
161873563|NCT01704651|584580617|FG001|Overall Study|Pre-op change in treatment plan|4|||
161873564|NCT01704651|584580616|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
161873565|NCT01704651|584580617|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
161873566|NCT01704651|584580616|FG000|Overall Study|Post-op did not have laparotomy|2|||
161873567|NCT01704651|584580617|FG001|Overall Study|Post-op did not have laparotomy|1|||
161873568|NCT01860040|584580618|FG000|Overall Study|Withdrawal by Subject|1|||
161873569|NCT01860040|584580619|FG001|Overall Study|Withdrawal by Subject|0|||
161873570|NCT01931995|584580620|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
161873571|NCT01931995|584580621|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
161873572|NCT01931995|584580620|FG000|First Intervention (1 Day)|Physician Decision|1|||
161873573|NCT01931995|584580621|FG001|First Intervention (1 Day)|Physician Decision|1|||
161873574|NCT01931995|584580620|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
161873575|NCT01931995|584580621|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
161873576|NCT00791661|584580622|FG000|7 Day Wash-out|Adverse Event|0|||
161873577|NCT00791661|584580623|FG001|7 Day Wash-out|Adverse Event|0|||
161873578|NCT00791661|584580624|FG002|7 Day Wash-out|Adverse Event|1|||
161873579|NCT00791661|584580622|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
161873580|NCT00791661|584580623|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
161873581|NCT00791661|584580624|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
161873582|NCT00364923|584580627|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
161873583|NCT00364923|584580627|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
161873584|NCT00427921|584580633|FG000|Overall Study|Adverse Event|26|||
161873585|NCT00427921|584580633|FG000|Overall Study|Withdrawal by Subject|4|||
161873586|NCT00427921|584580633|FG000|Overall Study|Lost to Follow-up|2|||
161873587|NCT00427921|584580633|FG000|Overall Study|Other reason not specified|10|||
161873588|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Hospitalization|1|||
161873589|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
161873590|NCT00427921|584580633|FG000|Overall Study|Adverse Event + No Response|1|||
161873591|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
161873592|NCT00427921|584580633|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
161873593|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Lost Response|1|||
161873594|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
161873595|NCT00427921|584580633|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
161873596|NCT00520533|584580636|FG000|Overall Study|Death|1|||
161873597|NCT00520533|584580636|FG000|Overall Study|Suspension of the study for safety reasons|1|||
161873598|NCT00520533|584580636|FG000|Overall Study|Withdrawal by Subject|1|||
161873599|NCT00520533|584580636|FG000|Overall Study|Physician Decision|1|||
161873600|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Death|1|||
161873601|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Death|0|||
161873602|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
161873603|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
161873604|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
161873605|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
161873606|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
161873607|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
161873608|NCT01972438|584580642|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
161873609|NCT01972438|584580643|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
161873610|NCT01972438|584580642|FG000|Months 6-12 Study Period|Death|1|||
161873611|NCT01972438|584580643|FG001|Months 6-12 Study Period|Death|0|||
161873612|NCT01972438|584580642|FG000|Months 6-12 Study Period|Early Study Closure|2|||
161873613|NCT01972438|584580643|FG001|Months 6-12 Study Period|Early Study Closure|2|||
161873614|NCT01972438|584580642|FG000|Post Month 12 Study Period|Early Study Closure|3|||
161873615|NCT01972438|584580643|FG001|Post Month 12 Study Period|Early Study Closure|4|||
161873616|NCT00697463|584580644|FG000|Overall Study|Withdrawal by Subject|1|||
161873617|NCT02568189|584580645|FG000|Overall Study|Protocol Violation|0|||
161873618|NCT02568189|584580646|FG001|Overall Study|Protocol Violation|0|||
161873619|NCT02568189|584580647|FG002|Overall Study|Protocol Violation|19|||
161873620|NCT02568189|584580648|FG003|Overall Study|Protocol Violation|18|||
161873621|NCT00529373|584580649|FG000|Base Study|Adverse Event|525|||
161873622|NCT00529373|584580650|FG001|Base Study|Adverse Event|470|||
161873623|NCT00529373|584580649|FG000|Base Study|Lack of Efficacy|16|||
161873624|NCT00529373|584580650|FG001|Base Study|Lack of Efficacy|75|||
161873625|NCT00529373|584580649|FG000|Base Study|Lost to Follow-up|221|||
161873626|NCT00529373|584580650|FG001|Base Study|Lost to Follow-up|208|||
161873627|NCT00529373|584580649|FG000|Base Study|Other Protocol Specified Criteria|19|||
161873628|NCT00529373|584580650|FG001|Base Study|Other Protocol Specified Criteria|20|||
161873629|NCT00529373|584580649|FG000|Base Study|Physician Decision|60|||
161873630|NCT00529373|584580650|FG001|Base Study|Physician Decision|52|||
161873631|NCT00529373|584580649|FG000|Base Study|Protocol Violation|48|||
161873632|NCT00529373|584580650|FG001|Base Study|Protocol Violation|38|||
161873633|NCT00529373|584580649|FG000|Base Study|Withdrawal by Subject|1062|||
161873634|NCT00529373|584580650|FG001|Base Study|Withdrawal by Subject|967|||
161873635|NCT00529373|584580649|FG000|Base Study|Did not continue into Extension|1795|||
161873636|NCT00529373|584580650|FG001|Base Study|Did not continue into Extension|2238|||
161873637|NCT00529373|584580649|FG000|First Extension Study|Adverse Event|162|||
161873638|NCT00529373|584580650|FG001|First Extension Study|Adverse Event|142|||
161873639|NCT00529373|584580649|FG000|First Extension Study|Lack of Efficacy|65|||
161873640|NCT00529373|584580650|FG001|First Extension Study|Lack of Efficacy|427|||
161873641|NCT00529373|584580649|FG000|First Extension Study|Lost to Follow-up|41|||
161873642|NCT00529373|584580650|FG001|First Extension Study|Lost to Follow-up|37|||
161873643|NCT00529373|584580649|FG000|First Extension Study|Other|27|||
161873644|NCT00529373|584580650|FG001|First Extension Study|Other|47|||
161873645|NCT00529373|584580649|FG000|First Extension Study|Physician Decision|50|||
161873646|NCT00529373|584580650|FG001|First Extension Study|Physician Decision|45|||
161873647|NCT00529373|584580649|FG000|First Extension Study|Protocol Violation|16|||
161873648|NCT00529373|584580650|FG001|First Extension Study|Protocol Violation|13|||
161873649|NCT00529373|584580649|FG000|First Extension Study|Withdrawal by Subject|296|||
161873650|NCT00529373|584580650|FG001|First Extension Study|Withdrawal by Subject|287|||
161873651|NCT00529373|584580649|FG000|First Extension Study|Disposition record non-existing|0|||
161873652|NCT00529373|584580650|FG001|First Extension Study|Disposition record non-existing|1|||
161873653|NCT00529373|584580649|FG000|First Extension Study|Discontinued after 5 years completion|208|||
161873654|NCT00529373|584580650|FG001|First Extension Study|Discontinued after 5 years completion|346|||
161873655|NCT00529373|584580649|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
161873656|NCT00529373|584580650|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
161873657|NCT00529373|584580649|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
161873658|NCT00529373|584580650|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
161873659|NCT00529373|584580649|FG000|Second Extension Study|Adverse Event|101|||
161873660|NCT00529373|584580650|FG001|Second Extension Study|Adverse Event|51|||
161873661|NCT00529373|584580649|FG000|Second Extension Study|Lack of Efficacy|7|||
161873662|NCT00529373|584580650|FG001|Second Extension Study|Lack of Efficacy|15|||
161873663|NCT00529373|584580649|FG000|Second Extension Study|Lost to Follow-up|18|||
161873664|NCT00529373|584580650|FG001|Second Extension Study|Lost to Follow-up|12|||
161873665|NCT00529373|584580649|FG000|Second Extension Study|Other|7|||
161873666|NCT00529373|584580650|FG001|Second Extension Study|Other|12|||
161873667|NCT00529373|584580649|FG000|Second Extension Study|Physician Decision|63|||
161873668|NCT00529373|584580650|FG001|Second Extension Study|Physician Decision|26|||
161873669|NCT00529373|584580649|FG000|Second Extension Study|Protocol Violation|2|||
161873670|NCT00529373|584580650|FG001|Second Extension Study|Protocol Violation|1|||
161873671|NCT00529373|584580649|FG000|Second Extension Study|Withdrawal by Subject|97|||
161873672|NCT00529373|584580650|FG001|Second Extension Study|Withdrawal by Subject|75|||
161873673|NCT00529373|584580649|FG000|Second Extension Study|Status Missing|5|||
161873674|NCT00529373|584580650|FG001|Second Extension Study|Status Missing|5|||
161873675|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
161873676|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
161873677|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
161873678|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
161873679|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
161873680|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
161873681|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
161873682|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
161873683|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
161873684|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
161873685|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
161873686|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
161873687|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
161873688|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
161873689|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
161873690|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
161873691|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
161873692|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
161873693|NCT01119859|584580655|FG000|Overall Study|Adverse Event|9|||
161873694|NCT01119859|584580656|FG001|Overall Study|Adverse Event|10|||
161873695|NCT01119859|584580655|FG000|Overall Study|Death|2|||
161873696|NCT01119859|584580656|FG001|Overall Study|Death|0|||
161873697|NCT01119859|584580655|FG000|Overall Study|Insufficient therapeutic response|7|||
161873698|NCT01119859|584580656|FG001|Overall Study|Insufficient therapeutic response|14|||
161873699|NCT01119859|584580655|FG000|Overall Study|Refused treatment|3|||
161776037|NCT00223990|584221351|FG001|Overall Study|Lost to Follow-up|0|||
161776038|NCT03505606|584223067|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
161776039|NCT03505606|584223068|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
161776040|NCT03505606|584223069|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
161776041|NCT03505606|584223067|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
161776042|NCT03505606|584223068|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
161776043|NCT03505606|584223069|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
161776044|NCT03505606|584223067|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
161776045|NCT03505606|584223068|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
161776046|NCT03505606|584223069|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
161776047|NCT03505606|584223067|FG000|Overall Study|Poor compliance with refractive correction|0|||
161776048|NCT03505606|584223068|FG001|Overall Study|Poor compliance with refractive correction|0|||
161776049|NCT03505606|584223069|FG002|Overall Study|Poor compliance with refractive correction|1|||
161776050|NCT03505606|584223067|FG000|Overall Study|Insufficient anisometropia|0|||
161776051|NCT03505606|584223068|FG001|Overall Study|Insufficient anisometropia|0|||
161776052|NCT03505606|584223069|FG002|Overall Study|Insufficient anisometropia|2|||
161873700|NCT01119859|584580656|FG001|Overall Study|Refused treatment|6|||
161873701|NCT01119859|584580655|FG000|Overall Study|Failure to return|3|||
161873702|NCT01119859|584580656|FG001|Overall Study|Failure to return|0|||
161873703|NCT00603473|584580657|FG000|Overall Study|Adverse Event|4|||
161873704|NCT00603473|584580657|FG000|Overall Study|Lack of Efficacy|4|||
161873705|NCT00603473|584580657|FG000|Overall Study|Protocol Violation|1|||
161873706|NCT01134939|584580661|FG000|Overall Study|Adverse Event|9|||
161873707|NCT01134939|584580662|FG001|Overall Study|Adverse Event|3|||
161873708|NCT01134939|584580663|FG002|Overall Study|Adverse Event|4|||
161873709|NCT01134939|584580664|FG003|Overall Study|Adverse Event|5|||
161873710|NCT01134939|584580665|FG004|Overall Study|Adverse Event|5|||
161873711|NCT01134939|584580666|FG005|Overall Study|Adverse Event|5|||
161873712|NCT01134939|584580667|FG006|Overall Study|Adverse Event|1|||
161873713|NCT01134939|584580668|FG007|Overall Study|Adverse Event|0|||
161873714|NCT01134939|584580661|FG000|Overall Study|Lack of Efficacy|2|||
161873715|NCT01134939|584580662|FG001|Overall Study|Lack of Efficacy|5|||
161873716|NCT01134939|584580663|FG002|Overall Study|Lack of Efficacy|1|||
161873717|NCT01134939|584580664|FG003|Overall Study|Lack of Efficacy|0|||
161873718|NCT01134939|584580665|FG004|Overall Study|Lack of Efficacy|3|||
161873719|NCT01134939|584580666|FG005|Overall Study|Lack of Efficacy|0|||
161873720|NCT01134939|584580667|FG006|Overall Study|Lack of Efficacy|1|||
161873721|NCT01134939|584580668|FG007|Overall Study|Lack of Efficacy|0|||
161873722|NCT01134939|584580661|FG000|Overall Study|Lost to Follow-up|2|||
161873723|NCT01134939|584580662|FG001|Overall Study|Lost to Follow-up|3|||
161873724|NCT01134939|584580663|FG002|Overall Study|Lost to Follow-up|0|||
161873725|NCT01134939|584580664|FG003|Overall Study|Lost to Follow-up|1|||
161873726|NCT01134939|584580665|FG004|Overall Study|Lost to Follow-up|2|||
161873727|NCT01134939|584580666|FG005|Overall Study|Lost to Follow-up|1|||
161873728|NCT01134939|584580667|FG006|Overall Study|Lost to Follow-up|0|||
161873729|NCT01134939|584580668|FG007|Overall Study|Lost to Follow-up|0|||
161873730|NCT01134939|584580661|FG000|Overall Study|Death|0|||
161873731|NCT01134939|584580662|FG001|Overall Study|Death|1|||
161873732|NCT01134939|584580663|FG002|Overall Study|Death|0|||
161873733|NCT01134939|584580664|FG003|Overall Study|Death|0|||
161873734|NCT01134939|584580665|FG004|Overall Study|Death|0|||
161873735|NCT01134939|584580666|FG005|Overall Study|Death|0|||
161873736|NCT01134939|584580667|FG006|Overall Study|Death|0|||
161873737|NCT01134939|584580668|FG007|Overall Study|Death|0|||
161873738|NCT01134939|584580661|FG000|Overall Study|Termination page not available|4|||
161873739|NCT01134939|584580662|FG001|Overall Study|Termination page not available|6|||
161873740|NCT01134939|584580663|FG002|Overall Study|Termination page not available|5|||
161873741|NCT01134939|584580664|FG003|Overall Study|Termination page not available|8|||
161873742|NCT01134939|584580665|FG004|Overall Study|Termination page not available|0|||
161873743|NCT01134939|584580666|FG005|Overall Study|Termination page not available|3|||
161873744|NCT01134939|584580667|FG006|Overall Study|Termination page not available|7|||
161873745|NCT01134939|584580668|FG007|Overall Study|Termination page not available|0|||
161873746|NCT00733421|584580669|FG000|Overall Study|Withdrawal by Subject|1|||
161873747|NCT00733421|584580670|FG001|Overall Study|Withdrawal by Subject|1|||
161873748|NCT03652636|584582192|FG000|Overall Study|Withdrawal by Subject|7|||
161873749|NCT00679029|584582195|FG000|Overall Study|Adverse Event|3|||
161873750|NCT00679029|584582195|FG000|Overall Study|Withdrawal by Subject|1|||
161873751|NCT00679029|584582195|FG000|Overall Study|Lost to Follow-up|1|||
161873752|NCT04075682|584582196|FG000|Overall Study|Lost to Follow-up|5|||
161873753|NCT04075682|584582197|FG001|Overall Study|Lost to Follow-up|5|||
161873754|NCT04075682|584582198|FG002|Overall Study|Lost to Follow-up|2|||
161873755|NCT04075682|584582199|FG003|Overall Study|Lost to Follow-up|2|||
161873756|NCT04075682|584582196|FG000|Overall Study|Withdrawal by Subject|1|||
161873757|NCT04075682|584582197|FG001|Overall Study|Withdrawal by Subject|0|||
161873758|NCT04075682|584582198|FG002|Overall Study|Withdrawal by Subject|1|||
161873759|NCT04075682|584582199|FG003|Overall Study|Withdrawal by Subject|0|||
161873760|NCT04075682|584582196|FG000|Overall Study|Protocol Violation|0|||
161873761|NCT04075682|584582197|FG001|Overall Study|Protocol Violation|1|||
161873762|NCT04075682|584582198|FG002|Overall Study|Protocol Violation|1|||
161873763|NCT04075682|584582199|FG003|Overall Study|Protocol Violation|0|||
161873764|NCT04075682|584582196|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
161873765|NCT04075682|584582197|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
161873766|NCT04075682|584582198|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
161873767|NCT04075682|584582199|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
161873768|NCT04075682|584582196|FG000|Overall Study|Lost study phone the first day of study participation|0|||
161873769|NCT04075682|584582197|FG001|Overall Study|Lost study phone the first day of study participation|1|||
161873770|NCT04075682|584582198|FG002|Overall Study|Lost study phone the first day of study participation|0|||
161873771|NCT04075682|584582199|FG003|Overall Study|Lost study phone the first day of study participation|0|||
161873772|NCT03423173|584582200|FG000|Overall Study|Randomized but not vaccinated|1|||
161873773|NCT03423173|584582201|FG001|Overall Study|Randomized but not vaccinated|0|||
161873774|NCT03423173|584582202|FG002|Overall Study|Randomized but not vaccinated|2|||
161873775|NCT03423173|584582203|FG003|Overall Study|Randomized but not vaccinated|1|||
161873776|NCT03423173|584582200|FG000|Overall Study|Adverse Event|1|||
161873777|NCT03423173|584582201|FG001|Overall Study|Adverse Event|1|||
161873778|NCT03423173|584582202|FG002|Overall Study|Adverse Event|1|||
161873779|NCT03423173|584582203|FG003|Overall Study|Adverse Event|1|||
161873780|NCT03423173|584582200|FG000|Overall Study|Lost to Follow-up|10|||
161873781|NCT03423173|584582201|FG001|Overall Study|Lost to Follow-up|19|||
161873782|NCT03423173|584582202|FG002|Overall Study|Lost to Follow-up|17|||
161873783|NCT03423173|584582203|FG003|Overall Study|Lost to Follow-up|22|||
161873784|NCT03423173|584582200|FG000|Overall Study|Withdrawal of consent|4|||
161873785|NCT03423173|584582201|FG001|Overall Study|Withdrawal of consent|10|||
161873786|NCT03423173|584582202|FG002|Overall Study|Withdrawal of consent|4|||
161873787|NCT03423173|584582203|FG003|Overall Study|Withdrawal of consent|5|||
161873788|NCT03423173|584582200|FG000|Overall Study|Death|1|||
161873789|NCT03423173|584582201|FG001|Overall Study|Death|0|||
161873790|NCT03423173|584582202|FG002|Overall Study|Death|0|||
161873791|NCT03423173|584582203|FG003|Overall Study|Death|0|||
161873792|NCT03423173|584582200|FG000|Overall Study|Reason not Specified|2|||
161873793|NCT03423173|584582201|FG001|Overall Study|Reason not Specified|5|||
161873794|NCT03423173|584582202|FG002|Overall Study|Reason not Specified|3|||
161873795|NCT03423173|584582203|FG003|Overall Study|Reason not Specified|1|||
161873796|NCT05338502|584582204|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
161873797|NCT05338502|584582205|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
161873798|NCT05338502|584582206|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
161873799|NCT05338502|584582204|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
161873800|NCT05338502|584582205|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
161873801|NCT05338502|584582206|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
161873802|NCT02071706|584582207|FG000|Overall Study|Adverse Event|1|||
161873803|NCT02071706|584582207|FG000|Overall Study|Withdrawal by Subject|2|||
161873804|NCT02247440|584582208|FG000|Overall Study|Withdrawal by Subject|1|||
161873805|NCT02247440|584582208|FG000|Overall Study|Lack of Efficacy|3|||
161873806|NCT00729157|584582209|FG000|Overall Study|Withdrawal by Subject|1|||
161873807|NCT01062113|584582210|FG000|Overall Study|Adverse Event|1|||
161873808|NCT01062113|584582211|FG001|Overall Study|Adverse Event|0|||
161873809|NCT01062113|584582212|FG002|Overall Study|Adverse Event|0|||
161873810|NCT01062113|584582210|FG000|Overall Study|Lack of Efficacy|38|||
161873811|NCT01062113|584582211|FG001|Overall Study|Lack of Efficacy|22|||
161873812|NCT01062113|584582212|FG002|Overall Study|Lack of Efficacy|31|||
161873813|NCT01062113|584582210|FG000|Overall Study|Withdrawal by Subject|1|||
161873814|NCT01062113|584582211|FG001|Overall Study|Withdrawal by Subject|0|||
161873815|NCT01062113|584582212|FG002|Overall Study|Withdrawal by Subject|0|||
161873816|NCT03499899|584582213|FG000|Overall Study|Adverse Event|2|||
161873817|NCT03499899|584582214|FG001|Overall Study|Adverse Event|3|||
161873818|NCT03499899|584582215|FG002|Overall Study|Adverse Event|3|||
161873819|NCT03499899|584582213|FG000|Overall Study|Death|0|||
161873820|NCT03499899|584582214|FG001|Overall Study|Death|0|||
161873821|NCT03499899|584582215|FG002|Overall Study|Death|1|||
161873822|NCT03499899|584582213|FG000|Overall Study|Physician Decision|3|||
161873823|NCT03499899|584582214|FG001|Overall Study|Physician Decision|6|||
161873824|NCT03499899|584582215|FG002|Overall Study|Physician Decision|6|||
161873825|NCT03499899|584582213|FG000|Overall Study|Progressive disease|15|||
161873826|NCT03499899|584582214|FG001|Overall Study|Progressive disease|23|||
161873827|NCT03499899|584582215|FG002|Overall Study|Progressive disease|23|||
161873828|NCT03499899|584582213|FG000|Overall Study|Patient decision|0|||
161873829|NCT03499899|584582214|FG001|Overall Study|Patient decision|1|||
161873830|NCT03499899|584582215|FG002|Overall Study|Patient decision|1|||
161873831|NCT03499899|584582213|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
161873832|NCT03499899|584582214|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
161873833|NCT03499899|584582215|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
161873834|NCT03655470|584582216|FG000|Overall Study|Lost to Follow-up|6|||
161873835|NCT03655470|584582217|FG001|Overall Study|Lost to Follow-up|7|||
161873836|NCT03063086|584582218|FG000|Overall Study|technical problems|1|||
161873837|NCT03063086|584582219|FG001|Overall Study|technical problems|0|||
161873838|NCT03063086|584582220|FG002|Overall Study|technical problems|0|||
161873839|NCT03063086|584582221|FG003|Overall Study|technical problems|0|||
161873840|NCT03063086|584582222|FG004|Overall Study|technical problems|0|||
161873841|NCT03063086|584582223|FG005|Overall Study|technical problems|0|||
161873842|NCT03063086|584582218|FG000|Overall Study|Adverse Event|1|||
161873843|NCT03063086|584582219|FG001|Overall Study|Adverse Event|1|||
161873844|NCT03063086|584582220|FG002|Overall Study|Adverse Event|1|||
161873845|NCT03063086|584582221|FG003|Overall Study|Adverse Event|1|||
161873846|NCT03063086|584582222|FG004|Overall Study|Adverse Event|0|||
161873847|NCT03063086|584582223|FG005|Overall Study|Adverse Event|0|||
161873848|NCT03063086|584582218|FG000|Overall Study|subject/guardian decision|1|||
161873849|NCT03063086|584582219|FG001|Overall Study|subject/guardian decision|0|||
161873850|NCT03063086|584582220|FG002|Overall Study|subject/guardian decision|0|||
161873851|NCT03063086|584582221|FG003|Overall Study|subject/guardian decision|0|||
161873852|NCT03063086|584582222|FG004|Overall Study|subject/guardian decision|0|||
161873853|NCT03063086|584582223|FG005|Overall Study|subject/guardian decision|0|||
161873854|NCT03063086|584582218|FG000|Overall Study|Non-compliance with study treatment|0|||
161873855|NCT03063086|584582219|FG001|Overall Study|Non-compliance with study treatment|0|||
161873856|NCT03063086|584582220|FG002|Overall Study|Non-compliance with study treatment|0|||
161873857|NCT03063086|584582221|FG003|Overall Study|Non-compliance with study treatment|1|||
161873858|NCT03063086|584582222|FG004|Overall Study|Non-compliance with study treatment|0|||
161873859|NCT03063086|584582223|FG005|Overall Study|Non-compliance with study treatment|1|||
161873860|NCT03063086|584582218|FG000|Overall Study|Physician Decision|0|||
161873861|NCT03063086|584582219|FG001|Overall Study|Physician Decision|0|||
161873862|NCT03063086|584582220|FG002|Overall Study|Physician Decision|0|||
161873863|NCT03063086|584582221|FG003|Overall Study|Physician Decision|1|||
161873864|NCT03063086|584582222|FG004|Overall Study|Physician Decision|0|||
161873865|NCT03063086|584582223|FG005|Overall Study|Physician Decision|0|||
161873866|NCT02244463|584582226|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
161873867|NCT02244463|584582227|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873868|NCT02244463|584582228|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873869|NCT02244463|584582229|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873870|NCT02244463|584582230|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873871|NCT02244463|584582231|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873872|NCT02244463|584582226|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
161873873|NCT02244463|584582227|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
161873874|NCT02244463|584582228|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
161873875|NCT02244463|584582229|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
161873876|NCT02244463|584582230|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
161873877|NCT02244463|584582231|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
161873878|NCT02244463|584582226|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873879|NCT02244463|584582227|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
161873880|NCT02244463|584582228|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873881|NCT02244463|584582229|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873882|NCT02244463|584582230|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873883|NCT02244463|584582231|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873884|NCT02244463|584582226|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873885|NCT02244463|584582227|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873886|NCT02244463|584582228|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
161873887|NCT02244463|584582229|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873888|NCT02244463|584582230|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873889|NCT02244463|584582231|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873890|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873891|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873892|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873893|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
161873894|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873895|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873896|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873897|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873898|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873899|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
161873900|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873901|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873902|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873903|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873904|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873905|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
161873906|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873907|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873908|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873909|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873910|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873911|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
161873912|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873913|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873914|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873915|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873916|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873917|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
161873918|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873919|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873920|NCT02244463|584582226|FG000|Period 5: Phase II|Disease Progression|0|||
161873921|NCT02244463|584582227|FG001|Period 5: Phase II|Disease Progression|0|||
161873922|NCT02244463|584582228|FG002|Period 5: Phase II|Disease Progression|0|||
161873923|NCT02244463|584582229|FG003|Period 5: Phase II|Disease Progression|0|||
161873924|NCT02244463|584582230|FG004|Period 5: Phase II|Disease Progression|10|||
161873925|NCT02244463|584582231|FG005|Period 5: Phase II|Disease Progression|11|||
161873926|NCT02244463|584582226|FG000|Period 5: Phase II|Physician Decision|0|||
161873927|NCT02244463|584582227|FG001|Period 5: Phase II|Physician Decision|0|||
161873928|NCT02244463|584582228|FG002|Period 5: Phase II|Physician Decision|0|||
161873929|NCT02244463|584582229|FG003|Period 5: Phase II|Physician Decision|0|||
161873930|NCT02244463|584582230|FG004|Period 5: Phase II|Physician Decision|3|||
161873931|NCT02244463|584582231|FG005|Period 5: Phase II|Physician Decision|2|||
161873932|NCT02244463|584582226|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
161873933|NCT02244463|584582227|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
161873934|NCT02244463|584582228|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
161873935|NCT02244463|584582229|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
161873936|NCT02244463|584582230|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
161873937|NCT02244463|584582231|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
161873938|NCT02244463|584582226|FG000|Period 5: Phase II|Intercurrent Illness|0|||
161873939|NCT02244463|584582227|FG001|Period 5: Phase II|Intercurrent Illness|0|||
161873940|NCT02244463|584582228|FG002|Period 5: Phase II|Intercurrent Illness|0|||
161873941|NCT02244463|584582229|FG003|Period 5: Phase II|Intercurrent Illness|0|||
161873942|NCT02244463|584582230|FG004|Period 5: Phase II|Intercurrent Illness|2|||
161873943|NCT02244463|584582231|FG005|Period 5: Phase II|Intercurrent Illness|0|||
161873944|NCT02244463|584582226|FG000|Period 5: Phase II|Adverse Event|0|||
161873945|NCT02244463|584582227|FG001|Period 5: Phase II|Adverse Event|0|||
161873946|NCT02244463|584582228|FG002|Period 5: Phase II|Adverse Event|0|||
161873947|NCT02244463|584582229|FG003|Period 5: Phase II|Adverse Event|0|||
161873948|NCT02244463|584582230|FG004|Period 5: Phase II|Adverse Event|0|||
161873949|NCT02244463|584582231|FG005|Period 5: Phase II|Adverse Event|2|||
161873950|NCT02244463|584582226|FG000|Period 5: Phase II|Still On treatment|0|||
161873951|NCT02244463|584582227|FG001|Period 5: Phase II|Still On treatment|0|||
161873952|NCT02244463|584582228|FG002|Period 5: Phase II|Still On treatment|0|||
161873953|NCT02244463|584582229|FG003|Period 5: Phase II|Still On treatment|0|||
161873954|NCT02244463|584582230|FG004|Period 5: Phase II|Still On treatment|0|||
161873955|NCT02244463|584582231|FG005|Period 5: Phase II|Still On treatment|3|||
161873956|NCT05481125|584582232|FG000|Overall Study|Adverse Event|1|||
161873957|NCT05481125|584582233|FG001|Overall Study|Adverse Event|0|||
161873958|NCT05481125|584582232|FG000|Overall Study|Lost to Follow-up|0|||
161873959|NCT05481125|584582233|FG001|Overall Study|Lost to Follow-up|1|||
161873960|NCT05481125|584582232|FG000|Overall Study|Withdrawal by Subject|0|||
161873961|NCT05481125|584582233|FG001|Overall Study|Withdrawal by Subject|1|||
161873962|NCT03702010|584582238|FG000|Follow-up (30days)|Lack of Efficacy|2|||
161873963|NCT03702010|584582239|FG001|Follow-up (30days)|Lack of Efficacy|2|||
161873964|NCT03474731|584582247|FG000|Overall Study|Withdrawal by Subject|36|||
161873965|NCT03474731|584582248|FG001|Overall Study|Withdrawal by Subject|29|||
161873966|NCT03474731|584582249|FG002|Overall Study|Withdrawal by Subject|11|||
161873967|NCT03474731|584582250|FG003|Overall Study|Withdrawal by Subject|27|||
161873968|NCT03474731|584582247|FG000|Overall Study|COVID|0|||
161873969|NCT03474731|584582248|FG001|Overall Study|COVID|23|||
161873970|NCT03474731|584582249|FG002|Overall Study|COVID|0|||
161873971|NCT03474731|584582250|FG003|Overall Study|COVID|0|||
161873972|NCT03474731|584582247|FG000|Overall Study|Participant moved from area|1|||
161873973|NCT03474731|584582248|FG001|Overall Study|Participant moved from area|0|||
161873974|NCT03474731|584582249|FG002|Overall Study|Participant moved from area|0|||
161873975|NCT03474731|584582250|FG003|Overall Study|Participant moved from area|0|||
161873976|NCT03474731|584582247|FG000|Overall Study|Lost to Follow-up|11|||
161873977|NCT03474731|584582248|FG001|Overall Study|Lost to Follow-up|3|||
161873978|NCT03474731|584582249|FG002|Overall Study|Lost to Follow-up|18|||
161873979|NCT03474731|584582250|FG003|Overall Study|Lost to Follow-up|17|||
161873980|NCT03474731|584582247|FG000|Overall Study|Death|0|||
161873981|NCT03474731|584582248|FG001|Overall Study|Death|1|||
161873982|NCT03474731|584582249|FG002|Overall Study|Death|0|||
161873983|NCT03474731|584582250|FG003|Overall Study|Death|0|||
161873984|NCT03474731|584582247|FG000|Overall Study|Participant Removed|0|||
161873985|NCT03474731|584582248|FG001|Overall Study|Participant Removed|0|||
161873986|NCT03474731|584582249|FG002|Overall Study|Participant Removed|0|||
161873987|NCT03474731|584582250|FG003|Overall Study|Participant Removed|1|||
161873988|NCT00554515|584582253|FG000|Overall Study|Withdrawal by Subject|3|||
161873989|NCT00554515|584582253|FG000|Overall Study|Disease progression|52|||
161873990|NCT00554515|584582253|FG000|Overall Study|Physician Decision|18|||
161873991|NCT00554515|584582253|FG000|Overall Study|Withdrawal by Subject|11|||
161873992|NCT00554515|584582253|FG000|Overall Study|Adverse Event|9|||
161873993|NCT00554515|584582253|FG000|Overall Study|Death|2|||
161873994|NCT00554515|584582253|FG000|Overall Study|Achieved Stable Disease|7|||
161873995|NCT00554515|584582253|FG000|Overall Study|Other|1|||
161873996|NCT00554515|584582253|FG000|Overall Study|Misc|15|||
161873997|NCT02549287|584582261|FG000|Overall Study|Lost to Follow-up|65|||
161873998|NCT02549287|584582262|FG001|Overall Study|Lost to Follow-up|26|||
161873999|NCT02549287|584582261|FG000|Overall Study|Withdrawal by Subject|15|||
161874000|NCT02549287|584582262|FG001|Overall Study|Withdrawal by Subject|6|||
161874001|NCT03793842|584582263|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
161874002|NCT03793842|584582264|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
161874003|NCT03793842|584582263|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
161874004|NCT03793842|584582264|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
161874005|NCT04087720|584582265|FG000|Overall Study|Withdrawal by Subject|2|||
161874006|NCT04087720|584582265|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
161874007|NCT00900159|584582268|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
161874008|NCT00900159|584582269|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
161874009|NCT00765336|584582270|FG000|Overall Study|Protocol Violation|4|||
161874010|NCT00765336|584582271|FG001|Overall Study|Protocol Violation|2|||
161874011|NCT00765336|584582270|FG000|Overall Study|Withdrawal by Subject|6|||
161874012|NCT00765336|584582271|FG001|Overall Study|Withdrawal by Subject|4|||
161874013|NCT00765336|584582270|FG000|Overall Study|Lost to Follow-up|7|||
161874014|NCT00765336|584582271|FG001|Overall Study|Lost to Follow-up|9|||
161874015|NCT00765336|584582270|FG000|Overall Study|Adverse Event|2|||
161874016|NCT00765336|584582271|FG001|Overall Study|Adverse Event|1|||
161874017|NCT01377922|584582272|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
161874018|NCT01377922|584582273|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
161874019|NCT04615403|584582274|FG000|Overall Study|Death|1|||
161776053|NCT03505606|584223067|FG000|Overall Study|Ectopia Lentis|0|||
161776054|NCT03505606|584223068|FG001|Overall Study|Ectopia Lentis|0|||
161776055|NCT03505606|584223069|FG002|Overall Study|Ectopia Lentis|1|||
161776056|NCT03505606|584223067|FG000|Overall Study|alternation of amblyopic eye|0|||
161776057|NCT03505606|584223068|FG001|Overall Study|alternation of amblyopic eye|1|||
161776058|NCT03505606|584223069|FG002|Overall Study|alternation of amblyopic eye|0|||
161776059|NCT02087865|584223072|FG000|Overall Study|Withdrawal by Subject|6|||
161776060|NCT02087865|584223073|FG001|Overall Study|Withdrawal by Subject|0|||
161776061|NCT02087865|584223074|FG002|Overall Study|Withdrawal by Subject|1|||
161776062|NCT02087865|584223072|FG000|Overall Study|Lost to Follow-up|0|||
161776063|NCT02087865|584223073|FG001|Overall Study|Lost to Follow-up|0|||
161776064|NCT02087865|584223074|FG002|Overall Study|Lost to Follow-up|1|||
161776065|NCT02087865|584223072|FG000|Overall Study|Drug Non-compliance|0|||
161776066|NCT02087865|584223073|FG001|Overall Study|Drug Non-compliance|2|||
161776067|NCT02087865|584223074|FG002|Overall Study|Drug Non-compliance|0|||
161776068|NCT02087865|584223072|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
161776069|NCT02087865|584223073|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
161776070|NCT02087865|584223074|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
161776071|NCT01392469|584223075|FG000|Overall Study|Adverse Event|2|||
161776072|NCT01392469|584223075|FG000|Overall Study|Withdrawal by Subject|1|||
161776073|NCT01392469|584223075|FG000|Overall Study|Protocol Violation|1|||
161776074|NCT03443973|584223078|FG000|Double-blind Treatment Period|Adverse Event|5|||
161776075|NCT03443973|584223079|FG001|Double-blind Treatment Period|Adverse Event|19|||
161776076|NCT03443973|584223080|FG002|Double-blind Treatment Period|Adverse Event|0|||
161776077|NCT03443973|584223081|FG003|Double-blind Treatment Period|Adverse Event|0|||
161776078|NCT03443973|584223078|FG000|Double-blind Treatment Period|Death|5|||
161776079|NCT03443973|584223079|FG001|Double-blind Treatment Period|Death|7|||
161776080|NCT03443973|584223080|FG002|Double-blind Treatment Period|Death|0|||
161776081|NCT03443973|584223081|FG003|Double-blind Treatment Period|Death|0|||
161776082|NCT03443973|584223078|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
161776083|NCT03443973|584223079|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161776084|NCT03443973|584223080|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161776085|NCT03443973|584223081|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161776086|NCT03443973|584223078|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161776087|NCT03443973|584223079|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161776088|NCT03443973|584223080|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161776089|NCT03443973|584223081|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161776090|NCT03443973|584223078|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
161776091|NCT03443973|584223079|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
161776092|NCT03443973|584223080|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
161776093|NCT03443973|584223081|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
161776094|NCT03443973|584223078|FG000|Double-blind Treatment Period|Physician Decision|5|||
161776095|NCT03443973|584223079|FG001|Double-blind Treatment Period|Physician Decision|6|||
161776096|NCT03443973|584223080|FG002|Double-blind Treatment Period|Physician Decision|0|||
161776097|NCT03443973|584223081|FG003|Double-blind Treatment Period|Physician Decision|0|||
161776098|NCT03443973|584223078|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
161776099|NCT03443973|584223079|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
161776100|NCT03443973|584223080|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
161776101|NCT03443973|584223081|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
161776102|NCT03443973|584223078|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
161776103|NCT03443973|584223079|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
161776104|NCT03443973|584223080|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161776105|NCT03443973|584223081|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
161776106|NCT03443973|584223078|FG000|Open-label Extension Period|Reason Not Specified|0|||
161776107|NCT03443973|584223079|FG001|Open-label Extension Period|Reason Not Specified|0|||
161776108|NCT03443973|584223080|FG002|Open-label Extension Period|Reason Not Specified|3|||
161776109|NCT03443973|584223081|FG003|Open-label Extension Period|Reason Not Specified|0|||
161776110|NCT03443973|584223078|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161776111|NCT03443973|584223079|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161776112|NCT03443973|584223080|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
161776113|NCT03443973|584223081|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
161776114|NCT04930536|584223082|FG000|Overall Study|Adverse Event|1|||
161776115|NCT04930536|584223083|FG001|Overall Study|Adverse Event|0|||
161776116|NCT04930536|584223082|FG000|Overall Study|Disease Progression|2|||
161776117|NCT04930536|584223083|FG001|Overall Study|Disease Progression|0|||
161776118|NCT04930536|584223082|FG000|Overall Study|Patient Decision|4|||
161776119|NCT04930536|584223083|FG001|Overall Study|Patient Decision|2|||
161776120|NCT04930536|584223082|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
161874020|NCT00665431|584582275|FG000|Overall Study|Adverse Event|16|||
161874021|NCT00665431|584582276|FG001|Overall Study|Adverse Event|22|||
161874022|NCT00665431|584582277|FG002|Overall Study|Adverse Event|6|||
161874023|NCT00665431|584582275|FG000|Overall Study|Withdrawal by Subject|17|||
161874024|NCT00665431|584582276|FG001|Overall Study|Withdrawal by Subject|25|||
161874025|NCT00665431|584582277|FG002|Overall Study|Withdrawal by Subject|15|||
161874026|NCT00665431|584582275|FG000|Overall Study|Lost to Follow-up|3|||
161874027|NCT00665431|584582276|FG001|Overall Study|Lost to Follow-up|3|||
161874028|NCT00665431|584582277|FG002|Overall Study|Lost to Follow-up|1|||
161874029|NCT00665431|584582275|FG000|Overall Study|Other|4|||
161874030|NCT00665431|584582276|FG001|Overall Study|Other|7|||
161874031|NCT00665431|584582277|FG002|Overall Study|Other|2|||
161874032|NCT01464164|584582281|FG000|Overall Study|Screen failure|0|||
161874033|NCT01464164|584582282|FG001|Overall Study|Screen failure|1|||
161874034|NCT01464164|584582283|FG002|Overall Study|Screen failure|2|||
161874035|NCT01464164|584582284|FG003|Overall Study|Screen failure|0|||
161874036|NCT01464164|584582285|FG004|Overall Study|Screen failure|0|||
161874037|NCT01464164|584582286|FG005|Overall Study|Screen failure|0|||
161874038|NCT01464164|584582287|FG006|Overall Study|Screen failure|0|||
161874039|NCT01464164|584582281|FG000|Overall Study|Physician Decision|0|||
161874040|NCT01464164|584582282|FG001|Overall Study|Physician Decision|1|||
161874041|NCT01464164|584582283|FG002|Overall Study|Physician Decision|0|||
161874042|NCT01464164|584582284|FG003|Overall Study|Physician Decision|0|||
161874043|NCT01464164|584582285|FG004|Overall Study|Physician Decision|0|||
161874044|NCT01464164|584582286|FG005|Overall Study|Physician Decision|0|||
161874045|NCT01464164|584582287|FG006|Overall Study|Physician Decision|2|||
161874046|NCT01578239|584582288|FG000|Treatment Period|Progressive Disease|19|||
161874047|NCT01578239|584582289|FG001|Treatment Period|Progressive Disease|64|||
161874048|NCT01578239|584582288|FG000|Treatment Period|Physician Decision|17|||
161874049|NCT01578239|584582289|FG001|Treatment Period|Physician Decision|17|||
161874050|NCT01578239|584582288|FG000|Treatment Period|Adverse Event|13|||
161874051|NCT01578239|584582289|FG001|Treatment Period|Adverse Event|10|||
161874052|NCT01578239|584582288|FG000|Treatment Period|Non-compliance|2|||
161874053|NCT01578239|584582289|FG001|Treatment Period|Non-compliance|0|||
161874054|NCT01578239|584582288|FG000|Treatment Period|Withdrawal by Subject|10|||
161874055|NCT01578239|584582289|FG001|Treatment Period|Withdrawal by Subject|9|||
161874056|NCT01578239|584582288|FG000|Treatment Period|Other|6|||
161874057|NCT01578239|584582289|FG001|Treatment Period|Other|1|||
161874058|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Death|69|||
161874059|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Death|64|||
161874060|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
161874061|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
161874062|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
161874063|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
161874064|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Other|2|||
161874065|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Other|2|||
161874066|NCT02347813|584582292|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
161874067|NCT02347813|584582293|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
161874068|NCT02347813|584582292|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
161874069|NCT02347813|584582293|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
161874070|NCT02547220|584582297|FG000|Overall Study|Withdrawal by Subject|1|||
161874071|NCT02547220|584582298|FG001|Overall Study|Withdrawal by Subject|0|||
161874072|NCT02547220|584582297|FG000|Overall Study|Study terminated by sponsor|18|||
161874073|NCT02547220|584582298|FG001|Overall Study|Study terminated by sponsor|20|||
161874074|NCT03817229|584582299|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
161874075|NCT03817229|584582300|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
161874076|NCT03817229|584582301|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
161874077|NCT03817229|584582302|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
161874078|NCT03817229|584582299|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161874079|NCT03817229|584582300|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
161874080|NCT03817229|584582301|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161874081|NCT03817229|584582302|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161874082|NCT03817229|584582299|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
161874083|NCT03817229|584582300|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
161874084|NCT03817229|584582301|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
161874085|NCT03817229|584582302|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
161874086|NCT03817229|584582299|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
161874087|NCT03817229|584582300|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
161874088|NCT03817229|584582301|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
161874089|NCT03817229|584582302|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
161874090|NCT03817229|584582299|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161874091|NCT03817229|584582300|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161874092|NCT03817229|584582301|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161874093|NCT03817229|584582302|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
161874094|NCT03817229|584582299|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
161874095|NCT03817229|584582300|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
161874096|NCT03817229|584582301|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
161874097|NCT03817229|584582302|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
161874098|NCT03817229|584582299|FG000|Post-Intervention|Withdrawal by Subject|6|||
161874099|NCT03817229|584582300|FG001|Post-Intervention|Withdrawal by Subject|0|||
161874100|NCT03817229|584582301|FG002|Post-Intervention|Withdrawal by Subject|2|||
161874101|NCT03817229|584582302|FG003|Post-Intervention|Withdrawal by Subject|2|||
161874102|NCT03817229|584582299|FG000|Post-Intervention|Withdrawal by Study Team|3|||
161874103|NCT03817229|584582300|FG001|Post-Intervention|Withdrawal by Study Team|1|||
161874104|NCT03817229|584582301|FG002|Post-Intervention|Withdrawal by Study Team|1|||
161874105|NCT03817229|584582302|FG003|Post-Intervention|Withdrawal by Study Team|4|||
161874106|NCT03817229|584582299|FG000|Post-Intervention|Weaned from medication|3|||
161874107|NCT03817229|584582300|FG001|Post-Intervention|Weaned from medication|0|||
161874108|NCT03817229|584582301|FG002|Post-Intervention|Weaned from medication|2|||
161874109|NCT03817229|584582302|FG003|Post-Intervention|Weaned from medication|1|||
161874110|NCT03817229|584582299|FG000|Post-Intervention|Transferred care to another institution|1|||
161874111|NCT03817229|584582300|FG001|Post-Intervention|Transferred care to another institution|0|||
161874112|NCT03817229|584582301|FG002|Post-Intervention|Transferred care to another institution|0|||
161874113|NCT03817229|584582302|FG003|Post-Intervention|Transferred care to another institution|0|||
161874114|NCT03817229|584582299|FG000|Post-Intervention|Change in parental guardianship|0|||
161874115|NCT03817229|584582300|FG001|Post-Intervention|Change in parental guardianship|0|||
161874116|NCT03817229|584582301|FG002|Post-Intervention|Change in parental guardianship|1|||
161874117|NCT03817229|584582302|FG003|Post-Intervention|Change in parental guardianship|0|||
161874118|NCT03817229|584582299|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
161874119|NCT03817229|584582300|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
161874120|NCT03817229|584582301|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
161874121|NCT03817229|584582302|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
161874122|NCT03817229|584582299|FG000|Follow-up 1|Withdrawal by Subject|1|||
161874123|NCT03817229|584582300|FG001|Follow-up 1|Withdrawal by Subject|2|||
161874124|NCT03817229|584582301|FG002|Follow-up 1|Withdrawal by Subject|0|||
161874125|NCT03817229|584582302|FG003|Follow-up 1|Withdrawal by Subject|0|||
161874126|NCT03817229|584582299|FG000|Follow-up 1|Withdrawal by Study Team|3|||
161874127|NCT03817229|584582300|FG001|Follow-up 1|Withdrawal by Study Team|1|||
161874128|NCT03817229|584582301|FG002|Follow-up 1|Withdrawal by Study Team|0|||
161874129|NCT03817229|584582302|FG003|Follow-up 1|Withdrawal by Study Team|0|||
161874130|NCT03817229|584582299|FG000|Follow-up 1|Wean from medication|3|||
161874131|NCT03817229|584582300|FG001|Follow-up 1|Wean from medication|4|||
161874132|NCT03817229|584582301|FG002|Follow-up 1|Wean from medication|0|||
161874133|NCT03817229|584582302|FG003|Follow-up 1|Wean from medication|1|||
161874134|NCT03817229|584582299|FG000|Follow-up 1|Transferred care to another hospital|1|||
161874135|NCT03817229|584582300|FG001|Follow-up 1|Transferred care to another hospital|0|||
161874136|NCT03817229|584582301|FG002|Follow-up 1|Transferred care to another hospital|0|||
161874137|NCT03817229|584582302|FG003|Follow-up 1|Transferred care to another hospital|0|||
161874138|NCT03817229|584582299|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
161874139|NCT03817229|584582300|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
161874140|NCT03817229|584582301|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
161874141|NCT03817229|584582302|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
161874142|NCT03817229|584582299|FG000|Follow-up 2|Withdrawal by Subject|2|||
161874143|NCT03817229|584582300|FG001|Follow-up 2|Withdrawal by Subject|0|||
161874144|NCT03817229|584582301|FG002|Follow-up 2|Withdrawal by Subject|1|||
161874145|NCT03817229|584582302|FG003|Follow-up 2|Withdrawal by Subject|1|||
161874146|NCT03817229|584582299|FG000|Follow-up 2|Withdrawal by Study Team|2|||
161874147|NCT03817229|584582300|FG001|Follow-up 2|Withdrawal by Study Team|0|||
161874148|NCT03817229|584582301|FG002|Follow-up 2|Withdrawal by Study Team|1|||
161874149|NCT03817229|584582302|FG003|Follow-up 2|Withdrawal by Study Team|0|||
161874150|NCT03817229|584582299|FG000|Follow-up 2|Wean from medication|1|||
161874151|NCT03817229|584582300|FG001|Follow-up 2|Wean from medication|0|||
161874152|NCT03817229|584582301|FG002|Follow-up 2|Wean from medication|0|||
161874153|NCT03817229|584582302|FG003|Follow-up 2|Wean from medication|0|||
161874154|NCT03817229|584582299|FG000|Follow-up 2|Transferred care|0|||
161874155|NCT03817229|584582300|FG001|Follow-up 2|Transferred care|0|||
161874156|NCT03817229|584582301|FG002|Follow-up 2|Transferred care|1|||
161874157|NCT03817229|584582302|FG003|Follow-up 2|Transferred care|0|||
161874158|NCT02887183|584582304|FG000|Overall Study|Adverse Event|44|||
161874159|NCT02887183|584582304|FG000|Overall Study|Death|30|||
161874160|NCT02887183|584582304|FG000|Overall Study|Pregnancy|1|||
161874161|NCT02887183|584582304|FG000|Overall Study|Protocol Violation|6|||
161874162|NCT02887183|584582304|FG000|Overall Study|Technical Problems|2|||
161874163|NCT02887183|584582304|FG000|Overall Study|Lost to Follow-up|13|||
161874164|NCT02887183|584582304|FG000|Overall Study|Physician Decision|10|||
161874165|NCT02887183|584582304|FG000|Overall Study|Withdrawal by Subject|35|||
161874166|NCT01029782|584582305|FG000|Overall Study|Lost to Follow-up|2|||
161874167|NCT01029782|584582306|FG001|Overall Study|Lost to Follow-up|2|||
161874168|NCT01029782|584582305|FG000|Overall Study|Diagnosis changed|1|||
161874169|NCT01029782|584582306|FG001|Overall Study|Diagnosis changed|1|||
161874170|NCT01029782|584582305|FG000|Overall Study|Adverse Event|0|||
161874171|NCT01029782|584582306|FG001|Overall Study|Adverse Event|1|||
161874172|NCT01029782|584582305|FG000|Overall Study|Physician Decision|0|||
161874173|NCT01029782|584582306|FG001|Overall Study|Physician Decision|1|||
161874174|NCT01029782|584582305|FG000|Overall Study|Protocol Violation|0|||
161874175|NCT01029782|584582306|FG001|Overall Study|Protocol Violation|2|||
161874176|NCT01029782|584582305|FG000|Overall Study|Withdrawal by Subject|0|||
161874177|NCT01029782|584582306|FG001|Overall Study|Withdrawal by Subject|1|||
161874178|NCT02195869|584582308|FG000|Overall Study|cGVHD Progression|5|||
161874179|NCT02195869|584582308|FG000|Overall Study|Malignancy Progression/relapse|2|||
161874180|NCT02195869|584582308|FG000|Overall Study|Adverse Event|15|||
161874181|NCT02195869|584582308|FG000|Overall Study|Withdrawal by Subject|7|||
161874182|NCT02195869|584582308|FG000|Overall Study|Physician Decision|4|||
161874183|NCT02195869|584582308|FG000|Overall Study|Study Terminated by Sponsor|7|||
161874184|NCT02195869|584582308|FG000|Overall Study|Noncompliance with study drug|2|||
161874185|NCT00757042|584582312|FG000|Overall Study|Lost to Follow-up|0|||
161874186|NCT00757042|584582313|FG001|Overall Study|Lost to Follow-up|0|||
161874187|NCT00757042|584582314|FG002|Overall Study|Lost to Follow-up|0|||
161874188|NCT00757042|584582315|FG003|Overall Study|Lost to Follow-up|0|||
161874189|NCT00757042|584582316|FG004|Overall Study|Lost to Follow-up|0|||
161874190|NCT00757042|584582317|FG005|Overall Study|Lost to Follow-up|0|||
161874191|NCT00757042|584582318|FG006|Overall Study|Lost to Follow-up|0|||
161874192|NCT00757042|584582319|FG007|Overall Study|Lost to Follow-up|0|||
161874193|NCT00757042|584582320|FG008|Overall Study|Lost to Follow-up|1|||
161874194|NCT00757042|584582321|FG009|Overall Study|Lost to Follow-up|0|||
161874195|NCT00757042|584582322|FG010|Overall Study|Lost to Follow-up|0|||
161874196|NCT00757042|584582312|FG000|Overall Study|Ineligibility Determined|0|||
161874197|NCT00757042|584582313|FG001|Overall Study|Ineligibility Determined|0|||
161874198|NCT00757042|584582314|FG002|Overall Study|Ineligibility Determined|0|||
161874199|NCT00757042|584582315|FG003|Overall Study|Ineligibility Determined|0|||
161874200|NCT00757042|584582316|FG004|Overall Study|Ineligibility Determined|0|||
161874201|NCT00757042|584582317|FG005|Overall Study|Ineligibility Determined|0|||
161874202|NCT00757042|584582318|FG006|Overall Study|Ineligibility Determined|0|||
161874203|NCT00757042|584582319|FG007|Overall Study|Ineligibility Determined|0|||
161874204|NCT00757042|584582320|FG008|Overall Study|Ineligibility Determined|0|||
161874205|NCT00757042|584582321|FG009|Overall Study|Ineligibility Determined|0|||
161874206|NCT00757042|584582322|FG010|Overall Study|Ineligibility Determined|1|||
161874207|NCT00757042|584582312|FG000|Overall Study|Withdrawal by Subject|0|||
161874208|NCT00757042|584582313|FG001|Overall Study|Withdrawal by Subject|0|||
161874209|NCT00757042|584582314|FG002|Overall Study|Withdrawal by Subject|0|||
161874210|NCT00757042|584582315|FG003|Overall Study|Withdrawal by Subject|0|||
161874211|NCT00757042|584582316|FG004|Overall Study|Withdrawal by Subject|0|||
161874212|NCT00757042|584582317|FG005|Overall Study|Withdrawal by Subject|0|||
161874213|NCT00757042|584582318|FG006|Overall Study|Withdrawal by Subject|0|||
161874214|NCT00757042|584582319|FG007|Overall Study|Withdrawal by Subject|0|||
161874215|NCT00757042|584582320|FG008|Overall Study|Withdrawal by Subject|0|||
161874216|NCT00757042|584582321|FG009|Overall Study|Withdrawal by Subject|1|||
161874217|NCT00757042|584582322|FG010|Overall Study|Withdrawal by Subject|0|||
161874218|NCT02654977|584582323|FG000|Overall Study|Death|1|||
161874219|NCT02654977|584582323|FG000|Overall Study|Lost to Follow-up|1|||
161874220|NCT02654977|584582323|FG000|Overall Study|Adverse Event|1|||
161874221|NCT02654977|584582323|FG000|Overall Study|Withdrawal by Subject|1|||
161874222|NCT02654977|584582323|FG000|Overall Study|Lack of Efficacy|3|||
161874223|NCT01266291|584582324|FG000|Overall Study|Adverse Event|1|||
161874224|NCT02702388|584582328|FG000|Overall Study|Disease Progression|18|||
161874225|NCT02702388|584582329|FG001|Overall Study|Disease Progression|25|||
161874226|NCT02702388|584582328|FG000|Overall Study|Withdrawal by Subject|9|||
161874227|NCT02702388|584582329|FG001|Overall Study|Withdrawal by Subject|7|||
161874228|NCT02702388|584582328|FG000|Overall Study|Adverse Event|11|||
161874229|NCT02702388|584582329|FG001|Overall Study|Adverse Event|15|||
161874230|NCT02702388|584582328|FG000|Overall Study|Other|2|||
161874231|NCT02702388|584582329|FG001|Overall Study|Other|4|||
161874232|NCT02729051|584582330|FG000|Overall Study|Adverse Event|21|||
161874233|NCT02729051|584582331|FG001|Overall Study|Adverse Event|11|||
161874234|NCT02729051|584582330|FG000|Overall Study|Lack of Efficacy|1|||
161874235|NCT02729051|584582331|FG001|Overall Study|Lack of Efficacy|1|||
161874236|NCT02729051|584582330|FG000|Overall Study|Lost to Follow-up|1|||
161874237|NCT02729051|584582331|FG001|Overall Study|Lost to Follow-up|2|||
161874238|NCT02729051|584582330|FG000|Overall Study|Physician Decision|1|||
161874239|NCT02729051|584582331|FG001|Overall Study|Physician Decision|1|||
161874240|NCT02729051|584582330|FG000|Overall Study|Withdrawal by Subject|6|||
161874241|NCT02729051|584582331|FG001|Overall Study|Withdrawal by Subject|17|||
161874242|NCT02981082|584582332|FG000|Overall Study|Withdrawal by Subject|2|||
161874243|NCT02981082|584582333|FG001|Overall Study|Withdrawal by Subject|0|||
161874244|NCT02981082|584582332|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
161874245|NCT02981082|584582333|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
161874246|NCT02981082|584582332|FG000|Overall Study|Adverse Event|0|||
161874247|NCT02981082|584582333|FG001|Overall Study|Adverse Event|1|||
161874248|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
161874249|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
161874250|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
161874251|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
161874252|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Death|0|||
161874253|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Death|0|||
161874254|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Death|1|||
161874255|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Death|0|||
161874256|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
161874257|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161874258|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161874259|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161874260|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
161874261|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
161874262|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
161874263|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
161874264|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
161874265|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
161874266|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
161874267|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
161874268|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
161874269|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
161874270|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161874271|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
161874272|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
161874273|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161874274|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
161874275|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
161874276|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
161874277|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
161874278|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
161874279|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
161874280|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161874281|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
161874282|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161874283|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161874284|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
161874285|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
161874286|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
161874287|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
161874288|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
161874289|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
161874290|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
161874291|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
161874292|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Other|8|||
161874293|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Other|14|||
161874294|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Other|8|||
161874295|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Other|23|||
161874296|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
161874297|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
161874298|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
161874299|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
161874300|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161874301|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161874302|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
161874303|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
161874304|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Death|0|||
161874305|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Death|0|||
161874306|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161874307|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Death|1|||
161874308|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
161874309|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
161874310|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
161874311|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
161874312|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161874313|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161874314|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161874315|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161874316|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161874317|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
161874318|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161874319|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
161874320|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161874321|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161874322|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161874323|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161874324|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161874325|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
161874326|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
161874327|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161874328|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161874329|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
161874330|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
161874331|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161874332|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161874333|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161874334|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161874335|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161874336|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Other|6|||
161874337|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161874338|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Other|8|||
161874339|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Other|5|||
161874340|NCT00972816|584583889|FG000|Overall Study|Adverse Event|0|||
161874341|NCT00972816|584583890|FG001|Overall Study|Adverse Event|0|||
161874342|NCT00972816|584583891|FG002|Overall Study|Adverse Event|1|||
161874343|NCT00972816|584583892|FG003|Overall Study|Adverse Event|0|||
161874344|NCT00972816|584583893|FG004|Overall Study|Adverse Event|0|||
161874345|NCT00972816|584583894|FG005|Overall Study|Adverse Event|0|||
161874346|NCT00972816|584583895|FG006|Overall Study|Adverse Event|0|||
161874347|NCT00972816|584583896|FG007|Overall Study|Adverse Event|0|||
161874348|NCT00972816|584583889|FG000|Overall Study|Withdrawal by Subject|4|||
161874349|NCT00972816|584583890|FG001|Overall Study|Withdrawal by Subject|2|||
161874350|NCT00972816|584583891|FG002|Overall Study|Withdrawal by Subject|1|||
161874351|NCT00972816|584583892|FG003|Overall Study|Withdrawal by Subject|3|||
161874352|NCT00972816|584583893|FG004|Overall Study|Withdrawal by Subject|0|||
161874353|NCT00972816|584583894|FG005|Overall Study|Withdrawal by Subject|1|||
161874354|NCT00972816|584583895|FG006|Overall Study|Withdrawal by Subject|1|||
161874355|NCT00972816|584583896|FG007|Overall Study|Withdrawal by Subject|2|||
161874356|NCT00972816|584583889|FG000|Overall Study|Lost to Follow-up|11|||
161874357|NCT00972816|584583890|FG001|Overall Study|Lost to Follow-up|9|||
161874358|NCT00972816|584583891|FG002|Overall Study|Lost to Follow-up|7|||
161874359|NCT00972816|584583892|FG003|Overall Study|Lost to Follow-up|5|||
161874360|NCT00972816|584583893|FG004|Overall Study|Lost to Follow-up|11|||
161874361|NCT00972816|584583894|FG005|Overall Study|Lost to Follow-up|10|||
161874362|NCT00972816|584583895|FG006|Overall Study|Lost to Follow-up|7|||
161874363|NCT00972816|584583896|FG007|Overall Study|Lost to Follow-up|7|||
161874364|NCT00972816|584583889|FG000|Overall Study|Inappropriate enrolment|0|||
161874365|NCT00972816|584583890|FG001|Overall Study|Inappropriate enrolment|0|||
161874366|NCT00972816|584583891|FG002|Overall Study|Inappropriate enrolment|0|||
161874367|NCT00972816|584583892|FG003|Overall Study|Inappropriate enrolment|0|||
161874368|NCT00972816|584583893|FG004|Overall Study|Inappropriate enrolment|0|||
161874369|NCT00972816|584583894|FG005|Overall Study|Inappropriate enrolment|0|||
161874370|NCT00972816|584583895|FG006|Overall Study|Inappropriate enrolment|2|||
161874371|NCT00972816|584583896|FG007|Overall Study|Inappropriate enrolment|0|||
161874372|NCT00972816|584583889|FG000|Overall Study|Unable to classify|2|||
161874373|NCT00972816|584583890|FG001|Overall Study|Unable to classify|0|||
161874374|NCT00972816|584583891|FG002|Overall Study|Unable to classify|0|||
161874375|NCT00972816|584583892|FG003|Overall Study|Unable to classify|0|||
161874376|NCT00972816|584583893|FG004|Overall Study|Unable to classify|1|||
161874377|NCT00972816|584583894|FG005|Overall Study|Unable to classify|0|||
161874378|NCT00972816|584583895|FG006|Overall Study|Unable to classify|0|||
161874379|NCT00972816|584583896|FG007|Overall Study|Unable to classify|0|||
161874380|NCT03806933|584583897|FG000|Main Period|Physician Decision|0|||
161874381|NCT03806933|584583898|FG001|Main Period|Physician Decision|0|||
161874382|NCT03806933|584583899|FG002|Main Period|Physician Decision|0|||
161874383|NCT03806933|584583900|FG003|Main Period|Physician Decision|1|||
161874384|NCT03806933|584583897|FG000|Main Period|Pregnancy|0|||
161874385|NCT03806933|584583898|FG001|Main Period|Pregnancy|0|||
161874386|NCT03806933|584583899|FG002|Main Period|Pregnancy|1|||
161874387|NCT03806933|584583900|FG003|Main Period|Pregnancy|0|||
161874388|NCT03806933|584583897|FG000|Main Period|Withdrawal by Subject|2|||
161874389|NCT03806933|584583898|FG001|Main Period|Withdrawal by Subject|1|||
161874390|NCT03806933|584583899|FG002|Main Period|Withdrawal by Subject|1|||
161874391|NCT03806933|584583900|FG003|Main Period|Withdrawal by Subject|2|||
161874392|NCT03806933|584583897|FG000|Main Period|Lost to Follow-up|2|||
161874393|NCT03806933|584583898|FG001|Main Period|Lost to Follow-up|2|||
161874394|NCT03806933|584583899|FG002|Main Period|Lost to Follow-up|0|||
161874395|NCT03806933|584583900|FG003|Main Period|Lost to Follow-up|0|||
161874396|NCT03806933|584583897|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161874397|NCT03806933|584583898|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161874398|NCT03806933|584583899|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161874399|NCT03806933|584583900|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
161874400|NCT05088603|584583901|FG000|Overall Study|Protocol Violation|6|||
161874401|NCT05088603|584583902|FG001|Overall Study|Protocol Violation|1|||
161874402|NCT00956592|584583907|FG000|Overall Study|Protocol Violation|1|||
161874403|NCT00956592|584583908|FG001|Overall Study|Protocol Violation|3|||
161874404|NCT02162719|584583909|FG000|Overall Study|Death|41|||
161874405|NCT02162719|584583910|FG001|Overall Study|Death|46|||
161874406|NCT02162719|584583909|FG000|Overall Study|Lost to Follow-up|1|||
161874407|NCT02162719|584583910|FG001|Overall Study|Lost to Follow-up|3|||
161874408|NCT02162719|584583909|FG000|Overall Study|Disease Progression|2|||
161874409|NCT02162719|584583910|FG001|Overall Study|Disease Progression|1|||
161874410|NCT02162719|584583909|FG000|Overall Study|Withdrawal by Subject|8|||
161874411|NCT02162719|584583910|FG001|Overall Study|Withdrawal by Subject|2|||
161776121|NCT04930536|584223083|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
161776122|NCT01432600|584223084|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
161776123|NCT01432600|584223085|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
161776124|NCT01432600|584223086|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
161776125|NCT00398632|584223087|FG000|Overall Study|Withdrawal by Subject|1|||
161776126|NCT00398632|584223087|FG000|Overall Study|Lack of Efficacy|1|||
161776127|NCT00267020|584223088|FG000|Overall Study|Adverse Event|22|||
161776128|NCT00267020|584223089|FG001|Overall Study|Adverse Event|5|||
161776129|NCT00267020|584223088|FG000|Overall Study|Death|2|||
161776130|NCT00267020|584223089|FG001|Overall Study|Death|1|||
161776131|NCT00267020|584223088|FG000|Overall Study|Withdrawal by Subject|17|||
161776132|NCT00267020|584223089|FG001|Overall Study|Withdrawal by Subject|7|||
161776133|NCT00267020|584223088|FG000|Overall Study|Physician Decision|3|||
161776134|NCT00267020|584223089|FG001|Overall Study|Physician Decision|2|||
161776135|NCT00267020|584223088|FG000|Overall Study|Disease Progression|39|||
161776136|NCT00267020|584223089|FG001|Overall Study|Disease Progression|25|||
161776137|NCT00267020|584223088|FG000|Overall Study|Unrelated Complication|1|||
161776138|NCT00267020|584223089|FG001|Overall Study|Unrelated Complication|1|||
161776139|NCT00267020|584223088|FG000|Overall Study|Sponsor Request|1|||
161776140|NCT00267020|584223089|FG001|Overall Study|Sponsor Request|0|||
161776141|NCT00267020|584223088|FG000|Overall Study|Other|1|||
161776142|NCT00267020|584223089|FG001|Overall Study|Other|2|||
161776143|NCT04292171|584223093|FG000|Overall Study|Pharmacy error|2|||
161776144|NCT04292171|584223094|FG001|Overall Study|Pharmacy error|0|||
161776145|NCT04292171|584223093|FG000|Overall Study|Delivered prior to procedure|0|||
161776146|NCT04292171|584223094|FG001|Overall Study|Delivered prior to procedure|1|||
161776147|NCT04465916|584223095|FG000|Overall Study|Withdrawal by Subject|0|||
161776148|NCT04465916|584223096|FG001|Overall Study|Withdrawal by Subject|1|||
161776149|NCT04633434|584223100|FG000|Overall Study|Lost to Follow-up|32|||
161776150|NCT04633434|584223101|FG001|Overall Study|Lost to Follow-up|32|||
161776151|NCT00297882|584223105|FG000|Day 14|Lack of Efficacy|12|||
161776152|NCT00297882|584223106|FG001|Day 14|Lack of Efficacy|49|||
161776153|NCT00297882|584223105|FG000|Day 28|Lost to Follow-up|13|||
161776154|NCT00297882|584223106|FG001|Day 28|Lost to Follow-up|23|||
161776155|NCT00297882|584223105|FG000|Day 28|Lack of Efficacy|3|||
161776156|NCT00297882|584223106|FG001|Day 28|Lack of Efficacy|0|||
161776157|NCT04242264|584223107|FG000|Overall Study|Lost to Follow-up|2|||
161776158|NCT04242264|584223108|FG001|Overall Study|Lost to Follow-up|2|||
161776159|NCT04242264|584223109|FG002|Overall Study|Lost to Follow-up|1|||
161776160|NCT04242264|584223110|FG003|Overall Study|Lost to Follow-up|1|||
161776161|NCT04242264|584223107|FG000|Overall Study|Withdrawal by Subject|1|||
161776162|NCT04242264|584223108|FG001|Overall Study|Withdrawal by Subject|0|||
161776163|NCT04242264|584223109|FG002|Overall Study|Withdrawal by Subject|0|||
161776164|NCT04242264|584223110|FG003|Overall Study|Withdrawal by Subject|0|||
161776165|NCT04221373|584223111|FG000|Overall Study|Physician Decision|4|||
161776166|NCT04221373|584223112|FG001|Overall Study|Physician Decision|0|||
161776167|NCT04139642|584223122|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
161776168|NCT04139642|584223123|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
161776169|NCT00577031|584223129|FG000|Overall Study|Adverse Event|52|||
161776170|NCT00577031|584223129|FG000|Overall Study|Progression of disease|93|||
161776171|NCT00577031|584223129|FG000|Overall Study|Protocol Violation|5|||
161776172|NCT00577031|584223129|FG000|Overall Study|Participant withdrew consent|13|||
161776173|NCT00577031|584223129|FG000|Overall Study|Participant non-compliance|5|||
161776174|NCT00577031|584223129|FG000|Overall Study|Need for surgery|17|||
161776175|NCT00577031|584223129|FG000|Overall Study|Medical decision|14|||
161874412|NCT02162719|584583909|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
161874413|NCT02162719|584583910|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
161874414|NCT03555565|584583912|FG000|Overall Study|Case Report Forms Uncollected|2|||
161874415|NCT03555565|584583912|FG000|Overall Study|Protocol Deviation|13|||
161874416|NCT03854370|584583915|FG000|Overall Study|samples not collected|1|||
161874417|NCT03854370|584583916|FG001|Overall Study|samples not collected|1|||
161874418|NCT03854370|584583917|FG002|Overall Study|samples not collected|1|||
161874419|NCT03854370|584583918|FG003|Overall Study|samples not collected|1|||
161874420|NCT02656290|584583921|FG000|Overall Study|Lost to Follow-up|1|||
161874421|NCT02656290|584583921|FG000|Overall Study|Reintervention|3|||
161874422|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
161874423|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
161874424|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
161874425|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
161874426|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
161874427|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
161874428|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
161874429|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
161874430|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Death|0|||
161874431|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Death|1|||
161874432|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
161874433|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
161874434|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
161874435|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
161874436|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
161874437|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
161874438|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
161874439|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
161874440|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
161874441|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
161874442|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Non compliance|0|||
161874443|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Non compliance|1|||
161874444|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
161874445|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
161874446|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
161874447|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
161874448|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
161874449|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
161874450|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
161874451|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
161874452|NCT03692325|584583924|FG000|Overall Study|Adverse Event|2|||
161874453|NCT03692325|584583924|FG000|Overall Study|Progression/Recurrence|2|||
161874454|NCT02817516|584583925|FG000|Overall Study|Other|0|||
161874455|NCT02817516|584583926|FG001|Overall Study|Other|0|||
161874456|NCT02817516|584583927|FG002|Overall Study|Other|1|||
161874457|NCT02817516|584583928|FG003|Overall Study|Other|0|||
161874458|NCT00610155|584583932|FG000|Period 1|Withdrawal by Subject|0|||
161874459|NCT00610155|584583933|FG001|Period 1|Withdrawal by Subject|0|||
161874460|NCT00610155|584583934|FG002|Period 1|Withdrawal by Subject|1|||
161874461|NCT00610155|584583935|FG003|Period 1|Withdrawal by Subject|0|||
161874462|NCT00610155|584583936|FG004|Period 1|Withdrawal by Subject|0|||
161874463|NCT00610155|584583937|FG005|Period 1|Withdrawal by Subject|0|||
161874464|NCT00610155|584583932|FG000|Period 3|Adverse Event|1|||
161874465|NCT00610155|584583933|FG001|Period 3|Adverse Event|0|||
161874466|NCT00610155|584583934|FG002|Period 3|Adverse Event|0|||
161874467|NCT00610155|584583935|FG003|Period 3|Adverse Event|0|||
161874468|NCT00610155|584583936|FG004|Period 3|Adverse Event|0|||
161874469|NCT00610155|584583937|FG005|Period 3|Adverse Event|0|||
161874470|NCT01560234|584583938|FG000|Overall Study|Lost to Follow-up|3|||
161874471|NCT01560234|584583939|FG001|Overall Study|Lost to Follow-up|0|||
161874472|NCT01560234|584583940|FG002|Overall Study|Lost to Follow-up|1|||
161874473|NCT01560234|584583941|FG003|Overall Study|Lost to Follow-up|0|||
161874474|NCT01560234|584583942|FG004|Overall Study|Lost to Follow-up|0|||
161874475|NCT01560234|584583943|FG005|Overall Study|Lost to Follow-up|2|||
161874476|NCT01560234|584583944|FG006|Overall Study|Lost to Follow-up|0|||
161874477|NCT01560234|584583945|FG007|Overall Study|Lost to Follow-up|2|||
161874478|NCT00083759|584583949|FG000|Overall Study|Adverse Event|5|||
161874479|NCT00083759|584583950|FG001|Overall Study|Adverse Event|3|||
161874480|NCT00083759|584583949|FG000|Overall Study|Lost to Follow-up|1|||
161874481|NCT00083759|584583950|FG001|Overall Study|Lost to Follow-up|0|||
161874482|NCT00083759|584583949|FG000|Overall Study|Death|1|||
161874483|NCT00083759|584583950|FG001|Overall Study|Death|1|||
161874484|NCT00083759|584583949|FG000|Overall Study|Inadequate Therapeutic Response|32|||
161874485|NCT00083759|584583950|FG001|Overall Study|Inadequate Therapeutic Response|35|||
161874486|NCT00083759|584583949|FG000|Overall Study|Subject Withdrew Consent|2|||
161874487|NCT00083759|584583950|FG001|Overall Study|Subject Withdrew Consent|2|||
161874488|NCT00083759|584583949|FG000|Overall Study|Non-Compliance|1|||
161874489|NCT00083759|584583950|FG001|Overall Study|Non-Compliance|0|||
161874490|NCT00083759|584583949|FG000|Overall Study|Sponsor's Discretion|28|||
161874491|NCT00083759|584583950|FG001|Overall Study|Sponsor's Discretion|29|||
161874492|NCT00083759|584583949|FG000|Overall Study|Other|14|||
161874493|NCT00083759|584583950|FG001|Overall Study|Other|13|||
161874494|NCT04292912|584583955|FG000|Overall Study|Physician Decision|1|||
161874495|NCT04292912|584583955|FG000|Overall Study|Protocol Violation|6|||
161874496|NCT03348930|584583956|FG000|Washout (1 Week)|Lost to Follow-up|1|||
161874497|NCT03348930|584583957|FG001|Washout (1 Week)|Lost to Follow-up|1|||
161874498|NCT01290679|584583965|FG000|Overall Study|Adverse Event|2|||
161874499|NCT01290679|584583966|FG001|Overall Study|Adverse Event|0|||
161874500|NCT01290679|584583965|FG000|Overall Study|Lost to Follow-up|8|||
161874501|NCT01290679|584583966|FG001|Overall Study|Lost to Follow-up|10|||
161874502|NCT01290679|584583965|FG000|Overall Study|Protocol Violation|0|||
161874503|NCT01290679|584583966|FG001|Overall Study|Protocol Violation|1|||
161874504|NCT01290679|584583965|FG000|Overall Study|Withdrawal by Subject|6|||
161874505|NCT01290679|584583966|FG001|Overall Study|Withdrawal by Subject|5|||
161874506|NCT01290679|584583965|FG000|Overall Study|Subject Entered Another Trial|0|||
161874507|NCT01290679|584583966|FG001|Overall Study|Subject Entered Another Trial|5|||
161874508|NCT01598090|584583967|FG000|Treatment Period|Poor/non-compliance|0|||
161874509|NCT01598090|584583968|FG001|Treatment Period|Poor/non-compliance|2|||
161874510|NCT01598090|584583969|FG002|Treatment Period|Poor/non-compliance|0|||
161874511|NCT01598090|584583967|FG000|Treatment Period|No longer meet study criteria|0|||
161874512|NCT01598090|584583968|FG001|Treatment Period|No longer meet study criteria|1|||
161874513|NCT01598090|584583969|FG002|Treatment Period|No longer meet study criteria|0|||
161874514|NCT01598090|584583967|FG000|Treatment Period|Lack of Efficacy|5|||
161874515|NCT01598090|584583968|FG001|Treatment Period|Lack of Efficacy|14|||
161874516|NCT01598090|584583969|FG002|Treatment Period|Lack of Efficacy|6|||
161874517|NCT01598090|584583967|FG000|Treatment Period|Adverse Event|2|||
161874518|NCT01598090|584583968|FG001|Treatment Period|Adverse Event|33|||
161874519|NCT01598090|584583969|FG002|Treatment Period|Adverse Event|17|||
161874520|NCT01598090|584583967|FG000|Treatment Period|Other reasons|0|||
161874521|NCT01598090|584583968|FG001|Treatment Period|Other reasons|4|||
161874522|NCT01598090|584583969|FG002|Treatment Period|Other reasons|1|||
161874523|NCT01598090|584583967|FG000|Treatment Period|Withdrawal by Subject|3|||
161874524|NCT01598090|584583968|FG001|Treatment Period|Withdrawal by Subject|13|||
161874525|NCT01598090|584583969|FG002|Treatment Period|Withdrawal by Subject|10|||
161874526|NCT01598090|584583967|FG000|Treatment Period|Lost to Follow-up|1|||
161874527|NCT01598090|584583968|FG001|Treatment Period|Lost to Follow-up|5|||
161874528|NCT01598090|584583969|FG002|Treatment Period|Lost to Follow-up|1|||
161874529|NCT01598090|584583967|FG000|Follow-up Period|Death|0|||
161874530|NCT01598090|584583968|FG001|Follow-up Period|Death|1|||
161874531|NCT01598090|584583969|FG002|Follow-up Period|Death|0|||
161874532|NCT01598090|584583967|FG000|Follow-up Period|No longer required per protocol|1|||
161874533|NCT01598090|584583968|FG001|Follow-up Period|No longer required per protocol|3|||
161874534|NCT01598090|584583969|FG002|Follow-up Period|No longer required per protocol|2|||
161874535|NCT01598090|584583967|FG000|Follow-up Period|Not reported|0|||
161874536|NCT01598090|584583968|FG001|Follow-up Period|Not reported|10|||
161874537|NCT01598090|584583969|FG002|Follow-up Period|Not reported|4|||
161874538|NCT01598090|584583967|FG000|Follow-up Period|Withdrawal by Subject|0|||
161874539|NCT01598090|584583968|FG001|Follow-up Period|Withdrawal by Subject|3|||
161874540|NCT01598090|584583969|FG002|Follow-up Period|Withdrawal by Subject|2|||
161874541|NCT01598090|584583967|FG000|Follow-up Period|Other reasons|2|||
161874542|NCT01598090|584583968|FG001|Follow-up Period|Other reasons|8|||
161874543|NCT01598090|584583969|FG002|Follow-up Period|Other reasons|8|||
161874544|NCT01598090|584583967|FG000|Follow-up Period|Lost to Follow-up|2|||
161874545|NCT01598090|584583968|FG001|Follow-up Period|Lost to Follow-up|10|||
161874546|NCT01598090|584583969|FG002|Follow-up Period|Lost to Follow-up|12|||
161874547|NCT00355147|584583974|FG000|Overall Study|Lost to Follow-up|10|||
161874548|NCT00355147|584583975|FG001|Overall Study|Lost to Follow-up|8|||
161874549|NCT00355147|584583974|FG000|Overall Study|Withdrawal by Subject|8|||
161874550|NCT00355147|584583975|FG001|Overall Study|Withdrawal by Subject|12|||
161874551|NCT03557931|584583982|FG000|Overall Study|Adverse Event|4|||
161874552|NCT03557931|584583983|FG001|Overall Study|Adverse Event|6|||
161874553|NCT03557931|584583984|FG002|Overall Study|Adverse Event|1|||
161874554|NCT03557931|584583982|FG000|Overall Study|Lost to Follow-up|4|||
161874555|NCT03557931|584583983|FG001|Overall Study|Lost to Follow-up|4|||
161874556|NCT03557931|584583984|FG002|Overall Study|Lost to Follow-up|1|||
161874557|NCT03557931|584583982|FG000|Overall Study|Protocol Violation|1|||
161874558|NCT03557931|584583983|FG001|Overall Study|Protocol Violation|4|||
161874559|NCT03557931|584583984|FG002|Overall Study|Protocol Violation|1|||
161874560|NCT03557931|584583982|FG000|Overall Study|Withdrawal by Subject|14|||
161874561|NCT03557931|584583983|FG001|Overall Study|Withdrawal by Subject|0|||
161874562|NCT03557931|584583984|FG002|Overall Study|Withdrawal by Subject|7|||
161874563|NCT03557931|584583982|FG000|Overall Study|Miscellaneous|8|||
161874564|NCT03557931|584583983|FG001|Overall Study|Miscellaneous|5|||
161874565|NCT03557931|584583984|FG002|Overall Study|Miscellaneous|3|||
161874566|NCT02394340|584583987|FG000|Overall Study|Failed drug screen test|1|||
161874567|NCT02394340|584583987|FG000|Overall Study|Adverse Event|1|||
161874568|NCT03605862|584583988|FG000|Overall Study|Withdrawal by Subject|12|||
161874569|NCT03605862|584583989|FG001|Overall Study|Withdrawal by Subject|9|||
161874570|NCT03605862|584583988|FG000|Overall Study|Adverse Event|2|||
161874571|NCT03605862|584583989|FG001|Overall Study|Adverse Event|1|||
161874572|NCT03605862|584583988|FG000|Overall Study|Physician Decision|3|||
161874573|NCT03605862|584583989|FG001|Overall Study|Physician Decision|1|||
161874574|NCT03605862|584583988|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
161874575|NCT03605862|584583989|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
161874576|NCT00675428|584583992|FG000|Overall Study|Disease Progression|2|||
161874577|NCT00675428|584583993|FG001|Overall Study|Disease Progression|2|||
161874578|NCT00675428|584583992|FG000|Overall Study|No Disease Response After Cycle 6|0|||
161874579|NCT00675428|584583993|FG001|Overall Study|No Disease Response After Cycle 6|1|||
161874580|NCT00675428|584583992|FG000|Overall Study|Physician Decision|1|||
161874581|NCT00675428|584583993|FG001|Overall Study|Physician Decision|0|||
161874582|NCT00886743|584583995|FG000|Overall Study|Adverse Event|3|||
161874583|NCT00886743|584583995|FG000|Overall Study|Other|1|||
161874584|NCT00478777|584583996|FG000|Overall Study|Adverse Event|29|||
161874585|NCT00478777|584583996|FG000|Overall Study|Lack of Efficacy|23|||
161874586|NCT00478777|584583996|FG000|Overall Study|Withdrawal by Subject|4|||
161874587|NCT00478777|584583996|FG000|Overall Study|Death|3|||
161874588|NCT00478777|584583996|FG000|Overall Study|Protocol Violation|3|||
161874589|NCT00478777|584583996|FG000|Overall Study|Lost to Follow-up|3|||
161874590|NCT00478777|584583996|FG000|Overall Study|Physician Decision|1|||
161874591|NCT00478777|584583996|FG000|Overall Study|Intolerance of therapy|1|||
161874592|NCT00478777|584583996|FG000|Overall Study|Lack of compliance|1|||
161874593|NCT00478777|584583996|FG000|Overall Study|Lymphocytes infusion|1|||
161874594|NCT00478777|584583996|FG000|Overall Study|End of therapy|2|||
161874595|NCT00478777|584583996|FG000|Overall Study|Not treated with lenalidomide|6|||
161874596|NCT01582178|584583999|FG000|Overall Study|Physician Decision|6|||
161874597|NCT01582178|584584000|FG001|Overall Study|Physician Decision|5|||
161874598|NCT01323387|584584001|FG000|Overall Study|Withdrawal by Subject|41|||
161874599|NCT01323387|584584001|FG000|Overall Study|Radiographic Data Unavailable|1|||
161874600|NCT01323387|584584001|FG000|Overall Study|Revision|14|||
161874601|NCT01323387|584584001|FG000|Overall Study|Protocol Violation|12|||
161874602|NCT01323387|584584001|FG000|Overall Study|Randomized but Never Treated|16|||
161874603|NCT01726270|584584002|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
161874604|NCT01726270|584584002|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
161874605|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
161874606|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
161874607|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
161874608|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
161874609|NCT02157376|584584005|FG000|Overall Study|Death|10|||
161874610|NCT02157376|584584006|FG001|Overall Study|Death|4|||
161874611|NCT02157376|584584005|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161874612|NCT02157376|584584006|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161874613|NCT02157376|584584005|FG000|Overall Study|Withdrawal by Subject|3|||
161776176|NCT00577031|584223129|FG000|Overall Study|Death|6|||
161776177|NCT00557830|584223130|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
161776178|NCT00557830|584223131|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
161776179|NCT00557830|584223132|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
161776180|NCT00557830|584223130|FG000|Screening Treatment Phase|Adverse Event|2|||
161776181|NCT00557830|584223131|FG001|Screening Treatment Phase|Adverse Event|0|||
161776182|NCT00557830|584223132|FG002|Screening Treatment Phase|Adverse Event|0|||
161776183|NCT00557830|584223130|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
161776184|NCT00557830|584223131|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
161776185|NCT00557830|584223132|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
161776186|NCT00538473|584223134|FG000|Overall Study|Adverse Event|1|||
161776187|NCT00538473|584223135|FG001|Overall Study|Adverse Event|0|||
161776188|NCT01569074|584223136|FG000|Overall Study|Study stopped|6|||
161776189|NCT01569074|584223137|FG001|Overall Study|Study stopped|6|||
161776190|NCT01569074|584223138|FG002|Overall Study|Study stopped|8|||
161776191|NCT01569074|584223139|FG003|Overall Study|Study stopped|7|||
161874614|NCT02157376|584584006|FG001|Overall Study|Withdrawal by Subject|8|||
161874615|NCT02157376|584584005|FG000|Overall Study|Not treated|8|||
161874616|NCT02157376|584584006|FG001|Overall Study|Not treated|3|||
161874617|NCT02157376|584584005|FG000|Overall Study|Investigator's misjudgement|1|||
161874618|NCT02157376|584584006|FG001|Overall Study|Investigator's misjudgement|2|||
161874619|NCT04200651|584584007|FG000|Overall Study|Moved to another country during follow-up|2|||
161874620|NCT04200651|584584008|FG001|Overall Study|Moved to another country during follow-up|2|||
161874621|NCT04200651|584584007|FG000|Overall Study|Lost to Follow-up|1|||
161874622|NCT04200651|584584008|FG001|Overall Study|Lost to Follow-up|3|||
161874623|NCT01031680|584584009|FG000|Overall Study|Adverse Event|8|||
161874624|NCT01031680|584584010|FG001|Overall Study|Adverse Event|3|||
161874625|NCT01031680|584584009|FG000|Overall Study|Lost to Follow-up|2|||
161874626|NCT01031680|584584010|FG001|Overall Study|Lost to Follow-up|10|||
161874627|NCT01031680|584584009|FG000|Overall Study|Withdrawal by Subject|12|||
161874628|NCT01031680|584584010|FG001|Overall Study|Withdrawal by Subject|16|||
161874629|NCT01031680|584584009|FG000|Overall Study|Death|2|||
161874630|NCT01031680|584584010|FG001|Overall Study|Death|1|||
161874631|NCT01031680|584584009|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
161874632|NCT01031680|584584010|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
161874633|NCT01031680|584584009|FG000|Overall Study|Poor/Non-compliance|5|||
161874634|NCT01031680|584584010|FG001|Overall Study|Poor/Non-compliance|6|||
161874635|NCT01031680|584584009|FG000|Overall Study|Safety|1|||
161874636|NCT01031680|584584010|FG001|Overall Study|Safety|0|||
161874637|NCT01031680|584584009|FG000|Overall Study|Incorrect Enrolment|1|||
161874638|NCT01031680|584584010|FG001|Overall Study|Incorrect Enrolment|2|||
161874639|NCT01031680|584584009|FG000|Overall Study|Administrative Reason by Sponsor|0|||
161874640|NCT01031680|584584010|FG001|Overall Study|Administrative Reason by Sponsor|1|||
161874641|NCT01031680|584584009|FG000|Overall Study|Various|0|||
161874642|NCT01031680|584584010|FG001|Overall Study|Various|2|||
161874643|NCT01186692|584584017|FG000|Overall Study|Not Catheterized|11|||
161874644|NCT01186692|584584017|FG000|Overall Study|Futher testing contraindicated implant|19|||
161874645|NCT01186692|584584017|FG000|Overall Study|Adverse Event|2|||
161874646|NCT03319732|584584018|FG000|Overall Study|Adverse Event|40|||
161874647|NCT03319732|584584018|FG000|Overall Study|Withdrawal by Subject|50|||
161874648|NCT03319732|584584018|FG000|Overall Study|MS relapse|10|||
161874649|NCT03319732|584584018|FG000|Overall Study|reason not specified|5|||
161874650|NCT01921101|584584020|FG000|Overall Study|Death|16|||
161874651|NCT01921101|584584021|FG001|Overall Study|Death|6|||
161874652|NCT00596817|584584023|FG000|Open-label Period|Adverse Event|0|||
161874653|NCT00596817|584584024|FG001|Open-label Period|Adverse Event|49|||
161874654|NCT00596817|584584023|FG000|Open-label Period|Lack of Efficacy|0|||
161874655|NCT00596817|584584024|FG001|Open-label Period|Lack of Efficacy|33|||
161874656|NCT00596817|584584023|FG000|Open-label Period|Other Reasons|0|||
161874657|NCT00596817|584584024|FG001|Open-label Period|Other Reasons|65|||
161874658|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
161874659|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
161874660|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
161874661|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
161874662|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
161874663|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
161874664|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
161874665|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
161874666|NCT00596817|584584023|FG000|Double-blind Period|Adverse Event|5|||
161874667|NCT00596817|584584024|FG001|Double-blind Period|Adverse Event|16|||
161874668|NCT00596817|584584023|FG000|Double-blind Period|Lack of Efficacy|52|||
161874669|NCT00596817|584584024|FG001|Double-blind Period|Lack of Efficacy|28|||
161874670|NCT00596817|584584023|FG000|Double-blind Period|Non-compliance With Study Product|3|||
161874671|NCT00596817|584584024|FG001|Double-blind Period|Non-compliance With Study Product|4|||
161874672|NCT00596817|584584023|FG000|Double-blind Period|Protocol Violation|11|||
161874673|NCT00596817|584584024|FG001|Double-blind Period|Protocol Violation|8|||
161874674|NCT00596817|584584023|FG000|Double-blind Period|Withdrawal of Consent|7|||
161874675|NCT00596817|584584024|FG001|Double-blind Period|Withdrawal of Consent|3|||
161874676|NCT00596817|584584023|FG000|Double-blind Period|Lost to Follow-up|0|||
161874677|NCT00596817|584584024|FG001|Double-blind Period|Lost to Follow-up|2|||
161874678|NCT00596817|584584023|FG000|Double-blind Period|Other Reasons|10|||
161874679|NCT00596817|584584024|FG001|Double-blind Period|Other Reasons|18|||
161874680|NCT01314872|584584030|FG000|Treatment Period 1|Protocol Violation|2|||
161874681|NCT01314872|584584031|FG001|Treatment Period 1|Protocol Violation|1|||
161874682|NCT01314872|584584032|FG002|Treatment Period 1|Protocol Violation|1|||
161874683|NCT01314872|584584033|FG003|Treatment Period 1|Protocol Violation|0|||
161874684|NCT01314872|584584034|FG004|Treatment Period 1|Protocol Violation|1|||
161874685|NCT01314872|584584035|FG005|Treatment Period 1|Protocol Violation|0|||
161874686|NCT01314872|584584036|FG006|Treatment Period 1|Protocol Violation|0|||
161874687|NCT01314872|584584037|FG007|Treatment Period 1|Protocol Violation|0|||
161874688|NCT01314872|584584038|FG008|Treatment Period 1|Protocol Violation|0|||
161874689|NCT01314872|584584039|FG009|Treatment Period 1|Protocol Violation|1|||
161874690|NCT01314872|584584040|FG010|Treatment Period 1|Protocol Violation|1|||
161874691|NCT01314872|584584041|FG011|Treatment Period 1|Protocol Violation|0|||
161874692|NCT01314872|584584042|FG012|Treatment Period 1|Protocol Violation|0|||
161874693|NCT01314872|584584043|FG013|Treatment Period 1|Protocol Violation|0|||
161874694|NCT01314872|584584044|FG014|Treatment Period 1|Protocol Violation|0|||
161874695|NCT01314872|584584030|FG000|Treatment Period 1|Physician Decision|0|||
161874696|NCT01314872|584584031|FG001|Treatment Period 1|Physician Decision|1|||
161874697|NCT01314872|584584032|FG002|Treatment Period 1|Physician Decision|0|||
161874698|NCT01314872|584584033|FG003|Treatment Period 1|Physician Decision|1|||
161874699|NCT01314872|584584034|FG004|Treatment Period 1|Physician Decision|0|||
161874700|NCT01314872|584584035|FG005|Treatment Period 1|Physician Decision|0|||
161874701|NCT01314872|584584036|FG006|Treatment Period 1|Physician Decision|0|||
161874702|NCT01314872|584584037|FG007|Treatment Period 1|Physician Decision|0|||
161874703|NCT01314872|584584038|FG008|Treatment Period 1|Physician Decision|0|||
161874704|NCT01314872|584584039|FG009|Treatment Period 1|Physician Decision|1|||
161874705|NCT01314872|584584040|FG010|Treatment Period 1|Physician Decision|0|||
161874706|NCT01314872|584584041|FG011|Treatment Period 1|Physician Decision|0|||
161874707|NCT01314872|584584042|FG012|Treatment Period 1|Physician Decision|0|||
161874708|NCT01314872|584584043|FG013|Treatment Period 1|Physician Decision|0|||
161874709|NCT01314872|584584044|FG014|Treatment Period 1|Physician Decision|0|||
161874710|NCT01314872|584584030|FG000|Treatment Period 1|Lack of Efficacy|1|||
161874711|NCT01314872|584584031|FG001|Treatment Period 1|Lack of Efficacy|0|||
161874712|NCT01314872|584584032|FG002|Treatment Period 1|Lack of Efficacy|0|||
161874713|NCT01314872|584584033|FG003|Treatment Period 1|Lack of Efficacy|0|||
161874714|NCT01314872|584584034|FG004|Treatment Period 1|Lack of Efficacy|0|||
161874715|NCT01314872|584584035|FG005|Treatment Period 1|Lack of Efficacy|1|||
161874716|NCT01314872|584584036|FG006|Treatment Period 1|Lack of Efficacy|0|||
161874717|NCT01314872|584584037|FG007|Treatment Period 1|Lack of Efficacy|2|||
161874718|NCT01314872|584584038|FG008|Treatment Period 1|Lack of Efficacy|0|||
161874719|NCT01314872|584584039|FG009|Treatment Period 1|Lack of Efficacy|0|||
161874720|NCT01314872|584584040|FG010|Treatment Period 1|Lack of Efficacy|0|||
161874721|NCT01314872|584584041|FG011|Treatment Period 1|Lack of Efficacy|0|||
161874722|NCT01314872|584584042|FG012|Treatment Period 1|Lack of Efficacy|0|||
161874723|NCT01314872|584584043|FG013|Treatment Period 1|Lack of Efficacy|0|||
161874724|NCT01314872|584584044|FG014|Treatment Period 1|Lack of Efficacy|0|||
161874725|NCT01314872|584584030|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
161874726|NCT01314872|584584031|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
161874727|NCT01314872|584584032|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
161874728|NCT01314872|584584033|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
161874729|NCT01314872|584584034|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
161874730|NCT01314872|584584035|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
161874731|NCT01314872|584584036|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
161874732|NCT01314872|584584037|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
161874733|NCT01314872|584584038|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
161874734|NCT01314872|584584039|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
161874735|NCT01314872|584584040|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
161874736|NCT01314872|584584041|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
161874737|NCT01314872|584584042|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
161874738|NCT01314872|584584043|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
161874739|NCT01314872|584584044|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
161874740|NCT01314872|584584030|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161874741|NCT01314872|584584031|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161874742|NCT01314872|584584032|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161874743|NCT01314872|584584033|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161874744|NCT01314872|584584034|FG004|Treatment Period 1|Withdrawal by Subject|3|||
161874745|NCT01314872|584584035|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161874746|NCT01314872|584584036|FG006|Treatment Period 1|Withdrawal by Subject|3|||
161874747|NCT01314872|584584037|FG007|Treatment Period 1|Withdrawal by Subject|2|||
161874748|NCT01314872|584584038|FG008|Treatment Period 1|Withdrawal by Subject|2|||
161874749|NCT01314872|584584039|FG009|Treatment Period 1|Withdrawal by Subject|2|||
161874750|NCT01314872|584584040|FG010|Treatment Period 1|Withdrawal by Subject|1|||
161874751|NCT01314872|584584041|FG011|Treatment Period 1|Withdrawal by Subject|0|||
161874752|NCT01314872|584584042|FG012|Treatment Period 1|Withdrawal by Subject|0|||
161874753|NCT01314872|584584043|FG013|Treatment Period 1|Withdrawal by Subject|0|||
161874754|NCT01314872|584584044|FG014|Treatment Period 1|Withdrawal by Subject|0|||
161874755|NCT01314872|584584030|FG000|Treatment Period 1|Lost to Follow-up|0|||
161874756|NCT01314872|584584031|FG001|Treatment Period 1|Lost to Follow-up|1|||
161874757|NCT01314872|584584032|FG002|Treatment Period 1|Lost to Follow-up|2|||
161874758|NCT01314872|584584033|FG003|Treatment Period 1|Lost to Follow-up|2|||
161874759|NCT01314872|584584034|FG004|Treatment Period 1|Lost to Follow-up|1|||
161874760|NCT01314872|584584035|FG005|Treatment Period 1|Lost to Follow-up|1|||
161874761|NCT01314872|584584036|FG006|Treatment Period 1|Lost to Follow-up|1|||
161874762|NCT01314872|584584037|FG007|Treatment Period 1|Lost to Follow-up|1|||
161874763|NCT01314872|584584038|FG008|Treatment Period 1|Lost to Follow-up|1|||
161874764|NCT01314872|584584039|FG009|Treatment Period 1|Lost to Follow-up|0|||
161874765|NCT01314872|584584040|FG010|Treatment Period 1|Lost to Follow-up|0|||
161874766|NCT01314872|584584041|FG011|Treatment Period 1|Lost to Follow-up|0|||
161874767|NCT01314872|584584042|FG012|Treatment Period 1|Lost to Follow-up|0|||
161874768|NCT01314872|584584043|FG013|Treatment Period 1|Lost to Follow-up|0|||
161874769|NCT01314872|584584044|FG014|Treatment Period 1|Lost to Follow-up|0|||
161874770|NCT01314872|584584030|FG000|Period 2|Protocol Violation|0|||
161874771|NCT01314872|584584031|FG001|Period 2|Protocol Violation|0|||
161874772|NCT01314872|584584032|FG002|Period 2|Protocol Violation|0|||
161874773|NCT01314872|584584033|FG003|Period 2|Protocol Violation|0|||
161874774|NCT01314872|584584034|FG004|Period 2|Protocol Violation|0|||
161874775|NCT01314872|584584035|FG005|Period 2|Protocol Violation|0|||
161874776|NCT01314872|584584036|FG006|Period 2|Protocol Violation|0|||
161874777|NCT01314872|584584037|FG007|Period 2|Protocol Violation|0|||
161874778|NCT01314872|584584038|FG008|Period 2|Protocol Violation|0|||
161874779|NCT01314872|584584039|FG009|Period 2|Protocol Violation|0|||
161874780|NCT01314872|584584040|FG010|Period 2|Protocol Violation|0|||
161874781|NCT01314872|584584041|FG011|Period 2|Protocol Violation|3|||
161874782|NCT01314872|584584042|FG012|Period 2|Protocol Violation|3|||
161874783|NCT01314872|584584043|FG013|Period 2|Protocol Violation|2|||
161874784|NCT01314872|584584044|FG014|Period 2|Protocol Violation|0|||
161874785|NCT01314872|584584030|FG000|Period 2|Non-compliance with study drug|0|||
161874786|NCT01314872|584584031|FG001|Period 2|Non-compliance with study drug|0|||
161874787|NCT01314872|584584032|FG002|Period 2|Non-compliance with study drug|0|||
161874788|NCT01314872|584584033|FG003|Period 2|Non-compliance with study drug|0|||
161874789|NCT01314872|584584034|FG004|Period 2|Non-compliance with study drug|0|||
161874790|NCT01314872|584584035|FG005|Period 2|Non-compliance with study drug|0|||
161874791|NCT01314872|584584036|FG006|Period 2|Non-compliance with study drug|0|||
161874792|NCT01314872|584584037|FG007|Period 2|Non-compliance with study drug|0|||
161874793|NCT01314872|584584038|FG008|Period 2|Non-compliance with study drug|0|||
161874794|NCT01314872|584584039|FG009|Period 2|Non-compliance with study drug|0|||
161874795|NCT01314872|584584040|FG010|Period 2|Non-compliance with study drug|0|||
161874796|NCT01314872|584584041|FG011|Period 2|Non-compliance with study drug|3|||
161874797|NCT01314872|584584042|FG012|Period 2|Non-compliance with study drug|3|||
161874798|NCT01314872|584584043|FG013|Period 2|Non-compliance with study drug|1|||
161874799|NCT01314872|584584044|FG014|Period 2|Non-compliance with study drug|2|||
161874800|NCT01314872|584584030|FG000|Period 2|Lack of Efficacy|0|||
161874801|NCT01314872|584584031|FG001|Period 2|Lack of Efficacy|0|||
161874802|NCT01314872|584584032|FG002|Period 2|Lack of Efficacy|0|||
161874803|NCT01314872|584584033|FG003|Period 2|Lack of Efficacy|0|||
161874804|NCT01314872|584584034|FG004|Period 2|Lack of Efficacy|0|||
161874805|NCT01314872|584584035|FG005|Period 2|Lack of Efficacy|0|||
161874806|NCT01314872|584584036|FG006|Period 2|Lack of Efficacy|0|||
161874807|NCT01314872|584584037|FG007|Period 2|Lack of Efficacy|0|||
161874808|NCT01314872|584584038|FG008|Period 2|Lack of Efficacy|0|||
161874809|NCT01314872|584584039|FG009|Period 2|Lack of Efficacy|0|||
161874810|NCT01314872|584584040|FG010|Period 2|Lack of Efficacy|0|||
161874811|NCT01314872|584584041|FG011|Period 2|Lack of Efficacy|7|||
161874812|NCT01314872|584584042|FG012|Period 2|Lack of Efficacy|12|||
161874813|NCT01314872|584584043|FG013|Period 2|Lack of Efficacy|9|||
161874814|NCT01314872|584584044|FG014|Period 2|Lack of Efficacy|2|||
161874815|NCT01314872|584584030|FG000|Period 2|Pregnancy|0|||
161874816|NCT01314872|584584031|FG001|Period 2|Pregnancy|0|||
161874817|NCT01314872|584584032|FG002|Period 2|Pregnancy|0|||
161874818|NCT01314872|584584033|FG003|Period 2|Pregnancy|0|||
161874819|NCT01314872|584584034|FG004|Period 2|Pregnancy|0|||
161874820|NCT01314872|584584035|FG005|Period 2|Pregnancy|0|||
161874821|NCT01314872|584584036|FG006|Period 2|Pregnancy|0|||
161874822|NCT01314872|584584037|FG007|Period 2|Pregnancy|0|||
161874823|NCT01314872|584584038|FG008|Period 2|Pregnancy|0|||
161874824|NCT01314872|584584039|FG009|Period 2|Pregnancy|0|||
161874825|NCT01314872|584584040|FG010|Period 2|Pregnancy|0|||
161874826|NCT01314872|584584041|FG011|Period 2|Pregnancy|0|||
161874827|NCT01314872|584584042|FG012|Period 2|Pregnancy|0|||
161874828|NCT01314872|584584043|FG013|Period 2|Pregnancy|0|||
161874829|NCT01314872|584584044|FG014|Period 2|Pregnancy|1|||
161874830|NCT01314872|584584030|FG000|Period 2|Study terminated by Sponsor|0|||
161874831|NCT01314872|584584031|FG001|Period 2|Study terminated by Sponsor|0|||
161874832|NCT01314872|584584032|FG002|Period 2|Study terminated by Sponsor|0|||
161874833|NCT01314872|584584033|FG003|Period 2|Study terminated by Sponsor|0|||
161874834|NCT01314872|584584034|FG004|Period 2|Study terminated by Sponsor|0|||
161874835|NCT01314872|584584035|FG005|Period 2|Study terminated by Sponsor|0|||
161874836|NCT01314872|584584036|FG006|Period 2|Study terminated by Sponsor|0|||
161874837|NCT01314872|584584037|FG007|Period 2|Study terminated by Sponsor|0|||
161874838|NCT01314872|584584038|FG008|Period 2|Study terminated by Sponsor|0|||
161776192|NCT01569074|584223140|FG004|Overall Study|Study stopped|7|||
161776193|NCT01569074|584223136|FG000|Overall Study|Study-specific discontinuation criteria|0|||
161776194|NCT01569074|584223137|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161776195|NCT01569074|584223138|FG002|Overall Study|Study-specific discontinuation criteria|0|||
161776196|NCT01569074|584223139|FG003|Overall Study|Study-specific discontinuation criteria|0|||
161776197|NCT01569074|584223140|FG004|Overall Study|Study-specific discontinuation criteria|0|||
161776198|NCT01569074|584223136|FG000|Overall Study|Severe non-compliance to protocol|0|||
161776199|NCT01569074|584223137|FG001|Overall Study|Severe non-compliance to protocol|0|||
161874839|NCT01314872|584584039|FG009|Period 2|Study terminated by Sponsor|0|||
161874840|NCT01314872|584584040|FG010|Period 2|Study terminated by Sponsor|0|||
161874841|NCT01314872|584584041|FG011|Period 2|Study terminated by Sponsor|2|||
161874842|NCT01314872|584584042|FG012|Period 2|Study terminated by Sponsor|2|||
161874843|NCT01314872|584584043|FG013|Period 2|Study terminated by Sponsor|3|||
161874844|NCT01314872|584584044|FG014|Period 2|Study terminated by Sponsor|0|||
161874845|NCT01314872|584584030|FG000|Period 2|Adverse event, non-fatal|0|||
161874846|NCT01314872|584584031|FG001|Period 2|Adverse event, non-fatal|0|||
161874847|NCT01314872|584584032|FG002|Period 2|Adverse event, non-fatal|0|||
161874848|NCT01314872|584584033|FG003|Period 2|Adverse event, non-fatal|0|||
161874849|NCT01314872|584584034|FG004|Period 2|Adverse event, non-fatal|0|||
161874850|NCT01314872|584584035|FG005|Period 2|Adverse event, non-fatal|0|||
161874851|NCT01314872|584584036|FG006|Period 2|Adverse event, non-fatal|0|||
161874852|NCT01314872|584584037|FG007|Period 2|Adverse event, non-fatal|0|||
161874853|NCT01314872|584584038|FG008|Period 2|Adverse event, non-fatal|0|||
161874854|NCT01314872|584584039|FG009|Period 2|Adverse event, non-fatal|0|||
161874855|NCT01314872|584584040|FG010|Period 2|Adverse event, non-fatal|0|||
161874856|NCT01314872|584584041|FG011|Period 2|Adverse event, non-fatal|13|||
161874857|NCT01314872|584584042|FG012|Period 2|Adverse event, non-fatal|16|||
161874858|NCT01314872|584584043|FG013|Period 2|Adverse event, non-fatal|24|||
161874859|NCT01314872|584584044|FG014|Period 2|Adverse event, non-fatal|9|||
161874860|NCT01314872|584584030|FG000|Period 2|Withdrawal by Subject|0|||
161874861|NCT01314872|584584031|FG001|Period 2|Withdrawal by Subject|0|||
161874862|NCT01314872|584584032|FG002|Period 2|Withdrawal by Subject|0|||
161874863|NCT01314872|584584033|FG003|Period 2|Withdrawal by Subject|0|||
161874864|NCT01314872|584584034|FG004|Period 2|Withdrawal by Subject|0|||
161874865|NCT01314872|584584035|FG005|Period 2|Withdrawal by Subject|0|||
161874866|NCT01314872|584584036|FG006|Period 2|Withdrawal by Subject|0|||
161874867|NCT01314872|584584037|FG007|Period 2|Withdrawal by Subject|0|||
161874868|NCT01314872|584584038|FG008|Period 2|Withdrawal by Subject|0|||
161874869|NCT01314872|584584039|FG009|Period 2|Withdrawal by Subject|0|||
161874870|NCT01314872|584584040|FG010|Period 2|Withdrawal by Subject|0|||
161874871|NCT01314872|584584041|FG011|Period 2|Withdrawal by Subject|14|||
161874872|NCT01314872|584584042|FG012|Period 2|Withdrawal by Subject|17|||
161874873|NCT01314872|584584043|FG013|Period 2|Withdrawal by Subject|12|||
161874874|NCT01314872|584584044|FG014|Period 2|Withdrawal by Subject|4|||
161874875|NCT01314872|584584030|FG000|Period 2|Lost to Follow-up|0|||
161874876|NCT01314872|584584031|FG001|Period 2|Lost to Follow-up|0|||
161874877|NCT01314872|584584032|FG002|Period 2|Lost to Follow-up|0|||
161874878|NCT01314872|584584033|FG003|Period 2|Lost to Follow-up|0|||
161874879|NCT01314872|584584034|FG004|Period 2|Lost to Follow-up|0|||
161874880|NCT01314872|584584035|FG005|Period 2|Lost to Follow-up|0|||
161874881|NCT01314872|584584036|FG006|Period 2|Lost to Follow-up|0|||
161874882|NCT01314872|584584037|FG007|Period 2|Lost to Follow-up|0|||
161874883|NCT01314872|584584038|FG008|Period 2|Lost to Follow-up|0|||
161874884|NCT01314872|584584039|FG009|Period 2|Lost to Follow-up|0|||
161874885|NCT01314872|584584040|FG010|Period 2|Lost to Follow-up|0|||
161874886|NCT01314872|584584041|FG011|Period 2|Lost to Follow-up|6|||
161874887|NCT01314872|584584042|FG012|Period 2|Lost to Follow-up|7|||
161874888|NCT01314872|584584043|FG013|Period 2|Lost to Follow-up|2|||
161874889|NCT01314872|584584044|FG014|Period 2|Lost to Follow-up|6|||
161874890|NCT03634033|584585344|FG000|Overall Study|Did not have a post-assessment|384|||
161874891|NCT03634033|584585345|FG001|Overall Study|Did not have a post-assessment|291|||
161874892|NCT03634033|584585346|FG002|Overall Study|Did not have a post-assessment|114|||
161874893|NCT03634033|584585347|FG003|Overall Study|Did not have a post-assessment|161|||
161874894|NCT03634033|584585348|FG004|Overall Study|Did not have a post-assessment|5|||
161874895|NCT03634033|584585349|FG005|Overall Study|Did not have a post-assessment|0|||
161874896|NCT03634033|584585350|FG006|Overall Study|Did not have a post-assessment|0|||
161874897|NCT03634033|584585344|FG000|Overall Study|Death|0|||
161874898|NCT03634033|584585345|FG001|Overall Study|Death|0|||
161874899|NCT03634033|584585346|FG002|Overall Study|Death|0|||
161874900|NCT03634033|584585347|FG003|Overall Study|Death|0|||
161874901|NCT03634033|584585348|FG004|Overall Study|Death|0|||
161874902|NCT03634033|584585349|FG005|Overall Study|Death|7|||
161874903|NCT03634033|584585350|FG006|Overall Study|Death|7|||
161874904|NCT03634033|584585344|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874905|NCT03634033|584585345|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874906|NCT03634033|584585346|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874907|NCT03634033|584585347|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874908|NCT03634033|584585348|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874909|NCT03634033|584585349|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
161874910|NCT03634033|584585350|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
161874911|NCT03634033|584585344|FG000|Overall Study|Lost to Follow-up|0|||
161874912|NCT03634033|584585345|FG001|Overall Study|Lost to Follow-up|0|||
161874913|NCT03634033|584585346|FG002|Overall Study|Lost to Follow-up|0|||
161874914|NCT03634033|584585347|FG003|Overall Study|Lost to Follow-up|0|||
161874915|NCT03634033|584585348|FG004|Overall Study|Lost to Follow-up|0|||
161874916|NCT03634033|584585349|FG005|Overall Study|Lost to Follow-up|1|||
161874917|NCT03634033|584585350|FG006|Overall Study|Lost to Follow-up|2|||
161874918|NCT03634033|584585344|FG000|Overall Study|Withdrawal by Subject|0|||
161874919|NCT03634033|584585345|FG001|Overall Study|Withdrawal by Subject|0|||
161874920|NCT03634033|584585346|FG002|Overall Study|Withdrawal by Subject|0|||
161874921|NCT03634033|584585347|FG003|Overall Study|Withdrawal by Subject|0|||
161874922|NCT03634033|584585348|FG004|Overall Study|Withdrawal by Subject|0|||
161874923|NCT03634033|584585349|FG005|Overall Study|Withdrawal by Subject|0|||
161874924|NCT03634033|584585350|FG006|Overall Study|Withdrawal by Subject|1|||
161874925|NCT06366087|584585351|FG000|Overall Study|Withdrawal by Subject|0|||
161874926|NCT06366087|584585352|FG001|Overall Study|Withdrawal by Subject|1|||
161874927|NCT00199797|584585353|FG000|Overall Study|Progressive Disease|1|||
161874928|NCT00199797|584585353|FG000|Overall Study|Adverse Event|1|||
161874929|NCT00199797|584585353|FG000|Overall Study|Physician Decision|1|||
161874930|NCT00504725|584585361|FG000|Overall Study|Protocol Violation|1|||
161874931|NCT00504725|584585362|FG001|Overall Study|Protocol Violation|0|||
161874932|NCT01435018|584585363|FG000|Overall Study|Death|37|||
161874933|NCT01435018|584585364|FG001|Overall Study|Death|18|||
161874934|NCT01435018|584585365|FG002|Overall Study|Death|25|||
161874935|NCT01435018|584585363|FG000|Overall Study|Site is closing|4|||
161874936|NCT01435018|584585364|FG001|Overall Study|Site is closing|9|||
161874937|NCT01435018|584585365|FG002|Overall Study|Site is closing|7|||
161874938|NCT01435018|584585363|FG000|Overall Study|Withdrew consent|0|||
161874939|NCT01435018|584585364|FG001|Overall Study|Withdrew consent|3|||
161874940|NCT01435018|584585365|FG002|Overall Study|Withdrew consent|1|||
161874941|NCT01435018|584585363|FG000|Overall Study|Not willing to adhere to requirements|0|||
161874942|NCT01435018|584585364|FG001|Overall Study|Not willing to adhere to requirements|2|||
161874943|NCT01435018|584585365|FG002|Overall Study|Not willing to adhere to requirements|3|||
161874944|NCT01435018|584585363|FG000|Overall Study|Not able to get to clinic|2|||
161874945|NCT01435018|584585364|FG001|Overall Study|Not able to get to clinic|0|||
161874946|NCT01435018|584585365|FG002|Overall Study|Not able to get to clinic|2|||
161874947|NCT01435018|584585363|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161874948|NCT01435018|584585364|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161874949|NCT01435018|584585365|FG002|Overall Study|Severe debilitation, unable to continue|1|||
161874950|NCT01435018|584585363|FG000|Overall Study|Unable to contact participant/parent|1|||
161874951|NCT01435018|584585364|FG001|Overall Study|Unable to contact participant/parent|1|||
161874952|NCT01435018|584585365|FG002|Overall Study|Unable to contact participant/parent|1|||
161874953|NCT01435018|584585363|FG000|Overall Study|Enrollment Violation|0|||
161874954|NCT01435018|584585364|FG001|Overall Study|Enrollment Violation|1|||
161874955|NCT01435018|584585365|FG002|Overall Study|Enrollment Violation|0|||
161874956|NCT01435018|584585363|FG000|Overall Study|Never started chemotherapy|3|||
161874957|NCT01435018|584585364|FG001|Overall Study|Never started chemotherapy|0|||
161874958|NCT01435018|584585365|FG002|Overall Study|Never started chemotherapy|1|||
161874959|NCT03937908|584585366|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
161874960|NCT03937908|584585367|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
161874961|NCT03875092|584585368|FG000|Overall Study|Adverse Event|2|||
161874962|NCT03875092|584585369|FG001|Overall Study|Adverse Event|5|||
161874963|NCT03875092|584585368|FG000|Overall Study|Death|44|||
161874964|NCT03875092|584585369|FG001|Overall Study|Death|51|||
161874965|NCT03875092|584585368|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
161874966|NCT03875092|584585369|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
161874967|NCT03205761|584585370|FG000|Overall Study|Withdrawal by Subject|1|||
161874968|NCT03205761|584585370|FG000|Overall Study|Progressive Disease|10|||
161874969|NCT00636194|584585371|FG000|Overall Study|Study related symptoms and complaints|1|||
161874970|NCT00636194|584585372|FG001|Overall Study|Study related symptoms and complaints|0|||
161874971|NCT00636194|584585371|FG000|Overall Study|Protocol Violation|2|||
161874972|NCT00636194|584585372|FG001|Overall Study|Protocol Violation|0|||
161874973|NCT04114357|584585374|FG000|Baseline-Randomization|Adverse Event|2|||
161874974|NCT04114357|584585375|FG001|Baseline-Randomization|Adverse Event|1|||
161874975|NCT04114357|584585374|FG000|Baseline-Randomization|Lost to Follow-up|1|||
161874976|NCT04114357|584585375|FG001|Baseline-Randomization|Lost to Follow-up|1|||
161874977|NCT04114357|584585374|FG000|Cross-over|Adverse Event|0|||
161874978|NCT04114357|584585375|FG001|Cross-over|Adverse Event|1|||
161874979|NCT02163226|584585376|FG000|Overall Study|Death|2|||
161874980|NCT02163226|584585377|FG001|Overall Study|Death|1|||
161874981|NCT02163226|584585376|FG000|Overall Study|Withdrawal by Subject|5|||
161874982|NCT02163226|584585377|FG001|Overall Study|Withdrawal by Subject|2|||
161874983|NCT02163226|584585376|FG000|Overall Study|Returned home, local radiotherapy|3|||
161874984|NCT02163226|584585377|FG001|Overall Study|Returned home, local radiotherapy|0|||
161874985|NCT02163226|584585376|FG000|Overall Study|Repeat imaging showed no disease|2|||
161874986|NCT02163226|584585377|FG001|Overall Study|Repeat imaging showed no disease|0|||
161874987|NCT02163226|584585376|FG000|Overall Study|Incomplete radiotherapy|3|||
161874988|NCT02163226|584585377|FG001|Overall Study|Incomplete radiotherapy|0|||
161874989|NCT02163226|584585376|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
161874990|NCT02163226|584585377|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
161874991|NCT02163226|584585376|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
161874992|NCT02163226|584585377|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
161874993|NCT02163226|584585376|FG000|Overall Study|ineligible|0|||
161874994|NCT02163226|584585377|FG001|Overall Study|ineligible|3|||
161874995|NCT03625466|584585381|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
161874996|NCT03625466|584585382|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
161874997|NCT03625466|584585383|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
161874998|NCT03625466|584585381|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161874999|NCT03625466|584585382|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161875000|NCT03625466|584585383|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161875001|NCT03625466|584585381|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161875002|NCT03625466|584585382|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161875003|NCT03625466|584585383|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161875004|NCT00809471|584585386|FG000|Overall Study|Protocol non-compliance|15|||
161875005|NCT00809471|584585387|FG001|Overall Study|Protocol non-compliance|15|||
161875006|NCT00809471|584585388|FG002|Overall Study|Protocol non-compliance|6|||
161875007|NCT00809471|584585386|FG000|Overall Study|Lost to Follow-up|4|||
161875008|NCT00809471|584585387|FG001|Overall Study|Lost to Follow-up|2|||
161875009|NCT00809471|584585388|FG002|Overall Study|Lost to Follow-up|9|||
161875010|NCT00809471|584585386|FG000|Overall Study|Adverse Event|0|||
161875011|NCT00809471|584585387|FG001|Overall Study|Adverse Event|2|||
161875012|NCT00809471|584585388|FG002|Overall Study|Adverse Event|2|||
161875013|NCT00809471|584585386|FG000|Overall Study|Requirement for restricted medication|1|||
161875014|NCT00809471|584585387|FG001|Overall Study|Requirement for restricted medication|1|||
161875015|NCT00809471|584585388|FG002|Overall Study|Requirement for restricted medication|0|||
161875016|NCT00831311|584585389|FG000|Overall Study|Definitive Contraindication|3|||
161875017|NCT00831311|584585390|FG001|Overall Study|Definitive Contraindication|3|||
161875018|NCT00831311|584585389|FG000|Overall Study|Lost to Follow-up|3|||
161875019|NCT00831311|584585390|FG001|Overall Study|Lost to Follow-up|0|||
161875020|NCT00831311|584585389|FG000|Overall Study|Physician Decision|0|||
161875021|NCT00831311|584585390|FG001|Overall Study|Physician Decision|1|||
161875022|NCT00831311|584585389|FG000|Overall Study|Withdrawal by Subject|6|||
161875023|NCT00831311|584585390|FG001|Overall Study|Withdrawal by Subject|4|||
161875024|NCT05318092|584585394|FG000|Overall Study|Lost to Follow-up|3|||
161875025|NCT05318092|584585394|FG000|Overall Study|Withdrawal by Subject|1|||
161875026|NCT00160706|584585396|FG000|Overall Study|Adverse Event|53|||
161875027|NCT00160706|584585396|FG000|Overall Study|Adverse Event and Other Reason|105|||
161875028|NCT00160706|584585396|FG000|Overall Study|Protocol Violation|3|||
161875029|NCT00160706|584585396|FG000|Overall Study|Withdrawal by Subject|41|||
161875030|NCT00160706|584585396|FG000|Overall Study|Withdrawal by Subject and Other|12|||
161875031|NCT00160706|584585396|FG000|Overall Study|Physician Decision|10|||
161875032|NCT00160706|584585396|FG000|Overall Study|Physician Decision and Other|3|||
161875033|NCT00160706|584585396|FG000|Overall Study|Lost to Follow-up|4|||
161875034|NCT00160706|584585396|FG000|Overall Study|Lost to Follow-up and Other|1|||
161875035|NCT00160706|584585396|FG000|Overall Study|Lack of Efficacy|42|||
161875036|NCT00160706|584585396|FG000|Overall Study|Lack of Efficacy and Other|1|||
161875037|NCT00160706|584585396|FG000|Overall Study|Other Reason|11|||
161875038|NCT03214380|584585397|FG000|Lead-in|Adverse Event|3|||
161875039|NCT03214380|584585398|FG001|Lead-in|Adverse Event|0|||
161875040|NCT03214380|584585399|FG002|Lead-in|Adverse Event|0|||
161875041|NCT03214380|584585400|FG003|Lead-in|Adverse Event|1|||
161875042|NCT03214380|584585401|FG004|Lead-in|Adverse Event|0|||
161875043|NCT03214380|584585402|FG005|Lead-in|Adverse Event|0|||
161875044|NCT03214380|584585397|FG000|Lead-in|Lost to Follow-up|4|||
161875045|NCT03214380|584585398|FG001|Lead-in|Lost to Follow-up|0|||
161875046|NCT03214380|584585399|FG002|Lead-in|Lost to Follow-up|0|||
161875047|NCT03214380|584585400|FG003|Lead-in|Lost to Follow-up|1|||
161875048|NCT03214380|584585401|FG004|Lead-in|Lost to Follow-up|0|||
161875049|NCT03214380|584585402|FG005|Lead-in|Lost to Follow-up|0|||
161875050|NCT03214380|584585397|FG000|Lead-in|Eligibility Criteria|3|||
161875051|NCT03214380|584585398|FG001|Lead-in|Eligibility Criteria|0|||
161875052|NCT03214380|584585399|FG002|Lead-in|Eligibility Criteria|0|||
161875053|NCT03214380|584585400|FG003|Lead-in|Eligibility Criteria|0|||
161875054|NCT03214380|584585401|FG004|Lead-in|Eligibility Criteria|0|||
161875055|NCT03214380|584585402|FG005|Lead-in|Eligibility Criteria|0|||
161875056|NCT03214380|584585397|FG000|Lead-in|Physician Decision|6|||
161875057|NCT03214380|584585398|FG001|Lead-in|Physician Decision|0|||
161875058|NCT03214380|584585399|FG002|Lead-in|Physician Decision|0|||
161875059|NCT03214380|584585400|FG003|Lead-in|Physician Decision|0|||
161875060|NCT03214380|584585401|FG004|Lead-in|Physician Decision|0|||
161875061|NCT03214380|584585402|FG005|Lead-in|Physician Decision|0|||
161875062|NCT03214380|584585397|FG000|Lead-in|Protocol Deviation|7|||
161875063|NCT03214380|584585398|FG001|Lead-in|Protocol Deviation|0|||
161875064|NCT03214380|584585399|FG002|Lead-in|Protocol Deviation|0|||
161875065|NCT03214380|584585400|FG003|Lead-in|Protocol Deviation|3|||
161875066|NCT03214380|584585401|FG004|Lead-in|Protocol Deviation|0|||
161875067|NCT03214380|584585402|FG005|Lead-in|Protocol Deviation|0|||
161875068|NCT03214380|584585397|FG000|Lead-in|Withdrawal by Subject|41|||
161875069|NCT03214380|584585398|FG001|Lead-in|Withdrawal by Subject|0|||
161875070|NCT03214380|584585399|FG002|Lead-in|Withdrawal by Subject|0|||
161875071|NCT03214380|584585400|FG003|Lead-in|Withdrawal by Subject|14|||
161875072|NCT03214380|584585401|FG004|Lead-in|Withdrawal by Subject|0|||
161875073|NCT03214380|584585402|FG005|Lead-in|Withdrawal by Subject|0|||
161875074|NCT03214380|584585397|FG000|Lead-in|Family Emergency|1|||
161875075|NCT03214380|584585398|FG001|Lead-in|Family Emergency|0|||
161875076|NCT03214380|584585399|FG002|Lead-in|Family Emergency|0|||
161875077|NCT03214380|584585400|FG003|Lead-in|Family Emergency|0|||
161875078|NCT03214380|584585401|FG004|Lead-in|Family Emergency|0|||
161875079|NCT03214380|584585402|FG005|Lead-in|Family Emergency|0|||
161875080|NCT03214380|584585397|FG000|Lead-in|Natural Disaster|9|||
161875081|NCT03214380|584585398|FG001|Lead-in|Natural Disaster|0|||
161875082|NCT03214380|584585399|FG002|Lead-in|Natural Disaster|0|||
161875083|NCT03214380|584585400|FG003|Lead-in|Natural Disaster|0|||
161875084|NCT03214380|584585401|FG004|Lead-in|Natural Disaster|0|||
161875085|NCT03214380|584585402|FG005|Lead-in|Natural Disaster|0|||
161875086|NCT03214380|584585397|FG000|Lead-in|Non Compliance|1|||
161875087|NCT03214380|584585398|FG001|Lead-in|Non Compliance|0|||
161875088|NCT03214380|584585399|FG002|Lead-in|Non Compliance|0|||
161875089|NCT03214380|584585400|FG003|Lead-in|Non Compliance|0|||
161875090|NCT03214380|584585401|FG004|Lead-in|Non Compliance|0|||
161875091|NCT03214380|584585402|FG005|Lead-in|Non Compliance|0|||
161875092|NCT03214380|584585397|FG000|Lead-in|Participant Schedule|2|||
161875093|NCT03214380|584585398|FG001|Lead-in|Participant Schedule|0|||
161875094|NCT03214380|584585399|FG002|Lead-in|Participant Schedule|0|||
161875095|NCT03214380|584585400|FG003|Lead-in|Participant Schedule|0|||
161875096|NCT03214380|584585401|FG004|Lead-in|Participant Schedule|0|||
161875097|NCT03214380|584585402|FG005|Lead-in|Participant Schedule|0|||
161875098|NCT03214380|584585397|FG000|Treatment Period|Adverse Event|0|||
161875099|NCT03214380|584585398|FG001|Treatment Period|Adverse Event|1|||
161875100|NCT03214380|584585399|FG002|Treatment Period|Adverse Event|1|||
161875101|NCT03214380|584585400|FG003|Treatment Period|Adverse Event|0|||
161875102|NCT03214380|584585401|FG004|Treatment Period|Adverse Event|1|||
161875103|NCT03214380|584585402|FG005|Treatment Period|Adverse Event|0|||
161875104|NCT03214380|584585397|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
161875105|NCT03214380|584585398|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
161875106|NCT03214380|584585399|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
161875107|NCT03214380|584585400|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
161875108|NCT03214380|584585401|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
161875109|NCT03214380|584585402|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
161875110|NCT03214380|584585397|FG000|Treatment Period|Withdrawal by Subject|0|||
161875111|NCT03214380|584585398|FG001|Treatment Period|Withdrawal by Subject|10|||
161875112|NCT03214380|584585399|FG002|Treatment Period|Withdrawal by Subject|8|||
161875113|NCT03214380|584585400|FG003|Treatment Period|Withdrawal by Subject|0|||
161875114|NCT03214380|584585401|FG004|Treatment Period|Withdrawal by Subject|7|||
161875115|NCT03214380|584585402|FG005|Treatment Period|Withdrawal by Subject|11|||
161875116|NCT03214380|584585397|FG000|Treatment Period|Death|0|||
161875117|NCT03214380|584585398|FG001|Treatment Period|Death|1|||
161875118|NCT03214380|584585399|FG002|Treatment Period|Death|2|||
161875119|NCT03214380|584585400|FG003|Treatment Period|Death|0|||
161875120|NCT03214380|584585401|FG004|Treatment Period|Death|0|||
161875121|NCT03214380|584585402|FG005|Treatment Period|Death|0|||
161875122|NCT03214380|584585397|FG000|Treatment Period|Lost to Follow-up|0|||
161875123|NCT03214380|584585398|FG001|Treatment Period|Lost to Follow-up|6|||
161875124|NCT03214380|584585399|FG002|Treatment Period|Lost to Follow-up|3|||
161875125|NCT03214380|584585400|FG003|Treatment Period|Lost to Follow-up|0|||
161875126|NCT03214380|584585401|FG004|Treatment Period|Lost to Follow-up|0|||
161875127|NCT03214380|584585402|FG005|Treatment Period|Lost to Follow-up|0|||
161875128|NCT03214380|584585397|FG000|Treatment Period|Participant schedule|0|||
161875129|NCT03214380|584585398|FG001|Treatment Period|Participant schedule|0|||
161875130|NCT03214380|584585399|FG002|Treatment Period|Participant schedule|1|||
161875131|NCT03214380|584585400|FG003|Treatment Period|Participant schedule|0|||
161875132|NCT03214380|584585401|FG004|Treatment Period|Participant schedule|0|||
161875133|NCT03214380|584585402|FG005|Treatment Period|Participant schedule|0|||
161875134|NCT03214380|584585397|FG000|Treatment Period|Treatment Interruption|0|||
161875135|NCT03214380|584585398|FG001|Treatment Period|Treatment Interruption|0|||
161875136|NCT03214380|584585399|FG002|Treatment Period|Treatment Interruption|1|||
161875137|NCT03214380|584585400|FG003|Treatment Period|Treatment Interruption|0|||
161875138|NCT03214380|584585401|FG004|Treatment Period|Treatment Interruption|0|||
161875139|NCT03214380|584585402|FG005|Treatment Period|Treatment Interruption|0|||
161875140|NCT00723255|584585408|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
161875141|NCT00723255|584585408|FG000|Overall Study|Ineligible: Second primary|1|||
161875142|NCT00723255|584585408|FG000|Overall Study|Ineligible: Wrong Primary|2|||
161875143|NCT00614523|584585409|FG000|Overall Study|Adverse Event|4|||
161875144|NCT00614523|584585410|FG001|Overall Study|Adverse Event|20|||
161875145|NCT00614523|584585409|FG000|Overall Study|Death|5|||
161875146|NCT00614523|584585410|FG001|Overall Study|Death|8|||
161875147|NCT00614523|584585409|FG000|Overall Study|Lack of Efficacy|9|||
161875148|NCT00614523|584585410|FG001|Overall Study|Lack of Efficacy|11|||
161875149|NCT00614523|584585409|FG000|Overall Study|Lost to Follow-up|0|||
161875150|NCT00614523|584585410|FG001|Overall Study|Lost to Follow-up|1|||
161875151|NCT00614523|584585409|FG000|Overall Study|Protocol Violation|3|||
161875152|NCT00614523|584585410|FG001|Overall Study|Protocol Violation|2|||
161875153|NCT00614523|584585409|FG000|Overall Study|Withdrawal by Subject|12|||
161875154|NCT00614523|584585410|FG001|Overall Study|Withdrawal by Subject|22|||
161875155|NCT00614523|584585409|FG000|Overall Study|Other|6|||
161875156|NCT00614523|584585410|FG001|Overall Study|Other|11|||
161875157|NCT00614523|584585409|FG000|Overall Study|Ineligibility Determined|1|||
161875158|NCT00614523|584585410|FG001|Overall Study|Ineligibility Determined|2|||
161875159|NCT00614523|584585409|FG000|Overall Study|Disease Progression|0|||
161875160|NCT00614523|584585410|FG001|Overall Study|Disease Progression|8|||
161875161|NCT00614523|584585409|FG000|Overall Study|Administrative Decision|23|||
161875162|NCT00614523|584585410|FG001|Overall Study|Administrative Decision|46|||
161875163|NCT00452673|584585417|FG000|Dose Escalation Period|Disease Progression|6|||
161875164|NCT00452673|584585418|FG001|Dose Escalation Period|Disease Progression|6|||
161875165|NCT00452673|584585419|FG002|Dose Escalation Period|Disease Progression|2|||
161875166|NCT00452673|584585420|FG003|Dose Escalation Period|Disease Progression|6|||
161875167|NCT00452673|584585421|FG004|Dose Escalation Period|Disease Progression|0|||
161875168|NCT00452673|584585417|FG000|Dose Escalation Period|study drug toxicity|1|||
161875169|NCT00452673|584585418|FG001|Dose Escalation Period|study drug toxicity|3|||
161875170|NCT00452673|584585419|FG002|Dose Escalation Period|study drug toxicity|3|||
161875171|NCT00452673|584585420|FG003|Dose Escalation Period|study drug toxicity|1|||
161875172|NCT00452673|584585421|FG004|Dose Escalation Period|study drug toxicity|0|||
161875173|NCT00452673|584585417|FG000|Dose Escalation Period|Other|0|||
161875174|NCT00452673|584585418|FG001|Dose Escalation Period|Other|0|||
161875175|NCT00452673|584585419|FG002|Dose Escalation Period|Other|1|||
161875176|NCT00452673|584585420|FG003|Dose Escalation Period|Other|0|||
161875177|NCT00452673|584585421|FG004|Dose Escalation Period|Other|0|||
161875178|NCT00452673|584585417|FG000|Dose Escalation Period|Adverse Event|0|||
161875179|NCT00452673|584585418|FG001|Dose Escalation Period|Adverse Event|0|||
161875180|NCT00452673|584585419|FG002|Dose Escalation Period|Adverse Event|0|||
161875181|NCT00452673|584585420|FG003|Dose Escalation Period|Adverse Event|1|||
161875182|NCT00452673|584585421|FG004|Dose Escalation Period|Adverse Event|0|||
161875183|NCT00452673|584585417|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
161875184|NCT00452673|584585418|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
161875185|NCT00452673|584585419|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
161875186|NCT00452673|584585420|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
161875187|NCT00452673|584585421|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
161875188|NCT00452673|584585417|FG000|Dose Expansion Period|Disease Progression|0|||
161875189|NCT00452673|584585418|FG001|Dose Expansion Period|Disease Progression|0|||
161875190|NCT00452673|584585419|FG002|Dose Expansion Period|Disease Progression|0|||
161875191|NCT00452673|584585420|FG003|Dose Expansion Period|Disease Progression|0|||
161875192|NCT00452673|584585421|FG004|Dose Expansion Period|Disease Progression|19|||
161875193|NCT00452673|584585417|FG000|Dose Expansion Period|Other|0|||
161875194|NCT00452673|584585418|FG001|Dose Expansion Period|Other|0|||
161875195|NCT00452673|584585419|FG002|Dose Expansion Period|Other|0|||
161875196|NCT00452673|584585420|FG003|Dose Expansion Period|Other|0|||
161875197|NCT00452673|584585421|FG004|Dose Expansion Period|Other|2|||
161875198|NCT00748189|584585424|FG000|Overall Study|Death|99|||
161875199|NCT00748189|584585425|FG001|Overall Study|Death|84|||
161875200|NCT00748189|584585424|FG000|Overall Study|Withdrawal by Subject|23|||
161875201|NCT00748189|584585425|FG001|Overall Study|Withdrawal by Subject|29|||
161875202|NCT00748189|584585424|FG000|Overall Study|Physician Decision|16|||
161875203|NCT00748189|584585425|FG001|Overall Study|Physician Decision|5|||
161875204|NCT00748189|584585424|FG000|Overall Study|Lost to Follow-up|8|||
161875205|NCT00748189|584585425|FG001|Overall Study|Lost to Follow-up|15|||
161875206|NCT00748189|584585424|FG000|Overall Study|Study terminated by Sponsor|70|||
161875207|NCT00748189|584585425|FG001|Overall Study|Study terminated by Sponsor|79|||
161875208|NCT04481191|584585432|FG000|Overall Study|Withdrawn by parent/guardian|15|||
161875209|NCT04481191|584585433|FG001|Overall Study|Withdrawn by parent/guardian|10|||
161875210|NCT00546117|584585438|FG000|Overall Study|Withdrawal by Subject|3|||
161875211|NCT00546117|584585439|FG001|Overall Study|Withdrawal by Subject|0|||
161875212|NCT00546117|584585438|FG000|Overall Study|Inability to schedule follow-up visit|1|||
161875213|NCT00546117|584585439|FG001|Overall Study|Inability to schedule follow-up visit|0|||
161875214|NCT04984278|584585444|FG000|Period 1|Withdrawal by Subject|1|||
161875215|NCT04984278|584585445|FG001|Period 1|Withdrawal by Subject|0|||
161875216|NCT04984278|584585444|FG000|Period 1|Other|0|||
161875217|NCT04984278|584585445|FG001|Period 1|Other|1|||
161875218|NCT04984278|584585444|FG000|Period 2|Adverse Event|1|||
161875219|NCT04984278|584585445|FG001|Period 2|Adverse Event|0|||
161875220|NCT04984278|584585444|FG000|Period 2|Other|0|||
161875221|NCT04984278|584585445|FG001|Period 2|Other|1|||
161875222|NCT04696055|584585446|FG000|Overall Study|Adverse Event|10|||
161875223|NCT04696055|584585447|FG001|Overall Study|Adverse Event|2|||
161875224|NCT04696055|584585446|FG000|Overall Study|Death|4|||
161875225|NCT04696055|584585447|FG001|Overall Study|Death|0|||
161875226|NCT04696055|584585446|FG000|Overall Study|Other|7|||
161875227|NCT04696055|584585447|FG001|Overall Study|Other|2|||
161875228|NCT04696055|584585446|FG000|Overall Study|Physician Decision|3|||
161875229|NCT04696055|584585447|FG001|Overall Study|Physician Decision|0|||
161875230|NCT04696055|584585446|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
161875231|NCT04696055|584585447|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
161875232|NCT04696055|584585446|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
161875233|NCT04696055|584585447|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
161875234|NCT04696055|584585446|FG000|Overall Study|Subject Decision|1|||
161875235|NCT04696055|584585447|FG001|Overall Study|Subject Decision|2|||
161875236|NCT03969901|584585448|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161875237|NCT03969901|584585449|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161875238|NCT03969901|584585450|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161875239|NCT03969901|584585451|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161875240|NCT03969901|584585452|FG004|Overall Study|Withdrawal by parent/guardian|1|||
161875241|NCT03969901|584585453|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161875242|NCT03969901|584585454|FG006|Overall Study|Withdrawal by parent/guardian|0|||
161875243|NCT03969901|584585455|FG007|Overall Study|Withdrawal by parent/guardian|1|||
161875244|NCT03969901|584585456|FG008|Overall Study|Withdrawal by parent/guardian|1|||
161875245|NCT03969901|584585457|FG009|Overall Study|Withdrawal by parent/guardian|0|||
161875246|NCT00348595|584585458|FG000|Overall Study|Adverse Event|5|||
161875247|NCT00348595|584585459|FG001|Overall Study|Adverse Event|8|||
161875248|NCT01920958|584585460|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
161875249|NCT03192306|584585465|FG000|Overall Study|Did not treat cold sore during study|149|||
161875250|NCT03192306|584585466|FG001|Overall Study|Did not treat cold sore during study|143|||
161875251|NCT03192306|584585465|FG000|Overall Study|Withdrawal by Subject|1|||
161875252|NCT03192306|584585466|FG001|Overall Study|Withdrawal by Subject|1|||
161875253|NCT03192306|584585465|FG000|Overall Study|Lost to Follow-up|1|||
161875254|NCT03192306|584585466|FG001|Overall Study|Lost to Follow-up|0|||
161875255|NCT03192306|584585465|FG000|Overall Study|Protocol Violation|1|||
161875256|NCT03192306|584585466|FG001|Overall Study|Protocol Violation|1|||
161875257|NCT02589626|584585471|FG000|Overall Study|Other than the reason specified|1|||
161875258|NCT02589626|584585472|FG001|Overall Study|Other than the reason specified|0|||
161875259|NCT02589626|584585471|FG000|Overall Study|Withdrawal by Subject|1|||
161875260|NCT02589626|584585472|FG001|Overall Study|Withdrawal by Subject|1|||
161875261|NCT02589626|584585471|FG000|Overall Study|Adverse Event|1|||
161875262|NCT02589626|584585472|FG001|Overall Study|Adverse Event|1|||
161875263|NCT00379080|584585473|FG000|Overall Study|Withdrawal by Subject|0|||
161875264|NCT00379080|584585474|FG001|Overall Study|Withdrawal by Subject|4|||
161875265|NCT00379080|584585475|FG002|Overall Study|Withdrawal by Subject|0|||
161875266|NCT01089608|584585476|FG000|Overall Study|Adverse Event|0|||
161875267|NCT01089608|584585477|FG001|Overall Study|Adverse Event|4|||
161875268|NCT01089608|584585476|FG000|Overall Study|Lost to Follow-up|0|||
161875269|NCT01089608|584585477|FG001|Overall Study|Lost to Follow-up|2|||
161875270|NCT02429778|584585479|FG000|Overall Study|Lost to Follow-up|2|||
161875271|NCT02429778|584585480|FG001|Overall Study|Lost to Follow-up|0|||
161875272|NCT02429778|584585479|FG000|Overall Study|Withdrawal by Subject|5|||
161875273|NCT02429778|584585480|FG001|Overall Study|Withdrawal by Subject|0|||
161875274|NCT01893281|584585481|FG000|Overall Study|Adverse Event|1|||
161875275|NCT01893281|584585481|FG000|Overall Study|Protocol Violation|1|||
161875276|NCT01893281|584585481|FG000|Overall Study|Withdrawal by Subject|1|||
161875277|NCT00789698|584585485|FG000|Overall Study|Lack of Efficacy|10|||
161875278|NCT00789698|584585486|FG001|Overall Study|Lack of Efficacy|4|||
161875279|NCT00789698|584585487|FG002|Overall Study|Lack of Efficacy|5|||
161875280|NCT00789698|584585488|FG003|Overall Study|Lack of Efficacy|18|||
161875281|NCT00789698|584585485|FG000|Overall Study|Adverse Event|5|||
161875282|NCT00789698|584585486|FG001|Overall Study|Adverse Event|5|||
161875283|NCT00789698|584585487|FG002|Overall Study|Adverse Event|3|||
161875284|NCT00789698|584585488|FG003|Overall Study|Adverse Event|4|||
161875285|NCT00789698|584585485|FG000|Overall Study|Lost to Follow-up|5|||
161875286|NCT00789698|584585486|FG001|Overall Study|Lost to Follow-up|5|||
161875287|NCT00789698|584585487|FG002|Overall Study|Lost to Follow-up|2|||
161875288|NCT00789698|584585488|FG003|Overall Study|Lost to Follow-up|9|||
161875289|NCT00789698|584585485|FG000|Overall Study|Protocol Violation|6|||
161875290|NCT00789698|584585486|FG001|Overall Study|Protocol Violation|1|||
161875291|NCT00789698|584585487|FG002|Overall Study|Protocol Violation|2|||
161875292|NCT00789698|584585488|FG003|Overall Study|Protocol Violation|1|||
161875293|NCT00789698|584585485|FG000|Overall Study|Withdrawal by Subject|14|||
161875294|NCT00789698|584585486|FG001|Overall Study|Withdrawal by Subject|15|||
161875295|NCT00789698|584585487|FG002|Overall Study|Withdrawal by Subject|12|||
161875296|NCT00789698|584585488|FG003|Overall Study|Withdrawal by Subject|19|||
161875297|NCT00789698|584585485|FG000|Overall Study|Administrative|0|||
161875298|NCT00789698|584585486|FG001|Overall Study|Administrative|3|||
161875299|NCT00789698|584585487|FG002|Overall Study|Administrative|3|||
161875300|NCT00789698|584585488|FG003|Overall Study|Administrative|1|||
161875301|NCT01397786|584587026|FG000|Phase A|Lost to Follow-up|0|||
161875302|NCT01397786|584587027|FG001|Phase A|Lost to Follow-up|0|||
161875303|NCT01397786|584587028|FG002|Phase A|Lost to Follow-up|6|||
161875304|NCT01397786|584587026|FG000|Phase A|Adverse Event|0|||
161875305|NCT01397786|584587027|FG001|Phase A|Adverse Event|0|||
161875306|NCT01397786|584587028|FG002|Phase A|Adverse Event|8|||
161875307|NCT01397786|584587026|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
161875308|NCT01397786|584587027|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
161875309|NCT01397786|584587028|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
161875310|NCT01397786|584587026|FG000|Phase A|Physician Decision|0|||
161875311|NCT01397786|584587027|FG001|Phase A|Physician Decision|0|||
161875312|NCT01397786|584587028|FG002|Phase A|Physician Decision|1|||
161875313|NCT01397786|584587026|FG000|Phase A|Withdrawal by Subject|0|||
161875314|NCT01397786|584587027|FG001|Phase A|Withdrawal by Subject|0|||
161875315|NCT01397786|584587028|FG002|Phase A|Withdrawal by Subject|5|||
161875316|NCT01397786|584587026|FG000|Phase A|Lack of Efficacy|0|||
161875317|NCT01397786|584587027|FG001|Phase A|Lack of Efficacy|0|||
161875318|NCT01397786|584587028|FG002|Phase A|Lack of Efficacy|1|||
161875319|NCT01397786|584587026|FG000|Phase B|Lost to Follow-up|22|||
161875320|NCT01397786|584587027|FG001|Phase B|Lost to Follow-up|12|||
161875321|NCT01397786|584587028|FG002|Phase B|Lost to Follow-up|22|||
161875322|NCT01397786|584587026|FG000|Phase B|Adverse Event|109|||
161875323|NCT01397786|584587027|FG001|Phase B|Adverse Event|23|||
161875324|NCT01397786|584587028|FG002|Phase B|Adverse Event|27|||
161875325|NCT01397786|584587026|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
161875326|NCT01397786|584587027|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
161875327|NCT01397786|584587028|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
161875328|NCT01397786|584587026|FG000|Phase B|Physician Decision|9|||
161875329|NCT01397786|584587027|FG001|Phase B|Physician Decision|1|||
161875330|NCT01397786|584587028|FG002|Phase B|Physician Decision|3|||
161875331|NCT01397786|584587026|FG000|Phase B|Withdrawal by Subject|102|||
161875332|NCT01397786|584587027|FG001|Phase B|Withdrawal by Subject|45|||
161875333|NCT01397786|584587028|FG002|Phase B|Withdrawal by Subject|30|||
161875334|NCT01397786|584587026|FG000|Phase B|Protocol Deviation|1|||
161875335|NCT01397786|584587027|FG001|Phase B|Protocol Deviation|2|||
161875336|NCT01397786|584587028|FG002|Phase B|Protocol Deviation|4|||
161875337|NCT01397786|584587026|FG000|Phase B|Lack of Efficacy|22|||
161875338|NCT01397786|584587027|FG001|Phase B|Lack of Efficacy|7|||
161875339|NCT01397786|584587028|FG002|Phase B|Lack of Efficacy|14|||
161875340|NCT04250350|584587032|FG000|Overall Study|Withdrawal by Subject|13|||
161875341|NCT04250350|584587032|FG000|Overall Study|Lost to Follow-up|8|||
161875342|NCT04250350|584587032|FG000|Overall Study|Adverse Event|5|||
161875343|NCT04250350|584587032|FG000|Overall Study|Lack of Efficacy|4|||
161875344|NCT04250350|584587032|FG000|Overall Study|Physician Decision|1|||
161875345|NCT04250350|584587032|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
161875346|NCT00860249|584587033|FG000|Overall Study|trial was terminated prior to completion|21|||
161875347|NCT00860249|584587034|FG001|Overall Study|trial was terminated prior to completion|18|||
161875348|NCT00860249|584587035|FG002|Overall Study|trial was terminated prior to completion|21|||
161875349|NCT00743288|584587036|FG000|Overall Study|Adverse Event|1|||
161875350|NCT00743288|584587037|FG001|Overall Study|Adverse Event|1|||
161875351|NCT00743288|584587038|FG002|Overall Study|Adverse Event|2|||
161875352|NCT00743288|584587039|FG003|Overall Study|Adverse Event|2|||
161875353|NCT00743288|584587040|FG004|Overall Study|Adverse Event|1|||
161875354|NCT00743288|584587041|FG005|Overall Study|Adverse Event|1|||
161875355|NCT00743288|584587042|FG006|Overall Study|Adverse Event|2|||
161875356|NCT00743288|584587036|FG000|Overall Study|Withdrawal by Subject|0|||
161875357|NCT00743288|584587037|FG001|Overall Study|Withdrawal by Subject|0|||
161875358|NCT00743288|584587038|FG002|Overall Study|Withdrawal by Subject|1|||
161875359|NCT00743288|584587039|FG003|Overall Study|Withdrawal by Subject|0|||
161875360|NCT00743288|584587040|FG004|Overall Study|Withdrawal by Subject|0|||
161875361|NCT00743288|584587041|FG005|Overall Study|Withdrawal by Subject|1|||
161875362|NCT00743288|584587042|FG006|Overall Study|Withdrawal by Subject|1|||
161875363|NCT00743288|584587036|FG000|Overall Study|Progressive disease (PD)|2|||
161875364|NCT00743288|584587037|FG001|Overall Study|Progressive disease (PD)|0|||
161875365|NCT00743288|584587038|FG002|Overall Study|Progressive disease (PD)|1|||
161875366|NCT00743288|584587039|FG003|Overall Study|Progressive disease (PD)|4|||
161875367|NCT00743288|584587040|FG004|Overall Study|Progressive disease (PD)|5|||
161875368|NCT00743288|584587041|FG005|Overall Study|Progressive disease (PD)|3|||
161875369|NCT00743288|584587042|FG006|Overall Study|Progressive disease (PD)|6|||
161875370|NCT00743288|584587036|FG000|Overall Study|Worsening of condition (Not PD)|0|||
161875371|NCT00743288|584587037|FG001|Overall Study|Worsening of condition (Not PD)|2|||
161875372|NCT00743288|584587038|FG002|Overall Study|Worsening of condition (Not PD)|1|||
161875373|NCT00743288|584587039|FG003|Overall Study|Worsening of condition (Not PD)|1|||
161875374|NCT00743288|584587040|FG004|Overall Study|Worsening of condition (Not PD)|0|||
161875375|NCT00743288|584587041|FG005|Overall Study|Worsening of condition (Not PD)|0|||
161875376|NCT00743288|584587042|FG006|Overall Study|Worsening of condition (Not PD)|0|||
161875377|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
161875378|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
161875379|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161875380|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161875381|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
161875382|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
161875383|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161875384|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161875385|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161875386|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
161875387|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161875388|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161875389|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
161875390|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161875391|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161875392|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161875393|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161875394|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161875395|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
161875396|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
161875397|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161875398|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161875399|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
161875400|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
161875401|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Death|0|||
161875402|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Death|0|||
161875403|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Death|1|||
161875404|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Death|1|||
161875405|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161875406|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161875407|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
161875408|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161875409|NCT00378508|584587051|FG000|Overall Study|Withdrawal by Subject|1|||
161875410|NCT00378508|584587052|FG001|Overall Study|Withdrawal by Subject|3|||
161875411|NCT00378508|584587051|FG000|Overall Study|Lost to Follow-up|1|||
161875412|NCT00378508|584587052|FG001|Overall Study|Lost to Follow-up|0|||
161875413|NCT00593684|584587053|FG000|Overall Study|Death|2|||
161875414|NCT00593684|584587054|FG001|Overall Study|Death|1|||
161875415|NCT01669174|584587061|FG000|Overall Study|Subject withdrew consent|2|||
161875416|NCT01669174|584587062|FG001|Overall Study|Subject withdrew consent|2|||
161875417|NCT01669174|584587061|FG000|Overall Study|Lost to Follow-up|1|||
161875418|NCT01669174|584587062|FG001|Overall Study|Lost to Follow-up|0|||
161875419|NCT01669174|584587061|FG000|Overall Study|Adverse Event|2|||
161875420|NCT01669174|584587062|FG001|Overall Study|Adverse Event|2|||
161875421|NCT01669174|584587061|FG000|Overall Study|Administrative problems|1|||
161875422|NCT01669174|584587062|FG001|Overall Study|Administrative problems|2|||
161875423|NCT01953601|584587066|FG000|Part 1 (Base Study)|Adverse Event|24|||
161875424|NCT01953601|584587067|FG001|Part 1 (Base Study)|Adverse Event|37|||
161875425|NCT01953601|584587068|FG002|Part 1 (Base Study)|Adverse Event|15|||
161875426|NCT01953601|584587066|FG000|Part 1 (Base Study)|Death|2|||
161875427|NCT01953601|584587067|FG001|Part 1 (Base Study)|Death|0|||
161875428|NCT01953601|584587068|FG002|Part 1 (Base Study)|Death|3|||
161875429|NCT01953601|584587066|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
161875430|NCT01953601|584587067|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
161875431|NCT01953601|584587068|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
161875432|NCT01953601|584587066|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
161875433|NCT01953601|584587067|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
161875434|NCT01953601|584587068|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
161875435|NCT01953601|584587066|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
161875436|NCT01953601|584587067|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
161875437|NCT01953601|584587068|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
161875438|NCT01953601|584587066|FG000|Part 1 (Base Study)|Physician Decision|3|||
161875439|NCT01953601|584587067|FG001|Part 1 (Base Study)|Physician Decision|7|||
161875440|NCT01953601|584587068|FG002|Part 1 (Base Study)|Physician Decision|4|||
161875441|NCT01953601|584587066|FG000|Part 1 (Base Study)|Screen failure|1|||
161875442|NCT01953601|584587067|FG001|Part 1 (Base Study)|Screen failure|0|||
161875443|NCT01953601|584587068|FG002|Part 1 (Base Study)|Screen failure|1|||
161875444|NCT01953601|584587066|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
161875445|NCT01953601|584587067|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
161875446|NCT01953601|584587068|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
161875447|NCT01953601|584587066|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
161875448|NCT01953601|584587067|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
161875449|NCT01953601|584587068|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
161875450|NCT01953601|584587066|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
161875451|NCT01953601|584587067|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
161875452|NCT01953601|584587068|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
161875453|NCT01953601|584587066|FG000|Part 1 (Base Study)|Subject moved|2|||
161875454|NCT01953601|584587067|FG001|Part 1 (Base Study)|Subject moved|2|||
161875455|NCT01953601|584587068|FG002|Part 1 (Base Study)|Subject moved|1|||
161875456|NCT01953601|584587066|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
161875457|NCT01953601|584587067|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
161875458|NCT01953601|584587068|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
161875459|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Adverse Event|1|||
161875460|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Adverse Event|1|||
161875461|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Adverse Event|10|||
161875462|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Death|0|||
161875463|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Death|3|||
161875464|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Death|0|||
161875465|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
161875466|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
161875467|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
161875468|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
161875469|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
161875470|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
161875471|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Physician Decision|2|||
161875472|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Physician Decision|0|||
161875473|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Physician Decision|2|||
161875474|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
161875475|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
161875476|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
161875477|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
161875478|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
161875479|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
161875480|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
161875481|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
161875482|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
161875483|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Subject moved|0|||
161875484|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Subject moved|0|||
161875485|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Subject moved|1|||
161875486|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
161875487|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
161875488|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
161875489|NCT01905553|584587075|FG000|Period 2|Adverse Event|1|||
161875490|NCT01905553|584587076|FG001|Period 2|Adverse Event|0|||
161875491|NCT04310397|584587077|FG000|Overall Study|Lack of Efficacy|3|||
161875492|NCT04310397|584587077|FG000|Overall Study|Withdrawal by Subject|1|||
161875493|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
161875494|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
161875495|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
161875496|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
161875497|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
161875498|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
161875499|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
161875500|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
161875501|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161875502|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161875503|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
161875504|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161875505|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
161875506|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
161875507|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
161875508|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
161875509|NCT01289639|584587091|FG000|Overall Study|Lost to Follow-up|1|||
161875510|NCT01289639|584587092|FG001|Overall Study|Lost to Follow-up|0|||
161875511|NCT01289639|584587093|FG002|Overall Study|Lost to Follow-up|0|||
161875512|NCT02780713|584587094|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875513|NCT02780713|584587095|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875514|NCT02780713|584587096|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
161875515|NCT02780713|584587097|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875516|NCT02780713|584587098|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875517|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
161875518|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
161875519|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
161875520|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
161875521|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
161875522|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
161875523|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
161875524|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
161875525|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
161875526|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
161875527|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
161875528|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
161875529|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
161875530|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
161875531|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
161875532|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
161875533|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
161875534|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
161875535|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
161875536|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
161875537|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
161875538|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
161875539|NCT00280397|584587103|FG000|Overall Study|Adverse Event|1|||
161875540|NCT01028014|584587113|FG000|Overall Study|Lost to Follow-up|1|||
161875541|NCT01028014|584587114|FG001|Overall Study|Lost to Follow-up|2|||
161875542|NCT01028014|584587115|FG002|Overall Study|Lost to Follow-up|0|||
161875543|NCT01028014|584587116|FG003|Overall Study|Lost to Follow-up|1|||
161875544|NCT01028014|584587117|FG004|Overall Study|Lost to Follow-up|1|||
161875545|NCT01028014|584587118|FG005|Overall Study|Lost to Follow-up|2|||
161875546|NCT01127451|584587119|FG000|Overall Study|Other|2|||
161875547|NCT01127451|584587120|FG001|Overall Study|Other|1|||
161875548|NCT01127451|584587119|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
161875549|NCT01127451|584587120|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
161875550|NCT01127451|584587119|FG000|Overall Study|Death|22|||
161875551|NCT01127451|584587120|FG001|Overall Study|Death|17|||
161875552|NCT01127451|584587119|FG000|Overall Study|Lost to Follow-up|3|||
161875553|NCT01127451|584587120|FG001|Overall Study|Lost to Follow-up|0|||
161875554|NCT01127451|584587119|FG000|Overall Study|Administrative Reason by Sponsor|2|||
161875555|NCT01127451|584587120|FG001|Overall Study|Administrative Reason by Sponsor|2|||
161875556|NCT00425061|584587121|FG000|Overall Study|Adverse Event|1|||
161875557|NCT00425061|584587122|FG001|Overall Study|Adverse Event|0|||
161875558|NCT00425061|584587123|FG002|Overall Study|Adverse Event|0|||
161875559|NCT00425061|584587124|FG003|Overall Study|Adverse Event|2|||
161875560|NCT00425061|584587125|FG004|Overall Study|Adverse Event|2|||
161875561|NCT00425061|584587126|FG005|Overall Study|Adverse Event|0|||
161875562|NCT00425061|584587127|FG006|Overall Study|Adverse Event|0|||
161875563|NCT00425061|584587121|FG000|Overall Study|Lost to Follow-up|0|||
161875564|NCT00425061|584587122|FG001|Overall Study|Lost to Follow-up|1|||
161875565|NCT00425061|584587123|FG002|Overall Study|Lost to Follow-up|0|||
161875566|NCT00425061|584587124|FG003|Overall Study|Lost to Follow-up|0|||
161875567|NCT00425061|584587125|FG004|Overall Study|Lost to Follow-up|0|||
161875568|NCT00425061|584587126|FG005|Overall Study|Lost to Follow-up|0|||
161875569|NCT00425061|584587127|FG006|Overall Study|Lost to Follow-up|0|||
161875570|NCT00425061|584587121|FG000|Overall Study|Protocol Violation|1|||
161875571|NCT00425061|584587122|FG001|Overall Study|Protocol Violation|0|||
161875572|NCT00425061|584587123|FG002|Overall Study|Protocol Violation|0|||
161875573|NCT00425061|584587124|FG003|Overall Study|Protocol Violation|0|||
161875574|NCT00425061|584587125|FG004|Overall Study|Protocol Violation|0|||
161875575|NCT00425061|584587126|FG005|Overall Study|Protocol Violation|0|||
161875576|NCT00425061|584587127|FG006|Overall Study|Protocol Violation|0|||
161875577|NCT00425061|584587121|FG000|Overall Study|Withdrawal by Subject|0|||
161875578|NCT00425061|584587122|FG001|Overall Study|Withdrawal by Subject|1|||
161875579|NCT00425061|584587123|FG002|Overall Study|Withdrawal by Subject|0|||
161875580|NCT00425061|584587124|FG003|Overall Study|Withdrawal by Subject|0|||
161875581|NCT00425061|584587125|FG004|Overall Study|Withdrawal by Subject|1|||
161875582|NCT00425061|584587126|FG005|Overall Study|Withdrawal by Subject|0|||
161875583|NCT00425061|584587127|FG006|Overall Study|Withdrawal by Subject|3|||
161875584|NCT00425061|584587121|FG000|Overall Study|Sponsor's request|0|||
161875585|NCT00425061|584587122|FG001|Overall Study|Sponsor's request|0|||
161875586|NCT00425061|584587123|FG002|Overall Study|Sponsor's request|0|||
161875587|NCT00425061|584587124|FG003|Overall Study|Sponsor's request|0|||
161875588|NCT00425061|584587125|FG004|Overall Study|Sponsor's request|19|||
161875589|NCT00425061|584587126|FG005|Overall Study|Sponsor's request|4|||
161875590|NCT00425061|584587127|FG006|Overall Study|Sponsor's request|15|||
161875591|NCT00425061|584587121|FG000|Overall Study|Physician Decision|0|||
161875592|NCT00425061|584587122|FG001|Overall Study|Physician Decision|0|||
161875593|NCT00425061|584587123|FG002|Overall Study|Physician Decision|0|||
161875594|NCT00425061|584587124|FG003|Overall Study|Physician Decision|0|||
161875595|NCT00425061|584587125|FG004|Overall Study|Physician Decision|1|||
161875596|NCT00425061|584587126|FG005|Overall Study|Physician Decision|0|||
161875597|NCT00425061|584587127|FG006|Overall Study|Physician Decision|0|||
161875598|NCT00425061|584587121|FG000|Overall Study|Other|0|||
161875599|NCT00425061|584587122|FG001|Overall Study|Other|0|||
161875600|NCT00425061|584587123|FG002|Overall Study|Other|0|||
161875601|NCT00425061|584587124|FG003|Overall Study|Other|0|||
161875602|NCT00425061|584587125|FG004|Overall Study|Other|3|||
161875603|NCT00425061|584587126|FG005|Overall Study|Other|0|||
161875604|NCT00425061|584587127|FG006|Overall Study|Other|1|||
161875605|NCT02111577|584587128|FG000|Overall Study|Protocol Violation|2|||
161875606|NCT02111577|584587129|FG001|Overall Study|Protocol Violation|0|||
161875607|NCT02111577|584587128|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
161875608|NCT02111577|584587129|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
161875609|NCT02111577|584587128|FG000|Overall Study|Failure to produce study treatment|6|||
161875610|NCT02111577|584587129|FG001|Overall Study|Failure to produce study treatment|0|||
161875611|NCT02111577|584587128|FG000|Overall Study|Death|518|||
161875612|NCT02111577|584587129|FG001|Overall Study|Death|254|||
161875613|NCT02111577|584587128|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
161875614|NCT02111577|584587129|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
161875615|NCT02111577|584587128|FG000|Overall Study|Adverse Event|1|||
161875616|NCT02111577|584587129|FG001|Overall Study|Adverse Event|1|||
161875617|NCT02111577|584587128|FG000|Overall Study|Withdrawal by Subject|51|||
161875618|NCT02111577|584587129|FG001|Overall Study|Withdrawal by Subject|23|||
161875619|NCT02111577|584587128|FG000|Overall Study|Disease progression|0|||
161875620|NCT02111577|584587129|FG001|Overall Study|Disease progression|1|||
161875621|NCT02111577|584587128|FG000|Overall Study|Lost to Follow-up|19|||
161875622|NCT02111577|584587129|FG001|Overall Study|Lost to Follow-up|10|||
161875623|NCT04590586|584587136|FG000|Overall Study|Death|7|||
161875624|NCT04590586|584587137|FG001|Overall Study|Death|1|||
161875625|NCT04590586|584587138|FG002|Overall Study|Death|37|||
161875626|NCT04590586|584587139|FG003|Overall Study|Death|34|||
161875627|NCT04590586|584587140|FG004|Overall Study|Death|19|||
161875628|NCT04590586|584587141|FG005|Overall Study|Death|3|||
161875629|NCT04590586|584587136|FG000|Overall Study|Lost to Follow-up|3|||
161875630|NCT04590586|584587137|FG001|Overall Study|Lost to Follow-up|0|||
161875631|NCT04590586|584587138|FG002|Overall Study|Lost to Follow-up|11|||
161875632|NCT04590586|584587139|FG003|Overall Study|Lost to Follow-up|11|||
161875633|NCT04590586|584587140|FG004|Overall Study|Lost to Follow-up|6|||
161875634|NCT04590586|584587141|FG005|Overall Study|Lost to Follow-up|0|||
161875635|NCT04590586|584587136|FG000|Overall Study|Withdrawal by Subject|0|||
161875636|NCT04590586|584587137|FG001|Overall Study|Withdrawal by Subject|0|||
161875637|NCT04590586|584587138|FG002|Overall Study|Withdrawal by Subject|6|||
161875638|NCT04590586|584587139|FG003|Overall Study|Withdrawal by Subject|0|||
161875639|NCT04590586|584587140|FG004|Overall Study|Withdrawal by Subject|3|||
161875640|NCT04590586|584587141|FG005|Overall Study|Withdrawal by Subject|0|||
161875641|NCT04590586|584587136|FG000|Overall Study|Other|3|||
161875642|NCT04590586|584587137|FG001|Overall Study|Other|0|||
161875643|NCT04590586|584587138|FG002|Overall Study|Other|1|||
161875644|NCT04590586|584587139|FG003|Overall Study|Other|1|||
161875645|NCT04590586|584587140|FG004|Overall Study|Other|2|||
161875646|NCT04590586|584587141|FG005|Overall Study|Other|1|||
161875647|NCT01609543|584587142|FG000|Overall Study|Disease Progression|28|||
161875648|NCT01609543|584587142|FG000|Overall Study|Adverse Event|5|||
161875649|NCT01609543|584587142|FG000|Overall Study|Withdrawal by Subject|1|||
161875650|NCT01609543|584587142|FG000|Overall Study|Protocol Violation|1|||
161875651|NCT01609543|584587142|FG000|Overall Study|Death|7|||
161875652|NCT01254318|584587143|FG000|Overall Study|Lost to Follow-up|5|||
161875653|NCT01254318|584587143|FG000|Overall Study|Death|47|||
161875654|NCT01137110|584587144|FG000|Overall Study|Protocol Violation|1|||
161875655|NCT01137110|584587145|FG001|Overall Study|Protocol Violation|0|||
161875656|NCT02828124|584587148|FG000|Overall Study|Disease Progression|1|||
161875657|NCT02828124|584587149|FG001|Overall Study|Disease Progression|2|||
161875658|NCT02828124|584587150|FG002|Overall Study|Disease Progression|1|||
161875659|NCT02828124|584587151|FG003|Overall Study|Disease Progression|4|||
161875660|NCT02828124|584587148|FG000|Overall Study|AE Unrelated to Study Drug|0|||
161875661|NCT02828124|584587149|FG001|Overall Study|AE Unrelated to Study Drug|0|||
161875662|NCT02828124|584587150|FG002|Overall Study|AE Unrelated to Study Drug|0|||
161875663|NCT02828124|584587151|FG003|Overall Study|AE Unrelated to Study Drug|1|||
161875664|NCT02828124|584587148|FG000|Overall Study|Subject Withdrew Consent|0|||
161875665|NCT02828124|584587149|FG001|Overall Study|Subject Withdrew Consent|0|||
161875666|NCT02828124|584587150|FG002|Overall Study|Subject Withdrew Consent|0|||
161875667|NCT02828124|584587151|FG003|Overall Study|Subject Withdrew Consent|1|||
161875668|NCT03990571|584587152|FG000|Overall Study|Withdrawal by Subject|1|||
161875669|NCT03990571|584587152|FG000|Overall Study|Insurance Issues|3|||
161875670|NCT03990571|584587152|FG000|Overall Study|Covid Restrictions|2|||
161875671|NCT00634803|584587153|FG000|Overall Study|Lost to Follow-up|6|||
161875672|NCT00634803|584587154|FG001|Overall Study|Lost to Follow-up|7|||
161875673|NCT00634803|584587155|FG002|Overall Study|Lost to Follow-up|7|||
161875674|NCT04105218|584587157|FG000|Overall Study|Withdrawal by Subject|3|||
161875675|NCT04105218|584587158|FG001|Overall Study|Withdrawal by Subject|2|||
161875676|NCT04105218|584587157|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
161875677|NCT04105218|584587158|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
161875678|NCT04105218|584587157|FG000|Overall Study|Failed screening tests|2|||
161875679|NCT04105218|584587158|FG001|Overall Study|Failed screening tests|1|||
161875680|NCT02553499|584587165|FG000|Overall Study|Adverse Event|0|||
161875681|NCT02553499|584587166|FG001|Overall Study|Adverse Event|0|||
161875682|NCT02553499|584587167|FG002|Overall Study|Adverse Event|0|||
161875683|NCT02553499|584587168|FG003|Overall Study|Adverse Event|0|||
161875684|NCT02553499|584587169|FG004|Overall Study|Adverse Event|0|||
161875685|NCT02553499|584587170|FG005|Overall Study|Adverse Event|0|||
161875686|NCT02553499|584587171|FG006|Overall Study|Adverse Event|1|||
161875687|NCT02553499|584587172|FG007|Overall Study|Adverse Event|1|||
161875688|NCT02553499|584587173|FG008|Overall Study|Adverse Event|0|||
161875689|NCT02553499|584587174|FG009|Overall Study|Adverse Event|0|||
161875690|NCT02553499|584587175|FG010|Overall Study|Adverse Event|0|||
161875691|NCT02553499|584587176|FG011|Overall Study|Adverse Event|0|||
161875692|NCT02553499|584587177|FG012|Overall Study|Adverse Event|0|||
161875693|NCT02553499|584587178|FG013|Overall Study|Adverse Event|1|||
161875694|NCT02553499|584587165|FG000|Overall Study|Death|0|||
161875695|NCT02553499|584587166|FG001|Overall Study|Death|1|||
161875696|NCT02553499|584587167|FG002|Overall Study|Death|1|||
161875697|NCT02553499|584587168|FG003|Overall Study|Death|0|||
161875698|NCT02553499|584587169|FG004|Overall Study|Death|1|||
161875699|NCT02553499|584587170|FG005|Overall Study|Death|2|||
161875700|NCT02553499|584587171|FG006|Overall Study|Death|0|||
161875701|NCT02553499|584587172|FG007|Overall Study|Death|0|||
161875702|NCT02553499|584587173|FG008|Overall Study|Death|0|||
161875703|NCT02553499|584587174|FG009|Overall Study|Death|0|||
161875704|NCT02553499|584587175|FG010|Overall Study|Death|1|||
161875705|NCT02553499|584587176|FG011|Overall Study|Death|0|||
161875706|NCT02553499|584587177|FG012|Overall Study|Death|0|||
161875707|NCT02553499|584587178|FG013|Overall Study|Death|0|||
161875708|NCT02553499|584587165|FG000|Overall Study|Lost to Follow-up|0|||
161875709|NCT02553499|584587166|FG001|Overall Study|Lost to Follow-up|0|||
161875710|NCT02553499|584587167|FG002|Overall Study|Lost to Follow-up|0|||
161875711|NCT02553499|584587168|FG003|Overall Study|Lost to Follow-up|0|||
161875712|NCT02553499|584587169|FG004|Overall Study|Lost to Follow-up|0|||
161875713|NCT02553499|584587170|FG005|Overall Study|Lost to Follow-up|0|||
161875714|NCT02553499|584587171|FG006|Overall Study|Lost to Follow-up|1|||
161875715|NCT02553499|584587172|FG007|Overall Study|Lost to Follow-up|0|||
161875716|NCT02553499|584587173|FG008|Overall Study|Lost to Follow-up|0|||
161875717|NCT02553499|584587174|FG009|Overall Study|Lost to Follow-up|0|||
161875718|NCT02553499|584587175|FG010|Overall Study|Lost to Follow-up|0|||
161875719|NCT02553499|584587176|FG011|Overall Study|Lost to Follow-up|0|||
161875720|NCT02553499|584587177|FG012|Overall Study|Lost to Follow-up|0|||
161875721|NCT02553499|584587178|FG013|Overall Study|Lost to Follow-up|0|||
161875722|NCT02553499|584587165|FG000|Overall Study|Physician Decision|0|||
161875723|NCT02553499|584587166|FG001|Overall Study|Physician Decision|1|||
161875724|NCT02553499|584587167|FG002|Overall Study|Physician Decision|1|||
161875725|NCT02553499|584587168|FG003|Overall Study|Physician Decision|0|||
161875726|NCT02553499|584587169|FG004|Overall Study|Physician Decision|1|||
161875727|NCT02553499|584587170|FG005|Overall Study|Physician Decision|0|||
161875728|NCT02553499|584587171|FG006|Overall Study|Physician Decision|0|||
161875729|NCT02553499|584587172|FG007|Overall Study|Physician Decision|1|||
161875730|NCT02553499|584587173|FG008|Overall Study|Physician Decision|1|||
161875731|NCT02553499|584587174|FG009|Overall Study|Physician Decision|2|||
161875732|NCT02553499|584587175|FG010|Overall Study|Physician Decision|1|||
161875733|NCT02553499|584587176|FG011|Overall Study|Physician Decision|3|||
161875734|NCT02553499|584587177|FG012|Overall Study|Physician Decision|1|||
161875735|NCT02553499|584587178|FG013|Overall Study|Physician Decision|0|||
161875736|NCT02553499|584587165|FG000|Overall Study|Progressive Disease|0|||
161875737|NCT02553499|584587166|FG001|Overall Study|Progressive Disease|0|||
161875738|NCT02553499|584587167|FG002|Overall Study|Progressive Disease|0|||
161875739|NCT02553499|584587168|FG003|Overall Study|Progressive Disease|2|||
161875740|NCT02553499|584587169|FG004|Overall Study|Progressive Disease|1|||
161875741|NCT02553499|584587170|FG005|Overall Study|Progressive Disease|1|||
161875742|NCT02553499|584587171|FG006|Overall Study|Progressive Disease|1|||
161875743|NCT02553499|584587172|FG007|Overall Study|Progressive Disease|0|||
161875744|NCT02553499|584587173|FG008|Overall Study|Progressive Disease|0|||
161875745|NCT02553499|584587174|FG009|Overall Study|Progressive Disease|1|||
161875746|NCT02553499|584587175|FG010|Overall Study|Progressive Disease|0|||
161875747|NCT02553499|584587176|FG011|Overall Study|Progressive Disease|0|||
161875748|NCT02553499|584587177|FG012|Overall Study|Progressive Disease|2|||
161875749|NCT02553499|584587178|FG013|Overall Study|Progressive Disease|1|||
161875750|NCT02553499|584587165|FG000|Overall Study|Study Terminated by Sponsor|0|||
161875751|NCT02553499|584587166|FG001|Overall Study|Study Terminated by Sponsor|0|||
161875752|NCT02553499|584587167|FG002|Overall Study|Study Terminated by Sponsor|0|||
161875753|NCT02553499|584587168|FG003|Overall Study|Study Terminated by Sponsor|0|||
161875754|NCT02553499|584587169|FG004|Overall Study|Study Terminated by Sponsor|0|||
161875755|NCT02553499|584587170|FG005|Overall Study|Study Terminated by Sponsor|0|||
161875756|NCT02553499|584587171|FG006|Overall Study|Study Terminated by Sponsor|0|||
161875757|NCT02553499|584587172|FG007|Overall Study|Study Terminated by Sponsor|0|||
161875758|NCT02553499|584587173|FG008|Overall Study|Study Terminated by Sponsor|1|||
161875759|NCT02553499|584587174|FG009|Overall Study|Study Terminated by Sponsor|0|||
161875760|NCT02553499|584587175|FG010|Overall Study|Study Terminated by Sponsor|0|||
161875761|NCT02553499|584587176|FG011|Overall Study|Study Terminated by Sponsor|0|||
161875762|NCT02553499|584587177|FG012|Overall Study|Study Terminated by Sponsor|0|||
161875763|NCT02553499|584587178|FG013|Overall Study|Study Terminated by Sponsor|0|||
161875764|NCT02553499|584587165|FG000|Overall Study|Withdrawal by Subject|2|||
161875765|NCT02553499|584587166|FG001|Overall Study|Withdrawal by Subject|0|||
161875766|NCT02553499|584587167|FG002|Overall Study|Withdrawal by Subject|0|||
161875767|NCT02553499|584587168|FG003|Overall Study|Withdrawal by Subject|0|||
161875768|NCT02553499|584587169|FG004|Overall Study|Withdrawal by Subject|0|||
161875769|NCT02553499|584587170|FG005|Overall Study|Withdrawal by Subject|0|||
161875770|NCT02553499|584587171|FG006|Overall Study|Withdrawal by Subject|0|||
161875771|NCT02553499|584587172|FG007|Overall Study|Withdrawal by Subject|1|||
161875772|NCT02553499|584587173|FG008|Overall Study|Withdrawal by Subject|1|||
161875773|NCT02553499|584587174|FG009|Overall Study|Withdrawal by Subject|0|||
161776200|NCT01569074|584223138|FG002|Overall Study|Severe non-compliance to protocol|1|||
161776201|NCT01569074|584223139|FG003|Overall Study|Severe non-compliance to protocol|0|||
161776202|NCT01569074|584223140|FG004|Overall Study|Severe non-compliance to protocol|0|||
161776203|NCT01569074|584223136|FG000|Overall Study|eg change in circumstances|0|||
161776204|NCT01569074|584223137|FG001|Overall Study|eg change in circumstances|2|||
161776205|NCT01569074|584223138|FG002|Overall Study|eg change in circumstances|0|||
161776206|NCT01569074|584223139|FG003|Overall Study|eg change in circumstances|1|||
161776207|NCT01569074|584223140|FG004|Overall Study|eg change in circumstances|1|||
161776208|NCT01569074|584223136|FG000|Overall Study|Adverse Event|1|||
161776209|NCT01569074|584223137|FG001|Overall Study|Adverse Event|0|||
161776210|NCT01569074|584223138|FG002|Overall Study|Adverse Event|3|||
161776211|NCT01569074|584223139|FG003|Overall Study|Adverse Event|0|||
161776212|NCT01569074|584223140|FG004|Overall Study|Adverse Event|0|||
161875774|NCT02553499|584587175|FG010|Overall Study|Withdrawal by Subject|1|||
161875775|NCT02553499|584587176|FG011|Overall Study|Withdrawal by Subject|0|||
161875776|NCT02553499|584587177|FG012|Overall Study|Withdrawal by Subject|0|||
161875777|NCT02553499|584587178|FG013|Overall Study|Withdrawal by Subject|0|||
161875778|NCT00570063|584587179|FG000|Overall Study|Adverse Event|4|||
161875779|NCT00570063|584587180|FG001|Overall Study|Adverse Event|1|||
161875780|NCT00570063|584587179|FG000|Overall Study|Lack of Efficacy|0|||
161875781|NCT00570063|584587180|FG001|Overall Study|Lack of Efficacy|1|||
161875782|NCT00570063|584587179|FG000|Overall Study|Withdrawal by Subject|4|||
161875783|NCT00570063|584587180|FG001|Overall Study|Withdrawal by Subject|3|||
161875784|NCT00570063|584587179|FG000|Overall Study|Sponsor's Decision|7|||
161776213|NCT00669110|584223141|FG000|Overall Study|Adverse Event|4|||
161776214|NCT00669110|584223142|FG001|Overall Study|Adverse Event|3|||
161776215|NCT00669110|584223141|FG000|Overall Study|Caregiver request|3|||
161776216|NCT00669110|584223142|FG001|Overall Study|Caregiver request|2|||
161875785|NCT00570063|584587180|FG001|Overall Study|Sponsor's Decision|3|||
161875786|NCT00550043|584587184|FG000|Overall Study|Adverse Event|0|||
161875787|NCT00550043|584587185|FG001|Overall Study|Adverse Event|0|||
161875788|NCT00550043|584587186|FG002|Overall Study|Adverse Event|0|||
161875789|NCT00550043|584587187|FG003|Overall Study|Adverse Event|1|||
161875790|NCT00550043|584587188|FG004|Overall Study|Adverse Event|1|||
161776217|NCT00669110|584223141|FG000|Overall Study|Physician Decision|0|||
161776218|NCT00669110|584223142|FG001|Overall Study|Physician Decision|1|||
161776219|NCT00669110|584223141|FG000|Overall Study|Lost to Follow-up|1|||
161776220|NCT00669110|584223142|FG001|Overall Study|Lost to Follow-up|0|||
161776221|NCT00669110|584223141|FG000|Overall Study|Protocol Violation|0|||
161776222|NCT00669110|584223142|FG001|Overall Study|Protocol Violation|5|||
161776223|NCT00669110|584223141|FG000|Overall Study|Withdrawal by Subject|0|||
161776224|NCT00669110|584223142|FG001|Overall Study|Withdrawal by Subject|2|||
161776225|NCT05168657|584223145|FG000|Overall Study|Adverse Event|0|||
161776226|NCT05168657|584223146|FG001|Overall Study|Adverse Event|0|||
161776227|NCT05168657|584223147|FG002|Overall Study|Adverse Event|1|||
161776228|NCT05168657|584223148|FG003|Overall Study|Adverse Event|0|||
161776229|NCT05168657|584223149|FG004|Overall Study|Adverse Event|0|||
161776230|NCT05168657|584223150|FG005|Overall Study|Adverse Event|0|||
161776231|NCT05168657|584223151|FG006|Overall Study|Adverse Event|0|||
161776232|NCT05168657|584223152|FG007|Overall Study|Adverse Event|0|||
161776233|NCT00962013|584223153|FG000|Overall Study|Did not have surgery|1|||
161776234|NCT00962013|584223153|FG000|Overall Study|Death|8|||
161776235|NCT00962013|584223153|FG000|Overall Study|Lost to Follow-up|12|||
161776236|NCT00962013|584223153|FG000|Overall Study|Unable/Unwilling to return|6|||
161776237|NCT00962013|584223153|FG000|Overall Study|Withdrawal by Subject|8|||
161776238|NCT00962013|584223153|FG000|Overall Study|Removal of study device|3|||
161776239|NCT00962013|584223153|FG000|Overall Study|Site Termination|24|||
161776240|NCT00962013|584223153|FG000|Overall Study|No 5 year evaluation|6|||
161776241|NCT03843775|584223156|FG000|Overall Study|Adverse Event|1|||
161776242|NCT03843775|584223157|FG001|Overall Study|Adverse Event|1|||
161776243|NCT03843775|584223156|FG000|Overall Study|Lack of Efficacy|2|||
161776244|NCT03843775|584223157|FG001|Overall Study|Lack of Efficacy|6|||
161776245|NCT03843775|584223156|FG000|Overall Study|Withdrawal by Subject|0|||
161776246|NCT03843775|584223157|FG001|Overall Study|Withdrawal by Subject|1|||
161776247|NCT00530621|584223160|FG000|Overall Study|Adverse Event|11|||
161776248|NCT00530621|584223161|FG001|Overall Study|Adverse Event|8|||
161776249|NCT00530621|584223160|FG000|Overall Study|Physician Decision|2|||
161776250|NCT00530621|584223161|FG001|Overall Study|Physician Decision|4|||
161776251|NCT00530621|584223160|FG000|Overall Study|Progressive Disease (PD)|47|||
161776252|NCT00530621|584223161|FG001|Overall Study|Progressive Disease (PD)|40|||
161776253|NCT00530621|584223160|FG000|Overall Study|Sponsor Decision|12|||
161776254|NCT00530621|584223161|FG001|Overall Study|Sponsor Decision|15|||
161776255|NCT00530621|584223160|FG000|Overall Study|Subject Decision|4|||
161776256|NCT00530621|584223161|FG001|Overall Study|Subject Decision|7|||
161776257|NCT00530621|584223160|FG000|Overall Study|Death|3|||
161776258|NCT00530621|584223161|FG001|Overall Study|Death|6|||
161776259|NCT00530621|584223160|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
161776260|NCT00530621|584223161|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
161776261|NCT04611152|584223164|FG000|Overall Study|Adverse Event|9|||
161776262|NCT04611152|584223165|FG001|Overall Study|Adverse Event|8|||
161776263|NCT04611152|584223164|FG000|Overall Study|Non-compliance with study schedule|1|||
161776264|NCT04611152|584223165|FG001|Overall Study|Non-compliance with study schedule|3|||
161776265|NCT04611152|584223164|FG000|Overall Study|Withdrawal by Subject|5|||
161776266|NCT04611152|584223165|FG001|Overall Study|Withdrawal by Subject|6|||
161776267|NCT04611152|584223164|FG000|Overall Study|Lost to Follow-up|11|||
161776268|NCT04611152|584223165|FG001|Overall Study|Lost to Follow-up|2|||
161776269|NCT03917654|584223172|FG000|Year 1|Withdrawal by Subject|1|||
161776270|NCT03917654|584223173|FG001|Year 1|Withdrawal by Subject|0|||
161776271|NCT03917654|584223174|FG002|Year 1|Withdrawal by Subject|0|||
161776272|NCT03917654|584223175|FG003|Year 1|Withdrawal by Subject|0|||
161776273|NCT03917654|584223176|FG004|Year 1|Withdrawal by Subject|0|||
161776274|NCT03917654|584223177|FG005|Year 1|Withdrawal by Subject|1|||
161776275|NCT03917654|584223178|FG006|Year 1|Withdrawal by Subject|6|||
161776276|NCT03917654|584223179|FG007|Year 1|Withdrawal by Subject|2|||
161776277|NCT03917654|584223180|FG008|Year 1|Withdrawal by Subject|5|||
161776278|NCT03917654|584223181|FG009|Year 1|Withdrawal by Subject|3|||
161776279|NCT03917654|584223182|FG010|Year 1|Withdrawal by Subject|1|||
161776280|NCT03917654|584223183|FG011|Year 1|Withdrawal by Subject|0|||
161776281|NCT03917654|584223172|FG000|Year 1|Travel|0|||
161776282|NCT03917654|584223173|FG001|Year 1|Travel|1|||
161776283|NCT03917654|584223174|FG002|Year 1|Travel|1|||
161776284|NCT03917654|584223175|FG003|Year 1|Travel|0|||
161776285|NCT03917654|584223176|FG004|Year 1|Travel|4|||
161776286|NCT03917654|584223177|FG005|Year 1|Travel|4|||
161776287|NCT03917654|584223178|FG006|Year 1|Travel|10|||
161776288|NCT03917654|584223179|FG007|Year 1|Travel|8|||
161875791|NCT00550043|584587184|FG000|Overall Study|Subject Withdrew Consent|0|||
161875792|NCT00550043|584587185|FG001|Overall Study|Subject Withdrew Consent|2|||
161875793|NCT00550043|584587186|FG002|Overall Study|Subject Withdrew Consent|1|||
161875794|NCT00550043|584587187|FG003|Overall Study|Subject Withdrew Consent|0|||
161875795|NCT00550043|584587188|FG004|Overall Study|Subject Withdrew Consent|0|||
161875796|NCT00550043|584587184|FG000|Overall Study|Other Reasons- Unspecified|0|||
161875797|NCT00550043|584587185|FG001|Overall Study|Other Reasons- Unspecified|1|||
161875798|NCT00550043|584587186|FG002|Overall Study|Other Reasons- Unspecified|0|||
161875799|NCT00550043|584587187|FG003|Overall Study|Other Reasons- Unspecified|1|||
161875800|NCT00550043|584587188|FG004|Overall Study|Other Reasons- Unspecified|0|||
161875801|NCT00519428|584589555|FG000|Overall Study|Adverse Event|5|||
161875802|NCT00519428|584589556|FG001|Overall Study|Adverse Event|2|||
161875803|NCT00519428|584589557|FG002|Overall Study|Adverse Event|10|||
161875804|NCT00519428|584589555|FG000|Overall Study|Lost to Follow-up|7|||
161875805|NCT00519428|584589556|FG001|Overall Study|Lost to Follow-up|7|||
161875806|NCT00519428|584589557|FG002|Overall Study|Lost to Follow-up|6|||
161875807|NCT00519428|584589555|FG000|Overall Study|Withdrawal by Subject|8|||
161875808|NCT00519428|584589556|FG001|Overall Study|Withdrawal by Subject|3|||
161875809|NCT00519428|584589557|FG002|Overall Study|Withdrawal by Subject|7|||
161875810|NCT00519428|584589555|FG000|Overall Study|unstated|1|||
161875811|NCT00519428|584589556|FG001|Overall Study|unstated|3|||
161875812|NCT00519428|584589557|FG002|Overall Study|unstated|2|||
161875813|NCT00688701|584589558|FG000|Overall Study|Adverse Event|1|||
161875814|NCT00688701|584589559|FG001|Overall Study|Adverse Event|0|||
161875815|NCT00688701|584589560|FG002|Overall Study|Adverse Event|5|||
161875816|NCT00688701|584589561|FG003|Overall Study|Adverse Event|3|||
161875817|NCT00688701|584589558|FG000|Overall Study|Lack of Efficacy|0|||
161875818|NCT00688701|584589559|FG001|Overall Study|Lack of Efficacy|1|||
161875819|NCT00688701|584589560|FG002|Overall Study|Lack of Efficacy|0|||
161875820|NCT00688701|584589561|FG003|Overall Study|Lack of Efficacy|0|||
161875821|NCT00688701|584589558|FG000|Overall Study|Withdrawal by Subject|3|||
161875822|NCT00688701|584589559|FG001|Overall Study|Withdrawal by Subject|3|||
161875823|NCT00688701|584589560|FG002|Overall Study|Withdrawal by Subject|4|||
161875824|NCT00688701|584589561|FG003|Overall Study|Withdrawal by Subject|8|||
161875825|NCT00688701|584589558|FG000|Overall Study|Poor compliance to protocol|0|||
161875826|NCT00688701|584589559|FG001|Overall Study|Poor compliance to protocol|1|||
161875827|NCT00688701|584589560|FG002|Overall Study|Poor compliance to protocol|1|||
161875828|NCT00688701|584589561|FG003|Overall Study|Poor compliance to protocol|0|||
161875829|NCT01275755|584589571|FG000|Double-blind Treatment Period|Adverse Event|0|||
161875830|NCT01275755|584589572|FG001|Double-blind Treatment Period|Adverse Event|2|||
161875831|NCT01275755|584589571|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161875832|NCT01275755|584589572|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161875833|NCT01275755|584589571|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161875834|NCT01275755|584589572|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161875835|NCT01275755|584589571|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
161875836|NCT01275755|584589572|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
161875837|NCT04420585|584589575|FG000|Overall Study|Adverse Event|1|||
161875838|NCT04420585|584589575|FG000|Overall Study|Never initiated medication|2|||
161875839|NCT03693612|584589578|FG000|Overall Study|Lost to Follow-up|0|||
161875840|NCT03693612|584589579|FG001|Overall Study|Lost to Follow-up|0|||
161875841|NCT03693612|584589580|FG002|Overall Study|Lost to Follow-up|0|||
161875842|NCT03693612|584589581|FG003|Overall Study|Lost to Follow-up|0|||
161875843|NCT03693612|584589582|FG004|Overall Study|Lost to Follow-up|1|||
161875844|NCT03693612|584589583|FG005|Overall Study|Lost to Follow-up|0|||
161875845|NCT03693612|584589584|FG006|Overall Study|Lost to Follow-up|0|||
161875846|NCT03693612|584589578|FG000|Overall Study|Withdrawal by Subject|0|||
161875847|NCT03693612|584589579|FG001|Overall Study|Withdrawal by Subject|0|||
161875848|NCT03693612|584589580|FG002|Overall Study|Withdrawal by Subject|1|||
161875849|NCT03693612|584589581|FG003|Overall Study|Withdrawal by Subject|0|||
161875850|NCT03693612|584589582|FG004|Overall Study|Withdrawal by Subject|2|||
161875851|NCT03693612|584589583|FG005|Overall Study|Withdrawal by Subject|0|||
161875852|NCT03693612|584589584|FG006|Overall Study|Withdrawal by Subject|0|||
161875853|NCT03693612|584589578|FG000|Overall Study|Study Terminated by Sponsor|0|||
161875854|NCT03693612|584589579|FG001|Overall Study|Study Terminated by Sponsor|1|||
161875855|NCT03693612|584589580|FG002|Overall Study|Study Terminated by Sponsor|0|||
161875856|NCT03693612|584589581|FG003|Overall Study|Study Terminated by Sponsor|0|||
161875857|NCT03693612|584589582|FG004|Overall Study|Study Terminated by Sponsor|3|||
161875858|NCT03693612|584589583|FG005|Overall Study|Study Terminated by Sponsor|0|||
161875859|NCT03693612|584589584|FG006|Overall Study|Study Terminated by Sponsor|0|||
161875860|NCT03962790|584589585|FG000|Period 1|Adverse Event|0|||
161875861|NCT03962790|584589586|FG001|Period 1|Adverse Event|1|||
161875862|NCT03962790|584589585|FG000|Period 1|Failed to meet all eligibility criteria|1|||
161875863|NCT03962790|584589586|FG001|Period 1|Failed to meet all eligibility criteria|1|||
161875864|NCT03962790|584589585|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
161875865|NCT03962790|584589586|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
161875866|NCT03962790|584589585|FG000|Period 1|Withdrawal by Subject|1|||
161875867|NCT03962790|584589586|FG001|Period 1|Withdrawal by Subject|0|||
161875868|NCT01608087|584589592|FG000|Overall Study|Lost to Follow-up|0|||
161875869|NCT01608087|584589593|FG001|Overall Study|Lost to Follow-up|1|||
161875870|NCT01608087|584589594|FG002|Overall Study|Lost to Follow-up|0|||
161875871|NCT01608087|584589592|FG000|Overall Study|Other Reason|0|||
161875872|NCT01608087|584589593|FG001|Overall Study|Other Reason|1|||
161875873|NCT01608087|584589594|FG002|Overall Study|Other Reason|0|||
161875874|NCT00664859|584589604|FG000|Overall Study|Adverse Event|2|||
161875875|NCT00664859|584589605|FG001|Overall Study|Adverse Event|1|||
161875876|NCT00664859|584589606|FG002|Overall Study|Adverse Event|3|||
161875877|NCT00664859|584589604|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
161875878|NCT00664859|584589605|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
161875879|NCT00664859|584589606|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
161875880|NCT00664859|584589604|FG000|Overall Study|Noncompliance with protocol|1|||
161875881|NCT00664859|584589605|FG001|Overall Study|Noncompliance with protocol|0|||
161875882|NCT00664859|584589606|FG002|Overall Study|Noncompliance with protocol|4|||
161875883|NCT00664859|584589604|FG000|Overall Study|Laboratory abnormality|2|||
161875884|NCT00664859|584589605|FG001|Overall Study|Laboratory abnormality|1|||
161875885|NCT00664859|584589606|FG002|Overall Study|Laboratory abnormality|4|||
161875886|NCT00664859|584589604|FG000|Overall Study|Withdrawal by Subject|4|||
161875887|NCT00664859|584589605|FG001|Overall Study|Withdrawal by Subject|1|||
161875888|NCT00664859|584589606|FG002|Overall Study|Withdrawal by Subject|3|||
161875889|NCT00664859|584589604|FG000|Overall Study|Lost to Follow-up|2|||
161875890|NCT00664859|584589605|FG001|Overall Study|Lost to Follow-up|2|||
161875891|NCT00664859|584589606|FG002|Overall Study|Lost to Follow-up|1|||
161875892|NCT00664859|584589604|FG000|Overall Study|Other|0|||
161875893|NCT00664859|584589605|FG001|Overall Study|Other|1|||
161875894|NCT00664859|584589606|FG002|Overall Study|Other|2|||
161875895|NCT01943851|584589607|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875896|NCT01943851|584589608|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875897|NCT01943851|584589609|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875898|NCT01943851|584589610|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875899|NCT01943851|584589611|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875900|NCT01943851|584589612|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875901|NCT01943851|584589613|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875902|NCT01943851|584589614|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875903|NCT01943851|584589615|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875904|NCT01943851|584589616|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875905|NCT01943851|584589617|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875906|NCT01943851|584589618|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875907|NCT01943851|584589619|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875908|NCT01943851|584589620|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875909|NCT01943851|584589621|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875910|NCT01943851|584589622|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875911|NCT01943851|584589623|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875912|NCT01943851|584589624|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875913|NCT01943851|584589607|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875914|NCT01943851|584589608|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875915|NCT01943851|584589609|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875916|NCT01943851|584589610|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875917|NCT01943851|584589611|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
161875918|NCT01943851|584589612|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875919|NCT01943851|584589613|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875920|NCT01943851|584589614|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
161875921|NCT01943851|584589615|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875922|NCT01943851|584589616|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875923|NCT01943851|584589617|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875924|NCT01943851|584589618|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875925|NCT01943851|584589619|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875926|NCT01943851|584589620|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875927|NCT01943851|584589621|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875928|NCT01943851|584589622|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875929|NCT01943851|584589623|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875930|NCT01943851|584589624|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875931|NCT01943851|584589607|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875932|NCT01943851|584589608|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875933|NCT01943851|584589609|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875934|NCT01943851|584589610|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875935|NCT01943851|584589611|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875936|NCT01943851|584589612|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875937|NCT01943851|584589613|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875938|NCT01943851|584589614|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875939|NCT01943851|584589615|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875940|NCT01943851|584589616|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875941|NCT01943851|584589617|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875942|NCT01943851|584589618|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875943|NCT01943851|584589619|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875944|NCT01943851|584589620|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
161875945|NCT01943851|584589621|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875946|NCT01943851|584589622|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875947|NCT01943851|584589623|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875948|NCT01943851|584589624|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875949|NCT01943851|584589607|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875950|NCT01943851|584589608|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875951|NCT01943851|584589609|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875952|NCT01943851|584589610|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875953|NCT01943851|584589611|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875954|NCT01943851|584589612|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875955|NCT01943851|584589613|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875956|NCT01943851|584589614|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875957|NCT01943851|584589615|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875958|NCT01943851|584589616|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875959|NCT01943851|584589617|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875960|NCT01943851|584589618|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875961|NCT01943851|584589619|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875962|NCT01943851|584589620|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875963|NCT01943851|584589621|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875964|NCT01943851|584589622|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
161776289|NCT03917654|584223180|FG008|Year 1|Travel|2|||
161776290|NCT03917654|584223181|FG009|Year 1|Travel|5|||
161776291|NCT03917654|584223182|FG010|Year 1|Travel|3|||
161776292|NCT03917654|584223183|FG011|Year 1|Travel|3|||
161776293|NCT03917654|584223172|FG000|Year 1|Subject moved away from site|0|||
161776294|NCT03917654|584223173|FG001|Year 1|Subject moved away from site|1|||
161776295|NCT03917654|584223174|FG002|Year 1|Subject moved away from site|0|||
161776296|NCT03917654|584223175|FG003|Year 1|Subject moved away from site|0|||
161776297|NCT03917654|584223176|FG004|Year 1|Subject moved away from site|0|||
161776298|NCT03917654|584223177|FG005|Year 1|Subject moved away from site|0|||
161776299|NCT03917654|584223178|FG006|Year 1|Subject moved away from site|1|||
161776300|NCT03917654|584223179|FG007|Year 1|Subject moved away from site|2|||
161776301|NCT03917654|584223180|FG008|Year 1|Subject moved away from site|1|||
161776302|NCT03917654|584223181|FG009|Year 1|Subject moved away from site|0|||
161776303|NCT03917654|584223182|FG010|Year 1|Subject moved away from site|0|||
161776304|NCT03917654|584223183|FG011|Year 1|Subject moved away from site|3|||
161776305|NCT03917654|584223172|FG000|Year 1|Spouse/Family member request|0|||
161776306|NCT03917654|584223173|FG001|Year 1|Spouse/Family member request|0|||
161776307|NCT03917654|584223174|FG002|Year 1|Spouse/Family member request|1|||
161776308|NCT03917654|584223175|FG003|Year 1|Spouse/Family member request|0|||
161776309|NCT03917654|584223176|FG004|Year 1|Spouse/Family member request|1|||
161776310|NCT03917654|584223177|FG005|Year 1|Spouse/Family member request|0|||
161776311|NCT03917654|584223178|FG006|Year 1|Spouse/Family member request|0|||
161776312|NCT03917654|584223179|FG007|Year 1|Spouse/Family member request|2|||
161776313|NCT03917654|584223180|FG008|Year 1|Spouse/Family member request|0|||
161776314|NCT03917654|584223181|FG009|Year 1|Spouse/Family member request|0|||
161776315|NCT03917654|584223182|FG010|Year 1|Spouse/Family member request|0|||
161776316|NCT03917654|584223183|FG011|Year 1|Spouse/Family member request|1|||
161776317|NCT03917654|584223172|FG000|Year 1|Death|0|||
161776318|NCT03917654|584223173|FG001|Year 1|Death|0|||
161776319|NCT03917654|584223174|FG002|Year 1|Death|0|||
161776320|NCT03917654|584223175|FG003|Year 1|Death|0|||
161776321|NCT03917654|584223176|FG004|Year 1|Death|0|||
161776322|NCT03917654|584223177|FG005|Year 1|Death|0|||
161776323|NCT03917654|584223178|FG006|Year 1|Death|0|||
161776324|NCT03917654|584223179|FG007|Year 1|Death|0|||
161776325|NCT03917654|584223180|FG008|Year 1|Death|1|||
161776326|NCT03917654|584223181|FG009|Year 1|Death|1|||
161776327|NCT03917654|584223182|FG010|Year 1|Death|0|||
161875965|NCT01943851|584589623|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875966|NCT01943851|584589624|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875967|NCT01943851|584589607|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161776328|NCT03917654|584223183|FG011|Year 1|Death|0|||
161776329|NCT03917654|584223172|FG000|Year 1|Lost to Follow-up|0|||
161776330|NCT03917654|584223173|FG001|Year 1|Lost to Follow-up|0|||
161776331|NCT03917654|584223174|FG002|Year 1|Lost to Follow-up|0|||
161776332|NCT03917654|584223175|FG003|Year 1|Lost to Follow-up|0|||
161875968|NCT01943851|584589608|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875969|NCT01943851|584589609|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875970|NCT01943851|584589610|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875971|NCT01943851|584589611|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875972|NCT01943851|584589612|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875973|NCT01943851|584589613|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875974|NCT01943851|584589614|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875975|NCT01943851|584589615|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875976|NCT01943851|584589616|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875977|NCT01943851|584589617|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875978|NCT01943851|584589618|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875979|NCT01943851|584589619|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875980|NCT01943851|584589620|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875981|NCT01943851|584589621|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875982|NCT01943851|584589622|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
161875983|NCT01943851|584589623|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
161875984|NCT01943851|584589624|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
161875985|NCT00401544|584589627|FG000|Overall Study|Adverse Event|5|||
161875986|NCT00401544|584589628|FG001|Overall Study|Adverse Event|1|||
161875987|NCT00401544|584589629|FG002|Overall Study|Adverse Event|1|||
161875988|NCT00401544|584589630|FG003|Overall Study|Adverse Event|1|||
161875989|NCT00401544|584589627|FG000|Overall Study|Death|3|||
161875990|NCT00401544|584589628|FG001|Overall Study|Death|6|||
161875991|NCT00401544|584589629|FG002|Overall Study|Death|2|||
161875992|NCT00401544|584589630|FG003|Overall Study|Death|5|||
161875993|NCT00401544|584589627|FG000|Overall Study|Lost to Follow-up|2|||
161875994|NCT00401544|584589628|FG001|Overall Study|Lost to Follow-up|0|||
161875995|NCT00401544|584589629|FG002|Overall Study|Lost to Follow-up|1|||
161875996|NCT00401544|584589630|FG003|Overall Study|Lost to Follow-up|1|||
161875997|NCT00401544|584589627|FG000|Overall Study|Withdrawal by Subject|7|||
161875998|NCT00401544|584589628|FG001|Overall Study|Withdrawal by Subject|6|||
161875999|NCT00401544|584589629|FG002|Overall Study|Withdrawal by Subject|6|||
161876000|NCT00401544|584589630|FG003|Overall Study|Withdrawal by Subject|5|||
161876001|NCT00401544|584589627|FG000|Overall Study|Physician Decision|1|||
161876002|NCT00401544|584589628|FG001|Overall Study|Physician Decision|3|||
161876003|NCT00401544|584589629|FG002|Overall Study|Physician Decision|0|||
161876004|NCT00401544|584589630|FG003|Overall Study|Physician Decision|0|||
161876005|NCT00401544|584589627|FG000|Overall Study|Ineligibility determined|0|||
161876006|NCT00401544|584589628|FG001|Overall Study|Ineligibility determined|1|||
161876007|NCT00401544|584589629|FG002|Overall Study|Ineligibility determined|0|||
161876008|NCT00401544|584589630|FG003|Overall Study|Ineligibility determined|2|||
161876009|NCT00401544|584589627|FG000|Overall Study|Disease progression|0|||
161876010|NCT00401544|584589628|FG001|Overall Study|Disease progression|1|||
161876011|NCT00401544|584589629|FG002|Overall Study|Disease progression|0|||
161876012|NCT00401544|584589630|FG003|Overall Study|Disease progression|0|||
161876013|NCT00401544|584589627|FG000|Overall Study|Other|0|||
161876014|NCT00401544|584589628|FG001|Overall Study|Other|0|||
161876015|NCT00401544|584589629|FG002|Overall Study|Other|2|||
161876016|NCT00401544|584589630|FG003|Overall Study|Other|2|||
161876017|NCT01250873|584589631|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
161876018|NCT01250873|584589631|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
161876019|NCT04429555|584589632|FG000|Overall Study|Death|0|||
161876020|NCT04429555|584589633|FG001|Overall Study|Death|2|||
161876021|NCT04429555|584589632|FG000|Overall Study|Other|2|||
161876022|NCT04429555|584589633|FG001|Overall Study|Other|0|||
161876023|NCT00930774|584589634|FG000|Overall Study|Withdrawal by Subject|1|||
161876024|NCT00930774|584589635|FG001|Overall Study|Withdrawal by Subject|9|||
161876025|NCT00930774|584589636|FG002|Overall Study|Withdrawal by Subject|2|||
161876026|NCT00930774|584589637|FG003|Overall Study|Withdrawal by Subject|0|||
161876027|NCT03200704|584589638|FG000|Overall Study|Withdrawal by Subject|1|||
161876028|NCT04967885|584589639|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
161876029|NCT04967885|584589640|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
161876030|NCT04967885|584589639|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
161876031|NCT04967885|584589640|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
161876032|NCT04967885|584589639|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
161876033|NCT04967885|584589640|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
161876034|NCT04967885|584589639|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
161876035|NCT04967885|584589640|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
161876036|NCT04967885|584589639|FG000|EMI-II Intervention|Lost to Follow-up|14|||
161876037|NCT04967885|584589640|FG001|EMI-II Intervention|Lost to Follow-up|10|||
161876038|NCT01011465|584589641|FG000|Overall Study|Withdrawal by Subject|2|||
161876039|NCT01011465|584589642|FG001|Overall Study|Withdrawal by Subject|1|||
161876040|NCT01011465|584589643|FG002|Overall Study|Withdrawal by Subject|0|||
161876041|NCT01011465|584589644|FG003|Overall Study|Withdrawal by Subject|0|||
161876042|NCT01011465|584589645|FG004|Overall Study|Withdrawal by Subject|1|||
161876043|NCT01011465|584589646|FG005|Overall Study|Withdrawal by Subject|0|||
161876044|NCT01011465|584589647|FG006|Overall Study|Withdrawal by Subject|1|||
161876045|NCT01011465|584589648|FG007|Overall Study|Withdrawal by Subject|0|||
161876046|NCT02042950|584589651|FG000|Overall Study|Progressive Disease|4|||
161876047|NCT02217410|584589655|FG000|Overall Study|Graft Loss|0|||
161876048|NCT02217410|584589656|FG001|Overall Study|Graft Loss|0|||
161876049|NCT02217410|584589657|FG002|Overall Study|Graft Loss|2|||
161876050|NCT02217410|584589655|FG000|Overall Study|Withdrawal by Subject|0|||
161876051|NCT02217410|584589656|FG001|Overall Study|Withdrawal by Subject|0|||
161876052|NCT02217410|584589657|FG002|Overall Study|Withdrawal by Subject|2|||
161876053|NCT02217410|584589655|FG000|Overall Study|Lost to Follow-up|0|||
161876054|NCT02217410|584589656|FG001|Overall Study|Lost to Follow-up|0|||
161876055|NCT02217410|584589657|FG002|Overall Study|Lost to Follow-up|1|||
161876056|NCT02217410|584589655|FG000|Overall Study|Lack of Efficacy|0|||
161876057|NCT02217410|584589656|FG001|Overall Study|Lack of Efficacy|1|||
161876058|NCT02217410|584589657|FG002|Overall Study|Lack of Efficacy|0|||
161876059|NCT02217410|584589655|FG000|Overall Study|Physician Decision|1|||
161876060|NCT02217410|584589656|FG001|Overall Study|Physician Decision|3|||
161876061|NCT02217410|584589657|FG002|Overall Study|Physician Decision|0|||
161876062|NCT00626821|584589658|FG000|Overall Study|Adverse Event|44|||
161876063|NCT00626821|584589658|FG000|Overall Study|Protocol Violation|33|||
161876064|NCT00626821|584589658|FG000|Overall Study|Withdrawal by Subject|10|||
161876065|NCT00626821|584589658|FG000|Overall Study|Physician Decision|9|||
161876066|NCT00626821|584589658|FG000|Overall Study|Product dysfunction|21|||
161876067|NCT00626821|584589658|FG000|Overall Study|other/unknown reason|104|||
161876068|NCT01940887|584589659|FG000|Year 1|Protocol Violation|0|||
161876069|NCT01940887|584589660|FG001|Year 1|Protocol Violation|1|||
161876070|NCT01940887|584589659|FG000|Year 1|Physician Decision|7|||
161876071|NCT01940887|584589660|FG001|Year 1|Physician Decision|3|||
161876072|NCT01940887|584589659|FG000|Year 1|Death|5|||
161876073|NCT01940887|584589660|FG001|Year 1|Death|3|||
161876074|NCT01940887|584589659|FG000|Year 1|Adverse Event|7|||
161876075|NCT01940887|584589660|FG001|Year 1|Adverse Event|6|||
161876076|NCT01940887|584589659|FG000|Year 1|Withdrawal by Subject|18|||
161876077|NCT01940887|584589660|FG001|Year 1|Withdrawal by Subject|9|||
161876078|NCT01940887|584589659|FG000|Year 1|Lost to Follow-up|2|||
161876079|NCT01940887|584589660|FG001|Year 1|Lost to Follow-up|1|||
161876080|NCT01940887|584589659|FG000|Year 2|Physician Decision|8|||
161876081|NCT01940887|584589660|FG001|Year 2|Physician Decision|1|||
161876082|NCT01940887|584589659|FG000|Year 2|Death|0|||
161876083|NCT01940887|584589660|FG001|Year 2|Death|2|||
161876084|NCT01940887|584589659|FG000|Year 2|Sponsor Decision, early termination|192|||
161876085|NCT01940887|584589660|FG001|Year 2|Sponsor Decision, early termination|203|||
161876086|NCT01940887|584589659|FG000|Year 2|Adverse Event|8|||
161876087|NCT01940887|584589660|FG001|Year 2|Adverse Event|2|||
161876088|NCT01940887|584589659|FG000|Year 2|Withdrawal by Subject|8|||
161876089|NCT01940887|584589660|FG001|Year 2|Withdrawal by Subject|8|||
161876090|NCT01940887|584589659|FG000|Year 2|Lost to Follow-up|1|||
161876091|NCT01940887|584589660|FG001|Year 2|Lost to Follow-up|6|||
161876092|NCT02475265|584589661|FG000|Overall Study|Physician Decision|1|||
161876093|NCT02475265|584589661|FG000|Overall Study|Withdrawal by Subject|2|||
161876094|NCT06586788|584589675|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
161876095|NCT03514485|584589676|FG000|Overall Study|Lost to Follow-up|5|||
161876096|NCT03514485|584589677|FG001|Overall Study|Lost to Follow-up|3|||
161876097|NCT03514485|584589678|FG002|Overall Study|Lost to Follow-up|2|||
161876098|NCT03514485|584589679|FG003|Overall Study|Lost to Follow-up|0|||
161876099|NCT03514485|584589680|FG004|Overall Study|Lost to Follow-up|1|||
161876100|NCT03514485|584589681|FG005|Overall Study|Lost to Follow-up|4|||
161876101|NCT03514485|584589676|FG000|Overall Study|Withdrawal by Subject|0|||
161876102|NCT03514485|584589677|FG001|Overall Study|Withdrawal by Subject|1|||
161876103|NCT03514485|584589678|FG002|Overall Study|Withdrawal by Subject|3|||
161876104|NCT03514485|584589679|FG003|Overall Study|Withdrawal by Subject|1|||
161876105|NCT03514485|584589680|FG004|Overall Study|Withdrawal by Subject|2|||
161876106|NCT03514485|584589681|FG005|Overall Study|Withdrawal by Subject|1|||
161876107|NCT03075891|584589682|FG000|Overall Study|Withdrawal by Subject|3|||
161876108|NCT03075891|584589683|FG001|Overall Study|Withdrawal by Subject|6|||
161876109|NCT03075891|584589682|FG000|Overall Study|Lost to Follow-up|1|||
161876110|NCT03075891|584589683|FG001|Overall Study|Lost to Follow-up|0|||
161876111|NCT03075891|584589682|FG000|Overall Study|Pregnancy|3|||
161876112|NCT03075891|584589683|FG001|Overall Study|Pregnancy|1|||
161876113|NCT03075891|584589682|FG000|Overall Study|visits not performed (no time)|1|||
161876114|NCT03075891|584589683|FG001|Overall Study|visits not performed (no time)|0|||
161876115|NCT03075891|584589682|FG000|Overall Study|Drug abuse relapse issue|0|||
161876116|NCT03075891|584589683|FG001|Overall Study|Drug abuse relapse issue|1|||
161876117|NCT03075891|584589682|FG000|Overall Study|Participant requiring study withdrawal|0|||
161876118|NCT03075891|584589683|FG001|Overall Study|Participant requiring study withdrawal|1|||
161876119|NCT03075891|584589682|FG000|Overall Study|Adverse event, non-fatal|1|||
161876120|NCT03075891|584589683|FG001|Overall Study|Adverse event, non-fatal|4|||
161876121|NCT00582608|584589699|FG000|Overall Study|Not Treated|7|||
161876122|NCT00582608|584589699|FG000|Overall Study|Patient Ineligible|1|||
161776333|NCT03917654|584223176|FG004|Year 1|Lost to Follow-up|0|||
161776334|NCT03917654|584223177|FG005|Year 1|Lost to Follow-up|0|||
161776335|NCT03917654|584223178|FG006|Year 1|Lost to Follow-up|2|||
161776336|NCT03917654|584223179|FG007|Year 1|Lost to Follow-up|0|||
161776337|NCT03917654|584223180|FG008|Year 1|Lost to Follow-up|0|||
161776338|NCT03917654|584223181|FG009|Year 1|Lost to Follow-up|0|||
161776339|NCT03917654|584223182|FG010|Year 1|Lost to Follow-up|0|||
161776340|NCT03917654|584223183|FG011|Year 1|Lost to Follow-up|0|||
161776341|NCT03917654|584223172|FG000|Year 1|Missed visits|0|||
161776342|NCT03917654|584223173|FG001|Year 1|Missed visits|0|||
161776343|NCT03917654|584223174|FG002|Year 1|Missed visits|0|||
161776344|NCT03917654|584223175|FG003|Year 1|Missed visits|0|||
161776345|NCT03917654|584223176|FG004|Year 1|Missed visits|0|||
161776346|NCT03917654|584223177|FG005|Year 1|Missed visits|0|||
161776347|NCT03917654|584223178|FG006|Year 1|Missed visits|0|||
161776348|NCT03917654|584223179|FG007|Year 1|Missed visits|0|||
161776349|NCT03917654|584223180|FG008|Year 1|Missed visits|0|||
161776350|NCT03917654|584223181|FG009|Year 1|Missed visits|0|||
161776351|NCT03917654|584223182|FG010|Year 1|Missed visits|1|||
161776352|NCT03917654|584223183|FG011|Year 1|Missed visits|1|||
161776353|NCT03917654|584223172|FG000|Year 1|Pregnancy|0|||
161776354|NCT03917654|584223173|FG001|Year 1|Pregnancy|0|||
161776355|NCT03917654|584223174|FG002|Year 1|Pregnancy|0|||
161776356|NCT03917654|584223175|FG003|Year 1|Pregnancy|0|||
161776357|NCT03917654|584223176|FG004|Year 1|Pregnancy|0|||
161776358|NCT03917654|584223177|FG005|Year 1|Pregnancy|0|||
161776359|NCT03917654|584223178|FG006|Year 1|Pregnancy|0|||
161776360|NCT03917654|584223179|FG007|Year 1|Pregnancy|1|||
161776361|NCT03917654|584223180|FG008|Year 1|Pregnancy|0|||
161776362|NCT03917654|584223181|FG009|Year 1|Pregnancy|1|||
161776363|NCT03917654|584223182|FG010|Year 1|Pregnancy|0|||
161776364|NCT03917654|584223183|FG011|Year 1|Pregnancy|0|||
161776365|NCT03917654|584223172|FG000|Year 2|Travel|1|||
161776366|NCT03917654|584223173|FG001|Year 2|Travel|0|||
161776367|NCT03917654|584223174|FG002|Year 2|Travel|0|||
161776368|NCT03917654|584223175|FG003|Year 2|Travel|0|||
161776369|NCT03917654|584223176|FG004|Year 2|Travel|1|||
161776370|NCT03917654|584223177|FG005|Year 2|Travel|1|||
161776371|NCT03917654|584223178|FG006|Year 2|Travel|2|||
161776372|NCT03917654|584223179|FG007|Year 2|Travel|1|||
161776373|NCT03917654|584223180|FG008|Year 2|Travel|0|||
161776374|NCT03917654|584223181|FG009|Year 2|Travel|1|||
161776375|NCT03917654|584223182|FG010|Year 2|Travel|0|||
161776376|NCT03917654|584223183|FG011|Year 2|Travel|1|||
161776377|NCT03917654|584223172|FG000|Year 2|Married|1|||
161776378|NCT03917654|584223173|FG001|Year 2|Married|0|||
161776379|NCT03917654|584223174|FG002|Year 2|Married|0|||
161776380|NCT03917654|584223175|FG003|Year 2|Married|0|||
161776381|NCT03917654|584223176|FG004|Year 2|Married|0|||
161776382|NCT03917654|584223177|FG005|Year 2|Married|0|||
161776383|NCT03917654|584223178|FG006|Year 2|Married|1|||
161776384|NCT03917654|584223179|FG007|Year 2|Married|1|||
161776385|NCT03917654|584223180|FG008|Year 2|Married|0|||
161776386|NCT03917654|584223181|FG009|Year 2|Married|0|||
161776387|NCT03917654|584223182|FG010|Year 2|Married|0|||
161776388|NCT03917654|584223183|FG011|Year 2|Married|0|||
161776389|NCT03917654|584223172|FG000|Year 2|Subject moved away from site|1|||
161776390|NCT03917654|584223173|FG001|Year 2|Subject moved away from site|0|||
161776391|NCT03917654|584223174|FG002|Year 2|Subject moved away from site|0|||
161776392|NCT03917654|584223175|FG003|Year 2|Subject moved away from site|0|||
161776393|NCT03917654|584223176|FG004|Year 2|Subject moved away from site|1|||
161876123|NCT00582608|584589699|FG000|Overall Study|Lack of accrual|4|||
161776394|NCT03917654|584223177|FG005|Year 2|Subject moved away from site|0|||
161776395|NCT03917654|584223178|FG006|Year 2|Subject moved away from site|2|||
161776396|NCT03917654|584223179|FG007|Year 2|Subject moved away from site|3|||
161776397|NCT03917654|584223180|FG008|Year 2|Subject moved away from site|0|||
161776398|NCT03917654|584223181|FG009|Year 2|Subject moved away from site|2|||
161776399|NCT03917654|584223182|FG010|Year 2|Subject moved away from site|0|||
161876124|NCT03482453|584589700|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161776400|NCT03917654|584223183|FG011|Year 2|Subject moved away from site|1|||
161776401|NCT03917654|584223172|FG000|Year 2|Year 2 Screening failure|0|||
161776402|NCT03917654|584223173|FG001|Year 2|Year 2 Screening failure|1|||
161776403|NCT03917654|584223174|FG002|Year 2|Year 2 Screening failure|0|||
161776404|NCT03917654|584223175|FG003|Year 2|Year 2 Screening failure|0|||
161776405|NCT03917654|584223176|FG004|Year 2|Year 2 Screening failure|2|||
161776406|NCT03917654|584223177|FG005|Year 2|Year 2 Screening failure|0|||
161776407|NCT03917654|584223178|FG006|Year 2|Year 2 Screening failure|4|||
161776408|NCT03917654|584223179|FG007|Year 2|Year 2 Screening failure|3|||
161776409|NCT03917654|584223180|FG008|Year 2|Year 2 Screening failure|10|||
161776410|NCT03917654|584223181|FG009|Year 2|Year 2 Screening failure|2|||
161776411|NCT03917654|584223182|FG010|Year 2|Year 2 Screening failure|1|||
161776412|NCT03917654|584223183|FG011|Year 2|Year 2 Screening failure|1|||
161776413|NCT03917654|584223172|FG000|Year 2|Death|0|||
161776414|NCT03917654|584223173|FG001|Year 2|Death|0|||
161776415|NCT03917654|584223174|FG002|Year 2|Death|0|||
161776416|NCT03917654|584223175|FG003|Year 2|Death|0|||
161776417|NCT03917654|584223176|FG004|Year 2|Death|0|||
161776418|NCT03917654|584223177|FG005|Year 2|Death|1|||
161776419|NCT03917654|584223178|FG006|Year 2|Death|0|||
161776420|NCT03917654|584223179|FG007|Year 2|Death|0|||
161776421|NCT03917654|584223180|FG008|Year 2|Death|1|||
161776422|NCT03917654|584223181|FG009|Year 2|Death|1|||
161776423|NCT03917654|584223182|FG010|Year 2|Death|0|||
161776424|NCT03917654|584223183|FG011|Year 2|Death|0|||
161776425|NCT03917654|584223172|FG000|Year 2|Withdrawal by Subject|0|||
161776426|NCT03917654|584223173|FG001|Year 2|Withdrawal by Subject|0|||
161776427|NCT03917654|584223174|FG002|Year 2|Withdrawal by Subject|0|||
161776428|NCT03917654|584223175|FG003|Year 2|Withdrawal by Subject|0|||
161776429|NCT03917654|584223176|FG004|Year 2|Withdrawal by Subject|0|||
161776430|NCT03917654|584223177|FG005|Year 2|Withdrawal by Subject|0|||
161776431|NCT03917654|584223178|FG006|Year 2|Withdrawal by Subject|3|||
161776432|NCT03917654|584223179|FG007|Year 2|Withdrawal by Subject|0|||
161776433|NCT03917654|584223180|FG008|Year 2|Withdrawal by Subject|2|||
161776434|NCT03917654|584223181|FG009|Year 2|Withdrawal by Subject|5|||
161776435|NCT03917654|584223182|FG010|Year 2|Withdrawal by Subject|0|||
161776436|NCT03917654|584223183|FG011|Year 2|Withdrawal by Subject|0|||
161776437|NCT03917654|584223172|FG000|Year 2|Spouse/family member request|0|||
161776438|NCT03917654|584223173|FG001|Year 2|Spouse/family member request|0|||
161776439|NCT03917654|584223174|FG002|Year 2|Spouse/family member request|0|||
161776440|NCT03917654|584223175|FG003|Year 2|Spouse/family member request|0|||
161776441|NCT03917654|584223176|FG004|Year 2|Spouse/family member request|0|||
161776442|NCT03917654|584223177|FG005|Year 2|Spouse/family member request|0|||
161776443|NCT03917654|584223178|FG006|Year 2|Spouse/family member request|1|||
161776444|NCT03917654|584223179|FG007|Year 2|Spouse/family member request|0|||
161776445|NCT03917654|584223180|FG008|Year 2|Spouse/family member request|0|||
161776446|NCT03917654|584223181|FG009|Year 2|Spouse/family member request|0|||
161776447|NCT03917654|584223182|FG010|Year 2|Spouse/family member request|0|||
161776448|NCT03917654|584223183|FG011|Year 2|Spouse/family member request|0|||
161776449|NCT03917654|584223172|FG000|Year 2|Lost to Follow-up|0|||
161776450|NCT03917654|584223173|FG001|Year 2|Lost to Follow-up|0|||
161776451|NCT03917654|584223174|FG002|Year 2|Lost to Follow-up|0|||
161776452|NCT03917654|584223175|FG003|Year 2|Lost to Follow-up|0|||
161876125|NCT03482453|584589701|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876126|NCT03482453|584589702|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876127|NCT03482453|584589703|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876128|NCT03482453|584589704|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876129|NCT03482453|584589705|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876130|NCT03482453|584589706|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876131|NCT03482453|584589707|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876132|NCT03482453|584589708|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876133|NCT03482453|584589709|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876134|NCT03482453|584589710|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
161876135|NCT03482453|584589711|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876136|NCT03478644|584589712|FG000|Phase 2|Withdrawal by Subject|2|||
161876137|NCT03478644|584589713|FG001|Phase 2|Withdrawal by Subject|1|||
161876138|NCT03478644|584589712|FG000|Phase 2|Lost to Follow-up|1|||
161876139|NCT03478644|584589713|FG001|Phase 2|Lost to Follow-up|0|||
161876140|NCT02073929|584589714|FG000|Overall Study|Lost to Follow-up|2|||
161876141|NCT02073929|584589715|FG001|Overall Study|Lost to Follow-up|1|||
161876142|NCT02073929|584589714|FG000|Overall Study|Adverse Event|2|||
161876143|NCT02073929|584589715|FG001|Overall Study|Adverse Event|1|||
161876144|NCT02073929|584589714|FG000|Overall Study|Withdrawal by Subject|0|||
161876145|NCT02073929|584589715|FG001|Overall Study|Withdrawal by Subject|1|||
161876146|NCT01870973|584589716|FG000|Overall Study|Lost to Follow-up|10|||
161876147|NCT01870973|584589717|FG001|Overall Study|Lost to Follow-up|3|||
161876148|NCT02504827|584589720|FG000|Overall Study|Could not produce sputum|1|||
161876149|NCT00686829|584589721|FG000|Overall Study|Adverse Event|5|||
161876150|NCT00686829|584589721|FG000|Overall Study|Lack of Efficacy|6|||
161876151|NCT00686829|584589721|FG000|Overall Study|Lost to Follow-up|4|||
161876152|NCT00686829|584589721|FG000|Overall Study|Withdrawal by Subject|14|||
161876153|NCT00686829|584589721|FG000|Overall Study|Protocol Violation|3|||
161876154|NCT00686829|584589721|FG000|Overall Study|Sponsor discontinued VCV|47|||
161876155|NCT00712543|584589722|FG000|Day 8-14|Lost to Follow-up|0|||
161876156|NCT00712543|584589723|FG001|Day 8-14|Lost to Follow-up|2|||
161876157|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
161876158|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
161876159|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
161876160|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
161876161|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
161876162|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
161876163|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
161876164|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
161876165|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
161876166|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
161876167|NCT04740827|584589724|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
161876168|NCT04740827|584589725|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
161876169|NCT00940823|584589726|FG000|Overall Study|Death|8|||
161876170|NCT00940823|584589727|FG001|Overall Study|Death|12|||
161876171|NCT00940823|584589726|FG000|Overall Study|Lost to Follow-up|27|||
161876172|NCT00940823|584589727|FG001|Overall Study|Lost to Follow-up|20|||
161876173|NCT00477750|584592475|FG000|Overall Study|Currently Receiving Treatment|11|||
161876174|NCT01300338|584592477|FG000|Overall Study|Lost to Follow-up|5|||
161876175|NCT01300338|584592478|FG001|Overall Study|Lost to Follow-up|0|||
161876176|NCT02461524|584592479|FG000|Overall Study|Death|16|||
161876177|NCT02461524|584592479|FG000|Overall Study|Withdrawal by Subject|4|||
161876178|NCT02461524|584592479|FG000|Overall Study|Device Explanted|5|||
161876179|NCT02461524|584592479|FG000|Overall Study|Missed Visit|6|||
161876180|NCT00381238|584592483|FG000|Overall Study|Adverse Event|3|||
161876181|NCT00381238|584592483|FG000|Overall Study|Protocol Violation|1|||
161876182|NCT00381238|584592483|FG000|Overall Study|Withdrawal by Subject|4|||
161876183|NCT00381238|584592483|FG000|Overall Study|Lack of Efficacy|2|||
161876184|NCT00381238|584592483|FG000|Overall Study|Withdrew by physician|1|||
161876185|NCT00381238|584592483|FG000|Overall Study|Disease progression|1|||
161876186|NCT00843037|584592486|FG000|Overall Study|Lost to Follow-up|1|||
161876187|NCT02564900|584592487|FG000|Dose Escalation|Progressive disease per RECIST|2|||
161876188|NCT02564900|584592488|FG001|Dose Escalation|Progressive disease per RECIST|3|||
161876189|NCT02564900|584592489|FG002|Dose Escalation|Progressive disease per RECIST|3|||
161876190|NCT02564900|584592490|FG003|Dose Escalation|Progressive disease per RECIST|3|||
161876191|NCT02564900|584592491|FG004|Dose Escalation|Progressive disease per RECIST|3|||
161876192|NCT02564900|584592492|FG005|Dose Escalation|Progressive disease per RECIST|1|||
161876193|NCT02564900|584592493|FG006|Dose Escalation|Progressive disease per RECIST|0|||
161876194|NCT02564900|584592494|FG007|Dose Escalation|Progressive disease per RECIST|0|||
161876195|NCT02564900|584592495|FG008|Dose Escalation|Progressive disease per RECIST|0|||
161876196|NCT02564900|584592496|FG009|Dose Escalation|Progressive disease per RECIST|0|||
161776453|NCT03917654|584223176|FG004|Year 2|Lost to Follow-up|0|||
161776454|NCT03917654|584223177|FG005|Year 2|Lost to Follow-up|0|||
161776455|NCT03917654|584223178|FG006|Year 2|Lost to Follow-up|1|||
161776456|NCT03917654|584223179|FG007|Year 2|Lost to Follow-up|0|||
161776457|NCT03917654|584223180|FG008|Year 2|Lost to Follow-up|1|||
161776458|NCT03917654|584223181|FG009|Year 2|Lost to Follow-up|0|||
161776459|NCT03917654|584223182|FG010|Year 2|Lost to Follow-up|0|||
161776460|NCT03917654|584223183|FG011|Year 2|Lost to Follow-up|1|||
161876197|NCT02564900|584592497|FG010|Dose Escalation|Progressive disease per RECIST|0|||
161876198|NCT02564900|584592498|FG011|Dose Escalation|Progressive disease per RECIST|0|||
161876199|NCT02564900|584592499|FG012|Dose Escalation|Progressive disease per RECIST|0|||
161876200|NCT02564900|584592500|FG013|Dose Escalation|Progressive disease per RECIST|0|||
161876201|NCT02564900|584592501|FG014|Dose Escalation|Progressive disease per RECIST|0|||
161876202|NCT02564900|584592487|FG000|Dose Escalation|Ongoing|1|||
161876203|NCT02564900|584592488|FG001|Dose Escalation|Ongoing|0|||
161876204|NCT02564900|584592489|FG002|Dose Escalation|Ongoing|0|||
161876205|NCT02564900|584592490|FG003|Dose Escalation|Ongoing|2|||
161876206|NCT02564900|584592491|FG004|Dose Escalation|Ongoing|2|||
161876207|NCT02564900|584592492|FG005|Dose Escalation|Ongoing|2|||
161876208|NCT02564900|584592493|FG006|Dose Escalation|Ongoing|0|||
161876209|NCT02564900|584592494|FG007|Dose Escalation|Ongoing|0|||
161876210|NCT02564900|584592495|FG008|Dose Escalation|Ongoing|0|||
161876211|NCT02564900|584592496|FG009|Dose Escalation|Ongoing|0|||
161876212|NCT02564900|584592497|FG010|Dose Escalation|Ongoing|0|||
161876213|NCT02564900|584592498|FG011|Dose Escalation|Ongoing|0|||
161876214|NCT02564900|584592499|FG012|Dose Escalation|Ongoing|0|||
161876215|NCT02564900|584592500|FG013|Dose Escalation|Ongoing|0|||
161876216|NCT02564900|584592501|FG014|Dose Escalation|Ongoing|0|||
161876217|NCT02564900|584592487|FG000|Dose Escalation|Adverse Event|0|||
161876218|NCT02564900|584592488|FG001|Dose Escalation|Adverse Event|0|||
161876219|NCT02564900|584592489|FG002|Dose Escalation|Adverse Event|0|||
161876220|NCT02564900|584592490|FG003|Dose Escalation|Adverse Event|1|||
161876221|NCT02564900|584592491|FG004|Dose Escalation|Adverse Event|1|||
161876222|NCT02564900|584592492|FG005|Dose Escalation|Adverse Event|3|||
161876223|NCT02564900|584592493|FG006|Dose Escalation|Adverse Event|0|||
161876224|NCT02564900|584592494|FG007|Dose Escalation|Adverse Event|0|||
161876225|NCT02564900|584592495|FG008|Dose Escalation|Adverse Event|0|||
161876226|NCT02564900|584592496|FG009|Dose Escalation|Adverse Event|0|||
161876227|NCT02564900|584592497|FG010|Dose Escalation|Adverse Event|0|||
161876228|NCT02564900|584592498|FG011|Dose Escalation|Adverse Event|0|||
161876229|NCT02564900|584592499|FG012|Dose Escalation|Adverse Event|0|||
161876230|NCT02564900|584592500|FG013|Dose Escalation|Adverse Event|0|||
161876231|NCT02564900|584592501|FG014|Dose Escalation|Adverse Event|0|||
161876232|NCT02564900|584592487|FG000|Dose Expansion|Progressive disease per RECIST|0|||
161876233|NCT02564900|584592488|FG001|Dose Expansion|Progressive disease per RECIST|0|||
161876234|NCT02564900|584592489|FG002|Dose Expansion|Progressive disease per RECIST|0|||
161876235|NCT02564900|584592490|FG003|Dose Expansion|Progressive disease per RECIST|0|||
161876236|NCT02564900|584592491|FG004|Dose Expansion|Progressive disease per RECIST|0|||
161876237|NCT02564900|584592492|FG005|Dose Expansion|Progressive disease per RECIST|0|||
161876238|NCT02564900|584592493|FG006|Dose Expansion|Progressive disease per RECIST|19|||
161876239|NCT02564900|584592494|FG007|Dose Expansion|Progressive disease per RECIST|17|||
161876240|NCT02564900|584592495|FG008|Dose Expansion|Progressive disease per RECIST|8|||
161876241|NCT02564900|584592496|FG009|Dose Expansion|Progressive disease per RECIST|16|||
161876242|NCT02564900|584592497|FG010|Dose Expansion|Progressive disease per RECIST|13|||
161876243|NCT02564900|584592498|FG011|Dose Expansion|Progressive disease per RECIST|19|||
161876244|NCT02564900|584592499|FG012|Dose Expansion|Progressive disease per RECIST|10|||
161876245|NCT02564900|584592500|FG013|Dose Expansion|Progressive disease per RECIST|13|||
161876246|NCT02564900|584592501|FG014|Dose Expansion|Progressive disease per RECIST|11|||
161876247|NCT02564900|584592487|FG000|Dose Expansion|Clinical progression|0|||
161876248|NCT02564900|584592488|FG001|Dose Expansion|Clinical progression|0|||
161876249|NCT02564900|584592489|FG002|Dose Expansion|Clinical progression|0|||
161876250|NCT02564900|584592490|FG003|Dose Expansion|Clinical progression|0|||
161876251|NCT02564900|584592491|FG004|Dose Expansion|Clinical progression|0|||
161876252|NCT02564900|584592492|FG005|Dose Expansion|Clinical progression|0|||
161876253|NCT02564900|584592493|FG006|Dose Expansion|Clinical progression|5|||
161876254|NCT02564900|584592494|FG007|Dose Expansion|Clinical progression|12|||
161776461|NCT03917654|584223172|FG000|Year 2|Adverse Event|0|||
161776462|NCT03917654|584223173|FG001|Year 2|Adverse Event|0|||
161876255|NCT02564900|584592495|FG008|Dose Expansion|Clinical progression|0|||
161876256|NCT02564900|584592496|FG009|Dose Expansion|Clinical progression|3|||
161876257|NCT02564900|584592497|FG010|Dose Expansion|Clinical progression|2|||
161876258|NCT02564900|584592498|FG011|Dose Expansion|Clinical progression|0|||
161876259|NCT02564900|584592499|FG012|Dose Expansion|Clinical progression|1|||
161876260|NCT02564900|584592500|FG013|Dose Expansion|Clinical progression|3|||
161876261|NCT02564900|584592501|FG014|Dose Expansion|Clinical progression|1|||
161876262|NCT02564900|584592487|FG000|Dose Expansion|Adverse Event|0|||
161876263|NCT02564900|584592488|FG001|Dose Expansion|Adverse Event|0|||
161776463|NCT03917654|584223174|FG002|Year 2|Adverse Event|0|||
161776464|NCT03917654|584223175|FG003|Year 2|Adverse Event|0|||
161876264|NCT02564900|584592489|FG002|Dose Expansion|Adverse Event|0|||
161876265|NCT02564900|584592490|FG003|Dose Expansion|Adverse Event|0|||
161876266|NCT02564900|584592491|FG004|Dose Expansion|Adverse Event|0|||
161876267|NCT02564900|584592492|FG005|Dose Expansion|Adverse Event|0|||
161876268|NCT02564900|584592493|FG006|Dose Expansion|Adverse Event|9|||
161876269|NCT02564900|584592494|FG007|Dose Expansion|Adverse Event|22|||
161876270|NCT02564900|584592495|FG008|Dose Expansion|Adverse Event|0|||
161876271|NCT02564900|584592496|FG009|Dose Expansion|Adverse Event|11|||
161876272|NCT02564900|584592497|FG010|Dose Expansion|Adverse Event|0|||
161876273|NCT02564900|584592498|FG011|Dose Expansion|Adverse Event|5|||
161876274|NCT02564900|584592499|FG012|Dose Expansion|Adverse Event|2|||
161876275|NCT02564900|584592500|FG013|Dose Expansion|Adverse Event|2|||
161876276|NCT02564900|584592501|FG014|Dose Expansion|Adverse Event|1|||
161776465|NCT03917654|584223176|FG004|Year 2|Adverse Event|0|||
161776466|NCT03917654|584223177|FG005|Year 2|Adverse Event|0|||
161776467|NCT03917654|584223178|FG006|Year 2|Adverse Event|0|||
161776468|NCT03917654|584223179|FG007|Year 2|Adverse Event|0|||
161776469|NCT03917654|584223180|FG008|Year 2|Adverse Event|0|||
161776470|NCT03917654|584223181|FG009|Year 2|Adverse Event|1|||
161776471|NCT03917654|584223182|FG010|Year 2|Adverse Event|0|||
161776472|NCT03917654|584223183|FG011|Year 2|Adverse Event|0|||
161776473|NCT05012943|584223184|FG000|Overall Study|Adverse Event|2|||
161776474|NCT05012943|584223185|FG001|Overall Study|Adverse Event|1|||
161776475|NCT05012943|584223186|FG002|Overall Study|Adverse Event|0|||
161876277|NCT02564900|584592487|FG000|Dose Expansion|Ongoing|0|||
161876278|NCT02564900|584592488|FG001|Dose Expansion|Ongoing|0|||
161876279|NCT02564900|584592489|FG002|Dose Expansion|Ongoing|0|||
161876280|NCT02564900|584592490|FG003|Dose Expansion|Ongoing|0|||
161876281|NCT02564900|584592491|FG004|Dose Expansion|Ongoing|0|||
161876282|NCT02564900|584592492|FG005|Dose Expansion|Ongoing|0|||
161876283|NCT02564900|584592493|FG006|Dose Expansion|Ongoing|9|||
161876284|NCT02564900|584592494|FG007|Dose Expansion|Ongoing|10|||
161876285|NCT02564900|584592495|FG008|Dose Expansion|Ongoing|11|||
161876286|NCT02564900|584592496|FG009|Dose Expansion|Ongoing|3|||
161876287|NCT02564900|584592497|FG010|Dose Expansion|Ongoing|0|||
161876288|NCT02564900|584592498|FG011|Dose Expansion|Ongoing|0|||
161876289|NCT02564900|584592499|FG012|Dose Expansion|Ongoing|4|||
161876290|NCT02564900|584592500|FG013|Dose Expansion|Ongoing|0|||
161876291|NCT02564900|584592501|FG014|Dose Expansion|Ongoing|6|||
161876292|NCT02564900|584592487|FG000|Dose Expansion|Death|0|||
161876293|NCT02564900|584592488|FG001|Dose Expansion|Death|0|||
161876294|NCT02564900|584592489|FG002|Dose Expansion|Death|0|||
161876295|NCT02564900|584592490|FG003|Dose Expansion|Death|0|||
161876296|NCT02564900|584592491|FG004|Dose Expansion|Death|0|||
161876297|NCT02564900|584592492|FG005|Dose Expansion|Death|0|||
161876298|NCT02564900|584592493|FG006|Dose Expansion|Death|1|||
161876299|NCT02564900|584592494|FG007|Dose Expansion|Death|0|||
161876300|NCT02564900|584592495|FG008|Dose Expansion|Death|0|||
161876301|NCT02564900|584592496|FG009|Dose Expansion|Death|0|||
161876302|NCT02564900|584592497|FG010|Dose Expansion|Death|1|||
161876303|NCT02564900|584592498|FG011|Dose Expansion|Death|0|||
161876304|NCT02564900|584592499|FG012|Dose Expansion|Death|1|||
161876305|NCT02564900|584592500|FG013|Dose Expansion|Death|1|||
161876306|NCT02564900|584592501|FG014|Dose Expansion|Death|0|||
161876307|NCT02564900|584592487|FG000|Dose Expansion|Withdrawal by Subject|0|||
161876308|NCT02564900|584592488|FG001|Dose Expansion|Withdrawal by Subject|0|||
161876309|NCT02564900|584592489|FG002|Dose Expansion|Withdrawal by Subject|0|||
161876310|NCT02564900|584592490|FG003|Dose Expansion|Withdrawal by Subject|0|||
161876311|NCT02564900|584592491|FG004|Dose Expansion|Withdrawal by Subject|0|||
161876312|NCT02564900|584592492|FG005|Dose Expansion|Withdrawal by Subject|0|||
161876313|NCT02564900|584592493|FG006|Dose Expansion|Withdrawal by Subject|4|||
161876314|NCT02564900|584592494|FG007|Dose Expansion|Withdrawal by Subject|0|||
161876315|NCT02564900|584592495|FG008|Dose Expansion|Withdrawal by Subject|0|||
161876316|NCT02564900|584592496|FG009|Dose Expansion|Withdrawal by Subject|0|||
161876317|NCT02564900|584592497|FG010|Dose Expansion|Withdrawal by Subject|1|||
161876318|NCT02564900|584592498|FG011|Dose Expansion|Withdrawal by Subject|0|||
161876319|NCT02564900|584592499|FG012|Dose Expansion|Withdrawal by Subject|0|||
161876320|NCT02564900|584592500|FG013|Dose Expansion|Withdrawal by Subject|1|||
161876321|NCT02564900|584592501|FG014|Dose Expansion|Withdrawal by Subject|1|||
161876322|NCT02564900|584592487|FG000|Dose Expansion|Other|0|||
161876323|NCT02564900|584592488|FG001|Dose Expansion|Other|0|||
161876324|NCT02564900|584592489|FG002|Dose Expansion|Other|0|||
161876325|NCT02564900|584592490|FG003|Dose Expansion|Other|0|||
161876326|NCT02564900|584592491|FG004|Dose Expansion|Other|0|||
161876327|NCT02564900|584592492|FG005|Dose Expansion|Other|0|||
161876328|NCT02564900|584592493|FG006|Dose Expansion|Other|1|||
161876329|NCT02564900|584592494|FG007|Dose Expansion|Other|0|||
161876330|NCT02564900|584592495|FG008|Dose Expansion|Other|1|||
161776476|NCT05012943|584223184|FG000|Overall Study|Withdrawal by Subject|1052|||
161876331|NCT02564900|584592496|FG009|Dose Expansion|Other|0|||
161876332|NCT02564900|584592497|FG010|Dose Expansion|Other|0|||
161876333|NCT02564900|584592498|FG011|Dose Expansion|Other|0|||
161876334|NCT02564900|584592499|FG012|Dose Expansion|Other|0|||
161876335|NCT02564900|584592500|FG013|Dose Expansion|Other|0|||
161876336|NCT02564900|584592501|FG014|Dose Expansion|Other|1|||
161876337|NCT02564900|584592487|FG000|Dose Expansion|Did not receive treatment|0|||
161876338|NCT02564900|584592488|FG001|Dose Expansion|Did not receive treatment|0|||
161876339|NCT02564900|584592489|FG002|Dose Expansion|Did not receive treatment|0|||
161876340|NCT02564900|584592490|FG003|Dose Expansion|Did not receive treatment|0|||
161876341|NCT02564900|584592491|FG004|Dose Expansion|Did not receive treatment|0|||
161876342|NCT02564900|584592492|FG005|Dose Expansion|Did not receive treatment|0|||
161876343|NCT02564900|584592493|FG006|Dose Expansion|Did not receive treatment|1|||
161876344|NCT02564900|584592494|FG007|Dose Expansion|Did not receive treatment|1|||
161876345|NCT02564900|584592495|FG008|Dose Expansion|Did not receive treatment|0|||
161876346|NCT02564900|584592496|FG009|Dose Expansion|Did not receive treatment|0|||
161876347|NCT02564900|584592497|FG010|Dose Expansion|Did not receive treatment|0|||
161876348|NCT02564900|584592498|FG011|Dose Expansion|Did not receive treatment|0|||
161876349|NCT02564900|584592499|FG012|Dose Expansion|Did not receive treatment|0|||
161876350|NCT02564900|584592500|FG013|Dose Expansion|Did not receive treatment|0|||
161876351|NCT02564900|584592501|FG014|Dose Expansion|Did not receive treatment|1|||
161876352|NCT03991299|584592502|FG000|Overall Study|Study closed, sponsor decision|3|||
161876353|NCT03991299|584592502|FG000|Overall Study|Withdrawal by Subject|1|||
161876354|NCT02278939|584592507|FG000|Overall Study|lack of time|1|||
161876355|NCT02278939|584592508|FG001|Overall Study|lack of time|0|||
161876356|NCT02278939|584592507|FG000|Overall Study|Lost to Follow-up|1|||
161876357|NCT02278939|584592508|FG001|Overall Study|Lost to Follow-up|1|||
161876358|NCT02278939|584592507|FG000|Overall Study|death in family|1|||
161876359|NCT02278939|584592508|FG001|Overall Study|death in family|0|||
161876360|NCT02278939|584592507|FG000|Overall Study|family emergency unable to commit|2|||
161876361|NCT02278939|584592508|FG001|Overall Study|family emergency unable to commit|0|||
161876362|NCT02423343|584592511|FG000|Overall Study|Withdrawal by Subject|0|||
161876363|NCT02423343|584592512|FG001|Overall Study|Withdrawal by Subject|1|||
161876364|NCT02423343|584592513|FG002|Overall Study|Withdrawal by Subject|0|||
161876365|NCT02423343|584592514|FG003|Overall Study|Withdrawal by Subject|0|||
161876366|NCT02423343|584592515|FG004|Overall Study|Withdrawal by Subject|0|||
161876367|NCT02423343|584592516|FG005|Overall Study|Withdrawal by Subject|0|||
161876368|NCT02423343|584592511|FG000|Overall Study|Progressive Disease|0|||
161876369|NCT02423343|584592512|FG001|Overall Study|Progressive Disease|0|||
161876370|NCT02423343|584592513|FG002|Overall Study|Progressive Disease|0|||
161876371|NCT02423343|584592514|FG003|Overall Study|Progressive Disease|0|||
161876372|NCT02423343|584592515|FG004|Overall Study|Progressive Disease|2|||
161876373|NCT02423343|584592516|FG005|Overall Study|Progressive Disease|0|||
161876374|NCT02423343|584592511|FG000|Overall Study|Adverse Event|0|||
161876375|NCT02423343|584592512|FG001|Overall Study|Adverse Event|0|||
161876376|NCT02423343|584592513|FG002|Overall Study|Adverse Event|0|||
161876377|NCT02423343|584592514|FG003|Overall Study|Adverse Event|0|||
161876378|NCT02423343|584592515|FG004|Overall Study|Adverse Event|2|||
161876379|NCT02423343|584592516|FG005|Overall Study|Adverse Event|0|||
161876380|NCT02423343|584592511|FG000|Overall Study|Death|0|||
161876381|NCT02423343|584592512|FG001|Overall Study|Death|0|||
161876382|NCT02423343|584592513|FG002|Overall Study|Death|0|||
161876383|NCT02423343|584592514|FG003|Overall Study|Death|0|||
161876384|NCT02423343|584592515|FG004|Overall Study|Death|1|||
161876385|NCT02423343|584592516|FG005|Overall Study|Death|0|||
161876386|NCT02703272|584592524|FG000|Overall Study|Death|4|||
161876387|NCT02703272|584592525|FG001|Overall Study|Death|9|||
161876388|NCT02703272|584592526|FG002|Overall Study|Death|19|||
161876389|NCT02703272|584592527|FG003|Overall Study|Death|10|||
161876390|NCT02703272|584592524|FG000|Overall Study|Withdrawal by Subject|0|||
161876391|NCT02703272|584592525|FG001|Overall Study|Withdrawal by Subject|0|||
161876392|NCT02703272|584592526|FG002|Overall Study|Withdrawal by Subject|4|||
161876393|NCT02703272|584592527|FG003|Overall Study|Withdrawal by Subject|2|||
161876394|NCT02703272|584592524|FG000|Overall Study|Study Terminated by Sponsor|6|||
161876395|NCT02703272|584592525|FG001|Overall Study|Study Terminated by Sponsor|1|||
161876396|NCT02703272|584592526|FG002|Overall Study|Study Terminated by Sponsor|12|||
161876397|NCT02703272|584592527|FG003|Overall Study|Study Terminated by Sponsor|4|||
161876398|NCT02703272|584592524|FG000|Overall Study|Other|1|||
161876399|NCT02703272|584592525|FG001|Overall Study|Other|0|||
161876400|NCT02703272|584592526|FG002|Overall Study|Other|0|||
161876401|NCT02703272|584592527|FG003|Overall Study|Other|0|||
161876402|NCT00712881|584592528|FG000|Overall Study|Adverse Event|3|||
161876403|NCT00712881|584592529|FG001|Overall Study|Adverse Event|3|||
161876404|NCT00712881|584592528|FG000|Overall Study|Withdrawal by Subject|1|||
161876405|NCT00712881|584592529|FG001|Overall Study|Withdrawal by Subject|1|||
161876406|NCT00712881|584592528|FG000|Overall Study|Disease Progression|2|||
161876407|NCT00712881|584592529|FG001|Overall Study|Disease Progression|1|||
161876408|NCT00712881|584592528|FG000|Overall Study|Lost to Follow-up|1|||
161876409|NCT00712881|584592529|FG001|Overall Study|Lost to Follow-up|1|||
161876410|NCT00712881|584592528|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
161876411|NCT00712881|584592529|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
161876412|NCT00712881|584592528|FG000|Overall Study|Protocol Violation|1|||
161876413|NCT00712881|584592529|FG001|Overall Study|Protocol Violation|1|||
161876414|NCT00712881|584592528|FG000|Overall Study|Randomized but not treated|1|||
161876415|NCT00712881|584592529|FG001|Overall Study|Randomized but not treated|0|||
161876416|NCT01680861|584592530|FG000|Early Post-transplant Period|Protocol Violation|1|||
161876417|NCT01680861|584592531|FG001|Early Post-transplant Period|Protocol Violation|1|||
161876418|NCT00654875|584592532|FG000|Overall Study|Adverse Event|5|||
161876419|NCT00654875|584592533|FG001|Overall Study|Adverse Event|5|||
161876420|NCT00654875|584592532|FG000|Overall Study|Withdrawal by Subject|4|||
161876421|NCT00654875|584592533|FG001|Overall Study|Withdrawal by Subject|4|||
161876422|NCT00654875|584592532|FG000|Overall Study|Protocol Violation|3|||
161876423|NCT00654875|584592533|FG001|Overall Study|Protocol Violation|3|||
161876424|NCT00654875|584592532|FG000|Overall Study|Lack of Efficacy|2|||
161876425|NCT00654875|584592533|FG001|Overall Study|Lack of Efficacy|2|||
161876426|NCT00654875|584592532|FG000|Overall Study|Lost to Follow-up|1|||
161876427|NCT00654875|584592533|FG001|Overall Study|Lost to Follow-up|3|||
161876428|NCT00654875|584592532|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
161876429|NCT00654875|584592533|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161876430|NCT00654875|584592532|FG000|Overall Study|Administrative Problems|1|||
161876431|NCT00654875|584592533|FG001|Overall Study|Administrative Problems|0|||
161876432|NCT00723008|584592534|FG000|Enrollment|Lost to Follow-up|1|||
161876433|NCT00723008|584592535|FG001|Enrollment|Lost to Follow-up|0|||
161876434|NCT00723008|584592534|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
161876435|NCT00723008|584592535|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
161876436|NCT00723008|584592534|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
161876437|NCT00723008|584592535|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
161876438|NCT00723008|584592534|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
161876439|NCT00723008|584592535|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
161876440|NCT00723008|584592534|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
161876441|NCT00723008|584592535|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
161876442|NCT00723008|584592534|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
161876443|NCT00723008|584592535|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
161876444|NCT01014988|584592536|FG000|Overall Study|Adverse Event|20|||
161876445|NCT01014988|584592537|FG001|Overall Study|Adverse Event|0|||
161876446|NCT01014988|584592538|FG002|Overall Study|Adverse Event|1|||
161876447|NCT01014988|584592539|FG003|Overall Study|Adverse Event|0|||
161876448|NCT01014988|584592540|FG004|Overall Study|Adverse Event|1|||
161876449|NCT01014988|584592541|FG005|Overall Study|Adverse Event|3|||
161876450|NCT01014988|584592536|FG000|Overall Study|Lost to Follow-up|1|||
161876451|NCT01014988|584592537|FG001|Overall Study|Lost to Follow-up|0|||
161876452|NCT01014988|584592538|FG002|Overall Study|Lost to Follow-up|1|||
161876453|NCT01014988|584592539|FG003|Overall Study|Lost to Follow-up|0|||
161876454|NCT01014988|584592540|FG004|Overall Study|Lost to Follow-up|0|||
161876455|NCT01014988|584592541|FG005|Overall Study|Lost to Follow-up|0|||
161876456|NCT01014988|584592536|FG000|Overall Study|Physician Decision|1|||
161876457|NCT01014988|584592537|FG001|Overall Study|Physician Decision|0|||
161876458|NCT01014988|584592538|FG002|Overall Study|Physician Decision|0|||
161876459|NCT01014988|584592539|FG003|Overall Study|Physician Decision|0|||
161876460|NCT01014988|584592540|FG004|Overall Study|Physician Decision|0|||
161876461|NCT01014988|584592541|FG005|Overall Study|Physician Decision|0|||
161876462|NCT01014988|584592536|FG000|Overall Study|Withdrawal by Subject|1|||
161876463|NCT01014988|584592537|FG001|Overall Study|Withdrawal by Subject|0|||
161876464|NCT01014988|584592538|FG002|Overall Study|Withdrawal by Subject|0|||
161876465|NCT01014988|584592539|FG003|Overall Study|Withdrawal by Subject|0|||
161876466|NCT01014988|584592540|FG004|Overall Study|Withdrawal by Subject|0|||
161876467|NCT01014988|584592541|FG005|Overall Study|Withdrawal by Subject|0|||
161876468|NCT05835011|584592543|FG000|Overall Study|Study Terminated by the Sponsor|1|||
161876469|NCT05835011|584592543|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
161876470|NCT01683266|584592544|FG000|Overall Study|Adverse Event|5|||
161876471|NCT01683266|584592545|FG001|Overall Study|Adverse Event|4|||
161876472|NCT01683266|584592544|FG000|Overall Study|Lack of Efficacy|5|||
161876473|NCT01683266|584592545|FG001|Overall Study|Lack of Efficacy|2|||
161876474|NCT01683266|584592544|FG000|Overall Study|Protocol Violation|13|||
161876475|NCT01683266|584592545|FG001|Overall Study|Protocol Violation|6|||
161876476|NCT01683266|584592544|FG000|Overall Study|Personal Reason|17|||
161876477|NCT01683266|584592545|FG001|Overall Study|Personal Reason|25|||
161876478|NCT01683266|584592544|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
161876479|NCT01683266|584592545|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
161876480|NCT01683266|584592544|FG000|Overall Study|Lost to Follow-up|5|||
161876481|NCT01683266|584592545|FG001|Overall Study|Lost to Follow-up|0|||
161876482|NCT01683266|584592544|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
161876483|NCT01683266|584592545|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
161876484|NCT01683266|584592544|FG000|Overall Study|Nonserious Hypoglycemia|0|||
161876485|NCT01683266|584592545|FG001|Overall Study|Nonserious Hypoglycemia|3|||
161876486|NCT01683266|584592544|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161876487|NCT01683266|584592545|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161876488|NCT01683266|584592544|FG000|Overall Study|Possibly Hypoglycemia|1|||
161876489|NCT01683266|584592545|FG001|Overall Study|Possibly Hypoglycemia|0|||
161876490|NCT01683266|584592544|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
161876491|NCT01683266|584592545|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
161876492|NCT02222545|584592550|FG000|Overall Study|Adverse Event|1|||
161876493|NCT02222545|584592551|FG001|Overall Study|Adverse Event|0|||
161876494|NCT02222545|584592552|FG002|Overall Study|Adverse Event|2|||
161876495|NCT02222545|584592550|FG000|Overall Study|Death|0|||
161876496|NCT02222545|584592551|FG001|Overall Study|Death|0|||
161876497|NCT02222545|584592552|FG002|Overall Study|Death|9|||
161876498|NCT02222545|584592550|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
161876499|NCT02222545|584592551|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
161876500|NCT02222545|584592552|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
161876501|NCT02222545|584592550|FG000|Overall Study|Withdrawal by Subject|0|||
161876502|NCT02222545|584592551|FG001|Overall Study|Withdrawal by Subject|0|||
161876503|NCT02222545|584592552|FG002|Overall Study|Withdrawal by Subject|3|||
161876504|NCT02222545|584592550|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
161876505|NCT02222545|584592551|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
161876506|NCT02222545|584592552|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
161876507|NCT00090220|584592553|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
161876508|NCT00090220|584592554|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
161876509|NCT00090220|584592555|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876510|NCT00090220|584592556|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876511|NCT00090220|584592557|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876512|NCT00090220|584592558|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876513|NCT00090220|584592553|FG000|Base Study Vaccination Period|Adverse Event|6|||
161876514|NCT00090220|584592554|FG001|Base Study Vaccination Period|Adverse Event|1|||
161876515|NCT00090220|584592555|FG002|Base Study Vaccination Period|Adverse Event|0|||
161876516|NCT00090220|584592556|FG003|Base Study Vaccination Period|Adverse Event|0|||
161876517|NCT00090220|584592557|FG004|Base Study Vaccination Period|Adverse Event|0|||
161876518|NCT00090220|584592558|FG005|Base Study Vaccination Period|Adverse Event|0|||
161876519|NCT00090220|584592553|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
161876520|NCT00090220|584592554|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
161776477|NCT05012943|584223185|FG001|Overall Study|Withdrawal by Subject|1006|||
161776478|NCT05012943|584223186|FG002|Overall Study|Withdrawal by Subject|20|||
161776479|NCT05012943|584223184|FG000|Overall Study|Death|25|||
161776480|NCT05012943|584223185|FG001|Overall Study|Death|17|||
161776481|NCT05012943|584223186|FG002|Overall Study|Death|4|||
161776482|NCT05012943|584223184|FG000|Overall Study|Lost to Follow-up|11|||
161776483|NCT05012943|584223185|FG001|Overall Study|Lost to Follow-up|24|||
161776484|NCT05012943|584223186|FG002|Overall Study|Lost to Follow-up|3|||
161776485|NCT05012943|584223184|FG000|Overall Study|Physician Decision|1|||
161776486|NCT05012943|584223185|FG001|Overall Study|Physician Decision|1|||
161776487|NCT05012943|584223186|FG002|Overall Study|Physician Decision|0|||
161776488|NCT05012943|584223184|FG000|Overall Study|Other than Specified|2|||
161776489|NCT05012943|584223185|FG001|Overall Study|Other than Specified|1|||
161776490|NCT05012943|584223186|FG002|Overall Study|Other than Specified|0|||
161776491|NCT00400985|584223188|FG000|Overall Study|Withdrawal by Subject|5|||
161776492|NCT00400985|584223188|FG000|Overall Study|system modification|8|||
161776493|NCT00400985|584223188|FG000|Overall Study|Death|30|||
161776494|NCT00400985|584223188|FG000|Overall Study|Lost to Follow-up|9|||
161776495|NCT05048875|584223190|FG000|Overall Study|Withdrawal by Subject|1|||
161776496|NCT05048875|584223191|FG001|Overall Study|Withdrawal by Subject|0|||
161776497|NCT05048875|584223192|FG002|Overall Study|Withdrawal by Subject|0|||
161776498|NCT05048875|584223193|FG003|Overall Study|Withdrawal by Subject|0|||
161776499|NCT05048875|584223194|FG004|Overall Study|Withdrawal by Subject|0|||
161776500|NCT05048875|584223195|FG005|Overall Study|Withdrawal by Subject|0|||
161776501|NCT05048875|584223196|FG006|Overall Study|Withdrawal by Subject|0|||
161776502|NCT05048875|584223197|FG007|Overall Study|Withdrawal by Subject|0|||
161776503|NCT05048875|584223190|FG000|Overall Study|Adverse Event|0|||
161776504|NCT05048875|584223191|FG001|Overall Study|Adverse Event|0|||
161776505|NCT05048875|584223192|FG002|Overall Study|Adverse Event|0|||
161776506|NCT05048875|584223193|FG003|Overall Study|Adverse Event|1|||
161776507|NCT05048875|584223194|FG004|Overall Study|Adverse Event|0|||
161776508|NCT05048875|584223195|FG005|Overall Study|Adverse Event|0|||
161776509|NCT05048875|584223196|FG006|Overall Study|Adverse Event|0|||
161776510|NCT05048875|584223197|FG007|Overall Study|Adverse Event|0|||
161876521|NCT00090220|584592555|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161876522|NCT00090220|584592556|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161876523|NCT00090220|584592557|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161876524|NCT00090220|584592558|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
161876525|NCT00090220|584592553|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
161876526|NCT00090220|584592554|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
161876527|NCT00090220|584592555|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876528|NCT00090220|584592556|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876529|NCT00090220|584592557|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876530|NCT00090220|584592558|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876531|NCT00090220|584592553|FG000|Base Study Vaccination Period|Patient Moved|6|||
161876532|NCT00090220|584592554|FG001|Base Study Vaccination Period|Patient Moved|2|||
161876533|NCT00090220|584592555|FG002|Base Study Vaccination Period|Patient Moved|0|||
161876534|NCT00090220|584592556|FG003|Base Study Vaccination Period|Patient Moved|0|||
161876535|NCT00090220|584592557|FG004|Base Study Vaccination Period|Patient Moved|0|||
161876536|NCT00090220|584592558|FG005|Base Study Vaccination Period|Patient Moved|0|||
161876537|NCT00090220|584592553|FG000|Base Study Vaccination Period|Other|4|||
161876538|NCT00090220|584592554|FG001|Base Study Vaccination Period|Other|4|||
161876539|NCT00090220|584592555|FG002|Base Study Vaccination Period|Other|0|||
161876540|NCT00090220|584592556|FG003|Base Study Vaccination Period|Other|0|||
161876541|NCT00090220|584592557|FG004|Base Study Vaccination Period|Other|0|||
161876542|NCT00090220|584592558|FG005|Base Study Vaccination Period|Other|0|||
161876543|NCT00090220|584592553|FG000|Base Study Follow-up Period|Adverse Event|6|||
161876544|NCT00090220|584592554|FG001|Base Study Follow-up Period|Adverse Event|1|||
161876545|NCT00090220|584592555|FG002|Base Study Follow-up Period|Adverse Event|0|||
161876546|NCT00090220|584592556|FG003|Base Study Follow-up Period|Adverse Event|0|||
161876547|NCT00090220|584592557|FG004|Base Study Follow-up Period|Adverse Event|0|||
161876548|NCT00090220|584592558|FG005|Base Study Follow-up Period|Adverse Event|0|||
161876549|NCT00090220|584592553|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
161876550|NCT00090220|584592554|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
161876551|NCT00090220|584592555|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
161876552|NCT00090220|584592556|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
161876553|NCT00090220|584592557|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161876554|NCT00090220|584592558|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
161876555|NCT00090220|584592553|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
161876556|NCT00090220|584592554|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
161876557|NCT00090220|584592555|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876558|NCT00090220|584592556|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876559|NCT00090220|584592557|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876560|NCT00090220|584592558|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876561|NCT00090220|584592553|FG000|Base Study Follow-up Period|Patient Moved|20|||
161876562|NCT00090220|584592554|FG001|Base Study Follow-up Period|Patient Moved|28|||
161876563|NCT00090220|584592555|FG002|Base Study Follow-up Period|Patient Moved|0|||
161876564|NCT00090220|584592556|FG003|Base Study Follow-up Period|Patient Moved|0|||
161876565|NCT00090220|584592557|FG004|Base Study Follow-up Period|Patient Moved|0|||
161876566|NCT00090220|584592558|FG005|Base Study Follow-up Period|Patient Moved|0|||
161876567|NCT00090220|584592553|FG000|Base Study Follow-up Period|Other|19|||
161876568|NCT00090220|584592554|FG001|Base Study Follow-up Period|Other|21|||
161876569|NCT00090220|584592555|FG002|Base Study Follow-up Period|Other|0|||
161876570|NCT00090220|584592556|FG003|Base Study Follow-up Period|Other|0|||
161876571|NCT00090220|584592557|FG004|Base Study Follow-up Period|Other|0|||
161876572|NCT00090220|584592558|FG005|Base Study Follow-up Period|Other|0|||
161876573|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Adverse Event|0|||
161876574|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Adverse Event|0|||
161876575|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Adverse Event|4|||
161876576|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Adverse Event|0|||
161876577|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Adverse Event|0|||
161876578|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Adverse Event|0|||
161876579|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876580|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876581|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
161876582|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876583|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876584|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876585|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Moved|0|||
161876586|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Moved|0|||
161876587|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Moved|2|||
161876588|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Moved|1|||
161876589|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Moved|0|||
161876590|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Moved|0|||
161876591|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876592|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876593|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
161876594|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876595|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876596|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876597|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
161876598|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
161876599|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
161876600|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
161876601|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
161876602|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
161876603|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Other reason|0|||
161876604|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Other reason|0|||
161876605|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Other reason|2|||
161876606|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Other reason|0|||
161876607|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Other reason|0|||
161876608|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Other reason|0|||
161876609|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876610|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876611|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876612|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876613|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
161876614|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
161876615|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Death|0|||
161876616|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Death|0|||
161876617|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Death|0|||
161876618|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Death|0|||
161876619|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Death|1|||
161876620|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Death|1|||
161876621|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876622|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876623|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876624|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876625|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
161876626|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
161876627|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Other|0|||
161876628|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Other|0|||
161876629|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Other|0|||
161876630|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Other|0|||
161876631|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Other|1|||
161876632|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Other|0|||
161876633|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
161876634|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
161876635|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
161876636|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
161876637|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
161876638|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876639|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876640|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876641|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876642|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
161876643|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161876644|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161876645|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
161876646|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161876647|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
161876648|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Death|0|||
161876649|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Death|0|||
161876650|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Death|1|||
161876651|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Death|2|||
161876652|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Death|7|||
161876653|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
161876654|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
161876655|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
161876656|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
161876657|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
161876658|NCT00941863|584592559|FG000|Continued After PCD|Withdrawal by Subject|0|||
161876659|NCT00941863|584592560|FG001|Continued After PCD|Withdrawal by Subject|0|||
161876660|NCT00941863|584592561|FG002|Continued After PCD|Withdrawal by Subject|0|||
161876661|NCT00941863|584592562|FG003|Continued After PCD|Withdrawal by Subject|0|||
161876662|NCT00941863|584592563|FG004|Continued After PCD|Withdrawal by Subject|1|||
161876663|NCT00941863|584592559|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876664|NCT00941863|584592560|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876665|NCT00941863|584592561|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876666|NCT00941863|584592562|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876667|NCT00941863|584592563|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
161876668|NCT01471340|584592564|FG000|Overall Study|Death|5|||
161876669|NCT01471340|584592565|FG001|Overall Study|Death|4|||
161876670|NCT01471340|584592564|FG000|Overall Study|Lost to Follow-up|0|||
161876671|NCT01471340|584592565|FG001|Overall Study|Lost to Follow-up|1|||
161876672|NCT01471340|584592564|FG000|Overall Study|Investigational site closure|0|||
161876673|NCT01471340|584592565|FG001|Overall Study|Investigational site closure|1|||
161876674|NCT01471340|584592564|FG000|Overall Study|Invalid informed consent|1|||
161876675|NCT01471340|584592565|FG001|Overall Study|Invalid informed consent|0|||
161876676|NCT03452488|584592566|FG000|Overall Study|Adverse Event|4|||
161876677|NCT03452488|584592567|FG001|Overall Study|Adverse Event|6|||
161876678|NCT03452488|584592568|FG002|Overall Study|Adverse Event|1|||
161876679|NCT03452488|584592566|FG000|Overall Study|Death|0|||
161876680|NCT03452488|584592567|FG001|Overall Study|Death|0|||
161876681|NCT03452488|584592568|FG002|Overall Study|Death|1|||
161876682|NCT03452488|584592566|FG000|Overall Study|Lost to Follow-up|1|||
161876683|NCT03452488|584592567|FG001|Overall Study|Lost to Follow-up|2|||
161876684|NCT03452488|584592568|FG002|Overall Study|Lost to Follow-up|0|||
161876685|NCT03452488|584592566|FG000|Overall Study|PI Decision|1|||
161876686|NCT03452488|584592567|FG001|Overall Study|PI Decision|0|||
161876687|NCT03452488|584592568|FG002|Overall Study|PI Decision|0|||
161876688|NCT03452488|584592566|FG000|Overall Study|Withdrew consent|4|||
161876689|NCT03452488|584592567|FG001|Overall Study|Withdrew consent|2|||
161876690|NCT03452488|584592568|FG002|Overall Study|Withdrew consent|2|||
161876691|NCT03452488|584592566|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
161876692|NCT03452488|584592567|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
161876693|NCT03452488|584592568|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
161876694|NCT03452488|584592566|FG000|Overall Study|Other|0|||
161876695|NCT03452488|584592567|FG001|Overall Study|Other|2|||
161876696|NCT03452488|584592568|FG002|Overall Study|Other|2|||
161876697|NCT03315286|584592569|FG000|Overall Study|Lost to Follow-up|0|||
161876698|NCT03315286|584592570|FG001|Overall Study|Lost to Follow-up|3|||
161876699|NCT03315286|584592569|FG000|Overall Study|Withdrawal by Subject|1|||
161876700|NCT03315286|584592570|FG001|Overall Study|Withdrawal by Subject|0|||
161876701|NCT03315286|584592569|FG000|Overall Study|Protocol Violation|0|||
161876702|NCT03315286|584592570|FG001|Overall Study|Protocol Violation|1|||
161876703|NCT00747474|584592571|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876704|NCT00747474|584592572|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876705|NCT00747474|584592573|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876706|NCT00747474|584592574|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876707|NCT00747474|584592575|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876708|NCT00747474|584592576|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876709|NCT00747474|584592577|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876710|NCT00747474|584592578|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
161876711|NCT00747474|584592579|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876712|NCT00747474|584592580|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876713|NCT00747474|584592581|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876714|NCT00747474|584592582|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876715|NCT02829723|584592584|FG000|Overall Study|Adverse Event|0|||
161876716|NCT02829723|584592585|FG001|Overall Study|Adverse Event|0|||
161876717|NCT02829723|584592586|FG002|Overall Study|Adverse Event|1|||
161876718|NCT02829723|584592587|FG003|Overall Study|Adverse Event|1|||
161876719|NCT02829723|584592588|FG004|Overall Study|Adverse Event|0|||
161876720|NCT02829723|584592589|FG005|Overall Study|Adverse Event|0|||
161876721|NCT02829723|584592590|FG006|Overall Study|Adverse Event|0|||
161876722|NCT02829723|584592591|FG007|Overall Study|Adverse Event|1|||
161876723|NCT02829723|584592592|FG008|Overall Study|Adverse Event|0|||
161876724|NCT02829723|584592593|FG009|Overall Study|Adverse Event|0|||
161876725|NCT02829723|584592594|FG010|Overall Study|Adverse Event|0|||
161876726|NCT02829723|584592595|FG011|Overall Study|Adverse Event|0|||
161876727|NCT02829723|584592596|FG012|Overall Study|Adverse Event|0|||
161876728|NCT02829723|584592597|FG013|Overall Study|Adverse Event|0|||
161876729|NCT02829723|584592598|FG014|Overall Study|Adverse Event|1|||
161876730|NCT02829723|584592599|FG015|Overall Study|Adverse Event|1|||
161876731|NCT02829723|584592600|FG016|Overall Study|Adverse Event|1|||
161876732|NCT02829723|584592601|FG017|Overall Study|Adverse Event|2|||
161876733|NCT02829723|584592602|FG018|Overall Study|Adverse Event|1|||
161876734|NCT02829723|584592603|FG019|Overall Study|Adverse Event|1|||
161876735|NCT02829723|584592604|FG020|Overall Study|Adverse Event|3|||
161876736|NCT02829723|584592605|FG021|Overall Study|Adverse Event|0|||
161876737|NCT02829723|584592606|FG022|Overall Study|Adverse Event|0|||
161876738|NCT02829723|584592607|FG023|Overall Study|Adverse Event|1|||
161876739|NCT02829723|584592608|FG024|Overall Study|Adverse Event|1|||
161876740|NCT02829723|584592609|FG025|Overall Study|Adverse Event|3|||
161876741|NCT02829723|584592610|FG026|Overall Study|Adverse Event|5|||
161876742|NCT02829723|584592584|FG000|Overall Study|Death|1|||
161876743|NCT02829723|584592585|FG001|Overall Study|Death|0|||
161876744|NCT02829723|584592586|FG002|Overall Study|Death|1|||
161876745|NCT02829723|584592587|FG003|Overall Study|Death|1|||
161876746|NCT02829723|584592588|FG004|Overall Study|Death|0|||
161876747|NCT02829723|584592589|FG005|Overall Study|Death|0|||
161876748|NCT02829723|584592590|FG006|Overall Study|Death|2|||
161876749|NCT02829723|584592591|FG007|Overall Study|Death|0|||
161876750|NCT02829723|584592592|FG008|Overall Study|Death|1|||
161876751|NCT02829723|584592593|FG009|Overall Study|Death|0|||
161876752|NCT02829723|584592594|FG010|Overall Study|Death|0|||
161876753|NCT02829723|584592595|FG011|Overall Study|Death|0|||
161876754|NCT02829723|584592596|FG012|Overall Study|Death|2|||
161876755|NCT02829723|584592597|FG013|Overall Study|Death|1|||
161876756|NCT02829723|584592598|FG014|Overall Study|Death|0|||
161876757|NCT02829723|584592599|FG015|Overall Study|Death|0|||
161876758|NCT02829723|584592600|FG016|Overall Study|Death|0|||
161876759|NCT02829723|584592601|FG017|Overall Study|Death|0|||
161876760|NCT02829723|584592602|FG018|Overall Study|Death|0|||
161876761|NCT02829723|584592603|FG019|Overall Study|Death|0|||
161876762|NCT02829723|584592604|FG020|Overall Study|Death|0|||
161876763|NCT02829723|584592605|FG021|Overall Study|Death|2|||
161876764|NCT02829723|584592606|FG022|Overall Study|Death|0|||
161876765|NCT02829723|584592607|FG023|Overall Study|Death|0|||
161876766|NCT02829723|584592608|FG024|Overall Study|Death|0|||
161876767|NCT02829723|584592609|FG025|Overall Study|Death|1|||
161876768|NCT02829723|584592610|FG026|Overall Study|Death|2|||
161876769|NCT02829723|584592584|FG000|Overall Study|Physician Decision|0|||
161876770|NCT02829723|584592585|FG001|Overall Study|Physician Decision|0|||
161876771|NCT02829723|584592586|FG002|Overall Study|Physician Decision|0|||
161876772|NCT02829723|584592587|FG003|Overall Study|Physician Decision|0|||
161876773|NCT02829723|584592588|FG004|Overall Study|Physician Decision|0|||
161876774|NCT02829723|584592589|FG005|Overall Study|Physician Decision|0|||
161876775|NCT02829723|584592590|FG006|Overall Study|Physician Decision|0|||
161876776|NCT02829723|584592591|FG007|Overall Study|Physician Decision|0|||
161876777|NCT02829723|584592592|FG008|Overall Study|Physician Decision|0|||
161876778|NCT02829723|584592593|FG009|Overall Study|Physician Decision|1|||
161876779|NCT02829723|584592594|FG010|Overall Study|Physician Decision|1|||
161876780|NCT02829723|584592595|FG011|Overall Study|Physician Decision|0|||
161876781|NCT02829723|584592596|FG012|Overall Study|Physician Decision|0|||
161876782|NCT02829723|584592597|FG013|Overall Study|Physician Decision|1|||
161876783|NCT02829723|584592598|FG014|Overall Study|Physician Decision|0|||
161876784|NCT02829723|584592599|FG015|Overall Study|Physician Decision|0|||
161876785|NCT02829723|584592600|FG016|Overall Study|Physician Decision|2|||
161876786|NCT02829723|584592601|FG017|Overall Study|Physician Decision|0|||
161876787|NCT02829723|584592602|FG018|Overall Study|Physician Decision|0|||
161876788|NCT02829723|584592603|FG019|Overall Study|Physician Decision|0|||
161876789|NCT02829723|584592604|FG020|Overall Study|Physician Decision|0|||
161876790|NCT02829723|584592605|FG021|Overall Study|Physician Decision|0|||
161876791|NCT02829723|584592606|FG022|Overall Study|Physician Decision|1|||
161876792|NCT02829723|584592607|FG023|Overall Study|Physician Decision|1|||
161876793|NCT02829723|584592608|FG024|Overall Study|Physician Decision|1|||
161876794|NCT02829723|584592609|FG025|Overall Study|Physician Decision|1|||
161876795|NCT02829723|584592610|FG026|Overall Study|Physician Decision|3|||
161876796|NCT02829723|584592584|FG000|Overall Study|Progressive disease|4|||
161876797|NCT02829723|584592585|FG001|Overall Study|Progressive disease|6|||
161876798|NCT02829723|584592586|FG002|Overall Study|Progressive disease|3|||
161876799|NCT02829723|584592587|FG003|Overall Study|Progressive disease|3|||
161876800|NCT02829723|584592588|FG004|Overall Study|Progressive disease|3|||
161876801|NCT02829723|584592589|FG005|Overall Study|Progressive disease|5|||
161876802|NCT02829723|584592590|FG006|Overall Study|Progressive disease|4|||
161876803|NCT02829723|584592591|FG007|Overall Study|Progressive disease|6|||
161876804|NCT02829723|584592592|FG008|Overall Study|Progressive disease|8|||
161876805|NCT02829723|584592593|FG009|Overall Study|Progressive disease|4|||
161876806|NCT02829723|584592594|FG010|Overall Study|Progressive disease|9|||
161876807|NCT02829723|584592595|FG011|Overall Study|Progressive disease|0|||
161876808|NCT02829723|584592596|FG012|Overall Study|Progressive disease|3|||
161876809|NCT02829723|584592597|FG013|Overall Study|Progressive disease|4|||
161876810|NCT02829723|584592598|FG014|Overall Study|Progressive disease|2|||
161876811|NCT02829723|584592599|FG015|Overall Study|Progressive disease|4|||
161876812|NCT02829723|584592600|FG016|Overall Study|Progressive disease|5|||
161876813|NCT02829723|584592601|FG017|Overall Study|Progressive disease|3|||
161876814|NCT02829723|584592602|FG018|Overall Study|Progressive disease|4|||
161876815|NCT02829723|584592603|FG019|Overall Study|Progressive disease|4|||
161876816|NCT02829723|584592604|FG020|Overall Study|Progressive disease|7|||
161876817|NCT02829723|584592605|FG021|Overall Study|Progressive disease|6|||
161876818|NCT02829723|584592606|FG022|Overall Study|Progressive disease|3|||
161876819|NCT02829723|584592607|FG023|Overall Study|Progressive disease|3|||
161876820|NCT02829723|584592608|FG024|Overall Study|Progressive disease|3|||
161876821|NCT02829723|584592609|FG025|Overall Study|Progressive disease|16|||
161876822|NCT02829723|584592610|FG026|Overall Study|Progressive disease|10|||
161876823|NCT02829723|584592584|FG000|Overall Study|Subject/guardian decision|0|||
161876824|NCT02829723|584592585|FG001|Overall Study|Subject/guardian decision|1|||
161876825|NCT02829723|584592586|FG002|Overall Study|Subject/guardian decision|0|||
161876826|NCT02829723|584592587|FG003|Overall Study|Subject/guardian decision|1|||
161876827|NCT02829723|584592588|FG004|Overall Study|Subject/guardian decision|0|||
161876828|NCT02829723|584592589|FG005|Overall Study|Subject/guardian decision|0|||
161876829|NCT02829723|584592590|FG006|Overall Study|Subject/guardian decision|0|||
161876830|NCT02829723|584592591|FG007|Overall Study|Subject/guardian decision|1|||
161876831|NCT02829723|584592592|FG008|Overall Study|Subject/guardian decision|0|||
161876832|NCT02829723|584592593|FG009|Overall Study|Subject/guardian decision|0|||
161876833|NCT02829723|584592594|FG010|Overall Study|Subject/guardian decision|0|||
161876834|NCT02829723|584592595|FG011|Overall Study|Subject/guardian decision|0|||
161876835|NCT02829723|584592596|FG012|Overall Study|Subject/guardian decision|0|||
161876836|NCT02829723|584592597|FG013|Overall Study|Subject/guardian decision|0|||
161876837|NCT02829723|584592598|FG014|Overall Study|Subject/guardian decision|1|||
161876838|NCT02829723|584592599|FG015|Overall Study|Subject/guardian decision|0|||
161876839|NCT02829723|584592600|FG016|Overall Study|Subject/guardian decision|1|||
161876840|NCT02829723|584592601|FG017|Overall Study|Subject/guardian decision|0|||
161876841|NCT02829723|584592602|FG018|Overall Study|Subject/guardian decision|1|||
161876842|NCT02829723|584592603|FG019|Overall Study|Subject/guardian decision|0|||
161876843|NCT02829723|584592604|FG020|Overall Study|Subject/guardian decision|1|||
161876844|NCT02829723|584592605|FG021|Overall Study|Subject/guardian decision|0|||
161876845|NCT02829723|584592606|FG022|Overall Study|Subject/guardian decision|0|||
161876846|NCT02829723|584592607|FG023|Overall Study|Subject/guardian decision|1|||
161876847|NCT02829723|584592608|FG024|Overall Study|Subject/guardian decision|0|||
161876848|NCT02829723|584592609|FG025|Overall Study|Subject/guardian decision|1|||
161876849|NCT02829723|584592610|FG026|Overall Study|Subject/guardian decision|1|||
161876850|NCT02829723|584592584|FG000|Overall Study|Study terminated by sponsor|0|||
161876851|NCT02829723|584592585|FG001|Overall Study|Study terminated by sponsor|0|||
161876852|NCT02829723|584592586|FG002|Overall Study|Study terminated by sponsor|0|||
161876853|NCT02829723|584592587|FG003|Overall Study|Study terminated by sponsor|0|||
161876854|NCT02829723|584592588|FG004|Overall Study|Study terminated by sponsor|0|||
161876855|NCT02829723|584592589|FG005|Overall Study|Study terminated by sponsor|0|||
161876856|NCT02829723|584592590|FG006|Overall Study|Study terminated by sponsor|0|||
161876857|NCT02829723|584592591|FG007|Overall Study|Study terminated by sponsor|0|||
161876858|NCT02829723|584592592|FG008|Overall Study|Study terminated by sponsor|0|||
161876859|NCT02829723|584592593|FG009|Overall Study|Study terminated by sponsor|0|||
161876860|NCT02829723|584592594|FG010|Overall Study|Study terminated by sponsor|0|||
161876861|NCT02829723|584592595|FG011|Overall Study|Study terminated by sponsor|0|||
161876862|NCT02829723|584592596|FG012|Overall Study|Study terminated by sponsor|0|||
161876863|NCT02829723|584592597|FG013|Overall Study|Study terminated by sponsor|0|||
161876864|NCT02829723|584592598|FG014|Overall Study|Study terminated by sponsor|0|||
161876865|NCT02829723|584592599|FG015|Overall Study|Study terminated by sponsor|0|||
161876866|NCT02829723|584592600|FG016|Overall Study|Study terminated by sponsor|0|||
161876867|NCT02829723|584592601|FG017|Overall Study|Study terminated by sponsor|0|||
161876868|NCT02829723|584592602|FG018|Overall Study|Study terminated by sponsor|0|||
161876869|NCT02829723|584592603|FG019|Overall Study|Study terminated by sponsor|0|||
161876870|NCT02829723|584592604|FG020|Overall Study|Study terminated by sponsor|0|||
161876871|NCT02829723|584592605|FG021|Overall Study|Study terminated by sponsor|1|||
161876872|NCT02829723|584592606|FG022|Overall Study|Study terminated by sponsor|0|||
161876873|NCT02829723|584592607|FG023|Overall Study|Study terminated by sponsor|0|||
161876874|NCT02829723|584592608|FG024|Overall Study|Study terminated by sponsor|0|||
161876875|NCT02829723|584592609|FG025|Overall Study|Study terminated by sponsor|0|||
161876876|NCT02829723|584592610|FG026|Overall Study|Study terminated by sponsor|0|||
161876877|NCT02989649|584592611|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
161876878|NCT02989649|584592611|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
161876879|NCT02989649|584592611|FG000|Overall Study|Lost For Observation During Study|3|||
161876880|NCT02989649|584592611|FG000|Overall Study|Reason Not Specified|13|||
161876881|NCT00330343|584592612|FG000|Overall Study|Lost to Follow-up|5|||
161876882|NCT00256854|584592613|FG000|Overall Study|Withdrawal by Subject|2|||
161876883|NCT00256854|584592614|FG001|Overall Study|Withdrawal by Subject|3|||
161876884|NCT00256854|584592615|FG002|Overall Study|Withdrawal by Subject|0|||
161876885|NCT00256854|584592616|FG003|Overall Study|Withdrawal by Subject|0|||
161876886|NCT00256854|584592617|FG004|Overall Study|Withdrawal by Subject|0|||
161876887|NCT00256854|584592618|FG005|Overall Study|Withdrawal by Subject|0|||
161876888|NCT00256854|584592613|FG000|Overall Study|Lack of Efficacy|1|||
161876889|NCT00256854|584592614|FG001|Overall Study|Lack of Efficacy|0|||
161876890|NCT00256854|584592615|FG002|Overall Study|Lack of Efficacy|0|||
161876891|NCT00256854|584592616|FG003|Overall Study|Lack of Efficacy|0|||
161876892|NCT00256854|584592617|FG004|Overall Study|Lack of Efficacy|0|||
161876893|NCT00256854|584592618|FG005|Overall Study|Lack of Efficacy|0|||
161876894|NCT00256854|584592613|FG000|Overall Study|Protocol Violation|0|||
161876895|NCT00256854|584592614|FG001|Overall Study|Protocol Violation|1|||
161876896|NCT00256854|584592615|FG002|Overall Study|Protocol Violation|1|||
161876897|NCT00256854|584592616|FG003|Overall Study|Protocol Violation|1|||
161876898|NCT00256854|584592617|FG004|Overall Study|Protocol Violation|0|||
161876899|NCT00256854|584592618|FG005|Overall Study|Protocol Violation|0|||
161876900|NCT00256854|584592613|FG000|Overall Study|Adverse Event|0|||
161876901|NCT00256854|584592614|FG001|Overall Study|Adverse Event|0|||
161876902|NCT00256854|584592615|FG002|Overall Study|Adverse Event|2|||
161876903|NCT00256854|584592616|FG003|Overall Study|Adverse Event|2|||
161876904|NCT00256854|584592617|FG004|Overall Study|Adverse Event|0|||
161876905|NCT00256854|584592618|FG005|Overall Study|Adverse Event|1|||
161876906|NCT00256854|584592613|FG000|Overall Study|Not compliant with the study drug|0|||
161876907|NCT00256854|584592614|FG001|Overall Study|Not compliant with the study drug|0|||
161876908|NCT00256854|584592615|FG002|Overall Study|Not compliant with the study drug|0|||
161876909|NCT00256854|584592616|FG003|Overall Study|Not compliant with the study drug|0|||
161876910|NCT00256854|584592617|FG004|Overall Study|Not compliant with the study drug|1|||
161876911|NCT00256854|584592618|FG005|Overall Study|Not compliant with the study drug|0|||
161876912|NCT00281632|584592619|FG000|Overall Study|Adverse Event|7|||
161876913|NCT00281632|584592619|FG000|Overall Study|Withdrawal by Subject|2|||
161876914|NCT00281632|584592619|FG000|Overall Study|Disease Progression|22|||
161876915|NCT00281632|584592619|FG000|Overall Study|Death|1|||
161876916|NCT00281632|584592619|FG000|Overall Study|Physician Decision|1|||
161876917|NCT00281632|584592619|FG000|Overall Study|Ongoing|3|||
161876918|NCT03047720|584592625|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
161876919|NCT03047720|584592626|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
161876920|NCT01475851|584592637|FG000|Overall Study|Protocol defined stopping criteria|1|||
161876921|NCT01475851|584592638|FG001|Overall Study|Protocol defined stopping criteria|0|||
161876922|NCT04603482|584592639|FG000|Overall Study|Lost to Follow-up|15|||
161876923|NCT04603482|584592640|FG001|Overall Study|Lost to Follow-up|15|||
161876924|NCT04603482|584592641|FG002|Overall Study|Lost to Follow-up|15|||
161876925|NCT00732758|584592642|FG000|Overall Study|Lost to Follow-up|8|||
161876926|NCT00732758|584592643|FG001|Overall Study|Lost to Follow-up|16|||
161876927|NCT00373958|584592644|FG000|Infant Series|Withdrawal by Subject|13|||
161876928|NCT00373958|584592645|FG001|Infant Series|Withdrawal by Subject|15|||
161876929|NCT00373958|584592644|FG000|Infant Series|Failed to return|8|||
161876930|NCT00373958|584592645|FG001|Infant Series|Failed to return|13|||
161876931|NCT00373958|584592644|FG000|Infant Series|Lost to Follow-up|6|||
161876932|NCT00373958|584592645|FG001|Infant Series|Lost to Follow-up|5|||
161876933|NCT00373958|584592644|FG000|Infant Series|Protocol Violation|3|||
161876934|NCT00373958|584592645|FG001|Infant Series|Protocol Violation|7|||
161876935|NCT00373958|584592644|FG000|Infant Series|Lost Kaiser coverage|4|||
161876936|NCT00373958|584592645|FG001|Infant Series|Lost Kaiser coverage|0|||
161876937|NCT00373958|584592644|FG000|Infant Series|Child relocated|1|||
161876938|NCT00373958|584592645|FG001|Infant Series|Child relocated|0|||
161876939|NCT00373958|584592644|FG000|Infant Series|Consent was not received|1|||
161876940|NCT00373958|584592645|FG001|Infant Series|Consent was not received|0|||
161876941|NCT00373958|584592644|FG000|Infant Series|Adverse Event|3|||
161876942|NCT00373958|584592645|FG001|Infant Series|Adverse Event|1|||
161876943|NCT00373958|584592644|FG000|Infant Series|Physician Decision|1|||
161876944|NCT00373958|584592645|FG001|Infant Series|Physician Decision|1|||
161876945|NCT00373958|584592644|FG000|Toddler Dose|Lost to Follow-up|5|||
161876946|NCT00373958|584592645|FG001|Toddler Dose|Lost to Follow-up|8|||
161876947|NCT00373958|584592644|FG000|Toddler Dose|Withdrawal by Subject|2|||
161876948|NCT00373958|584592645|FG001|Toddler Dose|Withdrawal by Subject|2|||
161876949|NCT00373958|584592644|FG000|Toddler Dose|Failed to return|1|||
161876950|NCT00373958|584592645|FG001|Toddler Dose|Failed to return|2|||
161876951|NCT00373958|584592644|FG000|Toddler Dose|Protocol Violation|0|||
161876952|NCT00373958|584592645|FG001|Toddler Dose|Protocol Violation|1|||
161876953|NCT00373958|584592644|FG000|Toddler Dose|Withdrawn after infant series|22|||
161876954|NCT00373958|584592645|FG001|Toddler Dose|Withdrawn after infant series|25|||
161876955|NCT01552915|584592646|FG000|Overall Study|Adverse Event|3|||
161876956|NCT01552915|584592647|FG001|Overall Study|Adverse Event|14|||
161876957|NCT01552915|584592648|FG002|Overall Study|Adverse Event|3|||
161876958|NCT01552915|584592646|FG000|Overall Study|Lost to Follow-up|4|||
161876959|NCT01552915|584592647|FG001|Overall Study|Lost to Follow-up|6|||
161876960|NCT01552915|584592648|FG002|Overall Study|Lost to Follow-up|5|||
161876961|NCT01552915|584592646|FG000|Overall Study|Withdrawal by Subject|6|||
161876962|NCT01552915|584592647|FG001|Overall Study|Withdrawal by Subject|4|||
161876963|NCT01552915|584592648|FG002|Overall Study|Withdrawal by Subject|5|||
161876964|NCT01552915|584592646|FG000|Overall Study|Protocol Violation|0|||
161876965|NCT01552915|584592647|FG001|Overall Study|Protocol Violation|4|||
161876966|NCT01552915|584592648|FG002|Overall Study|Protocol Violation|4|||
161876967|NCT01552915|584592646|FG000|Overall Study|Lack of Efficacy|8|||
161876968|NCT01552915|584592647|FG001|Overall Study|Lack of Efficacy|1|||
161876969|NCT01552915|584592648|FG002|Overall Study|Lack of Efficacy|4|||
161876970|NCT01552915|584592646|FG000|Overall Study|Other|2|||
161876971|NCT01552915|584592647|FG001|Overall Study|Other|0|||
161876972|NCT01552915|584592648|FG002|Overall Study|Other|6|||
161876973|NCT00179673|584592651|FG000|Overall Study|Adverse Event|7|||
161876974|NCT00179673|584592651|FG000|Overall Study|Lack of Efficacy|15|||
161876975|NCT00179673|584592651|FG000|Overall Study|Withdrawal by Subject|3|||
161876976|NCT00179673|584592651|FG000|Overall Study|Death|4|||
161876977|NCT00179673|584592651|FG000|Overall Study|Other Observations and options|14|||
161876978|NCT00492648|584592652|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
161876979|NCT00492648|584592653|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
161876980|NCT00282113|584592654|FG000|Overall Study|Removed at parents request|1|||
161876981|NCT00282113|584592655|FG001|Overall Study|Removed at parents request|0|||
161876982|NCT00282113|584592656|FG002|Overall Study|Removed at parents request|0|||
161876983|NCT03382834|584592657|FG000|Step 1|Lost to Follow-up|0|||
161876984|NCT03382834|584592658|FG001|Step 1|Lost to Follow-up|1|||
161876985|NCT03382834|584592657|FG000|Step 2|Death|1|||
161876986|NCT03382834|584592658|FG001|Step 2|Death|0|||
161876987|NCT03382834|584592657|FG000|Step 2|Lost to Follow-up|2|||
161876988|NCT03382834|584592658|FG001|Step 2|Lost to Follow-up|2|||
161876989|NCT03382834|584592657|FG000|Step 2|Site Terminated by Sponsor|1|||
161876990|NCT03382834|584592658|FG001|Step 2|Site Terminated by Sponsor|0|||
161876991|NCT02387957|584592659|FG000|Overall Study|The study was discontinued|21|||
161876992|NCT02387957|584592660|FG001|Overall Study|The study was discontinued|21|||
161876993|NCT02387957|584592661|FG002|Overall Study|The study was discontinued|20|||
161876994|NCT02887248|584592662|FG000|Overall Study|Withdrawal by Subject|1|||
161876995|NCT02887248|584592662|FG000|Overall Study|Adverse Event|1|||
161876996|NCT02887248|584592662|FG000|Overall Study|Progressive Disease|1|||
161876997|NCT02294396|584592663|FG000|Overall Study|Adverse Event|26|||
161876998|NCT02294396|584592664|FG001|Overall Study|Adverse Event|25|||
161876999|NCT02294396|584592665|FG002|Overall Study|Adverse Event|21|||
161877000|NCT02294396|584592666|FG003|Overall Study|Adverse Event|24|||
161877001|NCT02294396|584592663|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
161877002|NCT02294396|584592664|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
161877003|NCT02294396|584592665|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
161877004|NCT02294396|584592666|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
161877005|NCT02294396|584592663|FG000|Overall Study|Withdrawal by Subject|8|||
161877006|NCT02294396|584592664|FG001|Overall Study|Withdrawal by Subject|6|||
161877007|NCT02294396|584592665|FG002|Overall Study|Withdrawal by Subject|6|||
161877008|NCT02294396|584592666|FG003|Overall Study|Withdrawal by Subject|8|||
161877009|NCT02294396|584592663|FG000|Overall Study|Lost to Follow-up|0|||
161877010|NCT02294396|584592664|FG001|Overall Study|Lost to Follow-up|0|||
161877011|NCT02294396|584592665|FG002|Overall Study|Lost to Follow-up|1|||
161877012|NCT02294396|584592666|FG003|Overall Study|Lost to Follow-up|1|||
161877013|NCT02294396|584592663|FG000|Overall Study|Protocol Deviation|3|||
161877014|NCT02294396|584592664|FG001|Overall Study|Protocol Deviation|2|||
161877015|NCT02294396|584592665|FG002|Overall Study|Protocol Deviation|2|||
161877016|NCT02294396|584592666|FG003|Overall Study|Protocol Deviation|1|||
161877017|NCT02294396|584592663|FG000|Overall Study|Miscellaneous|2|||
161877018|NCT02294396|584592664|FG001|Overall Study|Miscellaneous|0|||
161877019|NCT02294396|584592665|FG002|Overall Study|Miscellaneous|5|||
161877020|NCT02294396|584592666|FG003|Overall Study|Miscellaneous|2|||
161877021|NCT02120833|584592667|FG000|Overall Study|Adverse Event|1|||
161877022|NCT02120833|584592668|FG001|Overall Study|Adverse Event|0|||
161877023|NCT02120833|584592667|FG000|Overall Study|Withdrawal by Subject|2|||
161877024|NCT02120833|584592668|FG001|Overall Study|Withdrawal by Subject|0|||
161877025|NCT02120833|584592667|FG000|Overall Study|Lost to Follow-up|1|||
161877026|NCT02120833|584592668|FG001|Overall Study|Lost to Follow-up|1|||
161877027|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
161877028|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
161877029|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161877030|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161877031|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
161877032|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161877033|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161877034|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161877035|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161877036|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161877037|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161877038|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161877039|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161877040|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
161877041|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161877042|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161877043|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
161877044|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
161877045|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
161877046|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
161877047|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Adverse Event|11|||
161877048|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Adverse Event|6|||
161877049|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Adverse Event|0|||
161877050|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Adverse Event|0|||
161877051|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
161877052|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
161877053|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
161877054|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
161877055|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
161877056|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
161877057|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
161877058|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
161877059|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
161877060|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
161877061|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
161877062|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
161877063|NCT02438826|584592669|FG000|Post-Treatment Phase|Adverse Event|3|||
161877064|NCT02438826|584592670|FG001|Post-Treatment Phase|Adverse Event|0|||
161877065|NCT02438826|584592671|FG002|Post-Treatment Phase|Adverse Event|0|||
161877066|NCT02438826|584592672|FG003|Post-Treatment Phase|Adverse Event|0|||
161877067|NCT02438826|584592669|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
161877068|NCT02438826|584592670|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
161877069|NCT02438826|584592671|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
161877070|NCT02438826|584592672|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
161877071|NCT02438826|584592669|FG000|Post-Treatment Phase|Physician Decision|1|||
161877072|NCT02438826|584592670|FG001|Post-Treatment Phase|Physician Decision|0|||
161877073|NCT02438826|584592671|FG002|Post-Treatment Phase|Physician Decision|0|||
161877074|NCT02438826|584592672|FG003|Post-Treatment Phase|Physician Decision|0|||
161877075|NCT02438826|584592669|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
161877076|NCT02438826|584592670|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
161877077|NCT02438826|584592671|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
161877078|NCT02438826|584592672|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
161877079|NCT03429244|584592676|FG000|Overall Study|Withdrawal by Subject|2|||
161877080|NCT03429244|584592677|FG001|Overall Study|Withdrawal by Subject|1|||
161877081|NCT03429244|584592678|FG002|Overall Study|Withdrawal by Subject|1|||
161877082|NCT01500187|584592679|FG000|Overall Study|Lost to Follow-up|6|||
161877083|NCT01500187|584592680|FG001|Overall Study|Lost to Follow-up|0|||
161877084|NCT00784550|584594188|FG000|Overall Study|Adverse Event|12|||
161877085|NCT00784550|584594189|FG001|Overall Study|Adverse Event|10|||
161877086|NCT00784550|584594188|FG000|Overall Study|Lack of Efficacy|0|||
161877087|NCT00784550|584594189|FG001|Overall Study|Lack of Efficacy|1|||
161877088|NCT00784550|584594188|FG000|Overall Study|Protocol Violation|10|||
161877089|NCT00784550|584594189|FG001|Overall Study|Protocol Violation|10|||
161877090|NCT00784550|584594188|FG000|Overall Study|Lost to Follow-up|8|||
161877091|NCT00784550|584594189|FG001|Overall Study|Lost to Follow-up|5|||
161877092|NCT00784550|584594188|FG000|Overall Study|Physician Decision|2|||
161877093|NCT00784550|584594189|FG001|Overall Study|Physician Decision|3|||
161877094|NCT00784550|584594188|FG000|Overall Study|Withdrawal by Subject|4|||
161877095|NCT00784550|584594189|FG001|Overall Study|Withdrawal by Subject|13|||
161877096|NCT03558152|584594191|FG000|Overall Study|Adverse Event|0|||
161877097|NCT03558152|584594192|FG001|Overall Study|Adverse Event|0|||
161877098|NCT03558152|584594193|FG002|Overall Study|Adverse Event|1|||
161877099|NCT03558152|584594194|FG003|Overall Study|Adverse Event|1|||
161877100|NCT03558152|584594195|FG004|Overall Study|Adverse Event|2|||
161877101|NCT03558152|584594196|FG005|Overall Study|Adverse Event|1|||
161877102|NCT03558152|584594197|FG006|Overall Study|Adverse Event|1|||
161877103|NCT03558152|584594198|FG007|Overall Study|Adverse Event|0|||
161877104|NCT03558152|584594191|FG000|Overall Study|Death|0|||
161877105|NCT03558152|584594192|FG001|Overall Study|Death|0|||
161877106|NCT03558152|584594193|FG002|Overall Study|Death|0|||
161877107|NCT03558152|584594194|FG003|Overall Study|Death|0|||
161877108|NCT03558152|584594195|FG004|Overall Study|Death|1|||
161877109|NCT03558152|584594196|FG005|Overall Study|Death|0|||
161877110|NCT03558152|584594197|FG006|Overall Study|Death|0|||
161877111|NCT03558152|584594198|FG007|Overall Study|Death|0|||
161877112|NCT03558152|584594191|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
161877113|NCT03558152|584594192|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877114|NCT03558152|584594193|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877115|NCT03558152|584594194|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877116|NCT03558152|584594195|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877117|NCT03558152|584594196|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877118|NCT03558152|584594197|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877119|NCT03558152|584594198|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877120|NCT03558152|584594191|FG000|Overall Study|Miscalculation in mmcs|0|||
161877121|NCT03558152|584594192|FG001|Overall Study|Miscalculation in mmcs|0|||
161877122|NCT03558152|584594193|FG002|Overall Study|Miscalculation in mmcs|0|||
161877123|NCT03558152|584594194|FG003|Overall Study|Miscalculation in mmcs|0|||
161877124|NCT03558152|584594195|FG004|Overall Study|Miscalculation in mmcs|0|||
161877125|NCT03558152|584594196|FG005|Overall Study|Miscalculation in mmcs|0|||
161877126|NCT03558152|584594197|FG006|Overall Study|Miscalculation in mmcs|1|||
161877127|NCT03558152|584594198|FG007|Overall Study|Miscalculation in mmcs|0|||
161877128|NCT03558152|584594191|FG000|Overall Study|Mistake in calculation|0|||
161877129|NCT03558152|584594192|FG001|Overall Study|Mistake in calculation|0|||
161877130|NCT03558152|584594193|FG002|Overall Study|Mistake in calculation|0|||
161877131|NCT03558152|584594194|FG003|Overall Study|Mistake in calculation|1|||
161877132|NCT03558152|584594195|FG004|Overall Study|Mistake in calculation|0|||
161877133|NCT03558152|584594196|FG005|Overall Study|Mistake in calculation|0|||
161877134|NCT03558152|584594197|FG006|Overall Study|Mistake in calculation|0|||
161877135|NCT03558152|584594198|FG007|Overall Study|Mistake in calculation|0|||
161877136|NCT03558152|584594191|FG000|Overall Study|Mistake in evaluation of disease status|0|||
161877137|NCT03558152|584594192|FG001|Overall Study|Mistake in evaluation of disease status|0|||
161877138|NCT03558152|584594193|FG002|Overall Study|Mistake in evaluation of disease status|0|||
161877139|NCT03558152|584594194|FG003|Overall Study|Mistake in evaluation of disease status|0|||
161877140|NCT03558152|584594195|FG004|Overall Study|Mistake in evaluation of disease status|0|||
161877141|NCT03558152|584594196|FG005|Overall Study|Mistake in evaluation of disease status|0|||
161877142|NCT03558152|584594197|FG006|Overall Study|Mistake in evaluation of disease status|0|||
161877143|NCT03558152|584594198|FG007|Overall Study|Mistake in evaluation of disease status|1|||
161877144|NCT03558152|584594191|FG000|Overall Study|Physician Decision|0|||
161877145|NCT03558152|584594192|FG001|Overall Study|Physician Decision|0|||
161877146|NCT03558152|584594193|FG002|Overall Study|Physician Decision|0|||
161877147|NCT03558152|584594194|FG003|Overall Study|Physician Decision|0|||
161877148|NCT03558152|584594195|FG004|Overall Study|Physician Decision|0|||
161877149|NCT03558152|584594196|FG005|Overall Study|Physician Decision|0|||
161877150|NCT03558152|584594197|FG006|Overall Study|Physician Decision|1|||
161877151|NCT03558152|584594198|FG007|Overall Study|Physician Decision|0|||
161877152|NCT03558152|584594191|FG000|Overall Study|Withdrawal by Subject|2|||
161877153|NCT03558152|584594192|FG001|Overall Study|Withdrawal by Subject|3|||
161877154|NCT03558152|584594193|FG002|Overall Study|Withdrawal by Subject|2|||
161877155|NCT03558152|584594194|FG003|Overall Study|Withdrawal by Subject|1|||
161877156|NCT03558152|584594195|FG004|Overall Study|Withdrawal by Subject|1|||
161877157|NCT03558152|584594196|FG005|Overall Study|Withdrawal by Subject|1|||
161877158|NCT03558152|584594197|FG006|Overall Study|Withdrawal by Subject|3|||
161877159|NCT03558152|584594198|FG007|Overall Study|Withdrawal by Subject|2|||
161877160|NCT03558152|584594191|FG000|Overall Study|Lack of Efficacy|11|||
161877161|NCT03558152|584594192|FG001|Overall Study|Lack of Efficacy|11|||
161877162|NCT03558152|584594193|FG002|Overall Study|Lack of Efficacy|10|||
161877163|NCT03558152|584594194|FG003|Overall Study|Lack of Efficacy|11|||
161877164|NCT03558152|584594195|FG004|Overall Study|Lack of Efficacy|14|||
161877165|NCT03558152|584594196|FG005|Overall Study|Lack of Efficacy|12|||
161877166|NCT03558152|584594197|FG006|Overall Study|Lack of Efficacy|14|||
161877167|NCT03558152|584594198|FG007|Overall Study|Lack of Efficacy|13|||
161877168|NCT03558152|584594191|FG000|Overall Study|Protocol Violation|1|||
161877169|NCT03558152|584594192|FG001|Overall Study|Protocol Violation|1|||
161877170|NCT03558152|584594193|FG002|Overall Study|Protocol Violation|0|||
161877171|NCT03558152|584594194|FG003|Overall Study|Protocol Violation|1|||
161877172|NCT03558152|584594195|FG004|Overall Study|Protocol Violation|1|||
161877173|NCT03558152|584594196|FG005|Overall Study|Protocol Violation|0|||
161877174|NCT03558152|584594197|FG006|Overall Study|Protocol Violation|2|||
161877175|NCT03558152|584594198|FG007|Overall Study|Protocol Violation|0|||
161877176|NCT04166591|584594199|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161877177|NCT04166591|584594200|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161877178|NCT04166591|584594201|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877179|NCT04166591|584594202|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877180|NCT04166591|584594199|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161877181|NCT04166591|584594200|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161877182|NCT04166591|584594201|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877183|NCT04166591|584594202|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877186|NCT03960021|584594205|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
161877187|NCT00601172|584594206|FG000|Overall Study|Adverse Event|43|||
161877188|NCT00601172|584594207|FG001|Overall Study|Adverse Event|32|||
161877189|NCT00601172|584594206|FG000|Overall Study|Lack of Efficacy|11|||
161877190|NCT00601172|584594207|FG001|Overall Study|Lack of Efficacy|12|||
161877191|NCT00601172|584594206|FG000|Overall Study|Protocol Violation|2|||
161877192|NCT00601172|584594207|FG001|Overall Study|Protocol Violation|5|||
161877193|NCT00601172|584594206|FG000|Overall Study|Lost to Follow-up|4|||
161877194|NCT00601172|584594207|FG001|Overall Study|Lost to Follow-up|3|||
161877195|NCT00601172|584594206|FG000|Overall Study|Physician Decision|27|||
161877196|NCT00601172|584594207|FG001|Overall Study|Physician Decision|28|||
161877197|NCT00601172|584594206|FG000|Overall Study|Withdrawal by Subject|35|||
161877198|NCT00601172|584594207|FG001|Overall Study|Withdrawal by Subject|27|||
161877199|NCT00601172|584594206|FG000|Overall Study|Did not meet continuation criteria|19|||
161877200|NCT00601172|584594207|FG001|Overall Study|Did not meet continuation criteria|20|||
161877201|NCT04434469|584594211|FG000|Overall Study|Death|2|||
161877202|NCT04434469|584594212|FG001|Overall Study|Death|3|||
161877203|NCT04434469|584594213|FG002|Overall Study|Death|2|||
161877204|NCT04434469|584594214|FG003|Overall Study|Death|2|||
161877205|NCT04434469|584594215|FG004|Overall Study|Death|2|||
161877206|NCT04434469|584594216|FG005|Overall Study|Death|0|||
161877207|NCT04434469|584594211|FG000|Overall Study|Lost to Follow-up|0|||
161877208|NCT04434469|584594212|FG001|Overall Study|Lost to Follow-up|0|||
161877209|NCT04434469|584594213|FG002|Overall Study|Lost to Follow-up|0|||
161877210|NCT04434469|584594214|FG003|Overall Study|Lost to Follow-up|1|||
161877211|NCT04434469|584594215|FG004|Overall Study|Lost to Follow-up|1|||
161877212|NCT04434469|584594216|FG005|Overall Study|Lost to Follow-up|0|||
161877213|NCT04434469|584594211|FG000|Overall Study|Study terminated by sponsor|1|||
161877214|NCT04434469|584594212|FG001|Overall Study|Study terminated by sponsor|1|||
161877215|NCT04434469|584594213|FG002|Overall Study|Study terminated by sponsor|1|||
161877216|NCT04434469|584594214|FG003|Overall Study|Study terminated by sponsor|2|||
161877217|NCT04434469|584594215|FG004|Overall Study|Study terminated by sponsor|3|||
161877218|NCT04434469|584594216|FG005|Overall Study|Study terminated by sponsor|3|||
161877219|NCT04434469|584594211|FG000|Overall Study|Withdrawal by Subject|0|||
161877220|NCT04434469|584594212|FG001|Overall Study|Withdrawal by Subject|0|||
161877221|NCT04434469|584594213|FG002|Overall Study|Withdrawal by Subject|1|||
161877222|NCT04434469|584594214|FG003|Overall Study|Withdrawal by Subject|0|||
161877223|NCT04434469|584594215|FG004|Overall Study|Withdrawal by Subject|0|||
161877224|NCT04434469|584594216|FG005|Overall Study|Withdrawal by Subject|0|||
161877225|NCT01936181|584594220|FG000|Randomised, Double-blind|Adverse Event|27|||
161877226|NCT01936181|584594221|FG001|Randomised, Double-blind|Adverse Event|21|||
161877227|NCT01936181|584594222|FG002|Randomised, Double-blind|Adverse Event|0|||
161877228|NCT01936181|584594223|FG003|Randomised, Double-blind|Adverse Event|0|||
161877229|NCT01936181|584594220|FG000|Randomised, Double-blind|Protocol Violation|1|||
161877230|NCT01936181|584594221|FG001|Randomised, Double-blind|Protocol Violation|5|||
161877231|NCT01936181|584594222|FG002|Randomised, Double-blind|Protocol Violation|0|||
161877232|NCT01936181|584594223|FG003|Randomised, Double-blind|Protocol Violation|0|||
161877233|NCT01936181|584594220|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
161877234|NCT01936181|584594221|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
161877235|NCT01936181|584594222|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
161877236|NCT01936181|584594223|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
161877237|NCT01936181|584594220|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
161877238|NCT01936181|584594221|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
161877239|NCT01936181|584594222|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
161877240|NCT01936181|584594223|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
161877241|NCT01936181|584594220|FG000|Randomised, Double-blind|Pregnancy|0|||
161877242|NCT01936181|584594221|FG001|Randomised, Double-blind|Pregnancy|1|||
161877243|NCT01936181|584594222|FG002|Randomised, Double-blind|Pregnancy|0|||
161877244|NCT01936181|584594223|FG003|Randomised, Double-blind|Pregnancy|0|||
161877245|NCT01936181|584594220|FG000|Randomised, Double-blind|Physician Decision|4|||
161877246|NCT01936181|584594221|FG001|Randomised, Double-blind|Physician Decision|4|||
161877247|NCT01936181|584594222|FG002|Randomised, Double-blind|Physician Decision|0|||
161877248|NCT01936181|584594223|FG003|Randomised, Double-blind|Physician Decision|0|||
161877249|NCT01936181|584594220|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
161877250|NCT01936181|584594221|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
161877251|NCT01936181|584594222|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
161877252|NCT01936181|584594223|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
161877253|NCT01936181|584594220|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
161877254|NCT01936181|584594221|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
161877255|NCT01936181|584594222|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
161877256|NCT01936181|584594223|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
161877257|NCT01936181|584594220|FG000|Transition-extension|Adverse Event|3|||
161877258|NCT01936181|584594221|FG001|Transition-extension|Adverse Event|0|||
161877259|NCT01936181|584594222|FG002|Transition-extension|Adverse Event|3|||
161877260|NCT01936181|584594223|FG003|Transition-extension|Adverse Event|1|||
161877261|NCT01936181|584594220|FG000|Transition-extension|Lost to Follow-up|3|||
161877262|NCT01936181|584594221|FG001|Transition-extension|Lost to Follow-up|0|||
161877263|NCT01936181|584594222|FG002|Transition-extension|Lost to Follow-up|1|||
161877264|NCT01936181|584594223|FG003|Transition-extension|Lost to Follow-up|2|||
161877265|NCT01936181|584594220|FG000|Transition-extension|Physician Decision|2|||
161877266|NCT01936181|584594221|FG001|Transition-extension|Physician Decision|0|||
161877267|NCT01936181|584594222|FG002|Transition-extension|Physician Decision|0|||
161877268|NCT01936181|584594223|FG003|Transition-extension|Physician Decision|1|||
161776511|NCT02255422|584223199|FG000|Overall Study|Withdrawal by Subject|0|||
161776512|NCT02255422|584223200|FG001|Overall Study|Withdrawal by Subject|0|||
161776513|NCT02255422|584223201|FG002|Overall Study|Withdrawal by Subject|0|||
161776514|NCT02255422|584223202|FG003|Overall Study|Withdrawal by Subject|0|||
161776515|NCT02255422|584223203|FG004|Overall Study|Withdrawal by Subject|0|||
161776516|NCT02255422|584223204|FG005|Overall Study|Withdrawal by Subject|0|||
161776517|NCT02255422|584223205|FG006|Overall Study|Withdrawal by Subject|2|||
161776518|NCT02255422|584223199|FG000|Overall Study|Lost to Follow-up|0|||
161877269|NCT01936181|584594220|FG000|Transition-extension|Withdrawal by Subject|7|||
161877270|NCT01936181|584594221|FG001|Transition-extension|Withdrawal by Subject|0|||
161877271|NCT01936181|584594222|FG002|Transition-extension|Withdrawal by Subject|2|||
161877272|NCT01936181|584594223|FG003|Transition-extension|Withdrawal by Subject|1|||
161877273|NCT01346189|584594224|FG000|Overall Study|Withdrawal by Subject|7|||
161877274|NCT01346189|584594225|FG001|Overall Study|Withdrawal by Subject|5|||
161877275|NCT01346189|584594226|FG002|Overall Study|Withdrawal by Subject|3|||
161877276|NCT01346189|584594227|FG003|Overall Study|Withdrawal by Subject|5|||
161776519|NCT02255422|584223200|FG001|Overall Study|Lost to Follow-up|0|||
161776520|NCT02255422|584223201|FG002|Overall Study|Lost to Follow-up|1|||
161776521|NCT02255422|584223202|FG003|Overall Study|Lost to Follow-up|0|||
161877277|NCT01346189|584594224|FG000|Overall Study|Physician Decision|4|||
161877278|NCT01346189|584594225|FG001|Overall Study|Physician Decision|0|||
161776522|NCT02255422|584223203|FG004|Overall Study|Lost to Follow-up|0|||
161776523|NCT02255422|584223204|FG005|Overall Study|Lost to Follow-up|0|||
161776524|NCT02255422|584223205|FG006|Overall Study|Lost to Follow-up|0|||
161776525|NCT03179462|584223213|FG000|Overall Study|screening failure|1|||
161877279|NCT01346189|584594226|FG002|Overall Study|Physician Decision|0|||
161877280|NCT01346189|584594227|FG003|Overall Study|Physician Decision|0|||
161877281|NCT01346189|584594224|FG000|Overall Study|Moved|3|||
161877282|NCT01346189|584594225|FG001|Overall Study|Moved|0|||
161877283|NCT01346189|584594226|FG002|Overall Study|Moved|4|||
161877284|NCT01346189|584594227|FG003|Overall Study|Moved|0|||
161877285|NCT01346189|584594224|FG000|Overall Study|Other|2|||
161877286|NCT01346189|584594225|FG001|Overall Study|Other|4|||
161877287|NCT01346189|584594226|FG002|Overall Study|Other|7|||
161877288|NCT01346189|584594227|FG003|Overall Study|Other|3|||
161877289|NCT01346189|584594224|FG000|Overall Study|Death|0|||
161877290|NCT01346189|584594225|FG001|Overall Study|Death|3|||
161877291|NCT01346189|584594226|FG002|Overall Study|Death|0|||
161877292|NCT01346189|584594227|FG003|Overall Study|Death|0|||
161877293|NCT01346189|584594224|FG000|Overall Study|Non-health system primary care physician|0|||
161877294|NCT01346189|584594225|FG001|Overall Study|Non-health system primary care physician|5|||
161877295|NCT01346189|584594226|FG002|Overall Study|Non-health system primary care physician|0|||
161877296|NCT01346189|584594227|FG003|Overall Study|Non-health system primary care physician|0|||
161877297|NCT01346189|584594224|FG000|Overall Study|Travel|0|||
161877298|NCT01346189|584594225|FG001|Overall Study|Travel|0|||
161877299|NCT01346189|584594226|FG002|Overall Study|Travel|0|||
161877300|NCT01346189|584594227|FG003|Overall Study|Travel|3|||
161877301|NCT00900757|584594228|FG000|Overall Study|screen failure|19|||
161877302|NCT03535194|584594231|FG000|Induction Period|Adverse Event|2|||
161877303|NCT03535194|584594232|FG001|Induction Period|Adverse Event|2|||
161877304|NCT03535194|584594233|FG002|Induction Period|Adverse Event|1|||
161877305|NCT03535194|584594234|FG003|Induction Period|Adverse Event|3|||
161877306|NCT03535194|584594235|FG004|Induction Period|Adverse Event|0|||
161877307|NCT03535194|584594231|FG000|Induction Period|Death|0|||
161877308|NCT03535194|584594232|FG001|Induction Period|Death|1|||
161877309|NCT03535194|584594233|FG002|Induction Period|Death|0|||
161877310|NCT03535194|584594234|FG003|Induction Period|Death|0|||
161877311|NCT03535194|584594235|FG004|Induction Period|Death|0|||
161877312|NCT03535194|584594231|FG000|Induction Period|Lack of Efficacy|1|||
161877313|NCT03535194|584594232|FG001|Induction Period|Lack of Efficacy|3|||
161877314|NCT03535194|584594233|FG002|Induction Period|Lack of Efficacy|2|||
161877315|NCT03535194|584594234|FG003|Induction Period|Lack of Efficacy|2|||
161877316|NCT03535194|584594235|FG004|Induction Period|Lack of Efficacy|0|||
161877317|NCT03535194|584594231|FG000|Induction Period|Lost to Follow-up|3|||
161877318|NCT03535194|584594232|FG001|Induction Period|Lost to Follow-up|5|||
161877319|NCT03535194|584594233|FG002|Induction Period|Lost to Follow-up|2|||
161877320|NCT03535194|584594234|FG003|Induction Period|Lost to Follow-up|3|||
161877321|NCT03535194|584594235|FG004|Induction Period|Lost to Follow-up|0|||
161877322|NCT03535194|584594231|FG000|Induction Period|Physician Decision|1|||
161877323|NCT03535194|584594232|FG001|Induction Period|Physician Decision|1|||
161877324|NCT03535194|584594233|FG002|Induction Period|Physician Decision|0|||
161877325|NCT03535194|584594234|FG003|Induction Period|Physician Decision|0|||
161877326|NCT03535194|584594235|FG004|Induction Period|Physician Decision|0|||
161877327|NCT03535194|584594231|FG000|Induction Period|Protocol Violation|1|||
161877328|NCT03535194|584594232|FG001|Induction Period|Protocol Violation|0|||
161877329|NCT03535194|584594233|FG002|Induction Period|Protocol Violation|0|||
161877330|NCT03535194|584594234|FG003|Induction Period|Protocol Violation|1|||
161877331|NCT03535194|584594235|FG004|Induction Period|Protocol Violation|0|||
161877332|NCT03535194|584594231|FG000|Induction Period|Screen Failure|0|||
161877333|NCT03535194|584594232|FG001|Induction Period|Screen Failure|1|||
161877334|NCT03535194|584594233|FG002|Induction Period|Screen Failure|0|||
161877335|NCT03535194|584594234|FG003|Induction Period|Screen Failure|0|||
161877336|NCT03535194|584594235|FG004|Induction Period|Screen Failure|0|||
161877337|NCT03535194|584594231|FG000|Induction Period|Withdrawal by Subject|3|||
161877338|NCT03535194|584594232|FG001|Induction Period|Withdrawal by Subject|4|||
161877339|NCT03535194|584594233|FG002|Induction Period|Withdrawal by Subject|3|||
161877340|NCT03535194|584594234|FG003|Induction Period|Withdrawal by Subject|2|||
161877341|NCT03535194|584594235|FG004|Induction Period|Withdrawal by Subject|0|||
161877342|NCT03535194|584594231|FG000|Maintenance Period|Adverse Event|6|||
161877343|NCT03535194|584594232|FG001|Maintenance Period|Adverse Event|5|||
161877344|NCT03535194|584594233|FG002|Maintenance Period|Adverse Event|1|||
161877345|NCT03535194|584594234|FG003|Maintenance Period|Adverse Event|11|||
161877346|NCT03535194|584594235|FG004|Maintenance Period|Adverse Event|4|||
161877347|NCT03535194|584594231|FG000|Maintenance Period|Lack of Efficacy|3|||
161877348|NCT03535194|584594232|FG001|Maintenance Period|Lack of Efficacy|2|||
161877349|NCT03535194|584594233|FG002|Maintenance Period|Lack of Efficacy|5|||
161877350|NCT03535194|584594234|FG003|Maintenance Period|Lack of Efficacy|9|||
161877351|NCT03535194|584594235|FG004|Maintenance Period|Lack of Efficacy|0|||
161877352|NCT03535194|584594231|FG000|Maintenance Period|Lost to Follow-up|4|||
161877353|NCT03535194|584594232|FG001|Maintenance Period|Lost to Follow-up|2|||
161877354|NCT03535194|584594233|FG002|Maintenance Period|Lost to Follow-up|1|||
161877355|NCT03535194|584594234|FG003|Maintenance Period|Lost to Follow-up|5|||
161877356|NCT03535194|584594235|FG004|Maintenance Period|Lost to Follow-up|2|||
161877357|NCT03535194|584594231|FG000|Maintenance Period|Other|1|||
161877358|NCT03535194|584594232|FG001|Maintenance Period|Other|2|||
161877359|NCT03535194|584594233|FG002|Maintenance Period|Other|0|||
161877360|NCT03535194|584594234|FG003|Maintenance Period|Other|0|||
161877361|NCT03535194|584594235|FG004|Maintenance Period|Other|0|||
161877362|NCT03535194|584594231|FG000|Maintenance Period|Physician Decision|1|||
161877363|NCT03535194|584594232|FG001|Maintenance Period|Physician Decision|2|||
161877364|NCT03535194|584594233|FG002|Maintenance Period|Physician Decision|0|||
161877365|NCT03535194|584594234|FG003|Maintenance Period|Physician Decision|2|||
161877366|NCT03535194|584594235|FG004|Maintenance Period|Physician Decision|0|||
161877367|NCT03535194|584594231|FG000|Maintenance Period|Pregnancy|0|||
161877368|NCT03535194|584594232|FG001|Maintenance Period|Pregnancy|0|||
161877369|NCT03535194|584594233|FG002|Maintenance Period|Pregnancy|0|||
161877370|NCT03535194|584594234|FG003|Maintenance Period|Pregnancy|2|||
161877371|NCT03535194|584594235|FG004|Maintenance Period|Pregnancy|0|||
161877372|NCT03535194|584594231|FG000|Maintenance Period|Protocol Violation|0|||
161877373|NCT03535194|584594232|FG001|Maintenance Period|Protocol Violation|1|||
161877374|NCT03535194|584594233|FG002|Maintenance Period|Protocol Violation|0|||
161877375|NCT03535194|584594234|FG003|Maintenance Period|Protocol Violation|0|||
161877376|NCT03535194|584594235|FG004|Maintenance Period|Protocol Violation|0|||
161877377|NCT03535194|584594231|FG000|Maintenance Period|Withdrawal by Subject|7|||
161877378|NCT03535194|584594232|FG001|Maintenance Period|Withdrawal by Subject|2|||
161877379|NCT03535194|584594233|FG002|Maintenance Period|Withdrawal by Subject|1|||
161877380|NCT03535194|584594234|FG003|Maintenance Period|Withdrawal by Subject|8|||
161877381|NCT03535194|584594235|FG004|Maintenance Period|Withdrawal by Subject|0|||
161877382|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Adverse Event|4|||
161877383|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Adverse Event|5|||
161877384|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Adverse Event|1|||
161877385|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Adverse Event|8|||
161877386|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Adverse Event|0|||
161877387|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
161877388|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
161877389|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
161877390|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
161877391|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
161877392|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
161877393|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
161877394|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
161877395|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
161877396|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
161877397|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Other|1|||
161877398|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Other|0|||
161877399|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Other|0|||
161877400|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Other|5|||
161877401|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Other|0|||
161877402|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Physician Decision|0|||
161877403|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Physician Decision|2|||
161877404|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Physician Decision|1|||
161877405|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Physician Decision|1|||
161877406|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Physician Decision|0|||
161877407|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
161877408|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
161877409|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
161877410|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
161877411|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161877412|NCT04411810|584594236|FG000|Overall Study|Screen failure|1|||
161877413|NCT04411810|584594236|FG000|Overall Study|Withdrawal by Subject|1|||
161877414|NCT04304235|584594240|FG000|Overall Study|incomplete triage data|0|||
161877415|NCT04304235|584594241|FG001|Overall Study|incomplete triage data|69|||
161877416|NCT04304235|584594242|FG002|Overall Study|incomplete triage data|0|||
161877417|NCT04304235|584594243|FG003|Overall Study|incomplete triage data|0|||
161877418|NCT04304235|584594244|FG004|Overall Study|incomplete triage data|289|||
161877419|NCT04304235|584594245|FG005|Overall Study|incomplete triage data|123|||
161877420|NCT04304235|584594246|FG006|Overall Study|incomplete triage data|65|||
161877421|NCT04470544|584594247|FG000|Overall Study|Withdrawal by Subject|4|||
161877422|NCT04470544|584594248|FG001|Overall Study|Withdrawal by Subject|6|||
161877423|NCT05113979|584594252|FG000|Overall Study|Death|2|||
161877424|NCT05113979|584594252|FG000|Overall Study|Lost to Follow-up|1|||
161877425|NCT00526669|584594253|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
161877426|NCT00526669|584594254|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
161877427|NCT00526669|584594253|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
161877428|NCT00526669|584594254|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
161877429|NCT00526669|584594253|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
161877430|NCT00526669|584594254|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
161877431|NCT00526669|584594253|FG000|Combined Treatment Phase|Death|0|||
161877432|NCT00526669|584594254|FG001|Combined Treatment Phase|Death|2|||
161877433|NCT02218736|584594258|FG000|Overall Study|Withdrawal by Subject|10|||
161877434|NCT02218736|584594259|FG001|Overall Study|Withdrawal by Subject|9|||
161877435|NCT02218736|584594258|FG000|Overall Study|Protocol Violation|2|||
161877436|NCT02218736|584594259|FG001|Overall Study|Protocol Violation|0|||
161877437|NCT04016779|584594262|FG000|Overall Study|Adverse Event|9|||
161877438|NCT04016779|584594263|FG001|Overall Study|Adverse Event|17|||
161877439|NCT04016779|584594262|FG000|Overall Study|Lack of Efficacy|4|||
161877440|NCT04016779|584594263|FG001|Overall Study|Lack of Efficacy|1|||
161877441|NCT04016779|584594262|FG000|Overall Study|Lost to Follow-up|5|||
161877442|NCT04016779|584594263|FG001|Overall Study|Lost to Follow-up|14|||
161877443|NCT04016779|584594262|FG000|Overall Study|Physician Decision|1|||
161877444|NCT04016779|584594263|FG001|Overall Study|Physician Decision|3|||
161877445|NCT04016779|584594262|FG000|Overall Study|Withdrawal by Subject|6|||
161877446|NCT04016779|584594263|FG001|Overall Study|Withdrawal by Subject|8|||
161877447|NCT04016779|584594262|FG000|Overall Study|Non-compliance with Study Drug|2|||
161877448|NCT04016779|584594263|FG001|Overall Study|Non-compliance with Study Drug|3|||
161877449|NCT04016779|584594262|FG000|Overall Study|Other, Multiple categories|17|||
161877450|NCT04016779|584594263|FG001|Overall Study|Other, Multiple categories|17|||
161877451|NCT00623935|584594264|FG000|Overall Study|Death|1|||
161877452|NCT00623935|584594264|FG000|Overall Study|Patient Declined Transplant|1|||
161877453|NCT01878084|584594265|FG000|Overall Study|Physician Decision|2|||
161877454|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
161877455|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
161877456|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
161877457|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
161877458|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
161877459|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
161877460|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
161877461|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
161877462|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
161877463|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
161877464|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Death|1|||
161877465|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Death|0|||
161877466|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
161877467|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
161877468|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
161877469|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
161877470|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
161877471|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
161877472|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
161877473|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
161877474|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Adverse Event|2|||
161877475|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Adverse Event|6|||
161877476|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
161877477|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
161877478|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Progressive disease|4|||
161877479|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Progressive disease|35|||
161877480|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
161877481|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
161877482|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
161877483|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
161877484|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Death|0|||
161877485|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Death|1|||
161877486|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Other than specified above|9|||
161877487|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Other than specified above|18|||
161877488|NCT00638443|584594268|FG000|First Intervention|Adverse Event|2|||
161877489|NCT00638443|584594269|FG001|First Intervention|Adverse Event|1|||
161877490|NCT01044290|584594270|FG000|Follow-up 1|Death|3|||
161877491|NCT01044290|584594271|FG001|Follow-up 1|Death|3|||
161877492|NCT01044290|584594272|FG002|Follow-up 1|Death|1|||
161877493|NCT01044290|584594270|FG000|Follow-up 1|Withdrawal by Subject|2|||
161877494|NCT01044290|584594271|FG001|Follow-up 1|Withdrawal by Subject|2|||
161877495|NCT01044290|584594272|FG002|Follow-up 1|Withdrawal by Subject|0|||
161877496|NCT01044290|584594270|FG000|Follow-Up 2|Death|0|||
161877497|NCT01044290|584594271|FG001|Follow-Up 2|Death|1|||
161877498|NCT01044290|584594272|FG002|Follow-Up 2|Death|1|||
161877499|NCT01044290|584594270|FG000|Follow-Up 2|Withdrawal by Subject|0|||
161877500|NCT01044290|584594271|FG001|Follow-Up 2|Withdrawal by Subject|1|||
161877501|NCT01044290|584594272|FG002|Follow-Up 2|Withdrawal by Subject|1|||
161877502|NCT01967706|584594275|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161877503|NCT01967706|584594276|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
161877504|NCT01967706|584594277|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161877505|NCT01967706|584594278|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161877506|NCT04152837|584594291|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
161877507|NCT04152837|584594291|FG000|Maintenance Period|Adverse Event|1|||
161877508|NCT04152837|584594291|FG000|Maintenance Period|Withdrawal by Subject|1|||
161877509|NCT04152837|584594291|FG000|Maintenance Period|Sponsor Termination of Study|2|||
161877510|NCT00586820|584594292|FG000|Overall Study|Unsuccessful PCI|1|||
161877511|NCT00586820|584594293|FG001|Overall Study|Unsuccessful PCI|0|||
161877512|NCT00430573|584594294|FG000|Overall Study|Withdrawal by Subject|5|||
161877513|NCT01483027|584594299|FG000|Overall Study|Administrative Reasons|2|||
161877514|NCT01483027|584594300|FG001|Overall Study|Administrative Reasons|1|||
161877515|NCT01483027|584594299|FG000|Overall Study|Withdrawal by Subject|21|||
161877516|NCT01483027|584594300|FG001|Overall Study|Withdrawal by Subject|32|||
161877517|NCT01483027|584594299|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
161776526|NCT03179462|584223214|FG001|Overall Study|screening failure|2|||
161776527|NCT03179462|584223215|FG002|Overall Study|screening failure|0|||
161776528|NCT02851069|584223216|FG000|Overall Study|Failure to Return|3|||
161776529|NCT02851069|584223216|FG000|Overall Study|Other|3|||
161776530|NCT02684162|584223217|FG000|Overall Study|Physician Decision|0|||
161776531|NCT02684162|584223218|FG001|Overall Study|Physician Decision|1|||
161776532|NCT02684162|584223219|FG002|Overall Study|Physician Decision|0|||
161776533|NCT03743571|584223222|FG000|Overall Study|Withdrawal by Subject|1|||
161776534|NCT03743571|584223223|FG001|Overall Study|Withdrawal by Subject|1|||
161776535|NCT03743571|584223222|FG000|Overall Study|Lost to Follow-up|1|||
161776536|NCT03743571|584223223|FG001|Overall Study|Lost to Follow-up|2|||
161776537|NCT01489865|584223224|FG000|Overall Study|Progression of Disease|4|||
161776538|NCT01489865|584223225|FG001|Overall Study|Progression of Disease|2|||
161776539|NCT01489865|584223226|FG002|Overall Study|Progression of Disease|2|||
161776540|NCT01489865|584223227|FG003|Overall Study|Progression of Disease|3|||
161776541|NCT01489865|584223228|FG004|Overall Study|Progression of Disease|1|||
161776542|NCT01489865|584223229|FG005|Overall Study|Progression of Disease|6|||
161776543|NCT01489865|584223230|FG006|Overall Study|Progression of Disease|3|||
161776544|NCT01489865|584223231|FG007|Overall Study|Progression of Disease|0|||
161776545|NCT01489865|584223232|FG008|Overall Study|Progression of Disease|23|||
161776546|NCT01489865|584223224|FG000|Overall Study|Adverse Event|2|||
161776547|NCT01489865|584223225|FG001|Overall Study|Adverse Event|0|||
161776548|NCT01489865|584223226|FG002|Overall Study|Adverse Event|0|||
161776549|NCT01489865|584223227|FG003|Overall Study|Adverse Event|0|||
161776550|NCT01489865|584223228|FG004|Overall Study|Adverse Event|1|||
161776551|NCT01489865|584223229|FG005|Overall Study|Adverse Event|0|||
161776552|NCT01489865|584223230|FG006|Overall Study|Adverse Event|2|||
161776553|NCT01489865|584223231|FG007|Overall Study|Adverse Event|0|||
161776554|NCT01489865|584223232|FG008|Overall Study|Adverse Event|5|||
161776555|NCT01489865|584223224|FG000|Overall Study|Death|0|||
161776556|NCT01489865|584223225|FG001|Overall Study|Death|1|||
161776557|NCT01489865|584223226|FG002|Overall Study|Death|0|||
161776558|NCT01489865|584223227|FG003|Overall Study|Death|0|||
161776559|NCT01489865|584223228|FG004|Overall Study|Death|1|||
161776560|NCT01489865|584223229|FG005|Overall Study|Death|0|||
161776561|NCT01489865|584223230|FG006|Overall Study|Death|0|||
161776562|NCT01489865|584223231|FG007|Overall Study|Death|0|||
161776563|NCT01489865|584223232|FG008|Overall Study|Death|2|||
161776564|NCT01489865|584223224|FG000|Overall Study|Withdrawal by Subject|0|||
161776565|NCT01489865|584223225|FG001|Overall Study|Withdrawal by Subject|0|||
161776566|NCT01489865|584223226|FG002|Overall Study|Withdrawal by Subject|0|||
161776567|NCT01489865|584223227|FG003|Overall Study|Withdrawal by Subject|0|||
161776568|NCT01489865|584223228|FG004|Overall Study|Withdrawal by Subject|0|||
161776569|NCT01489865|584223229|FG005|Overall Study|Withdrawal by Subject|1|||
161776570|NCT01489865|584223230|FG006|Overall Study|Withdrawal by Subject|1|||
161776571|NCT01489865|584223231|FG007|Overall Study|Withdrawal by Subject|0|||
161776572|NCT01489865|584223232|FG008|Overall Study|Withdrawal by Subject|2|||
161776573|NCT01489865|584223224|FG000|Overall Study|Shifted|0|||
161776574|NCT01489865|584223225|FG001|Overall Study|Shifted|0|||
161776575|NCT01489865|584223226|FG002|Overall Study|Shifted|1|||
161776576|NCT01489865|584223227|FG003|Overall Study|Shifted|0|||
161776577|NCT01489865|584223228|FG004|Overall Study|Shifted|0|||
161776578|NCT01489865|584223229|FG005|Overall Study|Shifted|0|||
161776579|NCT01489865|584223230|FG006|Overall Study|Shifted|0|||
161776580|NCT01489865|584223231|FG007|Overall Study|Shifted|0|||
161776581|NCT01489865|584223232|FG008|Overall Study|Shifted|0|||
161776582|NCT04115488|584223233|FG000|Overall Study|Adverse Event|8|||
161776583|NCT04115488|584223234|FG001|Overall Study|Adverse Event|4|||
161877518|NCT01483027|584594300|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
161776584|NCT04115488|584223233|FG000|Overall Study|Withdrawal by Subject|3|||
161776585|NCT04115488|584223234|FG001|Overall Study|Withdrawal by Subject|6|||
161776586|NCT04115488|584223233|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
161776587|NCT04115488|584223234|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
161776588|NCT04115488|584223233|FG000|Overall Study|Patient 's location change|1|||
161776589|NCT04115488|584223234|FG001|Overall Study|Patient 's location change|0|||
161776590|NCT04115488|584223233|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
161776591|NCT04115488|584223234|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
161776592|NCT00885677|584223235|FG000|Overall Study|Death|40|||
161776593|NCT00885677|584223236|FG001|Overall Study|Death|34|||
161877519|NCT01483027|584594299|FG000|Overall Study|Lost to Follow-up|1|||
161776594|NCT00885677|584223235|FG000|Overall Study|Lost to Follow-up|15|||
161776595|NCT00885677|584223236|FG001|Overall Study|Lost to Follow-up|13|||
161776596|NCT00885677|584223235|FG000|Overall Study|Protocol Violation|54|||
161776597|NCT00885677|584223236|FG001|Overall Study|Protocol Violation|54|||
161776598|NCT00885677|584223235|FG000|Overall Study|premature study closure|41|||
161776599|NCT00885677|584223236|FG001|Overall Study|premature study closure|44|||
161776600|NCT00885677|584223235|FG000|Overall Study|device/lead revision or replacement|7|||
161776601|NCT00885677|584223236|FG001|Overall Study|device/lead revision or replacement|6|||
161776602|NCT00885677|584223235|FG000|Overall Study|Heart transplantation|1|||
161776603|NCT00885677|584223236|FG001|Overall Study|Heart transplantation|0|||
161776604|NCT00885677|584223235|FG000|Overall Study|Inclusion/exclusion not met|25|||
161776605|NCT00885677|584223236|FG001|Overall Study|Inclusion/exclusion not met|27|||
161776606|NCT00972309|584223237|FG000|Overall Study|Switched to alternative treatment|0|||
161776607|NCT00972309|584223238|FG001|Overall Study|Switched to alternative treatment|2|||
161776608|NCT00972309|584223237|FG000|Overall Study|Refused further treatment|0|||
161776609|NCT00972309|584223238|FG001|Overall Study|Refused further treatment|1|||
161776610|NCT00972309|584223237|FG000|Overall Study|Late determination of ineligibility|0|||
161776611|NCT00972309|584223238|FG001|Overall Study|Late determination of ineligibility|1|||
161776612|NCT00972309|584223237|FG000|Overall Study|Second malignancy|1|||
161776613|NCT00972309|584223238|FG001|Overall Study|Second malignancy|1|||
161776614|NCT00972309|584223237|FG000|Overall Study|Visa issues|0|||
161776615|NCT00972309|584223238|FG001|Overall Study|Visa issues|1|||
161776616|NCT00972309|584223237|FG000|Overall Study|Secondary cancer (SCC)|0|||
161776617|NCT00972309|584223238|FG001|Overall Study|Secondary cancer (SCC)|1|||
161776618|NCT00972309|584223237|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
161776619|NCT00972309|584223238|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
161776620|NCT00972309|584223237|FG000|Overall Study|Lost to Follow-up|1|||
161776621|NCT00972309|584223238|FG001|Overall Study|Lost to Follow-up|1|||
161776622|NCT00972309|584223237|FG000|Overall Study|Disease progression on study|10|||
161776623|NCT00972309|584223238|FG001|Overall Study|Disease progression on study|4|||
161776624|NCT01058707|584223250|FG000|Overall Study|Disease Progression|15|||
161776625|NCT01058707|584223251|FG001|Overall Study|Disease Progression|20|||
161776626|NCT01058707|584223252|FG002|Overall Study|Disease Progression|20|||
161776627|NCT01058707|584223253|FG003|Overall Study|Disease Progression|15|||
161776628|NCT01058707|584223254|FG004|Overall Study|Disease Progression|23|||
161776629|NCT01058707|584223255|FG005|Overall Study|Disease Progression|10|||
161776630|NCT01058707|584223256|FG006|Overall Study|Disease Progression|12|||
161776631|NCT01058707|584223250|FG000|Overall Study|Adverse Event|11|||
161776632|NCT01058707|584223251|FG001|Overall Study|Adverse Event|4|||
161776633|NCT01058707|584223252|FG002|Overall Study|Adverse Event|7|||
161776634|NCT01058707|584223253|FG003|Overall Study|Adverse Event|6|||
161776635|NCT01058707|584223254|FG004|Overall Study|Adverse Event|7|||
161776636|NCT01058707|584223255|FG005|Overall Study|Adverse Event|3|||
161776637|NCT01058707|584223256|FG006|Overall Study|Adverse Event|1|||
161776638|NCT01058707|584223250|FG000|Overall Study|Subject Decision|5|||
161776639|NCT01058707|584223251|FG001|Overall Study|Subject Decision|3|||
161776640|NCT01058707|584223252|FG002|Overall Study|Subject Decision|3|||
161776641|NCT01058707|584223253|FG003|Overall Study|Subject Decision|1|||
161776642|NCT01058707|584223254|FG004|Overall Study|Subject Decision|2|||
161776643|NCT01058707|584223255|FG005|Overall Study|Subject Decision|3|||
161776644|NCT01058707|584223256|FG006|Overall Study|Subject Decision|6|||
161776645|NCT01058707|584223250|FG000|Overall Study|Lost to Follow-up|0|||
161776646|NCT01058707|584223251|FG001|Overall Study|Lost to Follow-up|0|||
161776647|NCT01058707|584223252|FG002|Overall Study|Lost to Follow-up|1|||
161776648|NCT01058707|584223253|FG003|Overall Study|Lost to Follow-up|0|||
161776649|NCT01058707|584223254|FG004|Overall Study|Lost to Follow-up|0|||
161776650|NCT01058707|584223255|FG005|Overall Study|Lost to Follow-up|0|||
161776651|NCT01058707|584223256|FG006|Overall Study|Lost to Follow-up|0|||
161776652|NCT01058707|584223250|FG000|Overall Study|Reason Not Specified|0|||
161776653|NCT01058707|584223251|FG001|Overall Study|Reason Not Specified|3|||
161776654|NCT01058707|584223252|FG002|Overall Study|Reason Not Specified|2|||
161776655|NCT01058707|584223253|FG003|Overall Study|Reason Not Specified|0|||
161776656|NCT01058707|584223254|FG004|Overall Study|Reason Not Specified|7|||
161776657|NCT01058707|584223255|FG005|Overall Study|Reason Not Specified|1|||
161776658|NCT01058707|584223256|FG006|Overall Study|Reason Not Specified|7|||
161776659|NCT00167414|584223259|FG000|Overall Study|Death|10|||
161776660|NCT00795886|584223264|FG000|Overall Study|Death|10|||
161877520|NCT01483027|584594300|FG001|Overall Study|Lost to Follow-up|1|||
161877521|NCT01483027|584594299|FG000|Overall Study|Adverse Event|0|||
161877522|NCT01483027|584594300|FG001|Overall Study|Adverse Event|1|||
161877523|NCT01483027|584594299|FG000|Overall Study|Withdrawal by Subject|0|||
161877524|NCT01483027|584594300|FG001|Overall Study|Withdrawal by Subject|1|||
161877525|NCT04463251|584594303|FG000|Overall Study|Death|1|||
161877526|NCT04463251|584594304|FG001|Overall Study|Death|0|||
161877527|NCT04463251|584594305|FG002|Overall Study|Death|1|||
161877528|NCT04463251|584594303|FG000|Overall Study|Adverse Event|0|||
161877529|NCT04463251|584594304|FG001|Overall Study|Adverse Event|1|||
161877530|NCT04463251|584594305|FG002|Overall Study|Adverse Event|0|||
161877531|NCT04463251|584594303|FG000|Overall Study|Lost to Follow-up|0|||
161877532|NCT04463251|584594304|FG001|Overall Study|Lost to Follow-up|1|||
161877533|NCT04463251|584594305|FG002|Overall Study|Lost to Follow-up|0|||
161877534|NCT04463251|584594303|FG000|Overall Study|Withdrawal by Subject|0|||
161877535|NCT04463251|584594304|FG001|Overall Study|Withdrawal by Subject|2|||
161877536|NCT04463251|584594305|FG002|Overall Study|Withdrawal by Subject|2|||
161877537|NCT05020665|584594306|FG000|Overall Study|Study terminated by Sponsor|5|||
161877538|NCT05020665|584594307|FG001|Overall Study|Study terminated by Sponsor|4|||
161877539|NCT05020665|584594306|FG000|Overall Study|Death|2|||
161877540|NCT05020665|584594307|FG001|Overall Study|Death|1|||
161877541|NCT05020665|584594306|FG000|Overall Study|Physician Decision|0|||
161877542|NCT05020665|584594307|FG001|Overall Study|Physician Decision|1|||
161877543|NCT05020665|584594306|FG000|Overall Study|Withdrawal by Subject|0|||
161877544|NCT05020665|584594307|FG001|Overall Study|Withdrawal by Subject|1|||
161877545|NCT05020665|584594306|FG000|Overall Study|Reason not specified|1|||
161877546|NCT05020665|584594307|FG001|Overall Study|Reason not specified|0|||
161877547|NCT01743560|584594312|FG000|Overall Study|Disease progression|26|||
161877548|NCT01743560|584594312|FG000|Overall Study|Adverse Event|8|||
161877549|NCT01743560|584594312|FG000|Overall Study|Death|3|||
161877550|NCT01743560|584594312|FG000|Overall Study|Withdrawal by Subject|2|||
161877551|NCT01743560|584594312|FG000|Overall Study|Protocol Violation|1|||
161877552|NCT01743560|584594312|FG000|Overall Study|>1 dose of study drug|3|||
161877553|NCT01732640|584594318|FG000|Overall Study|Adverse Event|0|||
161877554|NCT01732640|584594319|FG001|Overall Study|Adverse Event|1|||
161877555|NCT01732640|584594318|FG000|Overall Study|Death|0|||
161877556|NCT01732640|584594319|FG001|Overall Study|Death|1|||
161877557|NCT00877487|584594322|FG000|Open-label Treatment Phase|Adverse Event|1|||
161877558|NCT00877487|584594323|FG001|Open-label Treatment Phase|Adverse Event|0|||
161877559|NCT00877487|584594322|FG000|Open-label Treatment Phase|Protocol Violation|3|||
161877560|NCT00877487|584594323|FG001|Open-label Treatment Phase|Protocol Violation|0|||
161877561|NCT00877487|584594322|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
161877562|NCT00877487|584594323|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161877563|NCT00877487|584594322|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
161877564|NCT00877487|584594323|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161877565|NCT00877487|584594322|FG000|Open-label Treatment Phase|Out of country for business|1|||
161877566|NCT00877487|584594323|FG001|Open-label Treatment Phase|Out of country for business|0|||
161877567|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
161877568|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
161877569|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
161877570|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
161877571|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
161877572|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
161877573|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
161877574|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
161877575|NCT03070002|584594324|FG000|Follow up for 2 Years|Death|1|||
161877576|NCT03425396|584594336|FG000|Overall Study|Lost to Follow-up|2|||
161877577|NCT03425396|584594337|FG001|Overall Study|Lost to Follow-up|5|||
161877578|NCT03425396|584594338|FG002|Overall Study|Lost to Follow-up|2|||
161877579|NCT03425396|584594339|FG003|Overall Study|Lost to Follow-up|0|||
161877580|NCT03425396|584594340|FG004|Overall Study|Lost to Follow-up|0|||
161877581|NCT03425396|584594336|FG000|Overall Study|Withdrawal by Subject|0|||
161877582|NCT03425396|584594337|FG001|Overall Study|Withdrawal by Subject|1|||
161877583|NCT03425396|584594338|FG002|Overall Study|Withdrawal by Subject|0|||
161877584|NCT03425396|584594339|FG003|Overall Study|Withdrawal by Subject|1|||
161877585|NCT03425396|584594340|FG004|Overall Study|Withdrawal by Subject|0|||
161877586|NCT03425396|584594336|FG000|Overall Study|Other|0|||
161877587|NCT03425396|584594337|FG001|Overall Study|Other|1|||
161877588|NCT03425396|584594338|FG002|Overall Study|Other|1|||
161877589|NCT03425396|584594339|FG003|Overall Study|Other|0|||
161877590|NCT03425396|584594340|FG004|Overall Study|Other|1|||
161877591|NCT01082211|584594343|FG000|Overall Study|Protocol Violation|4|||
161877592|NCT01082211|584594343|FG000|Overall Study|No protocol treatment received|3|||
161877593|NCT04999163|584594344|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
161877594|NCT04999163|584594345|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
161877595|NCT04999163|584594344|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
161877596|NCT04999163|584594345|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
161877597|NCT04999163|584594344|FG000|Overall Study|Withdrawal by Subject|1|||
161877598|NCT04999163|584594345|FG001|Overall Study|Withdrawal by Subject|0|||
161877599|NCT03917472|584596548|FG000|Overall Study|Physician Decision|4|||
161877600|NCT03917472|584596549|FG001|Overall Study|Physician Decision|0|||
161877601|NCT03917472|584596548|FG000|Overall Study|Adverse Event|3|||
161877602|NCT03917472|584596549|FG001|Overall Study|Adverse Event|1|||
161877603|NCT03917472|584596548|FG000|Overall Study|Death|7|||
161877604|NCT03917472|584596549|FG001|Overall Study|Death|5|||
161877605|NCT03917472|584596548|FG000|Overall Study|Withdrawal by Subject|11|||
161877606|NCT03917472|584596549|FG001|Overall Study|Withdrawal by Subject|4|||
161877607|NCT03917472|584596548|FG000|Overall Study|Lost to Follow-up|10|||
161877608|NCT03917472|584596549|FG001|Overall Study|Lost to Follow-up|5|||
161877609|NCT01154296|584596550|FG000|Randomization and Intervention|Decided to decline|1|||
161877610|NCT01154296|584596551|FG001|Randomization and Intervention|Decided to decline|1|||
161877611|NCT01154296|584596550|FG000|Randomization and Intervention|Declined by staff|1|||
161877612|NCT01154296|584596551|FG001|Randomization and Intervention|Declined by staff|0|||
161877613|NCT01154296|584596550|FG000|Randomization and Intervention|Did not return|1|||
161877614|NCT01154296|584596551|FG001|Randomization and Intervention|Did not return|0|||
161877615|NCT01154296|584596550|FG000|Randomization and Intervention|Left before test|0|||
161877616|NCT01154296|584596551|FG001|Randomization and Intervention|Left before test|1|||
161877617|NCT01154296|584596550|FG000|Randomization and Intervention|Left clinic early|2|||
161877618|NCT01154296|584596551|FG001|Randomization and Intervention|Left clinic early|0|||
161877619|NCT01154296|584596550|FG000|6-month Follow-up|Lost contact|269|||
161877620|NCT01154296|584596551|FG001|6-month Follow-up|Lost contact|275|||
161877621|NCT01154296|584596550|FG000|6-month Follow-up|Incarcerated|37|||
161877622|NCT01154296|584596551|FG001|6-month Follow-up|Incarcerated|32|||
161877623|NCT01154296|584596550|FG000|6-month Follow-up|Withdrew consent|14|||
161877624|NCT01154296|584596551|FG001|6-month Follow-up|Withdrew consent|15|||
161877625|NCT01154296|584596550|FG000|6-month Follow-up|Death|3|||
161877626|NCT01154296|584596551|FG001|6-month Follow-up|Death|2|||
161877627|NCT01154296|584596550|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
161877628|NCT01154296|584596551|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
161877629|NCT02203851|584596552|FG000|Overall Study|Lost to Follow-up|4|||
161877630|NCT02203851|584596552|FG000|Overall Study|Withdrawal by Subject|6|||
161877631|NCT02203851|584596552|FG000|Overall Study|Other|1|||
161877632|NCT02005692|584596555|FG000|Overall Study|Protocol Violation|1|||
161877633|NCT02005692|584596555|FG000|Overall Study|Withdrawal by Subject|1|||
161877634|NCT02005692|584596555|FG000|Overall Study|Discharged earlier than anticipated|5|||
161877635|NCT05896527|584596557|FG000|Overall Study|Withdrawal by Subject|11|||
161877636|NCT05896527|584596558|FG001|Overall Study|Withdrawal by Subject|10|||
161877637|NCT05896527|584596559|FG002|Overall Study|Withdrawal by Subject|4|||
161877638|NCT05896527|584596560|FG003|Overall Study|Withdrawal by Subject|3|||
161877639|NCT05896527|584596561|FG004|Overall Study|Withdrawal by Subject|2|||
161877640|NCT05896527|584596557|FG000|Overall Study|Lost to Follow-up|0|||
161877641|NCT05896527|584596558|FG001|Overall Study|Lost to Follow-up|2|||
161877642|NCT05896527|584596559|FG002|Overall Study|Lost to Follow-up|2|||
161877643|NCT05896527|584596560|FG003|Overall Study|Lost to Follow-up|2|||
161877644|NCT05896527|584596561|FG004|Overall Study|Lost to Follow-up|1|||
161877645|NCT05896527|584596557|FG000|Overall Study|Significant protocol noncompliance|0|||
161877646|NCT05896527|584596558|FG001|Overall Study|Significant protocol noncompliance|1|||
161877647|NCT05896527|584596559|FG002|Overall Study|Significant protocol noncompliance|0|||
161877648|NCT05896527|584596560|FG003|Overall Study|Significant protocol noncompliance|0|||
161877649|NCT05896527|584596561|FG004|Overall Study|Significant protocol noncompliance|0|||
161877650|NCT05896527|584596557|FG000|Overall Study|Eligibility criteria not met|1|||
161877651|NCT05896527|584596558|FG001|Overall Study|Eligibility criteria not met|0|||
161877652|NCT05896527|584596559|FG002|Overall Study|Eligibility criteria not met|0|||
161877653|NCT05896527|584596560|FG003|Overall Study|Eligibility criteria not met|0|||
161877654|NCT05896527|584596561|FG004|Overall Study|Eligibility criteria not met|0|||
161877655|NCT05896527|584596557|FG000|Overall Study|Sponsor's decision|0|||
161877656|NCT05896527|584596558|FG001|Overall Study|Sponsor's decision|0|||
161877657|NCT05896527|584596559|FG002|Overall Study|Sponsor's decision|0|||
161877658|NCT05896527|584596560|FG003|Overall Study|Sponsor's decision|1|||
161877659|NCT05896527|584596561|FG004|Overall Study|Sponsor's decision|0|||
161877660|NCT05896527|584596557|FG000|Overall Study|Investigator's decision|0|||
161877661|NCT05896527|584596558|FG001|Overall Study|Investigator's decision|1|||
161877662|NCT05896527|584596559|FG002|Overall Study|Investigator's decision|0|||
161877663|NCT05896527|584596560|FG003|Overall Study|Investigator's decision|0|||
161877664|NCT05896527|584596561|FG004|Overall Study|Investigator's decision|0|||
161877665|NCT05896527|584596557|FG000|Overall Study|Pregnancy of his partner|0|||
161877666|NCT05896527|584596558|FG001|Overall Study|Pregnancy of his partner|0|||
161877667|NCT05896527|584596559|FG002|Overall Study|Pregnancy of his partner|0|||
161877668|NCT05896527|584596560|FG003|Overall Study|Pregnancy of his partner|1|||
161877669|NCT05896527|584596561|FG004|Overall Study|Pregnancy of his partner|0|||
161877670|NCT01279070|584596562|FG000|Overall Study|Withdrawal by Subject|2|||
161877671|NCT01279070|584596563|FG001|Overall Study|Withdrawal by Subject|3|||
161877672|NCT01279070|584596562|FG000|Overall Study|Acute exacerbation|3|||
161877673|NCT01279070|584596563|FG001|Overall Study|Acute exacerbation|1|||
161877674|NCT02651155|584596564|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161877675|NCT02651155|584596565|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
161877676|NCT02651155|584596564|FG000|Overall Study|Voluntary Withdrawal|5|||
161877677|NCT02651155|584596565|FG001|Overall Study|Voluntary Withdrawal|0|||
161877678|NCT01867710|584596568|FG000|Overall Study|Death|25|||
161877679|NCT01867710|584596569|FG001|Overall Study|Death|15|||
161877680|NCT01867710|584596570|FG002|Overall Study|Death|27|||
161877681|NCT01867710|584596571|FG003|Overall Study|Death|20|||
161877682|NCT01867710|584596568|FG000|Overall Study|Lost to Follow-up|3|||
161877683|NCT01867710|584596569|FG001|Overall Study|Lost to Follow-up|4|||
161877684|NCT01867710|584596570|FG002|Overall Study|Lost to Follow-up|3|||
161877685|NCT01867710|584596571|FG003|Overall Study|Lost to Follow-up|2|||
161877686|NCT01867710|584596568|FG000|Overall Study|Withdrawal of consent|2|||
161877687|NCT01867710|584596569|FG001|Overall Study|Withdrawal of consent|5|||
161877688|NCT01867710|584596570|FG002|Overall Study|Withdrawal of consent|1|||
161877689|NCT01867710|584596571|FG003|Overall Study|Withdrawal of consent|2|||
161877690|NCT01867710|584596568|FG000|Overall Study|Study Terminated by Sponsor|9|||
161877691|NCT01867710|584596569|FG001|Overall Study|Study Terminated by Sponsor|13|||
161877692|NCT01867710|584596570|FG002|Overall Study|Study Terminated by Sponsor|8|||
161877693|NCT01867710|584596571|FG003|Overall Study|Study Terminated by Sponsor|16|||
161877694|NCT01867710|584596568|FG000|Overall Study|Biochemical progression|0|||
161877695|NCT01867710|584596569|FG001|Overall Study|Biochemical progression|1|||
161877696|NCT01867710|584596570|FG002|Overall Study|Biochemical progression|0|||
161877697|NCT01867710|584596571|FG003|Overall Study|Biochemical progression|0|||
161877698|NCT01867710|584596568|FG000|Overall Study|Clinical progression|0|||
161877699|NCT01867710|584596569|FG001|Overall Study|Clinical progression|0|||
161877700|NCT01867710|584596570|FG002|Overall Study|Clinical progression|1|||
161877701|NCT01867710|584596571|FG003|Overall Study|Clinical progression|0|||
161877702|NCT01867710|584596568|FG000|Overall Study|Disease progression|1|||
161877703|NCT01867710|584596569|FG001|Overall Study|Disease progression|0|||
161877704|NCT01867710|584596570|FG002|Overall Study|Disease progression|0|||
161877705|NCT01867710|584596571|FG003|Overall Study|Disease progression|0|||
161877706|NCT01867710|584596568|FG000|Overall Study|Patient decision|0|||
161877707|NCT01867710|584596569|FG001|Overall Study|Patient decision|0|||
161877708|NCT01867710|584596570|FG002|Overall Study|Patient decision|0|||
161877709|NCT01867710|584596571|FG003|Overall Study|Patient decision|1|||
161877710|NCT01867710|584596568|FG000|Overall Study|Patient to follow subsequent treatment|0|||
161877711|NCT01867710|584596569|FG001|Overall Study|Patient to follow subsequent treatment|1|||
161877712|NCT01867710|584596570|FG002|Overall Study|Patient to follow subsequent treatment|0|||
161877713|NCT01867710|584596571|FG003|Overall Study|Patient to follow subsequent treatment|0|||
161877714|NCT01867710|584596568|FG000|Overall Study|Progressive disease|1|||
161877715|NCT01867710|584596569|FG001|Overall Study|Progressive disease|0|||
161877716|NCT01867710|584596570|FG002|Overall Study|Progressive disease|0|||
161877717|NCT01867710|584596571|FG003|Overall Study|Progressive disease|0|||
161877718|NCT01867710|584596568|FG000|Overall Study|Protocol Violation|0|||
161877719|NCT01867710|584596569|FG001|Overall Study|Protocol Violation|0|||
161877720|NCT01867710|584596570|FG002|Overall Study|Protocol Violation|0|||
161877721|NCT01867710|584596571|FG003|Overall Study|Protocol Violation|1|||
161877722|NCT01867710|584596568|FG000|Overall Study|PSA-progression|0|||
161877723|NCT01867710|584596569|FG001|Overall Study|PSA-progression|1|||
161877724|NCT01867710|584596570|FG002|Overall Study|PSA-progression|0|||
161877725|NCT01867710|584596571|FG003|Overall Study|PSA-progression|0|||
161877726|NCT01867710|584596568|FG000|Overall Study|Study medication no longer effective|0|||
161877727|NCT01867710|584596569|FG001|Overall Study|Study medication no longer effective|1|||
161877728|NCT01867710|584596570|FG002|Overall Study|Study medication no longer effective|0|||
161877729|NCT01867710|584596571|FG003|Overall Study|Study medication no longer effective|0|||
161877730|NCT00976820|584596572|FG000|Overall Study|Lost to Follow-up|5|||
161877731|NCT00976820|584596573|FG001|Overall Study|Lost to Follow-up|16|||
161877732|NCT00976820|584596574|FG002|Overall Study|Lost to Follow-up|2|||
161877733|NCT00976820|584596575|FG003|Overall Study|Lost to Follow-up|3|||
161877734|NCT00976820|584596572|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
161877735|NCT00976820|584596573|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
161877736|NCT00976820|584596574|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
161877737|NCT00976820|584596575|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
161877738|NCT00976820|584596572|FG000|Overall Study|Withdrawal by Subject|2|||
161877739|NCT00976820|584596573|FG001|Overall Study|Withdrawal by Subject|4|||
161877740|NCT00976820|584596574|FG002|Overall Study|Withdrawal by Subject|1|||
161877741|NCT00976820|584596575|FG003|Overall Study|Withdrawal by Subject|4|||
161877742|NCT02048826|584596576|FG000|Overall Study|Withdrawal by Subject|1|||
161877743|NCT02048826|584596577|FG001|Overall Study|Withdrawal by Subject|0|||
161877744|NCT00968981|584596578|FG000|Overall Study|Adverse Event|2|||
161877745|NCT00968981|584596579|FG001|Overall Study|Adverse Event|0|||
161877746|NCT00968981|584596580|FG002|Overall Study|Adverse Event|0|||
161877747|NCT00968981|584596578|FG000|Overall Study|Disease Progression|14|||
161877748|NCT00968981|584596579|FG001|Overall Study|Disease Progression|16|||
161877749|NCT00968981|584596580|FG002|Overall Study|Disease Progression|13|||
161877750|NCT00968981|584596578|FG000|Overall Study|Lost to Follow-up|0|||
161877751|NCT00968981|584596579|FG001|Overall Study|Lost to Follow-up|0|||
161877752|NCT00968981|584596580|FG002|Overall Study|Lost to Follow-up|1|||
161877753|NCT00968981|584596578|FG000|Overall Study|Physician Decision|5|||
161877754|NCT00968981|584596579|FG001|Overall Study|Physician Decision|3|||
161877755|NCT00968981|584596580|FG002|Overall Study|Physician Decision|5|||
161877756|NCT00968981|584596578|FG000|Overall Study|Withdrawal by Subject|1|||
161877757|NCT00968981|584596579|FG001|Overall Study|Withdrawal by Subject|3|||
161877758|NCT00968981|584596580|FG002|Overall Study|Withdrawal by Subject|3|||
161877759|NCT01981954|584596591|FG000|Titration Period|Protocol Deviation|1|||
161877760|NCT01981954|584596591|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
161877761|NCT01489254|584596592|FG000|Double-blind Part|Adverse Event|7|||
161877762|NCT01489254|584596593|FG001|Double-blind Part|Adverse Event|2|||
161877763|NCT01489254|584596594|FG002|Double-blind Part|Adverse Event|2|||
161877764|NCT01489254|584596595|FG003|Double-blind Part|Adverse Event|0|||
161877765|NCT01489254|584596592|FG000|Double-blind Part|Pregnancy|1|||
161877766|NCT01489254|584596593|FG001|Double-blind Part|Pregnancy|3|||
161877767|NCT01489254|584596594|FG002|Double-blind Part|Pregnancy|0|||
161877768|NCT01489254|584596595|FG003|Double-blind Part|Pregnancy|0|||
161877769|NCT01489254|584596592|FG000|Double-blind Part|Withdrawal by Subject|12|||
161877770|NCT01489254|584596593|FG001|Double-blind Part|Withdrawal by Subject|20|||
161877771|NCT01489254|584596594|FG002|Double-blind Part|Withdrawal by Subject|1|||
161877772|NCT01489254|584596595|FG003|Double-blind Part|Withdrawal by Subject|0|||
161877773|NCT01489254|584596592|FG000|Double-blind Part|Lost to Follow-up|1|||
161877774|NCT01489254|584596593|FG001|Double-blind Part|Lost to Follow-up|2|||
161877775|NCT01489254|584596594|FG002|Double-blind Part|Lost to Follow-up|0|||
161877776|NCT01489254|584596595|FG003|Double-blind Part|Lost to Follow-up|0|||
161877777|NCT01489254|584596592|FG000|Double-blind Part|Other reasons for not completing study|4|||
161877778|NCT01489254|584596593|FG001|Double-blind Part|Other reasons for not completing study|6|||
161877779|NCT01489254|584596594|FG002|Double-blind Part|Other reasons for not completing study|0|||
161877780|NCT01489254|584596595|FG003|Double-blind Part|Other reasons for not completing study|0|||
161877781|NCT01489254|584596592|FG000|Open-label Extension Part|Adverse Event|0|||
161877782|NCT01489254|584596593|FG001|Open-label Extension Part|Adverse Event|0|||
161877783|NCT01489254|584596594|FG002|Open-label Extension Part|Adverse Event|0|||
161877784|NCT01489254|584596595|FG003|Open-label Extension Part|Adverse Event|10|||
161877785|NCT01489254|584596592|FG000|Open-label Extension Part|Pregnancy|0|||
161877786|NCT01489254|584596593|FG001|Open-label Extension Part|Pregnancy|0|||
161877787|NCT01489254|584596594|FG002|Open-label Extension Part|Pregnancy|0|||
161877788|NCT01489254|584596595|FG003|Open-label Extension Part|Pregnancy|3|||
161877789|NCT01489254|584596592|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
161877790|NCT01489254|584596593|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
161877791|NCT01489254|584596594|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
161877792|NCT01489254|584596595|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
161877793|NCT01489254|584596592|FG000|Open-label Extension Part|Protocol Violation|0|||
161877794|NCT01489254|584596593|FG001|Open-label Extension Part|Protocol Violation|0|||
161877795|NCT01489254|584596594|FG002|Open-label Extension Part|Protocol Violation|0|||
161877796|NCT01489254|584596595|FG003|Open-label Extension Part|Protocol Violation|1|||
161877797|NCT01489254|584596592|FG000|Open-label Extension Part|Lost to Follow-up|0|||
161877798|NCT01489254|584596593|FG001|Open-label Extension Part|Lost to Follow-up|0|||
161877799|NCT01489254|584596594|FG002|Open-label Extension Part|Lost to Follow-up|0|||
161877800|NCT01489254|584596595|FG003|Open-label Extension Part|Lost to Follow-up|9|||
161877801|NCT01489254|584596592|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
161877802|NCT01489254|584596593|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
161877803|NCT01489254|584596594|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
161877804|NCT01489254|584596595|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
161877805|NCT00890084|584596609|FG000|Overall Study|Adverse Event|16|||
161877806|NCT00890084|584596609|FG000|Overall Study|Lost to Follow-up|126|||
161877807|NCT02738879|584596610|FG000|Overall Study|Adverse Event|1|||
161877808|NCT02738879|584596611|FG001|Overall Study|Adverse Event|1|||
161877809|NCT02738879|584596610|FG000|Overall Study|Death|0|||
161877810|NCT02738879|584596611|FG001|Overall Study|Death|2|||
161877811|NCT02738879|584596610|FG000|Overall Study|Lost to Follow-up|1|||
161877812|NCT02738879|584596611|FG001|Overall Study|Lost to Follow-up|5|||
161877813|NCT02738879|584596610|FG000|Overall Study|Protocol Violation|1|||
161877814|NCT02738879|584596611|FG001|Overall Study|Protocol Violation|3|||
161877815|NCT02738879|584596610|FG000|Overall Study|Physician Decision|3|||
161877816|NCT02738879|584596611|FG001|Overall Study|Physician Decision|4|||
161877817|NCT02738879|584596610|FG000|Overall Study|Pregnancy|0|||
161877818|NCT02738879|584596611|FG001|Overall Study|Pregnancy|1|||
161877819|NCT02738879|584596610|FG000|Overall Study|Screen Failure|1|||
161877820|NCT02738879|584596611|FG001|Overall Study|Screen Failure|2|||
161877821|NCT02738879|584596610|FG000|Overall Study|Site Discontinued Study Participation|1|||
161877822|NCT02738879|584596611|FG001|Overall Study|Site Discontinued Study Participation|0|||
161877823|NCT02738879|584596610|FG000|Overall Study|Withdrawal by Subject|5|||
161877824|NCT02738879|584596611|FG001|Overall Study|Withdrawal by Subject|7|||
161877825|NCT01647516|584596616|FG000|Induction Period (IP)|Physician Decision|2|||
161877826|NCT01647516|584596617|FG001|Induction Period (IP)|Physician Decision|0|||
161877827|NCT01647516|584596618|FG002|Induction Period (IP)|Physician Decision|0|||
161877828|NCT01647516|584596619|FG003|Induction Period (IP)|Physician Decision|0|||
161877829|NCT01647516|584596620|FG004|Induction Period (IP)|Physician Decision|0|||
161877830|NCT01647516|584596621|FG005|Induction Period (IP)|Physician Decision|0|||
161877831|NCT01647516|584596616|FG000|Induction Period (IP)|Adverse Event|1|||
161877832|NCT01647516|584596617|FG001|Induction Period (IP)|Adverse Event|2|||
161877833|NCT01647516|584596618|FG002|Induction Period (IP)|Adverse Event|0|||
161877834|NCT01647516|584596619|FG003|Induction Period (IP)|Adverse Event|0|||
161877835|NCT01647516|584596620|FG004|Induction Period (IP)|Adverse Event|0|||
161877836|NCT01647516|584596621|FG005|Induction Period (IP)|Adverse Event|0|||
161877837|NCT01647516|584596616|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
161877838|NCT01647516|584596617|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
161877839|NCT01647516|584596618|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
161877840|NCT01647516|584596619|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
161877841|NCT01647516|584596620|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
161877842|NCT01647516|584596621|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
161877843|NCT01647516|584596616|FG000|Induction Period (IP)|Participant Choice|0|||
161877844|NCT01647516|584596617|FG001|Induction Period (IP)|Participant Choice|0|||
161877845|NCT01647516|584596618|FG002|Induction Period (IP)|Participant Choice|1|||
161877846|NCT01647516|584596619|FG003|Induction Period (IP)|Participant Choice|0|||
161877847|NCT01647516|584596620|FG004|Induction Period (IP)|Participant Choice|0|||
161877848|NCT01647516|584596621|FG005|Induction Period (IP)|Participant Choice|0|||
161877849|NCT01647516|584596616|FG000|Induction Period (IP)|Lack of Efficacy|1|||
161877850|NCT01647516|584596617|FG001|Induction Period (IP)|Lack of Efficacy|0|||
161877851|NCT01647516|584596618|FG002|Induction Period (IP)|Lack of Efficacy|0|||
161877852|NCT01647516|584596619|FG003|Induction Period (IP)|Lack of Efficacy|0|||
161877853|NCT01647516|584596620|FG004|Induction Period (IP)|Lack of Efficacy|0|||
161877854|NCT01647516|584596621|FG005|Induction Period (IP)|Lack of Efficacy|0|||
161877855|NCT01647516|584596616|FG000|Induction Period (IP)|No study drug received|1|||
161877856|NCT01647516|584596617|FG001|Induction Period (IP)|No study drug received|1|||
161877857|NCT01647516|584596618|FG002|Induction Period (IP)|No study drug received|0|||
161877858|NCT01647516|584596619|FG003|Induction Period (IP)|No study drug received|0|||
161877859|NCT01647516|584596620|FG004|Induction Period (IP)|No study drug received|0|||
161877860|NCT01647516|584596621|FG005|Induction Period (IP)|No study drug received|0|||
161877861|NCT01647516|584596616|FG000|Maintenance Period (MP)|Adverse Event|2|||
161877862|NCT01647516|584596617|FG001|Maintenance Period (MP)|Adverse Event|1|||
161877863|NCT01647516|584596618|FG002|Maintenance Period (MP)|Adverse Event|0|||
161877864|NCT01647516|584596619|FG003|Maintenance Period (MP)|Adverse Event|0|||
161877865|NCT01647516|584596620|FG004|Maintenance Period (MP)|Adverse Event|0|||
161877866|NCT01647516|584596621|FG005|Maintenance Period (MP)|Adverse Event|0|||
161877867|NCT01647516|584596616|FG000|Maintenance Period (MP)|Non-compliance|1|||
161877868|NCT01647516|584596617|FG001|Maintenance Period (MP)|Non-compliance|0|||
161877869|NCT01647516|584596618|FG002|Maintenance Period (MP)|Non-compliance|0|||
161877870|NCT01647516|584596619|FG003|Maintenance Period (MP)|Non-compliance|0|||
161877871|NCT01647516|584596620|FG004|Maintenance Period (MP)|Non-compliance|0|||
161877872|NCT01647516|584596621|FG005|Maintenance Period (MP)|Non-compliance|0|||
161877873|NCT01647516|584596616|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877874|NCT01647516|584596617|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
161776661|NCT05554471|584223265|FG000|Overall Study|Physician Decision|2|||
161776662|NCT05554471|584223266|FG001|Overall Study|Physician Decision|1|||
161776663|NCT05554471|584223265|FG000|Overall Study|Lost to Follow-up|2|||
161776664|NCT05554471|584223266|FG001|Overall Study|Lost to Follow-up|1|||
161776665|NCT05554471|584223265|FG000|Overall Study|Death|0|||
161776666|NCT05554471|584223266|FG001|Overall Study|Death|1|||
161776667|NCT01319994|584225372|FG000|Overall Study|Protocol Violation|7|||
161776668|NCT01319994|584225373|FG001|Overall Study|Protocol Violation|6|||
161776669|NCT01340794|584225374|FG000|Overall Study|Withdrawal by Subject|0|||
161776670|NCT01340794|584225375|FG001|Overall Study|Withdrawal by Subject|1|||
161776671|NCT02674568|584225384|FG000|Overall Study|Withdrawal by Subject|5|||
161776672|NCT02674568|584225384|FG000|Overall Study|Death|303|||
161776673|NCT02674568|584225384|FG000|Overall Study|Physician Decision|2|||
161776674|NCT02674568|584225384|FG000|Overall Study|Lost to Follow-up|9|||
161776675|NCT02674568|584225384|FG000|Overall Study|Other, Not Specified|20|||
161776676|NCT01808508|584225387|FG000|Overall Study|Lost to Follow-up|1|||
161776677|NCT01808508|584225388|FG001|Overall Study|Lost to Follow-up|0|||
161776678|NCT01808508|584225389|FG002|Overall Study|Lost to Follow-up|0|||
161776679|NCT01118949|584225390|FG000|Overall Study|Adverse Event|5|||
161776680|NCT01118949|584225390|FG000|Overall Study|Withdrawal by Subject|4|||
161776681|NCT00648739|584225391|FG000|Overall Study|Adverse Event|1|||
161776682|NCT00648739|584225392|FG001|Overall Study|Adverse Event|0|||
161776683|NCT00648739|584225393|FG002|Overall Study|Adverse Event|1|||
161776684|NCT00648739|584225394|FG003|Overall Study|Adverse Event|2|||
161776685|NCT00648739|584225395|FG004|Overall Study|Adverse Event|1|||
161776686|NCT00648739|584225396|FG005|Overall Study|Adverse Event|0|||
161776687|NCT00648739|584225397|FG006|Overall Study|Adverse Event|0|||
161877875|NCT01647516|584596618|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
161877876|NCT01647516|584596619|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877877|NCT01647516|584596620|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877878|NCT01647516|584596621|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877879|NCT01647516|584596616|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
161877880|NCT01647516|584596617|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
161877881|NCT01647516|584596618|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
161877882|NCT01647516|584596619|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
161877883|NCT01647516|584596620|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
161877884|NCT01647516|584596621|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
161776688|NCT00648739|584225391|FG000|Overall Study|Withdrawal by Subject|1|||
161776689|NCT00648739|584225392|FG001|Overall Study|Withdrawal by Subject|0|||
161776690|NCT00648739|584225393|FG002|Overall Study|Withdrawal by Subject|1|||
161776691|NCT00648739|584225394|FG003|Overall Study|Withdrawal by Subject|0|||
161776692|NCT00648739|584225395|FG004|Overall Study|Withdrawal by Subject|0|||
161776693|NCT00648739|584225396|FG005|Overall Study|Withdrawal by Subject|2|||
161776694|NCT00648739|584225397|FG006|Overall Study|Withdrawal by Subject|0|||
161776695|NCT00648739|584225391|FG000|Overall Study|Lack of Efficacy|0|||
161776696|NCT00648739|584225392|FG001|Overall Study|Lack of Efficacy|0|||
161776697|NCT00648739|584225393|FG002|Overall Study|Lack of Efficacy|0|||
161877885|NCT01647516|584596616|FG000|Open-Label Period|Adverse Event|0|||
161877886|NCT01647516|584596617|FG001|Open-Label Period|Adverse Event|0|||
161877887|NCT01647516|584596618|FG002|Open-Label Period|Adverse Event|0|||
161877888|NCT01647516|584596619|FG003|Open-Label Period|Adverse Event|5|||
161877889|NCT01647516|584596620|FG004|Open-Label Period|Adverse Event|6|||
161877890|NCT01647516|584596621|FG005|Open-Label Period|Adverse Event|3|||
161877891|NCT01647516|584596616|FG000|Open-Label Period|Pregnancy|0|||
161877892|NCT01647516|584596617|FG001|Open-Label Period|Pregnancy|0|||
161877893|NCT01647516|584596618|FG002|Open-Label Period|Pregnancy|0|||
161877894|NCT01647516|584596619|FG003|Open-Label Period|Pregnancy|0|||
161877895|NCT01647516|584596620|FG004|Open-Label Period|Pregnancy|0|||
161877896|NCT01647516|584596621|FG005|Open-Label Period|Pregnancy|1|||
161877897|NCT01647516|584596616|FG000|Open-Label Period|Non-compliance|0|||
161877898|NCT01647516|584596617|FG001|Open-Label Period|Non-compliance|0|||
161877899|NCT01647516|584596618|FG002|Open-Label Period|Non-compliance|0|||
161877900|NCT01647516|584596619|FG003|Open-Label Period|Non-compliance|1|||
161877901|NCT01647516|584596620|FG004|Open-Label Period|Non-compliance|0|||
161877902|NCT01647516|584596621|FG005|Open-Label Period|Non-compliance|1|||
161877903|NCT01647516|584596616|FG000|Open-Label Period|Physician Decision|0|||
161877904|NCT01647516|584596617|FG001|Open-Label Period|Physician Decision|0|||
161877905|NCT01647516|584596618|FG002|Open-Label Period|Physician Decision|0|||
161877906|NCT01647516|584596619|FG003|Open-Label Period|Physician Decision|1|||
161877907|NCT01647516|584596620|FG004|Open-Label Period|Physician Decision|1|||
161877908|NCT01647516|584596621|FG005|Open-Label Period|Physician Decision|0|||
161877909|NCT01647516|584596616|FG000|Open-Label Period|Withdrawal by Subject|0|||
161877910|NCT01647516|584596617|FG001|Open-Label Period|Withdrawal by Subject|0|||
161877911|NCT01647516|584596618|FG002|Open-Label Period|Withdrawal by Subject|0|||
161877912|NCT01647516|584596619|FG003|Open-Label Period|Withdrawal by Subject|9|||
161877913|NCT01647516|584596620|FG004|Open-Label Period|Withdrawal by Subject|11|||
161877914|NCT01647516|584596621|FG005|Open-Label Period|Withdrawal by Subject|6|||
161877915|NCT01647516|584596616|FG000|Open-Label Period|Lost to Follow-up|0|||
161877916|NCT01647516|584596617|FG001|Open-Label Period|Lost to Follow-up|0|||
161877917|NCT01647516|584596618|FG002|Open-Label Period|Lost to Follow-up|0|||
161877918|NCT01647516|584596619|FG003|Open-Label Period|Lost to Follow-up|1|||
161877919|NCT01647516|584596620|FG004|Open-Label Period|Lost to Follow-up|0|||
161877920|NCT01647516|584596621|FG005|Open-Label Period|Lost to Follow-up|1|||
161877921|NCT01647516|584596616|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161877922|NCT01647516|584596617|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161877923|NCT01647516|584596618|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161877924|NCT01647516|584596619|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
161877925|NCT01647516|584596620|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
161877926|NCT01647516|584596621|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
161877927|NCT01647516|584596616|FG000|Open-Label Period|Lack of Efficacy|0|||
161877928|NCT01647516|584596617|FG001|Open-Label Period|Lack of Efficacy|0|||
161877929|NCT01647516|584596618|FG002|Open-Label Period|Lack of Efficacy|0|||
161877930|NCT01647516|584596619|FG003|Open-Label Period|Lack of Efficacy|7|||
161877931|NCT01647516|584596620|FG004|Open-Label Period|Lack of Efficacy|9|||
161877932|NCT01647516|584596621|FG005|Open-Label Period|Lack of Efficacy|10|||
161877933|NCT01647516|584596616|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161877934|NCT01647516|584596617|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161877935|NCT01647516|584596618|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161877936|NCT01647516|584596619|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
161877937|NCT01647516|584596620|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
161877938|NCT01647516|584596621|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
161877939|NCT01647516|584596616|FG000|Open-Label Period|No completion / discontinuation visit|0|||
161776698|NCT00648739|584225394|FG003|Overall Study|Lack of Efficacy|0|||
161776699|NCT00648739|584225395|FG004|Overall Study|Lack of Efficacy|1|||
161776700|NCT00648739|584225396|FG005|Overall Study|Lack of Efficacy|2|||
161776701|NCT00648739|584225397|FG006|Overall Study|Lack of Efficacy|0|||
161776702|NCT00648739|584225391|FG000|Overall Study|Investigator Considered it Advisable|0|||
161776703|NCT00648739|584225392|FG001|Overall Study|Investigator Considered it Advisable|0|||
161776704|NCT00648739|584225393|FG002|Overall Study|Investigator Considered it Advisable|0|||
161877940|NCT01647516|584596617|FG001|Open-Label Period|No completion / discontinuation visit|0|||
161877941|NCT01647516|584596618|FG002|Open-Label Period|No completion / discontinuation visit|0|||
161877942|NCT01647516|584596619|FG003|Open-Label Period|No completion / discontinuation visit|0|||
161877943|NCT01647516|584596620|FG004|Open-Label Period|No completion / discontinuation visit|2|||
161877944|NCT01647516|584596621|FG005|Open-Label Period|No completion / discontinuation visit|1|||
161877945|NCT02980341|584596622|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161877946|NCT02980341|584596623|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161877947|NCT02980341|584596624|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
161877948|NCT02980341|584596625|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
161877949|NCT02980341|584596626|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161776705|NCT00648739|584225394|FG003|Overall Study|Investigator Considered it Advisable|0|||
161776706|NCT00648739|584225395|FG004|Overall Study|Investigator Considered it Advisable|0|||
161776707|NCT00648739|584225396|FG005|Overall Study|Investigator Considered it Advisable|1|||
161776708|NCT00648739|584225397|FG006|Overall Study|Investigator Considered it Advisable|1|||
161776709|NCT00648739|584225391|FG000|Overall Study|Death|0|||
161776710|NCT00648739|584225392|FG001|Overall Study|Death|1|||
161776711|NCT00648739|584225393|FG002|Overall Study|Death|0|||
161776712|NCT00648739|584225394|FG003|Overall Study|Death|0|||
161776713|NCT00648739|584225395|FG004|Overall Study|Death|0|||
161776714|NCT00648739|584225396|FG005|Overall Study|Death|0|||
161776715|NCT00648739|584225397|FG006|Overall Study|Death|0|||
161776716|NCT00648739|584225391|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
161776717|NCT00648739|584225392|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
161776718|NCT00648739|584225393|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
161776719|NCT00648739|584225394|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
161776720|NCT00648739|584225395|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
161776721|NCT00648739|584225396|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
161776722|NCT00648739|584225397|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
161776723|NCT00648739|584225391|FG000|Overall Study|Follow-up Visits Not Completed|0|||
161776724|NCT00648739|584225392|FG001|Overall Study|Follow-up Visits Not Completed|1|||
161776725|NCT00648739|584225393|FG002|Overall Study|Follow-up Visits Not Completed|0|||
161776726|NCT00648739|584225394|FG003|Overall Study|Follow-up Visits Not Completed|0|||
161776727|NCT00648739|584225395|FG004|Overall Study|Follow-up Visits Not Completed|0|||
161776728|NCT00648739|584225396|FG005|Overall Study|Follow-up Visits Not Completed|0|||
161776729|NCT00648739|584225397|FG006|Overall Study|Follow-up Visits Not Completed|0|||
161776730|NCT03387423|584225402|FG000|Overall Study|Lost to Follow-up|16|||
161776731|NCT03387423|584225403|FG001|Overall Study|Lost to Follow-up|12|||
161776732|NCT03387423|584225404|FG002|Overall Study|Lost to Follow-up|1|||
161776733|NCT03387423|584225405|FG003|Overall Study|Lost to Follow-up|0|||
161776734|NCT03387423|584225402|FG000|Overall Study|Other|0|||
161776735|NCT03387423|584225403|FG001|Overall Study|Other|3|||
161776736|NCT03387423|584225404|FG002|Overall Study|Other|0|||
161776737|NCT03387423|584225405|FG003|Overall Study|Other|0|||
161776738|NCT03387423|584225402|FG000|Overall Study|Administrative Reason|166|||
161776739|NCT03387423|584225403|FG001|Overall Study|Administrative Reason|89|||
161776740|NCT03387423|584225404|FG002|Overall Study|Administrative Reason|17|||
161776741|NCT03387423|584225405|FG003|Overall Study|Administrative Reason|19|||
161776742|NCT03387423|584225402|FG000|Overall Study|Revocation Consent|76|||
161776743|NCT03387423|584225403|FG001|Overall Study|Revocation Consent|32|||
161776744|NCT03387423|584225404|FG002|Overall Study|Revocation Consent|3|||
161776745|NCT03387423|584225405|FG003|Overall Study|Revocation Consent|5|||
161776746|NCT04362761|584225412|FG000|Part A (48 Weeks)|Adverse Event|2|||
161776747|NCT04362761|584225412|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
161776748|NCT04362761|584225412|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
161776749|NCT04362761|584225412|FG000|Part A (48 Weeks)|Other|5|||
161776750|NCT04362761|584225412|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
161776751|NCT04362761|584225412|FG000|Part B (86 Weeks)|Other|4|||
161776752|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
161776753|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161776754|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161776755|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161776756|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
161776757|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
161776758|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
161776759|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
161776760|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
161776761|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161776762|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161776763|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161776764|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
161776765|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
161776766|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
161776767|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
161776768|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
161776769|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161776770|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161877950|NCT02980341|584596627|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161776771|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161776772|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
161776773|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
161776774|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
161776775|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
161776776|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
161877951|NCT02980341|584596628|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877952|NCT02980341|584596629|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877953|NCT02980341|584596630|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877954|NCT02980341|584596631|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877955|NCT02980341|584596632|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877956|NCT02980341|584596622|FG000|Dose Escalation|Clinical progression|0|||
161877957|NCT02980341|584596623|FG001|Dose Escalation|Clinical progression|0|||
161877958|NCT02980341|584596624|FG002|Dose Escalation|Clinical progression|2|||
161877959|NCT02980341|584596625|FG003|Dose Escalation|Clinical progression|1|||
161877960|NCT02980341|584596626|FG004|Dose Escalation|Clinical progression|0|||
161877961|NCT02980341|584596627|FG005|Dose Escalation|Clinical progression|0|||
161877962|NCT02980341|584596628|FG006|Dose Escalation|Clinical progression|0|||
161877963|NCT02980341|584596629|FG007|Dose Escalation|Clinical progression|0|||
161877964|NCT02980341|584596630|FG008|Dose Escalation|Clinical progression|0|||
161877965|NCT02980341|584596631|FG009|Dose Escalation|Clinical progression|0|||
161877966|NCT02980341|584596632|FG010|Dose Escalation|Clinical progression|0|||
161877967|NCT02980341|584596622|FG000|Dose Escalation|Adverse Event|0|||
161877968|NCT02980341|584596623|FG001|Dose Escalation|Adverse Event|0|||
161877969|NCT02980341|584596624|FG002|Dose Escalation|Adverse Event|1|||
161877970|NCT02980341|584596625|FG003|Dose Escalation|Adverse Event|2|||
161877971|NCT02980341|584596626|FG004|Dose Escalation|Adverse Event|2|||
161877972|NCT02980341|584596627|FG005|Dose Escalation|Adverse Event|0|||
161877973|NCT02980341|584596628|FG006|Dose Escalation|Adverse Event|0|||
161776777|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161776778|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161776779|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161776780|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
161776781|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
161776782|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
161776783|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
161776784|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161776785|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
161776786|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161776787|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161776788|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161776789|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
161776790|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161776791|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161776792|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
161776793|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
161776794|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
161776795|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
161776796|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161776797|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
161776798|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161776799|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161776800|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161776801|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
161776802|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161776803|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161776804|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161776805|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
161776806|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161776807|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161776808|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161776809|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
161776810|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161776811|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161776812|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161877974|NCT02980341|584596629|FG007|Dose Escalation|Adverse Event|0|||
161877975|NCT02980341|584596630|FG008|Dose Escalation|Adverse Event|0|||
161877976|NCT02980341|584596631|FG009|Dose Escalation|Adverse Event|0|||
161877977|NCT02980341|584596632|FG010|Dose Escalation|Adverse Event|0|||
161877978|NCT02980341|584596622|FG000|Dose Escalation|Withdrawal by Subject|0|||
161877979|NCT02980341|584596623|FG001|Dose Escalation|Withdrawal by Subject|0|||
161877980|NCT02980341|584596624|FG002|Dose Escalation|Withdrawal by Subject|1|||
161877981|NCT02980341|584596625|FG003|Dose Escalation|Withdrawal by Subject|0|||
161877982|NCT02980341|584596626|FG004|Dose Escalation|Withdrawal by Subject|0|||
161877983|NCT02980341|584596627|FG005|Dose Escalation|Withdrawal by Subject|0|||
161776813|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
161776814|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161776815|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161776816|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
161776817|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
161776818|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
161776819|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
161776820|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
161776821|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
161776822|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
161776823|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
161776824|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
161776825|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
161776826|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
161776827|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
161776828|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
161776829|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
161776830|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
161776831|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
161776832|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
161776833|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
161776834|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
161776835|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
161776836|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
161776837|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
161776838|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
161776839|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
161776840|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
161776841|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
161776842|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
161776843|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
161776844|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
161776845|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
161776846|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
161776847|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
161776848|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
161776849|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
161776850|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
161776851|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
161776852|NCT00464308|584225426|FG000|Overall Study|Adverse Event|22|||
161776853|NCT00464308|584225427|FG001|Overall Study|Adverse Event|27|||
161776854|NCT00464308|584225428|FG002|Overall Study|Adverse Event|16|||
161776855|NCT00464308|584225426|FG000|Overall Study|Lost to Follow-up|29|||
161776856|NCT00464308|584225427|FG001|Overall Study|Lost to Follow-up|19|||
161776857|NCT00464308|584225428|FG002|Overall Study|Lost to Follow-up|20|||
161776858|NCT00464308|584225426|FG000|Overall Study|Patient discontinued and other reasons|17|||
161776859|NCT00464308|584225427|FG001|Overall Study|Patient discontinued and other reasons|17|||
161776860|NCT00464308|584225428|FG002|Overall Study|Patient discontinued and other reasons|23|||
161776861|NCT00464308|584225426|FG000|Overall Study|Physician Decision|1|||
161776862|NCT00464308|584225427|FG001|Overall Study|Physician Decision|0|||
161776863|NCT00464308|584225428|FG002|Overall Study|Physician Decision|0|||
161776864|NCT01721200|584225429|FG000|Overall Study|Lost to Follow-up|3|||
161776865|NCT01721200|584225430|FG001|Overall Study|Lost to Follow-up|5|||
161776866|NCT01513759|584225431|FG000|Overall Study|Protocol Violation|4|||
161776867|NCT01513759|584225431|FG000|Overall Study|Death during catheter placement|1|||
161776868|NCT03606109|584225432|FG000|Overall Study|Lost to Follow-up|2|||
161776869|NCT03606109|584225433|FG001|Overall Study|Lost to Follow-up|1|||
161776870|NCT03926728|584225434|FG000|Overall Study|Withdrawal by Subject|0|||
161776871|NCT03926728|584225435|FG001|Overall Study|Withdrawal by Subject|1|||
161776872|NCT03926728|584225436|FG002|Overall Study|Withdrawal by Subject|1|||
161776873|NCT03926728|584225437|FG003|Overall Study|Withdrawal by Subject|0|||
161776874|NCT03926728|584225438|FG004|Overall Study|Withdrawal by Subject|0|||
161776875|NCT03926728|584225439|FG005|Overall Study|Withdrawal by Subject|1|||
161776876|NCT03926728|584225440|FG006|Overall Study|Withdrawal by Subject|1|||
161776877|NCT03926728|584225441|FG007|Overall Study|Withdrawal by Subject|0|||
161776878|NCT03926728|584225442|FG008|Overall Study|Withdrawal by Subject|0|||
161776879|NCT03926728|584225443|FG009|Overall Study|Withdrawal by Subject|1|||
161776880|NCT03926728|584225444|FG010|Overall Study|Withdrawal by Subject|0|||
161776881|NCT03926728|584225445|FG011|Overall Study|Withdrawal by Subject|0|||
161877984|NCT02980341|584596628|FG006|Dose Escalation|Withdrawal by Subject|0|||
161877985|NCT02980341|584596629|FG007|Dose Escalation|Withdrawal by Subject|0|||
161877986|NCT02980341|584596630|FG008|Dose Escalation|Withdrawal by Subject|0|||
161877987|NCT02980341|584596631|FG009|Dose Escalation|Withdrawal by Subject|0|||
161877988|NCT02980341|584596632|FG010|Dose Escalation|Withdrawal by Subject|0|||
161877989|NCT02980341|584596622|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877990|NCT02980341|584596623|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877991|NCT02980341|584596624|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877992|NCT02980341|584596625|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
161877993|NCT02980341|584596626|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877994|NCT02980341|584596627|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877995|NCT02980341|584596628|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877996|NCT02980341|584596629|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877997|NCT02980341|584596630|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877998|NCT02980341|584596631|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877999|NCT02980341|584596632|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
161878000|NCT02980341|584596622|FG000|Dose Escalation|Due to investigator's decision|0|||
161878001|NCT02980341|584596623|FG001|Dose Escalation|Due to investigator's decision|0|||
161878002|NCT02980341|584596624|FG002|Dose Escalation|Due to investigator's decision|0|||
161878003|NCT02980341|584596625|FG003|Dose Escalation|Due to investigator's decision|0|||
161878004|NCT02980341|584596626|FG004|Dose Escalation|Due to investigator's decision|1|||
161878005|NCT02980341|584596627|FG005|Dose Escalation|Due to investigator's decision|0|||
161878006|NCT02980341|584596628|FG006|Dose Escalation|Due to investigator's decision|0|||
161878007|NCT02980341|584596629|FG007|Dose Escalation|Due to investigator's decision|0|||
161878008|NCT02980341|584596630|FG008|Dose Escalation|Due to investigator's decision|0|||
161878009|NCT02980341|584596631|FG009|Dose Escalation|Due to investigator's decision|0|||
161878010|NCT02980341|584596632|FG010|Dose Escalation|Due to investigator's decision|0|||
161878011|NCT02980341|584596622|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878012|NCT02980341|584596623|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
161776882|NCT03669640|584225450|FG000|Overall Study|Study Terminated by Sponsor|0|||
161776883|NCT03669640|584225451|FG001|Overall Study|Study Terminated by Sponsor|0|||
161776884|NCT03669640|584225452|FG002|Overall Study|Study Terminated by Sponsor|0|||
161776885|NCT03669640|584225453|FG003|Overall Study|Study Terminated by Sponsor|0|||
161776886|NCT03669640|584225454|FG004|Overall Study|Study Terminated by Sponsor|1|||
161776887|NCT03669640|584225455|FG005|Overall Study|Study Terminated by Sponsor|0|||
161776888|NCT03669640|584225450|FG000|Overall Study|Lost to Follow-up|0|||
161776889|NCT03669640|584225451|FG001|Overall Study|Lost to Follow-up|0|||
161776890|NCT03669640|584225452|FG002|Overall Study|Lost to Follow-up|2|||
161776891|NCT03669640|584225453|FG003|Overall Study|Lost to Follow-up|0|||
161776892|NCT03669640|584225454|FG004|Overall Study|Lost to Follow-up|0|||
161776893|NCT03669640|584225455|FG005|Overall Study|Lost to Follow-up|0|||
161776894|NCT03669640|584225450|FG000|Overall Study|Death|0|||
161776895|NCT03669640|584225451|FG001|Overall Study|Death|0|||
161776896|NCT03669640|584225452|FG002|Overall Study|Death|1|||
161776897|NCT03669640|584225453|FG003|Overall Study|Death|0|||
161776898|NCT03669640|584225454|FG004|Overall Study|Death|0|||
161776899|NCT03669640|584225455|FG005|Overall Study|Death|0|||
161776900|NCT03669640|584225450|FG000|Overall Study|Withdrawal by Subject|1|||
161878013|NCT02980341|584596624|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878014|NCT02980341|584596625|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878015|NCT02980341|584596626|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878016|NCT02980341|584596627|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
161878017|NCT02980341|584596628|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
161878018|NCT02980341|584596629|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878019|NCT02980341|584596630|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878020|NCT02980341|584596631|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878021|NCT02980341|584596632|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878022|NCT02980341|584596622|FG000|Dose Finding|Adverse Event|0|||
161878023|NCT02980341|584596623|FG001|Dose Finding|Adverse Event|0|||
161878024|NCT02980341|584596624|FG002|Dose Finding|Adverse Event|0|||
161878025|NCT02980341|584596625|FG003|Dose Finding|Adverse Event|0|||
161878026|NCT02980341|584596626|FG004|Dose Finding|Adverse Event|0|||
161878027|NCT02980341|584596627|FG005|Dose Finding|Adverse Event|3|||
161878028|NCT02980341|584596628|FG006|Dose Finding|Adverse Event|0|||
161776901|NCT03669640|584225451|FG001|Overall Study|Withdrawal by Subject|2|||
161776902|NCT03669640|584225452|FG002|Overall Study|Withdrawal by Subject|1|||
161776903|NCT03669640|584225453|FG003|Overall Study|Withdrawal by Subject|0|||
161776904|NCT03669640|584225454|FG004|Overall Study|Withdrawal by Subject|1|||
161776905|NCT03669640|584225455|FG005|Overall Study|Withdrawal by Subject|3|||
161776906|NCT03669640|584225450|FG000|Overall Study|Protocol Violation|1|||
161878029|NCT02980341|584596629|FG007|Dose Finding|Adverse Event|0|||
161878030|NCT02980341|584596630|FG008|Dose Finding|Adverse Event|0|||
161878031|NCT02980341|584596631|FG009|Dose Finding|Adverse Event|0|||
161878032|NCT02980341|584596632|FG010|Dose Finding|Adverse Event|0|||
161878033|NCT02980341|584596622|FG000|Dose Finding|Withdrawal by Subject|0|||
161878034|NCT02980341|584596623|FG001|Dose Finding|Withdrawal by Subject|0|||
161878035|NCT02980341|584596624|FG002|Dose Finding|Withdrawal by Subject|0|||
161878036|NCT02980341|584596625|FG003|Dose Finding|Withdrawal by Subject|0|||
161878037|NCT02980341|584596626|FG004|Dose Finding|Withdrawal by Subject|0|||
161878038|NCT02980341|584596627|FG005|Dose Finding|Withdrawal by Subject|1|||
161878039|NCT02980341|584596628|FG006|Dose Finding|Withdrawal by Subject|1|||
161878040|NCT02980341|584596629|FG007|Dose Finding|Withdrawal by Subject|0|||
161878041|NCT02980341|584596630|FG008|Dose Finding|Withdrawal by Subject|0|||
161776907|NCT03669640|584225451|FG001|Overall Study|Protocol Violation|0|||
161776908|NCT03669640|584225452|FG002|Overall Study|Protocol Violation|0|||
161776909|NCT03669640|584225453|FG003|Overall Study|Protocol Violation|0|||
161776910|NCT03669640|584225454|FG004|Overall Study|Protocol Violation|0|||
161776911|NCT03669640|584225455|FG005|Overall Study|Protocol Violation|0|||
161776912|NCT03669640|584225450|FG000|Overall Study|Physician Decision|0|||
161776913|NCT03669640|584225451|FG001|Overall Study|Physician Decision|2|||
161878042|NCT02980341|584596631|FG009|Dose Finding|Withdrawal by Subject|0|||
161878043|NCT02980341|584596632|FG010|Dose Finding|Withdrawal by Subject|0|||
161878044|NCT02980341|584596622|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878045|NCT02980341|584596623|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161776914|NCT03669640|584225452|FG002|Overall Study|Physician Decision|0|||
161776915|NCT03669640|584225453|FG003|Overall Study|Physician Decision|0|||
161776916|NCT03669640|584225454|FG004|Overall Study|Physician Decision|0|||
161776917|NCT03669640|584225455|FG005|Overall Study|Physician Decision|0|||
161776918|NCT03669640|584225450|FG000|Overall Study|Disease Relapse|1|||
161776919|NCT03669640|584225451|FG001|Overall Study|Disease Relapse|0|||
161776920|NCT03669640|584225452|FG002|Overall Study|Disease Relapse|0|||
161776921|NCT03669640|584225453|FG003|Overall Study|Disease Relapse|0|||
161776922|NCT03669640|584225454|FG004|Overall Study|Disease Relapse|0|||
161878046|NCT02980341|584596624|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878047|NCT02980341|584596625|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161776923|NCT03669640|584225455|FG005|Overall Study|Disease Relapse|0|||
161776924|NCT03669640|584225450|FG000|Overall Study|Adverse Event|2|||
161776925|NCT03669640|584225451|FG001|Overall Study|Adverse Event|1|||
161776926|NCT03669640|584225452|FG002|Overall Study|Adverse Event|0|||
161776927|NCT03669640|584225453|FG003|Overall Study|Adverse Event|0|||
161776928|NCT03669640|584225454|FG004|Overall Study|Adverse Event|1|||
161776929|NCT03669640|584225455|FG005|Overall Study|Adverse Event|0|||
161776930|NCT03722849|584225458|FG000|Overall Study|Withdrawal by Subject|1|||
161776931|NCT03722849|584225459|FG001|Overall Study|Withdrawal by Subject|1|||
161776932|NCT03993288|584225460|FG000|Overall Study|Lost to Follow-up|2|||
161776933|NCT03993288|584225461|FG001|Overall Study|Lost to Follow-up|1|||
161776934|NCT03993288|584225460|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
161776935|NCT03993288|584225461|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
161776936|NCT03993288|584225460|FG000|Overall Study|wrong randomization|0|||
161776937|NCT03993288|584225461|FG001|Overall Study|wrong randomization|1|||
161878048|NCT02980341|584596626|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878049|NCT02980341|584596627|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878050|NCT02980341|584596628|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878051|NCT02980341|584596629|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
161878052|NCT02980341|584596630|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
161878053|NCT02980341|584596631|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
161878054|NCT02980341|584596632|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
161878055|NCT02980341|584596622|FG000|Dose Expansion|Clinical progression|0|||
161878056|NCT02980341|584596623|FG001|Dose Expansion|Clinical progression|0|||
161878057|NCT02980341|584596624|FG002|Dose Expansion|Clinical progression|0|||
161878058|NCT02980341|584596625|FG003|Dose Expansion|Clinical progression|0|||
161776938|NCT03993288|584225460|FG000|Overall Study|improper enrollment|0|||
161776939|NCT03993288|584225461|FG001|Overall Study|improper enrollment|1|||
161776940|NCT03993288|584225460|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
161776941|NCT03993288|584225461|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
161776942|NCT03993288|584225460|FG000|Overall Study|developed SAE|2|||
161776943|NCT03993288|584225461|FG001|Overall Study|developed SAE|0|||
161776944|NCT03993288|584225460|FG000|Overall Study|consent withdrawal|1|||
161776945|NCT03993288|584225461|FG001|Overall Study|consent withdrawal|0|||
161776946|NCT03993288|584225460|FG000|Overall Study|did not follow the treatment schedule|1|||
161776947|NCT03993288|584225461|FG001|Overall Study|did not follow the treatment schedule|0|||
161878059|NCT02980341|584596626|FG004|Dose Expansion|Clinical progression|0|||
161878060|NCT02980341|584596627|FG005|Dose Expansion|Clinical progression|0|||
161878061|NCT02980341|584596628|FG006|Dose Expansion|Clinical progression|0|||
161878062|NCT02980341|584596629|FG007|Dose Expansion|Clinical progression|4|||
161878063|NCT02980341|584596630|FG008|Dose Expansion|Clinical progression|3|||
161878064|NCT02980341|584596631|FG009|Dose Expansion|Clinical progression|1|||
161878065|NCT02980341|584596632|FG010|Dose Expansion|Clinical progression|4|||
161878066|NCT02980341|584596622|FG000|Dose Expansion|Adverse Event|0|||
161878067|NCT02980341|584596623|FG001|Dose Expansion|Adverse Event|0|||
161878068|NCT02980341|584596624|FG002|Dose Expansion|Adverse Event|0|||
161878069|NCT02980341|584596625|FG003|Dose Expansion|Adverse Event|0|||
161878070|NCT02980341|584596626|FG004|Dose Expansion|Adverse Event|0|||
161878071|NCT02980341|584596627|FG005|Dose Expansion|Adverse Event|0|||
161878072|NCT02980341|584596628|FG006|Dose Expansion|Adverse Event|0|||
161878073|NCT02980341|584596629|FG007|Dose Expansion|Adverse Event|3|||
161878074|NCT02980341|584596630|FG008|Dose Expansion|Adverse Event|0|||
161878075|NCT02980341|584596631|FG009|Dose Expansion|Adverse Event|1|||
161878076|NCT02980341|584596632|FG010|Dose Expansion|Adverse Event|3|||
161878077|NCT02980341|584596622|FG000|Dose Expansion|Death|0|||
161878078|NCT02980341|584596623|FG001|Dose Expansion|Death|0|||
161878079|NCT02980341|584596624|FG002|Dose Expansion|Death|0|||
161878080|NCT02980341|584596625|FG003|Dose Expansion|Death|0|||
161878081|NCT02980341|584596626|FG004|Dose Expansion|Death|0|||
161878082|NCT02980341|584596627|FG005|Dose Expansion|Death|0|||
161878083|NCT02980341|584596628|FG006|Dose Expansion|Death|0|||
161878084|NCT02980341|584596629|FG007|Dose Expansion|Death|0|||
161878085|NCT02980341|584596630|FG008|Dose Expansion|Death|2|||
161878086|NCT02980341|584596631|FG009|Dose Expansion|Death|1|||
161878087|NCT02980341|584596632|FG010|Dose Expansion|Death|0|||
161878088|NCT02980341|584596622|FG000|Dose Expansion|Withdrawal by Subject|0|||
161776948|NCT03993288|584225460|FG000|Overall Study|did not follow the treatment regimen|1|||
161776949|NCT03993288|584225461|FG001|Overall Study|did not follow the treatment regimen|0|||
161878089|NCT02980341|584596623|FG001|Dose Expansion|Withdrawal by Subject|0|||
161878090|NCT02980341|584596624|FG002|Dose Expansion|Withdrawal by Subject|0|||
161878091|NCT02980341|584596625|FG003|Dose Expansion|Withdrawal by Subject|0|||
161878092|NCT02980341|584596626|FG004|Dose Expansion|Withdrawal by Subject|0|||
161878093|NCT02980341|584596627|FG005|Dose Expansion|Withdrawal by Subject|0|||
161878094|NCT02980341|584596628|FG006|Dose Expansion|Withdrawal by Subject|0|||
161776950|NCT03993288|584225460|FG000|Overall Study|Adverse Event|1|||
161776951|NCT03993288|584225461|FG001|Overall Study|Adverse Event|0|||
161776952|NCT03993288|584225460|FG000|Overall Study|Withdrawal by Subject|1|||
161878095|NCT02980341|584596629|FG007|Dose Expansion|Withdrawal by Subject|2|||
161878096|NCT02980341|584596630|FG008|Dose Expansion|Withdrawal by Subject|0|||
161878097|NCT02980341|584596631|FG009|Dose Expansion|Withdrawal by Subject|1|||
161878098|NCT02980341|584596632|FG010|Dose Expansion|Withdrawal by Subject|0|||
161878099|NCT02980341|584596622|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878100|NCT02980341|584596623|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878101|NCT02980341|584596624|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878102|NCT02980341|584596625|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878103|NCT02980341|584596626|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878104|NCT02980341|584596627|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878105|NCT02980341|584596628|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878106|NCT02980341|584596629|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
161878107|NCT02980341|584596630|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878108|NCT02980341|584596631|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878109|NCT02980341|584596632|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878110|NCT02980341|584596622|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878111|NCT02980341|584596623|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878112|NCT02980341|584596624|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878113|NCT02980341|584596625|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878114|NCT02980341|584596626|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161776953|NCT03993288|584225461|FG001|Overall Study|Withdrawal by Subject|1|||
161776954|NCT02729545|584225462|FG000|Overall Study|Pregnancy|1|||
161776955|NCT02729545|584225463|FG001|Overall Study|Pregnancy|1|||
161776956|NCT02729545|584225462|FG000|Overall Study|Lost to Follow-up|0|||
161776957|NCT02729545|584225463|FG001|Overall Study|Lost to Follow-up|1|||
161776958|NCT02729545|584225462|FG000|Overall Study|Withdrawal by Subject|2|||
161776959|NCT02729545|584225463|FG001|Overall Study|Withdrawal by Subject|3|||
161776960|NCT03533608|584225464|FG000|Overall Study|Withdrawal by Subject|3|||
161776961|NCT03533608|584225464|FG000|Overall Study|Physician Decision|2|||
161776962|NCT00915473|584225465|FG000|Screening|Withdrawal by Subject|1|||
161776963|NCT00915473|584225466|FG001|Screening|Withdrawal by Subject|0|||
161776964|NCT00915473|584225465|FG000|4-week Follow Up|Lost to Follow-up|1|||
161776965|NCT00915473|584225466|FG001|4-week Follow Up|Lost to Follow-up|5|||
161776966|NCT01389024|584225467|FG000|Overall Study|Withdrawal by Subject|0|||
161776967|NCT01389024|584225468|FG001|Overall Study|Withdrawal by Subject|1|||
161776968|NCT01389024|584225467|FG000|Overall Study|Lost to Follow-up|1|||
161776969|NCT01389024|584225468|FG001|Overall Study|Lost to Follow-up|0|||
161776970|NCT00640614|584225470|FG000|Overall Study|Lost to Follow-up|1|||
161776971|NCT00640614|584225471|FG001|Overall Study|Lost to Follow-up|0|||
161776972|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
161776973|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
161776974|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
161776975|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Death|1|||
161776976|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
161776977|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
161776978|NCT00529802|584225472|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
161776979|NCT02209454|584225476|FG000|Second Period|Adverse Event|1|||
161776980|NCT02209454|584225477|FG001|Second Period|Adverse Event|0|||
161776981|NCT00366678|584225478|FG000|Infant Series|Withdrawal by Subject|8|||
161776982|NCT00366678|584225479|FG001|Infant Series|Withdrawal by Subject|6|||
161776983|NCT00366678|584225480|FG002|Infant Series|Withdrawal by Subject|0|||
161776984|NCT00366678|584225478|FG000|Infant Series|Protocol Violation|4|||
161776985|NCT00366678|584225479|FG001|Infant Series|Protocol Violation|3|||
161776986|NCT00366678|584225480|FG002|Infant Series|Protocol Violation|0|||
161776987|NCT00366678|584225478|FG000|Infant Series|Failed to return|1|||
161776988|NCT00366678|584225479|FG001|Infant Series|Failed to return|1|||
161776989|NCT00366678|584225480|FG002|Infant Series|Failed to return|0|||
161776990|NCT00366678|584225478|FG000|Infant Series|Adverse Event|1|||
161776991|NCT00366678|584225479|FG001|Infant Series|Adverse Event|0|||
161776992|NCT00366678|584225480|FG002|Infant Series|Adverse Event|0|||
161776993|NCT00366678|584225478|FG000|After Infant|Withdrawal by Subject|8|||
161776994|NCT00366678|584225479|FG001|After Infant|Withdrawal by Subject|4|||
161776995|NCT00366678|584225480|FG002|After Infant|Withdrawal by Subject|0|||
161776996|NCT00366678|584225478|FG000|After Infant|Lost to Follow-up|2|||
161776997|NCT00366678|584225479|FG001|After Infant|Lost to Follow-up|1|||
161776998|NCT00366678|584225480|FG002|After Infant|Lost to Follow-up|0|||
161776999|NCT00366678|584225478|FG000|After Infant|Failed to return|5|||
161777000|NCT00366678|584225479|FG001|After Infant|Failed to return|5|||
161777001|NCT00366678|584225480|FG002|After Infant|Failed to return|0|||
161777002|NCT00366678|584225478|FG000|After Infant|Adverse Event|1|||
161878115|NCT02980341|584596627|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878116|NCT02980341|584596628|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878117|NCT02980341|584596629|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878118|NCT02980341|584596630|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
161878119|NCT02980341|584596631|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161777003|NCT00366678|584225479|FG001|After Infant|Adverse Event|0|||
161777004|NCT00366678|584225480|FG002|After Infant|Adverse Event|0|||
161777005|NCT00366678|584225478|FG000|After Infant|Protocol Violation|1|||
161777006|NCT00366678|584225479|FG001|After Infant|Protocol Violation|0|||
161777007|NCT00366678|584225480|FG002|After Infant|Protocol Violation|0|||
161777008|NCT00366678|584225478|FG000|Toddler Dose|Protocol Violation|2|||
161777009|NCT00366678|584225479|FG001|Toddler Dose|Protocol Violation|1|||
161777010|NCT00366678|584225480|FG002|Toddler Dose|Protocol Violation|0|||
161777011|NCT00366678|584225478|FG000|Toddler Dose|Failed to return|1|||
161777012|NCT00366678|584225479|FG001|Toddler Dose|Failed to return|0|||
161777013|NCT00366678|584225480|FG002|Toddler Dose|Failed to return|0|||
161777014|NCT00366678|584225478|FG000|Toddler Dose|Withdrawal by Subject|1|||
161777015|NCT00366678|584225479|FG001|Toddler Dose|Withdrawal by Subject|0|||
161777016|NCT00366678|584225480|FG002|Toddler Dose|Withdrawal by Subject|0|||
161777017|NCT00366678|584225478|FG000|Toddler Dose|protocol deviation|1|||
161777018|NCT00366678|584225479|FG001|Toddler Dose|protocol deviation|0|||
161777019|NCT00366678|584225480|FG002|Toddler Dose|protocol deviation|0|||
161777020|NCT00740480|584225484|FG000|Overall Study|Adverse Event|1|||
161777021|NCT00740480|584225484|FG000|Overall Study|Physician Decision|1|||
161777022|NCT03079869|584225485|FG000|Overall Study|Adverse Event|6|||
161777023|NCT03079869|584225486|FG001|Overall Study|Adverse Event|8|||
161777024|NCT03079869|584225485|FG000|Overall Study|Withdrawal by Subject|4|||
161777025|NCT03079869|584225486|FG001|Overall Study|Withdrawal by Subject|1|||
161777026|NCT03079869|584225485|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
161777027|NCT03079869|584225486|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
161777028|NCT01325701|584225487|FG000|Overall Study|Adverse Event|12|||
161777029|NCT01325701|584225488|FG001|Overall Study|Adverse Event|0|||
161777030|NCT01325701|584225487|FG000|Overall Study|Protocol Violation|1|||
161777031|NCT01325701|584225488|FG001|Overall Study|Protocol Violation|0|||
161777032|NCT01325701|584225487|FG000|Overall Study|Physician Decision|2|||
161777033|NCT01325701|584225488|FG001|Overall Study|Physician Decision|2|||
161777034|NCT01325701|584225487|FG000|Overall Study|Withdrawal by Subject|2|||
161777035|NCT01325701|584225488|FG001|Overall Study|Withdrawal by Subject|1|||
161777036|NCT01325701|584225487|FG000|Overall Study|Rollerover Extension Study|4|||
161777037|NCT01325701|584225488|FG001|Overall Study|Rollerover Extension Study|0|||
161777038|NCT01005680|584225494|FG000|Overall Study|Lost to Follow-up|4|||
161777039|NCT01005680|584225495|FG001|Overall Study|Lost to Follow-up|6|||
161777040|NCT01005680|584225494|FG000|Overall Study|Withdrawal by Subject|1|||
161777041|NCT01005680|584225495|FG001|Overall Study|Withdrawal by Subject|4|||
161777042|NCT01005680|584225494|FG000|Overall Study|Physician Decision|1|||
161777043|NCT01005680|584225495|FG001|Overall Study|Physician Decision|1|||
161777044|NCT04484805|584225500|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
161777045|NCT04484805|584225501|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
161777046|NCT04484805|584225500|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
161777047|NCT04484805|584225501|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
161777048|NCT02118896|584225502|FG000|Overall Study|Death|4|||
161777049|NCT02118896|584225503|FG001|Overall Study|Death|0|||
161777050|NCT02118896|584225504|FG002|Overall Study|Death|4|||
161777051|NCT02118896|584225505|FG003|Overall Study|Death|6|||
161777052|NCT02118896|584225506|FG004|Overall Study|Death|3|||
161777053|NCT02118896|584225507|FG005|Overall Study|Death|1|||
161878120|NCT02980341|584596632|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878121|NCT02980341|584596622|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878122|NCT02980341|584596623|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878123|NCT02980341|584596624|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878124|NCT02980341|584596625|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878125|NCT02980341|584596626|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878126|NCT02980341|584596627|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878127|NCT02980341|584596628|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878128|NCT02980341|584596629|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878129|NCT02980341|584596630|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
161878130|NCT02980341|584596631|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878131|NCT02980341|584596632|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878132|NCT02980341|584596622|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878133|NCT02980341|584596623|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878134|NCT02980341|584596624|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878135|NCT02980341|584596625|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878136|NCT02980341|584596626|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878137|NCT02980341|584596627|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878138|NCT02980341|584596628|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878139|NCT02980341|584596629|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878140|NCT02980341|584596630|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878141|NCT02980341|584596631|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878142|NCT02980341|584596632|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
161878143|NCT04964544|584596639|FG000|Overall Study|Screen failure or other uncategorised|10|||
161878144|NCT04964544|584596639|FG000|Overall Study|Physician Decision|4|||
161878145|NCT04964544|584596639|FG000|Overall Study|Lost to Follow-up|9|||
161878146|NCT04964544|584596639|FG000|Overall Study|Withdrawal by Subject|18|||
161878147|NCT04964544|584596639|FG000|Overall Study|Death|1|||
161878148|NCT04143594|584596643|FG000|Overall Study|Withdrew consent|3|||
161878149|NCT04143594|584596644|FG001|Overall Study|Withdrew consent|10|||
161878150|NCT04143594|584596645|FG002|Overall Study|Withdrew consent|3|||
161878151|NCT04143594|584596646|FG003|Overall Study|Withdrew consent|1|||
161878152|NCT04143594|584596643|FG000|Overall Study|Lost to Follow-up|3|||
161878153|NCT04143594|584596644|FG001|Overall Study|Lost to Follow-up|5|||
161878154|NCT04143594|584596645|FG002|Overall Study|Lost to Follow-up|11|||
161878155|NCT04143594|584596646|FG003|Overall Study|Lost to Follow-up|0|||
161878156|NCT04143594|584596643|FG000|Overall Study|Investigator's discretion|2|||
161878157|NCT04143594|584596644|FG001|Overall Study|Investigator's discretion|2|||
161878158|NCT04143594|584596645|FG002|Overall Study|Investigator's discretion|0|||
161878159|NCT04143594|584596646|FG003|Overall Study|Investigator's discretion|0|||
161878160|NCT04143594|584596643|FG000|Overall Study|Randomized but never treated|0|||
161878161|NCT04143594|584596644|FG001|Overall Study|Randomized but never treated|0|||
161878162|NCT04143594|584596645|FG002|Overall Study|Randomized but never treated|0|||
161878163|NCT04143594|584596646|FG003|Overall Study|Randomized but never treated|1|||
161878164|NCT04143594|584596643|FG000|Overall Study|Death|1|||
161878165|NCT04143594|584596644|FG001|Overall Study|Death|0|||
161878166|NCT04143594|584596645|FG002|Overall Study|Death|1|||
161878167|NCT04143594|584596646|FG003|Overall Study|Death|0|||
161878168|NCT04143594|584596643|FG000|Overall Study|Adverse Event|1|||
161878169|NCT04143594|584596644|FG001|Overall Study|Adverse Event|0|||
161878170|NCT04143594|584596645|FG002|Overall Study|Adverse Event|0|||
161878171|NCT04143594|584596646|FG003|Overall Study|Adverse Event|0|||
161878172|NCT04143594|584596643|FG000|Overall Study|Pregnancy|0|||
161878173|NCT04143594|584596644|FG001|Overall Study|Pregnancy|0|||
161878174|NCT04143594|584596645|FG002|Overall Study|Pregnancy|1|||
161878175|NCT04143594|584596646|FG003|Overall Study|Pregnancy|0|||
161878176|NCT04143594|584596643|FG000|Overall Study|Lack of Efficacy|1|||
161878177|NCT04143594|584596644|FG001|Overall Study|Lack of Efficacy|1|||
161878178|NCT04143594|584596645|FG002|Overall Study|Lack of Efficacy|0|||
161878179|NCT04143594|584596646|FG003|Overall Study|Lack of Efficacy|0|||
161878180|NCT01023256|584596647|FG000|Overall Study|Protocol Violation|2|||
161878181|NCT01023256|584596648|FG001|Overall Study|Protocol Violation|3|||
161878182|NCT01023256|584596649|FG002|Overall Study|Protocol Violation|0|||
161878183|NCT01023256|584596650|FG003|Overall Study|Protocol Violation|0|||
161878184|NCT01023256|584596647|FG000|Overall Study|Randomized but not treated|1|||
161878185|NCT01023256|584596648|FG001|Overall Study|Randomized but not treated|0|||
161878186|NCT01023256|584596649|FG002|Overall Study|Randomized but not treated|1|||
161878187|NCT01023256|584596650|FG003|Overall Study|Randomized but not treated|0|||
161878188|NCT01023256|584596647|FG000|Overall Study|Other|1|||
161777054|NCT02118896|584225508|FG006|Overall Study|Death|0|||
161777055|NCT02118896|584225509|FG007|Overall Study|Death|0|||
161777056|NCT02118896|584225510|FG008|Overall Study|Death|0|||
161777057|NCT02118896|584225511|FG009|Overall Study|Death|0|||
161777058|NCT02118896|584225502|FG000|Overall Study|Adverse Event|5|||
161777059|NCT02118896|584225503|FG001|Overall Study|Adverse Event|4|||
161777060|NCT02118896|584225504|FG002|Overall Study|Adverse Event|4|||
161777061|NCT02118896|584225505|FG003|Overall Study|Adverse Event|5|||
161777062|NCT02118896|584225506|FG004|Overall Study|Adverse Event|5|||
161777063|NCT02118896|584225507|FG005|Overall Study|Adverse Event|9|||
161777064|NCT02118896|584225508|FG006|Overall Study|Adverse Event|1|||
161777065|NCT02118896|584225509|FG007|Overall Study|Adverse Event|1|||
161777066|NCT02118896|584225510|FG008|Overall Study|Adverse Event|4|||
161777067|NCT02118896|584225511|FG009|Overall Study|Adverse Event|0|||
161777068|NCT02118896|584225502|FG000|Overall Study|Consent withdrawn|2|||
161777069|NCT02118896|584225503|FG001|Overall Study|Consent withdrawn|0|||
161777070|NCT02118896|584225504|FG002|Overall Study|Consent withdrawn|3|||
161777071|NCT02118896|584225505|FG003|Overall Study|Consent withdrawn|4|||
161777072|NCT02118896|584225506|FG004|Overall Study|Consent withdrawn|1|||
161777073|NCT02118896|584225507|FG005|Overall Study|Consent withdrawn|4|||
161777074|NCT02118896|584225508|FG006|Overall Study|Consent withdrawn|0|||
161777075|NCT02118896|584225509|FG007|Overall Study|Consent withdrawn|0|||
161777076|NCT02118896|584225510|FG008|Overall Study|Consent withdrawn|0|||
161777077|NCT02118896|584225511|FG009|Overall Study|Consent withdrawn|0|||
161777078|NCT02118896|584225502|FG000|Overall Study|Non-compliance|2|||
161777079|NCT02118896|584225503|FG001|Overall Study|Non-compliance|1|||
161777080|NCT02118896|584225504|FG002|Overall Study|Non-compliance|1|||
161777081|NCT02118896|584225505|FG003|Overall Study|Non-compliance|5|||
161777082|NCT02118896|584225506|FG004|Overall Study|Non-compliance|0|||
161777083|NCT02118896|584225507|FG005|Overall Study|Non-compliance|1|||
161777084|NCT02118896|584225508|FG006|Overall Study|Non-compliance|0|||
161777085|NCT02118896|584225509|FG007|Overall Study|Non-compliance|1|||
161777086|NCT02118896|584225510|FG008|Overall Study|Non-compliance|0|||
161777087|NCT02118896|584225511|FG009|Overall Study|Non-compliance|0|||
161777088|NCT02118896|584225502|FG000|Overall Study|Pregnancy|1|||
161777089|NCT02118896|584225503|FG001|Overall Study|Pregnancy|1|||
161777090|NCT02118896|584225504|FG002|Overall Study|Pregnancy|0|||
161777091|NCT02118896|584225505|FG003|Overall Study|Pregnancy|0|||
161777092|NCT02118896|584225506|FG004|Overall Study|Pregnancy|1|||
161777093|NCT02118896|584225507|FG005|Overall Study|Pregnancy|3|||
161777094|NCT02118896|584225508|FG006|Overall Study|Pregnancy|1|||
161777095|NCT02118896|584225509|FG007|Overall Study|Pregnancy|0|||
161777096|NCT02118896|584225510|FG008|Overall Study|Pregnancy|0|||
161777097|NCT02118896|584225511|FG009|Overall Study|Pregnancy|0|||
161777098|NCT02118896|584225502|FG000|Overall Study|Lost to Follow-up|1|||
161777099|NCT02118896|584225503|FG001|Overall Study|Lost to Follow-up|2|||
161777100|NCT02118896|584225504|FG002|Overall Study|Lost to Follow-up|1|||
161777101|NCT02118896|584225505|FG003|Overall Study|Lost to Follow-up|0|||
161777102|NCT02118896|584225506|FG004|Overall Study|Lost to Follow-up|2|||
161777103|NCT02118896|584225507|FG005|Overall Study|Lost to Follow-up|1|||
161777104|NCT02118896|584225508|FG006|Overall Study|Lost to Follow-up|0|||
161777105|NCT02118896|584225509|FG007|Overall Study|Lost to Follow-up|0|||
161777106|NCT02118896|584225510|FG008|Overall Study|Lost to Follow-up|0|||
161777107|NCT02118896|584225511|FG009|Overall Study|Lost to Follow-up|0|||
161777108|NCT02118896|584225502|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
161777109|NCT02118896|584225503|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
161777110|NCT02118896|584225504|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
161777111|NCT02118896|584225505|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161777112|NCT02118896|584225506|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
161777113|NCT02118896|584225507|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161777114|NCT02118896|584225508|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161878189|NCT01023256|584596648|FG001|Overall Study|Other|0|||
161878190|NCT01023256|584596649|FG002|Overall Study|Other|0|||
161777115|NCT02118896|584225509|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161777116|NCT02118896|584225510|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161777117|NCT02118896|584225511|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161777118|NCT02118896|584225502|FG000|Overall Study|Prohibited medication|0|||
161777119|NCT02118896|584225503|FG001|Overall Study|Prohibited medication|0|||
161777120|NCT02118896|584225504|FG002|Overall Study|Prohibited medication|0|||
161777121|NCT02118896|584225505|FG003|Overall Study|Prohibited medication|0|||
161777122|NCT02118896|584225506|FG004|Overall Study|Prohibited medication|1|||
161777123|NCT02118896|584225507|FG005|Overall Study|Prohibited medication|3|||
161777124|NCT02118896|584225508|FG006|Overall Study|Prohibited medication|0|||
161777125|NCT02118896|584225509|FG007|Overall Study|Prohibited medication|0|||
161777126|NCT02118896|584225510|FG008|Overall Study|Prohibited medication|0|||
161777127|NCT02118896|584225511|FG009|Overall Study|Prohibited medication|0|||
161777128|NCT02118896|584225502|FG000|Overall Study|Miscellaneous|1|||
161777129|NCT02118896|584225503|FG001|Overall Study|Miscellaneous|2|||
161777130|NCT02118896|584225504|FG002|Overall Study|Miscellaneous|0|||
161777131|NCT02118896|584225505|FG003|Overall Study|Miscellaneous|2|||
161777132|NCT02118896|584225506|FG004|Overall Study|Miscellaneous|0|||
161777133|NCT02118896|584225507|FG005|Overall Study|Miscellaneous|4|||
161777134|NCT02118896|584225508|FG006|Overall Study|Miscellaneous|0|||
161777135|NCT02118896|584225509|FG007|Overall Study|Miscellaneous|0|||
161777136|NCT02118896|584225510|FG008|Overall Study|Miscellaneous|0|||
161777137|NCT02118896|584225511|FG009|Overall Study|Miscellaneous|0|||
161777138|NCT00539006|584225515|FG000|Pre-treatment|Other|0|||
161777139|NCT00539006|584225516|FG001|Pre-treatment|Other|1|||
161777140|NCT00539006|584225517|FG002|Pre-treatment|Other|0|||
161777141|NCT00539006|584225518|FG003|Pre-treatment|Other|0|||
161777142|NCT00539006|584225515|FG000|Treatment Period 1|Lost to Follow-up|0|||
161777143|NCT00539006|584225516|FG001|Treatment Period 1|Lost to Follow-up|0|||
161777144|NCT00539006|584225517|FG002|Treatment Period 1|Lost to Follow-up|1|||
161777145|NCT00539006|584225518|FG003|Treatment Period 1|Lost to Follow-up|0|||
161777146|NCT00539006|584225515|FG000|Treatment Period 1|Protocol Violation|0|||
161777147|NCT00539006|584225516|FG001|Treatment Period 1|Protocol Violation|0|||
161777148|NCT00539006|584225517|FG002|Treatment Period 1|Protocol Violation|1|||
161777149|NCT00539006|584225518|FG003|Treatment Period 1|Protocol Violation|0|||
161777150|NCT00539006|584225515|FG000|Treatment Period 1|Lack of Efficacy|0|||
161777151|NCT00539006|584225516|FG001|Treatment Period 1|Lack of Efficacy|0|||
161777152|NCT00539006|584225517|FG002|Treatment Period 1|Lack of Efficacy|0|||
161777153|NCT00539006|584225518|FG003|Treatment Period 1|Lack of Efficacy|1|||
161777154|NCT00539006|584225515|FG000|Washout|Adverse Event|2|||
161777155|NCT00539006|584225516|FG001|Washout|Adverse Event|1|||
161777156|NCT00539006|584225517|FG002|Washout|Adverse Event|0|||
161777157|NCT00539006|584225518|FG003|Washout|Adverse Event|0|||
161777158|NCT00539006|584225515|FG000|Washout|Protocol Violation|1|||
161777159|NCT00539006|584225516|FG001|Washout|Protocol Violation|1|||
161777160|NCT00539006|584225517|FG002|Washout|Protocol Violation|0|||
161777161|NCT00539006|584225518|FG003|Washout|Protocol Violation|0|||
161777162|NCT00539006|584225515|FG000|Washout|Withdrawal by Subject|0|||
161777163|NCT00539006|584225516|FG001|Washout|Withdrawal by Subject|2|||
161777164|NCT00539006|584225517|FG002|Washout|Withdrawal by Subject|0|||
161777165|NCT00539006|584225518|FG003|Washout|Withdrawal by Subject|0|||
161777166|NCT00539006|584225515|FG000|Washout|Failed to meet continuation criteria|16|||
161777167|NCT00539006|584225516|FG001|Washout|Failed to meet continuation criteria|5|||
161777168|NCT00539006|584225517|FG002|Washout|Failed to meet continuation criteria|14|||
161777169|NCT00539006|584225518|FG003|Washout|Failed to meet continuation criteria|6|||
161777170|NCT00539006|584225515|FG000|Washout|Other|1|||
161777171|NCT00539006|584225516|FG001|Washout|Other|1|||
161777172|NCT00539006|584225517|FG002|Washout|Other|2|||
161777173|NCT00539006|584225518|FG003|Washout|Other|3|||
161777174|NCT00539006|584225515|FG000|Treatment Period 2|Protocol Violation|1|||
161777175|NCT00539006|584225516|FG001|Treatment Period 2|Protocol Violation|0|||
161777176|NCT00539006|584225517|FG002|Treatment Period 2|Protocol Violation|0|||
161777177|NCT00539006|584225518|FG003|Treatment Period 2|Protocol Violation|0|||
161777178|NCT00539006|584225515|FG000|Treatment Period 2|Other|0|||
161777179|NCT00539006|584225516|FG001|Treatment Period 2|Other|1|||
161777180|NCT00539006|584225517|FG002|Treatment Period 2|Other|0|||
161777181|NCT00539006|584225518|FG003|Treatment Period 2|Other|0|||
161777182|NCT03733301|584225519|FG000|Overall Study|Screen Fail|1|||
161777183|NCT03733301|584225520|FG001|Overall Study|Screen Fail|0|||
161777184|NCT03733301|584225521|FG002|Overall Study|Screen Fail|0|||
161777185|NCT03733301|584225519|FG000|Overall Study|Non-compliance|1|||
161878191|NCT01023256|584596650|FG003|Overall Study|Other|2|||
161878192|NCT01023256|584596647|FG000|Overall Study|Adverse Event|0|||
161777186|NCT03733301|584225520|FG001|Overall Study|Non-compliance|0|||
161777187|NCT03733301|584225521|FG002|Overall Study|Non-compliance|0|||
161777188|NCT03733301|584225519|FG000|Overall Study|Lack of Efficacy|2|||
161777189|NCT03733301|584225520|FG001|Overall Study|Lack of Efficacy|3|||
161777190|NCT03733301|584225521|FG002|Overall Study|Lack of Efficacy|0|||
161777191|NCT03733301|584225519|FG000|Overall Study|Adverse Event|0|||
161777192|NCT03733301|584225520|FG001|Overall Study|Adverse Event|1|||
161777193|NCT03733301|584225521|FG002|Overall Study|Adverse Event|3|||
161777194|NCT03733301|584225519|FG000|Overall Study|Withdrawal by Subject|3|||
161777195|NCT03733301|584225520|FG001|Overall Study|Withdrawal by Subject|5|||
161777196|NCT03733301|584225521|FG002|Overall Study|Withdrawal by Subject|1|||
161777197|NCT01965431|584225522|FG000|Overall Study|Adverse Event|0|||
161777198|NCT01965431|584225523|FG001|Overall Study|Adverse Event|1|||
161777199|NCT01965431|584225524|FG002|Overall Study|Adverse Event|0|||
161777200|NCT01965431|584225525|FG003|Overall Study|Adverse Event|0|||
161777201|NCT01965431|584225526|FG004|Overall Study|Adverse Event|0|||
161777202|NCT01965431|584225527|FG005|Overall Study|Adverse Event|0|||
161777203|NCT01965431|584225522|FG000|Overall Study|Other than stated above|6|||
161777204|NCT01965431|584225523|FG001|Overall Study|Other than stated above|5|||
161777205|NCT01965431|584225524|FG002|Overall Study|Other than stated above|6|||
161777206|NCT01965431|584225525|FG003|Overall Study|Other than stated above|6|||
161777207|NCT01965431|584225526|FG004|Overall Study|Other than stated above|6|||
161777208|NCT01965431|584225527|FG005|Overall Study|Other than stated above|6|||
161777209|NCT04635631|584225528|FG000|Overall Study|Adverse Event|1|||
161777210|NCT04635631|584225528|FG000|Overall Study|Progressive disease|13|||
161777211|NCT04635631|584225528|FG000|Overall Study|Withdrawal by Subject|1|||
161777212|NCT00943826|584225529|FG000|Concurrent Phase|Adverse Event|50|||
161777213|NCT00943826|584225530|FG001|Concurrent Phase|Adverse Event|27|||
161777214|NCT00943826|584225529|FG000|Concurrent Phase|Withdrew consent|3|||
161777215|NCT00943826|584225530|FG001|Concurrent Phase|Withdrew consent|7|||
161777216|NCT00943826|584225529|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
161777217|NCT00943826|584225530|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
161777218|NCT00943826|584225529|FG000|Concurrent Phase|Administrative reasons|2|||
161777219|NCT00943826|584225530|FG001|Concurrent Phase|Administrative reasons|1|||
161777220|NCT00943826|584225529|FG000|Concurrent Phase|Protocol Violation|1|||
161777221|NCT00943826|584225530|FG001|Concurrent Phase|Protocol Violation|0|||
161777222|NCT00943826|584225529|FG000|Maintenance Phase|Adverse Event|31|||
161777223|NCT00943826|584225530|FG001|Maintenance Phase|Adverse Event|30|||
161777224|NCT00943826|584225529|FG000|Maintenance Phase|Withdrew consent|2|||
161777225|NCT00943826|584225530|FG001|Maintenance Phase|Withdrew consent|4|||
161777226|NCT00943826|584225529|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
161777227|NCT00943826|584225530|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
161777228|NCT00943826|584225529|FG000|Maintenance Phase|Administrative reasons|4|||
161777229|NCT00943826|584225530|FG001|Maintenance Phase|Administrative reasons|1|||
161777230|NCT00943826|584225529|FG000|Maintenance Phase|Failure to return|0|||
161777231|NCT00943826|584225530|FG001|Maintenance Phase|Failure to return|1|||
161777232|NCT00943826|584225529|FG000|Monotherapy Phase|Adverse Event|42|||
161777233|NCT00943826|584225530|FG001|Monotherapy Phase|Adverse Event|5|||
161777234|NCT00943826|584225529|FG000|Monotherapy Phase|Administrative reasons|11|||
161878193|NCT01023256|584596648|FG001|Overall Study|Adverse Event|0|||
161878194|NCT01023256|584596649|FG002|Overall Study|Adverse Event|0|||
161878195|NCT01023256|584596650|FG003|Overall Study|Adverse Event|1|||
161878196|NCT01023256|584596647|FG000|Overall Study|Withdrawal by Subject|0|||
161878197|NCT01023256|584596648|FG001|Overall Study|Withdrawal by Subject|0|||
161878198|NCT01023256|584596649|FG002|Overall Study|Withdrawal by Subject|0|||
161878199|NCT01023256|584596650|FG003|Overall Study|Withdrawal by Subject|2|||
161878200|NCT03089697|584596651|FG000|Overall Study|Adverse Event|1|||
161878201|NCT03089697|584596652|FG001|Overall Study|Adverse Event|2|||
161878202|NCT03089697|584596651|FG000|Overall Study|Withdrawal by Subject|1|||
161878203|NCT03089697|584596652|FG001|Overall Study|Withdrawal by Subject|0|||
161878204|NCT00308087|584596653|FG000|Overall Study|Progressive Disease|19|||
161878205|NCT00308087|584596654|FG001|Overall Study|Progressive Disease|21|||
161878206|NCT00308087|584596653|FG000|Overall Study|Study Closure|11|||
161878207|NCT00308087|584596654|FG001|Overall Study|Study Closure|12|||
161878208|NCT00308087|584596653|FG000|Overall Study|Withdrawal by Subject|2|||
161878209|NCT00308087|584596654|FG001|Overall Study|Withdrawal by Subject|1|||
161878210|NCT00308087|584596653|FG000|Overall Study|Other|4|||
161878211|NCT00308087|584596654|FG001|Overall Study|Other|3|||
161878212|NCT02949843|584596658|FG000|Overall Study|Withdrawal by Subject|0|||
161878213|NCT02949843|584596659|FG001|Overall Study|Withdrawal by Subject|1|||
161878214|NCT02949843|584596660|FG002|Overall Study|Withdrawal by Subject|1|||
161878215|NCT03613649|584596661|FG000|Second Treatment|Lost to Follow-up|0|||
161878216|NCT03613649|584596662|FG001|Second Treatment|Lost to Follow-up|0|||
161878217|NCT03613649|584596663|FG002|Second Treatment|Lost to Follow-up|1|||
161878218|NCT03613649|584596664|FG003|Second Treatment|Lost to Follow-up|0|||
161777235|NCT00943826|584225530|FG001|Monotherapy Phase|Administrative reasons|5|||
161777236|NCT00943826|584225529|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
161878219|NCT03613649|584596665|FG004|Second Treatment|Lost to Follow-up|0|||
161777237|NCT00943826|584225530|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
161777238|NCT00943826|584225529|FG000|Monotherapy Phase|Withdrew Consent|2|||
161878220|NCT03613649|584596666|FG005|Second Treatment|Lost to Follow-up|0|||
161878221|NCT03613649|584596667|FG006|Second Treatment|Lost to Follow-up|0|||
161878222|NCT03613649|584596668|FG007|Second Treatment|Lost to Follow-up|0|||
161878223|NCT03613649|584596669|FG008|Second Treatment|Lost to Follow-up|0|||
161878224|NCT03613649|584596670|FG009|Second Treatment|Lost to Follow-up|0|||
161878225|NCT03613649|584596671|FG010|Second Treatment|Lost to Follow-up|0|||
161878226|NCT03613649|584596672|FG011|Second Treatment|Lost to Follow-up|0|||
161878227|NCT03613649|584596661|FG000|Second Treatment|Withdrawal by Subject|0|||
161878228|NCT03613649|584596662|FG001|Second Treatment|Withdrawal by Subject|0|||
161878229|NCT03613649|584596663|FG002|Second Treatment|Withdrawal by Subject|0|||
161878230|NCT03613649|584596664|FG003|Second Treatment|Withdrawal by Subject|0|||
161878231|NCT03613649|584596665|FG004|Second Treatment|Withdrawal by Subject|1|||
161878232|NCT03613649|584596666|FG005|Second Treatment|Withdrawal by Subject|0|||
161878233|NCT03613649|584596667|FG006|Second Treatment|Withdrawal by Subject|0|||
161878234|NCT03613649|584596668|FG007|Second Treatment|Withdrawal by Subject|0|||
161878235|NCT03613649|584596669|FG008|Second Treatment|Withdrawal by Subject|0|||
161878236|NCT03613649|584596670|FG009|Second Treatment|Withdrawal by Subject|0|||
161878237|NCT03613649|584596671|FG010|Second Treatment|Withdrawal by Subject|0|||
161878238|NCT03613649|584596672|FG011|Second Treatment|Withdrawal by Subject|0|||
161878239|NCT03613649|584596661|FG000|Third Treatment|Lost to Follow-up|0|||
161878240|NCT03613649|584596662|FG001|Third Treatment|Lost to Follow-up|0|||
161878241|NCT03613649|584596663|FG002|Third Treatment|Lost to Follow-up|0|||
161878242|NCT03613649|584596664|FG003|Third Treatment|Lost to Follow-up|0|||
161878243|NCT03613649|584596665|FG004|Third Treatment|Lost to Follow-up|1|||
161878244|NCT03613649|584596666|FG005|Third Treatment|Lost to Follow-up|0|||
161878245|NCT03613649|584596667|FG006|Third Treatment|Lost to Follow-up|0|||
161878246|NCT03613649|584596668|FG007|Third Treatment|Lost to Follow-up|0|||
161878247|NCT03613649|584596669|FG008|Third Treatment|Lost to Follow-up|0|||
161878248|NCT03613649|584596670|FG009|Third Treatment|Lost to Follow-up|0|||
161878249|NCT03613649|584596671|FG010|Third Treatment|Lost to Follow-up|0|||
161878250|NCT03613649|584596672|FG011|Third Treatment|Lost to Follow-up|1|||
161878251|NCT03613649|584596661|FG000|Third Treatment|Protocol Violation|0|||
161878252|NCT03613649|584596662|FG001|Third Treatment|Protocol Violation|0|||
161878253|NCT03613649|584596663|FG002|Third Treatment|Protocol Violation|0|||
161878254|NCT03613649|584596664|FG003|Third Treatment|Protocol Violation|0|||
161878255|NCT03613649|584596665|FG004|Third Treatment|Protocol Violation|0|||
161878256|NCT03613649|584596666|FG005|Third Treatment|Protocol Violation|0|||
161878257|NCT03613649|584596667|FG006|Third Treatment|Protocol Violation|1|||
161878258|NCT03613649|584596668|FG007|Third Treatment|Protocol Violation|0|||
161878259|NCT03613649|584596669|FG008|Third Treatment|Protocol Violation|0|||
161878260|NCT03613649|584596670|FG009|Third Treatment|Protocol Violation|0|||
161878261|NCT03613649|584596671|FG010|Third Treatment|Protocol Violation|0|||
161878262|NCT03613649|584596672|FG011|Third Treatment|Protocol Violation|1|||
161878263|NCT03613649|584596661|FG000|Fourth Treatment|Protocol Violation|1|||
161878264|NCT03613649|584596662|FG001|Fourth Treatment|Protocol Violation|0|||
161878265|NCT03613649|584596663|FG002|Fourth Treatment|Protocol Violation|0|||
161878266|NCT03613649|584596664|FG003|Fourth Treatment|Protocol Violation|0|||
161878267|NCT03613649|584596665|FG004|Fourth Treatment|Protocol Violation|1|||
161878268|NCT03613649|584596666|FG005|Fourth Treatment|Protocol Violation|0|||
161878269|NCT03613649|584596667|FG006|Fourth Treatment|Protocol Violation|0|||
161878270|NCT03613649|584596668|FG007|Fourth Treatment|Protocol Violation|0|||
161878271|NCT03613649|584596669|FG008|Fourth Treatment|Protocol Violation|0|||
161878272|NCT03613649|584596670|FG009|Fourth Treatment|Protocol Violation|0|||
161878273|NCT03613649|584596671|FG010|Fourth Treatment|Protocol Violation|0|||
161878274|NCT03613649|584596672|FG011|Fourth Treatment|Protocol Violation|0|||
161878275|NCT03613649|584596661|FG000|Fourth Treatment|Physician Decision|0|||
161878276|NCT03613649|584596662|FG001|Fourth Treatment|Physician Decision|0|||
161878277|NCT03613649|584596663|FG002|Fourth Treatment|Physician Decision|0|||
161878278|NCT03613649|584596664|FG003|Fourth Treatment|Physician Decision|0|||
161878279|NCT03613649|584596665|FG004|Fourth Treatment|Physician Decision|0|||
161878280|NCT03613649|584596666|FG005|Fourth Treatment|Physician Decision|0|||
161878281|NCT03613649|584596667|FG006|Fourth Treatment|Physician Decision|1|||
161878282|NCT03613649|584596668|FG007|Fourth Treatment|Physician Decision|0|||
161878283|NCT03613649|584596669|FG008|Fourth Treatment|Physician Decision|0|||
161878284|NCT03613649|584596670|FG009|Fourth Treatment|Physician Decision|0|||
161878285|NCT03613649|584596671|FG010|Fourth Treatment|Physician Decision|0|||
161878286|NCT03613649|584596672|FG011|Fourth Treatment|Physician Decision|0|||
161878287|NCT02783729|584596673|FG000|Overall Study|Lack of Efficacy|1|||
161878288|NCT02783729|584596674|FG001|Overall Study|Lack of Efficacy|0|||
161878289|NCT02783729|584596675|FG002|Overall Study|Lack of Efficacy|0|||
161878290|NCT02783729|584596676|FG003|Overall Study|Lack of Efficacy|0|||
161878291|NCT02783729|584596673|FG000|Overall Study|Adverse Event|2|||
161878292|NCT02783729|584596674|FG001|Overall Study|Adverse Event|6|||
161878293|NCT02783729|584596675|FG002|Overall Study|Adverse Event|2|||
161878294|NCT02783729|584596676|FG003|Overall Study|Adverse Event|3|||
161878295|NCT02783729|584596673|FG000|Overall Study|Other|1|||
161878296|NCT02783729|584596674|FG001|Overall Study|Other|6|||
161878297|NCT02783729|584596675|FG002|Overall Study|Other|2|||
161878298|NCT02783729|584596676|FG003|Overall Study|Other|3|||
161878299|NCT02783729|584596673|FG000|Overall Study|Withdrawal by Subject|2|||
161878300|NCT02783729|584596674|FG001|Overall Study|Withdrawal by Subject|3|||
161878301|NCT02783729|584596675|FG002|Overall Study|Withdrawal by Subject|1|||
161878302|NCT02783729|584596676|FG003|Overall Study|Withdrawal by Subject|2|||
161878303|NCT02783729|584596673|FG000|Overall Study|Participant's choice|2|||
161878304|NCT02783729|584596674|FG001|Overall Study|Participant's choice|1|||
161878305|NCT02783729|584596675|FG002|Overall Study|Participant's choice|2|||
161878306|NCT02783729|584596676|FG003|Overall Study|Participant's choice|1|||
161878307|NCT02783729|584596673|FG000|Overall Study|Lost to Follow-up|2|||
161878308|NCT02783729|584596674|FG001|Overall Study|Lost to Follow-up|1|||
161878309|NCT02783729|584596675|FG002|Overall Study|Lost to Follow-up|1|||
161878310|NCT02783729|584596676|FG003|Overall Study|Lost to Follow-up|0|||
161878311|NCT02693171|584596677|FG000|Overall Study|Adverse Event|1|||
161878312|NCT02693171|584596677|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
161878313|NCT00319592|584596679|FG000|Overall Study|Protocol Violation|1|||
161878314|NCT00319592|584596680|FG001|Overall Study|Protocol Violation|0|||
161878315|NCT00319592|584596679|FG000|Overall Study|Physician Decision|0|||
161878316|NCT00319592|584596680|FG001|Overall Study|Physician Decision|1|||
161878317|NCT00750139|584596689|FG000|Overall Study|Adverse Event|1|||
161878318|NCT00750139|584596690|FG001|Overall Study|Adverse Event|2|||
161878319|NCT00750139|584596691|FG002|Overall Study|Adverse Event|0|||
161878320|NCT00750139|584596692|FG003|Overall Study|Adverse Event|1|||
161878321|NCT00750139|584596689|FG000|Overall Study|Lost to Follow-up|17|||
161878322|NCT00750139|584596690|FG001|Overall Study|Lost to Follow-up|12|||
161878323|NCT00750139|584596691|FG002|Overall Study|Lost to Follow-up|15|||
161878324|NCT00750139|584596692|FG003|Overall Study|Lost to Follow-up|6|||
161878325|NCT00750139|584596689|FG000|Overall Study|Withdrawal by Subject|3|||
161878326|NCT00750139|584596690|FG001|Overall Study|Withdrawal by Subject|2|||
161878327|NCT00750139|584596691|FG002|Overall Study|Withdrawal by Subject|6|||
161878328|NCT00750139|584596692|FG003|Overall Study|Withdrawal by Subject|2|||
161878329|NCT00750139|584596689|FG000|Overall Study|Physician Decision|1|||
161878330|NCT00750139|584596690|FG001|Overall Study|Physician Decision|1|||
161878331|NCT00750139|584596691|FG002|Overall Study|Physician Decision|0|||
161878332|NCT00750139|584596692|FG003|Overall Study|Physician Decision|0|||
161878333|NCT00750139|584596689|FG000|Overall Study|Non-compliance|1|||
161878334|NCT00750139|584596690|FG001|Overall Study|Non-compliance|0|||
161878335|NCT00750139|584596691|FG002|Overall Study|Non-compliance|1|||
161878336|NCT00750139|584596692|FG003|Overall Study|Non-compliance|3|||
161878337|NCT00750139|584596689|FG000|Overall Study|Termination by sponsor|4|||
161878338|NCT00750139|584596690|FG001|Overall Study|Termination by sponsor|0|||
161878339|NCT00750139|584596691|FG002|Overall Study|Termination by sponsor|0|||
161878340|NCT00750139|584596692|FG003|Overall Study|Termination by sponsor|1|||
161878341|NCT00750139|584596689|FG000|Overall Study|Non-specific|62|||
161878342|NCT00750139|584596690|FG001|Overall Study|Non-specific|42|||
161878343|NCT00750139|584596691|FG002|Overall Study|Non-specific|79|||
161878344|NCT00750139|584596692|FG003|Overall Study|Non-specific|33|||
161878345|NCT00658775|584596693|FG000|Overall Study|Adverse Event|4|||
161878346|NCT00658775|584596694|FG001|Overall Study|Adverse Event|6|||
161878347|NCT00658775|584596693|FG000|Overall Study|Lost to Follow-up|17|||
161878348|NCT00658775|584596694|FG001|Overall Study|Lost to Follow-up|18|||
161878349|NCT00658775|584596693|FG000|Overall Study|Withdrawal by Subject|6|||
161878350|NCT00658775|584596694|FG001|Overall Study|Withdrawal by Subject|4|||
161878351|NCT00658775|584596693|FG000|Overall Study|Withdrawal of consent|8|||
161878352|NCT00658775|584596694|FG001|Overall Study|Withdrawal of consent|7|||
161878353|NCT00658775|584596693|FG000|Overall Study|Other|7|||
161878354|NCT00658775|584596694|FG001|Overall Study|Other|8|||
161878355|NCT03085238|584596695|FG000|Overall Study|Adverse Event|2|||
161878356|NCT03085238|584596695|FG000|Overall Study|Death|2|||
161878357|NCT03887442|584596700|FG000|Overall Study|Adverse Event|1|||
161878358|NCT03887442|584596701|FG001|Overall Study|Adverse Event|0|||
161878359|NCT00767455|584596702|FG000|Overall Study|Investigator error|19|||
161878360|NCT00746564|584596705|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
161878361|NCT01628198|584596706|FG000|Overall Study|Lost to Follow-up|7|||
161878362|NCT01628198|584596706|FG000|Overall Study|Withdrawal by Subject|10|||
161878363|NCT01628198|584596706|FG000|Overall Study|Screen failure|1|||
161878364|NCT03386994|584596707|FG000|Overall Study|Lung transplant|1|||
161878365|NCT03386994|584596707|FG000|Overall Study|Adverse Event|14|||
161878366|NCT03386994|584596707|FG000|Overall Study|Lost to Follow-up|4|||
161878367|NCT03386994|584596707|FG000|Overall Study|Withdrawal by Subject|3|||
161878368|NCT03386994|584596707|FG000|Overall Study|Death|16|||
161878369|NCT01827267|584596708|FG000|Overall Study|Did not receive study drug|1|||
161878370|NCT01827267|584596709|FG001|Overall Study|Did not receive study drug|1|||
161878371|NCT01827267|584596708|FG000|Overall Study|Physician Decision|1|||
161878372|NCT01827267|584596709|FG001|Overall Study|Physician Decision|0|||
161878373|NCT01827267|584596708|FG000|Overall Study|Disease Progression|1|||
161878374|NCT01827267|584596709|FG001|Overall Study|Disease Progression|1|||
161878375|NCT01827267|584596708|FG000|Overall Study|Sponsor Discontinued Study|2|||
161878376|NCT01827267|584596709|FG001|Overall Study|Sponsor Discontinued Study|8|||
161878377|NCT01827267|584596708|FG000|Overall Study|Still on study|0|||
161878378|NCT01827267|584596709|FG001|Overall Study|Still on study|2|||
161878379|NCT02147158|584596713|FG000|Treatment Course 1|Adverse Event|1|||
161878380|NCT02147158|584596714|FG001|Treatment Course 1|Adverse Event|4|||
161878381|NCT02147158|584596715|FG002|Treatment Course 1|Adverse Event|3|||
161878382|NCT02147158|584596716|FG003|Treatment Course 1|Adverse Event|4|||
161878383|NCT02147158|584596717|FG004|Treatment Course 1|Adverse Event|1|||
161878384|NCT02147158|584596718|FG005|Treatment Course 1|Adverse Event|2|||
161878385|NCT02147158|584596713|FG000|Treatment Course 1|Lost to Follow-up|2|||
161878386|NCT02147158|584596714|FG001|Treatment Course 1|Lost to Follow-up|4|||
161878387|NCT02147158|584596715|FG002|Treatment Course 1|Lost to Follow-up|3|||
161878388|NCT02147158|584596716|FG003|Treatment Course 1|Lost to Follow-up|3|||
161878389|NCT02147158|584596717|FG004|Treatment Course 1|Lost to Follow-up|2|||
161878390|NCT02147158|584596718|FG005|Treatment Course 1|Lost to Follow-up|4|||
161878391|NCT02147158|584596713|FG000|Treatment Course 1|Protocol Violation|0|||
161878392|NCT02147158|584596714|FG001|Treatment Course 1|Protocol Violation|0|||
161878393|NCT02147158|584596715|FG002|Treatment Course 1|Protocol Violation|1|||
161878394|NCT02147158|584596716|FG003|Treatment Course 1|Protocol Violation|1|||
161878395|NCT02147158|584596717|FG004|Treatment Course 1|Protocol Violation|0|||
161878396|NCT02147158|584596718|FG005|Treatment Course 1|Protocol Violation|0|||
161878397|NCT02147158|584596713|FG000|Treatment Course 1|Withdrawal of Consent|1|||
161878398|NCT02147158|584596714|FG001|Treatment Course 1|Withdrawal of Consent|1|||
161878399|NCT02147158|584596715|FG002|Treatment Course 1|Withdrawal of Consent|1|||
161878400|NCT02147158|584596716|FG003|Treatment Course 1|Withdrawal of Consent|5|||
161878401|NCT02147158|584596717|FG004|Treatment Course 1|Withdrawal of Consent|3|||
161878402|NCT02147158|584596718|FG005|Treatment Course 1|Withdrawal of Consent|2|||
161878403|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Adverse Event|1|||
161878404|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Adverse Event|0|||
161878405|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Adverse Event|0|||
161878406|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Adverse Event|1|||
161878407|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Adverse Event|0|||
161878408|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Adverse Event|0|||
161878409|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
161878410|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
161878411|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
161878412|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
161878413|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
161878414|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
161878415|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
161878416|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
161878417|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
161878418|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
161878419|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
161878420|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
161878421|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
161878422|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
161878423|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
161878424|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
161878425|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
161878426|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
161878427|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878428|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878429|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
161878430|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878431|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
161878432|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878433|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
161878434|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161878435|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
161878436|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
161878437|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161878438|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161878439|NCT02147158|584596713|FG000|Treatment Course 2|Adverse Event|0|||
161878440|NCT02147158|584596714|FG001|Treatment Course 2|Adverse Event|4|||
161878441|NCT02147158|584596715|FG002|Treatment Course 2|Adverse Event|2|||
161878442|NCT02147158|584596716|FG003|Treatment Course 2|Adverse Event|1|||
161878443|NCT02147158|584596717|FG004|Treatment Course 2|Adverse Event|0|||
161878444|NCT02147158|584596718|FG005|Treatment Course 2|Adverse Event|1|||
161878445|NCT02147158|584596713|FG000|Treatment Course 2|Withdrawal of Consent|0|||
161878446|NCT02147158|584596714|FG001|Treatment Course 2|Withdrawal of Consent|1|||
161878447|NCT02147158|584596715|FG002|Treatment Course 2|Withdrawal of Consent|2|||
161878448|NCT02147158|584596716|FG003|Treatment Course 2|Withdrawal of Consent|3|||
161878449|NCT02147158|584596717|FG004|Treatment Course 2|Withdrawal of Consent|0|||
161878450|NCT02147158|584596718|FG005|Treatment Course 2|Withdrawal of Consent|0|||
161878451|NCT02147158|584596713|FG000|Treatment Course 2|Lost to Follow-up|1|||
161878452|NCT02147158|584596714|FG001|Treatment Course 2|Lost to Follow-up|0|||
161878453|NCT02147158|584596715|FG002|Treatment Course 2|Lost to Follow-up|1|||
161878454|NCT02147158|584596716|FG003|Treatment Course 2|Lost to Follow-up|1|||
161878455|NCT02147158|584596717|FG004|Treatment Course 2|Lost to Follow-up|0|||
161878456|NCT02147158|584596718|FG005|Treatment Course 2|Lost to Follow-up|1|||
161878457|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878458|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
161878459|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
161878460|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878461|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878462|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878463|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
161878464|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
161878465|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
161878466|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
161878467|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
161878468|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
161878469|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
161878470|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
161878471|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
161878472|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
161878473|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
161878474|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
161878475|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
161878476|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
161878477|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
161878478|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
161878479|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
161878480|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
161878481|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
161878482|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
161878483|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
161878484|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
161878485|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
161878486|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
161878487|NCT04520997|584596719|FG000|Overall Study|Lost to Follow-up|1|||
161878488|NCT04520997|584596720|FG001|Overall Study|Lost to Follow-up|1|||
161878489|NCT04520997|584596719|FG000|Overall Study|Withdrawal by Subject|1|||
161878490|NCT04520997|584596720|FG001|Overall Study|Withdrawal by Subject|0|||
161878491|NCT04520997|584596719|FG000|Overall Study|Not Treated|0|||
161878492|NCT04520997|584596720|FG001|Overall Study|Not Treated|1|||
161878493|NCT03689374|584596721|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
161878494|NCT03689374|584596722|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
161878495|NCT03689374|584596723|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
161878496|NCT03689374|584596721|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
161878497|NCT03689374|584596722|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
161878498|NCT03689374|584596723|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
161878499|NCT03689374|584596721|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
161878500|NCT03689374|584596722|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
161878501|NCT03689374|584596723|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
161878502|NCT03689374|584596721|FG000|Treatment Period (Week 0 to 52)|Death|0|||
161878503|NCT03689374|584596722|FG001|Treatment Period (Week 0 to 52)|Death|11|||
161878504|NCT03689374|584596723|FG002|Treatment Period (Week 0 to 52)|Death|1|||
161878505|NCT05367973|584596724|FG000|Overall Study|Adverse Event|0|||
161878506|NCT05367973|584596725|FG001|Overall Study|Adverse Event|2|||
161878507|NCT00986921|584596726|FG000|Overall Study|Physician Decision|1|||
161878508|NCT00986921|584596727|FG001|Overall Study|Physician Decision|0|||
161878509|NCT01758731|584596728|FG000|Overall Study|Physician Decision|1|||
161878510|NCT04445714|584596729|FG000|Overall Study|Discontinuation of the study|14|||
161878511|NCT04445714|584596729|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
161878512|NCT04445714|584596729|FG000|Overall Study|Withdrawal of Informed Consent|8|||
161878513|NCT02396420|584596734|FG000|Overall Study|Death|1|||
161878514|NCT01273623|584596735|FG000|Overall Study|did not meet IVUS criteria|29|||
161878515|NCT02122887|584596743|FG000|Overall Study|Withdrawal by Subject|20|||
161878516|NCT02122887|584596744|FG001|Overall Study|Withdrawal by Subject|2|||
161878517|NCT05903924|584598688|FG000|Overall Study|Lost to Follow-up|1|||
161878518|NCT05903924|584598689|FG001|Overall Study|Lost to Follow-up|0|||
161878519|NCT05903924|584598690|FG002|Overall Study|Lost to Follow-up|0|||
161878520|NCT04338269|584598691|FG000|Overall Study|Death|86|||
161878521|NCT04338269|584598692|FG001|Overall Study|Death|89|||
161878522|NCT04338269|584598691|FG000|Overall Study|Lost to Follow-up|1|||
161878523|NCT04338269|584598692|FG001|Overall Study|Lost to Follow-up|2|||
161878524|NCT04338269|584598691|FG000|Overall Study|Physician Decision|1|||
161878525|NCT04338269|584598692|FG001|Overall Study|Physician Decision|0|||
161878526|NCT04338269|584598691|FG000|Overall Study|Withdrawal by Subject|14|||
161878527|NCT04338269|584598692|FG001|Overall Study|Withdrawal by Subject|11|||
161878528|NCT00174967|584598693|FG000|Overall Study|Adverse Event|1|||
161878529|NCT00174967|584598694|FG001|Overall Study|Adverse Event|2|||
161878530|NCT00174967|584598695|FG002|Overall Study|Adverse Event|2|||
161878531|NCT00174967|584598696|FG003|Overall Study|Adverse Event|1|||
161878532|NCT00174967|584598693|FG000|Overall Study|Gout Flare|0|||
161878533|NCT00174967|584598694|FG001|Overall Study|Gout Flare|0|||
161878534|NCT00174967|584598695|FG002|Overall Study|Gout Flare|0|||
161878535|NCT00174967|584598696|FG003|Overall Study|Gout Flare|1|||
161878536|NCT00174967|584598693|FG000|Overall Study|Other|0|||
161878537|NCT00174967|584598694|FG001|Overall Study|Other|1|||
161878538|NCT00174967|584598695|FG002|Overall Study|Other|0|||
161878539|NCT00174967|584598696|FG003|Overall Study|Other|0|||
161878540|NCT03030989|584598697|FG000|Overall Study|Fever|2|||
161878541|NCT03030989|584598698|FG001|Overall Study|Fever|2|||
161878542|NCT03030989|584598697|FG000|Overall Study|Rash|2|||
161878543|NCT03030989|584598698|FG001|Overall Study|Rash|1|||
161878544|NCT03030989|584598697|FG000|Overall Study|Fatigue/Overwhelmed|1|||
161878545|NCT03030989|584598698|FG001|Overall Study|Fatigue/Overwhelmed|5|||
161878546|NCT03030989|584598697|FG000|Overall Study|Positive Blood Cultures|2|||
161878547|NCT03030989|584598698|FG001|Overall Study|Positive Blood Cultures|1|||
161878548|NCT03030989|584598697|FG000|Overall Study|Line Removed|0|||
161878549|NCT03030989|584598698|FG001|Overall Study|Line Removed|2|||
161878550|NCT03030989|584598697|FG000|Overall Study|No longer interested|5|||
161878551|NCT03030989|584598698|FG001|Overall Study|No longer interested|3|||
161878552|NCT02730377|584598699|FG000|Overall Study|Other|5|||
161878553|NCT02730377|584598700|FG001|Overall Study|Other|4|||
161878554|NCT02730377|584598699|FG000|Overall Study|Death|1|||
161878555|NCT02730377|584598700|FG001|Overall Study|Death|8|||
161878556|NCT02730377|584598699|FG000|Overall Study|Inadequate glycaemic control|368|||
161878557|NCT02730377|584598700|FG001|Overall Study|Inadequate glycaemic control|473|||
161878558|NCT02730377|584598699|FG000|Overall Study|Adverse Event|79|||
161878559|NCT02730377|584598700|FG001|Overall Study|Adverse Event|41|||
161878560|NCT02730377|584598699|FG000|Overall Study|Protocol Violation|23|||
161878561|NCT02730377|584598700|FG001|Overall Study|Protocol Violation|30|||
161878562|NCT02730377|584598699|FG000|Overall Study|Lack of Efficacy|4|||
161878563|NCT02730377|584598700|FG001|Overall Study|Lack of Efficacy|13|||
161878564|NCT02730377|584598699|FG000|Overall Study|Pregnancy|0|||
161878565|NCT02730377|584598700|FG001|Overall Study|Pregnancy|1|||
161878566|NCT02730377|584598699|FG000|Overall Study|Withdrawal by Subject|45|||
161878567|NCT02730377|584598700|FG001|Overall Study|Withdrawal by Subject|42|||
161878568|NCT02730377|584598699|FG000|Overall Study|Lost to Follow-up|25|||
161878569|NCT02730377|584598700|FG001|Overall Study|Lost to Follow-up|21|||
161878570|NCT02706886|584598701|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
161878571|NCT02706886|584598702|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
161878572|NCT02706886|584598703|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
161878573|NCT02706886|584598704|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
161878574|NCT02706886|584598705|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
161878575|NCT02706886|584598706|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
161878576|NCT02706886|584598707|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
161878577|NCT02706886|584598708|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
161878578|NCT02706886|584598709|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
161878579|NCT04934189|584598710|FG000|Overall Study|Lost to Follow-up|4|||
161878580|NCT04934189|584598710|FG000|Overall Study|Withdrawal by Subject|17|||
161878581|NCT03320850|584598711|FG000|Overall Study|Lost to Follow-up|0|||
161878582|NCT03320850|584598712|FG001|Overall Study|Lost to Follow-up|0|||
161878583|NCT03320850|584598713|FG002|Overall Study|Lost to Follow-up|0|||
161878584|NCT03320850|584598714|FG003|Overall Study|Lost to Follow-up|0|||
161878585|NCT03320850|584598715|FG004|Overall Study|Lost to Follow-up|1|||
161878586|NCT03320850|584598716|FG005|Overall Study|Lost to Follow-up|2|||
161878587|NCT03320850|584598717|FG006|Overall Study|Lost to Follow-up|2|||
161878588|NCT03320850|584598718|FG007|Overall Study|Lost to Follow-up|0|||
161878589|NCT03320850|584598719|FG008|Overall Study|Lost to Follow-up|6|||
161878590|NCT03320850|584598720|FG009|Overall Study|Lost to Follow-up|4|||
161878591|NCT03320850|584598711|FG000|Overall Study|Withdrawal by Subject|0|||
161878592|NCT03320850|584598712|FG001|Overall Study|Withdrawal by Subject|0|||
161878593|NCT03320850|584598713|FG002|Overall Study|Withdrawal by Subject|0|||
161878594|NCT03320850|584598714|FG003|Overall Study|Withdrawal by Subject|0|||
161878595|NCT03320850|584598715|FG004|Overall Study|Withdrawal by Subject|1|||
161878596|NCT03320850|584598716|FG005|Overall Study|Withdrawal by Subject|2|||
161878597|NCT03320850|584598717|FG006|Overall Study|Withdrawal by Subject|4|||
161878598|NCT03320850|584598718|FG007|Overall Study|Withdrawal by Subject|5|||
161878599|NCT03320850|584598719|FG008|Overall Study|Withdrawal by Subject|2|||
161878600|NCT03320850|584598720|FG009|Overall Study|Withdrawal by Subject|1|||
161878601|NCT03320850|584598711|FG000|Overall Study|Lack of Efficacy|0|||
161878602|NCT03320850|584598712|FG001|Overall Study|Lack of Efficacy|0|||
161878603|NCT03320850|584598713|FG002|Overall Study|Lack of Efficacy|0|||
161878604|NCT03320850|584598714|FG003|Overall Study|Lack of Efficacy|1|||
161878605|NCT03320850|584598715|FG004|Overall Study|Lack of Efficacy|0|||
161878606|NCT03320850|584598716|FG005|Overall Study|Lack of Efficacy|1|||
161878607|NCT03320850|584598717|FG006|Overall Study|Lack of Efficacy|0|||
161878608|NCT03320850|584598718|FG007|Overall Study|Lack of Efficacy|2|||
161878609|NCT03320850|584598719|FG008|Overall Study|Lack of Efficacy|0|||
161878610|NCT03320850|584598720|FG009|Overall Study|Lack of Efficacy|3|||
161878611|NCT03320850|584598711|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161878612|NCT03320850|584598712|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161878613|NCT03320850|584598713|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161878614|NCT03320850|584598714|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
161878615|NCT03320850|584598715|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161878616|NCT03320850|584598716|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
161878617|NCT03320850|584598717|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
161878618|NCT03320850|584598718|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
161878619|NCT03320850|584598719|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
161878620|NCT03320850|584598720|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
161878621|NCT03320850|584598711|FG000|Overall Study|Adverse Event|0|||
161878622|NCT03320850|584598712|FG001|Overall Study|Adverse Event|0|||
161878623|NCT03320850|584598713|FG002|Overall Study|Adverse Event|0|||
161878624|NCT03320850|584598714|FG003|Overall Study|Adverse Event|0|||
161878625|NCT03320850|584598715|FG004|Overall Study|Adverse Event|0|||
161878626|NCT03320850|584598716|FG005|Overall Study|Adverse Event|2|||
161878627|NCT03320850|584598717|FG006|Overall Study|Adverse Event|1|||
161878628|NCT03320850|584598718|FG007|Overall Study|Adverse Event|0|||
161878629|NCT03320850|584598719|FG008|Overall Study|Adverse Event|2|||
161878630|NCT03320850|584598720|FG009|Overall Study|Adverse Event|0|||
161878631|NCT03320850|584598711|FG000|Overall Study|Reason Not Specified|0|||
161878632|NCT03320850|584598712|FG001|Overall Study|Reason Not Specified|0|||
161878633|NCT03320850|584598713|FG002|Overall Study|Reason Not Specified|0|||
161878634|NCT03320850|584598714|FG003|Overall Study|Reason Not Specified|0|||
161878635|NCT03320850|584598715|FG004|Overall Study|Reason Not Specified|0|||
161878636|NCT03320850|584598716|FG005|Overall Study|Reason Not Specified|1|||
161878637|NCT03320850|584598717|FG006|Overall Study|Reason Not Specified|0|||
161878638|NCT03320850|584598718|FG007|Overall Study|Reason Not Specified|0|||
161878639|NCT03320850|584598719|FG008|Overall Study|Reason Not Specified|0|||
161878640|NCT03320850|584598720|FG009|Overall Study|Reason Not Specified|1|||
161878641|NCT02002533|584598723|FG000|Overall Study|Withdrawal by Subject|6|||
161878642|NCT02002533|584598724|FG001|Overall Study|Withdrawal by Subject|13|||
161878643|NCT02002533|584598723|FG000|Overall Study|Protocol Violation|0|||
161878644|NCT02002533|584598724|FG001|Overall Study|Protocol Violation|1|||
161878645|NCT02002533|584598723|FG000|Overall Study|Adverse Event|0|||
161878646|NCT02002533|584598724|FG001|Overall Study|Adverse Event|3|||
161878647|NCT02002533|584598723|FG000|Overall Study|Lost to Follow-up|0|||
161878648|NCT02002533|584598724|FG001|Overall Study|Lost to Follow-up|1|||
161878649|NCT02086448|584598730|FG000|Overall Study|Withdrawal by Subject|1|||
161878650|NCT02086448|584598731|FG001|Overall Study|Withdrawal by Subject|0|||
161878651|NCT02086448|584598732|FG002|Overall Study|Withdrawal by Subject|0|||
161878652|NCT02086448|584598733|FG003|Overall Study|Withdrawal by Subject|2|||
161878653|NCT02031640|584598744|FG000|Screening Period|Adverse Event|1|||
161878654|NCT02031640|584598745|FG001|Screening Period|Adverse Event|0|||
161878655|NCT02031640|584598746|FG002|Screening Period|Adverse Event|0|||
161878656|NCT02031640|584598747|FG003|Screening Period|Adverse Event|0|||
161878657|NCT02031640|584598748|FG004|Screening Period|Adverse Event|0|||
161878658|NCT02031640|584598749|FG005|Screening Period|Adverse Event|0|||
161878659|NCT02031640|584598744|FG000|Screening Period|Withdrawal by Subject|29|||
161878660|NCT02031640|584598745|FG001|Screening Period|Withdrawal by Subject|0|||
161878661|NCT02031640|584598746|FG002|Screening Period|Withdrawal by Subject|0|||
161878662|NCT02031640|584598747|FG003|Screening Period|Withdrawal by Subject|0|||
161878663|NCT02031640|584598748|FG004|Screening Period|Withdrawal by Subject|0|||
161878664|NCT02031640|584598749|FG005|Screening Period|Withdrawal by Subject|0|||
161878665|NCT02031640|584598744|FG000|Screening Period|Inclusion criteria not met|312|||
161878666|NCT02031640|584598745|FG001|Screening Period|Inclusion criteria not met|0|||
161878667|NCT02031640|584598746|FG002|Screening Period|Inclusion criteria not met|0|||
161878668|NCT02031640|584598747|FG003|Screening Period|Inclusion criteria not met|0|||
161878669|NCT02031640|584598748|FG004|Screening Period|Inclusion criteria not met|0|||
161878670|NCT02031640|584598749|FG005|Screening Period|Inclusion criteria not met|0|||
161878671|NCT02031640|584598744|FG000|Screening Period|Exclusion criteria met|30|||
161878672|NCT02031640|584598745|FG001|Screening Period|Exclusion criteria met|0|||
161878673|NCT02031640|584598746|FG002|Screening Period|Exclusion criteria met|0|||
161878674|NCT02031640|584598747|FG003|Screening Period|Exclusion criteria met|0|||
161878675|NCT02031640|584598748|FG004|Screening Period|Exclusion criteria met|0|||
161878676|NCT02031640|584598749|FG005|Screening Period|Exclusion criteria met|0|||
161878677|NCT02031640|584598744|FG000|Screening Period|Lost to Follow-up|14|||
161878678|NCT02031640|584598745|FG001|Screening Period|Lost to Follow-up|0|||
161878679|NCT02031640|584598746|FG002|Screening Period|Lost to Follow-up|0|||
161878680|NCT02031640|584598747|FG003|Screening Period|Lost to Follow-up|0|||
161878681|NCT02031640|584598748|FG004|Screening Period|Lost to Follow-up|0|||
161878682|NCT02031640|584598749|FG005|Screening Period|Lost to Follow-up|0|||
161878683|NCT02031640|584598744|FG000|Screening Period|Enrollment closed|26|||
161878684|NCT02031640|584598745|FG001|Screening Period|Enrollment closed|0|||
161878685|NCT02031640|584598746|FG002|Screening Period|Enrollment closed|0|||
161878686|NCT02031640|584598747|FG003|Screening Period|Enrollment closed|0|||
161878687|NCT02031640|584598748|FG004|Screening Period|Enrollment closed|0|||
161878688|NCT02031640|584598749|FG005|Screening Period|Enrollment closed|0|||
161878689|NCT02031640|584598744|FG000|Run-In Period|Adverse Event|4|||
161878690|NCT02031640|584598745|FG001|Run-In Period|Adverse Event|0|||
161878691|NCT02031640|584598746|FG002|Run-In Period|Adverse Event|0|||
161878692|NCT02031640|584598747|FG003|Run-In Period|Adverse Event|0|||
161878693|NCT02031640|584598748|FG004|Run-In Period|Adverse Event|0|||
161878694|NCT02031640|584598749|FG005|Run-In Period|Adverse Event|0|||
161878695|NCT02031640|584598744|FG000|Run-In Period|Withdrawal by Subject|17|||
161878696|NCT02031640|584598745|FG001|Run-In Period|Withdrawal by Subject|0|||
161878697|NCT02031640|584598746|FG002|Run-In Period|Withdrawal by Subject|0|||
161878698|NCT02031640|584598747|FG003|Run-In Period|Withdrawal by Subject|0|||
161878699|NCT02031640|584598748|FG004|Run-In Period|Withdrawal by Subject|0|||
161878700|NCT02031640|584598749|FG005|Run-In Period|Withdrawal by Subject|0|||
161878701|NCT02031640|584598744|FG000|Run-In Period|Inclusion criteria not met|38|||
161878702|NCT02031640|584598745|FG001|Run-In Period|Inclusion criteria not met|0|||
161878703|NCT02031640|584598746|FG002|Run-In Period|Inclusion criteria not met|0|||
161878704|NCT02031640|584598747|FG003|Run-In Period|Inclusion criteria not met|0|||
161878705|NCT02031640|584598748|FG004|Run-In Period|Inclusion criteria not met|0|||
161878706|NCT02031640|584598749|FG005|Run-In Period|Inclusion criteria not met|0|||
161878707|NCT02031640|584598744|FG000|Run-In Period|Exclusion criteria met|8|||
161878708|NCT02031640|584598745|FG001|Run-In Period|Exclusion criteria met|0|||
161878709|NCT02031640|584598746|FG002|Run-In Period|Exclusion criteria met|0|||
161878710|NCT02031640|584598747|FG003|Run-In Period|Exclusion criteria met|0|||
161878711|NCT02031640|584598748|FG004|Run-In Period|Exclusion criteria met|0|||
161878712|NCT02031640|584598749|FG005|Run-In Period|Exclusion criteria met|0|||
161878713|NCT02031640|584598744|FG000|Run-In Period|Randomization criteria not met|85|||
161878714|NCT02031640|584598745|FG001|Run-In Period|Randomization criteria not met|0|||
161878715|NCT02031640|584598746|FG002|Run-In Period|Randomization criteria not met|0|||
161878716|NCT02031640|584598747|FG003|Run-In Period|Randomization criteria not met|0|||
161878717|NCT02031640|584598748|FG004|Run-In Period|Randomization criteria not met|0|||
161878718|NCT02031640|584598749|FG005|Run-In Period|Randomization criteria not met|0|||
161878719|NCT02031640|584598744|FG000|Run-In Period|Various administrative reasons|17|||
161878720|NCT02031640|584598745|FG001|Run-In Period|Various administrative reasons|0|||
161878721|NCT02031640|584598746|FG002|Run-In Period|Various administrative reasons|0|||
161878722|NCT02031640|584598747|FG003|Run-In Period|Various administrative reasons|0|||
161878723|NCT02031640|584598748|FG004|Run-In Period|Various administrative reasons|0|||
161878724|NCT02031640|584598749|FG005|Run-In Period|Various administrative reasons|0|||
161878725|NCT02031640|584598744|FG000|Double-blind Treatment Period|Protocol deviation|0|||
161878726|NCT02031640|584598745|FG001|Double-blind Treatment Period|Protocol deviation|2|||
161878727|NCT02031640|584598746|FG002|Double-blind Treatment Period|Protocol deviation|0|||
161878728|NCT02031640|584598747|FG003|Double-blind Treatment Period|Protocol deviation|1|||
161878729|NCT02031640|584598748|FG004|Double-blind Treatment Period|Protocol deviation|3|||
161878730|NCT02031640|584598749|FG005|Double-blind Treatment Period|Protocol deviation|1|||
161878731|NCT02031640|584598744|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161878732|NCT02031640|584598745|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
161878733|NCT02031640|584598746|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
161878734|NCT02031640|584598747|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
161878735|NCT02031640|584598748|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
161878736|NCT02031640|584598749|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
161878737|NCT02031640|584598744|FG000|Double-blind Treatment Period|Non-compliance|0|||
161878738|NCT02031640|584598745|FG001|Double-blind Treatment Period|Non-compliance|1|||
161878739|NCT02031640|584598746|FG002|Double-blind Treatment Period|Non-compliance|0|||
161878740|NCT02031640|584598747|FG003|Double-blind Treatment Period|Non-compliance|1|||
161878741|NCT02031640|584598748|FG004|Double-blind Treatment Period|Non-compliance|1|||
161878742|NCT02031640|584598749|FG005|Double-blind Treatment Period|Non-compliance|0|||
161878743|NCT02031640|584598744|FG000|Double-blind Treatment Period|Adverse Event|0|||
161878744|NCT02031640|584598745|FG001|Double-blind Treatment Period|Adverse Event|0|||
161878745|NCT02031640|584598746|FG002|Double-blind Treatment Period|Adverse Event|0|||
161878746|NCT02031640|584598747|FG003|Double-blind Treatment Period|Adverse Event|2|||
161878747|NCT02031640|584598748|FG004|Double-blind Treatment Period|Adverse Event|0|||
161878748|NCT02031640|584598749|FG005|Double-blind Treatment Period|Adverse Event|0|||
161878749|NCT02031640|584598744|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161878750|NCT02031640|584598745|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161878751|NCT02031640|584598746|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
161878752|NCT02031640|584598747|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
161878753|NCT02031640|584598748|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
161878754|NCT02031640|584598749|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
161878755|NCT02031640|584598744|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161878756|NCT02031640|584598745|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
161878757|NCT02031640|584598746|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161878758|NCT02031640|584598747|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161878759|NCT02031640|584598748|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
161878760|NCT02031640|584598749|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
161878761|NCT01194999|584598752|FG000|Overall Study|Lost to Follow-up|17|||
161878762|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
161878763|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
161878764|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
161878765|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
161878766|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
161878767|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
161878768|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
161878769|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
161878770|NCT01895270|584598753|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
161878771|NCT01895270|584598754|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
161878772|NCT01895270|584598753|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
161878773|NCT01895270|584598754|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
161878774|NCT01895270|584598753|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
161878775|NCT01895270|584598754|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
161878776|NCT02091375|584598757|FG000|Overall Study|Adverse Event|8|||
161878777|NCT02091375|584598758|FG001|Overall Study|Adverse Event|1|||
161878778|NCT02091375|584598757|FG000|Overall Study|Lost to Follow-up|0|||
161878779|NCT02091375|584598758|FG001|Overall Study|Lost to Follow-up|1|||
161878780|NCT02091375|584598757|FG000|Overall Study|Withdrawal by Subject|0|||
161878781|NCT02091375|584598758|FG001|Overall Study|Withdrawal by Subject|1|||
161878782|NCT02091375|584598757|FG000|Overall Study|Withdrawn by the investigator|1|||
161878783|NCT02091375|584598758|FG001|Overall Study|Withdrawn by the investigator|0|||
161878784|NCT03781583|584598762|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
161878785|NCT03781583|584598763|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
161878786|NCT03781583|584598764|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
161878787|NCT03781583|584598765|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
161878788|NCT03781583|584598762|FG000|Overall Study|Technology did not work for that person in that environment|1|||
161878789|NCT03781583|584598763|FG001|Overall Study|Technology did not work for that person in that environment|0|||
161878790|NCT03781583|584598764|FG002|Overall Study|Technology did not work for that person in that environment|0|||
161878791|NCT03781583|584598765|FG003|Overall Study|Technology did not work for that person in that environment|0|||
161878792|NCT03781583|584598762|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
161878793|NCT03781583|584598763|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
161878794|NCT03781583|584598764|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
161878795|NCT03781583|584598765|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
161878796|NCT03781583|584598762|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161878797|NCT03781583|584598763|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
161878798|NCT03781583|584598764|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161878799|NCT03781583|584598765|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161878800|NCT01938430|584598767|FG000|Overall Study|Randomized but Not Treated|0|||
161878801|NCT01938430|584598768|FG001|Overall Study|Randomized but Not Treated|0|||
161878802|NCT01938430|584598769|FG002|Overall Study|Randomized but Not Treated|0|||
161878803|NCT01938430|584598770|FG003|Overall Study|Randomized but Not Treated|0|||
161878804|NCT01938430|584598771|FG004|Overall Study|Randomized but Not Treated|0|||
161878805|NCT01938430|584598772|FG005|Overall Study|Randomized but Not Treated|0|||
161878806|NCT01938430|584598773|FG006|Overall Study|Randomized but Not Treated|0|||
161878807|NCT01938430|584598774|FG007|Overall Study|Randomized but Not Treated|0|||
161777239|NCT00943826|584225530|FG001|Monotherapy Phase|Withdrew Consent|3|||
161777240|NCT00943826|584225529|FG000|Monotherapy Phase|Failure to return|2|||
161777241|NCT00943826|584225530|FG001|Monotherapy Phase|Failure to return|1|||
161777242|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
161777243|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
161777244|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
161777245|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
161777246|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
161777247|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
161777248|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
161777249|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
161777250|NCT04764669|584225531|FG000|Overall Study|Adverse Event|1|||
161777251|NCT04764669|584225532|FG001|Overall Study|Adverse Event|0|||
161777252|NCT04764669|584225533|FG002|Overall Study|Adverse Event|1|||
161777253|NCT04764669|584225534|FG003|Overall Study|Adverse Event|0|||
161777254|NCT04764669|584225531|FG000|Overall Study|Subject Choice|0|||
161777255|NCT04764669|584225532|FG001|Overall Study|Subject Choice|0|||
161777256|NCT04764669|584225533|FG002|Overall Study|Subject Choice|1|||
161777257|NCT04764669|584225534|FG003|Overall Study|Subject Choice|0|||
161777258|NCT04764669|584225531|FG000|Overall Study|Withdrawal by Subject|2|||
161777259|NCT04764669|584225532|FG001|Overall Study|Withdrawal by Subject|0|||
161777260|NCT04764669|584225533|FG002|Overall Study|Withdrawal by Subject|0|||
161777261|NCT04764669|584225534|FG003|Overall Study|Withdrawal by Subject|0|||
161777262|NCT00592007|584225536|FG000|Overall Study|Withdrawal by Subject|1|||
161777263|NCT00592007|584225536|FG000|Overall Study|patient ineligible (out of lab range)|1|||
161777264|NCT01275170|584225538|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
161777265|NCT01275170|584225539|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777266|NCT01275170|584225540|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777267|NCT01275170|584225541|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777268|NCT01275170|584225542|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777269|NCT01275170|584225543|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777270|NCT01275170|584225544|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777271|NCT01275170|584225545|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777272|NCT00605839|584225546|FG000|Overall Study|Protocol Violation|1|||
161777273|NCT00605839|584225547|FG001|Overall Study|Protocol Violation|0|||
161777274|NCT00605839|584225548|FG002|Overall Study|Protocol Violation|0|||
161777275|NCT04636437|584225552|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
161777276|NCT04636437|584225553|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
161777277|NCT04636437|584225554|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
161777278|NCT04636437|584225552|FG000|Overall Study|Started weight loss drug/program|2|||
161878808|NCT01938430|584598775|FG008|Overall Study|Randomized but Not Treated|0|||
161878809|NCT01938430|584598776|FG009|Overall Study|Randomized but Not Treated|0|||
161878810|NCT01938430|584598777|FG010|Overall Study|Randomized but Not Treated|1|||
161878811|NCT01938430|584598778|FG011|Overall Study|Randomized but Not Treated|0|||
161878812|NCT01938430|584598779|FG012|Overall Study|Randomized but Not Treated|0|||
161878813|NCT01938430|584598780|FG013|Overall Study|Randomized but Not Treated|1|||
161878814|NCT01938430|584598767|FG000|Overall Study|Adverse Event|0|||
161878815|NCT01938430|584598768|FG001|Overall Study|Adverse Event|0|||
161878816|NCT01938430|584598769|FG002|Overall Study|Adverse Event|0|||
161878817|NCT01938430|584598770|FG003|Overall Study|Adverse Event|0|||
161878818|NCT01938430|584598771|FG004|Overall Study|Adverse Event|0|||
161878819|NCT01938430|584598772|FG005|Overall Study|Adverse Event|0|||
161878820|NCT01938430|584598773|FG006|Overall Study|Adverse Event|1|||
161878821|NCT01938430|584598774|FG007|Overall Study|Adverse Event|0|||
161878822|NCT01938430|584598775|FG008|Overall Study|Adverse Event|0|||
161878823|NCT01938430|584598776|FG009|Overall Study|Adverse Event|0|||
161878824|NCT01938430|584598777|FG010|Overall Study|Adverse Event|0|||
161878825|NCT01938430|584598778|FG011|Overall Study|Adverse Event|0|||
161878826|NCT01938430|584598779|FG012|Overall Study|Adverse Event|0|||
161878827|NCT01938430|584598780|FG013|Overall Study|Adverse Event|0|||
161878828|NCT01938430|584598767|FG000|Overall Study|Death|1|||
161878829|NCT01938430|584598768|FG001|Overall Study|Death|2|||
161878830|NCT01938430|584598769|FG002|Overall Study|Death|2|||
161878831|NCT01938430|584598770|FG003|Overall Study|Death|1|||
161878832|NCT01938430|584598771|FG004|Overall Study|Death|0|||
161878833|NCT01938430|584598772|FG005|Overall Study|Death|0|||
161878834|NCT01938430|584598773|FG006|Overall Study|Death|1|||
161878835|NCT01938430|584598774|FG007|Overall Study|Death|1|||
161878836|NCT01938430|584598775|FG008|Overall Study|Death|2|||
161878837|NCT01938430|584598776|FG009|Overall Study|Death|3|||
161878838|NCT01938430|584598777|FG010|Overall Study|Death|0|||
161878839|NCT01938430|584598778|FG011|Overall Study|Death|0|||
161878840|NCT01938430|584598779|FG012|Overall Study|Death|0|||
161878841|NCT01938430|584598780|FG013|Overall Study|Death|0|||
161878842|NCT01938430|584598767|FG000|Overall Study|Investigator's Discretion|0|||
161878843|NCT01938430|584598768|FG001|Overall Study|Investigator's Discretion|0|||
161878844|NCT01938430|584598769|FG002|Overall Study|Investigator's Discretion|1|||
161878845|NCT01938430|584598770|FG003|Overall Study|Investigator's Discretion|0|||
161878846|NCT01938430|584598771|FG004|Overall Study|Investigator's Discretion|0|||
161878847|NCT01938430|584598772|FG005|Overall Study|Investigator's Discretion|0|||
161878848|NCT01938430|584598773|FG006|Overall Study|Investigator's Discretion|0|||
161878849|NCT01938430|584598774|FG007|Overall Study|Investigator's Discretion|0|||
161878850|NCT01938430|584598775|FG008|Overall Study|Investigator's Discretion|0|||
161878851|NCT01938430|584598776|FG009|Overall Study|Investigator's Discretion|0|||
161878852|NCT01938430|584598777|FG010|Overall Study|Investigator's Discretion|0|||
161878853|NCT01938430|584598778|FG011|Overall Study|Investigator's Discretion|0|||
161878854|NCT01938430|584598779|FG012|Overall Study|Investigator's Discretion|0|||
161878855|NCT01938430|584598780|FG013|Overall Study|Investigator's Discretion|0|||
161878856|NCT01938430|584598767|FG000|Overall Study|Lack of Efficacy|3|||
161878857|NCT01938430|584598768|FG001|Overall Study|Lack of Efficacy|1|||
161878858|NCT01938430|584598769|FG002|Overall Study|Lack of Efficacy|1|||
161878859|NCT01938430|584598770|FG003|Overall Study|Lack of Efficacy|1|||
161878860|NCT01938430|584598771|FG004|Overall Study|Lack of Efficacy|0|||
161878861|NCT01938430|584598772|FG005|Overall Study|Lack of Efficacy|0|||
161878862|NCT01938430|584598773|FG006|Overall Study|Lack of Efficacy|0|||
161878863|NCT01938430|584598774|FG007|Overall Study|Lack of Efficacy|0|||
161878864|NCT01938430|584598775|FG008|Overall Study|Lack of Efficacy|1|||
161878865|NCT01938430|584598776|FG009|Overall Study|Lack of Efficacy|0|||
161878866|NCT01938430|584598777|FG010|Overall Study|Lack of Efficacy|2|||
161878867|NCT01938430|584598778|FG011|Overall Study|Lack of Efficacy|1|||
161878868|NCT01938430|584598779|FG012|Overall Study|Lack of Efficacy|0|||
161878869|NCT01938430|584598780|FG013|Overall Study|Lack of Efficacy|0|||
161878870|NCT01938430|584598767|FG000|Overall Study|Lost to Follow-up|0|||
161878871|NCT01938430|584598768|FG001|Overall Study|Lost to Follow-up|0|||
161878872|NCT01938430|584598769|FG002|Overall Study|Lost to Follow-up|1|||
161878873|NCT01938430|584598770|FG003|Overall Study|Lost to Follow-up|0|||
161878874|NCT01938430|584598771|FG004|Overall Study|Lost to Follow-up|0|||
161878875|NCT01938430|584598772|FG005|Overall Study|Lost to Follow-up|1|||
161878876|NCT01938430|584598773|FG006|Overall Study|Lost to Follow-up|0|||
161878877|NCT01938430|584598774|FG007|Overall Study|Lost to Follow-up|0|||
161878878|NCT01938430|584598775|FG008|Overall Study|Lost to Follow-up|0|||
161878879|NCT01938430|584598776|FG009|Overall Study|Lost to Follow-up|0|||
161878880|NCT01938430|584598777|FG010|Overall Study|Lost to Follow-up|0|||
161878881|NCT01938430|584598778|FG011|Overall Study|Lost to Follow-up|0|||
161878882|NCT01938430|584598779|FG012|Overall Study|Lost to Follow-up|0|||
161878883|NCT01938430|584598780|FG013|Overall Study|Lost to Follow-up|0|||
161878884|NCT01938430|584598767|FG000|Overall Study|Withdrew Consent|0|||
161878885|NCT01938430|584598768|FG001|Overall Study|Withdrew Consent|0|||
161878886|NCT01938430|584598769|FG002|Overall Study|Withdrew Consent|0|||
161878887|NCT01938430|584598770|FG003|Overall Study|Withdrew Consent|0|||
161878888|NCT01938430|584598771|FG004|Overall Study|Withdrew Consent|0|||
161878889|NCT01938430|584598772|FG005|Overall Study|Withdrew Consent|0|||
161878890|NCT01938430|584598773|FG006|Overall Study|Withdrew Consent|0|||
161878891|NCT01938430|584598774|FG007|Overall Study|Withdrew Consent|0|||
161878892|NCT01938430|584598775|FG008|Overall Study|Withdrew Consent|1|||
161878893|NCT01938430|584598776|FG009|Overall Study|Withdrew Consent|0|||
161878894|NCT01938430|584598777|FG010|Overall Study|Withdrew Consent|0|||
161878895|NCT01938430|584598778|FG011|Overall Study|Withdrew Consent|0|||
161878896|NCT01938430|584598779|FG012|Overall Study|Withdrew Consent|0|||
161878897|NCT01938430|584598780|FG013|Overall Study|Withdrew Consent|0|||
161878898|NCT01613222|584598783|FG000|Overall Study|Physician Decision|1|||
161878899|NCT01613222|584598783|FG000|Overall Study|Unable to place arterial line|1|||
161878900|NCT01613222|584598783|FG000|Overall Study|Reused disposable sensors|10|||
161878901|NCT01895608|584598785|FG000|Overall Study|change in health status|0|||
161878902|NCT01895608|584598786|FG001|Overall Study|change in health status|1|||
161878903|NCT01895608|584598787|FG002|Overall Study|change in health status|1|||
161878904|NCT01895608|584598788|FG003|Overall Study|change in health status|0|||
161878905|NCT01895608|584598785|FG000|Overall Study|Withdrawal by Subject|0|||
161878906|NCT01895608|584598786|FG001|Overall Study|Withdrawal by Subject|0|||
161878907|NCT01895608|584598787|FG002|Overall Study|Withdrawal by Subject|2|||
161878908|NCT01895608|584598788|FG003|Overall Study|Withdrawal by Subject|0|||
161878909|NCT02691936|584598791|FG000|Overall Study|Withdrawal by Subject|2|||
161878910|NCT02691936|584598792|FG001|Overall Study|Withdrawal by Subject|5|||
161878911|NCT00749684|584598793|FG000|Overall Study|Death|1|||
161878912|NCT00749684|584598793|FG000|Overall Study|Adverse Event|27|||
161878913|NCT00749684|584598793|FG000|Overall Study|Participant's Wish|10|||
161878914|NCT00749684|584598793|FG000|Overall Study|Not Documented|1|||
161878915|NCT00749684|584598793|FG000|Overall Study|Progressive Desease|31|||
161878916|NCT00749684|584598793|FG000|Overall Study|Therapy according to protocol + AE|2|||
161878917|NCT00749684|584598793|FG000|Overall Study|AE+discontinuation on participants wish|1|||
161878918|NCT00749684|584598793|FG000|Overall Study|Missing|9|||
161878919|NCT03696108|584598794|FG000|Overall Study|Physician Decision|1|||
161878920|NCT03696108|584598795|FG001|Overall Study|Physician Decision|0|||
161878921|NCT03696108|584598794|FG000|Overall Study|Withdrawal by Subject|3|||
161878922|NCT03696108|584598795|FG001|Overall Study|Withdrawal by Subject|6|||
161878923|NCT03505593|584598797|FG000|Overall Study|Withdrawal by Subject|1|||
161878924|NCT03505593|584598797|FG000|Overall Study|Died before procedure|1|||
161878925|NCT03505593|584598797|FG000|Overall Study|Anatomical abnormality|1|||
161878926|NCT03505593|584598797|FG000|Overall Study|Unable to pass through esophagus|1|||
161878927|NCT03505593|584598797|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
161878928|NCT01194531|584598798|FG000|Overall Study|Withdrawal by Subject|1|||
161878929|NCT01194531|584598799|FG001|Overall Study|Withdrawal by Subject|0|||
161878930|NCT01194531|584598798|FG000|Overall Study|Protocol Violation|4|||
161878931|NCT01194531|584598799|FG001|Overall Study|Protocol Violation|1|||
161878932|NCT01194531|584598798|FG000|Overall Study|Physician Decision|0|||
161878933|NCT01194531|584598799|FG001|Overall Study|Physician Decision|2|||
161878934|NCT03891862|584598800|FG000|Open-label Period|Adverse Event|2|||
161878935|NCT03891862|584598801|FG001|Open-label Period|Adverse Event|0|||
161878936|NCT03891862|584598802|FG002|Open-label Period|Adverse Event|0|||
161878937|NCT03891862|584598800|FG000|Open-label Period|Protocol Violation|5|||
161878938|NCT03891862|584598801|FG001|Open-label Period|Protocol Violation|0|||
161878939|NCT03891862|584598802|FG002|Open-label Period|Protocol Violation|0|||
161878940|NCT03891862|584598800|FG000|Open-label Period|Withdrawal by Subject|6|||
161878941|NCT03891862|584598801|FG001|Open-label Period|Withdrawal by Subject|0|||
161878942|NCT03891862|584598802|FG002|Open-label Period|Withdrawal by Subject|0|||
161878943|NCT03891862|584598800|FG000|Open-label Period|Death|1|||
161878944|NCT03891862|584598801|FG001|Open-label Period|Death|0|||
161878945|NCT03891862|584598802|FG002|Open-label Period|Death|0|||
161878946|NCT03891862|584598800|FG000|Open-label Period|Lost to Follow-up|2|||
161878947|NCT03891862|584598801|FG001|Open-label Period|Lost to Follow-up|0|||
161878948|NCT03891862|584598802|FG002|Open-label Period|Lost to Follow-up|0|||
161878949|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
161878950|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
161878951|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
161878952|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
161878953|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
161878954|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
161878955|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
161878956|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
161878957|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
161878958|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
161878959|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
161878960|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
161878961|NCT01053962|584598803|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161878962|NCT01053962|584598804|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161878963|NCT01053962|584598805|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161878964|NCT01053962|584598806|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
161878965|NCT01053962|584598807|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
161878966|NCT01053962|584598803|FG000|Pretreatment Period|Venipuncture Failure|0|||
161878967|NCT01053962|584598804|FG001|Pretreatment Period|Venipuncture Failure|0|||
161878968|NCT01053962|584598805|FG002|Pretreatment Period|Venipuncture Failure|1|||
161878969|NCT01053962|584598806|FG003|Pretreatment Period|Venipuncture Failure|0|||
161878970|NCT01053962|584598807|FG004|Pretreatment Period|Venipuncture Failure|0|||
161878971|NCT01053962|584598803|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878972|NCT01053962|584598804|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
161878973|NCT01053962|584598805|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878974|NCT01053962|584598806|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878975|NCT01053962|584598807|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878976|NCT01053962|584598803|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878977|NCT01053962|584598804|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878978|NCT01053962|584598805|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878979|NCT01053962|584598806|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
161878980|NCT01053962|584598807|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878981|NCT01053962|584598803|FG000|Treatment Period|Lack of Efficacy|0|||
161878982|NCT01053962|584598804|FG001|Treatment Period|Lack of Efficacy|0|||
161878983|NCT01053962|584598805|FG002|Treatment Period|Lack of Efficacy|0|||
161878984|NCT01053962|584598806|FG003|Treatment Period|Lack of Efficacy|0|||
161878985|NCT01053962|584598807|FG004|Treatment Period|Lack of Efficacy|1|||
161878986|NCT01053962|584598803|FG000|Treatment Period|Adverse Event|0|||
161878987|NCT01053962|584598804|FG001|Treatment Period|Adverse Event|0|||
161878988|NCT01053962|584598805|FG002|Treatment Period|Adverse Event|0|||
161878989|NCT01053962|584598806|FG003|Treatment Period|Adverse Event|0|||
161878990|NCT01053962|584598807|FG004|Treatment Period|Adverse Event|1|||
161878991|NCT01053962|584598803|FG000|Treatment Period|Withdrawal by Subject|0|||
161878992|NCT01053962|584598804|FG001|Treatment Period|Withdrawal by Subject|0|||
161878993|NCT01053962|584598805|FG002|Treatment Period|Withdrawal by Subject|0|||
161878994|NCT01053962|584598806|FG003|Treatment Period|Withdrawal by Subject|0|||
161878995|NCT01053962|584598807|FG004|Treatment Period|Withdrawal by Subject|1|||
161878996|NCT01053962|584598803|FG000|Treatment Period|Noncompliance with protocol|1|||
161878997|NCT01053962|584598804|FG001|Treatment Period|Noncompliance with protocol|0|||
161878998|NCT01053962|584598805|FG002|Treatment Period|Noncompliance with protocol|0|||
161878999|NCT01053962|584598806|FG003|Treatment Period|Noncompliance with protocol|0|||
161879000|NCT01053962|584598807|FG004|Treatment Period|Noncompliance with protocol|0|||
161879001|NCT01154088|584598813|FG000|Overall Study|Lost to Follow-up|4|||
161879002|NCT01154088|584598814|FG001|Overall Study|Lost to Follow-up|6|||
161879003|NCT01154088|584598815|FG002|Overall Study|Lost to Follow-up|7|||
161879004|NCT05129137|584598816|FG000|Second Period|Adverse Event|1|||
161879005|NCT05129137|584598817|FG001|Second Period|Adverse Event|0|||
161879006|NCT05129137|584598818|FG002|Second Period|Adverse Event|0|||
161879007|NCT05129137|584598819|FG003|Second Period|Adverse Event|0|||
161879008|NCT05129137|584598816|FG000|Second Period|Protocol Violation|0|||
161879009|NCT05129137|584598817|FG001|Second Period|Protocol Violation|0|||
161879010|NCT05129137|584598818|FG002|Second Period|Protocol Violation|0|||
161879011|NCT05129137|584598819|FG003|Second Period|Protocol Violation|1|||
161879012|NCT05129137|584598816|FG000|Third Period|Protocol Violation|0|||
161879013|NCT05129137|584598817|FG001|Third Period|Protocol Violation|0|||
161879014|NCT05129137|584598818|FG002|Third Period|Protocol Violation|0|||
161879015|NCT05129137|584598819|FG003|Third Period|Protocol Violation|1|||
161879016|NCT05129137|584598816|FG000|Forth Period|Protocol Violation|0|||
161879017|NCT05129137|584598817|FG001|Forth Period|Protocol Violation|1|||
161879018|NCT05129137|584598818|FG002|Forth Period|Protocol Violation|0|||
161879019|NCT05129137|584598819|FG003|Forth Period|Protocol Violation|0|||
161879020|NCT05129137|584598816|FG000|Forth Period|Withdrawal by Subject|0|||
161879021|NCT05129137|584598817|FG001|Forth Period|Withdrawal by Subject|0|||
161879022|NCT05129137|584598818|FG002|Forth Period|Withdrawal by Subject|1|||
161879023|NCT05129137|584598819|FG003|Forth Period|Withdrawal by Subject|0|||
161879024|NCT01992653|584598823|FG000|Overall Study|Death|0|||
161879025|NCT01992653|584598824|FG001|Overall Study|Death|0|||
161879026|NCT01992653|584598825|FG002|Overall Study|Death|1|||
161879027|NCT01992653|584598826|FG003|Overall Study|Death|0|||
161879028|NCT01992653|584598827|FG004|Overall Study|Death|1|||
161879029|NCT01992653|584598828|FG005|Overall Study|Death|0|||
161879030|NCT01992653|584598829|FG006|Overall Study|Death|4|||
161879031|NCT01992653|584598830|FG007|Overall Study|Death|2|||
161879032|NCT01992653|584598823|FG000|Overall Study|Lost to Follow-up|0|||
161879033|NCT01992653|584598824|FG001|Overall Study|Lost to Follow-up|0|||
161879034|NCT01992653|584598825|FG002|Overall Study|Lost to Follow-up|0|||
161879035|NCT01992653|584598826|FG003|Overall Study|Lost to Follow-up|0|||
161879036|NCT01992653|584598827|FG004|Overall Study|Lost to Follow-up|0|||
161879037|NCT01992653|584598828|FG005|Overall Study|Lost to Follow-up|0|||
161879038|NCT01992653|584598829|FG006|Overall Study|Lost to Follow-up|0|||
161879039|NCT01992653|584598830|FG007|Overall Study|Lost to Follow-up|1|||
161879040|NCT01992653|584598823|FG000|Overall Study|Study Completed|0|||
161879041|NCT01992653|584598824|FG001|Overall Study|Study Completed|0|||
161879042|NCT01992653|584598825|FG002|Overall Study|Study Completed|0|||
161777279|NCT04636437|584225553|FG001|Overall Study|Started weight loss drug/program|1|||
161777280|NCT04636437|584225554|FG002|Overall Study|Started weight loss drug/program|1|||
161777281|NCT04636437|584225552|FG000|Overall Study|Lost to Follow-up|3|||
161777282|NCT04636437|584225553|FG001|Overall Study|Lost to Follow-up|1|||
161777283|NCT04636437|584225554|FG002|Overall Study|Lost to Follow-up|4|||
161777284|NCT04636437|584225552|FG000|Overall Study|Participant or physician decision|3|||
161777285|NCT04636437|584225553|FG001|Overall Study|Participant or physician decision|1|||
161777286|NCT04636437|584225554|FG002|Overall Study|Participant or physician decision|1|||
161777287|NCT00816166|584225555|FG000|Overall Study|Lost to Follow-up|6|||
161777288|NCT00816166|584225556|FG001|Overall Study|Lost to Follow-up|10|||
161777289|NCT00816166|584225555|FG000|Overall Study|Death|4|||
161777290|NCT00816166|584225556|FG001|Overall Study|Death|2|||
161777291|NCT01071278|584225557|FG000|Overall Study|Premature Discontinuation|254|||
161777292|NCT01071278|584225557|FG000|Overall Study|Completion Status Unknown|459|||
161777293|NCT00352664|584225558|FG000|Overall Study|Withdrawal by Subject|7|||
161777294|NCT00352664|584225559|FG001|Overall Study|Withdrawal by Subject|0|||
161777295|NCT01821391|584225565|FG000|Overall Study|Adverse Event|1|||
161777296|NCT01821391|584225566|FG001|Overall Study|Adverse Event|0|||
161777297|NCT01875731|584225568|FG000|Overall Study|Fail to obtain lab sample|1|||
161777298|NCT01875731|584225569|FG001|Overall Study|Fail to obtain lab sample|0|||
161777299|NCT03417102|584225570|FG000|Overall Study|Adverse Event|0|||
161777300|NCT03417102|584225571|FG001|Overall Study|Adverse Event|1|||
161777301|NCT03417102|584225570|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
161777302|NCT03417102|584225571|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
161777303|NCT03417102|584225570|FG000|Overall Study|Other|0|||
161777304|NCT03417102|584225571|FG001|Overall Study|Other|1|||
161777305|NCT02062385|584225575|FG000|Overall Study|Adverse Event|19|||
161777306|NCT02062385|584225576|FG001|Overall Study|Adverse Event|13|||
161777307|NCT02062385|584225577|FG002|Overall Study|Adverse Event|1|||
161777308|NCT02062385|584225578|FG003|Overall Study|Adverse Event|0|||
161777309|NCT02062385|584225575|FG000|Overall Study|Protocol Violation|1|||
161777310|NCT02062385|584225576|FG001|Overall Study|Protocol Violation|0|||
161777311|NCT02062385|584225577|FG002|Overall Study|Protocol Violation|0|||
161777312|NCT02062385|584225578|FG003|Overall Study|Protocol Violation|0|||
161777313|NCT02062385|584225575|FG000|Overall Study|Incomplete EPI by database lock|2|||
161777314|NCT02062385|584225576|FG001|Overall Study|Incomplete EPI by database lock|0|||
161777315|NCT02062385|584225577|FG002|Overall Study|Incomplete EPI by database lock|0|||
161777316|NCT02062385|584225578|FG003|Overall Study|Incomplete EPI by database lock|0|||
161777317|NCT02062385|584225575|FG000|Overall Study|Moved|10|||
161777318|NCT02062385|584225576|FG001|Overall Study|Moved|11|||
161777319|NCT02062385|584225577|FG002|Overall Study|Moved|1|||
161777320|NCT02062385|584225578|FG003|Overall Study|Moved|0|||
161879043|NCT01992653|584598826|FG003|Overall Study|Study Completed|0|||
161879044|NCT01992653|584598827|FG004|Overall Study|Study Completed|0|||
161879045|NCT01992653|584598828|FG005|Overall Study|Study Completed|0|||
161879046|NCT01992653|584598829|FG006|Overall Study|Study Completed|0|||
161879047|NCT01992653|584598830|FG007|Overall Study|Study Completed|1|||
161879048|NCT01992653|584598823|FG000|Overall Study|Disease Progression|0|||
161879049|NCT01992653|584598824|FG001|Overall Study|Disease Progression|0|||
161879050|NCT01992653|584598825|FG002|Overall Study|Disease Progression|0|||
161879051|NCT01992653|584598826|FG003|Overall Study|Disease Progression|0|||
161879052|NCT01992653|584598827|FG004|Overall Study|Disease Progression|0|||
161879053|NCT01992653|584598828|FG005|Overall Study|Disease Progression|0|||
161879054|NCT01992653|584598829|FG006|Overall Study|Disease Progression|4|||
161879055|NCT01992653|584598830|FG007|Overall Study|Disease Progression|0|||
161879056|NCT01435460|584598831|FG000|Overall Study|Adverse Event|2|||
161879057|NCT01435460|584598832|FG001|Overall Study|Adverse Event|1|||
161879058|NCT01435460|584598831|FG000|Overall Study|Lost to Follow-up|6|||
161879059|NCT01435460|584598832|FG001|Overall Study|Lost to Follow-up|1|||
161879060|NCT01435460|584598831|FG000|Overall Study|Withdrawal by Subject|1|||
161879061|NCT01435460|584598832|FG001|Overall Study|Withdrawal by Subject|3|||
161879062|NCT01435460|584598831|FG000|Overall Study|Protocol Violation|0|||
161879063|NCT01435460|584598832|FG001|Overall Study|Protocol Violation|1|||
161879064|NCT01435460|584598831|FG000|Overall Study|Did not meet eligibility criteria|2|||
161879065|NCT01435460|584598832|FG001|Overall Study|Did not meet eligibility criteria|0|||
161879066|NCT01706939|584598833|FG000|Pre Randomization|Screen Failure|1|||
161879067|NCT01706939|584598834|FG001|Pre Randomization|Screen Failure|0|||
161879068|NCT01706939|584598835|FG002|Pre Randomization|Screen Failure|0|||
161879069|NCT01706939|584598833|FG000|Pre Randomization|Ineligible for Randomization|1|||
161879070|NCT01706939|584598834|FG001|Pre Randomization|Ineligible for Randomization|0|||
161879071|NCT01706939|584598835|FG002|Pre Randomization|Ineligible for Randomization|0|||
161879072|NCT01706939|584598833|FG000|Pre Randomization|Withdrawal by Subject|1|||
161879073|NCT01706939|584598834|FG001|Pre Randomization|Withdrawal by Subject|0|||
161879074|NCT01706939|584598835|FG002|Pre Randomization|Withdrawal by Subject|0|||
161879075|NCT01706939|584598833|FG000|Randomization|Insufficient QoL survey compliance|0|||
161879076|NCT01706939|584598834|FG001|Randomization|Insufficient QoL survey compliance|1|||
161879077|NCT01706939|584598835|FG002|Randomization|Insufficient QoL survey compliance|1|||
161879078|NCT01706939|584598833|FG000|Randomization|Progression of disease|0|||
161879079|NCT01706939|584598834|FG001|Randomization|Progression of disease|2|||
161879080|NCT01706939|584598835|FG002|Randomization|Progression of disease|1|||
161879081|NCT01046903|584598836|FG000|Overall Study|Lost to Follow-up|16|||
161879082|NCT01046903|584598836|FG000|Overall Study|Adverse Event|4|||
161879083|NCT01046903|584598836|FG000|Overall Study|Withdrawal by Subject|3|||
161879084|NCT01046903|584598836|FG000|Overall Study|Other|5|||
161879085|NCT00977314|584598837|FG000|Overall Study|Withdrawal by Subject|1|||
161879086|NCT00977314|584598838|FG001|Overall Study|Withdrawal by Subject|0|||
161879087|NCT00977314|584598837|FG000|Overall Study|Physician Decision|1|||
161879088|NCT00977314|584598838|FG001|Overall Study|Physician Decision|0|||
161879089|NCT01343277|584598839|FG000|Overall Study|Other|3|||
161879090|NCT01343277|584598840|FG001|Overall Study|Other|3|||
161879091|NCT01343277|584598839|FG000|Overall Study|Withdrawal by Subject|18|||
161879092|NCT01343277|584598840|FG001|Overall Study|Withdrawal by Subject|13|||
161879093|NCT01343277|584598839|FG000|Overall Study|Physician Decision|1|||
161879094|NCT01343277|584598840|FG001|Overall Study|Physician Decision|2|||
161879095|NCT01343277|584598839|FG000|Overall Study|Death|10|||
161879096|NCT01343277|584598840|FG001|Overall Study|Death|1|||
161879097|NCT01343277|584598839|FG000|Overall Study|Adverse Event|67|||
161879098|NCT01343277|584598840|FG001|Overall Study|Adverse Event|13|||
161879099|NCT01343277|584598839|FG000|Overall Study|Disease progression|270|||
161879100|NCT01343277|584598840|FG001|Overall Study|Disease progression|138|||
161879101|NCT01343277|584598839|FG000|Overall Study|Randomized not treated|6|||
161879102|NCT01343277|584598840|FG001|Overall Study|Randomized not treated|21|||
161879103|NCT01343277|584598839|FG000|Overall Study|Treatment ongoing|8|||
161879104|NCT01343277|584598840|FG001|Overall Study|Treatment ongoing|2|||
161879105|NCT01343277|584598839|FG000|Overall Study|Subsequent anticancer therapy|1|||
161879106|NCT01343277|584598840|FG001|Overall Study|Subsequent anticancer therapy|0|||
161879107|NCT01894100|584598843|FG000|Overall Study|Lost to Follow-up|0|||
161879108|NCT01894100|584598844|FG001|Overall Study|Lost to Follow-up|1|||
161879109|NCT01894100|584598843|FG000|Overall Study|Withdrawal by Subject|3|||
161879110|NCT01894100|584598844|FG001|Overall Study|Withdrawal by Subject|0|||
161879111|NCT01094301|584598847|FG000|Trial Stage|Withdrawal by Subject|1|||
161879112|NCT01094301|584598847|FG000|Implant Stage|Adverse Event|1|||
161879113|NCT01094301|584598847|FG000|Implant Stage|Protocol Violation|1|||
161879114|NCT01094301|584598847|FG000|Implant Stage|Withdrawal by Subject|2|||
161879115|NCT01094301|584598847|FG000|Implant Stage|No return of pain|4|||
161879116|NCT00135512|584598848|FG000|Overall Study|Adverse Event|56|||
161879117|NCT00135512|584598848|FG000|Overall Study|Lack of Efficacy|25|||
161879118|NCT00135512|584598848|FG000|Overall Study|Other|42|||
161879119|NCT04439214|584598852|FG000|Overall Study|Adverse Event|13|||
161879120|NCT04439214|584598852|FG000|Overall Study|Disease progression|16|||
161879121|NCT04439214|584598852|FG000|Overall Study|Death|1|||
161879122|NCT04439214|584598852|FG000|Overall Study|Withdrawal by Subject|2|||
161879123|NCT04439214|584598852|FG000|Overall Study|Declining health|1|||
161879124|NCT04439214|584598852|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
161879125|NCT04439214|584598852|FG000|Overall Study|Ineligible|5|||
161879126|NCT02964208|584598853|FG000|Overall Study|Death|103|||
161879127|NCT02964208|584598853|FG000|Overall Study|Withdrawal by Subject|6|||
161879128|NCT02964208|584598853|FG000|Overall Study|Lost to Follow-up|6|||
161879129|NCT02964208|584598853|FG000|Overall Study|Unsuccessful Procedure|5|||
161879130|NCT02964208|584598853|FG000|Overall Study|Device Explant|1|||
161879131|NCT02964208|584598853|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
161879132|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
161879133|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
161879134|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
161879135|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
161879136|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161879137|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161879138|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
161879139|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161879140|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
161879141|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161879142|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161879143|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161879144|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
161879145|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
161879146|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
161879147|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
161879148|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161879149|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
161879150|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161879151|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161879152|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161879153|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
161879154|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161879155|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161879156|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
161879157|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
161879158|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
161879159|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
161879160|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
161879161|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
161879162|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
161879163|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
161879164|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
161879165|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
161879166|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
161879167|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
161879168|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
161879169|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
161879170|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
161879171|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
161879172|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Death|0|||
161879173|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Death|0|||
161879174|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Death|0|||
161879175|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Death|1|||
161879176|NCT01493284|584598872|FG000|Overall Study|Death|29|||
161879177|NCT01493284|584598872|FG000|Overall Study|Withdrawal by Subject|32|||
161879178|NCT01871402|584600380|FG000|Overall Study|Lost to Follow-up|1|||
161879179|NCT01871402|584600381|FG001|Overall Study|Lost to Follow-up|0|||
161879180|NCT01871402|584600380|FG000|Overall Study|Withdrawal by Subject|0|||
161879181|NCT01871402|584600381|FG001|Overall Study|Withdrawal by Subject|2|||
161879182|NCT01871402|584600380|FG000|Overall Study|Non-compliance|0|||
161879183|NCT01871402|584600381|FG001|Overall Study|Non-compliance|1|||
161879184|NCT04594941|584600382|FG000|Overall Study|Other|0|||
161879185|NCT04594941|584600383|FG001|Overall Study|Other|3|||
161879186|NCT04594941|584600384|FG002|Overall Study|Other|1|||
161879187|NCT04594941|584600385|FG003|Overall Study|Other|0|||
161879188|NCT03408444|584600386|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
161879189|NCT03408444|584600387|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161879190|NCT03408444|584600388|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161879191|NCT03408444|584600389|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161879192|NCT03408444|584600386|FG000|Overall Study|Lens Discomfort|0|||
161879193|NCT03408444|584600387|FG001|Overall Study|Lens Discomfort|1|||
161879194|NCT03408444|584600388|FG002|Overall Study|Lens Discomfort|0|||
161879195|NCT03408444|584600389|FG003|Overall Study|Lens Discomfort|0|||
161879196|NCT03408444|584600386|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161879197|NCT03408444|584600387|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161879198|NCT03408444|584600388|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161879199|NCT03408444|584600389|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161879200|NCT03408444|584600386|FG000|Overall Study|Withdrawal by Subject|0|||
161879201|NCT03408444|584600387|FG001|Overall Study|Withdrawal by Subject|2|||
161879202|NCT03408444|584600388|FG002|Overall Study|Withdrawal by Subject|3|||
161879203|NCT03408444|584600389|FG003|Overall Study|Withdrawal by Subject|0|||
161879204|NCT03408444|584600386|FG000|Overall Study|Lost to Follow-up|0|||
161879205|NCT03408444|584600387|FG001|Overall Study|Lost to Follow-up|0|||
161879206|NCT03408444|584600388|FG002|Overall Study|Lost to Follow-up|1|||
161879207|NCT03408444|584600389|FG003|Overall Study|Lost to Follow-up|0|||
161879208|NCT03408444|584600386|FG000|Overall Study|Adverse Event|0|||
161879209|NCT03408444|584600387|FG001|Overall Study|Adverse Event|0|||
161879210|NCT03408444|584600388|FG002|Overall Study|Adverse Event|0|||
161879211|NCT03408444|584600389|FG003|Overall Study|Adverse Event|1|||
161879212|NCT03408444|584600386|FG000|Overall Study|Lens Handling Difficulties|0|||
161879213|NCT03408444|584600387|FG001|Overall Study|Lens Handling Difficulties|0|||
161879214|NCT03408444|584600388|FG002|Overall Study|Lens Handling Difficulties|1|||
161879215|NCT03408444|584600389|FG003|Overall Study|Lens Handling Difficulties|0|||
161879216|NCT03408444|584600386|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161879217|NCT03408444|584600387|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161879218|NCT03408444|584600388|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161879219|NCT03408444|584600389|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
161879220|NCT00231114|584600390|FG000|Randomized|Withdrawal by Subject|6|||
161879221|NCT00231114|584600391|FG001|Randomized|Withdrawal by Subject|3|||
161879222|NCT00231114|584600390|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
161879223|NCT00231114|584600391|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
161879224|NCT00231114|584600390|FG000|Post-Treatment Period|Lost to Follow-up|6|||
161879225|NCT00231114|584600391|FG001|Post-Treatment Period|Lost to Follow-up|1|||
161879226|NCT00231114|584600390|FG000|Post-Treatment Period|Physician Decision|1|||
161879227|NCT00231114|584600391|FG001|Post-Treatment Period|Physician Decision|0|||
161879228|NCT00231114|584600390|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
161879229|NCT00231114|584600391|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
161879230|NCT04720911|584600393|FG000|Overall Study|Withdrawal by Subject|0|||
161879231|NCT04720911|584600394|FG001|Overall Study|Withdrawal by Subject|1|||
161879232|NCT04720911|584600395|FG002|Overall Study|Withdrawal by Subject|0|||
161879233|NCT00537316|584600396|FG000|Part 1|Adverse Event|7|||
161879234|NCT00537316|584600397|FG001|Part 1|Adverse Event|11|||
161879235|NCT00537316|584600398|FG002|Part 1|Adverse Event|8|||
161879236|NCT00537316|584600399|FG003|Part 1|Adverse Event|0|||
161879237|NCT00537316|584600400|FG004|Part 1|Adverse Event|0|||
161879238|NCT00537316|584600401|FG005|Part 1|Adverse Event|0|||
161879239|NCT00537316|584600402|FG006|Part 1|Adverse Event|0|||
161879240|NCT00537316|584600396|FG000|Part 1|Protocol defined clinical event|1|||
161879241|NCT00537316|584600397|FG001|Part 1|Protocol defined clinical event|0|||
161879242|NCT00537316|584600398|FG002|Part 1|Protocol defined clinical event|0|||
161879243|NCT00537316|584600399|FG003|Part 1|Protocol defined clinical event|0|||
161879244|NCT00537316|584600400|FG004|Part 1|Protocol defined clinical event|0|||
161879245|NCT00537316|584600401|FG005|Part 1|Protocol defined clinical event|0|||
161879246|NCT00537316|584600402|FG006|Part 1|Protocol defined clinical event|0|||
161879247|NCT00537316|584600396|FG000|Part 1|Lost to Follow-up|1|||
161879248|NCT00537316|584600397|FG001|Part 1|Lost to Follow-up|0|||
161879249|NCT00537316|584600398|FG002|Part 1|Lost to Follow-up|0|||
161879250|NCT00537316|584600399|FG003|Part 1|Lost to Follow-up|0|||
161879251|NCT00537316|584600400|FG004|Part 1|Lost to Follow-up|0|||
161879252|NCT00537316|584600401|FG005|Part 1|Lost to Follow-up|0|||
161879253|NCT00537316|584600402|FG006|Part 1|Lost to Follow-up|0|||
161879254|NCT00537316|584600396|FG000|Part 1|Withdrawal by Subject|3|||
161879255|NCT00537316|584600397|FG001|Part 1|Withdrawal by Subject|8|||
161879256|NCT00537316|584600398|FG002|Part 1|Withdrawal by Subject|4|||
161879257|NCT00537316|584600399|FG003|Part 1|Withdrawal by Subject|0|||
161879258|NCT00537316|584600400|FG004|Part 1|Withdrawal by Subject|0|||
161879259|NCT00537316|584600401|FG005|Part 1|Withdrawal by Subject|0|||
161879260|NCT00537316|584600402|FG006|Part 1|Withdrawal by Subject|0|||
161879261|NCT00537316|584600396|FG000|Part 1|Protocol Violation|1|||
161879262|NCT00537316|584600397|FG001|Part 1|Protocol Violation|5|||
161879263|NCT00537316|584600398|FG002|Part 1|Protocol Violation|1|||
161777321|NCT02062385|584225575|FG000|Overall Study|Withdrawn by parent/guardian|46|||
161777322|NCT02062385|584225576|FG001|Overall Study|Withdrawn by parent/guardian|41|||
161777323|NCT02062385|584225577|FG002|Overall Study|Withdrawn by parent/guardian|9|||
161777324|NCT02062385|584225578|FG003|Overall Study|Withdrawn by parent/guardian|8|||
161777325|NCT02062385|584225575|FG000|Overall Study|Death|0|||
161879264|NCT00537316|584600399|FG003|Part 1|Protocol Violation|0|||
161879265|NCT00537316|584600400|FG004|Part 1|Protocol Violation|0|||
161879266|NCT00537316|584600401|FG005|Part 1|Protocol Violation|0|||
161879267|NCT00537316|584600402|FG006|Part 1|Protocol Violation|0|||
161879268|NCT00537316|584600396|FG000|Part 1|Did not meet protocol eligibility|1|||
161879269|NCT00537316|584600397|FG001|Part 1|Did not meet protocol eligibility|3|||
161777326|NCT02062385|584225576|FG001|Overall Study|Death|0|||
161777327|NCT02062385|584225577|FG002|Overall Study|Death|0|||
161777328|NCT02062385|584225578|FG003|Overall Study|Death|1|||
161777329|NCT02062385|584225575|FG000|Overall Study|Lost to Follow-up|0|||
161777330|NCT02062385|584225576|FG001|Overall Study|Lost to Follow-up|0|||
161777331|NCT02062385|584225577|FG002|Overall Study|Lost to Follow-up|1|||
161879270|NCT00537316|584600398|FG002|Part 1|Did not meet protocol eligibility|2|||
161879271|NCT00537316|584600399|FG003|Part 1|Did not meet protocol eligibility|0|||
161879272|NCT00537316|584600400|FG004|Part 1|Did not meet protocol eligibility|0|||
161879273|NCT00537316|584600401|FG005|Part 1|Did not meet protocol eligibility|0|||
161879274|NCT00537316|584600402|FG006|Part 1|Did not meet protocol eligibility|0|||
161879275|NCT00537316|584600396|FG000|Part 1|Administrative|0|||
161879276|NCT00537316|584600397|FG001|Part 1|Administrative|0|||
161879277|NCT00537316|584600398|FG002|Part 1|Administrative|2|||
161879278|NCT00537316|584600399|FG003|Part 1|Administrative|0|||
161879279|NCT00537316|584600400|FG004|Part 1|Administrative|0|||
161879280|NCT00537316|584600401|FG005|Part 1|Administrative|0|||
161879281|NCT00537316|584600402|FG006|Part 1|Administrative|0|||
161879282|NCT00537316|584600396|FG000|Part 2|Never entered follow-up|0|||
161879283|NCT00537316|584600397|FG001|Part 2|Never entered follow-up|0|||
161879284|NCT00537316|584600398|FG002|Part 2|Never entered follow-up|0|||
161879285|NCT00537316|584600399|FG003|Part 2|Never entered follow-up|0|||
161879286|NCT00537316|584600400|FG004|Part 2|Never entered follow-up|0|||
161879287|NCT00537316|584600401|FG005|Part 2|Never entered follow-up|0|||
161879288|NCT00537316|584600402|FG006|Part 2|Never entered follow-up|1|||
161879289|NCT00537316|584600396|FG000|Part 2|Adverse Event|4|||
161879290|NCT00537316|584600397|FG001|Part 2|Adverse Event|0|||
161879291|NCT00537316|584600398|FG002|Part 2|Adverse Event|2|||
161879292|NCT00537316|584600399|FG003|Part 2|Adverse Event|0|||
161879293|NCT00537316|584600400|FG004|Part 2|Adverse Event|0|||
161879294|NCT00537316|584600401|FG005|Part 2|Adverse Event|0|||
161879295|NCT00537316|584600402|FG006|Part 2|Adverse Event|0|||
161879296|NCT00537316|584600396|FG000|Part 2|Lost to Follow-up|1|||
161879297|NCT00537316|584600397|FG001|Part 2|Lost to Follow-up|0|||
161879298|NCT00537316|584600398|FG002|Part 2|Lost to Follow-up|2|||
161879299|NCT00537316|584600399|FG003|Part 2|Lost to Follow-up|0|||
161879300|NCT00537316|584600400|FG004|Part 2|Lost to Follow-up|0|||
161879301|NCT00537316|584600401|FG005|Part 2|Lost to Follow-up|0|||
161879302|NCT00537316|584600402|FG006|Part 2|Lost to Follow-up|0|||
161879303|NCT00537316|584600396|FG000|Part 2|Withdrawal by Subject|5|||
161879304|NCT00537316|584600397|FG001|Part 2|Withdrawal by Subject|1|||
161879305|NCT00537316|584600398|FG002|Part 2|Withdrawal by Subject|4|||
161879306|NCT00537316|584600399|FG003|Part 2|Withdrawal by Subject|0|||
161879307|NCT00537316|584600400|FG004|Part 2|Withdrawal by Subject|0|||
161879308|NCT00537316|584600401|FG005|Part 2|Withdrawal by Subject|0|||
161879309|NCT00537316|584600402|FG006|Part 2|Withdrawal by Subject|0|||
161879310|NCT00537316|584600396|FG000|Part 2|Administrative|16|||
161879311|NCT00537316|584600397|FG001|Part 2|Administrative|8|||
161879312|NCT00537316|584600398|FG002|Part 2|Administrative|24|||
161879313|NCT00537316|584600399|FG003|Part 2|Administrative|3|||
161879314|NCT00537316|584600400|FG004|Part 2|Administrative|1|||
161879315|NCT00537316|584600401|FG005|Part 2|Administrative|4|||
161879316|NCT00537316|584600402|FG006|Part 2|Administrative|1|||
161879317|NCT04533412|584600404|FG000|Overall Study|Withdrawal by Subject|1|||
161777332|NCT02062385|584225578|FG003|Overall Study|Lost to Follow-up|0|||
161879318|NCT04533412|584600405|FG001|Overall Study|Withdrawal by Subject|1|||
161879319|NCT04533412|584600404|FG000|Overall Study|Lost to Follow-up|1|||
161879320|NCT04533412|584600405|FG001|Overall Study|Lost to Follow-up|4|||
161879321|NCT03261674|584600406|FG000|Overall Study|Lost to Follow-up|6|||
161879322|NCT03261674|584600407|FG001|Overall Study|Lost to Follow-up|7|||
161879323|NCT03261674|584600406|FG000|Overall Study|Protocol Violation|1|||
161879324|NCT03261674|584600407|FG001|Overall Study|Protocol Violation|4|||
161879325|NCT03261674|584600406|FG000|Overall Study|Withdrawal by Subject|1|||
161879326|NCT03261674|584600407|FG001|Overall Study|Withdrawal by Subject|4|||
161879327|NCT03261674|584600406|FG000|Overall Study|Physician Decision|1|||
161879328|NCT03261674|584600407|FG001|Overall Study|Physician Decision|0|||
161879329|NCT00782184|584600408|FG000|Overall Study|Adverse Event|1|||
161879330|NCT00782184|584600409|FG001|Overall Study|Adverse Event|2|||
161879331|NCT00782184|584600408|FG000|Overall Study|Protocol Violation|0|||
161879332|NCT00782184|584600409|FG001|Overall Study|Protocol Violation|1|||
161879333|NCT00782184|584600408|FG000|Overall Study|Withdrawal by Subject|3|||
161879334|NCT00782184|584600409|FG001|Overall Study|Withdrawal by Subject|2|||
161879335|NCT01438294|584600410|FG000|Overall Study|Lost to Follow-up|3|||
161879336|NCT01438294|584600411|FG001|Overall Study|Lost to Follow-up|7|||
161879337|NCT01730534|584600416|FG000|Overall Study|Withdrawal by Subject|97|||
161879338|NCT01730534|584600417|FG001|Overall Study|Withdrawal by Subject|127|||
161879339|NCT01730534|584600416|FG000|Overall Study|Lost to Follow-up|12|||
161879340|NCT01730534|584600417|FG001|Overall Study|Lost to Follow-up|18|||
161879341|NCT01676896|584600418|FG000|Overall Study|Withdrawal by Subject|12|||
161879342|NCT01676896|584600419|FG001|Overall Study|Withdrawal by Subject|7|||
161879343|NCT01676896|584600420|FG002|Overall Study|Withdrawal by Subject|19|||
161879344|NCT03614078|584600421|FG000|Overall Study|Withdrawal by Subject|2|||
161879345|NCT03614078|584600422|FG001|Overall Study|Withdrawal by Subject|2|||
161879346|NCT03614078|584600423|FG002|Overall Study|Withdrawal by Subject|3|||
161879347|NCT03614078|584600421|FG000|Overall Study|Participant Did Not Return for Visit|0|||
161879348|NCT03614078|584600422|FG001|Overall Study|Participant Did Not Return for Visit|1|||
161879349|NCT03614078|584600423|FG002|Overall Study|Participant Did Not Return for Visit|0|||
161879350|NCT03614078|584600421|FG000|Overall Study|High Neutrophils|0|||
161879351|NCT03614078|584600422|FG001|Overall Study|High Neutrophils|0|||
161879352|NCT03614078|584600423|FG002|Overall Study|High Neutrophils|2|||
161879353|NCT03614078|584600421|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
161879354|NCT03614078|584600422|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
161879355|NCT03614078|584600423|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
161879356|NCT03614078|584600421|FG000|Overall Study|Exacerbation of Psoriasis|0|||
161879357|NCT03614078|584600422|FG001|Overall Study|Exacerbation of Psoriasis|1|||
161879358|NCT03614078|584600423|FG002|Overall Study|Exacerbation of Psoriasis|0|||
161879359|NCT03614078|584600421|FG000|Overall Study|Adverse Event|0|||
161879360|NCT03614078|584600422|FG001|Overall Study|Adverse Event|2|||
161879361|NCT03614078|584600423|FG002|Overall Study|Adverse Event|0|||
161879362|NCT03614078|584600421|FG000|Overall Study|Dizziness and Rash|0|||
161879363|NCT03614078|584600422|FG001|Overall Study|Dizziness and Rash|1|||
161879364|NCT03614078|584600423|FG002|Overall Study|Dizziness and Rash|0|||
161879365|NCT02833844|584600424|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161879366|NCT02833844|584600425|FG001|Double-Blind Period|Withdrawal by Subject|3|||
161777333|NCT03188991|584225579|FG000|Overall Study|Withdrawal by Subject|0|||
161777334|NCT03188991|584225580|FG001|Overall Study|Withdrawal by Subject|0|||
161777335|NCT03188991|584225581|FG002|Overall Study|Withdrawal by Subject|0|||
161777336|NCT03188991|584225582|FG003|Overall Study|Withdrawal by Subject|1|||
161777337|NCT03255226|584226985|FG000|Overall Study|Adverse Event|2|||
161777338|NCT03255226|584226985|FG000|Overall Study|Physician Decision|3|||
161777339|NCT03255226|584226985|FG000|Overall Study|Withdrawal by Subject|1|||
161777340|NCT03255226|584226985|FG000|Overall Study|Serum or blood sodium increased|4|||
161777341|NCT03255226|584226985|FG000|Overall Study|Serum or blood potassium increased|4|||
161777342|NCT01017731|584226986|FG000|Overall Study|Lost to Follow-up|2|||
161777343|NCT01017731|584226986|FG000|Overall Study|Withdrawal by Subject|3|||
161777344|NCT01017731|584226986|FG000|Overall Study|Physician Decision|2|||
161777345|NCT01017731|584226986|FG000|Overall Study|Adverse Event|1|||
161777346|NCT01035229|584226987|FG000|Overall Study|Adverse Event|61|||
161777347|NCT01035229|584226988|FG001|Overall Study|Adverse Event|14|||
161777348|NCT01035229|584226987|FG000|Overall Study|Withdrawal by Subject|20|||
161777349|NCT01035229|584226988|FG001|Overall Study|Withdrawal by Subject|7|||
161777350|NCT01035229|584226987|FG000|Overall Study|Lost to Follow-up|1|||
161777351|NCT01035229|584226988|FG001|Overall Study|Lost to Follow-up|0|||
161777352|NCT01035229|584226987|FG000|Overall Study|Administrative problems|1|||
161777353|NCT01035229|584226988|FG001|Overall Study|Administrative problems|1|||
161777354|NCT01035229|584226987|FG000|Overall Study|Death|13|||
161777355|NCT01035229|584226988|FG001|Overall Study|Death|5|||
161777356|NCT01035229|584226987|FG000|Overall Study|New cancer therapy|2|||
161777357|NCT01035229|584226988|FG001|Overall Study|New cancer therapy|0|||
161777358|NCT01035229|584226987|FG000|Overall Study|Protocol Violation|0|||
161879367|NCT02833844|584600424|FG000|Double-Blind Period|Protocol Violation|0|||
161879368|NCT02833844|584600425|FG001|Double-Blind Period|Protocol Violation|4|||
161879369|NCT02833844|584600424|FG000|Open-Label Period|Death|0|||
161879370|NCT02833844|584600425|FG001|Open-Label Period|Death|2|||
161879371|NCT02833844|584600424|FG000|Open-Label Period|Lost to Follow-up|1|||
161879372|NCT02833844|584600425|FG001|Open-Label Period|Lost to Follow-up|0|||
161879373|NCT02833844|584600424|FG000|Open-Label Period|Withdrawal by Subject|1|||
161879374|NCT02833844|584600425|FG001|Open-Label Period|Withdrawal by Subject|0|||
161879375|NCT04323306|584600426|FG000|Overall Study|Physician Decision|1|||
161879376|NCT04323306|584600427|FG001|Overall Study|Physician Decision|0|||
161879377|NCT04323306|584600428|FG002|Overall Study|Physician Decision|0|||
161879378|NCT04323306|584600429|FG003|Overall Study|Physician Decision|0|||
161879379|NCT04323306|584600430|FG004|Overall Study|Physician Decision|0|||
161879380|NCT04323306|584600431|FG005|Overall Study|Physician Decision|0|||
161879381|NCT04323306|584600432|FG006|Overall Study|Physician Decision|0|||
161879382|NCT04323306|584600433|FG007|Overall Study|Physician Decision|0|||
161879383|NCT04323306|584600434|FG008|Overall Study|Physician Decision|0|||
161879384|NCT04323306|584600426|FG000|Overall Study|Withdrawal by Subject|0|||
161879385|NCT04323306|584600427|FG001|Overall Study|Withdrawal by Subject|0|||
161879386|NCT04323306|584600428|FG002|Overall Study|Withdrawal by Subject|0|||
161879387|NCT04323306|584600429|FG003|Overall Study|Withdrawal by Subject|0|||
161879388|NCT04323306|584600430|FG004|Overall Study|Withdrawal by Subject|0|||
161879389|NCT04323306|584600431|FG005|Overall Study|Withdrawal by Subject|1|||
161879390|NCT04323306|584600432|FG006|Overall Study|Withdrawal by Subject|3|||
161879391|NCT04323306|584600433|FG007|Overall Study|Withdrawal by Subject|0|||
161879392|NCT04323306|584600434|FG008|Overall Study|Withdrawal by Subject|1|||
161879393|NCT00089778|584600435|FG000|Overall Study|Protocol Violation|0|||
161879394|NCT00089778|584600436|FG001|Overall Study|Protocol Violation|0|||
161879395|NCT00089778|584600437|FG002|Overall Study|Protocol Violation|1|||
161879396|NCT04712019|584600438|FG000|Overall Study|Withdrawal by Subject|2|||
161879397|NCT04712019|584600439|FG001|Overall Study|Withdrawal by Subject|2|||
161879398|NCT04712019|584600438|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
161879399|NCT04712019|584600439|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
161879400|NCT01646021|584600440|FG000|Overall Study|Death|77|||
161879401|NCT01646021|584600441|FG001|Overall Study|Death|83|||
161879402|NCT01646021|584600440|FG000|Overall Study|Study Terminated by Sponsor|50|||
161879403|NCT01646021|584600441|FG001|Overall Study|Study Terminated by Sponsor|41|||
161879404|NCT01646021|584600440|FG000|Overall Study|Lost to Follow-up|2|||
161879405|NCT01646021|584600441|FG001|Overall Study|Lost to Follow-up|2|||
161879406|NCT01646021|584600440|FG000|Overall Study|Withdrawal by Subject|10|||
161879407|NCT01646021|584600441|FG001|Overall Study|Withdrawal by Subject|15|||
161879408|NCT02347891|584600449|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
161879409|NCT02347891|584600450|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
161879410|NCT02347891|584600449|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
161879411|NCT02347891|584600450|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
161879412|NCT00725608|584600454|FG000|Overall Study|Lost to Follow-up|60|||
161879413|NCT00725608|584600454|FG000|Overall Study|Adverse Event|14|||
161879414|NCT00725608|584600454|FG000|Overall Study|Individual reasons|86|||
161879415|NCT00725608|584600454|FG000|Overall Study|Other|7|||
161879416|NCT00614120|584600458|FG000|Overall Study|Adverse Event|9|||
161879417|NCT00614120|584600459|FG001|Overall Study|Adverse Event|22|||
161879418|NCT00614120|584600460|FG002|Overall Study|Adverse Event|30|||
161879419|NCT00614120|584600461|FG003|Overall Study|Adverse Event|3|||
161879420|NCT00614120|584600458|FG000|Overall Study|Lack of Efficacy|3|||
161879421|NCT00614120|584600459|FG001|Overall Study|Lack of Efficacy|3|||
161879422|NCT00614120|584600460|FG002|Overall Study|Lack of Efficacy|2|||
161879423|NCT00614120|584600461|FG003|Overall Study|Lack of Efficacy|2|||
161879424|NCT00614120|584600458|FG000|Overall Study|Protocol Violation|2|||
161879425|NCT00614120|584600459|FG001|Overall Study|Protocol Violation|5|||
161879426|NCT00614120|584600460|FG002|Overall Study|Protocol Violation|3|||
161879427|NCT00614120|584600461|FG003|Overall Study|Protocol Violation|1|||
161879428|NCT00614120|584600458|FG000|Overall Study|Withdrawal criteria|1|||
161879429|NCT00614120|584600459|FG001|Overall Study|Withdrawal criteria|0|||
161879430|NCT00614120|584600460|FG002|Overall Study|Withdrawal criteria|0|||
161879431|NCT00614120|584600461|FG003|Overall Study|Withdrawal criteria|0|||
161879432|NCT00614120|584600458|FG000|Overall Study|Withdrawal by Subject|9|||
161879433|NCT00614120|584600459|FG001|Overall Study|Withdrawal by Subject|10|||
161879434|NCT00614120|584600460|FG002|Overall Study|Withdrawal by Subject|16|||
161879435|NCT00614120|584600461|FG003|Overall Study|Withdrawal by Subject|3|||
161879436|NCT00614120|584600458|FG000|Overall Study|Did not meet trial criteria|0|||
161879437|NCT00614120|584600459|FG001|Overall Study|Did not meet trial criteria|1|||
161879438|NCT00614120|584600460|FG002|Overall Study|Did not meet trial criteria|1|||
161879439|NCT00614120|584600461|FG003|Overall Study|Did not meet trial criteria|1|||
161879440|NCT00614120|584600458|FG000|Overall Study|hCG positive (not pregnant)|0|||
161879441|NCT00614120|584600459|FG001|Overall Study|hCG positive (not pregnant)|0|||
161879442|NCT00614120|584600460|FG002|Overall Study|hCG positive (not pregnant)|1|||
161879443|NCT00614120|584600461|FG003|Overall Study|hCG positive (not pregnant)|0|||
161879444|NCT00614120|584600458|FG000|Overall Study|Hypoglycaemia|0|||
161879445|NCT00614120|584600459|FG001|Overall Study|Hypoglycaemia|0|||
161879446|NCT00614120|584600460|FG002|Overall Study|Hypoglycaemia|0|||
161879447|NCT00614120|584600461|FG003|Overall Study|Hypoglycaemia|1|||
161879448|NCT00614120|584600458|FG000|Overall Study|Lack of trial product|3|||
161879449|NCT00614120|584600459|FG001|Overall Study|Lack of trial product|3|||
161879450|NCT00614120|584600460|FG002|Overall Study|Lack of trial product|2|||
161777359|NCT01035229|584226988|FG001|Overall Study|Protocol Violation|2|||
161777360|NCT01035229|584226987|FG000|Overall Study|Sponsor's decision to end study|3|||
161777361|NCT01035229|584226988|FG001|Overall Study|Sponsor's decision to end study|3|||
161879451|NCT00614120|584600461|FG003|Overall Study|Lack of trial product|0|||
161879452|NCT00614120|584600458|FG000|Overall Study|Late syphilis, latent|1|||
161879453|NCT00614120|584600459|FG001|Overall Study|Late syphilis, latent|0|||
161879454|NCT00614120|584600460|FG002|Overall Study|Late syphilis, latent|0|||
161879455|NCT00614120|584600461|FG003|Overall Study|Late syphilis, latent|0|||
161777362|NCT01035229|584226987|FG000|Overall Study|Disease Progression|261|||
161777363|NCT01035229|584226988|FG001|Overall Study|Disease Progression|152|||
161777364|NCT00685763|584226990|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
161777365|NCT00685763|584226990|FG000|Overall Study|Protocol Violation|1|||
161777366|NCT00698009|584226994|FG000|Overall Study|Withdrawal by Subject|1|||
161777367|NCT00564486|584226998|FG000|Overall Study|Adverse Event|0|||
161777368|NCT00564486|584226999|FG001|Overall Study|Adverse Event|1|||
161777369|NCT00564486|584227000|FG002|Overall Study|Adverse Event|0|||
161777370|NCT00564486|584227001|FG003|Overall Study|Adverse Event|0|||
161777371|NCT00564486|584226998|FG000|Overall Study|Withdrawal by Subject|4|||
161777372|NCT00564486|584226999|FG001|Overall Study|Withdrawal by Subject|0|||
161777373|NCT00564486|584227000|FG002|Overall Study|Withdrawal by Subject|0|||
161777374|NCT00564486|584227001|FG003|Overall Study|Withdrawal by Subject|5|||
161777375|NCT00564486|584226998|FG000|Overall Study|Subject refused to have blood drawn|0|||
161879456|NCT00614120|584600458|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
161879457|NCT00614120|584600459|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
161879458|NCT00614120|584600460|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
161879459|NCT00614120|584600461|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
161879460|NCT00614120|584600458|FG000|Overall Study|Lost to Follow-up|1|||
161879461|NCT00614120|584600459|FG001|Overall Study|Lost to Follow-up|2|||
161879462|NCT00614120|584600460|FG002|Overall Study|Lost to Follow-up|3|||
161879463|NCT00614120|584600461|FG003|Overall Study|Lost to Follow-up|4|||
161879464|NCT01084668|584600462|FG000|Overall Study|Lack of Efficacy|5|||
161879465|NCT01084668|584600462|FG000|Overall Study|Withdrawal by Subject|2|||
161879466|NCT01084668|584600462|FG000|Overall Study|Pregnancy|1|||
161879467|NCT01084668|584600462|FG000|Overall Study|Non-compliance|1|||
161879468|NCT02447497|584600463|FG000|Overall Study|Did not meet treatment day baseline.|6|||
161879469|NCT02447497|584600464|FG001|Overall Study|Did not meet treatment day baseline.|5|||
161879470|NCT02447497|584600465|FG002|Overall Study|Did not meet treatment day baseline.|2|||
161879471|NCT02447497|584600466|FG003|Overall Study|Did not meet treatment day baseline.|2|||
161879472|NCT02447497|584600463|FG000|Overall Study|Dressing was compromised|0|||
161879473|NCT02447497|584600464|FG001|Overall Study|Dressing was compromised|1|||
161879474|NCT02447497|584600465|FG002|Overall Study|Dressing was compromised|0|||
161879475|NCT02447497|584600466|FG003|Overall Study|Dressing was compromised|0|||
161879476|NCT02017912|584600467|FG000|Overall Study|Withdrawal by Subject|2|||
161879477|NCT02017912|584600468|FG001|Overall Study|Withdrawal by Subject|1|||
161879478|NCT02017912|584600467|FG000|Overall Study|miscellaneous|1|||
161879479|NCT02017912|584600468|FG001|Overall Study|miscellaneous|1|||
161879480|NCT04569968|584600469|FG000|Overall Study|Lost to Follow-up|2|||
161879481|NCT04569968|584600470|FG001|Overall Study|Lost to Follow-up|5|||
161879482|NCT04569968|584600469|FG000|Overall Study|Story of head and/or neck surgery|2|||
161879483|NCT04569968|584600470|FG001|Overall Study|Story of head and/or neck surgery|2|||
161879484|NCT04569968|584600469|FG000|Overall Study|Time of stroke onset|8|||
161879485|NCT04569968|584600470|FG001|Overall Study|Time of stroke onset|7|||
161879486|NCT04569968|584600469|FG000|Overall Study|Type of strokr|12|||
161879487|NCT04569968|584600470|FG001|Overall Study|Type of strokr|8|||
161879488|NCT04569968|584600469|FG000|Overall Study|Cooperation|8|||
161879489|NCT04569968|584600470|FG001|Overall Study|Cooperation|8|||
161879490|NCT04569968|584600469|FG000|Overall Study|Age interval|17|||
161879491|NCT04569968|584600470|FG001|Overall Study|Age interval|6|||
161879492|NCT04569968|584600469|FG000|Overall Study|Denial of participation to the study|0|||
161879493|NCT04569968|584600470|FG001|Overall Study|Denial of participation to the study|3|||
161879494|NCT04569968|584600469|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
161879495|NCT04569968|584600470|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
161879496|NCT04569968|584600469|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
161879497|NCT04569968|584600470|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
161879498|NCT04569968|584600469|FG000|Overall Study|Quarantine|1|||
161879499|NCT04569968|584600470|FG001|Overall Study|Quarantine|0|||
161879500|NCT04569968|584600469|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
161879501|NCT04569968|584600470|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
161879502|NCT04569968|584600469|FG000|Overall Study|Repetitive stroke|8|||
161879503|NCT04569968|584600470|FG001|Overall Study|Repetitive stroke|0|||
161777376|NCT00564486|584226999|FG001|Overall Study|Subject refused to have blood drawn|0|||
161777377|NCT00564486|584227000|FG002|Overall Study|Subject refused to have blood drawn|1|||
161879504|NCT04569968|584600469|FG000|Overall Study|Insufficient mastication|1|||
161777378|NCT00564486|584227001|FG003|Overall Study|Subject refused to have blood drawn|0|||
161777379|NCT00564486|584226998|FG000|Overall Study|Lost to Follow-up|3|||
161777380|NCT00564486|584226999|FG001|Overall Study|Lost to Follow-up|0|||
161777381|NCT00564486|584227000|FG002|Overall Study|Lost to Follow-up|2|||
161777382|NCT00564486|584227001|FG003|Overall Study|Lost to Follow-up|2|||
161777383|NCT03862807|584227002|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
161777384|NCT00798707|584227003|FG000|Overall Study|Adverse Event|6|||
161777385|NCT00798707|584227004|FG001|Overall Study|Adverse Event|8|||
161777386|NCT00798707|584227005|FG002|Overall Study|Adverse Event|8|||
161777387|NCT00798707|584227003|FG000|Overall Study|Failed to return|2|||
161777388|NCT00798707|584227004|FG001|Overall Study|Failed to return|2|||
161777389|NCT00798707|584227005|FG002|Overall Study|Failed to return|0|||
161777390|NCT00798707|584227003|FG000|Overall Study|Investigator|0|||
161777391|NCT00798707|584227004|FG001|Overall Study|Investigator|1|||
161777392|NCT00798707|584227005|FG002|Overall Study|Investigator|2|||
161777393|NCT00798707|584227003|FG000|Overall Study|Lack of Efficacy|2|||
161879505|NCT04569968|584600470|FG001|Overall Study|Insufficient mastication|0|||
161879506|NCT04569968|584600469|FG000|Overall Study|Infection|1|||
161777394|NCT00798707|584227004|FG001|Overall Study|Lack of Efficacy|2|||
161777395|NCT00798707|584227005|FG002|Overall Study|Lack of Efficacy|1|||
161777396|NCT00798707|584227003|FG000|Overall Study|Lost to Follow-up|5|||
161879507|NCT04569968|584600470|FG001|Overall Study|Infection|0|||
161879508|NCT00727844|584600471|FG000|Initial Randomization|Physician Decision|2|||
161879509|NCT00727844|584600472|FG001|Initial Randomization|Physician Decision|0|||
161879510|NCT00727844|584600473|FG002|Initial Randomization|Physician Decision|0|||
161777397|NCT00798707|584227004|FG001|Overall Study|Lost to Follow-up|6|||
161777398|NCT00798707|584227005|FG002|Overall Study|Lost to Follow-up|6|||
161777399|NCT00798707|584227003|FG000|Overall Study|Other|0|||
161777400|NCT00798707|584227004|FG001|Overall Study|Other|1|||
161777401|NCT00798707|584227005|FG002|Overall Study|Other|0|||
161777402|NCT00798707|584227003|FG000|Overall Study|Protocol Violation|4|||
161777403|NCT00798707|584227004|FG001|Overall Study|Protocol Violation|0|||
161777404|NCT00798707|584227005|FG002|Overall Study|Protocol Violation|2|||
161879511|NCT00727844|584600474|FG003|Initial Randomization|Physician Decision|0|||
161879512|NCT00985959|584600479|FG000|Overall Study|Adverse Event|0|||
161879513|NCT00985959|584600480|FG001|Overall Study|Adverse Event|0|||
161879514|NCT00985959|584600481|FG002|Overall Study|Adverse Event|19|||
161879515|NCT00985959|584600479|FG000|Overall Study|Withdrawal by Subject|0|||
161879516|NCT00985959|584600480|FG001|Overall Study|Withdrawal by Subject|0|||
161879517|NCT00985959|584600481|FG002|Overall Study|Withdrawal by Subject|8|||
161879518|NCT00985959|584600479|FG000|Overall Study|Progressive disease|1|||
161879519|NCT00985959|584600480|FG001|Overall Study|Progressive disease|2|||
161879520|NCT00985959|584600481|FG002|Overall Study|Progressive disease|8|||
161879521|NCT00985959|584600479|FG000|Overall Study|Unrecovered toxicity|0|||
161879522|NCT00985959|584600480|FG001|Overall Study|Unrecovered toxicity|0|||
161879523|NCT00985959|584600481|FG002|Overall Study|Unrecovered toxicity|7|||
161879524|NCT00985959|584600479|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
161879525|NCT00985959|584600480|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
161879526|NCT00985959|584600481|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
161879527|NCT00985959|584600479|FG000|Overall Study|Complete response observed over 2 cycles|0|||
161879528|NCT00985959|584600480|FG001|Overall Study|Complete response observed over 2 cycles|1|||
161879529|NCT00985959|584600481|FG002|Overall Study|Complete response observed over 2 cycles|4|||
161879530|NCT00985959|584600479|FG000|Overall Study|Other|0|||
161879531|NCT00985959|584600480|FG001|Overall Study|Other|0|||
161879532|NCT00985959|584600481|FG002|Overall Study|Other|11|||
161879533|NCT00979420|584600482|FG000|Overall Study|Adverse Event|1|||
161879534|NCT00979420|584600483|FG001|Overall Study|Adverse Event|0|||
161879535|NCT00979420|584600484|FG002|Overall Study|Adverse Event|0|||
161879536|NCT00979420|584600485|FG003|Overall Study|Adverse Event|0|||
161879537|NCT00979420|584600482|FG000|Overall Study|Lack of Efficacy|3|||
161879538|NCT00979420|584600483|FG001|Overall Study|Lack of Efficacy|0|||
161879539|NCT00979420|584600484|FG002|Overall Study|Lack of Efficacy|1|||
161879540|NCT00979420|584600485|FG003|Overall Study|Lack of Efficacy|1|||
161879541|NCT00979420|584600482|FG000|Overall Study|Other reasons not related to Viramune|3|||
161879542|NCT00979420|584600483|FG001|Overall Study|Other reasons not related to Viramune|0|||
161879543|NCT00979420|584600484|FG002|Overall Study|Other reasons not related to Viramune|0|||
161777405|NCT00798707|584227003|FG000|Overall Study|Withdrawal by Subject|3|||
161777406|NCT00798707|584227004|FG001|Overall Study|Withdrawal by Subject|8|||
161777407|NCT00798707|584227005|FG002|Overall Study|Withdrawal by Subject|2|||
161777408|NCT00798707|584227003|FG000|Overall Study|Randomized not treated|4|||
161777409|NCT00798707|584227004|FG001|Overall Study|Randomized not treated|5|||
161777410|NCT00798707|584227005|FG002|Overall Study|Randomized not treated|1|||
161777411|NCT01473589|584227006|FG000|Overall Study|Adverse Event|1|||
161879544|NCT00979420|584600485|FG003|Overall Study|Other reasons not related to Viramune|1|||
161879545|NCT02107859|584600487|FG000|Overall Study|Withdrawal by Subject|14|||
161879546|NCT02107859|584600487|FG000|Overall Study|Adverse Event|3|||
161879547|NCT02107859|584600487|FG000|Overall Study|Study closure|41|||
161879548|NCT02107859|584600487|FG000|Overall Study|Other than specified|3|||
161777412|NCT01473589|584227007|FG001|Overall Study|Adverse Event|1|||
161879549|NCT02235077|584600488|FG000|Overall Study|Death|5|||
161879550|NCT02235077|584600489|FG001|Overall Study|Death|7|||
161879551|NCT02235077|584600488|FG000|Overall Study|Lost to Follow-up|5|||
161879552|NCT02235077|584600489|FG001|Overall Study|Lost to Follow-up|6|||
161879553|NCT02235077|584600488|FG000|Overall Study|Withdrawal by Subject|8|||
161879554|NCT02235077|584600489|FG001|Overall Study|Withdrawal by Subject|5|||
161879555|NCT02235077|584600488|FG000|Overall Study|Physician Decision|0|||
161879556|NCT02235077|584600489|FG001|Overall Study|Physician Decision|1|||
161879557|NCT03852628|584600490|FG000|Overall Study|Lost to Follow-up|7|||
161879558|NCT03852628|584600491|FG001|Overall Study|Lost to Follow-up|6|||
161879559|NCT03852628|584600490|FG000|Overall Study|Lack of Efficacy|6|||
161879560|NCT03852628|584600491|FG001|Overall Study|Lack of Efficacy|6|||
161879561|NCT04013672|584600496|FG000|Overall Study|Withdrawal by Subject|3|||
161879562|NCT04013672|584600497|FG001|Overall Study|Withdrawal by Subject|0|||
161879563|NCT04013672|584600496|FG000|Overall Study|Death|1|||
161879564|NCT04013672|584600497|FG001|Overall Study|Death|0|||
161879565|NCT04013672|584600496|FG000|Overall Study|Physician Decision|5|||
161879566|NCT04013672|584600497|FG001|Overall Study|Physician Decision|0|||
161879567|NCT02847494|584600502|FG000|Overall Study|Lost to Follow-up|8|||
161879568|NCT02847494|584600503|FG001|Overall Study|Lost to Follow-up|5|||
161879569|NCT00022698|584600506|FG000|Overall Study|Adverse Event|5|||
161879570|NCT00022698|584600507|FG001|Overall Study|Adverse Event|9|||
161879571|NCT00022698|584600506|FG000|Overall Study|Death|0|||
161879572|NCT00022698|584600507|FG001|Overall Study|Death|2|||
161879573|NCT00022698|584600506|FG000|Overall Study|Failure to return|0|||
161879574|NCT00022698|584600507|FG001|Overall Study|Failure to return|1|||
161879575|NCT00022698|584600506|FG000|Overall Study|Refused treatment|0|||
161879576|NCT00022698|584600507|FG001|Overall Study|Refused treatment|2|||
161879577|NCT00022698|584600506|FG000|Overall Study|Insufficient therapeutic response|2|||
161879578|NCT00022698|584600507|FG001|Overall Study|Insufficient therapeutic response|14|||
161879579|NCT00022698|584600506|FG000|Overall Study|Administrative /other|1|||
161879580|NCT00022698|584600507|FG001|Overall Study|Administrative /other|7|||
161879581|NCT04553471|584600508|FG000|Overall Study|Did not start treatment on protocol|3|||
161879582|NCT04553471|584600508|FG000|Overall Study|Death|1|||
161879583|NCT01441765|584600509|FG000|Overall Study|Death|1|||
161879584|NCT01441765|584600510|FG001|Overall Study|Death|0|||
161879585|NCT00813813|584600511|FG000|Overall Study|Withdrawal by Subject|1|||
161879586|NCT00813813|584600512|FG001|Overall Study|Withdrawal by Subject|1|||
161879587|NCT00813813|584600511|FG000|Overall Study|Lost to Follow-up|2|||
161879588|NCT00813813|584600512|FG001|Overall Study|Lost to Follow-up|7|||
161879589|NCT00813813|584600511|FG000|Overall Study|Other|0|||
161879590|NCT00813813|584600512|FG001|Overall Study|Other|1|||
161879591|NCT01684943|584600514|FG000|Overall Study|Inadequate Venous Access|3|||
161879592|NCT01684943|584600515|FG001|Overall Study|Inadequate Venous Access|0|||
161879593|NCT01684943|584600516|FG002|Overall Study|Inadequate Venous Access|0|||
161879594|NCT01684943|584600514|FG000|Overall Study|Principal Investigator Determination|1|||
161879595|NCT01684943|584600515|FG001|Overall Study|Principal Investigator Determination|0|||
161879596|NCT01684943|584600516|FG002|Overall Study|Principal Investigator Determination|0|||
161879597|NCT01684943|584600514|FG000|Overall Study|Excluded from Analysis|1|||
161879598|NCT01684943|584600515|FG001|Overall Study|Excluded from Analysis|1|||
161879599|NCT01684943|584600516|FG002|Overall Study|Excluded from Analysis|1|||
161879600|NCT01684943|584600514|FG000|Overall Study|Lost to Follow-up|3|||
161879601|NCT01684943|584600515|FG001|Overall Study|Lost to Follow-up|0|||
161879602|NCT01684943|584600516|FG002|Overall Study|Lost to Follow-up|0|||
161879603|NCT01684943|584600514|FG000|Overall Study|Planning Pregnancy|1|||
161879604|NCT01684943|584600515|FG001|Overall Study|Planning Pregnancy|0|||
161879605|NCT01684943|584600516|FG002|Overall Study|Planning Pregnancy|0|||
161879606|NCT00325156|584600517|FG000|Overall Study|Protocol Violation|8|||
161879607|NCT00325156|584600517|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
161879608|NCT00325156|584600517|FG000|Overall Study|Migrated/moved from study area|12|||
161879609|NCT00325156|584600517|FG000|Overall Study|Adverse event, non-fatal|3|||
161879610|NCT00325156|584600517|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
161879611|NCT00325156|584600517|FG000|Overall Study|Other|1|||
161879612|NCT00325156|584600517|FG000|Overall Study|Withdrawal by Subject|31|||
161879613|NCT04064411|584600518|FG000|Overall Study|Adverse Event|29|||
161879614|NCT04064411|584600519|FG001|Overall Study|Adverse Event|19|||
161879615|NCT04064411|584600518|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
161879616|NCT04064411|584600519|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
161879617|NCT04064411|584600518|FG000|Overall Study|Protocol Deviation|0|||
161879618|NCT04064411|584600519|FG001|Overall Study|Protocol Deviation|2|||
161879619|NCT04064411|584600518|FG000|Overall Study|Withdrawal by Subject|25|||
161879620|NCT04064411|584600519|FG001|Overall Study|Withdrawal by Subject|29|||
161879621|NCT04064411|584600518|FG000|Overall Study|Lost to Follow-up|5|||
161879622|NCT04064411|584600519|FG001|Overall Study|Lost to Follow-up|2|||
161879623|NCT04064411|584600518|FG000|Overall Study|Other than Specified|4|||
161879624|NCT04064411|584600519|FG001|Overall Study|Other than Specified|1|||
161879625|NCT04064411|584600518|FG000|Overall Study|Death|1|||
161879626|NCT04064411|584600519|FG001|Overall Study|Death|0|||
161879627|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
161879628|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
161879629|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
161879630|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879631|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879632|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879633|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879634|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879635|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
161879636|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
161879637|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879638|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879639|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879640|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879641|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
161879642|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
161879643|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879644|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879645|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879646|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879647|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879648|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879649|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
161879650|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879651|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879652|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879653|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879654|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879655|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
161879656|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879657|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
161879658|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879659|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879660|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879661|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879662|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
161879663|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
161879664|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
161879665|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
161879666|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
161879667|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
161879668|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
161879669|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
161879670|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
161879671|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
161879672|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
161879673|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
161879674|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
161879675|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
161879676|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161879677|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161879678|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161879679|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
161879680|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
161879681|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
161879682|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
161879683|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879684|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879685|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879686|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879687|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
161879688|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879689|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879690|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161879691|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161879692|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161879693|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
161879694|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
161879695|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
161879696|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
161879697|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879698|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879699|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879700|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
161879701|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879702|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
161879703|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879704|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161879705|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161879706|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161879707|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
161879708|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
161879709|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
161879710|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
161879711|NCT03512210|584600530|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
161879712|NCT03512210|584600530|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
161879713|NCT03512210|584600530|FG000|Step 2:Post-MINMON|Death|2|||
161879714|NCT03512210|584600530|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
161879715|NCT03512210|584600530|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
161879716|NCT01672710|584600531|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
161879717|NCT01672710|584600532|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
161879718|NCT01672710|584600531|FG000|3 Month Follow up|Lost to Follow-up|2|||
161879719|NCT01672710|584600532|FG001|3 Month Follow up|Lost to Follow-up|3|||
161879720|NCT01672710|584600531|FG000|3 Month Follow up|follow up due after termination date|4|||
161879721|NCT01672710|584600532|FG001|3 Month Follow up|follow up due after termination date|1|||
161879722|NCT05033262|584600533|FG000|Overall Study|Lost to Follow-up|1|||
161879723|NCT05033262|584600534|FG001|Overall Study|Lost to Follow-up|0|||
161879724|NCT05033262|584600535|FG002|Overall Study|Lost to Follow-up|0|||
161879725|NCT05033262|584600536|FG003|Overall Study|Lost to Follow-up|1|||
161879726|NCT03725761|584600537|FG000|Overall Study|still on study|1|||
161879727|NCT03197467|584602747|FG000|Overall Study|Withdrawal by Subject|1|||
161879728|NCT03666533|584602748|FG000|Overall Study|Lost to Follow-up|2|||
161879729|NCT03666533|584602749|FG001|Overall Study|Lost to Follow-up|2|||
161879730|NCT02017717|584602750|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879731|NCT02017717|584602751|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879732|NCT02017717|584602752|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879733|NCT02017717|584602753|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879734|NCT02017717|584602754|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879735|NCT02017717|584602755|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879736|NCT02017717|584602756|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879737|NCT02017717|584602757|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
161879738|NCT02017717|584602758|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879739|NCT02017717|584602750|FG000|Before Treatment Period|Participant request to stop therapy|0|||
161879740|NCT02017717|584602751|FG001|Before Treatment Period|Participant request to stop therapy|0|||
161879741|NCT02017717|584602752|FG002|Before Treatment Period|Participant request to stop therapy|0|||
161879742|NCT02017717|584602753|FG003|Before Treatment Period|Participant request to stop therapy|0|||
161879743|NCT02017717|584602754|FG004|Before Treatment Period|Participant request to stop therapy|0|||
161879744|NCT02017717|584602755|FG005|Before Treatment Period|Participant request to stop therapy|0|||
161879745|NCT02017717|584602756|FG006|Before Treatment Period|Participant request to stop therapy|0|||
161879746|NCT02017717|584602757|FG007|Before Treatment Period|Participant request to stop therapy|0|||
161879747|NCT02017717|584602758|FG008|Before Treatment Period|Participant request to stop therapy|5|||
161879748|NCT02017717|584602750|FG000|Before Treatment Period|Participant withdrew consent|0|||
161879749|NCT02017717|584602751|FG001|Before Treatment Period|Participant withdrew consent|0|||
161879750|NCT02017717|584602752|FG002|Before Treatment Period|Participant withdrew consent|0|||
161879751|NCT02017717|584602753|FG003|Before Treatment Period|Participant withdrew consent|0|||
161879752|NCT02017717|584602754|FG004|Before Treatment Period|Participant withdrew consent|0|||
161879753|NCT02017717|584602755|FG005|Before Treatment Period|Participant withdrew consent|0|||
161879754|NCT02017717|584602756|FG006|Before Treatment Period|Participant withdrew consent|2|||
161879755|NCT02017717|584602757|FG007|Before Treatment Period|Participant withdrew consent|0|||
161879756|NCT02017717|584602758|FG008|Before Treatment Period|Participant withdrew consent|11|||
161879757|NCT02017717|584602750|FG000|Before Treatment Period|Lost to Follow-up|0|||
161879758|NCT02017717|584602751|FG001|Before Treatment Period|Lost to Follow-up|0|||
161879759|NCT02017717|584602752|FG002|Before Treatment Period|Lost to Follow-up|0|||
161879760|NCT02017717|584602753|FG003|Before Treatment Period|Lost to Follow-up|0|||
161879761|NCT02017717|584602754|FG004|Before Treatment Period|Lost to Follow-up|0|||
161879762|NCT02017717|584602755|FG005|Before Treatment Period|Lost to Follow-up|0|||
161879763|NCT02017717|584602756|FG006|Before Treatment Period|Lost to Follow-up|0|||
161879764|NCT02017717|584602757|FG007|Before Treatment Period|Lost to Follow-up|0|||
161879765|NCT02017717|584602758|FG008|Before Treatment Period|Lost to Follow-up|1|||
161879766|NCT02017717|584602750|FG000|Before Treatment Period|Participant no longer met criteria|0|||
161879767|NCT02017717|584602751|FG001|Before Treatment Period|Participant no longer met criteria|0|||
161879768|NCT02017717|584602752|FG002|Before Treatment Period|Participant no longer met criteria|0|||
161777413|NCT01473589|584227006|FG000|Overall Study|Death|2|||
161777414|NCT01473589|584227007|FG001|Overall Study|Death|0|||
161777415|NCT01473589|584227006|FG000|Overall Study|Lost to Follow-up|2|||
161777416|NCT01473589|584227007|FG001|Overall Study|Lost to Follow-up|2|||
161777417|NCT01473589|584227006|FG000|Overall Study|Protocol Violation|1|||
161777418|NCT01473589|584227007|FG001|Overall Study|Protocol Violation|0|||
161777419|NCT01473589|584227006|FG000|Overall Study|Withdrawal by Subject|5|||
161777420|NCT01473589|584227007|FG001|Overall Study|Withdrawal by Subject|11|||
161777421|NCT01473589|584227006|FG000|Overall Study|Physician Decision|0|||
161777422|NCT01473589|584227007|FG001|Overall Study|Physician Decision|1|||
161777423|NCT01473589|584227006|FG000|Overall Study|Entry criteria not met|0|||
161879769|NCT02017717|584602753|FG003|Before Treatment Period|Participant no longer met criteria|0|||
161879770|NCT02017717|584602754|FG004|Before Treatment Period|Participant no longer met criteria|0|||
161879771|NCT02017717|584602755|FG005|Before Treatment Period|Participant no longer met criteria|1|||
161879772|NCT02017717|584602756|FG006|Before Treatment Period|Participant no longer met criteria|0|||
161879773|NCT02017717|584602757|FG007|Before Treatment Period|Participant no longer met criteria|1|||
161879774|NCT02017717|584602758|FG008|Before Treatment Period|Participant no longer met criteria|2|||
161879775|NCT02017717|584602750|FG000|Before Treatment Period|other reason|0|||
161879776|NCT02017717|584602751|FG001|Before Treatment Period|other reason|0|||
161879777|NCT02017717|584602752|FG002|Before Treatment Period|other reason|0|||
161879778|NCT02017717|584602753|FG003|Before Treatment Period|other reason|0|||
161879779|NCT02017717|584602754|FG004|Before Treatment Period|other reason|0|||
161879780|NCT02017717|584602755|FG005|Before Treatment Period|other reason|0|||
161879781|NCT02017717|584602756|FG006|Before Treatment Period|other reason|0|||
161777424|NCT01473589|584227007|FG001|Overall Study|Entry criteria not met|1|||
161777425|NCT03286426|584227011|FG000|Overall Study|Physician Decision|3|||
161879782|NCT02017717|584602757|FG007|Before Treatment Period|other reason|0|||
161777426|NCT01817764|584227012|FG000|Overall Study|Adverse Event|7|||
161777427|NCT01817764|584227013|FG001|Overall Study|Adverse Event|10|||
161777428|NCT01817764|584227012|FG000|Overall Study|Lack of Efficacy|9|||
161777429|NCT01817764|584227013|FG001|Overall Study|Lack of Efficacy|7|||
161777430|NCT01817764|584227012|FG000|Overall Study|Protocol Violation|7|||
161777431|NCT01817764|584227013|FG001|Overall Study|Protocol Violation|5|||
161777432|NCT01817764|584227012|FG000|Overall Study|Lost to Follow-up|1|||
161777433|NCT01817764|584227013|FG001|Overall Study|Lost to Follow-up|4|||
161777434|NCT01817764|584227012|FG000|Overall Study|Withdrawal by Subject|10|||
161777435|NCT01817764|584227013|FG001|Overall Study|Withdrawal by Subject|12|||
161777436|NCT01956123|584227014|FG000|COS Cycle 2|Protocol Violation|8|||
161777437|NCT01956123|584227015|FG001|COS Cycle 2|Protocol Violation|3|||
161777438|NCT01956123|584227016|FG002|COS Cycle 2|Protocol Violation|0|||
161777439|NCT01956123|584227017|FG003|COS Cycle 2|Protocol Violation|0|||
161777440|NCT01956123|584227014|FG000|COS Cycle 2|Adverse Event|3|||
161777441|NCT01956123|584227015|FG001|COS Cycle 2|Adverse Event|4|||
161777442|NCT01956123|584227016|FG002|COS Cycle 2|Adverse Event|0|||
161777443|NCT01956123|584227017|FG003|COS Cycle 2|Adverse Event|0|||
161777444|NCT01956123|584227014|FG000|COS Cycle 2|Personal Reasons|2|||
161777445|NCT01956123|584227015|FG001|COS Cycle 2|Personal Reasons|0|||
161777446|NCT01956123|584227016|FG002|COS Cycle 2|Personal Reasons|0|||
161777447|NCT01956123|584227017|FG003|COS Cycle 2|Personal Reasons|0|||
161777448|NCT01956123|584227014|FG000|COS Cycle 2|Withdrawal by Subject|1|||
161777449|NCT01956123|584227015|FG001|COS Cycle 2|Withdrawal by Subject|0|||
161777450|NCT01956123|584227016|FG002|COS Cycle 2|Withdrawal by Subject|0|||
161777451|NCT01956123|584227017|FG003|COS Cycle 2|Withdrawal by Subject|0|||
161777452|NCT01956123|584227014|FG000|COS Cycle 3|Protocol Violation|0|||
161777453|NCT01956123|584227015|FG001|COS Cycle 3|Protocol Violation|0|||
161777454|NCT01956123|584227016|FG002|COS Cycle 3|Protocol Violation|2|||
161777455|NCT01956123|584227017|FG003|COS Cycle 3|Protocol Violation|1|||
161777456|NCT01956123|584227014|FG000|COS Cycle 3|Adverse Event|0|||
161777457|NCT01956123|584227015|FG001|COS Cycle 3|Adverse Event|0|||
161777458|NCT01956123|584227016|FG002|COS Cycle 3|Adverse Event|3|||
161777459|NCT01956123|584227017|FG003|COS Cycle 3|Adverse Event|0|||
161777460|NCT01956123|584227014|FG000|COS Cycle 3|Personal Reasons|0|||
161777461|NCT01956123|584227015|FG001|COS Cycle 3|Personal Reasons|0|||
161777462|NCT01956123|584227016|FG002|COS Cycle 3|Personal Reasons|1|||
161777463|NCT01956123|584227017|FG003|COS Cycle 3|Personal Reasons|0|||
161777464|NCT01956123|584227014|FG000|COS Cycle 3|Withdrawal by Subject|0|||
161777465|NCT01956123|584227015|FG001|COS Cycle 3|Withdrawal by Subject|0|||
161777466|NCT01956123|584227016|FG002|COS Cycle 3|Withdrawal by Subject|0|||
161777467|NCT01956123|584227017|FG003|COS Cycle 3|Withdrawal by Subject|1|||
161777468|NCT00826176|584227030|FG000|Overall Study|Lost to Follow-up|1|||
161777469|NCT00826176|584227031|FG001|Overall Study|Lost to Follow-up|0|||
161777470|NCT00826176|584227030|FG000|Overall Study|Subject Withdrew Consent|3|||
161879783|NCT02017717|584602758|FG008|Before Treatment Period|other reason|1|||
161777471|NCT00826176|584227031|FG001|Overall Study|Subject Withdrew Consent|0|||
161777472|NCT00826176|584227030|FG000|Overall Study|Administrative|9|||
161879784|NCT02017717|584602750|FG000|Treatment Period|Disease progression|7|||
161879785|NCT02017717|584602751|FG001|Treatment Period|Disease progression|9|||
161879786|NCT02017717|584602752|FG002|Treatment Period|Disease progression|12|||
161879787|NCT02017717|584602753|FG003|Treatment Period|Disease progression|20|||
161879788|NCT02017717|584602754|FG004|Treatment Period|Disease progression|26|||
161879789|NCT02017717|584602755|FG005|Treatment Period|Disease progression|16|||
161879790|NCT02017717|584602756|FG006|Treatment Period|Disease progression|22|||
161879791|NCT02017717|584602757|FG007|Treatment Period|Disease progression|165|||
161879792|NCT02017717|584602758|FG008|Treatment Period|Disease progression|135|||
161879793|NCT02017717|584602750|FG000|Treatment Period|Study drug toxicity|3|||
161879794|NCT02017717|584602751|FG001|Treatment Period|Study drug toxicity|0|||
161879795|NCT02017717|584602752|FG002|Treatment Period|Study drug toxicity|1|||
161879796|NCT02017717|584602753|FG003|Treatment Period|Study drug toxicity|4|||
161879797|NCT02017717|584602754|FG004|Treatment Period|Study drug toxicity|4|||
161879798|NCT02017717|584602755|FG005|Treatment Period|Study drug toxicity|5|||
161879799|NCT02017717|584602756|FG006|Treatment Period|Study drug toxicity|3|||
161879800|NCT02017717|584602757|FG007|Treatment Period|Study drug toxicity|7|||
161879801|NCT02017717|584602758|FG008|Treatment Period|Study drug toxicity|11|||
161879802|NCT02017717|584602750|FG000|Treatment Period|Death|0|||
161879803|NCT02017717|584602751|FG001|Treatment Period|Death|0|||
161879804|NCT02017717|584602752|FG002|Treatment Period|Death|1|||
161879805|NCT02017717|584602753|FG003|Treatment Period|Death|0|||
161879806|NCT02017717|584602754|FG004|Treatment Period|Death|0|||
161879807|NCT02017717|584602755|FG005|Treatment Period|Death|2|||
161879808|NCT02017717|584602756|FG006|Treatment Period|Death|0|||
161777473|NCT00826176|584227031|FG001|Overall Study|Administrative|0|||
161777474|NCT00568776|584227034|FG000|Overall Study|Adverse Event|8|||
161777475|NCT00568776|584227035|FG001|Overall Study|Adverse Event|8|||
161777476|NCT00568776|584227036|FG002|Overall Study|Adverse Event|10|||
161777477|NCT00568776|584227037|FG003|Overall Study|Adverse Event|8|||
161777478|NCT00568776|584227034|FG000|Overall Study|Death|0|||
161777479|NCT00568776|584227035|FG001|Overall Study|Death|1|||
161879809|NCT02017717|584602757|FG007|Treatment Period|Death|0|||
161879810|NCT02017717|584602758|FG008|Treatment Period|Death|0|||
161879811|NCT02017717|584602750|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
161879812|NCT02017717|584602751|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
161879813|NCT02017717|584602752|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
161879814|NCT02017717|584602753|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
161879815|NCT02017717|584602754|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
161777480|NCT00568776|584227036|FG002|Overall Study|Death|4|||
161777481|NCT00568776|584227037|FG003|Overall Study|Death|3|||
161879816|NCT02017717|584602755|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
161879817|NCT02017717|584602756|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
161777482|NCT00568776|584227034|FG000|Overall Study|Physician Decision|0|||
161777483|NCT00568776|584227035|FG001|Overall Study|Physician Decision|2|||
161777484|NCT00568776|584227036|FG002|Overall Study|Physician Decision|0|||
161777485|NCT00568776|584227037|FG003|Overall Study|Physician Decision|0|||
161777486|NCT00568776|584227034|FG000|Overall Study|Lack of Efficacy|2|||
161777487|NCT00568776|584227035|FG001|Overall Study|Lack of Efficacy|2|||
161879818|NCT02017717|584602757|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
161879819|NCT02017717|584602758|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
161879820|NCT02017717|584602750|FG000|Treatment Period|Participant request to stop therapy|0|||
161879821|NCT02017717|584602751|FG001|Treatment Period|Participant request to stop therapy|0|||
161879822|NCT02017717|584602752|FG002|Treatment Period|Participant request to stop therapy|3|||
161777488|NCT00568776|584227036|FG002|Overall Study|Lack of Efficacy|2|||
161777489|NCT00568776|584227037|FG003|Overall Study|Lack of Efficacy|4|||
161777490|NCT00568776|584227034|FG000|Overall Study|Lost to Follow-up|1|||
161777491|NCT00568776|584227035|FG001|Overall Study|Lost to Follow-up|1|||
161777492|NCT00568776|584227036|FG002|Overall Study|Lost to Follow-up|1|||
161777493|NCT00568776|584227037|FG003|Overall Study|Lost to Follow-up|1|||
161777494|NCT00568776|584227034|FG000|Overall Study|Protocol Violation|1|||
161777495|NCT00568776|584227035|FG001|Overall Study|Protocol Violation|0|||
161777496|NCT00568776|584227036|FG002|Overall Study|Protocol Violation|1|||
161777497|NCT00568776|584227037|FG003|Overall Study|Protocol Violation|1|||
161777498|NCT00568776|584227034|FG000|Overall Study|Withdrawal by Subject|13|||
161777499|NCT00568776|584227035|FG001|Overall Study|Withdrawal by Subject|15|||
161777500|NCT00568776|584227036|FG002|Overall Study|Withdrawal by Subject|13|||
161777501|NCT00568776|584227037|FG003|Overall Study|Withdrawal by Subject|7|||
161777502|NCT00568776|584227034|FG000|Overall Study|Loss of Caregiver|0|||
161879823|NCT02017717|584602753|FG003|Treatment Period|Participant request to stop therapy|6|||
161879824|NCT02017717|584602754|FG004|Treatment Period|Participant request to stop therapy|0|||
161879825|NCT02017717|584602755|FG005|Treatment Period|Participant request to stop therapy|2|||
161777503|NCT00568776|584227035|FG001|Overall Study|Loss of Caregiver|2|||
161777504|NCT00568776|584227036|FG002|Overall Study|Loss of Caregiver|1|||
161777505|NCT00568776|584227037|FG003|Overall Study|Loss of Caregiver|2|||
161777506|NCT00568776|584227034|FG000|Overall Study|Sponsor Decision|2|||
161777507|NCT00568776|584227035|FG001|Overall Study|Sponsor Decision|2|||
161777508|NCT00568776|584227036|FG002|Overall Study|Sponsor Decision|41|||
161777509|NCT00568776|584227037|FG003|Overall Study|Sponsor Decision|42|||
161777510|NCT00568776|584227034|FG000|Overall Study|Miscellaeneous|3|||
161777511|NCT00568776|584227035|FG001|Overall Study|Miscellaeneous|3|||
161777512|NCT00568776|584227036|FG002|Overall Study|Miscellaeneous|1|||
161777513|NCT00568776|584227037|FG003|Overall Study|Miscellaeneous|4|||
161777514|NCT03576131|584227038|FG000|Overall Study|Investigator decision|0|||
161777515|NCT03576131|584227039|FG001|Overall Study|Investigator decision|0|||
161777516|NCT03576131|584227040|FG002|Overall Study|Investigator decision|0|||
161777517|NCT03576131|584227041|FG003|Overall Study|Investigator decision|1|||
161777518|NCT03576131|584227042|FG004|Overall Study|Investigator decision|0|||
161777519|NCT03576131|584227043|FG005|Overall Study|Investigator decision|1|||
161777520|NCT03576131|584227044|FG006|Overall Study|Investigator decision|0|||
161777521|NCT03576131|584227045|FG007|Overall Study|Investigator decision|0|||
161777522|NCT03576131|584227038|FG000|Overall Study|Withdrawal by Subject|1|||
161777523|NCT03576131|584227039|FG001|Overall Study|Withdrawal by Subject|1|||
161777524|NCT03576131|584227040|FG002|Overall Study|Withdrawal by Subject|0|||
161777525|NCT03576131|584227041|FG003|Overall Study|Withdrawal by Subject|1|||
161777526|NCT03576131|584227042|FG004|Overall Study|Withdrawal by Subject|2|||
161777527|NCT03576131|584227043|FG005|Overall Study|Withdrawal by Subject|3|||
161777528|NCT03576131|584227044|FG006|Overall Study|Withdrawal by Subject|1|||
161777529|NCT03576131|584227045|FG007|Overall Study|Withdrawal by Subject|0|||
161777530|NCT03576131|584227038|FG000|Overall Study|Death|3|||
161777531|NCT03576131|584227039|FG001|Overall Study|Death|3|||
161777532|NCT03576131|584227040|FG002|Overall Study|Death|1|||
161777533|NCT03576131|584227041|FG003|Overall Study|Death|5|||
161777534|NCT03576131|584227042|FG004|Overall Study|Death|4|||
161777535|NCT03576131|584227043|FG005|Overall Study|Death|1|||
161777536|NCT03576131|584227044|FG006|Overall Study|Death|0|||
161777537|NCT03576131|584227045|FG007|Overall Study|Death|1|||
161777538|NCT03576131|584227038|FG000|Overall Study|New anti-cancer treatment|5|||
161777539|NCT03576131|584227039|FG001|Overall Study|New anti-cancer treatment|1|||
161777540|NCT03576131|584227040|FG002|Overall Study|New anti-cancer treatment|2|||
161777541|NCT03576131|584227041|FG003|Overall Study|New anti-cancer treatment|3|||
161777542|NCT03576131|584227042|FG004|Overall Study|New anti-cancer treatment|0|||
161777543|NCT03576131|584227043|FG005|Overall Study|New anti-cancer treatment|0|||
161777544|NCT03576131|584227044|FG006|Overall Study|New anti-cancer treatment|0|||
161777545|NCT03576131|584227045|FG007|Overall Study|New anti-cancer treatment|0|||
161777546|NCT03576131|584227038|FG000|Overall Study|Unspecified reason|0|||
161777547|NCT03576131|584227039|FG001|Overall Study|Unspecified reason|0|||
161777548|NCT03576131|584227040|FG002|Overall Study|Unspecified reason|1|||
161777549|NCT03576131|584227041|FG003|Overall Study|Unspecified reason|1|||
161777550|NCT03576131|584227042|FG004|Overall Study|Unspecified reason|1|||
161777551|NCT03576131|584227043|FG005|Overall Study|Unspecified reason|1|||
161777552|NCT03576131|584227044|FG006|Overall Study|Unspecified reason|0|||
161777553|NCT03576131|584227045|FG007|Overall Study|Unspecified reason|0|||
161777554|NCT03576131|584227038|FG000|Overall Study|Subject non-compliance|0|||
161777555|NCT03576131|584227039|FG001|Overall Study|Subject non-compliance|0|||
161777556|NCT03576131|584227040|FG002|Overall Study|Subject non-compliance|0|||
161777557|NCT03576131|584227041|FG003|Overall Study|Subject non-compliance|0|||
161777558|NCT03576131|584227042|FG004|Overall Study|Subject non-compliance|0|||
161879826|NCT02017717|584602756|FG006|Treatment Period|Participant request to stop therapy|1|||
161879827|NCT02017717|584602757|FG007|Treatment Period|Participant request to stop therapy|4|||
161879828|NCT02017717|584602758|FG008|Treatment Period|Participant request to stop therapy|7|||
161777559|NCT03576131|584227043|FG005|Overall Study|Subject non-compliance|1|||
161777560|NCT03576131|584227044|FG006|Overall Study|Subject non-compliance|0|||
161777561|NCT03576131|584227045|FG007|Overall Study|Subject non-compliance|0|||
161777562|NCT01569594|584227050|FG000|Overall Study|Physician Decision|4|||
161777563|NCT01569594|584227050|FG000|Overall Study|Death|13|||
161777564|NCT01569594|584227050|FG000|Overall Study|Lost to Follow-up|22|||
161777565|NCT01569594|584227050|FG000|Overall Study|Adverse Event|2|||
161777566|NCT01569594|584227050|FG000|Overall Study|Withdrawal by Subject|13|||
161777567|NCT01569594|584227050|FG000|Overall Study|Other|4|||
161777568|NCT01569594|584227050|FG000|Overall Study|No ECM used|9|||
161777569|NCT00877799|584227051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
161777570|NCT00877799|584227052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
161777571|NCT00877799|584227053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
161777572|NCT00877799|584227054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
161777573|NCT00877799|584227055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
161879829|NCT02017717|584602750|FG000|Treatment Period|Participant withdrew consent|0|||
161879830|NCT02017717|584602751|FG001|Treatment Period|Participant withdrew consent|0|||
161777574|NCT00877799|584227051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
161777575|NCT00877799|584227052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
161777576|NCT00877799|584227053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
161777577|NCT00877799|584227054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
161777578|NCT00877799|584227055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
161777579|NCT00877799|584227051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777580|NCT00877799|584227052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
161777581|NCT00877799|584227053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777582|NCT00877799|584227054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777583|NCT00877799|584227055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777584|NCT00877799|584227051|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777585|NCT00877799|584227052|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777586|NCT00877799|584227053|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777587|NCT00877799|584227054|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
161777588|NCT00877799|584227055|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777589|NCT00877799|584227051|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161777590|NCT00877799|584227052|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161777591|NCT00877799|584227053|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161777592|NCT00877799|584227054|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
161777593|NCT00877799|584227055|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
161777594|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
161777595|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
161777596|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
161777597|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
161777598|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
161777599|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
161777600|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
161777601|NCT00566631|584227056|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
161777602|NCT00566631|584227056|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
161777603|NCT00566631|584227056|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
161777604|NCT00566631|584227056|FG000|Part 2: Extension Phase|Adverse Event|11|||
161777605|NCT00566631|584227056|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
161777606|NCT00566631|584227056|FG000|Part 2: Extension Phase|Death|1|||
161777607|NCT00566631|584227056|FG000|Part 2: Extension Phase|Other|5|||
161777608|NCT04054011|584227057|FG000|Overall Study|COVID|3|||
161777609|NCT01785472|584227058|FG000|Overall Study|Adverse Event|5|||
161777610|NCT01785472|584227059|FG001|Overall Study|Adverse Event|4|||
161777611|NCT01785472|584227060|FG002|Overall Study|Adverse Event|6|||
161777612|NCT01785472|584227058|FG000|Overall Study|Lack of Efficacy|2|||
161777613|NCT01785472|584227059|FG001|Overall Study|Lack of Efficacy|0|||
161777614|NCT01785472|584227060|FG002|Overall Study|Lack of Efficacy|1|||
161777615|NCT01785472|584227058|FG000|Overall Study|Lost to Follow-up|1|||
161777616|NCT01785472|584227059|FG001|Overall Study|Lost to Follow-up|2|||
161777617|NCT01785472|584227060|FG002|Overall Study|Lost to Follow-up|0|||
161777618|NCT01785472|584227058|FG000|Overall Study|Physician Decision|1|||
161777619|NCT01785472|584227059|FG001|Overall Study|Physician Decision|1|||
161777620|NCT01785472|584227060|FG002|Overall Study|Physician Decision|1|||
161777621|NCT01785472|584227058|FG000|Overall Study|Protocol deviation|0|||
161777622|NCT01785472|584227059|FG001|Overall Study|Protocol deviation|2|||
161777623|NCT01785472|584227060|FG002|Overall Study|Protocol deviation|2|||
161777624|NCT01785472|584227058|FG000|Overall Study|Subject/guardian decision|15|||
161777625|NCT01785472|584227059|FG001|Overall Study|Subject/guardian decision|10|||
161777626|NCT01785472|584227060|FG002|Overall Study|Subject/guardian decision|11|||
161777627|NCT01785472|584227058|FG000|Overall Study|Technical problems|0|||
161777628|NCT01785472|584227059|FG001|Overall Study|Technical problems|0|||
161777629|NCT01785472|584227060|FG002|Overall Study|Technical problems|1|||
161777630|NCT00595127|584227061|FG000|Overall Study|Death|6|||
161777631|NCT00595127|584227061|FG000|Overall Study|Relapsed|3|||
161777632|NCT00595127|584227061|FG000|Overall Study|joined another trial|1|||
161777633|NCT01803464|584227063|FG000|Overall Study|Incomplete data|0|||
161777634|NCT01803464|584227064|FG001|Overall Study|Incomplete data|0|||
161777635|NCT01803464|584227065|FG002|Overall Study|Incomplete data|4|||
161777636|NCT01803464|584227066|FG003|Overall Study|Incomplete data|0|||
161777637|NCT01803464|584227063|FG000|Overall Study|Withdrawal by Subject|1|||
161777638|NCT01803464|584227064|FG001|Overall Study|Withdrawal by Subject|0|||
161777639|NCT01803464|584227065|FG002|Overall Study|Withdrawal by Subject|0|||
161777640|NCT01803464|584227066|FG003|Overall Study|Withdrawal by Subject|0|||
161777641|NCT02860039|584227072|FG000|Overall Study|Death|4|||
161777642|NCT02860039|584227073|FG001|Overall Study|Death|0|||
161777643|NCT02860039|584227072|FG000|Overall Study|Lost to Follow-up|2|||
161777644|NCT02860039|584227073|FG001|Overall Study|Lost to Follow-up|2|||
161777645|NCT02860039|584227072|FG000|Overall Study|Protocol Violation|3|||
161777646|NCT02860039|584227073|FG001|Overall Study|Protocol Violation|1|||
161777647|NCT02860039|584227072|FG000|Overall Study|Withdrawal by Subject|1|||
161777648|NCT02860039|584227073|FG001|Overall Study|Withdrawal by Subject|0|||
161879831|NCT02017717|584602752|FG002|Treatment Period|Participant withdrew consent|1|||
161879832|NCT02017717|584602753|FG003|Treatment Period|Participant withdrew consent|0|||
161879833|NCT02017717|584602754|FG004|Treatment Period|Participant withdrew consent|0|||
161879834|NCT02017717|584602755|FG005|Treatment Period|Participant withdrew consent|2|||
161879835|NCT02017717|584602756|FG006|Treatment Period|Participant withdrew consent|0|||
161879836|NCT02017717|584602757|FG007|Treatment Period|Participant withdrew consent|1|||
161879837|NCT02017717|584602758|FG008|Treatment Period|Participant withdrew consent|4|||
161879838|NCT02017717|584602750|FG000|Treatment Period|Participant no longer met criteria|0|||
161879839|NCT02017717|584602751|FG001|Treatment Period|Participant no longer met criteria|0|||
161879840|NCT02017717|584602752|FG002|Treatment Period|Participant no longer met criteria|0|||
161879841|NCT02017717|584602753|FG003|Treatment Period|Participant no longer met criteria|0|||
161879842|NCT02017717|584602754|FG004|Treatment Period|Participant no longer met criteria|0|||
161879843|NCT02017717|584602755|FG005|Treatment Period|Participant no longer met criteria|0|||
161879844|NCT02017717|584602756|FG006|Treatment Period|Participant no longer met criteria|0|||
161879845|NCT02017717|584602757|FG007|Treatment Period|Participant no longer met criteria|0|||
161879846|NCT02017717|584602758|FG008|Treatment Period|Participant no longer met criteria|1|||
161879847|NCT02017717|584602750|FG000|Treatment Period|Other reasons|0|||
161879848|NCT02017717|584602751|FG001|Treatment Period|Other reasons|0|||
161879849|NCT02017717|584602752|FG002|Treatment Period|Other reasons|0|||
161879850|NCT02017717|584602753|FG003|Treatment Period|Other reasons|1|||
161879851|NCT02017717|584602754|FG004|Treatment Period|Other reasons|0|||
161879852|NCT02017717|584602755|FG005|Treatment Period|Other reasons|1|||
161879853|NCT02017717|584602756|FG006|Treatment Period|Other reasons|1|||
161879854|NCT02017717|584602757|FG007|Treatment Period|Other reasons|1|||
161879855|NCT02017717|584602758|FG008|Treatment Period|Other reasons|1|||
161879856|NCT02017717|584602750|FG000|Treatment Period|Maximum clinical benefit|0|||
161879857|NCT02017717|584602751|FG001|Treatment Period|Maximum clinical benefit|0|||
161777649|NCT02860039|584227072|FG000|Overall Study|Not otherwise eligible|1|||
161777650|NCT02860039|584227073|FG001|Overall Study|Not otherwise eligible|1|||
161777651|NCT02723786|584227076|FG000|Overall Study|Lost to Follow-up|1|||
161777652|NCT03170271|584227077|FG000|Overall Study|Adverse Event|7|||
161777653|NCT03170271|584227078|FG001|Overall Study|Adverse Event|2|||
161777654|NCT03170271|584227077|FG000|Overall Study|Lost to Follow-up|0|||
161777655|NCT03170271|584227078|FG001|Overall Study|Lost to Follow-up|1|||
161777656|NCT03170271|584227077|FG000|Overall Study|Physician Decision|1|||
161777657|NCT03170271|584227078|FG001|Overall Study|Physician Decision|0|||
161879858|NCT02017717|584602752|FG002|Treatment Period|Maximum clinical benefit|0|||
161879859|NCT02017717|584602753|FG003|Treatment Period|Maximum clinical benefit|0|||
161879860|NCT02017717|584602754|FG004|Treatment Period|Maximum clinical benefit|0|||
161879861|NCT02017717|584602755|FG005|Treatment Period|Maximum clinical benefit|0|||
161879862|NCT02017717|584602756|FG006|Treatment Period|Maximum clinical benefit|0|||
161879863|NCT02017717|584602757|FG007|Treatment Period|Maximum clinical benefit|0|||
161879864|NCT02017717|584602758|FG008|Treatment Period|Maximum clinical benefit|1|||
161879865|NCT02017717|584602750|FG000|Treatment Period|Not reported|0|||
161879866|NCT02017717|584602751|FG001|Treatment Period|Not reported|1|||
161879867|NCT02017717|584602752|FG002|Treatment Period|Not reported|0|||
161879868|NCT02017717|584602753|FG003|Treatment Period|Not reported|0|||
161879869|NCT02017717|584602754|FG004|Treatment Period|Not reported|0|||
161879870|NCT02017717|584602755|FG005|Treatment Period|Not reported|0|||
161879871|NCT02017717|584602756|FG006|Treatment Period|Not reported|0|||
161879872|NCT02017717|584602757|FG007|Treatment Period|Not reported|0|||
161879873|NCT02017717|584602758|FG008|Treatment Period|Not reported|0|||
161879874|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
161879875|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
161879876|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
161879877|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
161879878|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
161879879|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
161879880|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
161879881|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
161879882|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
161879883|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
161879884|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
161879885|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
161879886|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
161879887|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
161879888|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
161879889|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
161879890|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
161879891|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
161879892|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
161879893|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
161879894|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
161879895|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
161879896|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
161879897|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
161879898|NCT04488419|584602760|FG000|Primary Analysis Population|Adverse Event|6|||
161879899|NCT04488419|584602761|FG001|Primary Analysis Population|Adverse Event|9|||
161879900|NCT04488419|584602762|FG002|Primary Analysis Population|Adverse Event|0|||
161879901|NCT04488419|584602760|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
161879902|NCT04488419|584602761|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
161879903|NCT04488419|584602762|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
161879904|NCT04488419|584602760|FG000|Primary Analysis Population|Protocol Violation|1|||
161879905|NCT04488419|584602761|FG001|Primary Analysis Population|Protocol Violation|1|||
161879906|NCT04488419|584602762|FG002|Primary Analysis Population|Protocol Violation|0|||
161879907|NCT04488419|584602760|FG000|Primary Analysis Population|Undetermined|7|||
161879908|NCT04488419|584602761|FG001|Primary Analysis Population|Undetermined|3|||
161879909|NCT04488419|584602762|FG002|Primary Analysis Population|Undetermined|0|||
161879910|NCT04488419|584602760|FG000|Primary Analysis Population|>1 Reason|2|||
161879911|NCT04488419|584602761|FG001|Primary Analysis Population|>1 Reason|4|||
161879912|NCT04488419|584602762|FG002|Primary Analysis Population|>1 Reason|0|||
161879913|NCT00970632|584602768|FG000|Overall Study|Adverse Event|2|||
161879914|NCT00970632|584602769|FG001|Overall Study|Adverse Event|2|||
161879915|NCT00970632|584602770|FG002|Overall Study|Adverse Event|1|||
161777658|NCT03170271|584227077|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
161777659|NCT03170271|584227078|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
161777660|NCT03170271|584227077|FG000|Overall Study|Withdrawal by Subject|17|||
161777661|NCT03170271|584227078|FG001|Overall Study|Withdrawal by Subject|5|||
161777662|NCT03170271|584227077|FG000|Overall Study|Other|2|||
161777663|NCT03170271|584227078|FG001|Overall Study|Other|2|||
161777664|NCT03170271|584227077|FG000|Overall Study|Randomized in error|4|||
161777665|NCT03170271|584227078|FG001|Overall Study|Randomized in error|0|||
161777666|NCT01125358|584227081|FG000|Overall Study|Adverse Event|3|||
161777667|NCT01125358|584227082|FG001|Overall Study|Adverse Event|0|||
161777668|NCT01125358|584227083|FG002|Overall Study|Adverse Event|0|||
161777669|NCT01125358|584227084|FG003|Overall Study|Adverse Event|2|||
161777670|NCT01125358|584227081|FG000|Overall Study|Perceived Lack of Efficacy|6|||
161879916|NCT00970632|584602768|FG000|Overall Study|Lack of Efficacy|3|||
161879917|NCT00970632|584602769|FG001|Overall Study|Lack of Efficacy|0|||
161879918|NCT00970632|584602770|FG002|Overall Study|Lack of Efficacy|0|||
161879919|NCT00970632|584602768|FG000|Overall Study|Lost to Follow-up|3|||
161879920|NCT00970632|584602769|FG001|Overall Study|Lost to Follow-up|0|||
161879921|NCT00970632|584602770|FG002|Overall Study|Lost to Follow-up|2|||
161879922|NCT00970632|584602768|FG000|Overall Study|Protocol Violation|8|||
161879923|NCT00970632|584602769|FG001|Overall Study|Protocol Violation|5|||
161879924|NCT00970632|584602770|FG002|Overall Study|Protocol Violation|8|||
161879925|NCT00970632|584602768|FG000|Overall Study|Withdrawal by Subject|7|||
161879926|NCT00970632|584602769|FG001|Overall Study|Withdrawal by Subject|6|||
161879927|NCT00970632|584602770|FG002|Overall Study|Withdrawal by Subject|4|||
161879928|NCT00970632|584602768|FG000|Overall Study|Entry criteria not met|0|||
161879929|NCT00970632|584602769|FG001|Overall Study|Entry criteria not met|2|||
161879930|NCT00970632|584602770|FG002|Overall Study|Entry criteria not met|2|||
161879931|NCT00970632|584602768|FG000|Overall Study|Sponsor decision|1|||
161879932|NCT00970632|584602769|FG001|Overall Study|Sponsor decision|0|||
161879933|NCT00970632|584602770|FG002|Overall Study|Sponsor decision|1|||
161879934|NCT01286168|584602777|FG000|Overall Study|Withdrawal by Subject|1|||
161879935|NCT01286168|584602777|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
161879936|NCT02487771|584602778|FG000|Overall Study|Lost to Follow-up|2|||
161879937|NCT02487771|584602779|FG001|Overall Study|Lost to Follow-up|3|||
161879938|NCT02487771|584602778|FG000|Overall Study|Moved out of area|5|||
161879939|NCT02487771|584602779|FG001|Overall Study|Moved out of area|6|||
161879940|NCT02487771|584602778|FG000|Overall Study|Withdrawal by Subject|3|||
161879941|NCT02487771|584602779|FG001|Overall Study|Withdrawal by Subject|5|||
161879942|NCT01482065|584602782|FG000|Overall Study|Withdrawal by Subject|0|||
161879943|NCT01482065|584602783|FG001|Overall Study|Withdrawal by Subject|1|||
161879944|NCT03728426|584602784|FG000|Overall Study|Death|3|||
161879945|NCT02682823|584602785|FG000|Overall Study|Withdrawal by Subject|0|||
161879946|NCT02682823|584602786|FG001|Overall Study|Withdrawal by Subject|0|||
161879947|NCT02682823|584602787|FG002|Overall Study|Withdrawal by Subject|1|||
161879948|NCT02682823|584602788|FG003|Overall Study|Withdrawal by Subject|0|||
161879949|NCT02682823|584602789|FG004|Overall Study|Withdrawal by Subject|1|||
161879950|NCT02682823|584602785|FG000|Overall Study|Protocol Deviation|0|||
161879951|NCT02682823|584602786|FG001|Overall Study|Protocol Deviation|1|||
161879952|NCT02682823|584602787|FG002|Overall Study|Protocol Deviation|0|||
161879953|NCT02682823|584602788|FG003|Overall Study|Protocol Deviation|0|||
161879954|NCT02682823|584602789|FG004|Overall Study|Protocol Deviation|0|||
161879955|NCT02682823|584602785|FG000|Overall Study|Adverse Event|0|||
161879956|NCT02682823|584602786|FG001|Overall Study|Adverse Event|0|||
161879957|NCT02682823|584602787|FG002|Overall Study|Adverse Event|0|||
161879958|NCT02682823|584602788|FG003|Overall Study|Adverse Event|1|||
161879959|NCT02682823|584602789|FG004|Overall Study|Adverse Event|0|||
161879960|NCT01741792|584602790|FG000|Overall Study|Death|6|||
161879961|NCT01741792|584602791|FG001|Overall Study|Death|1|||
161879962|NCT01741792|584602792|FG002|Overall Study|Death|12|||
161879963|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
161879964|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
161879965|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
161879966|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
161879967|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
161879968|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
161879969|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
161879970|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
161879971|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
161879972|NCT02045862|584602794|FG000|Overall Study|Death|0|||
161879973|NCT02045862|584602795|FG001|Overall Study|Death|0|||
161879974|NCT02045862|584602796|FG002|Overall Study|Death|1|||
161879975|NCT02045862|584602794|FG000|Overall Study|Miscellaneous|5|||
161879976|NCT02045862|584602795|FG001|Overall Study|Miscellaneous|0|||
161879977|NCT02045862|584602796|FG002|Overall Study|Miscellaneous|8|||
161879978|NCT02045862|584602794|FG000|Overall Study|Withdrawal by Patient|18|||
161879979|NCT02045862|584602795|FG001|Overall Study|Withdrawal by Patient|27|||
161879980|NCT02045862|584602796|FG002|Overall Study|Withdrawal by Patient|57|||
161879981|NCT02045862|584602794|FG000|Overall Study|Protocol Violation|0|||
161879982|NCT02045862|584602795|FG001|Overall Study|Protocol Violation|0|||
161879983|NCT02045862|584602796|FG002|Overall Study|Protocol Violation|6|||
161879984|NCT02045862|584602794|FG000|Overall Study|Lack of Efficacy|8|||
161879985|NCT02045862|584602795|FG001|Overall Study|Lack of Efficacy|4|||
161879986|NCT02045862|584602796|FG002|Overall Study|Lack of Efficacy|13|||
161879987|NCT02045862|584602794|FG000|Overall Study|Randomized but not Received Study Drug|0|||
161879988|NCT02045862|584602795|FG001|Overall Study|Randomized but not Received Study Drug|2|||
161879989|NCT02045862|584602796|FG002|Overall Study|Randomized but not Received Study Drug|8|||
161879990|NCT02045862|584602794|FG000|Overall Study|Adverse Event|7|||
161879991|NCT02045862|584602795|FG001|Overall Study|Adverse Event|5|||
161879992|NCT02045862|584602796|FG002|Overall Study|Adverse Event|27|||
161879993|NCT02045862|584602794|FG000|Overall Study|Lost to Follow-up|1|||
161879994|NCT02045862|584602795|FG001|Overall Study|Lost to Follow-up|2|||
161879995|NCT02045862|584602796|FG002|Overall Study|Lost to Follow-up|6|||
161879996|NCT02353442|584602801|FG000|Overall Study|Withdrawal by Subject|3|||
161879997|NCT02353442|584602802|FG001|Overall Study|Withdrawal by Subject|4|||
161879998|NCT01075646|584602805|FG000|Overall Study|Lost to Follow-up|4|||
161879999|NCT01075646|584602806|FG001|Overall Study|Lost to Follow-up|3|||
161880000|NCT01075646|584602807|FG002|Overall Study|Lost to Follow-up|1|||
161880001|NCT01075646|584602808|FG003|Overall Study|Lost to Follow-up|2|||
161880002|NCT02004886|584602812|FG000|Overall Study|Adverse Event|0|||
161880003|NCT02004886|584602813|FG001|Overall Study|Adverse Event|1|||
161880004|NCT02004886|584602814|FG002|Overall Study|Adverse Event|0|||
161880005|NCT02004886|584602815|FG003|Overall Study|Adverse Event|0|||
161880006|NCT02004886|584602812|FG000|Overall Study|Unable to attend future visits|1|||
161880007|NCT02004886|584602813|FG001|Overall Study|Unable to attend future visits|0|||
161880008|NCT02004886|584602814|FG002|Overall Study|Unable to attend future visits|0|||
161880009|NCT02004886|584602815|FG003|Overall Study|Unable to attend future visits|0|||
161880010|NCT05239494|584602817|FG000|Overall Study|Lost to Follow-up|1|||
161880011|NCT02822573|584602818|FG000|Overall Study|Lost to Follow-up|5|||
161880012|NCT02822573|584602819|FG001|Overall Study|Lost to Follow-up|3|||
161880013|NCT02822573|584602818|FG000|Overall Study|Physician Decision|1|||
161880014|NCT02822573|584602819|FG001|Overall Study|Physician Decision|1|||
161880015|NCT02822573|584602818|FG000|Overall Study|Withdrawal by Subject|9|||
161880016|NCT02822573|584602819|FG001|Overall Study|Withdrawal by Subject|5|||
161880017|NCT02822573|584602818|FG000|Overall Study|Protocol Violation|6|||
161880018|NCT02822573|584602819|FG001|Overall Study|Protocol Violation|4|||
161880019|NCT02822573|584602818|FG000|Overall Study|Too sick or ill|2|||
161880020|NCT02822573|584602819|FG001|Overall Study|Too sick or ill|1|||
161880021|NCT02822573|584602818|FG000|Overall Study|Disease Progression|1|||
161880022|NCT02822573|584602819|FG001|Overall Study|Disease Progression|1|||
161880023|NCT02822573|584602818|FG000|Overall Study|No reason given|6|||
161880024|NCT02822573|584602819|FG001|Overall Study|No reason given|4|||
161880025|NCT02892422|584602820|FG000|Overall Study|Enrolled not treated|4|||
161880026|NCT02892422|584602820|FG000|Overall Study|Adverse Event|38|||
161880027|NCT02892422|584602820|FG000|Overall Study|Lack of Efficacy|32|||
161880028|NCT02892422|584602820|FG000|Overall Study|Non-compliance with study drug|11|||
161880029|NCT02892422|584602820|FG000|Overall Study|Protocol Violation|4|||
161880030|NCT02892422|584602820|FG000|Overall Study|Withdrawal by Subject|56|||
161880031|NCT02892422|584602820|FG000|Overall Study|Lost to Follow-up|5|||
161880032|NCT02892422|584602820|FG000|Overall Study|sponsor information 16159A results|21|||
161880033|NCT02892422|584602820|FG000|Overall Study|withdrawal of consent|13|||
161880034|NCT02892422|584602820|FG000|Overall Study|exclusion criteria met|3|||
161880035|NCT02892422|584602820|FG000|Overall Study|moving elsewhere|4|||
161880036|NCT02892422|584602820|FG000|Overall Study|non-compliance|10|||
161880037|NCT02892422|584602820|FG000|Overall Study|patient legally incapable|1|||
161880038|NCT02892422|584602820|FG000|Overall Study|patient decision|7|||
161880039|NCT02892422|584602820|FG000|Overall Study|Investigator decision|1|||
161880040|NCT02855359|584602821|FG000|Overall Study|Death|2|||
161880041|NCT02855359|584602822|FG001|Overall Study|Death|2|||
161880042|NCT02855359|584602823|FG002|Overall Study|Death|0|||
161880043|NCT02855359|584602824|FG003|Overall Study|Death|0|||
161880044|NCT02855359|584602821|FG000|Overall Study|Study Termination by Sponsor|9|||
161880045|NCT02855359|584602822|FG001|Overall Study|Study Termination by Sponsor|11|||
161880046|NCT02855359|584602823|FG002|Overall Study|Study Termination by Sponsor|0|||
161880047|NCT02855359|584602824|FG003|Overall Study|Study Termination by Sponsor|0|||
161880048|NCT03155178|584602825|FG000|Overall Study|Did not meet treatment day baseline|7|||
161880049|NCT03155178|584602826|FG001|Overall Study|Did not meet treatment day baseline|7|||
161880050|NCT03155178|584602827|FG002|Overall Study|Did not meet treatment day baseline|7|||
161880051|NCT03155178|584602828|FG003|Overall Study|Did not meet treatment day baseline|7|||
161880052|NCT00759785|584602829|FG000|Overall Study|Participant sample not evaluable|11|||
161880053|NCT00759785|584602830|FG001|Overall Study|Participant sample not evaluable|2|||
161880054|NCT00759785|584602829|FG000|Overall Study|Participant sample lost|0|||
161880055|NCT00759785|584602830|FG001|Overall Study|Participant sample lost|1|||
161880056|NCT00759785|584602829|FG000|Overall Study|Protocol Violation|1|||
161880057|NCT00759785|584602830|FG001|Overall Study|Protocol Violation|0|||
161880058|NCT00759785|584602829|FG000|Overall Study|Physician Decision|0|||
161880059|NCT00759785|584602830|FG001|Overall Study|Physician Decision|1|||
161880060|NCT00759785|584602829|FG000|Overall Study|Withdrawal by Subject|0|||
161880061|NCT00759785|584602830|FG001|Overall Study|Withdrawal by Subject|1|||
161880062|NCT03729570|584602834|FG000|Overall Study|Lost to Follow-up|16|||
161880063|NCT03729570|584602835|FG001|Overall Study|Lost to Follow-up|20|||
161880064|NCT03729570|584602834|FG000|Overall Study|Seroconversion|5|||
161880065|NCT03729570|584602835|FG001|Overall Study|Seroconversion|0|||
161880066|NCT03729570|584602834|FG000|Overall Study|Moved out of the city|1|||
161880067|NCT03729570|584602835|FG001|Overall Study|Moved out of the city|0|||
161880068|NCT03729570|584602834|FG000|Overall Study|Time Conflict|1|||
161880069|NCT03729570|584602835|FG001|Overall Study|Time Conflict|0|||
161880070|NCT03729570|584602834|FG000|Overall Study|Time Commitment|2|||
161880071|NCT03729570|584602835|FG001|Overall Study|Time Commitment|0|||
161880072|NCT03729570|584602834|FG000|Overall Study|Bad Experience|0|||
161880073|NCT03729570|584602835|FG001|Overall Study|Bad Experience|1|||
161880074|NCT03729570|584602834|FG000|Overall Study|No reason provided|2|||
161880075|NCT03729570|584602835|FG001|Overall Study|No reason provided|1|||
161880076|NCT03729570|584602834|FG000|Overall Study|Family Conflict|0|||
161880077|NCT03729570|584602835|FG001|Overall Study|Family Conflict|1|||
161880078|NCT03729570|584602834|FG000|Overall Study|Did not want to continue taking medications|0|||
161880079|NCT03729570|584602835|FG001|Overall Study|Did not want to continue taking medications|1|||
161880080|NCT03729570|584602834|FG000|Overall Study|Found another PrEP provider|1|||
161880081|NCT03729570|584602835|FG001|Overall Study|Found another PrEP provider|0|||
161880082|NCT03729570|584602834|FG000|Overall Study|Did not enjoy being in the control group|0|||
161880083|NCT03729570|584602835|FG001|Overall Study|Did not enjoy being in the control group|1|||
161880084|NCT00631410|584602836|FG000|Overall Study|Adverse Event|1|||
161880085|NCT00631410|584602837|FG001|Overall Study|Adverse Event|3|||
161880086|NCT00631410|584602836|FG000|Overall Study|Objective Progression or Relapse|4|||
161880087|NCT00631410|584602837|FG001|Overall Study|Objective Progression or Relapse|3|||
161880088|NCT00631410|584602836|FG000|Overall Study|Surgery|1|||
161880089|NCT00631410|584602837|FG001|Overall Study|Surgery|0|||
161880090|NCT02858180|584602838|FG000|Overall Study|Lost to Follow-up|0|||
161880091|NCT02858180|584602839|FG001|Overall Study|Lost to Follow-up|2|||
161880092|NCT01054196|584602840|FG000|Overall Study|Physician Decision|0|||
161880093|NCT01054196|584602841|FG001|Overall Study|Physician Decision|0|||
161880094|NCT01054196|584602842|FG002|Overall Study|Physician Decision|0|||
161880095|NCT01054196|584602843|FG003|Overall Study|Physician Decision|1|||
161880096|NCT01054196|584602844|FG004|Overall Study|Physician Decision|0|||
161880097|NCT01054196|584602845|FG005|Overall Study|Physician Decision|0|||
161880098|NCT01054196|584602846|FG006|Overall Study|Physician Decision|1|||
161880099|NCT03843632|584602851|FG000|Overall Study|Withdrawal by Subject|1|||
161880100|NCT03843632|584602852|FG001|Overall Study|Withdrawal by Subject|0|||
161880101|NCT03843632|584602853|FG002|Overall Study|Withdrawal by Subject|0|||
161880102|NCT03843632|584602854|FG003|Overall Study|Withdrawal by Subject|0|||
161880103|NCT01820572|584602855|FG000|Randomization|Not Treated|2|||
161880104|NCT01820572|584602856|FG001|Randomization|Not Treated|1|||
161880105|NCT01820572|584602855|FG000|Treatment Period|Adverse Event|12|||
161880106|NCT01820572|584602856|FG001|Treatment Period|Adverse Event|7|||
161880107|NCT01820572|584602855|FG000|Treatment Period|Death|3|||
161880108|NCT01820572|584602856|FG001|Treatment Period|Death|3|||
161880109|NCT01820572|584602855|FG000|Treatment Period|Lack of Efficacy|1|||
161880110|NCT01820572|584602856|FG001|Treatment Period|Lack of Efficacy|0|||
161880111|NCT01820572|584602855|FG000|Treatment Period|poor/non compliance|0|||
161880112|NCT01820572|584602856|FG001|Treatment Period|poor/non compliance|3|||
161880113|NCT01820572|584602855|FG000|Treatment Period|request to discontinue|6|||
161880114|NCT01820572|584602856|FG001|Treatment Period|request to discontinue|11|||
161880115|NCT01820572|584602855|FG000|Treatment Period|No longer meets study criteria|3|||
161880116|NCT01820572|584602856|FG001|Treatment Period|No longer meets study criteria|10|||
161880117|NCT01820572|584602855|FG000|Treatment Period|withdrew consent|1|||
161880118|NCT01820572|584602856|FG001|Treatment Period|withdrew consent|2|||
161880119|NCT00595517|584602857|FG000|Overall Study|Adverse Event|6|||
161880120|NCT00595517|584602857|FG000|Overall Study|Withdrawal by Subject|4|||
161880121|NCT00595517|584602857|FG000|Overall Study|Protocol Violation|2|||
161880122|NCT00595517|584602857|FG000|Overall Study|Recurrence of ulcer|5|||
161880123|NCT00595517|584602857|FG000|Overall Study|usage of prohibited treatment|1|||
161880124|NCT00595517|584602857|FG000|Overall Study|No intention to attend regularly|1|||
161880125|NCT00387010|584602860|FG000|Dose Titration Period|Adverse Event|12|||
161880126|NCT00387010|584602860|FG000|Dose Titration Period|Lack of Efficacy|5|||
161880127|NCT00387010|584602860|FG000|Dose Titration Period|Withdrawal by Subject|3|||
161880128|NCT00387010|584602860|FG000|Dose Titration Period|Protocol Violation|1|||
161880129|NCT00387010|584602860|FG000|Dose Titration Period|Lost to Follow-up|2|||
161880130|NCT00387010|584602860|FG000|Dose Titration Period|Noncompliance with study medication|8|||
161880131|NCT00387010|584602860|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
161880132|NCT00387010|584602860|FG000|Treatment Period|Adverse Event|4|||
161880133|NCT00387010|584602860|FG000|Treatment Period|Withdrawal by Subject|1|||
161880134|NCT00387010|584602860|FG000|Treatment Period|Noncompliance with study medication|2|||
161880135|NCT00387010|584602860|FG000|Treatment Period|Noncompliance with study procedures|3|||
161880136|NCT00387010|584602860|FG000|Treatment Period|Participant reported study drug stolen|1|||
161880137|NCT01167881|584602863|FG000|Overall Study|Adverse Event|47|||
161880138|NCT01167881|584602864|FG001|Overall Study|Adverse Event|51|||
161880139|NCT01167881|584602863|FG000|Overall Study|Lack of Efficacy|4|||
161880140|NCT01167881|584602864|FG001|Overall Study|Lack of Efficacy|7|||
161880141|NCT01167881|584602863|FG000|Overall Study|Non compliant with protocol|9|||
161880142|NCT01167881|584602864|FG001|Overall Study|Non compliant with protocol|18|||
161880143|NCT01167881|584602863|FG000|Overall Study|Lost to Follow-up|19|||
161880144|NCT01167881|584602864|FG001|Overall Study|Lost to Follow-up|20|||
161880145|NCT01167881|584602863|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
161880146|NCT01167881|584602864|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
161880147|NCT01167881|584602863|FG000|Overall Study|Not treated|4|||
161880148|NCT01167881|584602864|FG001|Overall Study|Not treated|0|||
161880149|NCT01167881|584602863|FG000|Overall Study|Other not defined above|31|||
161880150|NCT01167881|584602864|FG001|Overall Study|Other not defined above|55|||
161880151|NCT01668173|584602869|FG000|Overall Study|Adverse Event|3|||
161880152|NCT01668173|584602869|FG000|Overall Study|Trial suspension|4|||
161880153|NCT01295827|584602870|FG000|Overall Study|Adverse Event|1|||
161880154|NCT01295827|584602871|FG001|Overall Study|Adverse Event|2|||
161880155|NCT01295827|584602872|FG002|Overall Study|Adverse Event|2|||
161880156|NCT01295827|584602873|FG003|Overall Study|Adverse Event|1|||
161880157|NCT01295827|584602874|FG004|Overall Study|Adverse Event|1|||
161880158|NCT01295827|584602875|FG005|Overall Study|Adverse Event|4|||
161880159|NCT01295827|584602876|FG006|Overall Study|Adverse Event|15|||
161880160|NCT01295827|584602877|FG007|Overall Study|Adverse Event|49|||
161880161|NCT01295827|584602878|FG008|Overall Study|Adverse Event|22|||
161880162|NCT01295827|584602879|FG009|Overall Study|Adverse Event|7|||
161880163|NCT01295827|584602880|FG010|Overall Study|Adverse Event|50|||
161880164|NCT01295827|584602881|FG011|Overall Study|Adverse Event|21|||
161880165|NCT01295827|584602882|FG012|Overall Study|Adverse Event|0|||
161880166|NCT01295827|584602883|FG013|Overall Study|Adverse Event|0|||
161880167|NCT01295827|584602884|FG014|Overall Study|Adverse Event|0|||
161880168|NCT01295827|584602870|FG000|Overall Study|Lost to Follow-up|0|||
161880169|NCT01295827|584602871|FG001|Overall Study|Lost to Follow-up|0|||
161880170|NCT01295827|584602872|FG002|Overall Study|Lost to Follow-up|3|||
161880171|NCT01295827|584602873|FG003|Overall Study|Lost to Follow-up|0|||
161880172|NCT01295827|584602874|FG004|Overall Study|Lost to Follow-up|1|||
161880173|NCT01295827|584602875|FG005|Overall Study|Lost to Follow-up|0|||
161880174|NCT01295827|584602876|FG006|Overall Study|Lost to Follow-up|4|||
161880175|NCT01295827|584602877|FG007|Overall Study|Lost to Follow-up|8|||
161880176|NCT01295827|584602878|FG008|Overall Study|Lost to Follow-up|7|||
161880177|NCT01295827|584602879|FG009|Overall Study|Lost to Follow-up|4|||
161880178|NCT01295827|584602880|FG010|Overall Study|Lost to Follow-up|7|||
161880179|NCT01295827|584602881|FG011|Overall Study|Lost to Follow-up|3|||
161880180|NCT01295827|584602882|FG012|Overall Study|Lost to Follow-up|0|||
161880181|NCT01295827|584602883|FG013|Overall Study|Lost to Follow-up|0|||
161880182|NCT01295827|584602884|FG014|Overall Study|Lost to Follow-up|0|||
161880183|NCT01295827|584602870|FG000|Overall Study|Not Reported|0|||
161880184|NCT01295827|584602871|FG001|Overall Study|Not Reported|0|||
161880185|NCT01295827|584602872|FG002|Overall Study|Not Reported|0|||
161880186|NCT01295827|584602873|FG003|Overall Study|Not Reported|1|||
161880187|NCT01295827|584602874|FG004|Overall Study|Not Reported|0|||
161880188|NCT01295827|584602875|FG005|Overall Study|Not Reported|0|||
161880189|NCT01295827|584602876|FG006|Overall Study|Not Reported|24|||
161880190|NCT01295827|584602877|FG007|Overall Study|Not Reported|58|||
161880191|NCT01295827|584602878|FG008|Overall Study|Not Reported|41|||
161880192|NCT01295827|584602879|FG009|Overall Study|Not Reported|2|||
161880193|NCT01295827|584602880|FG010|Overall Study|Not Reported|23|||
161880194|NCT01295827|584602881|FG011|Overall Study|Not Reported|13|||
161880195|NCT01295827|584602882|FG012|Overall Study|Not Reported|0|||
161880196|NCT01295827|584602883|FG013|Overall Study|Not Reported|0|||
161880197|NCT01295827|584602884|FG014|Overall Study|Not Reported|0|||
161880198|NCT01295827|584602870|FG000|Overall Study|Progressive Disease|2|||
161880199|NCT01295827|584602871|FG001|Overall Study|Progressive Disease|1|||
161880200|NCT01295827|584602872|FG002|Overall Study|Progressive Disease|5|||
161880201|NCT01295827|584602873|FG003|Overall Study|Progressive Disease|2|||
161880202|NCT01295827|584602874|FG004|Overall Study|Progressive Disease|0|||
161880203|NCT01295827|584602875|FG005|Overall Study|Progressive Disease|1|||
161880204|NCT01295827|584602876|FG006|Overall Study|Progressive Disease|87|||
161880205|NCT01295827|584602877|FG007|Overall Study|Progressive Disease|144|||
161880206|NCT01295827|584602878|FG008|Overall Study|Progressive Disease|85|||
161880207|NCT01295827|584602879|FG009|Overall Study|Progressive Disease|40|||
161880208|NCT01295827|584602880|FG010|Overall Study|Progressive Disease|175|||
161880209|NCT01295827|584602881|FG011|Overall Study|Progressive Disease|136|||
161880210|NCT01295827|584602882|FG012|Overall Study|Progressive Disease|0|||
161880211|NCT01295827|584602883|FG013|Overall Study|Progressive Disease|0|||
161880212|NCT01295827|584602884|FG014|Overall Study|Progressive Disease|0|||
161880213|NCT01295827|584602870|FG000|Overall Study|Screen Failure|0|||
161880214|NCT01295827|584602871|FG001|Overall Study|Screen Failure|0|||
161880215|NCT01295827|584602872|FG002|Overall Study|Screen Failure|0|||
161880216|NCT01295827|584602873|FG003|Overall Study|Screen Failure|0|||
161880217|NCT01295827|584602874|FG004|Overall Study|Screen Failure|0|||
161880218|NCT01295827|584602875|FG005|Overall Study|Screen Failure|0|||
161880219|NCT01295827|584602876|FG006|Overall Study|Screen Failure|2|||
161880220|NCT01295827|584602877|FG007|Overall Study|Screen Failure|2|||
161777671|NCT01125358|584227082|FG001|Overall Study|Perceived Lack of Efficacy|3|||
161777672|NCT01125358|584227083|FG002|Overall Study|Perceived Lack of Efficacy|7|||
161777673|NCT01125358|584227084|FG003|Overall Study|Perceived Lack of Efficacy|4|||
161777674|NCT01125358|584227081|FG000|Overall Study|Protocol Violation|1|||
161777675|NCT01125358|584227082|FG001|Overall Study|Protocol Violation|0|||
161777676|NCT01125358|584227083|FG002|Overall Study|Protocol Violation|0|||
161777677|NCT01125358|584227084|FG003|Overall Study|Protocol Violation|0|||
161777678|NCT01125358|584227081|FG000|Overall Study|Sponsor Decision|0|||
161777679|NCT01125358|584227082|FG001|Overall Study|Sponsor Decision|0|||
161777680|NCT01125358|584227083|FG002|Overall Study|Sponsor Decision|1|||
161777681|NCT01125358|584227084|FG003|Overall Study|Sponsor Decision|1|||
161777682|NCT01125358|584227081|FG000|Overall Study|Withdrawal by Subject|2|||
161777683|NCT01125358|584227082|FG001|Overall Study|Withdrawal by Subject|1|||
161777684|NCT01125358|584227083|FG002|Overall Study|Withdrawal by Subject|1|||
161777685|NCT01125358|584227084|FG003|Overall Study|Withdrawal by Subject|1|||
161777686|NCT01060007|584227085|FG000|Overall Study|Withdrawal by Subject|1|||
161777687|NCT01060007|584227085|FG000|Overall Study|Inevaluable for response at surgery|3|||
161777688|NCT04935931|584227091|FG000|Overall Study|Withdrawal by Subject|1|||
161777689|NCT02628418|584227094|FG000|Overall Study|Lost to Follow-up|1|||
161777690|NCT02628418|584227095|FG001|Overall Study|Lost to Follow-up|2|||
161777691|NCT03159611|584227099|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
161777692|NCT03159611|584227100|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
161777693|NCT03159611|584227099|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
161777694|NCT03159611|584227100|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
161777695|NCT03159611|584227099|FG000|Overall Study|Protocol Violation|7|||
161777696|NCT03159611|584227100|FG001|Overall Study|Protocol Violation|4|||
161777697|NCT03159611|584227099|FG000|Overall Study|Adverse Event|1|||
161777698|NCT03159611|584227100|FG001|Overall Study|Adverse Event|0|||
161777699|NCT03159611|584227099|FG000|Overall Study|Withdrawal by Subject|1|||
161777700|NCT03159611|584227100|FG001|Overall Study|Withdrawal by Subject|1|||
161777701|NCT03159611|584227099|FG000|Overall Study|Non-compliance with protocol requirement|3|||
161777702|NCT03159611|584227100|FG001|Overall Study|Non-compliance with protocol requirement|2|||
161777703|NCT03159611|584227099|FG000|Overall Study|Inability to perform procedures|1|||
161777704|NCT03159611|584227100|FG001|Overall Study|Inability to perform procedures|0|||
161777705|NCT01984229|584227101|FG000|Safety Follow-up Period|Adverse Event|1|||
161777706|NCT01984229|584227102|FG001|Safety Follow-up Period|Adverse Event|1|||
161777707|NCT01984229|584227101|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
161777708|NCT01984229|584227102|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161777709|NCT02072174|584227103|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
161777710|NCT02072174|584227104|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
161777711|NCT02072174|584227103|FG000|Overall Study|Protocol Violation|16|||
161777712|NCT02072174|584227104|FG001|Overall Study|Protocol Violation|23|||
161777713|NCT02072174|584227103|FG000|Overall Study|Physician Decision|0|||
161777714|NCT02072174|584227104|FG001|Overall Study|Physician Decision|1|||
161777715|NCT02072174|584227103|FG000|Overall Study|Non-compliance with protocol requirement|2|||
161777716|NCT02072174|584227104|FG001|Overall Study|Non-compliance with protocol requirement|0|||
161777717|NCT01608321|584227109|FG000|Overall Study|Withdrawal by Subject|1|||
161777718|NCT01608321|584227110|FG001|Overall Study|Withdrawal by Subject|0|||
161777719|NCT03222856|584227111|FG000|Overall Study|Adverse Event|6|||
161777720|NCT03222856|584227111|FG000|Overall Study|Death|1|||
161777721|NCT03457727|584228778|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161777722|NCT03457727|584228779|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161777723|NCT03457727|584228780|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161777724|NCT03457727|584228781|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
161777725|NCT00929201|584228782|FG000|Period 1|Withdrawal by Subject|0|||
161777726|NCT00929201|584228783|FG001|Period 1|Withdrawal by Subject|1|||
161777727|NCT00388674|584228789|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
161777728|NCT00388674|584228790|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
161777729|NCT00388674|584228789|FG000|Initial Treatment|Adverse Event|22|||
161777730|NCT00388674|584228790|FG001|Initial Treatment|Adverse Event|87|||
161777731|NCT00388674|584228789|FG000|Initial Treatment|Death|215|||
161777732|NCT00388674|584228790|FG001|Initial Treatment|Death|216|||
161777733|NCT00388674|584228789|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
161777734|NCT00388674|584228790|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
161777735|NCT00388674|584228789|FG000|Initial Treatment|HCC|12|||
161777736|NCT00388674|584228790|FG001|Initial Treatment|HCC|20|||
161777737|NCT00388674|584228789|FG000|Initial Treatment|Lost to Follow-up|526|||
161777738|NCT00388674|584228790|FG001|Initial Treatment|Lost to Follow-up|624|||
161777739|NCT00388674|584228789|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
161777740|NCT00388674|584228790|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
161777741|NCT00388674|584228789|FG000|Initial Treatment|Never Treated with Study Medication|1|||
161777742|NCT00388674|584228790|FG001|Initial Treatment|Never Treated with Study Medication|7|||
161777743|NCT00388674|584228789|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
161777744|NCT00388674|584228790|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
161777745|NCT00388674|584228789|FG000|Initial Treatment|Not Defined|125|||
161880221|NCT01295827|584602878|FG008|Overall Study|Screen Failure|2|||
161880222|NCT01295827|584602879|FG009|Overall Study|Screen Failure|0|||
161880223|NCT01295827|584602880|FG010|Overall Study|Screen Failure|1|||
161880224|NCT01295827|584602881|FG011|Overall Study|Screen Failure|0|||
161880225|NCT01295827|584602882|FG012|Overall Study|Screen Failure|0|||
161880226|NCT01295827|584602883|FG013|Overall Study|Screen Failure|0|||
161880227|NCT01295827|584602884|FG014|Overall Study|Screen Failure|0|||
161880228|NCT01295827|584602870|FG000|Overall Study|Withdrawal by Subject|1|||
161880229|NCT01295827|584602871|FG001|Overall Study|Withdrawal by Subject|0|||
161777746|NCT00388674|584228790|FG001|Initial Treatment|Not Defined|172|||
161777747|NCT00388674|584228789|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
161777748|NCT00388674|584228790|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
161777749|NCT00388674|584228789|FG000|Initial Treatment|Pregnancy|26|||
161777750|NCT00388674|584228790|FG001|Initial Treatment|Pregnancy|16|||
161777751|NCT00388674|584228789|FG000|Initial Treatment|Study Drug Toxicity|5|||
161777752|NCT00388674|584228790|FG001|Initial Treatment|Study Drug Toxicity|92|||
161777753|NCT00388674|584228789|FG000|Initial Treatment|Participant Request|501|||
161777754|NCT00388674|584228790|FG001|Initial Treatment|Participant Request|673|||
161777755|NCT00388674|584228789|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
161880230|NCT01295827|584602872|FG002|Overall Study|Withdrawal by Subject|2|||
161880231|NCT01295827|584602873|FG003|Overall Study|Withdrawal by Subject|0|||
161880232|NCT01295827|584602874|FG004|Overall Study|Withdrawal by Subject|0|||
161880233|NCT01295827|584602875|FG005|Overall Study|Withdrawal by Subject|1|||
161880234|NCT01295827|584602876|FG006|Overall Study|Withdrawal by Subject|13|||
161880235|NCT01295827|584602877|FG007|Overall Study|Withdrawal by Subject|35|||
161777756|NCT00388674|584228790|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
161777757|NCT00388674|584228789|FG000|Initial Treatment|Not Reported|10|||
161777758|NCT00388674|584228790|FG001|Initial Treatment|Not Reported|12|||
161777759|NCT00388674|584228789|FG000|End of Study|Administrative Reason By Sponsor|299|||
161777760|NCT00388674|584228790|FG001|End of Study|Administrative Reason By Sponsor|253|||
161777761|NCT00388674|584228789|FG000|End of Study|Death|239|||
161777762|NCT00388674|584228790|FG001|End of Study|Death|262|||
161777763|NCT00388674|584228789|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
161777764|NCT00388674|584228790|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
161777765|NCT00388674|584228789|FG000|End of Study|HCC|8|||
161777766|NCT00388674|584228790|FG001|End of Study|HCC|7|||
161777767|NCT00388674|584228789|FG000|End of Study|Lost to Follow-up|587|||
161777768|NCT00388674|584228790|FG001|End of Study|Lost to Follow-up|715|||
161777769|NCT00388674|584228789|FG000|End of Study|Malignancy (Non-HCC)|1|||
161777770|NCT00388674|584228790|FG001|End of Study|Malignancy (Non-HCC)|1|||
161880236|NCT01295827|584602878|FG008|Overall Study|Withdrawal by Subject|11|||
161880237|NCT01295827|584602879|FG009|Overall Study|Withdrawal by Subject|2|||
161880238|NCT01295827|584602880|FG010|Overall Study|Withdrawal by Subject|18|||
161880239|NCT01295827|584602881|FG011|Overall Study|Withdrawal by Subject|13|||
161880240|NCT01295827|584602882|FG012|Overall Study|Withdrawal by Subject|0|||
161880241|NCT01295827|584602883|FG013|Overall Study|Withdrawal by Subject|0|||
161777771|NCT00388674|584228789|FG000|End of Study|Non-Study Related Comorbidities|3|||
161777772|NCT00388674|584228790|FG001|End of Study|Non-Study Related Comorbidities|4|||
161777773|NCT00388674|584228789|FG000|End of Study|Not Defined|135|||
161777774|NCT00388674|584228790|FG001|End of Study|Not Defined|214|||
161777775|NCT00388674|584228789|FG000|End of Study|Participant Withdrew Consent|437|||
161777776|NCT00388674|584228790|FG001|End of Study|Participant Withdrew Consent|673|||
161777777|NCT00388674|584228789|FG000|End of Study|No Off-Treatment Status Data|22|||
161777778|NCT00388674|584228790|FG001|End of Study|No Off-Treatment Status Data|30|||
161777779|NCT00388674|584228789|FG000|End of Study|Not Reported|0|||
161777780|NCT00388674|584228790|FG001|End of Study|Not Reported|1|||
161880242|NCT01295827|584602884|FG014|Overall Study|Withdrawal by Subject|0|||
161880243|NCT01295827|584602870|FG000|Overall Study|Other|0|||
161880244|NCT01295827|584602871|FG001|Overall Study|Other|0|||
161880245|NCT01295827|584602872|FG002|Overall Study|Other|0|||
161880246|NCT01295827|584602873|FG003|Overall Study|Other|0|||
161880247|NCT01295827|584602874|FG004|Overall Study|Other|0|||
161880248|NCT01295827|584602875|FG005|Overall Study|Other|0|||
161880249|NCT01295827|584602876|FG006|Overall Study|Other|1|||
161880250|NCT01295827|584602877|FG007|Overall Study|Other|1|||
161880251|NCT01295827|584602878|FG008|Overall Study|Other|1|||
161777781|NCT01563029|584228797|FG000|Overall Study|Adverse Event|1|||
161777782|NCT01563029|584228798|FG001|Overall Study|Adverse Event|0|||
161777783|NCT01563029|584228799|FG002|Overall Study|Adverse Event|1|||
161777784|NCT01563029|584228800|FG003|Overall Study|Adverse Event|2|||
161777785|NCT01563029|584228801|FG004|Overall Study|Adverse Event|1|||
161777786|NCT01563029|584228797|FG000|Overall Study|Lack of Efficacy|42|||
161777787|NCT01563029|584228798|FG001|Overall Study|Lack of Efficacy|16|||
161777788|NCT01563029|584228799|FG002|Overall Study|Lack of Efficacy|23|||
161777789|NCT01563029|584228800|FG003|Overall Study|Lack of Efficacy|21|||
161777790|NCT01563029|584228801|FG004|Overall Study|Lack of Efficacy|19|||
161880252|NCT01295827|584602879|FG009|Overall Study|Other|0|||
161777791|NCT01563029|584228797|FG000|Overall Study|Protocol Violation|1|||
161880253|NCT01295827|584602880|FG010|Overall Study|Other|2|||
161880254|NCT01295827|584602881|FG011|Overall Study|Other|0|||
161880255|NCT01295827|584602882|FG012|Overall Study|Other|0|||
161880256|NCT01295827|584602883|FG013|Overall Study|Other|0|||
161880257|NCT01295827|584602884|FG014|Overall Study|Other|0|||
161880258|NCT00101166|584602885|FG000|Overall Study|progressive disease|10|||
161880259|NCT01868022|584602886|FG000|Overall Study|Withdrawal by Subject|0|||
161880260|NCT01868022|584602887|FG001|Overall Study|Withdrawal by Subject|0|||
161880261|NCT01868022|584602888|FG002|Overall Study|Withdrawal by Subject|1|||
161880262|NCT01868022|584602889|FG003|Overall Study|Withdrawal by Subject|1|||
161880263|NCT01868022|584602890|FG004|Overall Study|Withdrawal by Subject|0|||
161880264|NCT01868022|584602891|FG005|Overall Study|Withdrawal by Subject|0|||
161880265|NCT01868022|584602892|FG006|Overall Study|Withdrawal by Subject|0|||
161880266|NCT01868022|584602893|FG007|Overall Study|Withdrawal by Subject|1|||
161880267|NCT01868022|584602894|FG008|Overall Study|Withdrawal by Subject|0|||
161880268|NCT01868022|584602886|FG000|Overall Study|Adverse Event|0|||
161880269|NCT01868022|584602887|FG001|Overall Study|Adverse Event|0|||
161880270|NCT01868022|584602888|FG002|Overall Study|Adverse Event|0|||
161880271|NCT01868022|584602889|FG003|Overall Study|Adverse Event|0|||
161880272|NCT01868022|584602890|FG004|Overall Study|Adverse Event|2|||
161880273|NCT01868022|584602891|FG005|Overall Study|Adverse Event|0|||
161880274|NCT01868022|584602892|FG006|Overall Study|Adverse Event|0|||
161880275|NCT01868022|584602893|FG007|Overall Study|Adverse Event|2|||
161880276|NCT01868022|584602894|FG008|Overall Study|Adverse Event|2|||
161880277|NCT01868022|584602886|FG000|Overall Study|Physician Decision|0|||
161880278|NCT01868022|584602887|FG001|Overall Study|Physician Decision|0|||
161880279|NCT01868022|584602888|FG002|Overall Study|Physician Decision|0|||
161880280|NCT01868022|584602889|FG003|Overall Study|Physician Decision|0|||
161880281|NCT01868022|584602890|FG004|Overall Study|Physician Decision|0|||
161880282|NCT01868022|584602891|FG005|Overall Study|Physician Decision|1|||
161880283|NCT01868022|584602892|FG006|Overall Study|Physician Decision|0|||
161880284|NCT01868022|584602893|FG007|Overall Study|Physician Decision|2|||
161880285|NCT01868022|584602894|FG008|Overall Study|Physician Decision|0|||
161880286|NCT01868022|584602886|FG000|Overall Study|Study closed/terminated|0|||
161880287|NCT01868022|584602887|FG001|Overall Study|Study closed/terminated|0|||
161880288|NCT01868022|584602888|FG002|Overall Study|Study closed/terminated|0|||
161880289|NCT01868022|584602889|FG003|Overall Study|Study closed/terminated|0|||
161880290|NCT01868022|584602890|FG004|Overall Study|Study closed/terminated|0|||
161880291|NCT01868022|584602891|FG005|Overall Study|Study closed/terminated|0|||
161880292|NCT01868022|584602892|FG006|Overall Study|Study closed/terminated|0|||
161880293|NCT01868022|584602893|FG007|Overall Study|Study closed/terminated|1|||
161880294|NCT01868022|584602894|FG008|Overall Study|Study closed/terminated|0|||
161880295|NCT01868022|584602886|FG000|Overall Study|Ongoing|0|||
161880296|NCT01868022|584602887|FG001|Overall Study|Ongoing|0|||
161880297|NCT01868022|584602888|FG002|Overall Study|Ongoing|0|||
161880298|NCT01868022|584602889|FG003|Overall Study|Ongoing|0|||
161880299|NCT01868022|584602890|FG004|Overall Study|Ongoing|0|||
161880300|NCT01868022|584602891|FG005|Overall Study|Ongoing|0|||
161880301|NCT01868022|584602892|FG006|Overall Study|Ongoing|0|||
161880302|NCT01868022|584602893|FG007|Overall Study|Ongoing|3|||
161880303|NCT01868022|584602894|FG008|Overall Study|Ongoing|0|||
161880304|NCT03226769|584602897|FG000|Overall Study|Withdrawal by Subject|0|||
161880305|NCT03226769|584602898|FG001|Overall Study|Withdrawal by Subject|1|||
161880306|NCT02640677|584602899|FG000|Overall Study|Lost to Follow-up|1|||
161880307|NCT02640677|584602899|FG000|Overall Study|Withdrawal by Subject|1|||
161880308|NCT01516008|584602906|FG000|Overall Study|Adverse Event|0|||
161880309|NCT01516008|584602907|FG001|Overall Study|Adverse Event|2|||
161880310|NCT01516008|584602908|FG002|Overall Study|Adverse Event|7|||
161880311|NCT01516008|584602906|FG000|Overall Study|Lack of Efficacy|44|||
161880312|NCT01516008|584602907|FG001|Overall Study|Lack of Efficacy|14|||
161880313|NCT01516008|584602908|FG002|Overall Study|Lack of Efficacy|10|||
161880314|NCT01516008|584602906|FG000|Overall Study|Protocol Violation|1|||
161880315|NCT01516008|584602907|FG001|Overall Study|Protocol Violation|0|||
161880316|NCT01516008|584602908|FG002|Overall Study|Protocol Violation|0|||
161880317|NCT01516008|584602906|FG000|Overall Study|Reason not specified|0|||
161880318|NCT01516008|584602907|FG001|Overall Study|Reason not specified|0|||
161880319|NCT01516008|584602908|FG002|Overall Study|Reason not specified|1|||
161880320|NCT01217476|584602909|FG000|Overall Study|Adverse Event|6|||
161880321|NCT01217476|584602910|FG001|Overall Study|Adverse Event|1|||
161880322|NCT01217476|584602909|FG000|Overall Study|Physician Decision|0|||
161880323|NCT01217476|584602910|FG001|Overall Study|Physician Decision|1|||
161880324|NCT01217476|584602909|FG000|Overall Study|Withdrawal by Subject|3|||
161880325|NCT01217476|584602910|FG001|Overall Study|Withdrawal by Subject|3|||
161880326|NCT01217476|584602909|FG000|Overall Study|Surgery on the Target Limb|0|||
161880327|NCT01217476|584602910|FG001|Overall Study|Surgery on the Target Limb|2|||
161880328|NCT01217476|584602909|FG000|Overall Study|Protocol Deviation|1|||
161880329|NCT01217476|584602910|FG001|Overall Study|Protocol Deviation|0|||
161777792|NCT01563029|584228798|FG001|Overall Study|Protocol Violation|2|||
161777793|NCT01563029|584228799|FG002|Overall Study|Protocol Violation|3|||
161777794|NCT01563029|584228800|FG003|Overall Study|Protocol Violation|1|||
161777795|NCT01563029|584228801|FG004|Overall Study|Protocol Violation|3|||
161777796|NCT01563029|584228797|FG000|Overall Study|Protocol defined stopping criteria|1|||
161777797|NCT01563029|584228798|FG001|Overall Study|Protocol defined stopping criteria|0|||
161880330|NCT01217476|584602909|FG000|Overall Study|Other|2|||
161880331|NCT01217476|584602910|FG001|Overall Study|Other|0|||
161777798|NCT01563029|584228799|FG002|Overall Study|Protocol defined stopping criteria|0|||
161777799|NCT01563029|584228800|FG003|Overall Study|Protocol defined stopping criteria|0|||
161777800|NCT01563029|584228801|FG004|Overall Study|Protocol defined stopping criteria|0|||
161777801|NCT01563029|584228797|FG000|Overall Study|Lost to Follow-up|1|||
161880332|NCT03033602|584602911|FG000|Overall Study|Withdrawal by Subject|11|||
161880333|NCT03033602|584602912|FG001|Overall Study|Withdrawal by Subject|21|||
161880334|NCT03033602|584602911|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
161880335|NCT03033602|584602912|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
161880336|NCT02778074|584602914|FG000|Overall Study|Lost to Follow-up|7|||
161880337|NCT02778074|584602915|FG001|Overall Study|Lost to Follow-up|10|||
161880338|NCT03489707|584602918|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
161880339|NCT03489707|584602919|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
161880340|NCT03489707|584602918|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
161880341|NCT03489707|584602919|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
161880342|NCT03617770|584602920|FG000|Overall Study|Lost to Follow-up|1|||
161880343|NCT03617770|584602921|FG001|Overall Study|Lost to Follow-up|0|||
161880344|NCT00356135|584602922|FG000|Overall Study|Protocol Violation|1|||
161880345|NCT00356135|584602923|FG001|Overall Study|Protocol Violation|0|||
161880346|NCT00356135|584602924|FG002|Overall Study|Protocol Violation|0|||
161880347|NCT00356135|584602922|FG000|Overall Study|Adverse Event|1|||
161880348|NCT00356135|584602923|FG001|Overall Study|Adverse Event|0|||
161880349|NCT00356135|584602924|FG002|Overall Study|Adverse Event|0|||
161880350|NCT00356135|584602922|FG000|Overall Study|Lost to Follow-up|0|||
161880351|NCT00356135|584602923|FG001|Overall Study|Lost to Follow-up|0|||
161880352|NCT00356135|584602924|FG002|Overall Study|Lost to Follow-up|1|||
161880353|NCT00356135|584602922|FG000|Overall Study|Physician Decision|1|||
161880354|NCT00356135|584602923|FG001|Overall Study|Physician Decision|1|||
161880355|NCT00356135|584602924|FG002|Overall Study|Physician Decision|1|||
161880356|NCT00356135|584602922|FG000|Overall Study|Subject non-compliance|1|||
161880357|NCT00356135|584602923|FG001|Overall Study|Subject non-compliance|1|||
161880358|NCT00356135|584602924|FG002|Overall Study|Subject non-compliance|3|||
161880359|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161880360|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
161880361|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161880362|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161777802|NCT01563029|584228798|FG001|Overall Study|Lost to Follow-up|0|||
161777803|NCT01563029|584228799|FG002|Overall Study|Lost to Follow-up|1|||
161777804|NCT01563029|584228800|FG003|Overall Study|Lost to Follow-up|1|||
161777805|NCT01563029|584228801|FG004|Overall Study|Lost to Follow-up|1|||
161880363|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
161880364|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161880365|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
161880366|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161880367|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
161880368|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
161880369|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Adverse Event|1|||
161880370|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Adverse Event|2|||
161880371|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
161880372|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
161777806|NCT01563029|584228797|FG000|Overall Study|Physician Decision|3|||
161777807|NCT01563029|584228798|FG001|Overall Study|Physician Decision|5|||
161880373|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
161880374|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
161880375|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Pregnancy|1|||
161880376|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Pregnancy|0|||
161880377|NCT03963232|584602925|FG000|Follow-up Phase|Withdrawal by Subject|7|||
161880378|NCT03963232|584602926|FG001|Follow-up Phase|Withdrawal by Subject|5|||
161880379|NCT03963232|584602925|FG000|Follow-up Phase|Protocol Violation|0|||
161880380|NCT03963232|584602926|FG001|Follow-up Phase|Protocol Violation|2|||
161777808|NCT01563029|584228799|FG002|Overall Study|Physician Decision|2|||
161880381|NCT03963232|584602925|FG000|Follow-up Phase|Adverse Event|0|||
161777809|NCT01563029|584228800|FG003|Overall Study|Physician Decision|4|||
161777810|NCT01563029|584228801|FG004|Overall Study|Physician Decision|2|||
161880382|NCT03963232|584602926|FG001|Follow-up Phase|Adverse Event|1|||
161880383|NCT03963232|584602925|FG000|Follow-up Phase|Lost to Follow-up|0|||
161880384|NCT03963232|584602926|FG001|Follow-up Phase|Lost to Follow-up|1|||
161880385|NCT05270395|584602932|FG000|Overall Study|Lost to Follow-up|2|||
161880386|NCT05270395|584602933|FG001|Overall Study|Lost to Follow-up|2|||
161880387|NCT05270395|584602932|FG000|Overall Study|Death|1|||
161880388|NCT05270395|584602933|FG001|Overall Study|Death|2|||
161880389|NCT05270395|584602932|FG000|Overall Study|Study Team Withdrew|1|||
161880390|NCT05270395|584602933|FG001|Overall Study|Study Team Withdrew|0|||
161880391|NCT03055494|584604962|FG000|Overall Study|Lost to Follow-up|6|||
161880392|NCT03055494|584604963|FG001|Overall Study|Lost to Follow-up|0|||
161880393|NCT03055494|584604962|FG000|Overall Study|Physician Decision|2|||
161880394|NCT03055494|584604963|FG001|Overall Study|Physician Decision|0|||
161880395|NCT03055494|584604962|FG000|Overall Study|Withdrawal by Subject|1|||
161880396|NCT03055494|584604963|FG001|Overall Study|Withdrawal by Subject|0|||
161880397|NCT03055494|584604962|FG000|Overall Study|Adverse Event|0|||
161880398|NCT03055494|584604963|FG001|Overall Study|Adverse Event|1|||
161880399|NCT03055494|584604962|FG000|Overall Study|Non-compliance with study treatment|1|||
161880400|NCT03055494|584604963|FG001|Overall Study|Non-compliance with study treatment|0|||
161880401|NCT04743804|584604966|FG000|Overall Study|Other|1|||
161880402|NCT04743804|584604967|FG001|Overall Study|Other|0|||
161880403|NCT04743804|584604966|FG000|Overall Study|Withdrawal by Subject|0|||
161880404|NCT04743804|584604967|FG001|Overall Study|Withdrawal by Subject|1|||
161880405|NCT04743804|584604966|FG000|Overall Study|Study Terminated by Sponsor|1|||
161880406|NCT04743804|584604967|FG001|Overall Study|Study Terminated by Sponsor|4|||
161880407|NCT04743804|584604966|FG000|Overall Study|Physician Decision|0|||
161880408|NCT04743804|584604967|FG001|Overall Study|Physician Decision|1|||
161880409|NCT04743804|584604966|FG000|Overall Study|Death|3|||
161880410|NCT04743804|584604967|FG001|Overall Study|Death|0|||
161880411|NCT01942486|584604968|FG000|Overall Study|Lost to Follow-up|27|||
161880412|NCT02424630|584604971|FG000|Overall Study|No rotator cuff tear|1|||
161880413|NCT02424630|584604972|FG001|Overall Study|No rotator cuff tear|2|||
161880414|NCT02424630|584604971|FG000|Overall Study|Open procedure|0|||
161880415|NCT02424630|584604972|FG001|Overall Study|Open procedure|1|||
161880416|NCT02691013|584604973|FG000|Overall Study|Withdrawal by Subject|3|||
161880417|NCT02691013|584604974|FG001|Overall Study|Withdrawal by Subject|0|||
161880418|NCT02111785|584604975|FG000|Overall Study|Death|0|||
161880419|NCT02111785|584604976|FG001|Overall Study|Death|1|||
161880420|NCT02111785|584604977|FG002|Overall Study|Death|0|||
161880421|NCT02111785|584604978|FG003|Overall Study|Death|0|||
161880422|NCT04507256|584604979|FG000|Overall Study|Withdrawal by Subject|1|||
161880423|NCT04507256|584604980|FG001|Overall Study|Withdrawal by Subject|0|||
161880424|NCT04507256|584604981|FG002|Overall Study|Withdrawal by Subject|0|||
161880425|NCT04507256|584604982|FG003|Overall Study|Withdrawal by Subject|1|||
161880426|NCT04507256|584604983|FG004|Overall Study|Withdrawal by Subject|0|||
161880427|NCT04507256|584604984|FG005|Overall Study|Withdrawal by Subject|0|||
161880428|NCT02677038|584604989|FG000|Overall Study|Physician Decision|1|||
161880429|NCT02677038|584604989|FG000|Overall Study|Withdrawal by Subject|1|||
161880430|NCT02777970|584604994|FG000|Overall Study|Lost to Follow-up|0|||
161880431|NCT02777970|584604995|FG001|Overall Study|Lost to Follow-up|1|||
161880432|NCT02777970|584604996|FG002|Overall Study|Lost to Follow-up|0|||
161880433|NCT02777970|584604994|FG000|Overall Study|Protocol Violation|1|||
161880434|NCT02777970|584604995|FG001|Overall Study|Protocol Violation|0|||
161880435|NCT02777970|584604996|FG002|Overall Study|Protocol Violation|0|||
161880436|NCT02541669|584605001|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161880437|NCT02541669|584605002|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161880438|NCT02541669|584605003|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161880439|NCT02541669|584605004|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161880440|NCT02541669|584605005|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161880441|NCT00834639|584605006|FG000|Second Intervention|Physician Decision|0|||
161880442|NCT00834639|584605007|FG001|Second Intervention|Physician Decision|2|||
161880443|NCT04739722|584605008|FG000|Overall Study|Lost to Follow-up|5301|||
161880444|NCT04739722|584605008|FG000|Overall Study|Withdrawal by Subject|42|||
161880445|NCT04739722|584605008|FG000|Overall Study|Non Average-risk|1157|||
161880446|NCT01968707|584605012|FG000|Overall Study|Did not meet treatment day baseline|49|||
161880447|NCT01968707|584605013|FG001|Overall Study|Did not meet treatment day baseline|12|||
161880448|NCT01968707|584605014|FG002|Overall Study|Did not meet treatment day baseline|41|||
161880449|NCT01968707|584605015|FG003|Overall Study|Did not meet treatment day baseline|44|||
161880450|NCT01968707|584605016|FG004|Overall Study|Did not meet treatment day baseline|36|||
161880451|NCT01968707|584605017|FG005|Overall Study|Did not meet treatment day baseline|11|||
161880452|NCT01968707|584605018|FG006|Overall Study|Did not meet treatment day baseline|34|||
161880453|NCT01968707|584605019|FG007|Overall Study|Did not meet treatment day baseline|35|||
161880454|NCT02083185|584605027|FG000|Overall Study|Lost to Follow-up|0|||
161880455|NCT02083185|584605028|FG001|Overall Study|Lost to Follow-up|3|||
161880456|NCT02083185|584605029|FG002|Overall Study|Lost to Follow-up|0|||
161880457|NCT02083185|584605027|FG000|Overall Study|Withdrawal by Subject|9|||
161880458|NCT02083185|584605028|FG001|Overall Study|Withdrawal by Subject|15|||
161880459|NCT02083185|584605029|FG002|Overall Study|Withdrawal by Subject|1|||
161880460|NCT02083185|584605027|FG000|Overall Study|Death|2|||
161880461|NCT02083185|584605028|FG001|Overall Study|Death|2|||
161880462|NCT02083185|584605029|FG002|Overall Study|Death|1|||
161880463|NCT02083185|584605027|FG000|Overall Study|Reason not Specified|9|||
161880464|NCT02083185|584605028|FG001|Overall Study|Reason not Specified|6|||
161880465|NCT02083185|584605029|FG002|Overall Study|Reason not Specified|5|||
161880466|NCT02083185|584605027|FG000|Overall Study|Study Terminated by Sponsor|0|||
161880467|NCT02083185|584605028|FG001|Overall Study|Study Terminated by Sponsor|1|||
161880468|NCT02083185|584605029|FG002|Overall Study|Study Terminated by Sponsor|0|||
161880469|NCT02083185|584605027|FG000|Overall Study|Did not Receive Study Drug|0|||
161880470|NCT02083185|584605028|FG001|Overall Study|Did not Receive Study Drug|2|||
161880471|NCT02083185|584605029|FG002|Overall Study|Did not Receive Study Drug|0|||
161880472|NCT03419598|584605030|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
161880473|NCT02474589|584605031|FG000|Overall Study|Adverse Event|6|||
161880474|NCT02474589|584605032|FG001|Overall Study|Adverse Event|2|||
161880475|NCT02474589|584605031|FG000|Overall Study|Lost to Follow-up|6|||
161880476|NCT02474589|584605032|FG001|Overall Study|Lost to Follow-up|1|||
161880477|NCT02474589|584605031|FG000|Overall Study|Protocol Violation|4|||
161880478|NCT02474589|584605032|FG001|Overall Study|Protocol Violation|1|||
161880479|NCT02474589|584605031|FG000|Overall Study|Withdrawal by Subject|4|||
161880480|NCT02474589|584605032|FG001|Overall Study|Withdrawal by Subject|0|||
161880481|NCT02474589|584605031|FG000|Overall Study|Inability to complete study procedures|5|||
161880482|NCT02474589|584605032|FG001|Overall Study|Inability to complete study procedures|1|||
161880483|NCT00380081|584605035|FG000|Overall Study|Withdrawal by Subject|0|||
161880484|NCT00380081|584605036|FG001|Overall Study|Withdrawal by Subject|0|||
161880485|NCT00380081|584605037|FG002|Overall Study|Withdrawal by Subject|0|||
161880486|NCT00380081|584605038|FG003|Overall Study|Withdrawal by Subject|0|||
161880487|NCT00380081|584605039|FG004|Overall Study|Withdrawal by Subject|1|||
161880488|NCT00380081|584605040|FG005|Overall Study|Withdrawal by Subject|0|||
161880489|NCT00380081|584605035|FG000|Overall Study|Family Emergency|0|||
161880490|NCT00380081|584605036|FG001|Overall Study|Family Emergency|0|||
161880491|NCT00380081|584605037|FG002|Overall Study|Family Emergency|0|||
161880492|NCT00380081|584605038|FG003|Overall Study|Family Emergency|0|||
161880493|NCT00380081|584605039|FG004|Overall Study|Family Emergency|0|||
161880494|NCT00380081|584605040|FG005|Overall Study|Family Emergency|1|||
161880495|NCT02231879|584605041|FG000|Overall Study|Adverse Event|2|||
161880496|NCT02231879|584605042|FG001|Overall Study|Adverse Event|1|||
161880497|NCT02231879|584605041|FG000|Overall Study|Lack of Efficacy|0|||
161880498|NCT02231879|584605042|FG001|Overall Study|Lack of Efficacy|1|||
161880499|NCT00459706|584605043|FG000|Overall Study|Adverse Event|19|||
161880500|NCT00459706|584605044|FG001|Overall Study|Adverse Event|13|||
161880501|NCT00459706|584605043|FG000|Overall Study|Withdrawal by Subject|1|||
161880502|NCT00459706|584605044|FG001|Overall Study|Withdrawal by Subject|6|||
161880503|NCT00459706|584605043|FG000|Overall Study|Physician Decision|2|||
161880504|NCT00459706|584605044|FG001|Overall Study|Physician Decision|0|||
161880505|NCT00459706|584605043|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161880506|NCT00459706|584605044|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161880507|NCT00459706|584605043|FG000|Overall Study|Protocol Violation|2|||
161880508|NCT00459706|584605044|FG001|Overall Study|Protocol Violation|1|||
161880509|NCT00459706|584605043|FG000|Overall Study|Failed to Return|1|||
161880510|NCT00459706|584605044|FG001|Overall Study|Failed to Return|0|||
161880511|NCT00459706|584605043|FG000|Overall Study|Other|0|||
161880512|NCT00459706|584605044|FG001|Overall Study|Other|1|||
161880513|NCT00189306|584605045|FG000|Treatment Period|Withdrawal by Subject|2|||
161880514|NCT00189306|584605045|FG000|Treatment Period|Adverse Event|2|||
161880515|NCT00189306|584605045|FG000|Treatment Period|Protocol Violation|1|||
161880516|NCT00189306|584605045|FG000|Posttreatment Period|Death|1|||
161880517|NCT00189306|584605045|FG000|Posttreatment Period|Withdrawal by Subject|2|||
161880518|NCT00189306|584605045|FG000|Posttreatment Period|Noncompliance|1|||
161880519|NCT00189306|584605045|FG000|Posttreatment Period|Target lesion excised|1|||
161880520|NCT00189306|584605045|FG000|Posttreatment Period|Protocol Violation|1|||
161880521|NCT00189306|584605045|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
161880522|NCT00189306|584605045|FG000|Posttreatment Period|Local skin reaction/sign|1|||
161880523|NCT00189306|584605045|FG000|Long-Term Follow-up|Adverse Event|2|||
161880524|NCT00189306|584605045|FG000|Long-Term Follow-up|Death|4|||
161880525|NCT00189306|584605045|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
161880526|NCT00189306|584605045|FG000|Long-Term Follow-up|Intercurrent disease|2|||
161880527|NCT00189306|584605045|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
161880528|NCT00189306|584605045|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
161880529|NCT03640481|584605046|FG000|Overall Study|Death|14|||
161880530|NCT03640481|584605047|FG001|Overall Study|Death|14|||
161880531|NCT03640481|584605048|FG002|Overall Study|Death|0|||
161880532|NCT03640481|584605049|FG003|Overall Study|Death|0|||
161880533|NCT03640481|584605046|FG000|Overall Study|Lost to Follow-up|2|||
161880534|NCT03640481|584605047|FG001|Overall Study|Lost to Follow-up|0|||
161880535|NCT03640481|584605048|FG002|Overall Study|Lost to Follow-up|0|||
161777811|NCT01563029|584228797|FG000|Overall Study|Withdrawal by Subject|4|||
161777812|NCT01563029|584228798|FG001|Overall Study|Withdrawal by Subject|1|||
161777813|NCT01563029|584228799|FG002|Overall Study|Withdrawal by Subject|3|||
161777814|NCT01563029|584228800|FG003|Overall Study|Withdrawal by Subject|4|||
161777815|NCT01563029|584228801|FG004|Overall Study|Withdrawal by Subject|3|||
161777816|NCT03069365|584228802|FG000|Overall Study|Adverse Event|1|||
161777817|NCT02780115|584228803|FG000|Overall Study|Withdrawal by Subject|0|||
161777818|NCT02780115|584228804|FG001|Overall Study|Withdrawal by Subject|1|||
161777819|NCT02780115|584228805|FG002|Overall Study|Withdrawal by Subject|1|||
161777820|NCT02780115|584228806|FG003|Overall Study|Withdrawal by Subject|0|||
161777821|NCT02780115|584228807|FG004|Overall Study|Withdrawal by Subject|0|||
161777822|NCT02780115|584228803|FG000|Overall Study|Adverse Event|0|||
161777823|NCT02780115|584228804|FG001|Overall Study|Adverse Event|0|||
161777824|NCT02780115|584228805|FG002|Overall Study|Adverse Event|0|||
161777825|NCT02780115|584228806|FG003|Overall Study|Adverse Event|1|||
161777826|NCT02780115|584228807|FG004|Overall Study|Adverse Event|1|||
161777827|NCT00769132|584228808|FG000|Period 1|Adverse Event|1|||
161777828|NCT00769132|584228809|FG001|Period 1|Adverse Event|0|||
161777829|NCT00769132|584228810|FG002|Period 1|Adverse Event|0|||
161777830|NCT00769132|584228811|FG003|Period 1|Adverse Event|1|||
161777831|NCT00769132|584228808|FG000|Period 2|Withdrawal by Subject|0|||
161777832|NCT00769132|584228809|FG001|Period 2|Withdrawal by Subject|0|||
161777833|NCT00769132|584228810|FG002|Period 2|Withdrawal by Subject|0|||
161777834|NCT00769132|584228811|FG003|Period 2|Withdrawal by Subject|1|||
161777835|NCT00769132|584228808|FG000|Period 3|Withdrawal by Subject|1|||
161777836|NCT00769132|584228809|FG001|Period 3|Withdrawal by Subject|0|||
161777837|NCT00769132|584228810|FG002|Period 3|Withdrawal by Subject|0|||
161777838|NCT00769132|584228811|FG003|Period 3|Withdrawal by Subject|0|||
161777839|NCT00769132|584228808|FG000|Period 4|Withdrawal by Subject|0|||
161777840|NCT00769132|584228809|FG001|Period 4|Withdrawal by Subject|1|||
161777841|NCT00769132|584228810|FG002|Period 4|Withdrawal by Subject|0|||
161777842|NCT00769132|584228811|FG003|Period 4|Withdrawal by Subject|0|||
161777843|NCT01257737|584228812|FG000|Overall Study|Lost to Follow-up|1|||
161777844|NCT01257737|584228813|FG001|Overall Study|Lost to Follow-up|2|||
161777845|NCT01257737|584228812|FG000|Overall Study|Liver transplant|1|||
161777846|NCT01257737|584228813|FG001|Overall Study|Liver transplant|0|||
161777847|NCT01257737|584228812|FG000|Overall Study|Relocation out of the country|0|||
161777848|NCT01257737|584228813|FG001|Overall Study|Relocation out of the country|1|||
161777849|NCT01257737|584228812|FG000|Overall Study|Withdrew from study|0|||
161777850|NCT01257737|584228813|FG001|Overall Study|Withdrew from study|1|||
161777851|NCT00127192|584228816|FG000|Overall Study|Adverse Event|0|||
161777852|NCT00127192|584228817|FG001|Overall Study|Adverse Event|1|||
161777853|NCT00127192|584228818|FG002|Overall Study|Adverse Event|1|||
161777854|NCT00127192|584228819|FG003|Overall Study|Adverse Event|1|||
161777855|NCT00127192|584228820|FG004|Overall Study|Adverse Event|0|||
161777856|NCT00127192|584228816|FG000|Overall Study|Lack of Efficacy|2|||
161777857|NCT00127192|584228817|FG001|Overall Study|Lack of Efficacy|0|||
161777858|NCT00127192|584228818|FG002|Overall Study|Lack of Efficacy|0|||
161777859|NCT00127192|584228819|FG003|Overall Study|Lack of Efficacy|0|||
161777860|NCT00127192|584228820|FG004|Overall Study|Lack of Efficacy|2|||
161777861|NCT00127192|584228816|FG000|Overall Study|Withdrawal by Subject|0|||
161777862|NCT00127192|584228817|FG001|Overall Study|Withdrawal by Subject|0|||
161777863|NCT00127192|584228818|FG002|Overall Study|Withdrawal by Subject|1|||
161777864|NCT00127192|584228819|FG003|Overall Study|Withdrawal by Subject|0|||
161777865|NCT00127192|584228820|FG004|Overall Study|Withdrawal by Subject|3|||
161777866|NCT00127192|584228816|FG000|Overall Study|Adverse event in pre-treatment period|1|||
161777867|NCT00127192|584228817|FG001|Overall Study|Adverse event in pre-treatment period|0|||
161777868|NCT00127192|584228818|FG002|Overall Study|Adverse event in pre-treatment period|0|||
161880536|NCT03640481|584605049|FG003|Overall Study|Lost to Follow-up|0|||
161880537|NCT03640481|584605046|FG000|Overall Study|Site terminated by sponsor|1|||
161880538|NCT03640481|584605047|FG001|Overall Study|Site terminated by sponsor|3|||
161880539|NCT03640481|584605048|FG002|Overall Study|Site terminated by sponsor|0|||
161880540|NCT03640481|584605049|FG003|Overall Study|Site terminated by sponsor|0|||
161880541|NCT03640481|584605046|FG000|Overall Study|Study terminated by sponsor|29|||
161777869|NCT00127192|584228819|FG003|Overall Study|Adverse event in pre-treatment period|0|||
161777870|NCT00127192|584228820|FG004|Overall Study|Adverse event in pre-treatment period|0|||
161777871|NCT01036594|584228835|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
161777872|NCT01036594|584228836|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
161777873|NCT01036594|584228835|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
161777874|NCT01036594|584228836|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
161777875|NCT01036594|584228835|FG000|Week 12 Evaluation|Adverse Event|5|||
161777876|NCT01036594|584228836|FG001|Week 12 Evaluation|Adverse Event|0|||
161777877|NCT01036594|584228835|FG000|Week 12 Evaluation|Physician Decision|1|||
161777878|NCT01036594|584228836|FG001|Week 12 Evaluation|Physician Decision|0|||
161777879|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
161777880|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
161777881|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
161777882|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
161777883|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
161777884|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
161777885|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
161777886|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
161777887|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
161777888|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
161777889|NCT01612780|584228839|FG000|Overall Study|Treatment not completed|1|||
161777890|NCT01612780|584228839|FG000|Overall Study|Withdrawal by Subject|5|||
161777891|NCT03466060|584228840|FG000|Period 1|Test Lens Damage|0|||
161777892|NCT03466060|584228841|FG001|Period 1|Test Lens Damage|2|||
161777893|NCT03466060|584228842|FG002|Period 1|Test Lens Damage|0|||
161777894|NCT03466060|584228843|FG003|Period 1|Test Lens Damage|0|||
161777895|NCT03466060|584228844|FG004|Period 1|Test Lens Damage|0|||
161777896|NCT03466060|584228845|FG005|Period 1|Test Lens Damage|0|||
161777897|NCT03466060|584228840|FG000|Period 1|Withdrawal by Subject|0|||
161777898|NCT03466060|584228841|FG001|Period 1|Withdrawal by Subject|0|||
161777899|NCT03466060|584228842|FG002|Period 1|Withdrawal by Subject|2|||
161777900|NCT03466060|584228843|FG003|Period 1|Withdrawal by Subject|0|||
161777901|NCT03466060|584228844|FG004|Period 1|Withdrawal by Subject|0|||
161777902|NCT03466060|584228845|FG005|Period 1|Withdrawal by Subject|0|||
161777903|NCT03466060|584228840|FG000|Period 1|Lost to Follow-up|0|||
161880542|NCT03640481|584605047|FG001|Overall Study|Study terminated by sponsor|42|||
161880543|NCT03640481|584605048|FG002|Overall Study|Study terminated by sponsor|1|||
161880544|NCT03640481|584605049|FG003|Overall Study|Study terminated by sponsor|0|||
161880545|NCT03640481|584605046|FG000|Overall Study|Withdrawal by Subject|5|||
161880546|NCT03640481|584605047|FG001|Overall Study|Withdrawal by Subject|4|||
161880547|NCT03640481|584605048|FG002|Overall Study|Withdrawal by Subject|0|||
161880548|NCT03640481|584605049|FG003|Overall Study|Withdrawal by Subject|1|||
161880549|NCT03640481|584605046|FG000|Overall Study|Other|26|||
161880550|NCT03640481|584605047|FG001|Overall Study|Other|12|||
161880551|NCT03640481|584605048|FG002|Overall Study|Other|1|||
161880552|NCT03640481|584605049|FG003|Overall Study|Other|0|||
161880553|NCT03640481|584605046|FG000|Overall Study|Randomized, but not treated|1|||
161880554|NCT03640481|584605047|FG001|Overall Study|Randomized, but not treated|3|||
161880555|NCT03640481|584605048|FG002|Overall Study|Randomized, but not treated|0|||
161880556|NCT03640481|584605049|FG003|Overall Study|Randomized, but not treated|0|||
161880557|NCT01322035|584605050|FG000|Overall Study|Lost to Follow-up|8|||
161880558|NCT01322035|584605051|FG001|Overall Study|Lost to Follow-up|3|||
161880559|NCT00535847|584605052|FG000|Overall Study|Adverse Event|5|||
161880560|NCT00535847|584605053|FG001|Overall Study|Adverse Event|3|||
161880561|NCT00535847|584605054|FG002|Overall Study|Adverse Event|2|||
161880562|NCT00535847|584605052|FG000|Overall Study|Non compliance|1|||
161880563|NCT00535847|584605053|FG001|Overall Study|Non compliance|1|||
161880564|NCT00535847|584605054|FG002|Overall Study|Non compliance|0|||
161880565|NCT00535847|584605052|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
161880566|NCT00535847|584605053|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
161880567|NCT00535847|584605054|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
161880568|NCT01546168|584605057|FG000|Overall Study|Lost to Follow-up|1|||
161880569|NCT01546168|584605058|FG001|Overall Study|Lost to Follow-up|0|||
161880570|NCT01546168|584605057|FG000|Overall Study|Withdrawal by Subject|1|||
161880571|NCT01546168|584605058|FG001|Overall Study|Withdrawal by Subject|0|||
161880572|NCT01546168|584605057|FG000|Overall Study|ineligible after signing consent|2|||
161880573|NCT01546168|584605058|FG001|Overall Study|ineligible after signing consent|0|||
161880574|NCT02850016|584605061|FG000|Overall Study|Withdrawal by Subject|1|||
161880575|NCT02850016|584605062|FG001|Overall Study|Withdrawal by Subject|2|||
161880576|NCT00070018|584605065|FG000|Overall Study|Adverse Event|2|||
161880577|NCT00070018|584605065|FG000|Overall Study|Lack of Efficacy|1|||
161880578|NCT00070018|584605065|FG000|Overall Study|Withdrawal by Subject|1|||
161880579|NCT02939716|584605066|FG000|Overall Study|scanner failure|0|||
161880580|NCT02939716|584605067|FG001|Overall Study|scanner failure|0|||
161880581|NCT02939716|584605068|FG002|Overall Study|scanner failure|0|||
161880582|NCT02939716|584605069|FG003|Overall Study|scanner failure|1|||
161880583|NCT02939716|584605070|FG004|Overall Study|scanner failure|1|||
161880584|NCT02939716|584605071|FG005|Overall Study|scanner failure|1|||
161880585|NCT04240457|584605077|FG000|Overall Study|Lost to Follow-up|5|||
161880586|NCT04240457|584605078|FG001|Overall Study|Lost to Follow-up|1|||
161880587|NCT00844480|584605083|FG000|Overall Study|Withdrawal by Subject|2|||
161880588|NCT00844480|584605084|FG001|Overall Study|Withdrawal by Subject|3|||
161880589|NCT03197870|584605089|FG000|Overall Study|Adverse Event|9|||
161880590|NCT03197870|584605090|FG001|Overall Study|Adverse Event|4|||
161880591|NCT03197870|584605091|FG002|Overall Study|Adverse Event|6|||
161880592|NCT03197870|584605089|FG000|Overall Study|Withdrawal by Subject|2|||
161880593|NCT03197870|584605090|FG001|Overall Study|Withdrawal by Subject|3|||
161880594|NCT03197870|584605091|FG002|Overall Study|Withdrawal by Subject|0|||
161880595|NCT03197870|584605089|FG000|Overall Study|Lost to Follow-up|2|||
161880596|NCT03197870|584605090|FG001|Overall Study|Lost to Follow-up|2|||
161880597|NCT03197870|584605091|FG002|Overall Study|Lost to Follow-up|0|||
161880598|NCT03197870|584605089|FG000|Overall Study|data not available|1|||
161880599|NCT03197870|584605090|FG001|Overall Study|data not available|1|||
161880600|NCT03197870|584605091|FG002|Overall Study|data not available|0|||
161880601|NCT01618019|584605093|FG000|Overall Study|Withdrawal by Subject|14|||
161880602|NCT01618019|584605094|FG001|Overall Study|Withdrawal by Subject|14|||
161880603|NCT01508130|584605098|FG000|Overall Study|Adverse Event|81|||
161880604|NCT01508130|584605099|FG001|Overall Study|Adverse Event|28|||
161880605|NCT01508130|584605098|FG000|Overall Study|Death|3|||
161880606|NCT01508130|584605099|FG001|Overall Study|Death|1|||
161880607|NCT01508130|584605098|FG000|Overall Study|Protocol Violation|2|||
161880608|NCT01508130|584605099|FG001|Overall Study|Protocol Violation|0|||
161880609|NCT01508130|584605098|FG000|Overall Study|Lost to Follow-up|25|||
161880610|NCT01508130|584605099|FG001|Overall Study|Lost to Follow-up|2|||
161880611|NCT01508130|584605098|FG000|Overall Study|Withdrawal by Subject|3|||
161880612|NCT01508130|584605099|FG001|Overall Study|Withdrawal by Subject|3|||
161880613|NCT01508130|584605098|FG000|Overall Study|Subject's substantial non-compliance|25|||
161880614|NCT01508130|584605099|FG001|Overall Study|Subject's substantial non-compliance|9|||
161880615|NCT01508130|584605098|FG000|Overall Study|Insufficient therapeutic response|74|||
161880616|NCT01508130|584605099|FG001|Overall Study|Insufficient therapeutic response|23|||
161880617|NCT01508130|584605098|FG000|Overall Study|Administrative|14|||
161880618|NCT01508130|584605099|FG001|Overall Study|Administrative|3|||
161880619|NCT02288091|584605102|FG000|Overall Study|Lost to Follow-up|1|||
161880620|NCT02288091|584605102|FG000|Overall Study|Screen fail|7|||
161880621|NCT03403751|584605107|FG000|Overall Study|Death|5|||
161880622|NCT03403751|584605108|FG001|Overall Study|Death|6|||
161880623|NCT03403751|584605107|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
161880624|NCT03403751|584605108|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
161880625|NCT00520481|584605115|FG000|Overall Study|Adverse Event|4|||
161880626|NCT00520481|584605116|FG001|Overall Study|Adverse Event|1|||
161880627|NCT00520481|584605115|FG000|Overall Study|Withdrawal by Subject|3|||
161880628|NCT00520481|584605116|FG001|Overall Study|Withdrawal by Subject|0|||
161880629|NCT04442269|584605119|FG000|Overall Study|Adverse Event|1|||
161880630|NCT04442269|584605120|FG001|Overall Study|Adverse Event|0|||
161880631|NCT04442269|584605119|FG000|Overall Study|Death|0|||
161880632|NCT04442269|584605120|FG001|Overall Study|Death|1|||
161880633|NCT04442269|584605119|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
161880634|NCT04442269|584605120|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
161880635|NCT04442269|584605119|FG000|Overall Study|Lost to Follow-up|1|||
161880636|NCT04442269|584605120|FG001|Overall Study|Lost to Follow-up|0|||
161880637|NCT04442269|584605119|FG000|Overall Study|Withdrawal by Subject|3|||
161880638|NCT04442269|584605120|FG001|Overall Study|Withdrawal by Subject|2|||
161880639|NCT04442269|584605119|FG000|Overall Study|Protocol Deviation|0|||
161880640|NCT04442269|584605120|FG001|Overall Study|Protocol Deviation|1|||
161880641|NCT04442269|584605119|FG000|Overall Study|Travel Limitations|1|||
161880642|NCT04442269|584605120|FG001|Overall Study|Travel Limitations|1|||
161880643|NCT03802565|584605124|FG000|Overall Study|Adverse Event|0|||
161880644|NCT03802565|584605125|FG001|Overall Study|Adverse Event|1|||
161880645|NCT03802565|584605126|FG002|Overall Study|Adverse Event|2|||
161880646|NCT03802565|584605127|FG003|Overall Study|Adverse Event|1|||
161880647|NCT03802565|584605128|FG004|Overall Study|Adverse Event|1|||
161880648|NCT03802565|584605124|FG000|Overall Study|Withdrawal by Subject|2|||
161880649|NCT03802565|584605125|FG001|Overall Study|Withdrawal by Subject|2|||
161880650|NCT03802565|584605126|FG002|Overall Study|Withdrawal by Subject|2|||
161880651|NCT03802565|584605127|FG003|Overall Study|Withdrawal by Subject|0|||
161880652|NCT03802565|584605128|FG004|Overall Study|Withdrawal by Subject|1|||
161880653|NCT03802565|584605124|FG000|Overall Study|Protocol Violation|2|||
161880654|NCT03802565|584605125|FG001|Overall Study|Protocol Violation|1|||
161880655|NCT03802565|584605126|FG002|Overall Study|Protocol Violation|4|||
161880656|NCT03802565|584605127|FG003|Overall Study|Protocol Violation|5|||
161880657|NCT03802565|584605128|FG004|Overall Study|Protocol Violation|1|||
161880658|NCT03802565|584605124|FG000|Overall Study|Lost to Follow-up|0|||
161880659|NCT03802565|584605125|FG001|Overall Study|Lost to Follow-up|0|||
161880660|NCT03802565|584605126|FG002|Overall Study|Lost to Follow-up|1|||
161880661|NCT03802565|584605127|FG003|Overall Study|Lost to Follow-up|0|||
161880662|NCT03802565|584605128|FG004|Overall Study|Lost to Follow-up|0|||
161880663|NCT03802565|584605124|FG000|Overall Study|Subjects Related to Each Other|1|||
161880664|NCT03802565|584605125|FG001|Overall Study|Subjects Related to Each Other|0|||
161880665|NCT03802565|584605126|FG002|Overall Study|Subjects Related to Each Other|0|||
161880666|NCT03802565|584605127|FG003|Overall Study|Subjects Related to Each Other|2|||
161880667|NCT03802565|584605128|FG004|Overall Study|Subjects Related to Each Other|1|||
161880668|NCT03802565|584605124|FG000|Overall Study|Elevated Enzymes|0|||
161880669|NCT03802565|584605125|FG001|Overall Study|Elevated Enzymes|0|||
161880670|NCT03802565|584605126|FG002|Overall Study|Elevated Enzymes|0|||
161880671|NCT03802565|584605127|FG003|Overall Study|Elevated Enzymes|0|||
161880672|NCT03802565|584605128|FG004|Overall Study|Elevated Enzymes|2|||
161880673|NCT00430352|584605129|FG000|Overall Study|Disease progression|58|||
161880674|NCT00430352|584605129|FG000|Overall Study|Withdrawal by Subject|11|||
161880675|NCT00430352|584605129|FG000|Overall Study|Adverse Event|16|||
161880676|NCT00430352|584605129|FG000|Overall Study|Death|5|||
161880677|NCT00430352|584605129|FG000|Overall Study|Other|48|||
161880678|NCT03099694|584605130|FG000|Overall Study|Withdrawal by Subject|11|||
161880679|NCT03099694|584605131|FG001|Overall Study|Withdrawal by Subject|13|||
161880680|NCT03099694|584605130|FG000|Overall Study|Lost to Follow-up|9|||
161880681|NCT03099694|584605131|FG001|Overall Study|Lost to Follow-up|5|||
161880682|NCT04326439|584605132|FG000|Overall Study|Withdrawal by Subject|1|||
161880683|NCT04326439|584605133|FG001|Overall Study|Withdrawal by Subject|0|||
161880684|NCT04326439|584605132|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
161880685|NCT04326439|584605133|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
161880686|NCT04326439|584605132|FG000|Overall Study|Relapse after Induction 2|0|||
161880687|NCT04326439|584605133|FG001|Overall Study|Relapse after Induction 2|1|||
161880688|NCT04326439|584605132|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
161880689|NCT04326439|584605133|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
161880690|NCT01931956|584605137|FG000|Overall Study|Death|42|||
161880691|NCT01931956|584605138|FG001|Overall Study|Death|7|||
161880692|NCT01931956|584605139|FG002|Overall Study|Death|379|||
161880693|NCT01931956|584605140|FG003|Overall Study|Death|96|||
161880694|NCT01931956|584605137|FG000|Overall Study|Withdrawal by Subject|5|||
161880695|NCT01931956|584605138|FG001|Overall Study|Withdrawal by Subject|0|||
161880696|NCT01931956|584605139|FG002|Overall Study|Withdrawal by Subject|70|||
161880697|NCT01931956|584605140|FG003|Overall Study|Withdrawal by Subject|30|||
161880698|NCT01931956|584605137|FG000|Overall Study|Lost to Follow-up|2|||
161880699|NCT01931956|584605138|FG001|Overall Study|Lost to Follow-up|0|||
161880700|NCT01931956|584605139|FG002|Overall Study|Lost to Follow-up|11|||
161880701|NCT01931956|584605140|FG003|Overall Study|Lost to Follow-up|7|||
161880702|NCT01931956|584605137|FG000|Overall Study|Expected|2|||
161880703|NCT01931956|584605138|FG001|Overall Study|Expected|0|||
161880704|NCT01931956|584605139|FG002|Overall Study|Expected|6|||
161880705|NCT01931956|584605140|FG003|Overall Study|Expected|0|||
161880706|NCT01931956|584605137|FG000|Overall Study|Not due|0|||
161880707|NCT01931956|584605138|FG001|Overall Study|Not due|0|||
161777904|NCT03466060|584228841|FG001|Period 1|Lost to Follow-up|0|||
161777905|NCT03466060|584228842|FG002|Period 1|Lost to Follow-up|0|||
161880708|NCT01931956|584605139|FG002|Overall Study|Not due|21|||
161777906|NCT03466060|584228843|FG003|Period 1|Lost to Follow-up|1|||
161777907|NCT03466060|584228844|FG004|Period 1|Lost to Follow-up|0|||
161777908|NCT03466060|584228845|FG005|Period 1|Lost to Follow-up|0|||
161777909|NCT03466060|584228840|FG000|Period 1|Grade 2 Conjunctivitis|0|||
161777910|NCT03466060|584228841|FG001|Period 1|Grade 2 Conjunctivitis|0|||
161777911|NCT03466060|584228842|FG002|Period 1|Grade 2 Conjunctivitis|1|||
161777912|NCT03466060|584228843|FG003|Period 1|Grade 2 Conjunctivitis|0|||
161777913|NCT03466060|584228844|FG004|Period 1|Grade 2 Conjunctivitis|0|||
161777914|NCT03466060|584228845|FG005|Period 1|Grade 2 Conjunctivitis|0|||
161777915|NCT03466060|584228840|FG000|Period 2|Lens Handling Difficulties|0|||
161777916|NCT03466060|584228841|FG001|Period 2|Lens Handling Difficulties|0|||
161777917|NCT03466060|584228842|FG002|Period 2|Lens Handling Difficulties|1|||
161777918|NCT03466060|584228843|FG003|Period 2|Lens Handling Difficulties|0|||
161777919|NCT03466060|584228844|FG004|Period 2|Lens Handling Difficulties|0|||
161777920|NCT03466060|584228845|FG005|Period 2|Lens Handling Difficulties|0|||
161777921|NCT03345485|584228848|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
161777922|NCT03345485|584228849|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
161777923|NCT03345485|584228850|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
161777924|NCT03345485|584228851|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
161777925|NCT03345485|584228852|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
161777926|NCT03345485|584228853|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
161777927|NCT03345485|584228854|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
161777928|NCT03345485|584228855|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
161777929|NCT03345485|584228856|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
161777930|NCT03345485|584228857|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
161777931|NCT03345485|584228858|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
161777932|NCT03345485|584228859|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
161777933|NCT03345485|584228860|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
161777934|NCT02985515|584228861|FG000|Olfaction Testing|Lost to Follow-up|0|||
161880709|NCT01931956|584605140|FG003|Overall Study|Not due|0|||
161880710|NCT02294175|584605141|FG000|Overall Study|Withdrawal by Subject|1|||
161880711|NCT02294175|584605142|FG001|Overall Study|Withdrawal by Subject|2|||
161880712|NCT02294175|584605141|FG000|Overall Study|pt taking excluded medication|3|||
161880713|NCT02294175|584605142|FG001|Overall Study|pt taking excluded medication|1|||
161880714|NCT02294175|584605141|FG000|Overall Study|Protocol Violation|1|||
161880715|NCT02294175|584605142|FG001|Overall Study|Protocol Violation|0|||
161880716|NCT02294175|584605141|FG000|Overall Study|Lost to Follow-up|0|||
161880717|NCT02294175|584605142|FG001|Overall Study|Lost to Follow-up|1|||
161880718|NCT02294175|584605141|FG000|Overall Study|wound healed|0|||
161880719|NCT02294175|584605142|FG001|Overall Study|wound healed|2|||
161880720|NCT01901653|584605143|FG000|Overall Study|Death|2|||
161880721|NCT01901653|584605144|FG001|Overall Study|Death|1|||
161880722|NCT01901653|584605145|FG002|Overall Study|Death|8|||
161880723|NCT01901653|584605146|FG003|Overall Study|Death|3|||
161880724|NCT01901653|584605147|FG004|Overall Study|Death|2|||
161880725|NCT01901653|584605148|FG005|Overall Study|Death|2|||
161880726|NCT01901653|584605149|FG006|Overall Study|Death|6|||
161880727|NCT01901653|584605150|FG007|Overall Study|Death|9|||
161880728|NCT01901653|584605151|FG008|Overall Study|Death|1|||
161880729|NCT01901653|584605152|FG009|Overall Study|Death|16|||
161880730|NCT01901653|584605153|FG010|Overall Study|Death|2|||
161880731|NCT01901653|584605154|FG011|Overall Study|Death|15|||
161777935|NCT02985515|584228862|FG001|Olfaction Testing|Lost to Follow-up|5|||
161777936|NCT02985515|584228861|FG000|Olfaction Testing|Protocol Violation|0|||
161880732|NCT01901653|584605155|FG012|Overall Study|Death|4|||
161880733|NCT01901653|584605143|FG000|Overall Study|Lost to Follow-up|1|||
161880734|NCT01901653|584605144|FG001|Overall Study|Lost to Follow-up|0|||
161880735|NCT01901653|584605145|FG002|Overall Study|Lost to Follow-up|2|||
161880736|NCT01901653|584605146|FG003|Overall Study|Lost to Follow-up|0|||
161880737|NCT01901653|584605147|FG004|Overall Study|Lost to Follow-up|0|||
161880738|NCT01901653|584605148|FG005|Overall Study|Lost to Follow-up|1|||
161880739|NCT01901653|584605149|FG006|Overall Study|Lost to Follow-up|0|||
161880740|NCT01901653|584605150|FG007|Overall Study|Lost to Follow-up|1|||
161880741|NCT01901653|584605151|FG008|Overall Study|Lost to Follow-up|0|||
161880742|NCT01901653|584605152|FG009|Overall Study|Lost to Follow-up|0|||
161880743|NCT01901653|584605153|FG010|Overall Study|Lost to Follow-up|0|||
161880744|NCT01901653|584605154|FG011|Overall Study|Lost to Follow-up|0|||
161880745|NCT01901653|584605155|FG012|Overall Study|Lost to Follow-up|0|||
161880746|NCT01901653|584605143|FG000|Overall Study|Withdrawal by Subject|0|||
161880747|NCT01901653|584605144|FG001|Overall Study|Withdrawal by Subject|0|||
161880748|NCT01901653|584605145|FG002|Overall Study|Withdrawal by Subject|0|||
161880749|NCT01901653|584605146|FG003|Overall Study|Withdrawal by Subject|0|||
161880750|NCT01901653|584605147|FG004|Overall Study|Withdrawal by Subject|0|||
161880751|NCT01901653|584605148|FG005|Overall Study|Withdrawal by Subject|0|||
161880752|NCT01901653|584605149|FG006|Overall Study|Withdrawal by Subject|1|||
161880753|NCT01901653|584605150|FG007|Overall Study|Withdrawal by Subject|0|||
161880754|NCT01901653|584605151|FG008|Overall Study|Withdrawal by Subject|0|||
161880755|NCT01901653|584605152|FG009|Overall Study|Withdrawal by Subject|0|||
161880756|NCT01901653|584605153|FG010|Overall Study|Withdrawal by Subject|0|||
161880757|NCT01901653|584605154|FG011|Overall Study|Withdrawal by Subject|0|||
161880758|NCT01901653|584605155|FG012|Overall Study|Withdrawal by Subject|0|||
161880759|NCT01901653|584605143|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
161880760|NCT01901653|584605144|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
161880761|NCT01901653|584605145|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
161880762|NCT01901653|584605146|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
161880763|NCT01901653|584605147|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
161880764|NCT01901653|584605148|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
161880765|NCT01901653|584605149|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
161880766|NCT01901653|584605150|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
161880767|NCT01901653|584605151|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
161880768|NCT01901653|584605152|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
161880769|NCT01901653|584605153|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
161880770|NCT01901653|584605154|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
161880771|NCT01901653|584605155|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
161880772|NCT02548351|584605156|FG000|Overall Study|Withdrawal by Subject|149|||
161880773|NCT02548351|584605157|FG001|Overall Study|Withdrawal by Subject|154|||
161880774|NCT02548351|584605158|FG002|Overall Study|Withdrawal by Subject|152|||
161880775|NCT02548351|584605156|FG000|Overall Study|Death|11|||
161880776|NCT02548351|584605157|FG001|Overall Study|Death|15|||
161880777|NCT02548351|584605158|FG002|Overall Study|Death|12|||
161880778|NCT02548351|584605156|FG000|Overall Study|Adverse Event|22|||
161880779|NCT02548351|584605157|FG001|Overall Study|Adverse Event|56|||
161880780|NCT02548351|584605158|FG002|Overall Study|Adverse Event|36|||
161880781|NCT02548351|584605156|FG000|Overall Study|Study Terminated by Sponsor|549|||
161880782|NCT02548351|584605157|FG001|Overall Study|Study Terminated by Sponsor|509|||
161880783|NCT02548351|584605158|FG002|Overall Study|Study Terminated by Sponsor|528|||
161880784|NCT02548351|584605156|FG000|Overall Study|Site Closure|14|||
161880785|NCT02548351|584605157|FG001|Overall Study|Site Closure|5|||
161880786|NCT02548351|584605158|FG002|Overall Study|Site Closure|7|||
161880787|NCT02548351|584605156|FG000|Overall Study|Non-compliance with Study Drug|4|||
161880788|NCT02548351|584605157|FG001|Overall Study|Non-compliance with Study Drug|2|||
161880789|NCT02548351|584605158|FG002|Overall Study|Non-compliance with Study Drug|0|||
161880790|NCT02548351|584605156|FG000|Overall Study|Protocol Violation|2|||
161880791|NCT02548351|584605157|FG001|Overall Study|Protocol Violation|1|||
161880792|NCT02548351|584605158|FG002|Overall Study|Protocol Violation|2|||
161880793|NCT02548351|584605156|FG000|Overall Study|Physician Decision|11|||
161880794|NCT02548351|584605157|FG001|Overall Study|Physician Decision|18|||
161880795|NCT02548351|584605158|FG002|Overall Study|Physician Decision|11|||
161880796|NCT02548351|584605156|FG000|Overall Study|Lost to Follow-up|43|||
161880797|NCT02548351|584605157|FG001|Overall Study|Lost to Follow-up|50|||
161880798|NCT02548351|584605158|FG002|Overall Study|Lost to Follow-up|57|||
161880799|NCT02548351|584605156|FG000|Overall Study|Other|19|||
161880800|NCT02548351|584605157|FG001|Overall Study|Other|16|||
161880801|NCT02548351|584605158|FG002|Overall Study|Other|20|||
161880802|NCT02548351|584605156|FG000|Overall Study|Missing|1|||
161880803|NCT02548351|584605157|FG001|Overall Study|Missing|1|||
161880804|NCT02548351|584605158|FG002|Overall Study|Missing|0|||
161880805|NCT02805660|584605159|FG000|Overall Study|Death|5|||
161880806|NCT02805660|584605160|FG001|Overall Study|Death|2|||
161880807|NCT02805660|584605161|FG002|Overall Study|Death|9|||
161880808|NCT02805660|584605162|FG003|Overall Study|Death|5|||
161880809|NCT02805660|584605163|FG004|Overall Study|Death|0|||
161880810|NCT02805660|584605164|FG005|Overall Study|Death|14|||
161880811|NCT02805660|584605165|FG006|Overall Study|Death|12|||
161880812|NCT02805660|584605159|FG000|Overall Study|Lost to Follow-up|0|||
161880813|NCT02805660|584605160|FG001|Overall Study|Lost to Follow-up|1|||
161880814|NCT02805660|584605161|FG002|Overall Study|Lost to Follow-up|1|||
161880815|NCT02805660|584605162|FG003|Overall Study|Lost to Follow-up|2|||
161880816|NCT02805660|584605163|FG004|Overall Study|Lost to Follow-up|0|||
161880817|NCT02805660|584605164|FG005|Overall Study|Lost to Follow-up|0|||
161880818|NCT02805660|584605165|FG006|Overall Study|Lost to Follow-up|0|||
161880819|NCT02805660|584605159|FG000|Overall Study|Withdrawal by Subject|0|||
161880820|NCT02805660|584605160|FG001|Overall Study|Withdrawal by Subject|0|||
161880821|NCT02805660|584605161|FG002|Overall Study|Withdrawal by Subject|0|||
161880822|NCT02805660|584605162|FG003|Overall Study|Withdrawal by Subject|3|||
161880823|NCT02805660|584605163|FG004|Overall Study|Withdrawal by Subject|1|||
161880824|NCT02805660|584605164|FG005|Overall Study|Withdrawal by Subject|0|||
161880825|NCT02805660|584605165|FG006|Overall Study|Withdrawal by Subject|2|||
161880826|NCT02805660|584605159|FG000|Overall Study|Study terminated by Sponsor|0|||
161880827|NCT02805660|584605160|FG001|Overall Study|Study terminated by Sponsor|0|||
161880828|NCT02805660|584605161|FG002|Overall Study|Study terminated by Sponsor|1|||
161880829|NCT02805660|584605162|FG003|Overall Study|Study terminated by Sponsor|4|||
161880830|NCT02805660|584605163|FG004|Overall Study|Study terminated by Sponsor|2|||
161880831|NCT02805660|584605164|FG005|Overall Study|Study terminated by Sponsor|3|||
161880832|NCT02805660|584605165|FG006|Overall Study|Study terminated by Sponsor|1|||
161880833|NCT02805660|584605159|FG000|Overall Study|Miscellaneous|0|||
161880834|NCT02805660|584605160|FG001|Overall Study|Miscellaneous|1|||
161880835|NCT02805660|584605161|FG002|Overall Study|Miscellaneous|0|||
161880836|NCT02805660|584605162|FG003|Overall Study|Miscellaneous|4|||
161880837|NCT02805660|584605163|FG004|Overall Study|Miscellaneous|0|||
161880838|NCT02805660|584605164|FG005|Overall Study|Miscellaneous|6|||
161880839|NCT02805660|584605165|FG006|Overall Study|Miscellaneous|4|||
161880840|NCT02572076|584605166|FG000|Overall Study|Protocol Violation|1|||
161880841|NCT00197002|584607092|FG000|Overall Study|Adverse Event|0|||
161880842|NCT00197002|584607093|FG001|Overall Study|Adverse Event|1|||
161880843|NCT00197002|584607094|FG002|Overall Study|Adverse Event|0|||
161880844|NCT00197002|584607092|FG000|Overall Study|Protocol Violation|1|||
161880845|NCT00197002|584607093|FG001|Overall Study|Protocol Violation|0|||
161880846|NCT00197002|584607094|FG002|Overall Study|Protocol Violation|2|||
161880847|NCT00197002|584607092|FG000|Overall Study|Withdrawal by Subject|9|||
161880848|NCT00197002|584607093|FG001|Overall Study|Withdrawal by Subject|5|||
161880849|NCT00197002|584607094|FG002|Overall Study|Withdrawal by Subject|7|||
161880850|NCT00197002|584607092|FG000|Overall Study|Migrated/moved from study area|3|||
161880851|NCT00197002|584607093|FG001|Overall Study|Migrated/moved from study area|5|||
161880852|NCT00197002|584607094|FG002|Overall Study|Migrated/moved from study area|1|||
161880853|NCT00197002|584607092|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
161880854|NCT00197002|584607093|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
161880855|NCT00197002|584607094|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
161880856|NCT00197002|584607092|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
161880857|NCT00197002|584607093|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
161880858|NCT00197002|584607094|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
161880859|NCT00197002|584607092|FG000|Overall Study|Others|3|||
161880860|NCT00197002|584607093|FG001|Overall Study|Others|1|||
161880861|NCT00197002|584607094|FG002|Overall Study|Others|1|||
161880862|NCT02759055|584607100|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
161880863|NCT02759055|584607101|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
161880864|NCT02515994|584607102|FG000|Overall Study|Protocol Violation|3|||
161880865|NCT02515994|584607103|FG001|Overall Study|Protocol Violation|5|||
161880866|NCT02515994|584607102|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
161880867|NCT02515994|584607103|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161880868|NCT02515994|584607102|FG000|Overall Study|Adverse Event|3|||
161880869|NCT02515994|584607103|FG001|Overall Study|Adverse Event|1|||
161880870|NCT02515994|584607102|FG000|Overall Study|Withdrawal by Subject|2|||
161880871|NCT02515994|584607103|FG001|Overall Study|Withdrawal by Subject|0|||
161880872|NCT01424514|584607105|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
161880873|NCT01424514|584607106|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
161880874|NCT01424514|584607105|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
161880875|NCT01424514|584607106|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
161880876|NCT02653170|584607107|FG000|Overall Study|Withdrawal by Subject|3|||
161880877|NCT02653170|584607108|FG001|Overall Study|Withdrawal by Subject|8|||
161880878|NCT02653170|584607109|FG002|Overall Study|Withdrawal by Subject|3|||
161880879|NCT02653170|584607107|FG000|Overall Study|withdrawn by study team|2|||
161880880|NCT02653170|584607108|FG001|Overall Study|withdrawn by study team|4|||
161880881|NCT02653170|584607109|FG002|Overall Study|withdrawn by study team|5|||
161880882|NCT02653170|584607107|FG000|Overall Study|Lost to Follow-up|12|||
161880883|NCT02653170|584607108|FG001|Overall Study|Lost to Follow-up|4|||
161880884|NCT02653170|584607109|FG002|Overall Study|Lost to Follow-up|10|||
161880885|NCT04598451|584607110|FG000|Overall Study|Adverse Event|3|||
161880886|NCT04598451|584607111|FG001|Overall Study|Adverse Event|2|||
161880887|NCT04598451|584607110|FG000|Overall Study|Withdrawal by Subject|3|||
161880888|NCT04598451|584607111|FG001|Overall Study|Withdrawal by Subject|7|||
161880889|NCT04598451|584607110|FG000|Overall Study|Lost to Follow-up|2|||
161880890|NCT04598451|584607111|FG001|Overall Study|Lost to Follow-up|0|||
161880891|NCT04598451|584607110|FG000|Overall Study|Physician Decision|4|||
161880892|NCT04598451|584607111|FG001|Overall Study|Physician Decision|1|||
161880893|NCT04598451|584607110|FG000|Overall Study|Requires Prohibited Medication|1|||
161880894|NCT04598451|584607111|FG001|Overall Study|Requires Prohibited Medication|0|||
161880895|NCT04598451|584607110|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
161880896|NCT04598451|584607111|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
161880897|NCT01632150|584607112|FG000|Overall Study|Disease progression|27|||
161880898|NCT01632150|584607112|FG000|Overall Study|Study drug toxicity|1|||
161880899|NCT01632150|584607112|FG000|Overall Study|Unrelated adverse event|7|||
161880900|NCT01632150|584607112|FG000|Overall Study|Withdrawal by Subject|2|||
161880901|NCT01632150|584607112|FG000|Overall Study|Patient underwent autologous transplant|1|||
161880902|NCT01632150|584607112|FG000|Overall Study|Moved to compassionate program|2|||
161880903|NCT02879994|584607115|FG000|Overall Study|off treatment early|7|||
161880904|NCT02879994|584607115|FG000|Overall Study|Adverse Event|2|||
161880905|NCT02879994|584607115|FG000|Overall Study|Death|2|||
161880906|NCT02143791|584607116|FG000|Enrolled|Withdrawal by Subject|4|||
161880907|NCT02143791|584607116|FG000|Trial Stimulation|Lack of Efficacy|21|||
161880908|NCT02143791|584607116|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
161880909|NCT02143791|584607116|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
161880910|NCT02143791|584607116|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
161880911|NCT02143791|584607116|FG000|Any Programming (3-6 Months)|Missing Data|1|||
161880912|NCT02143791|584607116|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
161880913|NCT04984681|584607121|FG000|Overall Study|Lost to Follow-up|3|||
161880914|NCT04984681|584607122|FG001|Overall Study|Lost to Follow-up|1|||
161880915|NCT04327661|584607123|FG000|Overall Study|Withdrawal by Subject|1|||
161880916|NCT04327661|584607124|FG001|Overall Study|Withdrawal by Subject|0|||
161880917|NCT04327661|584607125|FG002|Overall Study|Withdrawal by Subject|0|||
161880918|NCT01473394|584607126|FG000|Overall Study|Adverse Event|13|||
161880919|NCT01473394|584607127|FG001|Overall Study|Adverse Event|16|||
161880920|NCT01473394|584607126|FG000|Overall Study|Insufficient Therapeutic Response|4|||
161880921|NCT01473394|584607127|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161880922|NCT01473394|584607126|FG000|Overall Study|Protocol Violation|7|||
161880923|NCT01473394|584607127|FG001|Overall Study|Protocol Violation|5|||
161880924|NCT01473394|584607126|FG000|Overall Study|Withdrew Consent|12|||
161880925|NCT01473394|584607127|FG001|Overall Study|Withdrew Consent|10|||
161880926|NCT01473394|584607126|FG000|Overall Study|Lost to Follow-up|9|||
161880927|NCT01473394|584607127|FG001|Overall Study|Lost to Follow-up|11|||
161880928|NCT03391232|584607128|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
161880929|NCT03391232|584607129|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
161880930|NCT03391232|584607128|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
161880931|NCT03391232|584607129|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
161880932|NCT02091960|584607130|FG000|Overall Study|Death|7|||
161880933|NCT02091960|584607130|FG000|Overall Study|Withdrawal by Subject|1|||
161880934|NCT02091960|584607130|FG000|Overall Study|Miscellaneous Reasons|37|||
161880935|NCT02637895|584607141|FG000|Overall Study|Lost to Follow-up|4|||
161880936|NCT02637895|584607142|FG001|Overall Study|Lost to Follow-up|0|||
161880937|NCT02637895|584607141|FG000|Overall Study|Protocol Violation|0|||
161880938|NCT02637895|584607142|FG001|Overall Study|Protocol Violation|1|||
161880939|NCT02637895|584607141|FG000|Overall Study|Lack of Efficacy|1|||
161880940|NCT02637895|584607142|FG001|Overall Study|Lack of Efficacy|0|||
161880941|NCT02637895|584607141|FG000|Overall Study|Withdrawal by Subject|1|||
161880942|NCT02637895|584607142|FG001|Overall Study|Withdrawal by Subject|1|||
161880943|NCT02637895|584607141|FG000|Overall Study|Abnormal baseline lab|0|||
161880944|NCT02637895|584607142|FG001|Overall Study|Abnormal baseline lab|1|||
161880945|NCT00984061|584607145|FG000|Clarithromycin Alone|Protocol Violation|1|||
161880946|NCT05139303|584607146|FG000|Overall Study|Lost to Follow-up|3|||
161880947|NCT05139303|584607147|FG001|Overall Study|Lost to Follow-up|0|||
161880948|NCT05139303|584607146|FG000|Overall Study|Adverse Event|1|||
161880949|NCT05139303|584607147|FG001|Overall Study|Adverse Event|0|||
161880950|NCT00761280|584607148|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
161880951|NCT00761280|584607149|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
161880952|NCT00761280|584607148|FG000|Randomization to First Dose|Sponsor decision|1|||
161880953|NCT00761280|584607149|FG001|Randomization to First Dose|Sponsor decision|0|||
161880954|NCT00761280|584607148|FG000|Randomization to First Dose|Other|1|||
161880955|NCT00761280|584607149|FG001|Randomization to First Dose|Other|0|||
161880956|NCT00761280|584607148|FG000|First Dose to End of Study|End of trial|5|||
161880957|NCT00761280|584607149|FG001|First Dose to End of Study|End of trial|5|||
161880958|NCT00761280|584607148|FG000|First Dose to End of Study|Progressive disease|5|||
161880959|NCT00761280|584607149|FG001|First Dose to End of Study|Progressive disease|3|||
161880960|NCT00761280|584607148|FG000|First Dose to End of Study|Sponsor decision|1|||
161880961|NCT00761280|584607149|FG001|First Dose to End of Study|Sponsor decision|2|||
161880962|NCT00761280|584607148|FG000|First Dose to End of Study|Death|1|||
161880963|NCT00761280|584607149|FG001|First Dose to End of Study|Death|0|||
161880964|NCT00761280|584607148|FG000|First Dose to End of Study|Lost to Follow-up|0|||
161880965|NCT00761280|584607149|FG001|First Dose to End of Study|Lost to Follow-up|1|||
161880966|NCT03875482|584607153|FG000|Overall Study|Adverse Event|0|||
161880967|NCT03875482|584607154|FG001|Overall Study|Adverse Event|1|||
161880968|NCT03875482|584607153|FG000|Overall Study|Withdrew consent|5|||
161880969|NCT03875482|584607154|FG001|Overall Study|Withdrew consent|6|||
161880970|NCT03875482|584607153|FG000|Overall Study|Lost to Follow-up|8|||
161880971|NCT03875482|584607154|FG001|Overall Study|Lost to Follow-up|2|||
161880972|NCT03875482|584607153|FG000|Overall Study|Lack of Efficacy|0|||
161880973|NCT03875482|584607154|FG001|Overall Study|Lack of Efficacy|11|||
161880974|NCT04777201|584607155|FG000|Main Study|Withdrawal by Subject|19|||
161880975|NCT04777201|584607156|FG001|Main Study|Withdrawal by Subject|27|||
161880976|NCT04777201|584607157|FG002|Main Study|Withdrawal by Subject|0|||
161880977|NCT04777201|584607155|FG000|Main Study|Death|13|||
161880978|NCT04777201|584607156|FG001|Main Study|Death|27|||
161880979|NCT04777201|584607157|FG002|Main Study|Death|0|||
161880980|NCT04777201|584607155|FG000|Main Study|Subject missed the safety follow-up visit|9|||
161880981|NCT04777201|584607156|FG001|Main Study|Subject missed the safety follow-up visit|10|||
161880982|NCT04777201|584607157|FG002|Main Study|Subject missed the safety follow-up visit|0|||
161880983|NCT04777201|584607155|FG000|Main Study|Physician Decision|8|||
161880984|NCT04777201|584607156|FG001|Main Study|Physician Decision|10|||
161880985|NCT04777201|584607157|FG002|Main Study|Physician Decision|0|||
161880986|NCT04777201|584607155|FG000|Main Study|Adverse Event|8|||
161880987|NCT04777201|584607156|FG001|Main Study|Adverse Event|8|||
161880988|NCT04777201|584607157|FG002|Main Study|Adverse Event|0|||
161880989|NCT04777201|584607155|FG000|Main Study|Lost to Follow-up|9|||
161880990|NCT04777201|584607156|FG001|Main Study|Lost to Follow-up|4|||
161880991|NCT04777201|584607157|FG002|Main Study|Lost to Follow-up|0|||
161880992|NCT04777201|584607155|FG000|Main Study|Reason not specified|3|||
161880993|NCT04777201|584607156|FG001|Main Study|Reason not specified|3|||
161880994|NCT04777201|584607157|FG002|Main Study|Reason not specified|0|||
161880995|NCT04777201|584607155|FG000|Main Study|Lack of Efficacy|1|||
161880996|NCT04777201|584607156|FG001|Main Study|Lack of Efficacy|1|||
161880997|NCT04777201|584607157|FG002|Main Study|Lack of Efficacy|0|||
161880998|NCT04777201|584607155|FG000|Main Study|Protocol Violation|1|||
161880999|NCT04777201|584607156|FG001|Main Study|Protocol Violation|0|||
161881000|NCT04777201|584607157|FG002|Main Study|Protocol Violation|0|||
161881001|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
161881002|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
161881003|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
161881004|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
161881005|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
161881006|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
161881007|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
161881008|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
161881009|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
161881010|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
161881011|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
161881012|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
161881013|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
161881014|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
161881015|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
161881016|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
161881017|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
161881018|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
161881019|NCT00507819|584607160|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
161881020|NCT00507819|584607161|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161881021|NCT02256982|584607167|FG000|Overall Study|Disease Progression|0|||
161881022|NCT02256982|584607168|FG001|Overall Study|Disease Progression|1|||
161881023|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Adverse Event|6|||
161881024|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Adverse Event|14|||
161881025|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Death|3|||
161881026|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Death|1|||
161881027|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
161881028|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
161881029|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
161881030|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
161881031|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
161881032|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
161881033|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
161881034|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
161881035|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
161881036|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
161881037|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Physician Decision|2|||
161881038|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Physician Decision|4|||
161881039|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Pregnancy|2|||
161881040|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Pregnancy|1|||
161881041|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
161881042|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
161881043|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
161881044|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
161881045|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
161881046|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
161881047|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
161881048|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
161881049|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
161881050|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
161881051|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
161881052|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
161881053|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
161881054|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
161881055|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
161881056|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
161881057|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
161881058|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
161881059|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
161881060|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
161881061|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
161881062|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
161881063|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
161881064|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
161881065|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
161881066|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
161881067|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
161881068|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
161881069|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
161881070|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
161881071|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
161881072|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
161881073|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
161881074|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
161881075|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
161881076|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
161881077|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
161881078|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
161881079|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
161881080|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
161881081|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
161881082|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
161881083|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
161881084|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
161881085|NCT01054300|584607177|FG000|Period 1|Adverse Event|1|||
161881086|NCT01054300|584607178|FG001|Period 1|Adverse Event|0|||
161881087|NCT01054300|584607179|FG002|Period 1|Adverse Event|0|||
161881088|NCT01054300|584607180|FG003|Period 1|Adverse Event|0|||
161881089|NCT01054300|584607177|FG000|Period 2|Withdrawal by Subject|0|||
161881090|NCT01054300|584607178|FG001|Period 2|Withdrawal by Subject|0|||
161881091|NCT01054300|584607179|FG002|Period 2|Withdrawal by Subject|1|||
161881092|NCT01054300|584607180|FG003|Period 2|Withdrawal by Subject|0|||
161881093|NCT01899742|584607183|FG000|Overall Study|Adverse Event|5|||
161881094|NCT01899742|584607184|FG001|Overall Study|Adverse Event|4|||
161881095|NCT01899742|584607183|FG000|Overall Study|Lack of Efficacy|1|||
161881096|NCT01899742|584607184|FG001|Overall Study|Lack of Efficacy|5|||
161881097|NCT01899742|584607183|FG000|Overall Study|Protocol Violation|2|||
161881098|NCT01899742|584607184|FG001|Overall Study|Protocol Violation|2|||
161881099|NCT01899742|584607183|FG000|Overall Study|Withdrawal by Subject|9|||
161881100|NCT01899742|584607184|FG001|Overall Study|Withdrawal by Subject|5|||
161881101|NCT00738881|584607188|FG000|Overall Study|Withdrawal by Subject|0|||
161881102|NCT00738881|584607189|FG001|Overall Study|Withdrawal by Subject|2|||
161881103|NCT02662764|584607190|FG000|Overall Study|Adverse Event|6|||
161881104|NCT02662764|584607190|FG000|Overall Study|Lack of Efficacy|8|||
161881105|NCT02662764|584607190|FG000|Overall Study|Protocol Violation|1|||
161881106|NCT02662764|584607190|FG000|Overall Study|Withdrawal by Subject|5|||
161881107|NCT02662764|584607190|FG000|Overall Study|Device failure|4|||
161881108|NCT02662764|584607190|FG000|Overall Study|Patient changed treatment|1|||
161881109|NCT02662764|584607190|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
161881110|NCT00177307|584607194|FG000|Overall Study|Withdrawal by Subject|1|||
161881111|NCT01282164|584607195|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
161881112|NCT01282164|584607196|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
161881113|NCT03671564|584607197|FG000|Overall Study|Progressive Disease|3|||
161881114|NCT03671564|584607198|FG001|Overall Study|Progressive Disease|5|||
161881115|NCT03671564|584607199|FG002|Overall Study|Progressive Disease|3|||
161881116|NCT03671564|584607197|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
161881117|NCT03671564|584607198|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
161881118|NCT03671564|584607199|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
161881119|NCT03671564|584607197|FG000|Overall Study|Withdrawal by Subject|1|||
161881120|NCT03671564|584607198|FG001|Overall Study|Withdrawal by Subject|1|||
161881121|NCT03671564|584607199|FG002|Overall Study|Withdrawal by Subject|0|||
161881122|NCT04521621|584607200|FG000|Overall Study|Death|17|||
161881123|NCT04521621|584607201|FG001|Overall Study|Death|8|||
161777937|NCT02985515|584228862|FG001|Olfaction Testing|Protocol Violation|3|||
161777938|NCT01610284|584228863|FG000|Randomization Phase|Adverse Event|1|||
161777939|NCT01610284|584228864|FG001|Randomization Phase|Adverse Event|0|||
161777940|NCT01610284|584228863|FG000|Randomization Phase|Physician Decision|1|||
161777941|NCT01610284|584228864|FG001|Randomization Phase|Physician Decision|1|||
161777942|NCT01610284|584228863|FG000|Randomization Phase|Death|0|||
161777943|NCT01610284|584228864|FG001|Randomization Phase|Death|1|||
161777944|NCT01610284|584228863|FG000|Treatment Phase|Adverse Event|80|||
161777945|NCT01610284|584228864|FG001|Treatment Phase|Adverse Event|12|||
161777946|NCT01610284|584228863|FG000|Treatment Phase|Lost to Follow-up|1|||
161777947|NCT01610284|584228864|FG001|Treatment Phase|Lost to Follow-up|0|||
161777948|NCT01610284|584228863|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
161777949|NCT01610284|584228864|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
161777950|NCT01610284|584228863|FG000|Treatment Phase|Physician Decision|27|||
161777951|NCT01610284|584228864|FG001|Treatment Phase|Physician Decision|24|||
161777952|NCT01610284|584228863|FG000|Treatment Phase|Progressive Disease|377|||
161777953|NCT01610284|584228864|FG001|Treatment Phase|Progressive Disease|486|||
161777954|NCT01610284|584228863|FG000|Treatment Phase|Protocol Deviation|2|||
161777955|NCT01610284|584228864|FG001|Treatment Phase|Protocol Deviation|3|||
161777956|NCT01610284|584228863|FG000|Treatment Phase|Study terminated by Sponsor|18|||
161777957|NCT01610284|584228864|FG001|Treatment Phase|Study terminated by Sponsor|15|||
161777958|NCT01610284|584228863|FG000|Treatment Phase|Subject/Guardian Decision|55|||
161777959|NCT01610284|584228864|FG001|Treatment Phase|Subject/Guardian Decision|23|||
161777960|NCT01610284|584228863|FG000|Treatment Phase|Death|6|||
161777961|NCT01610284|584228864|FG001|Treatment Phase|Death|5|||
161777962|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
161777963|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161777964|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
161777965|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
161777966|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
161777967|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
161777968|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
161777969|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161777970|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
161777971|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
161777972|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
161777973|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
161777974|NCT03020966|584228865|FG000|Overall Study|Withdrawal by Subject|2|||
161777975|NCT03020966|584228866|FG001|Overall Study|Withdrawal by Subject|0|||
161777976|NCT01856257|584228867|FG000|Overall Study|Death|2|||
161777977|NCT01856257|584228868|FG001|Overall Study|Death|0|||
161881124|NCT04521621|584607202|FG002|Overall Study|Death|8|||
161881125|NCT04521621|584607203|FG003|Overall Study|Death|5|||
161881126|NCT04521621|584607204|FG004|Overall Study|Death|2|||
161881127|NCT04521621|584607205|FG005|Overall Study|Death|7|||
161881128|NCT04521621|584607206|FG006|Overall Study|Death|0|||
161881129|NCT04521621|584607207|FG007|Overall Study|Death|0|||
161881130|NCT04521621|584607200|FG000|Overall Study|Study Terminated by Sponsor|4|||
161881131|NCT04521621|584607201|FG001|Overall Study|Study Terminated by Sponsor|6|||
161881132|NCT04521621|584607202|FG002|Overall Study|Study Terminated by Sponsor|8|||
161881133|NCT04521621|584607203|FG003|Overall Study|Study Terminated by Sponsor|0|||
161881134|NCT04521621|584607204|FG004|Overall Study|Study Terminated by Sponsor|1|||
161881135|NCT04521621|584607205|FG005|Overall Study|Study Terminated by Sponsor|7|||
161881136|NCT04521621|584607206|FG006|Overall Study|Study Terminated by Sponsor|0|||
161881137|NCT04521621|584607207|FG007|Overall Study|Study Terminated by Sponsor|0|||
161881138|NCT04521621|584607200|FG000|Overall Study|Withdrawal by Subject|0|||
161881139|NCT04521621|584607201|FG001|Overall Study|Withdrawal by Subject|0|||
161881140|NCT04521621|584607202|FG002|Overall Study|Withdrawal by Subject|1|||
161881141|NCT04521621|584607203|FG003|Overall Study|Withdrawal by Subject|1|||
161881142|NCT04521621|584607204|FG004|Overall Study|Withdrawal by Subject|0|||
161881143|NCT04521621|584607205|FG005|Overall Study|Withdrawal by Subject|0|||
161881144|NCT04521621|584607206|FG006|Overall Study|Withdrawal by Subject|0|||
161881145|NCT04521621|584607207|FG007|Overall Study|Withdrawal by Subject|0|||
161881146|NCT04521621|584607200|FG000|Overall Study|Allocated in error without study intervention|1|||
161881147|NCT04521621|584607201|FG001|Overall Study|Allocated in error without study intervention|0|||
161881148|NCT04521621|584607202|FG002|Overall Study|Allocated in error without study intervention|0|||
161881149|NCT04521621|584607203|FG003|Overall Study|Allocated in error without study intervention|0|||
161881150|NCT04521621|584607204|FG004|Overall Study|Allocated in error without study intervention|0|||
161881151|NCT04521621|584607205|FG005|Overall Study|Allocated in error without study intervention|0|||
161881152|NCT04521621|584607206|FG006|Overall Study|Allocated in error without study intervention|0|||
161881153|NCT04521621|584607207|FG007|Overall Study|Allocated in error without study intervention|0|||
161881154|NCT01740128|584607212|FG000|Overall Study|Pregnancy|0|||
161881155|NCT01740128|584607213|FG001|Overall Study|Pregnancy|1|||
161881156|NCT01740128|584607212|FG000|Overall Study|Protocol Violation|1|||
161881157|NCT01740128|584607213|FG001|Overall Study|Protocol Violation|2|||
161881158|NCT01740128|584607212|FG000|Overall Study|Lost to Follow-up|2|||
161881159|NCT01740128|584607213|FG001|Overall Study|Lost to Follow-up|2|||
161881160|NCT01740128|584607212|FG000|Overall Study|Withdrawal by Subject|1|||
161881161|NCT01740128|584607213|FG001|Overall Study|Withdrawal by Subject|0|||
161881162|NCT01740128|584607212|FG000|Overall Study|Insufficient protocol compliance|2|||
161881163|NCT01740128|584607213|FG001|Overall Study|Insufficient protocol compliance|2|||
161881164|NCT01041976|584607214|FG000|Overall Study|Withdrawal by Subject|3|||
161881165|NCT01041976|584607215|FG001|Overall Study|Withdrawal by Subject|0|||
161881166|NCT01041976|584607214|FG000|Overall Study|Incarceration|2|||
161881167|NCT01041976|584607215|FG001|Overall Study|Incarceration|0|||
161881168|NCT01041976|584607214|FG000|Overall Study|Death|0|||
161881169|NCT01041976|584607215|FG001|Overall Study|Death|4|||
161881170|NCT02658734|584607216|FG000|Overall Study|Adverse Event|2|||
161881171|NCT02658734|584607216|FG000|Overall Study|Death|4|||
161881172|NCT02658734|584607216|FG000|Overall Study|Lost to Follow-up|7|||
161881173|NCT02658734|584607216|FG000|Overall Study|Withdrawal of Consent|16|||
161881174|NCT02658734|584607216|FG000|Overall Study|Disease Progression|28|||
161881175|NCT00574249|584607217|FG000|Overall Study|Adverse Event|6|||
161881176|NCT00574249|584607218|FG001|Overall Study|Adverse Event|18|||
161881177|NCT00574249|584607217|FG000|Overall Study|Lack of Efficacy|5|||
161881178|NCT00574249|584607218|FG001|Overall Study|Lack of Efficacy|3|||
161881179|NCT00574249|584607217|FG000|Overall Study|Lost to Follow-up|4|||
161881180|NCT00574249|584607218|FG001|Overall Study|Lost to Follow-up|3|||
161881181|NCT00574249|584607217|FG000|Overall Study|Protocol Violation|5|||
161881182|NCT00574249|584607218|FG001|Overall Study|Protocol Violation|2|||
161881183|NCT00574249|584607217|FG000|Overall Study|History of carcinoma|1|||
161881184|NCT00574249|584607218|FG001|Overall Study|History of carcinoma|0|||
161881185|NCT00574249|584607217|FG000|Overall Study|Withdrawal by Subject|3|||
161881186|NCT00574249|584607218|FG001|Overall Study|Withdrawal by Subject|0|||
161881187|NCT00574249|584607217|FG000|Overall Study|Physician Decision|1|||
161881188|NCT00574249|584607218|FG001|Overall Study|Physician Decision|0|||
161881189|NCT00574249|584607217|FG000|Overall Study|Pregnancy|1|||
161881190|NCT00574249|584607218|FG001|Overall Study|Pregnancy|0|||
161881191|NCT00574249|584607217|FG000|Overall Study|Excluded by company|0|||
161881192|NCT00574249|584607218|FG001|Overall Study|Excluded by company|1|||
161881193|NCT00574249|584607217|FG000|Overall Study|PPD test taken twice|0|||
161881194|NCT00574249|584607218|FG001|Overall Study|PPD test taken twice|1|||
161881195|NCT01542034|584607219|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
161881196|NCT01542034|584607220|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
161881197|NCT01542034|584607219|FG000|Overall Study|Administrative decision|0|||
161881198|NCT01542034|584607220|FG001|Overall Study|Administrative decision|3|||
161881199|NCT01542034|584607219|FG000|Overall Study|Subject Noncompliance|1|||
161881200|NCT01542034|584607220|FG001|Overall Study|Subject Noncompliance|0|||
161881201|NCT01542034|584607219|FG000|Overall Study|Adverse Event|2|||
161881202|NCT01542034|584607220|FG001|Overall Study|Adverse Event|2|||
161881203|NCT01542034|584607219|FG000|Overall Study|Lost to Follow-up|7|||
161881204|NCT01542034|584607220|FG001|Overall Study|Lost to Follow-up|6|||
161881205|NCT02612610|584607221|FG000|Overall Study|Withdrawal by Subject|1|||
161881206|NCT02612610|584607222|FG001|Overall Study|Withdrawal by Subject|1|||
161881207|NCT02612610|584607223|FG002|Overall Study|Withdrawal by Subject|0|||
161881208|NCT02612610|584607224|FG003|Overall Study|Withdrawal by Subject|2|||
161881209|NCT02612610|584607221|FG000|Overall Study|Adverse Event|2|||
161881210|NCT02612610|584607222|FG001|Overall Study|Adverse Event|2|||
161881211|NCT02612610|584607223|FG002|Overall Study|Adverse Event|3|||
161881212|NCT02612610|584607224|FG003|Overall Study|Adverse Event|10|||
161881213|NCT02612610|584607221|FG000|Overall Study|Lost to Follow-up|0|||
161881214|NCT02612610|584607222|FG001|Overall Study|Lost to Follow-up|1|||
161881215|NCT02612610|584607223|FG002|Overall Study|Lost to Follow-up|0|||
161881216|NCT02612610|584607224|FG003|Overall Study|Lost to Follow-up|0|||
161881217|NCT02612610|584607221|FG000|Overall Study|Protocol Violation|0|||
161881218|NCT02612610|584607222|FG001|Overall Study|Protocol Violation|1|||
161881219|NCT02612610|584607223|FG002|Overall Study|Protocol Violation|1|||
161881220|NCT02612610|584607224|FG003|Overall Study|Protocol Violation|0|||
161881221|NCT02612610|584607221|FG000|Overall Study|Lack of Efficacy|1|||
161881222|NCT02612610|584607222|FG001|Overall Study|Lack of Efficacy|2|||
161881223|NCT02612610|584607223|FG002|Overall Study|Lack of Efficacy|0|||
161881224|NCT02612610|584607224|FG003|Overall Study|Lack of Efficacy|1|||
161881225|NCT02612610|584607221|FG000|Overall Study|Physician Decision|0|||
161881226|NCT02612610|584607222|FG001|Overall Study|Physician Decision|1|||
161881227|NCT02612610|584607223|FG002|Overall Study|Physician Decision|0|||
161881228|NCT02612610|584607224|FG003|Overall Study|Physician Decision|0|||
161881229|NCT02612610|584607221|FG000|Overall Study|Noncompliance|1|||
161881230|NCT02612610|584607222|FG001|Overall Study|Noncompliance|0|||
161881231|NCT02612610|584607223|FG002|Overall Study|Noncompliance|0|||
161881232|NCT02612610|584607224|FG003|Overall Study|Noncompliance|0|||
161881233|NCT02612610|584607221|FG000|Overall Study|Cough Improvement|0|||
161881234|NCT02612610|584607222|FG001|Overall Study|Cough Improvement|0|||
161881235|NCT02612610|584607223|FG002|Overall Study|Cough Improvement|1|||
161881236|NCT02612610|584607224|FG003|Overall Study|Cough Improvement|0|||
161881237|NCT01546571|584607227|FG000|Overall Study|Adverse Event|1|||
161881238|NCT01546571|584607228|FG001|Overall Study|Adverse Event|0|||
161881239|NCT01546571|584607229|FG002|Overall Study|Adverse Event|0|||
161881240|NCT01546571|584607230|FG003|Overall Study|Adverse Event|1|||
161881241|NCT01546571|584607231|FG004|Overall Study|Adverse Event|0|||
161881242|NCT01546571|584607227|FG000|Overall Study|assigned placebo in Part A|0|||
161881243|NCT01546571|584607228|FG001|Overall Study|assigned placebo in Part A|0|||
161881244|NCT01546571|584607229|FG002|Overall Study|assigned placebo in Part A|22|||
161881245|NCT01546571|584607230|FG003|Overall Study|assigned placebo in Part A|0|||
161881246|NCT01546571|584607231|FG004|Overall Study|assigned placebo in Part A|0|||
161881247|NCT01546571|584607227|FG000|Overall Study|Death|0|||
161881248|NCT01546571|584607228|FG001|Overall Study|Death|1|||
161881249|NCT01546571|584607229|FG002|Overall Study|Death|0|||
161881250|NCT01546571|584607230|FG003|Overall Study|Death|0|||
161881251|NCT01546571|584607231|FG004|Overall Study|Death|0|||
161881252|NCT01546571|584607227|FG000|Overall Study|Lost to Follow-up|0|||
161881253|NCT01546571|584607228|FG001|Overall Study|Lost to Follow-up|0|||
161881254|NCT01546571|584607229|FG002|Overall Study|Lost to Follow-up|2|||
161881255|NCT01546571|584607230|FG003|Overall Study|Lost to Follow-up|2|||
161881256|NCT01546571|584607231|FG004|Overall Study|Lost to Follow-up|3|||
161881257|NCT01546571|584607227|FG000|Overall Study|Pregnancy|0|||
161881258|NCT01546571|584607228|FG001|Overall Study|Pregnancy|0|||
161881259|NCT01546571|584607229|FG002|Overall Study|Pregnancy|0|||
161881260|NCT01546571|584607230|FG003|Overall Study|Pregnancy|1|||
161881261|NCT01546571|584607231|FG004|Overall Study|Pregnancy|0|||
161881262|NCT01546571|584607227|FG000|Overall Study|Disease Progression|20|||
161881263|NCT01546571|584607228|FG001|Overall Study|Disease Progression|18|||
161881264|NCT01546571|584607229|FG002|Overall Study|Disease Progression|15|||
161881265|NCT01546571|584607230|FG003|Overall Study|Disease Progression|73|||
161881266|NCT01546571|584607231|FG004|Overall Study|Disease Progression|37|||
161881267|NCT01546571|584607227|FG000|Overall Study|Withdrawal by Subject|1|||
161881268|NCT01546571|584607228|FG001|Overall Study|Withdrawal by Subject|2|||
161881269|NCT01546571|584607229|FG002|Overall Study|Withdrawal by Subject|4|||
161881270|NCT01546571|584607230|FG003|Overall Study|Withdrawal by Subject|9|||
161881271|NCT01546571|584607231|FG004|Overall Study|Withdrawal by Subject|2|||
161881272|NCT01546571|584607227|FG000|Overall Study|Intercurrent Illness|1|||
161881273|NCT01546571|584607228|FG001|Overall Study|Intercurrent Illness|2|||
161881274|NCT01546571|584607229|FG002|Overall Study|Intercurrent Illness|0|||
161881275|NCT01546571|584607230|FG003|Overall Study|Intercurrent Illness|0|||
161881276|NCT01546571|584607231|FG004|Overall Study|Intercurrent Illness|0|||
161881277|NCT01546571|584607227|FG000|Overall Study|Other Cancers|0|||
161881278|NCT01546571|584607228|FG001|Overall Study|Other Cancers|0|||
161881279|NCT01546571|584607229|FG002|Overall Study|Other Cancers|0|||
161881280|NCT01546571|584607230|FG003|Overall Study|Other Cancers|3|||
161881281|NCT01546571|584607231|FG004|Overall Study|Other Cancers|1|||
161881282|NCT01546571|584607227|FG000|Overall Study|Other|0|||
161881283|NCT01546571|584607228|FG001|Overall Study|Other|0|||
161881284|NCT01546571|584607229|FG002|Overall Study|Other|3|||
161881285|NCT01546571|584607230|FG003|Overall Study|Other|0|||
161881286|NCT01546571|584607231|FG004|Overall Study|Other|0|||
161881287|NCT00478699|584607232|FG000|Overall Study|Inclusion Error|1|||
161881288|NCT00478699|584607233|FG001|Overall Study|Inclusion Error|7|||
161881289|NCT00478699|584607232|FG000|Overall Study|Not receive study treatment|6|||
161881290|NCT00478699|584607233|FG001|Overall Study|Not receive study treatment|30|||
161881291|NCT01880086|584607237|FG000|Overall Study|Lost to Follow-up|1|||
161881292|NCT01880086|584607238|FG001|Overall Study|Lost to Follow-up|1|||
161881293|NCT00471718|584607242|FG000|Overall Study|Adverse Event|3|||
161881294|NCT00471718|584607242|FG000|Overall Study|other complicating disease|1|||
161881295|NCT00471718|584607242|FG000|Overall Study|disease progression|22|||
161881296|NCT00471718|584607242|FG000|Overall Study|Withdrawal by Subject|1|||
161881297|NCT01446237|584607243|FG000|Overall Study|Adverse Event|1|||
161881298|NCT01446237|584607243|FG000|Overall Study|Lost to Follow-up|2|||
161881299|NCT01446237|584607243|FG000|Overall Study|Withdrawal by Subject|7|||
161881300|NCT01817582|584607260|FG000|Overall Study|Withdrawal by Subject|0|||
161881301|NCT01817582|584607261|FG001|Overall Study|Withdrawal by Subject|1|||
161881302|NCT01817582|584607262|FG002|Overall Study|Withdrawal by Subject|0|||
161881303|NCT01817582|584607260|FG000|Overall Study|Participant revealed masked treatment|1|||
161881304|NCT01817582|584607261|FG001|Overall Study|Participant revealed masked treatment|0|||
161881305|NCT01817582|584607262|FG002|Overall Study|Participant revealed masked treatment|0|||
161881306|NCT01817582|584607260|FG000|Overall Study|Randomized but exclusion criteria met|1|||
161881307|NCT01817582|584607261|FG001|Overall Study|Randomized but exclusion criteria met|0|||
161881308|NCT01817582|584607262|FG002|Overall Study|Randomized but exclusion criteria met|0|||
161881309|NCT03053063|584607268|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
161881310|NCT03053063|584607269|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
161881311|NCT03053063|584607270|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
161881312|NCT03053063|584607271|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
161881313|NCT03053063|584607268|FG000|Randomized Phase|Withdrew consent|8|||
161881314|NCT03053063|584607269|FG001|Randomized Phase|Withdrew consent|11|||
161881315|NCT03053063|584607270|FG002|Randomized Phase|Withdrew consent|5|||
161881316|NCT03053063|584607271|FG003|Randomized Phase|Withdrew consent|0|||
161881317|NCT03053063|584607268|FG000|Randomized Phase|Investigator's Discretion|8|||
161881318|NCT03053063|584607269|FG001|Randomized Phase|Investigator's Discretion|6|||
161881319|NCT03053063|584607270|FG002|Randomized Phase|Investigator's Discretion|2|||
161881320|NCT03053063|584607271|FG003|Randomized Phase|Investigator's Discretion|0|||
161881321|NCT03053063|584607268|FG000|Randomized Phase|Lost to Follow-up|3|||
161881322|NCT03053063|584607269|FG001|Randomized Phase|Lost to Follow-up|5|||
161881323|NCT03053063|584607270|FG002|Randomized Phase|Lost to Follow-up|1|||
161881324|NCT03053063|584607271|FG003|Randomized Phase|Lost to Follow-up|0|||
161881325|NCT03053063|584607268|FG000|Randomized Phase|Adverse Event|0|||
161881326|NCT03053063|584607269|FG001|Randomized Phase|Adverse Event|1|||
161881327|NCT03053063|584607270|FG002|Randomized Phase|Adverse Event|0|||
161881328|NCT03053063|584607271|FG003|Randomized Phase|Adverse Event|0|||
161881329|NCT03053063|584607268|FG000|Randomized Phase|Randomized but Never Treated|1|||
161881330|NCT03053063|584607269|FG001|Randomized Phase|Randomized but Never Treated|3|||
161881331|NCT03053063|584607270|FG002|Randomized Phase|Randomized but Never Treated|2|||
161881332|NCT03053063|584607271|FG003|Randomized Phase|Randomized but Never Treated|0|||
161881333|NCT03053063|584607268|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
161881334|NCT03053063|584607269|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
161881335|NCT03053063|584607270|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
161881336|NCT03053063|584607271|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
161881337|NCT03053063|584607268|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
161881338|NCT03053063|584607269|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161881339|NCT03053063|584607270|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161881340|NCT03053063|584607271|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
161881341|NCT03053063|584607268|FG000|Open-Label Phase|Death|0|||
161881342|NCT03053063|584607269|FG001|Open-Label Phase|Death|0|||
161881343|NCT03053063|584607270|FG002|Open-Label Phase|Death|0|||
161881344|NCT03053063|584607271|FG003|Open-Label Phase|Death|2|||
161881345|NCT03053063|584607268|FG000|Open-Label Phase|Investigator's discretion|0|||
161881346|NCT03053063|584607269|FG001|Open-Label Phase|Investigator's discretion|0|||
161881347|NCT03053063|584607270|FG002|Open-Label Phase|Investigator's discretion|0|||
161881348|NCT03053063|584607271|FG003|Open-Label Phase|Investigator's discretion|2|||
161881349|NCT02600845|584607272|FG000|Overall Study|Reason Not Specified|3|||
161881350|NCT02600845|584607272|FG000|Overall Study|Non-compliance with Study Procedures|10|||
161881351|NCT02600845|584607272|FG000|Overall Study|Consent Withdrawal|5|||
161881352|NCT03569293|584609291|FG000|Overall Study|Adverse Event|4|||
161881353|NCT03569293|584609292|FG001|Overall Study|Adverse Event|1|||
161881354|NCT03569293|584609293|FG002|Overall Study|Adverse Event|5|||
161881355|NCT03569293|584609294|FG003|Overall Study|Adverse Event|1|||
161881356|NCT03569293|584609295|FG004|Overall Study|Adverse Event|0|||
161881357|NCT03569293|584609296|FG005|Overall Study|Adverse Event|0|||
161881358|NCT03569293|584609291|FG000|Overall Study|Withdrawal by Subject|16|||
161881359|NCT03569293|584609292|FG001|Overall Study|Withdrawal by Subject|2|||
161881360|NCT03569293|584609293|FG002|Overall Study|Withdrawal by Subject|4|||
161881361|NCT03569293|584609294|FG003|Overall Study|Withdrawal by Subject|1|||
161881362|NCT03569293|584609295|FG004|Overall Study|Withdrawal by Subject|0|||
161881363|NCT03569293|584609296|FG005|Overall Study|Withdrawal by Subject|0|||
161881364|NCT03569293|584609291|FG000|Overall Study|Lost to Follow-up|1|||
161881365|NCT03569293|584609292|FG001|Overall Study|Lost to Follow-up|3|||
161881366|NCT03569293|584609293|FG002|Overall Study|Lost to Follow-up|1|||
161777978|NCT01856257|584228869|FG002|Overall Study|Death|0|||
161777979|NCT01856257|584228870|FG003|Overall Study|Death|0|||
161777980|NCT01856257|584228867|FG000|Overall Study|Physician Decision|0|||
161777981|NCT01856257|584228868|FG001|Overall Study|Physician Decision|0|||
161777982|NCT01856257|584228869|FG002|Overall Study|Physician Decision|0|||
161777983|NCT01856257|584228870|FG003|Overall Study|Physician Decision|1|||
161777984|NCT01856257|584228867|FG000|Overall Study|Withdrawal by Subject|1|||
161777985|NCT01856257|584228868|FG001|Overall Study|Withdrawal by Subject|1|||
161777986|NCT01856257|584228869|FG002|Overall Study|Withdrawal by Subject|0|||
161777987|NCT01856257|584228870|FG003|Overall Study|Withdrawal by Subject|0|||
161777988|NCT01856257|584228867|FG000|Overall Study|Donor complication|0|||
161777989|NCT01856257|584228868|FG001|Overall Study|Donor complication|0|||
161777990|NCT01856257|584228869|FG002|Overall Study|Donor complication|0|||
161777991|NCT01856257|584228870|FG003|Overall Study|Donor complication|1|||
161777992|NCT00424632|584228874|FG000|Overall Study|Death|0|||
161777993|NCT00424632|584228875|FG001|Overall Study|Death|0|||
161777994|NCT00424632|584228876|FG002|Overall Study|Death|0|||
161777995|NCT00424632|584228877|FG003|Overall Study|Death|0|||
161777996|NCT00424632|584228878|FG004|Overall Study|Death|0|||
161777997|NCT00424632|584228879|FG005|Overall Study|Death|2|||
161777998|NCT00424632|584228880|FG006|Overall Study|Death|0|||
161777999|NCT00424632|584228881|FG007|Overall Study|Death|0|||
161778000|NCT00424632|584228882|FG008|Overall Study|Death|0|||
161778001|NCT00424632|584228883|FG009|Overall Study|Death|0|||
161778002|NCT00424632|584228874|FG000|Overall Study|Adverse Event|0|||
161778003|NCT00424632|584228875|FG001|Overall Study|Adverse Event|0|||
161778004|NCT00424632|584228876|FG002|Overall Study|Adverse Event|0|||
161778005|NCT00424632|584228877|FG003|Overall Study|Adverse Event|0|||
161778006|NCT00424632|584228878|FG004|Overall Study|Adverse Event|0|||
161778007|NCT00424632|584228879|FG005|Overall Study|Adverse Event|0|||
161778008|NCT00424632|584228880|FG006|Overall Study|Adverse Event|0|||
161778009|NCT00424632|584228881|FG007|Overall Study|Adverse Event|0|||
161778010|NCT00424632|584228882|FG008|Overall Study|Adverse Event|3|||
161778011|NCT00424632|584228883|FG009|Overall Study|Adverse Event|2|||
161778012|NCT00424632|584228874|FG000|Overall Study|Global deterioration of health status|0|||
161778013|NCT00424632|584228875|FG001|Overall Study|Global deterioration of health status|0|||
161778014|NCT00424632|584228876|FG002|Overall Study|Global deterioration of health status|0|||
161778015|NCT00424632|584228877|FG003|Overall Study|Global deterioration of health status|1|||
161778016|NCT00424632|584228878|FG004|Overall Study|Global deterioration of health status|1|||
161778017|NCT00424632|584228879|FG005|Overall Study|Global deterioration of health status|0|||
161778018|NCT00424632|584228880|FG006|Overall Study|Global deterioration of health status|0|||
161778019|NCT00424632|584228881|FG007|Overall Study|Global deterioration of health status|0|||
161778020|NCT00424632|584228882|FG008|Overall Study|Global deterioration of health status|0|||
161778021|NCT00424632|584228883|FG009|Overall Study|Global deterioration of health status|0|||
161778022|NCT00424632|584228874|FG000|Overall Study|Objective progression or relapse|1|||
161778023|NCT00424632|584228875|FG001|Overall Study|Objective progression or relapse|1|||
161778024|NCT00424632|584228876|FG002|Overall Study|Objective progression or relapse|1|||
161778025|NCT00424632|584228877|FG003|Overall Study|Objective progression or relapse|2|||
161778026|NCT00424632|584228878|FG004|Overall Study|Objective progression or relapse|2|||
161778027|NCT00424632|584228879|FG005|Overall Study|Objective progression or relapse|13|||
161778028|NCT00424632|584228880|FG006|Overall Study|Objective progression or relapse|7|||
161778029|NCT00424632|584228881|FG007|Overall Study|Objective progression or relapse|3|||
161778030|NCT00424632|584228882|FG008|Overall Study|Objective progression or relapse|12|||
161778031|NCT00424632|584228883|FG009|Overall Study|Objective progression or relapse|4|||
161778032|NCT00424632|584228874|FG000|Overall Study|Other|0|||
161778033|NCT00424632|584228875|FG001|Overall Study|Other|0|||
161778034|NCT00424632|584228876|FG002|Overall Study|Other|0|||
161778035|NCT00424632|584228877|FG003|Overall Study|Other|1|||
161778036|NCT00424632|584228878|FG004|Overall Study|Other|0|||
161778037|NCT00424632|584228879|FG005|Overall Study|Other|0|||
161778038|NCT00424632|584228880|FG006|Overall Study|Other|0|||
161778039|NCT00424632|584228881|FG007|Overall Study|Other|0|||
161778040|NCT00424632|584228882|FG008|Overall Study|Other|1|||
161778041|NCT00424632|584228883|FG009|Overall Study|Other|0|||
161881367|NCT03569293|584609294|FG003|Overall Study|Lost to Follow-up|1|||
161881368|NCT03569293|584609295|FG004|Overall Study|Lost to Follow-up|0|||
161881369|NCT03569293|584609296|FG005|Overall Study|Lost to Follow-up|0|||
161881370|NCT03569293|584609291|FG000|Overall Study|Other|8|||
161881371|NCT03569293|584609292|FG001|Overall Study|Other|2|||
161881372|NCT03569293|584609293|FG002|Overall Study|Other|1|||
161881373|NCT03569293|584609294|FG003|Overall Study|Other|1|||
161881374|NCT03569293|584609295|FG004|Overall Study|Other|0|||
161881375|NCT03569293|584609296|FG005|Overall Study|Other|0|||
161881376|NCT03569293|584609291|FG000|Overall Study|Ongoing at Time of Analysis|8|||
161881377|NCT03569293|584609292|FG001|Overall Study|Ongoing at Time of Analysis|1|||
161881378|NCT03569293|584609293|FG002|Overall Study|Ongoing at Time of Analysis|3|||
161881379|NCT03569293|584609294|FG003|Overall Study|Ongoing at Time of Analysis|0|||
161881380|NCT03569293|584609295|FG004|Overall Study|Ongoing at Time of Analysis|0|||
161881381|NCT03569293|584609296|FG005|Overall Study|Ongoing at Time of Analysis|0|||
161881382|NCT05072106|584609307|FG000|Overall Study|Progressive disease|3|||
161881383|NCT05072106|584609308|FG001|Overall Study|Progressive disease|3|||
161881384|NCT05072106|584609307|FG000|Overall Study|Compassionate use|3|||
161881385|NCT05072106|584609308|FG001|Overall Study|Compassionate use|1|||
161881386|NCT05072106|584609307|FG000|Overall Study|Withdrawal by Subject|1|||
161881387|NCT05072106|584609308|FG001|Overall Study|Withdrawal by Subject|0|||
161881388|NCT03839459|584609309|FG000|Overall Study|Withdrawal by Subject|2|||
161881389|NCT03839459|584609309|FG000|Overall Study|progression of disease|3|||
161881390|NCT05376241|584609310|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
161881391|NCT05376241|584609310|FG000|Overall Study|103 did not complete the survey|103|||
161881392|NCT05376241|584609310|FG000|Overall Study|17 failed 2 attention check questions|17|||
161881393|NCT03036098|584609311|FG000|Pre-Treatment|Other Reasons|1|||
161881394|NCT03036098|584609312|FG001|Pre-Treatment|Other Reasons|2|||
161881395|NCT03036098|584609313|FG002|Pre-Treatment|Other Reasons|0|||
161881396|NCT03036098|584609314|FG003|Pre-Treatment|Other Reasons|5|||
161881397|NCT03036098|584609311|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
161881398|NCT03036098|584609312|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
161881399|NCT03036098|584609313|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
161881400|NCT03036098|584609314|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
161881401|NCT03036098|584609311|FG000|Pre-Treatment|Withdrawal by Subject|1|||
161881402|NCT03036098|584609312|FG001|Pre-Treatment|Withdrawal by Subject|14|||
161881403|NCT03036098|584609313|FG002|Pre-Treatment|Withdrawal by Subject|0|||
161881404|NCT03036098|584609314|FG003|Pre-Treatment|Withdrawal by Subject|5|||
161881405|NCT03036098|584609311|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
161881406|NCT03036098|584609312|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
161881407|NCT03036098|584609313|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
161881408|NCT03036098|584609314|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
161881409|NCT03036098|584609311|FG000|Treatment|Disease Progression|130|||
161881410|NCT03036098|584609312|FG001|Treatment|Disease Progression|77|||
161881411|NCT03036098|584609313|FG002|Treatment|Disease Progression|168|||
161881412|NCT03036098|584609314|FG003|Treatment|Disease Progression|50|||
161881413|NCT03036098|584609311|FG000|Treatment|Study Drug Toxicity|95|||
161881414|NCT03036098|584609312|FG001|Treatment|Study Drug Toxicity|45|||
161881415|NCT03036098|584609313|FG002|Treatment|Study Drug Toxicity|26|||
161881416|NCT03036098|584609314|FG003|Treatment|Study Drug Toxicity|22|||
161881417|NCT03036098|584609311|FG000|Treatment|Death|9|||
161881418|NCT03036098|584609312|FG001|Treatment|Death|3|||
161881419|NCT03036098|584609313|FG002|Treatment|Death|1|||
161881420|NCT03036098|584609314|FG003|Treatment|Death|2|||
161881421|NCT03036098|584609311|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
161881422|NCT03036098|584609312|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
161881423|NCT03036098|584609313|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
161881424|NCT03036098|584609314|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
161881425|NCT03036098|584609311|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
161881426|NCT03036098|584609312|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
161881427|NCT03036098|584609313|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
161881428|NCT03036098|584609314|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
161881429|NCT03036098|584609311|FG000|Treatment|Withdrawal by Subject|2|||
161881430|NCT03036098|584609312|FG001|Treatment|Withdrawal by Subject|9|||
161881431|NCT03036098|584609313|FG002|Treatment|Withdrawal by Subject|2|||
161881432|NCT03036098|584609314|FG003|Treatment|Withdrawal by Subject|4|||
161881433|NCT03036098|584609311|FG000|Treatment|Maximum Clinical Benefit|6|||
161881434|NCT03036098|584609312|FG001|Treatment|Maximum Clinical Benefit|1|||
161881435|NCT03036098|584609313|FG002|Treatment|Maximum Clinical Benefit|6|||
161881436|NCT03036098|584609314|FG003|Treatment|Maximum Clinical Benefit|10|||
161881437|NCT03036098|584609311|FG000|Treatment|Poor/Non Compliance|1|||
161881438|NCT03036098|584609312|FG001|Treatment|Poor/Non Compliance|2|||
161881439|NCT03036098|584609313|FG002|Treatment|Poor/Non Compliance|0|||
161881440|NCT03036098|584609314|FG003|Treatment|Poor/Non Compliance|1|||
161881441|NCT03036098|584609311|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
161881442|NCT03036098|584609312|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
161881443|NCT03036098|584609313|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
161881444|NCT03036098|584609314|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
161881445|NCT03036098|584609311|FG000|Treatment|Administrative Reason by Sponsor|1|||
161881446|NCT03036098|584609312|FG001|Treatment|Administrative Reason by Sponsor|0|||
161881447|NCT03036098|584609313|FG002|Treatment|Administrative Reason by Sponsor|2|||
161881448|NCT03036098|584609314|FG003|Treatment|Administrative Reason by Sponsor|1|||
161881449|NCT03036098|584609311|FG000|Treatment|Other Reasons|31|||
161881450|NCT03036098|584609312|FG001|Treatment|Other Reasons|5|||
161881451|NCT03036098|584609313|FG002|Treatment|Other Reasons|21|||
161881452|NCT03036098|584609314|FG003|Treatment|Other Reasons|8|||
161881453|NCT03036098|584609311|FG000|Treatment|Ongoing Treatment|0|||
161881454|NCT03036098|584609312|FG001|Treatment|Ongoing Treatment|0|||
161881455|NCT03036098|584609313|FG002|Treatment|Ongoing Treatment|23|||
161881456|NCT03036098|584609314|FG003|Treatment|Ongoing Treatment|0|||
161881457|NCT04240886|584609317|FG000|Treatment Phase|Death|4|||
161881458|NCT04240886|584609317|FG000|Treatment Phase|Discontinuation by Subject|1|||
161881459|NCT04240886|584609317|FG000|Treatment Phase|Adverse Event|5|||
161881460|NCT04240886|584609317|FG000|Follow-up Phase|Withdrawal by Subject|1|||
161881461|NCT04240886|584609317|FG000|Follow-up Phase|Discontinuation by Subject|1|||
161881462|NCT04240886|584609317|FG000|Follow-up Phase|Death|2|||
161881463|NCT02276053|584609320|FG000|Overall Study|Death|2|||
161881464|NCT02276053|584609320|FG000|Overall Study|Adverse Event|5|||
161881465|NCT02276053|584609320|FG000|Overall Study|Lack of Efficacy|2|||
161881466|NCT02276053|584609320|FG000|Overall Study|Withdrawal by Subject|1|||
161881467|NCT02276053|584609320|FG000|Overall Study|Patient does not meet selection criteria|3|||
161881468|NCT02276053|584609320|FG000|Overall Study|Patient needs to increase baseline AED|1|||
161881469|NCT01632904|584609321|FG000|Overall Study|Adverse Event|4|||
161881470|NCT01632904|584609322|FG001|Overall Study|Adverse Event|1|||
161881471|NCT01632904|584609321|FG000|Overall Study|Physician Decision|0|||
161881472|NCT01632904|584609322|FG001|Overall Study|Physician Decision|1|||
161881473|NCT01632904|584609321|FG000|Overall Study|Subject decision|3|||
161881474|NCT01632904|584609322|FG001|Overall Study|Subject decision|2|||
161881475|NCT01632904|584609321|FG000|Overall Study|Disease Progression|0|||
161881476|NCT01632904|584609322|FG001|Overall Study|Disease Progression|1|||
161881477|NCT01632904|584609321|FG000|Overall Study|Reason for discontinuation not available|0|||
161881478|NCT01632904|584609322|FG001|Overall Study|Reason for discontinuation not available|1|||
161881479|NCT02059434|584609323|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
161881480|NCT02059434|584609324|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
161881481|NCT02059434|584609325|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
161881482|NCT02059434|584609326|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
161881483|NCT02059434|584609327|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
161881484|NCT02059434|584609328|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
161881485|NCT02059434|584609329|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
161881486|NCT02059434|584609330|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
161881487|NCT02059434|584609331|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
161881488|NCT02059434|584609323|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
161881489|NCT02059434|584609324|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
161881490|NCT02059434|584609325|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
161881491|NCT02059434|584609326|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
161881492|NCT02059434|584609327|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
161881493|NCT02059434|584609328|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
161881494|NCT02059434|584609329|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
161881495|NCT02059434|584609330|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
161881496|NCT02059434|584609331|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
161881497|NCT02059434|584609323|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
161881498|NCT02059434|584609324|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
161881499|NCT02059434|584609325|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
161881500|NCT02059434|584609326|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
161881501|NCT02059434|584609327|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
161881502|NCT02059434|584609328|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
161881503|NCT02059434|584609329|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
161881504|NCT02059434|584609330|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
161881505|NCT02059434|584609331|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
161881506|NCT02059434|584609323|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
161881507|NCT02059434|584609324|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
161881508|NCT02059434|584609325|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
161881509|NCT02059434|584609326|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
161881510|NCT02059434|584609327|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
161881511|NCT02059434|584609328|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
161881512|NCT02059434|584609329|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
161881513|NCT02059434|584609330|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
161881514|NCT02059434|584609331|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
161881515|NCT02059434|584609323|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881516|NCT02059434|584609324|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881517|NCT02059434|584609325|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881518|NCT02059434|584609326|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881519|NCT02059434|584609327|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881520|NCT02059434|584609328|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881521|NCT02059434|584609329|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881522|NCT02059434|584609330|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881523|NCT02059434|584609331|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
161881524|NCT01004406|584609336|FG000|Overall Study|Withdrawal by Subject|2|||
161881525|NCT01004406|584609337|FG001|Overall Study|Withdrawal by Subject|0|||
161881526|NCT01004406|584609336|FG000|Overall Study|Lost to Follow-up|1|||
161881527|NCT01004406|584609337|FG001|Overall Study|Lost to Follow-up|0|||
161881528|NCT02928770|584609338|FG000|Overall Study|Withdrawal by Subject|2|||
161881529|NCT03201874|584609339|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
161881530|NCT03201874|584609340|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
161881531|NCT03201874|584609339|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
161881532|NCT03201874|584609340|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
161881533|NCT03339726|584609345|FG000|Overall Study|Withdrawal by Subject|1|||
161881534|NCT03339726|584609346|FG001|Overall Study|Withdrawal by Subject|0|||
161881535|NCT03339726|584609347|FG002|Overall Study|Withdrawal by Subject|0|||
161881536|NCT03339726|584609345|FG000|Overall Study|Lost to Follow-up|0|||
161881537|NCT03339726|584609346|FG001|Overall Study|Lost to Follow-up|1|||
161881538|NCT03339726|584609347|FG002|Overall Study|Lost to Follow-up|0|||
161881539|NCT04542499|584609348|FG000|Overall Study|Adverse Event|23|||
161881540|NCT04542499|584609349|FG001|Overall Study|Adverse Event|43|||
161881541|NCT04542499|584609348|FG000|Overall Study|Lack of Efficacy|5|||
161881542|NCT04542499|584609349|FG001|Overall Study|Lack of Efficacy|2|||
161881543|NCT04542499|584609348|FG000|Overall Study|Lost to Follow-up|3|||
161881544|NCT04542499|584609349|FG001|Overall Study|Lost to Follow-up|4|||
161881545|NCT04542499|584609348|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161881546|NCT04542499|584609349|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
161881547|NCT04542499|584609348|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
161881548|NCT04542499|584609349|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161881549|NCT04542499|584609348|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161881550|NCT04542499|584609349|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161881551|NCT04542499|584609348|FG000|Overall Study|Physician Decision|0|||
161881552|NCT04542499|584609349|FG001|Overall Study|Physician Decision|1|||
161881553|NCT04542499|584609348|FG000|Overall Study|Site Terminated by Sponsor|3|||
161881554|NCT04542499|584609349|FG001|Overall Study|Site Terminated by Sponsor|5|||
161881555|NCT04542499|584609348|FG000|Overall Study|Withdrawal by Subject|12|||
161881556|NCT04542499|584609349|FG001|Overall Study|Withdrawal by Subject|33|||
161881557|NCT04542499|584609348|FG000|Overall Study|Other|2|||
161881558|NCT04542499|584609349|FG001|Overall Study|Other|2|||
161881559|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881560|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881561|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881562|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
161881563|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881564|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881565|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881566|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881567|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881568|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881569|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881570|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881571|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881572|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881573|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161881574|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
161881575|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881576|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
161881577|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881578|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
161881579|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161881580|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881581|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
161881582|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881583|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
161881584|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161881585|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881586|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881587|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161881588|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881589|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881590|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881591|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881592|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881593|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161881594|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881595|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881596|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161881597|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
161881598|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881599|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881600|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881601|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
161881602|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881603|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881604|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881605|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881606|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881607|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881608|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881609|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881610|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881611|NCT04035434|584609355|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881612|NCT04035434|584609356|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881613|NCT04035434|584609357|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881614|NCT04035434|584609358|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881615|NCT04035434|584609359|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881616|NCT04035434|584609360|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
161881617|NCT04035434|584609361|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
161881618|NCT04035434|584609362|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881619|NCT04035434|584609363|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881620|NCT04035434|584609364|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881621|NCT04035434|584609365|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881622|NCT04035434|584609366|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881623|NCT04035434|584609367|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881624|NCT04035434|584609355|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881625|NCT04035434|584609356|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881626|NCT04035434|584609357|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881627|NCT04035434|584609358|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881628|NCT04035434|584609359|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881629|NCT04035434|584609360|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881630|NCT04035434|584609361|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881631|NCT04035434|584609362|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881632|NCT04035434|584609363|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881633|NCT04035434|584609364|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881634|NCT04035434|584609365|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881635|NCT04035434|584609366|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881636|NCT04035434|584609367|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881637|NCT04035434|584609355|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881638|NCT04035434|584609356|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881639|NCT04035434|584609357|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881640|NCT04035434|584609358|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161778042|NCT05674721|584228885|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
161778043|NCT05674721|584228886|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
161778044|NCT05674721|584228885|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
161778045|NCT05674721|584228886|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
161778046|NCT03506425|584228901|FG000|Overall Study|Adverse Event|1|||
161778047|NCT03506425|584228902|FG001|Overall Study|Adverse Event|3|||
161778048|NCT03506425|584228903|FG002|Overall Study|Adverse Event|0|||
161778049|NCT03506425|584228901|FG000|Overall Study|Death|1|||
161778050|NCT03506425|584228902|FG001|Overall Study|Death|0|||
161778051|NCT03506425|584228903|FG002|Overall Study|Death|0|||
161778052|NCT03506425|584228901|FG000|Overall Study|Withdrawal by Subject|0|||
161778053|NCT03506425|584228902|FG001|Overall Study|Withdrawal by Subject|0|||
161778054|NCT03506425|584228903|FG002|Overall Study|Withdrawal by Subject|1|||
161778055|NCT02057549|584228907|FG000|Overall Study|Lost to Follow-up|1|||
161778056|NCT02057549|584228908|FG001|Overall Study|Lost to Follow-up|0|||
161778057|NCT02057549|584228907|FG000|Overall Study|Physician Decision|1|||
161778058|NCT02057549|584228908|FG001|Overall Study|Physician Decision|0|||
161778059|NCT02057549|584228907|FG000|Overall Study|Withdrawal by Subject|1|||
161778060|NCT02057549|584228908|FG001|Overall Study|Withdrawal by Subject|0|||
161778061|NCT01418365|584228909|FG000|First Intervention|Withdrawal by Subject|0|||
161778062|NCT01418365|584228910|FG001|First Intervention|Withdrawal by Subject|1|||
161778063|NCT01418365|584228909|FG000|First Intervention|Non-compliance|1|||
161778064|NCT01418365|584228910|FG001|First Intervention|Non-compliance|0|||
161881641|NCT04035434|584609359|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881642|NCT04035434|584609360|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
161881643|NCT04035434|584609361|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
161881644|NCT04035434|584609362|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881645|NCT04035434|584609363|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881646|NCT04035434|584609364|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881647|NCT04035434|584609365|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881648|NCT04035434|584609366|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881649|NCT04035434|584609367|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881650|NCT04322539|584609368|FG000|Overall Study|Adverse Event|2|||
161881651|NCT04322539|584609369|FG001|Overall Study|Adverse Event|0|||
161881652|NCT04322539|584609368|FG000|Overall Study|Death|411|||
161881653|NCT04322539|584609369|FG001|Overall Study|Death|203|||
161778065|NCT01418365|584228909|FG000|Second Intervention|Withdrawal by Subject|0|||
161778066|NCT01418365|584228910|FG001|Second Intervention|Withdrawal by Subject|1|||
161778067|NCT03319368|584228911|FG000|Overall Study|Discharge swabs not collected from resident|57|||
161778068|NCT03319368|584228912|FG001|Overall Study|Discharge swabs not collected from resident|46|||
161778069|NCT04150107|584228919|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
161778070|NCT04150107|584228920|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
161778071|NCT04150107|584228919|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
161778072|NCT04150107|584228920|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
161778073|NCT00824993|584228921|FG000|Overall Study|Withdrawal by Subject|1|||
161778074|NCT00824993|584228922|FG001|Overall Study|Withdrawal by Subject|1|||
161881654|NCT04322539|584609368|FG000|Overall Study|Lost to Follow-up|3|||
161881655|NCT04322539|584609369|FG001|Overall Study|Lost to Follow-up|1|||
161881656|NCT04322539|584609368|FG000|Overall Study|Withdrawal of consent|14|||
161881657|NCT04322539|584609369|FG001|Overall Study|Withdrawal of consent|8|||
161881658|NCT04322539|584609368|FG000|Overall Study|Radiological Disease Progression|6|||
161881659|NCT04322539|584609369|FG001|Overall Study|Radiological Disease Progression|0|||
161881660|NCT04322539|584609368|FG000|Overall Study|Sponsor Decision|19|||
161881661|NCT04322539|584609369|FG001|Overall Study|Sponsor Decision|14|||
161881662|NCT04322539|584609368|FG000|Overall Study|Other|6|||
161881663|NCT04322539|584609369|FG001|Overall Study|Other|4|||
161881664|NCT04161079|584609372|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
161881665|NCT04045132|584609375|FG000|Overall Study|Lost to Follow-up|3|||
161881666|NCT04045132|584609376|FG001|Overall Study|Lost to Follow-up|6|||
161881667|NCT04063657|584609377|FG000|Overall Study|Lost to Follow-up|1|||
161881668|NCT04063657|584609378|FG001|Overall Study|Lost to Follow-up|0|||
161881669|NCT00552032|584609379|FG000|Overall Study|Withdrawal by Subject|2|||
161881670|NCT00552032|584609380|FG001|Overall Study|Withdrawal by Subject|2|||
161881671|NCT00552032|584609379|FG000|Overall Study|Protocol Violation|7|||
161778075|NCT00824993|584228921|FG000|Overall Study|Malignancy Relapse|9|||
161778076|NCT00824993|584228922|FG001|Overall Study|Malignancy Relapse|10|||
161778077|NCT00824993|584228921|FG000|Overall Study|Rapid Bone Loss|0|||
161778078|NCT00824993|584228922|FG001|Overall Study|Rapid Bone Loss|1|||
161778079|NCT00824993|584228921|FG000|Overall Study|Non-Compliant|2|||
161778080|NCT00824993|584228922|FG001|Overall Study|Non-Compliant|1|||
161778081|NCT00824993|584228921|FG000|Overall Study|Insurance Issue|2|||
161881672|NCT00552032|584609380|FG001|Overall Study|Protocol Violation|12|||
161881673|NCT00552032|584609379|FG000|Overall Study|Lost to Follow-up|8|||
161881674|NCT00552032|584609380|FG001|Overall Study|Lost to Follow-up|5|||
161881675|NCT05845567|584609383|FG000|Overall Study|Withdrawal by Subject|1|||
161881676|NCT01104246|584609388|FG000|Overall Study|Withdrawal by Subject|1|||
161881677|NCT01104246|584609388|FG000|Overall Study|did not meet inclusion criteria|4|||
161881678|NCT05178641|584609391|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
161881679|NCT05178641|584609392|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
161881680|NCT05178641|584609391|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
161881681|NCT05178641|584609392|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
161881682|NCT01869699|584609393|FG000|Overall Study|Withdrawal by Subject|1|||
161881683|NCT01869699|584609394|FG001|Overall Study|Withdrawal by Subject|0|||
161881684|NCT01083186|584609399|FG000|Overall Study|Lost to Follow-up|48|||
161881685|NCT01083186|584609399|FG000|Overall Study|Consent Withdrawal|7|||
161881686|NCT01083186|584609399|FG000|Overall Study|Death|3|||
161881687|NCT01083186|584609399|FG000|Overall Study|Adverse Event|3|||
161881688|NCT01083186|584609399|FG000|Overall Study|Lack of Efficacy|2|||
161881689|NCT01083186|584609399|FG000|Overall Study|Hemodialysis Initiation|28|||
161881690|NCT01083186|584609399|FG000|Overall Study|Administrative Reasons|2|||
161881691|NCT01083186|584609399|FG000|Overall Study|Non-compliance to Study Treatment|1|||
161881692|NCT01867294|584609410|FG000|Overall Study|Withdrawal by Subject|1|||
161881693|NCT01867294|584609411|FG001|Overall Study|Withdrawal by Subject|1|||
161881694|NCT01867294|584609412|FG002|Overall Study|Withdrawal by Subject|0|||
161881695|NCT01867294|584609413|FG003|Overall Study|Withdrawal by Subject|0|||
161881696|NCT02062944|584609414|FG000|Overall Study|Lost to Follow-up|1|||
161881697|NCT02062944|584609414|FG000|Overall Study|New hemotological disorder identified|1|||
161881698|NCT02062944|584609414|FG000|Overall Study|Uncontrolled Hypertension|1|||
161881699|NCT02062944|584609414|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
161881700|NCT00278148|584609415|FG000|Phase II - Expansion Phase|Disease progression|0|||
161881701|NCT00278148|584609416|FG001|Phase II - Expansion Phase|Disease progression|0|||
161881702|NCT00278148|584609417|FG002|Phase II - Expansion Phase|Disease progression|4|||
161881703|NCT00278148|584609415|FG000|Phase II - Expansion Phase|Adverse Event|0|||
161881704|NCT00278148|584609416|FG001|Phase II - Expansion Phase|Adverse Event|0|||
161881705|NCT00278148|584609417|FG002|Phase II - Expansion Phase|Adverse Event|2|||
161881706|NCT02035748|584609418|FG000|Overall Study|Adverse Event|5|||
161881707|NCT02035748|584609418|FG000|Overall Study|Death|3|||
161881708|NCT02035748|584609418|FG000|Overall Study|Lost to Follow-up|2|||
161881709|NCT02035748|584609418|FG000|Overall Study|Physician Decision|3|||
161881710|NCT02035748|584609418|FG000|Overall Study|Withdrawal by Subject|6|||
161881711|NCT02035748|584609418|FG000|Overall Study|Progressive Disease|1|||
161881712|NCT00976209|584609421|FG000|Treatment Period 1|Protocol Violation|1|||
161881713|NCT00976209|584609422|FG001|Treatment Period 1|Protocol Violation|0|||
161881714|NCT00976209|584609421|FG000|Treatment Period 1|Lost to Follow-up|2|||
161881715|NCT00976209|584609422|FG001|Treatment Period 1|Lost to Follow-up|0|||
161881716|NCT00976209|584609421|FG000|Treatment Period 1|Other|0|||
161881717|NCT00976209|584609422|FG001|Treatment Period 1|Other|1|||
161881718|NCT00976209|584609421|FG000|Wash-out Period|Adverse Event|1|||
161881719|NCT00976209|584609422|FG001|Wash-out Period|Adverse Event|2|||
161881720|NCT00976209|584609421|FG000|Wash-out Period|Lost to Follow-up|1|||
161881721|NCT00976209|584609422|FG001|Wash-out Period|Lost to Follow-up|0|||
161881722|NCT00976209|584609421|FG000|Wash-out Period|Protocol Violation|1|||
161881723|NCT00976209|584609422|FG001|Wash-out Period|Protocol Violation|0|||
161881724|NCT00976209|584609421|FG000|Wash-out Period|Other|1|||
161881725|NCT00976209|584609422|FG001|Wash-out Period|Other|0|||
161881726|NCT00976209|584609421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161881727|NCT00976209|584609422|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161881728|NCT00976209|584609421|FG000|Treatment Period 2|Lost to Follow-up|0|||
161881729|NCT00976209|584609422|FG001|Treatment Period 2|Lost to Follow-up|1|||
161881730|NCT01252563|584609423|FG000|Overall Study|Contract Deviation|41|||
161881731|NCT01252563|584609423|FG000|Overall Study|Centralized Registration Deviation|30|||
161881732|NCT01252563|584609423|FG000|Overall Study|Lost to Follow-up|161|||
161881733|NCT01252563|584609423|FG000|Overall Study|No visit after first day of treatment|194|||
161881734|NCT01252563|584609423|FG000|Overall Study|No drug administration|6|||
161881735|NCT01866657|584609429|FG000|Overall Study|Surgery canceled|2|||
161881736|NCT01866657|584609430|FG001|Overall Study|Surgery canceled|0|||
161881737|NCT00978250|584609431|FG000|Overall Study|Late determination of ineligibility|0|||
161881738|NCT00978250|584609432|FG001|Overall Study|Late determination of ineligibility|1|||
161881739|NCT00978250|584609433|FG002|Overall Study|Late determination of ineligibility|0|||
161881740|NCT00978250|584609434|FG003|Overall Study|Late determination of ineligibility|1|||
161881741|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
161881742|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
161778082|NCT00824993|584228922|FG001|Overall Study|Insurance Issue|1|||
161778083|NCT00824993|584228921|FG000|Overall Study|Death|0|||
161778084|NCT00824993|584228922|FG001|Overall Study|Death|3|||
161778085|NCT00440193|584228923|FG000|Treatment Period|Adverse Event|74|||
161778086|NCT00440193|584228924|FG001|Treatment Period|Adverse Event|67|||
161778087|NCT00440193|584228923|FG000|Treatment Period|Death|19|||
161778088|NCT00440193|584228924|FG001|Treatment Period|Death|22|||
161778089|NCT00440193|584228923|FG000|Treatment Period|Lack of Efficacy|0|||
161778090|NCT00440193|584228924|FG001|Treatment Period|Lack of Efficacy|1|||
161778091|NCT00440193|584228923|FG000|Treatment Period|Lost to Follow-up|12|||
161778092|NCT00440193|584228924|FG001|Treatment Period|Lost to Follow-up|18|||
161778093|NCT00440193|584228923|FG000|Treatment Period|Physician Decision|3|||
161778094|NCT00440193|584228924|FG001|Treatment Period|Physician Decision|6|||
161778095|NCT00440193|584228923|FG000|Treatment Period|Protocol Violation|16|||
161778096|NCT00440193|584228924|FG001|Treatment Period|Protocol Violation|19|||
161778097|NCT00440193|584228923|FG000|Treatment Period|Withdrawal by Subject|36|||
161778098|NCT00440193|584228924|FG001|Treatment Period|Withdrawal by Subject|77|||
161778099|NCT00440193|584228923|FG000|Treatment Period|Clinical endpoint reached|28|||
161778100|NCT00440193|584228924|FG001|Treatment Period|Clinical endpoint reached|25|||
161778101|NCT00440193|584228923|FG000|Treatment Period|Study terminated by sponsor|102|||
161778102|NCT00440193|584228924|FG001|Treatment Period|Study terminated by sponsor|94|||
161778103|NCT00440193|584228923|FG000|Treatment Period|Protocol driven decision point|2|||
161778104|NCT00440193|584228924|FG001|Treatment Period|Protocol driven decision point|2|||
161778105|NCT00440193|584228923|FG000|Treatment Period|Switch to commercial drug|0|||
161778106|NCT00440193|584228924|FG001|Treatment Period|Switch to commercial drug|2|||
161778107|NCT00440193|584228923|FG000|Treatment Period|Technical problems|1|||
161778108|NCT00440193|584228924|FG001|Treatment Period|Technical problems|1|||
161778109|NCT00440193|584228923|FG000|Treatment Period|Participant convenience|5|||
161778110|NCT00440193|584228924|FG001|Treatment Period|Participant convenience|2|||
161778111|NCT00440193|584228923|FG000|Treatment Period|Participant did not receive treatment|7|||
161778112|NCT00440193|584228924|FG001|Treatment Period|Participant did not receive treatment|13|||
161778113|NCT00440193|584228923|FG000|Treatment Period|Site closed by investigator|0|||
161778114|NCT00440193|584228924|FG001|Treatment Period|Site closed by investigator|2|||
161778115|NCT00440193|584228923|FG000|Observational Period|Adverse Event|2|||
161778116|NCT00440193|584228924|FG001|Observational Period|Adverse Event|2|||
161778117|NCT00440193|584228923|FG000|Observational Period|Death|15|||
161778118|NCT00440193|584228924|FG001|Observational Period|Death|20|||
161778119|NCT00440193|584228923|FG000|Observational Period|Lost to Follow-up|12|||
161778120|NCT00440193|584228924|FG001|Observational Period|Lost to Follow-up|8|||
161778121|NCT00440193|584228923|FG000|Observational Period|Protocol Violation|1|||
161778122|NCT00440193|584228924|FG001|Observational Period|Protocol Violation|0|||
161778123|NCT00440193|584228923|FG000|Observational Period|Withdrawal by Subject|11|||
161778124|NCT00440193|584228924|FG001|Observational Period|Withdrawal by Subject|8|||
161778125|NCT00440193|584228923|FG000|Observational Period|Physician Decision|1|||
161778126|NCT00440193|584228924|FG001|Observational Period|Physician Decision|0|||
161778127|NCT00440193|584228923|FG000|Observational Period|Clinical endpoint reached|1|||
161778128|NCT00440193|584228924|FG001|Observational Period|Clinical endpoint reached|0|||
161778129|NCT00440193|584228923|FG000|Observational Period|Participant convenience|2|||
161778130|NCT00440193|584228924|FG001|Observational Period|Participant convenience|0|||
161778131|NCT00834366|584228925|FG000|Treatment Period 1|Adverse Event|1|||
161778132|NCT00834366|584228926|FG001|Treatment Period 1|Adverse Event|1|||
161778133|NCT03409328|584228932|FG000|Overall Study|Lost to Follow-up|6|||
161778134|NCT03409328|584228933|FG001|Overall Study|Lost to Follow-up|3|||
161778135|NCT02998645|584228934|FG000|Treatment Period 1|Adverse Event|6|||
161778136|NCT02998645|584228934|FG000|Treatment Period 1|Death|5|||
161778137|NCT02998645|584228934|FG000|Treatment Period 1|Technical Problems|4|||
161778138|NCT02998645|584228934|FG000|Treatment Period 1|Lack of Efficacy|2|||
161778139|NCT02998645|584228934|FG000|Treatment Period 1|Progressive disease|1|||
161778140|NCT02998645|584228934|FG000|Treatment Period 1|Subject/guardian decision|1|||
161778141|NCT02998645|584228934|FG000|Treatment Period 2|Lack of Efficacy|5|||
161778142|NCT02998645|584228934|FG000|Treatment Period 2|Adverse Event|2|||
161778143|NCT02998645|584228934|FG000|Treatment Period 2|Progressive disease|2|||
161778144|NCT02998645|584228934|FG000|Treatment Period 2|Physician Decision|1|||
161778145|NCT03701516|584228935|FG000|Period 1|Lost to Follow-up|0|||
161778146|NCT03701516|584228936|FG001|Period 1|Lost to Follow-up|1|||
161778147|NCT03701516|584228935|FG000|Period 1|Adverse Event|0|||
161778148|NCT03701516|584228936|FG001|Period 1|Adverse Event|2|||
161778149|NCT03701516|584228935|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
161778150|NCT03701516|584228936|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161778151|NCT03701516|584228935|FG000|Period 1|Non Compliance to Protocol|2|||
161778152|NCT03701516|584228936|FG001|Period 1|Non Compliance to Protocol|1|||
161778153|NCT03701516|584228935|FG000|Period 1|Withdrawal by Subject|0|||
161881743|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
161881744|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
161881745|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
161881746|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
161881747|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
161881748|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
161881749|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
161881750|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
161881751|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
161881752|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
161881753|NCT02951533|584609440|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
161881754|NCT02951533|584609441|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
161881755|NCT02951533|584609442|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
161881756|NCT02951533|584609440|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
161881757|NCT02951533|584609441|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
161881758|NCT02951533|584609442|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
161881759|NCT02951533|584609440|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
161881760|NCT02951533|584609441|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
161881761|NCT02951533|584609442|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
161881762|NCT02951533|584609440|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
161881763|NCT02951533|584609441|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
161881764|NCT02951533|584609442|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
161881765|NCT02951533|584609440|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
161881766|NCT02951533|584609441|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
161881767|NCT02951533|584609442|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
161881768|NCT02951533|584609440|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
161881769|NCT02951533|584609441|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
161881770|NCT02951533|584609442|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
161881771|NCT02951533|584609440|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
161881772|NCT02951533|584609441|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
161881773|NCT02951533|584609442|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
161881774|NCT05174949|584609443|FG000|Overall Study|Physician Decision|1|||
161881775|NCT05174949|584609444|FG001|Overall Study|Physician Decision|2|||
161881776|NCT05174949|584609445|FG002|Overall Study|Physician Decision|0|||
161881777|NCT05174949|584609446|FG003|Overall Study|Physician Decision|1|||
161881778|NCT05174949|584609447|FG004|Overall Study|Physician Decision|0|||
161881779|NCT05174949|584609448|FG005|Overall Study|Physician Decision|0|||
161881780|NCT05174949|584609443|FG000|Overall Study|Withdrawal by Subject|0|||
161881781|NCT05174949|584609444|FG001|Overall Study|Withdrawal by Subject|1|||
161881782|NCT05174949|584609445|FG002|Overall Study|Withdrawal by Subject|0|||
161881783|NCT05174949|584609446|FG003|Overall Study|Withdrawal by Subject|0|||
161881784|NCT05174949|584609447|FG004|Overall Study|Withdrawal by Subject|0|||
161881785|NCT05174949|584609448|FG005|Overall Study|Withdrawal by Subject|0|||
161881786|NCT05174949|584609443|FG000|Overall Study|Lost to Follow-up|0|||
161881787|NCT05174949|584609444|FG001|Overall Study|Lost to Follow-up|0|||
161881788|NCT05174949|584609445|FG002|Overall Study|Lost to Follow-up|0|||
161881789|NCT05174949|584609446|FG003|Overall Study|Lost to Follow-up|1|||
161881790|NCT05174949|584609447|FG004|Overall Study|Lost to Follow-up|0|||
161881791|NCT05174949|584609448|FG005|Overall Study|Lost to Follow-up|0|||
161881792|NCT02029989|584609449|FG000|Overall Study|Withdrawal by Subject|1|||
161881793|NCT02029989|584609450|FG001|Overall Study|Withdrawal by Subject|0|||
161881794|NCT02029989|584609449|FG000|Overall Study|Withdrawal: Fear of needles|1|||
161881795|NCT02029989|584609450|FG001|Overall Study|Withdrawal: Fear of needles|0|||
161881796|NCT02029989|584609449|FG000|Overall Study|Change of location|2|||
161881797|NCT02029989|584609450|FG001|Overall Study|Change of location|3|||
161881798|NCT02029989|584609449|FG000|Overall Study|Physician Decision|2|||
161881799|NCT02029989|584609450|FG001|Overall Study|Physician Decision|0|||
161881800|NCT02029989|584609449|FG000|Overall Study|Lost to Follow-up|9|||
161881801|NCT02029989|584609450|FG001|Overall Study|Lost to Follow-up|7|||
161881802|NCT02029989|584609449|FG000|Overall Study|Death|0|||
161881803|NCT02029989|584609450|FG001|Overall Study|Death|1|||
161881804|NCT02029989|584609449|FG000|Overall Study|Protocol Violation|1|||
161881805|NCT02029989|584609450|FG001|Overall Study|Protocol Violation|0|||
161881806|NCT04351373|584609451|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
161881807|NCT01123941|584609457|FG000|Overall Study|Lost to Follow-up|2|||
161881808|NCT01123941|584609458|FG001|Overall Study|Lost to Follow-up|1|||
161881809|NCT05036668|584609459|FG000|Overall Study|lost to follow Up|0|||
161881810|NCT05036668|584609460|FG001|Overall Study|lost to follow Up|0|||
161881811|NCT05036668|584609461|FG002|Overall Study|lost to follow Up|1|||
161881812|NCT01537068|584609462|FG000|Overall Study|Lost to Follow-up|2|||
161881813|NCT01537068|584609463|FG001|Overall Study|Lost to Follow-up|1|||
161881814|NCT01537068|584609462|FG000|Overall Study|Adverse Event|0|||
161881815|NCT01537068|584609463|FG001|Overall Study|Adverse Event|1|||
161881816|NCT01537068|584609462|FG000|Overall Study|Withdrawal by Subject|1|||
161881817|NCT01537068|584609463|FG001|Overall Study|Withdrawal by Subject|1|||
161881818|NCT01537068|584609462|FG000|Overall Study|Lack of Efficacy|1|||
161881819|NCT01537068|584609463|FG001|Overall Study|Lack of Efficacy|0|||
161881820|NCT00072280|584609465|FG000|Treatment|Found ineligible|1|||
161881821|NCT00072280|584609466|FG001|Treatment|Found ineligible|2|||
161881822|NCT00072280|584609465|FG000|Follow-up|Early termination of study|2|||
161881823|NCT00072280|584609466|FG001|Follow-up|Early termination of study|2|||
161881824|NCT00833482|584609468|FG000|Days 11-20|Adverse Event|0|||
161881825|NCT00833482|584609469|FG001|Days 11-20|Adverse Event|2|||
161881826|NCT00833482|584609470|FG002|Days 11-20|Adverse Event|0|||
161881827|NCT00833482|584609471|FG003|Days 11-20|Adverse Event|0|||
161881828|NCT00833482|584609472|FG004|Days 11-20|Adverse Event|0|||
161881829|NCT00833482|584609473|FG005|Days 11-20|Adverse Event|0|||
161881830|NCT00833482|584609468|FG000|Days 11-20|Withdrawal by Subject|0|||
161881831|NCT00833482|584609469|FG001|Days 11-20|Withdrawal by Subject|1|||
161881832|NCT00833482|584609470|FG002|Days 11-20|Withdrawal by Subject|0|||
161881833|NCT00833482|584609471|FG003|Days 11-20|Withdrawal by Subject|0|||
161881834|NCT00833482|584609472|FG004|Days 11-20|Withdrawal by Subject|0|||
161881835|NCT00833482|584609473|FG005|Days 11-20|Withdrawal by Subject|0|||
161881836|NCT00833482|584609468|FG000|Days 21-30|Adverse Event|0|||
161881837|NCT00833482|584609469|FG001|Days 21-30|Adverse Event|0|||
161881838|NCT00833482|584609470|FG002|Days 21-30|Adverse Event|1|||
161881839|NCT00833482|584609471|FG003|Days 21-30|Adverse Event|0|||
161881840|NCT00833482|584609472|FG004|Days 21-30|Adverse Event|0|||
161881841|NCT00833482|584609473|FG005|Days 21-30|Adverse Event|0|||
161881842|NCT00833482|584609468|FG000|Days 21-30|Withdrawal by Subject|0|||
161881843|NCT00833482|584609469|FG001|Days 21-30|Withdrawal by Subject|0|||
161881844|NCT00833482|584609470|FG002|Days 21-30|Withdrawal by Subject|0|||
161881845|NCT00833482|584609471|FG003|Days 21-30|Withdrawal by Subject|0|||
161881846|NCT00833482|584609472|FG004|Days 21-30|Withdrawal by Subject|1|||
161881847|NCT00833482|584609473|FG005|Days 21-30|Withdrawal by Subject|0|||
161881848|NCT02234596|584609474|FG000|Overall Study|Participant not treated|2|||
161881849|NCT01944670|584611571|FG000|Overall Study|Lost to Follow-up|2|||
161881850|NCT02907593|584611572|FG000|Overall Study|Withdrawal by Subject|0|||
161881851|NCT02907593|584611573|FG001|Overall Study|Withdrawal by Subject|0|||
161881852|NCT02907593|584611574|FG002|Overall Study|Withdrawal by Subject|1|||
161881853|NCT02907593|584611575|FG003|Overall Study|Withdrawal by Subject|0|||
161881854|NCT05128773|584611584|FG000|Overall Study|Sponsor decision to terminate study|3|||
161881855|NCT05906836|584611586|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
161881856|NCT05906836|584611586|FG000|Overall Study|Lost to Follow-up|1|||
161881857|NCT04488497|584611587|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
161881858|NCT04488497|584611588|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
161881859|NCT04488497|584611587|FG000|Intervention|Physician Decision|2|||
161881860|NCT04488497|584611588|FG001|Intervention|Physician Decision|1|||
161881861|NCT04488497|584611587|FG000|Intervention|Withdrawal by Subject|5|||
161881862|NCT04488497|584611588|FG001|Intervention|Withdrawal by Subject|6|||
161881863|NCT04488497|584611587|FG000|Intervention|Lost to Follow-up|2|||
161881864|NCT04488497|584611588|FG001|Intervention|Lost to Follow-up|0|||
161881865|NCT04488497|584611587|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
161881866|NCT04488497|584611588|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
161881867|NCT04488497|584611587|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
161881868|NCT04488497|584611588|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
161881869|NCT01702532|584611589|FG000|Overall Study|Adverse Event|0|||
161881870|NCT01702532|584611590|FG001|Overall Study|Adverse Event|1|||
161881871|NCT03617861|584611591|FG000|Second Intervention (1 Day)|Adverse Event|0|||
161881872|NCT03617861|584611592|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161881873|NCT03617861|584611593|FG002|Second Intervention (1 Day)|Adverse Event|1|||
161881874|NCT03617861|584611594|FG003|Second Intervention (1 Day)|Adverse Event|0|||
161881875|NCT00623597|584611595|FG000|Overall Study|Failed to return|1|||
161881876|NCT00623597|584611596|FG001|Overall Study|Failed to return|0|||
161881877|NCT01451164|584611597|FG000|Overall Study|Adverse Event|19|||
161881878|NCT01451164|584611598|FG001|Overall Study|Adverse Event|12|||
161881879|NCT01451164|584611599|FG002|Overall Study|Adverse Event|18|||
161881880|NCT01451164|584611600|FG003|Overall Study|Adverse Event|21|||
161881881|NCT01451164|584611597|FG000|Overall Study|Withdrawal Criteria|1|||
161881882|NCT01451164|584611598|FG001|Overall Study|Withdrawal Criteria|1|||
161881883|NCT01451164|584611599|FG002|Overall Study|Withdrawal Criteria|1|||
161881884|NCT01451164|584611600|FG003|Overall Study|Withdrawal Criteria|1|||
161881885|NCT01451164|584611597|FG000|Overall Study|Physician Decision|2|||
161881886|NCT01451164|584611598|FG001|Overall Study|Physician Decision|0|||
161881887|NCT01451164|584611599|FG002|Overall Study|Physician Decision|1|||
161881888|NCT01451164|584611600|FG003|Overall Study|Physician Decision|0|||
161881889|NCT01451164|584611597|FG000|Overall Study|Withdrawal by Subject|14|||
161881890|NCT01451164|584611598|FG001|Overall Study|Withdrawal by Subject|11|||
161881891|NCT01451164|584611599|FG002|Overall Study|Withdrawal by Subject|16|||
161881892|NCT01451164|584611600|FG003|Overall Study|Withdrawal by Subject|17|||
161881893|NCT01451164|584611597|FG000|Overall Study|Protocol Violation|0|||
161881894|NCT01451164|584611598|FG001|Overall Study|Protocol Violation|1|||
161881895|NCT01451164|584611599|FG002|Overall Study|Protocol Violation|0|||
161881896|NCT01451164|584611600|FG003|Overall Study|Protocol Violation|0|||
161881897|NCT01451164|584611597|FG000|Overall Study|Lack of Efficacy|7|||
161881898|NCT01451164|584611598|FG001|Overall Study|Lack of Efficacy|9|||
161881899|NCT01451164|584611599|FG002|Overall Study|Lack of Efficacy|9|||
161881900|NCT01451164|584611600|FG003|Overall Study|Lack of Efficacy|7|||
161881901|NCT02963558|584611603|FG000|Overall Study|Withdrawn by investigator|1|||
161881902|NCT02963558|584611604|FG001|Overall Study|Withdrawn by investigator|0|||
161881903|NCT02963558|584611603|FG000|Overall Study|Withdrawal by Subject|0|||
161881904|NCT02963558|584611604|FG001|Overall Study|Withdrawal by Subject|1|||
161881905|NCT01214252|584611608|FG000|Overall Study|Not eligible per protocol|82|||
161881906|NCT01371877|584611610|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
161881907|NCT01371877|584611611|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
161881908|NCT05932225|584611612|FG000|Overall Study|Lost to Follow-up|0|||
161881909|NCT05932225|584611613|FG001|Overall Study|Lost to Follow-up|1|||
161881910|NCT05932225|584611614|FG002|Overall Study|Lost to Follow-up|0|||
161881911|NCT05932225|584611612|FG000|Overall Study|Withdrawal by Subject|1|||
161881912|NCT05932225|584611613|FG001|Overall Study|Withdrawal by Subject|0|||
161881913|NCT05932225|584611614|FG002|Overall Study|Withdrawal by Subject|0|||
161881914|NCT05932225|584611612|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
161881915|NCT05932225|584611613|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
161881916|NCT05932225|584611614|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
161881917|NCT00345878|584611615|FG000|Overall Study|Adverse Event|1|||
161881918|NCT00345878|584611616|FG001|Overall Study|Adverse Event|0|||
161881919|NCT00345878|584611615|FG000|Overall Study|Lost to Follow-up|2|||
161881920|NCT00345878|584611616|FG001|Overall Study|Lost to Follow-up|1|||
161881921|NCT00345878|584611615|FG000|Overall Study|Other|1|||
161881922|NCT00345878|584611616|FG001|Overall Study|Other|0|||
161881923|NCT02045732|584611617|FG000|Overall Study|At the discretion of the investigator|1|||
161881924|NCT02045732|584611618|FG001|Overall Study|At the discretion of the investigator|1|||
161881925|NCT01877551|584611622|FG000|Overall Study|Physician Decision|0|||
161881926|NCT01877551|584611623|FG001|Overall Study|Physician Decision|1|||
161881927|NCT02659514|584611624|FG000|Overall Study|Adverse Event|3|||
161881928|NCT02659514|584611625|FG001|Overall Study|Adverse Event|12|||
161881929|NCT02659514|584611624|FG000|Overall Study|Disease Progression|23|||
161881930|NCT02659514|584611625|FG001|Overall Study|Disease Progression|13|||
161881931|NCT02659514|584611624|FG000|Overall Study|Withdrawal by Subject|0|||
161881932|NCT02659514|584611625|FG001|Overall Study|Withdrawal by Subject|4|||
161881933|NCT02659514|584611624|FG000|Overall Study|Lost to Follow-up|0|||
161881934|NCT02659514|584611625|FG001|Overall Study|Lost to Follow-up|1|||
161881935|NCT02659514|584611624|FG000|Overall Study|Death|6|||
161881936|NCT02659514|584611625|FG001|Overall Study|Death|1|||
161881937|NCT02659514|584611624|FG000|Overall Study|Reason Unspecified|0|||
161881938|NCT02659514|584611625|FG001|Overall Study|Reason Unspecified|3|||
161881939|NCT03409107|584611626|FG000|Overall Study|Withdrawal by Subject|4|||
161881940|NCT03409107|584611627|FG001|Overall Study|Withdrawal by Subject|2|||
161881941|NCT03409107|584611626|FG000|Overall Study|Physician Decision|1|||
161881942|NCT03409107|584611627|FG001|Overall Study|Physician Decision|0|||
161881943|NCT03409107|584611626|FG000|Overall Study|Lost to Follow-up|7|||
161881944|NCT03409107|584611627|FG001|Overall Study|Lost to Follow-up|2|||
161881945|NCT03409107|584611626|FG000|Overall Study|Adverse Event|5|||
161881946|NCT03409107|584611627|FG001|Overall Study|Adverse Event|3|||
161881947|NCT05007041|584611643|FG000|Overall Study|Missing Diary Entries|0|||
161881948|NCT05007041|584611644|FG001|Overall Study|Missing Diary Entries|1|||
161881949|NCT04495816|584611645|FG000|Overall Study|Lost to Follow-up|10|||
161881950|NCT04495816|584611646|FG001|Overall Study|Lost to Follow-up|4|||
161881951|NCT04495816|584611645|FG000|Overall Study|Withdrawal by Subject|3|||
161881952|NCT04495816|584611646|FG001|Overall Study|Withdrawal by Subject|5|||
161881953|NCT00705718|584611647|FG000|Overall Study|Death|6|||
161881954|NCT00705718|584611648|FG001|Overall Study|Death|6|||
161881955|NCT00705718|584611647|FG000|Overall Study|Not due for Visit|0|||
161881956|NCT00705718|584611648|FG001|Overall Study|Not due for Visit|12|||
161881957|NCT00705718|584611647|FG000|Overall Study|Follow up not done|1|||
161881958|NCT00705718|584611648|FG001|Overall Study|Follow up not done|4|||
161881959|NCT01459718|584611652|FG000|Overall Study|Physician Decision|1|||
161881960|NCT01459718|584611652|FG000|Overall Study|Lost to Follow-up|1|||
161881961|NCT01459718|584611652|FG000|Overall Study|Adverse Event|1|||
161881962|NCT01258075|584611653|FG000|Overall Study|Adverse Event|8|||
161881963|NCT01258075|584611654|FG001|Overall Study|Adverse Event|3|||
161881964|NCT01258075|584611653|FG000|Overall Study|Lost to Follow-up|11|||
161881965|NCT01258075|584611654|FG001|Overall Study|Lost to Follow-up|6|||
161881966|NCT01258075|584611653|FG000|Overall Study|Withdrawal by Subject|10|||
161881967|NCT01258075|584611654|FG001|Overall Study|Withdrawal by Subject|7|||
161881968|NCT01258075|584611653|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
161881969|NCT01258075|584611654|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
161881970|NCT01258075|584611653|FG000|Overall Study|Other|12|||
161881971|NCT01258075|584611654|FG001|Overall Study|Other|5|||
161881972|NCT04021121|584611659|FG000|Overall Study|Death|3|||
161881973|NCT04021121|584611660|FG001|Overall Study|Death|3|||
161881974|NCT04021121|584611661|FG002|Overall Study|Death|5|||
161881975|NCT04021121|584611662|FG003|Overall Study|Death|4|||
161881976|NCT06011161|584611663|FG000|Overall Study|Withdrawal by Subject|2|||
161881977|NCT06011161|584611663|FG000|Overall Study|Lost to Follow-up|5|||
161881978|NCT02291601|584611666|FG000|Abdomen|Did not qualify|333|||
161881979|NCT02291601|584611667|FG001|Abdomen|Did not qualify|54|||
161881980|NCT02291601|584611668|FG002|Abdomen|Did not qualify|339|||
161881981|NCT02291601|584611666|FG000|Groin|Did not qualify|183|||
161881982|NCT02291601|584611667|FG001|Groin|Did not qualify|30|||
161881983|NCT02291601|584611668|FG002|Groin|Did not qualify|177|||
161881984|NCT01597375|584611676|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
161881985|NCT01597375|584611677|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
161881986|NCT01597375|584611676|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
161881987|NCT01597375|584611677|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
161881988|NCT01597375|584611676|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161881989|NCT01597375|584611677|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161881990|NCT01597375|584611676|FG000|Washout (2 Weeks)|Adverse Event|1|||
161881991|NCT01597375|584611677|FG001|Washout (2 Weeks)|Adverse Event|0|||
161881992|NCT01597375|584611676|FG000|Second Intervention|Failed to react at both Aspirin|1|||
161881993|NCT01597375|584611677|FG001|Second Intervention|Failed to react at both Aspirin|1|||
161881994|NCT04017832|584611680|FG000|Overall Study|Withdrawal by Subject|13|||
161881995|NCT04017832|584611681|FG001|Overall Study|Withdrawal by Subject|12|||
161881996|NCT04017832|584611682|FG002|Overall Study|Withdrawal by Subject|21|||
161881997|NCT04017832|584611683|FG003|Overall Study|Withdrawal by Subject|7|||
161881998|NCT04017832|584611680|FG000|Overall Study|Lost to Follow-up|0|||
161881999|NCT04017832|584611681|FG001|Overall Study|Lost to Follow-up|3|||
161882000|NCT04017832|584611682|FG002|Overall Study|Lost to Follow-up|3|||
161882001|NCT04017832|584611683|FG003|Overall Study|Lost to Follow-up|1|||
161882002|NCT04017832|584611680|FG000|Overall Study|Physician Decision|1|||
161882003|NCT04017832|584611681|FG001|Overall Study|Physician Decision|1|||
161882004|NCT04017832|584611682|FG002|Overall Study|Physician Decision|1|||
161882005|NCT04017832|584611683|FG003|Overall Study|Physician Decision|1|||
161882006|NCT04017832|584611680|FG000|Overall Study|Death|2|||
161882007|NCT04017832|584611681|FG001|Overall Study|Death|2|||
161882008|NCT04017832|584611682|FG002|Overall Study|Death|1|||
161882009|NCT04017832|584611683|FG003|Overall Study|Death|0|||
161882010|NCT02375555|584611684|FG000|Induction Period|Adverse Event|7|||
161882011|NCT02375555|584611684|FG000|Induction Period|Withdrawal by Subject|2|||
161882012|NCT02375555|584611684|FG000|Induction Period|Other|1|||
161882013|NCT02375555|584611684|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
161882014|NCT02375555|584611684|FG000|Maintenance Period|Adverse Event|2|||
161882015|NCT02375555|584611684|FG000|Maintenance Period|Withdrawal by Subject|4|||
161882016|NCT02375555|584611684|FG000|Maintenance Period|Death|1|||
161882017|NCT02375555|584611684|FG000|Maintenance Period|Disease Progression|5|||
161882018|NCT02375555|584611684|FG000|Maintenance Period|Patient Non-compliance|1|||
161882019|NCT02375555|584611684|FG000|Maintenance Period|Still on maintenance|16|||
161882020|NCT01744184|584611690|FG000|Overall Study|Adverse Event|1|||
161882021|NCT01744184|584611691|FG001|Overall Study|Adverse Event|0|||
161882022|NCT01744184|584611690|FG000|Overall Study|Withdrawal by Subject|0|||
161882023|NCT01744184|584611691|FG001|Overall Study|Withdrawal by Subject|1|||
161882024|NCT02091986|584611692|FG000|Overall Study|7 rand in error 1 patient decision|2|||
161882025|NCT02091986|584611693|FG001|Overall Study|7 rand in error 1 patient decision|3|||
161882026|NCT02091986|584611694|FG002|Overall Study|7 rand in error 1 patient decision|3|||
161882027|NCT02091986|584611692|FG000|Overall Study|Lost to Follow-up|1|||
161882028|NCT02091986|584611693|FG001|Overall Study|Lost to Follow-up|0|||
161882029|NCT02091986|584611694|FG002|Overall Study|Lost to Follow-up|0|||
161882030|NCT02091986|584611692|FG000|Overall Study|Withdrawal by Subject|4|||
161882031|NCT02091986|584611693|FG001|Overall Study|Withdrawal by Subject|8|||
161882032|NCT02091986|584611694|FG002|Overall Study|Withdrawal by Subject|3|||
161882033|NCT02091986|584611692|FG000|Overall Study|Adverse Event|0|||
161882034|NCT02091986|584611693|FG001|Overall Study|Adverse Event|0|||
161882035|NCT02091986|584611694|FG002|Overall Study|Adverse Event|2|||
161882036|NCT02841280|584611695|FG000|Overall Study|Adverse Event|2|||
161882037|NCT02841280|584611696|FG001|Overall Study|Adverse Event|1|||
161882038|NCT02841280|584611695|FG000|Overall Study|Death|1|||
161882039|NCT02841280|584611696|FG001|Overall Study|Death|0|||
161882040|NCT02841280|584611695|FG000|Overall Study|Lost to Follow-up|2|||
161882041|NCT02841280|584611696|FG001|Overall Study|Lost to Follow-up|2|||
161882042|NCT02841280|584611695|FG000|Overall Study|Withdrawal by Subject|7|||
161882043|NCT02841280|584611696|FG001|Overall Study|Withdrawal by Subject|3|||
161882044|NCT02841280|584611695|FG000|Overall Study|Stop Point: BP above threshold|2|||
161882045|NCT02841280|584611696|FG001|Overall Study|Stop Point: BP above threshold|0|||
161882046|NCT00125242|584611697|FG000|Overall Study|did not qualify|7|||
161882047|NCT00125242|584611698|FG001|Overall Study|did not qualify|2|||
161882048|NCT01664949|584611699|FG000|Overall Study|Adverse Event|11|||
161882049|NCT01664949|584611700|FG001|Overall Study|Adverse Event|12|||
161882050|NCT01664949|584611699|FG000|Overall Study|Lack of Efficacy|1|||
161882051|NCT01664949|584611700|FG001|Overall Study|Lack of Efficacy|1|||
161882052|NCT01664949|584611699|FG000|Overall Study|Lost to Follow-up|1|||
161882053|NCT01664949|584611700|FG001|Overall Study|Lost to Follow-up|2|||
161882054|NCT01664949|584611699|FG000|Overall Study|Personal Reasons|3|||
161882055|NCT01664949|584611700|FG001|Overall Study|Personal Reasons|4|||
161882056|NCT01664949|584611699|FG000|Overall Study|Protocol Violation|5|||
161882057|NCT01664949|584611700|FG001|Overall Study|Protocol Violation|5|||
161882058|NCT01664949|584611699|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161882059|NCT01664949|584611700|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161882060|NCT02727777|584611707|FG000|Overall Study|Screen Failure|2|||
161882061|NCT02727777|584611708|FG001|Overall Study|Screen Failure|0|||
161882062|NCT02727777|584611709|FG002|Overall Study|Screen Failure|0|||
161882063|NCT02727777|584611707|FG000|Overall Study|Progressive disease|2|||
161882064|NCT02727777|584611708|FG001|Overall Study|Progressive disease|0|||
161882065|NCT02727777|584611709|FG002|Overall Study|Progressive disease|0|||
161882066|NCT00957268|584611710|FG000|Overall Study|Voluntary Withdrawal|0|||
161882067|NCT00957268|584611711|FG001|Overall Study|Voluntary Withdrawal|0|||
161882068|NCT00957268|584611712|FG002|Overall Study|Voluntary Withdrawal|1|||
161882069|NCT00957268|584611713|FG003|Overall Study|Voluntary Withdrawal|0|||
161882070|NCT00957268|584611714|FG004|Overall Study|Voluntary Withdrawal|0|||
161882071|NCT03003494|584611715|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
161882072|NCT01738503|584611716|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
161882073|NCT01738503|584611717|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882074|NCT01738503|584611718|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882075|NCT01738503|584611719|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882076|NCT01738503|584611720|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882077|NCT01738503|584611721|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882078|NCT01738503|584611722|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882079|NCT01738503|584611716|FG000|Treatment Period|Adverse Event|0|||
161882080|NCT01738503|584611717|FG001|Treatment Period|Adverse Event|1|||
161882081|NCT01738503|584611718|FG002|Treatment Period|Adverse Event|0|||
161882082|NCT01738503|584611719|FG003|Treatment Period|Adverse Event|1|||
161882083|NCT01738503|584611720|FG004|Treatment Period|Adverse Event|2|||
161882084|NCT01738503|584611721|FG005|Treatment Period|Adverse Event|2|||
161882085|NCT01738503|584611722|FG006|Treatment Period|Adverse Event|2|||
161882086|NCT01738503|584611716|FG000|Treatment Period|Lost to Follow-up|0|||
161882087|NCT01738503|584611717|FG001|Treatment Period|Lost to Follow-up|0|||
161882088|NCT01738503|584611718|FG002|Treatment Period|Lost to Follow-up|3|||
161882089|NCT01738503|584611719|FG003|Treatment Period|Lost to Follow-up|4|||
161882090|NCT01738503|584611720|FG004|Treatment Period|Lost to Follow-up|1|||
161882091|NCT01738503|584611721|FG005|Treatment Period|Lost to Follow-up|1|||
161882092|NCT01738503|584611722|FG006|Treatment Period|Lost to Follow-up|5|||
161882093|NCT01738503|584611716|FG000|Treatment Period|Withdrawal by Subject|0|||
161882094|NCT01738503|584611717|FG001|Treatment Period|Withdrawal by Subject|1|||
161882095|NCT01738503|584611718|FG002|Treatment Period|Withdrawal by Subject|0|||
161882096|NCT01738503|584611719|FG003|Treatment Period|Withdrawal by Subject|1|||
161882097|NCT01738503|584611720|FG004|Treatment Period|Withdrawal by Subject|1|||
161882098|NCT01738503|584611721|FG005|Treatment Period|Withdrawal by Subject|1|||
161882099|NCT01738503|584611722|FG006|Treatment Period|Withdrawal by Subject|1|||
161882100|NCT01738503|584611716|FG000|Treatment Period|Protocol Violation|0|||
161882101|NCT01738503|584611717|FG001|Treatment Period|Protocol Violation|3|||
161882102|NCT01738503|584611718|FG002|Treatment Period|Protocol Violation|1|||
161882103|NCT01738503|584611719|FG003|Treatment Period|Protocol Violation|0|||
161882104|NCT01738503|584611720|FG004|Treatment Period|Protocol Violation|4|||
161882105|NCT01738503|584611721|FG005|Treatment Period|Protocol Violation|2|||
161882106|NCT01738503|584611722|FG006|Treatment Period|Protocol Violation|0|||
161882107|NCT01738503|584611716|FG000|Treatment Period|Other|0|||
161882108|NCT01738503|584611717|FG001|Treatment Period|Other|0|||
161882109|NCT01738503|584611718|FG002|Treatment Period|Other|1|||
161882110|NCT01738503|584611719|FG003|Treatment Period|Other|0|||
161882111|NCT01738503|584611720|FG004|Treatment Period|Other|0|||
161882112|NCT01738503|584611721|FG005|Treatment Period|Other|0|||
161882113|NCT01738503|584611722|FG006|Treatment Period|Other|0|||
161882114|NCT01738503|584611716|FG000|PET Imaging Sub-study|Adverse Event|0|||
161882115|NCT01738503|584611717|FG001|PET Imaging Sub-study|Adverse Event|0|||
161882116|NCT01738503|584611718|FG002|PET Imaging Sub-study|Adverse Event|0|||
161882117|NCT01738503|584611719|FG003|PET Imaging Sub-study|Adverse Event|0|||
161882118|NCT01738503|584611720|FG004|PET Imaging Sub-study|Adverse Event|0|||
161882119|NCT01738503|584611721|FG005|PET Imaging Sub-study|Adverse Event|1|||
161882120|NCT01738503|584611722|FG006|PET Imaging Sub-study|Adverse Event|0|||
161882121|NCT01738503|584611716|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882122|NCT01738503|584611717|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882123|NCT01738503|584611718|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882124|NCT01738503|584611719|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882125|NCT01738503|584611720|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882126|NCT01738503|584611721|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
161882127|NCT01738503|584611722|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
161882128|NCT01340027|584611723|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
161882129|NCT01340027|584611724|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
161882130|NCT01340027|584611725|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
161882131|NCT01340027|584611726|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
161882132|NCT01340027|584611727|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
161882133|NCT01340027|584611728|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
161882134|NCT01340027|584611729|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
161882135|NCT01340027|584611730|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
161882136|NCT01340027|584611731|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
161882137|NCT01340027|584611732|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
161882138|NCT01340027|584611733|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
161882139|NCT01340027|584611734|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
161882140|NCT01340027|584611723|FG000|Overall Study|Adverse Event|0|||
161882141|NCT01340027|584611724|FG001|Overall Study|Adverse Event|1|||
161778154|NCT03701516|584228936|FG001|Period 1|Withdrawal by Subject|1|||
161778155|NCT03701516|584228935|FG000|Period 2|failed to meet all eligibility creiteria|1|||
161778156|NCT03701516|584228936|FG001|Period 2|failed to meet all eligibility creiteria|0|||
161778157|NCT03701516|584228935|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
161778158|NCT03701516|584228936|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
161778159|NCT00478673|584228937|FG000|30-Days Post-Procedure|Death|2|||
161778160|NCT00478673|584228937|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
161778161|NCT00478673|584228937|FG000|30-Days Post-Procedure|Missed Visit|7|||
161778162|NCT00478673|584228937|FG000|12-Months Post-Procedure|Death|23|||
161778163|NCT00478673|584228937|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
161778164|NCT00478673|584228937|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
161778165|NCT00478673|584228937|FG000|12-Months Post-Procedure|Missed Visit|25|||
161778166|NCT00478673|584228937|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
161778167|NCT03930615|584228938|FG000|Overall Study|Death|9|||
161778168|NCT03930615|584228939|FG001|Overall Study|Death|3|||
161778169|NCT03930615|584228938|FG000|Overall Study|Lost to Follow-up|1|||
161778170|NCT03930615|584228939|FG001|Overall Study|Lost to Follow-up|2|||
161778171|NCT03930615|584228938|FG000|Overall Study|Physician Decision|3|||
161778172|NCT03930615|584228939|FG001|Overall Study|Physician Decision|4|||
161778173|NCT03930615|584228938|FG000|Overall Study|Withdrawal by Subject|13|||
161778174|NCT03930615|584228939|FG001|Overall Study|Withdrawal by Subject|2|||
161778175|NCT03930615|584228938|FG000|Overall Study|Not treated|1|||
161778176|NCT03930615|584228939|FG001|Overall Study|Not treated|1|||
161778177|NCT02864953|584228940|FG000|Overall Study|Adverse Event|22|||
161778178|NCT02864953|584228941|FG001|Overall Study|Adverse Event|19|||
161778179|NCT02864953|584228940|FG000|Overall Study|Withdrawal by Subject|1|||
161778180|NCT02864953|584228941|FG001|Overall Study|Withdrawal by Subject|0|||
161778181|NCT02864953|584228940|FG000|Overall Study|Physician Decision|4|||
161778182|NCT02864953|584228941|FG001|Overall Study|Physician Decision|2|||
161778183|NCT02864953|584228940|FG000|Overall Study|Death|3|||
161778184|NCT02864953|584228941|FG001|Overall Study|Death|13|||
161778185|NCT02864953|584228940|FG000|Overall Study|Reason not specified|14|||
161778186|NCT02864953|584228941|FG001|Overall Study|Reason not specified|12|||
161778187|NCT02864953|584228940|FG000|Overall Study|Withdrew Prior to Dosing|9|||
161778188|NCT02864953|584228941|FG001|Overall Study|Withdrew Prior to Dosing|8|||
161778189|NCT00358670|584228942|FG000|Overall Study|Adverse Event|26|||
161778190|NCT00358670|584228943|FG001|Overall Study|Adverse Event|29|||
161778191|NCT00358670|584228942|FG000|Overall Study|Lack of Efficacy|20|||
161778192|NCT00358670|584228943|FG001|Overall Study|Lack of Efficacy|23|||
161778193|NCT00358670|584228942|FG000|Overall Study|Protocol Violation|6|||
161778194|NCT00358670|584228943|FG001|Overall Study|Protocol Violation|9|||
161778195|NCT00358670|584228942|FG000|Overall Study|Lost to Follow-up|4|||
161778196|NCT00358670|584228943|FG001|Overall Study|Lost to Follow-up|5|||
161778197|NCT00358670|584228942|FG000|Overall Study|Withdrawal by Subject|13|||
161778198|NCT00358670|584228943|FG001|Overall Study|Withdrawal by Subject|24|||
161778199|NCT00358670|584228942|FG000|Overall Study|Protocol Defined Clinical Event|0|||
161778200|NCT00358670|584228943|FG001|Overall Study|Protocol Defined Clinical Event|1|||
161778201|NCT00358670|584228942|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161882142|NCT01340027|584611725|FG002|Overall Study|Adverse Event|2|||
161882143|NCT01340027|584611726|FG003|Overall Study|Adverse Event|0|||
161882144|NCT01340027|584611727|FG004|Overall Study|Adverse Event|1|||
161882145|NCT01340027|584611728|FG005|Overall Study|Adverse Event|2|||
161882146|NCT01340027|584611729|FG006|Overall Study|Adverse Event|2|||
161882147|NCT01340027|584611730|FG007|Overall Study|Adverse Event|1|||
161882148|NCT01340027|584611731|FG008|Overall Study|Adverse Event|4|||
161882149|NCT01340027|584611732|FG009|Overall Study|Adverse Event|1|||
161882150|NCT01340027|584611733|FG010|Overall Study|Adverse Event|1|||
161882151|NCT01340027|584611734|FG011|Overall Study|Adverse Event|3|||
161882152|NCT01340027|584611723|FG000|Overall Study|Lack of Efficacy|0|||
161882153|NCT01340027|584611724|FG001|Overall Study|Lack of Efficacy|0|||
161882154|NCT01340027|584611725|FG002|Overall Study|Lack of Efficacy|0|||
161882155|NCT01340027|584611726|FG003|Overall Study|Lack of Efficacy|0|||
161882156|NCT01340027|584611727|FG004|Overall Study|Lack of Efficacy|0|||
161882157|NCT01340027|584611728|FG005|Overall Study|Lack of Efficacy|0|||
161882158|NCT01340027|584611729|FG006|Overall Study|Lack of Efficacy|1|||
161882159|NCT01340027|584611730|FG007|Overall Study|Lack of Efficacy|1|||
161882160|NCT01340027|584611731|FG008|Overall Study|Lack of Efficacy|1|||
161882161|NCT01340027|584611732|FG009|Overall Study|Lack of Efficacy|0|||
161882162|NCT01340027|584611733|FG010|Overall Study|Lack of Efficacy|0|||
161882163|NCT01340027|584611734|FG011|Overall Study|Lack of Efficacy|0|||
161882164|NCT01340027|584611723|FG000|Overall Study|Lost to Follow-up|0|||
161882165|NCT01340027|584611724|FG001|Overall Study|Lost to Follow-up|1|||
161882166|NCT01340027|584611725|FG002|Overall Study|Lost to Follow-up|0|||
161882167|NCT01340027|584611726|FG003|Overall Study|Lost to Follow-up|0|||
161882168|NCT01340027|584611727|FG004|Overall Study|Lost to Follow-up|0|||
161882169|NCT01340027|584611728|FG005|Overall Study|Lost to Follow-up|0|||
161882170|NCT01340027|584611729|FG006|Overall Study|Lost to Follow-up|1|||
161882171|NCT01340027|584611730|FG007|Overall Study|Lost to Follow-up|0|||
161882172|NCT01340027|584611731|FG008|Overall Study|Lost to Follow-up|0|||
161882173|NCT01340027|584611732|FG009|Overall Study|Lost to Follow-up|1|||
161882174|NCT01340027|584611733|FG010|Overall Study|Lost to Follow-up|0|||
161882175|NCT01340027|584611734|FG011|Overall Study|Lost to Follow-up|0|||
161882176|NCT01340027|584611723|FG000|Overall Study|Protocol Violation|1|||
161882177|NCT01340027|584611724|FG001|Overall Study|Protocol Violation|2|||
161882178|NCT01340027|584611725|FG002|Overall Study|Protocol Violation|0|||
161882179|NCT01340027|584611726|FG003|Overall Study|Protocol Violation|0|||
161882180|NCT01340027|584611727|FG004|Overall Study|Protocol Violation|6|||
161882181|NCT01340027|584611728|FG005|Overall Study|Protocol Violation|0|||
161882182|NCT01340027|584611729|FG006|Overall Study|Protocol Violation|0|||
161882183|NCT01340027|584611730|FG007|Overall Study|Protocol Violation|1|||
161882184|NCT01340027|584611731|FG008|Overall Study|Protocol Violation|2|||
161882185|NCT01340027|584611732|FG009|Overall Study|Protocol Violation|2|||
161882186|NCT01340027|584611733|FG010|Overall Study|Protocol Violation|0|||
161882187|NCT01340027|584611734|FG011|Overall Study|Protocol Violation|0|||
161882188|NCT01340027|584611723|FG000|Overall Study|Withdrawal by Subject|4|||
161882189|NCT01340027|584611724|FG001|Overall Study|Withdrawal by Subject|3|||
161882190|NCT01340027|584611725|FG002|Overall Study|Withdrawal by Subject|1|||
161882191|NCT01340027|584611726|FG003|Overall Study|Withdrawal by Subject|3|||
161882192|NCT01340027|584611727|FG004|Overall Study|Withdrawal by Subject|3|||
161882193|NCT01340027|584611728|FG005|Overall Study|Withdrawal by Subject|2|||
161882194|NCT01340027|584611729|FG006|Overall Study|Withdrawal by Subject|3|||
161882195|NCT01340027|584611730|FG007|Overall Study|Withdrawal by Subject|4|||
161882196|NCT01340027|584611731|FG008|Overall Study|Withdrawal by Subject|1|||
161882197|NCT01340027|584611732|FG009|Overall Study|Withdrawal by Subject|2|||
161882198|NCT01340027|584611733|FG010|Overall Study|Withdrawal by Subject|0|||
161882199|NCT01340027|584611734|FG011|Overall Study|Withdrawal by Subject|1|||
161882200|NCT01340027|584611723|FG000|Overall Study|Miscellaneous|0|||
161882201|NCT01340027|584611724|FG001|Overall Study|Miscellaneous|0|||
161882202|NCT01340027|584611725|FG002|Overall Study|Miscellaneous|0|||
161882203|NCT01340027|584611726|FG003|Overall Study|Miscellaneous|1|||
161882204|NCT01340027|584611727|FG004|Overall Study|Miscellaneous|0|||
161882205|NCT01340027|584611728|FG005|Overall Study|Miscellaneous|0|||
161882206|NCT01340027|584611729|FG006|Overall Study|Miscellaneous|0|||
161882207|NCT01340027|584611730|FG007|Overall Study|Miscellaneous|0|||
161882208|NCT01340027|584611731|FG008|Overall Study|Miscellaneous|0|||
161882209|NCT01340027|584611732|FG009|Overall Study|Miscellaneous|0|||
161882210|NCT01340027|584611733|FG010|Overall Study|Miscellaneous|1|||
161882211|NCT01340027|584611734|FG011|Overall Study|Miscellaneous|0|||
161882212|NCT03005327|584611735|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161882213|NCT03005327|584611736|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161882214|NCT03005327|584611737|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
161882215|NCT03005327|584611738|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161882216|NCT03005327|584611735|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161882217|NCT03005327|584611736|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161882218|NCT03005327|584611737|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161882219|NCT03005327|584611738|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161882220|NCT01794793|584611740|FG000|Treatment Period|Withdrawal by Subject|24|||
161882221|NCT01794793|584611740|FG000|Treatment Period|Lack of Efficacy|22|||
161882222|NCT01794793|584611740|FG000|Treatment Period|Adverse Event|17|||
161882223|NCT01794793|584611740|FG000|Treatment Period|Physician Decision|14|||
161882224|NCT01794793|584611740|FG000|Treatment Period|Lost to Follow-up|7|||
161882225|NCT01794793|584611740|FG000|Treatment Period|Death|6|||
161882226|NCT01794793|584611740|FG000|Treatment Period|Protocol Violation|5|||
161882227|NCT01794793|584611740|FG000|Treatment Period|administrative problem|3|||
161882228|NCT01794793|584611740|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
161882229|NCT01794793|584611740|FG000|Post-treatment Follow-up|Adverse Event|8|||
161882230|NCT01794793|584611740|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
161882231|NCT01794793|584611740|FG000|Post-treatment Follow-up|administrative problem|5|||
161882232|NCT01794793|584611740|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
161882233|NCT01794793|584611740|FG000|Post-treatment Follow-up|Protocol Violation|3|||
161882234|NCT04852679|584611741|FG000|Main Intervention Period|Withdrawal by Subject|3|||
161882235|NCT04852679|584611741|FG000|Main Intervention Period|Adverse Event|1|||
161882236|NCT04852679|584611741|FG000|Main Intervention Period|Progressive Disease|16|||
161882237|NCT04852679|584611741|FG000|Main Intervention Period|Refused study visit|1|||
161882238|NCT04852679|584611741|FG000|Independent Injection Period|Missed study visit|1|||
161882239|NCT02000882|584612841|FG000|Overall Study|Adverse Event|3|||
161882240|NCT02000882|584612841|FG000|Overall Study|Physician Decision|2|||
161882241|NCT02000882|584612841|FG000|Overall Study|Withdrawal by Subject|1|||
161882242|NCT02417961|584612842|FG000|Overall Study|Adverse Event|1|||
161882243|NCT02417961|584612842|FG000|Overall Study|Lost to Follow-up|1|||
161882244|NCT02417961|584612842|FG000|Overall Study|Withdrawal by Subject|2|||
161882245|NCT01390428|584612843|FG000|Overall Study|Elective Surgery|0|||
161882246|NCT01390428|584612844|FG001|Overall Study|Elective Surgery|0|||
161882247|NCT01390428|584612845|FG002|Overall Study|Elective Surgery|0|||
161882248|NCT01390428|584612846|FG003|Overall Study|Elective Surgery|0|||
161882249|NCT01390428|584612847|FG004|Overall Study|Elective Surgery|1|||
161882250|NCT01390428|584612848|FG005|Overall Study|Elective Surgery|0|||
161882251|NCT01390428|584612843|FG000|Overall Study|Withdrawal by Subject|0|||
161882252|NCT01390428|584612844|FG001|Overall Study|Withdrawal by Subject|0|||
161882253|NCT01390428|584612845|FG002|Overall Study|Withdrawal by Subject|1|||
161882254|NCT01390428|584612846|FG003|Overall Study|Withdrawal by Subject|0|||
161778202|NCT00358670|584228943|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
161778203|NCT00358670|584228942|FG000|Overall Study|Administrative|153|||
161778204|NCT00358670|584228943|FG001|Overall Study|Administrative|125|||
161778205|NCT00981019|584228944|FG000|Overall Study|Did not respond|65|||
161778206|NCT00981019|584228944|FG000|Overall Study|Did not match target population|94|||
161778207|NCT00981019|584228944|FG000|Overall Study|Inadvertent exclusion|239|||
161778208|NCT00981019|584228944|FG000|Overall Study|Hit the survey after closure|79|||
161778209|NCT00865306|584228945|FG000|Controlled Trial|Lost to Follow-up|1|||
161778210|NCT00865306|584228946|FG001|Controlled Trial|Lost to Follow-up|1|||
161778211|NCT00865306|584228945|FG000|Controlled Trial|Difficulty commuting|2|||
161778212|NCT00865306|584228946|FG001|Controlled Trial|Difficulty commuting|0|||
161778213|NCT00865306|584228945|FG000|Controlled Trial|Improved btw baseline and first session|1|||
161778214|NCT00865306|584228946|FG001|Controlled Trial|Improved btw baseline and first session|0|||
161778215|NCT00865306|584228945|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
161778216|NCT00865306|584228946|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
161778217|NCT00865306|584228945|FG000|Controlled Trial|Withdrawal by Subject|0|||
161778218|NCT00865306|584228946|FG001|Controlled Trial|Withdrawal by Subject|1|||
161778219|NCT05083559|584228947|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
161778220|NCT05083559|584228948|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
161778221|NCT05083559|584228947|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
161778222|NCT05083559|584228948|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
161778223|NCT05083559|584228947|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
161778224|NCT05083559|584228948|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
161778225|NCT02704130|584228950|FG000|Overall Study|Physician Decision|5|||
161778226|NCT02704130|584228951|FG001|Overall Study|Physician Decision|3|||
161778227|NCT01023022|584228954|FG000|Overall Study|Death|5|||
161778228|NCT01023022|584228954|FG000|Overall Study|Lost to Follow-up|7|||
161778229|NCT01023022|584228954|FG000|Overall Study|due to technical issues|2|||
161778230|NCT00359073|584230373|FG000|Overall Study|Withdrawal by Subject|1|||
161778231|NCT00359073|584230374|FG001|Overall Study|Withdrawal by Subject|1|||
161778232|NCT00359073|584230373|FG000|Overall Study|Eligibility criteria no longer met|3|||
161778233|NCT00359073|584230374|FG001|Overall Study|Eligibility criteria no longer met|0|||
161778234|NCT00359073|584230373|FG000|Overall Study|developed RV16 antibody|0|||
161778235|NCT00359073|584230374|FG001|Overall Study|developed RV16 antibody|1|||
161778236|NCT00684645|584230375|FG000|Overall Study|Death|2|||
161778237|NCT00684645|584230375|FG000|Overall Study|Progressive disease|67|||
161778238|NCT00684645|584230375|FG000|Overall Study|Adverse Event|27|||
161778239|NCT00684645|584230375|FG000|Overall Study|Lost to Follow-up|3|||
161778240|NCT00684645|584230375|FG000|Overall Study|Other|15|||
161778241|NCT01819467|584230380|FG000|Overall Study|Physician Decision|20|||
161778242|NCT01819467|584230381|FG001|Overall Study|Physician Decision|9|||
161778243|NCT03514121|584230382|FG000|Overall Study|Withdrawal by Subject|0|||
161778244|NCT03514121|584230383|FG001|Overall Study|Withdrawal by Subject|0|||
161778245|NCT03514121|584230384|FG002|Overall Study|Withdrawal by Subject|0|||
161778246|NCT03514121|584230385|FG003|Overall Study|Withdrawal by Subject|0|||
161778247|NCT03514121|584230386|FG004|Overall Study|Withdrawal by Subject|1|||
161778248|NCT03514121|584230387|FG005|Overall Study|Withdrawal by Subject|2|||
161778249|NCT03514121|584230388|FG006|Overall Study|Withdrawal by Subject|1|||
161778250|NCT03514121|584230389|FG007|Overall Study|Withdrawal by Subject|1|||
161778251|NCT03514121|584230390|FG008|Overall Study|Withdrawal by Subject|7|||
161778252|NCT03514121|584230391|FG009|Overall Study|Withdrawal by Subject|2|||
161778253|NCT03514121|584230382|FG000|Overall Study|Death|0|||
161778254|NCT03514121|584230383|FG001|Overall Study|Death|0|||
161778255|NCT03514121|584230384|FG002|Overall Study|Death|0|||
161778256|NCT03514121|584230385|FG003|Overall Study|Death|0|||
161778257|NCT03514121|584230386|FG004|Overall Study|Death|0|||
161778258|NCT03514121|584230387|FG005|Overall Study|Death|3|||
161778259|NCT03514121|584230388|FG006|Overall Study|Death|2|||
161778260|NCT03514121|584230389|FG007|Overall Study|Death|1|||
161778261|NCT03514121|584230390|FG008|Overall Study|Death|26|||
161882255|NCT01390428|584612847|FG004|Overall Study|Withdrawal by Subject|0|||
161882256|NCT01390428|584612848|FG005|Overall Study|Withdrawal by Subject|0|||
161882257|NCT05079750|584612849|FG000|Overall Study|Lost to Follow-up|0|||
161882258|NCT05079750|584612850|FG001|Overall Study|Lost to Follow-up|0|||
161882259|NCT05079750|584612851|FG002|Overall Study|Lost to Follow-up|1|||
161882260|NCT05091346|584612854|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
161882261|NCT05091346|584612855|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
161882262|NCT05091346|584612856|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
161882263|NCT05091346|584612857|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
161882264|NCT05091346|584612858|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
161882265|NCT05091346|584612854|FG000|Overall Study|Death|6|||
161882266|NCT05091346|584612855|FG001|Overall Study|Death|5|||
161882267|NCT05091346|584612856|FG002|Overall Study|Death|8|||
161882268|NCT05091346|584612857|FG003|Overall Study|Death|16|||
161882269|NCT05091346|584612858|FG004|Overall Study|Death|26|||
161882270|NCT05091346|584612854|FG000|Overall Study|Lost to Follow-up|0|||
161882271|NCT05091346|584612855|FG001|Overall Study|Lost to Follow-up|0|||
161882272|NCT05091346|584612856|FG002|Overall Study|Lost to Follow-up|0|||
161882273|NCT05091346|584612857|FG003|Overall Study|Lost to Follow-up|1|||
161882274|NCT05091346|584612858|FG004|Overall Study|Lost to Follow-up|0|||
161882275|NCT05091346|584612854|FG000|Overall Study|Withdrawal by Subject|0|||
161882276|NCT05091346|584612855|FG001|Overall Study|Withdrawal by Subject|1|||
161882277|NCT05091346|584612856|FG002|Overall Study|Withdrawal by Subject|2|||
161882278|NCT05091346|584612857|FG003|Overall Study|Withdrawal by Subject|2|||
161882279|NCT05091346|584612858|FG004|Overall Study|Withdrawal by Subject|1|||
161882280|NCT05897827|584612859|FG000|Overall Study|Lost to Follow-up|33|||
161882281|NCT05897827|584612860|FG001|Overall Study|Lost to Follow-up|14|||
161882282|NCT05897827|584612859|FG000|Overall Study|Withdrawal by Subject|1|||
161882283|NCT05897827|584612860|FG001|Overall Study|Withdrawal by Subject|1|||
161882284|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161882285|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161882286|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161882287|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
161882288|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
161882289|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
161882290|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882291|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
161882292|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882293|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882294|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882295|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882296|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
161882297|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
161882298|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161882299|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161882300|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161882301|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
161882302|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
161778262|NCT03514121|584230391|FG009|Overall Study|Death|3|||
161778263|NCT03514121|584230382|FG000|Overall Study|Lost to Follow-up|0|||
161778264|NCT03514121|584230383|FG001|Overall Study|Lost to Follow-up|0|||
161778265|NCT03514121|584230384|FG002|Overall Study|Lost to Follow-up|1|||
161778266|NCT03514121|584230385|FG003|Overall Study|Lost to Follow-up|0|||
161778267|NCT03514121|584230386|FG004|Overall Study|Lost to Follow-up|0|||
161778268|NCT03514121|584230387|FG005|Overall Study|Lost to Follow-up|0|||
161778269|NCT03514121|584230388|FG006|Overall Study|Lost to Follow-up|0|||
161778270|NCT03514121|584230389|FG007|Overall Study|Lost to Follow-up|0|||
161778271|NCT03514121|584230390|FG008|Overall Study|Lost to Follow-up|1|||
161778272|NCT03514121|584230391|FG009|Overall Study|Lost to Follow-up|0|||
161778273|NCT03514121|584230382|FG000|Overall Study|Adverse Event|0|||
161778274|NCT03514121|584230383|FG001|Overall Study|Adverse Event|0|||
161778275|NCT03514121|584230384|FG002|Overall Study|Adverse Event|0|||
161778276|NCT03514121|584230385|FG003|Overall Study|Adverse Event|0|||
161778277|NCT03514121|584230386|FG004|Overall Study|Adverse Event|0|||
161778278|NCT03514121|584230387|FG005|Overall Study|Adverse Event|0|||
161778279|NCT03514121|584230388|FG006|Overall Study|Adverse Event|1|||
161778280|NCT03514121|584230389|FG007|Overall Study|Adverse Event|0|||
161778281|NCT03514121|584230390|FG008|Overall Study|Adverse Event|0|||
161778282|NCT03514121|584230391|FG009|Overall Study|Adverse Event|0|||
161778283|NCT03514121|584230382|FG000|Overall Study|Other|0|||
161778284|NCT03514121|584230383|FG001|Overall Study|Other|1|||
161778285|NCT03514121|584230384|FG002|Overall Study|Other|1|||
161778286|NCT03514121|584230385|FG003|Overall Study|Other|0|||
161778287|NCT03514121|584230386|FG004|Overall Study|Other|1|||
161882303|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161882304|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
161882305|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161882306|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161882307|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
161882308|NCT01752634|584612861|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
161882309|NCT01752634|584612862|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
161882310|NCT01752634|584612863|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
161882311|NCT01752634|584612864|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
161882312|NCT01752634|584612865|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
161778288|NCT03514121|584230387|FG005|Overall Study|Other|2|||
161778289|NCT03514121|584230388|FG006|Overall Study|Other|3|||
161778290|NCT03514121|584230389|FG007|Overall Study|Other|2|||
161778291|NCT03514121|584230390|FG008|Overall Study|Other|7|||
161778292|NCT03514121|584230391|FG009|Overall Study|Other|3|||
161778293|NCT03514121|584230382|FG000|Overall Study|Study termination by Sponsor|0|||
161778294|NCT03514121|584230383|FG001|Overall Study|Study termination by Sponsor|0|||
161778295|NCT03514121|584230384|FG002|Overall Study|Study termination by Sponsor|0|||
161778296|NCT03514121|584230385|FG003|Overall Study|Study termination by Sponsor|0|||
161778297|NCT03514121|584230386|FG004|Overall Study|Study termination by Sponsor|0|||
161778298|NCT03514121|584230387|FG005|Overall Study|Study termination by Sponsor|0|||
161778299|NCT03514121|584230388|FG006|Overall Study|Study termination by Sponsor|0|||
161778300|NCT03514121|584230389|FG007|Overall Study|Study termination by Sponsor|0|||
161778301|NCT03514121|584230390|FG008|Overall Study|Study termination by Sponsor|11|||
161778302|NCT03514121|584230391|FG009|Overall Study|Study termination by Sponsor|3|||
161778303|NCT03514121|584230382|FG000|Overall Study|Investigator decision|0|||
161778304|NCT03514121|584230383|FG001|Overall Study|Investigator decision|0|||
161778305|NCT03514121|584230384|FG002|Overall Study|Investigator decision|0|||
161778306|NCT03514121|584230385|FG003|Overall Study|Investigator decision|0|||
161778307|NCT03514121|584230386|FG004|Overall Study|Investigator decision|0|||
161778308|NCT03514121|584230387|FG005|Overall Study|Investigator decision|0|||
161778309|NCT03514121|584230388|FG006|Overall Study|Investigator decision|0|||
161778310|NCT03514121|584230389|FG007|Overall Study|Investigator decision|0|||
161778311|NCT03514121|584230390|FG008|Overall Study|Investigator decision|1|||
161778312|NCT03514121|584230391|FG009|Overall Study|Investigator decision|0|||
161778313|NCT00391092|584230392|FG000|Overall Study|Death|78|||
161778314|NCT00391092|584230393|FG001|Overall Study|Death|81|||
161778315|NCT00391092|584230392|FG000|Overall Study|Lost to Follow-up|13|||
161778316|NCT00391092|584230393|FG001|Overall Study|Lost to Follow-up|18|||
161778317|NCT00391092|584230392|FG000|Overall Study|Alive on treatment|29|||
161778318|NCT00391092|584230393|FG001|Overall Study|Alive on treatment|33|||
161778319|NCT00391092|584230392|FG000|Overall Study|Alive in follow-up|88|||
161778320|NCT00391092|584230393|FG001|Overall Study|Alive in follow-up|84|||
161778321|NCT02545868|584230398|FG000|Overall Study|Lack of Efficacy|1|||
161778322|NCT02545868|584230399|FG001|Overall Study|Lack of Efficacy|1|||
161778323|NCT02545868|584230400|FG002|Overall Study|Lack of Efficacy|0|||
161778324|NCT02545868|584230398|FG000|Overall Study|Lost to Follow-up|1|||
161778325|NCT02545868|584230399|FG001|Overall Study|Lost to Follow-up|5|||
161778326|NCT02545868|584230400|FG002|Overall Study|Lost to Follow-up|1|||
161778327|NCT02545868|584230398|FG000|Overall Study|Non-compliance|1|||
161778328|NCT02545868|584230399|FG001|Overall Study|Non-compliance|1|||
161778329|NCT02545868|584230400|FG002|Overall Study|Non-compliance|1|||
161778330|NCT02545868|584230398|FG000|Overall Study|Treatment change|21|||
161778331|NCT02545868|584230399|FG001|Overall Study|Treatment change|19|||
161778332|NCT02545868|584230400|FG002|Overall Study|Treatment change|22|||
161778333|NCT02545868|584230398|FG000|Overall Study|Physician Decision|1|||
161778334|NCT02545868|584230399|FG001|Overall Study|Physician Decision|1|||
161778335|NCT02545868|584230400|FG002|Overall Study|Physician Decision|1|||
161778336|NCT02545868|584230398|FG000|Overall Study|Withdrawal by Subject|6|||
161778337|NCT02545868|584230399|FG001|Overall Study|Withdrawal by Subject|7|||
161778338|NCT02545868|584230400|FG002|Overall Study|Withdrawal by Subject|9|||
161778339|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
161778340|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
161778341|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
161778342|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
161778343|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
161778344|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
161778345|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
161778346|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
161778347|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
161778348|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
161778349|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
161882313|NCT01752634|584612866|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
161882314|NCT01752634|584612861|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
161882315|NCT01752634|584612862|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
161882316|NCT01752634|584612863|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
161882317|NCT01752634|584612864|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
161882318|NCT01752634|584612865|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
161882319|NCT01752634|584612866|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
161882320|NCT01752634|584612861|FG000|Week 24 to Week 260|Physician Decision|1|||
161882321|NCT01752634|584612862|FG001|Week 24 to Week 260|Physician Decision|2|||
161882322|NCT01752634|584612863|FG002|Week 24 to Week 260|Physician Decision|4|||
161882323|NCT01752634|584612864|FG003|Week 24 to Week 260|Physician Decision|2|||
161882324|NCT01752634|584612865|FG004|Week 24 to Week 260|Physician Decision|1|||
161882325|NCT01752634|584612866|FG005|Week 24 to Week 260|Physician Decision|0|||
161882326|NCT01752634|584612861|FG000|Week 24 to Week 260|Death|0|||
161882327|NCT01752634|584612862|FG001|Week 24 to Week 260|Death|1|||
161882328|NCT01752634|584612863|FG002|Week 24 to Week 260|Death|0|||
161882329|NCT01752634|584612864|FG003|Week 24 to Week 260|Death|0|||
161882330|NCT01752634|584612865|FG004|Week 24 to Week 260|Death|0|||
161882331|NCT01752634|584612866|FG005|Week 24 to Week 260|Death|0|||
161882332|NCT01752634|584612861|FG000|Week 24 to Week 260|Pregnancy|0|||
161882333|NCT01752634|584612862|FG001|Week 24 to Week 260|Pregnancy|0|||
161882334|NCT01752634|584612863|FG002|Week 24 to Week 260|Pregnancy|1|||
161882335|NCT01752634|584612864|FG003|Week 24 to Week 260|Pregnancy|0|||
161882336|NCT01752634|584612865|FG004|Week 24 to Week 260|Pregnancy|0|||
161882337|NCT01752634|584612866|FG005|Week 24 to Week 260|Pregnancy|0|||
161882338|NCT01752634|584612861|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882339|NCT01752634|584612862|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882340|NCT01752634|584612863|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
161882341|NCT01752634|584612864|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882342|NCT01752634|584612865|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882343|NCT01752634|584612866|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882344|NCT01752634|584612861|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
161882345|NCT01752634|584612862|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
161882346|NCT01752634|584612863|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
161882347|NCT01752634|584612864|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
161882348|NCT01752634|584612865|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
161882349|NCT01752634|584612866|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
161882350|NCT01752634|584612861|FG000|Week 24 to Week 260|Adverse Event|4|||
161882351|NCT01752634|584612862|FG001|Week 24 to Week 260|Adverse Event|8|||
161882352|NCT01752634|584612863|FG002|Week 24 to Week 260|Adverse Event|8|||
161882353|NCT01752634|584612864|FG003|Week 24 to Week 260|Adverse Event|4|||
161882354|NCT01752634|584612865|FG004|Week 24 to Week 260|Adverse Event|2|||
161882355|NCT01752634|584612866|FG005|Week 24 to Week 260|Adverse Event|0|||
161882356|NCT04250714|584612870|FG000|Overall Study|Treatment - withdrawal by subject|14|||
161882357|NCT04250714|584612870|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
161882358|NCT04250714|584612870|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
161882359|NCT04250714|584612870|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
161882360|NCT04250714|584612870|FG000|Overall Study|Treatment - Death|1|||
161882361|NCT04250714|584612870|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
161882362|NCT04250714|584612870|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
161882363|NCT04250714|584612870|FG000|Overall Study|Attempt|2|||
161882364|NCT04250714|584612870|FG000|Overall Study|Intent|7|||
161882365|NCT04697056|584612871|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
161882366|NCT04697056|584612872|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
161882367|NCT00308750|584612877|FG000|Overall Study|Adverse Event|9|||
161882368|NCT00308750|584612878|FG001|Overall Study|Adverse Event|9|||
161882369|NCT00308750|584612879|FG002|Overall Study|Adverse Event|13|||
161882370|NCT00308750|584612877|FG000|Overall Study|Withdrawal by Subject|6|||
161882371|NCT00308750|584612878|FG001|Overall Study|Withdrawal by Subject|2|||
161882372|NCT00308750|584612879|FG002|Overall Study|Withdrawal by Subject|3|||
161882373|NCT00308750|584612877|FG000|Overall Study|Physician Decision|3|||
161882374|NCT00308750|584612878|FG001|Overall Study|Physician Decision|4|||
161882375|NCT00308750|584612879|FG002|Overall Study|Physician Decision|3|||
161882376|NCT00308750|584612877|FG000|Overall Study|Sponsor Decision|1|||
161882377|NCT00308750|584612878|FG001|Overall Study|Sponsor Decision|0|||
161882378|NCT00308750|584612879|FG002|Overall Study|Sponsor Decision|0|||
161882379|NCT00308750|584612877|FG000|Overall Study|Disease Progression|47|||
161882380|NCT00308750|584612878|FG001|Overall Study|Disease Progression|24|||
161882381|NCT00308750|584612879|FG002|Overall Study|Disease Progression|28|||
161882382|NCT00308750|584612877|FG000|Overall Study|Unrelated Complication|3|||
161882383|NCT00308750|584612878|FG001|Overall Study|Unrelated Complication|0|||
161882384|NCT00308750|584612879|FG002|Overall Study|Unrelated Complication|1|||
161882385|NCT00308750|584612877|FG000|Overall Study|Death|1|||
161882386|NCT00308750|584612878|FG001|Overall Study|Death|0|||
161882387|NCT00308750|584612879|FG002|Overall Study|Death|1|||
161882388|NCT00308750|584612877|FG000|Overall Study|Protocol Violation|1|||
161882389|NCT00308750|584612878|FG001|Overall Study|Protocol Violation|0|||
161882390|NCT00308750|584612879|FG002|Overall Study|Protocol Violation|0|||
161882391|NCT00308750|584612877|FG000|Overall Study|New Primary Disease Identified|1|||
161882392|NCT00308750|584612878|FG001|Overall Study|New Primary Disease Identified|1|||
161882393|NCT00308750|584612879|FG002|Overall Study|New Primary Disease Identified|0|||
161882394|NCT01911780|584612880|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
161778350|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
161778351|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
161778352|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
161778353|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
161778354|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
161778355|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
161778356|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
161882395|NCT01911780|584612881|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
161882396|NCT01911780|584612880|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
161882397|NCT01911780|584612881|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
161882398|NCT01911780|584612880|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
161882399|NCT01911780|584612881|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
161882400|NCT01911780|584612880|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
161882401|NCT01911780|584612881|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
161882402|NCT01911780|584612880|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
161882403|NCT01911780|584612881|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
161882404|NCT01911780|584612880|FG000|Extension Period (52 Weeks)|Personal reason|1|||
161882405|NCT01911780|584612881|FG001|Extension Period (52 Weeks)|Personal reason|1|||
161882406|NCT00348790|584612884|FG000|Completed Treatment|Withdrawal by Subject|4|||
161882407|NCT00348790|584612884|FG000|Completed Treatment|Disease progression|14|||
161882408|NCT00348790|584612884|FG000|Completed Treatment|Adverse Event|4|||
161882409|NCT00348790|584612884|FG000|Completed Treatment|Required surgery|2|||
161882410|NCT00348790|584612884|FG000|Completed Treatment|Unable to travel to study site|1|||
161882411|NCT01185509|584612888|FG000|Overall Study|Progression/Relapse|9|||
161882412|NCT01185509|584612889|FG001|Overall Study|Progression/Relapse|15|||
161882413|NCT01185509|584612888|FG000|Overall Study|Physician Decision|2|||
161882414|NCT01185509|584612889|FG001|Overall Study|Physician Decision|2|||
161882415|NCT01185509|584612888|FG000|Overall Study|Withdrawal by Subject|0|||
161882416|NCT01185509|584612889|FG001|Overall Study|Withdrawal by Subject|1|||
161882417|NCT01185509|584612888|FG000|Overall Study|Death|0|||
161882418|NCT01185509|584612889|FG001|Overall Study|Death|1|||
161882419|NCT01185509|584612888|FG000|Overall Study|Intercurrent Illness|0|||
161882420|NCT01185509|584612889|FG001|Overall Study|Intercurrent Illness|1|||
161882421|NCT03687372|584612890|FG000|Overall Study|Lost to Follow-up|12|||
161882422|NCT03687372|584612891|FG001|Overall Study|Lost to Follow-up|21|||
161882423|NCT03687372|584612890|FG000|Overall Study|Withdrawal by Subject|4|||
161882424|NCT03687372|584612891|FG001|Overall Study|Withdrawal by Subject|17|||
161882425|NCT03687372|584612890|FG000|Overall Study|Investigator Decision|1|||
161882426|NCT03687372|584612891|FG001|Overall Study|Investigator Decision|1|||
161882427|NCT01088243|584612895|FG000|Overall Study|Adverse Event|1|||
161882428|NCT01088243|584612896|FG001|Overall Study|Adverse Event|0|||
161882429|NCT02370667|584612899|FG000|Overall Study|Lost to Follow-up|0|||
161882430|NCT02370667|584612900|FG001|Overall Study|Lost to Follow-up|1|||
161882431|NCT02370667|584612901|FG002|Overall Study|Lost to Follow-up|0|||
161882432|NCT03536949|584612902|FG000|Overall Study|Adverse Event|4|||
161882433|NCT03536949|584612903|FG001|Overall Study|Adverse Event|0|||
161882434|NCT03536949|584612902|FG000|Overall Study|Lost to Follow-up|2|||
161882435|NCT03536949|584612903|FG001|Overall Study|Lost to Follow-up|1|||
161882436|NCT03536949|584612902|FG000|Overall Study|Withdrawal by Subject|6|||
161882437|NCT03536949|584612903|FG001|Overall Study|Withdrawal by Subject|0|||
161882438|NCT03536949|584612902|FG000|Overall Study|Non-compliance|2|||
161882439|NCT03536949|584612903|FG001|Overall Study|Non-compliance|1|||
161882440|NCT00423189|584612907|FG000|Overall Study|Death|0|||
161882441|NCT00423189|584612908|FG001|Overall Study|Death|1|||
161882442|NCT00423189|584612909|FG002|Overall Study|Death|0|||
161882443|NCT03787303|584612910|FG000|Overall Study|Death|1|||
161778357|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
161882444|NCT03787303|584612910|FG000|Overall Study|Premature Termination of Study|1|||
161882445|NCT01826370|584612913|FG000|Overall Study|Protocol Violation|6|||
161882446|NCT01826370|584612913|FG000|Overall Study|Lost to Follow-up|12|||
161882447|NCT01826370|584612913|FG000|Overall Study|Other reason not defined above|2|||
161882448|NCT04416737|584612914|FG000|Week 1 (First Injection)|Physician Decision|0|||
161882449|NCT04416737|584612915|FG001|Week 1 (First Injection)|Physician Decision|1|||
161882450|NCT03332628|584612916|FG000|Overall Study|Physician Decision|2|||
161882451|NCT01195844|584612924|FG000|Overall Study|Fecal sample not collected|40|||
161882452|NCT00176644|584612925|FG000|Overall Study|Withdrawal by Subject|1|||
161882453|NCT01801280|584612926|FG000|Period 1|Withdrawal by Subject|0|||
161882454|NCT01801280|584612927|FG001|Period 1|Withdrawal by Subject|1|||
161778358|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
161778359|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
161778360|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
161778361|NCT03286400|584230407|FG000|Overall Study|Death|10|||
161778362|NCT03286400|584230407|FG000|Overall Study|Lost to Follow-up|10|||
161778363|NCT03286400|584230407|FG000|Overall Study|Physician Decision|1|||
161778364|NCT03286400|584230407|FG000|Overall Study|Scheduling difficulty|4|||
161778365|NCT00602979|584230410|FG000|Overall Study|Lost to Follow-up|3|||
161778366|NCT00602979|584230411|FG001|Overall Study|Lost to Follow-up|2|||
161778367|NCT00602979|584230412|FG002|Overall Study|Lost to Follow-up|3|||
161778368|NCT00602979|584230413|FG003|Overall Study|Lost to Follow-up|2|||
161778369|NCT00602979|584230414|FG004|Overall Study|Lost to Follow-up|3|||
161778370|NCT00602979|584230410|FG000|Overall Study|Failed Intubation|0|||
161778371|NCT00602979|584230411|FG001|Overall Study|Failed Intubation|1|||
161778372|NCT00602979|584230412|FG002|Overall Study|Failed Intubation|0|||
161778373|NCT00602979|584230413|FG003|Overall Study|Failed Intubation|1|||
161778374|NCT00602979|584230414|FG004|Overall Study|Failed Intubation|0|||
161778375|NCT01461369|584230415|FG000|Overall Study|Lack of Efficacy|2|||
161778376|NCT01461369|584230416|FG001|Overall Study|Lack of Efficacy|0|||
161778377|NCT01461369|584230417|FG002|Overall Study|Lack of Efficacy|6|||
161778378|NCT01461369|584230415|FG000|Overall Study|Lost to Follow-up|0|||
161778379|NCT01461369|584230416|FG001|Overall Study|Lost to Follow-up|0|||
161778380|NCT01461369|584230417|FG002|Overall Study|Lost to Follow-up|3|||
161778381|NCT01461369|584230415|FG000|Overall Study|Adverse Event|9|||
161778382|NCT01461369|584230416|FG001|Overall Study|Adverse Event|12|||
161778383|NCT01461369|584230417|FG002|Overall Study|Adverse Event|4|||
161778384|NCT01461369|584230415|FG000|Overall Study|Protocol Violation|1|||
161778385|NCT01461369|584230416|FG001|Overall Study|Protocol Violation|2|||
161778386|NCT01461369|584230417|FG002|Overall Study|Protocol Violation|2|||
161778387|NCT01461369|584230415|FG000|Overall Study|Withdrawal by Subject|1|||
161778388|NCT01461369|584230416|FG001|Overall Study|Withdrawal by Subject|3|||
161778389|NCT01461369|584230417|FG002|Overall Study|Withdrawal by Subject|2|||
161778390|NCT00734617|584230422|FG000|Overall Study|Adverse Event|4|||
161778391|NCT00734617|584230423|FG001|Overall Study|Adverse Event|7|||
161778392|NCT00734617|584230422|FG000|Overall Study|Withdrawal by Subject|103|||
161778393|NCT00734617|584230423|FG001|Overall Study|Withdrawal by Subject|95|||
161778394|NCT03692078|584230426|FG000|Overall Study|Adverse Event|0|||
161778395|NCT03692078|584230427|FG001|Overall Study|Adverse Event|0|||
161778396|NCT03692078|584230428|FG002|Overall Study|Adverse Event|0|||
161778397|NCT03692078|584230429|FG003|Overall Study|Adverse Event|0|||
161778398|NCT03692078|584230430|FG004|Overall Study|Adverse Event|0|||
161778399|NCT03692078|584230431|FG005|Overall Study|Adverse Event|1|||
161778400|NCT03692078|584230432|FG006|Overall Study|Adverse Event|0|||
161778401|NCT03692078|584230426|FG000|Overall Study|Enrollment Closed|5|||
161778402|NCT03692078|584230427|FG001|Overall Study|Enrollment Closed|0|||
161778403|NCT03692078|584230428|FG002|Overall Study|Enrollment Closed|0|||
161778404|NCT03692078|584230429|FG003|Overall Study|Enrollment Closed|0|||
161778405|NCT03692078|584230430|FG004|Overall Study|Enrollment Closed|0|||
161778406|NCT03692078|584230431|FG005|Overall Study|Enrollment Closed|0|||
161778407|NCT03692078|584230432|FG006|Overall Study|Enrollment Closed|0|||
161778408|NCT03692078|584230426|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
161778409|NCT03692078|584230427|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
161778410|NCT03692078|584230428|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
161778411|NCT03692078|584230429|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
161778412|NCT03692078|584230430|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
161778413|NCT03692078|584230431|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
161778414|NCT03692078|584230432|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
161778415|NCT03692078|584230426|FG000|Overall Study|Withdrawal by Subject|0|||
161778416|NCT03692078|584230427|FG001|Overall Study|Withdrawal by Subject|2|||
161778417|NCT03692078|584230428|FG002|Overall Study|Withdrawal by Subject|0|||
161778418|NCT03692078|584230429|FG003|Overall Study|Withdrawal by Subject|1|||
161778419|NCT03692078|584230430|FG004|Overall Study|Withdrawal by Subject|5|||
161778420|NCT03692078|584230431|FG005|Overall Study|Withdrawal by Subject|3|||
161778421|NCT03692078|584230432|FG006|Overall Study|Withdrawal by Subject|3|||
161778422|NCT00996632|584230435|FG000|Overall Study|Physician Decision|0|||
161778423|NCT00996632|584230436|FG001|Overall Study|Physician Decision|0|||
161778424|NCT01615822|584230438|FG000|Period 1|Withdrawal by Subject|0|||
161778425|NCT01615822|584230439|FG001|Period 1|Withdrawal by Subject|1|||
161778426|NCT01615822|584230440|FG002|Period 1|Withdrawal by Subject|0|||
161778427|NCT01615822|584230438|FG000|Period 1|Adverse Event|1|||
161778428|NCT01615822|584230439|FG001|Period 1|Adverse Event|1|||
161778429|NCT01615822|584230440|FG002|Period 1|Adverse Event|0|||
161778430|NCT01615822|584230438|FG000|Period 2|Lost to Follow-up|0|||
161778431|NCT01615822|584230439|FG001|Period 2|Lost to Follow-up|1|||
161778432|NCT01615822|584230440|FG002|Period 2|Lost to Follow-up|2|||
161882455|NCT01801280|584612928|FG002|Period 1|Withdrawal by Subject|0|||
161882456|NCT01801280|584612929|FG003|Period 1|Withdrawal by Subject|0|||
161882457|NCT01801280|584612926|FG000|Period 2|Withdrawal by Subject|1|||
161882458|NCT01801280|584612927|FG001|Period 2|Withdrawal by Subject|0|||
161882459|NCT01801280|584612928|FG002|Period 2|Withdrawal by Subject|0|||
161882460|NCT01801280|584612929|FG003|Period 2|Withdrawal by Subject|0|||
161882461|NCT01801280|584612926|FG000|Period 4|Protocol Violation|0|||
161882462|NCT01801280|584612927|FG001|Period 4|Protocol Violation|0|||
161882463|NCT01801280|584612928|FG002|Period 4|Protocol Violation|1|||
161778433|NCT02861534|584230441|FG000|Overall Study|Death|541|||
161778434|NCT02861534|584230442|FG001|Overall Study|Death|552|||
161778435|NCT02861534|584230441|FG000|Overall Study|Lost to Follow-up|14|||
161778436|NCT02861534|584230442|FG001|Overall Study|Lost to Follow-up|14|||
161778437|NCT02861534|584230441|FG000|Overall Study|Site Terminated by Sponsor|4|||
161778438|NCT02861534|584230442|FG001|Overall Study|Site Terminated by Sponsor|3|||
161778439|NCT02861534|584230441|FG000|Overall Study|Withdrawal by Subject|15|||
161778440|NCT02861534|584230442|FG001|Overall Study|Withdrawal by Subject|18|||
161778441|NCT02886494|584230445|FG000|Overall Study|Adverse Event|1|||
161778442|NCT02886494|584230446|FG001|Overall Study|Adverse Event|0|||
161778443|NCT02886494|584230445|FG000|Overall Study|Withdrawal by Subject|12|||
161778444|NCT02886494|584230446|FG001|Overall Study|Withdrawal by Subject|3|||
161778445|NCT02886494|584230445|FG000|Overall Study|Protocol Violation|4|||
161778446|NCT02886494|584230446|FG001|Overall Study|Protocol Violation|1|||
161778447|NCT00916617|584230449|FG000|Overall Study|Adverse Event|3|||
161778448|NCT00916617|584230450|FG001|Overall Study|Adverse Event|2|||
161778449|NCT00916617|584230451|FG002|Overall Study|Adverse Event|6|||
161778450|NCT00916617|584230452|FG003|Overall Study|Adverse Event|3|||
161778451|NCT00916617|584230449|FG000|Overall Study|Withdrawal by Subject|3|||
161778452|NCT00916617|584230450|FG001|Overall Study|Withdrawal by Subject|2|||
161778453|NCT00916617|584230451|FG002|Overall Study|Withdrawal by Subject|0|||
161778454|NCT00916617|584230452|FG003|Overall Study|Withdrawal by Subject|1|||
161778455|NCT00916617|584230449|FG000|Overall Study|Caregiver Request|3|||
161778456|NCT00916617|584230450|FG001|Overall Study|Caregiver Request|2|||
161778457|NCT00916617|584230451|FG002|Overall Study|Caregiver Request|1|||
161778458|NCT00916617|584230452|FG003|Overall Study|Caregiver Request|0|||
161778459|NCT00916617|584230449|FG000|Overall Study|Physician Decision|1|||
161778460|NCT00916617|584230450|FG001|Overall Study|Physician Decision|1|||
161778461|NCT00916617|584230451|FG002|Overall Study|Physician Decision|0|||
161778462|NCT00916617|584230452|FG003|Overall Study|Physician Decision|0|||
161778463|NCT00916617|584230449|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
161778464|NCT00916617|584230450|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
161778465|NCT00916617|584230451|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
161778466|NCT00916617|584230452|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
161778467|NCT00916617|584230449|FG000|Overall Study|Lost to Follow-up|2|||
161778468|NCT00916617|584230450|FG001|Overall Study|Lost to Follow-up|1|||
161778469|NCT00916617|584230451|FG002|Overall Study|Lost to Follow-up|0|||
161778470|NCT00916617|584230452|FG003|Overall Study|Lost to Follow-up|0|||
161778471|NCT00916617|584230449|FG000|Overall Study|Lack of Efficacy|1|||
161882464|NCT01801280|584612929|FG003|Period 4|Protocol Violation|0|||
161882465|NCT00581542|584612930|FG000|Overall Study|they met an exclusion criteria|2|||
161882466|NCT00581542|584612931|FG001|Overall Study|they met an exclusion criteria|2|||
161778472|NCT00916617|584230450|FG001|Overall Study|Lack of Efficacy|0|||
161778473|NCT00916617|584230451|FG002|Overall Study|Lack of Efficacy|0|||
161778474|NCT00916617|584230452|FG003|Overall Study|Lack of Efficacy|0|||
161778475|NCT00916617|584230449|FG000|Overall Study|Other|2|||
161778476|NCT00916617|584230450|FG001|Overall Study|Other|0|||
161778477|NCT00916617|584230451|FG002|Overall Study|Other|0|||
161778478|NCT00916617|584230452|FG003|Overall Study|Other|2|||
161778479|NCT00499252|584230454|FG000|Overall Study|Adverse Event|3|||
161778480|NCT00499252|584230454|FG000|Overall Study|Refused further treatment|2|||
161778481|NCT00499252|584230454|FG000|Overall Study|Ineligible|4|||
161778482|NCT00499252|584230454|FG000|Overall Study|<no further label>|3|||
161778483|NCT02230332|584230455|FG000|Overall Study|Adverse Event|2|||
161778484|NCT02230332|584230456|FG001|Overall Study|Adverse Event|1|||
161778485|NCT02230332|584230455|FG000|Overall Study|Lost to Follow-up|1|||
161778486|NCT02230332|584230456|FG001|Overall Study|Lost to Follow-up|0|||
161778487|NCT02230332|584230455|FG000|Overall Study|Protocol Violation|1|||
161778488|NCT02230332|584230456|FG001|Overall Study|Protocol Violation|0|||
161778489|NCT01260194|584230459|FG000|Overall Study|Withdrawal of Consent|1|||
161778490|NCT00537056|584230463|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
161778491|NCT00244881|584230469|FG000|Overall Study|Withdrawal by Subject|3|||
161778492|NCT00445458|584230470|FG000|Overall Study|Disease Progression|3|||
161778493|NCT00445458|584230471|FG001|Overall Study|Disease Progression|4|||
161778494|NCT00445458|584230472|FG002|Overall Study|Disease Progression|54|||
161778495|NCT00445458|584230473|FG003|Overall Study|Disease Progression|27|||
161778496|NCT00445458|584230470|FG000|Overall Study|Withdrawal by Subject|0|||
161778497|NCT00445458|584230471|FG001|Overall Study|Withdrawal by Subject|0|||
161778498|NCT00445458|584230472|FG002|Overall Study|Withdrawal by Subject|7|||
161778499|NCT00445458|584230473|FG003|Overall Study|Withdrawal by Subject|0|||
161778500|NCT00445458|584230470|FG000|Overall Study|Adverse Event|0|||
161778501|NCT00445458|584230471|FG001|Overall Study|Adverse Event|0|||
161778502|NCT00445458|584230472|FG002|Overall Study|Adverse Event|3|||
161778503|NCT00445458|584230473|FG003|Overall Study|Adverse Event|0|||
161778504|NCT00445458|584230470|FG000|Overall Study|Death|0|||
161778505|NCT00445458|584230471|FG001|Overall Study|Death|1|||
161778506|NCT00445458|584230472|FG002|Overall Study|Death|2|||
161778507|NCT00445458|584230473|FG003|Overall Study|Death|0|||
161778508|NCT00445458|584230470|FG000|Overall Study|Physician Decision|0|||
161778509|NCT00445458|584230471|FG001|Overall Study|Physician Decision|0|||
161778510|NCT00445458|584230472|FG002|Overall Study|Physician Decision|1|||
161778511|NCT00445458|584230473|FG003|Overall Study|Physician Decision|1|||
161778512|NCT00445458|584230470|FG000|Overall Study|Surgery|0|||
161778513|NCT00445458|584230471|FG001|Overall Study|Surgery|0|||
161778514|NCT00445458|584230472|FG002|Overall Study|Surgery|1|||
161778515|NCT00445458|584230473|FG003|Overall Study|Surgery|0|||
161778516|NCT01393626|584230477|FG000|Overall Study|Adverse Event|2|||
161778517|NCT01393626|584230478|FG001|Overall Study|Adverse Event|1|||
161778518|NCT01393626|584230479|FG002|Overall Study|Adverse Event|5|||
161778519|NCT01393626|584230480|FG003|Overall Study|Adverse Event|0|||
161778520|NCT01393626|584230477|FG000|Overall Study|Did not meet entrance criteria|1|||
161778521|NCT01393626|584230478|FG001|Overall Study|Did not meet entrance criteria|0|||
161778522|NCT01393626|584230479|FG002|Overall Study|Did not meet entrance criteria|0|||
161778523|NCT01393626|584230480|FG003|Overall Study|Did not meet entrance criteria|0|||
161778524|NCT01393626|584230477|FG000|Overall Study|Lack of Efficacy|6|||
161778525|NCT01393626|584230478|FG001|Overall Study|Lack of Efficacy|6|||
161778526|NCT01393626|584230479|FG002|Overall Study|Lack of Efficacy|4|||
161778527|NCT01393626|584230480|FG003|Overall Study|Lack of Efficacy|1|||
161778528|NCT01393626|584230477|FG000|Overall Study|Lost to Follow-up|1|||
161778529|NCT01393626|584230478|FG001|Overall Study|Lost to Follow-up|1|||
161778530|NCT01393626|584230479|FG002|Overall Study|Lost to Follow-up|1|||
161778531|NCT01393626|584230480|FG003|Overall Study|Lost to Follow-up|0|||
161778532|NCT01393626|584230477|FG000|Overall Study|Withdrawal by Subject|6|||
161778533|NCT01393626|584230478|FG001|Overall Study|Withdrawal by Subject|4|||
161778534|NCT01393626|584230479|FG002|Overall Study|Withdrawal by Subject|0|||
161778535|NCT01393626|584230480|FG003|Overall Study|Withdrawal by Subject|0|||
161778536|NCT01393626|584230477|FG000|Overall Study|Other|1|||
161778537|NCT01393626|584230478|FG001|Overall Study|Other|0|||
161778538|NCT01393626|584230479|FG002|Overall Study|Other|0|||
161778539|NCT01393626|584230480|FG003|Overall Study|Other|0|||
161778540|NCT01393626|584230477|FG000|Overall Study|Protocol Violation|1|||
161778541|NCT01393626|584230478|FG001|Overall Study|Protocol Violation|0|||
161778542|NCT01393626|584230479|FG002|Overall Study|Protocol Violation|2|||
161778543|NCT01393626|584230480|FG003|Overall Study|Protocol Violation|0|||
161778544|NCT02426125|584230481|FG000|Overall Study|Lost to Follow-up|14|||
161778545|NCT02426125|584230482|FG001|Overall Study|Lost to Follow-up|12|||
161778546|NCT02426125|584230481|FG000|Overall Study|Withdrawal by Subject|13|||
161778547|NCT02426125|584230482|FG001|Overall Study|Withdrawal by Subject|14|||
161778548|NCT02426125|584230481|FG000|Overall Study|Death|185|||
161778549|NCT02426125|584230482|FG001|Overall Study|Death|200|||
161778550|NCT02426125|584230481|FG000|Overall Study|Randomized, But Never Treated|5|||
161778551|NCT02426125|584230482|FG001|Overall Study|Randomized, But Never Treated|2|||
161778552|NCT03644927|584230485|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
161778553|NCT03644927|584230486|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
161778554|NCT00956813|584230487|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
161778555|NCT00956813|584230488|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
161778556|NCT00956813|584230487|FG000|Flaxseed and Placebo|Ineligible|3|||
161778557|NCT00956813|584230488|FG001|Flaxseed and Placebo|Ineligible|1|||
161778558|NCT02380248|584230489|FG000|Overall Study|Lost to Follow-up|11|||
161778559|NCT02380248|584230489|FG000|Overall Study|Withdrawal by Subject|3|||
161778560|NCT03128931|584230491|FG000|Overall Study|Physician Decision|1|||
161778561|NCT03128931|584230491|FG000|Overall Study|Equipment Issues|3|||
161778562|NCT03151226|584230492|FG000|Overall Study|Withdrawal by Subject|2|||
161778563|NCT03151226|584230492|FG000|Overall Study|not wear device correctly|1|||
161778564|NCT00903409|584230493|FG000|Overall Study|Adverse Event|11|||
161778565|NCT00903409|584230494|FG001|Overall Study|Adverse Event|9|||
161778566|NCT00903409|584230493|FG000|Overall Study|Non-compliance with Protocol|1|||
161778567|NCT00903409|584230494|FG001|Overall Study|Non-compliance with Protocol|1|||
161778568|NCT00903409|584230493|FG000|Overall Study|Laboratory Abnormality|2|||
161778569|NCT00903409|584230494|FG001|Overall Study|Laboratory Abnormality|0|||
161778570|NCT00903409|584230493|FG000|Overall Study|Withdrawal by Subject|8|||
161778571|NCT00903409|584230494|FG001|Overall Study|Withdrawal by Subject|8|||
161778572|NCT00903409|584230493|FG000|Overall Study|Other|2|||
161778573|NCT00903409|584230494|FG001|Overall Study|Other|3|||
161778574|NCT00903409|584230493|FG000|Overall Study|Lost to Follow-up|2|||
161778575|NCT00903409|584230494|FG001|Overall Study|Lost to Follow-up|6|||
161778576|NCT03239340|584230495|FG000|Overall Study|Other|26|||
161778577|NCT03239340|584230495|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
161778578|NCT03239340|584230495|FG000|Overall Study|Death|40|||
161778579|NCT03239340|584230495|FG000|Overall Study|Lost to Follow-up|2|||
161778580|NCT03239340|584230495|FG000|Overall Study|Physician Decision|16|||
161778581|NCT03239340|584230495|FG000|Overall Study|Withdrawal by Subject|27|||
161778582|NCT03539952|584230497|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
161778583|NCT03539952|584230498|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
161778584|NCT03539952|584230497|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
161778585|NCT03539952|584230498|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
161778586|NCT03539952|584230497|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
161778587|NCT03539952|584230498|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
161778588|NCT03539952|584230497|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
161778589|NCT03539952|584230498|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
161778590|NCT03539952|584230497|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
161778591|NCT03539952|584230498|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
161778592|NCT03539952|584230497|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
161778593|NCT03539952|584230498|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
161778594|NCT03539952|584230497|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
161778595|NCT03539952|584230498|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
161778596|NCT02184988|584230499|FG000|Overall Study|Pregnancy|2|||
161778597|NCT02184988|584230499|FG000|Overall Study|Adverse Event|2|||
161778598|NCT02184988|584230499|FG000|Overall Study|moving away/travelling/unable to complet|6|||
161778599|NCT02184988|584230499|FG000|Overall Study|work scheduling issues|4|||
161778600|NCT02184988|584230499|FG000|Overall Study|various other reasons|9|||
161778601|NCT02184988|584230499|FG000|Overall Study|Lost to Follow-up|32|||
161778602|NCT05378269|584232277|FG000|Overall Study|Protocol Violation|1|||
161778603|NCT05378269|584232278|FG001|Overall Study|Protocol Violation|0|||
161778604|NCT05378269|584232279|FG002|Overall Study|Protocol Violation|2|||
161778605|NCT05378269|584232280|FG003|Overall Study|Protocol Violation|0|||
161778606|NCT05378269|584232281|FG004|Overall Study|Protocol Violation|0|||
161778607|NCT01371006|584232282|FG000|Overall Study|Adverse Event|1|||
161778608|NCT01371006|584232283|FG001|Overall Study|Adverse Event|0|||
161778609|NCT03256526|584232284|FG000|Overall Study|Adverse Event|1|||
161778610|NCT03256526|584232285|FG001|Overall Study|Adverse Event|0|||
161778611|NCT03256526|584232286|FG002|Overall Study|Adverse Event|1|||
161778612|NCT03256526|584232284|FG000|Overall Study|Lost to Follow-up|1|||
161778613|NCT03256526|584232285|FG001|Overall Study|Lost to Follow-up|0|||
161778614|NCT03256526|584232286|FG002|Overall Study|Lost to Follow-up|2|||
161778615|NCT00891527|584232287|FG000|Overall Study|Withdrawal by Subject|2|||
161778616|NCT01186744|584232288|FG000|Overall Study|Lack of Efficacy|156|||
161778617|NCT01186744|584232289|FG001|Overall Study|Lack of Efficacy|99|||
161778618|NCT01186744|584232290|FG002|Overall Study|Lack of Efficacy|0|||
161778619|NCT01186744|584232291|FG003|Overall Study|Lack of Efficacy|2|||
161778620|NCT01186744|584232292|FG004|Overall Study|Lack of Efficacy|2|||
161778621|NCT01186744|584232293|FG005|Overall Study|Lack of Efficacy|5|||
161778622|NCT01186744|584232288|FG000|Overall Study|Protocol Violation|1|||
161778623|NCT01186744|584232289|FG001|Overall Study|Protocol Violation|2|||
161778624|NCT01186744|584232290|FG002|Overall Study|Protocol Violation|0|||
161778625|NCT01186744|584232291|FG003|Overall Study|Protocol Violation|1|||
161778626|NCT01186744|584232292|FG004|Overall Study|Protocol Violation|1|||
161778627|NCT01186744|584232293|FG005|Overall Study|Protocol Violation|2|||
161778628|NCT01186744|584232288|FG000|Overall Study|Lost to Follow-up|15|||
161778629|NCT01186744|584232289|FG001|Overall Study|Lost to Follow-up|16|||
161778630|NCT01186744|584232290|FG002|Overall Study|Lost to Follow-up|2|||
161778631|NCT01186744|584232291|FG003|Overall Study|Lost to Follow-up|1|||
161778632|NCT01186744|584232292|FG004|Overall Study|Lost to Follow-up|1|||
161778633|NCT01186744|584232293|FG005|Overall Study|Lost to Follow-up|4|||
161778634|NCT01186744|584232288|FG000|Overall Study|Screen failure|1|||
161778635|NCT01186744|584232289|FG001|Overall Study|Screen failure|1|||
161778636|NCT01186744|584232290|FG002|Overall Study|Screen failure|0|||
161778637|NCT01186744|584232291|FG003|Overall Study|Screen failure|1|||
161778638|NCT01186744|584232292|FG004|Overall Study|Screen failure|0|||
161778639|NCT01186744|584232293|FG005|Overall Study|Screen failure|0|||
161778640|NCT01186744|584232288|FG000|Overall Study|Withdrawal by Subject|14|||
161778641|NCT01186744|584232289|FG001|Overall Study|Withdrawal by Subject|10|||
161778642|NCT01186744|584232290|FG002|Overall Study|Withdrawal by Subject|2|||
161778643|NCT01186744|584232291|FG003|Overall Study|Withdrawal by Subject|5|||
161778644|NCT01186744|584232292|FG004|Overall Study|Withdrawal by Subject|0|||
161778645|NCT01186744|584232293|FG005|Overall Study|Withdrawal by Subject|6|||
161778646|NCT01186744|584232288|FG000|Overall Study|Study terminated by Sponsor|1|||
161778647|NCT01186744|584232289|FG001|Overall Study|Study terminated by Sponsor|0|||
161778648|NCT01186744|584232290|FG002|Overall Study|Study terminated by Sponsor|0|||
161778649|NCT01186744|584232291|FG003|Overall Study|Study terminated by Sponsor|0|||
161778650|NCT01186744|584232292|FG004|Overall Study|Study terminated by Sponsor|0|||
161778651|NCT01186744|584232293|FG005|Overall Study|Study terminated by Sponsor|0|||
161778652|NCT01186744|584232288|FG000|Overall Study|Other|9|||
161778653|NCT01186744|584232289|FG001|Overall Study|Other|10|||
161778654|NCT01186744|584232290|FG002|Overall Study|Other|1|||
161778655|NCT01186744|584232291|FG003|Overall Study|Other|2|||
161778656|NCT01186744|584232292|FG004|Overall Study|Other|1|||
161778657|NCT01186744|584232293|FG005|Overall Study|Other|5|||
161778658|NCT01186744|584232288|FG000|Overall Study|Adverse Event|10|||
161778659|NCT01186744|584232289|FG001|Overall Study|Adverse Event|14|||
161778660|NCT01186744|584232290|FG002|Overall Study|Adverse Event|1|||
161778661|NCT01186744|584232291|FG003|Overall Study|Adverse Event|0|||
161778662|NCT01186744|584232292|FG004|Overall Study|Adverse Event|1|||
161778663|NCT01186744|584232293|FG005|Overall Study|Adverse Event|4|||
161778664|NCT01186744|584232288|FG000|Overall Study|Death|1|||
161778665|NCT01186744|584232289|FG001|Overall Study|Death|0|||
161778666|NCT01186744|584232290|FG002|Overall Study|Death|0|||
161778667|NCT01186744|584232291|FG003|Overall Study|Death|0|||
161778668|NCT01186744|584232292|FG004|Overall Study|Death|0|||
161778669|NCT01186744|584232293|FG005|Overall Study|Death|0|||
161778670|NCT03515837|584232297|FG000|Overall Study|Death|219|||
161778671|NCT03515837|584232298|FG001|Overall Study|Death|227|||
161882467|NCT00581542|584612930|FG000|Overall Study|Lost to Follow-up|9|||
161778672|NCT03515837|584232297|FG000|Overall Study|Lost to Follow-up|0|||
161778673|NCT03515837|584232298|FG001|Overall Study|Lost to Follow-up|1|||
161778674|NCT03515837|584232297|FG000|Overall Study|Withdrawal by Subject|0|||
161778675|NCT03515837|584232298|FG001|Overall Study|Withdrawal by Subject|4|||
161778676|NCT03515837|584232297|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
161778677|NCT03515837|584232298|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
161778678|NCT02325401|584232299|FG000|Overall Study|Withdrawal by Subject|0|||
161778679|NCT02325401|584232300|FG001|Overall Study|Withdrawal by Subject|1|||
161778680|NCT02325401|584232301|FG002|Overall Study|Withdrawal by Subject|1|||
161778681|NCT01856686|584232302|FG000|Overall Study|Lost to Follow-up|5|||
161778682|NCT01856686|584232303|FG001|Overall Study|Lost to Follow-up|11|||
161778683|NCT02086968|584232310|FG000|Overall Study|Adverse Event|1|||
161778684|NCT02086968|584232311|FG001|Overall Study|Adverse Event|5|||
161778685|NCT02086968|584232310|FG000|Overall Study|Lost to Follow-up|2|||
161778686|NCT02086968|584232311|FG001|Overall Study|Lost to Follow-up|3|||
161778687|NCT02086968|584232310|FG000|Overall Study|Study drug received outside protocol|0|||
161778688|NCT02086968|584232311|FG001|Overall Study|Study drug received outside protocol|1|||
161778689|NCT02086968|584232310|FG000|Overall Study|Physician Decision|4|||
161778690|NCT02086968|584232311|FG001|Overall Study|Physician Decision|0|||
161778691|NCT02086968|584232310|FG000|Overall Study|Withdrawal by Subject|1|||
161778692|NCT02086968|584232311|FG001|Overall Study|Withdrawal by Subject|4|||
161778693|NCT04101721|584232312|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
161778694|NCT04101721|584232313|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161778695|NCT04101721|584232312|FG000|Overall Study|Death|0|||
161778696|NCT04101721|584232313|FG001|Overall Study|Death|1|||
161778697|NCT04101721|584232312|FG000|Overall Study|Lost to Follow-up|0|||
161778698|NCT04101721|584232313|FG001|Overall Study|Lost to Follow-up|3|||
161778699|NCT01215955|584232314|FG000|Overall Study|Adverse Event|1|||
161778700|NCT01215955|584232315|FG001|Overall Study|Adverse Event|4|||
161778701|NCT01215955|584232316|FG002|Overall Study|Adverse Event|2|||
161778702|NCT01215955|584232317|FG003|Overall Study|Adverse Event|3|||
161778703|NCT01215955|584232314|FG000|Overall Study|Death|2|||
161778704|NCT01215955|584232315|FG001|Overall Study|Death|0|||
161778705|NCT01215955|584232316|FG002|Overall Study|Death|1|||
161778706|NCT01215955|584232317|FG003|Overall Study|Death|3|||
161778707|NCT01215955|584232314|FG000|Overall Study|Entry Criteria Not Met|1|||
161778708|NCT01215955|584232315|FG001|Overall Study|Entry Criteria Not Met|3|||
161778709|NCT01215955|584232316|FG002|Overall Study|Entry Criteria Not Met|4|||
161778710|NCT01215955|584232317|FG003|Overall Study|Entry Criteria Not Met|7|||
161778711|NCT01215955|584232314|FG000|Overall Study|Lack of Efficacy|1|||
161778712|NCT01215955|584232315|FG001|Overall Study|Lack of Efficacy|2|||
161778713|NCT01215955|584232316|FG002|Overall Study|Lack of Efficacy|1|||
161778714|NCT01215955|584232317|FG003|Overall Study|Lack of Efficacy|0|||
161778715|NCT01215955|584232314|FG000|Overall Study|Lost to Follow-up|4|||
161778716|NCT01215955|584232315|FG001|Overall Study|Lost to Follow-up|4|||
161778717|NCT01215955|584232316|FG002|Overall Study|Lost to Follow-up|8|||
161778718|NCT01215955|584232317|FG003|Overall Study|Lost to Follow-up|9|||
161778719|NCT01215955|584232314|FG000|Overall Study|Physician Decision|4|||
161778720|NCT01215955|584232315|FG001|Overall Study|Physician Decision|10|||
161778721|NCT01215955|584232316|FG002|Overall Study|Physician Decision|8|||
161778722|NCT01215955|584232317|FG003|Overall Study|Physician Decision|11|||
161778723|NCT01215955|584232314|FG000|Overall Study|Protocol Violation|17|||
161778724|NCT01215955|584232315|FG001|Overall Study|Protocol Violation|13|||
161778725|NCT01215955|584232316|FG002|Overall Study|Protocol Violation|8|||
161778726|NCT01215955|584232317|FG003|Overall Study|Protocol Violation|8|||
161882468|NCT00581542|584612931|FG001|Overall Study|Lost to Follow-up|21|||
161882469|NCT00195494|584612937|FG000|Year 1|Adverse Event|0|||
161882470|NCT00195494|584612938|FG001|Year 1|Adverse Event|0|||
161882471|NCT00195494|584612939|FG002|Year 1|Adverse Event|0|||
161882472|NCT00195494|584612940|FG003|Year 1|Adverse Event|0|||
161882473|NCT00195494|584612941|FG004|Year 1|Adverse Event|34|||
161778727|NCT01215955|584232314|FG000|Overall Study|Sponsor Decision|1|||
161778728|NCT01215955|584232315|FG001|Overall Study|Sponsor Decision|2|||
161778729|NCT01215955|584232316|FG002|Overall Study|Sponsor Decision|0|||
161778730|NCT01215955|584232317|FG003|Overall Study|Sponsor Decision|1|||
161778731|NCT01215955|584232314|FG000|Overall Study|Withdrawal by Subject|14|||
161778732|NCT01215955|584232315|FG001|Overall Study|Withdrawal by Subject|15|||
161778733|NCT01215955|584232316|FG002|Overall Study|Withdrawal by Subject|13|||
161778734|NCT01215955|584232317|FG003|Overall Study|Withdrawal by Subject|9|||
161778735|NCT01215955|584232314|FG000|Overall Study|Quality Issues|0|||
161778736|NCT01215955|584232315|FG001|Overall Study|Quality Issues|0|||
161778737|NCT01215955|584232316|FG002|Overall Study|Quality Issues|3|||
161778738|NCT01215955|584232317|FG003|Overall Study|Quality Issues|2|||
161882474|NCT00195494|584612942|FG005|Year 1|Adverse Event|27|||
161882475|NCT00195494|584612937|FG000|Year 1|System Toxicity|0|||
161882476|NCT00195494|584612938|FG001|Year 1|System Toxicity|0|||
161882477|NCT00195494|584612939|FG002|Year 1|System Toxicity|0|||
161882478|NCT00195494|584612940|FG003|Year 1|System Toxicity|0|||
161882479|NCT00195494|584612941|FG004|Year 1|System Toxicity|0|||
161882480|NCT00195494|584612942|FG005|Year 1|System Toxicity|1|||
161882481|NCT00195494|584612937|FG000|Year 1|Lack of Efficacy|0|||
161882482|NCT00195494|584612938|FG001|Year 1|Lack of Efficacy|0|||
161882483|NCT00195494|584612939|FG002|Year 1|Lack of Efficacy|0|||
161882484|NCT00195494|584612940|FG003|Year 1|Lack of Efficacy|0|||
161882485|NCT00195494|584612941|FG004|Year 1|Lack of Efficacy|24|||
161882486|NCT00195494|584612942|FG005|Year 1|Lack of Efficacy|9|||
161882487|NCT00195494|584612937|FG000|Year 1|Compliance|0|||
161882488|NCT00195494|584612938|FG001|Year 1|Compliance|0|||
161882489|NCT00195494|584612939|FG002|Year 1|Compliance|0|||
161882490|NCT00195494|584612940|FG003|Year 1|Compliance|0|||
161882491|NCT00195494|584612941|FG004|Year 1|Compliance|5|||
161882492|NCT00195494|584612942|FG005|Year 1|Compliance|1|||
161882493|NCT00195494|584612937|FG000|Year 1|Lost to Follow-up|0|||
161882494|NCT00195494|584612938|FG001|Year 1|Lost to Follow-up|0|||
161882495|NCT00195494|584612939|FG002|Year 1|Lost to Follow-up|0|||
161882496|NCT00195494|584612940|FG003|Year 1|Lost to Follow-up|0|||
161882497|NCT00195494|584612941|FG004|Year 1|Lost to Follow-up|1|||
161882498|NCT00195494|584612942|FG005|Year 1|Lost to Follow-up|0|||
161882499|NCT00195494|584612937|FG000|Year 1|Missed >4 consecutive doses|0|||
161882500|NCT00195494|584612938|FG001|Year 1|Missed >4 consecutive doses|0|||
161882501|NCT00195494|584612939|FG002|Year 1|Missed >4 consecutive doses|0|||
161882502|NCT00195494|584612940|FG003|Year 1|Missed >4 consecutive doses|0|||
161882503|NCT00195494|584612941|FG004|Year 1|Missed >4 consecutive doses|3|||
161882504|NCT00195494|584612942|FG005|Year 1|Missed >4 consecutive doses|2|||
161882505|NCT00195494|584612937|FG000|Year 1|Protocol deviation|0|||
161882506|NCT00195494|584612938|FG001|Year 1|Protocol deviation|0|||
161882507|NCT00195494|584612939|FG002|Year 1|Protocol deviation|0|||
161882508|NCT00195494|584612940|FG003|Year 1|Protocol deviation|0|||
161882509|NCT00195494|584612941|FG004|Year 1|Protocol deviation|2|||
161882510|NCT00195494|584612942|FG005|Year 1|Protocol deviation|3|||
161882511|NCT00195494|584612937|FG000|Year 1|Physician Decision|0|||
161882512|NCT00195494|584612938|FG001|Year 1|Physician Decision|0|||
161882513|NCT00195494|584612939|FG002|Year 1|Physician Decision|0|||
161882514|NCT00195494|584612940|FG003|Year 1|Physician Decision|0|||
161882515|NCT00195494|584612941|FG004|Year 1|Physician Decision|1|||
161882516|NCT00195494|584612942|FG005|Year 1|Physician Decision|0|||
161882517|NCT00195494|584612937|FG000|Year 1|Withdrawal by Subject|0|||
161882518|NCT00195494|584612938|FG001|Year 1|Withdrawal by Subject|0|||
161882519|NCT00195494|584612939|FG002|Year 1|Withdrawal by Subject|0|||
161882520|NCT00195494|584612940|FG003|Year 1|Withdrawal by Subject|0|||
161882521|NCT00195494|584612941|FG004|Year 1|Withdrawal by Subject|8|||
161882522|NCT00195494|584612942|FG005|Year 1|Withdrawal by Subject|9|||
161882523|NCT00195494|584612937|FG000|Year 1|Protocol Violation|0|||
161882524|NCT00195494|584612938|FG001|Year 1|Protocol Violation|0|||
161882525|NCT00195494|584612939|FG002|Year 1|Protocol Violation|0|||
161882526|NCT00195494|584612940|FG003|Year 1|Protocol Violation|0|||
161882527|NCT00195494|584612941|FG004|Year 1|Protocol Violation|1|||
161882528|NCT00195494|584612942|FG005|Year 1|Protocol Violation|1|||
161882529|NCT00195494|584612937|FG000|Year 2|Adverse Event|3|||
161882530|NCT00195494|584612938|FG001|Year 2|Adverse Event|7|||
161882531|NCT00195494|584612939|FG002|Year 2|Adverse Event|5|||
161882532|NCT00195494|584612940|FG003|Year 2|Adverse Event|9|||
161882533|NCT00195494|584612941|FG004|Year 2|Adverse Event|0|||
161882534|NCT00195494|584612942|FG005|Year 2|Adverse Event|0|||
161882535|NCT00195494|584612937|FG000|Year 2|Lack of Efficacy|0|||
161882536|NCT00195494|584612938|FG001|Year 2|Lack of Efficacy|1|||
161882537|NCT00195494|584612939|FG002|Year 2|Lack of Efficacy|7|||
161882538|NCT00195494|584612940|FG003|Year 2|Lack of Efficacy|7|||
161882539|NCT00195494|584612941|FG004|Year 2|Lack of Efficacy|0|||
161882540|NCT00195494|584612942|FG005|Year 2|Lack of Efficacy|0|||
161882541|NCT00195494|584612937|FG000|Year 2|Compliance|1|||
161882542|NCT00195494|584612938|FG001|Year 2|Compliance|0|||
161882543|NCT00195494|584612939|FG002|Year 2|Compliance|0|||
161882544|NCT00195494|584612940|FG003|Year 2|Compliance|2|||
161882545|NCT00195494|584612941|FG004|Year 2|Compliance|0|||
161882546|NCT00195494|584612942|FG005|Year 2|Compliance|0|||
161882547|NCT00195494|584612937|FG000|Year 2|Lost to Follow-up|0|||
161882548|NCT00195494|584612938|FG001|Year 2|Lost to Follow-up|0|||
161882549|NCT00195494|584612939|FG002|Year 2|Lost to Follow-up|1|||
161882550|NCT00195494|584612940|FG003|Year 2|Lost to Follow-up|1|||
161882551|NCT00195494|584612941|FG004|Year 2|Lost to Follow-up|0|||
161882552|NCT00195494|584612942|FG005|Year 2|Lost to Follow-up|0|||
161882553|NCT00195494|584612937|FG000|Year 2|Missed >4 consecutive doses|1|||
161882554|NCT00195494|584612938|FG001|Year 2|Missed >4 consecutive doses|1|||
161882555|NCT00195494|584612939|FG002|Year 2|Missed >4 consecutive doses|1|||
161882556|NCT00195494|584612940|FG003|Year 2|Missed >4 consecutive doses|0|||
161882557|NCT00195494|584612941|FG004|Year 2|Missed >4 consecutive doses|0|||
161882558|NCT00195494|584612942|FG005|Year 2|Missed >4 consecutive doses|0|||
161882559|NCT00195494|584612937|FG000|Year 2|Protocol deviation|0|||
161882560|NCT00195494|584612938|FG001|Year 2|Protocol deviation|1|||
161882561|NCT00195494|584612939|FG002|Year 2|Protocol deviation|0|||
161882562|NCT00195494|584612940|FG003|Year 2|Protocol deviation|0|||
161882563|NCT00195494|584612941|FG004|Year 2|Protocol deviation|0|||
161882564|NCT00195494|584612942|FG005|Year 2|Protocol deviation|0|||
161882565|NCT00195494|584612937|FG000|Year 2|Physician Decision|1|||
161882566|NCT00195494|584612938|FG001|Year 2|Physician Decision|1|||
161882567|NCT00195494|584612939|FG002|Year 2|Physician Decision|0|||
161882568|NCT00195494|584612940|FG003|Year 2|Physician Decision|0|||
161882569|NCT00195494|584612941|FG004|Year 2|Physician Decision|0|||
161882570|NCT00195494|584612942|FG005|Year 2|Physician Decision|0|||
161882571|NCT00195494|584612937|FG000|Year 2|Withdrawal by Subject|1|||
161882572|NCT00195494|584612938|FG001|Year 2|Withdrawal by Subject|5|||
161882573|NCT00195494|584612939|FG002|Year 2|Withdrawal by Subject|4|||
161882574|NCT00195494|584612940|FG003|Year 2|Withdrawal by Subject|3|||
161882575|NCT00195494|584612941|FG004|Year 2|Withdrawal by Subject|0|||
161882576|NCT00195494|584612942|FG005|Year 2|Withdrawal by Subject|0|||
161882577|NCT00195494|584612937|FG000|Year 2|System toxicity|0|||
161882578|NCT00195494|584612938|FG001|Year 2|System toxicity|0|||
161882579|NCT00195494|584612939|FG002|Year 2|System toxicity|0|||
161882580|NCT00195494|584612940|FG003|Year 2|System toxicity|1|||
161882581|NCT00195494|584612941|FG004|Year 2|System toxicity|0|||
161882582|NCT00195494|584612942|FG005|Year 2|System toxicity|0|||
161882583|NCT00381043|584612951|FG000|Overall Study|Lost to Follow-up|8|||
161882584|NCT00381043|584612952|FG001|Overall Study|Lost to Follow-up|6|||
161882585|NCT00381043|584612951|FG000|Overall Study|Withdrawal by Subject|3|||
161882586|NCT00381043|584612952|FG001|Overall Study|Withdrawal by Subject|1|||
161882587|NCT00381043|584612951|FG000|Overall Study|wanted more care|0|||
161882588|NCT00381043|584612952|FG001|Overall Study|wanted more care|1|||
161882589|NCT00381043|584612951|FG000|Overall Study|incarcerated|1|||
161882590|NCT00381043|584612952|FG001|Overall Study|incarcerated|0|||
161882591|NCT03045276|584612953|FG000|Intervention Phase|Withdrawal by Subject|7|||
161882592|NCT03045276|584612954|FG001|Intervention Phase|Withdrawal by Subject|2|||
161882593|NCT03045276|584612955|FG002|Intervention Phase|Withdrawal by Subject|3|||
161882594|NCT03045276|584612956|FG003|Intervention Phase|Withdrawal by Subject|7|||
161882595|NCT03045276|584612953|FG000|Intervention Phase|Developed exclusionary criteria|3|||
161882596|NCT03045276|584612954|FG001|Intervention Phase|Developed exclusionary criteria|3|||
161882597|NCT03045276|584612955|FG002|Intervention Phase|Developed exclusionary criteria|0|||
161882598|NCT03045276|584612956|FG003|Intervention Phase|Developed exclusionary criteria|0|||
161882599|NCT03045276|584612953|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161882600|NCT03045276|584612954|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
161882601|NCT03045276|584612955|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
161882602|NCT03045276|584612956|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
161882603|NCT03045276|584612953|FG000|Follow-Up Phase|Lost to Follow-up|0|||
161882604|NCT03045276|584612954|FG001|Follow-Up Phase|Lost to Follow-up|1|||
161882605|NCT03045276|584612955|FG002|Follow-Up Phase|Lost to Follow-up|0|||
161882606|NCT03045276|584612956|FG003|Follow-Up Phase|Lost to Follow-up|1|||
161882607|NCT03045276|584612953|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
161882608|NCT03045276|584612954|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
161882609|NCT03045276|584612955|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
161882610|NCT03045276|584612956|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
161882611|NCT00915876|584612961|FG000|Overall Study|Adverse Event|0|||
161882612|NCT00915876|584612962|FG001|Overall Study|Adverse Event|1|||
161882613|NCT02496091|584612968|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161882614|NCT02272842|584612969|FG000|Overall Study|Lost to Follow-up|8|||
161882615|NCT02272842|584612970|FG001|Overall Study|Lost to Follow-up|8|||
161882616|NCT02272842|584612969|FG000|Overall Study|Withdrawal by Subject|8|||
161882617|NCT02272842|584612970|FG001|Overall Study|Withdrawal by Subject|2|||
161882618|NCT01984892|584612973|FG000|Overall Study|Progressive disease|7|||
161882619|NCT04464720|584612974|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
161882620|NCT05723328|584612976|FG000|Overall Study|Investigator's Decision|5|||
161882621|NCT05723328|584612977|FG001|Overall Study|Investigator's Decision|2|||
161882622|NCT04599933|584615032|FG000|Overall Study|Adverse Event|4|||
161882623|NCT04599933|584615033|FG001|Overall Study|Adverse Event|1|||
161882624|NCT04599933|584615032|FG000|Overall Study|Withdrawal by Subject|4|||
161882625|NCT04599933|584615033|FG001|Overall Study|Withdrawal by Subject|2|||
161882626|NCT04599933|584615032|FG000|Overall Study|Lost to Follow-up|0|||
161882627|NCT04599933|584615033|FG001|Overall Study|Lost to Follow-up|1|||
161882628|NCT04599933|584615032|FG000|Overall Study|Physician Decision|0|||
161882629|NCT04599933|584615033|FG001|Overall Study|Physician Decision|1|||
161882630|NCT04599933|584615032|FG000|Overall Study|Screen Failure|1|||
161882631|NCT04599933|584615033|FG001|Overall Study|Screen Failure|2|||
161882632|NCT01358578|584615041|FG000|Induction Period|Adverse Event|2|||
161882633|NCT01358578|584615042|FG001|Induction Period|Adverse Event|4|||
161882634|NCT01358578|584615043|FG002|Induction Period|Adverse Event|2|||
161882635|NCT01358578|584615044|FG003|Induction Period|Adverse Event|6|||
161882636|NCT01358578|584615045|FG004|Induction Period|Adverse Event|0|||
161882637|NCT01358578|584615046|FG005|Induction Period|Adverse Event|0|||
161882638|NCT01358578|584615041|FG000|Induction Period|Lack of Efficacy|0|||
161882639|NCT01358578|584615042|FG001|Induction Period|Lack of Efficacy|0|||
161882640|NCT01358578|584615043|FG002|Induction Period|Lack of Efficacy|9|||
161882641|NCT01358578|584615044|FG003|Induction Period|Lack of Efficacy|1|||
161882642|NCT01358578|584615045|FG004|Induction Period|Lack of Efficacy|0|||
161882643|NCT01358578|584615046|FG005|Induction Period|Lack of Efficacy|0|||
161882644|NCT01358578|584615041|FG000|Induction Period|Lost to Follow-up|0|||
161882645|NCT01358578|584615042|FG001|Induction Period|Lost to Follow-up|0|||
161882646|NCT01358578|584615043|FG002|Induction Period|Lost to Follow-up|1|||
161882647|NCT01358578|584615044|FG003|Induction Period|Lost to Follow-up|4|||
161882648|NCT01358578|584615045|FG004|Induction Period|Lost to Follow-up|0|||
161882649|NCT01358578|584615046|FG005|Induction Period|Lost to Follow-up|0|||
161882650|NCT01358578|584615041|FG000|Induction Period|Physician Decision|2|||
161882651|NCT01358578|584615042|FG001|Induction Period|Physician Decision|1|||
161882652|NCT01358578|584615043|FG002|Induction Period|Physician Decision|2|||
161882653|NCT01358578|584615044|FG003|Induction Period|Physician Decision|0|||
161882654|NCT01358578|584615045|FG004|Induction Period|Physician Decision|0|||
161882655|NCT01358578|584615046|FG005|Induction Period|Physician Decision|0|||
161882656|NCT01358578|584615041|FG000|Induction Period|Protocol Deviation|3|||
161882657|NCT01358578|584615042|FG001|Induction Period|Protocol Deviation|5|||
161882658|NCT01358578|584615043|FG002|Induction Period|Protocol Deviation|0|||
161882659|NCT01358578|584615044|FG003|Induction Period|Protocol Deviation|3|||
161882660|NCT01358578|584615045|FG004|Induction Period|Protocol Deviation|0|||
161882661|NCT01358578|584615046|FG005|Induction Period|Protocol Deviation|0|||
161882662|NCT01358578|584615041|FG000|Induction Period|technical problems|0|||
161882663|NCT01358578|584615042|FG001|Induction Period|technical problems|0|||
161882664|NCT01358578|584615043|FG002|Induction Period|technical problems|1|||
161882665|NCT01358578|584615044|FG003|Induction Period|technical problems|1|||
161882666|NCT01358578|584615045|FG004|Induction Period|technical problems|0|||
161882667|NCT01358578|584615046|FG005|Induction Period|technical problems|0|||
161882668|NCT01358578|584615041|FG000|Induction Period|Withdrawal by Subject|5|||
161882669|NCT01358578|584615042|FG001|Induction Period|Withdrawal by Subject|5|||
161882670|NCT01358578|584615043|FG002|Induction Period|Withdrawal by Subject|10|||
161882671|NCT01358578|584615044|FG003|Induction Period|Withdrawal by Subject|6|||
161882672|NCT01358578|584615045|FG004|Induction Period|Withdrawal by Subject|0|||
161882673|NCT01358578|584615046|FG005|Induction Period|Withdrawal by Subject|0|||
161882674|NCT01358578|584615041|FG000|Maintenance Period|Adverse Event|2|||
161882675|NCT01358578|584615042|FG001|Maintenance Period|Adverse Event|7|||
161882676|NCT01358578|584615043|FG002|Maintenance Period|Adverse Event|0|||
161882677|NCT01358578|584615044|FG003|Maintenance Period|Adverse Event|6|||
161882678|NCT01358578|584615045|FG004|Maintenance Period|Adverse Event|4|||
161882679|NCT01358578|584615046|FG005|Maintenance Period|Adverse Event|3|||
161882680|NCT01358578|584615041|FG000|Maintenance Period|Lack of Efficacy|10|||
161882681|NCT01358578|584615042|FG001|Maintenance Period|Lack of Efficacy|2|||
161882682|NCT01358578|584615043|FG002|Maintenance Period|Lack of Efficacy|0|||
161882683|NCT01358578|584615044|FG003|Maintenance Period|Lack of Efficacy|11|||
161882684|NCT01358578|584615045|FG004|Maintenance Period|Lack of Efficacy|3|||
161882685|NCT01358578|584615046|FG005|Maintenance Period|Lack of Efficacy|0|||
161882686|NCT01358578|584615041|FG000|Maintenance Period|Lost to Follow-up|4|||
161882687|NCT01358578|584615042|FG001|Maintenance Period|Lost to Follow-up|0|||
161882688|NCT01358578|584615043|FG002|Maintenance Period|Lost to Follow-up|0|||
161882689|NCT01358578|584615044|FG003|Maintenance Period|Lost to Follow-up|5|||
161882690|NCT01358578|584615045|FG004|Maintenance Period|Lost to Follow-up|1|||
161882691|NCT01358578|584615046|FG005|Maintenance Period|Lost to Follow-up|1|||
161882692|NCT01358578|584615041|FG000|Maintenance Period|Non-compliance with study treatment|3|||
161882693|NCT01358578|584615042|FG001|Maintenance Period|Non-compliance with study treatment|1|||
161882694|NCT01358578|584615043|FG002|Maintenance Period|Non-compliance with study treatment|0|||
161882695|NCT01358578|584615044|FG003|Maintenance Period|Non-compliance with study treatment|2|||
161882696|NCT01358578|584615045|FG004|Maintenance Period|Non-compliance with study treatment|1|||
161882697|NCT01358578|584615046|FG005|Maintenance Period|Non-compliance with study treatment|2|||
161882698|NCT01358578|584615041|FG000|Maintenance Period|Physician Decision|0|||
161882699|NCT01358578|584615042|FG001|Maintenance Period|Physician Decision|1|||
161882700|NCT01358578|584615043|FG002|Maintenance Period|Physician Decision|0|||
161882701|NCT01358578|584615044|FG003|Maintenance Period|Physician Decision|1|||
161882702|NCT01358578|584615045|FG004|Maintenance Period|Physician Decision|0|||
161882703|NCT01358578|584615046|FG005|Maintenance Period|Physician Decision|0|||
161882704|NCT01358578|584615041|FG000|Maintenance Period|Pregnancy|1|||
161882705|NCT01358578|584615042|FG001|Maintenance Period|Pregnancy|0|||
161882706|NCT01358578|584615043|FG002|Maintenance Period|Pregnancy|0|||
161882707|NCT01358578|584615044|FG003|Maintenance Period|Pregnancy|0|||
161882708|NCT01358578|584615045|FG004|Maintenance Period|Pregnancy|0|||
161882709|NCT01358578|584615046|FG005|Maintenance Period|Pregnancy|0|||
161778739|NCT05013749|584232318|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
161778740|NCT05013749|584232319|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
161778741|NCT05013749|584232318|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
161778742|NCT05013749|584232319|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
161778743|NCT02858076|584232320|FG000|Overall Study|Death|6|||
161778744|NCT02858076|584232321|FG001|Overall Study|Death|3|||
161778745|NCT02858076|584232320|FG000|Overall Study|Withdrawal by Subject|1|||
161778746|NCT02858076|584232321|FG001|Overall Study|Withdrawal by Subject|5|||
161778747|NCT02858076|584232320|FG000|Overall Study|Lost to Follow-up|2|||
161778748|NCT02858076|584232321|FG001|Overall Study|Lost to Follow-up|7|||
161778749|NCT02858076|584232320|FG000|Overall Study|Completed Out of Window|1|||
161778750|NCT02858076|584232321|FG001|Overall Study|Completed Out of Window|3|||
161778751|NCT02643394|584232322|FG000|Overall Study|Protocol Violation|4|||
161778752|NCT02643394|584232323|FG001|Overall Study|Protocol Violation|5|||
161778753|NCT00943384|584232324|FG000|Overall Study|Dispositioned prior to treatment|23|||
161778754|NCT00943384|584232324|FG000|Overall Study|Treated off protocol-protocol violation|5|||
161778755|NCT00943384|584232324|FG000|Overall Study|Lost to Follow-up|16|||
161778756|NCT00943384|584232324|FG000|Overall Study|Withdrawal by Subject|5|||
161778757|NCT00096200|584232325|FG000|Overall Study|Adverse Event|0|||
161778758|NCT00096200|584232326|FG001|Overall Study|Adverse Event|4|||
161778759|NCT00096200|584232327|FG002|Overall Study|Adverse Event|0|||
161778760|NCT00096200|584232325|FG000|Overall Study|Withdrawal by Subject|1|||
161778761|NCT00096200|584232326|FG001|Overall Study|Withdrawal by Subject|2|||
161778762|NCT00096200|584232327|FG002|Overall Study|Withdrawal by Subject|0|||
161778763|NCT00096200|584232325|FG000|Overall Study|Ineligible pathology|0|||
161778764|NCT00096200|584232326|FG001|Overall Study|Ineligible pathology|1|||
161778765|NCT00096200|584232327|FG002|Overall Study|Ineligible pathology|0|||
161778766|NCT00077766|584232329|FG000|Overall Study|Adverse Event|1|||
161778767|NCT00077766|584232330|FG001|Overall Study|Adverse Event|1|||
161778768|NCT00077766|584232329|FG000|Overall Study|Withdrawal by Subject|4|||
161778769|NCT00077766|584232330|FG001|Overall Study|Withdrawal by Subject|3|||
161778770|NCT00077766|584232329|FG000|Overall Study|Death|12|||
161778771|NCT00077766|584232330|FG001|Overall Study|Death|10|||
161778772|NCT00077766|584232329|FG000|Overall Study|Lost to Follow-up|2|||
161778773|NCT00077766|584232330|FG001|Overall Study|Lost to Follow-up|0|||
161778774|NCT00077766|584232329|FG000|Overall Study|Protocol Violation|1|||
161778775|NCT00077766|584232330|FG001|Overall Study|Protocol Violation|0|||
161778776|NCT00077766|584232329|FG000|Overall Study|Kidney Transplantation|9|||
161778777|NCT00077766|584232330|FG001|Overall Study|Kidney Transplantation|5|||
161778778|NCT00077766|584232329|FG000|Overall Study|Transplantation|5|||
161778779|NCT00077766|584232330|FG001|Overall Study|Transplantation|1|||
161778780|NCT00077766|584232329|FG000|Overall Study|Investigators Discretion|1|||
161778781|NCT00077766|584232330|FG001|Overall Study|Investigators Discretion|0|||
161778782|NCT00077766|584232329|FG000|Overall Study|Participant's decision|1|||
161778783|NCT00077766|584232330|FG001|Overall Study|Participant's decision|0|||
161778784|NCT00077766|584232329|FG000|Overall Study|Dialysis Discontinued|1|||
161778785|NCT00077766|584232330|FG001|Overall Study|Dialysis Discontinued|0|||
161778786|NCT00077766|584232329|FG000|Overall Study|Dialysis|0|||
161778787|NCT00077766|584232330|FG001|Overall Study|Dialysis|1|||
161778788|NCT00077766|584232329|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
161778789|NCT00077766|584232330|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
161778790|NCT00077766|584232329|FG000|Overall Study|Started Nocturnal Dialysis|0|||
161778791|NCT00077766|584232330|FG001|Overall Study|Started Nocturnal Dialysis|1|||
161778792|NCT00077766|584232329|FG000|Overall Study|Stop Dialysis|0|||
161778793|NCT00077766|584232330|FG001|Overall Study|Stop Dialysis|1|||
161778794|NCT00077766|584232329|FG000|Overall Study|Participants Vacation|2|||
161778795|NCT00077766|584232330|FG001|Overall Study|Participants Vacation|1|||
161778796|NCT00938015|584232331|FG000|Overall Study|Death|2|||
161778797|NCT00938015|584232331|FG000|Overall Study|Lost to Follow-up|32|||
161778798|NCT00938015|584232331|FG000|Overall Study|Adverse Event|32|||
161778799|NCT00938015|584232331|FG000|Overall Study|Non-responder|52|||
161778800|NCT00938015|584232331|FG000|Overall Study|Reason not related to Etanercept|29|||
161778801|NCT02341482|584232332|FG000|Overall Study|Adverse Event|1|||
161778802|NCT03186794|584232333|FG000|Overall Study|Physician Decision|2|||
161778803|NCT03186794|584232333|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
161778804|NCT02575807|584232338|FG000|Overall Study|Death|8|||
161778805|NCT02575807|584232339|FG001|Overall Study|Death|3|||
161778806|NCT02575807|584232340|FG002|Overall Study|Death|7|||
161778807|NCT02575807|584232341|FG003|Overall Study|Death|0|||
161778808|NCT02575807|584232342|FG004|Overall Study|Death|1|||
161778809|NCT02575807|584232338|FG000|Overall Study|Study terminated by Sponsor|0|||
161778810|NCT02575807|584232339|FG001|Overall Study|Study terminated by Sponsor|1|||
161778811|NCT02575807|584232340|FG002|Overall Study|Study terminated by Sponsor|7|||
161778812|NCT02575807|584232341|FG003|Overall Study|Study terminated by Sponsor|0|||
161778813|NCT02575807|584232342|FG004|Overall Study|Study terminated by Sponsor|1|||
161778814|NCT02575807|584232338|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
161778815|NCT02575807|584232339|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
161778816|NCT02575807|584232340|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
161778817|NCT02575807|584232341|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
161778818|NCT02575807|584232342|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
161778819|NCT02575807|584232338|FG000|Overall Study|Terminated due to physician decision|0|||
161778820|NCT02575807|584232339|FG001|Overall Study|Terminated due to physician decision|0|||
161882710|NCT01358578|584615041|FG000|Maintenance Period|Protocol deviation|7|||
161882711|NCT01358578|584615042|FG001|Maintenance Period|Protocol deviation|4|||
161882712|NCT01358578|584615043|FG002|Maintenance Period|Protocol deviation|0|||
161882713|NCT01358578|584615044|FG003|Maintenance Period|Protocol deviation|2|||
161882714|NCT01358578|584615045|FG004|Maintenance Period|Protocol deviation|2|||
161882715|NCT01358578|584615046|FG005|Maintenance Period|Protocol deviation|2|||
161882716|NCT01358578|584615041|FG000|Maintenance Period|Withdrawal by Subject|12|||
161882717|NCT01358578|584615042|FG001|Maintenance Period|Withdrawal by Subject|7|||
161882718|NCT01358578|584615043|FG002|Maintenance Period|Withdrawal by Subject|2|||
161882719|NCT01358578|584615044|FG003|Maintenance Period|Withdrawal by Subject|15|||
161882720|NCT01358578|584615045|FG004|Maintenance Period|Withdrawal by Subject|6|||
161882721|NCT01358578|584615046|FG005|Maintenance Period|Withdrawal by Subject|3|||
161882722|NCT01358578|584615041|FG000|Follow-up Period|Adverse Event|1|||
161882723|NCT01358578|584615042|FG001|Follow-up Period|Adverse Event|1|||
161882724|NCT01358578|584615043|FG002|Follow-up Period|Adverse Event|0|||
161882725|NCT01358578|584615044|FG003|Follow-up Period|Adverse Event|0|||
161882726|NCT01358578|584615045|FG004|Follow-up Period|Adverse Event|0|||
161882727|NCT01358578|584615046|FG005|Follow-up Period|Adverse Event|0|||
161882728|NCT01358578|584615041|FG000|Follow-up Period|Lack of Efficacy|3|||
161882729|NCT01358578|584615042|FG001|Follow-up Period|Lack of Efficacy|0|||
161882730|NCT01358578|584615043|FG002|Follow-up Period|Lack of Efficacy|4|||
161882731|NCT01358578|584615044|FG003|Follow-up Period|Lack of Efficacy|1|||
161882732|NCT01358578|584615045|FG004|Follow-up Period|Lack of Efficacy|0|||
161882733|NCT01358578|584615046|FG005|Follow-up Period|Lack of Efficacy|0|||
161882734|NCT01358578|584615041|FG000|Follow-up Period|Lost to Follow-up|0|||
161882735|NCT01358578|584615042|FG001|Follow-up Period|Lost to Follow-up|1|||
161882736|NCT01358578|584615043|FG002|Follow-up Period|Lost to Follow-up|0|||
161882737|NCT01358578|584615044|FG003|Follow-up Period|Lost to Follow-up|4|||
161882738|NCT01358578|584615045|FG004|Follow-up Period|Lost to Follow-up|0|||
161882739|NCT01358578|584615046|FG005|Follow-up Period|Lost to Follow-up|0|||
161882740|NCT01358578|584615041|FG000|Follow-up Period|non- compliance with study treatment|1|||
161882741|NCT01358578|584615042|FG001|Follow-up Period|non- compliance with study treatment|0|||
161882742|NCT01358578|584615043|FG002|Follow-up Period|non- compliance with study treatment|0|||
161882743|NCT01358578|584615044|FG003|Follow-up Period|non- compliance with study treatment|0|||
161882744|NCT01358578|584615045|FG004|Follow-up Period|non- compliance with study treatment|0|||
161882745|NCT01358578|584615046|FG005|Follow-up Period|non- compliance with study treatment|0|||
161882746|NCT01358578|584615041|FG000|Follow-up Period|Pregnancy|1|||
161882747|NCT01358578|584615042|FG001|Follow-up Period|Pregnancy|0|||
161882748|NCT01358578|584615043|FG002|Follow-up Period|Pregnancy|0|||
161882749|NCT01358578|584615044|FG003|Follow-up Period|Pregnancy|0|||
161882750|NCT01358578|584615045|FG004|Follow-up Period|Pregnancy|0|||
161882751|NCT01358578|584615046|FG005|Follow-up Period|Pregnancy|0|||
161882752|NCT01358578|584615041|FG000|Follow-up Period|Withdrawal by Subject|3|||
161882753|NCT01358578|584615042|FG001|Follow-up Period|Withdrawal by Subject|3|||
161882754|NCT01358578|584615043|FG002|Follow-up Period|Withdrawal by Subject|1|||
161882755|NCT01358578|584615044|FG003|Follow-up Period|Withdrawal by Subject|12|||
161882756|NCT01358578|584615045|FG004|Follow-up Period|Withdrawal by Subject|0|||
161882757|NCT01358578|584615046|FG005|Follow-up Period|Withdrawal by Subject|0|||
161882758|NCT01358578|584615041|FG000|Follow-up Period|Physician Decision|1|||
161882759|NCT01358578|584615042|FG001|Follow-up Period|Physician Decision|1|||
161882760|NCT01358578|584615043|FG002|Follow-up Period|Physician Decision|0|||
161882761|NCT01358578|584615044|FG003|Follow-up Period|Physician Decision|2|||
161882762|NCT01358578|584615045|FG004|Follow-up Period|Physician Decision|0|||
161882763|NCT01358578|584615046|FG005|Follow-up Period|Physician Decision|0|||
161882764|NCT01643798|584615047|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
161882765|NCT01643798|584615048|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
161882766|NCT03605849|584615049|FG000|Overall Study|Adverse Event|20|||
161882767|NCT03605849|584615050|FG001|Overall Study|Adverse Event|21|||
161882768|NCT03605849|584615051|FG002|Overall Study|Adverse Event|29|||
161882769|NCT03605849|584615052|FG003|Overall Study|Adverse Event|11|||
161882770|NCT03605849|584615049|FG000|Overall Study|Lack of Efficacy|4|||
161882771|NCT03605849|584615050|FG001|Overall Study|Lack of Efficacy|7|||
161882772|NCT03605849|584615051|FG002|Overall Study|Lack of Efficacy|9|||
161882773|NCT03605849|584615052|FG003|Overall Study|Lack of Efficacy|2|||
161778821|NCT02575807|584232340|FG002|Overall Study|Terminated due to physician decision|1|||
161882774|NCT03605849|584615049|FG000|Overall Study|Lost to Follow-up|8|||
161882775|NCT03605849|584615050|FG001|Overall Study|Lost to Follow-up|8|||
161882776|NCT03605849|584615051|FG002|Overall Study|Lost to Follow-up|14|||
161882777|NCT03605849|584615052|FG003|Overall Study|Lost to Follow-up|11|||
161882778|NCT03605849|584615049|FG000|Overall Study|Non-compliance With IMP|6|||
161882779|NCT03605849|584615050|FG001|Overall Study|Non-compliance With IMP|5|||
161882780|NCT03605849|584615051|FG002|Overall Study|Non-compliance With IMP|2|||
161882781|NCT03605849|584615052|FG003|Overall Study|Non-compliance With IMP|1|||
161882782|NCT03605849|584615049|FG000|Overall Study|Protocol Deviation|1|||
161882783|NCT03605849|584615050|FG001|Overall Study|Protocol Deviation|2|||
161882784|NCT03605849|584615051|FG002|Overall Study|Protocol Deviation|1|||
161882785|NCT03605849|584615052|FG003|Overall Study|Protocol Deviation|3|||
161882786|NCT03605849|584615049|FG000|Overall Study|Withdrawal by Subject|33|||
161882787|NCT03605849|584615050|FG001|Overall Study|Withdrawal by Subject|28|||
161882788|NCT03605849|584615051|FG002|Overall Study|Withdrawal by Subject|30|||
161882789|NCT03605849|584615052|FG003|Overall Study|Withdrawal by Subject|28|||
161882790|NCT03605849|584615049|FG000|Overall Study|Site Terminated by Sponsor|0|||
161882791|NCT03605849|584615050|FG001|Overall Study|Site Terminated by Sponsor|0|||
161882792|NCT03605849|584615051|FG002|Overall Study|Site Terminated by Sponsor|0|||
161882793|NCT03605849|584615052|FG003|Overall Study|Site Terminated by Sponsor|1|||
161882794|NCT03605849|584615049|FG000|Overall Study|Physician Decision|2|||
161882795|NCT03605849|584615050|FG001|Overall Study|Physician Decision|1|||
161882796|NCT03605849|584615051|FG002|Overall Study|Physician Decision|2|||
161882797|NCT03605849|584615052|FG003|Overall Study|Physician Decision|1|||
161882798|NCT03605849|584615049|FG000|Overall Study|Enrolled, but not Treated|2|||
161882799|NCT03605849|584615050|FG001|Overall Study|Enrolled, but not Treated|2|||
161882800|NCT03605849|584615051|FG002|Overall Study|Enrolled, but not Treated|3|||
161882801|NCT03605849|584615052|FG003|Overall Study|Enrolled, but not Treated|2|||
161882802|NCT03605849|584615049|FG000|Overall Study|Other (COVID-19 Related)|0|||
161882803|NCT03605849|584615050|FG001|Overall Study|Other (COVID-19 Related)|1|||
161882804|NCT03605849|584615051|FG002|Overall Study|Other (COVID-19 Related)|1|||
161882805|NCT03605849|584615052|FG003|Overall Study|Other (COVID-19 Related)|0|||
161882806|NCT03605849|584615049|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
161882807|NCT03605849|584615050|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
161882808|NCT03605849|584615051|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
161882809|NCT03605849|584615052|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
161882810|NCT05014815|584615053|FG000|Overall Study|Death|63|||
161882811|NCT05014815|584615054|FG001|Overall Study|Death|70|||
161882812|NCT05014815|584615053|FG000|Overall Study|Withdrawal by Subject|10|||
161882813|NCT05014815|584615054|FG001|Overall Study|Withdrawal by Subject|10|||
161882814|NCT05014815|584615053|FG000|Overall Study|Lost to Follow-up|4|||
161882815|NCT05014815|584615054|FG001|Overall Study|Lost to Follow-up|2|||
161882816|NCT05014815|584615053|FG000|Overall Study|Physician Decision|2|||
161882817|NCT05014815|584615054|FG001|Overall Study|Physician Decision|4|||
161882818|NCT06303167|584615065|FG000|Overall Study|Ineligible|1|||
161882819|NCT06303167|584615065|FG000|Overall Study|Never start protocol therapy|2|||
161882820|NCT06303167|584615065|FG000|Overall Study|Disease progression|16|||
161882821|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Death|117|||
161882822|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Death|197|||
161882823|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
161882824|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
161882825|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
161882826|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
161882827|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
161882828|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
161882829|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
161882830|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
161882831|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
161882832|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
161882833|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
161882834|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
161882835|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
161882836|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
161882837|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
161882838|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
161882839|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
161882840|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
161882841|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
161882842|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
161882843|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
161882844|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
161882845|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
161882846|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
161882847|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
161882848|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
161882849|NCT00655733|584615073|FG000|Overall Study|Lost to Follow-up|2|||
161882850|NCT00655733|584615074|FG001|Overall Study|Lost to Follow-up|2|||
161882851|NCT00655733|584615073|FG000|Overall Study|Adverse Event|2|||
161882852|NCT00655733|584615074|FG001|Overall Study|Adverse Event|2|||
161882853|NCT00655733|584615073|FG000|Overall Study|Withdrawal by Subject|3|||
161882854|NCT00655733|584615074|FG001|Overall Study|Withdrawal by Subject|3|||
161882855|NCT00655733|584615073|FG000|Overall Study|Physician Decision|0|||
161882856|NCT00655733|584615074|FG001|Overall Study|Physician Decision|1|||
161882857|NCT01482962|584615078|FG000|Overall Study|Progressive Disease|65|||
161882858|NCT01482962|584615079|FG001|Overall Study|Progressive Disease|53|||
161882859|NCT01482962|584615078|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
161882860|NCT01482962|584615079|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
161882861|NCT01482962|584615078|FG000|Overall Study|Adverse Event|18|||
161882862|NCT01482962|584615079|FG001|Overall Study|Adverse Event|22|||
161882863|NCT01482962|584615078|FG000|Overall Study|Withdrawal by Participant|8|||
161882864|NCT01482962|584615079|FG001|Overall Study|Withdrawal by Participant|13|||
161882865|NCT01482962|584615078|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
161882866|NCT01482962|584615079|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
161882867|NCT01482962|584615078|FG000|Overall Study|Other Reason|1|||
161882868|NCT01482962|584615079|FG001|Overall Study|Other Reason|5|||
161882869|NCT01482962|584615078|FG000|Overall Study|Study Terminated by Sponsor|5|||
161882870|NCT01482962|584615079|FG001|Overall Study|Study Terminated by Sponsor|2|||
161882871|NCT01482962|584615078|FG000|Overall Study|Did not Receive Study Drug|1|||
161882872|NCT01482962|584615079|FG001|Overall Study|Did not Receive Study Drug|6|||
161882873|NCT02407457|584615080|FG000|1 Month|Death|3|||
161882874|NCT02407457|584615081|FG001|1 Month|Death|0|||
161882875|NCT02407457|584615080|FG000|1 Month|Lost to Follow-up|1|||
161882876|NCT02407457|584615081|FG001|1 Month|Lost to Follow-up|1|||
161882877|NCT02407457|584615080|FG000|1 Month|missed visit|2|||
161882878|NCT02407457|584615081|FG001|1 Month|missed visit|5|||
161882879|NCT02407457|584615080|FG000|6-Month|Death|2|||
161882880|NCT02407457|584615081|FG001|6-Month|Death|8|||
161882881|NCT02407457|584615080|FG000|6-Month|Lost to Follow-up|2|||
161882882|NCT02407457|584615081|FG001|6-Month|Lost to Follow-up|2|||
161882883|NCT02407457|584615080|FG000|6-Month|missed visit|16|||
161882884|NCT02407457|584615081|FG001|6-Month|missed visit|14|||
161882885|NCT02407457|584615080|FG000|6-Month|Open Repair|0|||
161882886|NCT02407457|584615081|FG001|6-Month|Open Repair|1|||
161882887|NCT02407457|584615080|FG000|1 Year|Death|6|||
161882888|NCT02407457|584615081|FG001|1 Year|Death|11|||
161882889|NCT02407457|584615080|FG000|1 Year|Lost to Follow-up|3|||
161882890|NCT02407457|584615081|FG001|1 Year|Lost to Follow-up|2|||
161882891|NCT02407457|584615080|FG000|1 Year|Missed Visit|24|||
161882892|NCT02407457|584615081|FG001|1 Year|Missed Visit|14|||
161882893|NCT02407457|584615080|FG000|1 Year|Open Repair|0|||
161882894|NCT02407457|584615081|FG001|1 Year|Open Repair|1|||
161882895|NCT02407457|584615080|FG000|2-year|Death|14|||
161882896|NCT02407457|584615081|FG001|2-year|Death|8|||
161882897|NCT02407457|584615080|FG000|2-year|Lost to Follow-up|7|||
161882898|NCT02407457|584615081|FG001|2-year|Lost to Follow-up|10|||
161882899|NCT02407457|584615080|FG000|2-year|Missed Visit|13|||
161882900|NCT02407457|584615081|FG001|2-year|Missed Visit|15|||
161882901|NCT02407457|584615080|FG000|2-year|Open Repair|0|||
161882902|NCT02407457|584615081|FG001|2-year|Open Repair|2|||
161882903|NCT02407457|584615080|FG000|3-year|Death|11|||
161882904|NCT02407457|584615081|FG001|3-year|Death|10|||
161882905|NCT02407457|584615080|FG000|3-year|Lost to Follow-up|9|||
161778822|NCT02575807|584232341|FG003|Overall Study|Terminated due to physician decision|0|||
161778823|NCT02575807|584232342|FG004|Overall Study|Terminated due to physician decision|0|||
161778824|NCT02575807|584232338|FG000|Overall Study|Subject ineligible - medical implant|0|||
161778825|NCT02575807|584232339|FG001|Overall Study|Subject ineligible - medical implant|0|||
161778826|NCT02575807|584232340|FG002|Overall Study|Subject ineligible - medical implant|0|||
161778827|NCT02575807|584232341|FG003|Overall Study|Subject ineligible - medical implant|1|||
161778828|NCT02575807|584232342|FG004|Overall Study|Subject ineligible - medical implant|0|||
161778829|NCT02575807|584232338|FG000|Overall Study|Withdrawal by Subject|0|||
161778830|NCT02575807|584232339|FG001|Overall Study|Withdrawal by Subject|0|||
161778831|NCT02575807|584232340|FG002|Overall Study|Withdrawal by Subject|1|||
161778832|NCT02575807|584232341|FG003|Overall Study|Withdrawal by Subject|1|||
161778833|NCT02575807|584232342|FG004|Overall Study|Withdrawal by Subject|2|||
161778834|NCT02180659|584232343|FG000|Overall Study|Adverse Event|1|||
161778835|NCT02180659|584232344|FG001|Overall Study|Adverse Event|0|||
161778836|NCT02180659|584232343|FG000|Overall Study|Lost to Follow-up|4|||
161778837|NCT02180659|584232344|FG001|Overall Study|Lost to Follow-up|2|||
161778838|NCT02180659|584232343|FG000|Overall Study|Subject incarcerated during conduct|1|||
161778839|NCT02180659|584232344|FG001|Overall Study|Subject incarcerated during conduct|0|||
161778840|NCT02180659|584232343|FG000|Overall Study|Withdrawal by Subject|0|||
161778841|NCT02180659|584232344|FG001|Overall Study|Withdrawal by Subject|2|||
161778842|NCT02180659|584232343|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
161778843|NCT02180659|584232344|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
161778844|NCT01154673|584232345|FG000|Overall Study|Lost to Follow-up|1|||
161882906|NCT02407457|584615081|FG001|3-year|Lost to Follow-up|10|||
161882907|NCT02407457|584615080|FG000|3-year|Missed Visit|19|||
161882908|NCT02407457|584615081|FG001|3-year|Missed Visit|16|||
161882909|NCT02407457|584615080|FG000|4-year|Death|18|||
161882910|NCT02407457|584615081|FG001|4-year|Death|10|||
161882911|NCT02407457|584615080|FG000|4-year|Lost to Follow-up|10|||
161882912|NCT02407457|584615081|FG001|4-year|Lost to Follow-up|12|||
161882913|NCT02407457|584615080|FG000|4-year|Missed Visit|18|||
161882914|NCT02407457|584615081|FG001|4-year|Missed Visit|16|||
161882915|NCT02407457|584615080|FG000|5-year|Death|10|||
161882916|NCT02407457|584615081|FG001|5-year|Death|3|||
161882917|NCT02407457|584615080|FG000|5-year|Lost to Follow-up|22|||
161882918|NCT02407457|584615081|FG001|5-year|Lost to Follow-up|13|||
161882919|NCT02407457|584615080|FG000|5-year|Missed Visit|9|||
161882920|NCT02407457|584615081|FG001|5-year|Missed Visit|1|||
161882921|NCT02954653|584615084|FG000|Overall Study|Death|3|||
161882922|NCT02954653|584615085|FG001|Overall Study|Death|1|||
161882923|NCT02954653|584615086|FG002|Overall Study|Death|0|||
161882924|NCT02954653|584615087|FG003|Overall Study|Death|0|||
161882925|NCT02954653|584615088|FG004|Overall Study|Death|0|||
161882926|NCT02954653|584615089|FG005|Overall Study|Death|0|||
161882927|NCT02954653|584615090|FG006|Overall Study|Death|0|||
161882928|NCT02954653|584615091|FG007|Overall Study|Death|0|||
161882929|NCT02954653|584615092|FG008|Overall Study|Death|0|||
161882930|NCT02954653|584615084|FG000|Overall Study|Randomized but did not receive treatment|1|||
161882931|NCT02954653|584615085|FG001|Overall Study|Randomized but did not receive treatment|0|||
161882932|NCT02954653|584615086|FG002|Overall Study|Randomized but did not receive treatment|0|||
161882933|NCT02954653|584615087|FG003|Overall Study|Randomized but did not receive treatment|0|||
161882934|NCT02954653|584615088|FG004|Overall Study|Randomized but did not receive treatment|0|||
161882935|NCT02954653|584615089|FG005|Overall Study|Randomized but did not receive treatment|0|||
161882936|NCT02954653|584615090|FG006|Overall Study|Randomized but did not receive treatment|0|||
161882937|NCT02954653|584615091|FG007|Overall Study|Randomized but did not receive treatment|0|||
161882938|NCT02954653|584615092|FG008|Overall Study|Randomized but did not receive treatment|0|||
161882939|NCT02954653|584615084|FG000|Overall Study|Started another anti-cancer therapy|0|||
161882940|NCT02954653|584615085|FG001|Overall Study|Started another anti-cancer therapy|1|||
161882941|NCT02954653|584615086|FG002|Overall Study|Started another anti-cancer therapy|0|||
161882942|NCT02954653|584615087|FG003|Overall Study|Started another anti-cancer therapy|0|||
161882943|NCT02954653|584615088|FG004|Overall Study|Started another anti-cancer therapy|0|||
161882944|NCT02954653|584615089|FG005|Overall Study|Started another anti-cancer therapy|0|||
161882945|NCT02954653|584615090|FG006|Overall Study|Started another anti-cancer therapy|0|||
161882946|NCT02954653|584615091|FG007|Overall Study|Started another anti-cancer therapy|0|||
161882947|NCT02954653|584615092|FG008|Overall Study|Started another anti-cancer therapy|0|||
161882948|NCT02954653|584615084|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
161882949|NCT02954653|584615085|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
161882950|NCT02954653|584615086|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
161882951|NCT02954653|584615087|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
161882952|NCT02954653|584615088|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
161882953|NCT02954653|584615089|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
161882954|NCT02954653|584615090|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
161882955|NCT02954653|584615091|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
161882956|NCT02954653|584615092|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
161882957|NCT04329091|584615095|FG000|Overall Study|Physician Decision|5|||
161882958|NCT01210495|584615098|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
161882959|NCT01210495|584615099|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
161882960|NCT01210495|584615100|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
161882961|NCT01210495|584615101|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
161882962|NCT01210495|584615098|FG000|Overall Study|Death|14|||
161882963|NCT01210495|584615099|FG001|Overall Study|Death|7|||
161882964|NCT01210495|584615100|FG002|Overall Study|Death|112|||
161882965|NCT01210495|584615101|FG003|Overall Study|Death|54|||
161778845|NCT01154673|584232346|FG001|Overall Study|Lost to Follow-up|0|||
161778846|NCT01154673|584232345|FG000|Overall Study|moved out of province|1|||
161778847|NCT01154673|584232346|FG001|Overall Study|moved out of province|0|||
161778848|NCT00518011|584232347|FG000|Overall Study|Death|1|||
161778849|NCT00518011|584232348|FG001|Overall Study|Death|1|||
161778850|NCT00518011|584232347|FG000|Overall Study|Adverse Event|2|||
161778851|NCT00518011|584232348|FG001|Overall Study|Adverse Event|3|||
161778852|NCT00518011|584232347|FG000|Overall Study|Disease Progression|2|||
161778853|NCT00518011|584232348|FG001|Overall Study|Disease Progression|2|||
161778854|NCT00518011|584232347|FG000|Overall Study|Other Reasons|3|||
161778855|NCT00518011|584232348|FG001|Overall Study|Other Reasons|2|||
161778856|NCT00518011|584232347|FG000|Overall Study|Withdrawal by Subject|1|||
161778857|NCT00518011|584232348|FG001|Overall Study|Withdrawal by Subject|0|||
161778858|NCT00090259|584232349|FG000|Overall Study|Lost to Follow-up|30|||
161778859|NCT00090259|584232350|FG001|Overall Study|Lost to Follow-up|26|||
161778860|NCT00090259|584232349|FG000|Overall Study|Withdrawal by Subject|21|||
161882966|NCT01210495|584615098|FG000|Overall Study|Study Terminated by Sponsor|0|||
161882967|NCT01210495|584615099|FG001|Overall Study|Study Terminated by Sponsor|0|||
161882968|NCT01210495|584615100|FG002|Overall Study|Study Terminated by Sponsor|4|||
161882969|NCT01210495|584615101|FG003|Overall Study|Study Terminated by Sponsor|11|||
161882970|NCT01210495|584615098|FG000|Overall Study|Lost to Follow-up|0|||
161882971|NCT01210495|584615099|FG001|Overall Study|Lost to Follow-up|0|||
161882972|NCT01210495|584615100|FG002|Overall Study|Lost to Follow-up|1|||
161882973|NCT01210495|584615101|FG003|Overall Study|Lost to Follow-up|1|||
161882974|NCT01210495|584615098|FG000|Overall Study|Other unspecified|0|||
161882975|NCT01210495|584615099|FG001|Overall Study|Other unspecified|0|||
161882976|NCT01210495|584615100|FG002|Overall Study|Other unspecified|6|||
161882977|NCT01210495|584615101|FG003|Overall Study|Other unspecified|0|||
161882978|NCT04489381|584615112|FG000|Overall Study|Lost to Follow-up|2|||
161882979|NCT04489381|584615113|FG001|Overall Study|Lost to Follow-up|3|||
161882980|NCT04489381|584615112|FG000|Overall Study|Withdrawal by Subject|1|||
161882981|NCT04489381|584615113|FG001|Overall Study|Withdrawal by Subject|0|||
161882982|NCT03199612|584615114|FG000|Overall Study|Adverse Event|1|||
161882983|NCT03199612|584615115|FG001|Overall Study|Adverse Event|0|||
161882984|NCT02543892|584615116|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
161882985|NCT02543892|584615117|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
161882986|NCT02543892|584615118|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
161882987|NCT02543892|584615119|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
161882988|NCT02543892|584615120|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
161882989|NCT02543892|584615121|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
161882990|NCT02543892|584615122|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
161882991|NCT02543892|584615123|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
161882992|NCT02543892|584615116|FG000|Received Vaccination 2|Physician Decision|0|||
161882993|NCT02543892|584615117|FG001|Received Vaccination 2|Physician Decision|0|||
161882994|NCT02543892|584615118|FG002|Received Vaccination 2|Physician Decision|0|||
161882995|NCT02543892|584615119|FG003|Received Vaccination 2|Physician Decision|0|||
161882996|NCT02543892|584615120|FG004|Received Vaccination 2|Physician Decision|0|||
161882997|NCT02543892|584615121|FG005|Received Vaccination 2|Physician Decision|1|||
161882998|NCT02543892|584615122|FG006|Received Vaccination 2|Physician Decision|0|||
161882999|NCT02543892|584615123|FG007|Received Vaccination 2|Physician Decision|0|||
161883000|NCT02543892|584615116|FG000|Received Vaccination 2|Adverse Event|0|||
161883001|NCT02543892|584615117|FG001|Received Vaccination 2|Adverse Event|1|||
161883002|NCT02543892|584615118|FG002|Received Vaccination 2|Adverse Event|0|||
161883003|NCT02543892|584615119|FG003|Received Vaccination 2|Adverse Event|0|||
161883004|NCT02543892|584615120|FG004|Received Vaccination 2|Adverse Event|0|||
161883005|NCT02543892|584615121|FG005|Received Vaccination 2|Adverse Event|0|||
161883006|NCT02543892|584615122|FG006|Received Vaccination 2|Adverse Event|0|||
161883007|NCT02543892|584615123|FG007|Received Vaccination 2|Adverse Event|0|||
161883008|NCT02543892|584615116|FG000|Had Immunology Data|Withdrawal by Subject|0|||
161883009|NCT02543892|584615117|FG001|Had Immunology Data|Withdrawal by Subject|0|||
161883010|NCT02543892|584615118|FG002|Had Immunology Data|Withdrawal by Subject|0|||
161883011|NCT02543892|584615119|FG003|Had Immunology Data|Withdrawal by Subject|0|||
161883012|NCT02543892|584615120|FG004|Had Immunology Data|Withdrawal by Subject|0|||
161883013|NCT02543892|584615121|FG005|Had Immunology Data|Withdrawal by Subject|0|||
161883014|NCT02543892|584615122|FG006|Had Immunology Data|Withdrawal by Subject|1|||
161883015|NCT02543892|584615123|FG007|Had Immunology Data|Withdrawal by Subject|0|||
161883016|NCT01199822|584615126|FG000|Overall Study|Investigator discontinued therapy|0|||
161883017|NCT01199822|584615127|FG001|Overall Study|Investigator discontinued therapy|1|||
161883018|NCT01199822|584615128|FG002|Overall Study|Investigator discontinued therapy|0|||
161883019|NCT01500213|584615129|FG000|Overall Study|Adverse Event|35|||
161883020|NCT01500213|584615130|FG001|Overall Study|Adverse Event|35|||
161883021|NCT01500213|584615129|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
161883022|NCT01500213|584615130|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
161883023|NCT01500213|584615129|FG000|Overall Study|Withdrawal by Subject|28|||
161883024|NCT01500213|584615130|FG001|Overall Study|Withdrawal by Subject|37|||
161883025|NCT01500213|584615129|FG000|Overall Study|Death|7|||
161883026|NCT01500213|584615130|FG001|Overall Study|Death|3|||
161883027|NCT01500213|584615129|FG000|Overall Study|Disease Progression|13|||
161883028|NCT01500213|584615130|FG001|Overall Study|Disease Progression|21|||
161883029|NCT01500213|584615129|FG000|Overall Study|Protocol Violation|19|||
161883030|NCT01500213|584615130|FG001|Overall Study|Protocol Violation|19|||
161883031|NCT01500213|584615129|FG000|Overall Study|Physician Decision|12|||
161883032|NCT01500213|584615130|FG001|Overall Study|Physician Decision|10|||
161883033|NCT01500213|584615129|FG000|Overall Study|Lack of Efficacy|9|||
161883034|NCT01500213|584615130|FG001|Overall Study|Lack of Efficacy|7|||
161883035|NCT01500213|584615129|FG000|Overall Study|Lost to Follow-up|3|||
161883036|NCT01500213|584615130|FG001|Overall Study|Lost to Follow-up|6|||
161883037|NCT01500213|584615129|FG000|Overall Study|Other Reasons|7|||
161883038|NCT01500213|584615130|FG001|Overall Study|Other Reasons|5|||
161883039|NCT00785213|584615131|FG000|Quinine Sulfate Alone|Adverse Event|4|||
161883040|NCT00785213|584615131|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
161883041|NCT02386345|584615132|FG000|Overall Study|Not treated|14|||
161778861|NCT00090259|584232350|FG001|Overall Study|Withdrawal by Subject|15|||
161778862|NCT00090259|584232349|FG000|Overall Study|Investigator site closed|11|||
161778863|NCT00090259|584232350|FG001|Overall Study|Investigator site closed|7|||
161778864|NCT04797637|584232356|FG000|Overall Study|Lost to Follow-up|23|||
161778865|NCT04797637|584232357|FG001|Overall Study|Lost to Follow-up|32|||
161778866|NCT04797637|584232356|FG000|Overall Study|Withdrawal by Subject|0|||
161778867|NCT04797637|584232357|FG001|Overall Study|Withdrawal by Subject|1|||
161778868|NCT03083639|584232358|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
161778869|NCT03083639|584232359|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
161778870|NCT03083639|584232358|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
161778871|NCT03083639|584232359|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
161778872|NCT00960687|584232363|FG000|Washout Period of 7 Days|Adverse Event|3|||
161778873|NCT00960687|584232364|FG001|Washout Period of 7 Days|Adverse Event|2|||
161778874|NCT00960687|584232363|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161778875|NCT00960687|584232364|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161778876|NCT01216319|584232367|FG000|Overall Study|Lost to Follow-up|2|||
161778877|NCT01216319|584232367|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
161778878|NCT03611751|584232371|FG000|Pre-treatment|Randomized but not treated|1|||
161778879|NCT03611751|584232372|FG001|Pre-treatment|Randomized but not treated|1|||
161778880|NCT03611751|584232373|FG002|Pre-treatment|Randomized but not treated|0|||
161778881|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
161778882|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
161778883|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
161778884|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
161778885|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
161778886|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
161778887|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
161778888|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
161778889|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
161778890|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
161778891|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
161778892|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
161778893|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
161778894|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
161778895|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
161778896|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
161778897|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
161778898|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
161778899|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
161778900|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
161778901|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
161778902|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Death|0|||
161778903|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Death|0|||
161778904|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Death|1|||
161778905|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
161778906|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
161778907|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
161778908|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
161778909|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161778910|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
161778911|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
161778912|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161778913|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161778914|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
161778915|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
161778916|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
161778917|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
161778918|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
161778919|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
161778920|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
161778921|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
161778922|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
161778923|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
161778924|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
161778925|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
161778926|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
161778927|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
161778928|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
161778929|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
161778930|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
161778931|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161778932|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
161883042|NCT02386345|584615132|FG000|Overall Study|Lost to Follow-up|1|||
161883043|NCT02386345|584615132|FG000|Overall Study|Adverse Event|5|||
161883044|NCT02386345|584615132|FG000|Overall Study|Repeat Procedure|10|||
161883045|NCT02386345|584615132|FG000|Overall Study|Did not complete 12-month follow-up|72|||
161883046|NCT04027075|584615133|FG000|Overall Study|Lost to Follow-up|41|||
161883047|NCT04027075|584615134|FG001|Overall Study|Lost to Follow-up|22|||
161883048|NCT03448939|584615135|FG000|Overall Study|Adverse Event|5|||
161883049|NCT03448939|584615136|FG001|Overall Study|Adverse Event|1|||
161883050|NCT03448939|584615135|FG000|Overall Study|Lost to Follow-up|6|||
161883051|NCT03448939|584615136|FG001|Overall Study|Lost to Follow-up|6|||
161883052|NCT03448939|584615135|FG000|Overall Study|Pregnancy|1|||
161883053|NCT03448939|584615136|FG001|Overall Study|Pregnancy|1|||
161883054|NCT03448939|584615135|FG000|Overall Study|Withdrawal by Subject|9|||
161883055|NCT03448939|584615136|FG001|Overall Study|Withdrawal by Subject|3|||
161883056|NCT01259375|584615137|FG000|Overall Study|Adverse Event|1|||
161883057|NCT00986986|584615138|FG000|Overall Study|Lost to Follow-up|0|||
161883058|NCT00986986|584615139|FG001|Overall Study|Lost to Follow-up|1|||
161883059|NCT00628095|584615140|FG000|Overall Study|Adverse Event|5|||
161883060|NCT00628095|584615141|FG001|Overall Study|Adverse Event|3|||
161883061|NCT00628095|584615140|FG000|Overall Study|Lack of Efficacy|0|||
161883062|NCT00628095|584615141|FG001|Overall Study|Lack of Efficacy|3|||
161883063|NCT00628095|584615140|FG000|Overall Study|Withdrawal by Subject|2|||
161883064|NCT00628095|584615141|FG001|Overall Study|Withdrawal by Subject|0|||
161883065|NCT00628095|584615140|FG000|Overall Study|Other|0|||
161883066|NCT00628095|584615141|FG001|Overall Study|Other|1|||
161883067|NCT01043705|584615146|FG000|Overall Study|Death|28|||
161883068|NCT01043705|584615147|FG001|Overall Study|Death|60|||
161883069|NCT01043705|584615148|FG002|Overall Study|Death|26|||
161883070|NCT01043705|584615146|FG000|Overall Study|Lost to Follow-up|27|||
161883071|NCT01043705|584615147|FG001|Overall Study|Lost to Follow-up|12|||
161883072|NCT01043705|584615148|FG002|Overall Study|Lost to Follow-up|0|||
161883073|NCT01043705|584615146|FG000|Overall Study|Multiple Reasons|4|||
161883074|NCT01043705|584615147|FG001|Overall Study|Multiple Reasons|7|||
161883075|NCT01043705|584615148|FG002|Overall Study|Multiple Reasons|0|||
161883076|NCT01043705|584615146|FG000|Overall Study|Protocol Violation|2|||
161883077|NCT01043705|584615147|FG001|Overall Study|Protocol Violation|1|||
161883078|NCT01043705|584615148|FG002|Overall Study|Protocol Violation|0|||
161883079|NCT01043705|584615146|FG000|Overall Study|Withdrawal by Subject|8|||
161883080|NCT01043705|584615147|FG001|Overall Study|Withdrawal by Subject|6|||
161778933|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
161778934|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
161778935|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
161778936|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
161778937|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
161778938|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
161778939|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
161778940|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161778941|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
161778942|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
161778943|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
161778944|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
161778945|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
161778946|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
161778947|NCT02666768|584232376|FG000|Overall Study|Withdrawal by Subject|4|||
161778948|NCT03728257|584232377|FG000|Overall Study|Death|3|||
161778949|NCT03728257|584232378|FG001|Overall Study|Death|0|||
161778950|NCT03940742|584232379|FG000|Overall Study|Lost to Follow-up|0|||
161778951|NCT03940742|584232380|FG001|Overall Study|Lost to Follow-up|0|||
161778952|NCT03940742|584232381|FG002|Overall Study|Lost to Follow-up|0|||
161778953|NCT03940742|584232382|FG003|Overall Study|Lost to Follow-up|1|||
161778954|NCT04993339|584232383|FG000|Overall Study|Lost to Follow-up|0|||
161778955|NCT04993339|584232384|FG001|Overall Study|Lost to Follow-up|1|||
161778956|NCT04993339|584232383|FG000|Overall Study|no MRI scan|3|||
161778957|NCT04993339|584232384|FG001|Overall Study|no MRI scan|1|||
161778958|NCT00797316|584232385|FG000|Overall Study|Administrative problems|1|||
161778959|NCT00797316|584232386|FG001|Overall Study|Administrative problems|0|||
161778960|NCT00797316|584232385|FG000|Overall Study|Adverse Event|5|||
161778961|NCT00797316|584232386|FG001|Overall Study|Adverse Event|3|||
161778962|NCT00797316|584232385|FG000|Overall Study|Lost to Follow-up|4|||
161778963|NCT00797316|584232386|FG001|Overall Study|Lost to Follow-up|8|||
161778964|NCT00797316|584232385|FG000|Overall Study|Protocol Deviation|1|||
161778965|NCT00797316|584232386|FG001|Overall Study|Protocol Deviation|2|||
161778966|NCT00797316|584232385|FG000|Overall Study|Patient withdrew consent|12|||
161778967|NCT00797316|584232386|FG001|Overall Study|Patient withdrew consent|6|||
161778968|NCT00797316|584232385|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161883081|NCT01043705|584615148|FG002|Overall Study|Withdrawal by Subject|0|||
161883082|NCT01043705|584615146|FG000|Overall Study|Site Closure|8|||
161883083|NCT01043705|584615147|FG001|Overall Study|Site Closure|0|||
161883084|NCT01043705|584615148|FG002|Overall Study|Site Closure|0|||
161883085|NCT01043705|584615146|FG000|Overall Study|Subsequent Procedure|9|||
161883086|NCT01043705|584615147|FG001|Overall Study|Subsequent Procedure|24|||
161883087|NCT01043705|584615148|FG002|Overall Study|Subsequent Procedure|29|||
161883088|NCT01043705|584615146|FG000|Overall Study|Adverse Event|0|||
161883089|NCT01043705|584615147|FG001|Overall Study|Adverse Event|2|||
161883090|NCT01043705|584615148|FG002|Overall Study|Adverse Event|0|||
161883091|NCT01043705|584615146|FG000|Overall Study|Screen Fail|21|||
161883092|NCT01043705|584615147|FG001|Overall Study|Screen Fail|0|||
161883093|NCT01043705|584615148|FG002|Overall Study|Screen Fail|0|||
161883094|NCT01043705|584615146|FG000|Overall Study|Other|0|||
161883095|NCT01043705|584615147|FG001|Overall Study|Other|19|||
161883096|NCT01043705|584615148|FG002|Overall Study|Other|25|||
161883097|NCT02003963|584615152|FG000|Overall Study|Lost to Follow-up|2|||
161883098|NCT02003963|584615153|FG001|Overall Study|Lost to Follow-up|1|||
161883099|NCT05020366|584615154|FG000|Overall Study|Lost to Follow-up|2|||
161883100|NCT05020366|584615155|FG001|Overall Study|Lost to Follow-up|0|||
161883101|NCT05020366|584615154|FG000|Overall Study|Withdrawal by Subject|2|||
161883102|NCT05020366|584615155|FG001|Overall Study|Withdrawal by Subject|0|||
161883103|NCT05083923|584615161|FG000|Overall Study|Adverse Event|2|||
161883104|NCT05083923|584615162|FG001|Overall Study|Adverse Event|0|||
161883105|NCT05083923|584615161|FG000|Overall Study|Lack of Efficacy|1|||
161883106|NCT05083923|584615162|FG001|Overall Study|Lack of Efficacy|3|||
161883107|NCT05083923|584615161|FG000|Overall Study|Withdrawal by Subject|2|||
161883108|NCT05083923|584615162|FG001|Overall Study|Withdrawal by Subject|6|||
161883109|NCT05083923|584615161|FG000|Overall Study|Reason Not Specified|0|||
161883110|NCT05083923|584615162|FG001|Overall Study|Reason Not Specified|1|||
161883111|NCT02880865|584615163|FG000|Overall Study|Adverse Event|1|||
161883112|NCT02880865|584615164|FG001|Overall Study|Adverse Event|0|||
161883113|NCT02880865|584615163|FG000|Overall Study|Withdrawal by Subject|0|||
161883114|NCT02880865|584615164|FG001|Overall Study|Withdrawal by Subject|2|||
161883115|NCT02880865|584615163|FG000|Overall Study|Physician Decision|0|||
161883116|NCT02880865|584615164|FG001|Overall Study|Physician Decision|1|||
161883117|NCT03379753|584615165|FG000|Overall Study|Withdrawal by Subject|2|||
161883118|NCT03379753|584615166|FG001|Overall Study|Withdrawal by Subject|1|||
161883119|NCT03379753|584615165|FG000|Overall Study|not having correct procedure|1|||
161883120|NCT03379753|584615166|FG001|Overall Study|not having correct procedure|2|||
161883121|NCT03379753|584615165|FG000|Overall Study|No primary outcome|12|||
161883122|NCT03379753|584615166|FG001|Overall Study|No primary outcome|22|||
161883123|NCT00347919|584615167|FG000|Overall Study|Lost to Follow-up|11|||
161883124|NCT00347919|584615168|FG001|Overall Study|Lost to Follow-up|13|||
161883125|NCT00347919|584615169|FG002|Overall Study|Lost to Follow-up|0|||
161883126|NCT00347919|584615167|FG000|Overall Study|Withdrawal by Subject|6|||
161883127|NCT00347919|584615168|FG001|Overall Study|Withdrawal by Subject|8|||
161883128|NCT00347919|584615169|FG002|Overall Study|Withdrawal by Subject|0|||
161883129|NCT00347919|584615167|FG000|Overall Study|Physician Decision|1|||
161883130|NCT00347919|584615168|FG001|Overall Study|Physician Decision|1|||
161883131|NCT00347919|584615169|FG002|Overall Study|Physician Decision|0|||
161883132|NCT00347919|584615167|FG000|Overall Study|Sponsor terminated study|15|||
161883133|NCT00347919|584615168|FG001|Overall Study|Sponsor terminated study|10|||
161883134|NCT00347919|584615169|FG002|Overall Study|Sponsor terminated study|16|||
161883135|NCT00347919|584615167|FG000|Overall Study|Death|35|||
161883136|NCT00347919|584615168|FG001|Overall Study|Death|42|||
161883137|NCT00347919|584615169|FG002|Overall Study|Death|19|||
161883138|NCT00347919|584615167|FG000|Overall Study|Par. Started Other Treatment|1|||
161883139|NCT00347919|584615168|FG001|Overall Study|Par. Started Other Treatment|1|||
161883140|NCT00347919|584615169|FG002|Overall Study|Par. Started Other Treatment|1|||
161883141|NCT00347919|584615167|FG000|Overall Study|Missing|2|||
161883142|NCT00347919|584615168|FG001|Overall Study|Missing|1|||
161883143|NCT00347919|584615169|FG002|Overall Study|Missing|2|||
161883144|NCT01190267|584615174|FG000|Overall Study|Adverse Event|10|||
161883145|NCT01190267|584615175|FG001|Overall Study|Adverse Event|0|||
161883146|NCT01190267|584615174|FG000|Overall Study|Treatment Failure|8|||
161883147|NCT01190267|584615175|FG001|Overall Study|Treatment Failure|2|||
161883148|NCT01190267|584615174|FG000|Overall Study|Lost to Follow-up|2|||
161883149|NCT01190267|584615175|FG001|Overall Study|Lost to Follow-up|0|||
161883150|NCT01190267|584615174|FG000|Overall Study|Withdrawal by Subject|13|||
161883151|NCT01190267|584615175|FG001|Overall Study|Withdrawal by Subject|1|||
161883152|NCT01190267|584615174|FG000|Overall Study|Protocol Violation|8|||
161883153|NCT01190267|584615175|FG001|Overall Study|Protocol Violation|1|||
161883154|NCT04687072|584615186|FG000|Overall Study|Adverse Event|2|||
161883155|NCT04687072|584615187|FG001|Overall Study|Adverse Event|0|||
161883156|NCT04687072|584615186|FG000|Overall Study|Death|1|||
161883157|NCT04687072|584615187|FG001|Overall Study|Death|0|||
161883158|NCT04687072|584615186|FG000|Overall Study|Lack of Efficacy|2|||
161883159|NCT04687072|584615187|FG001|Overall Study|Lack of Efficacy|1|||
161883160|NCT04687072|584615186|FG000|Overall Study|Physician Decision|1|||
161883161|NCT04687072|584615187|FG001|Overall Study|Physician Decision|0|||
161883162|NCT04687072|584615186|FG000|Overall Study|Pregnancy|1|||
161883163|NCT04687072|584615187|FG001|Overall Study|Pregnancy|0|||
161883164|NCT04687072|584615186|FG000|Overall Study|Requires Prohibited Medication|2|||
161883165|NCT04687072|584615187|FG001|Overall Study|Requires Prohibited Medication|0|||
161883166|NCT04687072|584615186|FG000|Overall Study|Withdrawal of Consent|11|||
161883167|NCT04687072|584615187|FG001|Overall Study|Withdrawal of Consent|6|||
161883168|NCT04687072|584615186|FG000|Overall Study|Miscellaneous|4|||
161883169|NCT04687072|584615187|FG001|Overall Study|Miscellaneous|1|||
161883170|NCT01263782|584615188|FG000|Overall Study|Death|0|||
161883171|NCT01263782|584615189|FG001|Overall Study|Death|0|||
161883172|NCT01263782|584615190|FG002|Overall Study|Death|1|||
161883173|NCT01263782|584615191|FG003|Overall Study|Death|0|||
161883174|NCT01263782|584615188|FG000|Overall Study|Progressive disease|0|||
161883175|NCT01263782|584615189|FG001|Overall Study|Progressive disease|0|||
161883176|NCT01263782|584615190|FG002|Overall Study|Progressive disease|0|||
161883177|NCT01263782|584615191|FG003|Overall Study|Progressive disease|1|||
161883178|NCT01263782|584615188|FG000|Overall Study|Too early|0|||
161883179|NCT01263782|584615189|FG001|Overall Study|Too early|0|||
161883180|NCT01263782|584615190|FG002|Overall Study|Too early|1|||
161883181|NCT01263782|584615191|FG003|Overall Study|Too early|0|||
161883182|NCT01263782|584615188|FG000|Overall Study|Inevaluable|0|||
161883183|NCT01263782|584615189|FG001|Overall Study|Inevaluable|0|||
161883184|NCT01263782|584615190|FG002|Overall Study|Inevaluable|1|||
161883185|NCT01263782|584615191|FG003|Overall Study|Inevaluable|0|||
161883186|NCT04545567|584615192|FG000|Overall Study|tested positive for SARS-co-V2|1|||
161883187|NCT04545567|584615193|FG001|Overall Study|tested positive for SARS-co-V2|1|||
161883188|NCT04545567|584615192|FG000|Overall Study|Withdrawal by Subject|0|||
161883189|NCT04545567|584615193|FG001|Overall Study|Withdrawal by Subject|1|||
161883190|NCT00533702|584615194|FG000|Overall Study|Withdrawal by Subject|3|||
161883191|NCT00533702|584615195|FG001|Overall Study|Withdrawal by Subject|1|||
161883192|NCT00533702|584615194|FG000|Overall Study|Found ineligible after randomization|2|||
161883193|NCT00533702|584615195|FG001|Overall Study|Found ineligible after randomization|1|||
161883194|NCT01970475|584615198|FG000|Overall Study|Withdrawal by Subject|11|||
161883195|NCT01970475|584615199|FG001|Overall Study|Withdrawal by Subject|6|||
161883196|NCT01970475|584615198|FG000|Overall Study|Adverse Event|7|||
161883197|NCT01970475|584615199|FG001|Overall Study|Adverse Event|3|||
161883198|NCT01970475|584615198|FG000|Overall Study|Lost to Follow-up|2|||
161883199|NCT01970475|584615199|FG001|Overall Study|Lost to Follow-up|2|||
161883200|NCT01970475|584615198|FG000|Overall Study|Protocol Violation|1|||
161883201|NCT01970475|584615199|FG001|Overall Study|Protocol Violation|0|||
161883202|NCT04413552|584615204|FG000|Overall Study|Adverse Event|0|||
161883203|NCT04413552|584615205|FG001|Overall Study|Adverse Event|0|||
161883204|NCT04413552|584615206|FG002|Overall Study|Adverse Event|0|||
161883205|NCT04413552|584615207|FG003|Overall Study|Adverse Event|0|||
161883206|NCT04413552|584615208|FG004|Overall Study|Adverse Event|0|||
161778969|NCT00797316|584232386|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161778970|NCT00402779|584232389|FG000|Overall Study|Screen Failure|77|||
161778971|NCT00402779|584232390|FG001|Overall Study|Screen Failure|76|||
161778972|NCT03075215|584232391|FG000|12-Month Primary Endpoint|Death|152|||
161778973|NCT03075215|584232391|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
161778974|NCT03075215|584232391|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
161778975|NCT03075215|584232391|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
161778976|NCT00690573|584232400|FG000|Overall Study|Lack of Efficacy|8|||
161778977|NCT00690573|584232400|FG000|Overall Study|Withdrawal by Subject|1|||
161778978|NCT00777920|584232401|FG000|Overall Study|Adverse Event|39|||
161778979|NCT00777920|584232401|FG000|Overall Study|Withdrawal of Consent|4|||
161778980|NCT00777920|584232401|FG000|Overall Study|Lost to Follow-up|1|||
161778981|NCT00777920|584232401|FG000|Overall Study|Investigator's discretion|1|||
161778982|NCT00777920|584232401|FG000|Overall Study|Clinical status did not improve|1|||
161778983|NCT00777920|584232401|FG000|Overall Study|Other, not specified|4|||
161778984|NCT02146365|584232402|FG000|Overall Study|Lost to Follow-up|2|||
161778985|NCT02146365|584232403|FG001|Overall Study|Lost to Follow-up|1|||
161778986|NCT02146365|584232404|FG002|Overall Study|Lost to Follow-up|3|||
161778987|NCT02146365|584232405|FG003|Overall Study|Lost to Follow-up|3|||
161778988|NCT02146365|584232406|FG004|Overall Study|Lost to Follow-up|1|||
161778989|NCT02146365|584232407|FG005|Overall Study|Lost to Follow-up|1|||
161778990|NCT02146365|584232408|FG006|Overall Study|Lost to Follow-up|0|||
161883207|NCT04413552|584615209|FG005|Overall Study|Adverse Event|0|||
161883208|NCT04413552|584615210|FG006|Overall Study|Adverse Event|1|||
161883209|NCT04413552|584615211|FG007|Overall Study|Adverse Event|0|||
161883210|NCT04413552|584615212|FG008|Overall Study|Adverse Event|0|||
161883211|NCT04413552|584615213|FG009|Overall Study|Adverse Event|0|||
161883212|NCT01317797|584615214|FG000|Overall Study|Other|0|||
161883213|NCT01317797|584615215|FG001|Overall Study|Other|1|||
161883214|NCT01317797|584615216|FG002|Overall Study|Other|0|||
161883215|NCT01317797|584615214|FG000|Overall Study|Withdrawal of Patient|0|||
161883216|NCT01317797|584615215|FG001|Overall Study|Withdrawal of Patient|0|||
161883217|NCT01317797|584615216|FG002|Overall Study|Withdrawal of Patient|1|||
161883218|NCT03026530|584615217|FG000|Overall Study|Lost to Follow-up|19|||
161883219|NCT03026530|584615218|FG001|Overall Study|Lost to Follow-up|24|||
161883220|NCT03026530|584615217|FG000|Overall Study|Protocol Violation|2|||
161883221|NCT03026530|584615218|FG001|Overall Study|Protocol Violation|5|||
161883222|NCT03721835|584615220|FG000|Overall Study|Participant not able to return|1|||
161883223|NCT03721835|584615220|FG000|Overall Study|Lost to Follow-up|1|||
161883224|NCT03721835|584615220|FG000|Overall Study|Revision of the components of the study device|2|||
161883225|NCT03721835|584615220|FG000|Overall Study|Sponsor terminated study|6|||
161883226|NCT03721835|584615220|FG000|Overall Study|Death|1|||
161883227|NCT03721835|584615220|FG000|Overall Study|Sponsor decision|1|||
161883228|NCT03495154|584615221|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
161883229|NCT03495154|584615221|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
161883230|NCT03495154|584615221|FG000|Overall Study|Screen Failures During Surgery|6|||
161883231|NCT03495154|584615221|FG000|Overall Study|Death|2|||
161883232|NCT03495154|584615221|FG000|Overall Study|Lost to Follow-up|16|||
161883233|NCT03495154|584615221|FG000|Overall Study|Withdrawal by Subject|2|||
161883234|NCT03495154|584615221|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
161883235|NCT01294696|584615225|FG000|Overall Study|Screening failures|7|||
161883236|NCT01294696|584615225|FG000|Overall Study|Protocol Violation|8|||
161883237|NCT01294696|584615225|FG000|Overall Study|Missing BPI Response|7|||
161883238|NCT01294696|584615225|FG000|Overall Study|Site closure|52|||
161883239|NCT05741346|584616577|FG000|Overall Study|Withdrawn due to termination of study|28|||
161883240|NCT02339155|584616580|FG000|Overall Study|Adverse Event|0|||
161883241|NCT02339155|584616581|FG001|Overall Study|Adverse Event|6|||
161883242|NCT02339155|584616580|FG000|Overall Study|Death|1|||
161883243|NCT02339155|584616581|FG001|Overall Study|Death|1|||
161883244|NCT02339155|584616580|FG000|Overall Study|Lost to Follow-up|8|||
161883245|NCT02339155|584616581|FG001|Overall Study|Lost to Follow-up|9|||
161883246|NCT02339155|584616580|FG000|Overall Study|Physician Decision|2|||
161883247|NCT02339155|584616581|FG001|Overall Study|Physician Decision|1|||
161883248|NCT02339155|584616580|FG000|Overall Study|Withdrawal by Subject|4|||
161883249|NCT02339155|584616581|FG001|Overall Study|Withdrawal by Subject|4|||
161883250|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Adverse Event|0|||
161883251|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Adverse Event|1|||
161883252|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Adverse Event|0|||
161883253|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Adverse Event|0|||
161883254|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Adverse Event|0|||
161883255|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Adverse Event|0|||
161883256|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Death|0|||
161883257|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Death|0|||
161883258|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Death|1|||
161883259|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Death|0|||
161883260|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Death|0|||
161883261|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Death|0|||
161883262|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883263|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
161883264|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883265|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883266|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883267|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883268|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883269|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883270|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
161883271|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883272|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883273|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883274|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883275|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883276|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883277|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
161883278|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883279|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883280|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
161883281|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
161883282|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883283|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883284|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883285|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883286|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883287|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883288|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883289|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883290|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
161883291|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
161883292|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Death|0|||
161883293|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Death|0|||
161883294|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Death|0|||
161883295|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Death|0|||
161883296|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Death|0|||
161883297|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Death|1|||
161883298|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883299|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883300|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883301|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883302|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883303|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
161883304|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883305|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883306|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883307|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883308|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
161883309|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
161883310|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883311|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883312|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883313|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883314|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883315|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
161883316|NCT00916344|584616600|FG000|Overall Study|Death|2|||
161883317|NCT00916344|584616600|FG000|Overall Study|ICD upgrade|1|||
161883318|NCT00916344|584616600|FG000|Overall Study|Drop-out|5|||
161883319|NCT03602391|584616601|FG000|Overall Study|COVID-19|7|||
161883320|NCT03602391|584616602|FG001|Overall Study|COVID-19|6|||
161883321|NCT00108485|584616607|FG000|Overall Study|Withdrawal by Subject|3|||
161883322|NCT00108485|584616608|FG001|Overall Study|Withdrawal by Subject|0|||
161883323|NCT00108485|584616607|FG000|Overall Study|Lost to Follow-up|0|||
161883324|NCT00108485|584616608|FG001|Overall Study|Lost to Follow-up|2|||
161883325|NCT00878969|584616613|FG000|Overall Study|Physician Decision|5|||
161883326|NCT00878969|584616614|FG001|Overall Study|Physician Decision|3|||
161883327|NCT00878969|584616615|FG002|Overall Study|Physician Decision|2|||
161883328|NCT00878969|584616613|FG000|Overall Study|Withdrawal by Subject|1|||
161883329|NCT00878969|584616614|FG001|Overall Study|Withdrawal by Subject|6|||
161883330|NCT00878969|584616615|FG002|Overall Study|Withdrawal by Subject|3|||
161883331|NCT00878969|584616613|FG000|Overall Study|kidney transplant|2|||
161883332|NCT00878969|584616614|FG001|Overall Study|kidney transplant|3|||
161883333|NCT00878969|584616615|FG002|Overall Study|kidney transplant|2|||
161883334|NCT00878969|584616613|FG000|Overall Study|Adverse Event|3|||
161883335|NCT00878969|584616614|FG001|Overall Study|Adverse Event|1|||
161778991|NCT02146365|584232409|FG007|Overall Study|Lost to Follow-up|1|||
161778992|NCT02146365|584232402|FG000|Overall Study|Withdrawal by Subject|1|||
161778993|NCT02146365|584232403|FG001|Overall Study|Withdrawal by Subject|2|||
161778994|NCT02146365|584232404|FG002|Overall Study|Withdrawal by Subject|1|||
161778995|NCT02146365|584232405|FG003|Overall Study|Withdrawal by Subject|5|||
161778996|NCT02146365|584232406|FG004|Overall Study|Withdrawal by Subject|1|||
161778997|NCT02146365|584232407|FG005|Overall Study|Withdrawal by Subject|0|||
161778998|NCT02146365|584232408|FG006|Overall Study|Withdrawal by Subject|0|||
161778999|NCT02146365|584232409|FG007|Overall Study|Withdrawal by Subject|0|||
161779000|NCT02146365|584232402|FG000|Overall Study|Unable to Comply with Protocol|0|||
161779001|NCT02146365|584232403|FG001|Overall Study|Unable to Comply with Protocol|1|||
161779002|NCT02146365|584232404|FG002|Overall Study|Unable to Comply with Protocol|1|||
161779003|NCT02146365|584232405|FG003|Overall Study|Unable to Comply with Protocol|0|||
161779004|NCT02146365|584232406|FG004|Overall Study|Unable to Comply with Protocol|0|||
161779005|NCT02146365|584232407|FG005|Overall Study|Unable to Comply with Protocol|0|||
161779006|NCT02146365|584232408|FG006|Overall Study|Unable to Comply with Protocol|0|||
161779007|NCT02146365|584232409|FG007|Overall Study|Unable to Comply with Protocol|0|||
161779008|NCT02146365|584232402|FG000|Overall Study|Other|1|||
161779009|NCT02146365|584232403|FG001|Overall Study|Other|0|||
161779010|NCT02146365|584232404|FG002|Overall Study|Other|2|||
161779011|NCT02146365|584232405|FG003|Overall Study|Other|1|||
161779012|NCT02146365|584232406|FG004|Overall Study|Other|0|||
161883336|NCT00878969|584616615|FG002|Overall Study|Adverse Event|2|||
161883337|NCT00878969|584616613|FG000|Overall Study|Lost to Follow-up|2|||
161883338|NCT00878969|584616614|FG001|Overall Study|Lost to Follow-up|1|||
161883339|NCT00878969|584616615|FG002|Overall Study|Lost to Follow-up|0|||
161883340|NCT00878969|584616613|FG000|Overall Study|Protocol Violation|2|||
161883341|NCT00878969|584616614|FG001|Overall Study|Protocol Violation|0|||
161883342|NCT00878969|584616615|FG002|Overall Study|Protocol Violation|0|||
161883343|NCT00878969|584616613|FG000|Overall Study|Death|0|||
161883344|NCT00878969|584616614|FG001|Overall Study|Death|0|||
161883345|NCT00878969|584616615|FG002|Overall Study|Death|2|||
161883346|NCT00878969|584616613|FG000|Overall Study|Pregnancy|0|||
161883347|NCT00878969|584616614|FG001|Overall Study|Pregnancy|1|||
161883348|NCT00878969|584616615|FG002|Overall Study|Pregnancy|0|||
161883349|NCT01701193|584616618|FG000|Overall Study|Withdrawal by Subject|2|||
161883350|NCT01701193|584616619|FG001|Overall Study|Withdrawal by Subject|2|||
161883351|NCT01701193|584616620|FG002|Overall Study|Withdrawal by Subject|1|||
161883352|NCT01701193|584616621|FG003|Overall Study|Withdrawal by Subject|2|||
161883353|NCT01701193|584616618|FG000|Overall Study|Adverse Event|1|||
161883354|NCT01701193|584616619|FG001|Overall Study|Adverse Event|0|||
161883355|NCT01701193|584616620|FG002|Overall Study|Adverse Event|0|||
161883356|NCT01701193|584616621|FG003|Overall Study|Adverse Event|0|||
161883357|NCT03054064|584616622|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
161883358|NCT03054064|584616622|FG000|Overall Study|Investigator Decision|2|||
161883359|NCT03054064|584616622|FG000|Overall Study|Bladder Issue|1|||
161883360|NCT03054064|584616622|FG000|Overall Study|High Blood Pressure|1|||
161883361|NCT03054064|584616622|FG000|Overall Study|Change in Status|1|||
161883362|NCT01527487|584616623|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
161883363|NCT01527487|584616624|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
161883364|NCT01527487|584616623|FG000|Overall Study|Disease Progression|4|||
161883365|NCT01527487|584616624|FG001|Overall Study|Disease Progression|1|||
161883366|NCT01527487|584616623|FG000|Overall Study|Adverse Event|1|||
161883367|NCT01527487|584616624|FG001|Overall Study|Adverse Event|1|||
161883368|NCT01527487|584616623|FG000|Overall Study|Death|0|||
161883369|NCT01527487|584616624|FG001|Overall Study|Death|1|||
161883370|NCT01384019|584616625|FG000|Overall Study|Withdrawal by Subject|3|||
161883371|NCT01384019|584616626|FG001|Overall Study|Withdrawal by Subject|0|||
161883372|NCT01384019|584616625|FG000|Overall Study|Death|1|||
161883373|NCT01384019|584616626|FG001|Overall Study|Death|0|||
161883374|NCT01384019|584616625|FG000|Overall Study|MRI refusal|6|||
161883375|NCT01384019|584616626|FG001|Overall Study|MRI refusal|6|||
161883376|NCT00081731|584616630|FG000|Overall Study|scientific integrity issue|8|||
161883377|NCT00081731|584616631|FG001|Overall Study|scientific integrity issue|8|||
161883378|NCT01629823|584616636|FG000|Trial Period|Missed visit|11|||
161883379|NCT01629823|584616637|FG001|Trial Period|Missed visit|9|||
161883380|NCT01629823|584616638|FG002|Trial Period|Missed visit|8|||
161883381|NCT01629823|584616636|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161883382|NCT01629823|584616637|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161883383|NCT01629823|584616638|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161883384|NCT01629823|584616636|FG000|Trial Period|Pregnancy|1|||
161883385|NCT01629823|584616637|FG001|Trial Period|Pregnancy|0|||
161883386|NCT01629823|584616638|FG002|Trial Period|Pregnancy|0|||
161883387|NCT01629823|584616636|FG000|Trial Period|Adverse Event|0|||
161883388|NCT01629823|584616637|FG001|Trial Period|Adverse Event|1|||
161883389|NCT01629823|584616638|FG002|Trial Period|Adverse Event|0|||
161883390|NCT01629823|584616636|FG000|Trial Period|Out-of-window visit|0|||
161883391|NCT01629823|584616637|FG001|Trial Period|Out-of-window visit|2|||
161883392|NCT01629823|584616638|FG002|Trial Period|Out-of-window visit|0|||
161883393|NCT01629823|584616636|FG000|Trial Period|Failed to hold medication|0|||
161883394|NCT01629823|584616637|FG001|Trial Period|Failed to hold medication|0|||
161883395|NCT01629823|584616638|FG002|Trial Period|Failed to hold medication|1|||
161883396|NCT01629823|584616636|FG000|Washout Period|Safety|2|||
161883397|NCT01629823|584616637|FG001|Washout Period|Safety|5|||
161883398|NCT01629823|584616638|FG002|Washout Period|Safety|0|||
161883399|NCT01629823|584616636|FG000|Washout Period|Pregnancy|1|||
161883400|NCT01629823|584616637|FG001|Washout Period|Pregnancy|0|||
161883401|NCT01629823|584616638|FG002|Washout Period|Pregnancy|0|||
161883402|NCT01629823|584616636|FG000|Washout Period|Protocol Violation|0|||
161883403|NCT01629823|584616637|FG001|Washout Period|Protocol Violation|1|||
161883404|NCT01629823|584616638|FG002|Washout Period|Protocol Violation|0|||
161883405|NCT00526331|584616639|FG000|Overall Study|Sponsor Termination|55|||
161883406|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
161883407|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
161883408|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
161883409|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
161883410|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
161883411|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
161883412|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
161883413|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
161883414|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
161883415|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
161883416|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|All other|33|||
161883417|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|All other|0|||
161883418|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
161883419|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
161883420|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
161883421|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
161883422|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
161883423|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
161883424|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
161883425|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
161883426|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
161883427|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
161883428|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
161883429|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
161883430|NCT03973918|584616645|FG000|Overall Study|Adverse Event|0|||
161883431|NCT03973918|584616646|FG001|Overall Study|Adverse Event|0|||
161883432|NCT03973918|584616647|FG002|Overall Study|Adverse Event|0|||
161883433|NCT03973918|584616648|FG003|Overall Study|Adverse Event|1|||
161883434|NCT03973918|584616645|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161883435|NCT03973918|584616646|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
161883436|NCT03973918|584616647|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161883437|NCT03973918|584616648|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161779013|NCT02146365|584232407|FG005|Overall Study|Other|0|||
161779014|NCT02146365|584232408|FG006|Overall Study|Other|0|||
161779015|NCT02146365|584232409|FG007|Overall Study|Other|0|||
161779016|NCT02332655|584232410|FG000|Overall Study|Lack of Efficacy|1|||
161779017|NCT01977482|584232411|FG000|Overall Study|Adverse Event|0|||
161779018|NCT01977482|584232412|FG001|Overall Study|Adverse Event|1|||
161779019|NCT01977482|584232413|FG002|Overall Study|Adverse Event|1|||
161779020|NCT01977482|584232414|FG003|Overall Study|Adverse Event|0|||
161779021|NCT01977482|584232415|FG004|Overall Study|Adverse Event|2|||
161779022|NCT01977482|584232416|FG005|Overall Study|Adverse Event|0|||
161779023|NCT01977482|584232411|FG000|Overall Study|Lost to Follow-up|1|||
161779024|NCT01977482|584232412|FG001|Overall Study|Lost to Follow-up|0|||
161779025|NCT01977482|584232413|FG002|Overall Study|Lost to Follow-up|0|||
161779026|NCT01977482|584232414|FG003|Overall Study|Lost to Follow-up|0|||
161779027|NCT01977482|584232415|FG004|Overall Study|Lost to Follow-up|0|||
161779028|NCT01977482|584232416|FG005|Overall Study|Lost to Follow-up|0|||
161779029|NCT01977482|584232411|FG000|Overall Study|Physician Decision|0|||
161779030|NCT01977482|584232412|FG001|Overall Study|Physician Decision|1|||
161779031|NCT01977482|584232413|FG002|Overall Study|Physician Decision|0|||
161779032|NCT01977482|584232414|FG003|Overall Study|Physician Decision|0|||
161779033|NCT01977482|584232415|FG004|Overall Study|Physician Decision|0|||
161779034|NCT01977482|584232416|FG005|Overall Study|Physician Decision|0|||
161779035|NCT01977482|584232411|FG000|Overall Study|Protocol Violation|0|||
161779036|NCT01977482|584232412|FG001|Overall Study|Protocol Violation|0|||
161779037|NCT01977482|584232413|FG002|Overall Study|Protocol Violation|1|||
161779038|NCT01977482|584232414|FG003|Overall Study|Protocol Violation|0|||
161779039|NCT01977482|584232415|FG004|Overall Study|Protocol Violation|0|||
161779040|NCT01977482|584232416|FG005|Overall Study|Protocol Violation|0|||
161779041|NCT01977482|584232411|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161779042|NCT01977482|584232412|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
161779043|NCT01977482|584232413|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
161779044|NCT01977482|584232414|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
161779045|NCT01977482|584232415|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161779046|NCT01977482|584232416|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161779047|NCT01977482|584232411|FG000|Overall Study|Withdrawal by Subject|2|||
161779048|NCT01977482|584232412|FG001|Overall Study|Withdrawal by Subject|4|||
161779049|NCT01977482|584232413|FG002|Overall Study|Withdrawal by Subject|1|||
161779050|NCT01977482|584232414|FG003|Overall Study|Withdrawal by Subject|3|||
161779051|NCT01977482|584232415|FG004|Overall Study|Withdrawal by Subject|1|||
161779052|NCT01977482|584232416|FG005|Overall Study|Withdrawal by Subject|5|||
161779053|NCT01525407|584232423|FG000|Overall Study|Change in recipient treatment plan|2|||
161779054|NCT01525407|584232424|FG001|Overall Study|Change in recipient treatment plan|2|||
161779055|NCT01525407|584232423|FG000|Overall Study|Withdrawal by Subject|0|||
161779056|NCT01525407|584232424|FG001|Overall Study|Withdrawal by Subject|1|||
161779057|NCT01525407|584232423|FG000|Overall Study|Transplant was delayed|0|||
161779058|NCT01525407|584232424|FG001|Overall Study|Transplant was delayed|1|||
161779059|NCT01525407|584232423|FG000|Overall Study|Delay in Transplant|1|||
161779060|NCT01525407|584232424|FG001|Overall Study|Delay in Transplant|0|||
161883438|NCT04050124|584616649|FG000|Overall Study|Death|1|||
161883439|NCT04050124|584616650|FG001|Overall Study|Death|0|||
161883440|NCT04601103|584616653|FG000|Overall Study|Needed crown & cleaning|0|||
161883441|NCT04601103|584616654|FG001|Overall Study|Needed crown & cleaning|0|||
161883442|NCT04601103|584616655|FG002|Overall Study|Needed crown & cleaning|1|||
161883443|NCT04601103|584616653|FG000|Overall Study|study was terminated|18|||
161883444|NCT04601103|584616654|FG001|Overall Study|study was terminated|18|||
161883445|NCT04601103|584616655|FG002|Overall Study|study was terminated|16|||
161883446|NCT01068626|584616663|FG000|Overall Study|Adverse Event|3|||
161883447|NCT01068626|584616664|FG001|Overall Study|Adverse Event|0|||
161883448|NCT01068626|584616663|FG000|Overall Study|Withdrawal by Subject|0|||
161883449|NCT01068626|584616664|FG001|Overall Study|Withdrawal by Subject|2|||
161883450|NCT01785849|584616665|FG000|Overall Study|Death|7|||
161883451|NCT01785849|584616666|FG001|Overall Study|Death|9|||
161883452|NCT01785849|584616665|FG000|Overall Study|Protocol Specified Criteria|29|||
161883453|NCT01785849|584616666|FG001|Overall Study|Protocol Specified Criteria|1|||
161883454|NCT01785849|584616665|FG000|Overall Study|Withdrawal by Subject|15|||
161883455|NCT01785849|584616666|FG001|Overall Study|Withdrawal by Subject|12|||
161883456|NCT01785849|584616665|FG000|Overall Study|Sponsor Decision|0|||
161883457|NCT01785849|584616666|FG001|Overall Study|Sponsor Decision|1|||
161883458|NCT01785849|584616665|FG000|Overall Study|Lost to Follow-up|10|||
161883459|NCT01785849|584616666|FG001|Overall Study|Lost to Follow-up|11|||
161883460|NCT03932331|584616668|FG000|Overall Study|Death|0|||
161883461|NCT03932331|584616669|FG001|Overall Study|Death|7|||
161883462|NCT03932331|584616670|FG002|Overall Study|Death|2|||
161883463|NCT03932331|584616668|FG000|Overall Study|Withdrawal by Subject|0|||
161883464|NCT03932331|584616669|FG001|Overall Study|Withdrawal by Subject|3|||
161883465|NCT03932331|584616670|FG002|Overall Study|Withdrawal by Subject|0|||
161883466|NCT03932331|584616668|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
161883467|NCT03932331|584616669|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
161883468|NCT03932331|584616670|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
161883469|NCT03932331|584616668|FG000|Overall Study|Progressive disease|3|||
161883470|NCT03932331|584616669|FG001|Overall Study|Progressive disease|0|||
161883471|NCT03932331|584616670|FG002|Overall Study|Progressive disease|0|||
161883472|NCT03932331|584616668|FG000|Overall Study|Lung infection|1|||
161883473|NCT03932331|584616669|FG001|Overall Study|Lung infection|0|||
161883474|NCT03932331|584616670|FG002|Overall Study|Lung infection|0|||
161883475|NCT03932331|584616668|FG000|Overall Study|Other|0|||
161883476|NCT03932331|584616669|FG001|Overall Study|Other|0|||
161883477|NCT03932331|584616670|FG002|Overall Study|Other|58|||
161883478|NCT01032239|584616671|FG000|Overall Study|Lost to Follow-up|3|||
161883479|NCT01032239|584616672|FG001|Overall Study|Lost to Follow-up|2|||
161883480|NCT01032239|584616671|FG000|Overall Study|Withdrawal by Subject|2|||
161883481|NCT01032239|584616672|FG001|Overall Study|Withdrawal by Subject|3|||
161883482|NCT01032239|584616671|FG000|Overall Study|Death|1|||
161883483|NCT01032239|584616672|FG001|Overall Study|Death|0|||
161883484|NCT01032239|584616671|FG000|Overall Study|Protocol Violation|1|||
161883485|NCT01032239|584616672|FG001|Overall Study|Protocol Violation|0|||
161883486|NCT00204477|584616675|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
161883487|NCT00204477|584616676|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
161883488|NCT00204477|584616675|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
161883489|NCT00204477|584616676|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
161883490|NCT05513703|584616684|FG000|Overall Study|Death|4|||
161883491|NCT05513703|584616684|FG000|Overall Study|Study terminated by sponsor|5|||
161883492|NCT04450407|584616688|FG000|Overall Study|Withdrawal by Subject|10|||
161883493|NCT04450407|584616689|FG001|Overall Study|Withdrawal by Subject|1|||
161883494|NCT04450407|584616690|FG002|Overall Study|Withdrawal by Subject|4|||
161883495|NCT04450407|584616688|FG000|Overall Study|Adverse Event|0|||
161883496|NCT04450407|584616689|FG001|Overall Study|Adverse Event|0|||
161883497|NCT04450407|584616690|FG002|Overall Study|Adverse Event|1|||
161883498|NCT04450407|584616688|FG000|Overall Study|Lost to Follow-up|1|||
161883499|NCT04450407|584616689|FG001|Overall Study|Lost to Follow-up|0|||
161883500|NCT04450407|584616690|FG002|Overall Study|Lost to Follow-up|0|||
161883501|NCT04450407|584616688|FG000|Overall Study|Physician Decision|0|||
161883502|NCT04450407|584616689|FG001|Overall Study|Physician Decision|0|||
161883503|NCT04450407|584616690|FG002|Overall Study|Physician Decision|1|||
161883504|NCT04450407|584616688|FG000|Overall Study|Pregnancy|1|||
161883505|NCT04450407|584616689|FG001|Overall Study|Pregnancy|0|||
161883506|NCT04450407|584616690|FG002|Overall Study|Pregnancy|0|||
161883507|NCT04450407|584616688|FG000|Overall Study|Protocol Violation|2|||
161883508|NCT04450407|584616689|FG001|Overall Study|Protocol Violation|0|||
161883509|NCT04450407|584616690|FG002|Overall Study|Protocol Violation|0|||
161883510|NCT04450407|584616688|FG000|Overall Study|Investigational site terminated by sponsor|3|||
161883511|NCT04450407|584616689|FG001|Overall Study|Investigational site terminated by sponsor|0|||
161883512|NCT04450407|584616690|FG002|Overall Study|Investigational site terminated by sponsor|2|||
161883513|NCT00794040|584616692|FG000|Overall Study|Withdrawal by Subject|3|||
161883514|NCT00794040|584616693|FG001|Overall Study|Withdrawal by Subject|4|||
161883515|NCT00794040|584616692|FG000|Overall Study|Physician Decision|0|||
161883516|NCT00794040|584616693|FG001|Overall Study|Physician Decision|1|||
161883517|NCT04696354|584616696|FG000|Overall Study|Study termination|6|||
161883518|NCT04696354|584616697|FG001|Overall Study|Study termination|6|||
161883519|NCT03626363|584616701|FG000|Overall Study|Protocol Violation|4|||
161883520|NCT03626363|584616702|FG001|Overall Study|Protocol Violation|0|||
161883521|NCT03626363|584616701|FG000|Overall Study|Lost to Follow-up|5|||
161883522|NCT03626363|584616702|FG001|Overall Study|Lost to Follow-up|7|||
161883523|NCT00965341|584616703|FG000|Overall Study|Withdrew consent|1|||
161883524|NCT00965341|584616704|FG001|Overall Study|Withdrew consent|5|||
161883525|NCT00965341|584616703|FG000|Overall Study|Lost to Follow-up|1|||
161883526|NCT00965341|584616704|FG001|Overall Study|Lost to Follow-up|0|||
161883527|NCT00965341|584616703|FG000|Overall Study|Transportation issues|4|||
161883528|NCT00965341|584616704|FG001|Overall Study|Transportation issues|3|||
161883529|NCT01077739|584616705|FG000|Overall Study|Premature withdrawal|1|||
161883530|NCT01077739|584616706|FG001|Overall Study|Premature withdrawal|3|||
161883531|NCT01077739|584616705|FG000|Overall Study|Withdrawal by Subject|1|||
161883532|NCT01077739|584616706|FG001|Overall Study|Withdrawal by Subject|0|||
161883533|NCT01077739|584616705|FG000|Overall Study|Death|0|||
161883534|NCT01077739|584616706|FG001|Overall Study|Death|3|||
161883535|NCT01077739|584616705|FG000|Overall Study|Unacceptable toxicity|1|||
161883536|NCT01077739|584616706|FG001|Overall Study|Unacceptable toxicity|2|||
161883537|NCT01077739|584616705|FG000|Overall Study|Other|2|||
161883538|NCT01077739|584616706|FG001|Overall Study|Other|2|||
161883539|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
161883540|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
161883541|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
161883542|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
161883543|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
161883544|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
161883545|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
161883546|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
161883547|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
161883548|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
161883549|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
161883550|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
161883551|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161883552|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
161883553|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161883554|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161883555|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
161883556|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
161883557|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
161883558|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
161883559|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Death|0|||
161883560|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Death|0|||
161883561|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Death|1|||
161883562|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Death|0|||
161883563|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161883564|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161883565|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
161883566|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161883567|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
161883568|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
161883569|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
161883570|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
161883571|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161883572|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161883573|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
161883574|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161883575|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
161883576|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
161883577|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
161883578|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
161883579|NCT00877071|584616711|FG000|Overall Study|disease progression|2|||
161883580|NCT02100670|584616717|FG000|Overall Study|Adverse Event|10|||
161883581|NCT02100670|584616718|FG001|Overall Study|Adverse Event|3|||
161883582|NCT02100670|584616719|FG002|Overall Study|Adverse Event|3|||
161883583|NCT02100670|584616720|FG003|Overall Study|Adverse Event|0|||
161883584|NCT02100670|584616717|FG000|Overall Study|Lost to Follow-up|1|||
161883585|NCT02100670|584616718|FG001|Overall Study|Lost to Follow-up|0|||
161883586|NCT02100670|584616719|FG002|Overall Study|Lost to Follow-up|0|||
161883587|NCT02100670|584616720|FG003|Overall Study|Lost to Follow-up|0|||
161883588|NCT02100670|584616717|FG000|Overall Study|Protocol Violation|0|||
161883589|NCT02100670|584616718|FG001|Overall Study|Protocol Violation|1|||
161883590|NCT02100670|584616719|FG002|Overall Study|Protocol Violation|0|||
161883591|NCT02100670|584616720|FG003|Overall Study|Protocol Violation|1|||
161883592|NCT02100670|584616717|FG000|Overall Study|Withdrawal of Consent|0|||
161883593|NCT02100670|584616718|FG001|Overall Study|Withdrawal of Consent|1|||
161883594|NCT02100670|584616719|FG002|Overall Study|Withdrawal of Consent|1|||
161883595|NCT02100670|584616720|FG003|Overall Study|Withdrawal of Consent|0|||
161883596|NCT02100670|584616717|FG000|Overall Study|No swelling no pain|1|||
161883597|NCT02100670|584616718|FG001|Overall Study|No swelling no pain|0|||
161883598|NCT02100670|584616719|FG002|Overall Study|No swelling no pain|0|||
161883599|NCT02100670|584616720|FG003|Overall Study|No swelling no pain|0|||
161883600|NCT02100670|584616717|FG000|Overall Study|Poor Efficacy|0|||
161883601|NCT02100670|584616718|FG001|Overall Study|Poor Efficacy|1|||
161883602|NCT02100670|584616719|FG002|Overall Study|Poor Efficacy|0|||
161883603|NCT02100670|584616720|FG003|Overall Study|Poor Efficacy|0|||
161883604|NCT02100670|584616717|FG000|Overall Study|Physician Decision|0|||
161883605|NCT02100670|584616718|FG001|Overall Study|Physician Decision|1|||
161883606|NCT02100670|584616719|FG002|Overall Study|Physician Decision|0|||
161883607|NCT02100670|584616720|FG003|Overall Study|Physician Decision|0|||
161883608|NCT02100670|584616717|FG000|Overall Study|Withdrawal by Subject|1|||
161883609|NCT02100670|584616718|FG001|Overall Study|Withdrawal by Subject|0|||
161883610|NCT02100670|584616719|FG002|Overall Study|Withdrawal by Subject|0|||
161883611|NCT02100670|584616720|FG003|Overall Study|Withdrawal by Subject|0|||
161883612|NCT04439357|584618257|FG000|Overall Study|Disease Progression|4|||
161883613|NCT01668966|584618266|FG000|Overall Study|Withdrawal by Subject|1|||
161883614|NCT01668966|584618266|FG000|Overall Study|Death|1|||
161883615|NCT01668966|584618266|FG000|Overall Study|Not treated|2|||
161883616|NCT01573767|584618267|FG000|Overall Study|Adverse Event|0|||
161883617|NCT01573767|584618268|FG001|Overall Study|Adverse Event|1|||
161883618|NCT01573767|584618269|FG002|Overall Study|Adverse Event|0|||
161883619|NCT01573767|584618270|FG003|Overall Study|Adverse Event|1|||
161883620|NCT01573767|584618267|FG000|Overall Study|Lack of Efficacy|18|||
161883621|NCT01573767|584618268|FG001|Overall Study|Lack of Efficacy|15|||
161883622|NCT01573767|584618269|FG002|Overall Study|Lack of Efficacy|12|||
161883623|NCT01573767|584618270|FG003|Overall Study|Lack of Efficacy|17|||
161883624|NCT01573767|584618267|FG000|Overall Study|Protocol Violation|3|||
161883625|NCT01573767|584618268|FG001|Overall Study|Protocol Violation|1|||
161883626|NCT01573767|584618269|FG002|Overall Study|Protocol Violation|1|||
161883627|NCT01573767|584618270|FG003|Overall Study|Protocol Violation|3|||
161883628|NCT01573767|584618267|FG000|Overall Study|Lost to Follow-up|0|||
161883629|NCT01573767|584618268|FG001|Overall Study|Lost to Follow-up|1|||
161883630|NCT01573767|584618269|FG002|Overall Study|Lost to Follow-up|1|||
161883631|NCT01573767|584618270|FG003|Overall Study|Lost to Follow-up|1|||
161883632|NCT01573767|584618267|FG000|Overall Study|Physician Decision|1|||
161883633|NCT01573767|584618268|FG001|Overall Study|Physician Decision|2|||
161883634|NCT01573767|584618269|FG002|Overall Study|Physician Decision|0|||
161883635|NCT01573767|584618270|FG003|Overall Study|Physician Decision|2|||
161883636|NCT01573767|584618267|FG000|Overall Study|Withdrawal by Subject|0|||
161883637|NCT01573767|584618268|FG001|Overall Study|Withdrawal by Subject|1|||
161883638|NCT01573767|584618269|FG002|Overall Study|Withdrawal by Subject|0|||
161883639|NCT01573767|584618270|FG003|Overall Study|Withdrawal by Subject|0|||
161883640|NCT04247880|584618271|FG000|Overall Study|Lost to Follow-up|24|||
161883641|NCT04247880|584618272|FG001|Overall Study|Lost to Follow-up|17|||
161883642|NCT04247880|584618271|FG000|Overall Study|Withdrawal by Subject|3|||
161883643|NCT04247880|584618272|FG001|Overall Study|Withdrawal by Subject|0|||
161883644|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
161883645|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161883646|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
161883647|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
161883648|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161883649|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161883650|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Other|0|||
161883651|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Other|0|||
161883652|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Other|1|||
161883653|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Other|0|||
161883654|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Other|0|||
161883655|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Other|0|||
161883656|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883657|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
161883658|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883659|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883660|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883661|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883662|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
161883663|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
161883664|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161883665|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
161883666|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161883667|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161883668|NCT02122770|584618273|FG000|Part B: Standard of Care|Adverse Event|0|||
161883669|NCT02122770|584618274|FG001|Part B: Standard of Care|Adverse Event|0|||
161883670|NCT02122770|584618275|FG002|Part B: Standard of Care|Adverse Event|0|||
161883671|NCT02122770|584618276|FG003|Part B: Standard of Care|Adverse Event|0|||
161883672|NCT02122770|584618277|FG004|Part B: Standard of Care|Adverse Event|4|||
161883673|NCT02122770|584618278|FG005|Part B: Standard of Care|Adverse Event|1|||
161883674|NCT02122770|584618273|FG000|Part B: Standard of Care|Other|0|||
161883675|NCT02122770|584618274|FG001|Part B: Standard of Care|Other|0|||
161883676|NCT02122770|584618275|FG002|Part B: Standard of Care|Other|0|||
161883677|NCT02122770|584618276|FG003|Part B: Standard of Care|Other|0|||
161883678|NCT02122770|584618277|FG004|Part B: Standard of Care|Other|0|||
161883679|NCT02122770|584618278|FG005|Part B: Standard of Care|Other|2|||
161883680|NCT02122770|584618273|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
161883681|NCT02122770|584618274|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
161883682|NCT02122770|584618275|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
161883683|NCT02122770|584618276|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
161883684|NCT02122770|584618277|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
161883685|NCT02122770|584618278|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
161883686|NCT02122770|584618273|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883687|NCT02122770|584618274|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883688|NCT02122770|584618275|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883689|NCT02122770|584618276|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883690|NCT02122770|584618277|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
161883691|NCT02122770|584618278|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883692|NCT02122770|584618273|FG000|Part B: Standard of Care|Progressive Disease|0|||
161883693|NCT02122770|584618274|FG001|Part B: Standard of Care|Progressive Disease|0|||
161883694|NCT02122770|584618275|FG002|Part B: Standard of Care|Progressive Disease|0|||
161883695|NCT02122770|584618276|FG003|Part B: Standard of Care|Progressive Disease|0|||
161883696|NCT02122770|584618277|FG004|Part B: Standard of Care|Progressive Disease|10|||
161883697|NCT02122770|584618278|FG005|Part B: Standard of Care|Progressive Disease|8|||
161883698|NCT00250458|584618280|FG000|Overall Study|Lost to Follow-up|4|||
161883699|NCT00250458|584618281|FG001|Overall Study|Lost to Follow-up|2|||
161883700|NCT00250458|584618280|FG000|Overall Study|Protocol Violation|0|||
161883701|NCT00250458|584618281|FG001|Overall Study|Protocol Violation|1|||
161883702|NCT00250458|584618280|FG000|Overall Study|Withdrawal by Subject|4|||
161883703|NCT00250458|584618281|FG001|Overall Study|Withdrawal by Subject|2|||
161883704|NCT00250458|584618280|FG000|Overall Study|Lack of Migraine Attack|20|||
161883705|NCT00250458|584618281|FG001|Overall Study|Lack of Migraine Attack|9|||
161883706|NCT00250458|584618280|FG000|Overall Study|Qualifying migraine but did not treat|3|||
161883707|NCT00250458|584618281|FG001|Overall Study|Qualifying migraine but did not treat|3|||
161883708|NCT00250458|584618280|FG000|Overall Study|Other|1|||
161883709|NCT00250458|584618281|FG001|Overall Study|Other|0|||
161883710|NCT06137703|584618282|FG000|Overall Study|Other|0|||
161883711|NCT06137703|584618283|FG001|Overall Study|Other|1|||
161883712|NCT06137703|584618284|FG002|Overall Study|Other|0|||
161883713|NCT06137703|584618285|FG003|Overall Study|Other|0|||
161883714|NCT06137703|584618282|FG000|Overall Study|Adverse Event|0|||
161883715|NCT06137703|584618283|FG001|Overall Study|Adverse Event|0|||
161883716|NCT06137703|584618284|FG002|Overall Study|Adverse Event|1|||
161883717|NCT06137703|584618285|FG003|Overall Study|Adverse Event|0|||
161883718|NCT00767039|584618288|FG000|Overall Study|Death|5|||
161883719|NCT00767039|584618289|FG001|Overall Study|Death|2|||
161883720|NCT01472757|584618290|FG000|Overall Study|Withdrawal by Subject|1|||
161883721|NCT01472757|584618291|FG001|Overall Study|Withdrawal by Subject|2|||
161883722|NCT01472757|584618292|FG002|Overall Study|Withdrawal by Subject|2|||
161883723|NCT01472757|584618293|FG003|Overall Study|Withdrawal by Subject|0|||
161883724|NCT01472757|584618290|FG000|Overall Study|Asthma exacerbation|4|||
161883725|NCT01472757|584618291|FG001|Overall Study|Asthma exacerbation|1|||
161883726|NCT01472757|584618292|FG002|Overall Study|Asthma exacerbation|2|||
161883727|NCT01472757|584618293|FG003|Overall Study|Asthma exacerbation|1|||
161883728|NCT01472757|584618290|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
161883729|NCT01472757|584618291|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
161883730|NCT01472757|584618292|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
161883731|NCT01472757|584618293|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
161883732|NCT01472757|584618290|FG000|Overall Study|Protocol Violation|3|||
161883733|NCT01472757|584618291|FG001|Overall Study|Protocol Violation|2|||
161883734|NCT01472757|584618292|FG002|Overall Study|Protocol Violation|4|||
161883735|NCT01472757|584618293|FG003|Overall Study|Protocol Violation|4|||
161883736|NCT01472757|584618290|FG000|Overall Study|Other reasons|1|||
161883737|NCT01472757|584618291|FG001|Overall Study|Other reasons|0|||
161883738|NCT01472757|584618292|FG002|Overall Study|Other reasons|2|||
161883739|NCT01472757|584618293|FG003|Overall Study|Other reasons|2|||
161883740|NCT02505334|584618296|FG000|Main Treatment Period|Adverse Event|3|||
161883741|NCT02505334|584618297|FG001|Main Treatment Period|Adverse Event|3|||
161883742|NCT02505334|584618296|FG000|Main Treatment Period|Lack of Efficacy|7|||
161883743|NCT02505334|584618297|FG001|Main Treatment Period|Lack of Efficacy|17|||
161883744|NCT02505334|584618296|FG000|Main Treatment Period|Protocol Violation|0|||
161883745|NCT02505334|584618297|FG001|Main Treatment Period|Protocol Violation|1|||
161883746|NCT02505334|584618296|FG000|Main Treatment Period|Withdrawal by Subject|1|||
161883747|NCT02505334|584618297|FG001|Main Treatment Period|Withdrawal by Subject|8|||
161883748|NCT02505334|584618296|FG000|Main Treatment Period|Unclassified|4|||
161883749|NCT02505334|584618297|FG001|Main Treatment Period|Unclassified|10|||
161883750|NCT02505334|584618296|FG000|Extension Treatment Period|Adverse Event|5|||
161883751|NCT02505334|584618297|FG001|Extension Treatment Period|Adverse Event|0|||
161883752|NCT02505334|584618296|FG000|Extension Treatment Period|Lack of Efficacy|4|||
161883753|NCT02505334|584618297|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161883754|NCT02505334|584618296|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
161883755|NCT02505334|584618297|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161883756|NCT02505334|584618296|FG000|Extension Treatment Period|Unclassified|3|||
161883757|NCT02505334|584618297|FG001|Extension Treatment Period|Unclassified|0|||
161883758|NCT01549041|584618298|FG000|Overall Study|Lack of Efficacy|2|||
161883759|NCT01549041|584618299|FG001|Overall Study|Lack of Efficacy|4|||
161883760|NCT01549041|584618298|FG000|Overall Study|Adverse Event|0|||
161883761|NCT01549041|584618299|FG001|Overall Study|Adverse Event|4|||
161883762|NCT00597506|584618300|FG000|Overall Study|Subject is being followed for survival|1|||
161883763|NCT00525902|584618304|FG000|Overall Study|Lack of Efficacy|1|||
161883764|NCT03747302|584618305|FG000|Overall Study|Withdrawal by Subject|1|||
161883765|NCT03747302|584618306|FG001|Overall Study|Withdrawal by Subject|2|||
161883766|NCT00738062|584618309|FG000|Open Label Treatment|Lack of Efficacy|5|||
161883767|NCT00738062|584618310|FG001|Open Label Treatment|Lack of Efficacy|0|||
161883768|NCT00738062|584618311|FG002|Open Label Treatment|Lack of Efficacy|0|||
161883769|NCT00738062|584618309|FG000|Open Label Treatment|Adverse Event|11|||
161883770|NCT00738062|584618310|FG001|Open Label Treatment|Adverse Event|0|||
161883771|NCT00738062|584618311|FG002|Open Label Treatment|Adverse Event|0|||
161883772|NCT00738062|584618309|FG000|Open Label Treatment|Protocol Violation|2|||
161883773|NCT00738062|584618310|FG001|Open Label Treatment|Protocol Violation|0|||
161883774|NCT00738062|584618311|FG002|Open Label Treatment|Protocol Violation|0|||
161883775|NCT00738062|584618309|FG000|Open Label Treatment|Withdrawal by Subject|9|||
161883776|NCT00738062|584618310|FG001|Open Label Treatment|Withdrawal by Subject|0|||
161883777|NCT00738062|584618311|FG002|Open Label Treatment|Withdrawal by Subject|0|||
161883778|NCT00738062|584618309|FG000|Open Label Treatment|Investigator Decision|1|||
161883779|NCT00738062|584618310|FG001|Open Label Treatment|Investigator Decision|0|||
161883780|NCT00738062|584618311|FG002|Open Label Treatment|Investigator Decision|0|||
161883781|NCT00738062|584618309|FG000|Open-Label Extension|Adverse Event|5|||
161883782|NCT00738062|584618310|FG001|Open-Label Extension|Adverse Event|0|||
161883783|NCT00738062|584618311|FG002|Open-Label Extension|Adverse Event|0|||
161883784|NCT00738062|584618309|FG000|Open-Label Extension|Physician Decision|1|||
161883785|NCT00738062|584618310|FG001|Open-Label Extension|Physician Decision|0|||
161883786|NCT00738062|584618311|FG002|Open-Label Extension|Physician Decision|0|||
161883787|NCT00738062|584618309|FG000|Open-Label Extension|Lack of Efficacy|2|||
161883788|NCT00738062|584618310|FG001|Open-Label Extension|Lack of Efficacy|0|||
161883789|NCT00738062|584618311|FG002|Open-Label Extension|Lack of Efficacy|0|||
161883790|NCT00738062|584618309|FG000|Open-Label Extension|Withdrawal by Subject|6|||
161883791|NCT00738062|584618310|FG001|Open-Label Extension|Withdrawal by Subject|0|||
161883792|NCT00738062|584618311|FG002|Open-Label Extension|Withdrawal by Subject|0|||
161883793|NCT00738062|584618309|FG000|Open-Label Extension|Protocol Violation|1|||
161883794|NCT00738062|584618310|FG001|Open-Label Extension|Protocol Violation|0|||
161883795|NCT00738062|584618311|FG002|Open-Label Extension|Protocol Violation|0|||
161883796|NCT00738062|584618309|FG000|Open-Label Extension|Study Terminated|2|||
161883797|NCT00738062|584618310|FG001|Open-Label Extension|Study Terminated|0|||
161883798|NCT00738062|584618311|FG002|Open-Label Extension|Study Terminated|0|||
161883799|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
161883800|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
161883801|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
161883802|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
161883803|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Death|1|||
161883804|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Death|1|||
161883805|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
161883806|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
161883807|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
161883808|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
161883809|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
161883810|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
161883811|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
161883812|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
161883813|NCT00033657|584618313|FG000|Surgical Resection|not complete resection|0|||
161883814|NCT00033657|584618314|FG001|Surgical Resection|not complete resection|3|||
161883815|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
161883816|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
161883817|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
161883818|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
161883819|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Death|2|||
161883820|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Death|1|||
161883821|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
161883822|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
161883823|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
161883824|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
161883825|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Other|0|||
161883826|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Other|2|||
161883827|NCT03235115|584618315|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883828|NCT03235115|584618316|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883829|NCT03235115|584618317|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883830|NCT03235115|584618318|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883831|NCT03235115|584618319|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883832|NCT03235115|584618320|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
161883833|NCT00503997|584618322|FG000|Overall Study|disease progression|1|||
161883834|NCT00503997|584618322|FG000|Overall Study|Adverse Event|5|||
161883835|NCT00503997|584618322|FG000|Overall Study|Death|1|||
161883836|NCT00503997|584618322|FG000|Overall Study|Withdrawal by Subject|1|||
161883837|NCT00656851|584618327|FG000|Overall Study|Withdrawal by Subject|0|||
161883838|NCT00656851|584618328|FG001|Overall Study|Withdrawal by Subject|4|||
161883839|NCT00955968|584618333|FG000|Overall Study|Death|2|||
161883840|NCT00955968|584618334|FG001|Overall Study|Death|4|||
161883841|NCT00955968|584618333|FG000|Overall Study|Withdrawal by Subject|35|||
161883842|NCT00955968|584618334|FG001|Overall Study|Withdrawal by Subject|31|||
161883843|NCT00955968|584618333|FG000|Overall Study|Lost to Follow-up|45|||
161883844|NCT00955968|584618334|FG001|Overall Study|Lost to Follow-up|39|||
161883845|NCT00955968|584618333|FG000|Overall Study|Site closed|55|||
161883846|NCT00955968|584618334|FG001|Overall Study|Site closed|52|||
161883847|NCT05020899|584618336|FG000|8 Week Follow-up|Lost to Follow-up|3|||
161883848|NCT05020899|584618337|FG001|8 Week Follow-up|Lost to Follow-up|6|||
161883849|NCT05020899|584618336|FG000|12 Week Follow-up|Lost to Follow-up|1|||
161883850|NCT05020899|584618337|FG001|12 Week Follow-up|Lost to Follow-up|0|||
161883851|NCT05020899|584618336|FG000|12 Week Follow-up|Death|0|||
161883852|NCT05020899|584618337|FG001|12 Week Follow-up|Death|1|||
161883853|NCT01940900|584618340|FG000|Overall Study|Physician Decision|4|||
161883854|NCT01940900|584618341|FG001|Overall Study|Physician Decision|0|||
161883855|NCT01940900|584618340|FG000|Overall Study|Adverse Event|10|||
161883856|NCT01940900|584618341|FG001|Overall Study|Adverse Event|15|||
161883857|NCT01940900|584618340|FG000|Overall Study|Withdrawal by Subject|11|||
161883858|NCT01940900|584618341|FG001|Overall Study|Withdrawal by Subject|15|||
161883859|NCT01940900|584618340|FG000|Overall Study|Lost to Follow-up|1|||
161883860|NCT01940900|584618341|FG001|Overall Study|Lost to Follow-up|0|||
161883861|NCT01940900|584618340|FG000|Overall Study|Sponsor Decision|1|||
161883862|NCT01940900|584618341|FG001|Overall Study|Sponsor Decision|0|||
161883863|NCT01940900|584618340|FG000|Overall Study|subject non-compliance|1|||
161883864|NCT01940900|584618341|FG001|Overall Study|subject non-compliance|1|||
161883865|NCT01940900|584618340|FG000|Overall Study|other|1|||
161883866|NCT01940900|584618341|FG001|Overall Study|other|0|||
161883867|NCT04713592|584618342|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161883868|NCT04713592|584618343|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
161883869|NCT04713592|584618344|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161883870|NCT04713592|584618345|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161883871|NCT04713592|584618342|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
161883872|NCT04713592|584618343|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
161883873|NCT04713592|584618344|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
161883874|NCT04713592|584618345|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
161883875|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
161883876|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
161883877|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
161883878|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
161883879|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161883880|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161883881|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
161883882|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
161883883|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
161883884|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
161883885|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
161883886|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
161883887|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161883888|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161883889|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161883890|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161883891|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
161883892|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
161883893|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
161883894|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
161883895|NCT02225366|584618350|FG000|Overall Study|Lack of Efficacy|1|||
161883896|NCT02225366|584618351|FG001|Overall Study|Lack of Efficacy|0|||
161883897|NCT03782298|584618352|FG000|Overall Study|Protocol Deviation|4|||
161883898|NCT02431806|584618353|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
161883899|NCT02431806|584618354|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
161883900|NCT02431806|584618355|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
161883901|NCT02431806|584618356|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
161883902|NCT02431806|584618353|FG000|Double-blind Treatment Period|Adverse Event|4|||
161883903|NCT02431806|584618354|FG001|Double-blind Treatment Period|Adverse Event|7|||
161883904|NCT02431806|584618355|FG002|Double-blind Treatment Period|Adverse Event|11|||
161883905|NCT02431806|584618356|FG003|Double-blind Treatment Period|Adverse Event|7|||
161883906|NCT02431806|584618353|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
161883907|NCT02431806|584618354|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161883908|NCT02431806|584618355|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
161883909|NCT02431806|584618356|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
161883910|NCT02431806|584618353|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
161883911|NCT02431806|584618354|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
161883912|NCT02431806|584618355|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
161883913|NCT02431806|584618356|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
161883914|NCT02431806|584618353|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
161883915|NCT02431806|584618354|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
161883916|NCT02431806|584618355|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161883917|NCT02431806|584618356|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
161883918|NCT02431806|584618353|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
161883919|NCT02431806|584618354|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
161883920|NCT02431806|584618355|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
161883921|NCT02431806|584618356|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
161883922|NCT02431806|584618353|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
161883923|NCT02431806|584618354|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
161883924|NCT02431806|584618355|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
161883925|NCT02431806|584618356|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
161883926|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
161883927|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
161883928|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
161883929|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
161883930|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
161883931|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
161883932|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
161883933|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
161883934|NCT00742508|584618357|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
161883935|NCT00742508|584618358|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
161883936|NCT01382225|584618359|FG000|Overall Study|Adverse Event|3|||
161883937|NCT01382225|584618360|FG001|Overall Study|Adverse Event|2|||
161883938|NCT01382225|584618359|FG000|Overall Study|Protocol Violation|2|||
161883939|NCT01382225|584618360|FG001|Overall Study|Protocol Violation|1|||
161883940|NCT01382225|584618359|FG000|Overall Study|Subject Withdrew Consent|5|||
161883941|NCT01382225|584618360|FG001|Overall Study|Subject Withdrew Consent|2|||
161883942|NCT01382225|584618359|FG000|Overall Study|Other|4|||
161883943|NCT01382225|584618360|FG001|Overall Study|Other|2|||
161883944|NCT01797081|584618361|FG000|Overall Study|Adverse Event|1|||
161883945|NCT01797081|584618362|FG001|Overall Study|Adverse Event|0|||
161883946|NCT01797081|584618363|FG002|Overall Study|Adverse Event|1|||
161883947|NCT01797081|584618364|FG003|Overall Study|Adverse Event|0|||
161883948|NCT01797081|584618361|FG000|Overall Study|Pregnancy|1|||
161883949|NCT01797081|584618362|FG001|Overall Study|Pregnancy|0|||
161883950|NCT01797081|584618363|FG002|Overall Study|Pregnancy|0|||
161883951|NCT01797081|584618364|FG003|Overall Study|Pregnancy|0|||
161883952|NCT01797081|584618361|FG000|Overall Study|Personal Reasons|12|||
161883953|NCT01797081|584618362|FG001|Overall Study|Personal Reasons|4|||
161883954|NCT01797081|584618363|FG002|Overall Study|Personal Reasons|4|||
161883955|NCT01797081|584618364|FG003|Overall Study|Personal Reasons|8|||
161883956|NCT01797081|584618361|FG000|Overall Study|Protocol Violation|0|||
161883957|NCT01797081|584618362|FG001|Overall Study|Protocol Violation|0|||
161883958|NCT01797081|584618363|FG002|Overall Study|Protocol Violation|0|||
161883959|NCT01797081|584618364|FG003|Overall Study|Protocol Violation|1|||
161883960|NCT02484651|584618370|FG000|Overall Study|Patients' data files were corrupted.|1|||
161883961|NCT02484651|584618371|FG001|Overall Study|Patients' data files were corrupted.|1|||
161883962|NCT02484651|584618370|FG000|Overall Study|BIS monitoring failed.|1|||
161883963|NCT02484651|584618371|FG001|Overall Study|BIS monitoring failed.|1|||
161883964|NCT02484651|584618370|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
161883965|NCT02484651|584618371|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
161883966|NCT01419080|584618372|FG000|Overall Study|Withdrawal by Subject|75|||
161883967|NCT01419080|584618372|FG000|Overall Study|Death|30|||
161883968|NCT01419080|584618372|FG000|Overall Study|Lost to Follow-up|23|||
161883969|NCT01419080|584618372|FG000|Overall Study|Too Ill|3|||
161883970|NCT00150800|584618373|FG000|Overall Study|Adverse Event|89|||
161883971|NCT00150800|584618373|FG000|Overall Study|Death|18|||
161883972|NCT00150800|584618373|FG000|Overall Study|Lack of Efficacy|166|||
161883973|NCT00150800|584618373|FG000|Overall Study|Lost to Follow-up|58|||
161883974|NCT00150800|584618373|FG000|Overall Study|Subject's choice|90|||
161883975|NCT00150800|584618373|FG000|Overall Study|No compliance|18|||
161883976|NCT00150800|584618373|FG000|Overall Study|IP misshandling|1|||
161883977|NCT00150800|584618373|FG000|Overall Study|Site closure|24|||
161883978|NCT00150800|584618373|FG000|Overall Study|Protocol non-adherence|2|||
161883979|NCT00150800|584618373|FG000|Overall Study|Nobody to accompany patient|1|||
161883980|NCT00150800|584618373|FG000|Overall Study|Distance too long for patient|1|||
161883981|NCT00150800|584618373|FG000|Overall Study|Neurosurgery|2|||
161883982|NCT00150800|584618373|FG000|Overall Study|BRV monotherapy|1|||
161883983|NCT00150800|584618373|FG000|Overall Study|Visit refusal|3|||
161883984|NCT00150800|584618373|FG000|Overall Study|Sponsor's request|2|||
161883985|NCT00150800|584618373|FG000|Overall Study|Generalized Epilepsy|1|||
161883986|NCT00150800|584618373|FG000|Overall Study|Moved from area/country|8|||
161883987|NCT00150800|584618373|FG000|Overall Study|PI retiring|2|||
161883988|NCT00150800|584618373|FG000|Overall Study|PI leaving site|2|||
161883989|NCT00150800|584618373|FG000|Overall Study|Patient insurance|1|||
161883990|NCT00150800|584618373|FG000|Overall Study|Surgical intervention|4|||
161883991|NCT00150800|584618373|FG000|Overall Study|Pregnancy planned|1|||
161883992|NCT00150800|584618373|FG000|Overall Study|PI discontinuation request|1|||
161883993|NCT04972968|584618374|FG000|Overall Study|Adverse Event|3|||
161883994|NCT04972968|584618375|FG001|Overall Study|Adverse Event|1|||
161883995|NCT04972968|584618376|FG002|Overall Study|Adverse Event|1|||
161883996|NCT04972968|584618377|FG003|Overall Study|Adverse Event|7|||
161883997|NCT04972968|584618374|FG000|Overall Study|Lack of Efficacy|2|||
161883998|NCT04972968|584618375|FG001|Overall Study|Lack of Efficacy|1|||
161883999|NCT04972968|584618376|FG002|Overall Study|Lack of Efficacy|0|||
161884000|NCT04972968|584618377|FG003|Overall Study|Lack of Efficacy|0|||
161884001|NCT04972968|584618374|FG000|Overall Study|Withdrawal by Subject|7|||
161884002|NCT04972968|584618375|FG001|Overall Study|Withdrawal by Subject|4|||
161884003|NCT04972968|584618376|FG002|Overall Study|Withdrawal by Subject|3|||
161884004|NCT04972968|584618377|FG003|Overall Study|Withdrawal by Subject|2|||
161884005|NCT04972968|584618374|FG000|Overall Study|Study Terminated by Sponsor|25|||
161884006|NCT04972968|584618375|FG001|Overall Study|Study Terminated by Sponsor|28|||
161884007|NCT04972968|584618376|FG002|Overall Study|Study Terminated by Sponsor|32|||
161884008|NCT04972968|584618377|FG003|Overall Study|Study Terminated by Sponsor|27|||
161884009|NCT04972968|584618374|FG000|Overall Study|Other|1|||
161884010|NCT04972968|584618375|FG001|Overall Study|Other|0|||
161884011|NCT04972968|584618376|FG002|Overall Study|Other|1|||
161884012|NCT04972968|584618377|FG003|Overall Study|Other|1|||
161884013|NCT01698879|584618378|FG000|Overall Study|Withdrawal by Subject|1|||
161884014|NCT01698879|584618379|FG001|Overall Study|Withdrawal by Subject|0|||
161884015|NCT01698879|584618380|FG002|Overall Study|Withdrawal by Subject|0|||
161884016|NCT03649178|584618381|FG000|Overall Study|Adverse Event|1|||
161884017|NCT03649178|584618382|FG001|Overall Study|Adverse Event|2|||
161884018|NCT03649178|584618381|FG000|Overall Study|Withdrawal by Subject|0|||
161884019|NCT03649178|584618382|FG001|Overall Study|Withdrawal by Subject|2|||
161884020|NCT03649178|584618381|FG000|Overall Study|COVID regulation required halt in protocol|1|||
161884021|NCT03649178|584618382|FG001|Overall Study|COVID regulation required halt in protocol|0|||
161884022|NCT03619902|584618384|FG000|Overall Study|Termination of Study by Investigator|1|||
161884023|NCT03619902|584618384|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
161884024|NCT03814720|584618390|FG000|Overall Study|Lost to Follow-up|0|||
161884025|NCT03814720|584618391|FG001|Overall Study|Lost to Follow-up|1|||
161884026|NCT03814720|584618392|FG002|Overall Study|Lost to Follow-up|0|||
161884027|NCT03814720|584618393|FG003|Overall Study|Lost to Follow-up|0|||
161884028|NCT03814720|584618394|FG004|Overall Study|Lost to Follow-up|0|||
161884029|NCT01095978|584618395|FG000|Overall Study|Did not take Klacid SR|2|||
161884030|NCT01095978|584618395|FG000|Overall Study|Adverse Event|1|||
161884031|NCT03197324|584618399|FG000|Overall Study|Adverse Event|0|||
161884032|NCT03197324|584618400|FG001|Overall Study|Adverse Event|1|||
161884033|NCT03589976|584618407|FG000|Overall Study|Death|5|||
161884034|NCT03589976|584618408|FG001|Overall Study|Death|1|||
161884035|NCT03589976|584618407|FG000|Overall Study|Adverse Event|5|||
161884036|NCT03589976|584618408|FG001|Overall Study|Adverse Event|1|||
161884037|NCT03589976|584618407|FG000|Overall Study|Withdrawal by Subject|4|||
161884038|NCT03589976|584618408|FG001|Overall Study|Withdrawal by Subject|1|||
161884039|NCT03589976|584618407|FG000|Overall Study|Lost to Follow-up|1|||
161884040|NCT03589976|584618408|FG001|Overall Study|Lost to Follow-up|0|||
161884041|NCT03589976|584618407|FG000|Overall Study|Other|4|||
161884042|NCT03589976|584618408|FG001|Overall Study|Other|3|||
161884043|NCT00710684|584618409|FG000|Overall Study|Adverse Event|11|||
161884044|NCT00710684|584618410|FG001|Overall Study|Adverse Event|19|||
161884045|NCT00710684|584618411|FG002|Overall Study|Adverse Event|16|||
161884046|NCT00710684|584618409|FG000|Overall Study|Lack of Efficacy|4|||
161884047|NCT00710684|584618410|FG001|Overall Study|Lack of Efficacy|3|||
161884048|NCT00710684|584618411|FG002|Overall Study|Lack of Efficacy|5|||
161884049|NCT00710684|584618409|FG000|Overall Study|Protocol Violation|5|||
161884050|NCT00710684|584618410|FG001|Overall Study|Protocol Violation|5|||
161884051|NCT00710684|584618411|FG002|Overall Study|Protocol Violation|5|||
161884052|NCT00710684|584618409|FG000|Overall Study|Lost to Follow-up|4|||
161884053|NCT00710684|584618410|FG001|Overall Study|Lost to Follow-up|6|||
161884054|NCT00710684|584618411|FG002|Overall Study|Lost to Follow-up|7|||
161884055|NCT00710684|584618409|FG000|Overall Study|Physician Decision|0|||
161884056|NCT00710684|584618410|FG001|Overall Study|Physician Decision|2|||
161884057|NCT00710684|584618411|FG002|Overall Study|Physician Decision|4|||
161884058|NCT00710684|584618409|FG000|Overall Study|Withdrawal by Subject|24|||
161884059|NCT00710684|584618410|FG001|Overall Study|Withdrawal by Subject|18|||
161884060|NCT00710684|584618411|FG002|Overall Study|Withdrawal by Subject|11|||
161884061|NCT00710684|584618409|FG000|Overall Study|Missing|1|||
161884062|NCT00710684|584618410|FG001|Overall Study|Missing|0|||
161884063|NCT00710684|584618411|FG002|Overall Study|Missing|0|||
161884064|NCT00710684|584618409|FG000|Overall Study|Did not continue after week 24|25|||
161884065|NCT00710684|584618410|FG001|Overall Study|Did not continue after week 24|21|||
161884066|NCT00710684|584618411|FG002|Overall Study|Did not continue after week 24|16|||
161884067|NCT04778059|584618412|FG000|Overall Study|Death|2|||
161884068|NCT04778059|584618413|FG001|Overall Study|Death|2|||
161884069|NCT04778059|584618414|FG002|Overall Study|Death|1|||
161884070|NCT04778059|584618415|FG003|Overall Study|Death|1|||
161884071|NCT04778059|584618416|FG004|Overall Study|Death|1|||
161884072|NCT04778059|584618412|FG000|Overall Study|Lost to Follow-up|0|||
161884073|NCT04778059|584618413|FG001|Overall Study|Lost to Follow-up|0|||
161884074|NCT04778059|584618414|FG002|Overall Study|Lost to Follow-up|0|||
161884075|NCT04778059|584618415|FG003|Overall Study|Lost to Follow-up|0|||
161884076|NCT04778059|584618416|FG004|Overall Study|Lost to Follow-up|1|||
161884077|NCT04778059|584618412|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884078|NCT04778059|584618413|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884079|NCT04778059|584618414|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884080|NCT04778059|584618415|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884081|NCT04778059|584618416|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
161884082|NCT02832375|584618417|FG000|Overall Study|Lost to Follow-up|1|||
161884083|NCT02832375|584618418|FG001|Overall Study|Lost to Follow-up|0|||
161884084|NCT02832375|584618417|FG000|Overall Study|Withdrawal of Consent|1|||
161884085|NCT02832375|584618418|FG001|Overall Study|Withdrawal of Consent|0|||
161884086|NCT00514904|584618419|FG000|Overall Study|Withdrawal by Subject|3|||
161884087|NCT00514904|584618420|FG001|Overall Study|Withdrawal by Subject|2|||
161884088|NCT00514904|584618419|FG000|Overall Study|Lost to Follow-up|21|||
161884089|NCT00514904|584618420|FG001|Overall Study|Lost to Follow-up|3|||
161884090|NCT00084318|584618421|FG000|Overall Study|Withdrawal by Subject|5|||
161884091|NCT00084318|584618422|FG001|Overall Study|Withdrawal by Subject|2|||
161884092|NCT00084318|584618421|FG000|Overall Study|Protocol Violation|15|||
161884093|NCT00084318|584618422|FG001|Overall Study|Protocol Violation|11|||
161884094|NCT00084318|584618421|FG000|Overall Study|No protocol treatment|2|||
161884095|NCT00084318|584618422|FG001|Overall Study|No protocol treatment|0|||
161884096|NCT00549601|584620005|FG000|Randomized|Protocol Violation|0|||
161884097|NCT00549601|584620006|FG001|Randomized|Protocol Violation|0|||
161884098|NCT00549601|584620007|FG002|Randomized|Protocol Violation|1|||
161884099|NCT00549601|584620005|FG000|Randomized|Withdrawal by Subject|0|||
161884100|NCT00549601|584620006|FG001|Randomized|Withdrawal by Subject|1|||
161884101|NCT00549601|584620007|FG002|Randomized|Withdrawal by Subject|1|||
161884102|NCT00549601|584620005|FG000|Received Study Drug|Adverse Event|2|||
161884103|NCT00549601|584620006|FG001|Received Study Drug|Adverse Event|5|||
161884104|NCT00549601|584620007|FG002|Received Study Drug|Adverse Event|1|||
161884105|NCT00549601|584620005|FG000|Received Study Drug|Death|0|||
161884106|NCT00549601|584620006|FG001|Received Study Drug|Death|1|||
161884107|NCT00549601|584620007|FG002|Received Study Drug|Death|0|||
161884108|NCT00549601|584620005|FG000|Received Study Drug|Lost to Follow-up|0|||
161884109|NCT00549601|584620006|FG001|Received Study Drug|Lost to Follow-up|1|||
161884110|NCT00549601|584620007|FG002|Received Study Drug|Lost to Follow-up|1|||
161884111|NCT00549601|584620005|FG000|Received Study Drug|Protocol Violation|3|||
161884112|NCT00549601|584620006|FG001|Received Study Drug|Protocol Violation|4|||
161884113|NCT00549601|584620007|FG002|Received Study Drug|Protocol Violation|1|||
161884114|NCT00549601|584620005|FG000|Received Study Drug|Withdrawal by Subject|2|||
161884115|NCT00549601|584620006|FG001|Received Study Drug|Withdrawal by Subject|0|||
161884116|NCT00549601|584620007|FG002|Received Study Drug|Withdrawal by Subject|1|||
161884117|NCT00908596|584620011|FG000|Overall Study|Other reasons|46|||
161884118|NCT00908596|584620012|FG001|Overall Study|Other reasons|6|||
161884119|NCT00908596|584620013|FG002|Overall Study|Other reasons|2|||
161884120|NCT00908596|584620014|FG003|Overall Study|Other reasons|0|||
161884121|NCT00908596|584620011|FG000|Overall Study|Lost to Follow-up|0|||
161884122|NCT00908596|584620012|FG001|Overall Study|Lost to Follow-up|1|||
161884123|NCT00908596|584620013|FG002|Overall Study|Lost to Follow-up|12|||
161884124|NCT00908596|584620014|FG003|Overall Study|Lost to Follow-up|4|||
161884125|NCT00908596|584620011|FG000|Overall Study|Death|0|||
161884126|NCT00908596|584620012|FG001|Overall Study|Death|5|||
161884127|NCT00908596|584620013|FG002|Overall Study|Death|57|||
161884128|NCT00908596|584620014|FG003|Overall Study|Death|32|||
161884129|NCT00908596|584620011|FG000|Overall Study|Protocol Violation|1|||
161884130|NCT00908596|584620012|FG001|Overall Study|Protocol Violation|0|||
161884131|NCT00908596|584620013|FG002|Overall Study|Protocol Violation|0|||
161884132|NCT00908596|584620014|FG003|Overall Study|Protocol Violation|0|||
161884133|NCT00908596|584620011|FG000|Overall Study|Withdrawal by Subject|0|||
161884134|NCT00908596|584620012|FG001|Overall Study|Withdrawal by Subject|1|||
161884135|NCT00908596|584620013|FG002|Overall Study|Withdrawal by Subject|3|||
161884136|NCT00908596|584620014|FG003|Overall Study|Withdrawal by Subject|1|||
161884137|NCT01556997|584620017|FG000|Overall Study|Adverse Event|10|||
161884138|NCT01556997|584620018|FG001|Overall Study|Adverse Event|12|||
161884139|NCT01556997|584620019|FG002|Overall Study|Adverse Event|12|||
161884140|NCT01556997|584620017|FG000|Overall Study|Lost to Follow-up|6|||
161884141|NCT01556997|584620018|FG001|Overall Study|Lost to Follow-up|6|||
161884142|NCT01556997|584620019|FG002|Overall Study|Lost to Follow-up|4|||
161884143|NCT01556997|584620017|FG000|Overall Study|Physician Decision|1|||
161884144|NCT01556997|584620018|FG001|Overall Study|Physician Decision|1|||
161884145|NCT01556997|584620019|FG002|Overall Study|Physician Decision|1|||
161884146|NCT01556997|584620017|FG000|Overall Study|Withdrawal by Subject|7|||
161884147|NCT01556997|584620018|FG001|Overall Study|Withdrawal by Subject|6|||
161884148|NCT01556997|584620019|FG002|Overall Study|Withdrawal by Subject|8|||
161884149|NCT01556997|584620017|FG000|Overall Study|Other|2|||
161884150|NCT01556997|584620018|FG001|Overall Study|Other|3|||
161884151|NCT01556997|584620019|FG002|Overall Study|Other|7|||
161884152|NCT05459558|584620020|FG000|Overall Study|Adverse Event|1|||
161884153|NCT05459558|584620021|FG001|Overall Study|Adverse Event|0|||
161884154|NCT05459558|584620022|FG002|Overall Study|Adverse Event|0|||
161884155|NCT05459558|584620020|FG000|Overall Study|Scheduling issue|0|||
161884156|NCT05459558|584620021|FG001|Overall Study|Scheduling issue|1|||
161884157|NCT05459558|584620022|FG002|Overall Study|Scheduling issue|3|||
161884158|NCT05459558|584620020|FG000|Overall Study|Withdrawal by Subject|0|||
161884159|NCT05459558|584620021|FG001|Overall Study|Withdrawal by Subject|0|||
161884160|NCT05459558|584620022|FG002|Overall Study|Withdrawal by Subject|2|||
161884161|NCT01250171|584620028|FG000|Overall Study|Administrative reasons|1|||
161884162|NCT01250171|584620029|FG001|Overall Study|Administrative reasons|0|||
161884163|NCT01250171|584620030|FG002|Overall Study|Administrative reasons|0|||
161884164|NCT01458951|584620048|FG000|Overall Study|Other|1|||
161884165|NCT01458951|584620049|FG001|Overall Study|Other|0|||
161884166|NCT01458951|584620050|FG002|Overall Study|Other|0|||
161884167|NCT01458951|584620048|FG000|Overall Study|Protocol Violation|5|||
161884168|NCT01458951|584620049|FG001|Overall Study|Protocol Violation|1|||
161884169|NCT01458951|584620050|FG002|Overall Study|Protocol Violation|0|||
161884170|NCT01458951|584620048|FG000|Overall Study|Withdrawal by Subject|2|||
161884171|NCT01458951|584620049|FG001|Overall Study|Withdrawal by Subject|0|||
161884172|NCT01458951|584620050|FG002|Overall Study|Withdrawal by Subject|2|||
161884173|NCT01458951|584620048|FG000|Overall Study|Adverse Event|7|||
161884174|NCT01458951|584620049|FG001|Overall Study|Adverse Event|0|||
161884175|NCT01458951|584620050|FG002|Overall Study|Adverse Event|2|||
161884176|NCT01458951|584620048|FG000|Overall Study|Insufficient Clinical Response|17|||
161884177|NCT01458951|584620049|FG001|Overall Study|Insufficient Clinical Response|0|||
161884178|NCT01458951|584620050|FG002|Overall Study|Insufficient Clinical Response|11|||
161884179|NCT01846221|584620053|FG000|Overall Study|Catheter Failure|2|||
161884180|NCT01846221|584620054|FG001|Overall Study|Catheter Failure|0|||
161884181|NCT01846221|584620053|FG000|Overall Study|Age Exclusion|1|||
161884182|NCT01846221|584620054|FG001|Overall Study|Age Exclusion|0|||
161884183|NCT04392167|584620055|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
161884184|NCT03427268|584620056|FG000|Overall Study|Progressive disease|25|||
161884185|NCT03427268|584620056|FG000|Overall Study|Never treated|2|||
161884186|NCT03427268|584620056|FG000|Overall Study|Compassionate use|1|||
161884187|NCT03427268|584620056|FG000|Overall Study|Withdrawal by Subject|1|||
161884188|NCT03427268|584620056|FG000|Overall Study|Adverse Event|3|||
161884189|NCT03117881|584620057|FG000|Baseline|Withdrawal by Subject|21|||
161884190|NCT03117881|584620058|FG001|Baseline|Withdrawal by Subject|10|||
161884191|NCT03117881|584620059|FG002|Baseline|Withdrawal by Subject|0|||
161884192|NCT03117881|584620057|FG000|Baseline|Lost to Follow-up|22|||
161884193|NCT03117881|584620058|FG001|Baseline|Lost to Follow-up|25|||
161884194|NCT03117881|584620059|FG002|Baseline|Lost to Follow-up|0|||
161884195|NCT03117881|584620057|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
161884196|NCT03117881|584620058|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
161884197|NCT03117881|584620059|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
161884198|NCT03117881|584620057|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
161884199|NCT03117881|584620058|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
161884200|NCT03117881|584620059|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
161884201|NCT03117881|584620057|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
161884202|NCT03117881|584620058|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
161884203|NCT03117881|584620059|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
161884204|NCT03117881|584620057|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
161884205|NCT03117881|584620058|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
161884206|NCT03117881|584620059|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
161884207|NCT03117881|584620057|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
161884208|NCT03117881|584620058|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
161884209|NCT03117881|584620059|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
161884210|NCT03117881|584620057|FG000|6-Month Follow-Up|Did not complete test|53|||
161884211|NCT03117881|584620058|FG001|6-Month Follow-Up|Did not complete test|25|||
161884212|NCT03117881|584620059|FG002|6-Month Follow-Up|Did not complete test|7|||
161884213|NCT03117881|584620057|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
161884214|NCT03117881|584620058|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
161884215|NCT03117881|584620059|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
161884216|NCT03117881|584620057|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
161884217|NCT03117881|584620058|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
161884218|NCT03117881|584620059|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
161884219|NCT03117881|584620057|FG000|12-Month Follow-Up|Did not complete test|40|||
161884220|NCT03117881|584620058|FG001|12-Month Follow-Up|Did not complete test|0|||
161884221|NCT03117881|584620059|FG002|12-Month Follow-Up|Did not complete test|0|||
161884222|NCT00473824|584620060|FG000|Overall Study|Virologic Breakthrough|1|||
161884223|NCT00473824|584620061|FG001|Overall Study|Virologic Breakthrough|0|||
161884224|NCT00473824|584620060|FG000|Overall Study|Adverse Event|1|||
161884225|NCT00473824|584620061|FG001|Overall Study|Adverse Event|0|||
161884226|NCT00473824|584620060|FG000|Overall Study|Death|1|||
161884227|NCT00473824|584620061|FG001|Overall Study|Death|0|||
161884228|NCT00473824|584620060|FG000|Overall Study|Lost to Follow-up|1|||
161884229|NCT00473824|584620061|FG001|Overall Study|Lost to Follow-up|0|||
161884230|NCT00473824|584620060|FG000|Overall Study|Withdrawal by physician|1|||
161884231|NCT00473824|584620061|FG001|Overall Study|Withdrawal by physician|0|||
161884232|NCT04076059|584620067|FG000|Double Blind Phase|Progressive disease|22|||
161884233|NCT04076059|584620068|FG001|Double Blind Phase|Progressive disease|26|||
161884234|NCT04076059|584620069|FG002|Double Blind Phase|Progressive disease|0|||
161884235|NCT04076059|584620067|FG000|Double Blind Phase|Withdrawal by Subject|4|||
161884236|NCT04076059|584620068|FG001|Double Blind Phase|Withdrawal by Subject|11|||
161884237|NCT04076059|584620069|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161884238|NCT04076059|584620067|FG000|Double Blind Phase|Death|1|||
161884239|NCT04076059|584620068|FG001|Double Blind Phase|Death|1|||
161884240|NCT04076059|584620069|FG002|Double Blind Phase|Death|0|||
161884241|NCT04076059|584620067|FG000|Double Blind Phase|Lost to Follow-up|1|||
161884242|NCT04076059|584620068|FG001|Double Blind Phase|Lost to Follow-up|0|||
161884243|NCT04076059|584620069|FG002|Double Blind Phase|Lost to Follow-up|0|||
161884244|NCT04076059|584620067|FG000|Double Blind Phase|Adverse Event|5|||
161884245|NCT04076059|584620068|FG001|Double Blind Phase|Adverse Event|1|||
161884246|NCT04076059|584620069|FG002|Double Blind Phase|Adverse Event|0|||
161884247|NCT04076059|584620067|FG000|Double Blind Phase|Ongoing Participants|82|||
161884248|NCT04076059|584620068|FG001|Double Blind Phase|Ongoing Participants|18|||
161884249|NCT04076059|584620069|FG002|Double Blind Phase|Ongoing Participants|0|||
161884250|NCT04076059|584620067|FG000|Double Blind Phase|Miscellaneous|3|||
161884251|NCT04076059|584620068|FG001|Double Blind Phase|Miscellaneous|1|||
161884252|NCT04076059|584620069|FG002|Double Blind Phase|Miscellaneous|0|||
161884253|NCT04076059|584620067|FG000|Double Blind Phase|Protocol Deviation|1|||
161884254|NCT04076059|584620068|FG001|Double Blind Phase|Protocol Deviation|1|||
161884255|NCT04076059|584620069|FG002|Double Blind Phase|Protocol Deviation|0|||
161884256|NCT04076059|584620067|FG000|Double Blind Phase|Did not take study drug|1|||
161884257|NCT04076059|584620068|FG001|Double Blind Phase|Did not take study drug|1|||
161884258|NCT04076059|584620069|FG002|Double Blind Phase|Did not take study drug|0|||
161884259|NCT04076059|584620067|FG000|Open Label Phase|Progressive disease|0|||
161884260|NCT04076059|584620068|FG001|Open Label Phase|Progressive disease|0|||
161884261|NCT04076059|584620069|FG002|Open Label Phase|Progressive disease|7|||
161884262|NCT04076059|584620067|FG000|Open Label Phase|Withdrawal by Subject|0|||
161884263|NCT04076059|584620068|FG001|Open Label Phase|Withdrawal by Subject|0|||
161884264|NCT04076059|584620069|FG002|Open Label Phase|Withdrawal by Subject|3|||
161884265|NCT04076059|584620067|FG000|Open Label Phase|Death|0|||
161884266|NCT04076059|584620068|FG001|Open Label Phase|Death|0|||
161884267|NCT04076059|584620069|FG002|Open Label Phase|Death|2|||
161884268|NCT04076059|584620067|FG000|Open Label Phase|Ongoing Participants|0|||
161884269|NCT04076059|584620068|FG001|Open Label Phase|Ongoing Participants|0|||
161884270|NCT04076059|584620069|FG002|Open Label Phase|Ongoing Participants|11|||
161884271|NCT04186806|584620070|FG000|Period 1: 7 Days|Adverse Event|1|||
161884272|NCT04186806|584620071|FG001|Period 1: 7 Days|Adverse Event|0|||
161884273|NCT02720744|584620073|FG000|Overall Study|Protocol Violation|0|||
161884274|NCT02720744|584620074|FG001|Overall Study|Protocol Violation|2|||
161884275|NCT02720744|584620073|FG000|Overall Study|Pregnancy|2|||
161884276|NCT02720744|584620074|FG001|Overall Study|Pregnancy|0|||
161884277|NCT02720744|584620073|FG000|Overall Study|Lack of Efficacy|2|||
161884278|NCT02720744|584620074|FG001|Overall Study|Lack of Efficacy|8|||
161884279|NCT02720744|584620073|FG000|Overall Study|Adverse Event|21|||
161884280|NCT02720744|584620074|FG001|Overall Study|Adverse Event|3|||
161884281|NCT02720744|584620073|FG000|Overall Study|Withdrawal by Subject|11|||
161884282|NCT02720744|584620074|FG001|Overall Study|Withdrawal by Subject|11|||
161884283|NCT02720744|584620073|FG000|Overall Study|Lost to follow up|2|||
161884284|NCT02720744|584620074|FG001|Overall Study|Lost to follow up|0|||
161884285|NCT02720744|584620073|FG000|Overall Study|Non Compliance with Investigational Product|0|||
161884286|NCT02720744|584620074|FG001|Overall Study|Non Compliance with Investigational Product|1|||
161884287|NCT02720744|584620073|FG000|Overall Study|Excluded Concomitant Medication|0|||
161884288|NCT02720744|584620074|FG001|Overall Study|Excluded Concomitant Medication|1|||
161884289|NCT00741091|584620075|FG000|Overall Study|Death|13|||
161884290|NCT00741091|584620075|FG000|Overall Study|Lost to Follow-up|16|||
161884291|NCT00741091|584620075|FG000|Overall Study|Withdrawal by Subject|6|||
161884292|NCT00741091|584620075|FG000|Overall Study|Missed Visit|22|||
161884293|NCT01801358|584620076|FG000|Overall Study|Adverse Event|0|||
161884294|NCT01801358|584620077|FG001|Overall Study|Adverse Event|2|||
161884295|NCT01801358|584620078|FG002|Overall Study|Adverse Event|1|||
161884296|NCT01801358|584620079|FG003|Overall Study|Adverse Event|0|||
161884297|NCT01801358|584620080|FG004|Overall Study|Adverse Event|0|||
161884298|NCT01801358|584620081|FG005|Overall Study|Adverse Event|1|||
161884299|NCT01801358|584620076|FG000|Overall Study|Physician Decision|0|||
161884300|NCT01801358|584620077|FG001|Overall Study|Physician Decision|0|||
161884301|NCT01801358|584620078|FG002|Overall Study|Physician Decision|1|||
161884302|NCT01801358|584620079|FG003|Overall Study|Physician Decision|0|||
161884303|NCT01801358|584620080|FG004|Overall Study|Physician Decision|0|||
161884304|NCT01801358|584620081|FG005|Overall Study|Physician Decision|0|||
161884305|NCT01801358|584620076|FG000|Overall Study|Progressive Disease|6|||
161884306|NCT01801358|584620077|FG001|Overall Study|Progressive Disease|4|||
161884307|NCT01801358|584620078|FG002|Overall Study|Progressive Disease|4|||
161884308|NCT01801358|584620079|FG003|Overall Study|Progressive Disease|5|||
161884309|NCT01801358|584620080|FG004|Overall Study|Progressive Disease|6|||
161884310|NCT01801358|584620081|FG005|Overall Study|Progressive Disease|5|||
161884311|NCT01801358|584620076|FG000|Overall Study|Withdrawal by Subject|0|||
161884312|NCT01801358|584620077|FG001|Overall Study|Withdrawal by Subject|0|||
161884313|NCT01801358|584620078|FG002|Overall Study|Withdrawal by Subject|0|||
161884314|NCT01801358|584620079|FG003|Overall Study|Withdrawal by Subject|1|||
161884315|NCT01801358|584620080|FG004|Overall Study|Withdrawal by Subject|0|||
161884316|NCT01801358|584620081|FG005|Overall Study|Withdrawal by Subject|2|||
161884317|NCT01892085|584620082|FG000|Overall Study|Death|4|||
161884318|NCT01892085|584620083|FG001|Overall Study|Death|1|||
161884319|NCT01892085|584620084|FG002|Overall Study|Death|3|||
161884320|NCT01892085|584620082|FG000|Overall Study|Withdrawal by Subject|2|||
161884321|NCT01892085|584620083|FG001|Overall Study|Withdrawal by Subject|0|||
161884322|NCT01892085|584620084|FG002|Overall Study|Withdrawal by Subject|2|||
161884323|NCT00480493|584620085|FG000|Overall Study|moved|2|||
161884324|NCT00480493|584620086|FG001|Overall Study|moved|7|||
161884325|NCT03769675|584620087|FG000|Overall Study|Lost to Follow-up|1|||
161884326|NCT02844907|584620088|FG000|With Dexamethasone|No IV access|1|||
161884327|NCT02945254|584620096|FG000|Overall Study|Lost to Follow-up|1|||
161884328|NCT02945254|584620097|FG001|Overall Study|Lost to Follow-up|0|||
161884329|NCT02945254|584620096|FG000|Overall Study|Withdrawal by Subject|1|||
161884330|NCT02945254|584620097|FG001|Overall Study|Withdrawal by Subject|0|||
161884331|NCT00783224|584620098|FG000|Overall Study|Adverse Event|0|||
161884332|NCT00783224|584620099|FG001|Overall Study|Adverse Event|0|||
161884333|NCT00783224|584620100|FG002|Overall Study|Adverse Event|1|||
161884334|NCT00783224|584620101|FG003|Overall Study|Adverse Event|0|||
161884335|NCT00783224|584620098|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
161884336|NCT00783224|584620099|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
161884337|NCT00783224|584620100|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
161884338|NCT00783224|584620101|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
161884339|NCT00783224|584620098|FG000|Overall Study|Inappropriate as a study subject|0|||
161884340|NCT00783224|584620099|FG001|Overall Study|Inappropriate as a study subject|0|||
161884341|NCT00783224|584620100|FG002|Overall Study|Inappropriate as a study subject|0|||
161884342|NCT00783224|584620101|FG003|Overall Study|Inappropriate as a study subject|1|||
161884343|NCT01711619|584620102|FG000|Overall Study|Early study termination|10|||
161884344|NCT01711619|584620103|FG001|Overall Study|Early study termination|14|||
161884345|NCT01711619|584620102|FG000|Overall Study|Withdrawal by Subject|3|||
161884346|NCT01711619|584620103|FG001|Overall Study|Withdrawal by Subject|7|||
161884347|NCT01711619|584620102|FG000|Overall Study|Protocol Violation|2|||
161884348|NCT01711619|584620103|FG001|Overall Study|Protocol Violation|3|||
161884349|NCT01711619|584620102|FG000|Overall Study|Adverse Event|2|||
161884350|NCT01711619|584620103|FG001|Overall Study|Adverse Event|0|||
161884351|NCT01711619|584620102|FG000|Overall Study|Lost to Follow-up|1|||
161884352|NCT01711619|584620103|FG001|Overall Study|Lost to Follow-up|0|||
161884353|NCT03422159|584620104|FG000|Overall Study|Exclusion due to terminal disease|2|||
161884354|NCT03422159|584620105|FG001|Overall Study|Exclusion due to terminal disease|1|||
161884355|NCT04631107|584620106|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
161884356|NCT04631107|584620106|FG000|Second Intervention (1 Night)|Adverse Event|1|||
161884357|NCT04631107|584620106|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
161884358|NCT04631107|584620106|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
161884359|NCT00087126|584620110|FG000|Overall Study|Ineligible - second primary|1|||
161884360|NCT00087126|584620110|FG000|Overall Study|Never treated|1|||
161884361|NCT01432275|584620111|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
161884362|NCT01432275|584620112|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
161884363|NCT01432275|584620111|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
161884364|NCT01432275|584620112|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
161884365|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
161884366|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
161884367|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
161884368|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
161884369|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
161884370|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
161884371|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
161884372|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
161884373|NCT01432275|584620111|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
161884374|NCT01432275|584620112|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
161884375|NCT01432275|584620111|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
161884376|NCT01432275|584620112|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
161884377|NCT01432275|584620111|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
161884378|NCT01432275|584620112|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
161884379|NCT01935700|584620117|FG000|Overall Study|Withdrawal by Subject|1|||
161884380|NCT01935700|584620118|FG001|Overall Study|Withdrawal by Subject|0|||
161884381|NCT01935700|584620117|FG000|Overall Study|Physician Decision|4|||
161884382|NCT01935700|584620118|FG001|Overall Study|Physician Decision|0|||
161884383|NCT00096993|584620119|FG000|Overall Study|Death|1|||
161884384|NCT00096993|584620120|FG001|Overall Study|Death|0|||
161884385|NCT00096993|584620119|FG000|Overall Study|Disease progression|56|||
161884386|NCT00096993|584620120|FG001|Overall Study|Disease progression|53|||
161884387|NCT00096993|584620119|FG000|Overall Study|Adverse Event|2|||
161884388|NCT00096993|584620120|FG001|Overall Study|Adverse Event|8|||
161884389|NCT00096993|584620119|FG000|Overall Study|Subject's decision|3|||
161884390|NCT00096993|584620120|FG001|Overall Study|Subject's decision|1|||
161884391|NCT00096993|584620119|FG000|Overall Study|Physician Decision|2|||
161884392|NCT00096993|584620120|FG001|Overall Study|Physician Decision|1|||
161884393|NCT00096993|584620119|FG000|Overall Study|Non-compliance|0|||
161884394|NCT00096993|584620120|FG001|Overall Study|Non-compliance|1|||
161884395|NCT00096993|584620119|FG000|Overall Study|Other unspecified|1|||
161884396|NCT00096993|584620120|FG001|Overall Study|Other unspecified|1|||
161884397|NCT01935128|584620123|FG000|Overall Study|Death|1|||
161884398|NCT01935128|584620123|FG000|Overall Study|Adverse Event|6|||
161884399|NCT01162122|584620126|FG000|Overall Study|Withdrawal by Subject|52|||
161884400|NCT01162122|584620127|FG001|Overall Study|Withdrawal by Subject|43|||
161884401|NCT01162122|584620126|FG000|Overall Study|Lost to Follow-up|73|||
161884402|NCT01162122|584620127|FG001|Overall Study|Lost to Follow-up|91|||
161884403|NCT01162122|584620126|FG000|Overall Study|Adverse Event|3|||
161884404|NCT01162122|584620127|FG001|Overall Study|Adverse Event|2|||
161884405|NCT01162122|584620126|FG000|Overall Study|Death|51|||
161884406|NCT01162122|584620127|FG001|Overall Study|Death|46|||
161884407|NCT01162122|584620126|FG000|Overall Study|Protocol Violation|2|||
161884408|NCT01162122|584620127|FG001|Overall Study|Protocol Violation|2|||
161884409|NCT01162122|584620126|FG000|Overall Study|Inappropriate enrollment|5|||
161884410|NCT01162122|584620127|FG001|Overall Study|Inappropriate enrollment|4|||
161884411|NCT01162122|584620126|FG000|Overall Study|Administrative reason|1|||
161884412|NCT01162122|584620127|FG001|Overall Study|Administrative reason|1|||
161884413|NCT01162122|584620126|FG000|Overall Study|Unable to classify|3|||
161884414|NCT01162122|584620127|FG001|Overall Study|Unable to classify|7|||
161884415|NCT01162122|584620126|FG000|Overall Study|Missing primary reason|1|||
161884416|NCT01162122|584620127|FG001|Overall Study|Missing primary reason|0|||
161884417|NCT02020512|584620128|FG000|Overall Study|Adverse Event|1|||
161884418|NCT02020512|584620128|FG000|Overall Study|Lost to Follow-up|3|||
161884419|NCT02020512|584620128|FG000|Overall Study|Protocol Violation|4|||
161884420|NCT00835679|584620129|FG000|Overall Study|Withdrawal by Subject|1|||
161884421|NCT00835679|584620130|FG001|Overall Study|Withdrawal by Subject|0|||
161884422|NCT00835679|584620131|FG002|Overall Study|Withdrawal by Subject|0|||
161884423|NCT00835679|584620132|FG003|Overall Study|Withdrawal by Subject|0|||
161884424|NCT01793688|584620133|FG000|Overall Study|Protocol Violation|2|||
161884425|NCT02419612|584620134|FG000|Short-term Treatment Period|Adverse Event|1|||
161884426|NCT02419612|584620135|FG001|Short-term Treatment Period|Adverse Event|1|||
161884427|NCT02419612|584620134|FG000|Short-term Treatment Period|Death|0|||
161884428|NCT02419612|584620135|FG001|Short-term Treatment Period|Death|2|||
161884429|NCT02419612|584620134|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
161884430|NCT02419612|584620135|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
161884431|NCT02419612|584620134|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
161884432|NCT02419612|584620135|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
161884433|NCT02419612|584620134|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
161884434|NCT02419612|584620135|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
161884435|NCT02419612|584620134|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
161884436|NCT02419612|584620135|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
161884437|NCT02419612|584620134|FG000|Short-term Treatment Period|Worsening of liver function|0|||
161884438|NCT02419612|584620135|FG001|Short-term Treatment Period|Worsening of liver function|1|||
161884439|NCT02419612|584620134|FG000|Short-term Treatment Period|Subject moved out of state|0|||
161884440|NCT02419612|584620135|FG001|Short-term Treatment Period|Subject moved out of state|1|||
161884441|NCT02419612|584620134|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
161884442|NCT02419612|584620135|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
161884443|NCT02419612|584620134|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
161884444|NCT02419612|584620135|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
161884445|NCT02419612|584620134|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
161884446|NCT02419612|584620135|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
161884447|NCT02419612|584620134|FG000|Long-term Treatment Period|Death|0|||
161884448|NCT02419612|584620135|FG001|Long-term Treatment Period|Death|1|||
161884449|NCT02419612|584620134|FG000|Long-term Treatment Period|Adverse Event|0|||
161884450|NCT02419612|584620135|FG001|Long-term Treatment Period|Adverse Event|5|||
161884451|NCT02419612|584620134|FG000|Long-term Treatment Period|Other|4|||
161884452|NCT02419612|584620135|FG001|Long-term Treatment Period|Other|4|||
161884453|NCT02419612|584620134|FG000|Long-term Treatment Period|Subject Decision|2|||
161884454|NCT02419612|584620135|FG001|Long-term Treatment Period|Subject Decision|4|||
161884455|NCT02419612|584620134|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
161884456|NCT02419612|584620135|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
161884457|NCT02135107|584620142|FG000|Treatment Period|Withdrawal by Subject|11|||
161884458|NCT02135107|584620143|FG001|Treatment Period|Withdrawal by Subject|0|||
161884459|NCT02135107|584620144|FG002|Treatment Period|Withdrawal by Subject|0|||
161884460|NCT02135107|584620145|FG003|Treatment Period|Withdrawal by Subject|0|||
161884461|NCT02135107|584620142|FG000|Treatment Period|Adverse Event|5|||
161884462|NCT02135107|584620143|FG001|Treatment Period|Adverse Event|2|||
161884463|NCT02135107|584620144|FG002|Treatment Period|Adverse Event|0|||
161884464|NCT02135107|584620145|FG003|Treatment Period|Adverse Event|0|||
161884465|NCT02135107|584620142|FG000|Treatment Period|Pregnancy|1|||
161884466|NCT02135107|584620143|FG001|Treatment Period|Pregnancy|0|||
161884467|NCT02135107|584620144|FG002|Treatment Period|Pregnancy|0|||
161884468|NCT02135107|584620145|FG003|Treatment Period|Pregnancy|0|||
161884469|NCT02135107|584620142|FG000|Treatment Period|Other|115|||
161884470|NCT02135107|584620143|FG001|Treatment Period|Other|24|||
161884471|NCT02135107|584620144|FG002|Treatment Period|Other|0|||
161884472|NCT02135107|584620145|FG003|Treatment Period|Other|0|||
161884473|NCT02135107|584620142|FG000|Maintenance Therapy Period|Adverse Event|0|||
161884474|NCT02135107|584620143|FG001|Maintenance Therapy Period|Adverse Event|0|||
161884475|NCT02135107|584620144|FG002|Maintenance Therapy Period|Adverse Event|3|||
161884476|NCT02135107|584620145|FG003|Maintenance Therapy Period|Adverse Event|7|||
161884477|NCT02135107|584620142|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
161884478|NCT02135107|584620143|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
161884479|NCT02135107|584620144|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
161884480|NCT02135107|584620145|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
161884481|NCT02135107|584620142|FG000|Maintenance Therapy Period|Pregnancy|0|||
161884482|NCT02135107|584620143|FG001|Maintenance Therapy Period|Pregnancy|0|||
161884483|NCT02135107|584620144|FG002|Maintenance Therapy Period|Pregnancy|0|||
161884484|NCT02135107|584620145|FG003|Maintenance Therapy Period|Pregnancy|1|||
161884485|NCT02135107|584620142|FG000|Maintenance Therapy Period|Other|0|||
161884486|NCT02135107|584620143|FG001|Maintenance Therapy Period|Other|0|||
161884487|NCT02135107|584620144|FG002|Maintenance Therapy Period|Other|7|||
161884488|NCT02135107|584620145|FG003|Maintenance Therapy Period|Other|8|||
161884489|NCT00474045|584620146|FG000|Overall Study|Adverse Event|18|||
161884490|NCT00474045|584620147|FG001|Overall Study|Adverse Event|8|||
161884491|NCT00474045|584620146|FG000|Overall Study|Unclassified|1|||
161884492|NCT00474045|584620147|FG001|Overall Study|Unclassified|3|||
161884493|NCT00474045|584620146|FG000|Overall Study|Lack of Efficacy|0|||
161884494|NCT00474045|584620147|FG001|Overall Study|Lack of Efficacy|9|||
161884495|NCT00474045|584620146|FG000|Overall Study|Lost to Follow-up|1|||
161884496|NCT00474045|584620147|FG001|Overall Study|Lost to Follow-up|1|||
161884497|NCT00474045|584620146|FG000|Overall Study|Protocol Violation|10|||
161884498|NCT00474045|584620147|FG001|Overall Study|Protocol Violation|12|||
161884499|NCT00474045|584620146|FG000|Overall Study|Withdrawal by Subject|16|||
161884500|NCT00474045|584620147|FG001|Overall Study|Withdrawal by Subject|18|||
161884501|NCT00474045|584620146|FG000|Overall Study|Withdrawal criteria|60|||
161884502|NCT00474045|584620147|FG001|Overall Study|Withdrawal criteria|50|||
161884503|NCT02009397|584620151|FG000|Overall Study|Protocol Violation|6|||
161884504|NCT02009397|584620151|FG000|Overall Study|Death|8|||
161884505|NCT02009397|584620151|FG000|Overall Study|Lost to Follow-up|6|||
161884506|NCT02278120|584620153|FG000|Treatment Period|Progressive disease|234|||
161884507|NCT02278120|584620154|FG001|Treatment Period|Progressive disease|260|||
161884508|NCT02278120|584620153|FG000|Treatment Period|Subject/guardian decision|23|||
161884509|NCT02278120|584620154|FG001|Treatment Period|Subject/guardian decision|20|||
161884510|NCT02278120|584620153|FG000|Treatment Period|Adverse Event|16|||
161884511|NCT02278120|584620154|FG001|Treatment Period|Adverse Event|14|||
161884512|NCT02278120|584620153|FG000|Treatment Period|Physician Decision|14|||
161884513|NCT02278120|584620154|FG001|Treatment Period|Physician Decision|27|||
161884514|NCT02278120|584620153|FG000|Treatment Period|Death|3|||
161884515|NCT02278120|584620154|FG001|Treatment Period|Death|3|||
161884516|NCT02278120|584620153|FG000|Treatment Period|Lost to Follow-up|2|||
161884517|NCT02278120|584620154|FG001|Treatment Period|Lost to Follow-up|0|||
161884518|NCT02278120|584620153|FG000|Treatment Period|Protocol deviation|0|||
161884519|NCT02278120|584620154|FG001|Treatment Period|Protocol deviation|2|||
161884520|NCT02278120|584620153|FG000|Treatment Period|Study terminated as per protocol|43|||
161884521|NCT02278120|584620154|FG001|Treatment Period|Study terminated as per protocol|11|||
161884522|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161884523|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Death|1|||
161884524|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161884525|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161884526|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
161884527|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
161884528|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
161884529|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
161884530|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161884531|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161884532|NCT01966068|584620157|FG000|Overall Study|Withdrawal by Subject|57|||
161884533|NCT01966068|584620157|FG000|Overall Study|Lost to Follow-up|81|||
161884534|NCT00808639|584620158|FG000|Overall Study|Disease progression before surgery.|1|||
161884535|NCT00224406|584622130|FG000|Overall Study|Re-transplant|0|||
161884536|NCT00224406|584622131|FG001|Overall Study|Re-transplant|2|||
161884537|NCT00224406|584622130|FG000|Overall Study|Death|0|||
161884538|NCT00224406|584622131|FG001|Overall Study|Death|1|||
161884539|NCT00224406|584622130|FG000|Overall Study|Transplant cancelled|0|||
161884540|NCT00224406|584622131|FG001|Overall Study|Transplant cancelled|4|||
161884541|NCT00224406|584622130|FG000|Overall Study|Drug not delivered|2|||
161884542|NCT00224406|584622131|FG001|Overall Study|Drug not delivered|0|||
161884543|NCT00224406|584622130|FG000|Overall Study|Other|4|||
161884544|NCT00224406|584622131|FG001|Overall Study|Other|0|||
161884545|NCT00224406|584622130|FG000|Overall Study|Transplant cancelled|3|||
161884546|NCT00224406|584622131|FG001|Overall Study|Transplant cancelled|0|||
161884547|NCT04676412|584622136|FG000|Overall Study|Death|28|||
161884548|NCT04676412|584622137|FG001|Overall Study|Death|31|||
161884549|NCT04676412|584622136|FG000|Overall Study|Lost to Follow-up|1|||
161884550|NCT04676412|584622137|FG001|Overall Study|Lost to Follow-up|2|||
161884551|NCT04676412|584622136|FG000|Overall Study|Sponsor Decision|20|||
161884552|NCT04676412|584622137|FG001|Overall Study|Sponsor Decision|23|||
161884553|NCT04676412|584622136|FG000|Overall Study|Withdrawal by Subject|0|||
161884554|NCT04676412|584622137|FG001|Overall Study|Withdrawal by Subject|2|||
161884555|NCT04550832|584622138|FG000|Overall Study|Adverse Event|0|||
161884556|NCT04550832|584622139|FG001|Overall Study|Adverse Event|0|||
161884557|NCT04550832|584622140|FG002|Overall Study|Adverse Event|2|||
161884558|NCT04550832|584622141|FG003|Overall Study|Adverse Event|0|||
161884559|NCT04550832|584622142|FG004|Overall Study|Adverse Event|1|||
161884560|NCT04823130|584622143|FG000|Overall Study|Withdrawal by Subject|2|||
161884561|NCT04823130|584622144|FG001|Overall Study|Withdrawal by Subject|3|||
161884562|NCT04823130|584622143|FG000|Overall Study|Failure to meet inclusion criteria|6|||
161884563|NCT04823130|584622144|FG001|Overall Study|Failure to meet inclusion criteria|4|||
161884564|NCT04823130|584622143|FG000|Overall Study|Other-unspecified|1|||
161884565|NCT04823130|584622144|FG001|Overall Study|Other-unspecified|0|||
161884566|NCT03315455|584622146|FG000|Overall Study|Ongoing in the Study|13|||
161884567|NCT03315455|584622147|FG001|Overall Study|Ongoing in the Study|24|||
161884568|NCT03315455|584622148|FG002|Overall Study|Ongoing in the Study|17|||
161884569|NCT03315455|584622149|FG003|Overall Study|Ongoing in the Study|15|||
161884570|NCT03315455|584622146|FG000|Overall Study|Withdrawal by Subject|0|||
161884571|NCT03315455|584622147|FG001|Overall Study|Withdrawal by Subject|1|||
161884572|NCT03315455|584622148|FG002|Overall Study|Withdrawal by Subject|0|||
161884573|NCT03315455|584622149|FG003|Overall Study|Withdrawal by Subject|0|||
161884574|NCT02304380|584622153|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884575|NCT02304380|584622154|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884576|NCT02304380|584622155|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884577|NCT02304380|584622156|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
161884578|NCT02304380|584622157|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884579|NCT02304380|584622158|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884580|NCT01027897|584622159|FG000|Overall Study|Protocol Violation|1|||
161884581|NCT01027897|584622159|FG000|Overall Study|Withdrawal by Subject|1|||
161884582|NCT00328094|584622160|FG000|Overall Study|Physician Decision|3|||
161884583|NCT00328094|584622161|FG001|Overall Study|Physician Decision|3|||
161884584|NCT01349322|584622162|FG000|Overall Study|Protocol Violation|45|||
161884585|NCT01349322|584622163|FG001|Overall Study|Protocol Violation|47|||
161884586|NCT02453282|584622164|FG000|Overall Study|Death|275|||
161884587|NCT02453282|584622165|FG001|Overall Study|Death|277|||
161884588|NCT02453282|584622166|FG002|Overall Study|Death|296|||
161884589|NCT02453282|584622164|FG000|Overall Study|Lost to Follow-up|1|||
161884590|NCT02453282|584622165|FG001|Overall Study|Lost to Follow-up|0|||
161884591|NCT02453282|584622166|FG002|Overall Study|Lost to Follow-up|2|||
161884592|NCT02453282|584622164|FG000|Overall Study|Withdrawal by Subject|12|||
161884593|NCT02453282|584622165|FG001|Overall Study|Withdrawal by Subject|10|||
161884594|NCT02453282|584622166|FG002|Overall Study|Withdrawal by Subject|11|||
161884595|NCT02453282|584622164|FG000|Overall Study|Participants ongoing at data cut-off|85|||
161884596|NCT02453282|584622165|FG001|Overall Study|Participants ongoing at data cut-off|84|||
161884597|NCT02453282|584622166|FG002|Overall Study|Participants ongoing at data cut-off|62|||
161884598|NCT02453282|584622164|FG000|Overall Study|Other|1|||
161884599|NCT02453282|584622165|FG001|Overall Study|Other|1|||
161884600|NCT02453282|584622166|FG002|Overall Study|Other|1|||
161884601|NCT01143064|584622167|FG000|Overall Study|Death|109|||
161884602|NCT01143064|584622168|FG001|Overall Study|Death|91|||
161884603|NCT01143064|584622167|FG000|Overall Study|Adverse Event|0|||
161884604|NCT01143064|584622168|FG001|Overall Study|Adverse Event|1|||
161884605|NCT01143064|584622167|FG000|Overall Study|Withdrawal by Subject|7|||
161884606|NCT01143064|584622168|FG001|Overall Study|Withdrawal by Subject|5|||
161884607|NCT01143064|584622167|FG000|Overall Study|Lost to Follow-up|17|||
161884608|NCT01143064|584622168|FG001|Overall Study|Lost to Follow-up|14|||
161884609|NCT01143064|584622167|FG000|Overall Study|Physician Decision|0|||
161884610|NCT01143064|584622168|FG001|Overall Study|Physician Decision|4|||
161884611|NCT00985426|584622169|FG000|Overall Study|Adverse Event|0|||
161884612|NCT00985426|584622170|FG001|Overall Study|Adverse Event|1|||
161884613|NCT00985426|584622169|FG000|Overall Study|Subject Non-Compliance|3|||
161884614|NCT00985426|584622170|FG001|Overall Study|Subject Non-Compliance|3|||
161884615|NCT00985426|584622169|FG000|Overall Study|Withdrawal by Subject|12|||
161884616|NCT00985426|584622170|FG001|Overall Study|Withdrawal by Subject|16|||
161884617|NCT00985426|584622169|FG000|Overall Study|Lost to Follow-up|8|||
161884618|NCT00985426|584622170|FG001|Overall Study|Lost to Follow-up|10|||
161884619|NCT00985426|584622169|FG000|Overall Study|Death|7|||
161884620|NCT00985426|584622170|FG001|Overall Study|Death|3|||
161884621|NCT00985426|584622169|FG000|Overall Study|Protocol Violation|2|||
161884622|NCT00985426|584622170|FG001|Overall Study|Protocol Violation|0|||
161884623|NCT00985426|584622169|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
161884624|NCT00985426|584622170|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
161884625|NCT02327013|584622173|FG000|Overall Study|Adverse Event|4|||
161884626|NCT02327013|584622174|FG001|Overall Study|Adverse Event|4|||
161884627|NCT02327013|584622175|FG002|Overall Study|Adverse Event|3|||
161884628|NCT02327013|584622176|FG003|Overall Study|Adverse Event|0|||
161884629|NCT02327013|584622177|FG004|Overall Study|Adverse Event|1|||
161884630|NCT02327013|584622173|FG000|Overall Study|Lack of Efficacy|2|||
161884631|NCT02327013|584622174|FG001|Overall Study|Lack of Efficacy|0|||
161884632|NCT02327013|584622175|FG002|Overall Study|Lack of Efficacy|5|||
161884633|NCT02327013|584622176|FG003|Overall Study|Lack of Efficacy|0|||
161884634|NCT02327013|584622177|FG004|Overall Study|Lack of Efficacy|1|||
161884635|NCT02327013|584622173|FG000|Overall Study|Non-compliance with IMP|1|||
161884636|NCT02327013|584622174|FG001|Overall Study|Non-compliance with IMP|2|||
161884637|NCT02327013|584622175|FG002|Overall Study|Non-compliance with IMP|7|||
161884638|NCT02327013|584622176|FG003|Overall Study|Non-compliance with IMP|0|||
161884639|NCT02327013|584622177|FG004|Overall Study|Non-compliance with IMP|0|||
161884640|NCT02327013|584622173|FG000|Overall Study|Withdrawal of Consent|1|||
161884641|NCT02327013|584622174|FG001|Overall Study|Withdrawal of Consent|0|||
161884642|NCT02327013|584622175|FG002|Overall Study|Withdrawal of Consent|3|||
161884643|NCT02327013|584622176|FG003|Overall Study|Withdrawal of Consent|0|||
161884644|NCT02327013|584622177|FG004|Overall Study|Withdrawal of Consent|0|||
161884645|NCT02327013|584622173|FG000|Overall Study|Lost to Follow-up|2|||
161884646|NCT02327013|584622174|FG001|Overall Study|Lost to Follow-up|4|||
161884647|NCT02327013|584622175|FG002|Overall Study|Lost to Follow-up|5|||
161884648|NCT02327013|584622176|FG003|Overall Study|Lost to Follow-up|0|||
161884649|NCT02327013|584622177|FG004|Overall Study|Lost to Follow-up|0|||
161884650|NCT02327013|584622173|FG000|Overall Study|Administrative or other reason(s)|1|||
161884651|NCT02327013|584622174|FG001|Overall Study|Administrative or other reason(s)|5|||
161884652|NCT02327013|584622175|FG002|Overall Study|Administrative or other reason(s)|11|||
161884653|NCT02327013|584622176|FG003|Overall Study|Administrative or other reason(s)|1|||
161884654|NCT02327013|584622177|FG004|Overall Study|Administrative or other reason(s)|1|||
161884655|NCT02327013|584622173|FG000|Overall Study|Protocol Violation|0|||
161884656|NCT02327013|584622174|FG001|Overall Study|Protocol Violation|0|||
161884657|NCT02327013|584622175|FG002|Overall Study|Protocol Violation|3|||
161884658|NCT02327013|584622176|FG003|Overall Study|Protocol Violation|0|||
161884659|NCT02327013|584622177|FG004|Overall Study|Protocol Violation|1|||
161884660|NCT02327013|584622173|FG000|Overall Study|Withdrawal before treatment|2|||
161884661|NCT02327013|584622174|FG001|Overall Study|Withdrawal before treatment|1|||
161884662|NCT02327013|584622175|FG002|Overall Study|Withdrawal before treatment|5|||
161884663|NCT02327013|584622176|FG003|Overall Study|Withdrawal before treatment|0|||
161884664|NCT02327013|584622177|FG004|Overall Study|Withdrawal before treatment|0|||
161884665|NCT02380859|584622178|FG000|Overall Study|Withdrawal by Subject|2|||
161884666|NCT02380859|584622179|FG001|Overall Study|Withdrawal by Subject|0|||
161884667|NCT01661933|584622180|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
161884668|NCT01661933|584622180|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
161884669|NCT03385304|584622181|FG000|Overall Study|Death|19|||
161884670|NCT03385304|584622182|FG001|Overall Study|Death|7|||
161884671|NCT03385304|584622181|FG000|Overall Study|Lost to Follow-up|17|||
161884672|NCT03385304|584622182|FG001|Overall Study|Lost to Follow-up|14|||
161884673|NCT03385304|584622181|FG000|Overall Study|Withdrawal by Subject|3|||
161884674|NCT03385304|584622182|FG001|Overall Study|Withdrawal by Subject|2|||
161884675|NCT03385304|584622181|FG000|Overall Study|Incarceration|2|||
161884676|NCT03385304|584622182|FG001|Overall Study|Incarceration|3|||
161884677|NCT02772276|584622185|FG000|Overall Study|Lost to Follow-up|0|||
161884678|NCT02772276|584622186|FG001|Overall Study|Lost to Follow-up|0|||
161884679|NCT02772276|584622187|FG002|Overall Study|Lost to Follow-up|0|||
161884680|NCT02772276|584622188|FG003|Overall Study|Lost to Follow-up|0|||
161884681|NCT02772276|584622189|FG004|Overall Study|Lost to Follow-up|0|||
161884682|NCT02772276|584622190|FG005|Overall Study|Lost to Follow-up|0|||
161884683|NCT02772276|584622191|FG006|Overall Study|Lost to Follow-up|1|||
161884684|NCT02772276|584622192|FG007|Overall Study|Lost to Follow-up|0|||
161884685|NCT02772276|584622193|FG008|Overall Study|Lost to Follow-up|0|||
161884686|NCT02772276|584622194|FG009|Overall Study|Lost to Follow-up|0|||
161884687|NCT02772276|584622195|FG010|Overall Study|Lost to Follow-up|0|||
161884688|NCT02772276|584622196|FG011|Overall Study|Lost to Follow-up|0|||
161884689|NCT02772276|584622197|FG012|Overall Study|Lost to Follow-up|0|||
161884690|NCT02772276|584622185|FG000|Overall Study|Withdrew consent|0|||
161884691|NCT02772276|584622186|FG001|Overall Study|Withdrew consent|0|||
161884692|NCT02772276|584622187|FG002|Overall Study|Withdrew consent|0|||
161884693|NCT02772276|584622188|FG003|Overall Study|Withdrew consent|0|||
161884694|NCT02772276|584622189|FG004|Overall Study|Withdrew consent|0|||
161884695|NCT02772276|584622190|FG005|Overall Study|Withdrew consent|0|||
161884696|NCT02772276|584622191|FG006|Overall Study|Withdrew consent|0|||
161884697|NCT02772276|584622192|FG007|Overall Study|Withdrew consent|1|||
161884698|NCT02772276|584622193|FG008|Overall Study|Withdrew consent|0|||
161884699|NCT02772276|584622194|FG009|Overall Study|Withdrew consent|0|||
161884700|NCT02772276|584622195|FG010|Overall Study|Withdrew consent|0|||
161884701|NCT02772276|584622196|FG011|Overall Study|Withdrew consent|0|||
161884702|NCT02772276|584622197|FG012|Overall Study|Withdrew consent|0|||
161884703|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
161884704|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
161884705|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
161884706|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
161884707|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
161884708|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
161884709|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161884710|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
161884711|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161884712|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161884713|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884714|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884715|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
161884716|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884717|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884718|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884719|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884720|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
161884721|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884722|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884723|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884724|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
161884725|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884726|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884727|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884728|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884729|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884730|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884731|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884732|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
161884733|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884734|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884735|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884736|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884737|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
161884738|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884739|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884740|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884741|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884742|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
161884743|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
161884744|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
161884745|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
161884746|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
161884747|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
161884748|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884749|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884750|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884751|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884752|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
161884753|NCT02248974|584622203|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
161884754|NCT02248974|584622204|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
161884755|NCT02248974|584622203|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
161884756|NCT02248974|584622204|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
161884757|NCT02248974|584622203|FG000|1-Day Follow-Up|Enrolled in another study|1|||
161884758|NCT02248974|584622204|FG001|1-Day Follow-Up|Enrolled in another study|0|||
161884759|NCT02248974|584622203|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
161884760|NCT02248974|584622204|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
161884761|NCT02248974|584622203|FG000|1-Week Follow-Up|Enrolled in another study|1|||
161884762|NCT02248974|584622204|FG001|1-Week Follow-Up|Enrolled in another study|1|||
161884763|NCT02248974|584622203|FG000|1-Week Follow-Up|Transferred to another facility|1|||
161884764|NCT02248974|584622204|FG001|1-Week Follow-Up|Transferred to another facility|0|||
161884765|NCT02248974|584622203|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
161884766|NCT02248974|584622204|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
161884767|NCT02248974|584622203|FG000|1-Week Follow-Up|Death|1|||
161884768|NCT02248974|584622204|FG001|1-Week Follow-Up|Death|1|||
161884769|NCT02248974|584622203|FG000|1-Week Follow-Up|Excluded because of age|0|||
161884770|NCT02248974|584622204|FG001|1-Week Follow-Up|Excluded because of age|1|||
161884771|NCT02248974|584622203|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
161884772|NCT02248974|584622204|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
161884773|NCT02248974|584622203|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
161884774|NCT02248974|584622204|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
161884775|NCT02248974|584622203|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
161884776|NCT02248974|584622204|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
161884777|NCT02248974|584622203|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
161884778|NCT02248974|584622204|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
161884779|NCT02248974|584622203|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
161884780|NCT02248974|584622204|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
161884781|NCT03488225|584622205|FG000|Overall Study|Off Protocol Therapy|2|||
161884782|NCT03488225|584622205|FG000|Overall Study|Stem Cell Transplant|2|||
161884783|NCT04093492|584622206|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
161884784|NCT04093492|584622207|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
161884785|NCT04093492|584622208|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
161884786|NCT04093492|584622209|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
161884787|NCT04093492|584622206|FG000|25 Weeks Gestational Age (GA)|No response|5|||
161884788|NCT04093492|584622207|FG001|25 Weeks Gestational Age (GA)|No response|5|||
161884789|NCT04093492|584622208|FG002|25 Weeks Gestational Age (GA)|No response|5|||
161884790|NCT04093492|584622209|FG003|25 Weeks Gestational Age (GA)|No response|2|||
161884791|NCT04093492|584622206|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161884792|NCT04093492|584622207|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161884793|NCT04093492|584622208|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161884794|NCT04093492|584622209|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
161884795|NCT04093492|584622206|FG000|30 Weeks GA|Delivered before assessment|1|||
161884796|NCT04093492|584622207|FG001|30 Weeks GA|Delivered before assessment|2|||
161884797|NCT04093492|584622208|FG002|30 Weeks GA|Delivered before assessment|0|||
161884798|NCT04093492|584622209|FG003|30 Weeks GA|Delivered before assessment|0|||
161884799|NCT04093492|584622206|FG000|30 Weeks GA|No response|7|||
161884800|NCT04093492|584622207|FG001|30 Weeks GA|No response|5|||
161884801|NCT04093492|584622208|FG002|30 Weeks GA|No response|5|||
161884802|NCT04093492|584622209|FG003|30 Weeks GA|No response|2|||
161884803|NCT04093492|584622206|FG000|30 Weeks GA|Lost to Follow-up|0|||
161884804|NCT04093492|584622207|FG001|30 Weeks GA|Lost to Follow-up|1|||
161884805|NCT04093492|584622208|FG002|30 Weeks GA|Lost to Follow-up|0|||
161884806|NCT04093492|584622209|FG003|30 Weeks GA|Lost to Follow-up|0|||
161884807|NCT04093492|584622206|FG000|34 Weeks GA|Delivered before assessment|6|||
161884808|NCT04093492|584622207|FG001|34 Weeks GA|Delivered before assessment|3|||
161884809|NCT04093492|584622208|FG002|34 Weeks GA|Delivered before assessment|0|||
161884810|NCT04093492|584622209|FG003|34 Weeks GA|Delivered before assessment|0|||
161884811|NCT04093492|584622206|FG000|34 Weeks GA|No response|0|||
161884812|NCT04093492|584622207|FG001|34 Weeks GA|No response|7|||
161884813|NCT04093492|584622208|FG002|34 Weeks GA|No response|5|||
161884814|NCT04093492|584622209|FG003|34 Weeks GA|No response|3|||
161884815|NCT04093492|584622206|FG000|34 Weeks GA|Lost to Follow-up|0|||
161884816|NCT04093492|584622207|FG001|34 Weeks GA|Lost to Follow-up|1|||
161884817|NCT04093492|584622208|FG002|34 Weeks GA|Lost to Follow-up|0|||
161884818|NCT04093492|584622209|FG003|34 Weeks GA|Lost to Follow-up|0|||
161884819|NCT01438814|584622212|FG000|Overall Study|Adverse Event|3|||
161884820|NCT01438814|584622213|FG001|Overall Study|Adverse Event|3|||
161884821|NCT01438814|584622212|FG000|Overall Study|Protocol Violation|1|||
161884822|NCT01438814|584622213|FG001|Overall Study|Protocol Violation|2|||
161884823|NCT01438814|584622212|FG000|Overall Study|Lost to Follow-up|4|||
161884824|NCT01438814|584622213|FG001|Overall Study|Lost to Follow-up|3|||
161884825|NCT01438814|584622212|FG000|Overall Study|Withdrawal by Subject|4|||
161884826|NCT01438814|584622213|FG001|Overall Study|Withdrawal by Subject|2|||
161884827|NCT01438814|584622212|FG000|Overall Study|Other|2|||
161884828|NCT01438814|584622213|FG001|Overall Study|Other|4|||
161884829|NCT01739764|584622214|FG000|Overall Study|Adverse Event|0|||
161884830|NCT01739764|584622215|FG001|Overall Study|Adverse Event|3|||
161884831|NCT01739764|584622216|FG002|Overall Study|Adverse Event|4|||
161884832|NCT01739764|584622214|FG000|Overall Study|Death|4|||
161884833|NCT01739764|584622215|FG001|Overall Study|Death|6|||
161884834|NCT01739764|584622216|FG002|Overall Study|Death|38|||
161884835|NCT01739764|584622214|FG000|Overall Study|Lost to Follow-up|0|||
161884836|NCT01739764|584622215|FG001|Overall Study|Lost to Follow-up|0|||
161884837|NCT01739764|584622216|FG002|Overall Study|Lost to Follow-up|5|||
161884838|NCT01739764|584622214|FG000|Overall Study|Non-Compliance|0|||
161884839|NCT01739764|584622215|FG001|Overall Study|Non-Compliance|0|||
161884840|NCT01739764|584622216|FG002|Overall Study|Non-Compliance|1|||
161884841|NCT01739764|584622214|FG000|Overall Study|Multiple Reasons|3|||
161884842|NCT01739764|584622215|FG001|Overall Study|Multiple Reasons|2|||
161884843|NCT01739764|584622216|FG002|Overall Study|Multiple Reasons|3|||
161884844|NCT01739764|584622214|FG000|Overall Study|Physician Decision|2|||
161884845|NCT01739764|584622215|FG001|Overall Study|Physician Decision|2|||
161884846|NCT01739764|584622216|FG002|Overall Study|Physician Decision|4|||
161884847|NCT01739764|584622214|FG000|Overall Study|Progressive Disease|3|||
161884848|NCT01739764|584622215|FG001|Overall Study|Progressive Disease|5|||
161884849|NCT01739764|584622216|FG002|Overall Study|Progressive Disease|16|||
161884850|NCT01739764|584622214|FG000|Overall Study|Protocol Violation|0|||
161884851|NCT01739764|584622215|FG001|Overall Study|Protocol Violation|0|||
161884852|NCT01739764|584622216|FG002|Overall Study|Protocol Violation|2|||
161884853|NCT01739764|584622214|FG000|Overall Study|Study Terminated by Sponsor|8|||
161884854|NCT01739764|584622215|FG001|Overall Study|Study Terminated by Sponsor|13|||
161884855|NCT01739764|584622216|FG002|Overall Study|Study Terminated by Sponsor|26|||
161884856|NCT01739764|584622214|FG000|Overall Study|Withdrawal by Subject|6|||
161884857|NCT01739764|584622215|FG001|Overall Study|Withdrawal by Subject|5|||
161884858|NCT01739764|584622216|FG002|Overall Study|Withdrawal by Subject|27|||
161884859|NCT00404924|584622217|FG000|Overall Study|Adverse Event|75|||
161884860|NCT00404924|584622218|FG001|Overall Study|Adverse Event|16|||
161884861|NCT00404924|584622217|FG000|Overall Study|Condition under investigation worsened|475|||
161884862|NCT00404924|584622218|FG001|Overall Study|Condition under investigation worsened|264|||
161884863|NCT00404924|584622217|FG000|Overall Study|Lost to Follow-up|1|||
161884864|NCT00404924|584622218|FG001|Overall Study|Lost to Follow-up|1|||
161884865|NCT00404924|584622217|FG000|Overall Study|Withdrawal by Subject|26|||
161884866|NCT00404924|584622218|FG001|Overall Study|Withdrawal by Subject|13|||
161884867|NCT00404924|584622217|FG000|Overall Study|Other|25|||
161884868|NCT00404924|584622218|FG001|Overall Study|Other|11|||
161884869|NCT00404924|584622217|FG000|Overall Study|Randomised but not received treatment|1|||
161884870|NCT00404924|584622218|FG001|Overall Study|Randomised but not received treatment|1|||
161884871|NCT00513357|584622223|FG000|Overall Study|did not receive allocated placebo|2|||
161884872|NCT00513357|584622224|FG001|Overall Study|did not receive allocated placebo|3|||
161884873|NCT00513357|584622223|FG000|Overall Study|Adverse Event|4|||
161884874|NCT00513357|584622224|FG001|Overall Study|Adverse Event|2|||
161884875|NCT00513357|584622223|FG000|Overall Study|Death|2|||
161884876|NCT00513357|584622224|FG001|Overall Study|Death|0|||
161884877|NCT00513357|584622223|FG000|Overall Study|Withdrawal by Subject|5|||
161884878|NCT00513357|584622224|FG001|Overall Study|Withdrawal by Subject|4|||
161884879|NCT00513357|584622223|FG000|Overall Study|Disease Progression|2|||
161884880|NCT00513357|584622224|FG001|Overall Study|Disease Progression|1|||
161884881|NCT00435487|584622233|FG000|Overall Study|Death|3|||
161884882|NCT00435487|584622234|FG001|Overall Study|Death|4|||
161884883|NCT00435487|584622233|FG000|Overall Study|Adverse Event|0|||
161884884|NCT00435487|584622234|FG001|Overall Study|Adverse Event|3|||
161884885|NCT00435487|584622233|FG000|Overall Study|Lost to Follow-up|2|||
161884886|NCT00435487|584622234|FG001|Overall Study|Lost to Follow-up|2|||
161884887|NCT00435487|584622233|FG000|Overall Study|Other|5|||
161884888|NCT00435487|584622234|FG001|Overall Study|Other|2|||
161884889|NCT00435487|584622233|FG000|Overall Study|Withdrawal by Subject|2|||
161884890|NCT00435487|584622234|FG001|Overall Study|Withdrawal by Subject|1|||
161884891|NCT00435487|584622233|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
161884892|NCT00435487|584622234|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
161884893|NCT00435487|584622233|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
161884894|NCT00435487|584622234|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
161884895|NCT05087966|584622236|FG000|Overall Study|Lost to Follow-up|1|||
161884896|NCT05087966|584622236|FG000|Overall Study|Withdrawal by Subject|5|||
161884897|NCT02537431|584622245|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
161884898|NCT05238025|584622246|FG000|Overall Study|Adverse Event|2|||
161884899|NCT05238025|584622247|FG001|Overall Study|Adverse Event|2|||
161884900|NCT05238025|584622246|FG000|Overall Study|Lost to Follow-up|334|||
161884901|NCT05238025|584622247|FG001|Overall Study|Lost to Follow-up|339|||
161884902|NCT05238025|584622246|FG000|Overall Study|Withdrawal by Subject|203|||
161884903|NCT05238025|584622247|FG001|Overall Study|Withdrawal by Subject|222|||
161884904|NCT05238025|584622246|FG000|Overall Study|Physician Decision|20|||
161884905|NCT05238025|584622247|FG001|Overall Study|Physician Decision|8|||
161884906|NCT05238025|584622246|FG000|Overall Study|Protocol Violation|6|||
161884907|NCT05238025|584622247|FG001|Overall Study|Protocol Violation|2|||
161884908|NCT05238025|584622246|FG000|Overall Study|Death|38|||
161884909|NCT05238025|584622247|FG001|Overall Study|Death|32|||
161884910|NCT05238025|584622246|FG000|Overall Study|Study terminated by Sponsor|6358|||
161884911|NCT05238025|584622247|FG001|Overall Study|Study terminated by Sponsor|6358|||
161884912|NCT05238025|584622246|FG000|Overall Study|Other Reason|669|||
161884913|NCT05238025|584622247|FG001|Overall Study|Other Reason|690|||
161884914|NCT00191282|584622250|FG000|Overall Study|Adverse Event|5|||
161884915|NCT00191282|584622251|FG001|Overall Study|Adverse Event|6|||
161884916|NCT00191282|584622250|FG000|Overall Study|Death|51|||
161884917|NCT00191282|584622251|FG001|Overall Study|Death|51|||
161884918|NCT00191282|584622250|FG000|Overall Study|Lack of Efficacy|11|||
161884919|NCT00191282|584622251|FG001|Overall Study|Lack of Efficacy|6|||
161884920|NCT00191282|584622250|FG000|Overall Study|Noncompliance|14|||
161884921|NCT00191282|584622251|FG001|Overall Study|Noncompliance|17|||
161884922|NCT00191282|584622250|FG000|Overall Study|Patient moved|11|||
161884923|NCT00191282|584622251|FG001|Overall Study|Patient moved|14|||
161884924|NCT00191282|584622250|FG000|Overall Study|Withdrawal by Subject|59|||
161884925|NCT00191282|584622251|FG001|Overall Study|Withdrawal by Subject|44|||
161884926|NCT00191282|584622250|FG000|Overall Study|Physician Decision|18|||
161884927|NCT00191282|584622251|FG001|Overall Study|Physician Decision|15|||
161884928|NCT00191282|584622250|FG000|Overall Study|Protocol entry criteria not met|14|||
161884929|NCT00191282|584622251|FG001|Overall Study|Protocol entry criteria not met|9|||
161884930|NCT00191282|584622250|FG000|Overall Study|Protocol Violation|9|||
161884931|NCT00191282|584622251|FG001|Overall Study|Protocol Violation|12|||
161884932|NCT00191282|584622250|FG000|Overall Study|Severity of outcome|2|||
161884933|NCT00191282|584622251|FG001|Overall Study|Severity of outcome|5|||
161884934|NCT00191282|584622250|FG000|Overall Study|Sponsor's decision|2|||
161884935|NCT00191282|584622251|FG001|Overall Study|Sponsor's decision|2|||
161884936|NCT00191282|584622250|FG000|Overall Study|Lost to Follow-up|24|||
161884937|NCT00191282|584622251|FG001|Overall Study|Lost to Follow-up|31|||
161884938|NCT00102531|584622252|FG000|Overall Study|Adverse Event|0|||
161884939|NCT00102531|584622253|FG001|Overall Study|Adverse Event|1|||
161884940|NCT00102531|584622252|FG000|Overall Study|Disease Progression|5|||
161884941|NCT00102531|584622253|FG001|Overall Study|Disease Progression|9|||
161884942|NCT00102531|584622252|FG000|Overall Study|Physician Decision|0|||
161884943|NCT00102531|584622253|FG001|Overall Study|Physician Decision|1|||
161884944|NCT04756154|584622254|FG000|Overall Study|Did not meet treatment day baseline|30|||
161884945|NCT04756154|584622255|FG001|Overall Study|Did not meet treatment day baseline|28|||
161884946|NCT04756154|584622256|FG002|Overall Study|Did not meet treatment day baseline|7|||
161884947|NCT04756154|584622254|FG000|Overall Study|Did not return for final sample collection|1|||
161884948|NCT04756154|584622255|FG001|Overall Study|Did not return for final sample collection|1|||
161884949|NCT04756154|584622256|FG002|Overall Study|Did not return for final sample collection|0|||
161884950|NCT01790828|584622257|FG000|Overall Study|Other|34|||
161884951|NCT02089334|584622259|FG000|Overall Study|Withdrawal by Subject|0|||
161884952|NCT02089334|584622260|FG001|Overall Study|Withdrawal by Subject|0|||
161884953|NCT02089334|584622261|FG002|Overall Study|Withdrawal by Subject|0|||
161884954|NCT02089334|584622262|FG003|Overall Study|Withdrawal by Subject|2|||
161884955|NCT02089334|584622259|FG000|Overall Study|Adverse Event|0|||
161884956|NCT02089334|584622260|FG001|Overall Study|Adverse Event|0|||
161884957|NCT02089334|584622261|FG002|Overall Study|Adverse Event|0|||
161884958|NCT02089334|584622262|FG003|Overall Study|Adverse Event|2|||
161884959|NCT02089334|584622259|FG000|Overall Study|Progressive disease|0|||
161884960|NCT02089334|584622260|FG001|Overall Study|Progressive disease|0|||
161884961|NCT02089334|584622261|FG002|Overall Study|Progressive disease|0|||
161884962|NCT02089334|584622262|FG003|Overall Study|Progressive disease|2|||
161884963|NCT02089334|584622259|FG000|Overall Study|Physician Decision|0|||
161884964|NCT02089334|584622260|FG001|Overall Study|Physician Decision|0|||
161884965|NCT02089334|584622261|FG002|Overall Study|Physician Decision|1|||
161884966|NCT02089334|584622262|FG003|Overall Study|Physician Decision|1|||
161884967|NCT00954512|584622270|FG000|Overall Study|Withdrawal by Subject|0|||
161884968|NCT00954512|584622271|FG001|Overall Study|Withdrawal by Subject|0|||
161884969|NCT00954512|584622272|FG002|Overall Study|Withdrawal by Subject|0|||
161884970|NCT00954512|584622273|FG003|Overall Study|Withdrawal by Subject|0|||
161884971|NCT00954512|584622274|FG004|Overall Study|Withdrawal by Subject|0|||
161884972|NCT00954512|584622275|FG005|Overall Study|Withdrawal by Subject|1|||
161884973|NCT00954512|584622270|FG000|Overall Study|Adverse Event|0|||
161884974|NCT00954512|584622271|FG001|Overall Study|Adverse Event|0|||
161884975|NCT00954512|584622272|FG002|Overall Study|Adverse Event|0|||
161884976|NCT00954512|584622273|FG003|Overall Study|Adverse Event|0|||
161884977|NCT00954512|584622274|FG004|Overall Study|Adverse Event|1|||
161884978|NCT00954512|584622275|FG005|Overall Study|Adverse Event|2|||
161884979|NCT00954512|584622270|FG000|Overall Study|Physician Decision|0|||
161884980|NCT00954512|584622271|FG001|Overall Study|Physician Decision|1|||
161884981|NCT00954512|584622272|FG002|Overall Study|Physician Decision|0|||
161884982|NCT00954512|584622273|FG003|Overall Study|Physician Decision|1|||
161884983|NCT00954512|584622274|FG004|Overall Study|Physician Decision|0|||
161884984|NCT00954512|584622275|FG005|Overall Study|Physician Decision|0|||
161884985|NCT00954512|584622270|FG000|Overall Study|Symptomatic Deterioration|0|||
161884986|NCT00954512|584622271|FG001|Overall Study|Symptomatic Deterioration|1|||
161884987|NCT00954512|584622272|FG002|Overall Study|Symptomatic Deterioration|0|||
161884988|NCT00954512|584622273|FG003|Overall Study|Symptomatic Deterioration|0|||
161884989|NCT00954512|584622274|FG004|Overall Study|Symptomatic Deterioration|2|||
161884990|NCT00954512|584622275|FG005|Overall Study|Symptomatic Deterioration|0|||
161884991|NCT00954512|584622270|FG000|Overall Study|Progression of Disease|2|||
161884992|NCT00954512|584622271|FG001|Overall Study|Progression of Disease|1|||
161884993|NCT00954512|584622272|FG002|Overall Study|Progression of Disease|0|||
161884994|NCT00954512|584622273|FG003|Overall Study|Progression of Disease|1|||
161884995|NCT00954512|584622274|FG004|Overall Study|Progression of Disease|1|||
161884996|NCT00954512|584622275|FG005|Overall Study|Progression of Disease|1|||
161884997|NCT04814368|584622279|FG000|Overall Study|Study Terminated by Sponsor|0|||
161884998|NCT04814368|584622280|FG001|Overall Study|Study Terminated by Sponsor|3|||
161884999|NCT04814368|584622281|FG002|Overall Study|Study Terminated by Sponsor|0|||
161885000|NCT04814368|584622282|FG003|Overall Study|Study Terminated by Sponsor|2|||
161885001|NCT04814368|584622279|FG000|Overall Study|Subject Decision|1|||
161885002|NCT04814368|584622280|FG001|Overall Study|Subject Decision|2|||
161885003|NCT04814368|584622281|FG002|Overall Study|Subject Decision|0|||
161885004|NCT04814368|584622282|FG003|Overall Study|Subject Decision|0|||
161885005|NCT01173055|584622284|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
161885006|NCT01173055|584622285|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
161885007|NCT01173055|584622284|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
161885008|NCT01173055|584622285|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
161885009|NCT04216589|584622287|FG000|Overall Study|Withdrawal by Subject|2|||
161885010|NCT04216589|584622287|FG000|Overall Study|Protocol Violation|1|||
161885011|NCT04216589|584622287|FG000|Overall Study|Incarceration|1|||
161885012|NCT02824562|584624385|FG000|Overall Study|Lost to Follow-up|3|||
161885013|NCT02824562|584624386|FG001|Overall Study|Lost to Follow-up|4|||
161885014|NCT02824562|584624385|FG000|Overall Study|Death|0|||
161885015|NCT02824562|584624386|FG001|Overall Study|Death|1|||
161885016|NCT02921750|584624387|FG000|Overall Study|Adverse Event|1|||
161885017|NCT02921750|584624388|FG001|Overall Study|Adverse Event|2|||
161885018|NCT02921750|584624387|FG000|Overall Study|Withdrawal by Subject|1|||
161885019|NCT02921750|584624388|FG001|Overall Study|Withdrawal by Subject|1|||
161885020|NCT02921750|584624387|FG000|Overall Study|Lost to Follow-up|3|||
161885021|NCT02921750|584624388|FG001|Overall Study|Lost to Follow-up|3|||
161885022|NCT02921750|584624387|FG000|Overall Study|Wound healed|3|||
161885023|NCT02921750|584624388|FG001|Overall Study|Wound healed|3|||
161885024|NCT02921750|584624387|FG000|Overall Study|Serious Adverse Event|1|||
161885025|NCT02921750|584624388|FG001|Overall Study|Serious Adverse Event|2|||
161885026|NCT03309696|584624390|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
161885027|NCT03309696|584624391|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
161885028|NCT03309696|584624392|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
161885029|NCT03309696|584624393|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
161885030|NCT02638129|584624394|FG000|Overall Study|Study terminated|28|||
161885031|NCT02638129|584624395|FG001|Overall Study|Study terminated|30|||
161885032|NCT02368210|584624398|FG000|Overall Study|Withdrawal by Subject|1|||
161885033|NCT02368210|584624399|FG001|Overall Study|Withdrawal by Subject|0|||
161885034|NCT02368210|584624398|FG000|Overall Study|Adverse Event|0|||
161885035|NCT02368210|584624399|FG001|Overall Study|Adverse Event|1|||
161885036|NCT00078949|584624400|FG000|Overall Study|No treated|4|||
161885037|NCT00078949|584624401|FG001|Overall Study|No treated|5|||
161885038|NCT00078949|584624402|FG002|Overall Study|No treated|3|||
161885039|NCT00078949|584624403|FG003|Overall Study|No treated|3|||
161885040|NCT00577005|584624404|FG000|Overall Study|Lost to Follow-up|3|||
161885041|NCT00577005|584624405|FG001|Overall Study|Lost to Follow-up|2|||
161885042|NCT00577005|584624404|FG000|Overall Study|Withdrawal by Subject|2|||
161885043|NCT00577005|584624405|FG001|Overall Study|Withdrawal by Subject|1|||
161885044|NCT02667626|584624406|FG000|Overall Study|Withdrawal by Subject|0|||
161885045|NCT02667626|584624407|FG001|Overall Study|Withdrawal by Subject|1|||
161885046|NCT02309723|584624408|FG000|Overall Study|Withdrawal by Subject|24|||
161885047|NCT02309723|584624409|FG001|Overall Study|Withdrawal by Subject|23|||
161885048|NCT02309723|584624410|FG002|Overall Study|Withdrawal by Subject|24|||
161885049|NCT02560623|584624411|FG000|Overall Study|Unable to swallow sponge|0|||
161885050|NCT02560623|584624412|FG001|Overall Study|Unable to swallow sponge|1|||
161885051|NCT02560623|584624413|FG002|Overall Study|Unable to swallow sponge|0|||
161885052|NCT02560623|584624414|FG003|Overall Study|Unable to swallow sponge|0|||
161885053|NCT02560623|584624411|FG000|Overall Study|Intervention prior to sponge administration|0|||
161885054|NCT02560623|584624412|FG001|Overall Study|Intervention prior to sponge administration|1|||
161885055|NCT02560623|584624413|FG002|Overall Study|Intervention prior to sponge administration|0|||
161885056|NCT02560623|584624414|FG003|Overall Study|Intervention prior to sponge administration|0|||
161885057|NCT01565668|584624415|FG000|Overall Study|Death|2|||
161885058|NCT01565668|584624416|FG001|Overall Study|Death|1|||
161885059|NCT01565668|584624415|FG000|Overall Study|Lack of Efficacy|4|||
161885060|NCT01565668|584624416|FG001|Overall Study|Lack of Efficacy|2|||
161885061|NCT01565668|584624415|FG000|Overall Study|Participant went on Hospice Care|1|||
161885062|NCT01565668|584624416|FG001|Overall Study|Participant went on Hospice Care|0|||
161885063|NCT01565668|584624415|FG000|Overall Study|Adverse Event|6|||
161885064|NCT01565668|584624416|FG001|Overall Study|Adverse Event|1|||
161885065|NCT01565668|584624415|FG000|Overall Study|Randomized, but never received drug|0|||
161885066|NCT01565668|584624416|FG001|Overall Study|Randomized, but never received drug|2|||
161885067|NCT01565668|584624415|FG000|Overall Study|Progressive disease|13|||
161885068|NCT01565668|584624416|FG001|Overall Study|Progressive disease|14|||
161885069|NCT01565668|584624415|FG000|Overall Study|Withdrawal by Subject|1|||
161885070|NCT01565668|584624416|FG001|Overall Study|Withdrawal by Subject|3|||
161885071|NCT01565668|584624415|FG000|Overall Study|HSCT Transplant|11|||
161885072|NCT01565668|584624416|FG001|Overall Study|HSCT Transplant|15|||
161885073|NCT01097421|584624417|FG000|Overall Study|Adverse Event|8|||
161885074|NCT01097421|584624417|FG000|Overall Study|Protocol Violation|2|||
161885075|NCT01097421|584624417|FG000|Overall Study|Lost to Follow-up|1|||
161885076|NCT01097421|584624417|FG000|Overall Study|Withdrawal by Subject|3|||
161885077|NCT01120249|584624418|FG000|Overall Study|No protocol treatment received|21|||
161885078|NCT01120249|584624419|FG001|Overall Study|No protocol treatment received|15|||
161885079|NCT01120249|584624418|FG000|Overall Study|Disease recurrence|107|||
161885080|NCT01120249|584624419|FG001|Overall Study|Disease recurrence|57|||
161885081|NCT01120249|584624418|FG000|Overall Study|Death|1|||
161885082|NCT01120249|584624419|FG001|Overall Study|Death|0|||
161885083|NCT01120249|584624418|FG000|Overall Study|Adverse Event|40|||
161885084|NCT01120249|584624419|FG001|Overall Study|Adverse Event|276|||
161885085|NCT01120249|584624418|FG000|Overall Study|Participant refusal|34|||
161885086|NCT01120249|584624419|FG001|Overall Study|Participant refusal|42|||
161885087|NCT01120249|584624418|FG000|Overall Study|Other reasons, not protocol specified|29|||
161885088|NCT01120249|584624419|FG001|Overall Study|Other reasons, not protocol specified|22|||
161885089|NCT04258254|584624420|FG000|Overall Study|Withdrawal by Subject|0|||
161885090|NCT04258254|584624421|FG001|Overall Study|Withdrawal by Subject|1|||
161885091|NCT04258254|584624422|FG002|Overall Study|Withdrawal by Subject|0|||
161885092|NCT00723190|584624427|FG000|Overall Study|Withdrawal by Subject|45|||
161885093|NCT00723190|584624427|FG000|Overall Study|Lost to Follow-up|37|||
161885094|NCT00723190|584624427|FG000|Overall Study|Adverse Event|18|||
161885095|NCT00723190|584624427|FG000|Overall Study|Lack of Efficacy|16|||
161885096|NCT00723190|584624427|FG000|Overall Study|Protocol Violation|15|||
161885097|NCT00723190|584624427|FG000|Overall Study|Other-Premature Discontinuation|9|||
161885098|NCT00723190|584624427|FG000|Overall Study|Other-Not included in safety population|2|||
161885099|NCT04472026|584624431|FG000|Overall Study|Lost to Follow-up|5|||
161885100|NCT01404208|584624432|FG000|Overall Study|Discontinued|3|||
161885101|NCT01404208|584624433|FG001|Overall Study|Discontinued|0|||
161885102|NCT03436199|584624438|FG000|Overall Study|Adverse Event|15|||
161885103|NCT03436199|584624439|FG001|Overall Study|Adverse Event|40|||
161885104|NCT03436199|584624440|FG002|Overall Study|Adverse Event|7|||
161885105|NCT03436199|584624438|FG000|Overall Study|Withdrawal by Subject|4|||
161885106|NCT03436199|584624439|FG001|Overall Study|Withdrawal by Subject|10|||
161885107|NCT03436199|584624440|FG002|Overall Study|Withdrawal by Subject|3|||
161885108|NCT03436199|584624438|FG000|Overall Study|Lost to Follow-up|1|||
161885109|NCT03436199|584624439|FG001|Overall Study|Lost to Follow-up|0|||
161885110|NCT03436199|584624440|FG002|Overall Study|Lost to Follow-up|2|||
161885111|NCT03436199|584624438|FG000|Overall Study|Protocol Violation|1|||
161885112|NCT03436199|584624439|FG001|Overall Study|Protocol Violation|1|||
161885113|NCT03436199|584624440|FG002|Overall Study|Protocol Violation|0|||
161885114|NCT03436199|584624438|FG000|Overall Study|Physician Decision|0|||
161885115|NCT03436199|584624439|FG001|Overall Study|Physician Decision|1|||
161885116|NCT03436199|584624440|FG002|Overall Study|Physician Decision|0|||
161885117|NCT03436199|584624438|FG000|Overall Study|Could not return to clinic|1|||
161885118|NCT03436199|584624439|FG001|Overall Study|Could not return to clinic|0|||
161885119|NCT03436199|584624440|FG002|Overall Study|Could not return to clinic|0|||
161885120|NCT03436199|584624438|FG000|Overall Study|Withdrawn per physician|0|||
161885121|NCT03436199|584624439|FG001|Overall Study|Withdrawn per physician|1|||
161885122|NCT03436199|584624440|FG002|Overall Study|Withdrawn per physician|0|||
161885123|NCT00085098|584624441|FG000|Overall Study|Withdrawal by Subject|0|||
161885124|NCT00085098|584624442|FG001|Overall Study|Withdrawal by Subject|1|||
161885125|NCT00085098|584624441|FG000|Overall Study|Ineligible|1|||
161885126|NCT00085098|584624442|FG001|Overall Study|Ineligible|1|||
161885127|NCT01886781|584624443|FG000|Overall Study|Protocol Violation|5|||
161885128|NCT01886781|584624444|FG001|Overall Study|Protocol Violation|0|||
161885129|NCT01886781|584624443|FG000|Overall Study|Adverse Event|1|||
161885130|NCT01886781|584624444|FG001|Overall Study|Adverse Event|0|||
161885131|NCT01886781|584624443|FG000|Overall Study|Lost to Follow-up|5|||
161885132|NCT01886781|584624444|FG001|Overall Study|Lost to Follow-up|0|||
161885133|NCT01886781|584624443|FG000|Overall Study|Withdrawal by Subject|2|||
161885134|NCT01886781|584624444|FG001|Overall Study|Withdrawal by Subject|1|||
161885135|NCT01886781|584624443|FG000|Overall Study|Worsening of symptoms|1|||
161885136|NCT01886781|584624444|FG001|Overall Study|Worsening of symptoms|1|||
161885137|NCT00772005|584624451|FG000|Overall Study|Adverse Event|9|||
161885138|NCT00772005|584624452|FG001|Overall Study|Adverse Event|14|||
161885139|NCT00772005|584624453|FG002|Overall Study|Adverse Event|10|||
161885140|NCT00772005|584624454|FG003|Overall Study|Adverse Event|13|||
161885141|NCT00772005|584624451|FG000|Overall Study|Lack of Efficacy|0|||
161885142|NCT00772005|584624452|FG001|Overall Study|Lack of Efficacy|1|||
161885143|NCT00772005|584624453|FG002|Overall Study|Lack of Efficacy|0|||
161885144|NCT00772005|584624454|FG003|Overall Study|Lack of Efficacy|0|||
161885145|NCT00772005|584624451|FG000|Overall Study|Withdrawal by Subject|3|||
161885146|NCT00772005|584624452|FG001|Overall Study|Withdrawal by Subject|7|||
161885147|NCT00772005|584624453|FG002|Overall Study|Withdrawal by Subject|10|||
161885148|NCT00772005|584624454|FG003|Overall Study|Withdrawal by Subject|2|||
161885149|NCT00772005|584624451|FG000|Overall Study|Protocol Violation|2|||
161885150|NCT00772005|584624452|FG001|Overall Study|Protocol Violation|4|||
161885151|NCT00772005|584624453|FG002|Overall Study|Protocol Violation|1|||
161885152|NCT00772005|584624454|FG003|Overall Study|Protocol Violation|6|||
161885153|NCT00772005|584624451|FG000|Overall Study|Lost to Follow-up|7|||
161885154|NCT00772005|584624452|FG001|Overall Study|Lost to Follow-up|3|||
161885155|NCT00772005|584624453|FG002|Overall Study|Lost to Follow-up|6|||
161885156|NCT00772005|584624454|FG003|Overall Study|Lost to Follow-up|3|||
161885157|NCT00772005|584624451|FG000|Overall Study|Non-compliance with study procedures|1|||
161885158|NCT00772005|584624452|FG001|Overall Study|Non-compliance with study procedures|1|||
161885159|NCT00772005|584624453|FG002|Overall Study|Non-compliance with study procedures|0|||
161885160|NCT00772005|584624454|FG003|Overall Study|Non-compliance with study procedures|1|||
161885161|NCT00772005|584624451|FG000|Overall Study|Non-compliance with drug administration|3|||
161885162|NCT00772005|584624452|FG001|Overall Study|Non-compliance with drug administration|0|||
161885163|NCT00772005|584624453|FG002|Overall Study|Non-compliance with drug administration|1|||
161885164|NCT00772005|584624454|FG003|Overall Study|Non-compliance with drug administration|1|||
161885165|NCT01273155|584624458|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
161885166|NCT01273155|584624459|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
161885167|NCT01273155|584624460|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
161885168|NCT01273155|584624461|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
161885169|NCT01273155|584624462|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
161885170|NCT01273155|584624463|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
161885171|NCT01273155|584624464|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
161885172|NCT01273155|584624458|FG000|Overall Study|Change in liver function/no longer eval.|0|||
161885173|NCT01273155|584624459|FG001|Overall Study|Change in liver function/no longer eval.|1|||
161885174|NCT01273155|584624460|FG002|Overall Study|Change in liver function/no longer eval.|0|||
161885175|NCT01273155|584624461|FG003|Overall Study|Change in liver function/no longer eval.|0|||
161885176|NCT01273155|584624462|FG004|Overall Study|Change in liver function/no longer eval.|1|||
161885177|NCT01273155|584624463|FG005|Overall Study|Change in liver function/no longer eval.|0|||
161885178|NCT01273155|584624464|FG006|Overall Study|Change in liver function/no longer eval.|0|||
161885179|NCT01273155|584624458|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
161885180|NCT01273155|584624459|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
161885181|NCT01273155|584624460|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
161885182|NCT01273155|584624461|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
161885183|NCT01273155|584624462|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
161885184|NCT01273155|584624463|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
161885185|NCT01273155|584624464|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
161885186|NCT01273155|584624458|FG000|Overall Study|Died during Cycle 1|0|||
161885187|NCT01273155|584624459|FG001|Overall Study|Died during Cycle 1|0|||
161885188|NCT01273155|584624460|FG002|Overall Study|Died during Cycle 1|1|||
161885189|NCT01273155|584624461|FG003|Overall Study|Died during Cycle 1|1|||
161885190|NCT01273155|584624462|FG004|Overall Study|Died during Cycle 1|0|||
161885191|NCT01273155|584624463|FG005|Overall Study|Died during Cycle 1|2|||
161885192|NCT01273155|584624464|FG006|Overall Study|Died during Cycle 1|2|||
161885193|NCT01273155|584624458|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
161885194|NCT01273155|584624459|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
161885195|NCT01273155|584624460|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
161885196|NCT01273155|584624461|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
161885197|NCT01273155|584624462|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
161885198|NCT01273155|584624463|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
161885199|NCT01273155|584624464|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
161885200|NCT01440569|584624465|FG000|Main Study|Enrolled but not treated|1|||
161885201|NCT01440569|584624466|FG001|Main Study|Enrolled but not treated|0|||
161885202|NCT01440569|584624465|FG000|Main Study|Adverse Event|9|||
161885203|NCT01440569|584624466|FG001|Main Study|Adverse Event|0|||
161885204|NCT01440569|584624465|FG000|Main Study|Pregnancy|1|||
161885205|NCT01440569|584624466|FG001|Main Study|Pregnancy|0|||
161885206|NCT01440569|584624465|FG000|Main Study|Investigator's Discretion|1|||
161885207|NCT01440569|584624466|FG001|Main Study|Investigator's Discretion|1|||
161885208|NCT01440569|584624465|FG000|Main Study|Withdrew Consent|7|||
161885209|NCT01440569|584624466|FG001|Main Study|Withdrew Consent|1|||
161885210|NCT01440569|584624465|FG000|Main Study|Lost to Follow-up|13|||
161885211|NCT01440569|584624466|FG001|Main Study|Lost to Follow-up|2|||
161885212|NCT01440569|584624465|FG000|Main Study|Subject Non-Compliance|3|||
161885213|NCT01440569|584624466|FG001|Main Study|Subject Non-Compliance|0|||
161885214|NCT01440569|584624465|FG000|Main Study|Protocol Violation|1|||
161885215|NCT01440569|584624466|FG001|Main Study|Protocol Violation|0|||
161885216|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Adverse Event|3|||
161885217|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Adverse Event|0|||
161885218|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Pregnancy|1|||
161885219|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Pregnancy|0|||
161885220|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
161885221|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
161885222|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
161885223|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
161885224|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
161885225|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
161885226|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
161885227|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
161885228|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
161885229|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
161885230|NCT03887117|584624474|FG000|Overall Study|Discontinued prematurely|0|||
161885231|NCT03887117|584624475|FG001|Overall Study|Discontinued prematurely|1|||
161885232|NCT03887117|584624476|FG002|Overall Study|Discontinued prematurely|1|||
161885233|NCT03887117|584624477|FG003|Overall Study|Discontinued prematurely|2|||
161885234|NCT04908475|584624478|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
161885235|NCT04908475|584624479|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885236|NCT04908475|584624480|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885237|NCT04908475|584624481|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885238|NCT04908475|584624482|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885239|NCT04908475|584624483|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885240|NCT04908475|584624478|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
161885241|NCT04908475|584624479|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885242|NCT04908475|584624480|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885243|NCT04908475|584624481|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885244|NCT04908475|584624482|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885245|NCT04908475|584624483|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885246|NCT04908475|584624478|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
161885247|NCT04908475|584624479|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885248|NCT04908475|584624480|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885249|NCT04908475|584624481|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885250|NCT04908475|584624482|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885251|NCT04908475|584624483|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885252|NCT04908475|584624478|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161885253|NCT04908475|584624479|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
161885254|NCT04908475|584624480|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
161885255|NCT04908475|584624481|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
161885256|NCT04908475|584624482|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161885257|NCT04908475|584624483|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161885258|NCT04908475|584624478|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
161885259|NCT04908475|584624479|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
161885260|NCT04908475|584624480|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
161885261|NCT04908475|584624481|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
161885262|NCT04908475|584624482|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
161885263|NCT04908475|584624483|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
161885264|NCT04908475|584624478|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
161885265|NCT04908475|584624479|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
161885266|NCT04908475|584624480|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
161885267|NCT04908475|584624481|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
161885268|NCT04908475|584624482|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
161885269|NCT04908475|584624483|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
161885270|NCT02584959|584624484|FG000|Period 1|Withdrawn from study|3|||
161885271|NCT02584959|584624485|FG001|Period 1|Withdrawn from study|4|||
161885272|NCT02584959|584624486|FG002|Period 1|Withdrawn from study|0|||
161885273|NCT02584959|584624484|FG000|Period 2|Withdrawn from study|6|||
161885274|NCT02584959|584624485|FG001|Period 2|Withdrawn from study|1|||
161885275|NCT02584959|584624486|FG002|Period 2|Withdrawn from study|2|||
161885276|NCT00926536|584624487|FG000|Overall Study|Physician Decision|1|||
161885277|NCT00926536|584624488|FG001|Overall Study|Physician Decision|2|||
161885278|NCT01267201|584624490|FG000|First Intervention Period|Withdrawal by Subject|1|||
161885279|NCT01267201|584624491|FG001|First Intervention Period|Withdrawal by Subject|0|||
161885280|NCT01267201|584624492|FG002|First Intervention Period|Withdrawal by Subject|0|||
161885281|NCT01267201|584624493|FG003|First Intervention Period|Withdrawal by Subject|0|||
161885282|NCT01267201|584624494|FG004|First Intervention Period|Withdrawal by Subject|0|||
161885283|NCT01267201|584624495|FG005|First Intervention Period|Withdrawal by Subject|0|||
161885284|NCT01267201|584624490|FG000|Second Intervention Period|Withdrawal by Subject|0|||
161885285|NCT01267201|584624491|FG001|Second Intervention Period|Withdrawal by Subject|1|||
161885286|NCT01267201|584624492|FG002|Second Intervention Period|Withdrawal by Subject|0|||
161885287|NCT01267201|584624493|FG003|Second Intervention Period|Withdrawal by Subject|0|||
161885288|NCT01267201|584624494|FG004|Second Intervention Period|Withdrawal by Subject|0|||
161885289|NCT01267201|584624495|FG005|Second Intervention Period|Withdrawal by Subject|0|||
161885290|NCT00483704|584624496|FG000|Randomization|Withdrawal by Subject|19|||
161885291|NCT00483704|584624497|FG001|Randomization|Withdrawal by Subject|28|||
161885292|NCT00483704|584624498|FG002|Randomization|Withdrawal by Subject|18|||
161885293|NCT00483704|584624496|FG000|Randomization|Protocol Violation|14|||
161885294|NCT00483704|584624497|FG001|Randomization|Protocol Violation|25|||
161885295|NCT00483704|584624498|FG002|Randomization|Protocol Violation|22|||
161885296|NCT00483704|584624496|FG000|Randomization|Lost to Follow-up|14|||
161885297|NCT00483704|584624497|FG001|Randomization|Lost to Follow-up|14|||
161885298|NCT00483704|584624498|FG002|Randomization|Lost to Follow-up|19|||
161885299|NCT00483704|584624496|FG000|Randomization|Pregnancy|1|||
161885300|NCT00483704|584624497|FG001|Randomization|Pregnancy|0|||
161885301|NCT00483704|584624498|FG002|Randomization|Pregnancy|0|||
161885302|NCT00483704|584624496|FG000|Randomization|Physician Decision|2|||
161885303|NCT00483704|584624497|FG001|Randomization|Physician Decision|4|||
161885304|NCT00483704|584624498|FG002|Randomization|Physician Decision|0|||
161885305|NCT00483704|584624496|FG000|Randomization|Progressive disease|0|||
161885306|NCT00483704|584624497|FG001|Randomization|Progressive disease|0|||
161885307|NCT00483704|584624498|FG002|Randomization|Progressive disease|1|||
161885308|NCT00483704|584624496|FG000|Randomization|Lack of qualifying migraines|21|||
161885309|NCT00483704|584624497|FG001|Randomization|Lack of qualifying migraines|25|||
161885310|NCT00483704|584624498|FG002|Randomization|Lack of qualifying migraines|31|||
161885311|NCT00483704|584624496|FG000|Treatment|Lack of qualifying migraines|101|||
161885312|NCT00483704|584624497|FG001|Treatment|Lack of qualifying migraines|99|||
161885313|NCT00483704|584624498|FG002|Treatment|Lack of qualifying migraines|116|||
161885314|NCT00483704|584624496|FG000|Treatment|Adverse Event|3|||
161885315|NCT00483704|584624497|FG001|Treatment|Adverse Event|5|||
161885316|NCT00483704|584624498|FG002|Treatment|Adverse Event|4|||
161885317|NCT00483704|584624496|FG000|Treatment|Withdrawal by Subject|16|||
161885318|NCT00483704|584624497|FG001|Treatment|Withdrawal by Subject|12|||
161885319|NCT00483704|584624498|FG002|Treatment|Withdrawal by Subject|21|||
161885320|NCT00483704|584624496|FG000|Treatment|Protocol Violation|6|||
161885321|NCT00483704|584624497|FG001|Treatment|Protocol Violation|3|||
161885322|NCT00483704|584624498|FG002|Treatment|Protocol Violation|5|||
161885323|NCT00483704|584624496|FG000|Treatment|Lost to Follow-up|2|||
161885324|NCT00483704|584624497|FG001|Treatment|Lost to Follow-up|7|||
161885325|NCT00483704|584624498|FG002|Treatment|Lost to Follow-up|5|||
161885326|NCT00483704|584624496|FG000|Treatment|Lack of Efficacy|1|||
161885327|NCT00483704|584624497|FG001|Treatment|Lack of Efficacy|1|||
161885328|NCT00483704|584624498|FG002|Treatment|Lack of Efficacy|1|||
161885329|NCT00483704|584624496|FG000|Treatment|Pregnancy|0|||
161885330|NCT00483704|584624497|FG001|Treatment|Pregnancy|1|||
161885331|NCT00483704|584624498|FG002|Treatment|Pregnancy|0|||
161885332|NCT00483704|584624496|FG000|Treatment|Physician Decision|0|||
161885333|NCT00483704|584624497|FG001|Treatment|Physician Decision|1|||
161885334|NCT00483704|584624498|FG002|Treatment|Physician Decision|4|||
161885335|NCT04272606|584624499|FG000|Overall Study|Protocol Violation|1|||
161885336|NCT04272606|584624500|FG001|Overall Study|Protocol Violation|1|||
161885337|NCT04272606|584624499|FG000|Overall Study|Physician Decision|0|||
161885338|NCT04272606|584624500|FG001|Overall Study|Physician Decision|1|||
161885339|NCT03912428|584624501|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161885340|NCT03912428|584624502|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
161885341|NCT03912428|584624503|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161885342|NCT03912428|584624504|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161885343|NCT03912428|584624501|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
161885344|NCT03912428|584624502|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
161885345|NCT03912428|584624503|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
161885346|NCT03912428|584624504|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
161885347|NCT03912428|584624501|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161885348|NCT03912428|584624502|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161885349|NCT03912428|584624503|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161885350|NCT03912428|584624504|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
161885351|NCT01037127|584624506|FG000|Overall Study|Lost to Follow-up|2|||
161885352|NCT01037127|584624507|FG001|Overall Study|Lost to Follow-up|4|||
161885353|NCT01037127|584624506|FG000|Overall Study|Physician Decision|1|||
161885354|NCT01037127|584624507|FG001|Overall Study|Physician Decision|0|||
161885355|NCT01037127|584624506|FG000|Overall Study|Study Closed Terminated|2|||
161885356|NCT01037127|584624507|FG001|Overall Study|Study Closed Terminated|17|||
161885357|NCT04325698|584624508|FG000|Overall Study|Study Terminated By Sponsor|1|||
161885358|NCT04325698|584624509|FG001|Overall Study|Study Terminated By Sponsor|1|||
161885359|NCT04325698|584624508|FG000|Overall Study|Withdrawal by Subject|0|||
161885360|NCT04325698|584624509|FG001|Overall Study|Withdrawal by Subject|2|||
161885361|NCT04253782|584624510|FG000|Overall Study|Death|2|||
161885362|NCT04253782|584624511|FG001|Overall Study|Death|0|||
161885363|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885364|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885365|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161885366|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885367|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885368|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885369|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885370|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885371|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885372|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885373|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885374|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885375|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885376|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885377|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
161885378|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885379|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885380|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885381|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885382|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885383|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885384|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885385|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885386|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885387|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885388|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885389|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885390|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885391|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161885392|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161885393|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885394|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885395|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885396|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885397|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885398|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885399|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885400|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885401|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885402|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885403|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885404|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885405|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
161885406|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
161885407|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885408|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885409|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885410|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885411|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885412|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885413|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885414|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885415|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885416|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885417|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885418|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885419|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885420|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885421|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
161885422|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885423|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885424|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885425|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885426|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885427|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885428|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885429|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885430|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885431|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885432|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885433|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885434|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885435|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885436|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885437|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885438|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885439|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
161885440|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885441|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885442|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885443|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885444|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885445|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885446|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885447|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885448|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885449|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885450|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885451|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885452|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
161885453|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
161885454|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885455|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
161885456|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885457|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885458|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885459|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885460|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885461|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885462|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885463|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885464|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885465|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885466|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
161885467|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885468|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885469|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885470|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885471|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885472|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885473|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885474|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885475|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885476|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885477|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885478|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885479|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885480|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885481|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
161885482|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885483|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885484|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885485|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885486|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885487|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885488|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885489|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885490|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885491|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885492|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885493|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885494|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885495|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885496|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
161885497|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885498|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885499|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885500|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885501|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885502|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885503|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885504|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885505|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885506|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885507|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885508|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885509|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
161885510|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161885511|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885512|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885513|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885514|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885515|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885516|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885517|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885518|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885519|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885520|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885521|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885522|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885523|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885524|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161885525|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885526|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885527|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885528|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885529|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885530|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885531|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885532|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885533|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885534|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885535|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885536|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
161885537|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885538|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885539|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885540|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885541|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885542|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885543|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885544|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885545|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
161885546|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
161885547|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
161885548|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
161885549|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
161885550|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
161885551|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
161885552|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
161885553|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
161885554|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
161885555|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
161885556|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
161885557|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
161885558|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
161885559|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885560|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885561|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885562|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885563|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885564|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885565|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885566|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885567|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885568|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885569|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885570|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161885571|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161885572|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885573|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885574|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885575|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885576|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885577|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885578|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885579|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885580|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885581|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885582|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885583|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885584|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161885585|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161885586|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885587|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885588|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885589|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885590|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885591|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885592|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885593|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885594|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885595|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885596|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885597|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885598|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885599|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885600|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
161885601|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885602|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885603|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885604|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885605|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885606|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885607|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885608|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885609|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885610|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885611|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885612|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
161885613|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
161885614|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
161885615|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885616|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885617|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885618|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885619|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885620|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885621|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885622|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885623|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885624|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885625|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885626|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
161885627|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
161885628|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161885629|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885630|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885631|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885632|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885633|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885634|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885635|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885636|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885637|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885638|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885639|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885640|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
161885641|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
161885642|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
161885643|NCT02889835|584624530|FG000|Overall Study|Lost to Follow-up|13|||
161885644|NCT02889835|584624531|FG001|Overall Study|Lost to Follow-up|13|||
161885645|NCT02889835|584624532|FG002|Overall Study|Lost to Follow-up|13|||
161885646|NCT02889835|584624530|FG000|Overall Study|Withdrawal by Subject|2|||
161885647|NCT02889835|584624531|FG001|Overall Study|Withdrawal by Subject|2|||
161885648|NCT02889835|584624532|FG002|Overall Study|Withdrawal by Subject|2|||
161885649|NCT02889835|584624530|FG000|Overall Study|Protocol Violation|1|||
161885650|NCT02889835|584624531|FG001|Overall Study|Protocol Violation|1|||
161885651|NCT02889835|584624532|FG002|Overall Study|Protocol Violation|1|||
161885652|NCT02889835|584624530|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
161885653|NCT02889835|584624531|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
161885654|NCT02889835|584624532|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
161885655|NCT02889835|584624530|FG000|Overall Study|Death|1|||
161885656|NCT02889835|584624531|FG001|Overall Study|Death|1|||
161885657|NCT02889835|584624532|FG002|Overall Study|Death|1|||
161885658|NCT02987972|584624535|FG000|Overall Study|Adverse Event|1|||
161885659|NCT02987972|584624536|FG001|Overall Study|Adverse Event|1|||
161885660|NCT02987972|584624537|FG002|Overall Study|Adverse Event|0|||
161885661|NCT02987972|584624535|FG000|Overall Study|Death|1|||
161885662|NCT02987972|584624536|FG001|Overall Study|Death|0|||
161885663|NCT02987972|584624537|FG002|Overall Study|Death|0|||
161885664|NCT02987972|584624535|FG000|Overall Study|Lack of Efficacy|9|||
161885665|NCT02987972|584624536|FG001|Overall Study|Lack of Efficacy|12|||
161885666|NCT02987972|584624537|FG002|Overall Study|Lack of Efficacy|12|||
161885667|NCT02987972|584624535|FG000|Overall Study|Lost to Follow-up|7|||
161885668|NCT02987972|584624536|FG001|Overall Study|Lost to Follow-up|8|||
161885669|NCT02987972|584624537|FG002|Overall Study|Lost to Follow-up|4|||
161885670|NCT02987972|584624535|FG000|Overall Study|Physician Decision|1|||
161885671|NCT02987972|584624536|FG001|Overall Study|Physician Decision|6|||
161885672|NCT02987972|584624537|FG002|Overall Study|Physician Decision|0|||
161885673|NCT02987972|584624535|FG000|Overall Study|Protocol Violation|2|||
161885674|NCT02987972|584624536|FG001|Overall Study|Protocol Violation|1|||
161885675|NCT02987972|584624537|FG002|Overall Study|Protocol Violation|5|||
161885676|NCT02987972|584624535|FG000|Overall Study|Withdrawal by Subject|22|||
161885677|NCT02987972|584624536|FG001|Overall Study|Withdrawal by Subject|17|||
161885678|NCT02987972|584624537|FG002|Overall Study|Withdrawal by Subject|21|||
161885679|NCT02342548|584624538|FG000|Overall Study|Adverse Event|12|||
161885680|NCT02342548|584624539|FG001|Overall Study|Adverse Event|17|||
161885681|NCT02342548|584624540|FG002|Overall Study|Adverse Event|13|||
161885682|NCT02342548|584624538|FG000|Overall Study|Lost to Follow-up|0|||
161885683|NCT02342548|584624539|FG001|Overall Study|Lost to Follow-up|1|||
161885684|NCT02342548|584624540|FG002|Overall Study|Lost to Follow-up|0|||
161885685|NCT02342548|584624538|FG000|Overall Study|Study terminated by sponsor|20|||
161885686|NCT02342548|584624539|FG001|Overall Study|Study terminated by sponsor|39|||
161885687|NCT02342548|584624540|FG002|Overall Study|Study terminated by sponsor|25|||
161885688|NCT02342548|584624538|FG000|Overall Study|Protocol Violation|0|||
161885689|NCT02342548|584624539|FG001|Overall Study|Protocol Violation|1|||
161885690|NCT02342548|584624540|FG002|Overall Study|Protocol Violation|0|||
161885691|NCT02342548|584624538|FG000|Overall Study|Withdrawal by Subject|1|||
161885692|NCT02342548|584624539|FG001|Overall Study|Withdrawal by Subject|3|||
161885693|NCT02342548|584624540|FG002|Overall Study|Withdrawal by Subject|4|||
161885694|NCT02342548|584624538|FG000|Overall Study|Other|1|||
161885695|NCT02342548|584624539|FG001|Overall Study|Other|1|||
161885696|NCT02342548|584624540|FG002|Overall Study|Other|1|||
161885697|NCT01047332|584624543|FG000|Overall Study|SEMS Obstruction|11|||
161885698|NCT01047332|584624544|FG001|Overall Study|SEMS Obstruction|20|||
161885699|NCT01047332|584624543|FG000|Overall Study|Died Unobstructed|38|||
161885700|NCT01047332|584624544|FG001|Overall Study|Died Unobstructed|41|||
161885701|NCT01047332|584624543|FG000|Overall Study|Lost to Follow-up|8|||
161885702|NCT01047332|584624544|FG001|Overall Study|Lost to Follow-up|3|||
161885703|NCT03521817|584624545|FG000|Overall Study|Protocol Violation|0|||
161885704|NCT03521817|584624546|FG001|Overall Study|Protocol Violation|1|||
161885705|NCT00787917|584624547|FG000|Blinded Treatment|Adverse Event|1|||
161885706|NCT00787917|584624548|FG001|Blinded Treatment|Adverse Event|0|||
161885707|NCT00787917|584624547|FG000|Blinded Treatment|Lack of Efficacy|1|||
161885708|NCT00787917|584624548|FG001|Blinded Treatment|Lack of Efficacy|0|||
161885709|NCT00787917|584624547|FG000|Blinded Treatment|Administrative problems|3|||
161885710|NCT00787917|584624548|FG001|Blinded Treatment|Administrative problems|2|||
161885711|NCT00787917|584624547|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
161885712|NCT00787917|584624548|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
161885713|NCT00787917|584624547|FG000|Open Label|Administrative problems|3|||
161885714|NCT00787917|584624548|FG001|Open Label|Administrative problems|0|||
161885715|NCT05685732|584624550|FG000|Overall Study|Withdrawal by Subject|2|||
161885716|NCT05685732|584624551|FG001|Overall Study|Withdrawal by Subject|0|||
161885717|NCT05685732|584624552|FG002|Overall Study|Withdrawal by Subject|2|||
161885718|NCT05685732|584624553|FG003|Overall Study|Withdrawal by Subject|3|||
161885719|NCT05685732|584624550|FG000|Overall Study|Protocol Violation|1|||
161885720|NCT05685732|584624551|FG001|Overall Study|Protocol Violation|2|||
161885721|NCT05685732|584624552|FG002|Overall Study|Protocol Violation|4|||
161885722|NCT05685732|584624553|FG003|Overall Study|Protocol Violation|1|||
161885723|NCT05685732|584624550|FG000|Overall Study|Lost to Follow-up|5|||
161885724|NCT05685732|584624551|FG001|Overall Study|Lost to Follow-up|1|||
161885725|NCT05685732|584624552|FG002|Overall Study|Lost to Follow-up|3|||
161885726|NCT05685732|584624553|FG003|Overall Study|Lost to Follow-up|1|||
161885727|NCT05685732|584624550|FG000|Overall Study|Adverse Event|2|||
161885728|NCT05685732|584624551|FG001|Overall Study|Adverse Event|1|||
161885729|NCT05685732|584624552|FG002|Overall Study|Adverse Event|0|||
161885730|NCT05685732|584624553|FG003|Overall Study|Adverse Event|0|||
161885731|NCT05685732|584624550|FG000|Overall Study|Physician Decision|1|||
161885732|NCT05685732|584624551|FG001|Overall Study|Physician Decision|0|||
161885733|NCT05685732|584624552|FG002|Overall Study|Physician Decision|0|||
161885734|NCT05685732|584624553|FG003|Overall Study|Physician Decision|0|||
161885735|NCT02640404|584624554|FG000|Overall Study|Protocol Violation|1|||
161885736|NCT02640404|584624555|FG001|Overall Study|Protocol Violation|0|||
161885737|NCT02640404|584624554|FG000|Overall Study|Withdrawal by Subject|1|||
161885738|NCT02640404|584624555|FG001|Overall Study|Withdrawal by Subject|0|||
161885739|NCT00778102|584624556|FG000|Overall Study|Adverse Event|8|||
161885740|NCT00778102|584624557|FG001|Overall Study|Adverse Event|5|||
161885741|NCT00778102|584624556|FG000|Overall Study|Death|1|||
161885742|NCT00778102|584624557|FG001|Overall Study|Death|1|||
161885743|NCT00778102|584624556|FG000|Overall Study|Lost to Follow-up|1|||
161885744|NCT00778102|584624557|FG001|Overall Study|Lost to Follow-up|0|||
161885745|NCT00778102|584624556|FG000|Overall Study|Violation of Selection Criteria|1|||
161885746|NCT00778102|584624557|FG001|Overall Study|Violation of Selection Criteria|1|||
161885747|NCT00778102|584624556|FG000|Overall Study|Protocol Violation|0|||
161885748|NCT00778102|584624557|FG001|Overall Study|Protocol Violation|1|||
161885749|NCT00778102|584624556|FG000|Overall Study|Refused Treatment|2|||
161885750|NCT00778102|584624557|FG001|Overall Study|Refused Treatment|3|||
161885751|NCT00778102|584624556|FG000|Overall Study|Withdrawal by Subject|1|||
161885752|NCT00778102|584624557|FG001|Overall Study|Withdrawal by Subject|1|||
161885753|NCT00778102|584624556|FG000|Overall Study|Administrative Reason|7|||
161885754|NCT00778102|584624557|FG001|Overall Study|Administrative Reason|10|||
161885755|NCT05397171|584624558|FG000|Overall Study|Death|2|||
161885756|NCT05397171|584624559|FG001|Overall Study|Death|3|||
161885757|NCT05397171|584624560|FG002|Overall Study|Death|3|||
161885758|NCT05397171|584624558|FG000|Overall Study|Study Terminated By Sponsor|1|||
161885759|NCT05397171|584624559|FG001|Overall Study|Study Terminated By Sponsor|2|||
161885760|NCT05397171|584624560|FG002|Overall Study|Study Terminated By Sponsor|3|||
161885761|NCT05397171|584624558|FG000|Overall Study|Withdrawal by Subject|0|||
161885762|NCT05397171|584624559|FG001|Overall Study|Withdrawal by Subject|1|||
161885763|NCT05397171|584624560|FG002|Overall Study|Withdrawal by Subject|1|||
161885764|NCT01328548|584624561|FG000|Overall Study|Death|3|||
161885765|NCT01328548|584624562|FG001|Overall Study|Death|0|||
161885766|NCT01328548|584624561|FG000|Overall Study|Protocol Violation|1|||
161885767|NCT01328548|584624562|FG001|Overall Study|Protocol Violation|0|||
161885768|NCT01709864|584626621|FG000|Overall Study|Physician Decision|0|||
161885769|NCT01709864|584626622|FG001|Overall Study|Physician Decision|1|||
161885770|NCT01709864|584626621|FG000|Overall Study|subject/guardian decision|5|||
161885771|NCT01709864|584626622|FG001|Overall Study|subject/guardian decision|6|||
161885772|NCT01709864|584626621|FG000|Overall Study|Lost to Follow-up|1|||
161885773|NCT01709864|584626622|FG001|Overall Study|Lost to Follow-up|0|||
161885774|NCT01709864|584626621|FG000|Overall Study|non-compliance with study treatment|1|||
161885775|NCT01709864|584626622|FG001|Overall Study|non-compliance with study treatment|1|||
161885776|NCT01709864|584626621|FG000|Overall Study|Adverse Event|0|||
161885777|NCT01709864|584626622|FG001|Overall Study|Adverse Event|2|||
161885778|NCT01709864|584626621|FG000|Overall Study|Death|0|||
161885779|NCT01709864|584626622|FG001|Overall Study|Death|1|||
161885780|NCT01066793|584626623|FG000|Overall Study|Death|4|||
161885781|NCT01066793|584626624|FG001|Overall Study|Death|1|||
161885782|NCT01066793|584626625|FG002|Overall Study|Death|1|||
161885783|NCT01066793|584626626|FG003|Overall Study|Death|0|||
161885784|NCT01066793|584626627|FG004|Overall Study|Death|0|||
161885785|NCT01066793|584626628|FG005|Overall Study|Death|0|||
161885786|NCT01066793|584626623|FG000|Overall Study|Lack of Efficacy|2|||
161885787|NCT01066793|584626624|FG001|Overall Study|Lack of Efficacy|1|||
161885788|NCT01066793|584626625|FG002|Overall Study|Lack of Efficacy|0|||
161885789|NCT01066793|584626626|FG003|Overall Study|Lack of Efficacy|0|||
161885790|NCT01066793|584626627|FG004|Overall Study|Lack of Efficacy|0|||
161885791|NCT01066793|584626628|FG005|Overall Study|Lack of Efficacy|0|||
161885792|NCT01066793|584626623|FG000|Overall Study|Lost to Follow-up|180|||
161885793|NCT01066793|584626624|FG001|Overall Study|Lost to Follow-up|39|||
161885794|NCT01066793|584626625|FG002|Overall Study|Lost to Follow-up|82|||
161885795|NCT01066793|584626626|FG003|Overall Study|Lost to Follow-up|16|||
161885796|NCT01066793|584626627|FG004|Overall Study|Lost to Follow-up|0|||
161885797|NCT01066793|584626628|FG005|Overall Study|Lost to Follow-up|1|||
161885798|NCT01066793|584626623|FG000|Overall Study|Physician Decision|3|||
161885799|NCT01066793|584626624|FG001|Overall Study|Physician Decision|0|||
161885800|NCT01066793|584626625|FG002|Overall Study|Physician Decision|0|||
161885801|NCT01066793|584626626|FG003|Overall Study|Physician Decision|0|||
161885802|NCT01066793|584626627|FG004|Overall Study|Physician Decision|0|||
161885803|NCT01066793|584626628|FG005|Overall Study|Physician Decision|0|||
161885804|NCT01066793|584626623|FG000|Overall Study|Protocol Violation|3|||
161885805|NCT01066793|584626624|FG001|Overall Study|Protocol Violation|2|||
161885806|NCT01066793|584626625|FG002|Overall Study|Protocol Violation|2|||
161885807|NCT01066793|584626626|FG003|Overall Study|Protocol Violation|0|||
161885808|NCT01066793|584626627|FG004|Overall Study|Protocol Violation|0|||
161885809|NCT01066793|584626628|FG005|Overall Study|Protocol Violation|0|||
161885810|NCT01066793|584626623|FG000|Overall Study|Withdrawal by Subject|7|||
161885811|NCT01066793|584626624|FG001|Overall Study|Withdrawal by Subject|4|||
161885812|NCT01066793|584626625|FG002|Overall Study|Withdrawal by Subject|1|||
161885813|NCT01066793|584626626|FG003|Overall Study|Withdrawal by Subject|0|||
161885814|NCT01066793|584626627|FG004|Overall Study|Withdrawal by Subject|0|||
161885815|NCT01066793|584626628|FG005|Overall Study|Withdrawal by Subject|0|||
161885816|NCT01066793|584626623|FG000|Overall Study|Early Termination|3|||
161885817|NCT01066793|584626624|FG001|Overall Study|Early Termination|0|||
161885818|NCT01066793|584626625|FG002|Overall Study|Early Termination|0|||
161885819|NCT01066793|584626626|FG003|Overall Study|Early Termination|0|||
161885820|NCT01066793|584626627|FG004|Overall Study|Early Termination|0|||
161885821|NCT01066793|584626628|FG005|Overall Study|Early Termination|0|||
161885822|NCT01066793|584626623|FG000|Overall Study|Lab test not done|7|||
161885823|NCT01066793|584626624|FG001|Overall Study|Lab test not done|0|||
161885824|NCT01066793|584626625|FG002|Overall Study|Lab test not done|0|||
161885825|NCT01066793|584626626|FG003|Overall Study|Lab test not done|1|||
161885826|NCT01066793|584626627|FG004|Overall Study|Lab test not done|0|||
161885827|NCT01066793|584626628|FG005|Overall Study|Lab test not done|0|||
161885828|NCT01066793|584626623|FG000|Overall Study|Miscellaneous|4|||
161885829|NCT01066793|584626624|FG001|Overall Study|Miscellaneous|5|||
161885830|NCT01066793|584626625|FG002|Overall Study|Miscellaneous|6|||
161885831|NCT01066793|584626626|FG003|Overall Study|Miscellaneous|0|||
161885832|NCT01066793|584626627|FG004|Overall Study|Miscellaneous|0|||
161885833|NCT01066793|584626628|FG005|Overall Study|Miscellaneous|0|||
161885834|NCT01066793|584626623|FG000|Overall Study|Non-responders|104|||
161885835|NCT01066793|584626624|FG001|Overall Study|Non-responders|5|||
161885836|NCT01066793|584626625|FG002|Overall Study|Non-responders|11|||
161885837|NCT01066793|584626626|FG003|Overall Study|Non-responders|25|||
161885838|NCT01066793|584626627|FG004|Overall Study|Non-responders|0|||
161885839|NCT01066793|584626628|FG005|Overall Study|Non-responders|0|||
161885840|NCT01066793|584626623|FG000|Overall Study|Other|15|||
161885841|NCT01066793|584626624|FG001|Overall Study|Other|5|||
161885842|NCT01066793|584626625|FG002|Overall Study|Other|6|||
161885843|NCT01066793|584626626|FG003|Overall Study|Other|2|||
161885844|NCT01066793|584626627|FG004|Overall Study|Other|0|||
161885845|NCT01066793|584626628|FG005|Overall Study|Other|0|||
161885846|NCT01066793|584626623|FG000|Overall Study|Relapse|20|||
161885847|NCT01066793|584626624|FG001|Overall Study|Relapse|8|||
161885848|NCT01066793|584626625|FG002|Overall Study|Relapse|2|||
161885849|NCT01066793|584626626|FG003|Overall Study|Relapse|3|||
161885850|NCT01066793|584626627|FG004|Overall Study|Relapse|0|||
161885851|NCT01066793|584626628|FG005|Overall Study|Relapse|0|||
161885852|NCT01066793|584626623|FG000|Overall Study|Result Not Available|1|||
161885853|NCT01066793|584626624|FG001|Overall Study|Result Not Available|0|||
161885854|NCT01066793|584626625|FG002|Overall Study|Result Not Available|0|||
161885855|NCT01066793|584626626|FG003|Overall Study|Result Not Available|0|||
161885856|NCT01066793|584626627|FG004|Overall Study|Result Not Available|0|||
161885857|NCT01066793|584626628|FG005|Overall Study|Result Not Available|0|||
161885858|NCT01066793|584626623|FG000|Overall Study|Treatment Interrupted|1|||
161885859|NCT01066793|584626624|FG001|Overall Study|Treatment Interrupted|1|||
161885860|NCT01066793|584626625|FG002|Overall Study|Treatment Interrupted|0|||
161885861|NCT01066793|584626626|FG003|Overall Study|Treatment Interrupted|0|||
161885862|NCT01066793|584626627|FG004|Overall Study|Treatment Interrupted|0|||
161885863|NCT01066793|584626628|FG005|Overall Study|Treatment Interrupted|0|||
161885864|NCT01066793|584626623|FG000|Overall Study|Treatment Never Started|18|||
161885865|NCT01066793|584626624|FG001|Overall Study|Treatment Never Started|5|||
161885866|NCT01066793|584626625|FG002|Overall Study|Treatment Never Started|4|||
161885867|NCT01066793|584626626|FG003|Overall Study|Treatment Never Started|1|||
161885868|NCT01066793|584626627|FG004|Overall Study|Treatment Never Started|0|||
161885869|NCT01066793|584626628|FG005|Overall Study|Treatment Never Started|0|||
161885870|NCT01066793|584626623|FG000|Overall Study|Treatment Stopped|2|||
161885871|NCT01066793|584626624|FG001|Overall Study|Treatment Stopped|1|||
161885872|NCT01066793|584626625|FG002|Overall Study|Treatment Stopped|0|||
161885873|NCT01066793|584626626|FG003|Overall Study|Treatment Stopped|1|||
161885874|NCT01066793|584626627|FG004|Overall Study|Treatment Stopped|0|||
161885875|NCT01066793|584626628|FG005|Overall Study|Treatment Stopped|0|||
161885876|NCT02697916|584626630|FG000|Overall Study|Death|357|||
161885877|NCT02697916|584626631|FG001|Overall Study|Death|315|||
161885878|NCT02697916|584626630|FG000|Overall Study|Withdrawal by Subject|221|||
161885879|NCT02697916|584626631|FG001|Overall Study|Withdrawal by Subject|393|||
161885880|NCT04643964|584626632|FG000|Overall Study|Lost to Follow-up|55|||
161885881|NCT04643964|584626633|FG001|Overall Study|Lost to Follow-up|59|||
161885882|NCT04643964|584626634|FG002|Overall Study|Lost to Follow-up|54|||
161885883|NCT04643964|584626635|FG003|Overall Study|Lost to Follow-up|129|||
161885884|NCT04643964|584626636|FG004|Overall Study|Lost to Follow-up|48|||
161885885|NCT04643964|584626632|FG000|Overall Study|Failed attention check|1|||
161885886|NCT04643964|584626633|FG001|Overall Study|Failed attention check|8|||
161885887|NCT04643964|584626634|FG002|Overall Study|Failed attention check|2|||
161885888|NCT04643964|584626635|FG003|Overall Study|Failed attention check|14|||
161885889|NCT04643964|584626636|FG004|Overall Study|Failed attention check|11|||
161885890|NCT00590538|584626637|FG000|Overall Study|Study terminated before completed|2|||
161885891|NCT01125813|584626638|FG000|Overall Study|Death|1|||
161885892|NCT01125813|584626638|FG000|Overall Study|Withdrawal by Subject|1|||
161885893|NCT01125813|584626638|FG000|Overall Study|Screen Failures|4|||
161885894|NCT02539134|584626641|FG000|Overall Study|Lost to Follow-up|1|||
161885895|NCT02539134|584626642|FG001|Overall Study|Lost to Follow-up|0|||
161885896|NCT02539134|584626643|FG002|Overall Study|Lost to Follow-up|0|||
161885897|NCT02539134|584626644|FG003|Overall Study|Lost to Follow-up|0|||
161885898|NCT02539134|584626645|FG004|Overall Study|Lost to Follow-up|0|||
161885899|NCT02539134|584626646|FG005|Overall Study|Lost to Follow-up|0|||
161885900|NCT02255552|584626647|FG000|Overall Study|Participants enrolled into another study|0|||
161885901|NCT02255552|584626648|FG001|Overall Study|Participants enrolled into another study|11|||
161885902|NCT02255552|584626647|FG000|Overall Study|Withdrawal by Subject|1|||
161885903|NCT02255552|584626648|FG001|Overall Study|Withdrawal by Subject|4|||
161885904|NCT00558896|584626649|FG000|Overall Study|Adverse Event|1|||
161885905|NCT00558896|584626650|FG001|Overall Study|Adverse Event|1|||
161885906|NCT00558896|584626651|FG002|Overall Study|Adverse Event|1|||
161885907|NCT00558896|584626652|FG003|Overall Study|Adverse Event|3|||
161885908|NCT00558896|584626653|FG004|Overall Study|Adverse Event|4|||
161885909|NCT00558896|584626654|FG005|Overall Study|Adverse Event|10|||
161885910|NCT00558896|584626655|FG006|Overall Study|Adverse Event|3|||
161885911|NCT00558896|584626649|FG000|Overall Study|Death|3|||
161885912|NCT00558896|584626650|FG001|Overall Study|Death|0|||
161885913|NCT00558896|584626651|FG002|Overall Study|Death|2|||
161885914|NCT00558896|584626652|FG003|Overall Study|Death|3|||
161885915|NCT00558896|584626653|FG004|Overall Study|Death|2|||
161885916|NCT00558896|584626654|FG005|Overall Study|Death|2|||
161885917|NCT00558896|584626655|FG006|Overall Study|Death|6|||
161885918|NCT00558896|584626649|FG000|Overall Study|Withdrawal by Subject|2|||
161885919|NCT00558896|584626650|FG001|Overall Study|Withdrawal by Subject|1|||
161885920|NCT00558896|584626651|FG002|Overall Study|Withdrawal by Subject|1|||
161885921|NCT00558896|584626652|FG003|Overall Study|Withdrawal by Subject|1|||
161885922|NCT00558896|584626653|FG004|Overall Study|Withdrawal by Subject|1|||
161885923|NCT00558896|584626654|FG005|Overall Study|Withdrawal by Subject|5|||
161885924|NCT00558896|584626655|FG006|Overall Study|Withdrawal by Subject|5|||
161885925|NCT00558896|584626649|FG000|Overall Study|Alternative Treatment|2|||
161885926|NCT00558896|584626650|FG001|Overall Study|Alternative Treatment|2|||
161885927|NCT00558896|584626651|FG002|Overall Study|Alternative Treatment|0|||
161885928|NCT00558896|584626652|FG003|Overall Study|Alternative Treatment|2|||
161885929|NCT00558896|584626653|FG004|Overall Study|Alternative Treatment|6|||
161885930|NCT00558896|584626654|FG005|Overall Study|Alternative Treatment|7|||
161885931|NCT00558896|584626655|FG006|Overall Study|Alternative Treatment|1|||
161885932|NCT00558896|584626649|FG000|Overall Study|Physician discretion|3|||
161885933|NCT00558896|584626650|FG001|Overall Study|Physician discretion|2|||
161885934|NCT00558896|584626651|FG002|Overall Study|Physician discretion|1|||
161885935|NCT00558896|584626652|FG003|Overall Study|Physician discretion|2|||
161885936|NCT00558896|584626653|FG004|Overall Study|Physician discretion|1|||
161885937|NCT00558896|584626654|FG005|Overall Study|Physician discretion|3|||
161885938|NCT00558896|584626655|FG006|Overall Study|Physician discretion|3|||
161885939|NCT00558896|584626649|FG000|Overall Study|Continues on treatment|10|||
161885940|NCT00558896|584626650|FG001|Overall Study|Continues on treatment|1|||
161885941|NCT00558896|584626651|FG002|Overall Study|Continues on treatment|0|||
161885942|NCT00558896|584626652|FG003|Overall Study|Continues on treatment|1|||
161885943|NCT00558896|584626653|FG004|Overall Study|Continues on treatment|9|||
161885944|NCT00558896|584626654|FG005|Overall Study|Continues on treatment|25|||
161885945|NCT00558896|584626655|FG006|Overall Study|Continues on treatment|6|||
161885946|NCT03181503|584626656|FG000|Overall Study|Adverse Event|2|||
161885947|NCT03181503|584626657|FG001|Overall Study|Adverse Event|2|||
161885948|NCT03181503|584626656|FG000|Overall Study|Protocol Violation|1|||
161885949|NCT03181503|584626657|FG001|Overall Study|Protocol Violation|0|||
161885950|NCT03181503|584626656|FG000|Overall Study|Withdrawal by Subject|3|||
161885951|NCT03181503|584626657|FG001|Overall Study|Withdrawal by Subject|0|||
161885952|NCT03181503|584626656|FG000|Overall Study|Lost to Follow-up|1|||
161885953|NCT03181503|584626657|FG001|Overall Study|Lost to Follow-up|1|||
161885954|NCT02382796|584626660|FG000|Overall Study|Global deterioration of health status|1|||
161885955|NCT02382796|584626660|FG000|Overall Study|Objective progression or relapse|3|||
161885956|NCT02382796|584626660|FG000|Overall Study|Commercial dacomitinib became available|3|||
161885957|NCT03077659|584626661|FG000|Overall Study|Withdrawal by Subject|0|||
161885958|NCT03077659|584626662|FG001|Overall Study|Withdrawal by Subject|0|||
161885959|NCT03077659|584626663|FG002|Overall Study|Withdrawal by Subject|1|||
161885960|NCT02258542|584626670|FG000|Overall Study|eg. not made to the visit|7|||
161885961|NCT02258542|584626671|FG001|Overall Study|eg. not made to the visit|4|||
161885962|NCT02258542|584626672|FG002|Overall Study|eg. not made to the visit|0|||
161885963|NCT02258542|584626673|FG003|Overall Study|eg. not made to the visit|1|||
161885964|NCT02258542|584626670|FG000|Overall Study|study specific discount. criteria|1|||
161885965|NCT02258542|584626671|FG001|Overall Study|study specific discount. criteria|1|||
161885966|NCT02258542|584626672|FG002|Overall Study|study specific discount. criteria|0|||
161885967|NCT02258542|584626673|FG003|Overall Study|study specific discount. criteria|0|||
161885968|NCT02258542|584626670|FG000|Overall Study|Withdrawal by Subject|20|||
161885969|NCT02258542|584626671|FG001|Overall Study|Withdrawal by Subject|20|||
161885970|NCT02258542|584626672|FG002|Overall Study|Withdrawal by Subject|7|||
161885971|NCT02258542|584626673|FG003|Overall Study|Withdrawal by Subject|1|||
161885972|NCT02258542|584626670|FG000|Overall Study|Lost to Follow-up|5|||
161885973|NCT02258542|584626671|FG001|Overall Study|Lost to Follow-up|12|||
161885974|NCT02258542|584626672|FG002|Overall Study|Lost to Follow-up|1|||
161885975|NCT02258542|584626673|FG003|Overall Study|Lost to Follow-up|2|||
161885976|NCT02258542|584626670|FG000|Overall Study|Death|5|||
161885977|NCT02258542|584626671|FG001|Overall Study|Death|4|||
161885978|NCT02258542|584626672|FG002|Overall Study|Death|0|||
161885979|NCT02258542|584626673|FG003|Overall Study|Death|1|||
161885980|NCT02258542|584626670|FG000|Overall Study|Adverse Event|3|||
161885981|NCT02258542|584626671|FG001|Overall Study|Adverse Event|4|||
161885982|NCT02258542|584626672|FG002|Overall Study|Adverse Event|0|||
161885983|NCT02258542|584626673|FG003|Overall Study|Adverse Event|0|||
161885984|NCT02258542|584626670|FG000|Overall Study|Protocol Violation|1|||
161885985|NCT02258542|584626671|FG001|Overall Study|Protocol Violation|2|||
161885986|NCT02258542|584626672|FG002|Overall Study|Protocol Violation|0|||
161885987|NCT02258542|584626673|FG003|Overall Study|Protocol Violation|0|||
161885988|NCT02258542|584626670|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161885989|NCT02258542|584626671|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161885990|NCT02258542|584626672|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161885991|NCT02258542|584626673|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
161885992|NCT04068688|584626674|FG000|Overall Study|Lost to Follow-up|1|||
161885993|NCT04068688|584626675|FG001|Overall Study|Lost to Follow-up|1|||
161885994|NCT04068688|584626676|FG002|Overall Study|Lost to Follow-up|0|||
161885995|NCT04068688|584626677|FG003|Overall Study|Lost to Follow-up|0|||
161885996|NCT04068688|584626678|FG004|Overall Study|Lost to Follow-up|5|||
161885997|NCT04068688|584626679|FG005|Overall Study|Lost to Follow-up|5|||
161885998|NCT04068688|584626680|FG006|Overall Study|Lost to Follow-up|0|||
161885999|NCT04068688|584626681|FG007|Overall Study|Lost to Follow-up|0|||
161886000|NCT04068688|584626682|FG008|Overall Study|Lost to Follow-up|1|||
161886001|NCT04068688|584626683|FG009|Overall Study|Lost to Follow-up|0|||
161886002|NCT04068688|584626674|FG000|Overall Study|Withdrawal by Subject|1|||
161886003|NCT04068688|584626675|FG001|Overall Study|Withdrawal by Subject|1|||
161886004|NCT04068688|584626676|FG002|Overall Study|Withdrawal by Subject|0|||
161886005|NCT04068688|584626677|FG003|Overall Study|Withdrawal by Subject|0|||
161886006|NCT04068688|584626678|FG004|Overall Study|Withdrawal by Subject|0|||
161886007|NCT04068688|584626679|FG005|Overall Study|Withdrawal by Subject|0|||
161886008|NCT04068688|584626680|FG006|Overall Study|Withdrawal by Subject|0|||
161886009|NCT04068688|584626681|FG007|Overall Study|Withdrawal by Subject|0|||
161886010|NCT04068688|584626682|FG008|Overall Study|Withdrawal by Subject|0|||
161886011|NCT04068688|584626683|FG009|Overall Study|Withdrawal by Subject|0|||
161886012|NCT04068688|584626674|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
161886013|NCT04068688|584626675|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
161886014|NCT04068688|584626676|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886015|NCT04068688|584626677|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886016|NCT04068688|584626678|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886017|NCT04068688|584626679|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886018|NCT04068688|584626680|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886019|NCT04068688|584626681|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886020|NCT04068688|584626682|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886021|NCT04068688|584626683|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886022|NCT04679051|584626684|FG000|Overall Study|felt tired after restricted time in bed|3|||
161886023|NCT04679051|584626685|FG001|Overall Study|felt tired after restricted time in bed|0|||
161886024|NCT04679051|584626684|FG000|Overall Study|discomfort with blood pressure cuff|2|||
161886025|NCT04679051|584626685|FG001|Overall Study|discomfort with blood pressure cuff|0|||
161886026|NCT04679051|584626684|FG000|Overall Study|scheduling conflict|1|||
161886027|NCT04679051|584626685|FG001|Overall Study|scheduling conflict|1|||
161886028|NCT04679051|584626684|FG000|Overall Study|Protocol Violation|0|||
161886029|NCT04679051|584626685|FG001|Overall Study|Protocol Violation|4|||
161886030|NCT02554318|584626686|FG000|Overall Study|Withdrawal by Subject|10|||
161886031|NCT02554318|584626687|FG001|Overall Study|Withdrawal by Subject|8|||
161886032|NCT01472965|584626688|FG000|Overall Study|Withdrawal by Subject|1|||
161886033|NCT01472965|584626689|FG001|Overall Study|Withdrawal by Subject|0|||
161886034|NCT00334802|584626693|FG000|Overall Study|Progressive Disease|2|||
161886035|NCT00334802|584626694|FG001|Overall Study|Progressive Disease|24|||
161886036|NCT00334802|584626693|FG000|Overall Study|Toxicity|1|||
161886037|NCT00334802|584626694|FG001|Overall Study|Toxicity|5|||
161886038|NCT00334802|584626693|FG000|Overall Study|Lack of Efficacy|1|||
161886039|NCT00334802|584626694|FG001|Overall Study|Lack of Efficacy|3|||
161886040|NCT00334802|584626693|FG000|Overall Study|Patient Condition Aggrevated|1|||
161886041|NCT00334802|584626694|FG001|Overall Study|Patient Condition Aggrevated|0|||
161886042|NCT00334802|584626693|FG000|Overall Study|Physician Decision|1|||
161886043|NCT00334802|584626694|FG001|Overall Study|Physician Decision|0|||
161886044|NCT00334802|584626693|FG000|Overall Study|Withdrawal by Subject|0|||
161886045|NCT00334802|584626694|FG001|Overall Study|Withdrawal by Subject|4|||
161886046|NCT00334802|584626693|FG000|Overall Study|Adverse Event|0|||
161886047|NCT00334802|584626694|FG001|Overall Study|Adverse Event|3|||
161886048|NCT00334802|584626693|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
161886049|NCT00334802|584626694|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
161886050|NCT00980018|584626700|FG000|Overall Study|Adverse Event|8|||
161886051|NCT00980018|584626700|FG000|Overall Study|Patient withdrew consent|3|||
161886052|NCT00980018|584626700|FG000|Overall Study|Lost to Follow-up|1|||
161886053|NCT00551161|584626701|FG000|Overall Study|Withdrawal by Subject|1|||
161886054|NCT00934856|584626702|FG000|Feasibility Part|Progressive disease|4|||
161886055|NCT00934856|584626703|FG001|Feasibility Part|Progressive disease|4|||
161886056|NCT00934856|584626704|FG002|Feasibility Part|Progressive disease|2|||
161886057|NCT00934856|584626705|FG003|Feasibility Part|Progressive disease|3|||
161886058|NCT00934856|584626706|FG004|Feasibility Part|Progressive disease|0|||
161886059|NCT00934856|584626707|FG005|Feasibility Part|Progressive disease|0|||
161886060|NCT00934856|584626702|FG000|Feasibility Part|Physician Decision|0|||
161886061|NCT00934856|584626703|FG001|Feasibility Part|Physician Decision|0|||
161886062|NCT00934856|584626704|FG002|Feasibility Part|Physician Decision|1|||
161886063|NCT00934856|584626705|FG003|Feasibility Part|Physician Decision|0|||
161886064|NCT00934856|584626706|FG004|Feasibility Part|Physician Decision|0|||
161886065|NCT00934856|584626707|FG005|Feasibility Part|Physician Decision|0|||
161886066|NCT00934856|584626702|FG000|Feasibility Part|Adverse Event|1|||
161886067|NCT00934856|584626703|FG001|Feasibility Part|Adverse Event|1|||
161886068|NCT00934856|584626704|FG002|Feasibility Part|Adverse Event|0|||
161886069|NCT00934856|584626705|FG003|Feasibility Part|Adverse Event|1|||
161886070|NCT00934856|584626706|FG004|Feasibility Part|Adverse Event|0|||
161886071|NCT00934856|584626707|FG005|Feasibility Part|Adverse Event|2|||
161886072|NCT00934856|584626702|FG000|Feasibility Part|Withdrawal by Subject|0|||
161886073|NCT00934856|584626703|FG001|Feasibility Part|Withdrawal by Subject|0|||
161886074|NCT00934856|584626704|FG002|Feasibility Part|Withdrawal by Subject|0|||
161886075|NCT00934856|584626705|FG003|Feasibility Part|Withdrawal by Subject|1|||
161886076|NCT00934856|584626706|FG004|Feasibility Part|Withdrawal by Subject|0|||
161886077|NCT00934856|584626707|FG005|Feasibility Part|Withdrawal by Subject|1|||
161886078|NCT00934856|584626702|FG000|Extension Part|Adverse Event|0|||
161886079|NCT00934856|584626703|FG001|Extension Part|Adverse Event|0|||
161886080|NCT00934856|584626704|FG002|Extension Part|Adverse Event|0|||
161886081|NCT00934856|584626705|FG003|Extension Part|Adverse Event|1|||
161886082|NCT00934856|584626706|FG004|Extension Part|Adverse Event|4|||
161886083|NCT00934856|584626707|FG005|Extension Part|Adverse Event|4|||
161886084|NCT00934856|584626702|FG000|Extension Part|Progressive disease|0|||
161886085|NCT00934856|584626703|FG001|Extension Part|Progressive disease|0|||
161886086|NCT00934856|584626704|FG002|Extension Part|Progressive disease|0|||
161886087|NCT00934856|584626705|FG003|Extension Part|Progressive disease|1|||
161886088|NCT00934856|584626706|FG004|Extension Part|Progressive disease|0|||
161886089|NCT00934856|584626707|FG005|Extension Part|Progressive disease|0|||
161886090|NCT00934856|584626702|FG000|Extension Part|Non-compliance with drug|0|||
161886091|NCT00934856|584626703|FG001|Extension Part|Non-compliance with drug|0|||
161886092|NCT00934856|584626704|FG002|Extension Part|Non-compliance with drug|0|||
161886093|NCT00934856|584626705|FG003|Extension Part|Non-compliance with drug|0|||
161886094|NCT00934856|584626706|FG004|Extension Part|Non-compliance with drug|0|||
161886095|NCT00934856|584626707|FG005|Extension Part|Non-compliance with drug|1|||
161886096|NCT01256385|584626708|FG000|Overall Study|Physician Decision|1|||
161886097|NCT01256385|584626709|FG001|Overall Study|Physician Decision|1|||
161886098|NCT01256385|584626708|FG000|Overall Study|Withdrawal by Subject|2|||
161886099|NCT01256385|584626709|FG001|Overall Study|Withdrawal by Subject|2|||
161886100|NCT03430895|584626714|FG000|Overall Study|Not Treated|2|||
161886101|NCT01645891|584626717|FG000|Overall Study|Adverse Event|6|||
161886102|NCT01645891|584626718|FG001|Overall Study|Adverse Event|10|||
161886103|NCT01645891|584626717|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
161886104|NCT01645891|584626718|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
161886105|NCT01645891|584626717|FG000|Overall Study|Withdrawal by Subject|3|||
161886106|NCT01645891|584626718|FG001|Overall Study|Withdrawal by Subject|3|||
161886107|NCT01645891|584626717|FG000|Overall Study|Protocol Violation|4|||
161886108|NCT01645891|584626718|FG001|Overall Study|Protocol Violation|0|||
161886109|NCT01645891|584626717|FG000|Overall Study|Lost to Follow-up|4|||
161886110|NCT01645891|584626718|FG001|Overall Study|Lost to Follow-up|1|||
161886111|NCT01645891|584626717|FG000|Overall Study|Death|0|||
161886112|NCT01645891|584626718|FG001|Overall Study|Death|2|||
161886113|NCT00138073|584626721|FG000|Overall Study|lack of resources|55|||
161886114|NCT03301740|584626722|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
161886115|NCT03301740|584626723|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
161886116|NCT03301740|584626722|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
161886117|NCT03301740|584626723|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
161886118|NCT02847182|584626724|FG000|Overall Study|Withdrawal by Subject|0|||
161886119|NCT02847182|584626725|FG001|Overall Study|Withdrawal by Subject|1|||
161886120|NCT01306045|584626726|FG000|Met General Eligibility Criteria|Screen failures|193|||
161886121|NCT01306045|584626727|FG001|Met General Eligibility Criteria|Screen failures|11|||
161886122|NCT01306045|584626728|FG002|Met General Eligibility Criteria|Screen failures|8|||
161886123|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886124|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886125|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886126|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886127|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886128|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
161886129|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886130|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886131|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886132|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886133|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886134|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
161886135|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Adverse Event|0|||
161886136|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Adverse Event|0|||
161886137|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Adverse Event|0|||
161886138|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Adverse Event|0|||
161886139|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Adverse Event|0|||
161886140|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Adverse Event|2|||
161886141|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886142|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886143|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886144|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886145|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886146|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
161886147|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886148|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886149|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886150|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886151|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886152|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
161886153|NCT03191864|584626729|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886154|NCT03191864|584626730|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886155|NCT03191864|584626731|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
161886156|NCT03191864|584626732|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886157|NCT03191864|584626733|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886158|NCT03191864|584626734|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
161886159|NCT03191864|584626729|FG000|Part 1 - Induction|Adverse Event|0|||
161886160|NCT03191864|584626730|FG001|Part 1 - Induction|Adverse Event|2|||
161886161|NCT03191864|584626731|FG002|Part 1 - Induction|Adverse Event|0|||
161886162|NCT03191864|584626732|FG003|Part 1 - Induction|Adverse Event|1|||
161886163|NCT03191864|584626733|FG004|Part 1 - Induction|Adverse Event|0|||
161886164|NCT03191864|584626734|FG005|Part 1 - Induction|Adverse Event|2|||
161886165|NCT03191864|584626729|FG000|Part 1 - Induction|Randomized but never dosed|0|||
161886166|NCT03191864|584626730|FG001|Part 1 - Induction|Randomized but never dosed|0|||
161886167|NCT03191864|584626731|FG002|Part 1 - Induction|Randomized but never dosed|1|||
161886168|NCT03191864|584626732|FG003|Part 1 - Induction|Randomized but never dosed|0|||
161886169|NCT03191864|584626733|FG004|Part 1 - Induction|Randomized but never dosed|0|||
161886170|NCT03191864|584626734|FG005|Part 1 - Induction|Randomized but never dosed|0|||
161886171|NCT03191864|584626729|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
161886172|NCT03191864|584626730|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
161886173|NCT03191864|584626731|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
161886174|NCT03191864|584626732|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
161886175|NCT03191864|584626733|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
161886176|NCT03191864|584626734|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
161886177|NCT03191864|584626729|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886178|NCT03191864|584626730|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886179|NCT03191864|584626731|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
161886180|NCT03191864|584626732|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886181|NCT03191864|584626733|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886182|NCT03191864|584626734|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886183|NCT03191864|584626729|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
161886184|NCT03191864|584626730|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886185|NCT03191864|584626731|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886186|NCT03191864|584626732|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886187|NCT03191864|584626733|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886188|NCT03191864|584626734|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886189|NCT03191864|584626729|FG000|Part 2 - Maintenance|Physician Decision|1|||
161886190|NCT03191864|584626730|FG001|Part 2 - Maintenance|Physician Decision|0|||
161886191|NCT03191864|584626731|FG002|Part 2 - Maintenance|Physician Decision|0|||
161886192|NCT03191864|584626732|FG003|Part 2 - Maintenance|Physician Decision|0|||
161886193|NCT03191864|584626733|FG004|Part 2 - Maintenance|Physician Decision|0|||
161886194|NCT03191864|584626734|FG005|Part 2 - Maintenance|Physician Decision|0|||
161886195|NCT03191864|584626729|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
161886196|NCT03191864|584626730|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
161886197|NCT03191864|584626731|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
161886198|NCT03191864|584626732|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
161886199|NCT03191864|584626733|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
161886200|NCT03191864|584626734|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
161886201|NCT03191864|584626729|FG000|Part 2 - Maintenance|Adverse Event|0|||
161886202|NCT03191864|584626730|FG001|Part 2 - Maintenance|Adverse Event|0|||
161886203|NCT03191864|584626731|FG002|Part 2 - Maintenance|Adverse Event|0|||
161886204|NCT03191864|584626732|FG003|Part 2 - Maintenance|Adverse Event|0|||
161886205|NCT03191864|584626733|FG004|Part 2 - Maintenance|Adverse Event|1|||
161886206|NCT03191864|584626734|FG005|Part 2 - Maintenance|Adverse Event|0|||
161886207|NCT03191864|584626729|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
161886208|NCT03191864|584626730|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886209|NCT03191864|584626731|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886210|NCT03191864|584626732|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886211|NCT03191864|584626733|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
161886212|NCT03191864|584626734|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886213|NCT03191864|584626729|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886214|NCT03191864|584626730|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886215|NCT03191864|584626731|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886216|NCT03191864|584626732|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886217|NCT03191864|584626733|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
161886218|NCT03191864|584626734|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886219|NCT02044874|584626735|FG000|Overall Study|Adverse Event|5|||
161886220|NCT02044874|584626736|FG001|Overall Study|Adverse Event|6|||
161886221|NCT02044874|584626737|FG002|Overall Study|Adverse Event|6|||
161886222|NCT02044874|584626735|FG000|Overall Study|Withdrawal by Subject|8|||
161886223|NCT02044874|584626736|FG001|Overall Study|Withdrawal by Subject|16|||
161886224|NCT02044874|584626737|FG002|Overall Study|Withdrawal by Subject|23|||
161886225|NCT02044874|584626735|FG000|Overall Study|Physician Decision|0|||
161886226|NCT02044874|584626736|FG001|Overall Study|Physician Decision|2|||
161886227|NCT02044874|584626737|FG002|Overall Study|Physician Decision|1|||
161886228|NCT02044874|584626735|FG000|Overall Study|Lost to Follow-up|10|||
161886229|NCT02044874|584626736|FG001|Overall Study|Lost to Follow-up|27|||
161886230|NCT02044874|584626737|FG002|Overall Study|Lost to Follow-up|21|||
161886231|NCT02044874|584626735|FG000|Overall Study|Sponsor Decision|0|||
161886232|NCT02044874|584626736|FG001|Overall Study|Sponsor Decision|1|||
161886233|NCT02044874|584626737|FG002|Overall Study|Sponsor Decision|1|||
161886234|NCT02044874|584626735|FG000|Overall Study|Other|7|||
161886235|NCT02044874|584626736|FG001|Overall Study|Other|3|||
161886236|NCT02044874|584626737|FG002|Overall Study|Other|8|||
161886237|NCT05072964|584626738|FG000|Overall Study|Withdrawal by Subject|4|||
161886238|NCT05072964|584626738|FG000|Overall Study|Death|1|||
161886239|NCT00415597|584626739|FG000|Enrollment|Withdrawal by Subject|1|||
161886240|NCT00415597|584626739|FG000|Enrollment|Protocol Violation|1|||
161886241|NCT00415597|584626739|FG000|Treatment|Adverse Event|110|||
161886242|NCT00415597|584626739|FG000|Treatment|Lack of Efficacy|39|||
161886243|NCT00415597|584626739|FG000|Treatment|Protocol Violation|67|||
161886244|NCT00415597|584626739|FG000|Treatment|Physician Decision|3|||
161886245|NCT00415597|584626739|FG000|Treatment|Withdrawal by Subject|51|||
161886246|NCT00415597|584626739|FG000|Treatment|Lost to Follow-up|28|||
161886247|NCT00415597|584626739|FG000|Treatment|Drug Screen|2|||
161886248|NCT00415597|584626739|FG000|Treatment|Administrative|3|||
161886249|NCT00415597|584626739|FG000|Treatment|Sponsor Decision|1|||
161886250|NCT00415597|584626739|FG000|Treatment|Multiple Reasons|1|||
161886251|NCT02172040|584626741|FG000|Overall Study|Adverse Event|0|||
161886252|NCT02172040|584626742|FG001|Overall Study|Adverse Event|2|||
161886253|NCT02172040|584626743|FG002|Overall Study|Adverse Event|0|||
161886254|NCT02172040|584626744|FG003|Overall Study|Adverse Event|0|||
161886255|NCT02172040|584626741|FG000|Overall Study|Protocol Violation|0|||
161886256|NCT02172040|584626742|FG001|Overall Study|Protocol Violation|1|||
161886257|NCT02172040|584626743|FG002|Overall Study|Protocol Violation|0|||
161886258|NCT02172040|584626744|FG003|Overall Study|Protocol Violation|0|||
161886259|NCT02172040|584626741|FG000|Overall Study|Withdrawal by Subject|0|||
161886260|NCT02172040|584626742|FG001|Overall Study|Withdrawal by Subject|0|||
161886261|NCT02172040|584626743|FG002|Overall Study|Withdrawal by Subject|1|||
161886262|NCT02172040|584626744|FG003|Overall Study|Withdrawal by Subject|0|||
161886263|NCT02172040|584626741|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
161886264|NCT02172040|584626742|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
161886265|NCT02172040|584626743|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
161886266|NCT02172040|584626744|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
161886267|NCT02172040|584626741|FG000|Overall Study|Family emergency abroad|0|||
161886268|NCT02172040|584626742|FG001|Overall Study|Family emergency abroad|0|||
161886269|NCT02172040|584626743|FG002|Overall Study|Family emergency abroad|0|||
161886270|NCT02172040|584626744|FG003|Overall Study|Family emergency abroad|1|||
161886271|NCT04908202|584626749|FG000|Pre-Treatment Period|OTHER REASONS|3|||
161886272|NCT04908202|584626750|FG001|Pre-Treatment Period|OTHER REASONS|1|||
161886273|NCT04908202|584626751|FG002|Pre-Treatment Period|OTHER REASONS|0|||
161886274|NCT04908202|584626752|FG003|Pre-Treatment Period|OTHER REASONS|0|||
161886275|NCT04908202|584626749|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
161363818|NCT02544763|582720033|FG002|Overall Study|Withdrawn by parent/guardian|1|||
161886276|NCT04908202|584626750|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886277|NCT04908202|584626751|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886278|NCT04908202|584626752|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886279|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
161886280|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
161886281|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161886282|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161886283|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
161886284|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
161886285|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
161886286|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
161886287|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161886288|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161886289|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886290|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886291|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
161886292|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
161886293|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886294|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886295|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161886296|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
161886297|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161886298|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161886299|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886300|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161886301|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886302|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886303|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
161886304|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
161886305|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
161886306|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
161886307|NCT04908202|584626749|FG000|Active Treatment Period|OTHER REASONS|0|||
161886308|NCT04908202|584626750|FG001|Active Treatment Period|OTHER REASONS|0|||
161886309|NCT04908202|584626751|FG002|Active Treatment Period|OTHER REASONS|1|||
161886310|NCT04908202|584626752|FG003|Active Treatment Period|OTHER REASONS|3|||
161886311|NCT04908202|584626749|FG000|Active Treatment Period|Lack of Efficacy|0|||
161886312|NCT04908202|584626750|FG001|Active Treatment Period|Lack of Efficacy|0|||
161886313|NCT04908202|584626751|FG002|Active Treatment Period|Lack of Efficacy|4|||
161886314|NCT04908202|584626752|FG003|Active Treatment Period|Lack of Efficacy|5|||
161886315|NCT04908202|584626749|FG000|Active Treatment Period|Adverse Event|0|||
161886316|NCT04908202|584626750|FG001|Active Treatment Period|Adverse Event|0|||
161886317|NCT04908202|584626751|FG002|Active Treatment Period|Adverse Event|5|||
161886318|NCT04908202|584626752|FG003|Active Treatment Period|Adverse Event|8|||
161886319|NCT04908202|584626749|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886320|NCT04908202|584626750|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886321|NCT04908202|584626751|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161886322|NCT04908202|584626752|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161886323|NCT04908202|584626749|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886324|NCT04908202|584626750|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886325|NCT04908202|584626751|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
161886326|NCT04908202|584626752|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
161886327|NCT04908202|584626749|FG000|Active Treatment Period|Lost to Follow-up|0|||
161886328|NCT04908202|584626750|FG001|Active Treatment Period|Lost to Follow-up|0|||
161886329|NCT04908202|584626751|FG002|Active Treatment Period|Lost to Follow-up|2|||
161886330|NCT04908202|584626752|FG003|Active Treatment Period|Lost to Follow-up|2|||
161886331|NCT04908202|584626749|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161886332|NCT04908202|584626750|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161886333|NCT04908202|584626751|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
161886334|NCT04908202|584626752|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161886335|NCT04908202|584626749|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886336|NCT04908202|584626750|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886337|NCT04908202|584626751|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161886338|NCT04908202|584626752|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161886339|NCT04908202|584626749|FG000|Active Treatment Period|ONGOING Treatment|0|||
161886340|NCT04908202|584626750|FG001|Active Treatment Period|ONGOING Treatment|0|||
161886341|NCT04908202|584626751|FG002|Active Treatment Period|ONGOING Treatment|117|||
161886342|NCT04908202|584626752|FG003|Active Treatment Period|ONGOING Treatment|114|||
161886343|NCT04506905|584626755|FG000|Overall Study|Lost to Follow-up|1|||
161886344|NCT04506905|584626756|FG001|Overall Study|Lost to Follow-up|0|||
161886345|NCT04506905|584626757|FG002|Overall Study|Lost to Follow-up|0|||
161886346|NCT04506905|584626758|FG003|Overall Study|Lost to Follow-up|1|||
161886347|NCT04506905|584626759|FG004|Overall Study|Lost to Follow-up|0|||
161886348|NCT04506905|584626760|FG005|Overall Study|Lost to Follow-up|0|||
161886349|NCT04506905|584626761|FG006|Overall Study|Lost to Follow-up|0|||
161886350|NCT04506905|584626762|FG007|Overall Study|Lost to Follow-up|0|||
161886351|NCT04506905|584626763|FG008|Overall Study|Lost to Follow-up|0|||
161886352|NCT04506905|584626755|FG000|Overall Study|Withdrawal by Subject|0|||
161886353|NCT04506905|584626756|FG001|Overall Study|Withdrawal by Subject|0|||
161886354|NCT04506905|584626757|FG002|Overall Study|Withdrawal by Subject|0|||
161886355|NCT04506905|584626758|FG003|Overall Study|Withdrawal by Subject|2|||
161886356|NCT04506905|584626759|FG004|Overall Study|Withdrawal by Subject|0|||
161886357|NCT04506905|584626760|FG005|Overall Study|Withdrawal by Subject|0|||
161886358|NCT04506905|584626761|FG006|Overall Study|Withdrawal by Subject|0|||
161886359|NCT04506905|584626762|FG007|Overall Study|Withdrawal by Subject|0|||
161886360|NCT04506905|584626763|FG008|Overall Study|Withdrawal by Subject|0|||
161886361|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
161886362|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
161886363|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
161886364|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
161886365|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
161886366|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
161886367|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
161886368|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
161886369|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
161886370|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
161886371|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
161886372|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
161886373|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
161886374|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
161886375|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
161886376|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
161886377|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
161886378|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
161886379|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
161886380|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
161886381|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
161886382|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
161886383|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
161886384|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
161886385|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
161886386|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
161886387|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
161886388|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
161886389|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
161886390|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
161886391|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
161886392|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
161886393|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
161886394|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
161886395|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
161886396|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
161886397|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
161886398|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
161886399|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
161886400|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
161886401|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
161886402|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
161886403|NCT03800836|584626767|FG000|Overall Study|Other|2|||
161886404|NCT03800836|584626768|FG001|Overall Study|Other|1|||
161886405|NCT03800836|584626769|FG002|Overall Study|Other|0|||
161886406|NCT03800836|584626770|FG003|Overall Study|Other|2|||
161886407|NCT03800836|584626771|FG004|Overall Study|Other|0|||
161886408|NCT03800836|584626772|FG005|Overall Study|Other|1|||
161886409|NCT03800836|584626767|FG000|Overall Study|Lost to Follow-up|2|||
161886410|NCT03800836|584626768|FG001|Overall Study|Lost to Follow-up|0|||
161886411|NCT03800836|584626769|FG002|Overall Study|Lost to Follow-up|1|||
161886412|NCT03800836|584626770|FG003|Overall Study|Lost to Follow-up|1|||
161886413|NCT03800836|584626771|FG004|Overall Study|Lost to Follow-up|3|||
161886414|NCT03800836|584626772|FG005|Overall Study|Lost to Follow-up|0|||
161886415|NCT03800836|584626767|FG000|Overall Study|Withdrawal by Subject|1|||
161886416|NCT03800836|584626768|FG001|Overall Study|Withdrawal by Subject|0|||
161886417|NCT03800836|584626769|FG002|Overall Study|Withdrawal by Subject|0|||
161886418|NCT03800836|584626770|FG003|Overall Study|Withdrawal by Subject|0|||
161886419|NCT03800836|584626771|FG004|Overall Study|Withdrawal by Subject|0|||
161886420|NCT03800836|584626772|FG005|Overall Study|Withdrawal by Subject|0|||
161886421|NCT03800836|584626767|FG000|Overall Study|Physician Decision|31|||
161886422|NCT03800836|584626768|FG001|Overall Study|Physician Decision|3|||
161886423|NCT03800836|584626769|FG002|Overall Study|Physician Decision|6|||
161886424|NCT03800836|584626770|FG003|Overall Study|Physician Decision|4|||
161886425|NCT03800836|584626771|FG004|Overall Study|Physician Decision|4|||
161886426|NCT03800836|584626772|FG005|Overall Study|Physician Decision|5|||
161886427|NCT03800836|584626767|FG000|Overall Study|Death|34|||
161886428|NCT03800836|584626768|FG001|Overall Study|Death|16|||
161886429|NCT03800836|584626769|FG002|Overall Study|Death|5|||
161886430|NCT03800836|584626770|FG003|Overall Study|Death|5|||
161886431|NCT03800836|584626771|FG004|Overall Study|Death|10|||
161886432|NCT03800836|584626772|FG005|Overall Study|Death|0|||
161886433|NCT03800836|584626767|FG000|Overall Study|Symptomatic Deterioration|1|||
161886434|NCT03800836|584626768|FG001|Overall Study|Symptomatic Deterioration|0|||
161886435|NCT03800836|584626769|FG002|Overall Study|Symptomatic Deterioration|1|||
161886436|NCT03800836|584626770|FG003|Overall Study|Symptomatic Deterioration|0|||
161886437|NCT03800836|584626771|FG004|Overall Study|Symptomatic Deterioration|0|||
161886438|NCT03800836|584626772|FG005|Overall Study|Symptomatic Deterioration|0|||
161886439|NCT02864316|584628185|FG000|Overall Study|Progressive Disease|2|||
161886440|NCT02864316|584628186|FG001|Overall Study|Progressive Disease|1|||
161886441|NCT02864316|584628185|FG000|Overall Study|Adverse Event|0|||
161886442|NCT02864316|584628186|FG001|Overall Study|Adverse Event|1|||
161886443|NCT03030118|584628191|FG000|Overall Study|Achieved SLE Diagnosis|11|||
161886444|NCT03030118|584628192|FG001|Overall Study|Achieved SLE Diagnosis|10|||
161886445|NCT03030118|584628191|FG000|Overall Study|Adverse Event|1|||
161886446|NCT03030118|584628192|FG001|Overall Study|Adverse Event|1|||
161886447|NCT03030118|584628191|FG000|Overall Study|Pregnancy|2|||
161886448|NCT03030118|584628192|FG001|Overall Study|Pregnancy|2|||
161886449|NCT03030118|584628191|FG000|Overall Study|Lost to Follow-up|5|||
161886450|NCT03030118|584628192|FG001|Overall Study|Lost to Follow-up|6|||
161886451|NCT03030118|584628191|FG000|Overall Study|Concomitant Medications|1|||
161886452|NCT03030118|584628192|FG001|Overall Study|Concomitant Medications|1|||
161886453|NCT03030118|584628191|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
161886454|NCT03030118|584628192|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
161886455|NCT03030118|584628191|FG000|Overall Study|Other|2|||
161886456|NCT03030118|584628192|FG001|Overall Study|Other|0|||
161886457|NCT03030118|584628191|FG000|Overall Study|Withdrawal by Subject|26|||
161886458|NCT03030118|584628192|FG001|Overall Study|Withdrawal by Subject|21|||
161886459|NCT03030118|584628191|FG000|Overall Study|Protocol Violation|1|||
161886460|NCT03030118|584628192|FG001|Overall Study|Protocol Violation|6|||
161886461|NCT02607280|584628194|FG000|Overall Study|Adverse Event|4|||
161886462|NCT02607280|584628195|FG001|Overall Study|Adverse Event|0|||
161886463|NCT02607280|584628194|FG000|Overall Study|Decrease in CrCl <15|0|||
161886464|NCT02607280|584628195|FG001|Overall Study|Decrease in CrCl <15|1|||
161886465|NCT01447446|584628196|FG000|Overall Study|Death|6|||
161886466|NCT01447446|584628197|FG001|Overall Study|Death|3|||
161886467|NCT01447446|584628198|FG002|Overall Study|Death|2|||
161886468|NCT01447446|584628199|FG003|Overall Study|Death|1|||
161886469|NCT01447446|584628200|FG004|Overall Study|Death|7|||
161886470|NCT01447446|584628201|FG005|Overall Study|Death|0|||
161886471|NCT01447446|584628196|FG000|Overall Study|Adverse Event|3|||
161886472|NCT01447446|584628197|FG001|Overall Study|Adverse Event|0|||
161886473|NCT01447446|584628198|FG002|Overall Study|Adverse Event|1|||
161886474|NCT01447446|584628199|FG003|Overall Study|Adverse Event|0|||
161886475|NCT01447446|584628200|FG004|Overall Study|Adverse Event|2|||
161886476|NCT01447446|584628201|FG005|Overall Study|Adverse Event|0|||
161886477|NCT01447446|584628196|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
161886478|NCT01447446|584628197|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
161886479|NCT01447446|584628198|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
161886480|NCT01447446|584628199|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
161886481|NCT01447446|584628200|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
161886482|NCT01447446|584628201|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
161886483|NCT01447446|584628196|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
161886484|NCT01447446|584628197|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
161886485|NCT01447446|584628198|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
161886486|NCT01447446|584628199|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
161886487|NCT01447446|584628200|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
161886488|NCT01447446|584628201|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
161886489|NCT01447446|584628196|FG000|Overall Study|Administrative/Other|34|||
161886490|NCT01447446|584628197|FG001|Overall Study|Administrative/Other|9|||
161886491|NCT01447446|584628198|FG002|Overall Study|Administrative/Other|10|||
161886492|NCT01447446|584628199|FG003|Overall Study|Administrative/Other|2|||
161886493|NCT01447446|584628200|FG004|Overall Study|Administrative/Other|33|||
161886494|NCT01447446|584628201|FG005|Overall Study|Administrative/Other|4|||
161886495|NCT01447446|584628196|FG000|Overall Study|SVR12 Assessment|13|||
161886496|NCT01447446|584628197|FG001|Overall Study|SVR12 Assessment|1|||
161886497|NCT01447446|584628198|FG002|Overall Study|SVR12 Assessment|2|||
161886498|NCT01447446|584628199|FG003|Overall Study|SVR12 Assessment|1|||
161886499|NCT01447446|584628200|FG004|Overall Study|SVR12 Assessment|5|||
161886500|NCT01447446|584628201|FG005|Overall Study|SVR12 Assessment|5|||
161886501|NCT01447446|584628196|FG000|Overall Study|New Treatment Started|8|||
161886502|NCT01447446|584628197|FG001|Overall Study|New Treatment Started|2|||
161886503|NCT01447446|584628198|FG002|Overall Study|New Treatment Started|1|||
161886504|NCT01447446|584628199|FG003|Overall Study|New Treatment Started|0|||
161886505|NCT01447446|584628200|FG004|Overall Study|New Treatment Started|2|||
161886506|NCT01447446|584628201|FG005|Overall Study|New Treatment Started|0|||
161886507|NCT01447446|584628196|FG000|Overall Study|Reason not Specified|1|||
161886508|NCT01447446|584628197|FG001|Overall Study|Reason not Specified|1|||
161886509|NCT01447446|584628198|FG002|Overall Study|Reason not Specified|1|||
161886510|NCT01447446|584628199|FG003|Overall Study|Reason not Specified|1|||
161886511|NCT01447446|584628200|FG004|Overall Study|Reason not Specified|1|||
161886512|NCT01447446|584628201|FG005|Overall Study|Reason not Specified|0|||
161886513|NCT02052596|584628202|FG000|Active Phase|Adverse Event|3|||
161886514|NCT02052596|584628203|FG001|Active Phase|Adverse Event|2|||
161886515|NCT02052596|584628202|FG000|Active Phase|Lost to Follow-up|8|||
161886516|NCT02052596|584628203|FG001|Active Phase|Lost to Follow-up|11|||
161886517|NCT02052596|584628202|FG000|Active Phase|Protocol Violation|1|||
161886518|NCT02052596|584628203|FG001|Active Phase|Protocol Violation|2|||
161886519|NCT02052596|584628202|FG000|Active Phase|Withdrawal by Subject|3|||
161886520|NCT02052596|584628203|FG001|Active Phase|Withdrawal by Subject|4|||
161886521|NCT02052596|584628202|FG000|Active Phase|Enrolled in error|1|||
161886522|NCT02052596|584628203|FG001|Active Phase|Enrolled in error|0|||
161886523|NCT02052596|584628202|FG000|Active Phase|Lost due to Crohn's disease|0|||
161886524|NCT02052596|584628203|FG001|Active Phase|Lost due to Crohn's disease|1|||
161886525|NCT02052596|584628202|FG000|Safety Phase|Adverse Event|6|||
161886526|NCT02052596|584628203|FG001|Safety Phase|Adverse Event|3|||
161886527|NCT02052596|584628202|FG000|Safety Phase|Lost to Follow-up|11|||
161886528|NCT02052596|584628203|FG001|Safety Phase|Lost to Follow-up|18|||
161886529|NCT02052596|584628202|FG000|Safety Phase|Protocol Violation|1|||
161886530|NCT02052596|584628203|FG001|Safety Phase|Protocol Violation|2|||
161886531|NCT02052596|584628202|FG000|Safety Phase|Withdrawal by Subject|8|||
161886532|NCT02052596|584628203|FG001|Safety Phase|Withdrawal by Subject|11|||
161886533|NCT02052596|584628202|FG000|Safety Phase|Enrolled in error|1|||
161886534|NCT02052596|584628203|FG001|Safety Phase|Enrolled in error|0|||
161886535|NCT02052596|584628202|FG000|Safety Phase|Lost due to Crohn's disease|0|||
161886536|NCT02052596|584628203|FG001|Safety Phase|Lost due to Crohn's disease|1|||
161886537|NCT04829331|584628206|FG000|Overall Study|Lost to Follow-up|1|||
161886538|NCT04829331|584628207|FG001|Overall Study|Lost to Follow-up|0|||
161886539|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
161886540|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
161886541|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
161886542|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
161886543|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
161886544|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
161886545|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
161886546|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
161886547|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
161886548|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
161886549|NCT04526574|584628214|FG000|Overall Study|Protocol Violation|3|||
161886550|NCT04526574|584628215|FG001|Overall Study|Protocol Violation|1|||
161886551|NCT04526574|584628214|FG000|Overall Study|Withdrawal by Subject|12|||
161886552|NCT04526574|584628215|FG001|Overall Study|Withdrawal by Subject|9|||
161886553|NCT04526574|584628214|FG000|Overall Study|Other|1|||
161886554|NCT04526574|584628215|FG001|Overall Study|Other|2|||
161886555|NCT04526574|584628214|FG000|Overall Study|Adverse Event|1|||
161886556|NCT04526574|584628215|FG001|Overall Study|Adverse Event|1|||
161886557|NCT04526574|584628214|FG000|Overall Study|Death|2|||
161886558|NCT04526574|584628215|FG001|Overall Study|Death|3|||
161886559|NCT04526574|584628214|FG000|Overall Study|Lost to Follow-up|9|||
161886560|NCT04526574|584628215|FG001|Overall Study|Lost to Follow-up|9|||
161886561|NCT04526574|584628214|FG000|Overall Study|No longer meets eligibility criteria|8|||
161886562|NCT04526574|584628215|FG001|Overall Study|No longer meets eligibility criteria|8|||
161886563|NCT01032070|584628216|FG000|Overall Study|Disease progression|13|||
161886564|NCT01032070|584628217|FG001|Overall Study|Disease progression|8|||
161886565|NCT01032070|584628216|FG000|Overall Study|Medical or ethical reasons|0|||
161886566|NCT01032070|584628217|FG001|Overall Study|Medical or ethical reasons|2|||
161886567|NCT01032070|584628216|FG000|Overall Study|Withdrawal by Subject|0|||
161886568|NCT01032070|584628217|FG001|Overall Study|Withdrawal by Subject|2|||
161886569|NCT02332239|584628218|FG000|Overall Study|Lost to Follow-up|4|||
161886570|NCT02332239|584628219|FG001|Overall Study|Lost to Follow-up|6|||
161886571|NCT00894790|584628222|FG000|Overall Study|Protocol Violation|0|||
161886572|NCT00894790|584628223|FG001|Overall Study|Protocol Violation|1|||
161886573|NCT00894790|584628222|FG000|Overall Study|Lost to Follow-up|0|||
161886574|NCT00894790|584628223|FG001|Overall Study|Lost to Follow-up|1|||
161886575|NCT00894790|584628222|FG000|Overall Study|Did not meet entrance criteria|1|||
161886576|NCT00894790|584628223|FG001|Overall Study|Did not meet entrance criteria|0|||
161886577|NCT00396877|584628224|FG000|Overall Study|Lost to Follow-up|2|||
161886578|NCT00396877|584628225|FG001|Overall Study|Lost to Follow-up|1|||
161886579|NCT00396877|584628224|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
161886580|NCT00396877|584628225|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
161886581|NCT02273908|584628233|FG000|Overall Study|Adverse Event|16|||
161886582|NCT02273908|584628234|FG001|Overall Study|Adverse Event|0|||
161886583|NCT02273908|584628233|FG000|Overall Study|Lost to Follow-up|10|||
161886584|NCT02273908|584628234|FG001|Overall Study|Lost to Follow-up|1|||
161886585|NCT02273908|584628233|FG000|Overall Study|Did not meet entrance criteria|3|||
161886586|NCT02273908|584628234|FG001|Overall Study|Did not meet entrance criteria|2|||
161886587|NCT02273908|584628233|FG000|Overall Study|Withdrawal by Subject|4|||
161886588|NCT02273908|584628234|FG001|Overall Study|Withdrawal by Subject|2|||
161886589|NCT00422422|584628235|FG000|Overall Study|Lack of Efficacy|1|||
161886590|NCT00422422|584628235|FG000|Overall Study|Protocol Violation|1|||
161886591|NCT00422422|584628235|FG000|Overall Study|Withdrawal by Subject|2|||
161886592|NCT00422422|584628235|FG000|Overall Study|SAE, non-fatal|1|||
161886593|NCT00422422|584628235|FG000|Overall Study|AE, non-serious non-fatal|5|||
161886594|NCT03301844|584628236|FG000|Overall Study|suspected colon cancer|1|||
161886595|NCT03301844|584628237|FG001|Overall Study|suspected colon cancer|1|||
161886596|NCT00501059|584628238|FG000|Overall Study|Protocol Violation|80|||
161886597|NCT00501059|584628239|FG001|Overall Study|Protocol Violation|69|||
161886598|NCT00501059|584628238|FG000|Overall Study|Death|140|||
161886599|NCT00501059|584628239|FG001|Overall Study|Death|137|||
161886600|NCT00501059|584628238|FG000|Overall Study|Other|236|||
161886601|NCT00501059|584628239|FG001|Overall Study|Other|239|||
161886602|NCT00501059|584628238|FG000|Overall Study|Missing end-of-study page|91|||
161886603|NCT00501059|584628239|FG001|Overall Study|Missing end-of-study page|92|||
161886604|NCT00501059|584628238|FG000|Overall Study|Clinical endpoint reached|110|||
161886605|NCT00501059|584628239|FG001|Overall Study|Clinical endpoint reached|123|||
161886606|NCT00501059|584628238|FG000|Overall Study|Insufficient therapeutic effect|4|||
161886607|NCT00501059|584628239|FG001|Overall Study|Insufficient therapeutic effect|5|||
161886608|NCT00501059|584628238|FG000|Overall Study|Consent withdrawn by subject|817|||
161886609|NCT00501059|584628239|FG001|Overall Study|Consent withdrawn by subject|873|||
161886610|NCT00501059|584628238|FG000|Overall Study|Non-compliant with study treatment|23|||
161886611|NCT00501059|584628239|FG001|Overall Study|Non-compliant with study treatment|16|||
161886612|NCT00501059|584628238|FG000|Overall Study|Reason not given|3|||
161886613|NCT00501059|584628239|FG001|Overall Study|Reason not given|1|||
161886614|NCT00501059|584628238|FG000|Overall Study|Adverse Event|129|||
161886615|NCT00501059|584628239|FG001|Overall Study|Adverse Event|122|||
161886616|NCT00501059|584628238|FG000|Overall Study|Lost to Follow-up|210|||
161886617|NCT00501059|584628239|FG001|Overall Study|Lost to Follow-up|198|||
161886618|NCT00501059|584628238|FG000|Overall Study|Not treated|25|||
161886619|NCT00501059|584628239|FG001|Overall Study|Not treated|17|||
161886620|NCT02124759|584628240|FG000|Overall Study|Withdrawal by Subject|3|||
161886621|NCT02124759|584628241|FG001|Overall Study|Withdrawal by Subject|1|||
161886622|NCT02124759|584628242|FG002|Overall Study|Withdrawal by Subject|1|||
161886623|NCT02124759|584628240|FG000|Overall Study|Screen Fail|2|||
161886624|NCT02124759|584628241|FG001|Overall Study|Screen Fail|2|||
161886625|NCT02124759|584628242|FG002|Overall Study|Screen Fail|3|||
161886626|NCT02968433|584628244|FG000|Overall Study|Withdrawal by Subject|1|||
161886627|NCT00875433|584628245|FG000|Overall Study|Progressive disease|41|||
161886628|NCT00875433|584628245|FG000|Overall Study|Other Adverse Event|14|||
161886629|NCT00875433|584628245|FG000|Overall Study|Withdrawal by Subject|2|||
161886630|NCT00875433|584628245|FG000|Overall Study|Other|3|||
161886631|NCT00725101|584628246|FG000|Overall Study|Death|3|||
161886632|NCT00725101|584628246|FG000|Overall Study|Lost to Follow-up|353|||
161886633|NCT00725101|584628246|FG000|Overall Study|Protocol Violation|1|||
161886634|NCT00725101|584628246|FG000|Overall Study|Withdrawal by Subject|127|||
161886635|NCT00725101|584628246|FG000|Overall Study|not specified/no reason given|11|||
161886636|NCT03325894|584628247|FG000|Overall Study|Adverse Event|2|||
161886637|NCT03325894|584628248|FG001|Overall Study|Adverse Event|3|||
161886638|NCT03325894|584628247|FG000|Overall Study|Protocol Violation|1|||
161886639|NCT03325894|584628248|FG001|Overall Study|Protocol Violation|2|||
161886640|NCT03325894|584628247|FG000|Overall Study|Withdrawal by Subject|10|||
161886641|NCT03325894|584628248|FG001|Overall Study|Withdrawal by Subject|6|||
161886642|NCT03325894|584628247|FG000|Overall Study|Lost to Follow-up|4|||
161886643|NCT03325894|584628248|FG001|Overall Study|Lost to Follow-up|9|||
161886644|NCT03325894|584628247|FG000|Overall Study|Lack of Efficacy|8|||
161886645|NCT03325894|584628248|FG001|Overall Study|Lack of Efficacy|14|||
161886646|NCT03325894|584628247|FG000|Overall Study|Study Terminated by Sponsor|38|||
161886647|NCT03325894|584628248|FG001|Overall Study|Study Terminated by Sponsor|43|||
161886648|NCT03325894|584628247|FG000|Overall Study|Other (Not received Treatment)|1|||
161886649|NCT03325894|584628248|FG001|Overall Study|Other (Not received Treatment)|0|||
161886650|NCT03482167|584628251|FG000|Allocated to Intervention|Physician Decision|1|||
161886651|NCT03482167|584628252|FG001|Allocated to Intervention|Physician Decision|2|||
161886652|NCT03482167|584628251|FG000|Received Intervention|Adverse Event|3|||
161886653|NCT03482167|584628252|FG001|Received Intervention|Adverse Event|1|||
161886654|NCT03482167|584628251|FG000|Received Intervention|Physician Decision|1|||
161886655|NCT03482167|584628252|FG001|Received Intervention|Physician Decision|1|||
161886656|NCT03482167|584628251|FG000|Received Intervention|Withdrawal by Subject|1|||
161886657|NCT03482167|584628252|FG001|Received Intervention|Withdrawal by Subject|0|||
161886658|NCT00819780|584628254|FG000|Overall Study|Did not receive study drug|3|||
161886659|NCT00819780|584628255|FG001|Overall Study|Did not receive study drug|4|||
161886660|NCT00819780|584628254|FG000|Overall Study|Still in treatment|25|||
161886661|NCT00819780|584628255|FG001|Overall Study|Still in treatment|17|||
161886662|NCT00622336|584628256|FG000|Treatment Phase|Progression of Disease|181|||
161886663|NCT00622336|584628256|FG000|Treatment Phase|Adverse Event|46|||
161886664|NCT00622336|584628256|FG000|Treatment Phase|Other|40|||
161886665|NCT00622336|584628256|FG000|Treatment Phase|Death|14|||
161886666|NCT00622336|584628256|FG000|Treatment Phase|Lack of therapeutic effect|13|||
161886667|NCT00622336|584628256|FG000|Treatment Phase|Withdrawal by Subject|13|||
161886668|NCT00622336|584628256|FG000|Treatment Phase|Lost to Follow-up|2|||
161886669|NCT00622336|584628256|FG000|Extension Phase|Adverse Event|2|||
161886670|NCT00622336|584628256|FG000|Extension Phase|Progressive Disease|6|||
161886671|NCT00622336|584628256|FG000|Extension Phase|Lack of therapeutic effect|2|||
161886672|NCT00622336|584628256|FG000|Extension Phase|Withdrawal by Subject|1|||
161886673|NCT00622336|584628256|FG000|Extension Phase|Lost to Follow-up|1|||
161886674|NCT00622336|584628256|FG000|Extension Phase|Other|9|||
161886675|NCT04148287|584628261|FG000|Overall Study|Death|2|||
161886676|NCT00106639|584628263|FG000|Overall Study|Adverse Event|3|||
161886677|NCT00106639|584628264|FG001|Overall Study|Adverse Event|4|||
161886678|NCT00106639|584628265|FG002|Overall Study|Adverse Event|1|||
161886679|NCT00106639|584628263|FG000|Overall Study|Protocol Violation|0|||
161886680|NCT00106639|584628264|FG001|Overall Study|Protocol Violation|1|||
161886681|NCT00106639|584628265|FG002|Overall Study|Protocol Violation|0|||
161886682|NCT00106639|584628263|FG000|Overall Study|Withdrawal by Subject|0|||
161886683|NCT00106639|584628264|FG001|Overall Study|Withdrawal by Subject|1|||
161886684|NCT00106639|584628265|FG002|Overall Study|Withdrawal by Subject|0|||
161886685|NCT00106639|584628263|FG000|Overall Study|Participant defaulted|0|||
161886686|NCT00106639|584628264|FG001|Overall Study|Participant defaulted|1|||
161886687|NCT00106639|584628265|FG002|Overall Study|Participant defaulted|1|||
161886688|NCT02637713|584628273|FG000|Overall Study|Screen Failure|2|||
161886689|NCT02345889|584628274|FG000|Overall Study|Inadequate Bowel Prep|17|||
161886690|NCT02345889|584628275|FG001|Overall Study|Inadequate Bowel Prep|16|||
161886691|NCT02345889|584628276|FG002|Overall Study|Inadequate Bowel Prep|18|||
161886692|NCT02345889|584628277|FG003|Overall Study|Inadequate Bowel Prep|14|||
161886693|NCT02345889|584628274|FG000|Overall Study|Polyposis identified during procedure|1|||
161886694|NCT02345889|584628275|FG001|Overall Study|Polyposis identified during procedure|1|||
161886695|NCT02345889|584628276|FG002|Overall Study|Polyposis identified during procedure|0|||
161886696|NCT02345889|584628277|FG003|Overall Study|Polyposis identified during procedure|1|||
161886697|NCT02345889|584628274|FG000|Overall Study|Recognized ineligible post-randomization|1|||
161886698|NCT02345889|584628275|FG001|Overall Study|Recognized ineligible post-randomization|0|||
161886699|NCT02345889|584628276|FG002|Overall Study|Recognized ineligible post-randomization|2|||
161886700|NCT02345889|584628277|FG003|Overall Study|Recognized ineligible post-randomization|1|||
161886701|NCT02345889|584628274|FG000|Overall Study|Ulcerative Colitis identified|1|||
161886702|NCT02345889|584628275|FG001|Overall Study|Ulcerative Colitis identified|0|||
161886703|NCT02345889|584628276|FG002|Overall Study|Ulcerative Colitis identified|0|||
161886704|NCT02345889|584628277|FG003|Overall Study|Ulcerative Colitis identified|0|||
161886705|NCT02345889|584628274|FG000|Overall Study|Cecum not intubated|1|||
161886706|NCT02345889|584628275|FG001|Overall Study|Cecum not intubated|0|||
161886707|NCT02345889|584628276|FG002|Overall Study|Cecum not intubated|0|||
161886708|NCT02345889|584628277|FG003|Overall Study|Cecum not intubated|0|||
161886709|NCT00962091|584628278|FG000|Overall Study|Withdrawal by Subject|1|||
161886710|NCT00962091|584628279|FG001|Overall Study|Withdrawal by Subject|2|||
161886711|NCT00962091|584628280|FG002|Overall Study|Withdrawal by Subject|1|||
161886712|NCT00962091|584628281|FG003|Overall Study|Withdrawal by Subject|1|||
161886713|NCT00962091|584628282|FG004|Overall Study|Withdrawal by Subject|0|||
161886714|NCT00962091|584628283|FG005|Overall Study|Withdrawal by Subject|1|||
161886715|NCT00962091|584628284|FG006|Overall Study|Withdrawal by Subject|0|||
161886716|NCT00962091|584628278|FG000|Overall Study|Adverse Event|0|||
161886717|NCT00962091|584628279|FG001|Overall Study|Adverse Event|0|||
161886718|NCT00962091|584628280|FG002|Overall Study|Adverse Event|0|||
161886719|NCT00962091|584628281|FG003|Overall Study|Adverse Event|0|||
161886720|NCT00962091|584628282|FG004|Overall Study|Adverse Event|0|||
161886721|NCT00962091|584628283|FG005|Overall Study|Adverse Event|0|||
161886722|NCT00962091|584628284|FG006|Overall Study|Adverse Event|1|||
161886723|NCT02093390|584628291|FG000|Overall Study|Withdrawal by Subject|0|||
161886724|NCT02093390|584628292|FG001|Overall Study|Withdrawal by Subject|1|||
161886725|NCT00073983|584628293|FG000|Overall Study|not evaluable|1|||
161886726|NCT03976323|584628296|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
161886727|NCT03976323|584628297|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161886728|NCT03976323|584628298|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161886729|NCT03976323|584628296|FG000|Induction Phase|Death|80|||
161886730|NCT03976323|584628297|FG001|Induction Phase|Death|0|||
161886731|NCT03976323|584628298|FG002|Induction Phase|Death|0|||
161886732|NCT03976323|584628296|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
161886733|NCT03976323|584628297|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
161886734|NCT03976323|584628298|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
161886735|NCT03976323|584628296|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161886736|NCT03976323|584628297|FG001|Maintenance Phase|Withdrawal by Subject|9|||
161886737|NCT03976323|584628298|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161886738|NCT03976323|584628296|FG000|Maintenance Phase|Physician Decision|0|||
161886739|NCT03976323|584628297|FG001|Maintenance Phase|Physician Decision|0|||
161886740|NCT03976323|584628298|FG002|Maintenance Phase|Physician Decision|1|||
161886741|NCT03976323|584628296|FG000|Maintenance Phase|Death|0|||
161886742|NCT03976323|584628297|FG001|Maintenance Phase|Death|228|||
161886743|NCT03976323|584628298|FG002|Maintenance Phase|Death|234|||
161886744|NCT03774394|584630120|FG000|Overall Study|Withdrawal by Subject|2|||
161886745|NCT03774394|584630121|FG001|Overall Study|Withdrawal by Subject|0|||
161886746|NCT03334422|584630122|FG000|Overall Study|Adverse Event|1|||
161886747|NCT03334422|584630123|FG001|Overall Study|Adverse Event|3|||
161886748|NCT03334422|584630124|FG002|Overall Study|Adverse Event|2|||
161886749|NCT03334422|584630125|FG003|Overall Study|Adverse Event|2|||
161886750|NCT03334422|584630122|FG000|Overall Study|Lack of Efficacy|10|||
161886751|NCT03334422|584630123|FG001|Overall Study|Lack of Efficacy|2|||
161886752|NCT03334422|584630124|FG002|Overall Study|Lack of Efficacy|7|||
161886753|NCT03334422|584630125|FG003|Overall Study|Lack of Efficacy|3|||
161886754|NCT03334422|584630122|FG000|Overall Study|Withdrawal by Subject|8|||
161886755|NCT03334422|584630123|FG001|Overall Study|Withdrawal by Subject|3|||
161886756|NCT03334422|584630124|FG002|Overall Study|Withdrawal by Subject|1|||
161886757|NCT03334422|584630125|FG003|Overall Study|Withdrawal by Subject|0|||
161886758|NCT03334422|584630122|FG000|Overall Study|Lost to Follow-up|0|||
161886759|NCT03334422|584630123|FG001|Overall Study|Lost to Follow-up|0|||
161886760|NCT03334422|584630124|FG002|Overall Study|Lost to Follow-up|0|||
161886761|NCT03334422|584630125|FG003|Overall Study|Lost to Follow-up|1|||
161886762|NCT03334422|584630122|FG000|Overall Study|Inability to obtain laboratory samples|0|||
161886763|NCT03334422|584630123|FG001|Overall Study|Inability to obtain laboratory samples|1|||
161886764|NCT03334422|584630124|FG002|Overall Study|Inability to obtain laboratory samples|0|||
161886765|NCT03334422|584630125|FG003|Overall Study|Inability to obtain laboratory samples|0|||
161886766|NCT03334422|584630122|FG000|Overall Study|Pregnancy|0|||
161886767|NCT03334422|584630123|FG001|Overall Study|Pregnancy|1|||
161886768|NCT03334422|584630124|FG002|Overall Study|Pregnancy|0|||
161886769|NCT03334422|584630125|FG003|Overall Study|Pregnancy|0|||
161886770|NCT05916131|584630126|FG000|Overall Study|Lost to Follow-up|0|||
161886771|NCT05916131|584630127|FG001|Overall Study|Lost to Follow-up|0|||
161886772|NCT05916131|584630128|FG002|Overall Study|Lost to Follow-up|1|||
161886773|NCT05916131|584630129|FG003|Overall Study|Lost to Follow-up|0|||
161886774|NCT02949908|584630130|FG000|Overall Study|Study termination|2|||
161886775|NCT05323994|584630131|FG000|Overall Study|Protocol Violation|1|||
161886776|NCT00454818|584630132|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
161886777|NCT00454818|584630133|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886778|NCT00454818|584630134|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886779|NCT00454818|584630135|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886780|NCT00454818|584630136|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886781|NCT00454818|584630132|FG000|Phase I: Open-label Dose-escalation|Death|0|||
161886782|NCT00454818|584630133|FG001|Phase I: Open-label Dose-escalation|Death|1|||
161886783|NCT00454818|584630134|FG002|Phase I: Open-label Dose-escalation|Death|0|||
161886784|NCT00454818|584630135|FG003|Phase I: Open-label Dose-escalation|Death|0|||
161886785|NCT00454818|584630136|FG004|Phase I: Open-label Dose-escalation|Death|0|||
161886786|NCT00454818|584630132|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161886787|NCT00454818|584630133|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161886788|NCT00454818|584630134|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
161886789|NCT00454818|584630135|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
161886790|NCT00454818|584630136|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161886791|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161886792|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
161886793|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161886794|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
161886795|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161886796|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Death|0|||
161886797|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Death|1|||
161886798|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Death|0|||
161886799|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Death|0|||
161886800|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Death|1|||
161886801|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161886802|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161886803|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
161886804|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161886805|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
161886806|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161886807|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161886808|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
161886809|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161886810|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
161886811|NCT00616603|584630137|FG000|Overall Study|Physician Decision|2|||
161886812|NCT00616603|584630138|FG001|Overall Study|Physician Decision|0|||
161886813|NCT00616603|584630139|FG002|Overall Study|Physician Decision|2|||
161886814|NCT00766467|584630141|FG000|Overall Study|Withdrawal by Subject|7|||
161886815|NCT00766467|584630142|FG001|Overall Study|Withdrawal by Subject|2|||
161886816|NCT00766467|584630141|FG000|Overall Study|Adverse Event|1|||
161886817|NCT00766467|584630142|FG001|Overall Study|Adverse Event|1|||
161886818|NCT00766467|584630141|FG000|Overall Study|Protocol Violation|2|||
161886819|NCT00766467|584630142|FG001|Overall Study|Protocol Violation|4|||
161886820|NCT00766467|584630141|FG000|Overall Study|Tumor Progression on Study|0|||
161886821|NCT00766467|584630142|FG001|Overall Study|Tumor Progression on Study|1|||
161886822|NCT00766467|584630141|FG000|Overall Study|Physician Decision|1|||
161886823|NCT00766467|584630142|FG001|Overall Study|Physician Decision|0|||
161886824|NCT02604550|584630148|FG000|Overall Study|Lost to Follow-up|7|||
161886825|NCT02604550|584630149|FG001|Overall Study|Lost to Follow-up|6|||
161886826|NCT02604550|584630148|FG000|Overall Study|Withdrawal by Subject|0|||
161886827|NCT02604550|584630149|FG001|Overall Study|Withdrawal by Subject|1|||
161886828|NCT02604550|584630148|FG000|Overall Study|Incomplete data using paper journal|18|||
161886829|NCT02604550|584630149|FG001|Overall Study|Incomplete data using paper journal|19|||
161886830|NCT00908076|584630150|FG000|Overall Study|Lack of Efficacy|1|||
161886831|NCT00908076|584630151|FG001|Overall Study|Lack of Efficacy|1|||
161886832|NCT00662558|584630152|FG000|Overall Study|Adverse Event|21|||
161886833|NCT00662558|584630153|FG001|Overall Study|Adverse Event|59|||
161886834|NCT00662558|584630152|FG000|Overall Study|Lack of Efficacy|4|||
161886835|NCT00662558|584630153|FG001|Overall Study|Lack of Efficacy|7|||
161886836|NCT00662558|584630152|FG000|Overall Study|Lost to Follow-up|13|||
161886837|NCT00662558|584630153|FG001|Overall Study|Lost to Follow-up|10|||
161886838|NCT00662558|584630152|FG000|Overall Study|Other|9|||
161886839|NCT00662558|584630153|FG001|Overall Study|Other|14|||
161886840|NCT00662558|584630152|FG000|Overall Study|Withdrawal by Subject|7|||
161886841|NCT00662558|584630153|FG001|Overall Study|Withdrawal by Subject|12|||
161886842|NCT00662558|584630152|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
161886843|NCT00662558|584630153|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
161886844|NCT03329248|584630163|FG000|Overall Study|Progressive Disease|6|||
161886845|NCT00987402|584630164|FG000|Overall Study|Insufficient data entry|86|||
161886846|NCT00987402|584630165|FG001|Overall Study|Insufficient data entry|98|||
161886847|NCT03000530|584630169|FG000|Overall Study|Adverse Event|0|||
161886848|NCT03000530|584630170|FG001|Overall Study|Adverse Event|0|||
161886849|NCT03000530|584630171|FG002|Overall Study|Adverse Event|2|||
161886850|NCT03000530|584630169|FG000|Overall Study|Lost to Follow-up|0|||
161886851|NCT03000530|584630170|FG001|Overall Study|Lost to Follow-up|3|||
161886852|NCT03000530|584630171|FG002|Overall Study|Lost to Follow-up|1|||
161886853|NCT03000530|584630169|FG000|Overall Study|Withdrawal by Subject|0|||
161886854|NCT03000530|584630170|FG001|Overall Study|Withdrawal by Subject|2|||
161886855|NCT03000530|584630171|FG002|Overall Study|Withdrawal by Subject|1|||
161886856|NCT01672294|584630172|FG000|Overall Study|Withdrawal by Subject|4|||
161886857|NCT01672294|584630173|FG001|Overall Study|Withdrawal by Subject|4|||
161886858|NCT01672294|584630174|FG002|Overall Study|Withdrawal by Subject|4|||
161886859|NCT01672294|584630175|FG003|Overall Study|Withdrawal by Subject|4|||
161886860|NCT01672294|584630172|FG000|Overall Study|Excluded by study|1|||
161886861|NCT01672294|584630173|FG001|Overall Study|Excluded by study|1|||
161886862|NCT01672294|584630174|FG002|Overall Study|Excluded by study|0|||
161886863|NCT01672294|584630175|FG003|Overall Study|Excluded by study|0|||
161886864|NCT01672294|584630172|FG000|Overall Study|Lost to Follow-up|1|||
161886865|NCT01672294|584630173|FG001|Overall Study|Lost to Follow-up|16|||
161886866|NCT01672294|584630174|FG002|Overall Study|Lost to Follow-up|7|||
161886867|NCT01672294|584630175|FG003|Overall Study|Lost to Follow-up|9|||
161886868|NCT01285492|584630176|FG000|Overall Study|Adverse Event|11|||
161886869|NCT01285492|584630177|FG001|Overall Study|Adverse Event|0|||
161886870|NCT01285492|584630176|FG000|Overall Study|Protocol Violation|3|||
161886871|NCT01285492|584630177|FG001|Overall Study|Protocol Violation|0|||
161886872|NCT01285492|584630176|FG000|Overall Study|Withdrawal by Subject|2|||
161886873|NCT01285492|584630177|FG001|Overall Study|Withdrawal by Subject|1|||
161886874|NCT01285492|584630176|FG000|Overall Study|Death|1|||
161886875|NCT01285492|584630177|FG001|Overall Study|Death|0|||
161886876|NCT03379792|584630178|FG000|Overall Study|Physician Decision|0|||
161886877|NCT03379792|584630179|FG001|Overall Study|Physician Decision|0|||
161886878|NCT03379792|584630180|FG002|Overall Study|Physician Decision|0|||
161886879|NCT03379792|584630181|FG003|Overall Study|Physician Decision|1|||
161886880|NCT03379792|584630182|FG004|Overall Study|Physician Decision|0|||
161886881|NCT03379792|584630183|FG005|Overall Study|Physician Decision|0|||
161886882|NCT03379792|584630178|FG000|Overall Study|Withdrawal by Subject|0|||
161886883|NCT03379792|584630179|FG001|Overall Study|Withdrawal by Subject|0|||
161886884|NCT03379792|584630180|FG002|Overall Study|Withdrawal by Subject|0|||
161886885|NCT03379792|584630181|FG003|Overall Study|Withdrawal by Subject|0|||
161886886|NCT03379792|584630182|FG004|Overall Study|Withdrawal by Subject|1|||
161886887|NCT03379792|584630183|FG005|Overall Study|Withdrawal by Subject|1|||
161886888|NCT01121536|584630185|FG000|Overall Study|Adverse Event|63|||
161886889|NCT01121536|584630185|FG000|Overall Study|Lack of Efficacy|35|||
161886890|NCT01121536|584630185|FG000|Overall Study|Withdrawal by Subject|65|||
161886891|NCT01121536|584630185|FG000|Overall Study|Protocol Violation|20|||
161886892|NCT01121536|584630185|FG000|Overall Study|Noncompliance with study medication|12|||
161886893|NCT01121536|584630185|FG000|Overall Study|Noncompliance with study procedures|9|||
161886894|NCT01121536|584630185|FG000|Overall Study|Lost to Follow-up|39|||
161886895|NCT01121536|584630185|FG000|Overall Study|Other|118|||
161886896|NCT02649426|584630186|FG000|Overall Study|Follow-up on going|1|||
161886897|NCT02649426|584630187|FG001|Overall Study|Follow-up on going|26|||
161886898|NCT02649426|584630188|FG002|Overall Study|Follow-up on going|28|||
161886899|NCT02649426|584630189|FG003|Overall Study|Follow-up on going|31|||
161886900|NCT01606202|584630190|FG000|Overall Study|Adverse Event|5|||
161886901|NCT01606202|584630191|FG001|Overall Study|Adverse Event|0|||
161886902|NCT01606202|584630190|FG000|Overall Study|Withdrawal by Subject|2|||
161886903|NCT01606202|584630191|FG001|Overall Study|Withdrawal by Subject|1|||
161886904|NCT01606202|584630190|FG000|Overall Study|Personal problems|0|||
161886905|NCT01606202|584630191|FG001|Overall Study|Personal problems|1|||
161886906|NCT01606202|584630190|FG000|Overall Study|Problems with administration|0|||
161886907|NCT01606202|584630191|FG001|Overall Study|Problems with administration|1|||
161886908|NCT00306787|584630192|FG000|Overall Study|Discontinued without taking study drug|208|||
161886909|NCT00306787|584630193|FG001|Overall Study|Discontinued without taking study drug|215|||
161886910|NCT00306787|584630192|FG000|Overall Study|Adverse Event|1|||
161886911|NCT00306787|584630193|FG001|Overall Study|Adverse Event|1|||
161886912|NCT00306787|584630192|FG000|Overall Study|Lack of Efficacy|1|||
161886913|NCT00306787|584630193|FG001|Overall Study|Lack of Efficacy|0|||
161886914|NCT00306787|584630192|FG000|Overall Study|Protocol Violation|8|||
161886915|NCT00306787|584630193|FG001|Overall Study|Protocol Violation|10|||
161886916|NCT00306787|584630192|FG000|Overall Study|Withdrawal by Subject|2|||
161886917|NCT00306787|584630193|FG001|Overall Study|Withdrawal by Subject|9|||
161886918|NCT00306787|584630192|FG000|Overall Study|Lost to Follow-up|9|||
161886919|NCT00306787|584630193|FG001|Overall Study|Lost to Follow-up|6|||
161886920|NCT00306787|584630192|FG000|Overall Study|Administrative problems|4|||
161886921|NCT00306787|584630193|FG001|Overall Study|Administrative problems|0|||
161886922|NCT00306787|584630192|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161886923|NCT00306787|584630193|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161886924|NCT00369161|584630194|FG000|Overall Study|Adverse Event|15|||
161886925|NCT00369161|584630195|FG001|Overall Study|Adverse Event|13|||
161886926|NCT00369161|584630194|FG000|Overall Study|Abnormal laboratory value|0|||
161886927|NCT00369161|584630195|FG001|Overall Study|Abnormal laboratory value|1|||
161886928|NCT00369161|584630194|FG000|Overall Study|Lack of Efficacy|3|||
161886929|NCT00369161|584630195|FG001|Overall Study|Lack of Efficacy|1|||
161886930|NCT00369161|584630194|FG000|Overall Study|Protocol Violation|0|||
161886931|NCT00369161|584630195|FG001|Overall Study|Protocol Violation|2|||
161886932|NCT00369161|584630194|FG000|Overall Study|Withdrawal by Subject|2|||
161886933|NCT00369161|584630195|FG001|Overall Study|Withdrawal by Subject|3|||
161886934|NCT00369161|584630194|FG000|Overall Study|Death|1|||
161886935|NCT00369161|584630195|FG001|Overall Study|Death|2|||
161886936|NCT00369161|584630194|FG000|Overall Study|Graft loss|4|||
161886937|NCT00369161|584630195|FG001|Overall Study|Graft loss|0|||
161886938|NCT00369161|584630194|FG000|Overall Study|Administrative Problem|2|||
161886939|NCT00369161|584630195|FG001|Overall Study|Administrative Problem|2|||
161886940|NCT01870297|584630198|FG000|Overall Study|Adverse Event|0|||
161886941|NCT01870297|584630199|FG001|Overall Study|Adverse Event|0|||
161886942|NCT01870297|584630200|FG002|Overall Study|Adverse Event|0|||
161886943|NCT01870297|584630201|FG003|Overall Study|Adverse Event|0|||
161886944|NCT01870297|584630202|FG004|Overall Study|Adverse Event|2|||
161886945|NCT01870297|584630203|FG005|Overall Study|Adverse Event|0|||
161886946|NCT01870297|584630204|FG006|Overall Study|Adverse Event|0|||
161886947|NCT01870297|584630198|FG000|Overall Study|Lost to Follow-up|0|||
161886948|NCT01870297|584630199|FG001|Overall Study|Lost to Follow-up|1|||
161886949|NCT01870297|584630200|FG002|Overall Study|Lost to Follow-up|1|||
161886950|NCT01870297|584630201|FG003|Overall Study|Lost to Follow-up|0|||
161886951|NCT01870297|584630202|FG004|Overall Study|Lost to Follow-up|0|||
161886952|NCT01870297|584630203|FG005|Overall Study|Lost to Follow-up|0|||
161886953|NCT01870297|584630204|FG006|Overall Study|Lost to Follow-up|0|||
161886954|NCT01870297|584630198|FG000|Overall Study|Withdrawal by Subject|0|||
161886955|NCT01870297|584630199|FG001|Overall Study|Withdrawal by Subject|0|||
161886956|NCT01870297|584630200|FG002|Overall Study|Withdrawal by Subject|0|||
161886957|NCT01870297|584630201|FG003|Overall Study|Withdrawal by Subject|0|||
161886958|NCT01870297|584630202|FG004|Overall Study|Withdrawal by Subject|1|||
161886959|NCT01870297|584630203|FG005|Overall Study|Withdrawal by Subject|1|||
161886960|NCT01870297|584630204|FG006|Overall Study|Withdrawal by Subject|1|||
161886961|NCT01870297|584630198|FG000|Overall Study|Sponsor Decision|0|||
161886962|NCT01870297|584630199|FG001|Overall Study|Sponsor Decision|6|||
161886963|NCT01870297|584630200|FG002|Overall Study|Sponsor Decision|0|||
161886964|NCT01870297|584630201|FG003|Overall Study|Sponsor Decision|0|||
161886965|NCT01870297|584630202|FG004|Overall Study|Sponsor Decision|0|||
161886966|NCT01870297|584630203|FG005|Overall Study|Sponsor Decision|0|||
161886967|NCT01870297|584630204|FG006|Overall Study|Sponsor Decision|1|||
161886968|NCT00337779|584630205|FG000|Overall Study|Withdrawal by Subject|10|||
161886969|NCT00337779|584630206|FG001|Overall Study|Withdrawal by Subject|12|||
161886970|NCT00337779|584630205|FG000|Overall Study|Sponsor decision|1|||
161886971|NCT00337779|584630206|FG001|Overall Study|Sponsor decision|1|||
161886972|NCT00337779|584630205|FG000|Overall Study|Physician Decision|3|||
161886973|NCT00337779|584630206|FG001|Overall Study|Physician Decision|6|||
161886974|NCT00337779|584630205|FG000|Overall Study|Protocol Violation|1|||
161886975|NCT00337779|584630206|FG001|Overall Study|Protocol Violation|1|||
161886976|NCT00337779|584630205|FG000|Overall Study|Lost to Follow-up|6|||
161886977|NCT00337779|584630206|FG001|Overall Study|Lost to Follow-up|5|||
161886978|NCT00337779|584630205|FG000|Overall Study|Adverse Event|28|||
161886979|NCT00337779|584630206|FG001|Overall Study|Adverse Event|51|||
161886980|NCT00337779|584630205|FG000|Overall Study|Pregnancy|3|||
161886981|NCT00337779|584630206|FG001|Overall Study|Pregnancy|2|||
161886982|NCT00337779|584630205|FG000|Overall Study|Death|0|||
161886983|NCT00337779|584630206|FG001|Overall Study|Death|1|||
161886984|NCT01593254|584630209|FG000|Overall Study|Disease progression|2|||
161886985|NCT01593254|584630210|FG001|Overall Study|Disease progression|7|||
161886986|NCT01593254|584630209|FG000|Overall Study|Study drug toxicity|6|||
161886987|NCT01593254|584630210|FG001|Overall Study|Study drug toxicity|20|||
161886988|NCT01593254|584630209|FG000|Overall Study|Death|3|||
161886989|NCT01593254|584630210|FG001|Overall Study|Death|3|||
161886990|NCT01593254|584630209|FG000|Overall Study|AE unrelated to study drug|0|||
161886991|NCT01593254|584630210|FG001|Overall Study|AE unrelated to study drug|1|||
161886992|NCT01593254|584630209|FG000|Overall Study|participant request to discontinue study treatment|1|||
161886993|NCT01593254|584630210|FG001|Overall Study|participant request to discontinue study treatment|3|||
161886994|NCT01593254|584630209|FG000|Overall Study|participant withdrew consent|0|||
161886995|NCT01593254|584630210|FG001|Overall Study|participant withdrew consent|9|||
161886996|NCT01593254|584630209|FG000|Overall Study|lost to follow up|1|||
161886997|NCT01593254|584630210|FG001|Overall Study|lost to follow up|6|||
161886998|NCT01593254|584630209|FG000|Overall Study|maximum clinical benefit|1|||
161886999|NCT01593254|584630210|FG001|Overall Study|maximum clinical benefit|2|||
161887000|NCT01593254|584630209|FG000|Overall Study|Poor/non compliance|1|||
161887001|NCT01593254|584630210|FG001|Overall Study|Poor/non compliance|1|||
161887002|NCT01593254|584630209|FG000|Overall Study|Pregnancy|0|||
161887003|NCT01593254|584630210|FG001|Overall Study|Pregnancy|3|||
161887004|NCT01593254|584630209|FG000|Overall Study|participant no longer meets study criteria|1|||
161887005|NCT01593254|584630210|FG001|Overall Study|participant no longer meets study criteria|1|||
161887006|NCT01593254|584630209|FG000|Overall Study|Admin reason by sponsor|7|||
161887007|NCT01593254|584630210|FG001|Overall Study|Admin reason by sponsor|3|||
161887008|NCT01593254|584630209|FG000|Overall Study|Imatinib treatment failure|2|||
161887009|NCT01593254|584630210|FG001|Overall Study|Imatinib treatment failure|0|||
161887010|NCT01593254|584630209|FG000|Overall Study|Other Reasons|61|||
161887011|NCT01593254|584630210|FG001|Overall Study|Other Reasons|115|||
161887012|NCT04249622|584630213|FG000|Overall Study|Withdrawal by Subject|1|||
161887013|NCT04249622|584630214|FG001|Overall Study|Withdrawal by Subject|1|||
161887014|NCT04249622|584630213|FG000|Overall Study|Alternative therapy|1|||
161887015|NCT04249622|584630214|FG001|Overall Study|Alternative therapy|0|||
161887016|NCT04249622|584630213|FG000|Overall Study|Discontinuation of pertuzumab|1|||
161887017|NCT04249622|584630214|FG001|Overall Study|Discontinuation of pertuzumab|0|||
161887018|NCT03689543|584630216|FG000|Overall Study|Adverse Event|0|||
161887019|NCT03689543|584630217|FG001|Overall Study|Adverse Event|0|||
161887020|NCT03689543|584630218|FG002|Overall Study|Adverse Event|1|||
161887021|NCT00932451|584630219|FG000|Overall Study|Withdrawal by Subject|69|||
161887022|NCT00932451|584630219|FG000|Overall Study|Lost to Follow-up|22|||
161887023|NCT00932451|584630219|FG000|Overall Study|Death|726|||
161887024|NCT00932451|584630219|FG000|Overall Study|Other reasons|5|||
161887025|NCT00586508|584630220|FG000|Overall Study|Progressive disease|52|||
161887026|NCT00586508|584630221|FG001|Overall Study|Progressive disease|8|||
161887027|NCT00586508|584630220|FG000|Overall Study|Death|0|||
161887028|NCT00586508|584630221|FG001|Overall Study|Death|1|||
161887029|NCT00586508|584630220|FG000|Overall Study|Adverse Event|12|||
161887030|NCT00586508|584630221|FG001|Overall Study|Adverse Event|4|||
161887031|NCT00586508|584630220|FG000|Overall Study|Withdrawal by Subject|4|||
161887032|NCT00586508|584630221|FG001|Overall Study|Withdrawal by Subject|0|||
161887033|NCT01294371|584630222|FG000|Overall Study|Adverse Event|1|||
161887034|NCT01294371|584630222|FG000|Overall Study|Withdrawal by Subject|12|||
161887035|NCT01294371|584630222|FG000|Overall Study|Lost to Follow-up|6|||
161887036|NCT01294371|584630222|FG000|Overall Study|Administrative Reason|1|||
161887037|NCT01294371|584630222|FG000|Overall Study|Other|14|||
161887038|NCT05619536|584630223|FG000|Overall Study|Withdrawal by Subject|0|||
161887039|NCT05619536|584630224|FG001|Overall Study|Withdrawal by Subject|1|||
161887040|NCT05619536|584630225|FG002|Overall Study|Withdrawal by Subject|0|||
161887041|NCT05619536|584630226|FG003|Overall Study|Withdrawal by Subject|1|||
161887042|NCT05619536|584630223|FG000|Overall Study|Lost to Follow-up|0|||
161887043|NCT05619536|584630224|FG001|Overall Study|Lost to Follow-up|1|||
161887044|NCT05619536|584630225|FG002|Overall Study|Lost to Follow-up|1|||
161887045|NCT05619536|584630226|FG003|Overall Study|Lost to Follow-up|0|||
161887046|NCT01592292|584630227|FG000|Overall Study|Follow-up loss|3|||
161887047|NCT01592292|584630228|FG001|Overall Study|Follow-up loss|3|||
161887048|NCT01592292|584630229|FG002|Overall Study|Follow-up loss|1|||
161887049|NCT01592292|584630230|FG003|Overall Study|Follow-up loss|0|||
161887050|NCT01592292|584630227|FG000|Overall Study|Withdrew consent|2|||
161887051|NCT01592292|584630228|FG001|Overall Study|Withdrew consent|1|||
161887052|NCT01592292|584630229|FG002|Overall Study|Withdrew consent|0|||
161887053|NCT01592292|584630230|FG003|Overall Study|Withdrew consent|0|||
161887054|NCT01592292|584630227|FG000|Overall Study|Other|1|||
161887055|NCT01592292|584630228|FG001|Overall Study|Other|1|||
161887056|NCT01592292|584630229|FG002|Overall Study|Other|2|||
161887057|NCT01592292|584630230|FG003|Overall Study|Other|1|||
161887058|NCT02923245|584630234|FG000|Overall Study|ultrasound order was cancelled|2|||
161887059|NCT02923245|584630235|FG001|Overall Study|ultrasound order was cancelled|1|||
161887060|NCT02680834|584630236|FG000|Overall Study|Physician Decision|5|||
161887061|NCT02680834|584630237|FG001|Overall Study|Physician Decision|2|||
161887062|NCT02680834|584630236|FG000|Overall Study|Withdrawal by Subject|6|||
161887063|NCT02680834|584630237|FG001|Overall Study|Withdrawal by Subject|0|||
161887064|NCT02680834|584630236|FG000|Overall Study|Lost to Follow-up|0|||
161887065|NCT02680834|584630237|FG001|Overall Study|Lost to Follow-up|1|||
161887066|NCT02520427|584630238|FG000|Overall Study|Decision by sponsor|0|||
161887067|NCT02520427|584630239|FG001|Overall Study|Decision by sponsor|0|||
161887068|NCT02520427|584630240|FG002|Overall Study|Decision by sponsor|0|||
161887069|NCT02520427|584630241|FG003|Overall Study|Decision by sponsor|0|||
161887070|NCT02520427|584630242|FG004|Overall Study|Decision by sponsor|0|||
161887071|NCT02520427|584630243|FG005|Overall Study|Decision by sponsor|0|||
161887072|NCT02520427|584630244|FG006|Overall Study|Decision by sponsor|0|||
161887073|NCT02520427|584630245|FG007|Overall Study|Decision by sponsor|0|||
161887074|NCT02520427|584630246|FG008|Overall Study|Decision by sponsor|1|||
161887075|NCT02520427|584630247|FG009|Overall Study|Decision by sponsor|1|||
161887076|NCT02520427|584630248|FG010|Overall Study|Decision by sponsor|0|||
161887077|NCT02520427|584630249|FG011|Overall Study|Decision by sponsor|0|||
161887078|NCT02520427|584630250|FG012|Overall Study|Decision by sponsor|0|||
161887079|NCT02520427|584630251|FG013|Overall Study|Decision by sponsor|0|||
161887080|NCT02520427|584630252|FG014|Overall Study|Decision by sponsor|0|||
161887081|NCT02520427|584630253|FG015|Overall Study|Decision by sponsor|0|||
161887082|NCT02520427|584630254|FG016|Overall Study|Decision by sponsor|0|||
161887083|NCT02520427|584630255|FG017|Overall Study|Decision by sponsor|0|||
161887084|NCT02520427|584630256|FG018|Overall Study|Decision by sponsor|0|||
161887085|NCT02520427|584630257|FG019|Overall Study|Decision by sponsor|0|||
161887086|NCT02520427|584630258|FG020|Overall Study|Decision by sponsor|0|||
161887087|NCT02520427|584630259|FG021|Overall Study|Decision by sponsor|0|||
161887088|NCT02520427|584630260|FG022|Overall Study|Decision by sponsor|0|||
161887089|NCT02520427|584630261|FG023|Overall Study|Decision by sponsor|0|||
161887090|NCT02520427|584630262|FG024|Overall Study|Decision by sponsor|0|||
161887091|NCT02520427|584630263|FG025|Overall Study|Decision by sponsor|0|||
161887092|NCT02520427|584630238|FG000|Overall Study|Withdrawal by Subject|0|||
161887093|NCT02520427|584630239|FG001|Overall Study|Withdrawal by Subject|0|||
161887094|NCT02520427|584630240|FG002|Overall Study|Withdrawal by Subject|1|||
161887095|NCT02520427|584630241|FG003|Overall Study|Withdrawal by Subject|0|||
161887096|NCT02520427|584630242|FG004|Overall Study|Withdrawal by Subject|0|||
161887097|NCT02520427|584630243|FG005|Overall Study|Withdrawal by Subject|0|||
161887098|NCT02520427|584630244|FG006|Overall Study|Withdrawal by Subject|0|||
161887099|NCT02520427|584630245|FG007|Overall Study|Withdrawal by Subject|0|||
161887100|NCT02520427|584630246|FG008|Overall Study|Withdrawal by Subject|0|||
161887101|NCT02520427|584630247|FG009|Overall Study|Withdrawal by Subject|0|||
161887102|NCT02520427|584630248|FG010|Overall Study|Withdrawal by Subject|0|||
161887103|NCT02520427|584630249|FG011|Overall Study|Withdrawal by Subject|0|||
161887104|NCT02520427|584630250|FG012|Overall Study|Withdrawal by Subject|1|||
161887105|NCT02520427|584630251|FG013|Overall Study|Withdrawal by Subject|1|||
161887106|NCT02520427|584630252|FG014|Overall Study|Withdrawal by Subject|1|||
161887107|NCT02520427|584630253|FG015|Overall Study|Withdrawal by Subject|0|||
161887108|NCT02520427|584630254|FG016|Overall Study|Withdrawal by Subject|1|||
161887109|NCT02520427|584630255|FG017|Overall Study|Withdrawal by Subject|0|||
161887110|NCT02520427|584630256|FG018|Overall Study|Withdrawal by Subject|0|||
161887111|NCT02520427|584630257|FG019|Overall Study|Withdrawal by Subject|3|||
161887112|NCT02520427|584630258|FG020|Overall Study|Withdrawal by Subject|2|||
161887113|NCT02520427|584630259|FG021|Overall Study|Withdrawal by Subject|0|||
161887114|NCT02520427|584630260|FG022|Overall Study|Withdrawal by Subject|0|||
161887115|NCT02520427|584630261|FG023|Overall Study|Withdrawal by Subject|0|||
161887116|NCT02520427|584630262|FG024|Overall Study|Withdrawal by Subject|0|||
161887117|NCT02520427|584630263|FG025|Overall Study|Withdrawal by Subject|0|||
161887118|NCT02520427|584630238|FG000|Overall Study|Death|1|||
161887119|NCT02520427|584630239|FG001|Overall Study|Death|0|||
161887120|NCT02520427|584630240|FG002|Overall Study|Death|0|||
161887121|NCT02520427|584630241|FG003|Overall Study|Death|0|||
161887122|NCT02520427|584630242|FG004|Overall Study|Death|0|||
161887123|NCT02520427|584630243|FG005|Overall Study|Death|0|||
161887124|NCT02520427|584630244|FG006|Overall Study|Death|0|||
161887125|NCT02520427|584630245|FG007|Overall Study|Death|0|||
161887126|NCT02520427|584630246|FG008|Overall Study|Death|0|||
161887127|NCT02520427|584630247|FG009|Overall Study|Death|0|||
161887128|NCT02520427|584630248|FG010|Overall Study|Death|0|||
161887129|NCT02520427|584630249|FG011|Overall Study|Death|0|||
161887130|NCT02520427|584630250|FG012|Overall Study|Death|0|||
161887131|NCT02520427|584630251|FG013|Overall Study|Death|0|||
161887132|NCT02520427|584630252|FG014|Overall Study|Death|0|||
161887133|NCT02520427|584630253|FG015|Overall Study|Death|0|||
161887134|NCT02520427|584630254|FG016|Overall Study|Death|2|||
161887135|NCT02520427|584630255|FG017|Overall Study|Death|1|||
161887136|NCT02520427|584630256|FG018|Overall Study|Death|3|||
161887137|NCT02520427|584630257|FG019|Overall Study|Death|2|||
161887138|NCT02520427|584630258|FG020|Overall Study|Death|0|||
161887139|NCT02520427|584630259|FG021|Overall Study|Death|0|||
161887140|NCT02520427|584630260|FG022|Overall Study|Death|1|||
161887141|NCT02520427|584630261|FG023|Overall Study|Death|0|||
161887142|NCT02520427|584630262|FG024|Overall Study|Death|1|||
161887143|NCT02520427|584630263|FG025|Overall Study|Death|0|||
161887144|NCT00793624|584630264|FG000|Overall Study|Adverse Event|18|||
161887145|NCT00793624|584630265|FG001|Overall Study|Adverse Event|16|||
161887146|NCT00793624|584630266|FG002|Overall Study|Adverse Event|15|||
161887147|NCT00793624|584630267|FG003|Overall Study|Adverse Event|20|||
161887148|NCT00793624|584630264|FG000|Overall Study|Lost to Follow-up|2|||
161887149|NCT00793624|584630265|FG001|Overall Study|Lost to Follow-up|2|||
161887150|NCT00793624|584630266|FG002|Overall Study|Lost to Follow-up|4|||
161887151|NCT00793624|584630267|FG003|Overall Study|Lost to Follow-up|0|||
161887152|NCT00793624|584630264|FG000|Overall Study|Withdrawal by Subject|20|||
161887153|NCT00793624|584630265|FG001|Overall Study|Withdrawal by Subject|9|||
161887154|NCT00793624|584630266|FG002|Overall Study|Withdrawal by Subject|11|||
161887155|NCT00793624|584630267|FG003|Overall Study|Withdrawal by Subject|14|||
161887156|NCT00793624|584630264|FG000|Overall Study|Lack of Efficacy|9|||
161887157|NCT00793624|584630265|FG001|Overall Study|Lack of Efficacy|2|||
161887158|NCT00793624|584630266|FG002|Overall Study|Lack of Efficacy|1|||
161887159|NCT00793624|584630267|FG003|Overall Study|Lack of Efficacy|3|||
161887160|NCT00793624|584630264|FG000|Overall Study|Non compliance with protocol|2|||
161887161|NCT00793624|584630265|FG001|Overall Study|Non compliance with protocol|3|||
161887162|NCT00793624|584630266|FG002|Overall Study|Non compliance with protocol|2|||
161887163|NCT00793624|584630267|FG003|Overall Study|Non compliance with protocol|3|||
161887164|NCT00793624|584630264|FG000|Overall Study|Other reason not described above|6|||
161887165|NCT00793624|584630265|FG001|Overall Study|Other reason not described above|4|||
161887166|NCT00793624|584630266|FG002|Overall Study|Other reason not described above|6|||
161887167|NCT00793624|584630267|FG003|Overall Study|Other reason not described above|3|||
161887168|NCT00157248|584630268|FG000|Overall Study|Adverse Event|36|||
161887169|NCT00157248|584630269|FG001|Overall Study|Adverse Event|25|||
161887170|NCT00157248|584630270|FG002|Overall Study|Adverse Event|13|||
161887171|NCT00157248|584630271|FG003|Overall Study|Adverse Event|33|||
161887172|NCT00157248|584630268|FG000|Overall Study|Protocol Violation|4|||
161887173|NCT00157248|584630269|FG001|Overall Study|Protocol Violation|0|||
161887174|NCT00157248|584630270|FG002|Overall Study|Protocol Violation|2|||
161887175|NCT00157248|584630271|FG003|Overall Study|Protocol Violation|2|||
161887176|NCT00157248|584630268|FG000|Overall Study|Lost to Follow-up|0|||
161887177|NCT00157248|584630269|FG001|Overall Study|Lost to Follow-up|1|||
161887178|NCT00157248|584630270|FG002|Overall Study|Lost to Follow-up|0|||
161887179|NCT00157248|584630271|FG003|Overall Study|Lost to Follow-up|0|||
161887180|NCT00157248|584630268|FG000|Overall Study|Withdrawal by Subject|1|||
161887181|NCT00157248|584630269|FG001|Overall Study|Withdrawal by Subject|4|||
161887182|NCT00157248|584630270|FG002|Overall Study|Withdrawal by Subject|3|||
161887183|NCT00157248|584630271|FG003|Overall Study|Withdrawal by Subject|3|||
161887184|NCT00157248|584630268|FG000|Overall Study|site closures, subject moving|7|||
161887185|NCT00157248|584630269|FG001|Overall Study|site closures, subject moving|7|||
161887186|NCT00157248|584630270|FG002|Overall Study|site closures, subject moving|3|||
161887187|NCT00157248|584630271|FG003|Overall Study|site closures, subject moving|9|||
161887188|NCT04102865|584630272|FG000|Overall Study|Adverse Event|4|||
161887189|NCT04102865|584630273|FG001|Overall Study|Adverse Event|0|||
161887190|NCT04102865|584630272|FG000|Overall Study|Lost to Follow-up|1|||
161887191|NCT04102865|584630273|FG001|Overall Study|Lost to Follow-up|0|||
161887192|NCT04102865|584630272|FG000|Overall Study|Withdrawal by Subject|2|||
161887193|NCT04102865|584630273|FG001|Overall Study|Withdrawal by Subject|0|||
161887194|NCT02073565|584630274|FG000|Cohort A|Withdrawal by Subject|1|||
161887195|NCT02073565|584630275|FG001|Cohort A|Withdrawal by Subject|0|||
161887196|NCT02073565|584630274|FG000|Cohort B|Withdrawal by Subject|1|||
161887197|NCT02073565|584630275|FG001|Cohort B|Withdrawal by Subject|2|||
161887198|NCT02073565|584630274|FG000|Cohort C|Withdrawal by Subject|0|||
161887199|NCT02073565|584630275|FG001|Cohort C|Withdrawal by Subject|2|||
161887200|NCT02073565|584630274|FG000|Cohort C|Lost to Follow-up|0|||
161887201|NCT02073565|584630275|FG001|Cohort C|Lost to Follow-up|2|||
161887202|NCT01764997|584630280|FG000|Run-in Period|Adverse Event|15|||
161887203|NCT01764997|584630281|FG001|Run-in Period|Adverse Event|0|||
161887204|NCT01764997|584630282|FG002|Run-in Period|Adverse Event|0|||
161887205|NCT01764997|584630283|FG003|Run-in Period|Adverse Event|0|||
161887206|NCT01764997|584630284|FG004|Run-in Period|Adverse Event|0|||
161887207|NCT01764997|584630280|FG000|Run-in Period|Lack of Efficacy|5|||
161887208|NCT01764997|584630281|FG001|Run-in Period|Lack of Efficacy|0|||
161887209|NCT01764997|584630282|FG002|Run-in Period|Lack of Efficacy|0|||
161887210|NCT01764997|584630283|FG003|Run-in Period|Lack of Efficacy|0|||
161887211|NCT01764997|584630284|FG004|Run-in Period|Lack of Efficacy|0|||
161887212|NCT01764997|584630280|FG000|Run-in Period|Poor compliance to protocol|1|||
161887213|NCT01764997|584630281|FG001|Run-in Period|Poor compliance to protocol|0|||
161887214|NCT01764997|584630282|FG002|Run-in Period|Poor compliance to protocol|0|||
161887215|NCT01764997|584630283|FG003|Run-in Period|Poor compliance to protocol|0|||
161887216|NCT01764997|584630284|FG004|Run-in Period|Poor compliance to protocol|0|||
161887217|NCT01764997|584630280|FG000|Run-in Period|Other than specified above|17|||
161887218|NCT01764997|584630281|FG001|Run-in Period|Other than specified above|0|||
161887219|NCT01764997|584630282|FG002|Run-in Period|Other than specified above|0|||
161887220|NCT01764997|584630283|FG003|Run-in Period|Other than specified above|0|||
161887221|NCT01764997|584630284|FG004|Run-in Period|Other than specified above|0|||
161887222|NCT01764997|584630280|FG000|Study Drug Treatment Period|Adverse Event|0|||
161887223|NCT01764997|584630281|FG001|Study Drug Treatment Period|Adverse Event|1|||
161887224|NCT01764997|584630282|FG002|Study Drug Treatment Period|Adverse Event|0|||
161887225|NCT01764997|584630283|FG003|Study Drug Treatment Period|Adverse Event|0|||
161887226|NCT01764997|584630284|FG004|Study Drug Treatment Period|Adverse Event|24|||
161887227|NCT01764997|584630280|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
161887228|NCT01764997|584630281|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
161887229|NCT01764997|584630282|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
161887230|NCT01764997|584630283|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
161887231|NCT01764997|584630284|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
161887232|NCT01764997|584630280|FG000|Study Drug Treatment Period|Other than specified above|0|||
161887233|NCT01764997|584630281|FG001|Study Drug Treatment Period|Other than specified above|0|||
161887234|NCT01764997|584630282|FG002|Study Drug Treatment Period|Other than specified above|0|||
161887235|NCT01764997|584630283|FG003|Study Drug Treatment Period|Other than specified above|0|||
161887236|NCT01764997|584630284|FG004|Study Drug Treatment Period|Other than specified above|10|||
161887237|NCT00441363|584632312|FG000|Overall Study|Adverse Event|4|||
161887238|NCT00441363|584632313|FG001|Overall Study|Adverse Event|2|||
161887239|NCT00441363|584632312|FG000|Overall Study|Withdrawal by Subject|3|||
161887240|NCT00441363|584632313|FG001|Overall Study|Withdrawal by Subject|4|||
161887241|NCT00441363|584632312|FG000|Overall Study|Physician Decision|6|||
161887242|NCT00441363|584632313|FG001|Overall Study|Physician Decision|7|||
161887243|NCT00441363|584632312|FG000|Overall Study|Lost to Follow-up|2|||
161887244|NCT00441363|584632313|FG001|Overall Study|Lost to Follow-up|2|||
161887245|NCT00441363|584632312|FG000|Overall Study|Other|2|||
161887246|NCT00441363|584632313|FG001|Overall Study|Other|0|||
161887247|NCT01313221|584632316|FG000|Overall Study|Protocol Violation|0|||
161887248|NCT01313221|584632317|FG001|Overall Study|Protocol Violation|1|||
161887249|NCT01313221|584632318|FG002|Overall Study|Protocol Violation|1|||
161887250|NCT01313221|584632316|FG000|Overall Study|Non-compliance|3|||
161887251|NCT01313221|584632317|FG001|Overall Study|Non-compliance|0|||
161887252|NCT01313221|584632318|FG002|Overall Study|Non-compliance|2|||
161887253|NCT01313221|584632316|FG000|Overall Study|Withdrawal by Subject|2|||
161887254|NCT01313221|584632317|FG001|Overall Study|Withdrawal by Subject|3|||
161887255|NCT01313221|584632318|FG002|Overall Study|Withdrawal by Subject|5|||
161887256|NCT01313221|584632316|FG000|Overall Study|Requirement for alternative therapy|0|||
161887257|NCT01313221|584632317|FG001|Overall Study|Requirement for alternative therapy|1|||
161887258|NCT01313221|584632318|FG002|Overall Study|Requirement for alternative therapy|1|||
161887259|NCT01313221|584632316|FG000|Overall Study|Lost to Follow-up|6|||
161887260|NCT01313221|584632317|FG001|Overall Study|Lost to Follow-up|3|||
161887261|NCT01313221|584632318|FG002|Overall Study|Lost to Follow-up|1|||
161887262|NCT01313221|584632316|FG000|Overall Study|Other|1|||
161887263|NCT01313221|584632317|FG001|Overall Study|Other|0|||
161887264|NCT01313221|584632318|FG002|Overall Study|Other|0|||
161887265|NCT01313221|584632316|FG000|Overall Study|Adverse Event|0|||
161887266|NCT01313221|584632317|FG001|Overall Study|Adverse Event|0|||
161887267|NCT01313221|584632318|FG002|Overall Study|Adverse Event|7|||
161887268|NCT01313221|584632316|FG000|Overall Study|Disease progression|0|||
161887269|NCT01313221|584632317|FG001|Overall Study|Disease progression|0|||
161887270|NCT01313221|584632318|FG002|Overall Study|Disease progression|2|||
161887271|NCT01313221|584632316|FG000|Overall Study|Physician Decision|0|||
161887272|NCT01313221|584632317|FG001|Overall Study|Physician Decision|0|||
161887273|NCT01313221|584632318|FG002|Overall Study|Physician Decision|2|||
161887274|NCT01313221|584632316|FG000|Overall Study|Pregnancy|0|||
161887275|NCT01313221|584632317|FG001|Overall Study|Pregnancy|0|||
161887276|NCT01313221|584632318|FG002|Overall Study|Pregnancy|2|||
161887277|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161887278|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
161887279|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161887280|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161887281|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161887282|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161887283|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161887284|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
161887285|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
161887286|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161887287|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161887288|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161887289|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
161887290|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
161887291|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
161887292|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
161887293|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161887294|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161887295|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161887296|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
161887297|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
161887298|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
161887299|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
161887300|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
161887301|NCT03246061|584632323|FG000|Overall Study|Still in follow-up|15|||
161887302|NCT03246061|584632324|FG001|Overall Study|Still in follow-up|21|||
161887303|NCT04710368|584632329|FG000|Overall Study|Withdrawal by Subject|9|||
161887304|NCT04710368|584632329|FG000|Overall Study|Lost to Follow-up|4|||
161887305|NCT04710368|584632329|FG000|Overall Study|Death|2|||
161887306|NCT04710368|584632329|FG000|Overall Study|Patient preference|11|||
161887307|NCT04710368|584632329|FG000|Overall Study|Treatment discontinuation|1|||
161887308|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
161887309|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
161887310|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
161887311|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
161887312|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
161887313|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
161887314|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
161887315|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
161887316|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
161887317|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
161887318|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
161887319|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
161887320|NCT01777139|584632332|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
161887321|NCT01777139|584632333|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
161887322|NCT01777139|584632332|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
161887323|NCT01777139|584632333|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
161887324|NCT01887288|584632335|FG000|Overall Study|The study was terminated and the PI has|16|||
161887325|NCT00290693|584632336|FG000|Overall Study|Withdrawal by Subject|2|||
161887326|NCT05625477|584632337|FG000|Overall Study|Lost to Follow-up|2|||
161887327|NCT05625477|584632338|FG001|Overall Study|Lost to Follow-up|2|||
161887328|NCT05625477|584632339|FG002|Overall Study|Lost to Follow-up|1|||
161887329|NCT05625477|584632340|FG003|Overall Study|Lost to Follow-up|1|||
161887330|NCT05625477|584632341|FG004|Overall Study|Lost to Follow-up|0|||
161887331|NCT05625477|584632337|FG000|Overall Study|Covid quarantine|1|||
161887332|NCT05625477|584632338|FG001|Overall Study|Covid quarantine|0|||
161887333|NCT05625477|584632339|FG002|Overall Study|Covid quarantine|0|||
161887334|NCT05625477|584632340|FG003|Overall Study|Covid quarantine|0|||
161887335|NCT05625477|584632341|FG004|Overall Study|Covid quarantine|0|||
161887336|NCT04849416|584632344|FG000|Overall Study|Ongoing Treatment|12|||
161887337|NCT04849416|584632345|FG001|Overall Study|Ongoing Treatment|5|||
161887338|NCT04849416|584632346|FG002|Overall Study|Ongoing Treatment|3|||
161887339|NCT04849416|584632344|FG000|Overall Study|On Post-Treatment Follow-up|8|||
161887340|NCT04849416|584632345|FG001|Overall Study|On Post-Treatment Follow-up|9|||
161887341|NCT04849416|584632346|FG002|Overall Study|On Post-Treatment Follow-up|10|||
161887342|NCT04849416|584632344|FG000|Overall Study|Withdrawal by Subject|0|||
161887343|NCT04849416|584632345|FG001|Overall Study|Withdrawal by Subject|0|||
161887344|NCT04849416|584632346|FG002|Overall Study|Withdrawal by Subject|1|||
161887345|NCT04849416|584632344|FG000|Overall Study|Lost to Follow-up|1|||
161887346|NCT04849416|584632345|FG001|Overall Study|Lost to Follow-up|0|||
161887347|NCT04849416|584632346|FG002|Overall Study|Lost to Follow-up|0|||
161887348|NCT01092637|584632347|FG000|Overall Study|Death|47|||
161887349|NCT01092637|584632348|FG001|Overall Study|Death|49|||
161887350|NCT01716520|584632349|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161887351|NCT01716520|584632350|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887352|NCT01716520|584632351|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887353|NCT01716520|584632352|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887354|NCT01716520|584632353|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887355|NCT01716520|584632354|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887356|NCT01716520|584632349|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887357|NCT01716520|584632350|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887358|NCT01716520|584632351|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
161887359|NCT01716520|584632352|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887360|NCT01716520|584632353|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887361|NCT01716520|584632354|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887362|NCT01716520|584632349|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887363|NCT01716520|584632350|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161887364|NCT01716520|584632351|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887365|NCT01716520|584632352|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887366|NCT01716520|584632353|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887367|NCT01716520|584632354|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887368|NCT01716520|584632349|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887369|NCT01716520|584632350|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
161887370|NCT01716520|584632351|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887371|NCT01716520|584632352|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887372|NCT01716520|584632353|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161363819|NCT02544763|582720031|FG000|Overall Study|Met withdrawal criteria|0|||
161363820|NCT02544763|582720032|FG001|Overall Study|Met withdrawal criteria|2|||
161363821|NCT02544763|582720033|FG002|Overall Study|Met withdrawal criteria|0|||
161363822|NCT02544763|582720031|FG000|Overall Study|Physician Decision|0|||
161363823|NCT02544763|582720032|FG001|Overall Study|Physician Decision|1|||
161363824|NCT02544763|582720033|FG002|Overall Study|Physician Decision|0|||
161363825|NCT02544763|582720031|FG000|Overall Study|Difficulties taking IMP|1|||
161363826|NCT02544763|582720032|FG001|Overall Study|Difficulties taking IMP|0|||
161363827|NCT02544763|582720033|FG002|Overall Study|Difficulties taking IMP|0|||
161363828|NCT02097225|582720034|FG000|Dose Level 4|Adverse Event|0|||
161363829|NCT02097225|582720035|FG001|Dose Level 4|Adverse Event|0|||
161363830|NCT02097225|582720036|FG002|Dose Level 4|Adverse Event|0|||
161363831|NCT02097225|582720037|FG003|Dose Level 4|Adverse Event|0|||
161363832|NCT02097225|582720038|FG004|Dose Level 4|Adverse Event|1|||
161363833|NCT00911157|582720041|FG000|Overall Study|Adverse Event|4|||
161363834|NCT00911157|582720042|FG001|Overall Study|Adverse Event|1|||
161363835|NCT00911157|582720041|FG000|Overall Study|Withdrawal by Subject|1|||
161363836|NCT00911157|582720042|FG001|Overall Study|Withdrawal by Subject|1|||
161363837|NCT00911157|582720041|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
161363838|NCT00911157|582720042|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
161363839|NCT00911157|582720041|FG000|Overall Study|Need to treat for lung cancer|1|||
161363840|NCT00911157|582720042|FG001|Overall Study|Need to treat for lung cancer|0|||
161887373|NCT01716520|584632354|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887374|NCT01716520|584632349|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887375|NCT01716520|584632350|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887376|NCT01716520|584632351|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887377|NCT01716520|584632352|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887378|NCT01716520|584632353|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887379|NCT01716520|584632354|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
161887380|NCT01716520|584632349|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887381|NCT01716520|584632350|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887382|NCT01716520|584632351|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
161887383|NCT01716520|584632352|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887384|NCT01716520|584632353|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887385|NCT01716520|584632354|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
161887386|NCT01716520|584632349|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887387|NCT01716520|584632350|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887388|NCT01716520|584632351|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887389|NCT01716520|584632352|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887390|NCT01716520|584632353|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
161887391|NCT01716520|584632354|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887392|NCT01716520|584632349|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887393|NCT01716520|584632350|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887394|NCT01716520|584632351|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887395|NCT01716520|584632352|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887396|NCT01716520|584632353|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161887397|NCT01716520|584632354|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887398|NCT01716520|584632349|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887399|NCT01716520|584632350|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887400|NCT01716520|584632351|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887401|NCT01716520|584632352|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887402|NCT01716520|584632353|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887403|NCT01716520|584632354|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887404|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161887405|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161887406|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161887407|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161887408|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161887409|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161887410|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
161887411|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887412|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887413|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887414|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887415|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887416|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887417|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887418|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887419|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887420|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887421|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
161887422|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887423|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
161887424|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887425|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887426|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887427|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887428|NCT01716520|584632349|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887429|NCT01716520|584632350|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887430|NCT01716520|584632351|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887431|NCT01716520|584632352|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887432|NCT01716520|584632353|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887433|NCT01716520|584632354|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
161887434|NCT01716520|584632349|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887435|NCT01716520|584632350|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887436|NCT01716520|584632351|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
161887437|NCT01716520|584632352|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887438|NCT01716520|584632353|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887439|NCT01716520|584632354|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887440|NCT02278367|584632359|FG000|Overall Study|Physician Decision|5|||
161887441|NCT02278367|584632360|FG001|Overall Study|Physician Decision|0|||
161887442|NCT02278367|584632359|FG000|Overall Study|Withdrawal by Subject|5|||
161887443|NCT02278367|584632360|FG001|Overall Study|Withdrawal by Subject|0|||
161887444|NCT04105010|584632361|FG000|Overall Study|Death|3|||
161887445|NCT04105010|584632362|FG001|Overall Study|Death|1|||
161887446|NCT04105010|584632363|FG002|Overall Study|Death|1|||
161887447|NCT04105010|584632364|FG003|Overall Study|Death|54|||
161887448|NCT04105010|584632361|FG000|Overall Study|Lost to Follow-up|0|||
161887449|NCT04105010|584632362|FG001|Overall Study|Lost to Follow-up|0|||
161887450|NCT04105010|584632363|FG002|Overall Study|Lost to Follow-up|0|||
161887451|NCT04105010|584632364|FG003|Overall Study|Lost to Follow-up|4|||
161887452|NCT04105010|584632361|FG000|Overall Study|Withdrawal by Subject|8|||
161887453|NCT04105010|584632362|FG001|Overall Study|Withdrawal by Subject|1|||
161887454|NCT04105010|584632363|FG002|Overall Study|Withdrawal by Subject|1|||
161887455|NCT04105010|584632364|FG003|Overall Study|Withdrawal by Subject|4|||
161887456|NCT04105010|584632361|FG000|Overall Study|Other reason|4|||
161887457|NCT04105010|584632362|FG001|Overall Study|Other reason|7|||
161887458|NCT04105010|584632363|FG002|Overall Study|Other reason|0|||
161887459|NCT04105010|584632364|FG003|Overall Study|Other reason|19|||
161887460|NCT01211483|584632365|FG000|Phase 1b|Death|6|||
161887461|NCT01211483|584632366|FG001|Phase 1b|Death|0|||
161887462|NCT01211483|584632367|FG002|Phase 1b|Death|0|||
161887463|NCT01211483|584632368|FG003|Phase 1b|Death|0|||
161887464|NCT01211483|584632365|FG000|Phase 1b|Withdrawal by Subject|1|||
161887465|NCT01211483|584632366|FG001|Phase 1b|Withdrawal by Subject|0|||
161887466|NCT01211483|584632367|FG002|Phase 1b|Withdrawal by Subject|0|||
161887467|NCT01211483|584632368|FG003|Phase 1b|Withdrawal by Subject|0|||
161887468|NCT01211483|584632365|FG000|Phase 2|Lost to Follow-up|0|||
161887469|NCT01211483|584632366|FG001|Phase 2|Lost to Follow-up|1|||
161887470|NCT01211483|584632367|FG002|Phase 2|Lost to Follow-up|1|||
161887471|NCT01211483|584632368|FG003|Phase 2|Lost to Follow-up|2|||
161887472|NCT01211483|584632365|FG000|Phase 2|Death|0|||
161887473|NCT01211483|584632366|FG001|Phase 2|Death|64|||
161887474|NCT01211483|584632367|FG002|Phase 2|Death|53|||
161887475|NCT01211483|584632368|FG003|Phase 2|Death|53|||
161887476|NCT01211483|584632365|FG000|Phase 2|Withdrawal by Subject|0|||
161887477|NCT01211483|584632366|FG001|Phase 2|Withdrawal by Subject|1|||
161887478|NCT01211483|584632367|FG002|Phase 2|Withdrawal by Subject|10|||
161887479|NCT01211483|584632368|FG003|Phase 2|Withdrawal by Subject|5|||
161887480|NCT01211483|584632365|FG000|Phase 2|Study terminated by Sponsor|0|||
161887481|NCT01211483|584632366|FG001|Phase 2|Study terminated by Sponsor|6|||
161887482|NCT01211483|584632367|FG002|Phase 2|Study terminated by Sponsor|8|||
161887483|NCT01211483|584632368|FG003|Phase 2|Study terminated by Sponsor|11|||
161887484|NCT01675154|584632369|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161887485|NCT01675154|584632370|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
161887486|NCT01675154|584632371|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161887487|NCT01675154|584632372|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161887488|NCT02971800|584632375|FG000|Overall Study|Protocol Violation|1|||
161887489|NCT02971800|584632375|FG000|Overall Study|Withdrawal by Subject|1|||
161887490|NCT02971800|584632375|FG000|Overall Study|Exclusion criteria prior intervention|1|||
161887491|NCT02971800|584632375|FG000|Overall Study|Number evaluable participant already reached|4|||
161887492|NCT01149421|584632377|FG000|Overall Study|Adverse Event|22|||
161887493|NCT01149421|584632378|FG001|Overall Study|Adverse Event|6|||
161887494|NCT01149421|584632379|FG002|Overall Study|Adverse Event|11|||
161887495|NCT01149421|584632377|FG000|Overall Study|Withdrawal by Subject|20|||
161887496|NCT01149421|584632378|FG001|Overall Study|Withdrawal by Subject|12|||
161887497|NCT01149421|584632379|FG002|Overall Study|Withdrawal by Subject|13|||
161887498|NCT01149421|584632377|FG000|Overall Study|Sponsor Decision|0|||
161887499|NCT01149421|584632378|FG001|Overall Study|Sponsor Decision|1|||
161887500|NCT01149421|584632379|FG002|Overall Study|Sponsor Decision|1|||
161887501|NCT01149421|584632377|FG000|Overall Study|Lost to Follow-up|2|||
161887502|NCT01149421|584632378|FG001|Overall Study|Lost to Follow-up|4|||
161887503|NCT01149421|584632379|FG002|Overall Study|Lost to Follow-up|5|||
161887504|NCT01149421|584632377|FG000|Overall Study|Physician Decision|5|||
161887505|NCT01149421|584632378|FG001|Overall Study|Physician Decision|3|||
161887506|NCT01149421|584632379|FG002|Overall Study|Physician Decision|6|||
161887507|NCT01149421|584632377|FG000|Overall Study|Entry Criteria Not Met|1|||
161887508|NCT01149421|584632378|FG001|Overall Study|Entry Criteria Not Met|1|||
161887509|NCT01149421|584632379|FG002|Overall Study|Entry Criteria Not Met|2|||
161887510|NCT01149421|584632377|FG000|Overall Study|Protocol Violation|2|||
161887511|NCT01149421|584632378|FG001|Overall Study|Protocol Violation|2|||
161887512|NCT01149421|584632379|FG002|Overall Study|Protocol Violation|6|||
161887513|NCT03738800|584632382|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
161887514|NCT03738800|584632383|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161887515|NCT03738800|584632384|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161887516|NCT03738800|584632382|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
161887517|NCT03738800|584632383|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
161887518|NCT03738800|584632384|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
161887519|NCT03738800|584632382|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
161887520|NCT03738800|584632383|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161887521|NCT03738800|584632384|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161887522|NCT02223819|584632387|FG000|Overall Study|Lost to Follow-up|2|||
161887523|NCT01917344|584632389|FG000|Overall Study|Withdrawal by Subject|1|||
161887524|NCT03435224|584632390|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
161887525|NCT00367484|584632391|FG000|Overall Study|Adverse Event|7|||
161887526|NCT00367484|584632391|FG000|Overall Study|Withdrew informed consent|5|||
161887527|NCT00367484|584632391|FG000|Overall Study|Travel to USA|1|||
161887528|NCT00367484|584632391|FG000|Overall Study|Lost to Follow-up|1|||
161887529|NCT00367484|584632391|FG000|Overall Study|Protocol Violation|1|||
161887530|NCT00367484|584632391|FG000|Overall Study|The choice of the patient|1|||
161887531|NCT00367484|584632391|FG000|Overall Study|Lack of Efficacy|1|||
161887532|NCT00412217|584632392|FG000|Overall Study|Insufficient Data Available|8|||
161887533|NCT00412217|584632393|FG001|Overall Study|Insufficient Data Available|3|||
161887534|NCT00412217|584632392|FG000|Overall Study|Death|5|||
161887535|NCT00412217|584632393|FG001|Overall Study|Death|4|||
161887536|NCT00412217|584632392|FG000|Overall Study|Disease Progression|2|||
161887537|NCT00412217|584632393|FG001|Overall Study|Disease Progression|3|||
161887538|NCT00412217|584632392|FG000|Overall Study|Investigator Decision|1|||
161887539|NCT00412217|584632393|FG001|Overall Study|Investigator Decision|0|||
161887540|NCT00412217|584632392|FG000|Overall Study|Withdrawal by Subject|2|||
161887541|NCT00412217|584632393|FG001|Overall Study|Withdrawal by Subject|0|||
161887542|NCT00412217|584632392|FG000|Overall Study|Lost to Follow-up|1|||
161887543|NCT00412217|584632393|FG001|Overall Study|Lost to Follow-up|4|||
161887544|NCT00412217|584632392|FG000|Overall Study|Study Terminated by Sponsor|26|||
161887545|NCT00412217|584632393|FG001|Overall Study|Study Terminated by Sponsor|33|||
161887546|NCT00412217|584632392|FG000|Overall Study|Other|1|||
161887547|NCT00412217|584632393|FG001|Overall Study|Other|1|||
161887548|NCT01777295|584632394|FG000|Overall Study|Withdrawal by Subject|2|||
161887549|NCT01777295|584632395|FG001|Overall Study|Withdrawal by Subject|2|||
161887550|NCT01777295|584632394|FG000|Overall Study|Pregnancy|0|||
161887551|NCT01777295|584632395|FG001|Overall Study|Pregnancy|1|||
161887552|NCT01777295|584632394|FG000|Overall Study|Personal problem|1|||
161887553|NCT01777295|584632395|FG001|Overall Study|Personal problem|0|||
161887554|NCT01777295|584632394|FG000|Overall Study|Investigator call for AEs check|1|||
161887555|NCT01777295|584632395|FG001|Overall Study|Investigator call for AEs check|0|||
161887556|NCT02609724|584632396|FG000|Overall Study|Death|2|||
161887557|NCT02609724|584632397|FG001|Overall Study|Death|0|||
161887558|NCT02609724|584632398|FG002|Overall Study|Death|1|||
161887559|NCT02609724|584632396|FG000|Overall Study|Withdrawal by Subject|1|||
161887560|NCT02609724|584632397|FG001|Overall Study|Withdrawal by Subject|2|||
161887561|NCT02609724|584632398|FG002|Overall Study|Withdrawal by Subject|3|||
161887562|NCT02609724|584632396|FG000|Overall Study|Illness|2|||
161887563|NCT02609724|584632397|FG001|Overall Study|Illness|1|||
161887564|NCT02609724|584632398|FG002|Overall Study|Illness|0|||
161887565|NCT04007107|584632403|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161887566|NCT04007107|584632404|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
161887567|NCT04007107|584632405|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161887568|NCT04007107|584632406|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161887569|NCT00426660|584632412|FG000|Overall Study|Death|14|||
161887570|NCT00426660|584632412|FG000|Overall Study|Adverse Event|23|||
161887571|NCT00426660|584632412|FG000|Overall Study|Insufficient Clinical Response|22|||
161887572|NCT00426660|584632412|FG000|Overall Study|Lost to Follow-up|15|||
161887573|NCT00426660|584632412|FG000|Overall Study|Other|23|||
161887574|NCT00426660|584632412|FG000|Overall Study|Withdrawal by Subject|18|||
161887575|NCT00426660|584632412|FG000|Overall Study|Protocol Violation|1|||
161887576|NCT00426660|584632412|FG000|Overall Study|Enrolled Not Treated|15|||
161887577|NCT00006305|584632413|FG000|Overall Study|Withdrawal by Subject|17|||
161887578|NCT00006305|584632414|FG001|Overall Study|Withdrawal by Subject|10|||
161887579|NCT00006305|584632415|FG002|Overall Study|Withdrawal by Subject|15|||
161887580|NCT00006305|584632416|FG003|Overall Study|Withdrawal by Subject|14|||
161887581|NCT00329641|584632417|FG000|Overall Study|Did not start treatment|1|||
161887582|NCT00329641|584632417|FG000|Overall Study|Not eligible|1|||
161887583|NCT00329641|584632417|FG000|Overall Study|Adverse Event|3|||
161887584|NCT00329641|584632417|FG000|Overall Study|Other reason, not protocol specified|1|||
161887585|NCT00115037|584632418|FG000|Phase1|Lost to Follow-up|16|||
161887586|NCT00115037|584632419|FG001|Phase1|Lost to Follow-up|23|||
161887587|NCT00115037|584632420|FG002|Phase1|Lost to Follow-up|0|||
161887588|NCT00115037|584632421|FG003|Phase1|Lost to Follow-up|0|||
161887589|NCT00115037|584632422|FG004|Phase1|Lost to Follow-up|0|||
161887590|NCT00115037|584632423|FG005|Phase1|Lost to Follow-up|0|||
161887591|NCT00115037|584632418|FG000|Phase1|Withdrawal by Subject|9|||
161887592|NCT00115037|584632419|FG001|Phase1|Withdrawal by Subject|4|||
161887593|NCT00115037|584632420|FG002|Phase1|Withdrawal by Subject|0|||
161887594|NCT00115037|584632421|FG003|Phase1|Withdrawal by Subject|0|||
161887595|NCT00115037|584632422|FG004|Phase1|Withdrawal by Subject|0|||
161887596|NCT00115037|584632423|FG005|Phase1|Withdrawal by Subject|0|||
161887597|NCT00115037|584632418|FG000|Phase2|Death|0|||
161887598|NCT00115037|584632419|FG001|Phase2|Death|0|||
161887599|NCT00115037|584632420|FG002|Phase2|Death|1|||
161887600|NCT00115037|584632421|FG003|Phase2|Death|0|||
161887601|NCT00115037|584632422|FG004|Phase2|Death|0|||
161887602|NCT00115037|584632423|FG005|Phase2|Death|1|||
161887603|NCT00115037|584632418|FG000|Phase2|Withdrawal by Subject|0|||
161887604|NCT00115037|584632419|FG001|Phase2|Withdrawal by Subject|0|||
161887605|NCT00115037|584632420|FG002|Phase2|Withdrawal by Subject|2|||
161887606|NCT00115037|584632421|FG003|Phase2|Withdrawal by Subject|1|||
161887607|NCT00115037|584632422|FG004|Phase2|Withdrawal by Subject|2|||
161887608|NCT00115037|584632423|FG005|Phase2|Withdrawal by Subject|1|||
161887609|NCT00115037|584632418|FG000|Phase2|Lost to Follow-up|0|||
161887610|NCT00115037|584632419|FG001|Phase2|Lost to Follow-up|0|||
161887611|NCT00115037|584632420|FG002|Phase2|Lost to Follow-up|12|||
161887612|NCT00115037|584632421|FG003|Phase2|Lost to Follow-up|14|||
161887613|NCT00115037|584632422|FG004|Phase2|Lost to Follow-up|4|||
161887614|NCT00115037|584632423|FG005|Phase2|Lost to Follow-up|10|||
161887615|NCT01398410|584632424|FG000|Overall Study|Adverse Event|12|||
161887616|NCT01398410|584632425|FG001|Overall Study|Adverse Event|16|||
161887617|NCT01398410|584632424|FG000|Overall Study|Participants Choice|8|||
161887618|NCT01398410|584632425|FG001|Overall Study|Participants Choice|11|||
161887619|NCT01398410|584632424|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
161887620|NCT01398410|584632425|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
161887621|NCT01398410|584632424|FG000|Overall Study|Other|36|||
161887622|NCT01398410|584632425|FG001|Overall Study|Other|29|||
161887623|NCT02470403|584632426|FG000|Overall Study|Adverse Event|1|||
161887624|NCT02470403|584632427|FG001|Overall Study|Adverse Event|0|||
161887625|NCT02470403|584632428|FG002|Overall Study|Adverse Event|0|||
161887626|NCT02470403|584632429|FG003|Overall Study|Adverse Event|0|||
161887627|NCT02470403|584632430|FG004|Overall Study|Adverse Event|0|||
161887628|NCT02470403|584632426|FG000|Overall Study|Lost to Follow-up|0|||
161887629|NCT02470403|584632427|FG001|Overall Study|Lost to Follow-up|1|||
161887630|NCT02470403|584632428|FG002|Overall Study|Lost to Follow-up|0|||
161887631|NCT02470403|584632429|FG003|Overall Study|Lost to Follow-up|0|||
161887632|NCT02470403|584632430|FG004|Overall Study|Lost to Follow-up|0|||
161887633|NCT02470403|584632426|FG000|Overall Study|Subject/guardian decision|1|||
161887634|NCT02470403|584632427|FG001|Overall Study|Subject/guardian decision|0|||
161887635|NCT02470403|584632428|FG002|Overall Study|Subject/guardian decision|0|||
161887636|NCT02470403|584632429|FG003|Overall Study|Subject/guardian decision|4|||
161887637|NCT02470403|584632430|FG004|Overall Study|Subject/guardian decision|0|||
161887638|NCT02631070|584632431|FG000|Overall Study|Withdrawal by Subject|35|||
161887639|NCT02631070|584632432|FG001|Overall Study|Withdrawal by Subject|13|||
161887640|NCT02631070|584632431|FG000|Overall Study|Death|45|||
161887641|NCT02631070|584632432|FG001|Overall Study|Death|24|||
161887642|NCT02631070|584632431|FG000|Overall Study|Lost to Follow-up|5|||
161887643|NCT02631070|584632432|FG001|Overall Study|Lost to Follow-up|1|||
161887644|NCT02631070|584632431|FG000|Overall Study|Transition to rollover protocol|52|||
161887645|NCT02631070|584632432|FG001|Overall Study|Transition to rollover protocol|21|||
161887646|NCT02631070|584632431|FG000|Overall Study|Other reasons|12|||
161887647|NCT02631070|584632432|FG001|Overall Study|Other reasons|5|||
161887648|NCT03515629|584632433|FG000|Overall Study|Death|0|||
161887649|NCT03515629|584632434|FG001|Overall Study|Death|1|||
161887650|NCT03515629|584632435|FG002|Overall Study|Death|1|||
161887651|NCT03515629|584632433|FG000|Overall Study|Progressive disease|0|||
161887652|NCT03515629|584632434|FG001|Overall Study|Progressive disease|1|||
161887653|NCT03515629|584632435|FG002|Overall Study|Progressive disease|0|||
161887654|NCT01522235|584632436|FG000|Overall Study|Physician Decision|1|||
161887655|NCT01522235|584632437|FG001|Overall Study|Physician Decision|1|||
161887656|NCT03597022|584632440|FG000|Overall Study|Premature termination of the study|7|||
161887657|NCT03597022|584632441|FG001|Overall Study|Premature termination of the study|7|||
161887658|NCT03597022|584632442|FG002|Overall Study|Premature termination of the study|8|||
161887659|NCT03597022|584632440|FG000|Overall Study|Serious adverse event|1|||
161887660|NCT03597022|584632441|FG001|Overall Study|Serious adverse event|1|||
161887661|NCT03597022|584632442|FG002|Overall Study|Serious adverse event|0|||
161887662|NCT05385224|584632443|FG000|Overall Study|Unable to swallow capsule|2|||
161887663|NCT05385224|584632443|FG000|Overall Study|Withdrawal by Subject|2|||
161887664|NCT05385224|584632443|FG000|Overall Study|Did not meet study criteria|1|||
161887665|NCT01430624|584632444|FG000|Overall Study|Lost to Follow-up|23|||
161887666|NCT01430624|584632445|FG001|Overall Study|Lost to Follow-up|29|||
161887667|NCT01430624|584632446|FG002|Overall Study|Lost to Follow-up|27|||
161887668|NCT01430624|584632444|FG000|Overall Study|technical or eligibility|5|||
161887669|NCT01430624|584632445|FG001|Overall Study|technical or eligibility|5|||
161887670|NCT01430624|584632446|FG002|Overall Study|technical or eligibility|2|||
161887671|NCT00401960|584632451|FG000|Overall Study|Lost to Follow-up|3|||
161887672|NCT00401960|584632452|FG001|Overall Study|Lost to Follow-up|0|||
161887673|NCT00401960|584632451|FG000|Overall Study|Death|2|||
161887674|NCT00401960|584632452|FG001|Overall Study|Death|0|||
161887675|NCT03627416|584632456|FG000|Overall Study|Adverse Event|0|||
161887676|NCT03627416|584632457|FG001|Overall Study|Adverse Event|1|||
161887677|NCT02079636|584632458|FG000|Overall Study|Death|2|||
161887678|NCT02079636|584632459|FG001|Overall Study|Death|1|||
161887679|NCT02079636|584632460|FG002|Overall Study|Death|0|||
161887680|NCT02079636|584632461|FG003|Overall Study|Death|5|||
161887681|NCT02079636|584632462|FG004|Overall Study|Death|1|||
161887682|NCT02079636|584632463|FG005|Overall Study|Death|2|||
161887683|NCT02079636|584632464|FG006|Overall Study|Death|1|||
161887684|NCT02079636|584632465|FG007|Overall Study|Death|0|||
161887685|NCT02079636|584632466|FG008|Overall Study|Death|0|||
161887686|NCT02079636|584632467|FG009|Overall Study|Death|0|||
161887687|NCT02079636|584632468|FG010|Overall Study|Death|0|||
161887688|NCT02079636|584632469|FG011|Overall Study|Death|1|||
161887689|NCT02079636|584632470|FG012|Overall Study|Death|1|||
161887690|NCT02079636|584632471|FG013|Overall Study|Death|0|||
161887691|NCT02079636|584632472|FG014|Overall Study|Death|2|||
161887692|NCT02079636|584632458|FG000|Overall Study|Adverse Event|1|||
161887693|NCT02079636|584632459|FG001|Overall Study|Adverse Event|1|||
161887694|NCT02079636|584632460|FG002|Overall Study|Adverse Event|0|||
161887695|NCT02079636|584632461|FG003|Overall Study|Adverse Event|1|||
161887696|NCT02079636|584632462|FG004|Overall Study|Adverse Event|1|||
161887697|NCT02079636|584632463|FG005|Overall Study|Adverse Event|2|||
161887698|NCT02079636|584632464|FG006|Overall Study|Adverse Event|0|||
161887699|NCT02079636|584632465|FG007|Overall Study|Adverse Event|0|||
161887700|NCT02079636|584632466|FG008|Overall Study|Adverse Event|0|||
161887701|NCT02079636|584632467|FG009|Overall Study|Adverse Event|0|||
161887702|NCT02079636|584632468|FG010|Overall Study|Adverse Event|0|||
161887703|NCT02079636|584632469|FG011|Overall Study|Adverse Event|0|||
161887704|NCT02079636|584632470|FG012|Overall Study|Adverse Event|0|||
161887705|NCT02079636|584632471|FG013|Overall Study|Adverse Event|0|||
161887706|NCT02079636|584632472|FG014|Overall Study|Adverse Event|0|||
161887707|NCT02079636|584632458|FG000|Overall Study|Progressive disease|0|||
161887708|NCT02079636|584632459|FG001|Overall Study|Progressive disease|0|||
161887709|NCT02079636|584632460|FG002|Overall Study|Progressive disease|0|||
161887710|NCT02079636|584632461|FG003|Overall Study|Progressive disease|2|||
161887711|NCT02079636|584632462|FG004|Overall Study|Progressive disease|0|||
161887712|NCT02079636|584632463|FG005|Overall Study|Progressive disease|0|||
161887713|NCT02079636|584632464|FG006|Overall Study|Progressive disease|0|||
161887714|NCT02079636|584632465|FG007|Overall Study|Progressive disease|0|||
161887715|NCT02079636|584632466|FG008|Overall Study|Progressive disease|0|||
161887716|NCT02079636|584632467|FG009|Overall Study|Progressive disease|0|||
161887717|NCT02079636|584632468|FG010|Overall Study|Progressive disease|0|||
161887718|NCT02079636|584632469|FG011|Overall Study|Progressive disease|0|||
161887719|NCT02079636|584632470|FG012|Overall Study|Progressive disease|1|||
161887720|NCT02079636|584632471|FG013|Overall Study|Progressive disease|0|||
161887721|NCT02079636|584632472|FG014|Overall Study|Progressive disease|0|||
161887722|NCT02079636|584632458|FG000|Overall Study|Withdrawal by Subject|0|||
161887723|NCT02079636|584632459|FG001|Overall Study|Withdrawal by Subject|0|||
161887724|NCT02079636|584632460|FG002|Overall Study|Withdrawal by Subject|0|||
161887725|NCT02079636|584632461|FG003|Overall Study|Withdrawal by Subject|4|||
161887726|NCT02079636|584632462|FG004|Overall Study|Withdrawal by Subject|0|||
161887727|NCT02079636|584632463|FG005|Overall Study|Withdrawal by Subject|1|||
161887728|NCT02079636|584632464|FG006|Overall Study|Withdrawal by Subject|0|||
161887729|NCT02079636|584632465|FG007|Overall Study|Withdrawal by Subject|0|||
161887730|NCT02079636|584632466|FG008|Overall Study|Withdrawal by Subject|0|||
161887731|NCT02079636|584632467|FG009|Overall Study|Withdrawal by Subject|2|||
161887732|NCT02079636|584632468|FG010|Overall Study|Withdrawal by Subject|1|||
161887733|NCT02079636|584632469|FG011|Overall Study|Withdrawal by Subject|1|||
161887734|NCT02079636|584632470|FG012|Overall Study|Withdrawal by Subject|1|||
161887735|NCT02079636|584632471|FG013|Overall Study|Withdrawal by Subject|0|||
161887736|NCT02079636|584632472|FG014|Overall Study|Withdrawal by Subject|2|||
161887737|NCT02079636|584632458|FG000|Overall Study|Physician Decision|0|||
161887738|NCT02079636|584632459|FG001|Overall Study|Physician Decision|0|||
161887739|NCT02079636|584632460|FG002|Overall Study|Physician Decision|0|||
161887740|NCT02079636|584632461|FG003|Overall Study|Physician Decision|0|||
161887741|NCT02079636|584632462|FG004|Overall Study|Physician Decision|0|||
161887742|NCT02079636|584632463|FG005|Overall Study|Physician Decision|1|||
161887743|NCT02079636|584632464|FG006|Overall Study|Physician Decision|0|||
161887744|NCT02079636|584632465|FG007|Overall Study|Physician Decision|0|||
161887745|NCT02079636|584632466|FG008|Overall Study|Physician Decision|0|||
161887746|NCT02079636|584632467|FG009|Overall Study|Physician Decision|1|||
161887747|NCT02079636|584632468|FG010|Overall Study|Physician Decision|1|||
161887748|NCT02079636|584632469|FG011|Overall Study|Physician Decision|0|||
161887749|NCT02079636|584632470|FG012|Overall Study|Physician Decision|0|||
161887750|NCT02079636|584632471|FG013|Overall Study|Physician Decision|0|||
161887751|NCT02079636|584632472|FG014|Overall Study|Physician Decision|1|||
161887752|NCT02079636|584632458|FG000|Overall Study|Lost to Follow-up|0|||
161887753|NCT02079636|584632459|FG001|Overall Study|Lost to Follow-up|0|||
161887754|NCT02079636|584632460|FG002|Overall Study|Lost to Follow-up|0|||
161887755|NCT02079636|584632461|FG003|Overall Study|Lost to Follow-up|0|||
161887756|NCT02079636|584632462|FG004|Overall Study|Lost to Follow-up|0|||
161887757|NCT02079636|584632463|FG005|Overall Study|Lost to Follow-up|0|||
161887758|NCT02079636|584632464|FG006|Overall Study|Lost to Follow-up|0|||
161887759|NCT02079636|584632465|FG007|Overall Study|Lost to Follow-up|1|||
161887760|NCT02079636|584632466|FG008|Overall Study|Lost to Follow-up|0|||
161887761|NCT02079636|584632467|FG009|Overall Study|Lost to Follow-up|0|||
161887762|NCT02079636|584632468|FG010|Overall Study|Lost to Follow-up|0|||
161887763|NCT02079636|584632469|FG011|Overall Study|Lost to Follow-up|0|||
161887764|NCT02079636|584632470|FG012|Overall Study|Lost to Follow-up|0|||
161887765|NCT02079636|584632471|FG013|Overall Study|Lost to Follow-up|0|||
161887766|NCT02079636|584632472|FG014|Overall Study|Lost to Follow-up|0|||
161887767|NCT00561470|584632473|FG000|Overall Study|Adverse Event|74|||
161887768|NCT00561470|584632474|FG001|Overall Study|Adverse Event|163|||
161887769|NCT00561470|584632473|FG000|Overall Study|Disease progression|437|||
161887770|NCT00561470|584632474|FG001|Overall Study|Disease progression|305|||
161887771|NCT00561470|584632473|FG000|Overall Study|poor compliance to protocol|4|||
161887772|NCT00561470|584632474|FG001|Overall Study|poor compliance to protocol|4|||
161887773|NCT00561470|584632473|FG000|Overall Study|Lost to Follow-up|2|||
161887774|NCT00561470|584632474|FG001|Overall Study|Lost to Follow-up|0|||
161887775|NCT00561470|584632473|FG000|Overall Study|Physician Decision|21|||
161887776|NCT00561470|584632474|FG001|Overall Study|Physician Decision|20|||
161887777|NCT00561470|584632473|FG000|Overall Study|Consent Withdrawn|2|||
161887778|NCT00561470|584632474|FG001|Overall Study|Consent Withdrawn|6|||
161887779|NCT00561470|584632473|FG000|Overall Study|Subject request|43|||
161887780|NCT00561470|584632474|FG001|Overall Study|Subject request|77|||
161887781|NCT00561470|584632473|FG000|Overall Study|Metastatic surgery|10|||
161887782|NCT00561470|584632474|FG001|Overall Study|Metastatic surgery|12|||
161887783|NCT00561470|584632473|FG000|Overall Study|Unauthorized procedure|3|||
161887784|NCT00561470|584632474|FG001|Overall Study|Unauthorized procedure|1|||
161887785|NCT00561470|584632473|FG000|Overall Study|Randomized but not treated|5|||
161887786|NCT00561470|584632474|FG001|Overall Study|Randomized but not treated|5|||
161887787|NCT00561470|584632473|FG000|Overall Study|Missed visit window|1|||
161887788|NCT00561470|584632474|FG001|Overall Study|Missed visit window|4|||
161887789|NCT00561470|584632473|FG000|Overall Study|Planning surgery|1|||
161887790|NCT00561470|584632474|FG001|Overall Study|Planning surgery|1|||
161887791|NCT00561470|584632473|FG000|Overall Study|Ongoing Treatment|11|||
161887792|NCT00561470|584632474|FG001|Overall Study|Ongoing Treatment|14|||
161887793|NCT00637806|584632475|FG000|Double-blind Phase|Study Discontinued|2|||
161887794|NCT00637806|584632476|FG001|Double-blind Phase|Study Discontinued|0|||
161887795|NCT00637806|584632477|FG002|Double-blind Phase|Study Discontinued|1|||
161887796|NCT00637806|584632478|FG003|Double-blind Phase|Study Discontinued|0|||
161887797|NCT00637806|584632475|FG000|Extension Phase|Study Discontinued|0|||
161887798|NCT00637806|584632476|FG001|Extension Phase|Study Discontinued|0|||
161887799|NCT00637806|584632477|FG002|Extension Phase|Study Discontinued|0|||
161887800|NCT00637806|584632478|FG003|Extension Phase|Study Discontinued|1|||
161887801|NCT02028169|584632479|FG000|Overall Study|Lost to Follow-up|21|||
161887802|NCT02028169|584632479|FG000|Overall Study|Lack of Efficacy|2|||
161887803|NCT02028169|584632479|FG000|Overall Study|Withdrawal by Subject|2|||
161887804|NCT02028169|584632479|FG000|Overall Study|Adverse Event|1|||
161887805|NCT02028169|584632479|FG000|Overall Study|Cessation of Drug|1|||
161887806|NCT02028169|584632479|FG000|Overall Study|Concomitant Medication Usage|1|||
161887807|NCT01876979|584632484|FG000|Overall Study|Physician Decision|2|||
161887808|NCT01876979|584632485|FG001|Overall Study|Physician Decision|3|||
161887809|NCT02240069|584632486|FG000|Overall Study|Withdrawal by Subject|5|||
161887810|NCT02240069|584632487|FG001|Overall Study|Withdrawal by Subject|5|||
161887811|NCT02240069|584632488|FG002|Overall Study|Withdrawal by Subject|2|||
161887812|NCT01096589|584632489|FG000|Overall Study|Adverse Event|2|||
161887813|NCT01096589|584632490|FG001|Overall Study|Adverse Event|1|||
161887814|NCT01096589|584632491|FG002|Overall Study|Adverse Event|2|||
161887815|NCT01096589|584632492|FG003|Overall Study|Adverse Event|1|||
161887816|NCT01096589|584632489|FG000|Overall Study|Withdrawal by Subject|2|||
161887817|NCT01096589|584632490|FG001|Overall Study|Withdrawal by Subject|1|||
161887818|NCT01096589|584632491|FG002|Overall Study|Withdrawal by Subject|1|||
161887819|NCT01096589|584632492|FG003|Overall Study|Withdrawal by Subject|1|||
161887820|NCT01096589|584632489|FG000|Overall Study|Compliance with protocol|0|||
161887821|NCT01096589|584632490|FG001|Overall Study|Compliance with protocol|0|||
161887822|NCT01096589|584632491|FG002|Overall Study|Compliance with protocol|1|||
161887823|NCT01096589|584632492|FG003|Overall Study|Compliance with protocol|0|||
161887824|NCT01096589|584632489|FG000|Overall Study|found treatment exhausting|0|||
161887825|NCT01096589|584632490|FG001|Overall Study|found treatment exhausting|0|||
161887826|NCT01096589|584632491|FG002|Overall Study|found treatment exhausting|0|||
161887827|NCT01096589|584632492|FG003|Overall Study|found treatment exhausting|1|||
161887828|NCT00948506|584632493|FG000|Overall Study|Withdrawal by Subject|3|||
161887829|NCT00948506|584632494|FG001|Overall Study|Withdrawal by Subject|1|||
161887830|NCT03233204|584632496|FG000|Overall Study|Adverse Event|1|||
161887831|NCT03233204|584632496|FG000|Overall Study|Death|1|||
161887832|NCT03233204|584632496|FG000|Overall Study|Withdrawal by Subject|1|||
161887833|NCT03233204|584632496|FG000|Overall Study|Progressive Disease|3|||
161887834|NCT01712334|584632499|FG000|Treatment Period 1|Randomized in Error|0|||
161887835|NCT01712334|584632500|FG001|Treatment Period 1|Randomized in Error|2|||
161887836|NCT00232596|584632501|FG000|6-Week Titration Phase|Adverse Event|6|||
161887837|NCT00232596|584632502|FG001|6-Week Titration Phase|Adverse Event|19|||
161887838|NCT00232596|584632501|FG000|6-Week Titration Phase|Failed to Return|2|||
161887839|NCT00232596|584632502|FG001|6-Week Titration Phase|Failed to Return|1|||
161887840|NCT00232596|584632501|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
161887841|NCT00232596|584632502|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
161887842|NCT00232596|584632501|FG000|6-Week Titration Phase|Protocol Violation|1|||
161887843|NCT00232596|584632502|FG001|6-Week Titration Phase|Protocol Violation|3|||
161887844|NCT00232596|584632501|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
161887845|NCT00232596|584632502|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
161887846|NCT00232596|584632501|FG000|6-Week Titration Phase|Other|3|||
161887847|NCT00232596|584632502|FG001|6-Week Titration Phase|Other|3|||
161887848|NCT00232596|584632501|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161887849|NCT00232596|584632502|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
161887850|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Adverse Event|7|||
161887851|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Adverse Event|22|||
161887852|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
161887853|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
161887854|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
161887855|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
161887856|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Other|1|||
161887857|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Other|3|||
161887858|NCT03467763|584632505|FG000|Overall Study|Lost to Follow-up|1|||
161887859|NCT03467763|584632505|FG000|Overall Study|Protocol Violation|2|||
161887860|NCT02407054|584632506|FG000|Overall Study|Adverse Event|1|||
161887861|NCT02407054|584632507|FG001|Overall Study|Adverse Event|4|||
161887862|NCT02407054|584632508|FG002|Overall Study|Adverse Event|1|||
161887863|NCT02407054|584632506|FG000|Overall Study|Non-compliance with Study|0|||
161887864|NCT02407054|584632507|FG001|Overall Study|Non-compliance with Study|2|||
161887865|NCT02407054|584632508|FG002|Overall Study|Non-compliance with Study|1|||
161887866|NCT02407054|584632506|FG000|Overall Study|Physician Decision|1|||
161887867|NCT02407054|584632507|FG001|Overall Study|Physician Decision|3|||
161887868|NCT02407054|584632508|FG002|Overall Study|Physician Decision|3|||
161887869|NCT02407054|584632506|FG000|Overall Study|Withdrawal by Subject|5|||
161887870|NCT02407054|584632507|FG001|Overall Study|Withdrawal by Subject|9|||
161887871|NCT02407054|584632508|FG002|Overall Study|Withdrawal by Subject|2|||
161887872|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
161887873|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887874|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887875|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887876|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
161887877|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
161887878|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887879|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887880|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887881|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887882|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887883|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887884|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887885|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887886|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887887|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887888|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887889|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887890|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887891|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887892|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887893|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887894|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
161887895|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
161887896|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
161887897|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
161887898|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
161887899|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
161887900|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
161887901|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
161887902|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
161887903|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
161887904|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
161887905|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Other|0|||
161887906|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Other|0|||
161887907|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Other|1|||
161887908|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Other|0|||
161887909|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Other|0|||
161887910|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Other|0|||
161887911|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Other|1|||
161887912|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Other|0|||
161887913|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Other|0|||
161887914|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Other|0|||
161887915|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Other|0|||
161887916|NCT00932698|584632509|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887917|NCT00932698|584632510|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887918|NCT00932698|584632511|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887919|NCT00932698|584632512|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887920|NCT00932698|584632513|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887921|NCT00932698|584632514|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887922|NCT00932698|584632515|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887923|NCT00932698|584632516|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
161887924|NCT00932698|584632517|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
161887925|NCT00932698|584632518|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
161887926|NCT00932698|584632519|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
161887927|NCT00932698|584632509|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887928|NCT00932698|584632510|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887929|NCT00932698|584632511|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887930|NCT00932698|584632512|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887931|NCT00932698|584632513|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887932|NCT00932698|584632514|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887933|NCT00932698|584632515|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887934|NCT00932698|584632516|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
161887935|NCT00932698|584632517|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
161887936|NCT00932698|584632518|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
161887937|NCT00932698|584632519|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887938|NCT00932698|584632509|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
161887939|NCT00932698|584632510|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
161887940|NCT00932698|584632511|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
161887941|NCT00932698|584632512|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
161887942|NCT00932698|584632513|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
161887943|NCT00932698|584632514|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
161887944|NCT00932698|584632515|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
161887945|NCT00932698|584632516|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
161887946|NCT00932698|584632517|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
161887947|NCT00932698|584632518|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
161887948|NCT00932698|584632519|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
161887949|NCT01447927|584632522|FG000|Overall Study|Adverse Event|4|||
161887950|NCT01447927|584632523|FG001|Overall Study|Adverse Event|3|||
161887951|NCT01447927|584632522|FG000|Overall Study|Withdrawal by Subject|1|||
161887952|NCT01447927|584632523|FG001|Overall Study|Withdrawal by Subject|0|||
161887953|NCT02913105|584634456|FG000|Overall Study|Adverse Event|11|||
161887954|NCT02913105|584634457|FG001|Overall Study|Adverse Event|0|||
161887955|NCT02913105|584634458|FG002|Overall Study|Adverse Event|4|||
161887956|NCT02913105|584634456|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161887957|NCT02913105|584634457|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161887958|NCT02913105|584634458|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161887959|NCT02913105|584634456|FG000|Overall Study|Reason Not Specified|3|||
161887960|NCT02913105|584634457|FG001|Overall Study|Reason Not Specified|1|||
161887961|NCT02913105|584634458|FG002|Overall Study|Reason Not Specified|1|||
161887962|NCT02913105|584634456|FG000|Overall Study|Physician Decision|1|||
161887963|NCT02913105|584634457|FG001|Overall Study|Physician Decision|1|||
161887964|NCT02913105|584634458|FG002|Overall Study|Physician Decision|0|||
161887965|NCT02913105|584634456|FG000|Overall Study|Withdrawal by Subject|0|||
161887966|NCT02913105|584634457|FG001|Overall Study|Withdrawal by Subject|3|||
161887967|NCT02913105|584634458|FG002|Overall Study|Withdrawal by Subject|1|||
161887968|NCT02168777|584634459|FG000|Overall Study|Withdrawal by Subject|1|||
161887969|NCT02168777|584634460|FG001|Overall Study|Withdrawal by Subject|0|||
161887970|NCT02168777|584634461|FG002|Overall Study|Withdrawal by Subject|2|||
161887971|NCT02168777|584634459|FG000|Overall Study|Adverse Event|1|||
161887972|NCT02168777|584634460|FG001|Overall Study|Adverse Event|0|||
161887973|NCT02168777|584634461|FG002|Overall Study|Adverse Event|1|||
161887974|NCT02168777|584634459|FG000|Overall Study|Disease recurrence|0|||
161887975|NCT02168777|584634460|FG001|Overall Study|Disease recurrence|0|||
161887976|NCT02168777|584634461|FG002|Overall Study|Disease recurrence|1|||
161887977|NCT02168777|584634459|FG000|Overall Study|Radiological disease progression|0|||
161887978|NCT02168777|584634460|FG001|Overall Study|Radiological disease progression|5|||
161887979|NCT02168777|584634461|FG002|Overall Study|Radiological disease progression|5|||
161887980|NCT02168777|584634459|FG000|Overall Study|Clinical disease progression|0|||
161887981|NCT02168777|584634460|FG001|Overall Study|Clinical disease progression|1|||
161887982|NCT02168777|584634461|FG002|Overall Study|Clinical disease progression|2|||
161887983|NCT02168777|584634459|FG000|Overall Study|Other reason|0|||
161887984|NCT02168777|584634460|FG001|Overall Study|Other reason|1|||
161887985|NCT02168777|584634461|FG002|Overall Study|Other reason|0|||
161887986|NCT05243563|584634462|FG000|Overall Study|Withdrawal by Subject|1|||
161887987|NCT05243563|584634463|FG001|Overall Study|Withdrawal by Subject|0|||
161887988|NCT05243563|584634462|FG000|Overall Study|Physician Decision|1|||
161887989|NCT05243563|584634463|FG001|Overall Study|Physician Decision|0|||
161887990|NCT02437188|584634466|FG000|Overall Study|Randomized but did not receive surgery|4|||
161887991|NCT02437188|584634467|FG001|Overall Study|Randomized but did not receive surgery|8|||
161887992|NCT02437188|584634466|FG000|Overall Study|Adverse Event|0|||
161887993|NCT02437188|584634467|FG001|Overall Study|Adverse Event|1|||
161887994|NCT01663857|584634468|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
161887995|NCT01663857|584634469|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
161887996|NCT01663857|584634470|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
161887997|NCT01663857|584634471|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
161887998|NCT01663857|584634468|FG000|Overall Study|Lost to Follow-up|0|||
161887999|NCT01663857|584634469|FG001|Overall Study|Lost to Follow-up|0|||
161888000|NCT01663857|584634470|FG002|Overall Study|Lost to Follow-up|3|||
161888001|NCT01663857|584634471|FG003|Overall Study|Lost to Follow-up|1|||
161888002|NCT01172808|584634474|FG000|Overall Study|Adverse Event|8|||
161888003|NCT01172808|584634475|FG001|Overall Study|Adverse Event|4|||
161888004|NCT01172808|584634476|FG002|Overall Study|Adverse Event|8|||
161888005|NCT01172808|584634477|FG003|Overall Study|Adverse Event|3|||
161888006|NCT01172808|584634474|FG000|Overall Study|Lack of Efficacy|1|||
161888007|NCT01172808|584634475|FG001|Overall Study|Lack of Efficacy|0|||
161888008|NCT01172808|584634476|FG002|Overall Study|Lack of Efficacy|0|||
161888009|NCT01172808|584634477|FG003|Overall Study|Lack of Efficacy|0|||
161888010|NCT01172808|584634474|FG000|Overall Study|Protocol Violation|2|||
161888011|NCT01172808|584634475|FG001|Overall Study|Protocol Violation|2|||
161888012|NCT01172808|584634476|FG002|Overall Study|Protocol Violation|2|||
161888013|NCT01172808|584634477|FG003|Overall Study|Protocol Violation|0|||
161888014|NCT01172808|584634474|FG000|Overall Study|Lost to Follow-up|0|||
161888015|NCT01172808|584634475|FG001|Overall Study|Lost to Follow-up|1|||
161888016|NCT01172808|584634476|FG002|Overall Study|Lost to Follow-up|1|||
161888017|NCT01172808|584634477|FG003|Overall Study|Lost to Follow-up|3|||
161888018|NCT01172808|584634474|FG000|Overall Study|Withdrawal by Subject|4|||
161888019|NCT01172808|584634475|FG001|Overall Study|Withdrawal by Subject|1|||
161888020|NCT01172808|584634476|FG002|Overall Study|Withdrawal by Subject|3|||
161888021|NCT01172808|584634477|FG003|Overall Study|Withdrawal by Subject|2|||
161888022|NCT01172808|584634474|FG000|Overall Study|Other|6|||
161888023|NCT01172808|584634475|FG001|Overall Study|Other|5|||
161888024|NCT01172808|584634476|FG002|Overall Study|Other|9|||
161888025|NCT01172808|584634477|FG003|Overall Study|Other|7|||
161888026|NCT02578940|584634482|FG000|Overall Study|Screening failure|5|||
161888027|NCT02578940|584634482|FG000|Overall Study|Lost to Follow-up|1|||
161888028|NCT01911793|584634483|FG000|Overall Study|Physician Decision|1|||
161888029|NCT01911793|584634484|FG001|Overall Study|Physician Decision|5|||
161888030|NCT03959488|584634491|FG000|Season 1|Other|6|||
161888031|NCT03959488|584634492|FG001|Season 1|Other|7|||
161888032|NCT03959488|584634493|FG002|Season 1|Other|0|||
161888033|NCT03959488|584634494|FG003|Season 1|Other|0|||
161888034|NCT03959488|584634495|FG004|Season 1|Other|0|||
161888035|NCT03959488|584634491|FG000|Season 1|Withdrawal by parent/guardian|43|||
161888036|NCT03959488|584634492|FG001|Season 1|Withdrawal by parent/guardian|28|||
161888037|NCT03959488|584634493|FG002|Season 1|Withdrawal by parent/guardian|0|||
161888038|NCT03959488|584634494|FG003|Season 1|Withdrawal by parent/guardian|0|||
161888039|NCT03959488|584634495|FG004|Season 1|Withdrawal by parent/guardian|0|||
161888040|NCT03959488|584634491|FG000|Season 1|Due to COVID-19 pandemic|2|||
161888041|NCT03959488|584634492|FG001|Season 1|Due to COVID-19 pandemic|3|||
161888042|NCT03959488|584634493|FG002|Season 1|Due to COVID-19 pandemic|0|||
161888043|NCT03959488|584634494|FG003|Season 1|Due to COVID-19 pandemic|0|||
161888044|NCT03959488|584634495|FG004|Season 1|Due to COVID-19 pandemic|0|||
161888045|NCT03959488|584634491|FG000|Season 1|Lost to Follow-up|17|||
161888046|NCT03959488|584634492|FG001|Season 1|Lost to Follow-up|7|||
161888047|NCT03959488|584634493|FG002|Season 1|Lost to Follow-up|0|||
161888048|NCT03959488|584634494|FG003|Season 1|Lost to Follow-up|0|||
161888049|NCT03959488|584634495|FG004|Season 1|Lost to Follow-up|0|||
161888050|NCT03959488|584634491|FG000|Season 1|Death|5|||
161888051|NCT03959488|584634492|FG001|Season 1|Death|1|||
161888052|NCT03959488|584634493|FG002|Season 1|Death|0|||
161888053|NCT03959488|584634494|FG003|Season 1|Death|0|||
161888054|NCT03959488|584634495|FG004|Season 1|Death|0|||
161888055|NCT03959488|584634491|FG000|Season 2|Other|0|||
161888056|NCT03959488|584634492|FG001|Season 2|Other|0|||
161888057|NCT03959488|584634493|FG002|Season 2|Other|2|||
161888058|NCT03959488|584634494|FG003|Season 2|Other|0|||
161888059|NCT03959488|584634495|FG004|Season 2|Other|0|||
161888060|NCT03959488|584634491|FG000|Season 2|Withdrawal by parent/guardian|0|||
161888061|NCT03959488|584634492|FG001|Season 2|Withdrawal by parent/guardian|0|||
161888062|NCT03959488|584634493|FG002|Season 2|Withdrawal by parent/guardian|3|||
161888063|NCT03959488|584634494|FG003|Season 2|Withdrawal by parent/guardian|1|||
161888064|NCT03959488|584634495|FG004|Season 2|Withdrawal by parent/guardian|1|||
161888065|NCT03959488|584634491|FG000|Season 2|Lost to Follow-up|0|||
161888066|NCT03959488|584634492|FG001|Season 2|Lost to Follow-up|0|||
161888067|NCT03959488|584634493|FG002|Season 2|Lost to Follow-up|1|||
161888068|NCT03959488|584634494|FG003|Season 2|Lost to Follow-up|0|||
161888069|NCT03959488|584634495|FG004|Season 2|Lost to Follow-up|1|||
161888070|NCT03341936|584634496|FG000|Overall Study|Ineligible|1|||
161888071|NCT03341936|584634496|FG000|Overall Study|Disease Progression|2|||
161888072|NCT03341936|584634496|FG000|Overall Study|Withdrew Consent|4|||
161888073|NCT03341936|584634496|FG000|Overall Study|Non-Compliance|1|||
161888074|NCT03341936|584634496|FG000|Overall Study|Physician Decision|1|||
161888075|NCT03341936|584634496|FG000|Overall Study|Withdrawal by Subject|1|||
161888076|NCT03341936|584634496|FG000|Overall Study|Other|1|||
161888077|NCT00981058|584634505|FG000|Overall Study|Progressive Disease|38|||
161888078|NCT00981058|584634506|FG001|Overall Study|Progressive Disease|31|||
161888079|NCT00981058|584634505|FG000|Overall Study|Lost to Follow-up|3|||
161888080|NCT00981058|584634506|FG001|Overall Study|Lost to Follow-up|2|||
161888081|NCT00981058|584634505|FG000|Overall Study|Physician Decision|4|||
161888082|NCT00981058|584634506|FG001|Overall Study|Physician Decision|5|||
161888083|NCT00981058|584634505|FG000|Overall Study|Randomization Error|0|||
161888084|NCT00981058|584634506|FG001|Overall Study|Randomization Error|1|||
161888085|NCT00981058|584634505|FG000|Overall Study|Withdrawal by Subject|24|||
161888086|NCT00981058|584634506|FG001|Overall Study|Withdrawal by Subject|22|||
161888087|NCT02667587|584634507|FG000|Pre-Treatment|Not reported|1|||
161888088|NCT02667587|584634508|FG001|Pre-Treatment|Not reported|0|||
161888089|NCT02667587|584634507|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
161888090|NCT02667587|584634508|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
161888091|NCT02667587|584634507|FG000|Pre-Treatment|Participant withdrew consent|0|||
161888092|NCT02667587|584634508|FG001|Pre-Treatment|Participant withdrew consent|1|||
161888093|NCT02667587|584634507|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161888094|NCT02667587|584634508|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
161888095|NCT02667587|584634507|FG000|End of Treatment|Disease Progression|193|||
161888096|NCT02667587|584634508|FG001|End of Treatment|Disease Progression|226|||
161888097|NCT02667587|584634507|FG000|End of Treatment|Study Drug Toxicity|75|||
161888098|NCT02667587|584634508|FG001|End of Treatment|Study Drug Toxicity|19|||
161888099|NCT02667587|584634507|FG000|End of Treatment|Death|2|||
161888100|NCT02667587|584634508|FG001|End of Treatment|Death|1|||
161888101|NCT02667587|584634507|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
161888102|NCT02667587|584634508|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
161888103|NCT02667587|584634507|FG000|End of Treatment|participant request to discontinue treatment|33|||
161888104|NCT02667587|584634508|FG001|End of Treatment|participant request to discontinue treatment|35|||
161888105|NCT02667587|584634507|FG000|End of Treatment|participant withdrew consent|5|||
161888106|NCT02667587|584634508|FG001|End of Treatment|participant withdrew consent|6|||
161888107|NCT02667587|584634507|FG000|End of Treatment|Lost to Follow-up|1|||
161888108|NCT02667587|584634508|FG001|End of Treatment|Lost to Follow-up|2|||
161888109|NCT02667587|584634507|FG000|End of Treatment|maximum clinical benefit|4|||
161888110|NCT02667587|584634508|FG001|End of Treatment|maximum clinical benefit|4|||
161888111|NCT02667587|584634507|FG000|End of Treatment|poor or non compliant|0|||
161888112|NCT02667587|584634508|FG001|End of Treatment|poor or non compliant|1|||
161888113|NCT02667587|584634507|FG000|End of Treatment|participant no longer meets study criteria|1|||
161888114|NCT02667587|584634508|FG001|End of Treatment|participant no longer meets study criteria|1|||
161888115|NCT02667587|584634507|FG000|End of Treatment|administrative reason by sponsor|1|||
161888116|NCT02667587|584634508|FG001|End of Treatment|administrative reason by sponsor|29|||
161888117|NCT02667587|584634507|FG000|End of Treatment|other reasonse|21|||
161888118|NCT02667587|584634508|FG001|End of Treatment|other reasonse|10|||
161888119|NCT02542293|584634509|FG000|Overall Study|Death|367|||
161888120|NCT02542293|584634510|FG001|Overall Study|Death|377|||
161888121|NCT02542293|584634509|FG000|Overall Study|Withdrawal by Subject|8|||
161888122|NCT02542293|584634510|FG001|Overall Study|Withdrawal by Subject|19|||
161888123|NCT04529850|584634511|FG000|Overall Study|Death|2|||
161888124|NCT04529850|584634511|FG000|Overall Study|Physician Decision|1|||
161888125|NCT04529850|584634511|FG000|Overall Study|Withdrawal by Subject|2|||
161888126|NCT00593606|584634514|FG000|Overall Study|Adverse Event|13|||
161888127|NCT00593606|584634514|FG000|Overall Study|Withdrawal by Subject|1|||
161888128|NCT00593606|584634514|FG000|Overall Study|Protocol Violation|3|||
161888129|NCT00593606|584634514|FG000|Overall Study|Lost to Follow-up|2|||
161888130|NCT00593606|584634514|FG000|Overall Study|Run-In Failure|5|||
161888131|NCT00593606|584634514|FG000|Overall Study|Screen Failure|3|||
161888132|NCT00869557|584634515|FG000|Randomized Phase|Lost to Follow-up|2|||
161888133|NCT00869557|584634516|FG001|Randomized Phase|Lost to Follow-up|1|||
161888134|NCT00869557|584634515|FG000|Randomized Phase|Investigator's Discretion|1|||
161888135|NCT00869557|584634516|FG001|Randomized Phase|Investigator's Discretion|0|||
161888136|NCT00869557|584634515|FG000|Randomized Phase|Withdrew Consent|0|||
161888137|NCT00869557|584634516|FG001|Randomized Phase|Withdrew Consent|1|||
161888138|NCT00869557|584634515|FG000|Extension Phase|Adverse Event|2|||
161888139|NCT00869557|584634516|FG001|Extension Phase|Adverse Event|2|||
161888140|NCT00869557|584634515|FG000|Extension Phase|Lack of Efficacy|1|||
161888141|NCT00869557|584634516|FG001|Extension Phase|Lack of Efficacy|0|||
161888142|NCT00869557|584634515|FG000|Extension Phase|Lost to Follow-up|3|||
161888143|NCT00869557|584634516|FG001|Extension Phase|Lost to Follow-up|1|||
161888144|NCT00869557|584634515|FG000|Extension Phase|Investigator's Discretion|2|||
161888145|NCT00869557|584634516|FG001|Extension Phase|Investigator's Discretion|0|||
161888146|NCT00869557|584634515|FG000|Extension Phase|Withdrew Consent|2|||
161888147|NCT00869557|584634516|FG001|Extension Phase|Withdrew Consent|0|||
161888148|NCT01472939|584634519|FG000|Overall Study|Adverse Event|3|||
161888149|NCT01472939|584634520|FG001|Overall Study|Adverse Event|7|||
161888150|NCT01472939|584634521|FG002|Overall Study|Adverse Event|7|||
161888151|NCT01472939|584634522|FG003|Overall Study|Adverse Event|14|||
161888152|NCT01472939|584634519|FG000|Overall Study|Lack of Efficacy|1|||
161888153|NCT01472939|584634520|FG001|Overall Study|Lack of Efficacy|0|||
161888154|NCT01472939|584634521|FG002|Overall Study|Lack of Efficacy|0|||
161888155|NCT01472939|584634522|FG003|Overall Study|Lack of Efficacy|1|||
161888156|NCT01472939|584634519|FG000|Overall Study|Lost to Follow-up|3|||
161888157|NCT01472939|584634520|FG001|Overall Study|Lost to Follow-up|0|||
161888158|NCT01472939|584634521|FG002|Overall Study|Lost to Follow-up|2|||
161888159|NCT01472939|584634522|FG003|Overall Study|Lost to Follow-up|0|||
161888160|NCT01472939|584634519|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161888161|NCT01472939|584634520|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161888162|NCT01472939|584634521|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
161888163|NCT01472939|584634522|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161888164|NCT01472939|584634519|FG000|Overall Study|Prohibited Medication|0|||
161888165|NCT01472939|584634520|FG001|Overall Study|Prohibited Medication|1|||
161888166|NCT01472939|584634521|FG002|Overall Study|Prohibited Medication|0|||
161888167|NCT01472939|584634522|FG003|Overall Study|Prohibited Medication|0|||
161888168|NCT01472939|584634519|FG000|Overall Study|Withdrawal By PI|1|||
161888169|NCT01472939|584634520|FG001|Overall Study|Withdrawal By PI|0|||
161888170|NCT01472939|584634521|FG002|Overall Study|Withdrawal By PI|0|||
161888171|NCT01472939|584634522|FG003|Overall Study|Withdrawal By PI|0|||
161888172|NCT01472939|584634519|FG000|Overall Study|Protocol Violation|3|||
161888173|NCT01472939|584634520|FG001|Overall Study|Protocol Violation|3|||
161888174|NCT01472939|584634521|FG002|Overall Study|Protocol Violation|0|||
161888175|NCT01472939|584634522|FG003|Overall Study|Protocol Violation|1|||
161888176|NCT01472939|584634519|FG000|Overall Study|Withdrawal by Subject|9|||
161888177|NCT01472939|584634520|FG001|Overall Study|Withdrawal by Subject|3|||
161888178|NCT01472939|584634521|FG002|Overall Study|Withdrawal by Subject|1|||
161888179|NCT01472939|584634522|FG003|Overall Study|Withdrawal by Subject|4|||
161888180|NCT00114738|584634523|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
161888181|NCT00114738|584634524|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
161888182|NCT00114738|584634525|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
161888183|NCT00114738|584634523|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
161888184|NCT00114738|584634524|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
161888185|NCT00114738|584634525|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
161888186|NCT00114738|584634523|FG000|Screening for Randomization|Neuropathy|17|||
161888187|NCT00114738|584634524|FG001|Screening for Randomization|Neuropathy|0|||
161888188|NCT00114738|584634525|FG002|Screening for Randomization|Neuropathy|0|||
161888189|NCT00114738|584634523|FG000|Screening for Randomization|Progressive disease|2|||
161888190|NCT00114738|584634524|FG001|Screening for Randomization|Progressive disease|0|||
161888191|NCT00114738|584634525|FG002|Screening for Randomization|Progressive disease|0|||
161888192|NCT00114738|584634523|FG000|Screening for Randomization|CNS Hemorrhage|1|||
161888193|NCT00114738|584634524|FG001|Screening for Randomization|CNS Hemorrhage|0|||
161888194|NCT00114738|584634525|FG002|Screening for Randomization|CNS Hemorrhage|0|||
161888195|NCT00114738|584634523|FG000|Screening for Randomization|Other|1|||
161888196|NCT00114738|584634524|FG001|Screening for Randomization|Other|0|||
161888197|NCT00114738|584634525|FG002|Screening for Randomization|Other|0|||
161888198|NCT05940077|584634526|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
161888199|NCT01492101|584634527|FG000|Overall Study|Death|323|||
161888200|NCT01492101|584634528|FG001|Overall Study|Death|322|||
161888201|NCT01492101|584634527|FG000|Overall Study|Withdrawal by Subject|14|||
161888202|NCT01492101|584634528|FG001|Overall Study|Withdrawal by Subject|18|||
161888203|NCT01492101|584634527|FG000|Overall Study|Lost to Follow-up|0|||
161888204|NCT01492101|584634528|FG001|Overall Study|Lost to Follow-up|2|||
161888205|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
161888206|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888207|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888208|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888209|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888210|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
161888211|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888212|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888213|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888214|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888215|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
161888216|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888217|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888218|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888219|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888220|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
161888221|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888222|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888223|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888224|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888225|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
161888226|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888227|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888228|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888229|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888230|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
161888231|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
161888232|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
161888233|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
161888234|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
161888235|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
161888236|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
161888237|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
161888238|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
161888239|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
161888240|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
161888241|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
161888242|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
161888243|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
161888244|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
161888245|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888246|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888247|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888248|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
161888249|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888250|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
161888251|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
161888252|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
161888253|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
161888254|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
161888255|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
161888256|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
161888257|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
161888258|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
161888259|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
161888260|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888261|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888262|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888263|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888264|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
161888265|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888266|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888267|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888268|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888269|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
161888270|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888271|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888272|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888273|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888274|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
161888275|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888276|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888277|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888278|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888279|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
161888280|NCT02696434|584634537|FG000|Overall Study|Adverse Event|3|||
161888281|NCT02696434|584634538|FG001|Overall Study|Adverse Event|1|||
161888282|NCT02696434|584634537|FG000|Overall Study|Lost to Follow-up|5|||
161888283|NCT02696434|584634538|FG001|Overall Study|Lost to Follow-up|4|||
161888284|NCT02696434|584634537|FG000|Overall Study|Withdrawal by Subject|14|||
161888285|NCT02696434|584634538|FG001|Overall Study|Withdrawal by Subject|12|||
161888286|NCT02696434|584634537|FG000|Overall Study|Physician Decision|0|||
161888287|NCT02696434|584634538|FG001|Overall Study|Physician Decision|1|||
161888288|NCT03570554|584634543|FG000|Overall Study|Non-compliance with study drug|0|||
161888289|NCT03570554|584634544|FG001|Overall Study|Non-compliance with study drug|0|||
161888290|NCT03570554|584634545|FG002|Overall Study|Non-compliance with study drug|1|||
161888291|NCT03570554|584634546|FG003|Overall Study|Non-compliance with study drug|0|||
161888292|NCT03570554|584634543|FG000|Overall Study|Adverse Event|0|||
161888293|NCT03570554|584634544|FG001|Overall Study|Adverse Event|0|||
161888294|NCT03570554|584634545|FG002|Overall Study|Adverse Event|0|||
161888295|NCT03570554|584634546|FG003|Overall Study|Adverse Event|1|||
161888296|NCT02719353|584634550|FG000|First Intervention|Physician Decision|0|||
161888297|NCT02719353|584634551|FG001|First Intervention|Physician Decision|1|||
161888298|NCT03114657|584634552|FG000|Overall Study|Adverse Event|9|||
161888299|NCT03114657|584634553|FG001|Overall Study|Adverse Event|6|||
161888300|NCT03114657|584634552|FG000|Overall Study|Death|4|||
161888301|NCT03114657|584634553|FG001|Overall Study|Death|0|||
161888302|NCT03114657|584634552|FG000|Overall Study|Multiple Reasons|1|||
161888303|NCT03114657|584634553|FG001|Overall Study|Multiple Reasons|2|||
161888304|NCT03114657|584634552|FG000|Overall Study|Physician Decision|2|||
161888305|NCT03114657|584634553|FG001|Overall Study|Physician Decision|2|||
161888306|NCT03114657|584634552|FG000|Overall Study|Study Terminated By Sponsor|355|||
161888307|NCT03114657|584634553|FG001|Overall Study|Study Terminated By Sponsor|374|||
161888308|NCT03114657|584634552|FG000|Overall Study|Symptomatic Deterioration|0|||
161888309|NCT03114657|584634553|FG001|Overall Study|Symptomatic Deterioration|1|||
161888310|NCT03114657|584634552|FG000|Overall Study|Withdrawal by Subject|28|||
161888311|NCT03114657|584634553|FG001|Overall Study|Withdrawal by Subject|22|||
161888312|NCT04245202|584634554|FG000|Overall Study|Lack of Efficacy|10|||
161888313|NCT04245202|584634555|FG001|Overall Study|Lack of Efficacy|1|||
161888314|NCT00717275|584634556|FG000|Overall Study|Premature study termination.|3|||
161888315|NCT03769194|584634560|FG000|Overall Study|Withdrawal by Subject|0|||
161888316|NCT03769194|584634561|FG001|Overall Study|Withdrawal by Subject|7|||
161888317|NCT03769194|584634562|FG002|Overall Study|Withdrawal by Subject|4|||
161888318|NCT03769194|584634563|FG003|Overall Study|Withdrawal by Subject|1|||
161888319|NCT03769194|584634560|FG000|Overall Study|moved from study area|0|||
161888320|NCT03769194|584634561|FG001|Overall Study|moved from study area|2|||
161888321|NCT03769194|584634562|FG002|Overall Study|moved from study area|1|||
161888322|NCT03769194|584634563|FG003|Overall Study|moved from study area|1|||
161888323|NCT03769194|584634560|FG000|Overall Study|Lost to Follow-up|3|||
161888324|NCT03769194|584634561|FG001|Overall Study|Lost to Follow-up|6|||
161888325|NCT03769194|584634562|FG002|Overall Study|Lost to Follow-up|3|||
161888326|NCT03769194|584634563|FG003|Overall Study|Lost to Follow-up|6|||
161888327|NCT03769194|584634560|FG000|Overall Study|other|1|||
161888328|NCT03769194|584634561|FG001|Overall Study|other|3|||
161888329|NCT03769194|584634562|FG002|Overall Study|other|0|||
161888330|NCT03769194|584634563|FG003|Overall Study|other|1|||
161888331|NCT00312572|584634565|FG000|Overall Study|Adverse Event|10|||
161888332|NCT00312572|584634566|FG001|Overall Study|Adverse Event|16|||
161888333|NCT00312572|584634565|FG000|Overall Study|Lost to Follow-up|1|||
161888334|NCT00312572|584634566|FG001|Overall Study|Lost to Follow-up|1|||
161888335|NCT00312572|584634565|FG000|Overall Study|Administrative|4|||
161888336|NCT00312572|584634566|FG001|Overall Study|Administrative|2|||
161888337|NCT00312572|584634565|FG000|Overall Study|Lack of Efficacy|1|||
161888338|NCT00312572|584634566|FG001|Overall Study|Lack of Efficacy|2|||
161888339|NCT04521114|584634573|FG000|Overall Study|Lost to Follow-up|1|||
161888340|NCT04521114|584634574|FG001|Overall Study|Lost to Follow-up|2|||
161888341|NCT04521114|584634575|FG002|Overall Study|Lost to Follow-up|0|||
161888342|NCT04521114|584634573|FG000|Overall Study|Withdrawal by Subject|1|||
161888343|NCT04521114|584634574|FG001|Overall Study|Withdrawal by Subject|2|||
161888344|NCT04521114|584634575|FG002|Overall Study|Withdrawal by Subject|2|||
161888345|NCT04521114|584634573|FG000|Overall Study|Adverse Event|1|||
161888346|NCT04521114|584634574|FG001|Overall Study|Adverse Event|0|||
161888347|NCT04521114|584634575|FG002|Overall Study|Adverse Event|0|||
161888348|NCT04521114|584634573|FG000|Overall Study|Sponsor Wish|1|||
161888349|NCT04521114|584634574|FG001|Overall Study|Sponsor Wish|0|||
161888350|NCT04521114|584634575|FG002|Overall Study|Sponsor Wish|0|||
161888351|NCT04521114|584634573|FG000|Overall Study|Withdrawal of Consent|2|||
161888352|NCT04521114|584634574|FG001|Overall Study|Withdrawal of Consent|2|||
161888353|NCT04521114|584634575|FG002|Overall Study|Withdrawal of Consent|0|||
161888354|NCT01362517|584634576|FG000|Overall Study|Protocol Violation|1|||
161888355|NCT01362517|584634576|FG000|Overall Study|Lost to Follow-up|1|||
161888356|NCT01133288|584634579|FG000|Eligibility Assessment|met exclusion criteria|5|||
161888357|NCT01133288|584634579|FG000|Intervention Allocation|study terminated|2|||
161888358|NCT02614131|584634580|FG000|Overall Study|Withdrawal by Subject|1|||
161888359|NCT02614131|584634581|FG001|Overall Study|Withdrawal by Subject|0|||
161888360|NCT02614131|584634582|FG002|Overall Study|Withdrawal by Subject|0|||
161888361|NCT02614131|584634583|FG003|Overall Study|Withdrawal by Subject|0|||
161888362|NCT02614131|584634584|FG004|Overall Study|Withdrawal by Subject|0|||
161888363|NCT02614131|584634585|FG005|Overall Study|Withdrawal by Subject|0|||
161888364|NCT02614131|584634586|FG006|Overall Study|Withdrawal by Subject|0|||
161888365|NCT02614131|584634580|FG000|Overall Study|Adverse Event|0|||
161888366|NCT02614131|584634581|FG001|Overall Study|Adverse Event|0|||
161888367|NCT02614131|584634582|FG002|Overall Study|Adverse Event|0|||
161888368|NCT02614131|584634583|FG003|Overall Study|Adverse Event|0|||
161888369|NCT02614131|584634584|FG004|Overall Study|Adverse Event|0|||
161888370|NCT02614131|584634585|FG005|Overall Study|Adverse Event|0|||
161888371|NCT02614131|584634586|FG006|Overall Study|Adverse Event|1|||
161888372|NCT03209518|584634587|FG000|Overall Study|Case Report Forms Uncollected|1|||
161888373|NCT03209518|584634587|FG000|Overall Study|Protocol Deviation|1|||
161888374|NCT01832818|584634588|FG000|Overall Study|Lost to Follow-up|6|||
161888375|NCT00236899|584634593|FG000|Overall Study|Adverse Event (Study Related)|1|||
161888376|NCT00236899|584634594|FG001|Overall Study|Adverse Event (Study Related)|1|||
161888377|NCT00236899|584634595|FG002|Overall Study|Adverse Event (Study Related)|2|||
161888378|NCT00236899|584634596|FG003|Overall Study|Adverse Event (Study Related)|1|||
161888379|NCT00236899|584634593|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
161888380|NCT00236899|584634594|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
161888381|NCT00236899|584634595|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
161888382|NCT00236899|584634596|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
161888383|NCT00236899|584634593|FG000|Overall Study|Death (Study Disease)|1|||
161888384|NCT00236899|584634594|FG001|Overall Study|Death (Study Disease)|4|||
161888385|NCT00236899|584634595|FG002|Overall Study|Death (Study Disease)|0|||
161888386|NCT00236899|584634596|FG003|Overall Study|Death (Study Disease)|0|||
161888387|NCT00236899|584634593|FG000|Overall Study|Death (Not Study Related)|2|||
161888388|NCT00236899|584634594|FG001|Overall Study|Death (Not Study Related)|0|||
161888389|NCT00236899|584634595|FG002|Overall Study|Death (Not Study Related)|0|||
161888390|NCT00236899|584634596|FG003|Overall Study|Death (Not Study Related)|0|||
161888391|NCT00236899|584634593|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
161888392|NCT00236899|584634594|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
161888393|NCT00236899|584634595|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
161888394|NCT00236899|584634596|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
161888395|NCT00236899|584634593|FG000|Overall Study|Lost to Follow-up|0|||
161888396|NCT00236899|584634594|FG001|Overall Study|Lost to Follow-up|1|||
161888397|NCT00236899|584634595|FG002|Overall Study|Lost to Follow-up|0|||
161888398|NCT00236899|584634596|FG003|Overall Study|Lost to Follow-up|0|||
161888399|NCT00236899|584634593|FG000|Overall Study|Entry Criteria Exclusion|0|||
161888400|NCT00236899|584634594|FG001|Overall Study|Entry Criteria Exclusion|1|||
161888401|NCT00236899|584634595|FG002|Overall Study|Entry Criteria Exclusion|1|||
161888402|NCT00236899|584634596|FG003|Overall Study|Entry Criteria Exclusion|0|||
161888403|NCT00236899|584634593|FG000|Overall Study|Protocol Violation|1|||
161888404|NCT00236899|584634594|FG001|Overall Study|Protocol Violation|0|||
161888405|NCT00236899|584634595|FG002|Overall Study|Protocol Violation|0|||
161888406|NCT00236899|584634596|FG003|Overall Study|Protocol Violation|0|||
161888407|NCT00236899|584634593|FG000|Overall Study|Withdrawal by Subject|6|||
161888408|NCT00236899|584634594|FG001|Overall Study|Withdrawal by Subject|4|||
161888409|NCT00236899|584634595|FG002|Overall Study|Withdrawal by Subject|5|||
161888410|NCT00236899|584634596|FG003|Overall Study|Withdrawal by Subject|2|||
161888411|NCT00236899|584634593|FG000|Overall Study|Physician Decision|7|||
161888412|NCT00236899|584634594|FG001|Overall Study|Physician Decision|8|||
161888413|NCT00236899|584634595|FG002|Overall Study|Physician Decision|7|||
161888414|NCT00236899|584634596|FG003|Overall Study|Physician Decision|6|||
161888415|NCT00236899|584634593|FG000|Overall Study|Satisfactory Response|2|||
161888416|NCT00236899|584634594|FG001|Overall Study|Satisfactory Response|0|||
161888417|NCT00236899|584634595|FG002|Overall Study|Satisfactory Response|0|||
161888418|NCT00236899|584634596|FG003|Overall Study|Satisfactory Response|1|||
161888419|NCT00236899|584634593|FG000|Overall Study|Lack of Efficacy|18|||
161888420|NCT00236899|584634594|FG001|Overall Study|Lack of Efficacy|18|||
161888421|NCT00236899|584634595|FG002|Overall Study|Lack of Efficacy|25|||
161888422|NCT00236899|584634596|FG003|Overall Study|Lack of Efficacy|23|||
161888423|NCT02565706|584634597|FG000|Overall Study|Withdrawal by Subject|5|||
161888424|NCT02565706|584634598|FG001|Overall Study|Withdrawal by Subject|7|||
161888425|NCT02565706|584634599|FG002|Overall Study|Withdrawal by Subject|7|||
161888426|NCT02565706|584634600|FG003|Overall Study|Withdrawal by Subject|11|||
161888427|NCT02565706|584634597|FG000|Overall Study|Lost to Follow-up|72|||
161888428|NCT02565706|584634598|FG001|Overall Study|Lost to Follow-up|75|||
161888429|NCT02565706|584634599|FG002|Overall Study|Lost to Follow-up|82|||
161888430|NCT02565706|584634600|FG003|Overall Study|Lost to Follow-up|74|||
161888431|NCT00568334|584634601|FG000|Overall Study|Withdrawal by Subject|0|||
161888432|NCT00568334|584634602|FG001|Overall Study|Withdrawal by Subject|1|||
161888433|NCT00568334|584634601|FG000|Overall Study|Lost to Follow-up|1|||
161888434|NCT00568334|584634602|FG001|Overall Study|Lost to Follow-up|0|||
161888435|NCT01897571|584634603|FG000|Overall Study|Lost to Follow-up|3|||
161888436|NCT01897571|584634604|FG001|Overall Study|Lost to Follow-up|0|||
161888437|NCT01897571|584634605|FG002|Overall Study|Lost to Follow-up|0|||
161888438|NCT01897571|584634606|FG003|Overall Study|Lost to Follow-up|0|||
161888439|NCT01897571|584634607|FG004|Overall Study|Lost to Follow-up|2|||
161888440|NCT01897571|584634608|FG005|Overall Study|Lost to Follow-up|0|||
161888441|NCT01897571|584634609|FG006|Overall Study|Lost to Follow-up|0|||
161888442|NCT01897571|584634610|FG007|Overall Study|Lost to Follow-up|0|||
161888443|NCT01897571|584634611|FG008|Overall Study|Lost to Follow-up|1|||
161888444|NCT01897571|584634612|FG009|Overall Study|Lost to Follow-up|2|||
161888445|NCT01897571|584634613|FG010|Overall Study|Lost to Follow-up|4|||
161888446|NCT01897571|584634603|FG000|Overall Study|Withdrawal by Subject|0|||
161888447|NCT01897571|584634604|FG001|Overall Study|Withdrawal by Subject|0|||
161888448|NCT01897571|584634605|FG002|Overall Study|Withdrawal by Subject|0|||
161888449|NCT01897571|584634606|FG003|Overall Study|Withdrawal by Subject|0|||
161888450|NCT01897571|584634607|FG004|Overall Study|Withdrawal by Subject|0|||
161888451|NCT01897571|584634608|FG005|Overall Study|Withdrawal by Subject|0|||
161888452|NCT01897571|584634609|FG006|Overall Study|Withdrawal by Subject|0|||
161888453|NCT01897571|584634610|FG007|Overall Study|Withdrawal by Subject|1|||
161888454|NCT01897571|584634611|FG008|Overall Study|Withdrawal by Subject|4|||
161888455|NCT01897571|584634612|FG009|Overall Study|Withdrawal by Subject|3|||
161888456|NCT01897571|584634613|FG010|Overall Study|Withdrawal by Subject|1|||
161888457|NCT01897571|584634603|FG000|Overall Study|Other|1|||
161888458|NCT01897571|584634604|FG001|Overall Study|Other|0|||
161888459|NCT01897571|584634605|FG002|Overall Study|Other|0|||
161888460|NCT01897571|584634606|FG003|Overall Study|Other|3|||
161888461|NCT01897571|584634607|FG004|Overall Study|Other|3|||
161888462|NCT01897571|584634608|FG005|Overall Study|Other|4|||
161888463|NCT01897571|584634609|FG006|Overall Study|Other|7|||
161888464|NCT01897571|584634610|FG007|Overall Study|Other|0|||
161888465|NCT01897571|584634611|FG008|Overall Study|Other|0|||
161888466|NCT01897571|584634612|FG009|Overall Study|Other|0|||
161888467|NCT01897571|584634613|FG010|Overall Study|Other|0|||
161888468|NCT01897571|584634603|FG000|Overall Study|Enrolled in rollover study|0|||
161888469|NCT01897571|584634604|FG001|Overall Study|Enrolled in rollover study|0|||
161888470|NCT01897571|584634605|FG002|Overall Study|Enrolled in rollover study|0|||
161888471|NCT01897571|584634606|FG003|Overall Study|Enrolled in rollover study|0|||
161888472|NCT01897571|584634607|FG004|Overall Study|Enrolled in rollover study|0|||
161888473|NCT01897571|584634608|FG005|Overall Study|Enrolled in rollover study|0|||
161888474|NCT01897571|584634609|FG006|Overall Study|Enrolled in rollover study|0|||
161888475|NCT01897571|584634610|FG007|Overall Study|Enrolled in rollover study|9|||
161888476|NCT01897571|584634611|FG008|Overall Study|Enrolled in rollover study|7|||
161888477|NCT01897571|584634612|FG009|Overall Study|Enrolled in rollover study|9|||
161888478|NCT01897571|584634613|FG010|Overall Study|Enrolled in rollover study|1|||
161888479|NCT01897571|584634603|FG000|Overall Study|Death|2|||
161888480|NCT01897571|584634604|FG001|Overall Study|Death|2|||
161888481|NCT01897571|584634605|FG002|Overall Study|Death|3|||
161888482|NCT01897571|584634606|FG003|Overall Study|Death|6|||
161888483|NCT01897571|584634607|FG004|Overall Study|Death|7|||
161888484|NCT01897571|584634608|FG005|Overall Study|Death|9|||
161888485|NCT01897571|584634609|FG006|Overall Study|Death|5|||
161888486|NCT01897571|584634610|FG007|Overall Study|Death|22|||
161888487|NCT01897571|584634611|FG008|Overall Study|Death|23|||
161888488|NCT01897571|584634612|FG009|Overall Study|Death|129|||
161888489|NCT01897571|584634613|FG010|Overall Study|Death|59|||
161888490|NCT01797094|584634614|FG000|Overall Study|Adverse Event|1|||
161888491|NCT01797094|584634615|FG001|Overall Study|Adverse Event|1|||
161888492|NCT01797094|584634614|FG000|Overall Study|Personal Reasons|4|||
161888493|NCT01797094|584634615|FG001|Overall Study|Personal Reasons|0|||
161888494|NCT01797094|584634614|FG000|Overall Study|Protocol Violation|0|||
161888495|NCT01797094|584634615|FG001|Overall Study|Protocol Violation|1|||
161888496|NCT01797094|584634614|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161888497|NCT01797094|584634615|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161888498|NCT01281956|584634619|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
161888499|NCT01281956|584634620|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
161888500|NCT03677934|584634635|FG000|Overall Study|Adverse Event|1|||
161888501|NCT03677934|584634636|FG001|Overall Study|Adverse Event|1|||
161888502|NCT03677934|584634635|FG000|Overall Study|Death|8|||
161888503|NCT03677934|584634636|FG001|Overall Study|Death|4|||
161888504|NCT03677934|584634635|FG000|Overall Study|Lost to Follow-up|3|||
161888505|NCT03677934|584634636|FG001|Overall Study|Lost to Follow-up|0|||
161888506|NCT03677934|584634635|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161888507|NCT03677934|584634636|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161888508|NCT03677934|584634635|FG000|Overall Study|Physician Decision|0|||
161888509|NCT03677934|584634636|FG001|Overall Study|Physician Decision|1|||
161888510|NCT03677934|584634635|FG000|Overall Study|Withdrawal by Subject|1|||
161888511|NCT03677934|584634636|FG001|Overall Study|Withdrawal by Subject|7|||
161888512|NCT04769739|584634637|FG000|Overall Study|Colorectal cancer obstruction|2|||
161888513|NCT04769739|584634638|FG001|Overall Study|Colorectal cancer obstruction|0|||
161888514|NCT04769739|584634639|FG002|Overall Study|Colorectal cancer obstruction|0|||
161888515|NCT04769739|584634640|FG003|Overall Study|Colorectal cancer obstruction|0|||
161888516|NCT04769739|584634637|FG000|Overall Study|Failed cecal intubation|1|||
161888517|NCT04769739|584634638|FG001|Overall Study|Failed cecal intubation|0|||
161888518|NCT04769739|584634639|FG002|Overall Study|Failed cecal intubation|0|||
161888519|NCT04769739|584634640|FG003|Overall Study|Failed cecal intubation|1|||
161888520|NCT04769739|584634637|FG000|Overall Study|Poor bowel preparation|0|||
161888521|NCT04769739|584634638|FG001|Overall Study|Poor bowel preparation|0|||
161888522|NCT04769739|584634639|FG002|Overall Study|Poor bowel preparation|0|||
161888523|NCT04769739|584634640|FG003|Overall Study|Poor bowel preparation|1|||
161888524|NCT02227368|584636203|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
161888525|NCT02227368|584636204|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
161888526|NCT02227368|584636203|FG000|Overall Study|Lost to Follow-up|1|||
161888527|NCT02227368|584636204|FG001|Overall Study|Lost to Follow-up|0|||
161888528|NCT02227368|584636203|FG000|Overall Study|Adverse Event|1|||
161888529|NCT02227368|584636204|FG001|Overall Study|Adverse Event|0|||
161888530|NCT03046056|584636206|FG000|Overall Study|Non-responder at Week 10|6|||
161888531|NCT03046056|584636207|FG001|Overall Study|Non-responder at Week 10|6|||
161888532|NCT03046056|584636208|FG002|Overall Study|Non-responder at Week 10|4|||
161888533|NCT03046056|584636206|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
161888534|NCT03046056|584636207|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
161888535|NCT03046056|584636208|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
161888536|NCT03046056|584636206|FG000|Overall Study|Adverse Event|1|||
161888537|NCT03046056|584636207|FG001|Overall Study|Adverse Event|5|||
161888538|NCT03046056|584636208|FG002|Overall Study|Adverse Event|0|||
161888539|NCT03046056|584636206|FG000|Overall Study|Non-compliance With Study Drug|0|||
161888540|NCT03046056|584636207|FG001|Overall Study|Non-compliance With Study Drug|0|||
161888541|NCT03046056|584636208|FG002|Overall Study|Non-compliance With Study Drug|2|||
161888542|NCT03046056|584636206|FG000|Overall Study|Protocol Violation|1|||
161888543|NCT03046056|584636207|FG001|Overall Study|Protocol Violation|1|||
161888544|NCT03046056|584636208|FG002|Overall Study|Protocol Violation|0|||
161888545|NCT03046056|584636206|FG000|Overall Study|Investigator's Discretion|0|||
161888546|NCT03046056|584636207|FG001|Overall Study|Investigator's Discretion|1|||
161888547|NCT03046056|584636208|FG002|Overall Study|Investigator's Discretion|0|||
161888548|NCT03046056|584636206|FG000|Overall Study|Withdrew Consent|1|||
161888549|NCT03046056|584636207|FG001|Overall Study|Withdrew Consent|0|||
161888550|NCT03046056|584636208|FG002|Overall Study|Withdrew Consent|0|||
161888551|NCT03089853|584636209|FG000|Overall Study|Lost to Follow-up|2|||
161888552|NCT03089853|584636210|FG001|Overall Study|Lost to Follow-up|1|||
161888553|NCT01317004|584636211|FG000|Overall Study|Withdrawal by Subject|1|||
161888554|NCT01317004|584636212|FG001|Overall Study|Withdrawal by Subject|4|||
161888555|NCT01317004|584636211|FG000|Overall Study|Protocol Violation|0|||
161888556|NCT01317004|584636212|FG001|Overall Study|Protocol Violation|2|||
161888557|NCT01317004|584636211|FG000|Overall Study|Adverse Event|3|||
161888558|NCT01317004|584636212|FG001|Overall Study|Adverse Event|3|||
161888559|NCT01344759|584636215|FG000|Overall Study|Patients failed to reach sedation level|0|||
161888560|NCT01344759|584636216|FG001|Overall Study|Patients failed to reach sedation level|2|||
161888561|NCT01890759|584636217|FG000|Overall Study|Protocol Violation|0|||
161888562|NCT01890759|584636218|FG001|Overall Study|Protocol Violation|2|||
161888563|NCT01890759|584636217|FG000|Overall Study|Lost to Follow-up|0|||
161888564|NCT01890759|584636218|FG001|Overall Study|Lost to Follow-up|2|||
161888565|NCT01890759|584636217|FG000|Overall Study|Withdrawal by Subject|2|||
161888566|NCT01890759|584636218|FG001|Overall Study|Withdrawal by Subject|8|||
161888567|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
161888568|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
161888569|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
161888570|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
161888571|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
161888572|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
161888573|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
161888574|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
161888575|NCT04114656|584636219|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
161888576|NCT04114656|584636220|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
161888577|NCT00703326|584636221|FG000|Overall Study|Lost to Follow-up|47|||
161888578|NCT00703326|584636222|FG001|Overall Study|Lost to Follow-up|18|||
161888579|NCT00703326|584636221|FG000|Overall Study|Withdrawal by Subject|54|||
161888580|NCT00703326|584636222|FG001|Overall Study|Withdrawal by Subject|20|||
161888581|NCT00703326|584636221|FG000|Overall Study|Adverse Event|1|||
161888582|NCT00703326|584636222|FG001|Overall Study|Adverse Event|0|||
161888583|NCT02661061|584636224|FG000|Overall Study|Lack of Efficacy|1|||
161888584|NCT02661061|584636225|FG001|Overall Study|Lack of Efficacy|1|||
161888585|NCT02661061|584636224|FG000|Overall Study|Withdrawal by Subject|1|||
161888586|NCT02661061|584636225|FG001|Overall Study|Withdrawal by Subject|1|||
161888587|NCT01393106|584636226|FG000|Overall Study|Adverse Event|3|||
161888588|NCT01393106|584636226|FG000|Overall Study|Withdrawal by Subject|1|||
161888589|NCT01393106|584636226|FG000|Overall Study|Lack of Efficacy|1|||
161888590|NCT02732015|584636227|FG000|Overall Study|Lost to Follow-up|0|||
161888591|NCT02732015|584636228|FG001|Overall Study|Lost to Follow-up|1|||
161888592|NCT03052920|584636229|FG000|Overall Study|Withdrawal by Subject|1|||
161888593|NCT01980628|584636230|FG000|Overall Study|Adverse Event|12|||
161888594|NCT01980628|584636230|FG000|Overall Study|Physician Decision|5|||
161888595|NCT01980628|584636230|FG000|Overall Study|Withdrawal by Subject|4|||
161888596|NCT01980628|584636230|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
161888597|NCT05437640|584636233|FG000|Washout (1 Week)|Adverse Event|1|||
161888598|NCT05437640|584636234|FG001|Washout (1 Week)|Adverse Event|0|||
161888599|NCT02474355|584636235|FG000|Overall Study|Other|43|||
161888600|NCT02474355|584636235|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
161888601|NCT02474355|584636235|FG000|Overall Study|Lost to Follow-up|98|||
161888602|NCT02474355|584636235|FG000|Overall Study|Withdrawal by Subject|124|||
161888603|NCT02474355|584636235|FG000|Overall Study|Death|1361|||
161888604|NCT03015194|584636237|FG000|Overall Study|Death|10|||
161888605|NCT03015194|584636237|FG000|Overall Study|Withdrawal by Subject|2|||
161888606|NCT01698268|584636241|FG000|Overall Study|Physician Decision|2|||
161888607|NCT01698268|584636242|FG001|Overall Study|Physician Decision|1|||
161888608|NCT02263729|584636243|FG000|Overall Study|Lost to Follow-up|1|||
161888609|NCT02263729|584636244|FG001|Overall Study|Lost to Follow-up|1|||
161888610|NCT04591015|584636245|FG000|Overall Study|Death|6|||
161888611|NCT04591015|584636246|FG001|Overall Study|Death|4|||
161888612|NCT04591015|584636245|FG000|Overall Study|Withdrawal by Subject|6|||
161888613|NCT04591015|584636246|FG001|Overall Study|Withdrawal by Subject|3|||
161888614|NCT04591015|584636245|FG000|Overall Study|Lost to Follow-up|16|||
161888615|NCT04591015|584636246|FG001|Overall Study|Lost to Follow-up|11|||
161888616|NCT02509078|584636247|FG000|Overall Study|Protocol Violation|1|||
161888617|NCT02509078|584636248|FG001|Overall Study|Protocol Violation|1|||
161888618|NCT00631163|584636250|FG000|Number of Participants in Year 1|Adverse Event|12|||
161888619|NCT00631163|584636250|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
161888620|NCT00631163|584636250|FG000|Number of Participants in Year 1|Death|6|||
161888621|NCT00631163|584636250|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
161888622|NCT00631163|584636250|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
161888623|NCT00631163|584636250|FG000|Number of Participants in Year 1|Administrative problems|6|||
161888624|NCT00631163|584636250|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
161888625|NCT00631163|584636250|FG000|Number of Participants in Year 2|Adverse Event|1|||
161888626|NCT00631163|584636250|FG000|Number of Participants in Year 2|Protocol Violation|1|||
161888627|NCT00631163|584636250|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
161888628|NCT02290925|584636251|FG000|First Period of Three Months|Lost to Follow-up|2|||
161888629|NCT02290925|584636252|FG001|First Period of Three Months|Lost to Follow-up|1|||
161888630|NCT02290925|584636251|FG000|First Period of Three Months|Death|1|||
161888631|NCT02290925|584636252|FG001|First Period of Three Months|Death|0|||
161888632|NCT02290925|584636251|FG000|First Period of Three Months|Insulin Started|1|||
161888633|NCT02290925|584636252|FG001|First Period of Three Months|Insulin Started|1|||
161888634|NCT02290925|584636251|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
161888635|NCT02290925|584636252|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
161888636|NCT02290925|584636251|FG000|Second Period of 3 Months|insulin started|0|||
161888637|NCT02290925|584636252|FG001|Second Period of 3 Months|insulin started|1|||
161888638|NCT00388297|584636266|FG000|Overall Study|Lost to Follow-up|16|||
161888639|NCT00388297|584636267|FG001|Overall Study|Lost to Follow-up|12|||
161888640|NCT00388297|584636268|FG002|Overall Study|Lost to Follow-up|11|||
161888641|NCT00388297|584636269|FG003|Overall Study|Lost to Follow-up|8|||
161888642|NCT00316914|584636271|FG000|Overall Study|Withdrawal by Subject|5|||
161888643|NCT00316914|584636272|FG001|Overall Study|Withdrawal by Subject|3|||
161888644|NCT00316914|584636271|FG000|Overall Study|Adverse Event|8|||
161888645|NCT00316914|584636272|FG001|Overall Study|Adverse Event|7|||
161888646|NCT00316914|584636271|FG000|Overall Study|Other Problems|6|||
161888647|NCT00316914|584636272|FG001|Overall Study|Other Problems|11|||
161888648|NCT00316914|584636271|FG000|Overall Study|Missing end of treatment documentation|14|||
161888649|NCT00316914|584636272|FG001|Overall Study|Missing end of treatment documentation|15|||
161888650|NCT02284568|584636273|FG000|Overall Study|Adverse Event|2|||
161888651|NCT02284568|584636274|FG001|Overall Study|Adverse Event|9|||
161888652|NCT02284568|584636275|FG002|Overall Study|Adverse Event|4|||
161888653|NCT02284568|584636273|FG000|Overall Study|Withdrawal by Subject|22|||
161888654|NCT02284568|584636274|FG001|Overall Study|Withdrawal by Subject|21|||
161888655|NCT02284568|584636275|FG002|Overall Study|Withdrawal by Subject|1|||
161888656|NCT02284568|584636273|FG000|Overall Study|Noncompliance with study drug admin|1|||
161888657|NCT02284568|584636274|FG001|Overall Study|Noncompliance with study drug admin|2|||
161888658|NCT02284568|584636275|FG002|Overall Study|Noncompliance with study drug admin|0|||
161888659|NCT02284568|584636273|FG000|Overall Study|Noncompliance|1|||
161888660|NCT02284568|584636274|FG001|Overall Study|Noncompliance|0|||
161888661|NCT02284568|584636275|FG002|Overall Study|Noncompliance|0|||
161888662|NCT02284568|584636273|FG000|Overall Study|Protocol Violation|0|||
161888663|NCT02284568|584636274|FG001|Overall Study|Protocol Violation|1|||
161888664|NCT02284568|584636275|FG002|Overall Study|Protocol Violation|0|||
161888665|NCT02284568|584636273|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
161888666|NCT02284568|584636274|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
161888667|NCT02284568|584636275|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
161888668|NCT02284568|584636273|FG000|Overall Study|Lost to Follow-up|0|||
161888669|NCT02284568|584636274|FG001|Overall Study|Lost to Follow-up|3|||
161888670|NCT02284568|584636275|FG002|Overall Study|Lost to Follow-up|0|||
161888671|NCT02284568|584636273|FG000|Overall Study|Lack of Efficacy|4|||
161888672|NCT02284568|584636274|FG001|Overall Study|Lack of Efficacy|7|||
161888673|NCT02284568|584636275|FG002|Overall Study|Lack of Efficacy|0|||
161888674|NCT02284568|584636273|FG000|Overall Study|Other|1|||
161888675|NCT02284568|584636274|FG001|Overall Study|Other|2|||
161888676|NCT02284568|584636275|FG002|Overall Study|Other|0|||
161888677|NCT02284568|584636273|FG000|Overall Study|Withdrew before taking study drug|0|||
161888678|NCT02284568|584636274|FG001|Overall Study|Withdrew before taking study drug|1|||
161888679|NCT02284568|584636275|FG002|Overall Study|Withdrew before taking study drug|0|||
161888680|NCT00980174|584636279|FG000|Overall Study|Withdrawal by Subject|1|||
161888681|NCT00980174|584636280|FG001|Overall Study|Withdrawal by Subject|4|||
161888682|NCT00980174|584636279|FG000|Overall Study|Adverse Event|0|||
161888683|NCT00980174|584636280|FG001|Overall Study|Adverse Event|3|||
161888684|NCT00980174|584636279|FG000|Overall Study|Ineligibility determined|2|||
161888685|NCT00980174|584636280|FG001|Overall Study|Ineligibility determined|1|||
161888686|NCT00980174|584636279|FG000|Overall Study|Death|1|||
161888687|NCT00980174|584636280|FG001|Overall Study|Death|1|||
161888688|NCT00980174|584636279|FG000|Overall Study|Other|0|||
161888689|NCT00980174|584636280|FG001|Overall Study|Other|1|||
161888690|NCT01546038|584636282|FG000|Overall Study|Death|15|||
161888691|NCT01546038|584636283|FG001|Overall Study|Death|6|||
161888692|NCT01546038|584636284|FG002|Overall Study|Death|4|||
161888693|NCT01546038|584636285|FG003|Overall Study|Death|2|||
161888694|NCT01546038|584636286|FG004|Overall Study|Death|9|||
161888695|NCT01546038|584636287|FG005|Overall Study|Death|3|||
161888696|NCT01546038|584636288|FG006|Overall Study|Death|46|||
161888697|NCT01546038|584636289|FG007|Overall Study|Death|76|||
161888698|NCT01546038|584636290|FG008|Overall Study|Death|39|||
161888699|NCT01546038|584636282|FG000|Overall Study|Lost to Follow-up|0|||
161888700|NCT01546038|584636283|FG001|Overall Study|Lost to Follow-up|0|||
161888701|NCT01546038|584636284|FG002|Overall Study|Lost to Follow-up|0|||
161888702|NCT01546038|584636285|FG003|Overall Study|Lost to Follow-up|0|||
161888703|NCT01546038|584636286|FG004|Overall Study|Lost to Follow-up|1|||
161888704|NCT01546038|584636287|FG005|Overall Study|Lost to Follow-up|0|||
161888705|NCT01546038|584636288|FG006|Overall Study|Lost to Follow-up|2|||
161888706|NCT01546038|584636289|FG007|Overall Study|Lost to Follow-up|1|||
161888707|NCT01546038|584636290|FG008|Overall Study|Lost to Follow-up|0|||
161888708|NCT01546038|584636282|FG000|Overall Study|Withdrawal by Subject|1|||
161888709|NCT01546038|584636283|FG001|Overall Study|Withdrawal by Subject|0|||
161888710|NCT01546038|584636284|FG002|Overall Study|Withdrawal by Subject|0|||
161888711|NCT01546038|584636285|FG003|Overall Study|Withdrawal by Subject|1|||
161888712|NCT01546038|584636286|FG004|Overall Study|Withdrawal by Subject|0|||
161888713|NCT01546038|584636287|FG005|Overall Study|Withdrawal by Subject|1|||
161888714|NCT01546038|584636288|FG006|Overall Study|Withdrawal by Subject|3|||
161888715|NCT01546038|584636289|FG007|Overall Study|Withdrawal by Subject|3|||
161888716|NCT01546038|584636290|FG008|Overall Study|Withdrawal by Subject|1|||
161888717|NCT01546038|584636282|FG000|Overall Study|: Randomized, not treated|0|||
161888718|NCT01546038|584636283|FG001|Overall Study|: Randomized, not treated|0|||
161888719|NCT01546038|584636284|FG002|Overall Study|: Randomized, not treated|0|||
161888720|NCT01546038|584636285|FG003|Overall Study|: Randomized, not treated|0|||
161888721|NCT01546038|584636286|FG004|Overall Study|: Randomized, not treated|0|||
161888722|NCT01546038|584636287|FG005|Overall Study|: Randomized, not treated|0|||
161888723|NCT01546038|584636288|FG006|Overall Study|: Randomized, not treated|2|||
161888724|NCT01546038|584636289|FG007|Overall Study|: Randomized, not treated|4|||
161888725|NCT01546038|584636290|FG008|Overall Study|: Randomized, not treated|3|||
161888726|NCT00424021|584636291|FG000|NCT00046319 Study Period|Adverse Event|1|||
161888727|NCT00424021|584636292|FG001|NCT00046319 Study Period|Adverse Event|0|||
161888728|NCT00424021|584636293|FG002|NCT00046319 Study Period|Adverse Event|1|||
161888729|NCT00424021|584636294|FG003|NCT00046319 Study Period|Adverse Event|1|||
161888730|NCT00424021|584636291|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
161888731|NCT00424021|584636292|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
161888732|NCT00424021|584636293|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
161888733|NCT00424021|584636294|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
161888734|NCT00424021|584636291|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
161888735|NCT00424021|584636292|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
161888736|NCT00424021|584636293|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
161888737|NCT00424021|584636294|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
161888738|NCT00424021|584636291|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
161888739|NCT00424021|584636292|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
161888740|NCT00424021|584636293|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
161888741|NCT00424021|584636294|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
161888742|NCT00424021|584636291|FG000|AMB-220-E Study Period|Adverse Event|1|||
161888743|NCT00424021|584636292|FG001|AMB-220-E Study Period|Adverse Event|1|||
161888744|NCT00424021|584636293|FG002|AMB-220-E Study Period|Adverse Event|3|||
161888745|NCT00424021|584636294|FG003|AMB-220-E Study Period|Adverse Event|7|||
161888746|NCT00424021|584636291|FG000|AMB-220-E Study Period|Death|0|||
161888747|NCT00424021|584636292|FG001|AMB-220-E Study Period|Death|0|||
161888748|NCT00424021|584636293|FG002|AMB-220-E Study Period|Death|1|||
161888749|NCT00424021|584636294|FG003|AMB-220-E Study Period|Death|1|||
161888750|NCT00424021|584636291|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
161888751|NCT00424021|584636292|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
161888752|NCT00424021|584636293|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
161888753|NCT00424021|584636294|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
161888754|NCT00424021|584636291|FG000|AMB-220-E Study Period|Physician Decision|0|||
161888755|NCT00424021|584636292|FG001|AMB-220-E Study Period|Physician Decision|0|||
161888756|NCT00424021|584636293|FG002|AMB-220-E Study Period|Physician Decision|0|||
161888757|NCT00424021|584636294|FG003|AMB-220-E Study Period|Physician Decision|1|||
161888758|NCT03217968|584636295|FG000|Overall Study|Withdrawal by Subject|4|||
161888759|NCT03217968|584636295|FG000|Overall Study|Lost to Follow-up|1|||
161888760|NCT03217968|584636295|FG000|Overall Study|Protocol Violation|6|||
161888761|NCT03008278|584636296|FG000|Overall Study|Progressive Disease|0|||
161888762|NCT03008278|584636297|FG001|Overall Study|Progressive Disease|0|||
161888763|NCT03008278|584636298|FG002|Overall Study|Progressive Disease|32|||
161888764|NCT03008278|584636296|FG000|Overall Study|Adverse Event|0|||
161888765|NCT03008278|584636297|FG001|Overall Study|Adverse Event|0|||
161888766|NCT03008278|584636298|FG002|Overall Study|Adverse Event|4|||
161888767|NCT03008278|584636296|FG000|Overall Study|Withdrawal by Subject|0|||
161888768|NCT03008278|584636297|FG001|Overall Study|Withdrawal by Subject|0|||
161888769|NCT03008278|584636298|FG002|Overall Study|Withdrawal by Subject|3|||
161888770|NCT03008278|584636296|FG000|Overall Study|Physician Decision|0|||
161888771|NCT03008278|584636297|FG001|Overall Study|Physician Decision|2|||
161888772|NCT03008278|584636298|FG002|Overall Study|Physician Decision|0|||
161888773|NCT01074255|584636299|FG000|Overall Study|Did not receive EMEND|2|||
161888774|NCT01389258|584636300|FG000|Overall Study|Lost to Follow-up|5|||
161888775|NCT03313310|584636301|FG000|Phase 2|Lost to Follow-up|4|||
161888776|NCT03313310|584636302|FG001|Phase 2|Lost to Follow-up|0|||
161888777|NCT03313310|584636301|FG000|Phase 3|Lost to Follow-up|0|||
161888778|NCT03313310|584636302|FG001|Phase 3|Lost to Follow-up|1|||
161888779|NCT03170609|584636305|FG000|Overall Study|Death|0|||
161888780|NCT03170609|584636306|FG001|Overall Study|Death|0|||
161888781|NCT03170609|584636307|FG002|Overall Study|Death|1|||
161888782|NCT03170609|584636308|FG003|Overall Study|Death|0|||
161888783|NCT03170609|584636309|FG004|Overall Study|Death|0|||
161888784|NCT03170609|584636310|FG005|Overall Study|Death|0|||
161888785|NCT03170609|584636311|FG006|Overall Study|Death|0|||
161888786|NCT03170609|584636305|FG000|Overall Study|Withdrawal by Subject|1|||
161888787|NCT03170609|584636306|FG001|Overall Study|Withdrawal by Subject|2|||
161888788|NCT03170609|584636307|FG002|Overall Study|Withdrawal by Subject|0|||
161888789|NCT03170609|584636308|FG003|Overall Study|Withdrawal by Subject|0|||
161888790|NCT03170609|584636309|FG004|Overall Study|Withdrawal by Subject|0|||
161888791|NCT03170609|584636310|FG005|Overall Study|Withdrawal by Subject|0|||
161888792|NCT03170609|584636311|FG006|Overall Study|Withdrawal by Subject|1|||
161888793|NCT03170609|584636305|FG000|Overall Study|Lost to Follow-up|1|||
161888794|NCT03170609|584636306|FG001|Overall Study|Lost to Follow-up|0|||
161888795|NCT03170609|584636307|FG002|Overall Study|Lost to Follow-up|5|||
161888796|NCT03170609|584636308|FG003|Overall Study|Lost to Follow-up|2|||
161888797|NCT03170609|584636309|FG004|Overall Study|Lost to Follow-up|1|||
161888798|NCT03170609|584636310|FG005|Overall Study|Lost to Follow-up|1|||
161888799|NCT03170609|584636311|FG006|Overall Study|Lost to Follow-up|0|||
161888800|NCT03170609|584636305|FG000|Overall Study|Other|1|||
161888801|NCT03170609|584636306|FG001|Overall Study|Other|0|||
161888802|NCT03170609|584636307|FG002|Overall Study|Other|0|||
161888803|NCT03170609|584636308|FG003|Overall Study|Other|0|||
161888804|NCT03170609|584636309|FG004|Overall Study|Other|0|||
161888805|NCT03170609|584636310|FG005|Overall Study|Other|1|||
161888806|NCT03170609|584636311|FG006|Overall Study|Other|0|||
161888807|NCT01904903|584636312|FG000|Overall Study|Withdrawal by Subject|1|||
161888808|NCT00314132|584636313|FG000|Overall Study|Lost to Follow-up|3|||
161888809|NCT00314132|584636314|FG001|Overall Study|Lost to Follow-up|13|||
161888810|NCT00314132|584636313|FG000|Overall Study|Withdrawal by Subject|3|||
161888811|NCT00314132|584636314|FG001|Overall Study|Withdrawal by Subject|5|||
161888812|NCT00314132|584636313|FG000|Overall Study|Adverse Event|1|||
161888813|NCT00314132|584636314|FG001|Overall Study|Adverse Event|0|||
161888814|NCT00314132|584636313|FG000|Overall Study|Physician Decision|1|||
161888815|NCT00314132|584636314|FG001|Overall Study|Physician Decision|0|||
161888816|NCT01634659|584636316|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
161888817|NCT01634659|584636317|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
161888818|NCT01634659|584636316|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
161888819|NCT01634659|584636317|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
161888820|NCT02918552|584636318|FG000|Overall Study|Failed Pharmacokinetics|1|||
161888821|NCT02918552|584636319|FG001|Overall Study|Failed Pharmacokinetics|0|||
161888822|NCT02918552|584636318|FG000|Overall Study|Withdrawal by Subject|0|||
161888823|NCT02918552|584636319|FG001|Overall Study|Withdrawal by Subject|1|||
161888824|NCT02918552|584636318|FG000|Overall Study|Lost to Follow-up|0|||
161888825|NCT02918552|584636319|FG001|Overall Study|Lost to Follow-up|1|||
161888826|NCT04395274|584636320|FG000|Overall Study|Lost to Follow-up|20|||
161888827|NCT04395274|584636321|FG001|Overall Study|Lost to Follow-up|11|||
161888828|NCT04395274|584636320|FG000|Overall Study|Withdrawal by Subject|13|||
161888829|NCT04395274|584636321|FG001|Overall Study|Withdrawal by Subject|10|||
161888830|NCT04395274|584636320|FG000|Overall Study|Moved Abroad|0|||
161888831|NCT04395274|584636321|FG001|Overall Study|Moved Abroad|1|||
161888832|NCT00335959|584636322|FG000|Overall Study|Adverse Event|2|||
161888833|NCT00335959|584636322|FG000|Overall Study|Ineligible|1|||
161888834|NCT00824382|584636325|FG000|Overall Study|Adverse Event|4|||
161888835|NCT00824382|584636326|FG001|Overall Study|Adverse Event|1|||
161888836|NCT00824382|584636327|FG002|Overall Study|Adverse Event|1|||
161888837|NCT00824382|584636328|FG003|Overall Study|Adverse Event|4|||
161888838|NCT00824382|584636325|FG000|Overall Study|Protocol Violation|1|||
161888839|NCT00824382|584636326|FG001|Overall Study|Protocol Violation|0|||
161888840|NCT00824382|584636327|FG002|Overall Study|Protocol Violation|0|||
161888841|NCT00824382|584636328|FG003|Overall Study|Protocol Violation|1|||
161888842|NCT00824382|584636325|FG000|Overall Study|Investigator's decision|0|||
161888843|NCT00824382|584636326|FG001|Overall Study|Investigator's decision|1|||
161888844|NCT00824382|584636327|FG002|Overall Study|Investigator's decision|2|||
161888845|NCT00824382|584636328|FG003|Overall Study|Investigator's decision|0|||
161888846|NCT02908074|584636329|FG000|Overall Study|sponsor/ICON decision|0|||
161888847|NCT02908074|584636330|FG001|Overall Study|sponsor/ICON decision|0|||
161888848|NCT02908074|584636331|FG002|Overall Study|sponsor/ICON decision|1|||
161888849|NCT02908074|584636332|FG003|Overall Study|sponsor/ICON decision|0|||
161888850|NCT02908074|584636333|FG004|Overall Study|sponsor/ICON decision|0|||
161888851|NCT02908074|584636334|FG005|Overall Study|sponsor/ICON decision|0|||
161888852|NCT02908074|584636329|FG000|Overall Study|Protocol Violation|0|||
161888853|NCT02908074|584636330|FG001|Overall Study|Protocol Violation|1|||
161888854|NCT02908074|584636331|FG002|Overall Study|Protocol Violation|0|||
161888855|NCT02908074|584636332|FG003|Overall Study|Protocol Violation|0|||
161888856|NCT02908074|584636333|FG004|Overall Study|Protocol Violation|0|||
161888857|NCT02908074|584636334|FG005|Overall Study|Protocol Violation|0|||
161888858|NCT02908074|584636329|FG000|Overall Study|Adverse Event|5|||
161888859|NCT02908074|584636330|FG001|Overall Study|Adverse Event|2|||
161888860|NCT02908074|584636331|FG002|Overall Study|Adverse Event|0|||
161888861|NCT02908074|584636332|FG003|Overall Study|Adverse Event|0|||
161888862|NCT02908074|584636333|FG004|Overall Study|Adverse Event|1|||
161888863|NCT02908074|584636334|FG005|Overall Study|Adverse Event|0|||
161888864|NCT02908074|584636329|FG000|Overall Study|AESI|1|||
161888865|NCT02908074|584636330|FG001|Overall Study|AESI|0|||
161888866|NCT02908074|584636331|FG002|Overall Study|AESI|1|||
161888867|NCT02908074|584636332|FG003|Overall Study|AESI|0|||
161888868|NCT02908074|584636333|FG004|Overall Study|AESI|1|||
161888869|NCT02908074|584636334|FG005|Overall Study|AESI|0|||
161888870|NCT02908074|584636329|FG000|Overall Study|Discontinuation criteria per protocol|0|||
161888871|NCT02908074|584636330|FG001|Overall Study|Discontinuation criteria per protocol|0|||
161888872|NCT02908074|584636331|FG002|Overall Study|Discontinuation criteria per protocol|1|||
161888873|NCT02908074|584636332|FG003|Overall Study|Discontinuation criteria per protocol|0|||
161888874|NCT02908074|584636333|FG004|Overall Study|Discontinuation criteria per protocol|0|||
161888875|NCT02908074|584636334|FG005|Overall Study|Discontinuation criteria per protocol|1|||
161888876|NCT02908074|584636329|FG000|Overall Study|Withdrawal by Subject|3|||
161888877|NCT02908074|584636330|FG001|Overall Study|Withdrawal by Subject|2|||
161888878|NCT02908074|584636331|FG002|Overall Study|Withdrawal by Subject|2|||
161888879|NCT02908074|584636332|FG003|Overall Study|Withdrawal by Subject|2|||
161888880|NCT02908074|584636333|FG004|Overall Study|Withdrawal by Subject|2|||
161888881|NCT02908074|584636334|FG005|Overall Study|Withdrawal by Subject|2|||
161888882|NCT02908074|584636329|FG000|Overall Study|Lost to Follow-up|0|||
161888883|NCT02908074|584636330|FG001|Overall Study|Lost to Follow-up|1|||
161888884|NCT02908074|584636331|FG002|Overall Study|Lost to Follow-up|1|||
161888885|NCT02908074|584636332|FG003|Overall Study|Lost to Follow-up|1|||
161888886|NCT02908074|584636333|FG004|Overall Study|Lost to Follow-up|0|||
161888887|NCT02908074|584636334|FG005|Overall Study|Lost to Follow-up|1|||
161888888|NCT00642954|584638188|FG000|Overall Study|Progressive Disease|3|||
161888889|NCT00642954|584638189|FG001|Overall Study|Progressive Disease|3|||
161888890|NCT00642954|584638190|FG002|Overall Study|Progressive Disease|3|||
161888891|NCT00642954|584638191|FG003|Overall Study|Progressive Disease|3|||
161888892|NCT00642954|584638192|FG004|Overall Study|Progressive Disease|9|||
161888893|NCT00642954|584638188|FG000|Overall Study|Withdrawal by Subject|0|||
161888894|NCT00642954|584638189|FG001|Overall Study|Withdrawal by Subject|0|||
161888895|NCT00642954|584638190|FG002|Overall Study|Withdrawal by Subject|0|||
161888896|NCT00642954|584638191|FG003|Overall Study|Withdrawal by Subject|0|||
161888897|NCT00642954|584638192|FG004|Overall Study|Withdrawal by Subject|1|||
161888898|NCT00642954|584638188|FG000|Overall Study|Adverse Event|1|||
161888899|NCT00642954|584638189|FG001|Overall Study|Adverse Event|1|||
161888900|NCT00642954|584638190|FG002|Overall Study|Adverse Event|0|||
161888901|NCT00642954|584638191|FG003|Overall Study|Adverse Event|0|||
161888902|NCT00642954|584638192|FG004|Overall Study|Adverse Event|6|||
161888903|NCT01937715|584638195|FG000|Overall Study|Death|0|||
161888904|NCT01937715|584638196|FG001|Overall Study|Death|0|||
161888905|NCT01937715|584638197|FG002|Overall Study|Death|0|||
161888906|NCT01937715|584638198|FG003|Overall Study|Death|1|||
161888907|NCT01937715|584638199|FG004|Overall Study|Death|0|||
161888908|NCT01937715|584638195|FG000|Overall Study|Withdrawal by Subject|0|||
161888909|NCT01937715|584638196|FG001|Overall Study|Withdrawal by Subject|1|||
161888910|NCT01937715|584638197|FG002|Overall Study|Withdrawal by Subject|0|||
161888911|NCT01937715|584638198|FG003|Overall Study|Withdrawal by Subject|0|||
161888912|NCT01937715|584638199|FG004|Overall Study|Withdrawal by Subject|2|||
161888913|NCT01937715|584638195|FG000|Overall Study|Other|0|||
161888914|NCT01937715|584638196|FG001|Overall Study|Other|0|||
161888915|NCT01937715|584638197|FG002|Overall Study|Other|0|||
161888916|NCT01937715|584638198|FG003|Overall Study|Other|3|||
161888917|NCT01937715|584638199|FG004|Overall Study|Other|0|||
161888918|NCT00433017|584638202|FG000|Overall Study|Adverse Event|5|||
161888919|NCT00433017|584638203|FG001|Overall Study|Adverse Event|3|||
161888920|NCT00433017|584638202|FG000|Overall Study|Withdrawal by Subject|4|||
161888921|NCT00433017|584638203|FG001|Overall Study|Withdrawal by Subject|5|||
161888922|NCT00433017|584638202|FG000|Overall Study|Lost to Follow-up|3|||
161888923|NCT00433017|584638203|FG001|Overall Study|Lost to Follow-up|4|||
161888924|NCT00433017|584638202|FG000|Overall Study|Administrative problems|80|||
161888925|NCT00433017|584638203|FG001|Overall Study|Administrative problems|86|||
161888926|NCT00433017|584638202|FG000|Overall Study|Protocol Violation|1|||
161888927|NCT00433017|584638203|FG001|Overall Study|Protocol Violation|0|||
161888928|NCT00433017|584638202|FG000|Overall Study|Death|2|||
161888929|NCT00433017|584638203|FG001|Overall Study|Death|2|||
161888930|NCT00433017|584638202|FG000|Overall Study|Subject no longer requires study drug|1|||
161888931|NCT00433017|584638203|FG001|Overall Study|Subject no longer requires study drug|1|||
161888932|NCT00153816|584638204|FG000|Overall Study|Death|6|||
161888933|NCT00153816|584638205|FG001|Overall Study|Death|5|||
161888934|NCT00153816|584638206|FG002|Overall Study|Death|4|||
161888935|NCT00153816|584638207|FG003|Overall Study|Death|6|||
161888936|NCT00153816|584638208|FG004|Overall Study|Death|0|||
161888937|NCT00153816|584638209|FG005|Overall Study|Death|2|||
161888938|NCT00153816|584638204|FG000|Overall Study|Lost to Follow-up|7|||
161888939|NCT00153816|584638205|FG001|Overall Study|Lost to Follow-up|8|||
161888940|NCT00153816|584638206|FG002|Overall Study|Lost to Follow-up|5|||
161888941|NCT00153816|584638207|FG003|Overall Study|Lost to Follow-up|8|||
161888942|NCT00153816|584638208|FG004|Overall Study|Lost to Follow-up|7|||
161888943|NCT00153816|584638209|FG005|Overall Study|Lost to Follow-up|9|||
161888944|NCT00153816|584638204|FG000|Overall Study|Withdrawal by Subject|9|||
161888945|NCT00153816|584638205|FG001|Overall Study|Withdrawal by Subject|9|||
161888946|NCT00153816|584638206|FG002|Overall Study|Withdrawal by Subject|9|||
161888947|NCT00153816|584638207|FG003|Overall Study|Withdrawal by Subject|4|||
161888948|NCT00153816|584638208|FG004|Overall Study|Withdrawal by Subject|1|||
161888949|NCT00153816|584638209|FG005|Overall Study|Withdrawal by Subject|5|||
161888950|NCT00153816|584638204|FG000|Overall Study|Follow-up exam not done|8|||
161888951|NCT00153816|584638205|FG001|Overall Study|Follow-up exam not done|7|||
161888952|NCT00153816|584638206|FG002|Overall Study|Follow-up exam not done|11|||
161888953|NCT00153816|584638207|FG003|Overall Study|Follow-up exam not done|10|||
161888954|NCT00153816|584638208|FG004|Overall Study|Follow-up exam not done|8|||
161888955|NCT00153816|584638209|FG005|Overall Study|Follow-up exam not done|9|||
161888956|NCT00153816|584638204|FG000|Overall Study|Follow-up exam done, histology missing|2|||
161888957|NCT00153816|584638205|FG001|Overall Study|Follow-up exam done, histology missing|3|||
161888958|NCT00153816|584638206|FG002|Overall Study|Follow-up exam done, histology missing|3|||
161888959|NCT00153816|584638207|FG003|Overall Study|Follow-up exam done, histology missing|3|||
161888960|NCT00153816|584638208|FG004|Overall Study|Follow-up exam done, histology missing|1|||
161888961|NCT00153816|584638209|FG005|Overall Study|Follow-up exam done, histology missing|2|||
161888962|NCT03594955|584638212|FG000|Overall Study|Adverse Event|1|||
161888963|NCT03594955|584638212|FG000|Overall Study|Progressive disease|5|||
161888964|NCT03594955|584638212|FG000|Overall Study|Sponsor's decision|1|||
161888965|NCT03539484|584638214|FG000|Overall Study|Death|1|||
161888966|NCT03539484|584638215|FG001|Overall Study|Death|0|||
161888967|NCT03539484|584638216|FG002|Overall Study|Death|0|||
161888968|NCT03539484|584638217|FG003|Overall Study|Death|2|||
161888969|NCT03539484|584638218|FG004|Overall Study|Death|8|||
161888970|NCT03539484|584638219|FG005|Overall Study|Death|3|||
161888971|NCT03539484|584638220|FG006|Overall Study|Death|0|||
161888972|NCT03539484|584638214|FG000|Overall Study|Lost to Follow-up|0|||
161888973|NCT03539484|584638215|FG001|Overall Study|Lost to Follow-up|1|||
161888974|NCT03539484|584638216|FG002|Overall Study|Lost to Follow-up|0|||
161888975|NCT03539484|584638217|FG003|Overall Study|Lost to Follow-up|0|||
161888976|NCT03539484|584638218|FG004|Overall Study|Lost to Follow-up|1|||
161888977|NCT03539484|584638219|FG005|Overall Study|Lost to Follow-up|0|||
161888978|NCT03539484|584638220|FG006|Overall Study|Lost to Follow-up|0|||
161888979|NCT03539484|584638214|FG000|Overall Study|Withdrawal by Subject|0|||
161888980|NCT03539484|584638215|FG001|Overall Study|Withdrawal by Subject|0|||
161888981|NCT03539484|584638216|FG002|Overall Study|Withdrawal by Subject|0|||
161888982|NCT03539484|584638217|FG003|Overall Study|Withdrawal by Subject|0|||
161888983|NCT03539484|584638218|FG004|Overall Study|Withdrawal by Subject|2|||
161888984|NCT03539484|584638219|FG005|Overall Study|Withdrawal by Subject|0|||
161888985|NCT03539484|584638220|FG006|Overall Study|Withdrawal by Subject|1|||
161888986|NCT03539484|584638214|FG000|Overall Study|Study Terminated by Sponsor|0|||
161888987|NCT03539484|584638215|FG001|Overall Study|Study Terminated by Sponsor|0|||
161888988|NCT03539484|584638216|FG002|Overall Study|Study Terminated by Sponsor|1|||
161888989|NCT03539484|584638217|FG003|Overall Study|Study Terminated by Sponsor|1|||
161888990|NCT03539484|584638218|FG004|Overall Study|Study Terminated by Sponsor|2|||
161888991|NCT03539484|584638219|FG005|Overall Study|Study Terminated by Sponsor|2|||
161888992|NCT03539484|584638220|FG006|Overall Study|Study Terminated by Sponsor|1|||
161888993|NCT02131636|584638226|FG000|Overall Study|Personal Reasons|4|||
161888994|NCT02131636|584638227|FG001|Overall Study|Personal Reasons|4|||
161888995|NCT02131636|584638226|FG000|Overall Study|Lost to Follow-up|4|||
161888996|NCT02131636|584638227|FG001|Overall Study|Lost to Follow-up|0|||
161888997|NCT02131636|584638226|FG000|Overall Study|Adverse Event|4|||
161888998|NCT02131636|584638227|FG001|Overall Study|Adverse Event|1|||
161888999|NCT02173379|584638228|FG000|Overall Study|Lost to Follow-up|89|||
161889000|NCT02173379|584638229|FG001|Overall Study|Lost to Follow-up|81|||
161889001|NCT02173379|584638228|FG000|Overall Study|Withdrawal by Subject|24|||
161889002|NCT02173379|584638229|FG001|Overall Study|Withdrawal by Subject|29|||
161889003|NCT02173379|584638228|FG000|Overall Study|Physician Decision|8|||
161889004|NCT02173379|584638229|FG001|Overall Study|Physician Decision|8|||
161889005|NCT02173379|584638228|FG000|Overall Study|Death|75|||
161889006|NCT02173379|584638229|FG001|Overall Study|Death|72|||
161889007|NCT02173379|584638228|FG000|Overall Study|Other Reason|1|||
161889008|NCT02173379|584638229|FG001|Overall Study|Other Reason|0|||
161889009|NCT06226649|584638231|FG000|Overall Study|Withdrawal by Subject|4|||
161889010|NCT06226649|584638232|FG001|Overall Study|Withdrawal by Subject|1|||
161889011|NCT02305446|584638237|FG000|Overall Study|Adverse Event|1|||
161889012|NCT01636947|584638238|FG000|Overall Study|Not Treated|2|||
161889013|NCT01636947|584638239|FG001|Overall Study|Not Treated|2|||
161889014|NCT01636947|584638238|FG000|Overall Study|Lost to Follow-up|4|||
161889015|NCT01636947|584638239|FG001|Overall Study|Lost to Follow-up|0|||
161889016|NCT01636947|584638238|FG000|Overall Study|Protocol Violation|1|||
161889017|NCT01636947|584638239|FG001|Overall Study|Protocol Violation|1|||
161889018|NCT01636947|584638238|FG000|Overall Study|Withdrawal by Subject|3|||
161889019|NCT01636947|584638239|FG001|Overall Study|Withdrawal by Subject|3|||
161889020|NCT01636947|584638238|FG000|Overall Study|Adverse Event|1|||
161889021|NCT01636947|584638239|FG001|Overall Study|Adverse Event|1|||
161889022|NCT01636947|584638238|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161889023|NCT01636947|584638239|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
161889024|NCT00427999|584638244|FG000|Overall Study|Adverse Event|6|||
161889025|NCT00427999|584638244|FG000|Overall Study|Abnormal laboratory values|1|||
161889026|NCT00427999|584638244|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
161889027|NCT00427999|584638244|FG000|Overall Study|Protocol Violation|2|||
161889028|NCT00427999|584638244|FG000|Overall Study|Withdrawal by Subject|9|||
161889029|NCT00427999|584638244|FG000|Overall Study|Death|1|||
161889030|NCT00460265|584638245|FG000|Overall Study|Lost to Follow-up|14|||
161889031|NCT00460265|584638246|FG001|Overall Study|Lost to Follow-up|15|||
161889032|NCT00460265|584638245|FG000|Overall Study|Physician Decision|1|||
161889033|NCT00460265|584638246|FG001|Overall Study|Physician Decision|2|||
161889034|NCT00460265|584638245|FG000|Overall Study|Withdrawal by Subject|10|||
161889035|NCT00460265|584638246|FG001|Overall Study|Withdrawal by Subject|25|||
161889036|NCT00460265|584638245|FG000|Overall Study|Ongoing|60|||
161889037|NCT00460265|584638246|FG001|Overall Study|Ongoing|47|||
161889038|NCT02956057|584638258|FG000|Overall Study|Discontinued intervention|14|||
161889039|NCT02956057|584638259|FG001|Overall Study|Discontinued intervention|10|||
161889040|NCT02956057|584638260|FG002|Overall Study|Discontinued intervention|7|||
161889041|NCT02956057|584638261|FG003|Overall Study|Discontinued intervention|14|||
161889042|NCT02956057|584638262|FG004|Overall Study|Discontinued intervention|4|||
161889043|NCT02956057|584638263|FG005|Overall Study|Discontinued intervention|17|||
161889044|NCT02956057|584638258|FG000|Overall Study|Lost to Follow-up|0|||
161889045|NCT02956057|584638259|FG001|Overall Study|Lost to Follow-up|2|||
161889046|NCT02956057|584638260|FG002|Overall Study|Lost to Follow-up|1|||
161889047|NCT02956057|584638261|FG003|Overall Study|Lost to Follow-up|1|||
161889048|NCT02956057|584638262|FG004|Overall Study|Lost to Follow-up|1|||
161889049|NCT02956057|584638263|FG005|Overall Study|Lost to Follow-up|0|||
161889050|NCT01420679|584638268|FG000|Overall Study|Disease Progression|3|||
161889051|NCT01420679|584638269|FG001|Overall Study|Disease Progression|2|||
161889052|NCT01420679|584638268|FG000|Overall Study|Adverse Event|4|||
161889053|NCT01420679|584638269|FG001|Overall Study|Adverse Event|0|||
161889054|NCT01420679|584638268|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
161889055|NCT01420679|584638269|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
161889056|NCT01420679|584638268|FG000|Overall Study|Patient Decision|1|||
161889057|NCT01420679|584638269|FG001|Overall Study|Patient Decision|0|||
161889058|NCT01420679|584638268|FG000|Overall Study|Investigator Decision|1|||
161889059|NCT01420679|584638269|FG001|Overall Study|Investigator Decision|2|||
161889060|NCT01420679|584638268|FG000|Overall Study|Sponsor Decision|3|||
161889061|NCT01420679|584638269|FG001|Overall Study|Sponsor Decision|3|||
161889062|NCT01420679|584638268|FG000|Overall Study|Other|1|||
161889063|NCT01420679|584638269|FG001|Overall Study|Other|0|||
161889064|NCT03956615|584638270|FG000|Overall Study|No multiple myeloma confirmed|2|||
161889065|NCT03956615|584638270|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
161889066|NCT03956615|584638270|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
161889067|NCT03956615|584638270|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
161889068|NCT01069419|584638271|FG000|Overall Study|Adverse Event|233|||
161889069|NCT01069419|584638271|FG000|Overall Study|Lack of Efficacy|332|||
161889070|NCT01069419|584638271|FG000|Overall Study|Lost to Follow-up|49|||
161889071|NCT01069419|584638271|FG000|Overall Study|Remission of disease|11|||
161889072|NCT01069419|584638271|FG000|Overall Study|Withdrawal by Subject|34|||
161889073|NCT01069419|584638271|FG000|Overall Study|Other Reason|43|||
161889074|NCT01069419|584638271|FG000|Overall Study|Missing termination information|13|||
161889075|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
161889076|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
161889077|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
161889078|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
161889079|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
161889080|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
161889081|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
161889082|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
161889083|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
161889084|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
161889085|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
161889086|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
161889087|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Death|0|||
161889088|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Death|0|||
161889089|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Death|1|||
161889090|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Death|0|||
161889091|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161889092|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
161889093|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161889094|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161889095|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
161889096|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
161889097|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
161889098|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
161889099|NCT01179737|584638274|FG000|Extension|The study was terminated|3|||
161889100|NCT01179737|584638275|FG001|Extension|The study was terminated|0|||
161889101|NCT01179737|584638276|FG002|Extension|The study was terminated|0|||
161889102|NCT01179737|584638277|FG003|Extension|The study was terminated|0|||
161889103|NCT01254721|584638278|FG000|Overall Study|Lost to Follow-up|0|||
161889104|NCT01254721|584638279|FG001|Overall Study|Lost to Follow-up|4|||
161889105|NCT01254721|584638278|FG000|Overall Study|Lack of Efficacy|4|||
161889106|NCT01254721|584638279|FG001|Overall Study|Lack of Efficacy|2|||
161889107|NCT01254721|584638278|FG000|Overall Study|Death|0|||
161889108|NCT01254721|584638279|FG001|Overall Study|Death|1|||
161889109|NCT01254721|584638278|FG000|Overall Study|technical problum|1|||
161889110|NCT01254721|584638279|FG001|Overall Study|technical problum|0|||
161889111|NCT01254721|584638278|FG000|Overall Study|Adverse Event|2|||
161889112|NCT01254721|584638279|FG001|Overall Study|Adverse Event|3|||
161889113|NCT01254721|584638278|FG000|Overall Study|Withdrawal by Subject|8|||
161889114|NCT01254721|584638279|FG001|Overall Study|Withdrawal by Subject|11|||
161889115|NCT01254721|584638278|FG000|Overall Study|Wrongly randomization|0|||
161889116|NCT01254721|584638279|FG001|Overall Study|Wrongly randomization|1|||
161889117|NCT01955109|584638280|FG000|Overall Study|Adverse Event|2|||
161889118|NCT01955109|584638281|FG001|Overall Study|Adverse Event|0|||
161889119|NCT01955109|584638280|FG000|Overall Study|Participant unwilling to continue|35|||
161889120|NCT01955109|584638281|FG001|Overall Study|Participant unwilling to continue|7|||
161889121|NCT01955109|584638280|FG000|Overall Study|Physician Decision|2|||
161889122|NCT01955109|584638281|FG001|Overall Study|Physician Decision|0|||
161889123|NCT01955109|584638280|FG000|Overall Study|Lost to Follow-up|3|||
161889124|NCT01955109|584638281|FG001|Overall Study|Lost to Follow-up|1|||
161889125|NCT01955109|584638280|FG000|Overall Study|Non-compliance|3|||
161889126|NCT01955109|584638281|FG001|Overall Study|Non-compliance|1|||
161889127|NCT00904839|584638282|FG000|Overall Study|Adverse Event|0|||
161889128|NCT00904839|584638283|FG001|Overall Study|Adverse Event|5|||
161889129|NCT00904839|584638284|FG002|Overall Study|Adverse Event|4|||
161889130|NCT00904839|584638282|FG000|Overall Study|Protocol Violation|0|||
161889131|NCT00904839|584638283|FG001|Overall Study|Protocol Violation|1|||
161889132|NCT00904839|584638284|FG002|Overall Study|Protocol Violation|1|||
161889133|NCT00904839|584638282|FG000|Overall Study|Lost to Follow-up|0|||
161889134|NCT00904839|584638283|FG001|Overall Study|Lost to Follow-up|1|||
161889135|NCT00904839|584638284|FG002|Overall Study|Lost to Follow-up|2|||
161889136|NCT00904839|584638282|FG000|Overall Study|Withdrawal by Subject|0|||
161889137|NCT00904839|584638283|FG001|Overall Study|Withdrawal by Subject|2|||
161889138|NCT00904839|584638284|FG002|Overall Study|Withdrawal by Subject|0|||
161889139|NCT00904839|584638282|FG000|Overall Study|Not treated|1|||
161889140|NCT00904839|584638283|FG001|Overall Study|Not treated|0|||
161889141|NCT00904839|584638284|FG002|Overall Study|Not treated|1|||
161889142|NCT00904839|584638282|FG000|Overall Study|Other than above|0|||
161889143|NCT00904839|584638283|FG001|Overall Study|Other than above|9|||
161889144|NCT00904839|584638284|FG002|Overall Study|Other than above|7|||
161889145|NCT01853696|584638287|FG000|Overall Study|Withdrawal by Subject|1|||
161889146|NCT01853696|584638288|FG001|Overall Study|Withdrawal by Subject|1|||
161889147|NCT01853696|584638287|FG000|Overall Study|Lost to Follow-up|5|||
161889148|NCT01853696|584638288|FG001|Overall Study|Lost to Follow-up|4|||
161889149|NCT01167634|584638289|FG000|Overall Study|Lost to Follow-up|1|||
161889150|NCT01167634|584638290|FG001|Overall Study|Lost to Follow-up|3|||
161889151|NCT01167634|584638291|FG002|Overall Study|Lost to Follow-up|3|||
161889152|NCT01167634|584638292|FG003|Overall Study|Lost to Follow-up|4|||
161889153|NCT01167634|584638289|FG000|Overall Study|Withdrawal by Subject|1|||
161889154|NCT01167634|584638290|FG001|Overall Study|Withdrawal by Subject|1|||
161889155|NCT01167634|584638291|FG002|Overall Study|Withdrawal by Subject|0|||
161889156|NCT01167634|584638292|FG003|Overall Study|Withdrawal by Subject|0|||
161889157|NCT00553358|584638293|FG000|Overall Study|Randomized but did not receive treatment|3|||
161889158|NCT00553358|584638294|FG001|Overall Study|Randomized but did not receive treatment|3|||
161889159|NCT00553358|584638295|FG002|Overall Study|Randomized but did not receive treatment|1|||
161889160|NCT00553358|584638293|FG000|Overall Study|Lost to Follow-up|22|||
161889161|NCT00553358|584638294|FG001|Overall Study|Lost to Follow-up|26|||
161889162|NCT00553358|584638295|FG002|Overall Study|Lost to Follow-up|18|||
161889163|NCT00553358|584638293|FG000|Overall Study|Withdrew completely|23|||
161889164|NCT00553358|584638294|FG001|Overall Study|Withdrew completely|33|||
161889165|NCT00553358|584638295|FG002|Overall Study|Withdrew completely|34|||
161889166|NCT00553358|584638293|FG000|Overall Study|Died during clinical follow-up|25|||
161889167|NCT00553358|584638294|FG001|Overall Study|Died during clinical follow-up|29|||
161889168|NCT00553358|584638295|FG002|Overall Study|Died during clinical follow-up|32|||
161889169|NCT00553358|584638293|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
161889170|NCT00553358|584638294|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
161889171|NCT00553358|584638295|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
161889172|NCT00553358|584638293|FG000|Overall Study|Died after clinical follow-up ended|1|||
161889173|NCT00553358|584638294|FG001|Overall Study|Died after clinical follow-up ended|2|||
161889174|NCT00553358|584638295|FG002|Overall Study|Died after clinical follow-up ended|0|||
161889175|NCT00553358|584638293|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161889176|NCT00553358|584638294|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161889177|NCT00553358|584638295|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161889178|NCT02854605|584638300|FG000|Overall Study|Adverse Event|1|||
161889179|NCT02854605|584638301|FG001|Overall Study|Adverse Event|5|||
161889180|NCT02854605|584638302|FG002|Overall Study|Adverse Event|2|||
161889181|NCT02854605|584638300|FG000|Overall Study|Lost to Follow-up|0|||
161889182|NCT02854605|584638301|FG001|Overall Study|Lost to Follow-up|2|||
161889183|NCT02854605|584638302|FG002|Overall Study|Lost to Follow-up|0|||
161889184|NCT02854605|584638300|FG000|Overall Study|Withdrew Consent|1|||
161889185|NCT02854605|584638301|FG001|Overall Study|Withdrew Consent|0|||
161889186|NCT02854605|584638302|FG002|Overall Study|Withdrew Consent|1|||
161889187|NCT02854605|584638300|FG000|Overall Study|Investigator's Discretion|1|||
161889188|NCT02854605|584638301|FG001|Overall Study|Investigator's Discretion|0|||
161889189|NCT02854605|584638302|FG002|Overall Study|Investigator's Discretion|0|||
161889190|NCT02854605|584638300|FG000|Overall Study|Protocol Violation|0|||
161889191|NCT02854605|584638301|FG001|Overall Study|Protocol Violation|0|||
161889192|NCT02854605|584638302|FG002|Overall Study|Protocol Violation|1|||
161889193|NCT03003000|584638303|FG000|Overall Study|Adverse Event|1|||
161889194|NCT03003000|584638304|FG001|Overall Study|Adverse Event|2|||
161889195|NCT03003000|584638305|FG002|Overall Study|Adverse Event|3|||
161889196|NCT03003000|584638303|FG000|Overall Study|Lack of Efficacy|1|||
161889197|NCT03003000|584638304|FG001|Overall Study|Lack of Efficacy|0|||
161889198|NCT03003000|584638305|FG002|Overall Study|Lack of Efficacy|0|||
161889199|NCT03003000|584638303|FG000|Overall Study|Non-compliant with protocol|0|||
161889200|NCT03003000|584638304|FG001|Overall Study|Non-compliant with protocol|1|||
161889201|NCT03003000|584638305|FG002|Overall Study|Non-compliant with protocol|1|||
161889202|NCT03003000|584638303|FG000|Overall Study|Refused to continue medication|2|||
161889203|NCT03003000|584638304|FG001|Overall Study|Refused to continue medication|0|||
161889204|NCT03003000|584638305|FG002|Overall Study|Refused to continue medication|0|||
161889205|NCT03003000|584638303|FG000|Overall Study|Other than listed|1|||
161889206|NCT03003000|584638304|FG001|Overall Study|Other than listed|1|||
161889207|NCT03003000|584638305|FG002|Overall Study|Other than listed|1|||
161889208|NCT04933617|584638307|FG000|Dose Escalation|Early closure of study|0|||
161889209|NCT04933617|584638308|FG001|Dose Escalation|Early closure of study|3|||
161889210|NCT04933617|584638309|FG002|Dose Escalation|Early closure of study|0|||
161889211|NCT04933617|584638310|FG003|Dose Escalation|Early closure of study|0|||
161889212|NCT04933617|584638311|FG004|Dose Escalation|Early closure of study|0|||
161889213|NCT05268016|584638312|FG000|Overall Study|Unacceptable toxicity or AE|2|||
161889214|NCT05268016|584638313|FG001|Overall Study|Unacceptable toxicity or AE|2|||
161889215|NCT05268016|584638314|FG002|Overall Study|Unacceptable toxicity or AE|4|||
161889216|NCT05268016|584638315|FG003|Overall Study|Unacceptable toxicity or AE|3|||
161889217|NCT05268016|584638316|FG004|Overall Study|Unacceptable toxicity or AE|1|||
161889218|NCT05268016|584638312|FG000|Overall Study|Withdrawal by Subject|1|||
161889219|NCT05268016|584638313|FG001|Overall Study|Withdrawal by Subject|3|||
161889220|NCT05268016|584638314|FG002|Overall Study|Withdrawal by Subject|2|||
161889221|NCT05268016|584638315|FG003|Overall Study|Withdrawal by Subject|2|||
161889222|NCT05268016|584638316|FG004|Overall Study|Withdrawal by Subject|1|||
161889223|NCT05268016|584638312|FG000|Overall Study|Lost to Follow-up|4|||
161889224|NCT05268016|584638313|FG001|Overall Study|Lost to Follow-up|7|||
161889225|NCT05268016|584638314|FG002|Overall Study|Lost to Follow-up|1|||
161889226|NCT05268016|584638315|FG003|Overall Study|Lost to Follow-up|3|||
161889227|NCT05268016|584638316|FG004|Overall Study|Lost to Follow-up|5|||
161889228|NCT05268016|584638312|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
161889229|NCT05268016|584638313|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161889230|NCT05268016|584638314|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161889231|NCT05268016|584638315|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
161889232|NCT05268016|584638316|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161889233|NCT05268016|584638312|FG000|Overall Study|Lack of Efficacy|0|||
161889234|NCT05268016|584638313|FG001|Overall Study|Lack of Efficacy|0|||
161889235|NCT05268016|584638314|FG002|Overall Study|Lack of Efficacy|0|||
161889236|NCT05268016|584638315|FG003|Overall Study|Lack of Efficacy|0|||
161889237|NCT05268016|584638316|FG004|Overall Study|Lack of Efficacy|4|||
161889238|NCT05268016|584638312|FG000|Overall Study|Physician Decision|0|||
161889239|NCT05268016|584638313|FG001|Overall Study|Physician Decision|0|||
161889240|NCT05268016|584638314|FG002|Overall Study|Physician Decision|0|||
161889241|NCT05268016|584638315|FG003|Overall Study|Physician Decision|1|||
161889242|NCT05268016|584638316|FG004|Overall Study|Physician Decision|0|||
161889243|NCT05268016|584638312|FG000|Overall Study|Other|1|||
161889244|NCT05268016|584638313|FG001|Overall Study|Other|0|||
161889245|NCT05268016|584638314|FG002|Overall Study|Other|1|||
161889246|NCT05268016|584638315|FG003|Overall Study|Other|2|||
161889247|NCT05268016|584638316|FG004|Overall Study|Other|0|||
161889248|NCT01217385|584638318|FG000|Overall Study|Withdrawal by Subject|3|||
161889249|NCT01217385|584638318|FG000|Overall Study|DOSI not performed/not eval|12|||
161889250|NCT01217385|584638318|FG000|Overall Study|Central Path not Available|1|||
161889251|NCT01217385|584638318|FG000|Overall Study|Normal Breast TOI not available|10|||
161889252|NCT00090987|584638319|FG000|Overall Study|Adverse Event|5|||
161889253|NCT00090987|584638319|FG000|Overall Study|Lack of Efficacy|7|||
161889254|NCT00090987|584638319|FG000|Overall Study|Withdrawal by Subject|3|||
161889255|NCT00090987|584638319|FG000|Overall Study|alternative therapy|1|||
161889256|NCT00090987|584638319|FG000|Overall Study|Non-compliance|4|||
161889257|NCT00090987|584638319|FG000|Overall Study|Incarcerated|1|||
161889258|NCT00990665|584638324|FG000|Overall Study|Unsuccessful Implant|8|||
161889259|NCT00990665|584638324|FG000|Overall Study|Death|29|||
161889260|NCT00990665|584638324|FG000|Overall Study|Heart Transplant|1|||
161889261|NCT00990665|584638324|FG000|Overall Study|Withdrawal by Subject|6|||
161889262|NCT00990665|584638324|FG000|Overall Study|Lost to Follow-up|1|||
161889263|NCT00990665|584638324|FG000|Overall Study|System Explant|3|||
161889264|NCT00957905|584638325|FG000|Part B|Not Treated|0|||
161889265|NCT00957905|584638326|FG001|Part B|Not Treated|1|||
161889266|NCT00957905|584638325|FG000|Part B|Physician Decision|0|||
161889267|NCT00957905|584638326|FG001|Part B|Physician Decision|1|||
161889268|NCT00957905|584638325|FG000|Part B|Death|0|||
161889269|NCT00957905|584638326|FG001|Part B|Death|1|||
161889270|NCT00957905|584638325|FG000|Part B|Protocol Violation|0|||
161889271|NCT00957905|584638326|FG001|Part B|Protocol Violation|1|||
161889272|NCT01260584|584638343|FG000|Period 1|Protocol Violation|0|||
161889273|NCT01260584|584638344|FG001|Period 1|Protocol Violation|0|||
161889274|NCT01260584|584638345|FG002|Period 1|Protocol Violation|1|||
161889275|NCT01260584|584638346|FG003|Period 1|Protocol Violation|1|||
161889276|NCT01260584|584638343|FG000|Period 1|Adverse Event|0|||
161889277|NCT01260584|584638344|FG001|Period 1|Adverse Event|0|||
161889278|NCT01260584|584638345|FG002|Period 1|Adverse Event|1|||
161889279|NCT01260584|584638346|FG003|Period 1|Adverse Event|0|||
161889280|NCT01260584|584638343|FG000|Period 2|Protocol Violation|0|||
161889281|NCT01260584|584638344|FG001|Period 2|Protocol Violation|2|||
161889282|NCT01260584|584638345|FG002|Period 2|Protocol Violation|3|||
161889283|NCT01260584|584638346|FG003|Period 2|Protocol Violation|1|||
161889284|NCT01260584|584638343|FG000|Period 2|Adverse Event|1|||
161889285|NCT01260584|584638344|FG001|Period 2|Adverse Event|0|||
161889286|NCT01260584|584638345|FG002|Period 2|Adverse Event|2|||
161889287|NCT01260584|584638346|FG003|Period 2|Adverse Event|0|||
161889288|NCT01260584|584638343|FG000|Period 2|Withdrawal by Subject|0|||
161889289|NCT01260584|584638344|FG001|Period 2|Withdrawal by Subject|1|||
161889290|NCT01260584|584638345|FG002|Period 2|Withdrawal by Subject|0|||
161889291|NCT01260584|584638346|FG003|Period 2|Withdrawal by Subject|0|||
161889292|NCT00045734|584638347|FG000|Overall Study|Protocol Violation|1|||
161889293|NCT02069093|584638348|FG000|Overall Study|Disease progression|14|||
161889294|NCT02069093|584638348|FG000|Overall Study|New cancer therapy|1|||
161889295|NCT02069093|584638348|FG000|Overall Study|Death|1|||
161889296|NCT02069093|584638348|FG000|Overall Study|Administrative problems|1|||
161889297|NCT02069093|584638348|FG000|Overall Study|Withdrawal by Subject|2|||
161889298|NCT02069093|584638348|FG000|Overall Study|Abnormal laboratory values|1|||
161889299|NCT02069093|584638348|FG000|Overall Study|Adverse Event|10|||
161889300|NCT01969084|584638352|FG000|Overall Study|Adverse Event|0|||
161889301|NCT01969084|584638353|FG001|Overall Study|Adverse Event|1|||
161889302|NCT01362244|584638354|FG000|Overall Study|Adverse Event|3|||
161889303|NCT01362244|584638355|FG001|Overall Study|Adverse Event|5|||
161889304|NCT01362244|584638354|FG000|Overall Study|Lack of Efficacy|5|||
161889305|NCT01362244|584638355|FG001|Overall Study|Lack of Efficacy|11|||
161889306|NCT01362244|584638354|FG000|Overall Study|Lost to Follow-up|0|||
161889307|NCT01362244|584638355|FG001|Overall Study|Lost to Follow-up|2|||
161889308|NCT01362244|584638354|FG000|Overall Study|Protocol Violation|5|||
161889309|NCT01362244|584638355|FG001|Overall Study|Protocol Violation|1|||
161889310|NCT01362244|584638354|FG000|Overall Study|Withdrawal by Subject|2|||
161889311|NCT01362244|584638355|FG001|Overall Study|Withdrawal by Subject|1|||
161889312|NCT01362244|584638354|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
161889313|NCT01362244|584638355|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
161889314|NCT01362244|584638354|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
161889315|NCT01362244|584638355|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
161889316|NCT01253174|584638356|FG000|Period 1|Randomized but not treated|0|||
161889317|NCT01253174|584638357|FG001|Period 1|Randomized but not treated|1|||
161889318|NCT01253174|584638358|FG002|Period 1|Randomized but not treated|1|||
161889319|NCT01253174|584638359|FG003|Period 1|Randomized but not treated|0|||
161889320|NCT01253174|584638360|FG004|Period 1|Randomized but not treated|1|||
161889321|NCT01253174|584638361|FG005|Period 1|Randomized but not treated|0|||
161889322|NCT01253174|584638356|FG000|Period 2|Adverse Event|0|||
161889323|NCT01253174|584638357|FG001|Period 2|Adverse Event|0|||
161889324|NCT01253174|584638358|FG002|Period 2|Adverse Event|1|||
161889325|NCT01253174|584638359|FG003|Period 2|Adverse Event|0|||
161889326|NCT01253174|584638360|FG004|Period 2|Adverse Event|0|||
161889327|NCT01253174|584638361|FG005|Period 2|Adverse Event|0|||
161889328|NCT01253174|584638356|FG000|Period 3|Withdrawal by Subject|0|||
161889329|NCT01253174|584638357|FG001|Period 3|Withdrawal by Subject|1|||
161889330|NCT01253174|584638358|FG002|Period 3|Withdrawal by Subject|0|||
161889331|NCT01253174|584638359|FG003|Period 3|Withdrawal by Subject|0|||
161889332|NCT01253174|584638360|FG004|Period 3|Withdrawal by Subject|1|||
161889333|NCT01253174|584638361|FG005|Period 3|Withdrawal by Subject|0|||
161889334|NCT01253174|584638356|FG000|Period 3|Pregnancy|0|||
161889335|NCT01253174|584638357|FG001|Period 3|Pregnancy|0|||
161889336|NCT01253174|584638358|FG002|Period 3|Pregnancy|1|||
161889337|NCT01253174|584638359|FG003|Period 3|Pregnancy|0|||
161889338|NCT01253174|584638360|FG004|Period 3|Pregnancy|0|||
161889339|NCT01253174|584638361|FG005|Period 3|Pregnancy|0|||
161889340|NCT02267135|584638362|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
161889341|NCT02267135|584638363|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
161889342|NCT02267135|584638362|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
161889343|NCT02267135|584638363|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
161889344|NCT02267135|584638362|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
161889345|NCT02267135|584638363|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
161889346|NCT02267135|584638362|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
161889347|NCT02267135|584638363|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
161889348|NCT02267135|584638362|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
161889349|NCT02267135|584638363|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
161889350|NCT03806231|584638364|FG000|Overall Study|Physician Decision|1|||
161889351|NCT03806231|584638365|FG001|Overall Study|Physician Decision|0|||
161889352|NCT03806231|584638364|FG000|Overall Study|Withdrawal by Subject|1|||
161889353|NCT03806231|584638365|FG001|Overall Study|Withdrawal by Subject|0|||
161889354|NCT02919267|584638366|FG000|Overall Study|Protocol Violation|0|||
161889355|NCT02919267|584638367|FG001|Overall Study|Protocol Violation|3|||
161889356|NCT02919267|584638368|FG002|Overall Study|Protocol Violation|3|||
161889357|NCT02919267|584638369|FG003|Overall Study|Protocol Violation|4|||
161889358|NCT00467961|584638370|FG000|Overall Study|Technical Failures|5|||
161889359|NCT00467961|584638370|FG000|Overall Study|Disease Progression|2|||
161889360|NCT00394433|584638372|FG000|Overall Study|Adverse Event|2|||
161889361|NCT00394433|584638372|FG000|Overall Study|Alternative Therapy|1|||
161889362|NCT06439095|584639773|FG000|Overall Study|Lost to Follow-up|2|||
161889363|NCT03484403|584639775|FG000|Overall Study|Withdrawal by Subject|6|||
161889364|NCT03484403|584639776|FG001|Overall Study|Withdrawal by Subject|4|||
161889365|NCT01937884|584639778|FG000|Overall Study|Withdrawal by Subject|1|||
161889366|NCT01937884|584639779|FG001|Overall Study|Withdrawal by Subject|0|||
161889367|NCT02191046|584639780|FG000|Overall Study|low compliance|5|||
161889368|NCT02191046|584639781|FG001|Overall Study|low compliance|1|||
161889369|NCT01964716|584639782|FG000|Overall Study|Withdrawal by Subject|2|||
161889370|NCT01964716|584639783|FG001|Overall Study|Withdrawal by Subject|3|||
161889371|NCT01964716|584639782|FG000|Overall Study|Lost to Follow-up|1|||
161889372|NCT01964716|584639783|FG001|Overall Study|Lost to Follow-up|2|||
161889373|NCT01964716|584639782|FG000|Overall Study|No longer met eligibility criteria|1|||
161889374|NCT01964716|584639783|FG001|Overall Study|No longer met eligibility criteria|1|||
161889375|NCT01964716|584639782|FG000|Overall Study|Death|1|||
161889376|NCT01964716|584639783|FG001|Overall Study|Death|0|||
161889377|NCT02147067|584639784|FG000|Overall Study|Withdrawal by Subject|2|||
161889378|NCT02147067|584639785|FG001|Overall Study|Withdrawal by Subject|2|||
161889379|NCT00089635|584639786|FG000|Overall Study|Adverse Event|2|||
161889380|NCT00089635|584639786|FG000|Overall Study|Death|17|||
161889381|NCT00089635|584639786|FG000|Overall Study|Disease Progression|12|||
161889382|NCT00089635|584639786|FG000|Overall Study|Lost to Follow-up|3|||
161889383|NCT00089635|584639786|FG000|Overall Study|Withdrawal by Subject|6|||
161889384|NCT00089635|584639786|FG000|Overall Study|Ineligibility determined|1|||
161889385|NCT00089635|584639786|FG000|Overall Study|Other|2|||
161889386|NCT02943785|584639787|FG000|Overall Study|Adverse Event|112|||
161889387|NCT02943785|584639788|FG001|Overall Study|Adverse Event|97|||
161889388|NCT02943785|584639787|FG000|Overall Study|Withdrawal by Subject|63|||
161889389|NCT02943785|584639788|FG001|Overall Study|Withdrawal by Subject|126|||
161889390|NCT02943785|584639787|FG000|Overall Study|Physician Decision|23|||
161889391|NCT02943785|584639788|FG001|Overall Study|Physician Decision|47|||
161889392|NCT02943785|584639787|FG000|Overall Study|Death|46|||
161889393|NCT02943785|584639788|FG001|Overall Study|Death|46|||
161889394|NCT02943785|584639787|FG000|Overall Study|Lost to Follow-up|1|||
161889395|NCT02943785|584639788|FG001|Overall Study|Lost to Follow-up|0|||
161889396|NCT02943785|584639787|FG000|Overall Study|Other|16|||
161889397|NCT02943785|584639788|FG001|Overall Study|Other|19|||
161889398|NCT02943785|584639787|FG000|Overall Study|Did not receive any study medication|21|||
161889399|NCT02943785|584639788|FG001|Overall Study|Did not receive any study medication|28|||
161889400|NCT02603107|584639789|FG000|Randomized Phase|Withdrew consent|8|||
161889401|NCT02603107|584639790|FG001|Randomized Phase|Withdrew consent|15|||
161889402|NCT02603107|584639789|FG000|Randomized Phase|Lost to Follow-up|1|||
161889403|NCT02603107|584639790|FG001|Randomized Phase|Lost to Follow-up|3|||
161889404|NCT02603107|584639789|FG000|Randomized Phase|Adverse Event|2|||
161889405|NCT02603107|584639790|FG001|Randomized Phase|Adverse Event|0|||
161889406|NCT02603107|584639789|FG000|Randomized Phase|Death|1|||
161889407|NCT02603107|584639790|FG001|Randomized Phase|Death|1|||
161889408|NCT02603107|584639789|FG000|Randomized Phase|Non-compliance with study drug|1|||
161889409|NCT02603107|584639790|FG001|Randomized Phase|Non-compliance with study drug|1|||
161889410|NCT02603107|584639789|FG000|Randomized Phase|Investigator's discretion|0|||
161889411|NCT02603107|584639790|FG001|Randomized Phase|Investigator's discretion|1|||
161889412|NCT02603107|584639789|FG000|Randomized Phase|Lack of Efficacy|1|||
161889413|NCT02603107|584639790|FG001|Randomized Phase|Lack of Efficacy|0|||
161889414|NCT02603107|584639789|FG000|Randomized Phase|Protocol Violation|1|||
161889415|NCT02603107|584639790|FG001|Randomized Phase|Protocol Violation|0|||
161889416|NCT02603107|584639789|FG000|Optional Extension Phase|Lost to Follow-up|3|||
161889417|NCT02603107|584639790|FG001|Optional Extension Phase|Lost to Follow-up|3|||
161889418|NCT02603107|584639789|FG000|Optional Extension Phase|Withdrew consent|3|||
161889419|NCT02603107|584639790|FG001|Optional Extension Phase|Withdrew consent|2|||
161889420|NCT02603107|584639789|FG000|Optional Extension Phase|Investigator's discretion|2|||
161889421|NCT02603107|584639790|FG001|Optional Extension Phase|Investigator's discretion|2|||
161889422|NCT02603107|584639789|FG000|Optional Extension Phase|Pregnancy|0|||
161889423|NCT02603107|584639790|FG001|Optional Extension Phase|Pregnancy|3|||
161889424|NCT02603107|584639789|FG000|Optional Extension Phase|Adverse Event|0|||
161889425|NCT02603107|584639790|FG001|Optional Extension Phase|Adverse Event|2|||
161889426|NCT02603107|584639789|FG000|Optional Extension Phase|Not treated in extension phase|0|||
161889427|NCT02603107|584639790|FG001|Optional Extension Phase|Not treated in extension phase|1|||
161889428|NCT02603107|584639789|FG000|Optional Extension Phase|Protocol Violation|1|||
161889429|NCT02603107|584639790|FG001|Optional Extension Phase|Protocol Violation|0|||
161889430|NCT00821015|584639793|FG000|Overall Study|Lost to Follow-up|12|||
161889431|NCT03013985|584639799|FG000|Overall Study|Protocol Violation|2|||
161889432|NCT03013985|584639800|FG001|Overall Study|Protocol Violation|2|||
161889433|NCT03013985|584639799|FG000|Overall Study|Withdrawal by Subject|14|||
161889434|NCT03013985|584639800|FG001|Overall Study|Withdrawal by Subject|17|||
161889435|NCT01887678|584639801|FG000|Overall Study|Adverse Event|4|||
161889436|NCT01887678|584639802|FG001|Overall Study|Adverse Event|6|||
161889437|NCT01887678|584639801|FG000|Overall Study|Exceeded rescue medication dosage|4|||
161889438|NCT01887678|584639802|FG001|Overall Study|Exceeded rescue medication dosage|5|||
161889439|NCT01887678|584639801|FG000|Overall Study|Withdrawal of consent|3|||
161889440|NCT01887678|584639802|FG001|Overall Study|Withdrawal of consent|4|||
161889441|NCT01887678|584639801|FG000|Overall Study|Lost to Follow-up|4|||
161889442|NCT01887678|584639802|FG001|Overall Study|Lost to Follow-up|2|||
161889443|NCT01887678|584639801|FG000|Overall Study|Deterioration of clinical condition|0|||
161889444|NCT01887678|584639802|FG001|Overall Study|Deterioration of clinical condition|4|||
161889445|NCT01887678|584639801|FG000|Overall Study|Lack of Efficacy|1|||
161889446|NCT01887678|584639802|FG001|Overall Study|Lack of Efficacy|2|||
161889447|NCT01887678|584639801|FG000|Overall Study|Non-compliance|0|||
161889448|NCT01887678|584639802|FG001|Overall Study|Non-compliance|3|||
161889449|NCT01887678|584639801|FG000|Overall Study|Specified|1|||
161889450|NCT01887678|584639802|FG001|Overall Study|Specified|2|||
161889451|NCT00791492|584639806|FG000|Overall Study|Withdrawal by Subject|1|||
161889452|NCT00791492|584639807|FG001|Overall Study|Withdrawal by Subject|2|||
161889453|NCT00791492|584639806|FG000|Overall Study|Liver transplantation|5|||
161889454|NCT00791492|584639807|FG001|Overall Study|Liver transplantation|1|||
161889455|NCT01370616|584639808|FG000|Overall Study|Adverse Event|11|||
161889456|NCT01370616|584639809|FG001|Overall Study|Adverse Event|16|||
161889457|NCT01370616|584639808|FG000|Overall Study|Death|1|||
161889458|NCT01370616|584639809|FG001|Overall Study|Death|0|||
161889459|NCT01370616|584639808|FG000|Overall Study|Lack of Efficacy|6|||
161889460|NCT01370616|584639809|FG001|Overall Study|Lack of Efficacy|2|||
161889461|NCT01370616|584639808|FG000|Overall Study|Lost to Follow-up|0|||
161889462|NCT01370616|584639809|FG001|Overall Study|Lost to Follow-up|3|||
161889463|NCT01370616|584639808|FG000|Overall Study|Physician Decision|6|||
161889464|NCT01370616|584639809|FG001|Overall Study|Physician Decision|6|||
161889465|NCT01370616|584639808|FG000|Overall Study|Progressive Disease|0|||
161889466|NCT01370616|584639809|FG001|Overall Study|Progressive Disease|1|||
161889467|NCT01370616|584639808|FG000|Overall Study|Recovery|1|||
161889468|NCT01370616|584639809|FG001|Overall Study|Recovery|0|||
161889469|NCT01370616|584639808|FG000|Overall Study|Technical Problems|3|||
161889470|NCT01370616|584639809|FG001|Overall Study|Technical Problems|5|||
161889471|NCT01370616|584639808|FG000|Overall Study|Withdrawal by Subject|34|||
161889472|NCT01370616|584639809|FG001|Overall Study|Withdrawal by Subject|34|||
161889473|NCT01017601|584639810|FG000|Overall Study|Disease Progression|12|||
161889474|NCT01017601|584639811|FG001|Overall Study|Disease Progression|12|||
161889475|NCT01017601|584639810|FG000|Overall Study|Withdrawal by Subject|0|||
161889476|NCT01017601|584639811|FG001|Overall Study|Withdrawal by Subject|1|||
161889477|NCT00076999|584639812|FG000|Overall Study|Adverse Event|2|||
161889478|NCT00076999|584639813|FG001|Overall Study|Adverse Event|8|||
161889479|NCT00076999|584639814|FG002|Overall Study|Adverse Event|6|||
161889480|NCT00076999|584639815|FG003|Overall Study|Adverse Event|0|||
161889481|NCT00076999|584639816|FG004|Overall Study|Adverse Event|2|||
161889482|NCT00076999|584639812|FG000|Overall Study|Protocol Violation|0|||
161889483|NCT00076999|584639813|FG001|Overall Study|Protocol Violation|3|||
161889484|NCT00076999|584639814|FG002|Overall Study|Protocol Violation|4|||
161889485|NCT00076999|584639815|FG003|Overall Study|Protocol Violation|0|||
161889486|NCT00076999|584639816|FG004|Overall Study|Protocol Violation|9|||
161889487|NCT00076999|584639812|FG000|Overall Study|Lost to Follow-up|2|||
161889488|NCT00076999|584639813|FG001|Overall Study|Lost to Follow-up|1|||
161889489|NCT00076999|584639814|FG002|Overall Study|Lost to Follow-up|0|||
161889490|NCT00076999|584639815|FG003|Overall Study|Lost to Follow-up|0|||
161889491|NCT00076999|584639816|FG004|Overall Study|Lost to Follow-up|0|||
161889492|NCT00076999|584639812|FG000|Overall Study|Withdrawal by Subject|0|||
161889493|NCT00076999|584639813|FG001|Overall Study|Withdrawal by Subject|4|||
161889494|NCT00076999|584639814|FG002|Overall Study|Withdrawal by Subject|3|||
161889495|NCT00076999|584639815|FG003|Overall Study|Withdrawal by Subject|0|||
161889496|NCT00076999|584639816|FG004|Overall Study|Withdrawal by Subject|1|||
161889497|NCT00076999|584639812|FG000|Overall Study|Other reason (not specified)|8|||
161889498|NCT00076999|584639813|FG001|Overall Study|Other reason (not specified)|8|||
161889499|NCT00076999|584639814|FG002|Overall Study|Other reason (not specified)|4|||
161889500|NCT00076999|584639815|FG003|Overall Study|Other reason (not specified)|1|||
161889501|NCT00076999|584639816|FG004|Overall Study|Other reason (not specified)|13|||
161889502|NCT00803205|584639818|FG000|Overall Study|Adverse Event|7|||
161889503|NCT00803205|584639819|FG001|Overall Study|Adverse Event|2|||
161889504|NCT00803205|584639818|FG000|Overall Study|Lost to Follow-up|1|||
161889505|NCT00803205|584639819|FG001|Overall Study|Lost to Follow-up|0|||
161889506|NCT00803205|584639818|FG000|Overall Study|Withdrawal by Subject|9|||
161889507|NCT00803205|584639819|FG001|Overall Study|Withdrawal by Subject|9|||
161889508|NCT00803205|584639818|FG000|Overall Study|Physician Decision|1|||
161889509|NCT00803205|584639819|FG001|Overall Study|Physician Decision|0|||
161889510|NCT00803205|584639818|FG000|Overall Study|Protocol Violation|1|||
161889511|NCT00803205|584639819|FG001|Overall Study|Protocol Violation|1|||
161889512|NCT00803205|584639818|FG000|Overall Study|Medical Monitor Decision|1|||
161889513|NCT00803205|584639819|FG001|Overall Study|Medical Monitor Decision|0|||
161889514|NCT00803205|584639818|FG000|Overall Study|Acquired a Lung Infection|0|||
161889515|NCT00803205|584639819|FG001|Overall Study|Acquired a Lung Infection|1|||
161889516|NCT00803205|584639818|FG000|Overall Study|Sponsor Decision|0|||
161889517|NCT00803205|584639819|FG001|Overall Study|Sponsor Decision|1|||
161889518|NCT01857102|584639820|FG000|Period 1|No longer meets Eligibility Criteria|0|||
161889519|NCT01857102|584639821|FG001|Period 1|No longer meets Eligibility Criteria|2|||
161889520|NCT01857102|584639820|FG000|Period 1|Lost to Follow-up|0|||
161889521|NCT01857102|584639821|FG001|Period 1|Lost to Follow-up|3|||
161889522|NCT01857102|584639820|FG000|Period 1|Unsatisfactory Lens Fit|1|||
161889523|NCT01857102|584639821|FG001|Period 1|Unsatisfactory Lens Fit|0|||
161889524|NCT01857102|584639820|FG000|Period 1|Unsatisfactory Visual Response|1|||
161889525|NCT01857102|584639821|FG001|Period 1|Unsatisfactory Visual Response|0|||
161889526|NCT01857102|584639820|FG000|Period 1|Physician Decision|1|||
161889527|NCT01857102|584639821|FG001|Period 1|Physician Decision|0|||
161889528|NCT01857102|584639820|FG000|Period 2|Lens Discomfort|1|||
161889529|NCT01857102|584639821|FG001|Period 2|Lens Discomfort|0|||
161889530|NCT01857102|584639820|FG000|Period 2|Unsatisfactory Lens Fit|1|||
161889531|NCT01857102|584639821|FG001|Period 2|Unsatisfactory Lens Fit|0|||
161889532|NCT02603562|584639822|FG000|Overall Study|Lost to Follow-up|1|||
161889533|NCT00270231|584639823|FG000|First Intervention|Lost to Follow-up|1|||
161889534|NCT00270231|584639824|FG001|First Intervention|Lost to Follow-up|1|||
161889535|NCT00270231|584639823|FG000|Washout Period|Lost to Follow-up|1|||
161889536|NCT00270231|584639824|FG001|Washout Period|Lost to Follow-up|0|||
161889537|NCT00270231|584639823|FG000|Second Intervention|Lost to Follow-up|0|||
161889538|NCT00270231|584639824|FG001|Second Intervention|Lost to Follow-up|1|||
161889539|NCT00574795|584639826|FG000|Infant Series|Withdrawal by Subject|2|||
161889540|NCT00574795|584639826|FG000|Infant Series|Protocol Violation|2|||
161889541|NCT00574795|584639826|FG000|Infant Series|Adverse Event|1|||
161889542|NCT00574795|584639826|FG000|After Infant Series|Withdrawal by Subject|1|||
161889543|NCT00574795|584639826|FG000|After Infant Series|Adverse Event|2|||
161889544|NCT00574795|584639826|FG000|Toddler Dose|Withdrawal by Subject|1|||
161889545|NCT02638259|584639827|FG000|Treatment Period 1|Adverse Event|1|||
161889546|NCT02638259|584639828|FG001|Treatment Period 1|Adverse Event|5|||
161889547|NCT02638259|584639827|FG000|Treatment Period 1|Death|0|||
161889548|NCT02638259|584639828|FG001|Treatment Period 1|Death|1|||
161889549|NCT02638259|584639827|FG000|Treatment Period 1|Lack of Efficacy|0|||
161889550|NCT02638259|584639828|FG001|Treatment Period 1|Lack of Efficacy|1|||
161889551|NCT02638259|584639827|FG000|Treatment Period 1|Protocol Violation|0|||
161889552|NCT02638259|584639828|FG001|Treatment Period 1|Protocol Violation|3|||
161889553|NCT02638259|584639827|FG000|Treatment Period 1|Withdrawal by Subject|4|||
161889554|NCT02638259|584639828|FG001|Treatment Period 1|Withdrawal by Subject|6|||
161889555|NCT02638259|584639827|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
161889556|NCT02638259|584639828|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
161889557|NCT02638259|584639827|FG000|Treatment Period 2|Adverse Event|5|||
161889558|NCT02638259|584639828|FG001|Treatment Period 2|Adverse Event|4|||
161889559|NCT02638259|584639827|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161889560|NCT02638259|584639828|FG001|Treatment Period 2|Withdrawal by Subject|7|||
161889561|NCT04299048|584639829|FG000|Overall Study|Death|1|||
161889562|NCT04299048|584639829|FG000|Overall Study|Global deterioration of health status|2|||
161889563|NCT04299048|584639829|FG000|Overall Study|Enrolled and not treated|1|||
161889564|NCT00634049|584639830|FG000|Overall Study|Never received study drug|1|||
161889565|NCT00634049|584639830|FG000|Overall Study|Died prior to receiving study drug|1|||
161889566|NCT00634049|584639830|FG000|Overall Study|Screening failure|1|||
161889567|NCT01717391|584639831|FG000|Overall Study|Withdrawal by Subject|5|||
161889568|NCT01717391|584639831|FG000|Overall Study|Physician Decision|1|||
161889569|NCT01717391|584639831|FG000|Overall Study|FLT technical failure|3|||
161889570|NCT03434249|584639835|FG000|Overall Study|Adverse Event|1|||
161889571|NCT03434249|584639836|FG001|Overall Study|Adverse Event|0|||
161889572|NCT03434249|584639835|FG000|Overall Study|Lost to Follow-up|0|||
161889573|NCT03434249|584639836|FG001|Overall Study|Lost to Follow-up|1|||
161889574|NCT03434249|584639835|FG000|Overall Study|Non-compliance of family|2|||
161889575|NCT03434249|584639836|FG001|Overall Study|Non-compliance of family|1|||
161889576|NCT03434249|584639835|FG000|Overall Study|Difficulties in completing daily diary|2|||
161889577|NCT03434249|584639836|FG001|Overall Study|Difficulties in completing daily diary|1|||
161889578|NCT01001598|584639837|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
161889579|NCT01001598|584639837|FG000|Overall Study|Adverse Event|1|||
161889580|NCT02920177|584639841|FG000|Overall Study|Withdrawal by Subject|1|||
161889581|NCT02920177|584639842|FG001|Overall Study|Withdrawal by Subject|1|||
161889582|NCT02920177|584639841|FG000|Overall Study|Physician Decision|1|||
161889583|NCT02920177|584639842|FG001|Overall Study|Physician Decision|0|||
161889584|NCT02920177|584639841|FG000|Overall Study|Lost to Follow-up|0|||
161889585|NCT02920177|584639842|FG001|Overall Study|Lost to Follow-up|1|||
161889586|NCT03164265|584639843|FG000|Overall Study|Physician Decision|3|||
161889587|NCT04907227|584639844|FG000|Overall Study|Death|12|||
161889588|NCT04907227|584639845|FG001|Overall Study|Death|8|||
161889589|NCT04907227|584639844|FG000|Overall Study|Withdrawal by Subject|2|||
161889590|NCT04907227|584639845|FG001|Overall Study|Withdrawal by Subject|2|||
161889591|NCT04907227|584639844|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
161889592|NCT04907227|584639845|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161889593|NCT04907227|584639844|FG000|Overall Study|Sponsor Decision|25|||
161889594|NCT04907227|584639845|FG001|Overall Study|Sponsor Decision|30|||
161889595|NCT04907227|584639844|FG000|Overall Study|Physician Decision|1|||
161889596|NCT04907227|584639845|FG001|Overall Study|Physician Decision|0|||
161889597|NCT02208050|584639846|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
161889598|NCT02208050|584639847|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
161889599|NCT00721279|584639851|FG000|Overall Study|Lack of Efficacy|6|||
161889600|NCT00721279|584639852|FG001|Overall Study|Lack of Efficacy|3|||
161889601|NCT00721279|584639851|FG000|Overall Study|Tolerability insufficient|5|||
161889602|NCT00721279|584639852|FG001|Overall Study|Tolerability insufficient|2|||
161889603|NCT00721279|584639851|FG000|Overall Study|Withdrawal by Subject|13|||
161889604|NCT00721279|584639852|FG001|Overall Study|Withdrawal by Subject|3|||
161889605|NCT00721279|584639851|FG000|Overall Study|Other|12|||
161889606|NCT00721279|584639852|FG001|Overall Study|Other|16|||
161889607|NCT03673345|584639853|FG000|Overall Study|Lost to Follow-up|1|||
161889608|NCT03673345|584639854|FG001|Overall Study|Lost to Follow-up|0|||
161889609|NCT03673345|584639855|FG002|Overall Study|Lost to Follow-up|3|||
161889610|NCT03673345|584639856|FG003|Overall Study|Lost to Follow-up|3|||
161889611|NCT03673345|584639857|FG004|Overall Study|Lost to Follow-up|2|||
161889612|NCT03673345|584639858|FG005|Overall Study|Lost to Follow-up|1|||
161889613|NCT03673345|584639859|FG006|Overall Study|Lost to Follow-up|0|||
161889614|NCT03673345|584639860|FG007|Overall Study|Lost to Follow-up|0|||
161889615|NCT03673345|584639853|FG000|Overall Study|Withdrawal by Subject|1|||
161889616|NCT03673345|584639854|FG001|Overall Study|Withdrawal by Subject|0|||
161889617|NCT03673345|584639855|FG002|Overall Study|Withdrawal by Subject|4|||
161889618|NCT03673345|584639856|FG003|Overall Study|Withdrawal by Subject|2|||
161889619|NCT03673345|584639857|FG004|Overall Study|Withdrawal by Subject|0|||
161889620|NCT03673345|584639858|FG005|Overall Study|Withdrawal by Subject|0|||
161889621|NCT03673345|584639859|FG006|Overall Study|Withdrawal by Subject|0|||
161889622|NCT03673345|584639860|FG007|Overall Study|Withdrawal by Subject|0|||
161889623|NCT03673345|584639853|FG000|Overall Study|Physician Decision|0|||
161889624|NCT03673345|584639854|FG001|Overall Study|Physician Decision|0|||
161889625|NCT03673345|584639855|FG002|Overall Study|Physician Decision|2|||
161889626|NCT03673345|584639856|FG003|Overall Study|Physician Decision|0|||
161889627|NCT03673345|584639857|FG004|Overall Study|Physician Decision|0|||
161889628|NCT03673345|584639858|FG005|Overall Study|Physician Decision|0|||
161889629|NCT03673345|584639859|FG006|Overall Study|Physician Decision|0|||
161889630|NCT03673345|584639860|FG007|Overall Study|Physician Decision|0|||
161889631|NCT04608344|584639861|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
161889632|NCT04608344|584639862|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
161889633|NCT04608344|584639861|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
161889634|NCT04608344|584639862|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
161889635|NCT02429310|584639863|FG000|Overall Study|Lost to Follow-up|1|||
161889636|NCT02429310|584639864|FG001|Overall Study|Lost to Follow-up|2|||
161889637|NCT02429310|584639863|FG000|Overall Study|Protocol Violation|1|||
161889638|NCT02429310|584639864|FG001|Overall Study|Protocol Violation|1|||
161889639|NCT03646305|584639865|FG000|Overall Study|Lost to Follow-up|4|||
161889640|NCT03646305|584639866|FG001|Overall Study|Lost to Follow-up|2|||
161889641|NCT03646305|584639867|FG002|Overall Study|Lost to Follow-up|2|||
161889642|NCT03646305|584639868|FG003|Overall Study|Lost to Follow-up|1|||
161889643|NCT03646305|584639865|FG000|Overall Study|Withdrawal by Subject|1|||
161889644|NCT03646305|584639866|FG001|Overall Study|Withdrawal by Subject|0|||
161889645|NCT03646305|584639867|FG002|Overall Study|Withdrawal by Subject|0|||
161889646|NCT03646305|584639868|FG003|Overall Study|Withdrawal by Subject|1|||
161889647|NCT01554176|584639869|FG000|Treatment Phase|Protocol Violation|1|||
161889648|NCT01554176|584639870|FG001|Treatment Phase|Protocol Violation|2|||
161889649|NCT01554176|584639871|FG002|Treatment Phase|Protocol Violation|0|||
161889650|NCT01554176|584639872|FG003|Treatment Phase|Protocol Violation|0|||
161889651|NCT01554176|584639873|FG004|Treatment Phase|Protocol Violation|0|||
161889652|NCT01554176|584639869|FG000|Treatment Phase|Physician Decision|1|||
161889653|NCT01554176|584639870|FG001|Treatment Phase|Physician Decision|1|||
161889654|NCT01554176|584639871|FG002|Treatment Phase|Physician Decision|0|||
161889655|NCT01554176|584639872|FG003|Treatment Phase|Physician Decision|0|||
161889656|NCT01554176|584639873|FG004|Treatment Phase|Physician Decision|0|||
161889657|NCT01554176|584639869|FG000|Treatment Phase|Lack of Efficacy|0|||
161889658|NCT01554176|584639870|FG001|Treatment Phase|Lack of Efficacy|1|||
161889659|NCT01554176|584639871|FG002|Treatment Phase|Lack of Efficacy|0|||
161889660|NCT01554176|584639872|FG003|Treatment Phase|Lack of Efficacy|0|||
161889661|NCT01554176|584639873|FG004|Treatment Phase|Lack of Efficacy|0|||
161889662|NCT01554176|584639869|FG000|Treatment Phase|Adverse event, non-fatal|1|||
161889663|NCT01554176|584639870|FG001|Treatment Phase|Adverse event, non-fatal|1|||
161889664|NCT01554176|584639871|FG002|Treatment Phase|Adverse event, non-fatal|0|||
161889665|NCT01554176|584639872|FG003|Treatment Phase|Adverse event, non-fatal|0|||
161889666|NCT01554176|584639873|FG004|Treatment Phase|Adverse event, non-fatal|0|||
161889667|NCT01554176|584639869|FG000|Treatment Phase|Non-compliance with study drug|1|||
161889668|NCT01554176|584639870|FG001|Treatment Phase|Non-compliance with study drug|0|||
161889669|NCT01554176|584639871|FG002|Treatment Phase|Non-compliance with study drug|0|||
161889670|NCT01554176|584639872|FG003|Treatment Phase|Non-compliance with study drug|0|||
161889671|NCT01554176|584639873|FG004|Treatment Phase|Non-compliance with study drug|0|||
161889672|NCT01554176|584639869|FG000|Treatment Phase|Withdrawal by Subject|1|||
161889673|NCT01554176|584639870|FG001|Treatment Phase|Withdrawal by Subject|0|||
161889674|NCT01554176|584639871|FG002|Treatment Phase|Withdrawal by Subject|0|||
161889675|NCT01554176|584639872|FG003|Treatment Phase|Withdrawal by Subject|0|||
161889676|NCT01554176|584639873|FG004|Treatment Phase|Withdrawal by Subject|0|||
161889677|NCT01554176|584639869|FG000|Treatment Phase|Lost to Follow-up|3|||
161889678|NCT01554176|584639870|FG001|Treatment Phase|Lost to Follow-up|0|||
161889679|NCT01554176|584639871|FG002|Treatment Phase|Lost to Follow-up|0|||
161889680|NCT01554176|584639872|FG003|Treatment Phase|Lost to Follow-up|0|||
161889681|NCT01554176|584639873|FG004|Treatment Phase|Lost to Follow-up|0|||
161889682|NCT01554176|584639869|FG000|Run-out Phase|Protocol Violation|0|||
161889683|NCT01554176|584639870|FG001|Run-out Phase|Protocol Violation|0|||
161889684|NCT01554176|584639871|FG002|Run-out Phase|Protocol Violation|0|||
161889685|NCT01554176|584639872|FG003|Run-out Phase|Protocol Violation|1|||
161889686|NCT01554176|584639873|FG004|Run-out Phase|Protocol Violation|0|||
161889687|NCT02678000|584639876|FG000|PART 2|Adverse Event|0|||
161889688|NCT02678000|584639877|FG001|PART 2|Adverse Event|0|||
161889689|NCT02678000|584639878|FG002|PART 2|Adverse Event|2|||
161889690|NCT02678000|584639879|FG003|PART 2|Adverse Event|1|||
161889691|NCT02678000|584639880|FG004|PART 2|Adverse Event|0|||
161889692|NCT02678000|584639876|FG000|PART 2|Withdrawal by Subject|0|||
161889693|NCT02678000|584639877|FG001|PART 2|Withdrawal by Subject|0|||
161889694|NCT02678000|584639878|FG002|PART 2|Withdrawal by Subject|1|||
161889695|NCT02678000|584639879|FG003|PART 2|Withdrawal by Subject|0|||
161889696|NCT02678000|584639880|FG004|PART 2|Withdrawal by Subject|0|||
161889697|NCT03053427|584639881|FG000|Overall Study|Adverse Event|4|||
161889698|NCT03053427|584639882|FG001|Overall Study|Adverse Event|4|||
161889699|NCT03053427|584639881|FG000|Overall Study|Lack of Efficacy|1|||
161889700|NCT03053427|584639882|FG001|Overall Study|Lack of Efficacy|3|||
161889701|NCT03053427|584639881|FG000|Overall Study|Lost to Follow-up|2|||
161889702|NCT03053427|584639882|FG001|Overall Study|Lost to Follow-up|2|||
161889703|NCT03053427|584639881|FG000|Overall Study|Worsening of the target disease|0|||
161889704|NCT03053427|584639882|FG001|Overall Study|Worsening of the target disease|1|||
161889705|NCT03053427|584639881|FG000|Overall Study|Protocol Deviation|3|||
161889706|NCT03053427|584639882|FG001|Overall Study|Protocol Deviation|3|||
161889707|NCT03053427|584639881|FG000|Overall Study|Withdrawal by Subject|3|||
161889708|NCT03053427|584639882|FG001|Overall Study|Withdrawal by Subject|2|||
161889709|NCT03053427|584639881|FG000|Overall Study|Miscellaneous|0|||
161889710|NCT03053427|584639882|FG001|Overall Study|Miscellaneous|1|||
161889711|NCT02510820|584641754|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161889712|NCT02510820|584641755|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161889713|NCT02510820|584641754|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161889714|NCT02510820|584641755|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161889715|NCT01533688|584641756|FG000|Overall Study|Withdrawal by Subject|5|||
161889716|NCT01533688|584641757|FG001|Overall Study|Withdrawal by Subject|4|||
161889717|NCT01533688|584641758|FG002|Overall Study|Withdrawal by Subject|3|||
161889718|NCT01533688|584641756|FG000|Overall Study|Medically unstable|1|||
161889719|NCT01533688|584641757|FG001|Overall Study|Medically unstable|3|||
161889720|NCT01533688|584641758|FG002|Overall Study|Medically unstable|3|||
161889721|NCT01533688|584641756|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
161889722|NCT01533688|584641757|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
161889723|NCT01533688|584641758|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
161889724|NCT02190721|584641759|FG000|Overall Study|Patient was out of the city|0|||
161889725|NCT02190721|584641760|FG001|Overall Study|Patient was out of the city|1|||
161889726|NCT02190721|584641761|FG002|Overall Study|Patient was out of the city|0|||
161889727|NCT01760447|584641762|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
161889728|NCT01760447|584641763|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
161889729|NCT01760447|584641764|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
161889730|NCT01760447|584641765|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
161889731|NCT01760447|584641762|FG000|Weeks 0-20|Withdrawal by Subject|2|||
161889732|NCT01760447|584641763|FG001|Weeks 0-20|Withdrawal by Subject|0|||
161889733|NCT01760447|584641764|FG002|Weeks 0-20|Withdrawal by Subject|1|||
161889734|NCT01760447|584641765|FG003|Weeks 0-20|Withdrawal by Subject|0|||
161889735|NCT01760447|584641762|FG000|Weeks 0-20|Lost to Follow-up|1|||
161889736|NCT01760447|584641763|FG001|Weeks 0-20|Lost to Follow-up|0|||
161889737|NCT01760447|584641764|FG002|Weeks 0-20|Lost to Follow-up|1|||
161889738|NCT01760447|584641765|FG003|Weeks 0-20|Lost to Follow-up|1|||
161889739|NCT01760447|584641762|FG000|Weeks 0-20|Randomized but not treated|0|||
161889740|NCT01760447|584641763|FG001|Weeks 0-20|Randomized but not treated|0|||
161889741|NCT01760447|584641764|FG002|Weeks 0-20|Randomized but not treated|2|||
161889742|NCT01760447|584641765|FG003|Weeks 0-20|Randomized but not treated|0|||
161889743|NCT01760447|584641762|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161889744|NCT01760447|584641763|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161889745|NCT01760447|584641764|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161889746|NCT01760447|584641765|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
161889747|NCT01760447|584641762|FG000|Weeks 20-54|Withdrawal by Subject|2|||
161889748|NCT01760447|584641763|FG001|Weeks 20-54|Withdrawal by Subject|1|||
161889749|NCT01760447|584641764|FG002|Weeks 20-54|Withdrawal by Subject|1|||
161889750|NCT01760447|584641765|FG003|Weeks 20-54|Withdrawal by Subject|2|||
161889751|NCT01760447|584641762|FG000|Weeks 20-54|Lost to Follow-up|0|||
161889752|NCT01760447|584641763|FG001|Weeks 20-54|Lost to Follow-up|0|||
161889753|NCT01760447|584641764|FG002|Weeks 20-54|Lost to Follow-up|1|||
161889754|NCT01760447|584641765|FG003|Weeks 20-54|Lost to Follow-up|2|||
161889755|NCT01214668|584641766|FG000|Overall Study|Adverse Event|0|||
161889756|NCT01214668|584641767|FG001|Overall Study|Adverse Event|1|||
161889757|NCT01214668|584641768|FG002|Overall Study|Adverse Event|0|||
161889758|NCT01214668|584641769|FG003|Overall Study|Adverse Event|2|||
161889759|NCT01214668|584641770|FG004|Overall Study|Adverse Event|1|||
161889760|NCT01214668|584641771|FG005|Overall Study|Adverse Event|1|||
161889761|NCT01214668|584641766|FG000|Overall Study|Death|0|||
161889762|NCT01214668|584641767|FG001|Overall Study|Death|0|||
161889763|NCT01214668|584641768|FG002|Overall Study|Death|1|||
161889764|NCT01214668|584641769|FG003|Overall Study|Death|0|||
161889765|NCT01214668|584641770|FG004|Overall Study|Death|0|||
161889766|NCT01214668|584641771|FG005|Overall Study|Death|0|||
161889767|NCT01214668|584641766|FG000|Overall Study|Progressive Disease|4|||
161889768|NCT01214668|584641767|FG001|Overall Study|Progressive Disease|2|||
161889769|NCT01214668|584641768|FG002|Overall Study|Progressive Disease|5|||
161889770|NCT01214668|584641769|FG003|Overall Study|Progressive Disease|4|||
161889771|NCT01214668|584641770|FG004|Overall Study|Progressive Disease|4|||
161889772|NCT01214668|584641771|FG005|Overall Study|Progressive Disease|5|||
161889773|NCT01214668|584641766|FG000|Overall Study|Withdrawal by Subject|0|||
161889774|NCT01214668|584641767|FG001|Overall Study|Withdrawal by Subject|0|||
161889775|NCT01214668|584641768|FG002|Overall Study|Withdrawal by Subject|0|||
161889776|NCT01214668|584641769|FG003|Overall Study|Withdrawal by Subject|0|||
161889777|NCT01214668|584641770|FG004|Overall Study|Withdrawal by Subject|1|||
161889778|NCT01214668|584641771|FG005|Overall Study|Withdrawal by Subject|0|||
161889779|NCT02907619|584641772|FG000|Overall Study|Study terminated by sponsor|18|||
161889780|NCT02907619|584641773|FG001|Overall Study|Study terminated by sponsor|18|||
161889781|NCT02907619|584641774|FG002|Overall Study|Study terminated by sponsor|19|||
161889782|NCT02907619|584641772|FG000|Overall Study|Death|0|||
161889783|NCT02907619|584641773|FG001|Overall Study|Death|0|||
161889784|NCT02907619|584641774|FG002|Overall Study|Death|1|||
161889785|NCT02907619|584641772|FG000|Overall Study|Withdrawal by Subject|1|||
161889786|NCT02907619|584641773|FG001|Overall Study|Withdrawal by Subject|1|||
161889787|NCT02907619|584641774|FG002|Overall Study|Withdrawal by Subject|0|||
161889788|NCT02907619|584641772|FG000|Overall Study|Other|0|||
161889789|NCT02907619|584641773|FG001|Overall Study|Other|1|||
161889790|NCT02907619|584641774|FG002|Overall Study|Other|0|||
161889791|NCT03326518|584641775|FG000|Overall Study|Protocol Violation|1|||
161889792|NCT03326518|584641776|FG001|Overall Study|Protocol Violation|0|||
161889793|NCT03326518|584641777|FG002|Overall Study|Protocol Violation|0|||
161889794|NCT03326518|584641775|FG000|Overall Study|Withdrawal by Subject|1|||
161889795|NCT03326518|584641776|FG001|Overall Study|Withdrawal by Subject|0|||
161889796|NCT03326518|584641777|FG002|Overall Study|Withdrawal by Subject|0|||
161889797|NCT03326518|584641775|FG000|Overall Study|Lost to Follow-up|1|||
161889798|NCT03326518|584641776|FG001|Overall Study|Lost to Follow-up|0|||
161889799|NCT03326518|584641777|FG002|Overall Study|Lost to Follow-up|1|||
161889800|NCT03411902|584641795|FG000|Overall Study|Lost to Follow-up|3|||
161889801|NCT03411902|584641796|FG001|Overall Study|Lost to Follow-up|0|||
161889802|NCT01693185|584641797|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
161889803|NCT01693185|584641798|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
161889804|NCT00419159|584641803|FG000|Overall Study|Adverse Event|7|||
161889805|NCT00419159|584641804|FG001|Overall Study|Adverse Event|15|||
161889806|NCT00419159|584641803|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161889807|NCT00419159|584641804|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161889808|NCT00419159|584641803|FG000|Overall Study|Subject's no longer requires study drug|0|||
161889809|NCT00419159|584641804|FG001|Overall Study|Subject's no longer requires study drug|1|||
161889810|NCT00419159|584641803|FG000|Overall Study|Protocol Violation|1|||
161889811|NCT00419159|584641804|FG001|Overall Study|Protocol Violation|0|||
161889812|NCT00419159|584641803|FG000|Overall Study|Withdrawal by Subject|10|||
161889813|NCT00419159|584641804|FG001|Overall Study|Withdrawal by Subject|3|||
161889814|NCT00419159|584641803|FG000|Overall Study|Lost to Follow-up|0|||
161889815|NCT00419159|584641804|FG001|Overall Study|Lost to Follow-up|1|||
161889816|NCT00419159|584641803|FG000|Overall Study|Death|2|||
161889817|NCT00419159|584641804|FG001|Overall Study|Death|2|||
161889818|NCT00419159|584641803|FG000|Overall Study|Disease progression|79|||
161889819|NCT00419159|584641804|FG001|Overall Study|Disease progression|76|||
161889820|NCT02735096|584641812|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
161889821|NCT01080391|584641820|FG000|Overall Study|Randomized but not treated|7|||
161889822|NCT01080391|584641821|FG001|Overall Study|Randomized but not treated|4|||
161889823|NCT01534208|584641825|FG000|Overall Study|Lost to Follow-up|19|||
161889824|NCT01534208|584641826|FG001|Overall Study|Lost to Follow-up|14|||
161889825|NCT01534208|584641825|FG000|Overall Study|Withdrawal by Subject|6|||
161889826|NCT01534208|584641826|FG001|Overall Study|Withdrawal by Subject|20|||
161889827|NCT01534208|584641825|FG000|Overall Study|Adverse Event|15|||
161889828|NCT01534208|584641826|FG001|Overall Study|Adverse Event|8|||
161889829|NCT01534208|584641825|FG000|Overall Study|Physician Decision|2|||
161889830|NCT01534208|584641826|FG001|Overall Study|Physician Decision|0|||
161889831|NCT01534208|584641825|FG000|Overall Study|Lack of Efficacy|0|||
161889832|NCT01534208|584641826|FG001|Overall Study|Lack of Efficacy|3|||
161889833|NCT01534208|584641825|FG000|Overall Study|Protocol Violation|2|||
161889834|NCT01534208|584641826|FG001|Overall Study|Protocol Violation|2|||
161889835|NCT01534208|584641825|FG000|Overall Study|Sponsor decision|4|||
161889836|NCT01534208|584641826|FG001|Overall Study|Sponsor decision|1|||
161889837|NCT01534208|584641825|FG000|Overall Study|Subject relocation|2|||
161889838|NCT01534208|584641826|FG001|Overall Study|Subject relocation|0|||
161889839|NCT01534208|584641825|FG000|Overall Study|Lab assessment|2|||
161889840|NCT01534208|584641826|FG001|Overall Study|Lab assessment|1|||
161889841|NCT01534208|584641825|FG000|Overall Study|Eligibility error|3|||
161889842|NCT01534208|584641826|FG001|Overall Study|Eligibility error|0|||
161889843|NCT01534208|584641825|FG000|Overall Study|PCP decision|1|||
161889844|NCT01534208|584641826|FG001|Overall Study|PCP decision|0|||
161889845|NCT01534208|584641825|FG000|Overall Study|Needed prohibited meds|1|||
161889846|NCT01534208|584641826|FG001|Overall Study|Needed prohibited meds|0|||
161889847|NCT02117713|584641837|FG000|Week 48|Adverse Event|4|||
161889848|NCT02117713|584641837|FG000|Week 48|Withdrawal by caregiver|2|||
161889849|NCT02117713|584641837|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
161889850|NCT02117713|584641837|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
161889851|NCT02117713|584641837|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
161889852|NCT02117713|584641837|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
161889853|NCT00672841|584641838|FG000|Overall Study|Comfort care|1|||
161889854|NCT00672841|584641839|FG001|Overall Study|Comfort care|4|||
161889855|NCT00672841|584641838|FG000|Overall Study|icteric specimens|0|||
161889856|NCT00672841|584641839|FG001|Overall Study|icteric specimens|3|||
161889857|NCT00672841|584641838|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
161889858|NCT00672841|584641839|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
161889859|NCT00672841|584641838|FG000|Overall Study|Adverse Event|0|||
161889860|NCT00672841|584641839|FG001|Overall Study|Adverse Event|3|||
161889861|NCT00672841|584641838|FG000|Overall Study|Pregnancy|0|||
161889862|NCT00672841|584641839|FG001|Overall Study|Pregnancy|1|||
161889863|NCT03578146|584641841|FG000|Overall Study|Did Not Receive Treatment|1|||
161889864|NCT03578146|584641842|FG001|Overall Study|Did Not Receive Treatment|0|||
161889865|NCT03578146|584641843|FG002|Overall Study|Did Not Receive Treatment|0|||
161889866|NCT03578146|584641844|FG003|Overall Study|Did Not Receive Treatment|0|||
161889867|NCT03578146|584641845|FG004|Overall Study|Did Not Receive Treatment|0|||
161889868|NCT03578146|584641846|FG005|Overall Study|Did Not Receive Treatment|2|||
161889869|NCT03578146|584641841|FG000|Overall Study|Lost to Follow-up|0|||
161889870|NCT03578146|584641842|FG001|Overall Study|Lost to Follow-up|1|||
161889871|NCT03578146|584641843|FG002|Overall Study|Lost to Follow-up|1|||
161889872|NCT03578146|584641844|FG003|Overall Study|Lost to Follow-up|0|||
161889873|NCT03578146|584641845|FG004|Overall Study|Lost to Follow-up|0|||
161889874|NCT03578146|584641846|FG005|Overall Study|Lost to Follow-up|1|||
161889875|NCT01094782|584641847|FG000|Overall Study|Withdrawal by Subject|5|||
161889876|NCT01094782|584641848|FG001|Overall Study|Withdrawal by Subject|5|||
161889877|NCT01094782|584641849|FG002|Overall Study|Withdrawal by Subject|1|||
161889878|NCT01094782|584641850|FG003|Overall Study|Withdrawal by Subject|5|||
161889879|NCT01094782|584641851|FG004|Overall Study|Withdrawal by Subject|5|||
161889880|NCT01094782|584641852|FG005|Overall Study|Withdrawal by Subject|0|||
161889881|NCT01094782|584641847|FG000|Overall Study|Lost to Follow-up|1|||
161889882|NCT01094782|584641848|FG001|Overall Study|Lost to Follow-up|0|||
161889883|NCT01094782|584641849|FG002|Overall Study|Lost to Follow-up|0|||
161889884|NCT01094782|584641850|FG003|Overall Study|Lost to Follow-up|2|||
161889885|NCT01094782|584641851|FG004|Overall Study|Lost to Follow-up|1|||
161889886|NCT01094782|584641852|FG005|Overall Study|Lost to Follow-up|4|||
161889887|NCT01094782|584641847|FG000|Overall Study|Positive Drug Screen|2|||
161889888|NCT01094782|584641848|FG001|Overall Study|Positive Drug Screen|2|||
161889889|NCT01094782|584641849|FG002|Overall Study|Positive Drug Screen|1|||
161889890|NCT01094782|584641850|FG003|Overall Study|Positive Drug Screen|1|||
161889891|NCT01094782|584641851|FG004|Overall Study|Positive Drug Screen|3|||
161889892|NCT01094782|584641852|FG005|Overall Study|Positive Drug Screen|2|||
161889893|NCT01094782|584641847|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
161889894|NCT01094782|584641848|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
161889895|NCT01094782|584641849|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
161889896|NCT01094782|584641850|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
161889897|NCT01094782|584641851|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
161889898|NCT01094782|584641852|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
161889899|NCT01094782|584641847|FG000|Overall Study|Unable to Complete Questionnaires|0|||
161889900|NCT01094782|584641848|FG001|Overall Study|Unable to Complete Questionnaires|1|||
161889901|NCT01094782|584641849|FG002|Overall Study|Unable to Complete Questionnaires|0|||
161889902|NCT01094782|584641850|FG003|Overall Study|Unable to Complete Questionnaires|0|||
161889903|NCT01094782|584641851|FG004|Overall Study|Unable to Complete Questionnaires|0|||
161889904|NCT01094782|584641852|FG005|Overall Study|Unable to Complete Questionnaires|0|||
161889905|NCT01094782|584641847|FG000|Overall Study|Healthy Subject Had Pain|0|||
161889906|NCT01094782|584641848|FG001|Overall Study|Healthy Subject Had Pain|1|||
161889907|NCT01094782|584641849|FG002|Overall Study|Healthy Subject Had Pain|0|||
161889908|NCT01094782|584641850|FG003|Overall Study|Healthy Subject Had Pain|0|||
161889909|NCT01094782|584641851|FG004|Overall Study|Healthy Subject Had Pain|0|||
161889910|NCT01094782|584641852|FG005|Overall Study|Healthy Subject Had Pain|0|||
161889911|NCT01094782|584641847|FG000|Overall Study|Hypertension|0|||
161889912|NCT01094782|584641848|FG001|Overall Study|Hypertension|0|||
161889913|NCT01094782|584641849|FG002|Overall Study|Hypertension|1|||
161889914|NCT01094782|584641850|FG003|Overall Study|Hypertension|0|||
161889915|NCT01094782|584641851|FG004|Overall Study|Hypertension|0|||
161889916|NCT01094782|584641852|FG005|Overall Study|Hypertension|0|||
161889917|NCT01094782|584641847|FG000|Overall Study|Wrong Pain Condition|0|||
161889918|NCT01094782|584641848|FG001|Overall Study|Wrong Pain Condition|0|||
161889919|NCT01094782|584641849|FG002|Overall Study|Wrong Pain Condition|0|||
161889920|NCT01094782|584641850|FG003|Overall Study|Wrong Pain Condition|2|||
161889921|NCT01094782|584641851|FG004|Overall Study|Wrong Pain Condition|1|||
161889922|NCT01094782|584641852|FG005|Overall Study|Wrong Pain Condition|1|||
161889923|NCT01094782|584641847|FG000|Overall Study|Recent Interventional Injection|0|||
161889924|NCT01094782|584641848|FG001|Overall Study|Recent Interventional Injection|0|||
161889925|NCT01094782|584641849|FG002|Overall Study|Recent Interventional Injection|0|||
161889926|NCT01094782|584641850|FG003|Overall Study|Recent Interventional Injection|0|||
161889927|NCT01094782|584641851|FG004|Overall Study|Recent Interventional Injection|0|||
161889928|NCT01094782|584641852|FG005|Overall Study|Recent Interventional Injection|1|||
161889929|NCT01094782|584641847|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889930|NCT01094782|584641848|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889931|NCT01094782|584641849|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889932|NCT01094782|584641850|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889933|NCT01094782|584641851|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
161889934|NCT01094782|584641852|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889935|NCT01094782|584641847|FG000|Overall Study|Noncompliance With Study Schedule|0|||
161889936|NCT01094782|584641848|FG001|Overall Study|Noncompliance With Study Schedule|0|||
161889937|NCT01094782|584641849|FG002|Overall Study|Noncompliance With Study Schedule|0|||
161889938|NCT01094782|584641850|FG003|Overall Study|Noncompliance With Study Schedule|1|||
161889939|NCT01094782|584641851|FG004|Overall Study|Noncompliance With Study Schedule|0|||
161889940|NCT01094782|584641852|FG005|Overall Study|Noncompliance With Study Schedule|0|||
161889941|NCT02536781|584641857|FG000|Overall Study|Lost to Follow-up|2|||
161889942|NCT02536781|584641858|FG001|Overall Study|Lost to Follow-up|0|||
161889943|NCT03423147|584641859|FG000|Overall Study|Lost to Follow-up|5|||
161889944|NCT03423147|584641860|FG001|Overall Study|Lost to Follow-up|8|||
161889945|NCT03423147|584641859|FG000|Overall Study|Withdrawal by Subject|1|||
161889946|NCT03423147|584641860|FG001|Overall Study|Withdrawal by Subject|0|||
161889947|NCT03423147|584641859|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
161889948|NCT03423147|584641860|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
161889949|NCT03423147|584641859|FG000|Overall Study|Age < 18|1|||
161889950|NCT03423147|584641860|FG001|Overall Study|Age < 18|0|||
161889951|NCT03423147|584641859|FG000|Overall Study|No Trial of Labor|0|||
161889952|NCT03423147|584641860|FG001|Overall Study|No Trial of Labor|1|||
161889953|NCT02450552|584641862|FG000|Overall Study|Withdrawal by Subject|4|||
161889954|NCT02450552|584641863|FG001|Overall Study|Withdrawal by Subject|0|||
161889955|NCT02450552|584641864|FG002|Overall Study|Withdrawal by Subject|4|||
161889956|NCT02450552|584641862|FG000|Overall Study|Physician Decision|1|||
161889957|NCT02450552|584641863|FG001|Overall Study|Physician Decision|0|||
161889958|NCT02450552|584641864|FG002|Overall Study|Physician Decision|1|||
161889959|NCT01524783|584641865|FG000|Blinded Period|Adverse Event|64|||
161889960|NCT01524783|584641866|FG001|Blinded Period|Adverse Event|7|||
161889961|NCT01524783|584641867|FG002|Blinded Period|Adverse Event|0|||
161889962|NCT01524783|584641865|FG000|Blinded Period|Disease Progression|89|||
161889963|NCT01524783|584641866|FG001|Blinded Period|Disease Progression|75|||
161889964|NCT01524783|584641867|FG002|Blinded Period|Disease Progression|0|||
161889965|NCT01524783|584641865|FG000|Blinded Period|Withdrawal by Subject|19|||
161889966|NCT01524783|584641866|FG001|Blinded Period|Withdrawal by Subject|6|||
161889967|NCT01524783|584641867|FG002|Blinded Period|Withdrawal by Subject|0|||
161889968|NCT01524783|584641865|FG000|Blinded Period|Protocol deviation|2|||
161889969|NCT01524783|584641866|FG001|Blinded Period|Protocol deviation|1|||
161889970|NCT01524783|584641867|FG002|Blinded Period|Protocol deviation|0|||
161889971|NCT01524783|584641865|FG000|Blinded Period|Death|5|||
161889972|NCT01524783|584641866|FG001|Blinded Period|Death|2|||
161889973|NCT01524783|584641867|FG002|Blinded Period|Death|0|||
161889974|NCT01524783|584641865|FG000|Open-label Period|Disease progression|13|||
161889975|NCT01524783|584641866|FG001|Open-label Period|Disease progression|0|||
161889976|NCT01524783|584641867|FG002|Open-label Period|Disease progression|2|||
161889977|NCT01524783|584641865|FG000|Open-label Period|Administrative problems|5|||
161889978|NCT01524783|584641866|FG001|Open-label Period|Administrative problems|0|||
161889979|NCT01524783|584641867|FG002|Open-label Period|Administrative problems|2|||
161889980|NCT01524783|584641865|FG000|Open-label Period|Adverse Event|5|||
161889981|NCT01524783|584641866|FG001|Open-label Period|Adverse Event|0|||
161889982|NCT01524783|584641867|FG002|Open-label Period|Adverse Event|1|||
161889983|NCT01524783|584641865|FG000|Open-label Period|Withdrawal by Subject|2|||
161889984|NCT01524783|584641866|FG001|Open-label Period|Withdrawal by Subject|0|||
161889985|NCT01524783|584641867|FG002|Open-label Period|Withdrawal by Subject|1|||
161889986|NCT01524783|584641865|FG000|Open-label Period|Protocol deviation|1|||
161889987|NCT01524783|584641866|FG001|Open-label Period|Protocol deviation|0|||
161889988|NCT01524783|584641867|FG002|Open-label Period|Protocol deviation|0|||
161889989|NCT01625689|584641868|FG000|Overall Study|Migration|2|||
161889990|NCT01625689|584641869|FG001|Overall Study|Migration|1|||
161889991|NCT03723070|584641874|FG000|Overall Study|Lost to Follow-up|2|||
161889992|NCT03723070|584641874|FG000|Overall Study|Physician Decision|1|||
161889993|NCT03723070|584641874|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
161889994|NCT05153148|584641875|FG000|Overall Study|Adverse Event|1|||
161889995|NCT05153148|584641876|FG001|Overall Study|Adverse Event|0|||
161889996|NCT05153148|584641877|FG002|Overall Study|Adverse Event|3|||
161889997|NCT05153148|584641878|FG003|Overall Study|Adverse Event|5|||
161889998|NCT05153148|584641875|FG000|Overall Study|Lost to Follow-up|1|||
161889999|NCT05153148|584641876|FG001|Overall Study|Lost to Follow-up|1|||
161890000|NCT05153148|584641877|FG002|Overall Study|Lost to Follow-up|2|||
161890001|NCT05153148|584641878|FG003|Overall Study|Lost to Follow-up|0|||
161890002|NCT05153148|584641875|FG000|Overall Study|Withdrawal by Subject|6|||
161890003|NCT05153148|584641876|FG001|Overall Study|Withdrawal by Subject|8|||
161890004|NCT05153148|584641877|FG002|Overall Study|Withdrawal by Subject|6|||
161890005|NCT05153148|584641878|FG003|Overall Study|Withdrawal by Subject|8|||
161890006|NCT05153148|584641875|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161890007|NCT05153148|584641876|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161890008|NCT05153148|584641877|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
161890009|NCT05153148|584641878|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161890010|NCT05153148|584641875|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161890011|NCT05153148|584641876|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161890012|NCT05153148|584641877|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161890013|NCT05153148|584641878|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
161890014|NCT05153148|584641875|FG000|Overall Study|Reason not Specified|1|||
161890015|NCT05153148|584641876|FG001|Overall Study|Reason not Specified|1|||
161890016|NCT05153148|584641877|FG002|Overall Study|Reason not Specified|1|||
161890017|NCT05153148|584641878|FG003|Overall Study|Reason not Specified|1|||
161890018|NCT01732471|584641879|FG000|Overall Study|Withdrawal by Subject|1|||
161890019|NCT00474786|584641880|FG000|Overall Study|Not Meeting Study Criteria|0|||
161890020|NCT00474786|584641881|FG001|Overall Study|Not Meeting Study Criteria|1|||
161890021|NCT00474786|584641880|FG000|Overall Study|Investigator Request|2|||
161890022|NCT00474786|584641881|FG001|Overall Study|Investigator Request|1|||
161890023|NCT00474786|584641880|FG000|Overall Study|Death|189|||
161890024|NCT00474786|584641881|FG001|Overall Study|Death|170|||
161890025|NCT00474786|584641880|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
161890026|NCT00474786|584641881|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
161890027|NCT00474786|584641880|FG000|Overall Study|Lost to Follow-up|4|||
161890028|NCT00474786|584641881|FG001|Overall Study|Lost to Follow-up|7|||
161890029|NCT00474786|584641880|FG000|Overall Study|Protocol Violation|2|||
161890030|NCT00474786|584641881|FG001|Overall Study|Protocol Violation|0|||
161890031|NCT00474786|584641880|FG000|Overall Study|Withdrawal by Subject|15|||
161890032|NCT00474786|584641881|FG001|Overall Study|Withdrawal by Subject|15|||
161890033|NCT00474786|584641880|FG000|Overall Study|Other|5|||
161890034|NCT00474786|584641881|FG001|Overall Study|Other|0|||
161890035|NCT02892513|584641882|FG000|Overall Study|Withdrawal by Subject|0|||
161890036|NCT02892513|584641883|FG001|Overall Study|Withdrawal by Subject|1|||
161890037|NCT00900731|584641884|FG000|Overall Study|Adverse Event|31|||
161890038|NCT00900731|584641885|FG001|Overall Study|Adverse Event|27|||
161890039|NCT00900731|584641884|FG000|Overall Study|Withdrawal by Subject|8|||
161890040|NCT00900731|584641885|FG001|Overall Study|Withdrawal by Subject|7|||
161890041|NCT00900731|584641884|FG000|Overall Study|Protocol Deviation|8|||
161890042|NCT00900731|584641885|FG001|Overall Study|Protocol Deviation|11|||
161890043|NCT00900731|584641884|FG000|Overall Study|Administrative Problems|5|||
161890044|NCT00900731|584641885|FG001|Overall Study|Administrative Problems|4|||
161890045|NCT00900731|584641884|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
161890046|NCT00900731|584641885|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161890047|NCT00900731|584641884|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
161890048|NCT00900731|584641885|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
161890049|NCT00900731|584641884|FG000|Overall Study|Lost to Follow-up|2|||
161890050|NCT00900731|584641885|FG001|Overall Study|Lost to Follow-up|3|||
161890051|NCT00900731|584641884|FG000|Overall Study|Lack of Efficacy|1|||
161890052|NCT00900731|584641885|FG001|Overall Study|Lack of Efficacy|3|||
161890053|NCT00900731|584641884|FG000|Overall Study|Death|0|||
161890054|NCT00900731|584641885|FG001|Overall Study|Death|2|||
161890055|NCT00131365|584641886|FG000|Overall Study|Withdrawal by Subject|1|||
161890056|NCT00131365|584641886|FG000|Overall Study|Alternative treatment|3|||
161890057|NCT05249127|584641887|FG000|Overall Study|Protocol Violation|13|||
161890058|NCT05249127|584641887|FG000|Overall Study|Physician Decision|4|||
161890059|NCT05249127|584641887|FG000|Overall Study|Withdrawal by Subject|2|||
161890060|NCT05249127|584641887|FG000|Overall Study|Participant Non-compliance|1|||
161890061|NCT02607306|584641888|FG000|Overall Study|Adverse Event|8|||
161890062|NCT02607306|584641889|FG001|Overall Study|Adverse Event|6|||
161890063|NCT02607306|584641890|FG002|Overall Study|Adverse Event|6|||
161890064|NCT02607306|584641888|FG000|Overall Study|Unclassified|1|||
161890065|NCT02607306|584641889|FG001|Overall Study|Unclassified|4|||
161890066|NCT02607306|584641890|FG002|Overall Study|Unclassified|0|||
161890067|NCT02607306|584641888|FG000|Overall Study|Withdrawal by Subject|8|||
161890068|NCT02607306|584641889|FG001|Overall Study|Withdrawal by Subject|10|||
161890069|NCT02607306|584641890|FG002|Overall Study|Withdrawal by Subject|2|||
161890070|NCT02607306|584641888|FG000|Overall Study|Lack of Efficacy|0|||
161890071|NCT02607306|584641889|FG001|Overall Study|Lack of Efficacy|1|||
161890072|NCT02607306|584641890|FG002|Overall Study|Lack of Efficacy|1|||
161890073|NCT02607306|584641888|FG000|Overall Study|Protocol Violation|4|||
161890074|NCT02607306|584641889|FG001|Overall Study|Protocol Violation|2|||
161890075|NCT02607306|584641890|FG002|Overall Study|Protocol Violation|1|||
161890076|NCT01324570|584641891|FG000|Overall Study|Adverse Event|4|||
161890077|NCT01324570|584641892|FG001|Overall Study|Adverse Event|7|||
161890078|NCT01324570|584641891|FG000|Overall Study|Withdrawal by Subject|0|||
161890079|NCT01324570|584641892|FG001|Overall Study|Withdrawal by Subject|3|||
161890080|NCT01324570|584641891|FG000|Overall Study|Lack of Efficacy|0|||
161890081|NCT01324570|584641892|FG001|Overall Study|Lack of Efficacy|1|||
161890082|NCT01324570|584641891|FG000|Overall Study|Confirmed or suspected diversion|0|||
161890083|NCT01324570|584641892|FG001|Overall Study|Confirmed or suspected diversion|1|||
161890084|NCT01324570|584641891|FG000|Overall Study|Administrative|0|||
161890085|NCT01324570|584641892|FG001|Overall Study|Administrative|2|||
161890086|NCT02360475|584641895|FG000|Overall Study|Lost to Follow-up|4|||
161890087|NCT02360475|584641896|FG001|Overall Study|Lost to Follow-up|12|||
161890088|NCT02360475|584641897|FG002|Overall Study|Lost to Follow-up|6|||
161890089|NCT02360475|584641898|FG003|Overall Study|Lost to Follow-up|4|||
161890090|NCT02360475|584641895|FG000|Overall Study|Withdrawal by Subject|0|||
161890091|NCT02360475|584641896|FG001|Overall Study|Withdrawal by Subject|1|||
161890092|NCT02360475|584641897|FG002|Overall Study|Withdrawal by Subject|2|||
161890093|NCT02360475|584641898|FG003|Overall Study|Withdrawal by Subject|0|||
161890094|NCT02360475|584641895|FG000|Overall Study|Migrated/moved from study area|0|||
161890095|NCT02360475|584641896|FG001|Overall Study|Migrated/moved from study area|0|||
161890096|NCT02360475|584641897|FG002|Overall Study|Migrated/moved from study area|0|||
161890097|NCT02360475|584641898|FG003|Overall Study|Migrated/moved from study area|1|||
161890098|NCT00539032|584641900|FG000|Overall Study|Withdrawal by Subject|2|||
161890099|NCT00539032|584641901|FG001|Overall Study|Withdrawal by Subject|1|||
161890100|NCT04438499|584641902|FG000|Overall Study|Lack of Efficacy|3|||
161890101|NCT01859949|584643904|FG000|Overall Study|Family Matters|0|||
161890102|NCT01859949|584643905|FG001|Overall Study|Family Matters|1|||
161890103|NCT01859949|584643904|FG000|Overall Study|Physician Decision|2|||
161890104|NCT01859949|584643905|FG001|Overall Study|Physician Decision|4|||
161890105|NCT01859949|584643904|FG000|Overall Study|Withdrawal by Subject|11|||
161890106|NCT01859949|584643905|FG001|Overall Study|Withdrawal by Subject|10|||
161890107|NCT01859949|584643904|FG000|Overall Study|Protocol Violation|1|||
161890108|NCT01859949|584643905|FG001|Overall Study|Protocol Violation|1|||
161890109|NCT01859949|584643904|FG000|Overall Study|Adverse Event|0|||
161890110|NCT01859949|584643905|FG001|Overall Study|Adverse Event|1|||
161890111|NCT01153009|584643906|FG000|Overall Study|Adverse Event|4|||
161890112|NCT01153009|584643907|FG001|Overall Study|Adverse Event|14|||
161890113|NCT01153009|584643908|FG002|Overall Study|Adverse Event|14|||
161890114|NCT01153009|584643909|FG003|Overall Study|Adverse Event|10|||
161890115|NCT01153009|584643906|FG000|Overall Study|Lack of Efficacy|9|||
161890116|NCT01153009|584643907|FG001|Overall Study|Lack of Efficacy|0|||
161890117|NCT01153009|584643908|FG002|Overall Study|Lack of Efficacy|2|||
161890118|NCT01153009|584643909|FG003|Overall Study|Lack of Efficacy|1|||
161890119|NCT01153009|584643906|FG000|Overall Study|Noncompliance with Study Medication|1|||
161890120|NCT01153009|584643907|FG001|Overall Study|Noncompliance with Study Medication|3|||
161890121|NCT01153009|584643908|FG002|Overall Study|Noncompliance with Study Medication|4|||
161890122|NCT01153009|584643909|FG003|Overall Study|Noncompliance with Study Medication|1|||
161890123|NCT01153009|584643906|FG000|Overall Study|Protocol Deviations|4|||
161890124|NCT01153009|584643907|FG001|Overall Study|Protocol Deviations|3|||
161890125|NCT01153009|584643908|FG002|Overall Study|Protocol Deviations|3|||
161890126|NCT01153009|584643909|FG003|Overall Study|Protocol Deviations|2|||
161890127|NCT01153009|584643906|FG000|Overall Study|Withdrawal of Consent|5|||
161890128|NCT01153009|584643907|FG001|Overall Study|Withdrawal of Consent|5|||
161890129|NCT01153009|584643908|FG002|Overall Study|Withdrawal of Consent|4|||
161890130|NCT01153009|584643909|FG003|Overall Study|Withdrawal of Consent|6|||
161890131|NCT01153009|584643906|FG000|Overall Study|Lost to Follow-up|8|||
161890132|NCT01153009|584643907|FG001|Overall Study|Lost to Follow-up|8|||
161890133|NCT01153009|584643908|FG002|Overall Study|Lost to Follow-up|11|||
161890134|NCT01153009|584643909|FG003|Overall Study|Lost to Follow-up|15|||
161890135|NCT01153009|584643906|FG000|Overall Study|Other|1|||
161890136|NCT01153009|584643907|FG001|Overall Study|Other|1|||
161890137|NCT01153009|584643908|FG002|Overall Study|Other|3|||
161890138|NCT01153009|584643909|FG003|Overall Study|Other|2|||
161890139|NCT04494425|584643912|FG000|Overall Study|Death|160|||
161890140|NCT04494425|584643913|FG001|Overall Study|Death|166|||
161890141|NCT04494425|584643912|FG000|Overall Study|Withdrawal by Subject|10|||
161890142|NCT04494425|584643913|FG001|Overall Study|Withdrawal by Subject|40|||
161890143|NCT04494425|584643912|FG000|Overall Study|Other|1|||
161890144|NCT04494425|584643913|FG001|Overall Study|Other|1|||
161890145|NCT04494425|584643912|FG000|Overall Study|Ongoing at the time of PCD|265|||
161890146|NCT04494425|584643913|FG001|Overall Study|Ongoing at the time of PCD|223|||
161890147|NCT01270321|584643914|FG000|Overall Study|Death|3|||
161890148|NCT01270321|584643915|FG001|Overall Study|Death|1|||
161890149|NCT01270321|584643916|FG002|Overall Study|Death|4|||
161890150|NCT01270321|584643914|FG000|Overall Study|Adverse Event|7|||
161890151|NCT01270321|584643915|FG001|Overall Study|Adverse Event|9|||
161890152|NCT01270321|584643916|FG002|Overall Study|Adverse Event|5|||
161890153|NCT04003623|584643920|FG000|Overall Study|Withdrawal by Subject|1|||
161890154|NCT04003623|584643921|FG001|Overall Study|Withdrawal by Subject|0|||
161890155|NCT03307837|584643927|FG000|Overall Study|Withdrawal by Subject|0|||
161890156|NCT03307837|584643928|FG001|Overall Study|Withdrawal by Subject|0|||
161890157|NCT03307837|584643929|FG002|Overall Study|Withdrawal by Subject|1|||
161890158|NCT03307837|584643930|FG003|Overall Study|Withdrawal by Subject|0|||
161890159|NCT03307837|584643931|FG004|Overall Study|Withdrawal by Subject|0|||
161890160|NCT03307837|584643932|FG005|Overall Study|Withdrawal by Subject|1|||
161890161|NCT03307837|584643927|FG000|Overall Study|Lost to Follow-up|1|||
161890162|NCT03307837|584643928|FG001|Overall Study|Lost to Follow-up|1|||
161890163|NCT03307837|584643929|FG002|Overall Study|Lost to Follow-up|0|||
161890164|NCT03307837|584643930|FG003|Overall Study|Lost to Follow-up|0|||
161890165|NCT03307837|584643931|FG004|Overall Study|Lost to Follow-up|0|||
161890166|NCT03307837|584643932|FG005|Overall Study|Lost to Follow-up|1|||
161890167|NCT01744483|584643933|FG000|Overall Study|Death|9|||
161890168|NCT01744483|584643934|FG001|Overall Study|Death|4|||
161890169|NCT01744483|584643935|FG002|Overall Study|Death|11|||
161890170|NCT01744483|584643933|FG000|Overall Study|Lost to Follow-up|8|||
161890171|NCT01744483|584643934|FG001|Overall Study|Lost to Follow-up|9|||
161890172|NCT01744483|584643935|FG002|Overall Study|Lost to Follow-up|11|||
161890173|NCT01744483|584643933|FG000|Overall Study|Protocol Violation|1|||
161890174|NCT01744483|584643934|FG001|Overall Study|Protocol Violation|2|||
161890175|NCT01744483|584643935|FG002|Overall Study|Protocol Violation|1|||
161890176|NCT01744483|584643933|FG000|Overall Study|Withdrawal by Subject|4|||
161890177|NCT01744483|584643934|FG001|Overall Study|Withdrawal by Subject|6|||
161890178|NCT01744483|584643935|FG002|Overall Study|Withdrawal by Subject|2|||
161890179|NCT01744483|584643933|FG000|Overall Study|No ICU Admit|5|||
161890180|NCT01744483|584643934|FG001|Overall Study|No ICU Admit|1|||
161890181|NCT01744483|584643935|FG002|Overall Study|No ICU Admit|2|||
161890182|NCT01744483|584643933|FG000|Overall Study|Routed to OSH|2|||
161890183|NCT01744483|584643934|FG001|Overall Study|Routed to OSH|0|||
161890184|NCT01744483|584643935|FG002|Overall Study|Routed to OSH|1|||
161890185|NCT03041467|584643936|FG000|Overall Study|Death|46|||
161890186|NCT03041467|584643937|FG001|Overall Study|Death|39|||
161890187|NCT03041467|584643936|FG000|Overall Study|Withdrawal by Subject|36|||
161890188|NCT03041467|584643937|FG001|Overall Study|Withdrawal by Subject|37|||
161890189|NCT03041467|584643936|FG000|Overall Study|Lost to Follow-up|6|||
161890190|NCT03041467|584643937|FG001|Overall Study|Lost to Follow-up|8|||
161890191|NCT03041467|584643936|FG000|Overall Study|Declined consent for study extension|21|||
161890192|NCT03041467|584643937|FG001|Overall Study|Declined consent for study extension|33|||
161890193|NCT03041467|584643936|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
161890194|NCT03041467|584643937|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
161890195|NCT00734656|584643942|FG000|Lab Session 1|Withdrawal by Subject|2|||
161890196|NCT00734656|584643943|FG001|Lab Session 1|Withdrawal by Subject|0|||
161890197|NCT00734656|584643944|FG002|Lab Session 1|Withdrawal by Subject|0|||
161890198|NCT00734656|584643945|FG003|Lab Session 1|Withdrawal by Subject|0|||
161890199|NCT00734656|584643942|FG000|Washout 1|Withdrawal by Subject|1|||
161890200|NCT00734656|584643943|FG001|Washout 1|Withdrawal by Subject|5|||
161890201|NCT00734656|584643944|FG002|Washout 1|Withdrawal by Subject|2|||
161890202|NCT00734656|584643945|FG003|Washout 1|Withdrawal by Subject|3|||
161890203|NCT00734656|584643942|FG000|Lab Session 2|Withdrawal by Subject|1|||
161890204|NCT00734656|584643943|FG001|Lab Session 2|Withdrawal by Subject|0|||
161890205|NCT00734656|584643944|FG002|Lab Session 2|Withdrawal by Subject|0|||
161890206|NCT00734656|584643945|FG003|Lab Session 2|Withdrawal by Subject|1|||
161890207|NCT00734656|584643942|FG000|Washout 2|Withdrawal by Subject|1|||
161890208|NCT00734656|584643943|FG001|Washout 2|Withdrawal by Subject|1|||
161890209|NCT00734656|584643944|FG002|Washout 2|Withdrawal by Subject|1|||
161890210|NCT00734656|584643945|FG003|Washout 2|Withdrawal by Subject|0|||
161890211|NCT00734656|584643942|FG000|Washout 3|Withdrawal by Subject|1|||
161890212|NCT00734656|584643943|FG001|Washout 3|Withdrawal by Subject|0|||
161890213|NCT00734656|584643944|FG002|Washout 3|Withdrawal by Subject|0|||
161890214|NCT00734656|584643945|FG003|Washout 3|Withdrawal by Subject|1|||
161890215|NCT00734656|584643942|FG000|Lab Session 4|Withdrawal by Subject|0|||
161890216|NCT00734656|584643943|FG001|Lab Session 4|Withdrawal by Subject|0|||
161890217|NCT00734656|584643944|FG002|Lab Session 4|Withdrawal by Subject|0|||
161890218|NCT00734656|584643945|FG003|Lab Session 4|Withdrawal by Subject|1|||
161890219|NCT03214679|584643948|FG000|Overall Study|Lost to Follow-up|12|||
161890220|NCT03214679|584643949|FG001|Overall Study|Lost to Follow-up|14|||
161890221|NCT03214679|584643948|FG000|Overall Study|not eligible|2|||
161890222|NCT03214679|584643949|FG001|Overall Study|not eligible|0|||
161890223|NCT01754766|584643957|FG000|Overall Study|Personal reasons|1|||
161890224|NCT01754766|584643958|FG001|Overall Study|Personal reasons|1|||
161890225|NCT01754766|584643959|FG002|Overall Study|Personal reasons|0|||
161890226|NCT02469168|584643961|FG000|Overall Study|Trial closed|1|||
161890227|NCT02469168|584643962|FG001|Overall Study|Trial closed|0|||
161890228|NCT00298363|584643963|FG000|Overall Study|Lost to Follow-up|0|||
161890229|NCT00298363|584643964|FG001|Overall Study|Lost to Follow-up|0|||
161890230|NCT00298363|584643965|FG002|Overall Study|Lost to Follow-up|1|||
161890231|NCT00298363|584643963|FG000|Overall Study|Physician Decision|4|||
161890232|NCT00298363|584643964|FG001|Overall Study|Physician Decision|1|||
161890233|NCT00298363|584643965|FG002|Overall Study|Physician Decision|0|||
161890234|NCT00298363|584643963|FG000|Overall Study|Protocol Violation|1|||
161890235|NCT00298363|584643964|FG001|Overall Study|Protocol Violation|1|||
161890236|NCT00298363|584643965|FG002|Overall Study|Protocol Violation|0|||
161890237|NCT00298363|584643963|FG000|Overall Study|Withdrawal by Subject|5|||
161890238|NCT00298363|584643964|FG001|Overall Study|Withdrawal by Subject|1|||
161890239|NCT00298363|584643965|FG002|Overall Study|Withdrawal by Subject|3|||
161890240|NCT00298363|584643963|FG000|Overall Study|Adverse Event|5|||
161890241|NCT00298363|584643964|FG001|Overall Study|Adverse Event|2|||
161890242|NCT00298363|584643965|FG002|Overall Study|Adverse Event|2|||
161890243|NCT00298363|584643963|FG000|Overall Study|Lack of Efficacy|2|||
161890244|NCT00298363|584643964|FG001|Overall Study|Lack of Efficacy|3|||
161890245|NCT00298363|584643965|FG002|Overall Study|Lack of Efficacy|0|||
161890246|NCT00135356|584643966|FG000|Overall Study|Adverse Event|6|||
161890247|NCT00135356|584643967|FG001|Overall Study|Adverse Event|2|||
161890248|NCT00135356|584643966|FG000|Overall Study|Lack of Efficacy|2|||
161890249|NCT00135356|584643967|FG001|Overall Study|Lack of Efficacy|0|||
161890250|NCT00135356|584643966|FG000|Overall Study|Lost to Follow-up|3|||
161890251|NCT00135356|584643967|FG001|Overall Study|Lost to Follow-up|1|||
161890252|NCT00135356|584643966|FG000|Overall Study|Surgery for abdominal fat|1|||
161890253|NCT00135356|584643967|FG001|Overall Study|Surgery for abdominal fat|0|||
161890254|NCT00135356|584643966|FG000|Overall Study|Change in antiviral regimen|0|||
161890255|NCT00135356|584643967|FG001|Overall Study|Change in antiviral regimen|1|||
161890256|NCT00135356|584643966|FG000|Overall Study|Poor/noncompliance|1|||
161890257|NCT00135356|584643967|FG001|Overall Study|Poor/noncompliance|1|||
161890258|NCT00135356|584643966|FG000|Overall Study|No longer meets study criteria|2|||
161890259|NCT00135356|584643967|FG001|Overall Study|No longer meets study criteria|0|||
161890260|NCT00135356|584643966|FG000|Overall Study|Withdrawal by Subject|2|||
161890261|NCT00135356|584643967|FG001|Overall Study|Withdrawal by Subject|4|||
161890262|NCT02412878|584643968|FG000|Overall Study|Withdrawal by Subject|19|||
161890263|NCT02412878|584643969|FG001|Overall Study|Withdrawal by Subject|10|||
161890264|NCT02412878|584643968|FG000|Overall Study|Lost to Follow-up|2|||
161890265|NCT02412878|584643969|FG001|Overall Study|Lost to Follow-up|3|||
161890266|NCT04676152|584643971|FG000|Overall Study|screen fail|9|||
161890267|NCT01306214|584643972|FG000|Overall Study|Death|0|||
161890268|NCT01306214|584643973|FG001|Overall Study|Death|0|||
161890269|NCT01306214|584643974|FG002|Overall Study|Death|1|||
161890270|NCT01306214|584643972|FG000|Overall Study|Lost to Follow-up|3|||
161890271|NCT01306214|584643973|FG001|Overall Study|Lost to Follow-up|5|||
161890272|NCT01306214|584643974|FG002|Overall Study|Lost to Follow-up|4|||
161890273|NCT01306214|584643972|FG000|Overall Study|Withdrawal by Subject|24|||
161890274|NCT01306214|584643973|FG001|Overall Study|Withdrawal by Subject|22|||
161890275|NCT01306214|584643974|FG002|Overall Study|Withdrawal by Subject|16|||
161890276|NCT01306214|584643972|FG000|Overall Study|Not treated|1|||
161890277|NCT01306214|584643973|FG001|Overall Study|Not treated|1|||
161890278|NCT01306214|584643974|FG002|Overall Study|Not treated|1|||
161890279|NCT02686814|584643975|FG000|Overall Study|Physician Decision|14|||
161890280|NCT02686814|584643975|FG000|Overall Study|Withdrawal by Subject|4|||
161890281|NCT02686814|584643975|FG000|Overall Study|Death|1|||
161890282|NCT01026818|584643983|FG000|Screening Period|Entry Criteria Not Met|105|||
161890283|NCT01026818|584643984|FG001|Screening Period|Entry Criteria Not Met|0|||
161890284|NCT01026818|584643985|FG002|Screening Period|Entry Criteria Not Met|0|||
161890285|NCT01026818|584643986|FG003|Screening Period|Entry Criteria Not Met|0|||
161890286|NCT01026818|584643983|FG000|Screening Period|Withdrawal by Subject|49|||
161890287|NCT01026818|584643984|FG001|Screening Period|Withdrawal by Subject|0|||
161890288|NCT01026818|584643985|FG002|Screening Period|Withdrawal by Subject|0|||
161890289|NCT01026818|584643986|FG003|Screening Period|Withdrawal by Subject|0|||
161890290|NCT01026818|584643983|FG000|Screening Period|Protocol Deviation|3|||
161890291|NCT01026818|584643984|FG001|Screening Period|Protocol Deviation|0|||
161890292|NCT01026818|584643985|FG002|Screening Period|Protocol Deviation|0|||
161890293|NCT01026818|584643986|FG003|Screening Period|Protocol Deviation|0|||
161890294|NCT01026818|584643983|FG000|Screening Period|Adverse Event|2|||
161890295|NCT01026818|584643984|FG001|Screening Period|Adverse Event|0|||
161890296|NCT01026818|584643985|FG002|Screening Period|Adverse Event|0|||
161890297|NCT01026818|584643986|FG003|Screening Period|Adverse Event|0|||
161890298|NCT01026818|584643983|FG000|Screening Period|Physician Decision|1|||
161890299|NCT01026818|584643984|FG001|Screening Period|Physician Decision|0|||
161890300|NCT01026818|584643985|FG002|Screening Period|Physician Decision|0|||
161890301|NCT01026818|584643986|FG003|Screening Period|Physician Decision|0|||
161890302|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
161890303|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
161890304|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
161890305|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
161890306|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
161890307|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
161890308|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
161890309|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
161890310|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
161890311|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
161890312|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
161890313|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
161890314|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
161890315|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
161890316|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
161890317|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
161890318|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
161890319|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
161890320|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
161890321|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
161890322|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
161890323|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
161890324|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
161890325|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
161890326|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
161890327|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
161890328|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
161890329|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
161890330|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
161890331|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
161890332|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
161890333|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
161890334|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161890335|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
161890336|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161890337|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161890338|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
161890339|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
161890340|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
161890341|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
161890342|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
161890343|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
161890344|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
161890345|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
161890346|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161890347|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
161890348|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161890349|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161890350|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
161890351|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
161890352|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
161890353|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
161890354|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161890355|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161890356|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161890357|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
161890358|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161890359|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
161890360|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161890361|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161890362|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161890363|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
161890364|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161890365|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161890366|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
161890367|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
161890368|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
161890369|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
161890370|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
161890371|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
161890372|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
161890373|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
161890374|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
161890375|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
161890376|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
161890377|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
161890378|NCT01908582|584643987|FG000|Period 2|Physician Decision|1|||
161890379|NCT01908582|584643987|FG000|Period 2|Withdrawal by Subject|1|||
161890380|NCT00424593|584643988|FG000|Acute Double-Blind Period|Adverse Event|16|||
161890381|NCT00424593|584643989|FG001|Acute Double-Blind Period|Adverse Event|7|||
161890382|NCT00424593|584643988|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
161890383|NCT00424593|584643989|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
161890384|NCT00424593|584643988|FG000|Acute Double-Blind Period|Protocol Violation|2|||
161890385|NCT00424593|584643989|FG001|Acute Double-Blind Period|Protocol Violation|2|||
161890386|NCT00424593|584643988|FG000|Acute Double-Blind Period|Physician Decision|1|||
161890387|NCT00424593|584643989|FG001|Acute Double-Blind Period|Physician Decision|2|||
161890388|NCT00424593|584643988|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
161890389|NCT00424593|584643989|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
161890390|NCT00424593|584643988|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
161890391|NCT00424593|584643989|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
161890392|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
161890393|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
161890394|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Adverse Event|18|||
161890395|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Adverse Event|0|||
161890396|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
161890397|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
161890398|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
161890399|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
161890400|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
161890401|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
161890402|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Physician Decision|3|||
161890403|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Physician Decision|0|||
161890404|NCT02065518|584643990|FG000|Overall Study|Lost to Follow-up|3|||
161890405|NCT02065518|584643991|FG001|Overall Study|Lost to Follow-up|4|||
161890406|NCT02065518|584643992|FG002|Overall Study|Lost to Follow-up|0|||
161890407|NCT02065518|584643993|FG003|Overall Study|Lost to Follow-up|3|||
161890408|NCT02065518|584643990|FG000|Overall Study|Withdrawal by Subject|3|||
161890409|NCT02065518|584643991|FG001|Overall Study|Withdrawal by Subject|4|||
161890410|NCT02065518|584643992|FG002|Overall Study|Withdrawal by Subject|9|||
161890411|NCT02065518|584643993|FG003|Overall Study|Withdrawal by Subject|2|||
161890412|NCT01066663|584643995|FG000|Overall Study|Adverse Event|0|||
161890413|NCT01066663|584643996|FG001|Overall Study|Adverse Event|0|||
161890414|NCT01066663|584643997|FG002|Overall Study|Adverse Event|1|||
161890415|NCT01090050|584643998|FG000|Overall Study|Lost to Follow-up|0|||
161890416|NCT01090050|584643999|FG001|Overall Study|Lost to Follow-up|1|||
161890417|NCT01090050|584643998|FG000|Overall Study|Lack of Efficacy|1|||
161890418|NCT01090050|584643999|FG001|Overall Study|Lack of Efficacy|5|||
161890419|NCT01090050|584643998|FG000|Overall Study|Physician Decision|0|||
161890420|NCT01090050|584643999|FG001|Overall Study|Physician Decision|1|||
161890421|NCT02232061|584644000|FG000|Overall Study|Administrative problems|1|||
161890422|NCT02232061|584644000|FG000|Overall Study|Withdrawal by Subject|1|||
161890423|NCT00571103|584644001|FG000|Overall Study|Withdrawal by Subject|1|||
161890424|NCT00571103|584644001|FG000|Overall Study|Lost to Follow-up|1|||
161890425|NCT02368886|584644002|FG000|Overall Study|Cancel|1|||
161890426|NCT02368886|584644003|FG001|Overall Study|Cancel|1|||
161890427|NCT02368886|584644004|FG002|Overall Study|Cancel|1|||
161890428|NCT02368886|584644005|FG003|Overall Study|Cancel|3|||
161890429|NCT02368886|584644002|FG000|Overall Study|Ineligible|0|||
161890430|NCT02368886|584644003|FG001|Overall Study|Ineligible|0|||
161890431|NCT02368886|584644004|FG002|Overall Study|Ineligible|0|||
161890432|NCT02368886|584644005|FG003|Overall Study|Ineligible|1|||
161890433|NCT04278924|584644007|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
161890434|NCT04278924|584644008|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
161890435|NCT04278924|584644009|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890436|NCT04278924|584644010|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
161890437|NCT04278924|584644011|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890438|NCT04278924|584644012|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890439|NCT04278924|584644013|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890440|NCT04278924|584644007|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890441|NCT04278924|584644008|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
161890442|NCT04278924|584644009|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890443|NCT04278924|584644010|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890444|NCT04278924|584644011|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890445|NCT04278924|584644012|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890446|NCT04278924|584644013|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890447|NCT04767529|584644014|FG000|Overall Study|Adverse Event|0|||
161890448|NCT04767529|584644015|FG001|Overall Study|Adverse Event|4|||
161890449|NCT04767529|584644016|FG002|Overall Study|Adverse Event|3|||
161890450|NCT04767529|584644014|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
161890451|NCT04767529|584644015|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
161890452|NCT04767529|584644016|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
161890453|NCT04767529|584644014|FG000|Overall Study|Required use of a prohibited medication|0|||
161890454|NCT04767529|584644015|FG001|Overall Study|Required use of a prohibited medication|1|||
161890455|NCT04767529|584644016|FG002|Overall Study|Required use of a prohibited medication|0|||
161890456|NCT04767529|584644014|FG000|Overall Study|Withdrawal by Subject|7|||
161890457|NCT04767529|584644015|FG001|Overall Study|Withdrawal by Subject|5|||
161890458|NCT04767529|584644016|FG002|Overall Study|Withdrawal by Subject|4|||
161890459|NCT04767529|584644014|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
161890460|NCT04767529|584644015|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
161890461|NCT04767529|584644016|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
161890462|NCT04767529|584644014|FG000|Overall Study|Lost to Follow-up|0|||
161890463|NCT04767529|584644015|FG001|Overall Study|Lost to Follow-up|2|||
161890464|NCT04767529|584644016|FG002|Overall Study|Lost to Follow-up|3|||
161890465|NCT04847232|584644017|FG000|Overall Study|Death|123|||
161890466|NCT04847232|584644018|FG001|Overall Study|Death|115|||
161890467|NCT04847232|584644017|FG000|Overall Study|Lost to Follow-up|3|||
161890468|NCT04847232|584644018|FG001|Overall Study|Lost to Follow-up|10|||
161890469|NCT04847232|584644017|FG000|Overall Study|Withdrawal by Subject|73|||
161890470|NCT04847232|584644018|FG001|Overall Study|Withdrawal by Subject|101|||
161890471|NCT04847232|584644017|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
161890472|NCT04847232|584644018|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
161890473|NCT02476916|584644019|FG000|Core Period|Adverse Event|2|||
161890474|NCT02476916|584644020|FG001|Core Period|Adverse Event|2|||
161890475|NCT02476916|584644019|FG000|Core Period|Investigator decision|1|||
161890476|NCT02476916|584644020|FG001|Core Period|Investigator decision|1|||
161890477|NCT02476916|584644019|FG000|Core Period|Withdrawal by Subject|3|||
161890478|NCT02476916|584644020|FG001|Core Period|Withdrawal by Subject|0|||
161890479|NCT02476916|584644019|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
161890480|NCT02476916|584644020|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
161890481|NCT02476916|584644019|FG000|Extension Period|On Treatment|12|||
161890482|NCT02476916|584644020|FG001|Extension Period|On Treatment|17|||
161890483|NCT06010732|584644021|FG000|Crossover Period 1|Protocol Violation|0|||
161890484|NCT06010732|584644022|FG001|Crossover Period 1|Protocol Violation|0|||
161890485|NCT06010732|584644023|FG002|Crossover Period 1|Protocol Violation|1|||
161890486|NCT06010732|584644024|FG003|Crossover Period 1|Protocol Violation|0|||
161890487|NCT06010732|584644025|FG004|Crossover Period 1|Protocol Violation|1|||
161890488|NCT06010732|584644026|FG005|Crossover Period 1|Protocol Violation|0|||
161890489|NCT06010732|584644021|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890490|NCT06010732|584644022|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
161890491|NCT06010732|584644023|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890492|NCT06010732|584644024|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890493|NCT06010732|584644025|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890494|NCT06010732|584644026|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890495|NCT06010732|584644021|FG000|Crossover Period 2|Adverse Event|0|||
161890496|NCT06010732|584644022|FG001|Crossover Period 2|Adverse Event|1|||
161890497|NCT06010732|584644023|FG002|Crossover Period 2|Adverse Event|0|||
161890498|NCT06010732|584644024|FG003|Crossover Period 2|Adverse Event|0|||
161890499|NCT06010732|584644025|FG004|Crossover Period 2|Adverse Event|0|||
161890500|NCT06010732|584644026|FG005|Crossover Period 2|Adverse Event|0|||
161890501|NCT06010732|584644021|FG000|Crossover Period 2|broken denture|0|||
161890502|NCT06010732|584644022|FG001|Crossover Period 2|broken denture|0|||
161890503|NCT06010732|584644023|FG002|Crossover Period 2|broken denture|1|||
161890504|NCT06010732|584644024|FG003|Crossover Period 2|broken denture|0|||
161890505|NCT06010732|584644025|FG004|Crossover Period 2|broken denture|0|||
161890506|NCT06010732|584644026|FG005|Crossover Period 2|broken denture|0|||
161890507|NCT00253370|584644028|FG000|Overall Study|Adverse Event|18|||
161890508|NCT00253370|584644028|FG000|Overall Study|Disease progression|13|||
161890509|NCT00253370|584644028|FG000|Overall Study|Death|2|||
161890510|NCT00253370|584644028|FG000|Overall Study|Withdrawal by Subject|6|||
161890511|NCT00253370|584644028|FG000|Overall Study|Non-protocol therapy|1|||
161890512|NCT00253370|584644028|FG000|Overall Study|Physician Decision|1|||
161890513|NCT00253370|584644028|FG000|Overall Study|Protocol Violation|1|||
161890514|NCT00253370|584644028|FG000|Overall Study|Abdominal pain due to disease|1|||
161890515|NCT03699540|584644029|FG000|Overall Study|Lost to Follow-up|1|||
161890516|NCT02697591|584644030|FG000|Overall Study|Lost to Follow-up|0|||
161890517|NCT02697591|584644031|FG001|Overall Study|Lost to Follow-up|0|||
161890518|NCT02697591|584644032|FG002|Overall Study|Lost to Follow-up|0|||
161890519|NCT02697591|584644033|FG003|Overall Study|Lost to Follow-up|0|||
161890520|NCT02697591|584644034|FG004|Overall Study|Lost to Follow-up|0|||
161890521|NCT02697591|584644035|FG005|Overall Study|Lost to Follow-up|1|||
161890522|NCT02697591|584644036|FG006|Overall Study|Lost to Follow-up|1|||
161890523|NCT02697591|584644037|FG007|Overall Study|Lost to Follow-up|0|||
161890524|NCT02697591|584644038|FG008|Overall Study|Lost to Follow-up|0|||
161890525|NCT02697591|584644039|FG009|Overall Study|Lost to Follow-up|1|||
161890526|NCT02697591|584644030|FG000|Overall Study|Withdrawal by Subject|1|||
161890527|NCT02697591|584644031|FG001|Overall Study|Withdrawal by Subject|1|||
161890528|NCT02697591|584644032|FG002|Overall Study|Withdrawal by Subject|2|||
161890529|NCT02697591|584644033|FG003|Overall Study|Withdrawal by Subject|1|||
161890530|NCT02697591|584644034|FG004|Overall Study|Withdrawal by Subject|7|||
161890531|NCT02697591|584644035|FG005|Overall Study|Withdrawal by Subject|6|||
161890532|NCT02697591|584644036|FG006|Overall Study|Withdrawal by Subject|9|||
161890533|NCT02697591|584644037|FG007|Overall Study|Withdrawal by Subject|1|||
161890534|NCT02697591|584644038|FG008|Overall Study|Withdrawal by Subject|6|||
161890535|NCT02697591|584644039|FG009|Overall Study|Withdrawal by Subject|10|||
161890536|NCT02697591|584644030|FG000|Overall Study|Physician Decision|1|||
161890537|NCT02697591|584644031|FG001|Overall Study|Physician Decision|0|||
161890538|NCT02697591|584644032|FG002|Overall Study|Physician Decision|0|||
161890539|NCT02697591|584644033|FG003|Overall Study|Physician Decision|0|||
161890540|NCT02697591|584644034|FG004|Overall Study|Physician Decision|1|||
161890541|NCT02697591|584644035|FG005|Overall Study|Physician Decision|2|||
161890542|NCT02697591|584644036|FG006|Overall Study|Physician Decision|0|||
161890543|NCT02697591|584644037|FG007|Overall Study|Physician Decision|0|||
161890544|NCT02697591|584644038|FG008|Overall Study|Physician Decision|1|||
161890545|NCT02697591|584644039|FG009|Overall Study|Physician Decision|1|||
161890546|NCT02697591|584644030|FG000|Overall Study|Death|2|||
161890547|NCT02697591|584644031|FG001|Overall Study|Death|3|||
161890548|NCT02697591|584644032|FG002|Overall Study|Death|1|||
161890549|NCT02697591|584644033|FG003|Overall Study|Death|1|||
161890550|NCT02697591|584644034|FG004|Overall Study|Death|4|||
161890551|NCT02697591|584644035|FG005|Overall Study|Death|5|||
161890552|NCT02697591|584644036|FG006|Overall Study|Death|3|||
161890553|NCT02697591|584644037|FG007|Overall Study|Death|1|||
161890554|NCT02697591|584644038|FG008|Overall Study|Death|1|||
161890555|NCT02697591|584644039|FG009|Overall Study|Death|5|||
161890556|NCT02697591|584644030|FG000|Overall Study|Reason not Specified|0|||
161890557|NCT02697591|584644031|FG001|Overall Study|Reason not Specified|0|||
161890558|NCT02697591|584644032|FG002|Overall Study|Reason not Specified|0|||
161890559|NCT02697591|584644033|FG003|Overall Study|Reason not Specified|1|||
161890560|NCT02697591|584644034|FG004|Overall Study|Reason not Specified|1|||
161890561|NCT02697591|584644035|FG005|Overall Study|Reason not Specified|2|||
161890562|NCT02697591|584644036|FG006|Overall Study|Reason not Specified|3|||
161890563|NCT02697591|584644037|FG007|Overall Study|Reason not Specified|1|||
161890564|NCT02697591|584644038|FG008|Overall Study|Reason not Specified|1|||
161890565|NCT02697591|584644039|FG009|Overall Study|Reason not Specified|3|||
161890566|NCT00004088|584644041|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
161890567|NCT00004088|584644041|FG000|Overall Study|Withdrawal by Subject|1|||
161890568|NCT00004088|584644041|FG000|Overall Study|Protocol Violation|3|||
161890569|NCT00004088|584644041|FG000|Overall Study|Physician Decision|1|||
161890570|NCT02636699|584644042|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
161890571|NCT02636699|584644043|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
161890572|NCT02636699|584644044|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
161890573|NCT02636699|584644042|FG000|Screening Period|Withdrawal by Subject|0|||
161890574|NCT02636699|584644043|FG001|Screening Period|Withdrawal by Subject|0|||
161890575|NCT02636699|584644044|FG002|Screening Period|Withdrawal by Subject|23|||
161890576|NCT02636699|584644042|FG000|Screening Period|Adverse Event|0|||
161890577|NCT02636699|584644043|FG001|Screening Period|Adverse Event|0|||
161890578|NCT02636699|584644044|FG002|Screening Period|Adverse Event|1|||
161890579|NCT02636699|584644042|FG000|Screening Period|Other not specified|0|||
161890580|NCT02636699|584644043|FG001|Screening Period|Other not specified|0|||
161890581|NCT02636699|584644044|FG002|Screening Period|Other not specified|3|||
161890582|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
161890583|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
161890584|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
161890585|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
161890586|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
161890587|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
161890588|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
161890589|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
161890590|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
161890591|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
161890592|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
161890593|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
161890594|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
161890595|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
161890596|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
161890597|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Other|3|||
161890598|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Other|1|||
161890599|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Other|0|||
161890600|NCT00624832|584644045|FG000|Overall Study|Adverse Event|0|||
161890601|NCT00624832|584644046|FG001|Overall Study|Adverse Event|1|||
161890602|NCT00624832|584644047|FG002|Overall Study|Adverse Event|0|||
161890603|NCT00624832|584644048|FG003|Overall Study|Adverse Event|1|||
161890604|NCT00624832|584644045|FG000|Overall Study|Abnormal Laboratory Value|2|||
161890605|NCT00624832|584644046|FG001|Overall Study|Abnormal Laboratory Value|0|||
161890606|NCT00624832|584644047|FG002|Overall Study|Abnormal Laboratory Value|0|||
161890607|NCT00624832|584644048|FG003|Overall Study|Abnormal Laboratory Value|0|||
161890608|NCT01939223|584644049|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
161890609|NCT01939223|584644050|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
161890610|NCT01939223|584644049|FG000|Overall Study|Disease recurrence (radiological)|1|||
161890611|NCT01939223|584644050|FG001|Overall Study|Disease recurrence (radiological)|3|||
161890612|NCT01939223|584644049|FG000|Overall Study|Study stopped by Sponsor|5|||
161890613|NCT01939223|584644050|FG001|Overall Study|Study stopped by Sponsor|7|||
161890614|NCT01939223|584644049|FG000|Overall Study|Withdrawal by Subject|6|||
161890615|NCT01939223|584644050|FG001|Overall Study|Withdrawal by Subject|0|||
161890616|NCT04379700|584644051|FG000|Overall Study|Withdrawal by Subject|10|||
161890617|NCT04379700|584644051|FG000|Overall Study|Screen Fail|4|||
161890618|NCT04379700|584644051|FG000|Overall Study|Lost to Follow-up|3|||
161890619|NCT03624569|584644053|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161890620|NCT03624569|584644054|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161890621|NCT03624569|584644053|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
161890622|NCT03624569|584644054|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
161890623|NCT03004924|584644081|FG000|Overall Study|Adverse Event|6|||
161890624|NCT03004924|584644082|FG001|Overall Study|Adverse Event|5|||
161890625|NCT03004924|584644083|FG002|Overall Study|Adverse Event|10|||
161890626|NCT03004924|584644081|FG000|Overall Study|Protocol Violation|4|||
161890627|NCT03004924|584644082|FG001|Overall Study|Protocol Violation|0|||
161890628|NCT03004924|584644083|FG002|Overall Study|Protocol Violation|1|||
161890629|NCT03004924|584644081|FG000|Overall Study|Withdrawal by Subject|5|||
161890630|NCT03004924|584644082|FG001|Overall Study|Withdrawal by Subject|3|||
161890631|NCT03004924|584644083|FG002|Overall Study|Withdrawal by Subject|5|||
161890632|NCT03004924|584644081|FG000|Overall Study|Lost to Follow-up|6|||
161890633|NCT03004924|584644082|FG001|Overall Study|Lost to Follow-up|1|||
161890634|NCT03004924|584644083|FG002|Overall Study|Lost to Follow-up|4|||
161890635|NCT03004924|584644081|FG000|Overall Study|Lack of Efficacy|2|||
161890636|NCT03004924|584644082|FG001|Overall Study|Lack of Efficacy|4|||
161890637|NCT03004924|584644083|FG002|Overall Study|Lack of Efficacy|2|||
161890638|NCT03004924|584644081|FG000|Overall Study|Physician Decision|1|||
161890639|NCT03004924|584644082|FG001|Overall Study|Physician Decision|0|||
161890640|NCT03004924|584644083|FG002|Overall Study|Physician Decision|1|||
161890641|NCT03004924|584644081|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161890642|NCT03004924|584644082|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161890643|NCT03004924|584644083|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161890644|NCT03004924|584644081|FG000|Overall Study|Screen Failure|1|||
161890645|NCT03004924|584644082|FG001|Overall Study|Screen Failure|0|||
161890646|NCT03004924|584644083|FG002|Overall Study|Screen Failure|0|||
161890647|NCT03004924|584644081|FG000|Overall Study|Pregnancy|0|||
161890648|NCT03004924|584644082|FG001|Overall Study|Pregnancy|1|||
161890649|NCT03004924|584644083|FG002|Overall Study|Pregnancy|0|||
161890650|NCT03004924|584644081|FG000|Overall Study|Terminated by Sponsor|0|||
161890651|NCT03004924|584644082|FG001|Overall Study|Terminated by Sponsor|0|||
161890652|NCT03004924|584644083|FG002|Overall Study|Terminated by Sponsor|1|||
161890653|NCT03004924|584644081|FG000|Overall Study|Missed Study Visit|0|||
161890654|NCT03004924|584644082|FG001|Overall Study|Missed Study Visit|0|||
161890655|NCT03004924|584644083|FG002|Overall Study|Missed Study Visit|2|||
161890656|NCT03004924|584644081|FG000|Overall Study|HSV1 Positive|1|||
161890657|NCT03004924|584644082|FG001|Overall Study|HSV1 Positive|0|||
161890658|NCT03004924|584644083|FG002|Overall Study|HSV1 Positive|0|||
161890659|NCT02083653|584644088|FG000|Overall Study|Randomized but not Treated|0|||
161890660|NCT02083653|584644089|FG001|Overall Study|Randomized but not Treated|2|||
161890661|NCT02083653|584644090|FG002|Overall Study|Randomized but not Treated|7|||
161890662|NCT02083653|584644088|FG000|Overall Study|Adverse Event|12|||
161890663|NCT02083653|584644089|FG001|Overall Study|Adverse Event|5|||
161890664|NCT02083653|584644090|FG002|Overall Study|Adverse Event|4|||
161890665|NCT02083653|584644088|FG000|Overall Study|Lost to Follow-up|1|||
161890666|NCT02083653|584644089|FG001|Overall Study|Lost to Follow-up|0|||
161890667|NCT02083653|584644090|FG002|Overall Study|Lost to Follow-up|0|||
161890668|NCT02083653|584644088|FG000|Overall Study|Death|2|||
161890669|NCT02083653|584644089|FG001|Overall Study|Death|2|||
161890670|NCT02083653|584644090|FG002|Overall Study|Death|2|||
161890671|NCT02083653|584644088|FG000|Overall Study|Progressive Disease|65|||
161890672|NCT02083653|584644089|FG001|Overall Study|Progressive Disease|73|||
161890673|NCT02083653|584644090|FG002|Overall Study|Progressive Disease|63|||
161890674|NCT02083653|584644088|FG000|Overall Study|Withdrawal by Subject|2|||
161890675|NCT02083653|584644089|FG001|Overall Study|Withdrawal by Subject|1|||
161890676|NCT02083653|584644090|FG002|Overall Study|Withdrawal by Subject|2|||
161890677|NCT02083653|584644088|FG000|Overall Study|Other Events|0|||
161890678|NCT02083653|584644089|FG001|Overall Study|Other Events|2|||
161890679|NCT02083653|584644090|FG002|Overall Study|Other Events|2|||
161890680|NCT02083653|584644088|FG000|Overall Study|Reason Missing|0|||
161890681|NCT02083653|584644089|FG001|Overall Study|Reason Missing|0|||
161890682|NCT02083653|584644090|FG002|Overall Study|Reason Missing|4|||
161890683|NCT02073656|584644091|FG000|Primary Study|Lost to Follow-up|6|||
161890684|NCT02073656|584644091|FG000|Primary Study|Death|1|||
161890685|NCT02073656|584644091|FG000|Primary Study|Withdrew Consent|1|||
161890686|NCT05079230|584644092|FG000|Overall Study|Study Terminated by Sponsor|101|||
161890687|NCT05079230|584644093|FG001|Overall Study|Study Terminated by Sponsor|102|||
161890688|NCT05079230|584644092|FG000|Overall Study|Death|72|||
161890689|NCT05079230|584644093|FG001|Overall Study|Death|66|||
161890690|NCT05079230|584644092|FG000|Overall Study|Withdrew Consent|16|||
161890691|NCT05079230|584644093|FG001|Overall Study|Withdrew Consent|18|||
161890692|NCT05079230|584644092|FG000|Overall Study|Lost to Follow-up|0|||
161890693|NCT05079230|584644093|FG001|Overall Study|Lost to Follow-up|3|||
161890694|NCT02054910|584644098|FG000|Overall Study|Lost to Follow-up|4|||
161890695|NCT02054910|584644099|FG001|Overall Study|Lost to Follow-up|1|||
161890696|NCT00207727|584644100|FG000|Overall Study|Withdrawal by Subject|0|||
161890697|NCT00207727|584644101|FG001|Overall Study|Withdrawal by Subject|0|||
161890698|NCT00207727|584644102|FG002|Overall Study|Withdrawal by Subject|0|||
161890699|NCT00207727|584644103|FG003|Overall Study|Withdrawal by Subject|0|||
161890700|NCT00207727|584644104|FG004|Overall Study|Withdrawal by Subject|1|||
161890701|NCT00207727|584644100|FG000|Overall Study|Lost to Follow-up|0|||
161890702|NCT00207727|584644101|FG001|Overall Study|Lost to Follow-up|1|||
161890703|NCT00207727|584644102|FG002|Overall Study|Lost to Follow-up|0|||
161890704|NCT00207727|584644103|FG003|Overall Study|Lost to Follow-up|0|||
161890705|NCT00207727|584644104|FG004|Overall Study|Lost to Follow-up|0|||
161890706|NCT00207727|584644100|FG000|Overall Study|Other|38|||
161890707|NCT00207727|584644101|FG001|Overall Study|Other|41|||
161890708|NCT00207727|584644102|FG002|Overall Study|Other|41|||
161890709|NCT00207727|584644103|FG003|Overall Study|Other|37|||
161890710|NCT00207727|584644104|FG004|Overall Study|Other|33|||
161890711|NCT03759366|584644105|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
161890712|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
161890713|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
161890714|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
161890715|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
161890716|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
161890717|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
161890718|NCT03611582|584644106|FG000|Overall Study|Adverse Event|26|||
161890719|NCT03611582|584644107|FG001|Overall Study|Adverse Event|6|||
161890720|NCT03611582|584644106|FG000|Overall Study|Protocol Violation|0|||
161890721|NCT03611582|584644107|FG001|Overall Study|Protocol Violation|1|||
161890722|NCT03611582|584644106|FG000|Overall Study|Pregnancy|1|||
161890723|NCT03611582|584644107|FG001|Overall Study|Pregnancy|2|||
161890724|NCT03611582|584644106|FG000|Overall Study|Lack of Efficacy|0|||
161890725|NCT03611582|584644107|FG001|Overall Study|Lack of Efficacy|1|||
161890726|NCT03611582|584644106|FG000|Overall Study|At the discretion of the investigator|1|||
161890727|NCT03611582|584644107|FG001|Overall Study|At the discretion of the investigator|0|||
161890728|NCT03611582|584644106|FG000|Overall Study|Safety concern as judged by the investigator|1|||
161890729|NCT03611582|584644107|FG001|Overall Study|Safety concern as judged by the investigator|2|||
161890730|NCT03611582|584644106|FG000|Overall Study|Withdrawal by Subject|4|||
161890731|NCT03611582|584644107|FG001|Overall Study|Withdrawal by Subject|3|||
161890732|NCT03611582|584644106|FG000|Overall Study|Lost to Follow-up|18|||
161890733|NCT03611582|584644107|FG001|Overall Study|Lost to Follow-up|7|||
161890734|NCT03611582|584644106|FG000|Overall Study|other|17|||
161890735|NCT03611582|584644107|FG001|Overall Study|other|16|||
161890736|NCT00463840|584644108|FG000|Overall Study|Disease progression|7|||
161890737|NCT00463840|584644108|FG000|Overall Study|Withdrawal by Subject|2|||
161890738|NCT00463840|584644108|FG000|Overall Study|Adverse Event|3|||
161890739|NCT01653327|584644109|FG000|Overall Study|Withdrawal by Subject|1|||
161890740|NCT00422292|584644110|FG000|Overall Study|Serious adverse events|1|||
161890741|NCT00422292|584644111|FG001|Overall Study|Serious adverse events|4|||
161890742|NCT00422292|584644112|FG002|Overall Study|Serious adverse events|0|||
161890743|NCT00422292|584644113|FG003|Overall Study|Serious adverse events|0|||
161890744|NCT00422292|584644110|FG000|Overall Study|Adverse Event|1|||
161890745|NCT00422292|584644111|FG001|Overall Study|Adverse Event|0|||
161890746|NCT00422292|584644112|FG002|Overall Study|Adverse Event|1|||
161890747|NCT00422292|584644113|FG003|Overall Study|Adverse Event|0|||
161890748|NCT00422292|584644110|FG000|Overall Study|Protocol Violation|4|||
161890749|NCT00422292|584644111|FG001|Overall Study|Protocol Violation|25|||
161890750|NCT00422292|584644112|FG002|Overall Study|Protocol Violation|8|||
161890751|NCT00422292|584644113|FG003|Overall Study|Protocol Violation|5|||
161890752|NCT00422292|584644110|FG000|Overall Study|Lost to Follow-up|6|||
161890753|NCT00422292|584644111|FG001|Overall Study|Lost to Follow-up|12|||
161890754|NCT00422292|584644112|FG002|Overall Study|Lost to Follow-up|6|||
161890755|NCT00422292|584644113|FG003|Overall Study|Lost to Follow-up|6|||
161890756|NCT00422292|584644110|FG000|Overall Study|Withdrawal by Subject|6|||
161890757|NCT00422292|584644111|FG001|Overall Study|Withdrawal by Subject|25|||
161890758|NCT00422292|584644112|FG002|Overall Study|Withdrawal by Subject|7|||
161890759|NCT00422292|584644113|FG003|Overall Study|Withdrawal by Subject|13|||
161890760|NCT01190189|584646058|FG000|Overall Study|Lost to Follow-up|4|||
161890761|NCT01190189|584646058|FG000|Overall Study|Withdrawal by Subject|1|||
161890762|NCT01190189|584646058|FG000|Overall Study|Migrated/moved from study area|1|||
161890763|NCT00762034|584646061|FG000|Induction Period|Protocol Violation|1|||
161890764|NCT00762034|584646062|FG001|Induction Period|Protocol Violation|2|||
161890765|NCT00762034|584646061|FG000|Induction Period|Entry Criterion Not Met|12|||
161890766|NCT00762034|584646062|FG001|Induction Period|Entry Criterion Not Met|11|||
161890767|NCT00762034|584646061|FG000|Induction Period|Adverse Event|27|||
161890768|NCT00762034|584646062|FG001|Induction Period|Adverse Event|38|||
161890769|NCT00762034|584646061|FG000|Induction Period|Lost to Follow-up|1|||
161890770|NCT00762034|584646062|FG001|Induction Period|Lost to Follow-up|1|||
161890771|NCT00762034|584646061|FG000|Induction Period|Progressive Disease|73|||
161890772|NCT00762034|584646062|FG001|Induction Period|Progressive Disease|55|||
161890773|NCT00762034|584646061|FG000|Induction Period|Physician Decision|21|||
161890774|NCT00762034|584646062|FG001|Induction Period|Physician Decision|20|||
161890775|NCT00762034|584646061|FG000|Induction Period|Withdrawal by Subject|15|||
161890776|NCT00762034|584646062|FG001|Induction Period|Withdrawal by Subject|19|||
161890777|NCT00762034|584646061|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
161890778|NCT00762034|584646062|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
161890779|NCT00762034|584646061|FG000|Induction Period|Deaths Due to Study Disease|9|||
161890780|NCT00762034|584646062|FG001|Induction Period|Deaths Due to Study Disease|9|||
161890781|NCT00762034|584646061|FG000|Maintenance Period|Protocol Violation|1|||
161890782|NCT00762034|584646062|FG001|Maintenance Period|Protocol Violation|3|||
161890783|NCT00762034|584646061|FG000|Maintenance Period|Entry Criterion Not Met|0|||
161890784|NCT00762034|584646062|FG001|Maintenance Period|Entry Criterion Not Met|2|||
161890785|NCT00762034|584646061|FG000|Maintenance Period|Adverse Event|42|||
161890786|NCT00762034|584646062|FG001|Maintenance Period|Adverse Event|26|||
161890787|NCT00762034|584646061|FG000|Maintenance Period|Progressive Disease|186|||
161890788|NCT00762034|584646062|FG001|Maintenance Period|Progressive Disease|224|||
161890789|NCT00762034|584646061|FG000|Maintenance Period|Physician Decision|25|||
161890790|NCT00762034|584646062|FG001|Maintenance Period|Physician Decision|20|||
161890791|NCT00762034|584646061|FG000|Maintenance Period|Withdrawal by Subject|34|||
161890792|NCT00762034|584646062|FG001|Maintenance Period|Withdrawal by Subject|14|||
161890793|NCT00762034|584646061|FG000|Maintenance Period|Death not due to study disease|2|||
161890794|NCT00762034|584646062|FG001|Maintenance Period|Death not due to study disease|5|||
161890795|NCT00762034|584646061|FG000|Maintenance Period|Death due to study disease|3|||
161890796|NCT00762034|584646062|FG001|Maintenance Period|Death due to study disease|3|||
161890797|NCT00762034|584646061|FG000|Maintenance Period|Other|1|||
161890798|NCT00762034|584646062|FG001|Maintenance Period|Other|1|||
161890799|NCT04228965|584646063|FG000|Overall Study|Lost to Follow-up|26|||
161890800|NCT04228965|584646064|FG001|Overall Study|Lost to Follow-up|11|||
161890801|NCT04228965|584646063|FG000|Overall Study|Withdrawal by Subject|18|||
161890802|NCT04228965|584646064|FG001|Overall Study|Withdrawal by Subject|5|||
161890803|NCT02442206|584646065|FG000|Period 1|Adverse Event|1|||
161890804|NCT02442206|584646066|FG001|Period 1|Adverse Event|1|||
161890805|NCT02442206|584646065|FG000|Period 1|withdrew consent|0|||
161890806|NCT02442206|584646066|FG001|Period 1|withdrew consent|1|||
161890807|NCT02442206|584646065|FG000|Period 1|COPD exacerbation|0|||
161890808|NCT02442206|584646066|FG001|Period 1|COPD exacerbation|1|||
161890809|NCT02442206|584646065|FG000|Period 2|Adverse Event|1|||
161890810|NCT02442206|584646066|FG001|Period 2|Adverse Event|0|||
161890811|NCT03300050|584646069|FG000|Overall Study|Lost to Follow-up|2|||
161890812|NCT03300050|584646070|FG001|Overall Study|Lost to Follow-up|1|||
161890813|NCT03300050|584646071|FG002|Overall Study|Lost to Follow-up|0|||
161890814|NCT03300050|584646072|FG003|Overall Study|Lost to Follow-up|0|||
161890815|NCT03300050|584646073|FG004|Overall Study|Lost to Follow-up|1|||
161890816|NCT03300050|584646069|FG000|Overall Study|Withdrawal by Subject|1|||
161890817|NCT03300050|584646070|FG001|Overall Study|Withdrawal by Subject|1|||
161890818|NCT03300050|584646071|FG002|Overall Study|Withdrawal by Subject|1|||
161890819|NCT03300050|584646072|FG003|Overall Study|Withdrawal by Subject|0|||
161890820|NCT03300050|584646073|FG004|Overall Study|Withdrawal by Subject|0|||
161890821|NCT03300050|584646069|FG000|Overall Study|Death|0|||
161890822|NCT03300050|584646070|FG001|Overall Study|Death|0|||
161890823|NCT03300050|584646071|FG002|Overall Study|Death|1|||
161890824|NCT03300050|584646072|FG003|Overall Study|Death|0|||
161890825|NCT03300050|584646073|FG004|Overall Study|Death|0|||
161890826|NCT03300050|584646069|FG000|Overall Study|Not Eligible at Randomization|0|||
161890827|NCT03300050|584646070|FG001|Overall Study|Not Eligible at Randomization|0|||
161890828|NCT03300050|584646071|FG002|Overall Study|Not Eligible at Randomization|1|||
161890829|NCT03300050|584646072|FG003|Overall Study|Not Eligible at Randomization|1|||
161890830|NCT03300050|584646073|FG004|Overall Study|Not Eligible at Randomization|0|||
161890831|NCT01375374|584646074|FG000|Overall Study|Adverse Event|1|||
161890832|NCT03297021|584646075|FG000|Overall Study|Incomplete/illegible data sheet|4|||
161890833|NCT03297021|584646076|FG001|Overall Study|Incomplete/illegible data sheet|2|||
161890834|NCT03297021|584646077|FG002|Overall Study|Incomplete/illegible data sheet|3|||
161890835|NCT03297021|584646075|FG000|Overall Study|Missing Post-Op Data|1|||
161890836|NCT03297021|584646076|FG001|Overall Study|Missing Post-Op Data|2|||
161890837|NCT03297021|584646077|FG002|Overall Study|Missing Post-Op Data|1|||
161890838|NCT02784288|584646079|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
161890839|NCT02734862|584646080|FG000|Part A|Death|3|||
161890840|NCT02734862|584646081|FG001|Part A|Death|4|||
161890841|NCT02734862|584646082|FG002|Part A|Death|6|||
161890842|NCT02734862|584646080|FG000|Part A|Lost to Follow-up|2|||
161890843|NCT02734862|584646081|FG001|Part A|Lost to Follow-up|1|||
161890844|NCT02734862|584646082|FG002|Part A|Lost to Follow-up|1|||
161890845|NCT02734862|584646080|FG000|Part A|Withdrawal by Subject|1|||
161890846|NCT02734862|584646081|FG001|Part A|Withdrawal by Subject|1|||
161890847|NCT02734862|584646082|FG002|Part A|Withdrawal by Subject|2|||
161890848|NCT02734862|584646080|FG000|Part A|Physician Decision|2|||
161890849|NCT02734862|584646081|FG001|Part A|Physician Decision|0|||
161890850|NCT02734862|584646082|FG002|Part A|Physician Decision|1|||
161890851|NCT02734862|584646080|FG000|Part A|Adverse Event|2|||
161890852|NCT02734862|584646081|FG001|Part A|Adverse Event|0|||
161890853|NCT02734862|584646082|FG002|Part A|Adverse Event|1|||
161890854|NCT02734862|584646080|FG000|Part A|Noncompliance|1|||
161890855|NCT02734862|584646081|FG001|Part A|Noncompliance|1|||
161890856|NCT02734862|584646082|FG002|Part A|Noncompliance|0|||
161890857|NCT02734862|584646080|FG000|Part A|Other|1|||
161890858|NCT02734862|584646081|FG001|Part A|Other|1|||
161890859|NCT02734862|584646082|FG002|Part A|Other|3|||
161890860|NCT02734862|584646080|FG000|Part B|Death|8|||
161890861|NCT02734862|584646081|FG001|Part B|Death|3|||
161890862|NCT02734862|584646082|FG002|Part B|Death|5|||
161890863|NCT02734862|584646080|FG000|Part B|Lost to Follow-up|2|||
161890864|NCT02734862|584646081|FG001|Part B|Lost to Follow-up|2|||
161890865|NCT02734862|584646082|FG002|Part B|Lost to Follow-up|0|||
161890866|NCT02734862|584646080|FG000|Part B|Withdrawal by Subject|3|||
161890867|NCT02734862|584646081|FG001|Part B|Withdrawal by Subject|1|||
161890868|NCT02734862|584646082|FG002|Part B|Withdrawal by Subject|0|||
161890869|NCT02734862|584646080|FG000|Part B|Other|0|||
161890870|NCT02734862|584646081|FG001|Part B|Other|1|||
161890871|NCT02734862|584646082|FG002|Part B|Other|0|||
161890872|NCT02757625|584646083|FG000|Overall Study|Investigator's discretion|0|||
161890873|NCT02757625|584646084|FG001|Overall Study|Investigator's discretion|0|||
161890874|NCT02757625|584646085|FG002|Overall Study|Investigator's discretion|1|||
161890875|NCT02757625|584646086|FG003|Overall Study|Investigator's discretion|0|||
161890876|NCT02757625|584646083|FG000|Overall Study|Adverse Event|0|||
161890877|NCT02757625|584646084|FG001|Overall Study|Adverse Event|0|||
161890878|NCT02757625|584646085|FG002|Overall Study|Adverse Event|1|||
161890879|NCT02757625|584646086|FG003|Overall Study|Adverse Event|0|||
161890880|NCT00564278|584646087|FG000|Overall Study|Lost to Follow-up|35|||
161890881|NCT00564278|584646088|FG001|Overall Study|Lost to Follow-up|33|||
161890882|NCT00564278|584646087|FG000|Overall Study|Physician Decision|1|||
161890883|NCT00564278|584646088|FG001|Overall Study|Physician Decision|2|||
161890884|NCT00564278|584646087|FG000|Overall Study|Withdrawal by Subject|11|||
161890885|NCT00564278|584646088|FG001|Overall Study|Withdrawal by Subject|7|||
161890886|NCT00560703|584646089|FG000|Overall Study|Adverse Event|0|||
161890887|NCT00560703|584646090|FG001|Overall Study|Adverse Event|2|||
161890888|NCT00560703|584646089|FG000|Overall Study|Protocol Violation|0|||
161890889|NCT00560703|584646090|FG001|Overall Study|Protocol Violation|2|||
161890890|NCT00560703|584646089|FG000|Overall Study|Withdrawal by Subject|0|||
161890891|NCT00560703|584646090|FG001|Overall Study|Withdrawal by Subject|1|||
161890892|NCT00560703|584646089|FG000|Overall Study|non-compliance|0|||
161890893|NCT00560703|584646090|FG001|Overall Study|non-compliance|1|||
161890894|NCT02095197|584646091|FG000|Overall Study|Lost to Follow-up|0|||
161890895|NCT02095197|584646092|FG001|Overall Study|Lost to Follow-up|3|||
161890896|NCT02779075|584646093|FG000|Overall Study|Withdrawal by Subject|1|||
161890897|NCT02779075|584646094|FG001|Overall Study|Withdrawal by Subject|3|||
161890898|NCT02779075|584646093|FG000|Overall Study|IV lost during 2nd study|1|||
161890899|NCT02779075|584646094|FG001|Overall Study|IV lost during 2nd study|0|||
161890900|NCT02714036|584646095|FG000|Overall Study|Adverse Event|9|||
161890901|NCT02714036|584646096|FG001|Overall Study|Adverse Event|2|||
161890902|NCT02714036|584646095|FG000|Overall Study|Withdrawal by Subject|3|||
161890903|NCT02714036|584646096|FG001|Overall Study|Withdrawal by Subject|2|||
161890904|NCT01618916|584646097|FG000|Overall Study|Adverse Event|1|||
161890905|NCT01618916|584646098|FG001|Overall Study|Adverse Event|0|||
161890906|NCT01618916|584646099|FG002|Overall Study|Adverse Event|0|||
161890907|NCT01618916|584646100|FG003|Overall Study|Adverse Event|0|||
161890908|NCT01618916|584646101|FG004|Overall Study|Adverse Event|0|||
161890909|NCT01618916|584646102|FG005|Overall Study|Adverse Event|0|||
161890910|NCT01618916|584646097|FG000|Overall Study|Withdrawal by Subject|0|||
161890911|NCT01618916|584646098|FG001|Overall Study|Withdrawal by Subject|1|||
161890912|NCT01618916|584646099|FG002|Overall Study|Withdrawal by Subject|1|||
161890913|NCT01618916|584646100|FG003|Overall Study|Withdrawal by Subject|0|||
161890914|NCT01618916|584646101|FG004|Overall Study|Withdrawal by Subject|1|||
161890915|NCT01618916|584646102|FG005|Overall Study|Withdrawal by Subject|0|||
161890916|NCT01618916|584646097|FG000|Overall Study|Lost to Follow-up|1|||
161890917|NCT01618916|584646098|FG001|Overall Study|Lost to Follow-up|0|||
161890918|NCT01618916|584646099|FG002|Overall Study|Lost to Follow-up|0|||
161890919|NCT01618916|584646100|FG003|Overall Study|Lost to Follow-up|2|||
161890920|NCT01618916|584646101|FG004|Overall Study|Lost to Follow-up|0|||
161890921|NCT01618916|584646102|FG005|Overall Study|Lost to Follow-up|0|||
161890922|NCT00938587|584646106|FG000|Overall Study|Adverse Event|2|||
161890923|NCT00938587|584646107|FG001|Overall Study|Adverse Event|0|||
161890924|NCT00938587|584646108|FG002|Overall Study|Adverse Event|0|||
161890925|NCT00938587|584646109|FG003|Overall Study|Adverse Event|2|||
161890926|NCT00938587|584646106|FG000|Overall Study|Did not meet entrance criteria|0|||
161890927|NCT00938587|584646107|FG001|Overall Study|Did not meet entrance criteria|0|||
161890928|NCT00938587|584646108|FG002|Overall Study|Did not meet entrance criteria|1|||
161890929|NCT00938587|584646109|FG003|Overall Study|Did not meet entrance criteria|0|||
161890930|NCT00938587|584646106|FG000|Overall Study|Withdrawal by Subject|1|||
161890931|NCT00938587|584646107|FG001|Overall Study|Withdrawal by Subject|1|||
161890932|NCT00938587|584646108|FG002|Overall Study|Withdrawal by Subject|0|||
161890933|NCT00938587|584646109|FG003|Overall Study|Withdrawal by Subject|0|||
161890934|NCT01464619|584646114|FG000|Overall Study|Lost to Follow-up|3|||
161890935|NCT01464619|584646115|FG001|Overall Study|Lost to Follow-up|4|||
161890936|NCT02819440|584646116|FG000|Overall Study|Adverse Event|3|||
161890937|NCT02819440|584646117|FG001|Overall Study|Adverse Event|1|||
161890938|NCT02819440|584646116|FG000|Overall Study|Lost to Follow-up|1|||
161890939|NCT02819440|584646117|FG001|Overall Study|Lost to Follow-up|3|||
161890940|NCT02819440|584646116|FG000|Overall Study|Withdrawal by Subject|9|||
161890941|NCT02819440|584646117|FG001|Overall Study|Withdrawal by Subject|8|||
161890942|NCT01490697|584646120|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
161890943|NCT01490697|584646121|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
161890944|NCT00090584|584646122|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
161890945|NCT00090584|584646123|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
161890946|NCT00090584|584646122|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
161890947|NCT00090584|584646123|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
161890948|NCT00379808|584646124|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
161890949|NCT00379808|584646125|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
161890950|NCT01048099|584646134|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
161890951|NCT01048099|584646134|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
161890952|NCT00508157|584646135|FG000|Overall Study|Adverse Event|0|||
161890953|NCT00508157|584646136|FG001|Overall Study|Adverse Event|1|||
161890954|NCT00508157|584646135|FG000|Overall Study|Subject Withdrew Consent|1|||
161890955|NCT00508157|584646136|FG001|Overall Study|Subject Withdrew Consent|0|||
161890956|NCT00508157|584646135|FG000|Overall Study|Lost to Follow-up|1|||
161890957|NCT00508157|584646136|FG001|Overall Study|Lost to Follow-up|0|||
161890958|NCT00508157|584646135|FG000|Overall Study|Subject no longer met study criteria|0|||
161890959|NCT00508157|584646136|FG001|Overall Study|Subject no longer met study criteria|1|||
161890960|NCT00508157|584646135|FG000|Overall Study|Other known cause|0|||
161890961|NCT00508157|584646136|FG001|Overall Study|Other known cause|1|||
161890962|NCT01987232|584646137|FG000|Overall Study|Ongoing in Study|0|||
161890963|NCT01987232|584646138|FG001|Overall Study|Ongoing in Study|0|||
161890964|NCT01987232|584646139|FG002|Overall Study|Ongoing in Study|0|||
161890965|NCT01987232|584646140|FG003|Overall Study|Ongoing in Study|1|||
161890966|NCT01987232|584646141|FG004|Overall Study|Ongoing in Study|0|||
161890967|NCT01731470|584646144|FG000|Overall Study|Withdrawal by Subject|1|||
161890968|NCT01731470|584646144|FG000|Overall Study|Did not meet study criteria|1|||
161890969|NCT02258334|584646147|FG000|Overall Study|Adverse Event|1|||
161890970|NCT02258334|584646148|FG001|Overall Study|Adverse Event|0|||
161890971|NCT02258334|584646149|FG002|Overall Study|Adverse Event|0|||
161890972|NCT02258334|584646150|FG003|Overall Study|Adverse Event|0|||
161890973|NCT03564795|584646157|FG000|Overall Study|Withdrawal by Subject|3|||
161890974|NCT03564795|584646157|FG000|Overall Study|Lost to Follow-up|6|||
161890975|NCT03564795|584646157|FG000|Overall Study|Physician Decision|2|||
161890976|NCT00564395|584646158|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
161890977|NCT00564395|584646159|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
161890978|NCT00564395|584646158|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
161890979|NCT00564395|584646159|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
161890980|NCT00477607|584646165|FG000|Overall Study|Lost to Follow-up|7|||
161890981|NCT00477607|584646166|FG001|Overall Study|Lost to Follow-up|7|||
161890982|NCT00432276|584646167|FG000|Overall Study|Hyperglycemic Rescue|44|||
161890983|NCT00432276|584646168|FG001|Overall Study|Hyperglycemic Rescue|87|||
161890984|NCT00432276|584646167|FG000|Overall Study|Adverse Event|13|||
161890985|NCT00432276|584646168|FG001|Overall Study|Adverse Event|16|||
161890986|NCT00432276|584646167|FG000|Overall Study|Protocol Violation|25|||
161890987|NCT00432276|584646168|FG001|Overall Study|Protocol Violation|20|||
161890988|NCT00432276|584646167|FG000|Overall Study|Lost to Follow-up|6|||
161890989|NCT00432276|584646168|FG001|Overall Study|Lost to Follow-up|2|||
161890990|NCT00432276|584646167|FG000|Overall Study|Withdrawal by Subject|25|||
161890991|NCT00432276|584646168|FG001|Overall Study|Withdrawal by Subject|20|||
161890992|NCT00432276|584646167|FG000|Overall Study|Physician Decision|6|||
161890993|NCT00432276|584646168|FG001|Overall Study|Physician Decision|8|||
161890994|NCT00432276|584646167|FG000|Overall Study|Other|2|||
161890995|NCT00432276|584646168|FG001|Overall Study|Other|3|||
161890996|NCT00594386|584646169|FG000|Overall Study|Major protocol violation|2|||
161890997|NCT00594386|584646169|FG000|Overall Study|Lack of Efficacy|12|||
161890998|NCT00594386|584646169|FG000|Overall Study|Adverse Event|68|||
161890999|NCT00594386|584646169|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
161891000|NCT00594386|584646169|FG000|Overall Study|Subject withdrew consent|35|||
161891001|NCT00594386|584646169|FG000|Overall Study|Study ended per sponsor|115|||
161891002|NCT00594386|584646169|FG000|Overall Study|Lost to Follow-up|6|||
161891003|NCT00594386|584646169|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
161891004|NCT00594386|584646169|FG000|Overall Study|Other: Subject moved to Seattle|1|||
161891005|NCT00594386|584646169|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
161891006|NCT00594386|584646169|FG000|Overall Study|Other: Study terminated per investigator|2|||
161891007|NCT00594386|584646169|FG000|Overall Study|Other: Sponsor closure of study|1|||
161891008|NCT00594386|584646169|FG000|Overall Study|Other: Site terminated participation|1|||
161891009|NCT00594386|584646169|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
161891010|NCT00594386|584646169|FG000|Overall Study|Other: Loss of drivers license|1|||
161891011|NCT01210144|584646173|FG000|Overall Study|Lack of ovarian response|1|||
161891012|NCT01210144|584646174|FG001|Overall Study|Lack of ovarian response|0|||
161891013|NCT01210144|584646173|FG000|Overall Study|No fertilization|1|||
161891014|NCT01210144|584646174|FG001|Overall Study|No fertilization|0|||
161891015|NCT01210144|584646173|FG000|Overall Study|No transfer|1|||
161891016|NCT01210144|584646174|FG001|Overall Study|No transfer|0|||
161891017|NCT00505661|584646186|FG000|Overall Study|Not Eligible|4|||
161891018|NCT01573754|584646191|FG000|Overall Study|Noncompliance or remission not achieved|3|||
161891019|NCT01573754|584646192|FG001|Overall Study|Noncompliance or remission not achieved|15|||
161891020|NCT00866333|584646193|FG000|Overall Study|Withdrawal of consent|0|||
161891021|NCT00866333|584646194|FG001|Overall Study|Withdrawal of consent|1|||
161891022|NCT00866333|584646195|FG002|Overall Study|Withdrawal of consent|2|||
161891023|NCT00866333|584646193|FG000|Overall Study|Reason not Specified|3|||
161891024|NCT00866333|584646194|FG001|Overall Study|Reason not Specified|1|||
161891025|NCT00866333|584646195|FG002|Overall Study|Reason not Specified|1|||
161891026|NCT00866333|584646193|FG000|Overall Study|Study Terminated by Sponsor|2|||
161891027|NCT00866333|584646194|FG001|Overall Study|Study Terminated by Sponsor|5|||
161891028|NCT00866333|584646195|FG002|Overall Study|Study Terminated by Sponsor|9|||
161891029|NCT02243046|584646196|FG000|Overall Study|Lost to Follow-up|1|||
161891030|NCT02243046|584646197|FG001|Overall Study|Lost to Follow-up|1|||
161891031|NCT02243046|584646198|FG002|Overall Study|Lost to Follow-up|4|||
161891032|NCT04918355|584646199|FG000|Overall Study|no qualifying health encounter|497|||
161891033|NCT04918355|584646200|FG001|Overall Study|no qualifying health encounter|192|||
161891034|NCT04918355|584646201|FG002|Overall Study|no qualifying health encounter|438|||
161891035|NCT04918355|584646202|FG003|Overall Study|no qualifying health encounter|424|||
161891036|NCT04683939|584646203|FG000|Overall Study|Study termination by the sponsor|0|||
161891037|NCT04683939|584646204|FG001|Overall Study|Study termination by the sponsor|1|||
161891038|NCT04683939|584646205|FG002|Overall Study|Study termination by the sponsor|2|||
161891039|NCT04683939|584646206|FG003|Overall Study|Study termination by the sponsor|2|||
161891040|NCT04683939|584646203|FG000|Overall Study|Death|1|||
161891041|NCT04683939|584646204|FG001|Overall Study|Death|1|||
161891042|NCT04683939|584646205|FG002|Overall Study|Death|2|||
161891043|NCT04683939|584646206|FG003|Overall Study|Death|1|||
161891044|NCT04683939|584646203|FG000|Overall Study|Withdrawal by Subject|1|||
161891045|NCT04683939|584646204|FG001|Overall Study|Withdrawal by Subject|0|||
161891046|NCT04683939|584646205|FG002|Overall Study|Withdrawal by Subject|0|||
161891047|NCT04683939|584646206|FG003|Overall Study|Withdrawal by Subject|0|||
161891048|NCT04683939|584646203|FG000|Overall Study|Physician Decision|1|||
161891049|NCT04683939|584646204|FG001|Overall Study|Physician Decision|0|||
161891050|NCT04683939|584646205|FG002|Overall Study|Physician Decision|0|||
161891051|NCT04683939|584646206|FG003|Overall Study|Physician Decision|0|||
161891052|NCT04683939|584646203|FG000|Overall Study|Lost to Follow-up|0|||
161891053|NCT04683939|584646204|FG001|Overall Study|Lost to Follow-up|1|||
161891054|NCT04683939|584646205|FG002|Overall Study|Lost to Follow-up|0|||
161891055|NCT04683939|584646206|FG003|Overall Study|Lost to Follow-up|0|||
161891056|NCT04852276|584646207|FG000|Overall Study|Death|2|||
161891057|NCT04852276|584646208|FG001|Overall Study|Death|0|||
161891058|NCT04852276|584646207|FG000|Overall Study|Lost to Follow-up|15|||
161891059|NCT04852276|584646208|FG001|Overall Study|Lost to Follow-up|9|||
161891060|NCT04852276|584646207|FG000|Overall Study|Withdrawal by Subject|26|||
161891061|NCT04852276|584646208|FG001|Overall Study|Withdrawal by Subject|6|||
161891062|NCT01687283|584648067|FG000|Overall Study|Adverse Event|11|||
161891063|NCT01687283|584648068|FG001|Overall Study|Adverse Event|4|||
161891064|NCT01687283|584648067|FG000|Overall Study|Lack of Efficacy|3|||
161891065|NCT01687283|584648068|FG001|Overall Study|Lack of Efficacy|1|||
161891066|NCT01687283|584648067|FG000|Overall Study|Protocol Violation|1|||
161891067|NCT01687283|584648068|FG001|Overall Study|Protocol Violation|3|||
161891068|NCT01687283|584648067|FG000|Overall Study|protocol defined stopping criteria|8|||
161891069|NCT01687283|584648068|FG001|Overall Study|protocol defined stopping criteria|10|||
161891070|NCT01687283|584648067|FG000|Overall Study|Lost to Follow-up|1|||
161891071|NCT01687283|584648068|FG001|Overall Study|Lost to Follow-up|1|||
161891072|NCT01687283|584648067|FG000|Overall Study|Investigator discretion|2|||
161891073|NCT01687283|584648068|FG001|Overall Study|Investigator discretion|0|||
161891074|NCT01687283|584648067|FG000|Overall Study|Withdrawal by Subject|9|||
161891075|NCT01687283|584648068|FG001|Overall Study|Withdrawal by Subject|8|||
161891076|NCT00410072|584648072|FG000|Day 1 to Week 48|Adverse Event|1|||
161891077|NCT00410072|584648073|FG001|Day 1 to Week 48|Adverse Event|2|||
161891078|NCT00410072|584648072|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
161891079|NCT00410072|584648073|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
161891080|NCT00410072|584648072|FG000|Day 1 to Week 48|Other|0|||
161891081|NCT00410072|584648073|FG001|Day 1 to Week 48|Other|1|||
161891082|NCT00410072|584648072|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
161891083|NCT00410072|584648073|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
161891084|NCT00410072|584648072|FG000|Day 1 to Week 48|Pregnancy|0|||
161891085|NCT00410072|584648073|FG001|Day 1 to Week 48|Pregnancy|2|||
161891086|NCT00410072|584648072|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
161891087|NCT00410072|584648073|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
161891088|NCT00410072|584648072|FG000|After Week 48 to Week 96|Adverse Event|1|||
161891089|NCT00410072|584648073|FG001|After Week 48 to Week 96|Adverse Event|2|||
161891090|NCT00410072|584648072|FG000|After Week 48 to Week 96|Death|0|||
161891091|NCT00410072|584648073|FG001|After Week 48 to Week 96|Death|1|||
161891092|NCT00410072|584648072|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
161891093|NCT00410072|584648073|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
161891094|NCT00410072|584648072|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
161891095|NCT00410072|584648073|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
161891096|NCT00410072|584648072|FG000|After Week 48 to Week 96|Other|2|||
161891097|NCT00410072|584648073|FG001|After Week 48 to Week 96|Other|0|||
161891098|NCT00410072|584648072|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
161891099|NCT00410072|584648073|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
161891100|NCT00410072|584648072|FG000|After Week 48 to Week 96|Pregnancy|0|||
161891101|NCT00410072|584648073|FG001|After Week 48 to Week 96|Pregnancy|2|||
161891102|NCT00410072|584648072|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
161891103|NCT00410072|584648073|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
161891104|NCT01471444|584648074|FG000|Overall Study|Physician Decision|3|||
161891105|NCT01471444|584648075|FG001|Overall Study|Physician Decision|2|||
161891106|NCT01471444|584648074|FG000|Overall Study|Withdrawal by Subject|0|||
161891107|NCT01471444|584648075|FG001|Overall Study|Withdrawal by Subject|1|||
161891108|NCT03915626|584648076|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
161891109|NCT01709409|584648079|FG000|Overall Study|Protocol Violation|1|||
161891110|NCT01709409|584648080|FG001|Overall Study|Protocol Violation|0|||
161891111|NCT04571385|584648081|FG000|Overall Study|Participant non-compliance|1|||
161891112|NCT04571385|584648082|FG001|Overall Study|Participant non-compliance|0|||
161891113|NCT04571385|584648083|FG002|Overall Study|Participant non-compliance|0|||
161891114|NCT04571385|584648081|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
161891115|NCT04571385|584648082|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
161891116|NCT04571385|584648083|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
161891117|NCT04571385|584648081|FG000|Overall Study|Screen failure|0|||
161891118|NCT04571385|584648082|FG001|Overall Study|Screen failure|0|||
161891119|NCT04571385|584648083|FG002|Overall Study|Screen failure|1|||
161891120|NCT05025332|584648084|FG000|Screening|Screen failure|12|||
161891121|NCT05025332|584648084|FG000|Treatment & Follow Up|Protocol Violation|1|||
161891122|NCT05025332|584648084|FG000|Treatment & Follow Up|Adverse Event|4|||
161891123|NCT01928199|584648087|FG000|Overall Study|Lost to Follow-up|2|||
161891124|NCT01928199|584648088|FG001|Overall Study|Lost to Follow-up|1|||
161891125|NCT01928199|584648087|FG000|Overall Study|Withdrawal by Subject|3|||
161891126|NCT01928199|584648088|FG001|Overall Study|Withdrawal by Subject|5|||
161891127|NCT01641471|584648089|FG000|Overall Study|Withdrawal by Subject|19|||
161891128|NCT01641471|584648090|FG001|Overall Study|Withdrawal by Subject|19|||
161891129|NCT01641471|584648089|FG000|Overall Study|Lost to Follow-up|2|||
161891130|NCT01641471|584648090|FG001|Overall Study|Lost to Follow-up|4|||
161891131|NCT01641471|584648089|FG000|Overall Study|Protocol Violation|2|||
161891132|NCT01641471|584648090|FG001|Overall Study|Protocol Violation|4|||
161891133|NCT02499263|584648091|FG000|Overall Study|Lost to Follow-up|9|||
161891134|NCT02499263|584648091|FG000|Overall Study|Participant's withdrawal of consent|4|||
161891135|NCT02499263|584648091|FG000|Overall Study|Lack of Efficacy|22|||
161891136|NCT02499263|584648091|FG000|Overall Study|investigator's judgment|12|||
161891137|NCT02499263|584648091|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
161891138|NCT02499263|584648091|FG000|Overall Study|Participant's decision|3|||
161891139|NCT02499263|584648091|FG000|Overall Study|Pregnancy|1|||
161891140|NCT01108237|584648092|FG000|Overall Study|No alignment data|2|||
161891141|NCT01108237|584648093|FG001|Overall Study|No alignment data|15|||
161891142|NCT01108237|584648092|FG000|Overall Study|Did not meet criteria for analysis|7|||
161891143|NCT01108237|584648093|FG001|Overall Study|Did not meet criteria for analysis|0|||
161891144|NCT00790556|584648094|FG000|Treatment Period 1|Physician Decision|1|||
161891145|NCT00790556|584648095|FG001|Treatment Period 1|Physician Decision|0|||
161891146|NCT00790556|584648094|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161891147|NCT00790556|584648095|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161891148|NCT03077607|584648096|FG000|Period 1 (15 Days)|Adverse Event|1|||
161891149|NCT03077607|584648097|FG001|Period 1 (15 Days)|Adverse Event|0|||
161891150|NCT03077607|584648096|FG000|Period 1 (15 Days)|Death|1|||
161891151|NCT03077607|584648097|FG001|Period 1 (15 Days)|Death|0|||
161891152|NCT03077607|584648096|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
161891153|NCT03077607|584648097|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
161891154|NCT03077607|584648096|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
161891155|NCT03077607|584648097|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
161891156|NCT04401202|584648099|FG000|Overall Study|Lost to Follow-up|2|||
161891157|NCT04401202|584648100|FG001|Overall Study|Lost to Follow-up|2|||
161891158|NCT04401202|584648099|FG000|Overall Study|Adverse Event|0|||
161891159|NCT04401202|584648100|FG001|Overall Study|Adverse Event|1|||
161891160|NCT04401202|584648099|FG000|Overall Study|Hospitalized|4|||
161891161|NCT04401202|584648100|FG001|Overall Study|Hospitalized|1|||
161891162|NCT05697627|584648104|FG000|Overall Study|Adverse Event|1|||
161891163|NCT04122625|584648105|FG000|Part A (up to 2.92 Years)|Death|2|||
161891164|NCT04122625|584648106|FG001|Part A (up to 2.92 Years)|Death|4|||
161891165|NCT04122625|584648107|FG002|Part A (up to 2.92 Years)|Death|0|||
161891166|NCT04122625|584648108|FG003|Part A (up to 2.92 Years)|Death|0|||
161891167|NCT04122625|584648109|FG004|Part A (up to 2.92 Years)|Death|0|||
161891168|NCT04122625|584648110|FG005|Part A (up to 2.92 Years)|Death|0|||
161891169|NCT04122625|584648105|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161891170|NCT04122625|584648106|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161891171|NCT04122625|584648107|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
161891172|NCT04122625|584648108|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
161891173|NCT04122625|584648109|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
161891174|NCT04122625|584648110|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161891175|NCT04122625|584648105|FG000|Part B (up to 2.33 Years)|Death|0|||
161891176|NCT04122625|584648106|FG001|Part B (up to 2.33 Years)|Death|0|||
161891177|NCT04122625|584648107|FG002|Part B (up to 2.33 Years)|Death|5|||
161891178|NCT04122625|584648108|FG003|Part B (up to 2.33 Years)|Death|7|||
161891179|NCT04122625|584648109|FG004|Part B (up to 2.33 Years)|Death|6|||
161891180|NCT04122625|584648110|FG005|Part B (up to 2.33 Years)|Death|7|||
161891181|NCT02722746|584648111|FG000|Overall Study|Withdrawal by Subject|0|||
161891182|NCT02722746|584648112|FG001|Overall Study|Withdrawal by Subject|1|||
161891183|NCT02722746|584648113|FG002|Overall Study|Withdrawal by Subject|0|||
161891184|NCT02722746|584648111|FG000|Overall Study|Protocol Violation|8|||
161891185|NCT02722746|584648112|FG001|Overall Study|Protocol Violation|4|||
161891186|NCT02722746|584648113|FG002|Overall Study|Protocol Violation|6|||
161891187|NCT01038752|584648114|FG000|Overall Study|Tumor Progression|2|||
161891188|NCT01038752|584648115|FG001|Overall Study|Tumor Progression|2|||
161891189|NCT01038752|584648114|FG000|Overall Study|Lost to Follow-up|3|||
161891190|NCT01038752|584648115|FG001|Overall Study|Lost to Follow-up|3|||
161891191|NCT02700698|584648122|FG000|Overall Study|Withdrawal by Subject|1|||
161891192|NCT02700698|584648123|FG001|Overall Study|Withdrawal by Subject|0|||
161891193|NCT00703118|584648124|FG000|Overall Study|Adverse Event|1|||
161891194|NCT00703118|584648125|FG001|Overall Study|Adverse Event|2|||
161891195|NCT00703118|584648126|FG002|Overall Study|Adverse Event|2|||
161891196|NCT00703118|584648124|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
161891197|NCT00703118|584648125|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
161891198|NCT00703118|584648126|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
161891199|NCT00703118|584648124|FG000|Overall Study|Lost to Follow-up|6|||
161891200|NCT00703118|584648125|FG001|Overall Study|Lost to Follow-up|4|||
161891201|NCT00703118|584648126|FG002|Overall Study|Lost to Follow-up|4|||
161891202|NCT00703118|584648124|FG000|Overall Study|Withdrawal by Subject|8|||
161891203|NCT00703118|584648125|FG001|Overall Study|Withdrawal by Subject|7|||
161891204|NCT00703118|584648126|FG002|Overall Study|Withdrawal by Subject|13|||
161891205|NCT00703118|584648124|FG000|Overall Study|Other|0|||
161891206|NCT00703118|584648125|FG001|Overall Study|Other|0|||
161891207|NCT00703118|584648126|FG002|Overall Study|Other|1|||
161891208|NCT04165135|584648129|FG000|Overall Study|Protocol Violation|10|||
161891209|NCT04165135|584648129|FG000|Overall Study|Participants withdrawal of consent|5|||
161891210|NCT00530790|584648130|FG000|Overall Study|Adverse Event|2|||
161891211|NCT00530790|584648130|FG000|Overall Study|Withdrawal by Subject|2|||
161891212|NCT00530790|584648130|FG000|Overall Study|Physician Decision|1|||
161891213|NCT05053035|584648137|FG000|Overall Study|Withdrawal by Subject|1|||
161891214|NCT05053035|584648138|FG001|Overall Study|Withdrawal by Subject|0|||
161891215|NCT00438256|584648139|FG000|Overall Study|Ineligible for Resection|2|||
161891216|NCT00438256|584648140|FG001|Overall Study|Ineligible for Resection|1|||
161891217|NCT00438256|584648141|FG002|Overall Study|Ineligible for Resection|1|||
161891218|NCT00438256|584648142|FG003|Overall Study|Ineligible for Resection|7|||
161891219|NCT00438256|584648139|FG000|Overall Study|Excluded final Diagnosis|0|||
161891220|NCT00438256|584648140|FG001|Overall Study|Excluded final Diagnosis|0|||
161891221|NCT00438256|584648141|FG002|Overall Study|Excluded final Diagnosis|0|||
161891222|NCT00438256|584648142|FG003|Overall Study|Excluded final Diagnosis|2|||
161891223|NCT02005627|584648143|FG000|Overall Study|Lost to Follow-up|1|||
161891224|NCT02005627|584648144|FG001|Overall Study|Lost to Follow-up|2|||
161891225|NCT02005627|584648143|FG000|Overall Study|Withdrawal by Subject|1|||
161891226|NCT02005627|584648144|FG001|Overall Study|Withdrawal by Subject|2|||
161891227|NCT00849290|584648150|FG000|Overall Study|Adverse Event|3|||
161891228|NCT00849290|584648150|FG000|Overall Study|Death|14|||
161891229|NCT00849290|584648150|FG000|Overall Study|Withdrawal by Subject|11|||
161891230|NCT00849290|584648150|FG000|Overall Study|Lost to Follow-up|2|||
161891231|NCT00849290|584648150|FG000|Overall Study|Protocol Violation|5|||
161891232|NCT00849290|584648150|FG000|Overall Study|Disease Progression|20|||
161891233|NCT02334384|584648166|FG000|Overall Study|Lost to Follow-up|1|||
161891234|NCT02334384|584648167|FG001|Overall Study|Lost to Follow-up|1|||
161891235|NCT00055497|584648168|FG000|Overall Study|Adverse Event|1|||
161891236|NCT00055497|584648169|FG001|Overall Study|Adverse Event|1|||
161891237|NCT00055497|584648170|FG002|Overall Study|Adverse Event|1|||
161891238|NCT00055497|584648171|FG003|Overall Study|Adverse Event|28|||
161891239|NCT00055497|584648168|FG000|Overall Study|Withdrawal by Subject|3|||
161891240|NCT00055497|584648169|FG001|Overall Study|Withdrawal by Subject|1|||
161891241|NCT00055497|584648170|FG002|Overall Study|Withdrawal by Subject|1|||
161891242|NCT00055497|584648171|FG003|Overall Study|Withdrawal by Subject|15|||
161891243|NCT00055497|584648168|FG000|Overall Study|Lost to Follow-up|0|||
161891244|NCT00055497|584648169|FG001|Overall Study|Lost to Follow-up|1|||
161891245|NCT00055497|584648170|FG002|Overall Study|Lost to Follow-up|0|||
161891246|NCT00055497|584648171|FG003|Overall Study|Lost to Follow-up|5|||
161891247|NCT00055497|584648168|FG000|Overall Study|Protocol Violation|0|||
161891248|NCT00055497|584648169|FG001|Overall Study|Protocol Violation|0|||
161891249|NCT00055497|584648170|FG002|Overall Study|Protocol Violation|0|||
161891250|NCT00055497|584648171|FG003|Overall Study|Protocol Violation|3|||
161891251|NCT00055497|584648168|FG000|Overall Study|Lack of Efficacy|1|||
161891252|NCT00055497|584648169|FG001|Overall Study|Lack of Efficacy|0|||
161891253|NCT00055497|584648170|FG002|Overall Study|Lack of Efficacy|0|||
161891254|NCT00055497|584648171|FG003|Overall Study|Lack of Efficacy|27|||
161891255|NCT00055497|584648168|FG000|Overall Study|Administrative Reasons|0|||
161891256|NCT00055497|584648169|FG001|Overall Study|Administrative Reasons|0|||
161891257|NCT00055497|584648170|FG002|Overall Study|Administrative Reasons|0|||
161891258|NCT00055497|584648171|FG003|Overall Study|Administrative Reasons|1|||
161891259|NCT00055497|584648168|FG000|Overall Study|Other|0|||
161891260|NCT00055497|584648169|FG001|Overall Study|Other|0|||
161891261|NCT00055497|584648170|FG002|Overall Study|Other|0|||
161891262|NCT00055497|584648171|FG003|Overall Study|Other|11|||
161891263|NCT00048165|584648172|FG000|Completed 6 Months Study|Administration/Other|8|||
161891264|NCT00048165|584648173|FG001|Completed 6 Months Study|Administration/Other|8|||
161891265|NCT00048165|584648172|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
161891266|NCT00048165|584648173|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
161891267|NCT00048165|584648172|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
161891268|NCT00048165|584648173|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
161891269|NCT00048165|584648172|FG000|Completed 6 Months Study|Death|12|||
161891270|NCT00048165|584648173|FG001|Completed 6 Months Study|Death|6|||
161891271|NCT00048165|584648172|FG000|Completed 6 Months Study|Insufficient therapy|1|||
161891272|NCT00048165|584648173|FG001|Completed 6 Months Study|Insufficient therapy|4|||
161891273|NCT00048165|584648172|FG000|Completed 6 Months Study|Other violation|4|||
161891274|NCT00048165|584648173|FG001|Completed 6 Months Study|Other violation|6|||
161891275|NCT00048165|584648172|FG000|Completed 6 Months Study|Refused treatment|5|||
161891276|NCT00048165|584648173|FG001|Completed 6 Months Study|Refused treatment|5|||
161891277|NCT00048165|584648172|FG000|Completed 6 Months Study|Violation criteria|0|||
161891278|NCT00048165|584648173|FG001|Completed 6 Months Study|Violation criteria|2|||
161891279|NCT00048165|584648172|FG000|Completed 6 Months Study|Did not receive study drug|6|||
161891280|NCT00048165|584648173|FG001|Completed 6 Months Study|Did not receive study drug|6|||
161891281|NCT00048165|584648172|FG000|Completed 12 Months Study|Administration/Other|0|||
161891282|NCT00048165|584648173|FG001|Completed 12 Months Study|Administration/Other|2|||
161891283|NCT00048165|584648172|FG000|Completed 12 Months Study|Death|2|||
161891284|NCT00048165|584648173|FG001|Completed 12 Months Study|Death|1|||
161891285|NCT00048165|584648172|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
161891286|NCT00048165|584648173|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
161891287|NCT00731731|584648174|FG000|Overall Study|Protocol Violation|0|||
161891288|NCT00731731|584648175|FG001|Overall Study|Protocol Violation|0|||
161891289|NCT00731731|584648176|FG002|Overall Study|Protocol Violation|1|||
161891290|NCT00731731|584648174|FG000|Overall Study|Cancel prior to treatment|0|||
161891291|NCT00731731|584648175|FG001|Overall Study|Cancel prior to treatment|0|||
161891292|NCT00731731|584648176|FG002|Overall Study|Cancel prior to treatment|2|||
161891293|NCT01084538|584648177|FG000|Overall Study|Drug not available|30|||
161891294|NCT01084538|584648177|FG000|Overall Study|Adverse Event|9|||
161891295|NCT01084538|584648177|FG000|Overall Study|Kidney transplant|6|||
161891296|NCT01084538|584648177|FG000|Overall Study|Serious Adverse Event|3|||
161891297|NCT01084538|584648177|FG000|Overall Study|Lack of effectiveness|2|||
161891298|NCT01084538|584648177|FG000|Overall Study|Patient noncompliance|2|||
161891299|NCT01084538|584648177|FG000|Overall Study|Hyperphosphatemia|2|||
161891300|NCT01084538|584648177|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
161891301|NCT01084538|584648177|FG000|Overall Study|Change of residence|2|||
161891302|NCT01084538|584648177|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
161891303|NCT01084538|584648177|FG000|Overall Study|Reason unknown|8|||
161891304|NCT03742258|584648182|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
161891305|NCT03742258|584648183|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
161891306|NCT03742258|584648184|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
161891307|NCT03742258|584648182|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
161891308|NCT03742258|584648183|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
161891309|NCT03742258|584648184|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
161891310|NCT03742258|584648182|FG000|Survival Follow-Up|Still in Follow-up|0|||
161891311|NCT03742258|584648183|FG001|Survival Follow-Up|Still in Follow-up|0|||
161891312|NCT03742258|584648184|FG002|Survival Follow-Up|Still in Follow-up|2|||
161891313|NCT01952080|584648186|FG000|Overall Study|Withdrawal by Subject|0|||
161891314|NCT01952080|584648187|FG001|Overall Study|Withdrawal by Subject|0|||
161891315|NCT01952080|584648188|FG002|Overall Study|Withdrawal by Subject|0|||
161891316|NCT01952080|584648189|FG003|Overall Study|Withdrawal by Subject|1|||
161891317|NCT01952080|584648186|FG000|Overall Study|Protocol Non-compliance|0|||
161891318|NCT01952080|584648187|FG001|Overall Study|Protocol Non-compliance|1|||
161891319|NCT01952080|584648188|FG002|Overall Study|Protocol Non-compliance|0|||
161891320|NCT01952080|584648189|FG003|Overall Study|Protocol Non-compliance|0|||
161891321|NCT00862459|584648190|FG000|Overall Study|Lost to Follow-up|1|||
161891322|NCT00862459|584648191|FG001|Overall Study|Lost to Follow-up|2|||
161891323|NCT00862459|584648192|FG002|Overall Study|Lost to Follow-up|2|||
161891324|NCT00862459|584648190|FG000|Overall Study|Protocol Violation|1|||
161891325|NCT00862459|584648191|FG001|Overall Study|Protocol Violation|0|||
161891326|NCT00862459|584648192|FG002|Overall Study|Protocol Violation|0|||
161891327|NCT00862459|584648190|FG000|Overall Study|Withdrawal by Subject|1|||
161891328|NCT00862459|584648191|FG001|Overall Study|Withdrawal by Subject|1|||
161891329|NCT00862459|584648192|FG002|Overall Study|Withdrawal by Subject|3|||
161891330|NCT00862459|584648190|FG000|Overall Study|Adverse Event|0|||
161891331|NCT00862459|584648191|FG001|Overall Study|Adverse Event|1|||
161891332|NCT00862459|584648192|FG002|Overall Study|Adverse Event|0|||
161891333|NCT00862459|584648190|FG000|Overall Study|Personal reasons|1|||
161891334|NCT00862459|584648191|FG001|Overall Study|Personal reasons|0|||
161891335|NCT00862459|584648192|FG002|Overall Study|Personal reasons|0|||
161891336|NCT00862459|584648190|FG000|Overall Study|Operation|1|||
161891337|NCT00862459|584648191|FG001|Overall Study|Operation|1|||
161891338|NCT00862459|584648192|FG002|Overall Study|Operation|0|||
161891339|NCT00862459|584648190|FG000|Overall Study|Intravenous (IV) site problems|1|||
161891340|NCT00862459|584648191|FG001|Overall Study|Intravenous (IV) site problems|0|||
161891341|NCT00862459|584648192|FG002|Overall Study|Intravenous (IV) site problems|1|||
161891342|NCT00862459|584648190|FG000|Overall Study|Unable to hold still for imaging|0|||
161891343|NCT00862459|584648191|FG001|Overall Study|Unable to hold still for imaging|1|||
161891344|NCT00862459|584648192|FG002|Overall Study|Unable to hold still for imaging|0|||
161891345|NCT00862459|584648190|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
161891346|NCT00862459|584648191|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161891347|NCT00862459|584648192|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
161891348|NCT00862459|584648190|FG000|Overall Study|Administrative problems|0|||
161891349|NCT00862459|584648191|FG001|Overall Study|Administrative problems|1|||
161891350|NCT00862459|584648192|FG002|Overall Study|Administrative problems|0|||
161891351|NCT01333956|584648193|FG000|Overall Study|Lost to Follow-up|1|||
161891352|NCT01333956|584648194|FG001|Overall Study|Lost to Follow-up|2|||
161891353|NCT01333956|584648195|FG002|Overall Study|Lost to Follow-up|0|||
161891354|NCT01333956|584648196|FG003|Overall Study|Lost to Follow-up|1|||
161891355|NCT01333956|584648193|FG000|Overall Study|Unable to complete study procedure|1|||
161891356|NCT01333956|584648194|FG001|Overall Study|Unable to complete study procedure|0|||
161891357|NCT01333956|584648195|FG002|Overall Study|Unable to complete study procedure|0|||
161891358|NCT01333956|584648196|FG003|Overall Study|Unable to complete study procedure|1|||
161891359|NCT01333956|584648193|FG000|Overall Study|Withdrawal by Subject|0|||
161891360|NCT01333956|584648194|FG001|Overall Study|Withdrawal by Subject|2|||
161891361|NCT01333956|584648195|FG002|Overall Study|Withdrawal by Subject|1|||
161891362|NCT01333956|584648196|FG003|Overall Study|Withdrawal by Subject|0|||
161891363|NCT02134353|584648197|FG000|Overall Study|Adverse Event|10|||
161891364|NCT02134353|584648198|FG001|Overall Study|Adverse Event|6|||
161891365|NCT02134353|584648197|FG000|Overall Study|Lost to Follow-up|1|||
161891366|NCT02134353|584648198|FG001|Overall Study|Lost to Follow-up|1|||
161891367|NCT02134353|584648197|FG000|Overall Study|Lack of Efficacy|2|||
161891368|NCT02134353|584648198|FG001|Overall Study|Lack of Efficacy|1|||
161891369|NCT02134353|584648197|FG000|Overall Study|Withdrawal by Subject|12|||
161891370|NCT02134353|584648198|FG001|Overall Study|Withdrawal by Subject|13|||
161891371|NCT02134353|584648197|FG000|Overall Study|Death|0|||
161891372|NCT02134353|584648198|FG001|Overall Study|Death|1|||
161891373|NCT02134353|584648197|FG000|Overall Study|Pregnancy|0|||
161891374|NCT02134353|584648198|FG001|Overall Study|Pregnancy|1|||
161891375|NCT02134353|584648197|FG000|Overall Study|Relocation|1|||
161891376|NCT02134353|584648198|FG001|Overall Study|Relocation|0|||
161891377|NCT02134353|584648197|FG000|Overall Study|Other - Patient's Choice|0|||
161891378|NCT02134353|584648198|FG001|Overall Study|Other - Patient's Choice|1|||
161891379|NCT03426436|584648201|FG000|Overall Study|Incorrect lead placement|12|||
161891380|NCT03426436|584648201|FG000|Overall Study|Withdrawal by Subject|2|||
161891381|NCT03426436|584648201|FG000|Overall Study|Consent issue|1|||
161891382|NCT03426436|584648201|FG000|Overall Study|ECGs not saved|4|||
161891383|NCT00655681|584648202|FG000|Overall Study|Lost to Follow-up|1|||
161891384|NCT00655681|584648203|FG001|Overall Study|Lost to Follow-up|1|||
161891385|NCT03168919|584648204|FG000|Overall Study|Withdrawal by Subject|2|||
161891386|NCT01085136|584648205|FG000|Part A|Other Adverse event|223|||
161891387|NCT01085136|584648206|FG001|Part A|Other Adverse event|0|||
161891388|NCT01085136|584648207|FG002|Part A|Other Adverse event|0|||
161891389|NCT01085136|584648205|FG000|Part A|Protocol Violation|3|||
161891390|NCT01085136|584648206|FG001|Part A|Protocol Violation|0|||
161891391|NCT01085136|584648207|FG002|Part A|Protocol Violation|0|||
161891392|NCT01085136|584648205|FG000|Part A|Lost to Follow-up|3|||
161891393|NCT01085136|584648206|FG001|Part A|Lost to Follow-up|0|||
161891394|NCT01085136|584648207|FG002|Part A|Lost to Follow-up|0|||
161891395|NCT01085136|584648205|FG000|Part A|Refusal to continue trial medication|64|||
161891396|NCT01085136|584648206|FG001|Part A|Refusal to continue trial medication|0|||
161891397|NCT01085136|584648207|FG002|Part A|Refusal to continue trial medication|0|||
161891398|NCT01085136|584648205|FG000|Part A|Other reason not defined above|30|||
161891399|NCT01085136|584648206|FG001|Part A|Other reason not defined above|0|||
161891400|NCT01085136|584648207|FG002|Part A|Other reason not defined above|0|||
161891401|NCT01085136|584648205|FG000|Part B|Other AE|0|||
161891402|NCT01085136|584648206|FG001|Part B|Other AE|29|||
161891403|NCT01085136|584648207|FG002|Part B|Other AE|8|||
161891404|NCT01085136|584648205|FG000|Part B|Refusal to continue trial medication|0|||
161891405|NCT01085136|584648206|FG001|Part B|Refusal to continue trial medication|12|||
161891406|NCT01085136|584648207|FG002|Part B|Refusal to continue trial medication|7|||
161891407|NCT01085136|584648205|FG000|Part B|Not treated|0|||
161891408|NCT01085136|584648206|FG001|Part B|Not treated|4|||
161891409|NCT01085136|584648207|FG002|Part B|Not treated|8|||
161891410|NCT01085136|584648205|FG000|Part B|Other reason not defined above|0|||
161891411|NCT01085136|584648206|FG001|Part B|Other reason not defined above|6|||
161891412|NCT01085136|584648207|FG002|Part B|Other reason not defined above|3|||
161891413|NCT02655419|584648208|FG000|Overall Study|Enrolled but not treated|1|||
161891414|NCT02655419|584648209|FG001|Overall Study|Enrolled but not treated|5|||
161891415|NCT02655419|584648208|FG000|Overall Study|Withdrawal by Subject|4|||
161891416|NCT02655419|584648209|FG001|Overall Study|Withdrawal by Subject|1|||
161891417|NCT02655419|584648208|FG000|Overall Study|Other|0|||
161891418|NCT02655419|584648209|FG001|Overall Study|Other|1|||
161891419|NCT04226495|584648213|FG000|Overall Study|Withdrawal by Subject|3|||
161891420|NCT04226495|584648214|FG001|Overall Study|Withdrawal by Subject|3|||
161891421|NCT04226495|584648213|FG000|Overall Study|PI discretion|3|||
161891422|NCT04226495|584648214|FG001|Overall Study|PI discretion|4|||
161891423|NCT01783821|584648216|FG000|Overall Study|Screen Failure|1|||
161891424|NCT01783821|584648217|FG001|Overall Study|Screen Failure|1|||
161891425|NCT02333383|584648218|FG000|Overall Study|Adalimumab discontinuation|21|||
161891426|NCT02333383|584648218|FG000|Overall Study|Lost to Follow-up|15|||
161891427|NCT02333383|584648218|FG000|Overall Study|Withdrawal by Subject|3|||
161891428|NCT02333383|584648218|FG000|Overall Study|Transfer to another hospital|2|||
161891429|NCT04459598|584648219|FG000|Overall Study|Adverse Event|1|||
161891430|NCT04459598|584648220|FG001|Overall Study|Adverse Event|1|||
161891431|NCT02440854|584648227|FG000|Overall Study|Relocation of patient|1|||
161891432|NCT02440854|584648227|FG000|Overall Study|Death|6|||
161891433|NCT02440854|584648227|FG000|Overall Study|Lost to Follow-up|10|||
161891434|NCT02440854|584648227|FG000|Overall Study|Afatinib discontinuation|46|||
161891435|NCT02440854|584648227|FG000|Overall Study|stopped study at earlier timepoint|14|||
161891436|NCT02440854|584648227|FG000|Overall Study|Study medication not received|1|||
161891437|NCT02440854|584648227|FG000|Overall Study|Violation of inclusion criteria|2|||
161891438|NCT02669082|584648228|FG000|Overall Study|Adverse Event|1|||
161891439|NCT00904917|584650316|FG000|Overall Study|Lost to Follow-up|2|||
161891440|NCT00904917|584650317|FG001|Overall Study|Lost to Follow-up|2|||
161891441|NCT00904917|584650318|FG002|Overall Study|Lost to Follow-up|2|||
161891442|NCT00904917|584650319|FG003|Overall Study|Lost to Follow-up|2|||
161891443|NCT00497146|584650320|FG000|Treatment Period|Adverse Event|6|||
161891444|NCT00497146|584650321|FG001|Treatment Period|Adverse Event|2|||
161891445|NCT00497146|584650320|FG000|Treatment Period|Withdrawal by Subject|5|||
161891446|NCT00497146|584650321|FG001|Treatment Period|Withdrawal by Subject|9|||
161891447|NCT00497146|584650320|FG000|Treatment Period|Lost to Follow-up|1|||
161891448|NCT00497146|584650321|FG001|Treatment Period|Lost to Follow-up|3|||
161891449|NCT00497146|584650320|FG000|Treatment Period|Required dialysis|4|||
161891450|NCT00497146|584650321|FG001|Treatment Period|Required dialysis|1|||
161891451|NCT00497146|584650320|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
161891452|NCT00497146|584650321|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
161891453|NCT00497146|584650320|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
161891454|NCT00497146|584650321|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
161891455|NCT00497146|584650320|FG000|Treatment Period|Other Reason|2|||
161891456|NCT00497146|584650321|FG001|Treatment Period|Other Reason|3|||
161891457|NCT00497146|584650320|FG000|Long-term Follow-up Period|Adverse Event|2|||
161891458|NCT00497146|584650321|FG001|Long-term Follow-up Period|Adverse Event|2|||
161891459|NCT00497146|584650320|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
161891460|NCT00497146|584650321|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
161891461|NCT00497146|584650320|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
161891462|NCT00497146|584650321|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
161891463|NCT00497146|584650320|FG000|Long-term Follow-up Period|Other|0|||
161891464|NCT00497146|584650321|FG001|Long-term Follow-up Period|Other|1|||
161891465|NCT02107313|584650324|FG000|Overall Study|One participant did not do the FED cohor|0|||
161891466|NCT02107313|584650325|FG001|Overall Study|One participant did not do the FED cohor|1|||
161891467|NCT01031004|584650328|FG000|Overall Study|Protocol Violation|0|||
161891468|NCT01031004|584650329|FG001|Overall Study|Protocol Violation|1|||
161891469|NCT01031004|584650328|FG000|Overall Study|Lost to Follow-up|1|||
161891470|NCT01031004|584650329|FG001|Overall Study|Lost to Follow-up|0|||
161891471|NCT04575584|584650330|FG000|Overall Study|Death|6|||
161891472|NCT04575584|584650331|FG001|Overall Study|Death|4|||
161891473|NCT04575584|584650332|FG002|Overall Study|Death|6|||
161891474|NCT04575584|584650333|FG003|Overall Study|Death|2|||
161891475|NCT04575584|584650334|FG004|Overall Study|Death|0|||
161891476|NCT04575584|584650335|FG005|Overall Study|Death|0|||
161891477|NCT04575584|584650330|FG000|Overall Study|Lost to Follow-up|1|||
161891478|NCT04575584|584650331|FG001|Overall Study|Lost to Follow-up|1|||
161891479|NCT04575584|584650332|FG002|Overall Study|Lost to Follow-up|1|||
161891480|NCT04575584|584650333|FG003|Overall Study|Lost to Follow-up|1|||
161891481|NCT04575584|584650334|FG004|Overall Study|Lost to Follow-up|0|||
161891482|NCT04575584|584650335|FG005|Overall Study|Lost to Follow-up|0|||
161891483|NCT04575584|584650330|FG000|Overall Study|Physician Decision|0|||
161891484|NCT04575584|584650331|FG001|Overall Study|Physician Decision|1|||
161891485|NCT04575584|584650332|FG002|Overall Study|Physician Decision|1|||
161891486|NCT04575584|584650333|FG003|Overall Study|Physician Decision|1|||
161891487|NCT04575584|584650334|FG004|Overall Study|Physician Decision|0|||
161891488|NCT04575584|584650335|FG005|Overall Study|Physician Decision|0|||
161891489|NCT04575584|584650330|FG000|Overall Study|Withdrawal by Subject|7|||
161891490|NCT04575584|584650331|FG001|Overall Study|Withdrawal by Subject|9|||
161891491|NCT04575584|584650332|FG002|Overall Study|Withdrawal by Subject|5|||
161891492|NCT04575584|584650333|FG003|Overall Study|Withdrawal by Subject|3|||
161891493|NCT04575584|584650334|FG004|Overall Study|Withdrawal by Subject|0|||
161891494|NCT04575584|584650335|FG005|Overall Study|Withdrawal by Subject|0|||
161891495|NCT04575584|584650330|FG000|Overall Study|Not recorded|0|||
161891496|NCT04575584|584650331|FG001|Overall Study|Not recorded|0|||
161891497|NCT04575584|584650332|FG002|Overall Study|Not recorded|0|||
161891498|NCT04575584|584650333|FG003|Overall Study|Not recorded|1|||
161891499|NCT04575584|584650334|FG004|Overall Study|Not recorded|0|||
161891500|NCT04575584|584650335|FG005|Overall Study|Not recorded|0|||
161891501|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
161891502|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
161891503|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
161891504|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
161891505|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
161891506|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
161891507|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
161891508|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
161891509|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
161891510|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
161891511|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
161891512|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
161891513|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
161891514|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
161891515|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
161891516|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
161891517|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
161891518|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
161891519|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
161891520|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
161891521|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
161891522|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161891523|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161891524|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161891525|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
161891526|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
161891527|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
161891528|NCT02634801|584650336|FG000|Follow-up Period|Lost to Follow-up|3|||
161891529|NCT02634801|584650337|FG001|Follow-up Period|Lost to Follow-up|1|||
161891530|NCT02634801|584650338|FG002|Follow-up Period|Lost to Follow-up|2|||
161891531|NCT02634801|584650336|FG000|Follow-up Period|Physician Decision|0|||
161891532|NCT02634801|584650337|FG001|Follow-up Period|Physician Decision|0|||
161891533|NCT02634801|584650338|FG002|Follow-up Period|Physician Decision|1|||
161891534|NCT02634801|584650336|FG000|Follow-up Period|Withdrawal by Subject|1|||
161891535|NCT02634801|584650337|FG001|Follow-up Period|Withdrawal by Subject|2|||
161891536|NCT02634801|584650338|FG002|Follow-up Period|Withdrawal by Subject|5|||
161891537|NCT02634801|584650336|FG000|Follow-up Period|Adverse Event|1|||
161891538|NCT02634801|584650337|FG001|Follow-up Period|Adverse Event|5|||
161891539|NCT02634801|584650338|FG002|Follow-up Period|Adverse Event|0|||
161891540|NCT00199849|584650346|FG000|Overall Study|Unrelated illness or complication|0|||
161891541|NCT00199849|584650347|FG001|Overall Study|Unrelated illness or complication|1|||
161891542|NCT00199849|584650348|FG002|Overall Study|Unrelated illness or complication|0|||
161891543|NCT00199849|584650346|FG000|Overall Study|Progressive disease requiring intervention|0|||
161891544|NCT00199849|584650347|FG001|Overall Study|Progressive disease requiring intervention|0|||
161891545|NCT00199849|584650348|FG002|Overall Study|Progressive disease requiring intervention|1|||
161891546|NCT00199849|584650346|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
161891547|NCT00199849|584650347|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
161891548|NCT00199849|584650348|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
161891549|NCT00662311|584650349|FG000|Overall Study|Respiratory Infection|1|||
161891550|NCT00662311|584650350|FG001|Overall Study|Respiratory Infection|0|||
161891551|NCT00662311|584650351|FG002|Overall Study|Respiratory Infection|0|||
161891552|NCT02164318|584650352|FG000|Overall Study|Withdrawal by Subject|0|||
161891553|NCT02164318|584650353|FG001|Overall Study|Withdrawal by Subject|1|||
161891554|NCT02164318|584650354|FG002|Overall Study|Withdrawal by Subject|0|||
161891555|NCT02164318|584650355|FG003|Overall Study|Withdrawal by Subject|1|||
161891556|NCT02335346|584650356|FG000|Overall Study|Adverse Event|11|||
161891557|NCT02335346|584650356|FG000|Overall Study|Withdrawal by Subject|1|||
161891558|NCT01548768|584650357|FG000|Overall Study|Withdrawal by Subject|0|||
161891559|NCT01548768|584650358|FG001|Overall Study|Withdrawal by Subject|2|||
161891560|NCT01548768|584650359|FG002|Overall Study|Withdrawal by Subject|1|||
161891561|NCT01548768|584650360|FG003|Overall Study|Withdrawal by Subject|0|||
161891562|NCT01548768|584650357|FG000|Overall Study|Physician Decision|1|||
161891563|NCT01548768|584650358|FG001|Overall Study|Physician Decision|0|||
161891564|NCT01548768|584650359|FG002|Overall Study|Physician Decision|0|||
161891565|NCT01548768|584650360|FG003|Overall Study|Physician Decision|0|||
161891566|NCT01548768|584650357|FG000|Overall Study|Adverse Event|0|||
161891567|NCT01548768|584650358|FG001|Overall Study|Adverse Event|0|||
161891568|NCT01548768|584650359|FG002|Overall Study|Adverse Event|0|||
161891569|NCT01548768|584650360|FG003|Overall Study|Adverse Event|1|||
161891570|NCT01548768|584650357|FG000|Overall Study|Non-Compliance|0|||
161891571|NCT01548768|584650358|FG001|Overall Study|Non-Compliance|0|||
161891572|NCT01548768|584650359|FG002|Overall Study|Non-Compliance|0|||
161891573|NCT01548768|584650360|FG003|Overall Study|Non-Compliance|3|||
161891574|NCT02178358|584650363|FG000|Overall Study|Withdrawal by Subject|0|||
161891575|NCT02178358|584650364|FG001|Overall Study|Withdrawal by Subject|2|||
161891576|NCT02178358|584650365|FG002|Overall Study|Withdrawal by Subject|2|||
161891577|NCT02178358|584650363|FG000|Overall Study|Lost to Follow-up|1|||
161891578|NCT02178358|584650364|FG001|Overall Study|Lost to Follow-up|0|||
161891579|NCT02178358|584650365|FG002|Overall Study|Lost to Follow-up|0|||
161891580|NCT00645671|584650367|FG000|Overall Study|Protocol Violation|1|||
161891581|NCT00645671|584650368|FG001|Overall Study|Protocol Violation|0|||
161891582|NCT00645671|584650367|FG000|Overall Study|Withdrawal by Subject|0|||
161891583|NCT00645671|584650368|FG001|Overall Study|Withdrawal by Subject|4|||
161891584|NCT00645671|584650367|FG000|Overall Study|Adverse Event|0|||
161891585|NCT00645671|584650368|FG001|Overall Study|Adverse Event|1|||
161891586|NCT00645671|584650367|FG000|Overall Study|Physician Decision|0|||
161891587|NCT00645671|584650368|FG001|Overall Study|Physician Decision|1|||
161891588|NCT00493311|584650369|FG000|Overall Study|Need for rescue medication|2|||
161891589|NCT00493311|584650370|FG001|Overall Study|Need for rescue medication|2|||
161891590|NCT01005901|584650373|FG000|Overall Study|Withdrawal by Subject|38|||
161891591|NCT01005901|584650374|FG001|Overall Study|Withdrawal by Subject|14|||
161891592|NCT01005901|584650373|FG000|Overall Study|Adverse Event|30|||
161891593|NCT01005901|584650374|FG001|Overall Study|Adverse Event|16|||
161891594|NCT01005901|584650373|FG000|Overall Study|Administrative problems|21|||
161891595|NCT01005901|584650374|FG001|Overall Study|Administrative problems|13|||
161891596|NCT01005901|584650373|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161891597|NCT01005901|584650374|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161891598|NCT01005901|584650373|FG000|Overall Study|Protocol Violation|4|||
161891599|NCT01005901|584650374|FG001|Overall Study|Protocol Violation|3|||
161891600|NCT01005901|584650373|FG000|Overall Study|Death|2|||
161891601|NCT01005901|584650374|FG001|Overall Study|Death|3|||
161891602|NCT01005901|584650373|FG000|Overall Study|Lost to Follow-up|1|||
161891603|NCT01005901|584650374|FG001|Overall Study|Lost to Follow-up|2|||
161891604|NCT01005901|584650373|FG000|Overall Study|Patient's inability to use the device|1|||
161891605|NCT01005901|584650374|FG001|Overall Study|Patient's inability to use the device|1|||
161891606|NCT01005901|584650373|FG000|Overall Study|No longer requires study drug|0|||
161891607|NCT01005901|584650374|FG001|Overall Study|No longer requires study drug|1|||
161891608|NCT05600036|584650379|FG000|Overall Study|Adverse Event|0|||
161891609|NCT05600036|584650380|FG001|Overall Study|Adverse Event|2|||
161891610|NCT05600036|584650381|FG002|Overall Study|Adverse Event|1|||
161891611|NCT05600036|584650382|FG003|Overall Study|Adverse Event|0|||
161891612|NCT05600036|584650383|FG004|Overall Study|Adverse Event|1|||
161891613|NCT05600036|584650384|FG005|Overall Study|Adverse Event|0|||
161891614|NCT05600036|584650379|FG000|Overall Study|Lost to Follow-up|0|||
161891615|NCT05600036|584650380|FG001|Overall Study|Lost to Follow-up|2|||
161891616|NCT05600036|584650381|FG002|Overall Study|Lost to Follow-up|1|||
161891617|NCT05600036|584650382|FG003|Overall Study|Lost to Follow-up|1|||
161891618|NCT05600036|584650383|FG004|Overall Study|Lost to Follow-up|0|||
161891619|NCT05600036|584650384|FG005|Overall Study|Lost to Follow-up|0|||
161891620|NCT05600036|584650379|FG000|Overall Study|Protocol Violation|0|||
161891621|NCT05600036|584650380|FG001|Overall Study|Protocol Violation|0|||
161891622|NCT05600036|584650381|FG002|Overall Study|Protocol Violation|2|||
161891623|NCT05600036|584650382|FG003|Overall Study|Protocol Violation|0|||
161891624|NCT05600036|584650383|FG004|Overall Study|Protocol Violation|0|||
161891625|NCT05600036|584650384|FG005|Overall Study|Protocol Violation|0|||
161891626|NCT05600036|584650379|FG000|Overall Study|Withdrawal by Subject|0|||
161891627|NCT05600036|584650380|FG001|Overall Study|Withdrawal by Subject|1|||
161891628|NCT05600036|584650381|FG002|Overall Study|Withdrawal by Subject|2|||
161891629|NCT05600036|584650382|FG003|Overall Study|Withdrawal by Subject|0|||
161891630|NCT05600036|584650383|FG004|Overall Study|Withdrawal by Subject|3|||
161891631|NCT05600036|584650384|FG005|Overall Study|Withdrawal by Subject|5|||
161891632|NCT05600036|584650379|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891633|NCT05600036|584650380|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891634|NCT05600036|584650381|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891635|NCT05600036|584650382|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
161891636|NCT05600036|584650383|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891637|NCT05600036|584650384|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891638|NCT05600036|584650379|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891639|NCT05600036|584650380|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
161891640|NCT05600036|584650381|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891641|NCT05600036|584650382|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891642|NCT05600036|584650383|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891643|NCT05600036|584650384|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891644|NCT05600036|584650379|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891645|NCT05600036|584650380|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891646|NCT05600036|584650381|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891647|NCT05600036|584650382|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
161891648|NCT05600036|584650383|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891649|NCT05600036|584650384|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891650|NCT00715520|584650385|FG000|Overall Study|Screen failure|8|||
161891651|NCT00715520|584650386|FG001|Overall Study|Screen failure|1|||
161891652|NCT00715520|584650387|FG002|Overall Study|Screen failure|1|||
161891653|NCT00715520|584650385|FG000|Overall Study|Withdrawal by Subject|2|||
161891654|NCT00715520|584650386|FG001|Overall Study|Withdrawal by Subject|0|||
161891655|NCT00715520|584650387|FG002|Overall Study|Withdrawal by Subject|1|||
161891656|NCT01006590|584650388|FG000|Overall Study|Adverse Event|2|||
161891657|NCT01006590|584650389|FG001|Overall Study|Adverse Event|3|||
161891658|NCT01006590|584650388|FG000|Overall Study|Death|1|||
161891659|NCT01006590|584650389|FG001|Overall Study|Death|1|||
161891660|NCT01006590|584650388|FG000|Overall Study|Lost to Follow-up|1|||
161891661|NCT01006590|584650389|FG001|Overall Study|Lost to Follow-up|1|||
161891662|NCT01006590|584650388|FG000|Overall Study|Protocol Violation|1|||
161891663|NCT01006590|584650389|FG001|Overall Study|Protocol Violation|0|||
161891664|NCT01006590|584650388|FG000|Overall Study|Withdrawal by Subject|4|||
161891665|NCT01006590|584650389|FG001|Overall Study|Withdrawal by Subject|2|||
161891666|NCT01006590|584650388|FG000|Overall Study|Study specific discontinuation criteria|16|||
161891667|NCT01006590|584650389|FG001|Overall Study|Study specific discontinuation criteria|23|||
161891668|NCT01006590|584650388|FG000|Overall Study|Other|3|||
161891669|NCT01006590|584650389|FG001|Overall Study|Other|2|||
161891670|NCT03332095|584650390|FG000|Overall Study|Lost to Follow-up|1|||
161891671|NCT03332095|584650391|FG001|Overall Study|Lost to Follow-up|0|||
161891672|NCT03332095|584650390|FG000|Overall Study|Pregnancy|0|||
161891673|NCT03332095|584650391|FG001|Overall Study|Pregnancy|1|||
161891674|NCT04942210|584650395|FG000|Overall Study|Adverse Event|0|||
161891675|NCT04942210|584650396|FG001|Overall Study|Adverse Event|1|||
161891676|NCT04942210|584650395|FG000|Overall Study|Protocol Deviation|4|||
161891677|NCT04942210|584650396|FG001|Overall Study|Protocol Deviation|1|||
161891678|NCT04942210|584650395|FG000|Overall Study|Withdrawal by Subject|5|||
161891679|NCT04942210|584650396|FG001|Overall Study|Withdrawal by Subject|2|||
161891680|NCT04942210|584650395|FG000|Overall Study|Lost to Follow-up|16|||
161891681|NCT04942210|584650396|FG001|Overall Study|Lost to Follow-up|7|||
161891682|NCT04942210|584650395|FG000|Overall Study|Ongoing at the time of DBL date|60|||
161891683|NCT04942210|584650396|FG001|Overall Study|Ongoing at the time of DBL date|25|||
161891684|NCT04942210|584650395|FG000|Overall Study|Randomized but did not receive vaccination|3|||
161891685|NCT04942210|584650396|FG001|Overall Study|Randomized but did not receive vaccination|0|||
161891686|NCT04348500|584650397|FG000|Overall Study|Death|2|||
161891687|NCT04348500|584650398|FG001|Overall Study|Death|2|||
161891688|NCT04348500|584650397|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
161891689|NCT04348500|584650398|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
161891690|NCT02776670|584650399|FG000|Overall Study|Adverse Event|0|||
161891691|NCT02776670|584650400|FG001|Overall Study|Adverse Event|2|||
161891692|NCT02776670|584650399|FG000|Overall Study|Protocol Violation|0|||
161891693|NCT02776670|584650400|FG001|Overall Study|Protocol Violation|2|||
161891694|NCT02776670|584650399|FG000|Overall Study|Withdrawal by Subject|0|||
161891695|NCT02776670|584650400|FG001|Overall Study|Withdrawal by Subject|1|||
161891696|NCT02776670|584650399|FG000|Overall Study|Other - Reason not given|0|||
161891697|NCT02776670|584650400|FG001|Overall Study|Other - Reason not given|1|||
161891698|NCT00957424|584650409|FG000|Overall Study|Lost to Follow-up|19|||
161891699|NCT00957424|584650409|FG000|Overall Study|Protocol Violation|3|||
161891700|NCT00957424|584650409|FG000|Overall Study|Withdrawal by Subject|1|||
161891701|NCT03760458|584650419|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
161891702|NCT03760458|584650420|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
161891703|NCT03760458|584650421|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161891704|NCT03760458|584650422|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161891705|NCT03760458|584650423|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161891706|NCT00750919|584650424|FG000|Overall Study|Adverse Event|9|||
161891707|NCT00750919|584650424|FG000|Overall Study|Withdrawal by Subject|1|||
161891708|NCT00750919|584650424|FG000|Overall Study|Lack of Efficacy|8|||
161891709|NCT00750919|584650424|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
161891710|NCT00750919|584650424|FG000|Overall Study|Other|36|||
161891711|NCT03913104|584650429|FG000|Overall Study|Lost to Follow-up|20|||
161891712|NCT03913104|584650429|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
161891713|NCT03913104|584650429|FG000|Overall Study|Withdrawal by Subject|2|||
161891714|NCT01119846|584650430|FG000|Overall Study|Adverse Event|1|||
161891715|NCT01119846|584650431|FG001|Overall Study|Adverse Event|0|||
161891716|NCT01119846|584650432|FG002|Overall Study|Adverse Event|6|||
161891717|NCT01119846|584650430|FG000|Overall Study|Physician Decision|1|||
161891718|NCT01119846|584650431|FG001|Overall Study|Physician Decision|0|||
161891719|NCT01119846|584650432|FG002|Overall Study|Physician Decision|0|||
161891720|NCT01119846|584650430|FG000|Overall Study|Protocol Violation|0|||
161891721|NCT01119846|584650431|FG001|Overall Study|Protocol Violation|0|||
161891722|NCT01119846|584650432|FG002|Overall Study|Protocol Violation|1|||
161891723|NCT01119846|584650430|FG000|Overall Study|Withdrawal by Subject|0|||
161891724|NCT01119846|584650431|FG001|Overall Study|Withdrawal by Subject|0|||
161891725|NCT01119846|584650432|FG002|Overall Study|Withdrawal by Subject|4|||
161891726|NCT00048997|584650433|FG000|Overall Study|Protocol Violation|7|||
161891727|NCT00048997|584650434|FG001|Overall Study|Protocol Violation|2|||
161891728|NCT00048997|584650433|FG000|Overall Study|Withdrawal by Subject|6|||
161891729|NCT00048997|584650434|FG001|Overall Study|Withdrawal by Subject|1|||
161891730|NCT00002525|584650435|FG000|Overall Study|Adverse Event|36|||
161891731|NCT00002525|584650436|FG001|Overall Study|Adverse Event|0|||
161891732|NCT00002525|584650435|FG000|Overall Study|Death|5|||
161891733|NCT00002525|584650436|FG001|Overall Study|Death|0|||
161891734|NCT00002525|584650435|FG000|Overall Study|Withdrawal by Subject|11|||
161891735|NCT00002525|584650436|FG001|Overall Study|Withdrawal by Subject|0|||
161891736|NCT00002525|584650435|FG000|Overall Study|Start non-protocol therapy|1|||
161891737|NCT00002525|584650436|FG001|Overall Study|Start non-protocol therapy|0|||
161891738|NCT00002525|584650435|FG000|Overall Study|Other complicating disease|1|||
161891739|NCT00002525|584650436|FG001|Overall Study|Other complicating disease|0|||
161891740|NCT00002525|584650435|FG000|Overall Study|Duke's A, B1, D disease|92|||
161891741|NCT00002525|584650436|FG001|Overall Study|Duke's A, B1, D disease|0|||
161891742|NCT00002525|584650435|FG000|Overall Study|Error|6|||
161891743|NCT00002525|584650436|FG001|Overall Study|Error|0|||
161891744|NCT00002525|584650435|FG000|Overall Study|Other|26|||
161891745|NCT00002525|584650436|FG001|Overall Study|Other|0|||
161891746|NCT00002525|584650435|FG000|Overall Study|Never start protocol therapy|8|||
161891747|NCT00002525|584650436|FG001|Overall Study|Never start protocol therapy|0|||
161891748|NCT03304184|584650437|FG000|Overall Study|Withdrawal by Subject|1|||
161891749|NCT03304184|584650438|FG001|Overall Study|Withdrawal by Subject|2|||
161891750|NCT03420222|584650441|FG000|Overall Study|Withdrawal by Subject|5|||
161891751|NCT03420222|584650442|FG001|Overall Study|Withdrawal by Subject|0|||
161891752|NCT03420222|584650441|FG000|Overall Study|Physician Decision|0|||
161891753|NCT03420222|584650442|FG001|Overall Study|Physician Decision|1|||
161891754|NCT04527978|584650444|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161891755|NCT04527978|584650445|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161891756|NCT02112877|584650447|FG000|Overall Study|Withdrawal by Subject|1|||
161891757|NCT02112877|584650448|FG001|Overall Study|Withdrawal by Subject|7|||
161891758|NCT02112877|584650447|FG000|Overall Study|Visit Missed|1|||
161891759|NCT02112877|584650448|FG001|Overall Study|Visit Missed|6|||
161891760|NCT00187278|584650454|FG000|Overall Study|Protocol Violation|10|||
161891761|NCT00187278|584650455|FG001|Overall Study|Protocol Violation|13|||
161891762|NCT01578499|584650456|FG000|Overall Study|Reason not Specified|0|||
161891763|NCT01578499|584650457|FG001|Overall Study|Reason not Specified|1|||
161891764|NCT01578499|584650456|FG000|Overall Study|Lost to Follow-up|2|||
161891765|NCT01578499|584650457|FG001|Overall Study|Lost to Follow-up|1|||
161891766|NCT01578499|584650456|FG000|Overall Study|Withdrawal by Subject|10|||
161891767|NCT01578499|584650457|FG001|Overall Study|Withdrawal by Subject|16|||
161891768|NCT01578499|584650456|FG000|Overall Study|Death|20|||
161891769|NCT01578499|584650457|FG001|Overall Study|Death|25|||
161891770|NCT01578499|584650456|FG000|Overall Study|Died and End of Study Page not Completed|2|||
161891771|NCT01578499|584650457|FG001|Overall Study|Died and End of Study Page not Completed|0|||
161891772|NCT02791438|584650459|FG000|Treatment Period|Adverse Event|1|||
161891773|NCT02791438|584650460|FG001|Treatment Period|Adverse Event|0|||
161891774|NCT02791438|584650459|FG000|Treatment Period|Withdrawal by Subject|0|||
161891775|NCT02791438|584650460|FG001|Treatment Period|Withdrawal by Subject|1|||
161891776|NCT02791438|584650459|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
161891777|NCT02791438|584650460|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
161891778|NCT01603394|584650462|FG000|Overall Study|Adverse Event|1|||
161891779|NCT01854879|584650473|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
161891780|NCT01854879|584650473|FG000|Overall Study|screen fail|3|||
161891781|NCT01854879|584650473|FG000|Overall Study|incomplete data set|1|||
161891782|NCT00385827|584651513|FG000|Part 1|Adverse Event|1|||
161891783|NCT00385827|584651514|FG001|Part 1|Adverse Event|0|||
161891784|NCT00385827|584651515|FG002|Part 1|Adverse Event|0|||
161891785|NCT00385827|584651513|FG000|Part 1|Death|2|||
161891786|NCT00385827|584651514|FG001|Part 1|Death|0|||
161891787|NCT00385827|584651515|FG002|Part 1|Death|0|||
161891788|NCT00385827|584651513|FG000|Part 1|Lack of Efficacy|5|||
161891789|NCT00385827|584651514|FG001|Part 1|Lack of Efficacy|0|||
161891790|NCT00385827|584651515|FG002|Part 1|Lack of Efficacy|0|||
161891791|NCT00385827|584651513|FG000|Part 1|Other|1|||
161891792|NCT00385827|584651514|FG001|Part 1|Other|0|||
161891793|NCT00385827|584651515|FG002|Part 1|Other|0|||
161891794|NCT00385827|584651513|FG000|Part 2|Adverse Event|0|||
161891795|NCT00385827|584651514|FG001|Part 2|Adverse Event|6|||
161891796|NCT00385827|584651515|FG002|Part 2|Adverse Event|10|||
161891797|NCT00385827|584651513|FG000|Part 2|Death|0|||
161891798|NCT00385827|584651514|FG001|Part 2|Death|0|||
161891799|NCT00385827|584651515|FG002|Part 2|Death|2|||
161891800|NCT00385827|584651513|FG000|Part 2|Lack of Efficacy|0|||
161891801|NCT00385827|584651514|FG001|Part 2|Lack of Efficacy|14|||
161891802|NCT00385827|584651515|FG002|Part 2|Lack of Efficacy|13|||
161891803|NCT00385827|584651513|FG000|Part 2|Randomized but not treated|0|||
161891804|NCT00385827|584651514|FG001|Part 2|Randomized but not treated|2|||
161891805|NCT00385827|584651515|FG002|Part 2|Randomized but not treated|2|||
161891806|NCT00385827|584651513|FG000|Part 2|Other|0|||
161891807|NCT00385827|584651514|FG001|Part 2|Other|11|||
161891808|NCT00385827|584651515|FG002|Part 2|Other|21|||
161891809|NCT01421147|584651516|FG000|Treatment Period|Adverse Event|2|||
161891810|NCT01421147|584651517|FG001|Treatment Period|Adverse Event|3|||
161891811|NCT01421147|584651516|FG000|Treatment Period|Lost to Follow-up|2|||
161891812|NCT01421147|584651517|FG001|Treatment Period|Lost to Follow-up|1|||
161891813|NCT01421147|584651516|FG000|Treatment Period|Physician Decision|2|||
161891814|NCT01421147|584651517|FG001|Treatment Period|Physician Decision|2|||
161891815|NCT01421147|584651516|FG000|Treatment Period|Withdrawal by Subject|10|||
161891816|NCT01421147|584651517|FG001|Treatment Period|Withdrawal by Subject|5|||
161891817|NCT01421147|584651516|FG000|Extension Period|Adverse Event|0|||
161891818|NCT01421147|584651517|FG001|Extension Period|Adverse Event|2|||
161891819|NCT01421147|584651516|FG000|Extension Period|Death|0|||
161891820|NCT01421147|584651517|FG001|Extension Period|Death|1|||
161891821|NCT01421147|584651516|FG000|Extension Period|Lost to Follow-up|2|||
161891822|NCT01421147|584651517|FG001|Extension Period|Lost to Follow-up|5|||
161891823|NCT01421147|584651516|FG000|Extension Period|Physician Decision|1|||
161891824|NCT01421147|584651517|FG001|Extension Period|Physician Decision|0|||
161891825|NCT01421147|584651516|FG000|Extension Period|Withdrawal by Subject|5|||
161891826|NCT01421147|584651517|FG001|Extension Period|Withdrawal by Subject|3|||
161891827|NCT00582426|584651518|FG000|Overall Study|Lost to Follow-up|0|||
161891828|NCT00582426|584651519|FG001|Overall Study|Lost to Follow-up|2|||
161891829|NCT00582426|584651518|FG000|Overall Study|Adverse Event|4|||
161891830|NCT00582426|584651519|FG001|Overall Study|Adverse Event|2|||
161891831|NCT00582426|584651518|FG000|Overall Study|Protocol Violation|6|||
161891832|NCT00582426|584651519|FG001|Overall Study|Protocol Violation|2|||
161891833|NCT00582426|584651518|FG000|Overall Study|Death|4|||
161891834|NCT00582426|584651519|FG001|Overall Study|Death|3|||
161891835|NCT00582426|584651518|FG000|Overall Study|Withdrawal by Subject|3|||
161891836|NCT00582426|584651519|FG001|Overall Study|Withdrawal by Subject|2|||
161891837|NCT00582426|584651518|FG000|Overall Study|Disease Progression|2|||
161891838|NCT00582426|584651519|FG001|Overall Study|Disease Progression|2|||
161891839|NCT00582426|584651518|FG000|Overall Study|Use of illicit drugs|1|||
161891840|NCT00582426|584651519|FG001|Overall Study|Use of illicit drugs|0|||
161891841|NCT04727528|584651522|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
161891842|NCT04727528|584651523|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
161891843|NCT04727528|584651522|FG000|Open-label Period|Randomized who did not receive treatment|1|||
161891844|NCT04727528|584651523|FG001|Open-label Period|Randomized who did not receive treatment|0|||
161891845|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161891846|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Adverse Event|1|||
161891847|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Death|0|||
161891848|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Death|1|||
161891849|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
161891850|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
161891851|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
161891852|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
161891853|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Physician Decision|0|||
161891854|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Physician Decision|1|||
161891855|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
161891856|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161891857|NCT01964989|584651527|FG000|Overall Study|Protocol Violation|3|||
161891858|NCT01964989|584651528|FG001|Overall Study|Protocol Violation|4|||
161891859|NCT01964989|584651527|FG000|Overall Study|Administrative Reason|103|||
161891860|NCT01964989|584651528|FG001|Overall Study|Administrative Reason|95|||
161891861|NCT01964989|584651527|FG000|Overall Study|Adverse Event|0|||
161891862|NCT01964989|584651528|FG001|Overall Study|Adverse Event|1|||
161891863|NCT01964989|584651527|FG000|Overall Study|Death|1|||
161891864|NCT01964989|584651528|FG001|Overall Study|Death|3|||
161891865|NCT01964989|584651527|FG000|Overall Study|Withdrawal by Subject|156|||
161891866|NCT01964989|584651528|FG001|Overall Study|Withdrawal by Subject|160|||
161891867|NCT01964989|584651527|FG000|Overall Study|Lost to Follow-up|254|||
161891868|NCT01964989|584651528|FG001|Overall Study|Lost to Follow-up|232|||
161891869|NCT01964989|584651527|FG000|Overall Study|Other|267|||
161891870|NCT01964989|584651528|FG001|Overall Study|Other|252|||
161891871|NCT02769312|584651529|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
161891872|NCT02769312|584651530|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
161891873|NCT02769312|584651529|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
161891874|NCT02769312|584651530|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
161891875|NCT02769312|584651529|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
161891876|NCT02769312|584651530|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
161891877|NCT02769312|584651529|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
161891878|NCT02769312|584651530|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
161891879|NCT02769312|584651529|FG000|Follow-up|Lost to Follow-up|1|||
161891880|NCT02769312|584651530|FG001|Follow-up|Lost to Follow-up|1|||
161891881|NCT01148459|584651533|FG000|Overall Study|Serious Adverse Event|5|||
161891882|NCT01148459|584651534|FG001|Overall Study|Serious Adverse Event|4|||
161891883|NCT01148459|584651533|FG000|Overall Study|Withdrawal by Subject|1|||
161891884|NCT01148459|584651534|FG001|Overall Study|Withdrawal by Subject|0|||
161891885|NCT01148459|584651533|FG000|Overall Study|Migrated/moved from study area|3|||
161891886|NCT01148459|584651534|FG001|Overall Study|Migrated/moved from study area|6|||
161891887|NCT01148459|584651533|FG000|Overall Study|Lost to Follow-up|2|||
161891888|NCT01148459|584651534|FG001|Overall Study|Lost to Follow-up|0|||
161891889|NCT01148459|584651533|FG000|Overall Study|Refusal|1|||
161891890|NCT01148459|584651534|FG001|Overall Study|Refusal|0|||
161891891|NCT01148459|584651533|FG000|Overall Study|Failure to comply with study procedures|0|||
161891892|NCT01148459|584651534|FG001|Overall Study|Failure to comply with study procedures|1|||
161891893|NCT02496039|584651535|FG000|Overall Study|Adverse Event|3|||
161891894|NCT02496039|584651535|FG000|Overall Study|Protocol Violation|1|||
161891895|NCT00948922|584651536|FG000|Overall Study|Did not start study treatment|2|||
161891896|NCT00948922|584651537|FG001|Overall Study|Did not start study treatment|5|||
161891897|NCT00948922|584651538|FG002|Overall Study|Did not start study treatment|0|||
161891898|NCT00948922|584651536|FG000|Overall Study|Withdrawal by Subject|0|||
161891899|NCT00948922|584651537|FG001|Overall Study|Withdrawal by Subject|2|||
161891900|NCT00948922|584651538|FG002|Overall Study|Withdrawal by Subject|1|||
161891901|NCT00948922|584651536|FG000|Overall Study|Death|3|||
161891902|NCT00948922|584651537|FG001|Overall Study|Death|0|||
161891903|NCT00948922|584651538|FG002|Overall Study|Death|0|||
161891904|NCT00948922|584651536|FG000|Overall Study|Disease progression|0|||
161891905|NCT00948922|584651537|FG001|Overall Study|Disease progression|1|||
161891906|NCT00948922|584651538|FG002|Overall Study|Disease progression|0|||
161891907|NCT00948922|584651536|FG000|Overall Study|Insurance issues|1|||
161891908|NCT00948922|584651537|FG001|Overall Study|Insurance issues|0|||
161891909|NCT00948922|584651538|FG002|Overall Study|Insurance issues|0|||
161891910|NCT00948922|584651536|FG000|Overall Study|Transplant eligibility issues|2|||
161891911|NCT00948922|584651537|FG001|Overall Study|Transplant eligibility issues|3|||
161891912|NCT00948922|584651538|FG002|Overall Study|Transplant eligibility issues|0|||
161891913|NCT00948922|584651536|FG000|Overall Study|Not evaluable at time of analysis|0|||
161891914|NCT00948922|584651537|FG001|Overall Study|Not evaluable at time of analysis|3|||
161891915|NCT00948922|584651538|FG002|Overall Study|Not evaluable at time of analysis|0|||
161891916|NCT04854057|584651539|FG000|Overall Study|Adverse Event|0|||
161891917|NCT04854057|584651540|FG001|Overall Study|Adverse Event|1|||
161891918|NCT02131233|584651541|FG000|Overall Study|Not Treated|2|||
161891919|NCT02131233|584651542|FG001|Overall Study|Not Treated|3|||
161891920|NCT02131233|584651541|FG000|Overall Study|Adverse Event|7|||
161891921|NCT02131233|584651542|FG001|Overall Study|Adverse Event|6|||
161891922|NCT02131233|584651541|FG000|Overall Study|Death|0|||
161891923|NCT02131233|584651542|FG001|Overall Study|Death|1|||
161891924|NCT02131233|584651541|FG000|Overall Study|Lack of Efficacy|6|||
161891925|NCT02131233|584651542|FG001|Overall Study|Lack of Efficacy|3|||
161891926|NCT02131233|584651541|FG000|Overall Study|Lost to Follow-up|14|||
161891927|NCT02131233|584651542|FG001|Overall Study|Lost to Follow-up|13|||
161891928|NCT02131233|584651541|FG000|Overall Study|Non-Compliance With Study Drug|8|||
161891929|NCT02131233|584651542|FG001|Overall Study|Non-Compliance With Study Drug|5|||
161891930|NCT02131233|584651541|FG000|Overall Study|Physician Decision|7|||
161891931|NCT02131233|584651542|FG001|Overall Study|Physician Decision|0|||
161891932|NCT02131233|584651541|FG000|Overall Study|Pregnancy|4|||
161891933|NCT02131233|584651542|FG001|Overall Study|Pregnancy|0|||
161891934|NCT02131233|584651541|FG000|Overall Study|Withdrawal by Subject|18|||
161891935|NCT02131233|584651542|FG001|Overall Study|Withdrawal by Subject|11|||
161891936|NCT05114564|584651544|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
161891937|NCT05114564|584651545|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
161891938|NCT05114564|584651544|FG000|First Intervention|Adverse Event|0|||
161891939|NCT05114564|584651545|FG001|First Intervention|Adverse Event|1|||
161891940|NCT00255840|584651546|FG000|Overall Study|Lost to Follow-up|10|||
161891941|NCT00255840|584651547|FG001|Overall Study|Lost to Follow-up|14|||
161891942|NCT00255840|584651546|FG000|Overall Study|Discontinued intervention|53|||
161891943|NCT00255840|584651547|FG001|Overall Study|Discontinued intervention|56|||
161891944|NCT01280682|584651548|FG000|Overall Study|Lost to Follow-up|0|||
161891945|NCT01280682|584651549|FG001|Overall Study|Lost to Follow-up|6|||
161891946|NCT01280682|584651548|FG000|Overall Study|Withdrawal by Subject|0|||
161891947|NCT01280682|584651549|FG001|Overall Study|Withdrawal by Subject|7|||
161891948|NCT00431067|584651555|FG000|Overall Study|Other Adverse Event|9|||
161891949|NCT00431067|584651555|FG000|Overall Study|Progressive disease|30|||
161891950|NCT00431067|584651555|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
161891951|NCT00548249|584651556|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
161891952|NCT00548249|584651557|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161891953|NCT00548249|584651558|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161891954|NCT00548249|584651559|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
161891955|NCT00548249|584651560|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161891956|NCT00548249|584651556|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
161891957|NCT00548249|584651557|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
161891958|NCT00548249|584651558|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
161891959|NCT00548249|584651559|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
161891960|NCT00548249|584651560|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
161891961|NCT00548249|584651556|FG000|Overall Study|Protocol Violation|1|||
161891962|NCT00548249|584651557|FG001|Overall Study|Protocol Violation|1|||
161891963|NCT00548249|584651558|FG002|Overall Study|Protocol Violation|4|||
161891964|NCT00548249|584651559|FG003|Overall Study|Protocol Violation|0|||
161891965|NCT00548249|584651560|FG004|Overall Study|Protocol Violation|3|||
161891966|NCT00548249|584651556|FG000|Overall Study|Miscellaneous|2|||
161891967|NCT00548249|584651557|FG001|Overall Study|Miscellaneous|3|||
161891968|NCT00548249|584651558|FG002|Overall Study|Miscellaneous|2|||
161891969|NCT00548249|584651559|FG003|Overall Study|Miscellaneous|0|||
161891970|NCT00548249|584651560|FG004|Overall Study|Miscellaneous|2|||
161891971|NCT00548249|584651556|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
161891972|NCT00548249|584651557|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
161891973|NCT00548249|584651558|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
161891974|NCT00548249|584651559|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
161891975|NCT00548249|584651560|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
161891976|NCT00548249|584651556|FG000|Overall Study|Adverse Event|2|||
161891977|NCT00548249|584651557|FG001|Overall Study|Adverse Event|2|||
161891978|NCT00548249|584651558|FG002|Overall Study|Adverse Event|0|||
161891979|NCT00548249|584651559|FG003|Overall Study|Adverse Event|1|||
161891980|NCT00548249|584651560|FG004|Overall Study|Adverse Event|1|||
161891981|NCT00548249|584651556|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
161891982|NCT00548249|584651557|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
161891983|NCT00548249|584651558|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
161891984|NCT00548249|584651559|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
161891985|NCT00548249|584651560|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
161891986|NCT00548249|584651556|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
161891987|NCT00548249|584651557|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
161891988|NCT00548249|584651558|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
161891989|NCT00548249|584651559|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
161891990|NCT00548249|584651560|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
161891991|NCT00548249|584651556|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891992|NCT00548249|584651557|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891993|NCT00548249|584651558|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891994|NCT00548249|584651559|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891995|NCT00548249|584651560|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
161891996|NCT00548249|584651556|FG000|Overall Study|Prolonged hospitalization|0|||
161891997|NCT00548249|584651557|FG001|Overall Study|Prolonged hospitalization|0|||
161891998|NCT00548249|584651558|FG002|Overall Study|Prolonged hospitalization|2|||
161891999|NCT00548249|584651559|FG003|Overall Study|Prolonged hospitalization|1|||
161892000|NCT00548249|584651560|FG004|Overall Study|Prolonged hospitalization|0|||
161892001|NCT00548249|584651556|FG000|Overall Study|Withdrawal by Subject|2|||
161892002|NCT00548249|584651557|FG001|Overall Study|Withdrawal by Subject|0|||
161892003|NCT00548249|584651558|FG002|Overall Study|Withdrawal by Subject|0|||
161892004|NCT00548249|584651559|FG003|Overall Study|Withdrawal by Subject|0|||
161892005|NCT00548249|584651560|FG004|Overall Study|Withdrawal by Subject|0|||
161892006|NCT00548249|584651556|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161892007|NCT00548249|584651557|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
161892008|NCT00548249|584651558|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161892009|NCT00548249|584651559|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161892010|NCT00548249|584651560|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
161892011|NCT00548249|584651556|FG000|Overall Study|Sponsor's request|0|||
161892012|NCT00548249|584651557|FG001|Overall Study|Sponsor's request|0|||
161892013|NCT00548249|584651558|FG002|Overall Study|Sponsor's request|0|||
161892014|NCT00548249|584651559|FG003|Overall Study|Sponsor's request|1|||
161892015|NCT00548249|584651560|FG004|Overall Study|Sponsor's request|0|||
161892016|NCT00080483|584651562|FG000|Overall Study|Lost to Follow-up|1|||
161892017|NCT00080483|584651563|FG001|Overall Study|Lost to Follow-up|1|||
161892018|NCT00080483|584651562|FG000|Overall Study|Physician Decision|1|||
161892019|NCT00080483|584651563|FG001|Overall Study|Physician Decision|1|||
161892020|NCT01380691|584651573|FG000|Washout (7 Days)|Protocol Violation|0|||
161892021|NCT01380691|584651574|FG001|Washout (7 Days)|Protocol Violation|0|||
161892022|NCT01380691|584651575|FG002|Washout (7 Days)|Protocol Violation|0|||
161892023|NCT01380691|584651576|FG003|Washout (7 Days)|Protocol Violation|1|||
161892024|NCT01380691|584651573|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161892025|NCT01380691|584651574|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
161892026|NCT01380691|584651575|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
161892027|NCT01380691|584651576|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
161892028|NCT03084315|584651580|FG000|Overall Study|Lost to Follow-up|8|||
161892029|NCT03084315|584651581|FG001|Overall Study|Lost to Follow-up|7|||
161892030|NCT03084315|584651580|FG000|Overall Study|Withdrawal by Subject|2|||
161892031|NCT03084315|584651581|FG001|Overall Study|Withdrawal by Subject|2|||
161892032|NCT04424914|584651582|FG000|Overall Study|Other|0|||
161892033|NCT04424914|584651583|FG001|Overall Study|Other|0|||
161892034|NCT04424914|584651584|FG002|Overall Study|Other|28|||
161892035|NCT04424914|584651582|FG000|Overall Study|Withdrawal by Subject|3|||
161892036|NCT04424914|584651583|FG001|Overall Study|Withdrawal by Subject|0|||
161892037|NCT04424914|584651584|FG002|Overall Study|Withdrawal by Subject|0|||
161892038|NCT04424914|584651582|FG000|Overall Study|Study terminated by sponsor|23|||
161892039|NCT04424914|584651583|FG001|Overall Study|Study terminated by sponsor|7|||
161892040|NCT04424914|584651584|FG002|Overall Study|Study terminated by sponsor|0|||
161892041|NCT04424914|584651582|FG000|Overall Study|Lost to Follow-up|0|||
161892042|NCT04424914|584651583|FG001|Overall Study|Lost to Follow-up|0|||
161892043|NCT04424914|584651584|FG002|Overall Study|Lost to Follow-up|1|||
161892044|NCT04424914|584651582|FG000|Overall Study|Death|3|||
161892045|NCT04424914|584651583|FG001|Overall Study|Death|1|||
161892046|NCT04424914|584651584|FG002|Overall Study|Death|0|||
161892047|NCT00460746|584651587|FG000|Overall Study|Adverse Event|1|||
161892048|NCT00460746|584651587|FG000|Overall Study|Lost to Follow-up|1|||
161892049|NCT00394771|584651590|FG000|Overall Study|Did not meet protocol requirements|1|||
161892050|NCT00394771|584651591|FG001|Overall Study|Did not meet protocol requirements|0|||
161892051|NCT00394771|584651592|FG002|Overall Study|Did not meet protocol requirements|2|||
161892052|NCT00394771|584651593|FG003|Overall Study|Did not meet protocol requirements|0|||
161892053|NCT00394771|584651590|FG000|Overall Study|Protocol Violation|2|||
161892054|NCT00394771|584651591|FG001|Overall Study|Protocol Violation|4|||
161892055|NCT00394771|584651592|FG002|Overall Study|Protocol Violation|9|||
161892056|NCT00394771|584651593|FG003|Overall Study|Protocol Violation|7|||
161892057|NCT00394771|584651590|FG000|Overall Study|Withdrawal by Subject|10|||
161892058|NCT00394771|584651591|FG001|Overall Study|Withdrawal by Subject|6|||
161892059|NCT00394771|584651592|FG002|Overall Study|Withdrawal by Subject|8|||
161892060|NCT00394771|584651593|FG003|Overall Study|Withdrawal by Subject|12|||
161892061|NCT00394771|584651590|FG000|Overall Study|Adverse Event|10|||
161892062|NCT00394771|584651591|FG001|Overall Study|Adverse Event|5|||
161892063|NCT00394771|584651592|FG002|Overall Study|Adverse Event|12|||
161892064|NCT00394771|584651593|FG003|Overall Study|Adverse Event|8|||
161892065|NCT00394771|584651590|FG000|Overall Study|Participant pregnant|0|||
161892066|NCT00394771|584651591|FG001|Overall Study|Participant pregnant|1|||
161892067|NCT00394771|584651592|FG002|Overall Study|Participant pregnant|2|||
161892068|NCT00394771|584651593|FG003|Overall Study|Participant pregnant|2|||
161892069|NCT00394771|584651590|FG000|Overall Study|Lost to Follow-up|15|||
161892070|NCT00394771|584651591|FG001|Overall Study|Lost to Follow-up|15|||
161892071|NCT00394771|584651592|FG002|Overall Study|Lost to Follow-up|13|||
161892072|NCT00394771|584651593|FG003|Overall Study|Lost to Follow-up|10|||
161892073|NCT00394771|584651590|FG000|Overall Study|Other|3|||
161892074|NCT00394771|584651591|FG001|Overall Study|Other|3|||
161892075|NCT00394771|584651592|FG002|Overall Study|Other|1|||
161892076|NCT00394771|584651593|FG003|Overall Study|Other|0|||
161892077|NCT02906033|584651595|FG000|Baseline|Protocol Violation|37|||
161892078|NCT02906033|584651596|FG001|Baseline|Protocol Violation|33|||
161892079|NCT02906033|584651595|FG000|Follow-up|Lost to Follow-up|46|||
161892080|NCT02906033|584651596|FG001|Follow-up|Lost to Follow-up|62|||
161892081|NCT00358956|584651597|FG000|Overall Study|Adverse Event|3|||
161892082|NCT00358956|584651597|FG000|Overall Study|condition under investigation worsened|4|||
161892083|NCT00358956|584651597|FG000|Overall Study|Withdrawal by Subject|1|||
161892084|NCT03417024|584651600|FG000|Overall Study|Study Termination prior to follow-up|11|||
161892085|NCT03417024|584651600|FG000|Overall Study|Physician Decision|2|||
161892086|NCT02195427|584651601|FG000|Overall Study|Did not consent to study extension|13|||
161892087|NCT02195427|584651602|FG001|Overall Study|Did not consent to study extension|9|||
161892088|NCT02195427|584651601|FG000|Overall Study|Withdrawal by Subject|4|||
161892089|NCT02195427|584651602|FG001|Overall Study|Withdrawal by Subject|2|||
161892090|NCT02195427|584651601|FG000|Overall Study|Lost to Follow-up|0|||
161892091|NCT02195427|584651602|FG001|Overall Study|Lost to Follow-up|1|||
161892092|NCT02195427|584651601|FG000|Overall Study|Protocol Violation|7|||
161892093|NCT02195427|584651602|FG001|Overall Study|Protocol Violation|14|||
161892094|NCT02195427|584651601|FG000|Overall Study|Conditional re-treatment at W52|2|||
161892095|NCT02195427|584651602|FG001|Overall Study|Conditional re-treatment at W52|1|||
161892096|NCT00386425|584651603|FG000|Overall Study|Physician Decision|3|||
161892097|NCT00386425|584651604|FG001|Overall Study|Physician Decision|0|||
161892098|NCT00386425|584651605|FG002|Overall Study|Physician Decision|0|||
161892099|NCT00386425|584651603|FG000|Overall Study|Withdrawal by Subject|0|||
161892100|NCT00386425|584651604|FG001|Overall Study|Withdrawal by Subject|1|||
161892101|NCT00386425|584651605|FG002|Overall Study|Withdrawal by Subject|0|||
161892102|NCT03782974|584651608|FG000|Overall Study|Withdrawal by Subject|7|||
161892103|NCT03782974|584651609|FG001|Overall Study|Withdrawal by Subject|7|||
161892104|NCT03782974|584651608|FG000|Overall Study|Pregnancy|1|||
161892105|NCT03782974|584651609|FG001|Overall Study|Pregnancy|0|||
161892106|NCT01907217|584651610|FG000|Overall Study|Withdrawal by Subject|0|||
161892107|NCT01907217|584651611|FG001|Overall Study|Withdrawal by Subject|2|||
161892108|NCT04607980|584651617|FG000|Overall Study|Adverse Event|3|||
161892109|NCT04607980|584651618|FG001|Overall Study|Adverse Event|4|||
161892110|NCT04607980|584651617|FG000|Overall Study|Death|0|||
161892111|NCT04607980|584651618|FG001|Overall Study|Death|1|||
161892112|NCT04607980|584651617|FG000|Overall Study|Withdrawal by Subject|2|||
161892113|NCT04607980|584651618|FG001|Overall Study|Withdrawal by Subject|5|||
161892114|NCT04607980|584651617|FG000|Overall Study|Lost to Follow-up|4|||
161892115|NCT04607980|584651618|FG001|Overall Study|Lost to Follow-up|8|||
161892116|NCT04607980|584651617|FG000|Overall Study|Protocol Violation|0|||
161892117|NCT04607980|584651618|FG001|Overall Study|Protocol Violation|3|||
161892118|NCT04607980|584651617|FG000|Overall Study|Other|3|||
161892119|NCT04607980|584651618|FG001|Overall Study|Other|0|||
161892120|NCT00448812|584651619|FG000|Year 2|Missed visit but remained in study|4|||
161892121|NCT00448812|584651620|FG001|Year 2|Missed visit but remained in study|1|||
161892122|NCT00448812|584651619|FG000|Year 3|Withdrawal by Subject|1|||
161892123|NCT00448812|584651620|FG001|Year 3|Withdrawal by Subject|3|||
161892124|NCT00448812|584651619|FG000|Year 3|Lost to Follow-up|1|||
161892125|NCT00448812|584651620|FG001|Year 3|Lost to Follow-up|0|||
161892126|NCT00448812|584651619|FG000|Year 3|Missed visit but remained in study|2|||
161892127|NCT00448812|584651620|FG001|Year 3|Missed visit but remained in study|0|||
161892128|NCT00448812|584651619|FG000|Year 5|Missed visit but remained in study|1|||
161892129|NCT00448812|584651620|FG001|Year 5|Missed visit but remained in study|0|||
161892130|NCT02012959|584651621|FG000|Treatment Phase A|Adverse Event|2|||
161892131|NCT02012959|584651622|FG001|Treatment Phase A|Adverse Event|0|||
161892132|NCT02012959|584651623|FG002|Treatment Phase A|Adverse Event|0|||
161892133|NCT02012959|584651624|FG003|Treatment Phase A|Adverse Event|0|||
161892134|NCT02012959|584651625|FG004|Treatment Phase A|Adverse Event|0|||
161892135|NCT04985942|584653148|FG000|Overall Study|Adverse Event|14|||
161892136|NCT04985942|584653149|FG001|Overall Study|Adverse Event|2|||
161892137|NCT04985942|584653148|FG000|Overall Study|Lack of Efficacy|0|||
161892138|NCT04985942|584653149|FG001|Overall Study|Lack of Efficacy|3|||
161892139|NCT04985942|584653148|FG000|Overall Study|Lost to Follow-up|1|||
161892140|NCT04985942|584653149|FG001|Overall Study|Lost to Follow-up|1|||
161892141|NCT04985942|584653148|FG000|Overall Study|Protocol Violation|1|||
161892142|NCT04985942|584653149|FG001|Overall Study|Protocol Violation|1|||
161892143|NCT04985942|584653148|FG000|Overall Study|Withdrawal by Subject|5|||
161892144|NCT04985942|584653149|FG001|Overall Study|Withdrawal by Subject|4|||
161892145|NCT00171158|584653150|FG000|Core Study|Death|27|||
161892146|NCT00171158|584653150|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
161892147|NCT00171158|584653150|FG000|Core Study|Protocol Violation|4|||
161892148|NCT00171158|584653150|FG000|Core Study|Administrative problems|1|||
161892149|NCT00171158|584653150|FG000|Core Study|Adverse event, non-fatal|21|||
161892150|NCT00171158|584653150|FG000|Core Study|Consent withdrawn by subject|6|||
161892151|NCT00171158|584653150|FG000|Core Study|No longer required drug (BMT)|14|||
161892152|NCT00171158|584653150|FG000|Core Study|Abnormal Laboratory Values|2|||
161892153|NCT00171158|584653150|FG000|Core Study|Lost to Follow-up|1|||
161892154|NCT00171158|584653150|FG000|E2 Extension|Other|7|||
161892155|NCT03630705|584653151|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
161892156|NCT03630705|584653152|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
161892157|NCT03630705|584653153|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161892158|NCT03630705|584653154|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161892159|NCT03630705|584653151|FG000|Overall Study|Lost to Follow-up|1|||
161892160|NCT03630705|584653152|FG001|Overall Study|Lost to Follow-up|2|||
161892161|NCT03630705|584653153|FG002|Overall Study|Lost to Follow-up|0|||
161892162|NCT03630705|584653154|FG003|Overall Study|Lost to Follow-up|0|||
161892163|NCT02757352|584653155|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
161892164|NCT02757352|584653156|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892165|NCT02757352|584653157|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
161892166|NCT02757352|584653158|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892167|NCT02757352|584653159|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892168|NCT02757352|584653160|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892169|NCT02757352|584653161|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892170|NCT02757352|584653162|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892171|NCT02757352|584653163|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892172|NCT02757352|584653164|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892173|NCT02757352|584653155|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892174|NCT02757352|584653156|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892175|NCT02757352|584653157|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
161892176|NCT02757352|584653158|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892177|NCT02757352|584653159|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892178|NCT02757352|584653160|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892179|NCT02757352|584653161|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892180|NCT02757352|584653162|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892181|NCT02757352|584653163|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892182|NCT02757352|584653164|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892183|NCT02757352|584653155|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
161892184|NCT02757352|584653156|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
161892185|NCT02757352|584653157|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
161892186|NCT02757352|584653158|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892187|NCT02757352|584653159|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892188|NCT02757352|584653160|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892189|NCT02757352|584653161|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892190|NCT02757352|584653162|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892191|NCT02757352|584653163|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892192|NCT02757352|584653164|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892193|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892194|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
161892195|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892196|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892197|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892198|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892199|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892200|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892201|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892202|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892203|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892204|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161892205|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892206|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892207|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892208|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892209|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892210|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892211|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892212|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892213|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892214|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892215|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
161892216|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892217|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892218|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892219|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892220|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892221|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892222|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892223|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
161892224|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
161892225|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
161892226|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892227|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892228|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892229|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892230|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892231|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892232|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892233|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892234|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892235|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892236|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
161892237|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892238|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
161892239|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892240|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892241|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892242|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892243|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892244|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892245|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892246|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
161892247|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161892248|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
161892249|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892250|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892251|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892252|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892253|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892254|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892255|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892256|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892257|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
161892258|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892259|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892260|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892261|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892262|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892263|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892264|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892265|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892266|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892267|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892268|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
161892269|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892270|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892271|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892272|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892273|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892274|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892275|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892276|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
161892277|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892278|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892279|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892280|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892281|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892282|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892283|NCT02757352|584653155|FG000|Follow-Up Period|Adverse Event|0|||
161892284|NCT02757352|584653156|FG001|Follow-Up Period|Adverse Event|0|||
161892285|NCT02757352|584653157|FG002|Follow-Up Period|Adverse Event|0|||
161892286|NCT02757352|584653158|FG003|Follow-Up Period|Adverse Event|0|||
161892287|NCT02757352|584653159|FG004|Follow-Up Period|Adverse Event|0|||
161892288|NCT02757352|584653160|FG005|Follow-Up Period|Adverse Event|0|||
161892289|NCT02757352|584653161|FG006|Follow-Up Period|Adverse Event|1|||
161892290|NCT02757352|584653162|FG007|Follow-Up Period|Adverse Event|0|||
161892291|NCT02757352|584653163|FG008|Follow-Up Period|Adverse Event|2|||
161892292|NCT02757352|584653164|FG009|Follow-Up Period|Adverse Event|0|||
161892293|NCT02757352|584653155|FG000|Follow-Up Period|Lost to Follow-up|0|||
161892294|NCT02757352|584653156|FG001|Follow-Up Period|Lost to Follow-up|0|||
161892295|NCT02757352|584653157|FG002|Follow-Up Period|Lost to Follow-up|0|||
161892296|NCT02757352|584653158|FG003|Follow-Up Period|Lost to Follow-up|0|||
161892297|NCT02757352|584653159|FG004|Follow-Up Period|Lost to Follow-up|0|||
161892298|NCT02757352|584653160|FG005|Follow-Up Period|Lost to Follow-up|0|||
161892299|NCT02757352|584653161|FG006|Follow-Up Period|Lost to Follow-up|0|||
161892300|NCT02757352|584653162|FG007|Follow-Up Period|Lost to Follow-up|0|||
161892301|NCT02757352|584653163|FG008|Follow-Up Period|Lost to Follow-up|1|||
161892302|NCT02757352|584653164|FG009|Follow-Up Period|Lost to Follow-up|0|||
161892303|NCT02757352|584653155|FG000|Follow-Up Period|Lack of Efficacy|0|||
161892304|NCT02757352|584653156|FG001|Follow-Up Period|Lack of Efficacy|0|||
161892305|NCT02757352|584653157|FG002|Follow-Up Period|Lack of Efficacy|0|||
161892306|NCT02757352|584653158|FG003|Follow-Up Period|Lack of Efficacy|0|||
161892307|NCT02757352|584653159|FG004|Follow-Up Period|Lack of Efficacy|0|||
161892308|NCT02757352|584653160|FG005|Follow-Up Period|Lack of Efficacy|0|||
161892309|NCT02757352|584653161|FG006|Follow-Up Period|Lack of Efficacy|0|||
161892310|NCT02757352|584653162|FG007|Follow-Up Period|Lack of Efficacy|0|||
161892311|NCT02757352|584653163|FG008|Follow-Up Period|Lack of Efficacy|1|||
161892312|NCT02757352|584653164|FG009|Follow-Up Period|Lack of Efficacy|1|||
161892313|NCT02757352|584653155|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161892314|NCT02757352|584653156|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161892315|NCT02757352|584653157|FG002|Follow-Up Period|Withdrawal by Subject|0|||
161892316|NCT02757352|584653158|FG003|Follow-Up Period|Withdrawal by Subject|0|||
161892317|NCT02757352|584653159|FG004|Follow-Up Period|Withdrawal by Subject|0|||
161892318|NCT02757352|584653160|FG005|Follow-Up Period|Withdrawal by Subject|0|||
161892319|NCT02757352|584653161|FG006|Follow-Up Period|Withdrawal by Subject|0|||
161892320|NCT02757352|584653162|FG007|Follow-Up Period|Withdrawal by Subject|1|||
161892321|NCT02757352|584653163|FG008|Follow-Up Period|Withdrawal by Subject|6|||
161892322|NCT02757352|584653164|FG009|Follow-Up Period|Withdrawal by Subject|2|||
161892323|NCT04750278|584653165|FG000|Overall Study|Death|9|||
161892324|NCT04750278|584653166|FG001|Overall Study|Death|10|||
161892325|NCT04750278|584653167|FG002|Overall Study|Death|10|||
161892326|NCT04750278|584653165|FG000|Overall Study|Withdrawal by Subject|4|||
161892327|NCT04750278|584653166|FG001|Overall Study|Withdrawal by Subject|1|||
161892328|NCT04750278|584653167|FG002|Overall Study|Withdrawal by Subject|2|||
161892329|NCT04750278|584653165|FG000|Overall Study|Lost to Follow-up|1|||
161892330|NCT04750278|584653166|FG001|Overall Study|Lost to Follow-up|1|||
161892331|NCT04750278|584653167|FG002|Overall Study|Lost to Follow-up|1|||
161892332|NCT04750278|584653165|FG000|Overall Study|Pregnancy|1|||
161892333|NCT04750278|584653166|FG001|Overall Study|Pregnancy|0|||
161892334|NCT04750278|584653167|FG002|Overall Study|Pregnancy|0|||
161892335|NCT04750278|584653165|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
161892336|NCT04750278|584653166|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
161892337|NCT04750278|584653167|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
161892338|NCT04750278|584653165|FG000|Overall Study|Non-compliance|0|||
161892339|NCT04750278|584653166|FG001|Overall Study|Non-compliance|0|||
161892340|NCT04750278|584653167|FG002|Overall Study|Non-compliance|1|||
161892341|NCT04750278|584653165|FG000|Overall Study|Transfer to Outside Facility|0|||
161892342|NCT04750278|584653166|FG001|Overall Study|Transfer to Outside Facility|2|||
161892343|NCT04750278|584653167|FG002|Overall Study|Transfer to Outside Facility|1|||
161892344|NCT04750278|584653165|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
161892345|NCT04750278|584653166|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
161892346|NCT04750278|584653167|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
161892347|NCT04750278|584653165|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
161892348|NCT04750278|584653166|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
161892349|NCT04750278|584653167|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
161892350|NCT01212159|584653168|FG000|Overall Study|Withdrawal by Subject|12|||
161892351|NCT01212159|584653169|FG001|Overall Study|Withdrawal by Subject|12|||
161892352|NCT01299896|584653170|FG000|Overall Study|Withdrawal by Subject|1|||
161892353|NCT01299896|584653171|FG001|Overall Study|Withdrawal by Subject|7|||
161892354|NCT01299896|584653170|FG000|Overall Study|Lost to Follow-up|0|||
161892355|NCT01299896|584653171|FG001|Overall Study|Lost to Follow-up|11|||
161892356|NCT03488563|584653172|FG000|Overall Study|Lost to Follow-up|7|||
161892357|NCT03488563|584653173|FG001|Overall Study|Lost to Follow-up|6|||
161892358|NCT03488563|584653174|FG002|Overall Study|Lost to Follow-up|7|||
161892359|NCT03488563|584653172|FG000|Overall Study|Withdrawal by Subject|8|||
161892360|NCT03488563|584653173|FG001|Overall Study|Withdrawal by Subject|7|||
161892361|NCT03488563|584653174|FG002|Overall Study|Withdrawal by Subject|7|||
161892362|NCT03488563|584653172|FG000|Overall Study|Physician Decision|0|||
161892363|NCT03488563|584653173|FG001|Overall Study|Physician Decision|0|||
161892364|NCT03488563|584653174|FG002|Overall Study|Physician Decision|1|||
161892365|NCT03488563|584653172|FG000|Overall Study|Protocol Violation|3|||
161892366|NCT03488563|584653173|FG001|Overall Study|Protocol Violation|2|||
161892367|NCT03488563|584653174|FG002|Overall Study|Protocol Violation|6|||
161892368|NCT03488563|584653172|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
161892369|NCT03488563|584653173|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
161892370|NCT03488563|584653174|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
161892371|NCT03488563|584653172|FG000|Overall Study|Use of prohibited medication|2|||
161892372|NCT03488563|584653173|FG001|Overall Study|Use of prohibited medication|0|||
161892373|NCT03488563|584653174|FG002|Overall Study|Use of prohibited medication|0|||
161892374|NCT03488563|584653172|FG000|Overall Study|Adverse Event|1|||
161892375|NCT03488563|584653173|FG001|Overall Study|Adverse Event|0|||
161892376|NCT03488563|584653174|FG002|Overall Study|Adverse Event|1|||
161892377|NCT03488563|584653172|FG000|Overall Study|Subject returned for ET visit|0|||
161892378|NCT03488563|584653173|FG001|Overall Study|Subject returned for ET visit|1|||
161892379|NCT03488563|584653174|FG002|Overall Study|Subject returned for ET visit|0|||
161892380|NCT03488563|584653172|FG000|Overall Study|Sponsor's decision|0|||
161892381|NCT03488563|584653173|FG001|Overall Study|Sponsor's decision|0|||
161892382|NCT03488563|584653174|FG002|Overall Study|Sponsor's decision|1|||
161892383|NCT02626000|584653191|FG000|Overall Study|Decision by Sponsor|1|||
161892384|NCT02626000|584653191|FG000|Overall Study|Death|29|||
161892385|NCT01467271|584653194|FG000|Overall Study|Death|84|||
161892386|NCT01467271|584653194|FG000|Overall Study|Lost to Follow-up|83|||
161892387|NCT01467271|584653194|FG000|Overall Study|Retraction of patient's consent|21|||
161892388|NCT01467271|584653194|FG000|Overall Study|Other reason|14|||
161892389|NCT01411319|584653218|FG000|Overall Study|Lost to Follow-up|1|||
161892390|NCT02815267|584653219|FG000|Double-Blind Phase|Adverse Event|0|||
161892391|NCT02815267|584653220|FG001|Double-Blind Phase|Adverse Event|3|||
161892392|NCT02815267|584653219|FG000|Double-Blind Phase|Lost to Follow-up|17|||
161892393|NCT02815267|584653220|FG001|Double-Blind Phase|Lost to Follow-up|9|||
161892394|NCT02815267|584653219|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
161892395|NCT02815267|584653220|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
161892396|NCT02815267|584653219|FG000|Double-Blind Phase|Protocol Violation|3|||
161892397|NCT02815267|584653220|FG001|Double-Blind Phase|Protocol Violation|2|||
161892398|NCT02815267|584653219|FG000|Double-Blind Phase|Site withdrawal|1|||
161892399|NCT02815267|584653220|FG001|Double-Blind Phase|Site withdrawal|6|||
161892400|NCT02815267|584653219|FG000|Double-Blind Phase|Received a disallowed medication|1|||
161892401|NCT02815267|584653220|FG001|Double-Blind Phase|Received a disallowed medication|1|||
161892402|NCT02815267|584653219|FG000|Open-Label Phase|Adverse Event|1|||
161892403|NCT02815267|584653220|FG001|Open-Label Phase|Adverse Event|1|||
161892404|NCT02815267|584653219|FG000|Open-Label Phase|Lost to Follow-up|23|||
161892405|NCT02815267|584653220|FG001|Open-Label Phase|Lost to Follow-up|9|||
161892406|NCT02815267|584653219|FG000|Open-Label Phase|Withdrawal by Subject|24|||
161892407|NCT02815267|584653220|FG001|Open-Label Phase|Withdrawal by Subject|13|||
161892408|NCT02815267|584653219|FG000|Open-Label Phase|Protocol Violation|0|||
161892409|NCT02815267|584653220|FG001|Open-Label Phase|Protocol Violation|1|||
161892410|NCT02815267|584653219|FG000|Open-Label Phase|Administrative|21|||
161892411|NCT02815267|584653220|FG001|Open-Label Phase|Administrative|12|||
161892412|NCT02815267|584653219|FG000|Open-Label Phase|Other|2|||
161892413|NCT02815267|584653220|FG001|Open-Label Phase|Other|5|||
161892414|NCT04126317|584653237|FG000|Overall Study|Adverse Event|0|||
161892415|NCT04126317|584653238|FG001|Overall Study|Adverse Event|1|||
161892416|NCT04126317|584653237|FG000|Overall Study|Withdrawal by Subject|4|||
161892417|NCT04126317|584653238|FG001|Overall Study|Withdrawal by Subject|1|||
161892418|NCT01796301|584653241|FG000|Overall Study|Withdrawal by Subject|15|||
161892419|NCT01796301|584653242|FG001|Overall Study|Withdrawal by Subject|15|||
161892420|NCT01796301|584653241|FG000|Overall Study|Lost to Follow-up|3|||
161892421|NCT01796301|584653242|FG001|Overall Study|Lost to Follow-up|3|||
161892422|NCT01796301|584653241|FG000|Overall Study|Death|0|||
161892423|NCT01796301|584653242|FG001|Overall Study|Death|1|||
161892424|NCT01796301|584653241|FG000|Overall Study|Decision by Sponsor|0|||
161892425|NCT01796301|584653242|FG001|Overall Study|Decision by Sponsor|1|||
161892426|NCT00660595|584653243|FG000|Overall Study|Lost to Follow-up|0|||
161892427|NCT00660595|584653244|FG001|Overall Study|Lost to Follow-up|1|||
161892428|NCT00660595|584653243|FG000|Overall Study|Did not consent to participate in study|12|||
161892429|NCT00660595|584653244|FG001|Overall Study|Did not consent to participate in study|8|||
161892430|NCT00660595|584653243|FG000|Overall Study|Participant left hospital|1|||
161892431|NCT00660595|584653244|FG001|Overall Study|Participant left hospital|0|||
161892432|NCT00660595|584653243|FG000|Overall Study|Non Specified reasons|5|||
161892433|NCT00660595|584653244|FG001|Overall Study|Non Specified reasons|0|||
161892434|NCT00339833|584653255|FG000|Overall Study|Withdrawal by Subject|1|||
161892435|NCT00339833|584653256|FG001|Overall Study|Withdrawal by Subject|2|||
161892436|NCT00339833|584653255|FG000|Overall Study|toothache|0|||
161892437|NCT00339833|584653256|FG001|Overall Study|toothache|1|||
161892438|NCT00339833|584653255|FG000|Overall Study|indigestion|0|||
161892439|NCT00339833|584653256|FG001|Overall Study|indigestion|1|||
161892440|NCT00339833|584653255|FG000|Overall Study|Chest pain|0|||
161892441|NCT00339833|584653256|FG001|Overall Study|Chest pain|1|||
161892442|NCT00339833|584653255|FG000|Overall Study|minor infection|0|||
161892443|NCT00339833|584653256|FG001|Overall Study|minor infection|1|||
161892444|NCT00339833|584653255|FG000|Overall Study|Poor venous access|2|||
161892445|NCT00339833|584653256|FG001|Overall Study|Poor venous access|2|||
161892446|NCT00339833|584653255|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
161892447|NCT00339833|584653256|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
161892448|NCT00339833|584653255|FG000|Overall Study|Error in data records|1|||
161892449|NCT00339833|584653256|FG001|Overall Study|Error in data records|0|||
161892450|NCT00217581|584653257|FG000|Overall Study|Withdrawal by Subject|1|||
161892451|NCT02829047|584653258|FG000|Overall Study|Withdrawal by Subject|1|||
161892452|NCT01204918|584653278|FG000|Overall Study|Withdrawal by Subject|4|||
161892453|NCT01204918|584653279|FG001|Overall Study|Withdrawal by Subject|10|||
161892454|NCT01204918|584653280|FG002|Overall Study|Withdrawal by Subject|5|||
161892455|NCT00269477|584653285|FG000|Overall Study|Protocol Violation|5|||
161892456|NCT00269477|584653286|FG001|Overall Study|Protocol Violation|5|||
161892457|NCT00269477|584653287|FG002|Overall Study|Protocol Violation|1|||
161892458|NCT00269477|584653288|FG003|Overall Study|Protocol Violation|0|||
161892459|NCT00269477|584653285|FG000|Overall Study|Missed post-vaccination blood draw|0|||
161892460|NCT00269477|584653286|FG001|Overall Study|Missed post-vaccination blood draw|1|||
161892461|NCT00269477|584653287|FG002|Overall Study|Missed post-vaccination blood draw|0|||
161892462|NCT00269477|584653288|FG003|Overall Study|Missed post-vaccination blood draw|0|||
161892463|NCT01404949|584653289|FG000|Overall Study|Not Treated|1|||
161892464|NCT02007278|584653290|FG000|Overall Study|Failure to comply with an eligibility|0|||
161892465|NCT02007278|584653291|FG001|Overall Study|Failure to comply with an eligibility|1|||
161892466|NCT02007278|584653290|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
161892467|NCT02007278|584653291|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
161892468|NCT02007278|584653290|FG000|Overall Study|Incorrect medication administration|1|||
161892469|NCT02007278|584653291|FG001|Overall Study|Incorrect medication administration|0|||
161892470|NCT02007278|584653290|FG000|Overall Study|Mis-randomization|1|||
161892471|NCT02007278|584653291|FG001|Overall Study|Mis-randomization|1|||
161892472|NCT02886884|584653294|FG000|Follow-up|Withdrawal by Subject|0|||
161892473|NCT02886884|584653295|FG001|Follow-up|Withdrawal by Subject|0|||
161892474|NCT02886884|584653296|FG002|Follow-up|Withdrawal by Subject|0|||
161892475|NCT02886884|584653297|FG003|Follow-up|Withdrawal by Subject|1|||
161892476|NCT02651688|584653301|FG000|Overall Study|Non-compliance|0|||
161892477|NCT02651688|584653302|FG001|Overall Study|Non-compliance|0|||
161892478|NCT02651688|584653303|FG002|Overall Study|Non-compliance|1|||
161892479|NCT02651688|584653301|FG000|Overall Study|Principal Investigator (PI) decision|0|||
161892480|NCT02651688|584653302|FG001|Overall Study|Principal Investigator (PI) decision|2|||
161892481|NCT02651688|584653303|FG002|Overall Study|Principal Investigator (PI) decision|0|||
161892482|NCT02651688|584653301|FG000|Overall Study|Lost to Follow-up|1|||
161892483|NCT02651688|584653302|FG001|Overall Study|Lost to Follow-up|3|||
161892484|NCT02651688|584653303|FG002|Overall Study|Lost to Follow-up|0|||
161892485|NCT02651688|584653301|FG000|Overall Study|Withdrawal by Subject|1|||
161892486|NCT02651688|584653302|FG001|Overall Study|Withdrawal by Subject|0|||
161892487|NCT02651688|584653303|FG002|Overall Study|Withdrawal by Subject|2|||
161892488|NCT00625183|584653304|FG000|Overall Study|Disease Progression|1|||
161892489|NCT01429441|584653305|FG000|Overall Study|Adverse Event|5|||
161892490|NCT01429441|584653306|FG001|Overall Study|Adverse Event|1|||
161892491|NCT01429441|584653305|FG000|Overall Study|Death|0|||
161892492|NCT01429441|584653306|FG001|Overall Study|Death|2|||
161892493|NCT01429441|584653305|FG000|Overall Study|Lost to Follow-up|5|||
161892494|NCT01429441|584653306|FG001|Overall Study|Lost to Follow-up|2|||
161892495|NCT01429441|584653305|FG000|Overall Study|Physician Decision|1|||
161892496|NCT01429441|584653306|FG001|Overall Study|Physician Decision|0|||
161892497|NCT01429441|584653305|FG000|Overall Study|Withdrawal by Subject|27|||
161892498|NCT01429441|584653306|FG001|Overall Study|Withdrawal by Subject|18|||
161892499|NCT01606748|584653308|FG000|Overall Study|Adverse Event|1|||
161892500|NCT01606748|584653309|FG001|Overall Study|Adverse Event|0|||
161892501|NCT01606748|584653308|FG000|Overall Study|Progressive Disease|1|||
161892502|NCT01606748|584653309|FG001|Overall Study|Progressive Disease|0|||
161892503|NCT01606748|584653308|FG000|Overall Study|Withdrawal by Subject|1|||
161892504|NCT01606748|584653309|FG001|Overall Study|Withdrawal by Subject|0|||
161892505|NCT02670382|584653311|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
161892506|NCT02670382|584653312|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
161892507|NCT03244618|584653313|FG000|Overall Study|Lost to Follow-up|3|||
161892508|NCT03244618|584653314|FG001|Overall Study|Lost to Follow-up|4|||
161892509|NCT03244618|584653313|FG000|Overall Study|Protocol Violation|4|||
161892510|NCT03244618|584653314|FG001|Overall Study|Protocol Violation|3|||
161892511|NCT03244618|584653313|FG000|Overall Study|Withdrawal by Subject|0|||
161892512|NCT03244618|584653314|FG001|Overall Study|Withdrawal by Subject|2|||
161892513|NCT02155322|584653315|FG000|Overall Study|Adverse Event|1|||
161892514|NCT02155322|584653315|FG000|Overall Study|Physician Decision|1|||
161892515|NCT02155322|584653315|FG000|Overall Study|Relapse/Recurrence|8|||
161892516|NCT02155322|584653315|FG000|Overall Study|Withdrawal by Subject|4|||
161892517|NCT04776018|584653319|FG000|Overall Study|Death|0|||
161892518|NCT04776018|584653320|FG001|Overall Study|Death|1|||
161892519|NCT04776018|584653321|FG002|Overall Study|Death|4|||
161892520|NCT04776018|584653322|FG003|Overall Study|Death|1|||
161892521|NCT04776018|584653323|FG004|Overall Study|Death|4|||
161892522|NCT04776018|584653324|FG005|Overall Study|Death|0|||
161892523|NCT04776018|584653325|FG006|Overall Study|Death|0|||
161892524|NCT04776018|584653319|FG000|Overall Study|Study terminated by sponsor|2|||
161892525|NCT04776018|584653320|FG001|Overall Study|Study terminated by sponsor|1|||
161892526|NCT04776018|584653321|FG002|Overall Study|Study terminated by sponsor|4|||
161892527|NCT04776018|584653322|FG003|Overall Study|Study terminated by sponsor|0|||
161892528|NCT04776018|584653323|FG004|Overall Study|Study terminated by sponsor|3|||
161892529|NCT04776018|584653324|FG005|Overall Study|Study terminated by sponsor|0|||
161892530|NCT04776018|584653325|FG006|Overall Study|Study terminated by sponsor|0|||
161892531|NCT04776018|584653319|FG000|Overall Study|Withdrawal by Subject|1|||
161892532|NCT04776018|584653320|FG001|Overall Study|Withdrawal by Subject|0|||
161892533|NCT04776018|584653321|FG002|Overall Study|Withdrawal by Subject|0|||
161892534|NCT04776018|584653322|FG003|Overall Study|Withdrawal by Subject|2|||
161892535|NCT04776018|584653323|FG004|Overall Study|Withdrawal by Subject|1|||
161892536|NCT04776018|584653324|FG005|Overall Study|Withdrawal by Subject|0|||
161892537|NCT04776018|584653325|FG006|Overall Study|Withdrawal by Subject|0|||
161892538|NCT04776018|584653319|FG000|Overall Study|Other|0|||
161892539|NCT04776018|584653320|FG001|Overall Study|Other|1|||
161892540|NCT04776018|584653321|FG002|Overall Study|Other|1|||
161892541|NCT04776018|584653322|FG003|Overall Study|Other|0|||
161892542|NCT04776018|584653323|FG004|Overall Study|Other|0|||
161892543|NCT04776018|584653324|FG005|Overall Study|Other|0|||
161892544|NCT04776018|584653325|FG006|Overall Study|Other|0|||
161892545|NCT04776018|584653319|FG000|Overall Study|Lost to Follow-up|0|||
161892546|NCT04776018|584653320|FG001|Overall Study|Lost to Follow-up|0|||
161892547|NCT04776018|584653321|FG002|Overall Study|Lost to Follow-up|1|||
161892548|NCT04776018|584653322|FG003|Overall Study|Lost to Follow-up|0|||
161892549|NCT04776018|584653323|FG004|Overall Study|Lost to Follow-up|0|||
161892550|NCT04776018|584653324|FG005|Overall Study|Lost to Follow-up|0|||
161892551|NCT04776018|584653325|FG006|Overall Study|Lost to Follow-up|0|||
161892552|NCT03396822|584655046|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
161892553|NCT03396822|584655046|FG000|Overall Study|Physician Decision|1|||
161892554|NCT03536663|584655051|FG000|Endexo|Protocol Violation|1|||
161892555|NCT01128400|584655052|FG000|Overall Study|Lost to Follow-up|1|||
161892556|NCT01128400|584655053|FG001|Overall Study|Lost to Follow-up|0|||
161892557|NCT01128400|584655054|FG002|Overall Study|Lost to Follow-up|1|||
161892558|NCT01128400|584655052|FG000|Overall Study|Screening failure|1|||
161892559|NCT01128400|584655053|FG001|Overall Study|Screening failure|0|||
161892560|NCT01128400|584655054|FG002|Overall Study|Screening failure|0|||
161892561|NCT01128400|584655052|FG000|Overall Study|were not invited to participate on taste|0|||
161892562|NCT01128400|584655053|FG001|Overall Study|were not invited to participate on taste|0|||
161892563|NCT01128400|584655054|FG002|Overall Study|were not invited to participate on taste|15|||
161892564|NCT01128400|584655052|FG000|Overall Study|Excluded due to sinus problems|0|||
161892565|NCT01128400|584655053|FG001|Overall Study|Excluded due to sinus problems|1|||
161892566|NCT01128400|584655054|FG002|Overall Study|Excluded due to sinus problems|0|||
161892567|NCT03782571|584655060|FG000|Period 1|Withdrawal by Subject|1|||
161892568|NCT03782571|584655061|FG001|Period 1|Withdrawal by Subject|0|||
161892569|NCT03782571|584655062|FG002|Period 1|Withdrawal by Subject|0|||
161892570|NCT03782571|584655063|FG003|Period 1|Withdrawal by Subject|0|||
161892571|NCT03782571|584655060|FG000|Period 3|Subject Unable to Attend V5|1|||
161892572|NCT03782571|584655061|FG001|Period 3|Subject Unable to Attend V5|0|||
161892573|NCT03782571|584655062|FG002|Period 3|Subject Unable to Attend V5|0|||
161892574|NCT03782571|584655063|FG003|Period 3|Subject Unable to Attend V5|0|||
161892575|NCT03782571|584655060|FG000|Period 3|Adverse Event|1|||
161892576|NCT03782571|584655061|FG001|Period 3|Adverse Event|0|||
161892577|NCT03782571|584655062|FG002|Period 3|Adverse Event|0|||
161892578|NCT03782571|584655063|FG003|Period 3|Adverse Event|0|||
161892579|NCT03504189|584655064|FG000|Overall Study|Withdrawal by Subject|1|||
161892580|NCT03504189|584655064|FG000|Overall Study|Screening Failure|1|||
161892581|NCT03504189|584655064|FG000|Overall Study|Device Failure|2|||
161892582|NCT01597492|584655065|FG000|Overall Study|Withdrawal by Subject|1|||
161892583|NCT01597492|584655066|FG001|Overall Study|Withdrawal by Subject|2|||
161892584|NCT01597492|584655065|FG000|Overall Study|Adverse Event|3|||
161892585|NCT01597492|584655066|FG001|Overall Study|Adverse Event|0|||
161892586|NCT01597492|584655065|FG000|Overall Study|Lost to Follow-up|0|||
161892587|NCT01597492|584655066|FG001|Overall Study|Lost to Follow-up|2|||
161892588|NCT01597492|584655065|FG000|Overall Study|Other Reason|2|||
161892589|NCT01597492|584655066|FG001|Overall Study|Other Reason|0|||
161892590|NCT02570750|584655067|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
161892591|NCT02570750|584655068|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
161892592|NCT02570750|584655067|FG000|Overall Study|Protocol deviation|4|||
161892593|NCT02570750|584655068|FG001|Overall Study|Protocol deviation|2|||
161892594|NCT02570750|584655067|FG000|Overall Study|Withdrawal by Subject|5|||
161892595|NCT02570750|584655068|FG001|Overall Study|Withdrawal by Subject|0|||
161892596|NCT02570750|584655067|FG000|Overall Study|Lost to Follow-up|2|||
161892597|NCT02570750|584655068|FG001|Overall Study|Lost to Follow-up|2|||
161892598|NCT02570750|584655067|FG000|Overall Study|Adverse Event|2|||
161892599|NCT02570750|584655068|FG001|Overall Study|Adverse Event|1|||
161892600|NCT01884545|584655069|FG000|Overall Study|Lost to Follow-up|6|||
161892601|NCT01884545|584655070|FG001|Overall Study|Lost to Follow-up|4|||
161892602|NCT01884545|584655071|FG002|Overall Study|Lost to Follow-up|9|||
161892603|NCT01884545|584655072|FG003|Overall Study|Lost to Follow-up|4|||
161892604|NCT01884545|584655069|FG000|Overall Study|Patient withdrawn|7|||
161892605|NCT01884545|584655070|FG001|Overall Study|Patient withdrawn|12|||
161892606|NCT01884545|584655071|FG002|Overall Study|Patient withdrawn|5|||
161892607|NCT01884545|584655072|FG003|Overall Study|Patient withdrawn|5|||
161892608|NCT01884545|584655069|FG000|Overall Study|Non-adherence|0|||
161892609|NCT01884545|584655070|FG001|Overall Study|Non-adherence|2|||
161892610|NCT01884545|584655071|FG002|Overall Study|Non-adherence|0|||
161892611|NCT01884545|584655072|FG003|Overall Study|Non-adherence|0|||
161892612|NCT01410240|584655073|FG000|Overall Study|Physician Decision|0|||
161892613|NCT01410240|584655074|FG001|Overall Study|Physician Decision|0|||
161892614|NCT01410240|584655075|FG002|Overall Study|Physician Decision|1|||
161892615|NCT01410240|584655073|FG000|Overall Study|Missed week 6 assessments|1|||
161892616|NCT01410240|584655074|FG001|Overall Study|Missed week 6 assessments|1|||
161892617|NCT01410240|584655075|FG002|Overall Study|Missed week 6 assessments|1|||
161892618|NCT00496587|584655076|FG000|Overall Study|Adverse Event|2|||
161892619|NCT00496587|584655076|FG000|Overall Study|Progressive Disease|24|||
161892620|NCT00496587|584655076|FG000|Overall Study|Withdrawal by Subject|2|||
161892621|NCT00496587|584655076|FG000|Overall Study|Death|1|||
161892622|NCT00496587|584655076|FG000|Overall Study|Complications unrelated|2|||
161892623|NCT00482170|584655078|FG000|Overall Study|Adverse Event|5|||
161892624|NCT00482170|584655079|FG001|Overall Study|Adverse Event|14|||
161892625|NCT00482170|584655078|FG000|Overall Study|Withdrawal by Subject|6|||
161892626|NCT00482170|584655079|FG001|Overall Study|Withdrawal by Subject|1|||
161892627|NCT00482170|584655078|FG000|Overall Study|Protocol Violation|2|||
161892628|NCT00482170|584655079|FG001|Overall Study|Protocol Violation|3|||
161892629|NCT00482170|584655078|FG000|Overall Study|Lost to Follow-up|2|||
161892630|NCT00482170|584655079|FG001|Overall Study|Lost to Follow-up|0|||
161892631|NCT00482170|584655078|FG000|Overall Study|Unspecified reason|0|||
161892632|NCT00482170|584655079|FG001|Overall Study|Unspecified reason|2|||
161892633|NCT00592592|584655083|FG000|Overall Study|Patient found ineligible upon chart review|1|||
161892634|NCT01134263|584655084|FG000|Overall Study|Serious adverse event|2|||
161892635|NCT01134263|584655085|FG001|Overall Study|Serious adverse event|1|||
161892636|NCT01134263|584655086|FG002|Overall Study|Serious adverse event|1|||
161892637|NCT01134263|584655087|FG003|Overall Study|Serious adverse event|1|||
161892638|NCT01134263|584655088|FG004|Overall Study|Serious adverse event|1|||
161892639|NCT01134263|584655084|FG000|Overall Study|Other adverse event|1|||
161892640|NCT01134263|584655085|FG001|Overall Study|Other adverse event|2|||
161892641|NCT01134263|584655086|FG002|Overall Study|Other adverse event|5|||
161892642|NCT01134263|584655087|FG003|Overall Study|Other adverse event|3|||
161892643|NCT01134263|584655088|FG004|Overall Study|Other adverse event|0|||
161892644|NCT01134263|584655084|FG000|Overall Study|Protocol Violation|8|||
161892645|NCT01134263|584655085|FG001|Overall Study|Protocol Violation|7|||
161892646|NCT01134263|584655086|FG002|Overall Study|Protocol Violation|2|||
161892647|NCT01134263|584655087|FG003|Overall Study|Protocol Violation|4|||
161892648|NCT01134263|584655088|FG004|Overall Study|Protocol Violation|2|||
161892649|NCT01134263|584655084|FG000|Overall Study|Lost to Follow-up|4|||
161892650|NCT01134263|584655085|FG001|Overall Study|Lost to Follow-up|3|||
161892651|NCT01134263|584655086|FG002|Overall Study|Lost to Follow-up|5|||
161892652|NCT01134263|584655087|FG003|Overall Study|Lost to Follow-up|3|||
161892653|NCT01134263|584655088|FG004|Overall Study|Lost to Follow-up|1|||
161892654|NCT01134263|584655084|FG000|Overall Study|Withdrawal by Subject|8|||
161892655|NCT01134263|584655085|FG001|Overall Study|Withdrawal by Subject|6|||
161892656|NCT01134263|584655086|FG002|Overall Study|Withdrawal by Subject|16|||
161892657|NCT01134263|584655087|FG003|Overall Study|Withdrawal by Subject|7|||
161892658|NCT01134263|584655088|FG004|Overall Study|Withdrawal by Subject|5|||
161892659|NCT01134263|584655084|FG000|Overall Study|Enrolled, but not treated|1|||
161892660|NCT01134263|584655085|FG001|Overall Study|Enrolled, but not treated|1|||
161892661|NCT01134263|584655086|FG002|Overall Study|Enrolled, but not treated|0|||
161892662|NCT01134263|584655087|FG003|Overall Study|Enrolled, but not treated|1|||
161892663|NCT01134263|584655088|FG004|Overall Study|Enrolled, but not treated|0|||
161892664|NCT01557517|584655089|FG000|Overall Study|Death|1|||
161892665|NCT01557517|584655090|FG001|Overall Study|Death|0|||
161892666|NCT01557517|584655089|FG000|Overall Study|Refused further treatment|0|||
161892667|NCT01557517|584655090|FG001|Overall Study|Refused further treatment|2|||
161892668|NCT01557517|584655089|FG000|Overall Study|Adverse Event|0|||
161892669|NCT01557517|584655090|FG001|Overall Study|Adverse Event|2|||
161892670|NCT01557517|584655089|FG000|Overall Study|Pt declined before treatment started|1|||
161892671|NCT01557517|584655090|FG001|Overall Study|Pt declined before treatment started|0|||
161892672|NCT00162097|584655091|FG000|Overall Study|Participant no longer met study criteria|0|||
161892673|NCT00162097|584655092|FG001|Overall Study|Participant no longer met study criteria|0|||
161892674|NCT00162097|584655093|FG002|Overall Study|Participant no longer met study criteria|0|||
161892675|NCT00162097|584655094|FG003|Overall Study|Participant no longer met study criteria|1|||
161892676|NCT00770913|584655095|FG000|Overall Study|Adverse Event|1|||
161892677|NCT00770913|584655096|FG001|Overall Study|Adverse Event|3|||
161892678|NCT00770913|584655097|FG002|Overall Study|Adverse Event|6|||
161892679|NCT00770913|584655095|FG000|Overall Study|Refusal to continue participation|6|||
161892680|NCT00770913|584655096|FG001|Overall Study|Refusal to continue participation|4|||
161892681|NCT00770913|584655097|FG002|Overall Study|Refusal to continue participation|5|||
161892682|NCT00770913|584655095|FG000|Overall Study|Physician Decision|0|||
161892683|NCT00770913|584655096|FG001|Overall Study|Physician Decision|1|||
161892684|NCT00770913|584655097|FG002|Overall Study|Physician Decision|1|||
161892685|NCT00770913|584655095|FG000|Overall Study|Protocol Violation|3|||
161892686|NCT00770913|584655096|FG001|Overall Study|Protocol Violation|0|||
161892687|NCT00770913|584655097|FG002|Overall Study|Protocol Violation|1|||
161892688|NCT00770913|584655095|FG000|Overall Study|Incorrect drug was allocated|1|||
161892689|NCT00770913|584655096|FG001|Overall Study|Incorrect drug was allocated|0|||
161892690|NCT00770913|584655097|FG002|Overall Study|Incorrect drug was allocated|0|||
161892691|NCT01134393|584655098|FG000|Overall Study|Adverse Event|18|||
161892692|NCT01134393|584655098|FG000|Overall Study|Lack of Efficacy|2|||
161892693|NCT01134393|584655098|FG000|Overall Study|Protocol Violation|12|||
161892694|NCT01134393|584655098|FG000|Overall Study|Lost to Follow-up|3|||
161892695|NCT01134393|584655098|FG000|Overall Study|Withdrawal by Subject|11|||
161892696|NCT01134393|584655098|FG000|Overall Study|Other|6|||
161892697|NCT00575510|584655105|FG000|Overall Study|Lost to Follow-up|4|||
161892698|NCT00575510|584655106|FG001|Overall Study|Lost to Follow-up|6|||
161892699|NCT00575510|584655107|FG002|Overall Study|Lost to Follow-up|9|||
161892700|NCT00575510|584655105|FG000|Overall Study|Withdrawal by Subject|1|||
161892701|NCT00575510|584655106|FG001|Overall Study|Withdrawal by Subject|0|||
161892702|NCT00575510|584655107|FG002|Overall Study|Withdrawal by Subject|0|||
161892703|NCT00575510|584655105|FG000|Overall Study|Clinic Called Patient|7|||
161892704|NCT00575510|584655106|FG001|Overall Study|Clinic Called Patient|7|||
161892705|NCT00575510|584655107|FG002|Overall Study|Clinic Called Patient|7|||
161892706|NCT00575510|584655105|FG000|Overall Study|Pregnancy|0|||
161892707|NCT00575510|584655106|FG001|Overall Study|Pregnancy|0|||
161892708|NCT00575510|584655107|FG002|Overall Study|Pregnancy|1|||
161892709|NCT02697734|584655108|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
161892710|NCT02697734|584655109|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
161892711|NCT02697734|584655108|FG000|Core Phase - up to Week 48|Adverse Event|1|||
161892712|NCT02697734|584655109|FG001|Core Phase - up to Week 48|Adverse Event|2|||
161892713|NCT02697734|584655108|FG000|Core Phase - up to Week 48|Physician Decision|1|||
161892714|NCT02697734|584655109|FG001|Core Phase - up to Week 48|Physician Decision|0|||
161892715|NCT02697734|584655108|FG000|Optional Extension Phase|Adverse Event|5|||
161892716|NCT02697734|584655109|FG001|Optional Extension Phase|Adverse Event|1|||
161892717|NCT02697734|584655108|FG000|Optional Extension Phase|Physician Decision|0|||
161892718|NCT02697734|584655109|FG001|Optional Extension Phase|Physician Decision|1|||
161892719|NCT03970200|584655110|FG000|Overall Study|Death|2|||
161892720|NCT03970200|584655111|FG001|Overall Study|Death|2|||
161892721|NCT03970200|584655112|FG002|Overall Study|Death|1|||
161892722|NCT03970200|584655110|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
161892723|NCT03970200|584655111|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
161892724|NCT03970200|584655112|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
161892725|NCT02279745|584655113|FG000|Overall Study|Adverse Event|7|||
161892726|NCT02279745|584655113|FG000|Overall Study|Death|6|||
161892727|NCT02279745|584655113|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
161892728|NCT02279745|584655113|FG000|Overall Study|Withdrawal by Subject|2|||
161892729|NCT02279745|584655113|FG000|Overall Study|Pregnancy|1|||
161892730|NCT02279745|584655113|FG000|Overall Study|Study Non-compliance|1|||
161892731|NCT02279745|584655113|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
161892732|NCT01706575|584655117|FG000|Overall Study|Participant Withdrew Consent|4|||
161892733|NCT01706575|584655117|FG000|Overall Study|Lost to Follow-up|2|||
161892734|NCT01706575|584655117|FG000|Overall Study|Started but not Treated|6|||
161892735|NCT03469999|584655122|FG000|Overall Study|Lost to Follow-up|2|||
161892736|NCT01863732|584655123|FG000|Overall Study|Adverse Event|2|||
161892737|NCT01863732|584655124|FG001|Overall Study|Adverse Event|0|||
161892738|NCT01863732|584655125|FG002|Overall Study|Adverse Event|3|||
161892739|NCT01863732|584655126|FG003|Overall Study|Adverse Event|3|||
161892740|NCT01863732|584655123|FG000|Overall Study|Lack of Efficacy|1|||
161892741|NCT01863732|584655124|FG001|Overall Study|Lack of Efficacy|0|||
161892742|NCT01863732|584655125|FG002|Overall Study|Lack of Efficacy|2|||
161892743|NCT01863732|584655126|FG003|Overall Study|Lack of Efficacy|1|||
161892744|NCT01863732|584655123|FG000|Overall Study|Lost to Follow-up|2|||
161892745|NCT01863732|584655124|FG001|Overall Study|Lost to Follow-up|2|||
161892746|NCT01863732|584655125|FG002|Overall Study|Lost to Follow-up|1|||
161892747|NCT01863732|584655126|FG003|Overall Study|Lost to Follow-up|1|||
161892748|NCT01863732|584655123|FG000|Overall Study|Physician Decision|1|||
161892749|NCT01863732|584655124|FG001|Overall Study|Physician Decision|0|||
161892750|NCT01863732|584655125|FG002|Overall Study|Physician Decision|1|||
161892751|NCT01863732|584655126|FG003|Overall Study|Physician Decision|0|||
161892752|NCT01863732|584655123|FG000|Overall Study|Pregnancy|0|||
161892753|NCT01863732|584655124|FG001|Overall Study|Pregnancy|0|||
161892754|NCT01863732|584655125|FG002|Overall Study|Pregnancy|0|||
161892755|NCT01863732|584655126|FG003|Overall Study|Pregnancy|1|||
161892756|NCT01863732|584655123|FG000|Overall Study|Technical problems|0|||
161892757|NCT01863732|584655124|FG001|Overall Study|Technical problems|1|||
161892758|NCT01863732|584655125|FG002|Overall Study|Technical problems|1|||
161892759|NCT01863732|584655126|FG003|Overall Study|Technical problems|0|||
161892760|NCT01863732|584655123|FG000|Overall Study|Subject/guardian decision|6|||
161892761|NCT01863732|584655124|FG001|Overall Study|Subject/guardian decision|9|||
161892762|NCT01863732|584655125|FG002|Overall Study|Subject/guardian decision|3|||
161892763|NCT01863732|584655126|FG003|Overall Study|Subject/guardian decision|1|||
161892764|NCT01863732|584655123|FG000|Overall Study|Death|1|||
161892765|NCT01863732|584655124|FG001|Overall Study|Death|0|||
161892766|NCT01863732|584655125|FG002|Overall Study|Death|0|||
161892767|NCT01863732|584655126|FG003|Overall Study|Death|1|||
161892768|NCT01215435|584655132|FG000|Overall Study|Adverse Event|1|||
161892769|NCT01215435|584655133|FG001|Overall Study|Adverse Event|0|||
161892770|NCT01215435|584655132|FG000|Overall Study|Protocol Violation|2|||
161892771|NCT01215435|584655133|FG001|Overall Study|Protocol Violation|0|||
161892772|NCT01215435|584655132|FG000|Overall Study|Withdrawal Criteria|8|||
161892773|NCT01215435|584655133|FG001|Overall Study|Withdrawal Criteria|11|||
161892774|NCT01215435|584655132|FG000|Overall Study|Lost to Follow-up|3|||
161892775|NCT01215435|584655133|FG001|Overall Study|Lost to Follow-up|0|||
161892776|NCT01215435|584655132|FG000|Overall Study|Unclassified|5|||
161892777|NCT01215435|584655133|FG001|Overall Study|Unclassified|5|||
161892778|NCT00840034|584655134|FG000|Acute Treatment Phase|Adverse Event|6|||
161892779|NCT00840034|584655135|FG001|Acute Treatment Phase|Adverse Event|8|||
161892780|NCT00840034|584655134|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
161892781|NCT00840034|584655135|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
161892782|NCT00840034|584655134|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
161892783|NCT00840034|584655135|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
161892784|NCT00840034|584655134|FG000|Acute Treatment Phase|Physician Decision|0|||
161892785|NCT00840034|584655135|FG001|Acute Treatment Phase|Physician Decision|1|||
161892786|NCT00840034|584655134|FG000|Acute Treatment Phase|Protocol Violation|2|||
161892787|NCT00840034|584655135|FG001|Acute Treatment Phase|Protocol Violation|4|||
161892788|NCT00840034|584655134|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
161892789|NCT00840034|584655135|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
161892790|NCT00840034|584655134|FG000|Taper Phase|Adverse Event|1|||
161892791|NCT00840034|584655135|FG001|Taper Phase|Adverse Event|0|||
161892792|NCT00840034|584655134|FG000|Taper Phase|Lost to Follow-up|1|||
161892793|NCT00840034|584655135|FG001|Taper Phase|Lost to Follow-up|1|||
161892794|NCT00840034|584655134|FG000|Taper Phase|Withdrawal by Subject|1|||
161892795|NCT00840034|584655135|FG001|Taper Phase|Withdrawal by Subject|1|||
161892796|NCT03383692|584655142|FG000|Overall Study|Progressive disease as per RECIST|3|||
161892797|NCT03383692|584655143|FG001|Overall Study|Progressive disease as per RECIST|3|||
161892798|NCT03383692|584655142|FG000|Overall Study|Clinical progression|0|||
161892799|NCT03383692|584655143|FG001|Overall Study|Clinical progression|1|||
161892800|NCT03383692|584655142|FG000|Overall Study|Adverse Event|3|||
161892801|NCT03383692|584655143|FG001|Overall Study|Adverse Event|0|||
161892802|NCT03816007|584655145|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
161892803|NCT03816007|584655146|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
161892804|NCT03816007|584655145|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
161892805|NCT03816007|584655146|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
161892806|NCT03816007|584655145|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
161892807|NCT03816007|584655146|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
161892808|NCT02179749|584655149|FG000|Overall Study|Adverse Event|0|||
161892809|NCT02179749|584655150|FG001|Overall Study|Adverse Event|0|||
161892810|NCT02179749|584655151|FG002|Overall Study|Adverse Event|1|||
161892811|NCT02179749|584655149|FG000|Overall Study|Withdrawal by Subject|0|||
161892812|NCT02179749|584655150|FG001|Overall Study|Withdrawal by Subject|0|||
161892813|NCT02179749|584655151|FG002|Overall Study|Withdrawal by Subject|1|||
161892814|NCT01810783|584655153|FG000|Overall Study|Adverse Event|32|||
161892815|NCT01810783|584655153|FG000|Overall Study|Withdrawal by Subject|22|||
161892816|NCT01810783|584655153|FG000|Overall Study|Lack of Efficacy|12|||
161892817|NCT01810783|584655153|FG000|Overall Study|Lost to Follow-up|10|||
161892818|NCT01810783|584655153|FG000|Overall Study|Protocol Violation|5|||
161892819|NCT01810783|584655153|FG000|Overall Study|Non-compliance with IMP|4|||
161892820|NCT01810783|584655153|FG000|Overall Study|Adminstrative or other reason(s)|23|||
161892821|NCT01810783|584655153|FG000|Overall Study|Enrolled, not treated|1|||
161892822|NCT00793546|584655154|FG000|Overall Study|Death|3|||
161892823|NCT00793546|584655155|FG001|Overall Study|Death|0|||
161892824|NCT00793546|584655154|FG000|Overall Study|Lost to Follow-up|1|||
161892825|NCT00793546|584655155|FG001|Overall Study|Lost to Follow-up|0|||
161892826|NCT00793546|584655154|FG000|Overall Study|Withdrawal by Subject|1|||
161892827|NCT00793546|584655155|FG001|Overall Study|Withdrawal by Subject|1|||
161892828|NCT00793546|584655154|FG000|Overall Study|Study Terminated by Sponsor|8|||
161892829|NCT00793546|584655155|FG001|Overall Study|Study Terminated by Sponsor|27|||
161892830|NCT00793546|584655154|FG000|Overall Study|Other|1|||
161892831|NCT00793546|584655155|FG001|Overall Study|Other|0|||
161892832|NCT02071082|584655156|FG000|Overall Study|Enrolled and Never Treated|1|||
161892833|NCT02071082|584655157|FG001|Overall Study|Enrolled and Never Treated|1|||
161892834|NCT02071082|584655156|FG000|Overall Study|Adverse Event|0|||
161892835|NCT02071082|584655157|FG001|Overall Study|Adverse Event|1|||
161892836|NCT02071082|584655156|FG000|Overall Study|Withdrew Consent|0|||
161892837|NCT02071082|584655157|FG001|Overall Study|Withdrew Consent|4|||
161892838|NCT02071082|584655156|FG000|Overall Study|Lost to Follow-up|1|||
161892839|NCT02071082|584655157|FG001|Overall Study|Lost to Follow-up|1|||
161892840|NCT00630747|584655159|FG000|Overall Study|Death|1|||
161892841|NCT00630747|584655159|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
161892842|NCT00630747|584655159|FG000|Overall Study|Returned to country of origin|1|||
161892843|NCT00435019|584655162|FG000|Overall Study|Adverse Event|1|||
161892844|NCT00435019|584655163|FG001|Overall Study|Adverse Event|0|||
161892845|NCT00435019|584655162|FG000|Overall Study|Lack of Efficacy|1|||
161892846|NCT00435019|584655163|FG001|Overall Study|Lack of Efficacy|2|||
161892847|NCT00435019|584655162|FG000|Overall Study|Protocol Violation|3|||
161892848|NCT00435019|584655163|FG001|Overall Study|Protocol Violation|1|||
161892849|NCT00435019|584655162|FG000|Overall Study|Personal reasons for withdrawal|8|||
161892850|NCT00435019|584655163|FG001|Overall Study|Personal reasons for withdrawal|7|||
161892851|NCT04503668|584655164|FG000|Overall Study|Incomplete data|4|||
161892852|NCT04503668|584655165|FG001|Overall Study|Incomplete data|3|||
161892853|NCT04503668|584655164|FG000|Overall Study|Withdrawal by Subject|1|||
161892854|NCT04503668|584655165|FG001|Overall Study|Withdrawal by Subject|1|||
161892855|NCT04503668|584655164|FG000|Overall Study|Adverse Event|2|||
161892856|NCT04503668|584655165|FG001|Overall Study|Adverse Event|0|||
161892857|NCT02306694|584655166|FG000|Overall Study|Withdrawal by Subject|3|||
161892858|NCT02306694|584655166|FG000|Overall Study|Lost to Follow-up|1|||
161892859|NCT00603382|584655167|FG000|Overall Study|Adverse Event|0|||
161892860|NCT00603382|584655168|FG001|Overall Study|Adverse Event|1|||
161892861|NCT00603382|584655169|FG002|Overall Study|Adverse Event|1|||
161892862|NCT00603382|584655170|FG003|Overall Study|Adverse Event|2|||
161892863|NCT00603382|584655171|FG004|Overall Study|Adverse Event|1|||
161892864|NCT00603382|584655172|FG005|Overall Study|Adverse Event|2|||
161892865|NCT00603382|584655167|FG000|Overall Study|Lack of Efficacy|14|||
161892866|NCT00603382|584655168|FG001|Overall Study|Lack of Efficacy|9|||
161892867|NCT00603382|584655169|FG002|Overall Study|Lack of Efficacy|3|||
161892868|NCT00603382|584655170|FG003|Overall Study|Lack of Efficacy|6|||
161892869|NCT00603382|584655171|FG004|Overall Study|Lack of Efficacy|6|||
161892870|NCT00603382|584655172|FG005|Overall Study|Lack of Efficacy|11|||
161892871|NCT00603382|584655167|FG000|Overall Study|Protocol Violation|1|||
161892872|NCT00603382|584655168|FG001|Overall Study|Protocol Violation|0|||
161892873|NCT00603382|584655169|FG002|Overall Study|Protocol Violation|1|||
161892874|NCT00603382|584655170|FG003|Overall Study|Protocol Violation|2|||
161892875|NCT00603382|584655171|FG004|Overall Study|Protocol Violation|1|||
161892876|NCT00603382|584655172|FG005|Overall Study|Protocol Violation|0|||
161892877|NCT00603382|584655167|FG000|Overall Study|Lost to Follow-up|0|||
161892878|NCT00603382|584655168|FG001|Overall Study|Lost to Follow-up|1|||
161892879|NCT00603382|584655169|FG002|Overall Study|Lost to Follow-up|1|||
161892880|NCT00603382|584655170|FG003|Overall Study|Lost to Follow-up|1|||
161892881|NCT00603382|584655171|FG004|Overall Study|Lost to Follow-up|0|||
161892882|NCT00603382|584655172|FG005|Overall Study|Lost to Follow-up|1|||
161892883|NCT00603382|584655167|FG000|Overall Study|Physician Decision|0|||
161892884|NCT00603382|584655168|FG001|Overall Study|Physician Decision|0|||
161892885|NCT00603382|584655169|FG002|Overall Study|Physician Decision|2|||
161892886|NCT00603382|584655170|FG003|Overall Study|Physician Decision|0|||
161892887|NCT00603382|584655171|FG004|Overall Study|Physician Decision|1|||
161892888|NCT00603382|584655172|FG005|Overall Study|Physician Decision|3|||
161892889|NCT00603382|584655167|FG000|Overall Study|Withdrawal by Subject|3|||
161892890|NCT00603382|584655168|FG001|Overall Study|Withdrawal by Subject|3|||
161892891|NCT00603382|584655169|FG002|Overall Study|Withdrawal by Subject|1|||
161892892|NCT00603382|584655170|FG003|Overall Study|Withdrawal by Subject|1|||
161892893|NCT00603382|584655171|FG004|Overall Study|Withdrawal by Subject|0|||
161892894|NCT00603382|584655172|FG005|Overall Study|Withdrawal by Subject|1|||
161892895|NCT01078298|584655175|FG000|Overall Study|Lost to Follow-up|12|||
161892896|NCT01078298|584655176|FG001|Overall Study|Lost to Follow-up|13|||
161892897|NCT01078298|584655175|FG000|Overall Study|Withdrawal by Subject|31|||
161892898|NCT01078298|584655176|FG001|Overall Study|Withdrawal by Subject|33|||
161892899|NCT01078298|584655175|FG000|Overall Study|Protocol Violation|6|||
161892900|NCT01078298|584655176|FG001|Overall Study|Protocol Violation|6|||
161892901|NCT01078298|584655175|FG000|Overall Study|Adverse Event|6|||
161892902|NCT01078298|584655176|FG001|Overall Study|Adverse Event|5|||
161892903|NCT01078298|584655175|FG000|Overall Study|Death|2|||
161892904|NCT01078298|584655176|FG001|Overall Study|Death|0|||
161892905|NCT01078298|584655175|FG000|Overall Study|Did not meet entrance criteria|0|||
161892906|NCT01078298|584655176|FG001|Overall Study|Did not meet entrance criteria|1|||
161892907|NCT01078298|584655175|FG000|Overall Study|Other|24|||
161892908|NCT01078298|584655176|FG001|Overall Study|Other|32|||
161892909|NCT00742027|584655177|FG000|Overall Study|Disease Progression|76|||
161892910|NCT00742027|584655177|FG000|Overall Study|New Cancer Therapy|19|||
161892911|NCT00742027|584655177|FG000|Overall Study|Withdrawal by Subject|18|||
161892912|NCT00742027|584655177|FG000|Overall Study|Death|7|||
161892913|NCT00742027|584655177|FG000|Overall Study|Lost to Follow-up|4|||
161892914|NCT00742027|584655177|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
161892915|NCT00742027|584655177|FG000|Overall Study|Missing|2|||
161892916|NCT00742027|584655177|FG000|Overall Study|Administrative Problems|1|||
161892917|NCT01180049|584655178|FG000|Overall Study|Other|9|||
161892918|NCT01180049|584655179|FG001|Overall Study|Other|7|||
161892919|NCT01180049|584655178|FG000|Overall Study|Lost to Follow-up|8|||
161892920|NCT01180049|584655179|FG001|Overall Study|Lost to Follow-up|6|||
161892921|NCT01180049|584655178|FG000|Overall Study|Death|36|||
161892922|NCT01180049|584655179|FG001|Overall Study|Death|35|||
161892923|NCT01764659|584655180|FG000|Overall Study|Death|1|||
161892924|NCT01764659|584655180|FG000|Overall Study|Physician Decision|1|||
161892925|NCT01210352|584655181|FG000|Overall Study|Adverse Event|0|||
161892926|NCT01210352|584655182|FG001|Overall Study|Adverse Event|0|||
161892927|NCT01210352|584655183|FG002|Overall Study|Adverse Event|0|||
161892928|NCT01210352|584655184|FG003|Overall Study|Adverse Event|0|||
161892929|NCT01210352|584655185|FG004|Overall Study|Adverse Event|0|||
161892930|NCT01210352|584655186|FG005|Overall Study|Adverse Event|0|||
161892931|NCT01210352|584655187|FG006|Overall Study|Adverse Event|0|||
161892932|NCT01210352|584655188|FG007|Overall Study|Adverse Event|2|||
161892933|NCT01210352|584655189|FG008|Overall Study|Adverse Event|1|||
161892934|NCT01210352|584655181|FG000|Overall Study|Lack of Efficacy|0|||
161892935|NCT01210352|584655182|FG001|Overall Study|Lack of Efficacy|0|||
161892936|NCT01210352|584655183|FG002|Overall Study|Lack of Efficacy|0|||
161892937|NCT01210352|584655184|FG003|Overall Study|Lack of Efficacy|0|||
161892938|NCT01210352|584655185|FG004|Overall Study|Lack of Efficacy|0|||
161892939|NCT01210352|584655186|FG005|Overall Study|Lack of Efficacy|0|||
161892940|NCT01210352|584655187|FG006|Overall Study|Lack of Efficacy|1|||
161892941|NCT01210352|584655188|FG007|Overall Study|Lack of Efficacy|0|||
161892942|NCT01210352|584655189|FG008|Overall Study|Lack of Efficacy|0|||
161892943|NCT01210352|584655181|FG000|Overall Study|Physician Decision|0|||
161892944|NCT01210352|584655182|FG001|Overall Study|Physician Decision|0|||
161892945|NCT01210352|584655183|FG002|Overall Study|Physician Decision|0|||
161892946|NCT01210352|584655184|FG003|Overall Study|Physician Decision|0|||
161892947|NCT01210352|584655185|FG004|Overall Study|Physician Decision|0|||
161892948|NCT01210352|584655186|FG005|Overall Study|Physician Decision|0|||
161892949|NCT01210352|584655187|FG006|Overall Study|Physician Decision|0|||
161892950|NCT01210352|584655188|FG007|Overall Study|Physician Decision|1|||
161892951|NCT01210352|584655189|FG008|Overall Study|Physician Decision|2|||
161892952|NCT01210352|584655181|FG000|Overall Study|Withdrawal by Subject|0|||
161892953|NCT01210352|584655182|FG001|Overall Study|Withdrawal by Subject|0|||
161892954|NCT01210352|584655183|FG002|Overall Study|Withdrawal by Subject|1|||
161892955|NCT01210352|584655184|FG003|Overall Study|Withdrawal by Subject|0|||
161892956|NCT01210352|584655185|FG004|Overall Study|Withdrawal by Subject|0|||
161892957|NCT01210352|584655186|FG005|Overall Study|Withdrawal by Subject|0|||
161892958|NCT01210352|584655187|FG006|Overall Study|Withdrawal by Subject|1|||
161892959|NCT01210352|584655188|FG007|Overall Study|Withdrawal by Subject|0|||
161892960|NCT01210352|584655189|FG008|Overall Study|Withdrawal by Subject|1|||
161892961|NCT01210352|584655181|FG000|Overall Study|Patient Discharged Early|0|||
161892962|NCT01210352|584655182|FG001|Overall Study|Patient Discharged Early|0|||
161892963|NCT01210352|584655183|FG002|Overall Study|Patient Discharged Early|1|||
161892964|NCT01210352|584655184|FG003|Overall Study|Patient Discharged Early|0|||
161892965|NCT01210352|584655185|FG004|Overall Study|Patient Discharged Early|0|||
161892966|NCT01210352|584655186|FG005|Overall Study|Patient Discharged Early|0|||
161892967|NCT01210352|584655187|FG006|Overall Study|Patient Discharged Early|0|||
161892968|NCT01210352|584655188|FG007|Overall Study|Patient Discharged Early|0|||
161892969|NCT01210352|584655189|FG008|Overall Study|Patient Discharged Early|0|||
161892970|NCT03338569|584655190|FG000|Overall Study|Physician Decision|8|||
161892971|NCT03338569|584655191|FG001|Overall Study|Physician Decision|3|||
161892972|NCT03338569|584655190|FG000|Overall Study|Withdrawal by Subject|0|||
161892973|NCT03338569|584655191|FG001|Overall Study|Withdrawal by Subject|1|||
161892974|NCT03338569|584655190|FG000|Overall Study|Lost to Follow-up|0|||
161892975|NCT03338569|584655191|FG001|Overall Study|Lost to Follow-up|1|||
161892976|NCT02526160|584656768|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
161892977|NCT02526160|584656769|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
161892978|NCT02526160|584656768|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
161892979|NCT02526160|584656769|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
161892980|NCT02526160|584656768|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
161892981|NCT02526160|584656769|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
161892982|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Death|0|||
161892983|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Death|1|||
161892984|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
161892985|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
161892986|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
161892987|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
161892988|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
161892989|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
161892990|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
161892991|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
161892992|NCT04227405|584656770|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
161892993|NCT04227405|584656771|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
161892994|NCT04227405|584656770|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
161892995|NCT04227405|584656771|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
161892996|NCT04227405|584656770|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
161892997|NCT04227405|584656771|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
161892998|NCT01502956|584656772|FG000|Overall Study|Death|0|||
161892999|NCT01502956|584656773|FG001|Overall Study|Death|2|||
161893000|NCT01502956|584656772|FG000|Overall Study|Lost to Follow-up|14|||
161893001|NCT01502956|584656773|FG001|Overall Study|Lost to Follow-up|11|||
161893002|NCT01502956|584656772|FG000|Overall Study|Physician Decision|2|||
161893003|NCT01502956|584656773|FG001|Overall Study|Physician Decision|3|||
161893004|NCT01502956|584656772|FG000|Overall Study|Withdrawal by Subject|8|||
161893005|NCT01502956|584656773|FG001|Overall Study|Withdrawal by Subject|10|||
161893006|NCT01616758|584656774|FG000|Overall Study|Adverse Event|1|||
161893007|NCT01616758|584656774|FG000|Overall Study|Withdrawal by Subject|2|||
161893008|NCT01616758|584656774|FG000|Overall Study|Disease progression|18|||
161893009|NCT01616758|584656774|FG000|Overall Study|Study termination by Sponsor|1|||
161893010|NCT04076319|584656779|FG000|Overall Study|Withdrawal by Subject|2|||
161893011|NCT04076319|584656780|FG001|Overall Study|Withdrawal by Subject|0|||
161893012|NCT04076319|584656779|FG000|Overall Study|Death|1|||
161893013|NCT04076319|584656780|FG001|Overall Study|Death|0|||
161893014|NCT01054222|584656781|FG000|Overall Study|Lack of Efficacy|1|||
161893015|NCT01054222|584656781|FG000|Overall Study|Lost to Follow-up|4|||
161893016|NCT01054222|584656781|FG000|Overall Study|Withdrawal by Subject|6|||
161893017|NCT03252145|584656785|FG000|Overall Study|Withdrawal by Subject|1|||
161893018|NCT03252145|584656786|FG001|Overall Study|Withdrawal by Subject|0|||
161893019|NCT03252145|584656785|FG000|Overall Study|Complicating Disease|1|||
161893020|NCT03252145|584656786|FG001|Overall Study|Complicating Disease|2|||
161893021|NCT01763827|584656790|FG000|Overall Study|Withdrawal by Subject|1|||
161893022|NCT01763827|584656791|FG001|Overall Study|Withdrawal by Subject|0|||
161893023|NCT01763827|584656792|FG002|Overall Study|Withdrawal by Subject|0|||
161893024|NCT01763827|584656793|FG003|Overall Study|Withdrawal by Subject|0|||
161893025|NCT01763827|584656794|FG004|Overall Study|Withdrawal by Subject|2|||
161893026|NCT01763827|584656795|FG005|Overall Study|Withdrawal by Subject|0|||
161893027|NCT01763827|584656790|FG000|Overall Study|Decision by sponsor|2|||
161893028|NCT01763827|584656791|FG001|Overall Study|Decision by sponsor|0|||
161893029|NCT01763827|584656792|FG002|Overall Study|Decision by sponsor|3|||
161893030|NCT01763827|584656793|FG003|Overall Study|Decision by sponsor|0|||
161893031|NCT01763827|584656794|FG004|Overall Study|Decision by sponsor|2|||
161893032|NCT01763827|584656795|FG005|Overall Study|Decision by sponsor|1|||
161893033|NCT01763827|584656790|FG000|Overall Study|Lost to Follow-up|0|||
161893034|NCT01763827|584656791|FG001|Overall Study|Lost to Follow-up|1|||
161893035|NCT01763827|584656792|FG002|Overall Study|Lost to Follow-up|1|||
161893036|NCT01763827|584656793|FG003|Overall Study|Lost to Follow-up|1|||
161893037|NCT01763827|584656794|FG004|Overall Study|Lost to Follow-up|2|||
161893038|NCT01763827|584656795|FG005|Overall Study|Lost to Follow-up|1|||
161893039|NCT02187029|584656798|FG000|Overall Study|Adverse Event|0|||
161893040|NCT02187029|584656799|FG001|Overall Study|Adverse Event|1|||
161893041|NCT02187029|584656800|FG002|Overall Study|Adverse Event|1|||
161893042|NCT02187029|584656801|FG003|Overall Study|Adverse Event|0|||
161893043|NCT02187029|584656798|FG000|Overall Study|Study Terminated by Sponsor|0|||
161893044|NCT02187029|584656799|FG001|Overall Study|Study Terminated by Sponsor|0|||
161893045|NCT02187029|584656800|FG002|Overall Study|Study Terminated by Sponsor|10|||
161893046|NCT02187029|584656801|FG003|Overall Study|Study Terminated by Sponsor|3|||
161893047|NCT02187029|584656798|FG000|Overall Study|Withdrawal by Subject|1|||
161893048|NCT02187029|584656799|FG001|Overall Study|Withdrawal by Subject|0|||
161893049|NCT02187029|584656800|FG002|Overall Study|Withdrawal by Subject|0|||
161893050|NCT02187029|584656801|FG003|Overall Study|Withdrawal by Subject|0|||
161893051|NCT02985021|584656802|FG000|Overall Study|Inability to comply with study procedures|1|||
161893052|NCT04105842|584656803|FG000|Overall Study|Withdrawal by Subject|2|||
161893053|NCT01535443|584656809|FG000|Overall Study|Physician Decision|3|||
161893054|NCT00760487|584656811|FG000|Overall Study|Unilateral implantation|3|||
161893055|NCT02260817|584656815|FG000|Overall Study|Lost to Follow-up|0|||
161893056|NCT02260817|584656816|FG001|Overall Study|Lost to Follow-up|14|||
161893057|NCT02260817|584656815|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
161893058|NCT02260817|584656816|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
161893059|NCT02260817|584656815|FG000|Overall Study|Observation, no biopsy|0|||
161893060|NCT02260817|584656816|FG001|Overall Study|Observation, no biopsy|1|||
161893061|NCT02260817|584656815|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
161893062|NCT02260817|584656816|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
161893063|NCT02260817|584656815|FG000|Overall Study|Protocol Violation|0|||
161893064|NCT02260817|584656816|FG001|Overall Study|Protocol Violation|14|||
161893065|NCT03299101|584656817|FG000|Overall Study|Lost to Follow-up|1|||
161893066|NCT03299101|584656817|FG000|Overall Study|Withdrawal by Subject|5|||
161893067|NCT03299101|584656817|FG000|Overall Study|Surgery was changed|3|||
161893068|NCT03299101|584656817|FG000|Overall Study|Not enough time to complete prehab|1|||
161893069|NCT04217317|584656820|FG000|Overall Study|Lack of Efficacy|4|||
161893070|NCT04217317|584656820|FG000|Overall Study|Physician Decision|1|||
161893071|NCT00329745|584656821|FG000|Overall Study|Protocol Violation|1|||
161893072|NCT00329745|584656822|FG001|Overall Study|Protocol Violation|0|||
161893073|NCT00329745|584656821|FG000|Overall Study|Withdrawal by Subject|0|||
161893074|NCT00329745|584656822|FG001|Overall Study|Withdrawal by Subject|1|||
161893075|NCT00329745|584656821|FG000|Overall Study|Lost to Follow-up|86|||
161893076|NCT00329745|584656822|FG001|Overall Study|Lost to Follow-up|101|||
161893077|NCT03146741|584656823|FG000|Overall Study|Txp with non-HCV+ heart|4|||
161893078|NCT03146741|584656823|FG000|Overall Study|Listeted for MOT|2|||
161893079|NCT03146741|584656823|FG000|Overall Study|Physician Decision|2|||
161893080|NCT03146741|584656823|FG000|Overall Study|Awaiting txp|2|||
161893081|NCT03224624|584656824|FG000|Overall Study|Lost to Follow-up|9|||
161893082|NCT03224624|584656825|FG001|Overall Study|Lost to Follow-up|4|||
161893083|NCT03224624|584656824|FG000|Overall Study|Death|1|||
161893084|NCT03224624|584656825|FG001|Overall Study|Death|0|||
161893085|NCT01424241|584656828|FG000|Overall Study|Withdrawal by Subject|1|||
161893086|NCT01424241|584656828|FG000|Overall Study|Time constraints|2|||
161893087|NCT03585712|584656836|FG000|Treatment Period 1|Protocol Violation|1|||
161893088|NCT03585712|584656837|FG001|Treatment Period 1|Protocol Violation|0|||
161893089|NCT03585712|584656838|FG002|Treatment Period 1|Protocol Violation|0|||
161893090|NCT03585712|584656836|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
161893091|NCT03585712|584656837|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
161893092|NCT03585712|584656838|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
161893093|NCT03585712|584656836|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
161893094|NCT03585712|584656837|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
161893095|NCT03585712|584656838|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
161893096|NCT03585712|584656836|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
161893097|NCT03585712|584656837|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
161893098|NCT03585712|584656838|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
161893099|NCT03517449|584656839|FG000|Overall Study|Death|184|||
161893100|NCT03517449|584656840|FG001|Overall Study|Death|236|||
161893101|NCT03517449|584656839|FG000|Overall Study|Lost to Follow-up|0|||
161893102|NCT03517449|584656840|FG001|Overall Study|Lost to Follow-up|2|||
161893103|NCT03517449|584656839|FG000|Overall Study|Withdrawal by Subject|7|||
161893104|NCT03517449|584656840|FG001|Overall Study|Withdrawal by Subject|26|||
161893105|NCT03517449|584656839|FG000|Overall Study|Participants Ongoing|220|||
161893106|NCT03517449|584656840|FG001|Overall Study|Participants Ongoing|152|||
161893107|NCT02347072|584656844|FG000|Overall Study|Adverse Event|2|||
161893108|NCT02347072|584656844|FG000|Overall Study|Withdrawal by Subject|6|||
161893109|NCT02347072|584656844|FG000|Overall Study|Physician Decision|1|||
161893110|NCT02347072|584656844|FG000|Overall Study|Lost to Follow-up|2|||
161893111|NCT02347072|584656844|FG000|Overall Study|Protocol Violation|1|||
161893112|NCT02347072|584656844|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
161893113|NCT03230838|584656849|FG000|Overall Study|Withdrawal by Subject|3|||
161893114|NCT03230838|584656850|FG001|Overall Study|Withdrawal by Subject|0|||
161893115|NCT03230838|584656849|FG000|Overall Study|Temperature excursion|1|||
161893116|NCT03230838|584656850|FG001|Overall Study|Temperature excursion|0|||
161893117|NCT02324699|584656851|FG000|Overall Study|study terminated|1|||
161893118|NCT01607346|584656852|FG000|Overall Study|Adverse Event|3|||
161893119|NCT01098162|584656853|FG000|Overall Study|Adverse Event|37|||
161893120|NCT01098162|584656853|FG000|Overall Study|Lack of Efficacy|4|||
161893121|NCT01098162|584656853|FG000|Overall Study|Wish of Patient|7|||
161893122|NCT01098162|584656853|FG000|Overall Study|Lost to Follow-up|9|||
161893123|NCT01098162|584656853|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
161893124|NCT01098162|584656853|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
161893125|NCT01098162|584656853|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
161893126|NCT01098162|584656853|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
161893127|NCT01098162|584656853|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
161893128|NCT01098162|584656853|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
161893129|NCT01098162|584656853|FG000|Overall Study|Other Reason|1|||
161893130|NCT01098162|584656853|FG000|Overall Study|Reason Unknown|26|||
161893131|NCT01605825|584656854|FG000|Overall Study|Adverse Event|4|||
161893132|NCT01605825|584656855|FG001|Overall Study|Adverse Event|2|||
161893133|NCT01605825|584656854|FG000|Overall Study|Withdrawal by Subject|0|||
161893134|NCT01605825|584656855|FG001|Overall Study|Withdrawal by Subject|1|||
161893135|NCT01605825|584656854|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
161893136|NCT01605825|584656855|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
161893137|NCT01605825|584656854|FG000|Overall Study|Non-Compliance with Protocol|3|||
161893138|NCT01605825|584656855|FG001|Overall Study|Non-Compliance with Protocol|0|||
161893139|NCT00380718|584656858|FG000|Overall Study|Adverse Event|1|||
161893140|NCT00380718|584656858|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
161893141|NCT04318132|584656859|FG000|Overall Study|Protocol Violation|0|||
161893142|NCT04318132|584656860|FG001|Overall Study|Protocol Violation|0|||
161893143|NCT04318132|584656861|FG002|Overall Study|Protocol Violation|3|||
161893144|NCT04318132|584656862|FG003|Overall Study|Protocol Violation|0|||
161893145|NCT02839876|584656864|FG000|Overall Study|Protocol Violation|10|||
161893146|NCT02839876|584656865|FG001|Overall Study|Protocol Violation|11|||
161893147|NCT01156051|584656866|FG000|Overall Study|Lost to Follow-up|1|||
161893148|NCT01156051|584656867|FG001|Overall Study|Lost to Follow-up|0|||
161893149|NCT01156051|584656866|FG000|Overall Study|patient not compliant with protocol|0|||
161893150|NCT01156051|584656867|FG001|Overall Study|patient not compliant with protocol|1|||
161893151|NCT03628716|584656868|FG000|Overall Study|Adverse Event|1|||
161893152|NCT03628716|584656869|FG001|Overall Study|Adverse Event|1|||
161893153|NCT03628716|584656868|FG000|Overall Study|Death|1|||
161893154|NCT03628716|584656869|FG001|Overall Study|Death|0|||
161893155|NCT03628716|584656868|FG000|Overall Study|Lack of Efficacy|15|||
161893156|NCT03628716|584656869|FG001|Overall Study|Lack of Efficacy|20|||
161893157|NCT03628716|584656868|FG000|Overall Study|Withdrawal by Subject|1|||
161893158|NCT03628716|584656869|FG001|Overall Study|Withdrawal by Subject|2|||
161893159|NCT03628716|584656868|FG000|Overall Study|Study Terminated by Sponsor|1|||
161893160|NCT03628716|584656869|FG001|Overall Study|Study Terminated by Sponsor|0|||
161893161|NCT02620384|584656870|FG000|Overall Study|Adverse Event|2|||
161893162|NCT02620384|584656871|FG001|Overall Study|Adverse Event|1|||
161893163|NCT02620384|584656870|FG000|Overall Study|Discharged prior to 2nd dose|2|||
161893164|NCT02620384|584656871|FG001|Overall Study|Discharged prior to 2nd dose|5|||
161893165|NCT02620384|584656870|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
161893166|NCT02620384|584656871|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
161893167|NCT00094536|584656872|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
161893168|NCT00094536|584656872|FG000|Treatment and Follow-up|Adverse Event|4|||
161893169|NCT00094536|584656872|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
161893170|NCT00094536|584656872|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
161893171|NCT00094536|584656872|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
161893172|NCT00094536|584656872|FG000|Treatment and Follow-up|Subject non-compliance|9|||
161893173|NCT00094536|584656872|FG000|Treatment and Follow-up|Unable to attend visits|1|||
161893174|NCT02101359|584656873|FG000|Overall Study|Not included|23|||
161893175|NCT02101359|584656874|FG001|Overall Study|Not included|13|||
161893176|NCT02101359|584656873|FG000|Overall Study|Withdrawal by Subject|5|||
161893177|NCT02101359|584656874|FG001|Overall Study|Withdrawal by Subject|4|||
161893178|NCT02101359|584656873|FG000|Overall Study|Lost to Follow-up|1|||
161893179|NCT02101359|584656874|FG001|Overall Study|Lost to Follow-up|0|||
161893180|NCT02101359|584656873|FG000|Overall Study|Protocol Violation|0|||
161893181|NCT02101359|584656874|FG001|Overall Study|Protocol Violation|2|||
161893182|NCT00494221|584656875|FG000|Overall Study|Death|15|||
161893183|NCT00494221|584656876|FG001|Overall Study|Death|9|||
161893184|NCT00494221|584656877|FG002|Overall Study|Death|14|||
161893185|NCT00494221|584656875|FG000|Overall Study|Withdrawal by Subject|1|||
161893186|NCT00494221|584656876|FG001|Overall Study|Withdrawal by Subject|2|||
161893187|NCT00494221|584656877|FG002|Overall Study|Withdrawal by Subject|0|||
161893188|NCT01900431|584656881|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
161893189|NCT01900431|584656882|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
161893190|NCT01900431|584656883|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
161893191|NCT01900431|584656881|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
161893192|NCT01900431|584656882|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
161893193|NCT01900431|584656883|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
161893194|NCT01900431|584656881|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
161893195|NCT01900431|584656882|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
161893196|NCT01900431|584656883|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
161893197|NCT01900431|584656881|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
161893198|NCT01900431|584656882|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
161893199|NCT01900431|584656883|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
161893200|NCT01900431|584656881|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
161893201|NCT01900431|584656882|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
161893202|NCT01900431|584656883|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
161893203|NCT01900431|584656881|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
161893204|NCT01900431|584656882|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
161893205|NCT01900431|584656883|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
161893206|NCT01900431|584656881|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
161893207|NCT01900431|584656882|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
161893208|NCT01900431|584656883|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
161893209|NCT01900431|584656881|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
161893210|NCT01900431|584656882|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
161893211|NCT01900431|584656883|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
161893212|NCT01900431|584656881|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
161893213|NCT01900431|584656882|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
161893214|NCT01900431|584656883|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
161893215|NCT01841567|584656884|FG000|Overall Study|Adverse Event|3|||
161893216|NCT03172364|584656885|FG000|Overall Study|Adverse Event|1|||
161893217|NCT03172364|584656886|FG001|Overall Study|Adverse Event|1|||
161893218|NCT03172364|584656885|FG000|Overall Study|Protocol Violation|1|||
161893219|NCT03172364|584656886|FG001|Overall Study|Protocol Violation|0|||
161893220|NCT02732327|584656887|FG000|Overall Study|Protocol Violation|0|||
161893221|NCT02732327|584656888|FG001|Overall Study|Protocol Violation|1|||
161893222|NCT00659776|584656893|FG000|Overall Study|Withdrawal by Subject|12|||
161893223|NCT00659776|584656894|FG001|Overall Study|Withdrawal by Subject|2|||
161893224|NCT00659776|584656895|FG002|Overall Study|Withdrawal by Subject|0|||
161363506|NCT00866775|582719934|FG000|Overall Study|Adverse Event|5|||
161363507|NCT00866775|582719935|FG001|Overall Study|Adverse Event|19|||
161363508|NCT00866775|582719934|FG000|Overall Study|Death|1|||
161363509|NCT00866775|582719935|FG001|Overall Study|Death|0|||
161363510|NCT00866775|582719934|FG000|Overall Study|Lost to Follow-up|0|||
161363511|NCT00866775|582719935|FG001|Overall Study|Lost to Follow-up|4|||
161363512|NCT00866775|582719934|FG000|Overall Study|Physician Decision|0|||
161363513|NCT00866775|582719935|FG001|Overall Study|Physician Decision|3|||
161363514|NCT00866775|582719934|FG000|Overall Study|Protocol Violation|3|||
161363515|NCT00866775|582719935|FG001|Overall Study|Protocol Violation|4|||
161363516|NCT00866775|582719934|FG000|Overall Study|Withdrawal by Subject|4|||
161363517|NCT00866775|582719935|FG001|Overall Study|Withdrawal by Subject|4|||
161363518|NCT00866775|582719934|FG000|Overall Study|met exit criteria|23|||
161363519|NCT00866775|582719935|FG001|Overall Study|met exit criteria|17|||
161363520|NCT00866775|582719934|FG000|Overall Study|discontinued due to communication error|0|||
161363521|NCT00866775|582719935|FG001|Overall Study|discontinued due to communication error|1|||
161363522|NCT00833703|582719936|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
161363523|NCT00833703|582719937|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
161363524|NCT00003907|582719938|FG000|Overall Study|Adverse Event|2|||
161363525|NCT00003907|582719939|FG001|Overall Study|Adverse Event|11|||
161363526|NCT00003907|582719938|FG000|Overall Study|Death|2|||
161363527|NCT00003907|582719939|FG001|Overall Study|Death|0|||
161363528|NCT00003907|582719938|FG000|Overall Study|Withdrawal by Subject|1|||
161363529|NCT00003907|582719939|FG001|Overall Study|Withdrawal by Subject|3|||
161363530|NCT00003907|582719938|FG000|Overall Study|Progressive disease|4|||
161363531|NCT00003907|582719939|FG001|Overall Study|Progressive disease|4|||
161363532|NCT00003907|582719938|FG000|Overall Study|Complicating disease|1|||
161363533|NCT00003907|582719939|FG001|Overall Study|Complicating disease|0|||
161363534|NCT00003907|582719938|FG000|Overall Study|Other|1|||
161363535|NCT00003907|582719939|FG001|Overall Study|Other|3|||
161363536|NCT00003907|582719938|FG000|Overall Study|ineligible or not treated|2|||
161363537|NCT00003907|582719939|FG001|Overall Study|ineligible or not treated|2|||
161363552|NCT01682720|582719962|FG000|Overall Study|Randomized but Not Treated|0|||
161363553|NCT01682720|582719963|FG001|Overall Study|Randomized but Not Treated|1|||
161363554|NCT01682720|582719964|FG002|Overall Study|Randomized but Not Treated|1|||
161363555|NCT01682720|582719965|FG003|Overall Study|Randomized but Not Treated|0|||
161363556|NCT01682720|582719962|FG000|Overall Study|Terminated by Sponsor|83|||
161363557|NCT01682720|582719963|FG001|Overall Study|Terminated by Sponsor|0|||
161363558|NCT01682720|582719964|FG002|Overall Study|Terminated by Sponsor|0|||
161363559|NCT01682720|582719965|FG003|Overall Study|Terminated by Sponsor|0|||
161363560|NCT01682720|582719962|FG000|Overall Study|Efficacy Failure|0|||
161363561|NCT01682720|582719963|FG001|Overall Study|Efficacy Failure|3|||
161363562|NCT01682720|582719964|FG002|Overall Study|Efficacy Failure|3|||
161363563|NCT01682720|582719965|FG003|Overall Study|Efficacy Failure|30|||
161363564|NCT01682720|582719962|FG000|Overall Study|Lost to Follow-up|1|||
161363565|NCT01682720|582719963|FG001|Overall Study|Lost to Follow-up|1|||
161363566|NCT01682720|582719964|FG002|Overall Study|Lost to Follow-up|0|||
161363567|NCT01682720|582719965|FG003|Overall Study|Lost to Follow-up|6|||
161363568|NCT01682720|582719962|FG000|Overall Study|Subject Withdrew Consent|0|||
161363569|NCT01682720|582719963|FG001|Overall Study|Subject Withdrew Consent|0|||
161363570|NCT01682720|582719964|FG002|Overall Study|Subject Withdrew Consent|2|||
161363571|NCT01682720|582719965|FG003|Overall Study|Subject Withdrew Consent|2|||
161363572|NCT01682720|582719962|FG000|Overall Study|Adverse Event|1|||
161363573|NCT01682720|582719963|FG001|Overall Study|Adverse Event|0|||
161363574|NCT01682720|582719964|FG002|Overall Study|Adverse Event|1|||
161363575|NCT01682720|582719965|FG003|Overall Study|Adverse Event|1|||
161363576|NCT01687595|582719966|FG000|Overall Study|Withdrawal by Subject|8|||
161363577|NCT01687595|582719967|FG001|Overall Study|Withdrawal by Subject|0|||
161363578|NCT01687595|582719966|FG000|Overall Study|Lost to Follow-up|3|||
161363579|NCT01687595|582719967|FG001|Overall Study|Lost to Follow-up|1|||
161363580|NCT01687595|582719966|FG000|Overall Study|Investigator's decision|1|||
161363581|NCT01687595|582719967|FG001|Overall Study|Investigator's decision|0|||
161363582|NCT01687595|582719966|FG000|Overall Study|Sponsor's decision|1|||
161363583|NCT01687595|582719967|FG001|Overall Study|Sponsor's decision|0|||
161363584|NCT01687595|582719966|FG000|Overall Study|Noncompliance|1|||
161363585|NCT01687595|582719967|FG001|Overall Study|Noncompliance|2|||
161363586|NCT01687595|582719966|FG000|Overall Study|Other than specified|56|||
161363587|NCT01687595|582719967|FG001|Overall Study|Other than specified|7|||
161363588|NCT04204902|582719968|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
161363589|NCT04204902|582719969|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
161363600|NCT03829683|582719974|FG000|Overall Study|Lost to Follow-up|1|||
161363601|NCT03829683|582719975|FG001|Overall Study|Lost to Follow-up|0|||
161363602|NCT03829683|582719974|FG000|Overall Study|Physician Decision|3|||
161363603|NCT03829683|582719975|FG001|Overall Study|Physician Decision|1|||
161363604|NCT03829683|582719974|FG000|Overall Study|Withdrawal by Subject|0|||
161363605|NCT03829683|582719975|FG001|Overall Study|Withdrawal by Subject|1|||
161363606|NCT03829683|582719974|FG000|Overall Study|Discharge from hospital|1|||
161363607|NCT03829683|582719975|FG001|Overall Study|Discharge from hospital|0|||
161363614|NCT00803049|582719985|FG000|Overall Study|Adverse Event|21|||
161363615|NCT00803049|582719986|FG001|Overall Study|Adverse Event|33|||
161363616|NCT00803049|582719987|FG002|Overall Study|Adverse Event|13|||
161363617|NCT00803049|582719988|FG003|Overall Study|Adverse Event|27|||
161363618|NCT00803049|582719985|FG000|Overall Study|Lack of Efficacy|10|||
161363619|NCT00803049|582719986|FG001|Overall Study|Lack of Efficacy|19|||
161363620|NCT00803049|582719987|FG002|Overall Study|Lack of Efficacy|6|||
161363621|NCT00803049|582719988|FG003|Overall Study|Lack of Efficacy|13|||
161363622|NCT00803049|582719985|FG000|Overall Study|Lost to Follow-up|0|||
161363623|NCT00803049|582719986|FG001|Overall Study|Lost to Follow-up|2|||
161363624|NCT00803049|582719987|FG002|Overall Study|Lost to Follow-up|0|||
161363625|NCT00803049|582719988|FG003|Overall Study|Lost to Follow-up|3|||
161363626|NCT00803049|582719985|FG000|Overall Study|Death|2|||
161363627|NCT00803049|582719986|FG001|Overall Study|Death|1|||
161363628|NCT00803049|582719987|FG002|Overall Study|Death|0|||
161363629|NCT00803049|582719988|FG003|Overall Study|Death|2|||
161363630|NCT00803049|582719985|FG000|Overall Study|Progressive Disease|6|||
161363631|NCT00803049|582719986|FG001|Overall Study|Progressive Disease|10|||
161363632|NCT00803049|582719987|FG002|Overall Study|Progressive Disease|6|||
161363633|NCT00803049|582719988|FG003|Overall Study|Progressive Disease|6|||
161363634|NCT00803049|582719985|FG000|Overall Study|Withdrawal by Subject|19|||
161363635|NCT00803049|582719986|FG001|Overall Study|Withdrawal by Subject|43|||
161363636|NCT00803049|582719987|FG002|Overall Study|Withdrawal by Subject|16|||
161363637|NCT00803049|582719988|FG003|Overall Study|Withdrawal by Subject|44|||
161363638|NCT00803049|582719985|FG000|Overall Study|Protocol Violation|0|||
161363639|NCT00803049|582719986|FG001|Overall Study|Protocol Violation|1|||
161363640|NCT00803049|582719987|FG002|Overall Study|Protocol Violation|1|||
161363641|NCT00803049|582719988|FG003|Overall Study|Protocol Violation|0|||
161363642|NCT00803049|582719985|FG000|Overall Study|Randomized and Not Treated|0|||
161363643|NCT00803049|582719986|FG001|Overall Study|Randomized and Not Treated|0|||
161363644|NCT00803049|582719987|FG002|Overall Study|Randomized and Not Treated|0|||
161363645|NCT00803049|582719988|FG003|Overall Study|Randomized and Not Treated|2|||
161363646|NCT00803049|582719985|FG000|Overall Study|Other than Specified Above|3|||
161363647|NCT00803049|582719986|FG001|Overall Study|Other than Specified Above|9|||
161363648|NCT00803049|582719987|FG002|Overall Study|Other than Specified Above|2|||
161363649|NCT00803049|582719988|FG003|Overall Study|Other than Specified Above|5|||
161363650|NCT01272219|582719989|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
161363651|NCT01272219|582719990|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
161363652|NCT01272219|582719991|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
161363653|NCT01272219|582719992|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
161363654|NCT01272219|582719993|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
161363655|NCT01272219|582719994|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
161363656|NCT01272219|582719989|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
161363657|NCT01272219|582719990|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
161363658|NCT01272219|582719991|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
161363659|NCT01272219|582719992|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
161363660|NCT01272219|582719993|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
161363661|NCT01272219|582719994|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
161363662|NCT01272219|582719989|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
161363663|NCT01272219|582719990|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
161363664|NCT01272219|582719991|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
161363665|NCT01272219|582719992|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
161363666|NCT01272219|582719993|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
161363667|NCT01272219|582719994|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
161363668|NCT01272219|582719989|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
161363669|NCT01272219|582719990|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
161363670|NCT01272219|582719991|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
161363671|NCT01272219|582719992|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
161363672|NCT01272219|582719993|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
161363673|NCT01272219|582719994|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
161363674|NCT01272219|582719989|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
161363675|NCT01272219|582719990|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
161363676|NCT01272219|582719991|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
161363677|NCT01272219|582719992|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
161363678|NCT01272219|582719993|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
161363679|NCT01272219|582719994|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
161363680|NCT01272219|582719989|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
161363681|NCT01272219|582719990|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
161363682|NCT01272219|582719991|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
161363683|NCT01272219|582719992|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
161363684|NCT01272219|582719993|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
161363685|NCT01272219|582719994|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
161363686|NCT01272219|582719989|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161363687|NCT01272219|582719990|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161363688|NCT01272219|582719991|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161363689|NCT01272219|582719992|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
161363690|NCT01272219|582719993|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161363691|NCT01272219|582719994|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161363692|NCT01272219|582719989|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161363693|NCT01272219|582719990|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
161363694|NCT01272219|582719991|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161363695|NCT01272219|582719992|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
161363696|NCT01272219|582719993|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161363697|NCT01272219|582719994|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161363698|NCT01272219|582719989|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
161363699|NCT01272219|582719990|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
161363700|NCT01272219|582719991|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
161363701|NCT01272219|582719992|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
161363702|NCT01272219|582719993|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
161363703|NCT01272219|582719994|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
161363704|NCT01272219|582719989|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
161363705|NCT01272219|582719990|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
161363706|NCT01272219|582719991|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
161363707|NCT01272219|582719992|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
161363708|NCT01272219|582719993|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
161363709|NCT01272219|582719994|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
161363710|NCT01272219|582719989|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
161363711|NCT01272219|582719990|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
161363712|NCT01272219|582719991|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
161363713|NCT01272219|582719992|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
161363714|NCT01272219|582719993|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
161363715|NCT01272219|582719994|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
161363716|NCT01272219|582719989|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161363717|NCT01272219|582719990|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161363718|NCT01272219|582719991|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161363719|NCT01272219|582719992|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161363720|NCT01272219|582719993|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
161363721|NCT01272219|582719994|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
161363722|NCT01272219|582719989|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161363723|NCT01272219|582719990|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161363724|NCT01272219|582719991|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161363725|NCT01272219|582719992|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161363726|NCT01272219|582719993|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
161363727|NCT01272219|582719994|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
161363728|NCT01272219|582719989|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161363729|NCT01272219|582719990|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161363730|NCT01272219|582719991|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161363731|NCT01272219|582719992|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161363732|NCT01272219|582719993|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
161363733|NCT01272219|582719994|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
161363734|NCT01272219|582719989|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
161363735|NCT01272219|582719990|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
161363736|NCT01272219|582719991|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
161363737|NCT01272219|582719992|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
161363738|NCT01272219|582719993|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
161363739|NCT01272219|582719994|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
161363740|NCT01272219|582719989|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
161363741|NCT01272219|582719990|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
161363742|NCT01272219|582719991|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
161363743|NCT01272219|582719992|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
161363744|NCT01272219|582719993|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
161363745|NCT01272219|582719994|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
161363746|NCT05021224|582720004|FG000|Overall Study|Did not complete all survey items|4|||
161363747|NCT05021224|582720005|FG001|Overall Study|Did not complete all survey items|1|||
161363748|NCT05021224|582720006|FG002|Overall Study|Did not complete all survey items|0|||
161363749|NCT05021224|582720007|FG003|Overall Study|Did not complete all survey items|2|||
161363750|NCT03973489|582720019|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
161363751|NCT03973489|582720020|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161363752|NCT03973489|582720021|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161363753|NCT03973489|582720022|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161363754|NCT03973489|582720023|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
161363755|NCT03973489|582720024|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161363756|NCT03973489|582720025|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161363757|NCT03973489|582720026|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161363758|NCT03973489|582720019|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161363759|NCT03973489|582720020|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161363760|NCT03973489|582720021|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161363761|NCT03973489|582720022|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
161363762|NCT03973489|582720023|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
161363763|NCT03973489|582720024|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161363764|NCT03973489|582720025|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161363765|NCT03973489|582720026|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161363766|NCT03973489|582720019|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
161363767|NCT03973489|582720020|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
161363768|NCT03973489|582720021|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
161363769|NCT03973489|582720022|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
161363770|NCT03973489|582720023|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
161363771|NCT03973489|582720024|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
161363772|NCT03973489|582720025|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
161363773|NCT03973489|582720026|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
161363774|NCT03973489|582720019|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
161363775|NCT03973489|582720020|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161363776|NCT03973489|582720021|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161363777|NCT03973489|582720022|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
161363778|NCT03973489|582720023|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161363779|NCT03973489|582720024|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161363780|NCT03973489|582720025|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161363781|NCT03973489|582720026|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161363782|NCT03973489|582720019|FG000|Second Intervention (1 Day)|Adverse Event|0|||
161363783|NCT03973489|582720020|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161363784|NCT03973489|582720021|FG002|Second Intervention (1 Day)|Adverse Event|0|||
161363785|NCT03973489|582720022|FG003|Second Intervention (1 Day)|Adverse Event|1|||
161363786|NCT03973489|582720023|FG004|Second Intervention (1 Day)|Adverse Event|0|||
161363787|NCT03973489|582720024|FG005|Second Intervention (1 Day)|Adverse Event|0|||
161363788|NCT03973489|582720025|FG006|Second Intervention (1 Day)|Adverse Event|0|||
161363789|NCT03973489|582720026|FG007|Second Intervention (1 Day)|Adverse Event|0|||
161363790|NCT03301415|582720027|FG000|Overall Study|Lost to Follow-up|2|||
161363791|NCT03301415|582720027|FG000|Overall Study|Unable to comply with visit schedule|2|||
161363792|NCT00392288|582720028|FG000|Overall Study|Adverse Event|17|||
161363793|NCT00392288|582720029|FG001|Overall Study|Adverse Event|7|||
161363794|NCT00392288|582720030|FG002|Overall Study|Adverse Event|8|||
161363795|NCT00392288|582720028|FG000|Overall Study|Lack of Efficacy|8|||
161363796|NCT00392288|582720029|FG001|Overall Study|Lack of Efficacy|5|||
161363797|NCT00392288|582720030|FG002|Overall Study|Lack of Efficacy|3|||
161363798|NCT00392288|582720028|FG000|Overall Study|Protocol Violation|1|||
161363799|NCT00392288|582720029|FG001|Overall Study|Protocol Violation|3|||
161363800|NCT00392288|582720030|FG002|Overall Study|Protocol Violation|1|||
161363801|NCT00392288|582720028|FG000|Overall Study|Lost to Follow-up|1|||
161363802|NCT00392288|582720029|FG001|Overall Study|Lost to Follow-up|1|||
161363803|NCT00392288|582720030|FG002|Overall Study|Lost to Follow-up|1|||
161363804|NCT00392288|582720028|FG000|Overall Study|Withdrawal by Subject|1|||
161363805|NCT00392288|582720029|FG001|Overall Study|Withdrawal by Subject|0|||
161363806|NCT00392288|582720030|FG002|Overall Study|Withdrawal by Subject|2|||
161363807|NCT00392288|582720028|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
161363851|NCT00553475|582720059|FG000|Overall Study|Adverse Event|7|||
161363852|NCT00553475|582720060|FG001|Overall Study|Adverse Event|17|||
161363853|NCT00553475|582720061|FG002|Overall Study|Adverse Event|13|||
161363854|NCT00553475|582720059|FG000|Overall Study|Lack of Efficacy|7|||
161363855|NCT00553475|582720060|FG001|Overall Study|Lack of Efficacy|1|||
161363856|NCT00553475|582720061|FG002|Overall Study|Lack of Efficacy|0|||
161363857|NCT00553475|582720059|FG000|Overall Study|Withdrawal by Subject|1|||
161363858|NCT00553475|582720060|FG001|Overall Study|Withdrawal by Subject|1|||
161363859|NCT00553475|582720061|FG002|Overall Study|Withdrawal by Subject|0|||
161363860|NCT00553475|582720059|FG000|Overall Study|Physician Decision|1|||
161363861|NCT00553475|582720060|FG001|Overall Study|Physician Decision|0|||
161363862|NCT00553475|582720061|FG002|Overall Study|Physician Decision|0|||
161363863|NCT00553475|582720059|FG000|Overall Study|Due to moving|0|||
161363864|NCT00553475|582720060|FG001|Overall Study|Due to moving|1|||
161363865|NCT00553475|582720061|FG002|Overall Study|Due to moving|0|||
161363922|NCT04101331|582721669|FG000|Overall Study|Adverse Event|9|||
161363923|NCT04101331|582721669|FG000|Overall Study|Disease progression|82|||
161363924|NCT04101331|582721669|FG000|Overall Study|Withdrawal by Subject|1|||
161363925|NCT04101331|582721669|FG000|Overall Study|Investigator decision|6|||
161363926|NCT04101331|582721669|FG000|Overall Study|Death|6|||
161363927|NCT04101331|582721669|FG000|Overall Study|Allogenic transplant|1|||
161363928|NCT02579759|582721674|FG000|Overall Study|Protocol Violation|2|||
161363929|NCT02579759|582721675|FG001|Overall Study|Protocol Violation|0|||
161363930|NCT02579759|582721676|FG002|Overall Study|Protocol Violation|0|||
161363931|NCT02579759|582721674|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
161363932|NCT02579759|582721675|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
161363933|NCT02579759|582721676|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
161363934|NCT02579759|582721674|FG000|Overall Study|BfArM hold|13|||
161363935|NCT02579759|582721675|FG001|Overall Study|BfArM hold|12|||
161363936|NCT02579759|582721676|FG002|Overall Study|BfArM hold|12|||
161363937|NCT02579759|582721674|FG000|Overall Study|Sponsor stopped Dose 2|0|||
161363938|NCT02579759|582721675|FG001|Overall Study|Sponsor stopped Dose 2|41|||
161363939|NCT02579759|582721676|FG002|Overall Study|Sponsor stopped Dose 2|0|||
161363940|NCT02579759|582721674|FG000|Overall Study|Non compliance|0|||
161363941|NCT02579759|582721675|FG001|Overall Study|Non compliance|1|||
161363942|NCT02579759|582721676|FG002|Overall Study|Non compliance|0|||
161363943|NCT02579759|582721674|FG000|Overall Study|Pregnancy|0|||
161363944|NCT02579759|582721675|FG001|Overall Study|Pregnancy|1|||
161363945|NCT02579759|582721676|FG002|Overall Study|Pregnancy|0|||
161363946|NCT02579759|582721674|FG000|Overall Study|Inclusion/exclusion criteria|0|||
161363947|NCT02579759|582721675|FG001|Overall Study|Inclusion/exclusion criteria|0|||
161363948|NCT02579759|582721676|FG002|Overall Study|Inclusion/exclusion criteria|1|||
161363949|NCT02579759|582721674|FG000|Overall Study|Adverse Event|4|||
161363950|NCT02579759|582721675|FG001|Overall Study|Adverse Event|3|||
161363951|NCT02579759|582721676|FG002|Overall Study|Adverse Event|1|||
161363952|NCT02579759|582721674|FG000|Overall Study|Withdrawal by Subject|3|||
161363953|NCT02579759|582721675|FG001|Overall Study|Withdrawal by Subject|3|||
161363954|NCT02579759|582721676|FG002|Overall Study|Withdrawal by Subject|5|||
161363955|NCT02579759|582721674|FG000|Overall Study|Lost to Follow-up|2|||
161363956|NCT02579759|582721675|FG001|Overall Study|Lost to Follow-up|2|||
161363957|NCT02579759|582721676|FG002|Overall Study|Lost to Follow-up|2|||
161363958|NCT01904279|582721679|FG000|Overall Study|Lack of Efficacy|2|||
161363959|NCT01904279|582721680|FG001|Overall Study|Lack of Efficacy|3|||
161363960|NCT01904279|582721679|FG000|Overall Study|Withdrawal by Subject|1|||
161363961|NCT01904279|582721680|FG001|Overall Study|Withdrawal by Subject|0|||
161363962|NCT03283241|582721683|FG000|Overall Study|Adverse Event|4|||
161363963|NCT03283241|582721684|FG001|Overall Study|Adverse Event|1|||
161363964|NCT03283241|582721683|FG000|Overall Study|Withdrawal by Subject|0|||
161363965|NCT03283241|582721684|FG001|Overall Study|Withdrawal by Subject|1|||
161363966|NCT03283241|582721683|FG000|Overall Study|Subject relocated to Finland|0|||
161363967|NCT03283241|582721684|FG001|Overall Study|Subject relocated to Finland|1|||
161363968|NCT02439957|582721685|FG000|Overall Study|Study Terminated|3|||
161363969|NCT02439957|582721686|FG001|Overall Study|Study Terminated|3|||
161363970|NCT00666263|582721687|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
161363971|NCT00666263|582721688|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
161363972|NCT00666263|582721687|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
161363973|NCT00666263|582721688|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
161363974|NCT00666263|582721687|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
161363975|NCT00666263|582721688|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
161363976|NCT00586157|582721689|FG000|First Intervention|Worsening behavior|1|||
161363977|NCT00586157|582721690|FG001|First Intervention|Worsening behavior|0|||
161363978|NCT00586157|582721689|FG000|Second Intervention|Withdrawal by Subject|1|||
161363979|NCT00586157|582721690|FG001|Second Intervention|Withdrawal by Subject|0|||
161363980|NCT00586157|582721689|FG000|Second Intervention|Worsening behavior|1|||
161363981|NCT00586157|582721690|FG001|Second Intervention|Worsening behavior|0|||
161363982|NCT00586157|582721689|FG000|Second Intervention|Adverse Event|0|||
161363983|NCT00586157|582721690|FG001|Second Intervention|Adverse Event|1|||
161363984|NCT00831389|582721691|FG000|Overall Study|Withdrawal by Subject|0|||
161363985|NCT00831389|582721692|FG001|Overall Study|Withdrawal by Subject|1|||
161363986|NCT00278161|582721694|FG000|Overall Study|Death|11|||
161363987|NCT01817777|582721695|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
161363988|NCT01817777|582721696|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
161363989|NCT01817777|582721697|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
161363990|NCT01817777|582721695|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
161363991|NCT01817777|582721696|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
161363992|NCT01817777|582721697|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
161363993|NCT01817777|582721695|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
161363994|NCT01817777|582721696|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
161363995|NCT01817777|582721697|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
161363996|NCT01817777|582721695|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
161363997|NCT01817777|582721696|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
161363998|NCT01817777|582721697|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
161363999|NCT01817777|582721695|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
161364000|NCT01817777|582721696|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
161364001|NCT01817777|582721697|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
161364002|NCT00414609|582721698|FG000|Core Study|Adverse Event|9|||
161364003|NCT00414609|582721699|FG001|Core Study|Adverse Event|11|||
161364004|NCT00414609|582721700|FG002|Core Study|Adverse Event|0|||
161364005|NCT00414609|582721698|FG000|Core Study|Abnormal laboratory values|0|||
161364006|NCT00414609|582721699|FG001|Core Study|Abnormal laboratory values|1|||
161364007|NCT00414609|582721700|FG002|Core Study|Abnormal laboratory values|0|||
161364008|NCT00414609|582721698|FG000|Core Study|Abnormal test procedure results|1|||
161364009|NCT00414609|582721699|FG001|Core Study|Abnormal test procedure results|1|||
161364010|NCT00414609|582721700|FG002|Core Study|Abnormal test procedure results|0|||
161364011|NCT00414609|582721698|FG000|Core Study|Protocol deviation|0|||
161364012|NCT00414609|582721699|FG001|Core Study|Protocol deviation|1|||
161364013|NCT00414609|582721700|FG002|Core Study|Protocol deviation|0|||
161364014|NCT00414609|582721698|FG000|Core Study|Patient withdrew consent|10|||
161364015|NCT00414609|582721699|FG001|Core Study|Patient withdrew consent|11|||
161364016|NCT00414609|582721700|FG002|Core Study|Patient withdrew consent|0|||
161364017|NCT00414609|582721698|FG000|Core Study|Lost to Follow-up|7|||
161364018|NCT00414609|582721699|FG001|Core Study|Lost to Follow-up|4|||
161364019|NCT00414609|582721700|FG002|Core Study|Lost to Follow-up|0|||
161364020|NCT00414609|582721698|FG000|Core Study|Administrative problems|0|||
161364021|NCT00414609|582721699|FG001|Core Study|Administrative problems|2|||
161364022|NCT00414609|582721700|FG002|Core Study|Administrative problems|0|||
161364023|NCT00414609|582721698|FG000|Core Study|Death|7|||
161364024|NCT00414609|582721699|FG001|Core Study|Death|14|||
161364025|NCT00414609|582721700|FG002|Core Study|Death|0|||
161364026|NCT00414609|582721698|FG000|Extension Study|Adverse Event|0|||
161364027|NCT00414609|582721699|FG001|Extension Study|Adverse Event|0|||
161364028|NCT00414609|582721700|FG002|Extension Study|Adverse Event|14|||
161364029|NCT00414609|582721698|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
161364030|NCT00414609|582721699|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
161364031|NCT00414609|582721700|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
161364032|NCT00414609|582721698|FG000|Extension Study|Withdrawal by Subject|0|||
161364033|NCT00414609|582721699|FG001|Extension Study|Withdrawal by Subject|0|||
161364034|NCT00414609|582721700|FG002|Extension Study|Withdrawal by Subject|13|||
161364035|NCT00414609|582721698|FG000|Extension Study|Lost to Follow-up|0|||
161364036|NCT00414609|582721699|FG001|Extension Study|Lost to Follow-up|0|||
161364037|NCT00414609|582721700|FG002|Extension Study|Lost to Follow-up|10|||
161364038|NCT00414609|582721698|FG000|Extension Study|Administrative problems|0|||
161364039|NCT00414609|582721699|FG001|Extension Study|Administrative problems|0|||
161364040|NCT00414609|582721700|FG002|Extension Study|Administrative problems|1|||
161364041|NCT00414609|582721698|FG000|Extension Study|Death|0|||
161364042|NCT00414609|582721699|FG001|Extension Study|Death|0|||
161364043|NCT00414609|582721700|FG002|Extension Study|Death|17|||
161364044|NCT01592747|582721706|FG000|Overall Study|Loss of Therapeutic Response|107|||
161364045|NCT01592747|582721707|FG001|Overall Study|Loss of Therapeutic Response|108|||
161364046|NCT01592747|582721708|FG002|Overall Study|Loss of Therapeutic Response|100|||
161364047|NCT01592747|582721706|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161364048|NCT01592747|582721707|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
161364049|NCT01592747|582721708|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
161364050|NCT01592747|582721706|FG000|Overall Study|Adverse Event|1|||
161364051|NCT01592747|582721707|FG001|Overall Study|Adverse Event|0|||
161364052|NCT01592747|582721708|FG002|Overall Study|Adverse Event|0|||
161364053|NCT01592747|582721706|FG000|Overall Study|Protocol Violation|4|||
161364054|NCT01592747|582721707|FG001|Overall Study|Protocol Violation|0|||
161364055|NCT01592747|582721708|FG002|Overall Study|Protocol Violation|4|||
161364056|NCT01592747|582721706|FG000|Overall Study|Lack of Efficacy|0|||
161364057|NCT01592747|582721707|FG001|Overall Study|Lack of Efficacy|1|||
161364058|NCT01592747|582721708|FG002|Overall Study|Lack of Efficacy|0|||
161364059|NCT01592747|582721706|FG000|Overall Study|Withdrawal by Subject|2|||
161364060|NCT01592747|582721707|FG001|Overall Study|Withdrawal by Subject|0|||
161364061|NCT01592747|582721708|FG002|Overall Study|Withdrawal by Subject|2|||
161364062|NCT01592747|582721706|FG000|Overall Study|Lost to Follow-up|1|||
161364063|NCT01592747|582721707|FG001|Overall Study|Lost to Follow-up|0|||
161364064|NCT01592747|582721708|FG002|Overall Study|Lost to Follow-up|1|||
161364065|NCT01592747|582721706|FG000|Overall Study|Other Reasons|1|||
161364066|NCT01592747|582721707|FG001|Overall Study|Other Reasons|1|||
161364067|NCT01592747|582721708|FG002|Overall Study|Other Reasons|0|||
161364068|NCT00266032|582721709|FG000|Treatment|Adverse Event|42|||
161364069|NCT00266032|582721710|FG001|Treatment|Adverse Event|26|||
161364070|NCT00266032|582721711|FG002|Treatment|Adverse Event|10|||
161364071|NCT00266032|582721709|FG000|Treatment|Lost to Follow-up|19|||
161364072|NCT00266032|582721710|FG001|Treatment|Lost to Follow-up|4|||
161364073|NCT00266032|582721711|FG002|Treatment|Lost to Follow-up|2|||
161364074|NCT00266032|582721709|FG000|Treatment|Pregnancy|3|||
161364075|NCT00266032|582721710|FG001|Treatment|Pregnancy|2|||
161364076|NCT00266032|582721711|FG002|Treatment|Pregnancy|2|||
161364077|NCT00266032|582721709|FG000|Treatment|Protocol Violation|6|||
161364078|NCT00266032|582721710|FG001|Treatment|Protocol Violation|14|||
161364079|NCT00266032|582721711|FG002|Treatment|Protocol Violation|13|||
161364080|NCT00266032|582721709|FG000|Treatment|Withdrawal by Subject|28|||
161364081|NCT00266032|582721710|FG001|Treatment|Withdrawal by Subject|13|||
161364082|NCT00266032|582721711|FG002|Treatment|Withdrawal by Subject|12|||
161364083|NCT00266032|582721709|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
161364084|NCT00266032|582721710|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
161364085|NCT00266032|582721711|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
161364086|NCT00266032|582721709|FG000|Open-label Safety Extension|Adverse Event|5|||
161364087|NCT00266032|582721710|FG001|Open-label Safety Extension|Adverse Event|0|||
161364088|NCT00266032|582721711|FG002|Open-label Safety Extension|Adverse Event|4|||
161364089|NCT00266032|582721709|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
161364090|NCT00266032|582721710|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
161364091|NCT00266032|582721711|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
161364092|NCT00266032|582721709|FG000|Open-label Safety Extension|Pregnancy|4|||
161364093|NCT00266032|582721710|FG001|Open-label Safety Extension|Pregnancy|1|||
161364094|NCT00266032|582721711|FG002|Open-label Safety Extension|Pregnancy|2|||
161364095|NCT00266032|582721709|FG000|Open-label Safety Extension|Protocol Violation|1|||
161364096|NCT00266032|582721710|FG001|Open-label Safety Extension|Protocol Violation|3|||
161364097|NCT00266032|582721711|FG002|Open-label Safety Extension|Protocol Violation|2|||
161364098|NCT00266032|582721709|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
161364099|NCT00266032|582721710|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
161364100|NCT00266032|582721711|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
161364101|NCT00266032|582721709|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
161364102|NCT00266032|582721710|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
161364103|NCT00266032|582721711|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
161364104|NCT00124657|582721713|FG000|Overall Study|Toxicity|0|||
161364105|NCT00124657|582721714|FG001|Overall Study|Toxicity|0|||
161364106|NCT00124657|582721715|FG002|Overall Study|Toxicity|1|||
161364107|NCT00124657|582721713|FG000|Overall Study|Non-compliance|1|||
161364108|NCT00124657|582721714|FG001|Overall Study|Non-compliance|0|||
161364109|NCT00124657|582721715|FG002|Overall Study|Non-compliance|4|||
161364110|NCT00124657|582721713|FG000|Overall Study|Progressive disease|14|||
161364111|NCT00124657|582721714|FG001|Overall Study|Progressive disease|5|||
161364112|NCT00124657|582721715|FG002|Overall Study|Progressive disease|27|||
161364113|NCT00124657|582721713|FG000|Overall Study|Intercurrent illness|1|||
161364114|NCT00124657|582721714|FG001|Overall Study|Intercurrent illness|0|||
161364115|NCT00124657|582721715|FG002|Overall Study|Intercurrent illness|0|||
161364116|NCT01935947|582721720|FG000|Overall Study|Adverse Event|0|||
161364117|NCT01935947|582721721|FG001|Overall Study|Adverse Event|2|||
161364118|NCT01935947|582721722|FG002|Overall Study|Adverse Event|0|||
161364119|NCT01935947|582721720|FG000|Overall Study|Diease Progression|2|||
161364120|NCT01935947|582721721|FG001|Overall Study|Diease Progression|2|||
161364121|NCT01935947|582721722|FG002|Overall Study|Diease Progression|2|||
161364122|NCT01935947|582721720|FG000|Overall Study|Death|1|||
161364123|NCT01935947|582721721|FG001|Overall Study|Death|0|||
161364124|NCT01935947|582721722|FG002|Overall Study|Death|0|||
161364125|NCT02367885|582721723|FG000|Overall Study|Lost to Follow-up|1|||
161364126|NCT02367885|582721724|FG001|Overall Study|Lost to Follow-up|0|||
161364127|NCT02367885|582721725|FG002|Overall Study|Lost to Follow-up|0|||
161364128|NCT02367885|582721723|FG000|Overall Study|Withdrawal by Subject|1|||
161364129|NCT02367885|582721724|FG001|Overall Study|Withdrawal by Subject|0|||
161364130|NCT02367885|582721725|FG002|Overall Study|Withdrawal by Subject|0|||
161364131|NCT01378195|582721726|FG000|Overall Study|Lost to Follow-up|29|||
161364132|NCT01378195|582721727|FG001|Overall Study|Lost to Follow-up|18|||
161364133|NCT00752219|582721728|FG000|Overall Study|Clinical failure|0|||
161364134|NCT00752219|582721729|FG001|Overall Study|Clinical failure|1|||
161364135|NCT00752219|582721728|FG000|Overall Study|Adverse Event|5|||
161364136|NCT00752219|582721729|FG001|Overall Study|Adverse Event|3|||
161364137|NCT00752219|582721728|FG000|Overall Study|Protocol deviation|1|||
161364138|NCT00752219|582721729|FG001|Overall Study|Protocol deviation|0|||
161364139|NCT00752219|582721728|FG000|Overall Study|Lost to Follow-up|1|||
161364140|NCT00752219|582721729|FG001|Overall Study|Lost to Follow-up|2|||
161364141|NCT00752219|582721728|FG000|Overall Study|Randomized but not treated|1|||
161364142|NCT00752219|582721729|FG001|Overall Study|Randomized but not treated|0|||
161364143|NCT00752219|582721728|FG000|Overall Study|Other|3|||
161364144|NCT00752219|582721729|FG001|Overall Study|Other|0|||
161364145|NCT03533491|582721733|FG000|Overall Study|Lost to Follow-up|2|||
161364146|NCT05418426|582721741|FG000|Overall Study|Adverse Event|0|||
161364147|NCT05418426|582721742|FG001|Overall Study|Adverse Event|1|||
161364148|NCT05418426|582721743|FG002|Overall Study|Adverse Event|0|||
161364149|NCT05418426|582721741|FG000|Overall Study|Withdrawal by Subject|0|||
161364150|NCT05418426|582721742|FG001|Overall Study|Withdrawal by Subject|1|||
161364151|NCT05418426|582721743|FG002|Overall Study|Withdrawal by Subject|0|||
161364152|NCT05418426|582721741|FG000|Overall Study|Protocol Violation|0|||
161364153|NCT05418426|582721742|FG001|Overall Study|Protocol Violation|0|||
161364154|NCT05418426|582721743|FG002|Overall Study|Protocol Violation|1|||
161364155|NCT02758626|582721746|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
161364156|NCT02758626|582721747|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
161364157|NCT02758626|582721746|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
161364158|NCT02758626|582721747|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
161364159|NCT02758626|582721746|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
161364160|NCT02758626|582721747|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
161364161|NCT02758626|582721746|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
161364162|NCT02758626|582721747|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
161364163|NCT00456365|582721750|FG000|Overall Study|Lost to Follow-up|1|||
161364164|NCT00456365|582721751|FG001|Overall Study|Lost to Follow-up|3|||
161364165|NCT00456365|582721750|FG000|Overall Study|Withdrawal by Subject|4|||
161364166|NCT00456365|582721751|FG001|Overall Study|Withdrawal by Subject|7|||
161364167|NCT00456365|582721750|FG000|Overall Study|Pregnancy|1|||
161364168|NCT00456365|582721751|FG001|Overall Study|Pregnancy|1|||
161364169|NCT00456365|582721750|FG000|Overall Study|oncologic diagnosis|1|||
161364170|NCT00456365|582721751|FG001|Overall Study|oncologic diagnosis|1|||
161364171|NCT02096354|582721755|FG000|Overall Study|Physician Decision|4|||
161364172|NCT02096354|582721756|FG001|Overall Study|Physician Decision|5|||
161364173|NCT02096354|582721757|FG002|Overall Study|Physician Decision|0|||
161364174|NCT02096354|582721755|FG000|Overall Study|Withdrawal by Subject|3|||
161364175|NCT02096354|582721756|FG001|Overall Study|Withdrawal by Subject|1|||
161364176|NCT02096354|582721757|FG002|Overall Study|Withdrawal by Subject|0|||
161364177|NCT02096354|582721755|FG000|Overall Study|Adverse Event|7|||
161364178|NCT02096354|582721756|FG001|Overall Study|Adverse Event|4|||
161364179|NCT02096354|582721757|FG002|Overall Study|Adverse Event|0|||
161364180|NCT02096354|582721755|FG000|Overall Study|Ineligible|0|||
161364181|NCT02096354|582721756|FG001|Overall Study|Ineligible|0|||
161364182|NCT02096354|582721757|FG002|Overall Study|Ineligible|11|||
161364183|NCT03715829|582721758|FG000|Dose Ranging Period|Adverse Event|2|||
161364184|NCT03715829|582721759|FG001|Dose Ranging Period|Adverse Event|4|||
161364185|NCT03715829|582721760|FG002|Dose Ranging Period|Adverse Event|5|||
161364186|NCT03715829|582721761|FG003|Dose Ranging Period|Adverse Event|2|||
161364187|NCT03715829|582721762|FG004|Dose Ranging Period|Adverse Event|3|||
161364188|NCT03715829|582721763|FG005|Dose Ranging Period|Adverse Event|3|||
161364189|NCT03715829|582721764|FG006|Dose Ranging Period|Adverse Event|0|||
161364190|NCT03715829|582721765|FG007|Dose Ranging Period|Adverse Event|0|||
161364191|NCT03715829|582721766|FG008|Dose Ranging Period|Adverse Event|0|||
161364192|NCT03715829|582721767|FG009|Dose Ranging Period|Adverse Event|0|||
161364193|NCT03715829|582721768|FG010|Dose Ranging Period|Adverse Event|0|||
161364194|NCT03715829|582721758|FG000|Dose Ranging Period|Lack of Efficacy|0|||
161364195|NCT03715829|582721759|FG001|Dose Ranging Period|Lack of Efficacy|1|||
161364196|NCT03715829|582721760|FG002|Dose Ranging Period|Lack of Efficacy|0|||
161364197|NCT03715829|582721761|FG003|Dose Ranging Period|Lack of Efficacy|1|||
161364198|NCT03715829|582721762|FG004|Dose Ranging Period|Lack of Efficacy|0|||
161364199|NCT03715829|582721763|FG005|Dose Ranging Period|Lack of Efficacy|0|||
161364200|NCT03715829|582721764|FG006|Dose Ranging Period|Lack of Efficacy|0|||
161364201|NCT03715829|582721765|FG007|Dose Ranging Period|Lack of Efficacy|0|||
161364202|NCT03715829|582721766|FG008|Dose Ranging Period|Lack of Efficacy|0|||
161364203|NCT03715829|582721767|FG009|Dose Ranging Period|Lack of Efficacy|0|||
161364204|NCT03715829|582721768|FG010|Dose Ranging Period|Lack of Efficacy|0|||
161364205|NCT03715829|582721758|FG000|Dose Ranging Period|Lost to Follow-up|2|||
161364206|NCT03715829|582721759|FG001|Dose Ranging Period|Lost to Follow-up|0|||
161364207|NCT03715829|582721760|FG002|Dose Ranging Period|Lost to Follow-up|1|||
161364208|NCT03715829|582721761|FG003|Dose Ranging Period|Lost to Follow-up|1|||
161364209|NCT03715829|582721762|FG004|Dose Ranging Period|Lost to Follow-up|1|||
161364210|NCT03715829|582721763|FG005|Dose Ranging Period|Lost to Follow-up|2|||
161364211|NCT03715829|582721764|FG006|Dose Ranging Period|Lost to Follow-up|0|||
161364212|NCT03715829|582721765|FG007|Dose Ranging Period|Lost to Follow-up|0|||
161364213|NCT03715829|582721766|FG008|Dose Ranging Period|Lost to Follow-up|0|||
161364214|NCT03715829|582721767|FG009|Dose Ranging Period|Lost to Follow-up|0|||
161364215|NCT03715829|582721768|FG010|Dose Ranging Period|Lost to Follow-up|0|||
161364216|NCT03715829|582721758|FG000|Dose Ranging Period|Protocol Violation|0|||
161364217|NCT03715829|582721759|FG001|Dose Ranging Period|Protocol Violation|0|||
161364218|NCT03715829|582721760|FG002|Dose Ranging Period|Protocol Violation|0|||
161364219|NCT03715829|582721761|FG003|Dose Ranging Period|Protocol Violation|1|||
161364220|NCT03715829|582721762|FG004|Dose Ranging Period|Protocol Violation|0|||
161364221|NCT03715829|582721763|FG005|Dose Ranging Period|Protocol Violation|0|||
161364222|NCT03715829|582721764|FG006|Dose Ranging Period|Protocol Violation|0|||
161364223|NCT03715829|582721765|FG007|Dose Ranging Period|Protocol Violation|0|||
161364224|NCT03715829|582721766|FG008|Dose Ranging Period|Protocol Violation|0|||
161364225|NCT03715829|582721767|FG009|Dose Ranging Period|Protocol Violation|0|||
161364226|NCT03715829|582721768|FG010|Dose Ranging Period|Protocol Violation|0|||
161364227|NCT03715829|582721758|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
161364228|NCT03715829|582721759|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
161364229|NCT03715829|582721760|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
161364230|NCT03715829|582721761|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
161364231|NCT03715829|582721762|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
161364232|NCT03715829|582721763|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
161364233|NCT03715829|582721764|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
161364234|NCT03715829|582721765|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
161364235|NCT03715829|582721766|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
161364236|NCT03715829|582721767|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
161364237|NCT03715829|582721768|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
161364238|NCT03715829|582721758|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364239|NCT03715829|582721759|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364240|NCT03715829|582721760|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
161364241|NCT03715829|582721761|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364242|NCT03715829|582721762|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364243|NCT03715829|582721763|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364244|NCT03715829|582721764|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364245|NCT03715829|582721765|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364246|NCT03715829|582721766|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364247|NCT03715829|582721767|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364248|NCT03715829|582721768|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161364249|NCT03715829|582721758|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364250|NCT03715829|582721759|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364251|NCT03715829|582721760|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
161364252|NCT03715829|582721761|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364253|NCT03715829|582721762|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
161364254|NCT03715829|582721763|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364255|NCT03715829|582721764|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364256|NCT03715829|582721765|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364257|NCT03715829|582721766|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364258|NCT03715829|582721767|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364259|NCT03715829|582721768|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161364260|NCT03715829|582721758|FG000|Dose Ranging Period|Other|0|||
161364261|NCT03715829|582721759|FG001|Dose Ranging Period|Other|0|||
161364262|NCT03715829|582721760|FG002|Dose Ranging Period|Other|2|||
161364263|NCT03715829|582721761|FG003|Dose Ranging Period|Other|0|||
161364264|NCT03715829|582721762|FG004|Dose Ranging Period|Other|0|||
161364265|NCT03715829|582721763|FG005|Dose Ranging Period|Other|3|||
161364266|NCT03715829|582721764|FG006|Dose Ranging Period|Other|0|||
161364267|NCT03715829|582721765|FG007|Dose Ranging Period|Other|0|||
161364268|NCT03715829|582721766|FG008|Dose Ranging Period|Other|0|||
161364269|NCT03715829|582721767|FG009|Dose Ranging Period|Other|0|||
161364270|NCT03715829|582721768|FG010|Dose Ranging Period|Other|0|||
161364271|NCT03715829|582721758|FG000|Extension Period|Adverse Event|0|||
161364272|NCT03715829|582721759|FG001|Extension Period|Adverse Event|0|||
161364273|NCT03715829|582721760|FG002|Extension Period|Adverse Event|0|||
161364274|NCT03715829|582721761|FG003|Extension Period|Adverse Event|0|||
161364275|NCT03715829|582721762|FG004|Extension Period|Adverse Event|0|||
161364276|NCT03715829|582721763|FG005|Extension Period|Adverse Event|0|||
161364277|NCT03715829|582721764|FG006|Extension Period|Adverse Event|3|||
161364278|NCT03715829|582721765|FG007|Extension Period|Adverse Event|1|||
161364279|NCT03715829|582721766|FG008|Extension Period|Adverse Event|6|||
161364280|NCT03715829|582721767|FG009|Extension Period|Adverse Event|0|||
161364281|NCT03715829|582721768|FG010|Extension Period|Adverse Event|0|||
161364282|NCT03715829|582721758|FG000|Extension Period|Lack of Efficacy|0|||
161364283|NCT03715829|582721759|FG001|Extension Period|Lack of Efficacy|0|||
161364284|NCT03715829|582721760|FG002|Extension Period|Lack of Efficacy|0|||
161364285|NCT03715829|582721761|FG003|Extension Period|Lack of Efficacy|0|||
161364286|NCT03715829|582721762|FG004|Extension Period|Lack of Efficacy|0|||
161364287|NCT03715829|582721763|FG005|Extension Period|Lack of Efficacy|0|||
161364288|NCT03715829|582721764|FG006|Extension Period|Lack of Efficacy|1|||
161364289|NCT03715829|582721765|FG007|Extension Period|Lack of Efficacy|9|||
161364290|NCT03715829|582721766|FG008|Extension Period|Lack of Efficacy|2|||
161364291|NCT03715829|582721767|FG009|Extension Period|Lack of Efficacy|0|||
161364292|NCT03715829|582721768|FG010|Extension Period|Lack of Efficacy|0|||
161364293|NCT03715829|582721758|FG000|Extension Period|Lost to Follow-up|0|||
161364294|NCT03715829|582721759|FG001|Extension Period|Lost to Follow-up|0|||
161364295|NCT03715829|582721760|FG002|Extension Period|Lost to Follow-up|0|||
161364296|NCT03715829|582721761|FG003|Extension Period|Lost to Follow-up|0|||
161364297|NCT03715829|582721762|FG004|Extension Period|Lost to Follow-up|0|||
161364298|NCT03715829|582721763|FG005|Extension Period|Lost to Follow-up|0|||
161364299|NCT03715829|582721764|FG006|Extension Period|Lost to Follow-up|0|||
161364300|NCT03715829|582721765|FG007|Extension Period|Lost to Follow-up|0|||
161364301|NCT03715829|582721766|FG008|Extension Period|Lost to Follow-up|2|||
161364302|NCT03715829|582721767|FG009|Extension Period|Lost to Follow-up|0|||
161364303|NCT03715829|582721768|FG010|Extension Period|Lost to Follow-up|0|||
161364304|NCT03715829|582721758|FG000|Extension Period|Protocol Violation|0|||
161364305|NCT03715829|582721759|FG001|Extension Period|Protocol Violation|0|||
161364306|NCT03715829|582721760|FG002|Extension Period|Protocol Violation|0|||
161364307|NCT03715829|582721761|FG003|Extension Period|Protocol Violation|0|||
161364308|NCT03715829|582721762|FG004|Extension Period|Protocol Violation|0|||
161364309|NCT03715829|582721763|FG005|Extension Period|Protocol Violation|0|||
161364310|NCT03715829|582721764|FG006|Extension Period|Protocol Violation|0|||
161364311|NCT03715829|582721765|FG007|Extension Period|Protocol Violation|0|||
161364312|NCT03715829|582721766|FG008|Extension Period|Protocol Violation|1|||
161364313|NCT03715829|582721767|FG009|Extension Period|Protocol Violation|0|||
161364314|NCT03715829|582721768|FG010|Extension Period|Protocol Violation|0|||
161364315|NCT03715829|582721758|FG000|Extension Period|Withdrawal by Subject|0|||
161364316|NCT03715829|582721759|FG001|Extension Period|Withdrawal by Subject|0|||
161364317|NCT03715829|582721760|FG002|Extension Period|Withdrawal by Subject|0|||
161364318|NCT03715829|582721761|FG003|Extension Period|Withdrawal by Subject|0|||
161364319|NCT03715829|582721762|FG004|Extension Period|Withdrawal by Subject|0|||
161364320|NCT03715829|582721763|FG005|Extension Period|Withdrawal by Subject|0|||
161364321|NCT03715829|582721764|FG006|Extension Period|Withdrawal by Subject|3|||
161364322|NCT03715829|582721765|FG007|Extension Period|Withdrawal by Subject|3|||
161364323|NCT03715829|582721766|FG008|Extension Period|Withdrawal by Subject|12|||
161364324|NCT03715829|582721767|FG009|Extension Period|Withdrawal by Subject|3|||
161364325|NCT03715829|582721768|FG010|Extension Period|Withdrawal by Subject|0|||
161364326|NCT03715829|582721758|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364327|NCT03715829|582721759|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364328|NCT03715829|582721760|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364329|NCT03715829|582721761|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364330|NCT03715829|582721762|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364331|NCT03715829|582721763|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364332|NCT03715829|582721764|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364333|NCT03715829|582721765|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
161364334|NCT03715829|582721766|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
161364335|NCT03715829|582721767|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364336|NCT03715829|582721768|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
161364337|NCT03715829|582721758|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364338|NCT03715829|582721759|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364339|NCT03715829|582721760|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364340|NCT03715829|582721761|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364341|NCT03715829|582721762|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364342|NCT03715829|582721763|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364343|NCT03715829|582721764|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364344|NCT03715829|582721765|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364345|NCT03715829|582721766|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
161364346|NCT03715829|582721767|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364347|NCT03715829|582721768|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
161364348|NCT03715829|582721758|FG000|Extension Period|Other|0|||
161364349|NCT03715829|582721759|FG001|Extension Period|Other|0|||
161364350|NCT03715829|582721760|FG002|Extension Period|Other|0|||
161364351|NCT03715829|582721761|FG003|Extension Period|Other|0|||
161364352|NCT03715829|582721762|FG004|Extension Period|Other|0|||
161364353|NCT03715829|582721763|FG005|Extension Period|Other|0|||
161364354|NCT03715829|582721764|FG006|Extension Period|Other|1|||
161364355|NCT03715829|582721765|FG007|Extension Period|Other|2|||
161364356|NCT03715829|582721766|FG008|Extension Period|Other|4|||
161364357|NCT03715829|582721767|FG009|Extension Period|Other|0|||
161364358|NCT03715829|582721768|FG010|Extension Period|Other|0|||
161364359|NCT03647137|582721770|FG000|Overall Study|Scan Limitation|2|||
161364360|NCT03647137|582721771|FG001|Overall Study|Scan Limitation|1|||
161364361|NCT03647137|582721772|FG002|Overall Study|Scan Limitation|1|||
161364362|NCT03647137|582721773|FG003|Overall Study|Scan Limitation|2|||
161364363|NCT01554904|582721775|FG000|Overall Study|Withdrawal by Subject|3|||
161364364|NCT01554904|582721775|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
161364365|NCT04525183|582721778|FG000|Overall Study|Withdrawal by Subject|0|||
161364366|NCT04525183|582721779|FG001|Overall Study|Withdrawal by Subject|0|||
161364367|NCT04525183|582721780|FG002|Overall Study|Withdrawal by Subject|3|||
161364368|NCT04525183|582721778|FG000|Overall Study|Study non-compliance|0|||
161364369|NCT04525183|582721779|FG001|Overall Study|Study non-compliance|0|||
161364370|NCT04525183|582721780|FG002|Overall Study|Study non-compliance|1|||
161364371|NCT04525183|582721778|FG000|Overall Study|Recurrent disease before starting on study|0|||
161364372|NCT04525183|582721779|FG001|Overall Study|Recurrent disease before starting on study|0|||
161364373|NCT04525183|582721780|FG002|Overall Study|Recurrent disease before starting on study|1|||
161364374|NCT04126174|582721781|FG000|Overall Study|Lost to Follow-up|3|||
161364375|NCT04126174|582721782|FG001|Overall Study|Lost to Follow-up|3|||
161364376|NCT03773562|582721783|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
161364377|NCT03773562|582721783|FG000|Overall Study|Lost to Follow-up|10|||
161364378|NCT03773562|582721783|FG000|Overall Study|Withdrawal by Subject|1|||
161364379|NCT05305651|582721784|FG000|Overall Study|Death|1|||
161364380|NCT05305651|582721784|FG000|Overall Study|Withdrawal by Subject|4|||
161364381|NCT05305651|582721784|FG000|Overall Study|Lost to Follow-up|4|||
161364382|NCT03996395|582721790|FG000|Overall Study|Lost to Follow-up|4|||
161364383|NCT03996395|582721790|FG000|Overall Study|Withdrawal by Subject|1|||
161364384|NCT03996395|582721790|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
161364385|NCT05375929|582721791|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
161364386|NCT05375929|582721792|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
161364387|NCT05375929|582721793|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
161364388|NCT05375929|582721794|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
161364389|NCT05375929|582721791|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
161364390|NCT05375929|582721792|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
161364391|NCT05375929|582721793|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161364392|NCT05375929|582721794|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161364393|NCT05375929|582721791|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
161364394|NCT05375929|582721792|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
161364395|NCT05375929|582721793|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
161364396|NCT05375929|582721794|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
161364397|NCT05375929|582721791|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
161364398|NCT05375929|582721792|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
161364399|NCT05375929|582721793|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
161364400|NCT05375929|582721794|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
161364401|NCT05375929|582721791|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
161364402|NCT05375929|582721792|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
161364403|NCT05375929|582721793|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
161364404|NCT05375929|582721794|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
161364405|NCT05375929|582721791|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
161364406|NCT05375929|582721792|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
161364407|NCT05375929|582721793|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
161364408|NCT05375929|582721794|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
161364409|NCT05375929|582721791|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
161364410|NCT05375929|582721792|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
161364411|NCT05375929|582721793|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
161364412|NCT05375929|582721794|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
161364413|NCT05375929|582721791|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
161364414|NCT05375929|582721792|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
161364415|NCT05375929|582721793|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
161364416|NCT05375929|582721794|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
161364417|NCT05375929|582721791|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
161364418|NCT05375929|582721792|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
161364419|NCT05375929|582721793|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
161364420|NCT05375929|582721794|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
161364421|NCT05375929|582721791|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
161364422|NCT05375929|582721792|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
161364423|NCT05375929|582721793|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
161364424|NCT05375929|582721794|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
161364425|NCT02528305|582721795|FG000|Overall Study|Withdrawal by Subject|1|||
161364426|NCT02528305|582721795|FG000|Overall Study|Adverse Event|1|||
161364427|NCT02528305|582721795|FG000|Overall Study|Physician Decision|1|||
161364428|NCT01852214|582721796|FG000|Period 1|Adverse Event|1|||
161364429|NCT01852214|582721797|FG001|Period 1|Adverse Event|2|||
161364430|NCT01852214|582721796|FG000|Period 1|Withdrawal by Subject|0|||
161364431|NCT01852214|582721797|FG001|Period 1|Withdrawal by Subject|1|||
161364432|NCT01852214|582721796|FG000|Washout Period|Withdrawal by Subject|0|||
161364433|NCT01852214|582721797|FG001|Washout Period|Withdrawal by Subject|1|||
161364434|NCT00421408|582721798|FG000|Overall Study|Lost to Follow-up|30|||
161364435|NCT00421408|582721799|FG001|Overall Study|Lost to Follow-up|20|||
161364436|NCT00421408|582721798|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
161364437|NCT00421408|582721799|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
161364438|NCT04091438|582721800|FG000|Treatment Period 1 (1 Day)|Other|1|||
161364439|NCT04091438|582721801|FG001|Treatment Period 1 (1 Day)|Other|0|||
161364440|NCT04091438|582721800|FG000|Washout Period (1 Day)|Protocol deviation|0|||
161364441|NCT04091438|582721801|FG001|Washout Period (1 Day)|Protocol deviation|1|||
161364442|NCT04091438|582721800|FG000|Washout Period (1 Day)|Other|0|||
161364443|NCT04091438|582721801|FG001|Washout Period (1 Day)|Other|1|||
161364444|NCT04105725|582721802|FG000|Primary Intervention|Lost to Follow-up|0|||
161364445|NCT04105725|582721803|FG001|Primary Intervention|Lost to Follow-up|2|||
161364446|NCT04105725|582721802|FG000|Primary Intervention|Withdrawal by Subject|0|||
161364447|NCT04105725|582721803|FG001|Primary Intervention|Withdrawal by Subject|1|||
161364448|NCT01308788|582721806|FG000|2-year Treatment|medication change by treating physician|4|||
161364449|NCT01308788|582721807|FG001|2-year Treatment|medication change by treating physician|11|||
161364450|NCT00322218|582721808|FG000|Overall Study|Death|3|||
161364451|NCT00322218|582721809|FG001|Overall Study|Death|6|||
161364452|NCT03379870|582723615|FG000|Overall Study|Lost to Follow-up|1|||
161364453|NCT03379870|582723616|FG001|Overall Study|Lost to Follow-up|0|||
161364454|NCT03379870|582723615|FG000|Overall Study|Protocol Violation|1|||
161364455|NCT03379870|582723616|FG001|Overall Study|Protocol Violation|1|||
161364456|NCT00003645|582723617|FG000|Overall Study|Death|4|||
161364457|NCT00003645|582723618|FG001|Overall Study|Death|1|||
161364458|NCT00003645|582723617|FG000|Overall Study|Lost to Follow-up|7|||
161364459|NCT00003645|582723618|FG001|Overall Study|Lost to Follow-up|8|||
161364460|NCT00003645|582723617|FG000|Overall Study|Withdrawal by Subject|1|||
161364461|NCT00003645|582723618|FG001|Overall Study|Withdrawal by Subject|3|||
161364462|NCT04616196|582723619|FG000|Overall Study|Progressive Disease|3|||
161364463|NCT04616196|582723620|FG001|Overall Study|Progressive Disease|0|||
161364464|NCT04616196|582723621|FG002|Overall Study|Progressive Disease|4|||
161364465|NCT04616196|582723622|FG003|Overall Study|Progressive Disease|1|||
161364466|NCT04616196|582723619|FG000|Overall Study|Death|2|||
161364467|NCT04616196|582723620|FG001|Overall Study|Death|4|||
161364468|NCT04616196|582723621|FG002|Overall Study|Death|1|||
161364469|NCT04616196|582723622|FG003|Overall Study|Death|0|||
161364470|NCT04616196|582723619|FG000|Overall Study|Withdrawal by Subject|0|||
161364471|NCT04616196|582723620|FG001|Overall Study|Withdrawal by Subject|2|||
161364472|NCT04616196|582723621|FG002|Overall Study|Withdrawal by Subject|0|||
161364473|NCT04616196|582723622|FG003|Overall Study|Withdrawal by Subject|0|||
161364474|NCT04616196|582723619|FG000|Overall Study|Lost to Follow-up|1|||
161364475|NCT04616196|582723620|FG001|Overall Study|Lost to Follow-up|0|||
161364476|NCT04616196|582723621|FG002|Overall Study|Lost to Follow-up|0|||
161364477|NCT04616196|582723622|FG003|Overall Study|Lost to Follow-up|0|||
161364478|NCT04616196|582723619|FG000|Overall Study|Sponsor request|2|||
161364479|NCT04616196|582723620|FG001|Overall Study|Sponsor request|1|||
161364480|NCT04616196|582723621|FG002|Overall Study|Sponsor request|1|||
161364481|NCT04616196|582723622|FG003|Overall Study|Sponsor request|2|||
161364482|NCT02254291|582723623|FG000|Overall Study|Withdrawal by Subject|0|||
161364483|NCT02254291|582723624|FG001|Overall Study|Withdrawal by Subject|3|||
161364484|NCT02254291|582723625|FG002|Overall Study|Withdrawal by Subject|1|||
161364485|NCT02254291|582723623|FG000|Overall Study|Missing follow-up information|0|||
161364486|NCT02254291|582723624|FG001|Overall Study|Missing follow-up information|0|||
161364487|NCT02254291|582723625|FG002|Overall Study|Missing follow-up information|1|||
161364488|NCT06790303|582723626|FG000|Overall Study|Study Terminated by sponsor|4|||
161364489|NCT06790303|582723626|FG000|Overall Study|Death|4|||
161364490|NCT03436732|582723629|FG000|Overall Study|Not treated-enrolled in different study|1|||
161364491|NCT03436732|582723630|FG001|Overall Study|Not treated-enrolled in different study|0|||
161364492|NCT03436732|582723629|FG000|Overall Study|Off study after cycle 1|1|||
161364493|NCT03436732|582723630|FG001|Overall Study|Off study after cycle 1|0|||
161364494|NCT03436732|582723629|FG000|Overall Study|Adverse Event|2|||
161364495|NCT03436732|582723630|FG001|Overall Study|Adverse Event|0|||
161364496|NCT03436732|582723629|FG000|Overall Study|Death|0|||
161364497|NCT03436732|582723630|FG001|Overall Study|Death|1|||
161364498|NCT00443456|582723639|FG000|Overall Study|Adverse Event|16|||
161364499|NCT00443456|582723639|FG000|Overall Study|Move|1|||
161364500|NCT00443456|582723639|FG000|Overall Study|Withdrawal by Subject|1|||
161364501|NCT03242434|582723640|FG000|Overall Study|Death|0|||
161364502|NCT03242434|582723641|FG001|Overall Study|Death|2|||
161364503|NCT02157610|582723642|FG000|Overall Study|Death|4|||
161364504|NCT02157610|582723643|FG001|Overall Study|Death|4|||
161364505|NCT00814983|582723644|FG000|Overall Study|Screen failure|1|||
161364506|NCT00814983|582723645|FG001|Overall Study|Screen failure|0|||
161364507|NCT00814983|582723644|FG000|Overall Study|Withdrawal by Subject|1|||
161364508|NCT00814983|582723645|FG001|Overall Study|Withdrawal by Subject|0|||
161364509|NCT00814983|582723644|FG000|Overall Study|Graft failure|1|||
161364510|NCT00814983|582723645|FG001|Overall Study|Graft failure|0|||
161364511|NCT02853136|582723646|FG000|Wash-out|Adverse Event|0|||
161364512|NCT02853136|582723647|FG001|Wash-out|Adverse Event|0|||
161364513|NCT02853136|582723648|FG002|Wash-out|Adverse Event|0|||
161364514|NCT02853136|582723649|FG003|Wash-out|Adverse Event|1|||
161364515|NCT00841815|582723650|FG000|Washout|Withdrawal by Subject|0|||
161364516|NCT00841815|582723651|FG001|Washout|Withdrawal by Subject|1|||
161364517|NCT02327169|582723652|FG000|Overall Study|Progressive Disease|1|||
161364518|NCT02327169|582723653|FG001|Overall Study|Progressive Disease|3|||
161364519|NCT02327169|582723654|FG002|Overall Study|Progressive Disease|4|||
161364520|NCT02327169|582723655|FG003|Overall Study|Progressive Disease|3|||
161364521|NCT02327169|582723656|FG004|Overall Study|Progressive Disease|4|||
161364522|NCT02327169|582723657|FG005|Overall Study|Progressive Disease|3|||
161364523|NCT02327169|582723658|FG006|Overall Study|Progressive Disease|3|||
161364524|NCT02327169|582723659|FG007|Overall Study|Progressive Disease|3|||
161364525|NCT02327169|582723660|FG008|Overall Study|Progressive Disease|4|||
161364526|NCT02327169|582723661|FG009|Overall Study|Progressive Disease|4|||
161364527|NCT02327169|582723662|FG010|Overall Study|Progressive Disease|4|||
161364528|NCT02327169|582723663|FG011|Overall Study|Progressive Disease|3|||
161364529|NCT02327169|582723664|FG012|Overall Study|Progressive Disease|1|||
161364530|NCT02327169|582723665|FG013|Overall Study|Progressive Disease|3|||
161364531|NCT02327169|582723666|FG014|Overall Study|Progressive Disease|3|||
161364532|NCT02327169|582723652|FG000|Overall Study|Adverse Event|2|||
161364533|NCT02327169|582723653|FG001|Overall Study|Adverse Event|0|||
161364534|NCT02327169|582723654|FG002|Overall Study|Adverse Event|1|||
161364535|NCT02327169|582723655|FG003|Overall Study|Adverse Event|0|||
161364536|NCT02327169|582723656|FG004|Overall Study|Adverse Event|1|||
161364537|NCT02327169|582723657|FG005|Overall Study|Adverse Event|0|||
161364538|NCT02327169|582723658|FG006|Overall Study|Adverse Event|0|||
161364539|NCT02327169|582723659|FG007|Overall Study|Adverse Event|0|||
161364540|NCT02327169|582723660|FG008|Overall Study|Adverse Event|0|||
161364541|NCT02327169|582723661|FG009|Overall Study|Adverse Event|2|||
161364542|NCT02327169|582723662|FG010|Overall Study|Adverse Event|0|||
161364543|NCT02327169|582723663|FG011|Overall Study|Adverse Event|3|||
161364544|NCT02327169|582723664|FG012|Overall Study|Adverse Event|0|||
161364545|NCT02327169|582723665|FG013|Overall Study|Adverse Event|2|||
161364546|NCT02327169|582723666|FG014|Overall Study|Adverse Event|1|||
161364547|NCT02327169|582723652|FG000|Overall Study|Symptomatic Deterioration|0|||
161364548|NCT02327169|582723653|FG001|Overall Study|Symptomatic Deterioration|0|||
161364549|NCT02327169|582723654|FG002|Overall Study|Symptomatic Deterioration|1|||
161364550|NCT02327169|582723655|FG003|Overall Study|Symptomatic Deterioration|0|||
161364551|NCT02327169|582723656|FG004|Overall Study|Symptomatic Deterioration|1|||
161364552|NCT02327169|582723657|FG005|Overall Study|Symptomatic Deterioration|1|||
161364553|NCT02327169|582723658|FG006|Overall Study|Symptomatic Deterioration|0|||
161364554|NCT02327169|582723659|FG007|Overall Study|Symptomatic Deterioration|0|||
161364555|NCT02327169|582723660|FG008|Overall Study|Symptomatic Deterioration|2|||
161364556|NCT02327169|582723661|FG009|Overall Study|Symptomatic Deterioration|1|||
161364557|NCT02327169|582723662|FG010|Overall Study|Symptomatic Deterioration|0|||
161364558|NCT02327169|582723663|FG011|Overall Study|Symptomatic Deterioration|0|||
161364559|NCT02327169|582723664|FG012|Overall Study|Symptomatic Deterioration|0|||
161364560|NCT02327169|582723665|FG013|Overall Study|Symptomatic Deterioration|2|||
161364561|NCT02327169|582723666|FG014|Overall Study|Symptomatic Deterioration|1|||
161364562|NCT02327169|582723652|FG000|Overall Study|Reason Not Specified|0|||
161364563|NCT02327169|582723653|FG001|Overall Study|Reason Not Specified|0|||
161364564|NCT02327169|582723654|FG002|Overall Study|Reason Not Specified|1|||
161364565|NCT02327169|582723655|FG003|Overall Study|Reason Not Specified|0|||
161364566|NCT02327169|582723656|FG004|Overall Study|Reason Not Specified|0|||
161364567|NCT02327169|582723657|FG005|Overall Study|Reason Not Specified|0|||
161364568|NCT02327169|582723658|FG006|Overall Study|Reason Not Specified|0|||
161364569|NCT02327169|582723659|FG007|Overall Study|Reason Not Specified|0|||
161364570|NCT02327169|582723660|FG008|Overall Study|Reason Not Specified|0|||
161364571|NCT02327169|582723661|FG009|Overall Study|Reason Not Specified|1|||
161364572|NCT02327169|582723662|FG010|Overall Study|Reason Not Specified|2|||
161364573|NCT02327169|582723663|FG011|Overall Study|Reason Not Specified|1|||
161364574|NCT02327169|582723664|FG012|Overall Study|Reason Not Specified|0|||
161364575|NCT02327169|582723665|FG013|Overall Study|Reason Not Specified|0|||
161364576|NCT02327169|582723666|FG014|Overall Study|Reason Not Specified|2|||
161364577|NCT02327169|582723652|FG000|Overall Study|Withdrawal by Subject|1|||
161364578|NCT02327169|582723653|FG001|Overall Study|Withdrawal by Subject|0|||
161364579|NCT02327169|582723654|FG002|Overall Study|Withdrawal by Subject|0|||
161364580|NCT02327169|582723655|FG003|Overall Study|Withdrawal by Subject|0|||
161364581|NCT02327169|582723656|FG004|Overall Study|Withdrawal by Subject|1|||
161364582|NCT02327169|582723657|FG005|Overall Study|Withdrawal by Subject|0|||
161364583|NCT02327169|582723658|FG006|Overall Study|Withdrawal by Subject|0|||
161364584|NCT02327169|582723659|FG007|Overall Study|Withdrawal by Subject|1|||
161364585|NCT02327169|582723660|FG008|Overall Study|Withdrawal by Subject|0|||
161364586|NCT02327169|582723661|FG009|Overall Study|Withdrawal by Subject|0|||
161364587|NCT02327169|582723662|FG010|Overall Study|Withdrawal by Subject|0|||
161364588|NCT02327169|582723663|FG011|Overall Study|Withdrawal by Subject|0|||
161364589|NCT02327169|582723664|FG012|Overall Study|Withdrawal by Subject|0|||
161364590|NCT02327169|582723665|FG013|Overall Study|Withdrawal by Subject|0|||
161364591|NCT02327169|582723666|FG014|Overall Study|Withdrawal by Subject|3|||
161364592|NCT02327169|582723652|FG000|Overall Study|Lost to Follow-up|0|||
161364593|NCT02327169|582723653|FG001|Overall Study|Lost to Follow-up|0|||
161364594|NCT02327169|582723654|FG002|Overall Study|Lost to Follow-up|0|||
161364595|NCT02327169|582723655|FG003|Overall Study|Lost to Follow-up|0|||
161364596|NCT02327169|582723656|FG004|Overall Study|Lost to Follow-up|1|||
161364597|NCT02327169|582723657|FG005|Overall Study|Lost to Follow-up|0|||
161364598|NCT02327169|582723658|FG006|Overall Study|Lost to Follow-up|0|||
161364599|NCT02327169|582723659|FG007|Overall Study|Lost to Follow-up|0|||
161364600|NCT02327169|582723660|FG008|Overall Study|Lost to Follow-up|0|||
161364601|NCT02327169|582723661|FG009|Overall Study|Lost to Follow-up|0|||
161364602|NCT02327169|582723662|FG010|Overall Study|Lost to Follow-up|0|||
161364603|NCT02327169|582723663|FG011|Overall Study|Lost to Follow-up|0|||
161364604|NCT02327169|582723664|FG012|Overall Study|Lost to Follow-up|0|||
161364605|NCT02327169|582723665|FG013|Overall Study|Lost to Follow-up|0|||
161364606|NCT02327169|582723666|FG014|Overall Study|Lost to Follow-up|0|||
161364607|NCT03787615|582723667|FG000|Overall Study|Withdrawal by Subject|2|||
161364608|NCT03787615|582723667|FG000|Overall Study|Lost to Follow-up|2|||
161364609|NCT01229111|582723669|FG000|Overall Study|Death|1|||
161364610|NCT04102514|582723670|FG000|Overall Study|Death|3|||
161364611|NCT04102514|582723671|FG001|Overall Study|Death|0|||
161364612|NCT04102514|582723672|FG002|Overall Study|Death|0|||
161364613|NCT04102514|582723673|FG003|Overall Study|Death|0|||
161364614|NCT04102514|582723670|FG000|Overall Study|Lost to Follow-up|0|||
161364615|NCT04102514|582723671|FG001|Overall Study|Lost to Follow-up|0|||
161364616|NCT04102514|582723672|FG002|Overall Study|Lost to Follow-up|3|||
161364617|NCT04102514|582723673|FG003|Overall Study|Lost to Follow-up|0|||
161364618|NCT04102514|582723670|FG000|Overall Study|Physician Decision|0|||
161364619|NCT04102514|582723671|FG001|Overall Study|Physician Decision|0|||
161364620|NCT04102514|582723672|FG002|Overall Study|Physician Decision|1|||
161364621|NCT04102514|582723673|FG003|Overall Study|Physician Decision|0|||
161364622|NCT04102514|582723670|FG000|Overall Study|Withdrawal by Subject|7|||
161364623|NCT04102514|582723671|FG001|Overall Study|Withdrawal by Subject|13|||
161364624|NCT04102514|582723672|FG002|Overall Study|Withdrawal by Subject|7|||
161364625|NCT04102514|582723673|FG003|Overall Study|Withdrawal by Subject|14|||
161364626|NCT04102514|582723670|FG000|Overall Study|Moved to longterm care facility|6|||
161364627|NCT04102514|582723671|FG001|Overall Study|Moved to longterm care facility|0|||
161364628|NCT04102514|582723672|FG002|Overall Study|Moved to longterm care facility|4|||
161364629|NCT04102514|582723673|FG003|Overall Study|Moved to longterm care facility|0|||
161364630|NCT00619918|582723674|FG000|Overall Study|Withdrawal by Subject|4|||
161364631|NCT00619918|582723675|FG001|Overall Study|Withdrawal by Subject|3|||
161364632|NCT00619918|582723674|FG000|Overall Study|Physician Decision|2|||
161364633|NCT00619918|582723675|FG001|Overall Study|Physician Decision|4|||
161364634|NCT00619918|582723674|FG000|Overall Study|Transfer to outside facility|3|||
161364635|NCT00619918|582723675|FG001|Overall Study|Transfer to outside facility|3|||
161364636|NCT00619918|582723674|FG000|Overall Study|Left before receiving first dose|7|||
161364637|NCT00619918|582723675|FG001|Overall Study|Left before receiving first dose|6|||
161364638|NCT00619918|582723674|FG000|Overall Study|ICU admission|4|||
161364639|NCT00619918|582723675|FG001|Overall Study|ICU admission|6|||
161364640|NCT03579719|582723681|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
161364641|NCT01443026|582723682|FG000|Overall Study|Physician Decision|1|||
161364642|NCT01443026|582723683|FG001|Overall Study|Physician Decision|0|||
161364643|NCT01443026|582723682|FG000|Overall Study|Death|0|||
161364644|NCT01443026|582723683|FG001|Overall Study|Death|1|||
161364645|NCT01443026|582723682|FG000|Overall Study|Withdrawal by Subject|0|||
161364646|NCT01443026|582723683|FG001|Overall Study|Withdrawal by Subject|3|||
161364647|NCT01443026|582723682|FG000|Overall Study|Lost to Follow-up|2|||
161364648|NCT01443026|582723683|FG001|Overall Study|Lost to Follow-up|1|||
161364649|NCT03900650|582723684|FG000|Overall Study|Withdrawal by Subject|1|||
161364650|NCT03900650|582723685|FG001|Overall Study|Withdrawal by Subject|1|||
161364651|NCT03900650|582723686|FG002|Overall Study|Withdrawal by Subject|0|||
161364652|NCT03900650|582723687|FG003|Overall Study|Withdrawal by Subject|0|||
161364653|NCT03900650|582723684|FG000|Overall Study|Withdrawn by staff|1|||
161364654|NCT03900650|582723685|FG001|Overall Study|Withdrawn by staff|0|||
161364655|NCT03900650|582723686|FG002|Overall Study|Withdrawn by staff|0|||
161364656|NCT03900650|582723687|FG003|Overall Study|Withdrawn by staff|0|||
161364657|NCT00829868|582723692|FG000|Washout|Physician Decision|1|||
161364658|NCT00829868|582723693|FG001|Washout|Physician Decision|0|||
161364659|NCT01969409|582723694|FG000|Overall Study|Death|2|||
161364660|NCT01969409|582723695|FG001|Overall Study|Death|2|||
161364661|NCT01969409|582723694|FG000|Overall Study|Transplant|1|||
161364662|NCT01969409|582723695|FG001|Overall Study|Transplant|1|||
161364663|NCT01969409|582723694|FG000|Overall Study|Withdrawal by Subject|0|||
161364664|NCT01969409|582723695|FG001|Overall Study|Withdrawal by Subject|1|||
161364665|NCT00721110|582723696|FG000|Overall Study|Ultram use|1|||
161364666|NCT00721110|582723697|FG001|Overall Study|Ultram use|0|||
161364667|NCT00721110|582723698|FG002|Overall Study|Ultram use|0|||
161364668|NCT00721110|582723699|FG003|Overall Study|Ultram use|0|||
161364669|NCT00721110|582723696|FG000|Overall Study|vertical incision|0|||
161364670|NCT00721110|582723697|FG001|Overall Study|vertical incision|0|||
161364671|NCT00721110|582723698|FG002|Overall Study|vertical incision|1|||
161364672|NCT00721110|582723699|FG003|Overall Study|vertical incision|0|||
161364673|NCT01051661|582723704|FG000|Overall Study|Adverse Event|1|||
161364674|NCT01051661|582723705|FG001|Overall Study|Adverse Event|1|||
161364675|NCT01051661|582723706|FG002|Overall Study|Adverse Event|1|||
161364676|NCT01051661|582723707|FG003|Overall Study|Adverse Event|1|||
161364677|NCT01051661|582723708|FG004|Overall Study|Adverse Event|0|||
161364678|NCT01051661|582723709|FG005|Overall Study|Adverse Event|0|||
161364679|NCT01051661|582723704|FG000|Overall Study|Lost to Follow-up|13|||
161364680|NCT01051661|582723705|FG001|Overall Study|Lost to Follow-up|22|||
161364681|NCT01051661|582723706|FG002|Overall Study|Lost to Follow-up|15|||
161364682|NCT01051661|582723707|FG003|Overall Study|Lost to Follow-up|17|||
161364683|NCT01051661|582723708|FG004|Overall Study|Lost to Follow-up|10|||
161364684|NCT01051661|582723709|FG005|Overall Study|Lost to Follow-up|24|||
161364685|NCT01051661|582723704|FG000|Overall Study|Migrated/moved from study area|1|||
161364686|NCT01051661|582723705|FG001|Overall Study|Migrated/moved from study area|6|||
161364687|NCT01051661|582723706|FG002|Overall Study|Migrated/moved from study area|6|||
161364688|NCT01051661|582723707|FG003|Overall Study|Migrated/moved from study area|8|||
161364689|NCT01051661|582723708|FG004|Overall Study|Migrated/moved from study area|7|||
161364690|NCT01051661|582723709|FG005|Overall Study|Migrated/moved from study area|3|||
161364691|NCT01051661|582723704|FG000|Overall Study|Refused blood sampling|0|||
161364692|NCT01051661|582723705|FG001|Overall Study|Refused blood sampling|0|||
161364693|NCT01051661|582723706|FG002|Overall Study|Refused blood sampling|0|||
161364694|NCT01051661|582723707|FG003|Overall Study|Refused blood sampling|0|||
161364695|NCT01051661|582723708|FG004|Overall Study|Refused blood sampling|0|||
161364696|NCT01051661|582723709|FG005|Overall Study|Refused blood sampling|1|||
161364697|NCT01051661|582723704|FG000|Overall Study|Data not reliable|1|||
161364698|NCT01051661|582723705|FG001|Overall Study|Data not reliable|0|||
161364699|NCT01051661|582723706|FG002|Overall Study|Data not reliable|0|||
161364700|NCT01051661|582723707|FG003|Overall Study|Data not reliable|0|||
161364701|NCT01051661|582723708|FG004|Overall Study|Data not reliable|0|||
161364702|NCT01051661|582723709|FG005|Overall Study|Data not reliable|1|||
161364703|NCT01051661|582723704|FG000|Overall Study|Unable to attend visit(s)|2|||
161364704|NCT01051661|582723705|FG001|Overall Study|Unable to attend visit(s)|4|||
161364705|NCT01051661|582723706|FG002|Overall Study|Unable to attend visit(s)|2|||
161364706|NCT01051661|582723707|FG003|Overall Study|Unable to attend visit(s)|1|||
161364707|NCT01051661|582723708|FG004|Overall Study|Unable to attend visit(s)|3|||
161364708|NCT01051661|582723709|FG005|Overall Study|Unable to attend visit(s)|2|||
161364709|NCT01051661|582723704|FG000|Overall Study|Consent not received from both parents|0|||
161364710|NCT01051661|582723705|FG001|Overall Study|Consent not received from both parents|0|||
161364711|NCT01051661|582723706|FG002|Overall Study|Consent not received from both parents|0|||
161364712|NCT01051661|582723707|FG003|Overall Study|Consent not received from both parents|0|||
161364713|NCT01051661|582723708|FG004|Overall Study|Consent not received from both parents|0|||
161364714|NCT01051661|582723709|FG005|Overall Study|Consent not received from both parents|1|||
161364715|NCT01051661|582723704|FG000|Overall Study|Failure to comply with protocol|0|||
161364716|NCT01051661|582723705|FG001|Overall Study|Failure to comply with protocol|0|||
161364717|NCT01051661|582723706|FG002|Overall Study|Failure to comply with protocol|2|||
161364718|NCT01051661|582723707|FG003|Overall Study|Failure to comply with protocol|0|||
161364719|NCT01051661|582723708|FG004|Overall Study|Failure to comply with protocol|0|||
161364720|NCT01051661|582723709|FG005|Overall Study|Failure to comply with protocol|0|||
161364721|NCT01051661|582723704|FG000|Overall Study|Subject lost legal representation|0|||
161364722|NCT01051661|582723705|FG001|Overall Study|Subject lost legal representation|0|||
161364723|NCT01051661|582723706|FG002|Overall Study|Subject lost legal representation|0|||
161364724|NCT01051661|582723707|FG003|Overall Study|Subject lost legal representation|0|||
161364725|NCT01051661|582723708|FG004|Overall Study|Subject lost legal representation|1|||
161364726|NCT01051661|582723709|FG005|Overall Study|Subject lost legal representation|0|||
161364727|NCT01051661|582723704|FG000|Overall Study|Protocol Violation|0|||
161364728|NCT01051661|582723705|FG001|Overall Study|Protocol Violation|0|||
161364729|NCT01051661|582723706|FG002|Overall Study|Protocol Violation|0|||
161364730|NCT01051661|582723707|FG003|Overall Study|Protocol Violation|1|||
161364731|NCT01051661|582723708|FG004|Overall Study|Protocol Violation|2|||
161364732|NCT01051661|582723709|FG005|Overall Study|Protocol Violation|1|||
161364733|NCT01051661|582723704|FG000|Overall Study|Withdrawal by Subject|16|||
161364734|NCT01051661|582723705|FG001|Overall Study|Withdrawal by Subject|30|||
161364735|NCT01051661|582723706|FG002|Overall Study|Withdrawal by Subject|13|||
161364736|NCT01051661|582723707|FG003|Overall Study|Withdrawal by Subject|28|||
161364737|NCT01051661|582723708|FG004|Overall Study|Withdrawal by Subject|12|||
161364738|NCT01051661|582723709|FG005|Overall Study|Withdrawal by Subject|34|||
161364739|NCT01681849|582723710|FG000|Overall Study|Protocol Violation|2|||
161364740|NCT01681849|582723711|FG001|Overall Study|Protocol Violation|0|||
161364741|NCT01681849|582723712|FG002|Overall Study|Protocol Violation|0|||
161364742|NCT01681849|582723710|FG000|Overall Study|Withdrawal by Subject|3|||
161364743|NCT01681849|582723711|FG001|Overall Study|Withdrawal by Subject|5|||
161364744|NCT01681849|582723712|FG002|Overall Study|Withdrawal by Subject|33|||
161364745|NCT01681849|582723710|FG000|Overall Study|Lost to Follow-up|3|||
161364746|NCT01681849|582723711|FG001|Overall Study|Lost to Follow-up|2|||
161364747|NCT01681849|582723712|FG002|Overall Study|Lost to Follow-up|6|||
161364748|NCT02852005|582723714|FG000|Overall Study|Lost to Follow-up|0|||
161364749|NCT02852005|582723715|FG001|Overall Study|Lost to Follow-up|0|||
161364750|NCT02852005|582723716|FG002|Overall Study|Lost to Follow-up|0|||
161364751|NCT02852005|582723717|FG003|Overall Study|Lost to Follow-up|0|||
161364752|NCT02852005|582723718|FG004|Overall Study|Lost to Follow-up|1|||
161364753|NCT02852005|582723714|FG000|Overall Study|Withdrawal by Subject|1|||
161364754|NCT02852005|582723715|FG001|Overall Study|Withdrawal by Subject|0|||
161364755|NCT02852005|582723716|FG002|Overall Study|Withdrawal by Subject|0|||
161364756|NCT02852005|582723717|FG003|Overall Study|Withdrawal by Subject|0|||
161364757|NCT02852005|582723718|FG004|Overall Study|Withdrawal by Subject|0|||
161364758|NCT01922895|582723719|FG000|Overall Study|Death|0|||
161364759|NCT01922895|582723720|FG001|Overall Study|Death|1|||
161364760|NCT01922895|582723719|FG000|Overall Study|Withdrawal by Subject|1|||
161364761|NCT01922895|582723720|FG001|Overall Study|Withdrawal by Subject|2|||
161364762|NCT01922895|582723719|FG000|Overall Study|Lost to Follow-up|5|||
161364763|NCT01922895|582723720|FG001|Overall Study|Lost to Follow-up|11|||
161364764|NCT01916226|582723721|FG000|Overall Study|Adverse Event|1|||
161364765|NCT01916226|582723722|FG001|Overall Study|Adverse Event|0|||
161364766|NCT01916226|582723723|FG002|Overall Study|Adverse Event|1|||
161364767|NCT01916226|582723724|FG003|Overall Study|Adverse Event|1|||
161364768|NCT01916226|582723721|FG000|Overall Study|Lack of Efficacy|0|||
161364769|NCT01916226|582723722|FG001|Overall Study|Lack of Efficacy|0|||
161364770|NCT01916226|582723723|FG002|Overall Study|Lack of Efficacy|2|||
161364771|NCT01916226|582723724|FG003|Overall Study|Lack of Efficacy|1|||
161364772|NCT01916226|582723721|FG000|Overall Study|Protocol Violation|0|||
161364773|NCT01916226|582723722|FG001|Overall Study|Protocol Violation|1|||
161364774|NCT01916226|582723723|FG002|Overall Study|Protocol Violation|0|||
161364775|NCT01916226|582723724|FG003|Overall Study|Protocol Violation|1|||
161364776|NCT01916226|582723721|FG000|Overall Study|Physician Decision|0|||
161364777|NCT01916226|582723722|FG001|Overall Study|Physician Decision|0|||
161364778|NCT01916226|582723723|FG002|Overall Study|Physician Decision|0|||
161364779|NCT01916226|582723724|FG003|Overall Study|Physician Decision|1|||
161364780|NCT01166646|582723728|FG000|Overall Study|Protocol Violation|0|||
161364781|NCT01166646|582723729|FG001|Overall Study|Protocol Violation|1|||
161364782|NCT01166646|582723728|FG000|Overall Study|Adverse Event|1|||
161364783|NCT01166646|582723729|FG001|Overall Study|Adverse Event|0|||
161364784|NCT05142306|582723730|FG000|Overall Study|Withdrawal by Subject|0|||
161364785|NCT05142306|582723731|FG001|Overall Study|Withdrawal by Subject|0|||
161364786|NCT05142306|582723732|FG002|Overall Study|Withdrawal by Subject|1|||
161364787|NCT04079920|582723733|FG000|Overall Study|Adverse event, not related to study drug|2|||
161364788|NCT04079920|582723733|FG000|Overall Study|Adverse event related to study drug|10|||
161364789|NCT04079920|582723733|FG000|Overall Study|Death|2|||
161364790|NCT04079920|582723733|FG000|Overall Study|Lost to Follow-up|22|||
161364791|NCT04079920|582723733|FG000|Overall Study|Physician Decision|1|||
161364792|NCT04079920|582723733|FG000|Overall Study|Withdrawal by Subject|11|||
161364793|NCT05430919|582723734|FG000|Overall Study|Protocol Violation|0|||
161364794|NCT05430919|582723735|FG001|Overall Study|Protocol Violation|0|||
161364795|NCT05430919|582723736|FG002|Overall Study|Protocol Violation|1|||
161364796|NCT05430919|582723737|FG003|Overall Study|Protocol Violation|0|||
161364797|NCT05430919|582723734|FG000|Overall Study|Lost to Follow-up|0|||
161364798|NCT05430919|582723735|FG001|Overall Study|Lost to Follow-up|1|||
161364799|NCT05430919|582723736|FG002|Overall Study|Lost to Follow-up|0|||
161364800|NCT05430919|582723737|FG003|Overall Study|Lost to Follow-up|0|||
161364801|NCT05430919|582723734|FG000|Overall Study|Withdrawal by Subject|3|||
161364802|NCT05430919|582723735|FG001|Overall Study|Withdrawal by Subject|0|||
161364803|NCT05430919|582723736|FG002|Overall Study|Withdrawal by Subject|0|||
161364804|NCT05430919|582723737|FG003|Overall Study|Withdrawal by Subject|1|||
161364805|NCT05014919|582723738|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
161364806|NCT05014919|582723739|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
161364807|NCT05014919|582723740|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
161364808|NCT05014919|582723738|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
161364809|NCT05014919|582723739|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
161364810|NCT05014919|582723740|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
161364811|NCT05014919|582723738|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
161364812|NCT05014919|582723739|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
161364813|NCT05014919|582723740|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
161364814|NCT05014919|582723738|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
161364815|NCT05014919|582723739|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
161364816|NCT05014919|582723740|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
161364817|NCT05014919|582723738|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
161364818|NCT05014919|582723739|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
161364819|NCT05014919|582723740|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
161364820|NCT05014919|582723738|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
161364821|NCT05014919|582723739|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
161364822|NCT05014919|582723740|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
161364823|NCT05014919|582723738|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
161364824|NCT05014919|582723739|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
161364825|NCT05014919|582723740|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
161364826|NCT05014919|582723738|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
161364827|NCT05014919|582723739|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
161364828|NCT05014919|582723740|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
161364829|NCT01491919|582723758|FG000|Overall Study|Insufficient PK sampling|1|||
161364830|NCT01491919|582723759|FG001|Overall Study|Insufficient PK sampling|2|||
161364831|NCT01491919|582723760|FG002|Overall Study|Insufficient PK sampling|1|||
161364832|NCT04439903|582723761|FG000|Overall Study|Withdrawal by Subject|2|||
161364833|NCT04439903|582723761|FG000|Overall Study|Screen Failure|1|||
161364834|NCT04309500|582723767|FG000|Overall Study|Lost to Follow-up|1|||
161364835|NCT04309500|582723768|FG001|Overall Study|Lost to Follow-up|0|||
161364836|NCT04309500|582723769|FG002|Overall Study|Lost to Follow-up|0|||
161364837|NCT04309500|582723770|FG003|Overall Study|Lost to Follow-up|0|||
161364838|NCT00913835|582723771|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
161364839|NCT00913835|582723772|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
161364840|NCT00913835|582723771|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
161364841|NCT00913835|582723772|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
161364842|NCT00913835|582723771|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
161364843|NCT00913835|582723772|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
161364844|NCT00913835|582723771|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
161364845|NCT00913835|582723772|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
161364846|NCT00913835|582723771|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
161364847|NCT00913835|582723772|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
161364848|NCT00773461|582723773|FG000|Overall Study|Adverse Event|1|||
161364849|NCT00773461|582723774|FG001|Overall Study|Adverse Event|3|||
161364850|NCT00773461|582723773|FG000|Overall Study|Withdrawal by Subject|4|||
161364851|NCT00773461|582723774|FG001|Overall Study|Withdrawal by Subject|1|||
161364852|NCT01373281|582725119|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
161364853|NCT01373281|582725120|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
161364854|NCT01373281|582725119|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
161364855|NCT01373281|582725120|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
161364856|NCT01373281|582725119|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
161364857|NCT01373281|582725120|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
161364858|NCT01373281|582725119|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
161364859|NCT01373281|582725120|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
161364860|NCT01373281|582725119|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
161364861|NCT01373281|582725120|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
161364862|NCT01373281|582725119|FG000|Surveillance Expansion Period|Protocol Violation|9|||
161364863|NCT01373281|582725120|FG001|Surveillance Expansion Period|Protocol Violation|1|||
161364864|NCT01373281|582725119|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
161364865|NCT01373281|582725120|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
161364866|NCT01373281|582725119|FG000|Surveillance Expansion Period|Serious adverse event|3|||
161364867|NCT01373281|582725120|FG001|Surveillance Expansion Period|Serious adverse event|4|||
161364868|NCT02296476|582725121|FG000|Overall Study|Disease Progression|6|||
161364869|NCT02296476|582725122|FG001|Overall Study|Disease Progression|4|||
161364870|NCT02296476|582725123|FG002|Overall Study|Disease Progression|2|||
161364871|NCT00980044|582725124|FG000|Overall Study|Withdrawal by Subject|5|||
161364872|NCT00980044|582725125|FG001|Overall Study|Withdrawal by Subject|7|||
161364873|NCT00980044|582725126|FG002|Overall Study|Withdrawal by Subject|3|||
161364874|NCT00980044|582725124|FG000|Overall Study|Protocol Violation|0|||
161364875|NCT00980044|582725125|FG001|Overall Study|Protocol Violation|0|||
161364876|NCT00980044|582725126|FG002|Overall Study|Protocol Violation|2|||
161364877|NCT03502681|582725127|FG000|Overall Study|Adverse Event|1|||
161364878|NCT03502681|582725128|FG001|Overall Study|Adverse Event|1|||
161364879|NCT03502681|582725127|FG000|Overall Study|Disease Progression|2|||
161364880|NCT03502681|582725128|FG001|Overall Study|Disease Progression|1|||
161364881|NCT03257657|582725129|FG000|Overall Study|Lost to Follow-up|0|||
161364882|NCT03257657|582725130|FG001|Overall Study|Lost to Follow-up|3|||
161364883|NCT03257657|582725129|FG000|Overall Study|Withdrawn|0|||
161364884|NCT03257657|582725130|FG001|Overall Study|Withdrawn|1|||
161364885|NCT03257657|582725129|FG000|Overall Study|Noted not eligible right after enrolled|0|||
161364886|NCT03257657|582725130|FG001|Overall Study|Noted not eligible right after enrolled|1|||
161364887|NCT02801578|582725131|FG000|Overall Study|Adverse Event|2|||
161364888|NCT00668642|582725139|FG000|First Off-cycle|Cancer progression|1|||
161364889|NCT00668642|582725140|FG001|First Off-cycle|Cancer progression|0|||
161364890|NCT00668642|582725139|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
161364891|NCT00668642|582725140|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
161364892|NCT03412591|582725141|FG000|Overall Study|Withdrawal by Subject|1|||
161364893|NCT03412591|582725142|FG001|Overall Study|Withdrawal by Subject|8|||
161364894|NCT03412591|582725141|FG000|Overall Study|Adverse Event|0|||
161364895|NCT03412591|582725142|FG001|Overall Study|Adverse Event|1|||
161364896|NCT02272985|582725143|FG000|Overall Study|Withdrawal by Subject|1|||
161364897|NCT02272985|582725143|FG000|Overall Study|hip fracture|1|||
161364898|NCT02272985|582725143|FG000|Overall Study|kidney transplantation|1|||
161364899|NCT02263547|582725150|FG000|Overall Study|Adverse Event|1|||
161364900|NCT02263547|582725150|FG000|Overall Study|Lost to Follow-up|2|||
161364901|NCT00505687|582725153|FG000|Overall Study|Important protocol violation|2|||
161364902|NCT00505687|582725153|FG000|Overall Study|Lack of Efficacy|15|||
161364903|NCT00505687|582725153|FG000|Overall Study|Adverse Event|48|||
161364904|NCT00505687|582725153|FG000|Overall Study|Subject withdrew consent|15|||
161364905|NCT00505687|582725153|FG000|Overall Study|Lost to Follow-up|1|||
161364906|NCT00505687|582725153|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
161364907|NCT00505687|582725153|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
161364908|NCT00505687|582725153|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
161364909|NCT00505687|582725153|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
161364910|NCT00505687|582725153|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
161364911|NCT00505687|582725153|FG000|Overall Study|Other: Disease Progression|1|||
161364912|NCT00505687|582725153|FG000|Overall Study|Other: As Per Sponsor|8|||
161364913|NCT03707821|582725154|FG000|Overall Study|Protocol Violation|0|||
161364914|NCT03707821|582725155|FG001|Overall Study|Protocol Violation|1|||
161364915|NCT03707821|582725154|FG000|Overall Study|Unsatisfactory Visual Response|1|||
161364916|NCT03707821|582725155|FG001|Overall Study|Unsatisfactory Visual Response|0|||
161364917|NCT03707821|582725154|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
161364918|NCT03707821|582725155|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
161364919|NCT03673176|582725156|FG000|Overall Study|Death prior to intervention|1|||
161364920|NCT03673176|582725156|FG000|Overall Study|Death following intervention|3|||
161364921|NCT03673176|582725156|FG000|Overall Study|Withdrawal by Subject|1|||
161364922|NCT00337168|582725157|FG000|Overall Study|Death|5|||
161364923|NCT00337168|582725157|FG000|Overall Study|Not protocol specified|2|||
161364924|NCT00337168|582725157|FG000|Overall Study|Did not start therapy|1|||
161364925|NCT02378480|582725160|FG000|Overall Study|Physician Decision|1|||
161364926|NCT02378480|582725161|FG001|Overall Study|Physician Decision|1|||
161364927|NCT02378480|582725160|FG000|Overall Study|Death|1|||
161364928|NCT02378480|582725161|FG001|Overall Study|Death|2|||
161364929|NCT02378480|582725160|FG000|Overall Study|Randomized, but Not Treated|6|||
161364930|NCT02378480|582725161|FG001|Overall Study|Randomized, but Not Treated|4|||
161364931|NCT02378480|582725160|FG000|Overall Study|Adverse Event|0|||
161364932|NCT02378480|582725161|FG001|Overall Study|Adverse Event|1|||
161364933|NCT02378480|582725160|FG000|Overall Study|Missed EOT/PTE Visit|1|||
161364934|NCT02378480|582725161|FG001|Overall Study|Missed EOT/PTE Visit|2|||
161364935|NCT02378480|582725160|FG000|Overall Study|Withdrawal by Subject|9|||
161364936|NCT02378480|582725161|FG001|Overall Study|Withdrawal by Subject|4|||
161364937|NCT02378480|582725160|FG000|Overall Study|Lost to Follow-up|10|||
161364938|NCT02378480|582725161|FG001|Overall Study|Lost to Follow-up|18|||
161364939|NCT02014467|582725165|FG000|Overall Study|Adverse Event|4|||
161364940|NCT02014467|582725166|FG001|Overall Study|Adverse Event|0|||
161364941|NCT02014467|582725165|FG000|Overall Study|Protocol Violation|3|||
161364942|NCT02014467|582725166|FG001|Overall Study|Protocol Violation|0|||
161364943|NCT02014467|582725165|FG000|Overall Study|Physician Decision|2|||
161364944|NCT02014467|582725166|FG001|Overall Study|Physician Decision|3|||
161364945|NCT02014467|582725165|FG000|Overall Study|Withdrawal by Subject|16|||
161364946|NCT02014467|582725166|FG001|Overall Study|Withdrawal by Subject|4|||
161364947|NCT01230060|582725167|FG000|Overall Study|Withdrawal by Subject|1|||
161364948|NCT01217892|582725169|FG000|Overall Study|Adverse Event|1|||
161364949|NCT01217892|582725170|FG001|Overall Study|Adverse Event|1|||
161364950|NCT01217892|582725171|FG002|Overall Study|Adverse Event|1|||
161364951|NCT01217892|582725172|FG003|Overall Study|Adverse Event|0|||
161364952|NCT01217892|582725169|FG000|Overall Study|Withdrawal by Subject|0|||
161364953|NCT01217892|582725170|FG001|Overall Study|Withdrawal by Subject|2|||
161364954|NCT01217892|582725171|FG002|Overall Study|Withdrawal by Subject|1|||
161364955|NCT01217892|582725172|FG003|Overall Study|Withdrawal by Subject|0|||
161364956|NCT01217892|582725169|FG000|Overall Study|Lab value|1|||
161364957|NCT01217892|582725170|FG001|Overall Study|Lab value|0|||
161364958|NCT01217892|582725171|FG002|Overall Study|Lab value|1|||
161364959|NCT01217892|582725172|FG003|Overall Study|Lab value|0|||
161364960|NCT01217892|582725169|FG000|Overall Study|Subject no longer meets study criteria|5|||
161364961|NCT01217892|582725170|FG001|Overall Study|Subject no longer meets study criteria|2|||
161364962|NCT01217892|582725171|FG002|Overall Study|Subject no longer meets study criteria|4|||
161364963|NCT01217892|582725172|FG003|Overall Study|Subject no longer meets study criteria|8|||
161364964|NCT01217892|582725169|FG000|Overall Study|Incorrect enrollment|0|||
161364965|NCT01217892|582725170|FG001|Overall Study|Incorrect enrollment|1|||
161364966|NCT01217892|582725171|FG002|Overall Study|Incorrect enrollment|1|||
161364967|NCT01217892|582725172|FG003|Overall Study|Incorrect enrollment|0|||
161364968|NCT01217892|582725169|FG000|Overall Study|Poor/Non-Compliance|0|||
161364969|NCT01217892|582725170|FG001|Overall Study|Poor/Non-Compliance|0|||
161364970|NCT01217892|582725171|FG002|Overall Study|Poor/Non-Compliance|1|||
161364971|NCT01217892|582725172|FG003|Overall Study|Poor/Non-Compliance|0|||
161364972|NCT03802916|582725174|FG000|Overall Study|Adverse Event|0|||
161364973|NCT03802916|582725175|FG001|Overall Study|Adverse Event|1|||
161364974|NCT03802916|582725174|FG000|Overall Study|Withdrawal by Subject|0|||
161364975|NCT03802916|582725175|FG001|Overall Study|Withdrawal by Subject|1|||
161364976|NCT00480532|582725176|FG000|Overall Study|Withdrawal by Subject|2|||
161364977|NCT00480532|582725177|FG001|Overall Study|Withdrawal by Subject|4|||
161364978|NCT00480532|582725178|FG002|Overall Study|Withdrawal by Subject|3|||
161364979|NCT00480532|582725179|FG003|Overall Study|Withdrawal by Subject|1|||
161364980|NCT00480532|582725176|FG000|Overall Study|Protocol Violation|0|||
161364981|NCT00480532|582725177|FG001|Overall Study|Protocol Violation|0|||
161364982|NCT00480532|582725178|FG002|Overall Study|Protocol Violation|1|||
161364983|NCT00480532|582725179|FG003|Overall Study|Protocol Violation|0|||
161364984|NCT01285102|582725180|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
161364985|NCT00557440|582725181|FG000|Treatment Period 1|Adverse Event|0|||
161364986|NCT00557440|582725182|FG001|Treatment Period 1|Adverse Event|0|||
161364987|NCT00557440|582725183|FG002|Treatment Period 1|Adverse Event|1|||
161364988|NCT01946880|582725186|FG000|Overall Study|Lost to Follow-up|1|||
161364989|NCT01946880|582725187|FG001|Overall Study|Lost to Follow-up|0|||
161364990|NCT01946880|582725186|FG000|Overall Study|Physician Decision|1|||
161364991|NCT01946880|582725187|FG001|Overall Study|Physician Decision|1|||
161364992|NCT01946880|582725186|FG000|Overall Study|Withdrawal by Subject|3|||
161364993|NCT01946880|582725187|FG001|Overall Study|Withdrawal by Subject|2|||
161364994|NCT01946880|582725186|FG000|Overall Study|Met Primary Endpoint|1|||
161364995|NCT01946880|582725187|FG001|Overall Study|Met Primary Endpoint|0|||
161364996|NCT01946880|582725186|FG000|Overall Study|Personal and Family Issues|1|||
161364997|NCT01946880|582725187|FG001|Overall Study|Personal and Family Issues|0|||
161364998|NCT02951819|582725188|FG000|Overall Study|Death|9|||
161364999|NCT02951819|582725189|FG001|Overall Study|Death|7|||
161365000|NCT02951819|582725188|FG000|Overall Study|Withdrawal by Subject|3|||
161365001|NCT02951819|582725189|FG001|Overall Study|Withdrawal by Subject|0|||
161365002|NCT02951819|582725188|FG000|Overall Study|Adverse Event|1|||
161365003|NCT02951819|582725189|FG001|Overall Study|Adverse Event|0|||
161365004|NCT02951819|582725188|FG000|Overall Study|Lack of Efficacy|4|||
161365005|NCT02951819|582725189|FG001|Overall Study|Lack of Efficacy|0|||
161365006|NCT02951819|582725188|FG000|Overall Study|Lost to Follow-up|1|||
161365007|NCT02951819|582725189|FG001|Overall Study|Lost to Follow-up|0|||
161365008|NCT02951819|582725188|FG000|Overall Study|Progressive Disease|1|||
161365009|NCT02951819|582725189|FG001|Overall Study|Progressive Disease|0|||
161365010|NCT02951819|582725188|FG000|Overall Study|Other|9|||
161365011|NCT02951819|582725189|FG001|Overall Study|Other|0|||
161365012|NCT02799043|582725190|FG000|Overall Study|Adverse Event|0|||
161365013|NCT02799043|582725191|FG001|Overall Study|Adverse Event|1|||
161365014|NCT02799043|582725190|FG000|Overall Study|Death|1|||
161365015|NCT02799043|582725191|FG001|Overall Study|Death|1|||
161365016|NCT02799043|582725190|FG000|Overall Study|Lost to Follow-up|3|||
161365017|NCT02799043|582725191|FG001|Overall Study|Lost to Follow-up|6|||
161365018|NCT02799043|582725190|FG000|Overall Study|Withdrawal by Subject|4|||
161365019|NCT02799043|582725191|FG001|Overall Study|Withdrawal by Subject|4|||
161365020|NCT02799043|582725190|FG000|Overall Study|Moved to different country|0|||
161365021|NCT02799043|582725191|FG001|Overall Study|Moved to different country|1|||
161365022|NCT02799043|582725190|FG000|Overall Study|Trial Screen Failure|1|||
161365023|NCT02799043|582725191|FG001|Overall Study|Trial Screen Failure|0|||
161365024|NCT02799043|582725190|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
161365025|NCT02799043|582725191|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
161365026|NCT02420314|582725197|FG000|Overall Study|Withdrawal by Subject|1|||
161365027|NCT02420314|582725197|FG000|Overall Study|Protocol Violation|1|||
161365028|NCT03760068|582725198|FG000|Overall Study|Withdrawal by Subject|7|||
161365029|NCT03760068|582725199|FG001|Overall Study|Withdrawal by Subject|8|||
161365030|NCT03760068|582725198|FG000|Overall Study|Adverse Event|1|||
161365031|NCT03760068|582725199|FG001|Overall Study|Adverse Event|2|||
161365032|NCT03760068|582725198|FG000|Overall Study|Administrative Decision by Sponsor|0|||
161365033|NCT03760068|582725199|FG001|Overall Study|Administrative Decision by Sponsor|2|||
161365034|NCT03760068|582725198|FG000|Overall Study|Physician Decision|1|||
161365035|NCT03760068|582725199|FG001|Overall Study|Physician Decision|2|||
161365036|NCT03760068|582725198|FG000|Overall Study|Lost to Follow-up|4|||
161365037|NCT03760068|582725199|FG001|Overall Study|Lost to Follow-up|9|||
161365038|NCT03760068|582725198|FG000|Overall Study|Subject Moved Out of State|1|||
161365039|NCT03760068|582725199|FG001|Overall Study|Subject Moved Out of State|0|||
161365040|NCT01618708|582725200|FG000|Overall Study|Adverse Event|10|||
161365041|NCT01618708|582725201|FG001|Overall Study|Adverse Event|10|||
161365042|NCT01618708|582725200|FG000|Overall Study|Lost to Follow-up|3|||
161365043|NCT01618708|582725201|FG001|Overall Study|Lost to Follow-up|3|||
161365044|NCT01618708|582725200|FG000|Overall Study|Withdrawal by Subject|17|||
161365045|NCT01618708|582725201|FG001|Overall Study|Withdrawal by Subject|22|||
161365046|NCT01618708|582725200|FG000|Overall Study|Lack of Efficacy|8|||
161365047|NCT01618708|582725201|FG001|Overall Study|Lack of Efficacy|8|||
161365048|NCT01618708|582725200|FG000|Overall Study|Technical problems|2|||
161365049|NCT01618708|582725201|FG001|Overall Study|Technical problems|0|||
161365050|NCT01618708|582725200|FG000|Overall Study|Other than specified above|1|||
161365051|NCT01618708|582725201|FG001|Overall Study|Other than specified above|1|||
161365052|NCT01618708|582725200|FG000|Overall Study|Randomized but not treated|3|||
161365053|NCT01618708|582725201|FG001|Overall Study|Randomized but not treated|2|||
161365054|NCT00680914|582725204|FG000|Overall Study|Consent withdrawal|6|||
161365055|NCT00680914|582725205|FG001|Overall Study|Consent withdrawal|3|||
161365056|NCT00680914|582725204|FG000|Overall Study|Lost to Follow-up|4|||
161365057|NCT00680914|582725205|FG001|Overall Study|Lost to Follow-up|0|||
161365058|NCT00680914|582725204|FG000|Overall Study|serious adverse event (SAE)|0|||
161365059|NCT00680914|582725205|FG001|Overall Study|serious adverse event (SAE)|1|||
161365060|NCT03131479|582725206|FG000|Overall Study|Adverse Event|0|||
161365061|NCT03131479|582725207|FG001|Overall Study|Adverse Event|0|||
161365062|NCT03131479|582725208|FG002|Overall Study|Adverse Event|1|||
161365063|NCT03131479|582725209|FG003|Overall Study|Adverse Event|1|||
161365064|NCT03131479|582725210|FG004|Overall Study|Adverse Event|0|||
161365065|NCT03131479|582725206|FG000|Overall Study|Subject/Guardian Decision|0|||
161365066|NCT03131479|582725207|FG001|Overall Study|Subject/Guardian Decision|0|||
161365067|NCT03131479|582725208|FG002|Overall Study|Subject/Guardian Decision|0|||
161365068|NCT03131479|582725209|FG003|Overall Study|Subject/Guardian Decision|1|||
161365069|NCT03131479|582725210|FG004|Overall Study|Subject/Guardian Decision|0|||
161365070|NCT03204812|582725217|FG000|Overall Study|Adverse Event|3|||
161365071|NCT02412436|582725218|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
161365072|NCT02412436|582725218|FG000|Overall Study|Lost to Follow-up|6|||
161365073|NCT02412436|582725218|FG000|Overall Study|Unable to get to clinic|3|||
161365074|NCT02412436|582725218|FG000|Overall Study|Death|1|||
161365075|NCT02412436|582725218|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
161365076|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
161365077|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161365078|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161365079|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161365080|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161365081|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
161365082|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161365083|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161365084|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161365085|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161365086|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
161365087|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161365088|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161365089|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161365090|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161365091|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
161365092|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161365093|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161365094|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161365095|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161365096|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
161365097|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161365098|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161365099|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161365100|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161365101|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
161365102|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161365103|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161365104|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161365105|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161365106|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
161365107|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161365108|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161365109|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161365110|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161365111|NCT01111552|582725219|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
161365112|NCT01111552|582725220|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161365113|NCT01111552|582725221|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161365114|NCT01111552|582725222|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161365115|NCT01111552|582725223|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161365116|NCT01111552|582725219|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161365117|NCT01111552|582725220|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161365118|NCT01111552|582725221|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161365119|NCT01111552|582725222|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
161365120|NCT01111552|582725223|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161365121|NCT01111552|582725219|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161365122|NCT01111552|582725220|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161365123|NCT01111552|582725221|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
161365124|NCT01111552|582725222|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161365125|NCT01111552|582725223|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161365126|NCT01111552|582725219|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161365127|NCT01111552|582725220|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
161365128|NCT01111552|582725221|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161365129|NCT01111552|582725222|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161365130|NCT01111552|582725223|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161365131|NCT01111552|582725219|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161365132|NCT01111552|582725220|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
161365133|NCT01111552|582725221|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161365134|NCT01111552|582725222|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161365135|NCT01111552|582725223|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161365136|NCT01111552|582725219|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161365137|NCT01111552|582725220|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
161365138|NCT01111552|582725221|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161365139|NCT01111552|582725222|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161365140|NCT01111552|582725223|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161435950|NCT01535040|582989737|FG000|Overall Study|Physician Decision|0|||
161365141|NCT01111552|582725219|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161365142|NCT01111552|582725220|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161365143|NCT01111552|582725221|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
161365144|NCT01111552|582725222|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161365145|NCT01111552|582725223|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161365146|NCT01027351|582725225|FG000|Overall Study|Withdrawal by Subject|1|||
161365147|NCT01027351|582725226|FG001|Overall Study|Withdrawal by Subject|0|||
161365148|NCT01027351|582725227|FG002|Overall Study|Withdrawal by Subject|1|||
161365149|NCT01027351|582725228|FG003|Overall Study|Withdrawal by Subject|0|||
161365150|NCT01027351|582725229|FG004|Overall Study|Withdrawal by Subject|3|||
161365151|NCT01027351|582725230|FG005|Overall Study|Withdrawal by Subject|5|||
161365152|NCT01027351|582725225|FG000|Overall Study|Lost to Follow-up|1|||
161365153|NCT01027351|582725226|FG001|Overall Study|Lost to Follow-up|1|||
161365154|NCT01027351|582725227|FG002|Overall Study|Lost to Follow-up|0|||
161365155|NCT01027351|582725228|FG003|Overall Study|Lost to Follow-up|1|||
161365156|NCT01027351|582725229|FG004|Overall Study|Lost to Follow-up|6|||
161365157|NCT01027351|582725230|FG005|Overall Study|Lost to Follow-up|0|||
161365158|NCT01027351|582725225|FG000|Overall Study|Inappropriate enrollment|0|||
161365159|NCT01027351|582725226|FG001|Overall Study|Inappropriate enrollment|0|||
161365160|NCT01027351|582725227|FG002|Overall Study|Inappropriate enrollment|0|||
161365161|NCT01027351|582725228|FG003|Overall Study|Inappropriate enrollment|0|||
161365162|NCT01027351|582725229|FG004|Overall Study|Inappropriate enrollment|1|||
161365163|NCT01027351|582725230|FG005|Overall Study|Inappropriate enrollment|0|||
161365164|NCT01027351|582725225|FG000|Overall Study|Protocol Violation|1|||
161365165|NCT01027351|582725226|FG001|Overall Study|Protocol Violation|0|||
161365166|NCT01027351|582725227|FG002|Overall Study|Protocol Violation|0|||
161365167|NCT01027351|582725228|FG003|Overall Study|Protocol Violation|1|||
161365168|NCT01027351|582725229|FG004|Overall Study|Protocol Violation|1|||
161365169|NCT01027351|582725230|FG005|Overall Study|Protocol Violation|0|||
161365170|NCT04650893|582725231|FG000|Overall Study|Lost to Follow-up|11|||
161365171|NCT04650893|582725232|FG001|Overall Study|Lost to Follow-up|10|||
161365172|NCT04650893|582725233|FG002|Overall Study|Lost to Follow-up|11|||
161365173|NCT00637156|582725234|FG000|Overall Study|Withdrawal by Subject|0|||
161365174|NCT00637156|582725235|FG001|Overall Study|Withdrawal by Subject|7|||
161365175|NCT00637156|582725234|FG000|Overall Study|Death|0|||
161365176|NCT00637156|582725235|FG001|Overall Study|Death|1|||
161365177|NCT00637156|582725234|FG000|Overall Study|Lost to Follow-up|10|||
161365178|NCT00637156|582725235|FG001|Overall Study|Lost to Follow-up|16|||
161365179|NCT02679274|582725236|FG000|Overall Study|Withdrawal by Subject|1|||
161365180|NCT02679274|582725237|FG001|Overall Study|Withdrawal by Subject|0|||
161365181|NCT03193437|582725244|FG000|Overall Study|Adverse Event|4|||
161365182|NCT03193437|582725244|FG000|Overall Study|Withdrawal by Subject|2|||
161365183|NCT03193437|582725244|FG000|Overall Study|Disease Progression|2|||
161365184|NCT04976855|582725245|FG000|Part I|Withdrawal by Subject|0|||
161365185|NCT04976855|582725246|FG001|Part I|Withdrawal by Subject|1|||
161365186|NCT04976855|582725247|FG002|Part I|Withdrawal by Subject|0|||
161365187|NCT04976855|582725248|FG003|Part I|Withdrawal by Subject|0|||
161365188|NCT04976855|582725249|FG004|Part I|Withdrawal by Subject|0|||
161365189|NCT04976855|582725250|FG005|Part I|Withdrawal by Subject|0|||
161365190|NCT04976855|582725251|FG006|Part I|Withdrawal by Subject|0|||
161365191|NCT04976855|582725245|FG000|Part II|Adverse Event|0|||
161365192|NCT04976855|582725246|FG001|Part II|Adverse Event|0|||
161365193|NCT04976855|582725247|FG002|Part II|Adverse Event|0|||
161365194|NCT04976855|582725248|FG003|Part II|Adverse Event|1|||
161365195|NCT04976855|582725249|FG004|Part II|Adverse Event|0|||
161365196|NCT04976855|582725250|FG005|Part II|Adverse Event|0|||
161365197|NCT04976855|582725251|FG006|Part II|Adverse Event|0|||
161365198|NCT04976855|582725245|FG000|Part II|Withdrawal by Subject|0|||
161365199|NCT04976855|582725246|FG001|Part II|Withdrawal by Subject|0|||
161365200|NCT04976855|582725247|FG002|Part II|Withdrawal by Subject|0|||
161365201|NCT04976855|582725248|FG003|Part II|Withdrawal by Subject|0|||
161365202|NCT04976855|582725249|FG004|Part II|Withdrawal by Subject|1|||
161365203|NCT04976855|582725250|FG005|Part II|Withdrawal by Subject|0|||
161365204|NCT04976855|582725251|FG006|Part II|Withdrawal by Subject|0|||
161365205|NCT04976855|582725245|FG000|Part II|Lost to Follow-up|0|||
161365206|NCT04976855|582725246|FG001|Part II|Lost to Follow-up|0|||
161365207|NCT04976855|582725247|FG002|Part II|Lost to Follow-up|0|||
161365208|NCT04976855|582725248|FG003|Part II|Lost to Follow-up|0|||
161365209|NCT04976855|582725249|FG004|Part II|Lost to Follow-up|0|||
161365210|NCT04976855|582725250|FG005|Part II|Lost to Follow-up|1|||
161365211|NCT04976855|582725251|FG006|Part II|Lost to Follow-up|0|||
161365212|NCT02038036|582725252|FG000|Core Study|Adverse Event|7|||
161365213|NCT02038036|582725253|FG001|Core Study|Adverse Event|7|||
161365214|NCT02038036|582725252|FG000|Core Study|Death|1|||
161365215|NCT02038036|582725253|FG001|Core Study|Death|1|||
161365216|NCT02038036|582725252|FG000|Core Study|Disease progression|2|||
161365217|NCT02038036|582725253|FG001|Core Study|Disease progression|2|||
161365218|NCT02038036|582725252|FG000|Core Study|Lost to Follow-up|0|||
161365219|NCT02038036|582725253|FG001|Core Study|Lost to Follow-up|1|||
161365220|NCT02038036|582725252|FG000|Core Study|Physician Decision|2|||
161365221|NCT02038036|582725253|FG001|Core Study|Physician Decision|1|||
161365222|NCT02038036|582725252|FG000|Core Study|Subject/guardian decision|0|||
161365223|NCT02038036|582725253|FG001|Core Study|Subject/guardian decision|1|||
161365224|NCT02038036|582725252|FG000|Core Study|Withdrawal by Subject|3|||
161365225|NCT02038036|582725253|FG001|Core Study|Withdrawal by Subject|1|||
161365226|NCT02038036|582725252|FG000|Crossover Period|Withdrawal by Subject|0|||
161365227|NCT02038036|582725253|FG001|Crossover Period|Withdrawal by Subject|3|||
161365228|NCT02038036|582725252|FG000|Crossover Period|Adverse Event|0|||
161365229|NCT02038036|582725253|FG001|Crossover Period|Adverse Event|9|||
161365230|NCT02038036|582725252|FG000|Crossover Period|Death|0|||
161365231|NCT02038036|582725253|FG001|Crossover Period|Death|2|||
161365232|NCT02038036|582725252|FG000|Crossover Period|Disease progression|0|||
161365233|NCT02038036|582725253|FG001|Crossover Period|Disease progression|3|||
161365234|NCT02038036|582725252|FG000|Crossover Period|Lost to Follow-up|0|||
161365235|NCT02038036|582725253|FG001|Crossover Period|Lost to Follow-up|1|||
161365236|NCT02038036|582725252|FG000|Crossover Period|Physician Decision|0|||
161365237|NCT02038036|582725253|FG001|Crossover Period|Physician Decision|2|||
161365238|NCT00908141|582725262|FG000|Overall Study|Withdrawal by Subject|0|||
161365239|NCT00908141|582725263|FG001|Overall Study|Withdrawal by Subject|1|||
161365240|NCT02657356|582726556|FG000|Overall Study|Death|1|||
161365241|NCT02657356|582726557|FG001|Overall Study|Death|0|||
161365242|NCT02657356|582726556|FG000|Overall Study|Withdrawal by Subject|5|||
161365243|NCT02657356|582726557|FG001|Overall Study|Withdrawal by Subject|6|||
161365244|NCT02657356|582726556|FG000|Overall Study|Terminated by Sponsor|8|||
161365245|NCT02657356|582726557|FG001|Overall Study|Terminated by Sponsor|5|||
161365246|NCT02657356|582726556|FG000|Overall Study|Rolled over to EAP study|6|||
161365247|NCT02657356|582726557|FG001|Overall Study|Rolled over to EAP study|4|||
161365248|NCT03514134|582726558|FG000|Overall Study|Lost to Follow-up|0|||
161365249|NCT03514134|582726559|FG001|Overall Study|Lost to Follow-up|1|||
161365250|NCT03058952|582726560|FG000|Overall Study|Adverse Event|1|||
161365251|NCT03058952|582726561|FG001|Overall Study|Adverse Event|0|||
161365252|NCT03058952|582726560|FG000|Overall Study|Lost to Follow-up|15|||
161365253|NCT03058952|582726561|FG001|Overall Study|Lost to Follow-up|15|||
161365254|NCT03058952|582726560|FG000|Overall Study|Withdrawal by Subject|7|||
161365255|NCT03058952|582726561|FG001|Overall Study|Withdrawal by Subject|11|||
161365256|NCT03768336|582726562|FG000|Overall Study|Lost to Follow-up|3|||
161365257|NCT03768336|582726563|FG001|Overall Study|Lost to Follow-up|2|||
161365258|NCT03768336|582726562|FG000|Overall Study|Became Ineligible|2|||
161365259|NCT03768336|582726563|FG001|Overall Study|Became Ineligible|0|||
161365260|NCT03768336|582726562|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
161365261|NCT03768336|582726563|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
161365262|NCT03768336|582726562|FG000|Overall Study|Missed final survey (post-treatment|0|||
161365263|NCT03768336|582726563|FG001|Overall Study|Missed final survey (post-treatment|1|||
161365264|NCT02278003|582726564|FG000|Overall Study|Withdrawal by Subject|11|||
161365265|NCT02278003|582726565|FG001|Overall Study|Withdrawal by Subject|0|||
161365266|NCT02278003|582726564|FG000|Overall Study|Not Treated|1|||
161365267|NCT02278003|582726565|FG001|Overall Study|Not Treated|0|||
161365268|NCT02278003|582726564|FG000|Overall Study|Recognition task improperly completed|7|||
161365269|NCT02278003|582726565|FG001|Overall Study|Recognition task improperly completed|0|||
161365270|NCT01397253|582726566|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
161365271|NCT01397253|582726567|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
161365272|NCT00442702|582726572|FG000|Titration Period|Adverse Event|2|||
161365273|NCT00442702|582726573|FG001|Titration Period|Adverse Event|0|||
161365274|NCT00442702|582726572|FG000|Titration Period|Death|3|||
161365275|NCT00442702|582726573|FG001|Titration Period|Death|2|||
161365276|NCT00442702|582726572|FG000|Titration Period|Insufficient Therapeutic Response|1|||
161365277|NCT00442702|582726573|FG001|Titration Period|Insufficient Therapeutic Response|0|||
161365278|NCT00442702|582726572|FG000|Titration Period|Refused Treatment|4|||
161365279|NCT00442702|582726573|FG001|Titration Period|Refused Treatment|1|||
161365280|NCT00442702|582726572|FG000|Titration Period|Failure to return|1|||
161365281|NCT00442702|582726573|FG001|Titration Period|Failure to return|0|||
161365282|NCT00442702|582726572|FG000|Titration Period|Hospitalized in another hospital|1|||
161365283|NCT00442702|582726573|FG001|Titration Period|Hospitalized in another hospital|0|||
161365284|NCT00442702|582726572|FG000|Evaluation Period|Adverse Event|1|||
161365285|NCT00442702|582726573|FG001|Evaluation Period|Adverse Event|0|||
161365286|NCT00442702|582726572|FG000|Evaluation Period|Death|1|||
161365287|NCT00442702|582726573|FG001|Evaluation Period|Death|1|||
161365288|NCT00442702|582726572|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
161365289|NCT00442702|582726573|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
161365290|NCT00442702|582726572|FG000|Evaluation Period|Refused treatment|1|||
161365291|NCT00442702|582726573|FG001|Evaluation Period|Refused treatment|1|||
161365292|NCT00442702|582726572|FG000|Evaluation Period|Renal transplant|0|||
161365293|NCT00442702|582726573|FG001|Evaluation Period|Renal transplant|1|||
161365294|NCT00442702|582726572|FG000|Evaluation Period|Failure to return|1|||
161365295|NCT00442702|582726573|FG001|Evaluation Period|Failure to return|0|||
161365296|NCT00442702|582726572|FG000|Evaluation Period|Site closure|0|||
161365297|NCT00442702|582726573|FG001|Evaluation Period|Site closure|1|||
161365298|NCT01444781|582726574|FG000|Overall Study|Lost to Follow-up|0|||
161365299|NCT01444781|582726575|FG001|Overall Study|Lost to Follow-up|3|||
161365300|NCT01444781|582726576|FG002|Overall Study|Lost to Follow-up|1|||
161365301|NCT01444781|582726574|FG000|Overall Study|Withdrawal by Subject|3|||
161365302|NCT01444781|582726575|FG001|Overall Study|Withdrawal by Subject|1|||
161365303|NCT01444781|582726576|FG002|Overall Study|Withdrawal by Subject|2|||
161365304|NCT00500331|582726579|FG000|Overall Study|Adverse Event|0|||
161365305|NCT00500331|582726580|FG001|Overall Study|Adverse Event|2|||
161365306|NCT00500331|582726581|FG002|Overall Study|Adverse Event|0|||
161365307|NCT00500331|582726582|FG003|Overall Study|Adverse Event|1|||
161365308|NCT00500331|582726583|FG004|Overall Study|Adverse Event|2|||
161365309|NCT00500331|582726584|FG005|Overall Study|Adverse Event|2|||
161365310|NCT00500331|582726585|FG006|Overall Study|Adverse Event|0|||
161365311|NCT00500331|582726579|FG000|Overall Study|Lost to Follow-up|1|||
161365312|NCT00500331|582726580|FG001|Overall Study|Lost to Follow-up|1|||
161365313|NCT00500331|582726581|FG002|Overall Study|Lost to Follow-up|1|||
161365314|NCT00500331|582726582|FG003|Overall Study|Lost to Follow-up|2|||
161365315|NCT00500331|582726583|FG004|Overall Study|Lost to Follow-up|1|||
161365316|NCT00500331|582726584|FG005|Overall Study|Lost to Follow-up|0|||
161365317|NCT00500331|582726585|FG006|Overall Study|Lost to Follow-up|0|||
161365318|NCT00500331|582726579|FG000|Overall Study|Protocol Violation|3|||
161365319|NCT00500331|582726580|FG001|Overall Study|Protocol Violation|1|||
161365320|NCT00500331|582726581|FG002|Overall Study|Protocol Violation|1|||
161365321|NCT00500331|582726582|FG003|Overall Study|Protocol Violation|0|||
161365322|NCT00500331|582726583|FG004|Overall Study|Protocol Violation|1|||
161365323|NCT00500331|582726584|FG005|Overall Study|Protocol Violation|1|||
161365324|NCT00500331|582726585|FG006|Overall Study|Protocol Violation|1|||
161365325|NCT00500331|582726579|FG000|Overall Study|Withdrawal by Subject|4|||
161365326|NCT00500331|582726580|FG001|Overall Study|Withdrawal by Subject|0|||
161365327|NCT00500331|582726581|FG002|Overall Study|Withdrawal by Subject|1|||
161365328|NCT00500331|582726582|FG003|Overall Study|Withdrawal by Subject|5|||
161365329|NCT00500331|582726583|FG004|Overall Study|Withdrawal by Subject|0|||
161365330|NCT00500331|582726584|FG005|Overall Study|Withdrawal by Subject|1|||
161365331|NCT00500331|582726585|FG006|Overall Study|Withdrawal by Subject|1|||
161365332|NCT00500331|582726579|FG000|Overall Study|Lack of Efficacy|3|||
161365333|NCT00500331|582726580|FG001|Overall Study|Lack of Efficacy|1|||
161365334|NCT00500331|582726581|FG002|Overall Study|Lack of Efficacy|0|||
161365335|NCT00500331|582726582|FG003|Overall Study|Lack of Efficacy|0|||
161365336|NCT00500331|582726583|FG004|Overall Study|Lack of Efficacy|0|||
161365337|NCT00500331|582726584|FG005|Overall Study|Lack of Efficacy|0|||
161365338|NCT00500331|582726585|FG006|Overall Study|Lack of Efficacy|0|||
161365339|NCT00500331|582726579|FG000|Overall Study|Liver function test abnormality|0|||
161365340|NCT00500331|582726580|FG001|Overall Study|Liver function test abnormality|0|||
161365341|NCT00500331|582726581|FG002|Overall Study|Liver function test abnormality|1|||
161365342|NCT00500331|582726582|FG003|Overall Study|Liver function test abnormality|0|||
161365343|NCT00500331|582726583|FG004|Overall Study|Liver function test abnormality|0|||
161365344|NCT00500331|582726584|FG005|Overall Study|Liver function test abnormality|0|||
161365345|NCT00500331|582726585|FG006|Overall Study|Liver function test abnormality|0|||
161365346|NCT00500331|582726579|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
161365347|NCT00500331|582726580|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
161365348|NCT00500331|582726581|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
161365349|NCT00500331|582726582|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
161365350|NCT00500331|582726583|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
161365351|NCT00500331|582726584|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
161365352|NCT00500331|582726585|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
161365353|NCT00500331|582726579|FG000|Overall Study|Didn't return for continuation of study|1|||
161365354|NCT00500331|582726580|FG001|Overall Study|Didn't return for continuation of study|0|||
161365355|NCT00500331|582726581|FG002|Overall Study|Didn't return for continuation of study|0|||
161365356|NCT00500331|582726582|FG003|Overall Study|Didn't return for continuation of study|0|||
161365357|NCT00500331|582726583|FG004|Overall Study|Didn't return for continuation of study|0|||
161365358|NCT00500331|582726584|FG005|Overall Study|Didn't return for continuation of study|0|||
161365359|NCT00500331|582726585|FG006|Overall Study|Didn't return for continuation of study|0|||
161365360|NCT00500331|582726579|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
161365361|NCT00500331|582726580|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
161365362|NCT00500331|582726581|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
161365363|NCT00500331|582726582|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
161365364|NCT00500331|582726583|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
161365365|NCT00500331|582726584|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
161365366|NCT00500331|582726585|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
161365367|NCT00500331|582726579|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
161365368|NCT00500331|582726580|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
161365369|NCT00500331|582726581|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
161365370|NCT00500331|582726582|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
161365371|NCT00500331|582726583|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
161365372|NCT00500331|582726584|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
161365373|NCT00500331|582726585|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
161365374|NCT00500331|582726579|FG000|Overall Study|Participant was randomized by mistake|1|||
161365375|NCT00500331|582726580|FG001|Overall Study|Participant was randomized by mistake|0|||
161365376|NCT00500331|582726581|FG002|Overall Study|Participant was randomized by mistake|0|||
161365377|NCT00500331|582726582|FG003|Overall Study|Participant was randomized by mistake|0|||
161365378|NCT00500331|582726583|FG004|Overall Study|Participant was randomized by mistake|0|||
161365379|NCT00500331|582726584|FG005|Overall Study|Participant was randomized by mistake|0|||
161365380|NCT00500331|582726585|FG006|Overall Study|Participant was randomized by mistake|0|||
161365381|NCT00500331|582726579|FG000|Overall Study|Diabetologist nurse in the study|0|||
161365382|NCT00500331|582726580|FG001|Overall Study|Diabetologist nurse in the study|0|||
161365383|NCT00500331|582726581|FG002|Overall Study|Diabetologist nurse in the study|1|||
161365384|NCT00500331|582726582|FG003|Overall Study|Diabetologist nurse in the study|0|||
161365385|NCT00500331|582726583|FG004|Overall Study|Diabetologist nurse in the study|0|||
161365386|NCT00500331|582726584|FG005|Overall Study|Diabetologist nurse in the study|0|||
161365387|NCT00500331|582726585|FG006|Overall Study|Diabetologist nurse in the study|0|||
161365388|NCT00500331|582726579|FG000|Overall Study|State ban of biological samples export|0|||
161365389|NCT00500331|582726580|FG001|Overall Study|State ban of biological samples export|0|||
161365390|NCT00500331|582726581|FG002|Overall Study|State ban of biological samples export|0|||
161365391|NCT00500331|582726582|FG003|Overall Study|State ban of biological samples export|1|||
161365392|NCT00500331|582726583|FG004|Overall Study|State ban of biological samples export|0|||
161365393|NCT00500331|582726584|FG005|Overall Study|State ban of biological samples export|0|||
161365394|NCT00500331|582726585|FG006|Overall Study|State ban of biological samples export|0|||
161365395|NCT00500331|582726579|FG000|Overall Study|Protocol violated|0|||
161365396|NCT00500331|582726580|FG001|Overall Study|Protocol violated|0|||
161365397|NCT00500331|582726581|FG002|Overall Study|Protocol violated|0|||
161365398|NCT00500331|582726582|FG003|Overall Study|Protocol violated|1|||
161365399|NCT00500331|582726583|FG004|Overall Study|Protocol violated|0|||
161365400|NCT00500331|582726584|FG005|Overall Study|Protocol violated|0|||
161365401|NCT00500331|582726585|FG006|Overall Study|Protocol violated|0|||
161365402|NCT03345550|582726586|FG000|Overall Study|Withdrawal by Subject|1|||
161365403|NCT03345550|582726587|FG001|Overall Study|Withdrawal by Subject|0|||
161365404|NCT03345550|582726586|FG000|Overall Study|Lost to Follow-up|4|||
161365405|NCT03345550|582726587|FG001|Overall Study|Lost to Follow-up|5|||
161365406|NCT03014089|582726591|FG000|Overall Study|Withdrawal by Subject|0|||
161365407|NCT03014089|582726592|FG001|Overall Study|Withdrawal by Subject|1|||
161365408|NCT03014089|582726593|FG002|Overall Study|Withdrawal by Subject|1|||
161365409|NCT03014089|582726594|FG003|Overall Study|Withdrawal by Subject|1|||
161365410|NCT03014089|582726591|FG000|Overall Study|Lost to Follow-up|1|||
161365411|NCT03014089|582726592|FG001|Overall Study|Lost to Follow-up|0|||
161365412|NCT03014089|582726593|FG002|Overall Study|Lost to Follow-up|0|||
161365413|NCT03014089|582726594|FG003|Overall Study|Lost to Follow-up|0|||
161365414|NCT03014089|582726591|FG000|Overall Study|Adverse Event|1|||
161365415|NCT03014089|582726592|FG001|Overall Study|Adverse Event|0|||
161365416|NCT03014089|582726593|FG002|Overall Study|Adverse Event|1|||
161365417|NCT03014089|582726594|FG003|Overall Study|Adverse Event|0|||
161365418|NCT01149460|582726595|FG000|Overall Study|Withdrawal by Subject|0|||
161365419|NCT01149460|582726596|FG001|Overall Study|Withdrawal by Subject|2|||
161365420|NCT00321932|582726597|FG000|Overall Study|Death|3|||
161365421|NCT00321932|582726598|FG001|Overall Study|Death|6|||
161365422|NCT00321932|582726597|FG000|Overall Study|Withdrawal by Subject|3|||
161365423|NCT00321932|582726598|FG001|Overall Study|Withdrawal by Subject|6|||
161365424|NCT00321932|582726597|FG000|Overall Study|Early relapse|2|||
161365425|NCT00321932|582726598|FG001|Overall Study|Early relapse|8|||
161365426|NCT00321932|582726597|FG000|Overall Study|Missing data|2|||
161365427|NCT00321932|582726598|FG001|Overall Study|Missing data|1|||
161365428|NCT00734032|582726599|FG000|Overall Study|Adverse Event|0|||
161365429|NCT00734032|582726600|FG001|Overall Study|Adverse Event|1|||
161365430|NCT00734032|582726601|FG002|Overall Study|Adverse Event|0|||
161365431|NCT00734032|582726602|FG003|Overall Study|Adverse Event|0|||
161365432|NCT03468998|582726605|FG000|Overall Study|Withdrawal by Subject|1|||
161365433|NCT03468998|582726606|FG001|Overall Study|Withdrawal by Subject|1|||
161365434|NCT03468998|582726607|FG002|Overall Study|Withdrawal by Subject|0|||
161365435|NCT03468998|582726608|FG003|Overall Study|Withdrawal by Subject|4|||
161365436|NCT03468998|582726609|FG004|Overall Study|Withdrawal by Subject|1|||
161365437|NCT03468998|582726610|FG005|Overall Study|Withdrawal by Subject|0|||
161365438|NCT00137449|582726611|FG000|Overall Study|Disease Progression|8|||
161365439|NCT00137449|582726612|FG001|Overall Study|Disease Progression|13|||
161365440|NCT00137449|582726611|FG000|Overall Study|Death|4|||
161365441|NCT00137449|582726612|FG001|Overall Study|Death|3|||
161365442|NCT00137449|582726611|FG000|Overall Study|Adverse Event|3|||
161365443|NCT00137449|582726612|FG001|Overall Study|Adverse Event|1|||
161365444|NCT00137449|582726611|FG000|Overall Study|Withdrawal by Subject|1|||
161365445|NCT00137449|582726612|FG001|Overall Study|Withdrawal by Subject|1|||
161365446|NCT01356940|582726613|FG000|First Intervention (28 Days)|Adverse Event|1|||
161365447|NCT01356940|582726614|FG001|First Intervention (28 Days)|Adverse Event|0|||
161365448|NCT01356940|582726613|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
161365449|NCT01356940|582726614|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
161365450|NCT02489279|582726615|FG000|Overall Study|Lost to Follow-up|12|||
161365451|NCT02489279|582726616|FG001|Overall Study|Lost to Follow-up|10|||
161365452|NCT03440411|582726617|FG000|Overall Study|Adverse Event|0|||
161365453|NCT03440411|582726618|FG001|Overall Study|Adverse Event|0|||
161365454|NCT03440411|582726619|FG002|Overall Study|Adverse Event|1|||
161365455|NCT03440411|582726620|FG003|Overall Study|Adverse Event|0|||
161365456|NCT03440411|582726617|FG000|Overall Study|PD|2|||
161365457|NCT03440411|582726618|FG001|Overall Study|PD|1|||
161365458|NCT03440411|582726619|FG002|Overall Study|PD|1|||
161365459|NCT03440411|582726620|FG003|Overall Study|PD|1|||
161365460|NCT03440411|582726617|FG000|Overall Study|Withdrawal by Subject|1|||
161365461|NCT03440411|582726618|FG001|Overall Study|Withdrawal by Subject|0|||
161365462|NCT03440411|582726619|FG002|Overall Study|Withdrawal by Subject|0|||
161365463|NCT03440411|582726620|FG003|Overall Study|Withdrawal by Subject|0|||
161365464|NCT03440411|582726617|FG000|Overall Study|Closed study by sponsor|0|||
161365465|NCT03440411|582726618|FG001|Overall Study|Closed study by sponsor|0|||
161365466|NCT03440411|582726619|FG002|Overall Study|Closed study by sponsor|0|||
161365467|NCT03440411|582726620|FG003|Overall Study|Closed study by sponsor|1|||
161365468|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
161365469|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
161365470|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
161365471|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
161365472|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
161365473|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
161365474|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
161365475|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
161365476|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
161365477|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
161365478|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
161365479|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
161365480|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
161365481|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
161365482|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
161365483|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
161365484|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
161365485|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
161365486|NCT01432444|582726621|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
161365487|NCT01432444|582726622|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
161365488|NCT01432444|582726623|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
161365489|NCT01432444|582726621|FG000|Treatment Phase|Lost to Follow-up|0|||
161365490|NCT01432444|582726622|FG001|Treatment Phase|Lost to Follow-up|33|||
161365491|NCT01432444|582726623|FG002|Treatment Phase|Lost to Follow-up|0|||
161365492|NCT01432444|582726621|FG000|Treatment Phase|Adverse Event|0|||
161365493|NCT01432444|582726622|FG001|Treatment Phase|Adverse Event|37|||
161365494|NCT01432444|582726623|FG002|Treatment Phase|Adverse Event|0|||
161365495|NCT01432444|582726621|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
161365496|NCT01432444|582726622|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
161365497|NCT01432444|582726623|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
161365498|NCT01432444|582726621|FG000|Treatment Phase|Physician Decision|0|||
161365499|NCT01432444|582726622|FG001|Treatment Phase|Physician Decision|5|||
161365500|NCT01432444|582726623|FG002|Treatment Phase|Physician Decision|0|||
161365501|NCT01432444|582726621|FG000|Treatment Phase|Withdrawal by Subject|0|||
161365502|NCT01432444|582726622|FG001|Treatment Phase|Withdrawal by Subject|41|||
161365503|NCT01432444|582726623|FG002|Treatment Phase|Withdrawal by Subject|0|||
161365504|NCT01432444|582726621|FG000|Treatment Phase|Protocol Deviation|0|||
161365505|NCT01432444|582726622|FG001|Treatment Phase|Protocol Deviation|3|||
161365506|NCT01432444|582726623|FG002|Treatment Phase|Protocol Deviation|0|||
161365507|NCT01432444|582726621|FG000|Treatment Phase|Lack of Efficacy|0|||
161365508|NCT01432444|582726622|FG001|Treatment Phase|Lack of Efficacy|10|||
161365509|NCT01432444|582726623|FG002|Treatment Phase|Lack of Efficacy|0|||
161365510|NCT01432444|582726621|FG000|Extension Phase|Lost to Follow-up|0|||
161365511|NCT01432444|582726622|FG001|Extension Phase|Lost to Follow-up|0|||
161365512|NCT01432444|582726623|FG002|Extension Phase|Lost to Follow-up|17|||
161365513|NCT01432444|582726621|FG000|Extension Phase|Adverse Event|0|||
161365514|NCT01432444|582726622|FG001|Extension Phase|Adverse Event|0|||
161365515|NCT01432444|582726623|FG002|Extension Phase|Adverse Event|10|||
161365516|NCT01432444|582726621|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
161365517|NCT01432444|582726622|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
161365518|NCT01432444|582726623|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
161365519|NCT01432444|582726621|FG000|Extension Phase|Met Withdrawal Criteria|0|||
161365520|NCT01432444|582726622|FG001|Extension Phase|Met Withdrawal Criteria|0|||
161365521|NCT01432444|582726623|FG002|Extension Phase|Met Withdrawal Criteria|144|||
161365522|NCT01432444|582726621|FG000|Extension Phase|Physician Decision|0|||
161365523|NCT01432444|582726622|FG001|Extension Phase|Physician Decision|0|||
161365524|NCT01432444|582726623|FG002|Extension Phase|Physician Decision|1|||
161365525|NCT01432444|582726621|FG000|Extension Phase|Withdrawal by Subject|0|||
161365526|NCT01432444|582726622|FG001|Extension Phase|Withdrawal by Subject|0|||
161365527|NCT01432444|582726623|FG002|Extension Phase|Withdrawal by Subject|13|||
161365528|NCT02301897|582726624|FG000|Treatment Course 1|Non-Compliance|0|||
161365529|NCT02301897|582726625|FG001|Treatment Course 1|Non-Compliance|0|||
161365530|NCT02301897|582726626|FG002|Treatment Course 1|Non-Compliance|1|||
161365531|NCT02301897|582726624|FG000|Treatment Course 1|Adverse Event|1|||
161365532|NCT02301897|582726625|FG001|Treatment Course 1|Adverse Event|1|||
161365533|NCT02301897|582726626|FG002|Treatment Course 1|Adverse Event|0|||
161365534|NCT02301897|582726624|FG000|Treatment Course 1|Lost to Follow-up|1|||
161365535|NCT02301897|582726625|FG001|Treatment Course 1|Lost to Follow-up|2|||
161365536|NCT02301897|582726626|FG002|Treatment Course 1|Lost to Follow-up|1|||
161365537|NCT02301897|582726624|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
161365538|NCT02301897|582726625|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
161365539|NCT02301897|582726626|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
161365540|NCT02301897|582726624|FG000|Treatment Course 1|Withdrawal by Subject|0|||
161365541|NCT02301897|582726625|FG001|Treatment Course 1|Withdrawal by Subject|0|||
161365542|NCT02301897|582726626|FG002|Treatment Course 1|Withdrawal by Subject|2|||
161365543|NCT02301897|582726624|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
161365544|NCT02301897|582726625|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
161365545|NCT02301897|582726626|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
161365546|NCT02301897|582726624|FG000|Treatment Course 2|Lost to Follow-up|0|||
161365547|NCT02301897|582726625|FG001|Treatment Course 2|Lost to Follow-up|2|||
161365548|NCT02301897|582726626|FG002|Treatment Course 2|Lost to Follow-up|0|||
161365549|NCT02301897|582726624|FG000|Treatment Course 2|Pregnancy|0|||
161365550|NCT02301897|582726625|FG001|Treatment Course 2|Pregnancy|1|||
161365551|NCT02301897|582726626|FG002|Treatment Course 2|Pregnancy|1|||
161365552|NCT02301897|582726624|FG000|Treatment Course 2|Withdrawal by Subject|0|||
161365553|NCT02301897|582726625|FG001|Treatment Course 2|Withdrawal by Subject|2|||
161365554|NCT02301897|582726626|FG002|Treatment Course 2|Withdrawal by Subject|0|||
161365555|NCT02301897|582726624|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
161365556|NCT02301897|582726625|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
161365557|NCT02301897|582726626|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
161365558|NCT02332928|582726627|FG000|Overall Study|Withdrawal by Subject|0|||
161365559|NCT02332928|582726628|FG001|Overall Study|Withdrawal by Subject|2|||
161365560|NCT02332928|582726627|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
161365561|NCT02332928|582726628|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
161365562|NCT03663582|582726629|FG000|Overall Study|Physician Decision|1|||
161365563|NCT05763381|582726632|FG000|Overall Study|Lost to Follow-up|2|||
161365564|NCT05763381|582726633|FG001|Overall Study|Lost to Follow-up|3|||
161365565|NCT05763381|582726632|FG000|Overall Study|Withdrawal by Subject|1|||
161365566|NCT05763381|582726633|FG001|Overall Study|Withdrawal by Subject|2|||
161365567|NCT02697448|582726635|FG000|Overall Study|Protocol Violation|2|||
161365568|NCT02697448|582726636|FG001|Overall Study|Protocol Violation|4|||
161365569|NCT02697448|582726635|FG000|Overall Study|Clinical concerns during ablation|1|||
161365570|NCT02697448|582726636|FG001|Overall Study|Clinical concerns during ablation|1|||
161365571|NCT02697448|582726635|FG000|Overall Study|No data collected|2|||
161365572|NCT02697448|582726636|FG001|Overall Study|No data collected|0|||
161365573|NCT05473715|582726637|FG000|Overall Study|Trial terminate|2|||
161365574|NCT05473715|582726638|FG001|Overall Study|Trial terminate|1|||
161365575|NCT02592863|582726640|FG000|Overall Study|Withdrawal by Subject|2|||
161365576|NCT02592863|582726641|FG001|Overall Study|Withdrawal by Subject|2|||
161365577|NCT02592863|582726640|FG000|Overall Study|Lost to Follow-up|1|||
161365578|NCT02592863|582726641|FG001|Overall Study|Lost to Follow-up|1|||
161365579|NCT02743221|582726642|FG000|Overall Study|Progressive disease|29|||
161365580|NCT02743221|582726643|FG001|Overall Study|Progressive disease|38|||
161365581|NCT02743221|582726642|FG000|Overall Study|Adverse Event|17|||
161365582|NCT02743221|582726643|FG001|Overall Study|Adverse Event|14|||
161365583|NCT02743221|582726642|FG000|Overall Study|non medical reason|8|||
161365584|NCT02743221|582726643|FG001|Overall Study|non medical reason|2|||
161365585|NCT02743221|582726642|FG000|Overall Study|Physician Decision|2|||
161365586|NCT02743221|582726643|FG001|Overall Study|Physician Decision|5|||
161365587|NCT02743221|582726642|FG000|Overall Study|Patient not eligible, not treated|0|||
161365588|NCT02743221|582726643|FG001|Overall Study|Patient not eligible, not treated|1|||
161365589|NCT02609503|582726646|FG000|Overall Study|Adverse Event|1|||
161365590|NCT02609503|582726646|FG000|Overall Study|Death|1|||
161365591|NCT02609503|582726646|FG000|Overall Study|Withdrawal by Subject|1|||
161365592|NCT02609503|582726646|FG000|Overall Study|Disease progression|1|||
161365593|NCT04642079|582726647|FG000|Overall Study|Lost to Follow-up|2|||
161365594|NCT04642079|582726648|FG001|Overall Study|Lost to Follow-up|5|||
161365595|NCT04642079|582726649|FG002|Overall Study|Lost to Follow-up|2|||
161365596|NCT04642079|582726650|FG003|Overall Study|Lost to Follow-up|0|||
161365597|NCT04642079|582726647|FG000|Overall Study|Withdrawal by Subject|0|||
161365598|NCT04642079|582726648|FG001|Overall Study|Withdrawal by Subject|4|||
161365599|NCT04642079|582726649|FG002|Overall Study|Withdrawal by Subject|1|||
161365600|NCT04642079|582726650|FG003|Overall Study|Withdrawal by Subject|2|||
161365601|NCT04642079|582726647|FG000|Overall Study|Other|0|||
161365602|NCT04642079|582726648|FG001|Overall Study|Other|0|||
161365603|NCT04642079|582726649|FG002|Overall Study|Other|0|||
161365604|NCT04642079|582726650|FG003|Overall Study|Other|1|||
161365605|NCT04642079|582726647|FG000|Overall Study|No longer met eligibility criteria|1|||
161365606|NCT04642079|582726648|FG001|Overall Study|No longer met eligibility criteria|0|||
161365607|NCT04642079|582726649|FG002|Overall Study|No longer met eligibility criteria|1|||
161365608|NCT04642079|582726650|FG003|Overall Study|No longer met eligibility criteria|1|||
161365609|NCT02226653|582726651|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
161365610|NCT02226653|582726652|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
161365611|NCT02226653|582726651|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
161365612|NCT02226653|582726652|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
161365613|NCT00759395|582726654|FG000|Overall Study|Adverse Event|1|||
161365614|NCT00759395|582726655|FG001|Overall Study|Adverse Event|0|||
161365615|NCT00759395|582726654|FG000|Overall Study|Withdrawal by Subject|1|||
161365616|NCT00759395|582726655|FG001|Overall Study|Withdrawal by Subject|0|||
161365617|NCT00759395|582726654|FG000|Overall Study|Lack of Efficacy|0|||
161365618|NCT00759395|582726655|FG001|Overall Study|Lack of Efficacy|2|||
161365619|NCT01848457|582726656|FG000|Overall Study|Death|1|||
161365620|NCT01848457|582726657|FG001|Overall Study|Death|0|||
161365621|NCT01848457|582726658|FG002|Overall Study|Death|0|||
161365622|NCT01848457|582726659|FG003|Overall Study|Death|0|||
161365623|NCT02181413|582726660|FG000|Overall Study|Withdrawal by Subject|45|||
161365624|NCT02181413|582726661|FG001|Overall Study|Withdrawal by Subject|61|||
161365625|NCT02181413|582726660|FG000|Overall Study|Reason Not Specified|2|||
161365626|NCT02181413|582726661|FG001|Overall Study|Reason Not Specified|5|||
161365627|NCT02181413|582726660|FG000|Overall Study|Lost to Follow-up|8|||
161365628|NCT02181413|582726661|FG001|Overall Study|Lost to Follow-up|7|||
161365629|NCT02298946|582726663|FG000|Overall Study|Did not receive treatment|2|||
161365630|NCT02298946|582726664|FG001|Overall Study|Did not receive treatment|0|||
161365631|NCT02298946|582726663|FG000|Overall Study|Unevaluable|2|||
161365632|NCT02298946|582726664|FG001|Overall Study|Unevaluable|1|||
161365633|NCT03034044|582726665|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
161365634|NCT04042311|582726669|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
161365635|NCT04042311|582726669|FG000|Overall Study|Unable to tolerate|4|||
161365636|NCT04042311|582726669|FG000|Overall Study|Concurrent illness|2|||
161365637|NCT04042311|582726669|FG000|Overall Study|Adverse Event|2|||
161365638|NCT04042311|582726669|FG000|Overall Study|No longer meeting inclusion criteria|2|||
161365639|NCT04042311|582726669|FG000|Overall Study|No reason given|1|||
161365640|NCT04042311|582726669|FG000|Overall Study|Withdrawal by Subject|4|||
161365641|NCT03518060|582726670|FG000|Overall Study|Death|1|||
161365642|NCT03518060|582726670|FG000|Overall Study|Poor adherence|1|||
161365643|NCT03518060|582726670|FG000|Overall Study|Withdrawal of informed consent|2|||
161365644|NCT03518060|582726670|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
161365645|NCT03518060|582726670|FG000|Overall Study|Physician Decision|7|||
161365646|NCT03518060|582726670|FG000|Overall Study|Adverse drug reactions|23|||
161365647|NCT03518060|582726670|FG000|Overall Study|Withdrawal by Subject|25|||
161365648|NCT03518060|582726670|FG000|Overall Study|Lost to Follow-up|13|||
161365649|NCT00323622|582726671|FG000|Overall Study|Other|30|||
161365650|NCT00323622|582726672|FG001|Overall Study|Other|91|||
161365651|NCT00323622|582726673|FG002|Overall Study|Other|4|||
161365652|NCT00323622|582726674|FG003|Overall Study|Other|12|||
161365653|NCT00323622|582726675|FG004|Overall Study|Other|32|||
161365654|NCT00323622|582726676|FG005|Overall Study|Other|74|||
161365655|NCT00323622|582726677|FG006|Overall Study|Other|5|||
161365656|NCT00323622|582726678|FG007|Overall Study|Other|13|||
161365657|NCT00323622|582726671|FG000|Overall Study|Death|1|||
161365658|NCT00323622|582726672|FG001|Overall Study|Death|1|||
161365659|NCT00323622|582726673|FG002|Overall Study|Death|0|||
161365660|NCT00323622|582726674|FG003|Overall Study|Death|0|||
161365661|NCT00323622|582726675|FG004|Overall Study|Death|7|||
161365662|NCT00323622|582726676|FG005|Overall Study|Death|0|||
161365663|NCT00323622|582726677|FG006|Overall Study|Death|0|||
161365664|NCT00323622|582726678|FG007|Overall Study|Death|2|||
161365665|NCT03709472|582726679|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
161365666|NCT03709472|582726680|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
161365667|NCT03709472|582726679|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
161365668|NCT03709472|582726680|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
161365669|NCT01385995|582726688|FG000|Period 1, 2 Months|Physician Decision|1|||
161365670|NCT01385995|582726689|FG001|Period 1, 2 Months|Physician Decision|0|||
161365671|NCT04976777|582728154|FG000|Overall Study|COVID-19 Infection|1|||
161365672|NCT04976777|582728155|FG001|Overall Study|COVID-19 Infection|0|||
161365673|NCT00462826|582728156|FG000|Overall Study|Ineligible - second primary|1|||
161365674|NCT00462826|582728156|FG000|Overall Study|Ineligible - wrong cell type|1|||
161365675|NCT00462826|582728156|FG000|Overall Study|Ineligible - wrong primary|2|||
161365676|NCT00462826|582728156|FG000|Overall Study|Never treated|1|||
161365677|NCT05654181|582728157|FG000|Overall Study|Adverse Event|1|||
161365678|NCT05654181|582728158|FG001|Overall Study|Adverse Event|0|||
161365679|NCT05654181|582728159|FG002|Overall Study|Adverse Event|0|||
161365680|NCT05654181|582728160|FG003|Overall Study|Adverse Event|0|||
161365681|NCT05654181|582728161|FG004|Overall Study|Adverse Event|0|||
161365682|NCT05654181|582728162|FG005|Overall Study|Adverse Event|0|||
161365683|NCT05654181|582728163|FG006|Overall Study|Adverse Event|0|||
161365684|NCT05654181|582728164|FG007|Overall Study|Adverse Event|1|||
161365685|NCT05654181|582728165|FG008|Overall Study|Adverse Event|0|||
161365686|NCT05654181|582728166|FG009|Overall Study|Adverse Event|0|||
161365687|NCT05654181|582728157|FG000|Overall Study|Withdrawal by Subject|0|||
161365688|NCT05654181|582728158|FG001|Overall Study|Withdrawal by Subject|0|||
161365689|NCT05654181|582728159|FG002|Overall Study|Withdrawal by Subject|0|||
161365690|NCT05654181|582728160|FG003|Overall Study|Withdrawal by Subject|0|||
161365691|NCT05654181|582728161|FG004|Overall Study|Withdrawal by Subject|0|||
161365692|NCT05654181|582728162|FG005|Overall Study|Withdrawal by Subject|0|||
161365693|NCT05654181|582728163|FG006|Overall Study|Withdrawal by Subject|0|||
161365694|NCT05654181|582728164|FG007|Overall Study|Withdrawal by Subject|1|||
161365695|NCT05654181|582728165|FG008|Overall Study|Withdrawal by Subject|0|||
161365696|NCT05654181|582728166|FG009|Overall Study|Withdrawal by Subject|0|||
161365697|NCT05654181|582728157|FG000|Overall Study|Other|0|||
161365698|NCT05654181|582728158|FG001|Overall Study|Other|0|||
161365699|NCT05654181|582728159|FG002|Overall Study|Other|0|||
161365700|NCT05654181|582728160|FG003|Overall Study|Other|0|||
161365701|NCT05654181|582728161|FG004|Overall Study|Other|1|||
161365702|NCT05654181|582728162|FG005|Overall Study|Other|1|||
161365703|NCT05654181|582728163|FG006|Overall Study|Other|0|||
161365704|NCT05654181|582728164|FG007|Overall Study|Other|0|||
161365705|NCT05654181|582728165|FG008|Overall Study|Other|0|||
161365706|NCT05654181|582728166|FG009|Overall Study|Other|0|||
161365707|NCT03033784|582728170|FG000|Overall Study|Anxiety related to MRI scanner|0|||
161365708|NCT03033784|582728171|FG001|Overall Study|Anxiety related to MRI scanner|1|||
161365709|NCT03033784|582728172|FG002|Overall Study|Anxiety related to MRI scanner|0|||
161365710|NCT03033784|582728173|FG003|Overall Study|Anxiety related to MRI scanner|0|||
161365711|NCT03033784|582728174|FG004|Overall Study|Anxiety related to MRI scanner|0|||
161365712|NCT03033784|582728175|FG005|Overall Study|Anxiety related to MRI scanner|0|||
161365713|NCT03033784|582728176|FG006|Overall Study|Anxiety related to MRI scanner|0|||
161365714|NCT03033784|582728177|FG007|Overall Study|Anxiety related to MRI scanner|0|||
161365715|NCT03033784|582728178|FG008|Overall Study|Anxiety related to MRI scanner|0|||
161365716|NCT03033784|582728179|FG009|Overall Study|Anxiety related to MRI scanner|0|||
161365717|NCT03033784|582728180|FG010|Overall Study|Anxiety related to MRI scanner|0|||
161365718|NCT03033784|582728181|FG011|Overall Study|Anxiety related to MRI scanner|0|||
161365719|NCT03033784|582728182|FG012|Overall Study|Anxiety related to MRI scanner|0|||
161365720|NCT03033784|582728170|FG000|Overall Study|Withdrawal by Subject|0|||
161365721|NCT03033784|582728171|FG001|Overall Study|Withdrawal by Subject|0|||
161365722|NCT03033784|582728172|FG002|Overall Study|Withdrawal by Subject|0|||
161365723|NCT03033784|582728173|FG003|Overall Study|Withdrawal by Subject|0|||
161365724|NCT03033784|582728174|FG004|Overall Study|Withdrawal by Subject|0|||
161365725|NCT03033784|582728175|FG005|Overall Study|Withdrawal by Subject|0|||
161365726|NCT03033784|582728176|FG006|Overall Study|Withdrawal by Subject|0|||
161365727|NCT03033784|582728177|FG007|Overall Study|Withdrawal by Subject|0|||
161365728|NCT03033784|582728178|FG008|Overall Study|Withdrawal by Subject|0|||
161365729|NCT03033784|582728179|FG009|Overall Study|Withdrawal by Subject|0|||
161365730|NCT03033784|582728180|FG010|Overall Study|Withdrawal by Subject|0|||
161365731|NCT03033784|582728181|FG011|Overall Study|Withdrawal by Subject|0|||
161365732|NCT03033784|582728182|FG012|Overall Study|Withdrawal by Subject|2|||
161365733|NCT00267488|582728183|FG000|Overall Study|Sponsor Terminated Study|9|||
161365734|NCT00267488|582728183|FG000|Overall Study|Protocol Violation|1|||
161365735|NCT00267488|582728183|FG000|Overall Study|Other (Disease Progression)|1|||
161365736|NCT02093520|582728184|FG000|Overall Study|Not treated|6|||
161365737|NCT02093520|582728185|FG001|Overall Study|Not treated|22|||
161365738|NCT01892189|582728186|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
161365739|NCT01892189|582728187|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
161365740|NCT01892189|582728188|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
161365741|NCT01892189|582728189|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
161365742|NCT01892189|582728190|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
161365743|NCT01892189|582728191|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
161365744|NCT01892189|582728192|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
161365745|NCT01892189|582728193|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
161365746|NCT01892189|582728194|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
161365747|NCT01892189|582728186|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161365748|NCT01892189|582728187|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161365749|NCT01892189|582728188|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
161365750|NCT01892189|582728189|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161435951|NCT01535040|582989738|FG001|Overall Study|Physician Decision|1|||
161365751|NCT01892189|582728190|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161365752|NCT01892189|582728191|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161365753|NCT01892189|582728192|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161365754|NCT01892189|582728193|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161365755|NCT01892189|582728194|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161365756|NCT01892189|582728186|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365757|NCT01892189|582728187|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365758|NCT01892189|582728188|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365759|NCT01892189|582728189|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365760|NCT01892189|582728190|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365761|NCT01892189|582728191|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
161365762|NCT01892189|582728192|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365763|NCT01892189|582728193|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365764|NCT01892189|582728194|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161365765|NCT00856557|582728197|FG000|Overall Study|No patients with contextual flags|12|||
161365766|NCT00856557|582728198|FG001|Overall Study|No patients with contextual flags|16|||
161365767|NCT00565747|582728199|FG000|Overall Study|No embryo transfer|67|||
161365768|NCT00565747|582728200|FG001|Overall Study|No embryo transfer|73|||
161365769|NCT01052779|582728201|FG000|Overall Study|Adverse Event|1|||
161365770|NCT01052779|582728202|FG001|Overall Study|Adverse Event|4|||
161365771|NCT01052779|582728201|FG000|Overall Study|Withdrawal by Subject|1|||
161365772|NCT01052779|582728202|FG001|Overall Study|Withdrawal by Subject|2|||
161365773|NCT01052779|582728201|FG000|Overall Study|Other-Protocol Violation|1|||
161365774|NCT01052779|582728202|FG001|Overall Study|Other-Protocol Violation|1|||
161365775|NCT01052779|582728201|FG000|Overall Study|Other-Surgery|0|||
161365776|NCT01052779|582728202|FG001|Overall Study|Other-Surgery|2|||
161365777|NCT01052779|582728201|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
161365778|NCT01052779|582728202|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
161365779|NCT02684461|582728203|FG000|Overall Study|Adverse Event|1|||
161365780|NCT02684461|582728204|FG001|Overall Study|Adverse Event|0|||
161365781|NCT02684461|582728205|FG002|Overall Study|Adverse Event|0|||
161365782|NCT02684461|582728203|FG000|Overall Study|Lack of Efficacy|1|||
161365783|NCT02684461|582728204|FG001|Overall Study|Lack of Efficacy|2|||
161365784|NCT02684461|582728205|FG002|Overall Study|Lack of Efficacy|0|||
161365785|NCT03524157|582728215|FG000|Overall Study|cytology not readable|0|||
161365786|NCT03524157|582728216|FG001|Overall Study|cytology not readable|0|||
161365787|NCT03524157|582728217|FG002|Overall Study|cytology not readable|1|||
161365788|NCT04507763|582728218|FG000|Overall Study|Participants did not meet entrance criteria|201|||
161365789|NCT03322566|582728219|FG000|Overall Study|Death|34|||
161365790|NCT03322566|582728220|FG001|Overall Study|Death|35|||
161365791|NCT03322566|582728221|FG002|Overall Study|Death|23|||
161365792|NCT03322566|582728219|FG000|Overall Study|Physician Decision|6|||
161365793|NCT03322566|582728220|FG001|Overall Study|Physician Decision|7|||
161365794|NCT03322566|582728221|FG002|Overall Study|Physician Decision|2|||
161365795|NCT03322566|582728219|FG000|Overall Study|Withdrawal by Subject|4|||
161365796|NCT03322566|582728220|FG001|Overall Study|Withdrawal by Subject|3|||
161365797|NCT03322566|582728221|FG002|Overall Study|Withdrawal by Subject|6|||
161365798|NCT03322566|582728219|FG000|Overall Study|Lost to Follow-up|0|||
161365799|NCT03322566|582728220|FG001|Overall Study|Lost to Follow-up|0|||
161365800|NCT03322566|582728221|FG002|Overall Study|Lost to Follow-up|1|||
161365801|NCT03322566|582728219|FG000|Overall Study|Study terminated by sponsor|1|||
161365802|NCT03322566|582728220|FG001|Overall Study|Study terminated by sponsor|0|||
161365803|NCT03322566|582728221|FG002|Overall Study|Study terminated by sponsor|1|||
161365804|NCT01602484|582728222|FG000|Overall Study|Airway issues unrelated to study|0|||
161365805|NCT01602484|582728223|FG001|Overall Study|Airway issues unrelated to study|1|||
161365806|NCT00425555|582728226|FG000|Overall Study|Withdrawal by Subject|11|||
161365807|NCT00425555|582728227|FG001|Overall Study|Withdrawal by Subject|8|||
161365808|NCT00425555|582728226|FG000|Overall Study|Lost to Follow-up|0|||
161365809|NCT00425555|582728227|FG001|Overall Study|Lost to Follow-up|1|||
161365810|NCT00425555|582728226|FG000|Overall Study|Administrative problems|3|||
161365811|NCT00425555|582728227|FG001|Overall Study|Administrative problems|0|||
161365812|NCT00425555|582728226|FG000|Overall Study|Death|1|||
161365813|NCT00425555|582728227|FG001|Overall Study|Death|2|||
161365814|NCT00425555|582728226|FG000|Overall Study|New cancer therapy|2|||
161365815|NCT00425555|582728227|FG001|Overall Study|New cancer therapy|1|||
161365816|NCT00425555|582728226|FG000|Overall Study|Disease progression|36|||
161365817|NCT00425555|582728227|FG001|Overall Study|Disease progression|33|||
161365818|NCT00425555|582728226|FG000|Overall Study|Adverse Event|25|||
161365819|NCT00425555|582728227|FG001|Overall Study|Adverse Event|15|||
161365820|NCT00425555|582728226|FG000|Overall Study|Protocol Violation|1|||
161365821|NCT00425555|582728227|FG001|Overall Study|Protocol Violation|0|||
161365822|NCT03411044|582728231|FG000|Overall Study|Death|30|||
161365823|NCT03411044|582728231|FG000|Overall Study|Withdrawal by Subject|48|||
161365824|NCT03411044|582728231|FG000|Overall Study|Lost to Follow-up|78|||
161365825|NCT03411044|582728231|FG000|Overall Study|Adverse Event|30|||
161365826|NCT03411044|582728231|FG000|Overall Study|Missing status|4|||
161365827|NCT01674062|582728239|FG000|Overall Study|Insufficient Therapeutic Response|56|||
161365828|NCT01674062|582728240|FG001|Overall Study|Insufficient Therapeutic Response|26|||
161365829|NCT01674062|582728239|FG000|Overall Study|Other|8|||
161365830|NCT01674062|582728240|FG001|Overall Study|Other|1|||
161365831|NCT01674062|582728239|FG000|Overall Study|Adverse Event|1|||
161365832|NCT01674062|582728240|FG001|Overall Study|Adverse Event|1|||
161365833|NCT01674062|582728239|FG000|Overall Study|Death|0|||
161365834|NCT01674062|582728240|FG001|Overall Study|Death|1|||
161365835|NCT01674062|582728239|FG000|Overall Study|Programming Error|1|||
161365836|NCT01674062|582728240|FG001|Overall Study|Programming Error|0|||
161365837|NCT04661839|582728241|FG000|Overall Study|Not Treated|0|||
161365838|NCT04661839|582728242|FG001|Overall Study|Not Treated|0|||
161365839|NCT04661839|582728243|FG002|Overall Study|Not Treated|1|||
161365840|NCT04661839|582728244|FG003|Overall Study|Not Treated|0|||
161365841|NCT04661839|582728241|FG000|Overall Study|Lost to Follow-up|1|||
161365842|NCT04661839|582728242|FG001|Overall Study|Lost to Follow-up|0|||
161365843|NCT04661839|582728243|FG002|Overall Study|Lost to Follow-up|0|||
161365844|NCT04661839|582728244|FG003|Overall Study|Lost to Follow-up|1|||
161365845|NCT03895372|582728245|FG000|Investigational Treatment Period|Adverse Event|1|||
161365846|NCT03895372|582728246|FG001|Investigational Treatment Period|Adverse Event|0|||
161365847|NCT03895372|582728247|FG002|Investigational Treatment Period|Adverse Event|0|||
161365848|NCT03895372|582728248|FG003|Investigational Treatment Period|Adverse Event|0|||
161365849|NCT03895372|582728249|FG004|Investigational Treatment Period|Adverse Event|0|||
161365850|NCT03895372|582728250|FG005|Investigational Treatment Period|Adverse Event|0|||
161365851|NCT03895372|582728251|FG006|Investigational Treatment Period|Adverse Event|4|||
161365852|NCT03895372|582728252|FG007|Investigational Treatment Period|Adverse Event|3|||
161365853|NCT03895372|582728245|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
161365854|NCT03895372|582728246|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
161365855|NCT03895372|582728247|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
161365856|NCT03895372|582728248|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
161365857|NCT03895372|582728249|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
161365858|NCT03895372|582728250|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
161365859|NCT03895372|582728251|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
161365860|NCT03895372|582728252|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
161365861|NCT03895372|582728245|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
161365862|NCT03895372|582728246|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
161365863|NCT03895372|582728247|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
161365864|NCT03895372|582728248|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
161365865|NCT03895372|582728249|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
161365866|NCT03895372|582728250|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
161365867|NCT03895372|582728251|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
161365868|NCT03895372|582728252|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
161365869|NCT03895372|582728245|FG000|Investigational Treatment Period|Other|0|||
161365870|NCT03895372|582728246|FG001|Investigational Treatment Period|Other|0|||
161365871|NCT03895372|582728247|FG002|Investigational Treatment Period|Other|0|||
161365872|NCT03895372|582728248|FG003|Investigational Treatment Period|Other|0|||
161365873|NCT03895372|582728249|FG004|Investigational Treatment Period|Other|0|||
161365874|NCT03895372|582728250|FG005|Investigational Treatment Period|Other|1|||
161365875|NCT03895372|582728251|FG006|Investigational Treatment Period|Other|0|||
161365876|NCT03895372|582728252|FG007|Investigational Treatment Period|Other|2|||
161365877|NCT03895372|582728245|FG000|Investigational Treatment Period|Protocol Violation|0|||
161365878|NCT03895372|582728246|FG001|Investigational Treatment Period|Protocol Violation|0|||
161365879|NCT03895372|582728247|FG002|Investigational Treatment Period|Protocol Violation|0|||
161365880|NCT03895372|582728248|FG003|Investigational Treatment Period|Protocol Violation|1|||
161365881|NCT03895372|582728249|FG004|Investigational Treatment Period|Protocol Violation|0|||
161365882|NCT03895372|582728250|FG005|Investigational Treatment Period|Protocol Violation|0|||
161365883|NCT03895372|582728251|FG006|Investigational Treatment Period|Protocol Violation|0|||
161365884|NCT03895372|582728252|FG007|Investigational Treatment Period|Protocol Violation|0|||
161365885|NCT03895372|582728245|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
161365886|NCT03895372|582728246|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
161365887|NCT03895372|582728247|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
161365888|NCT03895372|582728248|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
161365889|NCT03895372|582728249|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
161365890|NCT03895372|582728250|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
161365891|NCT03895372|582728251|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
161365892|NCT03895372|582728252|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
161365893|NCT03895372|582728245|FG000|Extension Treatment Period|Adverse Event|0|||
161365894|NCT03895372|582728246|FG001|Extension Treatment Period|Adverse Event|1|||
161365895|NCT03895372|582728247|FG002|Extension Treatment Period|Adverse Event|0|||
161365896|NCT03895372|582728248|FG003|Extension Treatment Period|Adverse Event|1|||
161365897|NCT03895372|582728249|FG004|Extension Treatment Period|Adverse Event|0|||
161365898|NCT03895372|582728250|FG005|Extension Treatment Period|Adverse Event|0|||
161365899|NCT03895372|582728251|FG006|Extension Treatment Period|Adverse Event|3|||
161365900|NCT03895372|582728252|FG007|Extension Treatment Period|Adverse Event|3|||
161365901|NCT03895372|582728245|FG000|Extension Treatment Period|Other|1|||
161365902|NCT03895372|582728246|FG001|Extension Treatment Period|Other|3|||
161365903|NCT03895372|582728247|FG002|Extension Treatment Period|Other|0|||
161365904|NCT03895372|582728248|FG003|Extension Treatment Period|Other|0|||
161365905|NCT03895372|582728249|FG004|Extension Treatment Period|Other|1|||
161365906|NCT03895372|582728250|FG005|Extension Treatment Period|Other|0|||
161365907|NCT03895372|582728251|FG006|Extension Treatment Period|Other|0|||
161365908|NCT03895372|582728252|FG007|Extension Treatment Period|Other|2|||
161365909|NCT03895372|582728245|FG000|Extension Treatment Period|Pregnancy|0|||
161365910|NCT03895372|582728246|FG001|Extension Treatment Period|Pregnancy|0|||
161365911|NCT03895372|582728247|FG002|Extension Treatment Period|Pregnancy|0|||
161365912|NCT03895372|582728248|FG003|Extension Treatment Period|Pregnancy|0|||
161365913|NCT03895372|582728249|FG004|Extension Treatment Period|Pregnancy|1|||
161365914|NCT03895372|582728250|FG005|Extension Treatment Period|Pregnancy|0|||
161365915|NCT03895372|582728251|FG006|Extension Treatment Period|Pregnancy|0|||
161365916|NCT03895372|582728252|FG007|Extension Treatment Period|Pregnancy|0|||
161365917|NCT03895372|582728245|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
161365918|NCT03895372|582728246|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
161365919|NCT03895372|582728247|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161365920|NCT03895372|582728248|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
161365921|NCT03895372|582728249|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
161365922|NCT03895372|582728250|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
161365923|NCT03895372|582728251|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
161365924|NCT03895372|582728252|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
161365925|NCT03685149|582728253|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
161365926|NCT03685149|582728254|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
161365927|NCT03685149|582728253|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161365928|NCT03685149|582728254|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161365929|NCT03685149|582728253|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
161365930|NCT03685149|582728254|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
161365931|NCT00581919|582728259|FG000|Overall Study|Adverse Event|8|||
161365932|NCT00581919|582728259|FG000|Overall Study|Death|1|||
161365933|NCT00581919|582728259|FG000|Overall Study|Disease Progression|10|||
161365934|NCT00581919|582728259|FG000|Overall Study|Physician Decision|1|||
161365935|NCT00581919|582728259|FG000|Overall Study|Other Complicating Disease|1|||
161365936|NCT00581919|582728259|FG000|Overall Study|Started Non-Protocol Therapy|2|||
161365937|NCT00581919|582728259|FG000|Overall Study|Withdrawal by Subject|1|||
161365938|NCT02034565|582728260|FG000|Overall Study|Adverse Event|1|||
161365939|NCT02034565|582728261|FG001|Overall Study|Adverse Event|0|||
161365940|NCT03232567|582728264|FG000|Overall Study|Withdrawal by Subject|0|||
161365941|NCT03232567|582728265|FG001|Overall Study|Withdrawal by Subject|1|||
161365942|NCT03232567|582728266|FG002|Overall Study|Withdrawal by Subject|0|||
161365943|NCT03232567|582728267|FG003|Overall Study|Withdrawal by Subject|0|||
161365944|NCT02655601|582728268|FG000|Overall Study|Adverse Event|0|||
161365945|NCT02655601|582728269|FG001|Overall Study|Adverse Event|0|||
161365946|NCT02655601|582728270|FG002|Overall Study|Adverse Event|0|||
161365947|NCT02655601|582728271|FG003|Overall Study|Adverse Event|1|||
161365948|NCT02655601|582728272|FG004|Overall Study|Adverse Event|1|||
161365949|NCT02655601|582728273|FG005|Overall Study|Adverse Event|0|||
161365950|NCT02655601|582728268|FG000|Overall Study|Physician Decision|0|||
161365951|NCT02655601|582728269|FG001|Overall Study|Physician Decision|0|||
161365952|NCT02655601|582728270|FG002|Overall Study|Physician Decision|0|||
161365953|NCT02655601|582728271|FG003|Overall Study|Physician Decision|0|||
161365954|NCT02655601|582728272|FG004|Overall Study|Physician Decision|1|||
161365955|NCT02655601|582728273|FG005|Overall Study|Physician Decision|1|||
161365956|NCT02655601|582728268|FG000|Overall Study|Withdrawal by Subject|0|||
161365957|NCT02655601|582728269|FG001|Overall Study|Withdrawal by Subject|0|||
161365958|NCT02655601|582728270|FG002|Overall Study|Withdrawal by Subject|0|||
161365959|NCT02655601|582728271|FG003|Overall Study|Withdrawal by Subject|0|||
161365960|NCT02655601|582728272|FG004|Overall Study|Withdrawal by Subject|4|||
161365961|NCT02655601|582728273|FG005|Overall Study|Withdrawal by Subject|8|||
161365962|NCT02655601|582728268|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
161365963|NCT02655601|582728269|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161365964|NCT02655601|582728270|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161365965|NCT02655601|582728271|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161365966|NCT02655601|582728272|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161365967|NCT02655601|582728273|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161365968|NCT05837481|582728274|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
161365969|NCT05837481|582728275|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
161365970|NCT02014376|582728276|FG000|Overall Study|Adverse Event|1|||
161365971|NCT02014376|582728277|FG001|Overall Study|Adverse Event|1|||
161365972|NCT02014376|582728278|FG002|Overall Study|Adverse Event|0|||
161365973|NCT02014376|582728276|FG000|Overall Study|Lost to Follow-up|2|||
161365974|NCT02014376|582728277|FG001|Overall Study|Lost to Follow-up|0|||
161365975|NCT02014376|582728278|FG002|Overall Study|Lost to Follow-up|0|||
161365976|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
161365977|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
161365978|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
161365979|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
161365980|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
161365981|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
161365982|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
161365983|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
161365984|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
161365985|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
161365986|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
161365987|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
161365988|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
161365989|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
161365990|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
161365991|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
161365992|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
161365993|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
161365994|NCT00086515|582728280|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
161365995|NCT00086515|582728281|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
161365996|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
161365997|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
161365998|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
161365999|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
161366000|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
161366001|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
161366002|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
161366003|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
161366004|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
161366005|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
161366006|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
161366007|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
161366008|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
161366009|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
161366010|NCT00086515|582728280|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
161366011|NCT00086515|582728281|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
161366012|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
161366013|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
161366014|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
161366015|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
161366016|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
161366017|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
161366018|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
161366019|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
161366020|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
161366021|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
161366022|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
161366023|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
161366024|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
161366025|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
161366026|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
161366027|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
161366028|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
161366029|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
161366030|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
161366031|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
161366032|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
161366033|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
161366034|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
161366035|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
161366036|NCT00086515|582728280|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
161366037|NCT00086515|582728281|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
161366038|NCT02251041|582728282|FG000|Overall Study|Did not receive intervention|15|||
161366039|NCT02251041|582728283|FG001|Overall Study|Did not receive intervention|4|||
161366040|NCT00050011|582728287|FG000|Overall Study|Adverse Event|41|||
161366041|NCT00050011|582728288|FG001|Overall Study|Adverse Event|46|||
161366042|NCT00050011|582728287|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161366043|NCT00050011|582728288|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161366044|NCT00050011|582728287|FG000|Overall Study|Abnormal test procedure results|0|||
161366045|NCT00050011|582728288|FG001|Overall Study|Abnormal test procedure results|1|||
161366046|NCT00050011|582728287|FG000|Overall Study|Lack of Efficacy|16|||
161366047|NCT00050011|582728288|FG001|Overall Study|Lack of Efficacy|21|||
161366048|NCT00050011|582728287|FG000|Overall Study|Participant condition no longer required|1|||
161366049|NCT00050011|582728288|FG001|Overall Study|Participant condition no longer required|0|||
161366050|NCT00050011|582728287|FG000|Overall Study|Protocol Violation|4|||
161366051|NCT00050011|582728288|FG001|Overall Study|Protocol Violation|10|||
161366052|NCT00050011|582728287|FG000|Overall Study|Withdrawal by Subject|34|||
161366053|NCT00050011|582728288|FG001|Overall Study|Withdrawal by Subject|26|||
161366054|NCT00050011|582728287|FG000|Overall Study|Lost to Follow-up|7|||
161366055|NCT00050011|582728288|FG001|Overall Study|Lost to Follow-up|9|||
161366056|NCT00050011|582728287|FG000|Overall Study|Administrative problems|10|||
161366057|NCT00050011|582728288|FG001|Overall Study|Administrative problems|6|||
161366058|NCT00050011|582728287|FG000|Overall Study|Death|7|||
161366059|NCT00050011|582728288|FG001|Overall Study|Death|4|||
161366060|NCT00050011|582728287|FG000|Overall Study|Unknown - Reason is missing|0|||
161366061|NCT00050011|582728288|FG001|Overall Study|Unknown - Reason is missing|2|||
161366062|NCT03312543|582728289|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
161366063|NCT03312543|582728290|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
161366064|NCT03312543|582728289|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
161366065|NCT03312543|582728290|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
161366066|NCT03312543|582728289|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
161366067|NCT03312543|582728290|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
161366068|NCT03312543|582728289|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
161366069|NCT03312543|582728290|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
161366070|NCT03312543|582728289|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
161366071|NCT03312543|582728290|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
161366072|NCT03312543|582728289|FG000|Regression (Week 12 to Week 24)|Death|0|||
161366073|NCT03312543|582728290|FG001|Regression (Week 12 to Week 24)|Death|1|||
161366074|NCT04507269|582728291|FG000|Overall Study|Withdrawal by Subject|1|||
161366075|NCT04507269|582728292|FG001|Overall Study|Withdrawal by Subject|1|||
161366076|NCT04507269|582728293|FG002|Overall Study|Withdrawal by Subject|0|||
161366077|NCT04507269|582728294|FG003|Overall Study|Withdrawal by Subject|0|||
161366078|NCT04507269|582728295|FG004|Overall Study|Withdrawal by Subject|0|||
161366079|NCT04507269|582728296|FG005|Overall Study|Withdrawal by Subject|0|||
161366080|NCT04507269|582728291|FG000|Overall Study|Lost to Follow-up|0|||
161366081|NCT04507269|582728292|FG001|Overall Study|Lost to Follow-up|0|||
161366082|NCT04507269|582728293|FG002|Overall Study|Lost to Follow-up|0|||
161366083|NCT04507269|582728294|FG003|Overall Study|Lost to Follow-up|0|||
161366084|NCT04507269|582728295|FG004|Overall Study|Lost to Follow-up|1|||
161366085|NCT04507269|582728296|FG005|Overall Study|Lost to Follow-up|0|||
161366086|NCT04197583|582728297|FG000|Overall Study|Study Stent Replacement|34|||
161366087|NCT04197583|582728298|FG001|Overall Study|Study Stent Replacement|8|||
161366088|NCT04197583|582728297|FG000|Overall Study|Lost to Follow-up|14|||
161366089|NCT04197583|582728298|FG001|Overall Study|Lost to Follow-up|3|||
161366090|NCT04197583|582728297|FG000|Overall Study|Death|3|||
161366091|NCT04197583|582728298|FG001|Overall Study|Death|0|||
161366092|NCT04197583|582728297|FG000|Overall Study|Physician Decision|1|||
161366093|NCT04197583|582728298|FG001|Overall Study|Physician Decision|0|||
161366094|NCT04197583|582728297|FG000|Overall Study|Withdrawal by Subject|1|||
161366095|NCT04197583|582728298|FG001|Overall Study|Withdrawal by Subject|1|||
161366096|NCT04197583|582728297|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
161366097|NCT04197583|582728298|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
161366098|NCT04197583|582728297|FG000|Overall Study|Screen Failure|0|||
161366099|NCT04197583|582728298|FG001|Overall Study|Screen Failure|20|||
161366100|NCT04134936|582728299|FG000|Overall Study|Adverse Event|3|||
161366101|NCT04134936|582728300|FG001|Overall Study|Adverse Event|2|||
161366102|NCT04134936|582728299|FG000|Overall Study|Withdrawal by Subject|2|||
161366103|NCT04134936|582728300|FG001|Overall Study|Withdrawal by Subject|3|||
161366104|NCT04134936|582728299|FG000|Overall Study|Physician Decision|0|||
161366105|NCT04134936|582728300|FG001|Overall Study|Physician Decision|1|||
161366106|NCT04134936|582728299|FG000|Overall Study|Progressive disease, joined another trial|1|||
161366107|NCT04134936|582728300|FG001|Overall Study|Progressive disease, joined another trial|0|||
161366108|NCT04134936|582728299|FG000|Overall Study|Progressive disease|1|||
161366109|NCT04134936|582728300|FG001|Overall Study|Progressive disease|0|||
161366110|NCT04629196|582728301|FG000|Overall Study|Subject discontinued study drug|1|||
161366111|NCT04629196|582728302|FG001|Overall Study|Subject discontinued study drug|0|||
161366112|NCT04629196|582728301|FG000|Overall Study|Subject study drug dosing increased|1|||
161366113|NCT04629196|582728302|FG001|Overall Study|Subject study drug dosing increased|1|||
161366114|NCT04629196|582728301|FG000|Overall Study|Withdrawal by Subject|1|||
161366115|NCT04629196|582728302|FG001|Overall Study|Withdrawal by Subject|2|||
161366116|NCT02061085|582728308|FG000|Overall Study|Adverse Event|8|||
161366117|NCT02414841|582728310|FG000|Overall Study|Withdrawal by Subject|7|||
161366118|NCT02414841|582728311|FG001|Overall Study|Withdrawal by Subject|5|||
161366119|NCT02414841|582728310|FG000|Overall Study|Lost to Follow-up|13|||
161366120|NCT02414841|582728311|FG001|Overall Study|Lost to Follow-up|6|||
161366121|NCT02414841|582728310|FG000|Overall Study|Death|17|||
161366122|NCT02414841|582728311|FG001|Overall Study|Death|14|||
161366123|NCT02414841|582728310|FG000|Overall Study|Received a Kidney Transplant|13|||
161366124|NCT02414841|582728311|FG001|Overall Study|Received a Kidney Transplant|4|||
161366125|NCT02414841|582728310|FG000|Overall Study|Randomized But Not Treated|6|||
161366126|NCT02414841|582728311|FG001|Overall Study|Randomized But Not Treated|4|||
161366127|NCT02613507|582728315|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
161366128|NCT02613507|582728316|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
161366129|NCT02613507|582728315|FG000|Pre-Treamtent|Participant withdrew consent|0|||
161366130|NCT02613507|582728316|FG001|Pre-Treamtent|Participant withdrew consent|4|||
161366131|NCT02613507|582728315|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
161366132|NCT02613507|582728316|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
161366133|NCT02613507|582728315|FG000|Treatment|Not reported|3|||
161366134|NCT02613507|582728316|FG001|Treatment|Not reported|0|||
161366135|NCT02613507|582728315|FG000|Treatment|Other reasons|8|||
161366136|NCT02613507|582728316|FG001|Treatment|Other reasons|0|||
161366137|NCT02613507|582728315|FG000|Treatment|Participant no longer meets criteria|3|||
161366138|NCT02613507|582728316|FG001|Treatment|Participant no longer meets criteria|0|||
161366139|NCT02613507|582728315|FG000|Treatment|Maximum clinical benefit|5|||
161366140|NCT02613507|582728316|FG001|Treatment|Maximum clinical benefit|10|||
161366141|NCT02613507|582728315|FG000|Treatment|Lost to Follow-up|1|||
161366142|NCT02613507|582728316|FG001|Treatment|Lost to Follow-up|0|||
161366143|NCT02613507|582728315|FG000|Treatment|Participant withdrew consent|0|||
161366144|NCT02613507|582728316|FG001|Treatment|Participant withdrew consent|2|||
161366145|NCT02613507|582728315|FG000|Treatment|Participant request to discontinue study treatment|13|||
161366146|NCT02613507|582728316|FG001|Treatment|Participant request to discontinue study treatment|17|||
161366147|NCT02613507|582728315|FG000|Treatment|Adverse event unrelated to study drug|20|||
161366148|NCT02613507|582728316|FG001|Treatment|Adverse event unrelated to study drug|3|||
161366149|NCT02613507|582728315|FG000|Treatment|Death|2|||
161366150|NCT02613507|582728316|FG001|Treatment|Death|0|||
161366151|NCT02613507|582728315|FG000|Treatment|Study drug toxicity|19|||
161366152|NCT02613507|582728316|FG001|Treatment|Study drug toxicity|14|||
161366153|NCT02613507|582728315|FG000|Treatment|Disease progression|263|||
161366154|NCT02613507|582728316|FG001|Treatment|Disease progression|110|||
161366155|NCT02471144|582730112|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
161366156|NCT02471144|582730113|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
161366157|NCT02471144|582730114|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
161366158|NCT02471144|582730115|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
161366159|NCT02471144|582730116|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
161366160|NCT02471144|582730117|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
161366161|NCT02471144|582730118|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
161366162|NCT02471144|582730119|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
161366163|NCT02471144|582730120|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
161366164|NCT02471144|582730121|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
161366165|NCT02471144|582730122|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
161366166|NCT02471144|582730112|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366167|NCT02471144|582730113|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366168|NCT02471144|582730114|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366169|NCT02471144|582730115|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
161366170|NCT02471144|582730116|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366171|NCT02471144|582730117|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366172|NCT02471144|582730118|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366173|NCT02471144|582730119|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366174|NCT02471144|582730120|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366175|NCT02471144|582730121|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366176|NCT02471144|582730122|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161366177|NCT02471144|582730112|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366178|NCT02471144|582730113|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366179|NCT02471144|582730114|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
161366180|NCT02471144|582730115|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366181|NCT02471144|582730116|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366182|NCT02471144|582730117|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366183|NCT02471144|582730118|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366184|NCT02471144|582730119|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366185|NCT02471144|582730120|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366186|NCT02471144|582730121|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366187|NCT02471144|582730122|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161366188|NCT02471144|582730112|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
161366189|NCT02471144|582730113|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
161366190|NCT02471144|582730114|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366191|NCT02471144|582730115|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366192|NCT02471144|582730116|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366193|NCT02471144|582730117|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366194|NCT02471144|582730118|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366195|NCT02471144|582730119|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366196|NCT02471144|582730120|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366197|NCT02471144|582730121|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366198|NCT02471144|582730122|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161366199|NCT02471144|582730112|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366200|NCT02471144|582730113|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366201|NCT02471144|582730114|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366202|NCT02471144|582730115|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366203|NCT02471144|582730116|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
161366204|NCT02471144|582730117|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366205|NCT02471144|582730118|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
161366206|NCT02471144|582730119|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366207|NCT02471144|582730120|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
161366208|NCT02471144|582730121|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366209|NCT02471144|582730122|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161366210|NCT02471144|582730112|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366211|NCT02471144|582730113|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366212|NCT02471144|582730114|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366213|NCT02471144|582730115|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366214|NCT02471144|582730116|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366215|NCT02471144|582730117|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
161366216|NCT02471144|582730118|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366217|NCT02471144|582730119|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366218|NCT02471144|582730120|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
161366219|NCT02471144|582730121|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366220|NCT02471144|582730122|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161366221|NCT02471144|582730112|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366222|NCT02471144|582730113|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366223|NCT02471144|582730114|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366224|NCT02471144|582730115|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366225|NCT02471144|582730116|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366226|NCT02471144|582730117|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366227|NCT02471144|582730118|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366228|NCT02471144|582730119|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366229|NCT02471144|582730120|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
161366230|NCT02471144|582730121|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366231|NCT02471144|582730122|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161366232|NCT02471144|582730112|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366233|NCT02471144|582730113|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366234|NCT02471144|582730114|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366235|NCT02471144|582730115|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366236|NCT02471144|582730116|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366237|NCT02471144|582730117|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366238|NCT02471144|582730118|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366239|NCT02471144|582730119|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
161366240|NCT02471144|582730120|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
161366241|NCT02471144|582730121|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366242|NCT02471144|582730122|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161366243|NCT02471144|582730112|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366244|NCT02471144|582730113|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366245|NCT02471144|582730114|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366246|NCT02471144|582730115|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366247|NCT02471144|582730116|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366248|NCT02471144|582730117|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366249|NCT02471144|582730118|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366250|NCT02471144|582730119|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366251|NCT02471144|582730120|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161366252|NCT02471144|582730121|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
161366253|NCT02471144|582730122|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
161366254|NCT02471144|582730112|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366255|NCT02471144|582730113|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366256|NCT02471144|582730114|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366257|NCT02471144|582730115|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366258|NCT02471144|582730116|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366259|NCT02471144|582730117|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366260|NCT02471144|582730118|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366261|NCT02471144|582730119|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366262|NCT02471144|582730120|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366263|NCT02471144|582730121|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
161366264|NCT02471144|582730122|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161366265|NCT02471144|582730112|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366266|NCT02471144|582730113|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366267|NCT02471144|582730114|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366268|NCT02471144|582730115|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366269|NCT02471144|582730116|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366270|NCT02471144|582730117|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366271|NCT02471144|582730118|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366272|NCT02471144|582730119|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366273|NCT02471144|582730120|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366274|NCT02471144|582730121|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161366275|NCT02471144|582730122|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
161366276|NCT02471144|582730112|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366277|NCT02471144|582730113|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366278|NCT02471144|582730114|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366279|NCT02471144|582730115|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366280|NCT02471144|582730116|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366281|NCT02471144|582730117|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366282|NCT02471144|582730118|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366283|NCT02471144|582730119|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366284|NCT02471144|582730120|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161366285|NCT02471144|582730121|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
161366286|NCT02471144|582730122|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
161366287|NCT02471144|582730112|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366288|NCT02471144|582730113|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366289|NCT02471144|582730114|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366290|NCT02471144|582730115|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366291|NCT02471144|582730116|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366292|NCT02471144|582730117|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366293|NCT02471144|582730118|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366294|NCT02471144|582730119|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366295|NCT02471144|582730120|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366296|NCT02471144|582730121|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
161366297|NCT02471144|582730122|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161366298|NCT02471144|582730112|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366299|NCT02471144|582730113|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366300|NCT02471144|582730114|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366301|NCT02471144|582730115|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366302|NCT02471144|582730116|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366303|NCT02471144|582730117|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366304|NCT02471144|582730118|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366305|NCT02471144|582730119|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366306|NCT02471144|582730120|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161366307|NCT02471144|582730121|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
161366308|NCT02471144|582730122|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
161366309|NCT03977155|582730126|FG000|Overall Study|Adverse Event|3|||
161366310|NCT03977155|582730127|FG001|Overall Study|Adverse Event|0|||
161366311|NCT03977155|582730128|FG002|Overall Study|Adverse Event|0|||
161366312|NCT03977155|582730126|FG000|Overall Study|Lost to Follow-up|0|||
161366313|NCT03977155|582730127|FG001|Overall Study|Lost to Follow-up|1|||
161366314|NCT03977155|582730128|FG002|Overall Study|Lost to Follow-up|0|||
161366315|NCT03977155|582730126|FG000|Overall Study|Withdrawal by Subject|1|||
161366316|NCT03977155|582730127|FG001|Overall Study|Withdrawal by Subject|1|||
161366317|NCT03977155|582730128|FG002|Overall Study|Withdrawal by Subject|2|||
161366318|NCT03977155|582730126|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
161366319|NCT03977155|582730127|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
161366320|NCT03977155|582730128|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
161366321|NCT00936936|582730129|FG000|Overall Study|Adverse Event|7|||
161366322|NCT00936936|582730130|FG001|Overall Study|Adverse Event|1|||
161366323|NCT00936936|582730129|FG000|Overall Study|Disease Progression|2|||
161366324|NCT00936936|582730130|FG001|Overall Study|Disease Progression|2|||
161366325|NCT00936936|582730129|FG000|Overall Study|Unrelated|3|||
161366326|NCT00936936|582730130|FG001|Overall Study|Unrelated|1|||
161366327|NCT03440385|582730139|FG000|Overall Study|Other Reason|4|||
161366328|NCT03440385|582730140|FG001|Overall Study|Other Reason|1|||
161366329|NCT03440385|582730139|FG000|Overall Study|Site Closed|1|||
161366330|NCT03440385|582730140|FG001|Overall Study|Site Closed|0|||
161366331|NCT03440385|582730139|FG000|Overall Study|Lost to Follow-up|2|||
161366332|NCT03440385|582730140|FG001|Overall Study|Lost to Follow-up|0|||
161366333|NCT03440385|582730139|FG000|Overall Study|Withdrawal by Subject|12|||
161366334|NCT03440385|582730140|FG001|Overall Study|Withdrawal by Subject|6|||
161366335|NCT03440385|582730139|FG000|Overall Study|Lack of Efficacy|9|||
161366336|NCT03440385|582730140|FG001|Overall Study|Lack of Efficacy|2|||
161366337|NCT03440385|582730139|FG000|Overall Study|Adverse Event|15|||
161366338|NCT03440385|582730140|FG001|Overall Study|Adverse Event|11|||
161366339|NCT00488293|582730141|FG000|Overall Study|Lost to Follow-up|28|||
161366340|NCT00488293|582730142|FG001|Overall Study|Lost to Follow-up|25|||
161366341|NCT00488293|582730141|FG000|Overall Study|Withdrawal by Subject|5|||
161366342|NCT00488293|582730142|FG001|Overall Study|Withdrawal by Subject|3|||
161366343|NCT00488293|582730141|FG000|Overall Study|Death|2|||
161366344|NCT00488293|582730142|FG001|Overall Study|Death|1|||
161366345|NCT00488293|582730141|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
161366346|NCT00488293|582730142|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
161366347|NCT00939185|582730143|FG000|Overall Study|Adverse Event|3|||
161366348|NCT00939185|582730143|FG000|Overall Study|Lack of Efficacy|1|||
161366349|NCT00939185|582730143|FG000|Overall Study|Lost to Follow-up|6|||
161366350|NCT00939185|582730143|FG000|Overall Study|Other|3|||
161366351|NCT00939185|582730143|FG000|Overall Study|Withdrawal by Subject|2|||
161366352|NCT00939185|582730143|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
161366353|NCT00363298|582730144|FG000|First Study Week|Lack of Efficacy|6|||
161366354|NCT00363298|582730145|FG001|First Study Week|Lack of Efficacy|5|||
161366355|NCT00363298|582730144|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
161366356|NCT00363298|582730145|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
161366357|NCT02374255|582730147|FG000|Overall Study|Withdrawal by Subject|2|||
161366358|NCT02374255|582730148|FG001|Overall Study|Withdrawal by Subject|0|||
161366359|NCT02374255|582730149|FG002|Overall Study|Withdrawal by Subject|0|||
161366360|NCT02374255|582730150|FG003|Overall Study|Withdrawal by Subject|0|||
161366361|NCT00851084|582730151|FG000|Overall Study|Randomized but not treated|1|||
161366362|NCT00851084|582730152|FG001|Overall Study|Randomized but not treated|0|||
161366363|NCT00851084|582730151|FG000|Overall Study|Adverse Event|26|||
161366364|NCT00851084|582730152|FG001|Overall Study|Adverse Event|36|||
161366365|NCT00851084|582730151|FG000|Overall Study|Disease progression|52|||
161366366|NCT00851084|582730152|FG001|Overall Study|Disease progression|47|||
161366367|NCT00851084|582730151|FG000|Overall Study|Poor compliance to protocol|1|||
161366368|NCT00851084|582730152|FG001|Overall Study|Poor compliance to protocol|1|||
161366369|NCT00851084|582730151|FG000|Overall Study|Physician Decision|13|||
161366370|NCT00851084|582730152|FG001|Overall Study|Physician Decision|14|||
161366371|NCT00851084|582730151|FG000|Overall Study|Consent withdrawn|0|||
161366372|NCT00851084|582730152|FG001|Overall Study|Consent withdrawn|2|||
161366373|NCT00851084|582730151|FG000|Overall Study|Withdrawal by Subject|11|||
161366374|NCT00851084|582730152|FG001|Overall Study|Withdrawal by Subject|12|||
161366375|NCT00851084|582730151|FG000|Overall Study|Metastatic surgery|6|||
161366376|NCT00851084|582730152|FG001|Overall Study|Metastatic surgery|6|||
161366377|NCT00851084|582730151|FG000|Overall Study|Other|7|||
161366378|NCT00851084|582730152|FG001|Overall Study|Other|1|||
161366379|NCT00095576|582730155|FG000|Overall Study|Adverse Event|5|||
161366380|NCT00095576|582730156|FG001|Overall Study|Adverse Event|3|||
161366381|NCT00095576|582730155|FG000|Overall Study|Lost to Follow-up|233|||
161366382|NCT00095576|582730156|FG001|Overall Study|Lost to Follow-up|229|||
161366383|NCT00095576|582730155|FG000|Overall Study|Protocol Violation|1|||
161366384|NCT00095576|582730156|FG001|Overall Study|Protocol Violation|0|||
161366385|NCT00095576|582730155|FG000|Overall Study|Withdrawal by Subject|34|||
161366386|NCT00095576|582730156|FG001|Overall Study|Withdrawal by Subject|47|||
161366387|NCT00095576|582730155|FG000|Overall Study|Option to switch to a rollover study|1097|||
161366388|NCT00095576|582730156|FG001|Overall Study|Option to switch to a rollover study|1099|||
161366389|NCT00095576|582730155|FG000|Overall Study|Site terminated|75|||
161366390|NCT00095576|582730156|FG001|Overall Study|Site terminated|67|||
161366391|NCT00095576|582730155|FG000|Overall Study|Subject moved|30|||
161366392|NCT00095576|582730156|FG001|Overall Study|Subject moved|36|||
161366393|NCT01497197|582730157|FG000|Overall Study|Lost to Follow-up|1|||
161366394|NCT01497197|582730158|FG001|Overall Study|Lost to Follow-up|0|||
161366395|NCT01497197|582730157|FG000|Overall Study|Protocol Violation|0|||
161366396|NCT01497197|582730158|FG001|Overall Study|Protocol Violation|2|||
161366397|NCT01497197|582730157|FG000|Overall Study|Withdrawal by Subject|2|||
161366398|NCT01497197|582730158|FG001|Overall Study|Withdrawal by Subject|1|||
161366399|NCT01497197|582730157|FG000|Overall Study|Excessive/lack of response to treatment|1|||
161366400|NCT01497197|582730158|FG001|Overall Study|Excessive/lack of response to treatment|0|||
161366401|NCT01497197|582730157|FG000|Overall Study|Risk of OHSS|1|||
161366402|NCT01497197|582730158|FG001|Overall Study|Risk of OHSS|0|||
161366403|NCT01497197|582730157|FG000|Overall Study|No oocytes retrieved|3|||
161366404|NCT01497197|582730158|FG001|Overall Study|No oocytes retrieved|2|||
161366405|NCT01497197|582730157|FG000|Overall Study|No fertilisation|6|||
161366406|NCT01497197|582730158|FG001|Overall Study|No fertilisation|5|||
161366407|NCT01497197|582730157|FG000|Overall Study|Intention to freeze all embryos|0|||
161366408|NCT01497197|582730158|FG001|Overall Study|Intention to freeze all embryos|1|||
161366409|NCT01497197|582730157|FG000|Overall Study|All embryos discarded|0|||
161366410|NCT01497197|582730158|FG001|Overall Study|All embryos discarded|3|||
161366411|NCT01497197|582730157|FG000|Overall Study|Other|3|||
161366412|NCT01497197|582730158|FG001|Overall Study|Other|1|||
161366413|NCT01425814|582730160|FG000|Period 1|Stability criteria not fulfilled|0|||
161366414|NCT01425814|582730161|FG001|Period 1|Stability criteria not fulfilled|1|||
161366415|NCT01425814|582730162|FG002|Period 1|Stability criteria not fulfilled|0|||
161366416|NCT01425814|582730163|FG003|Period 1|Stability criteria not fulfilled|0|||
161366417|NCT01425814|582730164|FG004|Period 1|Stability criteria not fulfilled|0|||
161366418|NCT01425814|582730165|FG005|Period 1|Stability criteria not fulfilled|0|||
161366419|NCT01425814|582730160|FG000|Period 2|Stability criteria not fulfilled|0|||
161366420|NCT01425814|582730161|FG001|Period 2|Stability criteria not fulfilled|1|||
161366421|NCT01425814|582730162|FG002|Period 2|Stability criteria not fulfilled|0|||
161366422|NCT01425814|582730163|FG003|Period 2|Stability criteria not fulfilled|0|||
161366423|NCT01425814|582730164|FG004|Period 2|Stability criteria not fulfilled|0|||
161366424|NCT01425814|582730165|FG005|Period 2|Stability criteria not fulfilled|0|||
161366425|NCT01425814|582730160|FG000|Period 3|Adverse Event|0|||
161366426|NCT01425814|582730161|FG001|Period 3|Adverse Event|0|||
161366427|NCT01425814|582730162|FG002|Period 3|Adverse Event|0|||
161366428|NCT01425814|582730163|FG003|Period 3|Adverse Event|0|||
161366429|NCT01425814|582730164|FG004|Period 3|Adverse Event|0|||
161366430|NCT01425814|582730165|FG005|Period 3|Adverse Event|1|||
161366431|NCT01425814|582730160|FG000|Period 4|Adverse Event|1|||
161366432|NCT01425814|582730161|FG001|Period 4|Adverse Event|0|||
161366433|NCT01425814|582730162|FG002|Period 4|Adverse Event|1|||
161366434|NCT01425814|582730163|FG003|Period 4|Adverse Event|0|||
161366435|NCT01425814|582730164|FG004|Period 4|Adverse Event|0|||
161366436|NCT01425814|582730165|FG005|Period 4|Adverse Event|0|||
161366437|NCT01425814|582730160|FG000|Period 5|Stability criteria not fulfilled|0|||
161366438|NCT01425814|582730161|FG001|Period 5|Stability criteria not fulfilled|0|||
161366439|NCT01425814|582730162|FG002|Period 5|Stability criteria not fulfilled|1|||
161366440|NCT01425814|582730163|FG003|Period 5|Stability criteria not fulfilled|0|||
161366441|NCT01425814|582730164|FG004|Period 5|Stability criteria not fulfilled|0|||
161366442|NCT01425814|582730165|FG005|Period 5|Stability criteria not fulfilled|1|||
161366443|NCT03580044|582730166|FG000|Overall Study|Death|2|||
161366444|NCT03580044|582730167|FG001|Overall Study|Death|1|||
161366445|NCT03580044|582730166|FG000|Overall Study|Withdrawal by Subject|1|||
161366446|NCT03580044|582730167|FG001|Overall Study|Withdrawal by Subject|1|||
161366447|NCT02743962|582730170|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
161366448|NCT02743962|582730171|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
161366449|NCT06582732|582730176|FG000|Initial Study Period|Adverse Event|0|||
161366450|NCT06582732|582730177|FG001|Initial Study Period|Adverse Event|0|||
161366451|NCT06582732|582730178|FG002|Initial Study Period|Adverse Event|0|||
161366452|NCT06582732|582730179|FG003|Initial Study Period|Adverse Event|2|||
161366453|NCT06582732|582730180|FG004|Initial Study Period|Adverse Event|0|||
161366454|NCT06582732|582730181|FG005|Initial Study Period|Adverse Event|0|||
161366455|NCT06582732|582730182|FG006|Initial Study Period|Adverse Event|0|||
161366456|NCT06582732|582730176|FG000|Initial Study Period|Death|1|||
161366457|NCT06582732|582730177|FG001|Initial Study Period|Death|0|||
161366458|NCT06582732|582730178|FG002|Initial Study Period|Death|0|||
161366459|NCT06582732|582730179|FG003|Initial Study Period|Death|0|||
161366460|NCT06582732|582730180|FG004|Initial Study Period|Death|1|||
161366461|NCT06582732|582730181|FG005|Initial Study Period|Death|0|||
161366462|NCT06582732|582730182|FG006|Initial Study Period|Death|0|||
161366463|NCT06582732|582730176|FG000|Initial Study Period|Lost to Follow-up|0|||
161366464|NCT06582732|582730177|FG001|Initial Study Period|Lost to Follow-up|0|||
161366465|NCT06582732|582730178|FG002|Initial Study Period|Lost to Follow-up|2|||
161366466|NCT06582732|582730179|FG003|Initial Study Period|Lost to Follow-up|0|||
161366467|NCT06582732|582730180|FG004|Initial Study Period|Lost to Follow-up|0|||
161366468|NCT06582732|582730181|FG005|Initial Study Period|Lost to Follow-up|0|||
161366469|NCT06582732|582730182|FG006|Initial Study Period|Lost to Follow-up|0|||
161366470|NCT06582732|582730176|FG000|Initial Study Period|Withdrawal by Subject|0|||
161366471|NCT06582732|582730177|FG001|Initial Study Period|Withdrawal by Subject|1|||
161366472|NCT06582732|582730178|FG002|Initial Study Period|Withdrawal by Subject|0|||
161366473|NCT06582732|582730179|FG003|Initial Study Period|Withdrawal by Subject|1|||
161366474|NCT06582732|582730180|FG004|Initial Study Period|Withdrawal by Subject|3|||
161366475|NCT06582732|582730181|FG005|Initial Study Period|Withdrawal by Subject|1|||
161366476|NCT06582732|582730182|FG006|Initial Study Period|Withdrawal by Subject|2|||
161366477|NCT06582732|582730176|FG000|Initial Study Period|Moved Away|0|||
161366478|NCT06582732|582730177|FG001|Initial Study Period|Moved Away|0|||
161366479|NCT06582732|582730178|FG002|Initial Study Period|Moved Away|0|||
161366480|NCT06582732|582730179|FG003|Initial Study Period|Moved Away|0|||
161366481|NCT06582732|582730180|FG004|Initial Study Period|Moved Away|1|||
161366482|NCT06582732|582730181|FG005|Initial Study Period|Moved Away|0|||
161366483|NCT06582732|582730182|FG006|Initial Study Period|Moved Away|0|||
161366484|NCT03931330|582730183|FG000|Overall Study|Physician Decision|1|||
161366485|NCT03412929|582730184|FG000|Overall Study|Protocol Violation|3|||
161366486|NCT01381679|582730187|FG000|Overall Study|Adverse Event|3|||
161366487|NCT01381679|582730187|FG000|Overall Study|Lost to Follow-up|885|||
161366488|NCT02919618|582730191|FG000|Overall Study|Death|1|||
161366489|NCT03528902|582730192|FG000|Overall Study|Adverse Event|1|||
161366490|NCT03528902|582730193|FG001|Overall Study|Adverse Event|0|||
161366491|NCT04620668|582730194|FG000|Overall Study|Withdrawal by Subject|2|||
161366492|NCT04620668|582730195|FG001|Overall Study|Withdrawal by Subject|0|||
161366493|NCT04620668|582730194|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
161366494|NCT04620668|582730195|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
161366495|NCT04620668|582730194|FG000|Overall Study|Removed before analysis: missing data|2|||
161366496|NCT04620668|582730195|FG001|Overall Study|Removed before analysis: missing data|0|||
161366497|NCT04620668|582730194|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
161366498|NCT04620668|582730195|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
161366499|NCT04620668|582730194|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
161366500|NCT04620668|582730195|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
161366501|NCT00427700|582730204|FG000|Overall Study|Lost to Follow-up|2|||
161366502|NCT00427700|582730205|FG001|Overall Study|Lost to Follow-up|5|||
161366503|NCT00427700|582730204|FG000|Overall Study|no induction of menses|1|||
161366504|NCT00427700|582730205|FG001|Overall Study|no induction of menses|4|||
161366505|NCT00427700|582730204|FG000|Overall Study|Pregnancy|0|||
161366506|NCT00427700|582730205|FG001|Overall Study|Pregnancy|2|||
161366507|NCT04581395|582730206|FG000|Overall Study|Protocol Violation|4|||
161366508|NCT04581395|582730207|FG001|Overall Study|Protocol Violation|3|||
161366509|NCT04581395|582730208|FG002|Overall Study|Protocol Violation|2|||
161366510|NCT04581395|582730206|FG000|Overall Study|Physician Decision|0|||
161366511|NCT04581395|582730207|FG001|Overall Study|Physician Decision|1|||
161366512|NCT04581395|582730208|FG002|Overall Study|Physician Decision|0|||
161366513|NCT00815633|582730215|FG000|Overall Study|study terminated|1|||
161366514|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
161366515|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161366516|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161366517|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161366518|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161366519|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161366520|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161366521|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
161366522|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
161366523|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
161366524|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
161366525|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
161366526|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
161366527|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
161366528|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
161366529|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
161366530|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
161366531|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
161366532|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
161366533|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
161366534|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
161366535|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
161366536|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
161366537|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
161366538|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
161366539|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
161366540|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
161366541|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
161366542|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
161366543|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
161366544|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
161366545|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
161366546|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
161366547|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
161366548|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
161366549|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
161366550|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
161366551|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
161366552|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
161366553|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
161366554|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
161366555|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
161366556|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
161366557|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161366558|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161366559|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161366560|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161366561|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161366562|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161366563|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161366564|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
161366565|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161366566|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161366567|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161366568|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161366569|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161366570|NCT01362790|582730216|FG000|Pilot Phase & Phase 2|Death on study|0|||
161366571|NCT01362790|582730217|FG001|Pilot Phase & Phase 2|Death on study|0|||
161366572|NCT01362790|582730218|FG002|Pilot Phase & Phase 2|Death on study|0|||
161366573|NCT01362790|582730219|FG003|Pilot Phase & Phase 2|Death on study|1|||
161366574|NCT01362790|582730220|FG004|Pilot Phase & Phase 2|Death on study|0|||
161366575|NCT01362790|582730221|FG005|Pilot Phase & Phase 2|Death on study|0|||
161366576|NCT01362790|582730222|FG006|Pilot Phase & Phase 2|Death on study|0|||
161366577|NCT01362790|582730216|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
161366578|NCT01362790|582730217|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
161366579|NCT01362790|582730218|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
161366580|NCT01362790|582730219|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
161366581|NCT01362790|582730220|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
161366582|NCT01362790|582730221|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
161366583|NCT01362790|582730222|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
161366584|NCT01362790|582730216|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161366585|NCT01362790|582730217|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161366586|NCT01362790|582730218|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161366587|NCT01362790|582730219|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161366588|NCT01362790|582730220|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
161366589|NCT01362790|582730221|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161366590|NCT01362790|582730222|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161366591|NCT01362790|582730216|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
161366592|NCT01362790|582730217|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
161366593|NCT01362790|582730218|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
161366594|NCT01362790|582730219|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
161366595|NCT01362790|582730220|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
161366596|NCT01362790|582730221|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
161366597|NCT01362790|582730222|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
161366598|NCT03485157|582730223|FG000|Double Blind Phase|Lost to Follow-up|4|||
161366599|NCT03485157|582730224|FG001|Double Blind Phase|Lost to Follow-up|4|||
161366600|NCT03485157|582730223|FG000|Double Blind Phase|Adverse Event|2|||
161366601|NCT03485157|582730224|FG001|Double Blind Phase|Adverse Event|1|||
161366602|NCT03485157|582730223|FG000|Double Blind Phase|Withdrawal by Subject|6|||
161366603|NCT03485157|582730224|FG001|Double Blind Phase|Withdrawal by Subject|9|||
161366604|NCT03485157|582730223|FG000|Double Blind Phase|Removal by PI|3|||
161366605|NCT03485157|582730224|FG001|Double Blind Phase|Removal by PI|7|||
161366606|NCT03485157|582730223|FG000|Open Label Phase|Lost to Follow-up|1|||
161366607|NCT03485157|582730224|FG001|Open Label Phase|Lost to Follow-up|2|||
161366608|NCT03485157|582730223|FG000|Open Label Phase|Adverse Event|0|||
161366609|NCT03485157|582730224|FG001|Open Label Phase|Adverse Event|1|||
161366610|NCT03485157|582730223|FG000|Open Label Phase|Withdrawal by Subject|1|||
161366611|NCT03485157|582730224|FG001|Open Label Phase|Withdrawal by Subject|2|||
161366612|NCT03485157|582730223|FG000|Open Label Phase|Removal by PI|2|||
161366613|NCT03485157|582730224|FG001|Open Label Phase|Removal by PI|0|||
161366614|NCT04347538|582730230|FG000|Overall Study|Lost to Follow-up|4|||
161366615|NCT04347538|582730231|FG001|Overall Study|Lost to Follow-up|5|||
161366616|NCT04347538|582730232|FG002|Overall Study|Lost to Follow-up|7|||
161366617|NCT02135133|582730233|FG000|Overall Study|Adverse Event|10|||
161366618|NCT02135133|582730233|FG000|Overall Study|regulatory mandate|5|||
161366619|NCT02259231|582730234|FG000|Overall Study|Adverse Event|1|||
161366620|NCT02259231|582730235|FG001|Overall Study|Adverse Event|1|||
161366621|NCT02259231|582730236|FG002|Overall Study|Adverse Event|2|||
161366622|NCT02259231|582730237|FG003|Overall Study|Adverse Event|0|||
161366623|NCT02259231|582730238|FG004|Overall Study|Adverse Event|0|||
161366624|NCT02259231|582730239|FG005|Overall Study|Adverse Event|0|||
161366625|NCT02259231|582730240|FG006|Overall Study|Adverse Event|0|||
161366626|NCT02259231|582730234|FG000|Overall Study|Progressive Disease|4|||
161366627|NCT02259231|582730235|FG001|Overall Study|Progressive Disease|5|||
161366628|NCT02259231|582730236|FG002|Overall Study|Progressive Disease|4|||
161366629|NCT02259231|582730237|FG003|Overall Study|Progressive Disease|5|||
161366630|NCT02259231|582730238|FG004|Overall Study|Progressive Disease|4|||
161366631|NCT02259231|582730239|FG005|Overall Study|Progressive Disease|5|||
161366632|NCT02259231|582730240|FG006|Overall Study|Progressive Disease|4|||
161366633|NCT02259231|582730234|FG000|Overall Study|Sponsor termination of study|1|||
161366634|NCT02259231|582730235|FG001|Overall Study|Sponsor termination of study|0|||
161366635|NCT02259231|582730236|FG002|Overall Study|Sponsor termination of study|0|||
161366636|NCT02259231|582730237|FG003|Overall Study|Sponsor termination of study|1|||
161366637|NCT02259231|582730238|FG004|Overall Study|Sponsor termination of study|2|||
161366638|NCT02259231|582730239|FG005|Overall Study|Sponsor termination of study|1|||
161366639|NCT02259231|582730240|FG006|Overall Study|Sponsor termination of study|1|||
161366640|NCT05081843|582730241|FG000|Overall Study|Lost to Follow-up|135|||
161366641|NCT05081843|582730242|FG001|Overall Study|Lost to Follow-up|145|||
161366642|NCT05852340|582730253|FG000|Period 5|Not completing the meal|0|||
161366643|NCT05852340|582730254|FG001|Period 5|Not completing the meal|1|||
161366644|NCT05852340|582730255|FG002|Period 5|Not completing the meal|0|||
161366645|NCT05852340|582730256|FG003|Period 5|Not completing the meal|0|||
161366646|NCT05852340|582730253|FG000|Period 5|Adverse Event|0|||
161366647|NCT05852340|582730254|FG001|Period 5|Adverse Event|0|||
161366648|NCT05852340|582730255|FG002|Period 5|Adverse Event|0|||
161366649|NCT05852340|582730256|FG003|Period 5|Adverse Event|1|||
161366650|NCT00071032|582730259|FG000|Overall Study|Lost to Follow-up|1|||
161366651|NCT00071032|582730260|FG001|Overall Study|Lost to Follow-up|1|||
161366652|NCT00071032|582730259|FG000|Overall Study|Withdrawal by Subject|8|||
161366653|NCT00071032|582730260|FG001|Overall Study|Withdrawal by Subject|6|||
161366654|NCT00071032|582730259|FG000|Overall Study|Missing Primary Outcome|0|||
161366655|NCT00071032|582730260|FG001|Overall Study|Missing Primary Outcome|1|||
161366656|NCT05487378|582730269|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
161366657|NCT05487378|582730270|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
161366658|NCT05487378|582730269|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
161366659|NCT05487378|582730270|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
161366660|NCT00112385|582730272|FG000|Overall Study|Lost to Follow-up|1|||
161366661|NCT00112385|582730273|FG001|Overall Study|Lost to Follow-up|0|||
161366662|NCT00112385|582730272|FG000|Overall Study|Withdrawal by Subject|0|||
161366663|NCT00112385|582730273|FG001|Overall Study|Withdrawal by Subject|1|||
161366664|NCT03648372|582730282|FG000|Overall Study|Withdrawal by Subject|2|||
161366665|NCT03648372|582730283|FG001|Overall Study|Withdrawal by Subject|0|||
161366666|NCT03648372|582730284|FG002|Overall Study|Withdrawal by Subject|0|||
161366667|NCT03648372|582730285|FG003|Overall Study|Withdrawal by Subject|0|||
161366668|NCT03648372|582730286|FG004|Overall Study|Withdrawal by Subject|0|||
161366669|NCT03648372|582730287|FG005|Overall Study|Withdrawal by Subject|1|||
161366670|NCT03648372|582730288|FG006|Overall Study|Withdrawal by Subject|2|||
161366671|NCT03648372|582730289|FG007|Overall Study|Withdrawal by Subject|0|||
161366672|NCT03648372|582730290|FG008|Overall Study|Withdrawal by Subject|0|||
161366673|NCT03648372|582730291|FG009|Overall Study|Withdrawal by Subject|0|||
161366674|NCT03648372|582730292|FG010|Overall Study|Withdrawal by Subject|2|||
161366675|NCT03648372|582730293|FG011|Overall Study|Withdrawal by Subject|0|||
161366676|NCT03648372|582730294|FG012|Overall Study|Withdrawal by Subject|2|||
161366677|NCT03648372|582730295|FG013|Overall Study|Withdrawal by Subject|0|||
161366678|NCT03648372|582730296|FG014|Overall Study|Withdrawal by Subject|0|||
161366679|NCT03648372|582730297|FG015|Overall Study|Withdrawal by Subject|0|||
161366680|NCT03648372|582730298|FG016|Overall Study|Withdrawal by Subject|1|||
161366681|NCT03648372|582730299|FG017|Overall Study|Withdrawal by Subject|0|||
161366682|NCT03648372|582730300|FG018|Overall Study|Withdrawal by Subject|0|||
161366683|NCT03648372|582730301|FG019|Overall Study|Withdrawal by Subject|0|||
161366684|NCT03648372|582730302|FG020|Overall Study|Withdrawal by Subject|0|||
161366685|NCT03648372|582730282|FG000|Overall Study|Progressive Disease|2|||
161366686|NCT03648372|582730283|FG001|Overall Study|Progressive Disease|3|||
161366687|NCT03648372|582730284|FG002|Overall Study|Progressive Disease|4|||
161366688|NCT03648372|582730285|FG003|Overall Study|Progressive Disease|3|||
161366689|NCT03648372|582730286|FG004|Overall Study|Progressive Disease|2|||
161366690|NCT03648372|582730287|FG005|Overall Study|Progressive Disease|2|||
161366691|NCT03648372|582730288|FG006|Overall Study|Progressive Disease|3|||
161366692|NCT03648372|582730289|FG007|Overall Study|Progressive Disease|3|||
161366693|NCT03648372|582730290|FG008|Overall Study|Progressive Disease|5|||
161366694|NCT03648372|582730291|FG009|Overall Study|Progressive Disease|5|||
161366695|NCT03648372|582730292|FG010|Overall Study|Progressive Disease|2|||
161366696|NCT03648372|582730293|FG011|Overall Study|Progressive Disease|3|||
161366697|NCT03648372|582730294|FG012|Overall Study|Progressive Disease|3|||
161366698|NCT03648372|582730295|FG013|Overall Study|Progressive Disease|3|||
161366699|NCT03648372|582730296|FG014|Overall Study|Progressive Disease|6|||
161366700|NCT03648372|582730297|FG015|Overall Study|Progressive Disease|0|||
161366701|NCT03648372|582730298|FG016|Overall Study|Progressive Disease|0|||
161366702|NCT03648372|582730299|FG017|Overall Study|Progressive Disease|0|||
161366703|NCT03648372|582730300|FG018|Overall Study|Progressive Disease|0|||
161366704|NCT03648372|582730301|FG019|Overall Study|Progressive Disease|0|||
161366705|NCT03648372|582730302|FG020|Overall Study|Progressive Disease|0|||
161366706|NCT03648372|582730282|FG000|Overall Study|Other|0|||
161366707|NCT03648372|582730283|FG001|Overall Study|Other|0|||
161366708|NCT03648372|582730284|FG002|Overall Study|Other|0|||
161366709|NCT03648372|582730285|FG003|Overall Study|Other|0|||
161366710|NCT03648372|582730286|FG004|Overall Study|Other|1|||
161366711|NCT03648372|582730287|FG005|Overall Study|Other|0|||
161366712|NCT03648372|582730288|FG006|Overall Study|Other|0|||
161366713|NCT03648372|582730289|FG007|Overall Study|Other|0|||
161366714|NCT03648372|582730290|FG008|Overall Study|Other|0|||
161366715|NCT03648372|582730291|FG009|Overall Study|Other|0|||
161366716|NCT03648372|582730292|FG010|Overall Study|Other|1|||
161366717|NCT03648372|582730293|FG011|Overall Study|Other|2|||
161366718|NCT03648372|582730294|FG012|Overall Study|Other|1|||
161366719|NCT03648372|582730295|FG013|Overall Study|Other|3|||
161366720|NCT03648372|582730296|FG014|Overall Study|Other|0|||
161366721|NCT03648372|582730297|FG015|Overall Study|Other|5|||
161366722|NCT03648372|582730298|FG016|Overall Study|Other|1|||
161366723|NCT03648372|582730299|FG017|Overall Study|Other|5|||
161366724|NCT03648372|582730300|FG018|Overall Study|Other|0|||
161366725|NCT03648372|582730301|FG019|Overall Study|Other|1|||
161366726|NCT03648372|582730302|FG020|Overall Study|Other|0|||
161366727|NCT03648372|582730282|FG000|Overall Study|Lost to Follow-up|0|||
161366728|NCT03648372|582730283|FG001|Overall Study|Lost to Follow-up|0|||
161366729|NCT03648372|582730284|FG002|Overall Study|Lost to Follow-up|0|||
161366730|NCT03648372|582730285|FG003|Overall Study|Lost to Follow-up|0|||
161366731|NCT03648372|582730286|FG004|Overall Study|Lost to Follow-up|0|||
161366732|NCT03648372|582730287|FG005|Overall Study|Lost to Follow-up|0|||
161366733|NCT03648372|582730288|FG006|Overall Study|Lost to Follow-up|0|||
161366734|NCT03648372|582730289|FG007|Overall Study|Lost to Follow-up|0|||
161366735|NCT03648372|582730290|FG008|Overall Study|Lost to Follow-up|0|||
161366736|NCT03648372|582730291|FG009|Overall Study|Lost to Follow-up|0|||
161366737|NCT03648372|582730292|FG010|Overall Study|Lost to Follow-up|0|||
161366738|NCT03648372|582730293|FG011|Overall Study|Lost to Follow-up|0|||
161366739|NCT03648372|582730294|FG012|Overall Study|Lost to Follow-up|0|||
161366740|NCT03648372|582730295|FG013|Overall Study|Lost to Follow-up|1|||
161366741|NCT03648372|582730296|FG014|Overall Study|Lost to Follow-up|0|||
161366742|NCT03648372|582730297|FG015|Overall Study|Lost to Follow-up|1|||
161366743|NCT03648372|582730298|FG016|Overall Study|Lost to Follow-up|0|||
161366744|NCT03648372|582730299|FG017|Overall Study|Lost to Follow-up|1|||
161366745|NCT03648372|582730300|FG018|Overall Study|Lost to Follow-up|0|||
161366746|NCT03648372|582730301|FG019|Overall Study|Lost to Follow-up|0|||
161366747|NCT03648372|582730302|FG020|Overall Study|Lost to Follow-up|0|||
161366748|NCT03648372|582730282|FG000|Overall Study|Start of a New Systemic Treatment|0|||
161366749|NCT03648372|582730283|FG001|Overall Study|Start of a New Systemic Treatment|0|||
161366750|NCT03648372|582730284|FG002|Overall Study|Start of a New Systemic Treatment|0|||
161366751|NCT03648372|582730285|FG003|Overall Study|Start of a New Systemic Treatment|0|||
161366752|NCT03648372|582730286|FG004|Overall Study|Start of a New Systemic Treatment|0|||
161366753|NCT03648372|582730287|FG005|Overall Study|Start of a New Systemic Treatment|0|||
161366754|NCT03648372|582730288|FG006|Overall Study|Start of a New Systemic Treatment|0|||
161366755|NCT03648372|582730289|FG007|Overall Study|Start of a New Systemic Treatment|2|||
161366756|NCT03648372|582730290|FG008|Overall Study|Start of a New Systemic Treatment|0|||
161366757|NCT03648372|582730291|FG009|Overall Study|Start of a New Systemic Treatment|0|||
161366758|NCT03648372|582730292|FG010|Overall Study|Start of a New Systemic Treatment|1|||
161366759|NCT03648372|582730293|FG011|Overall Study|Start of a New Systemic Treatment|0|||
161366760|NCT03648372|582730294|FG012|Overall Study|Start of a New Systemic Treatment|0|||
161366761|NCT03648372|582730295|FG013|Overall Study|Start of a New Systemic Treatment|0|||
161366762|NCT03648372|582730296|FG014|Overall Study|Start of a New Systemic Treatment|0|||
161366763|NCT03648372|582730297|FG015|Overall Study|Start of a New Systemic Treatment|0|||
161366764|NCT03648372|582730298|FG016|Overall Study|Start of a New Systemic Treatment|0|||
161366765|NCT03648372|582730299|FG017|Overall Study|Start of a New Systemic Treatment|0|||
161366766|NCT03648372|582730300|FG018|Overall Study|Start of a New Systemic Treatment|0|||
161366767|NCT03648372|582730301|FG019|Overall Study|Start of a New Systemic Treatment|0|||
161366768|NCT03648372|582730302|FG020|Overall Study|Start of a New Systemic Treatment|0|||
161366769|NCT00730327|582731501|FG000|Overall Study|Lost to Follow-up|14|||
161366770|NCT00730327|582731502|FG001|Overall Study|Lost to Follow-up|16|||
161366771|NCT00730327|582731501|FG000|Overall Study|Adverse Event|8|||
161366772|NCT00730327|582731502|FG001|Overall Study|Adverse Event|1|||
161366773|NCT00730327|582731501|FG000|Overall Study|Withdrawal by Subject|3|||
161366774|NCT00730327|582731502|FG001|Overall Study|Withdrawal by Subject|13|||
161366775|NCT00730327|582731501|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
161366776|NCT00730327|582731502|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
161366777|NCT04484857|582731505|FG000|Overall Study|Adverse Event|2|||
161366778|NCT04484857|582731505|FG000|Overall Study|Death|10|||
161366779|NCT04484857|582731505|FG000|Overall Study|Withdrawal by Subject|3|||
161366780|NCT04484857|582731505|FG000|Overall Study|Transferred/Relocation|5|||
161366781|NCT04484857|582731505|FG000|Overall Study|Kidney Transplant|7|||
161366782|NCT04484857|582731505|FG000|Overall Study|Other than specified|4|||
161366783|NCT04484857|582731505|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
161366784|NCT04507204|582731506|FG000|Overall Study|Adverse Event|8|||
161366785|NCT04507204|582731507|FG001|Overall Study|Adverse Event|13|||
161366786|NCT04507204|582731506|FG000|Overall Study|Death|0|||
161366787|NCT04507204|582731507|FG001|Overall Study|Death|1|||
161366788|NCT04507204|582731506|FG000|Overall Study|Lost to Follow-up|15|||
161366789|NCT04507204|582731507|FG001|Overall Study|Lost to Follow-up|14|||
161366790|NCT04507204|582731506|FG000|Overall Study|Poor Compliance with Protocol|2|||
161366791|NCT04507204|582731507|FG001|Overall Study|Poor Compliance with Protocol|4|||
161366792|NCT04507204|582731506|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
161366793|NCT04507204|582731507|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
161366794|NCT04507204|582731506|FG000|Overall Study|Withdrawal of Patient Consent|21|||
161366795|NCT04507204|582731507|FG001|Overall Study|Withdrawal of Patient Consent|13|||
161366796|NCT01358734|582731510|FG000|Overall Study|Adverse Event|4|||
161366797|NCT01358734|582731511|FG001|Overall Study|Adverse Event|7|||
161366798|NCT01358734|582731512|FG002|Overall Study|Adverse Event|3|||
161366799|NCT01358734|582731510|FG000|Overall Study|Lack of Efficacy|0|||
161366800|NCT01358734|582731511|FG001|Overall Study|Lack of Efficacy|1|||
161366801|NCT01358734|582731512|FG002|Overall Study|Lack of Efficacy|3|||
161366802|NCT01358734|582731510|FG000|Overall Study|Withdrawal by Subject|1|||
161366803|NCT01358734|582731511|FG001|Overall Study|Withdrawal by Subject|6|||
161366804|NCT01358734|582731512|FG002|Overall Study|Withdrawal by Subject|3|||
161366805|NCT01358734|582731510|FG000|Overall Study|Death|3|||
161366806|NCT01358734|582731511|FG001|Overall Study|Death|7|||
161366807|NCT01358734|582731512|FG002|Overall Study|Death|2|||
161366808|NCT01358734|582731510|FG000|Overall Study|Progressive Disease|5|||
161366809|NCT01358734|582731511|FG001|Overall Study|Progressive Disease|13|||
161366810|NCT01358734|582731512|FG002|Overall Study|Progressive Disease|16|||
161366811|NCT01358734|582731510|FG000|Overall Study|Non-compliance with study drug|0|||
161366812|NCT01358734|582731511|FG001|Overall Study|Non-compliance with study drug|0|||
161366813|NCT01358734|582731512|FG002|Overall Study|Non-compliance with study drug|1|||
161366814|NCT01358734|582731510|FG000|Overall Study|Other|2|||
161366815|NCT01358734|582731511|FG001|Overall Study|Other|5|||
161366816|NCT01358734|582731512|FG002|Overall Study|Other|4|||
161366817|NCT01358734|582731510|FG000|Overall Study|Protocol Violation|0|||
161366818|NCT01358734|582731511|FG001|Overall Study|Protocol Violation|0|||
161366819|NCT01358734|582731512|FG002|Overall Study|Protocol Violation|2|||
161366820|NCT01905540|582731515|FG000|Period 3|Other|1|||
161366821|NCT01905540|582731516|FG001|Period 3|Other|0|||
161366822|NCT01905540|582731517|FG002|Period 3|Other|1|||
161366823|NCT01905540|582731518|FG003|Period 3|Other|1|||
161366824|NCT03427619|582731519|FG000|Overall Study|Physician Decision|3|||
161366825|NCT03427619|582731519|FG000|Overall Study|Withdrawal by Subject|4|||
161366826|NCT03427619|582731519|FG000|Overall Study|Lost to Follow-up|5|||
161366827|NCT03427619|582731519|FG000|Overall Study|Administrative|4|||
161366828|NCT03427619|582731519|FG000|Overall Study|Other|2|||
161366829|NCT03427619|582731519|FG000|Overall Study|Unknown or Missing Completion Status|48|||
161366830|NCT03729609|582731524|FG000|Overall Study|Protocol Violation|1|||
161366831|NCT01055028|582731530|FG000|Screening|Screen Failure|1|||
161366832|NCT01055028|582731531|FG001|Screening|Screen Failure|1|||
161366833|NCT01055028|582731530|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
161366834|NCT01055028|582731531|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
161366835|NCT01055028|582731530|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
161366836|NCT01055028|582731531|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
161366837|NCT01055028|582731530|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
161366838|NCT01055028|582731531|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
161366839|NCT04770285|582731532|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
161366840|NCT04770285|582731533|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
161366841|NCT04770285|582731532|FG000|Overall Study|Lack of Efficacy|0|||
161366842|NCT04770285|582731533|FG001|Overall Study|Lack of Efficacy|1|||
161366843|NCT04770285|582731532|FG000|Overall Study|Lost to Follow-up|11|||
161366844|NCT04770285|582731533|FG001|Overall Study|Lost to Follow-up|8|||
161366845|NCT04770285|582731532|FG000|Overall Study|Protocol Deviation|6|||
161366846|NCT04770285|582731533|FG001|Overall Study|Protocol Deviation|6|||
161366847|NCT04770285|582731532|FG000|Overall Study|Technical Problem|0|||
161366848|NCT04770285|582731533|FG001|Overall Study|Technical Problem|1|||
161366849|NCT04770285|582731532|FG000|Overall Study|Withdrawal by Subject|9|||
161366850|NCT04770285|582731533|FG001|Overall Study|Withdrawal by Subject|8|||
161366851|NCT04770285|582731532|FG000|Overall Study|Reason Not Specified|0|||
161366852|NCT04770285|582731533|FG001|Overall Study|Reason Not Specified|1|||
161366853|NCT00645658|582731534|FG000|Overall Study|Withdrawal by Subject|1|||
161366854|NCT00645658|582731535|FG001|Overall Study|Withdrawal by Subject|0|||
161366855|NCT00645658|582731534|FG000|Overall Study|Did not complete all assesments|0|||
161366856|NCT00645658|582731535|FG001|Overall Study|Did not complete all assesments|2|||
161366857|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
161366858|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
161366859|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
161366860|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
161366861|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
161366862|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
161366863|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
161366864|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
161366865|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
161366866|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
161366867|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
161366868|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
161366869|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
161366870|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
161366871|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
161366872|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
161366873|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
161366874|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
161366875|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
161366876|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
161366877|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
161366878|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
161366879|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
161366880|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
161366881|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
161366882|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
161366883|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
161366884|NCT03093415|582731538|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
161366885|NCT03093415|582731539|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
161366886|NCT03093415|582731540|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
161366887|NCT03093415|582731538|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
161366888|NCT03093415|582731539|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
161366889|NCT03093415|582731540|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
161366890|NCT02457065|582731541|FG000|Overall Study|Lost to Follow-up|9|||
161366891|NCT02457065|582731542|FG001|Overall Study|Lost to Follow-up|11|||
161366892|NCT03038087|582731543|FG000|Overall Study|lost data|1|||
161366893|NCT00654355|582731544|FG000|Overall Study|Lost to Follow-up|2|||
161366894|NCT00654355|582731545|FG001|Overall Study|Lost to Follow-up|2|||
161366895|NCT01435356|582731547|FG000|Overall Study|Adverse Event|2|||
161366896|NCT01435356|582731548|FG001|Overall Study|Adverse Event|0|||
161366897|NCT01435356|582731547|FG000|Overall Study|Disease progression/recurrence|17|||
161366898|NCT01435356|582731548|FG001|Overall Study|Disease progression/recurrence|10|||
161366899|NCT01435356|582731547|FG000|Overall Study|Protocol Violation|0|||
161366900|NCT01435356|582731548|FG001|Overall Study|Protocol Violation|1|||
161366901|NCT01435356|582731547|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
161366902|NCT01435356|582731548|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
161366903|NCT01435356|582731547|FG000|Overall Study|Withdrawal by Subject|1|||
161366904|NCT01435356|582731548|FG001|Overall Study|Withdrawal by Subject|1|||
161366905|NCT01435356|582731547|FG000|Overall Study|Facial palsy|1|||
161366906|NCT01435356|582731548|FG001|Overall Study|Facial palsy|0|||
161366907|NCT01435356|582731547|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
161366908|NCT01435356|582731548|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
161366909|NCT01435356|582731547|FG000|Overall Study|Physician Decision|1|||
161366910|NCT01435356|582731548|FG001|Overall Study|Physician Decision|0|||
161366911|NCT01435356|582731547|FG000|Overall Study|Patient decision|3|||
161366912|NCT01435356|582731548|FG001|Overall Study|Patient decision|0|||
161366913|NCT01435356|582731547|FG000|Overall Study|Patient moved to another city|1|||
161366914|NCT01435356|582731548|FG001|Overall Study|Patient moved to another city|1|||
161366915|NCT04918771|582731549|FG000|Overall Study|Withdrawal by Subject|4|||
161366916|NCT04918771|582731550|FG001|Overall Study|Withdrawal by Subject|5|||
161366917|NCT04918771|582731549|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
161366918|NCT04918771|582731550|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
161366919|NCT01849276|582731551|FG000|Followed for Survival for 5 Years|Death|1|||
161366920|NCT01849276|582731551|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
161366921|NCT02657343|582731552|FG000|Overall Study|Death|0|||
161366922|NCT02657343|582731553|FG001|Overall Study|Death|2|||
161366923|NCT02657343|582731554|FG002|Overall Study|Death|0|||
161366924|NCT02657343|582731555|FG003|Overall Study|Death|0|||
161366925|NCT02657343|582731556|FG004|Overall Study|Death|0|||
161366926|NCT02657343|582731557|FG005|Overall Study|Death|0|||
161366927|NCT02657343|582731552|FG000|Overall Study|Patient went to hospice|1|||
161366928|NCT02657343|582731553|FG001|Overall Study|Patient went to hospice|0|||
161366929|NCT02657343|582731554|FG002|Overall Study|Patient went to hospice|0|||
161366930|NCT02657343|582731555|FG003|Overall Study|Patient went to hospice|0|||
161366931|NCT02657343|582731556|FG004|Overall Study|Patient went to hospice|0|||
161366932|NCT02657343|582731557|FG005|Overall Study|Patient went to hospice|0|||
161366933|NCT02657343|582731552|FG000|Overall Study|Withdrawal by Subject|0|||
161366934|NCT02657343|582731553|FG001|Overall Study|Withdrawal by Subject|0|||
161366935|NCT02657343|582731554|FG002|Overall Study|Withdrawal by Subject|0|||
161366936|NCT02657343|582731555|FG003|Overall Study|Withdrawal by Subject|0|||
161366937|NCT02657343|582731556|FG004|Overall Study|Withdrawal by Subject|1|||
161366938|NCT02657343|582731557|FG005|Overall Study|Withdrawal by Subject|0|||
161366939|NCT01813357|582731564|FG000|Overall Study|Lost to Follow-up|5|||
161366940|NCT01813357|582731565|FG001|Overall Study|Lost to Follow-up|6|||
161366941|NCT02607722|582731575|FG000|Overall Study|No data reliability|1|||
161366942|NCT02607722|582731575|FG000|Overall Study|no patient visit|18|||
161366943|NCT02607722|582731575|FG000|Overall Study|missing info in CRF|13|||
161366944|NCT02607722|582731575|FG000|Overall Study|Withdrawal by Subject|616|||
161366945|NCT02607722|582731575|FG000|Overall Study|Lost to Follow-up|312|||
161366946|NCT02607722|582731575|FG000|Overall Study|Improved|22|||
161366947|NCT02607722|582731575|FG000|Overall Study|Lack of Efficacy|316|||
161366948|NCT02607722|582731575|FG000|Overall Study|Adverse Event|2553|||
161366949|NCT02607722|582731575|FG000|Overall Study|Not treated|1|||
161366950|NCT02607722|582731575|FG000|Overall Study|No CRF collected|138|||
161366951|NCT02607722|582731575|FG000|Overall Study|without CRF|4225|||
161366952|NCT02607722|582731575|FG000|Overall Study|Physician Decision|367|||
161366953|NCT02871219|582731576|FG000|Overall Study|Adverse Event|15|||
161366954|NCT02871219|582731576|FG000|Overall Study|Death|3|||
161366955|NCT02871219|582731576|FG000|Overall Study|Progression|3|||
161366956|NCT02871219|582731576|FG000|Overall Study|Infections|7|||
161366957|NCT02871219|582731576|FG000|Overall Study|Infusion Related|4|||
161366958|NCT03238196|582731577|FG000|Overall Study|Adverse Event|3|||
161366959|NCT03238196|582731578|FG001|Overall Study|Adverse Event|0|||
161366960|NCT03238196|582731579|FG002|Overall Study|Adverse Event|2|||
161366961|NCT03238196|582731580|FG003|Overall Study|Adverse Event|2|||
161366962|NCT03238196|582731577|FG000|Overall Study|Withdrawal by Subject|4|||
161366963|NCT03238196|582731578|FG001|Overall Study|Withdrawal by Subject|1|||
161366964|NCT03238196|582731579|FG002|Overall Study|Withdrawal by Subject|1|||
161366965|NCT03238196|582731580|FG003|Overall Study|Withdrawal by Subject|0|||
161366966|NCT03238196|582731577|FG000|Overall Study|Disease progression|14|||
161366967|NCT03238196|582731578|FG001|Overall Study|Disease progression|2|||
161366968|NCT03238196|582731579|FG002|Overall Study|Disease progression|3|||
161366969|NCT03238196|582731580|FG003|Overall Study|Disease progression|2|||
161366970|NCT03238196|582731577|FG000|Overall Study|Still on treatment|1|||
161366971|NCT03238196|582731578|FG001|Overall Study|Still on treatment|0|||
161366972|NCT03238196|582731579|FG002|Overall Study|Still on treatment|0|||
161366973|NCT03238196|582731580|FG003|Overall Study|Still on treatment|0|||
161366974|NCT00835354|582731581|FG000|First Intervention|Adverse Event|0|||
161366975|NCT00835354|582731582|FG001|First Intervention|Adverse Event|1|||
161366976|NCT03559556|582731588|FG000|Overall Study|Withdrawal by Subject|1|||
161366977|NCT02496000|582731589|FG000|Overall Study|Withdrawal by Subject|1|||
161366978|NCT02496000|582731590|FG001|Overall Study|Withdrawal by Subject|2|||
161366979|NCT02496000|582731591|FG002|Overall Study|Withdrawal by Subject|0|||
161366980|NCT02496000|582731589|FG000|Overall Study|Lost to Follow-up|1|||
161366981|NCT02496000|582731590|FG001|Overall Study|Lost to Follow-up|0|||
161366982|NCT02496000|582731591|FG002|Overall Study|Lost to Follow-up|1|||
161366983|NCT02496000|582731589|FG000|Overall Study|Protocol Violation|0|||
161366984|NCT02496000|582731590|FG001|Overall Study|Protocol Violation|0|||
161366985|NCT02496000|582731591|FG002|Overall Study|Protocol Violation|1|||
161366986|NCT02496000|582731589|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
161366987|NCT02496000|582731590|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
161366988|NCT02496000|582731591|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
161366989|NCT02496000|582731589|FG000|Overall Study|undetermined|0|||
161366990|NCT02496000|582731590|FG001|Overall Study|undetermined|1|||
161366991|NCT02496000|582731591|FG002|Overall Study|undetermined|0|||
161366992|NCT01877278|582731592|FG000|Overall Study|Lost to Follow-up|3|||
161366993|NCT01877278|582731593|FG001|Overall Study|Lost to Follow-up|3|||
161366994|NCT01969058|582731594|FG000|Overall Study|Withdrawal by Subject|2|||
161366995|NCT01969058|582731595|FG001|Overall Study|Withdrawal by Subject|0|||
161366996|NCT01969058|582731594|FG000|Overall Study|Adverse Event|1|||
161366997|NCT01969058|582731595|FG001|Overall Study|Adverse Event|0|||
161366998|NCT04090749|582731596|FG000|Open Label Pilot|Lost to Follow-up|1|||
161366999|NCT04090749|582731597|FG001|Open Label Pilot|Lost to Follow-up|0|||
161367000|NCT04090749|582731598|FG002|Open Label Pilot|Lost to Follow-up|0|||
161367001|NCT04090749|582731596|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
161367002|NCT04090749|582731597|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
161367003|NCT04090749|582731598|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
161367004|NCT04090749|582731596|FG000|Pilot Trial|Lost to Follow-up|0|||
161367005|NCT04090749|582731597|FG001|Pilot Trial|Lost to Follow-up|1|||
161367006|NCT04090749|582731598|FG002|Pilot Trial|Lost to Follow-up|1|||
161367007|NCT03510715|582731599|FG000|Overall Study|Adverse Event|1|||
161367008|NCT03510715|582731600|FG001|Overall Study|Adverse Event|0|||
161367009|NCT01972659|582731602|FG000|Overall Study|Protocol Violation|2|||
161367010|NCT01972659|582731603|FG001|Overall Study|Protocol Violation|2|||
161367011|NCT01972659|582731602|FG000|Overall Study|problems realted to acceleromyograph|2|||
161367012|NCT01972659|582731603|FG001|Overall Study|problems realted to acceleromyograph|1|||
161367013|NCT02457793|582731605|FG000|Overall Study|Reason not specified|0|||
161367014|NCT02457793|582731606|FG001|Overall Study|Reason not specified|0|||
161367015|NCT02457793|582731607|FG002|Overall Study|Reason not specified|0|||
161367016|NCT02457793|582731608|FG003|Overall Study|Reason not specified|1|||
161367017|NCT02457793|582731609|FG004|Overall Study|Reason not specified|1|||
161367018|NCT02457793|582731610|FG005|Overall Study|Reason not specified|1|||
161367019|NCT02457793|582731605|FG000|Overall Study|Withdrawal by Subject|0|||
161367020|NCT02457793|582731606|FG001|Overall Study|Withdrawal by Subject|4|||
161367021|NCT02457793|582731607|FG002|Overall Study|Withdrawal by Subject|2|||
161367022|NCT02457793|582731608|FG003|Overall Study|Withdrawal by Subject|2|||
161367023|NCT02457793|582731609|FG004|Overall Study|Withdrawal by Subject|2|||
161367024|NCT02457793|582731610|FG005|Overall Study|Withdrawal by Subject|2|||
161367025|NCT02457793|582731605|FG000|Overall Study|Adverse Event|0|||
161367026|NCT02457793|582731606|FG001|Overall Study|Adverse Event|0|||
161367027|NCT02457793|582731607|FG002|Overall Study|Adverse Event|0|||
161367028|NCT02457793|582731608|FG003|Overall Study|Adverse Event|1|||
161367029|NCT02457793|582731609|FG004|Overall Study|Adverse Event|0|||
161367030|NCT02457793|582731610|FG005|Overall Study|Adverse Event|0|||
161367031|NCT02457793|582731605|FG000|Overall Study|Physician Decision|1|||
161367032|NCT02457793|582731606|FG001|Overall Study|Physician Decision|0|||
161367033|NCT02457793|582731607|FG002|Overall Study|Physician Decision|1|||
161367034|NCT02457793|582731608|FG003|Overall Study|Physician Decision|1|||
161367035|NCT02457793|582731609|FG004|Overall Study|Physician Decision|1|||
161367036|NCT02457793|582731610|FG005|Overall Study|Physician Decision|3|||
161367037|NCT00835172|582731615|FG000|Washout|Protocol Violation|0|||
161367038|NCT00835172|582731616|FG001|Washout|Protocol Violation|1|||
161367039|NCT03164356|582731619|FG000|Overall Study|Lost to Follow-up|1|||
161367040|NCT03164356|582731620|FG001|Overall Study|Lost to Follow-up|1|||
161367041|NCT03164356|582731621|FG002|Overall Study|Lost to Follow-up|2|||
161367042|NCT03164356|582731622|FG003|Overall Study|Lost to Follow-up|1|||
161367043|NCT03164356|582731619|FG000|Overall Study|Physician Decision|0|||
161367044|NCT03164356|582731620|FG001|Overall Study|Physician Decision|0|||
161367045|NCT03164356|582731621|FG002|Overall Study|Physician Decision|3|||
161367046|NCT03164356|582731622|FG003|Overall Study|Physician Decision|0|||
161367047|NCT03164356|582731619|FG000|Overall Study|Protocol Violation|2|||
161367048|NCT03164356|582731620|FG001|Overall Study|Protocol Violation|1|||
161367049|NCT03164356|582731621|FG002|Overall Study|Protocol Violation|0|||
161367050|NCT03164356|582731622|FG003|Overall Study|Protocol Violation|0|||
161367051|NCT03164356|582731619|FG000|Overall Study|Withdrawal by Subject|1|||
161367052|NCT03164356|582731620|FG001|Overall Study|Withdrawal by Subject|0|||
161367053|NCT03164356|582731621|FG002|Overall Study|Withdrawal by Subject|0|||
161367054|NCT03164356|582731622|FG003|Overall Study|Withdrawal by Subject|0|||
161367055|NCT03164356|582731619|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
161367056|NCT03164356|582731620|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
161367057|NCT03164356|582731621|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
161367058|NCT03164356|582731622|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
161367059|NCT03164356|582731619|FG000|Overall Study|Subject Incarcerated|0|||
161367060|NCT03164356|582731620|FG001|Overall Study|Subject Incarcerated|1|||
161367061|NCT03164356|582731621|FG002|Overall Study|Subject Incarcerated|0|||
161367062|NCT03164356|582731622|FG003|Overall Study|Subject Incarcerated|0|||
161367063|NCT03164356|582731619|FG000|Overall Study|Prosthetist unable to participate|0|||
161367064|NCT03164356|582731620|FG001|Overall Study|Prosthetist unable to participate|2|||
161367065|NCT03164356|582731621|FG002|Overall Study|Prosthetist unable to participate|1|||
161367066|NCT03164356|582731622|FG003|Overall Study|Prosthetist unable to participate|0|||
161367067|NCT00791648|582733658|FG000|Overall Study|Physician Decision|0|||
161367068|NCT00791648|582733659|FG001|Overall Study|Physician Decision|1|||
161367069|NCT00791648|582733658|FG000|Overall Study|Withdrawal by Subject|0|||
161367070|NCT00791648|582733659|FG001|Overall Study|Withdrawal by Subject|1|||
161367071|NCT04123704|582733670|FG000|Overall Study|Disease progression|2|||
161367072|NCT03332056|582733676|FG000|Overall Study|Incomplete questionnaires|8|||
161367073|NCT03332056|582733677|FG001|Overall Study|Incomplete questionnaires|9|||
161367074|NCT03332056|582733676|FG000|Overall Study|Passed stone prior to surgery date|1|||
161367075|NCT03332056|582733677|FG001|Overall Study|Passed stone prior to surgery date|0|||
161367076|NCT03332056|582733676|FG000|Overall Study|Did not require a ureteral stent|0|||
161367077|NCT03332056|582733677|FG001|Overall Study|Did not require a ureteral stent|1|||
161367078|NCT03360344|582733680|FG000|Overall Study|Withdrawal by Subject|0|||
161367079|NCT03360344|582733681|FG001|Overall Study|Withdrawal by Subject|1|||
161367080|NCT03360344|582733682|FG002|Overall Study|Withdrawal by Subject|1|||
161367081|NCT00133705|582733687|FG000|Overall Study|Withdrawal by Subject|2|||
161367082|NCT00133705|582733688|FG001|Overall Study|Withdrawal by Subject|3|||
161367083|NCT00959049|582733689|FG000|Overall Study|Adverse Event|1|||
161367084|NCT00959049|582733690|FG001|Overall Study|Adverse Event|0|||
161367085|NCT00959049|582733691|FG002|Overall Study|Adverse Event|0|||
161367086|NCT00959049|582733692|FG003|Overall Study|Adverse Event|0|||
161367087|NCT00959049|582733693|FG004|Overall Study|Adverse Event|0|||
161367088|NCT00959049|582733694|FG005|Overall Study|Adverse Event|0|||
161367089|NCT00959049|582733689|FG000|Overall Study|Lost to Follow-up|17|||
161367090|NCT00959049|582733690|FG001|Overall Study|Lost to Follow-up|5|||
161367091|NCT00959049|582733691|FG002|Overall Study|Lost to Follow-up|1|||
161367092|NCT00959049|582733692|FG003|Overall Study|Lost to Follow-up|10|||
161367093|NCT00959049|582733693|FG004|Overall Study|Lost to Follow-up|9|||
161367094|NCT00959049|582733694|FG005|Overall Study|Lost to Follow-up|1|||
161367095|NCT00959049|582733689|FG000|Overall Study|Contraindicated medication|0|||
161367096|NCT00959049|582733690|FG001|Overall Study|Contraindicated medication|0|||
161367097|NCT00959049|582733691|FG002|Overall Study|Contraindicated medication|0|||
161367098|NCT00959049|582733692|FG003|Overall Study|Contraindicated medication|1|||
161367099|NCT00959049|582733693|FG004|Overall Study|Contraindicated medication|0|||
161367100|NCT00959049|582733694|FG005|Overall Study|Contraindicated medication|0|||
161367101|NCT00959049|582733689|FG000|Overall Study|Withdrawal by Subject|0|||
161367102|NCT00959049|582733690|FG001|Overall Study|Withdrawal by Subject|2|||
161367103|NCT00959049|582733691|FG002|Overall Study|Withdrawal by Subject|0|||
161367104|NCT00959049|582733692|FG003|Overall Study|Withdrawal by Subject|0|||
161367105|NCT00959049|582733693|FG004|Overall Study|Withdrawal by Subject|0|||
161367106|NCT00959049|582733694|FG005|Overall Study|Withdrawal by Subject|0|||
161367107|NCT00836706|582733702|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
161367108|NCT00836706|582733703|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161367109|NCT02989857|582733704|FG000|Randomization Phase|Not Treated|3|||
161367110|NCT02989857|582733705|FG001|Randomization Phase|Not Treated|2|||
161367111|NCT02989857|582733706|FG002|Randomization Phase|Not Treated|0|||
161367112|NCT01992757|582733707|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
161367113|NCT00688740|582733711|FG000|Overall Study|Adverse Event|45|||
161367114|NCT00688740|582733712|FG001|Overall Study|Adverse Event|8|||
161367115|NCT00688740|582733711|FG000|Overall Study|Death|2|||
161367116|NCT00688740|582733712|FG001|Overall Study|Death|2|||
161367117|NCT00688740|582733711|FG000|Overall Study|Lost to Follow-up|0|||
161367118|NCT00688740|582733712|FG001|Overall Study|Lost to Follow-up|1|||
161367119|NCT00688740|582733711|FG000|Overall Study|Consent Withdrawn|17|||
161367120|NCT00688740|582733712|FG001|Overall Study|Consent Withdrawn|17|||
161367121|NCT00688740|582733711|FG000|Overall Study|Breast Cancer Relapse|1|||
161367122|NCT00688740|582733712|FG001|Overall Study|Breast Cancer Relapse|4|||
161367123|NCT00688740|582733711|FG000|Overall Study|Violation of Inclusion Criteria|1|||
161367124|NCT00688740|582733712|FG001|Overall Study|Violation of Inclusion Criteria|3|||
161367125|NCT01344356|582733713|FG000|Overall Study|Physician Decision|0|||
161367126|NCT01344356|582733714|FG001|Overall Study|Physician Decision|3|||
161367127|NCT01344356|582733713|FG000|Overall Study|Lost to Follow-up|0|||
161367128|NCT01344356|582733714|FG001|Overall Study|Lost to Follow-up|6|||
161367129|NCT02390076|582733717|FG000|Overall Study|Lost to Follow-up|2|||
161367130|NCT02390076|582733718|FG001|Overall Study|Lost to Follow-up|1|||
161367131|NCT02390076|582733719|FG002|Overall Study|Lost to Follow-up|4|||
161367132|NCT01206517|582733720|FG000|Overall Study|Withdrawal by Subject|0|||
161367133|NCT01206517|582733721|FG001|Overall Study|Withdrawal by Subject|0|||
161367134|NCT01206517|582733722|FG002|Overall Study|Withdrawal by Subject|2|||
161367135|NCT01206517|582733723|FG003|Overall Study|Withdrawal by Subject|0|||
161367136|NCT01206517|582733724|FG004|Overall Study|Withdrawal by Subject|1|||
161367137|NCT01206517|582733725|FG005|Overall Study|Withdrawal by Subject|0|||
161367138|NCT00725985|582733726|FG000|ITP- Treatment Disposition|Adverse Event|20|||
161367139|NCT00725985|582733727|FG001|ITP- Treatment Disposition|Adverse Event|10|||
161367140|NCT00725985|582733728|FG002|ITP- Treatment Disposition|Adverse Event|5|||
161367141|NCT00725985|582733729|FG003|ITP- Treatment Disposition|Adverse Event|0|||
161367142|NCT00725985|582733730|FG004|ITP- Treatment Disposition|Adverse Event|0|||
161367143|NCT00725985|582733731|FG005|ITP- Treatment Disposition|Adverse Event|0|||
161367144|NCT00725985|582733732|FG006|ITP- Treatment Disposition|Adverse Event|0|||
161367145|NCT00725985|582733733|FG007|ITP- Treatment Disposition|Adverse Event|0|||
161367146|NCT00725985|582733734|FG008|ITP- Treatment Disposition|Adverse Event|0|||
161367147|NCT00725985|582733735|FG009|ITP- Treatment Disposition|Adverse Event|0|||
161367148|NCT00725985|582733736|FG010|ITP- Treatment Disposition|Adverse Event|0|||
161367149|NCT00725985|582733737|FG011|ITP- Treatment Disposition|Adverse Event|0|||
161367150|NCT00725985|582733726|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367151|NCT00725985|582733727|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367152|NCT00725985|582733728|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
161367153|NCT00725985|582733729|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367154|NCT00725985|582733730|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367155|NCT00725985|582733731|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367156|NCT00725985|582733732|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367157|NCT00725985|582733733|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367158|NCT00725985|582733734|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367159|NCT00725985|582733735|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367160|NCT00725985|582733736|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367161|NCT00725985|582733737|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
161367162|NCT00725985|582733726|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
161367163|NCT00725985|582733727|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
161367164|NCT00725985|582733728|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
161367165|NCT00725985|582733729|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
161367166|NCT00725985|582733730|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
161367167|NCT00725985|582733731|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
161367168|NCT00725985|582733732|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
161367169|NCT00725985|582733733|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
161367170|NCT00725985|582733734|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
161367171|NCT00725985|582733735|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
161367172|NCT00725985|582733736|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
161367173|NCT00725985|582733737|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
161367174|NCT00725985|582733726|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
161367175|NCT00725985|582733727|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
161367176|NCT00725985|582733728|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
161367177|NCT00725985|582733729|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
161367178|NCT00725985|582733730|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
161367179|NCT00725985|582733731|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
161367180|NCT00725985|582733732|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
161367181|NCT00725985|582733733|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
161367182|NCT00725985|582733734|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
161367183|NCT00725985|582733735|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
161367184|NCT00725985|582733736|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
161367185|NCT00725985|582733737|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
161367186|NCT00725985|582733726|FG000|ITP- Treatment Disposition|Other|50|||
161367187|NCT00725985|582733727|FG001|ITP- Treatment Disposition|Other|38|||
161367188|NCT00725985|582733728|FG002|ITP- Treatment Disposition|Other|24|||
161367189|NCT00725985|582733729|FG003|ITP- Treatment Disposition|Other|0|||
161367190|NCT00725985|582733730|FG004|ITP- Treatment Disposition|Other|0|||
161367191|NCT00725985|582733731|FG005|ITP- Treatment Disposition|Other|0|||
161367192|NCT00725985|582733732|FG006|ITP- Treatment Disposition|Other|0|||
161367193|NCT00725985|582733733|FG007|ITP- Treatment Disposition|Other|0|||
161367194|NCT00725985|582733734|FG008|ITP- Treatment Disposition|Other|0|||
161367195|NCT00725985|582733735|FG009|ITP- Treatment Disposition|Other|0|||
161367196|NCT00725985|582733736|FG010|ITP- Treatment Disposition|Other|0|||
161367197|NCT00725985|582733737|FG011|ITP- Treatment Disposition|Other|0|||
161367198|NCT00725985|582733726|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367199|NCT00725985|582733727|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367200|NCT00725985|582733728|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367201|NCT00725985|582733729|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
161367202|NCT00725985|582733730|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
161367203|NCT00725985|582733731|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
161367204|NCT00725985|582733732|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367205|NCT00725985|582733733|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367206|NCT00725985|582733734|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367207|NCT00725985|582733735|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367208|NCT00725985|582733736|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367209|NCT00725985|582733737|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161367210|NCT00725985|582733726|FG000|OLMP (Up to 96 Weeks)|Death|0|||
161367211|NCT00725985|582733727|FG001|OLMP (Up to 96 Weeks)|Death|0|||
161367212|NCT00725985|582733728|FG002|OLMP (Up to 96 Weeks)|Death|0|||
161367213|NCT00725985|582733729|FG003|OLMP (Up to 96 Weeks)|Death|0|||
161367214|NCT00725985|582733730|FG004|OLMP (Up to 96 Weeks)|Death|1|||
161367215|NCT00725985|582733731|FG005|OLMP (Up to 96 Weeks)|Death|0|||
161367216|NCT00725985|582733732|FG006|OLMP (Up to 96 Weeks)|Death|0|||
161367217|NCT00725985|582733733|FG007|OLMP (Up to 96 Weeks)|Death|0|||
161367218|NCT00725985|582733734|FG008|OLMP (Up to 96 Weeks)|Death|0|||
161367219|NCT00725985|582733735|FG009|OLMP (Up to 96 Weeks)|Death|0|||
161367220|NCT00725985|582733736|FG010|OLMP (Up to 96 Weeks)|Death|0|||
161367221|NCT00725985|582733737|FG011|OLMP (Up to 96 Weeks)|Death|0|||
161367222|NCT00725985|582733726|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367223|NCT00725985|582733727|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367224|NCT00725985|582733728|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367225|NCT00725985|582733729|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
161367226|NCT00725985|582733730|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367227|NCT00725985|582733731|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367228|NCT00725985|582733732|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367229|NCT00725985|582733733|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367230|NCT00725985|582733734|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367231|NCT00725985|582733735|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367232|NCT00725985|582733736|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367233|NCT00725985|582733737|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161367234|NCT00725985|582733726|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367235|NCT00725985|582733727|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367236|NCT00725985|582733728|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367237|NCT00725985|582733729|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367238|NCT00725985|582733730|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367239|NCT00725985|582733731|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
161367240|NCT00725985|582733732|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367241|NCT00725985|582733733|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367242|NCT00725985|582733734|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367243|NCT00725985|582733735|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367244|NCT00725985|582733736|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367245|NCT00725985|582733737|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
161367246|NCT00725985|582733726|FG000|OLMP (Up to 96 Weeks)|Other|0|||
161367247|NCT00725985|582733727|FG001|OLMP (Up to 96 Weeks)|Other|0|||
161367248|NCT00725985|582733728|FG002|OLMP (Up to 96 Weeks)|Other|0|||
161367249|NCT00725985|582733729|FG003|OLMP (Up to 96 Weeks)|Other|15|||
161367250|NCT00725985|582733730|FG004|OLMP (Up to 96 Weeks)|Other|20|||
161367251|NCT00725985|582733731|FG005|OLMP (Up to 96 Weeks)|Other|44|||
161367252|NCT00725985|582733732|FG006|OLMP (Up to 96 Weeks)|Other|0|||
161367253|NCT00725985|582733733|FG007|OLMP (Up to 96 Weeks)|Other|0|||
161367254|NCT00725985|582733734|FG008|OLMP (Up to 96 Weeks)|Other|0|||
161367255|NCT00725985|582733735|FG009|OLMP (Up to 96 Weeks)|Other|0|||
161367256|NCT00725985|582733736|FG010|OLMP (Up to 96 Weeks)|Other|0|||
161367257|NCT00725985|582733737|FG011|OLMP (Up to 96 Weeks)|Other|0|||
161367258|NCT00725985|582733726|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367259|NCT00725985|582733727|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367260|NCT00725985|582733728|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367261|NCT00725985|582733729|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367262|NCT00725985|582733730|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367263|NCT00725985|582733731|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367264|NCT00725985|582733732|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367265|NCT00725985|582733733|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
161367266|NCT00725985|582733734|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367267|NCT00725985|582733735|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367268|NCT00725985|582733736|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367269|NCT00725985|582733737|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161367270|NCT00725985|582733726|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367271|NCT00725985|582733727|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367272|NCT00725985|582733728|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367273|NCT00725985|582733729|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367274|NCT00725985|582733730|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367275|NCT00725985|582733731|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367276|NCT00725985|582733732|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367277|NCT00725985|582733733|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367278|NCT00725985|582733734|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
161367279|NCT00725985|582733735|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367280|NCT00725985|582733736|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367281|NCT00725985|582733737|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161367282|NCT00725985|582733726|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367283|NCT00725985|582733727|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367284|NCT00725985|582733728|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367285|NCT00725985|582733729|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367286|NCT00725985|582733730|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367287|NCT00725985|582733731|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367288|NCT00725985|582733732|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
161367289|NCT00725985|582733733|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
161367290|NCT00725985|582733734|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
161367291|NCT00725985|582733735|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367292|NCT00725985|582733736|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367293|NCT00725985|582733737|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161367294|NCT00725985|582733726|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367295|NCT00725985|582733727|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367296|NCT00725985|582733728|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367297|NCT00725985|582733729|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367298|NCT00725985|582733730|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367299|NCT00725985|582733731|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367300|NCT00725985|582733732|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367301|NCT00725985|582733733|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367302|NCT00725985|582733734|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161367303|NCT00725985|582733735|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
161367304|NCT00725985|582733736|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
161367305|NCT00725985|582733737|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
161367306|NCT01182350|582733738|FG000|Overall Study|Adverse Event|5|||
161367307|NCT01182350|582733739|FG001|Overall Study|Adverse Event|0|||
161367308|NCT01182350|582733740|FG002|Overall Study|Adverse Event|0|||
161367309|NCT01182350|582733741|FG003|Overall Study|Adverse Event|0|||
161367310|NCT01182350|582733742|FG004|Overall Study|Adverse Event|0|||
161367311|NCT01182350|582733738|FG000|Overall Study|Disease Progression|15|||
161367312|NCT01182350|582733739|FG001|Overall Study|Disease Progression|12|||
161367313|NCT01182350|582733740|FG002|Overall Study|Disease Progression|0|||
161367314|NCT01182350|582733741|FG003|Overall Study|Disease Progression|1|||
161367315|NCT01182350|582733742|FG004|Overall Study|Disease Progression|0|||
161367316|NCT01182350|582733738|FG000|Overall Study|Death|0|||
161367317|NCT01182350|582733739|FG001|Overall Study|Death|1|||
161367318|NCT01182350|582733740|FG002|Overall Study|Death|1|||
161367319|NCT01182350|582733741|FG003|Overall Study|Death|0|||
161367320|NCT01182350|582733742|FG004|Overall Study|Death|0|||
161367321|NCT01182350|582733738|FG000|Overall Study|Withdrawal by Subject|3|||
161367322|NCT01182350|582733739|FG001|Overall Study|Withdrawal by Subject|1|||
161367323|NCT01182350|582733740|FG002|Overall Study|Withdrawal by Subject|0|||
161367324|NCT01182350|582733741|FG003|Overall Study|Withdrawal by Subject|1|||
161367325|NCT01182350|582733742|FG004|Overall Study|Withdrawal by Subject|0|||
161367326|NCT01182350|582733738|FG000|Overall Study|Alternative Therapy|2|||
161367327|NCT01182350|582733739|FG001|Overall Study|Alternative Therapy|0|||
161367328|NCT01182350|582733740|FG002|Overall Study|Alternative Therapy|1|||
161367329|NCT01182350|582733741|FG003|Overall Study|Alternative Therapy|0|||
161367330|NCT01182350|582733742|FG004|Overall Study|Alternative Therapy|0|||
161367331|NCT01182350|582733738|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
161367332|NCT01182350|582733739|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
161367333|NCT01182350|582733740|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
161367334|NCT01182350|582733741|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
161367335|NCT01182350|582733742|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
161367336|NCT01182350|582733738|FG000|Overall Study|Unevaluable for Biopsy|0|||
161367337|NCT01182350|582733739|FG001|Overall Study|Unevaluable for Biopsy|0|||
161367338|NCT01182350|582733740|FG002|Overall Study|Unevaluable for Biopsy|0|||
161367339|NCT01182350|582733741|FG003|Overall Study|Unevaluable for Biopsy|0|||
161367340|NCT01182350|582733742|FG004|Overall Study|Unevaluable for Biopsy|3|||
161367341|NCT04023487|582733743|FG000|Overall Study|Lost to Follow-up|5|||
161367342|NCT04023487|582733744|FG001|Overall Study|Lost to Follow-up|4|||
161367343|NCT04023487|582733743|FG000|Overall Study|Pregnancy|1|||
161367344|NCT04023487|582733744|FG001|Overall Study|Pregnancy|2|||
161367345|NCT04023487|582733743|FG000|Overall Study|Withdrawal by Subject|4|||
161367346|NCT04023487|582733744|FG001|Overall Study|Withdrawal by Subject|5|||
161367347|NCT04023487|582733743|FG000|Overall Study|Partially completed testing|8|||
161367348|NCT04023487|582733744|FG001|Overall Study|Partially completed testing|4|||
161367349|NCT00605189|582733745|FG000|Overall Study|Adverse Event|1|||
161367350|NCT00605189|582733746|FG001|Overall Study|Adverse Event|0|||
161367351|NCT00605189|582733747|FG002|Overall Study|Adverse Event|0|||
161367352|NCT00605189|582733745|FG000|Overall Study|Other|2|||
161367353|NCT00605189|582733746|FG001|Overall Study|Other|2|||
161367354|NCT00605189|582733747|FG002|Overall Study|Other|0|||
161367355|NCT03898180|582733748|FG000|Overall Study|Death|178|||
161367356|NCT03898180|582733749|FG001|Overall Study|Death|173|||
161367357|NCT03898180|582733748|FG000|Overall Study|Physician Decision|1|||
161367358|NCT03898180|582733749|FG001|Overall Study|Physician Decision|0|||
161367359|NCT03898180|582733748|FG000|Overall Study|Sponsor Decision|3|||
161367360|NCT03898180|582733749|FG001|Overall Study|Sponsor Decision|0|||
161367361|NCT03898180|582733748|FG000|Overall Study|Lost to Follow-up|1|||
161367362|NCT03898180|582733749|FG001|Overall Study|Lost to Follow-up|0|||
161367363|NCT03898180|582733748|FG000|Overall Study|Withdrawal by Subject|5|||
161367364|NCT03898180|582733749|FG001|Overall Study|Withdrawal by Subject|4|||
161367365|NCT05030766|582733750|FG000|Phase 1 Participants|Lost to Follow-up|12|||
161367366|NCT05030766|582733751|FG001|Phase 1 Participants|Lost to Follow-up|22|||
161367367|NCT05030766|582733752|FG002|Phase 1 Participants|Lost to Follow-up|0|||
161367368|NCT05030766|582733753|FG003|Phase 1 Participants|Lost to Follow-up|0|||
161367369|NCT05030766|582733750|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
161367370|NCT05030766|582733751|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
161367371|NCT05030766|582733752|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
161367372|NCT05030766|582733753|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
161367373|NCT05030766|582733750|FG000|Phase 2 Participants|Lost to Follow-up|0|||
161367374|NCT05030766|582733751|FG001|Phase 2 Participants|Lost to Follow-up|0|||
161367375|NCT05030766|582733752|FG002|Phase 2 Participants|Lost to Follow-up|6|||
161367376|NCT05030766|582733753|FG003|Phase 2 Participants|Lost to Follow-up|2|||
161367377|NCT03559530|582733754|FG000|Overall Study|non-location of medical records|44|||
161367378|NCT03559530|582733755|FG001|Overall Study|non-location of medical records|0|||
161367379|NCT03559530|582733754|FG000|Overall Study|culture results not considered for treat|29|||
161367380|NCT03559530|582733755|FG001|Overall Study|culture results not considered for treat|0|||
161367381|NCT03559530|582733754|FG000|Overall Study|duplicate cases|8|||
161367382|NCT03559530|582733755|FG001|Overall Study|duplicate cases|0|||
161367383|NCT03559530|582733754|FG000|Overall Study|other species of Acinetobacte|7|||
161367384|NCT03559530|582733755|FG001|Overall Study|other species of Acinetobacte|0|||
161367385|NCT03559530|582733754|FG000|Overall Study|contamination / colonization|3|||
161367386|NCT03559530|582733755|FG001|Overall Study|contamination / colonization|0|||
161367387|NCT01472185|582733756|FG000|Overall Study|Randomized but Not Treated|0|||
161367388|NCT01472185|582733757|FG001|Overall Study|Randomized but Not Treated|1|||
161367389|NCT01472185|582733756|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
161367390|NCT01472185|582733757|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
161367391|NCT01472185|582733756|FG000|Overall Study|Hyperglycemia|5|||
161367392|NCT01472185|582733757|FG001|Overall Study|Hyperglycemia|2|||
161367393|NCT01472185|582733756|FG000|Overall Study|Investigator's Discretion|3|||
161367394|NCT01472185|582733757|FG001|Overall Study|Investigator's Discretion|1|||
161367395|NCT01472185|582733756|FG000|Overall Study|Lost to Follow-up|4|||
161367396|NCT01472185|582733757|FG001|Overall Study|Lost to Follow-up|1|||
161367397|NCT01472185|582733756|FG000|Overall Study|Protocol Violation|5|||
161367398|NCT01472185|582733757|FG001|Overall Study|Protocol Violation|1|||
161367399|NCT01472185|582733756|FG000|Overall Study|Subject Noncompliance|8|||
161367400|NCT01472185|582733757|FG001|Overall Study|Subject Noncompliance|15|||
161367401|NCT01472185|582733756|FG000|Overall Study|Subject Withdrew Consent|6|||
161367402|NCT01472185|582733757|FG001|Overall Study|Subject Withdrew Consent|3|||
161367403|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367404|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
161367405|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367406|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
161367407|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
161367408|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
161367409|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
161367410|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367411|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367412|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367413|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367414|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367415|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367416|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367417|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367418|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161367419|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
161367420|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
161367421|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
161367422|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
161367423|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
161367424|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
161367425|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
161367426|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
161367427|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
161367428|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
161367429|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
161367430|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
161367431|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
161367432|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
161367433|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
161367434|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
161367435|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
161367436|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
161367437|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367438|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367439|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367440|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367441|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367442|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367443|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367444|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367445|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367446|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367447|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367448|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367449|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367450|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161367451|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
161367452|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367453|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
161367454|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161367455|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161367456|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161367457|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161367458|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367459|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367460|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367461|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367462|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367463|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367464|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367465|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367466|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161367467|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367468|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367469|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367470|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
161367471|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367472|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367473|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
161367474|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367475|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367476|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367477|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367478|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367479|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367480|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367481|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367482|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161367483|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367484|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367485|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
161367486|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367487|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367488|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367489|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367490|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367491|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367492|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367493|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367494|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367495|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367496|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367497|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367498|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161367499|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161367500|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161367501|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161367502|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367503|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367504|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367505|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367506|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367507|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367508|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367509|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367510|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367511|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367512|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367513|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367514|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161367515|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
161367516|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
161367517|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
161367518|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
161367519|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
161367520|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
161367521|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
161367522|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
161367523|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
161367524|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
161367525|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
161367526|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
161367527|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
161367528|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
161367529|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
161367530|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
161367531|NCT02958865|582733758|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367532|NCT02958865|582733759|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367533|NCT02958865|582733760|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367534|NCT02958865|582733761|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367535|NCT02958865|582733762|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
161367536|NCT02958865|582733763|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367537|NCT02958865|582733764|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367538|NCT02958865|582733765|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367539|NCT02958865|582733766|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367540|NCT02958865|582733767|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367541|NCT02958865|582733768|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367542|NCT02958865|582733769|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367543|NCT02958865|582733770|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367544|NCT02958865|582733771|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367545|NCT02958865|582733772|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367546|NCT02958865|582733773|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161367547|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367548|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367549|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367550|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367551|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367552|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367553|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367554|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161367555|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161367556|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
161367557|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161367558|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161367559|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
161367560|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161367561|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161367562|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
161367563|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367564|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367565|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367566|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367567|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367568|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367569|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367570|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367571|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
161367572|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
161367573|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367574|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
161367575|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367576|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
161367577|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161367578|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
161367579|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367580|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367581|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367582|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367583|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367584|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367585|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367586|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367587|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367588|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
161367589|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367590|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367591|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367592|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367593|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161367594|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
161367595|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367596|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367597|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367598|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367599|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367600|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367601|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367602|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367603|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367604|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367605|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161367606|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
161367607|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
161367608|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
161367609|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
161367610|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
161367611|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
161367612|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
161367613|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
161367614|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
161367615|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
161367616|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
161367617|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
161367618|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
161367619|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
161367620|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
161367621|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
161367622|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
161367623|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
161367624|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
161367625|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
161367626|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
161367627|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367628|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367629|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367630|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367631|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367632|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367633|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367634|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367635|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367636|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367637|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367638|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367639|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367640|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
161367641|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367642|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161367643|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367644|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367645|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367646|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367647|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367648|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367649|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367650|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367651|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367652|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367653|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367654|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367655|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367656|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
161367657|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367658|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161367659|NCT02958865|582733758|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367660|NCT02958865|582733759|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367661|NCT02958865|582733760|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367662|NCT02958865|582733761|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367663|NCT02958865|582733762|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367664|NCT02958865|582733763|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367665|NCT02958865|582733764|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367666|NCT02958865|582733765|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367667|NCT02958865|582733766|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367668|NCT02958865|582733767|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
161367669|NCT02958865|582733768|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367670|NCT02958865|582733769|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367671|NCT02958865|582733770|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367672|NCT02958865|582733771|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367673|NCT02958865|582733772|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367674|NCT02958865|582733773|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161367675|NCT02661815|582733774|FG000|Overall Study|Withdrawal by Subject|1|||
161367676|NCT02661815|582733775|FG001|Overall Study|Withdrawal by Subject|0|||
161367677|NCT02661815|582733776|FG002|Overall Study|Withdrawal by Subject|0|||
161367678|NCT02661815|582733777|FG003|Overall Study|Withdrawal by Subject|0|||
161367679|NCT00635050|582733780|FG000|Overall Study|Withdrawal by Subject|1|||
161367680|NCT04380142|582733785|FG000|LD/CD Stabilization Period|Adverse Event|3|||
161367681|NCT04380142|582733786|FG001|LD/CD Stabilization Period|Adverse Event|0|||
161367682|NCT04380142|582733787|FG002|LD/CD Stabilization Period|Adverse Event|0|||
161367683|NCT04380142|582733785|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
161367684|NCT04380142|582733786|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
161367685|NCT04380142|582733787|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
161367686|NCT04380142|582733785|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
161367687|NCT04380142|582733786|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
161367688|NCT04380142|582733787|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
161367689|NCT04380142|582733785|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
161367690|NCT04380142|582733786|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
161367691|NCT04380142|582733787|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
161367692|NCT04380142|582733785|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
161367693|NCT04380142|582733786|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
161367694|NCT04380142|582733787|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
161367695|NCT04380142|582733785|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
161367696|NCT04380142|582733786|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
161367697|NCT04380142|582733787|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
161367698|NCT04380142|582733785|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161367699|NCT04380142|582733786|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161367700|NCT04380142|582733787|FG002|Double-Blind Treatment Period|Adverse Event|14|||
161367701|NCT04380142|582733785|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
161367702|NCT04380142|582733786|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
161367703|NCT04380142|582733787|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
161367704|NCT04380142|582733785|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161367705|NCT04380142|582733786|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
161367706|NCT04380142|582733787|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
161367707|NCT04380142|582733785|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
161367708|NCT04380142|582733786|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
161367709|NCT04380142|582733787|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
161367710|NCT04380142|582733785|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
161367711|NCT04380142|582733786|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
161367712|NCT04380142|582733787|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
161367713|NCT04380142|582733785|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
161367714|NCT04380142|582733786|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
161367715|NCT04380142|582733787|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
161367716|NCT00209131|582733788|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
161367717|NCT00209131|582733789|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
161367718|NCT05360784|582733790|FG000|Overall Study|Discontinued|25|||
161367719|NCT05360784|582733791|FG001|Overall Study|Discontinued|11|||
161367720|NCT02796651|582733792|FG000|Overall Study|Adverse Event|6|||
161367721|NCT02796651|582733792|FG000|Overall Study|Lost to Follow-up|1|||
161367722|NCT02796651|582733792|FG000|Overall Study|Withdrawal by Subject|4|||
161367723|NCT02796651|582733792|FG000|Overall Study|Protocol Violation|4|||
161367724|NCT02796651|582733792|FG000|Overall Study|Lack of Efficacy|1|||
161367725|NCT02796651|582733792|FG000|Overall Study|Other|10|||
161367726|NCT00437073|582733793|FG000|Overall Study|Sponsor Terminated Study|1|||
161367727|NCT00437073|582733794|FG001|Overall Study|Sponsor Terminated Study|0|||
161367728|NCT00437073|582733793|FG000|Overall Study|Physician Decision|0|||
161367729|NCT00437073|582733794|FG001|Overall Study|Physician Decision|1|||
161367730|NCT04875533|582733795|FG000|Overall Study|Adverse Event|6|||
161367731|NCT04875533|582733796|FG001|Overall Study|Adverse Event|4|||
161367732|NCT04875533|582733795|FG000|Overall Study|Protocol Violation|4|||
161367733|NCT04875533|582733796|FG001|Overall Study|Protocol Violation|0|||
161367734|NCT04875533|582733795|FG000|Overall Study|Withdrawal by Subject|8|||
161367735|NCT04875533|582733796|FG001|Overall Study|Withdrawal by Subject|5|||
161367736|NCT04875533|582733795|FG000|Overall Study|No longer meets eligibility criteria|1|||
161367737|NCT04875533|582733796|FG001|Overall Study|No longer meets eligibility criteria|0|||
161367738|NCT04875533|582733795|FG000|Overall Study|Other|0|||
161367739|NCT04875533|582733796|FG001|Overall Study|Other|2|||
161367740|NCT02971163|582733797|FG000|Overall Study|Lost to Follow-up|4|||
161367741|NCT02971163|582733798|FG001|Overall Study|Lost to Follow-up|2|||
161367742|NCT00539500|582733799|FG000|Overall Study|Disease Progression|1|||
161367743|NCT00539500|582733799|FG000|Overall Study|Lost to Follow-up|2|||
161367744|NCT02011542|582733803|FG000|Overall Study|Physician Decision|1|||
161367745|NCT01299961|582733804|FG000|Overall Study|Adverse Event|3|||
161367746|NCT01299961|582733804|FG000|Overall Study|Lack of Efficacy|2|||
161367747|NCT01299961|582733804|FG000|Overall Study|Lost to Follow-up|1|||
161367748|NCT02904096|582733805|FG000|Overall Study|Adverse Event|1|||
161367749|NCT02904096|582733806|FG001|Overall Study|Adverse Event|0|||
161367750|NCT02904096|582733805|FG000|Overall Study|Withdrawal by Subject|4|||
161367751|NCT02904096|582733806|FG001|Overall Study|Withdrawal by Subject|3|||
161367752|NCT02904096|582733805|FG000|Overall Study|Lost to Follow-up|10|||
161367753|NCT02904096|582733806|FG001|Overall Study|Lost to Follow-up|17|||
161367754|NCT02904096|582733805|FG000|Overall Study|Non-compliant|3|||
161367755|NCT02904096|582733806|FG001|Overall Study|Non-compliant|1|||
161367756|NCT02904096|582733805|FG000|Overall Study|Sponsor instructed|1|||
161367757|NCT02904096|582733806|FG001|Overall Study|Sponsor instructed|0|||
161367758|NCT00980798|582733807|FG000|Overall Study|Adverse Event|7|||
161367759|NCT00980798|582733808|FG001|Overall Study|Adverse Event|36|||
161367760|NCT00980798|582733807|FG000|Overall Study|Lack of Efficacy|16|||
161367761|NCT00980798|582733808|FG001|Overall Study|Lack of Efficacy|5|||
161367762|NCT00980798|582733807|FG000|Overall Study|Lost to Follow-up|0|||
161367763|NCT00980798|582733808|FG001|Overall Study|Lost to Follow-up|1|||
161367764|NCT00980798|582733807|FG000|Overall Study|Physician Decision|2|||
161367765|NCT00980798|582733808|FG001|Overall Study|Physician Decision|1|||
161367766|NCT00980798|582733807|FG000|Overall Study|Withdrawal by Subject|8|||
161367767|NCT00980798|582733808|FG001|Overall Study|Withdrawal by Subject|11|||
161367768|NCT00980798|582733807|FG000|Overall Study|Other|0|||
161367769|NCT00980798|582733808|FG001|Overall Study|Other|1|||
161367770|NCT00526799|582733809|FG000|Overall Study|Withdrawal by Subject|1|||
161367771|NCT00526799|582733810|FG001|Overall Study|Withdrawal by Subject|0|||
161367772|NCT00526799|582733809|FG000|Overall Study|Intercurrent Complicating Disease|0|||
161367773|NCT00526799|582733810|FG001|Overall Study|Intercurrent Complicating Disease|1|||
161367774|NCT04938427|582733811|FG000|Overall Study|Adverse Event|5|||
161367775|NCT04938427|582733812|FG001|Overall Study|Adverse Event|19|||
161367776|NCT04938427|582733811|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161367777|NCT04938427|582733812|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161367778|NCT04938427|582733811|FG000|Overall Study|Withdrawal by Subject|1|||
161367779|NCT04938427|582733812|FG001|Overall Study|Withdrawal by Subject|0|||
161367780|NCT04938427|582733811|FG000|Overall Study|Reason Not Specified|2|||
161367781|NCT04938427|582733812|FG001|Overall Study|Reason Not Specified|1|||
161367782|NCT03633058|582733813|FG000|Overall Study|Adverse Event|0|||
161367783|NCT03633058|582733814|FG001|Overall Study|Adverse Event|0|||
161367784|NCT03633058|582733815|FG002|Overall Study|Adverse Event|1|||
161367785|NCT03633058|582733816|FG003|Overall Study|Adverse Event|0|||
161367786|NCT01107496|582733817|FG000|Overall Study|Adverse Event|1|||
161367787|NCT01107496|582733818|FG001|Overall Study|Adverse Event|0|||
161367788|NCT01107496|582733817|FG000|Overall Study|Lack of Efficacy|1|||
161367789|NCT01107496|582733818|FG001|Overall Study|Lack of Efficacy|0|||
161367790|NCT01107496|582733817|FG000|Overall Study|Protocol Violation|0|||
161367791|NCT01107496|582733818|FG001|Overall Study|Protocol Violation|1|||
161367792|NCT01107496|582733817|FG000|Overall Study|Lost to Follow-up|0|||
161367793|NCT01107496|582733818|FG001|Overall Study|Lost to Follow-up|1|||
161367794|NCT03909971|582733819|FG000|Overall Study|Participant transition to rollover study|26|||
161367795|NCT03909971|582733820|FG001|Overall Study|Participant transition to rollover study|9|||
161367796|NCT03909971|582733819|FG000|Overall Study|Global Deterioration of Health Status|2|||
161367797|NCT03909971|582733820|FG001|Overall Study|Global Deterioration of Health Status|2|||
161367798|NCT03909971|582733819|FG000|Overall Study|Progressive Disease|28|||
161367799|NCT03909971|582733820|FG001|Overall Study|Progressive Disease|21|||
161367800|NCT03909971|582733819|FG000|Overall Study|Death|6|||
161367801|NCT03909971|582733820|FG001|Overall Study|Death|6|||
161367802|NCT03909971|582733819|FG000|Overall Study|Adverse Event|1|||
161367803|NCT03909971|582733820|FG001|Overall Study|Adverse Event|2|||
161367804|NCT03909971|582733819|FG000|Overall Study|Withdrawal by Subject|2|||
161367805|NCT03909971|582733820|FG001|Overall Study|Withdrawal by Subject|1|||
161367806|NCT03909971|582733819|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
161367807|NCT03909971|582733820|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
161367808|NCT03909971|582733819|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
161367809|NCT03909971|582733820|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
161367810|NCT04727151|582733824|FG000|Overall Study|Death|0|||
161367811|NCT04727151|582733825|FG001|Overall Study|Death|0|||
161367812|NCT04727151|582733826|FG002|Overall Study|Death|0|||
161367813|NCT04727151|582733827|FG003|Overall Study|Death|0|||
161367814|NCT04727151|582733828|FG004|Overall Study|Death|3|||
161367815|NCT04727151|582733824|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161367816|NCT04727151|582733825|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161367817|NCT04727151|582733826|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161367818|NCT04727151|582733827|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161367819|NCT04727151|582733828|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
161367820|NCT01587196|582733829|FG000|Overall Study|Lost to Follow-up|50|||
161367821|NCT01587196|582733829|FG000|Overall Study|Withdrawal by Subject|4|||
161367822|NCT00642759|582733832|FG000|Overall Study|Protocol Violation|1|||
161367823|NCT03537508|582733837|FG000|Overall Study|Adverse Event|2|||
161367824|NCT03537508|582733838|FG001|Overall Study|Adverse Event|1|||
161367825|NCT03537508|582733837|FG000|Overall Study|Protocol Violation|65|||
161367826|NCT03537508|582733838|FG001|Overall Study|Protocol Violation|48|||
161367827|NCT03537508|582733837|FG000|Overall Study|Lost to Follow-up|86|||
161367828|NCT03537508|582733838|FG001|Overall Study|Lost to Follow-up|60|||
161367829|NCT03537508|582733837|FG000|Overall Study|Withdrawal by parent/guardian|263|||
161367830|NCT03537508|582733838|FG001|Overall Study|Withdrawal by parent/guardian|149|||
161367831|NCT03814044|582733842|FG000|Overall Study|Protocol deviation|1|||
161367832|NCT02757768|582733843|FG000|Overall Study|Randomized Never Received Study Drug|3|||
161367833|NCT02757768|582733844|FG001|Overall Study|Randomized Never Received Study Drug|4|||
161367834|NCT02757768|582733843|FG000|Overall Study|Adverse Event|5|||
161367835|NCT02757768|582733844|FG001|Overall Study|Adverse Event|3|||
161367836|NCT02757768|582733843|FG000|Overall Study|Lack of Efficacy|2|||
161367837|NCT02757768|582733844|FG001|Overall Study|Lack of Efficacy|1|||
161367838|NCT02757768|582733843|FG000|Overall Study|Lost to Follow-up|1|||
161367839|NCT02757768|582733844|FG001|Overall Study|Lost to Follow-up|0|||
161367840|NCT02757768|582733843|FG000|Overall Study|Protocol Deviation|2|||
161367841|NCT02757768|582733844|FG001|Overall Study|Protocol Deviation|9|||
161367842|NCT02757768|582733843|FG000|Overall Study|Withdrawal by Subject|16|||
161367843|NCT02757768|582733844|FG001|Overall Study|Withdrawal by Subject|9|||
161367844|NCT02757768|582733843|FG000|Overall Study|Miscellaneous|4|||
161367845|NCT02757768|582733844|FG001|Overall Study|Miscellaneous|2|||
161367846|NCT00835367|582733856|FG000|Washout|Adverse Event|2|||
161367847|NCT00835367|582733857|FG001|Washout|Adverse Event|0|||
161367848|NCT00835367|582733856|FG000|Washout|Withdrawal by Subject|1|||
161367849|NCT00835367|582733857|FG001|Washout|Withdrawal by Subject|0|||
161367850|NCT00835367|582733856|FG000|Second Intervention|Adverse Event|1|||
161367851|NCT00835367|582733857|FG001|Second Intervention|Adverse Event|1|||
161367852|NCT03396445|582736179|FG000|Treatment Period|Death|2|||
161367853|NCT03396445|582736180|FG001|Treatment Period|Death|2|||
161367854|NCT03396445|582736181|FG002|Treatment Period|Death|1|||
161367855|NCT03396445|582736182|FG003|Treatment Period|Death|1|||
161367856|NCT03396445|582736183|FG004|Treatment Period|Death|3|||
161367857|NCT03396445|582736184|FG005|Treatment Period|Death|2|||
161367858|NCT03396445|582736185|FG006|Treatment Period|Death|5|||
161367859|NCT03396445|582736186|FG007|Treatment Period|Death|3|||
161367860|NCT03396445|582736187|FG008|Treatment Period|Death|3|||
161367861|NCT03396445|582736188|FG009|Treatment Period|Death|3|||
161367862|NCT03396445|582736189|FG010|Treatment Period|Death|7|||
161367863|NCT03396445|582736190|FG011|Treatment Period|Death|12|||
161367864|NCT03396445|582736191|FG012|Treatment Period|Death|28|||
161367865|NCT03396445|582736192|FG013|Treatment Period|Death|14|||
161367866|NCT03396445|582736193|FG014|Treatment Period|Death|10|||
161367867|NCT03396445|582736194|FG015|Treatment Period|Death|8|||
161367868|NCT03396445|582736195|FG016|Treatment Period|Death|18|||
161367869|NCT03396445|582736196|FG017|Treatment Period|Death|0|||
161367870|NCT03396445|582736197|FG018|Treatment Period|Death|0|||
161367871|NCT03396445|582736198|FG019|Treatment Period|Death|0|||
161367872|NCT03396445|582736199|FG020|Treatment Period|Death|0|||
161367873|NCT03396445|582736200|FG021|Treatment Period|Death|0|||
161367874|NCT03396445|582736201|FG022|Treatment Period|Death|0|||
161367875|NCT03396445|582736202|FG023|Treatment Period|Death|0|||
161367876|NCT03396445|582736203|FG024|Treatment Period|Death|0|||
161367877|NCT03396445|582736204|FG025|Treatment Period|Death|0|||
161367878|NCT03396445|582736179|FG000|Treatment Period|Lost to Follow-up|0|||
161367879|NCT03396445|582736180|FG001|Treatment Period|Lost to Follow-up|0|||
161367880|NCT03396445|582736181|FG002|Treatment Period|Lost to Follow-up|0|||
161367881|NCT03396445|582736182|FG003|Treatment Period|Lost to Follow-up|0|||
161367882|NCT03396445|582736183|FG004|Treatment Period|Lost to Follow-up|0|||
161367883|NCT03396445|582736184|FG005|Treatment Period|Lost to Follow-up|0|||
161367884|NCT03396445|582736185|FG006|Treatment Period|Lost to Follow-up|0|||
161367885|NCT03396445|582736186|FG007|Treatment Period|Lost to Follow-up|0|||
161367886|NCT03396445|582736187|FG008|Treatment Period|Lost to Follow-up|0|||
161367887|NCT03396445|582736188|FG009|Treatment Period|Lost to Follow-up|0|||
161367888|NCT03396445|582736189|FG010|Treatment Period|Lost to Follow-up|0|||
161367889|NCT03396445|582736190|FG011|Treatment Period|Lost to Follow-up|0|||
161367890|NCT03396445|582736191|FG012|Treatment Period|Lost to Follow-up|1|||
161367891|NCT03396445|582736192|FG013|Treatment Period|Lost to Follow-up|0|||
161367892|NCT03396445|582736193|FG014|Treatment Period|Lost to Follow-up|1|||
161367893|NCT03396445|582736194|FG015|Treatment Period|Lost to Follow-up|0|||
161367894|NCT03396445|582736195|FG016|Treatment Period|Lost to Follow-up|0|||
161367895|NCT03396445|582736196|FG017|Treatment Period|Lost to Follow-up|0|||
161367896|NCT03396445|582736197|FG018|Treatment Period|Lost to Follow-up|0|||
161367897|NCT03396445|582736198|FG019|Treatment Period|Lost to Follow-up|0|||
161367898|NCT03396445|582736199|FG020|Treatment Period|Lost to Follow-up|0|||
161367899|NCT03396445|582736200|FG021|Treatment Period|Lost to Follow-up|0|||
161367900|NCT03396445|582736201|FG022|Treatment Period|Lost to Follow-up|0|||
161367901|NCT03396445|582736202|FG023|Treatment Period|Lost to Follow-up|0|||
161367902|NCT03396445|582736203|FG024|Treatment Period|Lost to Follow-up|0|||
161367903|NCT03396445|582736204|FG025|Treatment Period|Lost to Follow-up|0|||
161367904|NCT03396445|582736179|FG000|Treatment Period|Physician Decision|0|||
161367905|NCT03396445|582736180|FG001|Treatment Period|Physician Decision|0|||
161367906|NCT03396445|582736181|FG002|Treatment Period|Physician Decision|0|||
161367907|NCT03396445|582736182|FG003|Treatment Period|Physician Decision|0|||
161367908|NCT03396445|582736183|FG004|Treatment Period|Physician Decision|1|||
161367909|NCT03396445|582736184|FG005|Treatment Period|Physician Decision|0|||
161367910|NCT03396445|582736185|FG006|Treatment Period|Physician Decision|0|||
161367911|NCT03396445|582736186|FG007|Treatment Period|Physician Decision|0|||
161367912|NCT03396445|582736187|FG008|Treatment Period|Physician Decision|0|||
161367913|NCT03396445|582736188|FG009|Treatment Period|Physician Decision|1|||
161367914|NCT03396445|582736189|FG010|Treatment Period|Physician Decision|0|||
161367915|NCT03396445|582736190|FG011|Treatment Period|Physician Decision|0|||
161367916|NCT03396445|582736191|FG012|Treatment Period|Physician Decision|0|||
161367917|NCT03396445|582736192|FG013|Treatment Period|Physician Decision|0|||
161367918|NCT03396445|582736193|FG014|Treatment Period|Physician Decision|0|||
161367919|NCT03396445|582736194|FG015|Treatment Period|Physician Decision|0|||
161367920|NCT03396445|582736195|FG016|Treatment Period|Physician Decision|0|||
161367921|NCT03396445|582736196|FG017|Treatment Period|Physician Decision|0|||
161367922|NCT03396445|582736197|FG018|Treatment Period|Physician Decision|0|||
161367923|NCT03396445|582736198|FG019|Treatment Period|Physician Decision|0|||
161367924|NCT03396445|582736199|FG020|Treatment Period|Physician Decision|0|||
161367925|NCT03396445|582736200|FG021|Treatment Period|Physician Decision|0|||
161367926|NCT03396445|582736201|FG022|Treatment Period|Physician Decision|0|||
161367927|NCT03396445|582736202|FG023|Treatment Period|Physician Decision|0|||
161367928|NCT03396445|582736203|FG024|Treatment Period|Physician Decision|0|||
161367929|NCT03396445|582736204|FG025|Treatment Period|Physician Decision|0|||
161367930|NCT03396445|582736179|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367931|NCT03396445|582736180|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367932|NCT03396445|582736181|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367933|NCT03396445|582736182|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367934|NCT03396445|582736183|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367935|NCT03396445|582736184|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367936|NCT03396445|582736185|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367937|NCT03396445|582736186|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367938|NCT03396445|582736187|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367939|NCT03396445|582736188|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367940|NCT03396445|582736189|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367941|NCT03396445|582736190|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367942|NCT03396445|582736191|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
161367943|NCT03396445|582736192|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367944|NCT03396445|582736193|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
161367945|NCT03396445|582736194|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367946|NCT03396445|582736195|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367947|NCT03396445|582736196|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367948|NCT03396445|582736197|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367949|NCT03396445|582736198|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367950|NCT03396445|582736199|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367951|NCT03396445|582736200|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367952|NCT03396445|582736201|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367953|NCT03396445|582736202|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367954|NCT03396445|582736203|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367955|NCT03396445|582736204|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161367956|NCT03396445|582736179|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
161367957|NCT03396445|582736180|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
161367958|NCT03396445|582736181|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
161367959|NCT03396445|582736182|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
161367960|NCT03396445|582736183|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
161367961|NCT03396445|582736184|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367962|NCT03396445|582736185|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
161367963|NCT03396445|582736186|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367964|NCT03396445|582736187|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367965|NCT03396445|582736188|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367966|NCT03396445|582736189|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367967|NCT03396445|582736190|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367968|NCT03396445|582736191|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367969|NCT03396445|582736192|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367970|NCT03396445|582736193|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367971|NCT03396445|582736194|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367972|NCT03396445|582736195|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367973|NCT03396445|582736196|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367974|NCT03396445|582736197|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367975|NCT03396445|582736198|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367976|NCT03396445|582736199|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367977|NCT03396445|582736200|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367978|NCT03396445|582736201|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367979|NCT03396445|582736202|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367980|NCT03396445|582736203|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367981|NCT03396445|582736204|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161367982|NCT03396445|582736179|FG000|Treatment Period|Withdrawal by Subject|0|||
161367983|NCT03396445|582736180|FG001|Treatment Period|Withdrawal by Subject|0|||
161367984|NCT03396445|582736181|FG002|Treatment Period|Withdrawal by Subject|0|||
161367985|NCT03396445|582736182|FG003|Treatment Period|Withdrawal by Subject|0|||
161367986|NCT03396445|582736183|FG004|Treatment Period|Withdrawal by Subject|0|||
161367987|NCT03396445|582736184|FG005|Treatment Period|Withdrawal by Subject|0|||
161367988|NCT03396445|582736185|FG006|Treatment Period|Withdrawal by Subject|0|||
161367989|NCT03396445|582736186|FG007|Treatment Period|Withdrawal by Subject|0|||
161367990|NCT03396445|582736187|FG008|Treatment Period|Withdrawal by Subject|0|||
161367991|NCT03396445|582736188|FG009|Treatment Period|Withdrawal by Subject|0|||
161367992|NCT03396445|582736189|FG010|Treatment Period|Withdrawal by Subject|0|||
161367993|NCT03396445|582736190|FG011|Treatment Period|Withdrawal by Subject|0|||
161367994|NCT03396445|582736191|FG012|Treatment Period|Withdrawal by Subject|0|||
161367995|NCT03396445|582736192|FG013|Treatment Period|Withdrawal by Subject|0|||
161367996|NCT03396445|582736193|FG014|Treatment Period|Withdrawal by Subject|1|||
161367997|NCT03396445|582736194|FG015|Treatment Period|Withdrawal by Subject|0|||
161367998|NCT03396445|582736195|FG016|Treatment Period|Withdrawal by Subject|1|||
161367999|NCT03396445|582736196|FG017|Treatment Period|Withdrawal by Subject|0|||
161368000|NCT03396445|582736197|FG018|Treatment Period|Withdrawal by Subject|0|||
161368001|NCT03396445|582736198|FG019|Treatment Period|Withdrawal by Subject|0|||
161368002|NCT03396445|582736199|FG020|Treatment Period|Withdrawal by Subject|0|||
161368003|NCT03396445|582736200|FG021|Treatment Period|Withdrawal by Subject|0|||
161368004|NCT03396445|582736201|FG022|Treatment Period|Withdrawal by Subject|0|||
161368005|NCT03396445|582736202|FG023|Treatment Period|Withdrawal by Subject|0|||
161368006|NCT03396445|582736203|FG024|Treatment Period|Withdrawal by Subject|0|||
161368007|NCT03396445|582736204|FG025|Treatment Period|Withdrawal by Subject|0|||
161368008|NCT03396445|582736179|FG000|Switch-over Period|Death|0|||
161368009|NCT03396445|582736180|FG001|Switch-over Period|Death|0|||
161368010|NCT03396445|582736181|FG002|Switch-over Period|Death|0|||
161368011|NCT03396445|582736182|FG003|Switch-over Period|Death|0|||
161368012|NCT03396445|582736183|FG004|Switch-over Period|Death|0|||
161368013|NCT03396445|582736184|FG005|Switch-over Period|Death|0|||
161368014|NCT03396445|582736185|FG006|Switch-over Period|Death|0|||
161368015|NCT03396445|582736186|FG007|Switch-over Period|Death|0|||
161368016|NCT03396445|582736187|FG008|Switch-over Period|Death|0|||
161368017|NCT03396445|582736188|FG009|Switch-over Period|Death|0|||
161368018|NCT03396445|582736189|FG010|Switch-over Period|Death|0|||
161368019|NCT03396445|582736190|FG011|Switch-over Period|Death|0|||
161368020|NCT03396445|582736191|FG012|Switch-over Period|Death|0|||
161368021|NCT03396445|582736192|FG013|Switch-over Period|Death|0|||
161368022|NCT03396445|582736193|FG014|Switch-over Period|Death|0|||
161368023|NCT03396445|582736194|FG015|Switch-over Period|Death|0|||
161368024|NCT03396445|582736195|FG016|Switch-over Period|Death|0|||
161368025|NCT03396445|582736196|FG017|Switch-over Period|Death|0|||
161368026|NCT03396445|582736197|FG018|Switch-over Period|Death|1|||
161368027|NCT03396445|582736198|FG019|Switch-over Period|Death|2|||
161368028|NCT03396445|582736199|FG020|Switch-over Period|Death|2|||
161368029|NCT03396445|582736200|FG021|Switch-over Period|Death|1|||
161368030|NCT03396445|582736201|FG022|Switch-over Period|Death|2|||
161368031|NCT03396445|582736202|FG023|Switch-over Period|Death|0|||
161368032|NCT03396445|582736203|FG024|Switch-over Period|Death|1|||
161368033|NCT03396445|582736204|FG025|Switch-over Period|Death|6|||
161368034|NCT03396445|582736179|FG000|Switch-over Period|Lost to Follow-up|0|||
161368035|NCT03396445|582736180|FG001|Switch-over Period|Lost to Follow-up|0|||
161368036|NCT03396445|582736181|FG002|Switch-over Period|Lost to Follow-up|0|||
161368037|NCT03396445|582736182|FG003|Switch-over Period|Lost to Follow-up|0|||
161368038|NCT03396445|582736183|FG004|Switch-over Period|Lost to Follow-up|0|||
161368039|NCT03396445|582736184|FG005|Switch-over Period|Lost to Follow-up|0|||
161368040|NCT03396445|582736185|FG006|Switch-over Period|Lost to Follow-up|0|||
161368041|NCT03396445|582736186|FG007|Switch-over Period|Lost to Follow-up|0|||
161368042|NCT03396445|582736187|FG008|Switch-over Period|Lost to Follow-up|0|||
161368043|NCT03396445|582736188|FG009|Switch-over Period|Lost to Follow-up|0|||
161368044|NCT03396445|582736189|FG010|Switch-over Period|Lost to Follow-up|0|||
161368045|NCT03396445|582736190|FG011|Switch-over Period|Lost to Follow-up|0|||
161368046|NCT03396445|582736191|FG012|Switch-over Period|Lost to Follow-up|0|||
161368047|NCT03396445|582736192|FG013|Switch-over Period|Lost to Follow-up|0|||
161368048|NCT03396445|582736193|FG014|Switch-over Period|Lost to Follow-up|0|||
161368049|NCT03396445|582736194|FG015|Switch-over Period|Lost to Follow-up|0|||
161368050|NCT03396445|582736195|FG016|Switch-over Period|Lost to Follow-up|0|||
161368051|NCT03396445|582736196|FG017|Switch-over Period|Lost to Follow-up|0|||
161368052|NCT03396445|582736197|FG018|Switch-over Period|Lost to Follow-up|0|||
161368053|NCT03396445|582736198|FG019|Switch-over Period|Lost to Follow-up|0|||
161368054|NCT03396445|582736199|FG020|Switch-over Period|Lost to Follow-up|0|||
161368055|NCT03396445|582736200|FG021|Switch-over Period|Lost to Follow-up|0|||
161368056|NCT03396445|582736201|FG022|Switch-over Period|Lost to Follow-up|0|||
161368057|NCT03396445|582736202|FG023|Switch-over Period|Lost to Follow-up|1|||
161368058|NCT03396445|582736203|FG024|Switch-over Period|Lost to Follow-up|0|||
161368059|NCT03396445|582736204|FG025|Switch-over Period|Lost to Follow-up|0|||
161368060|NCT00366457|582736218|FG000|Overall Study|never began study therapy|2|||
161368061|NCT02829996|582736219|FG000|Overall Study|Withdrawal by Subject|1|||
161368062|NCT02829996|582736220|FG001|Overall Study|Withdrawal by Subject|0|||
161368063|NCT02829996|582736221|FG002|Overall Study|Withdrawal by Subject|0|||
161368064|NCT02829996|582736222|FG003|Overall Study|Withdrawal by Subject|0|||
161368065|NCT02829996|582736223|FG004|Overall Study|Withdrawal by Subject|0|||
161368066|NCT02095106|582736232|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161368067|NCT02095106|582736233|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161368068|NCT00553254|582736241|FG000|Overall Study|Death|3|||
161368069|NCT00553254|582736242|FG001|Overall Study|Death|6|||
161368070|NCT00553254|582736243|FG002|Overall Study|Death|25|||
161368071|NCT00553254|582736241|FG000|Overall Study|Lost to Follow-up|0|||
161368072|NCT00553254|582736242|FG001|Overall Study|Lost to Follow-up|0|||
161368073|NCT00553254|582736243|FG002|Overall Study|Lost to Follow-up|2|||
161368074|NCT00553254|582736241|FG000|Overall Study|Withdrawal by Subject|2|||
161368075|NCT00553254|582736242|FG001|Overall Study|Withdrawal by Subject|0|||
161368076|NCT00553254|582736243|FG002|Overall Study|Withdrawal by Subject|2|||
161368077|NCT00553254|582736241|FG000|Overall Study|Study terminated by Sponsor|0|||
161368078|NCT00553254|582736242|FG001|Overall Study|Study terminated by Sponsor|0|||
161368079|NCT00553254|582736243|FG002|Overall Study|Study terminated by Sponsor|1|||
161368080|NCT00553254|582736241|FG000|Overall Study|Other|1|||
161368081|NCT00553254|582736242|FG001|Overall Study|Other|0|||
161368082|NCT00553254|582736243|FG002|Overall Study|Other|13|||
161368083|NCT02314923|582736246|FG000|Overall Study|Death|0|||
161368084|NCT02314923|582736247|FG001|Overall Study|Death|0|||
161368085|NCT02314923|582736248|FG002|Overall Study|Death|0|||
161368086|NCT02314923|582736249|FG003|Overall Study|Death|1|||
161368087|NCT02314923|582736250|FG004|Overall Study|Death|0|||
161368088|NCT02314923|582736251|FG005|Overall Study|Death|0|||
161368089|NCT02314923|582736252|FG006|Overall Study|Death|0|||
161368090|NCT02314923|582736253|FG007|Overall Study|Death|0|||
161368091|NCT02314923|582736254|FG008|Overall Study|Death|0|||
161368092|NCT02314923|582736255|FG009|Overall Study|Death|0|||
161368093|NCT02314923|582736246|FG000|Overall Study|Lost to Follow-up|2|||
161368094|NCT02314923|582736247|FG001|Overall Study|Lost to Follow-up|3|||
161368095|NCT02314923|582736248|FG002|Overall Study|Lost to Follow-up|1|||
161368096|NCT02314923|582736249|FG003|Overall Study|Lost to Follow-up|0|||
161368097|NCT02314923|582736250|FG004|Overall Study|Lost to Follow-up|0|||
161368098|NCT02314923|582736251|FG005|Overall Study|Lost to Follow-up|0|||
161368099|NCT02314923|582736252|FG006|Overall Study|Lost to Follow-up|3|||
161368100|NCT02314923|582736253|FG007|Overall Study|Lost to Follow-up|4|||
161368101|NCT02314923|582736254|FG008|Overall Study|Lost to Follow-up|2|||
161368102|NCT02314923|582736255|FG009|Overall Study|Lost to Follow-up|0|||
161368103|NCT02314923|582736246|FG000|Overall Study|Withdrawal by Subject|0|||
161368104|NCT02314923|582736247|FG001|Overall Study|Withdrawal by Subject|0|||
161368105|NCT02314923|582736248|FG002|Overall Study|Withdrawal by Subject|1|||
161368106|NCT02314923|582736249|FG003|Overall Study|Withdrawal by Subject|0|||
161368107|NCT02314923|582736250|FG004|Overall Study|Withdrawal by Subject|1|||
161368108|NCT02314923|582736251|FG005|Overall Study|Withdrawal by Subject|0|||
161368109|NCT02314923|582736252|FG006|Overall Study|Withdrawal by Subject|1|||
161368110|NCT02314923|582736253|FG007|Overall Study|Withdrawal by Subject|0|||
161368111|NCT02314923|582736254|FG008|Overall Study|Withdrawal by Subject|0|||
161368112|NCT02314923|582736255|FG009|Overall Study|Withdrawal by Subject|0|||
161368113|NCT02314923|582736246|FG000|Overall Study|Physician Decision|0|||
161368114|NCT02314923|582736247|FG001|Overall Study|Physician Decision|1|||
161368115|NCT02314923|582736248|FG002|Overall Study|Physician Decision|0|||
161368116|NCT02314923|582736249|FG003|Overall Study|Physician Decision|0|||
161368117|NCT02314923|582736250|FG004|Overall Study|Physician Decision|0|||
161368118|NCT02314923|582736251|FG005|Overall Study|Physician Decision|0|||
161368119|NCT02314923|582736252|FG006|Overall Study|Physician Decision|0|||
161368120|NCT02314923|582736253|FG007|Overall Study|Physician Decision|0|||
161368121|NCT02314923|582736254|FG008|Overall Study|Physician Decision|0|||
161368122|NCT02314923|582736255|FG009|Overall Study|Physician Decision|0|||
161368123|NCT02314923|582736246|FG000|Overall Study|Participant unavailable|0|||
161368124|NCT02314923|582736247|FG001|Overall Study|Participant unavailable|0|||
161368125|NCT02314923|582736248|FG002|Overall Study|Participant unavailable|0|||
161368126|NCT02314923|582736249|FG003|Overall Study|Participant unavailable|0|||
161368127|NCT02314923|582736250|FG004|Overall Study|Participant unavailable|0|||
161368128|NCT02314923|582736251|FG005|Overall Study|Participant unavailable|1|||
161368129|NCT02314923|582736252|FG006|Overall Study|Participant unavailable|0|||
161368130|NCT02314923|582736253|FG007|Overall Study|Participant unavailable|0|||
161368131|NCT02314923|582736254|FG008|Overall Study|Participant unavailable|0|||
161368132|NCT02314923|582736255|FG009|Overall Study|Participant unavailable|0|||
161368133|NCT02314923|582736246|FG000|Overall Study|Screen failure|0|||
161368134|NCT02314923|582736247|FG001|Overall Study|Screen failure|0|||
161368135|NCT02314923|582736248|FG002|Overall Study|Screen failure|0|||
161368136|NCT02314923|582736249|FG003|Overall Study|Screen failure|0|||
161368137|NCT02314923|582736250|FG004|Overall Study|Screen failure|0|||
161368138|NCT02314923|582736251|FG005|Overall Study|Screen failure|0|||
161368139|NCT02314923|582736252|FG006|Overall Study|Screen failure|1|||
161368140|NCT02314923|582736253|FG007|Overall Study|Screen failure|0|||
161368141|NCT02314923|582736254|FG008|Overall Study|Screen failure|0|||
161368142|NCT02314923|582736255|FG009|Overall Study|Screen failure|0|||
161368143|NCT02314923|582736246|FG000|Overall Study|Participant relocation|1|||
161368144|NCT02314923|582736247|FG001|Overall Study|Participant relocation|0|||
161368145|NCT02314923|582736248|FG002|Overall Study|Participant relocation|0|||
161368146|NCT02314923|582736249|FG003|Overall Study|Participant relocation|0|||
161368147|NCT02314923|582736250|FG004|Overall Study|Participant relocation|0|||
161368148|NCT02314923|582736251|FG005|Overall Study|Participant relocation|0|||
161368149|NCT02314923|582736252|FG006|Overall Study|Participant relocation|0|||
161368150|NCT02314923|582736253|FG007|Overall Study|Participant relocation|1|||
161368151|NCT02314923|582736254|FG008|Overall Study|Participant relocation|0|||
161368152|NCT02314923|582736255|FG009|Overall Study|Participant relocation|0|||
161368153|NCT02546323|582736256|FG000|Overall Study|Withdrawal by Subject|36|||
161368154|NCT02546323|582736257|FG001|Overall Study|Withdrawal by Subject|33|||
161368155|NCT02546323|582736256|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
161368156|NCT02546323|582736257|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
161368157|NCT02546323|582736256|FG000|Overall Study|Adverse Event|17|||
161368158|NCT02546323|582736257|FG001|Overall Study|Adverse Event|11|||
161368159|NCT02546323|582736256|FG000|Overall Study|Patient Specific Reasons|1|||
161368160|NCT02546323|582736257|FG001|Overall Study|Patient Specific Reasons|2|||
161368161|NCT02546323|582736256|FG000|Overall Study|Lost to Follow-up|2|||
161368162|NCT02546323|582736257|FG001|Overall Study|Lost to Follow-up|3|||
161368163|NCT02546323|582736256|FG000|Overall Study|Non-compliance with Study Drug|2|||
161368164|NCT02546323|582736257|FG001|Overall Study|Non-compliance with Study Drug|2|||
161368165|NCT02546323|582736256|FG000|Overall Study|Met Withdrawal Criteria|2|||
161368166|NCT02546323|582736257|FG001|Overall Study|Met Withdrawal Criteria|14|||
161368167|NCT04476784|582736258|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
161368168|NCT04476784|582736259|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
161368169|NCT00863304|582736263|FG000|Overall Study|Adverse Event|10|||
161368170|NCT00863304|582736264|FG001|Overall Study|Adverse Event|4|||
161368171|NCT00863304|582736265|FG002|Overall Study|Adverse Event|14|||
161368172|NCT00863304|582736266|FG003|Overall Study|Adverse Event|16|||
161368173|NCT00863304|582736263|FG000|Overall Study|Lost to Follow-up|1|||
161368174|NCT00863304|582736264|FG001|Overall Study|Lost to Follow-up|5|||
161368175|NCT00863304|582736265|FG002|Overall Study|Lost to Follow-up|4|||
161368176|NCT00863304|582736266|FG003|Overall Study|Lost to Follow-up|2|||
161368177|NCT00863304|582736263|FG000|Overall Study|Lack of Efficacy|57|||
161368178|NCT00863304|582736264|FG001|Overall Study|Lack of Efficacy|26|||
161368179|NCT00863304|582736265|FG002|Overall Study|Lack of Efficacy|30|||
161368180|NCT00863304|582736266|FG003|Overall Study|Lack of Efficacy|28|||
161368181|NCT00863304|582736263|FG000|Overall Study|Withdrawal by Subject|19|||
161368182|NCT00863304|582736264|FG001|Overall Study|Withdrawal by Subject|14|||
161368183|NCT00863304|582736265|FG002|Overall Study|Withdrawal by Subject|20|||
161368184|NCT00863304|582736266|FG003|Overall Study|Withdrawal by Subject|18|||
161368185|NCT00863304|582736263|FG000|Overall Study|Other|1|||
161368186|NCT00863304|582736264|FG001|Overall Study|Other|0|||
161368187|NCT00863304|582736265|FG002|Overall Study|Other|0|||
161368188|NCT00863304|582736266|FG003|Overall Study|Other|1|||
161368189|NCT00863304|582736263|FG000|Overall Study|Protocol Violation|2|||
161368190|NCT00863304|582736264|FG001|Overall Study|Protocol Violation|6|||
161368191|NCT00863304|582736265|FG002|Overall Study|Protocol Violation|2|||
161368192|NCT00863304|582736266|FG003|Overall Study|Protocol Violation|0|||
161368193|NCT00863304|582736263|FG000|Overall Study|Randomized, but not Treated|3|||
161368194|NCT00863304|582736264|FG001|Overall Study|Randomized, but not Treated|1|||
161368195|NCT00863304|582736265|FG002|Overall Study|Randomized, but not Treated|4|||
161368196|NCT00863304|582736266|FG003|Overall Study|Randomized, but not Treated|1|||
161368197|NCT00863304|582736263|FG000|Overall Study|Entered extension study|101|||
161368198|NCT00863304|582736264|FG001|Overall Study|Entered extension study|129|||
161368199|NCT00863304|582736265|FG002|Overall Study|Entered extension study|113|||
161368200|NCT00863304|582736266|FG003|Overall Study|Entered extension study|125|||
161368201|NCT00478257|582736267|FG000|Overall Study|Withdrawal by Subject|8|||
161368202|NCT00478257|582736268|FG001|Overall Study|Withdrawal by Subject|3|||
161368203|NCT00806585|582736269|FG000|Overall Study|Study terminated by Sponsor|0|||
161368204|NCT00806585|582736270|FG001|Overall Study|Study terminated by Sponsor|0|||
161368205|NCT00806585|582736271|FG002|Overall Study|Study terminated by Sponsor|1|||
161368206|NCT00806585|582736272|FG003|Overall Study|Study terminated by Sponsor|2|||
161368207|NCT00806585|582736273|FG004|Overall Study|Study terminated by Sponsor|0|||
161368208|NCT00806585|582736269|FG000|Overall Study|Protocol Violation|3|||
161368209|NCT00806585|582736270|FG001|Overall Study|Protocol Violation|1|||
161368210|NCT00806585|582736271|FG002|Overall Study|Protocol Violation|2|||
161368211|NCT00806585|582736272|FG003|Overall Study|Protocol Violation|0|||
161368212|NCT00806585|582736273|FG004|Overall Study|Protocol Violation|0|||
161368213|NCT00806585|582736269|FG000|Overall Study|Physician Decision|0|||
161368214|NCT00806585|582736270|FG001|Overall Study|Physician Decision|2|||
161368215|NCT00806585|582736271|FG002|Overall Study|Physician Decision|3|||
161368216|NCT00806585|582736272|FG003|Overall Study|Physician Decision|0|||
161368217|NCT00806585|582736273|FG004|Overall Study|Physician Decision|1|||
161368218|NCT00806585|582736269|FG000|Overall Study|Lost to Follow-up|2|||
161368219|NCT00806585|582736270|FG001|Overall Study|Lost to Follow-up|1|||
161368220|NCT00806585|582736271|FG002|Overall Study|Lost to Follow-up|2|||
161368221|NCT00806585|582736272|FG003|Overall Study|Lost to Follow-up|2|||
161368222|NCT00806585|582736273|FG004|Overall Study|Lost to Follow-up|5|||
161368223|NCT00806585|582736269|FG000|Overall Study|Lack of Efficacy|1|||
161368224|NCT00806585|582736270|FG001|Overall Study|Lack of Efficacy|0|||
161368225|NCT00806585|582736271|FG002|Overall Study|Lack of Efficacy|0|||
161368226|NCT00806585|582736272|FG003|Overall Study|Lack of Efficacy|0|||
161368227|NCT00806585|582736273|FG004|Overall Study|Lack of Efficacy|0|||
161368228|NCT00806585|582736269|FG000|Overall Study|Adverse Event|1|||
161368229|NCT00806585|582736270|FG001|Overall Study|Adverse Event|5|||
161368230|NCT00806585|582736271|FG002|Overall Study|Adverse Event|3|||
161368231|NCT00806585|582736272|FG003|Overall Study|Adverse Event|4|||
161368232|NCT00806585|582736273|FG004|Overall Study|Adverse Event|2|||
161368233|NCT00806585|582736269|FG000|Overall Study|Withdrawal by Subject|10|||
161368234|NCT00806585|582736270|FG001|Overall Study|Withdrawal by Subject|8|||
161368235|NCT00806585|582736271|FG002|Overall Study|Withdrawal by Subject|9|||
161368236|NCT00806585|582736272|FG003|Overall Study|Withdrawal by Subject|3|||
161368237|NCT00806585|582736273|FG004|Overall Study|Withdrawal by Subject|11|||
161368238|NCT00806585|582736269|FG000|Overall Study|Completion status unknown|15|||
161368239|NCT00806585|582736270|FG001|Overall Study|Completion status unknown|14|||
161368240|NCT00806585|582736271|FG002|Overall Study|Completion status unknown|12|||
161368241|NCT00806585|582736272|FG003|Overall Study|Completion status unknown|4|||
161368242|NCT00806585|582736273|FG004|Overall Study|Completion status unknown|12|||
161368243|NCT02507934|582736275|FG000|Overall Study|Lost to Follow-up|2|||
161368244|NCT02507934|582736276|FG001|Overall Study|Lost to Follow-up|0|||
161368245|NCT02507934|582736275|FG000|Overall Study|Withdrawal by Subject|2|||
161368246|NCT02507934|582736276|FG001|Overall Study|Withdrawal by Subject|0|||
161368247|NCT03766399|582736278|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368248|NCT03766399|582736279|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368249|NCT03766399|582736280|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368250|NCT03766399|582736281|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368251|NCT03766399|582736282|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368252|NCT03766399|582736283|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368253|NCT03766399|582736284|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368254|NCT03766399|582736285|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368255|NCT03766399|582736286|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368256|NCT03766399|582736287|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368257|NCT03766399|582736288|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368258|NCT03766399|582736289|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368259|NCT03766399|582736290|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368260|NCT03766399|582736291|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
161368261|NCT03766399|582736292|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368262|NCT03766399|582736293|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368263|NCT03766399|582736294|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368264|NCT03766399|582736295|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161368265|NCT01309230|582736296|FG000|Overall Study|Withdrawal by Subject|0|||
161368266|NCT01309230|582736297|FG001|Overall Study|Withdrawal by Subject|2|||
161368267|NCT01309230|582736296|FG000|Overall Study|Observation arm closed|0|||
161368268|NCT01309230|582736297|FG001|Overall Study|Observation arm closed|2|||
161368269|NCT01767987|582736298|FG000|Overall Study|Physician Decision|4|||
161368270|NCT01767987|582736299|FG001|Overall Study|Physician Decision|1|||
161368271|NCT01153516|582736300|FG000|Overall Study|Both subjects refused surgery|2|||
161368272|NCT01153516|582736301|FG001|Overall Study|Both subjects refused surgery|0|||
161368273|NCT01605097|582736309|FG000|Overall Study|Protocol Violation|1|||
161368274|NCT03261505|582736323|FG000|Overall Study|Withdrawal by Subject|2|||
161368275|NCT03261505|582736324|FG001|Overall Study|Withdrawal by Subject|3|||
161368276|NCT03261505|582736325|FG002|Overall Study|Withdrawal by Subject|4|||
161368277|NCT03261505|582736326|FG003|Overall Study|Withdrawal by Subject|3|||
161368278|NCT03261505|582736323|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
161368279|NCT03261505|582736324|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
161368280|NCT03261505|582736325|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
161368281|NCT03261505|582736326|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
161368282|NCT03261505|582736323|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
161368283|NCT03261505|582736324|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
161368284|NCT03261505|582736325|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
161368285|NCT03261505|582736326|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
161368286|NCT03261505|582736323|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
161368287|NCT03261505|582736324|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
161368288|NCT03261505|582736325|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
161368289|NCT03261505|582736326|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
161368290|NCT00663260|582736327|FG000|Overall Study|Lack of Efficacy|2|||
161368291|NCT00663260|582736328|FG001|Overall Study|Lack of Efficacy|0|||
161368292|NCT00663260|582736329|FG002|Overall Study|Lack of Efficacy|0|||
161368293|NCT00663260|582736327|FG000|Overall Study|Adverse Event|12|||
161368294|NCT00663260|582736328|FG001|Overall Study|Adverse Event|7|||
161368295|NCT00663260|582736329|FG002|Overall Study|Adverse Event|6|||
161368296|NCT00663260|582736327|FG000|Overall Study|Withdrawal by Subject|3|||
161368297|NCT00663260|582736328|FG001|Overall Study|Withdrawal by Subject|1|||
161368298|NCT00663260|582736329|FG002|Overall Study|Withdrawal by Subject|6|||
161368299|NCT00663260|582736327|FG000|Overall Study|Death|1|||
161368300|NCT00663260|582736328|FG001|Overall Study|Death|0|||
161368301|NCT00663260|582736329|FG002|Overall Study|Death|1|||
161368302|NCT00663260|582736327|FG000|Overall Study|Lost to Follow-up|0|||
161368303|NCT00663260|582736328|FG001|Overall Study|Lost to Follow-up|1|||
161368304|NCT00663260|582736329|FG002|Overall Study|Lost to Follow-up|0|||
161368305|NCT00663260|582736327|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
161368306|NCT00663260|582736328|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
161368307|NCT00663260|582736329|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
161368308|NCT01506726|582736330|FG000|Overall Study|Adverse Event|1|||
161368309|NCT01506726|582736331|FG001|Overall Study|Adverse Event|2|||
161368310|NCT04562090|582736332|FG000|Overall Study|Withdrawal by Subject|3|||
161368311|NCT04562090|582736333|FG001|Overall Study|Withdrawal by Subject|4|||
161368312|NCT04562090|582736332|FG000|Overall Study|Protocol Violation|2|||
161368313|NCT04562090|582736333|FG001|Overall Study|Protocol Violation|0|||
161368314|NCT04562090|582736332|FG000|Overall Study|Lack of Efficacy|0|||
161368315|NCT04562090|582736333|FG001|Overall Study|Lack of Efficacy|1|||
161368316|NCT04562090|582736332|FG000|Overall Study|Adverse Event|1|||
161368317|NCT04562090|582736333|FG001|Overall Study|Adverse Event|4|||
161368318|NCT04562090|582736332|FG000|Overall Study|Miscellaneous|0|||
161368319|NCT04562090|582736333|FG001|Overall Study|Miscellaneous|3|||
161368320|NCT00847730|582736334|FG000|Overall Study|Multiple interruptions in therapy|8|||
161368321|NCT00432965|582736337|FG000|Overall Study|Lost to Follow-up|22|||
161368322|NCT00432965|582736338|FG001|Overall Study|Lost to Follow-up|19|||
161368323|NCT00432965|582736337|FG000|Overall Study|Withdrawal by Subject|13|||
161368324|NCT00432965|582736338|FG001|Overall Study|Withdrawal by Subject|13|||
161368325|NCT00432965|582736337|FG000|Overall Study|Physician Decision|14|||
161368326|NCT00432965|582736338|FG001|Overall Study|Physician Decision|13|||
161368327|NCT00432965|582736337|FG000|Overall Study|Lack of Efficacy|8|||
161368328|NCT00432965|582736338|FG001|Overall Study|Lack of Efficacy|13|||
161368329|NCT00432965|582736337|FG000|Overall Study|Non-compliance|7|||
161368330|NCT00432965|582736338|FG001|Overall Study|Non-compliance|0|||
161368331|NCT00432965|582736337|FG000|Overall Study|Adverse Event|22|||
161368332|NCT00432965|582736338|FG001|Overall Study|Adverse Event|19|||
161368333|NCT00432965|582736337|FG000|Overall Study|Death|3|||
161368334|NCT00432965|582736338|FG001|Overall Study|Death|4|||
161368335|NCT00432965|582736337|FG000|Overall Study|Exclusionary Methods|1|||
161368336|NCT00432965|582736338|FG001|Overall Study|Exclusionary Methods|2|||
161368337|NCT00432965|582736337|FG000|Overall Study|Incomplete Data|4|||
161368338|NCT00432965|582736338|FG001|Overall Study|Incomplete Data|3|||
161368339|NCT01722669|582736345|FG000|Overall Study|Withdrawal by Subject|0|||
161368340|NCT01722669|582736346|FG001|Overall Study|Withdrawal by Subject|0|||
161368341|NCT01722669|582736347|FG002|Overall Study|Withdrawal by Subject|0|||
161368342|NCT01722669|582736348|FG003|Overall Study|Withdrawal by Subject|0|||
161368343|NCT01722669|582736349|FG004|Overall Study|Withdrawal by Subject|0|||
161368344|NCT01722669|582736350|FG005|Overall Study|Withdrawal by Subject|2|||
161368345|NCT01344226|582736351|FG000|Overall Study|Protocol Violation|2|||
161368346|NCT01344226|582736351|FG000|Overall Study|Withdrawal by Subject|3|||
161368347|NCT01344226|582736351|FG000|Overall Study|Lack of Efficacy|3|||
161368348|NCT02255656|582736358|FG000|Overall Study|Adverse Event|11|||
161368349|NCT02255656|582736358|FG000|Overall Study|Poor compliance to protocol|3|||
161368350|NCT02255656|582736358|FG000|Overall Study|Lost to Follow-up|30|||
161368351|NCT02255656|582736358|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
161368352|NCT02255656|582736358|FG000|Overall Study|Other|126|||
161368353|NCT03734536|582736359|FG000|Overall Study|Withdrew Consent|1|||
161368354|NCT03734536|582736360|FG001|Overall Study|Withdrew Consent|5|||
161368355|NCT03734536|582736359|FG000|Overall Study|Lost to Follow-up|10|||
161368356|NCT03734536|582736360|FG001|Overall Study|Lost to Follow-up|7|||
161368357|NCT03448393|582736361|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368358|NCT03448393|582736362|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368359|NCT03448393|582736363|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
161368360|NCT03448393|582736364|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368361|NCT03448393|582736365|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368362|NCT03448393|582736366|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368363|NCT03448393|582736367|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368364|NCT03448393|582736368|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161368365|NCT03448393|582736369|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
161368366|NCT03448393|582736361|FG000|Dose Expansion|Not treated - screen failure|0|||
161368367|NCT03448393|582736362|FG001|Dose Expansion|Not treated - screen failure|0|||
161368368|NCT03448393|582736363|FG002|Dose Expansion|Not treated - screen failure|0|||
161368369|NCT03448393|582736364|FG003|Dose Expansion|Not treated - screen failure|0|||
161368370|NCT03448393|582736365|FG004|Dose Expansion|Not treated - screen failure|0|||
161368371|NCT03448393|582736366|FG005|Dose Expansion|Not treated - screen failure|0|||
161368372|NCT03448393|582736367|FG006|Dose Expansion|Not treated - screen failure|0|||
161368373|NCT03448393|582736368|FG007|Dose Expansion|Not treated - screen failure|0|||
161368374|NCT03448393|582736369|FG008|Dose Expansion|Not treated - screen failure|7|||
161368375|NCT03612570|582736373|FG000|Overall Study|Lost to Follow-up|1|||
161368376|NCT05318287|582736378|FG000|Overall Study|Lost to Follow-up|8|||
161368377|NCT05185453|582736379|FG000|Overall Study|Lost to Follow-up|13|||
161368378|NCT05185453|582736380|FG001|Overall Study|Lost to Follow-up|3|||
161368379|NCT05929326|582736398|FG000|Overall Study|unqualified sample|2|||
161368380|NCT05929326|582736399|FG001|Overall Study|unqualified sample|3|||
161368381|NCT05929326|582736400|FG002|Overall Study|unqualified sample|7|||
161368382|NCT03941093|582736411|FG000|Overall Study|Protocol Violation|0|||
161368383|NCT03941093|582736412|FG001|Overall Study|Protocol Violation|1|||
161368384|NCT03941093|582736411|FG000|Overall Study|Withdrawal by Subject|9|||
161368385|NCT03941093|582736412|FG001|Overall Study|Withdrawal by Subject|6|||
161368386|NCT02495883|582736415|FG000|Overall Study|Excessive head motion|1|||
161368387|NCT02495883|582736416|FG001|Overall Study|Excessive head motion|0|||
161368388|NCT00964678|582736420|FG000|Overall Study|Physician Decision|4|||
161368389|NCT03359395|582736421|FG000|First Intervention A / B|Withdrawal by Subject|1|||
161368390|NCT03359395|582736422|FG001|First Intervention A / B|Withdrawal by Subject|0|||
161368391|NCT03359395|582736421|FG000|First Intervention A / B|Lost to Follow-up|2|||
161368392|NCT03359395|582736422|FG001|First Intervention A / B|Lost to Follow-up|3|||
161368393|NCT03359395|582736421|FG000|Second Intervention B/A|Exclusion criteria|0|||
161368394|NCT03359395|582736422|FG001|Second Intervention B/A|Exclusion criteria|1|||
161368395|NCT03359395|582736421|FG000|Second Intervention B/A|Lost to Follow-up|3|||
161368396|NCT03359395|582736422|FG001|Second Intervention B/A|Lost to Follow-up|2|||
161368397|NCT01323192|582738032|FG000|Overall Study|Adverse Event|6|||
161368398|NCT01323192|582738033|FG001|Overall Study|Adverse Event|1|||
161368399|NCT01323192|582738032|FG000|Overall Study|Withdrawal by Subject|3|||
161368400|NCT01323192|582738033|FG001|Overall Study|Withdrawal by Subject|1|||
161368401|NCT01323192|582738032|FG000|Overall Study|Noncompliance with study medication|0|||
161368402|NCT01323192|582738033|FG001|Overall Study|Noncompliance with study medication|3|||
161368403|NCT01323192|582738032|FG000|Overall Study|Nonmedical reasons|0|||
161368404|NCT01323192|582738033|FG001|Overall Study|Nonmedical reasons|1|||
161368405|NCT03122184|582738034|FG000|Overall Study|Lost to Follow-up|4|||
161368406|NCT03122184|582738035|FG001|Overall Study|Lost to Follow-up|6|||
161368407|NCT03122184|582738034|FG000|Overall Study|Withdrawal by Subject|3|||
161368408|NCT03122184|582738035|FG001|Overall Study|Withdrawal by Subject|0|||
161368409|NCT03122184|582738034|FG000|Overall Study|Terminated due to cognitive problem|1|||
161368410|NCT03122184|582738035|FG001|Overall Study|Terminated due to cognitive problem|0|||
161368411|NCT00633126|582738036|FG000|Overall Study|Did not receive full dose|1|||
161368412|NCT01276704|582738039|FG000|Overall Study|Lost to Follow-up|2|||
161368413|NCT01276704|582738040|FG001|Overall Study|Lost to Follow-up|3|||
161368414|NCT01276704|582738039|FG000|Overall Study|Non-compliant|2|||
161368415|NCT01276704|582738040|FG001|Overall Study|Non-compliant|2|||
161368416|NCT01276704|582738039|FG000|Overall Study|Withdrawal by Subject|7|||
161368417|NCT01276704|582738040|FG001|Overall Study|Withdrawal by Subject|1|||
161368418|NCT01276704|582738039|FG000|Overall Study|Physician Decision|3|||
161368419|NCT01276704|582738040|FG001|Overall Study|Physician Decision|5|||
161368420|NCT01168596|582738041|FG000|Overall Study|Withdrawal by Subject|3|||
161368421|NCT01168596|582738042|FG001|Overall Study|Withdrawal by Subject|1|||
161368422|NCT02297516|582738043|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
161368423|NCT02297516|582738044|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
161368424|NCT02297516|582738043|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
161368425|NCT02297516|582738044|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
161368426|NCT02297516|582738043|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
161368427|NCT02297516|582738044|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
161368428|NCT00710593|582738045|FG000|Overall Study|Incarceration|1|||
161368429|NCT00710593|582738046|FG001|Overall Study|Incarceration|0|||
161368430|NCT00710593|582738045|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
161368431|NCT00710593|582738046|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
161368432|NCT00710593|582738045|FG000|Overall Study|Lost to Follow-up|3|||
161368433|NCT00710593|582738046|FG001|Overall Study|Lost to Follow-up|1|||
161368434|NCT00710593|582738045|FG000|Overall Study|Moved out of area|1|||
161368435|NCT00710593|582738046|FG001|Overall Study|Moved out of area|0|||
161368436|NCT00710593|582738045|FG000|Overall Study|Failure to adhere or complete study eval|1|||
161368437|NCT00710593|582738046|FG001|Overall Study|Failure to adhere or complete study eval|1|||
161368438|NCT00710593|582738045|FG000|Overall Study|Protocol Violation|1|||
161368439|NCT00710593|582738046|FG001|Overall Study|Protocol Violation|1|||
161368440|NCT00710593|582738045|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
161368441|NCT00710593|582738046|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
161368442|NCT04490278|582738047|FG000|Overall Study|Lost to Follow-up|6|||
161368443|NCT03801525|582738057|FG000|Overall Study|Adverse Event|17|||
161368444|NCT03801525|582738058|FG001|Overall Study|Adverse Event|1|||
161368445|NCT03801525|582738059|FG002|Overall Study|Adverse Event|0|||
161368446|NCT03801525|582738057|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
161368447|NCT03801525|582738058|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
161368448|NCT03801525|582738059|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
161368449|NCT03801525|582738057|FG000|Overall Study|Death|29|||
161368450|NCT03801525|582738058|FG001|Overall Study|Death|1|||
161368451|NCT03801525|582738059|FG002|Overall Study|Death|4|||
161368452|NCT03801525|582738057|FG000|Overall Study|Disease Progression|6|||
161368453|NCT03801525|582738058|FG001|Overall Study|Disease Progression|0|||
161368454|NCT03801525|582738059|FG002|Overall Study|Disease Progression|1|||
161368455|NCT03801525|582738057|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
161368456|NCT03801525|582738058|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
161368457|NCT03801525|582738059|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
161368458|NCT03801525|582738057|FG000|Overall Study|Investigator Decision|18|||
161368459|NCT03801525|582738058|FG001|Overall Study|Investigator Decision|1|||
161368460|NCT03801525|582738059|FG002|Overall Study|Investigator Decision|0|||
161368461|NCT03801525|582738057|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
161368462|NCT03801525|582738058|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
161368463|NCT03801525|582738059|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
161368464|NCT03801525|582738057|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
161368465|NCT03801525|582738058|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
161368466|NCT03801525|582738059|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
161368467|NCT03801525|582738057|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
161368468|NCT03801525|582738058|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
161368469|NCT03801525|582738059|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
161368470|NCT03801525|582738057|FG000|Overall Study|Withdrawal of Subject Consent|38|||
161368471|NCT03801525|582738058|FG001|Overall Study|Withdrawal of Subject Consent|2|||
161368472|NCT03801525|582738059|FG002|Overall Study|Withdrawal of Subject Consent|1|||
161368473|NCT03801525|582738057|FG000|Overall Study|Reason not Specified|4|||
161368474|NCT03801525|582738058|FG001|Overall Study|Reason not Specified|0|||
161368475|NCT03801525|582738059|FG002|Overall Study|Reason not Specified|4|||
161368476|NCT00183248|582738060|FG000|Overall Study|Lost to Follow-up|0|||
161368477|NCT00183248|582738061|FG001|Overall Study|Lost to Follow-up|1|||
161368478|NCT00183248|582738060|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
161368479|NCT00183248|582738061|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
161368480|NCT03309202|582738062|FG000|Overall Study|Lost to Follow-up|1|||
161368481|NCT03309202|582738063|FG001|Overall Study|Lost to Follow-up|0|||
161368482|NCT03309202|582738064|FG002|Overall Study|Lost to Follow-up|0|||
161368483|NCT03309202|582738065|FG003|Overall Study|Lost to Follow-up|0|||
161368484|NCT04734210|582738066|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
161368485|NCT04734210|582738067|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
161368486|NCT04734210|582738068|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
161368487|NCT04734210|582738066|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
161368488|NCT04734210|582738067|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
161368489|NCT04734210|582738068|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
161368490|NCT04734210|582738066|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
161368491|NCT04734210|582738067|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
161368492|NCT04734210|582738068|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
161368493|NCT04734210|582738066|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
161368494|NCT04734210|582738067|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
161368495|NCT04734210|582738068|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
161368496|NCT01822925|582738069|FG000|Overall Study|Adverse Event|1|||
161368497|NCT01822925|582738070|FG001|Overall Study|Adverse Event|1|||
161368498|NCT01822925|582738071|FG002|Overall Study|Adverse Event|1|||
161368499|NCT01822925|582738072|FG003|Overall Study|Adverse Event|1|||
161368500|NCT01822925|582738069|FG000|Overall Study|Lost to Follow-up|0|||
161368501|NCT01822925|582738070|FG001|Overall Study|Lost to Follow-up|1|||
161368502|NCT01822925|582738071|FG002|Overall Study|Lost to Follow-up|0|||
161368503|NCT01822925|582738072|FG003|Overall Study|Lost to Follow-up|0|||
161368504|NCT01822925|582738069|FG000|Overall Study|Protocol Violation|1|||
161368505|NCT01822925|582738070|FG001|Overall Study|Protocol Violation|0|||
161368506|NCT01822925|582738071|FG002|Overall Study|Protocol Violation|0|||
161368507|NCT01822925|582738072|FG003|Overall Study|Protocol Violation|1|||
161368508|NCT01822925|582738069|FG000|Overall Study|Withdrawal by Subject|2|||
161368509|NCT01822925|582738070|FG001|Overall Study|Withdrawal by Subject|0|||
161368510|NCT01822925|582738071|FG002|Overall Study|Withdrawal by Subject|2|||
161368511|NCT01822925|582738072|FG003|Overall Study|Withdrawal by Subject|2|||
161368512|NCT01822925|582738069|FG000|Overall Study|Taking prohibited medication|2|||
161368513|NCT01822925|582738070|FG001|Overall Study|Taking prohibited medication|0|||
161368514|NCT01822925|582738071|FG002|Overall Study|Taking prohibited medication|0|||
161368515|NCT01822925|582738072|FG003|Overall Study|Taking prohibited medication|1|||
161368516|NCT00573768|582738074|FG000|Overall Study|Adverse Event|1|||
161368517|NCT00573768|582738075|FG001|Overall Study|Adverse Event|1|||
161368518|NCT00573768|582738076|FG002|Overall Study|Adverse Event|2|||
161368519|NCT00573768|582738074|FG000|Overall Study|Protocol Violation|1|||
161368520|NCT00573768|582738075|FG001|Overall Study|Protocol Violation|0|||
161368521|NCT00573768|582738076|FG002|Overall Study|Protocol Violation|1|||
161368522|NCT00573768|582738074|FG000|Overall Study|Withdrawal by Subject|0|||
161368523|NCT00573768|582738075|FG001|Overall Study|Withdrawal by Subject|1|||
161368524|NCT00573768|582738076|FG002|Overall Study|Withdrawal by Subject|0|||
161368525|NCT00573768|582738074|FG000|Overall Study|Lost to Follow-up|0|||
161368526|NCT00573768|582738075|FG001|Overall Study|Lost to Follow-up|0|||
161368527|NCT00573768|582738076|FG002|Overall Study|Lost to Follow-up|1|||
161368528|NCT03243084|582738077|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
161368529|NCT03243084|582738078|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
161368530|NCT03847519|582738084|FG000|Overall Study|Death|5|||
161368531|NCT03847519|582738085|FG001|Overall Study|Death|8|||
161368532|NCT03847519|582738086|FG002|Overall Study|Death|1|||
161368533|NCT03847519|582738084|FG000|Overall Study|Lost to Follow-up|1|||
161368534|NCT03847519|582738085|FG001|Overall Study|Lost to Follow-up|2|||
161368535|NCT03847519|582738086|FG002|Overall Study|Lost to Follow-up|0|||
161368536|NCT03847519|582738084|FG000|Overall Study|Study Terminated by Sponsor|0|||
161368537|NCT03847519|582738085|FG001|Overall Study|Study Terminated by Sponsor|3|||
161368538|NCT03847519|582738086|FG002|Overall Study|Study Terminated by Sponsor|2|||
161368539|NCT01500317|582738091|FG000|Overall Study|Withdrawal by Subject|3|||
161368540|NCT01500317|582738092|FG001|Overall Study|Withdrawal by Subject|2|||
161368541|NCT01500317|582738093|FG002|Overall Study|Withdrawal by Subject|0|||
161368542|NCT00976456|582738094|FG000|Overall Study|Adverse Event|17|||
161368543|NCT00976456|582738095|FG001|Overall Study|Adverse Event|22|||
161368544|NCT00976456|582738094|FG000|Overall Study|Death|7|||
161368545|NCT00976456|582738095|FG001|Overall Study|Death|9|||
161368546|NCT00976456|582738094|FG000|Overall Study|Lack of Efficacy|5|||
161368547|NCT00976456|582738095|FG001|Overall Study|Lack of Efficacy|2|||
161368548|NCT00976456|582738094|FG000|Overall Study|Withdrawal by Subject|3|||
161368549|NCT00976456|582738095|FG001|Overall Study|Withdrawal by Subject|1|||
161368550|NCT00976456|582738094|FG000|Overall Study|screening failure, unknown|11|||
161368551|NCT00976456|582738095|FG001|Overall Study|screening failure, unknown|4|||
161368552|NCT00335829|582738096|FG000|Overall Study|Withdrawal by Subject|1|||
161368553|NCT00335829|582738096|FG000|Overall Study|Lost to Follow-up|1|||
161368554|NCT00335829|582738096|FG000|Overall Study|Adverse Event|1|||
161368555|NCT04562116|582738097|FG000|Overall Study|Lost to Follow-up|1|||
161368556|NCT04562116|582738097|FG000|Overall Study|Withdrawal by Subject|3|||
161368557|NCT03331354|582738098|FG000|Overall Study|Withdrawal by Subject|1|||
161368558|NCT03331354|582738099|FG001|Overall Study|Withdrawal by Subject|3|||
161368559|NCT03331354|582738098|FG000|Overall Study|Lost to Follow-up|3|||
161368560|NCT03331354|582738099|FG001|Overall Study|Lost to Follow-up|3|||
161368561|NCT03331354|582738098|FG000|Overall Study|Found employment before initiated active intervention|0|||
161368562|NCT03331354|582738099|FG001|Overall Study|Found employment before initiated active intervention|4|||
161368563|NCT01559935|582738102|FG000|Car Phase|Toxicity|4|||
161368564|NCT01559935|582738102|FG000|Car Phase|Death|1|||
161368565|NCT01559935|582738102|FG000|Car Phase|Lack of Efficacy|2|||
161368566|NCT01559935|582738102|FG000|Car Phase|Lost to Follow-up|1|||
161368567|NCT01559935|582738102|FG000|Car Phase|Physician Decision|1|||
161368568|NCT01559935|582738102|FG000|Car Phase|Withdrawal by Subject|2|||
161368569|NCT01559935|582738102|FG000|Car Phase|Per protocol|1|||
161368570|NCT01559935|582738102|FG000|Car Phase|Insurance|1|||
161368571|NCT01559935|582738102|FG000|Car Phase|non-compliance|1|||
161368572|NCT01559935|582738102|FG000|BiRD Phase|Toxicity|1|||
161368573|NCT01559935|582738102|FG000|BiRD Phase|Lack of Efficacy|1|||
161368574|NCT01559935|582738102|FG000|BiRD Phase|Withdrawal by Subject|2|||
161368575|NCT01559935|582738102|FG000|Maintenance Phase|Remains on study|28|||
161368576|NCT01559935|582738102|FG000|Maintenance Phase|Toxicity|1|||
161368577|NCT01559935|582738102|FG000|Maintenance Phase|Lack of Efficacy|18|||
161368578|NCT01559935|582738102|FG000|Maintenance Phase|Withdrawal by Subject|5|||
161368579|NCT01559935|582738102|FG000|Maintenance Phase|Non-compliance|2|||
161368580|NCT05889468|582738104|FG000|Overall Study|Lost to Follow-up|9|||
161368581|NCT05889468|582738105|FG001|Overall Study|Lost to Follow-up|2|||
161368582|NCT05889468|582738104|FG000|Overall Study|Withdrawal by Subject|2|||
161368583|NCT05889468|582738105|FG001|Overall Study|Withdrawal by Subject|2|||
161368584|NCT02284893|582738111|FG000|26 Week (Short Term)|Adverse Event|1|||
161368585|NCT02284893|582738112|FG001|26 Week (Short Term)|Adverse Event|9|||
161368586|NCT02284893|582738111|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
161368587|NCT02284893|582738112|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
161368588|NCT02284893|582738111|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
161368589|NCT02284893|582738112|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
161368590|NCT02284893|582738111|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
161368591|NCT02284893|582738112|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
161368592|NCT02284893|582738111|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
161368593|NCT02284893|582738112|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
161368594|NCT02284893|582738111|FG000|26 Week (Short Term)|Other|1|||
161368595|NCT02284893|582738112|FG001|26 Week (Short Term)|Other|1|||
161368596|NCT02284893|582738111|FG000|52 Week (Long Term)|Adverse Event|3|||
161368597|NCT02284893|582738112|FG001|52 Week (Long Term)|Adverse Event|1|||
161368598|NCT02284893|582738111|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
161368599|NCT02284893|582738112|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
161368600|NCT02284893|582738111|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
161368601|NCT02284893|582738112|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
161368602|NCT02284893|582738111|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
161368603|NCT02284893|582738112|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
161368604|NCT02284893|582738111|FG000|52 Week (Long Term)|Non-Compliance|2|||
161368605|NCT02284893|582738112|FG001|52 Week (Long Term)|Non-Compliance|3|||
161368606|NCT03078868|582738117|FG000|Overall Study|Physician Decision|3|||
161368607|NCT03038620|582738118|FG000|Overall Study|Lost to Follow-up|18|||
161368608|NCT03038620|582738119|FG001|Overall Study|Lost to Follow-up|23|||
161368609|NCT03038620|582738118|FG000|Overall Study|Withdrawal by Subject|0|||
161368610|NCT03038620|582738119|FG001|Overall Study|Withdrawal by Subject|15|||
161368611|NCT03038620|582738118|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
161368612|NCT03038620|582738119|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
161368613|NCT02082977|582738120|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
161368614|NCT02082977|582738121|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
161368615|NCT02082977|582738122|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
161368616|NCT02082977|582738123|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
161368617|NCT02082977|582738124|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
161368618|NCT02082977|582738125|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
161368619|NCT02082977|582738126|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
161368620|NCT02082977|582738127|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
161368621|NCT02082977|582738128|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
161368622|NCT02082977|582738129|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
161368623|NCT02082977|582738120|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368624|NCT02082977|582738121|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368625|NCT02082977|582738122|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368626|NCT02082977|582738123|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368627|NCT02082977|582738124|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368628|NCT02082977|582738125|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368629|NCT02082977|582738126|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368630|NCT02082977|582738127|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
161368631|NCT02082977|582738128|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368632|NCT02082977|582738129|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161368633|NCT02082977|582738120|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368634|NCT02082977|582738121|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368635|NCT02082977|582738122|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368636|NCT02082977|582738123|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368637|NCT02082977|582738124|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368638|NCT02082977|582738125|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
161368639|NCT02082977|582738126|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368640|NCT02082977|582738127|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368641|NCT02082977|582738128|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368642|NCT02082977|582738129|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161368643|NCT02082977|582738120|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161368644|NCT02082977|582738121|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161368645|NCT02082977|582738122|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161368646|NCT02082977|582738123|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161368647|NCT02082977|582738124|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
161368648|NCT02082977|582738125|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
161368649|NCT02082977|582738126|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
161368650|NCT02082977|582738127|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
161368651|NCT02082977|582738128|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
161368652|NCT02082977|582738129|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161368653|NCT02082977|582738120|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368654|NCT02082977|582738121|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368655|NCT02082977|582738122|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368656|NCT02082977|582738123|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368657|NCT02082977|582738124|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368658|NCT02082977|582738125|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368659|NCT02082977|582738126|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368660|NCT02082977|582738127|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
161368661|NCT02082977|582738128|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368662|NCT02082977|582738129|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161368663|NCT00105066|582738130|FG000|Overall Study|Adverse Event|2|||
161368664|NCT00105066|582738131|FG001|Overall Study|Adverse Event|5|||
161368665|NCT01979185|582738143|FG000|Period 2|Other|0|||
161368666|NCT01979185|582738144|FG001|Period 2|Other|1|||
161368667|NCT00522379|582738145|FG000|Overall Study|Adverse Event|12|||
161368668|NCT00522379|582738146|FG001|Overall Study|Adverse Event|15|||
161368669|NCT00522379|582738147|FG002|Overall Study|Adverse Event|12|||
161368670|NCT00522379|582738148|FG003|Overall Study|Adverse Event|5|||
161368671|NCT00522379|582738149|FG004|Overall Study|Adverse Event|17|||
161368672|NCT00522379|582738145|FG000|Overall Study|Lack of Efficacy|3|||
161368673|NCT00522379|582738146|FG001|Overall Study|Lack of Efficacy|0|||
161368674|NCT00522379|582738147|FG002|Overall Study|Lack of Efficacy|2|||
161368675|NCT00522379|582738148|FG003|Overall Study|Lack of Efficacy|2|||
161368676|NCT00522379|582738149|FG004|Overall Study|Lack of Efficacy|7|||
161368677|NCT00522379|582738145|FG000|Overall Study|Withdrawal by Subject|2|||
161368678|NCT00522379|582738146|FG001|Overall Study|Withdrawal by Subject|3|||
161368679|NCT00522379|582738147|FG002|Overall Study|Withdrawal by Subject|1|||
161368680|NCT00522379|582738148|FG003|Overall Study|Withdrawal by Subject|2|||
161368681|NCT00522379|582738149|FG004|Overall Study|Withdrawal by Subject|0|||
161368682|NCT00522379|582738145|FG000|Overall Study|Protocol Violation|1|||
161368683|NCT00522379|582738146|FG001|Overall Study|Protocol Violation|1|||
161368684|NCT00522379|582738147|FG002|Overall Study|Protocol Violation|2|||
161368685|NCT00522379|582738148|FG003|Overall Study|Protocol Violation|0|||
161368686|NCT00522379|582738149|FG004|Overall Study|Protocol Violation|0|||
161368687|NCT00522379|582738145|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
161368688|NCT00522379|582738146|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
161368689|NCT00522379|582738147|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
161368690|NCT00522379|582738148|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
161368691|NCT00522379|582738149|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
161368692|NCT00522379|582738145|FG000|Overall Study|Lost to Follow-up|1|||
161368693|NCT00522379|582738146|FG001|Overall Study|Lost to Follow-up|0|||
161368694|NCT00522379|582738147|FG002|Overall Study|Lost to Follow-up|4|||
161368695|NCT00522379|582738148|FG003|Overall Study|Lost to Follow-up|2|||
161368696|NCT00522379|582738149|FG004|Overall Study|Lost to Follow-up|2|||
161368697|NCT00522379|582738145|FG000|Overall Study|Randomization error|0|||
161368698|NCT00522379|582738146|FG001|Overall Study|Randomization error|0|||
161368699|NCT00522379|582738147|FG002|Overall Study|Randomization error|0|||
161368700|NCT00522379|582738148|FG003|Overall Study|Randomization error|0|||
161368701|NCT00522379|582738149|FG004|Overall Study|Randomization error|1|||
161368702|NCT00522379|582738145|FG000|Overall Study|Dispensing error|1|||
161368703|NCT00522379|582738146|FG001|Overall Study|Dispensing error|0|||
161368704|NCT00522379|582738147|FG002|Overall Study|Dispensing error|0|||
161368705|NCT00522379|582738148|FG003|Overall Study|Dispensing error|1|||
161368706|NCT00522379|582738149|FG004|Overall Study|Dispensing error|0|||
161368707|NCT00522379|582738145|FG000|Overall Study|Subject Moved|1|||
161368708|NCT00522379|582738146|FG001|Overall Study|Subject Moved|1|||
161368709|NCT00522379|582738147|FG002|Overall Study|Subject Moved|0|||
161368710|NCT00522379|582738148|FG003|Overall Study|Subject Moved|0|||
161368711|NCT00522379|582738149|FG004|Overall Study|Subject Moved|0|||
161368712|NCT00522379|582738145|FG000|Overall Study|Sponsor Request|0|||
161368713|NCT00522379|582738146|FG001|Overall Study|Sponsor Request|1|||
161368714|NCT00522379|582738147|FG002|Overall Study|Sponsor Request|0|||
161368715|NCT00522379|582738148|FG003|Overall Study|Sponsor Request|0|||
161368716|NCT00522379|582738149|FG004|Overall Study|Sponsor Request|0|||
161368717|NCT00522379|582738145|FG000|Overall Study|Family Problem|0|||
161368718|NCT00522379|582738146|FG001|Overall Study|Family Problem|0|||
161368719|NCT00522379|582738147|FG002|Overall Study|Family Problem|1|||
161368720|NCT00522379|582738148|FG003|Overall Study|Family Problem|0|||
161368721|NCT00522379|582738149|FG004|Overall Study|Family Problem|0|||
161368722|NCT00522379|582738145|FG000|Overall Study|Site Closed|0|||
161368723|NCT00522379|582738146|FG001|Overall Study|Site Closed|0|||
161368724|NCT00522379|582738147|FG002|Overall Study|Site Closed|0|||
161368725|NCT00522379|582738148|FG003|Overall Study|Site Closed|1|||
161368726|NCT00522379|582738149|FG004|Overall Study|Site Closed|0|||
161368727|NCT00522379|582738145|FG000|Overall Study|Subject Withdrawal|0|||
161368728|NCT00522379|582738146|FG001|Overall Study|Subject Withdrawal|0|||
161368729|NCT00522379|582738147|FG002|Overall Study|Subject Withdrawal|0|||
161368730|NCT00522379|582738148|FG003|Overall Study|Subject Withdrawal|1|||
161368731|NCT00522379|582738149|FG004|Overall Study|Subject Withdrawal|0|||
161368732|NCT03213509|582738150|FG000|Overall Study|Did not consent for verbal autopsy|4|||
161368733|NCT03213509|582738151|FG001|Overall Study|Did not consent for verbal autopsy|5|||
161368734|NCT04079738|582738152|FG000|Study Treatment|Death|1|||
161368735|NCT04079738|582738153|FG001|Study Treatment|Death|0|||
161368736|NCT04079738|582738154|FG002|Study Treatment|Death|0|||
161368737|NCT04079738|582738155|FG003|Study Treatment|Death|0|||
161368738|NCT04079738|582738152|FG000|Study Treatment|Adverse Event|2|||
161368739|NCT04079738|582738153|FG001|Study Treatment|Adverse Event|0|||
161368740|NCT04079738|582738154|FG002|Study Treatment|Adverse Event|0|||
161368741|NCT04079738|582738155|FG003|Study Treatment|Adverse Event|0|||
161368742|NCT04079738|582738152|FG000|Study Treatment|withdrawal before treatment|1|||
161368743|NCT04079738|582738153|FG001|Study Treatment|withdrawal before treatment|0|||
161368744|NCT04079738|582738154|FG002|Study Treatment|withdrawal before treatment|0|||
161368745|NCT04079738|582738155|FG003|Study Treatment|withdrawal before treatment|0|||
161368746|NCT04079738|582738152|FG000|Study Treatment|symptomatic deterioration|2|||
161368747|NCT04079738|582738153|FG001|Study Treatment|symptomatic deterioration|0|||
161368748|NCT04079738|582738154|FG002|Study Treatment|symptomatic deterioration|0|||
161368749|NCT04079738|582738155|FG003|Study Treatment|symptomatic deterioration|0|||
161368750|NCT04079738|582738152|FG000|Study Treatment|Disease Progression|1|||
161368751|NCT04079738|582738153|FG001|Study Treatment|Disease Progression|0|||
161368752|NCT04079738|582738154|FG002|Study Treatment|Disease Progression|0|||
161368753|NCT04079738|582738155|FG003|Study Treatment|Disease Progression|0|||
161368754|NCT04079738|582738152|FG000|Study Treatment|withdrawal after treatment|1|||
161368755|NCT04079738|582738153|FG001|Study Treatment|withdrawal after treatment|0|||
161368756|NCT04079738|582738154|FG002|Study Treatment|withdrawal after treatment|0|||
161368757|NCT04079738|582738155|FG003|Study Treatment|withdrawal after treatment|0|||
161368758|NCT04079738|582738152|FG000|Follow up|Withdrawal by Subject|3|||
161368759|NCT04079738|582738153|FG001|Follow up|Withdrawal by Subject|0|||
161368760|NCT04079738|582738154|FG002|Follow up|Withdrawal by Subject|0|||
161368761|NCT04079738|582738155|FG003|Follow up|Withdrawal by Subject|0|||
161368762|NCT04079738|582738152|FG000|Follow up|Death|5|||
161368763|NCT04079738|582738153|FG001|Follow up|Death|0|||
161368764|NCT04079738|582738154|FG002|Follow up|Death|0|||
161368765|NCT04079738|582738155|FG003|Follow up|Death|0|||
161368766|NCT03620981|582738156|FG000|Overall Study|Adverse Event|14|||
161368767|NCT03620981|582738157|FG001|Overall Study|Adverse Event|38|||
161368768|NCT03620981|582738158|FG002|Overall Study|Adverse Event|25|||
161368769|NCT03620981|582738156|FG000|Overall Study|Lack of Efficacy|2|||
161368770|NCT03620981|582738157|FG001|Overall Study|Lack of Efficacy|1|||
161368771|NCT03620981|582738158|FG002|Overall Study|Lack of Efficacy|1|||
161368772|NCT03620981|582738156|FG000|Overall Study|Physician Decision|7|||
161368773|NCT03620981|582738157|FG001|Overall Study|Physician Decision|4|||
161368774|NCT03620981|582738158|FG002|Overall Study|Physician Decision|4|||
161368775|NCT03620981|582738156|FG000|Overall Study|Protocol Violation|1|||
161368776|NCT03620981|582738157|FG001|Overall Study|Protocol Violation|2|||
161368777|NCT03620981|582738158|FG002|Overall Study|Protocol Violation|1|||
161368778|NCT03620981|582738156|FG000|Overall Study|Withdrawal by Legal Representative|2|||
161368779|NCT03620981|582738157|FG001|Overall Study|Withdrawal by Legal Representative|1|||
161368780|NCT03620981|582738158|FG002|Overall Study|Withdrawal by Legal Representative|1|||
161368781|NCT03620981|582738156|FG000|Overall Study|Withdrawal by Care Giver|2|||
161368782|NCT03620981|582738157|FG001|Overall Study|Withdrawal by Care Giver|0|||
161368783|NCT03620981|582738158|FG002|Overall Study|Withdrawal by Care Giver|1|||
161368784|NCT03620981|582738156|FG000|Overall Study|Non-compliance with Study Drug|1|||
161368785|NCT03620981|582738157|FG001|Overall Study|Non-compliance with Study Drug|1|||
161368786|NCT03620981|582738158|FG002|Overall Study|Non-compliance with Study Drug|0|||
161368787|NCT05552859|582738159|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
161368788|NCT05552859|582738160|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
161368789|NCT02303821|582738161|FG000|Overall Study|Withdrawal by Subject|0|||
161368790|NCT02303821|582738162|FG001|Overall Study|Withdrawal by Subject|0|||
161368791|NCT02303821|582738163|FG002|Overall Study|Withdrawal by Subject|0|||
161368792|NCT02303821|582738164|FG003|Overall Study|Withdrawal by Subject|0|||
161368793|NCT02303821|582738165|FG004|Overall Study|Withdrawal by Subject|0|||
161368794|NCT02303821|582738166|FG005|Overall Study|Withdrawal by Subject|0|||
161368795|NCT02303821|582738167|FG006|Overall Study|Withdrawal by Subject|0|||
161368796|NCT02303821|582738168|FG007|Overall Study|Withdrawal by Subject|2|||
161368797|NCT02303821|582738161|FG000|Overall Study|Death|0|||
161368798|NCT02303821|582738162|FG001|Overall Study|Death|2|||
161368799|NCT02303821|582738163|FG002|Overall Study|Death|0|||
161368800|NCT02303821|582738164|FG003|Overall Study|Death|0|||
161368801|NCT02303821|582738165|FG004|Overall Study|Death|0|||
161368802|NCT02303821|582738166|FG005|Overall Study|Death|3|||
161368803|NCT02303821|582738167|FG006|Overall Study|Death|41|||
161368804|NCT02303821|582738168|FG007|Overall Study|Death|29|||
161368805|NCT02303821|582738161|FG000|Overall Study|Lost to Follow-up|0|||
161368806|NCT02303821|582738162|FG001|Overall Study|Lost to Follow-up|0|||
161368807|NCT02303821|582738163|FG002|Overall Study|Lost to Follow-up|0|||
161368808|NCT02303821|582738164|FG003|Overall Study|Lost to Follow-up|0|||
161368809|NCT02303821|582738165|FG004|Overall Study|Lost to Follow-up|0|||
161368810|NCT02303821|582738166|FG005|Overall Study|Lost to Follow-up|0|||
161368811|NCT02303821|582738167|FG006|Overall Study|Lost to Follow-up|1|||
161368812|NCT02303821|582738168|FG007|Overall Study|Lost to Follow-up|0|||
161368813|NCT02303821|582738161|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368814|NCT02303821|582738162|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368815|NCT02303821|582738163|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368816|NCT02303821|582738164|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368817|NCT02303821|582738165|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368818|NCT02303821|582738166|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368819|NCT02303821|582738167|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
161368820|NCT02303821|582738168|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161368821|NCT02303821|582738161|FG000|Overall Study|Decision by sponsor|0|||
161368822|NCT02303821|582738162|FG001|Overall Study|Decision by sponsor|0|||
161368823|NCT02303821|582738163|FG002|Overall Study|Decision by sponsor|0|||
161368824|NCT02303821|582738164|FG003|Overall Study|Decision by sponsor|0|||
161368825|NCT02303821|582738165|FG004|Overall Study|Decision by sponsor|0|||
161368826|NCT02303821|582738166|FG005|Overall Study|Decision by sponsor|1|||
161368827|NCT02303821|582738167|FG006|Overall Study|Decision by sponsor|0|||
161368828|NCT02303821|582738168|FG007|Overall Study|Decision by sponsor|0|||
161368829|NCT02303821|582738161|FG000|Overall Study|Protocol-specified criteria|0|||
161368830|NCT02303821|582738162|FG001|Overall Study|Protocol-specified criteria|1|||
161368831|NCT02303821|582738163|FG002|Overall Study|Protocol-specified criteria|0|||
161368832|NCT02303821|582738164|FG003|Overall Study|Protocol-specified criteria|0|||
161368833|NCT02303821|582738165|FG004|Overall Study|Protocol-specified criteria|0|||
161368834|NCT02303821|582738166|FG005|Overall Study|Protocol-specified criteria|1|||
161368835|NCT02303821|582738167|FG006|Overall Study|Protocol-specified criteria|0|||
161368836|NCT02303821|582738168|FG007|Overall Study|Protocol-specified criteria|0|||
161368837|NCT00210132|582738169|FG000|Overall Study|Protocol Violation|1|||
161368838|NCT00210132|582738170|FG001|Overall Study|Protocol Violation|4|||
161368839|NCT02711202|582738171|FG000|Overall Study|Adverse Event|3|||
161368840|NCT02711202|582738172|FG001|Overall Study|Adverse Event|0|||
161368841|NCT02711202|582738171|FG000|Overall Study|graft loss|1|||
161368842|NCT02711202|582738172|FG001|Overall Study|graft loss|0|||
161368843|NCT02402647|582738173|FG000|Overall Study|Lost to Follow-up|13|||
161368844|NCT02402647|582738174|FG001|Overall Study|Lost to Follow-up|7|||
161368845|NCT02402647|582738173|FG000|Overall Study|Protocol Violation|1|||
161368846|NCT02402647|582738174|FG001|Overall Study|Protocol Violation|1|||
161368847|NCT02402647|582738173|FG000|Overall Study|scheduled and timed out|2|||
161368848|NCT02402647|582738174|FG001|Overall Study|scheduled and timed out|1|||
161368849|NCT02402647|582738173|FG000|Overall Study|medical illness|2|||
161368850|NCT02402647|582738174|FG001|Overall Study|medical illness|4|||
161368851|NCT02402647|582738173|FG000|Overall Study|Moved|2|||
161368852|NCT02402647|582738174|FG001|Overall Study|Moved|0|||
161368853|NCT02402647|582738173|FG000|Overall Study|loved one illness|1|||
161368854|NCT02402647|582738174|FG001|Overall Study|loved one illness|0|||
161368855|NCT02402647|582738173|FG000|Overall Study|deceased preexisting condition|2|||
161368856|NCT02402647|582738174|FG001|Overall Study|deceased preexisting condition|0|||
161368857|NCT02402647|582738173|FG000|Overall Study|Other|2|||
161368858|NCT02402647|582738174|FG001|Overall Study|Other|1|||
161368859|NCT01889251|582738175|FG000|Overall Study|Adverse Event|1|||
161368860|NCT01889251|582738176|FG001|Overall Study|Adverse Event|0|||
161368861|NCT01903863|582738177|FG000|Overall Study|Physician Decision|2|||
161368862|NCT01903863|582738178|FG001|Overall Study|Physician Decision|0|||
161368863|NCT05484895|582739627|FG000|Overall Study|Lost to Follow-up|63|||
161368864|NCT05484895|582739628|FG001|Overall Study|Lost to Follow-up|64|||
161368865|NCT04795531|582739629|FG000|Overall Study|Withdrawal by Subject|4|||
161368866|NCT04795531|582739630|FG001|Overall Study|Withdrawal by Subject|4|||
161368867|NCT04795531|582739629|FG000|Overall Study|Lost to Follow-up|0|||
161368868|NCT04795531|582739630|FG001|Overall Study|Lost to Follow-up|1|||
161368869|NCT04795531|582739629|FG000|Overall Study|Physician Decision|0|||
161368870|NCT04795531|582739630|FG001|Overall Study|Physician Decision|2|||
161368871|NCT04795531|582739629|FG000|Overall Study|Death|2|||
161368872|NCT04795531|582739630|FG001|Overall Study|Death|1|||
161368873|NCT03698279|582739631|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161368874|NCT03698279|582739632|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161368875|NCT03698279|582739633|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161368876|NCT03698279|582739634|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161368877|NCT03698279|582739635|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161368878|NCT03698279|582739636|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161368879|NCT03698279|582739631|FG000|Overall Study|Protocol deviation|1|||
161368880|NCT03698279|582739632|FG001|Overall Study|Protocol deviation|0|||
161368881|NCT03698279|582739633|FG002|Overall Study|Protocol deviation|1|||
161368882|NCT03698279|582739634|FG003|Overall Study|Protocol deviation|0|||
161368883|NCT03698279|582739635|FG004|Overall Study|Protocol deviation|0|||
161368884|NCT03698279|582739636|FG005|Overall Study|Protocol deviation|0|||
161368885|NCT03698279|582739631|FG000|Overall Study|Withdrawal by Subject|0|||
161368886|NCT03698279|582739632|FG001|Overall Study|Withdrawal by Subject|0|||
161368887|NCT03698279|582739633|FG002|Overall Study|Withdrawal by Subject|1|||
161368888|NCT03698279|582739634|FG003|Overall Study|Withdrawal by Subject|0|||
161368889|NCT03698279|582739635|FG004|Overall Study|Withdrawal by Subject|0|||
161368890|NCT03698279|582739636|FG005|Overall Study|Withdrawal by Subject|0|||
161368891|NCT03698279|582739631|FG000|Overall Study|Lost to Follow-up|3|||
161368892|NCT03698279|582739632|FG001|Overall Study|Lost to Follow-up|1|||
161368893|NCT03698279|582739633|FG002|Overall Study|Lost to Follow-up|4|||
161368894|NCT03698279|582739634|FG003|Overall Study|Lost to Follow-up|5|||
161368895|NCT03698279|582739635|FG004|Overall Study|Lost to Follow-up|0|||
161368896|NCT03698279|582739636|FG005|Overall Study|Lost to Follow-up|0|||
161368897|NCT03552029|582739637|FG000|Overall Study|Death|3|||
161368898|NCT03552029|582739638|FG001|Overall Study|Death|0|||
161368899|NCT03552029|582739637|FG000|Overall Study|Adverse Event|1|||
161368900|NCT03552029|582739638|FG001|Overall Study|Adverse Event|0|||
161368901|NCT03552029|582739637|FG000|Overall Study|Lack of Efficacy|0|||
161368902|NCT03552029|582739638|FG001|Overall Study|Lack of Efficacy|2|||
161368903|NCT03552029|582739637|FG000|Overall Study|Physician Decision|0|||
161368904|NCT03552029|582739638|FG001|Overall Study|Physician Decision|1|||
161368905|NCT03552029|582739637|FG000|Overall Study|Study terminated by Sponsor|0|||
161368906|NCT03552029|582739638|FG001|Overall Study|Study terminated by Sponsor|1|||
161368907|NCT03552029|582739637|FG000|Overall Study|Other|0|||
161368908|NCT03552029|582739638|FG001|Overall Study|Other|2|||
161368909|NCT02552225|582739639|FG000|Overall Study|Withdrawal by Subject|1|||
161368910|NCT02552225|582739640|FG001|Overall Study|Withdrawal by Subject|0|||
161368911|NCT00876447|582739641|FG000|Overall Study|Other miscellaneous reasons|3|||
161368912|NCT00876447|582739642|FG001|Overall Study|Other miscellaneous reasons|8|||
161368913|NCT00876447|582739641|FG000|Overall Study|Site closure|19|||
161368914|NCT00876447|582739642|FG001|Overall Study|Site closure|14|||
161368915|NCT00876447|582739641|FG000|Overall Study|Protocol Violation|9|||
161368916|NCT00876447|582739642|FG001|Overall Study|Protocol Violation|3|||
161368917|NCT00876447|582739641|FG000|Overall Study|Personal reasons|30|||
161368918|NCT00876447|582739642|FG001|Overall Study|Personal reasons|28|||
161368919|NCT00876447|582739641|FG000|Overall Study|Lost to Follow-up|6|||
161368920|NCT00876447|582739642|FG001|Overall Study|Lost to Follow-up|15|||
161368921|NCT00876447|582739641|FG000|Overall Study|Pregnancy|4|||
161368922|NCT00876447|582739642|FG001|Overall Study|Pregnancy|2|||
161368923|NCT00876447|582739641|FG000|Overall Study|Lack of Efficacy|5|||
161368924|NCT00876447|582739642|FG001|Overall Study|Lack of Efficacy|3|||
161368925|NCT00876447|582739641|FG000|Overall Study|Adverse Event|4|||
161368926|NCT00876447|582739642|FG001|Overall Study|Adverse Event|8|||
161368927|NCT00567502|582739643|FG000|Overall Study|Lost to Follow-up|91|||
161368928|NCT00567502|582739644|FG001|Overall Study|Lost to Follow-up|14|||
161368929|NCT00567502|582739645|FG002|Overall Study|Lost to Follow-up|351|||
161368930|NCT00567502|582739646|FG003|Overall Study|Lost to Follow-up|2|||
161368931|NCT00567502|582739643|FG000|Overall Study|Death|65|||
161368932|NCT00567502|582739644|FG001|Overall Study|Death|16|||
161368933|NCT00567502|582739645|FG002|Overall Study|Death|360|||
161368934|NCT00567502|582739646|FG003|Overall Study|Death|5|||
161368935|NCT00567502|582739643|FG000|Overall Study|Other|64|||
161368936|NCT00567502|582739644|FG001|Overall Study|Other|2|||
161368937|NCT00567502|582739645|FG002|Overall Study|Other|134|||
161368938|NCT00567502|582739646|FG003|Overall Study|Other|6|||
161368939|NCT00567502|582739643|FG000|Overall Study|Participant request|12|||
161368940|NCT00567502|582739644|FG001|Overall Study|Participant request|1|||
161368941|NCT00567502|582739645|FG002|Overall Study|Participant request|33|||
161368942|NCT00567502|582739646|FG003|Overall Study|Participant request|1|||
161368943|NCT00567502|582739643|FG000|Overall Study|Sponsor request|9|||
161368944|NCT00567502|582739644|FG001|Overall Study|Sponsor request|0|||
161368945|NCT00567502|582739645|FG002|Overall Study|Sponsor request|30|||
161368946|NCT00567502|582739646|FG003|Overall Study|Sponsor request|1|||
161368947|NCT00567502|582739643|FG000|Overall Study|Never Initiated Treatment|0|||
161368948|NCT00567502|582739644|FG001|Overall Study|Never Initiated Treatment|0|||
161368949|NCT00567502|582739645|FG002|Overall Study|Never Initiated Treatment|0|||
161368950|NCT00567502|582739646|FG003|Overall Study|Never Initiated Treatment|72|||
161368951|NCT02835690|582739647|FG000|Overall Study|Death|12|||
161368952|NCT02835690|582739648|FG001|Overall Study|Death|11|||
161368953|NCT02835690|582739649|FG002|Overall Study|Death|13|||
161368954|NCT02835690|582739647|FG000|Overall Study|Transferred to Extension Study|2|||
161368955|NCT02835690|582739648|FG001|Overall Study|Transferred to Extension Study|2|||
161368956|NCT02835690|582739649|FG002|Overall Study|Transferred to Extension Study|1|||
161368957|NCT02835690|582739647|FG000|Overall Study|Did Not Continue on Extension Study|0|||
161368958|NCT02835690|582739648|FG001|Overall Study|Did Not Continue on Extension Study|0|||
161368959|NCT02835690|582739649|FG002|Overall Study|Did Not Continue on Extension Study|1|||
161368960|NCT02835690|582739647|FG000|Overall Study|Not Treated|0|||
161368961|NCT02835690|582739648|FG001|Overall Study|Not Treated|2|||
161368962|NCT02835690|582739649|FG002|Overall Study|Not Treated|0|||
161368963|NCT03728933|582739650|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161368964|NCT03728933|582739651|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161368965|NCT03728933|582739652|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161368966|NCT03728933|582739650|FG000|Overall Study|Withdrawal by Subject|0|||
161368967|NCT03728933|582739651|FG001|Overall Study|Withdrawal by Subject|0|||
161368968|NCT03728933|582739652|FG002|Overall Study|Withdrawal by Subject|1|||
161368969|NCT03728933|582739650|FG000|Overall Study|Lost to Follow-up|0|||
161368970|NCT03728933|582739651|FG001|Overall Study|Lost to Follow-up|1|||
161368971|NCT03728933|582739652|FG002|Overall Study|Lost to Follow-up|0|||
161368972|NCT03728933|582739650|FG000|Overall Study|Adverse Event|1|||
161368973|NCT03728933|582739651|FG001|Overall Study|Adverse Event|0|||
161368974|NCT03728933|582739652|FG002|Overall Study|Adverse Event|0|||
161368975|NCT00582907|582739655|FG000|1st Course|Withdrawal by Subject|1|||
161368976|NCT00582907|582739656|FG001|1st Course|Withdrawal by Subject|0|||
161368977|NCT00582907|582739657|FG002|1st Course|Withdrawal by Subject|0|||
161368978|NCT00582907|582739658|FG003|1st Course|Withdrawal by Subject|0|||
161368979|NCT00582907|582739655|FG000|1st Course|Lost to Follow-up|0|||
161368980|NCT00582907|582739656|FG001|1st Course|Lost to Follow-up|0|||
161368981|NCT00582907|582739657|FG002|1st Course|Lost to Follow-up|0|||
161368982|NCT00582907|582739658|FG003|1st Course|Lost to Follow-up|1|||
161368983|NCT00582907|582739655|FG000|2nd Course|Lack of Efficacy|1|||
161368984|NCT00582907|582739656|FG001|2nd Course|Lack of Efficacy|0|||
161368985|NCT00582907|582739657|FG002|2nd Course|Lack of Efficacy|0|||
161368986|NCT00582907|582739658|FG003|2nd Course|Lack of Efficacy|0|||
161368987|NCT02538614|582739659|FG000|Overall Study|Progressive Disease|2|||
161368988|NCT01441960|582739661|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
161368989|NCT01441960|582739662|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
161368990|NCT01441960|582739661|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
161368991|NCT01441960|582739662|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
161368992|NCT01441960|582739661|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
161368993|NCT01441960|582739662|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
161368994|NCT00189423|582739663|FG000|Overall Study|Death|746|||
161368995|NCT00189423|582739664|FG001|Overall Study|Death|747|||
161368996|NCT00189423|582739663|FG000|Overall Study|Withdrawal by Subject|9|||
161368997|NCT00189423|582739664|FG001|Overall Study|Withdrawal by Subject|9|||
161368998|NCT00189423|582739663|FG000|Overall Study|Lost to Follow-up|10|||
161368999|NCT00189423|582739664|FG001|Overall Study|Lost to Follow-up|10|||
161369000|NCT00415636|582739670|FG000|Overall Study|Symptomatic deterioration|1|||
161369001|NCT00415636|582739671|FG001|Overall Study|Symptomatic deterioration|0|||
161369002|NCT00415636|582739672|FG002|Overall Study|Symptomatic deterioration|1|||
161369003|NCT00415636|582739673|FG003|Overall Study|Symptomatic deterioration|2|||
161369004|NCT00415636|582739674|FG004|Overall Study|Symptomatic deterioration|0|||
161369005|NCT00415636|582739675|FG005|Overall Study|Symptomatic deterioration|1|||
161369006|NCT00415636|582739670|FG000|Overall Study|Adverse Event|0|||
161369007|NCT00415636|582739671|FG001|Overall Study|Adverse Event|0|||
161369008|NCT00415636|582739672|FG002|Overall Study|Adverse Event|0|||
161369009|NCT00415636|582739673|FG003|Overall Study|Adverse Event|1|||
161369010|NCT00415636|582739674|FG004|Overall Study|Adverse Event|1|||
161369011|NCT00415636|582739675|FG005|Overall Study|Adverse Event|0|||
161369012|NCT00415636|582739670|FG000|Overall Study|Withdrawal by Subject|0|||
161369013|NCT00415636|582739671|FG001|Overall Study|Withdrawal by Subject|0|||
161369014|NCT00415636|582739672|FG002|Overall Study|Withdrawal by Subject|0|||
161369015|NCT00415636|582739673|FG003|Overall Study|Withdrawal by Subject|0|||
161369016|NCT00415636|582739674|FG004|Overall Study|Withdrawal by Subject|1|||
161369017|NCT00415636|582739675|FG005|Overall Study|Withdrawal by Subject|0|||
161369018|NCT00415636|582739670|FG000|Overall Study|Disease progression|0|||
161369019|NCT00415636|582739671|FG001|Overall Study|Disease progression|0|||
161369020|NCT00415636|582739672|FG002|Overall Study|Disease progression|0|||
161369021|NCT00415636|582739673|FG003|Overall Study|Disease progression|3|||
161369022|NCT00415636|582739674|FG004|Overall Study|Disease progression|0|||
161369023|NCT00415636|582739675|FG005|Overall Study|Disease progression|1|||
161369024|NCT01263119|582739676|FG000|Period 1|Protocol Violation|2|||
161369025|NCT01263119|582739676|FG000|Period 2|Adverse Event|2|||
161369026|NCT02138825|582739677|FG000|Main Study Treatment|Adverse Event|11|||
161369027|NCT02138825|582739678|FG001|Main Study Treatment|Adverse Event|3|||
161369028|NCT02138825|582739677|FG000|Main Study Treatment|Death|1|||
161369029|NCT02138825|582739678|FG001|Main Study Treatment|Death|2|||
161369030|NCT02138825|582739677|FG000|Main Study Treatment|Protocol Violation|2|||
161369031|NCT02138825|582739678|FG001|Main Study Treatment|Protocol Violation|2|||
161369032|NCT02138825|582739677|FG000|Main Study Treatment|Sponsor decision|12|||
161369033|NCT02138825|582739678|FG001|Main Study Treatment|Sponsor decision|18|||
161369034|NCT02138825|582739677|FG000|Main Study Treatment|Study terminated by sponsor|10|||
161369035|NCT02138825|582739678|FG001|Main Study Treatment|Study terminated by sponsor|9|||
161369036|NCT02138825|582739677|FG000|Main Study Treatment|Withdrawal by Subject|3|||
161369037|NCT02138825|582739678|FG001|Main Study Treatment|Withdrawal by Subject|1|||
161369038|NCT02138825|582739677|FG000|Main Study Treatment|Medical decision|1|||
161369039|NCT02138825|582739678|FG001|Main Study Treatment|Medical decision|0|||
161369040|NCT02138825|582739677|FG000|Long-term Extension|Study termination by sponsor|32|||
161369041|NCT02138825|582739678|FG001|Long-term Extension|Study termination by sponsor|38|||
161369042|NCT02138825|582739677|FG000|Safety Follow-up|Adverse Event|4|||
161369043|NCT02138825|582739678|FG001|Safety Follow-up|Adverse Event|3|||
161369044|NCT02138825|582739677|FG000|Safety Follow-up|Death|11|||
161369045|NCT02138825|582739678|FG001|Safety Follow-up|Death|5|||
161369046|NCT02138825|582739677|FG000|Safety Follow-up|Withdrawal by Subject|5|||
161369047|NCT02138825|582739678|FG001|Safety Follow-up|Withdrawal by Subject|3|||
161369048|NCT02138825|582739677|FG000|Safety Follow-up|clinic worsening|1|||
161369049|NCT02138825|582739678|FG001|Safety Follow-up|clinic worsening|0|||
161369050|NCT02138825|582739677|FG000|Safety Follow-up|withdrawal by PI|1|||
161369051|NCT02138825|582739678|FG001|Safety Follow-up|withdrawal by PI|0|||
161369052|NCT02138825|582739677|FG000|Safety Follow-up|logistical difficulties|0|||
161369053|NCT02138825|582739678|FG001|Safety Follow-up|logistical difficulties|1|||
161369054|NCT02138825|582739677|FG000|Safety Follow-up|progressive disease|0|||
161369055|NCT02138825|582739678|FG001|Safety Follow-up|progressive disease|2|||
161369056|NCT02138825|582739677|FG000|Safety Follow-up|too unwell to attend the visit|0|||
161369057|NCT02138825|582739678|FG001|Safety Follow-up|too unwell to attend the visit|1|||
161369058|NCT02138825|582739677|FG000|Safety Follow-up|treatment unblinded|0|||
161369059|NCT02138825|582739678|FG001|Safety Follow-up|treatment unblinded|1|||
161369060|NCT02138825|582739677|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
161369061|NCT02138825|582739678|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
161369062|NCT01702298|582739684|FG000|Overall Study|Withdrawal by Subject|1|||
161369063|NCT02090764|582739692|FG000|Overall Study|Adverse Event|1|||
161369064|NCT02090764|582739693|FG001|Overall Study|Adverse Event|3|||
161369065|NCT02090764|582739692|FG000|Overall Study|Lack of Efficacy|0|||
161369066|NCT02090764|582739693|FG001|Overall Study|Lack of Efficacy|13|||
161369067|NCT02090764|582739692|FG000|Overall Study|Withdrawal by Subject|2|||
161369068|NCT02090764|582739693|FG001|Overall Study|Withdrawal by Subject|1|||
161369069|NCT02090764|582739692|FG000|Overall Study|Intercurrent illness and other|1|||
161369070|NCT02090764|582739693|FG001|Overall Study|Intercurrent illness and other|1|||
161369071|NCT02090764|582739692|FG000|Overall Study|Lost to Follow-up|2|||
161369072|NCT02090764|582739693|FG001|Overall Study|Lost to Follow-up|2|||
161369073|NCT03605693|582739696|FG000|Overall Study|Lost to Follow-up|4|||
161369074|NCT03605693|582739697|FG001|Overall Study|Lost to Follow-up|0|||
161369075|NCT03605693|582739696|FG000|Overall Study|Physician Decision|1|||
161369076|NCT03605693|582739697|FG001|Overall Study|Physician Decision|0|||
161369077|NCT04752566|582739698|FG000|Overall Study|Protocol Violation|0|||
161369078|NCT04752566|582739699|FG001|Overall Study|Protocol Violation|1|||
161369079|NCT04752566|582739698|FG000|Overall Study|Death|1|||
161369080|NCT04752566|582739699|FG001|Overall Study|Death|0|||
161369081|NCT04752566|582739698|FG000|Overall Study|Adverse Event|1|||
161369082|NCT04752566|582739699|FG001|Overall Study|Adverse Event|0|||
161369083|NCT04752566|582739698|FG000|Overall Study|Withdrawal by Subject|2|||
161369084|NCT04752566|582739699|FG001|Overall Study|Withdrawal by Subject|0|||
161369085|NCT04752566|582739698|FG000|Overall Study|Physician Decision|1|||
161369086|NCT04752566|582739699|FG001|Overall Study|Physician Decision|1|||
161369087|NCT05134649|582739700|FG000|Overall Study|Lost to Follow-up|12|||
161369088|NCT05134649|582739700|FG000|Overall Study|Withdrawal by Subject|14|||
161369089|NCT05134649|582739700|FG000|Overall Study|Pregnancy|1|||
161369090|NCT05134649|582739700|FG000|Overall Study|Other, not specified|3|||
161369091|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
161369092|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
161369093|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
161369094|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
161369095|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
161369096|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
161369097|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
161369098|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
161369099|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
161369100|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
161369101|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
161369102|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
161369103|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
161369104|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
161369105|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
161369106|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
161369107|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
161369108|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
161369109|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
161369110|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
161369111|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
161369112|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
161369113|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
161369114|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
161369115|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
161369116|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
161369117|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
161369118|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
161369119|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
161369120|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
161369121|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
161369122|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
161369123|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
161369124|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
161369125|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
161369126|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
161369127|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
161369128|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
161369129|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
161369130|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
161369131|NCT04392154|582739703|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
161369132|NCT04392154|582739704|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
161369133|NCT04392154|582739705|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
161369134|NCT04392154|582739706|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
161369135|NCT04392154|582739703|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
161369136|NCT04392154|582739704|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
161369137|NCT04392154|582739705|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
161369138|NCT04392154|582739706|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
161369139|NCT04392154|582739703|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
161369140|NCT04392154|582739704|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
161369141|NCT04392154|582739705|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
161369142|NCT04392154|582739706|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
161369143|NCT04392154|582739703|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
161369144|NCT04392154|582739704|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
161369145|NCT04392154|582739705|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
161369146|NCT04392154|582739706|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
161369147|NCT00023595|582739709|FG000|5 Year Follow up|Lost to Follow-up|2|||
161369148|NCT00023595|582739710|FG001|5 Year Follow up|Lost to Follow-up|2|||
161369149|NCT00023595|582739711|FG002|5 Year Follow up|Lost to Follow-up|1|||
161369150|NCT00023595|582739712|FG003|5 Year Follow up|Lost to Follow-up|7|||
161369151|NCT00023595|582739713|FG004|5 Year Follow up|Lost to Follow-up|3|||
161369152|NCT00023595|582739709|FG000|10 Year Follow up|Lost to Follow-up|12|||
161369153|NCT00023595|582739710|FG001|10 Year Follow up|Lost to Follow-up|10|||
161369154|NCT00023595|582739711|FG002|10 Year Follow up|Lost to Follow-up|3|||
161369155|NCT00023595|582739712|FG003|10 Year Follow up|Lost to Follow-up|0|||
161369156|NCT00023595|582739713|FG004|10 Year Follow up|Lost to Follow-up|0|||
161369157|NCT02231580|582739723|FG000|Overall Study|Adverse Event|5|||
161369158|NCT02231580|582739724|FG001|Overall Study|Adverse Event|0|||
161369159|NCT01380080|582739728|FG000|Overall Study|Death|36|||
161369160|NCT01380080|582739729|FG001|Overall Study|Death|44|||
161369161|NCT01380080|582739728|FG000|Overall Study|Site is closing|28|||
161369162|NCT01380080|582739729|FG001|Overall Study|Site is closing|31|||
161369163|NCT01380080|582739728|FG000|Overall Study|Not able to get to clinic|7|||
161369164|NCT01380080|582739729|FG001|Overall Study|Not able to get to clinic|1|||
161369165|NCT01380080|582739728|FG000|Overall Study|Not willing to adhere to requirements|6|||
161369166|NCT01380080|582739729|FG001|Overall Study|Not willing to adhere to requirements|2|||
161369167|NCT01380080|582739728|FG000|Overall Study|Withdrawal by Subject|5|||
161369168|NCT01380080|582739729|FG001|Overall Study|Withdrawal by Subject|2|||
161369169|NCT01380080|582739728|FG000|Overall Study|Lost to Follow-up|3|||
161369170|NCT01380080|582739729|FG001|Overall Study|Lost to Follow-up|3|||
161369171|NCT05852470|582739733|FG000|Overall Study|Withdrawal by Subject|0|||
161369172|NCT05852470|582739734|FG001|Overall Study|Withdrawal by Subject|1|||
161369173|NCT04144517|582739744|FG000|Overall Study|Physician Decision|0|||
161369174|NCT04144517|582739745|FG001|Overall Study|Physician Decision|1|||
161369175|NCT04144517|582739744|FG000|Overall Study|Other|2|||
161369176|NCT04144517|582739745|FG001|Overall Study|Other|2|||
161369177|NCT04144517|582739744|FG000|Overall Study|Death|6|||
161369178|NCT04144517|582739745|FG001|Overall Study|Death|3|||
161369179|NCT05212168|582739750|FG000|Overall Study|Lost to Follow-up|0|||
161369180|NCT05212168|582739751|FG001|Overall Study|Lost to Follow-up|3|||
161369181|NCT05212168|582739750|FG000|Overall Study|Study terminated by sponsor|30|||
161369182|NCT05212168|582739751|FG001|Overall Study|Study terminated by sponsor|27|||
161369183|NCT05212168|582739750|FG000|Overall Study|Other|4|||
161369184|NCT05212168|582739751|FG001|Overall Study|Other|7|||
161369185|NCT03557502|582739754|FG000|Protocol 2|Withdrawal by Subject|1|||
161369186|NCT03557502|582739755|FG001|Protocol 2|Withdrawal by Subject|1|||
161369187|NCT03557502|582739754|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
161369188|NCT03557502|582739755|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
161369189|NCT02333799|582741956|FG000|Treatment Period|Withdrawal by Subject|1|||
161369190|NCT02333799|582741956|FG000|Treatment Period|Death|6|||
161369191|NCT02333799|582741956|FG000|6 Month Follow Up Period|Physician Decision|1|||
161369192|NCT02333799|582741956|FG000|6 Month Follow Up Period|Death|1|||
161369193|NCT02333799|582741956|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
161369194|NCT02333799|582741956|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
161369195|NCT05847686|582741957|FG000|Overall Study|Withdrawal by Subject|3|||
161369196|NCT03716830|582741958|FG000|Overall Study|Withdrawal by Subject|2|||
161369197|NCT03716830|582741959|FG001|Overall Study|Withdrawal by Subject|2|||
161369198|NCT03716830|582741960|FG002|Overall Study|Withdrawal by Subject|6|||
161369199|NCT03716830|582741961|FG003|Overall Study|Withdrawal by Subject|5|||
161369200|NCT03716830|582741958|FG000|Overall Study|Adverse Event|1|||
161369201|NCT03716830|582741959|FG001|Overall Study|Adverse Event|2|||
161369202|NCT03716830|582741960|FG002|Overall Study|Adverse Event|0|||
161369203|NCT03716830|582741961|FG003|Overall Study|Adverse Event|1|||
161369204|NCT03716830|582741958|FG000|Overall Study|Lost to Follow-up|1|||
161369205|NCT03716830|582741959|FG001|Overall Study|Lost to Follow-up|1|||
161369206|NCT03716830|582741960|FG002|Overall Study|Lost to Follow-up|0|||
161369207|NCT03716830|582741961|FG003|Overall Study|Lost to Follow-up|0|||
161369208|NCT04887831|582741963|FG000|Overall Study|Death|26|||
161369209|NCT04887831|582741964|FG001|Overall Study|Death|26|||
161369210|NCT04887831|582741963|FG000|Overall Study|Lost to Follow-up|0|||
161369211|NCT04887831|582741964|FG001|Overall Study|Lost to Follow-up|1|||
161369212|NCT04887831|582741963|FG000|Overall Study|Withdrawal by Subject|2|||
161369213|NCT04887831|582741964|FG001|Overall Study|Withdrawal by Subject|1|||
161369214|NCT04887831|582741963|FG000|Overall Study|Study Terminated by Sponsor|18|||
161369215|NCT04887831|582741964|FG001|Overall Study|Study Terminated by Sponsor|17|||
161369216|NCT04887831|582741963|FG000|Overall Study|Other|1|||
161369217|NCT04887831|582741964|FG001|Overall Study|Other|0|||
161369218|NCT02276040|582741967|FG000|Overall Study|Physician Decision|15|||
161369219|NCT03674281|582741968|FG000|Overall Study|screen failure|2|||
161369220|NCT03674281|582741969|FG001|Overall Study|screen failure|0|||
161369221|NCT03674281|582741970|FG002|Overall Study|screen failure|0|||
161369222|NCT03674281|582741968|FG000|Overall Study|Withdrawal by Subject|1|||
161369223|NCT03674281|582741969|FG001|Overall Study|Withdrawal by Subject|3|||
161369224|NCT03674281|582741970|FG002|Overall Study|Withdrawal by Subject|3|||
161369225|NCT04622592|582741971|FG000|Overall Study|Death|0|||
161369226|NCT04622592|582741972|FG001|Overall Study|Death|0|||
161369227|NCT04622592|582741973|FG002|Overall Study|Death|1|||
161369228|NCT04622592|582741974|FG003|Overall Study|Death|0|||
161369229|NCT04622592|582741975|FG004|Overall Study|Death|0|||
161369230|NCT04622592|582741976|FG005|Overall Study|Death|0|||
161369231|NCT04622592|582741977|FG006|Overall Study|Death|0|||
161369232|NCT04622592|582741978|FG007|Overall Study|Death|1|||
161369233|NCT04622592|582741971|FG000|Overall Study|Lost to Follow-up|0|||
161369234|NCT04622592|582741972|FG001|Overall Study|Lost to Follow-up|0|||
161369235|NCT04622592|582741973|FG002|Overall Study|Lost to Follow-up|0|||
161369236|NCT04622592|582741974|FG003|Overall Study|Lost to Follow-up|3|||
161369237|NCT04622592|582741975|FG004|Overall Study|Lost to Follow-up|1|||
161369238|NCT04622592|582741976|FG005|Overall Study|Lost to Follow-up|0|||
161369239|NCT04622592|582741977|FG006|Overall Study|Lost to Follow-up|2|||
161369240|NCT04622592|582741978|FG007|Overall Study|Lost to Follow-up|2|||
161369241|NCT04622592|582741971|FG000|Overall Study|Physician Decision|0|||
161369242|NCT04622592|582741972|FG001|Overall Study|Physician Decision|0|||
161369243|NCT04622592|582741973|FG002|Overall Study|Physician Decision|0|||
161369244|NCT04622592|582741974|FG003|Overall Study|Physician Decision|0|||
161369245|NCT04622592|582741975|FG004|Overall Study|Physician Decision|1|||
161369246|NCT04622592|582741976|FG005|Overall Study|Physician Decision|0|||
161369247|NCT04622592|582741977|FG006|Overall Study|Physician Decision|0|||
161369248|NCT04622592|582741978|FG007|Overall Study|Physician Decision|0|||
161369249|NCT04622592|582741971|FG000|Overall Study|Withdrawal by Subject|1|||
161369250|NCT04622592|582741972|FG001|Overall Study|Withdrawal by Subject|0|||
161369251|NCT04622592|582741973|FG002|Overall Study|Withdrawal by Subject|2|||
161369252|NCT04622592|582741974|FG003|Overall Study|Withdrawal by Subject|0|||
161369253|NCT04622592|582741975|FG004|Overall Study|Withdrawal by Subject|0|||
161369254|NCT04622592|582741976|FG005|Overall Study|Withdrawal by Subject|0|||
161369255|NCT04622592|582741977|FG006|Overall Study|Withdrawal by Subject|1|||
161369256|NCT04622592|582741978|FG007|Overall Study|Withdrawal by Subject|4|||
161369257|NCT04622592|582741971|FG000|Overall Study|Other than specified above|0|||
161369258|NCT04622592|582741972|FG001|Overall Study|Other than specified above|0|||
161369259|NCT04622592|582741973|FG002|Overall Study|Other than specified above|1|||
161369260|NCT04622592|582741974|FG003|Overall Study|Other than specified above|0|||
161369261|NCT04622592|582741975|FG004|Overall Study|Other than specified above|0|||
161369262|NCT04622592|582741976|FG005|Overall Study|Other than specified above|0|||
161369263|NCT04622592|582741977|FG006|Overall Study|Other than specified above|0|||
161369264|NCT04622592|582741978|FG007|Overall Study|Other than specified above|0|||
161369265|NCT00276419|582741981|FG000|First Intervention|Adverse Event|1|||
161369266|NCT00276419|582741982|FG001|First Intervention|Adverse Event|0|||
161369267|NCT00276419|582741981|FG000|First Intervention|Withdrawal by Subject|0|||
161369268|NCT00276419|582741982|FG001|First Intervention|Withdrawal by Subject|2|||
161369269|NCT01645176|582741987|FG000|Overall Study|Lack of Efficacy|4|||
161369270|NCT01645176|582741987|FG000|Overall Study|did not complete final MRI|1|||
161369271|NCT02569853|582741988|FG000|Overall Study|Adverse Event|2|||
161369272|NCT02569853|582741989|FG001|Overall Study|Adverse Event|0|||
161369273|NCT02569853|582741988|FG000|Overall Study|Withdrawal by Subject|3|||
161369274|NCT02569853|582741989|FG001|Overall Study|Withdrawal by Subject|2|||
161369275|NCT02569853|582741988|FG000|Overall Study|Lost to Follow-up|3|||
161369276|NCT02569853|582741989|FG001|Overall Study|Lost to Follow-up|3|||
161369277|NCT02569853|582741988|FG000|Overall Study|Protocol Violation|1|||
161369278|NCT02569853|582741989|FG001|Overall Study|Protocol Violation|1|||
161369279|NCT02569853|582741988|FG000|Overall Study|Did not experience migraine attack|10|||
161369280|NCT02569853|582741989|FG001|Overall Study|Did not experience migraine attack|7|||
161369281|NCT02569853|582741988|FG000|Overall Study|Physician Decision|1|||
161369282|NCT02569853|582741989|FG001|Overall Study|Physician Decision|1|||
161369283|NCT00402987|582741990|FG000|Overall Study|Lack of Efficacy|0|||
161369284|NCT00402987|582741991|FG001|Overall Study|Lack of Efficacy|0|||
161369285|NCT00402987|582741992|FG002|Overall Study|Lack of Efficacy|1|||
161369286|NCT00402987|582741993|FG003|Overall Study|Lack of Efficacy|0|||
161369287|NCT01668004|582741994|FG000|Overall Study|Adverse Event|7|||
161369288|NCT01668004|582741994|FG000|Overall Study|Withdrawal by Subject|2|||
161369289|NCT01668004|582741994|FG000|Overall Study|Lost to Follow-up|5|||
161369290|NCT01668004|582741994|FG000|Overall Study|Lack of Efficacy|9|||
161369291|NCT01668004|582741994|FG000|Overall Study|Non-compliance with treatment|2|||
161369292|NCT02448381|582741996|FG000|Overall Study|Adverse Event|2|||
161369293|NCT02448381|582741997|FG001|Overall Study|Adverse Event|0|||
161369294|NCT02448381|582741996|FG000|Overall Study|Lost to Follow-up|16|||
161369295|NCT02448381|582741997|FG001|Overall Study|Lost to Follow-up|9|||
161369296|NCT02448381|582741996|FG000|Overall Study|Physician Decision|1|||
161369297|NCT02448381|582741997|FG001|Overall Study|Physician Decision|1|||
161369298|NCT02448381|582741996|FG000|Overall Study|Pregnancy|1|||
161369299|NCT02448381|582741997|FG001|Overall Study|Pregnancy|0|||
161369300|NCT02448381|582741996|FG000|Overall Study|Withdrawal by Subject|13|||
161369301|NCT02448381|582741997|FG001|Overall Study|Withdrawal by Subject|9|||
161369302|NCT02448381|582741996|FG000|Overall Study|Noncompliance with Study Procedures|2|||
161369303|NCT02448381|582741997|FG001|Overall Study|Noncompliance with Study Procedures|0|||
161369304|NCT02300233|582742003|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
161369305|NCT02300233|582742004|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161369306|NCT02300233|582742005|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
161369307|NCT02300233|582742003|FG000|Overall Study|Withdrawal by Subject|1|||
161369308|NCT02300233|582742004|FG001|Overall Study|Withdrawal by Subject|0|||
161369309|NCT02300233|582742005|FG002|Overall Study|Withdrawal by Subject|3|||
161369310|NCT02300233|582742003|FG000|Overall Study|Investigator Judgement|0|||
161369311|NCT02300233|582742004|FG001|Overall Study|Investigator Judgement|0|||
161369312|NCT02300233|582742005|FG002|Overall Study|Investigator Judgement|1|||
161369313|NCT02300233|582742003|FG000|Overall Study|Reason Not Specified|0|||
161369314|NCT02300233|582742004|FG001|Overall Study|Reason Not Specified|0|||
161369315|NCT02300233|582742005|FG002|Overall Study|Reason Not Specified|5|||
161369316|NCT00833690|582742006|FG000|Overall Study|Withdrawal by Subject|1|||
161369317|NCT00833690|582742007|FG001|Overall Study|Withdrawal by Subject|0|||
161369318|NCT00833690|582742008|FG002|Overall Study|Withdrawal by Subject|0|||
161369319|NCT00833690|582742006|FG000|Overall Study|Discontinued study drug|3|||
161369320|NCT00833690|582742007|FG001|Overall Study|Discontinued study drug|2|||
161369321|NCT00833690|582742008|FG002|Overall Study|Discontinued study drug|0|||
161369322|NCT00744861|582742009|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
161369323|NCT00744861|582742010|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
161369324|NCT00744861|582742011|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
161369325|NCT00744861|582742012|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
161369326|NCT00744861|582742009|FG000|Feasibility Stage 1|Pregnancy|0|||
161369327|NCT00744861|582742010|FG001|Feasibility Stage 1|Pregnancy|1|||
161369328|NCT00744861|582742011|FG002|Feasibility Stage 1|Pregnancy|0|||
161369329|NCT00744861|582742012|FG003|Feasibility Stage 1|Pregnancy|0|||
161369330|NCT00744861|582742009|FG000|Pivotal Stage 2|Adverse Event|0|||
161369331|NCT00744861|582742010|FG001|Pivotal Stage 2|Adverse Event|0|||
161369332|NCT00744861|582742011|FG002|Pivotal Stage 2|Adverse Event|6|||
161369333|NCT00744861|582742012|FG003|Pivotal Stage 2|Adverse Event|11|||
161369334|NCT00744861|582742009|FG000|Pivotal Stage 2|Death|0|||
161369335|NCT00744861|582742010|FG001|Pivotal Stage 2|Death|0|||
161369336|NCT00744861|582742011|FG002|Pivotal Stage 2|Death|0|||
161369337|NCT00744861|582742012|FG003|Pivotal Stage 2|Death|1|||
161369338|NCT00744861|582742009|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
161369339|NCT00744861|582742010|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
161369340|NCT00744861|582742011|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
161369341|NCT00744861|582742012|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
161369342|NCT00744861|582742009|FG000|Pivotal Stage 2|Physician Decision|0|||
161369343|NCT00744861|582742010|FG001|Pivotal Stage 2|Physician Decision|0|||
161369344|NCT00744861|582742011|FG002|Pivotal Stage 2|Physician Decision|3|||
161369345|NCT00744861|582742012|FG003|Pivotal Stage 2|Physician Decision|1|||
161369346|NCT00744861|582742009|FG000|Pivotal Stage 2|Protocol Violation|0|||
161369347|NCT00744861|582742010|FG001|Pivotal Stage 2|Protocol Violation|0|||
161369348|NCT00744861|582742011|FG002|Pivotal Stage 2|Protocol Violation|0|||
161369349|NCT00744861|582742012|FG003|Pivotal Stage 2|Protocol Violation|1|||
161369350|NCT00744861|582742009|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
161369351|NCT00744861|582742010|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
161369352|NCT00744861|582742011|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
161369353|NCT00744861|582742012|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
161369354|NCT00744861|582742009|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
161369355|NCT00744861|582742010|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
161369356|NCT00744861|582742011|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
161369357|NCT00744861|582742012|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
161369358|NCT04856527|582742013|FG000|Overall Study|Unable to complete experimental task|2|||
161369359|NCT04856527|582742014|FG001|Overall Study|Unable to complete experimental task|0|||
161369360|NCT02115321|582742015|FG000|Overall Study|Death|1|||
161369361|NCT02115321|582742016|FG001|Overall Study|Death|0|||
161369362|NCT04403919|582742019|FG000|Overall Study|Lost to Follow-up|0|||
161369363|NCT04403919|582742020|FG001|Overall Study|Lost to Follow-up|0|||
161369364|NCT04403919|582742021|FG002|Overall Study|Lost to Follow-up|0|||
161369365|NCT04403919|582742022|FG003|Overall Study|Lost to Follow-up|1|||
161369366|NCT02038647|582742024|FG000|Overall Study|Progressive Disease|50|||
161369367|NCT02038647|582742025|FG001|Overall Study|Progressive Disease|59|||
161369368|NCT02038647|582742024|FG000|Overall Study|Adverse Event|18|||
161369369|NCT02038647|582742025|FG001|Overall Study|Adverse Event|10|||
161369370|NCT02038647|582742024|FG000|Overall Study|Symptomatic Deterioration|7|||
161369371|NCT02038647|582742025|FG001|Overall Study|Symptomatic Deterioration|7|||
161369372|NCT02038647|582742024|FG000|Overall Study|Withdrawal by Subject|5|||
161369373|NCT02038647|582742025|FG001|Overall Study|Withdrawal by Subject|2|||
161369374|NCT02038647|582742024|FG000|Overall Study|Not Reported|0|||
161369375|NCT02038647|582742025|FG001|Overall Study|Not Reported|1|||
161369376|NCT02038647|582742024|FG000|Overall Study|Ongoing at Datacut|9|||
161369377|NCT02038647|582742025|FG001|Overall Study|Ongoing at Datacut|10|||
161369378|NCT02757430|582742026|FG000|Overall Study|Physician Decision|6|||
161369379|NCT02757430|582742026|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
161369380|NCT02757430|582742026|FG000|Overall Study|No informed consent|1|||
161369381|NCT02757430|582742026|FG000|Overall Study|No procedure performed|2|||
161369382|NCT01983111|582742027|FG000|Overall Study|Withdrawal by Subject|8|||
161369383|NCT01983111|582742028|FG001|Overall Study|Withdrawal by Subject|6|||
161369384|NCT01983111|582742027|FG000|Overall Study|Adverse Event|4|||
161369385|NCT01983111|582742028|FG001|Overall Study|Adverse Event|0|||
161369386|NCT01983111|582742027|FG000|Overall Study|Protocol Violation|0|||
161369387|NCT01983111|582742028|FG001|Overall Study|Protocol Violation|1|||
161369388|NCT03502200|582742029|FG000|Overall Study|Adverse Event|1|||
161369389|NCT03502200|582742030|FG001|Overall Study|Adverse Event|0|||
161369390|NCT03502200|582742029|FG000|Overall Study|Lost to Follow-up|36|||
161369391|NCT03502200|582742030|FG001|Overall Study|Lost to Follow-up|38|||
161369392|NCT03502200|582742029|FG000|Overall Study|Study Team Decision|1|||
161369393|NCT03502200|582742030|FG001|Overall Study|Study Team Decision|1|||
161369394|NCT03502200|582742029|FG000|Overall Study|Withdrawal by Subject|5|||
161369395|NCT03502200|582742030|FG001|Overall Study|Withdrawal by Subject|7|||
161369396|NCT03502200|582742029|FG000|Overall Study|Death|0|||
161369397|NCT03502200|582742030|FG001|Overall Study|Death|2|||
161369398|NCT00855335|582742031|FG000|Overall Study|Lost to Follow-up|0|||
161369399|NCT00855335|582742032|FG001|Overall Study|Lost to Follow-up|0|||
161369400|NCT00855335|582742033|FG002|Overall Study|Lost to Follow-up|3|||
161369401|NCT00855335|582742034|FG003|Overall Study|Lost to Follow-up|1|||
161369402|NCT00855335|582742035|FG004|Overall Study|Lost to Follow-up|0|||
161369403|NCT00855335|582742031|FG000|Overall Study|Withdrawal by Subject|0|||
161369404|NCT00855335|582742032|FG001|Overall Study|Withdrawal by Subject|0|||
161369405|NCT00855335|582742033|FG002|Overall Study|Withdrawal by Subject|0|||
161369406|NCT00855335|582742034|FG003|Overall Study|Withdrawal by Subject|1|||
161369407|NCT00855335|582742035|FG004|Overall Study|Withdrawal by Subject|0|||
161369408|NCT00855335|582742031|FG000|Overall Study|Adverse Event|2|||
161369409|NCT00855335|582742032|FG001|Overall Study|Adverse Event|0|||
161369410|NCT00855335|582742033|FG002|Overall Study|Adverse Event|0|||
161369411|NCT00855335|582742034|FG003|Overall Study|Adverse Event|0|||
161369412|NCT00855335|582742035|FG004|Overall Study|Adverse Event|0|||
161369413|NCT00855335|582742031|FG000|Overall Study|Physician Decision|1|||
161369414|NCT00855335|582742032|FG001|Overall Study|Physician Decision|1|||
161369415|NCT00855335|582742033|FG002|Overall Study|Physician Decision|0|||
161369416|NCT00855335|582742034|FG003|Overall Study|Physician Decision|0|||
161369417|NCT00855335|582742035|FG004|Overall Study|Physician Decision|0|||
161369418|NCT00855335|582742031|FG000|Overall Study|Other|2|||
161369419|NCT00855335|582742032|FG001|Overall Study|Other|1|||
161369420|NCT00855335|582742033|FG002|Overall Study|Other|2|||
161369421|NCT00855335|582742034|FG003|Overall Study|Other|5|||
161369422|NCT00855335|582742035|FG004|Overall Study|Other|1|||
161369423|NCT03097289|582742037|FG000|Overall Study|Adverse Event|1|||
161369424|NCT03097289|582742037|FG000|Overall Study|Equipment failure|2|||
161369425|NCT03097289|582742037|FG000|Overall Study|Collected platelet product unusable|3|||
161369426|NCT02526290|582742040|FG000|Overall Study|Adverse Event|3|||
161369427|NCT02526290|582742040|FG000|Overall Study|Withdrawal by Subject|4|||
161369428|NCT02526290|582742040|FG000|Overall Study|Physician Decision|1|||
161369429|NCT00049543|582742043|FG000|Overall Study|still on treatment|2|||
161369430|NCT00049543|582742044|FG001|Overall Study|still on treatment|9|||
161369431|NCT02106832|582742045|FG000|Overall Study|Adverse Event|1|||
161369432|NCT02106832|582742046|FG001|Overall Study|Adverse Event|2|||
161369433|NCT02106832|582742047|FG002|Overall Study|Adverse Event|3|||
161369434|NCT02106832|582742048|FG003|Overall Study|Adverse Event|0|||
161369435|NCT02106832|582742045|FG000|Overall Study|Death|4|||
161369436|NCT02106832|582742046|FG001|Overall Study|Death|4|||
161369437|NCT02106832|582742047|FG002|Overall Study|Death|1|||
161369438|NCT02106832|582742048|FG003|Overall Study|Death|4|||
161369439|NCT02106832|582742045|FG000|Overall Study|Deterioration of general conditions|0|||
161369440|NCT02106832|582742046|FG001|Overall Study|Deterioration of general conditions|0|||
161369441|NCT02106832|582742047|FG002|Overall Study|Deterioration of general conditions|1|||
161369442|NCT02106832|582742048|FG003|Overall Study|Deterioration of general conditions|0|||
161369443|NCT02106832|582742045|FG000|Overall Study|Lost to Follow-up|0|||
161369444|NCT02106832|582742046|FG001|Overall Study|Lost to Follow-up|1|||
161369445|NCT02106832|582742047|FG002|Overall Study|Lost to Follow-up|1|||
161369446|NCT02106832|582742048|FG003|Overall Study|Lost to Follow-up|3|||
161369447|NCT02106832|582742045|FG000|Overall Study|Physician Decision|1|||
161369448|NCT02106832|582742046|FG001|Overall Study|Physician Decision|0|||
161369449|NCT02106832|582742047|FG002|Overall Study|Physician Decision|0|||
161369450|NCT02106832|582742048|FG003|Overall Study|Physician Decision|0|||
161369451|NCT02106832|582742045|FG000|Overall Study|Protocol Violation|0|||
161369452|NCT02106832|582742046|FG001|Overall Study|Protocol Violation|0|||
161369453|NCT02106832|582742047|FG002|Overall Study|Protocol Violation|0|||
161369454|NCT02106832|582742048|FG003|Overall Study|Protocol Violation|1|||
161369455|NCT02106832|582742045|FG000|Overall Study|Withdrawal by Subject|17|||
161369456|NCT02106832|582742046|FG001|Overall Study|Withdrawal by Subject|17|||
161369457|NCT02106832|582742047|FG002|Overall Study|Withdrawal by Subject|10|||
161369458|NCT02106832|582742048|FG003|Overall Study|Withdrawal by Subject|7|||
161369459|NCT02106832|582742045|FG000|Overall Study|Technical problems|0|||
161369460|NCT02106832|582742046|FG001|Overall Study|Technical problems|1|||
161369461|NCT02106832|582742047|FG002|Overall Study|Technical problems|0|||
161369462|NCT02106832|582742048|FG003|Overall Study|Technical problems|0|||
161369463|NCT04716894|582742065|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
161369464|NCT04716894|582742065|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
161369465|NCT01467466|582742074|FG000|Overall Study|Withdrawal by Subject|15|||
161369466|NCT01467466|582742075|FG001|Overall Study|Withdrawal by Subject|18|||
161369467|NCT01467466|582742076|FG002|Overall Study|Withdrawal by Subject|13|||
161369468|NCT01467466|582742077|FG003|Overall Study|Withdrawal by Subject|11|||
161369469|NCT01467466|582742074|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
161369470|NCT01467466|582742075|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
161369471|NCT01467466|582742076|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
161369472|NCT01467466|582742077|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
161369473|NCT01467466|582742074|FG000|Overall Study|Procedure Cancelled|46|||
161369474|NCT01467466|582742075|FG001|Overall Study|Procedure Cancelled|45|||
161369475|NCT01467466|582742076|FG002|Overall Study|Procedure Cancelled|25|||
161369476|NCT01467466|582742077|FG003|Overall Study|Procedure Cancelled|29|||
161369477|NCT01467466|582742074|FG000|Overall Study|No Endpoint Blood Draw|38|||
161369478|NCT01467466|582742075|FG001|Overall Study|No Endpoint Blood Draw|32|||
161369479|NCT01467466|582742076|FG002|Overall Study|No Endpoint Blood Draw|51|||
161369480|NCT01467466|582742077|FG003|Overall Study|No Endpoint Blood Draw|43|||
161369481|NCT00787150|582742078|FG000|Overall Study|Adverse Event|4|||
161369482|NCT00787150|582742079|FG001|Overall Study|Adverse Event|4|||
161369483|NCT00787150|582742080|FG002|Overall Study|Adverse Event|4|||
161369484|NCT00787150|582742078|FG000|Overall Study|Physician Decision|1|||
161369485|NCT00787150|582742079|FG001|Overall Study|Physician Decision|2|||
161369486|NCT00787150|582742080|FG002|Overall Study|Physician Decision|1|||
161369487|NCT00787150|582742078|FG000|Overall Study|Withdrawal by Subject|2|||
161369488|NCT00787150|582742079|FG001|Overall Study|Withdrawal by Subject|1|||
161369489|NCT00787150|582742080|FG002|Overall Study|Withdrawal by Subject|0|||
161369490|NCT00787150|582742078|FG000|Overall Study|Dosing incorrect study durg|2|||
161369491|NCT00787150|582742079|FG001|Overall Study|Dosing incorrect study durg|0|||
161369492|NCT00787150|582742080|FG002|Overall Study|Dosing incorrect study durg|0|||
161369493|NCT00982280|582742085|FG000|Observation Period|Not eligible to be dosed|19|||
161369494|NCT00982280|582742085|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
161369495|NCT00982280|582742085|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
161369496|NCT00982280|582742085|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
161369497|NCT00982280|582742085|FG000|Maintenance Period|Adverse Event|1|||
161369498|NCT06028464|582742087|FG000|Washout|Positive drug test.|1|||
161369499|NCT03330847|582742088|FG000|Overall Study|Patients ongoing study|62|||
161369500|NCT03330847|582742089|FG001|Overall Study|Patients ongoing study|65|||
161369501|NCT03330847|582742090|FG002|Overall Study|Patients ongoing study|15|||
161369502|NCT00618787|582742097|FG000|Overall Study|Adverse Event|0|||
161369503|NCT00618787|582742098|FG001|Overall Study|Adverse Event|1|||
161369504|NCT00618787|582742097|FG000|Overall Study|Withdrawal by Subject|2|||
161369505|NCT00618787|582742098|FG001|Overall Study|Withdrawal by Subject|1|||
161369506|NCT00618787|582742097|FG000|Overall Study|Lost to Follow-up|1|||
161369507|NCT00618787|582742098|FG001|Overall Study|Lost to Follow-up|0|||
161369508|NCT01107886|582742099|FG000|Overall Study|Lost to Follow-up|15|||
161369509|NCT01107886|582742100|FG001|Overall Study|Lost to Follow-up|13|||
161369510|NCT01107886|582742099|FG000|Overall Study|Withdrawal by Subject|180|||
161369511|NCT01107886|582742100|FG001|Overall Study|Withdrawal by Subject|196|||
161369512|NCT01107886|582742099|FG000|Overall Study|Administrative withdrawal of consent|7|||
161369513|NCT01107886|582742100|FG001|Overall Study|Administrative withdrawal of consent|5|||
161369514|NCT01346176|582742101|FG000|Recruited|Protocol Violation|1|||
161369515|NCT01346176|582742102|FG001|Recruited|Protocol Violation|0|||
161369516|NCT01346176|582742103|FG002|Recruited|Protocol Violation|0|||
161369517|NCT01346176|582742101|FG000|Completed Advance Directive|Death|3|||
161369518|NCT01346176|582742102|FG001|Completed Advance Directive|Death|2|||
161369519|NCT01346176|582742103|FG002|Completed Advance Directive|Death|2|||
161369520|NCT01346176|582742101|FG000|Completed Advance Directive|Became Ineligible|3|||
161369521|NCT01346176|582742102|FG001|Completed Advance Directive|Became Ineligible|0|||
161369522|NCT01346176|582742103|FG002|Completed Advance Directive|Became Ineligible|1|||
161369523|NCT01346176|582742101|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
161369524|NCT01346176|582742102|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
161369525|NCT01346176|582742103|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
161369526|NCT01346176|582742101|FG000|Completed Satisfaction Survey|Death|3|||
161369527|NCT01346176|582742102|FG001|Completed Satisfaction Survey|Death|0|||
161369528|NCT01346176|582742103|FG002|Completed Satisfaction Survey|Death|2|||
161369529|NCT01346176|582742101|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
161369530|NCT01346176|582742102|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
161369531|NCT01346176|582742103|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
161369532|NCT01994876|582742104|FG000|Test Period 1|Withdrawal by Subject|0|||
161369533|NCT01994876|582742105|FG001|Test Period 1|Withdrawal by Subject|1|||
161369534|NCT01994876|582742104|FG000|Test Period 1|Adverse Event|0|||
161369535|NCT01994876|582742105|FG001|Test Period 1|Adverse Event|1|||
161369536|NCT01994876|582742104|FG000|Test Period 2|Adverse Event|1|||
161369537|NCT01994876|582742105|FG001|Test Period 2|Adverse Event|0|||
161369538|NCT01994876|582742104|FG000|Test Period 2|Protocol Violation|0|||
161369539|NCT01994876|582742105|FG001|Test Period 2|Protocol Violation|1|||
161369540|NCT05819398|582742106|FG000|Overall Study|Withdrawal by Subject|11|||
161369541|NCT05819398|582742107|FG001|Overall Study|Withdrawal by Subject|7|||
161369542|NCT05819398|582742108|FG002|Overall Study|Withdrawal by Subject|6|||
161369543|NCT05819398|582742109|FG003|Overall Study|Withdrawal by Subject|6|||
161369544|NCT05819398|582742106|FG000|Overall Study|Lost to Follow-up|0|||
161369545|NCT05819398|582742107|FG001|Overall Study|Lost to Follow-up|2|||
161369546|NCT05819398|582742108|FG002|Overall Study|Lost to Follow-up|0|||
161369547|NCT05819398|582742109|FG003|Overall Study|Lost to Follow-up|1|||
161369548|NCT05819398|582742106|FG000|Overall Study|Adverse Event|1|||
161369549|NCT05819398|582742107|FG001|Overall Study|Adverse Event|3|||
161369550|NCT05819398|582742108|FG002|Overall Study|Adverse Event|4|||
161369551|NCT05819398|582742109|FG003|Overall Study|Adverse Event|5|||
161369552|NCT05819398|582742106|FG000|Overall Study|Other than listed|0|||
161369553|NCT05819398|582742107|FG001|Overall Study|Other than listed|2|||
161369554|NCT05819398|582742108|FG002|Overall Study|Other than listed|2|||
161369555|NCT05819398|582742109|FG003|Overall Study|Other than listed|0|||
161369556|NCT05819398|582742106|FG000|Overall Study|Lack of Efficacy|0|||
161369557|NCT05819398|582742107|FG001|Overall Study|Lack of Efficacy|1|||
161369558|NCT05819398|582742108|FG002|Overall Study|Lack of Efficacy|0|||
161369559|NCT05819398|582742109|FG003|Overall Study|Lack of Efficacy|0|||
161369560|NCT05819398|582742106|FG000|Overall Study|Study terminated by sponsor|20|||
161369561|NCT05819398|582742107|FG001|Overall Study|Study terminated by sponsor|18|||
161369562|NCT05819398|582742108|FG002|Overall Study|Study terminated by sponsor|20|||
161369563|NCT05819398|582742109|FG003|Overall Study|Study terminated by sponsor|22|||
161369564|NCT02520154|582742110|FG000|Overall Study|Death|1|||
161369565|NCT02520154|582742110|FG000|Overall Study|Withdrawal by Subject|2|||
161369566|NCT02520154|582742110|FG000|Overall Study|Physician Decision|2|||
161369567|NCT06022107|582742111|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
161369568|NCT06022107|582742111|FG000|Overall Study|Dropped out of study for higher level of care|1|||
161369569|NCT06022107|582742111|FG000|Overall Study|Lost to Follow-up|2|||
161369570|NCT05943990|582742116|FG000|Overall Study|Study Terminated by Sponsor|0|||
161369571|NCT05943990|582742117|FG001|Overall Study|Study Terminated by Sponsor|0|||
161369572|NCT05943990|582742118|FG002|Overall Study|Study Terminated by Sponsor|1|||
161369573|NCT02581930|582742119|FG000|Overall Study|Withdrawal by Subject|1|||
161369574|NCT02581930|582742119|FG000|Overall Study|patient declined further treatment|1|||
161369575|NCT02776735|582742120|FG000|Overall Study|Adverse Event|0|||
161369576|NCT02776735|582742121|FG001|Overall Study|Adverse Event|0|||
161369577|NCT02776735|582742122|FG002|Overall Study|Adverse Event|0|||
161369578|NCT02776735|582742123|FG003|Overall Study|Adverse Event|1|||
161369579|NCT02776735|582742124|FG004|Overall Study|Adverse Event|0|||
161369580|NCT02776735|582742125|FG005|Overall Study|Adverse Event|1|||
161369581|NCT02776735|582742120|FG000|Overall Study|Lost to Follow-up|0|||
161369582|NCT02776735|582742121|FG001|Overall Study|Lost to Follow-up|0|||
161369583|NCT02776735|582742122|FG002|Overall Study|Lost to Follow-up|0|||
161369584|NCT02776735|582742123|FG003|Overall Study|Lost to Follow-up|1|||
161369585|NCT02776735|582742124|FG004|Overall Study|Lost to Follow-up|0|||
161369586|NCT02776735|582742125|FG005|Overall Study|Lost to Follow-up|0|||
161369587|NCT02776735|582742120|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161369588|NCT02776735|582742121|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161369589|NCT02776735|582742122|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161369590|NCT02776735|582742123|FG003|Overall Study|Withdrawal by parent/guardian|2|||
161369591|NCT02776735|582742124|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161369592|NCT02776735|582742125|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161369593|NCT02776735|582742120|FG000|Overall Study|Withdrawal by Subject|1|||
161369594|NCT02776735|582742121|FG001|Overall Study|Withdrawal by Subject|0|||
161369595|NCT02776735|582742122|FG002|Overall Study|Withdrawal by Subject|0|||
161369596|NCT02776735|582742123|FG003|Overall Study|Withdrawal by Subject|0|||
161369597|NCT02776735|582742124|FG004|Overall Study|Withdrawal by Subject|0|||
161369598|NCT02776735|582742125|FG005|Overall Study|Withdrawal by Subject|1|||
161369599|NCT02776735|582742120|FG000|Overall Study|Other|0|||
161369600|NCT02776735|582742121|FG001|Overall Study|Other|0|||
161369601|NCT02776735|582742122|FG002|Overall Study|Other|3|||
161369602|NCT02776735|582742123|FG003|Overall Study|Other|0|||
161369603|NCT02776735|582742124|FG004|Overall Study|Other|0|||
161369604|NCT02776735|582742125|FG005|Overall Study|Other|0|||
161369605|NCT00560508|582743433|FG000|12 Week Double-blind Period|Adverse Event|3|||
161369606|NCT00560508|582743434|FG001|12 Week Double-blind Period|Adverse Event|2|||
161369607|NCT00560508|582743433|FG000|12 Week Double-blind Period|Protocol Violation|1|||
161369608|NCT00560508|582743434|FG001|12 Week Double-blind Period|Protocol Violation|0|||
161369609|NCT00560508|582743433|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
161369610|NCT00560508|582743434|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
161369611|NCT00560508|582743433|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
161369612|NCT00560508|582743434|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
161369613|NCT00560508|582743433|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
161369614|NCT00560508|582743434|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
161369615|NCT00560508|582743433|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
161369616|NCT00560508|582743434|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
161369617|NCT00560508|582743433|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
161369618|NCT00560508|582743434|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
161369619|NCT03493958|582743435|FG000|Overall Study|Withdrawal by Subject|6|||
161369620|NCT03493958|582743435|FG000|Overall Study|Lost to Follow-up|7|||
161369621|NCT03493958|582743435|FG000|Overall Study|Did not complete all required study procedures|2|||
161369622|NCT02367456|582743436|FG000|Overall Study|Death|8|||
161369623|NCT02367456|582743437|FG001|Overall Study|Death|24|||
161369624|NCT02367456|582743438|FG002|Overall Study|Death|17|||
161369625|NCT02367456|582743436|FG000|Overall Study|Lost to Follow-up|1|||
161369626|NCT02367456|582743437|FG001|Overall Study|Lost to Follow-up|3|||
161369627|NCT02367456|582743438|FG002|Overall Study|Lost to Follow-up|1|||
161369628|NCT02367456|582743436|FG000|Overall Study|Other reason|3|||
161369629|NCT02367456|582743437|FG001|Overall Study|Other reason|3|||
161369630|NCT02367456|582743438|FG002|Overall Study|Other reason|9|||
161369631|NCT02367456|582743436|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
161369632|NCT02367456|582743437|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
161369633|NCT02367456|582743438|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
161369634|NCT04617860|582743440|FG000|Overall Study|Adverse Event|0|||
161369635|NCT04617860|582743441|FG001|Overall Study|Adverse Event|2|||
161369636|NCT04617860|582743442|FG002|Overall Study|Adverse Event|2|||
161369637|NCT04617860|582743440|FG000|Overall Study|Withdrawal by Subject|0|||
161369638|NCT04617860|582743441|FG001|Overall Study|Withdrawal by Subject|0|||
161369639|NCT04617860|582743442|FG002|Overall Study|Withdrawal by Subject|2|||
161369640|NCT04617860|582743440|FG000|Overall Study|Physician Decision|0|||
161369641|NCT04617860|582743441|FG001|Overall Study|Physician Decision|1|||
161369642|NCT04617860|582743442|FG002|Overall Study|Physician Decision|0|||
161369643|NCT04617860|582743440|FG000|Overall Study|Sponsor Decision|0|||
161369644|NCT04617860|582743441|FG001|Overall Study|Sponsor Decision|3|||
161369645|NCT04617860|582743442|FG002|Overall Study|Sponsor Decision|1|||
161369646|NCT04617860|582743440|FG000|Overall Study|Termination of Study by Sponsor|8|||
161369647|NCT04617860|582743441|FG001|Overall Study|Termination of Study by Sponsor|4|||
161369648|NCT04617860|582743442|FG002|Overall Study|Termination of Study by Sponsor|13|||
161369649|NCT02735200|582743447|FG000|Overall Study|Lost to Follow-up|0|||
161369650|NCT02735200|582743448|FG001|Overall Study|Lost to Follow-up|5|||
161369651|NCT02735200|582743447|FG000|Overall Study|Withdrawal by Subject|8|||
161369652|NCT02735200|582743448|FG001|Overall Study|Withdrawal by Subject|0|||
161369653|NCT01493414|582743451|FG000|Overall Study|Adverse Event|405|||
161369654|NCT01493414|582743451|FG000|Overall Study|Disease progression|204|||
161369655|NCT01493414|582743451|FG000|Overall Study|Death|101|||
161369656|NCT01493414|582743451|FG000|Overall Study|Physician Decision|93|||
161369657|NCT01493414|582743451|FG000|Overall Study|Withdrawal by Subject|79|||
161369658|NCT01493414|582743451|FG000|Overall Study|Protocol deviation|27|||
161369659|NCT01493414|582743451|FG000|Overall Study|Administrative problems|25|||
161369660|NCT01493414|582743451|FG000|Overall Study|Lost to Follow-up|16|||
161369661|NCT05448950|582743462|FG000|Overall Study|Death|2|||
161369662|NCT05448950|582743462|FG000|Overall Study|Withdrawal by Subject|1|||
161369663|NCT05448950|582743462|FG000|Overall Study|AVG abandoned|4|||
161369664|NCT02706392|582743480|FG000|Overall Study|Death|1|||
161369665|NCT02706392|582743481|FG001|Overall Study|Death|0|||
161369666|NCT02706392|582743482|FG002|Overall Study|Death|2|||
161369667|NCT02706392|582743483|FG003|Overall Study|Death|2|||
161369668|NCT02706392|582743484|FG004|Overall Study|Death|5|||
161369669|NCT02706392|582743485|FG005|Overall Study|Death|2|||
161369670|NCT00619866|582743488|FG000|Weeks 1 - 12|Adverse Event|0|||
161369671|NCT00619866|582743489|FG001|Weeks 1 - 12|Adverse Event|1|||
161369672|NCT00619866|582743490|FG002|Weeks 1 - 12|Adverse Event|2|||
161369673|NCT00619866|582743491|FG003|Weeks 1 - 12|Adverse Event|0|||
161369674|NCT00619866|582743492|FG004|Weeks 1 - 12|Adverse Event|0|||
161369675|NCT00619866|582743488|FG000|Weeks 1 - 12|Non-compliance|0|||
161369676|NCT00619866|582743489|FG001|Weeks 1 - 12|Non-compliance|0|||
161369677|NCT00619866|582743490|FG002|Weeks 1 - 12|Non-compliance|1|||
161369678|NCT00619866|582743491|FG003|Weeks 1 - 12|Non-compliance|0|||
161369679|NCT00619866|582743492|FG004|Weeks 1 - 12|Non-compliance|0|||
161369680|NCT00619866|582743488|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
161369681|NCT00619866|582743489|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
161369682|NCT00619866|582743490|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
161369683|NCT00619866|582743491|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
161369684|NCT00619866|582743492|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
161369685|NCT00619866|582743488|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
161369686|NCT00619866|582743489|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
161369687|NCT00619866|582743490|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
161369688|NCT00619866|582743491|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
161369689|NCT00619866|582743492|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
161369690|NCT00619866|582743488|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
161369691|NCT00619866|582743489|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
161369692|NCT00619866|582743490|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
161369693|NCT00619866|582743491|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
161369694|NCT00619866|582743492|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
161369695|NCT00619866|582743488|FG000|Weeks 1 - 12|Sponsor Decision|0|||
161369696|NCT00619866|582743489|FG001|Weeks 1 - 12|Sponsor Decision|1|||
161369697|NCT00619866|582743490|FG002|Weeks 1 - 12|Sponsor Decision|0|||
161369698|NCT00619866|582743491|FG003|Weeks 1 - 12|Sponsor Decision|0|||
161369699|NCT00619866|582743492|FG004|Weeks 1 - 12|Sponsor Decision|0|||
161369700|NCT00619866|582743488|FG000|Weeks 13 - 24|Adverse Event|0|||
161369701|NCT00619866|582743489|FG001|Weeks 13 - 24|Adverse Event|0|||
161369702|NCT00619866|582743490|FG002|Weeks 13 - 24|Adverse Event|2|||
161369703|NCT00619866|582743491|FG003|Weeks 13 - 24|Adverse Event|1|||
161369704|NCT00619866|582743492|FG004|Weeks 13 - 24|Adverse Event|0|||
161369705|NCT00619866|582743488|FG000|Weeks 13 - 24|Protocol Deviation|0|||
161369706|NCT00619866|582743489|FG001|Weeks 13 - 24|Protocol Deviation|0|||
161369707|NCT00619866|582743490|FG002|Weeks 13 - 24|Protocol Deviation|0|||
161369708|NCT00619866|582743491|FG003|Weeks 13 - 24|Protocol Deviation|1|||
161369709|NCT00619866|582743492|FG004|Weeks 13 - 24|Protocol Deviation|0|||
161369710|NCT00619866|582743488|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
161369711|NCT00619866|582743489|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
161369712|NCT00619866|582743490|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
161369713|NCT00619866|582743491|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
161369714|NCT00619866|582743492|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
161369715|NCT00619866|582743488|FG000|Weeks 13 - 24|Non-compliance|0|||
161369716|NCT00619866|582743489|FG001|Weeks 13 - 24|Non-compliance|1|||
161369717|NCT00619866|582743490|FG002|Weeks 13 - 24|Non-compliance|1|||
161369718|NCT00619866|582743491|FG003|Weeks 13 - 24|Non-compliance|0|||
161369719|NCT00619866|582743492|FG004|Weeks 13 - 24|Non-compliance|0|||
161369720|NCT00619866|582743488|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
161369721|NCT00619866|582743489|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
161369722|NCT00619866|582743490|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
161369723|NCT00619866|582743491|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
161369724|NCT00619866|582743492|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
161369725|NCT01656161|582743493|FG000|Overall Study|Death|3|||
161369726|NCT01656161|582743493|FG000|Overall Study|Adverse Event|2|||
161369727|NCT01656161|582743493|FG000|Overall Study|Protocol Violation|1|||
161369728|NCT01656161|582743493|FG000|Overall Study|Withdrawal by Subject|1|||
161369729|NCT03510273|582743498|FG000|Overall Study|Withdrawal by Subject|2|||
161369730|NCT03510273|582743498|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
161369731|NCT03510273|582743498|FG000|Overall Study|Moved away from study area|4|||
161369732|NCT02589938|582743502|FG000|Overall Study|Withdrawal by Subject|11|||
161369733|NCT02589938|582743503|FG001|Overall Study|Withdrawal by Subject|5|||
161369734|NCT02589938|582743504|FG002|Overall Study|Withdrawal by Subject|6|||
161369735|NCT02589938|582743502|FG000|Overall Study|Lost to Follow-up|3|||
161369736|NCT02589938|582743503|FG001|Overall Study|Lost to Follow-up|3|||
161369737|NCT02589938|582743504|FG002|Overall Study|Lost to Follow-up|3|||
161369738|NCT02589938|582743502|FG000|Overall Study|Death|1|||
161369739|NCT02589938|582743503|FG001|Overall Study|Death|0|||
161369740|NCT02589938|582743504|FG002|Overall Study|Death|1|||
161369741|NCT02589938|582743502|FG000|Overall Study|Protocol Violation|6|||
161369742|NCT02589938|582743503|FG001|Overall Study|Protocol Violation|2|||
161369743|NCT02589938|582743504|FG002|Overall Study|Protocol Violation|3|||
161369744|NCT02589938|582743502|FG000|Overall Study|Physician Decision|1|||
161369745|NCT02589938|582743503|FG001|Overall Study|Physician Decision|0|||
161369746|NCT02589938|582743504|FG002|Overall Study|Physician Decision|0|||
161369747|NCT02589938|582743502|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
161369748|NCT02589938|582743503|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
161369749|NCT02589938|582743504|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
161369750|NCT05205616|582743505|FG000|Overall Study|Lost to Follow-up|4|||
161369751|NCT05205616|582743506|FG001|Overall Study|Lost to Follow-up|4|||
161369752|NCT01121757|582743516|FG000|First Drug|Death|1|||
161369753|NCT01121757|582743517|FG001|First Drug|Death|0|||
161369754|NCT01121757|582743516|FG000|First Drug|Disease Progression|0|||
161369755|NCT01121757|582743517|FG001|First Drug|Disease Progression|2|||
161369756|NCT01121757|582743516|FG000|Combination|Physician Decision|0|||
161369757|NCT01121757|582743517|FG001|Combination|Physician Decision|1|||
161369758|NCT01121757|582743516|FG000|Combination|Disease Progression|2|||
161369759|NCT01121757|582743517|FG001|Combination|Disease Progression|0|||
161369760|NCT06071104|582743534|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
161369761|NCT04116489|582743538|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
161369762|NCT04116489|582743538|FG000|Overall Study|Withdrawal by Subject|1|||
161369763|NCT03781570|582743539|FG000|Overall Study|Technical Issues (equipment failure)|31|||
161369764|NCT03781570|582743539|FG000|Overall Study|Withdrawal by Subject|7|||
161369765|NCT03781570|582743539|FG000|Overall Study|Physical Constraints|11|||
161369766|NCT03636022|582743543|FG000|Overall Study|Withdrawal by Subject|1|||
161369767|NCT03636022|582743544|FG001|Overall Study|Withdrawal by Subject|3|||
161369768|NCT01346592|582743545|FG000|Overall Study|Lost to Follow-up|62|||
161369769|NCT01346592|582743546|FG001|Overall Study|Lost to Follow-up|29|||
161369770|NCT01346592|582743547|FG002|Overall Study|Lost to Follow-up|29|||
161369771|NCT01346592|582743545|FG000|Overall Study|Protocol Violation|2|||
161369772|NCT01346592|582743546|FG001|Overall Study|Protocol Violation|1|||
161369773|NCT01346592|582743547|FG002|Overall Study|Protocol Violation|0|||
161369774|NCT01346592|582743545|FG000|Overall Study|Death|1|||
161369775|NCT01346592|582743546|FG001|Overall Study|Death|3|||
161369776|NCT01346592|582743547|FG002|Overall Study|Death|4|||
161369777|NCT01346592|582743545|FG000|Overall Study|Adverse Event|0|||
161369778|NCT01346592|582743546|FG001|Overall Study|Adverse Event|1|||
161369779|NCT01346592|582743547|FG002|Overall Study|Adverse Event|0|||
161369780|NCT01346592|582743545|FG000|Overall Study|Withdrawal by Subject|77|||
161369781|NCT01346592|582743546|FG001|Overall Study|Withdrawal by Subject|51|||
161369782|NCT01346592|582743547|FG002|Overall Study|Withdrawal by Subject|38|||
161369783|NCT01346592|582743545|FG000|Overall Study|Inappropriate enrollment|3|||
161369784|NCT01346592|582743546|FG001|Overall Study|Inappropriate enrollment|1|||
161369785|NCT01346592|582743547|FG002|Overall Study|Inappropriate enrollment|1|||
161369786|NCT01346592|582743545|FG000|Overall Study|Administrative reason|1|||
161369787|NCT01346592|582743546|FG001|Overall Study|Administrative reason|0|||
161369788|NCT01346592|582743547|FG002|Overall Study|Administrative reason|0|||
161369789|NCT01346592|582743545|FG000|Overall Study|Unable to Classify|7|||
161369790|NCT01346592|582743546|FG001|Overall Study|Unable to Classify|3|||
161369791|NCT01346592|582743547|FG002|Overall Study|Unable to Classify|6|||
161369792|NCT00643279|582743550|FG000|Overall Study|Death|13|||
161369793|NCT00643279|582743551|FG001|Overall Study|Death|11|||
161369794|NCT00643279|582743550|FG000|Overall Study|Withdrawal by Subject|3|||
161369795|NCT00643279|582743551|FG001|Overall Study|Withdrawal by Subject|0|||
161369796|NCT00643279|582743550|FG000|Overall Study|Lost to Follow-up|0|||
161369797|NCT00643279|582743551|FG001|Overall Study|Lost to Follow-up|1|||
161369798|NCT00643279|582743550|FG000|Overall Study|Physician Decision|0|||
161369799|NCT00643279|582743551|FG001|Overall Study|Physician Decision|1|||
161369800|NCT04890509|582743552|FG000|Overall Study|Death|4|||
161369801|NCT04890509|582743553|FG001|Overall Study|Death|4|||
161369802|NCT04116853|582743554|FG000|Overall Study|Adverse Event|1|||
161369803|NCT04116853|582743555|FG001|Overall Study|Adverse Event|3|||
161369804|NCT04116853|582743554|FG000|Overall Study|Lost to Follow-up|2|||
161369805|NCT04116853|582743555|FG001|Overall Study|Lost to Follow-up|0|||
161369806|NCT04116853|582743554|FG000|Overall Study|Incarceration|0|||
161369807|NCT04116853|582743555|FG001|Overall Study|Incarceration|1|||
161369808|NCT04116853|582743554|FG000|Overall Study|Pregnancy|1|||
161369809|NCT04116853|582743555|FG001|Overall Study|Pregnancy|1|||
161369810|NCT04116853|582743554|FG000|Overall Study|Began Other Weight Loss program|4|||
161369811|NCT04116853|582743555|FG001|Overall Study|Began Other Weight Loss program|8|||
161369812|NCT04116853|582743554|FG000|Overall Study|Began Anti-Obesity Medication|3|||
161369813|NCT04116853|582743555|FG001|Overall Study|Began Anti-Obesity Medication|3|||
161369814|NCT04116853|582743554|FG000|Overall Study|Protocol Violation|0|||
161369815|NCT04116853|582743555|FG001|Overall Study|Protocol Violation|1|||
161369816|NCT03274466|582743556|FG000|Overall Study|Withdrawal by Subject|7|||
161369817|NCT03274466|582743557|FG001|Overall Study|Withdrawal by Subject|3|||
161369818|NCT03274466|582743556|FG000|Overall Study|Protocol Specified Withdrawal|5|||
161369819|NCT03274466|582743557|FG001|Overall Study|Protocol Specified Withdrawal|11|||
161369820|NCT03274466|582743556|FG000|Overall Study|Lost to Follow-up|5|||
161369821|NCT03274466|582743557|FG001|Overall Study|Lost to Follow-up|7|||
161369822|NCT03274466|582743556|FG000|Overall Study|Subject Non-compliance|0|||
161369823|NCT03274466|582743557|FG001|Overall Study|Subject Non-compliance|1|||
161369824|NCT03274466|582743556|FG000|Overall Study|Adverse Event|3|||
161369825|NCT03274466|582743557|FG001|Overall Study|Adverse Event|3|||
161369826|NCT03274466|582743556|FG000|Overall Study|Physician Decision|0|||
161369827|NCT03274466|582743557|FG001|Overall Study|Physician Decision|1|||
161369828|NCT03274466|582743556|FG000|Overall Study|Protocol Violation|3|||
161369829|NCT03274466|582743557|FG001|Overall Study|Protocol Violation|3|||
161369830|NCT04696146|582745369|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
161369831|NCT04696146|582745370|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
161369832|NCT04696146|582745369|FG000|Overall Study|Off hours issue with product|1|||
161369833|NCT04696146|582745370|FG001|Overall Study|Off hours issue with product|0|||
161369834|NCT01576783|582745376|FG000|Overall Study|Change in Medical Care|1|||
161369835|NCT01576783|582745377|FG001|Overall Study|Change in Medical Care|0|||
161369836|NCT01576783|582745376|FG000|Overall Study|Lost to Follow-up|14|||
161369837|NCT01576783|582745377|FG001|Overall Study|Lost to Follow-up|16|||
161369838|NCT01576783|582745376|FG000|Overall Study|Withdrawal by Subject|5|||
161369839|NCT01576783|582745377|FG001|Overall Study|Withdrawal by Subject|1|||
161369840|NCT05489328|582745378|FG000|Overall Study|Lost to Follow-up|0|||
161369841|NCT05489328|582745379|FG001|Overall Study|Lost to Follow-up|0|||
161369842|NCT05489328|582745380|FG002|Overall Study|Lost to Follow-up|1|||
161369843|NCT05489328|582745381|FG003|Overall Study|Lost to Follow-up|0|||
161369844|NCT05489328|582745382|FG004|Overall Study|Lost to Follow-up|2|||
161369845|NCT05489328|582745383|FG005|Overall Study|Lost to Follow-up|0|||
161369846|NCT05489328|582745384|FG006|Overall Study|Lost to Follow-up|0|||
161369847|NCT05489328|582745385|FG007|Overall Study|Lost to Follow-up|1|||
161369848|NCT05489328|582745386|FG008|Overall Study|Lost to Follow-up|0|||
161369849|NCT05489328|582745378|FG000|Overall Study|Withdrawal by Subject|0|||
161369850|NCT05489328|582745379|FG001|Overall Study|Withdrawal by Subject|0|||
161369851|NCT05489328|582745380|FG002|Overall Study|Withdrawal by Subject|0|||
161369852|NCT05489328|582745381|FG003|Overall Study|Withdrawal by Subject|0|||
161369853|NCT05489328|582745382|FG004|Overall Study|Withdrawal by Subject|0|||
161369854|NCT05489328|582745383|FG005|Overall Study|Withdrawal by Subject|0|||
161369855|NCT05489328|582745384|FG006|Overall Study|Withdrawal by Subject|1|||
161369856|NCT05489328|582745385|FG007|Overall Study|Withdrawal by Subject|1|||
161369857|NCT05489328|582745386|FG008|Overall Study|Withdrawal by Subject|0|||
161369858|NCT05489328|582745378|FG000|Overall Study|Other|0|||
161369859|NCT05489328|582745379|FG001|Overall Study|Other|0|||
161369860|NCT05489328|582745380|FG002|Overall Study|Other|0|||
161369861|NCT05489328|582745381|FG003|Overall Study|Other|0|||
161369862|NCT05489328|582745382|FG004|Overall Study|Other|0|||
161369863|NCT05489328|582745383|FG005|Overall Study|Other|0|||
161369864|NCT05489328|582745384|FG006|Overall Study|Other|0|||
161369865|NCT05489328|582745385|FG007|Overall Study|Other|1|||
161369866|NCT05489328|582745386|FG008|Overall Study|Other|1|||
161369867|NCT01083602|582745387|FG000|Overall Study|Adverse Event|11|||
161369868|NCT01083602|582745387|FG000|Overall Study|New Cancer Therapy|2|||
161369869|NCT01083602|582745387|FG000|Overall Study|Death|1|||
161369870|NCT01083602|582745387|FG000|Overall Study|Withdrawal by Subject|5|||
161369871|NCT01083602|582745387|FG000|Overall Study|Lack of Efficacy|36|||
161369872|NCT01657370|582745389|FG000|Overall Study|Withdrawal by Subject|0|||
161369873|NCT01657370|582745390|FG001|Overall Study|Withdrawal by Subject|0|||
161369874|NCT01657370|582745391|FG002|Overall Study|Withdrawal by Subject|1|||
161369875|NCT01657370|582745392|FG003|Overall Study|Withdrawal by Subject|0|||
161369876|NCT01657370|582745393|FG004|Overall Study|Withdrawal by Subject|0|||
161369877|NCT01657370|582745394|FG005|Overall Study|Withdrawal by Subject|1|||
161369878|NCT01657370|582745389|FG000|Overall Study|Physician Decision|2|||
161369879|NCT01657370|582745390|FG001|Overall Study|Physician Decision|3|||
161369880|NCT01657370|582745391|FG002|Overall Study|Physician Decision|1|||
161369881|NCT01657370|582745392|FG003|Overall Study|Physician Decision|2|||
161369882|NCT01657370|582745393|FG004|Overall Study|Physician Decision|5|||
161369883|NCT01657370|582745394|FG005|Overall Study|Physician Decision|0|||
161369884|NCT01657370|582745389|FG000|Overall Study|Lack of Qualifying Event|1|||
161369885|NCT01657370|582745390|FG001|Overall Study|Lack of Qualifying Event|0|||
161369886|NCT01657370|582745391|FG002|Overall Study|Lack of Qualifying Event|3|||
161369887|NCT01657370|582745392|FG003|Overall Study|Lack of Qualifying Event|2|||
161369888|NCT01657370|582745393|FG004|Overall Study|Lack of Qualifying Event|1|||
161369889|NCT01657370|582745394|FG005|Overall Study|Lack of Qualifying Event|2|||
161369890|NCT01657370|582745389|FG000|Overall Study|Adverse Event|0|||
161369891|NCT01657370|582745390|FG001|Overall Study|Adverse Event|0|||
161369892|NCT01657370|582745391|FG002|Overall Study|Adverse Event|0|||
161369893|NCT01657370|582745392|FG003|Overall Study|Adverse Event|0|||
161369894|NCT01657370|582745393|FG004|Overall Study|Adverse Event|1|||
161369895|NCT01657370|582745394|FG005|Overall Study|Adverse Event|0|||
161369896|NCT01657370|582745389|FG000|Overall Study|Protocol Violation|1|||
161369897|NCT01657370|582745390|FG001|Overall Study|Protocol Violation|1|||
161369898|NCT01657370|582745391|FG002|Overall Study|Protocol Violation|1|||
161369899|NCT01657370|582745392|FG003|Overall Study|Protocol Violation|1|||
161369900|NCT01657370|582745393|FG004|Overall Study|Protocol Violation|0|||
161369901|NCT01657370|582745394|FG005|Overall Study|Protocol Violation|0|||
161369902|NCT01657370|582745389|FG000|Overall Study|Lost to Follow-up|2|||
161369903|NCT01657370|582745390|FG001|Overall Study|Lost to Follow-up|0|||
161369904|NCT01657370|582745391|FG002|Overall Study|Lost to Follow-up|1|||
161369905|NCT01657370|582745392|FG003|Overall Study|Lost to Follow-up|0|||
161369906|NCT01657370|582745393|FG004|Overall Study|Lost to Follow-up|0|||
161369907|NCT01657370|582745394|FG005|Overall Study|Lost to Follow-up|1|||
161369908|NCT01819272|582745395|FG000|Overall Study|Adverse Event|1|||
161369909|NCT01819272|582745396|FG001|Overall Study|Adverse Event|0|||
161369910|NCT01819272|582745397|FG002|Overall Study|Adverse Event|0|||
161369911|NCT01819272|582745398|FG003|Overall Study|Adverse Event|2|||
161369912|NCT01819272|582745399|FG004|Overall Study|Adverse Event|0|||
161369913|NCT01819272|582745400|FG005|Overall Study|Adverse Event|0|||
161369914|NCT01819272|582745395|FG000|Overall Study|Lost to Follow-up|3|||
161369915|NCT01819272|582745396|FG001|Overall Study|Lost to Follow-up|0|||
161369916|NCT01819272|582745397|FG002|Overall Study|Lost to Follow-up|1|||
161369917|NCT01819272|582745398|FG003|Overall Study|Lost to Follow-up|0|||
161369918|NCT01819272|582745399|FG004|Overall Study|Lost to Follow-up|0|||
161369919|NCT01819272|582745400|FG005|Overall Study|Lost to Follow-up|3|||
161369920|NCT01819272|582745395|FG000|Overall Study|Protocol Violation|0|||
161369921|NCT01819272|582745396|FG001|Overall Study|Protocol Violation|0|||
161369922|NCT01819272|582745397|FG002|Overall Study|Protocol Violation|0|||
161369923|NCT01819272|582745398|FG003|Overall Study|Protocol Violation|1|||
161369924|NCT01819272|582745399|FG004|Overall Study|Protocol Violation|2|||
161369925|NCT01819272|582745400|FG005|Overall Study|Protocol Violation|3|||
161369926|NCT01819272|582745395|FG000|Overall Study|Physician Decision|0|||
161369927|NCT01819272|582745396|FG001|Overall Study|Physician Decision|1|||
161369928|NCT01819272|582745397|FG002|Overall Study|Physician Decision|0|||
161369929|NCT01819272|582745398|FG003|Overall Study|Physician Decision|0|||
161369930|NCT01819272|582745399|FG004|Overall Study|Physician Decision|0|||
161369931|NCT01819272|582745400|FG005|Overall Study|Physician Decision|0|||
161369932|NCT01819272|582745395|FG000|Overall Study|Withdrawal of Consent|0|||
161369933|NCT01819272|582745396|FG001|Overall Study|Withdrawal of Consent|1|||
161369934|NCT01819272|582745397|FG002|Overall Study|Withdrawal of Consent|2|||
161369935|NCT01819272|582745398|FG003|Overall Study|Withdrawal of Consent|1|||
161369936|NCT01819272|582745399|FG004|Overall Study|Withdrawal of Consent|0|||
161369937|NCT01819272|582745400|FG005|Overall Study|Withdrawal of Consent|1|||
161369938|NCT01819272|582745395|FG000|Overall Study|Loss of Glucose Control|2|||
161369939|NCT01819272|582745396|FG001|Overall Study|Loss of Glucose Control|1|||
161369940|NCT01819272|582745397|FG002|Overall Study|Loss of Glucose Control|0|||
161369941|NCT01819272|582745398|FG003|Overall Study|Loss of Glucose Control|1|||
161369942|NCT01819272|582745399|FG004|Overall Study|Loss of Glucose Control|2|||
161369943|NCT01819272|582745400|FG005|Overall Study|Loss of Glucose Control|0|||
161369944|NCT03021486|582745401|FG000|Overall Study|Withdrawal by Subject|1|||
161369945|NCT03021486|582745402|FG001|Overall Study|Withdrawal by Subject|1|||
161369946|NCT03021486|582745403|FG002|Overall Study|Withdrawal by Subject|3|||
161369947|NCT03021486|582745401|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
161369948|NCT03021486|582745402|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
161369949|NCT03021486|582745403|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
161369950|NCT04043286|582745404|FG000|Overall Study|Withdrawal by Subject|2|||
161369951|NCT04043286|582745405|FG001|Overall Study|Withdrawal by Subject|2|||
161369952|NCT01581684|582745406|FG000|Overall Study|Other reason not defined|0|||
161369953|NCT01581684|582745407|FG001|Overall Study|Other reason not defined|0|||
161369954|NCT01581684|582745408|FG002|Overall Study|Other reason not defined|0|||
161369955|NCT01581684|582745409|FG003|Overall Study|Other reason not defined|0|||
161369956|NCT01581684|582745410|FG004|Overall Study|Other reason not defined|0|||
161369957|NCT01581684|582745411|FG005|Overall Study|Other reason not defined|0|||
161369958|NCT01581684|582745412|FG006|Overall Study|Other reason not defined|0|||
161369959|NCT01581684|582745413|FG007|Overall Study|Other reason not defined|0|||
161369960|NCT01581684|582745414|FG008|Overall Study|Other reason not defined|1|||
161369961|NCT01581684|582745415|FG009|Overall Study|Other reason not defined|0|||
161369962|NCT03186638|582745416|FG000|Overall Study|Withdrawal by Subject|4|||
161369963|NCT03186638|582745417|FG001|Overall Study|Withdrawal by Subject|4|||
161369964|NCT03186638|582745416|FG000|Overall Study|Withdrawn due to medical problem|3|||
161369965|NCT03186638|582745417|FG001|Overall Study|Withdrawn due to medical problem|2|||
161369966|NCT03186638|582745416|FG000|Overall Study|Lost to Follow-up|1|||
161369967|NCT03186638|582745417|FG001|Overall Study|Lost to Follow-up|0|||
161369968|NCT01029535|582745418|FG000|Overall Study|Lost to Follow-up|24|||
161369969|NCT01029535|582745418|FG000|Overall Study|Protocol Violation|2|||
161369970|NCT01029535|582745418|FG000|Overall Study|Participant Withdrew Consent|2|||
161369971|NCT01029535|582745418|FG000|Overall Study|Adverse Event|1|||
161369972|NCT01029535|582745418|FG000|Overall Study|Use of Another Treatment|1|||
161369973|NCT01029535|582745418|FG000|Overall Study|Death|1|||
161369974|NCT02410772|582745425|FG000|Overall Study|Death|3|||
161369975|NCT02410772|582745426|FG001|Overall Study|Death|4|||
161369976|NCT02410772|582745427|FG002|Overall Study|Death|8|||
161369977|NCT02410772|582745425|FG000|Overall Study|Lost to Follow-up|31|||
161369978|NCT02410772|582745426|FG001|Overall Study|Lost to Follow-up|23|||
161369979|NCT02410772|582745427|FG002|Overall Study|Lost to Follow-up|22|||
161369980|NCT02410772|582745425|FG000|Overall Study|Pregnancy|8|||
161369981|NCT02410772|582745426|FG001|Overall Study|Pregnancy|4|||
161369982|NCT02410772|582745427|FG002|Overall Study|Pregnancy|5|||
161369983|NCT02410772|582745425|FG000|Overall Study|Protocol Violation|8|||
161369984|NCT02410772|582745426|FG001|Overall Study|Protocol Violation|8|||
161369985|NCT02410772|582745427|FG002|Overall Study|Protocol Violation|4|||
161369986|NCT02410772|582745425|FG000|Overall Study|Baseline Drug Resistance|49|||
161369987|NCT02410772|582745426|FG001|Overall Study|Baseline Drug Resistance|40|||
161369988|NCT02410772|582745427|FG002|Overall Study|Baseline Drug Resistance|51|||
161369989|NCT02410772|582745425|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
161369990|NCT02410772|582745426|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
161369991|NCT02410772|582745427|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
161369992|NCT02410772|582745425|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
161369993|NCT02410772|582745426|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
161369994|NCT02410772|582745427|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
161369995|NCT01870869|582745430|FG000|Overall Study|Implanted with nonstudy device|1|||
161369996|NCT01870869|582745431|FG001|Overall Study|Implanted with nonstudy device|3|||
161369997|NCT01870869|582745432|FG002|Overall Study|Implanted with nonstudy device|14|||
161369998|NCT01870869|582745433|FG003|Overall Study|Implanted with nonstudy device|4|||
161369999|NCT01870869|582745430|FG000|Overall Study|Death|0|||
161370000|NCT01870869|582745431|FG001|Overall Study|Death|0|||
161370001|NCT01870869|582745432|FG002|Overall Study|Death|7|||
161370002|NCT01870869|582745433|FG003|Overall Study|Death|1|||
161370003|NCT01870869|582745430|FG000|Overall Study|Subject choice|6|||
161370004|NCT01870869|582745431|FG001|Overall Study|Subject choice|2|||
161370005|NCT01870869|582745432|FG002|Overall Study|Subject choice|22|||
161370006|NCT01870869|582745433|FG003|Overall Study|Subject choice|8|||
161370007|NCT01870869|582745430|FG000|Overall Study|Lost to Follow-up|10|||
161370008|NCT01870869|582745431|FG001|Overall Study|Lost to Follow-up|2|||
161370009|NCT01870869|582745432|FG002|Overall Study|Lost to Follow-up|25|||
161370010|NCT01870869|582745433|FG003|Overall Study|Lost to Follow-up|3|||
161370011|NCT01870869|582745430|FG000|Overall Study|Reason not Specified|1|||
161370012|NCT01870869|582745431|FG001|Overall Study|Reason not Specified|2|||
161370013|NCT01870869|582745432|FG002|Overall Study|Reason not Specified|20|||
161370014|NCT01870869|582745433|FG003|Overall Study|Reason not Specified|4|||
161370015|NCT01870869|582745430|FG000|Overall Study|Not evaluable|10|||
161370016|NCT01870869|582745431|FG001|Overall Study|Not evaluable|5|||
161370017|NCT01870869|582745432|FG002|Overall Study|Not evaluable|42|||
161370018|NCT01870869|582745433|FG003|Overall Study|Not evaluable|10|||
161370019|NCT00904371|582745434|FG000|Overall Study|Adverse Event|2|||
161370020|NCT00904371|582745434|FG000|Overall Study|Lost to Follow-up|4|||
161370021|NCT00904371|582745434|FG000|Overall Study|Discontinued at target blood pressure|2|||
161370022|NCT00904371|582745434|FG000|Overall Study|Continued with Tritace|1|||
161370023|NCT00419744|582745437|FG000|Overall Study|Adverse Event|39|||
161370024|NCT00419744|582745438|FG001|Overall Study|Adverse Event|40|||
161370025|NCT00419744|582745439|FG002|Overall Study|Adverse Event|50|||
161370026|NCT00419744|582745437|FG000|Overall Study|Withdrawal by Subject|45|||
161370027|NCT00419744|582745438|FG001|Overall Study|Withdrawal by Subject|49|||
161370028|NCT00419744|582745439|FG002|Overall Study|Withdrawal by Subject|52|||
161370029|NCT00419744|582745437|FG000|Overall Study|Lost to Follow-up|8|||
161370030|NCT00419744|582745438|FG001|Overall Study|Lost to Follow-up|10|||
161370031|NCT00419744|582745439|FG002|Overall Study|Lost to Follow-up|6|||
161370032|NCT00419744|582745437|FG000|Overall Study|Protocol Violation|4|||
161370033|NCT00419744|582745438|FG001|Overall Study|Protocol Violation|7|||
161370034|NCT00419744|582745439|FG002|Overall Study|Protocol Violation|8|||
161370035|NCT00419744|582745437|FG000|Overall Study|Randomized in error|9|||
161370036|NCT00419744|582745438|FG001|Overall Study|Randomized in error|6|||
161370037|NCT00419744|582745439|FG002|Overall Study|Randomized in error|7|||
161370038|NCT00419744|582745437|FG000|Overall Study|Moving out of state|2|||
161370039|NCT00419744|582745438|FG001|Overall Study|Moving out of state|0|||
161370040|NCT00419744|582745439|FG002|Overall Study|Moving out of state|1|||
161370041|NCT00419744|582745437|FG000|Overall Study|Physician Decision|10|||
161370042|NCT00419744|582745438|FG001|Overall Study|Physician Decision|5|||
161370043|NCT00419744|582745439|FG002|Overall Study|Physician Decision|6|||
161370044|NCT00419744|582745437|FG000|Overall Study|Spirometry mouthpiece issues|0|||
161370045|NCT00419744|582745438|FG001|Overall Study|Spirometry mouthpiece issues|1|||
161370046|NCT00419744|582745439|FG002|Overall Study|Spirometry mouthpiece issues|2|||
161370047|NCT00419744|582745437|FG000|Overall Study|Incorrect medication kit dispensed|0|||
161370048|NCT00419744|582745438|FG001|Overall Study|Incorrect medication kit dispensed|0|||
161370049|NCT00419744|582745439|FG002|Overall Study|Incorrect medication kit dispensed|1|||
161370050|NCT00673920|582745441|FG000|Baseline up to Week 48|Withdrew consent|1|||
161370051|NCT00673920|582745442|FG001|Baseline up to Week 48|Withdrew consent|0|||
161370052|NCT00673920|582745443|FG002|Baseline up to Week 48|Withdrew consent|2|||
161370053|NCT00673920|582745444|FG003|Baseline up to Week 48|Withdrew consent|0|||
161370054|NCT00673920|582745445|FG004|Baseline up to Week 48|Withdrew consent|0|||
161370055|NCT00673920|582745446|FG005|Baseline up to Week 48|Withdrew consent|0|||
161370056|NCT00673920|582745447|FG006|Baseline up to Week 48|Withdrew consent|0|||
161370057|NCT00673920|582745448|FG007|Baseline up to Week 48|Withdrew consent|0|||
161370058|NCT00673920|582745441|FG000|Baseline up to Week 48|Refused treatment|1|||
161370059|NCT00673920|582745442|FG001|Baseline up to Week 48|Refused treatment|0|||
161370060|NCT00673920|582745443|FG002|Baseline up to Week 48|Refused treatment|0|||
161370061|NCT00673920|582745444|FG003|Baseline up to Week 48|Refused treatment|0|||
161370062|NCT00673920|582745445|FG004|Baseline up to Week 48|Refused treatment|0|||
161370063|NCT00673920|582745446|FG005|Baseline up to Week 48|Refused treatment|0|||
161370064|NCT00673920|582745447|FG006|Baseline up to Week 48|Refused treatment|0|||
161370065|NCT00673920|582745448|FG007|Baseline up to Week 48|Refused treatment|0|||
161370066|NCT00673920|582745441|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
161370067|NCT00673920|582745442|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
161370068|NCT00673920|582745443|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
161370069|NCT00673920|582745444|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
161370070|NCT00673920|582745445|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
161370071|NCT00673920|582745446|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
161370072|NCT00673920|582745447|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
161370073|NCT00673920|582745448|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
161370074|NCT00673920|582745441|FG000|Baseline up to Week 48|Protocol Violation|0|||
161370075|NCT00673920|582745442|FG001|Baseline up to Week 48|Protocol Violation|0|||
161370076|NCT00673920|582745443|FG002|Baseline up to Week 48|Protocol Violation|1|||
161370077|NCT00673920|582745444|FG003|Baseline up to Week 48|Protocol Violation|0|||
161370078|NCT00673920|582745445|FG004|Baseline up to Week 48|Protocol Violation|0|||
161370079|NCT00673920|582745446|FG005|Baseline up to Week 48|Protocol Violation|0|||
161370080|NCT00673920|582745447|FG006|Baseline up to Week 48|Protocol Violation|0|||
161370081|NCT00673920|582745448|FG007|Baseline up to Week 48|Protocol Violation|0|||
161370082|NCT00673920|582745441|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370083|NCT00673920|582745442|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370084|NCT00673920|582745443|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
161370085|NCT00673920|582745444|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370086|NCT00673920|582745445|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370087|NCT00673920|582745446|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370088|NCT00673920|582745447|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370089|NCT00673920|582745448|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161370090|NCT00673920|582745441|FG000|Baseline up to Week 48|Administrative/Other|0|||
161370091|NCT00673920|582745442|FG001|Baseline up to Week 48|Administrative/Other|1|||
161370092|NCT00673920|582745443|FG002|Baseline up to Week 48|Administrative/Other|2|||
161370093|NCT00673920|582745444|FG003|Baseline up to Week 48|Administrative/Other|0|||
161370094|NCT00673920|582745445|FG004|Baseline up to Week 48|Administrative/Other|0|||
161370095|NCT00673920|582745446|FG005|Baseline up to Week 48|Administrative/Other|0|||
161370096|NCT00673920|582745447|FG006|Baseline up to Week 48|Administrative/Other|0|||
161370097|NCT00673920|582745448|FG007|Baseline up to Week 48|Administrative/Other|0|||
161370098|NCT00673920|582745441|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161370099|NCT00673920|582745442|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
161370100|NCT00673920|582745443|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
161370101|NCT00673920|582745444|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161370102|NCT00673920|582745445|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161370103|NCT00673920|582745446|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161370104|NCT00673920|582745447|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161370105|NCT00673920|582745448|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161370106|NCT00673920|582745441|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370107|NCT00673920|582745442|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370108|NCT00673920|582745443|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370109|NCT00673920|582745444|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370110|NCT00673920|582745445|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370111|NCT00673920|582745446|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370112|NCT00673920|582745447|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
161370113|NCT00673920|582745448|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161370114|NCT00673920|582745441|FG000|Week 24 to Week 48|Failure to return|0|||
161370115|NCT00673920|582745442|FG001|Week 24 to Week 48|Failure to return|0|||
161370116|NCT00673920|582745443|FG002|Week 24 to Week 48|Failure to return|0|||
161370117|NCT00673920|582745444|FG003|Week 24 to Week 48|Failure to return|0|||
161370118|NCT00673920|582745445|FG004|Week 24 to Week 48|Failure to return|0|||
161370119|NCT00673920|582745446|FG005|Week 24 to Week 48|Failure to return|1|||
161370120|NCT00673920|582745447|FG006|Week 24 to Week 48|Failure to return|0|||
161370121|NCT00673920|582745448|FG007|Week 24 to Week 48|Failure to return|0|||
161370122|NCT00673920|582745441|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370123|NCT00673920|582745442|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370124|NCT00673920|582745443|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370125|NCT00673920|582745444|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370126|NCT00673920|582745445|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370127|NCT00673920|582745446|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
161370128|NCT00673920|582745447|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370129|NCT00673920|582745448|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
161370130|NCT00673920|582745441|FG000|Week 24 to Week 48|Death|0|||
161370131|NCT00673920|582745442|FG001|Week 24 to Week 48|Death|0|||
161370132|NCT00673920|582745443|FG002|Week 24 to Week 48|Death|0|||
161370133|NCT00673920|582745444|FG003|Week 24 to Week 48|Death|0|||
161370134|NCT00673920|582745445|FG004|Week 24 to Week 48|Death|0|||
161370135|NCT00673920|582745446|FG005|Week 24 to Week 48|Death|1|||
161370136|NCT00673920|582745447|FG006|Week 24 to Week 48|Death|0|||
161370137|NCT00673920|582745448|FG007|Week 24 to Week 48|Death|0|||
161370138|NCT00673920|582745441|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
161370139|NCT00673920|582745442|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
161370140|NCT00673920|582745443|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
161370141|NCT00673920|582745444|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
161370142|NCT00673920|582745445|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
161370143|NCT00673920|582745446|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
161370144|NCT00673920|582745447|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
161370145|NCT00673920|582745448|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
161370146|NCT02493764|582745449|FG000|Overall Study|Adverse Event|2|||
161370147|NCT02493764|582745450|FG001|Overall Study|Adverse Event|2|||
161370148|NCT02493764|582745449|FG000|Overall Study|Death|44|||
161370149|NCT02493764|582745450|FG001|Overall Study|Death|58|||
161370150|NCT02493764|582745449|FG000|Overall Study|Lost to Follow-up|2|||
161370151|NCT02493764|582745450|FG001|Overall Study|Lost to Follow-up|1|||
161370152|NCT02493764|582745449|FG000|Overall Study|Protocol Violation|6|||
161370153|NCT02493764|582745450|FG001|Overall Study|Protocol Violation|7|||
161370154|NCT02493764|582745449|FG000|Overall Study|Physician Decision|1|||
161370155|NCT02493764|582745450|FG001|Overall Study|Physician Decision|1|||
161370156|NCT02493764|582745449|FG000|Overall Study|Participant moved|17|||
161370157|NCT02493764|582745450|FG001|Overall Study|Participant moved|5|||
161370158|NCT02493764|582745449|FG000|Overall Study|Withdrawal parent/guardian|0|||
161370159|NCT02493764|582745450|FG001|Overall Study|Withdrawal parent/guardian|1|||
161370160|NCT02493764|582745449|FG000|Overall Study|Withdrawal by Subject|11|||
161370161|NCT02493764|582745450|FG001|Overall Study|Withdrawal by Subject|7|||
161370162|NCT01463527|582745451|FG000|Overall Study|Protocol Violation|1|||
161370163|NCT01463527|582745452|FG001|Overall Study|Protocol Violation|1|||
161370164|NCT01463527|582745451|FG000|Overall Study|Crying >20% of sedation|5|||
161370165|NCT01463527|582745452|FG001|Overall Study|Crying >20% of sedation|6|||
161370166|NCT04846231|582745453|FG000|Overall Study|Lost to Follow-up|1|||
161370167|NCT04846231|582745454|FG001|Overall Study|Lost to Follow-up|0|||
161370168|NCT04846231|582745455|FG002|Overall Study|Lost to Follow-up|0|||
161370169|NCT04846231|582745456|FG003|Overall Study|Lost to Follow-up|0|||
161370170|NCT04846231|582745457|FG004|Overall Study|Lost to Follow-up|0|||
161370171|NCT04846231|582745458|FG005|Overall Study|Lost to Follow-up|0|||
161370172|NCT04846231|582745459|FG006|Overall Study|Lost to Follow-up|0|||
161370173|NCT04846231|582745460|FG007|Overall Study|Lost to Follow-up|1|||
161370174|NCT04846231|582745453|FG000|Overall Study|Withdrawal by Subject|0|||
161370175|NCT04846231|582745454|FG001|Overall Study|Withdrawal by Subject|1|||
161370176|NCT04846231|582745455|FG002|Overall Study|Withdrawal by Subject|2|||
161370177|NCT04846231|582745456|FG003|Overall Study|Withdrawal by Subject|1|||
161370178|NCT04846231|582745457|FG004|Overall Study|Withdrawal by Subject|0|||
161370179|NCT04846231|582745458|FG005|Overall Study|Withdrawal by Subject|0|||
161370180|NCT04846231|582745459|FG006|Overall Study|Withdrawal by Subject|0|||
161370181|NCT04846231|582745460|FG007|Overall Study|Withdrawal by Subject|0|||
161370182|NCT04846231|582745453|FG000|Overall Study|Protocol Violation|0|||
161370183|NCT04846231|582745454|FG001|Overall Study|Protocol Violation|1|||
161370184|NCT04846231|582745455|FG002|Overall Study|Protocol Violation|0|||
161370185|NCT04846231|582745456|FG003|Overall Study|Protocol Violation|0|||
161370186|NCT04846231|582745457|FG004|Overall Study|Protocol Violation|0|||
161370187|NCT04846231|582745458|FG005|Overall Study|Protocol Violation|0|||
161370188|NCT04846231|582745459|FG006|Overall Study|Protocol Violation|0|||
161370189|NCT04846231|582745460|FG007|Overall Study|Protocol Violation|0|||
161370190|NCT04846231|582745453|FG000|Overall Study|Adverse Event|0|||
161370191|NCT04846231|582745454|FG001|Overall Study|Adverse Event|0|||
161370192|NCT04846231|582745455|FG002|Overall Study|Adverse Event|0|||
161370193|NCT04846231|582745456|FG003|Overall Study|Adverse Event|0|||
161370194|NCT04846231|582745457|FG004|Overall Study|Adverse Event|0|||
161370195|NCT04846231|582745458|FG005|Overall Study|Adverse Event|0|||
161370196|NCT04846231|582745459|FG006|Overall Study|Adverse Event|1|||
161370197|NCT04846231|582745460|FG007|Overall Study|Adverse Event|1|||
161370198|NCT02836249|582745463|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161370199|NCT02836249|582745464|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
161370200|NCT02836249|582745465|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161370201|NCT02836249|582745466|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161370202|NCT02836249|582745463|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
161370203|NCT02836249|582745464|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161370204|NCT02836249|582745465|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
161370205|NCT02836249|582745466|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
161370206|NCT02836249|582745463|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
161370207|NCT02836249|582745464|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
161370208|NCT02836249|582745465|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161370209|NCT02836249|582745466|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161370210|NCT02836249|582745463|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161370211|NCT02836249|582745464|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161370212|NCT02836249|582745465|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161370213|NCT02836249|582745466|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161370214|NCT02836249|582745463|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
161370215|NCT02836249|582745464|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
161370216|NCT02836249|582745465|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
161370217|NCT02836249|582745466|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
161370218|NCT02836249|582745463|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
161370219|NCT02836249|582745464|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161370220|NCT02836249|582745465|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161370221|NCT02836249|582745466|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161370222|NCT02836249|582745463|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161370223|NCT02836249|582745464|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161370224|NCT02836249|582745465|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
161370225|NCT02836249|582745466|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
161370226|NCT02836249|582745463|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161370227|NCT02836249|582745464|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161370228|NCT02836249|582745465|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
161370229|NCT02836249|582745466|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
161370230|NCT02836249|582745463|FG000|Open-Label TAF Treatment Phase|Death|0|||
161370231|NCT02836249|582745464|FG001|Open-Label TAF Treatment Phase|Death|0|||
161370232|NCT02836249|582745465|FG002|Open-Label TAF Treatment Phase|Death|1|||
161370233|NCT02836249|582745466|FG003|Open-Label TAF Treatment Phase|Death|0|||
161370234|NCT02836249|582745463|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
161370235|NCT02836249|582745464|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
161370236|NCT02836249|582745465|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
161370237|NCT02836249|582745466|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
161370238|NCT02836249|582745463|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
161370239|NCT02836249|582745464|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
161370240|NCT02836249|582745465|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
161370241|NCT02836249|582745466|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
161370242|NCT01646827|582745467|FG000|Overall Study|Lost to Follow-up|0|||
161370243|NCT01646827|582745468|FG001|Overall Study|Lost to Follow-up|3|||
161370244|NCT01646827|582745467|FG000|Overall Study|Physician Decision|1|||
161370245|NCT01646827|582745468|FG001|Overall Study|Physician Decision|2|||
161370246|NCT01646827|582745467|FG000|Overall Study|Withdrawal by Subject|1|||
161370247|NCT01646827|582745468|FG001|Overall Study|Withdrawal by Subject|0|||
161370248|NCT01143402|582745471|FG000|Overall Study|Rapid clinical decline|1|||
161370249|NCT01143402|582745472|FG001|Overall Study|Rapid clinical decline|1|||
161370250|NCT01143402|582745473|FG002|Overall Study|Rapid clinical decline|0|||
161370251|NCT01143402|582745471|FG000|Overall Study|Not Treated|0|||
161370252|NCT01143402|582745472|FG001|Overall Study|Not Treated|0|||
161370253|NCT01143402|582745473|FG002|Overall Study|Not Treated|1|||
161370254|NCT04462471|582745474|FG000|Overall Study|Adverse Event|0|||
161370255|NCT04462471|582745475|FG001|Overall Study|Adverse Event|1|||
161370256|NCT04462471|582745476|FG002|Overall Study|Adverse Event|0|||
161370257|NCT04462471|582745477|FG003|Overall Study|Adverse Event|0|||
161370258|NCT04462471|582745474|FG000|Overall Study|Disease progression|1|||
161370259|NCT04462471|582745475|FG001|Overall Study|Disease progression|0|||
161370260|NCT04462471|582745476|FG002|Overall Study|Disease progression|0|||
161370261|NCT04462471|582745477|FG003|Overall Study|Disease progression|0|||
161370262|NCT00265122|582745480|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
161370263|NCT00265122|582745481|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
161370264|NCT00265122|582745482|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
161370265|NCT00265122|582745483|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
161370266|NCT00265122|582745484|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
161370267|NCT00265122|582745485|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
161370268|NCT00265122|582745480|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
161370269|NCT00265122|582745481|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161370270|NCT00265122|582745482|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161370271|NCT00265122|582745483|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
161370272|NCT00265122|582745484|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161370273|NCT00265122|582745485|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161370274|NCT00265122|582745480|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
161370275|NCT00265122|582745481|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
161370276|NCT00265122|582745482|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
161370277|NCT00265122|582745483|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
161370278|NCT00265122|582745484|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
161370279|NCT00265122|582745485|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
161370280|NCT00265122|582745480|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
161370281|NCT00265122|582745481|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
161370282|NCT00265122|582745482|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
161370283|NCT00265122|582745483|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
161370284|NCT00265122|582745484|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
161370285|NCT00265122|582745485|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
161370286|NCT00265122|582745480|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
161370287|NCT00265122|582745481|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
161370288|NCT00265122|582745482|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
161370289|NCT00265122|582745483|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
161370290|NCT00265122|582745484|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
161370291|NCT00265122|582745485|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
161370292|NCT00265122|582745480|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
161370293|NCT00265122|582745481|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
161370294|NCT00265122|582745482|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
161370295|NCT00265122|582745483|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
161370296|NCT00265122|582745484|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
161370297|NCT00265122|582745485|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
161370298|NCT01276106|582745486|FG000|Overall Study|Adverse Event|3|||
161370299|NCT01276106|582745487|FG001|Overall Study|Adverse Event|3|||
161370300|NCT01276106|582745488|FG002|Overall Study|Adverse Event|11|||
161370301|NCT01276106|582745489|FG003|Overall Study|Adverse Event|3|||
161370302|NCT01276106|582745486|FG000|Overall Study|Withdrawal by Subject|6|||
161370303|NCT01276106|582745487|FG001|Overall Study|Withdrawal by Subject|3|||
161370304|NCT01276106|582745488|FG002|Overall Study|Withdrawal by Subject|1|||
161370305|NCT01276106|582745489|FG003|Overall Study|Withdrawal by Subject|6|||
161370306|NCT01276106|582745486|FG000|Overall Study|Lack of Efficacy|0|||
161370307|NCT01276106|582745487|FG001|Overall Study|Lack of Efficacy|1|||
161370308|NCT01276106|582745488|FG002|Overall Study|Lack of Efficacy|0|||
161370309|NCT01276106|582745489|FG003|Overall Study|Lack of Efficacy|1|||
161370310|NCT01276106|582745486|FG000|Overall Study|Lost to Follow-up|2|||
161370311|NCT01276106|582745487|FG001|Overall Study|Lost to Follow-up|1|||
161370312|NCT01276106|582745488|FG002|Overall Study|Lost to Follow-up|1|||
161370313|NCT01276106|582745489|FG003|Overall Study|Lost to Follow-up|0|||
161370314|NCT01276106|582745486|FG000|Overall Study|Physician Decision|0|||
161370315|NCT01276106|582745487|FG001|Overall Study|Physician Decision|0|||
161370316|NCT01276106|582745488|FG002|Overall Study|Physician Decision|1|||
161370317|NCT01276106|582745489|FG003|Overall Study|Physician Decision|1|||
161370318|NCT01276106|582745486|FG000|Overall Study|Protocol Violation|1|||
161370319|NCT01276106|582745487|FG001|Overall Study|Protocol Violation|1|||
161370320|NCT01276106|582745488|FG002|Overall Study|Protocol Violation|0|||
161370321|NCT01276106|582745489|FG003|Overall Study|Protocol Violation|2|||
161370322|NCT01276106|582745486|FG000|Overall Study|Insufficient therapeutic effects|0|||
161370323|NCT01276106|582745487|FG001|Overall Study|Insufficient therapeutic effects|0|||
161370324|NCT01276106|582745488|FG002|Overall Study|Insufficient therapeutic effects|2|||
161370325|NCT01276106|582745489|FG003|Overall Study|Insufficient therapeutic effects|0|||
161370326|NCT03773484|582745498|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
161370327|NCT04724837|582745499|FG000|Overall Study|Other|4|||
161370328|NCT04724837|582745500|FG001|Overall Study|Other|16|||
161370329|NCT04724837|582745501|FG002|Overall Study|Other|0|||
161370330|NCT04724837|582745499|FG000|Overall Study|Withdrawal by Subject|2|||
161370331|NCT04724837|582745500|FG001|Overall Study|Withdrawal by Subject|9|||
161370332|NCT04724837|582745501|FG002|Overall Study|Withdrawal by Subject|9|||
161370333|NCT04724837|582745499|FG000|Overall Study|Adverse Event|2|||
161370334|NCT04724837|582745500|FG001|Overall Study|Adverse Event|7|||
161370335|NCT04724837|582745501|FG002|Overall Study|Adverse Event|4|||
161370336|NCT04724837|582745499|FG000|Overall Study|Lost to Follow-up|0|||
161370337|NCT04724837|582745500|FG001|Overall Study|Lost to Follow-up|1|||
161370338|NCT04724837|582745501|FG002|Overall Study|Lost to Follow-up|3|||
161370339|NCT04724837|582745499|FG000|Overall Study|Physician Decision|1|||
161370340|NCT04724837|582745500|FG001|Overall Study|Physician Decision|2|||
161370341|NCT04724837|582745501|FG002|Overall Study|Physician Decision|0|||
161370342|NCT04724837|582745499|FG000|Overall Study|Death|0|||
161370343|NCT04724837|582745500|FG001|Overall Study|Death|0|||
161370344|NCT04724837|582745501|FG002|Overall Study|Death|1|||
161370345|NCT04724837|582745499|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161370346|NCT04724837|582745500|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161370347|NCT04724837|582745501|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
161370348|NCT04724837|582745499|FG000|Overall Study|Study Terminated by Sponsor|0|||
161370349|NCT04724837|582745500|FG001|Overall Study|Study Terminated by Sponsor|1|||
161370350|NCT04724837|582745501|FG002|Overall Study|Study Terminated by Sponsor|0|||
161370351|NCT04222673|582745502|FG000|Overall Study|Lost to Follow-up|5|||
161370352|NCT04251533|582745503|FG000|Overall Study|Progressive disease|33|||
161370353|NCT04251533|582745504|FG001|Overall Study|Progressive disease|29|||
161370354|NCT04251533|582745505|FG002|Overall Study|Progressive disease|22|||
161370355|NCT04251533|582745503|FG000|Overall Study|Death|5|||
161370356|NCT04251533|582745504|FG001|Overall Study|Death|1|||
161370357|NCT04251533|582745505|FG002|Overall Study|Death|3|||
161370358|NCT04251533|582745503|FG000|Overall Study|Physician Decision|3|||
161370359|NCT04251533|582745504|FG001|Overall Study|Physician Decision|2|||
161370360|NCT04251533|582745505|FG002|Overall Study|Physician Decision|4|||
161370361|NCT04251533|582745503|FG000|Overall Study|Participant decision|1|||
161370362|NCT04251533|582745504|FG001|Overall Study|Participant decision|3|||
161370363|NCT04251533|582745505|FG002|Overall Study|Participant decision|1|||
161370364|NCT04251533|582745503|FG000|Overall Study|Adverse Event|2|||
161370365|NCT04251533|582745504|FG001|Overall Study|Adverse Event|1|||
161370366|NCT04251533|582745505|FG002|Overall Study|Adverse Event|1|||
161370367|NCT02420717|582745512|FG000|Overall Study|Did not receive all study medication|2|||
161370368|NCT02420717|582745513|FG001|Overall Study|Did not receive all study medication|0|||
161370369|NCT02420717|582745514|FG002|Overall Study|Did not receive all study medication|0|||
161370370|NCT03138564|582745515|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
161370371|NCT03138564|582745516|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
161370372|NCT03138564|582745515|FG000|Overall Study|Lost to Follow-up|16|||
161370373|NCT03138564|582745516|FG001|Overall Study|Lost to Follow-up|2|||
161370374|NCT03138564|582745515|FG000|Overall Study|Withdrawal by Subject|48|||
161370375|NCT03138564|582745516|FG001|Overall Study|Withdrawal by Subject|4|||
161370376|NCT03138564|582745515|FG000|Overall Study|No longer met eligibility criteria|2|||
161370377|NCT03138564|582745516|FG001|Overall Study|No longer met eligibility criteria|0|||
161370378|NCT03138564|582745515|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
161370379|NCT03138564|582745516|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
161370380|NCT03138564|582745515|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
161370381|NCT03138564|582745516|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
161370382|NCT03138564|582745515|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
161370383|NCT03138564|582745516|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
161370384|NCT03138564|582745515|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
161370385|NCT03138564|582745516|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
161370386|NCT05177354|582745518|FG000|Implant to 30-day Visit|Physician Decision|1|||
161370387|NCT05177354|582745518|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
161370388|NCT05177354|582745518|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
161370389|NCT05177354|582745518|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
161370390|NCT02769481|582745521|FG000|Overall Study|Protocol Violation|1|||
161370391|NCT02769481|582745522|FG001|Overall Study|Protocol Violation|0|||
161370392|NCT02769481|582745521|FG000|Overall Study|Adverse Event|3|||
161370393|NCT02769481|582745522|FG001|Overall Study|Adverse Event|6|||
161370394|NCT02769481|582745521|FG000|Overall Study|Entry Criteria Not Met|1|||
161370395|NCT02769481|582745522|FG001|Overall Study|Entry Criteria Not Met|2|||
161370396|NCT02769481|582745521|FG000|Overall Study|Withdrawal by Subject|14|||
161370397|NCT02769481|582745522|FG001|Overall Study|Withdrawal by Subject|16|||
161370398|NCT02769481|582745521|FG000|Overall Study|Lost to Follow-up|9|||
161370399|NCT02769481|582745522|FG001|Overall Study|Lost to Follow-up|9|||
161370400|NCT02769481|582745521|FG000|Overall Study|Physician Decision|0|||
161370401|NCT02769481|582745522|FG001|Overall Study|Physician Decision|1|||
161370402|NCT02769481|582745521|FG000|Overall Study|Terminated by Sponsor|1|||
161370403|NCT02769481|582745522|FG001|Overall Study|Terminated by Sponsor|0|||
161370404|NCT02769481|582745521|FG000|Overall Study|Death|0|||
161370405|NCT02769481|582745522|FG001|Overall Study|Death|1|||
161370406|NCT02769481|582745521|FG000|Overall Study|Undefined|4|||
161370407|NCT02769481|582745522|FG001|Overall Study|Undefined|1|||
161370408|NCT02936323|582745523|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161370409|NCT02936323|582745524|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161370410|NCT02936323|582745525|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161370411|NCT02936323|582745526|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161370412|NCT02936323|582745527|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161370413|NCT02936323|582745528|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161370414|NCT02936323|582745529|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161370415|NCT02936323|582745530|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161370416|NCT02936323|582745531|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161370417|NCT02936323|582745532|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161370418|NCT02936323|582745523|FG000|Phase 1 Dose Escalation|Death|2|||
161370419|NCT02936323|582745524|FG001|Phase 1 Dose Escalation|Death|1|||
161370420|NCT02936323|582745525|FG002|Phase 1 Dose Escalation|Death|3|||
161370421|NCT02936323|582745526|FG003|Phase 1 Dose Escalation|Death|1|||
161370422|NCT02936323|582745527|FG004|Phase 1 Dose Escalation|Death|2|||
161370423|NCT02936323|582745528|FG005|Phase 1 Dose Escalation|Death|3|||
161370424|NCT02936323|582745529|FG006|Phase 1 Dose Escalation|Death|3|||
161370425|NCT02936323|582745530|FG007|Phase 1 Dose Escalation|Death|0|||
161370426|NCT02936323|582745531|FG008|Phase 1 Dose Escalation|Death|0|||
161370427|NCT02936323|582745532|FG009|Phase 1 Dose Escalation|Death|0|||
161370428|NCT02936323|582745523|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370429|NCT02936323|582745524|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370430|NCT02936323|582745525|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370431|NCT02936323|582745526|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370432|NCT02936323|582745527|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370433|NCT02936323|582745528|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
161370434|NCT02936323|582745529|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370435|NCT02936323|582745530|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370436|NCT02936323|582745531|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370437|NCT02936323|582745532|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161370438|NCT02936323|582745523|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370439|NCT02936323|582745524|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370440|NCT02936323|582745525|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370441|NCT02936323|582745526|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370442|NCT02936323|582745527|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370443|NCT02936323|582745528|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370444|NCT02936323|582745529|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161370445|NCT02936323|582745530|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
161370446|NCT02936323|582745531|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
161370447|NCT02936323|582745532|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
161370448|NCT02936323|582745523|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
161370449|NCT02936323|582745524|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
161370450|NCT02936323|582745525|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
161370451|NCT02936323|582745526|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
161370452|NCT02936323|582745527|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
161370453|NCT02936323|582745528|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
161370454|NCT02936323|582745529|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
161370455|NCT02936323|582745530|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
161370456|NCT02936323|582745531|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
161370457|NCT02936323|582745532|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
161370458|NCT02936323|582745523|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370459|NCT02936323|582745524|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370460|NCT02936323|582745525|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370461|NCT02936323|582745526|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370462|NCT02936323|582745527|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370463|NCT02936323|582745528|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370464|NCT02936323|582745529|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370465|NCT02936323|582745530|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
161370466|NCT02936323|582745531|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
161370467|NCT02936323|582745532|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161370468|NCT02936323|582745523|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370469|NCT02936323|582745524|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370470|NCT02936323|582745525|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370471|NCT02936323|582745526|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370472|NCT02936323|582745527|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370473|NCT02936323|582745528|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370474|NCT02936323|582745529|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370475|NCT02936323|582745530|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370476|NCT02936323|582745531|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161370477|NCT02936323|582745532|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
161370478|NCT02936323|582745523|FG000|Phase 2a Dose Expansion|Death|0|||
161370479|NCT02936323|582745524|FG001|Phase 2a Dose Expansion|Death|0|||
161370480|NCT02936323|582745525|FG002|Phase 2a Dose Expansion|Death|0|||
161370481|NCT02936323|582745526|FG003|Phase 2a Dose Expansion|Death|0|||
161370482|NCT02936323|582745527|FG004|Phase 2a Dose Expansion|Death|0|||
161370483|NCT02936323|582745528|FG005|Phase 2a Dose Expansion|Death|0|||
161370484|NCT02936323|582745529|FG006|Phase 2a Dose Expansion|Death|0|||
161370485|NCT02936323|582745530|FG007|Phase 2a Dose Expansion|Death|4|||
161370486|NCT02936323|582745531|FG008|Phase 2a Dose Expansion|Death|8|||
161370487|NCT02936323|582745532|FG009|Phase 2a Dose Expansion|Death|10|||
161370488|NCT02781558|582745533|FG000|Overall Study|Lost to Follow-up|2|||
161370489|NCT02781558|582745534|FG001|Overall Study|Lost to Follow-up|2|||
161370490|NCT02781558|582745533|FG000|Overall Study|Adverse Event|1|||
161370491|NCT02781558|582745534|FG001|Overall Study|Adverse Event|0|||
161370492|NCT06272383|582745535|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
161370493|NCT06272383|582745536|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
161370494|NCT05715827|582745537|FG000|Overall Study|Physician Decision|0|||
161370495|NCT05715827|582745538|FG001|Overall Study|Physician Decision|1|||
161370496|NCT05715827|582745537|FG000|Overall Study|console communication error|0|||
161370497|NCT05715827|582745538|FG001|Overall Study|console communication error|1|||
161370498|NCT04846868|582745539|FG000|Overall Study|Adverse Event|12|||
161370499|NCT04846868|582745540|FG001|Overall Study|Adverse Event|11|||
161370500|NCT04846868|582745539|FG000|Overall Study|Protocol deviation|6|||
161370501|NCT04846868|582745540|FG001|Overall Study|Protocol deviation|2|||
161370502|NCT04846868|582745539|FG000|Overall Study|Perceived lack of efficacy|3|||
161370503|NCT04846868|582745540|FG001|Overall Study|Perceived lack of efficacy|2|||
161370504|NCT04846868|582745539|FG000|Overall Study|Change of residence|2|||
161370505|NCT04846868|582745540|FG001|Overall Study|Change of residence|3|||
161370506|NCT04846868|582745539|FG000|Overall Study|Burden of study procedures|1|||
161370507|NCT04846868|582745540|FG001|Overall Study|Burden of study procedures|1|||
161370508|NCT04846868|582745539|FG000|Overall Study|No reason available|2|||
161370509|NCT04846868|582745540|FG001|Overall Study|No reason available|5|||
161370510|NCT04846868|582745539|FG000|Overall Study|Other reason listed|20|||
161370511|NCT04846868|582745540|FG001|Overall Study|Other reason listed|10|||
161370512|NCT04846868|582745539|FG000|Overall Study|Not treated|0|||
161370513|NCT04846868|582745540|FG001|Overall Study|Not treated|1|||
161370514|NCT04398706|582745541|FG000|Overall Study|Adverse Event|0|||
161370515|NCT04398706|582745542|FG001|Overall Study|Adverse Event|0|||
161370516|NCT04398706|582745543|FG002|Overall Study|Adverse Event|0|||
161370517|NCT04398706|582745544|FG003|Overall Study|Adverse Event|0|||
161370518|NCT04398706|582745545|FG004|Overall Study|Adverse Event|0|||
161370519|NCT04398706|582745546|FG005|Overall Study|Adverse Event|1|||
161370520|NCT04398706|582745547|FG006|Overall Study|Adverse Event|1|||
161370521|NCT04398706|582745548|FG007|Overall Study|Adverse Event|0|||
161370522|NCT04398706|582745541|FG000|Overall Study|Lost to Follow-up|0|||
161370523|NCT04398706|582745542|FG001|Overall Study|Lost to Follow-up|1|||
161370524|NCT04398706|582745543|FG002|Overall Study|Lost to Follow-up|2|||
161370525|NCT04398706|582745544|FG003|Overall Study|Lost to Follow-up|1|||
161370526|NCT04398706|582745545|FG004|Overall Study|Lost to Follow-up|6|||
161370527|NCT04398706|582745546|FG005|Overall Study|Lost to Follow-up|3|||
161370528|NCT04398706|582745547|FG006|Overall Study|Lost to Follow-up|8|||
161370529|NCT04398706|582745548|FG007|Overall Study|Lost to Follow-up|2|||
161370530|NCT04398706|582745541|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161370531|NCT04398706|582745542|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161370532|NCT04398706|582745543|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161370533|NCT04398706|582745544|FG003|Overall Study|Withdrawal by parent/guardian|2|||
161370534|NCT04398706|582745545|FG004|Overall Study|Withdrawal by parent/guardian|19|||
161370535|NCT04398706|582745546|FG005|Overall Study|Withdrawal by parent/guardian|23|||
161370536|NCT04398706|582745547|FG006|Overall Study|Withdrawal by parent/guardian|13|||
161370537|NCT04398706|582745548|FG007|Overall Study|Withdrawal by parent/guardian|11|||
161370538|NCT04398706|582745541|FG000|Overall Study|Protocol deviation|0|||
161370539|NCT04398706|582745542|FG001|Overall Study|Protocol deviation|1|||
161370540|NCT04398706|582745543|FG002|Overall Study|Protocol deviation|0|||
161370541|NCT04398706|582745544|FG003|Overall Study|Protocol deviation|0|||
161370542|NCT04398706|582745545|FG004|Overall Study|Protocol deviation|6|||
161370543|NCT04398706|582745546|FG005|Overall Study|Protocol deviation|4|||
161370544|NCT04398706|582745547|FG006|Overall Study|Protocol deviation|6|||
161370545|NCT04398706|582745548|FG007|Overall Study|Protocol deviation|3|||
161370546|NCT01334918|582747437|FG000|Overall Study|Did not receive study drug|6|||
161370547|NCT01334918|582747438|FG001|Overall Study|Did not receive study drug|0|||
161370548|NCT01334918|582747437|FG000|Overall Study|Adverse Event|2|||
161370549|NCT01334918|582747438|FG001|Overall Study|Adverse Event|0|||
161370550|NCT01334918|582747437|FG000|Overall Study|Withdrawal by Subject|0|||
161370551|NCT01334918|582747438|FG001|Overall Study|Withdrawal by Subject|1|||
161370552|NCT02777086|582747440|FG000|Overall Study|Lost to Follow-up|96|||
161370553|NCT02777086|582747441|FG001|Overall Study|Lost to Follow-up|99|||
161370554|NCT01133665|582747442|FG000|Overall Study|Physician Decision|2|||
161370555|NCT01732536|582747443|FG000|Overall Study|Withdrawal by Subject|1|||
161370556|NCT01732536|582747444|FG001|Overall Study|Withdrawal by Subject|1|||
161370557|NCT03376516|582747447|FG000|Overall Study|Not treated|1|||
161370558|NCT03376516|582747447|FG000|Overall Study|Consent withdrawn|1|||
161370559|NCT00370292|582747448|FG000|Overall Study|Disease Progression|4|||
161370560|NCT00370292|582747448|FG000|Overall Study|Adverse Event|7|||
161370561|NCT00370292|582747448|FG000|Overall Study|Physician Decision|2|||
161370562|NCT02986074|582747449|FG000|First Trial Period|Adverse Event|1|||
161370563|NCT02986074|582747450|FG001|First Trial Period|Adverse Event|0|||
161370564|NCT02986074|582747451|FG002|First Trial Period|Adverse Event|0|||
161370565|NCT02986074|582747452|FG003|First Trial Period|Adverse Event|0|||
161370566|NCT02986074|582747449|FG000|Follow up Period|system explant|0|||
161370567|NCT02986074|582747450|FG001|Follow up Period|system explant|0|||
161370568|NCT02986074|582747451|FG002|Follow up Period|system explant|1|||
161370569|NCT02986074|582747452|FG003|Follow up Period|system explant|2|||
161370570|NCT02986074|582747449|FG000|Follow up Period|Physician Decision|0|||
161370571|NCT02986074|582747450|FG001|Follow up Period|Physician Decision|0|||
161370572|NCT02986074|582747451|FG002|Follow up Period|Physician Decision|0|||
161370573|NCT02986074|582747452|FG003|Follow up Period|Physician Decision|1|||
161370574|NCT04099277|582747455|FG000|Overall Study|Physician Decision|1|||
161370575|NCT04099277|582747455|FG000|Overall Study|Withdrawal by Subject|1|||
161370576|NCT01664624|582747460|FG000|Overall Study|Adverse Event|0|||
161370577|NCT01664624|582747461|FG001|Overall Study|Adverse Event|1|||
161370578|NCT01664624|582747462|FG002|Overall Study|Adverse Event|0|||
161370579|NCT01664624|582747463|FG003|Overall Study|Adverse Event|0|||
161370580|NCT00524121|582747468|FG000|Overall Study|Disease progression|6|||
161370581|NCT00524121|582747468|FG000|Overall Study|Adverse Event|4|||
161370582|NCT00524121|582747468|FG000|Overall Study|Patient refused|2|||
161370583|NCT00524121|582747468|FG000|Overall Study|Other|1|||
161370584|NCT00524121|582747468|FG000|Overall Study|Death|1|||
161370585|NCT00524121|582747468|FG000|Overall Study|Not treated (became ineligible)|4|||
161370586|NCT00524121|582747468|FG000|Overall Study|Not treated (changed mind)|1|||
161370587|NCT02862574|582747469|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161370588|NCT02862574|582747470|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161370589|NCT02862574|582747471|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161370590|NCT02862574|582747469|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
161370591|NCT02862574|582747470|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
161370592|NCT02862574|582747471|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
161370593|NCT02862574|582747469|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
161370594|NCT02862574|582747470|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
161370595|NCT02862574|582747471|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
161370596|NCT00583219|582747478|FG000|Phase 2|Withdrawal by Subject|1|||
161370597|NCT02037529|582747479|FG000|Overall Study|Withdrawal by Subject|1|||
161370598|NCT02037529|582747480|FG001|Overall Study|Withdrawal by Subject|3|||
161370599|NCT02037529|582747479|FG000|Overall Study|Adverse Event|0|||
161370600|NCT02037529|582747480|FG001|Overall Study|Adverse Event|1|||
161370601|NCT02131766|582747481|FG000|Overall Study|Withdrawal by Subject|4|||
161370602|NCT00754572|582747482|FG000|Overall Study|Adverse Event|19|||
161370603|NCT00754572|582747482|FG000|Overall Study|Other|39|||
161370604|NCT00754572|582747482|FG000|Overall Study|Protocol Violation|3|||
161370605|NCT00754572|582747482|FG000|Overall Study|Withdrawal by Subject|3|||
161370606|NCT00754572|582747482|FG000|Overall Study|Lack of Efficacy|2|||
161370607|NCT00754572|582747482|FG000|Overall Study|Death|1|||
161370608|NCT00754572|582747482|FG000|Overall Study|Administrative Reason|3|||
161370609|NCT00754572|582747482|FG000|Overall Study|Lost to Follow-up|1|||
161370610|NCT00718315|582747483|FG000|Overall Study|Adverse Event|1|||
161370611|NCT00718315|582747484|FG001|Overall Study|Adverse Event|2|||
161370612|NCT00718315|582747485|FG002|Overall Study|Adverse Event|3|||
161370613|NCT00718315|582747483|FG000|Overall Study|Death|6|||
161370614|NCT00718315|582747484|FG001|Overall Study|Death|6|||
161370615|NCT00718315|582747485|FG002|Overall Study|Death|5|||
161370616|NCT00718315|582747483|FG000|Overall Study|Lost to Follow-up|2|||
161370617|NCT00718315|582747484|FG001|Overall Study|Lost to Follow-up|3|||
161370618|NCT00718315|582747485|FG002|Overall Study|Lost to Follow-up|4|||
161370619|NCT00718315|582747483|FG000|Overall Study|Protocol Violation|5|||
161370620|NCT00718315|582747484|FG001|Overall Study|Protocol Violation|5|||
161370621|NCT00718315|582747485|FG002|Overall Study|Protocol Violation|3|||
161370622|NCT00718315|582747483|FG000|Overall Study|Erlotinib dose decreased|4|||
161370623|NCT00718315|582747484|FG001|Overall Study|Erlotinib dose decreased|3|||
161370624|NCT00718315|582747485|FG002|Overall Study|Erlotinib dose decreased|1|||
161370625|NCT00718315|582747483|FG000|Overall Study|Use of Minocyclin|1|||
161370626|NCT00718315|582747484|FG001|Overall Study|Use of Minocyclin|1|||
161370627|NCT00718315|582747485|FG002|Overall Study|Use of Minocyclin|1|||
161370628|NCT00718315|582747483|FG000|Overall Study|Disease progression|0|||
161370629|NCT00718315|582747484|FG001|Overall Study|Disease progression|1|||
161370630|NCT00718315|582747485|FG002|Overall Study|Disease progression|1|||
161370631|NCT00718315|582747483|FG000|Overall Study|Other|0|||
161370632|NCT00718315|582747484|FG001|Overall Study|Other|0|||
161370633|NCT00718315|582747485|FG002|Overall Study|Other|1|||
161370634|NCT00718315|582747483|FG000|Overall Study|Use of ATB and Corticoids|0|||
161370635|NCT00718315|582747484|FG001|Overall Study|Use of ATB and Corticoids|1|||
161370636|NCT00718315|582747485|FG002|Overall Study|Use of ATB and Corticoids|2|||
161370637|NCT02271880|582747488|FG000|Overall Study|Premature discontinuation of study|3|||
161370638|NCT02271880|582747489|FG001|Overall Study|Premature discontinuation of study|4|||
161370639|NCT00474903|582747491|FG000|Overall Study|Protocol Violation|1|||
161370640|NCT00474903|582747492|FG001|Overall Study|Protocol Violation|5|||
161370641|NCT00474903|582747493|FG002|Overall Study|Protocol Violation|2|||
161370642|NCT02519842|582747496|FG000|Base Study: Cycle 1|Screening Failure|1|||
161370643|NCT02519842|582747497|FG001|Base Study: Cycle 1|Screening Failure|1|||
161370644|NCT02519842|582747498|FG002|Base Study: Cycle 1|Screening Failure|0|||
161370645|NCT02519842|582747496|FG000|Base Study: Cycle 1|Adverse Event|1|||
161370646|NCT02519842|582747497|FG001|Base Study: Cycle 1|Adverse Event|0|||
161370647|NCT02519842|582747498|FG002|Base Study: Cycle 1|Adverse Event|0|||
161370648|NCT02519842|582747496|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
161370649|NCT02519842|582747497|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
161370650|NCT02519842|582747498|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
161370651|NCT02519842|582747496|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
161370652|NCT02519842|582747497|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
161370653|NCT02519842|582747498|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
161370654|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
161370655|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
161370656|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
161370657|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
161370658|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
161370659|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
161370660|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161370661|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161370662|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
161370663|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
161370664|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
161370665|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
161370666|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Death|0|||
161370667|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Death|0|||
161370668|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Death|1|||
161370669|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
161370670|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
161370671|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
161370672|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
161370673|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
161370674|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
161370675|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
161370676|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
161370677|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
161370678|NCT02519842|582747496|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
161370679|NCT02519842|582747497|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
161370680|NCT02519842|582747498|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
161370681|NCT01561976|582747500|FG000|Period 1|Adverse Event|0|||
161370682|NCT01561976|582747501|FG001|Period 1|Adverse Event|0|||
161370683|NCT01561976|582747502|FG002|Period 1|Adverse Event|1|||
161370684|NCT01561976|582747503|FG003|Period 1|Adverse Event|0|||
161370685|NCT01561976|582747504|FG004|Period 1|Adverse Event|0|||
161370686|NCT01561976|582747505|FG005|Period 1|Adverse Event|0|||
161370687|NCT01561976|582747500|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
161370688|NCT01561976|582747501|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
161370689|NCT01561976|582747502|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
161370690|NCT01561976|582747503|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
161370691|NCT01561976|582747504|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
161370692|NCT01561976|582747505|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
161370693|NCT01561976|582747500|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161370694|NCT01561976|582747501|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161370695|NCT01561976|582747502|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161370696|NCT01561976|582747503|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161370697|NCT01561976|582747504|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161370698|NCT01561976|582747505|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161370699|NCT01561976|582747500|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
161370700|NCT01561976|582747501|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
161370701|NCT01561976|582747502|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
161370702|NCT01561976|582747503|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
161370703|NCT01561976|582747504|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
161370704|NCT01561976|582747505|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
161370705|NCT01977222|582747508|FG000|Overall Study|Withdrawal by Subject|1|||
161370706|NCT02980107|582747509|FG000|Overall Study|Withdrawal by Subject|51|||
161370707|NCT02980107|582747510|FG001|Overall Study|Withdrawal by Subject|62|||
161370708|NCT03746015|582747511|FG000|Overall Study|Withdrawal of Consent|1|||
161370709|NCT03746015|582747512|FG001|Overall Study|Withdrawal of Consent|0|||
161370710|NCT03746015|582747513|FG002|Overall Study|Withdrawal of Consent|0|||
161370711|NCT00928668|582747514|FG000|Overall Study|Adverse Event|1|||
161370712|NCT00928668|582747515|FG001|Overall Study|Adverse Event|0|||
161370713|NCT00928668|582747516|FG002|Overall Study|Adverse Event|0|||
161370714|NCT00928668|582747517|FG003|Overall Study|Adverse Event|0|||
161370715|NCT00928668|582747518|FG004|Overall Study|Adverse Event|0|||
161370716|NCT00928668|582747514|FG000|Overall Study|Protocol Violation|0|||
161370717|NCT00928668|582747515|FG001|Overall Study|Protocol Violation|0|||
161370718|NCT00928668|582747516|FG002|Overall Study|Protocol Violation|0|||
161370719|NCT00928668|582747517|FG003|Overall Study|Protocol Violation|0|||
161370720|NCT00928668|582747518|FG004|Overall Study|Protocol Violation|1|||
161370721|NCT00928668|582747514|FG000|Overall Study|Withdrawal by Subject|0|||
161370722|NCT00928668|582747515|FG001|Overall Study|Withdrawal by Subject|1|||
161370723|NCT00928668|582747516|FG002|Overall Study|Withdrawal by Subject|1|||
161370724|NCT00928668|582747517|FG003|Overall Study|Withdrawal by Subject|0|||
161370725|NCT00928668|582747518|FG004|Overall Study|Withdrawal by Subject|0|||
161370726|NCT00928668|582747514|FG000|Overall Study|Other reasons not listed above|0|||
161370727|NCT00928668|582747515|FG001|Overall Study|Other reasons not listed above|0|||
161370728|NCT00928668|582747516|FG002|Overall Study|Other reasons not listed above|0|||
161370729|NCT00928668|582747517|FG003|Overall Study|Other reasons not listed above|1|||
161370730|NCT00928668|582747518|FG004|Overall Study|Other reasons not listed above|0|||
161370731|NCT02303262|582747519|FG000|Overall Study|Withdrawal by Subject|2|||
161370732|NCT02943473|582747520|FG000|Overall Study|enrolled but not dosed|1|||
161370733|NCT02943473|582747520|FG000|Overall Study|screen failure|1|||
161370734|NCT02943473|582747520|FG000|Overall Study|Physician Decision|4|||
161370735|NCT01728246|582747521|FG000|Overall Study|Participant needed rescue medication|1|||
161370736|NCT01728246|582747522|FG001|Overall Study|Participant needed rescue medication|5|||
161370737|NCT01728246|582747521|FG000|Overall Study|Protocol Violation|1|||
161370738|NCT01728246|582747522|FG001|Overall Study|Protocol Violation|0|||
161370739|NCT01728246|582747521|FG000|Overall Study|Withdrawal by Subject|2|||
161370740|NCT01728246|582747522|FG001|Overall Study|Withdrawal by Subject|3|||
161370741|NCT01728246|582747521|FG000|Overall Study|Lost to Follow-up|23|||
161370742|NCT01728246|582747522|FG001|Overall Study|Lost to Follow-up|22|||
161370743|NCT01728246|582747521|FG000|Overall Study|Lack of Efficacy|1|||
161370744|NCT01728246|582747522|FG001|Overall Study|Lack of Efficacy|1|||
161370745|NCT01728246|582747521|FG000|Overall Study|Adverse Event|8|||
161370746|NCT01728246|582747522|FG001|Overall Study|Adverse Event|5|||
161370747|NCT05805150|582747523|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
161370748|NCT05805150|582747524|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
161370749|NCT04138056|582747527|FG000|Primary Study|Lost to Follow-up|3|||
161370750|NCT04138056|582747528|FG001|Primary Study|Lost to Follow-up|4|||
161370751|NCT04138056|582747529|FG002|Primary Study|Lost to Follow-up|1|||
161370752|NCT04138056|582747530|FG003|Primary Study|Lost to Follow-up|1|||
161370753|NCT04138056|582747531|FG004|Primary Study|Lost to Follow-up|4|||
161370754|NCT04138056|582747527|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
161370755|NCT04138056|582747528|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
161370756|NCT04138056|582747529|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
161370757|NCT04138056|582747530|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
161370758|NCT04138056|582747531|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
161370759|NCT04138056|582747527|FG000|Extension Study|Lost to Follow-up|1|||
161370760|NCT04138056|582747528|FG001|Extension Study|Lost to Follow-up|2|||
161370761|NCT04138056|582747529|FG002|Extension Study|Lost to Follow-up|1|||
161370762|NCT04138056|582747530|FG003|Extension Study|Lost to Follow-up|0|||
161370763|NCT04138056|582747531|FG004|Extension Study|Lost to Follow-up|1|||
161370764|NCT01968980|582747535|FG000|Overall Study|Death|0|||
161370765|NCT01968980|582747536|FG001|Overall Study|Death|1|||
161370766|NCT01968980|582747535|FG000|Overall Study|Adverse Event|1|||
161370767|NCT01968980|582747536|FG001|Overall Study|Adverse Event|3|||
161370768|NCT01968980|582747535|FG000|Overall Study|Does not meet entry criteria|1|||
161370769|NCT01968980|582747536|FG001|Overall Study|Does not meet entry criteria|3|||
161370770|NCT01968980|582747535|FG000|Overall Study|Withdrawal by Subject|13|||
161370771|NCT01968980|582747536|FG001|Overall Study|Withdrawal by Subject|5|||
161370772|NCT01968980|582747535|FG000|Overall Study|Other unspecified|1|||
161370773|NCT01968980|582747536|FG001|Overall Study|Other unspecified|2|||
161370774|NCT01242514|582747537|FG000|Overall Study|e.g., project closure|1042|||
161370775|NCT01242514|582747538|FG001|Overall Study|e.g., project closure|305|||
161370776|NCT01242514|582747539|FG002|Overall Study|e.g., project closure|171|||
161370777|NCT01242514|582747537|FG000|Overall Study|Subject decision|33|||
161370778|NCT01242514|582747538|FG001|Overall Study|Subject decision|8|||
161370779|NCT01242514|582747539|FG002|Overall Study|Subject decision|2|||
161370780|NCT01242514|582747537|FG000|Overall Study|Severe non-compliance to protocol|5|||
161370781|NCT01242514|582747538|FG001|Overall Study|Severe non-compliance to protocol|2|||
161370782|NCT01242514|582747539|FG002|Overall Study|Severe non-compliance to protocol|1|||
161370783|NCT01242514|582747537|FG000|Overall Study|Lack of therapeutic response|99|||
161370784|NCT01242514|582747538|FG001|Overall Study|Lack of therapeutic response|16|||
161370785|NCT01242514|582747539|FG002|Overall Study|Lack of therapeutic response|10|||
161370786|NCT01242514|582747537|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
161370787|NCT01242514|582747538|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
161370788|NCT01242514|582747539|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
161370789|NCT01242514|582747537|FG000|Overall Study|Lost to Follow-up|14|||
161370790|NCT01242514|582747538|FG001|Overall Study|Lost to Follow-up|5|||
161370791|NCT01242514|582747539|FG002|Overall Study|Lost to Follow-up|4|||
161370792|NCT01242514|582747537|FG000|Overall Study|Adverse Event|129|||
161370793|NCT01242514|582747538|FG001|Overall Study|Adverse Event|18|||
161370794|NCT01242514|582747539|FG002|Overall Study|Adverse Event|19|||
161370795|NCT00862940|582747544|FG000|Overall Study|Adverse Event|15|||
161370796|NCT00862940|582747545|FG001|Overall Study|Adverse Event|12|||
161370797|NCT00862940|582747544|FG000|Overall Study|Lack of Efficacy|1|||
161370798|NCT00862940|582747545|FG001|Overall Study|Lack of Efficacy|3|||
161370799|NCT00862940|582747544|FG000|Overall Study|Protocol Violation|2|||
161370800|NCT00862940|582747545|FG001|Overall Study|Protocol Violation|5|||
161370801|NCT00862940|582747544|FG000|Overall Study|Withdrawal by Subject|4|||
161370802|NCT00862940|582747545|FG001|Overall Study|Withdrawal by Subject|6|||
161370803|NCT00862940|582747544|FG000|Overall Study|Non-compliance|4|||
161370804|NCT00862940|582747545|FG001|Overall Study|Non-compliance|0|||
161370805|NCT00862940|582747544|FG000|Overall Study|Lost to Follow-up|0|||
161370806|NCT00862940|582747545|FG001|Overall Study|Lost to Follow-up|1|||
161370807|NCT00862940|582747544|FG000|Overall Study|Administrative or other reason(s)|4|||
161370808|NCT00862940|582747545|FG001|Overall Study|Administrative or other reason(s)|3|||
161370809|NCT00485173|582747546|FG000|Overall Study|Death|4|||
161370810|NCT00485173|582747547|FG001|Overall Study|Death|3|||
161370811|NCT00485173|582747546|FG000|Overall Study|Lost to Follow-up|32|||
161370812|NCT00485173|582747547|FG001|Overall Study|Lost to Follow-up|61|||
161370813|NCT00879398|582747550|FG000|Overall Study|Visit Stop|399|||
161370814|NCT00879398|582747550|FG000|Overall Study|Lack of Efficacy|64|||
161370815|NCT00879398|582747550|FG000|Overall Study|Adverse Event|41|||
161370816|NCT00879398|582747550|FG000|Overall Study|Other Reasons|171|||
161370817|NCT00829244|582747551|FG000|Overall Study|Adverse Event|1|||
161370818|NCT00829244|582747552|FG001|Overall Study|Adverse Event|3|||
161370819|NCT00829244|582747551|FG000|Overall Study|Protocol Violation|1|||
161370820|NCT00829244|582747552|FG001|Overall Study|Protocol Violation|0|||
161370821|NCT00829244|582747551|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
161370822|NCT00829244|582747552|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
161370823|NCT00829244|582747551|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
161370824|NCT00829244|582747552|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
161370825|NCT00829244|582747551|FG000|Overall Study|No fertilization|2|||
161370826|NCT00829244|582747552|FG001|Overall Study|No fertilization|2|||
161370827|NCT00829244|582747551|FG000|Overall Study|All embryos discarded|0|||
161370828|NCT00829244|582747552|FG001|Overall Study|All embryos discarded|3|||
161370829|NCT00829244|582747551|FG000|Overall Study|No embryo cleavage|0|||
161370830|NCT00829244|582747552|FG001|Overall Study|No embryo cleavage|2|||
161370831|NCT05901636|582747559|FG000|Overall Study|Lost to Follow-up|0|||
161370832|NCT05901636|582747560|FG001|Overall Study|Lost to Follow-up|1|||
161370833|NCT05901636|582747561|FG002|Overall Study|Lost to Follow-up|0|||
161370834|NCT05901636|582747562|FG003|Overall Study|Lost to Follow-up|1|||
161370835|NCT05901636|582747563|FG004|Overall Study|Lost to Follow-up|1|||
161370836|NCT05901636|582747564|FG005|Overall Study|Lost to Follow-up|3|||
161370837|NCT05901636|582747565|FG006|Overall Study|Lost to Follow-up|1|||
161370838|NCT05901636|582747559|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
161370839|NCT05901636|582747560|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
161370840|NCT05901636|582747561|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
161370841|NCT05901636|582747562|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
161370842|NCT05901636|582747563|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
161370843|NCT05901636|582747564|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
161370844|NCT05901636|582747565|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
161370845|NCT05901636|582747559|FG000|Overall Study|Withdrawal by Subject|1|||
161370846|NCT05901636|582747560|FG001|Overall Study|Withdrawal by Subject|1|||
161370847|NCT05901636|582747561|FG002|Overall Study|Withdrawal by Subject|0|||
161370848|NCT05901636|582747562|FG003|Overall Study|Withdrawal by Subject|0|||
161370849|NCT05901636|582747563|FG004|Overall Study|Withdrawal by Subject|1|||
161370850|NCT05901636|582747564|FG005|Overall Study|Withdrawal by Subject|1|||
161370851|NCT05901636|582747565|FG006|Overall Study|Withdrawal by Subject|0|||
161370852|NCT05901636|582747559|FG000|Overall Study|Other|0|||
161370853|NCT05901636|582747560|FG001|Overall Study|Other|0|||
161370854|NCT05901636|582747561|FG002|Overall Study|Other|1|||
161370855|NCT05901636|582747562|FG003|Overall Study|Other|1|||
161370856|NCT05901636|582747563|FG004|Overall Study|Other|0|||
161370857|NCT05901636|582747564|FG005|Overall Study|Other|0|||
161370858|NCT05901636|582747565|FG006|Overall Study|Other|0|||
161370859|NCT04583618|582747573|FG000|Overall Study|Adverse Event|0|||
161370860|NCT04583618|582747574|FG001|Overall Study|Adverse Event|0|||
161370861|NCT04583618|582747575|FG002|Overall Study|Adverse Event|1|||
161370862|NCT04583618|582747576|FG003|Overall Study|Adverse Event|0|||
161370863|NCT04583618|582747577|FG004|Overall Study|Adverse Event|0|||
161370864|NCT04583618|582747573|FG000|Overall Study|Protocol deviation|1|||
161370865|NCT04583618|582747574|FG001|Overall Study|Protocol deviation|1|||
161370866|NCT04583618|582747575|FG002|Overall Study|Protocol deviation|1|||
161370867|NCT04583618|582747576|FG003|Overall Study|Protocol deviation|0|||
161370868|NCT04583618|582747577|FG004|Overall Study|Protocol deviation|0|||
161370869|NCT04583618|582747573|FG000|Overall Study|Withdrawal by Subject|2|||
161370870|NCT04583618|582747574|FG001|Overall Study|Withdrawal by Subject|1|||
161370871|NCT04583618|582747575|FG002|Overall Study|Withdrawal by Subject|3|||
161370872|NCT04583618|582747576|FG003|Overall Study|Withdrawal by Subject|1|||
161370873|NCT04583618|582747577|FG004|Overall Study|Withdrawal by Subject|1|||
161370874|NCT04583618|582747573|FG000|Overall Study|Lost to Follow-up|0|||
161370875|NCT04583618|582747574|FG001|Overall Study|Lost to Follow-up|1|||
161370876|NCT04583618|582747575|FG002|Overall Study|Lost to Follow-up|3|||
161370877|NCT04583618|582747576|FG003|Overall Study|Lost to Follow-up|1|||
161370878|NCT04583618|582747577|FG004|Overall Study|Lost to Follow-up|1|||
161370879|NCT02302222|582747578|FG000|Overall Study|Physician Decision|0|||
161370880|NCT02302222|582747579|FG001|Overall Study|Physician Decision|4|||
161370881|NCT02302222|582747578|FG000|Overall Study|Lost to Follow-up|1|||
161370882|NCT02302222|582747579|FG001|Overall Study|Lost to Follow-up|0|||
161370883|NCT02302222|582747578|FG000|Overall Study|Treatment discontinued before day 5|0|||
161370884|NCT02302222|582747579|FG001|Overall Study|Treatment discontinued before day 5|1|||
161370885|NCT02302222|582747578|FG000|Overall Study|Withdrawn prior to any treatment|0|||
161370886|NCT02302222|582747579|FG001|Overall Study|Withdrawn prior to any treatment|1|||
161370887|NCT00016354|582747580|FG000|Overall Study|Lack of Efficacy|0|||
161370888|NCT00016354|582747581|FG001|Overall Study|Lack of Efficacy|0|||
161370889|NCT00016354|582747582|FG002|Overall Study|Lack of Efficacy|0|||
161370890|NCT00016354|582747583|FG003|Overall Study|Lack of Efficacy|0|||
161370891|NCT00016354|582747584|FG004|Overall Study|Lack of Efficacy|0|||
161370892|NCT00016354|582747585|FG005|Overall Study|Lack of Efficacy|0|||
161370893|NCT00016354|582747586|FG006|Overall Study|Lack of Efficacy|0|||
161370894|NCT00016354|582747587|FG007|Overall Study|Lack of Efficacy|1|||
161370895|NCT03193801|582747588|FG000|Overall Study|Physician Decision|2|||
161370896|NCT03193801|582747588|FG000|Overall Study|Withdrawal by Subject|1|||
161370897|NCT03110562|582747589|FG000|Initial Treatment Period|Disease Progression|1|||
161370898|NCT03110562|582747590|FG001|Initial Treatment Period|Disease Progression|1|||
161370899|NCT03110562|582747591|FG002|Initial Treatment Period|Disease Progression|0|||
161370900|NCT03110562|582747592|FG003|Initial Treatment Period|Disease Progression|0|||
161370901|NCT03110562|582747589|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
161370902|NCT03110562|582747590|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
161370903|NCT03110562|582747591|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
161370904|NCT03110562|582747592|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
161370905|NCT03110562|582747589|FG000|Initial Treatment Period|Adverse Event|1|||
161370906|NCT03110562|582747590|FG001|Initial Treatment Period|Adverse Event|0|||
161370907|NCT03110562|582747591|FG002|Initial Treatment Period|Adverse Event|0|||
161370908|NCT03110562|582747592|FG003|Initial Treatment Period|Adverse Event|0|||
161370909|NCT03110562|582747589|FG000|Initial Treatment Period|Death|74|||
161370910|NCT03110562|582747590|FG001|Initial Treatment Period|Death|82|||
161370911|NCT03110562|582747591|FG002|Initial Treatment Period|Death|0|||
161370912|NCT03110562|582747592|FG003|Initial Treatment Period|Death|0|||
161370913|NCT03110562|582747589|FG000|Initial Treatment Period|Lost to Follow-up|13|||
161370914|NCT03110562|582747590|FG001|Initial Treatment Period|Lost to Follow-up|8|||
161370915|NCT03110562|582747591|FG002|Initial Treatment Period|Lost to Follow-up|0|||
161370916|NCT03110562|582747592|FG003|Initial Treatment Period|Lost to Follow-up|0|||
161370917|NCT03110562|582747589|FG000|Initial Treatment Period|Protocol Deviation|1|||
161370918|NCT03110562|582747590|FG001|Initial Treatment Period|Protocol Deviation|0|||
161370919|NCT03110562|582747591|FG002|Initial Treatment Period|Protocol Deviation|0|||
161370920|NCT03110562|582747592|FG003|Initial Treatment Period|Protocol Deviation|0|||
161370921|NCT03110562|582747589|FG000|Initial Treatment Period|Physician Decision|2|||
161370922|NCT03110562|582747590|FG001|Initial Treatment Period|Physician Decision|1|||
161370923|NCT03110562|582747591|FG002|Initial Treatment Period|Physician Decision|0|||
161370924|NCT03110562|582747592|FG003|Initial Treatment Period|Physician Decision|0|||
161370925|NCT03110562|582747589|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
161370926|NCT03110562|582747590|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
161370927|NCT03110562|582747591|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
161370928|NCT03110562|582747592|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
161370929|NCT03110562|582747589|FG000|Initial Treatment Period|Other|5|||
161370930|NCT03110562|582747590|FG001|Initial Treatment Period|Other|4|||
161370931|NCT03110562|582747591|FG002|Initial Treatment Period|Other|0|||
161370932|NCT03110562|582747592|FG003|Initial Treatment Period|Other|0|||
161370933|NCT03110562|582747589|FG000|Initial Treatment Period|Randomized but never treated|0|||
161370934|NCT03110562|582747590|FG001|Initial Treatment Period|Randomized but never treated|3|||
161370935|NCT03110562|582747591|FG002|Initial Treatment Period|Randomized but never treated|0|||
161370936|NCT03110562|582747592|FG003|Initial Treatment Period|Randomized but never treated|0|||
161370937|NCT03110562|582747589|FG000|Crossover Period|Disease Progression|0|||
161370938|NCT03110562|582747590|FG001|Crossover Period|Disease Progression|0|||
161370939|NCT03110562|582747591|FG002|Crossover Period|Disease Progression|1|||
161370940|NCT03110562|582747592|FG003|Crossover Period|Disease Progression|0|||
161370941|NCT03110562|582747589|FG000|Crossover Period|Withdrawal by Subject|0|||
161370942|NCT03110562|582747590|FG001|Crossover Period|Withdrawal by Subject|0|||
161370943|NCT03110562|582747591|FG002|Crossover Period|Withdrawal by Subject|8|||
161370944|NCT03110562|582747592|FG003|Crossover Period|Withdrawal by Subject|6|||
161370945|NCT03110562|582747589|FG000|Crossover Period|Death|0|||
161370946|NCT03110562|582747590|FG001|Crossover Period|Death|0|||
161370947|NCT03110562|582747591|FG002|Crossover Period|Death|37|||
161370948|NCT03110562|582747592|FG003|Crossover Period|Death|3|||
161370949|NCT03110562|582747589|FG000|Crossover Period|Lost to Follow-up|0|||
161370950|NCT03110562|582747590|FG001|Crossover Period|Lost to Follow-up|0|||
161370951|NCT03110562|582747591|FG002|Crossover Period|Lost to Follow-up|0|||
161370952|NCT03110562|582747592|FG003|Crossover Period|Lost to Follow-up|1|||
161370953|NCT03110562|582747589|FG000|Crossover Period|Other|0|||
161370954|NCT03110562|582747590|FG001|Crossover Period|Other|0|||
161370955|NCT03110562|582747591|FG002|Crossover Period|Other|1|||
161370956|NCT03110562|582747592|FG003|Crossover Period|Other|1|||
161370957|NCT03110562|582747589|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
161370958|NCT03110562|582747590|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
161370959|NCT03110562|582747591|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
161370960|NCT03110562|582747592|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
161370961|NCT02114177|582749083|FG000|Overall Study|Lost to Follow-up|1|||
161370962|NCT02114177|582749084|FG001|Overall Study|Lost to Follow-up|2|||
161370963|NCT02114177|582749083|FG000|Overall Study|Withdrawal by Subject|6|||
161370964|NCT02114177|582749084|FG001|Overall Study|Withdrawal by Subject|1|||
161370965|NCT02114177|582749083|FG000|Overall Study|Other|2|||
161370966|NCT02114177|582749084|FG001|Overall Study|Other|1|||
161370967|NCT01897493|582749085|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
161370968|NCT00805389|582749090|FG000|Overall Study|Adverse Event|0|||
161370969|NCT00805389|582749091|FG001|Overall Study|Adverse Event|0|||
161370970|NCT00805389|582749092|FG002|Overall Study|Adverse Event|1|||
161370971|NCT00805389|582749093|FG003|Overall Study|Adverse Event|2|||
161370972|NCT00805389|582749094|FG004|Overall Study|Adverse Event|0|||
161370973|NCT00805389|582749090|FG000|Overall Study|Lost to Follow-up|4|||
161370974|NCT00805389|582749091|FG001|Overall Study|Lost to Follow-up|3|||
161370975|NCT00805389|582749092|FG002|Overall Study|Lost to Follow-up|6|||
161370976|NCT00805389|582749093|FG003|Overall Study|Lost to Follow-up|10|||
161370977|NCT00805389|582749094|FG004|Overall Study|Lost to Follow-up|9|||
161370978|NCT00805389|582749090|FG000|Overall Study|Protocol Violation|0|||
161370979|NCT00805389|582749091|FG001|Overall Study|Protocol Violation|0|||
161370980|NCT00805389|582749092|FG002|Overall Study|Protocol Violation|1|||
161370981|NCT00805389|582749093|FG003|Overall Study|Protocol Violation|0|||
161370982|NCT00805389|582749094|FG004|Overall Study|Protocol Violation|0|||
161370983|NCT00805389|582749090|FG000|Overall Study|Withdrawal by Subject|3|||
161370984|NCT00805389|582749091|FG001|Overall Study|Withdrawal by Subject|2|||
161370985|NCT00805389|582749092|FG002|Overall Study|Withdrawal by Subject|4|||
161370986|NCT00805389|582749093|FG003|Overall Study|Withdrawal by Subject|5|||
161370987|NCT00805389|582749094|FG004|Overall Study|Withdrawal by Subject|4|||
161370988|NCT01246960|582749095|FG000|Overall Study|Lost to Follow-up|3|||
161370989|NCT01246960|582749096|FG001|Overall Study|Lost to Follow-up|1|||
161370990|NCT01246960|582749095|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
161370991|NCT01246960|582749096|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
161370992|NCT05111145|582749099|FG000|Overall Study|Commercial drug is available for participant|76|||
161370993|NCT05111145|582749099|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
161370994|NCT02336815|582749100|FG000|Overall Study|Disease Progression|45|||
161370995|NCT02336815|582749101|FG001|Overall Study|Disease Progression|70|||
161370996|NCT02336815|582749100|FG000|Overall Study|Adverse Event|18|||
161370997|NCT02336815|582749101|FG001|Overall Study|Adverse Event|39|||
161370998|NCT02336815|582749100|FG000|Overall Study|Physician Decision|11|||
161370999|NCT02336815|582749101|FG001|Overall Study|Physician Decision|4|||
161371000|NCT02336815|582749100|FG000|Overall Study|Withdrawal by Subject|3|||
161371001|NCT02336815|582749101|FG001|Overall Study|Withdrawal by Subject|2|||
161371002|NCT02336815|582749100|FG000|Overall Study|Lost to Follow-up|1|||
161371003|NCT02336815|582749101|FG001|Overall Study|Lost to Follow-up|3|||
161371004|NCT02336815|582749100|FG000|Overall Study|Other|1|||
161371005|NCT02336815|582749101|FG001|Overall Study|Other|5|||
161371006|NCT02239926|582749102|FG000|Overall Study|Withdrawal by Subject|0|||
161371007|NCT02239926|582749103|FG001|Overall Study|Withdrawal by Subject|1|||
161371008|NCT00598650|582749104|FG000|Overall Study|Withdrawal by Subject|3|||
161371009|NCT00598650|582749104|FG000|Overall Study|Adverse Event|18|||
161371010|NCT00598650|582749104|FG000|Overall Study|No treatment for 3 weeks|1|||
161371011|NCT00598650|582749104|FG000|Overall Study|Not eligible|1|||
161371012|NCT00598650|582749104|FG000|Overall Study|Prohibited Concomitant Medication|2|||
161371013|NCT00598650|582749104|FG000|Overall Study|Physician Decision|2|||
161371014|NCT01628913|582749105|FG000|Overall Study|Adverse Event|12|||
161371015|NCT01628913|582749106|FG001|Overall Study|Adverse Event|5|||
161371016|NCT01628913|582749105|FG000|Overall Study|Disease Progression|11|||
161371017|NCT01628913|582749106|FG001|Overall Study|Disease Progression|14|||
161371018|NCT01628913|582749105|FG000|Overall Study|Protocol Violation|1|||
161371019|NCT01628913|582749106|FG001|Overall Study|Protocol Violation|0|||
161371020|NCT01628913|582749105|FG000|Overall Study|Death|1|||
161371021|NCT01628913|582749106|FG001|Overall Study|Death|0|||
161371022|NCT01628913|582749105|FG000|Overall Study|study terminated by Sponsor|4|||
161371023|NCT01628913|582749106|FG001|Overall Study|study terminated by Sponsor|9|||
161371024|NCT01628913|582749105|FG000|Overall Study|Withdrawal by Subject|1|||
161371025|NCT01628913|582749106|FG001|Overall Study|Withdrawal by Subject|0|||
161371026|NCT01628913|582749105|FG000|Overall Study|Physician Decision|1|||
161371027|NCT01628913|582749106|FG001|Overall Study|Physician Decision|3|||
161371028|NCT05201807|582749110|FG000|Overall Study|Adverse Event|1|||
161371029|NCT05201807|582749110|FG000|Overall Study|COVID-19 Related|1|||
161371030|NCT00105534|582749111|FG000|Overall Study|Adverse Event|2|||
161371031|NCT00105534|582749112|FG001|Overall Study|Adverse Event|5|||
161371032|NCT00105534|582749111|FG000|Overall Study|Protocol Violation|1|||
161371033|NCT00105534|582749112|FG001|Overall Study|Protocol Violation|4|||
161371034|NCT00105534|582749111|FG000|Overall Study|Withdrawal by Subject|6|||
161371035|NCT00105534|582749112|FG001|Overall Study|Withdrawal by Subject|6|||
161371036|NCT00105534|582749111|FG000|Overall Study|Lost to Follow-up|5|||
161371037|NCT00105534|582749112|FG001|Overall Study|Lost to Follow-up|1|||
161371038|NCT00105534|582749111|FG000|Overall Study|Lack of Efficacy|7|||
161371039|NCT00105534|582749112|FG001|Overall Study|Lack of Efficacy|15|||
161371040|NCT00105534|582749111|FG000|Overall Study|Treatment unmasked|1|||
161371041|NCT00105534|582749112|FG001|Overall Study|Treatment unmasked|0|||
161371042|NCT00105534|582749111|FG000|Overall Study|Other Reason|0|||
161371043|NCT00105534|582749112|FG001|Overall Study|Other Reason|2|||
161371044|NCT02465931|582749113|FG000|Overall Study|Lost to Follow-up|9|||
161371045|NCT02465931|582749114|FG001|Overall Study|Lost to Follow-up|11|||
161371046|NCT02465931|582749113|FG000|Overall Study|Protocol Violation|1|||
161371047|NCT02465931|582749114|FG001|Overall Study|Protocol Violation|0|||
161371048|NCT02465931|582749113|FG000|Overall Study|Withdrawal by Subject|1|||
161371049|NCT02465931|582749114|FG001|Overall Study|Withdrawal by Subject|0|||
161371050|NCT03423121|582749116|FG000|Overall Study|Lost to Follow-up|2|||
161371051|NCT03423121|582749117|FG001|Overall Study|Lost to Follow-up|6|||
161371052|NCT03423121|582749116|FG000|Overall Study|Adverse Event|1|||
161371053|NCT03423121|582749117|FG001|Overall Study|Adverse Event|0|||
161371054|NCT03289143|582749122|FG000|Overall Study|Caregiver Unavailability|1|||
161371055|NCT03289143|582749123|FG001|Overall Study|Caregiver Unavailability|1|||
161371056|NCT03289143|582749124|FG002|Overall Study|Caregiver Unavailability|0|||
161371057|NCT03289143|582749125|FG003|Overall Study|Caregiver Unavailability|0|||
161371058|NCT03289143|582749122|FG000|Overall Study|Research Department Closure|0|||
161371059|NCT03289143|582749123|FG001|Overall Study|Research Department Closure|0|||
161371060|NCT03289143|582749124|FG002|Overall Study|Research Department Closure|1|||
161371061|NCT03289143|582749125|FG003|Overall Study|Research Department Closure|0|||
161371062|NCT03289143|582749122|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
161371063|NCT03289143|582749123|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
161371064|NCT03289143|582749124|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
161371065|NCT03289143|582749125|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
161371066|NCT03289143|582749122|FG000|Overall Study|Medical Monitor Decision|1|||
161371067|NCT03289143|582749123|FG001|Overall Study|Medical Monitor Decision|0|||
161371068|NCT03289143|582749124|FG002|Overall Study|Medical Monitor Decision|0|||
161371069|NCT03289143|582749125|FG003|Overall Study|Medical Monitor Decision|0|||
161371070|NCT03289143|582749122|FG000|Overall Study|Participant Non-Compliance|0|||
161371071|NCT03289143|582749123|FG001|Overall Study|Participant Non-Compliance|0|||
161371072|NCT03289143|582749124|FG002|Overall Study|Participant Non-Compliance|1|||
161371073|NCT03289143|582749125|FG003|Overall Study|Participant Non-Compliance|0|||
161371074|NCT03289143|582749122|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
161371075|NCT03289143|582749123|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
161371076|NCT03289143|582749124|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
161371077|NCT03289143|582749125|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
161371078|NCT03289143|582749122|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
161371079|NCT03289143|582749123|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
161371080|NCT03289143|582749124|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
161371081|NCT03289143|582749125|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
161371082|NCT03289143|582749122|FG000|Overall Study|Caregiver Passed Away|1|||
161371083|NCT03289143|582749123|FG001|Overall Study|Caregiver Passed Away|0|||
161371084|NCT03289143|582749124|FG002|Overall Study|Caregiver Passed Away|0|||
161371085|NCT03289143|582749125|FG003|Overall Study|Caregiver Passed Away|0|||
161371086|NCT03289143|582749122|FG000|Overall Study|Physician Decision|0|||
161371087|NCT03289143|582749123|FG001|Overall Study|Physician Decision|2|||
161371088|NCT03289143|582749124|FG002|Overall Study|Physician Decision|2|||
161371089|NCT03289143|582749125|FG003|Overall Study|Physician Decision|2|||
161371090|NCT03289143|582749122|FG000|Overall Study|Protocol Deviation|2|||
161371091|NCT03289143|582749123|FG001|Overall Study|Protocol Deviation|1|||
161371092|NCT03289143|582749124|FG002|Overall Study|Protocol Deviation|3|||
161371093|NCT03289143|582749125|FG003|Overall Study|Protocol Deviation|1|||
161371094|NCT03289143|582749122|FG000|Overall Study|Study Terminated By Sponsor|101|||
161371095|NCT03289143|582749123|FG001|Overall Study|Study Terminated By Sponsor|75|||
161371096|NCT03289143|582749124|FG002|Overall Study|Study Terminated By Sponsor|100|||
161371097|NCT03289143|582749125|FG003|Overall Study|Study Terminated By Sponsor|69|||
161371098|NCT03289143|582749122|FG000|Overall Study|Withdrawal by Subject|14|||
161371099|NCT03289143|582749123|FG001|Overall Study|Withdrawal by Subject|6|||
161371100|NCT03289143|582749124|FG002|Overall Study|Withdrawal by Subject|14|||
161371101|NCT03289143|582749125|FG003|Overall Study|Withdrawal by Subject|12|||
161371102|NCT03289143|582749122|FG000|Overall Study|Adverse Event|10|||
161371103|NCT03289143|582749123|FG001|Overall Study|Adverse Event|7|||
161371104|NCT03289143|582749124|FG002|Overall Study|Adverse Event|6|||
161371105|NCT03289143|582749125|FG003|Overall Study|Adverse Event|5|||
161371106|NCT03289143|582749122|FG000|Overall Study|Death|2|||
161371107|NCT03289143|582749123|FG001|Overall Study|Death|0|||
161371108|NCT03289143|582749124|FG002|Overall Study|Death|2|||
161371109|NCT03289143|582749125|FG003|Overall Study|Death|1|||
161371110|NCT03289143|582749122|FG000|Overall Study|Lost to Follow-up|2|||
161371111|NCT03289143|582749123|FG001|Overall Study|Lost to Follow-up|1|||
161371112|NCT03289143|582749124|FG002|Overall Study|Lost to Follow-up|1|||
161371113|NCT03289143|582749125|FG003|Overall Study|Lost to Follow-up|0|||
161371114|NCT03289143|582749122|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
161371115|NCT03289143|582749123|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
161371116|NCT03289143|582749124|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
161371117|NCT03289143|582749125|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
161371118|NCT03289143|582749122|FG000|Overall Study|Withdrawal by Caregiver|0|||
161371119|NCT03289143|582749123|FG001|Overall Study|Withdrawal by Caregiver|1|||
161371120|NCT03289143|582749124|FG002|Overall Study|Withdrawal by Caregiver|0|||
161371121|NCT03289143|582749125|FG003|Overall Study|Withdrawal by Caregiver|0|||
161371122|NCT03289143|582749122|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
161371123|NCT03289143|582749123|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
161371124|NCT03289143|582749124|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
161371125|NCT03289143|582749125|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
161371126|NCT03289143|582749122|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
161371127|NCT03289143|582749123|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
161371128|NCT03289143|582749124|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
161371129|NCT03289143|582749125|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
161371130|NCT00730756|582749126|FG000|Overall Study|Adverse Event|2|||
161371131|NCT00730756|582749127|FG001|Overall Study|Adverse Event|0|||
161371132|NCT00730756|582749126|FG000|Overall Study|Lack of Efficacy|1|||
161371133|NCT00730756|582749127|FG001|Overall Study|Lack of Efficacy|1|||
161371134|NCT00730756|582749126|FG000|Overall Study|Protocol Deviation|1|||
161371135|NCT00730756|582749127|FG001|Overall Study|Protocol Deviation|2|||
161371136|NCT00730756|582749126|FG000|Overall Study|Lost to Follow-up|0|||
161371137|NCT00730756|582749127|FG001|Overall Study|Lost to Follow-up|1|||
161371138|NCT00730756|582749126|FG000|Overall Study|Withdrew Consent|0|||
161371139|NCT00730756|582749127|FG001|Overall Study|Withdrew Consent|1|||
161371140|NCT00948688|582749128|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
161371141|NCT00948688|582749129|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
161371142|NCT00948688|582749128|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
161371143|NCT00948688|582749129|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
161371144|NCT00948688|582749128|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
161371145|NCT00948688|582749129|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
161371146|NCT04388826|582749130|FG000|Overall Study|Lost to Follow-up|3|||
161371147|NCT04388826|582749131|FG001|Overall Study|Lost to Follow-up|2|||
161371148|NCT04388826|582749130|FG000|Overall Study|Adverse Event|1|||
161371149|NCT04388826|582749131|FG001|Overall Study|Adverse Event|0|||
161371150|NCT01840943|582749132|FG000|Overall Study|Withdrawal by Subject|5|||
161371151|NCT01840943|582749133|FG001|Overall Study|Withdrawal by Subject|6|||
161371152|NCT01840943|582749132|FG000|Overall Study|Physician Decision|4|||
161371153|NCT01840943|582749133|FG001|Overall Study|Physician Decision|2|||
161371154|NCT01840943|582749132|FG000|Overall Study|Lost to Follow-up|4|||
161371155|NCT01840943|582749133|FG001|Overall Study|Lost to Follow-up|4|||
161371156|NCT04573972|582749139|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
161371157|NCT04573972|582749140|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
161371158|NCT05067335|582749143|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
161371159|NCT05067335|582749144|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
161371160|NCT05067335|582749145|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
161371161|NCT05067335|582749146|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
161371162|NCT05067335|582749143|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
161371163|NCT05067335|582749144|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
161371164|NCT05067335|582749145|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
161371165|NCT05067335|582749146|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
161371166|NCT05067335|582749143|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
161371167|NCT05067335|582749144|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
161371168|NCT05067335|582749145|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
161371169|NCT05067335|582749146|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
161371170|NCT05067335|582749143|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
161371171|NCT05067335|582749144|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161371172|NCT05067335|582749145|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161371173|NCT05067335|582749146|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161371174|NCT05067335|582749143|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
161371175|NCT05067335|582749144|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
161371176|NCT05067335|582749145|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
161371177|NCT05067335|582749146|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
161371178|NCT05067335|582749143|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
161371179|NCT05067335|582749144|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
161371180|NCT05067335|582749145|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
161371181|NCT05067335|582749146|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
161371182|NCT05067335|582749143|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
161371183|NCT05067335|582749144|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
161371184|NCT05067335|582749145|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
161371185|NCT05067335|582749146|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
161371186|NCT05067335|582749143|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
161371187|NCT05067335|582749144|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
161371188|NCT05067335|582749145|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
161371189|NCT05067335|582749146|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
161371190|NCT05067335|582749143|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
161371191|NCT05067335|582749144|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
161371192|NCT05067335|582749145|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
161371193|NCT05067335|582749146|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
161371194|NCT05067335|582749143|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
161371195|NCT05067335|582749144|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
161371196|NCT05067335|582749145|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
161371197|NCT05067335|582749146|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
161371198|NCT02724839|582749147|FG000|Overall Study|Withdrawal by Subject|1|||
161371199|NCT02724839|582749148|FG001|Overall Study|Withdrawal by Subject|1|||
161371200|NCT02724839|582749149|FG002|Overall Study|Withdrawal by Subject|0|||
161371201|NCT02724839|582749147|FG000|Overall Study|Lost to Follow-up|0|||
161371202|NCT02724839|582749148|FG001|Overall Study|Lost to Follow-up|3|||
161371203|NCT02724839|582749149|FG002|Overall Study|Lost to Follow-up|2|||
161371204|NCT02724839|582749147|FG000|Overall Study|Physician Decision|0|||
161371205|NCT02724839|582749148|FG001|Overall Study|Physician Decision|0|||
161371206|NCT02724839|582749149|FG002|Overall Study|Physician Decision|3|||
161371207|NCT03610048|582749150|FG000|Overall Study|Study terminated by sponsor|84|||
161371208|NCT03610048|582749150|FG000|Overall Study|Adverse Event|32|||
161371209|NCT03610048|582749150|FG000|Overall Study|Withdrawal by Subject|31|||
161371210|NCT03610048|582749150|FG000|Overall Study|Lost to Follow-up|8|||
161371211|NCT03610048|582749150|FG000|Overall Study|Other|4|||
161371212|NCT03610048|582749150|FG000|Overall Study|Physician Decision|1|||
161371213|NCT03610048|582749150|FG000|Overall Study|Pregnancy|1|||
161371214|NCT01146613|582749152|FG000|Overall Study|Lost to Follow-up|3|||
161371215|NCT01146613|582749153|FG001|Overall Study|Lost to Follow-up|8|||
161371216|NCT01146613|582749152|FG000|Overall Study|Lack of Efficacy|0|||
161371217|NCT01146613|582749153|FG001|Overall Study|Lack of Efficacy|1|||
161371218|NCT01146613|582749152|FG000|Overall Study|Death|1|||
161371219|NCT01146613|582749153|FG001|Overall Study|Death|0|||
161371220|NCT01146613|582749152|FG000|Overall Study|Physician Decision|1|||
161371221|NCT01146613|582749153|FG001|Overall Study|Physician Decision|0|||
161371222|NCT01146613|582749152|FG000|Overall Study|Withdrawal by Subject|0|||
161371223|NCT01146613|582749153|FG001|Overall Study|Withdrawal by Subject|3|||
161371224|NCT01146613|582749152|FG000|Overall Study|schedule conflict|1|||
161371225|NCT01146613|582749153|FG001|Overall Study|schedule conflict|0|||
161371226|NCT01146613|582749152|FG000|Overall Study|Outpatient detox|1|||
161371227|NCT01146613|582749153|FG001|Overall Study|Outpatient detox|0|||
161371228|NCT02136914|582749154|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
161371229|NCT02136914|582749155|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
161371230|NCT02136914|582749154|FG000|Overall Study|Withdrawal by Subject|3|||
161371231|NCT02136914|582749155|FG001|Overall Study|Withdrawal by Subject|10|||
161371232|NCT02136914|582749154|FG000|Overall Study|Subject Unwilling to Proceed|7|||
161371233|NCT02136914|582749155|FG001|Overall Study|Subject Unwilling to Proceed|2|||
161371234|NCT02136914|582749154|FG000|Overall Study|Lost to Follow-up|1|||
161371235|NCT02136914|582749155|FG001|Overall Study|Lost to Follow-up|1|||
161371236|NCT02136914|582749154|FG000|Overall Study|Did Not Receive Study Drug|2|||
161371237|NCT02136914|582749155|FG001|Overall Study|Did Not Receive Study Drug|0|||
161371238|NCT02136914|582749154|FG000|Overall Study|Lack of Efficacy|1|||
161371239|NCT02136914|582749155|FG001|Overall Study|Lack of Efficacy|0|||
161371240|NCT02136914|582749154|FG000|Overall Study|Death|0|||
161371241|NCT02136914|582749155|FG001|Overall Study|Death|1|||
161371242|NCT00949533|582749158|FG000|Overall Study|Lost to Follow-up|0|||
161371243|NCT00949533|582749159|FG001|Overall Study|Lost to Follow-up|1|||
161371244|NCT01493089|582749162|FG000|Overall Study|Protocol Violation|2|||
161371245|NCT01493089|582749163|FG001|Overall Study|Protocol Violation|2|||
161371246|NCT01493089|582749162|FG000|Overall Study|Withdrawal by Subject|1|||
161371247|NCT01493089|582749163|FG001|Overall Study|Withdrawal by Subject|0|||
161371248|NCT01493089|582749162|FG000|Overall Study|Physician Decision|0|||
161371249|NCT01493089|582749163|FG001|Overall Study|Physician Decision|1|||
161371250|NCT02234362|582749164|FG000|Overall Study|Not eligible after first screening visit|17|||
161371251|NCT02234362|582749164|FG000|Overall Study|Lost to Follow-up|6|||
161371252|NCT02234362|582749164|FG000|Overall Study|Withdrawal by Subject|3|||
161371253|NCT00329030|582749165|FG000|Overall Study|Withdrawal by Subject|1|||
161371254|NCT00329030|582749166|FG001|Overall Study|Withdrawal by Subject|3|||
161371255|NCT00329030|582749165|FG000|Overall Study|Progressive Disease|6|||
161371256|NCT00329030|582749166|FG001|Overall Study|Progressive Disease|2|||
161371257|NCT00329030|582749165|FG000|Overall Study|Ineligible Pathology|1|||
161371258|NCT00329030|582749166|FG001|Overall Study|Ineligible Pathology|1|||
161371259|NCT00560417|582749167|FG000|Overall Study|Adverse Event|3|||
161371260|NCT00560417|582749168|FG001|Overall Study|Adverse Event|2|||
161371261|NCT00560417|582749167|FG000|Overall Study|Entry Criteria Not Met|1|||
161371262|NCT00560417|582749168|FG001|Overall Study|Entry Criteria Not Met|0|||
161371263|NCT00560417|582749167|FG000|Overall Study|Lost to Follow-up|0|||
161371264|NCT00560417|582749168|FG001|Overall Study|Lost to Follow-up|1|||
161371265|NCT00560417|582749167|FG000|Overall Study|Physician Decision|2|||
161371266|NCT00560417|582749168|FG001|Overall Study|Physician Decision|6|||
161371267|NCT00560417|582749167|FG000|Overall Study|Protocol Violation|6|||
161371268|NCT00560417|582749168|FG001|Overall Study|Protocol Violation|5|||
161371269|NCT00560417|582749167|FG000|Overall Study|Sponsor Decision|2|||
161371270|NCT00560417|582749168|FG001|Overall Study|Sponsor Decision|0|||
161371271|NCT00560417|582749167|FG000|Overall Study|Withdrawal by Subject|3|||
161371272|NCT00560417|582749168|FG001|Overall Study|Withdrawal by Subject|3|||
161371273|NCT02164864|582749169|FG000|Overall Study|Trial disease worsening|7|||
161371274|NCT02164864|582749170|FG001|Overall Study|Trial disease worsening|5|||
161371275|NCT02164864|582749171|FG002|Overall Study|Trial disease worsening|1|||
161371276|NCT02164864|582749169|FG000|Overall Study|Other pre-existing disease worsening|6|||
161371277|NCT02164864|582749170|FG001|Overall Study|Other pre-existing disease worsening|4|||
161371278|NCT02164864|582749171|FG002|Overall Study|Other pre-existing disease worsening|9|||
161371279|NCT02164864|582749169|FG000|Overall Study|Other Adverse Event (AE)|52|||
161371280|NCT02164864|582749170|FG001|Overall Study|Other Adverse Event (AE)|32|||
161371281|NCT02164864|582749171|FG002|Overall Study|Other Adverse Event (AE)|49|||
161371282|NCT02164864|582749169|FG000|Overall Study|Protocol Violation|2|||
161371283|NCT02164864|582749170|FG001|Overall Study|Protocol Violation|4|||
161371284|NCT02164864|582749171|FG002|Overall Study|Protocol Violation|1|||
161371285|NCT02164864|582749169|FG000|Overall Study|Lost to Follow-up|4|||
161371286|NCT02164864|582749170|FG001|Overall Study|Lost to Follow-up|3|||
161371287|NCT02164864|582749171|FG002|Overall Study|Lost to Follow-up|2|||
161371288|NCT02164864|582749169|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
161371289|NCT02164864|582749170|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
161371290|NCT02164864|582749171|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
161371291|NCT02164864|582749169|FG000|Overall Study|Other than stated|3|||
161371292|NCT02164864|582749170|FG001|Overall Study|Other than stated|4|||
161371293|NCT02164864|582749171|FG002|Overall Study|Other than stated|14|||
161371294|NCT00261833|582749172|FG000|Overall Study|Death|1|||
161371295|NCT00261833|582749173|FG001|Overall Study|Death|3|||
161371296|NCT00261833|582749172|FG000|Overall Study|Adverse Event|1|||
161371297|NCT00261833|582749173|FG001|Overall Study|Adverse Event|4|||
161371298|NCT00261833|582749172|FG000|Overall Study|Withdrawal by Subject|5|||
161371299|NCT00261833|582749173|FG001|Overall Study|Withdrawal by Subject|7|||
161371300|NCT00261833|582749172|FG000|Overall Study|Protocol Violation|0|||
161371301|NCT00261833|582749173|FG001|Overall Study|Protocol Violation|1|||
161371302|NCT00261833|582749172|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
161371303|NCT00261833|582749173|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
161371304|NCT00261833|582749172|FG000|Overall Study|Lung transplantation|1|||
161371305|NCT00261833|582749173|FG001|Overall Study|Lung transplantation|1|||
161371306|NCT00261833|582749172|FG000|Overall Study|Missing reason|1|||
161371307|NCT00261833|582749173|FG001|Overall Study|Missing reason|0|||
161371308|NCT00261833|582749172|FG000|Overall Study|Not interested in being participant|0|||
161371309|NCT00261833|582749173|FG001|Overall Study|Not interested in being participant|1|||
161371310|NCT02006927|582749174|FG000|Overall Study|Adverse Event|2|||
161371311|NCT02006927|582749174|FG000|Overall Study|Withdrawal by Subject|1|||
161371312|NCT02639390|582749175|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
161371313|NCT02639390|582749176|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
161371314|NCT02412670|582749177|FG000|Overall Study|Adverse Event|4|||
161371315|NCT02412670|582749178|FG001|Overall Study|Adverse Event|1|||
161371316|NCT02412670|582749177|FG000|Overall Study|Physician Decision|1|||
161371317|NCT02412670|582749178|FG001|Overall Study|Physician Decision|0|||
161371318|NCT02412670|582749177|FG000|Overall Study|Withdrawal by Subject|1|||
161371319|NCT02412670|582749178|FG001|Overall Study|Withdrawal by Subject|0|||
161371320|NCT02412670|582749177|FG000|Overall Study|Ineligible|1|||
161371321|NCT02412670|582749178|FG001|Overall Study|Ineligible|0|||
161371322|NCT00431964|582749182|FG000|Overall Study|Adverse Event|1|||
161371323|NCT00431964|582749183|FG001|Overall Study|Adverse Event|0|||
161371324|NCT00431964|582749182|FG000|Overall Study|Lost to Follow-up|1|||
161371325|NCT00431964|582749183|FG001|Overall Study|Lost to Follow-up|2|||
161371326|NCT00431964|582749182|FG000|Overall Study|Physician Decision|2|||
161371327|NCT00431964|582749183|FG001|Overall Study|Physician Decision|2|||
161371328|NCT00431964|582749182|FG000|Overall Study|Withdrawal by Subject|2|||
161371329|NCT00431964|582749183|FG001|Overall Study|Withdrawal by Subject|1|||
161371330|NCT00431964|582749182|FG000|Overall Study|Parental Consent Withdrawn|0|||
161371331|NCT00431964|582749183|FG001|Overall Study|Parental Consent Withdrawn|2|||
161371332|NCT00431964|582749182|FG000|Overall Study|Due to Unstable Health|0|||
161371333|NCT00431964|582749183|FG001|Overall Study|Due to Unstable Health|1|||
161371334|NCT00397540|582749184|FG000|Overall Study|short follow-up duration < 12 months|1|||
161371335|NCT00397540|582749185|FG001|Overall Study|short follow-up duration < 12 months|0|||
161371336|NCT00776230|582749189|FG000|Overall Study|Lost to Follow-up|2|||
161371337|NCT00776230|582749190|FG001|Overall Study|Lost to Follow-up|1|||
161371338|NCT00776230|582749191|FG002|Overall Study|Lost to Follow-up|5|||
161371339|NCT00776230|582749189|FG000|Overall Study|Not vaccinated at Day 0|1|||
161371340|NCT00776230|582749190|FG001|Overall Study|Not vaccinated at Day 0|0|||
161371341|NCT00776230|582749191|FG002|Overall Study|Not vaccinated at Day 0|0|||
161371342|NCT00776230|582749189|FG000|Overall Study|Withdrawal by Subject|0|||
161371343|NCT00776230|582749190|FG001|Overall Study|Withdrawal by Subject|1|||
161371344|NCT00776230|582749191|FG002|Overall Study|Withdrawal by Subject|0|||
161371345|NCT00776230|582749189|FG000|Overall Study|Subject missed Visit 4|0|||
161371346|NCT00776230|582749190|FG001|Overall Study|Subject missed Visit 4|1|||
161371347|NCT00776230|582749191|FG002|Overall Study|Subject missed Visit 4|0|||
161371348|NCT02297412|582749192|FG000|Overall Study|Canceled|1|||
161371349|NCT02297412|582749193|FG001|Overall Study|Canceled|1|||
161371350|NCT03189719|582749194|FG000|Overall Study|Death|325|||
161371351|NCT03189719|582749195|FG001|Overall Study|Death|361|||
161371352|NCT03189719|582749194|FG000|Overall Study|Physician Decision|1|||
161371353|NCT03189719|582749195|FG001|Overall Study|Physician Decision|0|||
161371354|NCT03189719|582749194|FG000|Overall Study|Sponsor Decision|40|||
161371355|NCT03189719|582749195|FG001|Overall Study|Sponsor Decision|12|||
161371356|NCT03189719|582749194|FG000|Overall Study|Withdrawal by Subject|7|||
161371357|NCT03189719|582749195|FG001|Overall Study|Withdrawal by Subject|3|||
161371358|NCT03012880|582749196|FG000|Overall Study|Withdrawal by Subject|1|||
161371359|NCT03012880|582749197|FG001|Overall Study|Withdrawal by Subject|0|||
161371360|NCT03012880|582749196|FG000|Overall Study|Ineligible|1|||
161371361|NCT03012880|582749197|FG001|Overall Study|Ineligible|0|||
161371362|NCT05211596|582749198|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
161371363|NCT05211596|582749198|FG000|Baseline to 6 Months|Death|1|||
161371364|NCT05211596|582749198|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
161371365|NCT05211596|582749198|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
161371366|NCT02293551|582749199|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
161371367|NCT02293551|582749200|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
161371368|NCT02293551|582749201|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
161371369|NCT02293551|582749202|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
161371370|NCT02293551|582749203|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
161371371|NCT02293551|582749204|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
161371372|NCT02293551|582749199|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
161371373|NCT02293551|582749200|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
161371374|NCT02293551|582749201|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
161371375|NCT02293551|582749202|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
161371376|NCT02293551|582749203|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
161371377|NCT02293551|582749204|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
161371378|NCT02293551|582749199|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
161371379|NCT02293551|582749200|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
161371380|NCT02293551|582749201|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
161371381|NCT02293551|582749202|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
161371382|NCT02293551|582749203|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
161371383|NCT02293551|582749204|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
161371384|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
161371385|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
161371386|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
161371387|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
161371388|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
161371389|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
161371390|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
161371391|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
161371392|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
161371393|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
161371394|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
161371395|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
161371396|NCT04532749|582749205|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
161371397|NCT04532749|582749206|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
161371398|NCT04532749|582749205|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
161371399|NCT04532749|582749206|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
161371400|NCT04532749|582749205|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
161371401|NCT04532749|582749206|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
161371402|NCT04532749|582749205|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
161371403|NCT04532749|582749206|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
161371404|NCT05239221|582749207|FG000|Overall Study|Adverse Event|0|||
161371405|NCT05239221|582749208|FG001|Overall Study|Adverse Event|0|||
161371406|NCT05239221|582749209|FG002|Overall Study|Adverse Event|0|||
161371407|NCT05239221|582749210|FG003|Overall Study|Adverse Event|0|||
161371408|NCT05239221|582749211|FG004|Overall Study|Adverse Event|0|||
161371409|NCT05239221|582749212|FG005|Overall Study|Adverse Event|0|||
161371410|NCT05239221|582749213|FG006|Overall Study|Adverse Event|1|||
161371411|NCT05239221|582749214|FG007|Overall Study|Adverse Event|0|||
161371412|NCT05239221|582749215|FG008|Overall Study|Adverse Event|0|||
161371413|NCT05239221|582749216|FG009|Overall Study|Adverse Event|0|||
161371414|NCT05239221|582749217|FG010|Overall Study|Adverse Event|1|||
161371415|NCT05239221|582749218|FG011|Overall Study|Adverse Event|1|||
161371416|NCT05239221|582749219|FG012|Overall Study|Adverse Event|0|||
161371417|NCT05239221|582749220|FG013|Overall Study|Adverse Event|0|||
161371418|NCT05239221|582749221|FG014|Overall Study|Adverse Event|0|||
161371419|NCT05239221|582749222|FG015|Overall Study|Adverse Event|0|||
161371420|NCT05239221|582749207|FG000|Overall Study|Withdrawal by Subject|0|||
161371421|NCT05239221|582749208|FG001|Overall Study|Withdrawal by Subject|0|||
161371422|NCT05239221|582749209|FG002|Overall Study|Withdrawal by Subject|0|||
161371423|NCT05239221|582749210|FG003|Overall Study|Withdrawal by Subject|0|||
161371424|NCT05239221|582749211|FG004|Overall Study|Withdrawal by Subject|0|||
161371425|NCT05239221|582749212|FG005|Overall Study|Withdrawal by Subject|0|||
161371426|NCT05239221|582749213|FG006|Overall Study|Withdrawal by Subject|0|||
161371427|NCT05239221|582749214|FG007|Overall Study|Withdrawal by Subject|0|||
161371428|NCT05239221|582749215|FG008|Overall Study|Withdrawal by Subject|0|||
161371429|NCT05239221|582749216|FG009|Overall Study|Withdrawal by Subject|0|||
161371430|NCT05239221|582749217|FG010|Overall Study|Withdrawal by Subject|1|||
161371431|NCT05239221|582749218|FG011|Overall Study|Withdrawal by Subject|0|||
161371432|NCT05239221|582749219|FG012|Overall Study|Withdrawal by Subject|0|||
161371433|NCT05239221|582749220|FG013|Overall Study|Withdrawal by Subject|0|||
161371434|NCT05239221|582749221|FG014|Overall Study|Withdrawal by Subject|0|||
161371435|NCT05239221|582749222|FG015|Overall Study|Withdrawal by Subject|1|||
161371436|NCT01400412|582749223|FG000|Overall Study|Lost to Follow-up|4|||
161371437|NCT01400412|582749224|FG001|Overall Study|Lost to Follow-up|7|||
161371438|NCT01400412|582749223|FG000|Overall Study|Withdrawal by Subject|3|||
161371439|NCT01400412|582749224|FG001|Overall Study|Withdrawal by Subject|4|||
161371440|NCT01400412|582749223|FG000|Overall Study|Unable to complete|3|||
161371441|NCT01400412|582749224|FG001|Overall Study|Unable to complete|3|||
161371442|NCT01400412|582749223|FG000|Overall Study|Never started study treatment|0|||
161371443|NCT01400412|582749224|FG001|Overall Study|Never started study treatment|3|||
161371444|NCT01649869|582749225|FG000|Overall Study|Family member illness|1|||
161371445|NCT01649869|582749226|FG001|Overall Study|Family member illness|0|||
161371446|NCT01649869|582749225|FG000|Overall Study|Required treatment outside protocol|1|||
161371447|NCT01649869|582749226|FG001|Overall Study|Required treatment outside protocol|0|||
161371448|NCT01649869|582749225|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
161371449|NCT01649869|582749226|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
161371450|NCT00529633|582751167|FG000|Overall Study|Withdrawal by Subject|1|||
161371451|NCT00529633|582751168|FG001|Overall Study|Withdrawal by Subject|1|||
161371452|NCT01359956|582751169|FG000|Overall Study|Death|58|||
161371453|NCT01359956|582751170|FG001|Overall Study|Death|60|||
161371454|NCT01359956|582751171|FG002|Overall Study|Death|66|||
161371455|NCT01359956|582751172|FG003|Overall Study|Death|57|||
161371456|NCT01359956|582751169|FG000|Overall Study|Lost to Follow-up|3|||
161371457|NCT01359956|582751170|FG001|Overall Study|Lost to Follow-up|4|||
161371458|NCT01359956|582751171|FG002|Overall Study|Lost to Follow-up|1|||
161371459|NCT01359956|582751172|FG003|Overall Study|Lost to Follow-up|1|||
161371460|NCT01784029|582751173|FG000|Overall Study|Lost to Follow-up|19|||
161371461|NCT01784029|582751174|FG001|Overall Study|Lost to Follow-up|20|||
161371462|NCT01784029|582751175|FG002|Overall Study|Lost to Follow-up|22|||
161371463|NCT03235050|582751178|FG000|Overall Study|Adverse Event|0|||
161371464|NCT03235050|582751179|FG001|Overall Study|Adverse Event|0|||
161371465|NCT03235050|582751180|FG002|Overall Study|Adverse Event|1|||
161371466|NCT03235050|582751181|FG003|Overall Study|Adverse Event|4|||
161371467|NCT03235050|582751182|FG004|Overall Study|Adverse Event|1|||
161371468|NCT03235050|582751178|FG000|Overall Study|Death|0|||
161371469|NCT03235050|582751179|FG001|Overall Study|Death|0|||
161371470|NCT03235050|582751180|FG002|Overall Study|Death|0|||
161371471|NCT03235050|582751181|FG003|Overall Study|Death|2|||
161371472|NCT03235050|582751182|FG004|Overall Study|Death|1|||
161371473|NCT03235050|582751178|FG000|Overall Study|Lost to Follow-up|1|||
161371474|NCT03235050|582751179|FG001|Overall Study|Lost to Follow-up|2|||
161371475|NCT03235050|582751180|FG002|Overall Study|Lost to Follow-up|1|||
161371476|NCT03235050|582751181|FG003|Overall Study|Lost to Follow-up|2|||
161371477|NCT03235050|582751182|FG004|Overall Study|Lost to Follow-up|0|||
161371478|NCT03235050|582751178|FG000|Overall Study|Withdrawal by Subject|3|||
161371479|NCT03235050|582751179|FG001|Overall Study|Withdrawal by Subject|2|||
161371480|NCT03235050|582751180|FG002|Overall Study|Withdrawal by Subject|2|||
161371481|NCT03235050|582751181|FG003|Overall Study|Withdrawal by Subject|5|||
161371482|NCT03235050|582751182|FG004|Overall Study|Withdrawal by Subject|7|||
161371483|NCT03235050|582751178|FG000|Overall Study|Other reasons|0|||
161371484|NCT03235050|582751179|FG001|Overall Study|Other reasons|1|||
161371485|NCT03235050|582751180|FG002|Overall Study|Other reasons|0|||
161371486|NCT03235050|582751181|FG003|Overall Study|Other reasons|1|||
161371487|NCT03235050|582751182|FG004|Overall Study|Other reasons|2|||
161371488|NCT00069641|582751183|FG000|Overall Study|Death|1|||
161371489|NCT00069641|582751184|FG001|Overall Study|Death|0|||
161371490|NCT00069641|582751185|FG002|Overall Study|Death|1|||
161371491|NCT02704208|582751186|FG000|Overall Study|Lost to Follow-up|42|||
161371492|NCT02704208|582751187|FG001|Overall Study|Lost to Follow-up|37|||
161371493|NCT03545672|582751188|FG000|Overall Study|Uncertain diagnosis|2|||
161371494|NCT03545672|582751189|FG001|Overall Study|Uncertain diagnosis|1|||
161371495|NCT03545672|582751188|FG000|Overall Study|Protocol Violation|2|||
161371496|NCT03545672|582751189|FG001|Overall Study|Protocol Violation|2|||
161371497|NCT02415556|582751190|FG000|Overall Study|Adverse Event|3|||
161371498|NCT02415556|582751191|FG001|Overall Study|Adverse Event|4|||
161371499|NCT02415556|582751192|FG002|Overall Study|Adverse Event|2|||
161371500|NCT02415556|582751193|FG003|Overall Study|Adverse Event|4|||
161371501|NCT02415556|582751190|FG000|Overall Study|Lost to Follow-up|4|||
161371502|NCT02415556|582751191|FG001|Overall Study|Lost to Follow-up|5|||
161371503|NCT02415556|582751192|FG002|Overall Study|Lost to Follow-up|4|||
161371504|NCT02415556|582751193|FG003|Overall Study|Lost to Follow-up|1|||
161371505|NCT02415556|582751190|FG000|Overall Study|Withdrawal by Subject|13|||
161371506|NCT02415556|582751191|FG001|Overall Study|Withdrawal by Subject|4|||
161371507|NCT02415556|582751192|FG002|Overall Study|Withdrawal by Subject|14|||
161371508|NCT02415556|582751193|FG003|Overall Study|Withdrawal by Subject|12|||
161371509|NCT02415556|582751190|FG000|Overall Study|Physician Decision|1|||
161371510|NCT02415556|582751191|FG001|Overall Study|Physician Decision|3|||
161371511|NCT02415556|582751192|FG002|Overall Study|Physician Decision|1|||
161371512|NCT02415556|582751193|FG003|Overall Study|Physician Decision|2|||
161371513|NCT02415556|582751190|FG000|Overall Study|Censored - study completion|4|||
161371514|NCT02415556|582751191|FG001|Overall Study|Censored - study completion|5|||
161371515|NCT02415556|582751192|FG002|Overall Study|Censored - study completion|1|||
161371516|NCT02415556|582751193|FG003|Overall Study|Censored - study completion|0|||
161371517|NCT02415556|582751190|FG000|Overall Study|Family-related issues|0|||
161371518|NCT02415556|582751191|FG001|Overall Study|Family-related issues|0|||
161371519|NCT02415556|582751192|FG002|Overall Study|Family-related issues|0|||
161371520|NCT02415556|582751193|FG003|Overall Study|Family-related issues|1|||
161371521|NCT01209767|582751194|FG000|Overall Study|Withdrawal by Subject|1|||
161371522|NCT01209767|582751194|FG000|Overall Study|Lost to Follow-up|3|||
161371523|NCT01621178|582751195|FG000|Overall Study|Adverse Event|5|||
161371524|NCT01621178|582751196|FG001|Overall Study|Adverse Event|2|||
161371525|NCT01621178|582751197|FG002|Overall Study|Adverse Event|8|||
161371526|NCT01621178|582751195|FG000|Overall Study|Death|6|||
161371527|NCT01621178|582751196|FG001|Overall Study|Death|7|||
161371528|NCT01621178|582751197|FG002|Overall Study|Death|2|||
161371529|NCT01621178|582751195|FG000|Overall Study|Lost to Follow-up|1|||
161371530|NCT01621178|582751196|FG001|Overall Study|Lost to Follow-up|2|||
161371531|NCT01621178|582751197|FG002|Overall Study|Lost to Follow-up|1|||
161371532|NCT01621178|582751195|FG000|Overall Study|Withdrawal by Subject|14|||
161371533|NCT01621178|582751196|FG001|Overall Study|Withdrawal by Subject|17|||
161371534|NCT01621178|582751197|FG002|Overall Study|Withdrawal by Subject|18|||
161371535|NCT01621178|582751195|FG000|Overall Study|Physician Decision|5|||
161371536|NCT01621178|582751196|FG001|Overall Study|Physician Decision|2|||
161371537|NCT01621178|582751197|FG002|Overall Study|Physician Decision|7|||
161371538|NCT02935192|582751198|FG000|Overall Study|Withdrawal by Subject|8|||
161371539|NCT02935192|582751199|FG001|Overall Study|Withdrawal by Subject|4|||
161371540|NCT00492557|582751201|FG000|Overall Study|Subject request|12|||
161371541|NCT00492557|582751202|FG001|Overall Study|Subject request|11|||
161371542|NCT00492557|582751201|FG000|Overall Study|Protocol Violation|7|||
161371543|NCT00492557|582751202|FG001|Overall Study|Protocol Violation|8|||
161371544|NCT00492557|582751201|FG000|Overall Study|Other|2|||
161371545|NCT00492557|582751202|FG001|Overall Study|Other|2|||
161371546|NCT00492557|582751201|FG000|Overall Study|Death|1|||
161371547|NCT00492557|582751202|FG001|Overall Study|Death|1|||
161371548|NCT00492557|582751201|FG000|Overall Study|Adverse Event|1|||
161371549|NCT00492557|582751202|FG001|Overall Study|Adverse Event|0|||
161371550|NCT00492557|582751201|FG000|Overall Study|Failed to return|1|||
161371551|NCT00492557|582751202|FG001|Overall Study|Failed to return|0|||
161371552|NCT00492557|582751201|FG000|Overall Study|Lost to Follow-up|0|||
161371553|NCT00492557|582751202|FG001|Overall Study|Lost to Follow-up|1|||
161371554|NCT04778592|582751206|FG000|Overall Study|Adverse Event|1|||
161371555|NCT04778592|582751207|FG001|Overall Study|Adverse Event|2|||
161371556|NCT04778592|582751206|FG000|Overall Study|Withdrawal by Subject|1|||
161371557|NCT04778592|582751207|FG001|Overall Study|Withdrawal by Subject|2|||
161371558|NCT01354223|582751209|FG000|Overall Study|Withdrawal by Subject|3|||
161371559|NCT01354223|582751210|FG001|Overall Study|Withdrawal by Subject|1|||
161371560|NCT04102007|582751214|FG000|Overall Study|Adverse Event|4|||
161371561|NCT04102007|582751214|FG000|Overall Study|Lost to Follow-up|3|||
161371562|NCT04102007|582751214|FG000|Overall Study|Withdrawal by Subject|12|||
161371563|NCT04102007|582751214|FG000|Overall Study|Eligibility Violation|5|||
161371564|NCT04102007|582751214|FG000|Overall Study|Lack of Efficacy|6|||
161371565|NCT04102007|582751214|FG000|Overall Study|Protocol Deviation|5|||
161371566|NCT04102007|582751214|FG000|Overall Study|Protocol Compliance|1|||
161371567|NCT04102007|582751214|FG000|Overall Study|Withdrew Treatment|2|||
161371568|NCT04102007|582751214|FG000|Overall Study|Pregnancy|1|||
161371569|NCT05173974|582751215|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
161371570|NCT05173974|582751216|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
161371571|NCT05173974|582751217|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
161371572|NCT05173974|582751218|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
161371573|NCT05173974|582751215|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
161371574|NCT05173974|582751216|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
161371575|NCT05173974|582751217|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
161371576|NCT05173974|582751218|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
161371577|NCT04047446|582751219|FG000|Overall Study|Physician Decision|1|||
161371578|NCT04047446|582751220|FG001|Overall Study|Physician Decision|0|||
161371579|NCT00329420|582751221|FG000|Re-induction Phase|Lack of Efficacy|0|||
161371580|NCT00329420|582751222|FG001|Re-induction Phase|Lack of Efficacy|1|||
161371581|NCT00329420|582751223|FG002|Re-induction Phase|Lack of Efficacy|0|||
161371582|NCT00329420|582751221|FG000|Re-induction Phase|Withdrawal of Consent|0|||
161371583|NCT00329420|582751222|FG001|Re-induction Phase|Withdrawal of Consent|0|||
161371584|NCT00329420|582751223|FG002|Re-induction Phase|Withdrawal of Consent|1|||
161371585|NCT00329420|582751221|FG000|Re-induction Phase|Did not respond to re-induction|6|||
161371586|NCT00329420|582751222|FG001|Re-induction Phase|Did not respond to re-induction|5|||
161371587|NCT00329420|582751223|FG002|Re-induction Phase|Did not respond to re-induction|7|||
161371588|NCT00329420|582751221|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
161371589|NCT00329420|582751222|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
161371590|NCT00329420|582751223|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
161371591|NCT00329420|582751221|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
161371592|NCT00329420|582751222|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
161371593|NCT00329420|582751223|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
161371594|NCT00329420|582751221|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
161371595|NCT00329420|582751222|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
161371596|NCT00329420|582751223|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
161371597|NCT01446874|582751224|FG000|Overall Study|Not eligible|1|||
161371598|NCT01446874|582751225|FG001|Overall Study|Not eligible|0|||
161371599|NCT01446874|582751226|FG002|Overall Study|Not eligible|0|||
161371600|NCT01446874|582751224|FG000|Overall Study|No surgery/No qualifying surgery|1|||
161371601|NCT01446874|582751225|FG001|Overall Study|No surgery/No qualifying surgery|0|||
161371602|NCT01446874|582751226|FG002|Overall Study|No surgery/No qualifying surgery|12|||
161371603|NCT01446874|582751224|FG000|Overall Study|Non-compliance|0|||
161371604|NCT01446874|582751225|FG001|Overall Study|Non-compliance|4|||
161371605|NCT01446874|582751226|FG002|Overall Study|Non-compliance|0|||
161371606|NCT01446874|582751224|FG000|Overall Study|Antibiotics for pre-op infection|0|||
161371607|NCT01446874|582751225|FG001|Overall Study|Antibiotics for pre-op infection|0|||
161371608|NCT01446874|582751226|FG002|Overall Study|Antibiotics for pre-op infection|2|||
161371609|NCT01446874|582751224|FG000|Overall Study|Withdrawal by Subject|0|||
161371610|NCT01446874|582751225|FG001|Overall Study|Withdrawal by Subject|0|||
161371611|NCT01446874|582751226|FG002|Overall Study|Withdrawal by Subject|4|||
161371612|NCT01977898|582751227|FG000|Overall Study|Non functioning catheter|1|||
161371613|NCT01977898|582751228|FG001|Overall Study|Non functioning catheter|1|||
161371614|NCT03983421|582751229|FG000|Overall Study|Lost to Follow-up|1|||
161371615|NCT03386773|582751230|FG000|Overall Study|Lost to Follow-up|24|||
161371616|NCT03386773|582751231|FG001|Overall Study|Lost to Follow-up|33|||
161371617|NCT03386773|582751230|FG000|Overall Study|Withdrawal by Subject|3|||
161371618|NCT03386773|582751231|FG001|Overall Study|Withdrawal by Subject|2|||
161371619|NCT03639610|582751232|FG000|Overall Study|Adverse Event|7|||
161371620|NCT03639610|582751233|FG001|Overall Study|Adverse Event|1|||
161371621|NCT03639610|582751234|FG002|Overall Study|Adverse Event|0|||
161371622|NCT03639610|582751232|FG000|Overall Study|Physician Decision|3|||
161371623|NCT03639610|582751233|FG001|Overall Study|Physician Decision|1|||
161371624|NCT03639610|582751234|FG002|Overall Study|Physician Decision|0|||
161371625|NCT03639610|582751232|FG000|Overall Study|Disease progression|8|||
161371626|NCT03639610|582751233|FG001|Overall Study|Disease progression|5|||
161371627|NCT03639610|582751234|FG002|Overall Study|Disease progression|3|||
161371628|NCT03639610|582751232|FG000|Overall Study|Study terminated by sponsor|2|||
161371629|NCT03639610|582751233|FG001|Overall Study|Study terminated by sponsor|1|||
161371630|NCT03639610|582751234|FG002|Overall Study|Study terminated by sponsor|1|||
161371631|NCT03639610|582751232|FG000|Overall Study|Patient request to stop treatment|1|||
161371632|NCT03639610|582751233|FG001|Overall Study|Patient request to stop treatment|2|||
161371633|NCT03639610|582751234|FG002|Overall Study|Patient request to stop treatment|0|||
161371634|NCT02660229|582751235|FG000|Overall Study|Adverse Event|2|||
161371635|NCT02660229|582751236|FG001|Overall Study|Adverse Event|0|||
161371636|NCT02660229|582751235|FG000|Overall Study|Withdrawal by Subject|0|||
161371637|NCT02660229|582751236|FG001|Overall Study|Withdrawal by Subject|1|||
161371638|NCT02727322|582751240|FG000|Overall Study|Withdrawal by Subject|1|||
161371639|NCT02727322|582751241|FG001|Overall Study|Withdrawal by Subject|1|||
161371640|NCT02727322|582751240|FG000|Overall Study|Protocol Violation|1|||
161371641|NCT02727322|582751241|FG001|Overall Study|Protocol Violation|0|||
161371642|NCT01049373|582751242|FG000|Overall Study|Protocol Violation|9|||
161371643|NCT01049373|582751243|FG001|Overall Study|Protocol Violation|9|||
161371644|NCT01049373|582751242|FG000|Overall Study|Withdrawal by Subject|8|||
161371645|NCT01049373|582751243|FG001|Overall Study|Withdrawal by Subject|5|||
161371646|NCT01049373|582751242|FG000|Overall Study|Adverse Event|3|||
161371647|NCT01049373|582751243|FG001|Overall Study|Adverse Event|3|||
161371648|NCT01049373|582751242|FG000|Overall Study|Lost to Follow-up|9|||
161371649|NCT01049373|582751243|FG001|Overall Study|Lost to Follow-up|4|||
161371650|NCT01049373|582751242|FG000|Overall Study|no evaluable study values|9|||
161371651|NCT01049373|582751243|FG001|Overall Study|no evaluable study values|21|||
161371652|NCT01049373|582751242|FG000|Overall Study|Other|1|||
161371653|NCT01049373|582751243|FG001|Overall Study|Other|1|||
161371654|NCT01049373|582751242|FG000|Overall Study|Non-cooperation|0|||
161371655|NCT01049373|582751243|FG001|Overall Study|Non-cooperation|1|||
161371656|NCT01517984|582751244|FG000|Overall Study|Lost to Follow-up|0|||
161371657|NCT01517984|582751245|FG001|Overall Study|Lost to Follow-up|1|||
161371658|NCT01517984|582751246|FG002|Overall Study|Lost to Follow-up|0|||
161371659|NCT01517984|582751247|FG003|Overall Study|Lost to Follow-up|0|||
161371660|NCT01517984|582751244|FG000|Overall Study|Withdrawal by Subject|1|||
161371661|NCT01517984|582751245|FG001|Overall Study|Withdrawal by Subject|8|||
161371662|NCT01517984|582751246|FG002|Overall Study|Withdrawal by Subject|4|||
161371663|NCT01517984|582751247|FG003|Overall Study|Withdrawal by Subject|1|||
161371664|NCT01517984|582751244|FG000|Overall Study|Screen Failure|4|||
161371665|NCT01517984|582751245|FG001|Overall Study|Screen Failure|0|||
161371666|NCT01517984|582751246|FG002|Overall Study|Screen Failure|0|||
161371667|NCT01517984|582751247|FG003|Overall Study|Screen Failure|0|||
161371668|NCT01517984|582751244|FG000|Overall Study|Ineligible for randomization|0|||
161371669|NCT01517984|582751245|FG001|Overall Study|Ineligible for randomization|14|||
161371670|NCT01517984|582751246|FG002|Overall Study|Ineligible for randomization|0|||
161371671|NCT01517984|582751247|FG003|Overall Study|Ineligible for randomization|0|||
161371672|NCT01155050|582751250|FG000|Overall Study|Lost to Follow-up|15|||
161371673|NCT01155050|582751251|FG001|Overall Study|Lost to Follow-up|20|||
161371674|NCT01155050|582751252|FG002|Overall Study|Lost to Follow-up|19|||
161371675|NCT01155050|582751253|FG003|Overall Study|Lost to Follow-up|22|||
161371676|NCT05878067|582751254|FG000|Overall Study|Lost to Follow-up|2|||
161371677|NCT01198587|582751255|FG000|Overall Study|Lost to Follow-up|8|||
161371678|NCT01198587|582751256|FG001|Overall Study|Lost to Follow-up|0|||
161371679|NCT01198587|582751257|FG002|Overall Study|Lost to Follow-up|9|||
161371680|NCT01198587|582751258|FG003|Overall Study|Lost to Follow-up|0|||
161371681|NCT01496287|582751259|FG000|Overall Study|Lost to Follow-up|1|||
161371682|NCT01496287|582751259|FG000|Overall Study|Incomplete anesthesia|5|||
161371683|NCT01959529|582751260|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
161371684|NCT01959529|582751261|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
161371685|NCT01959529|582751260|FG000|Overall Study|Lost to Follow-up|4|||
161371686|NCT01959529|582751261|FG001|Overall Study|Lost to Follow-up|1|||
161371687|NCT01959529|582751260|FG000|Overall Study|Other|70|||
161371688|NCT01959529|582751261|FG001|Overall Study|Other|68|||
161371689|NCT01959529|582751260|FG000|Overall Study|Hypoglycaemia|1|||
161371690|NCT01959529|582751261|FG001|Overall Study|Hypoglycaemia|1|||
161371691|NCT01959529|582751260|FG000|Overall Study|Lack of glycaemic control|1|||
161371692|NCT01959529|582751261|FG001|Overall Study|Lack of glycaemic control|1|||
161371693|NCT00557193|582751271|FG000|Induction|Adverse Event|2|||
161371694|NCT00557193|582751272|FG001|Induction|Adverse Event|0|||
161371695|NCT00557193|582751273|FG002|Induction|Adverse Event|0|||
161371696|NCT00557193|582751274|FG003|Induction|Adverse Event|0|||
161371697|NCT00557193|582751275|FG004|Induction|Adverse Event|0|||
161371698|NCT00557193|582751276|FG005|Induction|Adverse Event|0|||
161371699|NCT00557193|582751271|FG000|Induction|Death|6|||
161371700|NCT00557193|582751272|FG001|Induction|Death|0|||
161371701|NCT00557193|582751273|FG002|Induction|Death|0|||
161371702|NCT00557193|582751274|FG003|Induction|Death|0|||
161371703|NCT00557193|582751275|FG004|Induction|Death|0|||
161371704|NCT00557193|582751276|FG005|Induction|Death|0|||
161371705|NCT00557193|582751271|FG000|Induction|Physician Decision|3|||
161371706|NCT00557193|582751272|FG001|Induction|Physician Decision|0|||
161371707|NCT00557193|582751273|FG002|Induction|Physician Decision|0|||
161371708|NCT00557193|582751274|FG003|Induction|Physician Decision|0|||
161371709|NCT00557193|582751275|FG004|Induction|Physician Decision|0|||
161371710|NCT00557193|582751276|FG005|Induction|Physician Decision|0|||
161371711|NCT00557193|582751271|FG000|Induction|Withdrawal by Subject|1|||
161371712|NCT00557193|582751272|FG001|Induction|Withdrawal by Subject|0|||
161371713|NCT00557193|582751273|FG002|Induction|Withdrawal by Subject|0|||
161371714|NCT00557193|582751274|FG003|Induction|Withdrawal by Subject|0|||
161371715|NCT00557193|582751275|FG004|Induction|Withdrawal by Subject|0|||
161371716|NCT00557193|582751276|FG005|Induction|Withdrawal by Subject|0|||
161371717|NCT00557193|582751271|FG000|Induction|Refusal of Further Protocol Therapy|2|||
161371718|NCT00557193|582751272|FG001|Induction|Refusal of Further Protocol Therapy|0|||
161371719|NCT00557193|582751273|FG002|Induction|Refusal of Further Protocol Therapy|0|||
161371720|NCT00557193|582751274|FG003|Induction|Refusal of Further Protocol Therapy|0|||
161371721|NCT00557193|582751275|FG004|Induction|Refusal of Further Protocol Therapy|0|||
161371722|NCT00557193|582751276|FG005|Induction|Refusal of Further Protocol Therapy|0|||
161371723|NCT00557193|582751271|FG000|Induction|Ineligible|8|||
161371724|NCT00557193|582751272|FG001|Induction|Ineligible|0|||
161371725|NCT00557193|582751273|FG002|Induction|Ineligible|0|||
161371726|NCT00557193|582751274|FG003|Induction|Ineligible|0|||
161371727|NCT00557193|582751275|FG004|Induction|Ineligible|0|||
161371728|NCT00557193|582751276|FG005|Induction|Ineligible|0|||
161371729|NCT00557193|582751271|FG000|Induction|Inevaluable for post Induction|2|||
161371730|NCT00557193|582751272|FG001|Induction|Inevaluable for post Induction|0|||
161371731|NCT00557193|582751273|FG002|Induction|Inevaluable for post Induction|0|||
161371732|NCT00557193|582751274|FG003|Induction|Inevaluable for post Induction|0|||
161371733|NCT00557193|582751275|FG004|Induction|Inevaluable for post Induction|0|||
161371734|NCT00557193|582751276|FG005|Induction|Inevaluable for post Induction|0|||
161371735|NCT00557193|582751271|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
161371736|NCT00557193|582751272|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161371737|NCT00557193|582751273|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161371738|NCT00557193|582751274|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161371739|NCT00557193|582751275|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161371740|NCT00557193|582751276|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161371741|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161371742|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
161371743|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
161371744|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
161371745|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161371746|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
161371747|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
161371748|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
161371749|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
161371750|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
161371751|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
161371752|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
161371753|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161371754|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
161371755|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
161371756|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
161371757|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
161371758|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
161371759|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
161371760|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
161371761|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
161371762|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
161371763|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
161371764|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
161371765|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
161371766|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
161371767|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
161371768|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
161371769|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
161371770|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
161371771|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161371772|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161371773|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
161371774|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161371775|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161371776|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161371777|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161371778|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161371779|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
161371780|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161371781|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161371782|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161371783|NCT00557193|582751271|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161371784|NCT00557193|582751272|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161371785|NCT00557193|582751273|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
161371786|NCT00557193|582751274|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161371787|NCT00557193|582751275|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161371788|NCT00557193|582751276|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
161371789|NCT03036852|582751277|FG000|Overall Study|Death|2|||
161371790|NCT03036852|582751277|FG000|Overall Study|Lack of Efficacy|2|||
161371791|NCT03036852|582751277|FG000|Overall Study|Adverse Event|1|||
161371792|NCT03036852|582751277|FG000|Overall Study|Lost to Follow-up|1|||
161371793|NCT00652834|582751278|FG000|Overall Study|Withdrawal by Subject|3|||
161371794|NCT00652834|582751278|FG000|Overall Study|Lost to Follow-up|2|||
161371795|NCT00320606|582751279|FG000|Overall Study|Adverse Event|1|||
161371796|NCT00320606|582751279|FG000|Overall Study|Protocol Violation|1|||
161371797|NCT00320606|582751279|FG000|Overall Study|Withdrawal by Subject|1|||
161371798|NCT03984825|582751282|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
161371799|NCT03984825|582751282|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
161371800|NCT03984825|582751282|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
161371801|NCT00622726|582751283|FG000|March, 2008 to August, 2010|Death|5|||
161371802|NCT00622726|582751284|FG001|March, 2008 to August, 2010|Death|2|||
161371803|NCT00622726|582751283|FG000|August, 2010 to April, 2013|Death|1|||
161371804|NCT00622726|582751284|FG001|August, 2010 to April, 2013|Death|5|||
161371805|NCT01948427|582751287|FG000|Overall Study|Serious Adverse Event|3|||
161371806|NCT01948427|582751288|FG001|Overall Study|Serious Adverse Event|0|||
161371807|NCT01948427|582751289|FG002|Overall Study|Serious Adverse Event|0|||
161371808|NCT01948427|582751290|FG003|Overall Study|Serious Adverse Event|0|||
161371809|NCT01948427|582751291|FG004|Overall Study|Serious Adverse Event|1|||
161371810|NCT01948427|582751287|FG000|Overall Study|Investigator Request|0|||
161371811|NCT01948427|582751288|FG001|Overall Study|Investigator Request|8|||
161371812|NCT01948427|582751289|FG002|Overall Study|Investigator Request|0|||
161371813|NCT01948427|582751290|FG003|Overall Study|Investigator Request|0|||
161371814|NCT01948427|582751291|FG004|Overall Study|Investigator Request|6|||
161371815|NCT01948427|582751287|FG000|Overall Study|Lost to Follow-up|1|||
161371816|NCT01948427|582751288|FG001|Overall Study|Lost to Follow-up|0|||
161371817|NCT01948427|582751289|FG002|Overall Study|Lost to Follow-up|0|||
161371818|NCT01948427|582751290|FG003|Overall Study|Lost to Follow-up|0|||
161371819|NCT01948427|582751291|FG004|Overall Study|Lost to Follow-up|4|||
161371820|NCT01948427|582751287|FG000|Overall Study|Withdrawal by Subject|2|||
161371821|NCT01948427|582751288|FG001|Overall Study|Withdrawal by Subject|0|||
161371822|NCT01948427|582751289|FG002|Overall Study|Withdrawal by Subject|0|||
161371823|NCT01948427|582751290|FG003|Overall Study|Withdrawal by Subject|0|||
161371824|NCT01948427|582751291|FG004|Overall Study|Withdrawal by Subject|1|||
161371825|NCT01948427|582751287|FG000|Overall Study|Other, Not Specified|1|||
161371826|NCT01948427|582751288|FG001|Overall Study|Other, Not Specified|9|||
161371827|NCT01948427|582751289|FG002|Overall Study|Other, Not Specified|0|||
161371828|NCT01948427|582751290|FG003|Overall Study|Other, Not Specified|0|||
161371829|NCT01948427|582751291|FG004|Overall Study|Other, Not Specified|2|||
161371830|NCT02434081|582751292|FG000|Overall Study|Death (never started treatment)|2|||
161371831|NCT02434081|582751292|FG000|Overall Study|Death|2|||
161371832|NCT02434081|582751292|FG000|Overall Study|Progression|20|||
161371833|NCT02434081|582751292|FG000|Overall Study|Adverse Event|20|||
161371834|NCT02434081|582751292|FG000|Overall Study|Physician Decision|2|||
161371835|NCT02434081|582751292|FG000|Overall Study|Withdrawal by Subject|1|||
161371836|NCT02434081|582751292|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
161371837|NCT00854360|582751301|FG000|Overall Study|Adverse Event|0|||
161371838|NCT00854360|582751302|FG001|Overall Study|Adverse Event|1|||
161371839|NCT00854360|582751303|FG002|Overall Study|Adverse Event|2|||
161371840|NCT00854360|582751304|FG003|Overall Study|Adverse Event|6|||
161371841|NCT00854360|582751301|FG000|Overall Study|Withdrawal by Subject|0|||
161371842|NCT00854360|582751302|FG001|Overall Study|Withdrawal by Subject|0|||
161371843|NCT00854360|582751303|FG002|Overall Study|Withdrawal by Subject|0|||
161371844|NCT00854360|582751304|FG003|Overall Study|Withdrawal by Subject|1|||
161371845|NCT00854360|582751301|FG000|Overall Study|Pregnancy|0|||
161371846|NCT00854360|582751302|FG001|Overall Study|Pregnancy|1|||
161371847|NCT00854360|582751303|FG002|Overall Study|Pregnancy|0|||
161371848|NCT00854360|582751304|FG003|Overall Study|Pregnancy|0|||
161371849|NCT00854360|582751301|FG000|Overall Study|Lack of Efficacy|2|||
161371850|NCT00854360|582751302|FG001|Overall Study|Lack of Efficacy|1|||
161371851|NCT00854360|582751303|FG002|Overall Study|Lack of Efficacy|0|||
161371852|NCT00854360|582751304|FG003|Overall Study|Lack of Efficacy|0|||
161371853|NCT00854360|582751301|FG000|Overall Study|Other|0|||
161371854|NCT00854360|582751302|FG001|Overall Study|Other|0|||
161371855|NCT00854360|582751303|FG002|Overall Study|Other|0|||
161371856|NCT00854360|582751304|FG003|Overall Study|Other|3|||
161371857|NCT00399529|582751305|FG000|Overall Study|Off Study Prior to Treatment|2|||
161371858|NCT01164007|582751306|FG000|Overall Study|Adverse Event|5|||
161371859|NCT01164007|582751306|FG000|Overall Study|Progression of Disease|30|||
161371860|NCT01164007|582751306|FG000|Overall Study|Protocol Violation|1|||
161371861|NCT01164007|582751306|FG000|Overall Study|Withdrawal by Subject|1|||
161371862|NCT01164007|582751306|FG000|Overall Study|Medical Decision|3|||
161371863|NCT01908140|582751311|FG000|Overall Study|Other or Progressive Disease|5|||
161371864|NCT01908140|582751312|FG001|Overall Study|Other or Progressive Disease|12|||
161371865|NCT01908140|582751311|FG000|Overall Study|Lack of Efficacy|7|||
161371866|NCT01908140|582751312|FG001|Overall Study|Lack of Efficacy|5|||
161371867|NCT01908140|582751311|FG000|Overall Study|Withdrawal by Subject|23|||
161371868|NCT01908140|582751312|FG001|Overall Study|Withdrawal by Subject|24|||
161371869|NCT01908140|582751311|FG000|Overall Study|Lost to Follow-up|1|||
161371870|NCT01908140|582751312|FG001|Overall Study|Lost to Follow-up|6|||
161371871|NCT01908140|582751311|FG000|Overall Study|Protocol Violation|8|||
161371872|NCT01908140|582751312|FG001|Overall Study|Protocol Violation|9|||
161371873|NCT01908140|582751311|FG000|Overall Study|Adverse Event|22|||
161371874|NCT01908140|582751312|FG001|Overall Study|Adverse Event|23|||
161371875|NCT03218917|582751313|FG000|Overall Study|Adverse Event|3|||
161371876|NCT03218917|582751314|FG001|Overall Study|Adverse Event|3|||
161371877|NCT03218917|582751315|FG002|Overall Study|Adverse Event|2|||
161371878|NCT03218917|582751313|FG000|Overall Study|Subject withdrew consent|2|||
161371879|NCT03218917|582751314|FG001|Overall Study|Subject withdrew consent|4|||
161371880|NCT03218917|582751315|FG002|Overall Study|Subject withdrew consent|10|||
161371881|NCT03218917|582751313|FG000|Overall Study|Physician Decision|0|||
161371882|NCT03218917|582751314|FG001|Overall Study|Physician Decision|1|||
161371883|NCT03218917|582751315|FG002|Overall Study|Physician Decision|1|||
161371884|NCT03218917|582751313|FG000|Overall Study|Lost to Follow-up|1|||
161371885|NCT03218917|582751314|FG001|Overall Study|Lost to Follow-up|0|||
161371886|NCT03218917|582751315|FG002|Overall Study|Lost to Follow-up|0|||
161371887|NCT03218917|582751313|FG000|Overall Study|Reason Missing|0|||
161371888|NCT03218917|582751314|FG001|Overall Study|Reason Missing|2|||
161371889|NCT03218917|582751315|FG002|Overall Study|Reason Missing|0|||
161371890|NCT03218917|582751313|FG000|Overall Study|Death|0|||
161371891|NCT03218917|582751314|FG001|Overall Study|Death|1|||
161371892|NCT03218917|582751315|FG002|Overall Study|Death|0|||
161371893|NCT03218917|582751313|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161371894|NCT03218917|582751314|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161371895|NCT03218917|582751315|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161371896|NCT01076010|582751318|FG000|Overall Study|Death|15|||
161371897|NCT01076010|582751319|FG001|Overall Study|Death|1|||
161371898|NCT01076010|582751320|FG002|Overall Study|Death|0|||
161371899|NCT01076010|582751318|FG000|Overall Study|Adverse Event|7|||
161371900|NCT01076010|582751319|FG001|Overall Study|Adverse Event|2|||
161371901|NCT01076010|582751320|FG002|Overall Study|Adverse Event|0|||
161371902|NCT01076010|582751318|FG000|Overall Study|Progressive disease|90|||
161371903|NCT01076010|582751319|FG001|Overall Study|Progressive disease|30|||
161371904|NCT01076010|582751320|FG002|Overall Study|Progressive disease|1|||
161371905|NCT01076010|582751318|FG000|Overall Study|Lack of Efficacy|4|||
161371906|NCT01076010|582751319|FG001|Overall Study|Lack of Efficacy|0|||
161371907|NCT01076010|582751320|FG002|Overall Study|Lack of Efficacy|0|||
161371908|NCT01076010|582751318|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
161371909|NCT01076010|582751319|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
161371910|NCT01076010|582751320|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
161371911|NCT01076010|582751318|FG000|Overall Study|Significant Surgical Procedure|0|||
161371912|NCT01076010|582751319|FG001|Overall Study|Significant Surgical Procedure|1|||
161371913|NCT01076010|582751320|FG002|Overall Study|Significant Surgical Procedure|0|||
161371914|NCT01076010|582751318|FG000|Overall Study|Protocol Violation|0|||
161371915|NCT01076010|582751319|FG001|Overall Study|Protocol Violation|1|||
161371916|NCT01076010|582751320|FG002|Overall Study|Protocol Violation|0|||
161371917|NCT01076010|582751318|FG000|Overall Study|Noncompliance|1|||
161371918|NCT01076010|582751319|FG001|Overall Study|Noncompliance|1|||
161371919|NCT01076010|582751320|FG002|Overall Study|Noncompliance|0|||
161371920|NCT01076010|582751318|FG000|Overall Study|Withdrawal by Subject|3|||
161371921|NCT01076010|582751319|FG001|Overall Study|Withdrawal by Subject|0|||
161371922|NCT01076010|582751320|FG002|Overall Study|Withdrawal by Subject|1|||
161371923|NCT01076010|582751318|FG000|Overall Study|Other|5|||
161371924|NCT01076010|582751319|FG001|Overall Study|Other|2|||
161371925|NCT01076010|582751320|FG002|Overall Study|Other|0|||
161371926|NCT05200845|582751323|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
161371927|NCT05200845|582751324|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
161371928|NCT05200845|582751325|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
161371929|NCT05200845|582751326|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
161371930|NCT05200845|582751323|FG000|Overall Study|Withdrawal by Subject|0|||
161371931|NCT05200845|582751324|FG001|Overall Study|Withdrawal by Subject|1|||
161371932|NCT05200845|582751325|FG002|Overall Study|Withdrawal by Subject|1|||
161371933|NCT05200845|582751326|FG003|Overall Study|Withdrawal by Subject|0|||
161371934|NCT01959932|582751333|FG000|Overall Study|Withdrawal by Subject|1|||
161371935|NCT01959932|582751334|FG001|Overall Study|Withdrawal by Subject|0|||
161371936|NCT01959932|582751335|FG002|Overall Study|Withdrawal by Subject|0|||
161371937|NCT00060944|582751338|FG000|Overall Study|Adverse Event|12|||
161371938|NCT00060944|582751339|FG001|Overall Study|Adverse Event|10|||
161371939|NCT00060944|582751338|FG000|Overall Study|Death|2|||
161371940|NCT00060944|582751339|FG001|Overall Study|Death|3|||
161371941|NCT00060944|582751338|FG000|Overall Study|Withdrawal by Subject|18|||
161371942|NCT00060944|582751339|FG001|Overall Study|Withdrawal by Subject|5|||
161371943|NCT00060944|582751338|FG000|Overall Study|Disease Progression|93|||
161371944|NCT00060944|582751339|FG001|Overall Study|Disease Progression|94|||
161371945|NCT00060944|582751338|FG000|Overall Study|Lost to Follow-up|1|||
161371946|NCT00060944|582751339|FG001|Overall Study|Lost to Follow-up|0|||
161371947|NCT00060944|582751338|FG000|Overall Study|Subject Ineligible To Continue|2|||
161371948|NCT00060944|582751339|FG001|Overall Study|Subject Ineligible To Continue|1|||
161371949|NCT00060944|582751338|FG000|Overall Study|Treatment Switch|0|||
161371950|NCT00060944|582751339|FG001|Overall Study|Treatment Switch|13|||
161371951|NCT00060944|582751338|FG000|Overall Study|Other|2|||
161371952|NCT00060944|582751339|FG001|Overall Study|Other|4|||
161371953|NCT00060944|582751338|FG000|Overall Study|randomized but not treated|6|||
161371954|NCT00060944|582751339|FG001|Overall Study|randomized but not treated|4|||
161371955|NCT01215851|582751341|FG000|Treatment Period|Adverse Event|1|||
161371956|NCT01215851|582751342|FG001|Treatment Period|Adverse Event|1|||
161371957|NCT01215851|582751343|FG002|Treatment Period|Adverse Event|1|||
161371958|NCT01215851|582751344|FG003|Treatment Period|Adverse Event|3|||
161371959|NCT01215851|582751345|FG004|Treatment Period|Adverse Event|0|||
161371960|NCT01215851|582751346|FG005|Treatment Period|Adverse Event|1|||
161371961|NCT01215851|582751341|FG000|Follow up Period|Lost to Follow-up|0|||
161371962|NCT01215851|582751342|FG001|Follow up Period|Lost to Follow-up|0|||
161371963|NCT01215851|582751343|FG002|Follow up Period|Lost to Follow-up|0|||
161371964|NCT01215851|582751344|FG003|Follow up Period|Lost to Follow-up|0|||
161371965|NCT01215851|582751345|FG004|Follow up Period|Lost to Follow-up|0|||
161371966|NCT01215851|582751346|FG005|Follow up Period|Lost to Follow-up|1|||
161371967|NCT01135992|582752948|FG000|Overall Study|Adverse Event|1|||
161371968|NCT01135992|582752948|FG000|Overall Study|Lack of Efficacy|1|||
161371969|NCT01135992|582752948|FG000|Overall Study|Protocol Violation|2|||
161371970|NCT01135992|582752948|FG000|Overall Study|Withdrawal criteria|10|||
161371971|NCT01135992|582752948|FG000|Overall Study|Unclassified|7|||
161371972|NCT00256126|582752949|FG000|Overall Study|Adverse Event|1|||
161371973|NCT00256126|582752950|FG001|Overall Study|Adverse Event|0|||
161371974|NCT00256126|582752949|FG000|Overall Study|Other|1|||
161371975|NCT00256126|582752950|FG001|Overall Study|Other|2|||
161371976|NCT03435380|582752951|FG000|Overall Study|Death|1|||
161371977|NCT03435380|582752952|FG001|Overall Study|Death|2|||
161371978|NCT03435380|582752953|FG002|Overall Study|Death|1|||
161371979|NCT03435380|582752951|FG000|Overall Study|Lost to Follow-up|12|||
161371980|NCT03435380|582752952|FG001|Overall Study|Lost to Follow-up|8|||
161371981|NCT03435380|582752953|FG002|Overall Study|Lost to Follow-up|6|||
161371982|NCT03435380|582752951|FG000|Overall Study|Physician Decision|1|||
161371983|NCT03435380|582752952|FG001|Overall Study|Physician Decision|0|||
161371984|NCT03435380|582752953|FG002|Overall Study|Physician Decision|0|||
161371985|NCT03435380|582752951|FG000|Overall Study|Withdrawal by Subject|0|||
161371986|NCT03435380|582752952|FG001|Overall Study|Withdrawal by Subject|1|||
161371987|NCT03435380|582752953|FG002|Overall Study|Withdrawal by Subject|1|||
161371988|NCT03435380|582752951|FG000|Overall Study|Ineligible|0|||
161371989|NCT03435380|582752952|FG001|Overall Study|Ineligible|1|||
161371990|NCT03435380|582752953|FG002|Overall Study|Ineligible|1|||
161371991|NCT01170663|582752954|FG000|Overall Study|Lost to Follow-up|3|||
161371992|NCT01170663|582752955|FG001|Overall Study|Lost to Follow-up|9|||
161371993|NCT01170663|582752954|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
161371994|NCT01170663|582752955|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
161371995|NCT02746809|582752956|FG000|Enrollment|Inclusion Exclusion not met|9|||
161371996|NCT02746809|582752956|FG000|Enrollment|Withdrawal by Subject|1|||
161371997|NCT02746809|582752956|FG000|Enrollment|Expected Enrollment Met|2|||
161371998|NCT02746809|582752956|FG000|Procedure|Death|1|||
161371999|NCT02746809|582752956|FG000|1-Month|Death|5|||
161372000|NCT02746809|582752956|FG000|6-Month|Death|2|||
161372001|NCT02746809|582752956|FG000|6-Month|Withdrawal by Subject|1|||
161372002|NCT02746809|582752956|FG000|12-Month|Death|3|||
161372003|NCT02746809|582752956|FG000|12-Month|Withdrawal by Subject|2|||
161372004|NCT02746809|582752956|FG000|24-Month|Death|1|||
161372005|NCT02746809|582752956|FG000|24-Month|Withdrawal by Subject|1|||
161372006|NCT02746809|582752956|FG000|36-Month|Death|8|||
161372007|NCT02746809|582752956|FG000|36-Month|Withdrawal by Subject|1|||
161372008|NCT02746809|582752956|FG000|48-Month|Death|7|||
161372009|NCT02746809|582752956|FG000|48-Month|Withdrawal by Subject|1|||
161372010|NCT02746809|582752956|FG000|60-Month|Death|1|||
161372011|NCT02746809|582752956|FG000|60-Month|Lost to Follow-up|2|||
161372012|NCT00742625|582752960|FG000|Remission Induction|Progression|6|||
161372013|NCT00742625|582752960|FG000|Remission Induction|Failed induction|8|||
161372014|NCT00742625|582752960|FG000|Remission Induction|Adverse Event|3|||
161372015|NCT00742625|582752960|FG000|Remission Induction|Death|10|||
161372016|NCT00742625|582752960|FG000|Remission Induction|Refusal|5|||
161372017|NCT00742625|582752960|FG000|Remission Induction|Non protocol treatment|17|||
161372018|NCT00742625|582752960|FG000|Remission Induction|Other, not specified|5|||
161372019|NCT00742625|582752960|FG000|Consolidation|Progression|5|||
161372020|NCT00742625|582752960|FG000|Consolidation|Adverse Event|1|||
161372021|NCT00742625|582752960|FG000|Consolidation|Death|1|||
161372022|NCT00742625|582752960|FG000|Consolidation|Refused|1|||
161372023|NCT00742625|582752960|FG000|Consolidation|Non protocol therapy|13|||
161372024|NCT00894387|582752961|FG000|Overall Study|Adverse Event|44|||
161372025|NCT00894387|582752962|FG001|Overall Study|Adverse Event|45|||
161372026|NCT00894387|582752961|FG000|Overall Study|Abnormal Laboratory values|2|||
161372027|NCT00894387|582752962|FG001|Overall Study|Abnormal Laboratory values|2|||
161372028|NCT00894387|582752961|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161372029|NCT00894387|582752962|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161372030|NCT00894387|582752961|FG000|Overall Study|Lost to Follow-up|3|||
161372031|NCT00894387|582752962|FG001|Overall Study|Lost to Follow-up|5|||
161372032|NCT00894387|582752961|FG000|Overall Study|Administrative problems|2|||
161372033|NCT00894387|582752962|FG001|Overall Study|Administrative problems|2|||
161372034|NCT00894387|582752961|FG000|Overall Study|Death|77|||
161372035|NCT00894387|582752962|FG001|Overall Study|Death|76|||
161372036|NCT00894387|582752961|FG000|Overall Study|Protocol Deviation|4|||
161372037|NCT00894387|582752962|FG001|Overall Study|Protocol Deviation|0|||
161372038|NCT00894387|582752961|FG000|Overall Study|Patient's request|25|||
161372039|NCT00894387|582752962|FG001|Overall Study|Patient's request|30|||
161372040|NCT00894387|582752961|FG000|Overall Study|Other (Missing)|5|||
161372041|NCT00894387|582752962|FG001|Overall Study|Other (Missing)|3|||
161372042|NCT00894387|582752961|FG000|Overall Study|Mis-randomized|13|||
161372043|NCT00894387|582752962|FG001|Overall Study|Mis-randomized|9|||
161372044|NCT00894387|582752961|FG000|Overall Study|GCP non-compliance|0|||
161372045|NCT00894387|582752962|FG001|Overall Study|GCP non-compliance|2|||
161372046|NCT01865487|582752963|FG000|Overall Study|Lost to Follow-up|0|||
161372047|NCT01865487|582752964|FG001|Overall Study|Lost to Follow-up|0|||
161372048|NCT01865487|582752965|FG002|Overall Study|Lost to Follow-up|0|||
161372049|NCT01865487|582752966|FG003|Overall Study|Lost to Follow-up|1|||
161372050|NCT01865487|582752967|FG004|Overall Study|Lost to Follow-up|0|||
161372051|NCT01865487|582752968|FG005|Overall Study|Lost to Follow-up|0|||
161372052|NCT01865487|582752969|FG006|Overall Study|Lost to Follow-up|1|||
161372053|NCT01865487|582752970|FG007|Overall Study|Lost to Follow-up|0|||
161372054|NCT01865487|582752971|FG008|Overall Study|Lost to Follow-up|0|||
161372055|NCT01865487|582752972|FG009|Overall Study|Lost to Follow-up|0|||
161372056|NCT01865487|582752963|FG000|Overall Study|Withdrawal by Subject|0|||
161372057|NCT01865487|582752964|FG001|Overall Study|Withdrawal by Subject|0|||
161372058|NCT01865487|582752965|FG002|Overall Study|Withdrawal by Subject|0|||
161372059|NCT01865487|582752966|FG003|Overall Study|Withdrawal by Subject|0|||
161372060|NCT01865487|582752967|FG004|Overall Study|Withdrawal by Subject|1|||
161372061|NCT01865487|582752968|FG005|Overall Study|Withdrawal by Subject|0|||
161372062|NCT01865487|582752969|FG006|Overall Study|Withdrawal by Subject|0|||
161372063|NCT01865487|582752970|FG007|Overall Study|Withdrawal by Subject|0|||
161372064|NCT01865487|582752971|FG008|Overall Study|Withdrawal by Subject|0|||
161372065|NCT01865487|582752972|FG009|Overall Study|Withdrawal by Subject|0|||
161372066|NCT01307449|582752973|FG000|Overall Study|Adverse Event|1|||
161372067|NCT01307449|582752974|FG001|Overall Study|Adverse Event|0|||
161372068|NCT01307449|582752975|FG002|Overall Study|Adverse Event|0|||
161372069|NCT01307449|582752976|FG003|Overall Study|Adverse Event|0|||
161372070|NCT01531998|582752979|FG000|Overall Study|Withdrawal by Subject|3|||
161372071|NCT02581891|582752980|FG000|Overall Study|Adverse Event|4|||
161372072|NCT02581891|582752981|FG001|Overall Study|Adverse Event|6|||
161372073|NCT02581891|582752980|FG000|Overall Study|Death|3|||
161372074|NCT02581891|582752981|FG001|Overall Study|Death|4|||
161372075|NCT02581891|582752980|FG000|Overall Study|Lost to Follow-up|1|||
161372076|NCT02581891|582752981|FG001|Overall Study|Lost to Follow-up|2|||
161372077|NCT02581891|582752980|FG000|Overall Study|Physician Decision|0|||
161372078|NCT02581891|582752981|FG001|Overall Study|Physician Decision|1|||
161372079|NCT02581891|582752980|FG000|Overall Study|Withdrawal by Subject|4|||
161372080|NCT02581891|582752981|FG001|Overall Study|Withdrawal by Subject|5|||
161372081|NCT02581891|582752980|FG000|Overall Study|Other Reasons|3|||
161372082|NCT02581891|582752981|FG001|Overall Study|Other Reasons|1|||
161372083|NCT02581891|582752980|FG000|Overall Study|Discontinued during followup|1|||
161372084|NCT02581891|582752981|FG001|Overall Study|Discontinued during followup|0|||
161372085|NCT02927795|582752982|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
161372086|NCT02927795|582752982|FG000|Overall Study|Not Treated|4|||
161372087|NCT01612676|582752983|FG000|Overall Study|Adverse Event|2|||
161372088|NCT01612676|582752984|FG001|Overall Study|Adverse Event|3|||
161372089|NCT01612676|582752985|FG002|Overall Study|Adverse Event|1|||
161372090|NCT01612676|582752986|FG003|Overall Study|Adverse Event|3|||
161372091|NCT01612676|582752983|FG000|Overall Study|Protocol Violation|0|||
161372092|NCT01612676|582752984|FG001|Overall Study|Protocol Violation|1|||
161372093|NCT01612676|582752985|FG002|Overall Study|Protocol Violation|0|||
161372094|NCT01612676|582752986|FG003|Overall Study|Protocol Violation|0|||
161372095|NCT00181844|582752993|FG000|Signed Consent|Withdrawal by Subject|5|||
161372096|NCT00181844|582752993|FG000|Signed Consent|Did not meet entrance criteria|7|||
161372097|NCT00181844|582752993|FG000|Exposed to Study Medication|Adverse Event|10|||
161372098|NCT00181844|582752993|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
161372099|NCT00181844|582752993|FG000|Exposed to Study Medication|Non-compliance|2|||
161372100|NCT00181844|582752993|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
161372101|NCT00181844|582752993|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
161372102|NCT04661033|582752994|FG000|Overall Study|Adverse Event|0|||
161372103|NCT04661033|582752995|FG001|Overall Study|Adverse Event|0|||
161372104|NCT04661033|582752996|FG002|Overall Study|Adverse Event|1|||
161372105|NCT04661033|582752997|FG003|Overall Study|Adverse Event|0|||
161372106|NCT04661033|582752994|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
161372107|NCT04661033|582752995|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
161372108|NCT04661033|582752996|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
161372109|NCT04661033|582752997|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
161372110|NCT04661033|582752994|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
161372111|NCT04661033|582752995|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
161372112|NCT04661033|582752996|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
161372113|NCT04661033|582752997|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
161372114|NCT04661033|582752994|FG000|Overall Study|Early discontinuation as per PI|1|||
161372115|NCT04661033|582752995|FG001|Overall Study|Early discontinuation as per PI|0|||
161372116|NCT04661033|582752996|FG002|Overall Study|Early discontinuation as per PI|0|||
161372117|NCT04661033|582752997|FG003|Overall Study|Early discontinuation as per PI|0|||
161372118|NCT03440008|582752998|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
161372119|NCT03440008|582752999|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
161372120|NCT03440008|582752998|FG000|Overall Study|Withdrawal by Subject|1|||
161372121|NCT03440008|582752999|FG001|Overall Study|Withdrawal by Subject|0|||
161372122|NCT01734902|582753008|FG000|Overall Study|Other than listed|0|||
161372123|NCT01734902|582753009|FG001|Overall Study|Other than listed|2|||
161372124|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
161372125|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
161372126|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
161372127|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Death|0|||
161372128|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Death|0|||
161372129|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Death|1|||
161372130|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
161372131|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
161372132|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
161372133|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
161372134|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
161372135|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
161372136|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
161372137|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
161372138|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
161372139|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Graft loss|0|||
161372140|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Graft loss|0|||
161372141|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Graft loss|7|||
161372142|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
161372143|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
161372144|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
161372145|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
161372146|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
161372147|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
161372148|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
161372149|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
161372150|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
161372151|NCT00956293|582753013|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
161372152|NCT00956293|582753014|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
161372153|NCT00956293|582753015|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
161372154|NCT00956293|582753013|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
161372155|NCT00956293|582753014|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
161372156|NCT00956293|582753015|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
161372157|NCT00956293|582753013|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
161372158|NCT00956293|582753014|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
161372159|NCT00956293|582753015|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
161372160|NCT00956293|582753013|FG000|Main Period (Randomization)|Adverse Event|0|||
161372161|NCT00956293|582753014|FG001|Main Period (Randomization)|Adverse Event|15|||
161372162|NCT00956293|582753015|FG002|Main Period (Randomization)|Adverse Event|0|||
161372163|NCT00956293|582753013|FG000|Follow-up Period|Follow-up period was terminated.|20|||
161372164|NCT00956293|582753014|FG001|Follow-up Period|Follow-up period was terminated.|32|||
161372165|NCT00956293|582753015|FG002|Follow-up Period|Follow-up period was terminated.|0|||
161372166|NCT02359903|582753016|FG000|Overall Study|Adverse Event|0|||
161372167|NCT02359903|582753017|FG001|Overall Study|Adverse Event|2|||
161372168|NCT03383666|582753018|FG000|Overall Study|Withdrawal by Subject|2|||
161372169|NCT03383666|582753018|FG000|Overall Study|Lost to Follow-up|2|||
161372170|NCT02536664|582753019|FG000|Overall Study|Inadequate completion of documentation|2|||
161372171|NCT02536664|582753020|FG001|Overall Study|Inadequate completion of documentation|4|||
161372172|NCT02536664|582753019|FG000|Overall Study|Progression|13|||
161372173|NCT02536664|582753020|FG001|Overall Study|Progression|18|||
161372174|NCT02536664|582753019|FG000|Overall Study|Death due to lymphoma|2|||
161372175|NCT02536664|582753020|FG001|Overall Study|Death due to lymphoma|1|||
161372176|NCT02536664|582753019|FG000|Overall Study|Death due to other reason|3|||
161372177|NCT02536664|582753020|FG001|Overall Study|Death due to other reason|2|||
161372178|NCT02536664|582753019|FG000|Overall Study|Intolerability|8|||
161372179|NCT02536664|582753020|FG001|Overall Study|Intolerability|6|||
161372180|NCT02536664|582753019|FG000|Overall Study|Withdrawal by Subject|8|||
161372181|NCT02536664|582753020|FG001|Overall Study|Withdrawal by Subject|5|||
161372182|NCT02536664|582753019|FG000|Overall Study|Other|18|||
161372183|NCT02536664|582753020|FG001|Overall Study|Other|24|||
161372184|NCT02536664|582753019|FG000|Overall Study|Missing|53|||
161372185|NCT02536664|582753020|FG001|Overall Study|Missing|20|||
161372186|NCT03507127|582753024|FG000|Overall Study|Withdrawal by Subject|1|||
161372187|NCT03507127|582753025|FG001|Overall Study|Withdrawal by Subject|0|||
161372188|NCT03507127|582753024|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
161372189|NCT03507127|582753025|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
161372190|NCT01240863|582753026|FG000|Open-label Titration Period|Adverse Event|47|||
161372191|NCT01240863|582753027|FG001|Open-label Titration Period|Adverse Event|0|||
161372192|NCT01240863|582753028|FG002|Open-label Titration Period|Adverse Event|0|||
161372193|NCT01240863|582753026|FG000|Open-label Titration Period|Lack of Efficacy|19|||
161372194|NCT01240863|582753027|FG001|Open-label Titration Period|Lack of Efficacy|0|||
161372195|NCT01240863|582753028|FG002|Open-label Titration Period|Lack of Efficacy|0|||
161372196|NCT01240863|582753026|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
161372197|NCT01240863|582753027|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
161372198|NCT01240863|582753028|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
161372199|NCT01240863|582753026|FG000|Open-label Titration Period|Protocol Violation|7|||
161372200|NCT01240863|582753027|FG001|Open-label Titration Period|Protocol Violation|0|||
161372201|NCT01240863|582753028|FG002|Open-label Titration Period|Protocol Violation|0|||
161372202|NCT01240863|582753026|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
161372203|NCT01240863|582753027|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
161372204|NCT01240863|582753028|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
161372205|NCT01240863|582753026|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
161372206|NCT01240863|582753027|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
161372207|NCT01240863|582753028|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
161372208|NCT01240863|582753026|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
161372209|NCT01240863|582753027|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
161372210|NCT01240863|582753028|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
161372211|NCT01240863|582753026|FG000|Open-label Titration Period|Other|7|||
161372212|NCT01240863|582753027|FG001|Open-label Titration Period|Other|0|||
161372213|NCT01240863|582753028|FG002|Open-label Titration Period|Other|0|||
161372214|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
161372215|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
161372216|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
161372217|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161372218|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
161372219|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
161372220|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161372221|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
161372222|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
161372223|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161372224|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
161372225|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
161372226|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
161372227|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
161372228|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
161372229|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
161372230|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
161372231|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
161372232|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
161372233|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
161372234|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
161372235|NCT01240863|582753026|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
161372236|NCT01240863|582753027|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
161372237|NCT01240863|582753028|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
161372238|NCT03961308|582753030|FG000|Overall Study|Withdrawal by Subject|1|||
161372239|NCT03961308|582753031|FG001|Overall Study|Withdrawal by Subject|0|||
161372240|NCT03961308|582753030|FG000|Overall Study|Other|1|||
161372241|NCT03961308|582753031|FG001|Overall Study|Other|0|||
161372242|NCT03961308|582753030|FG000|Overall Study|Lost to Follow-up|0|||
161372243|NCT03961308|582753031|FG001|Overall Study|Lost to Follow-up|1|||
161372244|NCT03961308|582753030|FG000|Overall Study|Adverse Event|0|||
161372245|NCT03961308|582753031|FG001|Overall Study|Adverse Event|1|||
161372246|NCT02081586|582753037|FG000|Overall Study|Lost to Follow-up|0|||
161372247|NCT02081586|582753038|FG001|Overall Study|Lost to Follow-up|1|||
161372248|NCT02081586|582753039|FG002|Overall Study|Lost to Follow-up|0|||
161372249|NCT02081586|582753040|FG003|Overall Study|Lost to Follow-up|1|||
161372250|NCT02081586|582753037|FG000|Overall Study|Head injury not related to study|0|||
161372251|NCT02081586|582753038|FG001|Overall Study|Head injury not related to study|0|||
161372252|NCT02081586|582753039|FG002|Overall Study|Head injury not related to study|1|||
161372253|NCT02081586|582753040|FG003|Overall Study|Head injury not related to study|0|||
161372254|NCT04549454|582753042|FG000|T1 to T2|Lost to Follow-up|22|||
161372255|NCT04549454|582753043|FG001|T1 to T2|Lost to Follow-up|26|||
161372256|NCT04549454|582753042|FG000|T1 to T3|Lost to Follow-up|31|||
161372257|NCT04549454|582753043|FG001|T1 to T3|Lost to Follow-up|36|||
161372258|NCT01355627|582753054|FG000|Overall Study|Request By the Patient to Discontinue|5|||
161372259|NCT01355627|582753055|FG001|Overall Study|Request By the Patient to Discontinue|7|||
161372260|NCT01355627|582753054|FG000|Overall Study|Lost to Follow-up|8|||
161372261|NCT01355627|582753055|FG001|Overall Study|Lost to Follow-up|7|||
161372262|NCT01355627|582753054|FG000|Overall Study|Fatal Adverse Event|19|||
161372263|NCT01355627|582753055|FG001|Overall Study|Fatal Adverse Event|23|||
161372264|NCT01355627|582753054|FG000|Overall Study|Other|1|||
161372265|NCT01355627|582753055|FG001|Overall Study|Other|1|||
161372266|NCT00545779|582753060|FG000|Overall Study|Violation of selection criteria at entry|8|||
161372267|NCT00545779|582753060|FG000|Overall Study|Other protocol violation|1|||
161372268|NCT00545779|582753060|FG000|Overall Study|Did not cooperate|7|||
161372269|NCT00545779|582753060|FG000|Overall Study|Withdrawal by Subject|20|||
161372270|NCT00545779|582753060|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
161372271|NCT00545779|582753060|FG000|Overall Study|Failure to return|3|||
161372272|NCT01405196|582753061|FG000|Overall Study|Study Terminated by Sponsor|0|||
161372273|NCT01405196|582753062|FG001|Overall Study|Study Terminated by Sponsor|0|||
161372274|NCT01405196|582753063|FG002|Overall Study|Study Terminated by Sponsor|9|||
161372275|NCT01405196|582753064|FG003|Overall Study|Study Terminated by Sponsor|0|||
161372276|NCT01405196|582753061|FG000|Overall Study|Other|2|||
161372277|NCT01405196|582753062|FG001|Overall Study|Other|2|||
161372278|NCT01405196|582753063|FG002|Overall Study|Other|5|||
161372279|NCT01405196|582753064|FG003|Overall Study|Other|0|||
161372280|NCT01405196|582753061|FG000|Overall Study|Withdrawal by Subject|4|||
161372281|NCT01405196|582753062|FG001|Overall Study|Withdrawal by Subject|6|||
161372282|NCT01405196|582753063|FG002|Overall Study|Withdrawal by Subject|3|||
161372283|NCT01405196|582753064|FG003|Overall Study|Withdrawal by Subject|6|||
161372284|NCT01405196|582753061|FG000|Overall Study|Adverse Event|2|||
161372285|NCT01405196|582753062|FG001|Overall Study|Adverse Event|2|||
161372286|NCT01405196|582753063|FG002|Overall Study|Adverse Event|0|||
161372287|NCT01405196|582753064|FG003|Overall Study|Adverse Event|2|||
161372288|NCT01405196|582753061|FG000|Overall Study|Death|1|||
161372289|NCT01405196|582753062|FG001|Overall Study|Death|0|||
161372290|NCT01405196|582753063|FG002|Overall Study|Death|3|||
161372291|NCT01405196|582753064|FG003|Overall Study|Death|0|||
161372292|NCT01405196|582753061|FG000|Overall Study|Lost to Follow-up|2|||
161372293|NCT01405196|582753062|FG001|Overall Study|Lost to Follow-up|2|||
161372294|NCT01405196|582753063|FG002|Overall Study|Lost to Follow-up|3|||
161372295|NCT01405196|582753064|FG003|Overall Study|Lost to Follow-up|1|||
161372296|NCT01542788|582753065|FG000|Overall Study|Randomized but Not Treated|2|||
161372297|NCT01542788|582753066|FG001|Overall Study|Randomized but Not Treated|0|||
161372298|NCT01542788|582753065|FG000|Overall Study|Lack of Efficacy|41|||
161372299|NCT01542788|582753066|FG001|Overall Study|Lack of Efficacy|71|||
161372300|NCT01542788|582753065|FG000|Overall Study|Lost to Follow-up|5|||
161372301|NCT01542788|582753066|FG001|Overall Study|Lost to Follow-up|0|||
161372302|NCT01542788|582753065|FG000|Overall Study|Death|3|||
161372303|NCT01542788|582753066|FG001|Overall Study|Death|0|||
161372304|NCT01542788|582753065|FG000|Overall Study|Protocol Violation|2|||
161372305|NCT01542788|582753066|FG001|Overall Study|Protocol Violation|0|||
161372306|NCT01542788|582753065|FG000|Overall Study|Physician Decision|1|||
161372307|NCT01542788|582753066|FG001|Overall Study|Physician Decision|0|||
161372308|NCT01542788|582753065|FG000|Overall Study|Withdrawal by Subject|1|||
161372309|NCT01542788|582753066|FG001|Overall Study|Withdrawal by Subject|0|||
161372310|NCT04756531|582753067|FG000|Overall Study|Adverse Event|0|||
161372311|NCT04756531|582753068|FG001|Overall Study|Adverse Event|0|||
161372312|NCT04756531|582753069|FG002|Overall Study|Adverse Event|0|||
161372313|NCT04756531|582753070|FG003|Overall Study|Adverse Event|0|||
161372314|NCT04756531|582753071|FG004|Overall Study|Adverse Event|1|||
161372315|NCT04756531|582753072|FG005|Overall Study|Adverse Event|0|||
161372316|NCT04756531|582753073|FG006|Overall Study|Adverse Event|0|||
161372317|NCT04756531|582753074|FG007|Overall Study|Adverse Event|0|||
161372318|NCT04756531|582753075|FG008|Overall Study|Adverse Event|0|||
161372319|NCT04756531|582753076|FG009|Overall Study|Adverse Event|0|||
161372320|NCT04756531|582753077|FG010|Overall Study|Adverse Event|0|||
161372321|NCT04756531|582753078|FG011|Overall Study|Adverse Event|0|||
161372322|NCT04756531|582753079|FG012|Overall Study|Adverse Event|0|||
161372323|NCT04756531|582753080|FG013|Overall Study|Adverse Event|0|||
161372324|NCT04756531|582753081|FG014|Overall Study|Adverse Event|0|||
161372325|NCT04756531|582753082|FG015|Overall Study|Adverse Event|0|||
161372326|NCT04756531|582753083|FG016|Overall Study|Adverse Event|0|||
161372327|NCT04756531|582753084|FG017|Overall Study|Adverse Event|0|||
161372328|NCT04756531|582753067|FG000|Overall Study|Withdrawal by Subject|0|||
161372329|NCT04756531|582753068|FG001|Overall Study|Withdrawal by Subject|0|||
161372330|NCT04756531|582753069|FG002|Overall Study|Withdrawal by Subject|0|||
161372331|NCT04756531|582753070|FG003|Overall Study|Withdrawal by Subject|0|||
161372332|NCT04756531|582753071|FG004|Overall Study|Withdrawal by Subject|0|||
161372333|NCT04756531|582753072|FG005|Overall Study|Withdrawal by Subject|0|||
161372334|NCT04756531|582753073|FG006|Overall Study|Withdrawal by Subject|1|||
161372335|NCT04756531|582753074|FG007|Overall Study|Withdrawal by Subject|0|||
161372336|NCT04756531|582753075|FG008|Overall Study|Withdrawal by Subject|0|||
161372337|NCT04756531|582753076|FG009|Overall Study|Withdrawal by Subject|0|||
161372338|NCT04756531|582753077|FG010|Overall Study|Withdrawal by Subject|0|||
161372339|NCT04756531|582753078|FG011|Overall Study|Withdrawal by Subject|0|||
161372340|NCT04756531|582753079|FG012|Overall Study|Withdrawal by Subject|0|||
161372341|NCT04756531|582753080|FG013|Overall Study|Withdrawal by Subject|0|||
161372342|NCT04756531|582753081|FG014|Overall Study|Withdrawal by Subject|0|||
161372343|NCT04756531|582753082|FG015|Overall Study|Withdrawal by Subject|0|||
161372344|NCT04756531|582753083|FG016|Overall Study|Withdrawal by Subject|0|||
161372345|NCT04756531|582753084|FG017|Overall Study|Withdrawal by Subject|0|||
161372346|NCT05643495|582753085|FG000|Overall Study|Adverse Event|0|||
161372347|NCT05643495|582753086|FG001|Overall Study|Adverse Event|1|||
161372348|NCT05643495|582753085|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161372349|NCT05643495|582753086|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
161372350|NCT02257528|582753087|FG000|Overall Study|Never received study treatment|1|||
161372351|NCT01729039|582753090|FG000|Overall Study|disqualified|2|||
161372352|NCT01729039|582753091|FG001|Overall Study|disqualified|5|||
161372353|NCT01729039|582753090|FG000|Overall Study|Withdrawal by Subject|8|||
161372354|NCT01729039|582753091|FG001|Overall Study|Withdrawal by Subject|7|||
161372355|NCT00698841|582753092|FG000|Overall Study|Withdrawal by Subject|2|||
161372356|NCT00698841|582753092|FG000|Overall Study|Adverse Event|3|||
161372357|NCT00698841|582753092|FG000|Overall Study|Disease progression|7|||
161372358|NCT00698841|582753092|FG000|Overall Study|Failure to meet eligibility criteria|2|||
161372359|NCT00698841|582753092|FG000|Overall Study|Study drug toxicity|2|||
161372360|NCT00698841|582753092|FG000|Overall Study|Other|2|||
161372361|NCT04646005|582753096|FG000|Overall Study|Adverse Event|1|||
161372362|NCT04646005|582753096|FG000|Overall Study|Progressive Disease|71|||
161372363|NCT04646005|582753096|FG000|Overall Study|Death|20|||
161372364|NCT04646005|582753096|FG000|Overall Study|Withdrawal by Subject|12|||
161372365|NCT04646005|582753096|FG000|Overall Study|Sponsor Request|9|||
161372366|NCT04237584|582753098|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
161372367|NCT04237584|582753099|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
161372368|NCT04237584|582753100|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
161372369|NCT04237584|582753101|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
161372370|NCT04237584|582753098|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
161372371|NCT04237584|582753099|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
161372372|NCT04237584|582753100|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
161372373|NCT04237584|582753101|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
161372374|NCT04237584|582753098|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
161372375|NCT04237584|582753099|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
161372376|NCT04237584|582753100|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
161435260|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Not treated|0|||
161372377|NCT04237584|582753101|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
161372378|NCT04237584|582753098|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
161372379|NCT04237584|582753099|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
161372380|NCT04237584|582753100|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
161372381|NCT04237584|582753101|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
161372382|NCT04237584|582753098|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
161372383|NCT04237584|582753099|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
161372384|NCT04237584|582753100|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
161372385|NCT04237584|582753101|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
161372386|NCT01126190|582754148|FG000|Double-Blind Phase|Death|0|||
161372387|NCT01126190|582754149|FG001|Double-Blind Phase|Death|1|||
161372388|NCT01126190|582754150|FG002|Double-Blind Phase|Death|0|||
161372389|NCT01126190|582754148|FG000|Double-Blind Phase|Adverse Event|1|||
161372390|NCT01126190|582754149|FG001|Double-Blind Phase|Adverse Event|2|||
161372391|NCT01126190|582754150|FG002|Double-Blind Phase|Adverse Event|0|||
161372392|NCT01126190|582754148|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161372393|NCT01126190|582754149|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
161372394|NCT01126190|582754150|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161372395|NCT01126190|582754148|FG000|Double-Blind Phase|Request of Investigator|1|||
161372396|NCT01126190|582754149|FG001|Double-Blind Phase|Request of Investigator|0|||
161372397|NCT01126190|582754150|FG002|Double-Blind Phase|Request of Investigator|0|||
161372398|NCT01126190|582754148|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
161372399|NCT01126190|582754149|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
161372400|NCT01126190|582754150|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
161372401|NCT01126190|582754148|FG000|Double-Blind Phase|Non-compliance|1|||
161372402|NCT01126190|582754149|FG001|Double-Blind Phase|Non-compliance|0|||
161372403|NCT01126190|582754150|FG002|Double-Blind Phase|Non-compliance|0|||
161372404|NCT01126190|582754148|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161372405|NCT01126190|582754149|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161372406|NCT01126190|582754150|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161372407|NCT01126190|582754148|FG000|Open-Label Phase|Death|0|||
161372408|NCT01126190|582754149|FG001|Open-Label Phase|Death|0|||
161372409|NCT01126190|582754150|FG002|Open-Label Phase|Death|1|||
161372410|NCT01126190|582754148|FG000|Open-Label Phase|Adverse Event|0|||
161372411|NCT01126190|582754149|FG001|Open-Label Phase|Adverse Event|0|||
161372412|NCT01126190|582754150|FG002|Open-Label Phase|Adverse Event|4|||
161372413|NCT01126190|582754148|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161372414|NCT01126190|582754149|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161372415|NCT01126190|582754150|FG002|Open-Label Phase|Withdrawal by Subject|6|||
161372416|NCT01128569|582754151|FG000|Washout Period 1|Adverse Event|0|||
161372417|NCT01128569|582754152|FG001|Washout Period 1|Adverse Event|0|||
161372418|NCT01128569|582754153|FG002|Washout Period 1|Adverse Event|1|||
161372419|NCT01128569|582754154|FG003|Washout Period 1|Adverse Event|0|||
161372420|NCT01128569|582754155|FG004|Washout Period 1|Adverse Event|0|||
161372421|NCT01128569|582754156|FG005|Washout Period 1|Adverse Event|0|||
161372422|NCT01128569|582754151|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161372423|NCT01128569|582754152|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161372424|NCT01128569|582754153|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161372425|NCT01128569|582754154|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161372426|NCT01128569|582754155|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161372427|NCT01128569|582754156|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161372428|NCT03338400|582754157|FG000|Overall Study|Lost to Follow-up|1|||
161372429|NCT03338400|582754158|FG001|Overall Study|Lost to Follow-up|2|||
161372430|NCT01627691|582754159|FG000|Overall Study|Death|11|||
161372431|NCT01627691|582754159|FG000|Overall Study|Lost to Follow-up|3|||
161372432|NCT01627691|582754159|FG000|Overall Study|Withdrawal by Subject|1|||
161372433|NCT01627691|582754159|FG000|Overall Study|Missed the visit|3|||
161372434|NCT01156844|582754166|FG000|Overall Study|Adverse Event|0|||
161372435|NCT01156844|582754167|FG001|Overall Study|Adverse Event|0|||
161372436|NCT01156844|582754168|FG002|Overall Study|Adverse Event|1|||
161372437|NCT01156844|582754169|FG003|Overall Study|Adverse Event|1|||
161372438|NCT01156844|582754166|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161372439|NCT01156844|582754167|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161372440|NCT01156844|582754168|FG002|Overall Study|Abnormal test procedure result(s)|2|||
161372441|NCT01156844|582754169|FG003|Overall Study|Abnormal test procedure result(s)|2|||
161372442|NCT01156844|582754166|FG000|Overall Study|Withdrawal by Subject|0|||
161372443|NCT01156844|582754167|FG001|Overall Study|Withdrawal by Subject|0|||
161372444|NCT01156844|582754168|FG002|Overall Study|Withdrawal by Subject|2|||
161372445|NCT01156844|582754169|FG003|Overall Study|Withdrawal by Subject|2|||
161372446|NCT01156844|582754166|FG000|Overall Study|Lost to Follow-up|0|||
161372447|NCT01156844|582754167|FG001|Overall Study|Lost to Follow-up|0|||
161372448|NCT01156844|582754168|FG002|Overall Study|Lost to Follow-up|1|||
161372449|NCT01156844|582754169|FG003|Overall Study|Lost to Follow-up|0|||
161372450|NCT01156844|582754166|FG000|Overall Study|Administrative problems|0|||
161372451|NCT01156844|582754167|FG001|Overall Study|Administrative problems|1|||
161372452|NCT01156844|582754168|FG002|Overall Study|Administrative problems|0|||
161372453|NCT01156844|582754169|FG003|Overall Study|Administrative problems|1|||
161372454|NCT01156844|582754166|FG000|Overall Study|Protocol deviation|2|||
161372455|NCT01156844|582754167|FG001|Overall Study|Protocol deviation|0|||
161372456|NCT01156844|582754168|FG002|Overall Study|Protocol deviation|0|||
161372457|NCT01156844|582754169|FG003|Overall Study|Protocol deviation|0|||
161372458|NCT01130337|582754172|FG000|Overall Study|Withdrawal by Subject|3|||
161372459|NCT01130337|582754172|FG000|Overall Study|Principal investigator decision|1|||
161372460|NCT01130337|582754172|FG000|Overall Study|Death|1|||
161372461|NCT01130337|582754172|FG000|Overall Study|Disease progression|1|||
161372462|NCT01130337|582754172|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
161372463|NCT01130337|582754172|FG000|Overall Study|Surgical resection (R2)|1|||
161372464|NCT03886493|582754173|FG000|Overall Study|Adverse Event|1|||
161372465|NCT04067011|582754175|FG000|Overall Study|Not Treated|8|||
161372466|NCT04067011|582754176|FG001|Overall Study|Not Treated|7|||
161372467|NCT04067011|582754177|FG002|Overall Study|Not Treated|5|||
161372468|NCT04067011|582754175|FG000|Overall Study|Adverse Event|2|||
161372469|NCT04067011|582754176|FG001|Overall Study|Adverse Event|1|||
161372470|NCT04067011|582754177|FG002|Overall Study|Adverse Event|0|||
161372471|NCT04067011|582754175|FG000|Overall Study|Withdrawal by Subject|6|||
161372472|NCT04067011|582754176|FG001|Overall Study|Withdrawal by Subject|2|||
161372473|NCT04067011|582754177|FG002|Overall Study|Withdrawal by Subject|1|||
161372474|NCT04067011|582754175|FG000|Overall Study|Lost to Follow-up|0|||
161372475|NCT04067011|582754176|FG001|Overall Study|Lost to Follow-up|0|||
161372476|NCT04067011|582754177|FG002|Overall Study|Lost to Follow-up|1|||
161372477|NCT04067011|582754175|FG000|Overall Study|Physician Decision|1|||
161372478|NCT04067011|582754176|FG001|Overall Study|Physician Decision|1|||
161372479|NCT04067011|582754177|FG002|Overall Study|Physician Decision|0|||
161372480|NCT04067011|582754175|FG000|Overall Study|Other Reasons|2|||
161372481|NCT04067011|582754176|FG001|Overall Study|Other Reasons|0|||
161372482|NCT04067011|582754177|FG002|Overall Study|Other Reasons|1|||
161372483|NCT04067011|582754175|FG000|Overall Study|Missing|0|||
161372484|NCT04067011|582754176|FG001|Overall Study|Missing|2|||
161372485|NCT04067011|582754177|FG002|Overall Study|Missing|0|||
161372486|NCT05209386|582754178|FG000|Overall Study|Withdrawal by Subject|8|||
161372487|NCT05209386|582754178|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
161372488|NCT03139448|582754182|FG000|Overall Study|Lack of Efficacy|6|||
161372489|NCT03139448|582754183|FG001|Overall Study|Lack of Efficacy|7|||
161372490|NCT03139448|582754182|FG000|Overall Study|Location of procedure changed|2|||
161372491|NCT03139448|582754183|FG001|Overall Study|Location of procedure changed|8|||
161372492|NCT03139448|582754182|FG000|Overall Study|Withdrawal by Subject|3|||
161372493|NCT03139448|582754183|FG001|Overall Study|Withdrawal by Subject|6|||
161372494|NCT03139448|582754182|FG000|Overall Study|Screen fail|1|||
161372495|NCT03139448|582754183|FG001|Overall Study|Screen fail|3|||
161372496|NCT03139448|582754182|FG000|Overall Study|Physician Decision|0|||
161372497|NCT03139448|582754183|FG001|Overall Study|Physician Decision|2|||
161372498|NCT01038323|582754184|FG000|Overall Study|Withdrawal by Subject|3|||
161372499|NCT01038323|582754185|FG001|Overall Study|Withdrawal by Subject|2|||
161372500|NCT01038323|582754186|FG002|Overall Study|Withdrawal by Subject|4|||
161372501|NCT04436744|582754189|FG000|Overall Study|Adverse Event|1|||
161372502|NCT04436744|582754190|FG001|Overall Study|Adverse Event|1|||
161372503|NCT04436744|582754189|FG000|Overall Study|Death|1|||
161372504|NCT04436744|582754190|FG001|Overall Study|Death|0|||
161372505|NCT04436744|582754189|FG000|Overall Study|Lost to Follow-up|0|||
161372506|NCT04436744|582754190|FG001|Overall Study|Lost to Follow-up|2|||
161372507|NCT04436744|582754189|FG000|Overall Study|Physician Decision|0|||
161372508|NCT04436744|582754190|FG001|Overall Study|Physician Decision|1|||
161372509|NCT04436744|582754189|FG000|Overall Study|Progressive Disease|0|||
161372510|NCT04436744|582754190|FG001|Overall Study|Progressive Disease|4|||
161372511|NCT04436744|582754189|FG000|Overall Study|Protocol Deviation|1|||
161372512|NCT04436744|582754190|FG001|Overall Study|Protocol Deviation|1|||
161372513|NCT04436744|582754189|FG000|Overall Study|Withdrawal by Subject|1|||
161372514|NCT04436744|582754190|FG001|Overall Study|Withdrawal by Subject|2|||
161372515|NCT01463033|582754191|FG000|Overall Study|Lost to Follow-up|4|||
161372516|NCT01463033|582754192|FG001|Overall Study|Lost to Follow-up|4|||
161372517|NCT01463033|582754191|FG000|Overall Study|Death|3|||
161372518|NCT01463033|582754192|FG001|Overall Study|Death|2|||
161372519|NCT00746811|582754193|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
161372520|NCT00746811|582754194|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
161372521|NCT01538199|582754195|FG000|Overall Study|Lost to Follow-up|1|||
161372522|NCT01538199|582754196|FG001|Overall Study|Lost to Follow-up|2|||
161372523|NCT01538199|582754197|FG002|Overall Study|Lost to Follow-up|1|||
161372524|NCT01538199|582754198|FG003|Overall Study|Lost to Follow-up|0|||
161372525|NCT01538199|582754195|FG000|Overall Study|participant did not have time|1|||
161372526|NCT01538199|582754196|FG001|Overall Study|participant did not have time|0|||
161372527|NCT01538199|582754197|FG002|Overall Study|participant did not have time|0|||
161372528|NCT01538199|582754198|FG003|Overall Study|participant did not have time|2|||
161372529|NCT01538199|582754195|FG000|Overall Study|Lack of Efficacy|0|||
161372530|NCT01538199|582754196|FG001|Overall Study|Lack of Efficacy|1|||
161372531|NCT01538199|582754197|FG002|Overall Study|Lack of Efficacy|0|||
161372532|NCT01538199|582754198|FG003|Overall Study|Lack of Efficacy|0|||
161372533|NCT03358030|582754199|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
161372534|NCT03358030|582754200|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161372535|NCT03358030|582754201|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
161372536|NCT03358030|582754202|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
161372537|NCT03358030|582754199|FG000|Overall Study|Ineligibility|0|||
161372538|NCT03358030|582754200|FG001|Overall Study|Ineligibility|0|||
161372539|NCT03358030|582754201|FG002|Overall Study|Ineligibility|0|||
161372540|NCT03358030|582754202|FG003|Overall Study|Ineligibility|2|||
161372541|NCT03358030|582754199|FG000|Overall Study|Voluntary Withdrawal|1|||
161372542|NCT03358030|582754200|FG001|Overall Study|Voluntary Withdrawal|1|||
161372543|NCT03358030|582754201|FG002|Overall Study|Voluntary Withdrawal|3|||
161372544|NCT03358030|582754202|FG003|Overall Study|Voluntary Withdrawal|1|||
161372545|NCT03358030|582754199|FG000|Overall Study|Other|0|||
161372546|NCT03358030|582754200|FG001|Overall Study|Other|0|||
161372547|NCT03358030|582754201|FG002|Overall Study|Other|1|||
161372548|NCT03358030|582754202|FG003|Overall Study|Other|0|||
161372549|NCT03342560|582754203|FG000|Overall Study|Lost to Follow-up|2|||
161372550|NCT02604511|582754204|FG000|Overall Study|Adverse Event|3|||
161372551|NCT02604511|582754204|FG000|Overall Study|Disease Progression|4|||
161372552|NCT02604511|582754204|FG000|Overall Study|Withdrawal by Subject|3|||
161372553|NCT02604511|582754204|FG000|Overall Study|Participant ineligible|1|||
161372554|NCT02604511|582754204|FG000|Overall Study|Intercurrent illness|1|||
161372555|NCT03770286|582754205|FG000|Overall Study|Lost to Follow-up|6|||
161372556|NCT03770286|582754206|FG001|Overall Study|Lost to Follow-up|4|||
161372557|NCT03770286|582754207|FG002|Overall Study|Lost to Follow-up|3|||
161372558|NCT03770286|582754205|FG000|Overall Study|Protocol Violation|1|||
161372559|NCT03770286|582754206|FG001|Overall Study|Protocol Violation|0|||
161372560|NCT03770286|582754207|FG002|Overall Study|Protocol Violation|2|||
161372561|NCT02505425|582754208|FG000|Overall Study|Lost to Follow-up|41|||
161372562|NCT02505425|582754209|FG001|Overall Study|Lost to Follow-up|61|||
161372563|NCT02505425|582754210|FG002|Overall Study|Lost to Follow-up|31|||
161372564|NCT02505425|582754211|FG003|Overall Study|Lost to Follow-up|19|||
161372565|NCT02505425|582754208|FG000|Overall Study|Withdrawal by Subject|39|||
161372566|NCT02505425|582754209|FG001|Overall Study|Withdrawal by Subject|9|||
161372567|NCT02505425|582754210|FG002|Overall Study|Withdrawal by Subject|19|||
161372568|NCT02505425|582754211|FG003|Overall Study|Withdrawal by Subject|7|||
161372569|NCT02505425|582754208|FG000|Overall Study|Death|8|||
161372570|NCT02505425|582754209|FG001|Overall Study|Death|12|||
161372571|NCT02505425|582754210|FG002|Overall Study|Death|0|||
161372572|NCT02505425|582754211|FG003|Overall Study|Death|0|||
161372573|NCT00404248|582754220|FG000|Overall Study|pts declining status|0|||
161372574|NCT00404248|582754221|FG001|Overall Study|pts declining status|1|||
161372575|NCT00404248|582754222|FG002|Overall Study|pts declining status|0|||
161372576|NCT00404248|582754223|FG003|Overall Study|pts declining status|0|||
161372577|NCT00404248|582754224|FG004|Overall Study|pts declining status|0|||
161372578|NCT00404248|582754225|FG005|Overall Study|pts declining status|0|||
161372579|NCT00404248|582754226|FG006|Overall Study|pts declining status|0|||
161372580|NCT00404248|582754227|FG007|Overall Study|pts declining status|0|||
161372581|NCT00404248|582754228|FG008|Overall Study|pts declining status|0|||
161372582|NCT00789555|582754229|FG000|Overall Study|Protocol Amendment|78|||
161372583|NCT00789555|582754230|FG001|Overall Study|Protocol Amendment|76|||
161372584|NCT00789555|582754231|FG002|Overall Study|Protocol Amendment|80|||
161372585|NCT00789555|582754229|FG000|Overall Study|Adverse Event|17|||
161372586|NCT00789555|582754230|FG001|Overall Study|Adverse Event|7|||
161372587|NCT00789555|582754231|FG002|Overall Study|Adverse Event|10|||
161372588|NCT00789555|582754229|FG000|Overall Study|Lost to Follow-up|9|||
161372589|NCT00789555|582754230|FG001|Overall Study|Lost to Follow-up|10|||
161372590|NCT00789555|582754231|FG002|Overall Study|Lost to Follow-up|18|||
161372591|NCT00789555|582754229|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
161372592|NCT00789555|582754230|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
161372593|NCT00789555|582754231|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
161372594|NCT00789555|582754229|FG000|Overall Study|Treatment failure|11|||
161372595|NCT00789555|582754230|FG001|Overall Study|Treatment failure|8|||
161372596|NCT00789555|582754231|FG002|Overall Study|Treatment failure|12|||
161372597|NCT00789555|582754229|FG000|Overall Study|Protocol Violation|6|||
161372598|NCT00789555|582754230|FG001|Overall Study|Protocol Violation|9|||
161372599|NCT00789555|582754231|FG002|Overall Study|Protocol Violation|13|||
161372600|NCT05788991|582754232|FG000|Overall Study|Not treated with study medication|1|||
161372601|NCT05788991|582754233|FG001|Overall Study|Not treated with study medication|3|||
161372602|NCT05788991|582754232|FG000|Overall Study|Withdrawal by Subject|1|||
161372603|NCT05788991|582754233|FG001|Overall Study|Withdrawal by Subject|0|||
161372604|NCT05788991|582754232|FG000|Overall Study|Lack of Efficacy|0|||
161372605|NCT05788991|582754233|FG001|Overall Study|Lack of Efficacy|1|||
161372606|NCT05788991|582754232|FG000|Overall Study|Protocol Violation|1|||
161372607|NCT05788991|582754233|FG001|Overall Study|Protocol Violation|2|||
161372608|NCT04712669|582754234|FG000|Double Blind Phase|Adverse Event|4|||
161372609|NCT04712669|582754235|FG001|Double Blind Phase|Adverse Event|4|||
161372610|NCT04712669|582754236|FG002|Double Blind Phase|Adverse Event|3|||
161372611|NCT04712669|582754237|FG003|Double Blind Phase|Adverse Event|0|||
161372612|NCT04712669|582754238|FG004|Double Blind Phase|Adverse Event|0|||
161372613|NCT04712669|582754239|FG005|Double Blind Phase|Adverse Event|0|||
161372614|NCT04712669|582754240|FG006|Double Blind Phase|Adverse Event|0|||
161372615|NCT04712669|582754241|FG007|Double Blind Phase|Adverse Event|0|||
161372616|NCT04712669|582754234|FG000|Double Blind Phase|Physician Decision|1|||
161372617|NCT04712669|582754235|FG001|Double Blind Phase|Physician Decision|0|||
161372618|NCT04712669|582754236|FG002|Double Blind Phase|Physician Decision|0|||
161372619|NCT04712669|582754237|FG003|Double Blind Phase|Physician Decision|0|||
161372620|NCT04712669|582754238|FG004|Double Blind Phase|Physician Decision|0|||
161372621|NCT04712669|582754239|FG005|Double Blind Phase|Physician Decision|0|||
161372622|NCT04712669|582754240|FG006|Double Blind Phase|Physician Decision|0|||
161372623|NCT04712669|582754241|FG007|Double Blind Phase|Physician Decision|0|||
161372624|NCT04712669|582754234|FG000|Double Blind Phase|Withdrawal by Subject|3|||
161372625|NCT04712669|582754235|FG001|Double Blind Phase|Withdrawal by Subject|6|||
161372626|NCT04712669|582754236|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161372627|NCT04712669|582754237|FG003|Double Blind Phase|Withdrawal by Subject|0|||
161372628|NCT04712669|582754238|FG004|Double Blind Phase|Withdrawal by Subject|0|||
161372629|NCT04712669|582754239|FG005|Double Blind Phase|Withdrawal by Subject|0|||
161372630|NCT04712669|582754240|FG006|Double Blind Phase|Withdrawal by Subject|0|||
161372631|NCT04712669|582754241|FG007|Double Blind Phase|Withdrawal by Subject|0|||
161372632|NCT04712669|582754234|FG000|Double Blind Phase|Termination by Sponsor|0|||
161372633|NCT04712669|582754235|FG001|Double Blind Phase|Termination by Sponsor|0|||
161372634|NCT04712669|582754236|FG002|Double Blind Phase|Termination by Sponsor|1|||
161372635|NCT04712669|582754237|FG003|Double Blind Phase|Termination by Sponsor|0|||
161372636|NCT04712669|582754238|FG004|Double Blind Phase|Termination by Sponsor|0|||
161372637|NCT04712669|582754239|FG005|Double Blind Phase|Termination by Sponsor|0|||
161372638|NCT04712669|582754240|FG006|Double Blind Phase|Termination by Sponsor|0|||
161372639|NCT04712669|582754241|FG007|Double Blind Phase|Termination by Sponsor|0|||
161372640|NCT04712669|582754234|FG000|Open Label Phase|Adverse Event|0|||
161372641|NCT04712669|582754235|FG001|Open Label Phase|Adverse Event|0|||
161372642|NCT04712669|582754236|FG002|Open Label Phase|Adverse Event|0|||
161372643|NCT04712669|582754237|FG003|Open Label Phase|Adverse Event|1|||
161372644|NCT04712669|582754238|FG004|Open Label Phase|Adverse Event|1|||
161372645|NCT04712669|582754239|FG005|Open Label Phase|Adverse Event|3|||
161372646|NCT04712669|582754240|FG006|Open Label Phase|Adverse Event|1|||
161372647|NCT04712669|582754241|FG007|Open Label Phase|Adverse Event|2|||
161372648|NCT04712669|582754234|FG000|Open Label Phase|Death|0|||
161372649|NCT04712669|582754235|FG001|Open Label Phase|Death|0|||
161372650|NCT04712669|582754236|FG002|Open Label Phase|Death|0|||
161372651|NCT04712669|582754237|FG003|Open Label Phase|Death|1|||
161372652|NCT04712669|582754238|FG004|Open Label Phase|Death|0|||
161372653|NCT04712669|582754239|FG005|Open Label Phase|Death|0|||
161372654|NCT04712669|582754240|FG006|Open Label Phase|Death|0|||
161372655|NCT04712669|582754241|FG007|Open Label Phase|Death|0|||
161372656|NCT04712669|582754234|FG000|Open Label Phase|Lack of Efficacy|0|||
161372657|NCT04712669|582754235|FG001|Open Label Phase|Lack of Efficacy|0|||
161372658|NCT04712669|582754236|FG002|Open Label Phase|Lack of Efficacy|0|||
161372659|NCT04712669|582754237|FG003|Open Label Phase|Lack of Efficacy|0|||
161372660|NCT04712669|582754238|FG004|Open Label Phase|Lack of Efficacy|1|||
161372661|NCT04712669|582754239|FG005|Open Label Phase|Lack of Efficacy|0|||
161372662|NCT04712669|582754240|FG006|Open Label Phase|Lack of Efficacy|0|||
161372663|NCT04712669|582754241|FG007|Open Label Phase|Lack of Efficacy|0|||
161372664|NCT04712669|582754234|FG000|Open Label Phase|Lost to Follow-up|0|||
161372665|NCT04712669|582754235|FG001|Open Label Phase|Lost to Follow-up|0|||
161372666|NCT04712669|582754236|FG002|Open Label Phase|Lost to Follow-up|0|||
161372667|NCT04712669|582754237|FG003|Open Label Phase|Lost to Follow-up|0|||
161372668|NCT04712669|582754238|FG004|Open Label Phase|Lost to Follow-up|0|||
161372669|NCT04712669|582754239|FG005|Open Label Phase|Lost to Follow-up|0|||
161372670|NCT04712669|582754240|FG006|Open Label Phase|Lost to Follow-up|1|||
161372671|NCT04712669|582754241|FG007|Open Label Phase|Lost to Follow-up|1|||
161372672|NCT04712669|582754234|FG000|Open Label Phase|Physician Decision|0|||
161372673|NCT04712669|582754235|FG001|Open Label Phase|Physician Decision|0|||
161372674|NCT04712669|582754236|FG002|Open Label Phase|Physician Decision|0|||
161372675|NCT04712669|582754237|FG003|Open Label Phase|Physician Decision|1|||
161372676|NCT04712669|582754238|FG004|Open Label Phase|Physician Decision|0|||
161372677|NCT04712669|582754239|FG005|Open Label Phase|Physician Decision|0|||
161372678|NCT04712669|582754240|FG006|Open Label Phase|Physician Decision|0|||
161372679|NCT04712669|582754241|FG007|Open Label Phase|Physician Decision|0|||
161372680|NCT04712669|582754234|FG000|Open Label Phase|Withdrawal by Subject|0|||
161372681|NCT04712669|582754235|FG001|Open Label Phase|Withdrawal by Subject|0|||
161372682|NCT04712669|582754236|FG002|Open Label Phase|Withdrawal by Subject|0|||
161372683|NCT04712669|582754237|FG003|Open Label Phase|Withdrawal by Subject|1|||
161372684|NCT04712669|582754238|FG004|Open Label Phase|Withdrawal by Subject|5|||
161372685|NCT04712669|582754239|FG005|Open Label Phase|Withdrawal by Subject|5|||
161372686|NCT04712669|582754240|FG006|Open Label Phase|Withdrawal by Subject|0|||
161372687|NCT04712669|582754241|FG007|Open Label Phase|Withdrawal by Subject|4|||
161372688|NCT04712669|582754234|FG000|Open Label Phase|Termination by Sponsor|0|||
161372689|NCT04712669|582754235|FG001|Open Label Phase|Termination by Sponsor|0|||
161372690|NCT04712669|582754236|FG002|Open Label Phase|Termination by Sponsor|0|||
161372691|NCT04712669|582754237|FG003|Open Label Phase|Termination by Sponsor|11|||
161372692|NCT04712669|582754238|FG004|Open Label Phase|Termination by Sponsor|9|||
161372693|NCT04712669|582754239|FG005|Open Label Phase|Termination by Sponsor|14|||
161372694|NCT04712669|582754240|FG006|Open Label Phase|Termination by Sponsor|0|||
161372695|NCT04712669|582754241|FG007|Open Label Phase|Termination by Sponsor|14|||
161372696|NCT04464473|582754242|FG000|Overall Study|New piercing could not be removed for scanning|0|||
161372697|NCT04464473|582754243|FG001|Overall Study|New piercing could not be removed for scanning|0|||
161372698|NCT04464473|582754244|FG002|Overall Study|New piercing could not be removed for scanning|0|||
161372699|NCT04464473|582754245|FG003|Overall Study|New piercing could not be removed for scanning|1|||
161372700|NCT04464473|582754246|FG004|Overall Study|New piercing could not be removed for scanning|0|||
161372701|NCT04464473|582754247|FG005|Overall Study|New piercing could not be removed for scanning|0|||
161372702|NCT04464473|582754242|FG000|Overall Study|Adverse Event|0|||
161372703|NCT04464473|582754243|FG001|Overall Study|Adverse Event|0|||
161372704|NCT04464473|582754244|FG002|Overall Study|Adverse Event|0|||
161372705|NCT04464473|582754245|FG003|Overall Study|Adverse Event|1|||
161372706|NCT04464473|582754246|FG004|Overall Study|Adverse Event|0|||
161372707|NCT04464473|582754247|FG005|Overall Study|Adverse Event|0|||
161372708|NCT04464473|582754242|FG000|Overall Study|Lost to Follow-up|0|||
161372709|NCT04464473|582754243|FG001|Overall Study|Lost to Follow-up|0|||
161372710|NCT04464473|582754244|FG002|Overall Study|Lost to Follow-up|0|||
161372711|NCT04464473|582754245|FG003|Overall Study|Lost to Follow-up|1|||
161372712|NCT04464473|582754246|FG004|Overall Study|Lost to Follow-up|0|||
161372713|NCT04464473|582754247|FG005|Overall Study|Lost to Follow-up|0|||
161372714|NCT03802396|582754248|FG000|Overall Study|Withdrawal by Subject|2|||
161372715|NCT03802396|582754249|FG001|Overall Study|Withdrawal by Subject|0|||
161372716|NCT03802396|582754248|FG000|Overall Study|Surgery Cancelled|1|||
161372717|NCT03802396|582754249|FG001|Overall Study|Surgery Cancelled|0|||
161372718|NCT01150357|582754265|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
161372719|NCT01150357|582754266|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
161372720|NCT01150357|582754267|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
161372721|NCT01150357|582754265|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
161372722|NCT01150357|582754266|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
161372723|NCT01150357|582754267|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
161372724|NCT01150357|582754265|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
161372725|NCT01150357|582754266|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
161372726|NCT01150357|582754267|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
161372727|NCT01150357|582754265|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
161372728|NCT01150357|582754266|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
161372729|NCT01150357|582754267|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
161372730|NCT01150357|582754265|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
161372731|NCT01150357|582754266|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
161372732|NCT01150357|582754267|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
161372733|NCT01150357|582754265|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
161372734|NCT01150357|582754266|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
161372735|NCT01150357|582754267|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
161372736|NCT01150357|582754265|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
161372737|NCT01150357|582754266|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
161372738|NCT01150357|582754267|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
161372739|NCT02661672|582754268|FG000|Overall Study|Lost to Follow-up|1|||
161372740|NCT02661672|582754268|FG000|Overall Study|Death|4|||
161372741|NCT03549338|582756380|FG000|Overall Study|Progressive Disease|1|||
161372742|NCT03549338|582756381|FG001|Overall Study|Progressive Disease|0|||
161372743|NCT03549338|582756382|FG002|Overall Study|Progressive Disease|0|||
161372744|NCT03549338|582756380|FG000|Overall Study|Clinical Progression|0|||
161372745|NCT03549338|582756381|FG001|Overall Study|Clinical Progression|1|||
161372746|NCT03549338|582756382|FG002|Overall Study|Clinical Progression|0|||
161372747|NCT01492426|582756383|FG000|Treatment|Death|0|||
161372748|NCT01492426|582756384|FG001|Treatment|Death|1|||
161372749|NCT01492426|582756383|FG000|Treatment|Other|1|||
161372750|NCT01492426|582756384|FG001|Treatment|Other|0|||
161372751|NCT01492426|582756383|FG000|Treatment|Adverse Event|25|||
161372752|NCT01492426|582756384|FG001|Treatment|Adverse Event|25|||
161372753|NCT01492426|582756383|FG000|Treatment|Lack of Efficacy|38|||
161372754|NCT01492426|582756384|FG001|Treatment|Lack of Efficacy|5|||
161372755|NCT01492426|582756383|FG000|Treatment|Participant withdrew consent|1|||
161372756|NCT01492426|582756384|FG001|Treatment|Participant withdrew consent|2|||
161372757|NCT01492426|582756383|FG000|Treatment|Poor compliance/noncompliance|1|||
161372758|NCT01492426|582756384|FG001|Treatment|Poor compliance/noncompliance|0|||
161372759|NCT01492426|582756383|FG000|Treatment|Subject requested discontinue study drug|7|||
161372760|NCT01492426|582756384|FG001|Treatment|Subject requested discontinue study drug|3|||
161372761|NCT01492426|582756383|FG000|Treatment|Lost to Follow-up|9|||
161372762|NCT01492426|582756384|FG001|Treatment|Lost to Follow-up|4|||
161372763|NCT01492426|582756383|FG000|Treatment|Participant does not meet study criteria|1|||
161372764|NCT01492426|582756384|FG001|Treatment|Participant does not meet study criteria|0|||
161372765|NCT01492426|582756383|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
161372766|NCT01492426|582756384|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
161372767|NCT01492426|582756383|FG000|Follow-Up|Death|1|||
161372768|NCT01492426|582756384|FG001|Follow-Up|Death|0|||
161372769|NCT01492426|582756383|FG000|Follow-Up|Other|4|||
161372770|NCT01492426|582756384|FG001|Follow-Up|Other|2|||
161372771|NCT01492426|582756383|FG000|Follow-Up|Participant Withdrew Consent|6|||
161372772|NCT01492426|582756384|FG001|Follow-Up|Participant Withdrew Consent|1|||
161372773|NCT01492426|582756383|FG000|Follow-Up|Lost to Follow-up|12|||
161372774|NCT01492426|582756384|FG001|Follow-Up|Lost to Follow-up|6|||
161372775|NCT00269113|582756385|FG000|Overall Study|Adverse Event|14|||
161372776|NCT00269113|582756386|FG001|Overall Study|Adverse Event|7|||
161372777|NCT00269113|582756385|FG000|Overall Study|Lack of Efficacy|35|||
161372778|NCT00269113|582756386|FG001|Overall Study|Lack of Efficacy|18|||
161372779|NCT00269113|582756385|FG000|Overall Study|Early Improvement|2|||
161372780|NCT00269113|582756386|FG001|Overall Study|Early Improvement|0|||
161372781|NCT00269113|582756385|FG000|Overall Study|Withdrawal by Subject|0|||
161372782|NCT00269113|582756386|FG001|Overall Study|Withdrawal by Subject|2|||
161372783|NCT00269113|582756385|FG000|Overall Study|Death|6|||
161372784|NCT00269113|582756386|FG001|Overall Study|Death|2|||
161372785|NCT00269113|582756385|FG000|Overall Study|Lost to Follow-up|2|||
161372786|NCT00269113|582756386|FG001|Overall Study|Lost to Follow-up|1|||
161372787|NCT00269113|582756385|FG000|Overall Study|Protocol Violation|15|||
161372788|NCT00269113|582756386|FG001|Overall Study|Protocol Violation|5|||
161372789|NCT00269113|582756385|FG000|Overall Study|Other|0|||
161372790|NCT00269113|582756386|FG001|Overall Study|Other|2|||
161372791|NCT00140140|582756387|FG000|Overall Study|Unacceptable toxicity|1|||
161372792|NCT00140140|582756388|FG001|Overall Study|Unacceptable toxicity|1|||
161372793|NCT00140140|582756389|FG002|Overall Study|Unacceptable toxicity|2|||
161372794|NCT00140140|582756387|FG000|Overall Study|Physician Decision|1|||
161372795|NCT00140140|582756388|FG001|Overall Study|Physician Decision|1|||
161372796|NCT00140140|582756389|FG002|Overall Study|Physician Decision|0|||
161372797|NCT00639457|582756390|FG000|Overall Study|Withdrawal by Subject|2|||
161372798|NCT00639457|582756391|FG001|Overall Study|Withdrawal by Subject|3|||
161372799|NCT02580877|582756392|FG000|Overall Study|Withdrawal by Subject|1|||
161372800|NCT02580877|582756393|FG001|Overall Study|Withdrawal by Subject|3|||
161372801|NCT02580877|582756392|FG000|Overall Study|Adverse Event|0|||
161372802|NCT02580877|582756393|FG001|Overall Study|Adverse Event|1|||
161372803|NCT01466491|582756394|FG000|Overall Study|Protocol Violation|0|||
161372804|NCT01466491|582756395|FG001|Overall Study|Protocol Violation|3|||
161372805|NCT01466491|582756396|FG002|Overall Study|Protocol Violation|2|||
161372806|NCT01466491|582756397|FG003|Overall Study|Protocol Violation|0|||
161372807|NCT01466491|582756394|FG000|Overall Study|Missing Data|0|||
161372808|NCT01466491|582756395|FG001|Overall Study|Missing Data|0|||
161372809|NCT01466491|582756396|FG002|Overall Study|Missing Data|1|||
161372810|NCT01466491|582756397|FG003|Overall Study|Missing Data|0|||
161372811|NCT00892008|582756398|FG000|Overall Study|Death|5|||
161372812|NCT00892008|582756398|FG000|Overall Study|Lack of Efficacy|3|||
161372813|NCT00892008|582756398|FG000|Overall Study|Lost to Follow-up|142|||
161372814|NCT00892008|582756398|FG000|Overall Study|Other|378|||
161372815|NCT00892008|582756398|FG000|Overall Study|Adverse Event|37|||
161372816|NCT01123148|582756399|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
161372817|NCT01123148|582756399|FG000|Overall Study|Didn't meet milestone criteria|1|||
161372818|NCT00355030|582756400|FG000|Study Period 1 Treatment|Adverse Event|1|||
161372819|NCT00355030|582756401|FG001|Study Period 1 Treatment|Adverse Event|1|||
161372820|NCT00355030|582756400|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
161372821|NCT00355030|582756401|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
161372822|NCT00355030|582756400|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
161372823|NCT00355030|582756401|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
161372824|NCT00355030|582756400|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
161372825|NCT00355030|582756401|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
161372826|NCT00355030|582756400|FG000|Study Period 1 Treatment|Physician Decision|0|||
161372827|NCT00355030|582756401|FG001|Study Period 1 Treatment|Physician Decision|1|||
161372828|NCT00355030|582756400|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
161372829|NCT00355030|582756401|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
161372830|NCT00355030|582756400|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
161372831|NCT00355030|582756401|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
161372832|NCT00355030|582756400|FG000|Study Period 1 Treatment|Other|2|||
161372833|NCT00355030|582756401|FG001|Study Period 1 Treatment|Other|6|||
161372834|NCT00355030|582756400|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
161372835|NCT00355030|582756401|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
161372836|NCT00355030|582756400|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
161372837|NCT00355030|582756401|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
161372838|NCT01693367|582756402|FG000|Overall Study|Withdrawal by Subject|1|||
161372839|NCT01693367|582756403|FG001|Overall Study|Withdrawal by Subject|1|||
161372840|NCT01693367|582756402|FG000|Overall Study|Physician Decision|0|||
161372841|NCT01693367|582756403|FG001|Overall Study|Physician Decision|1|||
161372842|NCT00690794|582756404|FG000|Overall Study|Adverse Event|12|||
161372843|NCT00690794|582756405|FG001|Overall Study|Adverse Event|10|||
161372844|NCT00690794|582756404|FG000|Overall Study|Lost to Follow-up|1|||
161372845|NCT00690794|582756405|FG001|Overall Study|Lost to Follow-up|4|||
161372846|NCT00690794|582756404|FG000|Overall Study|Withdrawal by Subject|0|||
161372847|NCT00690794|582756405|FG001|Overall Study|Withdrawal by Subject|9|||
161372848|NCT00690794|582756404|FG000|Overall Study|Protocol Violation|6|||
161372849|NCT00690794|582756405|FG001|Overall Study|Protocol Violation|7|||
161372850|NCT00690794|582756404|FG000|Overall Study|Noncompliance|1|||
161372851|NCT00690794|582756405|FG001|Overall Study|Noncompliance|2|||
161372852|NCT00690794|582756404|FG000|Overall Study|Other not specified|1|||
161372853|NCT00690794|582756405|FG001|Overall Study|Other not specified|3|||
161372854|NCT00325143|582756406|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
161372855|NCT00325143|582756406|FG000|Overall Study|Migrated/moved from study area|1|||
161372856|NCT00325143|582756406|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
161372857|NCT00325143|582756406|FG000|Overall Study|Withdrawal by Subject|8|||
161372858|NCT02286895|582756407|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
161372859|NCT02286895|582756408|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
161372860|NCT02286895|582756407|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
161372861|NCT02286895|582756408|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
161372862|NCT02286895|582756407|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
161372863|NCT02286895|582756408|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
161372864|NCT00399035|582756410|FG000|Overall Study|Death|289|||
161372865|NCT00399035|582756411|FG001|Overall Study|Death|141|||
161372866|NCT00399035|582756412|FG002|Overall Study|Death|234|||
161372867|NCT00399035|582756410|FG000|Overall Study|Lost to Follow-up|2|||
161372868|NCT00399035|582756411|FG001|Overall Study|Lost to Follow-up|1|||
161372869|NCT00399035|582756412|FG002|Overall Study|Lost to Follow-up|5|||
161372870|NCT00399035|582756410|FG000|Overall Study|Withdrawal by Subject|19|||
161372871|NCT00399035|582756411|FG001|Overall Study|Withdrawal by Subject|15|||
161372872|NCT00399035|582756412|FG002|Overall Study|Withdrawal by Subject|12|||
161372873|NCT00399035|582756410|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
161372874|NCT00399035|582756411|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
161372875|NCT00399035|582756412|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
161372876|NCT00399035|582756410|FG000|Overall Study|Severe non-compliance with protocol|2|||
161372877|NCT00399035|582756411|FG001|Overall Study|Severe non-compliance with protocol|1|||
161372878|NCT00399035|582756412|FG002|Overall Study|Severe non-compliance with protocol|0|||
161372879|NCT02949011|582756415|FG000|Overall Study|Adverse Event|6|||
161372880|NCT02949011|582756416|FG001|Overall Study|Adverse Event|7|||
161372881|NCT02949011|582756417|FG002|Overall Study|Adverse Event|3|||
161372882|NCT02949011|582756415|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161372883|NCT02949011|582756416|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161372884|NCT02949011|582756417|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
161372885|NCT02949011|582756415|FG000|Overall Study|Protocol Deviation|5|||
161372886|NCT02949011|582756416|FG001|Overall Study|Protocol Deviation|3|||
161372887|NCT02949011|582756417|FG002|Overall Study|Protocol Deviation|3|||
161372888|NCT02949011|582756415|FG000|Overall Study|Lack of Efficacy|0|||
161372889|NCT02949011|582756416|FG001|Overall Study|Lack of Efficacy|2|||
161372890|NCT02949011|582756417|FG002|Overall Study|Lack of Efficacy|0|||
161372891|NCT02949011|582756415|FG000|Overall Study|Withdrawal by Subject|13|||
161372892|NCT02949011|582756416|FG001|Overall Study|Withdrawal by Subject|13|||
161372893|NCT02949011|582756417|FG002|Overall Study|Withdrawal by Subject|21|||
161372894|NCT02949011|582756415|FG000|Overall Study|Lost to Follow-up|7|||
161372895|NCT02949011|582756416|FG001|Overall Study|Lost to Follow-up|5|||
161372896|NCT02949011|582756417|FG002|Overall Study|Lost to Follow-up|5|||
161372897|NCT02949011|582756415|FG000|Overall Study|Death|0|||
161372898|NCT02949011|582756416|FG001|Overall Study|Death|0|||
161372899|NCT02949011|582756417|FG002|Overall Study|Death|1|||
161372900|NCT02949011|582756415|FG000|Overall Study|Miscellaneous|2|||
161372901|NCT02949011|582756416|FG001|Overall Study|Miscellaneous|4|||
161372902|NCT02949011|582756417|FG002|Overall Study|Miscellaneous|6|||
161372903|NCT00163189|582756418|FG000|Overall Study|Other|6|||
161372904|NCT00163189|582756418|FG000|Overall Study|Lost to Follow-up|1|||
161372905|NCT00163189|582756418|FG000|Overall Study|Protocol Violation|2|||
161372906|NCT00163189|582756418|FG000|Overall Study|Death|3|||
161372907|NCT00163189|582756418|FG000|Overall Study|Adverse Event|6|||
161372908|NCT00163189|582756418|FG000|Overall Study|Lack of Efficacy|7|||
161372909|NCT00163189|582756418|FG000|Overall Study|Study terminated by sponsor|11|||
161372910|NCT00163189|582756418|FG000|Overall Study|Withdrawal by Subject|11|||
161372911|NCT00163189|582756418|FG000|Overall Study|Did not meet continuation criterion|16|||
161372912|NCT00454116|582756419|FG000|Overall Study|Adverse Event|5|||
161372913|NCT00454116|582756420|FG001|Overall Study|Adverse Event|11|||
161372914|NCT00454116|582756421|FG002|Overall Study|Adverse Event|9|||
161372915|NCT00454116|582756419|FG000|Overall Study|Condition under investigation worsened|17|||
161372916|NCT00454116|582756420|FG001|Overall Study|Condition under investigation worsened|13|||
161372917|NCT00454116|582756421|FG002|Overall Study|Condition under investigation worsened|18|||
161372918|NCT00454116|582756419|FG000|Overall Study|Withdrawal by Subject|3|||
161372919|NCT00454116|582756420|FG001|Overall Study|Withdrawal by Subject|3|||
161372920|NCT00454116|582756421|FG002|Overall Study|Withdrawal by Subject|1|||
161372921|NCT00454116|582756419|FG000|Overall Study|Other|2|||
161372922|NCT00454116|582756420|FG001|Overall Study|Other|2|||
161372923|NCT00454116|582756421|FG002|Overall Study|Other|0|||
161372924|NCT03500211|582756424|FG000|Overall Study|Withdrawal by Subject|1|||
161372925|NCT03500211|582756425|FG001|Overall Study|Withdrawal by Subject|1|||
161372926|NCT02431325|582756426|FG000|Overall Study|Adverse Event|3|||
161372927|NCT02431325|582756427|FG001|Overall Study|Adverse Event|0|||
161372928|NCT02431325|582756426|FG000|Overall Study|Lost to Follow-up|0|||
161372929|NCT02431325|582756427|FG001|Overall Study|Lost to Follow-up|1|||
161372930|NCT02431325|582756426|FG000|Overall Study|Withdrawal by Subject|1|||
161372931|NCT02431325|582756427|FG001|Overall Study|Withdrawal by Subject|2|||
161372932|NCT02431325|582756426|FG000|Overall Study|Declined to take study medication|1|||
161372933|NCT02431325|582756427|FG001|Overall Study|Declined to take study medication|0|||
161372934|NCT02431325|582756426|FG000|Overall Study|Withdrew before starting study medication|1|||
161372935|NCT02431325|582756427|FG001|Overall Study|Withdrew before starting study medication|0|||
161372936|NCT02431325|582756426|FG000|Overall Study|Placebo shortage|2|||
161372937|NCT02431325|582756427|FG001|Overall Study|Placebo shortage|0|||
161372938|NCT01917318|582756428|FG000|First Treatment|Withdrawal by Subject|0|||
161372939|NCT01917318|582756429|FG001|First Treatment|Withdrawal by Subject|1|||
161372940|NCT01008618|582756430|FG000|Period 1 (Titration Period)|Physician Decision|2|||
161372941|NCT01008618|582756431|FG001|Period 1 (Titration Period)|Physician Decision|0|||
161372942|NCT01008618|582756432|FG002|Period 1 (Titration Period)|Physician Decision|0|||
161372943|NCT01008618|582756430|FG000|Period 1 (Titration Period)|Adverse Event|33|||
161372944|NCT01008618|582756431|FG001|Period 1 (Titration Period)|Adverse Event|0|||
161372945|NCT01008618|582756432|FG002|Period 1 (Titration Period)|Adverse Event|0|||
161372946|NCT01008618|582756430|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
161372947|NCT01008618|582756431|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161372948|NCT01008618|582756432|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161372949|NCT01008618|582756430|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
161372950|NCT01008618|582756431|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161372951|NCT01008618|582756432|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161372952|NCT01008618|582756430|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
161372953|NCT01008618|582756431|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
161372954|NCT01008618|582756432|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
161372955|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
161372956|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
161372957|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
161372958|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
161372959|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
161372960|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
161372961|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
161372962|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
161372963|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
161372964|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
161372965|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
161372966|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
161372967|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161372968|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161372969|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
161372970|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
161372971|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
161372972|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
161372973|NCT01008618|582756430|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
161372974|NCT01008618|582756431|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
161372975|NCT01008618|582756432|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
161372976|NCT00487981|582756435|FG000|Overall Study|Hypothyroidism diagnosis|1|||
161372977|NCT01213082|582756439|FG000|Overall Study|Lost to Follow-up|6|||
161372978|NCT01213082|582756440|FG001|Overall Study|Lost to Follow-up|7|||
161372979|NCT01213082|582756441|FG002|Overall Study|Lost to Follow-up|4|||
161372980|NCT01213082|582756439|FG000|Overall Study|Physician Decision|0|||
161372981|NCT01213082|582756440|FG001|Overall Study|Physician Decision|0|||
161372982|NCT01213082|582756441|FG002|Overall Study|Physician Decision|1|||
161372983|NCT00698828|582756447|FG000|Overall Study|Adverse Event|3|||
161372984|NCT00698828|582756448|FG001|Overall Study|Adverse Event|4|||
161372985|NCT00698828|582756449|FG002|Overall Study|Adverse Event|4|||
161372986|NCT00698828|582756447|FG000|Overall Study|Death|0|||
161372987|NCT00698828|582756448|FG001|Overall Study|Death|0|||
161372988|NCT00698828|582756449|FG002|Overall Study|Death|1|||
161372989|NCT00698828|582756447|FG000|Overall Study|Exacerbation of COPD|1|||
161372990|NCT00698828|582756448|FG001|Overall Study|Exacerbation of COPD|3|||
161372991|NCT00698828|582756449|FG002|Overall Study|Exacerbation of COPD|0|||
161372992|NCT00698828|582756447|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
161372993|NCT00698828|582756448|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
161372994|NCT00698828|582756449|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
161372995|NCT00698828|582756447|FG000|Overall Study|Investigator/Sponsor decision|1|||
161372996|NCT00698828|582756448|FG001|Overall Study|Investigator/Sponsor decision|0|||
161372997|NCT00698828|582756449|FG002|Overall Study|Investigator/Sponsor decision|2|||
161372998|NCT00698828|582756447|FG000|Overall Study|Lost to Follow-up|1|||
161372999|NCT00698828|582756448|FG001|Overall Study|Lost to Follow-up|1|||
161373000|NCT00698828|582756449|FG002|Overall Study|Lost to Follow-up|0|||
161373001|NCT00698828|582756447|FG000|Overall Study|Withdrew consent|0|||
161373002|NCT00698828|582756448|FG001|Overall Study|Withdrew consent|7|||
161373003|NCT00698828|582756449|FG002|Overall Study|Withdrew consent|4|||
161373004|NCT00698828|582756447|FG000|Overall Study|Withdrew consent (not treated)|2|||
161373005|NCT00698828|582756448|FG001|Overall Study|Withdrew consent (not treated)|0|||
161373006|NCT00698828|582756449|FG002|Overall Study|Withdrew consent (not treated)|0|||
161373007|NCT02013609|582756452|FG000|Overall Study|Withdrawal by Subject|9|||
161373008|NCT02013609|582756452|FG000|Overall Study|Lost to Follow-up|3|||
161373009|NCT02013609|582756452|FG000|Overall Study|Adverse Event|3|||
161373010|NCT02013609|582756452|FG000|Overall Study|Met Withdrawal Criteria|3|||
161373011|NCT01816295|582756453|FG000|Double Blind Phase|Adverse Event|11|||
161373012|NCT01816295|582756454|FG001|Double Blind Phase|Adverse Event|8|||
161373013|NCT01816295|582756453|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
161373014|NCT01816295|582756454|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
161373015|NCT01816295|582756453|FG000|Double Blind Phase|Lost to Follow-up|3|||
161373016|NCT01816295|582756454|FG001|Double Blind Phase|Lost to Follow-up|5|||
161373017|NCT01816295|582756453|FG000|Double Blind Phase|Physician Decision|2|||
161373018|NCT01816295|582756454|FG001|Double Blind Phase|Physician Decision|2|||
161373019|NCT01816295|582756453|FG000|Double Blind Phase|Protocol Violation|17|||
161373020|NCT01816295|582756454|FG001|Double Blind Phase|Protocol Violation|11|||
161373021|NCT01816295|582756453|FG000|Double Blind Phase|Sponsor Decision|8|||
161373022|NCT01816295|582756454|FG001|Double Blind Phase|Sponsor Decision|8|||
161373023|NCT01816295|582756453|FG000|Double Blind Phase|Withdrawal by Subject|22|||
161373024|NCT01816295|582756454|FG001|Double Blind Phase|Withdrawal by Subject|20|||
161373025|NCT01816295|582756453|FG000|OLE Phase|Adverse Event|17|||
161373026|NCT01816295|582756454|FG001|OLE Phase|Adverse Event|15|||
161373027|NCT01816295|582756453|FG000|OLE Phase|Death|1|||
161373028|NCT01816295|582756454|FG001|OLE Phase|Death|0|||
161373029|NCT01816295|582756453|FG000|OLE Phase|Entry Criteria Not Met|3|||
161373030|NCT01816295|582756454|FG001|OLE Phase|Entry Criteria Not Met|5|||
161373031|NCT01816295|582756453|FG000|OLE Phase|Lost to Follow-up|5|||
161373032|NCT01816295|582756454|FG001|OLE Phase|Lost to Follow-up|5|||
161373033|NCT01816295|582756453|FG000|OLE Phase|Physician Decision|3|||
161373034|NCT01816295|582756454|FG001|OLE Phase|Physician Decision|1|||
161373035|NCT01816295|582756453|FG000|OLE Phase|Protocol Violation|4|||
161373036|NCT01816295|582756454|FG001|OLE Phase|Protocol Violation|4|||
161373037|NCT01816295|582756453|FG000|OLE Phase|Sponsor Decision|7|||
161373038|NCT01816295|582756454|FG001|OLE Phase|Sponsor Decision|9|||
161373039|NCT01816295|582756453|FG000|OLE Phase|Withdrawal by Subject|10|||
161373040|NCT01816295|582756454|FG001|OLE Phase|Withdrawal by Subject|10|||
161373041|NCT01816295|582756453|FG000|OLE Phase|Lack of Efficacy|3|||
161373042|NCT01816295|582756454|FG001|OLE Phase|Lack of Efficacy|7|||
161373043|NCT01119287|582756455|FG000|Overall Study|Patient Decision, not related to AE|0|||
161373044|NCT01119287|582756456|FG001|Overall Study|Patient Decision, not related to AE|0|||
161373045|NCT01119287|582756457|FG002|Overall Study|Patient Decision, not related to AE|2|||
161373046|NCT01119287|582756458|FG003|Overall Study|Patient Decision, not related to AE|2|||
161373047|NCT01119287|582756459|FG004|Overall Study|Patient Decision, not related to AE|1|||
161373048|NCT01119287|582756460|FG005|Overall Study|Patient Decision, not related to AE|0|||
161373049|NCT00783432|582756461|FG000|Overall Study|Adverse Event|22|||
161373050|NCT00783432|582756462|FG001|Overall Study|Adverse Event|17|||
161373051|NCT00783432|582756461|FG000|Overall Study|Lack of Efficacy|20|||
161373052|NCT00783432|582756462|FG001|Overall Study|Lack of Efficacy|21|||
161373053|NCT00783432|582756461|FG000|Overall Study|Lost to Follow-up|11|||
161373054|NCT00783432|582756462|FG001|Overall Study|Lost to Follow-up|6|||
161373055|NCT00783432|582756461|FG000|Overall Study|Withdrawal by Subject|23|||
161373056|NCT00783432|582756462|FG001|Overall Study|Withdrawal by Subject|20|||
161373057|NCT00783432|582756461|FG000|Overall Study|subject moved|3|||
161373058|NCT00783432|582756462|FG001|Overall Study|subject moved|5|||
161373059|NCT00783432|582756461|FG000|Overall Study|Protocol Violation|6|||
161373060|NCT00783432|582756462|FG001|Overall Study|Protocol Violation|9|||
161373061|NCT01331681|582756469|FG000|Overall Study|Adverse Event|10|||
161373062|NCT01331681|582756470|FG001|Overall Study|Adverse Event|13|||
161373063|NCT01331681|582756471|FG002|Overall Study|Adverse Event|10|||
161373064|NCT01331681|582756469|FG000|Overall Study|Death|6|||
161373065|NCT01331681|582756470|FG001|Overall Study|Death|6|||
161373066|NCT01331681|582756471|FG002|Overall Study|Death|2|||
161373067|NCT01331681|582756469|FG000|Overall Study|Lack of Efficacy|0|||
161373068|NCT01331681|582756470|FG001|Overall Study|Lack of Efficacy|1|||
161373069|NCT01331681|582756471|FG002|Overall Study|Lack of Efficacy|0|||
161373070|NCT01331681|582756469|FG000|Overall Study|Withdrawal by Subject|12|||
161373071|NCT01331681|582756470|FG001|Overall Study|Withdrawal by Subject|8|||
161373072|NCT01331681|582756471|FG002|Overall Study|Withdrawal by Subject|15|||
161373073|NCT01331681|582756469|FG000|Overall Study|Protocol Violation|1|||
161373074|NCT01331681|582756470|FG001|Overall Study|Protocol Violation|1|||
161373075|NCT01331681|582756471|FG002|Overall Study|Protocol Violation|0|||
161373076|NCT01331681|582756469|FG000|Overall Study|Lost to Follow-up|2|||
161373077|NCT01331681|582756470|FG001|Overall Study|Lost to Follow-up|4|||
161373078|NCT01331681|582756471|FG002|Overall Study|Lost to Follow-up|1|||
161373079|NCT01331681|582756469|FG000|Overall Study|Physician Decision|2|||
161373080|NCT01331681|582756470|FG001|Overall Study|Physician Decision|0|||
161373081|NCT01331681|582756471|FG002|Overall Study|Physician Decision|4|||
161373082|NCT01331681|582756469|FG000|Overall Study|Therapeutic procedure required|1|||
161373083|NCT01331681|582756470|FG001|Overall Study|Therapeutic procedure required|0|||
161373084|NCT01331681|582756471|FG002|Overall Study|Therapeutic procedure required|0|||
161373085|NCT01331681|582756469|FG000|Overall Study|Sponsor decision|1|||
161373086|NCT01331681|582756470|FG001|Overall Study|Sponsor decision|1|||
161373087|NCT01331681|582756471|FG002|Overall Study|Sponsor decision|0|||
161373088|NCT01331681|582756469|FG000|Overall Study|Switching to other therapy|0|||
161373089|NCT01331681|582756470|FG001|Overall Study|Switching to other therapy|0|||
161373090|NCT01331681|582756471|FG002|Overall Study|Switching to other therapy|1|||
161373091|NCT01331681|582756469|FG000|Overall Study|Not Received Study Treatment|0|||
161373092|NCT01331681|582756470|FG001|Overall Study|Not Received Study Treatment|0|||
161373093|NCT01331681|582756471|FG002|Overall Study|Not Received Study Treatment|2|||
161373094|NCT01534481|582756472|FG000|Overall Study|Lost to Follow-up|29|||
161373095|NCT01534481|582756473|FG001|Overall Study|Lost to Follow-up|24|||
161373096|NCT01534481|582756472|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
161373097|NCT01534481|582756473|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
161373098|NCT05525910|582756474|FG000|Period 4|Per sponsor due to study timelines|0|||
161373099|NCT05525910|582756475|FG001|Period 4|Per sponsor due to study timelines|0|||
161373100|NCT05525910|582756476|FG002|Period 4|Per sponsor due to study timelines|1|||
161373101|NCT05525910|582756477|FG003|Period 4|Per sponsor due to study timelines|1|||
161373102|NCT05525910|582756478|FG004|Period 4|Per sponsor due to study timelines|1|||
161373103|NCT00107276|582756479|FG000|Overall Study|Progression|46|||
161373104|NCT00107276|582756479|FG000|Overall Study|Adverse Event|6|||
161373105|NCT00107276|582756479|FG000|Overall Study|M.D. decision|2|||
161373106|NCT00107276|582756479|FG000|Overall Study|Patient refusal|1|||
161373107|NCT00107276|582756479|FG000|Overall Study|Death|1|||
161373108|NCT00107276|582756479|FG000|Overall Study|Ineligible|16|||
161373109|NCT03179761|582756480|FG000|Overall Study|Death|2|||
161373110|NCT03179761|582756481|FG001|Overall Study|Death|5|||
161373111|NCT03179761|582756480|FG000|Overall Study|Lost to Follow-up|2|||
161373112|NCT03179761|582756481|FG001|Overall Study|Lost to Follow-up|2|||
161373113|NCT03179761|582756480|FG000|Overall Study|Protocol Violation|1|||
161373114|NCT03179761|582756481|FG001|Overall Study|Protocol Violation|0|||
161373115|NCT03179761|582756480|FG000|Overall Study|Withdrawal by Subject|1|||
161373116|NCT03179761|582756481|FG001|Overall Study|Withdrawal by Subject|4|||
161373117|NCT03179761|582756480|FG000|Overall Study|Investigator Request|0|||
161373118|NCT03179761|582756481|FG001|Overall Study|Investigator Request|2|||
161373119|NCT00565409|582756482|FG000|Period 1 Open Label|Adverse Event|17|||
161373120|NCT00565409|582756483|FG001|Period 1 Open Label|Adverse Event|0|||
161373121|NCT00565409|582756484|FG002|Period 1 Open Label|Adverse Event|0|||
161373122|NCT00565409|582756485|FG003|Period 1 Open Label|Adverse Event|0|||
161373123|NCT00565409|582756482|FG000|Period 1 Open Label|Death|2|||
161373124|NCT00565409|582756483|FG001|Period 1 Open Label|Death|0|||
161373125|NCT00565409|582756484|FG002|Period 1 Open Label|Death|0|||
161373126|NCT00565409|582756485|FG003|Period 1 Open Label|Death|0|||
161373127|NCT00565409|582756482|FG000|Period 1 Open Label|Lost to Follow-up|1|||
161373128|NCT00565409|582756483|FG001|Period 1 Open Label|Lost to Follow-up|0|||
161373129|NCT00565409|582756484|FG002|Period 1 Open Label|Lost to Follow-up|0|||
161373130|NCT00565409|582756485|FG003|Period 1 Open Label|Lost to Follow-up|0|||
161373131|NCT00565409|582756482|FG000|Period 1 Open Label|Other|21|||
161373132|NCT00565409|582756483|FG001|Period 1 Open Label|Other|0|||
161373133|NCT00565409|582756484|FG002|Period 1 Open Label|Other|0|||
161373134|NCT00565409|582756485|FG003|Period 1 Open Label|Other|0|||
161373135|NCT00565409|582756482|FG000|Period 1 Open Label|Protocol Violation|14|||
161373136|NCT00565409|582756483|FG001|Period 1 Open Label|Protocol Violation|0|||
161373137|NCT00565409|582756484|FG002|Period 1 Open Label|Protocol Violation|0|||
161373138|NCT00565409|582756485|FG003|Period 1 Open Label|Protocol Violation|0|||
161373139|NCT00565409|582756482|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
161373140|NCT00565409|582756483|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
161373141|NCT00565409|582756484|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
161373142|NCT00565409|582756485|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
161373143|NCT00565409|582756482|FG000|Period 1 Open Label|no conclusion of participation record|1|||
161373144|NCT00565409|582756483|FG001|Period 1 Open Label|no conclusion of participation record|0|||
161373145|NCT00565409|582756484|FG002|Period 1 Open Label|no conclusion of participation record|0|||
161373146|NCT00565409|582756485|FG003|Period 1 Open Label|no conclusion of participation record|0|||
161373147|NCT00565409|582756482|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
161373148|NCT00565409|582756483|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
161373149|NCT00565409|582756484|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
161373150|NCT00565409|582756485|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
161373151|NCT00565409|582756482|FG000|Period 2 Double-Blind|Adverse Event|0|||
161373152|NCT00565409|582756483|FG001|Period 2 Double-Blind|Adverse Event|7|||
161373153|NCT00565409|582756484|FG002|Period 2 Double-Blind|Adverse Event|4|||
161373154|NCT00565409|582756485|FG003|Period 2 Double-Blind|Adverse Event|5|||
161373155|NCT00565409|582756482|FG000|Period 2 Double-Blind|Death|0|||
161373156|NCT00565409|582756483|FG001|Period 2 Double-Blind|Death|2|||
161373157|NCT00565409|582756484|FG002|Period 2 Double-Blind|Death|0|||
161373158|NCT00565409|582756485|FG003|Period 2 Double-Blind|Death|0|||
161373159|NCT00565409|582756482|FG000|Period 2 Double-Blind|Protocol Violation|0|||
161373160|NCT00565409|582756483|FG001|Period 2 Double-Blind|Protocol Violation|4|||
161373161|NCT00565409|582756484|FG002|Period 2 Double-Blind|Protocol Violation|6|||
161373162|NCT00565409|582756485|FG003|Period 2 Double-Blind|Protocol Violation|2|||
161373163|NCT00565409|582756482|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
161373164|NCT00565409|582756483|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
161373165|NCT00565409|582756484|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
161373166|NCT00565409|582756485|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
161373167|NCT00565409|582756482|FG000|Period 2 Double-Blind|Other|0|||
161373168|NCT00565409|582756483|FG001|Period 2 Double-Blind|Other|4|||
161373169|NCT00565409|582756484|FG002|Period 2 Double-Blind|Other|5|||
161373170|NCT00565409|582756485|FG003|Period 2 Double-Blind|Other|9|||
161373171|NCT00565409|582756482|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
161373172|NCT00565409|582756483|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
161373173|NCT00565409|582756484|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
161373174|NCT00565409|582756485|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
161373175|NCT03498716|582756497|FG000|Overall Study|Withdrawal by Subject|88|||
161373176|NCT03498716|582756498|FG001|Overall Study|Withdrawal by Subject|73|||
161373177|NCT03498716|582756497|FG000|Overall Study|Study Terminated By Sponsor|933|||
161373178|NCT03498716|582756498|FG001|Overall Study|Study Terminated By Sponsor|927|||
161373179|NCT03498716|582756497|FG000|Overall Study|Lost to Follow-up|15|||
161373180|NCT03498716|582756498|FG001|Overall Study|Lost to Follow-up|26|||
161373181|NCT03498716|582756497|FG000|Overall Study|Disease Relapse|0|||
161373182|NCT03498716|582756498|FG001|Overall Study|Disease Relapse|1|||
161373183|NCT03498716|582756497|FG000|Overall Study|Death|58|||
161373184|NCT03498716|582756498|FG001|Overall Study|Death|72|||
161373185|NCT03498716|582756497|FG000|Overall Study|Physician Decision|4|||
161373186|NCT03498716|582756498|FG001|Overall Study|Physician Decision|2|||
161373187|NCT02284191|582756499|FG000|Overall Study|Withdrawal by Subject|1|||
161373188|NCT02284191|582756500|FG001|Overall Study|Withdrawal by Subject|3|||
161373189|NCT02284191|582756499|FG000|Overall Study|Lost to Follow-up|1|||
161373190|NCT02284191|582756500|FG001|Overall Study|Lost to Follow-up|0|||
161373191|NCT04064905|582756503|FG000|Overall Study|Lost to Follow-up|0|||
161373192|NCT04064905|582756504|FG001|Overall Study|Lost to Follow-up|3|||
161373193|NCT04064905|582756505|FG002|Overall Study|Lost to Follow-up|1|||
161373194|NCT04064905|582756506|FG003|Overall Study|Lost to Follow-up|4|||
161373195|NCT04064905|582756507|FG004|Overall Study|Lost to Follow-up|2|||
161373196|NCT02257684|582756508|FG000|Overall Study|Adverse Event|2|||
161373197|NCT02257684|582756508|FG000|Overall Study|Lack of Efficacy|1|||
161373198|NCT02257684|582756508|FG000|Overall Study|Sponsor's Decision|1|||
161373199|NCT01987557|582756509|FG000|Overall Study|Protocol Violation|1|||
161373200|NCT01987557|582756510|FG001|Overall Study|Protocol Violation|0|||
161373201|NCT01987557|582756511|FG002|Overall Study|Protocol Violation|1|||
161373202|NCT01987557|582756509|FG000|Overall Study|Withdrawal by Subject|2|||
161373203|NCT01987557|582756510|FG001|Overall Study|Withdrawal by Subject|1|||
161373204|NCT01987557|582756511|FG002|Overall Study|Withdrawal by Subject|2|||
161373205|NCT01987557|582756509|FG000|Overall Study|Adverse Event|0|||
161373206|NCT01987557|582756510|FG001|Overall Study|Adverse Event|2|||
161373207|NCT01987557|582756511|FG002|Overall Study|Adverse Event|0|||
161373208|NCT00760552|582756512|FG000|Overall Study|Death|2|||
161373209|NCT00760552|582756513|FG001|Overall Study|Death|0|||
161373210|NCT00760552|582756512|FG000|Overall Study|Lost to Follow-up|11|||
161373211|NCT00760552|582756513|FG001|Overall Study|Lost to Follow-up|10|||
161373212|NCT01832727|582756517|FG000|Overall Study|Adverse Event|4|||
161373213|NCT01832727|582756518|FG001|Overall Study|Adverse Event|6|||
161373214|NCT01832727|582756519|FG002|Overall Study|Adverse Event|1|||
161373215|NCT01832727|582756520|FG003|Overall Study|Adverse Event|0|||
161373216|NCT01832727|582756521|FG004|Overall Study|Adverse Event|1|||
161373217|NCT01832727|582756522|FG005|Overall Study|Adverse Event|1|||
161373218|NCT01832727|582756523|FG006|Overall Study|Adverse Event|2|||
161373219|NCT01832727|582756524|FG007|Overall Study|Adverse Event|1|||
161373220|NCT01832727|582756525|FG008|Overall Study|Adverse Event|9|||
161373221|NCT01832727|582756517|FG000|Overall Study|Disease progression|3|||
161373222|NCT01832727|582756518|FG001|Overall Study|Disease progression|0|||
161373223|NCT01832727|582756519|FG002|Overall Study|Disease progression|2|||
161373224|NCT01832727|582756520|FG003|Overall Study|Disease progression|1|||
161373225|NCT01832727|582756521|FG004|Overall Study|Disease progression|3|||
161373226|NCT01832727|582756522|FG005|Overall Study|Disease progression|3|||
161373227|NCT01832727|582756523|FG006|Overall Study|Disease progression|6|||
161373228|NCT01832727|582756524|FG007|Overall Study|Disease progression|2|||
161373229|NCT01832727|582756525|FG008|Overall Study|Disease progression|7|||
161373230|NCT01832727|582756517|FG000|Overall Study|Lost to Follow-up|0|||
161373231|NCT01832727|582756518|FG001|Overall Study|Lost to Follow-up|0|||
161373232|NCT01832727|582756519|FG002|Overall Study|Lost to Follow-up|0|||
161373233|NCT01832727|582756520|FG003|Overall Study|Lost to Follow-up|1|||
161373234|NCT01832727|582756521|FG004|Overall Study|Lost to Follow-up|0|||
161373235|NCT01832727|582756522|FG005|Overall Study|Lost to Follow-up|0|||
161373236|NCT01832727|582756523|FG006|Overall Study|Lost to Follow-up|0|||
161373237|NCT01832727|582756524|FG007|Overall Study|Lost to Follow-up|0|||
161373238|NCT01832727|582756525|FG008|Overall Study|Lost to Follow-up|0|||
161373239|NCT01832727|582756517|FG000|Overall Study|Physician Decision|1|||
161373240|NCT01832727|582756518|FG001|Overall Study|Physician Decision|0|||
161373241|NCT01832727|582756519|FG002|Overall Study|Physician Decision|0|||
161373242|NCT01832727|582756520|FG003|Overall Study|Physician Decision|1|||
161373243|NCT01832727|582756521|FG004|Overall Study|Physician Decision|0|||
161373244|NCT01832727|582756522|FG005|Overall Study|Physician Decision|1|||
161373245|NCT01832727|582756523|FG006|Overall Study|Physician Decision|0|||
161373246|NCT01832727|582756524|FG007|Overall Study|Physician Decision|0|||
161373247|NCT01832727|582756525|FG008|Overall Study|Physician Decision|0|||
161373248|NCT01832727|582756517|FG000|Overall Study|Withdrawal by Subject|1|||
161373249|NCT01832727|582756518|FG001|Overall Study|Withdrawal by Subject|1|||
161373250|NCT01832727|582756519|FG002|Overall Study|Withdrawal by Subject|0|||
161373251|NCT01832727|582756520|FG003|Overall Study|Withdrawal by Subject|1|||
161373252|NCT01832727|582756521|FG004|Overall Study|Withdrawal by Subject|0|||
161373253|NCT01832727|582756522|FG005|Overall Study|Withdrawal by Subject|1|||
161373254|NCT01832727|582756523|FG006|Overall Study|Withdrawal by Subject|0|||
161373255|NCT01832727|582756524|FG007|Overall Study|Withdrawal by Subject|2|||
161373256|NCT01832727|582756525|FG008|Overall Study|Withdrawal by Subject|1|||
161373257|NCT01832727|582756517|FG000|Overall Study|Study terminated by sponsor|0|||
161373258|NCT01832727|582756518|FG001|Overall Study|Study terminated by sponsor|0|||
161373259|NCT01832727|582756519|FG002|Overall Study|Study terminated by sponsor|0|||
161373260|NCT01832727|582756520|FG003|Overall Study|Study terminated by sponsor|0|||
161373261|NCT01832727|582756521|FG004|Overall Study|Study terminated by sponsor|0|||
161373262|NCT01832727|582756522|FG005|Overall Study|Study terminated by sponsor|0|||
161373263|NCT01832727|582756523|FG006|Overall Study|Study terminated by sponsor|0|||
161373264|NCT01832727|582756524|FG007|Overall Study|Study terminated by sponsor|1|||
161373265|NCT01832727|582756525|FG008|Overall Study|Study terminated by sponsor|1|||
161373266|NCT02170064|582756526|FG000|Overall Study|Withdrawal by Subject|5|||
161373267|NCT02170064|582756527|FG001|Overall Study|Withdrawal by Subject|1|||
161373268|NCT02170064|582756528|FG002|Overall Study|Withdrawal by Subject|1|||
161373269|NCT02170064|582756526|FG000|Overall Study|Physician Decision|1|||
161373270|NCT02170064|582756527|FG001|Overall Study|Physician Decision|1|||
161373271|NCT02170064|582756528|FG002|Overall Study|Physician Decision|0|||
161373272|NCT04211363|582756529|FG000|Overall Study|Adverse Event|5|||
161373273|NCT04211363|582756530|FG001|Overall Study|Adverse Event|2|||
161373274|NCT04211363|582756529|FG000|Overall Study|Physician Decision|0|||
161373275|NCT04211363|582756530|FG001|Overall Study|Physician Decision|1|||
161373276|NCT04211363|582756529|FG000|Overall Study|Protocol Violation|1|||
161373277|NCT04211363|582756530|FG001|Overall Study|Protocol Violation|0|||
161373278|NCT04211363|582756529|FG000|Overall Study|Pregnancy|1|||
161373279|NCT04211363|582756530|FG001|Overall Study|Pregnancy|0|||
161373280|NCT04211363|582756529|FG000|Overall Study|Lost to Follow-up|12|||
161373281|NCT04211363|582756530|FG001|Overall Study|Lost to Follow-up|4|||
161373282|NCT04211363|582756529|FG000|Overall Study|Withdrawal by Subject|11|||
161373283|NCT04211363|582756530|FG001|Overall Study|Withdrawal by Subject|11|||
161373284|NCT04211363|582756529|FG000|Overall Study|Other|1|||
161373285|NCT04211363|582756530|FG001|Overall Study|Other|2|||
161373286|NCT00461708|582756531|FG000|Overall Study|Adverse Event|17|||
161373287|NCT00461708|582756532|FG001|Overall Study|Adverse Event|7|||
161373288|NCT00461708|582756531|FG000|Overall Study|Lack of Efficacy|68|||
161373289|NCT00461708|582756532|FG001|Overall Study|Lack of Efficacy|20|||
161373290|NCT00461708|582756531|FG000|Overall Study|Physician Decision|10|||
161373291|NCT00461708|582756532|FG001|Overall Study|Physician Decision|4|||
161373292|NCT00461708|582756531|FG000|Overall Study|Withdrawal by Subject|8|||
161373293|NCT00461708|582756532|FG001|Overall Study|Withdrawal by Subject|2|||
161373294|NCT00461708|582756531|FG000|Overall Study|Other|4|||
161373295|NCT00461708|582756532|FG001|Overall Study|Other|4|||
161373296|NCT00461708|582756531|FG000|Overall Study|Death|8|||
161373297|NCT00461708|582756532|FG001|Overall Study|Death|1|||
161373298|NCT01812057|582756533|FG000|Overall Study|Protocol Violation|1|||
161373299|NCT01812057|582756534|FG001|Overall Study|Protocol Violation|0|||
161373300|NCT01812057|582756533|FG000|Overall Study|Physician Decision|1|||
161373301|NCT01812057|582756534|FG001|Overall Study|Physician Decision|0|||
161373302|NCT01736917|582756535|FG000|Overall Study|Adverse Event|1|||
161373303|NCT01736917|582756535|FG000|Overall Study|Protocol Violation|10|||
161373304|NCT02961244|582756538|FG000|Overall Study|Protocol Violation|0|||
161373305|NCT02961244|582756539|FG001|Overall Study|Protocol Violation|1|||
161373306|NCT02961244|582756538|FG000|Overall Study|Withdrawal by Subject|1|||
161373307|NCT02961244|582756539|FG001|Overall Study|Withdrawal by Subject|2|||
161373308|NCT02961244|582756538|FG000|Overall Study|Surgery plan change after study approval|0|||
161373309|NCT02961244|582756539|FG001|Overall Study|Surgery plan change after study approval|2|||
161373310|NCT02961244|582756538|FG000|Overall Study|Lost to Follow-up|0|||
161373311|NCT02961244|582756539|FG001|Overall Study|Lost to Follow-up|2|||
161373312|NCT02961244|582756538|FG000|Overall Study|İnadequate data|0|||
161373313|NCT02961244|582756539|FG001|Overall Study|İnadequate data|2|||
161373314|NCT01368614|582756540|FG000|Screening Period|Screen Failure|58|||
161373315|NCT01368614|582756541|FG001|Screening Period|Screen Failure|0|||
161373316|NCT01368614|582756542|FG002|Screening Period|Screen Failure|0|||
161373317|NCT01368614|582756543|FG003|Screening Period|Screen Failure|0|||
161373318|NCT01368614|582756540|FG000|Study Period|Withdrawal by Subject|0|||
161373319|NCT01368614|582756541|FG001|Study Period|Withdrawal by Subject|1|||
161373320|NCT01368614|582756542|FG002|Study Period|Withdrawal by Subject|1|||
161373321|NCT01368614|582756543|FG003|Study Period|Withdrawal by Subject|3|||
161373322|NCT01368614|582756540|FG000|Study Period|Lost to Follow-up|0|||
161373323|NCT01368614|582756541|FG001|Study Period|Lost to Follow-up|0|||
161373324|NCT01368614|582756542|FG002|Study Period|Lost to Follow-up|1|||
161373325|NCT01368614|582756543|FG003|Study Period|Lost to Follow-up|0|||
161373326|NCT00659425|582756550|FG000|Overall Study|Disease progression|1|||
161373327|NCT00659425|582756551|FG001|Overall Study|Disease progression|0|||
161373328|NCT00659425|582756552|FG002|Overall Study|Disease progression|0|||
161373329|NCT00659425|582756553|FG003|Overall Study|Disease progression|1|||
161373330|NCT00659425|582756554|FG004|Overall Study|Disease progression|0|||
161373331|NCT00659425|582756555|FG005|Overall Study|Disease progression|2|||
161373332|NCT00659425|582756556|FG006|Overall Study|Disease progression|4|||
161373333|NCT00659425|582756557|FG007|Overall Study|Disease progression|3|||
161373334|NCT00659425|582756558|FG008|Overall Study|Disease progression|5|||
161373335|NCT00659425|582756559|FG009|Overall Study|Disease progression|3|||
161373336|NCT00659425|582756550|FG000|Overall Study|Death|0|||
161373337|NCT00659425|582756551|FG001|Overall Study|Death|0|||
161373338|NCT00659425|582756552|FG002|Overall Study|Death|0|||
161373339|NCT00659425|582756553|FG003|Overall Study|Death|1|||
161373340|NCT00659425|582756554|FG004|Overall Study|Death|0|||
161373341|NCT00659425|582756555|FG005|Overall Study|Death|0|||
161373342|NCT00659425|582756556|FG006|Overall Study|Death|1|||
161373343|NCT00659425|582756557|FG007|Overall Study|Death|0|||
161373344|NCT00659425|582756558|FG008|Overall Study|Death|0|||
161373345|NCT00659425|582756559|FG009|Overall Study|Death|0|||
161373346|NCT00659425|582756550|FG000|Overall Study|Adverse Event|0|||
161373347|NCT00659425|582756551|FG001|Overall Study|Adverse Event|0|||
161373348|NCT00659425|582756552|FG002|Overall Study|Adverse Event|0|||
161373349|NCT00659425|582756553|FG003|Overall Study|Adverse Event|0|||
161373350|NCT00659425|582756554|FG004|Overall Study|Adverse Event|0|||
161373351|NCT00659425|582756555|FG005|Overall Study|Adverse Event|1|||
161373352|NCT00659425|582756556|FG006|Overall Study|Adverse Event|0|||
161373353|NCT00659425|582756557|FG007|Overall Study|Adverse Event|3|||
161373354|NCT00659425|582756558|FG008|Overall Study|Adverse Event|1|||
161373355|NCT00659425|582756559|FG009|Overall Study|Adverse Event|4|||
161373356|NCT00659425|582756550|FG000|Overall Study|Investigator Discretion|0|||
161373357|NCT00659425|582756551|FG001|Overall Study|Investigator Discretion|0|||
161373358|NCT00659425|582756552|FG002|Overall Study|Investigator Discretion|0|||
161373359|NCT00659425|582756553|FG003|Overall Study|Investigator Discretion|0|||
161373360|NCT00659425|582756554|FG004|Overall Study|Investigator Discretion|0|||
161373361|NCT00659425|582756555|FG005|Overall Study|Investigator Discretion|1|||
161373362|NCT00659425|582756556|FG006|Overall Study|Investigator Discretion|0|||
161373363|NCT00659425|582756557|FG007|Overall Study|Investigator Discretion|3|||
161373364|NCT00659425|582756558|FG008|Overall Study|Investigator Discretion|0|||
161373365|NCT00659425|582756559|FG009|Overall Study|Investigator Discretion|0|||
161373366|NCT00659425|582756550|FG000|Overall Study|Other|0|||
161373367|NCT00659425|582756551|FG001|Overall Study|Other|1|||
161373368|NCT00659425|582756552|FG002|Overall Study|Other|1|||
161373369|NCT00659425|582756553|FG003|Overall Study|Other|2|||
161373370|NCT00659425|582756554|FG004|Overall Study|Other|4|||
161373371|NCT00659425|582756555|FG005|Overall Study|Other|0|||
161373372|NCT00659425|582756556|FG006|Overall Study|Other|3|||
161373373|NCT00659425|582756557|FG007|Overall Study|Other|2|||
161373374|NCT00659425|582756558|FG008|Overall Study|Other|0|||
161373375|NCT00659425|582756559|FG009|Overall Study|Other|6|||
161373376|NCT00636181|582756563|FG000|Overall Study|Withdrawal by Subject|8|||
161373377|NCT00636181|582756564|FG001|Overall Study|Withdrawal by Subject|6|||
161373378|NCT00636181|582756565|FG002|Overall Study|Withdrawal by Subject|10|||
161373379|NCT02561962|582756567|FG000|Overall Study|Withdrawal by Subject|1|||
161373380|NCT02561962|582756568|FG001|Overall Study|Withdrawal by Subject|0|||
161373381|NCT02561962|582756569|FG002|Overall Study|Withdrawal by Subject|0|||
161373382|NCT02561962|582756570|FG003|Overall Study|Withdrawal by Subject|0|||
161373383|NCT02561962|582756571|FG004|Overall Study|Withdrawal by Subject|1|||
161373384|NCT02561962|582756572|FG005|Overall Study|Withdrawal by Subject|1|||
161373385|NCT02561962|582756573|FG006|Overall Study|Withdrawal by Subject|2|||
161373386|NCT02561962|582756574|FG007|Overall Study|Withdrawal by Subject|1|||
161373387|NCT02561962|582756575|FG008|Overall Study|Withdrawal by Subject|0|||
161373388|NCT02561962|582756567|FG000|Overall Study|Decision by sponsor|0|||
161373389|NCT02561962|582756568|FG001|Overall Study|Decision by sponsor|0|||
161373390|NCT02561962|582756569|FG002|Overall Study|Decision by sponsor|0|||
161373391|NCT02561962|582756570|FG003|Overall Study|Decision by sponsor|0|||
161373392|NCT02561962|582756571|FG004|Overall Study|Decision by sponsor|1|||
161373393|NCT02561962|582756572|FG005|Overall Study|Decision by sponsor|1|||
161373394|NCT02561962|582756573|FG006|Overall Study|Decision by sponsor|0|||
161373395|NCT02561962|582756574|FG007|Overall Study|Decision by sponsor|3|||
161373396|NCT02561962|582756575|FG008|Overall Study|Decision by sponsor|0|||
161373397|NCT02561962|582756567|FG000|Overall Study|Lost to Follow-up|0|||
161373398|NCT02561962|582756568|FG001|Overall Study|Lost to Follow-up|0|||
161373399|NCT02561962|582756569|FG002|Overall Study|Lost to Follow-up|0|||
161373400|NCT02561962|582756570|FG003|Overall Study|Lost to Follow-up|0|||
161373401|NCT02561962|582756571|FG004|Overall Study|Lost to Follow-up|0|||
161373402|NCT02561962|582756572|FG005|Overall Study|Lost to Follow-up|1|||
161373403|NCT02561962|582756573|FG006|Overall Study|Lost to Follow-up|0|||
161373404|NCT02561962|582756574|FG007|Overall Study|Lost to Follow-up|0|||
161373405|NCT02561962|582756575|FG008|Overall Study|Lost to Follow-up|0|||
161373406|NCT03586973|582756576|FG000|Overall Study|Death|15|||
161373407|NCT03586973|582756577|FG001|Overall Study|Death|8|||
161373408|NCT03586973|582756576|FG000|Overall Study|Site Terminated by Sponsor|3|||
161373409|NCT03586973|582756577|FG001|Overall Study|Site Terminated by Sponsor|6|||
161373410|NCT03586973|582756576|FG000|Overall Study|Withdrawal by Subject|1|||
161373411|NCT03586973|582756577|FG001|Overall Study|Withdrawal by Subject|0|||
161373412|NCT03586973|582756576|FG000|Overall Study|Lost to Follow-up|1|||
161373413|NCT03586973|582756577|FG001|Overall Study|Lost to Follow-up|0|||
161373414|NCT02735421|582758104|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
161373415|NCT02735421|582758104|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
161373416|NCT02735421|582758104|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
161373417|NCT02735421|582758104|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
161373418|NCT02735421|582758104|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
161373419|NCT02735421|582758104|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
161373420|NCT02735421|582758104|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
161373421|NCT01978145|582758105|FG000|Treatment Period 1|Adverse Event|1|||
161373422|NCT01978145|582758106|FG001|Treatment Period 1|Adverse Event|9|||
161373423|NCT01978145|582758105|FG000|Treatment Period 1|Physician Decision|1|||
161373424|NCT01978145|582758106|FG001|Treatment Period 1|Physician Decision|0|||
161373425|NCT01978145|582758105|FG000|Treatment Period 1|Withdrawal by Subject|5|||
161373426|NCT01978145|582758106|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161373427|NCT01978145|582758105|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
161373428|NCT01978145|582758106|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
161373429|NCT01978145|582758105|FG000|Washout Period 1|Adverse Event|0|||
161373430|NCT01978145|582758106|FG001|Washout Period 1|Adverse Event|1|||
161373431|NCT01978145|582758105|FG000|Washout Period 1|Withdrawal by Subject|1|||
161373432|NCT01978145|582758106|FG001|Washout Period 1|Withdrawal by Subject|1|||
161373433|NCT01978145|582758105|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
161373434|NCT01978145|582758106|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
161373435|NCT01978145|582758105|FG000|Treatment Period 2|Adverse Event|3|||
161373436|NCT01978145|582758106|FG001|Treatment Period 2|Adverse Event|3|||
161373437|NCT01978145|582758105|FG000|Treatment Period 2|Protocol Violation|0|||
161373438|NCT01978145|582758106|FG001|Treatment Period 2|Protocol Violation|1|||
161373439|NCT01978145|582758105|FG000|Treatment Period 2|Lost to Follow-up|1|||
161373440|NCT01978145|582758106|FG001|Treatment Period 2|Lost to Follow-up|1|||
161373441|NCT01978145|582758105|FG000|Treatment Period 2|Withdrawal by Subject|7|||
161373442|NCT01978145|582758106|FG001|Treatment Period 2|Withdrawal by Subject|4|||
161373443|NCT01978145|582758105|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
161373444|NCT01978145|582758106|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
161373445|NCT00322049|582758107|FG000|Overall Study|Moved out of area|0|||
161373446|NCT00322049|582758108|FG001|Overall Study|Moved out of area|0|||
161373447|NCT00322049|582758109|FG002|Overall Study|Moved out of area|0|||
161373448|NCT00322049|582758110|FG003|Overall Study|Moved out of area|1|||
161373449|NCT00322049|582758107|FG000|Overall Study|Infected with Dengue during study|0|||
161373450|NCT00322049|582758108|FG001|Overall Study|Infected with Dengue during study|1|||
161373451|NCT00322049|582758109|FG002|Overall Study|Infected with Dengue during study|0|||
161373452|NCT00322049|582758110|FG003|Overall Study|Infected with Dengue during study|0|||
161373453|NCT01250054|582758111|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
161373454|NCT01250054|582758112|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
161373455|NCT01770743|582758113|FG000|Overall Study|Adverse Event|1|||
161373456|NCT01770743|582758114|FG001|Overall Study|Adverse Event|0|||
161373457|NCT01770743|582758115|FG002|Overall Study|Adverse Event|0|||
161373458|NCT01770743|582758116|FG003|Overall Study|Adverse Event|0|||
161373459|NCT01770743|582758117|FG004|Overall Study|Adverse Event|0|||
161373460|NCT01770743|582758113|FG000|Overall Study|Withdrawal by Subject|0|||
161373461|NCT01770743|582758114|FG001|Overall Study|Withdrawal by Subject|0|||
161373462|NCT01770743|582758115|FG002|Overall Study|Withdrawal by Subject|1|||
161373463|NCT01770743|582758116|FG003|Overall Study|Withdrawal by Subject|1|||
161373464|NCT01770743|582758117|FG004|Overall Study|Withdrawal by Subject|1|||
161373465|NCT01770743|582758113|FG000|Overall Study|Lost to Follow-up|0|||
161373466|NCT01770743|582758114|FG001|Overall Study|Lost to Follow-up|2|||
161373467|NCT01770743|582758115|FG002|Overall Study|Lost to Follow-up|0|||
161373468|NCT01770743|582758116|FG003|Overall Study|Lost to Follow-up|0|||
161373469|NCT01770743|582758117|FG004|Overall Study|Lost to Follow-up|1|||
161373470|NCT01770743|582758113|FG000|Overall Study|Sponsor Terminated Subject|1|||
161373471|NCT01770743|582758114|FG001|Overall Study|Sponsor Terminated Subject|0|||
161373472|NCT01770743|582758115|FG002|Overall Study|Sponsor Terminated Subject|0|||
161373473|NCT01770743|582758116|FG003|Overall Study|Sponsor Terminated Subject|1|||
161373474|NCT01770743|582758117|FG004|Overall Study|Sponsor Terminated Subject|0|||
161373475|NCT01770743|582758113|FG000|Overall Study|Moving Out of State|0|||
161373476|NCT01770743|582758114|FG001|Overall Study|Moving Out of State|1|||
161373477|NCT01770743|582758115|FG002|Overall Study|Moving Out of State|0|||
161373478|NCT01770743|582758116|FG003|Overall Study|Moving Out of State|0|||
161373479|NCT01770743|582758117|FG004|Overall Study|Moving Out of State|0|||
161373480|NCT00755807|582758122|FG000|Acute Phase|Adverse Event|16|||
161373481|NCT00755807|582758123|FG001|Acute Phase|Adverse Event|5|||
161373482|NCT00755807|582758122|FG000|Acute Phase|Protocol Violation|1|||
161373483|NCT00755807|582758123|FG001|Acute Phase|Protocol Violation|3|||
161373484|NCT00755807|582758122|FG000|Acute Phase|Withdrawal by Subject|1|||
161373485|NCT00755807|582758123|FG001|Acute Phase|Withdrawal by Subject|2|||
161373486|NCT00755807|582758122|FG000|Acute Phase|Lack of Efficacy|0|||
161373487|NCT00755807|582758123|FG001|Acute Phase|Lack of Efficacy|1|||
161373488|NCT00755807|582758122|FG000|Acute Phase|Physician Decision|0|||
161373489|NCT00755807|582758123|FG001|Acute Phase|Physician Decision|1|||
161373490|NCT00755807|582758122|FG000|Open-label Extension Phase|Adverse Event|7|||
161373491|NCT00755807|582758123|FG001|Open-label Extension Phase|Adverse Event|7|||
161373492|NCT00755807|582758122|FG000|Open-label Extension Phase|Protocol Violation|5|||
161373493|NCT00755807|582758123|FG001|Open-label Extension Phase|Protocol Violation|2|||
161373494|NCT00755807|582758122|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
161373495|NCT00755807|582758123|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
161373496|NCT00755807|582758122|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
161373497|NCT00755807|582758123|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
161373498|NCT00755807|582758122|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
161373499|NCT00755807|582758123|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
161373500|NCT00755807|582758122|FG000|Open-label Extension Phase|Sponsor Decision|0|||
161373501|NCT00755807|582758123|FG001|Open-label Extension Phase|Sponsor Decision|1|||
161373502|NCT00939107|582758124|FG000|Overall Study|Lost to Follow-up|14|||
161373503|NCT00939107|582758125|FG001|Overall Study|Lost to Follow-up|12|||
161373504|NCT00652743|582758126|FG000|Months 12-18|Lost to Follow-up|1|||
161373505|NCT00652743|582758127|FG001|Months 12-18|Lost to Follow-up|2|||
161373506|NCT00652743|582758128|FG002|Months 12-18|Lost to Follow-up|7|||
161373507|NCT00652743|582758126|FG000|Months 24-30|Other|5|||
161373508|NCT00652743|582758127|FG001|Months 24-30|Other|1|||
161373509|NCT00652743|582758128|FG002|Months 24-30|Other|11|||
161373510|NCT00652743|582758126|FG000|Months 36-42|Serious Adverse Events|0|||
161373511|NCT00652743|582758127|FG001|Months 36-42|Serious Adverse Events|1|||
161373512|NCT00652743|582758128|FG002|Months 36-42|Serious Adverse Events|1|||
161373513|NCT00652743|582758126|FG000|Months 36-42|Withdrawal by Subject|1|||
161373514|NCT00652743|582758127|FG001|Months 36-42|Withdrawal by Subject|1|||
161373515|NCT00652743|582758128|FG002|Months 36-42|Withdrawal by Subject|0|||
161373516|NCT00652743|582758126|FG000|Months 36-42|Lost to Follow-up|0|||
161373517|NCT00652743|582758127|FG001|Months 36-42|Lost to Follow-up|1|||
161373518|NCT00652743|582758128|FG002|Months 36-42|Lost to Follow-up|0|||
161373519|NCT00652743|582758126|FG000|Months 36-42|Migrated/moved from study area|1|||
161373520|NCT00652743|582758127|FG001|Months 36-42|Migrated/moved from study area|0|||
161373521|NCT00652743|582758128|FG002|Months 36-42|Migrated/moved from study area|0|||
161373522|NCT00652743|582758126|FG000|Months 36-42|Other|4|||
161373523|NCT00652743|582758127|FG001|Months 36-42|Other|2|||
161373524|NCT00652743|582758128|FG002|Months 36-42|Other|8|||
161373525|NCT01585025|582758135|FG000|Overall Study|Withdrawal by Subject|0|||
161373526|NCT01585025|582758136|FG001|Overall Study|Withdrawal by Subject|3|||
161373527|NCT01585025|582758137|FG002|Overall Study|Withdrawal by Subject|4|||
161373528|NCT00503984|582758138|FG000|Overall Study|Protocol Violation|0|||
161373529|NCT00503984|582758139|FG001|Overall Study|Protocol Violation|1|||
161373530|NCT00503984|582758140|FG002|Overall Study|Protocol Violation|0|||
161373531|NCT00503984|582758141|FG003|Overall Study|Protocol Violation|0|||
161373532|NCT00503984|582758142|FG004|Overall Study|Protocol Violation|0|||
161373533|NCT00503984|582758143|FG005|Overall Study|Protocol Violation|0|||
161373534|NCT00503984|582758138|FG000|Overall Study|Adverse Event|0|||
161373535|NCT00503984|582758139|FG001|Overall Study|Adverse Event|1|||
161373536|NCT00503984|582758140|FG002|Overall Study|Adverse Event|0|||
161373537|NCT00503984|582758141|FG003|Overall Study|Adverse Event|0|||
161373538|NCT00503984|582758142|FG004|Overall Study|Adverse Event|0|||
161373539|NCT00503984|582758143|FG005|Overall Study|Adverse Event|0|||
161373540|NCT00503984|582758138|FG000|Overall Study|Death|0|||
161373541|NCT00503984|582758139|FG001|Overall Study|Death|0|||
161373542|NCT00503984|582758140|FG002|Overall Study|Death|0|||
161373543|NCT00503984|582758141|FG003|Overall Study|Death|0|||
161373544|NCT00503984|582758142|FG004|Overall Study|Death|1|||
161373545|NCT00503984|582758143|FG005|Overall Study|Death|0|||
161373546|NCT02122380|582758147|FG000|First Intervention (30 Days)|Adverse Event|1|||
161373547|NCT02122380|582758148|FG001|First Intervention (30 Days)|Adverse Event|0|||
161373548|NCT02122380|582758147|FG000|First Intervention (30 Days)|Physician Decision|0|||
161373549|NCT02122380|582758148|FG001|First Intervention (30 Days)|Physician Decision|1|||
161373550|NCT02122380|582758147|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
161373551|NCT02122380|582758148|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
161373552|NCT02122380|582758147|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
161373553|NCT02122380|582758148|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
161373554|NCT02122380|582758147|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
161373555|NCT02122380|582758148|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
161373556|NCT00427011|582758149|FG000|Overall Study|Adverse Event|10|||
161373557|NCT00427011|582758149|FG000|Overall Study|Withdrawal by Subject|1|||
161373558|NCT00427011|582758149|FG000|Overall Study|Lack of Efficacy|2|||
161373559|NCT00427011|582758149|FG000|Overall Study|Other|12|||
161373560|NCT00952705|582758150|FG000|Overall Study|Lost to Follow-up|24|||
161373561|NCT00952705|582758151|FG001|Overall Study|Lost to Follow-up|8|||
161373562|NCT00952705|582758152|FG002|Overall Study|Lost to Follow-up|9|||
161373563|NCT00952705|582758150|FG000|Overall Study|Withdrawal by Subject|2|||
161373564|NCT00952705|582758151|FG001|Overall Study|Withdrawal by Subject|1|||
161373565|NCT00952705|582758152|FG002|Overall Study|Withdrawal by Subject|1|||
161373566|NCT00952705|582758150|FG000|Overall Study|Death|2|||
161373567|NCT00952705|582758151|FG001|Overall Study|Death|0|||
161373568|NCT00952705|582758152|FG002|Overall Study|Death|0|||
161373569|NCT00952705|582758150|FG000|Overall Study|Incarcerated post dose|5|||
161373570|NCT00952705|582758151|FG001|Overall Study|Incarcerated post dose|0|||
161373571|NCT00952705|582758152|FG002|Overall Study|Incarcerated post dose|0|||
161373572|NCT00952705|582758150|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
161373573|NCT00952705|582758151|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
161373574|NCT00952705|582758152|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
161373575|NCT01192126|582758153|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
161373576|NCT01192126|582758154|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
161373577|NCT01192126|582758153|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
161373578|NCT01192126|582758154|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
161373579|NCT01248793|582758155|FG000|Overall Study|Lost to Follow-up|0|||
161373580|NCT01248793|582758156|FG001|Overall Study|Lost to Follow-up|1|||
161373581|NCT01248793|582758155|FG000|Overall Study|Adverse Event|1|||
161373582|NCT01248793|582758156|FG001|Overall Study|Adverse Event|1|||
161373583|NCT01248793|582758155|FG000|Overall Study|Protocol Violation|0|||
161373584|NCT01248793|582758156|FG001|Overall Study|Protocol Violation|1|||
161373585|NCT01248793|582758155|FG000|Overall Study|Withdrawal by Subject|3|||
161373586|NCT01248793|582758156|FG001|Overall Study|Withdrawal by Subject|3|||
161373587|NCT00517699|582758157|FG000|Overall Study|Withdrawal by Subject|1|||
161373588|NCT00517699|582758157|FG000|Overall Study|Lack of Efficacy|1|||
161373589|NCT00517699|582758157|FG000|Overall Study|Administrative error|1|||
161373590|NCT00517699|582758157|FG000|Overall Study|Study terminated by Sponsor|2|||
161373591|NCT01114737|582758158|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
161373592|NCT01114737|582758159|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
161373593|NCT01114737|582758158|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
161373594|NCT01114737|582758159|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
161373595|NCT01114737|582758158|FG000|Randomized Treatment Period|Pregnancy|1|||
161373596|NCT01114737|582758159|FG001|Randomized Treatment Period|Pregnancy|0|||
161373597|NCT01114737|582758158|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
161373598|NCT01114737|582758159|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
161373599|NCT01114737|582758158|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
161373600|NCT01114737|582758159|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
161373601|NCT01114737|582758158|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
161373602|NCT01114737|582758159|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
161373603|NCT00387088|582758162|FG000|Overall Study|Adverse Event|143|||
161373604|NCT00387088|582758163|FG001|Overall Study|Adverse Event|156|||
161373605|NCT00387088|582758162|FG000|Overall Study|Protocol Violation|47|||
161373606|NCT00387088|582758163|FG001|Overall Study|Protocol Violation|35|||
161373607|NCT00387088|582758162|FG000|Overall Study|Withdrawal by Subject|20|||
161373608|NCT00387088|582758163|FG001|Overall Study|Withdrawal by Subject|35|||
161373609|NCT00387088|582758162|FG000|Overall Study|Lack of Efficacy|28|||
161373610|NCT00387088|582758163|FG001|Overall Study|Lack of Efficacy|67|||
161373611|NCT00387088|582758162|FG000|Overall Study|Lost to Follow-up|22|||
161373612|NCT00387088|582758163|FG001|Overall Study|Lost to Follow-up|28|||
161373613|NCT00387088|582758162|FG000|Overall Study|Other|58|||
161373614|NCT00387088|582758163|FG001|Overall Study|Other|52|||
161373615|NCT04108273|582758164|FG000|Overall Study|COVID Pandemic|1|||
161373616|NCT04108273|582758165|FG001|Overall Study|COVID Pandemic|0|||
161373617|NCT02441218|582758166|FG000|Overall Study|Death|503|||
161373618|NCT02441218|582758167|FG001|Overall Study|Death|553|||
161373619|NCT02441218|582758166|FG000|Overall Study|Withdrawal by Subject|73|||
161373620|NCT02441218|582758167|FG001|Overall Study|Withdrawal by Subject|58|||
161373621|NCT02441218|582758166|FG000|Overall Study|Lost to Follow-up|2|||
161373622|NCT02441218|582758167|FG001|Overall Study|Lost to Follow-up|1|||
161373623|NCT01541371|582758168|FG000|Overall Study|Withdrawal by Subject|14|||
161373624|NCT01541371|582758168|FG000|Overall Study|Lost to Follow-up|21|||
161373625|NCT01541371|582758168|FG000|Overall Study|Adverse Event|15|||
161373626|NCT01541371|582758168|FG000|Overall Study|Lack of Efficacy|12|||
161373627|NCT01541371|582758168|FG000|Overall Study|Protocol Violation|6|||
161373628|NCT01541371|582758168|FG000|Overall Study|Study medication non-compliance|3|||
161373629|NCT01541371|582758168|FG000|Overall Study|Other|6|||
161373630|NCT04460183|582758172|FG000|Overall Study|Lost to Follow-up|3|||
161373631|NCT04460183|582758173|FG001|Overall Study|Lost to Follow-up|1|||
161373632|NCT04460183|582758172|FG000|Overall Study|Withdrawal by Subject|1|||
161373633|NCT04460183|582758173|FG001|Overall Study|Withdrawal by Subject|0|||
161373634|NCT00856609|582758176|FG000|Overall Study|Adverse Event|1|||
161373635|NCT00856609|582758177|FG001|Overall Study|Adverse Event|0|||
161373636|NCT01788943|582758178|FG000|Overall Study|Withdrawal by Subject|1|||
161373637|NCT01788943|582758179|FG001|Overall Study|Withdrawal by Subject|0|||
161373638|NCT00186628|582758180|FG000|Overall Study|Death|2|||
161373639|NCT00186628|582758180|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
161373640|NCT00945659|582758184|FG000|Overall Study|Lost to Follow-up|7|||
161373641|NCT00945659|582758185|FG001|Overall Study|Lost to Follow-up|20|||
161373642|NCT00945659|582758186|FG002|Overall Study|Lost to Follow-up|17|||
161373643|NCT00658541|582758187|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161373644|NCT00658541|582758188|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161373645|NCT00658541|582758187|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161373646|NCT00658541|582758188|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161373647|NCT04828707|582758189|FG000|Overall Study|Lost to Follow-up|3|||
161373648|NCT04828707|582758190|FG001|Overall Study|Lost to Follow-up|2|||
161373649|NCT04828707|582758189|FG000|Overall Study|Withdrawal by Subject|2|||
161373650|NCT04828707|582758190|FG001|Overall Study|Withdrawal by Subject|1|||
161373651|NCT01570387|582758197|FG000|Overall Study|Adverse Event|1|||
161373652|NCT01570387|582758198|FG001|Overall Study|Adverse Event|0|||
161373653|NCT01570387|582758199|FG002|Overall Study|Adverse Event|0|||
161373654|NCT01570387|582758200|FG003|Overall Study|Adverse Event|0|||
161373655|NCT01570387|582758197|FG000|Overall Study|Death|0|||
161373656|NCT01570387|582758198|FG001|Overall Study|Death|0|||
161373657|NCT01570387|582758199|FG002|Overall Study|Death|0|||
161373658|NCT01570387|582758200|FG003|Overall Study|Death|1|||
161373659|NCT01570387|582758197|FG000|Overall Study|Withdrawal by Subject|0|||
161373660|NCT01570387|582758198|FG001|Overall Study|Withdrawal by Subject|0|||
161373661|NCT01570387|582758199|FG002|Overall Study|Withdrawal by Subject|0|||
161373662|NCT01570387|582758200|FG003|Overall Study|Withdrawal by Subject|1|||
161373663|NCT01876381|582758201|FG000|Overall Study|Lack of Efficacy|5|||
161373664|NCT01876381|582758201|FG000|Overall Study|Physician Decision|1|||
161373665|NCT01876381|582758201|FG000|Overall Study|Withdrawal by Subject|1|||
161373666|NCT03323164|582758209|FG000|Overall Study|Poor quality imaging/scans|2|||
161373667|NCT03323164|582758210|FG001|Overall Study|Poor quality imaging/scans|2|||
161373668|NCT00501644|582758213|FG000|Overall Study|Adverse Event|4|||
161373669|NCT00501644|582758213|FG000|Overall Study|Withdrawal by Subject|1|||
161373670|NCT02394561|582758214|FG000|CORE Phase|Adverse Event|7|||
161373671|NCT02394561|582758215|FG001|CORE Phase|Adverse Event|9|||
161373672|NCT02394561|582758214|FG000|CORE Phase|Death|0|||
161373673|NCT02394561|582758215|FG001|CORE Phase|Death|1|||
161373674|NCT02394561|582758214|FG000|CORE Phase|Pregnancy|1|||
161373675|NCT02394561|582758215|FG001|CORE Phase|Pregnancy|0|||
161373676|NCT02394561|582758214|FG000|CORE Phase|Lost to Follow-up|1|||
161373677|NCT02394561|582758215|FG001|CORE Phase|Lost to Follow-up|0|||
161373678|NCT02394561|582758214|FG000|CORE Phase|Physician Decision|1|||
161373679|NCT02394561|582758215|FG001|CORE Phase|Physician Decision|1|||
161373680|NCT02394561|582758214|FG000|CORE Phase|Withdrawal by Subject|2|||
161373681|NCT02394561|582758215|FG001|CORE Phase|Withdrawal by Subject|2|||
161373682|NCT02394561|582758214|FG000|CORE Phase|Lack of Efficacy|1|||
161373683|NCT02394561|582758215|FG001|CORE Phase|Lack of Efficacy|6|||
161373684|NCT02394561|582758214|FG000|Extension Phase|Adverse Event|6|||
161373685|NCT02394561|582758215|FG001|Extension Phase|Adverse Event|1|||
161373686|NCT02394561|582758214|FG000|Extension Phase|Death|0|||
161373687|NCT02394561|582758215|FG001|Extension Phase|Death|1|||
161373688|NCT02394561|582758214|FG000|Extension Phase|Protocol Violation|1|||
161373689|NCT02394561|582758215|FG001|Extension Phase|Protocol Violation|0|||
161373690|NCT02394561|582758214|FG000|Extension Phase|Lost to Follow-up|1|||
161373691|NCT02394561|582758215|FG001|Extension Phase|Lost to Follow-up|0|||
161373692|NCT02394561|582758214|FG000|Extension Phase|Physician Decision|0|||
161373693|NCT02394561|582758215|FG001|Extension Phase|Physician Decision|2|||
161373694|NCT02394561|582758214|FG000|Extension Phase|Withdrawal by Subject|0|||
161373695|NCT02394561|582758215|FG001|Extension Phase|Withdrawal by Subject|5|||
161373696|NCT02394561|582758214|FG000|Extension Phase|Lack of Efficacy|3|||
161373697|NCT02394561|582758215|FG001|Extension Phase|Lack of Efficacy|3|||
161373698|NCT02553629|582758216|FG000|Overall Study|Logistic reasons|3|||
161373699|NCT02553629|582758217|FG001|Overall Study|Logistic reasons|6|||
161373700|NCT03434834|582758218|FG000|Overall Study|unable to swallow OCT probe|16|||
161373701|NCT01823289|582758223|FG000|Overall Study|Lost to Follow-up|5|||
161373702|NCT01823289|582758223|FG000|Overall Study|Adverse Event|5|||
161373703|NCT01823289|582758223|FG000|Overall Study|Lack of Efficacy|1|||
161373704|NCT01823289|582758223|FG000|Overall Study|Physician Decision|9|||
161373705|NCT01823289|582758223|FG000|Overall Study|Administered contraindicated medicine|1|||
161373706|NCT01823289|582758223|FG000|Overall Study|Transaminase increased more than 3 times|1|||
161373707|NCT01823289|582758223|FG000|Overall Study|Drug affected efficacy and safety|1|||
161373708|NCT01823289|582758223|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
161373709|NCT00654732|582758227|FG000|Overall Study|Adverse Event|4|||
161373710|NCT00654732|582758228|FG001|Overall Study|Adverse Event|6|||
161373711|NCT01133847|582758235|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
161373712|NCT01133847|582758236|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
161373713|NCT01133847|582758237|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
161373714|NCT01133847|582758235|FG000|Follow-Up Phase|Lost to Follow-up|1|||
161373715|NCT01133847|582758236|FG001|Follow-Up Phase|Lost to Follow-up|3|||
161373716|NCT01133847|582758237|FG002|Follow-Up Phase|Lost to Follow-up|7|||
161373717|NCT01880957|582758238|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
161373718|NCT01880957|582758239|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
161373719|NCT01880957|582758238|FG000|Overall Study|Lost to Follow-up|11|||
161373720|NCT01880957|582758239|FG001|Overall Study|Lost to Follow-up|0|||
161373721|NCT01880957|582758238|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
161373722|NCT01880957|582758239|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
161373723|NCT01378117|582758240|FG000|Overall Study|withdrawal|2|||
161373724|NCT01378117|582758241|FG001|Overall Study|withdrawal|1|||
161373725|NCT01378117|582758242|FG002|Overall Study|withdrawal|2|||
161373726|NCT01378117|582758240|FG000|Overall Study|discharged before med given|2|||
161373727|NCT01378117|582758241|FG001|Overall Study|discharged before med given|0|||
161373728|NCT01378117|582758242|FG002|Overall Study|discharged before med given|1|||
161373729|NCT01854528|582758243|FG000|Overall Study|Adverse Event|0|||
161373730|NCT01854528|582758244|FG001|Overall Study|Adverse Event|4|||
161373731|NCT01854528|582758243|FG000|Overall Study|Withdrawal by Subject|0|||
161373732|NCT01854528|582758244|FG001|Overall Study|Withdrawal by Subject|2|||
161373733|NCT01854528|582758243|FG000|Overall Study|Virologic Failure|0|||
161373734|NCT01854528|582758244|FG001|Overall Study|Virologic Failure|9|||
161373735|NCT02026011|582759606|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
161373736|NCT02026011|582759607|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
161373737|NCT02026011|582759606|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
161373738|NCT02026011|582759607|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
161373739|NCT02026011|582759606|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
161373740|NCT02026011|582759607|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
161373741|NCT02026011|582759606|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
161373742|NCT02026011|582759607|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
161373743|NCT05010070|582759608|FG000|Overall Study|Lost to Follow-up|1|||
161373744|NCT05010070|582759608|FG000|Overall Study|Withdrawal by Subject|1|||
161373745|NCT01669902|582759609|FG000|Overall Study|Adverse Event|11|||
161373746|NCT01669902|582759609|FG000|Overall Study|Lack of Efficacy|10|||
161373747|NCT01669902|582759609|FG000|Overall Study|Other|8|||
161373748|NCT00688467|582759618|FG000|Treatment Period 1|Adverse Event|2|||
161373749|NCT00688467|582759619|FG001|Treatment Period 1|Adverse Event|1|||
161373750|NCT00688467|582759618|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
161373751|NCT00688467|582759619|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
161373752|NCT00688467|582759618|FG000|Treatment Period 2|Protocol Violation|0|||
161373753|NCT00688467|582759619|FG001|Treatment Period 2|Protocol Violation|1|||
161373754|NCT00688467|582759618|FG000|Treatment Period 2|Adverse Event|0|||
161373755|NCT00688467|582759619|FG001|Treatment Period 2|Adverse Event|1|||
161373756|NCT02808897|582759620|FG000|Overall Study|Lost to Follow-up|9|||
161373757|NCT02808897|582759621|FG001|Overall Study|Lost to Follow-up|11|||
161373758|NCT00002766|582759622|FG000|Overall Study|Withdrawal by Subject|0|||
161373759|NCT00002766|582759623|FG001|Overall Study|Withdrawal by Subject|1|||
161373760|NCT00002766|582759622|FG000|Overall Study|Patient Not Treated|1|||
161373761|NCT00002766|582759623|FG001|Overall Study|Patient Not Treated|2|||
161373762|NCT00002766|582759622|FG000|Overall Study|Adverse Event|1|||
161373763|NCT00002766|582759623|FG001|Overall Study|Adverse Event|1|||
161373764|NCT00002766|582759622|FG000|Overall Study|Protocol Violation|1|||
161373765|NCT00002766|582759623|FG001|Overall Study|Protocol Violation|0|||
161373766|NCT03848416|582759643|FG000|Overall Study|Withdrawal by Subject|1|||
161373767|NCT03848416|582759644|FG001|Overall Study|Withdrawal by Subject|0|||
161373768|NCT03848416|582759645|FG002|Overall Study|Withdrawal by Subject|0|||
161373769|NCT03848416|582759643|FG000|Overall Study|Death|0|||
161373770|NCT03848416|582759644|FG001|Overall Study|Death|0|||
161373771|NCT03848416|582759645|FG002|Overall Study|Death|1|||
161373772|NCT01847092|582759651|FG000|Overall Study|Adverse Event|12|||
161373773|NCT01847092|582759652|FG001|Overall Study|Adverse Event|3|||
161373774|NCT01847092|582759651|FG000|Overall Study|Withdrawal by Subject|5|||
161373775|NCT01847092|582759652|FG001|Overall Study|Withdrawal by Subject|5|||
161373776|NCT01847092|582759651|FG000|Overall Study|Protocol Specified|8|||
161373777|NCT01847092|582759652|FG001|Overall Study|Protocol Specified|0|||
161373778|NCT01847092|582759651|FG000|Overall Study|Physician Decision|1|||
161373779|NCT01847092|582759652|FG001|Overall Study|Physician Decision|1|||
161373780|NCT01847092|582759651|FG000|Overall Study|Protocol Violation|0|||
161373781|NCT01847092|582759652|FG001|Overall Study|Protocol Violation|2|||
161373782|NCT03604497|582759654|FG000|Overall Study|Protocol Violation|52|||
161373783|NCT00811954|582759655|FG000|Overall Study|Death|10|||
161373784|NCT00811954|582759656|FG001|Overall Study|Death|6|||
161373785|NCT00811954|582759657|FG002|Overall Study|Death|13|||
161373786|NCT00811954|582759655|FG000|Overall Study|Lost to Follow-up|29|||
161373787|NCT00811954|582759656|FG001|Overall Study|Lost to Follow-up|23|||
161373788|NCT00811954|582759657|FG002|Overall Study|Lost to Follow-up|34|||
161373789|NCT00811954|582759655|FG000|Overall Study|Not able to get to clinic|28|||
161373790|NCT00811954|582759656|FG001|Overall Study|Not able to get to clinic|35|||
161373791|NCT00811954|582759657|FG002|Overall Study|Not able to get to clinic|30|||
161373792|NCT00811954|582759655|FG000|Overall Study|Not willing to adhere to requirements|12|||
161373793|NCT00811954|582759656|FG001|Overall Study|Not willing to adhere to requirements|2|||
161373794|NCT00811954|582759657|FG002|Overall Study|Not willing to adhere to requirements|16|||
161373795|NCT00811954|582759655|FG000|Overall Study|Withdraw consent prior study completion|4|||
161373796|NCT00811954|582759656|FG001|Overall Study|Withdraw consent prior study completion|6|||
161373797|NCT00811954|582759657|FG002|Overall Study|Withdraw consent prior study completion|5|||
161373798|NCT00811954|582759655|FG000|Overall Study|Site Closure|4|||
161373799|NCT00811954|582759656|FG001|Overall Study|Site Closure|0|||
161373800|NCT00811954|582759657|FG002|Overall Study|Site Closure|1|||
161373801|NCT00811954|582759655|FG000|Overall Study|Severe Debilitation|2|||
161373802|NCT00811954|582759656|FG001|Overall Study|Severe Debilitation|0|||
161373803|NCT00811954|582759657|FG002|Overall Study|Severe Debilitation|1|||
161373804|NCT00811954|582759655|FG000|Overall Study|Complete Protocol: No follow-up|0|||
161373805|NCT00811954|582759656|FG001|Overall Study|Complete Protocol: No follow-up|0|||
161373806|NCT00811954|582759657|FG002|Overall Study|Complete Protocol: No follow-up|1|||
161373807|NCT01016067|582759658|FG000|Overall Study|Lost to Follow-up|1|||
161373808|NCT01016067|582759659|FG001|Overall Study|Lost to Follow-up|2|||
161373809|NCT01016067|582759658|FG000|Overall Study|Physician Decision|1|||
161373810|NCT01016067|582759659|FG001|Overall Study|Physician Decision|1|||
161373811|NCT01016067|582759658|FG000|Overall Study|Withdrew due to Relocation|0|||
161373812|NCT01016067|582759659|FG001|Overall Study|Withdrew due to Relocation|1|||
161373813|NCT01664247|582759661|FG000|Overall Study|Adverse Event|5|||
161373814|NCT01664247|582759662|FG001|Overall Study|Adverse Event|3|||
161373815|NCT01664247|582759661|FG000|Overall Study|Protocol Violation|3|||
161373816|NCT01664247|582759662|FG001|Overall Study|Protocol Violation|5|||
161373817|NCT01664247|582759661|FG000|Overall Study|Withdrawal Criteria|1|||
161373818|NCT01664247|582759662|FG001|Overall Study|Withdrawal Criteria|4|||
161373819|NCT01664247|582759661|FG000|Overall Study|Unclassified|5|||
161373820|NCT01664247|582759662|FG001|Overall Study|Unclassified|29|||
161373821|NCT01000506|582759663|FG000|Overall Study|Adverse Event|6|||
161373822|NCT01000506|582759664|FG001|Overall Study|Adverse Event|5|||
161373823|NCT01000506|582759665|FG002|Overall Study|Adverse Event|8|||
161373824|NCT01000506|582759666|FG003|Overall Study|Adverse Event|9|||
161373825|NCT01000506|582759663|FG000|Overall Study|Lack of Efficacy|8|||
161373826|NCT01000506|582759664|FG001|Overall Study|Lack of Efficacy|6|||
161373827|NCT01000506|582759665|FG002|Overall Study|Lack of Efficacy|4|||
161373828|NCT01000506|582759666|FG003|Overall Study|Lack of Efficacy|4|||
161373829|NCT01000506|582759663|FG000|Overall Study|Protocol Violation|1|||
161373830|NCT01000506|582759664|FG001|Overall Study|Protocol Violation|1|||
161373831|NCT01000506|582759665|FG002|Overall Study|Protocol Violation|0|||
161373832|NCT01000506|582759666|FG003|Overall Study|Protocol Violation|0|||
161373833|NCT01000506|582759663|FG000|Overall Study|Lost to Follow-up|1|||
161373834|NCT01000506|582759664|FG001|Overall Study|Lost to Follow-up|1|||
161373835|NCT01000506|582759665|FG002|Overall Study|Lost to Follow-up|4|||
161373836|NCT01000506|582759666|FG003|Overall Study|Lost to Follow-up|0|||
161373837|NCT01000506|582759663|FG000|Overall Study|Physician Decision|1|||
161373838|NCT01000506|582759664|FG001|Overall Study|Physician Decision|3|||
161373839|NCT01000506|582759665|FG002|Overall Study|Physician Decision|3|||
161373840|NCT01000506|582759666|FG003|Overall Study|Physician Decision|3|||
161373841|NCT01000506|582759663|FG000|Overall Study|Withdrawal by Subject|11|||
161373842|NCT01000506|582759664|FG001|Overall Study|Withdrawal by Subject|8|||
161373843|NCT01000506|582759665|FG002|Overall Study|Withdrawal by Subject|2|||
161373844|NCT01000506|582759666|FG003|Overall Study|Withdrawal by Subject|7|||
161373845|NCT03064074|582759667|FG000|Overall Study|Physician Decision|0|||
161373846|NCT03064074|582759668|FG001|Overall Study|Physician Decision|0|||
161373847|NCT03064074|582759669|FG002|Overall Study|Physician Decision|0|||
161373848|NCT03064074|582759670|FG003|Overall Study|Physician Decision|1|||
161373849|NCT00269087|582759671|FG000|Overall Study|Adverse Event|20|||
161373850|NCT00269087|582759671|FG000|Overall Study|Withdrawal by Subject|1|||
161373851|NCT00269087|582759671|FG000|Overall Study|Exacerbation of COPD|13|||
161373852|NCT01188967|582759677|FG000|Overall Study|Withdrawal by Subject|1|||
161373853|NCT01188967|582759678|FG001|Overall Study|Withdrawal by Subject|1|||
161373854|NCT01188967|582759677|FG000|Overall Study|Physician Decision|1|||
161373855|NCT01188967|582759678|FG001|Overall Study|Physician Decision|1|||
161373856|NCT01188967|582759677|FG000|Overall Study|Lost to Follow-up|3|||
161373857|NCT01188967|582759678|FG001|Overall Study|Lost to Follow-up|2|||
161373858|NCT01448616|582759679|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
161373859|NCT01448616|582759680|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
161373860|NCT01448616|582759681|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
161373861|NCT01448616|582759682|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
161373862|NCT01448616|582759679|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
161373863|NCT01448616|582759680|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
161373864|NCT01448616|582759681|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
161373865|NCT01448616|582759682|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
161373866|NCT01448616|582759679|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
161373867|NCT01448616|582759680|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
161373868|NCT01448616|582759681|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
161373869|NCT01448616|582759682|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
161373870|NCT01448616|582759679|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
161373871|NCT01448616|582759680|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
161373872|NCT01448616|582759681|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
161373873|NCT01448616|582759682|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
161373874|NCT01448616|582759679|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
161373875|NCT01448616|582759680|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
161373876|NCT01448616|582759681|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
161373877|NCT01448616|582759682|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
161373878|NCT00523978|582759683|FG000|Overall Study|Withdrawal by Subject|3|||
161373879|NCT00523978|582759684|FG001|Overall Study|Withdrawal by Subject|7|||
161373880|NCT00523978|582759683|FG000|Overall Study|Screen Failures|5|||
161373881|NCT00523978|582759684|FG001|Overall Study|Screen Failures|1|||
161373882|NCT00523978|582759683|FG000|Overall Study|Death|1|||
161373883|NCT00523978|582759684|FG001|Overall Study|Death|0|||
161373884|NCT01911260|582759687|FG000|Supplementation Period|transference or evasion of school|7|||
161373885|NCT01911260|582759688|FG001|Supplementation Period|transference or evasion of school|9|||
161373886|NCT01911260|582759689|FG002|Supplementation Period|transference or evasion of school|7|||
161373887|NCT01911260|582759690|FG003|Supplementation Period|transference or evasion of school|6|||
161373888|NCT01911260|582759687|FG000|Supplementation Period|Adverse Event|2|||
161373889|NCT01911260|582759688|FG001|Supplementation Period|Adverse Event|0|||
161373890|NCT01911260|582759689|FG002|Supplementation Period|Adverse Event|1|||
161373891|NCT01911260|582759690|FG003|Supplementation Period|Adverse Event|0|||
161373892|NCT01911260|582759687|FG000|Supplementation Period|refused to receive supplement|1|||
161373893|NCT01911260|582759688|FG001|Supplementation Period|refused to receive supplement|0|||
161373894|NCT01911260|582759689|FG002|Supplementation Period|refused to receive supplement|1|||
161373895|NCT01911260|582759690|FG003|Supplementation Period|refused to receive supplement|0|||
161373896|NCT01911260|582759687|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
161373897|NCT01911260|582759688|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
161373898|NCT01911260|582759689|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
161373899|NCT01911260|582759690|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
161373900|NCT01911260|582759687|FG000|Follow-up Period|transference or evasion of school|13|||
161373901|NCT01911260|582759688|FG001|Follow-up Period|transference or evasion of school|20|||
161373902|NCT01911260|582759689|FG002|Follow-up Period|transference or evasion of school|15|||
161373903|NCT01911260|582759690|FG003|Follow-up Period|transference or evasion of school|12|||
161373904|NCT01696643|582759695|FG000|Overall Study|Adverse Event|15|||
161373905|NCT01696643|582759696|FG001|Overall Study|Adverse Event|7|||
161373906|NCT01696643|582759695|FG000|Overall Study|Death|1|||
161373907|NCT01696643|582759696|FG001|Overall Study|Death|2|||
161373908|NCT01696643|582759695|FG000|Overall Study|Lack of Efficacy|3|||
161373909|NCT01696643|582759696|FG001|Overall Study|Lack of Efficacy|0|||
161373910|NCT01696643|582759695|FG000|Overall Study|Lost to Follow-up|67|||
161373911|NCT01696643|582759696|FG001|Overall Study|Lost to Follow-up|67|||
161373912|NCT01696643|582759695|FG000|Overall Study|Physician Decision|3|||
161373913|NCT01696643|582759696|FG001|Overall Study|Physician Decision|2|||
161373914|NCT01696643|582759695|FG000|Overall Study|Pregnancy|0|||
161373915|NCT01696643|582759696|FG001|Overall Study|Pregnancy|1|||
161373916|NCT01696643|582759695|FG000|Overall Study|Protocol Violation|7|||
161373917|NCT01696643|582759696|FG001|Overall Study|Protocol Violation|7|||
161373918|NCT01696643|582759695|FG000|Overall Study|Study Terminated by Sponsor|286|||
161373919|NCT01696643|582759696|FG001|Overall Study|Study Terminated by Sponsor|294|||
161373920|NCT01696643|582759695|FG000|Overall Study|Withdrawal by Subject|142|||
161373921|NCT01696643|582759696|FG001|Overall Study|Withdrawal by Subject|149|||
161373922|NCT01696643|582759695|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
161373923|NCT01696643|582759696|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
161373924|NCT01696643|582759695|FG000|Overall Study|Site Error|2|||
161373925|NCT01696643|582759696|FG001|Overall Study|Site Error|1|||
161373926|NCT01696643|582759695|FG000|Overall Study|Participant Incarcerated|0|||
161373927|NCT01696643|582759696|FG001|Overall Study|Participant Incarcerated|1|||
161373928|NCT01696643|582759695|FG000|Overall Study|Medical Monitor Decision|0|||
161373929|NCT01696643|582759696|FG001|Overall Study|Medical Monitor Decision|2|||
161373930|NCT01696643|582759695|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
161373931|NCT01696643|582759696|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
161373932|NCT00518180|582759701|FG000|Overall Study|Withdrawal by Subject|29|||
161373933|NCT00518180|582759702|FG001|Overall Study|Withdrawal by Subject|30|||
161373934|NCT00518180|582759703|FG002|Overall Study|Withdrawal by Subject|42|||
161373935|NCT00518180|582759701|FG000|Overall Study|Lost to Follow-up|30|||
161373936|NCT00518180|582759702|FG001|Overall Study|Lost to Follow-up|28|||
161373937|NCT00518180|582759703|FG002|Overall Study|Lost to Follow-up|34|||
161373938|NCT00518180|582759701|FG000|Overall Study|Administrative reason|0|||
161373939|NCT00518180|582759702|FG001|Overall Study|Administrative reason|2|||
161373940|NCT00518180|582759703|FG002|Overall Study|Administrative reason|2|||
161373941|NCT00518180|582759701|FG000|Overall Study|Protocol Violation|5|||
161373942|NCT00518180|582759702|FG001|Overall Study|Protocol Violation|7|||
161373943|NCT00518180|582759703|FG002|Overall Study|Protocol Violation|4|||
161373944|NCT00518180|582759701|FG000|Overall Study|Unable to classify|0|||
161373945|NCT00518180|582759702|FG001|Overall Study|Unable to classify|2|||
161373946|NCT00518180|582759703|FG002|Overall Study|Unable to classify|0|||
161373947|NCT00518180|582759701|FG000|Overall Study|Adverse Event|1|||
161373948|NCT00518180|582759702|FG001|Overall Study|Adverse Event|0|||
161373949|NCT00518180|582759703|FG002|Overall Study|Adverse Event|0|||
161373950|NCT02951780|582759704|FG000|Period 1|Adverse Event|0|||
161373951|NCT02951780|582759705|FG001|Period 1|Adverse Event|0|||
161373952|NCT02951780|582759706|FG002|Period 1|Adverse Event|0|||
161373953|NCT02951780|582759707|FG003|Period 1|Adverse Event|1|||
161373954|NCT02951780|582759708|FG004|Period 1|Adverse Event|0|||
161373955|NCT02951780|582759709|FG005|Period 1|Adverse Event|0|||
161373956|NCT02951780|582759710|FG006|Period 1|Adverse Event|0|||
161373957|NCT02951780|582759711|FG007|Period 1|Adverse Event|0|||
161373958|NCT02951780|582759712|FG008|Period 1|Adverse Event|0|||
161373959|NCT02951780|582759704|FG000|Period 1|Scheduling Conflicts|0|||
161373960|NCT02951780|582759705|FG001|Period 1|Scheduling Conflicts|0|||
161373961|NCT02951780|582759706|FG002|Period 1|Scheduling Conflicts|0|||
161373962|NCT02951780|582759707|FG003|Period 1|Scheduling Conflicts|0|||
161373963|NCT02951780|582759708|FG004|Period 1|Scheduling Conflicts|0|||
161373964|NCT02951780|582759709|FG005|Period 1|Scheduling Conflicts|0|||
161373965|NCT02951780|582759710|FG006|Period 1|Scheduling Conflicts|0|||
161373966|NCT02951780|582759711|FG007|Period 1|Scheduling Conflicts|1|||
161373967|NCT02951780|582759712|FG008|Period 1|Scheduling Conflicts|0|||
161373968|NCT02951780|582759704|FG000|Period 2|Scheduling Conflicts|0|||
161373969|NCT02951780|582759705|FG001|Period 2|Scheduling Conflicts|0|||
161373970|NCT02951780|582759706|FG002|Period 2|Scheduling Conflicts|0|||
161373971|NCT02951780|582759707|FG003|Period 2|Scheduling Conflicts|0|||
161373972|NCT02951780|582759708|FG004|Period 2|Scheduling Conflicts|0|||
161373973|NCT02951780|582759709|FG005|Period 2|Scheduling Conflicts|0|||
161373974|NCT02951780|582759710|FG006|Period 2|Scheduling Conflicts|0|||
161373975|NCT02951780|582759711|FG007|Period 2|Scheduling Conflicts|1|||
161373976|NCT02951780|582759712|FG008|Period 2|Scheduling Conflicts|0|||
161373977|NCT00508482|582759713|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
161373978|NCT00508482|582759714|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
161373979|NCT00508482|582759715|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
161373980|NCT00508482|582759713|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
161373981|NCT00508482|582759714|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
161373982|NCT00508482|582759715|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
161373983|NCT00508482|582759713|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
161373984|NCT00508482|582759714|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
161373985|NCT00508482|582759715|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
161373986|NCT00546481|582759716|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
161373987|NCT00546481|582759717|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
161373988|NCT00546481|582759718|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
161373989|NCT00546481|582759716|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
161373990|NCT00546481|582759717|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
161373991|NCT00546481|582759718|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
161373992|NCT00546481|582759716|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
161373993|NCT00546481|582759717|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
161373994|NCT00546481|582759718|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
161373995|NCT00546481|582759716|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
161373996|NCT00546481|582759717|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
161373997|NCT00546481|582759718|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
161373998|NCT00546481|582759716|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
161373999|NCT00546481|582759717|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
161374000|NCT00546481|582759718|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
161374001|NCT00546481|582759716|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
161374002|NCT00546481|582759717|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
161374003|NCT00546481|582759718|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
161374004|NCT00546481|582759716|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
161374005|NCT00546481|582759717|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
161374006|NCT00546481|582759718|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
161374007|NCT00546481|582759716|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
161374008|NCT00546481|582759717|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
161374009|NCT00546481|582759718|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
161374010|NCT00546481|582759716|FG000|Maintenance Phase (CERA)|Other Reason|0|||
161374011|NCT00546481|582759717|FG001|Maintenance Phase (CERA)|Other Reason|0|||
161374012|NCT00546481|582759718|FG002|Maintenance Phase (CERA)|Other Reason|1|||
161374013|NCT00244621|582759719|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161374014|NCT00244621|582759720|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161374015|NCT00244621|582759721|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161374016|NCT00244621|582759719|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161374017|NCT00244621|582759720|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161374018|NCT00244621|582759721|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161374019|NCT00244621|582759719|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161374020|NCT00244621|582759720|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161374021|NCT00244621|582759721|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161374022|NCT00244621|582759719|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
161374023|NCT00244621|582759720|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
161374024|NCT00244621|582759721|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
161374025|NCT00244621|582759719|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161374026|NCT00244621|582759720|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
161374027|NCT00244621|582759721|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161374028|NCT00244621|582759719|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
161374029|NCT00244621|582759720|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161374030|NCT00244621|582759721|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161374031|NCT00244621|582759719|FG000|Open-label Treatment Period|Adverse Event|0|||
161374032|NCT00244621|582759720|FG001|Open-label Treatment Period|Adverse Event|0|||
161374033|NCT00244621|582759721|FG002|Open-label Treatment Period|Adverse Event|1|||
161374034|NCT00244621|582759719|FG000|Open-label Treatment Period|Moved abroad|0|||
161374035|NCT00244621|582759720|FG001|Open-label Treatment Period|Moved abroad|0|||
161374036|NCT00244621|582759721|FG002|Open-label Treatment Period|Moved abroad|1|||
161374037|NCT01193101|582759725|FG000|Overall Study|Adverse Event|0|||
161374038|NCT01193101|582759726|FG001|Overall Study|Adverse Event|1|||
161374039|NCT01193101|582759727|FG002|Overall Study|Adverse Event|1|||
161374040|NCT01193101|582759728|FG003|Overall Study|Adverse Event|3|||
161374041|NCT01193101|582759725|FG000|Overall Study|Lack of Efficacy|3|||
161374042|NCT01193101|582759726|FG001|Overall Study|Lack of Efficacy|1|||
161374043|NCT01193101|582759727|FG002|Overall Study|Lack of Efficacy|0|||
161374044|NCT01193101|582759728|FG003|Overall Study|Lack of Efficacy|8|||
161374045|NCT01193101|582759725|FG000|Overall Study|Withdrawal by Subject|2|||
161374046|NCT01193101|582759726|FG001|Overall Study|Withdrawal by Subject|4|||
161374047|NCT01193101|582759727|FG002|Overall Study|Withdrawal by Subject|1|||
161374048|NCT01193101|582759728|FG003|Overall Study|Withdrawal by Subject|1|||
161374049|NCT01193101|582759725|FG000|Overall Study|Administrative problems|0|||
161374050|NCT01193101|582759726|FG001|Overall Study|Administrative problems|0|||
161374051|NCT01193101|582759727|FG002|Overall Study|Administrative problems|1|||
161374052|NCT01193101|582759728|FG003|Overall Study|Administrative problems|0|||
161374053|NCT01193101|582759725|FG000|Overall Study|Abnormal test procedure results|0|||
161374054|NCT01193101|582759726|FG001|Overall Study|Abnormal test procedure results|1|||
161374055|NCT01193101|582759727|FG002|Overall Study|Abnormal test procedure results|0|||
161374056|NCT01193101|582759728|FG003|Overall Study|Abnormal test procedure results|0|||
161374057|NCT02347085|582759729|FG000|Overall Study|Adverse Event|2|||
161374058|NCT02347085|582759729|FG000|Overall Study|Lack of Efficacy|1|||
161374059|NCT02347085|582759729|FG000|Overall Study|Withdrawal by Subject|4|||
161374060|NCT02347085|582759729|FG000|Overall Study|Lost to Follow-up|1|||
161374061|NCT02347085|582759729|FG000|Overall Study|Protocol Criteria|2|||
161374062|NCT01957865|582759731|FG000|Overall Study|Found HIV negative|0|||
161374063|NCT01957865|582759732|FG001|Overall Study|Found HIV negative|0|||
161374064|NCT01957865|582759733|FG002|Overall Study|Found HIV negative|1|||
161374065|NCT01957865|582759731|FG000|Overall Study|Lost to Follow-up|0|||
161374066|NCT01957865|582759732|FG001|Overall Study|Lost to Follow-up|2|||
161374067|NCT01957865|582759733|FG002|Overall Study|Lost to Follow-up|2|||
161374068|NCT01082614|582759734|FG000|Overall Study|Adverse Event|1|||
161374069|NCT01082614|582759735|FG001|Overall Study|Adverse Event|4|||
161374070|NCT01082614|582759734|FG000|Overall Study|Equipment Malfunction|0|||
161374071|NCT01082614|582759735|FG001|Overall Study|Equipment Malfunction|1|||
161374072|NCT01082614|582759734|FG000|Overall Study|Physician Decision|2|||
161374073|NCT01082614|582759735|FG001|Overall Study|Physician Decision|0|||
161374074|NCT00811720|582759736|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
161374075|NCT00811720|582759737|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
161374076|NCT00811720|582759736|FG000|All Treated Patients|Adverse Event|20|||
161374077|NCT00811720|582759737|FG001|All Treated Patients|Adverse Event|62|||
161374078|NCT00811720|582759736|FG000|All Treated Patients|Lack of Efficacy|22|||
161374079|NCT00811720|582759737|FG001|All Treated Patients|Lack of Efficacy|18|||
161374080|NCT00811720|582759736|FG000|All Treated Patients|Non-compliance|0|||
161374081|NCT00811720|582759737|FG001|All Treated Patients|Non-compliance|14|||
161374082|NCT00811720|582759736|FG000|All Treated Patients|Protocol Violation|9|||
161374083|NCT00811720|582759737|FG001|All Treated Patients|Protocol Violation|16|||
161374084|NCT00811720|582759736|FG000|All Treated Patients|Withdrawal by Subject|28|||
161374085|NCT00811720|582759737|FG001|All Treated Patients|Withdrawal by Subject|34|||
161374086|NCT00811720|582759736|FG000|All Treated Patients|Lost to Follow-up|10|||
161374087|NCT00811720|582759737|FG001|All Treated Patients|Lost to Follow-up|16|||
161374088|NCT00811720|582759736|FG000|All Treated Patients|Other Reason|7|||
161374089|NCT00811720|582759737|FG001|All Treated Patients|Other Reason|4|||
161374090|NCT00950651|582759741|FG000|Overall Study|Adverse Event|17|||
161374091|NCT00950651|582759742|FG001|Overall Study|Adverse Event|20|||
161374092|NCT00950651|582759741|FG000|Overall Study|Death|1|||
161374093|NCT00950651|582759742|FG001|Overall Study|Death|0|||
161374094|NCT00950651|582759741|FG000|Overall Study|Lack of Efficacy|2|||
161374095|NCT00950651|582759742|FG001|Overall Study|Lack of Efficacy|2|||
161374096|NCT00950651|582759741|FG000|Overall Study|Protocol Violation|3|||
161374097|NCT00950651|582759742|FG001|Overall Study|Protocol Violation|4|||
161374098|NCT00950651|582759741|FG000|Overall Study|Withdrawal by Subject|8|||
161374099|NCT00950651|582759742|FG001|Overall Study|Withdrawal by Subject|9|||
161374100|NCT03783780|582759747|FG000|Overall Study|Withdrawn prior to completion|1|||
161374101|NCT03768427|582759748|FG000|Overall Study|Death|0|||
161374102|NCT03768427|582759749|FG001|Overall Study|Death|0|||
161374103|NCT03768427|582759750|FG002|Overall Study|Death|1|||
161374104|NCT03768427|582759751|FG003|Overall Study|Death|0|||
161374105|NCT03768427|582759748|FG000|Overall Study|Lost to Follow-up|2|||
161374106|NCT03768427|582759749|FG001|Overall Study|Lost to Follow-up|0|||
161374107|NCT03768427|582759750|FG002|Overall Study|Lost to Follow-up|0|||
161374108|NCT03768427|582759751|FG003|Overall Study|Lost to Follow-up|0|||
161374109|NCT03768427|582759748|FG000|Overall Study|Physician Decision|3|||
161374110|NCT03768427|582759749|FG001|Overall Study|Physician Decision|2|||
161374111|NCT03768427|582759750|FG002|Overall Study|Physician Decision|4|||
161374112|NCT03768427|582759751|FG003|Overall Study|Physician Decision|4|||
161374113|NCT03768427|582759748|FG000|Overall Study|Withdrawal by Subject|7|||
161374114|NCT03768427|582759749|FG001|Overall Study|Withdrawal by Subject|2|||
161374115|NCT03768427|582759750|FG002|Overall Study|Withdrawal by Subject|6|||
161374116|NCT03768427|582759751|FG003|Overall Study|Withdrawal by Subject|7|||
161374117|NCT03710889|582759754|FG000|Overall Study|Adverse Event|2|||
161374118|NCT03710889|582759754|FG000|Overall Study|Protocol Deviation|1|||
161374119|NCT02121509|582759758|FG000|Washout Period (35 Days)|Adverse Event|1|||
161374120|NCT02121509|582759759|FG001|Washout Period (35 Days)|Adverse Event|1|||
161374121|NCT02121509|582759760|FG002|Washout Period (35 Days)|Adverse Event|0|||
161374122|NCT02121509|582759761|FG003|Washout Period (35 Days)|Adverse Event|0|||
161374123|NCT02121509|582759758|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
161374124|NCT02121509|582759759|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
161374125|NCT02121509|582759760|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
161374126|NCT02121509|582759761|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
161374127|NCT02121509|582759758|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
161374128|NCT02121509|582759759|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
161374129|NCT02121509|582759760|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
161374130|NCT02121509|582759761|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
161374131|NCT00867035|582759762|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
161374132|NCT00867035|582759763|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
161374133|NCT00867035|582759762|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
161374134|NCT00867035|582759763|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
161374135|NCT02993263|582759765|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
161374136|NCT00542178|582759766|FG000|Overall Study|did not complete year 4 follow-up|75|||
161374137|NCT00542178|582759767|FG001|Overall Study|did not complete year 4 follow-up|80|||
161374138|NCT00542178|582759768|FG002|Overall Study|did not complete year 4 follow-up|74|||
161374139|NCT00542178|582759769|FG003|Overall Study|did not complete year 4 follow-up|62|||
161374140|NCT00542178|582759770|FG004|Overall Study|did not complete year 4 follow-up|64|||
161374141|NCT00542178|582759771|FG005|Overall Study|did not complete year 4 follow-up|89|||
161374142|NCT00542178|582759772|FG006|Overall Study|did not complete year 4 follow-up|87|||
161374143|NCT00542178|582759773|FG007|Overall Study|did not complete year 4 follow-up|85|||
161374144|NCT00829998|582759774|FG000|Washout|Adverse Event|0|||
161374145|NCT00829998|582759775|FG001|Washout|Adverse Event|1|||
161374146|NCT01173679|582761480|FG000|Overall Study|Death|1|||
161374147|NCT00441272|582761481|FG000|Overall Study|Study terminated prior to enrollment|25|||
161374148|NCT00441272|582761482|FG001|Overall Study|Study terminated prior to enrollment|25|||
161374149|NCT02921789|582761483|FG000|Overall Study|Adverse Event|0|||
161374150|NCT02921789|582761484|FG001|Overall Study|Adverse Event|1|||
161374151|NCT02921789|582761483|FG000|Overall Study|Lost to Follow-up|1|||
161374152|NCT02921789|582761484|FG001|Overall Study|Lost to Follow-up|0|||
161374153|NCT02921789|582761483|FG000|Overall Study|Protocol Deviation|2|||
161374154|NCT02921789|582761484|FG001|Overall Study|Protocol Deviation|0|||
161374155|NCT02921789|582761483|FG000|Overall Study|Withdrawal by Subject|2|||
161374156|NCT02921789|582761484|FG001|Overall Study|Withdrawal by Subject|1|||
161374157|NCT02921789|582761483|FG000|Overall Study|Miscellaneous|3|||
161374158|NCT02921789|582761484|FG001|Overall Study|Miscellaneous|2|||
161374159|NCT01944020|582761485|FG000|Overall Study|Withdrawal by Subject|5|||
161374160|NCT01944020|582761486|FG001|Overall Study|Withdrawal by Subject|0|||
161374161|NCT03423602|582761491|FG000|Overall Study|Death|1|||
161374162|NCT03423602|582761491|FG000|Overall Study|Lost to Follow-up|6|||
161374163|NCT03423602|582761491|FG000|Overall Study|Protocol Violation|1|||
161374164|NCT03423602|582761491|FG000|Overall Study|Withdrawal by Subject|4|||
161374165|NCT02332187|582761492|FG000|Overall Study|Withdrawal by Subject|2|||
161374166|NCT02332187|582761493|FG001|Overall Study|Withdrawal by Subject|2|||
161374167|NCT02332187|582761492|FG000|Overall Study|Adverse Event|0|||
161374168|NCT02332187|582761493|FG001|Overall Study|Adverse Event|1|||
161374169|NCT02903823|582761494|FG000|Overall Study|Physician Decision|5|||
161374170|NCT02903823|582761494|FG000|Overall Study|Could not advance catheter|1|||
161374171|NCT02903823|582761494|FG000|Overall Study|Catheter dislodgement|1|||
161374172|NCT01462929|582761501|FG000|Overall Study|Adverse Event|3|||
161374173|NCT01462929|582761502|FG001|Overall Study|Adverse Event|3|||
161374174|NCT01462929|582761503|FG002|Overall Study|Adverse Event|4|||
161374175|NCT01462929|582761501|FG000|Overall Study|Withdrawal by Subject|2|||
161374176|NCT01462929|582761502|FG001|Overall Study|Withdrawal by Subject|1|||
161374177|NCT01462929|582761503|FG002|Overall Study|Withdrawal by Subject|0|||
161374178|NCT01462929|582761501|FG000|Overall Study|Lack of Efficacy|0|||
161374179|NCT01462929|582761502|FG001|Overall Study|Lack of Efficacy|0|||
161374180|NCT01462929|582761503|FG002|Overall Study|Lack of Efficacy|1|||
161374181|NCT00887159|582761504|FG000|Overall Study|Disease progression|6|||
161374182|NCT00887159|582761505|FG001|Overall Study|Disease progression|39|||
161374183|NCT00887159|582761506|FG002|Overall Study|Disease progression|33|||
161374184|NCT00887159|582761504|FG000|Overall Study|Adverse Event|3|||
161374185|NCT00887159|582761505|FG001|Overall Study|Adverse Event|4|||
161374186|NCT00887159|582761506|FG002|Overall Study|Adverse Event|17|||
161374187|NCT00887159|582761504|FG000|Overall Study|Death|2|||
161374188|NCT00887159|582761505|FG001|Overall Study|Death|2|||
161374189|NCT00887159|582761506|FG002|Overall Study|Death|0|||
161374190|NCT00887159|582761504|FG000|Overall Study|Withdrawal by Subject|4|||
161374191|NCT00887159|582761505|FG001|Overall Study|Withdrawal by Subject|4|||
161374192|NCT00887159|582761506|FG002|Overall Study|Withdrawal by Subject|2|||
161374193|NCT00887159|582761504|FG000|Overall Study|Alternative therapy|2|||
161374194|NCT00887159|582761505|FG001|Overall Study|Alternative therapy|0|||
161374195|NCT00887159|582761506|FG002|Overall Study|Alternative therapy|0|||
161374196|NCT00887159|582761504|FG000|Overall Study|Physician Decision|1|||
161374197|NCT00887159|582761505|FG001|Overall Study|Physician Decision|1|||
161374198|NCT00887159|582761506|FG002|Overall Study|Physician Decision|0|||
161374199|NCT00887159|582761504|FG000|Overall Study|Sympomatic deterioration|1|||
161374200|NCT00887159|582761505|FG001|Overall Study|Sympomatic deterioration|0|||
161374201|NCT00887159|582761506|FG002|Overall Study|Sympomatic deterioration|0|||
161374202|NCT00887159|582761504|FG000|Overall Study|Treatment delayed|1|||
161374203|NCT00887159|582761505|FG001|Overall Study|Treatment delayed|1|||
161374204|NCT00887159|582761506|FG002|Overall Study|Treatment delayed|0|||
161374205|NCT00887159|582761504|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
161374206|NCT00887159|582761505|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
161374207|NCT00887159|582761506|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
161374208|NCT00887159|582761504|FG000|Overall Study|Received more tx instead of observation|1|||
161374209|NCT00887159|582761505|FG001|Overall Study|Received more tx instead of observation|0|||
161374210|NCT00887159|582761506|FG002|Overall Study|Received more tx instead of observation|0|||
161374211|NCT00887159|582761504|FG000|Overall Study|Ineligible|5|||
161374212|NCT00887159|582761505|FG001|Overall Study|Ineligible|1|||
161374213|NCT00887159|582761506|FG002|Overall Study|Ineligible|0|||
161374214|NCT00887159|582761504|FG000|Overall Study|Never started assigned therapy|3|||
161374215|NCT00887159|582761505|FG001|Overall Study|Never started assigned therapy|3|||
161374216|NCT00887159|582761506|FG002|Overall Study|Never started assigned therapy|4|||
161374217|NCT06164691|582761508|FG000|Overall Study|Withdrawal by Subject|2|||
161374218|NCT06164691|582761509|FG001|Overall Study|Withdrawal by Subject|0|||
161374219|NCT06164691|582761510|FG002|Overall Study|Withdrawal by Subject|0|||
161374220|NCT02391311|582761511|FG000|Overall Study|Lost to Follow-up|2|||
161374221|NCT02391311|582761512|FG001|Overall Study|Lost to Follow-up|1|||
161374222|NCT02391311|582761511|FG000|Overall Study|deemed ineligible after baseline|1|||
161374223|NCT02391311|582761512|FG001|Overall Study|deemed ineligible after baseline|1|||
161374224|NCT00305448|582761513|FG000|Overall Study|Protocol Violation|0|||
161374225|NCT00305448|582761514|FG001|Overall Study|Protocol Violation|1|||
161374226|NCT00305448|582761515|FG002|Overall Study|Protocol Violation|0|||
161374227|NCT00305448|582761513|FG000|Overall Study|Withdrawal by Subject|2|||
161374228|NCT00305448|582761514|FG001|Overall Study|Withdrawal by Subject|0|||
161374229|NCT00305448|582761515|FG002|Overall Study|Withdrawal by Subject|1|||
161374230|NCT00305448|582761513|FG000|Overall Study|Adverse Event|1|||
161374231|NCT00305448|582761514|FG001|Overall Study|Adverse Event|0|||
161374232|NCT00305448|582761515|FG002|Overall Study|Adverse Event|1|||
161374233|NCT00305448|582761513|FG000|Overall Study|Disease Progression|27|||
161374234|NCT00305448|582761514|FG001|Overall Study|Disease Progression|31|||
161374235|NCT00305448|582761515|FG002|Overall Study|Disease Progression|28|||
161374236|NCT00305448|582761513|FG000|Overall Study|Subjective Disease Progression|1|||
161374237|NCT00305448|582761514|FG001|Overall Study|Subjective Disease Progression|2|||
161374238|NCT00305448|582761515|FG002|Overall Study|Subjective Disease Progression|2|||
161374239|NCT00305448|582761513|FG000|Overall Study|Tumor Marker Elevation|0|||
161374240|NCT00305448|582761514|FG001|Overall Study|Tumor Marker Elevation|0|||
161374241|NCT00305448|582761515|FG002|Overall Study|Tumor Marker Elevation|1|||
161374242|NCT01343888|582761516|FG000|Overall Study|Adverse Event|12|||
161374243|NCT01343888|582761517|FG001|Overall Study|Adverse Event|22|||
161374244|NCT01343888|582761518|FG002|Overall Study|Adverse Event|5|||
161374245|NCT01343888|582761516|FG000|Overall Study|Lack of Efficacy|9|||
161374246|NCT01343888|582761517|FG001|Overall Study|Lack of Efficacy|9|||
161374247|NCT01343888|582761518|FG002|Overall Study|Lack of Efficacy|13|||
161374248|NCT01343888|582761516|FG000|Overall Study|Lost to Follow-up|0|||
161374249|NCT01343888|582761517|FG001|Overall Study|Lost to Follow-up|2|||
161374250|NCT01343888|582761518|FG002|Overall Study|Lost to Follow-up|1|||
161374251|NCT01343888|582761516|FG000|Overall Study|Protocol Violation|0|||
161374252|NCT01343888|582761517|FG001|Overall Study|Protocol Violation|2|||
161374253|NCT01343888|582761518|FG002|Overall Study|Protocol Violation|0|||
161374254|NCT01343888|582761516|FG000|Overall Study|Withdrawal by Subject|4|||
161374255|NCT01343888|582761517|FG001|Overall Study|Withdrawal by Subject|4|||
161374256|NCT01343888|582761518|FG002|Overall Study|Withdrawal by Subject|2|||
161374257|NCT01343888|582761516|FG000|Overall Study|other than stated above|0|||
161374258|NCT01343888|582761517|FG001|Overall Study|other than stated above|0|||
161374259|NCT01343888|582761518|FG002|Overall Study|other than stated above|1|||
161374260|NCT00558636|582761520|FG000|Treatment|Adverse Event|9|||
161374261|NCT00558636|582761521|FG001|Treatment|Adverse Event|2|||
161374262|NCT00558636|582761520|FG000|Treatment|Withdrawal by Subject|2|||
161374263|NCT00558636|582761521|FG001|Treatment|Withdrawal by Subject|0|||
161374264|NCT00558636|582761520|FG000|Treatment|Premature termination of the study|35|||
161374265|NCT00558636|582761521|FG001|Treatment|Premature termination of the study|37|||
161374266|NCT00558636|582761520|FG000|Treatment|Disease progression|1|||
161374267|NCT00558636|582761521|FG001|Treatment|Disease progression|5|||
161374268|NCT00558636|582761520|FG000|Follow-up|Premature termination of the study|12|||
161374269|NCT00558636|582761521|FG001|Follow-up|Premature termination of the study|7|||
161374270|NCT01990742|582761522|FG000|Overall Study|Withdrawal by facility|407|||
161374271|NCT01990742|582761523|FG001|Overall Study|Withdrawal by facility|1083|||
161374272|NCT01990742|582761522|FG000|Overall Study|Facility closed|0|||
161374273|NCT01990742|582761523|FG001|Overall Study|Facility closed|270|||
161374274|NCT03443687|582761524|FG000|Overall Study|Lost to Follow-up|3|||
161374275|NCT03443687|582761525|FG001|Overall Study|Lost to Follow-up|5|||
161374276|NCT03443687|582761524|FG000|Overall Study|Withdrawal by Subject|1|||
161374277|NCT03443687|582761525|FG001|Overall Study|Withdrawal by Subject|0|||
161374278|NCT03443687|582761524|FG000|Overall Study|Discontinued intervention|1|||
161374279|NCT03443687|582761525|FG001|Overall Study|Discontinued intervention|1|||
161374280|NCT02805790|582761526|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
161374281|NCT02805790|582761527|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
161374282|NCT00800735|582761528|FG000|Overall Study|Administrative/Other|2|||
161374283|NCT00800735|582761528|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161374284|NCT00800735|582761528|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
161374285|NCT00800735|582761528|FG000|Overall Study|Withdrew Consent|3|||
161374286|NCT00506142|582761529|FG000|Overall Study|Adverse Event|8|||
161374287|NCT00506142|582761530|FG001|Overall Study|Adverse Event|7|||
161374288|NCT00506142|582761529|FG000|Overall Study|Lack of Efficacy|21|||
161374289|NCT00506142|582761530|FG001|Overall Study|Lack of Efficacy|7|||
161374290|NCT00506142|582761529|FG000|Overall Study|Withdrawal by Subject|4|||
161374291|NCT00506142|582761530|FG001|Overall Study|Withdrawal by Subject|5|||
161374292|NCT00506142|582761529|FG000|Overall Study|Physician Decision|1|||
161374293|NCT00506142|582761530|FG001|Overall Study|Physician Decision|0|||
161374294|NCT00506142|582761529|FG000|Overall Study|New health condition|1|||
161374295|NCT00506142|582761530|FG001|Overall Study|New health condition|0|||
161374296|NCT02154061|582761531|FG000|Overall Study|Pregnancy|1|||
161374297|NCT02154061|582761532|FG001|Overall Study|Pregnancy|0|||
161374298|NCT02154061|582761531|FG000|Overall Study|enrolled but not vaccinated|1|||
161374299|NCT02154061|582761532|FG001|Overall Study|enrolled but not vaccinated|0|||
161374300|NCT01936831|582761538|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374301|NCT01936831|582761539|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374302|NCT01936831|582761540|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374303|NCT01936831|582761541|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374304|NCT01936831|582761542|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374305|NCT01936831|582761543|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
161374306|NCT01936831|582761544|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374307|NCT01936831|582761545|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374308|NCT01936831|582761546|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161374309|NCT02133573|582761547|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
161374310|NCT02133573|582761548|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
161374311|NCT02133573|582761547|FG000|Overall Study|Child Deaths|3|||
161374312|NCT02133573|582761548|FG001|Overall Study|Child Deaths|5|||
161374313|NCT02133573|582761547|FG000|Overall Study|Child Declined Follow Ups|2|||
161374314|NCT02133573|582761548|FG001|Overall Study|Child Declined Follow Ups|1|||
161374315|NCT02133573|582761547|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
161374316|NCT02133573|582761548|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
161374317|NCT02808429|582761550|FG000|Overall Study|Lost to Follow-up|1|||
161374318|NCT02808429|582761551|FG001|Overall Study|Lost to Follow-up|0|||
161374319|NCT02808429|582761552|FG002|Overall Study|Lost to Follow-up|0|||
161374320|NCT02808429|582761550|FG000|Overall Study|Protocol Violation|0|||
161374321|NCT02808429|582761551|FG001|Overall Study|Protocol Violation|1|||
161374322|NCT02808429|582761552|FG002|Overall Study|Protocol Violation|0|||
161374323|NCT02808429|582761550|FG000|Overall Study|Premature study termination by sponsor|2|||
161374324|NCT02808429|582761551|FG001|Overall Study|Premature study termination by sponsor|0|||
161374325|NCT02808429|582761552|FG002|Overall Study|Premature study termination by sponsor|1|||
161374326|NCT02808429|582761550|FG000|Overall Study|Relocation|0|||
161374327|NCT02808429|582761551|FG001|Overall Study|Relocation|0|||
161374328|NCT02808429|582761552|FG002|Overall Study|Relocation|1|||
161374329|NCT01436110|582761553|FG000|Overall Study|Lack of Efficacy|23|||
161374330|NCT01436110|582761554|FG001|Overall Study|Lack of Efficacy|14|||
161374331|NCT01436110|582761555|FG002|Overall Study|Lack of Efficacy|9|||
161374332|NCT01436110|582761553|FG000|Overall Study|Withdrawal by Subject|6|||
161374333|NCT01436110|582761554|FG001|Overall Study|Withdrawal by Subject|8|||
161374334|NCT01436110|582761555|FG002|Overall Study|Withdrawal by Subject|4|||
161374335|NCT01436110|582761553|FG000|Overall Study|Adverse Event|2|||
161374336|NCT01436110|582761554|FG001|Overall Study|Adverse Event|1|||
161374337|NCT01436110|582761555|FG002|Overall Study|Adverse Event|2|||
161374338|NCT01436110|582761553|FG000|Overall Study|Physician Decision|3|||
161374339|NCT01436110|582761554|FG001|Overall Study|Physician Decision|1|||
161374340|NCT01436110|582761555|FG002|Overall Study|Physician Decision|1|||
161374341|NCT01436110|582761553|FG000|Overall Study|Lost to Follow-up|1|||
161374342|NCT01436110|582761554|FG001|Overall Study|Lost to Follow-up|1|||
161374343|NCT01436110|582761555|FG002|Overall Study|Lost to Follow-up|3|||
161374344|NCT01436110|582761553|FG000|Overall Study|Protocol Violation|3|||
161374345|NCT01436110|582761554|FG001|Overall Study|Protocol Violation|1|||
161374346|NCT01436110|582761555|FG002|Overall Study|Protocol Violation|1|||
161374347|NCT01436110|582761553|FG000|Overall Study|Did Not Receive Trial Medication|1|||
161374348|NCT01436110|582761554|FG001|Overall Study|Did Not Receive Trial Medication|0|||
161374349|NCT01436110|582761555|FG002|Overall Study|Did Not Receive Trial Medication|3|||
161374350|NCT03273907|582761556|FG000|Overall Study|Death|1|||
161374351|NCT03273907|582761556|FG000|Overall Study|Lost to Follow-up|4|||
161374352|NCT03273907|582761556|FG000|Overall Study|Withdrawal by Subject|2|||
161374353|NCT03273907|582761556|FG000|Overall Study|COVID 19|2|||
161374354|NCT00110214|582761557|FG000|Overall Study|Never started treatment|21|||
161374355|NCT00110214|582761558|FG001|Overall Study|Never started treatment|20|||
161374356|NCT00110214|582761557|FG000|Overall Study|Disease progression or death|260|||
161374357|NCT00110214|582761558|FG001|Overall Study|Disease progression or death|151|||
161374358|NCT00110214|582761557|FG000|Overall Study|Adverse Event|115|||
161374359|NCT00110214|582761558|FG001|Overall Study|Adverse Event|192|||
161374360|NCT00110214|582761557|FG000|Overall Study|Refused further treatment|52|||
161374361|NCT00110214|582761558|FG001|Overall Study|Refused further treatment|65|||
161374362|NCT00110214|582761557|FG000|Overall Study|Other (not specified)|61|||
161374363|NCT00110214|582761558|FG001|Overall Study|Other (not specified)|75|||
161374364|NCT01088503|582761559|FG000|Overall Study|Withdrawal by Subject|118|||
161374365|NCT01088503|582761560|FG001|Overall Study|Withdrawal by Subject|327|||
161374366|NCT01088503|582761561|FG002|Overall Study|Withdrawal by Subject|10|||
161374367|NCT01088503|582761559|FG000|Overall Study|Death|64|||
161374368|NCT01088503|582761560|FG001|Overall Study|Death|358|||
161374369|NCT01088503|582761561|FG002|Overall Study|Death|7|||
161374370|NCT01673646|582761564|FG000|Overall Study|Adverse Event|2|||
161374371|NCT01673646|582761565|FG001|Overall Study|Adverse Event|1|||
161374372|NCT01673646|582761566|FG002|Overall Study|Adverse Event|1|||
161374373|NCT01673646|582761564|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161374374|NCT01673646|582761565|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161374375|NCT01673646|582761566|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161374376|NCT01673646|582761564|FG000|Overall Study|Condition no longer requires study drug|0|||
161374377|NCT01673646|582761565|FG001|Overall Study|Condition no longer requires study drug|1|||
161374378|NCT01673646|582761566|FG002|Overall Study|Condition no longer requires study drug|0|||
161374379|NCT01673646|582761564|FG000|Overall Study|Withdrawal by Subject|0|||
161374380|NCT01673646|582761565|FG001|Overall Study|Withdrawal by Subject|2|||
161374381|NCT01673646|582761566|FG002|Overall Study|Withdrawal by Subject|2|||
161374382|NCT01673646|582761564|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
161374383|NCT01673646|582761565|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
161374384|NCT01673646|582761566|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
161374385|NCT04577781|582761570|FG000|Overall Study|Adverse Event|2|||
161374386|NCT04577781|582761571|FG001|Overall Study|Adverse Event|2|||
161374387|NCT04577781|582761570|FG000|Overall Study|Physician Decision|1|||
161374388|NCT04577781|582761571|FG001|Overall Study|Physician Decision|0|||
161374389|NCT02271529|582761574|FG000|Overall Study|Withdrawal by Subject|1|||
161374390|NCT03508050|582761575|FG000|Overall Study|Pleural adhesions|1|||
161374391|NCT03508050|582761576|FG001|Overall Study|Pleural adhesions|0|||
161374392|NCT03508050|582761575|FG000|Overall Study|Mucus plug|1|||
161374393|NCT03508050|582761576|FG001|Overall Study|Mucus plug|0|||
161374394|NCT03508050|582761575|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
161374395|NCT03508050|582761576|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
161374396|NCT03508050|582761575|FG000|Overall Study|Sustained desaturation|0|||
161374397|NCT03508050|582761576|FG001|Overall Study|Sustained desaturation|1|||
161374398|NCT03894891|582761577|FG000|Overall Study|Withdrawal by Subject|1|||
161374399|NCT03894891|582761577|FG000|Overall Study|Completed protocol treatment per protocol|5|||
161374400|NCT04389866|582761578|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
161374401|NCT04389866|582761579|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
161374402|NCT04940130|582761587|FG000|Overall Study|Travel|1|||
161374403|NCT04940130|582761588|FG001|Overall Study|Travel|0|||
161374404|NCT04940130|582761589|FG002|Overall Study|Travel|2|||
161374405|NCT04940130|582761587|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
161374406|NCT04940130|582761588|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
161374407|NCT04940130|582761589|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
161374408|NCT04940130|582761587|FG000|Overall Study|Adverse Event|0|||
161374409|NCT04940130|582761588|FG001|Overall Study|Adverse Event|0|||
161374410|NCT04940130|582761589|FG002|Overall Study|Adverse Event|2|||
161374411|NCT04940130|582761587|FG000|Overall Study|Disease progression/treatment failure|0|||
161374412|NCT04940130|582761588|FG001|Overall Study|Disease progression/treatment failure|0|||
161374413|NCT04940130|582761589|FG002|Overall Study|Disease progression/treatment failure|1|||
161374414|NCT04940130|582761587|FG000|Overall Study|Participant refusal|0|||
161374415|NCT04940130|582761588|FG001|Overall Study|Participant refusal|0|||
161374416|NCT04940130|582761589|FG002|Overall Study|Participant refusal|1|||
161374417|NCT00776789|582761590|FG000|Overall Study|Consent refusal|2|||
161374418|NCT00776789|582761591|FG001|Overall Study|Consent refusal|2|||
161374419|NCT00776789|582761590|FG000|Overall Study|Poor quality video|1|||
161374420|NCT00776789|582761591|FG001|Overall Study|Poor quality video|1|||
161374421|NCT02850978|582761594|FG000|Overall Study|Uncollectable CRF|27|||
161374422|NCT02850978|582761594|FG000|Overall Study|No visit since the first visit|35|||
161374423|NCT02850978|582761594|FG000|Overall Study|Adverse Event|81|||
161374424|NCT02850978|582761594|FG000|Overall Study|Lack of Efficacy|40|||
161374425|NCT02850978|582761594|FG000|Overall Study|Improvement in condition|34|||
161374426|NCT02850978|582761594|FG000|Overall Study|Lost to Follow-up|121|||
161374427|NCT02850978|582761594|FG000|Overall Study|Reason not listed|88|||
161374428|NCT00114127|582761595|FG000|Overall Study|Adverse Event|2|||
161374429|NCT00114127|582761596|FG001|Overall Study|Adverse Event|1|||
161374430|NCT00114127|582761595|FG000|Overall Study|Lost to Follow-up|1|||
161374431|NCT00114127|582761596|FG001|Overall Study|Lost to Follow-up|0|||
161374432|NCT00114127|582761595|FG000|Overall Study|Withdrawal by Subject|1|||
161374433|NCT00114127|582761596|FG001|Overall Study|Withdrawal by Subject|3|||
161374434|NCT00421148|582761597|FG000|Overall Study|Lost to Follow-up|0|||
161374435|NCT00421148|582761598|FG001|Overall Study|Lost to Follow-up|0|||
161374436|NCT00421148|582761599|FG002|Overall Study|Lost to Follow-up|0|||
161374437|NCT00421148|582761600|FG003|Overall Study|Lost to Follow-up|0|||
161374438|NCT00421148|582761601|FG004|Overall Study|Lost to Follow-up|0|||
161374439|NCT00421148|582761602|FG005|Overall Study|Lost to Follow-up|0|||
161374440|NCT00421148|582761603|FG006|Overall Study|Lost to Follow-up|0|||
161374441|NCT00421148|582761604|FG007|Overall Study|Lost to Follow-up|0|||
161374442|NCT00421148|582761605|FG008|Overall Study|Lost to Follow-up|0|||
161374443|NCT00421148|582761606|FG009|Overall Study|Lost to Follow-up|0|||
161374444|NCT00421148|582761607|FG010|Overall Study|Lost to Follow-up|0|||
161374445|NCT00421148|582761608|FG011|Overall Study|Lost to Follow-up|0|||
161374446|NCT00421148|582761609|FG012|Overall Study|Lost to Follow-up|0|||
161374447|NCT00421148|582761610|FG013|Overall Study|Lost to Follow-up|0|||
161374448|NCT00421148|582761611|FG014|Overall Study|Lost to Follow-up|0|||
161374449|NCT00421148|582761612|FG015|Overall Study|Lost to Follow-up|0|||
161374450|NCT00421148|582761613|FG016|Overall Study|Lost to Follow-up|0|||
161374451|NCT00421148|582761614|FG017|Overall Study|Lost to Follow-up|1|||
161374452|NCT00421148|582761615|FG018|Overall Study|Lost to Follow-up|0|||
161374453|NCT00421148|582761616|FG019|Overall Study|Lost to Follow-up|0|||
161374454|NCT00421148|582761597|FG000|Overall Study|Withdrawal by Subject|0|||
161374455|NCT00421148|582761598|FG001|Overall Study|Withdrawal by Subject|0|||
161374456|NCT00421148|582761599|FG002|Overall Study|Withdrawal by Subject|0|||
161374457|NCT00421148|582761600|FG003|Overall Study|Withdrawal by Subject|0|||
161374458|NCT00421148|582761601|FG004|Overall Study|Withdrawal by Subject|0|||
161374459|NCT00421148|582761602|FG005|Overall Study|Withdrawal by Subject|0|||
161374460|NCT00421148|582761603|FG006|Overall Study|Withdrawal by Subject|0|||
161374461|NCT00421148|582761604|FG007|Overall Study|Withdrawal by Subject|0|||
161374462|NCT00421148|582761605|FG008|Overall Study|Withdrawal by Subject|0|||
161374463|NCT00421148|582761606|FG009|Overall Study|Withdrawal by Subject|0|||
161374464|NCT00421148|582761607|FG010|Overall Study|Withdrawal by Subject|0|||
161374465|NCT00421148|582761608|FG011|Overall Study|Withdrawal by Subject|0|||
161374466|NCT00421148|582761609|FG012|Overall Study|Withdrawal by Subject|0|||
161374467|NCT00421148|582761610|FG013|Overall Study|Withdrawal by Subject|0|||
161374468|NCT00421148|582761611|FG014|Overall Study|Withdrawal by Subject|0|||
161374469|NCT00421148|582761612|FG015|Overall Study|Withdrawal by Subject|0|||
161374470|NCT00421148|582761613|FG016|Overall Study|Withdrawal by Subject|0|||
161374471|NCT00421148|582761614|FG017|Overall Study|Withdrawal by Subject|1|||
161374472|NCT00421148|582761615|FG018|Overall Study|Withdrawal by Subject|0|||
161374473|NCT00421148|582761616|FG019|Overall Study|Withdrawal by Subject|0|||
161374474|NCT00421148|582761597|FG000|Overall Study|Protocol Violation|0|||
161374475|NCT00421148|582761598|FG001|Overall Study|Protocol Violation|0|||
161374476|NCT00421148|582761599|FG002|Overall Study|Protocol Violation|0|||
161374477|NCT00421148|582761600|FG003|Overall Study|Protocol Violation|0|||
161374478|NCT00421148|582761601|FG004|Overall Study|Protocol Violation|0|||
161374479|NCT00421148|582761602|FG005|Overall Study|Protocol Violation|1|||
161374480|NCT00421148|582761603|FG006|Overall Study|Protocol Violation|0|||
161374481|NCT00421148|582761604|FG007|Overall Study|Protocol Violation|0|||
161374482|NCT00421148|582761605|FG008|Overall Study|Protocol Violation|0|||
161374483|NCT00421148|582761606|FG009|Overall Study|Protocol Violation|0|||
161374484|NCT00421148|582761607|FG010|Overall Study|Protocol Violation|0|||
161374485|NCT00421148|582761608|FG011|Overall Study|Protocol Violation|0|||
161374486|NCT00421148|582761609|FG012|Overall Study|Protocol Violation|0|||
161374487|NCT00421148|582761610|FG013|Overall Study|Protocol Violation|0|||
161374488|NCT00421148|582761611|FG014|Overall Study|Protocol Violation|0|||
161374489|NCT00421148|582761612|FG015|Overall Study|Protocol Violation|0|||
161374490|NCT00421148|582761613|FG016|Overall Study|Protocol Violation|0|||
161374491|NCT00421148|582761614|FG017|Overall Study|Protocol Violation|0|||
161374492|NCT00421148|582761615|FG018|Overall Study|Protocol Violation|1|||
161374493|NCT00421148|582761616|FG019|Overall Study|Protocol Violation|0|||
161374494|NCT00570713|582761617|FG000|Overall Study|Adverse Event|16|||
161374495|NCT00570713|582761618|FG001|Overall Study|Adverse Event|9|||
161374496|NCT00570713|582761617|FG000|Overall Study|Death|7|||
161374497|NCT00570713|582761618|FG001|Overall Study|Death|7|||
161374498|NCT00570713|582761617|FG000|Overall Study|Lack of Efficacy|40|||
161374499|NCT00570713|582761618|FG001|Overall Study|Lack of Efficacy|49|||
161374500|NCT00570713|582761617|FG000|Overall Study|Physician Decision|2|||
161374501|NCT00570713|582761618|FG001|Overall Study|Physician Decision|2|||
161374502|NCT00570713|582761617|FG000|Overall Study|Withdrawal by Subject|3|||
161374503|NCT00570713|582761618|FG001|Overall Study|Withdrawal by Subject|3|||
161374504|NCT00570713|582761617|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
161374505|NCT00570713|582761618|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
161374506|NCT00469833|582761619|FG000|Overall Study|No IV access|2|||
161374507|NCT03289533|582761620|FG000|Overall Study|Death|12|||
161374508|NCT03289533|582761620|FG000|Overall Study|Terminated from study by sponsor|10|||
161374509|NCT00539240|582761621|FG000|Overall Study|Withdrawal by Subject|0|||
161374510|NCT00539240|582761622|FG001|Overall Study|Withdrawal by Subject|2|||
161374511|NCT00539240|582761623|FG002|Overall Study|Withdrawal by Subject|0|||
161374512|NCT00539240|582761621|FG000|Overall Study|Protocol Violation|1|||
161374513|NCT00539240|582761622|FG001|Overall Study|Protocol Violation|1|||
161374514|NCT00539240|582761623|FG002|Overall Study|Protocol Violation|4|||
161374515|NCT00539240|582761621|FG000|Overall Study|Lost to Follow-up|2|||
161374516|NCT00539240|582761622|FG001|Overall Study|Lost to Follow-up|3|||
161374517|NCT00539240|582761623|FG002|Overall Study|Lost to Follow-up|1|||
161374518|NCT00539240|582761621|FG000|Overall Study|Adverse Event|3|||
161374519|NCT00539240|582761622|FG001|Overall Study|Adverse Event|1|||
161374520|NCT00539240|582761623|FG002|Overall Study|Adverse Event|10|||
161374521|NCT01284959|582761624|FG000|Overall Study|Withdrawal by Subject|1|||
161374522|NCT01284959|582761625|FG001|Overall Study|Withdrawal by Subject|0|||
161374523|NCT01284959|582761626|FG002|Overall Study|Withdrawal by Subject|0|||
161374524|NCT01284959|582761624|FG000|Overall Study|Adverse Event|0|||
161374525|NCT01284959|582761625|FG001|Overall Study|Adverse Event|0|||
161374526|NCT01284959|582761626|FG002|Overall Study|Adverse Event|1|||
161374527|NCT01055613|582761627|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
161374528|NCT01055613|582761628|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161374529|NCT01055613|582761627|FG000|Overall Study|Unacceptable lens fit|1|||
161374530|NCT01055613|582761628|FG001|Overall Study|Unacceptable lens fit|0|||
161374531|NCT01055613|582761627|FG000|Overall Study|Discomfort|2|||
161374532|NCT01055613|582761628|FG001|Overall Study|Discomfort|1|||
161374533|NCT01055613|582761627|FG000|Overall Study|Lost to Follow-up|1|||
161374534|NCT01055613|582761628|FG001|Overall Study|Lost to Follow-up|1|||
161374535|NCT01055613|582761627|FG000|Overall Study|Protocol Violation|1|||
161374536|NCT01055613|582761628|FG001|Overall Study|Protocol Violation|1|||
161374537|NCT01055613|582761627|FG000|Overall Study|Subject Disinterest|1|||
161374538|NCT01055613|582761628|FG001|Overall Study|Subject Disinterest|1|||
161374539|NCT00363311|582761629|FG000|Overall Study|Adverse Event|6|||
161374540|NCT00363311|582761630|FG001|Overall Study|Adverse Event|4|||
161374541|NCT00363311|582761629|FG000|Overall Study|Lost to Follow-up|3|||
161374542|NCT00363311|582761630|FG001|Overall Study|Lost to Follow-up|0|||
161374543|NCT00363311|582761629|FG000|Overall Study|Protocol Violation|1|||
161374544|NCT00363311|582761630|FG001|Overall Study|Protocol Violation|2|||
161374545|NCT00363311|582761629|FG000|Overall Study|Withdrawal by Subject|12|||
161374546|NCT00363311|582761630|FG001|Overall Study|Withdrawal by Subject|6|||
161374547|NCT00363311|582761629|FG000|Overall Study|Physician Decision|1|||
161374548|NCT00363311|582761630|FG001|Overall Study|Physician Decision|1|||
161374549|NCT00363311|582761629|FG000|Overall Study|Sponsor Terminated Study|2|||
161374550|NCT00363311|582761630|FG001|Overall Study|Sponsor Terminated Study|2|||
161374551|NCT00363311|582761629|FG000|Overall Study|Disease Progression|46|||
161374552|NCT00363311|582761630|FG001|Overall Study|Disease Progression|26|||
161374553|NCT00363311|582761629|FG000|Overall Study|Non-Compliance|1|||
161374554|NCT00363311|582761630|FG001|Overall Study|Non-Compliance|1|||
161374555|NCT00363311|582761629|FG000|Overall Study|Participant Refused Biopsy|1|||
161374556|NCT00363311|582761630|FG001|Overall Study|Participant Refused Biopsy|0|||
161374557|NCT00363311|582761629|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
161374558|NCT00363311|582761630|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
161374559|NCT00363311|582761629|FG000|Overall Study|Participant Opted for Treatment|1|||
161374560|NCT00363311|582761630|FG001|Overall Study|Participant Opted for Treatment|0|||
161374561|NCT00363311|582761629|FG000|Overall Study|Participant Moved to Another Country|1|||
161374562|NCT00363311|582761630|FG001|Overall Study|Participant Moved to Another Country|0|||
161374563|NCT00363311|582761629|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
161374564|NCT00363311|582761630|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
161374565|NCT00363311|582761629|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
161374566|NCT00363311|582761630|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
161374567|NCT00363311|582761629|FG000|Overall Study|Participant Moved to Louisiana|0|||
161374568|NCT00363311|582761630|FG001|Overall Study|Participant Moved to Louisiana|1|||
161374569|NCT00401843|582761631|FG000|Overall Study|Achieved Complete Response|1|||
161374570|NCT00401843|582761632|FG001|Overall Study|Achieved Complete Response|5|||
161374571|NCT00401843|582761633|FG002|Overall Study|Achieved Complete Response|11|||
161374572|NCT00401843|582761631|FG000|Overall Study|Adverse Event|7|||
161374573|NCT00401843|582761632|FG001|Overall Study|Adverse Event|26|||
161374574|NCT00401843|582761633|FG002|Overall Study|Adverse Event|27|||
161374575|NCT00401843|582761631|FG000|Overall Study|Death|0|||
161374576|NCT00401843|582761632|FG001|Overall Study|Death|8|||
161374577|NCT00401843|582761633|FG002|Overall Study|Death|10|||
161374578|NCT00401843|582761631|FG000|Overall Study|Disease progression|10|||
161374579|NCT00401843|582761632|FG001|Overall Study|Disease progression|60|||
161374580|NCT00401843|582761633|FG002|Overall Study|Disease progression|49|||
161374581|NCT00401843|582761631|FG000|Overall Study|End of Study|1|||
161374582|NCT00401843|582761632|FG001|Overall Study|End of Study|1|||
161374583|NCT00401843|582761633|FG002|Overall Study|End of Study|2|||
161374584|NCT00401843|582761631|FG000|Overall Study|Lost to Follow-up|0|||
161374585|NCT00401843|582761632|FG001|Overall Study|Lost to Follow-up|0|||
161374586|NCT00401843|582761633|FG002|Overall Study|Lost to Follow-up|2|||
161374587|NCT00401843|582761631|FG000|Overall Study|Other Unspecified|0|||
161374588|NCT00401843|582761632|FG001|Overall Study|Other Unspecified|3|||
161374589|NCT00401843|582761633|FG002|Overall Study|Other Unspecified|5|||
161374590|NCT00401843|582761631|FG000|Overall Study|Physician Decision|0|||
161374591|NCT00401843|582761632|FG001|Overall Study|Physician Decision|16|||
161374592|NCT00401843|582761633|FG002|Overall Study|Physician Decision|10|||
161374593|NCT00401843|582761631|FG000|Overall Study|Protocol Violation|0|||
161374594|NCT00401843|582761632|FG001|Overall Study|Protocol Violation|0|||
161374595|NCT00401843|582761633|FG002|Overall Study|Protocol Violation|1|||
161374596|NCT00401843|582761631|FG000|Overall Study|Withdrawal by Subject|1|||
161374597|NCT00401843|582761632|FG001|Overall Study|Withdrawal by Subject|5|||
161374598|NCT00401843|582761633|FG002|Overall Study|Withdrawal by Subject|5|||
161374599|NCT00401843|582761631|FG000|Overall Study|Withdrawal of consent to study agent|1|||
161374600|NCT00401843|582761632|FG001|Overall Study|Withdrawal of consent to study agent|15|||
161374601|NCT00401843|582761633|FG002|Overall Study|Withdrawal of consent to study agent|17|||
161374602|NCT00401843|582761631|FG000|Overall Study|Randomized but not Treated|0|||
161374603|NCT00401843|582761632|FG001|Overall Study|Randomized but not Treated|2|||
161374604|NCT00401843|582761633|FG002|Overall Study|Randomized but not Treated|3|||
161374605|NCT00401843|582761631|FG000|Overall Study|Received incorrect treatment|0|||
161374606|NCT00401843|582761632|FG001|Overall Study|Received incorrect treatment|3|||
161374607|NCT00401843|582761633|FG002|Overall Study|Received incorrect treatment|0|||
161374608|NCT04881760|582761636|FG000|Overall Study|Adverse Event|0|||
161374609|NCT04881760|582761637|FG001|Overall Study|Adverse Event|1|||
161374610|NCT04881760|582761638|FG002|Overall Study|Adverse Event|1|||
161374611|NCT04881760|582761639|FG003|Overall Study|Adverse Event|0|||
161374612|NCT04881760|582761640|FG004|Overall Study|Adverse Event|1|||
161374613|NCT04881760|582761641|FG005|Overall Study|Adverse Event|1|||
161374614|NCT04881760|582761642|FG006|Overall Study|Adverse Event|2|||
161374615|NCT04881760|582761636|FG000|Overall Study|Death|0|||
161374616|NCT04881760|582761637|FG001|Overall Study|Death|0|||
161374617|NCT04881760|582761638|FG002|Overall Study|Death|0|||
161374618|NCT04881760|582761639|FG003|Overall Study|Death|1|||
161374619|NCT04881760|582761640|FG004|Overall Study|Death|0|||
161374620|NCT04881760|582761641|FG005|Overall Study|Death|0|||
161374621|NCT04881760|582761642|FG006|Overall Study|Death|0|||
161374622|NCT04881760|582761636|FG000|Overall Study|Lost to Follow-up|5|||
161374623|NCT04881760|582761637|FG001|Overall Study|Lost to Follow-up|7|||
161374624|NCT04881760|582761638|FG002|Overall Study|Lost to Follow-up|5|||
161374625|NCT04881760|582761639|FG003|Overall Study|Lost to Follow-up|1|||
161374626|NCT04881760|582761640|FG004|Overall Study|Lost to Follow-up|2|||
161374627|NCT04881760|582761641|FG005|Overall Study|Lost to Follow-up|4|||
161374628|NCT04881760|582761642|FG006|Overall Study|Lost to Follow-up|4|||
161374629|NCT04881760|582761636|FG000|Overall Study|Withdrawal by Subject|13|||
161374630|NCT04881760|582761637|FG001|Overall Study|Withdrawal by Subject|1|||
161374631|NCT04881760|582761638|FG002|Overall Study|Withdrawal by Subject|1|||
161374632|NCT04881760|582761639|FG003|Overall Study|Withdrawal by Subject|4|||
161374633|NCT04881760|582761640|FG004|Overall Study|Withdrawal by Subject|2|||
161374634|NCT04881760|582761641|FG005|Overall Study|Withdrawal by Subject|1|||
161374635|NCT04881760|582761642|FG006|Overall Study|Withdrawal by Subject|2|||
161374636|NCT04881760|582761636|FG000|Overall Study|Randomized but Never Treated|0|||
161374637|NCT04881760|582761637|FG001|Overall Study|Randomized but Never Treated|0|||
161374638|NCT04881760|582761638|FG002|Overall Study|Randomized but Never Treated|0|||
161374639|NCT04881760|582761639|FG003|Overall Study|Randomized but Never Treated|1|||
161374640|NCT04881760|582761640|FG004|Overall Study|Randomized but Never Treated|0|||
161374641|NCT04881760|582761641|FG005|Overall Study|Randomized but Never Treated|0|||
161374642|NCT04881760|582761642|FG006|Overall Study|Randomized but Never Treated|0|||
161374643|NCT04881760|582761636|FG000|Overall Study|Inadvertent Enrollment|2|||
161374644|NCT04881760|582761637|FG001|Overall Study|Inadvertent Enrollment|0|||
161374645|NCT04881760|582761638|FG002|Overall Study|Inadvertent Enrollment|0|||
161374646|NCT04881760|582761639|FG003|Overall Study|Inadvertent Enrollment|0|||
161374647|NCT04881760|582761640|FG004|Overall Study|Inadvertent Enrollment|0|||
161374648|NCT04881760|582761641|FG005|Overall Study|Inadvertent Enrollment|0|||
161374649|NCT04881760|582761642|FG006|Overall Study|Inadvertent Enrollment|0|||
161374650|NCT04881760|582761636|FG000|Overall Study|Site Closure|0|||
161374651|NCT04881760|582761637|FG001|Overall Study|Site Closure|0|||
161374652|NCT04881760|582761638|FG002|Overall Study|Site Closure|0|||
161374653|NCT04881760|582761639|FG003|Overall Study|Site Closure|1|||
161374654|NCT04881760|582761640|FG004|Overall Study|Site Closure|0|||
161374655|NCT04881760|582761641|FG005|Overall Study|Site Closure|0|||
161374656|NCT04881760|582761642|FG006|Overall Study|Site Closure|0|||
161374657|NCT01182298|582761643|FG000|Overall Study|Lack of Efficacy|4|||
161374658|NCT01182298|582761643|FG000|Overall Study|Withdrawal by Subject|2|||
161374659|NCT01595529|582761644|FG000|Overall Study|Adverse Event|2|||
161374660|NCT01595529|582761645|FG001|Overall Study|Adverse Event|0|||
161374661|NCT01595529|582761644|FG000|Overall Study|Subject Non-Compliant|2|||
161374662|NCT01595529|582761645|FG001|Overall Study|Subject Non-Compliant|0|||
161374663|NCT01595529|582761644|FG000|Overall Study|Lost to Follow-up|8|||
161374664|NCT01595529|582761645|FG001|Overall Study|Lost to Follow-up|14|||
161374665|NCT01595529|582761644|FG000|Overall Study|Protocol Violation|1|||
161374666|NCT01595529|582761645|FG001|Overall Study|Protocol Violation|2|||
161374667|NCT01595529|582761644|FG000|Overall Study|Physician Decision|1|||
161374668|NCT01595529|582761645|FG001|Overall Study|Physician Decision|0|||
161374669|NCT01595529|582761644|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
161374670|NCT01595529|582761645|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
161374671|NCT01595529|582761644|FG000|Overall Study|Administrative Decision|1|||
161374672|NCT01595529|582761645|FG001|Overall Study|Administrative Decision|0|||
161374673|NCT01595529|582761644|FG000|Overall Study|Entry Failure/Screening Failure|6|||
161374674|NCT01595529|582761645|FG001|Overall Study|Entry Failure/Screening Failure|1|||
161374675|NCT01508910|582761646|FG000|Treatment|Death|2|||
161374676|NCT01508910|582761647|FG001|Treatment|Death|3|||
161374677|NCT01508910|582761648|FG002|Treatment|Death|2|||
161374678|NCT01508910|582761649|FG003|Treatment|Death|0|||
161374679|NCT01508910|582761646|FG000|Treatment|Lost to Follow-up|0|||
161374680|NCT01508910|582761647|FG001|Treatment|Lost to Follow-up|0|||
161374681|NCT01508910|582761648|FG002|Treatment|Lost to Follow-up|2|||
161374682|NCT01508910|582761649|FG003|Treatment|Lost to Follow-up|1|||
161374683|NCT01508910|582761646|FG000|Treatment|Withdrawal by Subject|0|||
161374684|NCT01508910|582761647|FG001|Treatment|Withdrawal by Subject|1|||
161374685|NCT01508910|582761648|FG002|Treatment|Withdrawal by Subject|6|||
161374686|NCT01508910|582761649|FG003|Treatment|Withdrawal by Subject|1|||
161374687|NCT01508910|582761646|FG000|Treatment|Sponsor Decision|0|||
161374688|NCT01508910|582761647|FG001|Treatment|Sponsor Decision|0|||
161374689|NCT01508910|582761648|FG002|Treatment|Sponsor Decision|0|||
161374690|NCT01508910|582761649|FG003|Treatment|Sponsor Decision|1|||
161374691|NCT04016714|582761650|FG000|Overall Study|Death|1|||
161374692|NCT04016714|582761651|FG001|Overall Study|Death|0|||
161374693|NCT04016714|582761650|FG000|Overall Study|Lost to Follow-up|3|||
161374694|NCT04016714|582761651|FG001|Overall Study|Lost to Follow-up|1|||
161374695|NCT04016714|582761650|FG000|Overall Study|Physician Decision|3|||
161374696|NCT04016714|582761651|FG001|Overall Study|Physician Decision|3|||
161374697|NCT04016714|582761650|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
161374698|NCT04016714|582761651|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
161374699|NCT01677988|582761657|FG000|Overall Study|Lack of Efficacy|2|||
161374700|NCT02629861|582761662|FG000|Overall Study|Adverse Event|7|||
161374701|NCT02629861|582761663|FG001|Overall Study|Adverse Event|5|||
161374702|NCT02629861|582761664|FG002|Overall Study|Adverse Event|4|||
161374703|NCT02629861|582761662|FG000|Overall Study|Withdrawal by Subject|5|||
161374704|NCT02629861|582761663|FG001|Overall Study|Withdrawal by Subject|8|||
161374705|NCT02629861|582761664|FG002|Overall Study|Withdrawal by Subject|13|||
161374706|NCT02629861|582761662|FG000|Overall Study|Protocol Violation|2|||
161374707|NCT02629861|582761663|FG001|Overall Study|Protocol Violation|3|||
161374708|NCT02629861|582761664|FG002|Overall Study|Protocol Violation|7|||
161374709|NCT02629861|582761662|FG000|Overall Study|Lost to Follow-up|12|||
161374710|NCT02629861|582761663|FG001|Overall Study|Lost to Follow-up|9|||
161374711|NCT02629861|582761664|FG002|Overall Study|Lost to Follow-up|4|||
161374712|NCT02629861|582761662|FG000|Overall Study|Other|1|||
161374713|NCT02629861|582761663|FG001|Overall Study|Other|1|||
161374714|NCT02629861|582761664|FG002|Overall Study|Other|0|||
161374715|NCT02629861|582761662|FG000|Overall Study|Pregnancy|2|||
161374716|NCT02629861|582761663|FG001|Overall Study|Pregnancy|1|||
161374717|NCT02629861|582761664|FG002|Overall Study|Pregnancy|0|||
161374718|NCT01822665|582761665|FG000|Overall Study|Adverse Event|3|||
161374719|NCT01822665|582761665|FG000|Overall Study|Other Reason|5|||
161374720|NCT00165789|582761672|FG000|Overall Study|Adverse Event|0|||
161374721|NCT00165789|582761673|FG001|Overall Study|Adverse Event|3|||
161374722|NCT00165789|582761674|FG002|Overall Study|Adverse Event|0|||
161374723|NCT00165789|582761675|FG003|Overall Study|Adverse Event|12|||
161374724|NCT00165789|582761672|FG000|Overall Study|Withdrawal by Subject|0|||
161374725|NCT00165789|582761673|FG001|Overall Study|Withdrawal by Subject|1|||
161374726|NCT00165789|582761674|FG002|Overall Study|Withdrawal by Subject|1|||
161374727|NCT00165789|582761675|FG003|Overall Study|Withdrawal by Subject|2|||
161374728|NCT02031302|582761676|FG000|Overall Study|Death|115|||
161374729|NCT02031302|582761677|FG001|Overall Study|Death|0|||
161374730|NCT02031302|582761676|FG000|Overall Study|Not treated with study valve system|18|||
161374731|NCT02031302|582761677|FG001|Overall Study|Not treated with study valve system|0|||
161374732|NCT02031302|582761676|FG000|Overall Study|Missed Follow Up|27|||
161374733|NCT02031302|582761677|FG001|Overall Study|Missed Follow Up|0|||
161374734|NCT02031302|582761676|FG000|Overall Study|Lost to Follow-up|4|||
161374735|NCT02031302|582761677|FG001|Overall Study|Lost to Follow-up|0|||
161374736|NCT01847443|582761678|FG000|Study Period 1|Withdrawal by Subject|0|||
161374737|NCT01847443|582761679|FG001|Study Period 1|Withdrawal by Subject|1|||
161374738|NCT01847443|582761680|FG002|Study Period 1|Withdrawal by Subject|0|||
161374739|NCT01847443|582761681|FG003|Study Period 1|Withdrawal by Subject|0|||
161374740|NCT01847443|582761678|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
161374741|NCT01847443|582761679|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
161374742|NCT01847443|582761680|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
161374743|NCT01847443|582761681|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
161374744|NCT01847443|582761678|FG000|Washout Period Before Study Period 2|Other reason|1|||
161374745|NCT01847443|582761679|FG001|Washout Period Before Study Period 2|Other reason|0|||
161374746|NCT01847443|582761680|FG002|Washout Period Before Study Period 2|Other reason|0|||
161374747|NCT01847443|582761681|FG003|Washout Period Before Study Period 2|Other reason|0|||
161374748|NCT01847443|582761678|FG000|Washout Period Before Study Period 3|Other reason|1|||
161374749|NCT01847443|582761679|FG001|Washout Period Before Study Period 3|Other reason|0|||
161374750|NCT01847443|582761680|FG002|Washout Period Before Study Period 3|Other reason|0|||
161374751|NCT01847443|582761681|FG003|Washout Period Before Study Period 3|Other reason|0|||
161374752|NCT01847443|582761678|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
161374753|NCT01847443|582761679|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
161374754|NCT01847443|582761680|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
161374755|NCT01847443|582761681|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
161374756|NCT01847443|582761678|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
161374757|NCT01847443|582761679|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
161374758|NCT01847443|582761680|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
161374759|NCT01847443|582761681|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
161374760|NCT05076045|582761684|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
161374761|NCT05076045|582761685|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
161374762|NCT04592341|582764150|FG000|Overall Study|Physician Decision|5|||
161374763|NCT04592341|582764150|FG000|Overall Study|Study Terminated by Sponsor|5|||
161374764|NCT04592341|582764150|FG000|Overall Study|Withdrawal by Subject|53|||
161374765|NCT04592341|582764150|FG000|Overall Study|Lost to Follow-up|3|||
161374766|NCT04592341|582764150|FG000|Overall Study|Death|1|||
161374767|NCT04592341|582764150|FG000|Overall Study|Adverse Event|5|||
161374768|NCT04592341|582764150|FG000|Overall Study|other|4|||
161374769|NCT02896257|582764151|FG000|Providers|Without eligible patients|21|||
161374770|NCT02896257|582764152|FG001|Providers|Without eligible patients|28|||
161374771|NCT02896257|582764151|FG000|Patients|PFT entry criteria not met|43|||
161374772|NCT02896257|582764152|FG001|Patients|PFT entry criteria not met|50|||
161374773|NCT02896257|582764151|FG000|Patients|No capacity to review|8|||
161374774|NCT02896257|582764152|FG001|Patients|No capacity to review|11|||
161374775|NCT02896257|582764151|FG000|Patients|Appointment rescheduled/cancelled|5|||
161374776|NCT02896257|582764152|FG001|Patients|Appointment rescheduled/cancelled|7|||
161374777|NCT02896257|582764151|FG000|Patients|PCP not assigned a clinic|4|||
161374778|NCT02896257|582764152|FG001|Patients|PCP not assigned a clinic|0|||
161374779|NCT02896257|582764151|FG000|Patients|No history of COPD|0|||
161374780|NCT02896257|582764152|FG001|Patients|No history of COPD|1|||
161374781|NCT02896257|582764151|FG000|Patients|Deceased between review and index date|0|||
161374782|NCT02896257|582764152|FG001|Patients|Deceased between review and index date|1|||
161374783|NCT02896257|582764151|FG000|Patients|No ICS Rx upon review|1|||
161374784|NCT02896257|582764152|FG001|Patients|No ICS Rx upon review|1|||
161374785|NCT02896257|582764151|FG000|Patients|Protocol Violation|2|||
161374786|NCT02896257|582764152|FG001|Patients|Protocol Violation|1|||
161374787|NCT02896257|582764151|FG000|Patients|Hospice care|0|||
161374788|NCT02896257|582764152|FG001|Patients|Hospice care|1|||
161374789|NCT03759600|582764153|FG000|Overall Study|Adverse Event|2|||
161374790|NCT03759600|582764153|FG000|Overall Study|Progressive Disease|15|||
161374791|NCT03759600|582764153|FG000|Overall Study|Site Terminated by Sponsor|3|||
161374792|NCT00692003|582764155|FG000|Overall Study|Sponsor Decision|5|||
161374793|NCT00692003|582764156|FG001|Overall Study|Sponsor Decision|1|||
161374794|NCT03257358|582764157|FG000|Overall Study|Adverse Event|25|||
161374795|NCT03257358|582764158|FG001|Overall Study|Adverse Event|12|||
161374796|NCT03257358|582764157|FG000|Overall Study|Lack of Efficacy|1|||
161374797|NCT03257358|582764158|FG001|Overall Study|Lack of Efficacy|1|||
161374798|NCT03257358|582764157|FG000|Overall Study|Lost to Follow-up|12|||
161374799|NCT03257358|582764158|FG001|Overall Study|Lost to Follow-up|4|||
161374800|NCT03257358|582764157|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
161374801|NCT03257358|582764158|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
161374802|NCT03257358|582764157|FG000|Overall Study|Physician Decision|2|||
161374803|NCT03257358|582764158|FG001|Overall Study|Physician Decision|2|||
161374804|NCT03257358|582764157|FG000|Overall Study|Protocol Violation|5|||
161374805|NCT03257358|582764158|FG001|Overall Study|Protocol Violation|3|||
161374806|NCT03257358|582764157|FG000|Overall Study|Technical problems|4|||
161374807|NCT03257358|582764158|FG001|Overall Study|Technical problems|1|||
161374808|NCT03257358|582764157|FG000|Overall Study|Withdrawal by Subject|8|||
161374809|NCT03257358|582764158|FG001|Overall Study|Withdrawal by Subject|3|||
161374810|NCT03257358|582764157|FG000|Overall Study|Withdrawal of informed consent|9|||
161374811|NCT03257358|582764158|FG001|Overall Study|Withdrawal of informed consent|5|||
161374812|NCT03257358|582764157|FG000|Overall Study|New therapy for study indication|1|||
161374813|NCT03257358|582764158|FG001|Overall Study|New therapy for study indication|0|||
161374814|NCT03257358|582764157|FG000|Overall Study|No longer requires treatment|0|||
161374815|NCT03257358|582764158|FG001|Overall Study|No longer requires treatment|1|||
161374816|NCT02852967|582764159|FG000|Overall Study|Adverse Event|3|||
161374817|NCT02852967|582764160|FG001|Overall Study|Adverse Event|1|||
161374818|NCT02852967|582764161|FG002|Overall Study|Adverse Event|0|||
161374819|NCT02852967|582764162|FG003|Overall Study|Adverse Event|1|||
161374820|NCT02852967|582764163|FG004|Overall Study|Adverse Event|0|||
161374821|NCT02852967|582764159|FG000|Overall Study|Death|1|||
161374822|NCT02852967|582764160|FG001|Overall Study|Death|0|||
161374823|NCT02852967|582764161|FG002|Overall Study|Death|0|||
161374824|NCT02852967|582764162|FG003|Overall Study|Death|0|||
161374825|NCT02852967|582764163|FG004|Overall Study|Death|0|||
161374826|NCT02852967|582764159|FG000|Overall Study|Lost to Follow-up|1|||
161374827|NCT02852967|582764160|FG001|Overall Study|Lost to Follow-up|2|||
161374828|NCT02852967|582764161|FG002|Overall Study|Lost to Follow-up|3|||
161374829|NCT02852967|582764162|FG003|Overall Study|Lost to Follow-up|4|||
161374830|NCT02852967|582764163|FG004|Overall Study|Lost to Follow-up|4|||
161374831|NCT02852967|582764159|FG000|Overall Study|Withdrawal by Subject|6|||
161374832|NCT02852967|582764160|FG001|Overall Study|Withdrawal by Subject|12|||
161374833|NCT02852967|582764161|FG002|Overall Study|Withdrawal by Subject|7|||
161374834|NCT02852967|582764162|FG003|Overall Study|Withdrawal by Subject|10|||
161374835|NCT02852967|582764163|FG004|Overall Study|Withdrawal by Subject|10|||
161374836|NCT02852967|582764159|FG000|Overall Study|SAE|0|||
161374837|NCT02852967|582764160|FG001|Overall Study|SAE|0|||
161374838|NCT02852967|582764161|FG002|Overall Study|SAE|0|||
161374839|NCT02852967|582764162|FG003|Overall Study|SAE|3|||
161374840|NCT02852967|582764163|FG004|Overall Study|SAE|0|||
161374841|NCT02852967|582764159|FG000|Overall Study|Elevated Liver Enzymes|2|||
161374842|NCT02852967|582764160|FG001|Overall Study|Elevated Liver Enzymes|0|||
161374843|NCT02852967|582764161|FG002|Overall Study|Elevated Liver Enzymes|0|||
161374844|NCT02852967|582764162|FG003|Overall Study|Elevated Liver Enzymes|2|||
161374845|NCT02852967|582764163|FG004|Overall Study|Elevated Liver Enzymes|2|||
161374846|NCT02852967|582764159|FG000|Overall Study|Physician Decision|0|||
161374847|NCT02852967|582764160|FG001|Overall Study|Physician Decision|0|||
161374848|NCT02852967|582764161|FG002|Overall Study|Physician Decision|0|||
161374849|NCT02852967|582764162|FG003|Overall Study|Physician Decision|1|||
161374850|NCT02852967|582764163|FG004|Overall Study|Physician Decision|0|||
161374851|NCT02852967|582764159|FG000|Overall Study|Lack of Efficacy|0|||
161374852|NCT02852967|582764160|FG001|Overall Study|Lack of Efficacy|1|||
161374853|NCT02852967|582764161|FG002|Overall Study|Lack of Efficacy|0|||
161374854|NCT02852967|582764162|FG003|Overall Study|Lack of Efficacy|0|||
161374855|NCT02852967|582764163|FG004|Overall Study|Lack of Efficacy|0|||
161374856|NCT02852967|582764159|FG000|Overall Study|Non-compliance|0|||
161374857|NCT02852967|582764160|FG001|Overall Study|Non-compliance|0|||
161374858|NCT02852967|582764161|FG002|Overall Study|Non-compliance|1|||
161374859|NCT02852967|582764162|FG003|Overall Study|Non-compliance|1|||
161374860|NCT02852967|582764163|FG004|Overall Study|Non-compliance|0|||
161374861|NCT02852967|582764159|FG000|Overall Study|Dispensing Drug Violation|0|||
161374862|NCT02852967|582764160|FG001|Overall Study|Dispensing Drug Violation|0|||
161374863|NCT02852967|582764161|FG002|Overall Study|Dispensing Drug Violation|1|||
161374864|NCT02852967|582764162|FG003|Overall Study|Dispensing Drug Violation|0|||
161374865|NCT02852967|582764163|FG004|Overall Study|Dispensing Drug Violation|0|||
161374866|NCT02852967|582764159|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
161374867|NCT02852967|582764160|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
161374868|NCT02852967|582764161|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
161374869|NCT02852967|582764162|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
161374870|NCT02852967|582764163|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
161374871|NCT00339040|582764170|FG000|Stage I|Not able to attend clinic|1|||
161374872|NCT00339040|582764171|FG001|Stage I|Not able to attend clinic|0|||
161374873|NCT00339040|582764170|FG000|Stage I|Protocol Violation|1|||
161374874|NCT00339040|582764171|FG001|Stage I|Protocol Violation|1|||
161374875|NCT00339040|582764170|FG000|Stage II|Lost to Follow-up|3|||
161374876|NCT00339040|582764171|FG001|Stage II|Lost to Follow-up|0|||
161374877|NCT00339040|582764170|FG000|Stage II|Withdrawal by Subject|1|||
161374878|NCT00339040|582764171|FG001|Stage II|Withdrawal by Subject|2|||
161374879|NCT00339040|582764170|FG000|Stage II|Protocol Violation|3|||
161374880|NCT00339040|582764171|FG001|Stage II|Protocol Violation|0|||
161374881|NCT00339040|582764170|FG000|Stage II|Not able to attend clinic|1|||
161374882|NCT00339040|582764171|FG001|Stage II|Not able to attend clinic|0|||
161374883|NCT00339040|582764170|FG000|Stage II|Site closing|2|||
161374884|NCT00339040|582764171|FG001|Stage II|Site closing|0|||
161374885|NCT01747915|582764172|FG000|Overall Study|Other|1|||
161374886|NCT01747915|582764173|FG001|Overall Study|Other|1|||
161374887|NCT01747915|582764174|FG002|Overall Study|Other|1|||
161374888|NCT01747915|582764172|FG000|Overall Study|Adverse Event|8|||
161374889|NCT01747915|582764173|FG001|Overall Study|Adverse Event|5|||
161374890|NCT01747915|582764174|FG002|Overall Study|Adverse Event|2|||
161374891|NCT01747915|582764172|FG000|Overall Study|Death|0|||
161374892|NCT01747915|582764173|FG001|Overall Study|Death|0|||
161374893|NCT01747915|582764174|FG002|Overall Study|Death|1|||
161374894|NCT01747915|582764172|FG000|Overall Study|Lack of Efficacy|0|||
161374895|NCT01747915|582764173|FG001|Overall Study|Lack of Efficacy|1|||
161374896|NCT01747915|582764174|FG002|Overall Study|Lack of Efficacy|0|||
161374897|NCT01747915|582764172|FG000|Overall Study|Lost to Follow-up|1|||
161374898|NCT01747915|582764173|FG001|Overall Study|Lost to Follow-up|0|||
161374899|NCT01747915|582764174|FG002|Overall Study|Lost to Follow-up|0|||
161374900|NCT01747915|582764172|FG000|Overall Study|Withdrawal by Subject|4|||
161374901|NCT01747915|582764173|FG001|Overall Study|Withdrawal by Subject|4|||
161374902|NCT01747915|582764174|FG002|Overall Study|Withdrawal by Subject|1|||
161374903|NCT01747915|582764172|FG000|Overall Study|Protocol Violation|1|||
161374904|NCT01747915|582764173|FG001|Overall Study|Protocol Violation|0|||
161374905|NCT01747915|582764174|FG002|Overall Study|Protocol Violation|0|||
161374906|NCT01747915|582764172|FG000|Overall Study|Pregnancy|0|||
161374907|NCT01747915|582764173|FG001|Overall Study|Pregnancy|0|||
161374908|NCT01747915|582764174|FG002|Overall Study|Pregnancy|1|||
161374909|NCT03341637|582764175|FG000|Overall Study|Lost to Follow-up|1|||
161374910|NCT03341637|582764176|FG001|Overall Study|Lost to Follow-up|0|||
161374911|NCT03341637|582764175|FG000|Overall Study|Withdrawal by Subject|3|||
161374912|NCT03341637|582764176|FG001|Overall Study|Withdrawal by Subject|3|||
161374913|NCT03341637|582764175|FG000|Overall Study|Reason not Specified|1|||
161374914|NCT03341637|582764176|FG001|Overall Study|Reason not Specified|1|||
161374915|NCT00812955|582764177|FG000|Overall Study|Adverse Event|7|||
161374916|NCT00812955|582764178|FG001|Overall Study|Adverse Event|6|||
161374917|NCT00812955|582764179|FG002|Overall Study|Adverse Event|3|||
161374918|NCT00812955|582764180|FG003|Overall Study|Adverse Event|4|||
161374919|NCT00812955|582764177|FG000|Overall Study|Lost to Follow-up|2|||
161374920|NCT00812955|582764178|FG001|Overall Study|Lost to Follow-up|1|||
161374921|NCT00812955|582764179|FG002|Overall Study|Lost to Follow-up|1|||
161374922|NCT00812955|582764180|FG003|Overall Study|Lost to Follow-up|2|||
161374923|NCT00812955|582764177|FG000|Overall Study|Withdrawal by Subject|1|||
161374924|NCT00812955|582764178|FG001|Overall Study|Withdrawal by Subject|0|||
161374925|NCT00812955|582764179|FG002|Overall Study|Withdrawal by Subject|1|||
161374926|NCT00812955|582764180|FG003|Overall Study|Withdrawal by Subject|2|||
161374927|NCT00812955|582764177|FG000|Overall Study|randomized in error|0|||
161374928|NCT00812955|582764178|FG001|Overall Study|randomized in error|0|||
161374929|NCT00812955|582764179|FG002|Overall Study|randomized in error|1|||
161374930|NCT00812955|582764180|FG003|Overall Study|randomized in error|0|||
161374931|NCT03046446|582764181|FG000|Overall Study|Lack of Efficacy|7|||
161374932|NCT03046446|582764181|FG000|Overall Study|Adverse Event|6|||
161374933|NCT03046446|582764181|FG000|Overall Study|Lost to Follow-up|3|||
161374934|NCT03046446|582764181|FG000|Overall Study|Withdrawal by Subject|14|||
161374935|NCT03046446|582764181|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
161374936|NCT03046446|582764181|FG000|Overall Study|Disease Progression (see caveats)|25|||
161374937|NCT03046446|582764181|FG000|Overall Study|Non OA related knee surgery|1|||
161374938|NCT03183063|582764182|FG000|Overall Study|Withdrawal by Subject|2|||
161374939|NCT03183063|582764183|FG001|Overall Study|Withdrawal by Subject|0|||
161374940|NCT03183063|582764184|FG002|Overall Study|Withdrawal by Subject|0|||
161374941|NCT03183063|582764182|FG000|Overall Study|Physician Decision|3|||
161374942|NCT03183063|582764183|FG001|Overall Study|Physician Decision|4|||
161374943|NCT03183063|582764184|FG002|Overall Study|Physician Decision|4|||
161374944|NCT00399568|582764185|FG000|Overall Study|Adverse Event|1|||
161374945|NCT00399568|582764186|FG001|Overall Study|Adverse Event|2|||
161374946|NCT00399568|582764185|FG000|Overall Study|Withdrawal by Subject|7|||
161374947|NCT00399568|582764186|FG001|Overall Study|Withdrawal by Subject|3|||
161374948|NCT00399568|582764185|FG000|Overall Study|Protocol non-compliance|2|||
161374949|NCT00399568|582764186|FG001|Overall Study|Protocol non-compliance|2|||
161374950|NCT00399568|582764185|FG000|Overall Study|Lost to Follow-up|2|||
161374951|NCT00399568|582764186|FG001|Overall Study|Lost to Follow-up|2|||
161374952|NCT00925002|582764187|FG000|Overall Study|Other|1|||
161374953|NCT00925002|582764188|FG001|Overall Study|Other|4|||
161374954|NCT00925002|582764189|FG002|Overall Study|Other|0|||
161374955|NCT00925002|582764187|FG000|Overall Study|Death|1|||
161374956|NCT00925002|582764188|FG001|Overall Study|Death|1|||
161374957|NCT00925002|582764189|FG002|Overall Study|Death|5|||
161374958|NCT00925002|582764187|FG000|Overall Study|Adverse Event|3|||
161374959|NCT00925002|582764188|FG001|Overall Study|Adverse Event|1|||
161374960|NCT00925002|582764189|FG002|Overall Study|Adverse Event|2|||
161374961|NCT00925002|582764187|FG000|Overall Study|Participant withdrew consent|1|||
161374962|NCT00925002|582764188|FG001|Overall Study|Participant withdrew consent|3|||
161374963|NCT00925002|582764189|FG002|Overall Study|Participant withdrew consent|3|||
161374964|NCT02071771|582764199|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
161374965|NCT02071771|582764200|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
161374966|NCT02071771|582764199|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
161374967|NCT02071771|582764200|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
161374968|NCT02078752|582764201|FG000|Overall Study|Death|0|||
161374969|NCT02078752|582764202|FG001|Overall Study|Death|3|||
161374970|NCT02078752|582764203|FG002|Overall Study|Death|0|||
161374971|NCT02078752|582764204|FG003|Overall Study|Death|0|||
161374972|NCT02078752|582764205|FG004|Overall Study|Death|0|||
161374973|NCT02078752|582764206|FG005|Overall Study|Death|1|||
161374974|NCT02078752|582764207|FG006|Overall Study|Death|0|||
161374975|NCT02078752|582764208|FG007|Overall Study|Death|1|||
161374976|NCT02078752|582764209|FG008|Overall Study|Death|0|||
161374977|NCT02078752|582764210|FG009|Overall Study|Death|4|||
161374978|NCT02078752|582764201|FG000|Overall Study|Lost to Follow-up|1|||
161374979|NCT02078752|582764202|FG001|Overall Study|Lost to Follow-up|0|||
161374980|NCT02078752|582764203|FG002|Overall Study|Lost to Follow-up|0|||
161374981|NCT02078752|582764204|FG003|Overall Study|Lost to Follow-up|1|||
161374982|NCT02078752|582764205|FG004|Overall Study|Lost to Follow-up|0|||
161374983|NCT02078752|582764206|FG005|Overall Study|Lost to Follow-up|0|||
161374984|NCT02078752|582764207|FG006|Overall Study|Lost to Follow-up|0|||
161374985|NCT02078752|582764208|FG007|Overall Study|Lost to Follow-up|0|||
161374986|NCT02078752|582764209|FG008|Overall Study|Lost to Follow-up|0|||
161374987|NCT02078752|582764210|FG009|Overall Study|Lost to Follow-up|0|||
161374988|NCT02078752|582764201|FG000|Overall Study|Withdrawal by Subject|1|||
161374989|NCT02078752|582764202|FG001|Overall Study|Withdrawal by Subject|1|||
161374990|NCT02078752|582764203|FG002|Overall Study|Withdrawal by Subject|1|||
161374991|NCT02078752|582764204|FG003|Overall Study|Withdrawal by Subject|1|||
161374992|NCT02078752|582764205|FG004|Overall Study|Withdrawal by Subject|0|||
161374993|NCT02078752|582764206|FG005|Overall Study|Withdrawal by Subject|3|||
161374994|NCT02078752|582764207|FG006|Overall Study|Withdrawal by Subject|2|||
161374995|NCT02078752|582764208|FG007|Overall Study|Withdrawal by Subject|1|||
161374996|NCT02078752|582764209|FG008|Overall Study|Withdrawal by Subject|0|||
161374997|NCT02078752|582764210|FG009|Overall Study|Withdrawal by Subject|1|||
161374998|NCT02078752|582764201|FG000|Overall Study|Other|0|||
161374999|NCT02078752|582764202|FG001|Overall Study|Other|3|||
161375000|NCT02078752|582764203|FG002|Overall Study|Other|0|||
161375001|NCT02078752|582764204|FG003|Overall Study|Other|0|||
161375002|NCT02078752|582764205|FG004|Overall Study|Other|1|||
161375003|NCT02078752|582764206|FG005|Overall Study|Other|0|||
161375004|NCT02078752|582764207|FG006|Overall Study|Other|0|||
161375005|NCT02078752|582764208|FG007|Overall Study|Other|1|||
161375006|NCT02078752|582764209|FG008|Overall Study|Other|0|||
161375007|NCT02078752|582764210|FG009|Overall Study|Other|0|||
161375008|NCT02078752|582764201|FG000|Overall Study|Study terminated by sponsor|0|||
161375009|NCT02078752|582764202|FG001|Overall Study|Study terminated by sponsor|0|||
161375010|NCT02078752|582764203|FG002|Overall Study|Study terminated by sponsor|0|||
161375011|NCT02078752|582764204|FG003|Overall Study|Study terminated by sponsor|0|||
161375012|NCT02078752|582764205|FG004|Overall Study|Study terminated by sponsor|0|||
161375013|NCT02078752|582764206|FG005|Overall Study|Study terminated by sponsor|0|||
161375014|NCT02078752|582764207|FG006|Overall Study|Study terminated by sponsor|0|||
161375015|NCT02078752|582764208|FG007|Overall Study|Study terminated by sponsor|0|||
161375016|NCT02078752|582764209|FG008|Overall Study|Study terminated by sponsor|0|||
161375017|NCT02078752|582764210|FG009|Overall Study|Study terminated by sponsor|5|||
161375018|NCT01567722|582764219|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
161375019|NCT01567722|582764220|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
161375020|NCT01567722|582764221|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
161375021|NCT01567722|582764219|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
161375022|NCT01567722|582764220|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
161375023|NCT01567722|582764221|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
161375024|NCT01567722|582764219|FG000|Overall Study|Protocol closure by the OCG|2|||
161375025|NCT01567722|582764220|FG001|Overall Study|Protocol closure by the OCG|0|||
161375026|NCT01567722|582764221|FG002|Overall Study|Protocol closure by the OCG|0|||
161375027|NCT01567722|582764219|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
161375028|NCT01567722|582764220|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
161375029|NCT01567722|582764221|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
161375030|NCT00382174|582764222|FG000|Overall Study|Lost to Follow-up|1|||
161375031|NCT00382174|582764223|FG001|Overall Study|Lost to Follow-up|4|||
161375032|NCT00382174|582764224|FG002|Overall Study|Lost to Follow-up|5|||
161375033|NCT00382174|582764222|FG000|Overall Study|Adverse Event|1|||
161375034|NCT00382174|582764223|FG001|Overall Study|Adverse Event|4|||
161375035|NCT00382174|582764224|FG002|Overall Study|Adverse Event|5|||
161375036|NCT00382174|582764222|FG000|Overall Study|Withdrawal by Subject|1|||
161375037|NCT00382174|582764223|FG001|Overall Study|Withdrawal by Subject|4|||
161375038|NCT00382174|582764224|FG002|Overall Study|Withdrawal by Subject|5|||
161375039|NCT00382174|582764222|FG000|Overall Study|Non compliance|1|||
161375040|NCT00382174|582764223|FG001|Overall Study|Non compliance|0|||
161375041|NCT00382174|582764224|FG002|Overall Study|Non compliance|1|||
161375042|NCT00382174|582764222|FG000|Overall Study|Physician Decision|0|||
161375043|NCT00382174|582764223|FG001|Overall Study|Physician Decision|2|||
161375044|NCT00382174|582764224|FG002|Overall Study|Physician Decision|2|||
161375045|NCT00382174|582764222|FG000|Overall Study|Failed to meet criteria|0|||
161375046|NCT00382174|582764223|FG001|Overall Study|Failed to meet criteria|1|||
161375047|NCT00382174|582764224|FG002|Overall Study|Failed to meet criteria|1|||
161375048|NCT00382174|582764222|FG000|Overall Study|Wounds merged|0|||
161375049|NCT00382174|582764223|FG001|Overall Study|Wounds merged|2|||
161375050|NCT00382174|582764224|FG002|Overall Study|Wounds merged|2|||
161375051|NCT01464879|582764225|FG000|Overall Study|Physician Decision|1|||
161375052|NCT01464879|582764225|FG000|Overall Study|Non-compliance|1|||
161375053|NCT01657305|582764227|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
161375054|NCT01657305|582764227|FG000|Overall Study|Withdrawal by Subject|4|||
161375055|NCT01657305|582764227|FG000|Overall Study|Adverse Event|1|||
161375056|NCT01657305|582764227|FG000|Overall Study|Lost to Follow-up|1|||
161375057|NCT01657305|582764227|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
161375058|NCT02259114|582764229|FG000|Overall Study|Progressive Disease|14|||
161375059|NCT02259114|582764230|FG001|Overall Study|Progressive Disease|2|||
161375060|NCT02259114|582764231|FG002|Overall Study|Progressive Disease|10|||
161375061|NCT02259114|582764232|FG003|Overall Study|Progressive Disease|2|||
161375062|NCT02259114|582764233|FG004|Overall Study|Progressive Disease|5|||
161375063|NCT02259114|582764229|FG000|Overall Study|Adverse Event|2|||
161375064|NCT02259114|582764230|FG001|Overall Study|Adverse Event|1|||
161375065|NCT02259114|582764231|FG002|Overall Study|Adverse Event|0|||
161375066|NCT02259114|582764232|FG003|Overall Study|Adverse Event|0|||
161375067|NCT02259114|582764233|FG004|Overall Study|Adverse Event|1|||
161375068|NCT02259114|582764229|FG000|Overall Study|Death|3|||
161375069|NCT02259114|582764230|FG001|Overall Study|Death|0|||
161375070|NCT02259114|582764231|FG002|Overall Study|Death|1|||
161375071|NCT02259114|582764232|FG003|Overall Study|Death|0|||
161375072|NCT02259114|582764233|FG004|Overall Study|Death|0|||
161375073|NCT02259114|582764229|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161375074|NCT02259114|582764230|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161375075|NCT02259114|582764231|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
161375076|NCT02259114|582764232|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161375077|NCT02259114|582764233|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161375078|NCT02259114|582764229|FG000|Overall Study|Withdrawal by Subject|0|||
161375079|NCT02259114|582764230|FG001|Overall Study|Withdrawal by Subject|0|||
161375080|NCT02259114|582764231|FG002|Overall Study|Withdrawal by Subject|1|||
161375081|NCT02259114|582764232|FG003|Overall Study|Withdrawal by Subject|1|||
161375082|NCT02259114|582764233|FG004|Overall Study|Withdrawal by Subject|0|||
161375083|NCT02259114|582764229|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
161375084|NCT02259114|582764230|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
161375085|NCT02259114|582764231|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
161375086|NCT02259114|582764232|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
161375087|NCT02259114|582764233|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
161375088|NCT02259114|582764229|FG000|Overall Study|Not Treated|1|||
161375089|NCT02259114|582764230|FG001|Overall Study|Not Treated|0|||
161375090|NCT02259114|582764231|FG002|Overall Study|Not Treated|0|||
161375091|NCT02259114|582764232|FG003|Overall Study|Not Treated|0|||
161375092|NCT02259114|582764233|FG004|Overall Study|Not Treated|0|||
161375093|NCT03937479|582764234|FG000|Overall Study|Adverse Event|2|||
161375094|NCT03937479|582764235|FG001|Overall Study|Adverse Event|3|||
161375095|NCT03937479|582764236|FG002|Overall Study|Adverse Event|0|||
161375096|NCT03937479|582764237|FG003|Overall Study|Adverse Event|0|||
161375097|NCT03937479|582764238|FG004|Overall Study|Adverse Event|1|||
161375098|NCT03937479|582764234|FG000|Overall Study|Withdrawal by Subject|3|||
161375099|NCT03937479|582764235|FG001|Overall Study|Withdrawal by Subject|5|||
161375100|NCT03937479|582764236|FG002|Overall Study|Withdrawal by Subject|2|||
161375101|NCT03937479|582764237|FG003|Overall Study|Withdrawal by Subject|2|||
161375102|NCT03937479|582764238|FG004|Overall Study|Withdrawal by Subject|1|||
161375103|NCT03937479|582764234|FG000|Overall Study|Protocol Violation|5|||
161375104|NCT03937479|582764235|FG001|Overall Study|Protocol Violation|6|||
161375105|NCT03937479|582764236|FG002|Overall Study|Protocol Violation|4|||
161375106|NCT03937479|582764237|FG003|Overall Study|Protocol Violation|3|||
161375107|NCT03937479|582764238|FG004|Overall Study|Protocol Violation|2|||
161375108|NCT03937479|582764234|FG000|Overall Study|Lost to Follow-up|0|||
161375109|NCT03937479|582764235|FG001|Overall Study|Lost to Follow-up|1|||
161375110|NCT03937479|582764236|FG002|Overall Study|Lost to Follow-up|0|||
161375111|NCT03937479|582764237|FG003|Overall Study|Lost to Follow-up|1|||
161375112|NCT03937479|582764238|FG004|Overall Study|Lost to Follow-up|0|||
161375113|NCT03937479|582764234|FG000|Overall Study|Physician Decision|0|||
161375114|NCT03937479|582764235|FG001|Overall Study|Physician Decision|0|||
161375115|NCT03937479|582764236|FG002|Overall Study|Physician Decision|1|||
161375116|NCT03937479|582764237|FG003|Overall Study|Physician Decision|0|||
161375117|NCT03937479|582764238|FG004|Overall Study|Physician Decision|1|||
161375118|NCT00940602|582764241|FG000|Overall Study|Administrative problems|1|||
161375119|NCT00940602|582764242|FG001|Overall Study|Administrative problems|1|||
161375120|NCT00940602|582764241|FG000|Overall Study|Patient/guardian decision|13|||
161375121|NCT00940602|582764242|FG001|Overall Study|Patient/guardian decision|28|||
161375122|NCT00940602|582764241|FG000|Overall Study|Physician Decision|8|||
161375123|NCT00940602|582764242|FG001|Overall Study|Physician Decision|5|||
161375124|NCT00940602|582764241|FG000|Overall Study|Pregnancy|1|||
161375125|NCT00940602|582764242|FG001|Overall Study|Pregnancy|0|||
161375126|NCT00940602|582764241|FG000|Overall Study|Protocol Deviation (untreated)|1|||
161375127|NCT00940602|582764242|FG001|Overall Study|Protocol Deviation (untreated)|0|||
161375128|NCT00940602|582764241|FG000|Overall Study|Disease progression|8|||
161375129|NCT00940602|582764242|FG001|Overall Study|Disease progression|2|||
161375130|NCT00940602|582764241|FG000|Overall Study|Death|38|||
161375131|NCT00940602|582764242|FG001|Overall Study|Death|19|||
161375132|NCT00940602|582764241|FG000|Overall Study|Lost to Follow-up|3|||
161375133|NCT00940602|582764242|FG001|Overall Study|Lost to Follow-up|1|||
161375134|NCT00940602|582764241|FG000|Overall Study|Patient withdrew consent|26|||
161375135|NCT00940602|582764242|FG001|Overall Study|Patient withdrew consent|13|||
161375136|NCT00940602|582764241|FG000|Overall Study|Adverse Event|7|||
161375137|NCT00940602|582764242|FG001|Overall Study|Adverse Event|2|||
161375138|NCT00940602|582764241|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
161375139|NCT00940602|582764242|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
161375140|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
161375141|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
161375142|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
161375143|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
161375144|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
161375145|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
161375146|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
161375147|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
161375148|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
161375149|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
161375150|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
161375151|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
161375152|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
161375153|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
161375154|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
161375155|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
161375156|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
161375157|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
161375158|NCT03789292|582764243|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
161375159|NCT03789292|582764244|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
161375160|NCT03789292|582764245|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
161375161|NCT03789292|582764243|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
161375162|NCT03789292|582764244|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
161375163|NCT03789292|582764245|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
161375164|NCT03789292|582764243|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
161375165|NCT03789292|582764244|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
161375166|NCT03789292|582764245|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
161375167|NCT03789292|582764243|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
161375168|NCT03789292|582764244|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
161375169|NCT03789292|582764245|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
161375170|NCT03789292|582764243|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
161375171|NCT03789292|582764244|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
161375172|NCT03789292|582764245|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
161375173|NCT03789292|582764243|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
161375174|NCT03789292|582764244|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
161375175|NCT03789292|582764245|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
161375176|NCT03789292|582764243|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
161375177|NCT03789292|582764244|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
161375178|NCT03789292|582764245|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
161375179|NCT00575666|582764246|FG000|Overall Study|Withdrawal by Subject|3|||
161375180|NCT00575666|582764247|FG001|Overall Study|Withdrawal by Subject|2|||
161375181|NCT00575666|582764246|FG000|Overall Study|Physician Decision|1|||
161375182|NCT00575666|582764247|FG001|Overall Study|Physician Decision|1|||
161375183|NCT01374425|582764248|FG000|Overall Study|Radiographic Disease Progression|86|||
161375184|NCT01374425|582764249|FG001|Overall Study|Radiographic Disease Progression|81|||
161375185|NCT01374425|582764248|FG000|Overall Study|Clinical Disease Progression|9|||
161375186|NCT01374425|582764249|FG001|Overall Study|Clinical Disease Progression|6|||
161375187|NCT01374425|582764248|FG000|Overall Study|Adverse Event|29|||
161375188|NCT01374425|582764249|FG001|Overall Study|Adverse Event|18|||
161375189|NCT01374425|582764248|FG000|Overall Study|Death (Progression of Disease)|1|||
161375190|NCT01374425|582764249|FG001|Overall Study|Death (Progression of Disease)|0|||
161375191|NCT01374425|582764248|FG000|Overall Study|Death (Adverse Event)|2|||
161375192|NCT01374425|582764249|FG001|Overall Study|Death (Adverse Event)|4|||
161375193|NCT01374425|582764248|FG000|Overall Study|Withdrawal by Subject|6|||
161375194|NCT01374425|582764249|FG001|Overall Study|Withdrawal by Subject|7|||
161375195|NCT01374425|582764248|FG000|Overall Study|Refused Treatment|10|||
161375196|NCT01374425|582764249|FG001|Overall Study|Refused Treatment|24|||
161375197|NCT01374425|582764248|FG000|Overall Study|Protocol Violation|2|||
161375198|NCT01374425|582764249|FG001|Overall Study|Protocol Violation|3|||
161375199|NCT01374425|582764248|FG000|Overall Study|Sponsor Decision|0|||
161375200|NCT01374425|582764249|FG001|Overall Study|Sponsor Decision|1|||
161375201|NCT01374425|582764248|FG000|Overall Study|Lost to Follow-up|2|||
161375202|NCT01374425|582764249|FG001|Overall Study|Lost to Follow-up|1|||
161375203|NCT01374425|582764248|FG000|Overall Study|Other|41|||
161375204|NCT01374425|582764249|FG001|Overall Study|Other|43|||
161375205|NCT02289469|582764250|FG000|Overall Study|Unable to match a control|6|||
161375206|NCT02289469|582764251|FG001|Overall Study|Unable to match a control|0|||
161375207|NCT01904721|582764254|FG000|Overall Study|Other Reasons|0|||
161375208|NCT01904721|582764255|FG001|Overall Study|Other Reasons|0|||
161375209|NCT01904721|582764256|FG002|Overall Study|Other Reasons|1|||
161375210|NCT01904721|582764257|FG003|Overall Study|Other Reasons|1|||
161375211|NCT01904721|582764258|FG004|Overall Study|Other Reasons|2|||
161375212|NCT01904721|582764259|FG005|Overall Study|Other Reasons|2|||
161375213|NCT01904721|582764260|FG006|Overall Study|Other Reasons|2|||
161375214|NCT01904721|582764254|FG000|Overall Study|Personal Reasons|0|||
161375215|NCT01904721|582764255|FG001|Overall Study|Personal Reasons|0|||
161375216|NCT01904721|582764256|FG002|Overall Study|Personal Reasons|0|||
161375217|NCT01904721|582764257|FG003|Overall Study|Personal Reasons|0|||
161375218|NCT01904721|582764258|FG004|Overall Study|Personal Reasons|2|||
161375219|NCT01904721|582764259|FG005|Overall Study|Personal Reasons|3|||
161375220|NCT01904721|582764260|FG006|Overall Study|Personal Reasons|3|||
161375221|NCT01904721|582764254|FG000|Overall Study|Lost to Follow-up|0|||
161375222|NCT01904721|582764255|FG001|Overall Study|Lost to Follow-up|0|||
161375223|NCT01904721|582764256|FG002|Overall Study|Lost to Follow-up|0|||
161375224|NCT01904721|582764257|FG003|Overall Study|Lost to Follow-up|0|||
161375225|NCT01904721|582764258|FG004|Overall Study|Lost to Follow-up|1|||
161375226|NCT01904721|582764259|FG005|Overall Study|Lost to Follow-up|3|||
161375227|NCT01904721|582764260|FG006|Overall Study|Lost to Follow-up|1|||
161375228|NCT01904721|582764254|FG000|Overall Study|Lack of Efficacy|0|||
161375229|NCT01904721|582764255|FG001|Overall Study|Lack of Efficacy|0|||
161375230|NCT01904721|582764256|FG002|Overall Study|Lack of Efficacy|0|||
161375231|NCT01904721|582764257|FG003|Overall Study|Lack of Efficacy|0|||
161375232|NCT01904721|582764258|FG004|Overall Study|Lack of Efficacy|0|||
161375233|NCT01904721|582764259|FG005|Overall Study|Lack of Efficacy|0|||
161375234|NCT01904721|582764260|FG006|Overall Study|Lack of Efficacy|1|||
161375235|NCT01904721|582764254|FG000|Overall Study|Adverse Event|0|||
161375236|NCT01904721|582764255|FG001|Overall Study|Adverse Event|0|||
161375237|NCT01904721|582764256|FG002|Overall Study|Adverse Event|0|||
161375238|NCT01904721|582764257|FG003|Overall Study|Adverse Event|0|||
161375239|NCT01904721|582764258|FG004|Overall Study|Adverse Event|3|||
161375240|NCT01904721|582764259|FG005|Overall Study|Adverse Event|1|||
161375241|NCT01904721|582764260|FG006|Overall Study|Adverse Event|0|||
161375242|NCT00532844|582764264|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
161375243|NCT00532844|582764265|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
161375244|NCT00532844|582764264|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
161375245|NCT00532844|582764265|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
161375246|NCT00532844|582764264|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
161375247|NCT00532844|582764265|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
161375248|NCT00532844|582764264|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
161375249|NCT00532844|582764265|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
161375250|NCT00532844|582764264|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
161375251|NCT00532844|582764265|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
161375252|NCT01077063|582764267|FG000|Overall Study|Adverse Event|3|||
161375253|NCT01077063|582764268|FG001|Overall Study|Adverse Event|0|||
161375254|NCT01077063|582764267|FG000|Overall Study|Death|1|||
161375255|NCT01077063|582764268|FG001|Overall Study|Death|1|||
161375256|NCT01077063|582764267|FG000|Overall Study|Withdrawal by Subject|0|||
161375257|NCT01077063|582764268|FG001|Overall Study|Withdrawal by Subject|2|||
161375258|NCT02750930|582764269|FG000|Overall Study|Study closed/terminated|8|||
161375259|NCT00553631|582764271|FG000|Overall Study|Withdrawal by Subject|0|||
161375260|NCT00553631|582764272|FG001|Overall Study|Withdrawal by Subject|1|||
161375261|NCT00553631|582764271|FG000|Overall Study|Lost to Follow-up|1|||
161375262|NCT00553631|582764272|FG001|Overall Study|Lost to Follow-up|0|||
161375263|NCT02761642|582764273|FG000|Overall Study|Did not Receive Study Treatment|3|||
161375264|NCT02761642|582764273|FG000|Overall Study|Adverse Event|13|||
161375265|NCT02761642|582764273|FG000|Overall Study|Withdrawal by Subject|2|||
161375266|NCT02761642|582764273|FG000|Overall Study|Non-compliant|7|||
161375267|NCT02761642|582764273|FG000|Overall Study|Death|3|||
161375268|NCT02761642|582764273|FG000|Overall Study|Lack of Efficacy|20|||
161375269|NCT02761642|582764273|FG000|Overall Study|Physician Decision|1|||
161375270|NCT02761642|582764273|FG000|Overall Study|Reason Unspecified|21|||
161375271|NCT01644643|582764276|FG000|Overall Study|Death|1|||
161375272|NCT01644643|582764277|FG001|Overall Study|Death|0|||
161375273|NCT01644643|582764278|FG002|Overall Study|Death|3|||
161375274|NCT01644643|582764279|FG003|Overall Study|Death|3|||
161375275|NCT01644643|582764276|FG000|Overall Study|Lost to Follow-up|0|||
161375276|NCT01644643|582764277|FG001|Overall Study|Lost to Follow-up|0|||
161375277|NCT01644643|582764278|FG002|Overall Study|Lost to Follow-up|0|||
161375278|NCT01644643|582764279|FG003|Overall Study|Lost to Follow-up|4|||
161375279|NCT01644643|582764276|FG000|Overall Study|Withdrawal by Subject|1|||
161375280|NCT01644643|582764277|FG001|Overall Study|Withdrawal by Subject|0|||
161375281|NCT01644643|582764278|FG002|Overall Study|Withdrawal by Subject|2|||
161375282|NCT01644643|582764279|FG003|Overall Study|Withdrawal by Subject|1|||
161375283|NCT01644643|582764276|FG000|Overall Study|Other Eligibility criteria|0|||
161375284|NCT01644643|582764277|FG001|Overall Study|Other Eligibility criteria|0|||
161375285|NCT01644643|582764278|FG002|Overall Study|Other Eligibility criteria|0|||
161375286|NCT01644643|582764279|FG003|Overall Study|Other Eligibility criteria|2|||
161375287|NCT00271544|582764296|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
161375288|NCT00271544|582764296|FG000|Overall Study|Model 4196 lead not attempted|9|||
161375289|NCT00271544|582764296|FG000|Overall Study|Implant not attempted|4|||
161375290|NCT04540367|582764297|FG000|Overall Study|Withdrawal by Subject|0|||
161375291|NCT04540367|582764298|FG001|Overall Study|Withdrawal by Subject|0|||
161375292|NCT04540367|582764299|FG002|Overall Study|Withdrawal by Subject|0|||
161375293|NCT04540367|582764300|FG003|Overall Study|Withdrawal by Subject|2|||
161375294|NCT04540367|582764297|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
161375295|NCT04540367|582764298|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
161375296|NCT04540367|582764299|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
161375297|NCT04540367|582764300|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
161375298|NCT04540367|582764297|FG000|Overall Study|Adverse Event|0|||
161375299|NCT04540367|582764298|FG001|Overall Study|Adverse Event|0|||
161375300|NCT04540367|582764299|FG002|Overall Study|Adverse Event|1|||
161375301|NCT04540367|582764300|FG003|Overall Study|Adverse Event|1|||
161375302|NCT00902330|582764302|FG000|Overall Study|Too overwhelmed by treatment|2|||
161375303|NCT00902330|582764303|FG001|Overall Study|Too overwhelmed by treatment|5|||
161375304|NCT00902330|582764302|FG000|Overall Study|Adverse Event|1|||
161375305|NCT00902330|582764303|FG001|Overall Study|Adverse Event|0|||
161375306|NCT00902330|582764302|FG000|Overall Study|No post baseline data|1|||
161375307|NCT00902330|582764303|FG001|Overall Study|No post baseline data|0|||
161375308|NCT00730886|582764304|FG000|Overall Study|Lost to Follow-up|1|||
161375309|NCT00730886|582764305|FG001|Overall Study|Lost to Follow-up|0|||
161375310|NCT00730886|582764304|FG000|Overall Study|Physician Decision|1|||
161375311|NCT00730886|582764305|FG001|Overall Study|Physician Decision|0|||
161375312|NCT01816048|582764306|FG000|Overall Study|Adverse Event|1|||
161375313|NCT01816048|582764306|FG000|Overall Study|Death|1|||
161375314|NCT01816048|582764306|FG000|Overall Study|Withdrawal by Subject|1|||
161375315|NCT01816048|582764306|FG000|Overall Study|Disease Progression|3|||
161375316|NCT03571971|582764307|FG000|Overall Study|Lost to Follow-up|2|||
161375317|NCT03571971|582764308|FG001|Overall Study|Lost to Follow-up|2|||
161375318|NCT03571971|582764307|FG000|Overall Study|Protocol Violation|2|||
161375319|NCT03571971|582764308|FG001|Overall Study|Protocol Violation|3|||
161375320|NCT03571971|582764307|FG000|Overall Study|Withdrawal by Subject|2|||
161375321|NCT03571971|582764308|FG001|Overall Study|Withdrawal by Subject|0|||
161375322|NCT03571971|582764307|FG000|Overall Study|Incomplete primary outcome data|2|||
161375323|NCT03571971|582764308|FG001|Overall Study|Incomplete primary outcome data|0|||
161375324|NCT04067492|582764309|FG000|Overall Study|Lost to Follow-up|0|||
161375325|NCT04067492|582764310|FG001|Overall Study|Lost to Follow-up|0|||
161375326|NCT04067492|582764311|FG002|Overall Study|Lost to Follow-up|0|||
161375327|NCT04067492|582764312|FG003|Overall Study|Lost to Follow-up|0|||
161375328|NCT04067492|582764313|FG004|Overall Study|Lost to Follow-up|0|||
161375329|NCT04067492|582764314|FG005|Overall Study|Lost to Follow-up|1|||
161375330|NCT04067492|582764309|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161375331|NCT04067492|582764310|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
161375332|NCT04067492|582764311|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161375333|NCT04067492|582764312|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161375334|NCT04067492|582764313|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161375335|NCT04067492|582764314|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161375336|NCT04067492|582764309|FG000|Overall Study|COVID-19 epidemiological situation|0|||
161375337|NCT04067492|582764310|FG001|Overall Study|COVID-19 epidemiological situation|0|||
161375338|NCT04067492|582764311|FG002|Overall Study|COVID-19 epidemiological situation|0|||
161375339|NCT04067492|582764312|FG003|Overall Study|COVID-19 epidemiological situation|1|||
161375340|NCT04067492|582764313|FG004|Overall Study|COVID-19 epidemiological situation|0|||
161375341|NCT04067492|582764314|FG005|Overall Study|COVID-19 epidemiological situation|0|||
161375342|NCT03950856|582764322|FG000|Overall Study|Death|1|||
161375343|NCT03950856|582764323|FG001|Overall Study|Death|2|||
161375344|NCT03950856|582764324|FG002|Overall Study|Death|0|||
161375345|NCT03950856|582764325|FG003|Overall Study|Death|0|||
161375346|NCT03950856|582764322|FG000|Overall Study|Lost to Follow-up|5|||
161375347|NCT03950856|582764323|FG001|Overall Study|Lost to Follow-up|6|||
161375348|NCT03950856|582764324|FG002|Overall Study|Lost to Follow-up|8|||
161375349|NCT03950856|582764325|FG003|Overall Study|Lost to Follow-up|2|||
161375350|NCT03950856|582764322|FG000|Overall Study|Protocol Violation|2|||
161375351|NCT03950856|582764323|FG001|Overall Study|Protocol Violation|0|||
161375352|NCT03950856|582764324|FG002|Overall Study|Protocol Violation|0|||
161375353|NCT03950856|582764325|FG003|Overall Study|Protocol Violation|1|||
161375354|NCT03950856|582764322|FG000|Overall Study|Withdrawal by Subject|4|||
161375355|NCT03950856|582764323|FG001|Overall Study|Withdrawal by Subject|1|||
161375356|NCT03950856|582764324|FG002|Overall Study|Withdrawal by Subject|3|||
161375357|NCT03950856|582764325|FG003|Overall Study|Withdrawal by Subject|1|||
161375358|NCT03950856|582764322|FG000|Overall Study|Unable to phone|7|||
161375359|NCT03950856|582764323|FG001|Overall Study|Unable to phone|6|||
161375360|NCT03950856|582764324|FG002|Overall Study|Unable to phone|7|||
161375361|NCT03950856|582764325|FG003|Overall Study|Unable to phone|2|||
161375362|NCT01816984|582764326|FG000|Overall Study|declining health status|1|||
161375363|NCT05899829|582764329|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
161375364|NCT05899829|582764330|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
161375365|NCT05899829|582764329|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
161375366|NCT05899829|582764330|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
161375367|NCT04422431|582764331|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
161375368|NCT04422431|582764331|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
161375369|NCT04422431|582764331|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
161375370|NCT04422431|582764331|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
161375371|NCT04422431|582764331|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
161375372|NCT04422431|582764331|FG000|Extension Period (48 Weeks)|Other than specified|2|||
161375373|NCT01174563|582764336|FG000|Overall Study|Progressive Disease|45|||
161375374|NCT01174563|582764336|FG000|Overall Study|Death|5|||
161375375|NCT01174563|582764336|FG000|Overall Study|Investigator's Discretion|5|||
161375376|NCT01174563|582764336|FG000|Overall Study|Participant Withdrew Consent|3|||
161375377|NCT01174563|582764336|FG000|Overall Study|Rash Adverse Event|1|||
161375378|NCT01174563|582764336|FG000|Overall Study|Sponsor's decision|1|||
161375379|NCT03402841|582764337|FG000|Overall Study|Withdrawal by Subject|3|||
161375380|NCT03402841|582764337|FG000|Overall Study|Lost to Follow-up|2|||
161375381|NCT03402841|582764337|FG000|Overall Study|Death|146|||
161375382|NCT00444106|582764338|FG000|Overall Study|Lost to Follow-up|2|||
161375383|NCT00444106|582764339|FG001|Overall Study|Lost to Follow-up|1|||
161375384|NCT00444106|582764340|FG002|Overall Study|Lost to Follow-up|0|||
161375385|NCT00444106|582764338|FG000|Overall Study|Abnormal Test Procedure Results|0|||
161375386|NCT00444106|582764339|FG001|Overall Study|Abnormal Test Procedure Results|0|||
161375387|NCT00444106|582764340|FG002|Overall Study|Abnormal Test Procedure Results|1|||
161375388|NCT04704193|582764341|FG000|Overall Study|Withdrawal by Subject|1|||
161375389|NCT05270863|582764342|FG000|Visit 2 First Intervention|Randomization error|0|||
161375390|NCT05270863|582764343|FG001|Visit 2 First Intervention|Randomization error|0|||
161375391|NCT05270863|582764344|FG002|Visit 2 First Intervention|Randomization error|0|||
161375392|NCT05270863|582764345|FG003|Visit 2 First Intervention|Randomization error|1|||
161375393|NCT05270863|582764346|FG004|Visit 2 First Intervention|Randomization error|0|||
161375394|NCT05270863|582764347|FG005|Visit 2 First Intervention|Randomization error|0|||
161375395|NCT05270863|582764342|FG000|First Washout|Withdrawal by Subject|0|||
161375396|NCT05270863|582764343|FG001|First Washout|Withdrawal by Subject|0|||
161375397|NCT05270863|582764344|FG002|First Washout|Withdrawal by Subject|0|||
161375398|NCT05270863|582764345|FG003|First Washout|Withdrawal by Subject|0|||
161375399|NCT05270863|582764346|FG004|First Washout|Withdrawal by Subject|1|||
161375400|NCT05270863|582764347|FG005|First Washout|Withdrawal by Subject|1|||
161375401|NCT05270863|582764342|FG000|First Washout|Lost to Follow-up|0|||
161375402|NCT05270863|582764343|FG001|First Washout|Lost to Follow-up|0|||
161375403|NCT05270863|582764344|FG002|First Washout|Lost to Follow-up|0|||
161375404|NCT05270863|582764345|FG003|First Washout|Lost to Follow-up|0|||
161375405|NCT05270863|582764346|FG004|First Washout|Lost to Follow-up|0|||
161375406|NCT05270863|582764347|FG005|First Washout|Lost to Follow-up|1|||
161375407|NCT05270863|582764342|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
161375408|NCT05270863|582764343|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
161375409|NCT05270863|582764344|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
161375410|NCT05270863|582764345|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
161375411|NCT05270863|582764346|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
161375412|NCT05270863|582764347|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
161375413|NCT05270863|582764342|FG000|Second Washout|Withdrawal by Subject|1|||
161375414|NCT05270863|582764343|FG001|Second Washout|Withdrawal by Subject|1|||
161375415|NCT05270863|582764344|FG002|Second Washout|Withdrawal by Subject|0|||
161375416|NCT05270863|582764345|FG003|Second Washout|Withdrawal by Subject|0|||
161375417|NCT05270863|582764346|FG004|Second Washout|Withdrawal by Subject|0|||
161375418|NCT05270863|582764347|FG005|Second Washout|Withdrawal by Subject|0|||
161375419|NCT05270863|582764342|FG000|Second Washout|Lost to Follow-up|0|||
161375420|NCT05270863|582764343|FG001|Second Washout|Lost to Follow-up|0|||
161375421|NCT05270863|582764344|FG002|Second Washout|Lost to Follow-up|0|||
161375422|NCT05270863|582764345|FG003|Second Washout|Lost to Follow-up|1|||
161375423|NCT05270863|582764346|FG004|Second Washout|Lost to Follow-up|0|||
161375424|NCT05270863|582764347|FG005|Second Washout|Lost to Follow-up|0|||
161375425|NCT03984188|582764348|FG000|Overall Study|Death|2|||
161375426|NCT03984188|582764349|FG001|Overall Study|Death|4|||
161375427|NCT03984188|582764348|FG000|Overall Study|Physician Decision|0|||
161375428|NCT03984188|582764349|FG001|Overall Study|Physician Decision|2|||
161375429|NCT03984188|582764348|FG000|Overall Study|Lost to Follow-up|3|||
161375430|NCT03984188|582764349|FG001|Overall Study|Lost to Follow-up|2|||
161375431|NCT03984188|582764348|FG000|Overall Study|Withdrawal by Subject|6|||
161375432|NCT03984188|582764349|FG001|Overall Study|Withdrawal by Subject|0|||
161375433|NCT03384875|582764350|FG000|Overall Study|Death|1|||
161375434|NCT03384875|582764351|FG001|Overall Study|Death|1|||
161375435|NCT03384875|582764352|FG002|Overall Study|Death|0|||
161375436|NCT03384875|582764350|FG000|Overall Study|Reason not provided|1|||
161375437|NCT03384875|582764351|FG001|Overall Study|Reason not provided|0|||
161375438|NCT03384875|582764352|FG002|Overall Study|Reason not provided|0|||
161375439|NCT00810277|582765914|FG000|Overall Study|Adverse Event|1|||
161375440|NCT00529243|582765918|FG000|Overall Study|Adverse Event|1|||
161375441|NCT00529243|582765918|FG000|Overall Study|Death|1|||
161375442|NCT00529243|582765918|FG000|Overall Study|Relocated|1|||
161375443|NCT00678288|582765925|FG000|Overall Study|Adverse Event|0|||
161375444|NCT00678288|582765926|FG001|Overall Study|Adverse Event|2|||
161375445|NCT00678288|582765925|FG000|Overall Study|Withdrawal by Subject|1|||
161375446|NCT00678288|582765926|FG001|Overall Study|Withdrawal by Subject|1|||
161375447|NCT00678288|582765925|FG000|Overall Study|Study terminated by the sponsor|2|||
161375448|NCT00678288|582765926|FG001|Overall Study|Study terminated by the sponsor|0|||
161375449|NCT00678288|582765925|FG000|Overall Study|Not compliant with study medication|0|||
161375450|NCT00678288|582765926|FG001|Overall Study|Not compliant with study medication|1|||
161375451|NCT00678288|582765925|FG000|Overall Study|Switch to commercial drug|0|||
161375452|NCT00678288|582765926|FG001|Overall Study|Switch to commercial drug|1|||
161375453|NCT00678288|582765925|FG000|Overall Study|Reason not reported|1|||
161375454|NCT00678288|582765926|FG001|Overall Study|Reason not reported|0|||
161375455|NCT00678288|582765925|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
161375456|NCT00678288|582765926|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
161375457|NCT04472650|582765937|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
161375458|NCT04472650|582765938|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
161375459|NCT03247829|582765941|FG000|Overall Study|Death|3|||
161375460|NCT03247829|582765942|FG001|Overall Study|Death|4|||
161375461|NCT03247829|582765941|FG000|Overall Study|Enter Hospice Care|1|||
161375462|NCT03247829|582765942|FG001|Overall Study|Enter Hospice Care|0|||
161375463|NCT03247829|582765941|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
161375464|NCT03247829|582765942|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
161375465|NCT03247829|582765941|FG000|Overall Study|LVAD Explant|1|||
161375466|NCT03247829|582765942|FG001|Overall Study|LVAD Explant|1|||
161375467|NCT03247829|582765941|FG000|Overall Study|Transplant|1|||
161375468|NCT03247829|582765942|FG001|Overall Study|Transplant|1|||
161375469|NCT01783444|582765943|FG000|Treatment Phase|Adverse Event|9|||
161375470|NCT01783444|582765944|FG001|Treatment Phase|Adverse Event|20|||
161375471|NCT01783444|582765945|FG002|Treatment Phase|Adverse Event|19|||
161375472|NCT01783444|582765943|FG000|Treatment Phase|Disease Progression|76|||
161375473|NCT01783444|582765944|FG001|Treatment Phase|Disease Progression|66|||
161375474|NCT01783444|582765945|FG002|Treatment Phase|Disease Progression|64|||
161375475|NCT01783444|582765943|FG000|Treatment Phase|Death|2|||
161375476|NCT01783444|582765944|FG001|Treatment Phase|Death|2|||
161375477|NCT01783444|582765945|FG002|Treatment Phase|Death|2|||
161375478|NCT01783444|582765943|FG000|Treatment Phase|Protocol Violation|1|||
161375479|NCT01783444|582765944|FG001|Treatment Phase|Protocol Violation|1|||
161375480|NCT01783444|582765945|FG002|Treatment Phase|Protocol Violation|2|||
161375481|NCT01783444|582765943|FG000|Treatment Phase|Withdrawal by Subject|6|||
161375482|NCT01783444|582765944|FG001|Treatment Phase|Withdrawal by Subject|8|||
161375483|NCT01783444|582765945|FG002|Treatment Phase|Withdrawal by Subject|9|||
161375484|NCT01783444|582765943|FG000|Treatment Phase|Administrative problems|2|||
161375485|NCT01783444|582765944|FG001|Treatment Phase|Administrative problems|0|||
161375486|NCT01783444|582765945|FG002|Treatment Phase|Administrative problems|1|||
161375487|NCT01783444|582765943|FG000|Treatment Phase|Physician Decision|8|||
161375488|NCT01783444|582765944|FG001|Treatment Phase|Physician Decision|6|||
161375489|NCT01783444|582765945|FG002|Treatment Phase|Physician Decision|5|||
161375490|NCT01783444|582765943|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
161375491|NCT01783444|582765944|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
161375492|NCT01783444|582765945|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
161375493|NCT01783444|582765943|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
161375494|NCT01783444|582765944|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
161375495|NCT01783444|582765945|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
161375496|NCT01783444|582765943|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
161375497|NCT01783444|582765944|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
161375498|NCT01783444|582765945|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
161375499|NCT01783444|582765943|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
161375500|NCT01783444|582765944|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
161375501|NCT01783444|582765945|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
161375502|NCT01783444|582765943|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
161375503|NCT01783444|582765944|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
161375504|NCT01783444|582765945|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
161375505|NCT01783444|582765943|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
161375506|NCT01783444|582765944|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
161375507|NCT01783444|582765945|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
161375508|NCT00552071|582765947|FG000|Overall Study|Adverse Event|1|||
161375509|NCT00552071|582765948|FG001|Overall Study|Adverse Event|0|||
161375510|NCT00552071|582765947|FG000|Overall Study|Lack of Efficacy|1|||
161375511|NCT00552071|582765948|FG001|Overall Study|Lack of Efficacy|0|||
161375512|NCT00552071|582765947|FG000|Overall Study|Physician Decision|1|||
161375513|NCT00552071|582765948|FG001|Overall Study|Physician Decision|0|||
161375514|NCT00552071|582765947|FG000|Overall Study|Pregnancy|1|||
161375515|NCT00552071|582765948|FG001|Overall Study|Pregnancy|0|||
161375516|NCT00552071|582765947|FG000|Overall Study|Death|0|||
161375517|NCT00552071|582765948|FG001|Overall Study|Death|1|||
161375518|NCT00552071|582765947|FG000|Overall Study|Withdrawal by Subject|0|||
161375519|NCT00552071|582765948|FG001|Overall Study|Withdrawal by Subject|1|||
161375520|NCT00272792|582765949|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
161375521|NCT00272792|582765950|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
161375522|NCT00272792|582765949|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
161375523|NCT00272792|582765950|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
161375524|NCT00272792|582765949|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
161375525|NCT00272792|582765950|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
161375526|NCT00272792|582765949|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
161375527|NCT00272792|582765950|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
161375528|NCT00937495|582765955|FG000|Overall Study|Protocol Violation|2|||
161375529|NCT01856322|582765956|FG000|Overall Study|off study due to lack of accrual|0|||
161375530|NCT01856322|582765957|FG001|Overall Study|off study due to lack of accrual|0|||
161375531|NCT01856322|582765958|FG002|Overall Study|off study due to lack of accrual|3|||
161375532|NCT02628444|582765959|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
161375533|NCT02628444|582765960|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375534|NCT02628444|582765961|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375535|NCT02628444|582765962|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375536|NCT02628444|582765963|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375537|NCT02628444|582765964|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375538|NCT02628444|582765965|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375539|NCT02628444|582765966|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375540|NCT02628444|582765967|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161375541|NCT02628444|582765959|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375542|NCT02628444|582765960|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
161375543|NCT02628444|582765961|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
161375544|NCT02628444|582765962|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375545|NCT02628444|582765963|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375546|NCT02628444|582765964|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375547|NCT02628444|582765965|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375548|NCT02628444|582765966|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375549|NCT02628444|582765967|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161375550|NCT02628444|582765959|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
161375551|NCT02628444|582765960|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
161375552|NCT02628444|582765961|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
161375553|NCT02628444|582765962|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375554|NCT02628444|582765963|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375555|NCT02628444|582765964|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375556|NCT02628444|582765965|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375557|NCT02628444|582765966|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375558|NCT02628444|582765967|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375559|NCT02628444|582765959|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
161375560|NCT02628444|582765960|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
161375561|NCT02628444|582765961|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
161375562|NCT02628444|582765962|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161375563|NCT02628444|582765963|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161375564|NCT02628444|582765964|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161375565|NCT02628444|582765965|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161375566|NCT02628444|582765966|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161375567|NCT02628444|582765967|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161375568|NCT02628444|582765959|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
161375569|NCT02628444|582765960|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
161375570|NCT02628444|582765961|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
161375571|NCT02628444|582765962|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161375572|NCT02628444|582765963|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161375573|NCT02628444|582765964|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161375574|NCT02628444|582765965|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161375575|NCT02628444|582765966|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161375576|NCT02628444|582765967|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161375577|NCT02628444|582765959|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375578|NCT02628444|582765960|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375579|NCT02628444|582765961|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375580|NCT02628444|582765962|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
161375581|NCT02628444|582765963|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375582|NCT02628444|582765964|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375583|NCT02628444|582765965|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375584|NCT02628444|582765966|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375585|NCT02628444|582765967|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161375586|NCT02628444|582765959|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
161375587|NCT02628444|582765960|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
161375588|NCT02628444|582765961|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
161375589|NCT02628444|582765962|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
161375590|NCT02628444|582765963|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
161375591|NCT02628444|582765964|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
161375592|NCT02628444|582765965|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
161375593|NCT02628444|582765966|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
161375594|NCT02628444|582765967|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
161375595|NCT02628444|582765959|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375596|NCT02628444|582765960|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375597|NCT02628444|582765961|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
161375598|NCT02628444|582765962|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
161375599|NCT02628444|582765963|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
161375600|NCT02628444|582765964|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
161375601|NCT02628444|582765965|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
161375602|NCT02628444|582765966|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
161375603|NCT02628444|582765967|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
161375604|NCT02628444|582765959|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161375605|NCT02628444|582765960|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161375606|NCT02628444|582765961|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161375607|NCT02628444|582765962|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161375608|NCT02628444|582765963|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
161375609|NCT02628444|582765964|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161375610|NCT02628444|582765965|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161375611|NCT02628444|582765966|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
161375612|NCT02628444|582765967|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
161375613|NCT02628444|582765959|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
161375614|NCT02628444|582765960|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
161375615|NCT02628444|582765961|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
161375616|NCT02628444|582765962|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
161375617|NCT02628444|582765963|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
161375618|NCT02628444|582765964|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
161375619|NCT02628444|582765965|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
161375620|NCT02628444|582765966|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
161375621|NCT02628444|582765967|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
161375622|NCT00288015|582765968|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
161375623|NCT00288015|582765968|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
161375624|NCT00288015|582765968|FG000|First Response Assessment|Withdrawal by Subject|1|||
161375625|NCT00288015|582765968|FG000|First Response Assessment|Death|1|||
161375626|NCT00288015|582765968|FG000|First Response Assessment|Physician Decision|2|||
161375627|NCT00288015|582765968|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
161375628|NCT00288015|582765968|FG000|Follow up for Survival x 2 Years|Death|13|||
161375629|NCT00288015|582765968|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
161375630|NCT00288015|582765968|FG000|Follow up for Survival x 2 Years|Other|9|||
161375631|NCT00443703|582765969|FG000|Overall Study|Never Treated|3|||
161375632|NCT00443703|582765970|FG001|Overall Study|Never Treated|1|||
161375633|NCT00443703|582765969|FG000|Overall Study|Adverse Event|7|||
161375634|NCT00443703|582765970|FG001|Overall Study|Adverse Event|3|||
161375635|NCT00443703|582765969|FG000|Overall Study|Lack of Efficacy|3|||
161375636|NCT00443703|582765970|FG001|Overall Study|Lack of Efficacy|1|||
161375637|NCT00443703|582765969|FG000|Overall Study|Lost to Follow-up|0|||
161375638|NCT00443703|582765970|FG001|Overall Study|Lost to Follow-up|4|||
161375639|NCT00443703|582765969|FG000|Overall Study|Physician Decision|4|||
161375640|NCT00443703|582765970|FG001|Overall Study|Physician Decision|2|||
161375641|NCT00443703|582765969|FG000|Overall Study|Protocol Violation|1|||
161375642|NCT00443703|582765970|FG001|Overall Study|Protocol Violation|1|||
161375643|NCT00443703|582765969|FG000|Overall Study|Withdrawal by Subject|9|||
161375644|NCT00443703|582765970|FG001|Overall Study|Withdrawal by Subject|6|||
161375645|NCT00443703|582765969|FG000|Overall Study|Progressive Disease|1|||
161375646|NCT00443703|582765970|FG001|Overall Study|Progressive Disease|0|||
161375647|NCT01047007|582765973|FG000|Overall Study|Adverse Event|0|||
161375648|NCT01047007|582765974|FG001|Overall Study|Adverse Event|2|||
161375649|NCT01047007|582765975|FG002|Overall Study|Adverse Event|1|||
161375650|NCT01047007|582765976|FG003|Overall Study|Adverse Event|0|||
161375651|NCT01047007|582765973|FG000|Overall Study|Progressive Disease|2|||
161375652|NCT01047007|582765974|FG001|Overall Study|Progressive Disease|4|||
161375653|NCT01047007|582765975|FG002|Overall Study|Progressive Disease|1|||
161375654|NCT01047007|582765976|FG003|Overall Study|Progressive Disease|0|||
161375655|NCT00592631|582765980|FG000|Overall Study|Lost to Follow-up|0|||
161375656|NCT00592631|582765981|FG001|Overall Study|Lost to Follow-up|2|||
161375657|NCT03389308|582765983|FG000|Overall Study|Withdrawal by Subject|5|||
161375658|NCT03389308|582765983|FG000|Overall Study|Lost to Follow-up|3|||
161375659|NCT03389308|582765983|FG000|Overall Study|Adverse Event|2|||
161375660|NCT03389308|582765983|FG000|Overall Study|Sponsor Request|2|||
161375661|NCT00616642|582765985|FG000|Overall Study|Withdrawal by Subject|0|||
161375662|NCT00616642|582765986|FG001|Overall Study|Withdrawal by Subject|1|||
161375663|NCT00570323|582765987|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
161375664|NCT00570323|582765988|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
161375665|NCT00570323|582765987|FG000|Started Treatment After Randomization|Protocol Violation|1|||
161375666|NCT00570323|582765988|FG001|Started Treatment After Randomization|Protocol Violation|0|||
161375667|NCT00570323|582765987|FG000|Started Treatment After Randomization|Physician Decision|1|||
161375668|NCT00570323|582765988|FG001|Started Treatment After Randomization|Physician Decision|0|||
161375669|NCT00570323|582765987|FG000|Complete Study After Start|Lost to Follow-up|0|||
161375670|NCT00570323|582765988|FG001|Complete Study After Start|Lost to Follow-up|1|||
161375671|NCT00570323|582765987|FG000|Complete Study After Start|Withdrawal by Subject|2|||
161375672|NCT00570323|582765988|FG001|Complete Study After Start|Withdrawal by Subject|0|||
161375673|NCT00570323|582765987|FG000|Complete Study After Start|Physician Decision|1|||
161375674|NCT00570323|582765988|FG001|Complete Study After Start|Physician Decision|0|||
161375675|NCT02266147|582765991|FG000|PART 1: Dose Escalation|Physician Decision|0|||
161375676|NCT02266147|582765992|FG001|PART 1: Dose Escalation|Physician Decision|0|||
161375677|NCT02266147|582765993|FG002|PART 1: Dose Escalation|Physician Decision|1|||
161375678|NCT02266147|582765994|FG003|PART 1: Dose Escalation|Physician Decision|0|||
161375679|NCT02266147|582765991|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
161375680|NCT02266147|582765992|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
161375681|NCT02266147|582765993|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
161375682|NCT02266147|582765994|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
161375683|NCT02266147|582765991|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
161375684|NCT02266147|582765992|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
161375685|NCT02266147|582765993|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
161375686|NCT02266147|582765994|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
161375687|NCT02266147|582765991|FG000|PART 1: Dose Escalation|Other|1|||
161375688|NCT02266147|582765992|FG001|PART 1: Dose Escalation|Other|1|||
161375689|NCT02266147|582765993|FG002|PART 1: Dose Escalation|Other|0|||
161375690|NCT02266147|582765994|FG003|PART 1: Dose Escalation|Other|0|||
161375691|NCT02266147|582765991|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
161375692|NCT02266147|582765992|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
161375693|NCT02266147|582765993|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
161375694|NCT02266147|582765994|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
161375695|NCT02266147|582765991|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
161375696|NCT02266147|582765992|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
161375697|NCT02266147|582765993|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
161375698|NCT02266147|582765994|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
161375699|NCT01023217|582765995|FG000|Overall Study|Withdrawal by Subject|1|||
161375700|NCT01023217|582765996|FG001|Overall Study|Withdrawal by Subject|0|||
161375701|NCT00332696|582765997|FG000|Overall Study|Death|24|||
161375702|NCT00332696|582765998|FG001|Overall Study|Death|14|||
161375703|NCT00332696|582765997|FG000|Overall Study|Insufficient therapeutic effect|4|||
161375704|NCT00332696|582765998|FG001|Overall Study|Insufficient therapeutic effect|11|||
161375705|NCT00332696|582765997|FG000|Overall Study|Adverse Event|1|||
161375706|NCT00332696|582765998|FG001|Overall Study|Adverse Event|2|||
161375707|NCT00332696|582765997|FG000|Overall Study|Condition does not justify treatment|0|||
161375708|NCT00332696|582765998|FG001|Overall Study|Condition does not justify treatment|2|||
161375709|NCT00332696|582765997|FG000|Overall Study|Lost to Follow-up|0|||
161375710|NCT00332696|582765998|FG001|Overall Study|Lost to Follow-up|1|||
161375711|NCT00332696|582765997|FG000|Overall Study|Withdrawal by Subject|1|||
161375712|NCT00332696|582765998|FG001|Overall Study|Withdrawal by Subject|0|||
161375713|NCT02216526|582765999|FG000|Overall Study|Adverse Event|1|||
161375714|NCT02216526|582766000|FG001|Overall Study|Adverse Event|1|||
161375715|NCT02216526|582766001|FG002|Overall Study|Adverse Event|0|||
161375716|NCT02216526|582765999|FG000|Overall Study|Death|0|||
161375717|NCT02216526|582766000|FG001|Overall Study|Death|1|||
161375718|NCT02216526|582766001|FG002|Overall Study|Death|3|||
161375719|NCT02216526|582765999|FG000|Overall Study|Protocol Violation|2|||
161375720|NCT02216526|582766000|FG001|Overall Study|Protocol Violation|0|||
161375721|NCT02216526|582766001|FG002|Overall Study|Protocol Violation|2|||
161375722|NCT02216526|582765999|FG000|Overall Study|Hospitalization|2|||
161375723|NCT02216526|582766000|FG001|Overall Study|Hospitalization|1|||
161375724|NCT02216526|582766001|FG002|Overall Study|Hospitalization|3|||
161375725|NCT00696878|582766006|FG000|Overall Study|Adverse Event|8|||
161375726|NCT00696878|582766006|FG000|Overall Study|Withdrawal by Subject|87|||
161375727|NCT00696878|582766006|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
161375728|NCT00696878|582766006|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
161375729|NCT00696878|582766006|FG000|Overall Study|Trial stopped|32|||
161375730|NCT00696878|582766006|FG000|Overall Study|Other reason (not specified)|55|||
161375731|NCT04103450|582766007|FG000|Overall Study|Adverse Event|4|||
161375732|NCT04103450|582766008|FG001|Overall Study|Adverse Event|2|||
161375733|NCT04103450|582766007|FG000|Overall Study|Lack of Efficacy|3|||
161375734|NCT04103450|582766008|FG001|Overall Study|Lack of Efficacy|0|||
161375735|NCT04103450|582766007|FG000|Overall Study|Withdrawal by Subject|5|||
161375736|NCT04103450|582766008|FG001|Overall Study|Withdrawal by Subject|3|||
161375737|NCT04103450|582766007|FG000|Overall Study|Lost to Follow-up|1|||
161375738|NCT04103450|582766008|FG001|Overall Study|Lost to Follow-up|2|||
161375739|NCT04103450|582766007|FG000|Overall Study|Physician Decision|1|||
161375740|NCT04103450|582766008|FG001|Overall Study|Physician Decision|2|||
161375741|NCT04103450|582766007|FG000|Overall Study|Protocol Violation|1|||
161375742|NCT04103450|582766008|FG001|Overall Study|Protocol Violation|0|||
161375743|NCT04103450|582766007|FG000|Overall Study|Other|1|||
161375744|NCT04103450|582766008|FG001|Overall Study|Other|1|||
161375745|NCT02712788|582766012|FG000|Overall Study|Physician Decision|1|||
161375746|NCT02712788|582766013|FG001|Overall Study|Physician Decision|0|||
161375747|NCT02712788|582766012|FG000|Overall Study|Protocol Violation|1|||
161375748|NCT02712788|582766013|FG001|Overall Study|Protocol Violation|0|||
161375749|NCT00967616|582766017|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
161375750|NCT00967616|582766018|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
161375751|NCT00967616|582766017|FG000|Overall Study|Death|0|||
161375752|NCT00967616|582766018|FG001|Overall Study|Death|3|||
161375753|NCT00967616|582766017|FG000|Overall Study|Withdrawal by Subject|8|||
161375754|NCT00967616|582766018|FG001|Overall Study|Withdrawal by Subject|4|||
161375755|NCT00967616|582766017|FG000|Overall Study|Progressive Disease|31|||
161375756|NCT00967616|582766018|FG001|Overall Study|Progressive Disease|18|||
161375757|NCT00967616|582766017|FG000|Overall Study|Other|8|||
161375758|NCT00967616|582766018|FG001|Overall Study|Other|8|||
161375759|NCT00967616|582766017|FG000|Overall Study|Protocol Violation|1|||
161375760|NCT00967616|582766018|FG001|Overall Study|Protocol Violation|0|||
161375761|NCT03188263|582766024|FG000|Overall Study|Withdrawal by Subject|3|||
161375762|NCT03188263|582766025|FG001|Overall Study|Withdrawal by Subject|0|||
161375763|NCT03188263|582766024|FG000|Overall Study|Physician Decision|1|||
161375764|NCT03188263|582766025|FG001|Overall Study|Physician Decision|0|||
161375765|NCT00699413|582766026|FG000|Overall Study|Withdrawal by Subject|0|||
161375766|NCT00699413|582766027|FG001|Overall Study|Withdrawal by Subject|2|||
161375767|NCT00699413|582766026|FG000|Overall Study|Study terminated by sponsor|4|||
161375768|NCT00699413|582766027|FG001|Overall Study|Study terminated by sponsor|2|||
161375769|NCT02779777|582766028|FG000|Overall Study|Disease Progression|1|||
161375770|NCT02779777|582766029|FG001|Overall Study|Disease Progression|0|||
161375771|NCT02779777|582766030|FG002|Overall Study|Disease Progression|0|||
161375772|NCT02779777|582766028|FG000|Overall Study|Adverse Event|3|||
161375773|NCT02779777|582766029|FG001|Overall Study|Adverse Event|1|||
161375774|NCT02779777|582766030|FG002|Overall Study|Adverse Event|0|||
161375775|NCT02779777|582766028|FG000|Overall Study|Physician Decision|9|||
161375776|NCT02779777|582766029|FG001|Overall Study|Physician Decision|0|||
161375777|NCT02779777|582766030|FG002|Overall Study|Physician Decision|1|||
161375778|NCT02779777|582766028|FG000|Overall Study|Withdrawal by Subject|1|||
161375779|NCT02779777|582766029|FG001|Overall Study|Withdrawal by Subject|0|||
161375780|NCT02779777|582766030|FG002|Overall Study|Withdrawal by Subject|0|||
161375781|NCT00251693|582766031|FG000|Overall Study|Adverse Event|17|||
161375782|NCT00251693|582766032|FG001|Overall Study|Adverse Event|9|||
161375783|NCT00251693|582766033|FG002|Overall Study|Adverse Event|9|||
161375784|NCT00251693|582766031|FG000|Overall Study|Protocol Violation|2|||
161375785|NCT00251693|582766032|FG001|Overall Study|Protocol Violation|0|||
161375786|NCT00251693|582766033|FG002|Overall Study|Protocol Violation|2|||
161375787|NCT00251693|582766031|FG000|Overall Study|Lost to Follow-up|12|||
161375788|NCT00251693|582766032|FG001|Overall Study|Lost to Follow-up|7|||
161375789|NCT00251693|582766033|FG002|Overall Study|Lost to Follow-up|8|||
161375790|NCT00251693|582766031|FG000|Overall Study|Withdrawal by Subject|11|||
161375791|NCT00251693|582766032|FG001|Overall Study|Withdrawal by Subject|17|||
161375792|NCT00251693|582766033|FG002|Overall Study|Withdrawal by Subject|14|||
161375793|NCT00251693|582766031|FG000|Overall Study|Lack of Efficacy|0|||
161375794|NCT00251693|582766032|FG001|Overall Study|Lack of Efficacy|1|||
161375795|NCT00251693|582766033|FG002|Overall Study|Lack of Efficacy|0|||
161375796|NCT00251693|582766031|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
161375797|NCT00251693|582766032|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
161375798|NCT00251693|582766033|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
161375799|NCT00251693|582766031|FG000|Overall Study|Noncompliant|0|||
161375800|NCT00251693|582766032|FG001|Overall Study|Noncompliant|0|||
161375801|NCT00251693|582766033|FG002|Overall Study|Noncompliant|2|||
161375802|NCT00251693|582766031|FG000|Overall Study|Possible Barrett's esophagus|3|||
161375803|NCT00251693|582766032|FG001|Overall Study|Possible Barrett's esophagus|5|||
161375804|NCT00251693|582766033|FG002|Overall Study|Possible Barrett's esophagus|2|||
161375805|NCT00251693|582766031|FG000|Overall Study|Subject request/subject unavailable|1|||
161375806|NCT00251693|582766032|FG001|Overall Study|Subject request/subject unavailable|2|||
161375807|NCT00251693|582766033|FG002|Overall Study|Subject request/subject unavailable|0|||
161375808|NCT00251693|582766031|FG000|Overall Study|Abnormal laboratory findings|0|||
161375809|NCT00251693|582766032|FG001|Overall Study|Abnormal laboratory findings|0|||
161375810|NCT00251693|582766033|FG002|Overall Study|Abnormal laboratory findings|1|||
161375811|NCT01030822|582766035|FG000|Overall Study|Moved/migrated from study area|6|||
161375812|NCT01030822|582766036|FG001|Overall Study|Moved/migrated from study area|7|||
161375813|NCT01030822|582766037|FG002|Overall Study|Moved/migrated from study area|3|||
161375814|NCT01030822|582766035|FG000|Overall Study|Withdrawal by Subject|16|||
161375815|NCT01030822|582766036|FG001|Overall Study|Withdrawal by Subject|13|||
161375816|NCT01030822|582766037|FG002|Overall Study|Withdrawal by Subject|16|||
161375817|NCT01030822|582766035|FG000|Overall Study|Lost to Follow-up|9|||
161375818|NCT01030822|582766036|FG001|Overall Study|Lost to Follow-up|4|||
161375819|NCT01030822|582766037|FG002|Overall Study|Lost to Follow-up|7|||
161375820|NCT00120627|582766043|FG000|Overall Study|Withdrawal by Subject|5|||
161375821|NCT00120627|582766044|FG001|Overall Study|Withdrawal by Subject|5|||
161375822|NCT03386435|582766045|FG000|Overall Study|Protocol Violation|5|||
161375823|NCT03386435|582766046|FG001|Overall Study|Protocol Violation|7|||
161375824|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
161375825|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
161375826|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
161375827|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
161375828|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
161375829|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
161375830|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
161375831|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
161375832|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
161375833|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
161375834|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
161375835|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
161375836|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
161375837|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
161375838|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
161375839|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
161375840|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
161375841|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
161375842|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
161375843|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
161375844|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
161375845|NCT04021290|582766047|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
161375846|NCT04021290|582766048|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
161375847|NCT04021290|582766049|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
161375848|NCT04021290|582766047|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
161375849|NCT04021290|582766048|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
161375850|NCT04021290|582766049|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
161375851|NCT04021290|582766047|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
161375852|NCT04021290|582766048|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
161375853|NCT04021290|582766049|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
161375854|NCT04021290|582766047|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
161375855|NCT04021290|582766048|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
161375856|NCT04021290|582766049|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
161375857|NCT04021290|582766047|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
161375858|NCT04021290|582766048|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
161375859|NCT04021290|582766049|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
161375860|NCT03391882|582766050|FG000|Study Overall|Adverse Event|3|||
161375861|NCT03391882|582766051|FG001|Study Overall|Adverse Event|6|||
161375862|NCT03391882|582766052|FG002|Study Overall|Adverse Event|1|||
161375863|NCT03391882|582766053|FG003|Study Overall|Adverse Event|1|||
161375864|NCT03391882|582766054|FG004|Study Overall|Adverse Event|3|||
161375865|NCT03391882|582766055|FG005|Study Overall|Adverse Event|1|||
161375866|NCT03391882|582766050|FG000|Study Overall|Lack of Efficacy|13|||
161375867|NCT03391882|582766051|FG001|Study Overall|Lack of Efficacy|9|||
161375868|NCT03391882|582766052|FG002|Study Overall|Lack of Efficacy|0|||
161375869|NCT03391882|582766053|FG003|Study Overall|Lack of Efficacy|0|||
161375870|NCT03391882|582766054|FG004|Study Overall|Lack of Efficacy|0|||
161375871|NCT03391882|582766055|FG005|Study Overall|Lack of Efficacy|0|||
161375872|NCT03391882|582766050|FG000|Study Overall|Withdrawal by Subject|3|||
161375873|NCT03391882|582766051|FG001|Study Overall|Withdrawal by Subject|3|||
161375874|NCT03391882|582766052|FG002|Study Overall|Withdrawal by Subject|2|||
161375875|NCT03391882|582766053|FG003|Study Overall|Withdrawal by Subject|2|||
161375876|NCT03391882|582766054|FG004|Study Overall|Withdrawal by Subject|1|||
161375877|NCT03391882|582766055|FG005|Study Overall|Withdrawal by Subject|3|||
161375878|NCT03391882|582766050|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161375879|NCT03391882|582766051|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
161375880|NCT03391882|582766052|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161375881|NCT03391882|582766053|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161375882|NCT03391882|582766054|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161375883|NCT03391882|582766055|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161375884|NCT03391882|582766050|FG000|Study Overall|Protocol Violation|1|||
161375885|NCT03391882|582766051|FG001|Study Overall|Protocol Violation|0|||
161375886|NCT03391882|582766052|FG002|Study Overall|Protocol Violation|0|||
161375887|NCT03391882|582766053|FG003|Study Overall|Protocol Violation|0|||
161375888|NCT03391882|582766054|FG004|Study Overall|Protocol Violation|0|||
161375889|NCT03391882|582766055|FG005|Study Overall|Protocol Violation|0|||
161375890|NCT03391882|582766050|FG000|Part A - Titration Phase|Adverse Event|3|||
161375891|NCT03391882|582766051|FG001|Part A - Titration Phase|Adverse Event|6|||
161375892|NCT03391882|582766052|FG002|Part A - Titration Phase|Adverse Event|0|||
161375893|NCT03391882|582766053|FG003|Part A - Titration Phase|Adverse Event|0|||
161375894|NCT03391882|582766054|FG004|Part A - Titration Phase|Adverse Event|0|||
161375895|NCT03391882|582766055|FG005|Part A - Titration Phase|Adverse Event|0|||
161375896|NCT03391882|582766050|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
161375897|NCT03391882|582766051|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
161375898|NCT03391882|582766052|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
161375899|NCT03391882|582766053|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
161375900|NCT03391882|582766054|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
161375901|NCT03391882|582766055|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
161375902|NCT03391882|582766050|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
161375903|NCT03391882|582766051|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
161375904|NCT03391882|582766052|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
161375905|NCT03391882|582766053|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
161375906|NCT03391882|582766054|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
161375907|NCT03391882|582766055|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
161375908|NCT03391882|582766050|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161375909|NCT03391882|582766051|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
161375910|NCT03391882|582766052|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161375911|NCT03391882|582766053|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161375912|NCT03391882|582766054|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161375913|NCT03391882|582766055|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161375914|NCT03391882|582766050|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
161375915|NCT03391882|582766051|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
161375916|NCT03391882|582766052|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
161375917|NCT03391882|582766053|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
161375918|NCT03391882|582766054|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
161375919|NCT03391882|582766055|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
161375920|NCT03391882|582766050|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
161375921|NCT03391882|582766051|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
161375922|NCT03391882|582766052|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
161375923|NCT03391882|582766053|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
161375924|NCT03391882|582766054|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
161375925|NCT03391882|582766055|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
161375926|NCT03391882|582766050|FG000|Part B - Treatment Phase|Adverse Event|0|||
161375927|NCT03391882|582766051|FG001|Part B - Treatment Phase|Adverse Event|0|||
161375928|NCT03391882|582766052|FG002|Part B - Treatment Phase|Adverse Event|1|||
161375929|NCT03391882|582766053|FG003|Part B - Treatment Phase|Adverse Event|1|||
161375930|NCT03391882|582766054|FG004|Part B - Treatment Phase|Adverse Event|3|||
161375931|NCT03391882|582766055|FG005|Part B - Treatment Phase|Adverse Event|1|||
161375932|NCT03391882|582766050|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
161375933|NCT03391882|582766051|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
161375934|NCT03391882|582766052|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
161375935|NCT03391882|582766053|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
161375936|NCT03391882|582766054|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
161375937|NCT03391882|582766055|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
161375938|NCT03092479|582766056|FG000|Overall Study|Lost to Follow-up|3|||
161375939|NCT03092479|582766057|FG001|Overall Study|Lost to Follow-up|2|||
161375940|NCT03092479|582766056|FG000|Overall Study|Withdrawal by Subject|4|||
161375941|NCT03092479|582766057|FG001|Overall Study|Withdrawal by Subject|0|||
161375942|NCT03913130|582766060|FG000|Overall Study|Sponsor Decision|1|||
161375943|NCT04046939|582766065|FG000|Primary Assessment Period|Adverse Event|1|||
161375944|NCT04046939|582766066|FG001|Primary Assessment Period|Adverse Event|0|||
161375945|NCT04046939|582766067|FG002|Primary Assessment Period|Adverse Event|0|||
161375946|NCT04046939|582766068|FG003|Primary Assessment Period|Adverse Event|0|||
161375947|NCT04046939|582766065|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
161375948|NCT04046939|582766066|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
161375949|NCT04046939|582766067|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
161375950|NCT04046939|582766068|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
161375951|NCT04046939|582766065|FG000|Primary Assessment Period|Physician Decision|0|||
161375952|NCT04046939|582766066|FG001|Primary Assessment Period|Physician Decision|0|||
161375953|NCT04046939|582766067|FG002|Primary Assessment Period|Physician Decision|1|||
161375954|NCT04046939|582766068|FG003|Primary Assessment Period|Physician Decision|0|||
161375955|NCT04046939|582766065|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
161375956|NCT04046939|582766066|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
161375957|NCT04046939|582766067|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
161375958|NCT04046939|582766068|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
161375959|NCT00038948|582766069|FG000|Overall Study|Adverse Event|131|||
161375960|NCT00038948|582766070|FG001|Overall Study|Adverse Event|43|||
161375961|NCT00038948|582766069|FG000|Overall Study|Lost to Follow-up|4|||
161375962|NCT00038948|582766070|FG001|Overall Study|Lost to Follow-up|4|||
161375963|NCT00038948|582766069|FG000|Overall Study|Nonmedical event|5|||
161375964|NCT00038948|582766070|FG001|Overall Study|Nonmedical event|7|||
161375965|NCT00038948|582766069|FG000|Overall Study|Withdrawal by Subject|23|||
161375966|NCT00038948|582766070|FG001|Overall Study|Withdrawal by Subject|10|||
161375967|NCT00038948|582766069|FG000|Overall Study|Protocol Violation|3|||
161375968|NCT00038948|582766070|FG001|Overall Study|Protocol Violation|7|||
161375969|NCT00038948|582766069|FG000|Overall Study|Lack of Efficacy|3|||
161375970|NCT00038948|582766070|FG001|Overall Study|Lack of Efficacy|6|||
161375971|NCT02549989|582767716|FG000|Overall Study|Adverse Event|4|||
161375972|NCT02549989|582767716|FG000|Overall Study|Death|1|||
161375973|NCT02549989|582767716|FG000|Overall Study|Lack of Efficacy|19|||
161375974|NCT02549989|582767716|FG000|Overall Study|Withdrawal by Subject|3|||
161375975|NCT01333722|582767720|FG000|Overall Study|Lack of Efficacy|0|||
161375976|NCT01333722|582767721|FG001|Overall Study|Lack of Efficacy|2|||
161375977|NCT01333722|582767720|FG000|Overall Study|Withdrawal by Subject|0|||
161375978|NCT01333722|582767721|FG001|Overall Study|Withdrawal by Subject|1|||
161375979|NCT00784368|582767722|FG000|Overall Study|Physician Decision|0|||
161375980|NCT00784368|582767723|FG001|Overall Study|Physician Decision|0|||
161375981|NCT00784368|582767724|FG002|Overall Study|Physician Decision|6|||
161375982|NCT00784368|582767722|FG000|Overall Study|Lack of Efficacy|2|||
161375983|NCT00784368|582767723|FG001|Overall Study|Lack of Efficacy|0|||
161375984|NCT00784368|582767724|FG002|Overall Study|Lack of Efficacy|1|||
161375985|NCT00784368|582767722|FG000|Overall Study|Adverse Event|6|||
161375986|NCT00784368|582767723|FG001|Overall Study|Adverse Event|9|||
161375987|NCT00784368|582767724|FG002|Overall Study|Adverse Event|2|||
161375988|NCT00784368|582767722|FG000|Overall Study|Diagnosis of fever|0|||
161375989|NCT00784368|582767723|FG001|Overall Study|Diagnosis of fever|0|||
161375990|NCT00784368|582767724|FG002|Overall Study|Diagnosis of fever|1|||
161375991|NCT00784368|582767722|FG000|Overall Study|Worsening of complications|0|||
161375992|NCT00784368|582767723|FG001|Overall Study|Worsening of complications|0|||
161375993|NCT00784368|582767724|FG002|Overall Study|Worsening of complications|1|||
161375994|NCT00784368|582767722|FG000|Overall Study|Worsening of symptoms|0|||
161375995|NCT00784368|582767723|FG001|Overall Study|Worsening of symptoms|1|||
161375996|NCT00784368|582767724|FG002|Overall Study|Worsening of symptoms|0|||
161375997|NCT00784368|582767722|FG000|Overall Study|Withdrawal of informed consent|0|||
161375998|NCT00784368|582767723|FG001|Overall Study|Withdrawal of informed consent|1|||
161375999|NCT00784368|582767724|FG002|Overall Study|Withdrawal of informed consent|0|||
161376000|NCT02079909|582767725|FG000|Overall Study|Adverse Event|23|||
161376001|NCT02079909|582767726|FG001|Overall Study|Adverse Event|23|||
161376002|NCT02079909|582767727|FG002|Overall Study|Adverse Event|7|||
161376003|NCT02079909|582767725|FG000|Overall Study|Withdrawal by Subject|9|||
161376004|NCT02079909|582767726|FG001|Overall Study|Withdrawal by Subject|17|||
161376005|NCT02079909|582767727|FG002|Overall Study|Withdrawal by Subject|4|||
161376006|NCT02079909|582767725|FG000|Overall Study|Lost to Follow-up|2|||
161376007|NCT02079909|582767726|FG001|Overall Study|Lost to Follow-up|3|||
161376008|NCT02079909|582767727|FG002|Overall Study|Lost to Follow-up|1|||
161376009|NCT02079909|582767725|FG000|Overall Study|Death|2|||
161376010|NCT02079909|582767726|FG001|Overall Study|Death|2|||
161376011|NCT02079909|582767727|FG002|Overall Study|Death|0|||
161376012|NCT02079909|582767725|FG000|Overall Study|Lack of Efficacy|0|||
161376013|NCT02079909|582767726|FG001|Overall Study|Lack of Efficacy|0|||
161376014|NCT02079909|582767727|FG002|Overall Study|Lack of Efficacy|1|||
161376015|NCT02079909|582767725|FG000|Overall Study|Protocol Violation|0|||
161376016|NCT02079909|582767726|FG001|Overall Study|Protocol Violation|1|||
161376017|NCT02079909|582767727|FG002|Overall Study|Protocol Violation|1|||
161376018|NCT02079909|582767725|FG000|Overall Study|Physician Decision|0|||
161376019|NCT02079909|582767726|FG001|Overall Study|Physician Decision|1|||
161376020|NCT02079909|582767727|FG002|Overall Study|Physician Decision|1|||
161376021|NCT02079909|582767725|FG000|Overall Study|Relocation etc.|2|||
161376022|NCT02079909|582767726|FG001|Overall Study|Relocation etc.|2|||
161376023|NCT02079909|582767727|FG002|Overall Study|Relocation etc.|3|||
161376024|NCT00720356|582767732|FG000|Registration to Study|Determined to have methylated MGMT|67|||
161376025|NCT00720356|582767732|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
161376026|NCT00720356|582767732|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
161376027|NCT00720356|582767732|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
161376028|NCT00720356|582767732|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
161376029|NCT00720356|582767732|FG000|Follow up Until Death|Withdrawal by Subject|1|||
161376030|NCT00720356|582767732|FG000|Follow up Until Death|Alive at last data collection|4|||
161376031|NCT02237001|582767735|FG000|Overall Study|Lost to Follow-up|2|||
161376032|NCT02237001|582767735|FG000|Overall Study|Withdrawal by Subject|1|||
161376033|NCT02237001|582767735|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
161376034|NCT02237001|582767735|FG000|Overall Study|Re-operation|4|||
161376035|NCT02237001|582767735|FG000|Overall Study|Incarceration|1|||
161376036|NCT01713582|582767736|FG000|Overall Study|Disease progression|3|||
161376037|NCT01713582|582767737|FG001|Overall Study|Disease progression|3|||
161376038|NCT01713582|582767738|FG002|Overall Study|Disease progression|3|||
161376039|NCT01713582|582767739|FG003|Overall Study|Disease progression|2|||
161376040|NCT01713582|582767740|FG004|Overall Study|Disease progression|3|||
161376041|NCT01713582|582767741|FG005|Overall Study|Disease progression|3|||
161376042|NCT01713582|582767742|FG006|Overall Study|Disease progression|3|||
161376043|NCT01713582|582767743|FG007|Overall Study|Disease progression|3|||
161376044|NCT01713582|582767744|FG008|Overall Study|Disease progression|3|||
161376045|NCT01713582|582767745|FG009|Overall Study|Disease progression|11|||
161376046|NCT01713582|582767746|FG010|Overall Study|Disease progression|10|||
161376047|NCT01713582|582767747|FG011|Overall Study|Disease progression|5|||
161376048|NCT01713582|582767748|FG012|Overall Study|Disease progression|3|||
161376049|NCT01713582|582767749|FG013|Overall Study|Disease progression|3|||
161376050|NCT01713582|582767750|FG014|Overall Study|Disease progression|6|||
161376051|NCT01713582|582767751|FG015|Overall Study|Disease progression|6|||
161376052|NCT01713582|582767752|FG016|Overall Study|Disease progression|5|||
161376053|NCT01713582|582767753|FG017|Overall Study|Disease progression|2|||
161376054|NCT01713582|582767754|FG018|Overall Study|Disease progression|3|||
161376055|NCT01713582|582767755|FG019|Overall Study|Disease progression|5|||
161376056|NCT01713582|582767756|FG020|Overall Study|Disease progression|15|||
161376057|NCT01713582|582767736|FG000|Overall Study|Death|0|||
161376058|NCT01713582|582767737|FG001|Overall Study|Death|0|||
161376059|NCT01713582|582767738|FG002|Overall Study|Death|0|||
161376060|NCT01713582|582767739|FG003|Overall Study|Death|1|||
161376061|NCT01713582|582767740|FG004|Overall Study|Death|1|||
161376062|NCT01713582|582767741|FG005|Overall Study|Death|3|||
161376063|NCT01713582|582767742|FG006|Overall Study|Death|3|||
161376064|NCT01713582|582767743|FG007|Overall Study|Death|2|||
161376065|NCT01713582|582767744|FG008|Overall Study|Death|3|||
161376066|NCT01713582|582767745|FG009|Overall Study|Death|4|||
161376067|NCT01713582|582767746|FG010|Overall Study|Death|3|||
161376068|NCT01713582|582767747|FG011|Overall Study|Death|0|||
161376069|NCT01713582|582767748|FG012|Overall Study|Death|0|||
161376070|NCT01713582|582767749|FG013|Overall Study|Death|0|||
161376071|NCT01713582|582767750|FG014|Overall Study|Death|0|||
161376072|NCT01713582|582767751|FG015|Overall Study|Death|0|||
161376073|NCT01713582|582767752|FG016|Overall Study|Death|0|||
161376074|NCT01713582|582767753|FG017|Overall Study|Death|0|||
161376075|NCT01713582|582767754|FG018|Overall Study|Death|0|||
161376076|NCT01713582|582767755|FG019|Overall Study|Death|0|||
161376077|NCT01713582|582767756|FG020|Overall Study|Death|0|||
161376078|NCT01713582|582767736|FG000|Overall Study|Adverse event-related|0|||
161376079|NCT01713582|582767737|FG001|Overall Study|Adverse event-related|0|||
161376080|NCT01713582|582767738|FG002|Overall Study|Adverse event-related|0|||
161376081|NCT01713582|582767739|FG003|Overall Study|Adverse event-related|0|||
161376082|NCT01713582|582767740|FG004|Overall Study|Adverse event-related|0|||
161376083|NCT01713582|582767741|FG005|Overall Study|Adverse event-related|0|||
161376084|NCT01713582|582767742|FG006|Overall Study|Adverse event-related|0|||
161376085|NCT01713582|582767743|FG007|Overall Study|Adverse event-related|0|||
161376086|NCT01713582|582767744|FG008|Overall Study|Adverse event-related|0|||
161376087|NCT01713582|582767745|FG009|Overall Study|Adverse event-related|1|||
161376088|NCT01713582|582767746|FG010|Overall Study|Adverse event-related|1|||
161376089|NCT01713582|582767747|FG011|Overall Study|Adverse event-related|0|||
161376090|NCT01713582|582767748|FG012|Overall Study|Adverse event-related|0|||
161376091|NCT01713582|582767749|FG013|Overall Study|Adverse event-related|0|||
161376092|NCT01713582|582767750|FG014|Overall Study|Adverse event-related|0|||
161376093|NCT01713582|582767751|FG015|Overall Study|Adverse event-related|0|||
161376094|NCT01713582|582767752|FG016|Overall Study|Adverse event-related|0|||
161376095|NCT01713582|582767753|FG017|Overall Study|Adverse event-related|0|||
161376096|NCT01713582|582767754|FG018|Overall Study|Adverse event-related|1|||
161376097|NCT01713582|582767755|FG019|Overall Study|Adverse event-related|0|||
161376098|NCT01713582|582767756|FG020|Overall Study|Adverse event-related|0|||
161376099|NCT01713582|582767736|FG000|Overall Study|Adverse event-unrelated|0|||
161376100|NCT01713582|582767737|FG001|Overall Study|Adverse event-unrelated|0|||
161376101|NCT01713582|582767738|FG002|Overall Study|Adverse event-unrelated|0|||
161376102|NCT01713582|582767739|FG003|Overall Study|Adverse event-unrelated|0|||
161376103|NCT01713582|582767740|FG004|Overall Study|Adverse event-unrelated|0|||
161376104|NCT01713582|582767741|FG005|Overall Study|Adverse event-unrelated|1|||
161376105|NCT01713582|582767742|FG006|Overall Study|Adverse event-unrelated|1|||
161376106|NCT01713582|582767743|FG007|Overall Study|Adverse event-unrelated|1|||
161376107|NCT01713582|582767744|FG008|Overall Study|Adverse event-unrelated|0|||
161376108|NCT01713582|582767745|FG009|Overall Study|Adverse event-unrelated|0|||
161376109|NCT01713582|582767746|FG010|Overall Study|Adverse event-unrelated|0|||
161376110|NCT01713582|582767747|FG011|Overall Study|Adverse event-unrelated|0|||
161376111|NCT01713582|582767748|FG012|Overall Study|Adverse event-unrelated|0|||
161376112|NCT01713582|582767749|FG013|Overall Study|Adverse event-unrelated|1|||
161376113|NCT01713582|582767750|FG014|Overall Study|Adverse event-unrelated|1|||
161376114|NCT01713582|582767751|FG015|Overall Study|Adverse event-unrelated|0|||
161376115|NCT01713582|582767752|FG016|Overall Study|Adverse event-unrelated|0|||
161376116|NCT01713582|582767753|FG017|Overall Study|Adverse event-unrelated|0|||
161376117|NCT01713582|582767754|FG018|Overall Study|Adverse event-unrelated|0|||
161376118|NCT01713582|582767755|FG019|Overall Study|Adverse event-unrelated|0|||
161376119|NCT01713582|582767756|FG020|Overall Study|Adverse event-unrelated|0|||
161376120|NCT01713582|582767736|FG000|Overall Study|Withdrawal of consent|0|||
161376121|NCT01713582|582767737|FG001|Overall Study|Withdrawal of consent|0|||
161376122|NCT01713582|582767738|FG002|Overall Study|Withdrawal of consent|1|||
161376123|NCT01713582|582767739|FG003|Overall Study|Withdrawal of consent|0|||
161376124|NCT01713582|582767740|FG004|Overall Study|Withdrawal of consent|0|||
161376125|NCT01713582|582767741|FG005|Overall Study|Withdrawal of consent|1|||
161376126|NCT01713582|582767742|FG006|Overall Study|Withdrawal of consent|0|||
161376127|NCT01713582|582767743|FG007|Overall Study|Withdrawal of consent|0|||
161376128|NCT01713582|582767744|FG008|Overall Study|Withdrawal of consent|0|||
161376129|NCT01713582|582767745|FG009|Overall Study|Withdrawal of consent|1|||
161376130|NCT01713582|582767746|FG010|Overall Study|Withdrawal of consent|0|||
161376131|NCT01713582|582767747|FG011|Overall Study|Withdrawal of consent|0|||
161376132|NCT01713582|582767748|FG012|Overall Study|Withdrawal of consent|0|||
161376133|NCT01713582|582767749|FG013|Overall Study|Withdrawal of consent|0|||
161376134|NCT01713582|582767750|FG014|Overall Study|Withdrawal of consent|0|||
161376135|NCT01713582|582767751|FG015|Overall Study|Withdrawal of consent|0|||
161376136|NCT01713582|582767752|FG016|Overall Study|Withdrawal of consent|0|||
161376137|NCT01713582|582767753|FG017|Overall Study|Withdrawal of consent|0|||
161376138|NCT01713582|582767754|FG018|Overall Study|Withdrawal of consent|1|||
161376139|NCT01713582|582767755|FG019|Overall Study|Withdrawal of consent|0|||
161376140|NCT01713582|582767756|FG020|Overall Study|Withdrawal of consent|0|||
161376141|NCT01713582|582767736|FG000|Overall Study|Lack of Efficacy|0|||
161376142|NCT01713582|582767737|FG001|Overall Study|Lack of Efficacy|0|||
161376143|NCT01713582|582767738|FG002|Overall Study|Lack of Efficacy|0|||
161376144|NCT01713582|582767739|FG003|Overall Study|Lack of Efficacy|0|||
161376145|NCT01713582|582767740|FG004|Overall Study|Lack of Efficacy|0|||
161376146|NCT01713582|582767741|FG005|Overall Study|Lack of Efficacy|0|||
161376147|NCT01713582|582767742|FG006|Overall Study|Lack of Efficacy|0|||
161376148|NCT01713582|582767743|FG007|Overall Study|Lack of Efficacy|0|||
161376149|NCT01713582|582767744|FG008|Overall Study|Lack of Efficacy|0|||
161376150|NCT01713582|582767745|FG009|Overall Study|Lack of Efficacy|1|||
161376151|NCT01713582|582767746|FG010|Overall Study|Lack of Efficacy|2|||
161376152|NCT01713582|582767747|FG011|Overall Study|Lack of Efficacy|0|||
161376153|NCT01713582|582767748|FG012|Overall Study|Lack of Efficacy|0|||
161376154|NCT01713582|582767749|FG013|Overall Study|Lack of Efficacy|0|||
161376155|NCT01713582|582767750|FG014|Overall Study|Lack of Efficacy|0|||
161376156|NCT01713582|582767751|FG015|Overall Study|Lack of Efficacy|0|||
161376157|NCT01713582|582767752|FG016|Overall Study|Lack of Efficacy|0|||
161376158|NCT01713582|582767753|FG017|Overall Study|Lack of Efficacy|0|||
161376159|NCT01713582|582767754|FG018|Overall Study|Lack of Efficacy|0|||
161376160|NCT01713582|582767755|FG019|Overall Study|Lack of Efficacy|0|||
161376161|NCT01713582|582767756|FG020|Overall Study|Lack of Efficacy|0|||
161376162|NCT01713582|582767736|FG000|Overall Study|Withdrawal by Subject|0|||
161376163|NCT01713582|582767737|FG001|Overall Study|Withdrawal by Subject|0|||
161376164|NCT01713582|582767738|FG002|Overall Study|Withdrawal by Subject|0|||
161376165|NCT01713582|582767739|FG003|Overall Study|Withdrawal by Subject|0|||
161376166|NCT01713582|582767740|FG004|Overall Study|Withdrawal by Subject|0|||
161376167|NCT01713582|582767741|FG005|Overall Study|Withdrawal by Subject|0|||
161376168|NCT01713582|582767742|FG006|Overall Study|Withdrawal by Subject|0|||
161376169|NCT01713582|582767743|FG007|Overall Study|Withdrawal by Subject|0|||
161376170|NCT01713582|582767744|FG008|Overall Study|Withdrawal by Subject|0|||
161376171|NCT01713582|582767745|FG009|Overall Study|Withdrawal by Subject|0|||
161376172|NCT01713582|582767746|FG010|Overall Study|Withdrawal by Subject|0|||
161376173|NCT01713582|582767747|FG011|Overall Study|Withdrawal by Subject|0|||
161376174|NCT01713582|582767748|FG012|Overall Study|Withdrawal by Subject|0|||
161376175|NCT01713582|582767749|FG013|Overall Study|Withdrawal by Subject|0|||
161376176|NCT01713582|582767750|FG014|Overall Study|Withdrawal by Subject|0|||
161376177|NCT01713582|582767751|FG015|Overall Study|Withdrawal by Subject|0|||
161376178|NCT01713582|582767752|FG016|Overall Study|Withdrawal by Subject|0|||
161376179|NCT01713582|582767753|FG017|Overall Study|Withdrawal by Subject|1|||
161376180|NCT01713582|582767754|FG018|Overall Study|Withdrawal by Subject|0|||
161376181|NCT01713582|582767755|FG019|Overall Study|Withdrawal by Subject|0|||
161376182|NCT01713582|582767756|FG020|Overall Study|Withdrawal by Subject|0|||
161376183|NCT01713582|582767736|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
161376184|NCT01713582|582767737|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
161376185|NCT01713582|582767738|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
161376186|NCT01713582|582767739|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
161376187|NCT01713582|582767740|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
161376188|NCT01713582|582767741|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
161376189|NCT01713582|582767742|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
161376190|NCT01713582|582767743|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
161376191|NCT01713582|582767744|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
161376192|NCT01713582|582767745|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
161376193|NCT01713582|582767746|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
161376194|NCT01713582|582767747|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
161376195|NCT01713582|582767748|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
161376196|NCT01713582|582767749|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
161376197|NCT01713582|582767750|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
161376198|NCT01713582|582767751|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
161376199|NCT01713582|582767752|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
161376200|NCT01713582|582767753|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
161376201|NCT01713582|582767754|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
161376202|NCT01713582|582767755|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
161376203|NCT01713582|582767756|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
161376204|NCT01713582|582767736|FG000|Overall Study|Disease progression and adverse event|0|||
161376205|NCT01713582|582767737|FG001|Overall Study|Disease progression and adverse event|0|||
161376206|NCT01713582|582767738|FG002|Overall Study|Disease progression and adverse event|0|||
161376207|NCT01713582|582767739|FG003|Overall Study|Disease progression and adverse event|0|||
161376208|NCT01713582|582767740|FG004|Overall Study|Disease progression and adverse event|0|||
161376209|NCT01713582|582767741|FG005|Overall Study|Disease progression and adverse event|0|||
161376210|NCT01713582|582767742|FG006|Overall Study|Disease progression and adverse event|0|||
161376211|NCT01713582|582767743|FG007|Overall Study|Disease progression and adverse event|0|||
161376212|NCT01713582|582767744|FG008|Overall Study|Disease progression and adverse event|0|||
161376213|NCT01713582|582767745|FG009|Overall Study|Disease progression and adverse event|0|||
161376214|NCT01713582|582767746|FG010|Overall Study|Disease progression and adverse event|0|||
161376215|NCT01713582|582767747|FG011|Overall Study|Disease progression and adverse event|0|||
161376216|NCT01713582|582767748|FG012|Overall Study|Disease progression and adverse event|0|||
161376217|NCT01713582|582767749|FG013|Overall Study|Disease progression and adverse event|0|||
161376218|NCT01713582|582767750|FG014|Overall Study|Disease progression and adverse event|0|||
161376219|NCT01713582|582767751|FG015|Overall Study|Disease progression and adverse event|0|||
161376220|NCT01713582|582767752|FG016|Overall Study|Disease progression and adverse event|1|||
161376221|NCT01713582|582767753|FG017|Overall Study|Disease progression and adverse event|0|||
161376222|NCT01713582|582767754|FG018|Overall Study|Disease progression and adverse event|0|||
161376223|NCT01713582|582767755|FG019|Overall Study|Disease progression and adverse event|0|||
161376224|NCT01713582|582767756|FG020|Overall Study|Disease progression and adverse event|0|||
161376225|NCT03427814|582767757|FG000|Overall Study|Withdrawal by Subject|4|||
161376226|NCT03427814|582767758|FG001|Overall Study|Withdrawal by Subject|4|||
161376227|NCT03427814|582767757|FG000|Overall Study|Lost to Follow-up|0|||
161376228|NCT03427814|582767758|FG001|Overall Study|Lost to Follow-up|2|||
161376229|NCT03427814|582767757|FG000|Overall Study|Death|42|||
161376230|NCT03427814|582767758|FG001|Overall Study|Death|31|||
161376231|NCT03427814|582767757|FG000|Overall Study|Sponsor's Decision|1|||
161376232|NCT03427814|582767758|FG001|Overall Study|Sponsor's Decision|0|||
161376233|NCT03427814|582767757|FG000|Overall Study|Investigator's Decision|1|||
161376234|NCT03427814|582767758|FG001|Overall Study|Investigator's Decision|2|||
161376235|NCT03427814|582767757|FG000|Overall Study|Disease progression|1|||
161376236|NCT03427814|582767758|FG001|Overall Study|Disease progression|0|||
161376237|NCT03427814|582767757|FG000|Overall Study|Treatment Completed|0|||
161376238|NCT03427814|582767758|FG001|Overall Study|Treatment Completed|1|||
161376239|NCT03427814|582767757|FG000|Overall Study|Sponsor's Decision to End study|21|||
161376240|NCT03427814|582767758|FG001|Overall Study|Sponsor's Decision to End study|25|||
161376241|NCT03427814|582767757|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
161376242|NCT03427814|582767758|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
161376243|NCT03846427|582767759|FG000|Overall Study|Death|13|||
161376244|NCT03846427|582767759|FG000|Overall Study|Withdrawal by Subject|3|||
161376245|NCT03846427|582767759|FG000|Overall Study|Physician Decision|1|||
161376246|NCT01334554|582767760|FG000|Overall Study|Adverse Event|4|||
161376247|NCT01334554|582767761|FG001|Overall Study|Adverse Event|2|||
161376248|NCT02393859|582767763|FG000|Overall Study|Decision by Sponsor|2|||
161376249|NCT02393859|582767764|FG001|Overall Study|Decision by Sponsor|4|||
161376250|NCT02393859|582767763|FG000|Overall Study|Withdrawal by Subject|11|||
161376251|NCT02393859|582767764|FG001|Overall Study|Withdrawal by Subject|6|||
161376252|NCT02393859|582767763|FG000|Overall Study|Death|27|||
161376253|NCT02393859|582767764|FG001|Overall Study|Death|10|||
161376254|NCT02393859|582767763|FG000|Overall Study|Lost to Follow-up|1|||
161376255|NCT02393859|582767764|FG001|Overall Study|Lost to Follow-up|1|||
161376256|NCT00954447|582767765|FG000|Overall Study|Adverse Event|33|||
161376257|NCT00954447|582767766|FG001|Overall Study|Adverse Event|25|||
161376258|NCT00954447|582767765|FG000|Overall Study|Lack of Efficacy|17|||
161376259|NCT00954447|582767766|FG001|Overall Study|Lack of Efficacy|3|||
161376260|NCT00954447|582767765|FG000|Overall Study|Protocol Violation|5|||
161376261|NCT00954447|582767766|FG001|Overall Study|Protocol Violation|7|||
161376262|NCT00954447|582767765|FG000|Overall Study|Lost to Follow-up|8|||
161376263|NCT00954447|582767766|FG001|Overall Study|Lost to Follow-up|14|||
161376264|NCT00954447|582767765|FG000|Overall Study|Withdrawal by Subject|26|||
161376265|NCT00954447|582767766|FG001|Overall Study|Withdrawal by Subject|21|||
161376266|NCT00954447|582767765|FG000|Overall Study|Other|21|||
161376267|NCT00954447|582767766|FG001|Overall Study|Other|18|||
161376268|NCT00488514|582767767|FG000|Overall Study|Adverse Event|41|||
161376269|NCT00488514|582767767|FG000|Overall Study|Lost to Follow-up|44|||
161376270|NCT00488514|582767767|FG000|Overall Study|Protocol Violation|32|||
161376271|NCT00488514|582767767|FG000|Overall Study|Withdrawal by Subject|106|||
161376272|NCT00488514|582767767|FG000|Overall Study|Lack of Efficacy|28|||
161376273|NCT00488514|582767767|FG000|Overall Study|Did not meet criteria for treatment|30|||
161376274|NCT00488514|582767767|FG000|Overall Study|Postive drug screen|1|||
161376275|NCT00488514|582767767|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
161376276|NCT00488514|582767767|FG000|Overall Study|Investigator decision|1|||
161376277|NCT00488514|582767767|FG000|Overall Study|Participant had too few migraines|5|||
161376278|NCT00488514|582767767|FG000|Overall Study|Increase in number of migraines|2|||
161376279|NCT00488514|582767767|FG000|Overall Study|Increased use of concomitant medication|1|||
161376280|NCT00305877|582767768|FG000|Overall Study|Lack of Efficacy|6|||
161376281|NCT00305877|582767769|FG001|Overall Study|Lack of Efficacy|9|||
161376282|NCT00305877|582767768|FG000|Overall Study|Adverse Event|9|||
161376283|NCT00305877|582767769|FG001|Overall Study|Adverse Event|14|||
161376284|NCT00305877|582767768|FG000|Overall Study|Death|0|||
161376285|NCT00305877|582767769|FG001|Overall Study|Death|1|||
161376286|NCT00305877|582767768|FG000|Overall Study|Withdrawal by Subject|4|||
161376287|NCT00305877|582767769|FG001|Overall Study|Withdrawal by Subject|2|||
161376288|NCT00305877|582767768|FG000|Overall Study|Physician Decision|1|||
161376289|NCT00305877|582767769|FG001|Overall Study|Physician Decision|1|||
161376290|NCT00305877|582767768|FG000|Overall Study|Never start treatment|2|||
161376291|NCT00305877|582767769|FG001|Overall Study|Never start treatment|5|||
161376292|NCT00305877|582767768|FG000|Overall Study|Ineligible|2|||
161376293|NCT00305877|582767769|FG001|Overall Study|Ineligible|1|||
161376294|NCT00305877|582767768|FG000|Overall Study|Transportation issue with daily RT|0|||
161376295|NCT00305877|582767769|FG001|Overall Study|Transportation issue with daily RT|1|||
161376296|NCT00457392|582767770|FG000|Overall Study|Objective Progression or Relapse|229|||
161376297|NCT00457392|582767771|FG001|Overall Study|Objective Progression or Relapse|296|||
161376298|NCT00457392|582767770|FG000|Overall Study|Death|106|||
161376299|NCT00457392|582767771|FG001|Overall Study|Death|106|||
161376300|NCT00457392|582767770|FG000|Overall Study|Adverse Event|84|||
161376301|NCT00457392|582767771|FG001|Overall Study|Adverse Event|41|||
161376302|NCT00457392|582767770|FG000|Overall Study|Global Deterioration of Health Status|22|||
161376303|NCT00457392|582767771|FG001|Overall Study|Global Deterioration of Health Status|8|||
161376304|NCT00457392|582767770|FG000|Overall Study|Withdrawal by Subject|14|||
161376305|NCT00457392|582767771|FG001|Overall Study|Withdrawal by Subject|8|||
161376306|NCT00457392|582767770|FG000|Overall Study|Lost to Follow-up|6|||
161376307|NCT00457392|582767771|FG001|Overall Study|Lost to Follow-up|7|||
161376308|NCT00457392|582767770|FG000|Overall Study|Protocol Violation|4|||
161376309|NCT00457392|582767771|FG001|Overall Study|Protocol Violation|3|||
161376310|NCT00457392|582767770|FG000|Overall Study|Other|7|||
161376311|NCT00457392|582767771|FG001|Overall Study|Other|4|||
161376312|NCT00457392|582767770|FG000|Overall Study|Study Terminated by Sponsor|1|||
161376313|NCT00457392|582767771|FG001|Overall Study|Study Terminated by Sponsor|4|||
161376314|NCT00457392|582767770|FG000|Overall Study|Randomized, Not Treated|7|||
161376315|NCT00457392|582767771|FG001|Overall Study|Randomized, Not Treated|3|||
161376316|NCT00756275|582767772|FG000|Overall Study|Lost to Follow-up|25|||
161376317|NCT00756275|582767773|FG001|Overall Study|Lost to Follow-up|21|||
161376318|NCT00756275|582767772|FG000|Overall Study|Withdrawal by Subject|4|||
161376319|NCT00756275|582767773|FG001|Overall Study|Withdrawal by Subject|7|||
161376320|NCT00980148|582767774|FG000|Overall Study|Discharged from facility|89|||
161376321|NCT00980148|582767775|FG001|Overall Study|Discharged from facility|96|||
161376322|NCT00980148|582767774|FG000|Overall Study|Received other antichlamydia treatment|20|||
161376323|NCT00980148|582767775|FG001|Overall Study|Received other antichlamydia treatment|14|||
161376324|NCT00980148|582767774|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
161376325|NCT00980148|582767775|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
161376326|NCT00980148|582767774|FG000|Overall Study|Various other reasons|8|||
161376327|NCT00980148|582767775|FG001|Overall Study|Various other reasons|9|||
161376328|NCT03012334|582767778|FG000|Period 1|Withdrawal by Subject|0|||
161376329|NCT03012334|582767779|FG001|Period 1|Withdrawal by Subject|0|||
161376330|NCT03012334|582767780|FG002|Period 1|Withdrawal by Subject|0|||
161376331|NCT03012334|582767781|FG003|Period 1|Withdrawal by Subject|0|||
161376332|NCT03012334|582767782|FG004|Period 1|Withdrawal by Subject|0|||
161376333|NCT03012334|582767783|FG005|Period 1|Withdrawal by Subject|0|||
161376334|NCT03012334|582767784|FG006|Period 1|Withdrawal by Subject|0|||
161376335|NCT03012334|582767785|FG007|Period 1|Withdrawal by Subject|0|||
161376336|NCT03012334|582767786|FG008|Period 1|Withdrawal by Subject|0|||
161376337|NCT03012334|582767787|FG009|Period 1|Withdrawal by Subject|1|||
161376338|NCT03012334|582767778|FG000|Period 2|Withdrawal by Subject|0|||
161376339|NCT03012334|582767779|FG001|Period 2|Withdrawal by Subject|1|||
161376340|NCT03012334|582767780|FG002|Period 2|Withdrawal by Subject|0|||
161376341|NCT03012334|582767781|FG003|Period 2|Withdrawal by Subject|0|||
161376342|NCT03012334|582767782|FG004|Period 2|Withdrawal by Subject|0|||
161376343|NCT03012334|582767783|FG005|Period 2|Withdrawal by Subject|0|||
161376344|NCT03012334|582767784|FG006|Period 2|Withdrawal by Subject|0|||
161376345|NCT03012334|582767785|FG007|Period 2|Withdrawal by Subject|0|||
161376346|NCT03012334|582767786|FG008|Period 2|Withdrawal by Subject|0|||
161376347|NCT03012334|582767787|FG009|Period 2|Withdrawal by Subject|0|||
161376348|NCT03012334|582767778|FG000|Period 2|Protocol Violation|0|||
161376349|NCT03012334|582767779|FG001|Period 2|Protocol Violation|0|||
161376350|NCT03012334|582767780|FG002|Period 2|Protocol Violation|1|||
161376351|NCT03012334|582767781|FG003|Period 2|Protocol Violation|0|||
161376352|NCT03012334|582767782|FG004|Period 2|Protocol Violation|0|||
161376353|NCT03012334|582767783|FG005|Period 2|Protocol Violation|0|||
161376354|NCT03012334|582767784|FG006|Period 2|Protocol Violation|0|||
161376355|NCT03012334|582767785|FG007|Period 2|Protocol Violation|1|||
161376356|NCT03012334|582767786|FG008|Period 2|Protocol Violation|0|||
161376357|NCT03012334|582767787|FG009|Period 2|Protocol Violation|0|||
161376358|NCT03012334|582767778|FG000|Period 4|Non-Compliance|0|||
161376359|NCT03012334|582767779|FG001|Period 4|Non-Compliance|0|||
161376360|NCT03012334|582767780|FG002|Period 4|Non-Compliance|0|||
161376361|NCT03012334|582767781|FG003|Period 4|Non-Compliance|0|||
161376362|NCT03012334|582767782|FG004|Period 4|Non-Compliance|0|||
161376363|NCT03012334|582767783|FG005|Period 4|Non-Compliance|0|||
161376364|NCT03012334|582767784|FG006|Period 4|Non-Compliance|1|||
161376365|NCT03012334|582767785|FG007|Period 4|Non-Compliance|0|||
161376366|NCT03012334|582767786|FG008|Period 4|Non-Compliance|0|||
161376367|NCT03012334|582767787|FG009|Period 4|Non-Compliance|0|||
161376368|NCT03012334|582767778|FG000|Period 4|Adverse Event|0|||
161376369|NCT03012334|582767779|FG001|Period 4|Adverse Event|0|||
161376370|NCT03012334|582767780|FG002|Period 4|Adverse Event|0|||
161376371|NCT03012334|582767781|FG003|Period 4|Adverse Event|0|||
161376372|NCT03012334|582767782|FG004|Period 4|Adverse Event|0|||
161376373|NCT03012334|582767783|FG005|Period 4|Adverse Event|0|||
161376374|NCT03012334|582767784|FG006|Period 4|Adverse Event|0|||
161376375|NCT03012334|582767785|FG007|Period 4|Adverse Event|0|||
161376376|NCT03012334|582767786|FG008|Period 4|Adverse Event|1|||
161376377|NCT03012334|582767787|FG009|Period 4|Adverse Event|0|||
161376378|NCT01823107|582767788|FG000|Overall Study|Withdrawal by Subject|1|||
161376379|NCT01073293|582767789|FG000|Overall Study|Lost to Follow-up|0|||
161376380|NCT01073293|582767790|FG001|Overall Study|Lost to Follow-up|1|||
161376381|NCT01073293|582767789|FG000|Overall Study|Withdrawal by Subject|5|||
161376382|NCT01073293|582767790|FG001|Overall Study|Withdrawal by Subject|10|||
161376383|NCT00328172|582767793|FG000|Overall Study|Adverse Event|3|||
161376384|NCT00328172|582767794|FG001|Overall Study|Adverse Event|2|||
161376385|NCT00328172|582767795|FG002|Overall Study|Adverse Event|1|||
161376386|NCT00328172|582767796|FG003|Overall Study|Adverse Event|2|||
161376387|NCT00328172|582767797|FG004|Overall Study|Adverse Event|1|||
161376388|NCT00328172|582767793|FG000|Overall Study|Protocol Violation|0|||
161376389|NCT00328172|582767794|FG001|Overall Study|Protocol Violation|1|||
161376390|NCT00328172|582767795|FG002|Overall Study|Protocol Violation|1|||
161376391|NCT00328172|582767796|FG003|Overall Study|Protocol Violation|0|||
161376392|NCT00328172|582767797|FG004|Overall Study|Protocol Violation|0|||
161376393|NCT00328172|582767793|FG000|Overall Study|Lost to Follow-up|1|||
161376394|NCT00328172|582767794|FG001|Overall Study|Lost to Follow-up|1|||
161376395|NCT00328172|582767795|FG002|Overall Study|Lost to Follow-up|2|||
161376396|NCT00328172|582767796|FG003|Overall Study|Lost to Follow-up|1|||
161376397|NCT00328172|582767797|FG004|Overall Study|Lost to Follow-up|1|||
161376398|NCT00328172|582767793|FG000|Overall Study|Withdrawal by Subject|1|||
161376399|NCT00328172|582767794|FG001|Overall Study|Withdrawal by Subject|1|||
161376400|NCT00328172|582767795|FG002|Overall Study|Withdrawal by Subject|1|||
161376401|NCT00328172|582767796|FG003|Overall Study|Withdrawal by Subject|6|||
161376402|NCT00328172|582767797|FG004|Overall Study|Withdrawal by Subject|0|||
161376403|NCT00328172|582767793|FG000|Overall Study|Lack of Efficacy|14|||
161376404|NCT00328172|582767794|FG001|Overall Study|Lack of Efficacy|9|||
161376405|NCT00328172|582767795|FG002|Overall Study|Lack of Efficacy|4|||
161376406|NCT00328172|582767796|FG003|Overall Study|Lack of Efficacy|4|||
161376407|NCT00328172|582767797|FG004|Overall Study|Lack of Efficacy|3|||
161376408|NCT00328172|582767793|FG000|Overall Study|Other reason (not specified)|3|||
161376409|NCT00328172|582767794|FG001|Overall Study|Other reason (not specified)|0|||
161376410|NCT00328172|582767795|FG002|Overall Study|Other reason (not specified)|1|||
161376411|NCT00328172|582767796|FG003|Overall Study|Other reason (not specified)|0|||
161376412|NCT00328172|582767797|FG004|Overall Study|Other reason (not specified)|0|||
161376413|NCT00077974|582767798|FG000|Overall Study|Adverse Event|22|||
161376414|NCT00077974|582767798|FG000|Overall Study|Protocol Violation|1|||
161376415|NCT00077974|582767798|FG000|Overall Study|Withdrawal by Subject|3|||
161376416|NCT00077974|582767798|FG000|Overall Study|Lack of Efficacy|76|||
161376417|NCT00077974|582767798|FG000|Overall Study|Decision of Sponsor|2|||
161376418|NCT02897115|582767801|FG000|Overall Study|Early termination of study by sponsor|11|||
161376419|NCT02897115|582767802|FG001|Overall Study|Early termination of study by sponsor|8|||
161376420|NCT00420381|582767803|FG000|Overall Study|Protocol Violation|1|||
161376421|NCT01244035|582767815|FG000|Part 1: Period 1|Adverse Event|0|||
161376422|NCT01244035|582767816|FG001|Part 1: Period 1|Adverse Event|0|||
161376423|NCT01244035|582767817|FG002|Part 1: Period 1|Adverse Event|0|||
161376424|NCT01244035|582767818|FG003|Part 1: Period 1|Adverse Event|0|||
161376425|NCT01244035|582767819|FG004|Part 1: Period 1|Adverse Event|0|||
161376426|NCT01244035|582767820|FG005|Part 1: Period 1|Adverse Event|1|||
161376427|NCT01244035|582767815|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
161376428|NCT01244035|582767816|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
161376429|NCT01244035|582767817|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
161376430|NCT01244035|582767818|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
161376431|NCT01244035|582767819|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
161376432|NCT01244035|582767820|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
161376433|NCT01244035|582767815|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
161376434|NCT01244035|582767816|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
161376435|NCT01244035|582767817|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
161376436|NCT01244035|582767818|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
161376437|NCT01244035|582767819|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
161376438|NCT01244035|582767820|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
161376439|NCT01244035|582767815|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161376440|NCT01244035|582767816|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161376441|NCT01244035|582767817|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
161376442|NCT01244035|582767818|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161376443|NCT01244035|582767819|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161376444|NCT01244035|582767820|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161376445|NCT01244035|582767815|FG000|Part 1: Period 3|Adverse Event|0|||
161376446|NCT01244035|582767816|FG001|Part 1: Period 3|Adverse Event|0|||
161376447|NCT01244035|582767817|FG002|Part 1: Period 3|Adverse Event|0|||
161376448|NCT01244035|582767818|FG003|Part 1: Period 3|Adverse Event|0|||
161376449|NCT01244035|582767819|FG004|Part 1: Period 3|Adverse Event|0|||
161376450|NCT01244035|582767820|FG005|Part 1: Period 3|Adverse Event|1|||
161376451|NCT01244035|582767815|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
161376452|NCT01244035|582767816|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
161376453|NCT01244035|582767817|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
161376454|NCT01244035|582767818|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
161376455|NCT01244035|582767819|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
161376456|NCT01244035|582767820|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
161376457|NCT01244035|582767815|FG000|Part 1: Period 3|Protocol Deviation|0|||
161376458|NCT01244035|582767816|FG001|Part 1: Period 3|Protocol Deviation|1|||
161376459|NCT01244035|582767817|FG002|Part 1: Period 3|Protocol Deviation|0|||
161376460|NCT01244035|582767818|FG003|Part 1: Period 3|Protocol Deviation|0|||
161376461|NCT01244035|582767819|FG004|Part 1: Period 3|Protocol Deviation|0|||
161376462|NCT01244035|582767820|FG005|Part 1: Period 3|Protocol Deviation|0|||
161376463|NCT04512001|582767823|FG000|Week 0 to Week 24|Adverse Event|14|||
161376464|NCT04512001|582767824|FG001|Week 0 to Week 24|Adverse Event|10|||
161376465|NCT04512001|582767825|FG002|Week 0 to Week 24|Adverse Event|0|||
161376466|NCT04512001|582767826|FG003|Week 0 to Week 24|Adverse Event|0|||
161376467|NCT04512001|582767827|FG004|Week 0 to Week 24|Adverse Event|0|||
161376468|NCT04512001|582767823|FG000|Week 0 to Week 24|Death|0|||
161376469|NCT04512001|582767824|FG001|Week 0 to Week 24|Death|2|||
161376470|NCT04512001|582767825|FG002|Week 0 to Week 24|Death|0|||
161376471|NCT04512001|582767826|FG003|Week 0 to Week 24|Death|0|||
161376472|NCT04512001|582767827|FG004|Week 0 to Week 24|Death|0|||
161376473|NCT04512001|582767823|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
161376474|NCT04512001|582767824|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
161376475|NCT04512001|582767825|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
161376476|NCT04512001|582767826|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
161376477|NCT04512001|582767827|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
161376478|NCT04512001|582767823|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
161376479|NCT04512001|582767824|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
161376480|NCT04512001|582767825|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
161376481|NCT04512001|582767826|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
161376482|NCT04512001|582767827|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
161376483|NCT04512001|582767823|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
161376484|NCT04512001|582767824|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161376485|NCT04512001|582767825|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161376486|NCT04512001|582767826|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161376487|NCT04512001|582767827|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161376488|NCT04512001|582767823|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161376489|NCT04512001|582767824|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
161376490|NCT04512001|582767825|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161376491|NCT04512001|582767826|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161376492|NCT04512001|582767827|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161376493|NCT04512001|582767823|FG000|Week 24 to Week 63|Adverse Event|0|||
161376494|NCT04512001|582767824|FG001|Week 24 to Week 63|Adverse Event|0|||
161376495|NCT04512001|582767825|FG002|Week 24 to Week 63|Adverse Event|13|||
161376496|NCT04512001|582767826|FG003|Week 24 to Week 63|Adverse Event|8|||
161376497|NCT04512001|582767827|FG004|Week 24 to Week 63|Adverse Event|6|||
161376498|NCT04512001|582767823|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
161376499|NCT04512001|582767824|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
161376500|NCT04512001|582767825|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
161376501|NCT04512001|582767826|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
161376502|NCT04512001|582767827|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
161376503|NCT04512001|582767823|FG000|Week 24 to Week 63|Death|0|||
161376504|NCT04512001|582767824|FG001|Week 24 to Week 63|Death|0|||
161376505|NCT04512001|582767825|FG002|Week 24 to Week 63|Death|0|||
161376506|NCT04512001|582767826|FG003|Week 24 to Week 63|Death|1|||
161376507|NCT04512001|582767827|FG004|Week 24 to Week 63|Death|1|||
161376508|NCT04512001|582767823|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
161376509|NCT04512001|582767824|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
161376510|NCT04512001|582767825|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
161376511|NCT04512001|582767826|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
161376512|NCT04512001|582767827|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
161376513|NCT04512001|582767823|FG000|Week 24 to Week 63|Miscellaneous|0|||
161376514|NCT04512001|582767824|FG001|Week 24 to Week 63|Miscellaneous|0|||
161376515|NCT04512001|582767825|FG002|Week 24 to Week 63|Miscellaneous|3|||
161376516|NCT04512001|582767826|FG003|Week 24 to Week 63|Miscellaneous|2|||
161376517|NCT04512001|582767827|FG004|Week 24 to Week 63|Miscellaneous|1|||
161376518|NCT02776683|582767828|FG000|Pre-switch Period|Protocol Violation|1|||
161376519|NCT02776683|582767829|FG001|Pre-switch Period|Protocol Violation|0|||
161376520|NCT02776683|582767828|FG000|Pre-switch Period|Adverse Event|21|||
161376521|NCT02776683|582767829|FG001|Pre-switch Period|Adverse Event|0|||
161376522|NCT02776683|582767828|FG000|Pre-switch Period|Withdrawal by Subject|9|||
161376523|NCT02776683|582767829|FG001|Pre-switch Period|Withdrawal by Subject|0|||
161376524|NCT02776683|582767828|FG000|Pre-switch Period|Physician Decision|7|||
161376525|NCT02776683|582767829|FG001|Pre-switch Period|Physician Decision|0|||
161376526|NCT02776683|582767828|FG000|Pre-switch Period|Progressive disease|39|||
161376527|NCT02776683|582767829|FG001|Pre-switch Period|Progressive disease|0|||
161376528|NCT02776683|582767828|FG000|Pre-switch Period|Other than listed|3|||
161376529|NCT02776683|582767829|FG001|Pre-switch Period|Other than listed|0|||
161376530|NCT02776683|582767828|FG000|Post-switch Period|Adverse Event|0|||
161376531|NCT02776683|582767829|FG001|Post-switch Period|Adverse Event|3|||
161376532|NCT02776683|582767828|FG000|Post-switch Period|Withdrawal by Subject|0|||
161376533|NCT02776683|582767829|FG001|Post-switch Period|Withdrawal by Subject|2|||
161376534|NCT02776683|582767828|FG000|Post-switch Period|Physician Decision|0|||
161376535|NCT02776683|582767829|FG001|Post-switch Period|Physician Decision|3|||
161376536|NCT02776683|582767828|FG000|Post-switch Period|Progressive disease|0|||
161376537|NCT02776683|582767829|FG001|Post-switch Period|Progressive disease|20|||
161376538|NCT02776683|582767828|FG000|Post-switch Period|Other than listed|0|||
161376539|NCT02776683|582767829|FG001|Post-switch Period|Other than listed|15|||
161376540|NCT02298868|582767839|FG000|Overall Study|Adverse Event|1|||
161376541|NCT02298868|582767839|FG000|Overall Study|Death|1|||
161376542|NCT02298868|582767839|FG000|Overall Study|Patient underwent transplant|1|||
161376543|NCT01063348|582767840|FG000|Overall Study|Lost to Follow-up|3|||
161376544|NCT01063348|582767841|FG001|Overall Study|Lost to Follow-up|10|||
161376545|NCT02230189|582767842|FG000|Overall Study|Withdrawal by Subject|3|||
161376546|NCT02230189|582767843|FG001|Overall Study|Withdrawal by Subject|0|||
161376547|NCT02230189|582767844|FG002|Overall Study|Withdrawal by Subject|1|||
161376548|NCT02230189|582767842|FG000|Overall Study|Lost to Follow-up|1|||
161376549|NCT02230189|582767843|FG001|Overall Study|Lost to Follow-up|0|||
161376550|NCT02230189|582767844|FG002|Overall Study|Lost to Follow-up|0|||
161376551|NCT02230189|582767842|FG000|Overall Study|Physician Decision|1|||
161376552|NCT02230189|582767843|FG001|Overall Study|Physician Decision|0|||
161376553|NCT02230189|582767844|FG002|Overall Study|Physician Decision|0|||
161376554|NCT03824392|582767845|FG000|Overall Study|Adverse Event|1|||
161376555|NCT03824392|582767846|FG001|Overall Study|Adverse Event|0|||
161376556|NCT03824392|582767847|FG002|Overall Study|Adverse Event|0|||
161376557|NCT03824392|582767848|FG003|Overall Study|Adverse Event|0|||
161376558|NCT03824392|582767845|FG000|Overall Study|Investigator Decision|0|||
161376559|NCT03824392|582767846|FG001|Overall Study|Investigator Decision|1|||
161376560|NCT03824392|582767847|FG002|Overall Study|Investigator Decision|0|||
161376561|NCT03824392|582767848|FG003|Overall Study|Investigator Decision|0|||
161376562|NCT03824392|582767845|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
161376563|NCT03824392|582767846|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
161376564|NCT03824392|582767847|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
161376565|NCT03824392|582767848|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
161376566|NCT01847755|582767849|FG000|Overall Study|Adverse Event|2|||
161376567|NCT01847755|582767849|FG000|Overall Study|Withdrawal by Subject|2|||
161376568|NCT01847755|582767849|FG000|Overall Study|Physician Decision|1|||
161376569|NCT00907621|582767856|FG000|Overall Study|Lost to Follow-up|6|||
161376570|NCT00907621|582767857|FG001|Overall Study|Lost to Follow-up|3|||
161376571|NCT00907621|582767856|FG000|Overall Study|intercurrent febrile illness|1|||
161376572|NCT00907621|582767857|FG001|Overall Study|intercurrent febrile illness|1|||
161376573|NCT00959907|582767858|FG000|Overall Study|Protocol Violation|0|||
161376574|NCT00959907|582767859|FG001|Overall Study|Protocol Violation|1|||
161376575|NCT00959907|582767858|FG000|Overall Study|Adverse Event|1|||
161376576|NCT00959907|582767859|FG001|Overall Study|Adverse Event|0|||
161376577|NCT00959907|582767858|FG000|Overall Study|Withdrawal by Subject|2|||
161376578|NCT00959907|582767859|FG001|Overall Study|Withdrawal by Subject|0|||
161376579|NCT01261975|582767862|FG000|Overall Study|Surgical complication|1|||
161376580|NCT01932788|582767863|FG000|Overall Study|Protocol Violation|18|||
161376581|NCT01932788|582767864|FG001|Overall Study|Protocol Violation|0|||
161376582|NCT01932788|582767863|FG000|Overall Study|Lost to Follow-up|18|||
161376583|NCT01932788|582767864|FG001|Overall Study|Lost to Follow-up|46|||
161376584|NCT01932788|582767863|FG000|Overall Study|Lack of Efficacy|2|||
161376585|NCT01932788|582767864|FG001|Overall Study|Lack of Efficacy|0|||
161376586|NCT01932788|582767863|FG000|Overall Study|Withdrawal by Subject|0|||
161376587|NCT01932788|582767864|FG001|Overall Study|Withdrawal by Subject|5|||
161376588|NCT04290624|582767865|FG000|Overall Study|Adverse Event|1|||
161376589|NCT04290624|582767866|FG001|Overall Study|Adverse Event|0|||
161376590|NCT01171677|582767867|FG000|Overall Study|Withdrawal by Subject|0|||
161376591|NCT01171677|582767868|FG001|Overall Study|Withdrawal by Subject|3|||
161376592|NCT01171677|582767867|FG000|Overall Study|Adverse Event|1|||
161376593|NCT01171677|582767868|FG001|Overall Study|Adverse Event|0|||
161376594|NCT01171677|582767867|FG000|Overall Study|completed <70% IntenSati classes|5|||
161376595|NCT01171677|582767868|FG001|Overall Study|completed <70% IntenSati classes|0|||
161376596|NCT00656370|582767871|FG000|Overall Study|Screen Failures|7|||
161376597|NCT00656370|582767871|FG000|Overall Study|Alternates|3|||
161376598|NCT05653700|582767889|FG000|Overall Study|Non Responders|9|||
161376599|NCT05653700|582767890|FG001|Overall Study|Non Responders|0|||
161376600|NCT01900665|582767896|FG000|Placebo Controlled Period|Death|9|||
161376601|NCT01900665|582767897|FG001|Placebo Controlled Period|Death|16|||
161376602|NCT01900665|582767896|FG000|Placebo Controlled Period|Adverse Event|48|||
161376603|NCT01900665|582767897|FG001|Placebo Controlled Period|Adverse Event|39|||
161376604|NCT01900665|582767896|FG000|Placebo Controlled Period|Protocol Violation|1|||
161376605|NCT01900665|582767897|FG001|Placebo Controlled Period|Protocol Violation|7|||
161376606|NCT01900665|582767896|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
161376607|NCT01900665|582767897|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
161376608|NCT01900665|582767896|FG000|Placebo Controlled Period|Physician Decision|11|||
161376609|NCT01900665|582767897|FG001|Placebo Controlled Period|Physician Decision|7|||
161376610|NCT01900665|582767896|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
161376611|NCT01900665|582767897|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
161376612|NCT01900665|582767896|FG000|Placebo Controlled Period|Caregiver Decision|33|||
161376613|NCT01900665|582767897|FG001|Placebo Controlled Period|Caregiver Decision|41|||
161376614|NCT01900665|582767896|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
161376615|NCT01900665|582767897|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
161376616|NCT01900665|582767896|FG000|Open Label Period|Adverse Event|16|||
161376617|NCT01900665|582767897|FG001|Open Label Period|Adverse Event|20|||
161376618|NCT01900665|582767896|FG000|Open Label Period|Death|5|||
161376619|NCT01900665|582767897|FG001|Open Label Period|Death|6|||
161376620|NCT01900665|582767896|FG000|Open Label Period|Lost to Follow-up|1|||
161376621|NCT01900665|582767897|FG001|Open Label Period|Lost to Follow-up|1|||
161376622|NCT01900665|582767896|FG000|Open Label Period|Parent/Caregiver Decision|33|||
161376623|NCT01900665|582767897|FG001|Open Label Period|Parent/Caregiver Decision|34|||
161376624|NCT01900665|582767896|FG000|Open Label Period|Physician Decision|4|||
161376625|NCT01900665|582767897|FG001|Open Label Period|Physician Decision|4|||
161376626|NCT01900665|582767896|FG000|Open Label Period|Protocol Violation|0|||
161376627|NCT01900665|582767897|FG001|Open Label Period|Protocol Violation|1|||
161376628|NCT01900665|582767896|FG000|Open Label Period|Sponsor Decision|802|||
161376629|NCT01900665|582767897|FG001|Open Label Period|Sponsor Decision|765|||
161376630|NCT01900665|582767896|FG000|Open Label Period|Withdrawal by Subject|20|||
161376631|NCT01900665|582767897|FG001|Open Label Period|Withdrawal by Subject|28|||
161376632|NCT00027560|582767900|FG000|Overall Study|Withdrawal by Subject|1|||
161376633|NCT03559270|582767904|FG000|Overall Study|Adverse Event|6|||
161376634|NCT03559270|582767905|FG001|Overall Study|Adverse Event|5|||
161376635|NCT03559270|582767906|FG002|Overall Study|Adverse Event|3|||
161376636|NCT03559270|582767907|FG003|Overall Study|Adverse Event|0|||
161376637|NCT03559270|582767904|FG000|Overall Study|Lack of Efficacy|34|||
161376638|NCT03559270|582767905|FG001|Overall Study|Lack of Efficacy|52|||
161376639|NCT03559270|582767906|FG002|Overall Study|Lack of Efficacy|37|||
161376640|NCT03559270|582767907|FG003|Overall Study|Lack of Efficacy|2|||
161376641|NCT03559270|582767904|FG000|Overall Study|Death|0|||
161376642|NCT03559270|582767905|FG001|Overall Study|Death|2|||
161376643|NCT03559270|582767906|FG002|Overall Study|Death|0|||
161376644|NCT03559270|582767907|FG003|Overall Study|Death|0|||
161376645|NCT03559270|582767904|FG000|Overall Study|Lost to Follow-up|16|||
161376646|NCT03559270|582767905|FG001|Overall Study|Lost to Follow-up|4|||
161376647|NCT03559270|582767906|FG002|Overall Study|Lost to Follow-up|12|||
161376648|NCT03559270|582767907|FG003|Overall Study|Lost to Follow-up|3|||
161376649|NCT03559270|582767904|FG000|Overall Study|Sponsor Decision|38|||
161376650|NCT03559270|582767905|FG001|Overall Study|Sponsor Decision|31|||
161376651|NCT03559270|582767906|FG002|Overall Study|Sponsor Decision|35|||
161376652|NCT03559270|582767907|FG003|Overall Study|Sponsor Decision|18|||
161376653|NCT03559270|582767904|FG000|Overall Study|Withdrawal by Subject|19|||
161376654|NCT03559270|582767905|FG001|Overall Study|Withdrawal by Subject|21|||
161376655|NCT03559270|582767906|FG002|Overall Study|Withdrawal by Subject|18|||
161376656|NCT03559270|582767907|FG003|Overall Study|Withdrawal by Subject|7|||
161376657|NCT03559270|582767904|FG000|Overall Study|Physician Decision|3|||
161376658|NCT03559270|582767905|FG001|Overall Study|Physician Decision|2|||
161376659|NCT03559270|582767906|FG002|Overall Study|Physician Decision|1|||
161376660|NCT03559270|582767907|FG003|Overall Study|Physician Decision|0|||
161376661|NCT03559270|582767904|FG000|Overall Study|Pregnancy|0|||
161376662|NCT03559270|582767905|FG001|Overall Study|Pregnancy|1|||
161376663|NCT03559270|582767906|FG002|Overall Study|Pregnancy|0|||
161376664|NCT03559270|582767907|FG003|Overall Study|Pregnancy|0|||
161376665|NCT03559270|582767904|FG000|Overall Study|Protocol Violation|1|||
161376666|NCT03559270|582767905|FG001|Overall Study|Protocol Violation|0|||
161376667|NCT03559270|582767906|FG002|Overall Study|Protocol Violation|2|||
161376668|NCT03559270|582767907|FG003|Overall Study|Protocol Violation|0|||
161376669|NCT04790279|582769821|FG000|Overall Study|Did not meet medication start criteria|27|||
161376670|NCT04790279|582769822|FG001|Overall Study|Did not meet medication start criteria|15|||
161376671|NCT04790279|582769821|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
161376672|NCT04790279|582769822|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
161376673|NCT04790279|582769821|FG000|Overall Study|Protocol Violation|8|||
161376674|NCT04790279|582769822|FG001|Overall Study|Protocol Violation|3|||
161376675|NCT04790279|582769821|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
161376676|NCT04790279|582769822|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
161376677|NCT04776161|582769828|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
161376678|NCT04776161|582769829|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
161376679|NCT04776161|582769830|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
161376680|NCT04776161|582769828|FG000|Overall Study|Withdrawal by Subject|1|||
161376681|NCT04776161|582769829|FG001|Overall Study|Withdrawal by Subject|0|||
161376682|NCT04776161|582769830|FG002|Overall Study|Withdrawal by Subject|1|||
161376683|NCT04776161|582769828|FG000|Overall Study|Adverse Event|0|||
161376684|NCT04776161|582769829|FG001|Overall Study|Adverse Event|1|||
161376685|NCT04776161|582769830|FG002|Overall Study|Adverse Event|1|||
161376686|NCT00342628|582769831|FG000|Overall Study|Withdrawal by Subject|19|||
161376687|NCT00342628|582769832|FG001|Overall Study|Withdrawal by Subject|19|||
161376688|NCT00342628|582769833|FG002|Overall Study|Withdrawal by Subject|18|||
161376689|NCT00342628|582769831|FG000|Overall Study|Death|1|||
161376690|NCT00342628|582769832|FG001|Overall Study|Death|1|||
161376691|NCT00342628|582769833|FG002|Overall Study|Death|0|||
161376692|NCT00342628|582769831|FG000|Overall Study|moved residence|0|||
161376693|NCT00342628|582769832|FG001|Overall Study|moved residence|1|||
161376694|NCT00342628|582769833|FG002|Overall Study|moved residence|1|||
161376695|NCT04551898|582769834|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
161376696|NCT04551898|582769835|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
161376697|NCT04551898|582769836|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
161376698|NCT04551898|582769837|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
161376699|NCT04551898|582769834|FG000|Overall Study|Withdrawal by Subject|5|||
161376700|NCT04551898|582769835|FG001|Overall Study|Withdrawal by Subject|1|||
161376701|NCT04551898|582769836|FG002|Overall Study|Withdrawal by Subject|2|||
161376702|NCT04551898|582769837|FG003|Overall Study|Withdrawal by Subject|2|||
161376703|NCT04551898|582769834|FG000|Overall Study|Lost to Follow-up|2|||
161376704|NCT04551898|582769835|FG001|Overall Study|Lost to Follow-up|1|||
161376705|NCT04551898|582769836|FG002|Overall Study|Lost to Follow-up|2|||
161376706|NCT04551898|582769837|FG003|Overall Study|Lost to Follow-up|2|||
161376707|NCT04551898|582769834|FG000|Overall Study|Death|1|||
161376708|NCT04551898|582769835|FG001|Overall Study|Death|0|||
161376709|NCT04551898|582769836|FG002|Overall Study|Death|0|||
161376710|NCT04551898|582769837|FG003|Overall Study|Death|0|||
161376711|NCT04551898|582769834|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
161376712|NCT04551898|582769835|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
161376713|NCT04551898|582769836|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
161376714|NCT04551898|582769837|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
161376715|NCT01979614|582769838|FG000|Overall Study|Adverse Event|1|||
161376716|NCT01979614|582769839|FG001|Overall Study|Adverse Event|1|||
161376717|NCT01535287|582769840|FG000|Overall Study|drug not prepared in time|5|||
161376718|NCT01535287|582769841|FG001|Overall Study|drug not prepared in time|6|||
161376719|NCT00628446|582769844|FG000|Overall Study|Lost to Follow-up|3|||
161376720|NCT00628446|582769844|FG000|Overall Study|Withdrawal by Subject|1|||
161376721|NCT00628446|582769844|FG000|Overall Study|Protocol Violation|3|||
161376722|NCT04971967|582769845|FG000|Overall Study|Lost to Follow-up|6|||
161376723|NCT04971967|582769846|FG001|Overall Study|Lost to Follow-up|7|||
161376724|NCT00682929|582769849|FG000|Overall Study|Adverse Event|4|||
161376725|NCT00682929|582769850|FG001|Overall Study|Adverse Event|1|||
161376726|NCT00682929|582769851|FG002|Overall Study|Adverse Event|1|||
161376727|NCT00682929|582769849|FG000|Overall Study|Withdrawal by Subject|1|||
161376728|NCT00682929|582769850|FG001|Overall Study|Withdrawal by Subject|2|||
161376729|NCT00682929|582769851|FG002|Overall Study|Withdrawal by Subject|1|||
161376730|NCT00682929|582769849|FG000|Overall Study|dosing compliance < 80%|0|||
161376731|NCT00682929|582769850|FG001|Overall Study|dosing compliance < 80%|2|||
161376732|NCT00682929|582769851|FG002|Overall Study|dosing compliance < 80%|0|||
161376733|NCT00682929|582769849|FG000|Overall Study|lag in DEA renewal|1|||
161376734|NCT00682929|582769850|FG001|Overall Study|lag in DEA renewal|0|||
161376735|NCT00682929|582769851|FG002|Overall Study|lag in DEA renewal|0|||
161376736|NCT00938912|582769852|FG000|Overall Study|Withdrawal by Subject|28|||
161376737|NCT00938912|582769852|FG000|Overall Study|Lost to Follow-up|4|||
161376738|NCT00938912|582769852|FG000|Overall Study|Lack of Efficacy|43|||
161376739|NCT00938912|582769852|FG000|Overall Study|Adverse event, non-fatal|24|||
161376740|NCT00938912|582769852|FG000|Overall Study|Adverse event, fatal|1|||
161376741|NCT00938912|582769852|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
161376742|NCT00938912|582769852|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
161376743|NCT00938912|582769852|FG000|Overall Study|Participant needed prohibit medication|1|||
161376744|NCT00938912|582769852|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
161376745|NCT00938912|582769852|FG000|Overall Study|Did not meet Eligibility criteria|1|||
161376746|NCT00938912|582769852|FG000|Overall Study|Participant relocated not related to AE|1|||
161376747|NCT00938912|582769852|FG000|Overall Study|Participant moved to another city|1|||
161376748|NCT00938912|582769852|FG000|Overall Study|Participant experienced break through seizures|1|||
161376749|NCT00938912|582769852|FG000|Overall Study|No longer wished to participate in the study|1|||
161376750|NCT00938912|582769852|FG000|Overall Study|Protocol Deviation|2|||
161376751|NCT00803738|582769858|FG000|Overall Study|Adverse Event|3|||
161376752|NCT00803738|582769859|FG001|Overall Study|Adverse Event|5|||
161376753|NCT00803738|582769858|FG000|Overall Study|Lost to Follow-up|4|||
161376754|NCT00803738|582769859|FG001|Overall Study|Lost to Follow-up|4|||
161376755|NCT00803738|582769858|FG000|Overall Study|Protocol Violation|18|||
161376756|NCT00803738|582769859|FG001|Overall Study|Protocol Violation|10|||
161376757|NCT00803738|582769858|FG000|Overall Study|Withdrawal by Subject|1|||
161376758|NCT00803738|582769859|FG001|Overall Study|Withdrawal by Subject|4|||
161376759|NCT00803738|582769858|FG000|Overall Study|Lack of Efficacy|10|||
161376760|NCT00803738|582769859|FG001|Overall Study|Lack of Efficacy|16|||
161376761|NCT00803738|582769858|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
161376762|NCT00803738|582769859|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
161376763|NCT00803738|582769858|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
161376764|NCT00803738|582769859|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
161376765|NCT01048242|582769860|FG000|Overall Study|See study flow chart|4|||
161376766|NCT01048242|582769861|FG001|Overall Study|See study flow chart|2|||
161376767|NCT02964273|582769862|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
161376768|NCT02964273|582769863|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
161376769|NCT02964273|582769864|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
161376770|NCT02964273|582769865|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
161376771|NCT02964273|582769862|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
161376772|NCT02964273|582769863|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
161376773|NCT02964273|582769864|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
161376774|NCT02964273|582769865|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
161376775|NCT02964273|582769862|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
161376776|NCT02964273|582769863|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
161376777|NCT02964273|582769864|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
161376778|NCT02964273|582769865|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
161376779|NCT02964273|582769862|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
161376780|NCT02964273|582769863|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
161376781|NCT02964273|582769864|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
161376782|NCT02964273|582769865|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
161376783|NCT02964273|582769862|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
161376784|NCT02964273|582769863|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
161376785|NCT02964273|582769864|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
161376786|NCT02964273|582769865|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
161376787|NCT02964273|582769862|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
161376788|NCT02964273|582769863|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
161376789|NCT02964273|582769864|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
161376790|NCT02964273|582769865|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
161376791|NCT01309204|582769866|FG000|Overall Study|Adverse Event|48|||
161376792|NCT01309204|582769867|FG001|Overall Study|Adverse Event|58|||
161376793|NCT01309204|582769866|FG000|Overall Study|Lost to Follow-up|2|||
161376794|NCT01309204|582769867|FG001|Overall Study|Lost to Follow-up|2|||
161376795|NCT01309204|582769866|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
161376796|NCT01309204|582769867|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
161376797|NCT01309204|582769866|FG000|Overall Study|Inadequate control of IOP|4|||
161376798|NCT01309204|582769867|FG001|Overall Study|Inadequate control of IOP|4|||
161376799|NCT01309204|582769866|FG000|Overall Study|Other|4|||
161376800|NCT01309204|582769867|FG001|Overall Study|Other|1|||
161376801|NCT01127633|582769868|FG000|Overall Study|Adverse Event|74|||
161376802|NCT01127633|582769869|FG001|Overall Study|Adverse Event|73|||
161376803|NCT01127633|582769868|FG000|Overall Study|Death|40|||
161376804|NCT01127633|582769869|FG001|Overall Study|Death|43|||
161376805|NCT01127633|582769868|FG000|Overall Study|Lost to Follow-up|4|||
161376806|NCT01127633|582769869|FG001|Overall Study|Lost to Follow-up|0|||
161376807|NCT01127633|582769868|FG000|Overall Study|Parent/Caregiver Decision|246|||
161376808|NCT01127633|582769869|FG001|Overall Study|Parent/Caregiver Decision|228|||
161376809|NCT01127633|582769868|FG000|Overall Study|Physician Decision|60|||
161376810|NCT01127633|582769869|FG001|Overall Study|Physician Decision|45|||
161376811|NCT01127633|582769868|FG000|Overall Study|Withdrawal by Subject|57|||
161376812|NCT01127633|582769869|FG001|Overall Study|Withdrawal by Subject|72|||
161376813|NCT01127633|582769868|FG000|Overall Study|Sponsor Decision|163|||
161376814|NCT01127633|582769869|FG001|Overall Study|Sponsor Decision|195|||
161376815|NCT01127633|582769868|FG000|Overall Study|Protocol Violation|8|||
161376816|NCT01127633|582769869|FG001|Overall Study|Protocol Violation|16|||
161376817|NCT01127633|582769868|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
161376818|NCT01127633|582769869|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
161376819|NCT01127633|582769868|FG000|Overall Study|Not treated|1|||
161376820|NCT01127633|582769869|FG001|Overall Study|Not treated|0|||
161376821|NCT03432494|582769871|FG000|Overall Study|Death|1|||
161376822|NCT03432494|582769871|FG000|Overall Study|Noncompliance|1|||
161376823|NCT00775268|582769872|FG000|Baseline|Drug not synthesize dose|1|||
161376824|NCT00775268|582769873|FG001|Baseline|Drug not synthesize dose|0|||
161376825|NCT00775268|582769872|FG000|Baseline|Not treated-ineligible per CT|0|||
161376826|NCT00775268|582769873|FG001|Baseline|Not treated-ineligible per CT|1|||
161376827|NCT00775268|582769872|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
161376828|NCT00775268|582769873|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
161376829|NCT00775268|582769872|FG000|After Completion|Participant missed scan appointment|1|||
161376830|NCT00775268|582769873|FG001|After Completion|Participant missed scan appointment|0|||
161376831|NCT04263766|582769874|FG000|Overall Study|Withdrawal by Subject|6|||
161376832|NCT04263766|582769875|FG001|Overall Study|Withdrawal by Subject|4|||
161376833|NCT04263766|582769874|FG000|Overall Study|Lack of Efficacy|1|||
161376834|NCT04263766|582769875|FG001|Overall Study|Lack of Efficacy|3|||
161376835|NCT04232943|582769876|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
161376836|NCT04232943|582769877|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
161376837|NCT04232943|582769878|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
161376838|NCT04232943|582769876|FG000|Overall Study|Withdrawal by Subject|1|||
161376839|NCT04232943|582769877|FG001|Overall Study|Withdrawal by Subject|1|||
161376840|NCT04232943|582769878|FG002|Overall Study|Withdrawal by Subject|0|||
161376841|NCT03896477|582769884|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
161376842|NCT03896477|582769885|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
161376843|NCT03896477|582769886|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
161376844|NCT03896477|582769884|FG000|Overall Study|Parent Requested Withdrawal|8|||
161376845|NCT03896477|582769885|FG001|Overall Study|Parent Requested Withdrawal|12|||
161376846|NCT03896477|582769886|FG002|Overall Study|Parent Requested Withdrawal|9|||
161376847|NCT03896477|582769884|FG000|Overall Study|Adverse Event|0|||
161376848|NCT03896477|582769885|FG001|Overall Study|Adverse Event|0|||
161376849|NCT03896477|582769886|FG002|Overall Study|Adverse Event|1|||
161376850|NCT03896477|582769884|FG000|Overall Study|Death|1|||
161376851|NCT03896477|582769885|FG001|Overall Study|Death|0|||
161376852|NCT03896477|582769886|FG002|Overall Study|Death|0|||
161376853|NCT03896477|582769884|FG000|Overall Study|Other|5|||
161376854|NCT03896477|582769885|FG001|Overall Study|Other|6|||
161376855|NCT03896477|582769886|FG002|Overall Study|Other|7|||
161376856|NCT03896477|582769884|FG000|Overall Study|Lost to Follow-up|2|||
161376857|NCT03896477|582769885|FG001|Overall Study|Lost to Follow-up|1|||
161376858|NCT03896477|582769886|FG002|Overall Study|Lost to Follow-up|1|||
161376859|NCT01106157|582769887|FG000|Overall Study|Withdrawal by Subject|1|||
161376860|NCT01106157|582769888|FG001|Overall Study|Withdrawal by Subject|0|||
161376861|NCT01118780|582769889|FG000|Overall Study|Adverse Event|15|||
161376862|NCT01118780|582769890|FG001|Overall Study|Adverse Event|15|||
161376863|NCT01118780|582769889|FG000|Overall Study|Death|1|||
161376864|NCT01118780|582769890|FG001|Overall Study|Death|0|||
161376865|NCT01118780|582769889|FG000|Overall Study|Lack of Efficacy|2|||
161376866|NCT01118780|582769890|FG001|Overall Study|Lack of Efficacy|6|||
161376867|NCT01118780|582769889|FG000|Overall Study|Physician Decision|2|||
161376868|NCT01118780|582769890|FG001|Overall Study|Physician Decision|0|||
161376869|NCT01118780|582769889|FG000|Overall Study|Protocol Violation|3|||
161376870|NCT01118780|582769890|FG001|Overall Study|Protocol Violation|6|||
161376871|NCT01118780|582769889|FG000|Overall Study|Withdrawal by Subject|13|||
161376872|NCT01118780|582769890|FG001|Overall Study|Withdrawal by Subject|8|||
161376873|NCT01882465|582769892|FG000|Period 1|Lens Discomfort|0|||
161376874|NCT01882465|582769893|FG001|Period 1|Lens Discomfort|0|||
161376875|NCT01882465|582769894|FG002|Period 1|Lens Discomfort|0|||
161376876|NCT01882465|582769895|FG003|Period 1|Lens Discomfort|1|||
161376877|NCT01882465|582769896|FG004|Period 1|Lens Discomfort|0|||
161376878|NCT01882465|582769897|FG005|Period 1|Lens Discomfort|0|||
161376879|NCT01882465|582769898|FG006|Period 1|Lens Discomfort|0|||
161376880|NCT01882465|582769892|FG000|Period 1|Withdrawal by Subject|0|||
161376881|NCT01882465|582769893|FG001|Period 1|Withdrawal by Subject|0|||
161376882|NCT01882465|582769894|FG002|Period 1|Withdrawal by Subject|0|||
161376883|NCT01882465|582769895|FG003|Period 1|Withdrawal by Subject|0|||
161376884|NCT01882465|582769896|FG004|Period 1|Withdrawal by Subject|0|||
161376885|NCT01882465|582769897|FG005|Period 1|Withdrawal by Subject|0|||
161376886|NCT01882465|582769898|FG006|Period 1|Withdrawal by Subject|1|||
161376887|NCT01882465|582769892|FG000|Period 2|Protocol Violation|0|||
161376888|NCT01882465|582769893|FG001|Period 2|Protocol Violation|0|||
161376889|NCT01882465|582769894|FG002|Period 2|Protocol Violation|0|||
161376890|NCT01882465|582769895|FG003|Period 2|Protocol Violation|0|||
161376891|NCT01882465|582769896|FG004|Period 2|Protocol Violation|1|||
161376892|NCT01882465|582769897|FG005|Period 2|Protocol Violation|0|||
161376893|NCT01882465|582769898|FG006|Period 2|Protocol Violation|0|||
161376894|NCT00800982|582769901|FG000|Overall Study|Lost to Follow-up|1|||
161376895|NCT00800982|582769902|FG001|Overall Study|Lost to Follow-up|2|||
161376896|NCT00800982|582769901|FG000|Overall Study|Withdrawal by Subject|0|||
161376897|NCT00800982|582769902|FG001|Overall Study|Withdrawal by Subject|1|||
161376898|NCT00800982|582769901|FG000|Overall Study|Patient moved out of state|1|||
161376899|NCT00800982|582769902|FG001|Overall Study|Patient moved out of state|0|||
161376900|NCT01824290|582769903|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
161376901|NCT01824290|582769904|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
161376902|NCT01824290|582769905|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
161376903|NCT01824290|582769906|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
161376904|NCT01824290|582769903|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
161376905|NCT01824290|582769904|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
161376906|NCT01824290|582769905|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
161376907|NCT01824290|582769906|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
161376908|NCT01824290|582769903|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
161376909|NCT01824290|582769904|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
161376910|NCT01824290|582769905|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
161376911|NCT01824290|582769906|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
161376912|NCT01824290|582769903|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
161376913|NCT01824290|582769904|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
161376914|NCT01824290|582769905|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
161376915|NCT01824290|582769906|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
161376916|NCT01824290|582769903|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
161376917|NCT01824290|582769904|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
161376918|NCT01824290|582769905|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
161376919|NCT01824290|582769906|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
161376920|NCT01824290|582769903|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
161376921|NCT01824290|582769904|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
161376922|NCT01824290|582769905|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
161376923|NCT01824290|582769906|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
161376924|NCT01490918|582769907|FG000|Overall Study|Lost to Follow-up|2|||
161376925|NCT01490918|582769908|FG001|Overall Study|Lost to Follow-up|1|||
161376926|NCT01490918|582769909|FG002|Overall Study|Lost to Follow-up|0|||
161376927|NCT01490918|582769907|FG000|Overall Study|Withdrawal by Subject|7|||
161376928|NCT01490918|582769908|FG001|Overall Study|Withdrawal by Subject|8|||
161376929|NCT01490918|582769909|FG002|Overall Study|Withdrawal by Subject|3|||
161376930|NCT01490918|582769907|FG000|Overall Study|Adverse Event|0|||
161376931|NCT01490918|582769908|FG001|Overall Study|Adverse Event|0|||
161376932|NCT01490918|582769909|FG002|Overall Study|Adverse Event|1|||
161376933|NCT01490918|582769907|FG000|Overall Study|other cause|4|||
161376934|NCT01490918|582769908|FG001|Overall Study|other cause|5|||
161376935|NCT01490918|582769909|FG002|Overall Study|other cause|8|||
161376936|NCT02765399|582769922|FG000|Overall Study|Nausea|1|||
161376937|NCT02765399|582769923|FG001|Overall Study|Nausea|0|||
161376938|NCT04068922|582769924|FG000|Overall Study|Lost to Follow-up|5|||
161376939|NCT04068922|582769924|FG000|Overall Study|Withdrawal by Subject|7|||
161376940|NCT04068922|582769924|FG000|Overall Study|Adverse Event|1|||
161376941|NCT00716274|582769930|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
161376942|NCT00716274|582769931|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161376943|NCT00716274|582769932|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161376944|NCT00716274|582769933|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161376945|NCT00716274|582769934|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161376946|NCT00716274|582769935|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161376947|NCT00716274|582769930|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
161376948|NCT00716274|582769931|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
161376949|NCT00716274|582769932|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
161376950|NCT00716274|582769933|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
161376951|NCT00716274|582769934|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
161376952|NCT00716274|582769935|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
161376953|NCT00716274|582769930|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
161376954|NCT00716274|582769931|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161376955|NCT00716274|582769932|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161376956|NCT00716274|582769933|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161376957|NCT00716274|582769934|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161376958|NCT00716274|582769935|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161376959|NCT00716274|582769930|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
161376960|NCT00716274|582769931|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
161376961|NCT00716274|582769932|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
161376962|NCT00716274|582769933|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
161376963|NCT00716274|582769934|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
161376964|NCT00716274|582769935|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
161376965|NCT00716274|582769930|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
161376966|NCT00716274|582769931|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
161376967|NCT00716274|582769932|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161376968|NCT00716274|582769933|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161376969|NCT00716274|582769934|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161376970|NCT00716274|582769935|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161376971|NCT00716274|582769930|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161376972|NCT00716274|582769931|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
161376973|NCT00716274|582769932|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161376974|NCT00716274|582769933|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161376975|NCT00716274|582769934|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161376976|NCT00716274|582769935|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161376977|NCT00716274|582769930|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161376978|NCT00716274|582769931|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161376979|NCT00716274|582769932|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
161376980|NCT00716274|582769933|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161376981|NCT00716274|582769934|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161376982|NCT00716274|582769935|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161376983|NCT00716274|582769930|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
161376984|NCT00716274|582769931|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
161376985|NCT00716274|582769932|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
161376986|NCT00716274|582769933|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
161376987|NCT00716274|582769934|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
161376988|NCT00716274|582769935|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
161376989|NCT00716274|582769930|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161376990|NCT00716274|582769931|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161376991|NCT00716274|582769932|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161376992|NCT00716274|582769933|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
161376993|NCT00716274|582769934|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
161376994|NCT00716274|582769935|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161376995|NCT00716274|582769930|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
161376996|NCT00716274|582769931|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
161376997|NCT00716274|582769932|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
161376998|NCT00716274|582769933|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
161376999|NCT00716274|582769934|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
161377000|NCT00716274|582769935|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
161377001|NCT01342094|582769936|FG000|Overall Study|Adverse Event|5|||
161377002|NCT01342094|582769937|FG001|Overall Study|Adverse Event|0|||
161377003|NCT01342094|582769936|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161377004|NCT01342094|582769937|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161377005|NCT01342094|582769936|FG000|Overall Study|Withdrawal by Subject|0|||
161377006|NCT01342094|582769937|FG001|Overall Study|Withdrawal by Subject|2|||
161377007|NCT02806414|582769940|FG000|Overall Study|Lost to Follow-up|2|||
161377008|NCT00543985|582769943|FG000|Overall Study|Withdrawal by Subject|4|||
161377009|NCT01634152|582769944|FG000|Overall Study|Adverse Event|2|||
161377010|NCT01634152|582769945|FG001|Overall Study|Adverse Event|0|||
161377011|NCT01634152|582769946|FG002|Overall Study|Adverse Event|2|||
161377012|NCT01634152|582769944|FG000|Overall Study|Consent withdrawn not due to AE|1|||
161377013|NCT01634152|582769945|FG001|Overall Study|Consent withdrawn not due to AE|0|||
161377014|NCT01634152|582769946|FG002|Overall Study|Consent withdrawn not due to AE|1|||
161377015|NCT01634152|582769944|FG000|Overall Study|Not treated|0|||
161377016|NCT01634152|582769945|FG001|Overall Study|Not treated|1|||
161377017|NCT01634152|582769946|FG002|Overall Study|Not treated|0|||
161377018|NCT01634152|582769944|FG000|Overall Study|Other reason not defined above|1|||
161377019|NCT01634152|582769945|FG001|Overall Study|Other reason not defined above|0|||
161377020|NCT01634152|582769946|FG002|Overall Study|Other reason not defined above|1|||
161377021|NCT02317627|582769951|FG000|Overall Study|Withdrawal by Subject|0|||
161377022|NCT02317627|582769952|FG001|Overall Study|Withdrawal by Subject|1|||
161377023|NCT02317627|582769953|FG002|Overall Study|Withdrawal by Subject|1|||
161377024|NCT02317627|582769951|FG000|Overall Study|Lost to Follow-up|2|||
161377025|NCT02317627|582769952|FG001|Overall Study|Lost to Follow-up|0|||
161377026|NCT02317627|582769953|FG002|Overall Study|Lost to Follow-up|0|||
161377027|NCT02317627|582769951|FG000|Overall Study|Stopped by Investigator|0|||
161377028|NCT02317627|582769952|FG001|Overall Study|Stopped by Investigator|1|||
161377029|NCT02317627|582769953|FG002|Overall Study|Stopped by Investigator|0|||
161377030|NCT02317627|582769951|FG000|Overall Study|Adverse Event|0|||
161377031|NCT02317627|582769952|FG001|Overall Study|Adverse Event|2|||
161377032|NCT02317627|582769953|FG002|Overall Study|Adverse Event|3|||
161377033|NCT02317627|582769951|FG000|Overall Study|Non-compliance with study drug|0|||
161377034|NCT02317627|582769952|FG001|Overall Study|Non-compliance with study drug|1|||
161377035|NCT02317627|582769953|FG002|Overall Study|Non-compliance with study drug|0|||
161377036|NCT04749914|582769954|FG000|Period 1|Adverse Event|1|||
161377037|NCT04749914|582769955|FG001|Period 1|Adverse Event|0|||
161377038|NCT04749914|582769956|FG002|Period 1|Adverse Event|0|||
161377039|NCT04749914|582769957|FG003|Period 1|Adverse Event|0|||
161377040|NCT04749914|582769954|FG000|Period 1|Withdrawal by Subject|1|||
161377041|NCT04749914|582769955|FG001|Period 1|Withdrawal by Subject|0|||
161377042|NCT04749914|582769956|FG002|Period 1|Withdrawal by Subject|1|||
161377043|NCT04749914|582769957|FG003|Period 1|Withdrawal by Subject|0|||
161377044|NCT00279214|582769958|FG000|Overall Study|Physician Decision|3|||
161377045|NCT00279214|582769959|FG001|Overall Study|Physician Decision|2|||
161377046|NCT00403130|582769960|FG000|2 Years From Start of Treatment|Not Eligible|3|||
161377047|NCT00403130|582769960|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
161377048|NCT00403130|582769960|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
161377049|NCT00403130|582769960|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
161377050|NCT01280968|582769961|FG000|Overall Study|Lost to Follow-up|8|||
161377051|NCT01280968|582769962|FG001|Overall Study|Lost to Follow-up|2|||
161377052|NCT01280968|582769961|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
161377053|NCT01280968|582769962|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
161377054|NCT01280968|582769961|FG000|Overall Study|Commuting Problems|2|||
161377055|NCT01280968|582769962|FG001|Overall Study|Commuting Problems|0|||
161377056|NCT01280968|582769961|FG000|Overall Study|Anxiety|2|||
161377057|NCT01280968|582769962|FG001|Overall Study|Anxiety|0|||
161377058|NCT01280968|582769961|FG000|Overall Study|Adverse Event|1|||
161377059|NCT01280968|582769962|FG001|Overall Study|Adverse Event|0|||
161377060|NCT01280968|582769961|FG000|Overall Study|Scheduling Conflicts|1|||
161377061|NCT01280968|582769962|FG001|Overall Study|Scheduling Conflicts|1|||
161377062|NCT01280968|582769961|FG000|Overall Study|Pre-existing Neurological Condition|1|||
161377063|NCT01280968|582769962|FG001|Overall Study|Pre-existing Neurological Condition|0|||
161377064|NCT01280968|582769961|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
161377065|NCT01280968|582769962|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
161377066|NCT00806260|582769963|FG000|Period 1 (1 Day)|Adverse Event|0|||
161377067|NCT00806260|582769964|FG001|Period 1 (1 Day)|Adverse Event|0|||
161377068|NCT00806260|582769965|FG002|Period 1 (1 Day)|Adverse Event|0|||
161377069|NCT00806260|582769966|FG003|Period 1 (1 Day)|Adverse Event|0|||
161377070|NCT00806260|582769967|FG004|Period 1 (1 Day)|Adverse Event|3|||
161377071|NCT00806260|582769968|FG005|Period 1 (1 Day)|Adverse Event|0|||
161377072|NCT00806260|582769963|FG000|Period 2|Adverse Event|0|||
161377073|NCT00806260|582769964|FG001|Period 2|Adverse Event|0|||
161377074|NCT00806260|582769965|FG002|Period 2|Adverse Event|0|||
161377075|NCT00806260|582769966|FG003|Period 2|Adverse Event|1|||
161377076|NCT00806260|582769967|FG004|Period 2|Adverse Event|0|||
161377077|NCT00806260|582769968|FG005|Period 2|Adverse Event|0|||
161377078|NCT00806260|582769963|FG000|Period 2|Protocol Violation|1|||
161377079|NCT00806260|582769964|FG001|Period 2|Protocol Violation|0|||
161377080|NCT00806260|582769965|FG002|Period 2|Protocol Violation|1|||
161377081|NCT00806260|582769966|FG003|Period 2|Protocol Violation|0|||
161377082|NCT00806260|582769967|FG004|Period 2|Protocol Violation|0|||
161377083|NCT00806260|582769968|FG005|Period 2|Protocol Violation|0|||
161377084|NCT00806260|582769963|FG000|Period 2|Need to take concomitant medication|1|||
161377085|NCT00806260|582769964|FG001|Period 2|Need to take concomitant medication|0|||
161377086|NCT00806260|582769965|FG002|Period 2|Need to take concomitant medication|0|||
161377087|NCT00806260|582769966|FG003|Period 2|Need to take concomitant medication|0|||
161377088|NCT00806260|582769967|FG004|Period 2|Need to take concomitant medication|0|||
161377089|NCT00806260|582769968|FG005|Period 2|Need to take concomitant medication|0|||
161377090|NCT00806260|582769963|FG000|Period 2|sponsor request|0|||
161377091|NCT00806260|582769964|FG001|Period 2|sponsor request|0|||
161377092|NCT00806260|582769965|FG002|Period 2|sponsor request|1|||
161377093|NCT00806260|582769966|FG003|Period 2|sponsor request|1|||
161377094|NCT00806260|582769967|FG004|Period 2|sponsor request|0|||
161377095|NCT00806260|582769968|FG005|Period 2|sponsor request|0|||
161377096|NCT00806260|582769963|FG000|Period 3|Protocol Violation|0|||
161377097|NCT00806260|582769964|FG001|Period 3|Protocol Violation|1|||
161377098|NCT00806260|582769965|FG002|Period 3|Protocol Violation|1|||
161377099|NCT00806260|582769966|FG003|Period 3|Protocol Violation|0|||
161377100|NCT00806260|582769967|FG004|Period 3|Protocol Violation|0|||
161377101|NCT00806260|582769968|FG005|Period 3|Protocol Violation|0|||
161377102|NCT00806260|582769963|FG000|Period 3|Pregnancy|1|||
161377103|NCT00806260|582769964|FG001|Period 3|Pregnancy|0|||
161377104|NCT00806260|582769965|FG002|Period 3|Pregnancy|0|||
161377105|NCT00806260|582769966|FG003|Period 3|Pregnancy|0|||
161377106|NCT00806260|582769967|FG004|Period 3|Pregnancy|0|||
161377107|NCT00806260|582769968|FG005|Period 3|Pregnancy|0|||
161377108|NCT01897532|582769970|FG000|Discontinuation From Treatment|Not Treated|7|||
161377109|NCT01897532|582769971|FG001|Discontinuation From Treatment|Not Treated|5|||
161377110|NCT01897532|582769970|FG000|Discontinuation From Treatment|Other reason than specified|196|||
161377111|NCT01897532|582769971|FG001|Discontinuation From Treatment|Other reason than specified|176|||
161377112|NCT01897532|582769970|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
161377113|NCT01897532|582769971|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
161377114|NCT01897532|582769970|FG000|Discontinuation From Treatment|Non compliance|24|||
161377115|NCT01897532|582769971|FG001|Discontinuation From Treatment|Non compliance|15|||
161377116|NCT01897532|582769970|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
161377117|NCT01897532|582769971|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
161377118|NCT01897532|582769970|FG000|Discontinuation From Trial|Not Treated|7|||
161377119|NCT01897532|582769971|FG001|Discontinuation From Trial|Not Treated|5|||
161377120|NCT01897532|582769970|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
161377121|NCT01897532|582769971|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
161377122|NCT01074931|582769976|FG000|Overall Study|Economic reasons|1|||
161377123|NCT01074931|582769976|FG000|Overall Study|Death|5|||
161377124|NCT00953706|582769979|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
161377125|NCT00953706|582769980|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
161377126|NCT00953706|582769981|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
161377127|NCT00953706|582769982|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
161377128|NCT00953706|582769979|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
161377129|NCT00953706|582769980|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
161377130|NCT00953706|582769981|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
161377131|NCT00953706|582769982|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
161377132|NCT00953706|582769979|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
161377133|NCT00953706|582769980|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
161377134|NCT00953706|582769981|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
161377135|NCT00953706|582769982|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
161377136|NCT00953706|582769979|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
161377137|NCT00953706|582769980|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
161377138|NCT00953706|582769981|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
161377139|NCT00953706|582769982|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
161377140|NCT00953706|582769979|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
161377141|NCT00953706|582769980|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
161377142|NCT00953706|582769981|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
161377143|NCT00953706|582769982|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
161377144|NCT00953706|582769979|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
161377145|NCT00953706|582769980|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
161377146|NCT00953706|582769981|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
161377147|NCT00953706|582769982|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
161377148|NCT00953706|582769979|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
161377149|NCT00953706|582769980|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
161377150|NCT00953706|582769981|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
161377151|NCT00953706|582769982|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
161377152|NCT00953706|582769979|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
161377153|NCT00953706|582769980|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
161377154|NCT00953706|582769981|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
161377155|NCT00953706|582769982|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
161377156|NCT00953706|582769979|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
161377157|NCT00953706|582769980|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
161377158|NCT00953706|582769981|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
161377159|NCT00953706|582769982|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
161377160|NCT00953706|582769979|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
161377161|NCT00953706|582769980|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
161377162|NCT00953706|582769981|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
161377163|NCT00953706|582769982|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
161377164|NCT00953706|582769979|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
161377165|NCT00953706|582769980|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
161377166|NCT00953706|582769981|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
161377167|NCT00953706|582769982|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
161377168|NCT02670473|582769983|FG000|Overall Study|Withdrawal by Subject|1|||
161377169|NCT01404234|582769984|FG000|Overall Study|Withdrawal by Subject|2|||
161377170|NCT01214837|582769985|FG000|Overall Study|Death|0|||
161377171|NCT01214837|582769986|FG001|Overall Study|Death|0|||
161377172|NCT01214837|582769987|FG002|Overall Study|Death|1|||
161377173|NCT01214837|582769985|FG000|Overall Study|Adverse Event|1|||
161377174|NCT01214837|582769986|FG001|Overall Study|Adverse Event|2|||
161377175|NCT01214837|582769987|FG002|Overall Study|Adverse Event|1|||
161377176|NCT01214837|582769985|FG000|Overall Study|Withdrawal by Subject|27|||
161377177|NCT01214837|582769986|FG001|Overall Study|Withdrawal by Subject|36|||
161377178|NCT01214837|582769987|FG002|Overall Study|Withdrawal by Subject|28|||
161377179|NCT01214837|582769985|FG000|Overall Study|Lost to Follow-up|20|||
161377180|NCT01214837|582769986|FG001|Overall Study|Lost to Follow-up|15|||
161377181|NCT01214837|582769987|FG002|Overall Study|Lost to Follow-up|21|||
161377182|NCT01214837|582769985|FG000|Overall Study|Inappropriate Enrolment|0|||
161377183|NCT01214837|582769986|FG001|Overall Study|Inappropriate Enrolment|1|||
161377184|NCT01214837|582769987|FG002|Overall Study|Inappropriate Enrolment|2|||
161377185|NCT01214837|582769985|FG000|Overall Study|Administrative Reason|2|||
161377186|NCT01214837|582769986|FG001|Overall Study|Administrative Reason|6|||
161377187|NCT01214837|582769987|FG002|Overall Study|Administrative Reason|4|||
161377188|NCT01214837|582769985|FG000|Overall Study|Protocol Violation|3|||
161377189|NCT01214837|582769986|FG001|Overall Study|Protocol Violation|1|||
161377190|NCT01214837|582769987|FG002|Overall Study|Protocol Violation|5|||
161377191|NCT01214837|582769985|FG000|Overall Study|Unable to Classify|1|||
161377192|NCT01214837|582769986|FG001|Overall Study|Unable to Classify|3|||
161377193|NCT01214837|582769987|FG002|Overall Study|Unable to Classify|0|||
161377194|NCT05414175|582769988|FG000|Overall Study|Withdrawal by Subject|1|||
161377195|NCT05414175|582769988|FG000|Overall Study|Other Reasons|1|||
161377196|NCT00456755|582771535|FG000|Overall Study|Lost to Follow-up|2|||
161377197|NCT00456755|582771536|FG001|Overall Study|Lost to Follow-up|1|||
161377198|NCT01475721|582771539|FG000|Overall Study|Death|3|||
161377199|NCT01475721|582771540|FG001|Overall Study|Death|6|||
161377200|NCT01475721|582771539|FG000|Overall Study|Withdrawal by Subject|8|||
161377201|NCT01475721|582771540|FG001|Overall Study|Withdrawal by Subject|8|||
161377202|NCT01772550|582771543|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
161377203|NCT01772550|582771544|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
161377204|NCT01772550|582771545|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
161377205|NCT01772550|582771543|FG000|Overall Study|Adverse Event|0|||
161377206|NCT01772550|582771544|FG001|Overall Study|Adverse Event|0|||
161377207|NCT01772550|582771545|FG002|Overall Study|Adverse Event|1|||
161377208|NCT00559104|582771546|FG000|Overall Study|Lack of Efficacy|9|||
161377209|NCT00559104|582771547|FG001|Overall Study|Lack of Efficacy|0|||
161377210|NCT01815424|582771548|FG000|Week 0 to 16|Adverse Event|1|||
161377211|NCT01815424|582771549|FG001|Week 0 to 16|Adverse Event|3|||
161377212|NCT01815424|582771550|FG002|Week 0 to 16|Adverse Event|3|||
161377213|NCT01815424|582771551|FG003|Week 0 to 16|Adverse Event|0|||
161377214|NCT01815424|582771552|FG004|Week 0 to 16|Adverse Event|0|||
161377215|NCT01815424|582771548|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
161377216|NCT01815424|582771549|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161377217|NCT01815424|582771550|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161377218|NCT01815424|582771551|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161377219|NCT01815424|582771552|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161377220|NCT01815424|582771548|FG000|Week 0 to 16|Lost to Follow-up|0|||
161377221|NCT01815424|582771549|FG001|Week 0 to 16|Lost to Follow-up|1|||
161377222|NCT01815424|582771550|FG002|Week 0 to 16|Lost to Follow-up|0|||
161377223|NCT01815424|582771551|FG003|Week 0 to 16|Lost to Follow-up|0|||
161377224|NCT01815424|582771552|FG004|Week 0 to 16|Lost to Follow-up|0|||
161377225|NCT01815424|582771548|FG000|Week 0 to 16|Withdrawal by Subject|0|||
161377226|NCT01815424|582771549|FG001|Week 0 to 16|Withdrawal by Subject|0|||
161377227|NCT01815424|582771550|FG002|Week 0 to 16|Withdrawal by Subject|1|||
161377228|NCT01815424|582771551|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161377229|NCT01815424|582771552|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161377230|NCT01815424|582771548|FG000|Week 0 to 16|Other|1|||
161377231|NCT01815424|582771549|FG001|Week 0 to 16|Other|0|||
161377232|NCT01815424|582771550|FG002|Week 0 to 16|Other|3|||
161377233|NCT01815424|582771551|FG003|Week 0 to 16|Other|0|||
161377234|NCT01815424|582771552|FG004|Week 0 to 16|Other|0|||
161377235|NCT01815424|582771548|FG000|Week 0 to 16|Protocol Violation|1|||
161377236|NCT01815424|582771549|FG001|Week 0 to 16|Protocol Violation|0|||
161377237|NCT01815424|582771550|FG002|Week 0 to 16|Protocol Violation|0|||
161377238|NCT01815424|582771551|FG003|Week 0 to 16|Protocol Violation|0|||
161377239|NCT01815424|582771552|FG004|Week 0 to 16|Protocol Violation|0|||
161377240|NCT01815424|582771548|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
161377241|NCT01815424|582771549|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
161377242|NCT01815424|582771550|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
161377243|NCT01815424|582771551|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
161377244|NCT01815424|582771552|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
161377245|NCT01815424|582771548|FG000|Week 16 to 52|Other|0|||
161377246|NCT01815424|582771549|FG001|Week 16 to 52|Other|1|||
161377247|NCT01815424|582771550|FG002|Week 16 to 52|Other|0|||
161377248|NCT01815424|582771551|FG003|Week 16 to 52|Other|0|||
161377249|NCT01815424|582771552|FG004|Week 16 to 52|Other|0|||
161377250|NCT01815424|582771548|FG000|Week 16 to 52|Adverse Event|0|||
161377251|NCT01815424|582771549|FG001|Week 16 to 52|Adverse Event|0|||
161377252|NCT01815424|582771550|FG002|Week 16 to 52|Adverse Event|0|||
161377253|NCT01815424|582771551|FG003|Week 16 to 52|Adverse Event|0|||
161377254|NCT01815424|582771552|FG004|Week 16 to 52|Adverse Event|1|||
161377255|NCT01815424|582771548|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
161377256|NCT01815424|582771549|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
161377257|NCT01815424|582771550|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
161377258|NCT01815424|582771551|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
161377259|NCT01815424|582771552|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
161377260|NCT01815424|582771548|FG000|Week 16 to 52|Lost to Follow-up|0|||
161377261|NCT01815424|582771549|FG001|Week 16 to 52|Lost to Follow-up|2|||
161377262|NCT01815424|582771550|FG002|Week 16 to 52|Lost to Follow-up|0|||
161377263|NCT01815424|582771551|FG003|Week 16 to 52|Lost to Follow-up|2|||
161377264|NCT01815424|582771552|FG004|Week 16 to 52|Lost to Follow-up|1|||
161377265|NCT01815424|582771548|FG000|Week 16 to 52|Withdrawal by Subject|1|||
161377266|NCT01815424|582771549|FG001|Week 16 to 52|Withdrawal by Subject|2|||
161377267|NCT01815424|582771550|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161377268|NCT01815424|582771551|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161377269|NCT01815424|582771552|FG004|Week 16 to 52|Withdrawal by Subject|0|||
161377270|NCT04723355|582771553|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
161377271|NCT04723355|582771553|FG000|Overall Study|Errors in the informed consent form|2|||
161377272|NCT03374358|582771555|FG000|Overall Study|Withdrawal by Subject|0|||
161377273|NCT03374358|582771556|FG001|Overall Study|Withdrawal by Subject|2|||
161377274|NCT01147393|582771559|FG000|Dose Level 1|Dose limiting Toxicity|2|||
161377275|NCT01147393|582771559|FG000|Dose Level -1|Dose Limited Toxicity|1|||
161377276|NCT01833494|582771577|FG000|Overall Study|Adverse Event|24|||
161377277|NCT01833494|582771577|FG000|Overall Study|Physician Decision|6|||
161377278|NCT01833494|582771577|FG000|Overall Study|Withdrawal by Subject|6|||
161377279|NCT01833494|582771577|FG000|Overall Study|Decrease in serum phosphorus|4|||
161377280|NCT01833494|582771577|FG000|Overall Study|Decrease in serum calcium|4|||
161377281|NCT01833494|582771577|FG000|Overall Study|Increase in serum ferritin|1|||
161377282|NCT01694433|582771582|FG000|Overall Study|Adverse Event|7|||
161377283|NCT01694433|582771583|FG001|Overall Study|Adverse Event|0|||
161377284|NCT01694433|582771582|FG000|Overall Study|Physician Decision|1|||
161377285|NCT01694433|582771583|FG001|Overall Study|Physician Decision|0|||
161377286|NCT01694433|582771582|FG000|Overall Study|Withdrawal by Subject|3|||
161377287|NCT01694433|582771583|FG001|Overall Study|Withdrawal by Subject|4|||
161377288|NCT00374595|582771584|FG000|Overall Study|Death|23|||
161377289|NCT00374595|582771584|FG000|Overall Study|Withdrawal by Subject|39|||
161377290|NCT00374595|582771584|FG000|Overall Study|Lost to Follow-up|3|||
161377291|NCT00374595|582771584|FG000|Overall Study|too much time commitment|1|||
161377292|NCT00374595|582771584|FG000|Overall Study|transfer care to other clinical site|1|||
161377293|NCT00374595|582771584|FG000|Overall Study|relocation|3|||
161377294|NCT03745768|582771586|FG000|Overall Study|discontinued study|2|||
161377295|NCT03745768|582771587|FG001|Overall Study|discontinued study|0|||
161377296|NCT00443118|582771588|FG000|Overall Study|unknown primary outcome|3|||
161377297|NCT00443118|582771589|FG001|Overall Study|unknown primary outcome|1|||
161377298|NCT00443118|582771590|FG002|Overall Study|unknown primary outcome|0|||
161377299|NCT00443118|582771588|FG000|Overall Study|Withdrawal by Subject|1|||
161377300|NCT00443118|582771589|FG001|Overall Study|Withdrawal by Subject|0|||
161377301|NCT00443118|582771590|FG002|Overall Study|Withdrawal by Subject|0|||
161377302|NCT00506779|582771593|FG000|Overall Study|Withdrawal by Subject|1|||
161377303|NCT00506779|582771594|FG001|Overall Study|Withdrawal by Subject|0|||
161377304|NCT00506779|582771595|FG002|Overall Study|Withdrawal by Subject|1|||
161377305|NCT00506779|582771596|FG003|Overall Study|Withdrawal by Subject|0|||
161377306|NCT00506779|582771593|FG000|Overall Study|Adverse Event|0|||
161377307|NCT00506779|582771594|FG001|Overall Study|Adverse Event|1|||
161377308|NCT00506779|582771595|FG002|Overall Study|Adverse Event|1|||
161377309|NCT00506779|582771596|FG003|Overall Study|Adverse Event|1|||
161377310|NCT02639247|582771597|FG000|Overall Study|Lost to Follow-up|2|||
161377311|NCT02639247|582771598|FG001|Overall Study|Lost to Follow-up|1|||
161377312|NCT02639247|582771597|FG000|Overall Study|Death|2|||
161377313|NCT02639247|582771598|FG001|Overall Study|Death|0|||
161377314|NCT02639247|582771597|FG000|Overall Study|Withdrew Consent|0|||
161377315|NCT02639247|582771598|FG001|Overall Study|Withdrew Consent|1|||
161377316|NCT02639247|582771597|FG000|Overall Study|Protocol Violation|1|||
161377317|NCT02639247|582771598|FG001|Overall Study|Protocol Violation|0|||
161377318|NCT01891396|582771599|FG000|Overall Study|Withdrawal by Subject|4|||
161377319|NCT01891396|582771600|FG001|Overall Study|Withdrawal by Subject|4|||
161377320|NCT01891396|582771601|FG002|Overall Study|Withdrawal by Subject|3|||
161377321|NCT01891396|582771599|FG000|Overall Study|Lost to Follow-up|0|||
161377322|NCT01891396|582771600|FG001|Overall Study|Lost to Follow-up|1|||
161377323|NCT01891396|582771601|FG002|Overall Study|Lost to Follow-up|0|||
161377324|NCT00573391|582771602|FG000|Overall Study|study stopped|2|||
161377325|NCT00573391|582771603|FG001|Overall Study|study stopped|2|||
161377326|NCT00573391|582771602|FG000|Overall Study|Death|1|||
161377327|NCT00573391|582771603|FG001|Overall Study|Death|0|||
161377328|NCT02168101|582771606|FG000|Overall Study|Death|2|||
161377329|NCT02168101|582771607|FG001|Overall Study|Death|2|||
161377330|NCT02168101|582771608|FG002|Overall Study|Death|1|||
161377331|NCT00400517|582771609|FG000|Overall Study|Withdrawal by Subject|1|||
161377332|NCT00400517|582771609|FG000|Overall Study|Physician Decision|1|||
161377333|NCT01881009|582771610|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
161377334|NCT01881009|582771611|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
161377335|NCT04011735|582771612|FG000|Overall Study|Withdrawal by Subject|1|||
161377336|NCT04011735|582771613|FG001|Overall Study|Withdrawal by Subject|0|||
161377337|NCT04011735|582771614|FG002|Overall Study|Withdrawal by Subject|1|||
161377338|NCT04011735|582771612|FG000|Overall Study|Met exclusion criteria after study entry|0|||
161377339|NCT04011735|582771613|FG001|Overall Study|Met exclusion criteria after study entry|1|||
161377340|NCT04011735|582771614|FG002|Overall Study|Met exclusion criteria after study entry|0|||
161377341|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
161377342|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
161377343|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
161377344|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
161377345|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
161377346|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
161377347|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
161377348|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
161377349|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
161377350|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
161377351|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
161377352|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
161377353|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
161377354|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
161377355|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
161377356|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
161377357|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
161377358|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
161377359|NCT02831855|582771617|FG000|Open Label Phase (24 Weeks)|Other|4|||
161377360|NCT02831855|582771618|FG001|Open Label Phase (24 Weeks)|Other|0|||
161377361|NCT02831855|582771619|FG002|Open Label Phase (24 Weeks)|Other|0|||
161377362|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
161377363|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
161377364|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
161377365|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Death|0|||
161377366|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Death|0|||
161377367|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Death|2|||
161377368|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
161377369|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
161377370|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
161377371|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
161377372|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
161377373|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
161377374|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
161377375|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
161377376|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
161377377|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Other|0|||
161377378|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Other|2|||
161377379|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Other|5|||
161377380|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
161377381|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
161377382|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
161377383|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
161377384|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
161377385|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
161377386|NCT02831855|582771617|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
161377387|NCT02831855|582771618|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
161377388|NCT02831855|582771619|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
161377389|NCT01194245|582771621|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
161377390|NCT01194245|582771622|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161377391|NCT01194245|582771623|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161377392|NCT01194245|582771624|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161377393|NCT01194245|582771625|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161377394|NCT01194245|582771621|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
161377395|NCT01194245|582771622|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161377396|NCT01194245|582771623|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161377397|NCT01194245|582771624|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161377398|NCT01194245|582771625|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161377399|NCT01194245|582771621|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
161377400|NCT01194245|582771622|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161377401|NCT01194245|582771623|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161377402|NCT01194245|582771624|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161377403|NCT01194245|582771625|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161377404|NCT01194245|582771621|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
161377405|NCT01194245|582771622|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161377406|NCT01194245|582771623|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161377407|NCT01194245|582771624|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161377408|NCT01194245|582771625|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161377409|NCT01194245|582771621|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161377410|NCT01194245|582771622|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161377411|NCT01194245|582771623|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161377412|NCT01194245|582771624|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161377413|NCT01194245|582771625|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
161377414|NCT01194245|582771621|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161377415|NCT01194245|582771622|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161377416|NCT01194245|582771623|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
161377417|NCT01194245|582771624|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
161377418|NCT01194245|582771625|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
161377419|NCT05518461|582771626|FG000|Overall Study|Lost to Follow-up|25|||
161377420|NCT03962855|582771627|FG000|Overall Study|Death|0|||
161377421|NCT03962855|582771628|FG001|Overall Study|Death|1|||
161377422|NCT03962855|582771627|FG000|Overall Study|Lost to Follow-up|0|||
161377423|NCT03962855|582771628|FG001|Overall Study|Lost to Follow-up|1|||
161377424|NCT03962855|582771627|FG000|Overall Study|Adverse Event|0|||
161377425|NCT03962855|582771628|FG001|Overall Study|Adverse Event|1|||
161377426|NCT03962855|582771627|FG000|Overall Study|Physician Decision|0|||
161377427|NCT03962855|582771628|FG001|Overall Study|Physician Decision|2|||
161377428|NCT02457247|582771629|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
161377429|NCT02457247|582771630|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
161377430|NCT02457247|582771631|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
161377431|NCT02457247|582771632|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
161377432|NCT02457247|582771629|FG000|Period 1|Significant Protocol Deviation|1|||
161377433|NCT02457247|582771630|FG001|Period 1|Significant Protocol Deviation|1|||
161377434|NCT02457247|582771631|FG002|Period 1|Significant Protocol Deviation|0|||
161377435|NCT02457247|582771632|FG003|Period 1|Significant Protocol Deviation|0|||
161377436|NCT02457247|582771629|FG000|Period 1|Voluntary Withdrawal|1|||
161377437|NCT02457247|582771630|FG001|Period 1|Voluntary Withdrawal|0|||
161377438|NCT02457247|582771631|FG002|Period 1|Voluntary Withdrawal|0|||
161377439|NCT02457247|582771632|FG003|Period 1|Voluntary Withdrawal|0|||
161377440|NCT02457247|582771629|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
161377441|NCT02457247|582771630|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
161377442|NCT02457247|582771631|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
161377443|NCT02457247|582771632|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
161377444|NCT02457247|582771629|FG000|Period 2|Significant Protocol Deviation|1|||
161377445|NCT02457247|582771630|FG001|Period 2|Significant Protocol Deviation|0|||
161377446|NCT02457247|582771631|FG002|Period 2|Significant Protocol Deviation|0|||
161377447|NCT02457247|582771632|FG003|Period 2|Significant Protocol Deviation|0|||
161377448|NCT02457247|582771629|FG000|Period 2|Lost to Follow-up|0|||
161377449|NCT02457247|582771630|FG001|Period 2|Lost to Follow-up|1|||
161377450|NCT02457247|582771631|FG002|Period 2|Lost to Follow-up|0|||
161377451|NCT02457247|582771632|FG003|Period 2|Lost to Follow-up|0|||
161377452|NCT02457247|582771629|FG000|Period 2|Voluntary Withdrawal|1|||
161377453|NCT02457247|582771630|FG001|Period 2|Voluntary Withdrawal|1|||
161377454|NCT02457247|582771631|FG002|Period 2|Voluntary Withdrawal|0|||
161377455|NCT02457247|582771632|FG003|Period 2|Voluntary Withdrawal|0|||
161377456|NCT03326063|582771633|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
161377457|NCT03326063|582771634|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
161377458|NCT00739310|582771635|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
161377459|NCT00739310|582771635|FG000|Overall Study|Withdrawal by Subject|1|||
161377460|NCT00739310|582771635|FG000|Overall Study|Lost to Follow-up|2|||
161377461|NCT02954887|582771636|FG000|Overall Study|Withdrawal by Subject|3|||
161377462|NCT02954887|582771636|FG000|Overall Study|Lack of Efficacy|3|||
161377463|NCT02954887|582771636|FG000|Overall Study|Other|1|||
161377464|NCT02750514|582771637|FG000|Track 1|Disease progression|20|||
161377465|NCT02750514|582771638|FG001|Track 1|Disease progression|1|||
161377466|NCT02750514|582771639|FG002|Track 1|Disease progression|0|||
161377467|NCT02750514|582771640|FG003|Track 1|Disease progression|1|||
161377468|NCT02750514|582771641|FG004|Track 1|Disease progression|0|||
161377469|NCT02750514|582771637|FG000|Track 1|Adverse event unrelated to study drug|1|||
161377470|NCT02750514|582771638|FG001|Track 1|Adverse event unrelated to study drug|0|||
161377471|NCT02750514|582771639|FG002|Track 1|Adverse event unrelated to study drug|0|||
161377472|NCT02750514|582771640|FG003|Track 1|Adverse event unrelated to study drug|0|||
161377473|NCT02750514|582771641|FG004|Track 1|Adverse event unrelated to study drug|0|||
161377474|NCT02750514|582771637|FG000|Track 1|Study drug toxicity|4|||
161377475|NCT02750514|582771638|FG001|Track 1|Study drug toxicity|1|||
161377476|NCT02750514|582771639|FG002|Track 1|Study drug toxicity|0|||
161377477|NCT02750514|582771640|FG003|Track 1|Study drug toxicity|1|||
161377478|NCT02750514|582771641|FG004|Track 1|Study drug toxicity|0|||
161377479|NCT02750514|582771637|FG000|Track 1|Participant request to discontinue|1|||
161377480|NCT02750514|582771638|FG001|Track 1|Participant request to discontinue|0|||
161377481|NCT02750514|582771639|FG002|Track 1|Participant request to discontinue|0|||
161377482|NCT02750514|582771640|FG003|Track 1|Participant request to discontinue|0|||
161377483|NCT02750514|582771641|FG004|Track 1|Participant request to discontinue|0|||
161377484|NCT02750514|582771637|FG000|Track 1|Other reasons|1|||
161377485|NCT02750514|582771638|FG001|Track 1|Other reasons|0|||
161377486|NCT02750514|582771639|FG002|Track 1|Other reasons|0|||
161377487|NCT02750514|582771640|FG003|Track 1|Other reasons|0|||
161377488|NCT02750514|582771641|FG004|Track 1|Other reasons|0|||
161377489|NCT02750514|582771637|FG000|Track 2|Disease progression|4|||
161377490|NCT02750514|582771638|FG001|Track 2|Disease progression|5|||
161377491|NCT02750514|582771639|FG002|Track 2|Disease progression|2|||
161377492|NCT02750514|582771640|FG003|Track 2|Disease progression|5|||
161377493|NCT02750514|582771641|FG004|Track 2|Disease progression|0|||
161377494|NCT02750514|582771637|FG000|Track 2|Adverse event unrelated to study drug|1|||
161377495|NCT02750514|582771638|FG001|Track 2|Adverse event unrelated to study drug|0|||
161377496|NCT02750514|582771639|FG002|Track 2|Adverse event unrelated to study drug|0|||
161377497|NCT02750514|582771640|FG003|Track 2|Adverse event unrelated to study drug|0|||
161377498|NCT02750514|582771641|FG004|Track 2|Adverse event unrelated to study drug|0|||
161377499|NCT02750514|582771637|FG000|Track 2|Study drug toxicity|1|||
161377500|NCT02750514|582771638|FG001|Track 2|Study drug toxicity|2|||
161377501|NCT02750514|582771639|FG002|Track 2|Study drug toxicity|0|||
161377502|NCT02750514|582771640|FG003|Track 2|Study drug toxicity|2|||
161377503|NCT02750514|582771641|FG004|Track 2|Study drug toxicity|0|||
161377504|NCT02750514|582771637|FG000|Track 2|Participant withdrew consent|0|||
161377505|NCT02750514|582771638|FG001|Track 2|Participant withdrew consent|1|||
161377506|NCT02750514|582771639|FG002|Track 2|Participant withdrew consent|0|||
161377507|NCT02750514|582771640|FG003|Track 2|Participant withdrew consent|0|||
161377508|NCT02750514|582771641|FG004|Track 2|Participant withdrew consent|0|||
161377509|NCT02750514|582771637|FG000|Track 3|Disease progression|0|||
161377510|NCT02750514|582771638|FG001|Track 3|Disease progression|24|||
161377511|NCT02750514|582771639|FG002|Track 3|Disease progression|13|||
161377512|NCT02750514|582771640|FG003|Track 3|Disease progression|14|||
161377513|NCT02750514|582771641|FG004|Track 3|Disease progression|0|||
161377514|NCT02750514|582771637|FG000|Track 3|Adverse event unrelated to study drug|0|||
161377515|NCT02750514|582771638|FG001|Track 3|Adverse event unrelated to study drug|1|||
161377516|NCT02750514|582771639|FG002|Track 3|Adverse event unrelated to study drug|1|||
161377517|NCT02750514|582771640|FG003|Track 3|Adverse event unrelated to study drug|1|||
161377518|NCT02750514|582771641|FG004|Track 3|Adverse event unrelated to study drug|0|||
161377519|NCT02750514|582771637|FG000|Track 3|Study drug toxicity|0|||
161377520|NCT02750514|582771638|FG001|Track 3|Study drug toxicity|3|||
161377521|NCT02750514|582771639|FG002|Track 3|Study drug toxicity|0|||
161377522|NCT02750514|582771640|FG003|Track 3|Study drug toxicity|1|||
161377523|NCT02750514|582771641|FG004|Track 3|Study drug toxicity|0|||
161377524|NCT02750514|582771637|FG000|Track 3|Participant request to discontinue|0|||
161377525|NCT02750514|582771638|FG001|Track 3|Participant request to discontinue|2|||
161377526|NCT02750514|582771639|FG002|Track 3|Participant request to discontinue|0|||
161377527|NCT02750514|582771640|FG003|Track 3|Participant request to discontinue|0|||
161377528|NCT02750514|582771641|FG004|Track 3|Participant request to discontinue|0|||
161377529|NCT02750514|582771637|FG000|Track 3|Participant withdrew consent|0|||
161377530|NCT02750514|582771638|FG001|Track 3|Participant withdrew consent|3|||
161377531|NCT02750514|582771639|FG002|Track 3|Participant withdrew consent|1|||
161377532|NCT02750514|582771640|FG003|Track 3|Participant withdrew consent|0|||
161377533|NCT02750514|582771641|FG004|Track 3|Participant withdrew consent|0|||
161377534|NCT02750514|582771637|FG000|Track 3|Other reasons|0|||
161377535|NCT02750514|582771638|FG001|Track 3|Other reasons|3|||
161377536|NCT02750514|582771639|FG002|Track 3|Other reasons|0|||
161377537|NCT02750514|582771640|FG003|Track 3|Other reasons|0|||
161377538|NCT02750514|582771641|FG004|Track 3|Other reasons|0|||
161377539|NCT02750514|582771637|FG000|Track 4|Study drug toxicity|0|||
161377540|NCT02750514|582771638|FG001|Track 4|Study drug toxicity|6|||
161377541|NCT02750514|582771639|FG002|Track 4|Study drug toxicity|0|||
161377542|NCT02750514|582771640|FG003|Track 4|Study drug toxicity|5|||
161377543|NCT02750514|582771641|FG004|Track 4|Study drug toxicity|0|||
161377544|NCT02750514|582771637|FG000|Track 4|Participant request to discontinue|0|||
161377545|NCT02750514|582771638|FG001|Track 4|Participant request to discontinue|1|||
161377546|NCT02750514|582771639|FG002|Track 4|Participant request to discontinue|0|||
161377547|NCT02750514|582771640|FG003|Track 4|Participant request to discontinue|1|||
161377548|NCT02750514|582771641|FG004|Track 4|Participant request to discontinue|0|||
161377549|NCT02750514|582771637|FG000|Track 4|Participant withdrew consent|0|||
161377550|NCT02750514|582771638|FG001|Track 4|Participant withdrew consent|1|||
161377551|NCT02750514|582771639|FG002|Track 4|Participant withdrew consent|0|||
161377552|NCT02750514|582771640|FG003|Track 4|Participant withdrew consent|0|||
161377553|NCT02750514|582771641|FG004|Track 4|Participant withdrew consent|0|||
161377554|NCT02750514|582771637|FG000|Track 4|Other reasons|0|||
161377555|NCT02750514|582771638|FG001|Track 4|Other reasons|5|||
161377556|NCT02750514|582771639|FG002|Track 4|Other reasons|0|||
161377557|NCT02750514|582771640|FG003|Track 4|Other reasons|3|||
161377558|NCT02750514|582771641|FG004|Track 4|Other reasons|0|||
161377559|NCT02750514|582771637|FG000|Track 4|Disease progression|0|||
161377560|NCT02750514|582771638|FG001|Track 4|Disease progression|33|||
161377561|NCT02750514|582771639|FG002|Track 4|Disease progression|0|||
161377562|NCT02750514|582771640|FG003|Track 4|Disease progression|32|||
161377563|NCT02750514|582771641|FG004|Track 4|Disease progression|0|||
161377564|NCT02750514|582771637|FG000|Track 4|Adverse event unrelated to study drug|0|||
161377565|NCT02750514|582771638|FG001|Track 4|Adverse event unrelated to study drug|5|||
161377566|NCT02750514|582771639|FG002|Track 4|Adverse event unrelated to study drug|0|||
161377567|NCT02750514|582771640|FG003|Track 4|Adverse event unrelated to study drug|0|||
161377568|NCT02750514|582771641|FG004|Track 4|Adverse event unrelated to study drug|0|||
161377569|NCT02750514|582771637|FG000|Track 4|Death|0|||
161377570|NCT02750514|582771638|FG001|Track 4|Death|0|||
161377571|NCT02750514|582771639|FG002|Track 4|Death|0|||
161377572|NCT02750514|582771640|FG003|Track 4|Death|1|||
161377573|NCT02750514|582771641|FG004|Track 4|Death|0|||
161377574|NCT02750514|582771637|FG000|Track 5|Disease progression|0|||
161377575|NCT02750514|582771638|FG001|Track 5|Disease progression|0|||
161377576|NCT02750514|582771639|FG002|Track 5|Disease progression|0|||
161377577|NCT02750514|582771640|FG003|Track 5|Disease progression|0|||
161377578|NCT02750514|582771641|FG004|Track 5|Disease progression|34|||
161377579|NCT02750514|582771637|FG000|Track 5|Adverse event unrelated to study drug|0|||
161377580|NCT02750514|582771638|FG001|Track 5|Adverse event unrelated to study drug|0|||
161377581|NCT02750514|582771639|FG002|Track 5|Adverse event unrelated to study drug|0|||
161377582|NCT02750514|582771640|FG003|Track 5|Adverse event unrelated to study drug|0|||
161377583|NCT02750514|582771641|FG004|Track 5|Adverse event unrelated to study drug|2|||
161377584|NCT02750514|582771637|FG000|Track 5|Study drug toxicity|0|||
161377585|NCT02750514|582771638|FG001|Track 5|Study drug toxicity|0|||
161377586|NCT02750514|582771639|FG002|Track 5|Study drug toxicity|0|||
161377587|NCT02750514|582771640|FG003|Track 5|Study drug toxicity|0|||
161377588|NCT02750514|582771641|FG004|Track 5|Study drug toxicity|2|||
161377589|NCT02750514|582771637|FG000|Track 5|Participant request to discontinue|0|||
161377590|NCT02750514|582771638|FG001|Track 5|Participant request to discontinue|0|||
161377591|NCT02750514|582771639|FG002|Track 5|Participant request to discontinue|0|||
161377592|NCT02750514|582771640|FG003|Track 5|Participant request to discontinue|0|||
161377593|NCT02750514|582771641|FG004|Track 5|Participant request to discontinue|3|||
161377594|NCT02750514|582771637|FG000|Track 5|Other reasons|0|||
161377595|NCT02750514|582771638|FG001|Track 5|Other reasons|0|||
161377596|NCT02750514|582771639|FG002|Track 5|Other reasons|0|||
161377597|NCT02750514|582771640|FG003|Track 5|Other reasons|0|||
161377598|NCT02750514|582771641|FG004|Track 5|Other reasons|2|||
161377599|NCT00889707|582771642|FG000|Overall Study|Adverse Event|1|||
161377600|NCT00889707|582771643|FG001|Overall Study|Adverse Event|0|||
161377601|NCT00889707|582771642|FG000|Overall Study|Withdrawal by Subject|4|||
161377602|NCT00889707|582771643|FG001|Overall Study|Withdrawal by Subject|3|||
161377603|NCT00889707|582771642|FG000|Overall Study|Lost to Follow-up|0|||
161377604|NCT00889707|582771643|FG001|Overall Study|Lost to Follow-up|2|||
161377605|NCT00889707|582771642|FG000|Overall Study|Lack of Efficacy|2|||
161377606|NCT00889707|582771643|FG001|Overall Study|Lack of Efficacy|5|||
161377607|NCT00527618|582771645|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
161377608|NCT00527618|582771646|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
161377609|NCT00527618|582771645|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
161377610|NCT00527618|582771646|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
161377611|NCT00527618|582771645|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
161377612|NCT00527618|582771646|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
161377613|NCT00527618|582771645|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
161377614|NCT00527618|582771646|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
161377615|NCT00527618|582771645|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
161377616|NCT00527618|582771646|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
161377617|NCT00527618|582771645|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
161377618|NCT00527618|582771646|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
161377619|NCT02240121|582771649|FG000|Overall Study|Protocol Violation|1|||
161377620|NCT02240121|582771650|FG001|Overall Study|Protocol Violation|2|||
161377621|NCT02240121|582771649|FG000|Overall Study|Physician Decision|0|||
161377622|NCT02240121|582771650|FG001|Overall Study|Physician Decision|1|||
161377623|NCT02240121|582771649|FG000|Overall Study|Change in protocol interpretation|1|||
161377624|NCT02240121|582771650|FG001|Overall Study|Change in protocol interpretation|0|||
161377625|NCT02240121|582771649|FG000|Overall Study|Lack of Efficacy|2|||
161377626|NCT02240121|582771650|FG001|Overall Study|Lack of Efficacy|3|||
161377627|NCT02240121|582771649|FG000|Overall Study|Site closed|1|||
161377628|NCT02240121|582771650|FG001|Overall Study|Site closed|1|||
161377629|NCT02240121|582771649|FG000|Overall Study|Pregnancy|1|||
161377630|NCT02240121|582771650|FG001|Overall Study|Pregnancy|0|||
161377631|NCT02240121|582771649|FG000|Overall Study|Adverse Event|2|||
161377632|NCT02240121|582771650|FG001|Overall Study|Adverse Event|4|||
161377633|NCT02240121|582771649|FG000|Overall Study|Withdrawal by Subject|6|||
161377634|NCT02240121|582771650|FG001|Overall Study|Withdrawal by Subject|2|||
161377635|NCT02240121|582771649|FG000|Overall Study|Lost to Follow-up|3|||
161377636|NCT02240121|582771650|FG001|Overall Study|Lost to Follow-up|4|||
161377637|NCT02240121|582771649|FG000|Overall Study|Other than specified|1|||
161377638|NCT02240121|582771650|FG001|Overall Study|Other than specified|3|||
161377639|NCT01151020|582771651|FG000|Overall Study|Death|25|||
161377640|NCT01151020|582771651|FG000|Overall Study|Conversion to open repair|1|||
161377641|NCT01151020|582771651|FG000|Overall Study|Lost to Follow-up|4|||
161377642|NCT01151020|582771651|FG000|Overall Study|Withdrawal by Subject|22|||
161377643|NCT01151020|582771651|FG000|Overall Study|Patients did not receive the device|2|||
161377644|NCT00648037|582771652|FG000|Overall Study|Not Treated|1|||
161377645|NCT00648037|582771652|FG000|Overall Study|Withdrawal by Subject|1|||
161377646|NCT00648037|582771652|FG000|Overall Study|Adverse Event|11|||
161377647|NCT00648037|582771652|FG000|Overall Study|Relapse|2|||
161377648|NCT00648037|582771652|FG000|Overall Study|Other|1|||
161377649|NCT01635998|582771653|FG000|Overall Study|Death|1|||
161377650|NCT01635998|582771654|FG001|Overall Study|Death|1|||
161377651|NCT01635998|582771653|FG000|Overall Study|Lost to Follow-up|2|||
161377652|NCT01635998|582771654|FG001|Overall Study|Lost to Follow-up|1|||
161377653|NCT01635998|582771653|FG000|Overall Study|Withdrawal by Subject|1|||
161377654|NCT01635998|582771654|FG001|Overall Study|Withdrawal by Subject|5|||
161377655|NCT00846846|582771655|FG000|Overall Study|Death|56|||
161377656|NCT00846846|582771655|FG000|Overall Study|Withdrawal by Subject|19|||
161377657|NCT02967679|582771659|FG000|Overall Study|Adverse Event|1|||
161377658|NCT00600067|582771662|FG000|Overall Study|Adverse Event|0|||
161377659|NCT00600067|582771663|FG001|Overall Study|Adverse Event|1|||
161377660|NCT00600067|582771662|FG000|Overall Study|Lost to Follow-up|2|||
161377661|NCT00600067|582771663|FG001|Overall Study|Lost to Follow-up|3|||
161377662|NCT00600067|582771662|FG000|Overall Study|protocol non-compliance|0|||
161377663|NCT00600067|582771663|FG001|Overall Study|protocol non-compliance|3|||
161377664|NCT00600067|582771662|FG000|Overall Study|Lack of Efficacy|1|||
161377665|NCT00600067|582771663|FG001|Overall Study|Lack of Efficacy|0|||
161377666|NCT00003631|582771664|FG000|Overall Study|Patient not treated|1|||
161377667|NCT00003631|582771665|FG001|Overall Study|Patient not treated|0|||
161377668|NCT00003631|582771666|FG002|Overall Study|Patient not treated|1|||
161377669|NCT00003631|582771664|FG000|Overall Study|Protocol Violation|1|||
161377670|NCT00003631|582771665|FG001|Overall Study|Protocol Violation|0|||
161377671|NCT00003631|582771666|FG002|Overall Study|Protocol Violation|0|||
161377672|NCT00003631|582771664|FG000|Overall Study|Adverse Event|1|||
161377673|NCT00003631|582771665|FG001|Overall Study|Adverse Event|1|||
161377674|NCT00003631|582771666|FG002|Overall Study|Adverse Event|5|||
161377675|NCT00003631|582771664|FG000|Overall Study|Death|0|||
161377676|NCT00003631|582771665|FG001|Overall Study|Death|0|||
161377677|NCT00003631|582771666|FG002|Overall Study|Death|1|||
161377678|NCT00003631|582771664|FG000|Overall Study|Evaluable for toxicity only|0|||
161377679|NCT00003631|582771665|FG001|Overall Study|Evaluable for toxicity only|0|||
161377680|NCT00003631|582771666|FG002|Overall Study|Evaluable for toxicity only|2|||
161377681|NCT00881894|582771668|FG000|Overall Study|Consent withdrawn|0|||
161377682|NCT00881894|582771669|FG001|Overall Study|Consent withdrawn|1|||
161377683|NCT00881894|582771668|FG000|Overall Study|Other reasons for premature termination|1|||
161377684|NCT00881894|582771669|FG001|Overall Study|Other reasons for premature termination|2|||
161377685|NCT01220401|582771674|FG000|Overall Study|Withdrawal by Subject|2|||
161377686|NCT01220401|582771674|FG000|Overall Study|Protocol Violation|1|||
161377687|NCT01853462|582771675|FG000|Overall Study|Withdrawal by Subject|1|||
161377688|NCT01853462|582771676|FG001|Overall Study|Withdrawal by Subject|1|||
161377689|NCT02103062|582771677|FG000|Overall Study|Adverse Event|1|||
161377690|NCT02103062|582771678|FG001|Overall Study|Adverse Event|2|||
161377691|NCT02103062|582771677|FG000|Overall Study|Progressive Disease|17|||
161377692|NCT02103062|582771678|FG001|Overall Study|Progressive Disease|20|||
161377693|NCT02103062|582771677|FG000|Overall Study|Death|0|||
161377694|NCT02103062|582771678|FG001|Overall Study|Death|1|||
161377695|NCT03958331|582771679|FG000|Overall Study|Withdrawal by Subject|3|||
161377696|NCT03958331|582771680|FG001|Overall Study|Withdrawal by Subject|1|||
161377697|NCT03958331|582771681|FG002|Overall Study|Withdrawal by Subject|5|||
161377698|NCT03958331|582771679|FG000|Overall Study|Weaned from medicine|2|||
161377699|NCT03958331|582771680|FG001|Overall Study|Weaned from medicine|0|||
161377700|NCT03958331|582771681|FG002|Overall Study|Weaned from medicine|0|||
161377701|NCT03958331|582771679|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
161377702|NCT03958331|582771680|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
161377703|NCT03958331|582771681|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
161377704|NCT01991483|582771682|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
161377705|NCT01991483|582771683|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
161377706|NCT01991483|582771684|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
161377707|NCT01991483|582771685|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
161377708|NCT01991483|582771682|FG000|Dose Level 600 mg|Physician Decision|0|||
161377709|NCT01991483|582771683|FG001|Dose Level 600 mg|Physician Decision|0|||
161377710|NCT01991483|582771684|FG002|Dose Level 600 mg|Physician Decision|1|||
161377711|NCT01991483|582771685|FG003|Dose Level 600 mg|Physician Decision|0|||
161377712|NCT01991483|582771682|FG000|Dose Level 1000 mg|Protocol Violation|0|||
161377713|NCT01991483|582771683|FG001|Dose Level 1000 mg|Protocol Violation|0|||
161377714|NCT01991483|582771684|FG002|Dose Level 1000 mg|Protocol Violation|0|||
161377715|NCT01991483|582771685|FG003|Dose Level 1000 mg|Protocol Violation|1|||
161377716|NCT02030821|582771686|FG000|Overall Study|Physician Decision|2|||
161377717|NCT02030821|582771687|FG001|Overall Study|Physician Decision|2|||
161377718|NCT02030821|582771688|FG002|Overall Study|Physician Decision|5|||
161377719|NCT02030821|582771689|FG003|Overall Study|Physician Decision|2|||
161377720|NCT03192137|582771690|FG000|Overall Study|Adverse Event|10|||
161377721|NCT03192137|582771691|FG001|Overall Study|Adverse Event|11|||
161377722|NCT03192137|582771690|FG000|Overall Study|Physician Decision|1|||
161377723|NCT03192137|582771691|FG001|Overall Study|Physician Decision|0|||
161377724|NCT03192137|582771690|FG000|Overall Study|Lack of Efficacy|20|||
161377725|NCT03192137|582771691|FG001|Overall Study|Lack of Efficacy|37|||
161377726|NCT03192137|582771690|FG000|Overall Study|Withdrawal by Subject|3|||
161377727|NCT03192137|582771691|FG001|Overall Study|Withdrawal by Subject|3|||
161377728|NCT03192137|582771690|FG000|Overall Study|Protocol Violation|4|||
161377729|NCT03192137|582771691|FG001|Overall Study|Protocol Violation|3|||
161377730|NCT03192137|582771690|FG000|Overall Study|Surgery Cancelled|4|||
161377731|NCT03192137|582771691|FG001|Overall Study|Surgery Cancelled|1|||
161377732|NCT03192137|582771690|FG000|Overall Study|Other - Various Administrative Reasons|8|||
161377733|NCT03192137|582771691|FG001|Overall Study|Other - Various Administrative Reasons|3|||
161377734|NCT02364037|582772963|FG000|Overall Study|Withdrawal by Subject|7|||
161377735|NCT02364037|582772964|FG001|Overall Study|Withdrawal by Subject|4|||
161377736|NCT02364037|582772963|FG000|Overall Study|Lost to Follow-up|37|||
161377737|NCT02364037|582772964|FG001|Overall Study|Lost to Follow-up|49|||
161377738|NCT01453036|582772965|FG000|Overall Study|Lost to Follow-up|26|||
161377739|NCT01453036|582772966|FG001|Overall Study|Lost to Follow-up|115|||
161377740|NCT01453036|582772967|FG002|Overall Study|Lost to Follow-up|31|||
161377741|NCT04567524|582772968|FG000|Overall Study|Adverse Event|1|||
161377742|NCT04567524|582772969|FG001|Overall Study|Adverse Event|1|||
161377743|NCT04567524|582772970|FG002|Overall Study|Adverse Event|0|||
161377744|NCT04567524|582772971|FG003|Overall Study|Adverse Event|0|||
161377745|NCT04567524|582772968|FG000|Overall Study|Withdrawal by Subject|2|||
161377746|NCT04567524|582772969|FG001|Overall Study|Withdrawal by Subject|0|||
161377747|NCT04567524|582772970|FG002|Overall Study|Withdrawal by Subject|0|||
161377748|NCT04567524|582772971|FG003|Overall Study|Withdrawal by Subject|1|||
161377749|NCT02848092|582772972|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
161377750|NCT02848092|582772973|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
161377751|NCT02848092|582772972|FG000|1-month Post-training Follow-up|Adverse Event|2|||
161377752|NCT02848092|582772973|FG001|1-month Post-training Follow-up|Adverse Event|1|||
161377753|NCT02848092|582772972|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
161377754|NCT02848092|582772973|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
161377755|NCT02848092|582772972|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
161377756|NCT02848092|582772973|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
161377757|NCT02848092|582772972|FG000|1-month Post-training Follow-up|fatigue|0|||
161377758|NCT02848092|582772973|FG001|1-month Post-training Follow-up|fatigue|1|||
161377759|NCT02848092|582772972|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
161377760|NCT02848092|582772973|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
161377761|NCT02848092|582772972|FG000|6-month Post-training Follow-up|Adverse Event|1|||
161377762|NCT02848092|582772973|FG001|6-month Post-training Follow-up|Adverse Event|1|||
161377763|NCT02848092|582772972|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
161377764|NCT02848092|582772973|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
161377765|NCT02848092|582772972|FG000|6-month Post-training Follow-up|frustrated with task|1|||
161377766|NCT02848092|582772973|FG001|6-month Post-training Follow-up|frustrated with task|0|||
161377767|NCT02848092|582772972|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
161377768|NCT02848092|582772973|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
161377769|NCT02848092|582772972|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
161377770|NCT02848092|582772973|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
161377771|NCT01428219|582772978|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
161377772|NCT00825994|582772979|FG000|Overall Study|Withdrawal by Subject|2|||
161377773|NCT00825994|582772979|FG000|Overall Study|Lost to Follow-up|1|||
161377774|NCT00825994|582772979|FG000|Overall Study|Protocol Violation|1|||
161377775|NCT00825994|582772979|FG000|Overall Study|Placebo Responder at V2|1|||
161377776|NCT01665911|582772983|FG000|Overall Study|Protocol Violation|4|||
161377777|NCT01665911|582772983|FG000|Overall Study|Withdrawal by Subject|1|||
161377778|NCT01665911|582772983|FG000|Overall Study|Adverse Event|1|||
161377779|NCT01484496|582772984|FG000|Period 1|Protocol Violation|3|||
161377780|NCT01484496|582772985|FG001|Period 1|Protocol Violation|4|||
161377781|NCT01484496|582772986|FG002|Period 1|Protocol Violation|0|||
161377782|NCT01484496|582772987|FG003|Period 1|Protocol Violation|0|||
161377783|NCT01484496|582772984|FG000|Period 1|Physician Decision|5|||
161377784|NCT01484496|582772985|FG001|Period 1|Physician Decision|1|||
161377785|NCT01484496|582772986|FG002|Period 1|Physician Decision|0|||
161377786|NCT01484496|582772987|FG003|Period 1|Physician Decision|0|||
161377787|NCT01484496|582772984|FG000|Period 1|Lack of Efficacy|10|||
161377788|NCT01484496|582772985|FG001|Period 1|Lack of Efficacy|15|||
161377789|NCT01484496|582772986|FG002|Period 1|Lack of Efficacy|0|||
161377790|NCT01484496|582772987|FG003|Period 1|Lack of Efficacy|0|||
161377791|NCT01484496|582772984|FG000|Period 1|Adverse Event|25|||
161377792|NCT01484496|582772985|FG001|Period 1|Adverse Event|40|||
161377793|NCT01484496|582772986|FG002|Period 1|Adverse Event|0|||
161377794|NCT01484496|582772987|FG003|Period 1|Adverse Event|0|||
161377795|NCT01484496|582772984|FG000|Period 1|Withdrawal by Subject|15|||
161377796|NCT01484496|582772985|FG001|Period 1|Withdrawal by Subject|12|||
161377797|NCT01484496|582772986|FG002|Period 1|Withdrawal by Subject|0|||
161377798|NCT01484496|582772987|FG003|Period 1|Withdrawal by Subject|0|||
161377799|NCT01484496|582772984|FG000|Period 1|Lost to Follow-up|2|||
161377800|NCT01484496|582772985|FG001|Period 1|Lost to Follow-up|6|||
161377801|NCT01484496|582772986|FG002|Period 1|Lost to Follow-up|0|||
161377802|NCT01484496|582772987|FG003|Period 1|Lost to Follow-up|0|||
161377803|NCT01484496|582772984|FG000|Period 1|Positive Pregnancy|1|||
161377804|NCT01484496|582772985|FG001|Period 1|Positive Pregnancy|6|||
161377805|NCT01484496|582772986|FG002|Period 1|Positive Pregnancy|0|||
161377806|NCT01484496|582772987|FG003|Period 1|Positive Pregnancy|0|||
161377807|NCT01484496|582772984|FG000|Period 1|Treatment Failure|3|||
161377808|NCT01484496|582772985|FG001|Period 1|Treatment Failure|6|||
161377809|NCT01484496|582772986|FG002|Period 1|Treatment Failure|0|||
161377810|NCT01484496|582772987|FG003|Period 1|Treatment Failure|0|||
161377811|NCT01484496|582772984|FG000|Period 1|Lack of Compliance|2|||
161377812|NCT01484496|582772985|FG001|Period 1|Lack of Compliance|1|||
161377813|NCT01484496|582772986|FG002|Period 1|Lack of Compliance|0|||
161377814|NCT01484496|582772987|FG003|Period 1|Lack of Compliance|0|||
161377815|NCT01484496|582772984|FG000|Period 1|Unable to Visit Site|0|||
161377816|NCT01484496|582772985|FG001|Period 1|Unable to Visit Site|2|||
161377817|NCT01484496|582772986|FG002|Period 1|Unable to Visit Site|0|||
161377818|NCT01484496|582772987|FG003|Period 1|Unable to Visit Site|0|||
161377819|NCT01484496|582772984|FG000|Period 2|Lack of Efficacy|0|||
161377820|NCT01484496|582772985|FG001|Period 2|Lack of Efficacy|0|||
161377821|NCT01484496|582772986|FG002|Period 2|Lack of Efficacy|1|||
161377822|NCT01484496|582772987|FG003|Period 2|Lack of Efficacy|3|||
161377823|NCT01484496|582772984|FG000|Period 2|Adverse Event|0|||
161377824|NCT01484496|582772985|FG001|Period 2|Adverse Event|0|||
161377825|NCT01484496|582772986|FG002|Period 2|Adverse Event|5|||
161377826|NCT01484496|582772987|FG003|Period 2|Adverse Event|13|||
161377827|NCT01484496|582772984|FG000|Period 2|Other|0|||
161377828|NCT01484496|582772985|FG001|Period 2|Other|0|||
161377829|NCT01484496|582772986|FG002|Period 2|Other|9|||
161377830|NCT01484496|582772987|FG003|Period 2|Other|6|||
161377831|NCT01645735|582772988|FG000|Overall Study|Physician Decision|2|||
161377832|NCT01645735|582772989|FG001|Overall Study|Physician Decision|0|||
161377833|NCT01645735|582772988|FG000|Overall Study|Withdrawal by Subject|1|||
161377834|NCT01645735|582772989|FG001|Overall Study|Withdrawal by Subject|0|||
161377835|NCT01645735|582772988|FG000|Overall Study|Protocol Violation|1|||
161377836|NCT01645735|582772989|FG001|Overall Study|Protocol Violation|0|||
161377837|NCT01645735|582772988|FG000|Overall Study|Adverse Event|0|||
161377838|NCT01645735|582772989|FG001|Overall Study|Adverse Event|1|||
161377839|NCT01492088|582772992|FG000|Overall Study|Withdrawal by Patient|0|||
161377840|NCT01492088|582772993|FG001|Overall Study|Withdrawal by Patient|2|||
161377841|NCT01492088|582772994|FG002|Overall Study|Withdrawal by Patient|0|||
161377842|NCT01492088|582772992|FG000|Overall Study|Death|1|||
161377843|NCT01492088|582772993|FG001|Overall Study|Death|6|||
161377844|NCT01492088|582772994|FG002|Overall Study|Death|2|||
161377845|NCT01492088|582772992|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
161377846|NCT01492088|582772993|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
161377847|NCT01492088|582772994|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
161377848|NCT01492088|582772992|FG000|Overall Study|Alive at Last Follow-up|0|||
161377849|NCT01492088|582772993|FG001|Overall Study|Alive at Last Follow-up|6|||
161377850|NCT01492088|582772994|FG002|Overall Study|Alive at Last Follow-up|11|||
161377851|NCT03637491|582772995|FG000|Overall Study|Death|9|||
161377852|NCT03637491|582772996|FG001|Overall Study|Death|9|||
161377853|NCT03637491|582772997|FG002|Overall Study|Death|5|||
161377854|NCT03637491|582772998|FG003|Overall Study|Death|3|||
161377855|NCT03637491|582772995|FG000|Overall Study|Lost to Follow-up|0|||
161377856|NCT03637491|582772996|FG001|Overall Study|Lost to Follow-up|1|||
161377857|NCT03637491|582772997|FG002|Overall Study|Lost to Follow-up|0|||
161377858|NCT03637491|582772998|FG003|Overall Study|Lost to Follow-up|1|||
161377859|NCT03637491|582772995|FG000|Overall Study|Study Terminated By Sponsor|0|||
161377860|NCT03637491|582772996|FG001|Overall Study|Study Terminated By Sponsor|2|||
161377861|NCT03637491|582772997|FG002|Overall Study|Study Terminated By Sponsor|1|||
161377862|NCT03637491|582772998|FG003|Overall Study|Study Terminated By Sponsor|0|||
161377863|NCT03637491|582772995|FG000|Overall Study|Withdrawal by Subject|1|||
161377864|NCT03637491|582772996|FG001|Overall Study|Withdrawal by Subject|0|||
161377865|NCT03637491|582772997|FG002|Overall Study|Withdrawal by Subject|1|||
161377866|NCT03637491|582772998|FG003|Overall Study|Withdrawal by Subject|2|||
161377867|NCT02756403|582773000|FG000|Overall Study|Unable to swallow medication|0|||
161377868|NCT02756403|582773001|FG001|Overall Study|Unable to swallow medication|1|||
161377869|NCT02756403|582773002|FG002|Overall Study|Unable to swallow medication|1|||
161377870|NCT02756403|582773003|FG003|Overall Study|Unable to swallow medication|1|||
161377871|NCT02756403|582773000|FG000|Overall Study|Did not complete Procedure|0|||
161377872|NCT02756403|582773001|FG001|Overall Study|Did not complete Procedure|1|||
161377873|NCT02756403|582773002|FG002|Overall Study|Did not complete Procedure|0|||
161377874|NCT02756403|582773003|FG003|Overall Study|Did not complete Procedure|0|||
161377875|NCT02756403|582773000|FG000|Overall Study|Changed Mind About Procedure|0|||
161377876|NCT02756403|582773001|FG001|Overall Study|Changed Mind About Procedure|0|||
161377877|NCT02756403|582773002|FG002|Overall Study|Changed Mind About Procedure|1|||
161377878|NCT02756403|582773003|FG003|Overall Study|Changed Mind About Procedure|0|||
161377879|NCT02756403|582773000|FG000|Overall Study|Protocol Violation|0|||
161377880|NCT02756403|582773001|FG001|Overall Study|Protocol Violation|1|||
161377881|NCT02756403|582773002|FG002|Overall Study|Protocol Violation|0|||
161377882|NCT02756403|582773003|FG003|Overall Study|Protocol Violation|1|||
161377883|NCT04419467|582773006|FG000|Overall Study|Not treated with IP|0|||
161377884|NCT04419467|582773007|FG001|Overall Study|Not treated with IP|0|||
161377885|NCT04419467|582773008|FG002|Overall Study|Not treated with IP|2|||
161377886|NCT04419467|582773006|FG000|Overall Study|Adverse Event|0|||
161377887|NCT04419467|582773007|FG001|Overall Study|Adverse Event|2|||
161377888|NCT04419467|582773008|FG002|Overall Study|Adverse Event|0|||
161377889|NCT04419467|582773006|FG000|Overall Study|Death|1|||
161377890|NCT04419467|582773007|FG001|Overall Study|Death|0|||
161377891|NCT04419467|582773008|FG002|Overall Study|Death|0|||
161377892|NCT04419467|582773006|FG000|Overall Study|Lost to Follow-up|0|||
161377893|NCT04419467|582773007|FG001|Overall Study|Lost to Follow-up|1|||
161377894|NCT04419467|582773008|FG002|Overall Study|Lost to Follow-up|2|||
161377895|NCT04419467|582773006|FG000|Overall Study|Withdrawal by Subject|0|||
161377896|NCT04419467|582773007|FG001|Overall Study|Withdrawal by Subject|0|||
161377897|NCT04419467|582773008|FG002|Overall Study|Withdrawal by Subject|4|||
161377898|NCT04419467|582773006|FG000|Overall Study|Pandemic related|0|||
161377899|NCT04419467|582773007|FG001|Overall Study|Pandemic related|0|||
161377900|NCT04419467|582773008|FG002|Overall Study|Pandemic related|1|||
161377901|NCT04419467|582773006|FG000|Overall Study|Reason not known|1|||
161377902|NCT04419467|582773007|FG001|Overall Study|Reason not known|0|||
161377903|NCT04419467|582773008|FG002|Overall Study|Reason not known|0|||
161377904|NCT04571060|582773014|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
161377905|NCT04571060|582773015|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
161377906|NCT04571060|582773014|FG000|Overall Study|Never treated migraine|47|||
161377907|NCT04571060|582773015|FG001|Overall Study|Never treated migraine|36|||
161377908|NCT04571060|582773014|FG000|Overall Study|Protocol Violation|4|||
161377909|NCT04571060|582773015|FG001|Overall Study|Protocol Violation|2|||
161377910|NCT04571060|582773014|FG000|Overall Study|Withdrawal by Subject|6|||
161377911|NCT04571060|582773015|FG001|Overall Study|Withdrawal by Subject|2|||
161377912|NCT04571060|582773014|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
161377913|NCT04571060|582773015|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
161377914|NCT01253369|582773016|FG000|Overall Study|Adverse Event|4|||
161377915|NCT01253369|582773016|FG000|Overall Study|Withdrawal by Subject|2|||
161377916|NCT01253369|582773016|FG000|Overall Study|Death|1|||
161377917|NCT01253369|582773016|FG000|Overall Study|Progressive disease|23|||
161377918|NCT01253369|582773016|FG000|Overall Study|Not Evaluable|3|||
161377919|NCT03943290|582773019|FG000|Overall Study|Sponsor Terminated Study|6|||
161377920|NCT03943290|582773020|FG001|Overall Study|Sponsor Terminated Study|1|||
161377921|NCT03943290|582773021|FG002|Overall Study|Sponsor Terminated Study|11|||
161377922|NCT03943290|582773022|FG003|Overall Study|Sponsor Terminated Study|6|||
161377923|NCT03943290|582773023|FG004|Overall Study|Sponsor Terminated Study|7|||
161377924|NCT03943290|582773024|FG005|Overall Study|Sponsor Terminated Study|6|||
161377925|NCT03943290|582773025|FG006|Overall Study|Sponsor Terminated Study|6|||
161377926|NCT03943290|582773026|FG007|Overall Study|Sponsor Terminated Study|7|||
161377927|NCT03943290|582773027|FG008|Overall Study|Sponsor Terminated Study|8|||
161377928|NCT03943290|582773019|FG000|Overall Study|Lost to Follow-up|1|||
161377929|NCT03943290|582773020|FG001|Overall Study|Lost to Follow-up|0|||
161377930|NCT03943290|582773021|FG002|Overall Study|Lost to Follow-up|1|||
161377931|NCT03943290|582773022|FG003|Overall Study|Lost to Follow-up|0|||
161377932|NCT03943290|582773023|FG004|Overall Study|Lost to Follow-up|0|||
161377933|NCT03943290|582773024|FG005|Overall Study|Lost to Follow-up|0|||
161377934|NCT03943290|582773025|FG006|Overall Study|Lost to Follow-up|0|||
161377935|NCT03943290|582773026|FG007|Overall Study|Lost to Follow-up|1|||
161377936|NCT03943290|582773027|FG008|Overall Study|Lost to Follow-up|0|||
161377937|NCT03943290|582773019|FG000|Overall Study|Withdrawal by Subject|0|||
161377938|NCT03943290|582773020|FG001|Overall Study|Withdrawal by Subject|0|||
161377939|NCT03943290|582773021|FG002|Overall Study|Withdrawal by Subject|1|||
161377940|NCT03943290|582773022|FG003|Overall Study|Withdrawal by Subject|0|||
161377941|NCT03943290|582773023|FG004|Overall Study|Withdrawal by Subject|0|||
161377942|NCT03943290|582773024|FG005|Overall Study|Withdrawal by Subject|0|||
161377943|NCT03943290|582773025|FG006|Overall Study|Withdrawal by Subject|0|||
161377944|NCT03943290|582773026|FG007|Overall Study|Withdrawal by Subject|0|||
161377945|NCT03943290|582773027|FG008|Overall Study|Withdrawal by Subject|0|||
161377946|NCT04179305|582773028|FG000|Overall Study|Death|1|||
161377947|NCT04179305|582773029|FG001|Overall Study|Death|1|||
161377948|NCT04179305|582773030|FG002|Overall Study|Death|0|||
161377949|NCT04179305|582773031|FG003|Overall Study|Death|0|||
161377950|NCT04179305|582773028|FG000|Overall Study|Lost to Follow-up|1|||
161377951|NCT04179305|582773029|FG001|Overall Study|Lost to Follow-up|1|||
161377952|NCT04179305|582773030|FG002|Overall Study|Lost to Follow-up|0|||
161377953|NCT04179305|582773031|FG003|Overall Study|Lost to Follow-up|0|||
161377954|NCT04179305|582773028|FG000|Overall Study|Withdrawal by Subject|0|||
161377955|NCT04179305|582773029|FG001|Overall Study|Withdrawal by Subject|1|||
161377956|NCT04179305|582773030|FG002|Overall Study|Withdrawal by Subject|0|||
161377957|NCT04179305|582773031|FG003|Overall Study|Withdrawal by Subject|0|||
161377958|NCT04179305|582773028|FG000|Overall Study|Did not have scan|1|||
161377959|NCT04179305|582773029|FG001|Overall Study|Did not have scan|0|||
161377960|NCT04179305|582773030|FG002|Overall Study|Did not have scan|0|||
161377961|NCT04179305|582773031|FG003|Overall Study|Did not have scan|0|||
161377962|NCT04179305|582773028|FG000|Overall Study|In hospice care|3|||
161377963|NCT04179305|582773029|FG001|Overall Study|In hospice care|0|||
161377964|NCT04179305|582773030|FG002|Overall Study|In hospice care|0|||
161377965|NCT04179305|582773031|FG003|Overall Study|In hospice care|0|||
161377966|NCT01737762|582773034|FG000|Overall Study|Adverse Event|2|||
161377967|NCT01737762|582773035|FG001|Overall Study|Adverse Event|2|||
161377968|NCT01737762|582773034|FG000|Overall Study|Lost to Follow-up|1|||
161377969|NCT01737762|582773035|FG001|Overall Study|Lost to Follow-up|0|||
161377970|NCT01737762|582773034|FG000|Overall Study|Withdrawal by Subject|2|||
161377971|NCT01737762|582773035|FG001|Overall Study|Withdrawal by Subject|2|||
161377972|NCT01737762|582773034|FG000|Overall Study|Progressive disease|1|||
161377973|NCT01737762|582773035|FG001|Overall Study|Progressive disease|2|||
161377974|NCT01737762|582773034|FG000|Overall Study|Physician Decision|1|||
161377975|NCT01737762|582773035|FG001|Overall Study|Physician Decision|1|||
161377976|NCT01737762|582773034|FG000|Overall Study|Moved from area|2|||
161377977|NCT01737762|582773035|FG001|Overall Study|Moved from area|1|||
161377978|NCT01737762|582773034|FG000|Overall Study|Trial termination|11|||
161377979|NCT01737762|582773035|FG001|Overall Study|Trial termination|9|||
161377980|NCT00326599|582773036|FG000|Overall Study|Withdrawal by Subject|1|||
161377981|NCT00326599|582773037|FG001|Overall Study|Withdrawal by Subject|0|||
161377982|NCT00326599|582773038|FG002|Overall Study|Withdrawal by Subject|5|||
161377983|NCT00326599|582773039|FG003|Overall Study|Withdrawal by Subject|2|||
161377984|NCT00326599|582773036|FG000|Overall Study|Adverse Event|1|||
161377985|NCT00326599|582773037|FG001|Overall Study|Adverse Event|0|||
161377986|NCT00326599|582773038|FG002|Overall Study|Adverse Event|32|||
161377987|NCT00326599|582773039|FG003|Overall Study|Adverse Event|3|||
161377988|NCT00326599|582773036|FG000|Overall Study|Disease Progression|3|||
161377989|NCT00326599|582773037|FG001|Overall Study|Disease Progression|1|||
161377990|NCT00326599|582773038|FG002|Overall Study|Disease Progression|13|||
161377991|NCT00326599|582773039|FG003|Overall Study|Disease Progression|11|||
161377992|NCT00326599|582773036|FG000|Overall Study|Alternate Treatment|1|||
161377993|NCT00326599|582773037|FG001|Overall Study|Alternate Treatment|0|||
161377994|NCT00326599|582773038|FG002|Overall Study|Alternate Treatment|0|||
161377995|NCT00326599|582773039|FG003|Overall Study|Alternate Treatment|0|||
161377996|NCT00326599|582773036|FG000|Overall Study|Death|0|||
161377997|NCT00326599|582773037|FG001|Overall Study|Death|0|||
161377998|NCT00326599|582773038|FG002|Overall Study|Death|1|||
161377999|NCT00326599|582773039|FG003|Overall Study|Death|2|||
161378000|NCT00326599|582773036|FG000|Overall Study|Other Unspecified Reason|0|||
161378001|NCT00326599|582773037|FG001|Overall Study|Other Unspecified Reason|0|||
161378002|NCT00326599|582773038|FG002|Overall Study|Other Unspecified Reason|2|||
161378003|NCT00326599|582773039|FG003|Overall Study|Other Unspecified Reason|1|||
161378004|NCT00625586|582773040|FG000|Overall Study|Adverse Event|1|||
161378005|NCT00625586|582773040|FG000|Overall Study|Progressive disease|1|||
161378006|NCT00437268|582773044|FG000|Overall Study|Adverse Event|1|||
161378007|NCT00437268|582773045|FG001|Overall Study|Adverse Event|1|||
161378008|NCT00437268|582773044|FG000|Overall Study|Withdrawal by Subject|2|||
161378009|NCT00437268|582773045|FG001|Overall Study|Withdrawal by Subject|2|||
161378010|NCT00437268|582773044|FG000|Overall Study|Progressive disease|9|||
161378011|NCT00437268|582773045|FG001|Overall Study|Progressive disease|9|||
161378012|NCT00437268|582773044|FG000|Overall Study|Physician Decision|1|||
161378013|NCT00437268|582773045|FG001|Overall Study|Physician Decision|0|||
161378014|NCT00437268|582773044|FG000|Overall Study|Death|0|||
161378015|NCT00437268|582773045|FG001|Overall Study|Death|1|||
161378016|NCT01085214|582773048|FG000|Overall Study|Alternate treatment required|1|||
161378017|NCT01152437|582773063|FG000|Overall Study|Other Adverse Event|8|||
161378018|NCT01152437|582773064|FG001|Overall Study|Other Adverse Event|1|||
161378019|NCT01152437|582773065|FG002|Overall Study|Other Adverse Event|7|||
161378020|NCT01152437|582773063|FG000|Overall Study|Not treated|0|||
161378021|NCT01152437|582773064|FG001|Overall Study|Not treated|1|||
161378022|NCT01152437|582773065|FG002|Overall Study|Not treated|2|||
161378023|NCT01152437|582773063|FG000|Overall Study|Progressive disease|27|||
161378024|NCT01152437|582773064|FG001|Overall Study|Progressive disease|13|||
161378025|NCT01152437|582773065|FG002|Overall Study|Progressive disease|32|||
161378026|NCT01152437|582773063|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
161378027|NCT01152437|582773064|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
161378028|NCT01152437|582773065|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
161378029|NCT01985022|582773066|FG000|Overall Study|Lost to Follow-up|0|||
161378030|NCT01985022|582773067|FG001|Overall Study|Lost to Follow-up|1|||
161378031|NCT01985022|582773066|FG000|Overall Study|Protocol Violation|0|||
161378032|NCT01985022|582773067|FG001|Overall Study|Protocol Violation|1|||
161378033|NCT01985022|582773066|FG000|Overall Study|Withdrawal by Subject|4|||
161378034|NCT01985022|582773067|FG001|Overall Study|Withdrawal by Subject|1|||
161378035|NCT02015039|582773068|FG000|Overall Study|Not eligible|0|||
161378036|NCT02015039|582773069|FG001|Overall Study|Not eligible|1|||
161378037|NCT03132467|582773070|FG000|Overall Study|Adverse Event|2|||
161378038|NCT03132467|582773070|FG000|Overall Study|Withdrawal by Subject|2|||
161378039|NCT01088906|582773071|FG000|Overall Study|Inclusion error|1|||
161378040|NCT01088906|582773071|FG000|Overall Study|Did not receive study treatment|3|||
161378041|NCT01088906|582773071|FG000|Overall Study|Missing data|1|||
161378042|NCT00457626|582773074|FG000|Overall Study|Adverse Event|3|||
161378043|NCT00457626|582773074|FG000|Overall Study|Administrative Problems|2|||
161378044|NCT00457626|582773074|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
161378045|NCT01365455|582773075|FG000|Induction Period|Adverse Event|5|||
161378046|NCT01365455|582773076|FG001|Induction Period|Adverse Event|3|||
161378047|NCT01365455|582773077|FG002|Induction Period|Adverse Event|4|||
161378048|NCT01365455|582773078|FG003|Induction Period|Adverse Event|0|||
161378049|NCT01365455|582773079|FG004|Induction Period|Adverse Event|0|||
161378050|NCT01365455|582773075|FG000|Induction Period|Lack of Efficacy|1|||
161378051|NCT01365455|582773076|FG001|Induction Period|Lack of Efficacy|1|||
161378052|NCT01365455|582773077|FG002|Induction Period|Lack of Efficacy|0|||
161378053|NCT01365455|582773078|FG003|Induction Period|Lack of Efficacy|0|||
161378054|NCT01365455|582773079|FG004|Induction Period|Lack of Efficacy|0|||
161378055|NCT01365455|582773075|FG000|Induction Period|Pregnancy|0|||
161378056|NCT01365455|582773076|FG001|Induction Period|Pregnancy|1|||
161378057|NCT01365455|582773077|FG002|Induction Period|Pregnancy|0|||
161378058|NCT01365455|582773078|FG003|Induction Period|Pregnancy|0|||
161378059|NCT01365455|582773079|FG004|Induction Period|Pregnancy|0|||
161378060|NCT01365455|582773075|FG000|Induction Period|Protocol deviation|0|||
161378061|NCT01365455|582773076|FG001|Induction Period|Protocol deviation|1|||
161378062|NCT01365455|582773077|FG002|Induction Period|Protocol deviation|1|||
161378063|NCT01365455|582773078|FG003|Induction Period|Protocol deviation|0|||
161378064|NCT01365455|582773079|FG004|Induction Period|Protocol deviation|0|||
161378065|NCT01365455|582773075|FG000|Induction Period|Subject/guardian decision|9|||
161378066|NCT01365455|582773076|FG001|Induction Period|Subject/guardian decision|1|||
161378067|NCT01365455|582773077|FG002|Induction Period|Subject/guardian decision|8|||
161378068|NCT01365455|582773078|FG003|Induction Period|Subject/guardian decision|0|||
161378069|NCT01365455|582773079|FG004|Induction Period|Subject/guardian decision|0|||
161378070|NCT01365455|582773075|FG000|Induction Period|Lost to Follow-up|0|||
161378071|NCT01365455|582773076|FG001|Induction Period|Lost to Follow-up|0|||
161378072|NCT01365455|582773077|FG002|Induction Period|Lost to Follow-up|3|||
161378073|NCT01365455|582773078|FG003|Induction Period|Lost to Follow-up|0|||
161378074|NCT01365455|582773079|FG004|Induction Period|Lost to Follow-up|0|||
161378075|NCT01365455|582773075|FG000|Maintenance Period|Adverse Event|12|||
161378076|NCT01365455|582773076|FG001|Maintenance Period|Adverse Event|5|||
161378077|NCT01365455|582773077|FG002|Maintenance Period|Adverse Event|1|||
161378078|NCT01365455|582773078|FG003|Maintenance Period|Adverse Event|2|||
161378079|NCT01365455|582773079|FG004|Maintenance Period|Adverse Event|4|||
161378080|NCT01365455|582773075|FG000|Maintenance Period|Lack of Efficacy|10|||
161378081|NCT01365455|582773076|FG001|Maintenance Period|Lack of Efficacy|2|||
161378082|NCT01365455|582773077|FG002|Maintenance Period|Lack of Efficacy|0|||
161378083|NCT01365455|582773078|FG003|Maintenance Period|Lack of Efficacy|2|||
161378084|NCT01365455|582773079|FG004|Maintenance Period|Lack of Efficacy|2|||
161378085|NCT01365455|582773075|FG000|Maintenance Period|Lost to Follow-up|2|||
161378086|NCT01365455|582773076|FG001|Maintenance Period|Lost to Follow-up|4|||
161378087|NCT01365455|582773077|FG002|Maintenance Period|Lost to Follow-up|0|||
161378088|NCT01365455|582773078|FG003|Maintenance Period|Lost to Follow-up|0|||
161378089|NCT01365455|582773079|FG004|Maintenance Period|Lost to Follow-up|3|||
161378090|NCT01365455|582773075|FG000|Maintenance Period|Non-compliance with study treatment|0|||
161378091|NCT01365455|582773076|FG001|Maintenance Period|Non-compliance with study treatment|0|||
161378092|NCT01365455|582773077|FG002|Maintenance Period|Non-compliance with study treatment|0|||
161378093|NCT01365455|582773078|FG003|Maintenance Period|Non-compliance with study treatment|1|||
161378094|NCT01365455|582773079|FG004|Maintenance Period|Non-compliance with study treatment|0|||
161378095|NCT01365455|582773075|FG000|Maintenance Period|Physician Decision|0|||
161378096|NCT01365455|582773076|FG001|Maintenance Period|Physician Decision|1|||
161378097|NCT01365455|582773077|FG002|Maintenance Period|Physician Decision|0|||
161378098|NCT01365455|582773078|FG003|Maintenance Period|Physician Decision|0|||
161378099|NCT01365455|582773079|FG004|Maintenance Period|Physician Decision|1|||
161378100|NCT01365455|582773075|FG000|Maintenance Period|Pregnancy|0|||
161378101|NCT01365455|582773076|FG001|Maintenance Period|Pregnancy|4|||
161378102|NCT01365455|582773077|FG002|Maintenance Period|Pregnancy|0|||
161378103|NCT01365455|582773078|FG003|Maintenance Period|Pregnancy|0|||
161378104|NCT01365455|582773079|FG004|Maintenance Period|Pregnancy|2|||
161378105|NCT01365455|582773075|FG000|Maintenance Period|Protocol deviation|1|||
161378106|NCT01365455|582773076|FG001|Maintenance Period|Protocol deviation|1|||
161378107|NCT01365455|582773077|FG002|Maintenance Period|Protocol deviation|0|||
161378108|NCT01365455|582773078|FG003|Maintenance Period|Protocol deviation|0|||
161378109|NCT01365455|582773079|FG004|Maintenance Period|Protocol deviation|0|||
161378110|NCT01365455|582773075|FG000|Maintenance Period|Subject/guardian decision|4|||
161378111|NCT01365455|582773076|FG001|Maintenance Period|Subject/guardian decision|6|||
161378112|NCT01365455|582773077|FG002|Maintenance Period|Subject/guardian decision|2|||
161378113|NCT01365455|582773078|FG003|Maintenance Period|Subject/guardian decision|4|||
161378114|NCT01365455|582773079|FG004|Maintenance Period|Subject/guardian decision|1|||
161378115|NCT03965403|582773080|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
161378116|NCT00972023|582774799|FG000|Overall Study|Withdrawal by Subject|1|||
161378117|NCT00532129|582774800|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
161378118|NCT00532129|582774800|FG000|Treatment Period|Physician Decision|15|||
161378119|NCT00532129|582774800|FG000|Treatment Period|Disease progression|3|||
161378120|NCT00532129|582774800|FG000|Treatment Period|Protocol Violation|1|||
161378121|NCT00532129|582774800|FG000|Treatment Period|Other|5|||
161378122|NCT00532129|582774800|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
161378123|NCT00532129|582774800|FG000|Follow-up Period|Disease progression|57|||
161378124|NCT00532129|582774800|FG000|Follow-up Period|Lost to Follow-up|1|||
161378125|NCT00532129|582774800|FG000|Follow-up Period|Other|6|||
161378126|NCT03052608|582774801|FG000|Treatment Phase|Adverse Event|10|||
161378127|NCT03052608|582774802|FG001|Treatment Phase|Adverse Event|12|||
161378128|NCT03052608|582774801|FG000|Treatment Phase|Death|6|||
161378129|NCT03052608|582774802|FG001|Treatment Phase|Death|4|||
161378130|NCT03052608|582774801|FG000|Treatment Phase|Withdrawal by Subject|4|||
161378131|NCT03052608|582774802|FG001|Treatment Phase|Withdrawal by Subject|12|||
161378132|NCT03052608|582774801|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
161378133|NCT03052608|582774802|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
161378134|NCT03052608|582774801|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
161378135|NCT03052608|582774802|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
161378136|NCT03052608|582774801|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
161378137|NCT03052608|582774802|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
161378138|NCT03052608|582774801|FG000|Treatment Phase|Ongoing|103|||
161378139|NCT03052608|582774802|FG001|Treatment Phase|Ongoing|31|||
161378140|NCT03052608|582774801|FG000|Long-Term Follow-up Phase|Death|23|||
161378141|NCT03052608|582774802|FG001|Long-Term Follow-up Phase|Death|28|||
161378142|NCT03052608|582774801|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
161378143|NCT03052608|582774802|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
161378144|NCT03052608|582774801|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
161378145|NCT03052608|582774802|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
161378146|NCT03052608|582774801|FG000|Long-Term Follow-up Phase|Ongoing|122|||
161378147|NCT03052608|582774802|FG001|Long-Term Follow-up Phase|Ongoing|99|||
161378148|NCT00551031|582774803|FG000|Overall Study|Adverse Event|0|||
161378149|NCT00551031|582774804|FG001|Overall Study|Adverse Event|1|||
161378150|NCT00551031|582774805|FG002|Overall Study|Adverse Event|0|||
161378151|NCT00551031|582774806|FG003|Overall Study|Adverse Event|0|||
161378152|NCT00551031|582774807|FG004|Overall Study|Adverse Event|0|||
161378153|NCT00551031|582774803|FG000|Overall Study|Protocol Violation|1|||
161378154|NCT00551031|582774804|FG001|Overall Study|Protocol Violation|1|||
161378155|NCT00551031|582774805|FG002|Overall Study|Protocol Violation|0|||
161378156|NCT00551031|582774806|FG003|Overall Study|Protocol Violation|0|||
161378157|NCT00551031|582774807|FG004|Overall Study|Protocol Violation|0|||
161378158|NCT00551031|582774803|FG000|Overall Study|Lost to Follow-up|0|||
161378159|NCT00551031|582774804|FG001|Overall Study|Lost to Follow-up|1|||
161378160|NCT00551031|582774805|FG002|Overall Study|Lost to Follow-up|0|||
161378161|NCT00551031|582774806|FG003|Overall Study|Lost to Follow-up|1|||
161378162|NCT00551031|582774807|FG004|Overall Study|Lost to Follow-up|1|||
161378163|NCT00551031|582774803|FG000|Overall Study|Withdrawal by Subject|0|||
161378164|NCT00551031|582774804|FG001|Overall Study|Withdrawal by Subject|4|||
161378165|NCT00551031|582774805|FG002|Overall Study|Withdrawal by Subject|1|||
161378166|NCT00551031|582774806|FG003|Overall Study|Withdrawal by Subject|2|||
161378167|NCT00551031|582774807|FG004|Overall Study|Withdrawal by Subject|0|||
161378168|NCT00551031|582774803|FG000|Overall Study|Serious Adverse Event|0|||
161378169|NCT00551031|582774804|FG001|Overall Study|Serious Adverse Event|2|||
161378170|NCT00551031|582774805|FG002|Overall Study|Serious Adverse Event|1|||
161378171|NCT00551031|582774806|FG003|Overall Study|Serious Adverse Event|0|||
161378172|NCT00551031|582774807|FG004|Overall Study|Serious Adverse Event|0|||
161378173|NCT00551031|582774803|FG000|Overall Study|Did not receive vaccine|1|||
161378174|NCT00551031|582774804|FG001|Overall Study|Did not receive vaccine|2|||
161378175|NCT00551031|582774805|FG002|Overall Study|Did not receive vaccine|0|||
161378176|NCT00551031|582774806|FG003|Overall Study|Did not receive vaccine|0|||
161378177|NCT00551031|582774807|FG004|Overall Study|Did not receive vaccine|0|||
161378178|NCT04072835|582774809|FG000|Overall Study|Overall trial ended|603|||
161378179|NCT04072835|582774809|FG000|Overall Study|Ablation|97|||
161378180|NCT04072835|582774809|FG000|Overall Study|Withdrawal of consent|66|||
161378181|NCT04072835|582774809|FG000|Overall Study|Physician Decision|50|||
161378182|NCT04072835|582774809|FG000|Overall Study|Lost to Follow-up|39|||
161378183|NCT04072835|582774809|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
161378184|NCT04072835|582774809|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
161378185|NCT04072835|582774809|FG000|Overall Study|Adverse Event|25|||
161378186|NCT04072835|582774809|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
161378187|NCT04072835|582774809|FG000|Overall Study|Death|11|||
161378188|NCT04072835|582774809|FG000|Overall Study|Participant felt the drug did not work|8|||
161378189|NCT04072835|582774809|FG000|Overall Study|Participant tolerability|5|||
161378190|NCT04072835|582774809|FG000|Overall Study|Missing|5|||
161378191|NCT04072835|582774809|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
161378192|NCT04072835|582774809|FG000|Overall Study|Pregnancy|3|||
161378193|NCT01336712|582774810|FG000|Overall Study|Death|2|||
161378194|NCT01336712|582774810|FG000|Overall Study|Lack of Efficacy|1|||
161378195|NCT00841776|582774811|FG000|Overall Study|Lack of Efficacy|0|||
161378196|NCT00841776|582774812|FG001|Overall Study|Lack of Efficacy|1|||
161378197|NCT00841776|582774811|FG000|Overall Study|Lost to Follow-up|2|||
161378198|NCT00841776|582774812|FG001|Overall Study|Lost to Follow-up|1|||
161378199|NCT00841776|582774811|FG000|Overall Study|Withdrawal by Subject|0|||
161378200|NCT00841776|582774812|FG001|Overall Study|Withdrawal by Subject|1|||
161378201|NCT03073525|582774815|FG000|Overall Study|Withdrawal by Subject|0|||
161378202|NCT03073525|582774816|FG001|Overall Study|Withdrawal by Subject|0|||
161378203|NCT03073525|582774817|FG002|Overall Study|Withdrawal by Subject|3|||
161378204|NCT01976299|582774818|FG000|Overall Study|Withdrawal by Subject|3|||
161378205|NCT01976299|582774819|FG001|Overall Study|Withdrawal by Subject|1|||
161378206|NCT01976299|582774818|FG000|Overall Study|Death|4|||
161378207|NCT01976299|582774819|FG001|Overall Study|Death|2|||
161378208|NCT01976299|582774818|FG000|Overall Study|Lost to Follow-up|7|||
161378209|NCT01976299|582774819|FG001|Overall Study|Lost to Follow-up|1|||
161378210|NCT01976299|582774818|FG000|Overall Study|See clarification above in comments|9|||
161378211|NCT01976299|582774819|FG001|Overall Study|See clarification above in comments|2|||
161378212|NCT00856323|582774821|FG000|Overall Study|Withdrawal by Subject|2|||
161378213|NCT01639469|582774822|FG000|Overall Study|Death|4|||
161378214|NCT01639469|582774823|FG001|Overall Study|Death|2|||
161378215|NCT01639469|582774822|FG000|Overall Study|Lost to Follow-up|1|||
161378216|NCT01639469|582774823|FG001|Overall Study|Lost to Follow-up|1|||
161378217|NCT01119443|582774824|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
161378218|NCT01119443|582774825|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
161378219|NCT02329743|582774828|FG000|Overall Study|Adverse Event|1|||
161378220|NCT02329743|582774829|FG001|Overall Study|Adverse Event|1|||
161378221|NCT02329743|582774830|FG002|Overall Study|Adverse Event|3|||
161378222|NCT02329743|582774828|FG000|Overall Study|Lost to Follow-up|1|||
161378223|NCT02329743|582774829|FG001|Overall Study|Lost to Follow-up|0|||
161378224|NCT02329743|582774830|FG002|Overall Study|Lost to Follow-up|1|||
161378225|NCT02329743|582774828|FG000|Overall Study|Withdrawal by Subject|4|||
161378226|NCT02329743|582774829|FG001|Overall Study|Withdrawal by Subject|4|||
161378227|NCT02329743|582774830|FG002|Overall Study|Withdrawal by Subject|1|||
161378228|NCT02329743|582774828|FG000|Overall Study|Other|0|||
161378229|NCT02329743|582774829|FG001|Overall Study|Other|2|||
161378230|NCT02329743|582774830|FG002|Overall Study|Other|3|||
161378231|NCT00355368|582774835|FG000|Overall Study|Protocol Violation|8|||
161378232|NCT00355368|582774836|FG001|Overall Study|Protocol Violation|7|||
161378233|NCT00355368|582774835|FG000|Overall Study|cardiac arrest prior to intubation|2|||
161378234|NCT00355368|582774836|FG001|Overall Study|cardiac arrest prior to intubation|2|||
161378235|NCT00347932|582774840|FG000|Overall Study|Adverse Event|4|||
161378236|NCT00347932|582774841|FG001|Overall Study|Adverse Event|5|||
161378237|NCT00347932|582774840|FG000|Overall Study|Lack of Efficacy|3|||
161378238|NCT00347932|582774841|FG001|Overall Study|Lack of Efficacy|14|||
161378239|NCT00347932|582774840|FG000|Overall Study|Lost to Follow-up|10|||
161378240|NCT00347932|582774841|FG001|Overall Study|Lost to Follow-up|9|||
161378241|NCT00347932|582774840|FG000|Overall Study|Withdrawal by Subject|10|||
161378242|NCT00347932|582774841|FG001|Overall Study|Withdrawal by Subject|16|||
161378243|NCT00347932|582774840|FG000|Overall Study|Did not meet inclusion criteria|4|||
161378244|NCT00347932|582774841|FG001|Overall Study|Did not meet inclusion criteria|8|||
161378245|NCT03462758|582774844|FG000|Overall Study|Chose no or other method of contraception|20|||
161378246|NCT03462758|582774845|FG001|Overall Study|Chose no or other method of contraception|23|||
161378247|NCT03462758|582774844|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
161378248|NCT03462758|582774845|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
161378249|NCT03462758|582774844|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
161378250|NCT03462758|582774845|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
161378251|NCT03462758|582774844|FG000|Overall Study|Medical contraindication|2|||
161378252|NCT03462758|582774845|FG001|Overall Study|Medical contraindication|2|||
161378253|NCT03462758|582774844|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
161378254|NCT03462758|582774845|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
161378255|NCT02820844|582774846|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
161378256|NCT02820844|582774847|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
161378257|NCT02820844|582774848|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161378258|NCT02820844|582774849|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161378259|NCT02820844|582774850|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161378260|NCT02820844|582774851|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161378261|NCT02820844|582774846|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
161378262|NCT02820844|582774847|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
161378263|NCT02820844|582774848|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161378264|NCT02820844|582774849|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161378265|NCT02820844|582774850|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161378266|NCT02820844|582774851|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161378267|NCT02820844|582774846|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161378268|NCT02820844|582774847|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
161378269|NCT02820844|582774848|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161378270|NCT02820844|582774849|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161378271|NCT02820844|582774850|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161378272|NCT02820844|582774851|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161378273|NCT02820844|582774846|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
161378274|NCT02820844|582774847|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
161378275|NCT02820844|582774848|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161378276|NCT02820844|582774849|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161378277|NCT02820844|582774850|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161378278|NCT02820844|582774851|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161378279|NCT02820844|582774846|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
161378280|NCT02820844|582774847|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161378281|NCT02820844|582774848|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161378282|NCT02820844|582774849|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161378283|NCT02820844|582774850|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161378284|NCT02820844|582774851|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161378285|NCT02820844|582774846|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161378286|NCT02820844|582774847|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161378287|NCT02820844|582774848|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
161378288|NCT02820844|582774849|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
161378289|NCT02820844|582774850|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161378290|NCT02820844|582774851|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161378291|NCT02820844|582774846|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161378292|NCT02820844|582774847|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161378293|NCT02820844|582774848|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
161378294|NCT02820844|582774849|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161378295|NCT02820844|582774850|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161378296|NCT02820844|582774851|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161378297|NCT02820844|582774846|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378298|NCT02820844|582774847|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378299|NCT02820844|582774848|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
161378300|NCT02820844|582774849|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
161378301|NCT02820844|582774850|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378302|NCT02820844|582774851|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378303|NCT02820844|582774846|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161378304|NCT02820844|582774847|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161378305|NCT02820844|582774848|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161378306|NCT02820844|582774849|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161378307|NCT02820844|582774850|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
161378308|NCT02820844|582774851|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161378309|NCT02820844|582774846|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378310|NCT02820844|582774847|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378311|NCT02820844|582774848|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378312|NCT02820844|582774849|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378313|NCT02820844|582774850|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161378314|NCT02820844|582774851|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
161378315|NCT00413660|582774853|FG000|Up To Week 12|Adverse Event|1|||
161378316|NCT00413660|582774854|FG001|Up To Week 12|Adverse Event|3|||
161378317|NCT00413660|582774855|FG002|Up To Week 12|Adverse Event|1|||
161378318|NCT00413660|582774856|FG003|Up To Week 12|Adverse Event|4|||
161378319|NCT00413660|582774857|FG004|Up To Week 12|Adverse Event|6|||
161378320|NCT00413660|582774858|FG005|Up To Week 12|Adverse Event|4|||
161378321|NCT00413660|582774859|FG006|Up To Week 12|Adverse Event|1|||
161378322|NCT00413660|582774860|FG007|Up To Week 12|Adverse Event|0|||
161378323|NCT00413660|582774861|FG008|Up To Week 12|Adverse Event|0|||
161378324|NCT00413660|582774862|FG009|Up To Week 12|Adverse Event|0|||
161378325|NCT00413660|582774863|FG010|Up To Week 12|Adverse Event|0|||
161378326|NCT00413660|582774853|FG000|Up To Week 12|Lack of Efficacy|2|||
161378327|NCT00413660|582774854|FG001|Up To Week 12|Lack of Efficacy|0|||
161378328|NCT00413660|582774855|FG002|Up To Week 12|Lack of Efficacy|0|||
161378329|NCT00413660|582774856|FG003|Up To Week 12|Lack of Efficacy|0|||
161378330|NCT00413660|582774857|FG004|Up To Week 12|Lack of Efficacy|0|||
161378331|NCT00413660|582774858|FG005|Up To Week 12|Lack of Efficacy|0|||
161378332|NCT00413660|582774859|FG006|Up To Week 12|Lack of Efficacy|5|||
161378333|NCT00413660|582774860|FG007|Up To Week 12|Lack of Efficacy|0|||
161378334|NCT00413660|582774861|FG008|Up To Week 12|Lack of Efficacy|0|||
161378335|NCT00413660|582774862|FG009|Up To Week 12|Lack of Efficacy|0|||
161378336|NCT00413660|582774863|FG010|Up To Week 12|Lack of Efficacy|0|||
161378337|NCT00413660|582774853|FG000|Up To Week 12|Lost to Follow-up|0|||
161378338|NCT00413660|582774854|FG001|Up To Week 12|Lost to Follow-up|1|||
161378339|NCT00413660|582774855|FG002|Up To Week 12|Lost to Follow-up|0|||
161378340|NCT00413660|582774856|FG003|Up To Week 12|Lost to Follow-up|0|||
161378341|NCT00413660|582774857|FG004|Up To Week 12|Lost to Follow-up|1|||
161378342|NCT00413660|582774858|FG005|Up To Week 12|Lost to Follow-up|0|||
161378343|NCT00413660|582774859|FG006|Up To Week 12|Lost to Follow-up|0|||
161378344|NCT00413660|582774860|FG007|Up To Week 12|Lost to Follow-up|0|||
161378345|NCT00413660|582774861|FG008|Up To Week 12|Lost to Follow-up|0|||
161378346|NCT00413660|582774862|FG009|Up To Week 12|Lost to Follow-up|0|||
161378347|NCT00413660|582774863|FG010|Up To Week 12|Lost to Follow-up|0|||
161378348|NCT00413660|582774853|FG000|Up To Week 12|Withdrawal by Subject|0|||
161378349|NCT00413660|582774854|FG001|Up To Week 12|Withdrawal by Subject|2|||
161378350|NCT00413660|582774855|FG002|Up To Week 12|Withdrawal by Subject|0|||
161378351|NCT00413660|582774856|FG003|Up To Week 12|Withdrawal by Subject|2|||
161378352|NCT00413660|582774857|FG004|Up To Week 12|Withdrawal by Subject|0|||
161378353|NCT00413660|582774858|FG005|Up To Week 12|Withdrawal by Subject|2|||
161378354|NCT00413660|582774859|FG006|Up To Week 12|Withdrawal by Subject|2|||
161378355|NCT00413660|582774860|FG007|Up To Week 12|Withdrawal by Subject|0|||
161378356|NCT00413660|582774861|FG008|Up To Week 12|Withdrawal by Subject|0|||
161378357|NCT00413660|582774862|FG009|Up To Week 12|Withdrawal by Subject|0|||
161378358|NCT00413660|582774863|FG010|Up To Week 12|Withdrawal by Subject|0|||
161378359|NCT00413660|582774853|FG000|Up To Week 12|Randomized, Not Treated|1|||
161378360|NCT00413660|582774854|FG001|Up To Week 12|Randomized, Not Treated|0|||
161378361|NCT00413660|582774855|FG002|Up To Week 12|Randomized, Not Treated|0|||
161378362|NCT00413660|582774856|FG003|Up To Week 12|Randomized, Not Treated|1|||
161378363|NCT00413660|582774857|FG004|Up To Week 12|Randomized, Not Treated|0|||
161378364|NCT00413660|582774858|FG005|Up To Week 12|Randomized, Not Treated|0|||
161378365|NCT00413660|582774859|FG006|Up To Week 12|Randomized, Not Treated|0|||
161378366|NCT00413660|582774860|FG007|Up To Week 12|Randomized, Not Treated|0|||
161378367|NCT00413660|582774861|FG008|Up To Week 12|Randomized, Not Treated|0|||
161378368|NCT00413660|582774862|FG009|Up To Week 12|Randomized, Not Treated|0|||
161378369|NCT00413660|582774863|FG010|Up To Week 12|Randomized, Not Treated|0|||
161378370|NCT00413660|582774853|FG000|Up To Week 12|Other|3|||
161378371|NCT00413660|582774854|FG001|Up To Week 12|Other|1|||
161378372|NCT00413660|582774855|FG002|Up To Week 12|Other|6|||
161378373|NCT00413660|582774856|FG003|Up To Week 12|Other|1|||
161378374|NCT00413660|582774857|FG004|Up To Week 12|Other|2|||
161378375|NCT00413660|582774858|FG005|Up To Week 12|Other|4|||
161378376|NCT00413660|582774859|FG006|Up To Week 12|Other|3|||
161378377|NCT00413660|582774860|FG007|Up To Week 12|Other|0|||
161378378|NCT00413660|582774861|FG008|Up To Week 12|Other|0|||
161378379|NCT00413660|582774862|FG009|Up To Week 12|Other|0|||
161378380|NCT00413660|582774863|FG010|Up To Week 12|Other|0|||
161378381|NCT00413660|582774853|FG000|Post Week 12|Adverse Event|2|||
161378382|NCT00413660|582774854|FG001|Post Week 12|Adverse Event|0|||
161378383|NCT00413660|582774855|FG002|Post Week 12|Adverse Event|2|||
161378384|NCT00413660|582774856|FG003|Post Week 12|Adverse Event|1|||
161378385|NCT00413660|582774857|FG004|Post Week 12|Adverse Event|4|||
161378386|NCT00413660|582774858|FG005|Post Week 12|Adverse Event|2|||
161378387|NCT00413660|582774859|FG006|Post Week 12|Adverse Event|2|||
161378388|NCT00413660|582774860|FG007|Post Week 12|Adverse Event|0|||
161378389|NCT00413660|582774861|FG008|Post Week 12|Adverse Event|0|||
161378390|NCT00413660|582774862|FG009|Post Week 12|Adverse Event|0|||
161378391|NCT00413660|582774863|FG010|Post Week 12|Adverse Event|0|||
161378392|NCT00413660|582774853|FG000|Post Week 12|Lack of Efficacy|0|||
161378393|NCT00413660|582774854|FG001|Post Week 12|Lack of Efficacy|0|||
161378394|NCT00413660|582774855|FG002|Post Week 12|Lack of Efficacy|1|||
161378395|NCT00413660|582774856|FG003|Post Week 12|Lack of Efficacy|0|||
161378396|NCT00413660|582774857|FG004|Post Week 12|Lack of Efficacy|0|||
161378397|NCT00413660|582774858|FG005|Post Week 12|Lack of Efficacy|0|||
161378398|NCT00413660|582774859|FG006|Post Week 12|Lack of Efficacy|0|||
161378399|NCT00413660|582774860|FG007|Post Week 12|Lack of Efficacy|0|||
161378400|NCT00413660|582774861|FG008|Post Week 12|Lack of Efficacy|0|||
161378401|NCT00413660|582774862|FG009|Post Week 12|Lack of Efficacy|1|||
161378402|NCT00413660|582774863|FG010|Post Week 12|Lack of Efficacy|0|||
161378403|NCT00413660|582774853|FG000|Post Week 12|Lost to Follow-up|0|||
161378404|NCT00413660|582774854|FG001|Post Week 12|Lost to Follow-up|1|||
161378405|NCT00413660|582774855|FG002|Post Week 12|Lost to Follow-up|1|||
161378406|NCT00413660|582774856|FG003|Post Week 12|Lost to Follow-up|0|||
161378407|NCT00413660|582774857|FG004|Post Week 12|Lost to Follow-up|0|||
161378408|NCT00413660|582774858|FG005|Post Week 12|Lost to Follow-up|0|||
161378409|NCT00413660|582774859|FG006|Post Week 12|Lost to Follow-up|0|||
161378410|NCT00413660|582774860|FG007|Post Week 12|Lost to Follow-up|0|||
161378411|NCT00413660|582774861|FG008|Post Week 12|Lost to Follow-up|0|||
161378412|NCT00413660|582774862|FG009|Post Week 12|Lost to Follow-up|0|||
161378413|NCT00413660|582774863|FG010|Post Week 12|Lost to Follow-up|0|||
161378414|NCT00413660|582774853|FG000|Post Week 12|Withdrawal by Subject|0|||
161378415|NCT00413660|582774854|FG001|Post Week 12|Withdrawal by Subject|1|||
161378416|NCT00413660|582774855|FG002|Post Week 12|Withdrawal by Subject|1|||
161378417|NCT00413660|582774856|FG003|Post Week 12|Withdrawal by Subject|0|||
161378418|NCT00413660|582774857|FG004|Post Week 12|Withdrawal by Subject|1|||
161378419|NCT00413660|582774858|FG005|Post Week 12|Withdrawal by Subject|0|||
161378420|NCT00413660|582774859|FG006|Post Week 12|Withdrawal by Subject|0|||
161378421|NCT00413660|582774860|FG007|Post Week 12|Withdrawal by Subject|0|||
161378422|NCT00413660|582774861|FG008|Post Week 12|Withdrawal by Subject|0|||
161378423|NCT00413660|582774862|FG009|Post Week 12|Withdrawal by Subject|0|||
161378424|NCT00413660|582774863|FG010|Post Week 12|Withdrawal by Subject|1|||
161378425|NCT00413660|582774853|FG000|Post Week 12|Other|1|||
161378426|NCT00413660|582774854|FG001|Post Week 12|Other|2|||
161378427|NCT00413660|582774855|FG002|Post Week 12|Other|3|||
161378428|NCT00413660|582774856|FG003|Post Week 12|Other|0|||
161378429|NCT00413660|582774857|FG004|Post Week 12|Other|1|||
161378430|NCT00413660|582774858|FG005|Post Week 12|Other|1|||
161378431|NCT00413660|582774859|FG006|Post Week 12|Other|1|||
161378432|NCT00413660|582774860|FG007|Post Week 12|Other|0|||
161378433|NCT00413660|582774861|FG008|Post Week 12|Other|0|||
161378434|NCT00413660|582774862|FG009|Post Week 12|Other|0|||
161378435|NCT00413660|582774863|FG010|Post Week 12|Other|0|||
161378436|NCT01791517|582774864|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
161378437|NCT01791517|582774865|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
161378438|NCT01791517|582774866|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
161378439|NCT01791517|582774867|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
161378440|NCT01791517|582774868|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
161378441|NCT01791517|582774869|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
161378442|NCT01791517|582774870|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
161378443|NCT01791517|582774871|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
161378444|NCT01791517|582774872|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
161378445|NCT01791517|582774873|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
161378446|NCT01791517|582774874|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
161378447|NCT01791517|582774875|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
161378448|NCT01791517|582774864|FG000|Phase I: Period 1|Adverse Event|0|||
161378449|NCT01791517|582774865|FG001|Phase I: Period 1|Adverse Event|0|||
161378450|NCT01791517|582774866|FG002|Phase I: Period 1|Adverse Event|1|||
161378451|NCT01791517|582774867|FG003|Phase I: Period 1|Adverse Event|1|||
161378452|NCT01791517|582774868|FG004|Phase I: Period 1|Adverse Event|0|||
161378453|NCT01791517|582774869|FG005|Phase I: Period 1|Adverse Event|0|||
161378454|NCT01791517|582774870|FG006|Phase I: Period 1|Adverse Event|0|||
161378455|NCT01791517|582774871|FG007|Phase I: Period 1|Adverse Event|0|||
161378456|NCT01791517|582774872|FG008|Phase I: Period 1|Adverse Event|0|||
161378457|NCT01791517|582774873|FG009|Phase I: Period 1|Adverse Event|0|||
161378458|NCT01791517|582774874|FG010|Phase I: Period 1|Adverse Event|0|||
161378459|NCT01791517|582774875|FG011|Phase I: Period 1|Adverse Event|0|||
161378460|NCT01791517|582774864|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
161378461|NCT01791517|582774865|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378462|NCT01791517|582774866|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378463|NCT01791517|582774867|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378464|NCT01791517|582774868|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378465|NCT01791517|582774869|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378466|NCT01791517|582774870|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378467|NCT01791517|582774871|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378468|NCT01791517|582774872|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378469|NCT01791517|582774873|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378470|NCT01791517|582774874|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378471|NCT01791517|582774875|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161378472|NCT01791517|582774864|FG000|Phase I: Period 1|Protocol Violation|0|||
161378473|NCT01791517|582774865|FG001|Phase I: Period 1|Protocol Violation|1|||
161378474|NCT01791517|582774866|FG002|Phase I: Period 1|Protocol Violation|0|||
161378475|NCT01791517|582774867|FG003|Phase I: Period 1|Protocol Violation|0|||
161378476|NCT01791517|582774868|FG004|Phase I: Period 1|Protocol Violation|0|||
161378477|NCT01791517|582774869|FG005|Phase I: Period 1|Protocol Violation|0|||
161378478|NCT01791517|582774870|FG006|Phase I: Period 1|Protocol Violation|0|||
161378479|NCT01791517|582774871|FG007|Phase I: Period 1|Protocol Violation|0|||
161378480|NCT01791517|582774872|FG008|Phase I: Period 1|Protocol Violation|0|||
161378481|NCT01791517|582774873|FG009|Phase I: Period 1|Protocol Violation|0|||
161378482|NCT01791517|582774874|FG010|Phase I: Period 1|Protocol Violation|0|||
161378483|NCT01791517|582774875|FG011|Phase I: Period 1|Protocol Violation|0|||
161378484|NCT01791517|582774864|FG000|Phase I: Period 1|Lost to Follow-up|0|||
161378485|NCT01791517|582774865|FG001|Phase I: Period 1|Lost to Follow-up|0|||
161378486|NCT01791517|582774866|FG002|Phase I: Period 1|Lost to Follow-up|0|||
161378487|NCT01791517|582774867|FG003|Phase I: Period 1|Lost to Follow-up|1|||
161378488|NCT01791517|582774868|FG004|Phase I: Period 1|Lost to Follow-up|0|||
161378489|NCT01791517|582774869|FG005|Phase I: Period 1|Lost to Follow-up|0|||
161378490|NCT01791517|582774870|FG006|Phase I: Period 1|Lost to Follow-up|1|||
161378491|NCT01791517|582774871|FG007|Phase I: Period 1|Lost to Follow-up|0|||
161378492|NCT01791517|582774872|FG008|Phase I: Period 1|Lost to Follow-up|1|||
161378493|NCT01791517|582774873|FG009|Phase I: Period 1|Lost to Follow-up|1|||
161378494|NCT01791517|582774874|FG010|Phase I: Period 1|Lost to Follow-up|0|||
161378495|NCT01791517|582774875|FG011|Phase I: Period 1|Lost to Follow-up|0|||
161378496|NCT01791517|582774864|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378497|NCT01791517|582774865|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378498|NCT01791517|582774866|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378499|NCT01791517|582774867|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378500|NCT01791517|582774868|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378501|NCT01791517|582774869|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378502|NCT01791517|582774870|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378503|NCT01791517|582774871|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378504|NCT01791517|582774872|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378505|NCT01791517|582774873|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378506|NCT01791517|582774874|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
161378507|NCT01791517|582774875|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
161378508|NCT01791517|582774864|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
161378509|NCT01791517|582774865|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378510|NCT01791517|582774866|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378511|NCT01791517|582774867|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378512|NCT01791517|582774868|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378513|NCT01791517|582774869|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378514|NCT01791517|582774870|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378515|NCT01791517|582774871|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378516|NCT01791517|582774872|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378517|NCT01791517|582774873|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378518|NCT01791517|582774874|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378519|NCT01791517|582774875|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161378520|NCT01791517|582774864|FG000|Phase I: Period 2|Protocol Violation|0|||
161378521|NCT01791517|582774865|FG001|Phase I: Period 2|Protocol Violation|0|||
161378522|NCT01791517|582774866|FG002|Phase I: Period 2|Protocol Violation|0|||
161378523|NCT01791517|582774867|FG003|Phase I: Period 2|Protocol Violation|1|||
161378524|NCT01791517|582774868|FG004|Phase I: Period 2|Protocol Violation|0|||
161378525|NCT01791517|582774869|FG005|Phase I: Period 2|Protocol Violation|0|||
161378526|NCT01791517|582774870|FG006|Phase I: Period 2|Protocol Violation|0|||
161378527|NCT01791517|582774871|FG007|Phase I: Period 2|Protocol Violation|0|||
161378528|NCT01791517|582774872|FG008|Phase I: Period 2|Protocol Violation|0|||
161378529|NCT01791517|582774873|FG009|Phase I: Period 2|Protocol Violation|0|||
161378530|NCT01791517|582774874|FG010|Phase I: Period 2|Protocol Violation|0|||
161378531|NCT01791517|582774875|FG011|Phase I: Period 2|Protocol Violation|0|||
161378532|NCT01791517|582774864|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
161378533|NCT01791517|582774865|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
161378534|NCT01791517|582774866|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
161378535|NCT01791517|582774867|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
161378536|NCT01791517|582774868|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
161378537|NCT01791517|582774869|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
161378538|NCT01791517|582774870|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
161378539|NCT01791517|582774871|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
161378540|NCT01791517|582774872|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
161378541|NCT01791517|582774873|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
161378542|NCT01791517|582774874|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
161378543|NCT01791517|582774875|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
161378544|NCT01791517|582774864|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378545|NCT01791517|582774865|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378546|NCT01791517|582774866|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378547|NCT01791517|582774867|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378548|NCT01791517|582774868|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378549|NCT01791517|582774869|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378550|NCT01791517|582774870|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378551|NCT01791517|582774871|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378552|NCT01791517|582774872|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378553|NCT01791517|582774873|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378554|NCT01791517|582774874|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
161378555|NCT01791517|582774875|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161378556|NCT01791517|582774864|FG000|Phase I: Period 2|Lens Discomfort|0|||
161378557|NCT01791517|582774865|FG001|Phase I: Period 2|Lens Discomfort|0|||
161378558|NCT01791517|582774866|FG002|Phase I: Period 2|Lens Discomfort|0|||
161378559|NCT01791517|582774867|FG003|Phase I: Period 2|Lens Discomfort|0|||
161378560|NCT01791517|582774868|FG004|Phase I: Period 2|Lens Discomfort|0|||
161378561|NCT01791517|582774869|FG005|Phase I: Period 2|Lens Discomfort|1|||
161378562|NCT01791517|582774870|FG006|Phase I: Period 2|Lens Discomfort|0|||
161378563|NCT01791517|582774871|FG007|Phase I: Period 2|Lens Discomfort|0|||
161378564|NCT01791517|582774872|FG008|Phase I: Period 2|Lens Discomfort|0|||
161378565|NCT01791517|582774873|FG009|Phase I: Period 2|Lens Discomfort|0|||
161378566|NCT01791517|582774874|FG010|Phase I: Period 2|Lens Discomfort|0|||
161378567|NCT01791517|582774875|FG011|Phase I: Period 2|Lens Discomfort|0|||
161378568|NCT01791517|582774864|FG000|Phase I: Period 2|Lost to Follow-up|0|||
161378569|NCT01791517|582774865|FG001|Phase I: Period 2|Lost to Follow-up|3|||
161378570|NCT01791517|582774866|FG002|Phase I: Period 2|Lost to Follow-up|2|||
161378571|NCT01791517|582774867|FG003|Phase I: Period 2|Lost to Follow-up|0|||
161378572|NCT01791517|582774868|FG004|Phase I: Period 2|Lost to Follow-up|0|||
161378573|NCT01791517|582774869|FG005|Phase I: Period 2|Lost to Follow-up|0|||
161378574|NCT01791517|582774870|FG006|Phase I: Period 2|Lost to Follow-up|0|||
161378575|NCT01791517|582774871|FG007|Phase I: Period 2|Lost to Follow-up|0|||
161378576|NCT01791517|582774872|FG008|Phase I: Period 2|Lost to Follow-up|0|||
161378577|NCT01791517|582774873|FG009|Phase I: Period 2|Lost to Follow-up|0|||
161378578|NCT01791517|582774874|FG010|Phase I: Period 2|Lost to Follow-up|0|||
161378579|NCT01791517|582774875|FG011|Phase I: Period 2|Lost to Follow-up|0|||
161378580|NCT01791517|582774864|FG000|Phase I: Period 3|Lens Discomfort|0|||
161378581|NCT01791517|582774865|FG001|Phase I: Period 3|Lens Discomfort|0|||
161378582|NCT01791517|582774866|FG002|Phase I: Period 3|Lens Discomfort|0|||
161378583|NCT01791517|582774867|FG003|Phase I: Period 3|Lens Discomfort|0|||
161378584|NCT01791517|582774868|FG004|Phase I: Period 3|Lens Discomfort|0|||
161378585|NCT01791517|582774869|FG005|Phase I: Period 3|Lens Discomfort|0|||
161378586|NCT01791517|582774870|FG006|Phase I: Period 3|Lens Discomfort|0|||
161378587|NCT01791517|582774871|FG007|Phase I: Period 3|Lens Discomfort|0|||
161378588|NCT01791517|582774872|FG008|Phase I: Period 3|Lens Discomfort|0|||
161378589|NCT01791517|582774873|FG009|Phase I: Period 3|Lens Discomfort|0|||
161378590|NCT01791517|582774874|FG010|Phase I: Period 3|Lens Discomfort|0|||
161378591|NCT01791517|582774875|FG011|Phase I: Period 3|Lens Discomfort|1|||
161378592|NCT01791517|582774864|FG000|Phase I: Period 3|Lost to Follow-up|0|||
161378593|NCT01791517|582774865|FG001|Phase I: Period 3|Lost to Follow-up|1|||
161378594|NCT01791517|582774866|FG002|Phase I: Period 3|Lost to Follow-up|0|||
161378595|NCT01791517|582774867|FG003|Phase I: Period 3|Lost to Follow-up|0|||
161378596|NCT01791517|582774868|FG004|Phase I: Period 3|Lost to Follow-up|1|||
161378597|NCT01791517|582774869|FG005|Phase I: Period 3|Lost to Follow-up|0|||
161378598|NCT01791517|582774870|FG006|Phase I: Period 3|Lost to Follow-up|0|||
161378599|NCT01791517|582774871|FG007|Phase I: Period 3|Lost to Follow-up|0|||
161378600|NCT01791517|582774872|FG008|Phase I: Period 3|Lost to Follow-up|0|||
161378601|NCT01791517|582774873|FG009|Phase I: Period 3|Lost to Follow-up|0|||
161378602|NCT01791517|582774874|FG010|Phase I: Period 3|Lost to Follow-up|0|||
161378603|NCT01791517|582774875|FG011|Phase I: Period 3|Lost to Follow-up|0|||
161378604|NCT01791517|582774864|FG000|Phase I: Period 3|Adverse Event|0|||
161378605|NCT01791517|582774865|FG001|Phase I: Period 3|Adverse Event|0|||
161378606|NCT01791517|582774866|FG002|Phase I: Period 3|Adverse Event|0|||
161378607|NCT01791517|582774867|FG003|Phase I: Period 3|Adverse Event|1|||
161378608|NCT01791517|582774868|FG004|Phase I: Period 3|Adverse Event|0|||
161378609|NCT01791517|582774869|FG005|Phase I: Period 3|Adverse Event|0|||
161378610|NCT01791517|582774870|FG006|Phase I: Period 3|Adverse Event|0|||
161378611|NCT01791517|582774871|FG007|Phase I: Period 3|Adverse Event|0|||
161378612|NCT01791517|582774872|FG008|Phase I: Period 3|Adverse Event|0|||
161378613|NCT01791517|582774873|FG009|Phase I: Period 3|Adverse Event|0|||
161378614|NCT01791517|582774874|FG010|Phase I: Period 3|Adverse Event|0|||
161378615|NCT01791517|582774875|FG011|Phase I: Period 3|Adverse Event|0|||
161378616|NCT01791517|582774864|FG000|Phase II|Lost to Follow-up|1|||
161378617|NCT01791517|582774865|FG001|Phase II|Lost to Follow-up|0|||
161378618|NCT01791517|582774866|FG002|Phase II|Lost to Follow-up|1|||
161378619|NCT01791517|582774867|FG003|Phase II|Lost to Follow-up|0|||
161378620|NCT01791517|582774868|FG004|Phase II|Lost to Follow-up|1|||
161378621|NCT01791517|582774869|FG005|Phase II|Lost to Follow-up|2|||
161378622|NCT01791517|582774870|FG006|Phase II|Lost to Follow-up|0|||
161378623|NCT01791517|582774871|FG007|Phase II|Lost to Follow-up|1|||
161378624|NCT01791517|582774872|FG008|Phase II|Lost to Follow-up|1|||
161378625|NCT01791517|582774873|FG009|Phase II|Lost to Follow-up|1|||
161378626|NCT01791517|582774874|FG010|Phase II|Lost to Follow-up|0|||
161378627|NCT01791517|582774875|FG011|Phase II|Lost to Follow-up|0|||
161378628|NCT01791517|582774864|FG000|Phase II|Withdrawal by Subject|1|||
161378629|NCT01791517|582774865|FG001|Phase II|Withdrawal by Subject|0|||
161378630|NCT01791517|582774866|FG002|Phase II|Withdrawal by Subject|0|||
161378631|NCT01791517|582774867|FG003|Phase II|Withdrawal by Subject|0|||
161378632|NCT01791517|582774868|FG004|Phase II|Withdrawal by Subject|0|||
161378633|NCT01791517|582774869|FG005|Phase II|Withdrawal by Subject|2|||
161378634|NCT01791517|582774870|FG006|Phase II|Withdrawal by Subject|0|||
161378635|NCT01791517|582774871|FG007|Phase II|Withdrawal by Subject|1|||
161378636|NCT01791517|582774872|FG008|Phase II|Withdrawal by Subject|0|||
161378637|NCT01791517|582774873|FG009|Phase II|Withdrawal by Subject|0|||
161378638|NCT01791517|582774874|FG010|Phase II|Withdrawal by Subject|1|||
161378639|NCT01791517|582774875|FG011|Phase II|Withdrawal by Subject|0|||
161378640|NCT01791517|582774864|FG000|Phase II|Lack of Efficacy|0|||
161378641|NCT01791517|582774865|FG001|Phase II|Lack of Efficacy|0|||
161378642|NCT01791517|582774866|FG002|Phase II|Lack of Efficacy|0|||
161378643|NCT01791517|582774867|FG003|Phase II|Lack of Efficacy|0|||
161378644|NCT01791517|582774868|FG004|Phase II|Lack of Efficacy|1|||
161378645|NCT01791517|582774869|FG005|Phase II|Lack of Efficacy|0|||
161378646|NCT01791517|582774870|FG006|Phase II|Lack of Efficacy|0|||
161378647|NCT01791517|582774871|FG007|Phase II|Lack of Efficacy|0|||
161378648|NCT01791517|582774872|FG008|Phase II|Lack of Efficacy|0|||
161378649|NCT01791517|582774873|FG009|Phase II|Lack of Efficacy|0|||
161378650|NCT01791517|582774874|FG010|Phase II|Lack of Efficacy|0|||
161378651|NCT01791517|582774875|FG011|Phase II|Lack of Efficacy|0|||
161378652|NCT01791517|582774864|FG000|Phase II|Adverse Event|0|||
161378653|NCT01791517|582774865|FG001|Phase II|Adverse Event|0|||
161378654|NCT01791517|582774866|FG002|Phase II|Adverse Event|0|||
161378655|NCT01791517|582774867|FG003|Phase II|Adverse Event|0|||
161378656|NCT01791517|582774868|FG004|Phase II|Adverse Event|0|||
161378657|NCT01791517|582774869|FG005|Phase II|Adverse Event|0|||
161378658|NCT01791517|582774870|FG006|Phase II|Adverse Event|2|||
161378659|NCT01791517|582774871|FG007|Phase II|Adverse Event|1|||
161378660|NCT01791517|582774872|FG008|Phase II|Adverse Event|0|||
161378661|NCT01791517|582774873|FG009|Phase II|Adverse Event|1|||
161378662|NCT01791517|582774874|FG010|Phase II|Adverse Event|0|||
161378663|NCT01791517|582774875|FG011|Phase II|Adverse Event|0|||
161378664|NCT01791517|582774864|FG000|Phase II|Lens Handling Difficulties|0|||
161378665|NCT01791517|582774865|FG001|Phase II|Lens Handling Difficulties|0|||
161378666|NCT01791517|582774866|FG002|Phase II|Lens Handling Difficulties|0|||
161378667|NCT01791517|582774867|FG003|Phase II|Lens Handling Difficulties|0|||
161378668|NCT01791517|582774868|FG004|Phase II|Lens Handling Difficulties|0|||
161378669|NCT01791517|582774869|FG005|Phase II|Lens Handling Difficulties|0|||
161378670|NCT01791517|582774870|FG006|Phase II|Lens Handling Difficulties|0|||
161378671|NCT01791517|582774871|FG007|Phase II|Lens Handling Difficulties|0|||
161378672|NCT01791517|582774872|FG008|Phase II|Lens Handling Difficulties|1|||
161378673|NCT01791517|582774873|FG009|Phase II|Lens Handling Difficulties|0|||
161378674|NCT01791517|582774874|FG010|Phase II|Lens Handling Difficulties|0|||
161378675|NCT01791517|582774875|FG011|Phase II|Lens Handling Difficulties|0|||
161378676|NCT01791517|582774864|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
161378677|NCT01791517|582774865|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
161378678|NCT01791517|582774866|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
161378679|NCT01791517|582774867|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
161378680|NCT01791517|582774868|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
161378681|NCT01791517|582774869|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
161378682|NCT01791517|582774870|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
161378683|NCT01791517|582774871|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
161378684|NCT01791517|582774872|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
161378685|NCT01791517|582774873|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
161378686|NCT01791517|582774874|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
161378687|NCT01791517|582774875|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
161378688|NCT01791517|582774864|FG000|Phase II|Pre-Existing Ocular Issue|0|||
161378689|NCT01791517|582774865|FG001|Phase II|Pre-Existing Ocular Issue|0|||
161378690|NCT01791517|582774866|FG002|Phase II|Pre-Existing Ocular Issue|0|||
161378691|NCT01791517|582774867|FG003|Phase II|Pre-Existing Ocular Issue|0|||
161378692|NCT01791517|582774868|FG004|Phase II|Pre-Existing Ocular Issue|0|||
161378693|NCT01791517|582774869|FG005|Phase II|Pre-Existing Ocular Issue|0|||
161378694|NCT01791517|582774870|FG006|Phase II|Pre-Existing Ocular Issue|0|||
161378695|NCT01791517|582774871|FG007|Phase II|Pre-Existing Ocular Issue|0|||
161378696|NCT01791517|582774872|FG008|Phase II|Pre-Existing Ocular Issue|0|||
161378697|NCT01791517|582774873|FG009|Phase II|Pre-Existing Ocular Issue|0|||
161378698|NCT01791517|582774874|FG010|Phase II|Pre-Existing Ocular Issue|0|||
161378699|NCT01791517|582774875|FG011|Phase II|Pre-Existing Ocular Issue|1|||
161378700|NCT00589797|582774876|FG000|Overall Study|Death|1|||
161378701|NCT00589797|582774877|FG001|Overall Study|Death|0|||
161378702|NCT00589797|582774876|FG000|Overall Study|Lost to Follow-up|12|||
161378703|NCT00589797|582774877|FG001|Overall Study|Lost to Follow-up|9|||
161378704|NCT00589797|582774876|FG000|Overall Study|Physician Decision|8|||
161378705|NCT00589797|582774877|FG001|Overall Study|Physician Decision|3|||
161378706|NCT00589797|582774876|FG000|Overall Study|Withdrawal by Subject|6|||
161378707|NCT00589797|582774877|FG001|Overall Study|Withdrawal by Subject|5|||
161378708|NCT00589797|582774876|FG000|Overall Study|Non-Randomized Training Subjects|46|||
161378709|NCT00589797|582774877|FG001|Overall Study|Non-Randomized Training Subjects|6|||
161378710|NCT02141672|582774879|FG000|Overall Study|Adverse Event|0|||
161378711|NCT02141672|582774880|FG001|Overall Study|Adverse Event|1|||
161378712|NCT02141672|582774881|FG002|Overall Study|Adverse Event|0|||
161378713|NCT02141672|582774879|FG000|Overall Study|Death|10|||
161378714|NCT02141672|582774880|FG001|Overall Study|Death|2|||
161378715|NCT02141672|582774881|FG002|Overall Study|Death|1|||
161378716|NCT02141672|582774879|FG000|Overall Study|Lack of Efficacy|0|||
161378717|NCT02141672|582774880|FG001|Overall Study|Lack of Efficacy|0|||
161378718|NCT02141672|582774881|FG002|Overall Study|Lack of Efficacy|2|||
161378719|NCT02141672|582774879|FG000|Overall Study|Lost to Follow-up|1|||
161378720|NCT02141672|582774880|FG001|Overall Study|Lost to Follow-up|1|||
161378721|NCT02141672|582774881|FG002|Overall Study|Lost to Follow-up|3|||
161378722|NCT02141672|582774879|FG000|Overall Study|Physician Decision|1|||
161378723|NCT02141672|582774880|FG001|Overall Study|Physician Decision|2|||
161378724|NCT02141672|582774881|FG002|Overall Study|Physician Decision|5|||
161378725|NCT02141672|582774879|FG000|Overall Study|Protocol Violation|0|||
161378726|NCT02141672|582774880|FG001|Overall Study|Protocol Violation|0|||
161378727|NCT02141672|582774881|FG002|Overall Study|Protocol Violation|1|||
161378728|NCT02141672|582774879|FG000|Overall Study|Withdrawal by Subject|3|||
161378729|NCT02141672|582774880|FG001|Overall Study|Withdrawal by Subject|2|||
161378730|NCT02141672|582774881|FG002|Overall Study|Withdrawal by Subject|5|||
161378731|NCT02141672|582774879|FG000|Overall Study|refused to follow-up|1|||
161378732|NCT02141672|582774880|FG001|Overall Study|refused to follow-up|0|||
161378733|NCT02141672|582774881|FG002|Overall Study|refused to follow-up|1|||
161378734|NCT02688192|582774882|FG000|Overall Study|Lost to Follow-up|11|||
161378735|NCT02688192|582774883|FG001|Overall Study|Lost to Follow-up|5|||
161378736|NCT02688192|582774882|FG000|Overall Study|Physician Decision|1|||
161378737|NCT02688192|582774883|FG001|Overall Study|Physician Decision|0|||
161378738|NCT02010593|582774884|FG000|Overall Study|Lost to Follow-up|1|||
161378739|NCT02010593|582774885|FG001|Overall Study|Lost to Follow-up|0|||
161378740|NCT02010593|582774884|FG000|Overall Study|Physician Decision|1|||
161378741|NCT02010593|582774885|FG001|Overall Study|Physician Decision|0|||
161378742|NCT02010593|582774884|FG000|Overall Study|Unable to adhere to visit schedule|0|||
161378743|NCT02010593|582774885|FG001|Overall Study|Unable to adhere to visit schedule|2|||
161378744|NCT01773967|582774886|FG000|Overall Study|Lost to Follow-up|15|||
161378745|NCT01773967|582774887|FG001|Overall Study|Lost to Follow-up|13|||
161378746|NCT02803203|582774892|FG000|Overall Study|Adverse Event|4|||
161378747|NCT02803203|582774892|FG000|Overall Study|Death|4|||
161378748|NCT02803203|582774892|FG000|Overall Study|Progressive disease|29|||
161378749|NCT02803203|582774892|FG000|Overall Study|Withdrawal by Subject|8|||
161378750|NCT02803203|582774892|FG000|Overall Study|Complete resection of target disease|2|||
161378751|NCT02803203|582774892|FG000|Overall Study|Switched to commercial Osi|1|||
161378752|NCT02803203|582774892|FG000|Overall Study|Participant moved away|1|||
161378753|NCT00590967|582774893|FG000|Overall Study|Withdrawal by Subject|1|||
161378754|NCT00590967|582774894|FG001|Overall Study|Withdrawal by Subject|1|||
161378755|NCT00590967|582774893|FG000|Overall Study|Ineligible|1|||
161378756|NCT00590967|582774894|FG001|Overall Study|Ineligible|0|||
161378757|NCT00590967|582774893|FG000|Overall Study|Poor performance status|0|||
161378758|NCT00590967|582774894|FG001|Overall Study|Poor performance status|1|||
161378759|NCT00590967|582774893|FG000|Overall Study|Non-compliant|0|||
161378760|NCT00590967|582774894|FG001|Overall Study|Non-compliant|2|||
161378761|NCT00590967|582774893|FG000|Overall Study|Did not sign consent form|0|||
161378762|NCT00590967|582774894|FG001|Overall Study|Did not sign consent form|1|||
161378763|NCT00590967|582774893|FG000|Overall Study|Did not receive chemo per protocol|1|||
161378764|NCT00590967|582774894|FG001|Overall Study|Did not receive chemo per protocol|0|||
161378765|NCT01881789|582774895|FG000|Overall Study|Withdrawal by Subject|0|||
161378766|NCT01881789|582774896|FG001|Overall Study|Withdrawal by Subject|2|||
161378767|NCT01881789|582774897|FG002|Overall Study|Withdrawal by Subject|1|||
161378768|NCT01881789|582774898|FG003|Overall Study|Withdrawal by Subject|0|||
161378769|NCT01881789|582774899|FG004|Overall Study|Withdrawal by Subject|1|||
161378770|NCT01881789|582774900|FG005|Overall Study|Withdrawal by Subject|1|||
161378771|NCT01881789|582774895|FG000|Overall Study|Study Terminated by Sponsor|0|||
161378772|NCT01881789|582774896|FG001|Overall Study|Study Terminated by Sponsor|0|||
161378773|NCT01881789|582774897|FG002|Overall Study|Study Terminated by Sponsor|0|||
161378774|NCT01881789|582774898|FG003|Overall Study|Study Terminated by Sponsor|0|||
161378775|NCT01881789|582774899|FG004|Overall Study|Study Terminated by Sponsor|0|||
161378776|NCT01881789|582774900|FG005|Overall Study|Study Terminated by Sponsor|1|||
161378777|NCT01881789|582774895|FG000|Overall Study|Other|3|||
161378778|NCT01881789|582774896|FG001|Overall Study|Other|5|||
161378779|NCT01881789|582774897|FG002|Overall Study|Other|2|||
161378780|NCT01881789|582774898|FG003|Overall Study|Other|3|||
161378781|NCT01881789|582774899|FG004|Overall Study|Other|1|||
161378782|NCT01881789|582774900|FG005|Overall Study|Other|1|||
161378783|NCT01887717|582774901|FG000|Overall Study|Withdrawal by Subject|1|||
161378784|NCT01887717|582774902|FG001|Overall Study|Withdrawal by Subject|7|||
161378785|NCT01887717|582774901|FG000|Overall Study|Physician Decision|0|||
161378786|NCT01887717|582774902|FG001|Overall Study|Physician Decision|2|||
161378787|NCT01887717|582774901|FG000|Overall Study|Administrative reasons|5|||
161378788|NCT01887717|582774902|FG001|Overall Study|Administrative reasons|2|||
161378789|NCT01299389|582774903|FG000|Double-blind|Adverse Event|45|||
161378790|NCT01299389|582774904|FG001|Double-blind|Adverse Event|27|||
161378791|NCT01299389|582774905|FG002|Double-blind|Adverse Event|0|||
161378792|NCT01299389|582774906|FG003|Double-blind|Adverse Event|0|||
161378793|NCT01299389|582774903|FG000|Double-blind|Lack of Efficacy|45|||
161378794|NCT01299389|582774904|FG001|Double-blind|Lack of Efficacy|21|||
161378795|NCT01299389|582774905|FG002|Double-blind|Lack of Efficacy|0|||
161378796|NCT01299389|582774906|FG003|Double-blind|Lack of Efficacy|0|||
161378797|NCT01299389|582774903|FG000|Double-blind|Lost to Follow-up|2|||
161378798|NCT01299389|582774904|FG001|Double-blind|Lost to Follow-up|1|||
161378799|NCT01299389|582774905|FG002|Double-blind|Lost to Follow-up|0|||
161378800|NCT01299389|582774906|FG003|Double-blind|Lost to Follow-up|0|||
161378801|NCT01299389|582774903|FG000|Double-blind|Withdrawal by Subject|16|||
161378802|NCT01299389|582774904|FG001|Double-blind|Withdrawal by Subject|13|||
161378803|NCT01299389|582774905|FG002|Double-blind|Withdrawal by Subject|0|||
161378804|NCT01299389|582774906|FG003|Double-blind|Withdrawal by Subject|0|||
161378805|NCT01299389|582774903|FG000|Double-blind|Other|1|||
161378806|NCT01299389|582774904|FG001|Double-blind|Other|1|||
161378807|NCT01299389|582774905|FG002|Double-blind|Other|0|||
161378808|NCT01299389|582774906|FG003|Double-blind|Other|0|||
161378809|NCT01299389|582774903|FG000|Double-blind|"fail to meet study population criteria"|0|||
161378810|NCT01299389|582774904|FG001|Double-blind|"fail to meet study population criteria"|1|||
161378811|NCT01299389|582774905|FG002|Double-blind|"fail to meet study population criteria"|0|||
161378812|NCT01299389|582774906|FG003|Double-blind|"fail to meet study population criteria"|0|||
161378813|NCT01299389|582774903|FG000|Post-observational|Other|0|||
161378814|NCT01299389|582774904|FG001|Post-observational|Other|0|||
161378815|NCT01299389|582774905|FG002|Post-observational|Other|12|||
161378816|NCT01299389|582774906|FG003|Post-observational|Other|6|||
161378817|NCT02185534|582774907|FG000|First Period|Withdrawal by Subject|0|||
161378818|NCT02185534|582774908|FG001|First Period|Withdrawal by Subject|0|||
161378819|NCT02185534|582774909|FG002|First Period|Withdrawal by Subject|0|||
161378820|NCT02185534|582774910|FG003|First Period|Withdrawal by Subject|1|||
161378821|NCT02185534|582774911|FG004|First Period|Withdrawal by Subject|0|||
161378822|NCT02185534|582774912|FG005|First Period|Withdrawal by Subject|0|||
161378823|NCT02185534|582774907|FG000|First Washout Period|Withdrawal by Subject|1|||
161378824|NCT02185534|582774908|FG001|First Washout Period|Withdrawal by Subject|0|||
161378825|NCT02185534|582774909|FG002|First Washout Period|Withdrawal by Subject|0|||
161378826|NCT02185534|582774910|FG003|First Washout Period|Withdrawal by Subject|0|||
161378827|NCT02185534|582774911|FG004|First Washout Period|Withdrawal by Subject|1|||
161378828|NCT02185534|582774912|FG005|First Washout Period|Withdrawal by Subject|0|||
161378829|NCT02185534|582774907|FG000|First Washout Period|Protocol Violation|0|||
161378830|NCT02185534|582774908|FG001|First Washout Period|Protocol Violation|0|||
161378831|NCT02185534|582774909|FG002|First Washout Period|Protocol Violation|0|||
161378832|NCT02185534|582774910|FG003|First Washout Period|Protocol Violation|0|||
161378833|NCT02185534|582774911|FG004|First Washout Period|Protocol Violation|0|||
161378834|NCT02185534|582774912|FG005|First Washout Period|Protocol Violation|1|||
161378835|NCT02737501|582774925|FG000|Randomized Phase|Died|41|||
161378836|NCT02737501|582774926|FG001|Randomized Phase|Died|29|||
161378837|NCT02737501|582774927|FG002|Randomized Phase|Died|0|||
161378838|NCT02737501|582774925|FG000|Randomized Phase|Withdrawal by Subject|16|||
161378839|NCT02737501|582774926|FG001|Randomized Phase|Withdrawal by Subject|6|||
161378840|NCT02737501|582774927|FG002|Randomized Phase|Withdrawal by Subject|0|||
161378841|NCT02737501|582774925|FG000|Randomized Phase|Lost to Follow-up|0|||
161378842|NCT02737501|582774926|FG001|Randomized Phase|Lost to Follow-up|1|||
161378843|NCT02737501|582774927|FG002|Randomized Phase|Lost to Follow-up|0|||
161378844|NCT02737501|582774925|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
161378845|NCT02737501|582774926|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
161378846|NCT02737501|582774927|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
161378847|NCT02737501|582774925|FG000|Randomized Phase|Reason not Specified|1|||
161378848|NCT02737501|582774926|FG001|Randomized Phase|Reason not Specified|1|||
161378849|NCT02737501|582774927|FG002|Randomized Phase|Reason not Specified|0|||
161378850|NCT02737501|582774925|FG000|Randomized Phase|Never Treated|1|||
161378851|NCT02737501|582774926|FG001|Randomized Phase|Never Treated|1|||
161378852|NCT02737501|582774927|FG002|Randomized Phase|Never Treated|0|||
161378853|NCT02737501|582774925|FG000|Crossover Phase|Died|0|||
161378854|NCT02737501|582774926|FG001|Crossover Phase|Died|0|||
161378855|NCT02737501|582774927|FG002|Crossover Phase|Died|22|||
161378856|NCT02737501|582774925|FG000|Crossover Phase|Withdrew Consent|0|||
161378857|NCT02737501|582774926|FG001|Crossover Phase|Withdrew Consent|0|||
161378858|NCT02737501|582774927|FG002|Crossover Phase|Withdrew Consent|9|||
161378859|NCT02737501|582774925|FG000|Crossover Phase|Physician Decision|0|||
161378860|NCT02737501|582774926|FG001|Crossover Phase|Physician Decision|0|||
161378861|NCT02737501|582774927|FG002|Crossover Phase|Physician Decision|1|||
161378862|NCT02737501|582774925|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
161378863|NCT02737501|582774926|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
161378864|NCT02737501|582774927|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
161378865|NCT01070979|582774928|FG000|Overall Study|Adverse Event|2|||
161378866|NCT01070979|582774929|FG001|Overall Study|Adverse Event|3|||
161378867|NCT01070979|582774930|FG002|Overall Study|Adverse Event|3|||
161378868|NCT01070979|582774928|FG000|Overall Study|Lost to Follow-up|2|||
161378869|NCT01070979|582774929|FG001|Overall Study|Lost to Follow-up|1|||
161378870|NCT01070979|582774930|FG002|Overall Study|Lost to Follow-up|1|||
161378871|NCT01070979|582774928|FG000|Overall Study|Protocol Violation|0|||
161378872|NCT01070979|582774929|FG001|Overall Study|Protocol Violation|2|||
161378873|NCT01070979|582774930|FG002|Overall Study|Protocol Violation|6|||
161378874|NCT01070979|582774928|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
161378875|NCT01070979|582774929|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
161378876|NCT01070979|582774930|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
161378877|NCT01070979|582774928|FG000|Overall Study|Withdrawal by Subject|3|||
161378878|NCT01070979|582774929|FG001|Overall Study|Withdrawal by Subject|1|||
161378879|NCT01070979|582774930|FG002|Overall Study|Withdrawal by Subject|1|||
161378880|NCT01070979|582774928|FG000|Overall Study|No study drug taken|0|||
161378881|NCT01070979|582774929|FG001|Overall Study|No study drug taken|1|||
161378882|NCT01070979|582774930|FG002|Overall Study|No study drug taken|0|||
161378883|NCT04819113|582774931|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161378884|NCT04819113|582774931|FG000|Overall Study|Lost to Follow-up|1|||
161378885|NCT04819113|582774931|FG000|Overall Study|Withdrawn before vaccination|2|||
161378886|NCT04417257|582774936|FG000|Pilot Phase 2|Adverse Event|2|||
161378887|NCT04417257|582774937|FG001|Pilot Phase 2|Adverse Event|0|||
161378888|NCT04417257|582774936|FG000|Pilot Phase 2|Death|14|||
161378889|NCT04417257|582774937|FG001|Pilot Phase 2|Death|11|||
161378890|NCT04417257|582774936|FG000|Pilot Phase 2|Lost to Follow-up|3|||
161378891|NCT04417257|582774937|FG001|Pilot Phase 2|Lost to Follow-up|5|||
161378892|NCT04417257|582774936|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
161378893|NCT04417257|582774937|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
161378894|NCT04417257|582774936|FG000|Pilot Phase 2|Hepatic impairment|1|||
161378895|NCT04417257|582774937|FG001|Pilot Phase 2|Hepatic impairment|0|||
161378896|NCT04417257|582774936|FG000|Pilot Phase 2|Unblinding|1|||
161378897|NCT04417257|582774937|FG001|Pilot Phase 2|Unblinding|0|||
161378898|NCT04417257|582774936|FG000|Pilot Phase 2|All other|0|||
161378899|NCT04417257|582774937|FG001|Pilot Phase 2|All other|2|||
161378900|NCT04417257|582774936|FG000|Phase 3 Extension|Death|3|||
161378901|NCT04417257|582774937|FG001|Phase 3 Extension|Death|1|||
161378902|NCT04417257|582774936|FG000|Phase 3 Extension|Lost to Follow-up|4|||
161378903|NCT04417257|582774937|FG001|Phase 3 Extension|Lost to Follow-up|2|||
161378904|NCT04417257|582774936|FG000|Phase 3 Extension|Patient withdrawal|2|||
161378905|NCT04417257|582774937|FG001|Phase 3 Extension|Patient withdrawal|2|||
161378906|NCT04417257|582774936|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
161378907|NCT04417257|582774937|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
161378908|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Death|2|||
161378909|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
161378910|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
161378911|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Physician Decision|1|||
161378912|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
161378913|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
161378914|NCT00786422|582774938|FG000|Rivaroxaban Treatment|Adverse Event|2|||
161378915|NCT00786422|582774938|FG000|Follow-up Period|Death|1|||
161378916|NCT00786422|582774938|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
161378917|NCT03484429|582774939|FG000|Overall Study|Withdrawal by Subject|1|||
161378918|NCT03484429|582774940|FG001|Overall Study|Withdrawal by Subject|0|||
161378919|NCT03484429|582774939|FG000|Overall Study|Adverse Event|2|||
161378920|NCT03484429|582774940|FG001|Overall Study|Adverse Event|0|||
161378921|NCT04466384|582774941|FG000|First Phase|Protocol Violation|1|||
161378922|NCT04466384|582774942|FG001|First Phase|Protocol Violation|0|||
161378923|NCT04466384|582774941|FG000|First Phase|Missing data|1|||
161378924|NCT04466384|582774942|FG001|First Phase|Missing data|0|||
161378925|NCT04466384|582774941|FG000|Cross Over Phase|Physician Decision|1|||
161378926|NCT04466384|582774942|FG001|Cross Over Phase|Physician Decision|0|||
161378927|NCT04466384|582774941|FG000|Cross Over Phase|Withdrawal by Subject|0|||
161378928|NCT04466384|582774942|FG001|Cross Over Phase|Withdrawal by Subject|1|||
161378929|NCT04267926|582776451|FG000|Overall Study|abnormal labs. No longer eligible|0|||
161378930|NCT04267926|582776452|FG001|Overall Study|abnormal labs. No longer eligible|0|||
161378931|NCT04267926|582776453|FG002|Overall Study|abnormal labs. No longer eligible|1|||
161378932|NCT04267926|582776451|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
161378933|NCT04267926|582776452|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
161378934|NCT04267926|582776453|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
161378935|NCT02595879|582776454|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
161378936|NCT02595879|582776455|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
161378937|NCT03145064|582776456|FG000|Overall Study|Death|24|||
161378938|NCT03145064|582776456|FG000|Overall Study|Lost to Follow-up|3|||
161378939|NCT03145064|582776456|FG000|Overall Study|Withdrawal by Subject|6|||
161378940|NCT03145064|582776456|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
161378941|NCT03145064|582776456|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
161378942|NCT00661830|582776457|FG000|Overall Study|Death|37|||
161378943|NCT00661830|582776458|FG001|Overall Study|Death|33|||
161378944|NCT00661830|582776457|FG000|Overall Study|Lost to Follow-up|1|||
161378945|NCT00661830|582776458|FG001|Overall Study|Lost to Follow-up|3|||
161378946|NCT00661830|582776457|FG000|Overall Study|Withdrawal by Subject|1|||
161378947|NCT00661830|582776458|FG001|Overall Study|Withdrawal by Subject|1|||
161378948|NCT00661830|582776457|FG000|Overall Study|Other reason|1|||
161378949|NCT00661830|582776458|FG001|Overall Study|Other reason|5|||
161378950|NCT01396187|582776459|FG000|Overall Study|Adverse Event|0|||
161378951|NCT01396187|582776460|FG001|Overall Study|Adverse Event|1|||
161378952|NCT01396187|582776461|FG002|Overall Study|Adverse Event|0|||
161378953|NCT01396187|582776462|FG003|Overall Study|Adverse Event|0|||
161378954|NCT01396187|582776463|FG004|Overall Study|Adverse Event|0|||
161378955|NCT01396187|582776459|FG000|Overall Study|Withdrawal by Subject|0|||
161378956|NCT01396187|582776460|FG001|Overall Study|Withdrawal by Subject|1|||
161378957|NCT01396187|582776461|FG002|Overall Study|Withdrawal by Subject|1|||
161378958|NCT01396187|582776462|FG003|Overall Study|Withdrawal by Subject|0|||
161378959|NCT01396187|582776463|FG004|Overall Study|Withdrawal by Subject|0|||
161378960|NCT01396187|582776459|FG000|Overall Study|Other|1|||
161378961|NCT01396187|582776460|FG001|Overall Study|Other|1|||
161378962|NCT01396187|582776461|FG002|Overall Study|Other|0|||
161378963|NCT01396187|582776462|FG003|Overall Study|Other|0|||
161378964|NCT01396187|582776463|FG004|Overall Study|Other|1|||
161378965|NCT01898286|582776464|FG000|Overall Study|Withdrawal by Subject|1|||
161378966|NCT01898286|582776464|FG000|Overall Study|Protocol Violation|1|||
161378967|NCT01898286|582776464|FG000|Overall Study|Lost to Follow-up|1|||
161378968|NCT01650831|582776465|FG000|Overall Study|Screen failure|1|||
161378969|NCT05554146|582776468|FG000|Overall Study|Adverse Event|0|||
161378970|NCT05554146|582776469|FG001|Overall Study|Adverse Event|1|||
161378971|NCT05554146|582776470|FG002|Overall Study|Adverse Event|0|||
161378972|NCT05554146|582776471|FG003|Overall Study|Adverse Event|0|||
161378973|NCT05554146|582776468|FG000|Overall Study|Protocol Violation|0|||
161378974|NCT05554146|582776469|FG001|Overall Study|Protocol Violation|1|||
161378975|NCT05554146|582776470|FG002|Overall Study|Protocol Violation|0|||
161378976|NCT05554146|582776471|FG003|Overall Study|Protocol Violation|0|||
161378977|NCT05554146|582776468|FG000|Overall Study|No longer interested in participating|0|||
161378978|NCT05554146|582776469|FG001|Overall Study|No longer interested in participating|0|||
161378979|NCT05554146|582776470|FG002|Overall Study|No longer interested in participating|1|||
161378980|NCT05554146|582776471|FG003|Overall Study|No longer interested in participating|0|||
161378981|NCT05554146|582776468|FG000|Overall Study|Lost to Follow-up|1|||
161378982|NCT05554146|582776469|FG001|Overall Study|Lost to Follow-up|0|||
161378983|NCT05554146|582776470|FG002|Overall Study|Lost to Follow-up|0|||
161378984|NCT05554146|582776471|FG003|Overall Study|Lost to Follow-up|0|||
161378985|NCT02477527|582776472|FG000|Overall Study|Lost to Follow-up|2|||
161378986|NCT02477527|582776472|FG000|Overall Study|Withdrawal by Subject|1|||
161378987|NCT02477527|582776472|FG000|Overall Study|Screen Failure|3|||
161378988|NCT03692403|582776473|FG000|Overall Study|Withdrawal by Subject|1|||
161378989|NCT03692403|582776474|FG001|Overall Study|Withdrawal by Subject|0|||
161378990|NCT03692403|582776475|FG002|Overall Study|Withdrawal by Subject|1|||
161378991|NCT03692403|582776476|FG003|Overall Study|Withdrawal by Subject|0|||
161378992|NCT03692403|582776473|FG000|Overall Study|Adverse Event|0|||
161378993|NCT03692403|582776474|FG001|Overall Study|Adverse Event|0|||
161378994|NCT03692403|582776475|FG002|Overall Study|Adverse Event|0|||
161378995|NCT03692403|582776476|FG003|Overall Study|Adverse Event|1|||
161378996|NCT03692403|582776473|FG000|Overall Study|Pregnancy|0|||
161378997|NCT03692403|582776474|FG001|Overall Study|Pregnancy|1|||
161378998|NCT03692403|582776475|FG002|Overall Study|Pregnancy|0|||
161378999|NCT03692403|582776476|FG003|Overall Study|Pregnancy|0|||
161379000|NCT03692403|582776473|FG000|Overall Study|Other|0|||
161379001|NCT03692403|582776474|FG001|Overall Study|Other|0|||
161379002|NCT03692403|582776475|FG002|Overall Study|Other|1|||
161379003|NCT03692403|582776476|FG003|Overall Study|Other|0|||
161379004|NCT00856635|582776477|FG000|Overall Study|Lost to Follow-up|2|||
161379005|NCT00856635|582776478|FG001|Overall Study|Lost to Follow-up|5|||
161379006|NCT00856635|582776477|FG000|Overall Study|Pregnancy|1|||
161379007|NCT00856635|582776478|FG001|Overall Study|Pregnancy|0|||
161379008|NCT00856635|582776477|FG000|Overall Study|Withdrawal by Subject|3|||
161379009|NCT00856635|582776478|FG001|Overall Study|Withdrawal by Subject|1|||
161379010|NCT00856635|582776477|FG000|Overall Study|Serious Adverse Event|1|||
161379011|NCT00856635|582776478|FG001|Overall Study|Serious Adverse Event|0|||
161379012|NCT00856635|582776477|FG000|Overall Study|Other|1|||
161379013|NCT00856635|582776478|FG001|Overall Study|Other|0|||
161379014|NCT00856635|582776477|FG000|Overall Study|Discontinued at Randomization|2|||
161379015|NCT00856635|582776478|FG001|Overall Study|Discontinued at Randomization|2|||
161379016|NCT01349673|582776479|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
161379017|NCT01349673|582776479|FG000|Overall Study|No Longer Qualified For Study|1|||
161379018|NCT01349673|582776479|FG000|Overall Study|Site Closure|10|||
161379019|NCT01349673|582776479|FG000|Overall Study|Withdrawal by Subject|21|||
161379020|NCT01349673|582776479|FG000|Overall Study|Lost to Follow-up|6|||
161379021|NCT01349673|582776479|FG000|Overall Study|Adverse Event|17|||
161379022|NCT01349673|582776479|FG000|Overall Study|Study Terminated By Sponsor|50|||
161379023|NCT01349673|582776479|FG000|Overall Study|Lack of Efficacy|8|||
161379024|NCT00564733|582776480|FG000|Overall Study|Withdrawal by Subject|4|||
161379025|NCT00564733|582776480|FG000|Overall Study|Ineligible|5|||
161379026|NCT03198767|582776485|FG000|Overall Study|Protocol Violation|0|||
161379027|NCT03198767|582776486|FG001|Overall Study|Protocol Violation|0|||
161379028|NCT03198767|582776487|FG002|Overall Study|Protocol Violation|0|||
161379029|NCT03198767|582776488|FG003|Overall Study|Protocol Violation|6|||
161379030|NCT03198767|582776489|FG004|Overall Study|Protocol Violation|0|||
161379031|NCT03198767|582776490|FG005|Overall Study|Protocol Violation|0|||
161379032|NCT03198767|582776491|FG006|Overall Study|Protocol Violation|0|||
161379033|NCT00579553|582776495|FG000|Overall Study|Lost to Follow-up|16|||
161379034|NCT00579553|582776496|FG001|Overall Study|Lost to Follow-up|13|||
161379035|NCT04860869|582776501|FG000|Overall Study|Withdrawal by Subject|1|||
161379036|NCT04860869|582776502|FG001|Overall Study|Withdrawal by Subject|0|||
161379037|NCT02651116|582776503|FG000|Overall Study|Adverse Event|0|||
161379038|NCT02651116|582776504|FG001|Overall Study|Adverse Event|1|||
161379039|NCT02651116|582776503|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
161379040|NCT02651116|582776504|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
161379041|NCT01775553|582776505|FG000|Overall Study|Adverse Event|1|||
161379042|NCT01775553|582776505|FG000|Overall Study|Disease Progression|12|||
161379043|NCT00920556|582776515|FG000|Overall Study|Adverse Event|16|||
161379044|NCT00920556|582776515|FG000|Overall Study|Physician Decision|7|||
161379045|NCT00920556|582776515|FG000|Overall Study|Withdrawal by Subject|1|||
161379046|NCT02834819|582776516|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
161379047|NCT02834819|582776517|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
161379048|NCT01925768|582776518|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161379049|NCT01925768|582776519|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161379050|NCT01925768|582776518|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161379051|NCT01925768|582776519|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
161379052|NCT01925768|582776518|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
161379053|NCT01925768|582776519|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
161379054|NCT01925768|582776518|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161379055|NCT01925768|582776519|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
161379056|NCT01925768|582776518|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
161379057|NCT01925768|582776519|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
161379058|NCT01925768|582776518|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
161379059|NCT01925768|582776519|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
161379060|NCT01925768|582776518|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
161379061|NCT01925768|582776519|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
161379062|NCT01925768|582776518|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
161379063|NCT01925768|582776519|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
161379064|NCT01925768|582776518|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
161379065|NCT01925768|582776519|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
161379066|NCT01925768|582776518|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
161379067|NCT01925768|582776519|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
161379068|NCT01925768|582776518|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
161379069|NCT01925768|582776519|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
161379070|NCT04339413|582776522|FG000|Overall Study|Reason Not Specified|2|||
161379071|NCT04339413|582776523|FG001|Overall Study|Reason Not Specified|7|||
161379072|NCT04339413|582776522|FG000|Overall Study|Study Terminated by Sponsor|30|||
161379073|NCT04339413|582776523|FG001|Overall Study|Study Terminated by Sponsor|33|||
161379074|NCT04339413|582776522|FG000|Overall Study|Progressive Disease|9|||
161379075|NCT04339413|582776523|FG001|Overall Study|Progressive Disease|6|||
161379076|NCT04339413|582776522|FG000|Overall Study|Withdrawal by Subject|9|||
161379077|NCT04339413|582776523|FG001|Overall Study|Withdrawal by Subject|10|||
161379078|NCT04339413|582776522|FG000|Overall Study|Physician Decision|3|||
161379079|NCT04339413|582776523|FG001|Overall Study|Physician Decision|1|||
161379080|NCT04339413|582776522|FG000|Overall Study|Death|2|||
161379081|NCT04339413|582776523|FG001|Overall Study|Death|0|||
161379082|NCT04339413|582776522|FG000|Overall Study|Adverse Event|3|||
161379083|NCT04339413|582776523|FG001|Overall Study|Adverse Event|0|||
161379084|NCT00087698|582776526|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
161379085|NCT00087698|582776526|FG000|Overall Study|Death from Other Causes|3|||
161379086|NCT00087698|582776526|FG000|Overall Study|Adverse Event|4|||
161379087|NCT00087698|582776526|FG000|Overall Study|Withdrawal by Subject|4|||
161379088|NCT00087698|582776526|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
161379089|NCT00087698|582776526|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
161379090|NCT00087698|582776526|FG000|Overall Study|Clinical Relapse|1|||
161379091|NCT00087698|582776526|FG000|Overall Study|Death from Study Disease|2|||
161379092|NCT00087698|582776526|FG000|Overall Study|Death from Study Drug Toxicity|2|||
161379093|NCT00087698|582776526|FG000|Overall Study|Protocol Violation|1|||
161379094|NCT03542266|582776527|FG000|Treatment Phase|Withdrawal by Subject|1|||
161379095|NCT03542266|582776527|FG000|Treatment Phase|Adverse Event|1|||
161379096|NCT03542266|582776527|FG000|Treatment Phase|PD|1|||
161379097|NCT00657267|582776540|FG000|Overall Study|Progressive disease|45|||
161379098|NCT00657267|582776540|FG000|Overall Study|Adverse Event|9|||
161379099|NCT02012218|582776543|FG000|Overall Study|Withdrawal by Subject|1|||
161379100|NCT02012218|582776544|FG001|Overall Study|Withdrawal by Subject|0|||
161379101|NCT02012218|582776545|FG002|Overall Study|Withdrawal by Subject|1|||
161379102|NCT02012218|582776546|FG003|Overall Study|Withdrawal by Subject|1|||
161379103|NCT02012218|582776547|FG004|Overall Study|Withdrawal by Subject|1|||
161379104|NCT02012218|582776543|FG000|Overall Study|Adverse Event|1|||
161379105|NCT02012218|582776544|FG001|Overall Study|Adverse Event|0|||
161379106|NCT02012218|582776545|FG002|Overall Study|Adverse Event|0|||
161379107|NCT02012218|582776546|FG003|Overall Study|Adverse Event|1|||
161379108|NCT02012218|582776547|FG004|Overall Study|Adverse Event|0|||
161379109|NCT02012218|582776543|FG000|Overall Study|Lost to Follow-up|0|||
161379110|NCT02012218|582776544|FG001|Overall Study|Lost to Follow-up|1|||
161379111|NCT02012218|582776545|FG002|Overall Study|Lost to Follow-up|1|||
161379112|NCT02012218|582776546|FG003|Overall Study|Lost to Follow-up|0|||
161379113|NCT02012218|582776547|FG004|Overall Study|Lost to Follow-up|0|||
161379114|NCT02012218|582776543|FG000|Overall Study|Protocol Specified|1|||
161379115|NCT02012218|582776544|FG001|Overall Study|Protocol Specified|0|||
161379116|NCT02012218|582776545|FG002|Overall Study|Protocol Specified|0|||
161379117|NCT02012218|582776546|FG003|Overall Study|Protocol Specified|0|||
161379118|NCT02012218|582776547|FG004|Overall Study|Protocol Specified|0|||
161379119|NCT02012218|582776543|FG000|Overall Study|Protocol Deviation|1|||
161379120|NCT02012218|582776544|FG001|Overall Study|Protocol Deviation|0|||
161379121|NCT02012218|582776545|FG002|Overall Study|Protocol Deviation|0|||
161379122|NCT02012218|582776546|FG003|Overall Study|Protocol Deviation|0|||
161379123|NCT02012218|582776547|FG004|Overall Study|Protocol Deviation|0|||
161379124|NCT00142792|582776548|FG000|Overall Study|Death|0|||
161379125|NCT00142792|582776549|FG001|Overall Study|Death|0|||
161379126|NCT00142792|582776550|FG002|Overall Study|Death|1|||
161379127|NCT00142792|582776548|FG000|Overall Study|Withdrawal by Subject|3|||
161379128|NCT00142792|582776549|FG001|Overall Study|Withdrawal by Subject|2|||
161379129|NCT00142792|582776550|FG002|Overall Study|Withdrawal by Subject|3|||
161379130|NCT00142792|582776548|FG000|Overall Study|Lost to Follow-up|8|||
161379131|NCT00142792|582776549|FG001|Overall Study|Lost to Follow-up|11|||
161379132|NCT00142792|582776550|FG002|Overall Study|Lost to Follow-up|7|||
161379133|NCT00142792|582776548|FG000|Overall Study|No category|1|||
161379134|NCT00142792|582776549|FG001|Overall Study|No category|2|||
161379135|NCT00142792|582776550|FG002|Overall Study|No category|1|||
161379136|NCT00833027|582776551|FG000|Overall Study|Adverse Event|33|||
161379137|NCT00833027|582776551|FG000|Overall Study|Death|1|||
161379138|NCT00833027|582776551|FG000|Overall Study|Lack of Efficacy|12|||
161379139|NCT00833027|582776551|FG000|Overall Study|Lost to Follow-up|24|||
161379140|NCT00833027|582776551|FG000|Overall Study|Protocol Violation|115|||
161379141|NCT00833027|582776551|FG000|Overall Study|Withdrawal by Subject|16|||
161379142|NCT00833027|582776551|FG000|Overall Study|Missing|10|||
161379143|NCT00444925|582776552|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
161379144|NCT00444925|582776553|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
161379145|NCT00444925|582776554|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
161379146|NCT00444925|582776552|FG000|Double-blind Treatment Period|Death|2|||
161379147|NCT00444925|582776553|FG001|Double-blind Treatment Period|Death|0|||
161379148|NCT00444925|582776554|FG002|Double-blind Treatment Period|Death|0|||
161379149|NCT00444925|582776552|FG000|Double-blind Treatment Period|Adverse Event|6|||
161379150|NCT00444925|582776553|FG001|Double-blind Treatment Period|Adverse Event|28|||
161379151|NCT00444925|582776554|FG002|Double-blind Treatment Period|Adverse Event|44|||
161379152|NCT00444925|582776552|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
161379153|NCT00444925|582776553|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
161379154|NCT00444925|582776554|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
161379155|NCT00444925|582776552|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
161379156|NCT00444925|582776553|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
161379157|NCT00444925|582776554|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161379158|NCT00444925|582776552|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
161379159|NCT00444925|582776553|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
161379160|NCT00444925|582776554|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
161379161|NCT00444925|582776552|FG000|Double-blind Treatment Period|Other|7|||
161379162|NCT00444925|582776553|FG001|Double-blind Treatment Period|Other|7|||
161379163|NCT00444925|582776554|FG002|Double-blind Treatment Period|Other|12|||
161379164|NCT03069716|582776558|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
161379165|NCT03069716|582776559|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
161379166|NCT03069716|582776560|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
161379167|NCT03069716|582776558|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
161379168|NCT03069716|582776559|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
161379169|NCT03069716|582776560|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
161379170|NCT03069716|582776558|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
161379171|NCT03069716|582776559|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161379172|NCT03069716|582776560|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161379173|NCT03069716|582776558|FG000|Randomized Treatment|Withdrawal by Subject|0|||
161379174|NCT03069716|582776559|FG001|Randomized Treatment|Withdrawal by Subject|2|||
161379175|NCT03069716|582776560|FG002|Randomized Treatment|Withdrawal by Subject|0|||
161379176|NCT00714948|582776561|FG000|Overall Study|Adverse Event|2|||
161379177|NCT01673126|582776562|FG000|Overall Study|change of diagnosis|4|||
161379178|NCT01673126|582776563|FG001|Overall Study|change of diagnosis|3|||
161379179|NCT00237042|582776566|FG000|Treatment|Became ineligible post-randomization|0|||
161379180|NCT00237042|582776567|FG001|Treatment|Became ineligible post-randomization|1|||
161379181|NCT00237042|582776568|FG002|Treatment|Became ineligible post-randomization|16|||
161379182|NCT00237042|582776566|FG000|Treatment|Moved out of state|1|||
161379183|NCT00237042|582776567|FG001|Treatment|Moved out of state|1|||
161379184|NCT00237042|582776568|FG002|Treatment|Moved out of state|1|||
161379185|NCT00237042|582776566|FG000|Treatment|Completed no treatment|5|||
161379186|NCT00237042|582776567|FG001|Treatment|Completed no treatment|5|||
161379187|NCT00237042|582776568|FG002|Treatment|Completed no treatment|21|||
161379188|NCT00237042|582776566|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
161379189|NCT00237042|582776567|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
161379190|NCT00237042|582776568|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
161379191|NCT00237042|582776566|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
161379192|NCT00237042|582776567|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
161379193|NCT00237042|582776568|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
161379194|NCT01913327|582776575|FG000|Overall Study|Withdrawal by Subject|0|||
161379195|NCT01913327|582776576|FG001|Overall Study|Withdrawal by Subject|1|||
161379196|NCT00326001|582776577|FG000|Overall Study|Adverse Event|4|||
161379197|NCT00326001|582776578|FG001|Overall Study|Adverse Event|5|||
161379198|NCT00326001|582776577|FG000|Overall Study|Physician Decision|3|||
161379199|NCT00326001|582776578|FG001|Overall Study|Physician Decision|3|||
161379200|NCT03761056|582776583|FG000|Overall Study|Death|8|||
161379201|NCT03761056|582776583|FG000|Overall Study|Enrolled but never treated|2|||
161379202|NCT03761056|582776583|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
161379203|NCT03761056|582776583|FG000|Overall Study|Investigator decision|1|||
161379204|NCT00996658|582776584|FG000|Overall Study|Adverse Event|2|||
161379205|NCT00996658|582776585|FG001|Overall Study|Adverse Event|5|||
161379206|NCT00996658|582776584|FG000|Overall Study|Protocol Violation|0|||
161379207|NCT00996658|582776585|FG001|Overall Study|Protocol Violation|1|||
161379208|NCT00996658|582776584|FG000|Overall Study|Lost to Follow-up|2|||
161379209|NCT00996658|582776585|FG001|Overall Study|Lost to Follow-up|5|||
161379210|NCT00996658|582776584|FG000|Overall Study|Non-compliance issues|3|||
161379211|NCT00996658|582776585|FG001|Overall Study|Non-compliance issues|3|||
161379212|NCT00996658|582776584|FG000|Overall Study|Other|9|||
161379213|NCT00996658|582776585|FG001|Overall Study|Other|7|||
161379214|NCT04749745|582776586|FG000|Overall Study|Withdrawal by Subject|1|||
161379215|NCT04749745|582776587|FG001|Overall Study|Withdrawal by Subject|0|||
161379216|NCT01234480|582778029|FG000|Overall Study|Pregnancy|88|||
161379217|NCT01234480|582778029|FG000|Overall Study|>36/Normal History|50|||
161379218|NCT01234480|582778029|FG000|Overall Study|Age|3|||
161379219|NCT01234480|582778029|FG000|Overall Study|HPV Vaccine History|28|||
161379220|NCT01234480|582778029|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
161379221|NCT01234480|582778029|FG000|Overall Study|Hysterectomy|2|||
161379222|NCT01234480|582778029|FG000|Overall Study|Hysterectomy post enrollment|1|||
161379223|NCT01234480|582778029|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
161379224|NCT01234480|582778029|FG000|Overall Study|Informed Consent Form Violation|30|||
161379225|NCT01234480|582778029|FG000|Overall Study|Incorrect Visit|3|||
161379226|NCT01234480|582778029|FG000|Overall Study|No Florida Lab License|20|||
161379227|NCT01234480|582778029|FG000|Overall Study|Out of Window|42|||
161379228|NCT01234480|582778029|FG000|Overall Study|Sample Processing/Storage|92|||
161379229|NCT01234480|582778029|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
161379230|NCT01234480|582778029|FG000|Overall Study|Site/Subject non-compliance|44|||
161379231|NCT01234480|582778029|FG000|Overall Study|Missing Sample|9|||
161379232|NCT03370419|582778030|FG000|Overall Study|Lost to Follow-up|16|||
161379233|NCT01897727|582778036|FG000|Overall Study|Exclusion: central sleep apnea|0|||
161379234|NCT01897727|582778037|FG001|Overall Study|Exclusion: central sleep apnea|1|||
161379235|NCT04245449|582778038|FG000|Overall Study|COVID shutdown|7|||
161379236|NCT01273038|582778039|FG000|Second Intervention (14 Days)|Adverse Event|0|||
161379237|NCT01273038|582778040|FG001|Second Intervention (14 Days)|Adverse Event|1|||
161379238|NCT01273038|582778039|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161379239|NCT01273038|582778040|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161379240|NCT02197572|582778041|FG000|Overall Study|Progressive Disease|28|||
161379241|NCT02197572|582778041|FG000|Overall Study|Withdrawal by Subject|9|||
161379242|NCT02197572|582778041|FG000|Overall Study|Adverse Event|3|||
161379243|NCT02197572|582778041|FG000|Overall Study|Reason Not Specified|4|||
161379244|NCT02479880|582778042|FG000|Overall Study|Study Terminated by Sponsor|13|||
161379245|NCT02479880|582778043|FG001|Overall Study|Study Terminated by Sponsor|12|||
161379246|NCT02479880|582778042|FG000|Overall Study|Pregnancy|0|||
161379247|NCT02479880|582778043|FG001|Overall Study|Pregnancy|1|||
161379248|NCT02840253|582778044|FG000|Overall Study|Unsuccessful block|4|||
161379249|NCT02383862|582778045|FG000|3 Month Follow up|Lost to Follow-up|23|||
161379250|NCT02383862|582778046|FG001|3 Month Follow up|Lost to Follow-up|21|||
161379251|NCT03801928|582778047|FG000|Overall Study|Adverse Event|1|||
161379252|NCT03801928|582778048|FG001|Overall Study|Adverse Event|0|||
161379253|NCT03801928|582778049|FG002|Overall Study|Adverse Event|1|||
161379254|NCT03801928|582778050|FG003|Overall Study|Adverse Event|2|||
161379255|NCT03801928|582778051|FG004|Overall Study|Adverse Event|0|||
161379256|NCT03801928|582778052|FG005|Overall Study|Adverse Event|2|||
161379257|NCT03801928|582778047|FG000|Overall Study|Lack of Efficacy|0|||
161379258|NCT03801928|582778048|FG001|Overall Study|Lack of Efficacy|0|||
161379259|NCT03801928|582778049|FG002|Overall Study|Lack of Efficacy|1|||
161379260|NCT03801928|582778050|FG003|Overall Study|Lack of Efficacy|0|||
161379261|NCT03801928|582778051|FG004|Overall Study|Lack of Efficacy|0|||
161379262|NCT03801928|582778052|FG005|Overall Study|Lack of Efficacy|0|||
161379263|NCT03801928|582778047|FG000|Overall Study|Lost to Follow-up|5|||
161379264|NCT03801928|582778048|FG001|Overall Study|Lost to Follow-up|1|||
161379265|NCT03801928|582778049|FG002|Overall Study|Lost to Follow-up|1|||
161379266|NCT03801928|582778050|FG003|Overall Study|Lost to Follow-up|4|||
161379267|NCT03801928|582778051|FG004|Overall Study|Lost to Follow-up|4|||
161379268|NCT03801928|582778052|FG005|Overall Study|Lost to Follow-up|2|||
161379269|NCT03801928|582778047|FG000|Overall Study|Withdrawal by Subject|0|||
161379270|NCT03801928|582778048|FG001|Overall Study|Withdrawal by Subject|0|||
161379271|NCT03801928|582778049|FG002|Overall Study|Withdrawal by Subject|2|||
161379272|NCT03801928|582778050|FG003|Overall Study|Withdrawal by Subject|1|||
161379273|NCT03801928|582778051|FG004|Overall Study|Withdrawal by Subject|0|||
161379274|NCT03801928|582778052|FG005|Overall Study|Withdrawal by Subject|0|||
161379275|NCT03801928|582778047|FG000|Overall Study|Other|0|||
161379276|NCT03801928|582778048|FG001|Overall Study|Other|2|||
161379277|NCT03801928|582778049|FG002|Overall Study|Other|0|||
161379278|NCT03801928|582778050|FG003|Overall Study|Other|1|||
161379279|NCT03801928|582778051|FG004|Overall Study|Other|0|||
161379280|NCT03801928|582778052|FG005|Overall Study|Other|1|||
161379281|NCT03688919|582778053|FG000|Overall Study|Lost to Follow-up|2|||
161379282|NCT03688919|582778054|FG001|Overall Study|Lost to Follow-up|1|||
161379283|NCT03688919|582778053|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
161379284|NCT03688919|582778054|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
161379285|NCT01724216|582778055|FG000|Overall Study|Scan was not completed|1|||
161379286|NCT04423939|582778056|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
161379287|NCT04423939|582778057|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
161379288|NCT04423939|582778056|FG000|Overall Study|Death|3|||
161379289|NCT04423939|582778057|FG001|Overall Study|Death|0|||
161379290|NCT04423939|582778056|FG000|Overall Study|Withdrawal by Subject|3|||
161379291|NCT04423939|582778057|FG001|Overall Study|Withdrawal by Subject|0|||
161379292|NCT04423939|582778056|FG000|Overall Study|Caregiver to patient who died|0|||
161379293|NCT04423939|582778057|FG001|Overall Study|Caregiver to patient who died|3|||
161379294|NCT04423939|582778056|FG000|Overall Study|Caregiver to patient who withdrew|0|||
161379295|NCT04423939|582778057|FG001|Overall Study|Caregiver to patient who withdrew|3|||
161379296|NCT01456130|582778059|FG000|Overall Study|Adverse Event|4|||
161379297|NCT01456130|582778059|FG000|Overall Study|Voluntary Withdrawal|1|||
161379298|NCT01456130|582778059|FG000|Overall Study|Lack of Efficacy|4|||
161379299|NCT01456130|582778059|FG000|Overall Study|Other|1|||
161379300|NCT03369665|582778064|FG000|Overall Study|Adverse Event|3|||
161379301|NCT03369665|582778064|FG000|Overall Study|Lost to Follow-up|7|||
161379302|NCT03369665|582778064|FG000|Overall Study|Withdrawal by Subject|15|||
161379303|NCT03369665|582778064|FG000|Overall Study|Progression Disease|2|||
161379304|NCT03369665|582778064|FG000|Overall Study|Not classified|3|||
161379305|NCT01722994|582778065|FG000|Overall Study|Missing data|25|||
161379306|NCT01722994|582778066|FG001|Overall Study|Missing data|17|||
161379307|NCT01206140|582778070|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
161379308|NCT01206140|582778071|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
161379309|NCT00075764|582778072|FG000|Overall Study|Adverse Event|5|||
161379310|NCT00075764|582778073|FG001|Overall Study|Adverse Event|12|||
161379311|NCT00075764|582778072|FG000|Overall Study|Death|4|||
161379312|NCT00075764|582778073|FG001|Overall Study|Death|8|||
161379313|NCT00075764|582778072|FG000|Overall Study|Withdrawal by Subject|28|||
161379314|NCT00075764|582778073|FG001|Overall Study|Withdrawal by Subject|18|||
161379315|NCT00075764|582778072|FG000|Overall Study|Progression|269|||
161379316|NCT00075764|582778073|FG001|Overall Study|Progression|274|||
161379317|NCT00075764|582778072|FG000|Overall Study|Still on treatment|8|||
161379318|NCT00075764|582778073|FG001|Overall Study|Still on treatment|15|||
161379319|NCT00075764|582778072|FG000|Overall Study|Delinquent|4|||
161379320|NCT00075764|582778073|FG001|Overall Study|Delinquent|2|||
161379321|NCT00075764|582778072|FG000|Overall Study|Not protocol specified|27|||
161379322|NCT00075764|582778073|FG001|Overall Study|Not protocol specified|19|||
161379323|NCT00075764|582778072|FG000|Overall Study|Under review|0|||
161379324|NCT00075764|582778073|FG001|Overall Study|Under review|1|||
161379325|NCT02817594|582778077|FG000|Overall Study|Withdrawal by Subject|1|||
161379326|NCT02817594|582778077|FG000|Overall Study|Other|1|||
161379327|NCT02817594|582778077|FG000|Overall Study|Did Not Receive Treatment|1|||
161379328|NCT01135459|582778078|FG000|Overall Study|Adverse Event|8|||
161379329|NCT01135459|582778079|FG001|Overall Study|Adverse Event|10|||
161379330|NCT01135459|582778078|FG000|Overall Study|Lack of Efficacy|3|||
161379331|NCT01135459|582778079|FG001|Overall Study|Lack of Efficacy|1|||
161379332|NCT01135459|582778078|FG000|Overall Study|Withdrawal by Subject|2|||
161379333|NCT01135459|582778079|FG001|Overall Study|Withdrawal by Subject|3|||
161379334|NCT01135459|582778078|FG000|Overall Study|Protocol Violation|5|||
161379335|NCT01135459|582778079|FG001|Overall Study|Protocol Violation|3|||
161379336|NCT01135459|582778078|FG000|Overall Study|Lost to Follow-up|2|||
161379337|NCT01135459|582778079|FG001|Overall Study|Lost to Follow-up|1|||
161379338|NCT01135459|582778078|FG000|Overall Study|Non-compliance to study procedures|0|||
161379339|NCT01135459|582778079|FG001|Overall Study|Non-compliance to study procedures|1|||
161379340|NCT01135459|582778078|FG000|Overall Study|Other than specified|1|||
161379341|NCT01135459|582778079|FG001|Overall Study|Other than specified|1|||
161379342|NCT01803880|582778080|FG000|Overall Study|Adverse Event|1|||
161379343|NCT01803880|582778081|FG001|Overall Study|Adverse Event|0|||
161379344|NCT01803880|582778082|FG002|Overall Study|Adverse Event|0|||
161379345|NCT01803880|582778080|FG000|Overall Study|Withdrawal by Subject|1|||
161379346|NCT01803880|582778081|FG001|Overall Study|Withdrawal by Subject|1|||
161379347|NCT01803880|582778082|FG002|Overall Study|Withdrawal by Subject|4|||
161379348|NCT01803880|582778080|FG000|Overall Study|Physician Decision|0|||
161379349|NCT01803880|582778081|FG001|Overall Study|Physician Decision|0|||
161379350|NCT01803880|582778082|FG002|Overall Study|Physician Decision|1|||
161379351|NCT01803880|582778080|FG000|Overall Study|Unable to return for follow-up visits|0|||
161379352|NCT01803880|582778081|FG001|Overall Study|Unable to return for follow-up visits|1|||
161379353|NCT01803880|582778082|FG002|Overall Study|Unable to return for follow-up visits|2|||
161379354|NCT01803880|582778080|FG000|Overall Study|Lost to Follow-up|1|||
161379355|NCT01803880|582778081|FG001|Overall Study|Lost to Follow-up|2|||
161379356|NCT01803880|582778082|FG002|Overall Study|Lost to Follow-up|3|||
161379357|NCT01803880|582778080|FG000|Overall Study|Protocol Violation|1|||
161379358|NCT01803880|582778081|FG001|Overall Study|Protocol Violation|0|||
161379359|NCT01803880|582778082|FG002|Overall Study|Protocol Violation|0|||
161379360|NCT01803880|582778080|FG000|Overall Study|Early study termination|0|||
161379361|NCT01803880|582778081|FG001|Overall Study|Early study termination|6|||
161379362|NCT01803880|582778082|FG002|Overall Study|Early study termination|5|||
161379363|NCT01803880|582778080|FG000|Overall Study|Incomplete data entry by sites|2|||
161379364|NCT01803880|582778081|FG001|Overall Study|Incomplete data entry by sites|0|||
161379365|NCT01803880|582778082|FG002|Overall Study|Incomplete data entry by sites|0|||
161379366|NCT04158375|582778086|FG000|Overall Study|Withdrawal by Subject|0|||
161379367|NCT04158375|582778087|FG001|Overall Study|Withdrawal by Subject|3|||
161379368|NCT04158375|582778088|FG002|Overall Study|Withdrawal by Subject|0|||
161379369|NCT04847843|582778089|FG000|Overall Study|Scheduling Conflicts|6|||
161379370|NCT04847843|582778090|FG001|Overall Study|Scheduling Conflicts|9|||
161379371|NCT04847843|582778089|FG000|Overall Study|Withdrawal by Subject|1|||
161379372|NCT04847843|582778090|FG001|Overall Study|Withdrawal by Subject|0|||
161379373|NCT04847843|582778089|FG000|Overall Study|Lost to Follow-up|1|||
161379374|NCT04847843|582778090|FG001|Overall Study|Lost to Follow-up|1|||
161379375|NCT04847843|582778089|FG000|Overall Study|Pregnancy|0|||
161379376|NCT04847843|582778090|FG001|Overall Study|Pregnancy|2|||
161379377|NCT04847843|582778089|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
161379378|NCT04847843|582778090|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
161379379|NCT02734004|582778091|FG000|Overall Study|Death|36|||
161379380|NCT02734004|582778092|FG001|Overall Study|Death|24|||
161379381|NCT02734004|582778093|FG002|Overall Study|Death|26|||
161379382|NCT02734004|582778094|FG003|Overall Study|Death|35|||
161379383|NCT02734004|582778095|FG004|Overall Study|Death|13|||
161379384|NCT02734004|582778096|FG005|Overall Study|Death|17|||
161379385|NCT02734004|582778097|FG006|Overall Study|Death|20|||
161379386|NCT02734004|582778091|FG000|Overall Study|Lost to Follow-up|1|||
161379387|NCT02734004|582778092|FG001|Overall Study|Lost to Follow-up|1|||
161379388|NCT02734004|582778093|FG002|Overall Study|Lost to Follow-up|0|||
161379389|NCT02734004|582778094|FG003|Overall Study|Lost to Follow-up|0|||
161379390|NCT02734004|582778095|FG004|Overall Study|Lost to Follow-up|1|||
161379391|NCT02734004|582778096|FG005|Overall Study|Lost to Follow-up|0|||
161379392|NCT02734004|582778097|FG006|Overall Study|Lost to Follow-up|0|||
161379393|NCT02734004|582778091|FG000|Overall Study|Withdrawal by Subject|3|||
161379394|NCT02734004|582778092|FG001|Overall Study|Withdrawal by Subject|1|||
161379395|NCT02734004|582778093|FG002|Overall Study|Withdrawal by Subject|1|||
161379396|NCT02734004|582778094|FG003|Overall Study|Withdrawal by Subject|1|||
161379397|NCT02734004|582778095|FG004|Overall Study|Withdrawal by Subject|3|||
161379398|NCT02734004|582778096|FG005|Overall Study|Withdrawal by Subject|0|||
161379399|NCT02734004|582778097|FG006|Overall Study|Withdrawal by Subject|2|||
161379400|NCT02734004|582778091|FG000|Overall Study|Other|0|||
161379401|NCT02734004|582778092|FG001|Overall Study|Other|8|||
161379402|NCT02734004|582778093|FG002|Overall Study|Other|7|||
161379403|NCT02734004|582778094|FG003|Overall Study|Other|4|||
161379404|NCT02734004|582778095|FG004|Overall Study|Other|34|||
161379405|NCT02734004|582778096|FG005|Overall Study|Other|14|||
161379406|NCT02734004|582778097|FG006|Overall Study|Other|10|||
161379407|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
161379408|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
161379409|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
161379410|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
161379411|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
161379412|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
161379413|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
161379414|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
161379415|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
161379416|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
161379417|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
161379418|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
161379419|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
161379420|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
161379421|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
161379422|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
161379423|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
161379424|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
161379425|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
161379426|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
161379427|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
161379428|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
161379429|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
161379430|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
161379431|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Other|6|||
161379432|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Other|0|||
161379433|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Other|0|||
161379434|NCT05615220|582778098|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
161379435|NCT05615220|582778099|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
161379436|NCT05615220|582778100|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
161379437|NCT05615220|582778098|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
161379438|NCT05615220|582778099|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
161379439|NCT05615220|582778100|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
161379440|NCT05615220|582778098|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
161379441|NCT05615220|582778099|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
161379442|NCT05615220|582778100|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
161379443|NCT05615220|582778098|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
161379444|NCT05615220|582778099|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
161379445|NCT05615220|582778100|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
161379446|NCT05615220|582778098|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
161379447|NCT05615220|582778099|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
161379448|NCT05615220|582778100|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
161379449|NCT05615220|582778098|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
161379450|NCT05615220|582778099|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
161379451|NCT05615220|582778100|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
161379452|NCT01459666|582778101|FG000|Overall Study|PI left institution|5|||
161379453|NCT01459666|582778102|FG001|Overall Study|PI left institution|4|||
161379454|NCT01061385|582778104|FG000|Overall Study|Lost to Follow-up|1|||
161379455|NCT01061385|582778105|FG001|Overall Study|Lost to Follow-up|0|||
161379456|NCT01061385|582778104|FG000|Overall Study|subject decision not related to AE|0|||
161379457|NCT01061385|582778105|FG001|Overall Study|subject decision not related to AE|1|||
161379458|NCT00533429|582778106|FG000|Overall Study|Adverse Event|3|||
161379459|NCT00533429|582778107|FG001|Overall Study|Adverse Event|1|||
161379460|NCT00533429|582778106|FG000|Overall Study|Death|1|||
161379461|NCT00533429|582778107|FG001|Overall Study|Death|0|||
161379462|NCT00533429|582778106|FG000|Overall Study|Withdrawal by Subject|2|||
161379463|NCT00533429|582778107|FG001|Overall Study|Withdrawal by Subject|0|||
161379464|NCT00533429|582778106|FG000|Overall Study|Progressive Disease|12|||
161379465|NCT00533429|582778107|FG001|Overall Study|Progressive Disease|13|||
161379466|NCT00533429|582778106|FG000|Overall Study|Symptomatic deterioration|1|||
161379467|NCT00533429|582778107|FG001|Overall Study|Symptomatic deterioration|2|||
161379468|NCT02655887|582778108|FG000|Overall Study|Lost to Follow-up|3|||
161379469|NCT02655887|582778108|FG000|Overall Study|Death|4|||
161379470|NCT02655887|582778108|FG000|Overall Study|Withdrawal by Subject|3|||
161379471|NCT02655887|582778108|FG000|Overall Study|Missed 12-month follow-up visit|4|||
161379472|NCT04245709|582778111|FG000|Overall Study|Adverse Event|13|||
161379473|NCT04245709|582778111|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
161379474|NCT02041299|582778116|FG000|Overall Study|Adverse Event|9|||
161379475|NCT02041299|582778117|FG001|Overall Study|Adverse Event|3|||
161379476|NCT02041299|582778116|FG000|Overall Study|Lost to Follow-up|4|||
161379477|NCT02041299|582778117|FG001|Overall Study|Lost to Follow-up|1|||
161379478|NCT02041299|582778116|FG000|Overall Study|Physician Decision|1|||
161379479|NCT02041299|582778117|FG001|Overall Study|Physician Decision|1|||
161379480|NCT02041299|582778116|FG000|Overall Study|Withdrawal by Subject|13|||
161379481|NCT02041299|582778117|FG001|Overall Study|Withdrawal by Subject|7|||
161379482|NCT02041299|582778116|FG000|Overall Study|Protocol Violation|11|||
161379483|NCT02041299|582778117|FG001|Overall Study|Protocol Violation|4|||
161379484|NCT02041299|582778116|FG000|Overall Study|Termination of the study|7|||
161379485|NCT02041299|582778117|FG001|Overall Study|Termination of the study|3|||
161379486|NCT02041299|582778116|FG000|Overall Study|Required bone marrow transplant|0|||
161379487|NCT02041299|582778117|FG001|Overall Study|Required bone marrow transplant|1|||
161379488|NCT02041299|582778116|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
161379489|NCT02041299|582778117|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
161379490|NCT02389465|582778118|FG000|Overall Study|Lost to Follow-up|1|||
161379491|NCT02389465|582778119|FG001|Overall Study|Lost to Follow-up|3|||
161379492|NCT02389465|582778120|FG002|Overall Study|Lost to Follow-up|3|||
161379493|NCT02389465|582778121|FG003|Overall Study|Lost to Follow-up|0|||
161379494|NCT02389465|582778118|FG000|Overall Study|Physician Decision|0|||
161379495|NCT02389465|582778119|FG001|Overall Study|Physician Decision|0|||
161379496|NCT02389465|582778120|FG002|Overall Study|Physician Decision|0|||
161379497|NCT02389465|582778121|FG003|Overall Study|Physician Decision|1|||
161379498|NCT02389465|582778118|FG000|Overall Study|Withdrawal by Subject|0|||
161379499|NCT02389465|582778119|FG001|Overall Study|Withdrawal by Subject|1|||
161379500|NCT02389465|582778120|FG002|Overall Study|Withdrawal by Subject|2|||
161379501|NCT02389465|582778121|FG003|Overall Study|Withdrawal by Subject|2|||
161379502|NCT01964378|582778123|FG000|Overall Study|Disc. due to death before first dosing|0|||
161379503|NCT01964378|582778124|FG001|Overall Study|Disc. due to death before first dosing|1|||
161379504|NCT01964378|582778123|FG000|Overall Study|Disc. due to AE before first dosing|1|||
161379505|NCT01964378|582778124|FG001|Overall Study|Disc. due to AE before first dosing|0|||
161379506|NCT01964378|582778123|FG000|Overall Study|Death|3|||
161379507|NCT01964378|582778124|FG001|Overall Study|Death|2|||
161379508|NCT01964378|582778123|FG000|Overall Study|Adverse Event|12|||
161379509|NCT01964378|582778124|FG001|Overall Study|Adverse Event|5|||
161379510|NCT01964378|582778123|FG000|Overall Study|Lack of Efficacy|0|||
161379511|NCT01964378|582778124|FG001|Overall Study|Lack of Efficacy|1|||
161379512|NCT01964378|582778123|FG000|Overall Study|Protocol Violation|0|||
161379513|NCT01964378|582778124|FG001|Overall Study|Protocol Violation|1|||
161379514|NCT01964378|582778123|FG000|Overall Study|Lost to Follow-up|0|||
161379515|NCT01964378|582778124|FG001|Overall Study|Lost to Follow-up|1|||
161379516|NCT01964378|582778123|FG000|Overall Study|Withdrawal by Subject|7|||
161379517|NCT01964378|582778124|FG001|Overall Study|Withdrawal by Subject|5|||
161379518|NCT01964378|582778123|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
161379519|NCT01964378|582778124|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
161379520|NCT01964378|582778123|FG000|Overall Study|Other|1|||
161379521|NCT01964378|582778124|FG001|Overall Study|Other|2|||
161379522|NCT04721158|582778130|FG000|Overall Study|Lost to Follow-up|4|||
161379523|NCT04721158|582778130|FG000|Overall Study|Device did not connect|1|||
161379524|NCT02382991|582778137|FG000|Overall Study|Adverse Event|1|||
161379525|NCT02382991|582778138|FG001|Overall Study|Adverse Event|2|||
161379526|NCT02382991|582778137|FG000|Overall Study|Lost to Follow-up|1|||
161379527|NCT02382991|582778138|FG001|Overall Study|Lost to Follow-up|0|||
161379528|NCT02382991|582778137|FG000|Overall Study|Withdrawal by Subject|0|||
161379529|NCT02382991|582778138|FG001|Overall Study|Withdrawal by Subject|1|||
161379530|NCT02891226|582778141|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
161379531|NCT02891226|582778142|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
161379532|NCT02891226|582778143|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
161379533|NCT02891226|582778144|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379534|NCT02891226|582778145|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379535|NCT02891226|582778146|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379536|NCT02891226|582778147|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379537|NCT02891226|582778148|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379538|NCT02891226|582778149|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379539|NCT02891226|582778150|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379540|NCT02891226|582778151|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379541|NCT02891226|582778152|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379542|NCT02891226|582778153|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379543|NCT02891226|582778154|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379544|NCT02891226|582778155|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379545|NCT02891226|582778156|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161379546|NCT02891226|582778141|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
161379547|NCT02891226|582778142|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
161379548|NCT02891226|582778143|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379549|NCT02891226|582778144|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379550|NCT02891226|582778145|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379551|NCT02891226|582778146|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379552|NCT02891226|582778147|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379553|NCT02891226|582778148|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379554|NCT02891226|582778149|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379555|NCT02891226|582778150|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379556|NCT02891226|582778151|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379557|NCT02891226|582778152|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379558|NCT02891226|582778153|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379559|NCT02891226|582778154|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379560|NCT02891226|582778155|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379561|NCT02891226|582778156|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161379562|NCT02891226|582778141|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379563|NCT02891226|582778142|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379564|NCT02891226|582778143|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379565|NCT02891226|582778144|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
161379566|NCT02891226|582778145|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379567|NCT02891226|582778146|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379568|NCT02891226|582778147|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379569|NCT02891226|582778148|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379570|NCT02891226|582778149|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379571|NCT02891226|582778150|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379572|NCT02891226|582778151|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379573|NCT02891226|582778152|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379574|NCT02891226|582778153|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379575|NCT02891226|582778154|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379576|NCT02891226|582778155|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379577|NCT02891226|582778156|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161379578|NCT02891226|582778141|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379579|NCT02891226|582778142|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379580|NCT02891226|582778143|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
161379581|NCT02891226|582778144|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379582|NCT02891226|582778145|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379583|NCT02891226|582778146|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379584|NCT02891226|582778147|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379585|NCT02891226|582778148|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379586|NCT02891226|582778149|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379587|NCT02891226|582778150|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379588|NCT02891226|582778151|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379589|NCT02891226|582778152|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379590|NCT02891226|582778153|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379591|NCT02891226|582778154|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379592|NCT02891226|582778155|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379593|NCT02891226|582778156|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161379594|NCT02891226|582778141|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379595|NCT02891226|582778142|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379596|NCT02891226|582778143|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379597|NCT02891226|582778144|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
161379598|NCT02891226|582778145|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379599|NCT02891226|582778146|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379600|NCT02891226|582778147|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379601|NCT02891226|582778148|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379602|NCT02891226|582778149|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379603|NCT02891226|582778150|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379604|NCT02891226|582778151|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379605|NCT02891226|582778152|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379606|NCT02891226|582778153|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379607|NCT02891226|582778154|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379608|NCT02891226|582778155|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379609|NCT02891226|582778156|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161379610|NCT02891226|582778141|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379611|NCT02891226|582778142|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379612|NCT02891226|582778143|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379613|NCT02891226|582778144|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
161379614|NCT02891226|582778145|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379615|NCT02891226|582778146|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379616|NCT02891226|582778147|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379617|NCT02891226|582778148|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379618|NCT02891226|582778149|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379619|NCT02891226|582778150|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379620|NCT02891226|582778151|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379621|NCT02891226|582778152|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379622|NCT02891226|582778153|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379623|NCT02891226|582778154|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379624|NCT02891226|582778155|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379625|NCT02891226|582778156|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161379626|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379627|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379628|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379629|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379630|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379631|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379632|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
161379633|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
161379634|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
161379635|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
161379636|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379637|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379638|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379639|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379640|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379641|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161379642|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379643|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379644|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379645|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379646|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379647|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
161379648|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379649|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379650|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379651|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
161379652|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379653|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379654|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379655|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379656|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379657|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161379658|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379659|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379660|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379661|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379662|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379663|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379664|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
161379665|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
161379666|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
161379667|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
161379668|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379669|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379670|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379671|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379672|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379673|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161379674|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379675|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379676|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379677|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379678|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
161379679|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379680|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379681|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379682|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379683|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379684|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379685|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379686|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379687|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379688|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379689|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161379690|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379691|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379692|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379693|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379694|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161435261|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Not treated|0|||
161379695|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379696|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
161379697|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379698|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379699|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379700|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379701|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379702|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379703|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379704|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379705|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161379706|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379707|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379708|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379709|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379710|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379711|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379712|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379713|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
161379714|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
161379715|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
161379716|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379717|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379718|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379719|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379720|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379721|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161379722|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379723|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379724|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379725|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379726|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379727|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379728|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379729|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
161379730|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379731|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379732|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379733|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379734|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379735|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379736|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379737|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161379738|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379739|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379740|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379741|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379742|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379743|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379744|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379745|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379746|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
161379747|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379748|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379749|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379750|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379751|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379752|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379753|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161379754|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379755|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379756|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379757|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379758|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379759|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379760|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379761|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379762|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379763|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
161379764|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379765|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379766|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379767|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379768|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379769|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161379770|NCT02891226|582778141|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379771|NCT02891226|582778142|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379772|NCT02891226|582778143|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379773|NCT02891226|582778144|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379774|NCT02891226|582778145|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379775|NCT02891226|582778146|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379776|NCT02891226|582778147|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379777|NCT02891226|582778148|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379778|NCT02891226|582778149|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379779|NCT02891226|582778150|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
161379780|NCT02891226|582778151|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379781|NCT02891226|582778152|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379782|NCT02891226|582778153|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379783|NCT02891226|582778154|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379784|NCT02891226|582778155|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379785|NCT02891226|582778156|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161379786|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379787|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379788|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379789|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379790|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379791|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379792|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379793|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379794|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379795|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379796|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
161379797|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379798|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379799|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379800|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379801|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161379802|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379803|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379804|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379805|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379806|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379807|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379808|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379809|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379810|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379811|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379812|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
161379813|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379814|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379815|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379816|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379817|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161379818|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379819|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379820|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379821|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379822|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379823|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379824|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379825|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379826|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379827|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379828|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
161379829|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379830|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379831|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379832|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379833|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161379834|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379835|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379836|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379837|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379838|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379839|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379840|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379841|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379842|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379843|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379844|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
161379845|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379846|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379847|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379848|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379849|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161379850|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379851|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379852|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379853|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379854|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379855|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379856|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379857|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379858|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379859|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379860|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
161379861|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379862|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379863|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379864|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379865|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161379866|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379867|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379868|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379869|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379870|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379871|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379872|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379873|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379874|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379875|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379876|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
161379877|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379878|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379879|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379880|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379881|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161379882|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379883|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379884|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379885|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379886|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379887|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379888|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379889|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379890|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379891|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379892|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
161379893|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379894|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379895|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379896|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379897|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161379898|NCT02891226|582778141|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379899|NCT02891226|582778142|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379900|NCT02891226|582778143|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379901|NCT02891226|582778144|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379902|NCT02891226|582778145|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379903|NCT02891226|582778146|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379904|NCT02891226|582778147|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379905|NCT02891226|582778148|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379906|NCT02891226|582778149|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379907|NCT02891226|582778150|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379908|NCT02891226|582778151|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
161379909|NCT02891226|582778152|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379910|NCT02891226|582778153|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379911|NCT02891226|582778154|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379912|NCT02891226|582778155|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379913|NCT02891226|582778156|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161379914|NCT02891226|582778141|FG000|Follow-up Period|Withdrawal by Subject|0|||
161379915|NCT02891226|582778142|FG001|Follow-up Period|Withdrawal by Subject|0|||
161379916|NCT02891226|582778143|FG002|Follow-up Period|Withdrawal by Subject|0|||
161379917|NCT02891226|582778144|FG003|Follow-up Period|Withdrawal by Subject|0|||
161379918|NCT02891226|582778145|FG004|Follow-up Period|Withdrawal by Subject|0|||
161379919|NCT02891226|582778146|FG005|Follow-up Period|Withdrawal by Subject|0|||
161379920|NCT02891226|582778147|FG006|Follow-up Period|Withdrawal by Subject|0|||
161379921|NCT02891226|582778148|FG007|Follow-up Period|Withdrawal by Subject|0|||
161379922|NCT02891226|582778149|FG008|Follow-up Period|Withdrawal by Subject|0|||
161379923|NCT02891226|582778150|FG009|Follow-up Period|Withdrawal by Subject|0|||
161379924|NCT02891226|582778151|FG010|Follow-up Period|Withdrawal by Subject|0|||
161379925|NCT02891226|582778152|FG011|Follow-up Period|Withdrawal by Subject|1|||
161379926|NCT02891226|582778153|FG012|Follow-up Period|Withdrawal by Subject|0|||
161379927|NCT02891226|582778154|FG013|Follow-up Period|Withdrawal by Subject|0|||
161379928|NCT02891226|582778155|FG014|Follow-up Period|Withdrawal by Subject|1|||
161379929|NCT02891226|582778156|FG015|Follow-up Period|Withdrawal by Subject|1|||
161379930|NCT01445847|582778159|FG000|Overall Study|Protocol Violation|13|||
161379931|NCT01445847|582778160|FG001|Overall Study|Protocol Violation|14|||
161379932|NCT01445847|582778159|FG000|Overall Study|Missed Data|1|||
161379933|NCT01445847|582778160|FG001|Overall Study|Missed Data|0|||
161379934|NCT03654274|582778163|FG000|Overall Study|Adverse Event|19|||
161379935|NCT03654274|582778164|FG001|Overall Study|Adverse Event|23|||
161379936|NCT03654274|582778165|FG002|Overall Study|Adverse Event|24|||
161379937|NCT03654274|582778163|FG000|Overall Study|Protocol Deviation|0|||
161379938|NCT03654274|582778164|FG001|Overall Study|Protocol Deviation|2|||
161379939|NCT03654274|582778165|FG002|Overall Study|Protocol Deviation|0|||
161379940|NCT03654274|582778163|FG000|Overall Study|Lost to Follow-up|8|||
161379941|NCT03654274|582778164|FG001|Overall Study|Lost to Follow-up|6|||
161379942|NCT03654274|582778165|FG002|Overall Study|Lost to Follow-up|5|||
161379943|NCT03654274|582778163|FG000|Overall Study|Withdrawal by Subject|46|||
161379944|NCT03654274|582778164|FG001|Overall Study|Withdrawal by Subject|25|||
161379945|NCT03654274|582778165|FG002|Overall Study|Withdrawal by Subject|33|||
161379946|NCT03654274|582778163|FG000|Overall Study|Lack of Efficacy|4|||
161379947|NCT03654274|582778164|FG001|Overall Study|Lack of Efficacy|5|||
161379948|NCT03654274|582778165|FG002|Overall Study|Lack of Efficacy|7|||
161379949|NCT03654274|582778163|FG000|Overall Study|Pregnancy|2|||
161379950|NCT03654274|582778164|FG001|Overall Study|Pregnancy|2|||
161379951|NCT03654274|582778165|FG002|Overall Study|Pregnancy|1|||
161379952|NCT03654274|582778163|FG000|Overall Study|Other|27|||
161379953|NCT03654274|582778164|FG001|Overall Study|Other|29|||
161379954|NCT03654274|582778165|FG002|Overall Study|Other|32|||
161379955|NCT03654274|582778163|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
161379956|NCT03654274|582778164|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
161379957|NCT03654274|582778165|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
161379958|NCT01102491|582778168|FG000|Overall Study|Protocol Violation|11|||
161379959|NCT01102491|582778169|FG001|Overall Study|Protocol Violation|12|||
161379960|NCT01265992|582778170|FG000|Overall Study|Lost to Follow-up|1|||
161379961|NCT01265992|582778170|FG000|Overall Study|Withdrawal by Subject|1|||
161379962|NCT01265992|582778170|FG000|Overall Study|Adverse Event|1|||
161379963|NCT01265992|582778170|FG000|Overall Study|Administrative reasons|2|||
161379964|NCT01265992|582778170|FG000|Overall Study|Stopped treatment|3|||
161379965|NCT01265992|582778170|FG000|Overall Study|Did not receive treatment|1|||
161379966|NCT02454530|582778171|FG000|Overall Study|Other|8|||
161379967|NCT02454530|582778172|FG001|Overall Study|Other|13|||
161379968|NCT02454530|582778171|FG000|Overall Study|Missing information|56|||
161379969|NCT02454530|582778172|FG001|Overall Study|Missing information|69|||
161379970|NCT02454530|582778171|FG000|Overall Study|Death|2|||
161379971|NCT02454530|582778172|FG001|Overall Study|Death|41|||
161379972|NCT02454530|582778171|FG000|Overall Study|Lost to Follow-up|4|||
161379973|NCT02454530|582778172|FG001|Overall Study|Lost to Follow-up|4|||
161379974|NCT02137070|582778173|FG000|Overall Study|Adverse Event|12|||
161379975|NCT02137070|582778174|FG001|Overall Study|Adverse Event|3|||
161379976|NCT02137070|582778173|FG000|Overall Study|Death|2|||
161379977|NCT02137070|582778174|FG001|Overall Study|Death|0|||
161379978|NCT02137070|582778173|FG000|Overall Study|Lost to Follow-up|24|||
161379979|NCT02137070|582778174|FG001|Overall Study|Lost to Follow-up|9|||
161379980|NCT02137070|582778173|FG000|Overall Study|Physician Decision|0|||
161379981|NCT02137070|582778174|FG001|Overall Study|Physician Decision|1|||
161379982|NCT02137070|582778173|FG000|Overall Study|Protocol Violation|18|||
161379983|NCT02137070|582778174|FG001|Overall Study|Protocol Violation|4|||
161379984|NCT02137070|582778173|FG000|Overall Study|Withdrawal by Subject|18|||
161379985|NCT02137070|582778174|FG001|Overall Study|Withdrawal by Subject|1|||
161379986|NCT02151786|582778175|FG000|Overall Study|Unavailability of Case Report Form|26|||
161379987|NCT02151786|582778175|FG000|Overall Study|Outside the Contract Period|1|||
161379988|NCT02151786|582778175|FG000|Overall Study|Randomized, not Treated|1|||
161379989|NCT02151786|582778175|FG000|Overall Study|Unavailability of Information|8|||
161379990|NCT05223673|582778176|FG000|Overall Study|Protocol Violation|1|||
161379991|NCT05223673|582778176|FG000|Overall Study|Study termination|6|||
161379992|NCT02112656|582778177|FG000|Overall Study|Death|78|||
161379993|NCT02112656|582778178|FG001|Overall Study|Death|82|||
161379994|NCT02112656|582778177|FG000|Overall Study|Withdrawal by Subject|9|||
161379995|NCT02112656|582778178|FG001|Overall Study|Withdrawal by Subject|11|||
161379996|NCT02112656|582778177|FG000|Overall Study|Lost to Follow-up|2|||
161379997|NCT02112656|582778178|FG001|Overall Study|Lost to Follow-up|4|||
161379998|NCT02112656|582778177|FG000|Overall Study|Noncompliance|1|||
161379999|NCT02112656|582778178|FG001|Overall Study|Noncompliance|2|||
161435262|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Not treated|2|||
161435263|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Not treated|0|||
161435264|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Not treated|0|||
161435265|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
161435266|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
161435267|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
161435268|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
161435269|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
161435270|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
161435271|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
161435272|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
161435273|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
161435274|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
161435275|NCT05966142|582987972|FG000|Overall Study|Death|3|||
161435276|NCT05966142|582987973|FG001|Overall Study|Death|3|||
161435277|NCT05966142|582987972|FG000|Overall Study|Lost to Follow-up|55|||
161435278|NCT05966142|582987973|FG001|Overall Study|Lost to Follow-up|52|||
161435279|NCT05966142|582987972|FG000|Overall Study|Physician Decision|1|||
161435280|NCT05966142|582987973|FG001|Overall Study|Physician Decision|0|||
161435281|NCT05966142|582987972|FG000|Overall Study|Withdrawal by Subject|9|||
161435282|NCT05966142|582987973|FG001|Overall Study|Withdrawal by Subject|8|||
161435283|NCT05966142|582987972|FG000|Overall Study|Duplicate Enrollment|1|||
161435284|NCT05966142|582987973|FG001|Overall Study|Duplicate Enrollment|0|||
161435285|NCT05966142|582987972|FG000|Overall Study|Study Logistical Reason|1|||
161435286|NCT05966142|582987973|FG001|Overall Study|Study Logistical Reason|0|||
161435287|NCT05966142|582987972|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
161435288|NCT05966142|582987973|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
161435289|NCT00894803|582987974|FG000|Overall Study|Death|20|||
161435290|NCT00894803|582987975|FG001|Overall Study|Death|4|||
161435291|NCT00894803|582987974|FG000|Overall Study|Lost to Follow-up|0|||
161435292|NCT00894803|582987975|FG001|Overall Study|Lost to Follow-up|1|||
161435293|NCT01710345|582987976|FG000|Overall Study|Adverse Event|0|||
161380000|NCT03718325|582779248|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
161380001|NCT03718325|582779249|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
161380002|NCT03718325|582779250|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
161380003|NCT03718325|582779248|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
161380004|NCT03718325|582779249|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
161380005|NCT03718325|582779250|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
161380006|NCT01147965|582779256|FG000|Overall Study|Progressive Disease|3|||
161380007|NCT01147965|582779257|FG001|Overall Study|Progressive Disease|3|||
161380008|NCT01147965|582779258|FG002|Overall Study|Progressive Disease|5|||
161380009|NCT01147965|582779259|FG003|Overall Study|Progressive Disease|9|||
161380010|NCT01147965|582779260|FG004|Overall Study|Progressive Disease|5|||
161380011|NCT01147965|582779261|FG005|Overall Study|Progressive Disease|5|||
161380012|NCT01147965|582779256|FG000|Overall Study|Death|0|||
161380013|NCT01147965|582779257|FG001|Overall Study|Death|0|||
161380014|NCT01147965|582779258|FG002|Overall Study|Death|1|||
161380015|NCT01147965|582779259|FG003|Overall Study|Death|1|||
161380016|NCT01147965|582779260|FG004|Overall Study|Death|0|||
161380017|NCT01147965|582779261|FG005|Overall Study|Death|2|||
161380018|NCT01147965|582779256|FG000|Overall Study|Withdrawal by Subject|0|||
161380019|NCT01147965|582779257|FG001|Overall Study|Withdrawal by Subject|0|||
161380020|NCT01147965|582779258|FG002|Overall Study|Withdrawal by Subject|1|||
161380021|NCT01147965|582779259|FG003|Overall Study|Withdrawal by Subject|1|||
161380022|NCT01147965|582779260|FG004|Overall Study|Withdrawal by Subject|0|||
161380023|NCT01147965|582779261|FG005|Overall Study|Withdrawal by Subject|0|||
161380024|NCT01147965|582779256|FG000|Overall Study|Administration Of Alternative Therapy|0|||
161380025|NCT01147965|582779257|FG001|Overall Study|Administration Of Alternative Therapy|0|||
161380026|NCT01147965|582779258|FG002|Overall Study|Administration Of Alternative Therapy|0|||
161380027|NCT01147965|582779259|FG003|Overall Study|Administration Of Alternative Therapy|0|||
161380028|NCT01147965|582779260|FG004|Overall Study|Administration Of Alternative Therapy|0|||
161380029|NCT01147965|582779261|FG005|Overall Study|Administration Of Alternative Therapy|1|||
161380030|NCT01147965|582779256|FG000|Overall Study|Other|0|||
161380031|NCT01147965|582779257|FG001|Overall Study|Other|0|||
161380032|NCT01147965|582779258|FG002|Overall Study|Other|0|||
161380033|NCT01147965|582779259|FG003|Overall Study|Other|3|||
161380034|NCT01147965|582779260|FG004|Overall Study|Other|1|||
161380035|NCT01147965|582779261|FG005|Overall Study|Other|0|||
161380036|NCT00620373|582779262|FG000|Overall Study|Unverified cancer status|33|||
161380037|NCT01465386|582779267|FG000|Overall Study|Lack of Efficacy|3|||
161380038|NCT01465386|582779267|FG000|Overall Study|Adverse Event|1|||
161380039|NCT01279044|582779268|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
161380040|NCT01279044|582779269|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
161380041|NCT01279044|582779270|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
161380042|NCT01279044|582779268|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
161380043|NCT01279044|582779269|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
161380044|NCT01279044|582779270|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
161380045|NCT01279044|582779268|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
161380046|NCT01279044|582779269|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
161380047|NCT01279044|582779270|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
161380048|NCT01408277|582779273|FG000|Overall Study|Adverse Event|3|||
161380049|NCT01408277|582779274|FG001|Overall Study|Adverse Event|4|||
161380050|NCT01408277|582779273|FG000|Overall Study|Lost to Follow-up|1|||
161380051|NCT01408277|582779274|FG001|Overall Study|Lost to Follow-up|0|||
161380052|NCT01408277|582779273|FG000|Overall Study|Withdrawal by Subject|2|||
161380053|NCT01408277|582779274|FG001|Overall Study|Withdrawal by Subject|0|||
161380054|NCT01408277|582779273|FG000|Overall Study|Protocol Violation|2|||
161380055|NCT01408277|582779274|FG001|Overall Study|Protocol Violation|0|||
161380056|NCT02630693|582779281|FG000|Overall Study|No receive treatment|0|||
161380057|NCT02630693|582779282|FG001|Overall Study|No receive treatment|1|||
161380058|NCT02763059|582779283|FG000|Overall Study|Lost to Follow-up|4|||
161380059|NCT02763059|582779284|FG001|Overall Study|Lost to Follow-up|1|||
161380060|NCT02763059|582779285|FG002|Overall Study|Lost to Follow-up|6|||
161380061|NCT02763059|582779283|FG000|Overall Study|Withdrawal by Subject|1|||
161380062|NCT02763059|582779284|FG001|Overall Study|Withdrawal by Subject|0|||
161380063|NCT02763059|582779285|FG002|Overall Study|Withdrawal by Subject|3|||
161380064|NCT00175916|582779290|FG000|Overall Study|Death|19|||
161380065|NCT00175916|582779290|FG000|Overall Study|Adverse Event|81|||
161380066|NCT00175916|582779290|FG000|Overall Study|Lack of Efficacy|354|||
161380067|NCT00175916|582779290|FG000|Overall Study|Lost to Follow-up|17|||
161380068|NCT00175916|582779290|FG000|Overall Study|Subject Choice|98|||
161380069|NCT00175916|582779290|FG000|Overall Study|Lack of compliance|8|||
161380070|NCT00175916|582779290|FG000|Overall Study|Patient cannot record seizures|1|||
161380071|NCT00175916|582779290|FG000|Overall Study|Sponsor decision|17|||
161380072|NCT00175916|582779290|FG000|Overall Study|Vigabatrin intake|1|||
161380073|NCT00175916|582779290|FG000|Overall Study|Suicidal behaviour|1|||
161380074|NCT00175916|582779290|FG000|Overall Study|Withdrawal by Subject|1|||
161380075|NCT00175916|582779290|FG000|Overall Study|Seizure - free|4|||
161380076|NCT00175916|582779290|FG000|Overall Study|Administrative reason|1|||
161380077|NCT00175916|582779290|FG000|Overall Study|Pregnancy|1|||
161380078|NCT00175916|582779290|FG000|Overall Study|Patient's request|2|||
161380079|NCT00175916|582779290|FG000|Overall Study|Treating physiciant's choice|1|||
161380080|NCT00175916|582779290|FG000|Overall Study|Moved overseas|1|||
161380081|NCT00175916|582779290|FG000|Overall Study|Loss of job and economic burden|1|||
161380082|NCT00175916|582779290|FG000|Overall Study|Site was closed|9|||
161380083|NCT00175916|582779290|FG000|Overall Study|Patient went to prison|1|||
161380084|NCT03230318|582779294|FG000|Overall Study|Radiographic disease progression|72|||
161380085|NCT03230318|582779295|FG001|Overall Study|Radiographic disease progression|19|||
161380086|NCT03230318|582779294|FG000|Overall Study|Clinical progression|17|||
161380087|NCT03230318|582779295|FG001|Overall Study|Clinical progression|7|||
161380088|NCT03230318|582779294|FG000|Overall Study|Adverse Event|5|||
161380089|NCT03230318|582779295|FG001|Overall Study|Adverse Event|3|||
161380090|NCT03230318|582779294|FG000|Overall Study|Physician Decision|2|||
161380091|NCT03230318|582779295|FG001|Overall Study|Physician Decision|3|||
161380092|NCT03230318|582779294|FG000|Overall Study|Death|3|||
161380093|NCT03230318|582779295|FG001|Overall Study|Death|2|||
161380094|NCT03230318|582779294|FG000|Overall Study|Lost to Follow-up|1|||
161380095|NCT03230318|582779295|FG001|Overall Study|Lost to Follow-up|0|||
161380096|NCT03230318|582779294|FG000|Overall Study|Withdrawal by Subject|1|||
161380097|NCT03230318|582779295|FG001|Overall Study|Withdrawal by Subject|3|||
161380098|NCT03230318|582779294|FG000|Overall Study|Other|3|||
161380099|NCT03230318|582779295|FG001|Overall Study|Other|7|||
161380100|NCT01057693|582779297|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
161380101|NCT01057693|582779298|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
161380102|NCT01057693|582779299|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
161380103|NCT01057693|582779297|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
161380104|NCT01057693|582779298|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
161380105|NCT01057693|582779299|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
161380106|NCT01057693|582779297|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
161380107|NCT01057693|582779298|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
161380108|NCT01057693|582779299|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
161380109|NCT01057693|582779297|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
161380110|NCT01057693|582779298|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
161380111|NCT01057693|582779299|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
161380112|NCT01057693|582779297|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
161380113|NCT01057693|582779298|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
161380114|NCT01057693|582779299|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
161380115|NCT01057693|582779297|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
161380116|NCT01057693|582779298|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
161380117|NCT01057693|582779299|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
161380118|NCT01057693|582779297|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
161380119|NCT01057693|582779298|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
161380120|NCT01057693|582779299|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
161380121|NCT01057693|582779297|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
161380122|NCT01057693|582779298|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
161380123|NCT01057693|582779299|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
161380124|NCT01057693|582779297|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
161380125|NCT01057693|582779298|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
161380126|NCT01057693|582779299|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
161380127|NCT01057693|582779297|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
161380128|NCT01057693|582779298|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
161380129|NCT01057693|582779299|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
161380130|NCT01057693|582779297|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
161380131|NCT01057693|582779298|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
161380132|NCT01057693|582779299|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
161380133|NCT01057693|582779297|FG000|Between Single-Blind and Double-Blind|Other|6|||
161380134|NCT01057693|582779298|FG001|Between Single-Blind and Double-Blind|Other|0|||
161380135|NCT01057693|582779299|FG002|Between Single-Blind and Double-Blind|Other|0|||
161380136|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
161380137|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
161380138|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
161380139|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
161380140|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
161380141|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
161380142|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
161380143|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
161435294|NCT01710345|582987977|FG001|Overall Study|Adverse Event|2|||
161380144|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
161380145|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
161380146|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
161380147|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
161380148|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
161380149|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
161380150|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
161380151|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
161380152|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
161380153|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
161380154|NCT01057693|582779297|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
161380155|NCT01057693|582779298|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
161380156|NCT01057693|582779299|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
161380157|NCT02959463|582779300|FG000|Overall Study|Adverse Event|1|||
161380158|NCT02959463|582779301|FG001|Overall Study|Adverse Event|1|||
161380159|NCT02959463|582779300|FG000|Overall Study|Death|1|||
161380160|NCT02959463|582779301|FG001|Overall Study|Death|0|||
161380161|NCT02959463|582779300|FG000|Overall Study|Withdrawal by Subject|1|||
161380162|NCT02959463|582779301|FG001|Overall Study|Withdrawal by Subject|0|||
161380163|NCT02413996|582779302|FG000|Overall Study|not comfortable with the intervention|9|||
161380164|NCT02413996|582779303|FG001|Overall Study|not comfortable with the intervention|2|||
161380165|NCT00709319|582779304|FG000|Overall Study|Death|4|||
161380166|NCT00709319|582779304|FG000|Overall Study|Withdrawal by Subject|2|||
161380167|NCT00090779|582779305|FG000|Step 1|Withdrawal by Subject|4|||
161380168|NCT00090779|582779306|FG001|Step 1|Withdrawal by Subject|2|||
161380169|NCT00090779|582779305|FG000|Step 1|Lost to Follow-up|3|||
161380170|NCT00090779|582779306|FG001|Step 1|Lost to Follow-up|2|||
161380171|NCT00090779|582779305|FG000|Step 1|Death|0|||
161380172|NCT00090779|582779306|FG001|Step 1|Death|2|||
161380173|NCT00090779|582779305|FG000|Step 1|Physician Decision|1|||
161380174|NCT00090779|582779306|FG001|Step 1|Physician Decision|0|||
161380175|NCT00090779|582779305|FG000|Step 1|Pregnancy|1|||
161380176|NCT00090779|582779306|FG001|Step 1|Pregnancy|0|||
161380177|NCT00090779|582779305|FG000|Step 1|Non-compliance to study requirements|0|||
161380178|NCT00090779|582779306|FG001|Step 1|Non-compliance to study requirements|1|||
161380179|NCT00090779|582779305|FG000|Step 1|Subject relocated|2|||
161380180|NCT00090779|582779306|FG001|Step 1|Subject relocated|8|||
161380181|NCT00090779|582779305|FG000|Step 2|Off study per study closure|6|||
161380182|NCT00090779|582779306|FG001|Step 2|Off study per study closure|16|||
161380183|NCT00090779|582779305|FG000|Step 2|Subject relocated|0|||
161380184|NCT00090779|582779306|FG001|Step 2|Subject relocated|1|||
161380185|NCT00090779|582779305|FG000|Step 2|Non-compliance to study requirements|0|||
161380186|NCT00090779|582779306|FG001|Step 2|Non-compliance to study requirements|1|||
161380187|NCT00090779|582779305|FG000|Step 3|Initiation of ART and off extended study|3|||
161380188|NCT00090779|582779306|FG001|Step 3|Initiation of ART and off extended study|2|||
161380189|NCT00090779|582779305|FG000|Step 3|Off extended study due to study closure|4|||
161380190|NCT00090779|582779306|FG001|Step 3|Off extended study due to study closure|3|||
161380191|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
161380192|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
161380193|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
161380194|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
161380195|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
161380196|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
161380197|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
161380198|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
161380199|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
161380200|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
161380201|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
161380202|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
161380203|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
161380204|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
161380205|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
161380206|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
161380207|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
161380208|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
161380209|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
161380210|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
161380211|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
161380212|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
161380213|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
161380214|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
161380215|NCT01672879|582779309|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
161380216|NCT01672879|582779310|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
161380217|NCT01672879|582779311|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
161380218|NCT01672879|582779309|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
161380219|NCT01672879|582779310|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
161380220|NCT01672879|582779311|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
161380221|NCT01672879|582779309|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
161380222|NCT01672879|582779310|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
161380223|NCT01672879|582779311|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
161380224|NCT01672879|582779309|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
161380225|NCT01672879|582779310|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
161380226|NCT01672879|582779311|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
161380227|NCT01672879|582779309|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
161380228|NCT01672879|582779310|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
161380229|NCT01672879|582779311|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
161380230|NCT03951766|582779320|FG000|Treatment Phase|Lost to Follow-up|1|||
161380231|NCT03951766|582779320|FG000|Follow-up Phase|Lost to Follow-up|10|||
161380232|NCT00041470|582779321|FG000|Overall Study|Loss of Funding|38|||
161380233|NCT02379052|582779334|FG000|Overall Study|Protocol Violation|0|||
161380234|NCT02379052|582779335|FG001|Overall Study|Protocol Violation|1|||
161380235|NCT02379052|582779334|FG000|Overall Study|Adverse Event|0|||
161380236|NCT02379052|582779335|FG001|Overall Study|Adverse Event|1|||
161380237|NCT02379052|582779334|FG000|Overall Study|Physician Decision|1|||
161380238|NCT02379052|582779335|FG001|Overall Study|Physician Decision|1|||
161380239|NCT02379052|582779334|FG000|Overall Study|Withdrawal by Subject|2|||
161380240|NCT02379052|582779335|FG001|Overall Study|Withdrawal by Subject|0|||
161380241|NCT02379052|582779334|FG000|Overall Study|Lost to Follow-up|2|||
161380242|NCT02379052|582779335|FG001|Overall Study|Lost to Follow-up|1|||
161380243|NCT02379052|582779334|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
161380244|NCT02379052|582779335|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
161380245|NCT02379052|582779334|FG000|Overall Study|Subject was Incarcerated|0|||
161380246|NCT02379052|582779335|FG001|Overall Study|Subject was Incarcerated|1|||
161380247|NCT02343302|582779336|FG000|Overall Study|Physician Decision|1|||
161380248|NCT02343302|582779337|FG001|Overall Study|Physician Decision|1|||
161380249|NCT00886769|582779343|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161380250|NCT00886769|582779344|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
161380251|NCT03328832|582779345|FG000|Overall Study|Lost to Follow-up|0|||
161380252|NCT03328832|582779346|FG001|Overall Study|Lost to Follow-up|1|||
161380253|NCT04872569|582779347|FG000|Overall Study|Withdrawal by Subject|2|||
161380254|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
161380255|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
161380256|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
161380257|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
161380258|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
161380259|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
161380260|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
161380261|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
161380262|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
161380263|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
161380264|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
161380265|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
161380266|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
161380267|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
161380268|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
161380269|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161380270|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
161380271|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161380272|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161380273|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161380274|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
161380275|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
161380276|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
161380277|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
161380278|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
161380279|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161380280|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
161380281|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161380282|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161380283|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161380284|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
161380285|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161380286|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161380287|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161380288|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161380289|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
161380290|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161380291|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161380292|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161380293|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161380294|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
161380295|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161380296|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161380297|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161380298|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161380299|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161380300|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
161380301|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161380302|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161380303|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161380304|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
161380305|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161380306|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161380307|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161380308|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161380309|NCT04951622|582779348|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161380310|NCT04951622|582779349|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
161380311|NCT04951622|582779350|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161380312|NCT04951622|582779351|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161380313|NCT04951622|582779352|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161380314|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
161380315|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
161380316|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
161380317|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
161380318|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
161380319|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
161380320|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
161380321|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
161380322|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
161380323|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
161380324|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
161380325|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
161380326|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
161380327|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
161380328|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
161380329|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
161380330|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
161380331|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
161380332|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
161380333|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
161380334|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161380335|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161380336|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
161380337|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161380338|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161380339|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
161380340|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
161380341|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
161380342|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
161380343|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
161380344|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
161380345|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
161380346|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
161380347|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
161380348|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
161380349|NCT04951622|582779348|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161380350|NCT04951622|582779349|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161380351|NCT04951622|582779350|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161380352|NCT04951622|582779351|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161380353|NCT04951622|582779352|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
161380354|NCT04570384|582779355|FG000|Overall Study|Adverse Event|2|||
161380355|NCT04570384|582779356|FG001|Overall Study|Adverse Event|1|||
161380356|NCT04570384|582779355|FG000|Overall Study|Death|2|||
161380357|NCT04570384|582779356|FG001|Overall Study|Death|5|||
161380358|NCT04570384|582779355|FG000|Overall Study|Lost to Follow-up|1|||
161380359|NCT04570384|582779356|FG001|Overall Study|Lost to Follow-up|0|||
161380360|NCT04570384|582779355|FG000|Overall Study|Other|1|||
161380361|NCT04570384|582779356|FG001|Overall Study|Other|0|||
161380362|NCT04570384|582779355|FG000|Overall Study|Protocol Violation|0|||
161380363|NCT04570384|582779356|FG001|Overall Study|Protocol Violation|1|||
161380364|NCT04570384|582779355|FG000|Overall Study|Sponsor Decision|1|||
161380365|NCT04570384|582779356|FG001|Overall Study|Sponsor Decision|0|||
161380366|NCT04570384|582779355|FG000|Overall Study|Withdrawal by Subject|4|||
161380367|NCT04570384|582779356|FG001|Overall Study|Withdrawal by Subject|2|||
161380368|NCT03265145|582779357|FG000|Overall Study|Protocol Violation|2|||
161380369|NCT03265145|582779358|FG001|Overall Study|Protocol Violation|0|||
161380370|NCT03265145|582779357|FG000|Overall Study|Adverse Event|1|||
161380371|NCT03265145|582779358|FG001|Overall Study|Adverse Event|0|||
161380372|NCT03265145|582779357|FG000|Overall Study|Withdrawal by Subject|23|||
161380373|NCT03265145|582779358|FG001|Overall Study|Withdrawal by Subject|19|||
161380374|NCT03265145|582779357|FG000|Overall Study|Death|12|||
161380375|NCT03265145|582779358|FG001|Overall Study|Death|12|||
161380376|NCT03265145|582779357|FG000|Overall Study|Lost to Follow-up|13|||
161380377|NCT03265145|582779358|FG001|Overall Study|Lost to Follow-up|9|||
161380378|NCT03265145|582779357|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
161380379|NCT03265145|582779358|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
161380380|NCT03265145|582779357|FG000|Overall Study|Switched back to previous medication|1|||
161380381|NCT03265145|582779358|FG001|Overall Study|Switched back to previous medication|0|||
161380382|NCT03265145|582779357|FG000|Overall Study|Did not want to take medication|1|||
161380383|NCT03265145|582779358|FG001|Overall Study|Did not want to take medication|0|||
161380384|NCT03265145|582779357|FG000|Overall Study|Subject could not afford medication|0|||
161380385|NCT03265145|582779358|FG001|Overall Study|Subject could not afford medication|1|||
161380386|NCT03265145|582779357|FG000|Overall Study|Site closed|2|||
161380387|NCT03265145|582779358|FG001|Overall Study|Site closed|3|||
161380388|NCT03265145|582779357|FG000|Overall Study|Incorrectly randomized|16|||
161380389|NCT03265145|582779358|FG001|Overall Study|Incorrectly randomized|6|||
161380390|NCT03265145|582779357|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
161380391|NCT03265145|582779358|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
161380392|NCT03265145|582779357|FG000|Overall Study|Physician Decision|0|||
161380393|NCT03265145|582779358|FG001|Overall Study|Physician Decision|3|||
161380394|NCT03265145|582779357|FG000|Overall Study|Subject transferred to another facility|0|||
161380395|NCT03265145|582779358|FG001|Overall Study|Subject transferred to another facility|1|||
161380396|NCT03941483|582779359|FG000|Overall Study|Miscellaneous|2|||
161380397|NCT03941483|582779360|FG001|Overall Study|Miscellaneous|3|||
161380398|NCT03941483|582779361|FG002|Overall Study|Miscellaneous|0|||
161380399|NCT03941483|582779359|FG000|Overall Study|Study Terminated by Sponsor|1|||
161380400|NCT03941483|582779360|FG001|Overall Study|Study Terminated by Sponsor|0|||
161380401|NCT03941483|582779361|FG002|Overall Study|Study Terminated by Sponsor|0|||
161380402|NCT03941483|582779359|FG000|Overall Study|Withdrawal by Subject|1|||
161380403|NCT03941483|582779360|FG001|Overall Study|Withdrawal by Subject|4|||
161380404|NCT03941483|582779361|FG002|Overall Study|Withdrawal by Subject|1|||
161380405|NCT03941483|582779359|FG000|Overall Study|Lost to Follow-up|2|||
161380406|NCT03941483|582779360|FG001|Overall Study|Lost to Follow-up|1|||
161380407|NCT03941483|582779361|FG002|Overall Study|Lost to Follow-up|8|||
161380408|NCT03941483|582779359|FG000|Overall Study|Death|3|||
161380409|NCT03941483|582779360|FG001|Overall Study|Death|2|||
161380410|NCT03941483|582779361|FG002|Overall Study|Death|6|||
161380411|NCT02685826|582779366|FG000|Overall Study|Adverse Event|2|||
161380412|NCT02685826|582779367|FG001|Overall Study|Adverse Event|0|||
161380413|NCT02685826|582779368|FG002|Overall Study|Adverse Event|1|||
161380414|NCT02685826|582779366|FG000|Overall Study|Progressive Disease|2|||
161380415|NCT02685826|582779367|FG001|Overall Study|Progressive Disease|1|||
161380416|NCT02685826|582779368|FG002|Overall Study|Progressive Disease|0|||
161380417|NCT02685826|582779366|FG000|Overall Study|Withdrawal by Subject|2|||
161380418|NCT02685826|582779367|FG001|Overall Study|Withdrawal by Subject|0|||
161380419|NCT02685826|582779368|FG002|Overall Study|Withdrawal by Subject|0|||
161380420|NCT02685826|582779366|FG000|Overall Study|Full Clinical Hold by FDA|19|||
161380421|NCT02685826|582779367|FG001|Overall Study|Full Clinical Hold by FDA|9|||
161380422|NCT02685826|582779368|FG002|Overall Study|Full Clinical Hold by FDA|20|||
161380423|NCT03154476|582779369|FG000|Overall Study|Lost to Follow-up|4|||
161380424|NCT03154476|582779370|FG001|Overall Study|Lost to Follow-up|4|||
161380425|NCT01444430|582779372|FG000|Overall Study|Withdrawal by Subject|53|||
161380426|NCT01444430|582779373|FG001|Overall Study|Withdrawal by Subject|72|||
161380427|NCT01444430|582779372|FG000|Overall Study|Death|6|||
161380428|NCT01444430|582779373|FG001|Overall Study|Death|8|||
161380429|NCT01444430|582779372|FG000|Overall Study|Lost to Follow-up|2|||
161380430|NCT01444430|582779373|FG001|Overall Study|Lost to Follow-up|0|||
161380431|NCT01444430|582779372|FG000|Overall Study|CRF termination module not completed.|0|||
161380432|NCT01444430|582779373|FG001|Overall Study|CRF termination module not completed.|1|||
161380433|NCT01142388|582780894|FG000|Overall Study|Lack of Efficacy|21|||
161380434|NCT01142388|582780895|FG001|Overall Study|Lack of Efficacy|31|||
161380435|NCT01142388|582780894|FG000|Overall Study|Adverse Event|9|||
161380436|NCT01142388|582780895|FG001|Overall Study|Adverse Event|5|||
161380437|NCT01142388|582780894|FG000|Overall Study|Death|3|||
161380438|NCT01142388|582780895|FG001|Overall Study|Death|2|||
161380439|NCT01142388|582780894|FG000|Overall Study|Withdrawal by Subject|5|||
161380440|NCT01142388|582780895|FG001|Overall Study|Withdrawal by Subject|3|||
161380441|NCT01142388|582780894|FG000|Overall Study|Alternative therapy|1|||
161380442|NCT01142388|582780895|FG001|Overall Study|Alternative therapy|0|||
161380443|NCT01142388|582780894|FG000|Overall Study|Other complications|0|||
161380444|NCT01142388|582780895|FG001|Overall Study|Other complications|2|||
161380445|NCT01142388|582780894|FG000|Overall Study|Other|1|||
161380446|NCT01142388|582780895|FG001|Overall Study|Other|1|||
161380447|NCT01142388|582780894|FG000|Overall Study|Never started therapy|7|||
161380448|NCT01142388|582780895|FG001|Overall Study|Never started therapy|3|||
161380449|NCT03640325|582780901|FG000|Overall Study|Withdrawal by Subject|4|||
161380450|NCT03640325|582780902|FG001|Overall Study|Withdrawal by Subject|1|||
161380451|NCT03640325|582780903|FG002|Overall Study|Withdrawal by Subject|0|||
161380452|NCT03640325|582780901|FG000|Overall Study|Lost to Follow-up|4|||
161380453|NCT03640325|582780902|FG001|Overall Study|Lost to Follow-up|5|||
161380454|NCT03640325|582780903|FG002|Overall Study|Lost to Follow-up|21|||
161380455|NCT03640325|582780901|FG000|Overall Study|Death|5|||
161380456|NCT03640325|582780902|FG001|Overall Study|Death|5|||
161380457|NCT03640325|582780903|FG002|Overall Study|Death|0|||
161380458|NCT05265728|582780904|FG000|Overall Study|Adverse Event|1|||
161380459|NCT05265728|582780904|FG000|Overall Study|Study Terminated by Sponsor|5|||
161380460|NCT05265728|582780904|FG000|Overall Study|Withdrawal by Subject|2|||
161380461|NCT03493451|582780905|FG000|Overall Study|Death|11|||
161380462|NCT03493451|582780906|FG001|Overall Study|Death|26|||
161380463|NCT03493451|582780907|FG002|Overall Study|Death|3|||
161380464|NCT03493451|582780905|FG000|Overall Study|Lost to Follow-up|1|||
161380465|NCT03493451|582780906|FG001|Overall Study|Lost to Follow-up|4|||
161380466|NCT03493451|582780907|FG002|Overall Study|Lost to Follow-up|1|||
161380467|NCT03493451|582780905|FG000|Overall Study|Withdrawal by Subject|1|||
161380468|NCT03493451|582780906|FG001|Overall Study|Withdrawal by Subject|1|||
161380469|NCT03493451|582780907|FG002|Overall Study|Withdrawal by Subject|2|||
161380470|NCT03493451|582780905|FG000|Overall Study|Progressive Disease|1|||
161380471|NCT03493451|582780906|FG001|Overall Study|Progressive Disease|0|||
161380472|NCT03493451|582780907|FG002|Overall Study|Progressive Disease|0|||
161380473|NCT03493451|582780905|FG000|Overall Study|Transferred to long term extension study|8|||
161380474|NCT03493451|582780906|FG001|Overall Study|Transferred to long term extension study|13|||
161380475|NCT03493451|582780907|FG002|Overall Study|Transferred to long term extension study|5|||
161380476|NCT01566149|582780910|FG000|Overall Study|Adverse Event|0|||
161380477|NCT01566149|582780911|FG001|Overall Study|Adverse Event|1|||
161380478|NCT01566149|582780910|FG000|Overall Study|Non-compliance with study medication|2|||
161380479|NCT01566149|582780911|FG001|Overall Study|Non-compliance with study medication|0|||
161380480|NCT01566149|582780910|FG000|Overall Study|Protocol Violation|0|||
161380481|NCT01566149|582780911|FG001|Overall Study|Protocol Violation|1|||
161380482|NCT01566149|582780910|FG000|Overall Study|Withdrawal by Subject|1|||
161380483|NCT01566149|582780911|FG001|Overall Study|Withdrawal by Subject|0|||
161380484|NCT03687957|582780916|FG000|Overall Study|Withdrawal by Subject|0|||
161380485|NCT03687957|582780917|FG001|Overall Study|Withdrawal by Subject|0|||
161380486|NCT03687957|582780918|FG002|Overall Study|Withdrawal by Subject|0|||
161380487|NCT03687957|582780919|FG003|Overall Study|Withdrawal by Subject|2|||
161380488|NCT03687957|582780920|FG004|Overall Study|Withdrawal by Subject|0|||
161380489|NCT03687957|582780921|FG005|Overall Study|Withdrawal by Subject|0|||
161380490|NCT03687957|582780922|FG006|Overall Study|Withdrawal by Subject|3|||
161380491|NCT03687957|582780923|FG007|Overall Study|Withdrawal by Subject|1|||
161380492|NCT03687957|582780924|FG008|Overall Study|Withdrawal by Subject|1|||
161380493|NCT03687957|582780925|FG009|Overall Study|Withdrawal by Subject|0|||
161380494|NCT03687957|582780916|FG000|Overall Study|Disease progression|0|||
161380495|NCT03687957|582780917|FG001|Overall Study|Disease progression|1|||
161380496|NCT03687957|582780918|FG002|Overall Study|Disease progression|1|||
161380497|NCT03687957|582780919|FG003|Overall Study|Disease progression|2|||
161380498|NCT03687957|582780920|FG004|Overall Study|Disease progression|2|||
161380499|NCT03687957|582780921|FG005|Overall Study|Disease progression|0|||
161380500|NCT03687957|582780922|FG006|Overall Study|Disease progression|2|||
161380501|NCT03687957|582780923|FG007|Overall Study|Disease progression|1|||
161380502|NCT03687957|582780924|FG008|Overall Study|Disease progression|0|||
161380503|NCT03687957|582780925|FG009|Overall Study|Disease progression|0|||
161380504|NCT03687957|582780916|FG000|Overall Study|Physician Decision|0|||
161380505|NCT03687957|582780917|FG001|Overall Study|Physician Decision|0|||
161380506|NCT03687957|582780918|FG002|Overall Study|Physician Decision|0|||
161380507|NCT03687957|582780919|FG003|Overall Study|Physician Decision|2|||
161380508|NCT03687957|582780920|FG004|Overall Study|Physician Decision|1|||
161380509|NCT03687957|582780921|FG005|Overall Study|Physician Decision|0|||
161380510|NCT03687957|582780922|FG006|Overall Study|Physician Decision|1|||
161380511|NCT03687957|582780923|FG007|Overall Study|Physician Decision|0|||
161380512|NCT03687957|582780924|FG008|Overall Study|Physician Decision|0|||
161380513|NCT03687957|582780925|FG009|Overall Study|Physician Decision|0|||
161380514|NCT03687957|582780916|FG000|Overall Study|New malignancy|0|||
161380515|NCT03687957|582780917|FG001|Overall Study|New malignancy|0|||
161380516|NCT03687957|582780918|FG002|Overall Study|New malignancy|0|||
161380517|NCT03687957|582780919|FG003|Overall Study|New malignancy|0|||
161380518|NCT03687957|582780920|FG004|Overall Study|New malignancy|1|||
161380519|NCT03687957|582780921|FG005|Overall Study|New malignancy|0|||
161380520|NCT03687957|582780922|FG006|Overall Study|New malignancy|0|||
161380521|NCT03687957|582780923|FG007|Overall Study|New malignancy|0|||
161380522|NCT03687957|582780924|FG008|Overall Study|New malignancy|0|||
161380523|NCT03687957|582780925|FG009|Overall Study|New malignancy|0|||
161380524|NCT03687957|582780916|FG000|Overall Study|Adverse Event|0|||
161380525|NCT03687957|582780917|FG001|Overall Study|Adverse Event|0|||
161380526|NCT03687957|582780918|FG002|Overall Study|Adverse Event|0|||
161380527|NCT03687957|582780919|FG003|Overall Study|Adverse Event|0|||
161380528|NCT03687957|582780920|FG004|Overall Study|Adverse Event|0|||
161380529|NCT03687957|582780921|FG005|Overall Study|Adverse Event|2|||
161380530|NCT03687957|582780922|FG006|Overall Study|Adverse Event|0|||
161380531|NCT03687957|582780923|FG007|Overall Study|Adverse Event|3|||
161380532|NCT03687957|582780924|FG008|Overall Study|Adverse Event|0|||
161380533|NCT03687957|582780925|FG009|Overall Study|Adverse Event|0|||
161380534|NCT03687957|582780916|FG000|Overall Study|Patient went on hospice|0|||
161380535|NCT03687957|582780917|FG001|Overall Study|Patient went on hospice|0|||
161380536|NCT03687957|582780918|FG002|Overall Study|Patient went on hospice|0|||
161380537|NCT03687957|582780919|FG003|Overall Study|Patient went on hospice|0|||
161380538|NCT03687957|582780920|FG004|Overall Study|Patient went on hospice|0|||
161380539|NCT03687957|582780921|FG005|Overall Study|Patient went on hospice|0|||
161380540|NCT03687957|582780922|FG006|Overall Study|Patient went on hospice|1|||
161380541|NCT03687957|582780923|FG007|Overall Study|Patient went on hospice|0|||
161380542|NCT03687957|582780924|FG008|Overall Study|Patient went on hospice|0|||
161380543|NCT03687957|582780925|FG009|Overall Study|Patient went on hospice|0|||
161380544|NCT03687957|582780916|FG000|Overall Study|Death|0|||
161380545|NCT03687957|582780917|FG001|Overall Study|Death|0|||
161380546|NCT03687957|582780918|FG002|Overall Study|Death|0|||
161380547|NCT03687957|582780919|FG003|Overall Study|Death|0|||
161380548|NCT03687957|582780920|FG004|Overall Study|Death|0|||
161380549|NCT03687957|582780921|FG005|Overall Study|Death|0|||
161380550|NCT03687957|582780922|FG006|Overall Study|Death|0|||
161380551|NCT03687957|582780923|FG007|Overall Study|Death|1|||
161380552|NCT03687957|582780924|FG008|Overall Study|Death|0|||
161380553|NCT03687957|582780925|FG009|Overall Study|Death|0|||
161380554|NCT00617084|582780926|FG000|Overall Study|Withdrawal by Subject|5|||
161380555|NCT00617084|582780927|FG001|Overall Study|Withdrawal by Subject|7|||
161380556|NCT00617084|582780926|FG000|Overall Study|Missed 12 Months visit|16|||
161380557|NCT00617084|582780927|FG001|Overall Study|Missed 12 Months visit|19|||
161380558|NCT01693250|582780928|FG000|Overall Study|Lost to Follow-up|2|||
161380559|NCT01693250|582780929|FG001|Overall Study|Lost to Follow-up|2|||
161380560|NCT03783962|582780932|FG000|Overall Study|Lost to Follow-up|3|||
161380561|NCT03783962|582780933|FG001|Overall Study|Lost to Follow-up|6|||
161380562|NCT03783962|582780932|FG000|Overall Study|Protocol Violation|0|||
161380563|NCT03783962|582780933|FG001|Overall Study|Protocol Violation|1|||
161380564|NCT03458325|582780934|FG000|Overall Study|Withdrawal by Subject|1|||
161380565|NCT02370368|582780935|FG000|Overall Study|Adverse Event|1|||
161380566|NCT02370368|582780936|FG001|Overall Study|Adverse Event|2|||
161380567|NCT02370368|582780935|FG000|Overall Study|Withdrawal by Subject|5|||
161380568|NCT02370368|582780936|FG001|Overall Study|Withdrawal by Subject|4|||
161380569|NCT01766037|582780937|FG000|Overall Study|Adverse Event|1|||
161380570|NCT01766037|582780938|FG001|Overall Study|Adverse Event|0|||
161380571|NCT01766037|582780937|FG000|Overall Study|Lack of Efficacy|1|||
161380572|NCT01766037|582780938|FG001|Overall Study|Lack of Efficacy|0|||
161380573|NCT01766037|582780937|FG000|Overall Study|Lost to Follow-up|0|||
161380574|NCT01766037|582780938|FG001|Overall Study|Lost to Follow-up|10|||
161380575|NCT01766037|582780937|FG000|Overall Study|Physician Decision|0|||
161380576|NCT01766037|582780938|FG001|Overall Study|Physician Decision|1|||
161380577|NCT01766037|582780937|FG000|Overall Study|Withdrawal by Subject|18|||
161380578|NCT01766037|582780938|FG001|Overall Study|Withdrawal by Subject|16|||
161380579|NCT01766037|582780937|FG000|Overall Study|Moved from area|5|||
161380580|NCT01766037|582780938|FG001|Overall Study|Moved from area|0|||
161380581|NCT01766037|582780937|FG000|Overall Study|medical - unrelated|1|||
161380582|NCT01766037|582780938|FG001|Overall Study|medical - unrelated|2|||
161380583|NCT01766037|582780937|FG000|Overall Study|nausea / discomfort|3|||
161380584|NCT01766037|582780938|FG001|Overall Study|nausea / discomfort|0|||
161380585|NCT05226598|582780939|FG000|Overall Study|Death|186|||
161380586|NCT05226598|582780940|FG001|Overall Study|Death|191|||
161380587|NCT05226598|582780939|FG000|Overall Study|Withdrawal by Subject|6|||
161380588|NCT05226598|582780940|FG001|Overall Study|Withdrawal by Subject|6|||
161380589|NCT05226598|582780939|FG000|Overall Study|Ongoing|174|||
161380590|NCT05226598|582780940|FG001|Overall Study|Ongoing|176|||
161380591|NCT02236572|582780941|FG000|Overall Study|Withdrawal by Subject|1|||
161380592|NCT02236572|582780941|FG000|Overall Study|Protocol Violation|1|||
161380593|NCT02236572|582780941|FG000|Overall Study|Lost to Follow-up|1|||
161380594|NCT00127855|582780947|FG000|Primary Vaccination Course|Adverse Event|0|||
161380595|NCT00127855|582780948|FG001|Primary Vaccination Course|Adverse Event|0|||
161380596|NCT00127855|582780949|FG002|Primary Vaccination Course|Adverse Event|1|||
161380597|NCT00127855|582780950|FG003|Primary Vaccination Course|Adverse Event|0|||
161380598|NCT00127855|582780951|FG004|Primary Vaccination Course|Adverse Event|0|||
161380599|NCT00127855|582780947|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
161380600|NCT00127855|582780948|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
161380601|NCT00127855|582780949|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
161380602|NCT00127855|582780950|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
161380603|NCT00127855|582780951|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
161380604|NCT00127855|582780947|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
161380605|NCT00127855|582780948|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
161380606|NCT00127855|582780949|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
161380607|NCT00127855|582780950|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
161380608|NCT00127855|582780951|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
161380609|NCT00127855|582780947|FG000|Primary Vaccination Course|Other|0|||
161380610|NCT00127855|582780948|FG001|Primary Vaccination Course|Other|0|||
161380611|NCT00127855|582780949|FG002|Primary Vaccination Course|Other|0|||
161380612|NCT00127855|582780950|FG003|Primary Vaccination Course|Other|0|||
161380613|NCT00127855|582780951|FG004|Primary Vaccination Course|Other|1|||
161380614|NCT01282866|582780953|FG000|Overall Study|Adverse Event|1|||
161380615|NCT04834726|582780954|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
161380616|NCT04834726|582780955|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
161380617|NCT04834726|582780956|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
161380618|NCT04834726|582780957|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
161380619|NCT04834726|582780958|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
161380620|NCT04834726|582780959|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
161380621|NCT04834726|582780960|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
161380622|NCT04834726|582780961|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
161380623|NCT04834726|582780962|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
161380624|NCT03465722|582780964|FG000|Overall Study|Withdrawal by Subject|21|||
161380625|NCT03465722|582780965|FG001|Overall Study|Withdrawal by Subject|14|||
161380626|NCT03465722|582780964|FG000|Overall Study|Death|89|||
161380627|NCT03465722|582780965|FG001|Overall Study|Death|87|||
161380628|NCT03465722|582780964|FG000|Overall Study|Lost to Follow-up|5|||
161380629|NCT03465722|582780965|FG001|Overall Study|Lost to Follow-up|3|||
161380630|NCT03465722|582780964|FG000|Overall Study|Administrative/Other|33|||
161380631|NCT03465722|582780965|FG001|Overall Study|Administrative/Other|32|||
161380632|NCT03465722|582780964|FG000|Overall Study|Not treated|1|||
161380633|NCT03465722|582780965|FG001|Overall Study|Not treated|2|||
161380634|NCT03465722|582780964|FG000|Overall Study|Sponsor decision|91|||
161380635|NCT03465722|582780965|FG001|Overall Study|Sponsor decision|98|||
161380636|NCT02948582|582780968|FG000|Washout Period 1|Adverse Event|0|||
161380637|NCT02948582|582780969|FG001|Washout Period 1|Adverse Event|2|||
161380638|NCT02948582|582780970|FG002|Washout Period 1|Adverse Event|0|||
161380639|NCT02948582|582780971|FG003|Washout Period 1|Adverse Event|0|||
161380640|NCT02948582|582780972|FG004|Washout Period 1|Adverse Event|0|||
161380641|NCT02948582|582780973|FG005|Washout Period 1|Adverse Event|0|||
161380642|NCT02948582|582780968|FG000|Washout Period 1|Protocol Violation|0|||
161380643|NCT02948582|582780969|FG001|Washout Period 1|Protocol Violation|0|||
161380644|NCT02948582|582780970|FG002|Washout Period 1|Protocol Violation|0|||
161380645|NCT02948582|582780971|FG003|Washout Period 1|Protocol Violation|0|||
161380646|NCT02948582|582780972|FG004|Washout Period 1|Protocol Violation|0|||
161380647|NCT02948582|582780973|FG005|Washout Period 1|Protocol Violation|1|||
161380648|NCT02948582|582780968|FG000|Washout Period 2|Adverse Event|0|||
161380649|NCT02948582|582780969|FG001|Washout Period 2|Adverse Event|1|||
161380650|NCT02948582|582780970|FG002|Washout Period 2|Adverse Event|0|||
161380651|NCT02948582|582780971|FG003|Washout Period 2|Adverse Event|0|||
161380652|NCT02948582|582780972|FG004|Washout Period 2|Adverse Event|0|||
161380653|NCT02948582|582780973|FG005|Washout Period 2|Adverse Event|0|||
161380654|NCT02948582|582780968|FG000|Washout Period 2|personal reasons|0|||
161380655|NCT02948582|582780969|FG001|Washout Period 2|personal reasons|0|||
161380656|NCT02948582|582780970|FG002|Washout Period 2|personal reasons|0|||
161380657|NCT02948582|582780971|FG003|Washout Period 2|personal reasons|1|||
161380658|NCT02948582|582780972|FG004|Washout Period 2|personal reasons|0|||
161380659|NCT02948582|582780973|FG005|Washout Period 2|personal reasons|0|||
161380660|NCT02948582|582780968|FG000|Washout Period 4|Adverse Event|1|||
161380661|NCT02948582|582780969|FG001|Washout Period 4|Adverse Event|0|||
161380662|NCT02948582|582780970|FG002|Washout Period 4|Adverse Event|1|||
161380663|NCT02948582|582780971|FG003|Washout Period 4|Adverse Event|0|||
161380664|NCT02948582|582780972|FG004|Washout Period 4|Adverse Event|0|||
161380665|NCT02948582|582780973|FG005|Washout Period 4|Adverse Event|0|||
161380666|NCT03810014|582780976|FG000|Overall Study|Pregnancy|2|||
161380667|NCT03810014|582780977|FG001|Overall Study|Pregnancy|2|||
161380668|NCT03810014|582780978|FG002|Overall Study|Pregnancy|0|||
161380669|NCT03810014|582780979|FG003|Overall Study|Pregnancy|2|||
161380670|NCT03606486|582780983|FG000|Overall Study|Unable to collect sample|5|||
161380671|NCT00442416|582780990|FG000|Overall Study|Adverse Event|4|||
161380672|NCT00442416|582780991|FG001|Overall Study|Adverse Event|1|||
161380673|NCT00442416|582780990|FG000|Overall Study|Death|1|||
161380674|NCT00442416|582780991|FG001|Overall Study|Death|0|||
161380675|NCT00442416|582780990|FG000|Overall Study|Lack of Efficacy|2|||
161380676|NCT00442416|582780991|FG001|Overall Study|Lack of Efficacy|0|||
161380677|NCT00442416|582780990|FG000|Overall Study|Protocol Violation|2|||
161380678|NCT00442416|582780991|FG001|Overall Study|Protocol Violation|3|||
161380679|NCT00442416|582780990|FG000|Overall Study|Withdrew consent|1|||
161380680|NCT00442416|582780991|FG001|Overall Study|Withdrew consent|2|||
161380681|NCT00442416|582780990|FG000|Overall Study|Administrative/Other|27|||
161380682|NCT00442416|582780991|FG001|Overall Study|Administrative/Other|33|||
161380683|NCT00955474|582781005|FG000|Overall Study|Physician Decision|7|||
161380684|NCT00955474|582781006|FG001|Overall Study|Physician Decision|5|||
161380685|NCT00003869|582781008|FG000|Overall Study|Adverse Event|14|||
161380686|NCT00003869|582781009|FG001|Overall Study|Adverse Event|3|||
161380687|NCT00003869|582781008|FG000|Overall Study|Withdrawal by Subject|21|||
161380688|NCT00003869|582781009|FG001|Overall Study|Withdrawal by Subject|3|||
161380689|NCT00003869|582781008|FG000|Overall Study|Death|1|||
161380690|NCT00003869|582781009|FG001|Overall Study|Death|2|||
161380691|NCT00003869|582781008|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
161380692|NCT00003869|582781009|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
161380693|NCT01272037|582781014|FG000|Overall Study|Death|25|||
161380694|NCT01272037|582781015|FG001|Overall Study|Death|28|||
161380695|NCT01272037|582781014|FG000|Overall Study|Adverse Event|12|||
161380696|NCT01272037|582781015|FG001|Overall Study|Adverse Event|7|||
161380697|NCT01272037|582781014|FG000|Overall Study|Withdrawal by Subject|175|||
161380698|NCT01272037|582781015|FG001|Overall Study|Withdrawal by Subject|93|||
161380699|NCT01272037|582781014|FG000|Overall Study|Disease progression|70|||
161380700|NCT01272037|582781015|FG001|Overall Study|Disease progression|111|||
161380701|NCT01272037|582781014|FG000|Overall Study|Other reason|42|||
161380702|NCT01272037|582781015|FG001|Overall Study|Other reason|41|||
161380703|NCT01272037|582781014|FG000|Overall Study|Delinquent data|24|||
161380704|NCT01272037|582781015|FG001|Overall Study|Delinquent data|19|||
161380705|NCT01272037|582781014|FG000|Overall Study|Reason under review|33|||
161380706|NCT01272037|582781015|FG001|Overall Study|Reason under review|29|||
161380707|NCT01272037|582781014|FG000|Overall Study|On treatment|626|||
161380708|NCT01272037|582781015|FG001|Overall Study|On treatment|632|||
161380709|NCT02534883|582781017|FG000|Overall Study|Early Termination|8|||
161380710|NCT02534883|582781018|FG001|Overall Study|Early Termination|3|||
161380711|NCT00049257|582781019|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
161380712|NCT00049257|582781019|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
161380713|NCT00049257|582781019|FG000|Carboplatin, Paclitaxel|Death|2|||
161380714|NCT00049257|582781019|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
161380715|NCT00132301|582781020|FG000|Overall Study|Death|7|||
161380716|NCT00132301|582781021|FG001|Overall Study|Death|6|||
161380717|NCT00132301|582781020|FG000|Overall Study|Withdrawal by Subject|5|||
161380718|NCT00132301|582781021|FG001|Overall Study|Withdrawal by Subject|2|||
161380719|NCT00132301|582781020|FG000|Overall Study|Physician Decision|1|||
161380720|NCT00132301|582781021|FG001|Overall Study|Physician Decision|1|||
161380721|NCT00132301|582781020|FG000|Overall Study|Lost to Follow-up|5|||
161380722|NCT00132301|582781021|FG001|Overall Study|Lost to Follow-up|3|||
161380723|NCT00132301|582781020|FG000|Overall Study|Other|1|||
161380724|NCT00132301|582781021|FG001|Overall Study|Other|1|||
161380725|NCT00132301|582781020|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
161380726|NCT00132301|582781021|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
161380727|NCT01890265|582781024|FG000|Overall Study|Other (Unspecified reason)|0|||
161380728|NCT01890265|582781025|FG001|Overall Study|Other (Unspecified reason)|1|||
161380729|NCT01890265|582781026|FG002|Overall Study|Other (Unspecified reason)|0|||
161380730|NCT01890265|582781027|FG003|Overall Study|Other (Unspecified reason)|0|||
161380731|NCT01890265|582781028|FG004|Overall Study|Other (Unspecified reason)|0|||
161380732|NCT01890265|582781029|FG005|Overall Study|Other (Unspecified reason)|0|||
161380733|NCT01890265|582781024|FG000|Overall Study|Progressive disease|6|||
161380734|NCT01890265|582781025|FG001|Overall Study|Progressive disease|6|||
161380735|NCT01890265|582781026|FG002|Overall Study|Progressive disease|0|||
161380736|NCT01890265|582781027|FG003|Overall Study|Progressive disease|0|||
161380737|NCT01890265|582781028|FG004|Overall Study|Progressive disease|0|||
161380738|NCT01890265|582781029|FG005|Overall Study|Progressive disease|0|||
161380739|NCT01890265|582781024|FG000|Overall Study|Adverse Event|2|||
161380740|NCT01890265|582781025|FG001|Overall Study|Adverse Event|1|||
161380741|NCT01890265|582781026|FG002|Overall Study|Adverse Event|0|||
161380742|NCT01890265|582781027|FG003|Overall Study|Adverse Event|0|||
161380743|NCT01890265|582781028|FG004|Overall Study|Adverse Event|0|||
161380744|NCT01890265|582781029|FG005|Overall Study|Adverse Event|0|||
161380745|NCT01890265|582781024|FG000|Overall Study|Death|2|||
161380746|NCT01890265|582781025|FG001|Overall Study|Death|3|||
161380747|NCT01890265|582781026|FG002|Overall Study|Death|1|||
161380748|NCT01890265|582781027|FG003|Overall Study|Death|0|||
161380749|NCT01890265|582781028|FG004|Overall Study|Death|0|||
161380750|NCT01890265|582781029|FG005|Overall Study|Death|0|||
161380751|NCT01890265|582781024|FG000|Overall Study|Withdrawal by Subject|0|||
161380752|NCT01890265|582781025|FG001|Overall Study|Withdrawal by Subject|2|||
161380753|NCT01890265|582781026|FG002|Overall Study|Withdrawal by Subject|3|||
161380754|NCT01890265|582781027|FG003|Overall Study|Withdrawal by Subject|0|||
161380755|NCT01890265|582781028|FG004|Overall Study|Withdrawal by Subject|2|||
161380756|NCT01890265|582781029|FG005|Overall Study|Withdrawal by Subject|0|||
161380757|NCT03517436|582781031|FG000|Overall Study|Death|3|||
161380758|NCT03517436|582781031|FG000|Overall Study|Withdrawal by Subject|4|||
161380759|NCT03517436|582781031|FG000|Overall Study|Did not receive study valve.|1|||
161380760|NCT04271540|582781032|FG000|Overall Study|Lost to Follow-up|1|||
161380761|NCT04271540|582781032|FG000|Overall Study|Screen Fail|5|||
161380762|NCT04587869|582781035|FG000|Overall Study|Death|1|||
161380763|NCT04587869|582781036|FG001|Overall Study|Death|0|||
161380764|NCT04587869|582781035|FG000|Overall Study|Lost to Follow-up|27|||
161380765|NCT04587869|582781036|FG001|Overall Study|Lost to Follow-up|34|||
161380766|NCT04587869|582781035|FG000|Overall Study|Grant Termination|13|||
161380767|NCT04587869|582781036|FG001|Overall Study|Grant Termination|25|||
161380768|NCT04587869|582781035|FG000|Overall Study|too busy|2|||
161380769|NCT04587869|582781036|FG001|Overall Study|too busy|0|||
161380770|NCT04587869|582781035|FG000|Overall Study|Withdrawal by Subject|2|||
161380771|NCT04587869|582781036|FG001|Overall Study|Withdrawal by Subject|2|||
161380772|NCT04587869|582781035|FG000|Overall Study|Other|1|||
161380773|NCT04587869|582781036|FG001|Overall Study|Other|0|||
161380774|NCT00943761|582781037|FG000|Overall Study|Lost to Follow-up|2|||
161380775|NCT00943761|582781038|FG001|Overall Study|Lost to Follow-up|0|||
161380776|NCT00943761|582781037|FG000|Overall Study|Withdrawal by Subject|2|||
161380777|NCT00943761|582781038|FG001|Overall Study|Withdrawal by Subject|1|||
161380778|NCT03382912|582781039|FG000|Overall Study|Physician Decision|0|||
161380779|NCT03382912|582781040|FG001|Overall Study|Physician Decision|1|||
161380780|NCT03382912|582781039|FG000|Overall Study|Sponsor Decision|6|||
161380781|NCT03382912|582781040|FG001|Overall Study|Sponsor Decision|6|||
161380782|NCT03382912|582781039|FG000|Overall Study|Withdrawal by Subject|0|||
161380783|NCT03382912|582781040|FG001|Overall Study|Withdrawal by Subject|5|||
161380784|NCT03929913|582781041|FG000|Overall Study|Death|4|||
161380785|NCT03929913|582781041|FG000|Overall Study|Lost to Follow-up|1|||
161380786|NCT03929913|582781041|FG000|Overall Study|Failed Procedure|2|||
161380787|NCT03919929|582781042|FG000|Overall Study|Withdrawal by Subject|0|||
161380788|NCT03919929|582781043|FG001|Overall Study|Withdrawal by Subject|4|||
161380789|NCT03919929|582781042|FG000|Overall Study|Screen Failure|0|||
161380790|NCT03919929|582781043|FG001|Overall Study|Screen Failure|5|||
161380791|NCT01402869|582781044|FG000|Overall Study|Required Tooth Extraction|0|||
161380792|NCT01402869|582781045|FG001|Overall Study|Required Tooth Extraction|0|||
161380793|NCT01402869|582781046|FG002|Overall Study|Required Tooth Extraction|1|||
161380794|NCT00642707|582781047|FG000|Overall Study|Adverse Event|0|||
161380795|NCT00642707|582781048|FG001|Overall Study|Adverse Event|0|||
161380796|NCT00642707|582781049|FG002|Overall Study|Adverse Event|0|||
161380797|NCT00642707|582781050|FG003|Overall Study|Adverse Event|2|||
161380798|NCT00642707|582781047|FG000|Overall Study|Withdrawal by Subject|1|||
161380799|NCT00642707|582781048|FG001|Overall Study|Withdrawal by Subject|0|||
161380800|NCT00642707|582781049|FG002|Overall Study|Withdrawal by Subject|0|||
161380801|NCT00642707|582781050|FG003|Overall Study|Withdrawal by Subject|0|||
161380802|NCT02573948|582781056|FG000|Longitudinal Cohort|Death|9|||
161380803|NCT02573948|582781056|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
161380804|NCT02573948|582781056|FG000|Longitudinal Cohort|Incarcerated|25|||
161380805|NCT00707993|582781057|FG000|Overall Study|Adverse Event|16|||
161380806|NCT00707993|582781058|FG001|Overall Study|Adverse Event|20|||
161380807|NCT00707993|582781057|FG000|Overall Study|Protocol Violation|4|||
161380808|NCT00707993|582781058|FG001|Overall Study|Protocol Violation|7|||
161380809|NCT00707993|582781057|FG000|Overall Study|Lost to Follow-up|0|||
161380810|NCT00707993|582781058|FG001|Overall Study|Lost to Follow-up|4|||
161380811|NCT00707993|582781057|FG000|Overall Study|Withdrawal by Subject|12|||
161380812|NCT00707993|582781058|FG001|Overall Study|Withdrawal by Subject|16|||
161380813|NCT00707993|582781057|FG000|Overall Study|Hyperglycemic Rescue|55|||
161380814|NCT00707993|582781058|FG001|Overall Study|Hyperglycemic Rescue|47|||
161380815|NCT00707993|582781057|FG000|Overall Study|Other|2|||
161380816|NCT00707993|582781058|FG001|Overall Study|Other|0|||
161380817|NCT00436436|582781061|FG000|Overall Study|Progression|4|||
161380818|NCT00436436|582781061|FG000|Overall Study|Adverse Event|2|||
161380819|NCT00436436|582781061|FG000|Overall Study|Death|6|||
161380820|NCT01837680|582781062|FG000|Overall Study|Lost to Follow-up|2|||
161380821|NCT01837680|582781063|FG001|Overall Study|Lost to Follow-up|2|||
161380822|NCT01837680|582781062|FG000|Overall Study|lack of insurance|0|||
161380823|NCT01837680|582781063|FG001|Overall Study|lack of insurance|2|||
161380824|NCT01837680|582781062|FG000|Overall Study|allergic reaction|6|||
161380825|NCT01837680|582781063|FG001|Overall Study|allergic reaction|0|||
161380826|NCT01837680|582781062|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
161380827|NCT01837680|582781063|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
161380828|NCT03960684|582781064|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
161380829|NCT03533660|582781065|FG000|Overall Study|Withdrawal by Subject|2|||
161380830|NCT03533660|582781066|FG001|Overall Study|Withdrawal by Subject|2|||
161380831|NCT03533660|582781065|FG000|Overall Study|Death|2|||
161380832|NCT03533660|582781066|FG001|Overall Study|Death|4|||
161380833|NCT03533660|582781065|FG000|Overall Study|Adverse Event|0|||
161380834|NCT03533660|582781066|FG001|Overall Study|Adverse Event|2|||
161380835|NCT03941873|582782714|FG000|Overall Study|Death|0|||
161380836|NCT03941873|582782715|FG001|Overall Study|Death|12|||
161380837|NCT03941873|582782716|FG002|Overall Study|Death|2|||
161380838|NCT03941873|582782717|FG003|Overall Study|Death|53|||
161380839|NCT03941873|582782714|FG000|Overall Study|Withdrawal by Subject|1|||
161380840|NCT03941873|582782715|FG001|Overall Study|Withdrawal by Subject|1|||
161380841|NCT03941873|582782716|FG002|Overall Study|Withdrawal by Subject|0|||
161380842|NCT03941873|582782717|FG003|Overall Study|Withdrawal by Subject|5|||
161380843|NCT03941873|582782714|FG000|Overall Study|Lost to Follow-up|1|||
161380844|NCT03941873|582782715|FG001|Overall Study|Lost to Follow-up|2|||
161380845|NCT03941873|582782716|FG002|Overall Study|Lost to Follow-up|0|||
161380846|NCT03941873|582782717|FG003|Overall Study|Lost to Follow-up|0|||
161380847|NCT03941873|582782714|FG000|Overall Study|Sponsor Decision|0|||
161380848|NCT03941873|582782715|FG001|Overall Study|Sponsor Decision|6|||
161380849|NCT03941873|582782716|FG002|Overall Study|Sponsor Decision|0|||
161380850|NCT03941873|582782717|FG003|Overall Study|Sponsor Decision|15|||
161380851|NCT03276728|582782720|FG000|Overall Study|Lost to Follow-up|0|||
161380852|NCT03276728|582782721|FG001|Overall Study|Lost to Follow-up|0|||
161380853|NCT03276728|582782722|FG002|Overall Study|Lost to Follow-up|2|||
161380854|NCT03276728|582782723|FG003|Overall Study|Lost to Follow-up|2|||
161380855|NCT03276728|582782724|FG004|Overall Study|Lost to Follow-up|0|||
161380856|NCT03276728|582782725|FG005|Overall Study|Lost to Follow-up|0|||
161380857|NCT03276728|582782726|FG006|Overall Study|Lost to Follow-up|0|||
161380858|NCT03276728|582782727|FG007|Overall Study|Lost to Follow-up|0|||
161380859|NCT03276728|582782720|FG000|Overall Study|Withdrawal by Subject|0|||
161380860|NCT03276728|582782721|FG001|Overall Study|Withdrawal by Subject|0|||
161380861|NCT03276728|582782722|FG002|Overall Study|Withdrawal by Subject|0|||
161380862|NCT03276728|582782723|FG003|Overall Study|Withdrawal by Subject|3|||
161380863|NCT03276728|582782724|FG004|Overall Study|Withdrawal by Subject|0|||
161380864|NCT03276728|582782725|FG005|Overall Study|Withdrawal by Subject|0|||
161380865|NCT03276728|582782726|FG006|Overall Study|Withdrawal by Subject|0|||
161380866|NCT03276728|582782727|FG007|Overall Study|Withdrawal by Subject|0|||
161380867|NCT03276728|582782720|FG000|Overall Study|Decision by sponsor|0|||
161380868|NCT03276728|582782721|FG001|Overall Study|Decision by sponsor|0|||
161380869|NCT03276728|582782722|FG002|Overall Study|Decision by sponsor|0|||
161380870|NCT03276728|582782723|FG003|Overall Study|Decision by sponsor|0|||
161380871|NCT03276728|582782724|FG004|Overall Study|Decision by sponsor|1|||
161380872|NCT03276728|582782725|FG005|Overall Study|Decision by sponsor|0|||
161380873|NCT03276728|582782726|FG006|Overall Study|Decision by sponsor|2|||
161380874|NCT03276728|582782727|FG007|Overall Study|Decision by sponsor|1|||
161380875|NCT02257242|582782728|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
161380876|NCT02257242|582782729|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380877|NCT02257242|582782730|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380878|NCT02257242|582782731|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380879|NCT02257242|582782732|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380880|NCT02257242|582782733|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380881|NCT02257242|582782734|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380882|NCT02257242|582782735|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380883|NCT02257242|582782736|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161380884|NCT00600106|582782737|FG000|Overall Study|Withdrawal by Subject|1|||
161380885|NCT00600106|582782738|FG001|Overall Study|Withdrawal by Subject|1|||
161380886|NCT02213926|582782741|FG000|Overall Study|Death|59|||
161380887|NCT02213926|582782741|FG000|Overall Study|Withdrawal by Subject|10|||
161380888|NCT02213926|582782741|FG000|Overall Study|study terminated by sponsor|51|||
161380889|NCT02213926|582782741|FG000|Overall Study|Lost to Follow-up|3|||
161380890|NCT02213926|582782741|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
161380891|NCT01188551|582782742|FG000|Overall Study|Pharmacy issues|1|||
161380892|NCT01188551|582782743|FG001|Overall Study|Pharmacy issues|0|||
161380893|NCT01188551|582782744|FG002|Overall Study|Pharmacy issues|0|||
161380894|NCT01188551|582782745|FG003|Overall Study|Pharmacy issues|0|||
161380895|NCT01306643|582782750|FG000|Overall Study|Adverse Event|5|||
161380896|NCT01306643|582782750|FG000|Overall Study|Disease Progression|7|||
161380897|NCT01306643|582782750|FG000|Overall Study|Other: Change in Eligibility Status|1|||
161380898|NCT04024436|582782752|FG000|Overall Study|Death|10|||
161380899|NCT04024436|582782753|FG001|Overall Study|Death|14|||
161380900|NCT04024436|582782754|FG002|Overall Study|Death|2|||
161380901|NCT04024436|582782755|FG003|Overall Study|Death|7|||
161380902|NCT04024436|582782752|FG000|Overall Study|Loss to follow up|1|||
161380903|NCT04024436|582782753|FG001|Overall Study|Loss to follow up|0|||
161380904|NCT04024436|582782754|FG002|Overall Study|Loss to follow up|0|||
161380905|NCT04024436|582782755|FG003|Overall Study|Loss to follow up|1|||
161380906|NCT04024436|582782752|FG000|Overall Study|Withdrawal of consent|2|||
161380907|NCT04024436|582782753|FG001|Overall Study|Withdrawal of consent|0|||
161380908|NCT04024436|582782754|FG002|Overall Study|Withdrawal of consent|0|||
161380909|NCT04024436|582782755|FG003|Overall Study|Withdrawal of consent|1|||
161380910|NCT04024436|582782752|FG000|Overall Study|Study termination by sponsor|4|||
161380911|NCT04024436|582782753|FG001|Overall Study|Study termination by sponsor|6|||
161380912|NCT04024436|582782754|FG002|Overall Study|Study termination by sponsor|2|||
161380913|NCT04024436|582782755|FG003|Overall Study|Study termination by sponsor|11|||
161380914|NCT04024436|582782752|FG000|Overall Study|Reason Not Specified|0|||
161380915|NCT04024436|582782753|FG001|Overall Study|Reason Not Specified|1|||
161380916|NCT04024436|582782754|FG002|Overall Study|Reason Not Specified|0|||
161380917|NCT04024436|582782755|FG003|Overall Study|Reason Not Specified|2|||
161380918|NCT01169337|582782756|FG000|Overall Study|Lack of Efficacy|5|||
161380919|NCT01169337|582782757|FG001|Overall Study|Lack of Efficacy|7|||
161380920|NCT01169337|582782758|FG002|Overall Study|Lack of Efficacy|0|||
161380921|NCT01169337|582782756|FG000|Overall Study|Adverse Event|12|||
161380922|NCT01169337|582782757|FG001|Overall Study|Adverse Event|18|||
161380923|NCT01169337|582782758|FG002|Overall Study|Adverse Event|0|||
161380924|NCT01169337|582782756|FG000|Overall Study|Death|2|||
161380925|NCT01169337|582782757|FG001|Overall Study|Death|0|||
161380926|NCT01169337|582782758|FG002|Overall Study|Death|0|||
161380927|NCT01169337|582782756|FG000|Overall Study|Withdrawal by Subject|11|||
161380928|NCT01169337|582782757|FG001|Overall Study|Withdrawal by Subject|11|||
161380929|NCT01169337|582782758|FG002|Overall Study|Withdrawal by Subject|6|||
161380930|NCT01169337|582782756|FG000|Overall Study|Noncompliance|2|||
161380931|NCT01169337|582782757|FG001|Overall Study|Noncompliance|0|||
161380932|NCT01169337|582782758|FG002|Overall Study|Noncompliance|0|||
161380933|NCT01169337|582782756|FG000|Overall Study|Other complicating disease|1|||
161380934|NCT01169337|582782757|FG001|Overall Study|Other complicating disease|1|||
161380935|NCT01169337|582782758|FG002|Overall Study|Other complicating disease|0|||
161380936|NCT01169337|582782756|FG000|Overall Study|Physician Decision|1|||
161380937|NCT01169337|582782757|FG001|Overall Study|Physician Decision|5|||
161380938|NCT01169337|582782758|FG002|Overall Study|Physician Decision|0|||
161380939|NCT01169337|582782756|FG000|Overall Study|Alternative therapy|0|||
161380940|NCT01169337|582782757|FG001|Overall Study|Alternative therapy|2|||
161380941|NCT01169337|582782758|FG002|Overall Study|Alternative therapy|0|||
161380942|NCT01169337|582782756|FG000|Overall Study|Changed hospital|0|||
161380943|NCT01169337|582782757|FG001|Overall Study|Changed hospital|1|||
161380944|NCT01169337|582782758|FG002|Overall Study|Changed hospital|0|||
161380945|NCT01169337|582782756|FG000|Overall Study|Never started treatment|0|||
161380946|NCT01169337|582782757|FG001|Overall Study|Never started treatment|2|||
161380947|NCT01169337|582782758|FG002|Overall Study|Never started treatment|0|||
161380948|NCT01169337|582782756|FG000|Overall Study|Reason not reported|1|||
161380949|NCT01169337|582782757|FG001|Overall Study|Reason not reported|0|||
161380950|NCT01169337|582782758|FG002|Overall Study|Reason not reported|0|||
161380951|NCT01169337|582782756|FG000|Overall Study|Continuing lenalidomide|9|||
161380952|NCT01169337|582782757|FG001|Overall Study|Continuing lenalidomide|43|||
161380953|NCT01169337|582782758|FG002|Overall Study|Continuing lenalidomide|0|||
161380954|NCT05507567|582782760|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
161380955|NCT05507567|582782761|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
161380956|NCT05507567|582782762|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
161380957|NCT05507567|582782760|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
161380958|NCT05507567|582782761|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
161380959|NCT05507567|582782762|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
161380960|NCT05507567|582782760|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
161380961|NCT05507567|582782761|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
161380962|NCT05507567|582782762|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
161380963|NCT05507567|582782760|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
161380964|NCT05507567|582782761|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
161380965|NCT05507567|582782762|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
161380966|NCT01485796|582782763|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
161380967|NCT01485796|582782763|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
161380968|NCT01485796|582782763|FG000|Period 2: Epoch 2|Adverse Event|3|||
161380969|NCT01485796|582782763|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
161380970|NCT01485796|582782763|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
161380971|NCT01485796|582782763|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
161380972|NCT01485796|582782763|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
161380973|NCT01485796|582782763|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
161380974|NCT04830215|582782764|FG000|Overall Study|Adverse Event|6|||
161380975|NCT04830215|582782764|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
161380976|NCT04830215|582782764|FG000|Overall Study|Withdrawal by Subject|3|||
161380977|NCT04830215|582782764|FG000|Overall Study|Protocol Deviation|1|||
161380978|NCT01643408|582782766|FG000|Overall Study|Adverse Event|12|||
161380979|NCT01643408|582782766|FG000|Overall Study|Other|2|||
161380980|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
161380981|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
161380982|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380983|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380984|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380985|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380986|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380987|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380988|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380989|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161380990|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
161380991|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
161380992|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380993|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380994|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380995|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380996|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380997|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380998|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161380999|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161381000|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
161381001|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381002|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381003|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381004|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381005|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381006|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381007|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381008|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381009|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161381010|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
161381011|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
161381012|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381013|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381014|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381015|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381016|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381017|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381018|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381019|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161381020|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381021|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
161381022|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381023|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381024|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381025|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381026|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381027|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381028|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381029|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161381030|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
161381031|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
161381032|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381033|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381034|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381035|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381036|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381037|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381038|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161435295|NCT01710345|582987978|FG002|Overall Study|Adverse Event|0|||
161381039|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161381040|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
161381041|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
161381042|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381043|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381044|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381045|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381046|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381047|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381048|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381049|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161381050|NCT01194219|582782767|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
161381051|NCT01194219|582782768|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
161381052|NCT01194219|582782769|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381053|NCT01194219|582782770|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381054|NCT01194219|582782771|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381055|NCT01194219|582782772|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381056|NCT01194219|582782773|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381057|NCT01194219|582782774|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381058|NCT01194219|582782775|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381059|NCT01194219|582782776|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161381060|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381061|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381062|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
161381063|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
161381064|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381065|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381066|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381067|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381068|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381069|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
161381070|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381071|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381072|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
161381073|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
161381074|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381075|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381076|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381077|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381078|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381079|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161381080|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381081|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381082|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
161381083|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
161381084|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381085|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381086|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381087|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381088|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381089|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161381090|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381091|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381092|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
161381093|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
161381094|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381095|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381096|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381097|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381098|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381099|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161381100|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381101|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381102|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
161381103|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381104|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381105|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381106|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381107|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381108|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381109|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161381110|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381111|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381112|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381113|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
161381114|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381115|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381116|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381117|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381118|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381119|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161381120|NCT01194219|582782767|FG000|Maintenance Phase Weeks16-32|Other|0|||
161381121|NCT01194219|582782768|FG001|Maintenance Phase Weeks16-32|Other|0|||
161381122|NCT01194219|582782769|FG002|Maintenance Phase Weeks16-32|Other|2|||
161381123|NCT01194219|582782770|FG003|Maintenance Phase Weeks16-32|Other|1|||
161381124|NCT01194219|582782771|FG004|Maintenance Phase Weeks16-32|Other|0|||
161381125|NCT01194219|582782772|FG005|Maintenance Phase Weeks16-32|Other|0|||
161381126|NCT01194219|582782773|FG006|Maintenance Phase Weeks16-32|Other|0|||
161381127|NCT01194219|582782774|FG007|Maintenance Phase Weeks16-32|Other|0|||
161381128|NCT01194219|582782775|FG008|Maintenance Phase Weeks16-32|Other|0|||
161381129|NCT01194219|582782776|FG009|Maintenance Phase Weeks16-32|Other|0|||
161381130|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381131|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381132|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381133|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381134|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381135|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
161381136|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
161381137|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
161381138|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381139|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161381140|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161381141|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161381142|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161381143|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161381144|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
161381145|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
161381146|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
161381147|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
161381148|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161381149|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161381150|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381151|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381152|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381153|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381154|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
161381155|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381156|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
161381157|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381158|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381159|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161381160|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381161|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381162|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381163|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381164|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
161381165|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381166|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
161381167|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
161381168|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381169|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161381170|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381171|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381172|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381173|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381174|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
161381175|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
161381176|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
161381177|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381178|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381179|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161381180|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381181|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381182|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381183|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381184|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381185|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381186|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381187|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
161381188|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381189|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161381190|NCT01194219|582782767|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381191|NCT01194219|582782768|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381192|NCT01194219|582782769|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381193|NCT01194219|582782770|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381194|NCT01194219|582782771|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381195|NCT01194219|582782772|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381196|NCT01194219|582782773|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
161381197|NCT01194219|582782774|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381198|NCT01194219|582782775|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381199|NCT01194219|582782776|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161381200|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381201|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381202|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381203|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381204|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381205|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381206|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381207|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161381208|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
161381209|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
161381210|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381211|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381212|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381213|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381214|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381215|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381216|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381217|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161381218|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
161381219|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
161381220|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381221|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381222|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381223|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381224|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381225|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381226|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381227|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161381228|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
161381229|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
161381230|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381231|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381232|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381233|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381234|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381235|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381236|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381237|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161381238|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
161381239|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
161381240|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
161381241|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
161381242|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
161381243|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
161381244|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
161381245|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
161381246|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
161381247|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
161381248|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
161381249|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
161381250|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381251|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381252|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381253|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381254|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381255|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381256|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381257|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161381258|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
161381259|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
161381260|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381261|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381262|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381263|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381264|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381265|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381266|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381267|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381268|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
161381269|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161381270|NCT01194219|582782767|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381271|NCT01194219|582782768|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381272|NCT01194219|582782769|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381273|NCT01194219|582782770|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381274|NCT01194219|582782771|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381275|NCT01194219|582782772|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381276|NCT01194219|582782773|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381277|NCT01194219|582782774|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161381278|NCT01194219|582782775|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
161381279|NCT01194219|582782776|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
161381280|NCT03726658|582782777|FG000|Overall Study|Lost to Follow-up|0|||
161381281|NCT03726658|582782778|FG001|Overall Study|Lost to Follow-up|0|||
161381282|NCT03726658|582782779|FG002|Overall Study|Lost to Follow-up|2|||
161381283|NCT03726658|582782780|FG003|Overall Study|Lost to Follow-up|0|||
161381284|NCT03726658|582782781|FG004|Overall Study|Lost to Follow-up|0|||
161381285|NCT03726658|582782782|FG005|Overall Study|Lost to Follow-up|1|||
161381286|NCT03726658|582782783|FG006|Overall Study|Lost to Follow-up|1|||
161381287|NCT03726658|582782777|FG000|Overall Study|Withdrawal by Subject|1|||
161381288|NCT03726658|582782778|FG001|Overall Study|Withdrawal by Subject|0|||
161381289|NCT03726658|582782779|FG002|Overall Study|Withdrawal by Subject|0|||
161381290|NCT03726658|582782780|FG003|Overall Study|Withdrawal by Subject|0|||
161381291|NCT03726658|582782781|FG004|Overall Study|Withdrawal by Subject|6|||
161381292|NCT03726658|582782782|FG005|Overall Study|Withdrawal by Subject|4|||
161381293|NCT03726658|582782783|FG006|Overall Study|Withdrawal by Subject|2|||
161381294|NCT03726658|582782777|FG000|Overall Study|Pregnancy|0|||
161381295|NCT03726658|582782778|FG001|Overall Study|Pregnancy|0|||
161381296|NCT03726658|582782779|FG002|Overall Study|Pregnancy|0|||
161381297|NCT03726658|582782780|FG003|Overall Study|Pregnancy|0|||
161381298|NCT03726658|582782781|FG004|Overall Study|Pregnancy|0|||
161381299|NCT03726658|582782782|FG005|Overall Study|Pregnancy|0|||
161381300|NCT03726658|582782783|FG006|Overall Study|Pregnancy|1|||
161381301|NCT03726658|582782777|FG000|Overall Study|Not Reported|0|||
161381302|NCT03726658|582782778|FG001|Overall Study|Not Reported|0|||
161381303|NCT03726658|582782779|FG002|Overall Study|Not Reported|0|||
161381304|NCT03726658|582782780|FG003|Overall Study|Not Reported|0|||
161381305|NCT03726658|582782781|FG004|Overall Study|Not Reported|0|||
161381306|NCT03726658|582782782|FG005|Overall Study|Not Reported|0|||
161381307|NCT03726658|582782783|FG006|Overall Study|Not Reported|1|||
161381308|NCT05710640|582782784|FG000|Overall Study|Physician Decision|0|||
161381309|NCT05710640|582782785|FG001|Overall Study|Physician Decision|1|||
161381310|NCT05710640|582782784|FG000|Overall Study|Withdrawal by Subject|1|||
161381311|NCT05710640|582782785|FG001|Overall Study|Withdrawal by Subject|0|||
161381312|NCT05710640|582782784|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
161381313|NCT05710640|582782785|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
161381314|NCT04188509|582782786|FG000|Overall Study|Adverse Event|2|||
161381315|NCT04188509|582782786|FG000|Overall Study|Lost to Follow-up|1|||
161381316|NCT04188509|582782786|FG000|Overall Study|Withdrawal of Consent|1|||
161381317|NCT04188509|582782786|FG000|Overall Study|Discretion of Investigator|1|||
161381318|NCT04188509|582782786|FG000|Overall Study|Noncompliance|3|||
161381319|NCT04188509|582782786|FG000|Overall Study|Sponsor Decision|127|||
161381320|NCT04188509|582782786|FG000|Overall Study|Other|2|||
161381321|NCT00049322|582782796|FG000|Overall Study|disease burden|0|||
161381322|NCT00049322|582782797|FG001|Overall Study|disease burden|3|||
161381323|NCT00049322|582782796|FG000|Overall Study|Adverse Event|1|||
161381324|NCT00049322|582782797|FG001|Overall Study|Adverse Event|0|||
161381325|NCT00049322|582782796|FG000|Overall Study|refused angio|0|||
161381326|NCT00049322|582782797|FG001|Overall Study|refused angio|3|||
161381327|NCT00703963|582782798|FG000|Overall Study|Withdrawal by Subject|7|||
161381328|NCT00703963|582782799|FG001|Overall Study|Withdrawal by Subject|13|||
161381329|NCT00703963|582782798|FG000|Overall Study|Physician Decision|0|||
161381330|NCT00703963|582782799|FG001|Overall Study|Physician Decision|1|||
161381331|NCT03994211|582782800|FG000|Core Phase|Adverse Event|0|||
161381332|NCT03994211|582782801|FG001|Core Phase|Adverse Event|1|||
161381333|NCT03994211|582782802|FG002|Core Phase|Adverse Event|0|||
161381334|NCT03994211|582782800|FG000|Extension Phase|Adverse Event|0|||
161381335|NCT03994211|582782801|FG001|Extension Phase|Adverse Event|0|||
161381336|NCT03994211|582782802|FG002|Extension Phase|Adverse Event|1|||
161381337|NCT03994211|582782800|FG000|Extension Phase|Physician Decision|0|||
161381338|NCT03994211|582782801|FG001|Extension Phase|Physician Decision|0|||
161381339|NCT03994211|582782802|FG002|Extension Phase|Physician Decision|1|||
161381340|NCT03994211|582782800|FG000|Extension Phase|Progressive Disease|0|||
161381341|NCT03994211|582782801|FG001|Extension Phase|Progressive Disease|0|||
161381342|NCT03994211|582782802|FG002|Extension Phase|Progressive Disease|20|||
161381343|NCT03994211|582782800|FG000|Extension Phase|Withdrawal by Subject|0|||
161381344|NCT03994211|582782801|FG001|Extension Phase|Withdrawal by Subject|0|||
161381345|NCT03994211|582782802|FG002|Extension Phase|Withdrawal by Subject|2|||
161381346|NCT00503425|582782803|FG000|Overall Study|Participant files lost|6|||
161381347|NCT00503425|582782803|FG000|Overall Study|Adverse Event|5|||
161381348|NCT00503425|582782803|FG000|Overall Study|Lack of Efficacy|25|||
161381349|NCT00503425|582782803|FG000|Overall Study|Withdrawal by Subject|8|||
161381350|NCT00503425|582782803|FG000|Overall Study|Lost to Follow-up|3|||
161381351|NCT00503425|582782803|FG000|Overall Study|Death|3|||
161381352|NCT00503425|582782803|FG000|Overall Study|Missing Data/Unknown|4|||
161381353|NCT02148263|582782804|FG000|Overall Study|Withdrawal by Subject|3|||
161381354|NCT02148263|582782805|FG001|Overall Study|Withdrawal by Subject|2|||
161381355|NCT03900728|582782806|FG000|Overall Study|No text responses|0|||
161381356|NCT03900728|582782807|FG001|Overall Study|No text responses|0|||
161381357|NCT03900728|582782808|FG002|Overall Study|No text responses|4|||
161381358|NCT00763256|582782810|FG000|Overall Study|Didn't return for appointments|7|||
161381359|NCT00763256|582782811|FG001|Overall Study|Didn't return for appointments|10|||
161381360|NCT03364231|582782812|FG000|Overall Study|Adverse Event|1|||
161381361|NCT03364231|582782813|FG001|Overall Study|Adverse Event|4|||
161381362|NCT03364231|582782812|FG000|Overall Study|Death|1|||
161381363|NCT03364231|582782813|FG001|Overall Study|Death|0|||
161381364|NCT03364231|582782812|FG000|Overall Study|Investigator Decision|2|||
161381365|NCT03364231|582782813|FG001|Overall Study|Investigator Decision|2|||
161381366|NCT03364231|582782812|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
161381367|NCT03364231|582782813|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
161381368|NCT03364231|582782812|FG000|Overall Study|Withdrawal of Subject Consent|1|||
161381369|NCT03364231|582782813|FG001|Overall Study|Withdrawal of Subject Consent|0|||
161381370|NCT03364231|582782812|FG000|Overall Study|Reason Not Specified|1|||
161381371|NCT03364231|582782813|FG001|Overall Study|Reason Not Specified|0|||
161381372|NCT03364231|582782812|FG000|Overall Study|Disease Progression|0|||
161381373|NCT03364231|582782813|FG001|Overall Study|Disease Progression|6|||
161381374|NCT01393899|582782820|FG000|Overall Study|Study terminated by sponsor|1|||
161381375|NCT01393899|582782821|FG001|Overall Study|Study terminated by sponsor|0|||
161381376|NCT01393899|582782822|FG002|Overall Study|Study terminated by sponsor|1|||
161381377|NCT01393899|582782820|FG000|Overall Study|Other|1|||
161381378|NCT01393899|582782821|FG001|Overall Study|Other|0|||
161381379|NCT01393899|582782822|FG002|Overall Study|Other|0|||
161381380|NCT01393899|582782820|FG000|Overall Study|Withdrawal by Subject|2|||
161381381|NCT01393899|582782821|FG001|Overall Study|Withdrawal by Subject|2|||
161381382|NCT01393899|582782822|FG002|Overall Study|Withdrawal by Subject|1|||
161381383|NCT01393899|582782820|FG000|Overall Study|Lost to Follow-up|0|||
161381384|NCT01393899|582782821|FG001|Overall Study|Lost to Follow-up|0|||
161381385|NCT01393899|582782822|FG002|Overall Study|Lost to Follow-up|1|||
161381386|NCT01393899|582782820|FG000|Overall Study|Does not meet entrance criteria|1|||
161381387|NCT01393899|582782821|FG001|Overall Study|Does not meet entrance criteria|0|||
161381388|NCT01393899|582782822|FG002|Overall Study|Does not meet entrance criteria|1|||
161381389|NCT01393899|582782820|FG000|Overall Study|Lack of Efficacy|26|||
161381390|NCT01393899|582782821|FG001|Overall Study|Lack of Efficacy|21|||
161381391|NCT01393899|582782822|FG002|Overall Study|Lack of Efficacy|16|||
161381392|NCT01393899|582782820|FG000|Overall Study|Adverse Event|1|||
161381393|NCT01393899|582782821|FG001|Overall Study|Adverse Event|5|||
161381394|NCT01393899|582782822|FG002|Overall Study|Adverse Event|3|||
161381395|NCT02503085|582782823|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
161381396|NCT02503085|582782824|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
161381397|NCT02503085|582782825|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
161381398|NCT02503085|582782826|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
161381399|NCT01162473|582782830|FG000|Overall Study|Adverse Event|2|||
161381400|NCT01162473|582782831|FG001|Overall Study|Adverse Event|1|||
161381401|NCT01162473|582782830|FG000|Overall Study|Withdrawal by Subject|0|||
161381402|NCT01162473|582782831|FG001|Overall Study|Withdrawal by Subject|4|||
161381403|NCT01144416|582782832|FG000|Intervention Period|Adverse Event|5|||
161381404|NCT01144416|582782833|FG001|Intervention Period|Adverse Event|6|||
161381405|NCT01144416|582782832|FG000|Intervention Period|Insufficient ovarian response|11|||
161381406|NCT01144416|582782833|FG001|Intervention Period|Insufficient ovarian response|17|||
161381407|NCT01144416|582782832|FG000|Intervention Period|Risk of OHSS|0|||
161381408|NCT01144416|582782833|FG001|Intervention Period|Risk of OHSS|1|||
161381409|NCT01144416|582782832|FG000|Intervention Period|Too high ovarian response|4|||
161381410|NCT01144416|582782833|FG001|Intervention Period|Too high ovarian response|2|||
161381411|NCT01144416|582782832|FG000|Intervention Period|No/too few/bad oocytes|7|||
161381412|NCT01144416|582782833|FG001|Intervention Period|No/too few/bad oocytes|5|||
161381413|NCT01144416|582782832|FG000|Intervention Period|No or abnormal fertilization|25|||
161381414|NCT01144416|582782833|FG001|Intervention Period|No or abnormal fertilization|10|||
161381415|NCT01144416|582782832|FG000|Intervention Period|No/too few/bad quality embryos|3|||
161381416|NCT01144416|582782833|FG001|Intervention Period|No/too few/bad quality embryos|3|||
161381417|NCT01144416|582782832|FG000|Intervention Period|Other|7|||
161381418|NCT01144416|582782833|FG001|Intervention Period|Other|5|||
161381419|NCT00124072|582782834|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
161381420|NCT00124072|582782835|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
161381421|NCT00124072|582782836|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
161381422|NCT00124072|582782837|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
161381423|NCT00124072|582782834|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
161381424|NCT00124072|582782835|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
161381425|NCT00124072|582782836|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
161381426|NCT00124072|582782837|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
161381427|NCT00124072|582782834|FG000|Overall Study|Death|499|||
161381428|NCT00124072|582782835|FG001|Overall Study|Death|484|||
161381429|NCT00124072|582782836|FG002|Overall Study|Death|471|||
161381430|NCT00124072|582782837|FG003|Overall Study|Death|480|||
161381431|NCT00414076|582782838|FG000|Overall Study|Progression|1|||
161381432|NCT00414076|582782839|FG001|Overall Study|Progression|2|||
161381433|NCT00414076|582782838|FG000|Overall Study|Withdrawal by Subject|1|||
161381434|NCT00414076|582782839|FG001|Overall Study|Withdrawal by Subject|3|||
161381435|NCT00414076|582782838|FG000|Overall Study|Adverse Event|1|||
161381436|NCT00414076|582782839|FG001|Overall Study|Adverse Event|0|||
161381437|NCT03670355|582782847|FG000|Overall Study|Adverse Event|1|||
161381438|NCT03670355|582782848|FG001|Overall Study|Adverse Event|0|||
161381439|NCT03670355|582782847|FG000|Overall Study|Unable to comply with study procedures|0|||
161381440|NCT03670355|582782848|FG001|Overall Study|Unable to comply with study procedures|1|||
161381441|NCT03670355|582782847|FG000|Overall Study|Participant refused|0|||
161381442|NCT03670355|582782848|FG001|Overall Study|Participant refused|1|||
161381443|NCT02268383|582782851|FG000|Overall Study|Death|12|||
161381444|NCT02268383|582782851|FG000|Overall Study|Lost to Follow-up|2|||
161381445|NCT02268383|582782851|FG000|Overall Study|Withdrawal by Subject|9|||
161381446|NCT02268383|582782851|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
161381447|NCT02268383|582782851|FG000|Overall Study|Protocol deviation|3|||
161381448|NCT02268383|582782851|FG000|Overall Study|Sponsor decision|22|||
161381449|NCT02268383|582782851|FG000|Overall Study|Not reported|12|||
161381450|NCT02708680|582782854|FG000|Overall Study|Withdrawal by Subject|4|||
161381451|NCT02708680|582782855|FG001|Overall Study|Withdrawal by Subject|12|||
161381452|NCT02708680|582782856|FG002|Overall Study|Withdrawal by Subject|12|||
161381453|NCT02708680|582782854|FG000|Overall Study|Death|4|||
161381454|NCT02708680|582782855|FG001|Overall Study|Death|19|||
161381455|NCT02708680|582782856|FG002|Overall Study|Death|21|||
161381456|NCT02708680|582782854|FG000|Overall Study|Lost to Follow-up|0|||
161381457|NCT02708680|582782855|FG001|Overall Study|Lost to Follow-up|3|||
161381458|NCT02708680|582782856|FG002|Overall Study|Lost to Follow-up|3|||
161381459|NCT02708680|582782854|FG000|Overall Study|Study Terminated By Sponsor|0|||
161381460|NCT02708680|582782855|FG001|Overall Study|Study Terminated By Sponsor|5|||
161381461|NCT02708680|582782856|FG002|Overall Study|Study Terminated By Sponsor|4|||
161381462|NCT02708680|582782854|FG000|Overall Study|Other than Specified|0|||
161381463|NCT02708680|582782855|FG001|Overall Study|Other than Specified|0|||
161381464|NCT02708680|582782856|FG002|Overall Study|Other than Specified|1|||
161381465|NCT02708680|582782854|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
161381466|NCT02708680|582782855|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
161381467|NCT02708680|582782856|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
161381468|NCT01342926|582782857|FG000|Overall Study|Adverse Event|5|||
161381469|NCT01342926|582782858|FG001|Overall Study|Adverse Event|8|||
161381470|NCT01342926|582782859|FG002|Overall Study|Adverse Event|10|||
161381471|NCT01342926|582782860|FG003|Overall Study|Adverse Event|7|||
161381472|NCT01342926|582782857|FG000|Overall Study|Lost to Follow-up|0|||
161381473|NCT01342926|582782858|FG001|Overall Study|Lost to Follow-up|1|||
161381474|NCT01342926|582782859|FG002|Overall Study|Lost to Follow-up|1|||
161381475|NCT01342926|582782860|FG003|Overall Study|Lost to Follow-up|0|||
161381476|NCT01342926|582782857|FG000|Overall Study|Investigator Discretion|2|||
161381477|NCT01342926|582782858|FG001|Overall Study|Investigator Discretion|2|||
161381478|NCT01342926|582782859|FG002|Overall Study|Investigator Discretion|0|||
161381479|NCT01342926|582782860|FG003|Overall Study|Investigator Discretion|0|||
161381480|NCT01342926|582782857|FG000|Overall Study|Withdrawal by Subject|2|||
161381481|NCT01342926|582782858|FG001|Overall Study|Withdrawal by Subject|4|||
161381482|NCT01342926|582782859|FG002|Overall Study|Withdrawal by Subject|3|||
161381483|NCT01342926|582782860|FG003|Overall Study|Withdrawal by Subject|5|||
161381484|NCT04162470|582782861|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
161381485|NCT05526521|582782866|FG000|Overall Study|Withdrawal by Subject|0|||
161381486|NCT05526521|582782867|FG001|Overall Study|Withdrawal by Subject|1|||
161381487|NCT05526521|582782868|FG002|Overall Study|Withdrawal by Subject|0|||
161381488|NCT05526521|582782869|FG003|Overall Study|Withdrawal by Subject|0|||
161381489|NCT01544348|582782872|FG000|Overall Study|Lost to Follow-up|1|||
161381490|NCT01544348|582782873|FG001|Overall Study|Lost to Follow-up|0|||
161381491|NCT01544348|582782874|FG002|Overall Study|Lost to Follow-up|0|||
161381492|NCT01544348|582782875|FG003|Overall Study|Lost to Follow-up|0|||
161381493|NCT01544348|582782876|FG004|Overall Study|Lost to Follow-up|0|||
161381494|NCT01544348|582782877|FG005|Overall Study|Lost to Follow-up|0|||
161381495|NCT01544348|582782878|FG006|Overall Study|Lost to Follow-up|1|||
161381496|NCT01544348|582782879|FG007|Overall Study|Lost to Follow-up|0|||
161381497|NCT01544348|582782872|FG000|Overall Study|Withdrawal by Subject|1|||
161381498|NCT01544348|582782873|FG001|Overall Study|Withdrawal by Subject|0|||
161381499|NCT01544348|582782874|FG002|Overall Study|Withdrawal by Subject|0|||
161381500|NCT01544348|582782875|FG003|Overall Study|Withdrawal by Subject|0|||
161381501|NCT01544348|582782876|FG004|Overall Study|Withdrawal by Subject|1|||
161381502|NCT01544348|582782877|FG005|Overall Study|Withdrawal by Subject|2|||
161381503|NCT01544348|582782878|FG006|Overall Study|Withdrawal by Subject|1|||
161381504|NCT01544348|582782879|FG007|Overall Study|Withdrawal by Subject|0|||
161381505|NCT01544348|582782872|FG000|Overall Study|Physician Decision|0|||
161381506|NCT01544348|582782873|FG001|Overall Study|Physician Decision|0|||
161381507|NCT01544348|582782874|FG002|Overall Study|Physician Decision|0|||
161381508|NCT01544348|582782875|FG003|Overall Study|Physician Decision|0|||
161381509|NCT01544348|582782876|FG004|Overall Study|Physician Decision|0|||
161381510|NCT01544348|582782877|FG005|Overall Study|Physician Decision|1|||
161381511|NCT01544348|582782878|FG006|Overall Study|Physician Decision|0|||
161381512|NCT01544348|582782879|FG007|Overall Study|Physician Decision|0|||
161381513|NCT03008070|582782883|FG000|Overall Study|Adverse Event|3|||
161381514|NCT03008070|582782884|FG001|Overall Study|Adverse Event|3|||
161381515|NCT03008070|582782885|FG002|Overall Study|Adverse Event|3|||
161381516|NCT03008070|582782883|FG000|Overall Study|Lost to Follow-up|1|||
161381517|NCT03008070|582782884|FG001|Overall Study|Lost to Follow-up|1|||
161381518|NCT03008070|582782885|FG002|Overall Study|Lost to Follow-up|0|||
161381519|NCT03008070|582782883|FG000|Overall Study|Non compliance|0|||
161381520|NCT03008070|582782884|FG001|Overall Study|Non compliance|1|||
161381521|NCT03008070|582782885|FG002|Overall Study|Non compliance|1|||
161381522|NCT03008070|582782883|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
161381523|NCT03008070|582782884|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
161381524|NCT03008070|582782885|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
161381525|NCT03008070|582782883|FG000|Overall Study|Withdrawal by Subject|2|||
161381526|NCT03008070|582782884|FG001|Overall Study|Withdrawal by Subject|0|||
161381527|NCT03008070|582782885|FG002|Overall Study|Withdrawal by Subject|1|||
161381528|NCT03008070|582782883|FG000|Overall Study|Use of prohibited drug|0|||
161381529|NCT03008070|582782884|FG001|Overall Study|Use of prohibited drug|0|||
161381530|NCT03008070|582782885|FG002|Overall Study|Use of prohibited drug|2|||
161381531|NCT05005273|582782886|FG000|Overall Study|Study Terminated|1|||
161381532|NCT05005273|582782887|FG001|Overall Study|Study Terminated|0|||
161381533|NCT04409834|582782888|FG000|Overall Study|Death|55|||
161381534|NCT04409834|582782889|FG001|Overall Study|Death|62|||
161381535|NCT01671956|582782891|FG000|Overall Study|Disease progression|0|||
161381536|NCT01671956|582782892|FG001|Overall Study|Disease progression|1|||
161381537|NCT01671956|582782891|FG000|Overall Study|Withdrawal by Subject|1|||
161381538|NCT01671956|582782892|FG001|Overall Study|Withdrawal by Subject|1|||
161381539|NCT01671956|582782891|FG000|Overall Study|Adverse Event|1|||
161381540|NCT01671956|582782892|FG001|Overall Study|Adverse Event|0|||
161381541|NCT04266912|582782896|FG000|Overall Study|Withdrawal by Subject|1|||
161381542|NCT04266912|582782897|FG001|Overall Study|Withdrawal by Subject|0|||
161381543|NCT04266912|582782898|FG002|Overall Study|Withdrawal by Subject|0|||
161381544|NCT04266912|582782899|FG003|Overall Study|Withdrawal by Subject|0|||
161381545|NCT04266912|582782896|FG000|Overall Study|Progression|6|||
161381546|NCT04266912|582782897|FG001|Overall Study|Progression|6|||
161381547|NCT04266912|582782898|FG002|Overall Study|Progression|0|||
161381548|NCT04266912|582782899|FG003|Overall Study|Progression|10|||
161381549|NCT05823974|582784804|FG000|Overall Study|Lost to Follow-up|0|||
161381550|NCT05823974|582784805|FG001|Overall Study|Lost to Follow-up|3|||
161381551|NCT05823974|582784806|FG002|Overall Study|Lost to Follow-up|1|||
161381552|NCT05823974|582784807|FG003|Overall Study|Lost to Follow-up|0|||
161381553|NCT05823974|582784808|FG004|Overall Study|Lost to Follow-up|1|||
161381554|NCT05823974|582784809|FG005|Overall Study|Lost to Follow-up|0|||
161381555|NCT05823974|582784810|FG006|Overall Study|Lost to Follow-up|1|||
161381556|NCT05823974|582784811|FG007|Overall Study|Lost to Follow-up|0|||
161381557|NCT05823974|582784812|FG008|Overall Study|Lost to Follow-up|0|||
161381558|NCT05823974|582784813|FG009|Overall Study|Lost to Follow-up|1|||
161381559|NCT05823974|582784814|FG010|Overall Study|Lost to Follow-up|1|||
161381560|NCT05823974|582784815|FG011|Overall Study|Lost to Follow-up|0|||
161381561|NCT05823974|582784816|FG012|Overall Study|Lost to Follow-up|1|||
161381562|NCT05823974|582784817|FG013|Overall Study|Lost to Follow-up|2|||
161381563|NCT05823974|582784818|FG014|Overall Study|Lost to Follow-up|1|||
161381564|NCT05823974|582784819|FG015|Overall Study|Lost to Follow-up|1|||
161381565|NCT05823974|582784820|FG016|Overall Study|Lost to Follow-up|1|||
161381566|NCT05823974|582784821|FG017|Overall Study|Lost to Follow-up|0|||
161381567|NCT05823974|582784822|FG018|Overall Study|Lost to Follow-up|0|||
161381568|NCT05823974|582784823|FG019|Overall Study|Lost to Follow-up|2|||
161381569|NCT05823974|582784824|FG020|Overall Study|Lost to Follow-up|0|||
161381570|NCT05823974|582784804|FG000|Overall Study|Physician Decision|0|||
161381571|NCT05823974|582784805|FG001|Overall Study|Physician Decision|0|||
161381572|NCT05823974|582784806|FG002|Overall Study|Physician Decision|0|||
161381573|NCT05823974|582784807|FG003|Overall Study|Physician Decision|0|||
161381574|NCT05823974|582784808|FG004|Overall Study|Physician Decision|0|||
161381575|NCT05823974|582784809|FG005|Overall Study|Physician Decision|0|||
161381576|NCT05823974|582784810|FG006|Overall Study|Physician Decision|0|||
161381577|NCT05823974|582784811|FG007|Overall Study|Physician Decision|0|||
161381578|NCT05823974|582784812|FG008|Overall Study|Physician Decision|0|||
161381579|NCT05823974|582784813|FG009|Overall Study|Physician Decision|0|||
161381580|NCT05823974|582784814|FG010|Overall Study|Physician Decision|0|||
161381581|NCT05823974|582784815|FG011|Overall Study|Physician Decision|0|||
161381582|NCT05823974|582784816|FG012|Overall Study|Physician Decision|0|||
161381583|NCT05823974|582784817|FG013|Overall Study|Physician Decision|0|||
161381584|NCT05823974|582784818|FG014|Overall Study|Physician Decision|0|||
161381585|NCT05823974|582784819|FG015|Overall Study|Physician Decision|1|||
161381586|NCT05823974|582784820|FG016|Overall Study|Physician Decision|0|||
161381587|NCT05823974|582784821|FG017|Overall Study|Physician Decision|1|||
161381588|NCT05823974|582784822|FG018|Overall Study|Physician Decision|1|||
161381589|NCT05823974|582784823|FG019|Overall Study|Physician Decision|0|||
161381590|NCT05823974|582784824|FG020|Overall Study|Physician Decision|0|||
161381591|NCT05823974|582784804|FG000|Overall Study|Withdrawal by Subject|1|||
161381592|NCT05823974|582784805|FG001|Overall Study|Withdrawal by Subject|1|||
161381593|NCT05823974|582784806|FG002|Overall Study|Withdrawal by Subject|2|||
161381594|NCT05823974|582784807|FG003|Overall Study|Withdrawal by Subject|0|||
161381595|NCT05823974|582784808|FG004|Overall Study|Withdrawal by Subject|2|||
161381596|NCT05823974|582784809|FG005|Overall Study|Withdrawal by Subject|3|||
161381597|NCT05823974|582784810|FG006|Overall Study|Withdrawal by Subject|1|||
161381598|NCT05823974|582784811|FG007|Overall Study|Withdrawal by Subject|1|||
161381599|NCT05823974|582784812|FG008|Overall Study|Withdrawal by Subject|2|||
161381600|NCT05823974|582784813|FG009|Overall Study|Withdrawal by Subject|1|||
161381601|NCT05823974|582784814|FG010|Overall Study|Withdrawal by Subject|1|||
161381602|NCT05823974|582784815|FG011|Overall Study|Withdrawal by Subject|0|||
161381603|NCT05823974|582784816|FG012|Overall Study|Withdrawal by Subject|0|||
161381604|NCT05823974|582784817|FG013|Overall Study|Withdrawal by Subject|1|||
161381605|NCT05823974|582784818|FG014|Overall Study|Withdrawal by Subject|1|||
161381606|NCT05823974|582784819|FG015|Overall Study|Withdrawal by Subject|3|||
161381607|NCT05823974|582784820|FG016|Overall Study|Withdrawal by Subject|0|||
161381608|NCT05823974|582784821|FG017|Overall Study|Withdrawal by Subject|2|||
161381609|NCT05823974|582784822|FG018|Overall Study|Withdrawal by Subject|2|||
161381610|NCT05823974|582784823|FG019|Overall Study|Withdrawal by Subject|0|||
161381611|NCT05823974|582784824|FG020|Overall Study|Withdrawal by Subject|1|||
161381612|NCT05823974|582784804|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381613|NCT05823974|582784805|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381614|NCT05823974|582784806|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161381615|NCT05823974|582784807|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381616|NCT05823974|582784808|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381617|NCT05823974|582784809|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381618|NCT05823974|582784810|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381619|NCT05823974|582784811|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381620|NCT05823974|582784812|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381621|NCT05823974|582784813|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381622|NCT05823974|582784814|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381623|NCT05823974|582784815|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381624|NCT05823974|582784816|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381625|NCT05823974|582784817|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381626|NCT05823974|582784818|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161381627|NCT05823974|582784819|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381628|NCT05823974|582784820|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381629|NCT05823974|582784821|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381630|NCT05823974|582784822|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381631|NCT05823974|582784823|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381632|NCT05823974|582784824|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161381633|NCT05823974|582784804|FG000|Overall Study|Other|0|||
161381634|NCT05823974|582784805|FG001|Overall Study|Other|1|||
161381635|NCT05823974|582784806|FG002|Overall Study|Other|1|||
161381636|NCT05823974|582784807|FG003|Overall Study|Other|1|||
161381637|NCT05823974|582784808|FG004|Overall Study|Other|0|||
161381638|NCT05823974|582784809|FG005|Overall Study|Other|1|||
161381639|NCT05823974|582784810|FG006|Overall Study|Other|1|||
161381640|NCT05823974|582784811|FG007|Overall Study|Other|1|||
161381641|NCT05823974|582784812|FG008|Overall Study|Other|1|||
161381642|NCT05823974|582784813|FG009|Overall Study|Other|0|||
161381643|NCT05823974|582784814|FG010|Overall Study|Other|0|||
161381644|NCT05823974|582784815|FG011|Overall Study|Other|0|||
161381645|NCT05823974|582784816|FG012|Overall Study|Other|2|||
161381646|NCT05823974|582784817|FG013|Overall Study|Other|1|||
161381647|NCT05823974|582784818|FG014|Overall Study|Other|0|||
161381648|NCT05823974|582784819|FG015|Overall Study|Other|1|||
161381649|NCT05823974|582784820|FG016|Overall Study|Other|0|||
161381650|NCT05823974|582784821|FG017|Overall Study|Other|0|||
161381651|NCT05823974|582784822|FG018|Overall Study|Other|0|||
161381652|NCT05823974|582784823|FG019|Overall Study|Other|0|||
161381653|NCT05823974|582784824|FG020|Overall Study|Other|0|||
161381654|NCT02744612|582784825|FG000|Overall Study|Withdrawal by Subject|0|||
161381655|NCT02744612|582784826|FG001|Overall Study|Withdrawal by Subject|2|||
161381656|NCT00316706|582784827|FG000|Overall Study|Lost to Follow-up|38|||
161381657|NCT00316706|582784828|FG001|Overall Study|Lost to Follow-up|48|||
161381658|NCT01133756|582784831|FG000|Overall Study|Adverse Event|1|||
161381659|NCT01133756|582784832|FG001|Overall Study|Adverse Event|2|||
161381660|NCT01133756|582784833|FG002|Overall Study|Adverse Event|1|||
161381661|NCT01133756|582784831|FG000|Overall Study|Investigator Decision|1|||
161381662|NCT01133756|582784832|FG001|Overall Study|Investigator Decision|0|||
161381663|NCT01133756|582784833|FG002|Overall Study|Investigator Decision|0|||
161381664|NCT01133756|582784831|FG000|Overall Study|Withdrawal by Subject|0|||
161381665|NCT01133756|582784832|FG001|Overall Study|Withdrawal by Subject|1|||
161381666|NCT01133756|582784833|FG002|Overall Study|Withdrawal by Subject|0|||
161381667|NCT01133756|582784831|FG000|Overall Study|Progression of Disease|0|||
161381668|NCT01133756|582784832|FG001|Overall Study|Progression of Disease|0|||
161381669|NCT01133756|582784833|FG002|Overall Study|Progression of Disease|1|||
161381670|NCT02574078|582784845|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381671|NCT02574078|582784846|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381672|NCT02574078|582784847|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381673|NCT02574078|582784848|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381674|NCT02574078|582784849|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381675|NCT02574078|582784850|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161381676|NCT02574078|582784851|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
161381677|NCT02574078|582784852|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381678|NCT02574078|582784853|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161381679|NCT02574078|582784854|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381680|NCT02574078|582784855|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381681|NCT02574078|582784856|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381682|NCT02574078|582784857|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161381683|NCT02574078|582784845|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161381684|NCT02574078|582784846|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161381685|NCT02574078|582784847|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
161381686|NCT02574078|582784848|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
161381687|NCT02574078|582784849|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
161381688|NCT02574078|582784850|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
161381689|NCT02574078|582784851|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
161381690|NCT02574078|582784852|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
161381691|NCT02574078|582784853|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
161381692|NCT02574078|582784854|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
161381693|NCT02574078|582784855|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
161381694|NCT02574078|582784856|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
161381695|NCT02574078|582784857|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
161381696|NCT02574078|582784845|FG000|Pre-Treatment Period|Other reasons|0|||
161381697|NCT02574078|582784846|FG001|Pre-Treatment Period|Other reasons|0|||
161381698|NCT02574078|582784847|FG002|Pre-Treatment Period|Other reasons|0|||
161381699|NCT02574078|582784848|FG003|Pre-Treatment Period|Other reasons|0|||
161381700|NCT02574078|582784849|FG004|Pre-Treatment Period|Other reasons|0|||
161381701|NCT02574078|582784850|FG005|Pre-Treatment Period|Other reasons|0|||
161381702|NCT02574078|582784851|FG006|Pre-Treatment Period|Other reasons|2|||
161381703|NCT02574078|582784852|FG007|Pre-Treatment Period|Other reasons|0|||
161381704|NCT02574078|582784853|FG008|Pre-Treatment Period|Other reasons|0|||
161381705|NCT02574078|582784854|FG009|Pre-Treatment Period|Other reasons|0|||
161381706|NCT02574078|582784855|FG010|Pre-Treatment Period|Other reasons|2|||
161381707|NCT02574078|582784856|FG011|Pre-Treatment Period|Other reasons|0|||
161381708|NCT02574078|582784857|FG012|Pre-Treatment Period|Other reasons|0|||
161381709|NCT02574078|582784845|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
161381710|NCT02574078|582784846|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
161381711|NCT02574078|582784847|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
161381712|NCT02574078|582784848|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
161381713|NCT02574078|582784849|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
161381714|NCT02574078|582784850|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
161381715|NCT02574078|582784851|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
161381716|NCT02574078|582784852|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
161381717|NCT02574078|582784853|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
161381718|NCT02574078|582784854|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
161381719|NCT02574078|582784855|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
161381720|NCT02574078|582784856|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
161381721|NCT02574078|582784857|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
161381722|NCT02574078|582784845|FG000|Treatment Period|Disease progression|6|||
161381723|NCT02574078|582784846|FG001|Treatment Period|Disease progression|4|||
161381724|NCT02574078|582784847|FG002|Treatment Period|Disease progression|7|||
161381725|NCT02574078|582784848|FG003|Treatment Period|Disease progression|18|||
161381726|NCT02574078|582784849|FG004|Treatment Period|Disease progression|16|||
161381727|NCT02574078|582784850|FG005|Treatment Period|Disease progression|26|||
161381728|NCT02574078|582784851|FG006|Treatment Period|Disease progression|5|||
161381729|NCT02574078|582784852|FG007|Treatment Period|Disease progression|9|||
161381730|NCT02574078|582784853|FG008|Treatment Period|Disease progression|8|||
161381731|NCT02574078|582784854|FG009|Treatment Period|Disease progression|5|||
161381732|NCT02574078|582784855|FG010|Treatment Period|Disease progression|20|||
161381733|NCT02574078|582784856|FG011|Treatment Period|Disease progression|29|||
161381734|NCT02574078|582784857|FG012|Treatment Period|Disease progression|2|||
161381735|NCT02574078|582784845|FG000|Treatment Period|Study drug toxicity|1|||
161381736|NCT02574078|582784846|FG001|Treatment Period|Study drug toxicity|1|||
161381737|NCT02574078|582784847|FG002|Treatment Period|Study drug toxicity|0|||
161381738|NCT02574078|582784848|FG003|Treatment Period|Study drug toxicity|5|||
161381739|NCT02574078|582784849|FG004|Treatment Period|Study drug toxicity|3|||
161381740|NCT02574078|582784850|FG005|Treatment Period|Study drug toxicity|1|||
161381741|NCT02574078|582784851|FG006|Treatment Period|Study drug toxicity|2|||
161381742|NCT02574078|582784852|FG007|Treatment Period|Study drug toxicity|0|||
161381743|NCT02574078|582784853|FG008|Treatment Period|Study drug toxicity|2|||
161381744|NCT02574078|582784854|FG009|Treatment Period|Study drug toxicity|1|||
161381745|NCT02574078|582784855|FG010|Treatment Period|Study drug toxicity|16|||
161381746|NCT02574078|582784856|FG011|Treatment Period|Study drug toxicity|2|||
161381747|NCT02574078|582784857|FG012|Treatment Period|Study drug toxicity|4|||
161381748|NCT02574078|582784845|FG000|Treatment Period|Death|2|||
161381749|NCT02574078|582784846|FG001|Treatment Period|Death|0|||
161381750|NCT02574078|582784847|FG002|Treatment Period|Death|0|||
161381751|NCT02574078|582784848|FG003|Treatment Period|Death|0|||
161381752|NCT02574078|582784849|FG004|Treatment Period|Death|1|||
161381753|NCT02574078|582784850|FG005|Treatment Period|Death|1|||
161381754|NCT02574078|582784851|FG006|Treatment Period|Death|1|||
161381755|NCT02574078|582784852|FG007|Treatment Period|Death|1|||
161381756|NCT02574078|582784853|FG008|Treatment Period|Death|7|||
161381757|NCT02574078|582784854|FG009|Treatment Period|Death|1|||
161381758|NCT02574078|582784855|FG010|Treatment Period|Death|0|||
161381759|NCT02574078|582784856|FG011|Treatment Period|Death|2|||
161381760|NCT02574078|582784857|FG012|Treatment Period|Death|1|||
161381761|NCT02574078|582784845|FG000|Treatment Period|Adverse event unrelated to drug|0|||
161381762|NCT02574078|582784846|FG001|Treatment Period|Adverse event unrelated to drug|0|||
161381763|NCT02574078|582784847|FG002|Treatment Period|Adverse event unrelated to drug|1|||
161381764|NCT02574078|582784848|FG003|Treatment Period|Adverse event unrelated to drug|0|||
161381765|NCT02574078|582784849|FG004|Treatment Period|Adverse event unrelated to drug|2|||
161381766|NCT02574078|582784850|FG005|Treatment Period|Adverse event unrelated to drug|3|||
161381767|NCT02574078|582784851|FG006|Treatment Period|Adverse event unrelated to drug|0|||
161381768|NCT02574078|582784852|FG007|Treatment Period|Adverse event unrelated to drug|0|||
161381769|NCT02574078|582784853|FG008|Treatment Period|Adverse event unrelated to drug|1|||
161381770|NCT02574078|582784854|FG009|Treatment Period|Adverse event unrelated to drug|2|||
161381771|NCT02574078|582784855|FG010|Treatment Period|Adverse event unrelated to drug|4|||
161381772|NCT02574078|582784856|FG011|Treatment Period|Adverse event unrelated to drug|1|||
161381773|NCT02574078|582784857|FG012|Treatment Period|Adverse event unrelated to drug|0|||
161381774|NCT02574078|582784845|FG000|Treatment Period|Administrative reason by Sponsor|0|||
161381775|NCT02574078|582784846|FG001|Treatment Period|Administrative reason by Sponsor|1|||
161381776|NCT02574078|582784847|FG002|Treatment Period|Administrative reason by Sponsor|0|||
161381777|NCT02574078|582784848|FG003|Treatment Period|Administrative reason by Sponsor|0|||
161381778|NCT02574078|582784849|FG004|Treatment Period|Administrative reason by Sponsor|0|||
161381779|NCT02574078|582784850|FG005|Treatment Period|Administrative reason by Sponsor|0|||
161381780|NCT02574078|582784851|FG006|Treatment Period|Administrative reason by Sponsor|1|||
161381781|NCT02574078|582784852|FG007|Treatment Period|Administrative reason by Sponsor|0|||
161381782|NCT02574078|582784853|FG008|Treatment Period|Administrative reason by Sponsor|0|||
161381783|NCT02574078|582784854|FG009|Treatment Period|Administrative reason by Sponsor|0|||
161381784|NCT02574078|582784855|FG010|Treatment Period|Administrative reason by Sponsor|0|||
161381785|NCT02574078|582784856|FG011|Treatment Period|Administrative reason by Sponsor|0|||
161381786|NCT02574078|582784857|FG012|Treatment Period|Administrative reason by Sponsor|3|||
161381787|NCT02574078|582784845|FG000|Treatment Period|Other reasons|1|||
161381788|NCT02574078|582784846|FG001|Treatment Period|Other reasons|0|||
161381789|NCT02574078|582784847|FG002|Treatment Period|Other reasons|1|||
161381790|NCT02574078|582784848|FG003|Treatment Period|Other reasons|3|||
161381791|NCT02574078|582784849|FG004|Treatment Period|Other reasons|3|||
161381792|NCT02574078|582784850|FG005|Treatment Period|Other reasons|1|||
161381793|NCT02574078|582784851|FG006|Treatment Period|Other reasons|2|||
161381794|NCT02574078|582784852|FG007|Treatment Period|Other reasons|1|||
161381795|NCT02574078|582784853|FG008|Treatment Period|Other reasons|3|||
161381796|NCT02574078|582784854|FG009|Treatment Period|Other reasons|1|||
161381797|NCT02574078|582784855|FG010|Treatment Period|Other reasons|1|||
161381798|NCT02574078|582784856|FG011|Treatment Period|Other reasons|3|||
161381799|NCT02574078|582784857|FG012|Treatment Period|Other reasons|1|||
161381800|NCT02574078|582784845|FG000|Treatment Period|Participant request to stop drug|0|||
161381801|NCT02574078|582784846|FG001|Treatment Period|Participant request to stop drug|0|||
161381802|NCT02574078|582784847|FG002|Treatment Period|Participant request to stop drug|0|||
161381803|NCT02574078|582784848|FG003|Treatment Period|Participant request to stop drug|2|||
161381804|NCT02574078|582784849|FG004|Treatment Period|Participant request to stop drug|4|||
161381805|NCT02574078|582784850|FG005|Treatment Period|Participant request to stop drug|0|||
161381806|NCT02574078|582784851|FG006|Treatment Period|Participant request to stop drug|1|||
161381807|NCT02574078|582784852|FG007|Treatment Period|Participant request to stop drug|0|||
161381808|NCT02574078|582784853|FG008|Treatment Period|Participant request to stop drug|3|||
161381809|NCT02574078|582784854|FG009|Treatment Period|Participant request to stop drug|2|||
161381810|NCT02574078|582784855|FG010|Treatment Period|Participant request to stop drug|2|||
161381811|NCT02574078|582784856|FG011|Treatment Period|Participant request to stop drug|4|||
161381812|NCT02574078|582784857|FG012|Treatment Period|Participant request to stop drug|1|||
161381813|NCT02574078|582784845|FG000|Treatment Period|Participant withdrew consent|0|||
161381814|NCT02574078|582784846|FG001|Treatment Period|Participant withdrew consent|0|||
161381815|NCT02574078|582784847|FG002|Treatment Period|Participant withdrew consent|0|||
161381816|NCT02574078|582784848|FG003|Treatment Period|Participant withdrew consent|0|||
161381817|NCT02574078|582784849|FG004|Treatment Period|Participant withdrew consent|1|||
161381818|NCT02574078|582784850|FG005|Treatment Period|Participant withdrew consent|1|||
161381819|NCT02574078|582784851|FG006|Treatment Period|Participant withdrew consent|0|||
161381820|NCT02574078|582784852|FG007|Treatment Period|Participant withdrew consent|1|||
161381821|NCT02574078|582784853|FG008|Treatment Period|Participant withdrew consent|0|||
161381822|NCT02574078|582784854|FG009|Treatment Period|Participant withdrew consent|2|||
161381823|NCT02574078|582784855|FG010|Treatment Period|Participant withdrew consent|1|||
161381824|NCT02574078|582784856|FG011|Treatment Period|Participant withdrew consent|4|||
161381825|NCT02574078|582784857|FG012|Treatment Period|Participant withdrew consent|1|||
161381826|NCT02574078|582784845|FG000|Treatment Period|Participant no longer meets criteria|0|||
161381827|NCT02574078|582784846|FG001|Treatment Period|Participant no longer meets criteria|0|||
161381828|NCT02574078|582784847|FG002|Treatment Period|Participant no longer meets criteria|0|||
161381829|NCT02574078|582784848|FG003|Treatment Period|Participant no longer meets criteria|0|||
161381830|NCT02574078|582784849|FG004|Treatment Period|Participant no longer meets criteria|1|||
161381831|NCT02574078|582784850|FG005|Treatment Period|Participant no longer meets criteria|0|||
161381832|NCT02574078|582784851|FG006|Treatment Period|Participant no longer meets criteria|0|||
161381833|NCT02574078|582784852|FG007|Treatment Period|Participant no longer meets criteria|0|||
161381834|NCT02574078|582784853|FG008|Treatment Period|Participant no longer meets criteria|0|||
161381835|NCT02574078|582784854|FG009|Treatment Period|Participant no longer meets criteria|1|||
161381836|NCT02574078|582784855|FG010|Treatment Period|Participant no longer meets criteria|1|||
161381837|NCT02574078|582784856|FG011|Treatment Period|Participant no longer meets criteria|1|||
161381838|NCT02574078|582784857|FG012|Treatment Period|Participant no longer meets criteria|0|||
161381839|NCT02574078|582784845|FG000|Treatment Period|Lost to Follow-up|0|||
161381840|NCT02574078|582784846|FG001|Treatment Period|Lost to Follow-up|0|||
161381841|NCT02574078|582784847|FG002|Treatment Period|Lost to Follow-up|0|||
161381842|NCT02574078|582784848|FG003|Treatment Period|Lost to Follow-up|0|||
161381843|NCT02574078|582784849|FG004|Treatment Period|Lost to Follow-up|0|||
161381844|NCT02574078|582784850|FG005|Treatment Period|Lost to Follow-up|0|||
161381845|NCT02574078|582784851|FG006|Treatment Period|Lost to Follow-up|0|||
161381846|NCT02574078|582784852|FG007|Treatment Period|Lost to Follow-up|0|||
161381847|NCT02574078|582784853|FG008|Treatment Period|Lost to Follow-up|0|||
161381848|NCT02574078|582784854|FG009|Treatment Period|Lost to Follow-up|1|||
161381849|NCT02574078|582784855|FG010|Treatment Period|Lost to Follow-up|0|||
161381850|NCT02574078|582784856|FG011|Treatment Period|Lost to Follow-up|1|||
161381851|NCT02574078|582784857|FG012|Treatment Period|Lost to Follow-up|0|||
161381852|NCT02574078|582784845|FG000|Treatment Period|Maximum clinical benefit|0|||
161381853|NCT02574078|582784846|FG001|Treatment Period|Maximum clinical benefit|0|||
161381854|NCT02574078|582784847|FG002|Treatment Period|Maximum clinical benefit|0|||
161381855|NCT02574078|582784848|FG003|Treatment Period|Maximum clinical benefit|0|||
161381856|NCT02574078|582784849|FG004|Treatment Period|Maximum clinical benefit|0|||
161381857|NCT02574078|582784850|FG005|Treatment Period|Maximum clinical benefit|0|||
161381858|NCT02574078|582784851|FG006|Treatment Period|Maximum clinical benefit|0|||
161381859|NCT02574078|582784852|FG007|Treatment Period|Maximum clinical benefit|0|||
161381860|NCT02574078|582784853|FG008|Treatment Period|Maximum clinical benefit|0|||
161381861|NCT02574078|582784854|FG009|Treatment Period|Maximum clinical benefit|1|||
161381862|NCT02574078|582784855|FG010|Treatment Period|Maximum clinical benefit|0|||
161381863|NCT02574078|582784856|FG011|Treatment Period|Maximum clinical benefit|0|||
161381864|NCT02574078|582784857|FG012|Treatment Period|Maximum clinical benefit|0|||
161381865|NCT02222688|582784858|FG000|Overall Study|Withdrawal by Subject|0|||
161381866|NCT02222688|582784859|FG001|Overall Study|Withdrawal by Subject|0|||
161381867|NCT02222688|582784860|FG002|Overall Study|Withdrawal by Subject|0|||
161381868|NCT02222688|582784861|FG003|Overall Study|Withdrawal by Subject|2|||
161381869|NCT02222688|582784862|FG004|Overall Study|Withdrawal by Subject|1|||
161381870|NCT02222688|582784863|FG005|Overall Study|Withdrawal by Subject|0|||
161381871|NCT02222688|582784864|FG006|Overall Study|Withdrawal by Subject|1|||
161381872|NCT02222688|582784858|FG000|Overall Study|Disease progression|1|||
161381873|NCT02222688|582784859|FG001|Overall Study|Disease progression|0|||
161381874|NCT02222688|582784860|FG002|Overall Study|Disease progression|0|||
161381875|NCT02222688|582784861|FG003|Overall Study|Disease progression|0|||
161381876|NCT02222688|582784862|FG004|Overall Study|Disease progression|0|||
161381877|NCT02222688|582784863|FG005|Overall Study|Disease progression|0|||
161381878|NCT02222688|582784864|FG006|Overall Study|Disease progression|0|||
161381879|NCT05935878|582784865|FG000|Overall Study|Death|1|||
161381880|NCT05935878|582784866|FG001|Overall Study|Death|2|||
161381881|NCT05935878|582784865|FG000|Overall Study|Withdrawal by Subject|5|||
161381882|NCT05935878|582784866|FG001|Overall Study|Withdrawal by Subject|5|||
161381883|NCT05935878|582784865|FG000|Overall Study|Revision of implant|1|||
161381884|NCT05935878|582784866|FG001|Overall Study|Revision of implant|1|||
161381885|NCT05935878|582784865|FG000|Overall Study|Mobile bearing dislocation|0|||
161381886|NCT05935878|582784866|FG001|Overall Study|Mobile bearing dislocation|1|||
161381887|NCT01734785|582784875|FG000|Open-Label Period|Adverse Event|0|||
161381888|NCT01734785|582784876|FG001|Open-Label Period|Adverse Event|0|||
161381889|NCT01734785|582784877|FG002|Open-Label Period|Adverse Event|0|||
161381890|NCT01734785|582784878|FG003|Open-Label Period|Adverse Event|9|||
161381891|NCT01734785|582784875|FG000|Open-Label Period|Lack of Efficacy|0|||
161381892|NCT01734785|582784876|FG001|Open-Label Period|Lack of Efficacy|0|||
161381893|NCT01734785|582784877|FG002|Open-Label Period|Lack of Efficacy|0|||
161381894|NCT01734785|582784878|FG003|Open-Label Period|Lack of Efficacy|1|||
161381895|NCT01734785|582784875|FG000|Open-Label Period|Protocol Violation|0|||
161381896|NCT01734785|582784876|FG001|Open-Label Period|Protocol Violation|0|||
161381897|NCT01734785|582784877|FG002|Open-Label Period|Protocol Violation|0|||
161381898|NCT01734785|582784878|FG003|Open-Label Period|Protocol Violation|13|||
161381899|NCT01734785|582784875|FG000|Open-Label Period|Lost to Follow-up|0|||
161381900|NCT01734785|582784876|FG001|Open-Label Period|Lost to Follow-up|0|||
161381901|NCT01734785|582784877|FG002|Open-Label Period|Lost to Follow-up|0|||
161381902|NCT01734785|582784878|FG003|Open-Label Period|Lost to Follow-up|14|||
161381903|NCT01734785|582784875|FG000|Open-Label Period|Withdrawal by Subject|0|||
161381904|NCT01734785|582784876|FG001|Open-Label Period|Withdrawal by Subject|0|||
161381905|NCT01734785|582784877|FG002|Open-Label Period|Withdrawal by Subject|0|||
161381906|NCT01734785|582784878|FG003|Open-Label Period|Withdrawal by Subject|12|||
161381907|NCT01734785|582784875|FG000|Open-Label Period|Other Reasons|0|||
161381908|NCT01734785|582784876|FG001|Open-Label Period|Other Reasons|0|||
161381909|NCT01734785|582784877|FG002|Open-Label Period|Other Reasons|0|||
161381910|NCT01734785|582784878|FG003|Open-Label Period|Other Reasons|224|||
161381911|NCT01734785|582784875|FG000|Double-Blind Period|Adverse Event|0|||
161381912|NCT01734785|582784876|FG001|Double-Blind Period|Adverse Event|3|||
161381913|NCT01734785|582784877|FG002|Double-Blind Period|Adverse Event|2|||
161381914|NCT01734785|582784878|FG003|Double-Blind Period|Adverse Event|0|||
161381915|NCT01734785|582784875|FG000|Double-Blind Period|Lack of Efficacy|0|||
161381916|NCT01734785|582784876|FG001|Double-Blind Period|Lack of Efficacy|1|||
161381917|NCT01734785|582784877|FG002|Double-Blind Period|Lack of Efficacy|0|||
161381918|NCT01734785|582784878|FG003|Double-Blind Period|Lack of Efficacy|0|||
161381919|NCT01734785|582784875|FG000|Double-Blind Period|Protocol Violation|0|||
161381920|NCT01734785|582784876|FG001|Double-Blind Period|Protocol Violation|1|||
161381921|NCT01734785|582784877|FG002|Double-Blind Period|Protocol Violation|1|||
161381922|NCT01734785|582784878|FG003|Double-Blind Period|Protocol Violation|0|||
161381923|NCT01734785|582784875|FG000|Double-Blind Period|Lost to Follow-up|2|||
161381924|NCT01734785|582784876|FG001|Double-Blind Period|Lost to Follow-up|4|||
161381925|NCT01734785|582784877|FG002|Double-Blind Period|Lost to Follow-up|2|||
161381926|NCT01734785|582784878|FG003|Double-Blind Period|Lost to Follow-up|0|||
161381927|NCT01734785|582784875|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161381928|NCT01734785|582784876|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161381929|NCT01734785|582784877|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161381930|NCT01734785|582784878|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161381931|NCT01734785|582784875|FG000|Double-Blind Period|Not treated|1|||
161381932|NCT01734785|582784876|FG001|Double-Blind Period|Not treated|0|||
161381933|NCT01734785|582784877|FG002|Double-Blind Period|Not treated|0|||
161381934|NCT01734785|582784878|FG003|Double-Blind Period|Not treated|0|||
161381935|NCT02397915|582784879|FG000|Period 1|Protocol Violation|0|||
161381936|NCT02397915|582784880|FG001|Period 1|Protocol Violation|1|||
161381937|NCT02397915|582784881|FG002|Period 1|Protocol Violation|0|||
161381938|NCT02397915|582784882|FG003|Period 1|Protocol Violation|0|||
161381939|NCT02397915|582784879|FG000|Period 1|Physician Decision|1|||
161381940|NCT02397915|582784880|FG001|Period 1|Physician Decision|0|||
161381941|NCT02397915|582784881|FG002|Period 1|Physician Decision|0|||
161381942|NCT02397915|582784882|FG003|Period 1|Physician Decision|0|||
161381943|NCT00368745|582784883|FG000|Double-blind Treatment Period|Adverse Event|6|||
161381944|NCT00368745|582784884|FG001|Double-blind Treatment Period|Adverse Event|6|||
161381945|NCT00368745|582784883|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
161381946|NCT00368745|582784884|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
161381947|NCT00368745|582784883|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161381948|NCT00368745|582784884|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161381949|NCT00368745|582784883|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
161381950|NCT00368745|582784884|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
161381951|NCT00368745|582784883|FG000|Double-blind Treatment Period|Other|7|||
161381952|NCT00368745|582784884|FG001|Double-blind Treatment Period|Other|6|||
161381953|NCT00293813|582784888|FG000|Overall Study|Physician Decision|0|||
161381954|NCT00293813|582784889|FG001|Overall Study|Physician Decision|1|||
161381955|NCT00293813|582784890|FG002|Overall Study|Physician Decision|0|||
161381956|NCT00293813|582784888|FG000|Overall Study|Adverse Event|3|||
161381957|NCT00293813|582784889|FG001|Overall Study|Adverse Event|1|||
161381958|NCT00293813|582784890|FG002|Overall Study|Adverse Event|1|||
161381959|NCT00293813|582784888|FG000|Overall Study|Withdrawal by Subject|7|||
161381960|NCT00293813|582784889|FG001|Overall Study|Withdrawal by Subject|4|||
161381961|NCT00293813|582784890|FG002|Overall Study|Withdrawal by Subject|4|||
161381962|NCT00293813|582784888|FG000|Overall Study|Lost to Follow-up|3|||
161381963|NCT00293813|582784889|FG001|Overall Study|Lost to Follow-up|2|||
161381964|NCT00293813|582784890|FG002|Overall Study|Lost to Follow-up|3|||
161381965|NCT00293813|582784888|FG000|Overall Study|Noncompliance|0|||
161381966|NCT00293813|582784889|FG001|Overall Study|Noncompliance|1|||
161381967|NCT00293813|582784890|FG002|Overall Study|Noncompliance|0|||
161381968|NCT01582009|582784893|FG000|Overall Study|Withdrawal by Subject|1|||
161381969|NCT01582009|582784893|FG000|Overall Study|Physician Decision|1|||
161381970|NCT00310375|582784894|FG000|Primary Reporting Phase|Adverse Event|28|||
161381971|NCT00310375|582784895|FG001|Primary Reporting Phase|Adverse Event|22|||
161381972|NCT00310375|582784896|FG002|Primary Reporting Phase|Adverse Event|0|||
161381973|NCT00310375|582784894|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
161381974|NCT00310375|582784895|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
161381975|NCT00310375|582784896|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
161381976|NCT00310375|582784894|FG000|Primary Reporting Phase|Pregnancy|2|||
161381977|NCT00310375|582784895|FG001|Primary Reporting Phase|Pregnancy|2|||
161381978|NCT00310375|582784896|FG002|Primary Reporting Phase|Pregnancy|0|||
161381979|NCT00310375|582784894|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
161381980|NCT00310375|582784895|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
161381981|NCT00310375|582784896|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
161381982|NCT00310375|582784894|FG000|Primary Reporting Phase|Protocol Violation|8|||
161381983|NCT00310375|582784895|FG001|Primary Reporting Phase|Protocol Violation|5|||
161381984|NCT00310375|582784896|FG002|Primary Reporting Phase|Protocol Violation|0|||
161381985|NCT00310375|582784894|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
161381986|NCT00310375|582784895|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
161381987|NCT00310375|582784896|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
161381988|NCT00310375|582784894|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
161381989|NCT00310375|582784895|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
161381990|NCT00310375|582784896|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
161381991|NCT00310375|582784894|FG000|Primary Reporting Phase|Physician Decision|5|||
161381992|NCT00310375|582784895|FG001|Primary Reporting Phase|Physician Decision|3|||
161381993|NCT00310375|582784896|FG002|Primary Reporting Phase|Physician Decision|0|||
161381994|NCT00310375|582784894|FG000|Primary Reporting Phase|Request of the sponsor|2|||
161381995|NCT00310375|582784895|FG001|Primary Reporting Phase|Request of the sponsor|2|||
161381996|NCT00310375|582784896|FG002|Primary Reporting Phase|Request of the sponsor|0|||
161381997|NCT00310375|582784894|FG000|Primary Reporting Phase|Failed to return|1|||
161381998|NCT00310375|582784895|FG001|Primary Reporting Phase|Failed to return|3|||
161381999|NCT00310375|582784896|FG002|Primary Reporting Phase|Failed to return|0|||
161382000|NCT00310375|582784894|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
161382001|NCT00310375|582784895|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
161382002|NCT00310375|582784896|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
161382003|NCT00310375|582784894|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
161382004|NCT00310375|582784895|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
161382005|NCT00310375|582784896|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
161382006|NCT00310375|582784894|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
161382007|NCT00310375|582784895|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
161382008|NCT00310375|582784896|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
161382009|NCT00310375|582784894|FG000|Primary Reporting Phase|Site closure|3|||
161382010|NCT00310375|582784895|FG001|Primary Reporting Phase|Site closure|0|||
161382011|NCT00310375|582784896|FG002|Primary Reporting Phase|Site closure|0|||
161382012|NCT00310375|582784894|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
161382013|NCT00310375|582784895|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
161382014|NCT00310375|582784896|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
161382015|NCT00310375|582784894|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
161382016|NCT00310375|582784895|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
161382017|NCT00310375|582784896|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
161382018|NCT00310375|582784894|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
161382019|NCT00310375|582784895|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
161382020|NCT00310375|582784896|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
161382021|NCT00310375|582784894|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
161382022|NCT00310375|582784895|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
161382023|NCT00310375|582784896|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
161382024|NCT01134614|582784897|FG000|Overall Study|Still on treatment as of March 2013|21|||
161382025|NCT01134614|582784898|FG001|Overall Study|Still on treatment as of March 2013|13|||
161382026|NCT01134614|582784897|FG000|Overall Study|Progressive disease|60|||
161382027|NCT01134614|582784898|FG001|Overall Study|Progressive disease|54|||
161382028|NCT01134614|582784897|FG000|Overall Study|Adverse Event|26|||
161382029|NCT01134614|582784898|FG001|Overall Study|Adverse Event|39|||
161382030|NCT01134614|582784897|FG000|Overall Study|Death|5|||
161382031|NCT01134614|582784898|FG001|Overall Study|Death|8|||
161382032|NCT01134614|582784897|FG000|Overall Study|Withdrawal by Subject|3|||
161382033|NCT01134614|582784898|FG001|Overall Study|Withdrawal by Subject|2|||
161382034|NCT01134614|582784897|FG000|Overall Study|Alternative therapy|2|||
161382035|NCT01134614|582784898|FG001|Overall Study|Alternative therapy|0|||
161382036|NCT01134614|582784897|FG000|Overall Study|Complicating disease|2|||
161382037|NCT01134614|582784898|FG001|Overall Study|Complicating disease|1|||
161382038|NCT01134614|582784897|FG000|Overall Study|Physician's decision|0|||
161382039|NCT01134614|582784898|FG001|Overall Study|Physician's decision|1|||
161382040|NCT01134614|582784897|FG000|Overall Study|Never started treatment|4|||
161382041|NCT01134614|582784898|FG001|Overall Study|Never started treatment|1|||
161382042|NCT01134614|582784897|FG000|Overall Study|Pt received tx not allowed on study|0|||
161382043|NCT01134614|582784898|FG001|Overall Study|Pt received tx not allowed on study|1|||
161382044|NCT01134614|582784897|FG000|Overall Study|Symptomatic deterioration|0|||
161382045|NCT01134614|582784898|FG001|Overall Study|Symptomatic deterioration|1|||
161382046|NCT01134614|582784897|FG000|Overall Study|Patient in hospice care|0|||
161382047|NCT01134614|582784898|FG001|Overall Study|Patient in hospice care|1|||
161382048|NCT02553928|582784899|FG000|Overall Study|Adverse Event|2|||
161382049|NCT02553928|582784900|FG001|Overall Study|Adverse Event|1|||
161382050|NCT02553928|582784899|FG000|Overall Study|Lost to Follow-up|0|||
161382051|NCT02553928|582784900|FG001|Overall Study|Lost to Follow-up|1|||
161382052|NCT02553928|582784899|FG000|Overall Study|Administrative reason(s)|0|||
161382053|NCT02553928|582784900|FG001|Overall Study|Administrative reason(s)|1|||
161382054|NCT00770562|582784905|FG000|Overall Study|Did not take treatment|1|||
161382055|NCT00770562|582784906|FG001|Overall Study|Did not take treatment|1|||
161382056|NCT05338710|582784910|FG000|Overall Study|Withdrawal by Subject|3|||
161382057|NCT01081951|582784911|FG000|Overall Study|Death|54|||
161382058|NCT01081951|582784912|FG001|Overall Study|Death|47|||
161382059|NCT01081951|582784911|FG000|Overall Study|Withdrawal by Subject|2|||
161382060|NCT01081951|582784912|FG001|Overall Study|Withdrawal by Subject|6|||
161382061|NCT01081951|582784911|FG000|Overall Study|Allocated treatment but did not take it|0|||
161382062|NCT01081951|582784912|FG001|Overall Study|Allocated treatment but did not take it|1|||
161382063|NCT01081951|582784911|FG000|Overall Study|Lost to Follow-up|0|||
161382064|NCT01081951|582784912|FG001|Overall Study|Lost to Follow-up|1|||
161382065|NCT00292045|582784915|FG000|Core Study (Through Week 13)|Adverse Event|1|||
161382066|NCT00292045|582784915|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
161382067|NCT00606411|582784916|FG000|Overall Study|Adverse Event|1|||
161382068|NCT00606411|582784917|FG001|Overall Study|Adverse Event|2|||
161382069|NCT00606411|582784916|FG000|Overall Study|Lack of Adherence|1|||
161382070|NCT00606411|582784917|FG001|Overall Study|Lack of Adherence|1|||
161382071|NCT00606411|582784916|FG000|Overall Study|Lack of Efficacy|1|||
161382072|NCT00606411|582784917|FG001|Overall Study|Lack of Efficacy|1|||
161382073|NCT00606411|582784916|FG000|Overall Study|Withdrawal by Subject|2|||
161382074|NCT00606411|582784917|FG001|Overall Study|Withdrawal by Subject|0|||
161382075|NCT00606411|582784916|FG000|Overall Study|Lost to Follow-up|1|||
161382076|NCT00606411|582784917|FG001|Overall Study|Lost to Follow-up|2|||
161382077|NCT00606411|582784916|FG000|Overall Study|Move out of state|0|||
161382078|NCT00606411|582784917|FG001|Overall Study|Move out of state|1|||
161382079|NCT04503551|582784918|FG000|Overall Study|Withdrawal by Subject|5|||
161382080|NCT04503551|582784919|FG001|Overall Study|Withdrawal by Subject|3|||
161382081|NCT04503551|582784918|FG000|Overall Study|Physician Decision|1|||
161382082|NCT04503551|582784919|FG001|Overall Study|Physician Decision|0|||
161382083|NCT04503551|582784918|FG000|Overall Study|Death|0|||
161382084|NCT04503551|582784919|FG001|Overall Study|Death|1|||
161382085|NCT04503551|582784918|FG000|Overall Study|Lost to Follow-up|1|||
161382086|NCT04503551|582784919|FG001|Overall Study|Lost to Follow-up|2|||
161382087|NCT04503551|582784918|FG000|Overall Study|Ongoing at Week 52|99|||
161382088|NCT04503551|582784919|FG001|Overall Study|Ongoing at Week 52|62|||
161382089|NCT00412958|582784920|FG000|Overall Study|Withdrawal by Subject|3|||
161382090|NCT00412958|582784921|FG001|Overall Study|Withdrawal by Subject|0|||
161382091|NCT00412958|582784922|FG002|Overall Study|Withdrawal by Subject|0|||
161382092|NCT00412958|582784923|FG003|Overall Study|Withdrawal by Subject|1|||
161382093|NCT00412958|582784920|FG000|Overall Study|Adverse Event|0|||
161382094|NCT00412958|582784921|FG001|Overall Study|Adverse Event|1|||
161382095|NCT00412958|582784922|FG002|Overall Study|Adverse Event|0|||
161382096|NCT00412958|582784923|FG003|Overall Study|Adverse Event|0|||
161382097|NCT00412958|582784920|FG000|Overall Study|Lost to Follow-up|0|||
161382098|NCT00412958|582784921|FG001|Overall Study|Lost to Follow-up|1|||
161382099|NCT00412958|582784922|FG002|Overall Study|Lost to Follow-up|0|||
161382100|NCT00412958|582784923|FG003|Overall Study|Lost to Follow-up|0|||
161382101|NCT00412958|582784920|FG000|Overall Study|Death|0|||
161382102|NCT00412958|582784921|FG001|Overall Study|Death|1|||
161382103|NCT00412958|582784922|FG002|Overall Study|Death|0|||
161382104|NCT00412958|582784923|FG003|Overall Study|Death|0|||
161382105|NCT00412958|582784920|FG000|Overall Study|Transport issue|0|||
161382106|NCT00412958|582784921|FG001|Overall Study|Transport issue|1|||
161382107|NCT00412958|582784922|FG002|Overall Study|Transport issue|0|||
161382108|NCT00412958|582784923|FG003|Overall Study|Transport issue|0|||
161382109|NCT01318135|582784924|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161382110|NCT01318135|582784925|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382111|NCT01318135|582784926|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382112|NCT01318135|582784927|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382113|NCT01318135|582784928|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382114|NCT01318135|582784929|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382115|NCT01318135|582784930|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382116|NCT01318135|582784931|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161382117|NCT01318135|582784924|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
161382118|NCT01318135|582784925|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382119|NCT01318135|582784926|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382120|NCT01318135|582784927|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382121|NCT01318135|582784928|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382122|NCT01318135|582784929|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382123|NCT01318135|582784930|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382124|NCT01318135|582784931|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161382125|NCT01318135|582784924|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
161382126|NCT01318135|582784925|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
161382127|NCT01318135|582784926|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
161382128|NCT01318135|582784927|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
161382129|NCT01318135|582784928|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
161382130|NCT01318135|582784929|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
161382131|NCT01318135|582784930|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
161382132|NCT01318135|582784931|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
161382133|NCT01318135|582784924|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
161382134|NCT01318135|582784925|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
161382135|NCT01318135|582784926|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
161382136|NCT01318135|582784927|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
161382137|NCT01318135|582784928|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
161382138|NCT01318135|582784929|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
161382139|NCT01318135|582784930|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
161382140|NCT01318135|582784931|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
161382141|NCT01318135|582784924|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161382142|NCT01318135|582784925|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161382143|NCT01318135|582784926|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161382144|NCT01318135|582784927|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161382145|NCT01318135|582784928|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161382146|NCT01318135|582784929|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161382147|NCT01318135|582784930|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161382148|NCT01318135|582784931|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161382149|NCT01318135|582784924|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
161382150|NCT01318135|582784925|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
161382151|NCT01318135|582784926|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161382152|NCT01318135|582784927|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
161382153|NCT01318135|582784928|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161382154|NCT01318135|582784929|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161382155|NCT01318135|582784930|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161382156|NCT01318135|582784931|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161382157|NCT01318135|582784924|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382158|NCT01318135|582784925|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382159|NCT01318135|582784926|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382160|NCT01318135|582784927|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382161|NCT01318135|582784928|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382162|NCT01318135|582784929|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382163|NCT01318135|582784930|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161382164|NCT01318135|582784931|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
161382165|NCT05384834|582784935|FG000|Overall Study|Lost to Follow-up|43|||
161382166|NCT05384834|582784935|FG000|Overall Study|Withdrawal by Subject|5|||
161382167|NCT01871545|582784936|FG000|Overall Study|Death|2|||
161382168|NCT01871545|582784937|FG001|Overall Study|Death|0|||
161382169|NCT01871545|582784936|FG000|Overall Study|Lack of Efficacy|11|||
161382170|NCT01871545|582784937|FG001|Overall Study|Lack of Efficacy|2|||
161382171|NCT01871545|582784936|FG000|Overall Study|Physician Decision|4|||
161382172|NCT01871545|582784937|FG001|Overall Study|Physician Decision|0|||
161382173|NCT01871545|582784936|FG000|Overall Study|Withdrawal by Subject|0|||
161382174|NCT01871545|582784937|FG001|Overall Study|Withdrawal by Subject|1|||
161382175|NCT02569476|582784938|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
161382176|NCT02569476|582784938|FG000|Overall Study|Death|33|||
161382177|NCT02569476|582784938|FG000|Overall Study|Withdrawal by Subject|9|||
161382178|NCT02569476|582784938|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
161382179|NCT02569476|582784938|FG000|Overall Study|Palliative care|1|||
161382180|NCT02569476|582784938|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
161382181|NCT02569476|582784938|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
161382182|NCT01152788|582784939|FG000|Overall Study|Withdrawal by Subject|0|||
161382183|NCT01152788|582784940|FG001|Overall Study|Withdrawal by Subject|3|||
161382184|NCT01152788|582784939|FG000|Overall Study|No treatment|0|||
161382185|NCT01152788|582784940|FG001|Overall Study|No treatment|1|||
161382186|NCT01541865|582784941|FG000|Overall Study|Lost to Follow-up|11|||
161382187|NCT01541865|582784941|FG000|Overall Study|Withdrawal by Subject|9|||
161382188|NCT01541865|582784941|FG000|Overall Study|Adverse Event|1|||
161382189|NCT01541865|582784941|FG000|Overall Study|Protocol Violation|1|||
161382190|NCT01140867|582784942|FG000|Overall Study|Adverse Event|22|||
161382191|NCT01140867|582784942|FG000|Overall Study|Lack of Efficacy|3|||
161382192|NCT01140867|582784942|FG000|Overall Study|Lost to Follow-up|2|||
161382193|NCT01140867|582784942|FG000|Overall Study|Withdrawal by Subject|1|||
161382194|NCT01140867|582784942|FG000|Overall Study|Protocol Violation|1|||
161382195|NCT01140867|582784942|FG000|Overall Study|Uncooperative patient|2|||
161382196|NCT01140867|582784942|FG000|Overall Study|Medication Noncompliance|2|||
161382197|NCT00881530|582784943|FG000|Overall Study|Adverse Event|5|||
161382198|NCT00881530|582784944|FG001|Overall Study|Adverse Event|1|||
161382199|NCT00881530|582784945|FG002|Overall Study|Adverse Event|1|||
161382200|NCT00881530|582784946|FG003|Overall Study|Adverse Event|4|||
161382201|NCT00881530|582784947|FG004|Overall Study|Adverse Event|10|||
161382202|NCT00881530|582784948|FG005|Overall Study|Adverse Event|2|||
161382203|NCT00881530|582784943|FG000|Overall Study|Lack of Efficacy|1|||
161382204|NCT00881530|582784944|FG001|Overall Study|Lack of Efficacy|0|||
161382205|NCT00881530|582784945|FG002|Overall Study|Lack of Efficacy|0|||
161382206|NCT00881530|582784946|FG003|Overall Study|Lack of Efficacy|0|||
161382207|NCT00881530|582784947|FG004|Overall Study|Lack of Efficacy|1|||
161382208|NCT00881530|582784948|FG005|Overall Study|Lack of Efficacy|1|||
161382209|NCT00881530|582784943|FG000|Overall Study|Not compliant with the protocol|0|||
161382210|NCT00881530|582784944|FG001|Overall Study|Not compliant with the protocol|0|||
161382211|NCT00881530|582784945|FG002|Overall Study|Not compliant with the protocol|0|||
161382212|NCT00881530|582784946|FG003|Overall Study|Not compliant with the protocol|0|||
161382213|NCT00881530|582784947|FG004|Overall Study|Not compliant with the protocol|2|||
161382214|NCT00881530|582784948|FG005|Overall Study|Not compliant with the protocol|0|||
161382215|NCT00881530|582784943|FG000|Overall Study|Lost to Follow-up|0|||
161382216|NCT00881530|582784944|FG001|Overall Study|Lost to Follow-up|1|||
161382217|NCT00881530|582784945|FG002|Overall Study|Lost to Follow-up|1|||
161382218|NCT00881530|582784946|FG003|Overall Study|Lost to Follow-up|3|||
161382219|NCT00881530|582784947|FG004|Overall Study|Lost to Follow-up|1|||
161382220|NCT00881530|582784948|FG005|Overall Study|Lost to Follow-up|0|||
161382221|NCT00881530|582784943|FG000|Overall Study|Refused to continue medication|7|||
161382222|NCT00881530|582784944|FG001|Overall Study|Refused to continue medication|2|||
161382223|NCT00881530|582784945|FG002|Overall Study|Refused to continue medication|1|||
161382224|NCT00881530|582784946|FG003|Overall Study|Refused to continue medication|2|||
161382225|NCT00881530|582784947|FG004|Overall Study|Refused to continue medication|0|||
161382226|NCT00881530|582784948|FG005|Overall Study|Refused to continue medication|0|||
161382227|NCT00881530|582784943|FG000|Overall Study|Other reason not defined above|1|||
161382228|NCT00881530|582784944|FG001|Overall Study|Other reason not defined above|1|||
161382229|NCT00881530|582784945|FG002|Overall Study|Other reason not defined above|2|||
161382230|NCT00881530|582784946|FG003|Overall Study|Other reason not defined above|0|||
161382231|NCT00881530|582784947|FG004|Overall Study|Other reason not defined above|0|||
161382232|NCT00881530|582784948|FG005|Overall Study|Other reason not defined above|2|||
161382233|NCT02720523|582784949|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
161382234|NCT02720523|582784950|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
161382235|NCT02720523|582784951|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
161382236|NCT02720523|582784952|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
161382237|NCT02720523|582784953|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
161382238|NCT02720523|582784954|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
161382239|NCT02720523|582784955|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
161382240|NCT02720523|582784949|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
161382241|NCT02720523|582784950|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161382242|NCT02720523|582784951|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161435296|NCT01710345|582987976|FG000|Overall Study|Lack of Efficacy|2|||
161382243|NCT02720523|582784952|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161382244|NCT02720523|582784953|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161382245|NCT02720523|582784954|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161382246|NCT02720523|582784955|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161382247|NCT02720523|582784949|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
161382248|NCT02720523|582784950|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161382249|NCT02720523|582784951|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161382250|NCT02720523|582784952|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161382251|NCT02720523|582784953|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161382252|NCT02720523|582784954|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161382253|NCT02720523|582784955|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161382254|NCT02720523|582784949|FG000|Period 1: Placebo-controlled Period|Other|0|||
161382255|NCT02720523|582784950|FG001|Period 1: Placebo-controlled Period|Other|0|||
161382256|NCT02720523|582784951|FG002|Period 1: Placebo-controlled Period|Other|1|||
161382257|NCT02720523|582784952|FG003|Period 1: Placebo-controlled Period|Other|1|||
161382258|NCT02720523|582784953|FG004|Period 1: Placebo-controlled Period|Other|0|||
161382259|NCT02720523|582784954|FG005|Period 1: Placebo-controlled Period|Other|0|||
161382260|NCT02720523|582784955|FG006|Period 1: Placebo-controlled Period|Other|0|||
161382261|NCT02720523|582784949|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
161382262|NCT02720523|582784950|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
161382263|NCT02720523|582784951|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
161382264|NCT02720523|582784952|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
161382265|NCT02720523|582784953|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
161382266|NCT02720523|582784954|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
161382267|NCT02720523|582784955|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
161382268|NCT02720523|582784949|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
161382269|NCT02720523|582784950|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
161382270|NCT02720523|582784951|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
161382271|NCT02720523|582784952|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
161382272|NCT02720523|582784953|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
161382273|NCT02720523|582784954|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
161382274|NCT02720523|582784955|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
161382275|NCT02720523|582784949|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161382276|NCT02720523|582784950|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161382277|NCT02720523|582784951|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161382278|NCT02720523|582784952|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161382279|NCT02720523|582784953|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
161382280|NCT02720523|582784954|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
161382281|NCT02720523|582784955|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
161382282|NCT02720523|582784949|FG000|Period 2: Long-term Extension Period|Other|0|||
161382283|NCT02720523|582784950|FG001|Period 2: Long-term Extension Period|Other|0|||
161382284|NCT02720523|582784951|FG002|Period 2: Long-term Extension Period|Other|0|||
161382285|NCT02720523|582784952|FG003|Period 2: Long-term Extension Period|Other|0|||
161382286|NCT02720523|582784953|FG004|Period 2: Long-term Extension Period|Other|2|||
161382287|NCT02720523|582784954|FG005|Period 2: Long-term Extension Period|Other|0|||
161382288|NCT02720523|582784955|FG006|Period 2: Long-term Extension Period|Other|3|||
161382289|NCT03146663|582784956|FG000|Overall Study|Did not receive study treatment|1|||
161382290|NCT03146663|582784957|FG001|Overall Study|Did not receive study treatment|1|||
161382291|NCT03816176|582784962|FG000|Overall Study|Miscellaneous|5|||
161382292|NCT03816176|582784962|FG000|Overall Study|Lack of Efficacy|4|||
161382293|NCT03816176|582784962|FG000|Overall Study|Adverse Event|3|||
161382294|NCT05200572|582784963|FG000|Overall Study|Withdrawal by Subject|14|||
161382295|NCT07214935|582784966|FG000|Overall Study|Adverse Event|1|||
161382296|NCT07214935|582784967|FG001|Overall Study|Adverse Event|1|||
161382297|NCT07214935|582784968|FG002|Overall Study|Adverse Event|1|||
161382298|NCT07214935|582784969|FG003|Overall Study|Adverse Event|0|||
161382299|NCT07214935|582784966|FG000|Overall Study|Lost to Follow-up|0|||
161382300|NCT07214935|582784967|FG001|Overall Study|Lost to Follow-up|1|||
161382301|NCT07214935|582784968|FG002|Overall Study|Lost to Follow-up|0|||
161382302|NCT07214935|582784969|FG003|Overall Study|Lost to Follow-up|0|||
161382303|NCT07214935|582784966|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
161382304|NCT07214935|582784967|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161382305|NCT07214935|582784968|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161382306|NCT07214935|582784969|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161382307|NCT07214935|582784966|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
161382308|NCT07214935|582784967|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
161382309|NCT07214935|582784968|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
161382310|NCT07214935|582784969|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
161382311|NCT00283803|582787539|FG000|Overall Study|Physician Decision|9|||
161382312|NCT00283803|582787539|FG000|Overall Study|Withdrawal by Subject|4|||
161382313|NCT01127607|582787540|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
161382314|NCT01127607|582787541|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
161382315|NCT01127607|582787540|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
161382316|NCT01127607|582787541|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
161382317|NCT02220855|582787542|FG000|Overall Study|Adverse Event|8|||
161382318|NCT02220855|582787542|FG000|Overall Study|Disease Progression|5|||
161382319|NCT02220855|582787542|FG000|Overall Study|Withdrawal by Subject|1|||
161382320|NCT03419897|582787543|FG000|Overall Study|Death|180|||
161382321|NCT03419897|582787543|FG000|Overall Study|Lost to Follow-up|1|||
161382322|NCT03419897|582787543|FG000|Overall Study|Withdrawal by Subject|6|||
161382323|NCT03419897|582787543|FG000|Overall Study|Sponsor Decision|61|||
161382324|NCT03419897|582787543|FG000|Overall Study|Physician Decision|1|||
161382325|NCT05730725|582787546|FG000|Overall Study|Withdrawal by Subject|3|||
161382326|NCT05730725|582787547|FG001|Overall Study|Withdrawal by Subject|0|||
161382327|NCT05730725|582787548|FG002|Overall Study|Withdrawal by Subject|0|||
161382328|NCT05730725|582787549|FG003|Overall Study|Withdrawal by Subject|1|||
161382329|NCT05730725|582787546|FG000|Overall Study|Not Reported|1|||
161382330|NCT05730725|582787547|FG001|Overall Study|Not Reported|1|||
161382331|NCT05730725|582787548|FG002|Overall Study|Not Reported|1|||
161382332|NCT05730725|582787549|FG003|Overall Study|Not Reported|1|||
161382333|NCT01945216|582787552|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
161382334|NCT01945216|582787552|FG000|Overall Study|Protocol Violation|42|||
161382335|NCT01945216|582787552|FG000|Overall Study|CRF not assured by investigators|5|||
161382336|NCT02982772|582787554|FG000|Intervention|Lost to Follow-up|19|||
161382337|NCT02982772|582787555|FG001|Intervention|Lost to Follow-up|13|||
161382338|NCT02982772|582787554|FG000|1M Follow-Up|Lost to Follow-up|21|||
161382339|NCT02982772|582787555|FG001|1M Follow-Up|Lost to Follow-up|18|||
161382340|NCT02982772|582787554|FG000|3M Follow-Up|Lost to Follow-up|17|||
161382341|NCT02982772|582787555|FG001|3M Follow-Up|Lost to Follow-up|11|||
161382342|NCT02982772|582787554|FG000|6M Follow-Up|Lost to Follow-up|11|||
161382343|NCT02982772|582787555|FG001|6M Follow-Up|Lost to Follow-up|9|||
161382344|NCT02982772|582787554|FG000|12M Follow-Up|Lost to Follow-up|11|||
161382345|NCT02982772|582787555|FG001|12M Follow-Up|Lost to Follow-up|5|||
161382346|NCT02974140|582787556|FG000|Overall Study|Adverse Event|2|||
161382347|NCT02974140|582787556|FG000|Overall Study|Lost to Follow-up|1|||
161382348|NCT02974140|582787556|FG000|Overall Study|Study Terminated by Sponsor|36|||
161382349|NCT01905943|582787557|FG000|Overall Study|Withdrawal of consent|90|||
161382350|NCT01905943|582787557|FG000|Overall Study|Lost to Follow-up|16|||
161382351|NCT01905943|582787557|FG000|Overall Study|Investigator discretion|7|||
161382352|NCT01905943|582787557|FG000|Overall Study|Death|186|||
161382353|NCT01905943|582787557|FG000|Overall Study|Adverse Event|3|||
161382354|NCT01905943|582787557|FG000|Overall Study|Other|12|||
161382355|NCT01238991|582787560|FG000|Overall Study|Adverse Event|1|||
161382356|NCT01238991|582787561|FG001|Overall Study|Adverse Event|0|||
161382357|NCT01238991|582787562|FG002|Overall Study|Adverse Event|3|||
161382358|NCT01238991|582787563|FG003|Overall Study|Adverse Event|1|||
161382359|NCT01238991|582787564|FG004|Overall Study|Adverse Event|1|||
161382360|NCT01238991|582787565|FG005|Overall Study|Adverse Event|0|||
161382361|NCT01238991|582787566|FG006|Overall Study|Adverse Event|1|||
161382362|NCT01238991|582787567|FG007|Overall Study|Adverse Event|1|||
161382363|NCT01238991|582787568|FG008|Overall Study|Adverse Event|0|||
161382364|NCT01238991|582787569|FG009|Overall Study|Adverse Event|0|||
161382365|NCT01238991|582787560|FG000|Overall Study|Death|0|||
161382366|NCT01238991|582787561|FG001|Overall Study|Death|0|||
161382367|NCT01238991|582787562|FG002|Overall Study|Death|0|||
161382368|NCT01238991|582787563|FG003|Overall Study|Death|1|||
161382369|NCT01238991|582787564|FG004|Overall Study|Death|0|||
161382370|NCT01238991|582787565|FG005|Overall Study|Death|0|||
161382371|NCT01238991|582787566|FG006|Overall Study|Death|0|||
161382372|NCT01238991|582787567|FG007|Overall Study|Death|0|||
161382373|NCT01238991|582787568|FG008|Overall Study|Death|0|||
161382374|NCT01238991|582787569|FG009|Overall Study|Death|0|||
161382375|NCT01238991|582787560|FG000|Overall Study|Lack of Efficacy|0|||
161382376|NCT01238991|582787561|FG001|Overall Study|Lack of Efficacy|0|||
161382377|NCT01238991|582787562|FG002|Overall Study|Lack of Efficacy|1|||
161382378|NCT01238991|582787563|FG003|Overall Study|Lack of Efficacy|0|||
161382379|NCT01238991|582787564|FG004|Overall Study|Lack of Efficacy|0|||
161382380|NCT01238991|582787565|FG005|Overall Study|Lack of Efficacy|0|||
161382381|NCT01238991|582787566|FG006|Overall Study|Lack of Efficacy|0|||
161382382|NCT01238991|582787567|FG007|Overall Study|Lack of Efficacy|0|||
161382383|NCT01238991|582787568|FG008|Overall Study|Lack of Efficacy|1|||
161382384|NCT01238991|582787569|FG009|Overall Study|Lack of Efficacy|0|||
161382385|NCT01238991|582787560|FG000|Overall Study|Withdrawal by Subject|0|||
161382386|NCT01238991|582787561|FG001|Overall Study|Withdrawal by Subject|0|||
161382387|NCT01238991|582787562|FG002|Overall Study|Withdrawal by Subject|1|||
161382388|NCT01238991|582787563|FG003|Overall Study|Withdrawal by Subject|0|||
161382389|NCT01238991|582787564|FG004|Overall Study|Withdrawal by Subject|0|||
161382390|NCT01238991|582787565|FG005|Overall Study|Withdrawal by Subject|0|||
161382391|NCT01238991|582787566|FG006|Overall Study|Withdrawal by Subject|0|||
161382392|NCT01238991|582787567|FG007|Overall Study|Withdrawal by Subject|0|||
161382393|NCT01238991|582787568|FG008|Overall Study|Withdrawal by Subject|0|||
161382394|NCT01238991|582787569|FG009|Overall Study|Withdrawal by Subject|0|||
161382395|NCT01238991|582787560|FG000|Overall Study|Study Terminated by Sponsor|0|||
161382396|NCT01238991|582787561|FG001|Overall Study|Study Terminated by Sponsor|0|||
161382397|NCT01238991|582787562|FG002|Overall Study|Study Terminated by Sponsor|0|||
161382398|NCT01238991|582787563|FG003|Overall Study|Study Terminated by Sponsor|0|||
161382399|NCT01238991|582787564|FG004|Overall Study|Study Terminated by Sponsor|1|||
161382400|NCT01238991|582787565|FG005|Overall Study|Study Terminated by Sponsor|0|||
161382401|NCT01238991|582787566|FG006|Overall Study|Study Terminated by Sponsor|7|||
161382402|NCT01238991|582787567|FG007|Overall Study|Study Terminated by Sponsor|4|||
161382403|NCT01238991|582787568|FG008|Overall Study|Study Terminated by Sponsor|2|||
161382404|NCT01238991|582787569|FG009|Overall Study|Study Terminated by Sponsor|2|||
161382405|NCT01238991|582787560|FG000|Overall Study|Caregiver's request|0|||
161382406|NCT01238991|582787561|FG001|Overall Study|Caregiver's request|0|||
161382407|NCT01238991|582787562|FG002|Overall Study|Caregiver's request|0|||
161382408|NCT01238991|582787563|FG003|Overall Study|Caregiver's request|0|||
161382409|NCT01238991|582787564|FG004|Overall Study|Caregiver's request|0|||
161382410|NCT01238991|582787565|FG005|Overall Study|Caregiver's request|0|||
161382411|NCT01238991|582787566|FG006|Overall Study|Caregiver's request|0|||
161382412|NCT01238991|582787567|FG007|Overall Study|Caregiver's request|0|||
161382413|NCT01238991|582787568|FG008|Overall Study|Caregiver's request|1|||
161382414|NCT01238991|582787569|FG009|Overall Study|Caregiver's request|0|||
161382415|NCT01238991|582787560|FG000|Overall Study|Admission to a nursing home|1|||
161382416|NCT01238991|582787561|FG001|Overall Study|Admission to a nursing home|0|||
161382417|NCT01238991|582787562|FG002|Overall Study|Admission to a nursing home|1|||
161382418|NCT01238991|582787563|FG003|Overall Study|Admission to a nursing home|0|||
161382419|NCT01238991|582787564|FG004|Overall Study|Admission to a nursing home|0|||
161382420|NCT01238991|582787565|FG005|Overall Study|Admission to a nursing home|0|||
161382421|NCT01238991|582787566|FG006|Overall Study|Admission to a nursing home|0|||
161382422|NCT01238991|582787567|FG007|Overall Study|Admission to a nursing home|0|||
161382423|NCT01238991|582787568|FG008|Overall Study|Admission to a nursing home|0|||
161382424|NCT01238991|582787569|FG009|Overall Study|Admission to a nursing home|0|||
161382425|NCT02297815|582787590|FG000|Overall Study|Lost to Follow-up|236|||
161382426|NCT02297815|582787591|FG001|Overall Study|Lost to Follow-up|140|||
161382427|NCT00662831|582787592|FG000|Overall Study|Death|4|||
161382428|NCT00662831|582787593|FG001|Overall Study|Death|1|||
161382429|NCT00662831|582787592|FG000|Overall Study|Lack of Efficacy|6|||
161382430|NCT00662831|582787593|FG001|Overall Study|Lack of Efficacy|6|||
161382431|NCT00662831|582787592|FG000|Overall Study|Lost to Follow-up|1|||
161382432|NCT00662831|582787593|FG001|Overall Study|Lost to Follow-up|0|||
161382433|NCT00662831|582787592|FG000|Overall Study|Withdrawal by Subject|2|||
161382434|NCT00662831|582787593|FG001|Overall Study|Withdrawal by Subject|1|||
161382435|NCT00662831|582787592|FG000|Overall Study|Other|62|||
161382436|NCT00662831|582787593|FG001|Overall Study|Other|31|||
161382437|NCT00662831|582787592|FG000|Overall Study|Protocol Violation|8|||
161382438|NCT00662831|582787593|FG001|Overall Study|Protocol Violation|4|||
161382439|NCT00662831|582787592|FG000|Overall Study|Adverse Event|23|||
161382440|NCT00662831|582787593|FG001|Overall Study|Adverse Event|16|||
161382441|NCT02522429|582787594|FG000|Overall Study|Lost to Follow-up|8|||
161382442|NCT02522429|582787594|FG000|Overall Study|Adverse Event|2|||
161382443|NCT02522429|582787594|FG000|Overall Study|Death|1|||
161382444|NCT02522429|582787594|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
161382445|NCT00294671|582787595|FG000|Overall Study|Lack of Efficacy|11|||
161382446|NCT00294671|582787596|FG001|Overall Study|Lack of Efficacy|23|||
161382447|NCT00294671|582787595|FG000|Overall Study|Liver transplant|7|||
161382448|NCT00294671|582787596|FG001|Overall Study|Liver transplant|9|||
161382449|NCT00294671|582787595|FG000|Overall Study|Drug related adverse event (AE)|4|||
161382450|NCT00294671|582787596|FG001|Overall Study|Drug related adverse event (AE)|2|||
161382451|NCT00294671|582787595|FG000|Overall Study|Non-drug related AE|3|||
161382452|NCT00294671|582787596|FG001|Overall Study|Non-drug related AE|2|||
161382453|NCT00294671|582787595|FG000|Overall Study|Lost to Follow-up|1|||
161382454|NCT00294671|582787596|FG001|Overall Study|Lost to Follow-up|3|||
161382455|NCT00294671|582787595|FG000|Overall Study|Non-compliance|1|||
161382456|NCT00294671|582787596|FG001|Overall Study|Non-compliance|0|||
161382457|NCT00294671|582787595|FG000|Overall Study|Death|0|||
161382458|NCT00294671|582787596|FG001|Overall Study|Death|1|||
161382459|NCT03107052|582787601|FG000|Overall Study|Adverse Event|6|||
161382460|NCT03107052|582787602|FG001|Overall Study|Adverse Event|1|||
161382461|NCT03107052|582787603|FG002|Overall Study|Adverse Event|2|||
161382462|NCT03107052|582787601|FG000|Overall Study|Withdrawal by Subject|9|||
161382463|NCT03107052|582787602|FG001|Overall Study|Withdrawal by Subject|5|||
161382464|NCT03107052|582787603|FG002|Overall Study|Withdrawal by Subject|8|||
161382465|NCT03107052|582787601|FG000|Overall Study|Protocol Violation|6|||
161382466|NCT03107052|582787602|FG001|Overall Study|Protocol Violation|0|||
161382467|NCT03107052|582787603|FG002|Overall Study|Protocol Violation|3|||
161382468|NCT03107052|582787601|FG000|Overall Study|Lost to Follow-up|4|||
161382469|NCT03107052|582787602|FG001|Overall Study|Lost to Follow-up|0|||
161382470|NCT03107052|582787603|FG002|Overall Study|Lost to Follow-up|1|||
161382471|NCT03107052|582787601|FG000|Overall Study|Lack of Efficacy|23|||
161382472|NCT03107052|582787602|FG001|Overall Study|Lack of Efficacy|7|||
161382473|NCT03107052|582787603|FG002|Overall Study|Lack of Efficacy|4|||
161382474|NCT03107052|582787601|FG000|Overall Study|Other than specified|4|||
161382475|NCT03107052|582787602|FG001|Overall Study|Other than specified|2|||
161382476|NCT03107052|582787603|FG002|Overall Study|Other than specified|0|||
161382477|NCT03107052|582787601|FG000|Overall Study|Study terminated due to futility|67|||
161382478|NCT03107052|582787602|FG001|Overall Study|Study terminated due to futility|31|||
161382479|NCT03107052|582787603|FG002|Overall Study|Study terminated due to futility|23|||
161382480|NCT00958360|582787604|FG000|Overall Study|Withdrawal by Subject|3|||
161382481|NCT00958360|582787605|FG001|Overall Study|Withdrawal by Subject|1|||
161382482|NCT00958360|582787604|FG000|Overall Study|Death|6|||
161382483|NCT00958360|582787605|FG001|Overall Study|Death|7|||
161382484|NCT00958360|582787604|FG000|Overall Study|Physician Decision|2|||
161382485|NCT00958360|582787605|FG001|Overall Study|Physician Decision|1|||
161382486|NCT00958360|582787604|FG000|Overall Study|Lost to Follow-up|0|||
161382487|NCT00958360|582787605|FG001|Overall Study|Lost to Follow-up|1|||
161382488|NCT03015363|582787606|FG000|Overall Study|Physician Decision|14|||
161382489|NCT03015363|582787606|FG000|Overall Study|Withdrawal by Subject|3|||
161382490|NCT01061723|582787607|FG000|Overall Study|Adverse Event|0|||
161382491|NCT01061723|582787608|FG001|Overall Study|Adverse Event|2|||
161382492|NCT01061723|582787609|FG002|Overall Study|Adverse Event|5|||
161382493|NCT01061723|582787610|FG003|Overall Study|Adverse Event|5|||
161382494|NCT01061723|582787611|FG004|Overall Study|Adverse Event|2|||
161382495|NCT01061723|582787612|FG005|Overall Study|Adverse Event|6|||
161382496|NCT01061723|582787607|FG000|Overall Study|Lack of Efficacy|2|||
161382497|NCT01061723|582787608|FG001|Overall Study|Lack of Efficacy|3|||
161382498|NCT01061723|582787609|FG002|Overall Study|Lack of Efficacy|4|||
161382499|NCT01061723|582787610|FG003|Overall Study|Lack of Efficacy|2|||
161382500|NCT01061723|582787611|FG004|Overall Study|Lack of Efficacy|1|||
161382501|NCT01061723|582787612|FG005|Overall Study|Lack of Efficacy|1|||
161382502|NCT01061723|582787607|FG000|Overall Study|Randomized but not treated|0|||
161382503|NCT01061723|582787608|FG001|Overall Study|Randomized but not treated|0|||
161382504|NCT01061723|582787609|FG002|Overall Study|Randomized but not treated|0|||
161382505|NCT01061723|582787610|FG003|Overall Study|Randomized but not treated|0|||
161382506|NCT01061723|582787611|FG004|Overall Study|Randomized but not treated|0|||
161382507|NCT01061723|582787612|FG005|Overall Study|Randomized but not treated|1|||
161382508|NCT01061723|582787607|FG000|Overall Study|Other than specified above|2|||
161382509|NCT01061723|582787608|FG001|Overall Study|Other than specified above|1|||
161382510|NCT01061723|582787609|FG002|Overall Study|Other than specified above|1|||
161382511|NCT01061723|582787610|FG003|Overall Study|Other than specified above|1|||
161382512|NCT01061723|582787611|FG004|Overall Study|Other than specified above|0|||
161382513|NCT01061723|582787612|FG005|Overall Study|Other than specified above|1|||
161382514|NCT00500357|582787613|FG000|Overall Study|Death|1|||
161382515|NCT02263326|582787614|FG000|Overall Study|Lost to Follow-up|1|||
161382516|NCT02263326|582787615|FG001|Overall Study|Lost to Follow-up|1|||
161382517|NCT03292874|582787616|FG000|Overall Study|Due to pandemic|5|||
161382518|NCT01961297|582787619|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
161382519|NCT01961297|582787620|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
161382520|NCT02482298|582787621|FG000|Overall Study|Withdrawal by Subject|2|||
161382521|NCT02482298|582787622|FG001|Overall Study|Withdrawal by Subject|1|||
161382522|NCT02482298|582787623|FG002|Overall Study|Withdrawal by Subject|2|||
161382523|NCT02482298|582787621|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
161382524|NCT02482298|582787622|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
161382525|NCT02482298|582787623|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
161382526|NCT02482298|582787621|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
161382527|NCT02482298|582787622|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
161382528|NCT02482298|582787623|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
161382529|NCT02482298|582787621|FG000|Overall Study|Lost to Follow-up|0|||
161382530|NCT02482298|582787622|FG001|Overall Study|Lost to Follow-up|1|||
161382531|NCT02482298|582787623|FG002|Overall Study|Lost to Follow-up|0|||
161382532|NCT00540592|582787631|FG000|Overall Study|Adverse Event|0|||
161382533|NCT00540592|582787632|FG001|Overall Study|Adverse Event|1|||
161382534|NCT00540592|582787633|FG002|Overall Study|Adverse Event|0|||
161382535|NCT00540592|582787634|FG003|Overall Study|Adverse Event|0|||
161382536|NCT00540592|582787635|FG004|Overall Study|Adverse Event|1|||
161382537|NCT00540592|582787636|FG005|Overall Study|Adverse Event|0|||
161382538|NCT00540592|582787637|FG006|Overall Study|Adverse Event|0|||
161382539|NCT00540592|582787638|FG007|Overall Study|Adverse Event|1|||
161382540|NCT00540592|582787639|FG008|Overall Study|Adverse Event|1|||
161382541|NCT00540592|582787640|FG009|Overall Study|Adverse Event|2|||
161382542|NCT00540592|582787631|FG000|Overall Study|Lost to Follow-up|2|||
161382543|NCT00540592|582787632|FG001|Overall Study|Lost to Follow-up|0|||
161382544|NCT00540592|582787633|FG002|Overall Study|Lost to Follow-up|0|||
161382545|NCT00540592|582787634|FG003|Overall Study|Lost to Follow-up|0|||
161382546|NCT00540592|582787635|FG004|Overall Study|Lost to Follow-up|0|||
161382547|NCT00540592|582787636|FG005|Overall Study|Lost to Follow-up|0|||
161382548|NCT00540592|582787637|FG006|Overall Study|Lost to Follow-up|0|||
161382549|NCT00540592|582787638|FG007|Overall Study|Lost to Follow-up|0|||
161382550|NCT00540592|582787639|FG008|Overall Study|Lost to Follow-up|0|||
161382551|NCT00540592|582787640|FG009|Overall Study|Lost to Follow-up|0|||
161382552|NCT00540592|582787631|FG000|Overall Study|Withdrawal by Subject|0|||
161382553|NCT00540592|582787632|FG001|Overall Study|Withdrawal by Subject|0|||
161382554|NCT00540592|582787633|FG002|Overall Study|Withdrawal by Subject|1|||
161382555|NCT00540592|582787634|FG003|Overall Study|Withdrawal by Subject|1|||
161382556|NCT00540592|582787635|FG004|Overall Study|Withdrawal by Subject|0|||
161382557|NCT00540592|582787636|FG005|Overall Study|Withdrawal by Subject|0|||
161382558|NCT00540592|582787637|FG006|Overall Study|Withdrawal by Subject|0|||
161382559|NCT00540592|582787638|FG007|Overall Study|Withdrawal by Subject|0|||
161382560|NCT00540592|582787639|FG008|Overall Study|Withdrawal by Subject|0|||
161382561|NCT00540592|582787640|FG009|Overall Study|Withdrawal by Subject|0|||
161382562|NCT04908683|582787641|FG000|Overall Study|Failure to meet continuation criteria|34|||
161382563|NCT04908683|582787642|FG001|Overall Study|Failure to meet continuation criteria|22|||
161382564|NCT04908683|582787641|FG000|Overall Study|Initiated prohibited medication|3|||
161382565|NCT04908683|582787642|FG001|Overall Study|Initiated prohibited medication|0|||
161382566|NCT04908683|582787641|FG000|Overall Study|Randomized by mistake|1|||
161382567|NCT04908683|582787642|FG001|Overall Study|Randomized by mistake|0|||
161382568|NCT04908683|582787641|FG000|Overall Study|Lost to Follow-up|679|||
161382569|NCT04908683|582787642|FG001|Overall Study|Lost to Follow-up|341|||
161382570|NCT04908683|582787641|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
161382571|NCT04908683|582787642|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
161382572|NCT04908683|582787641|FG000|Overall Study|Physician Decision|44|||
161382573|NCT04908683|582787642|FG001|Overall Study|Physician Decision|35|||
161382574|NCT04908683|582787641|FG000|Overall Study|Technical problems|12|||
161382575|NCT04908683|582787642|FG001|Overall Study|Technical problems|9|||
161382576|NCT04908683|582787641|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
161382577|NCT04908683|582787642|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
161382578|NCT04908683|582787641|FG000|Overall Study|Protocol Violation|2|||
161382579|NCT04908683|582787642|FG001|Overall Study|Protocol Violation|0|||
161382580|NCT04908683|582787641|FG000|Overall Study|Withdrawal by Subject|1188|||
161382581|NCT04908683|582787642|FG001|Overall Study|Withdrawal by Subject|570|||
161382582|NCT04908683|582787641|FG000|Overall Study|Site Closure by Sponsor|6|||
161382583|NCT04908683|582787642|FG001|Overall Study|Site Closure by Sponsor|3|||
161382584|NCT04908683|582787641|FG000|Overall Study|Adverse Event|21|||
161382585|NCT04908683|582787642|FG001|Overall Study|Adverse Event|11|||
161382586|NCT04908683|582787641|FG000|Overall Study|Death|101|||
161382587|NCT04908683|582787642|FG001|Overall Study|Death|61|||
161382588|NCT04908683|582787641|FG000|Overall Study|Sponsor's decision|14398|||
161382589|NCT04908683|582787642|FG001|Overall Study|Sponsor's decision|7205|||
161382590|NCT04908683|582787641|FG000|Overall Study|Other|92|||
161382591|NCT04908683|582787642|FG001|Overall Study|Other|50|||
161382592|NCT04908683|582787641|FG000|Overall Study|Randomized not vaccinated|108|||
161382593|NCT04908683|582787642|FG001|Overall Study|Randomized not vaccinated|52|||
161382594|NCT00910910|582787643|FG000|Overall Study|Adverse Event|63|||
161382595|NCT00910910|582787644|FG001|Overall Study|Adverse Event|35|||
161382596|NCT00910910|582787643|FG000|Overall Study|PD without histologic change|27|||
161382597|NCT00910910|582787644|FG001|Overall Study|PD without histologic change|23|||
161382598|NCT00910910|582787643|FG000|Overall Study|PD with histologic change|0|||
161382599|NCT00910910|582787644|FG001|Overall Study|PD with histologic change|2|||
161382600|NCT00910910|582787643|FG000|Overall Study|Withdrawal by Subject|7|||
161382601|NCT00910910|582787644|FG001|Overall Study|Withdrawal by Subject|5|||
161382602|NCT00910910|582787643|FG000|Overall Study|Lost to Follow-up|2|||
161382603|NCT00910910|582787644|FG001|Overall Study|Lost to Follow-up|2|||
161382604|NCT00910910|582787643|FG000|Overall Study|Death|9|||
161382605|NCT00910910|582787644|FG001|Overall Study|Death|3|||
161382606|NCT00910910|582787643|FG000|Overall Study|Protocol Violation|2|||
161382607|NCT00910910|582787644|FG001|Overall Study|Protocol Violation|2|||
161382608|NCT00910910|582787643|FG000|Overall Study|Completed 13 cycles of treatment|0|||
161382609|NCT00910910|582787644|FG001|Overall Study|Completed 13 cycles of treatment|118|||
161382610|NCT00910910|582787643|FG000|Overall Study|Other|114|||
161382611|NCT00910910|582787644|FG001|Overall Study|Other|32|||
161382612|NCT00910910|582787643|FG000|Overall Study|Untreated before cycle 1|1|||
161382613|NCT00910910|582787644|FG001|Overall Study|Untreated before cycle 1|2|||
161382614|NCT01973231|582787645|FG000|Overall Study|Protocol Violation|1|||
161382615|NCT01973231|582787646|FG001|Overall Study|Protocol Violation|1|||
161382616|NCT01973231|582787645|FG000|Overall Study|Lost to Follow-up|1|||
161382617|NCT01973231|582787646|FG001|Overall Study|Lost to Follow-up|1|||
161382618|NCT01973231|582787645|FG000|Overall Study|unclassified|2|||
161382619|NCT01973231|582787646|FG001|Overall Study|unclassified|1|||
161382620|NCT01973231|582787645|FG000|Overall Study|Withdrawal by Subject|7|||
161382621|NCT01973231|582787646|FG001|Overall Study|Withdrawal by Subject|9|||
161382622|NCT01071954|582787651|FG000|Overall Study|Noncompliance|4|||
161382623|NCT01071954|582787651|FG000|Overall Study|Adverse Event|1|||
161382624|NCT01071954|582787651|FG000|Overall Study|Withdrawal by Subject|11|||
161382625|NCT01071954|582787651|FG000|Overall Study|Requirement for Alternative Therapy|5|||
161382626|NCT01071954|582787651|FG000|Overall Study|Administrative Decision|5|||
161382627|NCT01071954|582787651|FG000|Overall Study|Protocol Specified Criteria|1|||
161382628|NCT01434654|582787652|FG000|Overall Study|Withdrawal by Subject|1|||
161382629|NCT01434654|582787653|FG001|Overall Study|Withdrawal by Subject|0|||
161382630|NCT01434654|582787652|FG000|Overall Study|Lost to Follow-up|1|||
161382631|NCT01434654|582787653|FG001|Overall Study|Lost to Follow-up|0|||
161382632|NCT01823198|582787654|FG000|Overall Study|Physician Decision|0|||
161382633|NCT01823198|582787655|FG001|Overall Study|Physician Decision|1|||
161382634|NCT01823198|582787656|FG002|Overall Study|Physician Decision|0|||
161382635|NCT01823198|582787657|FG003|Overall Study|Physician Decision|0|||
161382636|NCT01823198|582787658|FG004|Overall Study|Physician Decision|0|||
161382637|NCT01823198|582787659|FG005|Overall Study|Physician Decision|3|||
161382638|NCT01823198|582787660|FG006|Overall Study|Physician Decision|3|||
161382639|NCT01926444|582787661|FG000|Overall Study|Colonoscopy not performed|0|||
161382640|NCT01926444|582787662|FG001|Overall Study|Colonoscopy not performed|0|||
161382641|NCT01926444|582787663|FG002|Overall Study|Colonoscopy not performed|4|||
161382642|NCT01926444|582787664|FG003|Overall Study|Colonoscopy not performed|2|||
161382643|NCT02243371|582787674|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
161382644|NCT02243371|582787675|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
161382645|NCT02243371|582787674|FG000|Overall Study|Death (unrelated)|2|||
161382646|NCT02243371|582787675|FG001|Overall Study|Death (unrelated)|4|||
161382647|NCT02243371|582787674|FG000|Overall Study|Adverse Event (unrelated)|0|||
161382648|NCT02243371|582787675|FG001|Overall Study|Adverse Event (unrelated)|1|||
161382649|NCT02243371|582787674|FG000|Overall Study|Lack of Clinical Benefit|0|||
161382650|NCT02243371|582787675|FG001|Overall Study|Lack of Clinical Benefit|1|||
161382651|NCT02243371|582787674|FG000|Overall Study|Withdrawal by Subject|0|||
161382652|NCT02243371|582787675|FG001|Overall Study|Withdrawal by Subject|2|||
161382653|NCT00778336|582787678|FG000|Index Procedure-Discharge|Death|6|||
161382654|NCT00778336|582787679|FG001|Index Procedure-Discharge|Death|3|||
161382655|NCT00778336|582787680|FG002|Index Procedure-Discharge|Death|2|||
161382656|NCT00778336|582787681|FG003|Index Procedure-Discharge|Death|0|||
161382657|NCT00778336|582787678|FG000|3 Month Follow Up|Lost to Follow-up|15|||
161382658|NCT00778336|582787679|FG001|3 Month Follow Up|Lost to Follow-up|20|||
161382659|NCT00778336|582787680|FG002|3 Month Follow Up|Lost to Follow-up|3|||
161382660|NCT00778336|582787681|FG003|3 Month Follow Up|Lost to Follow-up|0|||
161382661|NCT00778336|582787678|FG000|3 Month Follow Up|Death|8|||
161382662|NCT00778336|582787679|FG001|3 Month Follow Up|Death|3|||
161382663|NCT00778336|582787680|FG002|3 Month Follow Up|Death|2|||
161382664|NCT00778336|582787681|FG003|3 Month Follow Up|Death|0|||
161382665|NCT04585269|582787682|FG000|Intervention|Withdrawal by Subject|9|||
161382666|NCT04585269|582787683|FG001|Intervention|Withdrawal by Subject|0|||
161382667|NCT04585269|582787682|FG000|Intervention|Unable to schedule|15|||
161382668|NCT04585269|582787683|FG001|Intervention|Unable to schedule|0|||
161382669|NCT04585269|582787682|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
161382670|NCT04585269|582787683|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
161382671|NCT04585269|582787682|FG000|FU Time 2 (3 months)|Death|2|||
161382672|NCT04585269|582787683|FG001|FU Time 2 (3 months)|Death|2|||
161382673|NCT04585269|582787682|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
161382674|NCT04585269|582787683|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
161382675|NCT04585269|582787682|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
161382676|NCT04585269|582787683|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
161382677|NCT04585269|582787682|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
161382678|NCT04585269|582787683|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
161382679|NCT04585269|582787682|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
161382680|NCT04585269|582787683|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
161382681|NCT04585269|582787682|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
161382682|NCT04585269|582787683|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
161382683|NCT03307785|582787686|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
161382684|NCT03307785|582787687|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382685|NCT03307785|582787688|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382686|NCT03307785|582787689|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382687|NCT03307785|582787690|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382688|NCT03307785|582787691|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382689|NCT03307785|582787692|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382690|NCT03307785|582787693|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382691|NCT03307785|582787694|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382692|NCT03307785|582787695|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382693|NCT03307785|582787696|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382694|NCT03307785|582787697|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382695|NCT03307785|582787698|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161382696|NCT03307785|582787686|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
161382697|NCT03307785|582787687|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
161382698|NCT03307785|582787688|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382699|NCT03307785|582787689|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382700|NCT03307785|582787690|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382701|NCT03307785|582787691|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382702|NCT03307785|582787692|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382703|NCT03307785|582787693|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382704|NCT03307785|582787694|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382705|NCT03307785|582787695|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382706|NCT03307785|582787696|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382707|NCT03307785|582787697|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382708|NCT03307785|582787698|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161382709|NCT03307785|582787686|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
161382710|NCT03307785|582787687|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
161382711|NCT03307785|582787688|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382712|NCT03307785|582787689|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382713|NCT03307785|582787690|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382714|NCT03307785|582787691|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382715|NCT03307785|582787692|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382716|NCT03307785|582787693|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382717|NCT03307785|582787694|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382718|NCT03307785|582787695|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382719|NCT03307785|582787696|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382720|NCT03307785|582787697|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382721|NCT03307785|582787698|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
161382722|NCT03307785|582787686|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
161382723|NCT03307785|582787687|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
161382724|NCT03307785|582787688|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382725|NCT03307785|582787689|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382726|NCT03307785|582787690|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382727|NCT03307785|582787691|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382728|NCT03307785|582787692|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382729|NCT03307785|582787693|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382730|NCT03307785|582787694|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382731|NCT03307785|582787695|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382732|NCT03307785|582787696|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382733|NCT03307785|582787697|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382734|NCT03307785|582787698|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161382735|NCT03307785|582787686|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382736|NCT03307785|582787687|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382737|NCT03307785|582787688|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
161382738|NCT03307785|582787689|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382739|NCT03307785|582787690|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382740|NCT03307785|582787691|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382741|NCT03307785|582787692|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382742|NCT03307785|582787693|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382743|NCT03307785|582787694|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382744|NCT03307785|582787695|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382745|NCT03307785|582787696|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382746|NCT03307785|582787697|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382747|NCT03307785|582787698|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161382748|NCT03307785|582787686|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382749|NCT03307785|582787687|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382750|NCT03307785|582787688|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
161382751|NCT03307785|582787689|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382752|NCT03307785|582787690|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382753|NCT03307785|582787691|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382754|NCT03307785|582787692|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382755|NCT03307785|582787693|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382756|NCT03307785|582787694|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382757|NCT03307785|582787695|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382758|NCT03307785|582787696|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382759|NCT03307785|582787697|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
161382760|NCT03307785|582787698|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
161435297|NCT01710345|582987977|FG001|Overall Study|Lack of Efficacy|3|||
161382761|NCT03307785|582787686|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382762|NCT03307785|582787687|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382763|NCT03307785|582787688|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
161382764|NCT03307785|582787689|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382765|NCT03307785|582787690|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382766|NCT03307785|582787691|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382767|NCT03307785|582787692|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382768|NCT03307785|582787693|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382769|NCT03307785|582787694|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382770|NCT03307785|582787695|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382771|NCT03307785|582787696|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382772|NCT03307785|582787697|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382773|NCT03307785|582787698|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161382774|NCT03307785|582787686|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382775|NCT03307785|582787687|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382776|NCT03307785|582787688|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
161382777|NCT03307785|582787689|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382778|NCT03307785|582787690|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382779|NCT03307785|582787691|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382780|NCT03307785|582787692|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382781|NCT03307785|582787693|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382782|NCT03307785|582787694|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382783|NCT03307785|582787695|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382784|NCT03307785|582787696|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382785|NCT03307785|582787697|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382786|NCT03307785|582787698|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161382787|NCT03307785|582787686|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382788|NCT03307785|582787687|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382789|NCT03307785|582787688|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
161382790|NCT03307785|582787689|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382791|NCT03307785|582787690|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382792|NCT03307785|582787691|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382793|NCT03307785|582787692|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382794|NCT03307785|582787693|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382795|NCT03307785|582787694|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382796|NCT03307785|582787695|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382797|NCT03307785|582787696|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382798|NCT03307785|582787697|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382799|NCT03307785|582787698|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161382800|NCT03307785|582787686|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382801|NCT03307785|582787687|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382802|NCT03307785|582787688|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382803|NCT03307785|582787689|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
161382804|NCT03307785|582787690|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
161382805|NCT03307785|582787691|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382806|NCT03307785|582787692|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382807|NCT03307785|582787693|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382808|NCT03307785|582787694|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382809|NCT03307785|582787695|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382810|NCT03307785|582787696|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382811|NCT03307785|582787697|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382812|NCT03307785|582787698|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161382813|NCT03307785|582787686|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382814|NCT03307785|582787687|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382815|NCT03307785|582787688|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382816|NCT03307785|582787689|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
161382817|NCT03307785|582787690|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
161382818|NCT03307785|582787691|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382819|NCT03307785|582787692|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382820|NCT03307785|582787693|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382821|NCT03307785|582787694|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382822|NCT03307785|582787695|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382823|NCT03307785|582787696|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382824|NCT03307785|582787697|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382825|NCT03307785|582787698|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
161382826|NCT03307785|582787686|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382827|NCT03307785|582787687|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382828|NCT03307785|582787688|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382829|NCT03307785|582787689|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
161382830|NCT03307785|582787690|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382831|NCT03307785|582787691|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382832|NCT03307785|582787692|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382833|NCT03307785|582787693|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382834|NCT03307785|582787694|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382835|NCT03307785|582787695|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382836|NCT03307785|582787696|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382837|NCT03307785|582787697|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382838|NCT03307785|582787698|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161382839|NCT03307785|582787686|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382840|NCT03307785|582787687|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382841|NCT03307785|582787688|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382842|NCT03307785|582787689|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382843|NCT03307785|582787690|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
161382844|NCT03307785|582787691|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382845|NCT03307785|582787692|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382846|NCT03307785|582787693|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382847|NCT03307785|582787694|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382848|NCT03307785|582787695|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382849|NCT03307785|582787696|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382850|NCT03307785|582787697|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382851|NCT03307785|582787698|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161382852|NCT03307785|582787686|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382853|NCT03307785|582787687|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382854|NCT03307785|582787688|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382855|NCT03307785|582787689|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382856|NCT03307785|582787690|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382857|NCT03307785|582787691|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
161382858|NCT03307785|582787692|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382859|NCT03307785|582787693|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382860|NCT03307785|582787694|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382861|NCT03307785|582787695|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382862|NCT03307785|582787696|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382863|NCT03307785|582787697|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382864|NCT03307785|582787698|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161382865|NCT03307785|582787686|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382866|NCT03307785|582787687|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382867|NCT03307785|582787688|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382868|NCT03307785|582787689|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382869|NCT03307785|582787690|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382870|NCT03307785|582787691|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
161382871|NCT03307785|582787692|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382872|NCT03307785|582787693|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382873|NCT03307785|582787694|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382874|NCT03307785|582787695|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382875|NCT03307785|582787696|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382876|NCT03307785|582787697|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382877|NCT03307785|582787698|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161382878|NCT03307785|582787686|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382879|NCT03307785|582787687|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382880|NCT03307785|582787688|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382881|NCT03307785|582787689|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382882|NCT03307785|582787690|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382883|NCT03307785|582787691|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
161382884|NCT03307785|582787692|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382885|NCT03307785|582787693|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161435298|NCT01710345|582987978|FG002|Overall Study|Lack of Efficacy|1|||
161382886|NCT03307785|582787694|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382887|NCT03307785|582787695|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382888|NCT03307785|582787696|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382889|NCT03307785|582787697|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382890|NCT03307785|582787698|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161382891|NCT03307785|582787686|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382892|NCT03307785|582787687|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382893|NCT03307785|582787688|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382894|NCT03307785|582787689|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382895|NCT03307785|582787690|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382896|NCT03307785|582787691|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
161382897|NCT03307785|582787692|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382898|NCT03307785|582787693|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382899|NCT03307785|582787694|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382900|NCT03307785|582787695|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382901|NCT03307785|582787696|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382902|NCT03307785|582787697|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382903|NCT03307785|582787698|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161382904|NCT03307785|582787686|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382905|NCT03307785|582787687|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382906|NCT03307785|582787688|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382907|NCT03307785|582787689|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382908|NCT03307785|582787690|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382909|NCT03307785|582787691|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
161382910|NCT03307785|582787692|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382911|NCT03307785|582787693|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382912|NCT03307785|582787694|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382913|NCT03307785|582787695|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382914|NCT03307785|582787696|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382915|NCT03307785|582787697|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382916|NCT03307785|582787698|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161382917|NCT03307785|582787686|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382918|NCT03307785|582787687|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382919|NCT03307785|582787688|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382920|NCT03307785|582787689|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382921|NCT03307785|582787690|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382922|NCT03307785|582787691|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382923|NCT03307785|582787692|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
161382924|NCT03307785|582787693|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382925|NCT03307785|582787694|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382926|NCT03307785|582787695|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382927|NCT03307785|582787696|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382928|NCT03307785|582787697|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382929|NCT03307785|582787698|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
161382930|NCT03307785|582787686|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382931|NCT03307785|582787687|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382932|NCT03307785|582787688|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382933|NCT03307785|582787689|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382934|NCT03307785|582787690|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382935|NCT03307785|582787691|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382936|NCT03307785|582787692|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
161382937|NCT03307785|582787693|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382938|NCT03307785|582787694|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382939|NCT03307785|582787695|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382940|NCT03307785|582787696|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382941|NCT03307785|582787697|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382942|NCT03307785|582787698|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161382943|NCT03307785|582787686|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382944|NCT03307785|582787687|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382945|NCT03307785|582787688|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382946|NCT03307785|582787689|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382947|NCT03307785|582787690|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382948|NCT03307785|582787691|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382949|NCT03307785|582787692|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382950|NCT03307785|582787693|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
161382951|NCT03307785|582787694|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382952|NCT03307785|582787695|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382953|NCT03307785|582787696|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382954|NCT03307785|582787697|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382955|NCT03307785|582787698|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161382956|NCT03307785|582787686|FG000|PACT Phase: Up to 19 Months|Death|0|||
161382957|NCT03307785|582787687|FG001|PACT Phase: Up to 19 Months|Death|0|||
161382958|NCT03307785|582787688|FG002|PACT Phase: Up to 19 Months|Death|0|||
161382959|NCT03307785|582787689|FG003|PACT Phase: Up to 19 Months|Death|0|||
161382960|NCT03307785|582787690|FG004|PACT Phase: Up to 19 Months|Death|0|||
161382961|NCT03307785|582787691|FG005|PACT Phase: Up to 19 Months|Death|0|||
161382962|NCT03307785|582787692|FG006|PACT Phase: Up to 19 Months|Death|0|||
161382963|NCT03307785|582787693|FG007|PACT Phase: Up to 19 Months|Death|0|||
161382964|NCT03307785|582787694|FG008|PACT Phase: Up to 19 Months|Death|0|||
161382965|NCT03307785|582787695|FG009|PACT Phase: Up to 19 Months|Death|0|||
161382966|NCT03307785|582787696|FG010|PACT Phase: Up to 19 Months|Death|0|||
161382967|NCT03307785|582787697|FG011|PACT Phase: Up to 19 Months|Death|0|||
161382968|NCT03307785|582787698|FG012|PACT Phase: Up to 19 Months|Death|1|||
161382969|NCT03666988|582787699|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
161382970|NCT03666988|582787700|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
161382971|NCT03666988|582787701|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
161382972|NCT03666988|582787702|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
161382973|NCT03666988|582787703|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
161382974|NCT03666988|582787704|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
161382975|NCT03666988|582787699|FG000|Part 1 (Up to 28 Months)|Other|0|||
161382976|NCT03666988|582787700|FG001|Part 1 (Up to 28 Months)|Other|1|||
161382977|NCT03666988|582787701|FG002|Part 1 (Up to 28 Months)|Other|1|||
161382978|NCT03666988|582787702|FG003|Part 1 (Up to 28 Months)|Other|0|||
161382979|NCT03666988|582787703|FG004|Part 1 (Up to 28 Months)|Other|0|||
161382980|NCT03666988|582787704|FG005|Part 1 (Up to 28 Months)|Other|0|||
161382981|NCT03666988|582787699|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
161382982|NCT03666988|582787700|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
161382983|NCT03666988|582787701|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
161382984|NCT03666988|582787702|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
161382985|NCT03666988|582787703|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
161382986|NCT03666988|582787704|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
161382987|NCT03666988|582787699|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
161382988|NCT03666988|582787700|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
161382989|NCT03666988|582787701|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
161382990|NCT03666988|582787702|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
161382991|NCT03666988|582787703|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
161382992|NCT03666988|582787704|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
161382993|NCT03666988|582787699|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
161382994|NCT03666988|582787700|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161382995|NCT03666988|582787701|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161382996|NCT03666988|582787702|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161382997|NCT03666988|582787703|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161382998|NCT03666988|582787704|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161382999|NCT02517398|582787705|FG000|Overall Study|Death|2|||
161383000|NCT02517398|582787706|FG001|Overall Study|Death|3|||
161383001|NCT02517398|582787707|FG002|Overall Study|Death|4|||
161383002|NCT02517398|582787708|FG003|Overall Study|Death|2|||
161383003|NCT02517398|582787709|FG004|Overall Study|Death|3|||
161383004|NCT02517398|582787710|FG005|Overall Study|Death|8|||
161383005|NCT02517398|582787711|FG006|Overall Study|Death|3|||
161383006|NCT02517398|582787712|FG007|Overall Study|Death|2|||
161383007|NCT02517398|582787713|FG008|Overall Study|Death|6|||
161383008|NCT02517398|582787714|FG009|Overall Study|Death|24|||
161383009|NCT02517398|582787715|FG010|Overall Study|Death|53|||
161383010|NCT02517398|582787716|FG011|Overall Study|Death|25|||
161383011|NCT02517398|582787717|FG012|Overall Study|Death|73|||
161383012|NCT02517398|582787718|FG013|Overall Study|Death|29|||
161383013|NCT02517398|582787719|FG014|Overall Study|Death|26|||
161383014|NCT02517398|582787720|FG015|Overall Study|Death|23|||
161383015|NCT02517398|582787721|FG016|Overall Study|Death|26|||
161383016|NCT02517398|582787722|FG017|Overall Study|Death|25|||
161383017|NCT02517398|582787723|FG018|Overall Study|Death|22|||
161383018|NCT02517398|582787724|FG019|Overall Study|Death|7|||
161383019|NCT02517398|582787725|FG020|Overall Study|Death|26|||
161383020|NCT02517398|582787726|FG021|Overall Study|Death|30|||
161383021|NCT02517398|582787727|FG022|Overall Study|Death|20|||
161383022|NCT02517398|582787705|FG000|Overall Study|Other|0|||
161383023|NCT02517398|582787706|FG001|Overall Study|Other|0|||
161383024|NCT02517398|582787707|FG002|Overall Study|Other|0|||
161383025|NCT02517398|582787708|FG003|Overall Study|Other|1|||
161383026|NCT02517398|582787709|FG004|Overall Study|Other|0|||
161383027|NCT02517398|582787710|FG005|Overall Study|Other|0|||
161383028|NCT02517398|582787711|FG006|Overall Study|Other|0|||
161383029|NCT02517398|582787712|FG007|Overall Study|Other|0|||
161383030|NCT02517398|582787713|FG008|Overall Study|Other|0|||
161383031|NCT02517398|582787714|FG009|Overall Study|Other|1|||
161383032|NCT02517398|582787715|FG010|Overall Study|Other|0|||
161383033|NCT02517398|582787716|FG011|Overall Study|Other|0|||
161383034|NCT02517398|582787717|FG012|Overall Study|Other|0|||
161383035|NCT02517398|582787718|FG013|Overall Study|Other|1|||
161383036|NCT02517398|582787719|FG014|Overall Study|Other|0|||
161383037|NCT02517398|582787720|FG015|Overall Study|Other|1|||
161383038|NCT02517398|582787721|FG016|Overall Study|Other|1|||
161383039|NCT02517398|582787722|FG017|Overall Study|Other|0|||
161383040|NCT02517398|582787723|FG018|Overall Study|Other|0|||
161383041|NCT02517398|582787724|FG019|Overall Study|Other|1|||
161383042|NCT02517398|582787725|FG020|Overall Study|Other|0|||
161383043|NCT02517398|582787726|FG021|Overall Study|Other|0|||
161383044|NCT02517398|582787727|FG022|Overall Study|Other|0|||
161383045|NCT02517398|582787705|FG000|Overall Study|Lost to Follow-up|0|||
161383046|NCT02517398|582787706|FG001|Overall Study|Lost to Follow-up|0|||
161383047|NCT02517398|582787707|FG002|Overall Study|Lost to Follow-up|0|||
161383048|NCT02517398|582787708|FG003|Overall Study|Lost to Follow-up|0|||
161383049|NCT02517398|582787709|FG004|Overall Study|Lost to Follow-up|0|||
161383050|NCT02517398|582787710|FG005|Overall Study|Lost to Follow-up|0|||
161383051|NCT02517398|582787711|FG006|Overall Study|Lost to Follow-up|0|||
161383052|NCT02517398|582787712|FG007|Overall Study|Lost to Follow-up|0|||
161383053|NCT02517398|582787713|FG008|Overall Study|Lost to Follow-up|0|||
161383054|NCT02517398|582787714|FG009|Overall Study|Lost to Follow-up|1|||
161383055|NCT02517398|582787715|FG010|Overall Study|Lost to Follow-up|0|||
161383056|NCT02517398|582787716|FG011|Overall Study|Lost to Follow-up|2|||
161383057|NCT02517398|582787717|FG012|Overall Study|Lost to Follow-up|2|||
161383058|NCT02517398|582787718|FG013|Overall Study|Lost to Follow-up|0|||
161383059|NCT02517398|582787719|FG014|Overall Study|Lost to Follow-up|1|||
161383060|NCT02517398|582787720|FG015|Overall Study|Lost to Follow-up|1|||
161383061|NCT02517398|582787721|FG016|Overall Study|Lost to Follow-up|0|||
161383062|NCT02517398|582787722|FG017|Overall Study|Lost to Follow-up|3|||
161383063|NCT02517398|582787723|FG018|Overall Study|Lost to Follow-up|1|||
161383064|NCT02517398|582787724|FG019|Overall Study|Lost to Follow-up|0|||
161383065|NCT02517398|582787725|FG020|Overall Study|Lost to Follow-up|1|||
161383066|NCT02517398|582787726|FG021|Overall Study|Lost to Follow-up|0|||
161383067|NCT02517398|582787727|FG022|Overall Study|Lost to Follow-up|2|||
161383068|NCT02517398|582787705|FG000|Overall Study|Withdrew Consent|0|||
161383069|NCT02517398|582787706|FG001|Overall Study|Withdrew Consent|0|||
161383070|NCT02517398|582787707|FG002|Overall Study|Withdrew Consent|0|||
161383071|NCT02517398|582787708|FG003|Overall Study|Withdrew Consent|0|||
161383072|NCT02517398|582787709|FG004|Overall Study|Withdrew Consent|0|||
161383073|NCT02517398|582787710|FG005|Overall Study|Withdrew Consent|0|||
161383074|NCT02517398|582787711|FG006|Overall Study|Withdrew Consent|1|||
161383075|NCT02517398|582787712|FG007|Overall Study|Withdrew Consent|0|||
161383076|NCT02517398|582787713|FG008|Overall Study|Withdrew Consent|0|||
161383077|NCT02517398|582787714|FG009|Overall Study|Withdrew Consent|2|||
161383078|NCT02517398|582787715|FG010|Overall Study|Withdrew Consent|7|||
161383079|NCT02517398|582787716|FG011|Overall Study|Withdrew Consent|1|||
161383080|NCT02517398|582787717|FG012|Overall Study|Withdrew Consent|5|||
161383081|NCT02517398|582787718|FG013|Overall Study|Withdrew Consent|4|||
161383082|NCT02517398|582787719|FG014|Overall Study|Withdrew Consent|2|||
161383083|NCT02517398|582787720|FG015|Overall Study|Withdrew Consent|5|||
161383084|NCT02517398|582787721|FG016|Overall Study|Withdrew Consent|4|||
161383085|NCT02517398|582787722|FG017|Overall Study|Withdrew Consent|2|||
161383086|NCT02517398|582787723|FG018|Overall Study|Withdrew Consent|3|||
161383087|NCT02517398|582787724|FG019|Overall Study|Withdrew Consent|2|||
161383088|NCT02517398|582787725|FG020|Overall Study|Withdrew Consent|9|||
161383089|NCT02517398|582787726|FG021|Overall Study|Withdrew Consent|3|||
161383090|NCT02517398|582787727|FG022|Overall Study|Withdrew Consent|1|||
161383091|NCT05588440|582787738|FG000|Overall Study|Sponsor Decision|2|||
161383092|NCT05588440|582787739|FG001|Overall Study|Sponsor Decision|0|||
161383093|NCT05588440|582787740|FG002|Overall Study|Sponsor Decision|1|||
161383094|NCT05588440|582787738|FG000|Overall Study|Death|1|||
161383095|NCT05588440|582787739|FG001|Overall Study|Death|1|||
161383096|NCT05588440|582787740|FG002|Overall Study|Death|1|||
161383097|NCT05588440|582787738|FG000|Overall Study|Screen Fail|0|||
161383098|NCT05588440|582787739|FG001|Overall Study|Screen Fail|1|||
161383099|NCT05588440|582787740|FG002|Overall Study|Screen Fail|1|||
161383100|NCT05588440|582787738|FG000|Overall Study|Withdrawal by Subject|0|||
161383101|NCT05588440|582787739|FG001|Overall Study|Withdrawal by Subject|0|||
161383102|NCT05588440|582787740|FG002|Overall Study|Withdrawal by Subject|1|||
161383103|NCT03581292|582787741|FG000|Overall Study|Physician Decision|9|||
161383104|NCT03581292|582787742|FG001|Overall Study|Physician Decision|5|||
161383105|NCT03581292|582787741|FG000|Overall Study|Withdrawal by Subject|3|||
161383106|NCT03581292|582787742|FG001|Overall Study|Withdrawal by Subject|0|||
161383107|NCT03581292|582787741|FG000|Overall Study|Withdrawal before Therapy Start|1|||
161435299|NCT01710345|582987976|FG000|Overall Study|Drug Dosing Error|1|||
161383108|NCT03581292|582787742|FG001|Overall Study|Withdrawal before Therapy Start|0|||
161383109|NCT02524145|582787746|FG000|Overall Study|Withdrawal by Subject|2|||
161383110|NCT02524145|582787747|FG001|Overall Study|Withdrawal by Subject|2|||
161383111|NCT02524145|582787748|FG002|Overall Study|Withdrawal by Subject|3|||
161383112|NCT00590122|582789042|FG000|Overall Study|swallowed oral dissolving dose|1|||
161383113|NCT00590122|582789043|FG001|Overall Study|swallowed oral dissolving dose|0|||
161383114|NCT03050450|582789044|FG000|Overall Study|Physician Decision|1|||
161383115|NCT03050450|582789045|FG001|Overall Study|Physician Decision|0|||
161383116|NCT03050450|582789046|FG002|Overall Study|Physician Decision|0|||
161383117|NCT03050450|582789047|FG003|Overall Study|Physician Decision|0|||
161383118|NCT03050450|582789048|FG004|Overall Study|Physician Decision|0|||
161383119|NCT01642901|582789052|FG000|12-month Follow-up|Withdrawal by Subject|1|||
161383120|NCT01642901|582789053|FG001|12-month Follow-up|Withdrawal by Subject|0|||
161383121|NCT03592771|582789054|FG000|Overall Study|Adverse Event|2|||
161383122|NCT03592771|582789055|FG001|Overall Study|Adverse Event|0|||
161383123|NCT03592771|582789056|FG002|Overall Study|Adverse Event|1|||
161383124|NCT03592771|582789054|FG000|Overall Study|Death|0|||
161383125|NCT03592771|582789055|FG001|Overall Study|Death|1|||
161383126|NCT03592771|582789056|FG002|Overall Study|Death|1|||
161383127|NCT03592771|582789054|FG000|Overall Study|Lost to Follow-up|5|||
161383128|NCT03592771|582789055|FG001|Overall Study|Lost to Follow-up|11|||
161383129|NCT03592771|582789056|FG002|Overall Study|Lost to Follow-up|15|||
161383130|NCT03592771|582789054|FG000|Overall Study|Withdrawal by Subject|0|||
161383131|NCT03592771|582789055|FG001|Overall Study|Withdrawal by Subject|2|||
161383132|NCT03592771|582789056|FG002|Overall Study|Withdrawal by Subject|0|||
161383133|NCT05069597|582789057|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161383134|NCT05069597|582789058|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
161383135|NCT00735553|582789059|FG000|Overall Study|Study prematurely terminated|77|||
161383136|NCT02705105|582789060|FG000|Treatment|Objective Disease Progression|1|||
161383137|NCT02705105|582789061|FG001|Treatment|Objective Disease Progression|50|||
161383138|NCT02705105|582789060|FG000|Treatment|Withdrawal by Subject|3|||
161383139|NCT02705105|582789061|FG001|Treatment|Withdrawal by Subject|5|||
161383140|NCT02705105|582789060|FG000|Treatment|Adverse Event|0|||
161383141|NCT02705105|582789061|FG001|Treatment|Adverse Event|17|||
161383142|NCT02705105|582789060|FG000|Treatment|Clinical Disease Progression|0|||
161383143|NCT02705105|582789061|FG001|Treatment|Clinical Disease Progression|32|||
161383144|NCT02705105|582789060|FG000|Treatment|Physician Decision|0|||
161383145|NCT02705105|582789061|FG001|Treatment|Physician Decision|3|||
161383146|NCT02705105|582789060|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
161383147|NCT02705105|582789061|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
161383148|NCT02705105|582789060|FG000|Follow-Up|Death|3|||
161383149|NCT02705105|582789061|FG001|Follow-Up|Death|68|||
161383150|NCT02705105|582789060|FG000|Follow-Up|Withdrawal by Subject|1|||
161383151|NCT02705105|582789061|FG001|Follow-Up|Withdrawal by Subject|14|||
161383152|NCT02705105|582789060|FG000|Follow-Up|Study Terminated|0|||
161383153|NCT02705105|582789061|FG001|Follow-Up|Study Terminated|26|||
161383154|NCT02705105|582789060|FG000|Follow-Up|Discontinued per Amendment 3|0|||
161383155|NCT02705105|582789061|FG001|Follow-Up|Discontinued per Amendment 3|2|||
161383156|NCT02707965|582789062|FG000|Overall Study|Withdrawal by Subject|0|||
161383157|NCT02707965|582789063|FG001|Overall Study|Withdrawal by Subject|0|||
161383158|NCT02707965|582789064|FG002|Overall Study|Withdrawal by Subject|1|||
161383159|NCT02707965|582789065|FG003|Overall Study|Withdrawal by Subject|0|||
161383160|NCT02707965|582789066|FG004|Overall Study|Withdrawal by Subject|0|||
161383161|NCT02707965|582789067|FG005|Overall Study|Withdrawal by Subject|0|||
161383162|NCT02707965|582789068|FG006|Overall Study|Withdrawal by Subject|0|||
161383163|NCT02707965|582789069|FG007|Overall Study|Withdrawal by Subject|2|||
161383164|NCT02707965|582789070|FG008|Overall Study|Withdrawal by Subject|0|||
161383165|NCT02707965|582789071|FG009|Overall Study|Withdrawal by Subject|0|||
161383166|NCT02707965|582789072|FG010|Overall Study|Withdrawal by Subject|0|||
161383167|NCT02707965|582789073|FG011|Overall Study|Withdrawal by Subject|0|||
161383168|NCT02707965|582789074|FG012|Overall Study|Withdrawal by Subject|0|||
161383169|NCT02707965|582789075|FG013|Overall Study|Withdrawal by Subject|0|||
161383170|NCT02707965|582789076|FG014|Overall Study|Withdrawal by Subject|0|||
161383171|NCT02707965|582789077|FG015|Overall Study|Withdrawal by Subject|0|||
161383172|NCT02707965|582789062|FG000|Overall Study|PI decisions|0|||
161383173|NCT02707965|582789063|FG001|Overall Study|PI decisions|0|||
161383174|NCT02707965|582789064|FG002|Overall Study|PI decisions|0|||
161383175|NCT02707965|582789065|FG003|Overall Study|PI decisions|0|||
161383176|NCT02707965|582789066|FG004|Overall Study|PI decisions|0|||
161383177|NCT02707965|582789067|FG005|Overall Study|PI decisions|0|||
161383178|NCT02707965|582789068|FG006|Overall Study|PI decisions|0|||
161383179|NCT02707965|582789069|FG007|Overall Study|PI decisions|0|||
161383180|NCT02707965|582789070|FG008|Overall Study|PI decisions|0|||
161383181|NCT02707965|582789071|FG009|Overall Study|PI decisions|0|||
161383182|NCT02707965|582789072|FG010|Overall Study|PI decisions|0|||
161383183|NCT02707965|582789073|FG011|Overall Study|PI decisions|0|||
161383184|NCT02707965|582789074|FG012|Overall Study|PI decisions|0|||
161383185|NCT02707965|582789075|FG013|Overall Study|PI decisions|0|||
161383186|NCT02707965|582789076|FG014|Overall Study|PI decisions|2|||
161383187|NCT02707965|582789077|FG015|Overall Study|PI decisions|0|||
161383188|NCT02707965|582789062|FG000|Overall Study|Protocol deviation|1|||
161383189|NCT02707965|582789063|FG001|Overall Study|Protocol deviation|1|||
161383190|NCT02707965|582789064|FG002|Overall Study|Protocol deviation|0|||
161383191|NCT02707965|582789065|FG003|Overall Study|Protocol deviation|0|||
161383192|NCT02707965|582789066|FG004|Overall Study|Protocol deviation|0|||
161383193|NCT02707965|582789067|FG005|Overall Study|Protocol deviation|0|||
161383194|NCT02707965|582789068|FG006|Overall Study|Protocol deviation|0|||
161383195|NCT02707965|582789069|FG007|Overall Study|Protocol deviation|1|||
161383196|NCT02707965|582789070|FG008|Overall Study|Protocol deviation|0|||
161383197|NCT02707965|582789071|FG009|Overall Study|Protocol deviation|0|||
161383198|NCT02707965|582789072|FG010|Overall Study|Protocol deviation|0|||
161383199|NCT02707965|582789073|FG011|Overall Study|Protocol deviation|0|||
161383200|NCT02707965|582789074|FG012|Overall Study|Protocol deviation|0|||
161383201|NCT02707965|582789075|FG013|Overall Study|Protocol deviation|0|||
161383202|NCT02707965|582789076|FG014|Overall Study|Protocol deviation|0|||
161383203|NCT02707965|582789077|FG015|Overall Study|Protocol deviation|0|||
161383204|NCT03650413|582789078|FG000|Overall Study|Adverse Event|1|||
161383205|NCT03650413|582789078|FG000|Overall Study|Lack of Efficacy|17|||
161383206|NCT03650413|582789078|FG000|Overall Study|Other|9|||
161383207|NCT03650413|582789078|FG000|Overall Study|Physician Decision|2|||
161383208|NCT03650413|582789078|FG000|Overall Study|Study Terminated By Sponsor|16|||
161383209|NCT03650413|582789078|FG000|Overall Study|Withdrawal by Subject|16|||
161383210|NCT00485758|582789083|FG000|Overall Study|Adverse Event|102|||
161383211|NCT00485758|582789084|FG001|Overall Study|Adverse Event|31|||
161383212|NCT00485758|582789083|FG000|Overall Study|Death|0|||
161383213|NCT00485758|582789084|FG001|Overall Study|Death|1|||
161383214|NCT00485758|582789083|FG000|Overall Study|Lost to Follow-up|5|||
161383215|NCT00485758|582789084|FG001|Overall Study|Lost to Follow-up|1|||
161383216|NCT00485758|582789083|FG000|Overall Study|Physician Decision|3|||
161383217|NCT00485758|582789084|FG001|Overall Study|Physician Decision|3|||
161383218|NCT00485758|582789083|FG000|Overall Study|Protocol Violation|11|||
161383219|NCT00485758|582789084|FG001|Overall Study|Protocol Violation|2|||
161383220|NCT00485758|582789083|FG000|Overall Study|Withdrawal by Subject|32|||
161383221|NCT00485758|582789084|FG001|Overall Study|Withdrawal by Subject|27|||
161383222|NCT00485758|582789083|FG000|Overall Study|Study Terminated by Sponsor|3|||
161383223|NCT00485758|582789084|FG001|Overall Study|Study Terminated by Sponsor|0|||
161383224|NCT03332173|582789085|FG000|Overall Study|Death|7|||
161383225|NCT03332173|582789085|FG000|Overall Study|Withdrawal by Subject|6|||
161383226|NCT03332173|582789085|FG000|Overall Study|Lost to Follow-up|2|||
161383227|NCT03332173|582789085|FG000|Overall Study|Transferred to long-term extension study|29|||
161383228|NCT00131352|582789086|FG000|Initial Treatment Period|Adverse Event|1|||
161383229|NCT00131352|582789087|FG001|Initial Treatment Period|Adverse Event|3|||
161383230|NCT00131352|582789086|FG000|Initial Treatment Period|Non-compliant|1|||
161383231|NCT00131352|582789087|FG001|Initial Treatment Period|Non-compliant|2|||
161383232|NCT00131352|582789086|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161383233|NCT00131352|582789087|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
161383234|NCT00131352|582789086|FG000|Initial Treatment Period|Lack of Efficacy|6|||
161383235|NCT00131352|582789087|FG001|Initial Treatment Period|Lack of Efficacy|4|||
161383236|NCT00131352|582789086|FG000|Initial Treatment Period|Other|0|||
161383237|NCT00131352|582789087|FG001|Initial Treatment Period|Other|2|||
161383238|NCT00131352|582789086|FG000|Repeat Treatment Period|Adverse Event|1|||
161383239|NCT00131352|582789087|FG001|Repeat Treatment Period|Adverse Event|0|||
161383240|NCT00131352|582789086|FG000|Repeat Treatment Period|Other|1|||
161383241|NCT00131352|582789087|FG001|Repeat Treatment Period|Other|0|||
161383242|NCT00383331|582789088|FG000|Overall Study|Protocol Violation|0|||
161383243|NCT00383331|582789089|FG001|Overall Study|Protocol Violation|1|||
161383244|NCT00211172|582789091|FG000|Overall Study|Died or lost health plan eligibility|39|||
161383245|NCT00211172|582789092|FG001|Overall Study|Died or lost health plan eligibility|32|||
161383246|NCT02253433|582789093|FG000|Overall Study|Unable to Contact|9|||
161383247|NCT02253433|582789094|FG001|Overall Study|Unable to Contact|16|||
161383248|NCT02253433|582789093|FG000|Overall Study|Death|1|||
161383249|NCT02253433|582789094|FG001|Overall Study|Death|1|||
161383250|NCT02253433|582789093|FG000|Overall Study|No Longer Interested|3|||
161383251|NCT02253433|582789094|FG001|Overall Study|No Longer Interested|15|||
161383252|NCT02253433|582789093|FG000|Overall Study|Out of Study Area|2|||
161383253|NCT02253433|582789094|FG001|Overall Study|Out of Study Area|7|||
161383254|NCT02253433|582789093|FG000|Overall Study|Uncomfortable with home visitors|0|||
161383255|NCT02253433|582789094|FG001|Overall Study|Uncomfortable with home visitors|3|||
161383256|NCT02253433|582789093|FG000|Overall Study|Unstable Housing/Homeless|0|||
161383257|NCT02253433|582789094|FG001|Overall Study|Unstable Housing/Homeless|7|||
161383258|NCT02253433|582789093|FG000|Overall Study|Too Busy|0|||
161383259|NCT02253433|582789094|FG001|Overall Study|Too Busy|4|||
161383260|NCT02253433|582789093|FG000|Overall Study|Medical or Other Concerns|1|||
161383261|NCT02253433|582789094|FG001|Overall Study|Medical or Other Concerns|2|||
161383262|NCT02229825|582789095|FG000|Overall Study|Personal Reasons|0|||
161383263|NCT02229825|582789096|FG001|Overall Study|Personal Reasons|1|||
161383264|NCT02229825|582789095|FG000|Overall Study|Refused continuing medication|7|||
161383265|NCT02229825|582789096|FG001|Overall Study|Refused continuing medication|6|||
161383266|NCT02229825|582789095|FG000|Overall Study|Lost to Follow-up|1|||
161383267|NCT02229825|582789096|FG001|Overall Study|Lost to Follow-up|2|||
161383268|NCT02229825|582789095|FG000|Overall Study|Protocol Violation|1|||
161383269|NCT02229825|582789096|FG001|Overall Study|Protocol Violation|1|||
161383270|NCT02229825|582789095|FG000|Overall Study|Lack of Efficacy|4|||
161383271|NCT02229825|582789096|FG001|Overall Study|Lack of Efficacy|10|||
161383272|NCT02229825|582789095|FG000|Overall Study|Adverse Event|11|||
161383273|NCT02229825|582789096|FG001|Overall Study|Adverse Event|9|||
161383274|NCT02229825|582789095|FG000|Overall Study|Not treated|0|||
161383275|NCT02229825|582789096|FG001|Overall Study|Not treated|1|||
161383276|NCT02443337|582789097|FG000|Overall Study|Adverse Event|0|||
161383277|NCT02443337|582789098|FG001|Overall Study|Adverse Event|1|||
161383278|NCT02443337|582789097|FG000|Overall Study|Clinical Progressive Disease|3|||
161383279|NCT02443337|582789098|FG001|Overall Study|Clinical Progressive Disease|0|||
161383280|NCT02443337|582789097|FG000|Overall Study|Withdrawal by Subject|2|||
161383281|NCT02443337|582789098|FG001|Overall Study|Withdrawal by Subject|1|||
161383282|NCT00372619|582789099|FG000|Overall Study|Ineligible|0|||
161383283|NCT00372619|582789100|FG001|Overall Study|Ineligible|0|||
161383284|NCT00372619|582789101|FG002|Overall Study|Ineligible|0|||
161383285|NCT00372619|582789102|FG003|Overall Study|Ineligible|0|||
161383286|NCT00372619|582789103|FG004|Overall Study|Ineligible|0|||
161383287|NCT00372619|582789104|FG005|Overall Study|Ineligible|2|||
161383288|NCT00372619|582789105|FG006|Overall Study|Ineligible|0|||
161383289|NCT00372619|582789099|FG000|Overall Study|Inevaluable|0|||
161383290|NCT00372619|582789100|FG001|Overall Study|Inevaluable|0|||
161383291|NCT00372619|582789101|FG002|Overall Study|Inevaluable|0|||
161383292|NCT00372619|582789102|FG003|Overall Study|Inevaluable|0|||
161383293|NCT00372619|582789103|FG004|Overall Study|Inevaluable|0|||
161383294|NCT00372619|582789104|FG005|Overall Study|Inevaluable|1|||
161383295|NCT00372619|582789105|FG006|Overall Study|Inevaluable|0|||
161383296|NCT01523743|582789106|FG000|Period 1|Adverse Event|1|||
161383297|NCT01523743|582789107|FG001|Period 1|Adverse Event|0|||
161383298|NCT01523743|582789106|FG000|Period 1|Withdrawal by Subject|6|||
161383299|NCT01523743|582789107|FG001|Period 1|Withdrawal by Subject|2|||
161383300|NCT01523743|582789106|FG000|Period 1|Lost to Follow-up|1|||
161383301|NCT01523743|582789107|FG001|Period 1|Lost to Follow-up|0|||
161383302|NCT01523743|582789106|FG000|Period 1|Lack of Efficacy|1|||
161383303|NCT01523743|582789107|FG001|Period 1|Lack of Efficacy|0|||
161383304|NCT01523743|582789106|FG000|Period 1|Felt unable to empty bladder|1|||
161383305|NCT01523743|582789107|FG001|Period 1|Felt unable to empty bladder|0|||
161383306|NCT01523743|582789106|FG000|Period 2|Withdrawal by Subject|0|||
161383307|NCT01523743|582789107|FG001|Period 2|Withdrawal by Subject|2|||
161383308|NCT01523743|582789106|FG000|Period 2|Adverse Event|1|||
161383309|NCT01523743|582789107|FG001|Period 2|Adverse Event|0|||
161383310|NCT03782064|582789108|FG000|Overall Study|Lack of Efficacy|2|||
161383311|NCT03782064|582789108|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
161383312|NCT00363142|582789109|FG000|Overall Study|Adverse Event|2|||
161383313|NCT00363142|582789110|FG001|Overall Study|Adverse Event|0|||
161383314|NCT00363142|582789109|FG000|Overall Study|Lack of Efficacy|0|||
161383315|NCT00363142|582789110|FG001|Overall Study|Lack of Efficacy|1|||
161383316|NCT00363142|582789109|FG000|Overall Study|Lost to Follow-up|1|||
161383317|NCT00363142|582789110|FG001|Overall Study|Lost to Follow-up|0|||
161383318|NCT00363142|582789109|FG000|Overall Study|Non-compliance|1|||
161383319|NCT00363142|582789110|FG001|Overall Study|Non-compliance|1|||
161383320|NCT00363142|582789109|FG000|Overall Study|Withdrawal by Subject|3|||
161383321|NCT00363142|582789110|FG001|Overall Study|Withdrawal by Subject|1|||
161383322|NCT02446769|582789113|FG000|Screening Period|Screen Failure|11|||
161383323|NCT02446769|582789114|FG001|Screening Period|Screen Failure|0|||
161383324|NCT02446769|582789115|FG002|Screening Period|Screen Failure|0|||
161383325|NCT02446769|582789113|FG000|Study Period|Randomized in Error|0|||
161383326|NCT02446769|582789114|FG001|Study Period|Randomized in Error|2|||
161383327|NCT02446769|582789115|FG002|Study Period|Randomized in Error|0|||
161383328|NCT01340664|582789118|FG000|Overall Study|Adverse Event|0|||
161383329|NCT01340664|582789119|FG001|Overall Study|Adverse Event|1|||
161383330|NCT01340664|582789120|FG002|Overall Study|Adverse Event|7|||
161383331|NCT01340664|582789118|FG000|Overall Study|Lost to Follow-up|2|||
161383332|NCT01340664|582789119|FG001|Overall Study|Lost to Follow-up|0|||
161383333|NCT01340664|582789120|FG002|Overall Study|Lost to Follow-up|2|||
161383334|NCT01340664|582789118|FG000|Overall Study|Withdrawal by Subject|2|||
161383335|NCT01340664|582789119|FG001|Overall Study|Withdrawal by Subject|4|||
161383336|NCT01340664|582789120|FG002|Overall Study|Withdrawal by Subject|0|||
161383337|NCT01340664|582789118|FG000|Overall Study|Glycemic withdrawal criteria|2|||
161383338|NCT01340664|582789119|FG001|Overall Study|Glycemic withdrawal criteria|0|||
161383339|NCT01340664|582789120|FG002|Overall Study|Glycemic withdrawal criteria|0|||
161383340|NCT01340664|582789118|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
161383341|NCT01340664|582789119|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
161383342|NCT01340664|582789120|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
161383343|NCT01340664|582789118|FG000|Overall Study|Other|1|||
161383344|NCT01340664|582789119|FG001|Overall Study|Other|2|||
161383345|NCT01340664|582789120|FG002|Overall Study|Other|2|||
161383346|NCT02441101|582789122|FG000|Overall Study|Withdrawal by Subject|1|||
161383347|NCT02441101|582789123|FG001|Overall Study|Withdrawal by Subject|0|||
161383348|NCT02441101|582789122|FG000|Overall Study|Lost to Follow-up|1|||
161383349|NCT02441101|582789123|FG001|Overall Study|Lost to Follow-up|0|||
161383350|NCT02441101|582789122|FG000|Overall Study|PI relocated and study terminated|1|||
161383351|NCT02441101|582789123|FG001|Overall Study|PI relocated and study terminated|0|||
161383352|NCT02528942|582789126|FG000|Overall Study|Did not meet imaging criteria|9|||
161383353|NCT02528942|582789126|FG000|Overall Study|Lost to Follow-up|25|||
161383354|NCT00271856|582789127|FG000|Overall Study|Withdrawal by Subject|1|||
161383355|NCT00271856|582789128|FG001|Overall Study|Withdrawal by Subject|7|||
161383356|NCT00271856|582789127|FG000|Overall Study|Lost to Follow-up|10|||
161383357|NCT00271856|582789128|FG001|Overall Study|Lost to Follow-up|11|||
161383358|NCT04599803|582789129|FG000|Overall Study|Withdrawal by Subject|5|||
161383359|NCT04599803|582789129|FG000|Overall Study|Lost to Follow-up|26|||
161383360|NCT02544750|582789130|FG000|Overall Study|Physician Decision|3|||
161383361|NCT02544750|582789131|FG001|Overall Study|Physician Decision|1|||
161383362|NCT02544750|582789130|FG000|Overall Study|Other reasons|69|||
161383363|NCT02544750|582789131|FG001|Overall Study|Other reasons|39|||
161383364|NCT02544750|582789130|FG000|Overall Study|Met withdrawal criteria|2|||
161383365|NCT02544750|582789131|FG001|Overall Study|Met withdrawal criteria|2|||
161383366|NCT02544750|582789130|FG000|Overall Study|Transition To Commercial Product|1|||
161383367|NCT02544750|582789131|FG001|Overall Study|Transition To Commercial Product|0|||
161383368|NCT02544750|582789130|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
161383369|NCT02544750|582789131|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
161383370|NCT02544750|582789130|FG000|Overall Study|Adverse Event|8|||
161383371|NCT02544750|582789131|FG001|Overall Study|Adverse Event|10|||
161383372|NCT02544750|582789130|FG000|Overall Study|Withdrawal by Subject|10|||
161383373|NCT02544750|582789131|FG001|Overall Study|Withdrawal by Subject|4|||
161383374|NCT02544750|582789130|FG000|Overall Study|Lost to Follow-up|1|||
161383375|NCT02544750|582789131|FG001|Overall Study|Lost to Follow-up|0|||
161383376|NCT01154452|582789132|FG000|Phase Ib|Not Treated|1|||
161383377|NCT01154452|582789133|FG001|Phase Ib|Not Treated|0|||
161383378|NCT01154452|582789134|FG002|Phase Ib|Not Treated|0|||
161383379|NCT01154452|582789135|FG003|Phase Ib|Not Treated|0|||
161383380|NCT01154452|582789132|FG000|Phase Ib|Adverse Event|2|||
161383381|NCT01154452|582789133|FG001|Phase Ib|Adverse Event|1|||
161383382|NCT01154452|582789134|FG002|Phase Ib|Adverse Event|0|||
161383383|NCT01154452|582789135|FG003|Phase Ib|Adverse Event|0|||
161383384|NCT01154452|582789132|FG000|Phase II|Withdrawal by Subject|0|||
161383385|NCT01154452|582789133|FG001|Phase II|Withdrawal by Subject|0|||
161383386|NCT01154452|582789134|FG002|Phase II|Withdrawal by Subject|1|||
161383387|NCT01154452|582789135|FG003|Phase II|Withdrawal by Subject|2|||
161383388|NCT01154452|582789132|FG000|Phase II|Adverse Event|0|||
161383389|NCT01154452|582789133|FG001|Phase II|Adverse Event|0|||
161383390|NCT01154452|582789134|FG002|Phase II|Adverse Event|4|||
161383391|NCT01154452|582789135|FG003|Phase II|Adverse Event|4|||
161383392|NCT01392573|582789136|FG000|Overall Study|Adverse Event|1|||
161383393|NCT01392573|582789137|FG001|Overall Study|Adverse Event|3|||
161383394|NCT01392573|582789136|FG000|Overall Study|Lack of Efficacy|1|||
161383395|NCT01392573|582789137|FG001|Overall Study|Lack of Efficacy|2|||
161383396|NCT01392573|582789136|FG000|Overall Study|Protocol Violation|0|||
161383397|NCT01392573|582789137|FG001|Overall Study|Protocol Violation|2|||
161383398|NCT01392573|582789136|FG000|Overall Study|Withdrawal Criteria|13|||
161383399|NCT01392573|582789137|FG001|Overall Study|Withdrawal Criteria|15|||
161383400|NCT01392573|582789136|FG000|Overall Study|Site closure|8|||
161383401|NCT01392573|582789137|FG001|Overall Study|Site closure|7|||
161383402|NCT01392573|582789136|FG000|Overall Study|Unclassified|9|||
161383403|NCT01392573|582789137|FG001|Overall Study|Unclassified|6|||
161383404|NCT03381287|582789139|FG000|Overall Study|Withdrawal by Subject|0|||
161383405|NCT03381287|582789140|FG001|Overall Study|Withdrawal by Subject|1|||
161383406|NCT03381287|582789141|FG002|Overall Study|Withdrawal by Subject|0|||
161383407|NCT03381287|582789142|FG003|Overall Study|Withdrawal by Subject|0|||
161383408|NCT03381287|582789139|FG000|Overall Study|Adverse Event|0|||
161383409|NCT03381287|582789140|FG001|Overall Study|Adverse Event|0|||
161383410|NCT03381287|582789141|FG002|Overall Study|Adverse Event|0|||
161383411|NCT03381287|582789142|FG003|Overall Study|Adverse Event|1|||
161383412|NCT03381287|582789139|FG000|Overall Study|Physician Decision|0|||
161383413|NCT03381287|582789140|FG001|Overall Study|Physician Decision|0|||
161383414|NCT03381287|582789141|FG002|Overall Study|Physician Decision|0|||
161383415|NCT03381287|582789142|FG003|Overall Study|Physician Decision|1|||
161383416|NCT00325130|582789182|FG000|Overall Study|Lost to Follow-up|6|||
161383417|NCT00325130|582789183|FG001|Overall Study|Lost to Follow-up|14|||
161383418|NCT00325130|582789182|FG000|Overall Study|Withdrawal by Subject|12|||
161383419|NCT00325130|582789183|FG001|Overall Study|Withdrawal by Subject|14|||
161383420|NCT00325130|582789182|FG000|Overall Study|Protocol Deviation|0|||
161383421|NCT00325130|582789183|FG001|Overall Study|Protocol Deviation|1|||
161383422|NCT00325130|582789182|FG000|Overall Study|Moved|0|||
161383423|NCT00325130|582789183|FG001|Overall Study|Moved|1|||
161383424|NCT00325130|582789182|FG000|Overall Study|Patient Discontinued for Other|1|||
161383425|NCT00325130|582789183|FG001|Overall Study|Patient Discontinued for Other|0|||
161383426|NCT05959447|582790568|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
161383427|NCT05959447|582790569|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
161383428|NCT05959447|582790568|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
161383429|NCT05959447|582790569|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
161383430|NCT05959447|582790568|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
161383431|NCT05959447|582790569|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
161383432|NCT05959447|582790568|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
161383433|NCT05959447|582790569|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
161383434|NCT01893411|582790574|FG000|Overall Study|Protocol Violation|1|||
161383435|NCT01893411|582790575|FG001|Overall Study|Protocol Violation|0|||
161383436|NCT01893411|582790576|FG002|Overall Study|Protocol Violation|0|||
161383437|NCT01893411|582790574|FG000|Overall Study|Physician Decision|1|||
161383438|NCT01893411|582790575|FG001|Overall Study|Physician Decision|1|||
161383439|NCT01893411|582790576|FG002|Overall Study|Physician Decision|2|||
161383440|NCT01893411|582790574|FG000|Overall Study|Lack of Efficacy|2|||
161383441|NCT01893411|582790575|FG001|Overall Study|Lack of Efficacy|1|||
161383442|NCT01893411|582790576|FG002|Overall Study|Lack of Efficacy|0|||
161383443|NCT01893411|582790574|FG000|Overall Study|Other|3|||
161383444|NCT01893411|582790575|FG001|Overall Study|Other|1|||
161383445|NCT01893411|582790576|FG002|Overall Study|Other|3|||
161383446|NCT01893411|582790574|FG000|Overall Study|Adverse Event|1|||
161383447|NCT01893411|582790575|FG001|Overall Study|Adverse Event|0|||
161383448|NCT01893411|582790576|FG002|Overall Study|Adverse Event|0|||
161383449|NCT01893411|582790574|FG000|Overall Study|Withdrawal by Subject|7|||
161383450|NCT01893411|582790575|FG001|Overall Study|Withdrawal by Subject|4|||
161383451|NCT01893411|582790576|FG002|Overall Study|Withdrawal by Subject|3|||
161383452|NCT01893411|582790574|FG000|Overall Study|Lost to Follow-up|2|||
161383453|NCT01893411|582790575|FG001|Overall Study|Lost to Follow-up|0|||
161383454|NCT01893411|582790576|FG002|Overall Study|Lost to Follow-up|1|||
161383455|NCT00566982|582790577|FG000|Overall Study|Adverse Event|6|||
161383456|NCT00566982|582790578|FG001|Overall Study|Adverse Event|48|||
161383457|NCT00566982|582790577|FG000|Overall Study|Withdrawal by Subject|1|||
161383458|NCT00566982|582790578|FG001|Overall Study|Withdrawal by Subject|14|||
161383459|NCT00566982|582790577|FG000|Overall Study|Protocol Violation|1|||
161383460|NCT00566982|582790578|FG001|Overall Study|Protocol Violation|4|||
161383461|NCT00566982|582790577|FG000|Overall Study|Lost to Follow-up|0|||
161383462|NCT00566982|582790578|FG001|Overall Study|Lost to Follow-up|1|||
161383463|NCT00566982|582790577|FG000|Overall Study|Other-family problems & doctor's request|0|||
161383464|NCT00566982|582790578|FG001|Overall Study|Other-family problems & doctor's request|2|||
161383465|NCT03053440|582790581|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
161383466|NCT03053440|582790582|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
161383467|NCT03053440|582790581|FG000|Overall Study|Death|18|||
161383468|NCT03053440|582790582|FG001|Overall Study|Death|14|||
161383469|NCT03053440|582790581|FG000|Overall Study|Withdrawal by Subject|9|||
161383470|NCT03053440|582790582|FG001|Overall Study|Withdrawal by Subject|8|||
161383471|NCT03053440|582790581|FG000|Overall Study|Lost to Follow-up|1|||
161383472|NCT03053440|582790582|FG001|Overall Study|Lost to Follow-up|0|||
161383473|NCT03053440|582790581|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
161383474|NCT03053440|582790582|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
161383475|NCT03053440|582790581|FG000|Overall Study|Physician Decision|2|||
161383476|NCT03053440|582790582|FG001|Overall Study|Physician Decision|1|||
161383477|NCT03053440|582790581|FG000|Overall Study|Participant Randomized but died before dosing|1|||
161383478|NCT03053440|582790582|FG001|Overall Study|Participant Randomized but died before dosing|0|||
161383479|NCT00391053|582790588|FG000|Overall Study|Serious Adverse Events|1|||
161383480|NCT00391053|582790589|FG001|Overall Study|Serious Adverse Events|0|||
161383481|NCT00391053|582790590|FG002|Overall Study|Serious Adverse Events|1|||
161383482|NCT00391053|582790591|FG003|Overall Study|Serious Adverse Events|4|||
161383483|NCT00391053|582790588|FG000|Overall Study|Protocol Violation|2|||
161383484|NCT00391053|582790589|FG001|Overall Study|Protocol Violation|0|||
161383485|NCT00391053|582790590|FG002|Overall Study|Protocol Violation|0|||
161383486|NCT00391053|582790591|FG003|Overall Study|Protocol Violation|0|||
161383487|NCT00391053|582790588|FG000|Overall Study|Lost to Follow-up|1|||
161383488|NCT00391053|582790589|FG001|Overall Study|Lost to Follow-up|0|||
161383489|NCT00391053|582790590|FG002|Overall Study|Lost to Follow-up|0|||
161383490|NCT00391053|582790591|FG003|Overall Study|Lost to Follow-up|5|||
161383491|NCT00391053|582790588|FG000|Overall Study|Withdrawal by Subject|5|||
161383492|NCT00391053|582790589|FG001|Overall Study|Withdrawal by Subject|1|||
161383493|NCT00391053|582790590|FG002|Overall Study|Withdrawal by Subject|1|||
161383494|NCT00391053|582790591|FG003|Overall Study|Withdrawal by Subject|1|||
161383495|NCT00473889|582790593|FG000|Overall Study|Did not receive study medication|1|||
161383496|NCT00473889|582790594|FG001|Overall Study|Did not receive study medication|4|||
161383497|NCT00473889|582790593|FG000|Overall Study|Adverse Event|30|||
161383498|NCT00473889|582790594|FG001|Overall Study|Adverse Event|17|||
161383499|NCT00473889|582790593|FG000|Overall Study|Protocol Violation|4|||
161383500|NCT00473889|582790594|FG001|Overall Study|Protocol Violation|2|||
161383501|NCT00473889|582790593|FG000|Overall Study|Lack of Efficacy|28|||
161383502|NCT00473889|582790594|FG001|Overall Study|Lack of Efficacy|29|||
161383503|NCT00473889|582790593|FG000|Overall Study|Lost to Follow-up|2|||
161383504|NCT00473889|582790594|FG001|Overall Study|Lost to Follow-up|1|||
161383505|NCT00473889|582790593|FG000|Overall Study|Physician Decision|10|||
161383506|NCT00473889|582790594|FG001|Overall Study|Physician Decision|5|||
161383507|NCT00473889|582790593|FG000|Overall Study|Trial Terminated|3|||
161383508|NCT00473889|582790594|FG001|Overall Study|Trial Terminated|6|||
161383509|NCT00473889|582790593|FG000|Overall Study|Withdrawal by Subject|5|||
161383510|NCT00473889|582790594|FG001|Overall Study|Withdrawal by Subject|0|||
161383511|NCT02140970|582790595|FG000|Overall Study|Lost to Follow-up|1|||
161383512|NCT02140970|582790596|FG001|Overall Study|Lost to Follow-up|2|||
161383513|NCT02140970|582790595|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
161383514|NCT02140970|582790596|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
161383515|NCT02140970|582790595|FG000|Overall Study|Did not meet inclusion criteria|0|||
161383516|NCT02140970|582790596|FG001|Overall Study|Did not meet inclusion criteria|1|||
161383517|NCT01947283|582790600|FG000|Overall Study|Death|1|||
161383518|NCT01947283|582790601|FG001|Overall Study|Death|1|||
161383519|NCT01947283|582790602|FG002|Overall Study|Death|1|||
161383520|NCT01947283|582790603|FG003|Overall Study|Death|0|||
161383521|NCT01947283|582790604|FG004|Overall Study|Death|0|||
161383522|NCT01947283|582790605|FG005|Overall Study|Death|0|||
161383523|NCT01947283|582790606|FG006|Overall Study|Death|0|||
161383524|NCT01947283|582790600|FG000|Overall Study|Lost to Follow-up|4|||
161383525|NCT01947283|582790601|FG001|Overall Study|Lost to Follow-up|6|||
161383526|NCT01947283|582790602|FG002|Overall Study|Lost to Follow-up|5|||
161383527|NCT01947283|582790603|FG003|Overall Study|Lost to Follow-up|5|||
161383528|NCT01947283|582790604|FG004|Overall Study|Lost to Follow-up|0|||
161383529|NCT01947283|582790605|FG005|Overall Study|Lost to Follow-up|2|||
161383530|NCT01947283|582790606|FG006|Overall Study|Lost to Follow-up|5|||
161383531|NCT01947283|582790600|FG000|Overall Study|Withdrawal by Subject|10|||
161383532|NCT01947283|582790601|FG001|Overall Study|Withdrawal by Subject|8|||
161383533|NCT01947283|582790602|FG002|Overall Study|Withdrawal by Subject|4|||
161383534|NCT01947283|582790603|FG003|Overall Study|Withdrawal by Subject|1|||
161383535|NCT01947283|582790604|FG004|Overall Study|Withdrawal by Subject|0|||
161383536|NCT01947283|582790605|FG005|Overall Study|Withdrawal by Subject|0|||
161383537|NCT01947283|582790606|FG006|Overall Study|Withdrawal by Subject|2|||
161383538|NCT01947283|582790600|FG000|Overall Study|No Clinical Recording|12|||
161383539|NCT01947283|582790601|FG001|Overall Study|No Clinical Recording|6|||
161383540|NCT01947283|582790602|FG002|Overall Study|No Clinical Recording|8|||
161383541|NCT01947283|582790603|FG003|Overall Study|No Clinical Recording|10|||
161383542|NCT01947283|582790604|FG004|Overall Study|No Clinical Recording|0|||
161383543|NCT01947283|582790605|FG005|Overall Study|No Clinical Recording|0|||
161383544|NCT01947283|582790606|FG006|Overall Study|No Clinical Recording|0|||
161383545|NCT01947283|582790600|FG000|Overall Study|Non-coding Clinical Recording language|0|||
161383546|NCT01947283|582790601|FG001|Overall Study|Non-coding Clinical Recording language|0|||
161383547|NCT01947283|582790602|FG002|Overall Study|Non-coding Clinical Recording language|0|||
161383548|NCT01947283|582790603|FG003|Overall Study|Non-coding Clinical Recording language|1|||
161383549|NCT01947283|582790604|FG004|Overall Study|Non-coding Clinical Recording language|0|||
161383550|NCT01947283|582790605|FG005|Overall Study|Non-coding Clinical Recording language|0|||
161383551|NCT01947283|582790606|FG006|Overall Study|Non-coding Clinical Recording language|0|||
161383552|NCT01947283|582790600|FG000|Overall Study|Missing Follow-up Assessment|2|||
161383553|NCT01947283|582790601|FG001|Overall Study|Missing Follow-up Assessment|2|||
161383554|NCT01947283|582790602|FG002|Overall Study|Missing Follow-up Assessment|3|||
161383555|NCT01947283|582790603|FG003|Overall Study|Missing Follow-up Assessment|0|||
161383556|NCT01947283|582790604|FG004|Overall Study|Missing Follow-up Assessment|0|||
161383557|NCT01947283|582790605|FG005|Overall Study|Missing Follow-up Assessment|2|||
161383558|NCT01947283|582790606|FG006|Overall Study|Missing Follow-up Assessment|0|||
161383559|NCT01947283|582790600|FG000|Overall Study|No patients were enrolled in study|0|||
161383560|NCT01947283|582790601|FG001|Overall Study|No patients were enrolled in study|0|||
161383561|NCT01947283|582790602|FG002|Overall Study|No patients were enrolled in study|0|||
161383562|NCT01947283|582790603|FG003|Overall Study|No patients were enrolled in study|0|||
161383563|NCT01947283|582790604|FG004|Overall Study|No patients were enrolled in study|0|||
161383564|NCT01947283|582790605|FG005|Overall Study|No patients were enrolled in study|3|||
161383565|NCT01947283|582790606|FG006|Overall Study|No patients were enrolled in study|1|||
161383566|NCT01498692|582790607|FG000|Overall Study|Death|4|||
161383567|NCT01498692|582790607|FG000|Overall Study|Withdrawal by Subject|1|||
161383568|NCT01498692|582790607|FG000|Overall Study|Missed 12-month visit|3|||
161383569|NCT04729972|582790608|FG000|Overall Study|Adverse Event|1|||
161383570|NCT05002985|582790609|FG000|Overall Study|Withdrawal by Subject|1|||
161383571|NCT00430989|582790610|FG000|Overall Study|Lost to Follow-up|2|||
161383572|NCT00430989|582790611|FG001|Overall Study|Lost to Follow-up|3|||
161383573|NCT00430989|582790610|FG000|Overall Study|Withdrawal by Subject|15|||
161383574|NCT00430989|582790611|FG001|Overall Study|Withdrawal by Subject|14|||
161383575|NCT00430989|582790610|FG000|Overall Study|Protocol Violation|30|||
161383576|NCT00430989|582790611|FG001|Overall Study|Protocol Violation|37|||
161383577|NCT00430989|582790610|FG000|Overall Study|Not eligible|13|||
161383578|NCT00430989|582790611|FG001|Overall Study|Not eligible|6|||
161383579|NCT00460655|582790612|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
161383580|NCT00460655|582790613|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161383581|NCT00460655|582790614|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161383582|NCT00460655|582790615|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161383583|NCT00460655|582790612|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
161383584|NCT00460655|582790613|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161383585|NCT00460655|582790614|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161383586|NCT00460655|582790615|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161383587|NCT00460655|582790612|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
161383588|NCT00460655|582790613|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
161383589|NCT00460655|582790614|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
161383590|NCT00460655|582790615|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
161383591|NCT00460655|582790612|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161383592|NCT00460655|582790613|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161383593|NCT00460655|582790614|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
161383594|NCT00460655|582790615|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
161383595|NCT00460655|582790612|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161383596|NCT00460655|582790613|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161383597|NCT00460655|582790614|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
161383598|NCT00460655|582790615|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
161383599|NCT00460655|582790612|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
161383600|NCT00460655|582790613|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
161383601|NCT00460655|582790614|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
161383602|NCT00460655|582790615|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
161383603|NCT03782259|582790616|FG000|Overall Study|Lost to Follow-up|1|||
161383604|NCT03782259|582790617|FG001|Overall Study|Lost to Follow-up|1|||
161383605|NCT03782259|582790616|FG000|Overall Study|Moved out of state|0|||
161383606|NCT03782259|582790617|FG001|Overall Study|Moved out of state|2|||
161383607|NCT03782259|582790616|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
161383608|NCT03782259|582790617|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
161383609|NCT03782259|582790616|FG000|Overall Study|Subject discontinued intervention|1|||
161383610|NCT03782259|582790617|FG001|Overall Study|Subject discontinued intervention|0|||
161383611|NCT00603941|582790618|FG000|Overall Study|Disease progression|6|||
161383612|NCT00603941|582790619|FG001|Overall Study|Disease progression|7|||
161383613|NCT00603941|582790620|FG002|Overall Study|Disease progression|1|||
161383614|NCT00603941|582790618|FG000|Overall Study|Adverse Event|1|||
161383615|NCT00603941|582790619|FG001|Overall Study|Adverse Event|0|||
161383616|NCT00603941|582790620|FG002|Overall Study|Adverse Event|1|||
161383617|NCT00603941|582790618|FG000|Overall Study|Physician Decision|0|||
161383618|NCT00603941|582790619|FG001|Overall Study|Physician Decision|1|||
161383619|NCT00603941|582790620|FG002|Overall Study|Physician Decision|0|||
161383620|NCT00603941|582790618|FG000|Overall Study|Withdrawal by Subject|0|||
161383621|NCT00603941|582790619|FG001|Overall Study|Withdrawal by Subject|2|||
161383622|NCT00603941|582790620|FG002|Overall Study|Withdrawal by Subject|0|||
161383623|NCT00249808|582790622|FG000|Overall Study|Other|27|||
161383624|NCT00249808|582790622|FG000|Overall Study|Protocol Violation|3|||
161383625|NCT00249808|582790622|FG000|Overall Study|Lost to Follow-up|8|||
161383626|NCT00249808|582790622|FG000|Overall Study|Adverse Event|81|||
161383627|NCT00249808|582790622|FG000|Overall Study|Lack of Efficacy|52|||
161383628|NCT00249808|582790622|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
161383629|NCT00711594|582790623|FG000|Overall Study|Progressive disease|2|||
161383630|NCT00711594|582790624|FG001|Overall Study|Progressive disease|2|||
161383631|NCT00711594|582790625|FG002|Overall Study|Progressive disease|6|||
161383632|NCT00711594|582790626|FG003|Overall Study|Progressive disease|44|||
161383633|NCT00711594|582790623|FG000|Overall Study|Other Adverse Event|1|||
161383634|NCT00711594|582790624|FG001|Overall Study|Other Adverse Event|0|||
161383635|NCT00711594|582790625|FG002|Overall Study|Other Adverse Event|0|||
161383636|NCT00711594|582790626|FG003|Overall Study|Other Adverse Event|16|||
161383637|NCT00711594|582790623|FG000|Overall Study|Withdrawal by Subject|0|||
161383638|NCT00711594|582790624|FG001|Overall Study|Withdrawal by Subject|1|||
161383639|NCT00711594|582790625|FG002|Overall Study|Withdrawal by Subject|0|||
161383640|NCT00711594|582790626|FG003|Overall Study|Withdrawal by Subject|2|||
161383641|NCT04556591|582790631|FG000|Overall Study|Lost to Follow-up|1|||
161383642|NCT04556591|582790632|FG001|Overall Study|Lost to Follow-up|0|||
161383643|NCT04556591|582790631|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
161383644|NCT04556591|582790632|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
161383645|NCT00135330|582790634|FG000|Overall Study|Adverse Event|2|||
161383646|NCT00135330|582790635|FG001|Overall Study|Adverse Event|5|||
161383647|NCT00135330|582790636|FG002|Overall Study|Adverse Event|1|||
161383648|NCT00135330|582790634|FG000|Overall Study|Lost to Follow-up|0|||
161383649|NCT00135330|582790635|FG001|Overall Study|Lost to Follow-up|2|||
161383650|NCT00135330|582790636|FG002|Overall Study|Lost to Follow-up|3|||
161383651|NCT00135330|582790634|FG000|Overall Study|Physician Decision|1|||
161383652|NCT00135330|582790635|FG001|Overall Study|Physician Decision|1|||
161383653|NCT00135330|582790636|FG002|Overall Study|Physician Decision|0|||
161383654|NCT00135330|582790634|FG000|Overall Study|Protocol Violation|4|||
161383655|NCT00135330|582790635|FG001|Overall Study|Protocol Violation|3|||
161383656|NCT00135330|582790636|FG002|Overall Study|Protocol Violation|3|||
161383657|NCT00135330|582790634|FG000|Overall Study|Patient Decision|5|||
161383658|NCT00135330|582790635|FG001|Overall Study|Patient Decision|1|||
161383659|NCT00135330|582790636|FG002|Overall Study|Patient Decision|4|||
161383660|NCT00135330|582790634|FG000|Overall Study|Sponsor Decision|0|||
161383661|NCT00135330|582790635|FG001|Overall Study|Sponsor Decision|1|||
161383662|NCT00135330|582790636|FG002|Overall Study|Sponsor Decision|0|||
161383663|NCT02526212|582790646|FG000|Overall Study|Incarceration|1|||
161383664|NCT02526212|582790647|FG001|Overall Study|Incarceration|0|||
161383665|NCT02526212|582790646|FG000|Overall Study|Lost to Follow-up|1|||
161383666|NCT02526212|582790647|FG001|Overall Study|Lost to Follow-up|0|||
161383667|NCT02526212|582790646|FG000|Overall Study|Death|0|||
161383668|NCT02526212|582790647|FG001|Overall Study|Death|1|||
161383669|NCT02096952|582790649|FG000|Overall Study|Adverse Event|1|||
161383670|NCT00040742|582790650|FG000|Overall Study|Death|0|||
161383671|NCT00040742|582790651|FG001|Overall Study|Death|0|||
161383672|NCT00040742|582790652|FG002|Overall Study|Death|1|||
161383673|NCT00040742|582790653|FG003|Overall Study|Death|0|||
161383674|NCT00040742|582790650|FG000|Overall Study|Adverse Event|15|||
161383675|NCT00040742|582790651|FG001|Overall Study|Adverse Event|16|||
161383676|NCT00040742|582790652|FG002|Overall Study|Adverse Event|21|||
161383677|NCT00040742|582790653|FG003|Overall Study|Adverse Event|9|||
161383678|NCT00040742|582790650|FG000|Overall Study|Withdrawal by Subject|7|||
161383679|NCT00040742|582790651|FG001|Overall Study|Withdrawal by Subject|15|||
161383680|NCT00040742|582790652|FG002|Overall Study|Withdrawal by Subject|10|||
161383681|NCT00040742|582790653|FG003|Overall Study|Withdrawal by Subject|13|||
161383682|NCT00040742|582790650|FG000|Overall Study|Chemotoxicity|4|||
161383683|NCT00040742|582790651|FG001|Overall Study|Chemotoxicity|3|||
161383684|NCT00040742|582790652|FG002|Overall Study|Chemotoxicity|5|||
161383685|NCT00040742|582790653|FG003|Overall Study|Chemotoxicity|2|||
161383686|NCT00040742|582790650|FG000|Overall Study|Incomplete Forms|6|||
161383687|NCT00040742|582790651|FG001|Overall Study|Incomplete Forms|10|||
161383688|NCT00040742|582790652|FG002|Overall Study|Incomplete Forms|4|||
161383689|NCT00040742|582790653|FG003|Overall Study|Incomplete Forms|5|||
161383690|NCT00040742|582790650|FG000|Overall Study|Other medical|7|||
161383691|NCT00040742|582790651|FG001|Overall Study|Other medical|5|||
161383692|NCT00040742|582790652|FG002|Overall Study|Other medical|5|||
161383693|NCT00040742|582790653|FG003|Overall Study|Other medical|5|||
161383694|NCT00624468|582790654|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
161383695|NCT00624468|582790655|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
161383696|NCT00624468|582790656|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
161383697|NCT00624468|582790657|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
161383698|NCT00624468|582790654|FG000|Double-blind Period|Withdrew Prematurely|1|||
161383699|NCT00624468|582790655|FG001|Double-blind Period|Withdrew Prematurely|1|||
161383700|NCT00624468|582790656|FG002|Double-blind Period|Withdrew Prematurely|0|||
161383701|NCT00624468|582790657|FG003|Double-blind Period|Withdrew Prematurely|0|||
161383702|NCT00624468|582790654|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
161383703|NCT00624468|582790655|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
161383704|NCT00624468|582790656|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
161383705|NCT00624468|582790657|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
161383706|NCT00624468|582790654|FG000|Safety Follow-up (SFU) Period|Other|0|||
161383707|NCT00624468|582790655|FG001|Safety Follow-up (SFU) Period|Other|0|||
161383708|NCT00624468|582790656|FG002|Safety Follow-up (SFU) Period|Other|1|||
161383709|NCT00624468|582790657|FG003|Safety Follow-up (SFU) Period|Other|1|||
161383710|NCT03520920|582790658|FG000|Overall Study|Death|13|||
161383711|NCT03520920|582790659|FG001|Overall Study|Death|1|||
161383712|NCT03520920|582790660|FG002|Overall Study|Death|0|||
161383713|NCT03520920|582790658|FG000|Overall Study|Withdrawal by Subject|2|||
161383714|NCT03520920|582790659|FG001|Overall Study|Withdrawal by Subject|1|||
161383715|NCT03520920|582790660|FG002|Overall Study|Withdrawal by Subject|0|||
161383716|NCT03520920|582790658|FG000|Overall Study|Study Terminated by the Sponsor|5|||
161383717|NCT03520920|582790659|FG001|Overall Study|Study Terminated by the Sponsor|14|||
161383718|NCT03520920|582790660|FG002|Overall Study|Study Terminated by the Sponsor|5|||
161383719|NCT04677543|582790661|FG000|Overall Study|Withdrawal by Subject|4|||
161383720|NCT04677543|582790662|FG001|Overall Study|Withdrawal by Subject|1|||
161383721|NCT04677543|582790661|FG000|Overall Study|Physician Decision|0|||
161383722|NCT04677543|582790662|FG001|Overall Study|Physician Decision|1|||
161383723|NCT04677543|582790661|FG000|Overall Study|Adverse Event|0|||
161383724|NCT04677543|582790662|FG001|Overall Study|Adverse Event|1|||
161383725|NCT00995436|582790663|FG000|Overall Study|Withdrawal by Subject|2|||
161383726|NCT00995436|582790664|FG001|Overall Study|Withdrawal by Subject|5|||
161383727|NCT00995436|582790665|FG002|Overall Study|Withdrawal by Subject|0|||
161383728|NCT03035864|582790667|FG000|Treatment Period|Adverse Event|1|||
161383729|NCT03035864|582790668|FG001|Treatment Period|Adverse Event|0|||
161383730|NCT03035864|582790667|FG000|Treatment Period|Other|3|||
161383731|NCT03035864|582790668|FG001|Treatment Period|Other|1|||
161383732|NCT03035864|582790667|FG000|Follow-up Period|Adverse Event|1|||
161383733|NCT03035864|582790668|FG001|Follow-up Period|Adverse Event|0|||
161383734|NCT03035864|582790667|FG000|Follow-up Period|Lost to Follow-up|6|||
161383735|NCT03035864|582790668|FG001|Follow-up Period|Lost to Follow-up|2|||
161383736|NCT03035864|582790667|FG000|Follow-up Period|Physician Decision|1|||
161383737|NCT03035864|582790668|FG001|Follow-up Period|Physician Decision|0|||
161383738|NCT03035864|582790667|FG000|Follow-up Period|Other|3|||
161383739|NCT03035864|582790668|FG001|Follow-up Period|Other|2|||
161383740|NCT00407602|582790671|FG000|Overall Study|Death - unrelated to device|1|||
161383741|NCT00407602|582790671|FG000|Overall Study|Device explanted|5|||
161383742|NCT00407602|582790671|FG000|Overall Study|Withdrawal by Subject|1|||
161383743|NCT04188834|582790672|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
161383744|NCT00553436|582790673|FG000|Overall Study|Conversion to another procedure|1|||
161383745|NCT00577707|582790676|FG000|Overall Study|Withdrawal by Subject|3|||
161383746|NCT03706430|582790684|FG000|Overall Study|No A-Line placed|5|||
161383747|NCT03706430|582790684|FG000|Overall Study|Subject had gel nail polish|1|||
161383748|NCT03706430|582790684|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
161383749|NCT03706430|582790684|FG000|Overall Study|Cancelled Case|6|||
161383750|NCT03706430|582790684|FG000|Overall Study|Physician Decision|2|||
161383751|NCT01928433|582790685|FG000|Overall Study|Adverse Event|5|||
161383752|NCT01928433|582790686|FG001|Overall Study|Adverse Event|2|||
161383753|NCT01928433|582790687|FG002|Overall Study|Adverse Event|5|||
161383754|NCT01928433|582790685|FG000|Overall Study|Protocol Violation|0|||
161383755|NCT01928433|582790686|FG001|Overall Study|Protocol Violation|0|||
161383756|NCT01928433|582790687|FG002|Overall Study|Protocol Violation|2|||
161383757|NCT01928433|582790685|FG000|Overall Study|Lack of Efficacy|5|||
161383758|NCT01928433|582790686|FG001|Overall Study|Lack of Efficacy|4|||
161383759|NCT01928433|582790687|FG002|Overall Study|Lack of Efficacy|4|||
161383760|NCT01928433|582790685|FG000|Overall Study|Withdrawal by Subject|0|||
161383761|NCT01928433|582790686|FG001|Overall Study|Withdrawal by Subject|4|||
161383762|NCT01928433|582790687|FG002|Overall Study|Withdrawal by Subject|0|||
161383763|NCT01928433|582790685|FG000|Overall Study|Negative screening urine culture|7|||
161383764|NCT01928433|582790686|FG001|Overall Study|Negative screening urine culture|6|||
161383765|NCT01928433|582790687|FG002|Overall Study|Negative screening urine culture|10|||
161383766|NCT01928433|582790685|FG000|Overall Study|Lost to Follow-up|0|||
161383767|NCT01928433|582790686|FG001|Overall Study|Lost to Follow-up|2|||
161383768|NCT01928433|582790687|FG002|Overall Study|Lost to Follow-up|3|||
161383769|NCT01928433|582790685|FG000|Overall Study|Other reasons|3|||
161383770|NCT01928433|582790686|FG001|Overall Study|Other reasons|3|||
161383771|NCT01928433|582790687|FG002|Overall Study|Other reasons|4|||
161383772|NCT00145626|582790688|FG000|Overall Study|Did not have NK infusions|2|||
161383773|NCT00145626|582790688|FG000|Overall Study|Turned 2 years old before treatment|1|||
161383774|NCT00145626|582790688|FG000|Overall Study|Death|1|||
161383775|NCT00145626|582790688|FG000|Overall Study|Withdrawal by Subject|1|||
161383776|NCT00100802|582790689|FG000|Overall Study|Adverse Event|9|||
161383777|NCT00100802|582790689|FG000|Overall Study|Death|1|||
161383778|NCT00100802|582790689|FG000|Overall Study|Lack of Efficacy|47|||
161383779|NCT00100802|582790689|FG000|Overall Study|Physician Decision|5|||
161383780|NCT00100802|582790689|FG000|Overall Study|Protocol Violation|1|||
161383781|NCT00100802|582790689|FG000|Overall Study|Withdrawal by Subject|5|||
161383782|NCT00100802|582790689|FG000|Overall Study|Ineligible|12|||
161383783|NCT02709720|582790690|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
161383784|NCT02709720|582790690|FG000|Overall Study|Protocol Violation|1|||
161383785|NCT02709720|582790690|FG000|Overall Study|Not take study medication|1|||
161383786|NCT01198574|582790692|FG000|Overall Study|Resigned from schools|4|||
161383787|NCT01198574|582790693|FG001|Overall Study|Resigned from schools|1|||
161383788|NCT01198574|582790694|FG002|Overall Study|Resigned from schools|1|||
161383789|NCT01198574|582790695|FG003|Overall Study|Resigned from schools|4|||
161383790|NCT00980460|582790702|FG000|Overall Study|Death|0|||
161383791|NCT00980460|582790703|FG001|Overall Study|Death|0|||
161383792|NCT00980460|582790704|FG002|Overall Study|Death|1|||
161383793|NCT00980460|582790705|FG003|Overall Study|Death|2|||
161383794|NCT00980460|582790706|FG004|Overall Study|Death|1|||
161383795|NCT00980460|582790702|FG000|Overall Study|Lack of Efficacy|0|||
161383796|NCT00980460|582790703|FG001|Overall Study|Lack of Efficacy|0|||
161383797|NCT00980460|582790704|FG002|Overall Study|Lack of Efficacy|10|||
161383798|NCT00980460|582790705|FG003|Overall Study|Lack of Efficacy|6|||
161383799|NCT00980460|582790706|FG004|Overall Study|Lack of Efficacy|8|||
161383800|NCT00980460|582790702|FG000|Overall Study|Lost to Follow-up|0|||
161383801|NCT00980460|582790703|FG001|Overall Study|Lost to Follow-up|0|||
161383802|NCT00980460|582790704|FG002|Overall Study|Lost to Follow-up|0|||
161383803|NCT00980460|582790705|FG003|Overall Study|Lost to Follow-up|1|||
161383804|NCT00980460|582790706|FG004|Overall Study|Lost to Follow-up|0|||
161383805|NCT00980460|582790702|FG000|Overall Study|Physician Decision|0|||
161383806|NCT00980460|582790703|FG001|Overall Study|Physician Decision|0|||
161383807|NCT00980460|582790704|FG002|Overall Study|Physician Decision|11|||
161383808|NCT00980460|582790705|FG003|Overall Study|Physician Decision|5|||
161383809|NCT00980460|582790706|FG004|Overall Study|Physician Decision|3|||
161383810|NCT00980460|582790702|FG000|Overall Study|Withdrawal by Subject|0|||
161383811|NCT00980460|582790703|FG001|Overall Study|Withdrawal by Subject|0|||
161383812|NCT00980460|582790704|FG002|Overall Study|Withdrawal by Subject|1|||
161383813|NCT00980460|582790705|FG003|Overall Study|Withdrawal by Subject|0|||
161383814|NCT00980460|582790706|FG004|Overall Study|Withdrawal by Subject|0|||
161383815|NCT00980460|582790702|FG000|Overall Study|Ineligible|0|||
161383816|NCT00980460|582790703|FG001|Overall Study|Ineligible|2|||
161383817|NCT00980460|582790704|FG002|Overall Study|Ineligible|3|||
161383818|NCT00980460|582790705|FG003|Overall Study|Ineligible|1|||
161383819|NCT00980460|582790706|FG004|Overall Study|Ineligible|4|||
161383820|NCT00980460|582790702|FG000|Overall Study|Refusal of further therapy|0|||
161383821|NCT00980460|582790703|FG001|Overall Study|Refusal of further therapy|2|||
161383822|NCT00980460|582790704|FG002|Overall Study|Refusal of further therapy|3|||
161383823|NCT00980460|582790705|FG003|Overall Study|Refusal of further therapy|2|||
161383824|NCT00980460|582790706|FG004|Overall Study|Refusal of further therapy|0|||
161383825|NCT00980460|582790702|FG000|Overall Study|No therapy within 42 days of resection|0|||
161383826|NCT00980460|582790703|FG001|Overall Study|No therapy within 42 days of resection|0|||
161383827|NCT00980460|582790704|FG002|Overall Study|No therapy within 42 days of resection|3|||
161383828|NCT00980460|582790705|FG003|Overall Study|No therapy within 42 days of resection|1|||
161383829|NCT00980460|582790706|FG004|Overall Study|No therapy within 42 days of resection|0|||
161383830|NCT00980460|582790702|FG000|Overall Study|No transplant by protocol timepoints|0|||
161383831|NCT00980460|582790703|FG001|Overall Study|No transplant by protocol timepoints|0|||
161383832|NCT00980460|582790704|FG002|Overall Study|No transplant by protocol timepoints|3|||
161383833|NCT00980460|582790705|FG003|Overall Study|No transplant by protocol timepoints|0|||
161383834|NCT00980460|582790706|FG004|Overall Study|No transplant by protocol timepoints|0|||
161383835|NCT02842086|582790707|FG000|Overall Study|Randomized but Never Treated|6|||
161383836|NCT02842086|582790708|FG001|Overall Study|Randomized but Never Treated|6|||
161383837|NCT02842086|582790707|FG000|Overall Study|Still in Double-Blind Phase|7|||
161383838|NCT02842086|582790708|FG001|Overall Study|Still in Double-Blind Phase|3|||
161383839|NCT02842086|582790707|FG000|Overall Study|Adverse Event|18|||
161383840|NCT02842086|582790708|FG001|Overall Study|Adverse Event|20|||
161383841|NCT02842086|582790707|FG000|Overall Study|Death|3|||
161383842|NCT02842086|582790708|FG001|Overall Study|Death|3|||
161383843|NCT02842086|582790707|FG000|Overall Study|Investigator's Discretion|9|||
161383844|NCT02842086|582790708|FG001|Overall Study|Investigator's Discretion|13|||
161383845|NCT02842086|582790707|FG000|Overall Study|Non-Compliance with Study Drug|9|||
161383846|NCT02842086|582790708|FG001|Overall Study|Non-Compliance with Study Drug|8|||
161383847|NCT02842086|582790707|FG000|Overall Study|Protocol Violation|8|||
161383848|NCT02842086|582790708|FG001|Overall Study|Protocol Violation|4|||
161383849|NCT02842086|582790707|FG000|Overall Study|Withdrew Consent|205|||
161383850|NCT02842086|582790708|FG001|Overall Study|Withdrew Consent|194|||
161383851|NCT02842086|582790707|FG000|Overall Study|Lost to Follow-up|274|||
161383852|NCT02842086|582790708|FG001|Overall Study|Lost to Follow-up|236|||
161383853|NCT02842086|582790707|FG000|Overall Study|HIV-1 Infection|5|||
161383854|NCT02842086|582790708|FG001|Overall Study|HIV-1 Infection|6|||
161383855|NCT00928187|582790709|FG000|Overall Study|Death|1|||
161383856|NCT00928187|582790710|FG001|Overall Study|Death|2|||
161383857|NCT00928187|582790711|FG002|Overall Study|Death|3|||
161383858|NCT00928187|582790709|FG000|Overall Study|Lost to Follow-up|1|||
161383859|NCT00928187|582790710|FG001|Overall Study|Lost to Follow-up|2|||
161383860|NCT00928187|582790711|FG002|Overall Study|Lost to Follow-up|1|||
161383861|NCT00928187|582790709|FG000|Overall Study|Withdrawal by Subject|0|||
161383862|NCT00928187|582790710|FG001|Overall Study|Withdrawal by Subject|1|||
161383863|NCT00928187|582790711|FG002|Overall Study|Withdrawal by Subject|1|||
161383864|NCT00928187|582790709|FG000|Overall Study|Protocol Violation|0|||
161383865|NCT00928187|582790710|FG001|Overall Study|Protocol Violation|1|||
161383866|NCT00928187|582790711|FG002|Overall Study|Protocol Violation|0|||
161383867|NCT05696444|582790712|FG000|Treatment|Physician Decision|0|||
161383868|NCT05696444|582790713|FG001|Treatment|Physician Decision|1|||
161383869|NCT05696444|582790714|FG002|Treatment|Physician Decision|0|||
161383870|NCT05696444|582790712|FG000|30 Days|Death|1|||
161383871|NCT05696444|582790713|FG001|30 Days|Death|1|||
161383872|NCT05696444|582790714|FG002|30 Days|Death|0|||
161383873|NCT05696444|582790712|FG000|30 Days|Missed Visit|1|||
161383874|NCT05696444|582790713|FG001|30 Days|Missed Visit|1|||
161383875|NCT05696444|582790714|FG002|30 Days|Missed Visit|1|||
161383876|NCT03744910|582792659|FG000|Overall Study|Withdrew Consent|1|||
161383877|NCT03744910|582792660|FG001|Overall Study|Withdrew Consent|8|||
161383878|NCT03744910|582792659|FG000|Overall Study|Physician Decision|5|||
161383879|NCT03744910|582792660|FG001|Overall Study|Physician Decision|4|||
161383880|NCT03744910|582792659|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
161383881|NCT03744910|582792660|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
161383882|NCT03744910|582792659|FG000|Overall Study|Lost to Follow-up|0|||
161383883|NCT03744910|582792660|FG001|Overall Study|Lost to Follow-up|1|||
161383884|NCT03744910|582792659|FG000|Overall Study|Other-unspecified|4|||
161383885|NCT03744910|582792660|FG001|Overall Study|Other-unspecified|1|||
161383886|NCT02712983|582792661|FG000|Treatment Phase|Adverse Event|3|||
161383887|NCT02712983|582792662|FG001|Treatment Phase|Adverse Event|1|||
161383888|NCT02712983|582792663|FG002|Treatment Phase|Adverse Event|1|||
161383889|NCT02712983|582792664|FG003|Treatment Phase|Adverse Event|4|||
161383890|NCT02712983|582792665|FG004|Treatment Phase|Adverse Event|3|||
161383891|NCT02712983|582792666|FG005|Treatment Phase|Adverse Event|0|||
161383892|NCT02712983|582792667|FG006|Treatment Phase|Adverse Event|6|||
161383893|NCT02712983|582792668|FG007|Treatment Phase|Adverse Event|6|||
161383894|NCT02712983|582792669|FG008|Treatment Phase|Adverse Event|1|||
161383895|NCT02712983|582792661|FG000|Treatment Phase|Protocol Deviation|0|||
161383896|NCT02712983|582792662|FG001|Treatment Phase|Protocol Deviation|0|||
161383897|NCT02712983|582792663|FG002|Treatment Phase|Protocol Deviation|0|||
161383898|NCT02712983|582792664|FG003|Treatment Phase|Protocol Deviation|2|||
161383899|NCT02712983|582792665|FG004|Treatment Phase|Protocol Deviation|0|||
161383900|NCT02712983|582792666|FG005|Treatment Phase|Protocol Deviation|0|||
161383901|NCT02712983|582792667|FG006|Treatment Phase|Protocol Deviation|1|||
161383902|NCT02712983|582792668|FG007|Treatment Phase|Protocol Deviation|0|||
161383903|NCT02712983|582792669|FG008|Treatment Phase|Protocol Deviation|0|||
161383904|NCT02712983|582792661|FG000|Treatment Phase|Technical Problems|0|||
161383905|NCT02712983|582792662|FG001|Treatment Phase|Technical Problems|0|||
161383906|NCT02712983|582792663|FG002|Treatment Phase|Technical Problems|0|||
161383907|NCT02712983|582792664|FG003|Treatment Phase|Technical Problems|0|||
161383908|NCT02712983|582792665|FG004|Treatment Phase|Technical Problems|0|||
161383909|NCT02712983|582792666|FG005|Treatment Phase|Technical Problems|0|||
161383910|NCT02712983|582792667|FG006|Treatment Phase|Technical Problems|1|||
161383911|NCT02712983|582792668|FG007|Treatment Phase|Technical Problems|0|||
161383912|NCT02712983|582792669|FG008|Treatment Phase|Technical Problems|0|||
161383913|NCT02712983|582792661|FG000|Treatment Phase|Physician Decision|0|||
161383914|NCT02712983|582792662|FG001|Treatment Phase|Physician Decision|0|||
161383915|NCT02712983|582792663|FG002|Treatment Phase|Physician Decision|0|||
161383916|NCT02712983|582792664|FG003|Treatment Phase|Physician Decision|0|||
161383917|NCT02712983|582792665|FG004|Treatment Phase|Physician Decision|0|||
161383918|NCT02712983|582792666|FG005|Treatment Phase|Physician Decision|0|||
161383919|NCT02712983|582792667|FG006|Treatment Phase|Physician Decision|0|||
161383920|NCT02712983|582792668|FG007|Treatment Phase|Physician Decision|1|||
161383921|NCT02712983|582792669|FG008|Treatment Phase|Physician Decision|1|||
161383922|NCT02712983|582792661|FG000|Treatment Phase|Subject Decision|2|||
161383923|NCT02712983|582792662|FG001|Treatment Phase|Subject Decision|0|||
161383924|NCT02712983|582792663|FG002|Treatment Phase|Subject Decision|0|||
161383925|NCT02712983|582792664|FG003|Treatment Phase|Subject Decision|2|||
161383926|NCT02712983|582792665|FG004|Treatment Phase|Subject Decision|1|||
161383927|NCT02712983|582792666|FG005|Treatment Phase|Subject Decision|0|||
161383928|NCT02712983|582792667|FG006|Treatment Phase|Subject Decision|1|||
161383929|NCT02712983|582792668|FG007|Treatment Phase|Subject Decision|2|||
161383930|NCT02712983|582792669|FG008|Treatment Phase|Subject Decision|0|||
161383931|NCT02712983|582792661|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161383932|NCT02712983|582792662|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
161383933|NCT02712983|582792663|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161383934|NCT02712983|582792664|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161383935|NCT02712983|582792665|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161383936|NCT02712983|582792666|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161383937|NCT02712983|582792667|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
161383938|NCT02712983|582792668|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
161383939|NCT02712983|582792669|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161383940|NCT02712983|582792661|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383941|NCT02712983|582792662|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383942|NCT02712983|582792663|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383943|NCT02712983|582792664|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
161383944|NCT02712983|582792665|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383945|NCT02712983|582792666|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383946|NCT02712983|582792667|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383947|NCT02712983|582792668|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383948|NCT02712983|582792669|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161383949|NCT02712983|582792661|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161383950|NCT02712983|582792662|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161383951|NCT02712983|582792663|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161383952|NCT02712983|582792664|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161383953|NCT02712983|582792665|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
161383954|NCT02712983|582792666|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
161383955|NCT02712983|582792667|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
161383956|NCT02712983|582792668|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
161383957|NCT02712983|582792669|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161383958|NCT03280303|582792670|FG000|Overall Study|Death|505|||
161383959|NCT03280303|582792670|FG000|Overall Study|Study terminated by sponsor|383|||
161383960|NCT03280303|582792670|FG000|Overall Study|Other|148|||
161383961|NCT03280303|582792670|FG000|Overall Study|No longer willing to participate in study|101|||
161383962|NCT03280303|582792670|FG000|Overall Study|Lost to follow up|39|||
161383963|NCT03280303|582792670|FG000|Overall Study|Adverse Event|20|||
161383964|NCT01132651|582792673|FG000|Overall Study|Lost to Follow-up|1|||
161383965|NCT01132651|582792674|FG001|Overall Study|Lost to Follow-up|1|||
161383966|NCT00948857|582792675|FG000|Overall Study|Lost to Follow-up|1|||
161383967|NCT00948857|582792676|FG001|Overall Study|Lost to Follow-up|0|||
161383968|NCT03430843|582792680|FG000|Overall Study|Death|233|||
161383969|NCT03430843|582792681|FG001|Overall Study|Death|233|||
161383970|NCT03430843|582792680|FG000|Overall Study|Sponsor Decision|17|||
161383971|NCT03430843|582792681|FG001|Overall Study|Sponsor Decision|6|||
161383972|NCT03430843|582792680|FG000|Overall Study|Withdrawal by Subject|5|||
161383973|NCT03430843|582792681|FG001|Overall Study|Withdrawal by Subject|14|||
161383974|NCT03430843|582792680|FG000|Overall Study|Lost to Follow-up|1|||
161383975|NCT03430843|582792681|FG001|Overall Study|Lost to Follow-up|3|||
161383976|NCT05360966|582792686|FG000|Overall Study|Adverse Event|5|||
161383977|NCT05360966|582792687|FG001|Overall Study|Adverse Event|5|||
161383978|NCT05360966|582792686|FG000|Overall Study|Withdrawal of Consent|5|||
161383979|NCT05360966|582792687|FG001|Overall Study|Withdrawal of Consent|3|||
161383980|NCT05360966|582792686|FG000|Overall Study|Noncompliance|2|||
161383981|NCT05360966|582792687|FG001|Overall Study|Noncompliance|1|||
161383982|NCT05360966|582792686|FG000|Overall Study|Lost to Follow-up|2|||
161383983|NCT05360966|582792687|FG001|Overall Study|Lost to Follow-up|3|||
161383984|NCT05360966|582792686|FG000|Overall Study|Protocol Deviation|2|||
161383985|NCT05360966|582792687|FG001|Overall Study|Protocol Deviation|1|||
161383986|NCT05360966|582792686|FG000|Overall Study|As specified in the Clinical Study Report|1|||
161383987|NCT05360966|582792687|FG001|Overall Study|As specified in the Clinical Study Report|3|||
161383988|NCT05396014|582792688|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
161383989|NCT05396014|582792689|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383990|NCT05396014|582792690|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383991|NCT05396014|582792691|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383992|NCT05396014|582792692|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383993|NCT05396014|582792693|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383994|NCT05396014|582792694|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383995|NCT05396014|582792695|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383996|NCT05396014|582792696|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383997|NCT05396014|582792697|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383998|NCT05396014|582792698|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161383999|NCT05396014|582792699|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384000|NCT05396014|582792700|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384001|NCT05396014|582792701|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
161384002|NCT05396014|582792702|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384003|NCT05396014|582792703|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384004|NCT05396014|582792704|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384005|NCT05396014|582792705|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384006|NCT05396014|582792706|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384007|NCT05396014|582792707|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384008|NCT05396014|582792708|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384009|NCT05396014|582792709|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384010|NCT05396014|582792710|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384011|NCT05396014|582792711|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384012|NCT05396014|582792712|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384013|NCT05396014|582792713|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384014|NCT05396014|582792714|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
161384015|NCT05396014|582792715|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384016|NCT05396014|582792716|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384017|NCT05396014|582792717|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384018|NCT05396014|582792718|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384019|NCT05396014|582792719|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384020|NCT05396014|582792720|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384021|NCT05396014|582792721|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384022|NCT05396014|582792722|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384023|NCT05396014|582792723|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384024|NCT05396014|582792724|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384025|NCT05396014|582792725|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384026|NCT05396014|582792726|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384027|NCT05396014|582792727|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
161384028|NCT05396014|582792728|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384029|NCT05396014|582792729|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384030|NCT05396014|582792730|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161384031|NCT05396014|582792688|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
161384032|NCT05396014|582792689|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384033|NCT05396014|582792690|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384034|NCT05396014|582792691|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384035|NCT05396014|582792692|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384036|NCT05396014|582792693|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384037|NCT05396014|582792694|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384038|NCT05396014|582792695|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384039|NCT05396014|582792696|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384040|NCT05396014|582792697|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384041|NCT05396014|582792698|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384042|NCT05396014|582792699|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384043|NCT05396014|582792700|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384044|NCT05396014|582792701|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
161384045|NCT05396014|582792702|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384046|NCT05396014|582792703|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384047|NCT05396014|582792704|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384048|NCT05396014|582792705|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384049|NCT05396014|582792706|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384050|NCT05396014|582792707|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384051|NCT05396014|582792708|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384052|NCT05396014|582792709|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384053|NCT05396014|582792710|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384054|NCT05396014|582792711|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384055|NCT05396014|582792712|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384056|NCT05396014|582792713|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384057|NCT05396014|582792714|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
161384058|NCT05396014|582792715|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384059|NCT05396014|582792716|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384060|NCT05396014|582792717|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384061|NCT05396014|582792718|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384062|NCT05396014|582792719|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384063|NCT05396014|582792720|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384064|NCT05396014|582792721|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384065|NCT05396014|582792722|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384066|NCT05396014|582792723|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384067|NCT05396014|582792724|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384068|NCT05396014|582792725|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384069|NCT05396014|582792726|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384070|NCT05396014|582792727|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
161384071|NCT05396014|582792728|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384072|NCT05396014|582792729|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384073|NCT05396014|582792730|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161384074|NCT05396014|582792688|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
161384075|NCT05396014|582792689|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384076|NCT05396014|582792690|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384077|NCT05396014|582792691|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384078|NCT05396014|582792692|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384079|NCT05396014|582792693|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384080|NCT05396014|582792694|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384081|NCT05396014|582792695|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384082|NCT05396014|582792696|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384083|NCT05396014|582792697|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384084|NCT05396014|582792698|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384085|NCT05396014|582792699|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384086|NCT05396014|582792700|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384087|NCT05396014|582792701|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
161384088|NCT05396014|582792702|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384089|NCT05396014|582792703|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384090|NCT05396014|582792704|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384091|NCT05396014|582792705|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384092|NCT05396014|582792706|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384093|NCT05396014|582792707|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384094|NCT05396014|582792708|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384095|NCT05396014|582792709|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384096|NCT05396014|582792710|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384097|NCT05396014|582792711|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384098|NCT05396014|582792712|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384099|NCT05396014|582792713|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384100|NCT05396014|582792714|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
161384101|NCT05396014|582792715|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384102|NCT05396014|582792716|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384103|NCT05396014|582792717|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384104|NCT05396014|582792718|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384105|NCT05396014|582792719|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384106|NCT05396014|582792720|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384107|NCT05396014|582792721|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384108|NCT05396014|582792722|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384109|NCT05396014|582792723|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384110|NCT05396014|582792724|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384111|NCT05396014|582792725|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384112|NCT05396014|582792726|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384113|NCT05396014|582792727|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
161384114|NCT05396014|582792728|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384115|NCT05396014|582792729|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384116|NCT05396014|582792730|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161384117|NCT05396014|582792688|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384118|NCT05396014|582792689|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384119|NCT05396014|582792690|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384120|NCT05396014|582792691|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384121|NCT05396014|582792692|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384122|NCT05396014|582792693|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384123|NCT05396014|582792694|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384124|NCT05396014|582792695|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384125|NCT05396014|582792696|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384126|NCT05396014|582792697|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384127|NCT05396014|582792698|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384128|NCT05396014|582792699|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384129|NCT05396014|582792700|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384130|NCT05396014|582792701|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384131|NCT05396014|582792702|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384132|NCT05396014|582792703|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384133|NCT05396014|582792704|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384134|NCT05396014|582792705|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384135|NCT05396014|582792706|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384136|NCT05396014|582792707|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384137|NCT05396014|582792708|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384138|NCT05396014|582792709|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384139|NCT05396014|582792710|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384140|NCT05396014|582792711|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384141|NCT05396014|582792712|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384142|NCT05396014|582792713|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384143|NCT05396014|582792714|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
161384144|NCT05396014|582792715|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384145|NCT05396014|582792716|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384146|NCT05396014|582792717|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384147|NCT05396014|582792718|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384148|NCT05396014|582792719|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384149|NCT05396014|582792720|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384150|NCT05396014|582792721|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384151|NCT05396014|582792722|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384152|NCT05396014|582792723|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384153|NCT05396014|582792724|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384154|NCT05396014|582792725|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384155|NCT05396014|582792726|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384156|NCT05396014|582792727|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
161384157|NCT05396014|582792728|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384158|NCT05396014|582792729|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384159|NCT05396014|582792730|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161384160|NCT05396014|582792688|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384161|NCT05396014|582792689|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384162|NCT05396014|582792690|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384163|NCT05396014|582792691|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384164|NCT05396014|582792692|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384165|NCT05396014|582792693|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384166|NCT05396014|582792694|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384167|NCT05396014|582792695|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384168|NCT05396014|582792696|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384169|NCT05396014|582792697|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384170|NCT05396014|582792698|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384171|NCT05396014|582792699|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384172|NCT05396014|582792700|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384173|NCT05396014|582792701|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384174|NCT05396014|582792702|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384175|NCT05396014|582792703|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384176|NCT05396014|582792704|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384177|NCT05396014|582792705|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384178|NCT05396014|582792706|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384179|NCT05396014|582792707|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384180|NCT05396014|582792708|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384181|NCT05396014|582792709|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384182|NCT05396014|582792710|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384183|NCT05396014|582792711|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384184|NCT05396014|582792712|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384185|NCT05396014|582792713|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384186|NCT05396014|582792714|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
161384187|NCT05396014|582792715|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384188|NCT05396014|582792716|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384189|NCT05396014|582792717|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384190|NCT05396014|582792718|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384191|NCT05396014|582792719|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384192|NCT05396014|582792720|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384193|NCT05396014|582792721|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384194|NCT05396014|582792722|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384195|NCT05396014|582792723|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384196|NCT05396014|582792724|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384197|NCT05396014|582792725|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384198|NCT05396014|582792726|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384199|NCT05396014|582792727|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384200|NCT05396014|582792728|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384201|NCT05396014|582792729|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384202|NCT05396014|582792730|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161384203|NCT05396014|582792688|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384204|NCT05396014|582792689|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384205|NCT05396014|582792690|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384206|NCT05396014|582792691|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384207|NCT05396014|582792692|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384208|NCT05396014|582792693|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384209|NCT05396014|582792694|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384210|NCT05396014|582792695|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384211|NCT05396014|582792696|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384212|NCT05396014|582792697|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384213|NCT05396014|582792698|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384214|NCT05396014|582792699|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384215|NCT05396014|582792700|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161435300|NCT01710345|582987977|FG001|Overall Study|Drug Dosing Error|0|||
161384216|NCT05396014|582792701|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
161384217|NCT05396014|582792702|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384218|NCT05396014|582792703|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384219|NCT05396014|582792704|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384220|NCT05396014|582792705|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384221|NCT05396014|582792706|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384222|NCT05396014|582792707|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384223|NCT05396014|582792708|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384224|NCT05396014|582792709|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384225|NCT05396014|582792710|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384226|NCT05396014|582792711|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384227|NCT05396014|582792712|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384228|NCT05396014|582792713|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384229|NCT05396014|582792714|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384230|NCT05396014|582792715|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384231|NCT05396014|582792716|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384232|NCT05396014|582792717|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384233|NCT05396014|582792718|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384234|NCT05396014|582792719|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384235|NCT05396014|582792720|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384236|NCT05396014|582792721|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384237|NCT05396014|582792722|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384238|NCT05396014|582792723|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384239|NCT05396014|582792724|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384240|NCT05396014|582792725|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384241|NCT05396014|582792726|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384242|NCT05396014|582792727|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384243|NCT05396014|582792728|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384244|NCT05396014|582792729|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384245|NCT05396014|582792730|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161384246|NCT05396014|582792688|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
161384247|NCT05396014|582792689|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384248|NCT05396014|582792690|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384249|NCT05396014|582792691|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384250|NCT05396014|582792692|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384251|NCT05396014|582792693|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384252|NCT05396014|582792694|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384253|NCT05396014|582792695|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384254|NCT05396014|582792696|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384255|NCT05396014|582792697|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384256|NCT05396014|582792698|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384257|NCT05396014|582792699|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384258|NCT05396014|582792700|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384259|NCT05396014|582792701|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
161384260|NCT05396014|582792702|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384261|NCT05396014|582792703|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384262|NCT05396014|582792704|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384263|NCT05396014|582792705|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384264|NCT05396014|582792706|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384265|NCT05396014|582792707|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384266|NCT05396014|582792708|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384267|NCT05396014|582792709|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384268|NCT05396014|582792710|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384269|NCT05396014|582792711|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384270|NCT05396014|582792712|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384271|NCT05396014|582792713|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384272|NCT05396014|582792714|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384273|NCT05396014|582792715|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384274|NCT05396014|582792716|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384275|NCT05396014|582792717|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384276|NCT05396014|582792718|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384277|NCT05396014|582792719|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384278|NCT05396014|582792720|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161435301|NCT01710345|582987978|FG002|Overall Study|Drug Dosing Error|0|||
161384279|NCT05396014|582792721|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384280|NCT05396014|582792722|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384281|NCT05396014|582792723|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384282|NCT05396014|582792724|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384283|NCT05396014|582792725|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384284|NCT05396014|582792726|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384285|NCT05396014|582792727|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
161384286|NCT05396014|582792728|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384287|NCT05396014|582792729|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384288|NCT05396014|582792730|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161384289|NCT05396014|582792688|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
161384290|NCT05396014|582792689|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384291|NCT05396014|582792690|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384292|NCT05396014|582792691|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384293|NCT05396014|582792692|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384294|NCT05396014|582792693|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384295|NCT05396014|582792694|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384296|NCT05396014|582792695|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384297|NCT05396014|582792696|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384298|NCT05396014|582792697|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384299|NCT05396014|582792698|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384300|NCT05396014|582792699|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384301|NCT05396014|582792700|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384302|NCT05396014|582792701|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384303|NCT05396014|582792702|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384304|NCT05396014|582792703|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384305|NCT05396014|582792704|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384306|NCT05396014|582792705|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384307|NCT05396014|582792706|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384308|NCT05396014|582792707|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384309|NCT05396014|582792708|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384310|NCT05396014|582792709|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384311|NCT05396014|582792710|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384312|NCT05396014|582792711|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384313|NCT05396014|582792712|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384314|NCT05396014|582792713|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384315|NCT05396014|582792714|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
161384316|NCT05396014|582792715|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384317|NCT05396014|582792716|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384318|NCT05396014|582792717|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384319|NCT05396014|582792718|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384320|NCT05396014|582792719|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384321|NCT05396014|582792720|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384322|NCT05396014|582792721|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384323|NCT05396014|582792722|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384324|NCT05396014|582792723|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384325|NCT05396014|582792724|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384326|NCT05396014|582792725|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384327|NCT05396014|582792726|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384328|NCT05396014|582792727|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384329|NCT05396014|582792728|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384330|NCT05396014|582792729|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384331|NCT05396014|582792730|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161384332|NCT05396014|582792688|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384333|NCT05396014|582792689|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384334|NCT05396014|582792690|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384335|NCT05396014|582792691|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384336|NCT05396014|582792692|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384337|NCT05396014|582792693|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384338|NCT05396014|582792694|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384339|NCT05396014|582792695|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384340|NCT05396014|582792696|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384341|NCT05396014|582792697|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384342|NCT05396014|582792698|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384343|NCT05396014|582792699|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384344|NCT05396014|582792700|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384345|NCT05396014|582792701|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
161384346|NCT05396014|582792702|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384347|NCT05396014|582792703|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384348|NCT05396014|582792704|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384349|NCT05396014|582792705|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384350|NCT05396014|582792706|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384351|NCT05396014|582792707|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384352|NCT05396014|582792708|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384353|NCT05396014|582792709|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384354|NCT05396014|582792710|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384355|NCT05396014|582792711|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384356|NCT05396014|582792712|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384357|NCT05396014|582792713|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384358|NCT05396014|582792714|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384359|NCT05396014|582792715|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384360|NCT05396014|582792716|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384361|NCT05396014|582792717|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384362|NCT05396014|582792718|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384363|NCT05396014|582792719|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384364|NCT05396014|582792720|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384365|NCT05396014|582792721|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384366|NCT05396014|582792722|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384367|NCT05396014|582792723|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384368|NCT05396014|582792724|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384369|NCT05396014|582792725|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384370|NCT05396014|582792726|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384371|NCT05396014|582792727|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384372|NCT05396014|582792728|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384373|NCT05396014|582792729|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384374|NCT05396014|582792730|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161384375|NCT05396014|582792688|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384376|NCT05396014|582792689|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384377|NCT05396014|582792690|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384378|NCT05396014|582792691|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161384379|NCT05396014|582792692|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384380|NCT05396014|582792693|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384381|NCT05396014|582792694|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384382|NCT05396014|582792695|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384383|NCT05396014|582792696|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161384384|NCT05396014|582792697|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384385|NCT05396014|582792698|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384386|NCT05396014|582792699|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384387|NCT05396014|582792700|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384388|NCT05396014|582792701|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384389|NCT05396014|582792702|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384390|NCT05396014|582792703|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384391|NCT05396014|582792704|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384392|NCT05396014|582792705|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384393|NCT05396014|582792706|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384394|NCT05396014|582792707|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384395|NCT05396014|582792708|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384396|NCT05396014|582792709|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384397|NCT05396014|582792710|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384398|NCT05396014|582792711|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384399|NCT05396014|582792712|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384400|NCT05396014|582792713|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161384401|NCT05396014|582792714|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384402|NCT05396014|582792715|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384403|NCT05396014|582792716|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384404|NCT05396014|582792717|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384405|NCT05396014|582792718|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384406|NCT05396014|582792719|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384407|NCT05396014|582792720|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384408|NCT05396014|582792721|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384409|NCT05396014|582792722|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384410|NCT05396014|582792723|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384411|NCT05396014|582792724|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384412|NCT05396014|582792725|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384413|NCT05396014|582792726|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384414|NCT05396014|582792727|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161384415|NCT05396014|582792728|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
161384416|NCT05396014|582792729|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161384417|NCT05396014|582792730|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161384418|NCT05396014|582792688|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384419|NCT05396014|582792689|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384420|NCT05396014|582792690|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384421|NCT05396014|582792691|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384422|NCT05396014|582792692|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384423|NCT05396014|582792693|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384424|NCT05396014|582792694|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384425|NCT05396014|582792695|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384426|NCT05396014|582792696|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
161384427|NCT05396014|582792697|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384428|NCT05396014|582792698|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384429|NCT05396014|582792699|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384430|NCT05396014|582792700|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384431|NCT05396014|582792701|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384432|NCT05396014|582792702|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384433|NCT05396014|582792703|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384434|NCT05396014|582792704|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384435|NCT05396014|582792705|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384436|NCT05396014|582792706|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384437|NCT05396014|582792707|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384438|NCT05396014|582792708|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384439|NCT05396014|582792709|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384440|NCT05396014|582792710|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
161384441|NCT05396014|582792711|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384442|NCT05396014|582792712|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384443|NCT05396014|582792713|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384444|NCT05396014|582792714|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384445|NCT05396014|582792715|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384446|NCT05396014|582792716|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384447|NCT05396014|582792717|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384448|NCT05396014|582792718|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384449|NCT05396014|582792719|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384450|NCT05396014|582792720|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384451|NCT05396014|582792721|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384452|NCT05396014|582792722|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384453|NCT05396014|582792723|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
161384454|NCT05396014|582792724|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384455|NCT05396014|582792725|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384456|NCT05396014|582792726|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384457|NCT05396014|582792727|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161384458|NCT05396014|582792728|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384459|NCT05396014|582792729|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
161384460|NCT05396014|582792730|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161384461|NCT05396014|582792688|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384462|NCT05396014|582792689|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384463|NCT05396014|582792690|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384464|NCT05396014|582792691|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384465|NCT05396014|582792692|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384466|NCT05396014|582792693|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384467|NCT05396014|582792694|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384468|NCT05396014|582792695|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384469|NCT05396014|582792696|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384470|NCT05396014|582792697|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384471|NCT05396014|582792698|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384472|NCT05396014|582792699|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384473|NCT05396014|582792700|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384474|NCT05396014|582792701|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161384475|NCT05396014|582792702|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384476|NCT05396014|582792703|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384477|NCT05396014|582792704|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384478|NCT05396014|582792705|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384479|NCT05396014|582792706|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384480|NCT05396014|582792707|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384481|NCT05396014|582792708|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384482|NCT05396014|582792709|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384483|NCT05396014|582792710|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384484|NCT05396014|582792711|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384485|NCT05396014|582792712|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384486|NCT05396014|582792713|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384487|NCT05396014|582792714|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161384488|NCT05396014|582792715|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384489|NCT05396014|582792716|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384490|NCT05396014|582792717|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384491|NCT05396014|582792718|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384492|NCT05396014|582792719|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384493|NCT05396014|582792720|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384494|NCT05396014|582792721|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384495|NCT05396014|582792722|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161384496|NCT05396014|582792723|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384497|NCT05396014|582792724|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384498|NCT05396014|582792725|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384499|NCT05396014|582792726|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384500|NCT05396014|582792727|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384501|NCT05396014|582792728|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384502|NCT05396014|582792729|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161384503|NCT05396014|582792730|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161384504|NCT05396014|582792688|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384505|NCT05396014|582792689|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384506|NCT05396014|582792690|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384507|NCT05396014|582792691|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384508|NCT05396014|582792692|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384509|NCT05396014|582792693|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384510|NCT05396014|582792694|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384511|NCT05396014|582792695|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384512|NCT05396014|582792696|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384513|NCT05396014|582792697|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384514|NCT05396014|582792698|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384515|NCT05396014|582792699|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384516|NCT05396014|582792700|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384517|NCT05396014|582792701|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384518|NCT05396014|582792702|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384519|NCT05396014|582792703|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384520|NCT05396014|582792704|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384521|NCT05396014|582792705|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384522|NCT05396014|582792706|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384523|NCT05396014|582792707|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384524|NCT05396014|582792708|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384525|NCT05396014|582792709|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384526|NCT05396014|582792710|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384527|NCT05396014|582792711|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384528|NCT05396014|582792712|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384529|NCT05396014|582792713|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384530|NCT05396014|582792714|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
161384531|NCT05396014|582792715|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384532|NCT05396014|582792716|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384533|NCT05396014|582792717|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384534|NCT05396014|582792718|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384535|NCT05396014|582792719|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384536|NCT05396014|582792720|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384537|NCT05396014|582792721|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384538|NCT05396014|582792722|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384539|NCT05396014|582792723|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384540|NCT05396014|582792724|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384541|NCT05396014|582792725|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384542|NCT05396014|582792726|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384543|NCT05396014|582792727|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384544|NCT05396014|582792728|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384545|NCT05396014|582792729|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384546|NCT05396014|582792730|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161384547|NCT04439539|582792731|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
161384548|NCT04439539|582792732|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
161384549|NCT04439539|582792733|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
161384550|NCT04439539|582792731|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
161384551|NCT04439539|582792732|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
161384552|NCT04439539|582792733|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
161384553|NCT04439539|582792731|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
161384554|NCT04439539|582792732|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
161384555|NCT04439539|582792733|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
161384556|NCT05258890|582792735|FG000|Overall Study|Patient withdrawal|6|||
161384557|NCT05258890|582792736|FG001|Overall Study|Patient withdrawal|7|||
161384558|NCT05258890|582792735|FG000|Overall Study|Patient lost to follow-up|10|||
161384559|NCT05258890|582792736|FG001|Overall Study|Patient lost to follow-up|3|||
161384560|NCT05258890|582792735|FG000|Overall Study|Social network member withdrawal|1|||
161384561|NCT05258890|582792736|FG001|Overall Study|Social network member withdrawal|0|||
161384562|NCT05258890|582792735|FG000|Overall Study|Social network member lost to follow-up|5|||
161384563|NCT05258890|582792736|FG001|Overall Study|Social network member lost to follow-up|0|||
161384564|NCT02013778|582792740|FG000|Overall Study|Death|4|||
161384565|NCT02013778|582792740|FG000|Overall Study|Withdrawal by Subject|1|||
161384566|NCT02013778|582792740|FG000|Overall Study|Physician Decision|1|||
161384567|NCT02013778|582792740|FG000|Overall Study|Adverse Event|1|||
161384568|NCT02719691|582792741|FG000|Overall Study|Physician Decision|0|||
161384569|NCT02719691|582792742|FG001|Overall Study|Physician Decision|0|||
161384570|NCT02719691|582792743|FG002|Overall Study|Physician Decision|1|||
161384571|NCT02719691|582792744|FG003|Overall Study|Physician Decision|0|||
161384572|NCT02719691|582792745|FG004|Overall Study|Physician Decision|0|||
161384573|NCT02719691|582792746|FG005|Overall Study|Physician Decision|0|||
161384574|NCT02719691|582792747|FG006|Overall Study|Physician Decision|0|||
161384575|NCT02719691|582792741|FG000|Overall Study|Withdrawal by Subject|0|||
161384576|NCT02719691|582792742|FG001|Overall Study|Withdrawal by Subject|0|||
161384577|NCT02719691|582792743|FG002|Overall Study|Withdrawal by Subject|0|||
161384578|NCT02719691|582792744|FG003|Overall Study|Withdrawal by Subject|0|||
161384579|NCT02719691|582792745|FG004|Overall Study|Withdrawal by Subject|0|||
161384580|NCT02719691|582792746|FG005|Overall Study|Withdrawal by Subject|1|||
161384581|NCT02719691|582792747|FG006|Overall Study|Withdrawal by Subject|0|||
161384582|NCT01208324|582792750|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
161384583|NCT01208324|582792751|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
161384584|NCT01208324|582792752|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
161384585|NCT01208324|582792753|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
161384586|NCT00984165|582792754|FG000|Overall Study|Death on study|2|||
161384587|NCT00984165|582792755|FG001|Overall Study|Death on study|0|||
161384588|NCT00984165|582792756|FG002|Overall Study|Death on study|0|||
161384589|NCT00984165|582792757|FG003|Overall Study|Death on study|0|||
161384590|NCT00984165|582792754|FG000|Overall Study|Disease progression on study|5|||
161384591|NCT00984165|582792755|FG001|Overall Study|Disease progression on study|1|||
161384592|NCT00984165|582792756|FG002|Overall Study|Disease progression on study|0|||
161384593|NCT00984165|582792757|FG003|Overall Study|Disease progression on study|0|||
161384594|NCT00984165|582792754|FG000|Overall Study|Death of recipient|0|||
161384595|NCT00984165|582792755|FG001|Overall Study|Death of recipient|0|||
161384596|NCT00984165|582792756|FG002|Overall Study|Death of recipient|0|||
161384597|NCT00984165|582792757|FG003|Overall Study|Death of recipient|1|||
161384598|NCT00984165|582792754|FG000|Overall Study|New protocol|0|||
161384599|NCT00984165|582792755|FG001|Overall Study|New protocol|0|||
161384600|NCT00984165|582792756|FG002|Overall Study|New protocol|0|||
161384601|NCT00984165|582792757|FG003|Overall Study|New protocol|1|||
161384602|NCT00984165|582792754|FG000|Overall Study|P+/donor pair removed from protocol|0|||
161384603|NCT00984165|582792755|FG001|Overall Study|P+/donor pair removed from protocol|0|||
161384604|NCT00984165|582792756|FG002|Overall Study|P+/donor pair removed from protocol|0|||
161384605|NCT00984165|582792757|FG003|Overall Study|P+/donor pair removed from protocol|1|||
161384606|NCT00984165|582792754|FG000|Overall Study|removed with a pair recipient|0|||
161384607|NCT00984165|582792755|FG001|Overall Study|removed with a pair recipient|0|||
161384608|NCT00984165|582792756|FG002|Overall Study|removed with a pair recipient|0|||
161384609|NCT00984165|582792757|FG003|Overall Study|removed with a pair recipient|1|||
161384610|NCT01309997|582792758|FG000|Overall Study|Adverse Event|1|||
161384611|NCT01309997|582792759|FG001|Overall Study|Adverse Event|0|||
161384612|NCT01309997|582792758|FG000|Overall Study|Death|1|||
161384613|NCT01309997|582792759|FG001|Overall Study|Death|3|||
161384614|NCT01309997|582792758|FG000|Overall Study|Lack of Efficacy|2|||
161384615|NCT01309997|582792759|FG001|Overall Study|Lack of Efficacy|2|||
161384616|NCT01309997|582792758|FG000|Overall Study|Withdrawal by Subject|1|||
161384617|NCT01309997|582792759|FG001|Overall Study|Withdrawal by Subject|1|||
161384618|NCT01532921|582792760|FG000|Overall Study|Death|3|||
161384619|NCT01532921|582792760|FG000|Overall Study|Withdrawal by Subject|2|||
161384620|NCT01532921|582792760|FG000|Overall Study|Lost to Follow-up|3|||
161384621|NCT01532921|582792760|FG000|Overall Study|Physician Decision|7|||
161384622|NCT01532921|582792760|FG000|Overall Study|Device was explanted during procedure|1|||
161384623|NCT01390298|582792761|FG000|Overall Study|Death|1|||
161384624|NCT01390298|582792761|FG000|Overall Study|long term ICU admission|1|||
161384625|NCT01390298|582792761|FG000|Overall Study|Withdrawal by Subject|14|||
161384626|NCT01390298|582792761|FG000|Overall Study|Lost to Follow-up|7|||
161384627|NCT01390298|582792761|FG000|Overall Study|Surgery cancelled|1|||
161384628|NCT00066222|582792770|FG000|Overall Study|No protocol treatment received|1|||
161384629|NCT00635349|582792771|FG000|Overall Study|Other|8|||
161384630|NCT00635349|582792772|FG001|Overall Study|Other|6|||
161384631|NCT00635349|582792771|FG000|Overall Study|Protocol Violation|18|||
161384632|NCT00635349|582792772|FG001|Overall Study|Protocol Violation|22|||
161384633|NCT00635349|582792771|FG000|Overall Study|Withdrawal by Subject|3|||
161384634|NCT00635349|582792772|FG001|Overall Study|Withdrawal by Subject|8|||
161384635|NCT00635349|582792771|FG000|Overall Study|Lost to Follow-up|4|||
161384636|NCT00635349|582792772|FG001|Overall Study|Lost to Follow-up|3|||
161384637|NCT00635349|582792771|FG000|Overall Study|Adverse Event|11|||
161384638|NCT00635349|582792772|FG001|Overall Study|Adverse Event|9|||
161384639|NCT05420961|582792783|FG000|Overall Study|Withdrawal by Subject|2|||
161384640|NCT05420961|582792784|FG001|Overall Study|Withdrawal by Subject|1|||
161384641|NCT05420961|582792785|FG002|Overall Study|Withdrawal by Subject|1|||
161384642|NCT05420961|582792786|FG003|Overall Study|Withdrawal by Subject|0|||
161384643|NCT05420961|582792787|FG004|Overall Study|Withdrawal by Subject|0|||
161384644|NCT05420961|582792783|FG000|Overall Study|Lost to Follow-up|0|||
161384645|NCT05420961|582792784|FG001|Overall Study|Lost to Follow-up|0|||
161384646|NCT05420961|582792785|FG002|Overall Study|Lost to Follow-up|1|||
161384647|NCT05420961|582792786|FG003|Overall Study|Lost to Follow-up|0|||
161384648|NCT05420961|582792787|FG004|Overall Study|Lost to Follow-up|0|||
161384649|NCT05420961|582792783|FG000|Overall Study|Randomized by mistake without study treatment|0|||
161384650|NCT05420961|582792784|FG001|Overall Study|Randomized by mistake without study treatment|0|||
161384651|NCT05420961|582792785|FG002|Overall Study|Randomized by mistake without study treatment|1|||
161384652|NCT05420961|582792786|FG003|Overall Study|Randomized by mistake without study treatment|0|||
161384653|NCT05420961|582792787|FG004|Overall Study|Randomized by mistake without study treatment|1|||
161384654|NCT04283656|582792788|FG000|Overall Study|Adverse Event|1|||
161384655|NCT04283656|582792789|FG001|Overall Study|Adverse Event|0|||
161384656|NCT04283656|582792788|FG000|Overall Study|Lost to Follow-up|0|||
161384657|NCT04283656|582792789|FG001|Overall Study|Lost to Follow-up|1|||
161384658|NCT00803361|582792790|FG000|Overall Study|Adverse Event|13|||
161384659|NCT00803361|582792791|FG001|Overall Study|Adverse Event|3|||
161384660|NCT00803361|582792790|FG000|Overall Study|Lack of Efficacy|4|||
161384661|NCT00803361|582792791|FG001|Overall Study|Lack of Efficacy|13|||
161384662|NCT00803361|582792790|FG000|Overall Study|Lost to Follow-up|1|||
161384663|NCT00803361|582792791|FG001|Overall Study|Lost to Follow-up|2|||
161384664|NCT00803361|582792790|FG000|Overall Study|Physician Decision|1|||
161384665|NCT00803361|582792791|FG001|Overall Study|Physician Decision|0|||
161384666|NCT00803361|582792790|FG000|Overall Study|Protocol Violation|2|||
161384667|NCT00803361|582792791|FG001|Overall Study|Protocol Violation|4|||
161384668|NCT00803361|582792790|FG000|Overall Study|Withdrawal by Subject|5|||
161384669|NCT00803361|582792791|FG001|Overall Study|Withdrawal by Subject|6|||
161384670|NCT04445519|582792792|FG000|Overall Study|Due to adaptive design|3|||
161384671|NCT04445519|582792793|FG001|Overall Study|Due to adaptive design|0|||
161384672|NCT04445519|582792794|FG002|Overall Study|Due to adaptive design|0|||
161384673|NCT04445519|582792792|FG000|Overall Study|Lost to Follow-up|0|||
161384674|NCT04445519|582792793|FG001|Overall Study|Lost to Follow-up|1|||
161384675|NCT04445519|582792794|FG002|Overall Study|Lost to Follow-up|4|||
161384676|NCT04445519|582792792|FG000|Overall Study|Sponsor or IRB Decision|0|||
161384677|NCT04445519|582792793|FG001|Overall Study|Sponsor or IRB Decision|1|||
161384678|NCT04445519|582792794|FG002|Overall Study|Sponsor or IRB Decision|2|||
161384679|NCT04445519|582792792|FG000|Overall Study|Withdrawal by Subject|0|||
161384680|NCT04445519|582792793|FG001|Overall Study|Withdrawal by Subject|3|||
161384681|NCT04445519|582792794|FG002|Overall Study|Withdrawal by Subject|3|||
161384682|NCT04445519|582792792|FG000|Overall Study|Adverse Event|0|||
161384683|NCT04445519|582792793|FG001|Overall Study|Adverse Event|8|||
161384684|NCT04445519|582792794|FG002|Overall Study|Adverse Event|6|||
161384685|NCT04445519|582792792|FG000|Overall Study|Other Reason|0|||
161384686|NCT04445519|582792793|FG001|Overall Study|Other Reason|1|||
161384687|NCT04445519|582792794|FG002|Overall Study|Other Reason|1|||
161384688|NCT04445519|582792792|FG000|Overall Study|Protocol Violation|0|||
161384689|NCT04445519|582792793|FG001|Overall Study|Protocol Violation|0|||
161384690|NCT04445519|582792794|FG002|Overall Study|Protocol Violation|1|||
161384691|NCT04482439|582792799|FG000|Overall Study|Lost to Follow-up|1|||
161384692|NCT04482439|582792799|FG000|Overall Study|Unrelated illness|1|||
161384693|NCT03072043|582792800|FG000|Overall Study|Death|0|||
161384694|NCT03072043|582792801|FG001|Overall Study|Death|0|||
161384695|NCT03072043|582792802|FG002|Overall Study|Death|3|||
161384696|NCT03072043|582792800|FG000|Overall Study|Adverse Event|0|||
161384697|NCT03072043|582792801|FG001|Overall Study|Adverse Event|0|||
161384698|NCT03072043|582792802|FG002|Overall Study|Adverse Event|2|||
161384699|NCT03072043|582792800|FG000|Overall Study|Withdrawal by Subject|0|||
161384700|NCT03072043|582792801|FG001|Overall Study|Withdrawal by Subject|0|||
161384701|NCT03072043|582792802|FG002|Overall Study|Withdrawal by Subject|4|||
161384702|NCT00645840|582792803|FG000|Overall Study|Protocol Violation|3|||
161384703|NCT02625220|582792804|FG000|Overall Study|Adverse Event|2|||
161384704|NCT02625220|582792804|FG000|Overall Study|Lost to Follow-up|2|||
161384705|NCT02625220|582792804|FG000|Overall Study|Protocol Violation|1|||
161384706|NCT02625220|582792804|FG000|Overall Study|Study discontinued at site|2|||
161384707|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
161384708|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
161384709|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
161384710|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
161384711|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
161384712|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
161384713|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
161384714|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
161384715|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
161384716|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
161384717|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
161384718|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
161384719|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
161384720|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
161384721|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
161384722|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
161384723|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
161384724|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
161384725|NCT03162796|582792807|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
161384726|NCT03162796|582792808|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
161384727|NCT03162796|582792809|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
161384728|NCT03162796|582792807|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
161384729|NCT03162796|582792808|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
161384730|NCT03162796|582792809|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
161384731|NCT03162796|582792807|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
161384732|NCT03162796|582792808|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
161384733|NCT03162796|582792809|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
161384734|NCT03162796|582792807|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
161384735|NCT03162796|582792808|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
161384736|NCT03162796|582792809|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
161384737|NCT03162796|582792807|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
161384738|NCT03162796|582792808|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
161384739|NCT03162796|582792809|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
161384740|NCT02342288|582792810|FG000|Overall Study|no protocol anesthesiologist available|3|||
161384741|NCT02342288|582792811|FG001|Overall Study|no protocol anesthesiologist available|2|||
161384742|NCT02342288|582792810|FG000|Overall Study|anesthesia leak in system|1|||
161384743|NCT02342288|582792811|FG001|Overall Study|anesthesia leak in system|0|||
161384744|NCT02342288|582792810|FG000|Overall Study|Withdrawal by Subject|1|||
161384745|NCT02342288|582792811|FG001|Overall Study|Withdrawal by Subject|0|||
161384746|NCT02342288|582792810|FG000|Overall Study|coordinator contaminated with blood|0|||
161384747|NCT02342288|582792811|FG001|Overall Study|coordinator contaminated with blood|1|||
161384748|NCT02342288|582792810|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
161384749|NCT02342288|582792811|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
161384750|NCT02342288|582792810|FG000|Overall Study|coordinator not available|0|||
161384751|NCT02342288|582792811|FG001|Overall Study|coordinator not available|2|||
161384752|NCT02375373|582792813|FG000|Overall Study|Withdrawal by Subject|11|||
161384753|NCT02725476|582792814|FG000|Overall Study|Physician Decision|2|||
161384754|NCT02725476|582792815|FG001|Overall Study|Physician Decision|0|||
161384755|NCT02725476|582792814|FG000|Overall Study|Adverse Event|1|||
161384756|NCT02725476|582792815|FG001|Overall Study|Adverse Event|1|||
161384757|NCT00289289|582792817|FG000|Overall Study|Withdrawal by Subject|5|||
161384758|NCT00289289|582792818|FG001|Overall Study|Withdrawal by Subject|3|||
161384759|NCT00289289|582792819|FG002|Overall Study|Withdrawal by Subject|15|||
161384760|NCT00289289|582792817|FG000|Overall Study|Lost to Follow-up|1|||
161384761|NCT00289289|582792818|FG001|Overall Study|Lost to Follow-up|0|||
161384762|NCT00289289|582792819|FG002|Overall Study|Lost to Follow-up|1|||
161384763|NCT00289289|582792817|FG000|Overall Study|Death|4|||
161384764|NCT00289289|582792818|FG001|Overall Study|Death|2|||
161384765|NCT00289289|582792819|FG002|Overall Study|Death|5|||
161384766|NCT00289289|582792817|FG000|Overall Study|No implant attempted|0|||
161384767|NCT00289289|582792818|FG001|Overall Study|No implant attempted|0|||
161384768|NCT00289289|582792819|FG002|Overall Study|No implant attempted|1|||
161384769|NCT00289289|582792817|FG000|Overall Study|Physician Decision|1|||
161384770|NCT00289289|582792818|FG001|Overall Study|Physician Decision|0|||
161384771|NCT00289289|582792819|FG002|Overall Study|Physician Decision|6|||
161384772|NCT00289289|582792817|FG000|Overall Study|Non-study device implanted|2|||
161384773|NCT00289289|582792818|FG001|Overall Study|Non-study device implanted|1|||
161384774|NCT00289289|582792819|FG002|Overall Study|Non-study device implanted|3|||
161384775|NCT00289289|582792817|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
161384776|NCT00289289|582792818|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
161384777|NCT00289289|582792819|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
161384778|NCT00289289|582792817|FG000|Overall Study|Other Exit Reason|6|||
161384779|NCT00289289|582792818|FG001|Overall Study|Other Exit Reason|4|||
161384780|NCT00289289|582792819|FG002|Overall Study|Other Exit Reason|12|||
161384781|NCT01445613|582792820|FG000|30-day Follow-up|Withdrawal by Subject|6|||
161384782|NCT01445613|582792820|FG000|30-day Follow-up|Physician Decision|3|||
161384783|NCT01445613|582792820|FG000|30-day Follow-up|Missed visit|23|||
161384784|NCT01445613|582792820|FG000|30-day Follow-up|Death|3|||
161384785|NCT01445613|582792820|FG000|1-year Follow-up|Withdrawal by Subject|12|||
161384786|NCT01445613|582792820|FG000|1-year Follow-up|Missed visit|29|||
161384787|NCT01445613|582792820|FG000|1-year Follow-up|Lost to Follow-up|2|||
161384788|NCT01445613|582792820|FG000|1-year Follow-up|Death|30|||
161384789|NCT01445613|582792820|FG000|1-year Follow-up|Physician Decision|2|||
161384790|NCT01445613|582792820|FG000|1-year Follow-up|Received a non-study stent|2|||
161384791|NCT01169701|582792821|FG000|Overall Study|Lost to Follow-up|1|||
161384792|NCT01169701|582792822|FG001|Overall Study|Lost to Follow-up|1|||
161384793|NCT01169701|582792821|FG000|Overall Study|Withdrawal by Subject|1|||
161384794|NCT01169701|582792822|FG001|Overall Study|Withdrawal by Subject|3|||
161384795|NCT01169701|582792821|FG000|Overall Study|Adverse Event|1|||
161384796|NCT01169701|582792822|FG001|Overall Study|Adverse Event|2|||
161384797|NCT01169701|582792821|FG000|Overall Study|Exclusion criteria|2|||
161384798|NCT01169701|582792822|FG001|Overall Study|Exclusion criteria|0|||
161384799|NCT01169701|582792821|FG000|Overall Study|Death|0|||
161384800|NCT01169701|582792822|FG001|Overall Study|Death|1|||
161384801|NCT01169701|582792821|FG000|Overall Study|Administrative problems|0|||
161384802|NCT01169701|582792822|FG001|Overall Study|Administrative problems|1|||
161384803|NCT01169701|582792821|FG000|Overall Study|Serious adverse event|0|||
161384804|NCT01169701|582792822|FG001|Overall Study|Serious adverse event|1|||
161384805|NCT01169701|582792821|FG000|Overall Study|Sponsor decision|0|||
161384806|NCT01169701|582792822|FG001|Overall Study|Sponsor decision|1|||
161384807|NCT02455336|582792825|FG000|Overall Study|Withdrawal by Subject|0|||
161384808|NCT02455336|582792826|FG001|Overall Study|Withdrawal by Subject|2|||
161384809|NCT02455336|582792825|FG000|Overall Study|Adverse Event|3|||
161384810|NCT02455336|582792826|FG001|Overall Study|Adverse Event|0|||
161384811|NCT02455336|582792825|FG000|Overall Study|Non-responder to treatment|2|||
161384812|NCT02455336|582792826|FG001|Overall Study|Non-responder to treatment|0|||
161384813|NCT00391430|582792827|FG000|Overall Study|Withdrawal by Subject|3|||
161384814|NCT00391430|582792828|FG001|Overall Study|Withdrawal by Subject|0|||
161384815|NCT00391430|582792829|FG002|Overall Study|Withdrawal by Subject|12|||
161384816|NCT03299244|582792830|FG000|Overall Study|Withdrawal by Subject|34|||
161384817|NCT03299244|582792831|FG001|Overall Study|Withdrawal by Subject|29|||
161384818|NCT03299244|582792830|FG000|Overall Study|Decision by Sponsor|4|||
161384819|NCT03299244|582792831|FG001|Overall Study|Decision by Sponsor|5|||
161384820|NCT03299244|582792830|FG000|Overall Study|Death|9|||
161384821|NCT03299244|582792831|FG001|Overall Study|Death|4|||
161384822|NCT00130039|582792836|FG000|Overall Study|Withdrawal by Subject|15|||
161384823|NCT00130039|582792837|FG001|Overall Study|Withdrawal by Subject|11|||
161384824|NCT00130039|582792836|FG000|Overall Study|Lost to Follow-up|3|||
161384825|NCT00130039|582792837|FG001|Overall Study|Lost to Follow-up|1|||
161384826|NCT00130039|582792836|FG000|Overall Study|Adverse Event|4|||
161384827|NCT00130039|582792837|FG001|Overall Study|Adverse Event|2|||
161384828|NCT00130039|582792836|FG000|Overall Study|Physician Decision|3|||
161384829|NCT00130039|582792837|FG001|Overall Study|Physician Decision|0|||
161384830|NCT00130039|582792836|FG000|Overall Study|clinical events without follow up MRI|5|||
161384831|NCT00130039|582792837|FG001|Overall Study|clinical events without follow up MRI|4|||
161384832|NCT01740687|582792838|FG000|Overall Study|Lost to Follow-up|11|||
161384833|NCT01740687|582792838|FG000|Overall Study|Withdrawal by Subject|2|||
161384834|NCT01740687|582792838|FG000|Overall Study|other reason|22|||
161384835|NCT01740687|582792838|FG000|Overall Study|treatment not received|2|||
161384836|NCT00200967|582792840|FG000|First Treatment Period|Withdrawal by Subject|5|||
161384837|NCT00200967|582792841|FG001|First Treatment Period|Withdrawal by Subject|1|||
161384838|NCT00200967|582792840|FG000|First Treatment Period|Pregnancy|1|||
161384839|NCT00200967|582792841|FG001|First Treatment Period|Pregnancy|0|||
161384840|NCT00200967|582792840|FG000|Wash-out Period|Lost to Follow-up|0|||
161384841|NCT00200967|582792841|FG001|Wash-out Period|Lost to Follow-up|1|||
161384842|NCT00200967|582792840|FG000|Second Treatment Period|Withdrawal by Subject|1|||
161384843|NCT00200967|582792841|FG001|Second Treatment Period|Withdrawal by Subject|2|||
161384844|NCT00200967|582792840|FG000|Run-out Period|Lost to Follow-up|1|||
161384845|NCT00200967|582792841|FG001|Run-out Period|Lost to Follow-up|0|||
161384846|NCT00064259|582794581|FG000|Overall Study|Adverse Event|1|||
161384847|NCT00064259|582794582|FG001|Overall Study|Adverse Event|0|||
161384848|NCT00064259|582794583|FG002|Overall Study|Adverse Event|0|||
161384849|NCT00064259|582794584|FG003|Overall Study|Adverse Event|1|||
161384850|NCT00078806|582794588|FG000|Part 1A|Adverse Event|2|||
161384851|NCT00078806|582794589|FG001|Part 1A|Adverse Event|0|||
161384852|NCT00078806|582794590|FG002|Part 1A|Adverse Event|0|||
161384853|NCT00078806|582794591|FG003|Part 1A|Adverse Event|0|||
161384854|NCT00078806|582794588|FG000|Part 1A|Lack of Efficacy|7|||
161384855|NCT00078806|582794589|FG001|Part 1A|Lack of Efficacy|0|||
161384856|NCT00078806|582794590|FG002|Part 1A|Lack of Efficacy|0|||
161384857|NCT00078806|582794591|FG003|Part 1A|Lack of Efficacy|0|||
161384858|NCT00078806|582794588|FG000|Part 1A|Other|1|||
161384859|NCT00078806|582794589|FG001|Part 1A|Other|0|||
161384860|NCT00078806|582794590|FG002|Part 1A|Other|0|||
161384861|NCT00078806|582794591|FG003|Part 1A|Other|0|||
161384862|NCT00078806|582794588|FG000|Part 1B|Adverse Event|1|||
161384863|NCT00078806|582794589|FG001|Part 1B|Adverse Event|0|||
161384864|NCT00078806|582794590|FG002|Part 1B|Adverse Event|0|||
161384865|NCT00078806|582794591|FG003|Part 1B|Adverse Event|0|||
161384866|NCT00078806|582794588|FG000|Part 1B|Lack of Efficacy|7|||
161384867|NCT00078806|582794589|FG001|Part 1B|Lack of Efficacy|0|||
161384868|NCT00078806|582794590|FG002|Part 1B|Lack of Efficacy|0|||
161384869|NCT00078806|582794591|FG003|Part 1B|Lack of Efficacy|0|||
161384870|NCT00078806|582794588|FG000|Part 2|Adverse Event|0|||
161384871|NCT00078806|582794589|FG001|Part 2|Adverse Event|1|||
161384872|NCT00078806|582794590|FG002|Part 2|Adverse Event|0|||
161384873|NCT00078806|582794591|FG003|Part 2|Adverse Event|0|||
161384874|NCT00161616|582794592|FG000|Overall Study|Withdrawal by Subject|6|||
161384875|NCT00161616|582794593|FG001|Overall Study|Withdrawal by Subject|5|||
161384876|NCT00161616|582794592|FG000|Overall Study|Physician Decision|1|||
161384877|NCT00161616|582794593|FG001|Overall Study|Physician Decision|0|||
161384878|NCT00161616|582794592|FG000|Overall Study|Death|1|||
161384879|NCT00161616|582794593|FG001|Overall Study|Death|1|||
161384880|NCT00161616|582794592|FG000|Overall Study|Lost to Follow-up|17|||
161384881|NCT00161616|582794593|FG001|Overall Study|Lost to Follow-up|13|||
161384882|NCT00161616|582794592|FG000|Overall Study|Protocol deviation|1|||
161384883|NCT00161616|582794593|FG001|Overall Study|Protocol deviation|0|||
161384884|NCT00861757|582794594|FG000|Overall Study|Adverse Event|1|||
161384885|NCT00861757|582794595|FG001|Overall Study|Adverse Event|5|||
161384886|NCT00861757|582794596|FG002|Overall Study|Adverse Event|7|||
161384887|NCT00861757|582794597|FG003|Overall Study|Adverse Event|2|||
161384888|NCT00861757|582794594|FG000|Overall Study|Entry Criteria Not Met|1|||
161384889|NCT00861757|582794595|FG001|Overall Study|Entry Criteria Not Met|2|||
161384890|NCT00861757|582794596|FG002|Overall Study|Entry Criteria Not Met|1|||
161384891|NCT00861757|582794597|FG003|Overall Study|Entry Criteria Not Met|1|||
161384892|NCT00861757|582794594|FG000|Overall Study|Lack of Efficacy|3|||
161384893|NCT00861757|582794595|FG001|Overall Study|Lack of Efficacy|1|||
161384894|NCT00861757|582794596|FG002|Overall Study|Lack of Efficacy|0|||
161384895|NCT00861757|582794597|FG003|Overall Study|Lack of Efficacy|1|||
161384896|NCT00861757|582794594|FG000|Overall Study|Lost to Follow-up|1|||
161384897|NCT00861757|582794595|FG001|Overall Study|Lost to Follow-up|0|||
161384898|NCT00861757|582794596|FG002|Overall Study|Lost to Follow-up|1|||
161384899|NCT00861757|582794597|FG003|Overall Study|Lost to Follow-up|1|||
161384900|NCT00861757|582794594|FG000|Overall Study|Physician Decision|0|||
161384901|NCT00861757|582794595|FG001|Overall Study|Physician Decision|0|||
161384902|NCT00861757|582794596|FG002|Overall Study|Physician Decision|0|||
161384903|NCT00861757|582794597|FG003|Overall Study|Physician Decision|1|||
161384904|NCT00861757|582794594|FG000|Overall Study|Protocol Violation|2|||
161384905|NCT00861757|582794595|FG001|Overall Study|Protocol Violation|2|||
161384906|NCT00861757|582794596|FG002|Overall Study|Protocol Violation|4|||
161384907|NCT00861757|582794597|FG003|Overall Study|Protocol Violation|1|||
161384908|NCT00861757|582794594|FG000|Overall Study|Withdrawal by Subject|1|||
161384909|NCT00861757|582794595|FG001|Overall Study|Withdrawal by Subject|5|||
161384910|NCT00861757|582794596|FG002|Overall Study|Withdrawal by Subject|5|||
161384911|NCT00861757|582794597|FG003|Overall Study|Withdrawal by Subject|2|||
161384912|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
161384913|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
161384914|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
161384915|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
161384916|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
161384917|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
161384918|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
161384919|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
161384920|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
161384921|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
161384922|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
161384923|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
161384924|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
161384925|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
161384926|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
161384927|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
161384928|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
161384929|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
161384930|NCT03308968|582794598|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
161384931|NCT03308968|582794599|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
161384932|NCT03308968|582794600|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
161384933|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
161384934|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
161384935|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
161384936|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
161384937|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
161384938|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
161384939|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
161384940|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
161384941|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
161384942|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
161384943|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
161384944|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
161384945|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
161384946|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
161384947|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
161384948|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
161384949|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
161384950|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
161384951|NCT03308968|582794598|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
161384952|NCT03308968|582794599|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
161384953|NCT03308968|582794600|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
161384954|NCT01521923|582794606|FG000|Overall Study|AE, serious fatal|1|||
161384955|NCT01521923|582794607|FG001|Overall Study|AE, serious fatal|0|||
161384956|NCT01521923|582794608|FG002|Overall Study|AE, serious fatal|0|||
161384957|NCT01521923|582794609|FG003|Overall Study|AE, serious fatal|0|||
161384958|NCT01521923|582794606|FG000|Overall Study|SAE, non-fatal|0|||
161384959|NCT01521923|582794607|FG001|Overall Study|SAE, non-fatal|2|||
161384960|NCT01521923|582794608|FG002|Overall Study|SAE, non-fatal|2|||
161384961|NCT01521923|582794609|FG003|Overall Study|SAE, non-fatal|0|||
161384962|NCT01521923|582794606|FG000|Overall Study|AE, non-serious, non-fatal|1|||
161384963|NCT01521923|582794607|FG001|Overall Study|AE, non-serious, non-fatal|3|||
161384964|NCT01521923|582794608|FG002|Overall Study|AE, non-serious, non-fatal|6|||
161384965|NCT01521923|582794609|FG003|Overall Study|AE, non-serious, non-fatal|2|||
161384966|NCT01521923|582794606|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
161384967|NCT01521923|582794607|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
161384968|NCT01521923|582794608|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
161384969|NCT01521923|582794609|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
161384970|NCT01521923|582794606|FG000|Overall Study|Lack of Efficacy|1|||
161384971|NCT01521923|582794607|FG001|Overall Study|Lack of Efficacy|1|||
161384972|NCT01521923|582794608|FG002|Overall Study|Lack of Efficacy|0|||
161384973|NCT01521923|582794609|FG003|Overall Study|Lack of Efficacy|0|||
161384974|NCT01521923|582794606|FG000|Overall Study|Protocol Violation|0|||
161384975|NCT01521923|582794607|FG001|Overall Study|Protocol Violation|0|||
161384976|NCT01521923|582794608|FG002|Overall Study|Protocol Violation|1|||
161384977|NCT01521923|582794609|FG003|Overall Study|Protocol Violation|0|||
161384978|NCT01521923|582794606|FG000|Overall Study|Lost to Follow-up|1|||
161384979|NCT01521923|582794607|FG001|Overall Study|Lost to Follow-up|0|||
161384980|NCT01521923|582794608|FG002|Overall Study|Lost to Follow-up|2|||
161384981|NCT01521923|582794609|FG003|Overall Study|Lost to Follow-up|1|||
161384982|NCT01521923|582794606|FG000|Overall Study|Withdrawal by Subject|1|||
161384983|NCT01521923|582794607|FG001|Overall Study|Withdrawal by Subject|1|||
161384984|NCT01521923|582794608|FG002|Overall Study|Withdrawal by Subject|1|||
161384985|NCT01521923|582794609|FG003|Overall Study|Withdrawal by Subject|2|||
161384986|NCT01521923|582794606|FG000|Overall Study|Other|2|||
161384987|NCT01521923|582794607|FG001|Overall Study|Other|1|||
161384988|NCT01521923|582794608|FG002|Overall Study|Other|3|||
161384989|NCT01521923|582794609|FG003|Overall Study|Other|6|||
161384990|NCT01521923|582794606|FG000|Overall Study|AE, captured in Period 1|0|||
161384991|NCT01521923|582794607|FG001|Overall Study|AE, captured in Period 1|1|||
161384992|NCT01521923|582794608|FG002|Overall Study|AE, captured in Period 1|0|||
161384993|NCT01521923|582794609|FG003|Overall Study|AE, captured in Period 1|1|||
161384994|NCT03037476|582794610|FG000|Overall Study|Lost to Follow-up|63|||
161384995|NCT03037476|582794611|FG001|Overall Study|Lost to Follow-up|46|||
161384996|NCT02141633|582794612|FG000|Overall Study|Physician Decision|1|||
161384997|NCT02141633|582794613|FG001|Overall Study|Physician Decision|0|||
161384998|NCT02403817|582794614|FG000|Overall Study|Withdrawal by Subject|5|||
161384999|NCT02403817|582794615|FG001|Overall Study|Withdrawal by Subject|0|||
161385000|NCT04908384|582794621|FG000|Overall Study|Lost to Follow-up|4|||
161385001|NCT04908384|582794622|FG001|Overall Study|Lost to Follow-up|4|||
161385002|NCT04908384|582794623|FG002|Overall Study|Lost to Follow-up|0|||
161385003|NCT04908384|582794624|FG003|Overall Study|Lost to Follow-up|0|||
161385004|NCT00833469|582794625|FG000|Overall Study|Withdrawal by Subject|1|||
161385005|NCT00833469|582794625|FG000|Overall Study|Lost to Follow-up|1|||
161385006|NCT02943070|582794626|FG000|Overall Study|Physician Decision|1|||
161385007|NCT02943070|582794626|FG000|Overall Study|Adverse Event|2|||
161385008|NCT02943070|582794626|FG000|Overall Study|Death|2|||
161385009|NCT02943070|582794626|FG000|Overall Study|Withdrawal by Subject|3|||
161385010|NCT02943070|582794626|FG000|Overall Study|Lost to Follow-up|4|||
161385011|NCT02943070|582794626|FG000|Overall Study|Retreatment or TURP|13|||
161385012|NCT02943070|582794626|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
161385013|NCT01701362|582794627|FG000|Overall Study|Adverse events not related to study drug|1|||
161385014|NCT01701362|582794628|FG001|Overall Study|Adverse events not related to study drug|6|||
161385015|NCT01701362|582794627|FG000|Overall Study|Adverse events related to study drug|12|||
161385016|NCT01701362|582794628|FG001|Overall Study|Adverse events related to study drug|10|||
161385017|NCT01701362|582794627|FG000|Overall Study|Protocol Violation|5|||
161385018|NCT01701362|582794628|FG001|Overall Study|Protocol Violation|3|||
161385019|NCT01701362|582794627|FG000|Overall Study|No longer willing to participate|8|||
161385020|NCT01701362|582794628|FG001|Overall Study|No longer willing to participate|14|||
161385021|NCT01701362|582794627|FG000|Overall Study|Lost to Follow-up|6|||
161385022|NCT01701362|582794628|FG001|Overall Study|Lost to Follow-up|9|||
161385023|NCT01701362|582794627|FG000|Overall Study|Insufficient clinical response|6|||
161385024|NCT01701362|582794628|FG001|Overall Study|Insufficient clinical response|6|||
161385025|NCT01701362|582794627|FG000|Overall Study|Death|0|||
161385026|NCT01701362|582794628|FG001|Overall Study|Death|1|||
161385027|NCT01701362|582794627|FG000|Overall Study|Randomized but not treated|1|||
161385028|NCT01701362|582794628|FG001|Overall Study|Randomized but not treated|2|||
161385029|NCT01701362|582794627|FG000|Overall Study|Reasons other than those mentioned above|3|||
161385030|NCT01701362|582794628|FG001|Overall Study|Reasons other than those mentioned above|5|||
161385031|NCT00570778|582794629|FG000|Overall Study|Protocol deviation|2|||
161385032|NCT00570778|582794630|FG001|Overall Study|Protocol deviation|1|||
161385033|NCT00570778|582794631|FG002|Overall Study|Protocol deviation|2|||
161385034|NCT00570778|582794632|FG003|Overall Study|Protocol deviation|2|||
161385035|NCT00570778|582794629|FG000|Overall Study|Adverse Event|0|||
161385036|NCT00570778|582794630|FG001|Overall Study|Adverse Event|1|||
161385037|NCT00570778|582794631|FG002|Overall Study|Adverse Event|4|||
161385038|NCT00570778|582794632|FG003|Overall Study|Adverse Event|1|||
161385039|NCT00570778|582794629|FG000|Overall Study|Subject withdrew consent|0|||
161385040|NCT00570778|582794630|FG001|Overall Study|Subject withdrew consent|1|||
161385041|NCT00570778|582794631|FG002|Overall Study|Subject withdrew consent|0|||
161385042|NCT00570778|582794632|FG003|Overall Study|Subject withdrew consent|1|||
161385043|NCT00570778|582794629|FG000|Overall Study|Abnormal test procedure|1|||
161385044|NCT00570778|582794630|FG001|Overall Study|Abnormal test procedure|0|||
161385045|NCT00570778|582794631|FG002|Overall Study|Abnormal test procedure|0|||
161385046|NCT00570778|582794632|FG003|Overall Study|Abnormal test procedure|0|||
161385047|NCT00570778|582794629|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161385048|NCT00570778|582794630|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161385049|NCT00570778|582794631|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161385050|NCT00570778|582794632|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161385051|NCT00570778|582794629|FG000|Overall Study|Lost to Follow-up|0|||
161385052|NCT00570778|582794630|FG001|Overall Study|Lost to Follow-up|0|||
161385053|NCT00570778|582794631|FG002|Overall Study|Lost to Follow-up|1|||
161385054|NCT00570778|582794632|FG003|Overall Study|Lost to Follow-up|0|||
161385055|NCT00570778|582794629|FG000|Overall Study|Subject no longer requires study drug|0|||
161385056|NCT00570778|582794630|FG001|Overall Study|Subject no longer requires study drug|1|||
161385057|NCT00570778|582794631|FG002|Overall Study|Subject no longer requires study drug|0|||
161385058|NCT00570778|582794632|FG003|Overall Study|Subject no longer requires study drug|0|||
161385059|NCT00443872|582794635|FG000|Overall Study|Protocol Violation|7|||
161385060|NCT00443872|582794635|FG000|Overall Study|Lost to Follow-up|2|||
161385061|NCT00443872|582794635|FG000|Overall Study|Adverse Event|8|||
161385062|NCT01014767|582794636|FG000|Overall Study|PI left institution, data unavailable|12|||
161385063|NCT01014767|582794637|FG001|Overall Study|PI left institution, data unavailable|1|||
161385064|NCT01014767|582794638|FG002|Overall Study|PI left institution, data unavailable|4|||
161385065|NCT01014767|582794639|FG003|Overall Study|PI left institution, data unavailable|1|||
161385066|NCT00700622|582794640|FG000|Overall Study|Adverse Event|4|||
161385067|NCT00700622|582794641|FG001|Overall Study|Adverse Event|0|||
161385068|NCT00700622|582794640|FG000|Overall Study|Lost to Follow-up|0|||
161385069|NCT00700622|582794641|FG001|Overall Study|Lost to Follow-up|1|||
161385070|NCT00700622|582794640|FG000|Overall Study|Physician Decision|2|||
161385071|NCT00700622|582794641|FG001|Overall Study|Physician Decision|1|||
161385072|NCT00700622|582794640|FG000|Overall Study|Protocol Violation|0|||
161385073|NCT00700622|582794641|FG001|Overall Study|Protocol Violation|1|||
161385074|NCT00700622|582794640|FG000|Overall Study|Withdrawal by Subject|4|||
161385075|NCT00700622|582794641|FG001|Overall Study|Withdrawal by Subject|1|||
161385076|NCT00700622|582794640|FG000|Overall Study|Other|3|||
161385077|NCT00700622|582794641|FG001|Overall Study|Other|1|||
161385078|NCT04474197|582794642|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
161385079|NCT04474197|582794643|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
161385080|NCT04474197|582794644|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
161385081|NCT04474197|582794645|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
161385082|NCT00588237|582794648|FG000|Overall Study|Evaluable for toxicity only|3|||
161385083|NCT00588237|582794648|FG000|Overall Study|Patien not treated|1|||
161385084|NCT00405392|582794652|FG000|Overall Study|Adverse Event|15|||
161385085|NCT00405392|582794653|FG001|Overall Study|Adverse Event|14|||
161385086|NCT00405392|582794652|FG000|Overall Study|Did not meet Eligibility criteria|7|||
161385087|NCT00405392|582794653|FG001|Overall Study|Did not meet Eligibility criteria|2|||
161385088|NCT00405392|582794652|FG000|Overall Study|Withdrawal by Subject|4|||
161385089|NCT00405392|582794653|FG001|Overall Study|Withdrawal by Subject|3|||
161385090|NCT00405392|582794652|FG000|Overall Study|Lost to Follow-up|1|||
161385091|NCT00405392|582794653|FG001|Overall Study|Lost to Follow-up|2|||
161385092|NCT00405392|582794652|FG000|Overall Study|Data missing|2|||
161385093|NCT00405392|582794653|FG001|Overall Study|Data missing|0|||
161385094|NCT00405392|582794652|FG000|Overall Study|Non-compliance|0|||
161385095|NCT00405392|582794653|FG001|Overall Study|Non-compliance|1|||
161385096|NCT00405392|582794652|FG000|Overall Study|Other|1|||
161385097|NCT00405392|582794653|FG001|Overall Study|Other|5|||
161385098|NCT02550288|582794654|FG000|Overall Study|Adverse Event|0|||
161385099|NCT02550288|582794655|FG001|Overall Study|Adverse Event|1|||
161385100|NCT02550288|582794656|FG002|Overall Study|Adverse Event|0|||
161385101|NCT02550288|582794657|FG003|Overall Study|Adverse Event|0|||
161385102|NCT02550288|582794658|FG004|Overall Study|Adverse Event|0|||
161385103|NCT02550288|582794654|FG000|Overall Study|Physician Decision|0|||
161385104|NCT02550288|582794655|FG001|Overall Study|Physician Decision|0|||
161385105|NCT02550288|582794656|FG002|Overall Study|Physician Decision|0|||
161385106|NCT02550288|582794657|FG003|Overall Study|Physician Decision|1|||
161385107|NCT02550288|582794658|FG004|Overall Study|Physician Decision|0|||
161385108|NCT02550288|582794654|FG000|Overall Study|Protocol Violation|2|||
161385109|NCT02550288|582794655|FG001|Overall Study|Protocol Violation|2|||
161385110|NCT02550288|582794656|FG002|Overall Study|Protocol Violation|1|||
161385111|NCT02550288|582794657|FG003|Overall Study|Protocol Violation|0|||
161385112|NCT02550288|582794658|FG004|Overall Study|Protocol Violation|3|||
161385113|NCT02550288|582794654|FG000|Overall Study|Participant moved|0|||
161385114|NCT02550288|582794655|FG001|Overall Study|Participant moved|0|||
161385115|NCT02550288|582794656|FG002|Overall Study|Participant moved|0|||
161385116|NCT02550288|582794657|FG003|Overall Study|Participant moved|1|||
161385117|NCT02550288|582794658|FG004|Overall Study|Participant moved|0|||
161385118|NCT02550288|582794654|FG000|Overall Study|Withdrawal by Subject|0|||
161385119|NCT02550288|582794655|FG001|Overall Study|Withdrawal by Subject|0|||
161385120|NCT02550288|582794656|FG002|Overall Study|Withdrawal by Subject|0|||
161385121|NCT02550288|582794657|FG003|Overall Study|Withdrawal by Subject|1|||
161385122|NCT02550288|582794658|FG004|Overall Study|Withdrawal by Subject|0|||
161385123|NCT01524224|582794661|FG000|Overall Study|Progressive Disease|1|||
161385124|NCT01524224|582794662|FG001|Overall Study|Progressive Disease|0|||
161385125|NCT01524224|582794663|FG002|Overall Study|Progressive Disease|2|||
161385126|NCT01524224|582794664|FG003|Overall Study|Progressive Disease|1|||
161385127|NCT01524224|582794665|FG004|Overall Study|Progressive Disease|2|||
161385128|NCT01524224|582794666|FG005|Overall Study|Progressive Disease|1|||
161385129|NCT01524224|582794667|FG006|Overall Study|Progressive Disease|1|||
161385130|NCT01524224|582794668|FG007|Overall Study|Progressive Disease|5|||
161385131|NCT01524224|582794661|FG000|Overall Study|Withdrawal by Subject|2|||
161385132|NCT01524224|582794662|FG001|Overall Study|Withdrawal by Subject|0|||
161385133|NCT01524224|582794663|FG002|Overall Study|Withdrawal by Subject|0|||
161385134|NCT01524224|582794664|FG003|Overall Study|Withdrawal by Subject|0|||
161385135|NCT01524224|582794665|FG004|Overall Study|Withdrawal by Subject|0|||
161385136|NCT01524224|582794666|FG005|Overall Study|Withdrawal by Subject|0|||
161385137|NCT01524224|582794667|FG006|Overall Study|Withdrawal by Subject|2|||
161385138|NCT01524224|582794668|FG007|Overall Study|Withdrawal by Subject|0|||
161385139|NCT01524224|582794661|FG000|Overall Study|Adverse Event|0|||
161385140|NCT01524224|582794662|FG001|Overall Study|Adverse Event|1|||
161385141|NCT01524224|582794663|FG002|Overall Study|Adverse Event|0|||
161385142|NCT01524224|582794664|FG003|Overall Study|Adverse Event|0|||
161385143|NCT01524224|582794665|FG004|Overall Study|Adverse Event|0|||
161385144|NCT01524224|582794666|FG005|Overall Study|Adverse Event|1|||
161385145|NCT01524224|582794667|FG006|Overall Study|Adverse Event|0|||
161385146|NCT01524224|582794668|FG007|Overall Study|Adverse Event|0|||
161385147|NCT01524224|582794661|FG000|Overall Study|Physician Decision|0|||
161385148|NCT01524224|582794662|FG001|Overall Study|Physician Decision|0|||
161385149|NCT01524224|582794663|FG002|Overall Study|Physician Decision|0|||
161385150|NCT01524224|582794664|FG003|Overall Study|Physician Decision|1|||
161385151|NCT01524224|582794665|FG004|Overall Study|Physician Decision|1|||
161385152|NCT01524224|582794666|FG005|Overall Study|Physician Decision|0|||
161385153|NCT01524224|582794667|FG006|Overall Study|Physician Decision|0|||
161385154|NCT01524224|582794668|FG007|Overall Study|Physician Decision|1|||
161385155|NCT01524224|582794661|FG000|Overall Study|Sponsor Decision|0|||
161385156|NCT01524224|582794662|FG001|Overall Study|Sponsor Decision|0|||
161385157|NCT01524224|582794663|FG002|Overall Study|Sponsor Decision|0|||
161385158|NCT01524224|582794664|FG003|Overall Study|Sponsor Decision|0|||
161385159|NCT01524224|582794665|FG004|Overall Study|Sponsor Decision|1|||
161385160|NCT01524224|582794666|FG005|Overall Study|Sponsor Decision|0|||
161385161|NCT01524224|582794667|FG006|Overall Study|Sponsor Decision|0|||
161385162|NCT01524224|582794668|FG007|Overall Study|Sponsor Decision|0|||
161385163|NCT00988052|582794675|FG000|Overall Study|Missing|1|||
161385164|NCT00988052|582794676|FG001|Overall Study|Missing|0|||
161385165|NCT00988052|582794675|FG000|Overall Study|Teva requested subject withdrawal|3|||
161385166|NCT00988052|582794676|FG001|Overall Study|Teva requested subject withdrawal|1|||
161385167|NCT00988052|582794675|FG000|Overall Study|Death|1|||
161385168|NCT00988052|582794676|FG001|Overall Study|Death|3|||
161385169|NCT00988052|582794675|FG000|Overall Study|Protocol Violation|6|||
161385170|NCT00988052|582794676|FG001|Overall Study|Protocol Violation|5|||
161385171|NCT00988052|582794675|FG000|Overall Study|Pregnancy|6|||
161385172|NCT00988052|582794676|FG001|Overall Study|Pregnancy|6|||
161385173|NCT00988052|582794675|FG000|Overall Study|Lack of Efficacy|8|||
161385174|NCT00988052|582794676|FG001|Overall Study|Lack of Efficacy|7|||
161385175|NCT00988052|582794675|FG000|Overall Study|Lost to Follow-up|6|||
161385176|NCT00988052|582794676|FG001|Overall Study|Lost to Follow-up|11|||
161385177|NCT00988052|582794675|FG000|Overall Study|Physician Decision|27|||
161385178|NCT00988052|582794676|FG001|Overall Study|Physician Decision|28|||
161385179|NCT00988052|582794675|FG000|Overall Study|Adverse Event|35|||
161385180|NCT00988052|582794676|FG001|Overall Study|Adverse Event|28|||
161385181|NCT00988052|582794675|FG000|Overall Study|Withdrawal by Subject|90|||
161385182|NCT00988052|582794676|FG001|Overall Study|Withdrawal by Subject|91|||
161385183|NCT00988052|582794675|FG000|Overall Study|Study terminated by sponsor|240|||
161385184|NCT00988052|582794676|FG001|Overall Study|Study terminated by sponsor|236|||
161385185|NCT05312697|582794677|FG000|Overall Study|Sponsor Terminated Trial|2|||
161385186|NCT02858440|582794678|FG000|Overall Study|Lost to Follow-up|3|||
161385187|NCT02858440|582794678|FG000|Overall Study|Protocol Violation|2|||
161385188|NCT02858440|582794678|FG000|Overall Study|Consent withdrawal|3|||
161385189|NCT02858440|582794678|FG000|Overall Study|Migrated/moved from study area|4|||
161385190|NCT00402324|582794679|FG000|Overall Study|Lost to Follow-up|11|||
161385191|NCT00402324|582794680|FG001|Overall Study|Lost to Follow-up|11|||
161385192|NCT00402324|582794679|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
161385193|NCT00402324|582794680|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
161385194|NCT00402324|582794679|FG000|Overall Study|Protocol Violation|8|||
161385195|NCT00402324|582794680|FG001|Overall Study|Protocol Violation|7|||
161385196|NCT00402324|582794679|FG000|Overall Study|Withdrawal by Subject|5|||
161385197|NCT00402324|582794680|FG001|Overall Study|Withdrawal by Subject|2|||
161385198|NCT00402324|582794679|FG000|Overall Study|Physician Decision|2|||
161385199|NCT00402324|582794680|FG001|Overall Study|Physician Decision|4|||
161385200|NCT00402324|582794679|FG000|Overall Study|Sponsor Decision|4|||
161385201|NCT00402324|582794680|FG001|Overall Study|Sponsor Decision|5|||
161385202|NCT00402324|582794679|FG000|Overall Study|Lack of Efficacy|1|||
161385203|NCT00402324|582794680|FG001|Overall Study|Lack of Efficacy|4|||
161385204|NCT00402324|582794679|FG000|Overall Study|Adverse Event|6|||
161385205|NCT00402324|582794680|FG001|Overall Study|Adverse Event|4|||
161385206|NCT00402324|582794679|FG000|Overall Study|Death|1|||
161385207|NCT00402324|582794680|FG001|Overall Study|Death|0|||
161385208|NCT01277822|582794681|FG000|Overall Study|Adverse Event|2|||
161385209|NCT01277822|582794682|FG001|Overall Study|Adverse Event|1|||
161385210|NCT01277822|582794681|FG000|Overall Study|Withdrawal by Subject|6|||
161385211|NCT01277822|582794682|FG001|Overall Study|Withdrawal by Subject|7|||
161385212|NCT01277822|582794681|FG000|Overall Study|Physician Decision|1|||
161385213|NCT01277822|582794682|FG001|Overall Study|Physician Decision|1|||
161385214|NCT01277822|582794681|FG000|Overall Study|Protocol Violation|1|||
161385215|NCT01277822|582794682|FG001|Overall Study|Protocol Violation|0|||
161385216|NCT01277822|582794681|FG000|Overall Study|Lost to Follow-up|2|||
161385217|NCT01277822|582794682|FG001|Overall Study|Lost to Follow-up|1|||
161385218|NCT01277822|582794681|FG000|Overall Study|Contraindicated medication used|2|||
161385219|NCT01277822|582794682|FG001|Overall Study|Contraindicated medication used|1|||
161385220|NCT01277822|582794681|FG000|Overall Study|Participant moved|1|||
161385221|NCT01277822|582794682|FG001|Overall Study|Participant moved|0|||
161385222|NCT02923531|582794683|FG000|Overall Study|Adverse Event|4|||
161385223|NCT02923531|582794683|FG000|Overall Study|Clinical Deterioration|1|||
161385224|NCT02923531|582794683|FG000|Overall Study|Disease Progression|3|||
161385225|NCT02923531|582794683|FG000|Overall Study|Study Termination|1|||
161385226|NCT00997984|582794684|FG000|Overall Study|Adverse Event|1|||
161385227|NCT00997984|582794685|FG001|Overall Study|Adverse Event|8|||
161385228|NCT00997984|582794686|FG002|Overall Study|Adverse Event|8|||
161385229|NCT00997984|582794684|FG000|Overall Study|Protocol Violation|1|||
161385230|NCT00997984|582794685|FG001|Overall Study|Protocol Violation|3|||
161385231|NCT00997984|582794686|FG002|Overall Study|Protocol Violation|0|||
161385232|NCT00997984|582794684|FG000|Overall Study|Withdrawal by Subject|6|||
161385233|NCT00997984|582794685|FG001|Overall Study|Withdrawal by Subject|9|||
161385234|NCT00997984|582794686|FG002|Overall Study|Withdrawal by Subject|5|||
161385235|NCT00997984|582794684|FG000|Overall Study|Lost to Follow-up|8|||
161385236|NCT00997984|582794685|FG001|Overall Study|Lost to Follow-up|5|||
161385237|NCT00997984|582794686|FG002|Overall Study|Lost to Follow-up|4|||
161385238|NCT00997984|582794684|FG000|Overall Study|Lack of Efficacy|20|||
161385239|NCT00997984|582794685|FG001|Overall Study|Lack of Efficacy|6|||
161385240|NCT00997984|582794686|FG002|Overall Study|Lack of Efficacy|3|||
161385241|NCT00997984|582794684|FG000|Overall Study|Met exclusion criteria|1|||
161385242|NCT00997984|582794685|FG001|Overall Study|Met exclusion criteria|0|||
161385243|NCT00997984|582794686|FG002|Overall Study|Met exclusion criteria|0|||
161385244|NCT00997984|582794684|FG000|Overall Study|non-compliance|0|||
161385245|NCT00997984|582794685|FG001|Overall Study|non-compliance|2|||
161385246|NCT00997984|582794686|FG002|Overall Study|non-compliance|3|||
161385247|NCT00997984|582794684|FG000|Overall Study|Wrong medication dispensed|0|||
161385248|NCT00997984|582794685|FG001|Overall Study|Wrong medication dispensed|1|||
161385249|NCT00997984|582794686|FG002|Overall Study|Wrong medication dispensed|0|||
161385250|NCT00997984|582794684|FG000|Overall Study|Suicidal ideation|0|||
161385251|NCT00997984|582794685|FG001|Overall Study|Suicidal ideation|0|||
161385252|NCT00997984|582794686|FG002|Overall Study|Suicidal ideation|1|||
161385253|NCT00997984|582794684|FG000|Overall Study|Work schedule|0|||
161385254|NCT00997984|582794685|FG001|Overall Study|Work schedule|0|||
161385255|NCT00997984|582794686|FG002|Overall Study|Work schedule|2|||
161385256|NCT02997865|582794688|FG000|Overall Study|Death|2|||
161385257|NCT02997865|582794689|FG001|Overall Study|Death|1|||
161385258|NCT02997865|582794688|FG000|Overall Study|Lost to Follow-up|6|||
161385259|NCT02997865|582794689|FG001|Overall Study|Lost to Follow-up|3|||
161385260|NCT02997865|582794688|FG000|Overall Study|Withdrawal by Subject|5|||
161385261|NCT02997865|582794689|FG001|Overall Study|Withdrawal by Subject|0|||
161385262|NCT01119066|582794690|FG000|Overall Study|Withdrawal by Subject|4|||
161385263|NCT01119066|582794691|FG001|Overall Study|Withdrawal by Subject|6|||
161385264|NCT01119066|582794692|FG002|Overall Study|Withdrawal by Subject|0|||
161385265|NCT01119066|582794693|FG003|Overall Study|Withdrawal by Subject|0|||
161385266|NCT01119066|582794690|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
161385267|NCT01119066|582794691|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
161385268|NCT01119066|582794692|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
161385269|NCT01119066|582794693|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
161385270|NCT01119066|582794690|FG000|Overall Study|Relapse identified before transplant|1|||
161385271|NCT01119066|582794691|FG001|Overall Study|Relapse identified before transplant|0|||
161385272|NCT01119066|582794692|FG002|Overall Study|Relapse identified before transplant|0|||
161385273|NCT01119066|582794693|FG003|Overall Study|Relapse identified before transplant|0|||
161385274|NCT01119066|582794690|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
161385275|NCT01119066|582794691|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
161385276|NCT01119066|582794692|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
161385277|NCT01119066|582794693|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
161385278|NCT01119066|582794690|FG000|Overall Study|Relapse identified before transplant|0|||
161385279|NCT01119066|582794691|FG001|Overall Study|Relapse identified before transplant|4|||
161385280|NCT01119066|582794692|FG002|Overall Study|Relapse identified before transplant|0|||
161385281|NCT01119066|582794693|FG003|Overall Study|Relapse identified before transplant|0|||
161385282|NCT00783835|582794694|FG000|Overall Study|Adverse Event|3|||
161385283|NCT00783835|582794694|FG000|Overall Study|Medical Criteria|1|||
161385284|NCT00783835|582794694|FG000|Overall Study|Withdrawal by Subject|2|||
161385285|NCT00783835|582794694|FG000|Overall Study|Lost to Follow-up|1|||
161385286|NCT00783835|582794694|FG000|Overall Study|Participant not Adherent|3|||
161385287|NCT00295646|582794695|FG000|Overall Study|Protocol Violation|18|||
161385288|NCT00295646|582794696|FG001|Overall Study|Protocol Violation|20|||
161385289|NCT00295646|582794697|FG002|Overall Study|Protocol Violation|20|||
161385290|NCT00295646|582794698|FG003|Overall Study|Protocol Violation|18|||
161385291|NCT00295646|582794695|FG000|Overall Study|Withdrawal by Subject|8|||
161385292|NCT00295646|582794696|FG001|Overall Study|Withdrawal by Subject|9|||
161385293|NCT00295646|582794697|FG002|Overall Study|Withdrawal by Subject|11|||
161385294|NCT00295646|582794698|FG003|Overall Study|Withdrawal by Subject|14|||
161385295|NCT00295646|582794695|FG000|Overall Study|Lost to Follow-up|0|||
161385296|NCT00295646|582794696|FG001|Overall Study|Lost to Follow-up|5|||
161385297|NCT00295646|582794697|FG002|Overall Study|Lost to Follow-up|1|||
161385298|NCT00295646|582794698|FG003|Overall Study|Lost to Follow-up|5|||
161385299|NCT00295646|582794695|FG000|Overall Study|Death|9|||
161385300|NCT00295646|582794696|FG001|Overall Study|Death|7|||
161385301|NCT00295646|582794697|FG002|Overall Study|Death|18|||
161385302|NCT00295646|582794698|FG003|Overall Study|Death|8|||
161385303|NCT01945996|582794699|FG000|Overall Study|Lost to Follow-up|3|||
161385304|NCT01945996|582794700|FG001|Overall Study|Lost to Follow-up|5|||
161385305|NCT03012828|582794702|FG000|Overall Study|Lost to Follow-up|1|||
161385306|NCT03012828|582794703|FG001|Overall Study|Lost to Follow-up|0|||
161385307|NCT03012828|582794704|FG002|Overall Study|Lost to Follow-up|1|||
161385308|NCT03012828|582794705|FG003|Overall Study|Lost to Follow-up|0|||
161385309|NCT03012828|582794706|FG004|Overall Study|Lost to Follow-up|1|||
161385310|NCT03012828|582794707|FG005|Overall Study|Lost to Follow-up|0|||
161385311|NCT03012828|582794702|FG000|Overall Study|Withdrawal by Subject|0|||
161385312|NCT03012828|582794703|FG001|Overall Study|Withdrawal by Subject|0|||
161385313|NCT03012828|582794704|FG002|Overall Study|Withdrawal by Subject|1|||
161385314|NCT03012828|582794705|FG003|Overall Study|Withdrawal by Subject|0|||
161385315|NCT03012828|582794706|FG004|Overall Study|Withdrawal by Subject|0|||
161385316|NCT03012828|582794707|FG005|Overall Study|Withdrawal by Subject|1|||
161385317|NCT03012828|582794702|FG000|Overall Study|Non-compliance with protocol|0|||
161385318|NCT03012828|582794703|FG001|Overall Study|Non-compliance with protocol|0|||
161385319|NCT03012828|582794704|FG002|Overall Study|Non-compliance with protocol|0|||
161385320|NCT03012828|582794705|FG003|Overall Study|Non-compliance with protocol|0|||
161385321|NCT03012828|582794706|FG004|Overall Study|Non-compliance with protocol|1|||
161385322|NCT03012828|582794707|FG005|Overall Study|Non-compliance with protocol|0|||
161385323|NCT03012828|582794702|FG000|Overall Study|Delay to last visit would delay DBL|0|||
161385324|NCT03012828|582794703|FG001|Overall Study|Delay to last visit would delay DBL|0|||
161385325|NCT03012828|582794704|FG002|Overall Study|Delay to last visit would delay DBL|0|||
161385326|NCT03012828|582794705|FG003|Overall Study|Delay to last visit would delay DBL|0|||
161385327|NCT03012828|582794706|FG004|Overall Study|Delay to last visit would delay DBL|0|||
161385328|NCT03012828|582794707|FG005|Overall Study|Delay to last visit would delay DBL|1|||
161385329|NCT01970241|582794708|FG000|Overall Study|Withdrawal by Subject|2|||
161385330|NCT01970241|582794709|FG001|Overall Study|Withdrawal by Subject|0|||
161385331|NCT01970241|582794708|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
161385332|NCT01970241|582794709|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
161385333|NCT01107392|582794711|FG000|Overall Study|Adverse Event|2|||
161385334|NCT01107392|582794712|FG001|Overall Study|Adverse Event|0|||
161385335|NCT01107392|582794711|FG000|Overall Study|Personal Reasons|2|||
161385336|NCT01107392|582794712|FG001|Overall Study|Personal Reasons|3|||
161385337|NCT01107392|582794711|FG000|Overall Study|Administrative decision|1|||
161385338|NCT01107392|582794712|FG001|Overall Study|Administrative decision|0|||
161385339|NCT02689206|582794715|FG000|Overall Study|Adverse Event|0|||
161385340|NCT02689206|582794716|FG001|Overall Study|Adverse Event|0|||
161385341|NCT02689206|582794717|FG002|Overall Study|Adverse Event|1|||
161385342|NCT02689206|582794718|FG003|Overall Study|Adverse Event|0|||
161385343|NCT02689206|582794719|FG004|Overall Study|Adverse Event|2|||
161385344|NCT02689206|582794715|FG000|Overall Study|Protocol Violation|1|||
161385345|NCT02689206|582794716|FG001|Overall Study|Protocol Violation|0|||
161385346|NCT02689206|582794717|FG002|Overall Study|Protocol Violation|0|||
161385347|NCT02689206|582794718|FG003|Overall Study|Protocol Violation|1|||
161385348|NCT02689206|582794719|FG004|Overall Study|Protocol Violation|2|||
161385349|NCT02689206|582794715|FG000|Overall Study|Other: Reached stopping criteria|0|||
161385350|NCT02689206|582794716|FG001|Overall Study|Other: Reached stopping criteria|1|||
161385351|NCT02689206|582794717|FG002|Overall Study|Other: Reached stopping criteria|2|||
161385352|NCT02689206|582794718|FG003|Overall Study|Other: Reached stopping criteria|3|||
161385353|NCT02689206|582794719|FG004|Overall Study|Other: Reached stopping criteria|4|||
161385354|NCT02689206|582794715|FG000|Overall Study|Physician Decision|1|||
161385355|NCT02689206|582794716|FG001|Overall Study|Physician Decision|0|||
161385356|NCT02689206|582794717|FG002|Overall Study|Physician Decision|0|||
161385357|NCT02689206|582794718|FG003|Overall Study|Physician Decision|0|||
161385358|NCT02689206|582794719|FG004|Overall Study|Physician Decision|0|||
161385359|NCT02689206|582794715|FG000|Overall Study|Withdrawal by Subject|1|||
161385360|NCT02689206|582794716|FG001|Overall Study|Withdrawal by Subject|0|||
161385361|NCT02689206|582794717|FG002|Overall Study|Withdrawal by Subject|1|||
161385362|NCT02689206|582794718|FG003|Overall Study|Withdrawal by Subject|0|||
161385363|NCT02689206|582794719|FG004|Overall Study|Withdrawal by Subject|0|||
161385364|NCT02520388|582794720|FG000|Overall Study|Physician Decision|1|||
161385365|NCT02520388|582794721|FG001|Overall Study|Physician Decision|0|||
161385366|NCT02520388|582794720|FG000|Overall Study|Subject or parent/guardian request|0|||
161385367|NCT02520388|582794721|FG001|Overall Study|Subject or parent/guardian request|6|||
161385368|NCT02520388|582794720|FG000|Overall Study|Adverse Event|1|||
161385369|NCT02520388|582794721|FG001|Overall Study|Adverse Event|4|||
161385370|NCT02520388|582794720|FG000|Overall Study|Lost to Follow-up|3|||
161385371|NCT02520388|582794721|FG001|Overall Study|Lost to Follow-up|2|||
161385372|NCT02520388|582794720|FG000|Overall Study|Other (reason not defined)|4|||
161385373|NCT02520388|582794721|FG001|Overall Study|Other (reason not defined)|4|||
161385374|NCT01437111|582794722|FG000|Overall Study|Adverse Event|2|||
161385375|NCT01437111|582794722|FG000|Overall Study|Withdrawal by Subject|4|||
161385376|NCT01437111|582794722|FG000|Overall Study|Not reported|5|||
161385377|NCT01437111|582794722|FG000|Overall Study|Physician Decision|1|||
161385378|NCT01437111|582794722|FG000|Overall Study|Lost to Follow-up|5|||
161385379|NCT01437111|582794722|FG000|Overall Study|Protocol Violation|1|||
161385380|NCT01232127|582794723|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
161385381|NCT01232127|582794724|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
161385382|NCT01232127|582794725|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
161385383|NCT02623205|582794731|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
161385384|NCT02623205|582794732|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
161385385|NCT03062280|582796142|FG000|Overall Study|Adverse Event|1|||
161385386|NCT03062280|582796142|FG000|Overall Study|Death|1|||
161385387|NCT03062280|582796142|FG000|Overall Study|Fertility Treatment|2|||
161385388|NCT03062280|582796142|FG000|Overall Study|Physician Decision|2|||
161385389|NCT03062280|582796142|FG000|Overall Study|Pregnancy|5|||
161385390|NCT03062280|582796142|FG000|Overall Study|Withdrawal by Subject|11|||
161385391|NCT00282087|582796143|FG000|Overall Study|Death|1|||
161385392|NCT00441142|582796168|FG000|Overall Study|Adverse Event|2|||
161385393|NCT00441142|582796169|FG001|Overall Study|Adverse Event|3|||
161385394|NCT00441142|582796170|FG002|Overall Study|Adverse Event|3|||
161385395|NCT00441142|582796171|FG003|Overall Study|Adverse Event|22|||
161385396|NCT00441142|582796168|FG000|Overall Study|Lack of Efficacy|3|||
161385397|NCT00441142|582796169|FG001|Overall Study|Lack of Efficacy|3|||
161385398|NCT00441142|582796170|FG002|Overall Study|Lack of Efficacy|17|||
161385399|NCT00441142|582796171|FG003|Overall Study|Lack of Efficacy|32|||
161385400|NCT00441142|582796168|FG000|Overall Study|Withdrawal by Subject|0|||
161385401|NCT00441142|582796169|FG001|Overall Study|Withdrawal by Subject|0|||
161385402|NCT00441142|582796170|FG002|Overall Study|Withdrawal by Subject|2|||
161385403|NCT00441142|582796171|FG003|Overall Study|Withdrawal by Subject|10|||
161385404|NCT00441142|582796168|FG000|Overall Study|Patient still receiving active study tx|1|||
161385405|NCT00441142|582796169|FG001|Overall Study|Patient still receiving active study tx|0|||
161385406|NCT00441142|582796170|FG002|Overall Study|Patient still receiving active study tx|0|||
161385407|NCT00441142|582796171|FG003|Overall Study|Patient still receiving active study tx|2|||
161385408|NCT00441142|582796168|FG000|Overall Study|Physician Decision|0|||
161385409|NCT00441142|582796169|FG001|Overall Study|Physician Decision|1|||
161385410|NCT00441142|582796170|FG002|Overall Study|Physician Decision|0|||
161385411|NCT00441142|582796171|FG003|Overall Study|Physician Decision|1|||
161385412|NCT00441142|582796168|FG000|Overall Study|Death|0|||
161385413|NCT00441142|582796169|FG001|Overall Study|Death|0|||
161385414|NCT00441142|582796170|FG002|Overall Study|Death|0|||
161385415|NCT00441142|582796171|FG003|Overall Study|Death|1|||
161385416|NCT01703091|582796172|FG000|Overall Study|Adverse Event|5|||
161385417|NCT01703091|582796173|FG001|Overall Study|Adverse Event|3|||
161385418|NCT01703091|582796172|FG000|Overall Study|Physician Decision|2|||
161385419|NCT01703091|582796173|FG001|Overall Study|Physician Decision|1|||
161385420|NCT01703091|582796172|FG000|Overall Study|Withdrawal by Subject|1|||
161385421|NCT01703091|582796173|FG001|Overall Study|Withdrawal by Subject|0|||
161385422|NCT01703091|582796172|FG000|Overall Study|Sponsor Decision|1|||
161385423|NCT01703091|582796173|FG001|Overall Study|Sponsor Decision|0|||
161385424|NCT00022763|582796174|FG000|Overall Study|Adverse Event|1|||
161385425|NCT00022763|582796175|FG001|Overall Study|Adverse Event|2|||
161385426|NCT00022763|582796174|FG000|Overall Study|Injection Site Reactions|0|||
161385427|NCT00022763|582796175|FG001|Overall Study|Injection Site Reactions|2|||
161385428|NCT00022763|582796174|FG000|Overall Study|Death|0|||
161385429|NCT00022763|582796175|FG001|Overall Study|Death|1|||
161385430|NCT00022763|582796174|FG000|Overall Study|Lost to Follow-up|0|||
161385431|NCT00022763|582796175|FG001|Overall Study|Lost to Follow-up|3|||
161385432|NCT00022763|582796174|FG000|Overall Study|Withdrawal by Subject|4|||
161385433|NCT00022763|582796175|FG001|Overall Study|Withdrawal by Subject|7|||
161385434|NCT00022763|582796174|FG000|Overall Study|Insufficient Therapy|1|||
161385435|NCT00022763|582796175|FG001|Overall Study|Insufficient Therapy|0|||
161385436|NCT00022763|582796174|FG000|Overall Study|Admin|3|||
161385437|NCT00022763|582796175|FG001|Overall Study|Admin|2|||
161385438|NCT03248531|582796176|FG000|Overall Study|Adverse Event|0|||
161385439|NCT03248531|582796177|FG001|Overall Study|Adverse Event|0|||
161385440|NCT03248531|582796178|FG002|Overall Study|Adverse Event|1|||
161385441|NCT03248531|582796176|FG000|Overall Study|Lost to Follow-up|1|||
161385442|NCT03248531|582796177|FG001|Overall Study|Lost to Follow-up|0|||
161385443|NCT03248531|582796178|FG002|Overall Study|Lost to Follow-up|5|||
161385444|NCT03248531|582796176|FG000|Overall Study|Withdrawal by Subject|3|||
161385445|NCT03248531|582796177|FG001|Overall Study|Withdrawal by Subject|3|||
161385446|NCT03248531|582796178|FG002|Overall Study|Withdrawal by Subject|2|||
161385447|NCT03248531|582796176|FG000|Overall Study|Sponsor Request|0|||
161385448|NCT03248531|582796177|FG001|Overall Study|Sponsor Request|2|||
161385449|NCT03248531|582796178|FG002|Overall Study|Sponsor Request|0|||
161385450|NCT00842153|582796179|FG000|Overall Study|Adverse Event|0|||
161385451|NCT00842153|582796180|FG001|Overall Study|Adverse Event|1|||
161385452|NCT00842153|582796179|FG000|Overall Study|Lost to Follow-up|1|||
161385453|NCT00842153|582796180|FG001|Overall Study|Lost to Follow-up|2|||
161385454|NCT02201329|582796182|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
161385455|NCT02201329|582796182|FG000|Overall Study|Withdrawal by Subject|2|||
161385456|NCT04660552|582796183|FG000|Overall Study|Withdrawal by Subject|3|||
161385457|NCT04660552|582796184|FG001|Overall Study|Withdrawal by Subject|1|||
161385458|NCT01509846|582796185|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
161385459|NCT01509846|582796186|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
161385460|NCT01509846|582796187|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
161385461|NCT01509846|582796188|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
161385462|NCT01509846|582796189|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
161385463|NCT01509846|582796185|FG000|Received Vaccination 2|Illness|0|||
161385464|NCT01509846|582796186|FG001|Received Vaccination 2|Illness|0|||
161385465|NCT01509846|582796187|FG002|Received Vaccination 2|Illness|0|||
161385466|NCT01509846|582796188|FG003|Received Vaccination 2|Illness|0|||
161385467|NCT01509846|582796189|FG004|Received Vaccination 2|Illness|1|||
161385468|NCT01509846|582796185|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
161385469|NCT01509846|582796186|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
161385470|NCT01509846|582796187|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
161385471|NCT01509846|582796188|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
161385472|NCT01509846|582796189|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
161385473|NCT01509846|582796185|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
161385474|NCT01509846|582796186|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
161385475|NCT01509846|582796187|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
161385476|NCT01509846|582796188|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
161385477|NCT01509846|582796189|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
161385478|NCT01509846|582796185|FG000|Received Vaccination 3|Pregnancy|0|||
161385479|NCT01509846|582796186|FG001|Received Vaccination 3|Pregnancy|0|||
161385480|NCT01509846|582796187|FG002|Received Vaccination 3|Pregnancy|0|||
161385481|NCT01509846|582796188|FG003|Received Vaccination 3|Pregnancy|1|||
161385482|NCT01509846|582796189|FG004|Received Vaccination 3|Pregnancy|0|||
161385483|NCT01509846|582796185|FG000|Received Vaccination 3|Lost to Follow-up|0|||
161385484|NCT01509846|582796186|FG001|Received Vaccination 3|Lost to Follow-up|0|||
161385485|NCT01509846|582796187|FG002|Received Vaccination 3|Lost to Follow-up|1|||
161385486|NCT01509846|582796188|FG003|Received Vaccination 3|Lost to Follow-up|0|||
161385487|NCT01509846|582796189|FG004|Received Vaccination 3|Lost to Follow-up|0|||
161385488|NCT01637584|582796191|FG000|Overall Study|Withdrawal by Subject|1|||
161385489|NCT01637584|582796192|FG001|Overall Study|Withdrawal by Subject|3|||
161385490|NCT04396795|582796193|FG000|Month 1|Lost to Follow-up|2|||
161385491|NCT04396795|582796194|FG001|Month 1|Lost to Follow-up|3|||
161385492|NCT04396795|582796193|FG000|Month 3|Lost to Follow-up|1|||
161385493|NCT04396795|582796194|FG001|Month 3|Lost to Follow-up|3|||
161385494|NCT04396795|582796193|FG000|Month 6|Lost to Follow-up|3|||
161385495|NCT04396795|582796194|FG001|Month 6|Lost to Follow-up|3|||
161385496|NCT02366923|582796195|FG000|Overall Study|Withdrawal by Subject|1|||
161385497|NCT02366923|582796195|FG000|Overall Study|Positive Slit Lamp Findings|2|||
161385498|NCT02366923|582796195|FG000|Overall Study|High Astigmatism|3|||
161385499|NCT02484443|582796196|FG000|Overall Study|Lack of Efficacy|28|||
161385500|NCT02484443|582796196|FG000|Overall Study|Physician Decision|2|||
161385501|NCT02484443|582796196|FG000|Overall Study|Ineligible|2|||
161385502|NCT02122146|582796197|FG000|Part 1: Dose Escalation|Death|0|||
161385503|NCT02122146|582796198|FG001|Part 1: Dose Escalation|Death|1|||
161385504|NCT02122146|582796199|FG002|Part 1: Dose Escalation|Death|1|||
161385505|NCT02122146|582796200|FG003|Part 1: Dose Escalation|Death|0|||
161385506|NCT02122146|582796201|FG004|Part 1: Dose Escalation|Death|0|||
161385507|NCT02122146|582796202|FG005|Part 1: Dose Escalation|Death|0|||
161385508|NCT02122146|582796203|FG006|Part 1: Dose Escalation|Death|0|||
161385509|NCT02122146|582796204|FG007|Part 1: Dose Escalation|Death|0|||
161385510|NCT02122146|582796197|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
161385511|NCT02122146|582796198|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161385512|NCT02122146|582796199|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
161385513|NCT02122146|582796200|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161385514|NCT02122146|582796201|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
161385515|NCT02122146|582796202|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161385516|NCT02122146|582796203|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161385517|NCT02122146|582796204|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161385518|NCT02122146|582796197|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385519|NCT02122146|582796198|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385520|NCT02122146|582796199|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385521|NCT02122146|582796200|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161385522|NCT02122146|582796201|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385523|NCT02122146|582796202|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385524|NCT02122146|582796203|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385525|NCT02122146|582796204|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161385526|NCT02122146|582796197|FG000|Part 1: Dose Escalation|Other|1|||
161385527|NCT02122146|582796198|FG001|Part 1: Dose Escalation|Other|0|||
161385528|NCT02122146|582796199|FG002|Part 1: Dose Escalation|Other|0|||
161385529|NCT02122146|582796200|FG003|Part 1: Dose Escalation|Other|0|||
161385530|NCT02122146|582796201|FG004|Part 1: Dose Escalation|Other|0|||
161385531|NCT02122146|582796202|FG005|Part 1: Dose Escalation|Other|1|||
161385532|NCT02122146|582796203|FG006|Part 1: Dose Escalation|Other|1|||
161385533|NCT02122146|582796204|FG007|Part 1: Dose Escalation|Other|2|||
161385534|NCT03472495|582796205|FG000|Overall Study|Treatment no longer indicated|1|||
161385535|NCT03472495|582796206|FG001|Overall Study|Treatment no longer indicated|2|||
161385536|NCT03472495|582796205|FG000|Overall Study|Physician Decision|0|||
161385537|NCT03472495|582796206|FG001|Overall Study|Physician Decision|2|||
161385538|NCT00992056|582796209|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
161385539|NCT00992056|582796210|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
161385540|NCT00992056|582796209|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
161385541|NCT00992056|582796210|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
161385542|NCT02595866|582796211|FG000|Overall Study|Adverse Event|2|||
161385543|NCT02595866|582796212|FG001|Overall Study|Adverse Event|5|||
161385544|NCT02595866|582796211|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
161385545|NCT02595866|582796212|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
161385546|NCT02595866|582796211|FG000|Overall Study|Death|0|||
161385547|NCT02595866|582796212|FG001|Overall Study|Death|1|||
161385548|NCT02595866|582796211|FG000|Overall Study|Incarceration|1|||
161385549|NCT02595866|582796212|FG001|Overall Study|Incarceration|0|||
161385550|NCT02595866|582796211|FG000|Overall Study|Lack of Efficacy|17|||
161385551|NCT02595866|582796212|FG001|Overall Study|Lack of Efficacy|7|||
161385552|NCT02595866|582796211|FG000|Overall Study|Physician Decision|4|||
161385553|NCT02595866|582796212|FG001|Overall Study|Physician Decision|3|||
161385554|NCT02595866|582796211|FG000|Overall Study|Switched to Alternative Treatment|1|||
161385555|NCT02595866|582796212|FG001|Overall Study|Switched to Alternative Treatment|0|||
161385556|NCT02595866|582796211|FG000|Overall Study|Study Terminated|0|||
161385557|NCT02595866|582796212|FG001|Overall Study|Study Terminated|4|||
161385558|NCT02595866|582796211|FG000|Overall Study|Withdrawal by Subject|6|||
161385559|NCT02595866|582796212|FG001|Overall Study|Withdrawal by Subject|1|||
161385560|NCT01001767|582796215|FG000|Overall Study|no baseline study performed|1|||
161385561|NCT01001767|582796216|FG001|Overall Study|no baseline study performed|0|||
161385562|NCT01001767|582796215|FG000|Overall Study|Protocol Violation|1|||
161385563|NCT01001767|582796216|FG001|Overall Study|Protocol Violation|0|||
161385564|NCT01001767|582796215|FG000|Overall Study|Lost to Follow-up|1|||
161385565|NCT01001767|582796216|FG001|Overall Study|Lost to Follow-up|0|||
161385566|NCT01001767|582796215|FG000|Overall Study|Physician Decision|1|||
161385567|NCT01001767|582796216|FG001|Overall Study|Physician Decision|0|||
161385568|NCT02584452|582796217|FG000|Overall Study|Physician Decision|1|||
161385569|NCT02584452|582796218|FG001|Overall Study|Physician Decision|1|||
161385570|NCT02584452|582796217|FG000|Overall Study|Lost to Follow-up|1|||
161385571|NCT02584452|582796218|FG001|Overall Study|Lost to Follow-up|1|||
161385572|NCT00851552|582796219|FG000|Overall Study|Death|2|||
161385573|NCT00851552|582796219|FG000|Overall Study|Adverse Event|1|||
161385574|NCT00851552|582796219|FG000|Overall Study|Disease Progression|4|||
161385575|NCT00177294|582796220|FG000|Overall Study|Withdrawal by Subject|7|||
161385576|NCT00177294|582796221|FG001|Overall Study|Withdrawal by Subject|5|||
161385577|NCT02038946|582796222|FG000|Overall Study|Death|5|||
161385578|NCT02038946|582796222|FG000|Overall Study|Withdrawal by Subject|3|||
161385579|NCT02038946|582796222|FG000|Overall Study|Lost to Follow-up|2|||
161385580|NCT02038946|582796222|FG000|Overall Study|Other reasons|2|||
161385581|NCT02131311|582796223|FG000|Overall Study|Adverse Event|2|||
161385582|NCT02131311|582796223|FG000|Overall Study|Protocol Violation|1|||
161385583|NCT02131311|582796223|FG000|Overall Study|Lost to Follow-up|1|||
161385584|NCT01479764|582796224|FG000|Randomized|Adverse Event|1|||
161385585|NCT01479764|582796225|FG001|Randomized|Adverse Event|1|||
161385586|NCT01479764|582796224|FG000|Randomized|Withdrawal by Subject|1|||
161385587|NCT01479764|582796225|FG001|Randomized|Withdrawal by Subject|0|||
161385588|NCT01479764|582796224|FG000|Treated|Lost to Follow-up|0|||
161385589|NCT01479764|582796225|FG001|Treated|Lost to Follow-up|2|||
161385590|NCT02473471|582796226|FG000|Overall Study|poor oral hygiene|2|||
161385591|NCT02473471|582796226|FG000|Overall Study|Lost to Follow-up|1|||
161385592|NCT00255723|582796232|FG000|Overall Study|Adverse Event|1|||
161385593|NCT00255723|582796233|FG001|Overall Study|Adverse Event|1|||
161385594|NCT00255723|582796232|FG000|Overall Study|Death|0|||
161385595|NCT00255723|582796233|FG001|Overall Study|Death|1|||
161385596|NCT00255723|582796232|FG000|Overall Study|Response Data Not Available|1|||
161385597|NCT00255723|582796233|FG001|Overall Study|Response Data Not Available|0|||
161385598|NCT00191945|582796235|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
161385599|NCT00191945|582796236|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
161385600|NCT00191945|582796235|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
161385601|NCT00191945|582796236|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
161385602|NCT00191945|582796235|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
161385603|NCT00191945|582796236|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
161385604|NCT00191945|582796235|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
161385605|NCT00191945|582796236|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
161385606|NCT03711370|582796237|FG000|Overall Study|Lost to Follow-up|16|||
161385607|NCT03711370|582796238|FG001|Overall Study|Lost to Follow-up|10|||
161385608|NCT03711370|582796237|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
161385609|NCT03711370|582796238|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
161385610|NCT02063984|582796239|FG000|Overall Study|Lost to Follow-up|6|||
161385611|NCT02063984|582796240|FG001|Overall Study|Lost to Follow-up|5|||
161385612|NCT01536561|582796245|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
161385613|NCT01536561|582796245|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
161385614|NCT01536561|582796245|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
161385615|NCT01536561|582796245|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
161385616|NCT01536561|582796245|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
161385617|NCT01536561|582796245|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
161385618|NCT01030952|582796246|FG000|Overall Study|Protocol Violation|0|||
161385619|NCT01030952|582796247|FG001|Overall Study|Protocol Violation|1|||
161385620|NCT01030952|582796246|FG000|Overall Study|Informed consent withdrawal|1|||
161385621|NCT01030952|582796247|FG001|Overall Study|Informed consent withdrawal|0|||
161385622|NCT01030952|582796246|FG000|Overall Study|Lost to Follow-up|0|||
161385623|NCT01030952|582796247|FG001|Overall Study|Lost to Follow-up|1|||
161385624|NCT01030952|582796246|FG000|Overall Study|Unexplained|1|||
161385625|NCT01030952|582796247|FG001|Overall Study|Unexplained|1|||
161385626|NCT00431444|582796250|FG000|Overall Study|Protocol Violation|1|||
161385627|NCT00431444|582796251|FG001|Overall Study|Protocol Violation|4|||
161385628|NCT00431444|582796250|FG000|Overall Study|Adverse Event|2|||
161385629|NCT00431444|582796251|FG001|Overall Study|Adverse Event|1|||
161385630|NCT00431444|582796250|FG000|Overall Study|Withdrawal by Subject|1|||
161385631|NCT00431444|582796251|FG001|Overall Study|Withdrawal by Subject|1|||
161385632|NCT00431444|582796250|FG000|Overall Study|Lost to Follow-up|1|||
161385633|NCT00431444|582796251|FG001|Overall Study|Lost to Follow-up|0|||
161385634|NCT00431444|582796250|FG000|Overall Study|Administrative Problems|0|||
161385635|NCT00431444|582796251|FG001|Overall Study|Administrative Problems|1|||
161385636|NCT03583359|582796255|FG000|Overall Study|Withdrawal by Subject|15|||
161385637|NCT03583359|582796256|FG001|Overall Study|Withdrawal by Subject|6|||
161385638|NCT03583359|582796255|FG000|Overall Study|Lost to Follow-up|12|||
161385639|NCT03583359|582796256|FG001|Overall Study|Lost to Follow-up|3|||
161385640|NCT03583359|582796255|FG000|Overall Study|Adverse Event|0|||
161385641|NCT03583359|582796256|FG001|Overall Study|Adverse Event|1|||
161385642|NCT03583359|582796255|FG000|Overall Study|Protocol Violation|0|||
161385643|NCT03583359|582796256|FG001|Overall Study|Protocol Violation|1|||
161385644|NCT03583359|582796255|FG000|Overall Study|Other|2|||
161385645|NCT03583359|582796256|FG001|Overall Study|Other|1|||
161385646|NCT03497039|582796257|FG000|Overall Study|Withdrawal by Subject|1|||
161385647|NCT03497039|582796258|FG001|Overall Study|Withdrawal by Subject|0|||
161385648|NCT03497039|582796257|FG000|Overall Study|Protocol Violation|0|||
161385649|NCT03497039|582796258|FG001|Overall Study|Protocol Violation|1|||
161385650|NCT02131662|582796260|FG000|Overall Study|Protocol Violation|1|||
161385651|NCT02131662|582796261|FG001|Overall Study|Protocol Violation|0|||
161385652|NCT02131662|582796262|FG002|Overall Study|Protocol Violation|0|||
161385653|NCT02131662|582796263|FG003|Overall Study|Protocol Violation|0|||
161385654|NCT02131662|582796264|FG004|Overall Study|Protocol Violation|0|||
161385655|NCT02131662|582796260|FG000|Overall Study|Other|2|||
161385656|NCT02131662|582796261|FG001|Overall Study|Other|4|||
161385657|NCT02131662|582796262|FG002|Overall Study|Other|3|||
161385658|NCT02131662|582796263|FG003|Overall Study|Other|3|||
161385659|NCT02131662|582796264|FG004|Overall Study|Other|4|||
161385660|NCT02131662|582796260|FG000|Overall Study|Adverse Event|0|||
161385661|NCT02131662|582796261|FG001|Overall Study|Adverse Event|1|||
161385662|NCT02131662|582796262|FG002|Overall Study|Adverse Event|1|||
161385663|NCT02131662|582796263|FG003|Overall Study|Adverse Event|1|||
161385664|NCT02131662|582796264|FG004|Overall Study|Adverse Event|3|||
161385665|NCT02131662|582796260|FG000|Overall Study|Pregnancy|0|||
161385666|NCT02131662|582796261|FG001|Overall Study|Pregnancy|1|||
161385667|NCT02131662|582796262|FG002|Overall Study|Pregnancy|0|||
161385668|NCT02131662|582796263|FG003|Overall Study|Pregnancy|1|||
161385669|NCT02131662|582796264|FG004|Overall Study|Pregnancy|0|||
161385670|NCT02131662|582796260|FG000|Overall Study|Wish for pregnancy|0|||
161385671|NCT02131662|582796261|FG001|Overall Study|Wish for pregnancy|0|||
161385672|NCT02131662|582796262|FG002|Overall Study|Wish for pregnancy|0|||
161385673|NCT02131662|582796263|FG003|Overall Study|Wish for pregnancy|0|||
161385674|NCT02131662|582796264|FG004|Overall Study|Wish for pregnancy|1|||
161385675|NCT02131662|582796260|FG000|Overall Study|Lack of Efficacy|1|||
161385676|NCT02131662|582796261|FG001|Overall Study|Lack of Efficacy|0|||
161385677|NCT02131662|582796262|FG002|Overall Study|Lack of Efficacy|0|||
161385678|NCT02131662|582796263|FG003|Overall Study|Lack of Efficacy|0|||
161385679|NCT02131662|582796264|FG004|Overall Study|Lack of Efficacy|1|||
161385680|NCT02131662|582796260|FG000|Overall Study|Withdrawal by Subject|1|||
161385681|NCT02131662|582796261|FG001|Overall Study|Withdrawal by Subject|5|||
161385682|NCT02131662|582796262|FG002|Overall Study|Withdrawal by Subject|1|||
161385683|NCT02131662|582796263|FG003|Overall Study|Withdrawal by Subject|5|||
161385684|NCT02131662|582796264|FG004|Overall Study|Withdrawal by Subject|6|||
161385685|NCT02131662|582796260|FG000|Overall Study|Lost to Follow-up|1|||
161385686|NCT02131662|582796261|FG001|Overall Study|Lost to Follow-up|3|||
161385687|NCT02131662|582796262|FG002|Overall Study|Lost to Follow-up|0|||
161385688|NCT02131662|582796263|FG003|Overall Study|Lost to Follow-up|9|||
161385689|NCT02131662|582796264|FG004|Overall Study|Lost to Follow-up|0|||
161385690|NCT02131662|582796260|FG000|Overall Study|Not treated|2|||
161385691|NCT02131662|582796261|FG001|Overall Study|Not treated|0|||
161385692|NCT02131662|582796262|FG002|Overall Study|Not treated|2|||
161385693|NCT02131662|582796263|FG003|Overall Study|Not treated|2|||
161385694|NCT02131662|582796264|FG004|Overall Study|Not treated|3|||
161385695|NCT03554018|582796265|FG000|Overall Study|Lost to Follow-up|3|||
161385696|NCT03554018|582796266|FG001|Overall Study|Lost to Follow-up|7|||
161385697|NCT01016132|582796270|FG000|Overall Study|Discomfort|1|||
161385698|NCT02949024|582796271|FG000|Overall Study|Withdrawal by Subject|0|||
161385699|NCT02949024|582796272|FG001|Overall Study|Withdrawal by Subject|1|||
161385700|NCT00854724|582797842|FG000|First Intervention|Withdrawal by Subject|1|||
161385701|NCT00854724|582797843|FG001|First Intervention|Withdrawal by Subject|1|||
161385702|NCT00854724|582797842|FG000|Washout|Protocol Violation|1|||
161385703|NCT00854724|582797843|FG001|Washout|Protocol Violation|0|||
161385704|NCT00854724|582797842|FG000|Washout|Withdrawal by Subject|0|||
161385705|NCT00854724|582797843|FG001|Washout|Withdrawal by Subject|1|||
161385706|NCT00854724|582797842|FG000|Second Intervention|Protocol Violation|1|||
161385707|NCT00854724|582797843|FG001|Second Intervention|Protocol Violation|0|||
161385708|NCT00854724|582797842|FG000|Second Intervention|Physician Decision|0|||
161385709|NCT00854724|582797843|FG001|Second Intervention|Physician Decision|1|||
161385710|NCT00933608|582797845|FG000|Overall Study|Adverse Event|4|||
161385711|NCT00933608|582797846|FG001|Overall Study|Adverse Event|2|||
161385712|NCT00933608|582797845|FG000|Overall Study|Physician Decision|1|||
161385713|NCT00933608|582797846|FG001|Overall Study|Physician Decision|0|||
161385714|NCT00336284|582797849|FG000|Overall Study|Death|52|||
161385715|NCT00336284|582797850|FG001|Overall Study|Death|26|||
161385716|NCT00336284|582797849|FG000|Overall Study|Lost to Follow-up|82|||
161385717|NCT00336284|582797850|FG001|Overall Study|Lost to Follow-up|61|||
161385718|NCT00336284|582797849|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
161385719|NCT00336284|582797850|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
161385720|NCT01709110|582797855|FG000|Overall Study|Adverse Event|56|||
161385721|NCT01709110|582797856|FG001|Overall Study|Adverse Event|48|||
161385722|NCT01709110|582797855|FG000|Overall Study|Death|14|||
161385723|NCT01709110|582797856|FG001|Overall Study|Death|6|||
161385724|NCT01709110|582797855|FG000|Overall Study|Lost to Follow-up|7|||
161385725|NCT01709110|582797856|FG001|Overall Study|Lost to Follow-up|5|||
161385726|NCT01709110|582797855|FG000|Overall Study|Protocol Violation|4|||
161385727|NCT01709110|582797856|FG001|Overall Study|Protocol Violation|6|||
161385728|NCT01709110|582797855|FG000|Overall Study|Withdrawal by Subject|96|||
161385729|NCT01709110|582797856|FG001|Overall Study|Withdrawal by Subject|89|||
161385730|NCT01709110|582797855|FG000|Overall Study|Physician Decision|4|||
161385731|NCT01709110|582797856|FG001|Overall Study|Physician Decision|10|||
161385732|NCT01709110|582797855|FG000|Overall Study|Sponsor Decision|2|||
161385733|NCT01709110|582797856|FG001|Overall Study|Sponsor Decision|2|||
161385734|NCT01709110|582797855|FG000|Overall Study|Lack of Efficacy|1|||
161385735|NCT01709110|582797856|FG001|Overall Study|Lack of Efficacy|1|||
161385736|NCT01709110|582797855|FG000|Overall Study|Caregiver Decision|1|||
161385737|NCT01709110|582797856|FG001|Overall Study|Caregiver Decision|1|||
161385738|NCT02789345|582797857|FG000|Overall Study|Adverse Event|0|||
161385739|NCT02789345|582797858|FG001|Overall Study|Adverse Event|0|||
161385740|NCT02789345|582797859|FG002|Overall Study|Adverse Event|1|||
161385741|NCT02789345|582797857|FG000|Overall Study|Death|0|||
161385742|NCT02789345|582797858|FG001|Overall Study|Death|0|||
161385743|NCT02789345|582797859|FG002|Overall Study|Death|1|||
161385744|NCT02789345|582797857|FG000|Overall Study|Physician Decision|2|||
161385745|NCT02789345|582797858|FG001|Overall Study|Physician Decision|0|||
161385746|NCT02789345|582797859|FG002|Overall Study|Physician Decision|1|||
161385747|NCT02789345|582797857|FG000|Overall Study|Progressive Disease|1|||
161385748|NCT02789345|582797858|FG001|Overall Study|Progressive Disease|3|||
161385749|NCT02789345|582797859|FG002|Overall Study|Progressive Disease|14|||
161385750|NCT03645421|582797868|FG000|Overall Study|Adverse Event|0|||
161385751|NCT03645421|582797869|FG001|Overall Study|Adverse Event|0|||
161385752|NCT03645421|582797870|FG002|Overall Study|Adverse Event|4|||
161385753|NCT03645421|582797871|FG003|Overall Study|Adverse Event|1|||
161385754|NCT03645421|582797868|FG000|Overall Study|Withdrawal by patient|0|||
161385755|NCT03645421|582797869|FG001|Overall Study|Withdrawal by patient|0|||
161385756|NCT03645421|582797870|FG002|Overall Study|Withdrawal by patient|0|||
161385757|NCT03645421|582797871|FG003|Overall Study|Withdrawal by patient|3|||
161385758|NCT03645421|582797868|FG000|Overall Study|Study specific withdrawal criteria|0|||
161385759|NCT03645421|582797869|FG001|Overall Study|Study specific withdrawal criteria|0|||
161385760|NCT03645421|582797870|FG002|Overall Study|Study specific withdrawal criteria|1|||
161385761|NCT03645421|582797871|FG003|Overall Study|Study specific withdrawal criteria|0|||
161385762|NCT02120781|582797872|FG000|Overall Study|Physician Decision|2|||
161385763|NCT02120781|582797873|FG001|Overall Study|Physician Decision|0|||
161385764|NCT02120781|582797872|FG000|Overall Study|Completion not documented|2|||
161385765|NCT02120781|582797873|FG001|Overall Study|Completion not documented|1|||
161385766|NCT04123093|582797879|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
161385767|NCT04123093|582797880|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
161385768|NCT04123093|582797879|FG000|Phase 2|Physician Decision|0|||
161385769|NCT04123093|582797880|FG001|Phase 2|Physician Decision|1|||
161385770|NCT04123093|582797879|FG000|Phase 2|Withdrawal by Subject|0|||
161385771|NCT04123093|582797880|FG001|Phase 2|Withdrawal by Subject|1|||
161385772|NCT03286543|582797881|FG000|Consented|Screen failure before randomization|2|||
161385773|NCT03286543|582797882|FG001|Consented|Screen failure before randomization|0|||
161385774|NCT03286543|582797883|FG002|Consented|Screen failure before randomization|0|||
161385775|NCT03286543|582797881|FG000|Consented|Screen failure before enrollment|4|||
161385776|NCT03286543|582797882|FG001|Consented|Screen failure before enrollment|0|||
161385777|NCT03286543|582797883|FG002|Consented|Screen failure before enrollment|0|||
161385778|NCT03286543|582797881|FG000|Consented|TKA cancelled after enrollment|1|||
161385779|NCT03286543|582797882|FG001|Consented|TKA cancelled after enrollment|0|||
161385780|NCT03286543|582797883|FG002|Consented|TKA cancelled after enrollment|0|||
161385781|NCT03286543|582797881|FG000|Consented|Withdrawn from study|12|||
161385782|NCT03286543|582797882|FG001|Consented|Withdrawn from study|0|||
161385783|NCT03286543|582797883|FG002|Consented|Withdrawn from study|0|||
161385784|NCT03286543|582797881|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
161385785|NCT03286543|582797882|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
161385786|NCT03286543|582797883|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
161385787|NCT03286543|582797881|FG000|Study Enrollment|Withdrawn from study|0|||
161385788|NCT03286543|582797882|FG001|Study Enrollment|Withdrawn from study|6|||
161385789|NCT03286543|582797883|FG002|Study Enrollment|Withdrawn from study|6|||
161385790|NCT03850093|582797887|FG000|Overall Study|Withdrawal by Subject|1|||
161385791|NCT03850093|582797888|FG001|Overall Study|Withdrawal by Subject|0|||
161385792|NCT03850093|582797889|FG002|Overall Study|Withdrawal by Subject|2|||
161385793|NCT02836717|582797892|FG000|Test Phase|Lack of Efficacy|14|||
161385794|NCT02836717|582797893|FG001|Test Phase|Lack of Efficacy|8|||
161385795|NCT02836717|582797894|FG002|Test Phase|Lack of Efficacy|0|||
161385796|NCT02836717|582797892|FG000|Study Phase|Adverse Event|2|||
161385797|NCT02836717|582797893|FG001|Study Phase|Adverse Event|0|||
161385798|NCT02836717|582797894|FG002|Study Phase|Adverse Event|0|||
161385799|NCT02836717|582797892|FG000|Study Phase|Lack of Efficacy|8|||
161385800|NCT02836717|582797893|FG001|Study Phase|Lack of Efficacy|6|||
161385801|NCT02836717|582797894|FG002|Study Phase|Lack of Efficacy|1|||
161385802|NCT02836717|582797892|FG000|Study Phase|Withdrawal by Subject|1|||
161385803|NCT02836717|582797893|FG001|Study Phase|Withdrawal by Subject|0|||
161385804|NCT02836717|582797894|FG002|Study Phase|Withdrawal by Subject|0|||
161385805|NCT02836717|582797892|FG000|Study Phase|Death|1|||
161385806|NCT02836717|582797893|FG001|Study Phase|Death|0|||
161385807|NCT02836717|582797894|FG002|Study Phase|Death|0|||
161385808|NCT02836717|582797892|FG000|Study Phase|abdominal surgeries|2|||
161385809|NCT02836717|582797893|FG001|Study Phase|abdominal surgeries|1|||
161385810|NCT02836717|582797894|FG002|Study Phase|abdominal surgeries|0|||
161385811|NCT03226249|582797896|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
161385812|NCT03226249|582797896|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
161385813|NCT03226249|582797896|FG000|Survival Follow-up|Patients still in follow-up.|30|||
161385814|NCT03462641|582797897|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
161385815|NCT03462641|582797898|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
161385816|NCT03462641|582797897|FG000|Visit 2|Withdrawal by Subject|0|||
161385817|NCT03462641|582797898|FG001|Visit 2|Withdrawal by Subject|1|||
161385818|NCT01804049|582797899|FG000|Overall Study|Adverse Event|2|||
161385819|NCT01804049|582797900|FG001|Overall Study|Adverse Event|10|||
161385820|NCT01804049|582797899|FG000|Overall Study|Lost to Follow-up|2|||
161385821|NCT01804049|582797900|FG001|Overall Study|Lost to Follow-up|1|||
161385822|NCT01804049|582797899|FG000|Overall Study|Decreased interest/personal|4|||
161385823|NCT01804049|582797900|FG001|Overall Study|Decreased interest/personal|5|||
161385824|NCT01804049|582797899|FG000|Overall Study|Other health concerns|2|||
161385825|NCT01804049|582797900|FG001|Overall Study|Other health concerns|7|||
161385826|NCT01804049|582797899|FG000|Overall Study|Moved out of area|0|||
161385827|NCT01804049|582797900|FG001|Overall Study|Moved out of area|7|||
161385828|NCT01804049|582797899|FG000|Overall Study|other MD recommended|1|||
161385829|NCT01804049|582797900|FG001|Overall Study|other MD recommended|1|||
161385830|NCT01804049|582797899|FG000|Overall Study|Enrollment in dual studies|0|||
161385831|NCT01804049|582797900|FG001|Overall Study|Enrollment in dual studies|1|||
161385832|NCT00070109|582797901|FG000|Overall Study|Death|1|||
161385833|NCT00070109|582797902|FG001|Overall Study|Death|1|||
161385834|NCT00070109|582797903|FG002|Overall Study|Death|0|||
161385835|NCT00070109|582797904|FG003|Overall Study|Death|0|||
161385836|NCT00070109|582797905|FG004|Overall Study|Death|1|||
161385837|NCT00070109|582797901|FG000|Overall Study|Lack of Efficacy|6|||
161385838|NCT00070109|582797902|FG001|Overall Study|Lack of Efficacy|4|||
161385839|NCT00070109|582797903|FG002|Overall Study|Lack of Efficacy|5|||
161385840|NCT00070109|582797904|FG003|Overall Study|Lack of Efficacy|15|||
161385841|NCT00070109|582797905|FG004|Overall Study|Lack of Efficacy|5|||
161385842|NCT00070109|582797901|FG000|Overall Study|Physician Decision|1|||
161385843|NCT00070109|582797902|FG001|Overall Study|Physician Decision|0|||
161385844|NCT00070109|582797903|FG002|Overall Study|Physician Decision|0|||
161385845|NCT00070109|582797904|FG003|Overall Study|Physician Decision|0|||
161385846|NCT00070109|582797905|FG004|Overall Study|Physician Decision|0|||
161385847|NCT00070109|582797901|FG000|Overall Study|Withdrawal by Subject|0|||
161385848|NCT00070109|582797902|FG001|Overall Study|Withdrawal by Subject|1|||
161385849|NCT00070109|582797903|FG002|Overall Study|Withdrawal by Subject|1|||
161385850|NCT00070109|582797904|FG003|Overall Study|Withdrawal by Subject|0|||
161385851|NCT00070109|582797905|FG004|Overall Study|Withdrawal by Subject|0|||
161385852|NCT00070109|582797901|FG000|Overall Study|Adverse Event|0|||
161385853|NCT00070109|582797902|FG001|Overall Study|Adverse Event|0|||
161385854|NCT00070109|582797903|FG002|Overall Study|Adverse Event|2|||
161385855|NCT00070109|582797904|FG003|Overall Study|Adverse Event|4|||
161385856|NCT00070109|582797905|FG004|Overall Study|Adverse Event|2|||
161385857|NCT00070109|582797901|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
161385858|NCT00070109|582797902|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
161385859|NCT00070109|582797903|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
161385860|NCT00070109|582797904|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
161385861|NCT00070109|582797905|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
161385862|NCT01164891|582797906|FG000|Overall Study|Disease Progression|5|||
161385863|NCT01164891|582797906|FG000|Overall Study|Adverse Event|1|||
161385864|NCT00338286|582797907|FG000|Overall Study|Withdrawal by Subject|50|||
161385865|NCT00338286|582797908|FG001|Overall Study|Withdrawal by Subject|54|||
161385866|NCT00338286|582797907|FG000|Overall Study|Lost to Follow-up|80|||
161385867|NCT00338286|582797908|FG001|Overall Study|Lost to Follow-up|66|||
161385868|NCT00338286|582797907|FG000|Overall Study|Other|103|||
161385869|NCT00338286|582797908|FG001|Overall Study|Other|93|||
161385870|NCT01265563|582797909|FG000|Overall Study|Withdrawal by Subject|0|||
161385871|NCT01265563|582797910|FG001|Overall Study|Withdrawal by Subject|1|||
161385872|NCT01265563|582797911|FG002|Overall Study|Withdrawal by Subject|1|||
161385873|NCT01265563|582797912|FG003|Overall Study|Withdrawal by Subject|0|||
161385874|NCT01265563|582797913|FG004|Overall Study|Withdrawal by Subject|2|||
161385875|NCT04908865|582797917|FG000|Overall Study|Adverse Event|2|||
161385876|NCT04908865|582797917|FG000|Overall Study|Lack of Efficacy|5|||
161385877|NCT04908865|582797917|FG000|Overall Study|Lost to Follow-up|1|||
161385878|NCT05286658|582797918|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
161385879|NCT05286658|582797918|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
161385880|NCT00470262|582797921|FG000|Overall Study|Withdrawal by Subject|2|||
161385881|NCT00470262|582797922|FG001|Overall Study|Withdrawal by Subject|0|||
161385882|NCT02998671|582797923|FG000|Period 1|Study Terminated By Sponsor|2|||
161385883|NCT02998671|582797924|FG001|Period 1|Study Terminated By Sponsor|1|||
161385884|NCT02998671|582797925|FG002|Period 1|Study Terminated By Sponsor|0|||
161385885|NCT02998671|582797926|FG003|Period 1|Study Terminated By Sponsor|0|||
161385886|NCT02998671|582797927|FG004|Period 1|Study Terminated By Sponsor|1|||
161385887|NCT02998671|582797923|FG000|Period 1|Withdrawal by Subject|1|||
161385888|NCT02998671|582797924|FG001|Period 1|Withdrawal by Subject|2|||
161385889|NCT02998671|582797925|FG002|Period 1|Withdrawal by Subject|0|||
161385890|NCT02998671|582797926|FG003|Period 1|Withdrawal by Subject|0|||
161385891|NCT02998671|582797927|FG004|Period 1|Withdrawal by Subject|2|||
161385892|NCT02998671|582797923|FG000|Period 1|Pregnancy|1|||
161385893|NCT02998671|582797924|FG001|Period 1|Pregnancy|0|||
161385894|NCT02998671|582797925|FG002|Period 1|Pregnancy|0|||
161385895|NCT02998671|582797926|FG003|Period 1|Pregnancy|0|||
161385896|NCT02998671|582797927|FG004|Period 1|Pregnancy|0|||
161385897|NCT02998671|582797923|FG000|Period 1|Adverse Event|0|||
161385898|NCT02998671|582797924|FG001|Period 1|Adverse Event|0|||
161385899|NCT02998671|582797925|FG002|Period 1|Adverse Event|0|||
161385900|NCT02998671|582797926|FG003|Period 1|Adverse Event|0|||
161385901|NCT02998671|582797927|FG004|Period 1|Adverse Event|1|||
161385902|NCT02998671|582797923|FG000|Period 2|Adverse Event|0|||
161385903|NCT02998671|582797924|FG001|Period 2|Adverse Event|1|||
161385904|NCT02998671|582797925|FG002|Period 2|Adverse Event|0|||
161385905|NCT02998671|582797926|FG003|Period 2|Adverse Event|0|||
161385906|NCT02998671|582797927|FG004|Period 2|Adverse Event|0|||
161385907|NCT02998671|582797923|FG000|Period 2|Study Terminated By Sponsor|3|||
161385908|NCT02998671|582797924|FG001|Period 2|Study Terminated By Sponsor|5|||
161385909|NCT02998671|582797925|FG002|Period 2|Study Terminated By Sponsor|1|||
161385910|NCT02998671|582797926|FG003|Period 2|Study Terminated By Sponsor|3|||
161385911|NCT02998671|582797927|FG004|Period 2|Study Terminated By Sponsor|0|||
161385912|NCT02998671|582797923|FG000|Period 2|Withdrawal by Subject|0|||
161385913|NCT02998671|582797924|FG001|Period 2|Withdrawal by Subject|1|||
161385914|NCT02998671|582797925|FG002|Period 2|Withdrawal by Subject|0|||
161385915|NCT02998671|582797926|FG003|Period 2|Withdrawal by Subject|0|||
161385916|NCT02998671|582797927|FG004|Period 2|Withdrawal by Subject|0|||
161385917|NCT02998671|582797923|FG000|Period 2|Lost to Follow-up|0|||
161385918|NCT02998671|582797924|FG001|Period 2|Lost to Follow-up|0|||
161385919|NCT02998671|582797925|FG002|Period 2|Lost to Follow-up|0|||
161385920|NCT02998671|582797926|FG003|Period 2|Lost to Follow-up|1|||
161385921|NCT02998671|582797927|FG004|Period 2|Lost to Follow-up|0|||
161385922|NCT03082677|582797931|FG000|Overall Study|Not Treated|2|||
161385923|NCT01667133|582797932|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
161385924|NCT01667133|582797933|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
161385925|NCT01667133|582797934|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
161385926|NCT01667133|582797935|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
161385927|NCT01667133|582797936|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
161385928|NCT01667133|582797937|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
161385929|NCT01667133|582797938|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
161385930|NCT01667133|582797939|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
161385931|NCT01667133|582797940|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
161385932|NCT01667133|582797941|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
161385933|NCT01667133|582797942|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
161385934|NCT01667133|582797943|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
161385935|NCT01667133|582797932|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385936|NCT01667133|582797933|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385937|NCT01667133|582797934|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
161385938|NCT01667133|582797935|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385939|NCT01667133|582797936|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385940|NCT01667133|582797937|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385941|NCT01667133|582797938|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385942|NCT01667133|582797939|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385943|NCT01667133|582797940|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385944|NCT01667133|582797941|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385945|NCT01667133|582797942|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385946|NCT01667133|582797943|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161385947|NCT01667133|582797932|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
161385948|NCT01667133|582797933|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
161385949|NCT01667133|582797934|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
161385950|NCT01667133|582797935|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
161385951|NCT01667133|582797936|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
161385952|NCT01667133|582797937|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
161385953|NCT01667133|582797938|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
161385954|NCT01667133|582797939|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
161385955|NCT01667133|582797940|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
161385956|NCT01667133|582797941|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
161385957|NCT01667133|582797942|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
161385958|NCT01667133|582797943|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
161385959|NCT01667133|582797932|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385960|NCT01667133|582797933|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385961|NCT01667133|582797934|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385962|NCT01667133|582797935|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
161385963|NCT01667133|582797936|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385964|NCT01667133|582797937|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385965|NCT01667133|582797938|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385966|NCT01667133|582797939|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385967|NCT01667133|582797940|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385968|NCT01667133|582797941|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385969|NCT01667133|582797942|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385970|NCT01667133|582797943|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161385971|NCT01667133|582797932|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
161385972|NCT01667133|582797933|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
161385973|NCT01667133|582797934|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
161385974|NCT01667133|582797935|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
161385975|NCT01667133|582797936|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
161385976|NCT01667133|582797937|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
161385977|NCT01667133|582797938|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
161385978|NCT01667133|582797939|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
161385979|NCT01667133|582797940|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
161385980|NCT01667133|582797941|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
161385981|NCT01667133|582797942|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
161385982|NCT01667133|582797943|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
161385983|NCT01667133|582797932|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385984|NCT01667133|582797933|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385985|NCT01667133|582797934|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385986|NCT01667133|582797935|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385987|NCT01667133|582797936|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385988|NCT01667133|582797937|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385989|NCT01667133|582797938|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385990|NCT01667133|582797939|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385991|NCT01667133|582797940|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385992|NCT01667133|582797941|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
161385993|NCT01667133|582797942|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385994|NCT01667133|582797943|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161385995|NCT01667133|582797932|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
161385996|NCT01667133|582797933|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
161385997|NCT01667133|582797934|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
161385998|NCT01667133|582797935|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
161385999|NCT01667133|582797936|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
161386000|NCT01667133|582797937|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
161386001|NCT01667133|582797938|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
161386002|NCT01667133|582797939|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
161386003|NCT01667133|582797940|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
161386004|NCT01667133|582797941|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
161386005|NCT01667133|582797942|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
161386006|NCT01667133|582797943|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
161386007|NCT01667133|582797932|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386008|NCT01667133|582797933|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386009|NCT01667133|582797934|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386010|NCT01667133|582797935|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386011|NCT01667133|582797936|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386012|NCT01667133|582797937|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386013|NCT01667133|582797938|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386014|NCT01667133|582797939|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386015|NCT01667133|582797940|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386016|NCT01667133|582797941|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
161386017|NCT01667133|582797942|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386018|NCT01667133|582797943|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161386019|NCT01667133|582797932|FG000|Phase 2: Dose-expansion|Death|0|||
161386020|NCT01667133|582797933|FG001|Phase 2: Dose-expansion|Death|0|||
161386021|NCT01667133|582797934|FG002|Phase 2: Dose-expansion|Death|0|||
161386022|NCT01667133|582797935|FG003|Phase 2: Dose-expansion|Death|0|||
161386023|NCT01667133|582797936|FG004|Phase 2: Dose-expansion|Death|0|||
161386024|NCT01667133|582797937|FG005|Phase 2: Dose-expansion|Death|0|||
161386025|NCT01667133|582797938|FG006|Phase 2: Dose-expansion|Death|0|||
161386026|NCT01667133|582797939|FG007|Phase 2: Dose-expansion|Death|0|||
161386027|NCT01667133|582797940|FG008|Phase 2: Dose-expansion|Death|0|||
161386028|NCT01667133|582797941|FG009|Phase 2: Dose-expansion|Death|1|||
161386029|NCT01667133|582797942|FG010|Phase 2: Dose-expansion|Death|0|||
161386030|NCT01667133|582797943|FG011|Phase 2: Dose-expansion|Death|0|||
161386031|NCT01667133|582797932|FG000|Phase 2: Dose-expansion|Other|0|||
161386032|NCT01667133|582797933|FG001|Phase 2: Dose-expansion|Other|0|||
161386033|NCT01667133|582797934|FG002|Phase 2: Dose-expansion|Other|0|||
161386034|NCT01667133|582797935|FG003|Phase 2: Dose-expansion|Other|0|||
161386035|NCT01667133|582797936|FG004|Phase 2: Dose-expansion|Other|0|||
161386036|NCT01667133|582797937|FG005|Phase 2: Dose-expansion|Other|0|||
161386037|NCT01667133|582797938|FG006|Phase 2: Dose-expansion|Other|0|||
161386038|NCT01667133|582797939|FG007|Phase 2: Dose-expansion|Other|0|||
161386039|NCT01667133|582797940|FG008|Phase 2: Dose-expansion|Other|0|||
161386040|NCT01667133|582797941|FG009|Phase 2: Dose-expansion|Other|0|||
161386041|NCT01667133|582797942|FG010|Phase 2: Dose-expansion|Other|0|||
161386042|NCT01667133|582797943|FG011|Phase 2: Dose-expansion|Other|1|||
161386043|NCT01916824|582797946|FG000|Overall Study|Lost to Follow-up|3|||
161386044|NCT01916824|582797947|FG001|Overall Study|Lost to Follow-up|6|||
161386045|NCT01916824|582797946|FG000|Overall Study|Physician Decision|2|||
161386046|NCT01916824|582797947|FG001|Overall Study|Physician Decision|0|||
161386047|NCT01916824|582797946|FG000|Overall Study|Withdrawal by Subject|2|||
161386048|NCT01916824|582797947|FG001|Overall Study|Withdrawal by Subject|3|||
161386049|NCT03835481|582797950|FG000|Double-blind Period|Other not stated below|0|||
161386050|NCT03835481|582797951|FG001|Double-blind Period|Other not stated below|0|||
161386051|NCT03835481|582797952|FG002|Double-blind Period|Other not stated below|0|||
161386052|NCT03835481|582797953|FG003|Double-blind Period|Other not stated below|1|||
161386053|NCT03835481|582797954|FG004|Double-blind Period|Other not stated below|1|||
161386054|NCT03835481|582797950|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
161386055|NCT03835481|582797951|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
161386056|NCT03835481|582797952|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
161386057|NCT03835481|582797953|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
161386058|NCT03835481|582797954|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
161386059|NCT03835481|582797950|FG000|Double-blind Period|Withdrawal by Subject|0|||
161386060|NCT03835481|582797951|FG001|Double-blind Period|Withdrawal by Subject|0|||
161386061|NCT03835481|582797952|FG002|Double-blind Period|Withdrawal by Subject|1|||
161386062|NCT03835481|582797953|FG003|Double-blind Period|Withdrawal by Subject|0|||
161386063|NCT03835481|582797954|FG004|Double-blind Period|Withdrawal by Subject|5|||
161386064|NCT03835481|582797950|FG000|Double-blind Period|Lost to Follow-up|0|||
161386065|NCT03835481|582797951|FG001|Double-blind Period|Lost to Follow-up|0|||
161386066|NCT03835481|582797952|FG002|Double-blind Period|Lost to Follow-up|0|||
161386067|NCT03835481|582797953|FG003|Double-blind Period|Lost to Follow-up|1|||
161386068|NCT03835481|582797954|FG004|Double-blind Period|Lost to Follow-up|0|||
161386069|NCT03835481|582797950|FG000|Double-blind Period|Protocol Violation|0|||
161386070|NCT03835481|582797951|FG001|Double-blind Period|Protocol Violation|2|||
161386071|NCT03835481|582797952|FG002|Double-blind Period|Protocol Violation|0|||
161386072|NCT03835481|582797953|FG003|Double-blind Period|Protocol Violation|1|||
161386073|NCT03835481|582797954|FG004|Double-blind Period|Protocol Violation|0|||
161386074|NCT03835481|582797950|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
161386075|NCT03835481|582797951|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
161386076|NCT03835481|582797952|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
161386077|NCT03835481|582797953|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
161386078|NCT03835481|582797954|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
161386079|NCT03835481|582797950|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
161386080|NCT03835481|582797951|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
161386081|NCT03835481|582797952|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
161386082|NCT03835481|582797953|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
161386083|NCT03835481|582797954|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
161386084|NCT03835481|582797950|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
161386085|NCT03835481|582797951|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
161386086|NCT03835481|582797952|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
161386087|NCT03835481|582797953|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
161386088|NCT03835481|582797954|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
161386089|NCT03835481|582797950|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
161386090|NCT03835481|582797951|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
161386091|NCT03835481|582797952|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
161386092|NCT03835481|582797953|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
161386093|NCT03835481|582797954|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
161386094|NCT03835481|582797950|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161386095|NCT03835481|582797951|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161386096|NCT03835481|582797952|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161386097|NCT03835481|582797953|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
161386098|NCT03835481|582797954|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161386099|NCT03835481|582797950|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
161386100|NCT03835481|582797951|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
161386101|NCT03835481|582797952|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
161386102|NCT03835481|582797953|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
161386103|NCT03835481|582797954|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
161386104|NCT01831466|582797964|FG000|Overall Study|Protocol Violation|1|||
161386105|NCT01831466|582797965|FG001|Overall Study|Protocol Violation|1|||
161386106|NCT01831466|582797966|FG002|Overall Study|Protocol Violation|2|||
161386107|NCT01831466|582797967|FG003|Overall Study|Protocol Violation|0|||
161386108|NCT01831466|582797968|FG004|Overall Study|Protocol Violation|0|||
161386109|NCT01831466|582797969|FG005|Overall Study|Protocol Violation|1|||
161386110|NCT01831466|582797970|FG006|Overall Study|Protocol Violation|0|||
161386111|NCT01831466|582797971|FG007|Overall Study|Protocol Violation|0|||
161386112|NCT01831466|582797972|FG008|Overall Study|Protocol Violation|0|||
161386113|NCT01831466|582797973|FG009|Overall Study|Protocol Violation|0|||
161386114|NCT01831466|582797974|FG010|Overall Study|Protocol Violation|0|||
161386115|NCT01831466|582797975|FG011|Overall Study|Protocol Violation|0|||
161386116|NCT01831466|582797964|FG000|Overall Study|Other|2|||
161386117|NCT01831466|582797965|FG001|Overall Study|Other|3|||
161386118|NCT01831466|582797966|FG002|Overall Study|Other|2|||
161386119|NCT01831466|582797967|FG003|Overall Study|Other|2|||
161386120|NCT01831466|582797968|FG004|Overall Study|Other|2|||
161386121|NCT01831466|582797969|FG005|Overall Study|Other|1|||
161386122|NCT01831466|582797970|FG006|Overall Study|Other|0|||
161386123|NCT01831466|582797971|FG007|Overall Study|Other|0|||
161386124|NCT01831466|582797972|FG008|Overall Study|Other|0|||
161386125|NCT01831466|582797973|FG009|Overall Study|Other|0|||
161386126|NCT01831466|582797974|FG010|Overall Study|Other|0|||
161386127|NCT01831466|582797975|FG011|Overall Study|Other|0|||
161386128|NCT01831466|582797964|FG000|Overall Study|Non-compliance with study treatment|2|||
161386129|NCT01831466|582797965|FG001|Overall Study|Non-compliance with study treatment|1|||
161386130|NCT01831466|582797966|FG002|Overall Study|Non-compliance with study treatment|1|||
161386131|NCT01831466|582797967|FG003|Overall Study|Non-compliance with study treatment|0|||
161386132|NCT01831466|582797968|FG004|Overall Study|Non-compliance with study treatment|0|||
161386133|NCT01831466|582797969|FG005|Overall Study|Non-compliance with study treatment|1|||
161386134|NCT01831466|582797970|FG006|Overall Study|Non-compliance with study treatment|0|||
161386135|NCT01831466|582797971|FG007|Overall Study|Non-compliance with study treatment|0|||
161386136|NCT01831466|582797972|FG008|Overall Study|Non-compliance with study treatment|0|||
161386137|NCT01831466|582797973|FG009|Overall Study|Non-compliance with study treatment|0|||
161386138|NCT01831466|582797974|FG010|Overall Study|Non-compliance with study treatment|0|||
161386139|NCT01831466|582797975|FG011|Overall Study|Non-compliance with study treatment|0|||
161386140|NCT01831466|582797964|FG000|Overall Study|Death|0|||
161386141|NCT01831466|582797965|FG001|Overall Study|Death|1|||
161386142|NCT01831466|582797966|FG002|Overall Study|Death|0|||
161386143|NCT01831466|582797967|FG003|Overall Study|Death|0|||
161386144|NCT01831466|582797968|FG004|Overall Study|Death|0|||
161386145|NCT01831466|582797969|FG005|Overall Study|Death|0|||
161386146|NCT01831466|582797970|FG006|Overall Study|Death|0|||
161386147|NCT01831466|582797971|FG007|Overall Study|Death|0|||
161386148|NCT01831466|582797972|FG008|Overall Study|Death|0|||
161386149|NCT01831466|582797973|FG009|Overall Study|Death|0|||
161386150|NCT01831466|582797974|FG010|Overall Study|Death|0|||
161386151|NCT01831466|582797975|FG011|Overall Study|Death|0|||
161386152|NCT01831466|582797964|FG000|Overall Study|Withdrawal by Subject|6|||
161386153|NCT01831466|582797965|FG001|Overall Study|Withdrawal by Subject|3|||
161386154|NCT01831466|582797966|FG002|Overall Study|Withdrawal by Subject|3|||
161386155|NCT01831466|582797967|FG003|Overall Study|Withdrawal by Subject|3|||
161386156|NCT01831466|582797968|FG004|Overall Study|Withdrawal by Subject|3|||
161386157|NCT01831466|582797969|FG005|Overall Study|Withdrawal by Subject|5|||
161386158|NCT01831466|582797970|FG006|Overall Study|Withdrawal by Subject|0|||
161386159|NCT01831466|582797971|FG007|Overall Study|Withdrawal by Subject|0|||
161386160|NCT01831466|582797972|FG008|Overall Study|Withdrawal by Subject|0|||
161386161|NCT01831466|582797973|FG009|Overall Study|Withdrawal by Subject|1|||
161386162|NCT01831466|582797974|FG010|Overall Study|Withdrawal by Subject|0|||
161386163|NCT01831466|582797975|FG011|Overall Study|Withdrawal by Subject|1|||
161386164|NCT01831466|582797964|FG000|Overall Study|Lost to Follow-up|0|||
161386165|NCT01831466|582797965|FG001|Overall Study|Lost to Follow-up|1|||
161386166|NCT01831466|582797966|FG002|Overall Study|Lost to Follow-up|4|||
161386167|NCT01831466|582797967|FG003|Overall Study|Lost to Follow-up|2|||
161386168|NCT01831466|582797968|FG004|Overall Study|Lost to Follow-up|0|||
161386169|NCT01831466|582797969|FG005|Overall Study|Lost to Follow-up|3|||
161386170|NCT01831466|582797970|FG006|Overall Study|Lost to Follow-up|0|||
161386171|NCT01831466|582797971|FG007|Overall Study|Lost to Follow-up|0|||
161386172|NCT01831466|582797972|FG008|Overall Study|Lost to Follow-up|0|||
161386173|NCT01831466|582797973|FG009|Overall Study|Lost to Follow-up|1|||
161386174|NCT01831466|582797974|FG010|Overall Study|Lost to Follow-up|0|||
161386175|NCT01831466|582797975|FG011|Overall Study|Lost to Follow-up|1|||
161386176|NCT01831466|582797964|FG000|Overall Study|Lack of Efficacy|5|||
161386177|NCT01831466|582797965|FG001|Overall Study|Lack of Efficacy|8|||
161386178|NCT01831466|582797966|FG002|Overall Study|Lack of Efficacy|7|||
161386179|NCT01831466|582797967|FG003|Overall Study|Lack of Efficacy|6|||
161386180|NCT01831466|582797968|FG004|Overall Study|Lack of Efficacy|9|||
161386181|NCT01831466|582797969|FG005|Overall Study|Lack of Efficacy|8|||
161386182|NCT01831466|582797970|FG006|Overall Study|Lack of Efficacy|1|||
161386183|NCT01831466|582797971|FG007|Overall Study|Lack of Efficacy|1|||
161386184|NCT01831466|582797972|FG008|Overall Study|Lack of Efficacy|2|||
161386185|NCT01831466|582797973|FG009|Overall Study|Lack of Efficacy|2|||
161386186|NCT01831466|582797974|FG010|Overall Study|Lack of Efficacy|2|||
161386187|NCT01831466|582797975|FG011|Overall Study|Lack of Efficacy|0|||
161386188|NCT01831466|582797964|FG000|Overall Study|Adverse Event|0|||
161386189|NCT01831466|582797965|FG001|Overall Study|Adverse Event|0|||
161386190|NCT01831466|582797966|FG002|Overall Study|Adverse Event|4|||
161386191|NCT01831466|582797967|FG003|Overall Study|Adverse Event|6|||
161386192|NCT01831466|582797968|FG004|Overall Study|Adverse Event|3|||
161386193|NCT01831466|582797969|FG005|Overall Study|Adverse Event|7|||
161386194|NCT01831466|582797970|FG006|Overall Study|Adverse Event|0|||
161386195|NCT01831466|582797971|FG007|Overall Study|Adverse Event|1|||
161386196|NCT01831466|582797972|FG008|Overall Study|Adverse Event|1|||
161386197|NCT01831466|582797973|FG009|Overall Study|Adverse Event|1|||
161386198|NCT01831466|582797974|FG010|Overall Study|Adverse Event|0|||
161386199|NCT01831466|582797975|FG011|Overall Study|Adverse Event|2|||
161386200|NCT02567799|582797977|FG000|Concurrent Chemoradiotherapy|Death|1|||
161386201|NCT02567799|582797978|FG001|Concurrent Chemoradiotherapy|Death|0|||
161386202|NCT02567799|582797979|FG002|Concurrent Chemoradiotherapy|Death|0|||
161386203|NCT02567799|582797977|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
161386204|NCT02567799|582797978|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
161386205|NCT02567799|582797979|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
161386206|NCT02567799|582797977|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
161386207|NCT02567799|582797978|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
161386208|NCT02567799|582797979|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
161386209|NCT02567799|582797977|FG000|Follow-up|Death|1|||
161386210|NCT02567799|582797978|FG001|Follow-up|Death|0|||
161386211|NCT02567799|582797979|FG002|Follow-up|Death|1|||
161386212|NCT02567799|582797977|FG000|Follow-up|Progressive Disease|1|||
161386213|NCT02567799|582797978|FG001|Follow-up|Progressive Disease|1|||
161386214|NCT02567799|582797979|FG002|Follow-up|Progressive Disease|3|||
161386215|NCT00556439|582798005|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
161386216|NCT00556439|582798006|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
161386217|NCT00556439|582798007|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
161386218|NCT00556439|582798008|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
161386219|NCT00556439|582798005|FG000|Study Entry to Week 12|Physician Decision|1|||
161386220|NCT00556439|582798006|FG001|Study Entry to Week 12|Physician Decision|0|||
161386221|NCT00556439|582798007|FG002|Study Entry to Week 12|Physician Decision|0|||
161386222|NCT00556439|582798008|FG003|Study Entry to Week 12|Physician Decision|0|||
161386223|NCT00556439|582798005|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
161386224|NCT00556439|582798006|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
161386225|NCT00556439|582798007|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
161386226|NCT00556439|582798008|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
161386227|NCT00556439|582798005|FG000|Study Entry to Week 12|Recurrent infection|1|||
161386228|NCT00556439|582798006|FG001|Study Entry to Week 12|Recurrent infection|0|||
161386229|NCT00556439|582798007|FG002|Study Entry to Week 12|Recurrent infection|0|||
161386230|NCT00556439|582798008|FG003|Study Entry to Week 12|Recurrent infection|0|||
161386231|NCT00556439|582798005|FG000|Study Entry to Week 12|Malignancy|0|||
161386232|NCT00556439|582798006|FG001|Study Entry to Week 12|Malignancy|0|||
161386233|NCT00556439|582798007|FG002|Study Entry to Week 12|Malignancy|1|||
161386234|NCT00556439|582798008|FG003|Study Entry to Week 12|Malignancy|0|||
161386235|NCT00556439|582798005|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
161386236|NCT00556439|582798006|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
161386237|NCT00556439|582798007|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
161386238|NCT00556439|582798008|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
161386239|NCT00556439|582798005|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
161386240|NCT00556439|582798006|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
161386241|NCT00556439|582798007|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
161386242|NCT00556439|582798008|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
161386243|NCT00556439|582798005|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
161386244|NCT00556439|582798006|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
161386245|NCT00556439|582798007|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
161386246|NCT00556439|582798008|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
161386247|NCT00556439|582798005|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
161386248|NCT00556439|582798006|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
161386249|NCT00556439|582798007|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
161386250|NCT00556439|582798008|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
161386251|NCT02100423|582798009|FG000|Overall Study|Death|1|||
161386252|NCT02100423|582798009|FG000|Overall Study|Withdrawal by Subject|3|||
161386253|NCT02100423|582798009|FG000|Overall Study|Adverse Event|1|||
161386254|NCT02100423|582798009|FG000|Overall Study|Physician Decision|1|||
161386255|NCT00703846|582798010|FG000|Overall Study|Adverse Event|8|||
161386256|NCT00703846|582798010|FG000|Overall Study|Lost to Follow-up|55|||
161386257|NCT00703846|582798010|FG000|Overall Study|Lack of Efficacy|15|||
161386258|NCT00703846|582798010|FG000|Overall Study|Noncompliance with Study Treatment|2|||
161386259|NCT00703846|582798010|FG000|Overall Study|Withdrawal by Subject|40|||
161386260|NCT00703846|582798010|FG000|Overall Study|Death|1|||
161386261|NCT00703846|582798010|FG000|Overall Study|Other|14|||
161386262|NCT00703846|582798010|FG000|Overall Study|Did Not Receive Study Drug|2|||
161386263|NCT02195700|582798011|FG000|Overall Study|Protocol Violation|0|||
161386264|NCT02195700|582798012|FG001|Overall Study|Protocol Violation|2|||
161386265|NCT02195700|582798011|FG000|Overall Study|Noncompliance|1|||
161386266|NCT02195700|582798012|FG001|Overall Study|Noncompliance|0|||
161386267|NCT02195700|582798011|FG000|Overall Study|Adverse Event|1|||
161386268|NCT02195700|582798012|FG001|Overall Study|Adverse Event|2|||
161386269|NCT02195700|582798011|FG000|Overall Study|Withdrawal by Subject|3|||
161386270|NCT02195700|582798012|FG001|Overall Study|Withdrawal by Subject|2|||
161386271|NCT02195700|582798011|FG000|Overall Study|Lost to Follow-up|1|||
161386272|NCT02195700|582798012|FG001|Overall Study|Lost to Follow-up|1|||
161386273|NCT04601532|582798013|FG000|Overall Study|Lost to Follow-up|1|||
161386274|NCT04601532|582798014|FG001|Overall Study|Lost to Follow-up|2|||
161386275|NCT04601532|582798013|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
161386276|NCT04601532|582798014|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
161386277|NCT01352221|582798015|FG000|Double-blind Phase|Adverse Event|6|||
161386278|NCT01352221|582798016|FG001|Double-blind Phase|Adverse Event|4|||
161386279|NCT01352221|582798017|FG002|Double-blind Phase|Adverse Event|0|||
161386280|NCT01352221|582798018|FG003|Double-blind Phase|Adverse Event|0|||
161386281|NCT01352221|582798015|FG000|Double-blind Phase|Withdrawal by Subject|3|||
161386282|NCT01352221|582798016|FG001|Double-blind Phase|Withdrawal by Subject|5|||
161386283|NCT01352221|582798017|FG002|Double-blind Phase|Withdrawal by Subject|0|||
161386284|NCT01352221|582798018|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161386285|NCT01352221|582798015|FG000|Double-blind Phase|Lost to Follow-up|0|||
161386286|NCT01352221|582798016|FG001|Double-blind Phase|Lost to Follow-up|1|||
161386287|NCT01352221|582798017|FG002|Double-blind Phase|Lost to Follow-up|0|||
161386288|NCT01352221|582798018|FG003|Double-blind Phase|Lost to Follow-up|0|||
161386289|NCT01352221|582798015|FG000|Double-blind Phase|Protocol Violation|0|||
161386290|NCT01352221|582798016|FG001|Double-blind Phase|Protocol Violation|1|||
161386291|NCT01352221|582798017|FG002|Double-blind Phase|Protocol Violation|0|||
161386292|NCT01352221|582798018|FG003|Double-blind Phase|Protocol Violation|0|||
161386293|NCT01352221|582798015|FG000|Open-label Phase|Physician Decision|0|||
161386294|NCT01352221|582798016|FG001|Open-label Phase|Physician Decision|0|||
161386295|NCT01352221|582798017|FG002|Open-label Phase|Physician Decision|2|||
161386296|NCT01352221|582798018|FG003|Open-label Phase|Physician Decision|1|||
161386297|NCT01352221|582798015|FG000|Open-label Phase|Pregnancy|0|||
161386298|NCT01352221|582798016|FG001|Open-label Phase|Pregnancy|0|||
161386299|NCT01352221|582798017|FG002|Open-label Phase|Pregnancy|1|||
161386300|NCT01352221|582798018|FG003|Open-label Phase|Pregnancy|0|||
161386301|NCT01352221|582798015|FG000|Open-label Phase|Adverse Event|0|||
161386302|NCT01352221|582798016|FG001|Open-label Phase|Adverse Event|0|||
161386303|NCT01352221|582798017|FG002|Open-label Phase|Adverse Event|8|||
161386304|NCT01352221|582798018|FG003|Open-label Phase|Adverse Event|4|||
161386305|NCT01352221|582798015|FG000|Open-label Phase|Withdrawal by Subject|0|||
161386306|NCT01352221|582798016|FG001|Open-label Phase|Withdrawal by Subject|0|||
161386307|NCT01352221|582798017|FG002|Open-label Phase|Withdrawal by Subject|1|||
161386308|NCT01352221|582798018|FG003|Open-label Phase|Withdrawal by Subject|6|||
161386309|NCT01352221|582798015|FG000|Open-label Phase|Worsening of IBD|0|||
161386310|NCT01352221|582798016|FG001|Open-label Phase|Worsening of IBD|0|||
161386311|NCT01352221|582798017|FG002|Open-label Phase|Worsening of IBD|1|||
161386312|NCT01352221|582798018|FG003|Open-label Phase|Worsening of IBD|0|||
161386313|NCT02566785|582798019|FG000|Overall Study|Lost to Follow-up|0|||
161386314|NCT02566785|582798020|FG001|Overall Study|Lost to Follow-up|2|||
161386315|NCT02566785|582798019|FG000|Overall Study|Worsening condition|1|||
161386316|NCT02566785|582798020|FG001|Overall Study|Worsening condition|1|||
161386317|NCT01597908|582798021|FG000|Randomized Phase|Death|217|||
161386318|NCT01597908|582798022|FG001|Randomized Phase|Death|238|||
161386319|NCT01597908|582798023|FG002|Randomized Phase|Death|0|||
161386320|NCT01597908|582798021|FG000|Randomized Phase|Sponsor Decision|93|||
161386321|NCT01597908|582798022|FG001|Randomized Phase|Sponsor Decision|39|||
161386322|NCT01597908|582798023|FG002|Randomized Phase|Sponsor Decision|0|||
161386323|NCT01597908|582798021|FG000|Randomized Phase|Lost to Follow-up|9|||
161386324|NCT01597908|582798022|FG001|Randomized Phase|Lost to Follow-up|16|||
161386325|NCT01597908|582798023|FG002|Randomized Phase|Lost to Follow-up|0|||
161386326|NCT01597908|582798021|FG000|Randomized Phase|Physician Decision|6|||
161386327|NCT01597908|582798022|FG001|Randomized Phase|Physician Decision|3|||
161386328|NCT01597908|582798023|FG002|Randomized Phase|Physician Decision|0|||
161386329|NCT01597908|582798021|FG000|Randomized Phase|Withdrawal by Subject|26|||
161386330|NCT01597908|582798022|FG001|Randomized Phase|Withdrawal by Subject|22|||
161386331|NCT01597908|582798023|FG002|Randomized Phase|Withdrawal by Subject|0|||
161386332|NCT01597908|582798021|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
161386333|NCT01597908|582798022|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
161386334|NCT01597908|582798023|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
161386335|NCT01597908|582798021|FG000|Crossover Phase|Death|0|||
161386336|NCT01597908|582798022|FG001|Crossover Phase|Death|0|||
161386337|NCT01597908|582798023|FG002|Crossover Phase|Death|11|||
161386338|NCT01597908|582798021|FG000|Crossover Phase|Withdrawal by Subject|0|||
161386339|NCT01597908|582798022|FG001|Crossover Phase|Withdrawal by Subject|0|||
161386340|NCT01597908|582798023|FG002|Crossover Phase|Withdrawal by Subject|3|||
161386341|NCT01597908|582798021|FG000|Crossover Phase|Sponsor Decision|0|||
161386342|NCT01597908|582798022|FG001|Crossover Phase|Sponsor Decision|0|||
161386343|NCT01597908|582798023|FG002|Crossover Phase|Sponsor Decision|20|||
161386344|NCT02547038|582799719|FG000|Overall Study|Lost to Follow-up|3|||
161386345|NCT02547038|582799720|FG001|Overall Study|Lost to Follow-up|2|||
161386346|NCT01340625|582799723|FG000|First Intervention|Adverse Event|1|||
161386347|NCT01340625|582799724|FG001|First Intervention|Adverse Event|0|||
161386348|NCT01340625|582799723|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
161386349|NCT01340625|582799724|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
161386350|NCT05160415|582799725|FG000|Overall Study|Withdrawal by Subject|3|||
161386351|NCT00623233|582799726|FG000|Overall Study|Adverse Event|10|||
161386352|NCT00623233|582799726|FG000|Overall Study|Physician Decision|10|||
161386353|NCT00623233|582799726|FG000|Overall Study|Lost to Follow-up|1|||
161386354|NCT00623233|582799726|FG000|Overall Study|Withdrawal by Subject|3|||
161386355|NCT00459875|582799727|FG000|Overall Study|Ineligible participant|1|||
161386356|NCT00459875|582799727|FG000|Overall Study|Adverse Event|2|||
161386357|NCT00576628|582799730|FG000|Overall Study|Adverse Event|11|||
161386358|NCT00576628|582799730|FG000|Overall Study|Death|2|||
161386359|NCT00576628|582799730|FG000|Overall Study|Failure to return|1|||
161386360|NCT00576628|582799730|FG000|Overall Study|Refused Treatment|8|||
161386361|NCT00576628|582799730|FG000|Overall Study|Pregnancy|1|||
161386362|NCT00576628|582799730|FG000|Overall Study|RBC transfusion|1|||
161386363|NCT00576628|582799730|FG000|Overall Study|Progression of Kidney Disease|1|||
161386364|NCT00576628|582799730|FG000|Overall Study|Progression of Renal Failure|1|||
161386365|NCT00576628|582799730|FG000|Overall Study|The patient move into other town|1|||
161386366|NCT00576628|582799730|FG000|Overall Study|Transplantation|1|||
161386367|NCT00576628|582799730|FG000|Overall Study|Dialysis|15|||
161386368|NCT03206970|582799731|FG000|Overall Study|Death|21|||
161386369|NCT03206970|582799731|FG000|Overall Study|Withdrawal by Subject|13|||
161386370|NCT03206970|582799731|FG000|Overall Study|Lost to Follow-up|3|||
161386371|NCT03206970|582799731|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
161386372|NCT03654040|582799738|FG000|Overall Study|Death|1|||
161386373|NCT03654040|582799739|FG001|Overall Study|Death|0|||
161386374|NCT03654040|582799738|FG000|Overall Study|Withdrawal by Subject|1|||
161386375|NCT03654040|582799739|FG001|Overall Study|Withdrawal by Subject|0|||
161386376|NCT03654040|582799738|FG000|Overall Study|Study terminated by sponsor|8|||
161386377|NCT03654040|582799739|FG001|Overall Study|Study terminated by sponsor|2|||
161386378|NCT03654040|582799738|FG000|Overall Study|Failure to initiate study therapy|2|||
161386379|NCT03654040|582799739|FG001|Overall Study|Failure to initiate study therapy|0|||
161386380|NCT03654040|582799738|FG000|Overall Study|Transplanted at another center|2|||
161386381|NCT03654040|582799739|FG001|Overall Study|Transplanted at another center|0|||
161386382|NCT03654040|582799738|FG000|Overall Study|Failure to meet eligibility criteria|14|||
161386383|NCT03654040|582799739|FG001|Overall Study|Failure to meet eligibility criteria|2|||
161386384|NCT03654040|582799738|FG000|Overall Study|No longer transplant candidate|1|||
161386385|NCT03654040|582799739|FG001|Overall Study|No longer transplant candidate|0|||
161386386|NCT03654040|582799738|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
161386387|NCT03654040|582799739|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
161386388|NCT03654040|582799738|FG000|Overall Study|Recipient ineligible|0|||
161386389|NCT03654040|582799739|FG001|Overall Study|Recipient ineligible|2|||
161386390|NCT03654040|582799738|FG000|Overall Study|Received deceased liver|0|||
161386391|NCT03654040|582799739|FG001|Overall Study|Received deceased liver|1|||
161386392|NCT01951586|582799744|FG000|Overall Study|Death|61|||
161386393|NCT01951586|582799745|FG001|Overall Study|Death|120|||
161386394|NCT01951586|582799744|FG000|Overall Study|Withdrawal by Subject|8|||
161386395|NCT01951586|582799745|FG001|Overall Study|Withdrawal by Subject|17|||
161386396|NCT01951586|582799744|FG000|Overall Study|Lost to Follow-up|0|||
161386397|NCT01951586|582799745|FG001|Overall Study|Lost to Follow-up|1|||
161386398|NCT01951586|582799744|FG000|Overall Study|Sponsor Decision|9|||
161386399|NCT01951586|582799745|FG001|Overall Study|Sponsor Decision|10|||
161386400|NCT05332392|582799746|FG000|Overall Study|Did not meet inclusion criteria|25|||
161386401|NCT05332392|582799746|FG000|Overall Study|Principal Investigator's decision|17|||
161386402|NCT05332392|582799746|FG000|Overall Study|Adverse Event|1|||
161386403|NCT05332392|582799746|FG000|Overall Study|Subject's decision|1|||
161386404|NCT00224120|582799747|FG000|Overall Study|Adverse Event|10|||
161386405|NCT00224120|582799748|FG001|Overall Study|Adverse Event|4|||
161386406|NCT00224120|582799747|FG000|Overall Study|Protocol Violation|1|||
161386407|NCT00224120|582799748|FG001|Overall Study|Protocol Violation|0|||
161386408|NCT00224120|582799747|FG000|Overall Study|Withdrawal by Subject|5|||
161386409|NCT00224120|582799748|FG001|Overall Study|Withdrawal by Subject|10|||
161386410|NCT00224120|582799747|FG000|Overall Study|Lack of Efficacy|0|||
161386411|NCT00224120|582799748|FG001|Overall Study|Lack of Efficacy|2|||
161386412|NCT00224120|582799747|FG000|Overall Study|Lost to Follow-up|2|||
161386413|NCT00224120|582799748|FG001|Overall Study|Lost to Follow-up|3|||
161386414|NCT00224120|582799747|FG000|Overall Study|Other|4|||
161386415|NCT00224120|582799748|FG001|Overall Study|Other|5|||
161386416|NCT00104416|582799751|FG000|Double-Blind Phase|Adverse Event|2|||
161386417|NCT00104416|582799752|FG001|Double-Blind Phase|Adverse Event|1|||
161386418|NCT00104416|582799753|FG002|Double-Blind Phase|Adverse Event|0|||
161386419|NCT00104416|582799754|FG003|Double-Blind Phase|Adverse Event|0|||
161386420|NCT00104416|582799755|FG004|Double-Blind Phase|Adverse Event|0|||
161386421|NCT00104416|582799751|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161386422|NCT00104416|582799752|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161386423|NCT00104416|582799753|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161386424|NCT00104416|582799754|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161386425|NCT00104416|582799755|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161386426|NCT00104416|582799751|FG000|Double-Blind Phase|Protocol Violation|0|||
161386427|NCT00104416|582799752|FG001|Double-Blind Phase|Protocol Violation|1|||
161386428|NCT00104416|582799753|FG002|Double-Blind Phase|Protocol Violation|0|||
161386429|NCT00104416|582799754|FG003|Double-Blind Phase|Protocol Violation|0|||
161386430|NCT00104416|582799755|FG004|Double-Blind Phase|Protocol Violation|0|||
161386431|NCT00104416|582799751|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161386432|NCT00104416|582799752|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
161386433|NCT00104416|582799753|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161386434|NCT00104416|582799754|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161386435|NCT00104416|582799755|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161386436|NCT00104416|582799751|FG000|Double-Blind Phase|Pregnancy|1|||
161386437|NCT00104416|582799752|FG001|Double-Blind Phase|Pregnancy|0|||
161386438|NCT00104416|582799753|FG002|Double-Blind Phase|Pregnancy|0|||
161386439|NCT00104416|582799754|FG003|Double-Blind Phase|Pregnancy|0|||
161386440|NCT00104416|582799755|FG004|Double-Blind Phase|Pregnancy|0|||
161386441|NCT00104416|582799751|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
161386442|NCT00104416|582799752|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
161386443|NCT00104416|582799753|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
161386444|NCT00104416|582799754|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
161386445|NCT00104416|582799755|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
161386446|NCT00104416|582799751|FG000|Continuation Phase|Adverse Event|0|||
161386447|NCT00104416|582799752|FG001|Continuation Phase|Adverse Event|0|||
161386448|NCT00104416|582799753|FG002|Continuation Phase|Adverse Event|2|||
161386449|NCT00104416|582799754|FG003|Continuation Phase|Adverse Event|0|||
161386450|NCT00104416|582799755|FG004|Continuation Phase|Adverse Event|2|||
161386451|NCT00104416|582799751|FG000|Continuation Phase|Lost to Follow-up|0|||
161386452|NCT00104416|582799752|FG001|Continuation Phase|Lost to Follow-up|0|||
161386453|NCT00104416|582799753|FG002|Continuation Phase|Lost to Follow-up|1|||
161386454|NCT00104416|582799754|FG003|Continuation Phase|Lost to Follow-up|0|||
161386455|NCT00104416|582799755|FG004|Continuation Phase|Lost to Follow-up|1|||
161386456|NCT00104416|582799751|FG000|Continuation Phase|Withdrawal by Subject|0|||
161386457|NCT00104416|582799752|FG001|Continuation Phase|Withdrawal by Subject|0|||
161386458|NCT00104416|582799753|FG002|Continuation Phase|Withdrawal by Subject|2|||
161386459|NCT00104416|582799754|FG003|Continuation Phase|Withdrawal by Subject|1|||
161386460|NCT00104416|582799755|FG004|Continuation Phase|Withdrawal by Subject|1|||
161386461|NCT00104416|582799751|FG000|Continuation Phase|Pregnancy|0|||
161386462|NCT00104416|582799752|FG001|Continuation Phase|Pregnancy|0|||
161386463|NCT00104416|582799753|FG002|Continuation Phase|Pregnancy|1|||
161386464|NCT00104416|582799754|FG003|Continuation Phase|Pregnancy|1|||
161386465|NCT00104416|582799755|FG004|Continuation Phase|Pregnancy|0|||
161386466|NCT00104416|582799751|FG000|Continuation Phase|Non-compliance|0|||
161386467|NCT00104416|582799752|FG001|Continuation Phase|Non-compliance|0|||
161386468|NCT00104416|582799753|FG002|Continuation Phase|Non-compliance|0|||
161386469|NCT00104416|582799754|FG003|Continuation Phase|Non-compliance|0|||
161386470|NCT00104416|582799755|FG004|Continuation Phase|Non-compliance|1|||
161386471|NCT00438360|582799756|FG000|Overall Study|Adverse Event|6|||
161386472|NCT00438360|582799757|FG001|Overall Study|Adverse Event|1|||
161386473|NCT00438360|582799756|FG000|Overall Study|Lack of Efficacy|42|||
161386474|NCT00438360|582799757|FG001|Overall Study|Lack of Efficacy|27|||
161386475|NCT00438360|582799756|FG000|Overall Study|Other|24|||
161386476|NCT00438360|582799757|FG001|Overall Study|Other|15|||
161386477|NCT03629223|582799758|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
161386478|NCT03629223|582799759|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
161386479|NCT03629223|582799760|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
161386480|NCT03629223|582799761|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
161386481|NCT03629223|582799762|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
161386482|NCT03629223|582799763|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
161386483|NCT03629223|582799758|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161386484|NCT03629223|582799759|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161386485|NCT03629223|582799760|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161386486|NCT03629223|582799761|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
161386487|NCT03629223|582799762|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161386488|NCT03629223|582799763|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161386489|NCT03629223|582799758|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161386490|NCT03629223|582799759|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
161386491|NCT03629223|582799760|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161386492|NCT03629223|582799761|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161386493|NCT03629223|582799762|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161386494|NCT03629223|582799763|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161386495|NCT03629223|582799758|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161386496|NCT03629223|582799759|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
161386497|NCT03629223|582799760|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161386498|NCT03629223|582799761|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161386499|NCT03629223|582799762|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161386500|NCT03629223|582799763|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161386501|NCT03629223|582799758|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
161386502|NCT03629223|582799759|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161386503|NCT03629223|582799760|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161386504|NCT03629223|582799761|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161386505|NCT03629223|582799762|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161386506|NCT03629223|582799763|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161386507|NCT01534351|582799764|FG000|Overall Study|Study Terminated Early|1|||
161386508|NCT01534351|582799765|FG001|Overall Study|Study Terminated Early|0|||
161386509|NCT01534351|582799766|FG002|Overall Study|Study Terminated Early|0|||
161386510|NCT01071252|582799767|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
161386511|NCT01071252|582799768|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
161386512|NCT01071252|582799769|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
161386513|NCT01071252|582799770|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
161386514|NCT01071252|582799771|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
161386515|NCT01071252|582799767|FG000|Overall Study|Withdrawal by Subject|8|||
161386516|NCT01071252|582799768|FG001|Overall Study|Withdrawal by Subject|2|||
161386517|NCT01071252|582799769|FG002|Overall Study|Withdrawal by Subject|1|||
161386518|NCT01071252|582799770|FG003|Overall Study|Withdrawal by Subject|2|||
161386519|NCT01071252|582799771|FG004|Overall Study|Withdrawal by Subject|3|||
161386520|NCT01071252|582799767|FG000|Overall Study|administrative problems|1|||
161386521|NCT01071252|582799768|FG001|Overall Study|administrative problems|1|||
161386522|NCT01071252|582799769|FG002|Overall Study|administrative problems|0|||
161386523|NCT01071252|582799770|FG003|Overall Study|administrative problems|2|||
161386524|NCT01071252|582799771|FG004|Overall Study|administrative problems|1|||
161386525|NCT01071252|582799767|FG000|Overall Study|Lost to Follow-up|1|||
161386526|NCT01071252|582799768|FG001|Overall Study|Lost to Follow-up|0|||
161386527|NCT01071252|582799769|FG002|Overall Study|Lost to Follow-up|1|||
161386528|NCT01071252|582799770|FG003|Overall Study|Lost to Follow-up|2|||
161386529|NCT01071252|582799771|FG004|Overall Study|Lost to Follow-up|0|||
161386530|NCT01071252|582799767|FG000|Overall Study|Adverse Event|1|||
161386531|NCT01071252|582799768|FG001|Overall Study|Adverse Event|1|||
161386532|NCT01071252|582799769|FG002|Overall Study|Adverse Event|0|||
161386533|NCT01071252|582799770|FG003|Overall Study|Adverse Event|1|||
161386534|NCT01071252|582799771|FG004|Overall Study|Adverse Event|0|||
161386535|NCT01071252|582799767|FG000|Overall Study|Death|0|||
161386536|NCT01071252|582799768|FG001|Overall Study|Death|0|||
161386537|NCT01071252|582799769|FG002|Overall Study|Death|0|||
161386538|NCT01071252|582799770|FG003|Overall Study|Death|0|||
161386539|NCT01071252|582799771|FG004|Overall Study|Death|1|||
161386540|NCT01066104|582799772|FG000|Overall Study|Adverse Event|1|||
161386541|NCT01066104|582799773|FG001|Overall Study|Adverse Event|1|||
161386542|NCT01066104|582799772|FG000|Overall Study|Protocol Violation|1|||
161386543|NCT01066104|582799773|FG001|Overall Study|Protocol Violation|0|||
161386544|NCT03902392|582799776|FG000|Overall Study|Lost to Follow-up|7|||
161386545|NCT03902392|582799777|FG001|Overall Study|Lost to Follow-up|7|||
161386546|NCT03248167|582799780|FG000|Overall Study|Withdrawal by Subject|2|||
161386547|NCT03248167|582799781|FG001|Overall Study|Withdrawal by Subject|2|||
161386548|NCT03248167|582799780|FG000|Overall Study|Physician Decision|0|||
161386549|NCT03248167|582799781|FG001|Overall Study|Physician Decision|1|||
161386550|NCT03248167|582799780|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
161386551|NCT03248167|582799781|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
161386552|NCT03248167|582799780|FG000|Overall Study|Lost to Follow-up|1|||
161386553|NCT03248167|582799781|FG001|Overall Study|Lost to Follow-up|0|||
161386554|NCT01558596|582799784|FG000|Overall Study|Withdrawal by Subject|1|||
161386555|NCT01558596|582799785|FG001|Overall Study|Withdrawal by Subject|0|||
161386556|NCT01558596|582799784|FG000|Overall Study|surgery elsewhere or cancelled|1|||
161386557|NCT01558596|582799785|FG001|Overall Study|surgery elsewhere or cancelled|1|||
161386558|NCT01558596|582799784|FG000|Overall Study|Protocol Violation|1|||
161386559|NCT01558596|582799785|FG001|Overall Study|Protocol Violation|0|||
161386560|NCT00260832|582799787|FG000|Overall Study|Adverse Event|26|||
161386561|NCT00260832|582799788|FG001|Overall Study|Adverse Event|19|||
161386562|NCT00260832|582799787|FG000|Overall Study|Progression|116|||
161386563|NCT00260832|582799788|FG001|Overall Study|Progression|96|||
161386564|NCT00260832|582799787|FG000|Overall Study|Withdrawal by Subject|15|||
161386565|NCT00260832|582799788|FG001|Overall Study|Withdrawal by Subject|17|||
161386566|NCT00260832|582799787|FG000|Overall Study|Physician Decision|15|||
161386567|NCT00260832|582799788|FG001|Overall Study|Physician Decision|9|||
161386568|NCT00260832|582799787|FG000|Overall Study|Death|43|||
161386569|NCT00260832|582799788|FG001|Overall Study|Death|62|||
161386570|NCT00260832|582799787|FG000|Overall Study|Other|10|||
161386571|NCT00260832|582799788|FG001|Overall Study|Other|7|||
161386572|NCT00260832|582799787|FG000|Overall Study|Protocol Violation|3|||
161386573|NCT00260832|582799788|FG001|Overall Study|Protocol Violation|1|||
161386574|NCT00771927|582799789|FG000|Overall Study|Adverse Event|100|||
161386575|NCT00771927|582799790|FG001|Overall Study|Adverse Event|105|||
161386576|NCT00771927|582799789|FG000|Overall Study|Lack of Efficacy|70|||
161386577|NCT00771927|582799790|FG001|Overall Study|Lack of Efficacy|42|||
161386578|NCT00771927|582799789|FG000|Overall Study|Lost to Follow-up|46|||
161386579|NCT00771927|582799790|FG001|Overall Study|Lost to Follow-up|46|||
161386580|NCT00771927|582799789|FG000|Overall Study|Withdrawal by Subject|16|||
161386581|NCT00771927|582799790|FG001|Overall Study|Withdrawal by Subject|17|||
161386582|NCT00771927|582799789|FG000|Overall Study|Other reason|23|||
161386583|NCT00771927|582799790|FG001|Overall Study|Other reason|27|||
161386584|NCT04222699|582799794|FG000|Overall Study|Lost to Follow-up|2|||
161386585|NCT02467192|582799798|FG000|Overall Study|Death|1|||
161386586|NCT02467192|582799798|FG000|Overall Study|revealed to have pneumonia before|2|||
161386587|NCT03213938|582799799|FG000|Overall Study|Lost to Follow-up|4|||
161386588|NCT03213938|582799800|FG001|Overall Study|Lost to Follow-up|3|||
161386589|NCT03213938|582799799|FG000|Overall Study|Lack of Efficacy|1|||
161386590|NCT03213938|582799800|FG001|Overall Study|Lack of Efficacy|0|||
161386591|NCT03213938|582799799|FG000|Overall Study|Decline to participate|5|||
161386592|NCT03213938|582799800|FG001|Overall Study|Decline to participate|4|||
161386593|NCT03213938|582799799|FG000|Overall Study|Without reason|4|||
161386594|NCT03213938|582799800|FG001|Overall Study|Without reason|5|||
161386595|NCT00375505|582799817|FG000|Overall Study|Adverse Event|1|||
161386596|NCT00375505|582799818|FG001|Overall Study|Adverse Event|2|||
161386597|NCT00005947|582799819|FG000|Overall Study|Death|54|||
161386598|NCT00005947|582799820|FG001|Overall Study|Death|40|||
161386599|NCT00005947|582799819|FG000|Overall Study|Patient Refused to Continue|2|||
161386600|NCT00005947|582799820|FG001|Overall Study|Patient Refused to Continue|1|||
161386601|NCT00005947|582799819|FG000|Overall Study|Site Closure|1|||
161386602|NCT00005947|582799820|FG001|Overall Study|Site Closure|0|||
161386603|NCT00429182|582799821|FG000|Overall Study|Not evaluable, Disease Progression|2|||
161386604|NCT00429182|582799821|FG000|Overall Study|Not eligible|5|||
161386605|NCT02146131|582799822|FG000|Overall Study|Physician Decision|61|||
161386606|NCT02146131|582799823|FG001|Overall Study|Physician Decision|56|||
161386607|NCT03335150|582799826|FG000|Overall Study|Withdrawal by Subject|10|||
161386608|NCT03335150|582799827|FG001|Overall Study|Withdrawal by Subject|4|||
161386609|NCT03335150|582799826|FG000|Overall Study|Adverse Event|0|||
161386610|NCT03335150|582799827|FG001|Overall Study|Adverse Event|1|||
161386611|NCT02218697|582799832|FG000|Overall Study|Adverse Event|0|||
161386612|NCT02218697|582799833|FG001|Overall Study|Adverse Event|2|||
161386613|NCT02218697|582799832|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
161386614|NCT02218697|582799833|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
161386615|NCT02218697|582799832|FG000|Overall Study|Withdrawal by Subject|2|||
161386616|NCT02218697|582799833|FG001|Overall Study|Withdrawal by Subject|3|||
161386617|NCT02142803|582799836|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
161386618|NCT02142803|582799837|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
161386619|NCT02142803|582799838|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
161386620|NCT02142803|582799839|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
161386621|NCT05111002|582799842|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
161386622|NCT05111002|582799843|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
161386623|NCT05111002|582799842|FG000|Secondary Outcome|Lost to Follow-up|1|||
161386624|NCT05111002|582799843|FG001|Secondary Outcome|Lost to Follow-up|0|||
161386625|NCT04380753|582799844|FG000|Overall Study|Participants continuing study|4|||
161386626|NCT04380753|582799844|FG000|Overall Study|Death|2|||
161386627|NCT00809926|582799845|FG000|Overall Study|Adverse Event|18|||
161386628|NCT00809926|582799846|FG001|Overall Study|Adverse Event|10|||
161386629|NCT00809926|582799845|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161386630|NCT00809926|582799846|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161386631|NCT00809926|582799845|FG000|Overall Study|Patient withdrew consent|8|||
161386632|NCT00809926|582799846|FG001|Overall Study|Patient withdrew consent|6|||
161386633|NCT00809926|582799845|FG000|Overall Study|Lost to Follow-up|2|||
161386634|NCT00809926|582799846|FG001|Overall Study|Lost to Follow-up|1|||
161386635|NCT00809926|582799845|FG000|Overall Study|Administrative Problems|0|||
161386636|NCT00809926|582799846|FG001|Overall Study|Administrative Problems|1|||
161386637|NCT00809926|582799845|FG000|Overall Study|Protocol deviation|0|||
161386638|NCT00809926|582799846|FG001|Overall Study|Protocol deviation|2|||
161386639|NCT04776720|582799851|FG000|Overall Study|COVID Related|4|||
161386640|NCT04776720|582799852|FG001|Overall Study|COVID Related|2|||
161386641|NCT04776720|582799851|FG000|Overall Study|Adverse Event|2|||
161386642|NCT04776720|582799852|FG001|Overall Study|Adverse Event|0|||
161386643|NCT04776720|582799851|FG000|Overall Study|Serious Adverse Event|0|||
161386644|NCT04776720|582799852|FG001|Overall Study|Serious Adverse Event|1|||
161386645|NCT04776720|582799851|FG000|Overall Study|Too Busy|3|||
161386646|NCT04776720|582799852|FG001|Overall Study|Too Busy|1|||
161386647|NCT04776720|582799851|FG000|Overall Study|Lost to Follow-up|1|||
161386648|NCT04776720|582799852|FG001|Overall Study|Lost to Follow-up|2|||
161386649|NCT04776720|582799851|FG000|Overall Study|Family|2|||
161386650|NCT04776720|582799852|FG001|Overall Study|Family|2|||
161386651|NCT04776720|582799851|FG000|Overall Study|No remote technology access|0|||
161386652|NCT04776720|582799852|FG001|Overall Study|No remote technology access|1|||
161386653|NCT04776720|582799851|FG000|Overall Study|Withdrawal by Subject|1|||
161386654|NCT04776720|582799852|FG001|Overall Study|Withdrawal by Subject|0|||
161386655|NCT04776720|582799851|FG000|Overall Study|Cannot tolerate intervention|1|||
161386656|NCT04776720|582799852|FG001|Overall Study|Cannot tolerate intervention|0|||
161386657|NCT04776720|582799851|FG000|Overall Study|Incomplete outcome data|6|||
161386658|NCT04776720|582799852|FG001|Overall Study|Incomplete outcome data|1|||
161386659|NCT05356910|582799853|FG000|Overall Study|Lost to Follow-up|10|||
161386660|NCT05356910|582799854|FG001|Overall Study|Lost to Follow-up|19|||
161386661|NCT05356910|582799855|FG002|Overall Study|Lost to Follow-up|0|||
161386662|NCT05356910|582799856|FG003|Overall Study|Lost to Follow-up|0|||
161386663|NCT05356910|582799853|FG000|Overall Study|Withdrawal by Subject|4|||
161386664|NCT05356910|582799854|FG001|Overall Study|Withdrawal by Subject|2|||
161386665|NCT05356910|582799855|FG002|Overall Study|Withdrawal by Subject|0|||
161386666|NCT05356910|582799856|FG003|Overall Study|Withdrawal by Subject|0|||
161386667|NCT02712996|582799860|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
161386668|NCT02712996|582799861|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
161386669|NCT01451749|582799864|FG000|Overall Study|Protocol Violation|14|||
161386670|NCT01451749|582799865|FG001|Overall Study|Protocol Violation|7|||
161386671|NCT01451749|582799864|FG000|Overall Study|Lost to Follow-up|15|||
161386672|NCT01451749|582799865|FG001|Overall Study|Lost to Follow-up|5|||
161386673|NCT01451749|582799864|FG000|Overall Study|Meet the exclusion criteria,and|1|||
161386674|NCT01451749|582799865|FG001|Overall Study|Meet the exclusion criteria,and|1|||
161386675|NCT01451749|582799864|FG000|Overall Study|Adverse Event|2|||
161386676|NCT01451749|582799865|FG001|Overall Study|Adverse Event|0|||
161386677|NCT01451749|582799864|FG000|Overall Study|Withdrawal by Subject|0|||
161386678|NCT01451749|582799865|FG001|Overall Study|Withdrawal by Subject|1|||
161386679|NCT00972517|582799866|FG000|Overall Study|Adverse Event|0|||
161386680|NCT00972517|582799867|FG001|Overall Study|Adverse Event|0|||
161386681|NCT00972517|582799868|FG002|Overall Study|Adverse Event|0|||
161386682|NCT00972517|582799869|FG003|Overall Study|Adverse Event|1|||
161386683|NCT00972517|582799870|FG004|Overall Study|Adverse Event|0|||
161386684|NCT00972517|582799871|FG005|Overall Study|Adverse Event|0|||
161386685|NCT00972517|582799866|FG000|Overall Study|Withdrawal by Subject|0|||
161386686|NCT00972517|582799867|FG001|Overall Study|Withdrawal by Subject|1|||
161386687|NCT00972517|582799868|FG002|Overall Study|Withdrawal by Subject|0|||
161386688|NCT00972517|582799869|FG003|Overall Study|Withdrawal by Subject|2|||
161386689|NCT00972517|582799870|FG004|Overall Study|Withdrawal by Subject|1|||
161386690|NCT00972517|582799871|FG005|Overall Study|Withdrawal by Subject|0|||
161386691|NCT02311881|582799872|FG000|Overall Study|Did not meet the study criteria|2|||
161386692|NCT02311881|582799873|FG001|Overall Study|Did not meet the study criteria|2|||
161386693|NCT02311881|582799874|FG002|Overall Study|Did not meet the study criteria|0|||
161386694|NCT02311881|582799872|FG000|Overall Study|Adverse Event|7|||
161386695|NCT02311881|582799873|FG001|Overall Study|Adverse Event|15|||
161386696|NCT02311881|582799874|FG002|Overall Study|Adverse Event|8|||
161386697|NCT02311881|582799872|FG000|Overall Study|Lost to Follow-up|3|||
161386698|NCT02311881|582799873|FG001|Overall Study|Lost to Follow-up|3|||
161386699|NCT02311881|582799874|FG002|Overall Study|Lost to Follow-up|2|||
161386700|NCT02311881|582799872|FG000|Overall Study|Protocol Violation|1|||
161386701|NCT02311881|582799873|FG001|Overall Study|Protocol Violation|2|||
161386702|NCT02311881|582799874|FG002|Overall Study|Protocol Violation|3|||
161386703|NCT02311881|582799872|FG000|Overall Study|Withdrawal of consent|14|||
161386704|NCT02311881|582799873|FG001|Overall Study|Withdrawal of consent|16|||
161386705|NCT02311881|582799874|FG002|Overall Study|Withdrawal of consent|17|||
161386706|NCT02311881|582799872|FG000|Overall Study|Other|0|||
161386707|NCT02311881|582799873|FG001|Overall Study|Other|0|||
161386708|NCT02311881|582799874|FG002|Overall Study|Other|1|||
161386709|NCT02311881|582799872|FG000|Overall Study|Lack of Efficacy|1|||
161386710|NCT02311881|582799873|FG001|Overall Study|Lack of Efficacy|2|||
161386711|NCT02311881|582799874|FG002|Overall Study|Lack of Efficacy|0|||
161386712|NCT02311881|582799872|FG000|Overall Study|Subject has border line pregnancy test|1|||
161386713|NCT02311881|582799873|FG001|Overall Study|Subject has border line pregnancy test|0|||
161386714|NCT02311881|582799874|FG002|Overall Study|Subject has border line pregnancy test|0|||
161386715|NCT02311881|582799872|FG000|Overall Study|Withdrawal by Subject|3|||
161386716|NCT02311881|582799873|FG001|Overall Study|Withdrawal by Subject|1|||
161386717|NCT02311881|582799874|FG002|Overall Study|Withdrawal by Subject|4|||
161386718|NCT02311881|582799872|FG000|Overall Study|Sponsor Decision|1|||
161386719|NCT02311881|582799873|FG001|Overall Study|Sponsor Decision|1|||
161386720|NCT02311881|582799874|FG002|Overall Study|Sponsor Decision|1|||
161386721|NCT02311881|582799872|FG000|Overall Study|Protocol Deviation|1|||
161386722|NCT02311881|582799873|FG001|Overall Study|Protocol Deviation|0|||
161386723|NCT02311881|582799874|FG002|Overall Study|Protocol Deviation|0|||
161386724|NCT02311881|582799872|FG000|Overall Study|Non-Compliance|1|||
161386725|NCT02311881|582799873|FG001|Overall Study|Non-Compliance|0|||
161386726|NCT02311881|582799874|FG002|Overall Study|Non-Compliance|2|||
161386727|NCT02311881|582799872|FG000|Overall Study|Physician Decision|0|||
161386728|NCT02311881|582799873|FG001|Overall Study|Physician Decision|0|||
161386729|NCT02311881|582799874|FG002|Overall Study|Physician Decision|1|||
161386730|NCT02311881|582799872|FG000|Overall Study|Medical Monitor Discretion|0|||
161386731|NCT02311881|582799873|FG001|Overall Study|Medical Monitor Discretion|0|||
161386732|NCT02311881|582799874|FG002|Overall Study|Medical Monitor Discretion|1|||
161386733|NCT02311881|582799872|FG000|Overall Study|Participant taking another medication|0|||
161386734|NCT02311881|582799873|FG001|Overall Study|Participant taking another medication|0|||
161386735|NCT02311881|582799874|FG002|Overall Study|Participant taking another medication|1|||
161386736|NCT02311881|582799872|FG000|Overall Study|Serious Adverse Event|0|||
161386737|NCT02311881|582799873|FG001|Overall Study|Serious Adverse Event|1|||
161386738|NCT02311881|582799874|FG002|Overall Study|Serious Adverse Event|0|||
161386739|NCT03306433|582799875|FG000|Overall Study|Lost to Follow-up|3|||
161386740|NCT03306433|582799875|FG000|Overall Study|Patient did not have teeth extracted|1|||
161386741|NCT03306433|582799875|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
161386742|NCT00819156|582799876|FG000|Overall Study|Adverse Event|1|||
161386743|NCT00819156|582799877|FG001|Overall Study|Adverse Event|4|||
161386744|NCT00819156|582799878|FG002|Overall Study|Adverse Event|2|||
161386745|NCT00819156|582799879|FG003|Overall Study|Adverse Event|1|||
161386746|NCT00819156|582799880|FG004|Overall Study|Adverse Event|2|||
161386747|NCT00819156|582799881|FG005|Overall Study|Adverse Event|3|||
161386748|NCT00819156|582799876|FG000|Overall Study|Withdrawal by Subject|0|||
161386749|NCT00819156|582799877|FG001|Overall Study|Withdrawal by Subject|3|||
161386750|NCT00819156|582799878|FG002|Overall Study|Withdrawal by Subject|2|||
161386751|NCT00819156|582799879|FG003|Overall Study|Withdrawal by Subject|0|||
161386752|NCT00819156|582799880|FG004|Overall Study|Withdrawal by Subject|1|||
161386753|NCT00819156|582799881|FG005|Overall Study|Withdrawal by Subject|0|||
161386754|NCT00819156|582799876|FG000|Overall Study|Protocol Violation|1|||
161386755|NCT00819156|582799877|FG001|Overall Study|Protocol Violation|0|||
161386756|NCT00819156|582799878|FG002|Overall Study|Protocol Violation|1|||
161386757|NCT00819156|582799879|FG003|Overall Study|Protocol Violation|0|||
161386758|NCT00819156|582799880|FG004|Overall Study|Protocol Violation|0|||
161386759|NCT00819156|582799881|FG005|Overall Study|Protocol Violation|1|||
161386760|NCT00819156|582799876|FG000|Overall Study|Lost to Follow-up|0|||
161386761|NCT00819156|582799877|FG001|Overall Study|Lost to Follow-up|1|||
161386762|NCT00819156|582799878|FG002|Overall Study|Lost to Follow-up|0|||
161386763|NCT00819156|582799879|FG003|Overall Study|Lost to Follow-up|0|||
161386764|NCT00819156|582799880|FG004|Overall Study|Lost to Follow-up|0|||
161386765|NCT00819156|582799881|FG005|Overall Study|Lost to Follow-up|2|||
161386766|NCT00819156|582799876|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
161386767|NCT00819156|582799877|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
161386768|NCT00819156|582799878|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
161386769|NCT00819156|582799879|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
161386770|NCT00819156|582799880|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
161386771|NCT00819156|582799881|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
161386772|NCT00819156|582799876|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
161386773|NCT00819156|582799877|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161386774|NCT00819156|582799878|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161386775|NCT00819156|582799879|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161386776|NCT00819156|582799880|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
161386777|NCT00819156|582799881|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161386778|NCT00819156|582799876|FG000|Overall Study|Prostate-specific antigen progression|0|||
161386779|NCT00819156|582799877|FG001|Overall Study|Prostate-specific antigen progression|0|||
161386780|NCT00819156|582799878|FG002|Overall Study|Prostate-specific antigen progression|0|||
161386781|NCT00819156|582799879|FG003|Overall Study|Prostate-specific antigen progression|0|||
161386782|NCT00819156|582799880|FG004|Overall Study|Prostate-specific antigen progression|1|||
161386783|NCT00819156|582799881|FG005|Overall Study|Prostate-specific antigen progression|0|||
161386784|NCT00790582|582799882|FG000|Overall Study|Death|14|||
161386785|NCT00790582|582799883|FG001|Overall Study|Death|32|||
161386786|NCT00790582|582799882|FG000|Overall Study|Physician Decision|7|||
161386787|NCT00790582|582799883|FG001|Overall Study|Physician Decision|1|||
161386788|NCT00790582|582799882|FG000|Overall Study|Lost to Follow-up|3|||
161386789|NCT00790582|582799883|FG001|Overall Study|Lost to Follow-up|3|||
161386790|NCT00790582|582799882|FG000|Overall Study|Withdrawal by Subject|7|||
161386791|NCT00790582|582799883|FG001|Overall Study|Withdrawal by Subject|51|||
161386792|NCT00803595|582799884|FG000|Overall Study|Adverse Event|3|||
161386793|NCT00803595|582799885|FG001|Overall Study|Adverse Event|4|||
161386794|NCT00803595|582799886|FG002|Overall Study|Adverse Event|1|||
161386795|NCT00803595|582799884|FG000|Overall Study|Protocol Violation|7|||
161386796|NCT00803595|582799885|FG001|Overall Study|Protocol Violation|2|||
161386797|NCT00803595|582799886|FG002|Overall Study|Protocol Violation|12|||
161386798|NCT00803595|582799884|FG000|Overall Study|Withdrawal by Subject|5|||
161386799|NCT00803595|582799885|FG001|Overall Study|Withdrawal by Subject|2|||
161386800|NCT00803595|582799886|FG002|Overall Study|Withdrawal by Subject|3|||
161386801|NCT00451958|582799889|FG000|CS21A (NCT00451958)|Adverse Event|21|||
161386802|NCT00451958|582799890|FG001|CS21A (NCT00451958)|Adverse Event|34|||
161386803|NCT00451958|582799891|FG002|CS21A (NCT00451958)|Adverse Event|14|||
161386804|NCT00451958|582799892|FG003|CS21A (NCT00451958)|Adverse Event|17|||
161386805|NCT00451958|582799893|FG004|CS21A (NCT00451958)|Adverse Event|0|||
161386806|NCT00451958|582799889|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
161386807|NCT00451958|582799890|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
161386808|NCT00451958|582799891|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
161386809|NCT00451958|582799892|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
161386810|NCT00451958|582799893|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
161386811|NCT00451958|582799889|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
161386812|NCT00451958|582799890|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
161386813|NCT00451958|582799891|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
161386814|NCT00451958|582799892|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
161386815|NCT00451958|582799893|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
161386816|NCT00451958|582799889|FG000|CS21A (NCT00451958)|Physician Decision|2|||
161386817|NCT00451958|582799890|FG001|CS21A (NCT00451958)|Physician Decision|4|||
161386818|NCT00451958|582799891|FG002|CS21A (NCT00451958)|Physician Decision|4|||
161386819|NCT00451958|582799892|FG003|CS21A (NCT00451958)|Physician Decision|4|||
161386820|NCT00451958|582799893|FG004|CS21A (NCT00451958)|Physician Decision|0|||
161386821|NCT00451958|582799889|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
161386822|NCT00451958|582799890|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
161386823|NCT00451958|582799891|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
161386824|NCT00451958|582799892|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
161386825|NCT00451958|582799893|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
161386826|NCT00451958|582799889|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
161386827|NCT00451958|582799890|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
161386828|NCT00451958|582799891|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
161386829|NCT00451958|582799892|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
161386830|NCT00451958|582799893|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
161386831|NCT01027650|582799896|FG000|Overall Study|Personal Reasons|0|||
161386832|NCT01027650|582799897|FG001|Overall Study|Personal Reasons|0|||
161386833|NCT01027650|582799898|FG002|Overall Study|Personal Reasons|0|||
161386834|NCT01027650|582799899|FG003|Overall Study|Personal Reasons|0|||
161386835|NCT01027650|582799900|FG004|Overall Study|Personal Reasons|2|||
161386836|NCT01027650|582799901|FG005|Overall Study|Personal Reasons|1|||
161386837|NCT01027650|582799902|FG006|Overall Study|Personal Reasons|0|||
161386838|NCT01027650|582799903|FG007|Overall Study|Personal Reasons|0|||
161386839|NCT01027650|582799896|FG000|Overall Study|Lost to Follow-up|0|||
161386840|NCT01027650|582799897|FG001|Overall Study|Lost to Follow-up|0|||
161386841|NCT01027650|582799898|FG002|Overall Study|Lost to Follow-up|0|||
161386842|NCT01027650|582799899|FG003|Overall Study|Lost to Follow-up|0|||
161386843|NCT01027650|582799900|FG004|Overall Study|Lost to Follow-up|0|||
161386844|NCT01027650|582799901|FG005|Overall Study|Lost to Follow-up|0|||
161386845|NCT01027650|582799902|FG006|Overall Study|Lost to Follow-up|1|||
161386846|NCT01027650|582799903|FG007|Overall Study|Lost to Follow-up|0|||
161386847|NCT01027650|582799896|FG000|Overall Study|Lack of Efficacy|0|||
161386848|NCT01027650|582799897|FG001|Overall Study|Lack of Efficacy|0|||
161386849|NCT01027650|582799898|FG002|Overall Study|Lack of Efficacy|0|||
161386850|NCT01027650|582799899|FG003|Overall Study|Lack of Efficacy|0|||
161386851|NCT01027650|582799900|FG004|Overall Study|Lack of Efficacy|0|||
161386852|NCT01027650|582799901|FG005|Overall Study|Lack of Efficacy|1|||
161386853|NCT01027650|582799902|FG006|Overall Study|Lack of Efficacy|0|||
161386854|NCT01027650|582799903|FG007|Overall Study|Lack of Efficacy|0|||
161386855|NCT02175277|582799904|FG000|Overall Study|Protocol-specified Criteria|1|||
161386856|NCT00670930|582799905|FG000|Overall Study|Adminstrative Problem|0|||
161386857|NCT00670930|582799906|FG001|Overall Study|Adminstrative Problem|1|||
161386858|NCT00670930|582799905|FG000|Overall Study|Lost to Follow-up|1|||
161386859|NCT00670930|582799906|FG001|Overall Study|Lost to Follow-up|0|||
161386860|NCT01042158|582799907|FG000|Overall Study|Physician Decision|1|||
161386861|NCT00875485|582802012|FG000|Challenge Dose Epoch|Pregnancy|1|||
161386862|NCT00875485|582802013|FG001|Challenge Dose Epoch|Pregnancy|0|||
161386863|NCT01271010|582802014|FG000|Overall Study|Reason not specified|11|||
161386864|NCT01271010|582802014|FG000|Overall Study|Start of new CLL therapy|1|||
161386865|NCT01271010|582802014|FG000|Overall Study|Protocol Violation|1|||
161386866|NCT01271010|582802014|FG000|Overall Study|Death|2|||
161386867|NCT01271010|582802014|FG000|Overall Study|Progression and relapse of disease|1|||
161386868|NCT01271010|582802014|FG000|Overall Study|Withdrawal by Subject|18|||
161386869|NCT01271010|582802014|FG000|Overall Study|Disease progression|27|||
161386870|NCT01631747|582802015|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
161386871|NCT01631747|582802016|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
161386872|NCT01631747|582802015|FG000|Live Birth|Pregnancy Termination|1|||
161386873|NCT01631747|582802016|FG001|Live Birth|Pregnancy Termination|0|||
161386874|NCT01631747|582802015|FG000|Live Birth|MIscarriage|2|||
161386875|NCT01631747|582802016|FG001|Live Birth|MIscarriage|0|||
161386876|NCT01631747|582802015|FG000|Live Birth|Stillbirth|1|||
161386877|NCT01631747|582802016|FG001|Live Birth|Stillbirth|1|||
161386878|NCT01631747|582802015|FG000|One Year Infant Outcomes|Patient Refused|13|||
161386879|NCT01631747|582802016|FG001|One Year Infant Outcomes|Patient Refused|9|||
161386880|NCT02908685|582802017|FG000|Part 1 OLE|Withdrawal by Subject|0|||
161386881|NCT02908685|582802018|FG001|Part 1 OLE|Withdrawal by Subject|0|||
161386882|NCT02908685|582802019|FG002|Part 1 OLE|Withdrawal by Subject|0|||
161386883|NCT02908685|582802020|FG003|Part 1 OLE|Withdrawal by Subject|0|||
161386884|NCT02908685|582802021|FG004|Part 1 OLE|Withdrawal by Subject|0|||
161386885|NCT02908685|582802022|FG005|Part 1 OLE|Withdrawal by Subject|0|||
161386886|NCT02908685|582802023|FG006|Part 1 OLE|Withdrawal by Subject|0|||
161386887|NCT02908685|582802024|FG007|Part 1 OLE|Withdrawal by Subject|0|||
161386888|NCT02908685|582802025|FG008|Part 1 OLE|Withdrawal by Subject|0|||
161386889|NCT02908685|582802026|FG009|Part 1 OLE|Withdrawal by Subject|0|||
161386890|NCT02908685|582802027|FG010|Part 1 OLE|Withdrawal by Subject|2|||
161386891|NCT02908685|582802028|FG011|Part 1 OLE|Withdrawal by Subject|1|||
161386892|NCT02908685|582802029|FG012|Part 1 OLE|Withdrawal by Subject|0|||
161386893|NCT02908685|582802030|FG013|Part 1 OLE|Withdrawal by Subject|0|||
161386894|NCT02908685|582802017|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386895|NCT02908685|582802018|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386896|NCT02908685|582802019|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386897|NCT02908685|582802020|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386898|NCT02908685|582802021|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386899|NCT02908685|582802022|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386900|NCT02908685|582802023|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386901|NCT02908685|582802024|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386902|NCT02908685|582802025|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386903|NCT02908685|582802026|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386904|NCT02908685|582802027|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386905|NCT02908685|582802028|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161386906|NCT02908685|582802029|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
161386907|NCT02908685|582802030|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
161386908|NCT02908685|582802017|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386909|NCT02908685|582802018|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386910|NCT02908685|582802019|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386911|NCT02908685|582802020|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386912|NCT02908685|582802021|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386913|NCT02908685|582802022|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386914|NCT02908685|582802023|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386915|NCT02908685|582802024|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386916|NCT02908685|582802025|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386917|NCT02908685|582802026|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386918|NCT02908685|582802027|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386919|NCT02908685|582802028|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386920|NCT02908685|582802029|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
161386921|NCT02908685|582802030|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161386922|NCT02908685|582802017|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386923|NCT02908685|582802018|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386924|NCT02908685|582802019|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386925|NCT02908685|582802020|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386926|NCT02908685|582802021|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386927|NCT02908685|582802022|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386928|NCT02908685|582802023|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386929|NCT02908685|582802024|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386930|NCT02908685|582802025|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386931|NCT02908685|582802026|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386932|NCT02908685|582802027|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386933|NCT02908685|582802028|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386934|NCT02908685|582802029|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
161386935|NCT02908685|582802030|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161386936|NCT02908685|582802017|FG000|Part 2 OLE: > Month 24|Death|0|||
161386937|NCT02908685|582802018|FG001|Part 2 OLE: > Month 24|Death|0|||
161386938|NCT02908685|582802019|FG002|Part 2 OLE: > Month 24|Death|0|||
161386939|NCT02908685|582802020|FG003|Part 2 OLE: > Month 24|Death|0|||
161386940|NCT02908685|582802021|FG004|Part 2 OLE: > Month 24|Death|0|||
161386941|NCT02908685|582802022|FG005|Part 2 OLE: > Month 24|Death|0|||
161386942|NCT02908685|582802023|FG006|Part 2 OLE: > Month 24|Death|0|||
161386943|NCT02908685|582802024|FG007|Part 2 OLE: > Month 24|Death|0|||
161386944|NCT02908685|582802025|FG008|Part 2 OLE: > Month 24|Death|0|||
161386945|NCT02908685|582802026|FG009|Part 2 OLE: > Month 24|Death|0|||
161386946|NCT02908685|582802027|FG010|Part 2 OLE: > Month 24|Death|0|||
161386947|NCT02908685|582802028|FG011|Part 2 OLE: > Month 24|Death|0|||
161386948|NCT02908685|582802029|FG012|Part 2 OLE: > Month 24|Death|1|||
161386949|NCT02908685|582802030|FG013|Part 2 OLE: > Month 24|Death|0|||
161386950|NCT02908685|582802017|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
161386951|NCT02908685|582802018|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
161386952|NCT02908685|582802019|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
161386953|NCT02908685|582802020|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
161386954|NCT02908685|582802021|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
161386955|NCT02908685|582802022|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
161386956|NCT02908685|582802023|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
161386957|NCT02908685|582802024|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
161386958|NCT02908685|582802025|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
161386959|NCT02908685|582802026|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
161386960|NCT02908685|582802027|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
161386961|NCT02908685|582802028|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
161386962|NCT02908685|582802029|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
161386963|NCT02908685|582802030|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
161386964|NCT02908685|582802017|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386965|NCT02908685|582802018|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386966|NCT02908685|582802019|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386967|NCT02908685|582802020|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386968|NCT02908685|582802021|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386969|NCT02908685|582802022|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386970|NCT02908685|582802023|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386971|NCT02908685|582802024|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386972|NCT02908685|582802025|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386973|NCT02908685|582802026|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386974|NCT02908685|582802027|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386975|NCT02908685|582802028|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161386976|NCT02908685|582802029|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
161386977|NCT02908685|582802030|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
161386978|NCT02954406|582802031|FG000|Overall Study|Adverse Event|0|||
161386979|NCT02954406|582802032|FG001|Overall Study|Adverse Event|1|||
161386980|NCT02954406|582802033|FG002|Overall Study|Adverse Event|0|||
161386981|NCT02954406|582802034|FG003|Overall Study|Adverse Event|0|||
161386982|NCT02954406|582802035|FG004|Overall Study|Adverse Event|1|||
161386983|NCT02954406|582802036|FG005|Overall Study|Adverse Event|0|||
161386984|NCT02954406|582802037|FG006|Overall Study|Adverse Event|0|||
161386985|NCT02954406|582802038|FG007|Overall Study|Adverse Event|0|||
161386986|NCT02954406|582802039|FG008|Overall Study|Adverse Event|1|||
161386987|NCT02954406|582802040|FG009|Overall Study|Adverse Event|1|||
161386988|NCT02954406|582802041|FG010|Overall Study|Adverse Event|0|||
161386989|NCT02954406|582802031|FG000|Overall Study|Progressive Disease|3|||
161386990|NCT02954406|582802032|FG001|Overall Study|Progressive Disease|4|||
161386991|NCT02954406|582802033|FG002|Overall Study|Progressive Disease|3|||
161386992|NCT02954406|582802034|FG003|Overall Study|Progressive Disease|4|||
161386993|NCT02954406|582802035|FG004|Overall Study|Progressive Disease|3|||
161386994|NCT02954406|582802036|FG005|Overall Study|Progressive Disease|3|||
161386995|NCT02954406|582802037|FG006|Overall Study|Progressive Disease|2|||
161386996|NCT02954406|582802038|FG007|Overall Study|Progressive Disease|2|||
161386997|NCT02954406|582802039|FG008|Overall Study|Progressive Disease|1|||
161386998|NCT02954406|582802040|FG009|Overall Study|Progressive Disease|1|||
161386999|NCT02954406|582802041|FG010|Overall Study|Progressive Disease|0|||
161387000|NCT02954406|582802031|FG000|Overall Study|Symptomatic Deterioration|0|||
161387001|NCT02954406|582802032|FG001|Overall Study|Symptomatic Deterioration|1|||
161387002|NCT02954406|582802033|FG002|Overall Study|Symptomatic Deterioration|0|||
161387003|NCT02954406|582802034|FG003|Overall Study|Symptomatic Deterioration|0|||
161387004|NCT02954406|582802035|FG004|Overall Study|Symptomatic Deterioration|0|||
161387005|NCT02954406|582802036|FG005|Overall Study|Symptomatic Deterioration|0|||
161387006|NCT02954406|582802037|FG006|Overall Study|Symptomatic Deterioration|0|||
161387007|NCT02954406|582802038|FG007|Overall Study|Symptomatic Deterioration|0|||
161387008|NCT02954406|582802039|FG008|Overall Study|Symptomatic Deterioration|0|||
161387009|NCT02954406|582802040|FG009|Overall Study|Symptomatic Deterioration|0|||
161387010|NCT02954406|582802041|FG010|Overall Study|Symptomatic Deterioration|0|||
161387011|NCT02954406|582802031|FG000|Overall Study|Death|0|||
161387012|NCT02954406|582802032|FG001|Overall Study|Death|0|||
161387013|NCT02954406|582802033|FG002|Overall Study|Death|0|||
161387014|NCT02954406|582802034|FG003|Overall Study|Death|0|||
161387015|NCT02954406|582802035|FG004|Overall Study|Death|1|||
161387016|NCT02954406|582802036|FG005|Overall Study|Death|0|||
161387017|NCT02954406|582802037|FG006|Overall Study|Death|0|||
161387018|NCT02954406|582802038|FG007|Overall Study|Death|0|||
161387019|NCT02954406|582802039|FG008|Overall Study|Death|1|||
161387020|NCT02954406|582802040|FG009|Overall Study|Death|1|||
161387021|NCT02954406|582802041|FG010|Overall Study|Death|0|||
161387022|NCT02954406|582802031|FG000|Overall Study|Reason Not Specified|0|||
161387023|NCT02954406|582802032|FG001|Overall Study|Reason Not Specified|0|||
161387024|NCT02954406|582802033|FG002|Overall Study|Reason Not Specified|3|||
161387025|NCT02954406|582802034|FG003|Overall Study|Reason Not Specified|2|||
161387026|NCT02954406|582802035|FG004|Overall Study|Reason Not Specified|2|||
161387027|NCT02954406|582802036|FG005|Overall Study|Reason Not Specified|0|||
161387028|NCT02954406|582802037|FG006|Overall Study|Reason Not Specified|1|||
161387029|NCT02954406|582802038|FG007|Overall Study|Reason Not Specified|0|||
161387030|NCT02954406|582802039|FG008|Overall Study|Reason Not Specified|1|||
161387031|NCT02954406|582802040|FG009|Overall Study|Reason Not Specified|0|||
161387032|NCT02954406|582802041|FG010|Overall Study|Reason Not Specified|0|||
161387033|NCT00782171|582802042|FG000|Overall Study|Lost to Follow-up|2|||
161387034|NCT00782171|582802043|FG001|Overall Study|Lost to Follow-up|2|||
161387035|NCT00782171|582802042|FG000|Overall Study|Withdrawal by Subject|2|||
161387036|NCT00782171|582802043|FG001|Overall Study|Withdrawal by Subject|1|||
161387037|NCT00782171|582802042|FG000|Overall Study|complications|3|||
161387038|NCT00782171|582802043|FG001|Overall Study|complications|1|||
161387039|NCT00782171|582802042|FG000|Overall Study|others|7|||
161387040|NCT00782171|582802043|FG001|Overall Study|others|9|||
161387041|NCT00782171|582802042|FG000|Overall Study|not eligible|8|||
161387042|NCT00782171|582802043|FG001|Overall Study|not eligible|6|||
161387043|NCT01691014|582802044|FG000|Overall Study|Premature Termination|1|||
161387044|NCT01691014|582802045|FG001|Overall Study|Premature Termination|6|||
161387045|NCT01691014|582802046|FG002|Overall Study|Premature Termination|0|||
161387046|NCT01691014|582802047|FG003|Overall Study|Premature Termination|3|||
161387047|NCT01691014|582802044|FG000|Overall Study|Other|0|||
161387048|NCT01691014|582802045|FG001|Overall Study|Other|0|||
161387049|NCT01691014|582802046|FG002|Overall Study|Other|2|||
161387050|NCT01691014|582802047|FG003|Overall Study|Other|0|||
161387051|NCT01691014|582802044|FG000|Overall Study|Withdrawal by Subject|0|||
161387052|NCT01691014|582802045|FG001|Overall Study|Withdrawal by Subject|1|||
161387053|NCT01691014|582802046|FG002|Overall Study|Withdrawal by Subject|1|||
161387054|NCT01691014|582802047|FG003|Overall Study|Withdrawal by Subject|1|||
161387055|NCT01691014|582802044|FG000|Overall Study|Adverse Event|0|||
161387056|NCT01691014|582802045|FG001|Overall Study|Adverse Event|5|||
161387057|NCT01691014|582802046|FG002|Overall Study|Adverse Event|1|||
161387058|NCT01691014|582802047|FG003|Overall Study|Adverse Event|1|||
161387059|NCT01691014|582802044|FG000|Overall Study|Lack of Efficacy|2|||
161387060|NCT01691014|582802045|FG001|Overall Study|Lack of Efficacy|3|||
161387061|NCT01691014|582802046|FG002|Overall Study|Lack of Efficacy|7|||
161387062|NCT01691014|582802047|FG003|Overall Study|Lack of Efficacy|0|||
161387063|NCT05897242|582802050|FG000|Overall Study|Lost to Follow-up|6|||
161387064|NCT05897242|582802051|FG001|Overall Study|Lost to Follow-up|1|||
161387065|NCT05897242|582802050|FG000|Overall Study|Incomplete|1|||
161387066|NCT05897242|582802051|FG001|Overall Study|Incomplete|0|||
161387067|NCT05897242|582802050|FG000|Overall Study|Withdrawal by Subject|1|||
161387068|NCT05897242|582802051|FG001|Overall Study|Withdrawal by Subject|0|||
161387069|NCT03522246|582802052|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
161387070|NCT03522246|582802053|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
161387071|NCT03522246|582802054|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
161387072|NCT03522246|582802055|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
161387073|NCT03522246|582802056|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
161387074|NCT00814580|582802057|FG000|Overall Study|Adverse Event|6|||
161387075|NCT00814580|582802058|FG001|Overall Study|Adverse Event|15|||
161387076|NCT00814580|582802057|FG000|Overall Study|Lack of Efficacy|18|||
161387077|NCT00814580|582802058|FG001|Overall Study|Lack of Efficacy|25|||
161387078|NCT00814580|582802057|FG000|Overall Study|Protocol Violation|2|||
161387079|NCT00814580|582802058|FG001|Overall Study|Protocol Violation|0|||
161387080|NCT00814580|582802057|FG000|Overall Study|Withdrawal by Subject|2|||
161387081|NCT00814580|582802058|FG001|Overall Study|Withdrawal by Subject|2|||
161387082|NCT00814580|582802057|FG000|Overall Study|Other|1|||
161387083|NCT00814580|582802058|FG001|Overall Study|Other|3|||
161387084|NCT00814580|582802057|FG000|Overall Study|Did Not Take Drug|2|||
161387085|NCT00814580|582802058|FG001|Overall Study|Did Not Take Drug|2|||
161387086|NCT02482428|582802059|FG000|Overall Study|Lost to Follow-up|4|||
161387087|NCT02482428|582802060|FG001|Overall Study|Lost to Follow-up|9|||
161387088|NCT02482428|582802061|FG002|Overall Study|Lost to Follow-up|1|||
161387089|NCT02482428|582802062|FG003|Overall Study|Lost to Follow-up|2|||
161387090|NCT02482428|582802063|FG004|Overall Study|Lost to Follow-up|4|||
161387091|NCT02482428|582802059|FG000|Overall Study|Physician Decision|0|||
161387092|NCT02482428|582802060|FG001|Overall Study|Physician Decision|0|||
161387093|NCT02482428|582802061|FG002|Overall Study|Physician Decision|0|||
161387094|NCT02482428|582802062|FG003|Overall Study|Physician Decision|0|||
161387095|NCT02482428|582802063|FG004|Overall Study|Physician Decision|1|||
161387096|NCT02482428|582802059|FG000|Overall Study|protocol deviation|1|||
161387097|NCT02482428|582802060|FG001|Overall Study|protocol deviation|1|||
161387098|NCT02482428|582802061|FG002|Overall Study|protocol deviation|0|||
161387099|NCT02482428|582802062|FG003|Overall Study|protocol deviation|0|||
161387100|NCT02482428|582802063|FG004|Overall Study|protocol deviation|0|||
161387101|NCT02482428|582802059|FG000|Overall Study|subject/guardian decision|4|||
161387102|NCT02482428|582802060|FG001|Overall Study|subject/guardian decision|2|||
161387103|NCT02482428|582802061|FG002|Overall Study|subject/guardian decision|0|||
161387104|NCT02482428|582802062|FG003|Overall Study|subject/guardian decision|0|||
161387105|NCT02482428|582802063|FG004|Overall Study|subject/guardian decision|2|||
161387106|NCT00809835|582802066|FG000|Overall Study|Lost to Follow-up|7|||
161387107|NCT00809835|582802067|FG001|Overall Study|Lost to Follow-up|6|||
161387108|NCT00809835|582802068|FG002|Overall Study|Lost to Follow-up|10|||
161387109|NCT00809835|582802069|FG003|Overall Study|Lost to Follow-up|2|||
161387110|NCT00809835|582802066|FG000|Overall Study|Withdrawal by Subject|1|||
161387111|NCT00809835|582802067|FG001|Overall Study|Withdrawal by Subject|1|||
161387112|NCT00809835|582802068|FG002|Overall Study|Withdrawal by Subject|1|||
161387113|NCT00809835|582802069|FG003|Overall Study|Withdrawal by Subject|0|||
161387114|NCT00516893|582802070|FG000|Overall Study|Lost to Follow-up|4|||
161387115|NCT00516893|582802070|FG000|Overall Study|Adverse Event|3|||
161387116|NCT00516893|582802070|FG000|Overall Study|Withdrawal by Subject|2|||
161387117|NCT00516893|582802070|FG000|Overall Study|Noncompliance|2|||
161387118|NCT00516893|582802070|FG000|Overall Study|Death|1|||
161387119|NCT00516893|582802070|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
161387120|NCT00516893|582802070|FG000|Overall Study|Relocated|1|||
161387121|NCT00516893|582802070|FG000|Overall Study|Pregnancy|1|||
161387122|NCT00516893|582802070|FG000|Overall Study|Received Medication From Another Study|1|||
161387123|NCT01519791|582802072|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
161387124|NCT01519791|582802073|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
161387125|NCT01519791|582802072|FG000|Overall Study|Protocol Violation|6|||
161387126|NCT01519791|582802073|FG001|Overall Study|Protocol Violation|19|||
161387127|NCT01519791|582802072|FG000|Overall Study|Other Reason|87|||
161387128|NCT01519791|582802073|FG001|Overall Study|Other Reason|222|||
161387129|NCT01519791|582802072|FG000|Overall Study|subjects randomized in error|2|||
161387130|NCT01519791|582802073|FG001|Overall Study|subjects randomized in error|0|||
161387131|NCT01519791|582802072|FG000|Overall Study|Lack of Efficacy|16|||
161387132|NCT01519791|582802073|FG001|Overall Study|Lack of Efficacy|20|||
161387133|NCT01519791|582802072|FG000|Overall Study|SAE, non-fatal|6|||
161387134|NCT01519791|582802073|FG001|Overall Study|SAE, non-fatal|22|||
161387135|NCT01519791|582802072|FG000|Overall Study|AE, serious fatal|0|||
161387136|NCT01519791|582802073|FG001|Overall Study|AE, serious fatal|1|||
161387137|NCT01519791|582802072|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
161387138|NCT01519791|582802073|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
161387139|NCT01519791|582802072|FG000|Overall Study|AE, non-serious non-fatal|12|||
161387140|NCT01519791|582802073|FG001|Overall Study|AE, non-serious non-fatal|31|||
161387141|NCT01519791|582802072|FG000|Overall Study|Withdrawal by Subject|15|||
161387142|NCT01519791|582802073|FG001|Overall Study|Withdrawal by Subject|37|||
161387143|NCT01519791|582802072|FG000|Overall Study|Lost to Follow-up|6|||
161387144|NCT01519791|582802073|FG001|Overall Study|Lost to Follow-up|14|||
161387145|NCT00559845|582802074|FG000|Overall Study|Withdrew Consent|1|||
161387146|NCT00559845|582802074|FG000|Overall Study|Disease Progression|1|||
161387147|NCT00559845|582802074|FG000|Overall Study|Adverse Event|3|||
161387148|NCT00559845|582802074|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
161387149|NCT00559845|582802074|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
161387150|NCT05791565|582802075|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
161387151|NCT05791565|582802076|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
161387152|NCT00880269|582802077|FG000|Overall Study|Protocol Violation|1|||
161387153|NCT00880269|582802078|FG001|Overall Study|Protocol Violation|0|||
161387154|NCT00880269|582802077|FG000|Overall Study|Disease Progression|13|||
161387155|NCT00880269|582802078|FG001|Overall Study|Disease Progression|11|||
161387156|NCT00880269|582802077|FG000|Overall Study|New Cancer Therapy|1|||
161387157|NCT00880269|582802078|FG001|Overall Study|New Cancer Therapy|0|||
161387158|NCT00880269|582802077|FG000|Overall Study|Death|4|||
161387159|NCT00880269|582802078|FG001|Overall Study|Death|2|||
161387160|NCT00880269|582802077|FG000|Overall Study|Lost to Follow-up|0|||
161387161|NCT00880269|582802078|FG001|Overall Study|Lost to Follow-up|1|||
161387162|NCT00880269|582802077|FG000|Overall Study|Withdrawal by Subject|3|||
161387163|NCT00880269|582802078|FG001|Overall Study|Withdrawal by Subject|4|||
161387164|NCT00880269|582802077|FG000|Overall Study|Adverse Event|10|||
161387165|NCT00880269|582802078|FG001|Overall Study|Adverse Event|9|||
161387166|NCT02516982|582802079|FG000|Overall Study|Called in to antenatal appointment|32|||
161387167|NCT02516982|582802080|FG001|Overall Study|Called in to antenatal appointment|35|||
161387168|NCT02516982|582802081|FG002|Overall Study|Called in to antenatal appointment|0|||
161387169|NCT02516982|582802082|FG003|Overall Study|Called in to antenatal appointment|0|||
161387170|NCT02516982|582802079|FG000|Overall Study|Withdrawal by Subject|0|||
161387171|NCT02516982|582802080|FG001|Overall Study|Withdrawal by Subject|0|||
161387172|NCT02516982|582802081|FG002|Overall Study|Withdrawal by Subject|1|||
161387173|NCT02516982|582802082|FG003|Overall Study|Withdrawal by Subject|2|||
161387174|NCT02516982|582802079|FG000|Overall Study|Protocol Violation|0|||
161387175|NCT02516982|582802080|FG001|Overall Study|Protocol Violation|0|||
161387176|NCT02516982|582802081|FG002|Overall Study|Protocol Violation|1|||
161387177|NCT02516982|582802082|FG003|Overall Study|Protocol Violation|1|||
161387178|NCT02516982|582802079|FG000|Overall Study|Did not install the app|0|||
161387179|NCT02516982|582802080|FG001|Overall Study|Did not install the app|0|||
161387180|NCT02516982|582802081|FG002|Overall Study|Did not install the app|46|||
161387181|NCT02516982|582802082|FG003|Overall Study|Did not install the app|47|||
161387182|NCT03379259|582802084|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
161387183|NCT03379259|582802085|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
161387184|NCT03379259|582802086|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
161387185|NCT03379259|582802087|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
161387186|NCT03379259|582802088|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
161387187|NCT03379259|582802089|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
161387188|NCT03379259|582802084|FG000|Overall Study|Death|0|||
161387189|NCT03379259|582802085|FG001|Overall Study|Death|1|||
161387190|NCT03379259|582802086|FG002|Overall Study|Death|2|||
161387191|NCT03379259|582802087|FG003|Overall Study|Death|1|||
161387192|NCT03379259|582802088|FG004|Overall Study|Death|4|||
161387193|NCT03379259|582802089|FG005|Overall Study|Death|2|||
161387194|NCT03379259|582802084|FG000|Overall Study|Withdrawal by Subject|0|||
161387195|NCT03379259|582802085|FG001|Overall Study|Withdrawal by Subject|0|||
161387196|NCT03379259|582802086|FG002|Overall Study|Withdrawal by Subject|1|||
161387197|NCT03379259|582802087|FG003|Overall Study|Withdrawal by Subject|0|||
161387198|NCT03379259|582802088|FG004|Overall Study|Withdrawal by Subject|2|||
161387199|NCT03379259|582802089|FG005|Overall Study|Withdrawal by Subject|0|||
161387200|NCT03379259|582802084|FG000|Overall Study|Study terminated by sponsor|0|||
161387201|NCT03379259|582802085|FG001|Overall Study|Study terminated by sponsor|0|||
161387202|NCT03379259|582802086|FG002|Overall Study|Study terminated by sponsor|0|||
161387203|NCT03379259|582802087|FG003|Overall Study|Study terminated by sponsor|1|||
161387204|NCT03379259|582802088|FG004|Overall Study|Study terminated by sponsor|1|||
161387205|NCT03379259|582802089|FG005|Overall Study|Study terminated by sponsor|4|||
161387206|NCT03379259|582802084|FG000|Overall Study|Disease progression|0|||
161387207|NCT03379259|582802085|FG001|Overall Study|Disease progression|0|||
161387208|NCT03379259|582802086|FG002|Overall Study|Disease progression|0|||
161387209|NCT03379259|582802087|FG003|Overall Study|Disease progression|1|||
161387210|NCT03379259|582802088|FG004|Overall Study|Disease progression|0|||
161387211|NCT03379259|582802089|FG005|Overall Study|Disease progression|1|||
161387212|NCT03379259|582802084|FG000|Overall Study|Lost to Follow-up|0|||
161387213|NCT03379259|582802085|FG001|Overall Study|Lost to Follow-up|0|||
161387214|NCT03379259|582802086|FG002|Overall Study|Lost to Follow-up|0|||
161387215|NCT03379259|582802087|FG003|Overall Study|Lost to Follow-up|0|||
161387216|NCT03379259|582802088|FG004|Overall Study|Lost to Follow-up|1|||
161387217|NCT03379259|582802089|FG005|Overall Study|Lost to Follow-up|0|||
161387218|NCT03379259|582802084|FG000|Overall Study|Deteriorating condition|0|||
161387219|NCT03379259|582802085|FG001|Overall Study|Deteriorating condition|0|||
161387220|NCT03379259|582802086|FG002|Overall Study|Deteriorating condition|0|||
161387221|NCT03379259|582802087|FG003|Overall Study|Deteriorating condition|0|||
161387222|NCT03379259|582802088|FG004|Overall Study|Deteriorating condition|1|||
161387223|NCT03379259|582802089|FG005|Overall Study|Deteriorating condition|0|||
161387224|NCT03195660|582802090|FG000|Overall Study|The study was terminated|2|||
161387225|NCT00375427|582802091|FG000|Overall Study|Adverse Event|21|||
161387226|NCT00375427|582802092|FG001|Overall Study|Adverse Event|27|||
161387227|NCT00375427|582802091|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161387228|NCT00375427|582802092|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161387229|NCT00375427|582802091|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161387230|NCT00375427|582802092|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161387231|NCT00375427|582802091|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161387232|NCT00375427|582802092|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161387233|NCT00375427|582802091|FG000|Overall Study|Patient no longer requires study drug|3|||
161387234|NCT00375427|582802092|FG001|Overall Study|Patient no longer requires study drug|7|||
161387235|NCT00375427|582802091|FG000|Overall Study|Protocol Violation|10|||
161387236|NCT00375427|582802092|FG001|Overall Study|Protocol Violation|8|||
161387237|NCT00375427|582802091|FG000|Overall Study|Withdrawal by Subject|9|||
161387238|NCT00375427|582802092|FG001|Overall Study|Withdrawal by Subject|13|||
161387239|NCT00375427|582802091|FG000|Overall Study|Lost to Follow-up|1|||
161387240|NCT00375427|582802092|FG001|Overall Study|Lost to Follow-up|1|||
161387241|NCT00375427|582802091|FG000|Overall Study|Administrative reasons|0|||
161387242|NCT00375427|582802092|FG001|Overall Study|Administrative reasons|1|||
161387243|NCT00375427|582802091|FG000|Overall Study|Death|11|||
161387244|NCT00375427|582802092|FG001|Overall Study|Death|10|||
161387245|NCT01977729|582802098|FG000|Overall Study|Study terminated|1|||
161387246|NCT01268046|582802099|FG000|Overall Study|Withdrawal by Subject|1|||
161387247|NCT01268046|582802100|FG001|Overall Study|Withdrawal by Subject|0|||
161387248|NCT01268046|582802101|FG002|Overall Study|Withdrawal by Subject|0|||
161387249|NCT01268046|582802102|FG003|Overall Study|Withdrawal by Subject|1|||
161387250|NCT01268046|582802099|FG000|Overall Study|Lost to Follow-up|0|||
161387251|NCT01268046|582802100|FG001|Overall Study|Lost to Follow-up|0|||
161387252|NCT01268046|582802101|FG002|Overall Study|Lost to Follow-up|1|||
161387253|NCT01268046|582802102|FG003|Overall Study|Lost to Follow-up|0|||
161387254|NCT03636893|582802103|FG000|Overall Study|Death|0|||
161387255|NCT03636893|582802104|FG001|Overall Study|Death|1|||
161387256|NCT03636893|582802103|FG000|Overall Study|Protocol Violation|0|||
161387257|NCT03636893|582802104|FG001|Overall Study|Protocol Violation|3|||
161387258|NCT03636893|582802103|FG000|Overall Study|Withdrawal by Subject|1|||
161387259|NCT03636893|582802104|FG001|Overall Study|Withdrawal by Subject|2|||
161387260|NCT03636893|582802103|FG000|Overall Study|Refusal to surgery|4|||
161387261|NCT03636893|582802104|FG001|Overall Study|Refusal to surgery|3|||
161387262|NCT03636893|582802103|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
161387263|NCT03636893|582802104|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
161387264|NCT03636893|582802103|FG000|Overall Study|Adverse Event|1|||
161387265|NCT03636893|582802104|FG001|Overall Study|Adverse Event|1|||
161387266|NCT02314156|582802105|FG000|Overall Study|Adverse Event|1|||
161387267|NCT02314156|582802106|FG001|Overall Study|Adverse Event|0|||
161387268|NCT02314156|582802105|FG000|Overall Study|Withdrawal by Subject|1|||
161387269|NCT02314156|582802106|FG001|Overall Study|Withdrawal by Subject|0|||
161387270|NCT00758069|582802109|FG000|Overall Study|Lack of Efficacy|0|||
161387271|NCT00758069|582802110|FG001|Overall Study|Lack of Efficacy|0|||
161387272|NCT00758069|582802111|FG002|Overall Study|Lack of Efficacy|1|||
161387273|NCT00758069|582802109|FG000|Overall Study|Incorrect Study Drug|1|||
161387274|NCT00758069|582802110|FG001|Overall Study|Incorrect Study Drug|0|||
161387275|NCT00758069|582802111|FG002|Overall Study|Incorrect Study Drug|0|||
161387276|NCT04560816|582802112|FG000|Overall Study|Withdrawal by Subject|1|||
161387277|NCT04560816|582802113|FG001|Overall Study|Withdrawal by Subject|1|||
161387278|NCT04560816|582802114|FG002|Overall Study|Withdrawal by Subject|1|||
161387279|NCT04560816|582802115|FG003|Overall Study|Withdrawal by Subject|0|||
161387280|NCT04560816|582802116|FG004|Overall Study|Withdrawal by Subject|3|||
161387281|NCT04560816|582802117|FG005|Overall Study|Withdrawal by Subject|0|||
161387282|NCT04560816|582802112|FG000|Overall Study|Lost to Follow-up|1|||
161387283|NCT04560816|582802113|FG001|Overall Study|Lost to Follow-up|0|||
161387284|NCT04560816|582802114|FG002|Overall Study|Lost to Follow-up|0|||
161387285|NCT04560816|582802115|FG003|Overall Study|Lost to Follow-up|0|||
161387286|NCT04560816|582802116|FG004|Overall Study|Lost to Follow-up|0|||
161387287|NCT04560816|582802117|FG005|Overall Study|Lost to Follow-up|0|||
161387288|NCT04560816|582802112|FG000|Overall Study|Protocol Violation|1|||
161387289|NCT04560816|582802113|FG001|Overall Study|Protocol Violation|0|||
161387290|NCT04560816|582802114|FG002|Overall Study|Protocol Violation|0|||
161387291|NCT04560816|582802115|FG003|Overall Study|Protocol Violation|0|||
161387292|NCT04560816|582802116|FG004|Overall Study|Protocol Violation|0|||
161387293|NCT04560816|582802117|FG005|Overall Study|Protocol Violation|0|||
161387294|NCT02277691|582802120|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
161387295|NCT02277691|582802120|FG000|Overall Study|Voluntary Withdrawal|7|||
161387296|NCT02277691|582802120|FG000|Overall Study|Lack of Efficacy|5|||
161387297|NCT02277691|582802120|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
161387298|NCT02846389|582802121|FG000|Overall Study|Withdrawal by Subject|1|||
161387299|NCT02846389|582802122|FG001|Overall Study|Withdrawal by Subject|1|||
161387300|NCT03818607|582802125|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
161387301|NCT03818607|582802126|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
161387302|NCT03818607|582802125|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
161387303|NCT03818607|582802126|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
161387304|NCT03818607|582802125|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
161387305|NCT03818607|582802126|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
161387306|NCT01147250|582802130|FG000|Overall Study|Lost to Follow-up|14|||
161387307|NCT01147250|582802131|FG001|Overall Study|Lost to Follow-up|11|||
161387308|NCT01147250|582802130|FG000|Overall Study|Withdrawal by Subject|83|||
161387309|NCT01147250|582802131|FG001|Overall Study|Withdrawal by Subject|88|||
161387310|NCT01147250|582802130|FG000|Overall Study|Site termination by sponsor|13|||
161387311|NCT01147250|582802131|FG001|Overall Study|Site termination by sponsor|5|||
161387312|NCT01147250|582802130|FG000|Overall Study|Other than specified|0|||
161387313|NCT01147250|582802131|FG001|Overall Study|Other than specified|1|||
161387314|NCT02249091|582802133|FG000|Overall Study|Lack of Efficacy|8|||
161387315|NCT02249091|582802134|FG001|Overall Study|Lack of Efficacy|3|||
161387316|NCT02249091|582802133|FG000|Overall Study|Physician Decision|4|||
161387317|NCT02249091|582802134|FG001|Overall Study|Physician Decision|1|||
161387318|NCT02249091|582802133|FG000|Overall Study|Withdrawal by Subject|2|||
161387319|NCT02249091|582802134|FG001|Overall Study|Withdrawal by Subject|2|||
161387320|NCT02249091|582802133|FG000|Overall Study|Death|3|||
161387321|NCT02249091|582802134|FG001|Overall Study|Death|4|||
161387322|NCT02249091|582802133|FG000|Overall Study|Adverse Event|1|||
161387323|NCT02249091|582802134|FG001|Overall Study|Adverse Event|0|||
161387324|NCT02249091|582802133|FG000|Overall Study|Stable disease with following SCT|0|||
161387325|NCT02249091|582802134|FG001|Overall Study|Stable disease with following SCT|1|||
161387326|NCT02249091|582802133|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
161387327|NCT02249091|582802134|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
161387328|NCT02249091|582802133|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
161387329|NCT02249091|582802134|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
161387330|NCT02249091|582802133|FG000|Overall Study|Refractory AML|1|||
161387331|NCT02249091|582802134|FG001|Overall Study|Refractory AML|1|||
161387332|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161387333|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
161387334|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161387335|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161387336|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161387337|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161387338|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
161387339|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
161387340|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161387341|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161387342|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161387343|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161387344|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
161387345|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
161387346|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161387347|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161387348|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161387349|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161387350|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
161387351|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
161387352|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161387353|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161387354|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161387355|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161387356|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161387357|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
161387358|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161387359|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161387360|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161387361|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161387362|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
161387363|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
161387364|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161387365|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161387366|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161387367|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161387368|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161387369|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
161387370|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161387371|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161387372|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161387373|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161387374|NCT03985943|582802135|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161387375|NCT03985943|582802136|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
161387376|NCT03985943|582802137|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161387377|NCT03985943|582802138|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161387378|NCT03985943|582802139|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161387379|NCT03985943|582802140|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161387380|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161387381|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161387382|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
161387383|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
161387384|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
161387385|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
161387386|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161387387|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161387388|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
161387389|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
161387390|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
161387391|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
161387392|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
161387393|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
161387394|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
161387395|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
161387396|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
161387397|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
161387398|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161387399|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161387400|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161387401|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161387402|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161387403|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161387404|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161387405|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161387406|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
161387407|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161387408|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
161387409|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161387410|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
161387411|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
161387412|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
161387413|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
161387414|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
161387415|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
161387416|NCT03985943|582802135|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
161387417|NCT03985943|582802136|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
161387418|NCT03985943|582802137|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
161387419|NCT03985943|582802138|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
161387420|NCT03985943|582802139|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
161387421|NCT03985943|582802140|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
161387422|NCT04075513|582802143|FG000|Overall Study|Withdrawal by Subject|2|||
161387423|NCT04075513|582802144|FG001|Overall Study|Withdrawal by Subject|2|||
161387424|NCT04075513|582802143|FG000|Overall Study|Lack of Efficacy|1|||
161387425|NCT04075513|582802144|FG001|Overall Study|Lack of Efficacy|0|||
161387426|NCT04075513|582802143|FG000|Overall Study|Lost to Follow-up|4|||
161387427|NCT04075513|582802144|FG001|Overall Study|Lost to Follow-up|2|||
161387428|NCT04075513|582802143|FG000|Overall Study|Switch to insulin pump|1|||
161387429|NCT04075513|582802144|FG001|Overall Study|Switch to insulin pump|0|||
161387430|NCT05730335|582802145|FG000|Overall Study|Lost to Follow-up|8|||
161387431|NCT05730335|582802145|FG000|Overall Study|Withdrawal by Subject|6|||
161387432|NCT03249909|582802146|FG000|Overall Study|Withdrawal by Subject|3|||
161387433|NCT03249909|582802147|FG001|Overall Study|Withdrawal by Subject|0|||
161387434|NCT03249909|582802148|FG002|Overall Study|Withdrawal by Subject|0|||
161387435|NCT03249909|582802146|FG000|Overall Study|Adverse Event|3|||
161387436|NCT03249909|582802147|FG001|Overall Study|Adverse Event|0|||
161387437|NCT03249909|582802148|FG002|Overall Study|Adverse Event|0|||
161387438|NCT03249909|582802146|FG000|Overall Study|Lost to Follow-up|0|||
161387439|NCT03249909|582802147|FG001|Overall Study|Lost to Follow-up|1|||
161387440|NCT03249909|582802148|FG002|Overall Study|Lost to Follow-up|0|||
161387441|NCT03517371|582802149|FG000|Overall Study|Adverse Event|8|||
161387442|NCT03517371|582802150|FG001|Overall Study|Adverse Event|9|||
161387443|NCT03517371|582802149|FG000|Overall Study|Lost to Follow-up|1|||
161387444|NCT03517371|582802150|FG001|Overall Study|Lost to Follow-up|2|||
161387445|NCT03517371|582802149|FG000|Overall Study|Withdrawal by Subject|4|||
161387446|NCT03517371|582802150|FG001|Overall Study|Withdrawal by Subject|4|||
161387447|NCT03517371|582802149|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
161387448|NCT03517371|582802150|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
161387449|NCT03517371|582802149|FG000|Overall Study|COVID restrictions|2|||
161387450|NCT03517371|582802150|FG001|Overall Study|COVID restrictions|0|||
161387451|NCT03517371|582802149|FG000|Overall Study|Receiving DBS Surgery|0|||
161387452|NCT03517371|582802150|FG001|Overall Study|Receiving DBS Surgery|1|||
161387453|NCT01345929|582802151|FG000|Overall Study|Withdrawal by Subject|9|||
161387454|NCT01345929|582802152|FG001|Overall Study|Withdrawal by Subject|8|||
161387455|NCT01345929|582802151|FG000|Overall Study|Lost to Follow-up|9|||
161387456|NCT01345929|582802152|FG001|Overall Study|Lost to Follow-up|9|||
161387457|NCT01345929|582802151|FG000|Overall Study|Adverse Event|0|||
161387458|NCT01345929|582802152|FG001|Overall Study|Adverse Event|1|||
161387459|NCT01345929|582802151|FG000|Overall Study|Didn't meet eligibility criteria|2|||
161387460|NCT01345929|582802152|FG001|Overall Study|Didn't meet eligibility criteria|0|||
161387461|NCT01345929|582802151|FG000|Overall Study|40,000 CFU/ML|1|||
161387462|NCT01345929|582802152|FG001|Overall Study|40,000 CFU/ML|0|||
161387463|NCT01345929|582802151|FG000|Overall Study|Patient withdrawal|0|||
161387464|NCT01345929|582802152|FG001|Overall Study|Patient withdrawal|1|||
161387465|NCT02819297|582802153|FG000|Overall Study|Withdrawal by Subject|25|||
161387466|NCT02819297|582802154|FG001|Overall Study|Withdrawal by Subject|13|||
161387467|NCT02819297|582802153|FG000|Overall Study|Lost to Follow-up|12|||
161387468|NCT02819297|582802154|FG001|Overall Study|Lost to Follow-up|14|||
161387469|NCT02819297|582802153|FG000|Overall Study|Adverse Event|12|||
161387470|NCT02819297|582802154|FG001|Overall Study|Adverse Event|10|||
161387471|NCT02819297|582802153|FG000|Overall Study|Physician Decision|5|||
161387472|NCT02819297|582802154|FG001|Overall Study|Physician Decision|5|||
161387473|NCT02819297|582802153|FG000|Overall Study|Lack of Efficacy|5|||
161387474|NCT02819297|582802154|FG001|Overall Study|Lack of Efficacy|8|||
161387475|NCT02819297|582802153|FG000|Overall Study|Protocol Violation|1|||
161387476|NCT02819297|582802154|FG001|Overall Study|Protocol Violation|2|||
161387477|NCT01901614|582802155|FG000|Overall Study|Adverse Event|0|||
161387478|NCT01901614|582802156|FG001|Overall Study|Adverse Event|1|||
161387479|NCT01901614|582802155|FG000|Overall Study|Lost to Follow-up|1|||
161387480|NCT01901614|582802156|FG001|Overall Study|Lost to Follow-up|0|||
161387481|NCT01901614|582802155|FG000|Overall Study|Screen Fail|1|||
161387482|NCT01901614|582802156|FG001|Overall Study|Screen Fail|0|||
161387483|NCT02702609|582802157|FG000|Overall Study|Lost to Follow-up|8|||
161387484|NCT02702609|582802158|FG001|Overall Study|Lost to Follow-up|4|||
161387485|NCT02702609|582802157|FG000|Overall Study|Physician Decision|1|||
161387486|NCT02702609|582802158|FG001|Overall Study|Physician Decision|0|||
161387487|NCT02674464|582802159|FG000|Overall Study|Death|10|||
161387488|NCT02674464|582802160|FG001|Overall Study|Death|21|||
161387489|NCT02674464|582802159|FG000|Overall Study|Withdrawal by Subject|24|||
161387490|NCT02674464|582802160|FG001|Overall Study|Withdrawal by Subject|44|||
161387491|NCT02674464|582802159|FG000|Overall Study|Lost to Follow-up|97|||
161387492|NCT02674464|582802160|FG001|Overall Study|Lost to Follow-up|92|||
161387493|NCT02674464|582802159|FG000|Overall Study|Outside survey window|6|||
161387494|NCT02674464|582802160|FG001|Overall Study|Outside survey window|3|||
161387495|NCT04153981|582802161|FG000|Overall Study|Death|1|||
161387496|NCT04153981|582802161|FG000|Overall Study|Withdrawal by Subject|24|||
161387497|NCT04153981|582802161|FG000|Overall Study|Lost to Follow-up|1|||
161387498|NCT04153981|582802161|FG000|Overall Study|Physician Decision|1|||
161387499|NCT04153981|582802161|FG000|Overall Study|Due to Unavailable Glucometer|1|||
161387500|NCT04153981|582802161|FG000|Overall Study|Covid 19|52|||
161387501|NCT04153981|582802161|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
161387502|NCT04153981|582802161|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
161387503|NCT01262638|582802162|FG000|Overall Study|Adverse Event|3|||
161387504|NCT01262638|582802163|FG001|Overall Study|Adverse Event|4|||
161387505|NCT01262638|582802164|FG002|Overall Study|Adverse Event|3|||
161387506|NCT01262638|582802165|FG003|Overall Study|Adverse Event|4|||
161387507|NCT01262638|582802162|FG000|Overall Study|Protocol Violation|1|||
161387508|NCT01262638|582802163|FG001|Overall Study|Protocol Violation|0|||
161387509|NCT01262638|582802164|FG002|Overall Study|Protocol Violation|0|||
161387510|NCT01262638|582802165|FG003|Overall Study|Protocol Violation|1|||
161387511|NCT01262638|582802162|FG000|Overall Study|Withdrawal by Subject|2|||
161387512|NCT01262638|582802163|FG001|Overall Study|Withdrawal by Subject|1|||
161387513|NCT01262638|582802164|FG002|Overall Study|Withdrawal by Subject|0|||
161387514|NCT01262638|582802165|FG003|Overall Study|Withdrawal by Subject|1|||
161387515|NCT01262638|582802162|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161387516|NCT01262638|582802163|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161387517|NCT01262638|582802164|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
161387518|NCT01262638|582802165|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161387519|NCT01262638|582802162|FG000|Overall Study|Lost to Follow-up|1|||
161387520|NCT01262638|582802163|FG001|Overall Study|Lost to Follow-up|1|||
161387521|NCT01262638|582802164|FG002|Overall Study|Lost to Follow-up|1|||
161387522|NCT01262638|582802165|FG003|Overall Study|Lost to Follow-up|1|||
161387523|NCT01262638|582802162|FG000|Overall Study|Participant Went Out of Town|0|||
161387524|NCT01262638|582802163|FG001|Overall Study|Participant Went Out of Town|0|||
161387525|NCT01262638|582802164|FG002|Overall Study|Participant Went Out of Town|1|||
161387526|NCT01262638|582802165|FG003|Overall Study|Participant Went Out of Town|0|||
161387527|NCT01369199|582802168|FG000|Overall Study|Withdrawal by Subject|1|||
161387528|NCT01369199|582802168|FG000|Overall Study|Lost to Follow-up|2|||
161387529|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
161387530|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
161387531|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
161387532|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161387533|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161387534|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161387535|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161387536|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161387537|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161387538|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161387539|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161387540|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161387541|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161387542|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161387543|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
161387544|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
161387545|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
161387546|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161387547|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161387548|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161387549|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161387550|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
161387551|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
161387552|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161387553|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161387554|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161387555|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161387556|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161387557|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
161387558|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161387559|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161387560|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161387561|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161387562|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161387563|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161387564|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161387565|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
161387566|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161387567|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161387568|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161387569|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161387570|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161387571|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
161387572|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
161387573|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
161387574|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161387575|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161387576|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161387577|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161387578|NCT03745638|582802173|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
161387579|NCT03745638|582802174|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
161387580|NCT03745638|582802175|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161387581|NCT03745638|582802176|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161387582|NCT03745638|582802177|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161387583|NCT03745638|582802178|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161387584|NCT03745638|582802179|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161387585|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161387586|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161387587|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161387588|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161387589|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161387590|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
161387591|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
161387592|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161387593|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161387594|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161387595|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
161387596|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161387597|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
161387598|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
161387599|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161387600|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161387601|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161387602|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
161387603|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
161387604|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
161387605|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
161387606|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161387607|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161387608|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161387609|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161387610|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
161387611|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
161387612|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161387613|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161387614|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161387615|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161387616|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161387617|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161387618|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
161387619|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161387620|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161387621|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161387622|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161387623|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
161387624|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
161387625|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
161387626|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
161387627|NCT03745638|582802173|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161387628|NCT03745638|582802174|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161387629|NCT03745638|582802175|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161387630|NCT03745638|582802176|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161387631|NCT03745638|582802177|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161387632|NCT03745638|582802178|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
161387633|NCT03745638|582802179|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
161387634|NCT01814046|582802186|FG000|Drug Administration|Death due to complications of RSV|1|||
161387635|NCT01814046|582802187|FG001|Drug Administration|Death due to complications of RSV|0|||
161387636|NCT01814046|582802188|FG002|Drug Administration|Death due to complications of RSV|0|||
161387637|NCT00564902|582802189|FG000|Overall Study|Withdrawal by Subject|0|||
161387638|NCT00564902|582802190|FG001|Overall Study|Withdrawal by Subject|3|||
161387639|NCT00564902|582802191|FG002|Overall Study|Withdrawal by Subject|4|||
161387640|NCT00564902|582802189|FG000|Overall Study|Death|1|||
161387641|NCT00564902|582802190|FG001|Overall Study|Death|1|||
161387642|NCT00564902|582802191|FG002|Overall Study|Death|0|||
161387643|NCT00958347|582802192|FG000|Overall Study|Death|43|||
161387644|NCT00958347|582802192|FG000|Overall Study|Withdrawal by Subject|23|||
161387645|NCT00958347|582802192|FG000|Overall Study|Lost to Follow-up|15|||
161387646|NCT00958347|582802192|FG000|Overall Study|revision/removal|10|||
161387647|NCT00958347|582802192|FG000|Overall Study|study termination|135|||
161387648|NCT04552288|582802195|FG000|Overall Study|Death|3|||
161387649|NCT04552288|582802195|FG000|Overall Study|Lost to Follow-up|6|||
161387650|NCT04552288|582802195|FG000|Overall Study|Physician Decision|3|||
161387651|NCT04552288|582802195|FG000|Overall Study|Protocol Violation|9|||
161387652|NCT04552288|582802195|FG000|Overall Study|Withdrawal by Subject|6|||
161387653|NCT04552288|582802195|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
161387654|NCT01917929|582802196|FG000|Overall Study|Death|8|||
161387655|NCT01917929|582802196|FG000|Overall Study|Lost to Follow-up|19|||
161387656|NCT01917929|582802196|FG000|Overall Study|Withdrawal by Subject|33|||
161387657|NCT01917929|582802196|FG000|Overall Study|Adverse Event|6|||
161387658|NCT01917929|582802196|FG000|Overall Study|Investigative Site Terminated|35|||
161387659|NCT01917929|582802196|FG000|Overall Study|Censored because study device not implanted|6|||
161387660|NCT01917929|582802196|FG000|Overall Study|Censored because surgery not performed|3|||
161387661|NCT01917929|582802196|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
161387662|NCT01917929|582802196|FG000|Overall Study|Sponsor terminated study|175|||
161387663|NCT04532294|582802197|FG000|Overall Study|Withdrawal by Subject|0|||
161387664|NCT04532294|582802198|FG001|Overall Study|Withdrawal by Subject|0|||
161387665|NCT04532294|582802199|FG002|Overall Study|Withdrawal by Subject|1|||
161387666|NCT04532294|582802197|FG000|Overall Study|Participants Not Dosed|0|||
161387667|NCT04532294|582802198|FG001|Overall Study|Participants Not Dosed|0|||
161387668|NCT04532294|582802199|FG002|Overall Study|Participants Not Dosed|2|||
161387669|NCT03089047|582802200|FG000|Overall Study|Lost to Follow-up|1|||
161387670|NCT03089047|582802201|FG001|Overall Study|Lost to Follow-up|0|||
161387671|NCT03599518|582802202|FG000|Overall Study|Clinical progression|0|||
161387672|NCT03599518|582802203|FG001|Overall Study|Clinical progression|0|||
161387673|NCT03599518|582802204|FG002|Overall Study|Clinical progression|0|||
161387674|NCT03599518|582802205|FG003|Overall Study|Clinical progression|0|||
161387675|NCT03599518|582802206|FG004|Overall Study|Clinical progression|1|||
161387676|NCT03599518|582802202|FG000|Overall Study|Adverse Event|0|||
161387677|NCT03599518|582802203|FG001|Overall Study|Adverse Event|0|||
161387678|NCT03599518|582802204|FG002|Overall Study|Adverse Event|0|||
161387679|NCT03599518|582802205|FG003|Overall Study|Adverse Event|0|||
161387680|NCT03599518|582802206|FG004|Overall Study|Adverse Event|1|||
161387681|NCT03599518|582802202|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
161387682|NCT03599518|582802203|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
161387683|NCT03599518|582802204|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
161387684|NCT03599518|582802205|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
161387685|NCT03599518|582802206|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
161387686|NCT03599518|582802202|FG000|Overall Study|Participant withdrawal from study treatment|0|||
161387687|NCT03599518|582802203|FG001|Overall Study|Participant withdrawal from study treatment|0|||
161387688|NCT03599518|582802204|FG002|Overall Study|Participant withdrawal from study treatment|1|||
161387689|NCT03599518|582802205|FG003|Overall Study|Participant withdrawal from study treatment|0|||
161387690|NCT03599518|582802206|FG004|Overall Study|Participant withdrawal from study treatment|0|||
161387691|NCT00837161|582802207|FG000|Overall Study|refused hysterectomy|2|||
161387692|NCT06899737|582802208|FG000|Overall Study|Lost to Follow-up|19|||
161387693|NCT06899737|582802209|FG001|Overall Study|Lost to Follow-up|7|||
161387694|NCT01082081|582802210|FG000|Overall Study|Lost to Follow-up|0|||
161387695|NCT01082081|582802211|FG001|Overall Study|Lost to Follow-up|0|||
161387696|NCT01082081|582802212|FG002|Overall Study|Lost to Follow-up|1|||
161387697|NCT01082081|582802210|FG000|Overall Study|Withdrawal by Subject|0|||
161387698|NCT01082081|582802211|FG001|Overall Study|Withdrawal by Subject|0|||
161387699|NCT01082081|582802212|FG002|Overall Study|Withdrawal by Subject|1|||
161387700|NCT01082081|582802210|FG000|Overall Study|Other Reason|0|||
161387701|NCT01082081|582802211|FG001|Overall Study|Other Reason|1|||
161387702|NCT01082081|582802212|FG002|Overall Study|Other Reason|0|||
161387703|NCT01575808|582802213|FG000|Overall Study|Death|2|||
161387704|NCT01575808|582802214|FG001|Overall Study|Death|0|||
161387705|NCT01575808|582802213|FG000|Overall Study|Withdrawal by Subject|1|||
161387706|NCT01575808|582802214|FG001|Overall Study|Withdrawal by Subject|0|||
161387707|NCT03159468|582802215|FG000|Overall Study|Withdrawal by Subject|0|||
161387708|NCT03159468|582802216|FG001|Overall Study|Withdrawal by Subject|0|||
161387709|NCT03159468|582802217|FG002|Overall Study|Withdrawal by Subject|3|||
161387710|NCT03159468|582802218|FG003|Overall Study|Withdrawal by Subject|0|||
161387711|NCT03159468|582802219|FG004|Overall Study|Withdrawal by Subject|0|||
161387712|NCT03159468|582802220|FG005|Overall Study|Withdrawal by Subject|0|||
161387713|NCT04308239|582803657|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
161387714|NCT04308239|582803658|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
161387715|NCT04308239|582803657|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
161387716|NCT04308239|582803658|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
161387717|NCT04308239|582803657|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
161387718|NCT04308239|582803658|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
161387719|NCT04308239|582803657|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
161387720|NCT04308239|582803658|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
161387721|NCT00716482|582803664|FG000|Overall Study|Lost to Follow-up|6|||
161387722|NCT00716482|582803664|FG000|Overall Study|Inadequate acquisition or analysis|50|||
161387723|NCT00716482|582803664|FG000|Overall Study|no pathology obtained|10|||
161387724|NCT00716482|582803664|FG000|Overall Study|technical/machine error|28|||
161387725|NCT00716482|582803664|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
161387726|NCT05411822|582803665|FG000|Overall Study|Withdrawal by Subject|2|||
161387727|NCT05411822|582803666|FG001|Overall Study|Withdrawal by Subject|1|||
161387728|NCT01670279|582803667|FG000|Overall Study|Adverse Event|0|||
161387729|NCT01670279|582803668|FG001|Overall Study|Adverse Event|1|||
161387730|NCT01670279|582803669|FG002|Overall Study|Adverse Event|0|||
161387731|NCT01670279|582803670|FG003|Overall Study|Adverse Event|0|||
161387732|NCT01670279|582803667|FG000|Overall Study|Physician Decision|0|||
161387733|NCT01670279|582803668|FG001|Overall Study|Physician Decision|1|||
161387734|NCT01670279|582803669|FG002|Overall Study|Physician Decision|0|||
161387735|NCT01670279|582803670|FG003|Overall Study|Physician Decision|0|||
161387736|NCT01670279|582803667|FG000|Overall Study|Participant met withdrawal criteria|0|||
161387737|NCT01670279|582803668|FG001|Overall Study|Participant met withdrawal criteria|0|||
161387738|NCT01670279|582803669|FG002|Overall Study|Participant met withdrawal criteria|0|||
161387739|NCT01670279|582803670|FG003|Overall Study|Participant met withdrawal criteria|1|||
161387740|NCT02318368|582803671|FG000|Overall Study|Withdrawal by Subject|2|||
161387741|NCT02318368|582803672|FG001|Overall Study|Withdrawal by Subject|0|||
161387742|NCT02318368|582803671|FG000|Overall Study|Study terminated by the sponsor|5|||
161387743|NCT02318368|582803672|FG001|Overall Study|Study terminated by the sponsor|2|||
161387744|NCT02318368|582803671|FG000|Overall Study|Death|0|||
161387745|NCT02318368|582803672|FG001|Overall Study|Death|1|||
161387746|NCT01555073|582803673|FG000|Overall Study|Lost to Follow-up|1|||
161387747|NCT01555073|582803674|FG001|Overall Study|Lost to Follow-up|2|||
161387748|NCT01555073|582803675|FG002|Overall Study|Lost to Follow-up|0|||
161387749|NCT01555073|582803676|FG003|Overall Study|Lost to Follow-up|5|||
161387750|NCT02125838|582803677|FG000|Overall Study|Lost to Follow-up|4|||
161387751|NCT02125838|582803678|FG001|Overall Study|Lost to Follow-up|4|||
161387752|NCT02565147|582803679|FG000|Overall Study|Withdrawal by Subject|5|||
161387753|NCT02565147|582803680|FG001|Overall Study|Withdrawal by Subject|1|||
161387754|NCT02565147|582803679|FG000|Overall Study|Lost to Follow-up|0|||
161387755|NCT02565147|582803680|FG001|Overall Study|Lost to Follow-up|1|||
161387756|NCT02565147|582803679|FG000|Overall Study|Death|1|||
161387757|NCT02565147|582803680|FG001|Overall Study|Death|1|||
161387758|NCT00787839|582803681|FG000|Overall Study|Failure to have the OGTT was most common|404|||
161387759|NCT00244725|582803687|FG000|Overall Study|Lost to Follow-up|3|||
161387760|NCT00244725|582803688|FG001|Overall Study|Lost to Follow-up|4|||
161387761|NCT00244725|582803689|FG002|Overall Study|Lost to Follow-up|9|||
161387762|NCT00244725|582803690|FG003|Overall Study|Lost to Follow-up|2|||
161387763|NCT00244725|582803687|FG000|Overall Study|Withdrawal by Subject|9|||
161387764|NCT00244725|582803688|FG001|Overall Study|Withdrawal by Subject|7|||
161387765|NCT00244725|582803689|FG002|Overall Study|Withdrawal by Subject|7|||
161387766|NCT00244725|582803690|FG003|Overall Study|Withdrawal by Subject|8|||
161387767|NCT00244725|582803687|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
161387768|NCT00244725|582803688|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
161387769|NCT00244725|582803689|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
161387770|NCT00244725|582803690|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
161387771|NCT00244725|582803687|FG000|Overall Study|Physician Decision|3|||
161387772|NCT00244725|582803688|FG001|Overall Study|Physician Decision|0|||
161387773|NCT00244725|582803689|FG002|Overall Study|Physician Decision|1|||
161387774|NCT00244725|582803690|FG003|Overall Study|Physician Decision|2|||
161387775|NCT00244725|582803687|FG000|Overall Study|Adverse Events|3|||
161387776|NCT00244725|582803688|FG001|Overall Study|Adverse Events|1|||
161387777|NCT00244725|582803689|FG002|Overall Study|Adverse Events|4|||
161387778|NCT00244725|582803690|FG003|Overall Study|Adverse Events|4|||
161387779|NCT00244725|582803687|FG000|Overall Study|Withdrwal by participant|1|||
161387780|NCT00244725|582803688|FG001|Overall Study|Withdrwal by participant|0|||
161387781|NCT00244725|582803689|FG002|Overall Study|Withdrwal by participant|0|||
161387782|NCT00244725|582803690|FG003|Overall Study|Withdrwal by participant|1|||
161387783|NCT00244725|582803687|FG000|Overall Study|Liver function test abnormality|2|||
161387784|NCT00244725|582803688|FG001|Overall Study|Liver function test abnormality|0|||
161387785|NCT00244725|582803689|FG002|Overall Study|Liver function test abnormality|0|||
161387786|NCT00244725|582803690|FG003|Overall Study|Liver function test abnormality|1|||
161387787|NCT00244725|582803687|FG000|Overall Study|Sponsor withdrew the participant|1|||
161387788|NCT00244725|582803688|FG001|Overall Study|Sponsor withdrew the participant|0|||
161387789|NCT00244725|582803689|FG002|Overall Study|Sponsor withdrew the participant|0|||
161387790|NCT00244725|582803690|FG003|Overall Study|Sponsor withdrew the participant|1|||
161387791|NCT00244725|582803687|FG000|Overall Study|Mediciation Error|0|||
161387792|NCT00244725|582803688|FG001|Overall Study|Mediciation Error|1|||
161387793|NCT00244725|582803689|FG002|Overall Study|Mediciation Error|0|||
161387794|NCT00244725|582803690|FG003|Overall Study|Mediciation Error|0|||
161387795|NCT00244725|582803687|FG000|Overall Study|Rehab Refused to allow participantion|0|||
161387796|NCT00244725|582803688|FG001|Overall Study|Rehab Refused to allow participantion|1|||
161387797|NCT00244725|582803689|FG002|Overall Study|Rehab Refused to allow participantion|0|||
161387798|NCT00244725|582803690|FG003|Overall Study|Rehab Refused to allow participantion|0|||
161387799|NCT00244725|582803687|FG000|Overall Study|Headache|0|||
161387800|NCT00244725|582803688|FG001|Overall Study|Headache|1|||
161387801|NCT00244725|582803689|FG002|Overall Study|Headache|0|||
161387802|NCT00244725|582803690|FG003|Overall Study|Headache|0|||
161387803|NCT00244725|582803687|FG000|Overall Study|Received prohibited medication|0|||
161387804|NCT00244725|582803688|FG001|Overall Study|Received prohibited medication|1|||
161387805|NCT00244725|582803689|FG002|Overall Study|Received prohibited medication|0|||
161387806|NCT00244725|582803690|FG003|Overall Study|Received prohibited medication|1|||
161387807|NCT00244725|582803687|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
161387808|NCT00244725|582803688|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
161387809|NCT00244725|582803689|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
161387810|NCT00244725|582803690|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
161387811|NCT00244725|582803687|FG000|Overall Study|Administrative reason|0|||
161387812|NCT00244725|582803688|FG001|Overall Study|Administrative reason|0|||
161387813|NCT00244725|582803689|FG002|Overall Study|Administrative reason|1|||
161387814|NCT00244725|582803690|FG003|Overall Study|Administrative reason|0|||
161387815|NCT00244725|582803687|FG000|Overall Study|Vomit|0|||
161387816|NCT00244725|582803688|FG001|Overall Study|Vomit|0|||
161387817|NCT00244725|582803689|FG002|Overall Study|Vomit|1|||
161387818|NCT00244725|582803690|FG003|Overall Study|Vomit|0|||
161387819|NCT00244725|582803687|FG000|Overall Study|Failed to follow-up|0|||
161387820|NCT00244725|582803688|FG001|Overall Study|Failed to follow-up|0|||
161387821|NCT00244725|582803689|FG002|Overall Study|Failed to follow-up|1|||
161387822|NCT00244725|582803690|FG003|Overall Study|Failed to follow-up|1|||
161387823|NCT04004221|582803691|FG000|Overall Study|Death|89|||
161387824|NCT04004221|582803691|FG000|Overall Study|Withdrawal by Subject|5|||
161387825|NCT04004221|582803691|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
161387826|NCT04004221|582803691|FG000|Overall Study|Sponsor Decision|9|||
161387827|NCT04004221|582803691|FG000|Overall Study|Participant refused to enter LTE|1|||
161387828|NCT00506454|582803693|FG000|Overall Study|Withdrawal by Subject|1|||
161387829|NCT00506454|582803694|FG001|Overall Study|Withdrawal by Subject|1|||
161387830|NCT01104545|582803695|FG000|Overall Study|Adverse Event|0|||
161387831|NCT01104545|582803696|FG001|Overall Study|Adverse Event|1|||
161387832|NCT01104545|582803697|FG002|Overall Study|Adverse Event|2|||
161387833|NCT00976716|582803698|FG000|Overall Study|Adverse Event|1|||
161387834|NCT02993822|582803699|FG000|Overall Study|Lack of Efficacy|1|||
161387835|NCT02993822|582803700|FG001|Overall Study|Lack of Efficacy|1|||
161387836|NCT02993822|582803701|FG002|Overall Study|Lack of Efficacy|0|||
161387837|NCT02993822|582803702|FG003|Overall Study|Lack of Efficacy|0|||
161387838|NCT02993822|582803699|FG000|Overall Study|Protocol Violation|1|||
161387839|NCT02993822|582803700|FG001|Overall Study|Protocol Violation|0|||
161387840|NCT02993822|582803701|FG002|Overall Study|Protocol Violation|0|||
161387841|NCT02993822|582803702|FG003|Overall Study|Protocol Violation|0|||
161387842|NCT02993822|582803699|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
161387843|NCT02993822|582803700|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
161387844|NCT02993822|582803701|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
161387845|NCT02993822|582803702|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
161387846|NCT02993822|582803699|FG000|Overall Study|Adverse Event|3|||
161387847|NCT02993822|582803700|FG001|Overall Study|Adverse Event|1|||
161387848|NCT02993822|582803701|FG002|Overall Study|Adverse Event|7|||
161387849|NCT02993822|582803702|FG003|Overall Study|Adverse Event|0|||
161387850|NCT02993822|582803699|FG000|Overall Study|Withdrawal by Subject|4|||
161387851|NCT02993822|582803700|FG001|Overall Study|Withdrawal by Subject|2|||
161387852|NCT02993822|582803701|FG002|Overall Study|Withdrawal by Subject|2|||
161387853|NCT02993822|582803702|FG003|Overall Study|Withdrawal by Subject|3|||
161387854|NCT02993822|582803699|FG000|Overall Study|Lost to Follow-up|1|||
161387855|NCT02993822|582803700|FG001|Overall Study|Lost to Follow-up|0|||
161387856|NCT02993822|582803701|FG002|Overall Study|Lost to Follow-up|1|||
161387857|NCT02993822|582803702|FG003|Overall Study|Lost to Follow-up|0|||
161387858|NCT01221753|582803706|FG000|Overall Study|Adverse Event|1|||
161387859|NCT01939977|582803707|FG000|Overall Study|Adverse Event|4|||
161387860|NCT01939977|582803708|FG001|Overall Study|Adverse Event|3|||
161387861|NCT01939977|582803707|FG000|Overall Study|Lack of Efficacy|3|||
161387862|NCT01939977|582803708|FG001|Overall Study|Lack of Efficacy|0|||
161387863|NCT01939977|582803707|FG000|Overall Study|Physician Decision|1|||
161387864|NCT01939977|582803708|FG001|Overall Study|Physician Decision|1|||
161387865|NCT01939977|582803707|FG000|Overall Study|Withdrawal by Subject|0|||
161387866|NCT01939977|582803708|FG001|Overall Study|Withdrawal by Subject|2|||
161387867|NCT01939977|582803707|FG000|Overall Study|Did not meet inclusion criteria|1|||
161387868|NCT01939977|582803708|FG001|Overall Study|Did not meet inclusion criteria|0|||
161387869|NCT01939977|582803707|FG000|Overall Study|Did not receive study medication|0|||
161387870|NCT01939977|582803708|FG001|Overall Study|Did not receive study medication|1|||
161387871|NCT01603043|582803712|FG000|Overall Study|Study Futility|7|||
161387872|NCT01603043|582803713|FG001|Overall Study|Study Futility|3|||
161387873|NCT01696981|582803714|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
161387874|NCT01696981|582803715|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
161387875|NCT01696981|582803714|FG000|Overall Study|Died Before Randomization|3|||
161387876|NCT01696981|582803715|FG001|Overall Study|Died Before Randomization|8|||
161387877|NCT01696981|582803714|FG000|Overall Study|Died Before ASU (Control)|278|||
161387878|NCT01696981|582803715|FG001|Overall Study|Died Before ASU (Control)|0|||
161387879|NCT01696981|582803714|FG000|Overall Study|Refused ASU (Control)|920|||
161387880|NCT01696981|582803715|FG001|Overall Study|Refused ASU (Control)|0|||
161387881|NCT01696981|582803714|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
161387882|NCT01696981|582803715|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
161387883|NCT02798315|582803718|FG000|Overall Study|Failure to return|1|||
161387884|NCT00465972|582803719|FG000|Overall Study|Withdrawal by Subject|2|||
161387885|NCT00465972|582803720|FG001|Overall Study|Withdrawal by Subject|1|||
161387886|NCT02097719|582803721|FG000|Overall Study|Subject Withdrew Consent|1|||
161387887|NCT02097719|582803722|FG001|Overall Study|Subject Withdrew Consent|0|||
161387888|NCT02097719|582803721|FG000|Overall Study|Lost to Follow-up|0|||
161387889|NCT02097719|582803722|FG001|Overall Study|Lost to Follow-up|1|||
161387890|NCT02097719|582803721|FG000|Overall Study|Adverse Event|2|||
161387891|NCT02097719|582803722|FG001|Overall Study|Adverse Event|0|||
161387892|NCT03292640|582803723|FG000|Overall Study|Withdrawal by Subject|17|||
161387893|NCT03292640|582803724|FG001|Overall Study|Withdrawal by Subject|16|||
161387894|NCT03292640|582803723|FG000|Overall Study|Adverse Event|20|||
161387895|NCT03292640|582803724|FG001|Overall Study|Adverse Event|2|||
161387896|NCT03292640|582803723|FG000|Overall Study|Lost to Follow-up|24|||
161387897|NCT03292640|582803724|FG001|Overall Study|Lost to Follow-up|24|||
161387898|NCT01108731|582803732|FG000|Overall Study|Withdrawal by Subject|1|||
161387899|NCT01108731|582803733|FG001|Overall Study|Withdrawal by Subject|1|||
161387900|NCT01108731|582803732|FG000|Overall Study|Adverse Event|3|||
161387901|NCT01108731|582803733|FG001|Overall Study|Adverse Event|3|||
161387902|NCT00984594|582803734|FG000|Overall Study|Lost to Follow-up|1|||
161387903|NCT00984594|582803735|FG001|Overall Study|Lost to Follow-up|0|||
161387904|NCT00984594|582803734|FG000|Overall Study|Withdrawal by Subject|0|||
161387905|NCT00984594|582803735|FG001|Overall Study|Withdrawal by Subject|1|||
161387906|NCT00851890|582803736|FG000|Overall Study|Lost to Follow-up|0|||
161387907|NCT00851890|582803737|FG001|Overall Study|Lost to Follow-up|1|||
161387908|NCT00851890|582803738|FG002|Overall Study|Lost to Follow-up|0|||
161387909|NCT00851890|582803739|FG003|Overall Study|Lost to Follow-up|1|||
161387910|NCT03135431|582803740|FG000|Overall Study|Study Surgeon not available|2|||
161387911|NCT03135431|582803741|FG001|Overall Study|Study Surgeon not available|0|||
161387912|NCT01063062|582803742|FG000|Overall Study|Patient withdrew consent|0|||
161387913|NCT01063062|582803743|FG001|Overall Study|Patient withdrew consent|1|||
161387914|NCT01063062|582803742|FG000|Overall Study|Adverse Event|2|||
161387915|NCT01063062|582803743|FG001|Overall Study|Adverse Event|4|||
161387916|NCT01063062|582803742|FG000|Overall Study|Protocol Violation|5|||
161387917|NCT01063062|582803743|FG001|Overall Study|Protocol Violation|4|||
161387918|NCT01063062|582803742|FG000|Overall Study|Investigator's request|1|||
161387919|NCT01063062|582803743|FG001|Overall Study|Investigator's request|0|||
161387920|NCT01063062|582803742|FG000|Overall Study|Lost to Follow-up|0|||
161387921|NCT01063062|582803743|FG001|Overall Study|Lost to Follow-up|2|||
161387922|NCT01063062|582803742|FG000|Overall Study|Miscellaneous reason|0|||
161387923|NCT01063062|582803743|FG001|Overall Study|Miscellaneous reason|1|||
161387924|NCT02015481|582803744|FG000|Overall Study|Death|1|||
161387925|NCT02597452|582803746|FG000|Overall Study|testing incomplete|30|||
161387926|NCT03122145|582803749|FG000|Overall Study|Concurrent respiratory disease|3|||
161387927|NCT03122145|582803750|FG001|Overall Study|Concurrent respiratory disease|0|||
161387928|NCT02016716|582803755|FG000|Overall Study|Withdrawal by Subject|5|||
161387929|NCT02016716|582803756|FG001|Overall Study|Withdrawal by Subject|5|||
161387930|NCT02016716|582803757|FG002|Overall Study|Withdrawal by Subject|5|||
161387931|NCT02016716|582803755|FG000|Overall Study|Protocol-specified Criteria|0|||
161387932|NCT02016716|582803756|FG001|Overall Study|Protocol-specified Criteria|1|||
161387933|NCT02016716|582803757|FG002|Overall Study|Protocol-specified Criteria|0|||
161387934|NCT02016716|582803755|FG000|Overall Study|Lost to Follow-up|1|||
161387935|NCT02016716|582803756|FG001|Overall Study|Lost to Follow-up|2|||
161387936|NCT02016716|582803757|FG002|Overall Study|Lost to Follow-up|1|||
161387937|NCT00079391|582803758|FG000|Overall Study|Withdrawal by Subject|1|||
161387938|NCT00281099|582803759|FG000|Overall Study|Death|46|||
161387939|NCT00281099|582803760|FG001|Overall Study|Death|57|||
161387940|NCT00281099|582803759|FG000|Overall Study|Lost to Follow-up|10|||
161387941|NCT00281099|582803760|FG001|Overall Study|Lost to Follow-up|19|||
161387942|NCT00281099|582803759|FG000|Overall Study|Withdrawal by Subject|65|||
161387943|NCT00281099|582803760|FG001|Overall Study|Withdrawal by Subject|70|||
161387944|NCT00281099|582803759|FG000|Overall Study|Physician Decision|79|||
161387945|NCT00281099|582803760|FG001|Overall Study|Physician Decision|72|||
161387946|NCT00281099|582803759|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
161387947|NCT00281099|582803760|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
161387948|NCT02931838|582803761|FG000|Overall Study|Reason not provided by investigator|1|||
161387949|NCT02931838|582803762|FG001|Overall Study|Reason not provided by investigator|0|||
161387950|NCT02931838|582803763|FG002|Overall Study|Reason not provided by investigator|1|||
161387951|NCT02931838|582803764|FG003|Overall Study|Reason not provided by investigator|0|||
161387952|NCT02931838|582803765|FG004|Overall Study|Reason not provided by investigator|0|||
161387953|NCT02931838|582803766|FG005|Overall Study|Reason not provided by investigator|0|||
161387954|NCT02931838|582803761|FG000|Overall Study|Poor/non-compliance|0|||
161387955|NCT02931838|582803762|FG001|Overall Study|Poor/non-compliance|0|||
161387956|NCT02931838|582803763|FG002|Overall Study|Poor/non-compliance|1|||
161387957|NCT02931838|582803764|FG003|Overall Study|Poor/non-compliance|0|||
161387958|NCT02931838|582803765|FG004|Overall Study|Poor/non-compliance|0|||
161387959|NCT02931838|582803766|FG005|Overall Study|Poor/non-compliance|0|||
161387960|NCT02931838|582803761|FG000|Overall Study|Lack of Efficacy|5|||
161387961|NCT02931838|582803762|FG001|Overall Study|Lack of Efficacy|4|||
161387962|NCT02931838|582803763|FG002|Overall Study|Lack of Efficacy|0|||
161387963|NCT02931838|582803764|FG003|Overall Study|Lack of Efficacy|0|||
161387964|NCT02931838|582803765|FG004|Overall Study|Lack of Efficacy|0|||
161387965|NCT02931838|582803766|FG005|Overall Study|Lack of Efficacy|1|||
161387966|NCT02931838|582803761|FG000|Overall Study|Lost to Follow-up|1|||
161387967|NCT02931838|582803762|FG001|Overall Study|Lost to Follow-up|0|||
161387968|NCT02931838|582803763|FG002|Overall Study|Lost to Follow-up|1|||
161387969|NCT02931838|582803764|FG003|Overall Study|Lost to Follow-up|1|||
161387970|NCT02931838|582803765|FG004|Overall Study|Lost to Follow-up|2|||
161387971|NCT02931838|582803766|FG005|Overall Study|Lost to Follow-up|0|||
161387972|NCT02931838|582803761|FG000|Overall Study|Subject request to discontinue treatment|4|||
161387973|NCT02931838|582803762|FG001|Overall Study|Subject request to discontinue treatment|3|||
161387974|NCT02931838|582803763|FG002|Overall Study|Subject request to discontinue treatment|3|||
161387975|NCT02931838|582803764|FG003|Overall Study|Subject request to discontinue treatment|0|||
161387976|NCT02931838|582803765|FG004|Overall Study|Subject request to discontinue treatment|1|||
161387977|NCT02931838|582803766|FG005|Overall Study|Subject request to discontinue treatment|0|||
161387978|NCT02931838|582803761|FG000|Overall Study|Withdrawal by Subject|1|||
161387979|NCT02931838|582803762|FG001|Overall Study|Withdrawal by Subject|2|||
161387980|NCT02931838|582803763|FG002|Overall Study|Withdrawal by Subject|0|||
161387981|NCT02931838|582803764|FG003|Overall Study|Withdrawal by Subject|1|||
161387982|NCT02931838|582803765|FG004|Overall Study|Withdrawal by Subject|0|||
161387983|NCT02931838|582803766|FG005|Overall Study|Withdrawal by Subject|0|||
161387984|NCT02931838|582803761|FG000|Overall Study|Adverse Event|2|||
161387985|NCT02931838|582803762|FG001|Overall Study|Adverse Event|1|||
161387986|NCT02931838|582803763|FG002|Overall Study|Adverse Event|2|||
161387987|NCT02931838|582803764|FG003|Overall Study|Adverse Event|1|||
161387988|NCT02931838|582803765|FG004|Overall Study|Adverse Event|3|||
161387989|NCT02931838|582803766|FG005|Overall Study|Adverse Event|1|||
161387990|NCT00104728|582803767|FG000|Overall Study|screen failures|19|||
161387991|NCT01963767|582803768|FG000|Overall Study|Withdrawal by Subject|4|||
161387992|NCT01963767|582803769|FG001|Overall Study|Withdrawal by Subject|2|||
161387993|NCT01963767|582803768|FG000|Overall Study|Adverse Event|2|||
161387994|NCT01963767|582803769|FG001|Overall Study|Adverse Event|0|||
161387995|NCT01659996|582803770|FG000|Overall Study|Protocol Violation|3|||
161387996|NCT01659996|582803771|FG001|Overall Study|Protocol Violation|3|||
161387997|NCT01659996|582803772|FG002|Overall Study|Protocol Violation|3|||
161387998|NCT01659996|582803770|FG000|Overall Study|Lost to Follow-up|1|||
161387999|NCT01659996|582803771|FG001|Overall Study|Lost to Follow-up|3|||
161388000|NCT01659996|582803772|FG002|Overall Study|Lost to Follow-up|2|||
161388001|NCT01659996|582803770|FG000|Overall Study|Adverse Event|0|||
161388002|NCT01659996|582803771|FG001|Overall Study|Adverse Event|0|||
161388003|NCT01659996|582803772|FG002|Overall Study|Adverse Event|1|||
161388004|NCT01659996|582803770|FG000|Overall Study|Withdrawal by Subject|4|||
161388005|NCT01659996|582803771|FG001|Overall Study|Withdrawal by Subject|1|||
161388006|NCT01659996|582803772|FG002|Overall Study|Withdrawal by Subject|5|||
161388007|NCT03206918|582803773|FG000|Overall Study|Death|11|||
161388008|NCT03206918|582803773|FG000|Overall Study|Withdrawal by Subject|5|||
161388009|NCT03206918|582803773|FG000|Overall Study|Study terminated by sponsor|12|||
161388010|NCT03206918|582803773|FG000|Overall Study|Lost to Follow-up|3|||
161388011|NCT03206918|582803773|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
161388012|NCT02709577|582803774|FG000|Overall Study|non-accommodating anatomy|0|||
161388013|NCT02709577|582803775|FG001|Overall Study|non-accommodating anatomy|1|||
161388014|NCT02709577|582803776|FG002|Overall Study|non-accommodating anatomy|0|||
161388015|NCT02709577|582803777|FG003|Overall Study|non-accommodating anatomy|0|||
161388016|NCT02709577|582803774|FG000|Overall Study|procedural complication|0|||
161388017|NCT02709577|582803775|FG001|Overall Study|procedural complication|1|||
161388018|NCT02709577|582803776|FG002|Overall Study|procedural complication|0|||
161388019|NCT02709577|582803777|FG003|Overall Study|procedural complication|0|||
161388020|NCT02709577|582803774|FG000|Overall Study|Withdrawal by Subject|2|||
161388021|NCT02709577|582803775|FG001|Overall Study|Withdrawal by Subject|3|||
161388022|NCT02709577|582803776|FG002|Overall Study|Withdrawal by Subject|2|||
161388023|NCT02709577|582803777|FG003|Overall Study|Withdrawal by Subject|0|||
161388024|NCT02701764|582803778|FG000|Overall Study|Lost to Follow-up|0|||
161388025|NCT02701764|582803779|FG001|Overall Study|Lost to Follow-up|1|||
161388026|NCT00375674|582803784|FG000|Overall Study|Other|26|||
161388027|NCT00375674|582803785|FG001|Overall Study|Other|18|||
161388028|NCT00375674|582803784|FG000|Overall Study|Death|67|||
161388029|NCT00375674|582803785|FG001|Overall Study|Death|76|||
161388030|NCT00375674|582803784|FG000|Overall Study|Participants refused further follow-up|31|||
161388031|NCT00375674|582803785|FG001|Overall Study|Participants refused further follow-up|30|||
161388032|NCT00375674|582803784|FG000|Overall Study|Lost to Follow-up|17|||
161388033|NCT00375674|582803785|FG001|Overall Study|Lost to Follow-up|15|||
161388034|NCT00375674|582803784|FG000|Overall Study|Enrolled but not treated|3|||
161388035|NCT00375674|582803785|FG001|Overall Study|Enrolled but not treated|2|||
161388036|NCT00912782|582803786|FG000|Overall Study|Death|2|||
161388037|NCT00912782|582803787|FG001|Overall Study|Death|1|||
161388038|NCT00912782|582803786|FG000|Overall Study|Lost to Follow-up|0|||
161388039|NCT00912782|582803787|FG001|Overall Study|Lost to Follow-up|1|||
161388040|NCT00912782|582803786|FG000|Overall Study|Did not receive vascular access type|1|||
161388041|NCT00912782|582803787|FG001|Overall Study|Did not receive vascular access type|2|||
161388042|NCT00912782|582803786|FG000|Overall Study|Relocated before study completion|0|||
161388043|NCT00912782|582803787|FG001|Overall Study|Relocated before study completion|1|||
161388044|NCT05924165|582805285|FG000|Overall Study|Physician Decision|2|||
161388045|NCT05924165|582805286|FG001|Overall Study|Physician Decision|3|||
161388046|NCT01681186|582805287|FG000|Washout Period From Second Intervention|Adverse Event|0|||
161388047|NCT01681186|582805288|FG001|Washout Period From Second Intervention|Adverse Event|0|||
161388048|NCT01681186|582805289|FG002|Washout Period From Second Intervention|Adverse Event|0|||
161388049|NCT01681186|582805290|FG003|Washout Period From Second Intervention|Adverse Event|0|||
161388050|NCT01681186|582805291|FG004|Washout Period From Second Intervention|Adverse Event|0|||
161388051|NCT01681186|582805292|FG005|Washout Period From Second Intervention|Adverse Event|0|||
161388052|NCT01681186|582805293|FG006|Washout Period From Second Intervention|Adverse Event|1|||
161388053|NCT01681186|582805294|FG007|Washout Period From Second Intervention|Adverse Event|0|||
161388054|NCT01681186|582805287|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
161388055|NCT01681186|582805288|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
161388056|NCT01681186|582805289|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
161388057|NCT01681186|582805290|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
161388058|NCT01681186|582805291|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
161388059|NCT01681186|582805292|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
161388060|NCT01681186|582805293|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
161388061|NCT01681186|582805294|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
161388062|NCT01681186|582805287|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388063|NCT01681186|582805288|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388064|NCT01681186|582805289|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388065|NCT01681186|582805290|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388066|NCT01681186|582805291|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388067|NCT01681186|582805292|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388068|NCT01681186|582805293|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
161388069|NCT01681186|582805294|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
161388070|NCT01681186|582805287|FG000|Fourth Intervention|Protocol Violation|0|||
161388071|NCT01681186|582805288|FG001|Fourth Intervention|Protocol Violation|0|||
161388072|NCT01681186|582805289|FG002|Fourth Intervention|Protocol Violation|0|||
161388073|NCT01681186|582805290|FG003|Fourth Intervention|Protocol Violation|0|||
161388074|NCT01681186|582805291|FG004|Fourth Intervention|Protocol Violation|0|||
161388075|NCT01681186|582805292|FG005|Fourth Intervention|Protocol Violation|0|||
161388076|NCT01681186|582805293|FG006|Fourth Intervention|Protocol Violation|0|||
161388077|NCT01681186|582805294|FG007|Fourth Intervention|Protocol Violation|1|||
161388078|NCT00301262|582805301|FG000|Double Blind Phase (DB)|Adverse Event|1|||
161388079|NCT00301262|582805302|FG001|Double Blind Phase (DB)|Adverse Event|0|||
161388080|NCT00301262|582805301|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
161388081|NCT00301262|582805302|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
161388082|NCT00301262|582805301|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
161388083|NCT00301262|582805302|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
161388084|NCT00301262|582805301|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
161388085|NCT00301262|582805302|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
161388086|NCT00301262|582805301|FG000|Double Blind Phase (DB)|Other|1|||
161388087|NCT00301262|582805302|FG001|Double Blind Phase (DB)|Other|4|||
161388088|NCT00301262|582805301|FG000|Open Label Phase (OL)|Adverse Event|1|||
161388089|NCT00301262|582805302|FG001|Open Label Phase (OL)|Adverse Event|0|||
161388090|NCT00301262|582805301|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
161388091|NCT00301262|582805302|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
161388092|NCT00301262|582805301|FG000|Open Label Phase (OL)|Other|2|||
161388093|NCT00301262|582805302|FG001|Open Label Phase (OL)|Other|0|||
161388094|NCT03530995|582805306|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
161388095|NCT03530995|582805307|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
161388096|NCT03530995|582805306|FG000|Part 1 Period 3|Protocol Violation|1|||
161388097|NCT03530995|582805307|FG001|Part 1 Period 3|Protocol Violation|0|||
161388098|NCT03530995|582805306|FG000|Part 1 Period 4|Physician Decision|1|||
161388099|NCT03530995|582805307|FG001|Part 1 Period 4|Physician Decision|0|||
161388100|NCT03530995|582805306|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
161388101|NCT03530995|582805307|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
161388102|NCT01443364|582805312|FG000|Overall Study|Lack of Efficacy|14|||
161388103|NCT01443364|582805312|FG000|Overall Study|Lost to Follow-up|3|||
161388104|NCT01443364|582805312|FG000|Overall Study|Withdrawal by Subject|5|||
161388105|NCT01443364|582805312|FG000|Overall Study|Other Reason|4|||
161388106|NCT01443364|582805312|FG000|Overall Study|SAE, non-fatal|6|||
161388107|NCT01443364|582805312|FG000|Overall Study|AE, non-serious non-fatal|8|||
161388108|NCT01443364|582805312|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161388109|NCT02650804|582805313|FG000|Overall Study|Adverse Event|3|||
161388110|NCT02650804|582805314|FG001|Overall Study|Adverse Event|2|||
161388111|NCT02650804|582805313|FG000|Overall Study|Death|1|||
161388112|NCT02650804|582805314|FG001|Overall Study|Death|2|||
161388113|NCT02650804|582805313|FG000|Overall Study|Progressive Disease|7|||
161388114|NCT02650804|582805314|FG001|Overall Study|Progressive Disease|10|||
161388115|NCT02650804|582805313|FG000|Overall Study|Physician Decision|0|||
161388116|NCT02650804|582805314|FG001|Overall Study|Physician Decision|2|||
161388117|NCT02650804|582805313|FG000|Overall Study|Withdrawal by Subject|1|||
161388118|NCT02650804|582805314|FG001|Overall Study|Withdrawal by Subject|4|||
161388119|NCT02650804|582805313|FG000|Overall Study|Symptomatic deterioration|5|||
161388120|NCT02650804|582805314|FG001|Overall Study|Symptomatic deterioration|7|||
161388121|NCT02650804|582805313|FG000|Overall Study|Protocol Violation|0|||
161388122|NCT02650804|582805314|FG001|Overall Study|Protocol Violation|1|||
161388123|NCT01986231|582805319|FG000|Overall Study|Adverse Event|1|||
161388124|NCT02150057|582805320|FG000|Overall Study|Lost to Follow-up|6|||
161388125|NCT02150057|582805321|FG001|Overall Study|Lost to Follow-up|4|||
161388126|NCT02141399|582805330|FG000|Overall Study|Adverse Event|158|||
161388127|NCT02141399|582805330|FG000|Overall Study|Lack of Efficacy|62|||
161388128|NCT02141399|582805330|FG000|Overall Study|Lost to Follow-up|151|||
161388129|NCT02141399|582805330|FG000|Overall Study|Non-compliance with study drug|18|||
161388130|NCT02141399|582805330|FG000|Overall Study|Other|45|||
161388131|NCT02141399|582805330|FG000|Overall Study|Physician Decision|17|||
161388132|NCT02141399|582805330|FG000|Overall Study|Pregnancy|3|||
161388133|NCT02141399|582805330|FG000|Overall Study|Protocol Violation|38|||
161388134|NCT02141399|582805330|FG000|Overall Study|Withdrawal by Subject|238|||
161388135|NCT02141399|582805330|FG000|Overall Study|Failure to meet eligibility criteria|14|||
161388136|NCT00606034|582805335|FG000|Overall Study|incarceration|1|||
161388137|NCT02516098|582805337|FG000|Period 1|Protocol Violation|1|||
161388138|NCT02516098|582805338|FG001|Period 1|Protocol Violation|0|||
161388139|NCT02516098|582805337|FG000|Washout After Period 1|Adverse Event|0|||
161388140|NCT02516098|582805338|FG001|Washout After Period 1|Adverse Event|1|||
161388141|NCT02516098|582805337|FG000|Period 2|Withdrawal by Subject|0|||
161388142|NCT02516098|582805338|FG001|Period 2|Withdrawal by Subject|1|||
161388143|NCT01734395|582805339|FG000|Overall Study|Other|65|||
161388144|NCT01734395|582805339|FG000|Overall Study|Lost to Follow-up|287|||
161388145|NCT01734395|582805339|FG000|Overall Study|Lack of Efficacy|5|||
161388146|NCT01734395|582805339|FG000|Overall Study|Adverse Event|40|||
161388147|NCT01734395|582805339|FG000|Overall Study|Withdrawal by Subject|10|||
161388148|NCT01734395|582805339|FG000|Overall Study|Missing the reasons for not completed|3|||
161388149|NCT01092780|582805340|FG000|Washout Period 1|Adverse Event|0|||
161388150|NCT01092780|582805341|FG001|Washout Period 1|Adverse Event|1|||
161388151|NCT01092780|582805342|FG002|Washout Period 1|Adverse Event|0|||
161388152|NCT01092780|582805343|FG003|Washout Period 1|Adverse Event|0|||
161388153|NCT01092780|582805340|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
161388154|NCT01092780|582805341|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
161388155|NCT01092780|582805342|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
161388156|NCT01092780|582805343|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
161388157|NCT01092780|582805340|FG000|Washout Period 2|Adverse Event|0|||
161388158|NCT01092780|582805341|FG001|Washout Period 2|Adverse Event|1|||
161388159|NCT01092780|582805342|FG002|Washout Period 2|Adverse Event|1|||
161388160|NCT01092780|582805343|FG003|Washout Period 2|Adverse Event|0|||
161388161|NCT01257230|582805344|FG000|Overall Study|Not Treated|0|||
161388162|NCT01257230|582805345|FG001|Overall Study|Not Treated|0|||
161388163|NCT01257230|582805346|FG002|Overall Study|Not Treated|1|||
161388164|NCT01257230|582805344|FG000|Overall Study|Adverse Event|2|||
161388165|NCT01257230|582805345|FG001|Overall Study|Adverse Event|0|||
161388166|NCT01257230|582805346|FG002|Overall Study|Adverse Event|0|||
161388167|NCT01257230|582805344|FG000|Overall Study|Lack of Efficacy|0|||
161388168|NCT01257230|582805345|FG001|Overall Study|Lack of Efficacy|1|||
161388169|NCT01257230|582805346|FG002|Overall Study|Lack of Efficacy|0|||
161388170|NCT01257230|582805344|FG000|Overall Study|Protocol Violation|3|||
161388171|NCT01257230|582805345|FG001|Overall Study|Protocol Violation|0|||
161388172|NCT01257230|582805346|FG002|Overall Study|Protocol Violation|1|||
161388173|NCT01257230|582805344|FG000|Overall Study|Withdrawal by Subject|0|||
161388174|NCT01257230|582805345|FG001|Overall Study|Withdrawal by Subject|4|||
161388175|NCT01257230|582805346|FG002|Overall Study|Withdrawal by Subject|1|||
161388176|NCT01257230|582805344|FG000|Overall Study|Other reason not defined above|1|||
161388177|NCT01257230|582805345|FG001|Overall Study|Other reason not defined above|5|||
161388178|NCT01257230|582805346|FG002|Overall Study|Other reason not defined above|3|||
161388179|NCT00765037|582805352|FG000|Overall Study|Lost to Follow-up|5|||
161388180|NCT00765037|582805352|FG000|Overall Study|Adverse Event|1|||
161388181|NCT00615719|582805353|FG000|Overall Study|Physician Decision|5|||
161388182|NCT02300558|582805354|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
161388183|NCT02300558|582805354|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
161388184|NCT02300558|582805354|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
161388185|NCT02300558|582805354|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
161388186|NCT01471028|582805355|FG000|VTI-208|Adverse Event|39|||
161388187|NCT01471028|582805356|FG001|VTI-208|Adverse Event|41|||
161388188|NCT01471028|582805355|FG000|VTI-208|Withdrawal by Subject|0|||
161388189|NCT01471028|582805356|FG001|VTI-208|Withdrawal by Subject|2|||
161388190|NCT01471028|582805355|FG000|VTI-208|Lost to Follow-up|1|||
161388191|NCT01471028|582805356|FG001|VTI-208|Lost to Follow-up|1|||
161388192|NCT01471028|582805355|FG000|VTI-208E|Death|7|||
161388193|NCT01471028|582805356|FG001|VTI-208E|Death|10|||
161388194|NCT01471028|582805355|FG000|VTI-208E|Withdrawal by Subject|1|||
161388195|NCT01471028|582805356|FG001|VTI-208E|Withdrawal by Subject|0|||
161388196|NCT01471028|582805355|FG000|VTI-208E|Lost to Follow-up|0|||
161388197|NCT01471028|582805356|FG001|VTI-208E|Lost to Follow-up|2|||
161388198|NCT00935493|582805359|FG000|Overall Study|Lost to Follow-up|1|||
161388199|NCT00935493|582805360|FG001|Overall Study|Lost to Follow-up|1|||
161388200|NCT00935493|582805361|FG002|Overall Study|Lost to Follow-up|1|||
161388201|NCT00935493|582805359|FG000|Overall Study|Treatment Discontinued|0|||
161388202|NCT00935493|582805360|FG001|Overall Study|Treatment Discontinued|1|||
161388203|NCT00935493|582805361|FG002|Overall Study|Treatment Discontinued|0|||
161388204|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
161388205|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
161388206|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
161388207|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
161388208|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Death|58|||
161388209|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Death|65|||
161388210|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Adverse Event|28|||
161388211|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Adverse Event|40|||
161388212|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Disease Progression|22|||
161388213|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Disease Progression|35|||
161388214|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Other|25|||
161388215|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Other|33|||
161388216|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
161388217|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
161388218|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Noncompliance|8|||
161388219|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Noncompliance|8|||
161388220|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
161388221|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
161388222|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
161388223|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
161388224|NCT00286091|582805364|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
161388225|NCT00286091|582805365|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
161388226|NCT00286091|582805364|FG000|Open-label Treatment Phase|Physician Decision|24|||
161388227|NCT00286091|582805365|FG001|Open-label Treatment Phase|Physician Decision|21|||
161388228|NCT00286091|582805364|FG000|Open-label Treatment Phase|Adverse Event|5|||
161388229|NCT00286091|582805365|FG001|Open-label Treatment Phase|Adverse Event|16|||
161388230|NCT00286091|582805364|FG000|Open-label Treatment Phase|Other|11|||
161388231|NCT00286091|582805365|FG001|Open-label Treatment Phase|Other|11|||
161388232|NCT00286091|582805364|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
161388233|NCT00286091|582805365|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
161388234|NCT00286091|582805364|FG000|Open-label Treatment Phase|Death|10|||
161388235|NCT00286091|582805365|FG001|Open-label Treatment Phase|Death|7|||
161388236|NCT00286091|582805364|FG000|Open-label Treatment Phase|Disease Progression|9|||
161388237|NCT00286091|582805365|FG001|Open-label Treatment Phase|Disease Progression|3|||
161388238|NCT00286091|582805364|FG000|Open-label Treatment Phase|Noncompliance|3|||
161388239|NCT00286091|582805365|FG001|Open-label Treatment Phase|Noncompliance|1|||
161388240|NCT00286091|582805364|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161388241|NCT00286091|582805365|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
161388242|NCT00286091|582805364|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
161388243|NCT00286091|582805365|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
161388244|NCT00286091|582805364|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
161388245|NCT00286091|582805365|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
161388246|NCT03799952|582805368|FG000|Overall Study|Program was too easy, discontinued|1|||
161388247|NCT03799952|582805369|FG001|Overall Study|Program was too easy, discontinued|0|||
161388248|NCT03799952|582805368|FG000|Overall Study|Lost to Follow-up|0|||
161388249|NCT03799952|582805369|FG001|Overall Study|Lost to Follow-up|2|||
161388250|NCT02936869|582805370|FG000|Overall Study|Lost to Follow-up|1|||
161388251|NCT02936869|582805371|FG001|Overall Study|Lost to Follow-up|3|||
161388252|NCT02936869|582805370|FG000|Overall Study|Death|0|||
161388253|NCT02936869|582805371|FG001|Overall Study|Death|1|||
161388254|NCT02936869|582805370|FG000|Overall Study|Legal Case|0|||
161388255|NCT02936869|582805371|FG001|Overall Study|Legal Case|1|||
161388256|NCT02936869|582805370|FG000|Overall Study|Protocol Violation|1|||
161388257|NCT02936869|582805371|FG001|Overall Study|Protocol Violation|0|||
161388258|NCT00335738|582805372|FG000|Overall Study|Physician Decision|6|||
161388259|NCT00335738|582805373|FG001|Overall Study|Physician Decision|0|||
161388260|NCT00335738|582805372|FG000|Overall Study|Withdrawal by Subject|2|||
161388261|NCT00335738|582805373|FG001|Overall Study|Withdrawal by Subject|0|||
161388262|NCT00335738|582805372|FG000|Overall Study|Ineligible|3|||
161388263|NCT00335738|582805373|FG001|Overall Study|Ineligible|4|||
161388264|NCT03423238|582805378|FG000|Overall Study|Lost to Follow-up|1|||
161388265|NCT03423238|582805379|FG001|Overall Study|Lost to Follow-up|0|||
161388266|NCT03423238|582805378|FG000|Overall Study|Withdrawal by Subject|1|||
161388267|NCT03423238|582805379|FG001|Overall Study|Withdrawal by Subject|0|||
161388268|NCT02036580|582805380|FG000|Overall Study|Withdrawal by Subject|0|||
161388269|NCT02036580|582805381|FG001|Overall Study|Withdrawal by Subject|1|||
161388270|NCT02036580|582805382|FG002|Overall Study|Withdrawal by Subject|0|||
161388271|NCT02036580|582805380|FG000|Overall Study|Adverse Event|1|||
161388272|NCT02036580|582805381|FG001|Overall Study|Adverse Event|0|||
161388273|NCT02036580|582805382|FG002|Overall Study|Adverse Event|0|||
161388274|NCT03823287|582805390|FG000|Overall Study|Withdrawal by Subject|25|||
161388275|NCT03823287|582805391|FG001|Overall Study|Withdrawal by Subject|17|||
161388276|NCT03823287|582805390|FG000|Overall Study|Death|13|||
161388277|NCT03823287|582805391|FG001|Overall Study|Death|7|||
161388278|NCT03823287|582805390|FG000|Overall Study|Lost to Follow-up|7|||
161388279|NCT03823287|582805391|FG001|Overall Study|Lost to Follow-up|8|||
161388280|NCT03823287|582805390|FG000|Overall Study|Adverse Event|6|||
161388281|NCT03823287|582805391|FG001|Overall Study|Adverse Event|8|||
161388282|NCT03823287|582805390|FG000|Overall Study|Physician Decision|5|||
161388283|NCT03823287|582805391|FG001|Overall Study|Physician Decision|2|||
161388284|NCT03823287|582805390|FG000|Overall Study|Lack of Efficacy|2|||
161388285|NCT03823287|582805391|FG001|Overall Study|Lack of Efficacy|0|||
161388286|NCT03823287|582805390|FG000|Overall Study|Other|2|||
161388287|NCT03823287|582805391|FG001|Overall Study|Other|4|||
161388288|NCT01059864|582805394|FG000|Open-Label Run-In Phase|Adverse Event|7|||
161388289|NCT01059864|582805395|FG001|Open-Label Run-In Phase|Adverse Event|0|||
161388290|NCT01059864|582805396|FG002|Open-Label Run-In Phase|Adverse Event|0|||
161388291|NCT01059864|582805394|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
161388292|NCT01059864|582805395|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
161388293|NCT01059864|582805396|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
161388294|NCT01059864|582805394|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
161388295|NCT01059864|582805395|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
161388296|NCT01059864|582805396|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
161388297|NCT01059864|582805394|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
161388298|NCT01059864|582805395|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
161388299|NCT01059864|582805396|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
161388300|NCT01059864|582805394|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
161388301|NCT01059864|582805395|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
161388302|NCT01059864|582805396|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
161388303|NCT01059864|582805394|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161388304|NCT01059864|582805395|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161388305|NCT01059864|582805396|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
161388306|NCT03108521|582805397|FG000|Overall Study|Lost to Follow-up|3|||
161388307|NCT03108521|582805398|FG001|Overall Study|Lost to Follow-up|0|||
161388308|NCT03108521|582805397|FG000|Overall Study|Lack of Efficacy|2|||
161388309|NCT03108521|582805398|FG001|Overall Study|Lack of Efficacy|0|||
161388310|NCT03108521|582805397|FG000|Overall Study|Physician Decision|4|||
161388311|NCT03108521|582805398|FG001|Overall Study|Physician Decision|0|||
161388312|NCT03108521|582805397|FG000|Overall Study|Adverse Event|3|||
161388313|NCT03108521|582805398|FG001|Overall Study|Adverse Event|0|||
161388314|NCT03281629|582805405|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
161388315|NCT03281629|582805406|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
161388316|NCT03281629|582805405|FG000|Overall Study|Death|0|||
161388317|NCT03281629|582805406|FG001|Overall Study|Death|1|||
161388318|NCT03281629|582805405|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
161388319|NCT03281629|582805406|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
161388320|NCT01170273|582805412|FG000|Overall Study|Lost to Follow-up|6|||
161388321|NCT01170273|582805413|FG001|Overall Study|Lost to Follow-up|8|||
161388322|NCT01170273|582805412|FG000|Overall Study|Protocol Violation|1|||
161388323|NCT01170273|582805413|FG001|Overall Study|Protocol Violation|0|||
161388324|NCT01170273|582805412|FG000|Overall Study|Death|1|||
161388325|NCT01170273|582805413|FG001|Overall Study|Death|0|||
161388326|NCT01170273|582805412|FG000|Overall Study|Adverse Event|0|||
161388327|NCT01170273|582805413|FG001|Overall Study|Adverse Event|1|||
161388328|NCT01456195|582807447|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161388329|NCT01456195|582807448|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
161388330|NCT01456195|582807449|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161388331|NCT01456195|582807447|FG000|Overall Study|Lost to Follow-up|3|||
161388332|NCT01456195|582807448|FG001|Overall Study|Lost to Follow-up|1|||
161388333|NCT01456195|582807449|FG002|Overall Study|Lost to Follow-up|3|||
161388334|NCT01456195|582807447|FG000|Overall Study|Voluntary Withdrawal|5|||
161388335|NCT01456195|582807448|FG001|Overall Study|Voluntary Withdrawal|3|||
161388336|NCT01456195|582807449|FG002|Overall Study|Voluntary Withdrawal|7|||
161388337|NCT01456195|582807447|FG000|Overall Study|Lack of Efficacy|0|||
161388338|NCT01456195|582807448|FG001|Overall Study|Lack of Efficacy|1|||
161388339|NCT01456195|582807449|FG002|Overall Study|Lack of Efficacy|0|||
161388340|NCT01456195|582807447|FG000|Overall Study|Other Reasons|2|||
161388341|NCT01456195|582807448|FG001|Overall Study|Other Reasons|1|||
161388342|NCT01456195|582807449|FG002|Overall Study|Other Reasons|3|||
161388343|NCT02109432|582807450|FG000|Overall Study|Withdrawal by Subject|1|||
161388344|NCT03372551|582807457|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
161388345|NCT03372551|582807458|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
161388346|NCT04683029|582807466|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
161388347|NCT04683029|582807467|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
161388348|NCT04683029|582807468|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
161388349|NCT04683029|582807469|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
161388350|NCT04683029|582807466|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
161388351|NCT04683029|582807467|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
161388352|NCT04683029|582807468|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
161388353|NCT04683029|582807469|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
161388354|NCT04683029|582807466|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
161388355|NCT04683029|582807467|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
161388356|NCT04683029|582807468|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
161388357|NCT04683029|582807469|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
161388358|NCT02920528|582807472|FG000|Overall Study|Incomplete Data|1|||
161388359|NCT02920528|582807473|FG001|Overall Study|Incomplete Data|1|||
161388360|NCT02920528|582807474|FG002|Overall Study|Incomplete Data|1|||
161388361|NCT02920528|582807472|FG000|Overall Study|Adverse Event|0|||
161388362|NCT02920528|582807473|FG001|Overall Study|Adverse Event|0|||
161388363|NCT02920528|582807474|FG002|Overall Study|Adverse Event|3|||
161388364|NCT02920528|582807472|FG000|Overall Study|Did not meet inclusion criteria|2|||
161388365|NCT02920528|582807473|FG001|Overall Study|Did not meet inclusion criteria|0|||
161388366|NCT02920528|582807474|FG002|Overall Study|Did not meet inclusion criteria|1|||
161388367|NCT03596047|582807475|FG000|Overall Study|Withdrawal by Subject|7|||
161388368|NCT03596047|582807476|FG001|Overall Study|Withdrawal by Subject|4|||
161388369|NCT03596047|582807475|FG000|Overall Study|Lost to Follow-up|0|||
161388370|NCT03596047|582807476|FG001|Overall Study|Lost to Follow-up|2|||
161388371|NCT01696968|582807477|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
161388372|NCT01696968|582807478|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
161388373|NCT01696968|582807477|FG000|Overall Study|Died Before Randomization|3|||
161388374|NCT01696968|582807478|FG001|Overall Study|Died Before Randomization|8|||
161388375|NCT01696968|582807477|FG000|Overall Study|Died Before ASU (Control)|278|||
161388376|NCT01696968|582807478|FG001|Overall Study|Died Before ASU (Control)|0|||
161388377|NCT01696968|582807477|FG000|Overall Study|Refused ASU (Control)|920|||
161388378|NCT01696968|582807478|FG001|Overall Study|Refused ASU (Control)|0|||
161388379|NCT01696968|582807477|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
161388380|NCT01696968|582807478|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
161388381|NCT04848220|582807479|FG000|Overall Study|Unable to proceed to study procedure|0|||
161388382|NCT04848220|582807480|FG001|Overall Study|Unable to proceed to study procedure|1|||
161388383|NCT04848220|582807481|FG002|Overall Study|Unable to proceed to study procedure|0|||
161388384|NCT04848220|582807479|FG000|Overall Study|Fractional flow not significant|0|||
161388385|NCT04848220|582807480|FG001|Overall Study|Fractional flow not significant|1|||
161388386|NCT04848220|582807481|FG002|Overall Study|Fractional flow not significant|0|||
161388387|NCT02388165|582807484|FG000|Overall Study|Study terminated by sponsor|5|||
161388388|NCT02388165|582807485|FG001|Overall Study|Study terminated by sponsor|5|||
161388389|NCT02388165|582807484|FG000|Overall Study|Other|11|||
161388390|NCT02388165|582807485|FG001|Overall Study|Other|13|||
161388391|NCT02388165|582807484|FG000|Overall Study|No longer meet eligibility criteria|40|||
161388392|NCT02388165|582807485|FG001|Overall Study|No longer meet eligibility criteria|43|||
161388393|NCT02388165|582807484|FG000|Overall Study|Withdrawal of consent|31|||
161388394|NCT02388165|582807485|FG001|Overall Study|Withdrawal of consent|32|||
161388395|NCT02388165|582807484|FG000|Overall Study|Lost to Follow-up|19|||
161388396|NCT02388165|582807485|FG001|Overall Study|Lost to Follow-up|20|||
161388397|NCT02388165|582807484|FG000|Overall Study|Death|13|||
161388398|NCT02388165|582807485|FG001|Overall Study|Death|10|||
161388399|NCT02388165|582807484|FG000|Overall Study|Adverse Event|3|||
161388400|NCT02388165|582807485|FG001|Overall Study|Adverse Event|5|||
161388401|NCT02388165|582807484|FG000|Overall Study|Did not meet entrance criteria|5|||
161388402|NCT02388165|582807485|FG001|Overall Study|Did not meet entrance criteria|2|||
161388403|NCT01406938|582807486|FG000|Induction Period|Subject/guardian decision|6|||
161388404|NCT01406938|582807487|FG001|Induction Period|Subject/guardian decision|8|||
161388405|NCT01406938|582807488|FG002|Induction Period|Subject/guardian decision|0|||
161388406|NCT01406938|582807489|FG003|Induction Period|Subject/guardian decision|0|||
161388407|NCT01406938|582807490|FG004|Induction Period|Subject/guardian decision|0|||
161388408|NCT01406938|582807491|FG005|Induction Period|Subject/guardian decision|0|||
161388409|NCT01406938|582807486|FG000|Induction Period|Protocol deviation|1|||
161388410|NCT01406938|582807487|FG001|Induction Period|Protocol deviation|0|||
161388411|NCT01406938|582807488|FG002|Induction Period|Protocol deviation|0|||
161388412|NCT01406938|582807489|FG003|Induction Period|Protocol deviation|0|||
161388413|NCT01406938|582807490|FG004|Induction Period|Protocol deviation|0|||
161388414|NCT01406938|582807491|FG005|Induction Period|Protocol deviation|0|||
161388415|NCT01406938|582807486|FG000|Induction Period|Adverse Event|8|||
161388416|NCT01406938|582807487|FG001|Induction Period|Adverse Event|9|||
161388417|NCT01406938|582807488|FG002|Induction Period|Adverse Event|0|||
161388418|NCT01406938|582807489|FG003|Induction Period|Adverse Event|0|||
161388419|NCT01406938|582807490|FG004|Induction Period|Adverse Event|0|||
161388420|NCT01406938|582807491|FG005|Induction Period|Adverse Event|0|||
161388421|NCT01406938|582807486|FG000|Induction Period|Lack of Efficacy|1|||
161388422|NCT01406938|582807487|FG001|Induction Period|Lack of Efficacy|0|||
161388423|NCT01406938|582807488|FG002|Induction Period|Lack of Efficacy|0|||
161388424|NCT01406938|582807489|FG003|Induction Period|Lack of Efficacy|0|||
161388425|NCT01406938|582807490|FG004|Induction Period|Lack of Efficacy|0|||
161388426|NCT01406938|582807491|FG005|Induction Period|Lack of Efficacy|0|||
161388427|NCT01406938|582807486|FG000|Induction Period|Lost to Follow-up|2|||
161388428|NCT01406938|582807487|FG001|Induction Period|Lost to Follow-up|3|||
161388429|NCT01406938|582807488|FG002|Induction Period|Lost to Follow-up|0|||
161388430|NCT01406938|582807489|FG003|Induction Period|Lost to Follow-up|0|||
161388431|NCT01406938|582807490|FG004|Induction Period|Lost to Follow-up|0|||
161388432|NCT01406938|582807491|FG005|Induction Period|Lost to Follow-up|0|||
161388433|NCT01406938|582807486|FG000|Maintenance Period|Adverse Event|0|||
161388434|NCT01406938|582807487|FG001|Maintenance Period|Adverse Event|0|||
161388435|NCT01406938|582807488|FG002|Maintenance Period|Adverse Event|2|||
161388436|NCT01406938|582807489|FG003|Maintenance Period|Adverse Event|8|||
161388437|NCT01406938|582807490|FG004|Maintenance Period|Adverse Event|4|||
161388438|NCT01406938|582807491|FG005|Maintenance Period|Adverse Event|2|||
161388439|NCT01406938|582807486|FG000|Maintenance Period|Death|0|||
161388440|NCT01406938|582807487|FG001|Maintenance Period|Death|0|||
161388441|NCT01406938|582807488|FG002|Maintenance Period|Death|0|||
161388442|NCT01406938|582807489|FG003|Maintenance Period|Death|0|||
161388443|NCT01406938|582807490|FG004|Maintenance Period|Death|1|||
161388444|NCT01406938|582807491|FG005|Maintenance Period|Death|0|||
161388445|NCT01406938|582807486|FG000|Maintenance Period|Subject/guardian decision|0|||
161388446|NCT01406938|582807487|FG001|Maintenance Period|Subject/guardian decision|0|||
161388447|NCT01406938|582807488|FG002|Maintenance Period|Subject/guardian decision|11|||
161388448|NCT01406938|582807489|FG003|Maintenance Period|Subject/guardian decision|7|||
161388449|NCT01406938|582807490|FG004|Maintenance Period|Subject/guardian decision|10|||
161388450|NCT01406938|582807491|FG005|Maintenance Period|Subject/guardian decision|7|||
161388451|NCT01406938|582807486|FG000|Maintenance Period|Protocol Violation|0|||
161388452|NCT01406938|582807487|FG001|Maintenance Period|Protocol Violation|0|||
161388453|NCT01406938|582807488|FG002|Maintenance Period|Protocol Violation|2|||
161388454|NCT01406938|582807489|FG003|Maintenance Period|Protocol Violation|2|||
161388455|NCT01406938|582807490|FG004|Maintenance Period|Protocol Violation|2|||
161388456|NCT01406938|582807491|FG005|Maintenance Period|Protocol Violation|2|||
161388457|NCT01406938|582807486|FG000|Maintenance Period|Pregnancy|0|||
161388458|NCT01406938|582807487|FG001|Maintenance Period|Pregnancy|0|||
161388459|NCT01406938|582807488|FG002|Maintenance Period|Pregnancy|0|||
161388460|NCT01406938|582807489|FG003|Maintenance Period|Pregnancy|0|||
161388461|NCT01406938|582807490|FG004|Maintenance Period|Pregnancy|1|||
161388462|NCT01406938|582807491|FG005|Maintenance Period|Pregnancy|0|||
161388463|NCT01406938|582807486|FG000|Maintenance Period|Lost to Follow-up|0|||
161388464|NCT01406938|582807487|FG001|Maintenance Period|Lost to Follow-up|0|||
161388465|NCT01406938|582807488|FG002|Maintenance Period|Lost to Follow-up|0|||
161388466|NCT01406938|582807489|FG003|Maintenance Period|Lost to Follow-up|0|||
161388467|NCT01406938|582807490|FG004|Maintenance Period|Lost to Follow-up|4|||
161388468|NCT01406938|582807491|FG005|Maintenance Period|Lost to Follow-up|0|||
161388469|NCT01406938|582807486|FG000|Maintenance Period|Lack of Efficacy|0|||
161388470|NCT01406938|582807487|FG001|Maintenance Period|Lack of Efficacy|0|||
161388471|NCT01406938|582807488|FG002|Maintenance Period|Lack of Efficacy|2|||
161388472|NCT01406938|582807489|FG003|Maintenance Period|Lack of Efficacy|1|||
161388473|NCT01406938|582807490|FG004|Maintenance Period|Lack of Efficacy|3|||
161388474|NCT01406938|582807491|FG005|Maintenance Period|Lack of Efficacy|5|||
161388475|NCT01406938|582807486|FG000|Follow up|Lack of Efficacy|3|||
161388476|NCT01406938|582807487|FG001|Follow up|Lack of Efficacy|2|||
161388477|NCT01406938|582807488|FG002|Follow up|Lack of Efficacy|1|||
161388478|NCT01406938|582807489|FG003|Follow up|Lack of Efficacy|0|||
161388479|NCT01406938|582807490|FG004|Follow up|Lack of Efficacy|0|||
161388480|NCT01406938|582807491|FG005|Follow up|Lack of Efficacy|0|||
161388481|NCT01406938|582807486|FG000|Follow up|Patient/guardian decision|4|||
161388482|NCT01406938|582807487|FG001|Follow up|Patient/guardian decision|2|||
161388483|NCT01406938|582807488|FG002|Follow up|Patient/guardian decision|4|||
161388484|NCT01406938|582807489|FG003|Follow up|Patient/guardian decision|2|||
161388485|NCT01406938|582807490|FG004|Follow up|Patient/guardian decision|4|||
161388486|NCT01406938|582807491|FG005|Follow up|Patient/guardian decision|1|||
161388487|NCT01406938|582807486|FG000|Follow up|Protocol Violation|0|||
161388488|NCT01406938|582807487|FG001|Follow up|Protocol Violation|0|||
161388489|NCT01406938|582807488|FG002|Follow up|Protocol Violation|1|||
161388490|NCT01406938|582807489|FG003|Follow up|Protocol Violation|0|||
161388491|NCT01406938|582807490|FG004|Follow up|Protocol Violation|0|||
161388492|NCT01406938|582807491|FG005|Follow up|Protocol Violation|0|||
161388493|NCT01406938|582807486|FG000|Follow up|Physician Decision|0|||
161388494|NCT01406938|582807487|FG001|Follow up|Physician Decision|0|||
161388495|NCT01406938|582807488|FG002|Follow up|Physician Decision|2|||
161388496|NCT01406938|582807489|FG003|Follow up|Physician Decision|0|||
161388497|NCT01406938|582807490|FG004|Follow up|Physician Decision|3|||
161388498|NCT01406938|582807491|FG005|Follow up|Physician Decision|1|||
161388499|NCT01406938|582807486|FG000|Follow up|Lost to Follow-up|1|||
161388500|NCT01406938|582807487|FG001|Follow up|Lost to Follow-up|1|||
161388501|NCT01406938|582807488|FG002|Follow up|Lost to Follow-up|0|||
161388502|NCT01406938|582807489|FG003|Follow up|Lost to Follow-up|1|||
161388503|NCT01406938|582807490|FG004|Follow up|Lost to Follow-up|2|||
161388504|NCT01406938|582807491|FG005|Follow up|Lost to Follow-up|1|||
161388505|NCT00962741|582807493|FG000|Overall Study|Failed to return|3|||
161388506|NCT00962741|582807493|FG000|Overall Study|Lost to Follow-up|2|||
161388507|NCT00962741|582807493|FG000|Overall Study|Withdrawal by Subject|1|||
161388508|NCT00962741|582807493|FG000|Overall Study|Lack of Efficacy|1|||
161388509|NCT00962741|582807493|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
161388510|NCT03350035|582807494|FG000|Overall Study|Lack of Efficacy|2|||
161388511|NCT03350035|582807495|FG001|Overall Study|Lack of Efficacy|0|||
161388512|NCT03350035|582807496|FG002|Overall Study|Lack of Efficacy|0|||
161388513|NCT03350035|582807494|FG000|Overall Study|Subject discharged to hospice|0|||
161388514|NCT03350035|582807495|FG001|Overall Study|Subject discharged to hospice|0|||
161388515|NCT03350035|582807496|FG002|Overall Study|Subject discharged to hospice|1|||
161388516|NCT01811485|582807497|FG000|Overall Study|Adverse Event|1|||
161388517|NCT01811485|582807498|FG001|Overall Study|Adverse Event|3|||
161388518|NCT01811485|582807499|FG002|Overall Study|Adverse Event|2|||
161388519|NCT01811485|582807497|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161388520|NCT01811485|582807498|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161388521|NCT01811485|582807499|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
161388522|NCT01811485|582807497|FG000|Overall Study|Administrative problems|1|||
161388523|NCT01811485|582807498|FG001|Overall Study|Administrative problems|0|||
161388524|NCT01811485|582807499|FG002|Overall Study|Administrative problems|0|||
161388525|NCT01811485|582807497|FG000|Overall Study|Protocol Deviation|0|||
161388526|NCT01811485|582807498|FG001|Overall Study|Protocol Deviation|1|||
161388527|NCT01811485|582807499|FG002|Overall Study|Protocol Deviation|0|||
161388528|NCT03654404|582807500|FG000|Overall Study|Death|1|||
161388529|NCT03654404|582807500|FG000|Overall Study|Lost to Follow-up|2|||
161388530|NCT03654404|582807500|FG000|Overall Study|Withdrawal by Subject|5|||
161388531|NCT00654745|582807503|FG000|Overall Study|Adverse Event|12|||
161388532|NCT00654745|582807503|FG000|Overall Study|Lost to Follow-up|7|||
161388533|NCT00654745|582807503|FG000|Overall Study|Protocol Violation|11|||
161388534|NCT00654745|582807503|FG000|Overall Study|Withdrawal by Subject|10|||
161388535|NCT00654745|582807503|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
161388536|NCT04551963|582807504|FG000|Overall Study|Physician Decision|1|||
161388537|NCT04551963|582807505|FG001|Overall Study|Physician Decision|1|||
161388538|NCT04551963|582807504|FG000|Overall Study|Death|1|||
161388539|NCT04551963|582807505|FG001|Overall Study|Death|0|||
161388540|NCT02974855|582807506|FG000|Overall Study|Adverse Event|0|||
161388541|NCT02974855|582807507|FG001|Overall Study|Adverse Event|1|||
161388542|NCT02974855|582807508|FG002|Overall Study|Adverse Event|0|||
161388543|NCT02974855|582807509|FG003|Overall Study|Adverse Event|1|||
161388544|NCT01474772|582807510|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
161388545|NCT01474772|582807511|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
161388546|NCT01474772|582807510|FG000|Period 1|AE not Related to Study Drug|1|||
161388547|NCT01474772|582807511|FG001|Period 1|AE not Related to Study Drug|0|||
161388548|NCT01474772|582807510|FG000|Period 1|Withdrawal by Subject|3|||
161388549|NCT01474772|582807511|FG001|Period 1|Withdrawal by Subject|1|||
161388550|NCT01474772|582807510|FG000|Period 1|Lost to Follow-up|1|||
161388551|NCT01474772|582807511|FG001|Period 1|Lost to Follow-up|0|||
161388552|NCT01474772|582807510|FG000|Period 1|Reason not Specified|1|||
161388553|NCT01474772|582807511|FG001|Period 1|Reason not Specified|1|||
161388554|NCT01474772|582807510|FG000|Washout|AE not Related to Study Drug|2|||
161388555|NCT01474772|582807511|FG001|Washout|AE not Related to Study Drug|0|||
161388556|NCT01474772|582807510|FG000|Washout|Withdrawal by Subject|1|||
161388557|NCT01474772|582807511|FG001|Washout|Withdrawal by Subject|0|||
161388558|NCT01474772|582807510|FG000|Washout|Lost to Follow-up|0|||
161388559|NCT01474772|582807511|FG001|Washout|Lost to Follow-up|1|||
161388560|NCT01474772|582807510|FG000|Washout|Reason not Specified|0|||
161388561|NCT01474772|582807511|FG001|Washout|Reason not Specified|1|||
161388562|NCT01474772|582807510|FG000|Period 2|Death|0|||
161388563|NCT01474772|582807511|FG001|Period 2|Death|1|||
161388564|NCT01474772|582807510|FG000|Period 2|AE Related to Study Drug|0|||
161388565|NCT01474772|582807511|FG001|Period 2|AE Related to Study Drug|1|||
161388566|NCT01474772|582807510|FG000|Period 2|AE not Related to Study Drug|4|||
161388567|NCT01474772|582807511|FG001|Period 2|AE not Related to Study Drug|1|||
161388568|NCT01474772|582807510|FG000|Period 2|Lack of Efficacy|1|||
161388569|NCT01474772|582807511|FG001|Period 2|Lack of Efficacy|0|||
161388570|NCT01474772|582807510|FG000|Period 2|Withdrawal by Subject|3|||
161388571|NCT01474772|582807511|FG001|Period 2|Withdrawal by Subject|4|||
161388572|NCT01474772|582807510|FG000|Period 2|Lost to Follow-up|1|||
161388573|NCT01474772|582807511|FG001|Period 2|Lost to Follow-up|1|||
161388574|NCT01474772|582807510|FG000|Period 2|Reason not Specified|0|||
161388575|NCT01474772|582807511|FG001|Period 2|Reason not Specified|2|||
161388576|NCT01474772|582807510|FG000|Follow-up|AE not Related to Study Drug|0|||
161388577|NCT01474772|582807511|FG001|Follow-up|AE not Related to Study Drug|1|||
161388578|NCT00633074|582807512|FG000|Overall Study|Adverse Event|1|||
161388579|NCT00633074|582807513|FG001|Overall Study|Adverse Event|0|||
161388580|NCT00365105|582807514|FG000|Overall Study|Protocol Violation|5|||
161388581|NCT00365105|582807515|FG001|Overall Study|Protocol Violation|8|||
161388582|NCT00748618|582807516|FG000|Overall Study|Adverse Event|1|||
161388583|NCT00748618|582807517|FG001|Overall Study|Adverse Event|0|||
161388584|NCT06004895|582807518|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
161388585|NCT06004895|582807518|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
161388586|NCT00466947|582807519|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
161388587|NCT00466947|582807520|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
161388588|NCT00466947|582807519|FG000|Study End Analysis Period|Adverse Event|35|||
161388589|NCT00466947|582807520|FG001|Study End Analysis Period|Adverse Event|43|||
161388590|NCT00466947|582807519|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
161388591|NCT00466947|582807520|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
161388592|NCT00466947|582807519|FG000|Study End Analysis Period|Physician Decision|29|||
161388593|NCT00466947|582807520|FG001|Study End Analysis Period|Physician Decision|29|||
161388594|NCT00466947|582807519|FG000|Study End Analysis Period|Protocol Violation|9|||
161388595|NCT00466947|582807520|FG001|Study End Analysis Period|Protocol Violation|17|||
161388596|NCT00466947|582807519|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
161388597|NCT00466947|582807520|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
161388598|NCT00466947|582807519|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
161388599|NCT00466947|582807520|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
161388600|NCT00466947|582807519|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
161388601|NCT00466947|582807520|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
161388602|NCT00466947|582807519|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
161388603|NCT00466947|582807520|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
161388604|NCT00878254|582807521|FG000|Overall Study|Physician Decision|1|||
161388605|NCT00878254|582807521|FG000|Overall Study|Death|1|||
161388606|NCT00878254|582807521|FG000|Overall Study|Withdrawal by Subject|1|||
161388607|NCT01995526|582807522|FG000|Overall Study|Physician Decision|1|||
161388608|NCT03367403|582807528|FG000|Overall Study|Adverse Event|20|||
161388609|NCT03367403|582807529|FG001|Overall Study|Adverse Event|6|||
161388610|NCT03367403|582807530|FG002|Overall Study|Adverse Event|2|||
161388611|NCT03367403|582807528|FG000|Overall Study|Withdrawal by Subject|12|||
161388612|NCT03367403|582807529|FG001|Overall Study|Withdrawal by Subject|13|||
161388613|NCT03367403|582807530|FG002|Overall Study|Withdrawal by Subject|1|||
161388614|NCT03367403|582807528|FG000|Overall Study|Death|1|||
161388615|NCT03367403|582807529|FG001|Overall Study|Death|2|||
161388616|NCT03367403|582807530|FG002|Overall Study|Death|0|||
161388617|NCT03367403|582807528|FG000|Overall Study|Physician Decision|0|||
161388618|NCT03367403|582807529|FG001|Overall Study|Physician Decision|1|||
161388619|NCT03367403|582807530|FG002|Overall Study|Physician Decision|0|||
161388620|NCT03367403|582807528|FG000|Overall Study|Protocol Violation|1|||
161388621|NCT03367403|582807529|FG001|Overall Study|Protocol Violation|1|||
161388622|NCT03367403|582807530|FG002|Overall Study|Protocol Violation|0|||
161388623|NCT03367403|582807528|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161388624|NCT03367403|582807529|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
161388625|NCT03367403|582807530|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161388626|NCT03367403|582807528|FG000|Overall Study|COVID-19|3|||
161388627|NCT03367403|582807529|FG001|Overall Study|COVID-19|6|||
161388628|NCT03367403|582807530|FG002|Overall Study|COVID-19|0|||
161388629|NCT03367403|582807528|FG000|Overall Study|Abuse of Alcohol Intake|0|||
161388630|NCT03367403|582807529|FG001|Overall Study|Abuse of Alcohol Intake|1|||
161388631|NCT03367403|582807530|FG002|Overall Study|Abuse of Alcohol Intake|0|||
161388632|NCT03367403|582807528|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
161388633|NCT03367403|582807529|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
161388634|NCT03367403|582807530|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
161388635|NCT00194077|582807531|FG000|Overall Study|Lack of Efficacy|22|||
161388636|NCT00194077|582807532|FG001|Overall Study|Lack of Efficacy|29|||
161388637|NCT00194077|582807531|FG000|Overall Study|Study nonadherence|1|||
161388638|NCT00194077|582807532|FG001|Overall Study|Study nonadherence|0|||
161388639|NCT00194077|582807531|FG000|Overall Study|Withdrawal by Subject|1|||
161388640|NCT00194077|582807532|FG001|Overall Study|Withdrawal by Subject|1|||
161388641|NCT03470194|582807535|FG000|Overall Study|Lost to Follow-up|11|||
161388642|NCT03470194|582807536|FG001|Overall Study|Lost to Follow-up|17|||
161388643|NCT01822899|582807537|FG000|Overall Study|Adverse Event|6|||
161388644|NCT01822899|582807538|FG001|Overall Study|Adverse Event|5|||
161388645|NCT01822899|582807537|FG000|Overall Study|Lack of Efficacy|6|||
161388646|NCT01822899|582807538|FG001|Overall Study|Lack of Efficacy|3|||
161388647|NCT01822899|582807537|FG000|Overall Study|Protocol Violation|6|||
161388648|NCT01822899|582807538|FG001|Overall Study|Protocol Violation|3|||
161388649|NCT01822899|582807537|FG000|Overall Study|Lost to Follow-up|1|||
161388650|NCT01822899|582807538|FG001|Overall Study|Lost to Follow-up|0|||
161388651|NCT01822899|582807537|FG000|Overall Study|Withdrawal by Subject|5|||
161388652|NCT01822899|582807538|FG001|Overall Study|Withdrawal by Subject|7|||
161388653|NCT00759876|582807540|FG000|Overall Study|Sponsor terminated study early|36|||
161388654|NCT01450696|582807542|FG000|Overall Study|Never Treated|1|||
161388655|NCT01450696|582807543|FG001|Overall Study|Never Treated|1|||
161388656|NCT01450696|582807542|FG000|Overall Study|Death|77|||
161388657|NCT01450696|582807543|FG001|Overall Study|Death|84|||
161388658|NCT01450696|582807542|FG000|Overall Study|Lost to Follow-up|3|||
161388659|NCT01450696|582807543|FG001|Overall Study|Lost to Follow-up|3|||
161388660|NCT01450696|582807542|FG000|Overall Study|Non-Compliance|1|||
161388661|NCT01450696|582807543|FG001|Overall Study|Non-Compliance|0|||
161388662|NCT01450696|582807542|FG000|Overall Study|Withdrawal by Subject|13|||
161388663|NCT01450696|582807543|FG001|Overall Study|Withdrawal by Subject|2|||
161388664|NCT01450696|582807542|FG000|Overall Study|Study Terminated by Sponsor|53|||
161388665|NCT01450696|582807543|FG001|Overall Study|Study Terminated by Sponsor|58|||
161388666|NCT02321319|582807545|FG000|Overall Study|Product discontinued|5|||
161388667|NCT02570152|582807548|FG000|Overall Study|Protocol Violation|2|||
161388668|NCT02570152|582807548|FG000|Overall Study|Migrated/moved from study area|13|||
161388669|NCT02684617|582807549|FG000|Overall Study|Adverse Event|1|||
161388670|NCT02684617|582807550|FG001|Overall Study|Adverse Event|0|||
161388671|NCT02684617|582807551|FG002|Overall Study|Adverse Event|1|||
161388672|NCT02684617|582807549|FG000|Overall Study|Death|8|||
161388673|NCT02684617|582807550|FG001|Overall Study|Death|16|||
161388674|NCT02684617|582807551|FG002|Overall Study|Death|28|||
161388675|NCT02684617|582807549|FG000|Overall Study|Withdrawal by Subject|2|||
161388676|NCT02684617|582807550|FG001|Overall Study|Withdrawal by Subject|0|||
161388677|NCT02684617|582807551|FG002|Overall Study|Withdrawal by Subject|4|||
161388678|NCT02684617|582807549|FG000|Overall Study|Screen Failure|1|||
161388679|NCT02684617|582807550|FG001|Overall Study|Screen Failure|0|||
161388680|NCT02684617|582807551|FG002|Overall Study|Screen Failure|2|||
161388681|NCT02684617|582807549|FG000|Overall Study|Study Terminated by Sponsor|6|||
161388682|NCT02684617|582807550|FG001|Overall Study|Study Terminated by Sponsor|1|||
161388683|NCT02684617|582807551|FG002|Overall Study|Study Terminated by Sponsor|5|||
161388684|NCT00853242|582807552|FG000|Overall Study|Adverse Event|0|||
161388685|NCT00853242|582807553|FG001|Overall Study|Adverse Event|1|||
161388686|NCT00853242|582807554|FG002|Overall Study|Adverse Event|1|||
161388687|NCT00853242|582807555|FG003|Overall Study|Adverse Event|0|||
161388688|NCT00853242|582807556|FG004|Overall Study|Adverse Event|3|||
161388689|NCT00853242|582807557|FG005|Overall Study|Adverse Event|1|||
161388690|NCT00853242|582807558|FG006|Overall Study|Adverse Event|1|||
161388691|NCT00853242|582807552|FG000|Overall Study|Noncompliant|0|||
161388692|NCT00853242|582807553|FG001|Overall Study|Noncompliant|0|||
161388693|NCT00853242|582807554|FG002|Overall Study|Noncompliant|0|||
161388694|NCT00853242|582807555|FG003|Overall Study|Noncompliant|0|||
161388695|NCT00853242|582807556|FG004|Overall Study|Noncompliant|1|||
161388696|NCT00853242|582807557|FG005|Overall Study|Noncompliant|0|||
161388697|NCT00853242|582807558|FG006|Overall Study|Noncompliant|0|||
161388698|NCT00853242|582807552|FG000|Overall Study|Withdrawal by Subject|1|||
161388699|NCT00853242|582807553|FG001|Overall Study|Withdrawal by Subject|2|||
161388700|NCT00853242|582807554|FG002|Overall Study|Withdrawal by Subject|0|||
161388701|NCT00853242|582807555|FG003|Overall Study|Withdrawal by Subject|4|||
161388702|NCT00853242|582807556|FG004|Overall Study|Withdrawal by Subject|0|||
161388703|NCT00853242|582807557|FG005|Overall Study|Withdrawal by Subject|0|||
161388704|NCT00853242|582807558|FG006|Overall Study|Withdrawal by Subject|2|||
161388705|NCT00853242|582807552|FG000|Overall Study|Other|2|||
161388706|NCT00853242|582807553|FG001|Overall Study|Other|0|||
161388707|NCT00853242|582807554|FG002|Overall Study|Other|2|||
161388708|NCT00853242|582807555|FG003|Overall Study|Other|0|||
161388709|NCT00853242|582807556|FG004|Overall Study|Other|0|||
161388710|NCT00853242|582807557|FG005|Overall Study|Other|1|||
161388711|NCT00853242|582807558|FG006|Overall Study|Other|2|||
161388712|NCT03497975|582807559|FG000|Overall Study|Withdrew Consent|34|||
161388713|NCT03497975|582807560|FG001|Overall Study|Withdrew Consent|35|||
161388714|NCT03497975|582807559|FG000|Overall Study|Lost to Follow-up|7|||
161388715|NCT03497975|582807560|FG001|Overall Study|Lost to Follow-up|7|||
161388716|NCT03497975|582807559|FG000|Overall Study|Physician Decision|4|||
161388717|NCT03497975|582807560|FG001|Overall Study|Physician Decision|5|||
161388718|NCT03497975|582807559|FG000|Overall Study|Discontinued|42|||
161388719|NCT03497975|582807560|FG001|Overall Study|Discontinued|39|||
161388720|NCT03497975|582807559|FG000|Overall Study|Reason Not Specified|15|||
161388721|NCT03497975|582807560|FG001|Overall Study|Reason Not Specified|14|||
161388722|NCT02957747|582807563|FG000|Overall Study|Withdrawal by Subject|0|||
161388723|NCT02957747|582807564|FG001|Overall Study|Withdrawal by Subject|3|||
161388724|NCT02957747|582807563|FG000|Overall Study|Lost to Follow-up|10|||
161388725|NCT02957747|582807564|FG001|Overall Study|Lost to Follow-up|5|||
161388726|NCT01355679|582807566|FG000|Overall Study|benign tumor types found at biopsy|2|||
161388727|NCT02027311|582807567|FG000|Overall Study|Protocol Violation|3|||
161388728|NCT02027311|582807568|FG001|Overall Study|Protocol Violation|2|||
161388729|NCT00964002|582807570|FG000|Overall Study|Protocol Violation|8|||
161388730|NCT03768089|582807573|FG000|Part A|Lost to Follow-up|0|||
161388731|NCT03768089|582807574|FG001|Part A|Lost to Follow-up|0|||
161388732|NCT03768089|582807575|FG002|Part A|Lost to Follow-up|0|||
161388733|NCT03768089|582807576|FG003|Part A|Lost to Follow-up|0|||
161388734|NCT03768089|582807577|FG004|Part A|Lost to Follow-up|1|||
161388735|NCT03768089|582807578|FG005|Part A|Lost to Follow-up|0|||
161388736|NCT03768089|582807579|FG006|Part A|Lost to Follow-up|0|||
161388737|NCT03768089|582807580|FG007|Part A|Lost to Follow-up|0|||
161388738|NCT03768089|582807581|FG008|Part A|Lost to Follow-up|0|||
161388739|NCT03768089|582807582|FG009|Part A|Lost to Follow-up|0|||
161388740|NCT03768089|582807583|FG010|Part A|Lost to Follow-up|0|||
161388741|NCT03768089|582807584|FG011|Part A|Lost to Follow-up|0|||
161388742|NCT03768089|582807585|FG012|Part A|Lost to Follow-up|0|||
161388743|NCT03768089|582807586|FG013|Part A|Lost to Follow-up|0|||
161388744|NCT03768089|582807587|FG014|Part A|Lost to Follow-up|0|||
161388745|NCT03768089|582807588|FG015|Part A|Lost to Follow-up|0|||
161388746|NCT03768089|582807589|FG016|Part A|Lost to Follow-up|0|||
161388747|NCT03768089|582807590|FG017|Part A|Lost to Follow-up|0|||
161388748|NCT03768089|582807573|FG000|Part C|Randomized, Never Dosed|0|||
161388749|NCT03768089|582807574|FG001|Part C|Randomized, Never Dosed|0|||
161388750|NCT03768089|582807575|FG002|Part C|Randomized, Never Dosed|0|||
161388751|NCT03768089|582807576|FG003|Part C|Randomized, Never Dosed|0|||
161388752|NCT03768089|582807577|FG004|Part C|Randomized, Never Dosed|0|||
161388753|NCT03768089|582807578|FG005|Part C|Randomized, Never Dosed|0|||
161388754|NCT03768089|582807579|FG006|Part C|Randomized, Never Dosed|0|||
161388755|NCT03768089|582807580|FG007|Part C|Randomized, Never Dosed|0|||
161388756|NCT03768089|582807581|FG008|Part C|Randomized, Never Dosed|0|||
161388757|NCT03768089|582807582|FG009|Part C|Randomized, Never Dosed|0|||
161388758|NCT03768089|582807583|FG010|Part C|Randomized, Never Dosed|0|||
161388759|NCT03768089|582807584|FG011|Part C|Randomized, Never Dosed|0|||
161388760|NCT03768089|582807585|FG012|Part C|Randomized, Never Dosed|0|||
161388761|NCT03768089|582807586|FG013|Part C|Randomized, Never Dosed|0|||
161388762|NCT03768089|582807587|FG014|Part C|Randomized, Never Dosed|1|||
161388763|NCT03768089|582807588|FG015|Part C|Randomized, Never Dosed|0|||
161388764|NCT03768089|582807589|FG016|Part C|Randomized, Never Dosed|0|||
161388765|NCT03768089|582807590|FG017|Part C|Randomized, Never Dosed|0|||
161388766|NCT02091362|582807595|FG000|Period 1|Protocol Violation|1|||
161388767|NCT02091362|582807596|FG001|Period 1|Protocol Violation|0|||
161388768|NCT02091362|582807595|FG000|Period 1|Withdrawal by Subject|2|||
161388769|NCT02091362|582807596|FG001|Period 1|Withdrawal by Subject|3|||
161388770|NCT02091362|582807595|FG000|Period 1|Lost to Follow-up|0|||
161388771|NCT02091362|582807596|FG001|Period 1|Lost to Follow-up|1|||
161388772|NCT02091362|582807595|FG000|Period 1|Adverse Event|2|||
161388773|NCT02091362|582807596|FG001|Period 1|Adverse Event|0|||
161388774|NCT02091362|582807595|FG000|Wash-out|Lost to Follow-up|1|||
161388775|NCT02091362|582807596|FG001|Wash-out|Lost to Follow-up|1|||
161388776|NCT02091362|582807595|FG000|Wash-out|Withdrawal by Subject|0|||
161388777|NCT02091362|582807596|FG001|Wash-out|Withdrawal by Subject|2|||
161388778|NCT02091362|582807595|FG000|Period 2|Adverse Event|1|||
161388779|NCT02091362|582807596|FG001|Period 2|Adverse Event|0|||
161388780|NCT02091362|582807595|FG000|Period 2|Lost to Follow-up|0|||
161388781|NCT02091362|582807596|FG001|Period 2|Lost to Follow-up|1|||
161388782|NCT02091362|582807595|FG000|Period 2|Withdrawal by Subject|1|||
161388783|NCT02091362|582807596|FG001|Period 2|Withdrawal by Subject|1|||
161388784|NCT00902850|582807601|FG000|Overall Study|Physician Decision|2|||
161388785|NCT00902850|582807602|FG001|Overall Study|Physician Decision|2|||
161388786|NCT04470050|582807607|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161388787|NCT04470050|582807608|FG001|Double-blind Treatment Phase|Adverse Event|0|||
161388788|NCT04470050|582807609|FG002|Double-blind Treatment Phase|Adverse Event|0|||
161388789|NCT04470050|582807610|FG003|Double-blind Treatment Phase|Adverse Event|1|||
161388790|NCT04470050|582807611|FG004|Double-blind Treatment Phase|Adverse Event|0|||
161388791|NCT04470050|582807612|FG005|Double-blind Treatment Phase|Adverse Event|0|||
161388792|NCT04470050|582807613|FG006|Double-blind Treatment Phase|Adverse Event|0|||
161388793|NCT04470050|582807607|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161388794|NCT04470050|582807608|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
161388795|NCT04470050|582807609|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
161388796|NCT04470050|582807610|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
161388797|NCT04470050|582807611|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
161388798|NCT04470050|582807612|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
161388799|NCT04470050|582807613|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
161388800|NCT04470050|582807607|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
161388801|NCT04470050|582807608|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
161388802|NCT04470050|582807609|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
161388803|NCT04470050|582807610|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
161388804|NCT04470050|582807611|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
161388805|NCT04470050|582807612|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
161388806|NCT04470050|582807613|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
161388807|NCT03098433|582807614|FG000|Overall Study|Withdrawal by Subject|10|||
161388808|NCT01813058|582807615|FG000|Overall Study|Withdrawal by Subject|5|||
161388809|NCT01813058|582807616|FG001|Overall Study|Withdrawal by Subject|4|||
161388810|NCT03585764|582807617|FG000|Overall Study|Death|3|||
161388811|NCT03585764|582807618|FG001|Overall Study|Death|2|||
161388812|NCT03585764|582807619|FG002|Overall Study|Death|3|||
161388813|NCT03585764|582807620|FG003|Overall Study|Death|0|||
161388814|NCT03585764|582807617|FG000|Overall Study|Lost to Follow-up|0|||
161388815|NCT03585764|582807618|FG001|Overall Study|Lost to Follow-up|1|||
161388816|NCT03585764|582807619|FG002|Overall Study|Lost to Follow-up|0|||
161388817|NCT03585764|582807620|FG003|Overall Study|Lost to Follow-up|0|||
161388818|NCT03585764|582807617|FG000|Overall Study|Physician Decision|0|||
161388819|NCT03585764|582807618|FG001|Overall Study|Physician Decision|0|||
161388820|NCT03585764|582807619|FG002|Overall Study|Physician Decision|2|||
161388821|NCT03585764|582807620|FG003|Overall Study|Physician Decision|0|||
161388822|NCT01581021|582807622|FG000|Overall Study|Lost to Follow-up|4|||
161388823|NCT01581021|582807623|FG001|Overall Study|Lost to Follow-up|6|||
161388824|NCT01581021|582807622|FG000|Overall Study|More than 2 hooks in thoracic|3|||
161388825|NCT01581021|582807623|FG001|Overall Study|More than 2 hooks in thoracic|0|||
161388826|NCT01581021|582807622|FG000|Overall Study|Neuromuscular|2|||
161388827|NCT01581021|582807623|FG001|Overall Study|Neuromuscular|1|||
161388828|NCT01581021|582807622|FG000|Overall Study|Not Randomized|1|||
161388829|NCT01581021|582807623|FG001|Overall Study|Not Randomized|2|||
161388830|NCT01581021|582807622|FG000|Overall Study|Lenke 6 Classification|0|||
161388831|NCT01581021|582807623|FG001|Overall Study|Lenke 6 Classification|1|||
161388832|NCT01581021|582807622|FG000|Overall Study|Lack of Efficacy|0|||
161388833|NCT01581021|582807623|FG001|Overall Study|Lack of Efficacy|1|||
161388834|NCT03604172|582807626|FG000|Overall Study|Lost to Follow-up|1|||
161388835|NCT03604172|582807627|FG001|Overall Study|Lost to Follow-up|2|||
161388836|NCT00054327|582807628|FG000|Overall Study|Engraftment failure|1|||
161388837|NCT00054327|582807629|FG001|Overall Study|Engraftment failure|0|||
161388838|NCT00054327|582807630|FG002|Overall Study|Engraftment failure|0|||
161388839|NCT00054327|582807631|FG003|Overall Study|Engraftment failure|0|||
161388840|NCT00054327|582807632|FG004|Overall Study|Engraftment failure|0|||
161388841|NCT00054327|582807633|FG005|Overall Study|Engraftment failure|0|||
161388842|NCT03028129|582807636|FG000|Overall Study|Adverse Event|13|||
161388843|NCT03028129|582807637|FG001|Overall Study|Adverse Event|2|||
161388844|NCT03028129|582807636|FG000|Overall Study|Lost to Follow-up|50|||
161388845|NCT03028129|582807637|FG001|Overall Study|Lost to Follow-up|38|||
161388846|NCT03028129|582807636|FG000|Overall Study|Physician Decision|0|||
161388847|NCT03028129|582807637|FG001|Overall Study|Physician Decision|1|||
161388848|NCT03028129|582807636|FG000|Overall Study|Protocol Violation|1|||
161388849|NCT03028129|582807637|FG001|Overall Study|Protocol Violation|1|||
161388850|NCT03028129|582807636|FG000|Overall Study|Withdrawal by Subject|62|||
161388851|NCT03028129|582807637|FG001|Overall Study|Withdrawal by Subject|45|||
161388852|NCT00923351|582807638|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
161388853|NCT00923351|582807639|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
161388854|NCT00923351|582807640|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
161388855|NCT00395486|582807645|FG000|Overall Study|Adverse Event|1|||
161388856|NCT00395486|582807646|FG001|Overall Study|Adverse Event|2|||
161388857|NCT00395486|582807645|FG000|Overall Study|Withdrawal by Subject|5|||
161388858|NCT00395486|582807646|FG001|Overall Study|Withdrawal by Subject|2|||
161388859|NCT00395486|582807645|FG000|Overall Study|Lost to Follow-up|0|||
161388860|NCT00395486|582807646|FG001|Overall Study|Lost to Follow-up|1|||
161388861|NCT04299308|582809826|FG000|Overall Study|Withdrawal by Subject|1|||
161388862|NCT04299308|582809827|FG001|Overall Study|Withdrawal by Subject|0|||
161388863|NCT04299308|582809826|FG000|Overall Study|issue with PET image (1)|1|||
161388864|NCT04299308|582809827|FG001|Overall Study|issue with PET image (1)|0|||
161388865|NCT00066703|582809829|FG000|Overall Study|Adverse Event|80|||
161388866|NCT00066703|582809830|FG001|Overall Study|Adverse Event|111|||
161388867|NCT00066703|582809829|FG000|Overall Study|Death|3|||
161388868|NCT00066703|582809830|FG001|Overall Study|Death|0|||
161388869|NCT00066703|582809829|FG000|Overall Study|Lack of Efficacy|114|||
161388870|NCT00066703|582809830|FG001|Overall Study|Lack of Efficacy|69|||
161388871|NCT00066703|582809829|FG000|Overall Study|Lost to Follow-up|31|||
161388872|NCT00066703|582809830|FG001|Overall Study|Lost to Follow-up|28|||
161388873|NCT00066703|582809829|FG000|Overall Study|Withdrawal by Subject|38|||
161388874|NCT00066703|582809830|FG001|Overall Study|Withdrawal by Subject|63|||
161388875|NCT00066703|582809829|FG000|Overall Study|Treatment ongoing|346|||
161388876|NCT00066703|582809830|FG001|Overall Study|Treatment ongoing|311|||
161388877|NCT00734604|582809831|FG000|Overall Study|Adverse Event|0|||
161388878|NCT00734604|582809832|FG001|Overall Study|Adverse Event|2|||
161388879|NCT00734604|582809833|FG002|Overall Study|Adverse Event|0|||
161388880|NCT00734604|582809834|FG003|Overall Study|Adverse Event|2|||
161388881|NCT00734604|582809835|FG004|Overall Study|Adverse Event|1|||
161388882|NCT00734604|582809836|FG005|Overall Study|Adverse Event|1|||
161388883|NCT00734604|582809831|FG000|Overall Study|Serious Adverse Event|1|||
161388884|NCT00734604|582809832|FG001|Overall Study|Serious Adverse Event|0|||
161388885|NCT00734604|582809833|FG002|Overall Study|Serious Adverse Event|1|||
161388886|NCT00734604|582809834|FG003|Overall Study|Serious Adverse Event|2|||
161388887|NCT00734604|582809835|FG004|Overall Study|Serious Adverse Event|0|||
161388888|NCT00734604|582809836|FG005|Overall Study|Serious Adverse Event|1|||
161388889|NCT00734604|582809831|FG000|Overall Study|Lost to Follow-up|1|||
161388890|NCT00734604|582809832|FG001|Overall Study|Lost to Follow-up|2|||
161388891|NCT00734604|582809833|FG002|Overall Study|Lost to Follow-up|2|||
161388892|NCT00734604|582809834|FG003|Overall Study|Lost to Follow-up|4|||
161388893|NCT00734604|582809835|FG004|Overall Study|Lost to Follow-up|2|||
161388894|NCT00734604|582809836|FG005|Overall Study|Lost to Follow-up|3|||
161388895|NCT00734604|582809831|FG000|Overall Study|Physician Decision|0|||
161388896|NCT00734604|582809832|FG001|Overall Study|Physician Decision|1|||
161388897|NCT00734604|582809833|FG002|Overall Study|Physician Decision|1|||
161388898|NCT00734604|582809834|FG003|Overall Study|Physician Decision|0|||
161388899|NCT00734604|582809835|FG004|Overall Study|Physician Decision|0|||
161388900|NCT00734604|582809836|FG005|Overall Study|Physician Decision|0|||
161388901|NCT00734604|582809831|FG000|Overall Study|Protocol Violation|0|||
161388902|NCT00734604|582809832|FG001|Overall Study|Protocol Violation|2|||
161388903|NCT00734604|582809833|FG002|Overall Study|Protocol Violation|0|||
161388904|NCT00734604|582809834|FG003|Overall Study|Protocol Violation|0|||
161388905|NCT00734604|582809835|FG004|Overall Study|Protocol Violation|1|||
161388906|NCT00734604|582809836|FG005|Overall Study|Protocol Violation|0|||
161388907|NCT00734604|582809831|FG000|Overall Study|Sponsor Decision|1|||
161388908|NCT00734604|582809832|FG001|Overall Study|Sponsor Decision|2|||
161388909|NCT00734604|582809833|FG002|Overall Study|Sponsor Decision|1|||
161388910|NCT00734604|582809834|FG003|Overall Study|Sponsor Decision|0|||
161388911|NCT00734604|582809835|FG004|Overall Study|Sponsor Decision|2|||
161388912|NCT00734604|582809836|FG005|Overall Study|Sponsor Decision|0|||
161388913|NCT00734604|582809831|FG000|Overall Study|Withdrawal by Subject|0|||
161388914|NCT00734604|582809832|FG001|Overall Study|Withdrawal by Subject|2|||
161388915|NCT00734604|582809833|FG002|Overall Study|Withdrawal by Subject|0|||
161388916|NCT00734604|582809834|FG003|Overall Study|Withdrawal by Subject|1|||
161388917|NCT00734604|582809835|FG004|Overall Study|Withdrawal by Subject|2|||
161388918|NCT00734604|582809836|FG005|Overall Study|Withdrawal by Subject|1|||
161388919|NCT00734604|582809831|FG000|Overall Study|Lack of Efficacy|0|||
161388920|NCT00734604|582809832|FG001|Overall Study|Lack of Efficacy|1|||
161388921|NCT00734604|582809833|FG002|Overall Study|Lack of Efficacy|1|||
161388922|NCT00734604|582809834|FG003|Overall Study|Lack of Efficacy|0|||
161388923|NCT00734604|582809835|FG004|Overall Study|Lack of Efficacy|0|||
161388924|NCT00734604|582809836|FG005|Overall Study|Lack of Efficacy|0|||
161388925|NCT02199314|582809837|FG000|Overall Study|Withdrawal by Subject|6|||
161388926|NCT02199314|582809837|FG000|Overall Study|Physician Decision|10|||
161388927|NCT02557100|582809842|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
161388928|NCT02557100|582809843|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
161388929|NCT02557100|582809844|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
161388930|NCT02557100|582809842|FG000|Single Blind Treatment Period|Death|0|||
161388931|NCT02557100|582809843|FG001|Single Blind Treatment Period|Death|1|||
161388932|NCT02557100|582809844|FG002|Single Blind Treatment Period|Death|0|||
161388933|NCT02557100|582809842|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
161388934|NCT02557100|582809843|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
161388935|NCT02557100|582809844|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
161388936|NCT02557100|582809842|FG000|Single Blind Treatment Period|Adverse Event|0|||
161388937|NCT02557100|582809843|FG001|Single Blind Treatment Period|Adverse Event|1|||
161388938|NCT02557100|582809844|FG002|Single Blind Treatment Period|Adverse Event|0|||
161388939|NCT02557100|582809842|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
161388940|NCT02557100|582809843|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
161388941|NCT02557100|582809844|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
161388942|NCT02557100|582809842|FG000|Cumulative Abatacept Period|Other Reasons|0|||
161388943|NCT02557100|582809843|FG001|Cumulative Abatacept Period|Other Reasons|0|||
161388944|NCT02557100|582809844|FG002|Cumulative Abatacept Period|Other Reasons|1|||
161388945|NCT02557100|582809842|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
161388946|NCT02557100|582809843|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
161388947|NCT02557100|582809844|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
161388948|NCT02557100|582809842|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
161388949|NCT02557100|582809843|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
161388950|NCT02557100|582809844|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
161388951|NCT02513485|582809848|FG000|Overall Study|Adverse Event|1|||
161388952|NCT02513485|582809849|FG001|Overall Study|Adverse Event|0|||
161388953|NCT00489424|582809863|FG000|Overall Study|Adverse Event|3|||
161388954|NCT00489424|582809864|FG001|Overall Study|Adverse Event|3|||
161388955|NCT00489424|582809865|FG002|Overall Study|Adverse Event|4|||
161388956|NCT00489424|582809863|FG000|Overall Study|Lack of Efficacy|1|||
161388957|NCT00489424|582809864|FG001|Overall Study|Lack of Efficacy|0|||
161388958|NCT00489424|582809865|FG002|Overall Study|Lack of Efficacy|0|||
161388959|NCT00489424|582809863|FG000|Overall Study|Administrative problems|0|||
161388960|NCT00489424|582809864|FG001|Overall Study|Administrative problems|2|||
161388961|NCT00489424|582809865|FG002|Overall Study|Administrative problems|1|||
161388962|NCT00394251|582809866|FG000|Overall Study|Adverse Event|7|||
161388963|NCT00394251|582809867|FG001|Overall Study|Adverse Event|5|||
161388964|NCT00394251|582809866|FG000|Overall Study|Unacceptable Toxicity|20|||
161388965|NCT00394251|582809867|FG001|Overall Study|Unacceptable Toxicity|18|||
161388966|NCT00394251|582809866|FG000|Overall Study|Physician Decision|1|||
161388967|NCT00394251|582809867|FG001|Overall Study|Physician Decision|1|||
161388968|NCT00394251|582809866|FG000|Overall Study|Protocol Violation|0|||
161388969|NCT00394251|582809867|FG001|Overall Study|Protocol Violation|1|||
161388970|NCT00394251|582809866|FG000|Overall Study|Withdrawal by Subject|7|||
161388971|NCT00394251|582809867|FG001|Overall Study|Withdrawal by Subject|11|||
161388972|NCT00394251|582809866|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
161388973|NCT00394251|582809867|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
161388974|NCT01558115|582809868|FG000|Overall Study|Withdrawal by Subject|3|||
161388975|NCT01558115|582809868|FG000|Overall Study|Study closed due to poor enrollment|4|||
161388976|NCT01436656|582809869|FG000|Dose Escalation|Death|1|||
161388977|NCT01436656|582809870|FG001|Dose Escalation|Death|3|||
161388978|NCT01436656|582809871|FG002|Dose Escalation|Death|1|||
161388979|NCT01436656|582809872|FG003|Dose Escalation|Death|0|||
161388980|NCT01436656|582809873|FG004|Dose Escalation|Death|2|||
161388981|NCT01436656|582809874|FG005|Dose Escalation|Death|1|||
161388982|NCT01436656|582809875|FG006|Dose Escalation|Death|1|||
161388983|NCT01436656|582809876|FG007|Dose Escalation|Death|1|||
161388984|NCT01436656|582809877|FG008|Dose Escalation|Death|1|||
161388985|NCT01436656|582809878|FG009|Dose Escalation|Death|0|||
161388986|NCT01436656|582809879|FG010|Dose Escalation|Death|0|||
161388987|NCT01436656|582809880|FG011|Dose Escalation|Death|0|||
161388988|NCT01436656|582809881|FG012|Dose Escalation|Death|0|||
161388989|NCT01436656|582809882|FG013|Dose Escalation|Death|0|||
161388990|NCT01436656|582809883|FG014|Dose Escalation|Death|0|||
161388991|NCT01436656|582809884|FG015|Dose Escalation|Death|0|||
161388992|NCT01436656|582809885|FG016|Dose Escalation|Death|0|||
161388993|NCT01436656|582809886|FG017|Dose Escalation|Death|0|||
161388994|NCT01436656|582809869|FG000|Dose Escalation|Protocol Violation|0|||
161388995|NCT01436656|582809870|FG001|Dose Escalation|Protocol Violation|0|||
161388996|NCT01436656|582809871|FG002|Dose Escalation|Protocol Violation|0|||
161388997|NCT01436656|582809872|FG003|Dose Escalation|Protocol Violation|0|||
161388998|NCT01436656|582809873|FG004|Dose Escalation|Protocol Violation|0|||
161388999|NCT01436656|582809874|FG005|Dose Escalation|Protocol Violation|1|||
161389000|NCT01436656|582809875|FG006|Dose Escalation|Protocol Violation|0|||
161389001|NCT01436656|582809876|FG007|Dose Escalation|Protocol Violation|0|||
161389002|NCT01436656|582809877|FG008|Dose Escalation|Protocol Violation|0|||
161389003|NCT01436656|582809878|FG009|Dose Escalation|Protocol Violation|0|||
161389004|NCT01436656|582809879|FG010|Dose Escalation|Protocol Violation|0|||
161389005|NCT01436656|582809880|FG011|Dose Escalation|Protocol Violation|0|||
161389006|NCT01436656|582809881|FG012|Dose Escalation|Protocol Violation|0|||
161389007|NCT01436656|582809882|FG013|Dose Escalation|Protocol Violation|0|||
161389008|NCT01436656|582809883|FG014|Dose Escalation|Protocol Violation|0|||
161389009|NCT01436656|582809884|FG015|Dose Escalation|Protocol Violation|0|||
161389010|NCT01436656|582809885|FG016|Dose Escalation|Protocol Violation|0|||
161389011|NCT01436656|582809886|FG017|Dose Escalation|Protocol Violation|0|||
161389012|NCT01436656|582809869|FG000|Dose Escalation|Withdrawal by Subject|0|||
161389013|NCT01436656|582809870|FG001|Dose Escalation|Withdrawal by Subject|0|||
161389014|NCT01436656|582809871|FG002|Dose Escalation|Withdrawal by Subject|0|||
161389015|NCT01436656|582809872|FG003|Dose Escalation|Withdrawal by Subject|0|||
161389016|NCT01436656|582809873|FG004|Dose Escalation|Withdrawal by Subject|1|||
161389017|NCT01436656|582809874|FG005|Dose Escalation|Withdrawal by Subject|0|||
161389018|NCT01436656|582809875|FG006|Dose Escalation|Withdrawal by Subject|0|||
161389019|NCT01436656|582809876|FG007|Dose Escalation|Withdrawal by Subject|2|||
161389020|NCT01436656|582809877|FG008|Dose Escalation|Withdrawal by Subject|0|||
161389021|NCT01436656|582809878|FG009|Dose Escalation|Withdrawal by Subject|1|||
161389022|NCT01436656|582809879|FG010|Dose Escalation|Withdrawal by Subject|1|||
161389023|NCT01436656|582809880|FG011|Dose Escalation|Withdrawal by Subject|0|||
161389024|NCT01436656|582809881|FG012|Dose Escalation|Withdrawal by Subject|0|||
161389025|NCT01436656|582809882|FG013|Dose Escalation|Withdrawal by Subject|0|||
161389026|NCT01436656|582809883|FG014|Dose Escalation|Withdrawal by Subject|0|||
161389027|NCT01436656|582809884|FG015|Dose Escalation|Withdrawal by Subject|0|||
161389028|NCT01436656|582809885|FG016|Dose Escalation|Withdrawal by Subject|0|||
161389029|NCT01436656|582809886|FG017|Dose Escalation|Withdrawal by Subject|0|||
161389030|NCT01436656|582809869|FG000|Dose Escalation|Administrative problems|0|||
161389031|NCT01436656|582809870|FG001|Dose Escalation|Administrative problems|1|||
161389032|NCT01436656|582809871|FG002|Dose Escalation|Administrative problems|0|||
161389033|NCT01436656|582809872|FG003|Dose Escalation|Administrative problems|0|||
161389034|NCT01436656|582809873|FG004|Dose Escalation|Administrative problems|0|||
161389035|NCT01436656|582809874|FG005|Dose Escalation|Administrative problems|0|||
161389036|NCT01436656|582809875|FG006|Dose Escalation|Administrative problems|0|||
161389037|NCT01436656|582809876|FG007|Dose Escalation|Administrative problems|0|||
161389038|NCT01436656|582809877|FG008|Dose Escalation|Administrative problems|0|||
161389039|NCT01436656|582809878|FG009|Dose Escalation|Administrative problems|0|||
161389040|NCT01436656|582809879|FG010|Dose Escalation|Administrative problems|0|||
161389041|NCT01436656|582809880|FG011|Dose Escalation|Administrative problems|0|||
161389042|NCT01436656|582809881|FG012|Dose Escalation|Administrative problems|0|||
161389043|NCT01436656|582809882|FG013|Dose Escalation|Administrative problems|0|||
161389044|NCT01436656|582809883|FG014|Dose Escalation|Administrative problems|0|||
161389045|NCT01436656|582809884|FG015|Dose Escalation|Administrative problems|0|||
161389046|NCT01436656|582809885|FG016|Dose Escalation|Administrative problems|0|||
161389047|NCT01436656|582809886|FG017|Dose Escalation|Administrative problems|0|||
161389048|NCT01436656|582809869|FG000|Dose Escalation|Lost to Follow-up|1|||
161389049|NCT01436656|582809870|FG001|Dose Escalation|Lost to Follow-up|0|||
161389050|NCT01436656|582809871|FG002|Dose Escalation|Lost to Follow-up|0|||
161389051|NCT01436656|582809872|FG003|Dose Escalation|Lost to Follow-up|0|||
161389052|NCT01436656|582809873|FG004|Dose Escalation|Lost to Follow-up|1|||
161389053|NCT01436656|582809874|FG005|Dose Escalation|Lost to Follow-up|0|||
161389054|NCT01436656|582809875|FG006|Dose Escalation|Lost to Follow-up|0|||
161389055|NCT01436656|582809876|FG007|Dose Escalation|Lost to Follow-up|0|||
161389056|NCT01436656|582809877|FG008|Dose Escalation|Lost to Follow-up|0|||
161389057|NCT01436656|582809878|FG009|Dose Escalation|Lost to Follow-up|0|||
161389058|NCT01436656|582809879|FG010|Dose Escalation|Lost to Follow-up|0|||
161389059|NCT01436656|582809880|FG011|Dose Escalation|Lost to Follow-up|0|||
161389060|NCT01436656|582809881|FG012|Dose Escalation|Lost to Follow-up|0|||
161389061|NCT01436656|582809882|FG013|Dose Escalation|Lost to Follow-up|0|||
161389062|NCT01436656|582809883|FG014|Dose Escalation|Lost to Follow-up|0|||
161389063|NCT01436656|582809884|FG015|Dose Escalation|Lost to Follow-up|0|||
161389064|NCT01436656|582809885|FG016|Dose Escalation|Lost to Follow-up|0|||
161389065|NCT01436656|582809886|FG017|Dose Escalation|Lost to Follow-up|0|||
161389066|NCT01436656|582809869|FG000|Dose Escalation|New anti-cancer therapy|1|||
161389067|NCT01436656|582809870|FG001|Dose Escalation|New anti-cancer therapy|0|||
161389068|NCT01436656|582809871|FG002|Dose Escalation|New anti-cancer therapy|0|||
161389069|NCT01436656|582809872|FG003|Dose Escalation|New anti-cancer therapy|0|||
161389070|NCT01436656|582809873|FG004|Dose Escalation|New anti-cancer therapy|0|||
161389071|NCT01436656|582809874|FG005|Dose Escalation|New anti-cancer therapy|0|||
161389072|NCT01436656|582809875|FG006|Dose Escalation|New anti-cancer therapy|0|||
161389073|NCT01436656|582809876|FG007|Dose Escalation|New anti-cancer therapy|0|||
161389074|NCT01436656|582809877|FG008|Dose Escalation|New anti-cancer therapy|1|||
161389075|NCT01436656|582809878|FG009|Dose Escalation|New anti-cancer therapy|1|||
161389076|NCT01436656|582809879|FG010|Dose Escalation|New anti-cancer therapy|0|||
161389077|NCT01436656|582809880|FG011|Dose Escalation|New anti-cancer therapy|0|||
161389078|NCT01436656|582809881|FG012|Dose Escalation|New anti-cancer therapy|0|||
161389079|NCT01436656|582809882|FG013|Dose Escalation|New anti-cancer therapy|0|||
161389080|NCT01436656|582809883|FG014|Dose Escalation|New anti-cancer therapy|0|||
161389081|NCT01436656|582809884|FG015|Dose Escalation|New anti-cancer therapy|0|||
161389082|NCT01436656|582809885|FG016|Dose Escalation|New anti-cancer therapy|0|||
161389083|NCT01436656|582809886|FG017|Dose Escalation|New anti-cancer therapy|0|||
161389084|NCT01436656|582809869|FG000|Dose Expansion|Adverse Event|0|||
161389085|NCT01436656|582809870|FG001|Dose Expansion|Adverse Event|0|||
161389086|NCT01436656|582809871|FG002|Dose Expansion|Adverse Event|0|||
161389087|NCT01436656|582809872|FG003|Dose Expansion|Adverse Event|0|||
161389088|NCT01436656|582809873|FG004|Dose Expansion|Adverse Event|0|||
161389089|NCT01436656|582809874|FG005|Dose Expansion|Adverse Event|0|||
161389090|NCT01436656|582809875|FG006|Dose Expansion|Adverse Event|0|||
161389091|NCT01436656|582809876|FG007|Dose Expansion|Adverse Event|0|||
161389092|NCT01436656|582809877|FG008|Dose Expansion|Adverse Event|0|||
161389093|NCT01436656|582809878|FG009|Dose Expansion|Adverse Event|0|||
161389094|NCT01436656|582809879|FG010|Dose Expansion|Adverse Event|0|||
161389095|NCT01436656|582809880|FG011|Dose Expansion|Adverse Event|1|||
161389096|NCT01436656|582809881|FG012|Dose Expansion|Adverse Event|0|||
161389097|NCT01436656|582809882|FG013|Dose Expansion|Adverse Event|0|||
161389098|NCT01436656|582809883|FG014|Dose Expansion|Adverse Event|0|||
161389099|NCT01436656|582809884|FG015|Dose Expansion|Adverse Event|0|||
161389100|NCT01436656|582809885|FG016|Dose Expansion|Adverse Event|0|||
161389101|NCT01436656|582809886|FG017|Dose Expansion|Adverse Event|0|||
161389102|NCT01436656|582809869|FG000|Dose Expansion|Withdrawal by Subject|0|||
161389103|NCT01436656|582809870|FG001|Dose Expansion|Withdrawal by Subject|0|||
161389104|NCT01436656|582809871|FG002|Dose Expansion|Withdrawal by Subject|0|||
161389105|NCT01436656|582809872|FG003|Dose Expansion|Withdrawal by Subject|0|||
161389106|NCT01436656|582809873|FG004|Dose Expansion|Withdrawal by Subject|0|||
161389107|NCT01436656|582809874|FG005|Dose Expansion|Withdrawal by Subject|0|||
161389108|NCT01436656|582809875|FG006|Dose Expansion|Withdrawal by Subject|0|||
161389109|NCT01436656|582809876|FG007|Dose Expansion|Withdrawal by Subject|0|||
161389110|NCT01436656|582809877|FG008|Dose Expansion|Withdrawal by Subject|0|||
161389111|NCT01436656|582809878|FG009|Dose Expansion|Withdrawal by Subject|0|||
161389112|NCT01436656|582809879|FG010|Dose Expansion|Withdrawal by Subject|0|||
161389113|NCT01436656|582809880|FG011|Dose Expansion|Withdrawal by Subject|1|||
161389114|NCT01436656|582809881|FG012|Dose Expansion|Withdrawal by Subject|3|||
161389115|NCT01436656|582809882|FG013|Dose Expansion|Withdrawal by Subject|1|||
161389116|NCT01436656|582809883|FG014|Dose Expansion|Withdrawal by Subject|2|||
161389117|NCT01436656|582809884|FG015|Dose Expansion|Withdrawal by Subject|0|||
161389118|NCT01436656|582809885|FG016|Dose Expansion|Withdrawal by Subject|1|||
161389119|NCT01436656|582809886|FG017|Dose Expansion|Withdrawal by Subject|1|||
161389120|NCT01436656|582809869|FG000|Dose Expansion|Death|0|||
161389121|NCT01436656|582809870|FG001|Dose Expansion|Death|0|||
161389122|NCT01436656|582809871|FG002|Dose Expansion|Death|0|||
161389123|NCT01436656|582809872|FG003|Dose Expansion|Death|0|||
161389124|NCT01436656|582809873|FG004|Dose Expansion|Death|0|||
161389125|NCT01436656|582809874|FG005|Dose Expansion|Death|0|||
161389126|NCT01436656|582809875|FG006|Dose Expansion|Death|0|||
161389127|NCT01436656|582809876|FG007|Dose Expansion|Death|0|||
161389128|NCT01436656|582809877|FG008|Dose Expansion|Death|0|||
161389129|NCT01436656|582809878|FG009|Dose Expansion|Death|0|||
161389130|NCT01436656|582809879|FG010|Dose Expansion|Death|0|||
161389131|NCT01436656|582809880|FG011|Dose Expansion|Death|0|||
161389132|NCT01436656|582809881|FG012|Dose Expansion|Death|1|||
161389133|NCT01436656|582809882|FG013|Dose Expansion|Death|0|||
161389134|NCT01436656|582809883|FG014|Dose Expansion|Death|3|||
161389135|NCT01436656|582809884|FG015|Dose Expansion|Death|0|||
161389136|NCT01436656|582809885|FG016|Dose Expansion|Death|3|||
161389137|NCT01436656|582809886|FG017|Dose Expansion|Death|3|||
161389138|NCT01436656|582809869|FG000|Dose Expansion|Lost to Follow-up|0|||
161389139|NCT01436656|582809870|FG001|Dose Expansion|Lost to Follow-up|0|||
161389140|NCT01436656|582809871|FG002|Dose Expansion|Lost to Follow-up|0|||
161389141|NCT01436656|582809872|FG003|Dose Expansion|Lost to Follow-up|0|||
161389142|NCT01436656|582809873|FG004|Dose Expansion|Lost to Follow-up|0|||
161389143|NCT01436656|582809874|FG005|Dose Expansion|Lost to Follow-up|0|||
161389144|NCT01436656|582809875|FG006|Dose Expansion|Lost to Follow-up|0|||
161389145|NCT01436656|582809876|FG007|Dose Expansion|Lost to Follow-up|0|||
161389146|NCT01436656|582809877|FG008|Dose Expansion|Lost to Follow-up|0|||
161389147|NCT01436656|582809878|FG009|Dose Expansion|Lost to Follow-up|0|||
161389148|NCT01436656|582809879|FG010|Dose Expansion|Lost to Follow-up|0|||
161389149|NCT01436656|582809880|FG011|Dose Expansion|Lost to Follow-up|0|||
161389150|NCT01436656|582809881|FG012|Dose Expansion|Lost to Follow-up|0|||
161389151|NCT01436656|582809882|FG013|Dose Expansion|Lost to Follow-up|0|||
161389152|NCT01436656|582809883|FG014|Dose Expansion|Lost to Follow-up|0|||
161389153|NCT01436656|582809884|FG015|Dose Expansion|Lost to Follow-up|0|||
161389154|NCT01436656|582809885|FG016|Dose Expansion|Lost to Follow-up|0|||
161389155|NCT01436656|582809886|FG017|Dose Expansion|Lost to Follow-up|3|||
161389156|NCT01436656|582809869|FG000|Dose Expansion|Disease progression|0|||
161389157|NCT01436656|582809870|FG001|Dose Expansion|Disease progression|0|||
161389158|NCT01436656|582809871|FG002|Dose Expansion|Disease progression|0|||
161389159|NCT01436656|582809872|FG003|Dose Expansion|Disease progression|0|||
161389160|NCT01436656|582809873|FG004|Dose Expansion|Disease progression|0|||
161389161|NCT01436656|582809874|FG005|Dose Expansion|Disease progression|0|||
161389162|NCT01436656|582809875|FG006|Dose Expansion|Disease progression|0|||
161389163|NCT01436656|582809876|FG007|Dose Expansion|Disease progression|0|||
161389164|NCT01436656|582809877|FG008|Dose Expansion|Disease progression|0|||
161389165|NCT01436656|582809878|FG009|Dose Expansion|Disease progression|0|||
161389166|NCT01436656|582809879|FG010|Dose Expansion|Disease progression|0|||
161389167|NCT01436656|582809880|FG011|Dose Expansion|Disease progression|3|||
161389168|NCT01436656|582809881|FG012|Dose Expansion|Disease progression|1|||
161389169|NCT01436656|582809882|FG013|Dose Expansion|Disease progression|0|||
161389170|NCT01436656|582809883|FG014|Dose Expansion|Disease progression|1|||
161389171|NCT01436656|582809884|FG015|Dose Expansion|Disease progression|0|||
161389172|NCT01436656|582809885|FG016|Dose Expansion|Disease progression|0|||
161389173|NCT01436656|582809886|FG017|Dose Expansion|Disease progression|1|||
161389174|NCT01436656|582809869|FG000|Dose Expansion|New cancer therapy|0|||
161389175|NCT01436656|582809870|FG001|Dose Expansion|New cancer therapy|0|||
161389176|NCT01436656|582809871|FG002|Dose Expansion|New cancer therapy|0|||
161389177|NCT01436656|582809872|FG003|Dose Expansion|New cancer therapy|0|||
161389178|NCT01436656|582809873|FG004|Dose Expansion|New cancer therapy|0|||
161389179|NCT01436656|582809874|FG005|Dose Expansion|New cancer therapy|0|||
161389180|NCT01436656|582809875|FG006|Dose Expansion|New cancer therapy|0|||
161389181|NCT01436656|582809876|FG007|Dose Expansion|New cancer therapy|0|||
161389182|NCT01436656|582809877|FG008|Dose Expansion|New cancer therapy|0|||
161389183|NCT01436656|582809878|FG009|Dose Expansion|New cancer therapy|0|||
161389184|NCT01436656|582809879|FG010|Dose Expansion|New cancer therapy|0|||
161389185|NCT01436656|582809880|FG011|Dose Expansion|New cancer therapy|1|||
161389186|NCT01436656|582809881|FG012|Dose Expansion|New cancer therapy|1|||
161389187|NCT01436656|582809882|FG013|Dose Expansion|New cancer therapy|0|||
161389188|NCT01436656|582809883|FG014|Dose Expansion|New cancer therapy|2|||
161389189|NCT01436656|582809884|FG015|Dose Expansion|New cancer therapy|0|||
161389190|NCT01436656|582809885|FG016|Dose Expansion|New cancer therapy|0|||
161389191|NCT01436656|582809886|FG017|Dose Expansion|New cancer therapy|0|||
161389192|NCT01696994|582809887|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
161389193|NCT01696994|582809888|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
161389194|NCT01696994|582809887|FG000|Overall Study|Died Before Randomization|1|||
161389195|NCT01696994|582809888|FG001|Overall Study|Died Before Randomization|2|||
161389196|NCT01696994|582809887|FG000|Overall Study|Died Before ASU (Control)|73|||
161389197|NCT01696994|582809888|FG001|Overall Study|Died Before ASU (Control)|0|||
161389198|NCT01696994|582809887|FG000|Overall Study|No Ovaries at Baseline|4807|||
161389199|NCT01696994|582809888|FG001|Overall Study|No Ovaries at Baseline|4851|||
161389200|NCT01696994|582809887|FG000|Overall Study|Refused ASU (Control)|311|||
161389201|NCT01696994|582809888|FG001|Overall Study|Refused ASU (Control)|0|||
161389202|NCT01696994|582809887|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
161389203|NCT01696994|582809888|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
161389204|NCT04644276|582809889|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
161389205|NCT04644276|582809890|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
161389206|NCT04644276|582809891|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
161389207|NCT00705250|582809892|FG000|Overall Study|Withdrawal by Subject|1|||
161389208|NCT00705250|582809892|FG000|Overall Study|Patient died in car accident|1|||
161389209|NCT01576146|582809895|FG000|Extension Period 1|Adverse Event|2|||
161389210|NCT01576146|582809895|FG000|Extension Period 1|Death|2|||
161389211|NCT01576146|582809895|FG000|Extension Period 1|Physician Decision|2|||
161389212|NCT01576146|582809895|FG000|Extension Period 1|Withdrawal by Subject|1|||
161389213|NCT01576146|582809895|FG000|Extension Period 1|Lost to Follow-up|1|||
161389214|NCT01576146|582809895|FG000|Extension Period 1|Parathyroidectomy|1|||
161389215|NCT01576146|582809895|FG000|Extension Period 1|Renal Transplant|1|||
161389216|NCT01576146|582809895|FG000|Extension Period 2|Sponsor Decision|13|||
161389217|NCT01576146|582809895|FG000|Extension Period 2|Death|1|||
161389218|NCT01576146|582809895|FG000|Extension Period 2|Adverse Event|1|||
161389219|NCT01576146|582809895|FG000|Extension Period 2|Renal Transplant|1|||
161389220|NCT01576146|582809895|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
161389221|NCT01667224|582809897|FG000|Overall Study|Withdrawal by Subject|3|||
161389222|NCT01667224|582809898|FG001|Overall Study|Withdrawal by Subject|1|||
161389223|NCT01667224|582809897|FG000|Overall Study|Protocol Violation|1|||
161389224|NCT01667224|582809898|FG001|Overall Study|Protocol Violation|1|||
161389225|NCT00316225|582809899|FG000|Overall Study|Adverse Event|2|||
161389226|NCT00316225|582809899|FG000|Overall Study|Physician Decision|3|||
161389227|NCT00316225|582809899|FG000|Overall Study|Progressive Disease|15|||
161389228|NCT00316225|582809899|FG000|Overall Study|Withdrawal by Subject|3|||
161389229|NCT00316225|582809899|FG000|Overall Study|Death|2|||
161389230|NCT01814878|582809900|FG000|Overall Study|Adverse Event|16|||
161389231|NCT01814878|582809901|FG001|Overall Study|Adverse Event|5|||
161389232|NCT01814878|582809900|FG000|Overall Study|Withdrawal by Subject|20|||
161389233|NCT01814878|582809901|FG001|Overall Study|Withdrawal by Subject|16|||
161389234|NCT01814878|582809900|FG000|Overall Study|Protocol Violation|5|||
161389235|NCT01814878|582809901|FG001|Overall Study|Protocol Violation|5|||
161389236|NCT01814878|582809900|FG000|Overall Study|Physician Decision|3|||
161389237|NCT01814878|582809901|FG001|Overall Study|Physician Decision|1|||
161389238|NCT01814878|582809900|FG000|Overall Study|Screening failure (drop-out)|0|||
161389239|NCT01814878|582809901|FG001|Overall Study|Screening failure (drop-out)|3|||
161389240|NCT01814878|582809900|FG000|Overall Study|Other|2|||
161389241|NCT01814878|582809901|FG001|Overall Study|Other|0|||
161389242|NCT01545934|582809902|FG000|Overall Study|Withdrawal by Subject|4|||
161389243|NCT01545934|582809903|FG001|Overall Study|Withdrawal by Subject|3|||
161389244|NCT01545934|582809902|FG000|Overall Study|Lost to Follow-up|1|||
161389245|NCT01545934|582809903|FG001|Overall Study|Lost to Follow-up|0|||
161389246|NCT01843673|582809904|FG000|Overall Study|Lack of Efficacy|2|||
161389247|NCT01843673|582809904|FG000|Overall Study|Withdrawal by Subject|4|||
161389248|NCT00425698|582809905|FG000|Overall Study|Adverse Event|3|||
161389249|NCT00425698|582809906|FG001|Overall Study|Adverse Event|1|||
161389250|NCT00425698|582809905|FG000|Overall Study|Withdrawal by Subject|0|||
161389251|NCT00425698|582809906|FG001|Overall Study|Withdrawal by Subject|1|||
161389252|NCT01205061|582809907|FG000|Overall Study|Adverse Event|4|||
161389253|NCT01205061|582809907|FG000|Overall Study|Withdrawal by Subject|11|||
161389254|NCT01205061|582809907|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
161389255|NCT01205061|582809907|FG000|Overall Study|Lost to Follow-up|9|||
161389256|NCT01205061|582809907|FG000|Overall Study|Other|1|||
161389257|NCT04026009|582809912|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161389258|NCT04026009|582809913|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161389259|NCT04026009|582809914|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161389260|NCT04026009|582809915|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161389261|NCT04026009|582809916|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161389262|NCT04026009|582809912|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
161389263|NCT04026009|582809913|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
161389264|NCT04026009|582809914|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
161389265|NCT04026009|582809915|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
161389266|NCT04026009|582809916|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
161389267|NCT01988662|582809917|FG000|Overall Study|Subject/guardian decision|1|||
161389268|NCT01988662|582809918|FG001|Overall Study|Subject/guardian decision|1|||
161389269|NCT01988662|582809917|FG000|Overall Study|Adverse Event|3|||
161389270|NCT01988662|582809918|FG001|Overall Study|Adverse Event|1|||
161389271|NCT00695955|582809919|FG000|Cohort 1|Adverse Event|26|||
161389272|NCT00695955|582809919|FG000|Cohort 1|Protocol Violation|2|||
161389273|NCT00695955|582809919|FG000|Cohort 1|Lost to Follow-up|30|||
161389274|NCT00695955|582809919|FG000|Cohort 1|Withdrawal by Subject|25|||
161389275|NCT00695955|582809919|FG000|Cohort 1|Lack of Efficacy|3|||
161389276|NCT00695955|582809919|FG000|Cohort 1|Other|16|||
161389277|NCT00695955|582809919|FG000|Cohort 2|Adverse Event|24|||
161389278|NCT00695955|582809919|FG000|Cohort 2|Protocol Violation|5|||
161389279|NCT00695955|582809919|FG000|Cohort 2|Lost to Follow-up|38|||
161389280|NCT00695955|582809919|FG000|Cohort 2|Withdrawal by Subject|28|||
161389281|NCT00695955|582809919|FG000|Cohort 2|Lack of Efficacy|4|||
161389282|NCT00695955|582809919|FG000|Cohort 2|Other|5|||
161389283|NCT01177553|582809920|FG000|Overall Study|babies not yet 6 months of age|1|||
161389284|NCT01177553|582809921|FG001|Overall Study|babies not yet 6 months of age|0|||
161389285|NCT00888329|582809923|FG000|Overall Study|Physician Decision|6|||
161389286|NCT00888329|582809924|FG001|Overall Study|Physician Decision|9|||
161389287|NCT04826094|582809925|FG000|Overall Study|Lost to Follow-up|2|||
161389288|NCT04826094|582809926|FG001|Overall Study|Lost to Follow-up|1|||
161389289|NCT04826094|582809927|FG002|Overall Study|Lost to Follow-up|0|||
161389290|NCT04826094|582809928|FG003|Overall Study|Lost to Follow-up|0|||
161389291|NCT04826094|582809929|FG004|Overall Study|Lost to Follow-up|1|||
161389292|NCT04826094|582809930|FG005|Overall Study|Lost to Follow-up|3|||
161389293|NCT04826094|582809931|FG006|Overall Study|Lost to Follow-up|1|||
161389294|NCT04826094|582809932|FG007|Overall Study|Lost to Follow-up|1|||
161389295|NCT04826094|582809925|FG000|Overall Study|Participant withdrew consent|1|||
161389296|NCT04826094|582809926|FG001|Overall Study|Participant withdrew consent|0|||
161389297|NCT04826094|582809927|FG002|Overall Study|Participant withdrew consent|0|||
161389298|NCT04826094|582809928|FG003|Overall Study|Participant withdrew consent|1|||
161389299|NCT04826094|582809929|FG004|Overall Study|Participant withdrew consent|1|||
161389300|NCT04826094|582809930|FG005|Overall Study|Participant withdrew consent|1|||
161389301|NCT04826094|582809931|FG006|Overall Study|Participant withdrew consent|0|||
161389302|NCT04826094|582809932|FG007|Overall Study|Participant withdrew consent|1|||
161389303|NCT04826094|582809925|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
161389304|NCT04826094|582809926|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
161389305|NCT04826094|582809927|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
161389306|NCT04826094|582809928|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
161389307|NCT04826094|582809929|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
161389308|NCT04826094|582809930|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
161389309|NCT04826094|582809931|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
161389310|NCT04826094|582809932|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
161389311|NCT04826094|582809925|FG000|Overall Study|Withdrawn by Investigator|0|||
161389312|NCT04826094|582809926|FG001|Overall Study|Withdrawn by Investigator|0|||
161389313|NCT04826094|582809927|FG002|Overall Study|Withdrawn by Investigator|0|||
161389314|NCT04826094|582809928|FG003|Overall Study|Withdrawn by Investigator|0|||
161389315|NCT04826094|582809929|FG004|Overall Study|Withdrawn by Investigator|0|||
161389316|NCT04826094|582809930|FG005|Overall Study|Withdrawn by Investigator|1|||
161389317|NCT04826094|582809931|FG006|Overall Study|Withdrawn by Investigator|0|||
161389318|NCT04826094|582809932|FG007|Overall Study|Withdrawn by Investigator|1|||
161389319|NCT04826094|582809925|FG000|Overall Study|Other: Moved from area|1|||
161389320|NCT04826094|582809926|FG001|Overall Study|Other: Moved from area|1|||
161389321|NCT04826094|582809927|FG002|Overall Study|Other: Moved from area|1|||
161389322|NCT04826094|582809928|FG003|Overall Study|Other: Moved from area|0|||
161389323|NCT04826094|582809929|FG004|Overall Study|Other: Moved from area|0|||
161389324|NCT04826094|582809930|FG005|Overall Study|Other: Moved from area|0|||
161389325|NCT04826094|582809931|FG006|Overall Study|Other: Moved from area|0|||
161389326|NCT04826094|582809932|FG007|Overall Study|Other: Moved from area|0|||
161389327|NCT04826094|582809925|FG000|Overall Study|Other: Declined|0|||
161389328|NCT04826094|582809926|FG001|Overall Study|Other: Declined|0|||
161389329|NCT04826094|582809927|FG002|Overall Study|Other: Declined|0|||
161389330|NCT04826094|582809928|FG003|Overall Study|Other: Declined|0|||
161389331|NCT04826094|582809929|FG004|Overall Study|Other: Declined|1|||
161389332|NCT04826094|582809930|FG005|Overall Study|Other: Declined|0|||
161389333|NCT04826094|582809931|FG006|Overall Study|Other: Declined|0|||
161389334|NCT04826094|582809932|FG007|Overall Study|Other: Declined|0|||
161389335|NCT04826094|582809925|FG000|Overall Study|Other: Vaccine not administered|0|||
161389336|NCT04826094|582809926|FG001|Overall Study|Other: Vaccine not administered|0|||
161389337|NCT04826094|582809927|FG002|Overall Study|Other: Vaccine not administered|1|||
161389338|NCT04826094|582809928|FG003|Overall Study|Other: Vaccine not administered|0|||
161389339|NCT04826094|582809929|FG004|Overall Study|Other: Vaccine not administered|0|||
161389340|NCT04826094|582809930|FG005|Overall Study|Other: Vaccine not administered|1|||
161389341|NCT04826094|582809931|FG006|Overall Study|Other: Vaccine not administered|1|||
161389342|NCT04826094|582809932|FG007|Overall Study|Other: Vaccine not administered|3|||
161389343|NCT03928418|582809939|FG000|Overall Study|Lost to Follow-up|5|||
161389344|NCT03928418|582809940|FG001|Overall Study|Lost to Follow-up|3|||
161389345|NCT03928418|582809941|FG002|Overall Study|Lost to Follow-up|5|||
161389346|NCT03928418|582809939|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
161389347|NCT03928418|582809940|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
161389348|NCT03928418|582809941|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
161389349|NCT01421303|582809942|FG000|Overall Study|Lost to Follow-up|13|||
161389350|NCT01421303|582809942|FG000|Overall Study|Non compliance with study procedure|1|||
161389351|NCT01421303|582809942|FG000|Overall Study|Other|7|||
161389352|NCT01421303|582809942|FG000|Overall Study|Withdrawal by Subject|1|||
161389353|NCT00690430|582809948|FG000|Core Phase|Abnormal Laboratory value|0|||
161389354|NCT00690430|582809949|FG001|Core Phase|Abnormal Laboratory value|1|||
161389355|NCT00690430|582809950|FG002|Core Phase|Abnormal Laboratory value|0|||
161389356|NCT00690430|582809948|FG000|Core Phase|Adverse Event|5|||
161389357|NCT00690430|582809949|FG001|Core Phase|Adverse Event|1|||
161389358|NCT00690430|582809950|FG002|Core Phase|Adverse Event|0|||
161389359|NCT00690430|582809948|FG000|Core Phase|Death|0|||
161389360|NCT00690430|582809949|FG001|Core Phase|Death|2|||
161389361|NCT00690430|582809950|FG002|Core Phase|Death|0|||
161389362|NCT00690430|582809948|FG000|Core Phase|Protocol Violation|1|||
161389363|NCT00690430|582809949|FG001|Core Phase|Protocol Violation|0|||
161389364|NCT00690430|582809950|FG002|Core Phase|Protocol Violation|0|||
161389365|NCT00690430|582809948|FG000|Core Phase|Withdrawal by Subject|3|||
161389366|NCT00690430|582809949|FG001|Core Phase|Withdrawal by Subject|3|||
161389367|NCT00690430|582809950|FG002|Core Phase|Withdrawal by Subject|0|||
161389368|NCT00690430|582809948|FG000|Core Phase|Subject no longer requires study drug|1|||
161389369|NCT00690430|582809949|FG001|Core Phase|Subject no longer requires study drug|0|||
161389370|NCT00690430|582809950|FG002|Core Phase|Subject no longer requires study drug|0|||
161389371|NCT00690430|582809948|FG000|Core Phase|Lack of Efficacy|8|||
161389372|NCT00690430|582809949|FG001|Core Phase|Lack of Efficacy|10|||
161389373|NCT00690430|582809950|FG002|Core Phase|Lack of Efficacy|0|||
161389374|NCT00690430|582809948|FG000|Core Phase|Administrative Problems|0|||
161389375|NCT00690430|582809949|FG001|Core Phase|Administrative Problems|1|||
161389376|NCT00690430|582809950|FG002|Core Phase|Administrative Problems|0|||
161389377|NCT00690430|582809948|FG000|Core Phase|Early Termination|0|||
161389378|NCT00690430|582809949|FG001|Core Phase|Early Termination|5|||
161389379|NCT00690430|582809950|FG002|Core Phase|Early Termination|0|||
161389380|NCT00690430|582809948|FG000|Extension Phase|Lack of Efficacy|3|||
161389381|NCT00690430|582809949|FG001|Extension Phase|Lack of Efficacy|1|||
161389382|NCT00690430|582809950|FG002|Extension Phase|Lack of Efficacy|4|||
161389383|NCT00690430|582809948|FG000|Extension Phase|Abnormal Lab Values|1|||
161389384|NCT00690430|582809949|FG001|Extension Phase|Abnormal Lab Values|0|||
161389385|NCT00690430|582809950|FG002|Extension Phase|Abnormal Lab Values|0|||
161389386|NCT00690430|582809948|FG000|Extension Phase|Abnormal test procedure results|1|||
161389387|NCT00690430|582809949|FG001|Extension Phase|Abnormal test procedure results|0|||
161389388|NCT00690430|582809950|FG002|Extension Phase|Abnormal test procedure results|0|||
161389389|NCT00690430|582809948|FG000|Extension Phase|Administrative Problems|0|||
161389390|NCT00690430|582809949|FG001|Extension Phase|Administrative Problems|1|||
161389391|NCT00690430|582809950|FG002|Extension Phase|Administrative Problems|1|||
161389392|NCT00690430|582809948|FG000|Extension Phase|Adverse Event|2|||
161389393|NCT00690430|582809949|FG001|Extension Phase|Adverse Event|1|||
161389394|NCT00690430|582809950|FG002|Extension Phase|Adverse Event|2|||
161389395|NCT00690430|582809948|FG000|Extension Phase|Death|1|||
161389396|NCT00690430|582809949|FG001|Extension Phase|Death|1|||
161389397|NCT00690430|582809950|FG002|Extension Phase|Death|1|||
161389398|NCT00690430|582809948|FG000|Extension Phase|Withdrawal by Subject|0|||
161389399|NCT00690430|582809949|FG001|Extension Phase|Withdrawal by Subject|0|||
161389400|NCT00690430|582809950|FG002|Extension Phase|Withdrawal by Subject|2|||
161389401|NCT00690430|582809948|FG000|Extension Phase|Early Termination|10|||
161389402|NCT00690430|582809949|FG001|Extension Phase|Early Termination|1|||
161389403|NCT00690430|582809950|FG002|Extension Phase|Early Termination|3|||
161389404|NCT02466425|582809951|FG000|Overall Study|Adverse Event|3|||
161389405|NCT02466425|582809952|FG001|Overall Study|Adverse Event|11|||
161389406|NCT02466425|582809951|FG000|Overall Study|Lack of Efficacy|4|||
161389407|NCT02466425|582809952|FG001|Overall Study|Lack of Efficacy|1|||
161389408|NCT02466425|582809951|FG000|Overall Study|Lost to Follow-up|3|||
161389409|NCT02466425|582809952|FG001|Overall Study|Lost to Follow-up|0|||
161389410|NCT02466425|582809951|FG000|Overall Study|Protocol Violation|1|||
161389411|NCT02466425|582809952|FG001|Overall Study|Protocol Violation|0|||
161389412|NCT02466425|582809951|FG000|Overall Study|Withdrawal by Subject|0|||
161389413|NCT02466425|582809952|FG001|Overall Study|Withdrawal by Subject|1|||
161389414|NCT02466425|582809951|FG000|Overall Study|Other|1|||
161389415|NCT02466425|582809952|FG001|Overall Study|Other|3|||
161389416|NCT02466425|582809951|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161389417|NCT02466425|582809952|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161389418|NCT02120300|582809953|FG000|Overall Study|Enrolled but Never Treated|2|||
161389419|NCT02120300|582809954|FG001|Overall Study|Enrolled but Never Treated|0|||
161389420|NCT02120300|582809955|FG002|Overall Study|Enrolled but Never Treated|0|||
161389421|NCT02120300|582809956|FG003|Overall Study|Enrolled but Never Treated|0|||
161389422|NCT02120300|582809953|FG000|Overall Study|Lack of Efficacy|0|||
161389423|NCT02120300|582809954|FG001|Overall Study|Lack of Efficacy|0|||
161389424|NCT02120300|582809955|FG002|Overall Study|Lack of Efficacy|0|||
161389425|NCT02120300|582809956|FG003|Overall Study|Lack of Efficacy|1|||
161389426|NCT02120300|582809953|FG000|Overall Study|Lost to Follow-up|1|||
161389427|NCT02120300|582809954|FG001|Overall Study|Lost to Follow-up|0|||
161389428|NCT02120300|582809955|FG002|Overall Study|Lost to Follow-up|0|||
161389429|NCT02120300|582809956|FG003|Overall Study|Lost to Follow-up|0|||
161389430|NCT01721486|582809965|FG000|Overall Study|Protocol Violation|1|||
161389431|NCT01721486|582809966|FG001|Overall Study|Protocol Violation|0|||
161389432|NCT01721486|582809965|FG000|Overall Study|Physician Decision|0|||
161389433|NCT01721486|582809966|FG001|Overall Study|Physician Decision|1|||
161389434|NCT05141175|582809973|FG000|Overall Study|Withdrawal by Subject|1|||
161389435|NCT02676895|582809977|FG000|Overall Study|Administrative reason|1|||
161389436|NCT02676895|582809978|FG001|Overall Study|Administrative reason|0|||
161389437|NCT02676895|582809979|FG002|Overall Study|Administrative reason|0|||
161389438|NCT02676895|582809977|FG000|Overall Study|Protocol Violation|1|||
161389439|NCT02676895|582809978|FG001|Overall Study|Protocol Violation|0|||
161389440|NCT02676895|582809979|FG002|Overall Study|Protocol Violation|0|||
161389441|NCT02676895|582809977|FG000|Overall Study|Adverse Event|0|||
161389442|NCT02676895|582809978|FG001|Overall Study|Adverse Event|3|||
161389443|NCT02676895|582809979|FG002|Overall Study|Adverse Event|1|||
161389444|NCT02676895|582809977|FG000|Overall Study|Lost to Follow-up|0|||
161389445|NCT02676895|582809978|FG001|Overall Study|Lost to Follow-up|0|||
161389446|NCT02676895|582809979|FG002|Overall Study|Lost to Follow-up|1|||
161389447|NCT02676895|582809977|FG000|Overall Study|Withdrawal by Subject|0|||
161389448|NCT02676895|582809978|FG001|Overall Study|Withdrawal by Subject|0|||
161389449|NCT02676895|582809979|FG002|Overall Study|Withdrawal by Subject|1|||
161389450|NCT01270880|582809980|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
161389451|NCT00344318|582809981|FG000|Overall Study|Adverse Event|0|||
161389452|NCT00344318|582809982|FG001|Overall Study|Adverse Event|3|||
161389453|NCT00344318|582809983|FG002|Overall Study|Adverse Event|0|||
161389454|NCT00344318|582809984|FG003|Overall Study|Adverse Event|1|||
161389455|NCT00344318|582809981|FG000|Overall Study|Withdrawal by Subject|2|||
161389456|NCT00344318|582809982|FG001|Overall Study|Withdrawal by Subject|2|||
161389457|NCT00344318|582809983|FG002|Overall Study|Withdrawal by Subject|0|||
161389458|NCT00344318|582809984|FG003|Overall Study|Withdrawal by Subject|2|||
161389459|NCT00344318|582809981|FG000|Overall Study|Lost to Follow-up|2|||
161389460|NCT00344318|582809982|FG001|Overall Study|Lost to Follow-up|0|||
161389461|NCT00344318|582809983|FG002|Overall Study|Lost to Follow-up|1|||
161389462|NCT00344318|582809984|FG003|Overall Study|Lost to Follow-up|0|||
161389463|NCT00182078|582809985|FG000|Overall Study|Withdrawal by Subject|1|||
161389464|NCT00182078|582809986|FG001|Overall Study|Withdrawal by Subject|0|||
161389465|NCT01076205|582809987|FG000|Overall Study|Adverse Drug Reaction|299|||
161389466|NCT01076205|582809987|FG000|Overall Study|Lack of Effectiveness|1423|||
161389467|NCT01076205|582809987|FG000|Overall Study|Other Reason|1075|||
161389468|NCT01076205|582809987|FG000|Overall Study|Unknown Reason|71|||
161389469|NCT01076205|582809987|FG000|Overall Study|Lost to Follow-up|3151|||
161389470|NCT00361231|582809988|FG000|Overall Study|Physician Decision|3|||
161389471|NCT00361231|582809988|FG000|Overall Study|Symptomatic deterioration|5|||
161389472|NCT00361231|582809988|FG000|Overall Study|Radiographic disease progression|16|||
161389473|NCT00361231|582809988|FG000|Overall Study|Withdrawal by Subject|4|||
161389474|NCT00361231|582809988|FG000|Overall Study|Adverse Event|6|||
161389475|NCT01732510|582809989|FG000|Overall Study|Adverse Event|0|||
161389476|NCT01732510|582809990|FG001|Overall Study|Adverse Event|1|||
161389477|NCT01732510|582809991|FG002|Overall Study|Adverse Event|1|||
161389478|NCT01732510|582809992|FG003|Overall Study|Adverse Event|0|||
161389479|NCT01732510|582809993|FG004|Overall Study|Adverse Event|0|||
161389480|NCT01732510|582809994|FG005|Overall Study|Adverse Event|0|||
161389481|NCT01732510|582809995|FG006|Overall Study|Adverse Event|1|||
161389482|NCT01732510|582809989|FG000|Overall Study|Protocol Violation|0|||
161389483|NCT01732510|582809990|FG001|Overall Study|Protocol Violation|0|||
161389484|NCT01732510|582809991|FG002|Overall Study|Protocol Violation|0|||
161389485|NCT01732510|582809992|FG003|Overall Study|Protocol Violation|1|||
161389486|NCT01732510|582809993|FG004|Overall Study|Protocol Violation|0|||
161389487|NCT01732510|582809994|FG005|Overall Study|Protocol Violation|0|||
161389488|NCT01732510|582809995|FG006|Overall Study|Protocol Violation|0|||
161389489|NCT01732510|582809989|FG000|Overall Study|Withdrawal by Subject|1|||
161389490|NCT01732510|582809990|FG001|Overall Study|Withdrawal by Subject|3|||
161389491|NCT01732510|582809991|FG002|Overall Study|Withdrawal by Subject|2|||
161389492|NCT01732510|582809992|FG003|Overall Study|Withdrawal by Subject|1|||
161389493|NCT01732510|582809993|FG004|Overall Study|Withdrawal by Subject|5|||
161389494|NCT01732510|582809994|FG005|Overall Study|Withdrawal by Subject|0|||
161389495|NCT01732510|582809995|FG006|Overall Study|Withdrawal by Subject|1|||
161389496|NCT01732510|582809989|FG000|Overall Study|Lost to Follow-up|0|||
161389497|NCT01732510|582809990|FG001|Overall Study|Lost to Follow-up|0|||
161389498|NCT01732510|582809991|FG002|Overall Study|Lost to Follow-up|1|||
161389499|NCT01732510|582809992|FG003|Overall Study|Lost to Follow-up|1|||
161389500|NCT01732510|582809993|FG004|Overall Study|Lost to Follow-up|0|||
161389501|NCT01732510|582809994|FG005|Overall Study|Lost to Follow-up|1|||
161389502|NCT01732510|582809995|FG006|Overall Study|Lost to Follow-up|0|||
161389503|NCT01732510|582809989|FG000|Overall Study|Physician Decision|0|||
161389504|NCT01732510|582809990|FG001|Overall Study|Physician Decision|1|||
161389505|NCT01732510|582809991|FG002|Overall Study|Physician Decision|0|||
161389506|NCT01732510|582809992|FG003|Overall Study|Physician Decision|0|||
161389507|NCT01732510|582809993|FG004|Overall Study|Physician Decision|0|||
161389508|NCT01732510|582809994|FG005|Overall Study|Physician Decision|0|||
161389509|NCT01732510|582809995|FG006|Overall Study|Physician Decision|0|||
161389510|NCT01732510|582809989|FG000|Overall Study|Pregnancy|0|||
161389511|NCT01732510|582809990|FG001|Overall Study|Pregnancy|0|||
161389512|NCT01732510|582809991|FG002|Overall Study|Pregnancy|0|||
161389513|NCT01732510|582809992|FG003|Overall Study|Pregnancy|1|||
161389514|NCT01732510|582809993|FG004|Overall Study|Pregnancy|0|||
161389515|NCT01732510|582809994|FG005|Overall Study|Pregnancy|0|||
161389516|NCT01732510|582809995|FG006|Overall Study|Pregnancy|0|||
161389517|NCT01732510|582809989|FG000|Overall Study|Study Terminated By Sponsor|0|||
161389518|NCT01732510|582809990|FG001|Overall Study|Study Terminated By Sponsor|0|||
161389519|NCT01732510|582809991|FG002|Overall Study|Study Terminated By Sponsor|0|||
161389520|NCT01732510|582809992|FG003|Overall Study|Study Terminated By Sponsor|1|||
161389521|NCT01732510|582809993|FG004|Overall Study|Study Terminated By Sponsor|0|||
161389522|NCT01732510|582809994|FG005|Overall Study|Study Terminated By Sponsor|12|||
161389523|NCT01732510|582809995|FG006|Overall Study|Study Terminated By Sponsor|6|||
161389524|NCT03403361|582809996|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
161389525|NCT02487654|582809998|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
161389526|NCT02487654|582809999|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
161389527|NCT02487654|582809998|FG000|Overall Study|Withdrawal by Subject|3|||
161389528|NCT02487654|582809999|FG001|Overall Study|Withdrawal by Subject|7|||
161389529|NCT02443116|582810002|FG000|Part 1|Adverse Event|2|||
161389530|NCT02443116|582810003|FG001|Part 1|Adverse Event|3|||
161389531|NCT02443116|582810004|FG002|Part 1|Adverse Event|0|||
161389532|NCT02443116|582810005|FG003|Part 1|Adverse Event|0|||
161389533|NCT02443116|582810006|FG004|Part 1|Adverse Event|0|||
161389534|NCT02443116|582810007|FG005|Part 1|Adverse Event|0|||
161389535|NCT02443116|582810008|FG006|Part 1|Adverse Event|0|||
161389536|NCT02443116|582810009|FG007|Part 1|Adverse Event|0|||
161389537|NCT02443116|582810010|FG008|Part 1|Adverse Event|0|||
161389538|NCT02443116|582810002|FG000|Part 1|Withdrew informed consent|0|||
161389539|NCT02443116|582810003|FG001|Part 1|Withdrew informed consent|1|||
161389540|NCT02443116|582810004|FG002|Part 1|Withdrew informed consent|0|||
161389541|NCT02443116|582810005|FG003|Part 1|Withdrew informed consent|0|||
161389542|NCT02443116|582810006|FG004|Part 1|Withdrew informed consent|0|||
161389543|NCT02443116|582810007|FG005|Part 1|Withdrew informed consent|0|||
161389544|NCT02443116|582810008|FG006|Part 1|Withdrew informed consent|0|||
161389545|NCT02443116|582810009|FG007|Part 1|Withdrew informed consent|0|||
161389546|NCT02443116|582810010|FG008|Part 1|Withdrew informed consent|0|||
161389547|NCT02443116|582810002|FG000|Part 1|Lost to Follow-up|0|||
161389548|NCT02443116|582810003|FG001|Part 1|Lost to Follow-up|0|||
161389549|NCT02443116|582810004|FG002|Part 1|Lost to Follow-up|2|||
161389550|NCT02443116|582810005|FG003|Part 1|Lost to Follow-up|0|||
161389551|NCT02443116|582810006|FG004|Part 1|Lost to Follow-up|0|||
161389552|NCT02443116|582810007|FG005|Part 1|Lost to Follow-up|0|||
161389553|NCT02443116|582810008|FG006|Part 1|Lost to Follow-up|0|||
161389554|NCT02443116|582810009|FG007|Part 1|Lost to Follow-up|0|||
161389555|NCT02443116|582810010|FG008|Part 1|Lost to Follow-up|0|||
161389556|NCT02443116|582810002|FG000|Part 1|Participant moved out of state|0|||
161389557|NCT02443116|582810003|FG001|Part 1|Participant moved out of state|0|||
161389558|NCT02443116|582810004|FG002|Part 1|Participant moved out of state|1|||
161389559|NCT02443116|582810005|FG003|Part 1|Participant moved out of state|0|||
161389560|NCT02443116|582810006|FG004|Part 1|Participant moved out of state|0|||
161389561|NCT02443116|582810007|FG005|Part 1|Participant moved out of state|0|||
161389562|NCT02443116|582810008|FG006|Part 1|Participant moved out of state|0|||
161389563|NCT02443116|582810009|FG007|Part 1|Participant moved out of state|0|||
161389564|NCT02443116|582810010|FG008|Part 1|Participant moved out of state|0|||
161389565|NCT02443116|582810002|FG000|Part 1|Participant enrolled in another clinical trial|0|||
161389566|NCT02443116|582810003|FG001|Part 1|Participant enrolled in another clinical trial|0|||
161389567|NCT02443116|582810004|FG002|Part 1|Participant enrolled in another clinical trial|1|||
161389568|NCT02443116|582810005|FG003|Part 1|Participant enrolled in another clinical trial|0|||
161389569|NCT02443116|582810006|FG004|Part 1|Participant enrolled in another clinical trial|0|||
161389570|NCT02443116|582810007|FG005|Part 1|Participant enrolled in another clinical trial|0|||
161389571|NCT02443116|582810008|FG006|Part 1|Participant enrolled in another clinical trial|0|||
161389572|NCT02443116|582810009|FG007|Part 1|Participant enrolled in another clinical trial|0|||
161389573|NCT02443116|582810010|FG008|Part 1|Participant enrolled in another clinical trial|0|||
161389574|NCT02443116|582810002|FG000|Part 2|Adverse Event|0|||
161389575|NCT02443116|582810003|FG001|Part 2|Adverse Event|0|||
161389576|NCT02443116|582810004|FG002|Part 2|Adverse Event|0|||
161389577|NCT02443116|582810005|FG003|Part 2|Adverse Event|0|||
161389578|NCT02443116|582810006|FG004|Part 2|Adverse Event|1|||
161389579|NCT02443116|582810007|FG005|Part 2|Adverse Event|1|||
161389580|NCT02443116|582810008|FG006|Part 2|Adverse Event|2|||
161389581|NCT02443116|582810009|FG007|Part 2|Adverse Event|0|||
161389582|NCT02443116|582810010|FG008|Part 2|Adverse Event|0|||
161389583|NCT02443116|582810002|FG000|Part 2|Withdrew informed consent|0|||
161389584|NCT02443116|582810003|FG001|Part 2|Withdrew informed consent|0|||
161389585|NCT02443116|582810004|FG002|Part 2|Withdrew informed consent|0|||
161389586|NCT02443116|582810005|FG003|Part 2|Withdrew informed consent|0|||
161389587|NCT02443116|582810006|FG004|Part 2|Withdrew informed consent|0|||
161389588|NCT02443116|582810007|FG005|Part 2|Withdrew informed consent|1|||
161389589|NCT02443116|582810008|FG006|Part 2|Withdrew informed consent|1|||
161389590|NCT02443116|582810009|FG007|Part 2|Withdrew informed consent|0|||
161389591|NCT02443116|582810010|FG008|Part 2|Withdrew informed consent|0|||
161389592|NCT02443116|582810002|FG000|Part 2|Inability to comply with protocol|0|||
161389593|NCT02443116|582810003|FG001|Part 2|Inability to comply with protocol|0|||
161389594|NCT02443116|582810004|FG002|Part 2|Inability to comply with protocol|0|||
161389595|NCT02443116|582810005|FG003|Part 2|Inability to comply with protocol|1|||
161389596|NCT02443116|582810006|FG004|Part 2|Inability to comply with protocol|0|||
161389597|NCT02443116|582810007|FG005|Part 2|Inability to comply with protocol|0|||
161389598|NCT02443116|582810008|FG006|Part 2|Inability to comply with protocol|0|||
161389599|NCT02443116|582810009|FG007|Part 2|Inability to comply with protocol|0|||
161389600|NCT02443116|582810010|FG008|Part 2|Inability to comply with protocol|0|||
161389601|NCT02443116|582810002|FG000|Part 2|Lost to Follow-up|0|||
161389602|NCT02443116|582810003|FG001|Part 2|Lost to Follow-up|0|||
161389603|NCT02443116|582810004|FG002|Part 2|Lost to Follow-up|0|||
161389604|NCT02443116|582810005|FG003|Part 2|Lost to Follow-up|1|||
161389605|NCT02443116|582810006|FG004|Part 2|Lost to Follow-up|0|||
161389606|NCT02443116|582810007|FG005|Part 2|Lost to Follow-up|0|||
161389607|NCT02443116|582810008|FG006|Part 2|Lost to Follow-up|0|||
161389608|NCT02443116|582810009|FG007|Part 2|Lost to Follow-up|0|||
161389609|NCT02443116|582810010|FG008|Part 2|Lost to Follow-up|0|||
161389610|NCT02443116|582810002|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389611|NCT02443116|582810003|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389612|NCT02443116|582810004|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389613|NCT02443116|582810005|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389614|NCT02443116|582810006|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389615|NCT02443116|582810007|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
161389616|NCT02443116|582810008|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389617|NCT02443116|582810009|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389618|NCT02443116|582810010|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161389619|NCT02443116|582810002|FG000|Part 3|Adverse Event|0|||
161389620|NCT02443116|582810003|FG001|Part 3|Adverse Event|0|||
161389621|NCT02443116|582810004|FG002|Part 3|Adverse Event|0|||
161389622|NCT02443116|582810005|FG003|Part 3|Adverse Event|0|||
161389623|NCT02443116|582810006|FG004|Part 3|Adverse Event|0|||
161389624|NCT02443116|582810007|FG005|Part 3|Adverse Event|0|||
161389625|NCT02443116|582810008|FG006|Part 3|Adverse Event|0|||
161389626|NCT02443116|582810009|FG007|Part 3|Adverse Event|0|||
161389627|NCT02443116|582810010|FG008|Part 3|Adverse Event|1|||
161389628|NCT02443116|582810002|FG000|Part 3|Withdrew informed consent|0|||
161389629|NCT02443116|582810003|FG001|Part 3|Withdrew informed consent|0|||
161389630|NCT02443116|582810004|FG002|Part 3|Withdrew informed consent|0|||
161389631|NCT02443116|582810005|FG003|Part 3|Withdrew informed consent|0|||
161389632|NCT02443116|582810006|FG004|Part 3|Withdrew informed consent|0|||
161389633|NCT02443116|582810007|FG005|Part 3|Withdrew informed consent|0|||
161389634|NCT02443116|582810008|FG006|Part 3|Withdrew informed consent|0|||
161389635|NCT02443116|582810009|FG007|Part 3|Withdrew informed consent|3|||
161389636|NCT02443116|582810010|FG008|Part 3|Withdrew informed consent|2|||
161389637|NCT02443116|582810002|FG000|Part 3|Lost to Follow-up|0|||
161389638|NCT02443116|582810003|FG001|Part 3|Lost to Follow-up|0|||
161389639|NCT02443116|582810004|FG002|Part 3|Lost to Follow-up|0|||
161389640|NCT02443116|582810005|FG003|Part 3|Lost to Follow-up|0|||
161389641|NCT02443116|582810006|FG004|Part 3|Lost to Follow-up|0|||
161389642|NCT02443116|582810007|FG005|Part 3|Lost to Follow-up|0|||
161389643|NCT02443116|582810008|FG006|Part 3|Lost to Follow-up|0|||
161389644|NCT02443116|582810009|FG007|Part 3|Lost to Follow-up|1|||
161389645|NCT02443116|582810010|FG008|Part 3|Lost to Follow-up|2|||
161389646|NCT00349349|582810018|FG000|Overall Study|Adverse Event|5|||
161389647|NCT00349349|582810019|FG001|Overall Study|Adverse Event|6|||
161389648|NCT00349349|582810020|FG002|Overall Study|Adverse Event|2|||
161389649|NCT00349349|582810018|FG000|Overall Study|Withdrawal by Subject|5|||
161389650|NCT00349349|582810019|FG001|Overall Study|Withdrawal by Subject|2|||
161389651|NCT00349349|582810020|FG002|Overall Study|Withdrawal by Subject|1|||
161389652|NCT00349349|582810018|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
161389653|NCT00349349|582810019|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
161389654|NCT00349349|582810020|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
161389655|NCT00349349|582810018|FG000|Overall Study|Death|13|||
161389656|NCT00349349|582810019|FG001|Overall Study|Death|10|||
161389657|NCT00349349|582810020|FG002|Overall Study|Death|1|||
161389658|NCT00349349|582810018|FG000|Overall Study|Other Treatment Selected|2|||
161389659|NCT00349349|582810019|FG001|Overall Study|Other Treatment Selected|0|||
161389660|NCT00349349|582810020|FG002|Overall Study|Other Treatment Selected|0|||
161389661|NCT00349349|582810018|FG000|Overall Study|Participant Reduced General Condition|0|||
161389662|NCT00349349|582810019|FG001|Overall Study|Participant Reduced General Condition|1|||
161389663|NCT00349349|582810020|FG002|Overall Study|Participant Reduced General Condition|0|||
161389664|NCT00349349|582810018|FG000|Overall Study|Physician Decision|1|||
161389665|NCT00349349|582810019|FG001|Overall Study|Physician Decision|2|||
161389666|NCT00349349|582810020|FG002|Overall Study|Physician Decision|1|||
161389667|NCT00349349|582810018|FG000|Overall Study|No Response|0|||
161389668|NCT00349349|582810019|FG001|Overall Study|No Response|3|||
161389669|NCT00349349|582810020|FG002|Overall Study|No Response|0|||
161389670|NCT00349349|582810018|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
161389671|NCT00349349|582810019|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
161389672|NCT00349349|582810020|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
161389673|NCT03763656|582810021|FG000|Overall Study|Physician Decision|1|||
161389674|NCT03763656|582810021|FG000|Overall Study|Protocol Violation|1|||
161389675|NCT03763656|582810021|FG000|Overall Study|Withdrawal by Subject|7|||
161389676|NCT03479541|582810022|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
161389677|NCT03479541|582810023|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
161389678|NCT03479541|582810024|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
161389679|NCT03479541|582810025|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
161389680|NCT03479541|582810022|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
161389681|NCT03479541|582810023|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
161389682|NCT03479541|582810024|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
161389683|NCT03479541|582810025|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
161389684|NCT03479541|582810022|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
161389685|NCT03479541|582810023|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
161389686|NCT03479541|582810024|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
161389687|NCT03479541|582810025|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
161389688|NCT03479541|582810022|FG000|Home Monitoring|Lost to Follow-up|0|||
161389689|NCT03479541|582810023|FG001|Home Monitoring|Lost to Follow-up|0|||
161389690|NCT03479541|582810024|FG002|Home Monitoring|Lost to Follow-up|8|||
161389691|NCT03479541|582810025|FG003|Home Monitoring|Lost to Follow-up|12|||
161389692|NCT03479541|582810022|FG000|Home Monitoring|Withdrawal by Subject|0|||
161389693|NCT03479541|582810023|FG001|Home Monitoring|Withdrawal by Subject|0|||
161389694|NCT03479541|582810024|FG002|Home Monitoring|Withdrawal by Subject|17|||
161389695|NCT03479541|582810025|FG003|Home Monitoring|Withdrawal by Subject|30|||
161389696|NCT03479541|582810022|FG000|Home Monitoring|Early Termination - PI Decision|0|||
161389697|NCT03479541|582810023|FG001|Home Monitoring|Early Termination - PI Decision|0|||
161389698|NCT03479541|582810024|FG002|Home Monitoring|Early Termination - PI Decision|4|||
161389699|NCT03479541|582810025|FG003|Home Monitoring|Early Termination - PI Decision|6|||
161389700|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
161389701|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
161389702|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
161389703|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
161389704|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
161389705|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
161389706|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
161389707|NCT01673854|582810027|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
161389708|NCT01673854|582810027|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
161389709|NCT01673854|582810027|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
161389710|NCT01673854|582810027|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
161389711|NCT01673854|582810027|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
161389712|NCT00334737|582810028|FG000|Hospital Phase|Death|1|||
161389713|NCT00334737|582810029|FG001|Hospital Phase|Death|2|||
161389714|NCT00334737|582810030|FG002|Hospital Phase|Death|3|||
161389715|NCT00334737|582810028|FG000|Hospital Phase|Withdrawal by Subject|0|||
161389716|NCT00334737|582810029|FG001|Hospital Phase|Withdrawal by Subject|0|||
161389717|NCT00334737|582810030|FG002|Hospital Phase|Withdrawal by Subject|1|||
161389718|NCT00334737|582810028|FG000|Hospital Phase|Did not receive study drug|1|||
161389719|NCT00334737|582810029|FG001|Hospital Phase|Did not receive study drug|0|||
161389720|NCT00334737|582810030|FG002|Hospital Phase|Did not receive study drug|0|||
161389721|NCT00334737|582810028|FG000|Follow up Phase|Lost to Follow-up|5|||
161389722|NCT00334737|582810029|FG001|Follow up Phase|Lost to Follow-up|3|||
161389723|NCT00334737|582810030|FG002|Follow up Phase|Lost to Follow-up|6|||
161389724|NCT02316353|582810031|FG000|Overall Study|Pregnancy|1|||
161389725|NCT02316353|582810032|FG001|Overall Study|Pregnancy|3|||
161389726|NCT02316353|582810031|FG000|Overall Study|Adverse Event|1|||
161389727|NCT02316353|582810032|FG001|Overall Study|Adverse Event|3|||
161389728|NCT02316353|582810031|FG000|Overall Study|Withdrawal by Subject|6|||
161389729|NCT02316353|582810032|FG001|Overall Study|Withdrawal by Subject|2|||
161389730|NCT01579565|582811816|FG000|Randomized|Adverse Event|1|||
161389731|NCT01579565|582811817|FG001|Randomized|Adverse Event|3|||
161389732|NCT01579565|582811816|FG000|Randomized|Withdrawal by Subject|3|||
161389733|NCT01579565|582811817|FG001|Randomized|Withdrawal by Subject|0|||
161389734|NCT01579565|582811816|FG000|Randomized|inadequate preoperative pupil dilation|0|||
161389735|NCT01579565|582811817|FG001|Randomized|inadequate preoperative pupil dilation|1|||
161389736|NCT01579565|582811816|FG000|Randomized|prohibited preoperative eating|1|||
161389737|NCT01579565|582811817|FG001|Randomized|prohibited preoperative eating|0|||
161389738|NCT01579565|582811816|FG000|Randomized|prohibited preoperative medication|0|||
161389739|NCT01579565|582811817|FG001|Randomized|prohibited preoperative medication|1|||
161389740|NCT01579565|582811816|FG000|Treated|Physician Decision|0|||
161389741|NCT01579565|582811817|FG001|Treated|Physician Decision|1|||
161389742|NCT01579565|582811816|FG000|Treated|Lost to Follow-up|2|||
161389743|NCT01579565|582811817|FG001|Treated|Lost to Follow-up|1|||
161389744|NCT01579565|582811816|FG000|Treated|declined to return for final visit|0|||
161389745|NCT01579565|582811817|FG001|Treated|declined to return for final visit|1|||
161389746|NCT01380535|582811818|FG000|Overall Study|Adverse Event|3|||
161389747|NCT01380535|582811819|FG001|Overall Study|Adverse Event|3|||
161389748|NCT01380535|582811818|FG000|Overall Study|Death|3|||
161389749|NCT01380535|582811819|FG001|Overall Study|Death|0|||
161389750|NCT01380535|582811818|FG000|Overall Study|Study site closed|0|||
161389751|NCT01380535|582811819|FG001|Overall Study|Study site closed|5|||
161389752|NCT01380535|582811818|FG000|Overall Study|Withdrawal by Subject|1|||
161389753|NCT01380535|582811819|FG001|Overall Study|Withdrawal by Subject|2|||
161389754|NCT01380535|582811818|FG000|Overall Study|Protocol Violation|0|||
161389755|NCT01380535|582811819|FG001|Overall Study|Protocol Violation|2|||
161389756|NCT01380535|582811818|FG000|Overall Study|Lack of Efficacy|0|||
161389757|NCT01380535|582811819|FG001|Overall Study|Lack of Efficacy|3|||
161389758|NCT05425732|582811825|FG000|Overall Study|Death|4|||
161389759|NCT05425732|582811826|FG001|Overall Study|Death|2|||
161389760|NCT05425732|582811827|FG002|Overall Study|Death|0|||
161389761|NCT05425732|582811828|FG003|Overall Study|Death|0|||
161389762|NCT05425732|582811825|FG000|Overall Study|Lost to Follow-up|10|||
161389763|NCT05425732|582811826|FG001|Overall Study|Lost to Follow-up|15|||
161389764|NCT05425732|582811827|FG002|Overall Study|Lost to Follow-up|5|||
161389765|NCT05425732|582811828|FG003|Overall Study|Lost to Follow-up|3|||
161389766|NCT05425732|582811825|FG000|Overall Study|Physician Decision|0|||
161389767|NCT05425732|582811826|FG001|Overall Study|Physician Decision|2|||
161389768|NCT05425732|582811827|FG002|Overall Study|Physician Decision|0|||
161389769|NCT05425732|582811828|FG003|Overall Study|Physician Decision|0|||
161389770|NCT05425732|582811825|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161389771|NCT05425732|582811826|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161389772|NCT05425732|582811827|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161389773|NCT05425732|582811828|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161389774|NCT05425732|582811825|FG000|Overall Study|Withdrawal by Subject|4|||
161389775|NCT05425732|582811826|FG001|Overall Study|Withdrawal by Subject|8|||
161389776|NCT05425732|582811827|FG002|Overall Study|Withdrawal by Subject|1|||
161389777|NCT05425732|582811828|FG003|Overall Study|Withdrawal by Subject|1|||
161389778|NCT05425732|582811825|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
161389779|NCT05425732|582811826|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
161389780|NCT05425732|582811827|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
161389781|NCT05425732|582811828|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
161389782|NCT02582814|582811829|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161389783|NCT02582814|582811830|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161389784|NCT02582814|582811829|FG000|Overall Study|Withdrawal by Subject|4|||
161389785|NCT02582814|582811830|FG001|Overall Study|Withdrawal by Subject|3|||
161389786|NCT02582814|582811829|FG000|Overall Study|Adverse Event|4|||
161389787|NCT02582814|582811830|FG001|Overall Study|Adverse Event|4|||
161389788|NCT00306293|582811831|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
161389789|NCT00306293|582811832|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
161389790|NCT00306293|582811831|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
161389791|NCT00306293|582811832|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
161389792|NCT00306293|582811831|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
161389793|NCT00306293|582811832|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
161389794|NCT00306293|582811831|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
161389795|NCT00306293|582811832|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
161389796|NCT00306293|582811831|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
161389797|NCT00306293|582811832|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
161389798|NCT00306293|582811831|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
161389799|NCT00306293|582811832|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
161389800|NCT00306293|582811831|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
161389801|NCT00306293|582811832|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
161389802|NCT00306293|582811831|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
161389803|NCT00306293|582811832|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
161389804|NCT02242435|582811833|FG000|Overall Study|Lost to Follow-up|3|||
161389805|NCT02242435|582811834|FG001|Overall Study|Lost to Follow-up|4|||
161389806|NCT02242435|582811833|FG000|Overall Study|Adverse Event|3|||
161389807|NCT02242435|582811834|FG001|Overall Study|Adverse Event|2|||
161389808|NCT02242435|582811833|FG000|Overall Study|Withdrawal by Subject|13|||
161389809|NCT02242435|582811834|FG001|Overall Study|Withdrawal by Subject|8|||
161389810|NCT02242435|582811833|FG000|Overall Study|Death|0|||
161389811|NCT02242435|582811834|FG001|Overall Study|Death|1|||
161389812|NCT02242435|582811833|FG000|Overall Study|Protocol Violation|1|||
161389813|NCT02242435|582811834|FG001|Overall Study|Protocol Violation|0|||
161389814|NCT02242435|582811833|FG000|Overall Study|Physician Decision|0|||
161389815|NCT02242435|582811834|FG001|Overall Study|Physician Decision|1|||
161389816|NCT00510718|582811843|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
161389817|NCT00510718|582811844|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
161389818|NCT00510718|582811843|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
161389819|NCT00510718|582811844|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
161389820|NCT00510718|582811843|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
161389821|NCT00510718|582811844|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
161389822|NCT00510718|582811843|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
161389823|NCT00510718|582811844|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
161389824|NCT00510718|582811843|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
161389825|NCT00510718|582811844|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
161389826|NCT00510718|582811843|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
161389827|NCT00510718|582811844|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
161389828|NCT01089413|582811850|FG000|Overall Study|Lost to Follow-up|1|||
161389829|NCT01089413|582811850|FG000|Overall Study|Progressive Disease|93|||
161389830|NCT01089413|582811850|FG000|Overall Study|Participant Withdrew Consent|1|||
161389831|NCT01089413|582811850|FG000|Overall Study|Unacceptable Toxicity|12|||
161389832|NCT01089413|582811850|FG000|Overall Study|Death|10|||
161389833|NCT01089413|582811850|FG000|Overall Study|Metastasectomy|13|||
161389834|NCT01089413|582811850|FG000|Overall Study|Other|71|||
161389835|NCT01610557|582811857|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161389836|NCT01610557|582811858|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
161389837|NCT01610557|582811859|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161389838|NCT01610557|582811860|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161389839|NCT01610557|582811861|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161389840|NCT01610557|582811857|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161389841|NCT01610557|582811858|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161389842|NCT01610557|582811859|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161389843|NCT01610557|582811860|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161389844|NCT01610557|582811861|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
161389845|NCT01200407|582811864|FG000|Overall Study|Lost to Follow-up|56|||
161389846|NCT01200407|582811864|FG000|Overall Study|Adverse Event|3|||
161389847|NCT01200407|582811864|FG000|Overall Study|Withdrawal by Subject|4|||
161389848|NCT01200407|582811864|FG000|Overall Study|Other|19|||
161389849|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
161389850|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
161389851|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
161389852|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
161389853|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161389854|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161389855|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
161389856|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
161389857|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
161389858|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
161389859|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
161389860|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
161389861|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
161389862|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
161389863|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
161389864|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
161389865|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
161389866|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389867|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389868|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389869|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389870|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389871|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389872|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389873|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389874|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389875|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389876|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389877|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389878|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161389879|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
161389880|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
161389881|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
161389882|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
161389883|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
161389884|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
161389885|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
161389886|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
161389887|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
161389888|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
161389889|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
161389890|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
161389891|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
161389892|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
161389893|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
161389894|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
161389895|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
161389896|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
161389897|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
161389898|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
161389899|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
161389900|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
161389901|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
161389902|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
161389903|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
161389904|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
161389905|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
161389906|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
161389907|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
161389908|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
161389909|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
161389910|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
161389911|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
161389912|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
161389913|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389914|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389915|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389916|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389917|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389918|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389919|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389920|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389921|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389922|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389923|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161389924|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
161389925|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
161389926|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
161389927|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
161389928|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389929|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389930|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389931|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389932|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389933|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389934|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389935|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389936|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389937|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389938|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161389939|NCT03831191|582811869|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389940|NCT03831191|582811870|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389941|NCT03831191|582811871|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389942|NCT03831191|582811872|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
161389943|NCT03831191|582811873|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389944|NCT03831191|582811874|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389945|NCT03831191|582811875|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389946|NCT03831191|582811876|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389947|NCT03831191|582811877|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389948|NCT03831191|582811878|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389949|NCT03831191|582811879|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389950|NCT03831191|582811880|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389951|NCT03831191|582811881|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389952|NCT03831191|582811882|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389953|NCT03831191|582811883|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
161389954|NCT03831191|582811869|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161389955|NCT03831191|582811870|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161389956|NCT03831191|582811871|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161389957|NCT03831191|582811872|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161389958|NCT03831191|582811873|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
161389959|NCT03831191|582811874|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
161389960|NCT03831191|582811875|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
161389961|NCT03831191|582811876|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
161389962|NCT03831191|582811877|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
161389963|NCT03831191|582811878|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
161389964|NCT03831191|582811879|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
161389965|NCT03831191|582811880|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
161389966|NCT03831191|582811881|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
161389967|NCT03831191|582811882|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
161389968|NCT03831191|582811883|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
161389969|NCT03831191|582811869|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389970|NCT03831191|582811870|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389971|NCT03831191|582811871|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389972|NCT03831191|582811872|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389973|NCT03831191|582811873|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389974|NCT03831191|582811874|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389975|NCT03831191|582811875|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389976|NCT03831191|582811876|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389977|NCT03831191|582811877|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389978|NCT03831191|582811878|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389979|NCT03831191|582811879|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389980|NCT03831191|582811880|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389981|NCT03831191|582811881|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389982|NCT03831191|582811882|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161389983|NCT03831191|582811883|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161389984|NCT03831191|582811869|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389985|NCT03831191|582811870|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389986|NCT03831191|582811871|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389987|NCT03831191|582811872|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389988|NCT03831191|582811873|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389989|NCT03831191|582811874|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389990|NCT03831191|582811875|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389991|NCT03831191|582811876|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389992|NCT03831191|582811877|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389993|NCT03831191|582811878|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389994|NCT03831191|582811879|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389995|NCT03831191|582811880|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389996|NCT03831191|582811881|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389997|NCT03831191|582811882|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161389998|NCT03831191|582811883|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
161389999|NCT01864148|582811884|FG000|Overall Study|Other|2|||
161390000|NCT01864148|582811885|FG001|Overall Study|Other|1|||
161390001|NCT01864148|582811886|FG002|Overall Study|Other|1|||
161390002|NCT01864148|582811887|FG003|Overall Study|Other|3|||
161390003|NCT01864148|582811888|FG004|Overall Study|Other|1|||
161390004|NCT01864148|582811884|FG000|Overall Study|Death|0|||
161390005|NCT01864148|582811885|FG001|Overall Study|Death|0|||
161390006|NCT01864148|582811886|FG002|Overall Study|Death|0|||
161390007|NCT01864148|582811887|FG003|Overall Study|Death|1|||
161390008|NCT01864148|582811888|FG004|Overall Study|Death|0|||
161390009|NCT01864148|582811884|FG000|Overall Study|Investigator Decision|5|||
161390010|NCT01864148|582811885|FG001|Overall Study|Investigator Decision|0|||
161390011|NCT01864148|582811886|FG002|Overall Study|Investigator Decision|0|||
161390012|NCT01864148|582811887|FG003|Overall Study|Investigator Decision|4|||
161390013|NCT01864148|582811888|FG004|Overall Study|Investigator Decision|6|||
161390014|NCT01864148|582811884|FG000|Overall Study|Withdrawal by Subject|9|||
161390015|NCT01864148|582811885|FG001|Overall Study|Withdrawal by Subject|2|||
161390016|NCT01864148|582811886|FG002|Overall Study|Withdrawal by Subject|6|||
161390017|NCT01864148|582811887|FG003|Overall Study|Withdrawal by Subject|8|||
161390018|NCT01864148|582811888|FG004|Overall Study|Withdrawal by Subject|8|||
161390019|NCT01864148|582811884|FG000|Overall Study|Lost to Follow-up|0|||
161390020|NCT01864148|582811885|FG001|Overall Study|Lost to Follow-up|0|||
161390021|NCT01864148|582811886|FG002|Overall Study|Lost to Follow-up|0|||
161390022|NCT01864148|582811887|FG003|Overall Study|Lost to Follow-up|2|||
161390023|NCT01864148|582811888|FG004|Overall Study|Lost to Follow-up|1|||
161390024|NCT01864148|582811884|FG000|Overall Study|Adverse Event|4|||
161390025|NCT01864148|582811885|FG001|Overall Study|Adverse Event|2|||
161390026|NCT01864148|582811886|FG002|Overall Study|Adverse Event|4|||
161390027|NCT01864148|582811887|FG003|Overall Study|Adverse Event|7|||
161390028|NCT01864148|582811888|FG004|Overall Study|Adverse Event|7|||
161390029|NCT01864148|582811884|FG000|Overall Study|Not Dosed|0|||
161390030|NCT01864148|582811885|FG001|Overall Study|Not Dosed|0|||
161390031|NCT01864148|582811886|FG002|Overall Study|Not Dosed|0|||
161390032|NCT01864148|582811887|FG003|Overall Study|Not Dosed|1|||
161390033|NCT01864148|582811888|FG004|Overall Study|Not Dosed|0|||
161390034|NCT06003777|582811889|FG000|Period 1|Adverse Event|0|||
161390035|NCT06003777|582811890|FG001|Period 1|Adverse Event|0|||
161390036|NCT06003777|582811891|FG002|Period 1|Adverse Event|1|||
161390037|NCT06003777|582811892|FG003|Period 1|Adverse Event|0|||
161390038|NCT06003777|582811893|FG004|Period 1|Adverse Event|0|||
161390039|NCT06003777|582811894|FG005|Period 1|Adverse Event|0|||
161390040|NCT06003777|582811895|FG006|Period 1|Adverse Event|0|||
161390041|NCT06003777|582811896|FG007|Period 1|Adverse Event|0|||
161390042|NCT06003777|582811897|FG008|Period 1|Adverse Event|0|||
161390043|NCT06003777|582811898|FG009|Period 1|Adverse Event|0|||
161390044|NCT06003777|582811899|FG010|Period 1|Adverse Event|0|||
161390045|NCT06003777|582811900|FG011|Period 1|Adverse Event|0|||
161390046|NCT06003777|582811889|FG000|Period 1|Withdrawal by Subject|0|||
161390047|NCT06003777|582811890|FG001|Period 1|Withdrawal by Subject|0|||
161390048|NCT06003777|582811891|FG002|Period 1|Withdrawal by Subject|0|||
161390049|NCT06003777|582811892|FG003|Period 1|Withdrawal by Subject|0|||
161390050|NCT06003777|582811893|FG004|Period 1|Withdrawal by Subject|1|||
161390051|NCT06003777|582811894|FG005|Period 1|Withdrawal by Subject|0|||
161390052|NCT06003777|582811895|FG006|Period 1|Withdrawal by Subject|0|||
161390053|NCT06003777|582811896|FG007|Period 1|Withdrawal by Subject|0|||
161390054|NCT06003777|582811897|FG008|Period 1|Withdrawal by Subject|0|||
161390055|NCT06003777|582811898|FG009|Period 1|Withdrawal by Subject|0|||
161390056|NCT06003777|582811899|FG010|Period 1|Withdrawal by Subject|0|||
161390057|NCT06003777|582811900|FG011|Period 1|Withdrawal by Subject|0|||
161390058|NCT06003777|582811889|FG000|Period 2|Withdrawal by Subject|0|||
161390059|NCT06003777|582811890|FG001|Period 2|Withdrawal by Subject|0|||
161390060|NCT06003777|582811891|FG002|Period 2|Withdrawal by Subject|0|||
161390061|NCT06003777|582811892|FG003|Period 2|Withdrawal by Subject|0|||
161390062|NCT06003777|582811893|FG004|Period 2|Withdrawal by Subject|0|||
161390063|NCT06003777|582811894|FG005|Period 2|Withdrawal by Subject|0|||
161390064|NCT06003777|582811895|FG006|Period 2|Withdrawal by Subject|0|||
161390065|NCT06003777|582811896|FG007|Period 2|Withdrawal by Subject|0|||
161390066|NCT06003777|582811897|FG008|Period 2|Withdrawal by Subject|1|||
161390067|NCT06003777|582811898|FG009|Period 2|Withdrawal by Subject|0|||
161390068|NCT06003777|582811899|FG010|Period 2|Withdrawal by Subject|0|||
161390069|NCT06003777|582811900|FG011|Period 2|Withdrawal by Subject|0|||
161390070|NCT06003777|582811889|FG000|Period 3|Adverse Event|0|||
161390071|NCT06003777|582811890|FG001|Period 3|Adverse Event|0|||
161390072|NCT06003777|582811891|FG002|Period 3|Adverse Event|0|||
161390073|NCT06003777|582811892|FG003|Period 3|Adverse Event|0|||
161390074|NCT06003777|582811893|FG004|Period 3|Adverse Event|0|||
161390075|NCT06003777|582811894|FG005|Period 3|Adverse Event|0|||
161390076|NCT06003777|582811895|FG006|Period 3|Adverse Event|1|||
161390077|NCT06003777|582811896|FG007|Period 3|Adverse Event|0|||
161390078|NCT06003777|582811897|FG008|Period 3|Adverse Event|0|||
161390079|NCT06003777|582811898|FG009|Period 3|Adverse Event|0|||
161390080|NCT06003777|582811899|FG010|Period 3|Adverse Event|0|||
161390081|NCT06003777|582811900|FG011|Period 3|Adverse Event|0|||
161390082|NCT06003777|582811889|FG000|Period 4|No longer met eligibility criteria|0|||
161390083|NCT06003777|582811890|FG001|Period 4|No longer met eligibility criteria|0|||
161390084|NCT06003777|582811891|FG002|Period 4|No longer met eligibility criteria|1|||
161390085|NCT06003777|582811892|FG003|Period 4|No longer met eligibility criteria|0|||
161390086|NCT06003777|582811893|FG004|Period 4|No longer met eligibility criteria|0|||
161390087|NCT06003777|582811894|FG005|Period 4|No longer met eligibility criteria|0|||
161390088|NCT06003777|582811895|FG006|Period 4|No longer met eligibility criteria|0|||
161390089|NCT06003777|582811896|FG007|Period 4|No longer met eligibility criteria|0|||
161390090|NCT06003777|582811897|FG008|Period 4|No longer met eligibility criteria|0|||
161390091|NCT06003777|582811898|FG009|Period 4|No longer met eligibility criteria|0|||
161390092|NCT06003777|582811899|FG010|Period 4|No longer met eligibility criteria|0|||
161390093|NCT06003777|582811900|FG011|Period 4|No longer met eligibility criteria|0|||
161390094|NCT06003777|582811889|FG000|Period 4|Withdrawal by Subject|0|||
161390095|NCT06003777|582811890|FG001|Period 4|Withdrawal by Subject|1|||
161390096|NCT06003777|582811891|FG002|Period 4|Withdrawal by Subject|0|||
161390097|NCT06003777|582811892|FG003|Period 4|Withdrawal by Subject|0|||
161390098|NCT06003777|582811893|FG004|Period 4|Withdrawal by Subject|0|||
161390099|NCT06003777|582811894|FG005|Period 4|Withdrawal by Subject|0|||
161390100|NCT06003777|582811895|FG006|Period 4|Withdrawal by Subject|0|||
161390101|NCT06003777|582811896|FG007|Period 4|Withdrawal by Subject|0|||
161390102|NCT06003777|582811897|FG008|Period 4|Withdrawal by Subject|0|||
161390103|NCT06003777|582811898|FG009|Period 4|Withdrawal by Subject|0|||
161390104|NCT06003777|582811899|FG010|Period 4|Withdrawal by Subject|0|||
161390105|NCT06003777|582811900|FG011|Period 4|Withdrawal by Subject|0|||
161390106|NCT05319600|582811901|FG000|Overall Study|Withdrawal by Subject|1|||
161390107|NCT05319600|582811902|FG001|Overall Study|Withdrawal by Subject|0|||
161390108|NCT05319600|582811901|FG000|Overall Study|Lost to Follow-up|0|||
161390109|NCT05319600|582811902|FG001|Overall Study|Lost to Follow-up|4|||
161390110|NCT00904670|582811903|FG000|Open Label Phase|Withdrawal by Subject|2|||
161390111|NCT00904670|582811904|FG001|Open Label Phase|Withdrawal by Subject|0|||
161390112|NCT00904670|582811903|FG000|Open Label Phase|Adverse Event|2|||
161390113|NCT00904670|582811904|FG001|Open Label Phase|Adverse Event|0|||
161390114|NCT00904670|582811903|FG000|Open Label Phase|Lack of Efficacy|1|||
161390115|NCT00904670|582811904|FG001|Open Label Phase|Lack of Efficacy|0|||
161390116|NCT00904670|582811903|FG000|Open Label Phase|Lost to Follow-up|1|||
161390117|NCT00904670|582811904|FG001|Open Label Phase|Lost to Follow-up|0|||
161390118|NCT01106651|582811905|FG000|Overall Study|Adverse Event|17|||
161390119|NCT01106651|582811906|FG001|Overall Study|Adverse Event|9|||
161390120|NCT01106651|582811907|FG002|Overall Study|Adverse Event|23|||
161390121|NCT01106651|582811905|FG000|Overall Study|Lost to Follow-up|8|||
161390122|NCT01106651|582811906|FG001|Overall Study|Lost to Follow-up|2|||
161390123|NCT01106651|582811907|FG002|Overall Study|Lost to Follow-up|6|||
161390124|NCT01106651|582811905|FG000|Overall Study|Physician Decision|4|||
161390125|NCT01106651|582811906|FG001|Overall Study|Physician Decision|3|||
161390126|NCT01106651|582811907|FG002|Overall Study|Physician Decision|1|||
161390127|NCT01106651|582811905|FG000|Overall Study|Protocol Violation|1|||
161390128|NCT01106651|582811906|FG001|Overall Study|Protocol Violation|2|||
161390129|NCT01106651|582811907|FG002|Overall Study|Protocol Violation|1|||
161390130|NCT01106651|582811905|FG000|Overall Study|Withdrawal by Subject|14|||
161390131|NCT01106651|582811906|FG001|Overall Study|Withdrawal by Subject|7|||
161390132|NCT01106651|582811907|FG002|Overall Study|Withdrawal by Subject|4|||
161390133|NCT01106651|582811905|FG000|Overall Study|Noncompliance with study drug|1|||
161390134|NCT01106651|582811906|FG001|Overall Study|Noncompliance with study drug|0|||
161390135|NCT01106651|582811907|FG002|Overall Study|Noncompliance with study drug|2|||
161390136|NCT01106651|582811905|FG000|Overall Study|Other|34|||
161390137|NCT01106651|582811906|FG001|Overall Study|Other|31|||
161390138|NCT01106651|582811907|FG002|Overall Study|Other|21|||
161390139|NCT01106651|582811905|FG000|Overall Study|Death|0|||
161390140|NCT01106651|582811906|FG001|Overall Study|Death|3|||
161390141|NCT01106651|582811907|FG002|Overall Study|Death|0|||
161390142|NCT00582712|582811912|FG000|Overall Study|Adverse Event|1|||
161390143|NCT00582712|582811912|FG000|Overall Study|Lack of Efficacy|1|||
161390144|NCT00582712|582811912|FG000|Overall Study|Withdrawal by Subject|1|||
161390145|NCT00582712|582811912|FG000|Overall Study|Complicating disease requiring treatment|1|||
161390146|NCT03640507|582811913|FG000|Overall Study|Withdrawal by Subject|0|||
161390147|NCT03640507|582811914|FG001|Overall Study|Withdrawal by Subject|0|||
161390148|NCT03640507|582811915|FG002|Overall Study|Withdrawal by Subject|1|||
161390149|NCT00613327|582811919|FG000|Overall Study|Adverse Event|38|||
161390150|NCT00613327|582811919|FG000|Overall Study|Lost to Follow-up|8|||
161390151|NCT00613327|582811919|FG000|Overall Study|Withdrawal by Subject|6|||
161390152|NCT00613327|582811919|FG000|Overall Study|Protocol Violation|2|||
161390153|NCT00613327|582811919|FG000|Overall Study|Other|47|||
161390154|NCT00313144|582811924|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
161390155|NCT00313144|582811924|FG000|Overall Study|Death|7|||
161390156|NCT00313144|582811924|FG000|Overall Study|Lost to Follow-up|5|||
161390157|NCT00313144|582811924|FG000|Overall Study|Withdrawal by Subject|4|||
161390158|NCT00313144|582811924|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
161390159|NCT00313144|582811924|FG000|Overall Study|Physician Decision|4|||
161390160|NCT00313144|582811924|FG000|Overall Study|Adverse event - transient|5|||
161390161|NCT00313144|582811924|FG000|Overall Study|Liver transplant|1|||
161390162|NCT00313144|582811924|FG000|Overall Study|Insurance (homecare provider) change|1|||
161390163|NCT00313144|582811924|FG000|Overall Study|Change to different product|1|||
161390164|NCT00313144|582811924|FG000|Overall Study|Due to termination of the study|66|||
161390165|NCT04731298|582811925|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
161390166|NCT04731298|582811926|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
161390167|NCT01208961|582811927|FG000|High-Fat Period III|Protocol Violation|1|||
161390168|NCT01208961|582811928|FG001|High-Fat Period III|Protocol Violation|0|||
161390169|NCT01262560|582811929|FG000|Overall Study|Protocol Violation|0|||
161390170|NCT01262560|582811930|FG001|Overall Study|Protocol Violation|1|||
161390171|NCT01262560|582811931|FG002|Overall Study|Protocol Violation|2|||
161390172|NCT00350870|582811934|FG000|Overall Study|Withdrawal by Subject|21|||
161390173|NCT00350870|582811935|FG001|Overall Study|Withdrawal by Subject|17|||
161390174|NCT00350870|582811936|FG002|Overall Study|Withdrawal by Subject|15|||
161390175|NCT00350870|582811937|FG003|Overall Study|Withdrawal by Subject|14|||
161390176|NCT00350870|582811934|FG000|Overall Study|Physician Decision|1|||
161390177|NCT00350870|582811935|FG001|Overall Study|Physician Decision|0|||
161390178|NCT00350870|582811936|FG002|Overall Study|Physician Decision|1|||
161390179|NCT00350870|582811937|FG003|Overall Study|Physician Decision|1|||
161390180|NCT01932372|582811938|FG000|Overall Study|Not meeting eligibility criteria|33|||
161390181|NCT01932372|582811939|FG001|Overall Study|Not meeting eligibility criteria|179|||
161390182|NCT03594747|582811944|FG000|Overall Study|Death|78|||
161390183|NCT03594747|582811945|FG001|Overall Study|Death|86|||
161390184|NCT03594747|582811946|FG002|Overall Study|Death|87|||
161390185|NCT03594747|582811944|FG000|Overall Study|Withdrawal by Subject|5|||
161390186|NCT03594747|582811945|FG001|Overall Study|Withdrawal by Subject|2|||
161390187|NCT03594747|582811946|FG002|Overall Study|Withdrawal by Subject|11|||
161390188|NCT03594747|582811944|FG000|Overall Study|Lost to Follow-up|4|||
161390189|NCT03594747|582811945|FG001|Overall Study|Lost to Follow-up|1|||
161390190|NCT03594747|582811946|FG002|Overall Study|Lost to Follow-up|1|||
161390191|NCT03594747|582811944|FG000|Overall Study|Physician Decision|0|||
161390192|NCT03594747|582811945|FG001|Overall Study|Physician Decision|1|||
161390193|NCT03594747|582811946|FG002|Overall Study|Physician Decision|0|||
161390194|NCT03594747|582811944|FG000|Overall Study|Sponsor decision|23|||
161390195|NCT03594747|582811945|FG001|Overall Study|Sponsor decision|17|||
161390196|NCT03594747|582811946|FG002|Overall Study|Sponsor decision|16|||
161390197|NCT03594747|582811944|FG000|Overall Study|Did not meet inclusion criteria|0|||
161390198|NCT03594747|582811945|FG001|Overall Study|Did not meet inclusion criteria|0|||
161390199|NCT03594747|582811946|FG002|Overall Study|Did not meet inclusion criteria|1|||
161390200|NCT03594747|582811944|FG000|Overall Study|Transfer to long term extension study|10|||
161390201|NCT03594747|582811945|FG001|Overall Study|Transfer to long term extension study|12|||
161390202|NCT03594747|582811946|FG002|Overall Study|Transfer to long term extension study|5|||
161390203|NCT04382586|582811947|FG000|Overall Study|Death|3|||
161390204|NCT04382586|582811948|FG001|Overall Study|Death|4|||
161390205|NCT04382586|582811947|FG000|Overall Study|Lost to Follow-up|11|||
161390206|NCT04382586|582811948|FG001|Overall Study|Lost to Follow-up|8|||
161390207|NCT04382586|582811947|FG000|Overall Study|Withdrawal by Subject|3|||
161390208|NCT04382586|582811948|FG001|Overall Study|Withdrawal by Subject|1|||
161390209|NCT04382586|582811947|FG000|Overall Study|Physician Decision|0|||
161390210|NCT04382586|582811948|FG001|Overall Study|Physician Decision|3|||
161390211|NCT02265536|582811949|FG000|Overall Study|Adverse Event|1|||
161390212|NCT02265536|582811950|FG001|Overall Study|Adverse Event|0|||
161390213|NCT02265536|582811951|FG002|Overall Study|Adverse Event|0|||
161390214|NCT02265536|582811952|FG003|Overall Study|Adverse Event|0|||
161390215|NCT02265536|582811953|FG004|Overall Study|Adverse Event|1|||
161390216|NCT02265536|582811954|FG005|Overall Study|Adverse Event|0|||
161390217|NCT02265536|582811949|FG000|Overall Study|Physician Decision|0|||
161390218|NCT02265536|582811950|FG001|Overall Study|Physician Decision|0|||
161390219|NCT02265536|582811951|FG002|Overall Study|Physician Decision|0|||
161390220|NCT02265536|582811952|FG003|Overall Study|Physician Decision|0|||
161390221|NCT02265536|582811953|FG004|Overall Study|Physician Decision|2|||
161390222|NCT02265536|582811954|FG005|Overall Study|Physician Decision|0|||
161390223|NCT02265536|582811949|FG000|Overall Study|Withdrawal by Subject|0|||
161390224|NCT02265536|582811950|FG001|Overall Study|Withdrawal by Subject|3|||
161390225|NCT02265536|582811951|FG002|Overall Study|Withdrawal by Subject|0|||
161390226|NCT02265536|582811952|FG003|Overall Study|Withdrawal by Subject|0|||
161390227|NCT02265536|582811953|FG004|Overall Study|Withdrawal by Subject|0|||
161390228|NCT02265536|582811954|FG005|Overall Study|Withdrawal by Subject|0|||
161390229|NCT02907216|582811957|FG000|Overall Study|No benefit to be obtained by continuing|0|||
161390230|NCT02907216|582811958|FG001|Overall Study|No benefit to be obtained by continuing|1|||
161390231|NCT02907216|582811957|FG000|Overall Study|Withdrawal by Subject|1|||
161390232|NCT02907216|582811958|FG001|Overall Study|Withdrawal by Subject|0|||
161390233|NCT02095873|582811961|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161390234|NCT02095873|582811962|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161390235|NCT02095873|582811961|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161390236|NCT02095873|582811962|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161390237|NCT02095873|582811961|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
161390238|NCT02095873|582811962|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
161390239|NCT00792740|582811965|FG000|Overall Study|Disease Worsening|3|||
161390240|NCT00792740|582811966|FG001|Overall Study|Disease Worsening|2|||
161390241|NCT00792740|582811965|FG000|Overall Study|Personal Reason|1|||
161390242|NCT00792740|582811966|FG001|Overall Study|Personal Reason|0|||
161390243|NCT00792740|582811965|FG000|Overall Study|Adverse Event|1|||
161390244|NCT00792740|582811966|FG001|Overall Study|Adverse Event|3|||
161390245|NCT00792740|582811965|FG000|Overall Study|Patient's withdrawal of consent|0|||
161390246|NCT00792740|582811966|FG001|Overall Study|Patient's withdrawal of consent|1|||
161390247|NCT00792740|582811965|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
161390248|NCT00792740|582811966|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
161390249|NCT00792740|582811965|FG000|Overall Study|Other reasons|0|||
161390250|NCT00792740|582811966|FG001|Overall Study|Other reasons|1|||
161390251|NCT02485639|582811971|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
161390252|NCT02485639|582811971|FG000|Overall Study|Early termination|4|||
161390253|NCT02485639|582811971|FG000|Overall Study|Withdrawal by Subject|4|||
161390254|NCT03110029|582811975|FG000|Overall Study|Withdrawal by Subject|1|||
161390255|NCT03110029|582811976|FG001|Overall Study|Withdrawal by Subject|1|||
161390256|NCT02640625|582814929|FG000|Overall Study|Adverse Event|1|||
161390257|NCT00197145|582814930|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
161390258|NCT00197145|582814931|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
161390259|NCT00197145|582814930|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
161390260|NCT00197145|582814931|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
161390261|NCT00197145|582814930|FG000|Period 1: Randomized Treatment Phase|Other|2|||
161390262|NCT00197145|582814931|FG001|Period 1: Randomized Treatment Phase|Other|2|||
161390263|NCT00197145|582814930|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
161390264|NCT00197145|582814931|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
161390265|NCT00197145|582814930|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
161390266|NCT00197145|582814931|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
161390267|NCT00197145|582814930|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
161390268|NCT00197145|582814931|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
161390269|NCT00197145|582814930|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
161390270|NCT00197145|582814931|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
161390271|NCT00197145|582814930|FG000|Period 2 : Open Label Phase|Other|1|||
161390272|NCT00197145|582814931|FG001|Period 2 : Open Label Phase|Other|0|||
161390273|NCT00790868|582814932|FG000|Overall Study|Withdrawal by Subject|4|||
161390274|NCT00790868|582814933|FG001|Overall Study|Withdrawal by Subject|5|||
161390275|NCT00790868|582814932|FG000|Overall Study|Lost to Follow-up|2|||
161390276|NCT00790868|582814933|FG001|Overall Study|Lost to Follow-up|12|||
161390277|NCT02013206|582814934|FG000|Overall Study|Progressive disease (PD)|14|||
161390278|NCT02013206|582814935|FG001|Overall Study|Progressive disease (PD)|17|||
161390279|NCT02013206|582814934|FG000|Overall Study|Symptomatic deterioration|3|||
161390280|NCT02013206|582814935|FG001|Overall Study|Symptomatic deterioration|1|||
161390281|NCT02013206|582814934|FG000|Overall Study|Adverse Event|1|||
161390282|NCT02013206|582814935|FG001|Overall Study|Adverse Event|0|||
161390283|NCT02013206|582814934|FG000|Overall Study|Patient refusal|2|||
161390284|NCT02013206|582814935|FG001|Overall Study|Patient refusal|0|||
161390285|NCT02013206|582814934|FG000|Overall Study|Patient non-compliance|1|||
161390286|NCT02013206|582814935|FG001|Overall Study|Patient non-compliance|0|||
161390287|NCT02013206|582814934|FG000|Overall Study|Death|1|||
161390288|NCT02013206|582814935|FG001|Overall Study|Death|2|||
161390289|NCT02013206|582814934|FG000|Overall Study|Other reasons off treatment|5|||
161390290|NCT02013206|582814935|FG001|Overall Study|Other reasons off treatment|2|||
161390291|NCT02867813|582814939|FG000|Overall Study|Withdrawal by Subject|57|||
161390292|NCT02867813|582814940|FG001|Overall Study|Withdrawal by Subject|56|||
161390293|NCT02867813|582814939|FG000|Overall Study|Decision by Sponsor|7|||
161390294|NCT02867813|582814940|FG001|Overall Study|Decision by Sponsor|7|||
161390295|NCT02867813|582814939|FG000|Overall Study|Lost to Follow-up|91|||
161390296|NCT02867813|582814940|FG001|Overall Study|Lost to Follow-up|78|||
161390297|NCT02867813|582814939|FG000|Overall Study|Missing|2|||
161390298|NCT02867813|582814940|FG001|Overall Study|Missing|1|||
161390299|NCT02867813|582814939|FG000|Overall Study|Death|294|||
161390300|NCT02867813|582814940|FG001|Overall Study|Death|268|||
161390301|NCT02370537|582814941|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
161390302|NCT02370537|582814942|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
161390303|NCT02370537|582814943|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
161390304|NCT02370537|582814941|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
161390305|NCT02370537|582814942|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
161390306|NCT02370537|582814943|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
161390307|NCT02370537|582814941|FG000|Part B|Not randomised to receive treatment|1|||
161390308|NCT02370537|582814942|FG001|Part B|Not randomised to receive treatment|2|||
161390309|NCT02370537|582814943|FG002|Part B|Not randomised to receive treatment|259|||
161390310|NCT02370537|582814941|FG000|Part B|Withdrawal by Subject|0|||
161390311|NCT02370537|582814942|FG001|Part B|Withdrawal by Subject|1|||
161390312|NCT02370537|582814943|FG002|Part B|Withdrawal by Subject|0|||
161390313|NCT02578680|582814946|FG000|Overall Study|Death|329|||
161390314|NCT02578680|582814947|FG001|Overall Study|Death|181|||
161390315|NCT02578680|582814946|FG000|Overall Study|Lost to Follow-up|3|||
161390316|NCT02578680|582814947|FG001|Overall Study|Lost to Follow-up|1|||
161390317|NCT02578680|582814946|FG000|Overall Study|Physician Decision|0|||
161390318|NCT02578680|582814947|FG001|Overall Study|Physician Decision|1|||
161390319|NCT02578680|582814946|FG000|Overall Study|Protocol Violation|1|||
161390320|NCT02578680|582814947|FG001|Overall Study|Protocol Violation|1|||
161390321|NCT02578680|582814946|FG000|Overall Study|Sponsor Decision|64|||
161390322|NCT02578680|582814947|FG001|Overall Study|Sponsor Decision|13|||
161390323|NCT02578680|582814946|FG000|Overall Study|Withdrawal by Subject|13|||
161390324|NCT02578680|582814947|FG001|Overall Study|Withdrawal by Subject|9|||
161390325|NCT02596958|582814949|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
161390326|NCT02596958|582814949|FG000|Overall Study|Cancer Progression|441|||
161390327|NCT02596958|582814949|FG000|Overall Study|Death From Cancer|112|||
161390328|NCT02596958|582814949|FG000|Overall Study|Death From Other Cause|33|||
161390329|NCT02596958|582814949|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
161390330|NCT02596958|582814949|FG000|Overall Study|Administrative Reasons/Other|231|||
161390331|NCT02596958|582814949|FG000|Overall Study|Lost to Follow-up|33|||
161390332|NCT02596958|582814949|FG000|Overall Study|Missing|32|||
161390333|NCT02596958|582814949|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
161390334|NCT01559259|582814950|FG000|Overall Study|Withdrawal by Subject|0|||
161390335|NCT01559259|582814951|FG001|Overall Study|Withdrawal by Subject|0|||
161390336|NCT01559259|582814952|FG002|Overall Study|Withdrawal by Subject|0|||
161390337|NCT01559259|582814953|FG003|Overall Study|Withdrawal by Subject|1|||
161390338|NCT01559259|582814954|FG004|Overall Study|Withdrawal by Subject|0|||
161390339|NCT01559259|582814950|FG000|Overall Study|Adverse Event|0|||
161390340|NCT01559259|582814951|FG001|Overall Study|Adverse Event|1|||
161390341|NCT01559259|582814952|FG002|Overall Study|Adverse Event|1|||
161390342|NCT01559259|582814953|FG003|Overall Study|Adverse Event|0|||
161390343|NCT01559259|582814954|FG004|Overall Study|Adverse Event|0|||
161390344|NCT01995669|582814955|FG000|Overall Study|Progression|2|||
161390345|NCT01995669|582814956|FG001|Overall Study|Progression|1|||
161390346|NCT01995669|582814957|FG002|Overall Study|Progression|1|||
161390347|NCT01995669|582814958|FG003|Overall Study|Progression|13|||
161390348|NCT01995669|582814955|FG000|Overall Study|Adverse Event|0|||
161390349|NCT01995669|582814956|FG001|Overall Study|Adverse Event|0|||
161390350|NCT01995669|582814957|FG002|Overall Study|Adverse Event|0|||
161390351|NCT01995669|582814958|FG003|Overall Study|Adverse Event|3|||
161390352|NCT01995669|582814955|FG000|Overall Study|Death|0|||
161390353|NCT01995669|582814956|FG001|Overall Study|Death|0|||
161390354|NCT01995669|582814957|FG002|Overall Study|Death|0|||
161390355|NCT01995669|582814958|FG003|Overall Study|Death|6|||
161390356|NCT01995669|582814955|FG000|Overall Study|Withdrawal by Subject|0|||
161390357|NCT01995669|582814956|FG001|Overall Study|Withdrawal by Subject|0|||
161390358|NCT01995669|582814957|FG002|Overall Study|Withdrawal by Subject|0|||
161390359|NCT01995669|582814958|FG003|Overall Study|Withdrawal by Subject|6|||
161390360|NCT01995669|582814955|FG000|Overall Study|Insurance Expired|0|||
161390361|NCT01995669|582814956|FG001|Overall Study|Insurance Expired|0|||
161390362|NCT01995669|582814957|FG002|Overall Study|Insurance Expired|0|||
161390363|NCT01995669|582814958|FG003|Overall Study|Insurance Expired|1|||
161390364|NCT03727646|582814959|FG000|Overall Study|Adverse Event|1|||
161390365|NCT03727646|582814960|FG001|Overall Study|Adverse Event|0|||
161390366|NCT05659719|582814961|FG000|Overall Study|At sponsor's request|0|||
161390367|NCT05659719|582814962|FG001|Overall Study|At sponsor's request|0|||
161390368|NCT05659719|582814963|FG002|Overall Study|At sponsor's request|0|||
161390369|NCT05659719|582814964|FG003|Overall Study|At sponsor's request|95|||
161390370|NCT05659719|582814961|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
161390371|NCT05659719|582814962|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
161390372|NCT05659719|582814963|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
161390373|NCT05659719|582814964|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
161390374|NCT05659719|582814961|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
161390375|NCT05659719|582814962|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
161390376|NCT05659719|582814963|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
161390377|NCT05659719|582814964|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
161390378|NCT05659719|582814961|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161390379|NCT05659719|582814962|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161390380|NCT05659719|582814963|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161390381|NCT05659719|582814964|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
161390382|NCT05659719|582814961|FG000|Overall Study|Lost to Follow-up|0|||
161390383|NCT05659719|582814962|FG001|Overall Study|Lost to Follow-up|0|||
161390384|NCT05659719|582814963|FG002|Overall Study|Lost to Follow-up|0|||
161390385|NCT05659719|582814964|FG003|Overall Study|Lost to Follow-up|2|||
161390386|NCT05659719|582814961|FG000|Overall Study|Moved to another observational study|0|||
161390387|NCT05659719|582814962|FG001|Overall Study|Moved to another observational study|0|||
161390388|NCT05659719|582814963|FG002|Overall Study|Moved to another observational study|0|||
161390389|NCT05659719|582814964|FG003|Overall Study|Moved to another observational study|1|||
161390390|NCT05659719|582814961|FG000|Overall Study|The child was enrolled in an interventional study|0|||
161390391|NCT05659719|582814962|FG001|Overall Study|The child was enrolled in an interventional study|0|||
161390392|NCT05659719|582814963|FG002|Overall Study|The child was enrolled in an interventional study|0|||
161390393|NCT05659719|582814964|FG003|Overall Study|The child was enrolled in an interventional study|55|||
161390394|NCT05659719|582814961|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
161390395|NCT05659719|582814962|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
161390396|NCT05659719|582814963|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
161390397|NCT05659719|582814964|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
161390398|NCT05659719|582814961|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161390399|NCT05659719|582814962|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161390400|NCT05659719|582814963|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161390401|NCT05659719|582814964|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
161390402|NCT00218634|582814968|FG000|Overall Study|Lost to Follow-up|8|||
161390403|NCT00218634|582814969|FG001|Overall Study|Lost to Follow-up|15|||
161390404|NCT00978380|582814972|FG000|Overall Study|Protocol Violation|2|||
161390405|NCT00978380|582814972|FG000|Overall Study|Withdrawal criteria|9|||
161390406|NCT00978380|582814972|FG000|Overall Study|Unclassified|8|||
161390407|NCT00176488|582814973|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
161390408|NCT02003638|582814981|FG000|Overall Study|Withdrawal by Subject|1|||
161390409|NCT02003638|582814982|FG001|Overall Study|Withdrawal by Subject|0|||
161390410|NCT04115748|582814983|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
161390411|NCT04115748|582814984|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
161390412|NCT04115748|582814985|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
161390413|NCT04115748|582814986|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
161390414|NCT04115748|582814987|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161390415|NCT04115748|582814988|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161390416|NCT04115748|582814989|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161390417|NCT04115748|582814990|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161390418|NCT04115748|582814991|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161390419|NCT04115748|582814992|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161390420|NCT04115748|582814983|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390421|NCT04115748|582814984|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390422|NCT04115748|582814985|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390423|NCT04115748|582814986|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
161390424|NCT04115748|582814987|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390425|NCT04115748|582814988|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390426|NCT04115748|582814989|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390427|NCT04115748|582814990|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390428|NCT04115748|582814991|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390429|NCT04115748|582814992|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161390430|NCT04115748|582814983|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161390431|NCT04115748|582814984|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161390432|NCT04115748|582814985|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161390433|NCT04115748|582814986|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161390434|NCT04115748|582814987|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
161390435|NCT04115748|582814988|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
161390436|NCT04115748|582814989|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
161390437|NCT04115748|582814990|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
161390438|NCT04115748|582814991|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
161390439|NCT04115748|582814992|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
161390440|NCT04115748|582814983|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390441|NCT04115748|582814984|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390442|NCT04115748|582814985|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390443|NCT04115748|582814986|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390444|NCT04115748|582814987|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390445|NCT04115748|582814988|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390446|NCT04115748|582814989|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390447|NCT04115748|582814990|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390448|NCT04115748|582814991|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
161390449|NCT04115748|582814992|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161390450|NCT03299881|582814993|FG000|Overall Study|Study Termination|17|||
161390451|NCT03299881|582814994|FG001|Overall Study|Study Termination|13|||
161390452|NCT02752633|582814995|FG000|Overall Study|Withdrawal by Subject|1|||
161390453|NCT01296711|582814998|FG000|Overall Study|Adverse Event|3|||
161390454|NCT01296711|582814999|FG001|Overall Study|Adverse Event|1|||
161390455|NCT01296711|582815000|FG002|Overall Study|Adverse Event|4|||
161390456|NCT01296711|582815001|FG003|Overall Study|Adverse Event|3|||
161390457|NCT01296711|582815002|FG004|Overall Study|Adverse Event|1|||
161390458|NCT01296711|582815003|FG005|Overall Study|Adverse Event|6|||
161390459|NCT01296711|582815004|FG006|Overall Study|Adverse Event|11|||
161390460|NCT01296711|582815005|FG007|Overall Study|Adverse Event|3|||
161390461|NCT01296711|582814998|FG000|Overall Study|Lack of Efficacy|1|||
161390462|NCT01296711|582814999|FG001|Overall Study|Lack of Efficacy|4|||
161390463|NCT01296711|582815000|FG002|Overall Study|Lack of Efficacy|1|||
161390464|NCT01296711|582815001|FG003|Overall Study|Lack of Efficacy|1|||
161390465|NCT01296711|582815002|FG004|Overall Study|Lack of Efficacy|1|||
161390466|NCT01296711|582815003|FG005|Overall Study|Lack of Efficacy|0|||
161390467|NCT01296711|582815004|FG006|Overall Study|Lack of Efficacy|2|||
161390468|NCT01296711|582815005|FG007|Overall Study|Lack of Efficacy|3|||
161390469|NCT01296711|582814998|FG000|Overall Study|Lost to Follow-up|0|||
161390470|NCT01296711|582814999|FG001|Overall Study|Lost to Follow-up|0|||
161390471|NCT01296711|582815000|FG002|Overall Study|Lost to Follow-up|1|||
161390472|NCT01296711|582815001|FG003|Overall Study|Lost to Follow-up|1|||
161390473|NCT01296711|582815002|FG004|Overall Study|Lost to Follow-up|2|||
161390474|NCT01296711|582815003|FG005|Overall Study|Lost to Follow-up|0|||
161390475|NCT01296711|582815004|FG006|Overall Study|Lost to Follow-up|4|||
161390476|NCT01296711|582815005|FG007|Overall Study|Lost to Follow-up|2|||
161390477|NCT01296711|582814998|FG000|Overall Study|Protocol Violation|0|||
161390478|NCT01296711|582814999|FG001|Overall Study|Protocol Violation|0|||
161390479|NCT01296711|582815000|FG002|Overall Study|Protocol Violation|0|||
161390480|NCT01296711|582815001|FG003|Overall Study|Protocol Violation|1|||
161390481|NCT01296711|582815002|FG004|Overall Study|Protocol Violation|1|||
161390482|NCT01296711|582815003|FG005|Overall Study|Protocol Violation|0|||
161390483|NCT01296711|582815004|FG006|Overall Study|Protocol Violation|0|||
161390484|NCT01296711|582815005|FG007|Overall Study|Protocol Violation|0|||
161390485|NCT01296711|582814998|FG000|Overall Study|Withdrawal by Subject|4|||
161390486|NCT01296711|582814999|FG001|Overall Study|Withdrawal by Subject|2|||
161390487|NCT01296711|582815000|FG002|Overall Study|Withdrawal by Subject|2|||
161390488|NCT01296711|582815001|FG003|Overall Study|Withdrawal by Subject|1|||
161390489|NCT01296711|582815002|FG004|Overall Study|Withdrawal by Subject|1|||
161390490|NCT01296711|582815003|FG005|Overall Study|Withdrawal by Subject|1|||
161390491|NCT01296711|582815004|FG006|Overall Study|Withdrawal by Subject|2|||
161390492|NCT01296711|582815005|FG007|Overall Study|Withdrawal by Subject|1|||
161390493|NCT01296711|582814998|FG000|Overall Study|Study termination|8|||
161390494|NCT01296711|582814999|FG001|Overall Study|Study termination|1|||
161390495|NCT01296711|582815000|FG002|Overall Study|Study termination|5|||
161390496|NCT01296711|582815001|FG003|Overall Study|Study termination|4|||
161390497|NCT01296711|582815002|FG004|Overall Study|Study termination|4|||
161390498|NCT01296711|582815003|FG005|Overall Study|Study termination|4|||
161390499|NCT01296711|582815004|FG006|Overall Study|Study termination|8|||
161390500|NCT01296711|582815005|FG007|Overall Study|Study termination|10|||
161390501|NCT01296711|582814998|FG000|Overall Study|Continued elevated liver enzymes|0|||
161390502|NCT01296711|582814999|FG001|Overall Study|Continued elevated liver enzymes|0|||
161390503|NCT01296711|582815000|FG002|Overall Study|Continued elevated liver enzymes|0|||
161390504|NCT01296711|582815001|FG003|Overall Study|Continued elevated liver enzymes|1|||
161390505|NCT01296711|582815002|FG004|Overall Study|Continued elevated liver enzymes|0|||
161390506|NCT01296711|582815003|FG005|Overall Study|Continued elevated liver enzymes|0|||
161390507|NCT01296711|582815004|FG006|Overall Study|Continued elevated liver enzymes|0|||
161390508|NCT01296711|582815005|FG007|Overall Study|Continued elevated liver enzymes|0|||
161390509|NCT01296711|582814998|FG000|Overall Study|Methotrexate discontinued|0|||
161390510|NCT01296711|582814999|FG001|Overall Study|Methotrexate discontinued|0|||
161390511|NCT01296711|582815000|FG002|Overall Study|Methotrexate discontinued|0|||
161390512|NCT01296711|582815001|FG003|Overall Study|Methotrexate discontinued|1|||
161390513|NCT01296711|582815002|FG004|Overall Study|Methotrexate discontinued|0|||
161390514|NCT01296711|582815003|FG005|Overall Study|Methotrexate discontinued|0|||
161390515|NCT01296711|582815004|FG006|Overall Study|Methotrexate discontinued|0|||
161390516|NCT01296711|582815005|FG007|Overall Study|Methotrexate discontinued|0|||
161390517|NCT01296711|582814998|FG000|Overall Study|Investigator discretion|0|||
161390518|NCT01296711|582814999|FG001|Overall Study|Investigator discretion|0|||
161390519|NCT01296711|582815000|FG002|Overall Study|Investigator discretion|0|||
161390520|NCT01296711|582815001|FG003|Overall Study|Investigator discretion|0|||
161390521|NCT01296711|582815002|FG004|Overall Study|Investigator discretion|0|||
161390522|NCT01296711|582815003|FG005|Overall Study|Investigator discretion|0|||
161390523|NCT01296711|582815004|FG006|Overall Study|Investigator discretion|1|||
161390524|NCT01296711|582815005|FG007|Overall Study|Investigator discretion|0|||
161390525|NCT01296711|582814998|FG000|Overall Study|Other|0|||
161390526|NCT01296711|582814999|FG001|Overall Study|Other|0|||
161390527|NCT01296711|582815000|FG002|Overall Study|Other|0|||
161390528|NCT01296711|582815001|FG003|Overall Study|Other|0|||
161390529|NCT01296711|582815002|FG004|Overall Study|Other|0|||
161390530|NCT01296711|582815003|FG005|Overall Study|Other|0|||
161390531|NCT01296711|582815004|FG006|Overall Study|Other|1|||
161390532|NCT01296711|582815005|FG007|Overall Study|Other|0|||
161390533|NCT01296711|582814998|FG000|Overall Study|Required restricted steroid injections|0|||
161390534|NCT01296711|582814999|FG001|Overall Study|Required restricted steroid injections|0|||
161390535|NCT01296711|582815000|FG002|Overall Study|Required restricted steroid injections|0|||
161390536|NCT01296711|582815001|FG003|Overall Study|Required restricted steroid injections|0|||
161390537|NCT01296711|582815002|FG004|Overall Study|Required restricted steroid injections|0|||
161390538|NCT01296711|582815003|FG005|Overall Study|Required restricted steroid injections|0|||
161390539|NCT01296711|582815004|FG006|Overall Study|Required restricted steroid injections|1|||
161390540|NCT01296711|582815005|FG007|Overall Study|Required restricted steroid injections|0|||
161390541|NCT01296711|582814998|FG000|Overall Study|Ongoing missed appointments|0|||
161390542|NCT01296711|582814999|FG001|Overall Study|Ongoing missed appointments|0|||
161390543|NCT01296711|582815000|FG002|Overall Study|Ongoing missed appointments|0|||
161390544|NCT01296711|582815001|FG003|Overall Study|Ongoing missed appointments|0|||
161390545|NCT01296711|582815002|FG004|Overall Study|Ongoing missed appointments|0|||
161390546|NCT01296711|582815003|FG005|Overall Study|Ongoing missed appointments|0|||
161390547|NCT01296711|582815004|FG006|Overall Study|Ongoing missed appointments|1|||
161390548|NCT01296711|582815005|FG007|Overall Study|Ongoing missed appointments|0|||
161390549|NCT01296711|582814998|FG000|Overall Study|Failure to comply with visits|0|||
161390550|NCT01296711|582814999|FG001|Overall Study|Failure to comply with visits|0|||
161390551|NCT01296711|582815000|FG002|Overall Study|Failure to comply with visits|0|||
161390552|NCT01296711|582815001|FG003|Overall Study|Failure to comply with visits|0|||
161390553|NCT01296711|582815002|FG004|Overall Study|Failure to comply with visits|0|||
161390554|NCT01296711|582815003|FG005|Overall Study|Failure to comply with visits|0|||
161390555|NCT01296711|582815004|FG006|Overall Study|Failure to comply with visits|0|||
161390556|NCT01296711|582815005|FG007|Overall Study|Failure to comply with visits|1|||
161390557|NCT01296711|582814998|FG000|Overall Study|Patient decision due to transport|0|||
161390558|NCT01296711|582814999|FG001|Overall Study|Patient decision due to transport|0|||
161390559|NCT01296711|582815000|FG002|Overall Study|Patient decision due to transport|0|||
161390560|NCT01296711|582815001|FG003|Overall Study|Patient decision due to transport|0|||
161390561|NCT01296711|582815002|FG004|Overall Study|Patient decision due to transport|0|||
161390562|NCT01296711|582815003|FG005|Overall Study|Patient decision due to transport|0|||
161390563|NCT01296711|582815004|FG006|Overall Study|Patient decision due to transport|0|||
161390564|NCT01296711|582815005|FG007|Overall Study|Patient decision due to transport|1|||
161390565|NCT01328535|582815007|FG000|Overall Study|Ineligible|1|||
161390566|NCT01035463|582815008|FG000|Overall Study|Adverse Event|0|||
161390567|NCT01035463|582815009|FG001|Overall Study|Adverse Event|0|||
161390568|NCT01035463|582815010|FG002|Overall Study|Adverse Event|4|||
161390569|NCT01035463|582815011|FG003|Overall Study|Adverse Event|1|||
161390570|NCT01035463|582815012|FG004|Overall Study|Adverse Event|5|||
161390571|NCT01035463|582815013|FG005|Overall Study|Adverse Event|7|||
161390572|NCT01035463|582815008|FG000|Overall Study|Withdrawal by Subject|0|||
161390573|NCT01035463|582815009|FG001|Overall Study|Withdrawal by Subject|2|||
161390574|NCT01035463|582815010|FG002|Overall Study|Withdrawal by Subject|1|||
161390575|NCT01035463|582815011|FG003|Overall Study|Withdrawal by Subject|0|||
161390576|NCT01035463|582815012|FG004|Overall Study|Withdrawal by Subject|1|||
161390577|NCT01035463|582815013|FG005|Overall Study|Withdrawal by Subject|4|||
161390578|NCT01035463|582815008|FG000|Overall Study|Disease progression|0|||
161390579|NCT01035463|582815009|FG001|Overall Study|Disease progression|0|||
161390580|NCT01035463|582815010|FG002|Overall Study|Disease progression|0|||
161390581|NCT01035463|582815011|FG003|Overall Study|Disease progression|0|||
161390582|NCT01035463|582815012|FG004|Overall Study|Disease progression|0|||
161390583|NCT01035463|582815013|FG005|Overall Study|Disease progression|3|||
161390584|NCT01035463|582815008|FG000|Overall Study|Other Malignancy|0|||
161390585|NCT01035463|582815009|FG001|Overall Study|Other Malignancy|0|||
161390586|NCT01035463|582815010|FG002|Overall Study|Other Malignancy|0|||
161390587|NCT01035463|582815011|FG003|Overall Study|Other Malignancy|0|||
161390588|NCT01035463|582815012|FG004|Overall Study|Other Malignancy|0|||
161390589|NCT01035463|582815013|FG005|Overall Study|Other Malignancy|2|||
161390590|NCT01035463|582815008|FG000|Overall Study|Other|0|||
161390591|NCT01035463|582815009|FG001|Overall Study|Other|0|||
161390592|NCT01035463|582815010|FG002|Overall Study|Other|0|||
161390593|NCT01035463|582815011|FG003|Overall Study|Other|1|||
161390594|NCT01035463|582815012|FG004|Overall Study|Other|0|||
161390595|NCT01035463|582815013|FG005|Overall Study|Other|2|||
161390596|NCT01126268|582815020|FG000|Overall Study|Adverse Event|1|||
161390597|NCT03425006|582815021|FG000|Overall Study|Withdrawal by Subject|1|||
161390598|NCT03425006|582815021|FG000|Overall Study|Physician Decision|1|||
161390599|NCT03425006|582815021|FG000|Overall Study|Death|1|||
161390600|NCT03070171|582815028|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
161390601|NCT03070171|582815029|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
161390602|NCT03070171|582815028|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
161390603|NCT03070171|582815029|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
161390604|NCT00610857|582815035|FG000|Overall Study|Not evaluable for response|2|||
161390605|NCT03655054|582815036|FG000|Overall Study|Lost to Follow-up|1|||
161390606|NCT01626118|582815037|FG000|Overall Study|Lack of Efficacy|1|||
161390607|NCT01626118|582815038|FG001|Overall Study|Lack of Efficacy|0|||
161390608|NCT01626118|582815039|FG002|Overall Study|Lack of Efficacy|1|||
161390609|NCT01626118|582815040|FG003|Overall Study|Lack of Efficacy|3|||
161390610|NCT01626118|582815037|FG000|Overall Study|Lost to Follow-up|1|||
161390611|NCT01626118|582815038|FG001|Overall Study|Lost to Follow-up|0|||
161390612|NCT01626118|582815039|FG002|Overall Study|Lost to Follow-up|0|||
161390613|NCT01626118|582815040|FG003|Overall Study|Lost to Follow-up|0|||
161390614|NCT01626118|582815037|FG000|Overall Study|Adverse Event|0|||
161390615|NCT01626118|582815038|FG001|Overall Study|Adverse Event|1|||
161390616|NCT01626118|582815039|FG002|Overall Study|Adverse Event|1|||
161390617|NCT01626118|582815040|FG003|Overall Study|Adverse Event|0|||
161390618|NCT01626118|582815037|FG000|Overall Study|Investigator Decision|0|||
161390619|NCT01626118|582815038|FG001|Overall Study|Investigator Decision|1|||
161390620|NCT01626118|582815039|FG002|Overall Study|Investigator Decision|0|||
161390621|NCT01626118|582815040|FG003|Overall Study|Investigator Decision|0|||
161390622|NCT00002540|582815041|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
161390623|NCT00002540|582815042|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
161390624|NCT00002540|582815041|FG000|Overall Study|Died Before Randomization|2|||
161390625|NCT00002540|582815042|FG001|Overall Study|Died Before Randomization|6|||
161390626|NCT00002540|582815041|FG000|Overall Study|Died Before ASU (Control)|202|||
161390627|NCT00002540|582815042|FG001|Overall Study|Died Before ASU (Control)|0|||
161390628|NCT00002540|582815041|FG000|Overall Study|Refused ASU (Control)|597|||
161390629|NCT00002540|582815042|FG001|Overall Study|Refused ASU (Control)|0|||
161390630|NCT00002540|582815041|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
161390631|NCT00002540|582815042|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
161390632|NCT03931382|582815043|FG000|Overall Study|Equipment malfunction|2|||
161390633|NCT03931382|582815044|FG001|Overall Study|Equipment malfunction|0|||
161390634|NCT03931382|582815045|FG002|Overall Study|Equipment malfunction|2|||
161390635|NCT03931382|582815043|FG000|Overall Study|Withdrawal by Subject|0|||
161390636|NCT03931382|582815044|FG001|Overall Study|Withdrawal by Subject|1|||
161390637|NCT03931382|582815045|FG002|Overall Study|Withdrawal by Subject|0|||
161390638|NCT02151903|582815046|FG000|Overall Study|Withdrawal by Subject|1|||
161390639|NCT02151903|582815047|FG001|Overall Study|Withdrawal by Subject|0|||
161390640|NCT02151903|582815046|FG000|Overall Study|Progressive disease|2|||
161390641|NCT02151903|582815047|FG001|Overall Study|Progressive disease|1|||
161390642|NCT01500252|582815050|FG000|Overall Study|Death|4|||
161390643|NCT01500252|582815051|FG001|Overall Study|Death|2|||
161390644|NCT01500252|582815050|FG000|Overall Study|Lost to Follow-up|5|||
161390645|NCT01500252|582815051|FG001|Overall Study|Lost to Follow-up|4|||
161390646|NCT03490292|582815052|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
161390647|NCT03490292|582815053|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
161390648|NCT03490292|582815052|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
161390649|NCT03490292|582815053|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
161390650|NCT03490292|582815052|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
161390651|NCT03490292|582815053|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
161390652|NCT03490292|582815052|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
161390653|NCT03490292|582815053|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
161390654|NCT03490292|582815052|FG000|1 Year Follow Up Post Last Dose|Death|1|||
161390655|NCT03490292|582815053|FG001|1 Year Follow Up Post Last Dose|Death|1|||
161390656|NCT00778375|582815054|FG000|Overall Study|Ineligible|3|||
161390657|NCT00712725|582815058|FG000|Overall Study|Adverse Event|1|||
161390658|NCT00712725|582815059|FG001|Overall Study|Adverse Event|0|||
161390659|NCT00712725|582815060|FG002|Overall Study|Adverse Event|0|||
161390660|NCT00712725|582815061|FG003|Overall Study|Adverse Event|1|||
161390661|NCT00712725|582815062|FG004|Overall Study|Adverse Event|0|||
161390662|NCT00712725|582815063|FG005|Overall Study|Adverse Event|0|||
161390663|NCT00712725|582815064|FG006|Overall Study|Adverse Event|0|||
161390664|NCT00712725|582815065|FG007|Overall Study|Adverse Event|0|||
161390665|NCT00712725|582815058|FG000|Overall Study|Lost to Follow-up|3|||
161390666|NCT00712725|582815059|FG001|Overall Study|Lost to Follow-up|2|||
161390667|NCT00712725|582815060|FG002|Overall Study|Lost to Follow-up|1|||
161390668|NCT00712725|582815061|FG003|Overall Study|Lost to Follow-up|1|||
161390669|NCT00712725|582815062|FG004|Overall Study|Lost to Follow-up|2|||
161390670|NCT00712725|582815063|FG005|Overall Study|Lost to Follow-up|2|||
161390671|NCT00712725|582815064|FG006|Overall Study|Lost to Follow-up|3|||
161390672|NCT00712725|582815065|FG007|Overall Study|Lost to Follow-up|1|||
161390673|NCT00712725|582815058|FG000|Overall Study|Physician Decision|2|||
161390674|NCT00712725|582815059|FG001|Overall Study|Physician Decision|0|||
161390675|NCT00712725|582815060|FG002|Overall Study|Physician Decision|0|||
161390676|NCT00712725|582815061|FG003|Overall Study|Physician Decision|0|||
161390677|NCT00712725|582815062|FG004|Overall Study|Physician Decision|1|||
161390678|NCT00712725|582815063|FG005|Overall Study|Physician Decision|0|||
161390679|NCT00712725|582815064|FG006|Overall Study|Physician Decision|2|||
161390680|NCT00712725|582815065|FG007|Overall Study|Physician Decision|0|||
161390681|NCT00712725|582815058|FG000|Overall Study|Pregnancy|0|||
161390682|NCT00712725|582815059|FG001|Overall Study|Pregnancy|1|||
161390683|NCT00712725|582815060|FG002|Overall Study|Pregnancy|0|||
161390684|NCT00712725|582815061|FG003|Overall Study|Pregnancy|0|||
161390685|NCT00712725|582815062|FG004|Overall Study|Pregnancy|1|||
161390686|NCT00712725|582815063|FG005|Overall Study|Pregnancy|0|||
161390687|NCT00712725|582815064|FG006|Overall Study|Pregnancy|2|||
161390688|NCT00712725|582815065|FG007|Overall Study|Pregnancy|0|||
161390689|NCT00712725|582815058|FG000|Overall Study|Protocol Violation|2|||
161390690|NCT00712725|582815059|FG001|Overall Study|Protocol Violation|0|||
161390691|NCT00712725|582815060|FG002|Overall Study|Protocol Violation|1|||
161390692|NCT00712725|582815061|FG003|Overall Study|Protocol Violation|3|||
161390693|NCT00712725|582815062|FG004|Overall Study|Protocol Violation|2|||
161390694|NCT00712725|582815063|FG005|Overall Study|Protocol Violation|0|||
161390695|NCT00712725|582815064|FG006|Overall Study|Protocol Violation|1|||
161390696|NCT00712725|582815065|FG007|Overall Study|Protocol Violation|1|||
161390697|NCT00712725|582815058|FG000|Overall Study|Withdrawal by Subject|2|||
161390698|NCT00712725|582815059|FG001|Overall Study|Withdrawal by Subject|1|||
161390699|NCT00712725|582815060|FG002|Overall Study|Withdrawal by Subject|1|||
161390700|NCT00712725|582815061|FG003|Overall Study|Withdrawal by Subject|2|||
161390701|NCT00712725|582815062|FG004|Overall Study|Withdrawal by Subject|1|||
161390702|NCT00712725|582815063|FG005|Overall Study|Withdrawal by Subject|1|||
161390703|NCT00712725|582815064|FG006|Overall Study|Withdrawal by Subject|1|||
161390704|NCT00712725|582815065|FG007|Overall Study|Withdrawal by Subject|2|||
161390705|NCT00712725|582815058|FG000|Overall Study|Lack of Qualifying Event|16|||
161390706|NCT00712725|582815059|FG001|Overall Study|Lack of Qualifying Event|2|||
161390707|NCT00712725|582815060|FG002|Overall Study|Lack of Qualifying Event|6|||
161390708|NCT00712725|582815061|FG003|Overall Study|Lack of Qualifying Event|8|||
161390709|NCT00712725|582815062|FG004|Overall Study|Lack of Qualifying Event|11|||
161390710|NCT00712725|582815063|FG005|Overall Study|Lack of Qualifying Event|13|||
161390711|NCT00712725|582815064|FG006|Overall Study|Lack of Qualifying Event|11|||
161390712|NCT00712725|582815065|FG007|Overall Study|Lack of Qualifying Event|6|||
161390713|NCT00712725|582815058|FG000|Overall Study|Protocol Specified Criteria|3|||
161390714|NCT00712725|582815059|FG001|Overall Study|Protocol Specified Criteria|0|||
161390715|NCT00712725|582815060|FG002|Overall Study|Protocol Specified Criteria|1|||
161390716|NCT00712725|582815061|FG003|Overall Study|Protocol Specified Criteria|2|||
161390717|NCT00712725|582815062|FG004|Overall Study|Protocol Specified Criteria|1|||
161390718|NCT00712725|582815063|FG005|Overall Study|Protocol Specified Criteria|0|||
161390719|NCT00712725|582815064|FG006|Overall Study|Protocol Specified Criteria|2|||
161390720|NCT00712725|582815065|FG007|Overall Study|Protocol Specified Criteria|1|||
161390721|NCT01901289|582815066|FG000|Overall Study|Death|32|||
161390722|NCT01901289|582815066|FG000|Overall Study|Lost to Follow-up|16|||
161390723|NCT01901289|582815066|FG000|Overall Study|Withdrawal by Subject|35|||
161390724|NCT01901289|582815066|FG000|Overall Study|Other type of endpoint met|2|||
161390725|NCT00889603|582815067|FG000|Overall Study|Adverse Event|7|||
161390726|NCT00889603|582815067|FG000|Overall Study|Death|3|||
161390727|NCT00889603|582815067|FG000|Overall Study|Lost to Follow-up|19|||
161390728|NCT00889603|582815067|FG000|Overall Study|No longer willing to participant in stud|4|||
161390729|NCT00889603|582815067|FG000|Overall Study|Other|4|||
161390730|NCT03525600|582815068|FG000|Overall Study|Adverse Event|9|||
161390731|NCT03525600|582815069|FG001|Overall Study|Adverse Event|6|||
161390732|NCT03525600|582815070|FG002|Overall Study|Adverse Event|5|||
161390733|NCT03525600|582815071|FG003|Overall Study|Adverse Event|3|||
161390734|NCT03525600|582815068|FG000|Overall Study|Lost to Follow-up|2|||
161390735|NCT03525600|582815069|FG001|Overall Study|Lost to Follow-up|4|||
161390736|NCT03525600|582815070|FG002|Overall Study|Lost to Follow-up|4|||
161390737|NCT03525600|582815071|FG003|Overall Study|Lost to Follow-up|0|||
161390738|NCT03525600|582815068|FG000|Overall Study|Physician Decision|1|||
161390739|NCT03525600|582815069|FG001|Overall Study|Physician Decision|0|||
161390740|NCT03525600|582815070|FG002|Overall Study|Physician Decision|2|||
161390741|NCT03525600|582815071|FG003|Overall Study|Physician Decision|0|||
161390742|NCT03525600|582815068|FG000|Overall Study|Consent withdrawal|36|||
161390743|NCT03525600|582815069|FG001|Overall Study|Consent withdrawal|20|||
161390744|NCT03525600|582815070|FG002|Overall Study|Consent withdrawal|6|||
161390745|NCT03525600|582815071|FG003|Overall Study|Consent withdrawal|13|||
161390746|NCT03525600|582815068|FG000|Overall Study|Death|7|||
161390747|NCT03525600|582815069|FG001|Overall Study|Death|6|||
161390748|NCT03525600|582815070|FG002|Overall Study|Death|4|||
161390749|NCT03525600|582815071|FG003|Overall Study|Death|3|||
161390750|NCT03525600|582815068|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
161390751|NCT03525600|582815069|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
161390752|NCT03525600|582815070|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
161390753|NCT03525600|582815071|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
161390754|NCT03525600|582815068|FG000|Overall Study|Other|0|||
161390755|NCT03525600|582815069|FG001|Overall Study|Other|1|||
161390756|NCT03525600|582815070|FG002|Overall Study|Other|0|||
161390757|NCT03525600|582815071|FG003|Overall Study|Other|0|||
161390758|NCT00700882|582815072|FG000|Overall Study|Never received treatment|6|||
161390759|NCT00700882|582815072|FG000|Overall Study|Ineligible|2|||
161390760|NCT00700882|582815072|FG000|Overall Study|No KIT mutation|51|||
161390761|NCT01832493|582815076|FG000|Overall Study|Physician Decision|2|||
161390762|NCT01832493|582815076|FG000|Overall Study|Protocol Violation|4|||
161390763|NCT01832493|582815076|FG000|Overall Study|Unable to place LV lead|2|||
161390764|NCT01814397|582815083|FG000|Overall Study|Adverse Event|7|||
161390765|NCT01814397|582815083|FG000|Overall Study|Withdrawal by Subject|7|||
161390766|NCT00290771|582815084|FG000|Overall Study|Disease progression|95|||
161390767|NCT00290771|582815085|FG001|Overall Study|Disease progression|73|||
161390768|NCT00290771|582815084|FG000|Overall Study|Death|11|||
161390769|NCT00290771|582815085|FG001|Overall Study|Death|10|||
161390770|NCT00290771|582815084|FG000|Overall Study|Adverse Event|12|||
161390771|NCT00290771|582815085|FG001|Overall Study|Adverse Event|6|||
161390772|NCT00290771|582815084|FG000|Overall Study|Withdrawal by Subject|5|||
161390773|NCT00290771|582815085|FG001|Overall Study|Withdrawal by Subject|6|||
161390774|NCT00290771|582815084|FG000|Overall Study|Administrative problems|2|||
161390775|NCT00290771|582815085|FG001|Overall Study|Administrative problems|1|||
161390776|NCT00290771|582815084|FG000|Overall Study|Protocol Violation|2|||
161390777|NCT00290771|582815085|FG001|Overall Study|Protocol Violation|0|||
161390778|NCT00290771|582815084|FG000|Overall Study|Lost to Follow-up|0|||
161390779|NCT00290771|582815085|FG001|Overall Study|Lost to Follow-up|1|||
161390780|NCT04154293|582815088|FG000|Overall Study|Withdrawal by Subject|2|||
161390781|NCT04154293|582815089|FG001|Overall Study|Withdrawal by Subject|3|||
161390782|NCT04154293|582815090|FG002|Overall Study|Withdrawal by Subject|1|||
161390783|NCT04154293|582815088|FG000|Overall Study|Physician Decision|0|||
161390784|NCT04154293|582815089|FG001|Overall Study|Physician Decision|0|||
161390785|NCT04154293|582815090|FG002|Overall Study|Physician Decision|1|||
161390786|NCT02791516|582815091|FG000|Overall Study|Withdrawal by Subject|1|||
161390787|NCT02791516|582815092|FG001|Overall Study|Withdrawal by Subject|1|||
161390788|NCT02524275|582815093|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
161390789|NCT01439971|582815094|FG000|Overall Study|Required number in cohort dosed|0|||
161390790|NCT01439971|582815095|FG001|Overall Study|Required number in cohort dosed|1|||
161390791|NCT01439971|582815096|FG002|Overall Study|Required number in cohort dosed|2|||
161390792|NCT01439971|582815097|FG003|Overall Study|Required number in cohort dosed|0|||
161390793|NCT01439971|582815098|FG004|Overall Study|Required number in cohort dosed|1|||
161390794|NCT02628600|582815099|FG000|Overall Study|Death|2|||
161390795|NCT02628600|582815100|FG001|Overall Study|Death|1|||
161390796|NCT02628600|582815099|FG000|Overall Study|Adverse Event|3|||
161390797|NCT02628600|582815100|FG001|Overall Study|Adverse Event|20|||
161390798|NCT02628600|582815099|FG000|Overall Study|Protocol Violation|0|||
161390799|NCT02628600|582815100|FG001|Overall Study|Protocol Violation|1|||
161390800|NCT02628600|582815099|FG000|Overall Study|Lack of Efficacy|2|||
161390801|NCT02628600|582815100|FG001|Overall Study|Lack of Efficacy|0|||
161390802|NCT02628600|582815099|FG000|Overall Study|Withdrawal by Subject|13|||
161390803|NCT02628600|582815100|FG001|Overall Study|Withdrawal by Subject|8|||
161390804|NCT02628600|582815099|FG000|Overall Study|Lost to Follow-up|1|||
161390805|NCT02628600|582815100|FG001|Overall Study|Lost to Follow-up|0|||
161390806|NCT02628600|582815099|FG000|Overall Study|Physician Decision|2|||
161390807|NCT02628600|582815100|FG001|Overall Study|Physician Decision|2|||
161390808|NCT02628600|582815099|FG000|Overall Study|Other not specified|1|||
161390809|NCT02628600|582815100|FG001|Overall Study|Other not specified|0|||
161390810|NCT00107900|582815105|FG000|Overall Study|Adverse Event|3|||
161390811|NCT00107900|582815106|FG001|Overall Study|Adverse Event|2|||
161390812|NCT00107900|582815107|FG002|Overall Study|Adverse Event|10|||
161390813|NCT00107900|582815108|FG003|Overall Study|Adverse Event|3|||
161390814|NCT00107900|582815109|FG004|Overall Study|Adverse Event|5|||
161390815|NCT00107900|582815110|FG005|Overall Study|Adverse Event|3|||
161390816|NCT00107900|582815105|FG000|Overall Study|Death|0|||
161390817|NCT00107900|582815106|FG001|Overall Study|Death|0|||
161390818|NCT00107900|582815107|FG002|Overall Study|Death|0|||
161390819|NCT00107900|582815108|FG003|Overall Study|Death|0|||
161390820|NCT00107900|582815109|FG004|Overall Study|Death|1|||
161390821|NCT00107900|582815110|FG005|Overall Study|Death|0|||
161390822|NCT00107900|582815105|FG000|Overall Study|Lost to Follow-up|4|||
161390823|NCT00107900|582815106|FG001|Overall Study|Lost to Follow-up|1|||
161390824|NCT00107900|582815107|FG002|Overall Study|Lost to Follow-up|3|||
161390825|NCT00107900|582815108|FG003|Overall Study|Lost to Follow-up|2|||
161390826|NCT00107900|582815109|FG004|Overall Study|Lost to Follow-up|5|||
161390827|NCT00107900|582815110|FG005|Overall Study|Lost to Follow-up|5|||
161390828|NCT00107900|582815105|FG000|Overall Study|Protocol Violation|1|||
161390829|NCT00107900|582815106|FG001|Overall Study|Protocol Violation|0|||
161390830|NCT00107900|582815107|FG002|Overall Study|Protocol Violation|5|||
161390831|NCT00107900|582815108|FG003|Overall Study|Protocol Violation|5|||
161390832|NCT00107900|582815109|FG004|Overall Study|Protocol Violation|7|||
161390833|NCT00107900|582815110|FG005|Overall Study|Protocol Violation|0|||
161390834|NCT00107900|582815105|FG000|Overall Study|Withdrawal by Subject|1|||
161390835|NCT00107900|582815106|FG001|Overall Study|Withdrawal by Subject|0|||
161390836|NCT00107900|582815107|FG002|Overall Study|Withdrawal by Subject|5|||
161390837|NCT00107900|582815108|FG003|Overall Study|Withdrawal by Subject|0|||
161390838|NCT00107900|582815109|FG004|Overall Study|Withdrawal by Subject|1|||
161390839|NCT00107900|582815110|FG005|Overall Study|Withdrawal by Subject|1|||
161390840|NCT00107900|582815105|FG000|Overall Study|Administrative Reasons|1|||
161390841|NCT00107900|582815106|FG001|Overall Study|Administrative Reasons|0|||
161390842|NCT00107900|582815107|FG002|Overall Study|Administrative Reasons|2|||
161390843|NCT00107900|582815108|FG003|Overall Study|Administrative Reasons|2|||
161390844|NCT00107900|582815109|FG004|Overall Study|Administrative Reasons|2|||
161390845|NCT00107900|582815110|FG005|Overall Study|Administrative Reasons|0|||
161390846|NCT03724981|582817592|FG000|First Device|Protocol Violation|1|||
161390847|NCT03724981|582817593|FG001|First Device|Protocol Violation|1|||
161390848|NCT00511433|582817594|FG000|Overall Study|Adverse Event|5|||
161390849|NCT00511433|582817595|FG001|Overall Study|Adverse Event|0|||
161390850|NCT00511433|582817594|FG000|Overall Study|Other Reason|1|||
161390851|NCT00511433|582817595|FG001|Overall Study|Other Reason|1|||
161390852|NCT02791191|582817596|FG000|Overall Study|Adverse Event|2|||
161390853|NCT02791191|582817597|FG001|Overall Study|Adverse Event|4|||
161390854|NCT02791191|582817598|FG002|Overall Study|Adverse Event|5|||
161390855|NCT02791191|582817596|FG000|Overall Study|Lack of Efficacy|0|||
161390856|NCT02791191|582817597|FG001|Overall Study|Lack of Efficacy|1|||
161390857|NCT02791191|582817598|FG002|Overall Study|Lack of Efficacy|0|||
161390858|NCT02791191|582817596|FG000|Overall Study|Study Drug Non-Compliance|0|||
161390859|NCT02791191|582817597|FG001|Overall Study|Study Drug Non-Compliance|2|||
161390860|NCT02791191|582817598|FG002|Overall Study|Study Drug Non-Compliance|0|||
161390861|NCT02791191|582817596|FG000|Overall Study|Site Closed by Sponsor|1|||
161390862|NCT02791191|582817597|FG001|Overall Study|Site Closed by Sponsor|1|||
161390863|NCT02791191|582817598|FG002|Overall Study|Site Closed by Sponsor|3|||
161390864|NCT02791191|582817596|FG000|Overall Study|Progressive Disease|1|||
161390865|NCT02791191|582817597|FG001|Overall Study|Progressive Disease|0|||
161390866|NCT02791191|582817598|FG002|Overall Study|Progressive Disease|0|||
161390867|NCT02791191|582817596|FG000|Overall Study|Study Terminated by Sponsor|29|||
161390868|NCT02791191|582817597|FG001|Overall Study|Study Terminated by Sponsor|101|||
161390869|NCT02791191|582817598|FG002|Overall Study|Study Terminated by Sponsor|109|||
161390870|NCT02791191|582817596|FG000|Overall Study|Withdrawal by Subject|3|||
161390871|NCT02791191|582817597|FG001|Overall Study|Withdrawal by Subject|1|||
161390872|NCT02791191|582817598|FG002|Overall Study|Withdrawal by Subject|3|||
161390873|NCT02791191|582817596|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
161390874|NCT02791191|582817597|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
161390875|NCT02791191|582817598|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
161390876|NCT01952665|582817600|FG000|Overall Study|Physician Decision|3|||
161390877|NCT01952665|582817601|FG001|Overall Study|Physician Decision|2|||
161390878|NCT01952665|582817600|FG000|Overall Study|Lost to Follow-up|1|||
161390879|NCT01952665|582817601|FG001|Overall Study|Lost to Follow-up|2|||
161390880|NCT01952665|582817600|FG000|Overall Study|Adverse Event|2|||
161390881|NCT01952665|582817601|FG001|Overall Study|Adverse Event|1|||
161390882|NCT01952665|582817600|FG000|Overall Study|Protocol Violation|0|||
161390883|NCT01952665|582817601|FG001|Overall Study|Protocol Violation|1|||
161390884|NCT04753658|582817615|FG000|Overall Study|Progressive disease|7|||
161390885|NCT04753658|582817615|FG000|Overall Study|Other|7|||
161390886|NCT04753658|582817615|FG000|Overall Study|Adverse Event|1|||
161390887|NCT02290691|582817616|FG000|Overall Study|Noncompliance|0|||
161390888|NCT02290691|582817617|FG001|Overall Study|Noncompliance|1|||
161390889|NCT02290691|582817616|FG000|Overall Study|Withdrawal by Subject|1|||
161390890|NCT02290691|582817617|FG001|Overall Study|Withdrawal by Subject|1|||
161390891|NCT02290691|582817616|FG000|Overall Study|Lost to Follow-up|7|||
161390892|NCT02290691|582817617|FG001|Overall Study|Lost to Follow-up|7|||
161390893|NCT00185380|582817621|FG000|Overall Study|Adverse Event|41|||
161390894|NCT00185380|582817622|FG001|Overall Study|Adverse Event|43|||
161390895|NCT00185380|582817623|FG002|Overall Study|Adverse Event|48|||
161390896|NCT00185380|582817621|FG000|Overall Study|Lost to Follow-up|0|||
161390897|NCT00185380|582817622|FG001|Overall Study|Lost to Follow-up|4|||
161390898|NCT00185380|582817623|FG002|Overall Study|Lost to Follow-up|3|||
161390899|NCT00185380|582817621|FG000|Overall Study|Pregnancy|1|||
161390900|NCT00185380|582817622|FG001|Overall Study|Pregnancy|4|||
161390901|NCT00185380|582817623|FG002|Overall Study|Pregnancy|0|||
161390902|NCT00185380|582817621|FG000|Overall Study|Protocol Violation|2|||
161390903|NCT00185380|582817622|FG001|Overall Study|Protocol Violation|2|||
161390904|NCT00185380|582817623|FG002|Overall Study|Protocol Violation|1|||
161390905|NCT00185380|582817621|FG000|Overall Study|Withdrawal by Subject|1|||
161390906|NCT00185380|582817622|FG001|Overall Study|Withdrawal by Subject|2|||
161390907|NCT00185380|582817623|FG002|Overall Study|Withdrawal by Subject|0|||
161390908|NCT00185380|582817621|FG000|Overall Study|Failed insertion|1|||
161390909|NCT00185380|582817622|FG001|Overall Study|Failed insertion|1|||
161390910|NCT00185380|582817623|FG002|Overall Study|Failed insertion|2|||
161390911|NCT00185380|582817621|FG000|Overall Study|Planned pregnancy|9|||
161390912|NCT00185380|582817622|FG001|Overall Study|Planned pregnancy|12|||
161390913|NCT00185380|582817623|FG002|Overall Study|Planned pregnancy|12|||
161390914|NCT00185380|582817621|FG000|Overall Study|No need for contraception|3|||
161390915|NCT00185380|582817622|FG001|Overall Study|No need for contraception|3|||
161390916|NCT00185380|582817623|FG002|Overall Study|No need for contraception|3|||
161390917|NCT00185380|582817621|FG000|Overall Study|Could not attend visits|2|||
161390918|NCT00185380|582817622|FG001|Overall Study|Could not attend visits|0|||
161390919|NCT00185380|582817623|FG002|Overall Study|Could not attend visits|4|||
161390920|NCT00185380|582817621|FG000|Overall Study|personal reason|6|||
161390921|NCT00185380|582817622|FG001|Overall Study|personal reason|1|||
161390922|NCT00185380|582817623|FG002|Overall Study|personal reason|1|||
161390923|NCT02589665|582817624|FG000|Induction Period|Did not receive drug|0|||
161390924|NCT02589665|582817625|FG001|Induction Period|Did not receive drug|0|||
161390925|NCT02589665|582817626|FG002|Induction Period|Did not receive drug|0|||
161390926|NCT02589665|582817627|FG003|Induction Period|Did not receive drug|1|||
161390927|NCT02589665|582817628|FG004|Induction Period|Did not receive drug|0|||
161390928|NCT02589665|582817629|FG005|Induction Period|Did not receive drug|0|||
161390929|NCT02589665|582817630|FG006|Induction Period|Did not receive drug|0|||
161390930|NCT02589665|582817631|FG007|Induction Period|Did not receive drug|0|||
161390931|NCT02589665|582817632|FG008|Induction Period|Did not receive drug|0|||
161390932|NCT02589665|582817633|FG009|Induction Period|Did not receive drug|0|||
161390933|NCT02589665|582817624|FG000|Induction Period|Adverse Event|3|||
161390934|NCT02589665|582817625|FG001|Induction Period|Adverse Event|0|||
161390935|NCT02589665|582817626|FG002|Induction Period|Adverse Event|2|||
161390936|NCT02589665|582817627|FG003|Induction Period|Adverse Event|2|||
161390937|NCT02589665|582817628|FG004|Induction Period|Adverse Event|0|||
161390938|NCT02589665|582817629|FG005|Induction Period|Adverse Event|0|||
161390939|NCT02589665|582817630|FG006|Induction Period|Adverse Event|0|||
161390940|NCT02589665|582817631|FG007|Induction Period|Adverse Event|0|||
161390941|NCT02589665|582817632|FG008|Induction Period|Adverse Event|0|||
161390942|NCT02589665|582817633|FG009|Induction Period|Adverse Event|0|||
161390943|NCT02589665|582817624|FG000|Induction Period|Withdrawal by Subject|0|||
161390944|NCT02589665|582817625|FG001|Induction Period|Withdrawal by Subject|1|||
161390945|NCT02589665|582817626|FG002|Induction Period|Withdrawal by Subject|0|||
161390946|NCT02589665|582817627|FG003|Induction Period|Withdrawal by Subject|1|||
161390947|NCT02589665|582817628|FG004|Induction Period|Withdrawal by Subject|0|||
161390948|NCT02589665|582817629|FG005|Induction Period|Withdrawal by Subject|0|||
161390949|NCT02589665|582817630|FG006|Induction Period|Withdrawal by Subject|0|||
161390950|NCT02589665|582817631|FG007|Induction Period|Withdrawal by Subject|0|||
161390951|NCT02589665|582817632|FG008|Induction Period|Withdrawal by Subject|0|||
161390952|NCT02589665|582817633|FG009|Induction Period|Withdrawal by Subject|0|||
161390953|NCT02589665|582817624|FG000|Induction Period|Protocol Violation|0|||
161390954|NCT02589665|582817625|FG001|Induction Period|Protocol Violation|1|||
161390955|NCT02589665|582817626|FG002|Induction Period|Protocol Violation|0|||
161390956|NCT02589665|582817627|FG003|Induction Period|Protocol Violation|0|||
161390957|NCT02589665|582817628|FG004|Induction Period|Protocol Violation|0|||
161390958|NCT02589665|582817629|FG005|Induction Period|Protocol Violation|0|||
161390959|NCT02589665|582817630|FG006|Induction Period|Protocol Violation|0|||
161390960|NCT02589665|582817631|FG007|Induction Period|Protocol Violation|0|||
161390961|NCT02589665|582817632|FG008|Induction Period|Protocol Violation|0|||
161390962|NCT02589665|582817633|FG009|Induction Period|Protocol Violation|0|||
161390963|NCT02589665|582817624|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390964|NCT02589665|582817625|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390965|NCT02589665|582817626|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390966|NCT02589665|582817627|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390967|NCT02589665|582817628|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
161390968|NCT02589665|582817629|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
161390969|NCT02589665|582817630|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
161390970|NCT02589665|582817631|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390971|NCT02589665|582817632|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390972|NCT02589665|582817633|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161390973|NCT02589665|582817624|FG000|Maintenance Period|Withdrawal by Subject|0|||
161390974|NCT02589665|582817625|FG001|Maintenance Period|Withdrawal by Subject|0|||
161390975|NCT02589665|582817626|FG002|Maintenance Period|Withdrawal by Subject|0|||
161390976|NCT02589665|582817627|FG003|Maintenance Period|Withdrawal by Subject|0|||
161390977|NCT02589665|582817628|FG004|Maintenance Period|Withdrawal by Subject|4|||
161390978|NCT02589665|582817629|FG005|Maintenance Period|Withdrawal by Subject|2|||
161390979|NCT02589665|582817630|FG006|Maintenance Period|Withdrawal by Subject|4|||
161390980|NCT02589665|582817631|FG007|Maintenance Period|Withdrawal by Subject|0|||
161390981|NCT02589665|582817632|FG008|Maintenance Period|Withdrawal by Subject|0|||
161390982|NCT02589665|582817633|FG009|Maintenance Period|Withdrawal by Subject|0|||
161390983|NCT02589665|582817624|FG000|Maintenance Period|Lack of Efficacy|0|||
161390984|NCT02589665|582817625|FG001|Maintenance Period|Lack of Efficacy|0|||
161390985|NCT02589665|582817626|FG002|Maintenance Period|Lack of Efficacy|0|||
161390986|NCT02589665|582817627|FG003|Maintenance Period|Lack of Efficacy|0|||
161390987|NCT02589665|582817628|FG004|Maintenance Period|Lack of Efficacy|2|||
161390988|NCT02589665|582817629|FG005|Maintenance Period|Lack of Efficacy|1|||
161390989|NCT02589665|582817630|FG006|Maintenance Period|Lack of Efficacy|0|||
161390990|NCT02589665|582817631|FG007|Maintenance Period|Lack of Efficacy|0|||
161390991|NCT02589665|582817632|FG008|Maintenance Period|Lack of Efficacy|0|||
161390992|NCT02589665|582817633|FG009|Maintenance Period|Lack of Efficacy|0|||
161390993|NCT02589665|582817624|FG000|Maintenance Period|Adverse Event|0|||
161390994|NCT02589665|582817625|FG001|Maintenance Period|Adverse Event|0|||
161390995|NCT02589665|582817626|FG002|Maintenance Period|Adverse Event|0|||
161390996|NCT02589665|582817627|FG003|Maintenance Period|Adverse Event|0|||
161390997|NCT02589665|582817628|FG004|Maintenance Period|Adverse Event|0|||
161390998|NCT02589665|582817629|FG005|Maintenance Period|Adverse Event|0|||
161390999|NCT02589665|582817630|FG006|Maintenance Period|Adverse Event|2|||
161391000|NCT02589665|582817631|FG007|Maintenance Period|Adverse Event|0|||
161391001|NCT02589665|582817632|FG008|Maintenance Period|Adverse Event|0|||
161391002|NCT02589665|582817633|FG009|Maintenance Period|Adverse Event|0|||
161391003|NCT02589665|582817624|FG000|Maintenance Period|Lost to Follow-up|0|||
161391004|NCT02589665|582817625|FG001|Maintenance Period|Lost to Follow-up|0|||
161391005|NCT02589665|582817626|FG002|Maintenance Period|Lost to Follow-up|0|||
161391006|NCT02589665|582817627|FG003|Maintenance Period|Lost to Follow-up|0|||
161391007|NCT02589665|582817628|FG004|Maintenance Period|Lost to Follow-up|0|||
161391008|NCT02589665|582817629|FG005|Maintenance Period|Lost to Follow-up|1|||
161391009|NCT02589665|582817630|FG006|Maintenance Period|Lost to Follow-up|0|||
161391010|NCT02589665|582817631|FG007|Maintenance Period|Lost to Follow-up|0|||
161391011|NCT02589665|582817632|FG008|Maintenance Period|Lost to Follow-up|0|||
161391012|NCT02589665|582817633|FG009|Maintenance Period|Lost to Follow-up|0|||
161391013|NCT02589665|582817624|FG000|Maintenance Period|Physician Decision|0|||
161391014|NCT02589665|582817625|FG001|Maintenance Period|Physician Decision|0|||
161391015|NCT02589665|582817626|FG002|Maintenance Period|Physician Decision|0|||
161391016|NCT02589665|582817627|FG003|Maintenance Period|Physician Decision|0|||
161391017|NCT02589665|582817628|FG004|Maintenance Period|Physician Decision|0|||
161391018|NCT02589665|582817629|FG005|Maintenance Period|Physician Decision|1|||
161391019|NCT02589665|582817630|FG006|Maintenance Period|Physician Decision|0|||
161391020|NCT02589665|582817631|FG007|Maintenance Period|Physician Decision|0|||
161391021|NCT02589665|582817632|FG008|Maintenance Period|Physician Decision|0|||
161391022|NCT02589665|582817633|FG009|Maintenance Period|Physician Decision|0|||
161391023|NCT02589665|582817624|FG000|Maintenance Period|Reason Not Collected|0|||
161391024|NCT02589665|582817625|FG001|Maintenance Period|Reason Not Collected|0|||
161391025|NCT02589665|582817626|FG002|Maintenance Period|Reason Not Collected|0|||
161391026|NCT02589665|582817627|FG003|Maintenance Period|Reason Not Collected|0|||
161391027|NCT02589665|582817628|FG004|Maintenance Period|Reason Not Collected|0|||
161391028|NCT02589665|582817629|FG005|Maintenance Period|Reason Not Collected|1|||
161391029|NCT02589665|582817630|FG006|Maintenance Period|Reason Not Collected|1|||
161391030|NCT02589665|582817631|FG007|Maintenance Period|Reason Not Collected|0|||
161391031|NCT02589665|582817632|FG008|Maintenance Period|Reason Not Collected|0|||
161391032|NCT02589665|582817633|FG009|Maintenance Period|Reason Not Collected|0|||
161391033|NCT02589665|582817624|FG000|Induction Extension Period|Adverse Event|0|||
161391034|NCT02589665|582817625|FG001|Induction Extension Period|Adverse Event|0|||
161391035|NCT02589665|582817626|FG002|Induction Extension Period|Adverse Event|0|||
161391036|NCT02589665|582817627|FG003|Induction Extension Period|Adverse Event|0|||
161391037|NCT02589665|582817628|FG004|Induction Extension Period|Adverse Event|0|||
161391038|NCT02589665|582817629|FG005|Induction Extension Period|Adverse Event|0|||
161391039|NCT02589665|582817630|FG006|Induction Extension Period|Adverse Event|0|||
161391040|NCT02589665|582817631|FG007|Induction Extension Period|Adverse Event|0|||
161391041|NCT02589665|582817632|FG008|Induction Extension Period|Adverse Event|4|||
161391042|NCT02589665|582817633|FG009|Induction Extension Period|Adverse Event|0|||
161391043|NCT02589665|582817624|FG000|Induction Extension Period|Lack of Efficacy|0|||
161391044|NCT02589665|582817625|FG001|Induction Extension Period|Lack of Efficacy|0|||
161391045|NCT02589665|582817626|FG002|Induction Extension Period|Lack of Efficacy|0|||
161391046|NCT02589665|582817627|FG003|Induction Extension Period|Lack of Efficacy|0|||
161391047|NCT02589665|582817628|FG004|Induction Extension Period|Lack of Efficacy|0|||
161391048|NCT02589665|582817629|FG005|Induction Extension Period|Lack of Efficacy|0|||
161391049|NCT02589665|582817630|FG006|Induction Extension Period|Lack of Efficacy|0|||
161391050|NCT02589665|582817631|FG007|Induction Extension Period|Lack of Efficacy|0|||
161391051|NCT02589665|582817632|FG008|Induction Extension Period|Lack of Efficacy|3|||
161391052|NCT02589665|582817633|FG009|Induction Extension Period|Lack of Efficacy|0|||
161391053|NCT02589665|582817624|FG000|Induction Extension Period|Withdrawal by Subject|0|||
161391054|NCT02589665|582817625|FG001|Induction Extension Period|Withdrawal by Subject|0|||
161391055|NCT02589665|582817626|FG002|Induction Extension Period|Withdrawal by Subject|0|||
161391056|NCT02589665|582817627|FG003|Induction Extension Period|Withdrawal by Subject|0|||
161391057|NCT02589665|582817628|FG004|Induction Extension Period|Withdrawal by Subject|0|||
161391058|NCT02589665|582817629|FG005|Induction Extension Period|Withdrawal by Subject|0|||
161391059|NCT02589665|582817630|FG006|Induction Extension Period|Withdrawal by Subject|0|||
161391060|NCT02589665|582817631|FG007|Induction Extension Period|Withdrawal by Subject|2|||
161391061|NCT02589665|582817632|FG008|Induction Extension Period|Withdrawal by Subject|3|||
161391062|NCT02589665|582817633|FG009|Induction Extension Period|Withdrawal by Subject|0|||
161391063|NCT02589665|582817624|FG000|Induction Extension Period|Physician Decision|0|||
161391064|NCT02589665|582817625|FG001|Induction Extension Period|Physician Decision|0|||
161391065|NCT02589665|582817626|FG002|Induction Extension Period|Physician Decision|0|||
161391066|NCT02589665|582817627|FG003|Induction Extension Period|Physician Decision|0|||
161391067|NCT02589665|582817628|FG004|Induction Extension Period|Physician Decision|0|||
161391068|NCT02589665|582817629|FG005|Induction Extension Period|Physician Decision|0|||
161391069|NCT02589665|582817630|FG006|Induction Extension Period|Physician Decision|0|||
161391070|NCT02589665|582817631|FG007|Induction Extension Period|Physician Decision|0|||
161391071|NCT02589665|582817632|FG008|Induction Extension Period|Physician Decision|1|||
161391072|NCT02589665|582817633|FG009|Induction Extension Period|Physician Decision|0|||
161391073|NCT02589665|582817624|FG000|Induction Extension Period|Reason Not Collected|0|||
161391074|NCT02589665|582817625|FG001|Induction Extension Period|Reason Not Collected|0|||
161391075|NCT02589665|582817626|FG002|Induction Extension Period|Reason Not Collected|0|||
161391076|NCT02589665|582817627|FG003|Induction Extension Period|Reason Not Collected|0|||
161391077|NCT02589665|582817628|FG004|Induction Extension Period|Reason Not Collected|0|||
161391078|NCT02589665|582817629|FG005|Induction Extension Period|Reason Not Collected|0|||
161391079|NCT02589665|582817630|FG006|Induction Extension Period|Reason Not Collected|0|||
161391080|NCT02589665|582817631|FG007|Induction Extension Period|Reason Not Collected|0|||
161391081|NCT02589665|582817632|FG008|Induction Extension Period|Reason Not Collected|1|||
161391082|NCT02589665|582817633|FG009|Induction Extension Period|Reason Not Collected|0|||
161391083|NCT02589665|582817624|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391084|NCT02589665|582817625|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391085|NCT02589665|582817626|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391086|NCT02589665|582817627|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391087|NCT02589665|582817628|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391088|NCT02589665|582817629|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391089|NCT02589665|582817630|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391090|NCT02589665|582817631|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391091|NCT02589665|582817632|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161391092|NCT02589665|582817633|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
161391093|NCT02589665|582817624|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
161391094|NCT02589665|582817625|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
161391095|NCT02589665|582817626|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
161391096|NCT02589665|582817627|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
161391097|NCT02589665|582817628|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
161391098|NCT02589665|582817629|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
161391099|NCT02589665|582817630|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
161391100|NCT02589665|582817631|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
161391101|NCT02589665|582817632|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
161391102|NCT02589665|582817633|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
161391103|NCT02589665|582817624|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
161391104|NCT02589665|582817625|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
161391105|NCT02589665|582817626|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
161391106|NCT02589665|582817627|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
161391107|NCT02589665|582817628|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
161391108|NCT02589665|582817629|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
161391109|NCT02589665|582817630|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
161391110|NCT02589665|582817631|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
161391111|NCT02589665|582817632|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
161391112|NCT02589665|582817633|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
161391113|NCT02589665|582817624|FG000|Maintenance Extension Period|Adverse Event|0|||
161391114|NCT02589665|582817625|FG001|Maintenance Extension Period|Adverse Event|0|||
161391115|NCT02589665|582817626|FG002|Maintenance Extension Period|Adverse Event|0|||
161391116|NCT02589665|582817627|FG003|Maintenance Extension Period|Adverse Event|0|||
161391117|NCT02589665|582817628|FG004|Maintenance Extension Period|Adverse Event|0|||
161391118|NCT02589665|582817629|FG005|Maintenance Extension Period|Adverse Event|0|||
161391119|NCT02589665|582817630|FG006|Maintenance Extension Period|Adverse Event|0|||
161391120|NCT02589665|582817631|FG007|Maintenance Extension Period|Adverse Event|0|||
161391121|NCT02589665|582817632|FG008|Maintenance Extension Period|Adverse Event|0|||
161391122|NCT02589665|582817633|FG009|Maintenance Extension Period|Adverse Event|2|||
161391123|NCT02589665|582817624|FG000|Maintenance Extension Period|Non-responder|0|||
161391124|NCT02589665|582817625|FG001|Maintenance Extension Period|Non-responder|0|||
161391125|NCT02589665|582817626|FG002|Maintenance Extension Period|Non-responder|0|||
161391126|NCT02589665|582817627|FG003|Maintenance Extension Period|Non-responder|0|||
161391127|NCT02589665|582817628|FG004|Maintenance Extension Period|Non-responder|0|||
161391128|NCT02589665|582817629|FG005|Maintenance Extension Period|Non-responder|0|||
161391129|NCT02589665|582817630|FG006|Maintenance Extension Period|Non-responder|0|||
161391130|NCT02589665|582817631|FG007|Maintenance Extension Period|Non-responder|0|||
161391131|NCT02589665|582817632|FG008|Maintenance Extension Period|Non-responder|0|||
161391132|NCT02589665|582817633|FG009|Maintenance Extension Period|Non-responder|1|||
161391133|NCT00327015|582817634|FG000|Overall Study|Lack of Efficacy|18|||
161391134|NCT00327015|582817635|FG001|Overall Study|Lack of Efficacy|18|||
161391135|NCT00327015|582817636|FG002|Overall Study|Lack of Efficacy|35|||
161391136|NCT00327015|582817637|FG003|Overall Study|Lack of Efficacy|29|||
161391137|NCT00327015|582817634|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
161391138|NCT00327015|582817635|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
161391139|NCT00327015|582817636|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
161391140|NCT00327015|582817637|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
161391141|NCT00327015|582817634|FG000|Overall Study|Lost to Follow-up|22|||
161391142|NCT00327015|582817635|FG001|Overall Study|Lost to Follow-up|23|||
161391143|NCT00327015|582817636|FG002|Overall Study|Lost to Follow-up|29|||
161391144|NCT00327015|582817637|FG003|Overall Study|Lost to Follow-up|22|||
161391145|NCT00327015|582817634|FG000|Overall Study|Adverse Event|14|||
161391146|NCT00327015|582817635|FG001|Overall Study|Adverse Event|10|||
161391147|NCT00327015|582817636|FG002|Overall Study|Adverse Event|14|||
161391148|NCT00327015|582817637|FG003|Overall Study|Adverse Event|14|||
161391149|NCT00327015|582817634|FG000|Overall Study|Subject no longer meets study criteria|4|||
161391150|NCT00327015|582817635|FG001|Overall Study|Subject no longer meets study criteria|2|||
161391151|NCT00327015|582817636|FG002|Overall Study|Subject no longer meets study criteria|8|||
161391152|NCT00327015|582817637|FG003|Overall Study|Subject no longer meets study criteria|7|||
161391153|NCT00327015|582817634|FG000|Overall Study|Poor/Noncompliance|11|||
161391154|NCT00327015|582817635|FG001|Overall Study|Poor/Noncompliance|8|||
161391155|NCT00327015|582817636|FG002|Overall Study|Poor/Noncompliance|4|||
161391156|NCT00327015|582817637|FG003|Overall Study|Poor/Noncompliance|5|||
161391157|NCT00327015|582817634|FG000|Overall Study|Physician Decision|0|||
161391158|NCT00327015|582817635|FG001|Overall Study|Physician Decision|1|||
161391159|NCT00327015|582817636|FG002|Overall Study|Physician Decision|3|||
161391160|NCT00327015|582817637|FG003|Overall Study|Physician Decision|2|||
161391161|NCT00327015|582817634|FG000|Overall Study|Death|1|||
161391162|NCT00327015|582817635|FG001|Overall Study|Death|2|||
161391163|NCT00327015|582817636|FG002|Overall Study|Death|2|||
161391164|NCT00327015|582817637|FG003|Overall Study|Death|3|||
161391165|NCT00327015|582817634|FG000|Overall Study|Pregnancy|0|||
161391166|NCT00327015|582817635|FG001|Overall Study|Pregnancy|2|||
161391167|NCT00327015|582817636|FG002|Overall Study|Pregnancy|1|||
161391168|NCT00327015|582817637|FG003|Overall Study|Pregnancy|1|||
161391169|NCT00327015|582817634|FG000|Overall Study|Administrative Reason by Sponsor|1|||
161391170|NCT00327015|582817635|FG001|Overall Study|Administrative Reason by Sponsor|2|||
161391171|NCT00327015|582817636|FG002|Overall Study|Administrative Reason by Sponsor|2|||
161391172|NCT00327015|582817637|FG003|Overall Study|Administrative Reason by Sponsor|1|||
161391173|NCT02923830|582817641|FG000|Overall Study|Physician Decision|13|||
161391174|NCT02923830|582817642|FG001|Overall Study|Physician Decision|15|||
161391175|NCT00837265|582817643|FG000|Pilot Phase|Withdrawal by Subject|0|||
161391176|NCT00837265|582817644|FG001|Pilot Phase|Withdrawal by Subject|2|||
161391177|NCT00837265|582817645|FG002|Pilot Phase|Withdrawal by Subject|3|||
161391178|NCT00837265|582817646|FG003|Pilot Phase|Withdrawal by Subject|2|||
161391179|NCT00837265|582817647|FG004|Pilot Phase|Withdrawal by Subject|0|||
161391180|NCT00837265|582817648|FG005|Pilot Phase|Withdrawal by Subject|0|||
161391181|NCT00837265|582817649|FG006|Pilot Phase|Withdrawal by Subject|0|||
161391182|NCT00837265|582817643|FG000|Pilot Phase|Decision of the investigator|2|||
161391183|NCT00837265|582817644|FG001|Pilot Phase|Decision of the investigator|1|||
161391184|NCT00837265|582817645|FG002|Pilot Phase|Decision of the investigator|0|||
161391185|NCT00837265|582817646|FG003|Pilot Phase|Decision of the investigator|0|||
161391186|NCT00837265|582817647|FG004|Pilot Phase|Decision of the investigator|0|||
161391187|NCT00837265|582817648|FG005|Pilot Phase|Decision of the investigator|0|||
161391188|NCT00837265|582817649|FG006|Pilot Phase|Decision of the investigator|0|||
161391189|NCT00837265|582817643|FG000|Pilot Phase|Adverse Event|1|||
161391190|NCT00837265|582817644|FG001|Pilot Phase|Adverse Event|0|||
161391191|NCT00837265|582817645|FG002|Pilot Phase|Adverse Event|0|||
161391192|NCT00837265|582817646|FG003|Pilot Phase|Adverse Event|0|||
161391193|NCT00837265|582817647|FG004|Pilot Phase|Adverse Event|0|||
161391194|NCT00837265|582817648|FG005|Pilot Phase|Adverse Event|0|||
161391195|NCT00837265|582817649|FG006|Pilot Phase|Adverse Event|0|||
161391196|NCT00837265|582817643|FG000|Pilot Phase|Disease progression|0|||
161391197|NCT00837265|582817644|FG001|Pilot Phase|Disease progression|0|||
161391198|NCT00837265|582817645|FG002|Pilot Phase|Disease progression|0|||
161391199|NCT00837265|582817646|FG003|Pilot Phase|Disease progression|1|||
161391200|NCT00837265|582817647|FG004|Pilot Phase|Disease progression|0|||
161391201|NCT00837265|582817648|FG005|Pilot Phase|Disease progression|0|||
161391202|NCT00837265|582817649|FG006|Pilot Phase|Disease progression|0|||
161391203|NCT00837265|582817643|FG000|Pilot Phase|Participant left the city|0|||
161391204|NCT00837265|582817644|FG001|Pilot Phase|Participant left the city|0|||
161391205|NCT00837265|582817645|FG002|Pilot Phase|Participant left the city|0|||
161391206|NCT00837265|582817646|FG003|Pilot Phase|Participant left the city|1|||
161391207|NCT00837265|582817647|FG004|Pilot Phase|Participant left the city|0|||
161391208|NCT00837265|582817648|FG005|Pilot Phase|Participant left the city|0|||
161391209|NCT00837265|582817649|FG006|Pilot Phase|Participant left the city|0|||
161391210|NCT00837265|582817643|FG000|Main Phase|Withdrawal by Subject|0|||
161391211|NCT00837265|582817644|FG001|Main Phase|Withdrawal by Subject|0|||
161391212|NCT00837265|582817645|FG002|Main Phase|Withdrawal by Subject|0|||
161391213|NCT00837265|582817646|FG003|Main Phase|Withdrawal by Subject|0|||
161391214|NCT00837265|582817647|FG004|Main Phase|Withdrawal by Subject|4|||
161391215|NCT00837265|582817648|FG005|Main Phase|Withdrawal by Subject|2|||
161391216|NCT00837265|582817649|FG006|Main Phase|Withdrawal by Subject|1|||
161391217|NCT00837265|582817643|FG000|Main Phase|Decision of the investigator|0|||
161391218|NCT00837265|582817644|FG001|Main Phase|Decision of the investigator|0|||
161391219|NCT00837265|582817645|FG002|Main Phase|Decision of the investigator|0|||
161391220|NCT00837265|582817646|FG003|Main Phase|Decision of the investigator|0|||
161391221|NCT00837265|582817647|FG004|Main Phase|Decision of the investigator|0|||
161391222|NCT00837265|582817648|FG005|Main Phase|Decision of the investigator|2|||
161391223|NCT00837265|582817649|FG006|Main Phase|Decision of the investigator|1|||
161391224|NCT00837265|582817643|FG000|Main Phase|Adverse Event|0|||
161391225|NCT00837265|582817644|FG001|Main Phase|Adverse Event|0|||
161391226|NCT00837265|582817645|FG002|Main Phase|Adverse Event|0|||
161391227|NCT00837265|582817646|FG003|Main Phase|Adverse Event|0|||
161391228|NCT00837265|582817647|FG004|Main Phase|Adverse Event|0|||
161391229|NCT00837265|582817648|FG005|Main Phase|Adverse Event|1|||
161391230|NCT00837265|582817649|FG006|Main Phase|Adverse Event|0|||
161391231|NCT00837265|582817643|FG000|Main Phase|Death|0|||
161391232|NCT00837265|582817644|FG001|Main Phase|Death|0|||
161391233|NCT00837265|582817645|FG002|Main Phase|Death|0|||
161391234|NCT00837265|582817646|FG003|Main Phase|Death|0|||
161391235|NCT00837265|582817647|FG004|Main Phase|Death|2|||
161391236|NCT00837265|582817648|FG005|Main Phase|Death|0|||
161391237|NCT00837265|582817649|FG006|Main Phase|Death|1|||
161391238|NCT00837265|582817643|FG000|Main Phase|Lost to Follow-up|0|||
161391239|NCT00837265|582817644|FG001|Main Phase|Lost to Follow-up|0|||
161391240|NCT00837265|582817645|FG002|Main Phase|Lost to Follow-up|0|||
161391241|NCT00837265|582817646|FG003|Main Phase|Lost to Follow-up|0|||
161391242|NCT00837265|582817647|FG004|Main Phase|Lost to Follow-up|1|||
161391243|NCT00837265|582817648|FG005|Main Phase|Lost to Follow-up|0|||
161391244|NCT00837265|582817649|FG006|Main Phase|Lost to Follow-up|0|||
161391245|NCT00837265|582817643|FG000|Main Phase|Principal investigator resignation|0|||
161391246|NCT00837265|582817644|FG001|Main Phase|Principal investigator resignation|0|||
161391247|NCT00837265|582817645|FG002|Main Phase|Principal investigator resignation|0|||
161391248|NCT00837265|582817646|FG003|Main Phase|Principal investigator resignation|0|||
161391249|NCT00837265|582817647|FG004|Main Phase|Principal investigator resignation|2|||
161391250|NCT00837265|582817648|FG005|Main Phase|Principal investigator resignation|0|||
161391251|NCT00837265|582817649|FG006|Main Phase|Principal investigator resignation|0|||
161391252|NCT00837265|582817643|FG000|Main Phase|Participant's personal reason|0|||
161391253|NCT00837265|582817644|FG001|Main Phase|Participant's personal reason|0|||
161391254|NCT00837265|582817645|FG002|Main Phase|Participant's personal reason|0|||
161391255|NCT00837265|582817646|FG003|Main Phase|Participant's personal reason|0|||
161391256|NCT00837265|582817647|FG004|Main Phase|Participant's personal reason|1|||
161391257|NCT00837265|582817648|FG005|Main Phase|Participant's personal reason|0|||
161391258|NCT00837265|582817649|FG006|Main Phase|Participant's personal reason|0|||
161391259|NCT00733291|582817651|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
161391260|NCT00733291|582817652|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
161391261|NCT00733291|582817653|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
161391262|NCT00733291|582817654|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
161391263|NCT01751906|582817661|FG000|Overall Study|Lost to Follow-up|151|||
161391264|NCT01751906|582817662|FG001|Overall Study|Lost to Follow-up|68|||
161391265|NCT01751906|582817661|FG000|Overall Study|Withdrawal by Subject|22|||
161391266|NCT01751906|582817662|FG001|Overall Study|Withdrawal by Subject|18|||
161391267|NCT01751906|582817661|FG000|Overall Study|Physician Decision|5|||
161391268|NCT01751906|582817662|FG001|Overall Study|Physician Decision|2|||
161391269|NCT01751906|582817661|FG000|Overall Study|Death|84|||
161391270|NCT01751906|582817662|FG001|Overall Study|Death|43|||
161391271|NCT01751906|582817661|FG000|Overall Study|Denied on premises for follow-up by law|1|||
161391272|NCT01751906|582817662|FG001|Overall Study|Denied on premises for follow-up by law|0|||
161391273|NCT01110330|582817667|FG000|Overall Study|Adverse Event|0|||
161391274|NCT01110330|582817668|FG001|Overall Study|Adverse Event|4|||
161391275|NCT01110330|582817669|FG002|Overall Study|Adverse Event|3|||
161391276|NCT01110330|582817667|FG000|Overall Study|Lack of Efficacy|3|||
161391277|NCT01110330|582817668|FG001|Overall Study|Lack of Efficacy|1|||
161391278|NCT01110330|582817669|FG002|Overall Study|Lack of Efficacy|1|||
161391279|NCT01110330|582817667|FG000|Overall Study|Lost to Follow-up|9|||
161391280|NCT01110330|582817668|FG001|Overall Study|Lost to Follow-up|10|||
161391281|NCT01110330|582817669|FG002|Overall Study|Lost to Follow-up|15|||
161391282|NCT01110330|582817667|FG000|Overall Study|Physician Decision|0|||
161391283|NCT01110330|582817668|FG001|Overall Study|Physician Decision|1|||
161391284|NCT01110330|582817669|FG002|Overall Study|Physician Decision|0|||
161391285|NCT01110330|582817667|FG000|Overall Study|Protocol Violation|2|||
161391286|NCT01110330|582817668|FG001|Overall Study|Protocol Violation|0|||
161391287|NCT01110330|582817669|FG002|Overall Study|Protocol Violation|4|||
161391288|NCT01110330|582817667|FG000|Overall Study|Withdrawal by Subject|0|||
161391289|NCT01110330|582817668|FG001|Overall Study|Withdrawal by Subject|6|||
161391290|NCT01110330|582817669|FG002|Overall Study|Withdrawal by Subject|2|||
161391291|NCT01110330|582817667|FG000|Overall Study|Other|1|||
161391292|NCT01110330|582817668|FG001|Overall Study|Other|1|||
161391293|NCT01110330|582817669|FG002|Overall Study|Other|1|||
161391294|NCT02759107|582817670|FG000|Overall Study|Adverse Event|0|||
161391295|NCT02759107|582817671|FG001|Overall Study|Adverse Event|0|||
161391296|NCT02759107|582817672|FG002|Overall Study|Adverse Event|0|||
161391297|NCT02759107|582817673|FG003|Overall Study|Adverse Event|0|||
161391298|NCT02759107|582817674|FG004|Overall Study|Adverse Event|0|||
161391299|NCT02759107|582817675|FG005|Overall Study|Adverse Event|0|||
161391300|NCT02759107|582817676|FG006|Overall Study|Adverse Event|0|||
161391301|NCT02759107|582817677|FG007|Overall Study|Adverse Event|0|||
161391302|NCT02759107|582817678|FG008|Overall Study|Adverse Event|0|||
161391303|NCT02759107|582817679|FG009|Overall Study|Adverse Event|0|||
161391304|NCT02759107|582817680|FG010|Overall Study|Adverse Event|0|||
161391305|NCT02759107|582817681|FG011|Overall Study|Adverse Event|0|||
161391306|NCT02759107|582817682|FG012|Overall Study|Adverse Event|2|||
161391307|NCT02759107|582817683|FG013|Overall Study|Adverse Event|0|||
161391308|NCT02759107|582817684|FG014|Overall Study|Adverse Event|0|||
161391309|NCT02759107|582817685|FG015|Overall Study|Adverse Event|1|||
161391310|NCT02759107|582817686|FG016|Overall Study|Adverse Event|0|||
161391311|NCT02759107|582817687|FG017|Overall Study|Adverse Event|2|||
161391312|NCT02759107|582817670|FG000|Overall Study|Scheduling Conflict|0|||
161391313|NCT02759107|582817671|FG001|Overall Study|Scheduling Conflict|0|||
161391314|NCT02759107|582817672|FG002|Overall Study|Scheduling Conflict|0|||
161391315|NCT02759107|582817673|FG003|Overall Study|Scheduling Conflict|0|||
161391316|NCT02759107|582817674|FG004|Overall Study|Scheduling Conflict|0|||
161391317|NCT02759107|582817675|FG005|Overall Study|Scheduling Conflict|0|||
161391318|NCT02759107|582817676|FG006|Overall Study|Scheduling Conflict|0|||
161391319|NCT02759107|582817677|FG007|Overall Study|Scheduling Conflict|0|||
161391320|NCT02759107|582817678|FG008|Overall Study|Scheduling Conflict|0|||
161391321|NCT02759107|582817679|FG009|Overall Study|Scheduling Conflict|1|||
161391322|NCT02759107|582817680|FG010|Overall Study|Scheduling Conflict|0|||
161391323|NCT02759107|582817681|FG011|Overall Study|Scheduling Conflict|0|||
161391324|NCT02759107|582817682|FG012|Overall Study|Scheduling Conflict|0|||
161391325|NCT02759107|582817683|FG013|Overall Study|Scheduling Conflict|0|||
161391326|NCT02759107|582817684|FG014|Overall Study|Scheduling Conflict|0|||
161391327|NCT02759107|582817685|FG015|Overall Study|Scheduling Conflict|0|||
161391328|NCT02759107|582817686|FG016|Overall Study|Scheduling Conflict|0|||
161391329|NCT02759107|582817687|FG017|Overall Study|Scheduling Conflict|0|||
161391330|NCT00420004|582817694|FG000|Overall Study|Adverse Event|4|||
161391331|NCT00420004|582817695|FG001|Overall Study|Adverse Event|1|||
161391332|NCT00420004|582817696|FG002|Overall Study|Adverse Event|1|||
161391333|NCT00420004|582817694|FG000|Overall Study|Lack of Efficacy|5|||
161391334|NCT00420004|582817695|FG001|Overall Study|Lack of Efficacy|4|||
161391335|NCT00420004|582817696|FG002|Overall Study|Lack of Efficacy|1|||
161391336|NCT00420004|582817694|FG000|Overall Study|Lost to Follow-up|31|||
161391337|NCT00420004|582817695|FG001|Overall Study|Lost to Follow-up|12|||
161391338|NCT00420004|582817696|FG002|Overall Study|Lost to Follow-up|10|||
161391339|NCT00420004|582817694|FG000|Overall Study|Entry Criteria Not Met|0|||
161391340|NCT00420004|582817695|FG001|Overall Study|Entry Criteria Not Met|1|||
161391341|NCT00420004|582817696|FG002|Overall Study|Entry Criteria Not Met|0|||
161391342|NCT00420004|582817694|FG000|Overall Study|Physician Decision|14|||
161391343|NCT00420004|582817695|FG001|Overall Study|Physician Decision|4|||
161391344|NCT00420004|582817696|FG002|Overall Study|Physician Decision|2|||
161391345|NCT00420004|582817694|FG000|Overall Study|Protocol Violation|5|||
161391346|NCT00420004|582817695|FG001|Overall Study|Protocol Violation|4|||
161391347|NCT00420004|582817696|FG002|Overall Study|Protocol Violation|3|||
161391348|NCT00420004|582817694|FG000|Overall Study|Withdrawal by Subject|67|||
161391349|NCT00420004|582817695|FG001|Overall Study|Withdrawal by Subject|42|||
161391350|NCT00420004|582817696|FG002|Overall Study|Withdrawal by Subject|14|||
161391351|NCT00420004|582817694|FG000|Overall Study|Sponsor Decision|3|||
161391352|NCT00420004|582817695|FG001|Overall Study|Sponsor Decision|3|||
161391353|NCT00420004|582817696|FG002|Overall Study|Sponsor Decision|1|||
161391354|NCT00591149|582817697|FG000|Overall Study|Adverse Event|4|||
161391355|NCT00591149|582817697|FG000|Overall Study|Withdrawal by Subject|1|||
161391356|NCT03002818|582817698|FG000|Overall Study|Decision of the investigator|1|||
161391357|NCT01549886|582817699|FG000|Overall Study|Sponsor's decision|2|||
161391358|NCT01549886|582817700|FG001|Overall Study|Sponsor's decision|3|||
161391359|NCT00608023|582817701|FG000|Overall Study|Withdrawal by Subject|8|||
161391360|NCT00608023|582817702|FG001|Overall Study|Withdrawal by Subject|10|||
161391361|NCT00608023|582817703|FG002|Overall Study|Withdrawal by Subject|7|||
161391362|NCT00608023|582817701|FG000|Overall Study|Adverse Event|1|||
161391363|NCT00608023|582817702|FG001|Overall Study|Adverse Event|4|||
161391364|NCT00608023|582817703|FG002|Overall Study|Adverse Event|5|||
161391365|NCT00608023|582817701|FG000|Overall Study|Lost to Follow-up|2|||
161391366|NCT00608023|582817702|FG001|Overall Study|Lost to Follow-up|2|||
161391367|NCT00608023|582817703|FG002|Overall Study|Lost to Follow-up|1|||
161391368|NCT00608023|582817701|FG000|Overall Study|Protocol Violation|1|||
161391369|NCT00608023|582817702|FG001|Overall Study|Protocol Violation|3|||
161391370|NCT00608023|582817703|FG002|Overall Study|Protocol Violation|1|||
161391371|NCT00608023|582817701|FG000|Overall Study|Unknown reason|0|||
161391372|NCT00608023|582817702|FG001|Overall Study|Unknown reason|3|||
161391373|NCT00608023|582817703|FG002|Overall Study|Unknown reason|0|||
161391374|NCT01231321|582817704|FG000|Overall Study|Adverse Event|3|||
161391375|NCT01231321|582817704|FG000|Overall Study|Lack of Efficacy|2|||
161391376|NCT04021524|582817705|FG000|Overall Study|Change in surgical intervention|0|||
161391377|NCT04021524|582817706|FG001|Overall Study|Change in surgical intervention|1|||
161391378|NCT06422364|582817707|FG000|Overall Study|Withdrawn due to study closure|0|||
161391379|NCT06422364|582817708|FG001|Overall Study|Withdrawn due to study closure|2|||
161391380|NCT00245050|582817712|FG000|Overall Study|Adverse Event|3|||
161391381|NCT00245050|582817713|FG001|Overall Study|Adverse Event|2|||
161391382|NCT00152477|582817716|FG000|Chemotherapy Period|Adverse Event|9|||
161391383|NCT00152477|582817717|FG001|Chemotherapy Period|Adverse Event|4|||
161391384|NCT00152477|582817718|FG002|Chemotherapy Period|Adverse Event|5|||
161391385|NCT00152477|582817716|FG000|Chemotherapy Period|Death|1|||
161391386|NCT00152477|582817717|FG001|Chemotherapy Period|Death|3|||
161391387|NCT00152477|582817718|FG002|Chemotherapy Period|Death|3|||
161391388|NCT00152477|582817716|FG000|Chemotherapy Period|Lack of Efficacy|4|||
161391389|NCT00152477|582817717|FG001|Chemotherapy Period|Lack of Efficacy|5|||
161391390|NCT00152477|582817718|FG002|Chemotherapy Period|Lack of Efficacy|6|||
161391391|NCT00152477|582817716|FG000|Chemotherapy Period|Lost to Follow-up|1|||
161391392|NCT00152477|582817717|FG001|Chemotherapy Period|Lost to Follow-up|0|||
161391393|NCT00152477|582817718|FG002|Chemotherapy Period|Lost to Follow-up|1|||
161391394|NCT00152477|582817716|FG000|Chemotherapy Period|Protocol Violation|1|||
161391395|NCT00152477|582817717|FG001|Chemotherapy Period|Protocol Violation|1|||
161391396|NCT00152477|582817718|FG002|Chemotherapy Period|Protocol Violation|0|||
161391397|NCT00152477|582817716|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
161391398|NCT00152477|582817717|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
161391399|NCT00152477|582817718|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
161391400|NCT00152477|582817716|FG000|Chemotherapy Period|Progression of Disease|6|||
161391401|NCT00152477|582817717|FG001|Chemotherapy Period|Progression of Disease|8|||
161391402|NCT00152477|582817718|FG002|Chemotherapy Period|Progression of Disease|4|||
161391403|NCT00152477|582817716|FG000|Chemotherapy Period|Investigator decision|0|||
161391404|NCT00152477|582817717|FG001|Chemotherapy Period|Investigator decision|0|||
161391405|NCT00152477|582817718|FG002|Chemotherapy Period|Investigator decision|1|||
161391406|NCT00152477|582817716|FG000|Chemotherapy Period|Patient condition worsened|1|||
161391407|NCT00152477|582817717|FG001|Chemotherapy Period|Patient condition worsened|0|||
161391408|NCT00152477|582817718|FG002|Chemotherapy Period|Patient condition worsened|0|||
161391409|NCT00152477|582817716|FG000|Monotherapy Period|Adverse Event|1|||
161391410|NCT00152477|582817717|FG001|Monotherapy Period|Adverse Event|0|||
161391411|NCT00152477|582817718|FG002|Monotherapy Period|Adverse Event|5|||
161391412|NCT00152477|582817716|FG000|Monotherapy Period|Death|2|||
161391413|NCT00152477|582817717|FG001|Monotherapy Period|Death|0|||
161391414|NCT00152477|582817718|FG002|Monotherapy Period|Death|1|||
161391415|NCT00152477|582817716|FG000|Monotherapy Period|Lack of Efficacy|7|||
161391416|NCT00152477|582817717|FG001|Monotherapy Period|Lack of Efficacy|16|||
161391417|NCT00152477|582817718|FG002|Monotherapy Period|Lack of Efficacy|10|||
161391418|NCT00152477|582817716|FG000|Monotherapy Period|Protocol Violation|0|||
161391419|NCT00152477|582817717|FG001|Monotherapy Period|Protocol Violation|1|||
161391420|NCT00152477|582817718|FG002|Monotherapy Period|Protocol Violation|0|||
161391421|NCT00152477|582817716|FG000|Monotherapy Period|Withdrawal by Subject|0|||
161391422|NCT00152477|582817717|FG001|Monotherapy Period|Withdrawal by Subject|0|||
161391423|NCT00152477|582817718|FG002|Monotherapy Period|Withdrawal by Subject|4|||
161391424|NCT00152477|582817716|FG000|Monotherapy Period|Progression of Disease|5|||
161391425|NCT00152477|582817717|FG001|Monotherapy Period|Progression of Disease|11|||
161391426|NCT00152477|582817718|FG002|Monotherapy Period|Progression of Disease|12|||
161391427|NCT00152477|582817716|FG000|Monotherapy Period|Patient decision|0|||
161391428|NCT00152477|582817717|FG001|Monotherapy Period|Patient decision|1|||
161391429|NCT00152477|582817718|FG002|Monotherapy Period|Patient decision|1|||
161391430|NCT00152477|582817716|FG000|Monotherapy Period|Study personel decision|0|||
161391431|NCT00152477|582817717|FG001|Monotherapy Period|Study personel decision|0|||
161391432|NCT00152477|582817718|FG002|Monotherapy Period|Study personel decision|1|||
161391433|NCT03275246|582817721|FG000|Overall Study|Protocol Violation|5|||
161391434|NCT03275246|582817721|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
161391435|NCT00730041|582817722|FG000|Overall Study|Lost to Follow-up|0|||
161391436|NCT00730041|582817723|FG001|Overall Study|Lost to Follow-up|2|||
161391437|NCT02301546|582817724|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
161391438|NCT02301546|582817725|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
161391439|NCT02301546|582817724|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
161391440|NCT02301546|582817725|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
161391441|NCT02301546|582817724|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
161391442|NCT02301546|582817725|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
161391443|NCT02301546|582817724|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
161391444|NCT02301546|582817725|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
161391445|NCT02301546|582817724|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
161391446|NCT02301546|582817725|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
161391447|NCT02301546|582817724|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
161391448|NCT02301546|582817725|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
161391449|NCT02301546|582817724|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
161391450|NCT02301546|582817725|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
161391451|NCT00433966|582817726|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
161391452|NCT00433966|582817727|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
161391453|NCT00433966|582817728|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
161391454|NCT00433966|582817729|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
161391455|NCT00433966|582817726|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
161391456|NCT00433966|582817727|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
161391457|NCT00433966|582817728|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
161391458|NCT00433966|582817729|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
161391459|NCT00433966|582817726|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
161391460|NCT00433966|582817727|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
161391461|NCT00433966|582817728|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
161391462|NCT00433966|582817729|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
161391463|NCT00433966|582817726|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
161391464|NCT00433966|582817727|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
161391465|NCT00433966|582817728|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
161391466|NCT00433966|582817729|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
161391467|NCT00433966|582817726|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
161391468|NCT00433966|582817727|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
161391469|NCT00433966|582817728|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
161391470|NCT00433966|582817729|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
161391471|NCT05059301|582817730|FG000|Overall Study|Adverse Event|0|||
161391472|NCT05059301|582817731|FG001|Overall Study|Adverse Event|2|||
161391473|NCT05059301|582817732|FG002|Overall Study|Adverse Event|2|||
161391474|NCT05059301|582817730|FG000|Overall Study|Lost to Follow-up|2|||
161391475|NCT05059301|582817731|FG001|Overall Study|Lost to Follow-up|3|||
161391476|NCT05059301|582817732|FG002|Overall Study|Lost to Follow-up|3|||
161391477|NCT04952597|582817734|FG000|Overall Study|Death|12|||
161391478|NCT04952597|582817735|FG001|Overall Study|Death|13|||
161391479|NCT04952597|582817736|FG002|Overall Study|Death|14|||
161391480|NCT04952597|582817734|FG000|Overall Study|Withdrawal by Subject|1|||
161391481|NCT04952597|582817735|FG001|Overall Study|Withdrawal by Subject|0|||
161391482|NCT04952597|582817736|FG002|Overall Study|Withdrawal by Subject|3|||
161391483|NCT04952597|582817734|FG000|Overall Study|Lost to Follow-up|0|||
161391484|NCT04952597|582817735|FG001|Overall Study|Lost to Follow-up|1|||
161391485|NCT04952597|582817736|FG002|Overall Study|Lost to Follow-up|1|||
161391486|NCT00923975|582817741|FG000|Overall Study|Did not meet inclusion criteria|1|||
161391487|NCT01005316|582817744|FG000|Overall Study|Adverse Event|0|||
161391488|NCT01005316|582817745|FG001|Overall Study|Adverse Event|0|||
161391489|NCT01005316|582817746|FG002|Overall Study|Adverse Event|0|||
161391490|NCT01005316|582817747|FG003|Overall Study|Adverse Event|1|||
161391491|NCT01005316|582817744|FG000|Overall Study|Death|20|||
161391492|NCT01005316|582817745|FG001|Overall Study|Death|5|||
161391493|NCT01005316|582817746|FG002|Overall Study|Death|1|||
161391494|NCT01005316|582817747|FG003|Overall Study|Death|15|||
161391495|NCT01005316|582817744|FG000|Overall Study|Study Termination|5|||
161391496|NCT01005316|582817745|FG001|Overall Study|Study Termination|63|||
161391497|NCT01005316|582817746|FG002|Overall Study|Study Termination|9|||
161391498|NCT01005316|582817747|FG003|Overall Study|Study Termination|85|||
161391499|NCT01005316|582817744|FG000|Overall Study|Lost to Follow-up|1|||
161391500|NCT01005316|582817745|FG001|Overall Study|Lost to Follow-up|3|||
161391501|NCT01005316|582817746|FG002|Overall Study|Lost to Follow-up|0|||
161391502|NCT01005316|582817747|FG003|Overall Study|Lost to Follow-up|2|||
161391503|NCT01005316|582817744|FG000|Overall Study|Physician Decision|6|||
161391504|NCT01005316|582817745|FG001|Overall Study|Physician Decision|0|||
161391505|NCT01005316|582817746|FG002|Overall Study|Physician Decision|0|||
161391506|NCT01005316|582817747|FG003|Overall Study|Physician Decision|0|||
161391507|NCT01005316|582817744|FG000|Overall Study|Sponsor Decision|6|||
161391508|NCT01005316|582817745|FG001|Overall Study|Sponsor Decision|3|||
161391509|NCT01005316|582817746|FG002|Overall Study|Sponsor Decision|0|||
161391510|NCT01005316|582817747|FG003|Overall Study|Sponsor Decision|0|||
161391511|NCT01005316|582817744|FG000|Overall Study|Withdrawal by Subject|1|||
161391512|NCT01005316|582817745|FG001|Overall Study|Withdrawal by Subject|1|||
161391513|NCT01005316|582817746|FG002|Overall Study|Withdrawal by Subject|0|||
161391514|NCT01005316|582817747|FG003|Overall Study|Withdrawal by Subject|2|||
161391515|NCT01005316|582817744|FG000|Overall Study|Consented to Another Study|2|||
161391516|NCT01005316|582817745|FG001|Overall Study|Consented to Another Study|0|||
161391517|NCT01005316|582817746|FG002|Overall Study|Consented to Another Study|0|||
161391518|NCT01005316|582817747|FG003|Overall Study|Consented to Another Study|0|||
161391519|NCT01005316|582817744|FG000|Overall Study|Delisted|8|||
161391520|NCT01005316|582817745|FG001|Overall Study|Delisted|0|||
161391521|NCT01005316|582817746|FG002|Overall Study|Delisted|0|||
161391522|NCT01005316|582817747|FG003|Overall Study|Delisted|0|||
161391523|NCT01005316|582817744|FG000|Overall Study|Transferred Care|1|||
161391524|NCT01005316|582817745|FG001|Overall Study|Transferred Care|0|||
161391525|NCT01005316|582817746|FG002|Overall Study|Transferred Care|1|||
161391526|NCT01005316|582817747|FG003|Overall Study|Transferred Care|3|||
161391527|NCT01005316|582817744|FG000|Overall Study|Retransplanted|0|||
161391528|NCT01005316|582817745|FG001|Overall Study|Retransplanted|1|||
161391529|NCT01005316|582817746|FG002|Overall Study|Retransplanted|0|||
161391530|NCT01005316|582817747|FG003|Overall Study|Retransplanted|0|||
161391531|NCT00632827|582817748|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
161391532|NCT00632827|582817748|FG000|Overall Study|Death|2|||
161391533|NCT00632827|582817748|FG000|Overall Study|Adverse Event|5|||
161391534|NCT00632827|582817748|FG000|Overall Study|Lost to Follow-up|1|||
161391535|NCT03748706|582817749|FG000|Overall Study|Lost to Follow-up|1|||
161391536|NCT01606176|582817755|FG000|Overall Study|Adverse Event|2|||
161391537|NCT01606176|582817756|FG001|Overall Study|Adverse Event|3|||
161391538|NCT01606176|582817755|FG000|Overall Study|Disease progression|1|||
161391539|NCT01606176|582817756|FG001|Overall Study|Disease progression|0|||
161391540|NCT01606176|582817755|FG000|Overall Study|Withdrawal by Subject|1|||
161391541|NCT01606176|582817756|FG001|Overall Study|Withdrawal by Subject|0|||
161391542|NCT03703817|582817759|FG000|Overall Study|Not meeting eligibility criteria|7|||
161391543|NCT03703817|582817760|FG001|Overall Study|Not meeting eligibility criteria|4|||
161391544|NCT05129449|582817772|FG000|Overall Study|Protocol Violation|1|||
161391545|NCT04238481|582817773|FG000|Overall Study|Miscellaneous|0|||
161391546|NCT04238481|582817774|FG001|Overall Study|Miscellaneous|1|||
161391547|NCT04238481|582817775|FG002|Overall Study|Miscellaneous|0|||
161391548|NCT04238481|582817776|FG003|Overall Study|Miscellaneous|0|||
161391549|NCT02247011|582817777|FG000|Overall Study|Poor quality of radiological results|125|||
161391550|NCT02152371|582817778|FG000|Overall Study|Adverse Event|6|||
161391551|NCT02152371|582817779|FG001|Overall Study|Adverse Event|2|||
161391552|NCT02152371|582817778|FG000|Overall Study|Withdrawal by Subject|3|||
161391553|NCT02152371|582817779|FG001|Overall Study|Withdrawal by Subject|7|||
161391554|NCT02152371|582817778|FG000|Overall Study|Protocol Violation|2|||
161391555|NCT02152371|582817779|FG001|Overall Study|Protocol Violation|3|||
161391556|NCT02152371|582817778|FG000|Overall Study|Lost to Follow-up|1|||
161391557|NCT02152371|582817779|FG001|Overall Study|Lost to Follow-up|0|||
161391558|NCT02152371|582817778|FG000|Overall Study|Lack of Efficacy|0|||
161391559|NCT02152371|582817779|FG001|Overall Study|Lack of Efficacy|1|||
161391560|NCT02152371|582817778|FG000|Overall Study|Physician Decision|0|||
161391561|NCT02152371|582817779|FG001|Overall Study|Physician Decision|2|||
161391562|NCT02152371|582817778|FG000|Overall Study|Reason Not Given|0|||
161391563|NCT02152371|582817779|FG001|Overall Study|Reason Not Given|1|||
161391564|NCT00656058|582817781|FG000|Overall Study|Withdrawal by Subject|2|||
161391565|NCT00656058|582817781|FG000|Overall Study|Withdrawal by Subject|4|||
161391566|NCT00616018|582817782|FG000|Overall Study|Protocol Violation|3|||
161391567|NCT01818258|582817784|FG000|Overall Study|Death|3|||
161391568|NCT01818258|582817785|FG001|Overall Study|Death|0|||
161391569|NCT01818258|582817784|FG000|Overall Study|Withdrawal by Subject|0|||
161391570|NCT01818258|582817785|FG001|Overall Study|Withdrawal by Subject|1|||
161391571|NCT01818258|582817784|FG000|Overall Study|Lost to Follow-up|0|||
161391572|NCT01818258|582817785|FG001|Overall Study|Lost to Follow-up|1|||
161391573|NCT01818258|582817784|FG000|Overall Study|Unable to Travel to Clinic|0|||
161391574|NCT01818258|582817785|FG001|Overall Study|Unable to Travel to Clinic|1|||
161391575|NCT02839720|582817786|FG000|Overall Study|Adverse Event|2|||
161391576|NCT02839720|582817786|FG000|Overall Study|Non-compliance|2|||
161391577|NCT02839720|582817786|FG000|Overall Study|Intercurrent Illness|1|||
161391578|NCT02839720|582817786|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
161391579|NCT00349921|582817787|FG000|First Spinal Injection|Physician Decision|1|||
161391580|NCT00349921|582817788|FG001|First Spinal Injection|Physician Decision|0|||
161391581|NCT00349921|582817789|FG002|First Spinal Injection|Physician Decision|0|||
161391582|NCT00349921|582817790|FG003|First Spinal Injection|Physician Decision|0|||
161391583|NCT00349921|582817787|FG000|First Spinal Injection|Adverse Event|0|||
161391584|NCT00349921|582817788|FG001|First Spinal Injection|Adverse Event|0|||
161391585|NCT00349921|582817789|FG002|First Spinal Injection|Adverse Event|1|||
161391586|NCT00349921|582817790|FG003|First Spinal Injection|Adverse Event|0|||
161391587|NCT05145322|582817791|FG000|Overall Study|Lost to Follow-up|4|||
161391588|NCT05145322|582817792|FG001|Overall Study|Lost to Follow-up|5|||
161391589|NCT04700540|582817793|FG000|Overall Study|Withdrawal by Subject|12|||
161391590|NCT04700540|582817794|FG001|Overall Study|Withdrawal by Subject|8|||
161391591|NCT04700540|582817793|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
161391592|NCT04700540|582817794|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
161391593|NCT03194568|582817795|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
161391594|NCT05285644|582817798|FG000|Overall Study|Adverse Event|3|||
161391595|NCT05285644|582817799|FG001|Overall Study|Adverse Event|3|||
161391596|NCT05285644|582817798|FG000|Overall Study|Withdrawal of Consent|2|||
161391597|NCT05285644|582817799|FG001|Overall Study|Withdrawal of Consent|5|||
161391598|NCT05285644|582817798|FG000|Overall Study|Noncompliance|0|||
161391599|NCT05285644|582817799|FG001|Overall Study|Noncompliance|4|||
161391600|NCT05285644|582817798|FG000|Overall Study|Lost to Follow-up|4|||
161391601|NCT05285644|582817799|FG001|Overall Study|Lost to Follow-up|6|||
161391602|NCT05285644|582817798|FG000|Overall Study|Disallowed Concurrent Medication|1|||
161391603|NCT05285644|582817799|FG001|Overall Study|Disallowed Concurrent Medication|1|||
161391604|NCT05285644|582817798|FG000|Overall Study|Investigator Decision|2|||
161391605|NCT05285644|582817799|FG001|Overall Study|Investigator Decision|0|||
161391606|NCT05285644|582817798|FG000|Overall Study|Protocol Deviation|1|||
161391607|NCT05285644|582817799|FG001|Overall Study|Protocol Deviation|0|||
161391608|NCT05285644|582817798|FG000|Overall Study|As specified in the Clinical Study Report|7|||
161391609|NCT05285644|582817799|FG001|Overall Study|As specified in the Clinical Study Report|3|||
161391610|NCT01740089|582819796|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
161391611|NCT01740089|582819797|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
161391612|NCT01740089|582819798|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
161391613|NCT01740089|582819796|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
161391614|NCT01740089|582819797|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
161391615|NCT01740089|582819798|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
161391616|NCT01740089|582819796|FG000|After 12 Weeks|Lack of Efficacy|3|||
161391617|NCT01740089|582819797|FG001|After 12 Weeks|Lack of Efficacy|1|||
161391618|NCT01740089|582819798|FG002|After 12 Weeks|Lack of Efficacy|4|||
161391619|NCT01740089|582819796|FG000|After 12 Weeks|Adverse Event|2|||
161391620|NCT01740089|582819797|FG001|After 12 Weeks|Adverse Event|0|||
161391621|NCT01740089|582819798|FG002|After 12 Weeks|Adverse Event|5|||
161391622|NCT01740089|582819796|FG000|After 12 Weeks|Protocol Violation|1|||
161391623|NCT01740089|582819797|FG001|After 12 Weeks|Protocol Violation|1|||
161391624|NCT01740089|582819798|FG002|After 12 Weeks|Protocol Violation|1|||
161391625|NCT01740089|582819796|FG000|After 12 Weeks|Withdrawal by Subject|1|||
161391626|NCT01740089|582819797|FG001|After 12 Weeks|Withdrawal by Subject|1|||
161391627|NCT01740089|582819798|FG002|After 12 Weeks|Withdrawal by Subject|1|||
161391628|NCT03100539|582819802|FG000|Overall Study|Lost to Follow-up|60|||
161391629|NCT03100539|582819803|FG001|Overall Study|Lost to Follow-up|54|||
161391630|NCT03100539|582819804|FG002|Overall Study|Lost to Follow-up|17|||
161391631|NCT03100539|582819802|FG000|Overall Study|Uncollected|8|||
161391632|NCT03100539|582819803|FG001|Overall Study|Uncollected|8|||
161391633|NCT03100539|582819804|FG002|Overall Study|Uncollected|0|||
161391634|NCT03100539|582819802|FG000|Overall Study|Ally Health|0|||
161391635|NCT03100539|582819803|FG001|Overall Study|Ally Health|0|||
161391636|NCT03100539|582819804|FG002|Overall Study|Ally Health|3|||
161391637|NCT03100539|582819802|FG000|Overall Study|Disinterest|0|||
161391638|NCT03100539|582819803|FG001|Overall Study|Disinterest|0|||
161391639|NCT03100539|582819804|FG002|Overall Study|Disinterest|22|||
161391640|NCT03100539|582819802|FG000|Overall Study|Veteran Health|0|||
161391641|NCT03100539|582819803|FG001|Overall Study|Veteran Health|0|||
161391642|NCT03100539|582819804|FG002|Overall Study|Veteran Health|8|||
161391643|NCT03100539|582819802|FG000|Overall Study|Moved|0|||
161391644|NCT03100539|582819803|FG001|Overall Study|Moved|0|||
161391645|NCT03100539|582819804|FG002|Overall Study|Moved|1|||
161391646|NCT03100539|582819802|FG000|Overall Study|Scheduling Conflicts|0|||
161391647|NCT03100539|582819803|FG001|Overall Study|Scheduling Conflicts|0|||
161391648|NCT03100539|582819804|FG002|Overall Study|Scheduling Conflicts|12|||
161391649|NCT01892436|582819805|FG000|Overall Study|Withdrawal by Subject|8|||
161391650|NCT01892436|582819806|FG001|Overall Study|Withdrawal by Subject|15|||
161391651|NCT01892436|582819807|FG002|Overall Study|Withdrawal by Subject|4|||
161391652|NCT01892436|582819808|FG003|Overall Study|Withdrawal by Subject|4|||
161391653|NCT01892436|582819805|FG000|Overall Study|Death|1|||
161391654|NCT01892436|582819806|FG001|Overall Study|Death|1|||
161391655|NCT01892436|582819807|FG002|Overall Study|Death|0|||
161391656|NCT01892436|582819808|FG003|Overall Study|Death|0|||
161391657|NCT01892436|582819805|FG000|Overall Study|Physician Decision|2|||
161391658|NCT01892436|582819806|FG001|Overall Study|Physician Decision|1|||
161391659|NCT01892436|582819807|FG002|Overall Study|Physician Decision|0|||
161391660|NCT01892436|582819808|FG003|Overall Study|Physician Decision|1|||
161391661|NCT01892436|582819805|FG000|Overall Study|Pregnancy|0|||
161391662|NCT01892436|582819806|FG001|Overall Study|Pregnancy|2|||
161391663|NCT01892436|582819807|FG002|Overall Study|Pregnancy|1|||
161391664|NCT01892436|582819808|FG003|Overall Study|Pregnancy|0|||
161391665|NCT01892436|582819805|FG000|Overall Study|Technical problems|2|||
161391666|NCT01892436|582819806|FG001|Overall Study|Technical problems|1|||
161391667|NCT01892436|582819807|FG002|Overall Study|Technical problems|1|||
161391668|NCT01892436|582819808|FG003|Overall Study|Technical problems|1|||
161391669|NCT01892436|582819805|FG000|Overall Study|Lack of Efficacy|1|||
161391670|NCT01892436|582819806|FG001|Overall Study|Lack of Efficacy|2|||
161391671|NCT01892436|582819807|FG002|Overall Study|Lack of Efficacy|2|||
161391672|NCT01892436|582819808|FG003|Overall Study|Lack of Efficacy|2|||
161391673|NCT01892436|582819805|FG000|Overall Study|Lost to Follow-up|1|||
161391674|NCT01892436|582819806|FG001|Overall Study|Lost to Follow-up|1|||
161391675|NCT01892436|582819807|FG002|Overall Study|Lost to Follow-up|1|||
161391676|NCT01892436|582819808|FG003|Overall Study|Lost to Follow-up|3|||
161391677|NCT01892436|582819805|FG000|Overall Study|non-compliance with treatment|1|||
161391678|NCT01892436|582819806|FG001|Overall Study|non-compliance with treatment|0|||
161391679|NCT01892436|582819807|FG002|Overall Study|non-compliance with treatment|0|||
161391680|NCT01892436|582819808|FG003|Overall Study|non-compliance with treatment|0|||
161391681|NCT01892436|582819805|FG000|Overall Study|Adverse Event|7|||
161391682|NCT01892436|582819806|FG001|Overall Study|Adverse Event|6|||
161391683|NCT01892436|582819807|FG002|Overall Study|Adverse Event|2|||
161391684|NCT01892436|582819808|FG003|Overall Study|Adverse Event|3|||
161391685|NCT01606787|582819810|FG000|Overall Study|Withdrawal by Subject|4|||
161391686|NCT01606787|582819811|FG001|Overall Study|Withdrawal by Subject|5|||
161391687|NCT01606787|582819810|FG000|Overall Study|Surgery canceled|0|||
161391688|NCT01606787|582819811|FG001|Overall Study|Surgery canceled|2|||
161391689|NCT00713349|582819813|FG000|Overall Study|Protocol Violation|1|||
161391690|NCT03764631|582819814|FG000|Overall Study|Personal Reasons|3|||
161391691|NCT03764631|582819815|FG001|Overall Study|Personal Reasons|2|||
161391692|NCT03764631|582819814|FG000|Overall Study|Switching Therapy|3|||
161391693|NCT03764631|582819815|FG001|Overall Study|Switching Therapy|3|||
161391694|NCT03764631|582819814|FG000|Overall Study|Adverse Event|0|||
161391695|NCT03764631|582819815|FG001|Overall Study|Adverse Event|1|||
161391696|NCT03764631|582819814|FG000|Overall Study|Lost to Follow-up|33|||
161391697|NCT03764631|582819815|FG001|Overall Study|Lost to Follow-up|41|||
161391698|NCT03764631|582819814|FG000|Overall Study|No data as study site was closed|2|||
161391699|NCT03764631|582819815|FG001|Overall Study|No data as study site was closed|6|||
161391700|NCT01289353|582819816|FG000|Overall Study|Lost to Follow-up|2|||
161391701|NCT00473668|582819819|FG000|Overall Study|Withdrawal by Subject|0|||
161391702|NCT00473668|582819820|FG001|Overall Study|Withdrawal by Subject|2|||
161391703|NCT00473668|582819821|FG002|Overall Study|Withdrawal by Subject|0|||
161391704|NCT00473668|582819819|FG000|Overall Study|Migrated/moved from study area|3|||
161391705|NCT00473668|582819820|FG001|Overall Study|Migrated/moved from study area|2|||
161391706|NCT00473668|582819821|FG002|Overall Study|Migrated/moved from study area|0|||
161391707|NCT00473668|582819819|FG000|Overall Study|Lost to Follow-up|0|||
161391708|NCT00473668|582819820|FG001|Overall Study|Lost to Follow-up|4|||
161391709|NCT00473668|582819821|FG002|Overall Study|Lost to Follow-up|6|||
161391710|NCT00473668|582819819|FG000|Overall Study|Other|2|||
161391711|NCT00473668|582819820|FG001|Overall Study|Other|3|||
161391712|NCT00473668|582819821|FG002|Overall Study|Other|4|||
161391713|NCT02039219|582819822|FG000|Treatment|Withdrawal by Subject|1|||
161391714|NCT02039219|582819823|FG001|Treatment|Withdrawal by Subject|0|||
161391715|NCT02039219|582819822|FG000|Treatment|Adverse Event|0|||
161391716|NCT02039219|582819823|FG001|Treatment|Adverse Event|1|||
161391717|NCT02039219|582819822|FG000|Treatment|Physician Decision|1|||
161391718|NCT02039219|582819823|FG001|Treatment|Physician Decision|0|||
161391719|NCT02039219|582819822|FG000|Treatment|Lost to Follow-up|0|||
161391720|NCT02039219|582819823|FG001|Treatment|Lost to Follow-up|1|||
161391721|NCT02039219|582819822|FG000|Treatment|Protocol Violation|1|||
161391722|NCT02039219|582819823|FG001|Treatment|Protocol Violation|0|||
161391723|NCT02039219|582819822|FG000|Treatment|Death|1|||
161391724|NCT02039219|582819823|FG001|Treatment|Death|0|||
161391725|NCT02039219|582819822|FG000|Follow up|Adverse Event|0|||
161391726|NCT02039219|582819823|FG001|Follow up|Adverse Event|1|||
161391727|NCT02226562|582819829|FG000|Overall Study|Lost to Follow-up|0|||
161391728|NCT02226562|582819830|FG001|Overall Study|Lost to Follow-up|1|||
161391729|NCT04569136|582819831|FG000|Overall Study|Lost to Follow-up|2|||
161391730|NCT04569136|582819832|FG001|Overall Study|Lost to Follow-up|0|||
161391731|NCT04569136|582819833|FG002|Overall Study|Lost to Follow-up|1|||
161391732|NCT00129701|582819839|FG000|Overall Study|Withdrawal by Subject|33|||
161391733|NCT03576066|582819840|FG000|Overall Study|Noncompliance with study drug|0|||
161391734|NCT03576066|582819841|FG001|Overall Study|Noncompliance with study drug|1|||
161391735|NCT01466660|582819842|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
161391736|NCT01466660|582819843|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
161391737|NCT01466660|582819842|FG000|Overall Study|Worsening of underlying cancer disease|5|||
161391738|NCT01466660|582819843|FG001|Overall Study|Worsening of underlying cancer disease|2|||
161391739|NCT01466660|582819842|FG000|Overall Study|Other adverse event|19|||
161391740|NCT01466660|582819843|FG001|Overall Study|Other adverse event|18|||
161391741|NCT01466660|582819842|FG000|Overall Study|Protocol Violation|2|||
161391742|NCT01466660|582819843|FG001|Overall Study|Protocol Violation|1|||
161391743|NCT01466660|582819842|FG000|Overall Study|Refused continuation of trial medication|4|||
161391744|NCT01466660|582819843|FG001|Overall Study|Refused continuation of trial medication|3|||
161391745|NCT01466660|582819842|FG000|Overall Study|Other reason not defined above|10|||
161391746|NCT01466660|582819843|FG001|Overall Study|Other reason not defined above|8|||
161391747|NCT02750345|582819844|FG000|Intervention 1|Adverse Event|0|||
161391748|NCT02750345|582819845|FG001|Intervention 1|Adverse Event|0|||
161391749|NCT02750345|582819846|FG002|Intervention 1|Adverse Event|0|||
161391750|NCT02750345|582819847|FG003|Intervention 1|Adverse Event|0|||
161391751|NCT02750345|582819848|FG004|Intervention 1|Adverse Event|1|||
161391752|NCT02750345|582819849|FG005|Intervention 1|Adverse Event|0|||
161391753|NCT00006164|582819850|FG000|Overall Study|Withdrew or lost to follow-up|70|||
161391754|NCT00006164|582819851|FG001|Overall Study|Withdrew or lost to follow-up|81|||
161391755|NCT00223808|582819852|FG000|Overall Study|<5 hrs therapy before discharge|3|||
161391756|NCT00223808|582819853|FG001|Overall Study|<5 hrs therapy before discharge|5|||
161391757|NCT00223808|582819854|FG002|Overall Study|<5 hrs therapy before discharge|5|||
161391758|NCT00191724|582819857|FG000|Overall Study|Adverse Event|0|||
161391759|NCT00191724|582819858|FG001|Overall Study|Adverse Event|0|||
161391760|NCT00191724|582819859|FG002|Overall Study|Adverse Event|1|||
161391761|NCT00191724|582819860|FG003|Overall Study|Adverse Event|0|||
161391762|NCT00191724|582819861|FG004|Overall Study|Adverse Event|0|||
161391763|NCT00191724|582819857|FG000|Overall Study|Lost to Follow-up|1|||
161391764|NCT00191724|582819858|FG001|Overall Study|Lost to Follow-up|1|||
161391765|NCT00191724|582819859|FG002|Overall Study|Lost to Follow-up|0|||
161391766|NCT00191724|582819860|FG003|Overall Study|Lost to Follow-up|2|||
161391767|NCT00191724|582819861|FG004|Overall Study|Lost to Follow-up|3|||
161391768|NCT00191724|582819857|FG000|Overall Study|Withdrawal by Subject|0|||
161391769|NCT00191724|582819858|FG001|Overall Study|Withdrawal by Subject|0|||
161391770|NCT00191724|582819859|FG002|Overall Study|Withdrawal by Subject|0|||
161391771|NCT00191724|582819860|FG003|Overall Study|Withdrawal by Subject|1|||
161391772|NCT00191724|582819861|FG004|Overall Study|Withdrawal by Subject|0|||
161391773|NCT00489736|582819864|FG000|Overall Study|Lack of Efficacy|53|||
161391774|NCT00489736|582819865|FG001|Overall Study|Lack of Efficacy|14|||
161391775|NCT00489736|582819864|FG000|Overall Study|Adverse Event|32|||
161391776|NCT00489736|582819865|FG001|Overall Study|Adverse Event|45|||
161391777|NCT00489736|582819864|FG000|Overall Study|Poor compliance|6|||
161391778|NCT00489736|582819865|FG001|Overall Study|Poor compliance|2|||
161391779|NCT00489736|582819864|FG000|Overall Study|Not coded/ Not pre-specified|5|||
161391780|NCT00489736|582819865|FG001|Overall Study|Not coded/ Not pre-specified|8|||
161391781|NCT05260073|582819867|FG000|Overall Study|Physician Decision|1|||
161391782|NCT05260073|582819867|FG000|Overall Study|Withdrawal by Subject|6|||
161391783|NCT05260073|582819867|FG000|Overall Study|Lost to Follow-up|14|||
161391784|NCT03458910|582819868|FG000|Overall Study|Withdrawal by Subject|7|||
161391785|NCT03458910|582819869|FG001|Overall Study|Withdrawal by Subject|8|||
161391786|NCT03458910|582819870|FG002|Overall Study|Withdrawal by Subject|6|||
161391787|NCT03458910|582819871|FG003|Overall Study|Withdrawal by Subject|4|||
161391788|NCT03458910|582819868|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
161391789|NCT03458910|582819869|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
161391790|NCT03458910|582819870|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
161391791|NCT03458910|582819871|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
161391792|NCT05275010|582819872|FG000|Overall Study|Reason Not Specified|4|||
161391793|NCT05275010|582819873|FG001|Overall Study|Reason Not Specified|1|||
161391794|NCT05275010|582819872|FG000|Overall Study|Withdrawal by Subject|1|||
161391795|NCT05275010|582819873|FG001|Overall Study|Withdrawal by Subject|0|||
161391796|NCT05275010|582819872|FG000|Overall Study|Lost to Follow-up|0|||
161391797|NCT05275010|582819873|FG001|Overall Study|Lost to Follow-up|1|||
161391798|NCT04484649|582819876|FG000|Overall Study|Lost to Follow-up|2|||
161391799|NCT04484649|582819877|FG001|Overall Study|Lost to Follow-up|1|||
161391800|NCT04484649|582819876|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
161391801|NCT04484649|582819877|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
161391802|NCT03883165|582819878|FG000|Overall Study|Withdrawal by Subject|4|||
161391803|NCT03883165|582819879|FG001|Overall Study|Withdrawal by Subject|3|||
161391804|NCT00967694|582819882|FG000|Overall Study|Withdrawal by Subject|6|||
161391805|NCT03905265|582819883|FG000|Overall Study|Withdrawal by Subject|1|||
161391806|NCT03905265|582819884|FG001|Overall Study|Withdrawal by Subject|1|||
161391807|NCT03905265|582819885|FG002|Overall Study|Withdrawal by Subject|0|||
161391808|NCT03905265|582819886|FG003|Overall Study|Withdrawal by Subject|0|||
161391809|NCT04085458|582819889|FG000|Overall Study|Other|1|||
161391810|NCT04085458|582819889|FG000|Overall Study|Withdrawal by Subject|2|||
161391811|NCT04085458|582819889|FG000|Overall Study|Adverse Event|2|||
161391812|NCT03632993|582819890|FG000|Overall Study|Withdrawal by Subject|1|||
161391813|NCT03632993|582819891|FG001|Overall Study|Withdrawal by Subject|0|||
161391814|NCT03632993|582819892|FG002|Overall Study|Withdrawal by Subject|0|||
161391815|NCT03632993|582819893|FG003|Overall Study|Withdrawal by Subject|0|||
161391816|NCT03632993|582819894|FG004|Overall Study|Withdrawal by Subject|0|||
161391817|NCT03632993|582819895|FG005|Overall Study|Withdrawal by Subject|0|||
161391818|NCT03632993|582819896|FG006|Overall Study|Withdrawal by Subject|0|||
161391819|NCT03632993|582819897|FG007|Overall Study|Withdrawal by Subject|0|||
161391820|NCT03632993|582819898|FG008|Overall Study|Withdrawal by Subject|0|||
161391821|NCT03632993|582819899|FG009|Overall Study|Withdrawal by Subject|1|||
161391822|NCT03632993|582819890|FG000|Overall Study|Protocol Non-compliance|0|||
161391823|NCT03632993|582819891|FG001|Overall Study|Protocol Non-compliance|1|||
161391824|NCT03632993|582819892|FG002|Overall Study|Protocol Non-compliance|0|||
161391825|NCT03632993|582819893|FG003|Overall Study|Protocol Non-compliance|0|||
161391826|NCT03632993|582819894|FG004|Overall Study|Protocol Non-compliance|0|||
161391827|NCT03632993|582819895|FG005|Overall Study|Protocol Non-compliance|0|||
161391828|NCT03632993|582819896|FG006|Overall Study|Protocol Non-compliance|0|||
161391829|NCT03632993|582819897|FG007|Overall Study|Protocol Non-compliance|0|||
161391830|NCT03632993|582819898|FG008|Overall Study|Protocol Non-compliance|0|||
161391831|NCT03632993|582819899|FG009|Overall Study|Protocol Non-compliance|0|||
161391832|NCT03632993|582819890|FG000|Overall Study|Lost to Follow-up|0|||
161391833|NCT03632993|582819891|FG001|Overall Study|Lost to Follow-up|0|||
161391834|NCT03632993|582819892|FG002|Overall Study|Lost to Follow-up|0|||
161391835|NCT03632993|582819893|FG003|Overall Study|Lost to Follow-up|0|||
161391836|NCT03632993|582819894|FG004|Overall Study|Lost to Follow-up|0|||
161391837|NCT03632993|582819895|FG005|Overall Study|Lost to Follow-up|1|||
161391838|NCT03632993|582819896|FG006|Overall Study|Lost to Follow-up|0|||
161391839|NCT03632993|582819897|FG007|Overall Study|Lost to Follow-up|1|||
161391840|NCT03632993|582819898|FG008|Overall Study|Lost to Follow-up|0|||
161391841|NCT03632993|582819899|FG009|Overall Study|Lost to Follow-up|0|||
161391842|NCT03632993|582819890|FG000|Overall Study|Adverse Event|0|||
161391843|NCT03632993|582819891|FG001|Overall Study|Adverse Event|0|||
161391844|NCT03632993|582819892|FG002|Overall Study|Adverse Event|0|||
161391845|NCT03632993|582819893|FG003|Overall Study|Adverse Event|0|||
161391846|NCT03632993|582819894|FG004|Overall Study|Adverse Event|0|||
161391847|NCT03632993|582819895|FG005|Overall Study|Adverse Event|1|||
161391848|NCT03632993|582819896|FG006|Overall Study|Adverse Event|0|||
161391849|NCT03632993|582819897|FG007|Overall Study|Adverse Event|1|||
161391850|NCT03632993|582819898|FG008|Overall Study|Adverse Event|0|||
161391851|NCT03632993|582819899|FG009|Overall Study|Adverse Event|0|||
161391852|NCT00758264|582819900|FG000|Active Phase|Withdrawal by Subject|0|||
161391853|NCT00758264|582819901|FG001|Active Phase|Withdrawal by Subject|0|||
161391854|NCT00758264|582819902|FG002|Active Phase|Withdrawal by Subject|1|||
161391855|NCT00758264|582819900|FG000|Active Phase|Lost to Follow-up|1|||
161391856|NCT00758264|582819901|FG001|Active Phase|Lost to Follow-up|0|||
161391857|NCT00758264|582819902|FG002|Active Phase|Lost to Follow-up|0|||
161391858|NCT00758264|582819900|FG000|Active Phase|Other|0|||
161391859|NCT00758264|582819901|FG001|Active Phase|Other|0|||
161391860|NCT00758264|582819902|FG002|Active Phase|Other|4|||
161391861|NCT00368836|582819904|FG000|Phase II|Screen Failure|1|||
161391862|NCT00368836|582819904|FG000|Phase II|Withdrawal by Subject|1|||
161391863|NCT00368836|582819904|FG000|Phase II|unable to collect blood and/or breath|17|||
161391864|NCT00368836|582819904|FG000|Phase II|Protocol Violation|2|||
161391865|NCT00244933|582819912|FG000|Overall Study|Not response evaluable|2|||
161391866|NCT02901054|582819918|FG000|Overall Study|Physician Decision|1|||
161391867|NCT02901054|582819918|FG000|Overall Study|Withdrawal by Subject|3|||
161391868|NCT06359028|582819922|FG000|Overall Study|Adverse Event|1|||
161391869|NCT06359028|582819923|FG001|Overall Study|Adverse Event|0|||
161391870|NCT06359028|582819922|FG000|Overall Study|Withdrawal by Subject|1|||
161391871|NCT06359028|582819923|FG001|Overall Study|Withdrawal by Subject|0|||
161391872|NCT05248997|582819924|FG000|Overall Study|Lost to Follow-up|1|||
161391873|NCT05248997|582819925|FG001|Overall Study|Lost to Follow-up|1|||
161391874|NCT05248997|582819924|FG000|Overall Study|Randomized but not treated|32|||
161391875|NCT05248997|582819925|FG001|Overall Study|Randomized but not treated|25|||
161391876|NCT03515551|582819926|FG000|Overall Study|Death|4|||
161391877|NCT03515551|582819927|FG001|Overall Study|Death|1|||
161391878|NCT03515551|582819928|FG002|Overall Study|Death|2|||
161391879|NCT03515551|582819929|FG003|Overall Study|Death|2|||
161391880|NCT03515551|582819930|FG004|Overall Study|Death|2|||
161391881|NCT03515551|582819931|FG005|Overall Study|Death|4|||
161391882|NCT03515551|582819932|FG006|Overall Study|Death|1|||
161391883|NCT03515551|582819926|FG000|Overall Study|Lost to Follow-up|0|||
161391884|NCT03515551|582819927|FG001|Overall Study|Lost to Follow-up|0|||
161391885|NCT03515551|582819928|FG002|Overall Study|Lost to Follow-up|1|||
161391886|NCT03515551|582819929|FG003|Overall Study|Lost to Follow-up|0|||
161391887|NCT03515551|582819930|FG004|Overall Study|Lost to Follow-up|0|||
161391888|NCT03515551|582819931|FG005|Overall Study|Lost to Follow-up|0|||
161391889|NCT03515551|582819932|FG006|Overall Study|Lost to Follow-up|0|||
161391890|NCT03515551|582819926|FG000|Overall Study|Withdrawal by Subject|0|||
161391891|NCT03515551|582819927|FG001|Overall Study|Withdrawal by Subject|1|||
161391892|NCT03515551|582819928|FG002|Overall Study|Withdrawal by Subject|0|||
161391893|NCT03515551|582819929|FG003|Overall Study|Withdrawal by Subject|0|||
161391894|NCT03515551|582819930|FG004|Overall Study|Withdrawal by Subject|0|||
161391895|NCT03515551|582819931|FG005|Overall Study|Withdrawal by Subject|0|||
161391896|NCT03515551|582819932|FG006|Overall Study|Withdrawal by Subject|1|||
161391897|NCT03515551|582819926|FG000|Overall Study|Study ended by sponsor|0|||
161391898|NCT03515551|582819927|FG001|Overall Study|Study ended by sponsor|0|||
161391899|NCT03515551|582819928|FG002|Overall Study|Study ended by sponsor|2|||
161391900|NCT03515551|582819929|FG003|Overall Study|Study ended by sponsor|1|||
161391901|NCT03515551|582819930|FG004|Overall Study|Study ended by sponsor|3|||
161391902|NCT03515551|582819931|FG005|Overall Study|Study ended by sponsor|0|||
161391903|NCT03515551|582819932|FG006|Overall Study|Study ended by sponsor|3|||
161391904|NCT03515551|582819926|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161391905|NCT03515551|582819927|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
161391906|NCT03515551|582819928|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161391907|NCT03515551|582819929|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161391908|NCT03515551|582819930|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161391909|NCT03515551|582819931|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161391910|NCT03515551|582819932|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161391911|NCT00673231|582819933|FG000|Overall Study|Withdrawal by Subject|14|||
161391912|NCT00673231|582819934|FG001|Overall Study|Withdrawal by Subject|10|||
161391913|NCT00673231|582819935|FG002|Overall Study|Withdrawal by Subject|8|||
161391914|NCT00673231|582819936|FG003|Overall Study|Withdrawal by Subject|6|||
161391915|NCT00673231|582819933|FG000|Overall Study|Adverse Event|6|||
161391916|NCT00673231|582819934|FG001|Overall Study|Adverse Event|5|||
161391917|NCT00673231|582819935|FG002|Overall Study|Adverse Event|9|||
161391918|NCT00673231|582819936|FG003|Overall Study|Adverse Event|6|||
161391919|NCT00673231|582819933|FG000|Overall Study|Lost to Follow-up|1|||
161391920|NCT00673231|582819934|FG001|Overall Study|Lost to Follow-up|2|||
161391921|NCT00673231|582819935|FG002|Overall Study|Lost to Follow-up|1|||
161391922|NCT00673231|582819936|FG003|Overall Study|Lost to Follow-up|2|||
161391923|NCT00673231|582819933|FG000|Overall Study|Death|0|||
161391924|NCT00673231|582819934|FG001|Overall Study|Death|0|||
161391925|NCT00673231|582819935|FG002|Overall Study|Death|1|||
161391926|NCT00673231|582819936|FG003|Overall Study|Death|0|||
161391927|NCT00673231|582819933|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
161391928|NCT00673231|582819934|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
161391929|NCT00673231|582819935|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
161391930|NCT00673231|582819936|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
161391931|NCT02952313|582819937|FG000|Primary Endpoint|Lost to Follow-up|4|||
161391932|NCT02952313|582819937|FG000|Primary Endpoint|Withdrawal by Subject|1|||
161391933|NCT02952313|582819937|FG000|Primary Endpoint|Lack of Efficacy|1|||
161391934|NCT02952313|582819937|FG000|Primary Endpoint|Missed visit|1|||
161391935|NCT02952313|582819937|FG000|Long-term Follow-up|Lost to Follow-up|12|||
161391936|NCT02952313|582819937|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
161391937|NCT02952313|582819937|FG000|Long-term Follow-up|Lack of Efficacy|6|||
161391938|NCT02952313|582819937|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
161391939|NCT02952313|582819937|FG000|Long-term Follow-up|Physician Decision|1|||
161391940|NCT02952313|582819937|FG000|Long-term Follow-up|Death|1|||
161391941|NCT02470585|582819948|FG000|Overall Study|Death|224|||
161391942|NCT02470585|582819949|FG001|Overall Study|Death|227|||
161391943|NCT02470585|582819950|FG002|Overall Study|Death|199|||
161391944|NCT02470585|582819948|FG000|Overall Study|Withdrew consent|21|||
161391945|NCT02470585|582819949|FG001|Overall Study|Withdrew consent|22|||
161391946|NCT02470585|582819950|FG002|Overall Study|Withdrew consent|31|||
161391947|NCT02470585|582819948|FG000|Overall Study|Lost to Follow-up|8|||
161391948|NCT02470585|582819949|FG001|Overall Study|Lost to Follow-up|15|||
161391949|NCT02470585|582819950|FG002|Overall Study|Lost to Follow-up|13|||
161391950|NCT02470585|582819948|FG000|Overall Study|Sponsor discontinued study|117|||
161391951|NCT02470585|582819949|FG001|Overall Study|Sponsor discontinued study|110|||
161391952|NCT02470585|582819950|FG002|Overall Study|Sponsor discontinued study|122|||
161391953|NCT02470585|582819948|FG000|Overall Study|Other, not specified|5|||
161391954|NCT02470585|582819949|FG001|Overall Study|Other, not specified|7|||
161391955|NCT02470585|582819950|FG002|Overall Study|Other, not specified|14|||
161391956|NCT02470585|582819948|FG000|Overall Study|Missing due to site non-compliance|0|||
161391957|NCT02470585|582819949|FG001|Overall Study|Missing due to site non-compliance|2|||
161391958|NCT02470585|582819950|FG002|Overall Study|Missing due to site non-compliance|3|||
161391959|NCT02602275|582819951|FG000|Day 1|Physician Decision|0|||
161391960|NCT02602275|582819952|FG001|Day 1|Physician Decision|1|||
161391961|NCT03028415|582819953|FG000|Overall Study|Lost to Follow-up|6|||
161391962|NCT03028415|582819954|FG001|Overall Study|Lost to Follow-up|3|||
161391963|NCT03028415|582819953|FG000|Overall Study|Withdrawal by Subject|1|||
161391964|NCT03028415|582819954|FG001|Overall Study|Withdrawal by Subject|0|||
161391965|NCT03028415|582819953|FG000|Overall Study|Discontinued due to COVID-19|1|||
161391966|NCT03028415|582819954|FG001|Overall Study|Discontinued due to COVID-19|0|||
161391967|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
161391968|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
161391969|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
161391970|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
161391971|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
161391972|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
161391973|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
161391974|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
161391975|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
161391976|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
161391977|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
161391978|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
161391979|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
161391980|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
161391981|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
161391982|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
161391983|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
161391984|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
161391985|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
161391986|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
161391987|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
161391988|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
161391989|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
161391990|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
161391991|NCT01866111|582819955|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
161391992|NCT01866111|582819956|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
161391993|NCT01866111|582819957|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
161391994|NCT01866111|582819958|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
161391995|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
161391996|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
161391997|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
161391998|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
161391999|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
161392000|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
161392001|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
161392002|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
161392003|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
161392004|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
161392005|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
161392006|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
161392007|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
161392008|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
161392009|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
161392010|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
161392011|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Death|1|||
161392012|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Death|1|||
161392013|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Death|3|||
161392014|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Death|2|||
161392015|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
161392016|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
161392017|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
161392018|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
161392019|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
161392020|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
161392021|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
161392022|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
161392023|NCT01866111|582819955|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
161392024|NCT01866111|582819956|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
161392025|NCT01866111|582819957|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
161392026|NCT01866111|582819958|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
161392027|NCT04113018|582819961|FG000|Overall Study|Death|2|||
161392028|NCT04113018|582819961|FG000|Overall Study|Lost to Follow-up|1|||
161392029|NCT04113018|582819961|FG000|Overall Study|Still On Study (on study treatment)|24|||
161392030|NCT04113018|582819961|FG000|Overall Study|Still On Study (in follow up)|12|||
161392031|NCT05005013|582819962|FG000|Overall Study|Withdrawal by Subject|5|||
161392032|NCT05005013|582819963|FG001|Overall Study|Withdrawal by Subject|1|||
161392033|NCT05005013|582819962|FG000|Overall Study|Lost to Follow-up|3|||
161392034|NCT05005013|582819963|FG001|Overall Study|Lost to Follow-up|1|||
161392035|NCT05005013|582819962|FG000|Overall Study|Ineligibility|1|||
161392036|NCT05005013|582819963|FG001|Overall Study|Ineligibility|1|||
161392037|NCT04283994|582819964|FG000|Overall Study|Death|11|||
161392038|NCT04283994|582819965|FG001|Overall Study|Death|20|||
161392039|NCT04283994|582819966|FG002|Overall Study|Death|11|||
161392040|NCT04283994|582819967|FG003|Overall Study|Death|0|||
161392041|NCT04283994|582819968|FG004|Overall Study|Death|0|||
161392042|NCT04283994|582819969|FG005|Overall Study|Death|0|||
161392043|NCT04283994|582819970|FG006|Overall Study|Death|0|||
161392044|NCT04283994|582819964|FG000|Overall Study|Withdrawal by Subject|16|||
161392045|NCT04283994|582819965|FG001|Overall Study|Withdrawal by Subject|4|||
161392046|NCT04283994|582819966|FG002|Overall Study|Withdrawal by Subject|6|||
161392047|NCT04283994|582819967|FG003|Overall Study|Withdrawal by Subject|1|||
161392048|NCT04283994|582819968|FG004|Overall Study|Withdrawal by Subject|0|||
161392049|NCT04283994|582819969|FG005|Overall Study|Withdrawal by Subject|1|||
161392050|NCT04283994|582819970|FG006|Overall Study|Withdrawal by Subject|0|||
161392051|NCT00583752|582819971|FG000|Overall Study|Lost to Follow-up|5|||
161392052|NCT00583752|582819972|FG001|Overall Study|Lost to Follow-up|5|||
161392053|NCT03315793|582819973|FG000|Overall Study|Adverse Event|4|||
161392054|NCT03315793|582819974|FG001|Overall Study|Adverse Event|2|||
161392055|NCT03315793|582819973|FG000|Overall Study|Protocol Deviation|1|||
161392056|NCT03315793|582819974|FG001|Overall Study|Protocol Deviation|0|||
161392057|NCT03315793|582819973|FG000|Overall Study|Difficult for regular visit|0|||
161392058|NCT03315793|582819974|FG001|Overall Study|Difficult for regular visit|1|||
161392059|NCT01448824|582821493|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392060|NCT01448824|582821494|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392061|NCT01448824|582821495|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392062|NCT01448824|582821496|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392063|NCT01448824|582821497|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392064|NCT01448824|582821498|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392065|NCT01448824|582821499|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
161392066|NCT01448824|582821500|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161392067|NCT01448824|582821493|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161392068|NCT01448824|582821494|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161392069|NCT01448824|582821495|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161392070|NCT01448824|582821496|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
161392071|NCT01448824|582821497|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
161392072|NCT01448824|582821498|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
161392073|NCT01448824|582821499|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161392074|NCT01448824|582821500|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161392075|NCT01448824|582821493|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392076|NCT01448824|582821494|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392077|NCT01448824|582821495|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392078|NCT01448824|582821496|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392079|NCT01448824|582821497|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392080|NCT01448824|582821498|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
161392081|NCT01448824|582821499|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392082|NCT01448824|582821500|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161392083|NCT01448824|582821493|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
161392084|NCT01448824|582821494|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
161392085|NCT01448824|582821495|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
161392086|NCT01448824|582821496|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
161392087|NCT01448824|582821497|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
161392088|NCT01448824|582821498|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
161392089|NCT01448824|582821499|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
161392090|NCT01448824|582821500|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
161392091|NCT01448824|582821493|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392092|NCT01448824|582821494|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392093|NCT01448824|582821495|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392094|NCT01448824|582821496|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392095|NCT01448824|582821497|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392096|NCT01448824|582821498|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392097|NCT01448824|582821499|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161392098|NCT01448824|582821500|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
161392099|NCT01448824|582821493|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392100|NCT01448824|582821494|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392101|NCT01448824|582821495|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392102|NCT01448824|582821496|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392103|NCT01448824|582821497|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392104|NCT01448824|582821498|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392105|NCT01448824|582821499|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161392106|NCT01448824|582821500|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
161392107|NCT01448824|582821493|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392108|NCT01448824|582821494|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392109|NCT01448824|582821495|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392110|NCT01448824|582821496|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392111|NCT01448824|582821497|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392112|NCT01448824|582821498|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392113|NCT01448824|582821499|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161392114|NCT01448824|582821500|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
161392115|NCT01448824|582821493|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392116|NCT01448824|582821494|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392117|NCT01448824|582821495|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392118|NCT01448824|582821496|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392119|NCT01448824|582821497|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392120|NCT01448824|582821498|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392121|NCT01448824|582821499|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161392122|NCT01448824|582821500|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
161392123|NCT01537081|582821503|FG000|Overall Study|Adverse Event|5|||
161392124|NCT01537081|582821504|FG001|Overall Study|Adverse Event|2|||
161392125|NCT01537081|582821505|FG002|Overall Study|Adverse Event|2|||
161392126|NCT01537081|582821503|FG000|Overall Study|Lack of Efficacy|2|||
161392127|NCT01537081|582821504|FG001|Overall Study|Lack of Efficacy|1|||
161392128|NCT01537081|582821505|FG002|Overall Study|Lack of Efficacy|0|||
161392129|NCT01537081|582821503|FG000|Overall Study|Lost to Follow-up|17|||
161392130|NCT01537081|582821504|FG001|Overall Study|Lost to Follow-up|15|||
161392131|NCT01537081|582821505|FG002|Overall Study|Lost to Follow-up|9|||
161392132|NCT01537081|582821503|FG000|Overall Study|Protocol Violation|3|||
161392133|NCT01537081|582821504|FG001|Overall Study|Protocol Violation|2|||
161392134|NCT01537081|582821505|FG002|Overall Study|Protocol Violation|2|||
161392135|NCT01537081|582821503|FG000|Overall Study|Withdrawal by Subject|6|||
161392136|NCT01537081|582821504|FG001|Overall Study|Withdrawal by Subject|11|||
161392137|NCT01537081|582821505|FG002|Overall Study|Withdrawal by Subject|3|||
161392138|NCT01537081|582821503|FG000|Overall Study|Physician Decision|5|||
161392139|NCT01537081|582821504|FG001|Overall Study|Physician Decision|6|||
161392140|NCT01537081|582821505|FG002|Overall Study|Physician Decision|0|||
161392141|NCT01537081|582821503|FG000|Overall Study|Sponsor decision|0|||
161392142|NCT01537081|582821504|FG001|Overall Study|Sponsor decision|1|||
161392143|NCT01537081|582821505|FG002|Overall Study|Sponsor decision|0|||
161392144|NCT01537081|582821503|FG000|Overall Study|Assigned but never dosed|1|||
161392145|NCT01537081|582821504|FG001|Overall Study|Assigned but never dosed|0|||
161392146|NCT01537081|582821505|FG002|Overall Study|Assigned but never dosed|0|||
161392147|NCT01463111|582821506|FG000|Overall Study|Withdrawal by Subject|2|||
161392148|NCT01463111|582821506|FG000|Overall Study|Lost to Follow-up|5|||
161392149|NCT01463111|582821506|FG000|Overall Study|Physician Decision|2|||
161392150|NCT00882583|582821507|FG000|Overall Study|Physician Decision|1|||
161392151|NCT00882583|582821508|FG001|Overall Study|Physician Decision|0|||
161392152|NCT00882583|582821507|FG000|Overall Study|Adverse Event|0|||
161392153|NCT00882583|582821508|FG001|Overall Study|Adverse Event|1|||
161392154|NCT00983515|582821509|FG000|Ritonavir Alone|liver panel out of range|6|||
161392155|NCT00983515|582821509|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
161392156|NCT02526524|582821512|FG000|Overall Study|Withdrawal by Subject|3|||
161392157|NCT02526524|582821513|FG001|Overall Study|Withdrawal by Subject|3|||
161392158|NCT02526524|582821514|FG002|Overall Study|Withdrawal by Subject|6|||
161392159|NCT02526524|582821515|FG003|Overall Study|Withdrawal by Subject|1|||
161392160|NCT02526524|582821516|FG004|Overall Study|Withdrawal by Subject|9|||
161392161|NCT02526524|582821517|FG005|Overall Study|Withdrawal by Subject|5|||
161392162|NCT02526524|582821512|FG000|Overall Study|Adverse Event|3|||
161392163|NCT02526524|582821513|FG001|Overall Study|Adverse Event|2|||
161392164|NCT02526524|582821514|FG002|Overall Study|Adverse Event|4|||
161392165|NCT02526524|582821515|FG003|Overall Study|Adverse Event|2|||
161392166|NCT02526524|582821516|FG004|Overall Study|Adverse Event|6|||
161392167|NCT02526524|582821517|FG005|Overall Study|Adverse Event|8|||
161392168|NCT02526524|582821512|FG000|Overall Study|Lost to Follow-up|2|||
161392169|NCT02526524|582821513|FG001|Overall Study|Lost to Follow-up|3|||
161392170|NCT02526524|582821514|FG002|Overall Study|Lost to Follow-up|8|||
161392171|NCT02526524|582821515|FG003|Overall Study|Lost to Follow-up|1|||
161392172|NCT02526524|582821516|FG004|Overall Study|Lost to Follow-up|2|||
161392173|NCT02526524|582821517|FG005|Overall Study|Lost to Follow-up|5|||
161392174|NCT02526524|582821512|FG000|Overall Study|Protocol Violation|3|||
161392175|NCT02526524|582821513|FG001|Overall Study|Protocol Violation|1|||
161392176|NCT02526524|582821514|FG002|Overall Study|Protocol Violation|5|||
161392177|NCT02526524|582821515|FG003|Overall Study|Protocol Violation|3|||
161392178|NCT02526524|582821516|FG004|Overall Study|Protocol Violation|4|||
161392179|NCT02526524|582821517|FG005|Overall Study|Protocol Violation|3|||
161392180|NCT02526524|582821512|FG000|Overall Study|Loss of Glucose Control|0|||
161392181|NCT02526524|582821513|FG001|Overall Study|Loss of Glucose Control|0|||
161392182|NCT02526524|582821514|FG002|Overall Study|Loss of Glucose Control|3|||
161392183|NCT02526524|582821515|FG003|Overall Study|Loss of Glucose Control|0|||
161392184|NCT02526524|582821516|FG004|Overall Study|Loss of Glucose Control|2|||
161392185|NCT02526524|582821517|FG005|Overall Study|Loss of Glucose Control|0|||
161392186|NCT02526524|582821512|FG000|Overall Study|Physician Decision|0|||
161392187|NCT02526524|582821513|FG001|Overall Study|Physician Decision|0|||
161392188|NCT02526524|582821514|FG002|Overall Study|Physician Decision|0|||
161392189|NCT02526524|582821515|FG003|Overall Study|Physician Decision|0|||
161392190|NCT02526524|582821516|FG004|Overall Study|Physician Decision|1|||
161392191|NCT02526524|582821517|FG005|Overall Study|Physician Decision|0|||
161392192|NCT02526524|582821512|FG000|Overall Study|Sponsor Decision|1|||
161392193|NCT02526524|582821513|FG001|Overall Study|Sponsor Decision|0|||
161392194|NCT02526524|582821514|FG002|Overall Study|Sponsor Decision|0|||
161392195|NCT02526524|582821515|FG003|Overall Study|Sponsor Decision|0|||
161392196|NCT02526524|582821516|FG004|Overall Study|Sponsor Decision|0|||
161392197|NCT02526524|582821517|FG005|Overall Study|Sponsor Decision|0|||
161392198|NCT01681069|582821527|FG000|Overall Study|Withdrawal by Subject|4|||
161392199|NCT01681069|582821528|FG001|Overall Study|Withdrawal by Subject|5|||
161392200|NCT01681069|582821527|FG000|Overall Study|Protocol Violation|1|||
161392201|NCT01681069|582821528|FG001|Overall Study|Protocol Violation|1|||
161392202|NCT01681069|582821527|FG000|Overall Study|Adverse Event|0|||
161392203|NCT01681069|582821528|FG001|Overall Study|Adverse Event|1|||
161392204|NCT01463696|582821529|FG000|Overall Study|Adverse Event|0|||
161392205|NCT01463696|582821530|FG001|Overall Study|Adverse Event|1|||
161392206|NCT01463696|582821531|FG002|Overall Study|Adverse Event|0|||
161392207|NCT01463696|582821532|FG003|Overall Study|Adverse Event|2|||
161392208|NCT01463696|582821533|FG004|Overall Study|Adverse Event|0|||
161392209|NCT01463696|582821534|FG005|Overall Study|Adverse Event|1|||
161392210|NCT01463696|582821535|FG006|Overall Study|Adverse Event|3|||
161392211|NCT01463696|582821536|FG007|Overall Study|Adverse Event|2|||
161392212|NCT01463696|582821529|FG000|Overall Study|Lost to Follow-up|0|||
161392213|NCT01463696|582821530|FG001|Overall Study|Lost to Follow-up|0|||
161392214|NCT01463696|582821531|FG002|Overall Study|Lost to Follow-up|1|||
161392215|NCT01463696|582821532|FG003|Overall Study|Lost to Follow-up|0|||
161392216|NCT01463696|582821533|FG004|Overall Study|Lost to Follow-up|0|||
161392217|NCT01463696|582821534|FG005|Overall Study|Lost to Follow-up|0|||
161392218|NCT01463696|582821535|FG006|Overall Study|Lost to Follow-up|0|||
161392219|NCT01463696|582821536|FG007|Overall Study|Lost to Follow-up|0|||
161392220|NCT01463696|582821529|FG000|Overall Study|Progressive Disease|0|||
161392221|NCT01463696|582821530|FG001|Overall Study|Progressive Disease|1|||
161392222|NCT01463696|582821531|FG002|Overall Study|Progressive Disease|0|||
161392223|NCT01463696|582821532|FG003|Overall Study|Progressive Disease|1|||
161392224|NCT01463696|582821533|FG004|Overall Study|Progressive Disease|0|||
161392225|NCT01463696|582821534|FG005|Overall Study|Progressive Disease|1|||
161392226|NCT01463696|582821535|FG006|Overall Study|Progressive Disease|4|||
161392227|NCT01463696|582821536|FG007|Overall Study|Progressive Disease|2|||
161392228|NCT01463696|582821529|FG000|Overall Study|Withdrawal by Subject|0|||
161392229|NCT01463696|582821530|FG001|Overall Study|Withdrawal by Subject|0|||
161392230|NCT01463696|582821531|FG002|Overall Study|Withdrawal by Subject|0|||
161392231|NCT01463696|582821532|FG003|Overall Study|Withdrawal by Subject|1|||
161392232|NCT01463696|582821533|FG004|Overall Study|Withdrawal by Subject|1|||
161392233|NCT01463696|582821534|FG005|Overall Study|Withdrawal by Subject|1|||
161392234|NCT01463696|582821535|FG006|Overall Study|Withdrawal by Subject|2|||
161392235|NCT01463696|582821536|FG007|Overall Study|Withdrawal by Subject|0|||
161392236|NCT01463696|582821529|FG000|Overall Study|Not Treated|0|||
161392237|NCT01463696|582821530|FG001|Overall Study|Not Treated|0|||
161392238|NCT01463696|582821531|FG002|Overall Study|Not Treated|0|||
161392239|NCT01463696|582821532|FG003|Overall Study|Not Treated|0|||
161392240|NCT01463696|582821533|FG004|Overall Study|Not Treated|0|||
161392241|NCT01463696|582821534|FG005|Overall Study|Not Treated|0|||
161392242|NCT01463696|582821535|FG006|Overall Study|Not Treated|1|||
161392243|NCT01463696|582821536|FG007|Overall Study|Not Treated|0|||
161392244|NCT05526781|582821549|FG000|Overall Study|Lost to Follow-up|1|||
161392245|NCT01801436|582821550|FG000|Overall Study|Withdrawal by Subject|3|||
161392246|NCT01801436|582821550|FG000|Overall Study|Adverse Event|2|||
161392247|NCT01801436|582821550|FG000|Overall Study|Progressive disease|4|||
161392248|NCT02447250|582821553|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
161392249|NCT02447250|582821553|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
161392250|NCT02447250|582821553|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
161392251|NCT02743949|582821554|FG000|Overall Study|Adverse Event|0|||
161392252|NCT02743949|582821555|FG001|Overall Study|Adverse Event|0|||
161392253|NCT02743949|582821556|FG002|Overall Study|Adverse Event|2|||
161392254|NCT02743949|582821554|FG000|Overall Study|Significant Protocol Deviation|2|||
161392255|NCT02743949|582821555|FG001|Overall Study|Significant Protocol Deviation|0|||
161392256|NCT02743949|582821556|FG002|Overall Study|Significant Protocol Deviation|1|||
161392257|NCT02743949|582821554|FG000|Overall Study|Voluntary Withdrawal|2|||
161392258|NCT02743949|582821555|FG001|Overall Study|Voluntary Withdrawal|1|||
161392259|NCT02743949|582821556|FG002|Overall Study|Voluntary Withdrawal|0|||
161392260|NCT01921218|582821557|FG000|Overall Study|Death|2|||
161392261|NCT01921218|582821558|FG001|Overall Study|Death|1|||
161392262|NCT01921218|582821557|FG000|Overall Study|Withdrawal by Subject|0|||
161392263|NCT01921218|582821558|FG001|Overall Study|Withdrawal by Subject|2|||
161392264|NCT01921218|582821557|FG000|Overall Study|Kidney transplant|1|||
161392265|NCT01921218|582821558|FG001|Overall Study|Kidney transplant|1|||
161392266|NCT03389555|582821559|FG000|Overall Study|Protocol Violation|1|||
161392267|NCT03389555|582821560|FG001|Overall Study|Protocol Violation|3|||
161392268|NCT03389555|582821559|FG000|Overall Study|Death|1|||
161392269|NCT03389555|582821560|FG001|Overall Study|Death|0|||
161392270|NCT01885208|582821561|FG000|Overall Study|Unclassified|32|||
161392271|NCT01885208|582821562|FG001|Overall Study|Unclassified|38|||
161392272|NCT00920218|582821563|FG000|Overall Study|Serious Adverse Event|2|||
161392273|NCT00920218|582821564|FG001|Overall Study|Serious Adverse Event|0|||
161392274|NCT00920218|582821565|FG002|Overall Study|Serious Adverse Event|2|||
161392275|NCT00920218|582821566|FG003|Overall Study|Serious Adverse Event|1|||
161392276|NCT00920218|582821563|FG000|Overall Study|Withdrawal by Subject|0|||
161392277|NCT00920218|582821564|FG001|Overall Study|Withdrawal by Subject|3|||
161392278|NCT00920218|582821565|FG002|Overall Study|Withdrawal by Subject|2|||
161392279|NCT00920218|582821566|FG003|Overall Study|Withdrawal by Subject|0|||
161392280|NCT00920218|582821563|FG000|Overall Study|Migrated/moved from study area|0|||
161392281|NCT00920218|582821564|FG001|Overall Study|Migrated/moved from study area|0|||
161392282|NCT00920218|582821565|FG002|Overall Study|Migrated/moved from study area|1|||
161392283|NCT00920218|582821566|FG003|Overall Study|Migrated/moved from study area|0|||
161392284|NCT00920218|582821563|FG000|Overall Study|Lost to Follow-up|0|||
161392285|NCT00920218|582821564|FG001|Overall Study|Lost to Follow-up|1|||
161392286|NCT00920218|582821565|FG002|Overall Study|Lost to Follow-up|0|||
161392287|NCT00920218|582821566|FG003|Overall Study|Lost to Follow-up|3|||
161392288|NCT00920218|582821563|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
161392289|NCT00920218|582821564|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
161392290|NCT00920218|582821565|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
161392291|NCT00920218|582821566|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
161392292|NCT00920218|582821563|FG000|Overall Study|Other|0|||
161392293|NCT00920218|582821564|FG001|Overall Study|Other|0|||
161392294|NCT00920218|582821565|FG002|Overall Study|Other|1|||
161392295|NCT00920218|582821566|FG003|Overall Study|Other|0|||
161392296|NCT00960011|582821570|FG000|Overall Study|Death|5|||
161392297|NCT00960011|582821571|FG001|Overall Study|Death|0|||
161392298|NCT00960011|582821570|FG000|Overall Study|Lost to Follow-up|6|||
161392299|NCT00960011|582821571|FG001|Overall Study|Lost to Follow-up|2|||
161392300|NCT04417218|582821572|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
161392301|NCT04417218|582821573|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
161392302|NCT00873041|582821574|FG000|Core Study|Adverse Event|2|||
161392303|NCT00873041|582821575|FG001|Core Study|Adverse Event|3|||
161392304|NCT00873041|582821576|FG002|Core Study|Adverse Event|1|||
161392305|NCT00873041|582821574|FG000|Core Study|Withdrawal by Subject|1|||
161392306|NCT00873041|582821575|FG001|Core Study|Withdrawal by Subject|2|||
161392307|NCT00873041|582821576|FG002|Core Study|Withdrawal by Subject|2|||
161392308|NCT00873041|582821574|FG000|Core Study|Lost to Follow-up|3|||
161392309|NCT00873041|582821575|FG001|Core Study|Lost to Follow-up|1|||
161392310|NCT00873041|582821576|FG002|Core Study|Lost to Follow-up|0|||
161392311|NCT00873041|582821574|FG000|Core Study|Abnormal laboratory value|0|||
161392312|NCT00873041|582821575|FG001|Core Study|Abnormal laboratory value|0|||
161392313|NCT00873041|582821576|FG002|Core Study|Abnormal laboratory value|1|||
161392314|NCT00873041|582821574|FG000|Core Study|Protocol deviation|1|||
161392315|NCT00873041|582821575|FG001|Core Study|Protocol deviation|0|||
161392316|NCT00873041|582821576|FG002|Core Study|Protocol deviation|1|||
161392317|NCT00873041|582821574|FG000|Extension Study|Adverse Event|1|||
161392318|NCT00873041|582821575|FG001|Extension Study|Adverse Event|0|||
161392319|NCT00873041|582821576|FG002|Extension Study|Adverse Event|1|||
161392320|NCT00873041|582821574|FG000|Extension Study|Administrative reasons|0|||
161392321|NCT00873041|582821575|FG001|Extension Study|Administrative reasons|0|||
161392322|NCT00873041|582821576|FG002|Extension Study|Administrative reasons|1|||
161392323|NCT02449889|582821579|FG000|Overall Study|Adverse Event|1|||
161392324|NCT02449889|582821580|FG001|Overall Study|Adverse Event|2|||
161392325|NCT02449889|582821581|FG002|Overall Study|Adverse Event|0|||
161392326|NCT02449889|582821579|FG000|Overall Study|Protocol Violation|0|||
161392327|NCT02449889|582821580|FG001|Overall Study|Protocol Violation|4|||
161392328|NCT02449889|582821581|FG002|Overall Study|Protocol Violation|1|||
161392329|NCT01082874|582821582|FG000|Overall Study|Lost to Follow-up|10|||
161392330|NCT01082874|582821583|FG001|Overall Study|Lost to Follow-up|10|||
161392331|NCT01082874|582821584|FG002|Overall Study|Lost to Follow-up|6|||
161392332|NCT01082874|582821585|FG003|Overall Study|Lost to Follow-up|10|||
161392333|NCT01082874|582821582|FG000|Overall Study|Withdrawal by Subject|1|||
161392334|NCT01082874|582821583|FG001|Overall Study|Withdrawal by Subject|2|||
161392335|NCT01082874|582821584|FG002|Overall Study|Withdrawal by Subject|5|||
161392336|NCT01082874|582821585|FG003|Overall Study|Withdrawal by Subject|3|||
161392337|NCT03272828|582821598|FG000|Overall Study|Lost to Follow-up|7|||
161392338|NCT03272828|582821599|FG001|Overall Study|Lost to Follow-up|7|||
161392339|NCT03272828|582821598|FG000|Overall Study|Withdrawal by Subject|2|||
161392340|NCT03272828|582821599|FG001|Overall Study|Withdrawal by Subject|0|||
161392341|NCT03272828|582821598|FG000|Overall Study|Deceased|1|||
161392342|NCT03272828|582821599|FG001|Overall Study|Deceased|1|||
161392343|NCT03272828|582821598|FG000|Overall Study|Failed implant|1|||
161392344|NCT03272828|582821599|FG001|Overall Study|Failed implant|2|||
161392345|NCT03176472|582821600|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
161392346|NCT03176472|582821601|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
161392347|NCT03176472|582821600|FG000|Double Blind Treatment Period|Adverse Event|0|||
161392348|NCT03176472|582821601|FG001|Double Blind Treatment Period|Adverse Event|5|||
161392349|NCT03176472|582821600|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
161392350|NCT03176472|582821601|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161392351|NCT03176472|582821600|FG000|Double Blind Treatment Period|Physician Decision|0|||
161392352|NCT03176472|582821601|FG001|Double Blind Treatment Period|Physician Decision|1|||
161392353|NCT03176472|582821600|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161392354|NCT03176472|582821601|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161392355|NCT03176472|582821600|FG000|Double Blind Treatment Period|Not Provided|1|||
161392356|NCT03176472|582821601|FG001|Double Blind Treatment Period|Not Provided|0|||
161392357|NCT03176472|582821600|FG000|Open Label Extension|Withdrawal by Subject|3|||
161392358|NCT03176472|582821601|FG001|Open Label Extension|Withdrawal by Subject|4|||
161392359|NCT03176472|582821600|FG000|Open Label Extension|Adverse Event|2|||
161392360|NCT03176472|582821601|FG001|Open Label Extension|Adverse Event|4|||
161392361|NCT03176472|582821600|FG000|Open Label Extension|Lost to Follow-up|1|||
161392362|NCT03176472|582821601|FG001|Open Label Extension|Lost to Follow-up|2|||
161392363|NCT03176472|582821600|FG000|Open Label Extension|Protocol Violation|0|||
161392364|NCT03176472|582821601|FG001|Open Label Extension|Protocol Violation|1|||
161392365|NCT03176472|582821600|FG000|Open Label Extension|Not Provided|2|||
161392366|NCT03176472|582821601|FG001|Open Label Extension|Not Provided|1|||
161392367|NCT01846663|582821602|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
161392368|NCT01846663|582821603|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
161392369|NCT01846663|582821602|FG000|Overall Study|Withdrawal by Subject|1|||
161392370|NCT01846663|582821603|FG001|Overall Study|Withdrawal by Subject|0|||
161392371|NCT01846663|582821602|FG000|Overall Study|Adverse Event|1|||
161392372|NCT01846663|582821603|FG001|Overall Study|Adverse Event|2|||
161392373|NCT03888235|582821609|FG000|Overall Study|Lost to Follow-up|1|||
161392374|NCT03888235|582821610|FG001|Overall Study|Lost to Follow-up|1|||
161392375|NCT03888235|582821611|FG002|Overall Study|Lost to Follow-up|0|||
161392376|NCT01054560|582821612|FG000|Overall Study|Death|10|||
161392377|NCT01054560|582821613|FG001|Overall Study|Death|21|||
161392378|NCT01054560|582821612|FG000|Overall Study|Lost to Follow-up|2|||
161392379|NCT01054560|582821613|FG001|Overall Study|Lost to Follow-up|5|||
161392380|NCT01054560|582821612|FG000|Overall Study|Withdrawal by Subject|0|||
161392381|NCT01054560|582821613|FG001|Overall Study|Withdrawal by Subject|2|||
161392382|NCT01054560|582821612|FG000|Overall Study|Physician Decision|1|||
161392383|NCT01054560|582821613|FG001|Overall Study|Physician Decision|0|||
161392384|NCT00675441|582821614|FG000|Overall Study|Withdrawal by Subject|2|||
161392385|NCT00675441|582821614|FG000|Overall Study|Death|1|||
161392386|NCT03718884|582821617|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
161392387|NCT03718884|582821618|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
161392388|NCT03718884|582821617|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
161392389|NCT03718884|582821618|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
161392390|NCT00920387|582821623|FG000|Stage 1|Adverse Event|1|||
161392391|NCT00920387|582821624|FG001|Stage 1|Adverse Event|0|||
161392392|NCT00920387|582821625|FG002|Stage 1|Adverse Event|0|||
161392393|NCT04470908|582821626|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
161392394|NCT02241733|582821627|FG000|Overall Study|Lost to Follow-up|9|||
161392395|NCT02241733|582821628|FG001|Overall Study|Lost to Follow-up|4|||
161392396|NCT02241733|582821627|FG000|Overall Study|Physician Decision|6|||
161392397|NCT02241733|582821628|FG001|Overall Study|Physician Decision|2|||
161392398|NCT02241733|582821627|FG000|Overall Study|Withdrawal by Subject|0|||
161392399|NCT02241733|582821628|FG001|Overall Study|Withdrawal by Subject|2|||
161392400|NCT02241733|582821627|FG000|Overall Study|Death|0|||
161392401|NCT02241733|582821628|FG001|Overall Study|Death|2|||
161392402|NCT00157196|582821631|FG000|Overall Study|Ongoing at data cut-off|9|||
161392403|NCT06099223|582821632|FG000|Overall Study|Preoperative surveys missed|0|||
161392404|NCT06099223|582821633|FG001|Overall Study|Preoperative surveys missed|1|||
161392405|NCT01221623|582821634|FG000|Overall Study|Withdrawal by Subject|19|||
161392406|NCT01221623|582821635|FG001|Overall Study|Withdrawal by Subject|8|||
161392407|NCT01221623|582821634|FG000|Overall Study|Lost to Follow-up|7|||
161392408|NCT01221623|582821635|FG001|Overall Study|Lost to Follow-up|1|||
161392409|NCT01221623|582821634|FG000|Overall Study|Adverse Event|6|||
161392410|NCT01221623|582821635|FG001|Overall Study|Adverse Event|3|||
161392411|NCT01221623|582821634|FG000|Overall Study|Death|1|||
161392412|NCT01221623|582821635|FG001|Overall Study|Death|0|||
161392413|NCT01221623|582821634|FG000|Overall Study|Other|5|||
161392414|NCT01221623|582821635|FG001|Overall Study|Other|2|||
161392415|NCT00661726|582821636|FG000|Overall Study|Adverse Event|1|||
161392416|NCT02644096|582821637|FG000|Overall Study|Withdrawal by Subject|28|||
161392417|NCT02644096|582821638|FG001|Overall Study|Withdrawal by Subject|25|||
161392418|NCT02147197|582821639|FG000|Overall Study|Adverse Event|1|||
161392419|NCT02147197|582821640|FG001|Overall Study|Adverse Event|0|||
161392420|NCT02147197|582821641|FG002|Overall Study|Adverse Event|0|||
161392421|NCT02147197|582821639|FG000|Overall Study|Withdrawal of Consent|4|||
161392422|NCT02147197|582821640|FG001|Overall Study|Withdrawal of Consent|3|||
161392423|NCT02147197|582821641|FG002|Overall Study|Withdrawal of Consent|2|||
161392424|NCT02147197|582821639|FG000|Overall Study|Lost to Follow-up|2|||
161392425|NCT02147197|582821640|FG001|Overall Study|Lost to Follow-up|3|||
161392426|NCT02147197|582821641|FG002|Overall Study|Lost to Follow-up|1|||
161392427|NCT02147197|582821639|FG000|Overall Study|Protocol Violation|1|||
161392428|NCT02147197|582821640|FG001|Overall Study|Protocol Violation|0|||
161392429|NCT02147197|582821641|FG002|Overall Study|Protocol Violation|3|||
161392430|NCT02147197|582821639|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161392431|NCT02147197|582821640|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161392432|NCT02147197|582821641|FG002|Overall Study|Other Miscellaneous Reasons|3|||
161392433|NCT00830375|582821642|FG000|Overall Study|Lost to Follow-up|1|||
161392434|NCT01700959|582821643|FG000|Overall Study|Adverse Event|0|||
161392435|NCT01700959|582821644|FG001|Overall Study|Adverse Event|1|||
161392436|NCT01700959|582821645|FG002|Overall Study|Adverse Event|1|||
161392437|NCT01700959|582821646|FG003|Overall Study|Adverse Event|2|||
161392438|NCT01700959|582821647|FG004|Overall Study|Adverse Event|0|||
161392439|NCT01700959|582821648|FG005|Overall Study|Adverse Event|2|||
161392440|NCT01700959|582821643|FG000|Overall Study|Withdrawal by Subject|15|||
161392441|NCT01700959|582821644|FG001|Overall Study|Withdrawal by Subject|9|||
161392442|NCT01700959|582821645|FG002|Overall Study|Withdrawal by Subject|12|||
161392443|NCT01700959|582821646|FG003|Overall Study|Withdrawal by Subject|11|||
161392444|NCT01700959|582821647|FG004|Overall Study|Withdrawal by Subject|8|||
161392445|NCT01700959|582821648|FG005|Overall Study|Withdrawal by Subject|12|||
161392446|NCT01700959|582821643|FG000|Overall Study|Ineligible|2|||
161392447|NCT01700959|582821644|FG001|Overall Study|Ineligible|1|||
161392448|NCT01700959|582821645|FG002|Overall Study|Ineligible|2|||
161392449|NCT01700959|582821646|FG003|Overall Study|Ineligible|0|||
161392450|NCT01700959|582821647|FG004|Overall Study|Ineligible|0|||
161392451|NCT01700959|582821648|FG005|Overall Study|Ineligible|1|||
161392452|NCT01700959|582821643|FG000|Overall Study|Noncompliant|9|||
161392453|NCT01700959|582821644|FG001|Overall Study|Noncompliant|9|||
161392454|NCT01700959|582821645|FG002|Overall Study|Noncompliant|17|||
161392455|NCT01700959|582821646|FG003|Overall Study|Noncompliant|18|||
161392456|NCT01700959|582821647|FG004|Overall Study|Noncompliant|15|||
161392457|NCT01700959|582821648|FG005|Overall Study|Noncompliant|9|||
161392458|NCT01700959|582821643|FG000|Overall Study|Side effects|1|||
161392459|NCT01700959|582821644|FG001|Overall Study|Side effects|4|||
161392460|NCT01700959|582821645|FG002|Overall Study|Side effects|8|||
161392461|NCT01700959|582821646|FG003|Overall Study|Side effects|4|||
161392462|NCT01700959|582821647|FG004|Overall Study|Side effects|4|||
161392463|NCT01700959|582821648|FG005|Overall Study|Side effects|1|||
161392464|NCT00322452|582821649|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161392465|NCT00322452|582821650|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161392466|NCT00322452|582821649|FG000|Overall Study|Lost to Follow-up|5|||
161392467|NCT00322452|582821650|FG001|Overall Study|Lost to Follow-up|2|||
161392468|NCT00322452|582821649|FG000|Overall Study|Withdrawal by Subject|19|||
161392469|NCT00322452|582821650|FG001|Overall Study|Withdrawal by Subject|46|||
161392470|NCT00322452|582821649|FG000|Overall Study|Death|223|||
161392471|NCT00322452|582821650|FG001|Overall Study|Death|227|||
161392472|NCT00526656|582821651|FG000|Overall Study|Death|1|||
161392473|NCT00526656|582821651|FG000|Overall Study|Refused surgery|1|||
161392474|NCT04091581|582821652|FG000|Overall Study|Lost to Follow-up|0|||
161392475|NCT04091581|582821653|FG001|Overall Study|Lost to Follow-up|1|||
161392476|NCT01795495|582821654|FG000|Overall Study|Protocol Violation|1|||
161392477|NCT01795495|582821655|FG001|Overall Study|Protocol Violation|0|||
161392478|NCT01795495|582821656|FG002|Overall Study|Protocol Violation|1|||
161392479|NCT01795495|582821654|FG000|Overall Study|Physician Decision|0|||
161392480|NCT01795495|582821655|FG001|Overall Study|Physician Decision|0|||
161392481|NCT01795495|582821656|FG002|Overall Study|Physician Decision|1|||
161392482|NCT01331837|582821657|FG000|Overall Study|Death|30|||
161392483|NCT01331837|582821658|FG001|Overall Study|Death|34|||
161392484|NCT01331837|582821657|FG000|Overall Study|Lost to Follow-up|3|||
161392485|NCT01331837|582821658|FG001|Overall Study|Lost to Follow-up|1|||
161392486|NCT01331837|582821657|FG000|Overall Study|Info not recorded|10|||
161392487|NCT01331837|582821658|FG001|Overall Study|Info not recorded|16|||
161392488|NCT01331837|582821657|FG000|Overall Study|Withdrawal by Subject|13|||
161392489|NCT01331837|582821658|FG001|Overall Study|Withdrawal by Subject|16|||
161392490|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Adverse Event|76|||
161392491|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Adverse Event|0|||
161392492|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Adverse Event|0|||
161392493|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Death|3|||
161392494|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Death|0|||
161392495|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Death|0|||
161392496|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
161392497|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
161392498|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
161392499|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Physician Decision|9|||
161392500|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Physician Decision|0|||
161392501|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Physician Decision|0|||
161392502|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
161392503|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
161392504|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
161392505|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Disease progression|45|||
161392506|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Disease progression|0|||
161392507|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Disease progression|0|||
161392508|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
161392509|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
161392510|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
161392511|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
161392512|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
161392513|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
161392514|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
161392515|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
161392516|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
161392517|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
161392518|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
161392519|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
161392520|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
161392521|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
161392522|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
161392523|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
161392524|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
161392525|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
161392526|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
161392527|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
161392528|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
161392529|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
161392530|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
161392531|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
161392532|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
161392533|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
161392534|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
161392535|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Promotor request|1|||
161392536|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Promotor request|0|||
161392537|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Promotor request|0|||
161392538|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
161392539|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
161392540|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
161392541|NCT01461928|582823035|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
161392542|NCT01461928|582823036|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
161392543|NCT01461928|582823037|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
161392544|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Death|3|||
161392545|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Death|0|||
161392546|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Death|0|||
161392547|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
161392548|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
161392549|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
161392550|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
161392551|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
161392552|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
161392553|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Diseases progression|91|||
161392554|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Diseases progression|0|||
161392555|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Diseases progression|0|||
161392556|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Adverse Event|70|||
161392557|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Adverse Event|0|||
161392558|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Adverse Event|0|||
161392559|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Physician Decision|9|||
161392560|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Physician Decision|0|||
161392561|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Physician Decision|0|||
161392562|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
161392563|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
161392564|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
161392565|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
161392566|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
161392567|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
161392568|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
161392569|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
161392570|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
161392571|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Not compliant|1|||
161392572|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Not compliant|0|||
161392573|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Not compliant|0|||
161392574|NCT01461928|582823035|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
161392575|NCT01461928|582823036|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
161392576|NCT01461928|582823037|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
161392577|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Adverse Event|0|||
161392578|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Adverse Event|2|||
161392579|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Adverse Event|0|||
161392580|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Death|0|||
161392581|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Death|10|||
161392582|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Death|8|||
161392583|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Physician Decision|0|||
161392584|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Physician Decision|0|||
161392585|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Physician Decision|4|||
161392586|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
161392587|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
161392588|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
161392589|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Moved to another town|0|||
161392590|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Moved to another town|1|||
161392591|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Moved to another town|0|||
161392592|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Disease progression|0|||
161392593|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Disease progression|0|||
161392594|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Disease progression|3|||
161392595|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
161392596|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
161392597|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
161392598|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
161392599|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
161392600|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
161392601|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
161392602|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
161392603|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
161392604|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
161392605|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
161392606|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
161392607|NCT01461928|582823035|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
161392608|NCT01461928|582823036|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
161392609|NCT01461928|582823037|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
161392610|NCT00539513|582823042|FG000|Overall Study|Withdrawal by Subject|2|||
161392611|NCT00539513|582823043|FG001|Overall Study|Withdrawal by Subject|1|||
161392612|NCT00539513|582823042|FG000|Overall Study|Lost to Follow-up|0|||
161392613|NCT00539513|582823043|FG001|Overall Study|Lost to Follow-up|1|||
161392614|NCT02456636|582823044|FG000|Overall Study|Death|0|||
161392615|NCT02456636|582823045|FG001|Overall Study|Death|3|||
161392616|NCT02456636|582823046|FG002|Overall Study|Death|0|||
161392617|NCT02456636|582823044|FG000|Overall Study|Pregnancy|1|||
161392618|NCT02456636|582823045|FG001|Overall Study|Pregnancy|3|||
161392619|NCT02456636|582823046|FG002|Overall Study|Pregnancy|5|||
161392620|NCT02456636|582823044|FG000|Overall Study|Physician Decision|4|||
161392621|NCT02456636|582823045|FG001|Overall Study|Physician Decision|5|||
161392622|NCT02456636|582823046|FG002|Overall Study|Physician Decision|4|||
161392623|NCT02456636|582823044|FG000|Overall Study|Withdrawal by Subject|13|||
161392624|NCT02456636|582823045|FG001|Overall Study|Withdrawal by Subject|14|||
161392625|NCT02456636|582823046|FG002|Overall Study|Withdrawal by Subject|16|||
161392626|NCT02456636|582823044|FG000|Overall Study|Lost to Follow-up|50|||
161392627|NCT02456636|582823045|FG001|Overall Study|Lost to Follow-up|44|||
161392628|NCT02456636|582823046|FG002|Overall Study|Lost to Follow-up|50|||
161392629|NCT00090142|582823049|FG000|Treatment Period I|Lost to Follow-up|1|||
161392630|NCT00090142|582823050|FG001|Treatment Period I|Lost to Follow-up|2|||
161392631|NCT00090142|582823049|FG000|Treatment Period I|Protocol Violation|2|||
161392632|NCT00090142|582823050|FG001|Treatment Period I|Protocol Violation|0|||
161392633|NCT00090142|582823049|FG000|Treatment Period I|Withdrawal by Subject|2|||
161392634|NCT00090142|582823050|FG001|Treatment Period I|Withdrawal by Subject|0|||
161392635|NCT00090142|582823049|FG000|Treatment Period I|Other|0|||
161392636|NCT00090142|582823050|FG001|Treatment Period I|Other|1|||
161392637|NCT00090142|582823049|FG000|Treatment Period II|Other|1|||
161392638|NCT00090142|582823050|FG001|Treatment Period II|Other|0|||
161392639|NCT00006046|582823056|FG000|Overall Study|Adverse Event|3|||
161392640|NCT00006046|582823057|FG001|Overall Study|Adverse Event|0|||
161392641|NCT00006046|582823058|FG002|Overall Study|Adverse Event|0|||
161392642|NCT00006046|582823059|FG003|Overall Study|Adverse Event|0|||
161392643|NCT00006046|582823060|FG004|Overall Study|Adverse Event|0|||
161392644|NCT00006046|582823056|FG000|Overall Study|Disease Progression|2|||
161392645|NCT00006046|582823057|FG001|Overall Study|Disease Progression|0|||
161392646|NCT00006046|582823058|FG002|Overall Study|Disease Progression|0|||
161392647|NCT00006046|582823059|FG003|Overall Study|Disease Progression|0|||
161392648|NCT00006046|582823060|FG004|Overall Study|Disease Progression|0|||
161392649|NCT04295681|582823077|FG000|Overall Study|Eligibility error|1|||
161392650|NCT04295681|582823078|FG001|Overall Study|Eligibility error|3|||
161392651|NCT02210689|582823085|FG000|Overall Study|Withdrawal by Subject|7|||
161392652|NCT02210689|582823086|FG001|Overall Study|Withdrawal by Subject|4|||
161392653|NCT02210689|582823087|FG002|Overall Study|Withdrawal by Subject|2|||
161392654|NCT02210689|582823085|FG000|Overall Study|Adverse Event|0|||
161392655|NCT02210689|582823086|FG001|Overall Study|Adverse Event|1|||
161392656|NCT02210689|582823087|FG002|Overall Study|Adverse Event|0|||
161392657|NCT02210689|582823085|FG000|Overall Study|Protocol Violation|1|||
161392658|NCT02210689|582823086|FG001|Overall Study|Protocol Violation|0|||
161392659|NCT02210689|582823087|FG002|Overall Study|Protocol Violation|0|||
161392660|NCT02210689|582823085|FG000|Overall Study|Lost to Follow-up|11|||
161392661|NCT02210689|582823086|FG001|Overall Study|Lost to Follow-up|9|||
161392662|NCT02210689|582823087|FG002|Overall Study|Lost to Follow-up|5|||
161392663|NCT02210689|582823085|FG000|Overall Study|Pregnancy|0|||
161392664|NCT02210689|582823086|FG001|Overall Study|Pregnancy|1|||
161392665|NCT02210689|582823087|FG002|Overall Study|Pregnancy|0|||
161392666|NCT02210689|582823085|FG000|Overall Study|Lack of Efficacy|0|||
161392667|NCT02210689|582823086|FG001|Overall Study|Lack of Efficacy|1|||
161392668|NCT02210689|582823087|FG002|Overall Study|Lack of Efficacy|5|||
161392669|NCT02210689|582823085|FG000|Overall Study|Prohibited medication|2|||
161392670|NCT02210689|582823086|FG001|Overall Study|Prohibited medication|8|||
161392671|NCT02210689|582823087|FG002|Overall Study|Prohibited medication|1|||
161392672|NCT02210689|582823085|FG000|Overall Study|Negative Nugent score at baseline|6|||
161392673|NCT02210689|582823086|FG001|Overall Study|Negative Nugent score at baseline|2|||
161392674|NCT02210689|582823087|FG002|Overall Study|Negative Nugent score at baseline|2|||
161392675|NCT02210689|582823085|FG000|Overall Study|Other|25|||
161392676|NCT02210689|582823086|FG001|Overall Study|Other|21|||
161392677|NCT02210689|582823087|FG002|Overall Study|Other|8|||
161392678|NCT01923363|582823088|FG000|Overall Study|Protocol Violation|1|||
161392679|NCT00866047|582823089|FG000|Treatment Period|Progressive disease|13|||
161392680|NCT00866047|582823089|FG000|Treatment Period|Adverse Event|16|||
161392681|NCT00866047|582823089|FG000|Treatment Period|Physician Decision|14|||
161392682|NCT00866047|582823089|FG000|Treatment Period|Withdrawal by Subject|5|||
161392683|NCT00866047|582823089|FG000|Follow-up Period|Lost to Follow-up|5|||
161392684|NCT02928029|582823090|FG000|Overall Study|Withdrawal by Subject|0|||
161392685|NCT02928029|582823091|FG001|Overall Study|Withdrawal by Subject|1|||
161392686|NCT02928029|582823090|FG000|Overall Study|Radiological progression|1|||
161392687|NCT02928029|582823091|FG001|Overall Study|Radiological progression|0|||
161392688|NCT02928029|582823090|FG000|Overall Study|Clinical progression|1|||
161392689|NCT02928029|582823091|FG001|Overall Study|Clinical progression|2|||
161392690|NCT02928029|582823090|FG000|Overall Study|AE not related to clinical progression|1|||
161392691|NCT02928029|582823091|FG001|Overall Study|AE not related to clinical progression|1|||
161392692|NCT05427539|582823092|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161392693|NCT05427539|582823093|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161392694|NCT05427539|582823092|FG000|Period 1|Withdrawal by Subject|1|||
161392695|NCT05427539|582823093|FG001|Period 1|Withdrawal by Subject|0|||
161392696|NCT02099344|582823094|FG000|Overall Study|Physician Decision|1|||
161392697|NCT02099344|582823095|FG001|Overall Study|Physician Decision|0|||
161392698|NCT00404755|582823098|FG000|Phase I (Bupropion)|Adverse Event|3|||
161392699|NCT00404755|582823098|FG000|Phase I (Bupropion)|Other|1|||
161392700|NCT00404755|582823098|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
161392701|NCT05593913|582823101|FG000|Overall Study|Insufficient image quality|39|||
161392702|NCT01453205|582823102|FG000|Overall Study|Lost to Follow-up|3|||
161392703|NCT01453205|582823103|FG001|Overall Study|Lost to Follow-up|0|||
161392704|NCT01453205|582823104|FG002|Overall Study|Lost to Follow-up|1|||
161392705|NCT01453205|582823102|FG000|Overall Study|Withdrawal by Subject|8|||
161392706|NCT01453205|582823103|FG001|Overall Study|Withdrawal by Subject|3|||
161392707|NCT01453205|582823104|FG002|Overall Study|Withdrawal by Subject|0|||
161392708|NCT01453205|582823102|FG000|Overall Study|Death|24|||
161392709|NCT01453205|582823103|FG001|Overall Study|Death|22|||
161392710|NCT01453205|582823104|FG002|Overall Study|Death|18|||
161392711|NCT01453205|582823102|FG000|Overall Study|Other|45|||
161392712|NCT01453205|582823103|FG001|Overall Study|Other|27|||
161392713|NCT01453205|582823104|FG002|Overall Study|Other|35|||
161392714|NCT04376684|582823107|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
161392715|NCT04376684|582823108|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
161392716|NCT04376684|582823109|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
161392717|NCT04376684|582823110|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
161392718|NCT04376684|582823107|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
161392719|NCT04376684|582823108|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
161392720|NCT04376684|582823109|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
161392721|NCT04376684|582823110|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
161392722|NCT04376684|582823107|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
161392723|NCT04376684|582823108|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
161392724|NCT04376684|582823109|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
161392725|NCT04376684|582823110|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
161392726|NCT04376684|582823107|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
161392727|NCT04376684|582823108|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
161392728|NCT04376684|582823109|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
161392729|NCT04376684|582823110|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
161392730|NCT04376684|582823107|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
161392731|NCT04376684|582823108|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
161392732|NCT04376684|582823109|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
161392733|NCT04376684|582823110|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
161392734|NCT04376684|582823107|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
161392735|NCT04376684|582823108|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
161392736|NCT04376684|582823109|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
161392737|NCT04376684|582823110|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
161392738|NCT04376684|582823107|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
161392739|NCT04376684|582823108|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
161392740|NCT04376684|582823109|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
161392741|NCT04376684|582823110|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
161392742|NCT01666119|582823111|FG000|Overall Study|Adverse Event|6|||
161392743|NCT01666119|582823111|FG000|Overall Study|Withdrawal by Subject|16|||
161392744|NCT01666119|582823111|FG000|Overall Study|Lost to Follow-up|7|||
161392745|NCT01666119|582823111|FG000|Overall Study|non compliance with study medication, pa|18|||
161392746|NCT01666119|582823111|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
161392747|NCT00516906|582823124|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
161392748|NCT00516906|582823125|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
161392749|NCT01974206|582823126|FG000|Overall Study|Did Not Take Study Drug|0|||
161392750|NCT01974206|582823127|FG001|Overall Study|Did Not Take Study Drug|1|||
161392751|NCT01974206|582823126|FG000|Overall Study|Physician Decision|1|||
161392752|NCT01974206|582823127|FG001|Overall Study|Physician Decision|0|||
161392753|NCT01974206|582823126|FG000|Overall Study|Withdrawal by Subject|3|||
161392754|NCT01974206|582823127|FG001|Overall Study|Withdrawal by Subject|0|||
161392755|NCT01974206|582823126|FG000|Overall Study|Lost to Follow-up|1|||
161392756|NCT01974206|582823127|FG001|Overall Study|Lost to Follow-up|0|||
161392757|NCT01974206|582823126|FG000|Overall Study|Death|1|||
161392758|NCT01974206|582823127|FG001|Overall Study|Death|0|||
161392759|NCT03802630|582823128|FG000|Overall Study|Study terminated by sponsor|130|||
161392760|NCT03802630|582823129|FG001|Overall Study|Study terminated by sponsor|134|||
161392761|NCT03802630|582823128|FG000|Overall Study|Subject decision|16|||
161392762|NCT03802630|582823129|FG001|Overall Study|Subject decision|9|||
161392763|NCT03802630|582823128|FG000|Overall Study|Adverse Event|3|||
161392764|NCT03802630|582823129|FG001|Overall Study|Adverse Event|1|||
161392765|NCT03802630|582823128|FG000|Overall Study|Lost to Follow-up|2|||
161392766|NCT03802630|582823129|FG001|Overall Study|Lost to Follow-up|2|||
161392767|NCT03802630|582823128|FG000|Overall Study|Physician Decision|2|||
161392768|NCT03802630|582823129|FG001|Overall Study|Physician Decision|0|||
161392769|NCT03802630|582823128|FG000|Overall Study|Death|0|||
161392770|NCT03802630|582823129|FG001|Overall Study|Death|2|||
161392771|NCT02684058|582823134|FG000|Treatment Period|Progressive disease|4|||
161392772|NCT02684058|582823135|FG001|Treatment Period|Progressive disease|10|||
161392773|NCT02684058|582823136|FG002|Treatment Period|Progressive disease|19|||
161392774|NCT02684058|582823134|FG000|Treatment Period|Adverse Event|3|||
161392775|NCT02684058|582823135|FG001|Treatment Period|Adverse Event|8|||
161392776|NCT02684058|582823136|FG002|Treatment Period|Adverse Event|1|||
161392777|NCT02684058|582823134|FG000|Treatment Period|Physician Decision|5|||
161392778|NCT02684058|582823135|FG001|Treatment Period|Physician Decision|1|||
161392779|NCT02684058|582823136|FG002|Treatment Period|Physician Decision|2|||
161392780|NCT02684058|582823134|FG000|Treatment Period|New therapy for study indication|1|||
161392781|NCT02684058|582823135|FG001|Treatment Period|New therapy for study indication|0|||
161392782|NCT02684058|582823136|FG002|Treatment Period|New therapy for study indication|0|||
161392783|NCT02684058|582823134|FG000|Treatment Period|Protocol deviation|0|||
161392784|NCT02684058|582823135|FG001|Treatment Period|Protocol deviation|1|||
161392785|NCT02684058|582823136|FG002|Treatment Period|Protocol deviation|0|||
161392786|NCT02684058|582823134|FG000|Treatment Period|Subject/guardian decision|4|||
161392787|NCT02684058|582823135|FG001|Treatment Period|Subject/guardian decision|3|||
161392788|NCT02684058|582823136|FG002|Treatment Period|Subject/guardian decision|0|||
161392789|NCT02684058|582823134|FG000|Treatment Period|Death|0|||
161392790|NCT02684058|582823135|FG001|Treatment Period|Death|0|||
161392791|NCT02684058|582823136|FG002|Treatment Period|Death|2|||
161392792|NCT02684058|582823134|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161392793|NCT02684058|582823135|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161392794|NCT02684058|582823136|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161392795|NCT02684058|582823134|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
161392796|NCT02684058|582823135|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161392797|NCT02684058|582823136|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
161392798|NCT02684058|582823134|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161392799|NCT02684058|582823135|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161392800|NCT02684058|582823136|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
161392801|NCT02684058|582823134|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161392802|NCT02684058|582823135|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161392803|NCT02684058|582823136|FG002|Post-treatment Efficacy Follow-up|Death|3|||
161392804|NCT02684058|582823134|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
161392805|NCT02684058|582823135|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
161392806|NCT02684058|582823136|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
161392807|NCT02684058|582823134|FG000|Post-treatment Survival Follow-up|Death|0|||
161392808|NCT02684058|582823135|FG001|Post-treatment Survival Follow-up|Death|0|||
161392809|NCT02684058|582823136|FG002|Post-treatment Survival Follow-up|Death|7|||
161392810|NCT02684058|582823134|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
161392811|NCT02684058|582823135|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
161392812|NCT02684058|582823136|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
161392813|NCT02684058|582823134|FG000|Crossover Treatment Period|Progressive disease|0|||
161392814|NCT02684058|582823135|FG001|Crossover Treatment Period|Progressive disease|1|||
161392815|NCT02684058|582823136|FG002|Crossover Treatment Period|Progressive disease|0|||
161392816|NCT01252186|582823137|FG000|Overall Study|Adverse Event|9|||
161392817|NCT01252186|582823138|FG001|Overall Study|Adverse Event|6|||
161392818|NCT01252186|582823139|FG002|Overall Study|Adverse Event|8|||
161392819|NCT01252186|582823137|FG000|Overall Study|Withdrawal by Subject|2|||
161392820|NCT01252186|582823138|FG001|Overall Study|Withdrawal by Subject|5|||
161392821|NCT01252186|582823139|FG002|Overall Study|Withdrawal by Subject|2|||
161392822|NCT01252186|582823137|FG000|Overall Study|Physician Decision|0|||
161392823|NCT01252186|582823138|FG001|Overall Study|Physician Decision|0|||
161392824|NCT01252186|582823139|FG002|Overall Study|Physician Decision|1|||
161392825|NCT01252186|582823137|FG000|Overall Study|Non-compliance|0|||
161392826|NCT01252186|582823138|FG001|Overall Study|Non-compliance|3|||
161392827|NCT01252186|582823139|FG002|Overall Study|Non-compliance|4|||
161392828|NCT01252186|582823137|FG000|Overall Study|Protocol Violation|0|||
161392829|NCT01252186|582823138|FG001|Overall Study|Protocol Violation|0|||
161392830|NCT01252186|582823139|FG002|Overall Study|Protocol Violation|1|||
161392831|NCT01252186|582823137|FG000|Overall Study|Pregnancy|2|||
161392832|NCT01252186|582823138|FG001|Overall Study|Pregnancy|2|||
161392833|NCT01252186|582823139|FG002|Overall Study|Pregnancy|0|||
161392834|NCT01252186|582823137|FG000|Overall Study|Sponsor Request|2|||
161392835|NCT01252186|582823138|FG001|Overall Study|Sponsor Request|1|||
161392836|NCT01252186|582823139|FG002|Overall Study|Sponsor Request|0|||
161392837|NCT01252186|582823137|FG000|Overall Study|Lost to Follow-up|10|||
161392838|NCT01252186|582823138|FG001|Overall Study|Lost to Follow-up|10|||
161392839|NCT01252186|582823139|FG002|Overall Study|Lost to Follow-up|11|||
161392840|NCT01252186|582823137|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
161392841|NCT01252186|582823138|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
161392842|NCT01252186|582823139|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
161392843|NCT00780143|582823140|FG000|Overall Study|Progressive disease|1|||
161392844|NCT00780143|582823140|FG000|Overall Study|Toxicity|1|||
161392845|NCT00780143|582823140|FG000|Overall Study|Adverse Event|1|||
161392846|NCT02461290|582823145|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
161392847|NCT02461290|582823145|FG000|Overall Study|Lost to Follow-up|3|||
161392848|NCT01457014|582823146|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
161392849|NCT01457014|582823147|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
161392850|NCT01457014|582823148|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
161392851|NCT01457014|582823149|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
161392852|NCT01457014|582823146|FG000|First Night|Withdrawal by Subject|3|||
161392853|NCT01457014|582823147|FG001|First Night|Withdrawal by Subject|0|||
161392854|NCT01457014|582823148|FG002|First Night|Withdrawal by Subject|0|||
161392855|NCT01457014|582823149|FG003|First Night|Withdrawal by Subject|0|||
161392856|NCT02438384|582823154|FG000|Overall Study|Lost to Follow-up|8|||
161392857|NCT02438384|582823155|FG001|Overall Study|Lost to Follow-up|6|||
161392858|NCT02438384|582823156|FG002|Overall Study|Lost to Follow-up|4|||
161392859|NCT03319953|582823157|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
161392860|NCT03319953|582823158|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
161392861|NCT03319953|582823159|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
161392862|NCT03319953|582823160|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
161392863|NCT03319953|582823157|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
161392864|NCT03319953|582823158|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
161392865|NCT03319953|582823159|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
161392866|NCT03319953|582823160|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
161392867|NCT04027049|582823164|FG000|Overall Study|Withdrawn by family|1|||
161392868|NCT04027049|582823165|FG001|Overall Study|Withdrawn by family|0|||
161392869|NCT04027049|582823164|FG000|Overall Study|Participant safety|1|||
161392870|NCT04027049|582823165|FG001|Overall Study|Participant safety|0|||
161392871|NCT02650128|582823166|FG000|Overall Study|Death|2|||
161392872|NCT01159171|582825209|FG000|Overall Study|Adverse Event|11|||
161392873|NCT01159171|582825209|FG000|Overall Study|Progression of Disease|28|||
161392874|NCT01159171|582825209|FG000|Overall Study|Protocol Violation|1|||
161392875|NCT01159171|582825209|FG000|Overall Study|Need for Surgery|5|||
161392876|NCT01159171|582825209|FG000|Overall Study|Medical Decision|4|||
161392877|NCT01159171|582825209|FG000|Overall Study|Death|1|||
161392878|NCT02264665|582825210|FG000|Overall Study|Other|0|||
161392879|NCT02264665|582825211|FG001|Overall Study|Other|0|||
161392880|NCT02264665|582825212|FG002|Overall Study|Other|3|||
161392881|NCT02264665|582825213|FG003|Overall Study|Other|0|||
161392882|NCT02264665|582825214|FG004|Overall Study|Other|0|||
161392883|NCT02264665|582825215|FG005|Overall Study|Other|0|||
161392884|NCT02264665|582825216|FG006|Overall Study|Other|0|||
161392885|NCT02264665|582825210|FG000|Overall Study|Death|9|||
161392886|NCT02264665|582825211|FG001|Overall Study|Death|8|||
161392887|NCT02264665|582825212|FG002|Overall Study|Death|13|||
161392888|NCT02264665|582825213|FG003|Overall Study|Death|5|||
161392889|NCT02264665|582825214|FG004|Overall Study|Death|0|||
161392890|NCT02264665|582825215|FG005|Overall Study|Death|0|||
161392891|NCT02264665|582825216|FG006|Overall Study|Death|1|||
161392892|NCT02264665|582825210|FG000|Overall Study|Lost to Follow-up|1|||
161392893|NCT02264665|582825211|FG001|Overall Study|Lost to Follow-up|0|||
161392894|NCT02264665|582825212|FG002|Overall Study|Lost to Follow-up|2|||
161392895|NCT02264665|582825213|FG003|Overall Study|Lost to Follow-up|1|||
161392896|NCT02264665|582825214|FG004|Overall Study|Lost to Follow-up|0|||
161392897|NCT02264665|582825215|FG005|Overall Study|Lost to Follow-up|0|||
161392898|NCT02264665|582825216|FG006|Overall Study|Lost to Follow-up|0|||
161392899|NCT02264665|582825210|FG000|Overall Study|Participant decision|0|||
161392900|NCT02264665|582825211|FG001|Overall Study|Participant decision|0|||
161392901|NCT02264665|582825212|FG002|Overall Study|Participant decision|0|||
161392902|NCT02264665|582825213|FG003|Overall Study|Participant decision|1|||
161392903|NCT02264665|582825214|FG004|Overall Study|Participant decision|0|||
161392904|NCT02264665|582825215|FG005|Overall Study|Participant decision|0|||
161392905|NCT02264665|582825216|FG006|Overall Study|Participant decision|0|||
161392906|NCT02264665|582825210|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
161392907|NCT02264665|582825211|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
161392908|NCT02264665|582825212|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
161392909|NCT02264665|582825213|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
161392910|NCT02264665|582825214|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
161392911|NCT02264665|582825215|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
161392912|NCT02264665|582825216|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
161392913|NCT02264665|582825210|FG000|Overall Study|Data Missing|0|||
161392914|NCT02264665|582825211|FG001|Overall Study|Data Missing|0|||
161392915|NCT02264665|582825212|FG002|Overall Study|Data Missing|1|||
161392916|NCT02264665|582825213|FG003|Overall Study|Data Missing|0|||
161392917|NCT02264665|582825214|FG004|Overall Study|Data Missing|0|||
161392918|NCT02264665|582825215|FG005|Overall Study|Data Missing|0|||
161392919|NCT02264665|582825216|FG006|Overall Study|Data Missing|0|||
161392920|NCT00789581|582825220|FG000|AC Therapy|Adverse Event|2|||
161392921|NCT00789581|582825221|FG001|AC Therapy|Adverse Event|3|||
161392922|NCT00789581|582825220|FG000|AC Therapy|Withdrawal by Subject|4|||
161392923|NCT00789581|582825221|FG001|AC Therapy|Withdrawal by Subject|7|||
161392924|NCT00789581|582825220|FG000|AC Therapy|Disease recurrence|3|||
161392925|NCT00789581|582825221|FG001|AC Therapy|Disease recurrence|1|||
161392926|NCT00789581|582825220|FG000|AC Therapy|Intercurrent Illness|1|||
161392927|NCT00789581|582825221|FG001|AC Therapy|Intercurrent Illness|0|||
161392928|NCT00789581|582825220|FG000|AC Therapy|Never Treated|1|||
161392929|NCT00789581|582825221|FG001|AC Therapy|Never Treated|4|||
161392930|NCT00789581|582825220|FG000|AC Therapy|Other|0|||
161392931|NCT00789581|582825221|FG001|AC Therapy|Other|2|||
161392932|NCT00789581|582825220|FG000|Adjuvant Therapy|Never treated|2|||
161392933|NCT00789581|582825221|FG001|Adjuvant Therapy|Never treated|2|||
161392934|NCT00789581|582825220|FG000|Adjuvant Therapy|Adverse Event|20|||
161392935|NCT00789581|582825221|FG001|Adjuvant Therapy|Adverse Event|44|||
161392936|NCT00789581|582825220|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
161392937|NCT00789581|582825221|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
161392938|NCT00789581|582825220|FG000|Adjuvant Therapy|Disease recurrence|2|||
161392939|NCT00789581|582825221|FG001|Adjuvant Therapy|Disease recurrence|1|||
161392940|NCT00789581|582825220|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
161392941|NCT00789581|582825221|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
161392942|NCT00789581|582825220|FG000|Adjuvant Therapy|Protocol Violation|1|||
161392943|NCT00789581|582825221|FG001|Adjuvant Therapy|Protocol Violation|1|||
161392944|NCT00789581|582825220|FG000|Adjuvant Therapy|Other|0|||
161392945|NCT00789581|582825221|FG001|Adjuvant Therapy|Other|1|||
161392946|NCT00470093|582825222|FG000|Overall Study|Adverse Event|2|||
161392947|NCT00664560|582825223|FG000|Overall Study|Adverse Event|19|||
161392948|NCT00664560|582825224|FG001|Overall Study|Adverse Event|16|||
161392949|NCT00664560|582825225|FG002|Overall Study|Adverse Event|7|||
161392950|NCT00664560|582825223|FG000|Overall Study|Withdrawal by Subject|9|||
161392951|NCT00664560|582825224|FG001|Overall Study|Withdrawal by Subject|13|||
161392952|NCT00664560|582825225|FG002|Overall Study|Withdrawal by Subject|7|||
161392953|NCT00664560|582825223|FG000|Overall Study|Lost to Follow-up|0|||
161392954|NCT00664560|582825224|FG001|Overall Study|Lost to Follow-up|2|||
161392955|NCT00664560|582825225|FG002|Overall Study|Lost to Follow-up|0|||
161392956|NCT00664560|582825223|FG000|Overall Study|Other|11|||
161392957|NCT00664560|582825224|FG001|Overall Study|Other|4|||
161392958|NCT00664560|582825225|FG002|Overall Study|Other|5|||
161392959|NCT01328041|582825226|FG000|Overall Study|Adverse Event|7|||
161392960|NCT01328041|582825226|FG000|Overall Study|Lack of Efficacy|27|||
161392961|NCT01328041|582825226|FG000|Overall Study|Protocol Violation|7|||
161392962|NCT01328041|582825226|FG000|Overall Study|Lost to Follow-up|7|||
161392963|NCT01328041|582825226|FG000|Overall Study|Physician Decision|2|||
161392964|NCT01328041|582825226|FG000|Overall Study|Withdrawal by Subject|7|||
161392965|NCT00711113|582825227|FG000|Overall Study|Lost to Follow-up|9|||
161392966|NCT00711113|582825227|FG000|Overall Study|Implant lost|2|||
161392967|NCT05312632|582825230|FG000|Overall Study|Adverse Event|12|||
161392968|NCT05312632|582825230|FG000|Overall Study|Withdrawal by Subject|10|||
161392969|NCT05312632|582825230|FG000|Overall Study|Lack of Efficacy|4|||
161392970|NCT05312632|582825230|FG000|Overall Study|Non-compliance with study procedures|9|||
161392971|NCT05312632|582825230|FG000|Overall Study|Other|4|||
161392972|NCT02379221|582825231|FG000|Overall Study|Lost to Follow-up|1|||
161392973|NCT00519376|582825232|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392974|NCT00519376|582825233|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392975|NCT00519376|582825234|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392976|NCT00519376|582825235|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392977|NCT00519376|582825236|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392978|NCT00519376|582825237|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392979|NCT00519376|582825238|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392980|NCT00519376|582825239|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392981|NCT00519376|582825240|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392982|NCT00519376|582825241|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392983|NCT00519376|582825242|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392984|NCT00519376|582825243|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392985|NCT00519376|582825244|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
161392986|NCT00519376|582825245|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392987|NCT00519376|582825246|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392988|NCT00519376|582825247|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161392989|NCT00519376|582825232|FG000|Treatment Period 4|Lost to Follow-up|0|||
161392990|NCT00519376|582825233|FG001|Treatment Period 4|Lost to Follow-up|0|||
161392991|NCT00519376|582825234|FG002|Treatment Period 4|Lost to Follow-up|1|||
161392992|NCT00519376|582825235|FG003|Treatment Period 4|Lost to Follow-up|0|||
161392993|NCT00519376|582825236|FG004|Treatment Period 4|Lost to Follow-up|0|||
161392994|NCT00519376|582825237|FG005|Treatment Period 4|Lost to Follow-up|0|||
161392995|NCT00519376|582825238|FG006|Treatment Period 4|Lost to Follow-up|0|||
161392996|NCT00519376|582825239|FG007|Treatment Period 4|Lost to Follow-up|0|||
161392997|NCT00519376|582825240|FG008|Treatment Period 4|Lost to Follow-up|0|||
161392998|NCT00519376|582825241|FG009|Treatment Period 4|Lost to Follow-up|0|||
161392999|NCT00519376|582825242|FG010|Treatment Period 4|Lost to Follow-up|0|||
161393000|NCT00519376|582825243|FG011|Treatment Period 4|Lost to Follow-up|0|||
161393001|NCT00519376|582825244|FG012|Treatment Period 4|Lost to Follow-up|0|||
161393002|NCT00519376|582825245|FG013|Treatment Period 4|Lost to Follow-up|0|||
161393003|NCT00519376|582825246|FG014|Treatment Period 4|Lost to Follow-up|0|||
161393004|NCT00519376|582825247|FG015|Treatment Period 4|Lost to Follow-up|0|||
161393005|NCT02688088|582825251|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161393006|NCT02688088|582825252|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
161393007|NCT02688088|582825253|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161393008|NCT02688088|582825254|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161393009|NCT02688088|582825255|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161393010|NCT02688088|582825251|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161393011|NCT02688088|582825252|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
161393012|NCT02688088|582825253|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161393013|NCT02688088|582825254|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161393014|NCT02688088|582825255|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161393015|NCT02688088|582825251|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161393016|NCT02688088|582825252|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
161393017|NCT02688088|582825253|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161393018|NCT02688088|582825254|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161393019|NCT02688088|582825255|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161393020|NCT02688088|582825251|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161393021|NCT02688088|582825252|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
161393022|NCT02688088|582825253|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161393023|NCT02688088|582825254|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161393024|NCT02688088|582825255|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161393025|NCT02688088|582825251|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161393026|NCT02688088|582825252|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161393027|NCT02688088|582825253|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
161393028|NCT02688088|582825254|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161393029|NCT02688088|582825255|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161393030|NCT02688088|582825251|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161393031|NCT02688088|582825252|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161393032|NCT02688088|582825253|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
161393033|NCT02688088|582825254|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161393034|NCT02688088|582825255|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161393035|NCT02688088|582825251|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161393036|NCT02688088|582825252|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161393037|NCT02688088|582825253|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161393038|NCT02688088|582825254|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
161393039|NCT02688088|582825255|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161393040|NCT02688088|582825251|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161393041|NCT02688088|582825252|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161393042|NCT02688088|582825253|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161393043|NCT02688088|582825254|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
161393044|NCT02688088|582825255|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161393045|NCT02688088|582825251|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161393046|NCT02688088|582825252|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161393047|NCT02688088|582825253|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161393048|NCT02688088|582825254|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161393049|NCT02688088|582825255|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
161393050|NCT03812185|582825259|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
161393051|NCT00313313|582825261|FG000|Overall Study|Lack of Efficacy|14|||
161393052|NCT00313313|582825262|FG001|Overall Study|Lack of Efficacy|9|||
161393053|NCT00313313|582825263|FG002|Overall Study|Lack of Efficacy|20|||
161393054|NCT00313313|582825261|FG000|Overall Study|Withdrawal of consent by subject|18|||
161393055|NCT00313313|582825262|FG001|Overall Study|Withdrawal of consent by subject|17|||
161393056|NCT00313313|582825263|FG002|Overall Study|Withdrawal of consent by subject|31|||
161393057|NCT00313313|582825261|FG000|Overall Study|Lost to Follow-up|10|||
161393058|NCT00313313|582825262|FG001|Overall Study|Lost to Follow-up|7|||
161393059|NCT00313313|582825263|FG002|Overall Study|Lost to Follow-up|9|||
161393060|NCT00313313|582825261|FG000|Overall Study|Adverse Event|15|||
161393061|NCT00313313|582825262|FG001|Overall Study|Adverse Event|16|||
161393062|NCT00313313|582825263|FG002|Overall Study|Adverse Event|12|||
161393063|NCT00313313|582825261|FG000|Overall Study|Physician Decision|2|||
161393064|NCT00313313|582825262|FG001|Overall Study|Physician Decision|6|||
161393065|NCT00313313|582825263|FG002|Overall Study|Physician Decision|4|||
161393066|NCT00313313|582825261|FG000|Overall Study|Poor/Noncompliance|3|||
161393067|NCT00313313|582825262|FG001|Overall Study|Poor/Noncompliance|6|||
161393068|NCT00313313|582825263|FG002|Overall Study|Poor/Noncompliance|2|||
161393069|NCT00313313|582825261|FG000|Overall Study|Pregnancy|1|||
161393070|NCT00313313|582825262|FG001|Overall Study|Pregnancy|2|||
161393071|NCT00313313|582825263|FG002|Overall Study|Pregnancy|0|||
161393072|NCT00313313|582825261|FG000|Overall Study|Death|0|||
161393073|NCT00313313|582825262|FG001|Overall Study|Death|0|||
161393074|NCT00313313|582825263|FG002|Overall Study|Death|2|||
161393075|NCT00313313|582825261|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161393076|NCT00313313|582825262|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
161393077|NCT00313313|582825263|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
161393078|NCT01973387|582825264|FG000|Overall Study|Adverse Event|14|||
161393079|NCT01973387|582825265|FG001|Overall Study|Adverse Event|4|||
161393080|NCT01973387|582825264|FG000|Overall Study|Withdrawal by Subject|7|||
161393081|NCT01973387|582825265|FG001|Overall Study|Withdrawal by Subject|4|||
161393082|NCT01973387|582825264|FG000|Overall Study|Study terminated by sponsor|63|||
161393083|NCT01973387|582825265|FG001|Overall Study|Study terminated by sponsor|0|||
161393084|NCT01973387|582825264|FG000|Overall Study|Progressive disease or relapse|16|||
161393085|NCT01973387|582825265|FG001|Overall Study|Progressive disease or relapse|5|||
161393086|NCT01973387|582825264|FG000|Overall Study|Death|4|||
161393087|NCT01973387|582825265|FG001|Overall Study|Death|3|||
161393088|NCT01973387|582825264|FG000|Overall Study|Randomized, not treated|2|||
161393089|NCT01973387|582825265|FG001|Overall Study|Randomized, not treated|2|||
161393090|NCT01498575|582825266|FG000|Overall Sample|Withdrawal by Subject|60|||
161393091|NCT01498575|582825267|FG001|Overall Sample|Withdrawal by Subject|14|||
161393092|NCT01498575|582825266|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
161393093|NCT01498575|582825267|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
161393094|NCT01498575|582825266|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
161393095|NCT01498575|582825267|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
161393096|NCT01345591|582825271|FG000|Overall Study|Lost to Follow-up|1|||
161393097|NCT01126437|582825272|FG000|Overall Study|Not treated|11|||
161393098|NCT01126437|582825273|FG001|Overall Study|Not treated|18|||
161393099|NCT01126437|582825274|FG002|Overall Study|Not treated|19|||
161393100|NCT01126437|582825272|FG000|Overall Study|Sites with data irregularities/fraud|6|||
161393101|NCT01126437|582825273|FG001|Overall Study|Sites with data irregularities/fraud|6|||
161393102|NCT01126437|582825274|FG002|Overall Study|Sites with data irregularities/fraud|7|||
161393103|NCT01126437|582825272|FG000|Overall Study|Adverse Event|602|||
161393104|NCT01126437|582825273|FG001|Overall Study|Adverse Event|606|||
161393105|NCT01126437|582825274|FG002|Overall Study|Adverse Event|635|||
161393106|NCT01126437|582825272|FG000|Overall Study|Lack of Efficacy|65|||
161393107|NCT01126437|582825273|FG001|Overall Study|Lack of Efficacy|60|||
161393108|NCT01126437|582825274|FG002|Overall Study|Lack of Efficacy|59|||
161393109|NCT01126437|582825272|FG000|Overall Study|Protocol Violation|64|||
161393110|NCT01126437|582825273|FG001|Overall Study|Protocol Violation|66|||
161393111|NCT01126437|582825274|FG002|Overall Study|Protocol Violation|41|||
161393112|NCT01126437|582825272|FG000|Overall Study|Lost to Follow-up|52|||
161393113|NCT01126437|582825273|FG001|Overall Study|Lost to Follow-up|63|||
161393114|NCT01126437|582825274|FG002|Overall Study|Lost to Follow-up|55|||
161393115|NCT01126437|582825272|FG000|Overall Study|Withdrawal by Subject|331|||
161393116|NCT01126437|582825273|FG001|Overall Study|Withdrawal by Subject|335|||
161393117|NCT01126437|582825274|FG002|Overall Study|Withdrawal by Subject|319|||
161393118|NCT01126437|582825272|FG000|Overall Study|Other reason not specified|210|||
161393119|NCT01126437|582825273|FG001|Overall Study|Other reason not specified|176|||
161393120|NCT01126437|582825274|FG002|Overall Study|Other reason not specified|178|||
161393121|NCT00596154|582825275|FG000|Overall Study|Not Evaluable|2|||
161393122|NCT00642369|582825280|FG000|Overall Study|Adverse Event|2|||
161393123|NCT00642369|582825281|FG001|Overall Study|Adverse Event|3|||
161393124|NCT00642369|582825280|FG000|Overall Study|Withdrawal by Subject|1|||
161393125|NCT00642369|582825281|FG001|Overall Study|Withdrawal by Subject|0|||
161393126|NCT00642369|582825280|FG000|Overall Study|misdiagnosis|0|||
161393127|NCT00642369|582825281|FG001|Overall Study|misdiagnosis|1|||
161393128|NCT00642369|582825280|FG000|Overall Study|Lack of Efficacy|2|||
161393129|NCT00642369|582825281|FG001|Overall Study|Lack of Efficacy|2|||
161393130|NCT00996281|582825289|FG000|Overall Study|Adverse Event|75|||
161393131|NCT00996281|582825290|FG001|Overall Study|Adverse Event|37|||
161393132|NCT00996281|582825289|FG000|Overall Study|Major Protocol Deviation|6|||
161393133|NCT00996281|582825290|FG001|Overall Study|Major Protocol Deviation|7|||
161393134|NCT00996281|582825289|FG000|Overall Study|Lost to Follow-up|14|||
161393135|NCT00996281|582825290|FG001|Overall Study|Lost to Follow-up|16|||
161393136|NCT00996281|582825289|FG000|Overall Study|Withdrawal by Subject|31|||
161393137|NCT00996281|582825290|FG001|Overall Study|Withdrawal by Subject|20|||
161393138|NCT00996281|582825289|FG000|Overall Study|Lack of Efficacy|0|||
161393139|NCT00996281|582825290|FG001|Overall Study|Lack of Efficacy|2|||
161393140|NCT00996281|582825289|FG000|Overall Study|Other|5|||
161393141|NCT00996281|582825290|FG001|Overall Study|Other|7|||
161393142|NCT03622112|582825293|FG000|Overall Study|Withdrawal by Subject|6|||
161393143|NCT03622112|582825294|FG001|Overall Study|Withdrawal by Subject|2|||
161393144|NCT03622112|582825295|FG002|Overall Study|Withdrawal by Subject|4|||
161393145|NCT03622112|582825296|FG003|Overall Study|Withdrawal by Subject|2|||
161393146|NCT03622112|582825297|FG004|Overall Study|Withdrawal by Subject|1|||
161393147|NCT03622112|582825298|FG005|Overall Study|Withdrawal by Subject|2|||
161393148|NCT03622112|582825299|FG006|Overall Study|Withdrawal by Subject|2|||
161393149|NCT03622112|582825293|FG000|Overall Study|Death|0|||
161393150|NCT03622112|582825294|FG001|Overall Study|Death|0|||
161393151|NCT03622112|582825295|FG002|Overall Study|Death|0|||
161393152|NCT03622112|582825296|FG003|Overall Study|Death|1|||
161393153|NCT03622112|582825297|FG004|Overall Study|Death|0|||
161393154|NCT03622112|582825298|FG005|Overall Study|Death|0|||
161393155|NCT03622112|582825299|FG006|Overall Study|Death|0|||
161393156|NCT03622112|582825293|FG000|Overall Study|Lost to Follow-up|1|||
161393157|NCT03622112|582825294|FG001|Overall Study|Lost to Follow-up|1|||
161393158|NCT03622112|582825295|FG002|Overall Study|Lost to Follow-up|0|||
161393159|NCT03622112|582825296|FG003|Overall Study|Lost to Follow-up|0|||
161393160|NCT03622112|582825297|FG004|Overall Study|Lost to Follow-up|0|||
161393161|NCT03622112|582825298|FG005|Overall Study|Lost to Follow-up|0|||
161393162|NCT03622112|582825299|FG006|Overall Study|Lost to Follow-up|0|||
161393163|NCT03622112|582825293|FG000|Overall Study|Study-specific withdrawal criteria|10|||
161393164|NCT03622112|582825294|FG001|Overall Study|Study-specific withdrawal criteria|8|||
161393165|NCT03622112|582825295|FG002|Overall Study|Study-specific withdrawal criteria|7|||
161393166|NCT03622112|582825296|FG003|Overall Study|Study-specific withdrawal criteria|6|||
161393167|NCT03622112|582825297|FG004|Overall Study|Study-specific withdrawal criteria|4|||
161393168|NCT03622112|582825298|FG005|Overall Study|Study-specific withdrawal criteria|18|||
161393169|NCT03622112|582825299|FG006|Overall Study|Study-specific withdrawal criteria|4|||
161393170|NCT03622112|582825293|FG000|Overall Study|Protocol Violation|2|||
161393171|NCT03622112|582825294|FG001|Overall Study|Protocol Violation|0|||
161393172|NCT03622112|582825295|FG002|Overall Study|Protocol Violation|1|||
161393173|NCT03622112|582825296|FG003|Overall Study|Protocol Violation|1|||
161393174|NCT03622112|582825297|FG004|Overall Study|Protocol Violation|0|||
161393175|NCT03622112|582825298|FG005|Overall Study|Protocol Violation|0|||
161393176|NCT03622112|582825299|FG006|Overall Study|Protocol Violation|0|||
161393177|NCT03622112|582825293|FG000|Overall Study|Adverse Event|6|||
161393178|NCT03622112|582825294|FG001|Overall Study|Adverse Event|8|||
161393179|NCT03622112|582825295|FG002|Overall Study|Adverse Event|4|||
161393180|NCT03622112|582825296|FG003|Overall Study|Adverse Event|11|||
161393181|NCT03622112|582825297|FG004|Overall Study|Adverse Event|4|||
161393182|NCT03622112|582825298|FG005|Overall Study|Adverse Event|20|||
161393183|NCT03622112|582825299|FG006|Overall Study|Adverse Event|2|||
161393184|NCT03622112|582825293|FG000|Overall Study|Reason not specified|0|||
161393185|NCT03622112|582825294|FG001|Overall Study|Reason not specified|1|||
161393186|NCT03622112|582825295|FG002|Overall Study|Reason not specified|0|||
161393187|NCT03622112|582825296|FG003|Overall Study|Reason not specified|1|||
161393188|NCT03622112|582825297|FG004|Overall Study|Reason not specified|1|||
161393189|NCT03622112|582825298|FG005|Overall Study|Reason not specified|2|||
161393190|NCT03622112|582825299|FG006|Overall Study|Reason not specified|1|||
161393191|NCT01155466|582825300|FG000|Overall Study|Adverse Event|13|||
161393192|NCT01155466|582825301|FG001|Overall Study|Adverse Event|15|||
161393193|NCT01155466|582825302|FG002|Overall Study|Adverse Event|6|||
161393194|NCT01155466|582825303|FG003|Overall Study|Adverse Event|17|||
161393195|NCT01155466|582825304|FG004|Overall Study|Adverse Event|18|||
161393196|NCT01155466|582825300|FG000|Overall Study|Lost to Follow-up|0|||
161393197|NCT01155466|582825301|FG001|Overall Study|Lost to Follow-up|0|||
161393198|NCT01155466|582825302|FG002|Overall Study|Lost to Follow-up|0|||
161393199|NCT01155466|582825303|FG003|Overall Study|Lost to Follow-up|0|||
161393200|NCT01155466|582825304|FG004|Overall Study|Lost to Follow-up|2|||
161393201|NCT01155466|582825300|FG000|Overall Study|Withdrawal by Subject|7|||
161393202|NCT01155466|582825301|FG001|Overall Study|Withdrawal by Subject|5|||
161393203|NCT01155466|582825302|FG002|Overall Study|Withdrawal by Subject|9|||
161393204|NCT01155466|582825303|FG003|Overall Study|Withdrawal by Subject|4|||
161393205|NCT01155466|582825304|FG004|Overall Study|Withdrawal by Subject|4|||
161393206|NCT01155466|582825300|FG000|Overall Study|Protocol Violation|0|||
161393207|NCT01155466|582825301|FG001|Overall Study|Protocol Violation|0|||
161393208|NCT01155466|582825302|FG002|Overall Study|Protocol Violation|2|||
161393209|NCT01155466|582825303|FG003|Overall Study|Protocol Violation|0|||
161393210|NCT01155466|582825304|FG004|Overall Study|Protocol Violation|1|||
161393211|NCT01155466|582825300|FG000|Overall Study|Administrative|0|||
161393212|NCT01155466|582825301|FG001|Overall Study|Administrative|3|||
161393213|NCT01155466|582825302|FG002|Overall Study|Administrative|0|||
161393214|NCT01155466|582825303|FG003|Overall Study|Administrative|0|||
161393215|NCT01155466|582825304|FG004|Overall Study|Administrative|0|||
161393216|NCT01155466|582825300|FG000|Overall Study|Randomized not treated|2|||
161393217|NCT01155466|582825301|FG001|Overall Study|Randomized not treated|2|||
161393218|NCT01155466|582825302|FG002|Overall Study|Randomized not treated|3|||
161393219|NCT01155466|582825303|FG003|Overall Study|Randomized not treated|0|||
161393220|NCT01155466|582825304|FG004|Overall Study|Randomized not treated|2|||
161393221|NCT03305419|582825305|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393222|NCT03305419|582825306|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
161393223|NCT03305419|582825307|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393224|NCT03305419|582825308|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393225|NCT03305419|582825309|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393226|NCT03305419|582825310|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393227|NCT03305419|582825311|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393228|NCT03305419|582825312|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161393229|NCT03305419|582825305|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
161393230|NCT03305419|582825306|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393231|NCT03305419|582825307|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393232|NCT03305419|582825308|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393233|NCT03305419|582825309|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393234|NCT03305419|582825310|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393235|NCT03305419|582825311|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393236|NCT03305419|582825312|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161393237|NCT03305419|582825305|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
161393238|NCT03305419|582825306|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393239|NCT03305419|582825307|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393240|NCT03305419|582825308|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393241|NCT03305419|582825309|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393242|NCT03305419|582825310|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393243|NCT03305419|582825311|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393244|NCT03305419|582825312|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161393245|NCT03305419|582825305|FG000|Part B (14 Days)|Adverse Event|0|||
161393246|NCT03305419|582825306|FG001|Part B (14 Days)|Adverse Event|0|||
161393247|NCT03305419|582825307|FG002|Part B (14 Days)|Adverse Event|0|||
161393248|NCT03305419|582825308|FG003|Part B (14 Days)|Adverse Event|0|||
161393249|NCT03305419|582825309|FG004|Part B (14 Days)|Adverse Event|1|||
161393250|NCT03305419|582825310|FG005|Part B (14 Days)|Adverse Event|2|||
161393251|NCT03305419|582825311|FG006|Part B (14 Days)|Adverse Event|4|||
161393252|NCT03305419|582825312|FG007|Part B (14 Days)|Adverse Event|0|||
161393253|NCT03305419|582825305|FG000|Part B (14 Days)|Physician Decision|0|||
161393254|NCT03305419|582825306|FG001|Part B (14 Days)|Physician Decision|0|||
161393255|NCT03305419|582825307|FG002|Part B (14 Days)|Physician Decision|0|||
161393256|NCT03305419|582825308|FG003|Part B (14 Days)|Physician Decision|0|||
161393257|NCT03305419|582825309|FG004|Part B (14 Days)|Physician Decision|2|||
161393258|NCT03305419|582825310|FG005|Part B (14 Days)|Physician Decision|8|||
161393259|NCT03305419|582825311|FG006|Part B (14 Days)|Physician Decision|1|||
161393260|NCT03305419|582825312|FG007|Part B (14 Days)|Physician Decision|0|||
161393261|NCT04154605|582825317|FG000|Overall Study|Procedure Canceled|1|||
161393262|NCT04154605|582825318|FG001|Overall Study|Procedure Canceled|1|||
161393263|NCT04154605|582825317|FG000|Overall Study|Missed follow up|1|||
161393264|NCT04154605|582825318|FG001|Overall Study|Missed follow up|1|||
161393265|NCT04154605|582825317|FG000|Overall Study|Withdrawal by Subject|1|||
161393266|NCT04154605|582825318|FG001|Overall Study|Withdrawal by Subject|0|||
161393267|NCT01229254|582825319|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
161393268|NCT01229254|582825320|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
161393269|NCT01229254|582825321|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
161393270|NCT01229254|582825319|FG000|Overall Study|Adverse Event|4|||
161393271|NCT01229254|582825320|FG001|Overall Study|Adverse Event|5|||
161393272|NCT01229254|582825321|FG002|Overall Study|Adverse Event|3|||
161393273|NCT01229254|582825319|FG000|Overall Study|Lost to Follow-up|3|||
161393274|NCT01229254|582825320|FG001|Overall Study|Lost to Follow-up|0|||
161393275|NCT01229254|582825321|FG002|Overall Study|Lost to Follow-up|1|||
161393276|NCT01229254|582825319|FG000|Overall Study|Physician Decision|0|||
161393277|NCT01229254|582825320|FG001|Overall Study|Physician Decision|3|||
161393278|NCT01229254|582825321|FG002|Overall Study|Physician Decision|0|||
161393279|NCT01229254|582825319|FG000|Overall Study|Protocol Violation|4|||
161393280|NCT01229254|582825320|FG001|Overall Study|Protocol Violation|6|||
161393281|NCT01229254|582825321|FG002|Overall Study|Protocol Violation|5|||
161393282|NCT01229254|582825319|FG000|Overall Study|Withdrawal by Subject|1|||
161393283|NCT01229254|582825320|FG001|Overall Study|Withdrawal by Subject|0|||
161393284|NCT01229254|582825321|FG002|Overall Study|Withdrawal by Subject|1|||
161393285|NCT01229254|582825319|FG000|Overall Study|Non-compliance with Study Drug|0|||
161393286|NCT01229254|582825320|FG001|Overall Study|Non-compliance with Study Drug|1|||
161393287|NCT01229254|582825321|FG002|Overall Study|Non-compliance with Study Drug|1|||
161393288|NCT04934800|582825322|FG000|Overall Study|Other|1|||
161393289|NCT04934800|582825322|FG000|Overall Study|Withdrawal by Subject|5|||
161393290|NCT04934800|582825322|FG000|Overall Study|Lack of Efficacy|1|||
161393291|NCT04934800|582825322|FG000|Overall Study|Adverse Event|9|||
161393292|NCT04934800|582825322|FG000|Overall Study|Lost to Follow-up|5|||
161393293|NCT04934800|582825322|FG000|Overall Study|Enrolled but not treated|1|||
161393294|NCT05596734|582825323|FG000|Substudy A|Withdrawal by Subject|1|||
161393295|NCT05596734|582825324|FG001|Substudy A|Withdrawal by Subject|0|||
161393296|NCT05596734|582825325|FG002|Substudy A|Withdrawal by Subject|0|||
161393297|NCT05596734|582825326|FG003|Substudy A|Withdrawal by Subject|0|||
161393298|NCT05596734|582825327|FG004|Substudy A|Withdrawal by Subject|0|||
161393299|NCT05596734|582825328|FG005|Substudy A|Withdrawal by Subject|0|||
161393300|NCT05596734|582825329|FG006|Substudy A|Withdrawal by Subject|1|||
161393301|NCT05596734|582825330|FG007|Substudy A|Withdrawal by Subject|0|||
161393302|NCT05596734|582825331|FG008|Substudy A|Withdrawal by Subject|0|||
161393303|NCT05596734|582825332|FG009|Substudy A|Withdrawal by Subject|0|||
161393304|NCT05596734|582825333|FG010|Substudy A|Withdrawal by Subject|0|||
161393305|NCT05596734|582825334|FG011|Substudy A|Withdrawal by Subject|0|||
161393306|NCT05596734|582825335|FG012|Substudy A|Withdrawal by Subject|0|||
161393307|NCT05596734|582825336|FG013|Substudy A|Withdrawal by Subject|0|||
161393308|NCT05596734|582825337|FG014|Substudy A|Withdrawal by Subject|0|||
161393309|NCT05596734|582825338|FG015|Substudy A|Withdrawal by Subject|0|||
161393310|NCT05596734|582825339|FG016|Substudy A|Withdrawal by Subject|0|||
161393311|NCT05596734|582825340|FG017|Substudy A|Withdrawal by Subject|0|||
161393312|NCT05596734|582825341|FG018|Substudy A|Withdrawal by Subject|0|||
161393313|NCT05596734|582825342|FG019|Substudy A|Withdrawal by Subject|0|||
161393314|NCT05596734|582825343|FG020|Substudy A|Withdrawal by Subject|0|||
161393315|NCT05596734|582825344|FG021|Substudy A|Withdrawal by Subject|0|||
161393316|NCT05596734|582825345|FG022|Substudy A|Withdrawal by Subject|0|||
161393317|NCT05596734|582825346|FG023|Substudy A|Withdrawal by Subject|0|||
161393318|NCT05596734|582825323|FG000|Substudy A|Lost to Follow-up|1|||
161393319|NCT05596734|582825324|FG001|Substudy A|Lost to Follow-up|0|||
161393320|NCT05596734|582825325|FG002|Substudy A|Lost to Follow-up|1|||
161393321|NCT05596734|582825326|FG003|Substudy A|Lost to Follow-up|0|||
161393322|NCT05596734|582825327|FG004|Substudy A|Lost to Follow-up|0|||
161393323|NCT05596734|582825328|FG005|Substudy A|Lost to Follow-up|0|||
161393324|NCT05596734|582825329|FG006|Substudy A|Lost to Follow-up|0|||
161393325|NCT05596734|582825330|FG007|Substudy A|Lost to Follow-up|0|||
161393326|NCT05596734|582825331|FG008|Substudy A|Lost to Follow-up|0|||
161393327|NCT05596734|582825332|FG009|Substudy A|Lost to Follow-up|0|||
161393328|NCT05596734|582825333|FG010|Substudy A|Lost to Follow-up|0|||
161393329|NCT05596734|582825334|FG011|Substudy A|Lost to Follow-up|0|||
161393330|NCT05596734|582825335|FG012|Substudy A|Lost to Follow-up|0|||
161393331|NCT05596734|582825336|FG013|Substudy A|Lost to Follow-up|0|||
161393332|NCT05596734|582825337|FG014|Substudy A|Lost to Follow-up|0|||
161393333|NCT05596734|582825338|FG015|Substudy A|Lost to Follow-up|0|||
161393334|NCT05596734|582825339|FG016|Substudy A|Lost to Follow-up|0|||
161393335|NCT05596734|582825340|FG017|Substudy A|Lost to Follow-up|0|||
161393336|NCT05596734|582825341|FG018|Substudy A|Lost to Follow-up|0|||
161393337|NCT05596734|582825342|FG019|Substudy A|Lost to Follow-up|0|||
161393338|NCT05596734|582825343|FG020|Substudy A|Lost to Follow-up|0|||
161393339|NCT05596734|582825344|FG021|Substudy A|Lost to Follow-up|0|||
161393340|NCT05596734|582825345|FG022|Substudy A|Lost to Follow-up|0|||
161393341|NCT05596734|582825346|FG023|Substudy A|Lost to Follow-up|0|||
161393342|NCT05596734|582825323|FG000|Substudy B|Withdrawal by Subject|0|||
161393343|NCT05596734|582825324|FG001|Substudy B|Withdrawal by Subject|0|||
161393344|NCT05596734|582825325|FG002|Substudy B|Withdrawal by Subject|0|||
161393345|NCT05596734|582825326|FG003|Substudy B|Withdrawal by Subject|0|||
161393346|NCT05596734|582825327|FG004|Substudy B|Withdrawal by Subject|0|||
161393347|NCT05596734|582825328|FG005|Substudy B|Withdrawal by Subject|0|||
161393348|NCT05596734|582825329|FG006|Substudy B|Withdrawal by Subject|0|||
161393349|NCT05596734|582825330|FG007|Substudy B|Withdrawal by Subject|0|||
161393350|NCT05596734|582825331|FG008|Substudy B|Withdrawal by Subject|0|||
161393351|NCT05596734|582825332|FG009|Substudy B|Withdrawal by Subject|0|||
161393352|NCT05596734|582825333|FG010|Substudy B|Withdrawal by Subject|0|||
161393353|NCT05596734|582825334|FG011|Substudy B|Withdrawal by Subject|0|||
161393354|NCT05596734|582825335|FG012|Substudy B|Withdrawal by Subject|1|||
161393355|NCT05596734|582825336|FG013|Substudy B|Withdrawal by Subject|0|||
161393356|NCT05596734|582825337|FG014|Substudy B|Withdrawal by Subject|1|||
161393357|NCT05596734|582825338|FG015|Substudy B|Withdrawal by Subject|2|||
161393358|NCT05596734|582825339|FG016|Substudy B|Withdrawal by Subject|2|||
161393359|NCT05596734|582825340|FG017|Substudy B|Withdrawal by Subject|1|||
161393360|NCT05596734|582825341|FG018|Substudy B|Withdrawal by Subject|2|||
161393361|NCT05596734|582825342|FG019|Substudy B|Withdrawal by Subject|0|||
161393362|NCT05596734|582825343|FG020|Substudy B|Withdrawal by Subject|0|||
161393363|NCT05596734|582825344|FG021|Substudy B|Withdrawal by Subject|0|||
161393364|NCT05596734|582825345|FG022|Substudy B|Withdrawal by Subject|0|||
161393365|NCT05596734|582825346|FG023|Substudy B|Withdrawal by Subject|1|||
161393366|NCT05596734|582825323|FG000|Substudy B|Physician Decision|0|||
161393367|NCT05596734|582825324|FG001|Substudy B|Physician Decision|0|||
161393368|NCT05596734|582825325|FG002|Substudy B|Physician Decision|0|||
161393369|NCT05596734|582825326|FG003|Substudy B|Physician Decision|0|||
161393370|NCT05596734|582825327|FG004|Substudy B|Physician Decision|0|||
161393371|NCT05596734|582825328|FG005|Substudy B|Physician Decision|0|||
161393372|NCT05596734|582825329|FG006|Substudy B|Physician Decision|0|||
161393373|NCT05596734|582825330|FG007|Substudy B|Physician Decision|0|||
161393374|NCT05596734|582825331|FG008|Substudy B|Physician Decision|0|||
161393375|NCT05596734|582825332|FG009|Substudy B|Physician Decision|0|||
161393376|NCT05596734|582825333|FG010|Substudy B|Physician Decision|0|||
161393377|NCT05596734|582825334|FG011|Substudy B|Physician Decision|0|||
161393378|NCT05596734|582825335|FG012|Substudy B|Physician Decision|0|||
161393379|NCT05596734|582825336|FG013|Substudy B|Physician Decision|0|||
161393380|NCT05596734|582825337|FG014|Substudy B|Physician Decision|0|||
161393381|NCT05596734|582825338|FG015|Substudy B|Physician Decision|1|||
161393382|NCT05596734|582825339|FG016|Substudy B|Physician Decision|0|||
161393383|NCT05596734|582825340|FG017|Substudy B|Physician Decision|0|||
161393384|NCT05596734|582825341|FG018|Substudy B|Physician Decision|0|||
161393385|NCT05596734|582825342|FG019|Substudy B|Physician Decision|0|||
161393386|NCT05596734|582825343|FG020|Substudy B|Physician Decision|0|||
161393387|NCT05596734|582825344|FG021|Substudy B|Physician Decision|0|||
161393388|NCT05596734|582825345|FG022|Substudy B|Physician Decision|0|||
161393389|NCT05596734|582825346|FG023|Substudy B|Physician Decision|0|||
161393390|NCT05596734|582825323|FG000|Substudy B|Lost to Follow-up|0|||
161393391|NCT05596734|582825324|FG001|Substudy B|Lost to Follow-up|0|||
161393392|NCT05596734|582825325|FG002|Substudy B|Lost to Follow-up|0|||
161393393|NCT05596734|582825326|FG003|Substudy B|Lost to Follow-up|0|||
161393394|NCT05596734|582825327|FG004|Substudy B|Lost to Follow-up|0|||
161393395|NCT05596734|582825328|FG005|Substudy B|Lost to Follow-up|0|||
161393396|NCT05596734|582825329|FG006|Substudy B|Lost to Follow-up|0|||
161393397|NCT05596734|582825330|FG007|Substudy B|Lost to Follow-up|0|||
161393398|NCT05596734|582825331|FG008|Substudy B|Lost to Follow-up|0|||
161393399|NCT05596734|582825332|FG009|Substudy B|Lost to Follow-up|0|||
161393400|NCT05596734|582825333|FG010|Substudy B|Lost to Follow-up|0|||
161393401|NCT05596734|582825334|FG011|Substudy B|Lost to Follow-up|0|||
161393402|NCT05596734|582825335|FG012|Substudy B|Lost to Follow-up|1|||
161393403|NCT05596734|582825336|FG013|Substudy B|Lost to Follow-up|0|||
161393404|NCT05596734|582825337|FG014|Substudy B|Lost to Follow-up|1|||
161393405|NCT05596734|582825338|FG015|Substudy B|Lost to Follow-up|1|||
161393406|NCT05596734|582825339|FG016|Substudy B|Lost to Follow-up|0|||
161393407|NCT05596734|582825340|FG017|Substudy B|Lost to Follow-up|0|||
161393408|NCT05596734|582825341|FG018|Substudy B|Lost to Follow-up|0|||
161393409|NCT05596734|582825342|FG019|Substudy B|Lost to Follow-up|0|||
161393410|NCT05596734|582825343|FG020|Substudy B|Lost to Follow-up|0|||
161393411|NCT05596734|582825344|FG021|Substudy B|Lost to Follow-up|0|||
161393412|NCT05596734|582825345|FG022|Substudy B|Lost to Follow-up|0|||
161393413|NCT05596734|582825346|FG023|Substudy B|Lost to Follow-up|0|||
161393414|NCT02118766|582825351|FG000|Overall Study|Adverse Event|7|||
161393415|NCT02118766|582825352|FG001|Overall Study|Adverse Event|2|||
161393416|NCT02118766|582825351|FG000|Overall Study|Withdrawal by Subject|3|||
161393417|NCT02118766|582825352|FG001|Overall Study|Withdrawal by Subject|6|||
161393418|NCT02118766|582825351|FG000|Overall Study|Lost to Follow-up|5|||
161393419|NCT02118766|582825352|FG001|Overall Study|Lost to Follow-up|4|||
161393420|NCT02118766|582825351|FG000|Overall Study|Withdrawal by parent/guardian|12|||
161393421|NCT02118766|582825352|FG001|Overall Study|Withdrawal by parent/guardian|18|||
161393422|NCT02118766|582825351|FG000|Overall Study|Other|3|||
161393423|NCT02118766|582825352|FG001|Overall Study|Other|1|||
161393424|NCT02059499|582825354|FG000|Upto Week 20|Lost to Follow-up|2|||
161393425|NCT02059499|582825355|FG001|Upto Week 20|Lost to Follow-up|6|||
161393426|NCT02059499|582825356|FG002|Upto Week 20|Lost to Follow-up|0|||
161393427|NCT02059499|582825354|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
161393428|NCT02059499|582825355|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
161393429|NCT02059499|582825356|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
161393430|NCT02059499|582825354|FG000|Upto Week 20|Withdrawal by Subject|1|||
161393431|NCT02059499|582825355|FG001|Upto Week 20|Withdrawal by Subject|1|||
161393432|NCT02059499|582825356|FG002|Upto Week 20|Withdrawal by Subject|0|||
161393433|NCT02059499|582825354|FG000|Upto Week 20|No treatment per protocol criteria|0|||
161393434|NCT02059499|582825355|FG001|Upto Week 20|No treatment per protocol criteria|0|||
161393435|NCT02059499|582825356|FG002|Upto Week 20|No treatment per protocol criteria|5|||
161393436|NCT02059499|582825354|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
161393437|NCT02059499|582825355|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
161393438|NCT02059499|582825356|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
161393439|NCT02059499|582825354|FG000|Post-week 20|Lost to Follow-up|0|||
161393440|NCT02059499|582825355|FG001|Post-week 20|Lost to Follow-up|2|||
161393441|NCT02059499|582825356|FG002|Post-week 20|Lost to Follow-up|0|||
161393442|NCT02059499|582825354|FG000|Post-week 20|Withdrawal by Subject|0|||
161393443|NCT02059499|582825355|FG001|Post-week 20|Withdrawal by Subject|1|||
161393444|NCT02059499|582825356|FG002|Post-week 20|Withdrawal by Subject|0|||
161393445|NCT02059499|582825354|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
161393446|NCT02059499|582825355|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
161393447|NCT02059499|582825356|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
161393448|NCT04210245|582825357|FG000|Overall Study|Adverse Event|0|||
161393449|NCT04210245|582825358|FG001|Overall Study|Adverse Event|3|||
161393450|NCT04210245|582825359|FG002|Overall Study|Adverse Event|6|||
161393451|NCT04210245|582825360|FG003|Overall Study|Adverse Event|0|||
161393452|NCT04210245|582825357|FG000|Overall Study|Withdrawal by Subject|0|||
161393453|NCT04210245|582825358|FG001|Overall Study|Withdrawal by Subject|1|||
161393454|NCT04210245|582825359|FG002|Overall Study|Withdrawal by Subject|4|||
161393455|NCT04210245|582825360|FG003|Overall Study|Withdrawal by Subject|4|||
161393456|NCT04210245|582825357|FG000|Overall Study|Lost to Follow-up|0|||
161393457|NCT04210245|582825358|FG001|Overall Study|Lost to Follow-up|1|||
161393458|NCT04210245|582825359|FG002|Overall Study|Lost to Follow-up|1|||
161393459|NCT04210245|582825360|FG003|Overall Study|Lost to Follow-up|1|||
161393460|NCT04210245|582825357|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
161393461|NCT04210245|582825358|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
161435302|NCT00627393|582987982|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
161393462|NCT04210245|582825359|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
161393463|NCT04210245|582825360|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
161393464|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
161393465|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161393466|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161393467|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161393468|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161393469|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161393470|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
161393471|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
161393472|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161393473|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161393474|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161393475|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161393476|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
161393477|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
161393478|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161393479|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161393480|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161393481|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161393482|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
161393483|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
161393484|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161393485|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161393486|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161393487|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161393488|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
161393489|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
161393490|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161393491|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161393492|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161393493|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161393494|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
161393495|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161393496|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161393497|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161393498|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161393499|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161393500|NCT03989349|582825361|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
161393501|NCT03989349|582825362|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
161393502|NCT03989349|582825363|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161393503|NCT03989349|582825364|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161393504|NCT03989349|582825365|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161393505|NCT03989349|582825366|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161393506|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161393507|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161393508|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
161393509|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
161393510|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
161393511|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
161393512|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161393513|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161393514|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
161393515|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
161393516|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
161393517|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
161393518|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161393519|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161393520|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
161393521|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
161393522|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
161393523|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
161393524|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161393525|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161393526|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161393527|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161393528|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
161393529|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161393530|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161393531|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161393532|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161393533|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161393534|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161393535|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161393536|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
161393537|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
161393538|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
161393539|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
161393540|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
161393541|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
161393542|NCT03989349|582825361|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
161393543|NCT03989349|582825362|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
161393544|NCT03989349|582825363|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
161393545|NCT03989349|582825364|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
161393546|NCT03989349|582825365|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
161393547|NCT03989349|582825366|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
161393548|NCT02248649|582825367|FG000|Overall Study|Death|7|||
161393549|NCT02248649|582825368|FG001|Overall Study|Death|11|||
161393550|NCT02248649|582825367|FG000|Overall Study|Lost to Follow-up|14|||
161393551|NCT02248649|582825368|FG001|Overall Study|Lost to Follow-up|10|||
161393552|NCT01802580|582825371|FG000|Overall Study|Physician Decision|1|||
161393553|NCT01802580|582825372|FG001|Overall Study|Physician Decision|0|||
161393554|NCT01802580|582825371|FG000|Overall Study|Protocol Violation|2|||
161393555|NCT01802580|582825372|FG001|Overall Study|Protocol Violation|0|||
161393556|NCT01802580|582825371|FG000|Overall Study|Withdrawal by Subject|5|||
161393557|NCT01802580|582825372|FG001|Overall Study|Withdrawal by Subject|6|||
161393558|NCT01802580|582825371|FG000|Overall Study|Other|1|||
161393559|NCT01802580|582825372|FG001|Overall Study|Other|3|||
161393560|NCT01802580|582825371|FG000|Overall Study|Lack of Efficacy|0|||
161393561|NCT01802580|582825372|FG001|Overall Study|Lack of Efficacy|2|||
161393562|NCT03255967|582825373|FG000|Overall Study|Adverse Event|26|||
161393563|NCT03255967|582825374|FG001|Overall Study|Adverse Event|30|||
161393564|NCT03255967|582825373|FG000|Overall Study|Withdrawal by Subject|6|||
161393565|NCT03255967|582825374|FG001|Overall Study|Withdrawal by Subject|6|||
161393566|NCT03255967|582825373|FG000|Overall Study|Schedule conflict|6|||
161393567|NCT03255967|582825374|FG001|Overall Study|Schedule conflict|4|||
161393568|NCT03255967|582825373|FG000|Overall Study|POA did not sign consent form|2|||
161393569|NCT03255967|582825374|FG001|Overall Study|POA did not sign consent form|0|||
161393570|NCT01327053|582825379|FG000|Overall Study|Adverse Event|23|||
161393571|NCT01327053|582825380|FG001|Overall Study|Adverse Event|57|||
161393572|NCT01327053|582825379|FG000|Overall Study|Patient/guardian decision|11|||
161393573|NCT01327053|582825380|FG001|Overall Study|Patient/guardian decision|35|||
161393574|NCT01327053|582825379|FG000|Overall Study|Physician Decision|10|||
161393575|NCT01327053|582825380|FG001|Overall Study|Physician Decision|14|||
161393576|NCT01327053|582825379|FG000|Overall Study|Death|1|||
161393577|NCT01327053|582825380|FG001|Overall Study|Death|5|||
161393578|NCT01327053|582825379|FG000|Overall Study|Lost to Follow-up|2|||
161393579|NCT01327053|582825380|FG001|Overall Study|Lost to Follow-up|4|||
161393580|NCT01327053|582825379|FG000|Overall Study|Non-compliance with study treatment|0|||
161393581|NCT01327053|582825380|FG001|Overall Study|Non-compliance with study treatment|5|||
161393582|NCT01327053|582825379|FG000|Overall Study|Study terminated by Sponsor|1|||
161393583|NCT01327053|582825380|FG001|Overall Study|Study terminated by Sponsor|3|||
161393584|NCT01327053|582825379|FG000|Overall Study|Progressive disease|31|||
161393585|NCT01327053|582825380|FG001|Overall Study|Progressive disease|26|||
161393586|NCT01327053|582825379|FG000|Overall Study|Protocol Violation|0|||
161393587|NCT01327053|582825380|FG001|Overall Study|Protocol Violation|1|||
161393588|NCT01327053|582825379|FG000|Overall Study|Untreated|0|||
161393589|NCT01327053|582825380|FG001|Overall Study|Untreated|1|||
161393590|NCT00778258|582825385|FG000|Overall Study|Adverse Event|1|||
161393591|NCT00778258|582825386|FG001|Overall Study|Adverse Event|0|||
161393592|NCT00778258|582825387|FG002|Overall Study|Adverse Event|0|||
161393593|NCT00778258|582825388|FG003|Overall Study|Adverse Event|0|||
161393594|NCT00778258|582825389|FG004|Overall Study|Adverse Event|0|||
161393595|NCT00778258|582825390|FG005|Overall Study|Adverse Event|1|||
161393596|NCT00778258|582825391|FG006|Overall Study|Adverse Event|0|||
161393597|NCT00778258|582825392|FG007|Overall Study|Adverse Event|0|||
161393598|NCT00778258|582825393|FG008|Overall Study|Adverse Event|0|||
161393599|NCT00778258|582825385|FG000|Overall Study|Lost to Follow-up|0|||
161393600|NCT00778258|582825386|FG001|Overall Study|Lost to Follow-up|0|||
161393601|NCT00778258|582825387|FG002|Overall Study|Lost to Follow-up|2|||
161393602|NCT00778258|582825388|FG003|Overall Study|Lost to Follow-up|0|||
161393603|NCT00778258|582825389|FG004|Overall Study|Lost to Follow-up|0|||
161393604|NCT00778258|582825390|FG005|Overall Study|Lost to Follow-up|3|||
161393605|NCT00778258|582825391|FG006|Overall Study|Lost to Follow-up|2|||
161393606|NCT00778258|582825392|FG007|Overall Study|Lost to Follow-up|2|||
161393607|NCT00778258|582825393|FG008|Overall Study|Lost to Follow-up|0|||
161393608|NCT00778258|582825385|FG000|Overall Study|Withdrawal by Subject|6|||
161393609|NCT00778258|582825386|FG001|Overall Study|Withdrawal by Subject|2|||
161393610|NCT00778258|582825387|FG002|Overall Study|Withdrawal by Subject|8|||
161393611|NCT00778258|582825388|FG003|Overall Study|Withdrawal by Subject|2|||
161393612|NCT00778258|582825389|FG004|Overall Study|Withdrawal by Subject|0|||
161393613|NCT00778258|582825390|FG005|Overall Study|Withdrawal by Subject|6|||
161393614|NCT00778258|582825391|FG006|Overall Study|Withdrawal by Subject|12|||
161393615|NCT00778258|582825392|FG007|Overall Study|Withdrawal by Subject|12|||
161393616|NCT00778258|582825393|FG008|Overall Study|Withdrawal by Subject|4|||
161393617|NCT00778258|582825385|FG000|Overall Study|New Contraindication|0|||
161393618|NCT00778258|582825386|FG001|Overall Study|New Contraindication|0|||
161393619|NCT00778258|582825387|FG002|Overall Study|New Contraindication|0|||
161393620|NCT00778258|582825388|FG003|Overall Study|New Contraindication|0|||
161393621|NCT00778258|582825389|FG004|Overall Study|New Contraindication|0|||
161393622|NCT00778258|582825390|FG005|Overall Study|New Contraindication|0|||
161393623|NCT00778258|582825391|FG006|Overall Study|New Contraindication|0|||
161393624|NCT00778258|582825392|FG007|Overall Study|New Contraindication|1|||
161393625|NCT00778258|582825393|FG008|Overall Study|New Contraindication|0|||
161393626|NCT00778258|582825385|FG000|Overall Study|Non-compliance|0|||
161393627|NCT00778258|582825386|FG001|Overall Study|Non-compliance|0|||
161393628|NCT00778258|582825387|FG002|Overall Study|Non-compliance|0|||
161393629|NCT00778258|582825388|FG003|Overall Study|Non-compliance|1|||
161393630|NCT00778258|582825389|FG004|Overall Study|Non-compliance|0|||
161393631|NCT00778258|582825390|FG005|Overall Study|Non-compliance|0|||
161393632|NCT00778258|582825391|FG006|Overall Study|Non-compliance|0|||
161393633|NCT00778258|582825392|FG007|Overall Study|Non-compliance|0|||
161393634|NCT00778258|582825393|FG008|Overall Study|Non-compliance|0|||
161393635|NCT00778258|582825385|FG000|Overall Study|Other|0|||
161393636|NCT00778258|582825386|FG001|Overall Study|Other|0|||
161393637|NCT00778258|582825387|FG002|Overall Study|Other|0|||
161393638|NCT00778258|582825388|FG003|Overall Study|Other|0|||
161393639|NCT00778258|582825389|FG004|Overall Study|Other|0|||
161393640|NCT00778258|582825390|FG005|Overall Study|Other|0|||
161393641|NCT00778258|582825391|FG006|Overall Study|Other|1|||
161393642|NCT00778258|582825392|FG007|Overall Study|Other|0|||
161393643|NCT00778258|582825393|FG008|Overall Study|Other|0|||
161393644|NCT04621240|582825395|FG000|Overall Study|Withdrawal by Subject|36|||
161393645|NCT01263015|582827176|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
161393646|NCT01263015|582827177|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
161393647|NCT01263015|582827176|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
161393648|NCT01263015|582827177|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
161393649|NCT01263015|582827176|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
161393650|NCT01263015|582827177|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
161393651|NCT01263015|582827176|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
161393652|NCT01263015|582827177|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
161393653|NCT01263015|582827176|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
161393654|NCT01263015|582827177|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
161393655|NCT01263015|582827176|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
161393656|NCT01263015|582827177|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
161393657|NCT01263015|582827176|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
161393658|NCT01263015|582827177|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
161393659|NCT01263015|582827176|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
161393660|NCT01263015|582827177|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
161393661|NCT01263015|582827176|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
161393662|NCT01263015|582827177|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
161393663|NCT01263015|582827176|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
161393664|NCT01263015|582827177|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
161393665|NCT01263015|582827176|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
161393666|NCT01263015|582827177|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
161393667|NCT01263015|582827176|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
161393668|NCT01263015|582827177|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
161393669|NCT05599451|582827178|FG000|Overall Study|Not randomized|11|||
161393670|NCT05599451|582827179|FG001|Overall Study|Not randomized|0|||
161393671|NCT05599451|582827180|FG002|Overall Study|Not randomized|0|||
161393672|NCT05599451|582827181|FG003|Overall Study|Not randomized|0|||
161393673|NCT05599451|582827182|FG004|Overall Study|Not randomized|0|||
161393674|NCT05599451|582827178|FG000|Overall Study|Physician Decision|0|||
161393675|NCT05599451|582827179|FG001|Overall Study|Physician Decision|0|||
161393676|NCT05599451|582827180|FG002|Overall Study|Physician Decision|0|||
161393677|NCT05599451|582827181|FG003|Overall Study|Physician Decision|1|||
161393678|NCT05599451|582827182|FG004|Overall Study|Physician Decision|0|||
161393679|NCT02723006|582827183|FG000|Overall Study|Withdrawal by Subject|0|||
161393680|NCT02723006|582827184|FG001|Overall Study|Withdrawal by Subject|1|||
161393681|NCT02723006|582827185|FG002|Overall Study|Withdrawal by Subject|1|||
161393682|NCT02723006|582827183|FG000|Overall Study|Study Terminated by Sponsor|1|||
161393683|NCT02723006|582827184|FG001|Overall Study|Study Terminated by Sponsor|6|||
161393684|NCT02723006|582827185|FG002|Overall Study|Study Terminated by Sponsor|6|||
161393685|NCT00303446|582827186|FG000|Overall Study|Withdrawal by Subject|2|||
161393686|NCT00303446|582827187|FG001|Overall Study|Withdrawal by Subject|2|||
161393687|NCT00303446|582827186|FG000|Overall Study|Death|0|||
161393688|NCT00303446|582827187|FG001|Overall Study|Death|1|||
161393689|NCT00303446|582827186|FG000|Overall Study|Physician Decision|0|||
161393690|NCT00303446|582827187|FG001|Overall Study|Physician Decision|1|||
161393691|NCT03285958|582827188|FG000|Overall Study|Lost to Follow-up|1|||
161393692|NCT03285958|582827189|FG001|Overall Study|Lost to Follow-up|1|||
161393693|NCT03285958|582827188|FG000|Overall Study|Withdrawal by Subject|1|||
161393694|NCT03285958|582827189|FG001|Overall Study|Withdrawal by Subject|0|||
161393695|NCT03285958|582827188|FG000|Overall Study|Not able to attend required orientation|3|||
161393696|NCT03285958|582827189|FG001|Overall Study|Not able to attend required orientation|0|||
161393697|NCT03116828|582827191|FG000|Overall Study|Adverse Event|1|||
161393698|NCT03116828|582827192|FG001|Overall Study|Adverse Event|10|||
161393699|NCT03116828|582827191|FG000|Overall Study|Withdrawal by Subject|4|||
161393700|NCT03116828|582827192|FG001|Overall Study|Withdrawal by Subject|8|||
161393701|NCT03116828|582827191|FG000|Overall Study|OTHER|3|||
161393702|NCT03116828|582827192|FG001|Overall Study|OTHER|3|||
161393703|NCT05243745|582827195|FG000|Overall Study|Withdrawal by Subject|0|||
161393704|NCT05243745|582827196|FG001|Overall Study|Withdrawal by Subject|0|||
161393705|NCT05243745|582827197|FG002|Overall Study|Withdrawal by Subject|0|||
161393706|NCT05243745|582827198|FG003|Overall Study|Withdrawal by Subject|1|||
161393707|NCT05243745|582827195|FG000|Overall Study|Unable to Attend Visit 6|0|||
161393708|NCT05243745|582827196|FG001|Overall Study|Unable to Attend Visit 6|0|||
161393709|NCT05243745|582827197|FG002|Overall Study|Unable to Attend Visit 6|1|||
161393710|NCT05243745|582827198|FG003|Overall Study|Unable to Attend Visit 6|0|||
161393711|NCT02998203|582827199|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
161393712|NCT02998203|582827200|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
161393713|NCT02998203|582827199|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
161393714|NCT02998203|582827200|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
161393715|NCT03842969|582827213|FG000|Overall Study|Participant declined follow-up visit|0|||
161393716|NCT03842969|582827214|FG001|Overall Study|Participant declined follow-up visit|1|||
161393717|NCT03842969|582827215|FG002|Overall Study|Participant declined follow-up visit|0|||
161393718|NCT03842969|582827213|FG000|Overall Study|Sponsor's decision|12|||
161393719|NCT03842969|582827214|FG001|Overall Study|Sponsor's decision|99|||
161393720|NCT03842969|582827215|FG002|Overall Study|Sponsor's decision|61|||
161393721|NCT03842969|582827213|FG000|Overall Study|Pregnancy|0|||
161393722|NCT03842969|582827214|FG001|Overall Study|Pregnancy|0|||
161393723|NCT03842969|582827215|FG002|Overall Study|Pregnancy|1|||
161393724|NCT03842969|582827213|FG000|Overall Study|Death|1|||
161393725|NCT03842969|582827214|FG001|Overall Study|Death|0|||
161393726|NCT03842969|582827215|FG002|Overall Study|Death|1|||
161393727|NCT03842969|582827213|FG000|Overall Study|Withdrawal by Subject|3|||
161393728|NCT03842969|582827214|FG001|Overall Study|Withdrawal by Subject|30|||
161393729|NCT03842969|582827215|FG002|Overall Study|Withdrawal by Subject|18|||
161393730|NCT03842969|582827213|FG000|Overall Study|Protocol Violation|1|||
161393731|NCT03842969|582827214|FG001|Overall Study|Protocol Violation|1|||
161393732|NCT03842969|582827215|FG002|Overall Study|Protocol Violation|0|||
161393733|NCT03842969|582827213|FG000|Overall Study|Physician Decision|0|||
161393734|NCT03842969|582827214|FG001|Overall Study|Physician Decision|3|||
161393735|NCT03842969|582827215|FG002|Overall Study|Physician Decision|0|||
161393736|NCT03842969|582827213|FG000|Overall Study|Lost to Follow-up|0|||
161393737|NCT03842969|582827214|FG001|Overall Study|Lost to Follow-up|2|||
161393738|NCT03842969|582827215|FG002|Overall Study|Lost to Follow-up|0|||
161393739|NCT03842969|582827213|FG000|Overall Study|Adverse Event|0|||
161393740|NCT03842969|582827214|FG001|Overall Study|Adverse Event|2|||
161393741|NCT03842969|582827215|FG002|Overall Study|Adverse Event|0|||
161393742|NCT04187144|582827216|FG000|Overall Study|Lost to Follow-up|12|||
161393743|NCT04187144|582827217|FG001|Overall Study|Lost to Follow-up|11|||
161393744|NCT04187144|582827216|FG000|Overall Study|Withdrawal by Subject|20|||
161393745|NCT04187144|582827217|FG001|Overall Study|Withdrawal by Subject|18|||
161393746|NCT04187144|582827216|FG000|Overall Study|Adverse Event|19|||
161393747|NCT04187144|582827217|FG001|Overall Study|Adverse Event|4|||
161393748|NCT04187144|582827216|FG000|Overall Study|Physician Decision|5|||
161393749|NCT04187144|582827217|FG001|Overall Study|Physician Decision|3|||
161393750|NCT04187144|582827216|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
161393751|NCT04187144|582827217|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
161393752|NCT04187144|582827216|FG000|Overall Study|Protocol Deviation|1|||
161393753|NCT04187144|582827217|FG001|Overall Study|Protocol Deviation|4|||
161393754|NCT01044745|582827218|FG000|Overall Study|Ineiligible|2|||
161393755|NCT01962987|582827221|FG000|Overall Study|Adverse Event|4|||
161393756|NCT01962987|582827222|FG001|Overall Study|Adverse Event|4|||
161393757|NCT01962987|582827223|FG002|Overall Study|Adverse Event|0|||
161393758|NCT01962987|582827221|FG000|Overall Study|Lost to Follow-up|0|||
161393759|NCT01962987|582827222|FG001|Overall Study|Lost to Follow-up|0|||
161393760|NCT01962987|582827223|FG002|Overall Study|Lost to Follow-up|1|||
161393761|NCT01962987|582827221|FG000|Overall Study|Non compliance with dosing requirements|4|||
161393762|NCT01962987|582827222|FG001|Overall Study|Non compliance with dosing requirements|2|||
161393763|NCT01962987|582827223|FG002|Overall Study|Non compliance with dosing requirements|0|||
161393764|NCT01962987|582827221|FG000|Overall Study|Miscellaneous|1|||
161393765|NCT01962987|582827222|FG001|Overall Study|Miscellaneous|9|||
161393766|NCT01962987|582827223|FG002|Overall Study|Miscellaneous|2|||
161393767|NCT01962987|582827221|FG000|Overall Study|Restricted medication|5|||
161393768|NCT01962987|582827222|FG001|Overall Study|Restricted medication|1|||
161393769|NCT01962987|582827223|FG002|Overall Study|Restricted medication|1|||
161393770|NCT01962987|582827221|FG000|Overall Study|Serious Adverse Event|1|||
161393771|NCT01962987|582827222|FG001|Overall Study|Serious Adverse Event|0|||
161393772|NCT01962987|582827223|FG002|Overall Study|Serious Adverse Event|0|||
161393773|NCT01962987|582827221|FG000|Overall Study|Withdrawal by Subject|11|||
161393774|NCT01962987|582827222|FG001|Overall Study|Withdrawal by Subject|10|||
161393775|NCT01962987|582827223|FG002|Overall Study|Withdrawal by Subject|6|||
161393776|NCT01962987|582827221|FG000|Overall Study|Randomized in Error|4|||
161393777|NCT01962987|582827222|FG001|Overall Study|Randomized in Error|2|||
161393778|NCT01962987|582827223|FG002|Overall Study|Randomized in Error|2|||
161393779|NCT01468207|582827224|FG000|Treatment Period 1|Adverse Event|1|||
161393780|NCT01468207|582827225|FG001|Treatment Period 1|Adverse Event|0|||
161393781|NCT01468207|582827226|FG002|Treatment Period 1|Adverse Event|0|||
161393782|NCT01468207|582827227|FG003|Treatment Period 1|Adverse Event|0|||
161393783|NCT01468207|582827228|FG004|Treatment Period 1|Adverse Event|0|||
161393784|NCT01468207|582827229|FG005|Treatment Period 1|Adverse Event|0|||
161393785|NCT01468207|582827224|FG000|Treatment Period 1|Protocol Violation|1|||
161393786|NCT01468207|582827225|FG001|Treatment Period 1|Protocol Violation|1|||
161393787|NCT01468207|582827226|FG002|Treatment Period 1|Protocol Violation|0|||
161393788|NCT01468207|582827227|FG003|Treatment Period 1|Protocol Violation|0|||
161393789|NCT01468207|582827228|FG004|Treatment Period 1|Protocol Violation|0|||
161393790|NCT01468207|582827229|FG005|Treatment Period 1|Protocol Violation|0|||
161393791|NCT01468207|582827224|FG000|Treatment Period 1|Withdrawal by Subject|5|||
161393792|NCT01468207|582827225|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161393793|NCT01468207|582827226|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161393794|NCT01468207|582827227|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161393795|NCT01468207|582827228|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161393796|NCT01468207|582827229|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161393797|NCT01468207|582827224|FG000|Treatment Period 1|Lost to Follow-up|2|||
161393798|NCT01468207|582827225|FG001|Treatment Period 1|Lost to Follow-up|1|||
161393799|NCT01468207|582827226|FG002|Treatment Period 1|Lost to Follow-up|0|||
161393800|NCT01468207|582827227|FG003|Treatment Period 1|Lost to Follow-up|0|||
161393801|NCT01468207|582827228|FG004|Treatment Period 1|Lost to Follow-up|0|||
161393802|NCT01468207|582827229|FG005|Treatment Period 1|Lost to Follow-up|0|||
161393803|NCT01468207|582827224|FG000|Treatment Period 1|Other|0|||
161393804|NCT01468207|582827225|FG001|Treatment Period 1|Other|2|||
161393805|NCT01468207|582827226|FG002|Treatment Period 1|Other|0|||
161393806|NCT01468207|582827227|FG003|Treatment Period 1|Other|0|||
161393807|NCT01468207|582827228|FG004|Treatment Period 1|Other|0|||
161393808|NCT01468207|582827229|FG005|Treatment Period 1|Other|0|||
161393809|NCT01468207|582827224|FG000|Treatment Period 2|Adverse Event|0|||
161393810|NCT01468207|582827225|FG001|Treatment Period 2|Adverse Event|0|||
161393811|NCT01468207|582827226|FG002|Treatment Period 2|Adverse Event|6|||
161393812|NCT01468207|582827227|FG003|Treatment Period 2|Adverse Event|1|||
161393813|NCT01468207|582827228|FG004|Treatment Period 2|Adverse Event|2|||
161393814|NCT01468207|582827229|FG005|Treatment Period 2|Adverse Event|1|||
161393815|NCT01468207|582827224|FG000|Treatment Period 2|Lack of Efficacy|0|||
161393816|NCT01468207|582827225|FG001|Treatment Period 2|Lack of Efficacy|0|||
161393817|NCT01468207|582827226|FG002|Treatment Period 2|Lack of Efficacy|1|||
161393818|NCT01468207|582827227|FG003|Treatment Period 2|Lack of Efficacy|1|||
161393819|NCT01468207|582827228|FG004|Treatment Period 2|Lack of Efficacy|0|||
161393820|NCT01468207|582827229|FG005|Treatment Period 2|Lack of Efficacy|2|||
161393821|NCT01468207|582827224|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161393822|NCT01468207|582827225|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161393823|NCT01468207|582827226|FG002|Treatment Period 2|Withdrawal by Subject|5|||
161393824|NCT01468207|582827227|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161393825|NCT01468207|582827228|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161393826|NCT01468207|582827229|FG005|Treatment Period 2|Withdrawal by Subject|2|||
161393827|NCT01468207|582827224|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
161393828|NCT01468207|582827225|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
161393829|NCT01468207|582827226|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
161393830|NCT01468207|582827227|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
161393831|NCT01468207|582827228|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
161393832|NCT01468207|582827229|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
161393833|NCT01468207|582827224|FG000|Treatment Period 2|Lost to Follow-up|0|||
161393834|NCT01468207|582827225|FG001|Treatment Period 2|Lost to Follow-up|0|||
161393835|NCT01468207|582827226|FG002|Treatment Period 2|Lost to Follow-up|5|||
161393836|NCT01468207|582827227|FG003|Treatment Period 2|Lost to Follow-up|1|||
161393837|NCT01468207|582827228|FG004|Treatment Period 2|Lost to Follow-up|0|||
161393838|NCT01468207|582827229|FG005|Treatment Period 2|Lost to Follow-up|0|||
161393839|NCT01468207|582827224|FG000|Treatment Period 2|Other|0|||
161393840|NCT01468207|582827225|FG001|Treatment Period 2|Other|0|||
161393841|NCT01468207|582827226|FG002|Treatment Period 2|Other|5|||
161393842|NCT01468207|582827227|FG003|Treatment Period 2|Other|1|||
161393843|NCT01468207|582827228|FG004|Treatment Period 2|Other|1|||
161393844|NCT01468207|582827229|FG005|Treatment Period 2|Other|2|||
161393845|NCT00316693|582827232|FG000|Overall Study|Adverse Event|6|||
161393846|NCT00316693|582827233|FG001|Overall Study|Adverse Event|1|||
161393847|NCT00316693|582827232|FG000|Overall Study|Protocol Violation|1|||
161393848|NCT00316693|582827233|FG001|Overall Study|Protocol Violation|0|||
161393849|NCT00316693|582827232|FG000|Overall Study|Withdrawal by Subject|6|||
161393850|NCT00316693|582827233|FG001|Overall Study|Withdrawal by Subject|6|||
161393851|NCT00316693|582827232|FG000|Overall Study|Lost to Follow-up|26|||
161393852|NCT00316693|582827233|FG001|Overall Study|Lost to Follow-up|34|||
161393853|NCT00316693|582827232|FG000|Overall Study|Other|38|||
161393854|NCT00316693|582827233|FG001|Overall Study|Other|44|||
161393855|NCT01967823|582827234|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
161393856|NCT00413894|582827241|FG000|Overall Study|Withdrawal by Subject|10|||
161393857|NCT00413894|582827241|FG000|Overall Study|Administrative Reasons|1|||
161393858|NCT00413894|582827241|FG000|Overall Study|Hb <10 grams/deciliter|12|||
161393859|NCT00413894|582827241|FG000|Overall Study|Adverse Event|28|||
161393860|NCT00413894|582827241|FG000|Overall Study|Protocol Violation|11|||
161393861|NCT00413894|582827241|FG000|Overall Study|Other|18|||
161393862|NCT04225676|582827242|FG000|Overall Study|Physician Decision|1|||
161393863|NCT04225676|582827242|FG000|Overall Study|Lack of Efficacy|1|||
161393864|NCT04225676|582827242|FG000|Overall Study|Study terminated by sponsor|3|||
161393865|NCT05289271|582827245|FG000|Overall Study|Mistakenly allocated, untreated|1|||
161393866|NCT05289271|582827246|FG001|Overall Study|Mistakenly allocated, untreated|0|||
161393867|NCT02019108|582827247|FG000|Overall Study|Lost to Follow-up|5|||
161393868|NCT02019108|582827248|FG001|Overall Study|Lost to Follow-up|7|||
161393869|NCT03392883|582827251|FG000|Overall Study|Lost to Follow-up|122|||
161393870|NCT03392883|582827252|FG001|Overall Study|Lost to Follow-up|13|||
161393871|NCT03392883|582827253|FG002|Overall Study|Lost to Follow-up|9|||
161393872|NCT03392883|582827251|FG000|Overall Study|Death|4|||
161393873|NCT03392883|582827252|FG001|Overall Study|Death|0|||
161393874|NCT03392883|582827253|FG002|Overall Study|Death|0|||
161393875|NCT03392883|582827251|FG000|Overall Study|Lack of Efficacy|29|||
161393876|NCT03392883|582827252|FG001|Overall Study|Lack of Efficacy|0|||
161393877|NCT03392883|582827253|FG002|Overall Study|Lack of Efficacy|0|||
161393878|NCT03392883|582827251|FG000|Overall Study|Withdrawal by Subject|180|||
161393879|NCT03392883|582827252|FG001|Overall Study|Withdrawal by Subject|0|||
161393880|NCT03392883|582827253|FG002|Overall Study|Withdrawal by Subject|0|||
161393881|NCT03392883|582827251|FG000|Overall Study|Adverse Event|1|||
161393882|NCT03392883|582827252|FG001|Overall Study|Adverse Event|0|||
161393883|NCT03392883|582827253|FG002|Overall Study|Adverse Event|0|||
161393884|NCT00908115|582827262|FG000|Overall Study|Other|14|||
161393885|NCT02442310|582827272|FG000|Overall Study|Adverse Event|2|||
161393886|NCT02442310|582827272|FG000|Overall Study|Withdrawal by Subject|1|||
161393887|NCT03466099|582827273|FG000|Overall Study|Adverse Event|1|||
161393888|NCT03466099|582827274|FG001|Overall Study|Adverse Event|1|||
161393889|NCT03466099|582827275|FG002|Overall Study|Adverse Event|1|||
161393890|NCT03466099|582827273|FG000|Overall Study|Withdrawal by Subject|2|||
161393891|NCT03466099|582827274|FG001|Overall Study|Withdrawal by Subject|3|||
161393892|NCT03466099|582827275|FG002|Overall Study|Withdrawal by Subject|1|||
161393893|NCT03466099|582827273|FG000|Overall Study|Use of rescue medication|8|||
161393894|NCT03466099|582827274|FG001|Overall Study|Use of rescue medication|9|||
161393895|NCT03466099|582827275|FG002|Overall Study|Use of rescue medication|13|||
161393896|NCT03466099|582827273|FG000|Overall Study|Rescued without meeting criteria|4|||
161393897|NCT03466099|582827274|FG001|Overall Study|Rescued without meeting criteria|1|||
161393898|NCT03466099|582827275|FG002|Overall Study|Rescued without meeting criteria|1|||
161393899|NCT03466099|582827273|FG000|Overall Study|Subject compliance|2|||
161393900|NCT03466099|582827274|FG001|Overall Study|Subject compliance|0|||
161393901|NCT03466099|582827275|FG002|Overall Study|Subject compliance|0|||
161393902|NCT03466099|582827273|FG000|Overall Study|Worsening disease|0|||
161393903|NCT03466099|582827274|FG001|Overall Study|Worsening disease|0|||
161393904|NCT03466099|582827275|FG002|Overall Study|Worsening disease|1|||
161393905|NCT01165320|582827278|FG000|Overall Study|Clinical adverse experience|2|||
161393906|NCT01165320|582827279|FG001|Overall Study|Clinical adverse experience|1|||
161393907|NCT01165320|582827280|FG002|Overall Study|Clinical adverse experience|0|||
161393908|NCT01165320|582827278|FG000|Overall Study|Laboratory adverse experience|1|||
161393909|NCT01165320|582827279|FG001|Overall Study|Laboratory adverse experience|0|||
161393910|NCT01165320|582827280|FG002|Overall Study|Laboratory adverse experience|0|||
161393911|NCT01165320|582827278|FG000|Overall Study|Lack of Efficacy|0|||
161393912|NCT01165320|582827279|FG001|Overall Study|Lack of Efficacy|2|||
161393913|NCT01165320|582827280|FG002|Overall Study|Lack of Efficacy|0|||
161393914|NCT01165320|582827278|FG000|Overall Study|Reason unknown|0|||
161393915|NCT01165320|582827279|FG001|Overall Study|Reason unknown|1|||
161393916|NCT01165320|582827280|FG002|Overall Study|Reason unknown|0|||
161393917|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
161393918|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
161393919|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
161393920|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
161393921|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
161393922|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161393923|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
161393924|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
161393925|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
161393926|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
161393927|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Other|1|||
161393928|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Other|1|||
161393929|NCT02075047|582827284|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
161393930|NCT02075047|582827285|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
161393931|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
161393932|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
161393933|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
161393934|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
161393935|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
161393936|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
161393937|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
161393938|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
161393939|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
161393940|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
161393941|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Other|1|||
161393942|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Other|2|||
161393943|NCT02075047|582827284|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
161393944|NCT02075047|582827285|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
161393945|NCT00075946|582827286|FG000|Overall Study|Path ineligible: undetermined histology|0|||
161393946|NCT00075946|582827287|FG001|Overall Study|Path ineligible: undetermined histology|0|||
161393947|NCT00075946|582827288|FG002|Overall Study|Path ineligible: undetermined histology|0|||
161393948|NCT00075946|582827289|FG003|Overall Study|Path ineligible: undetermined histology|0|||
161393949|NCT00075946|582827290|FG004|Overall Study|Path ineligible: undetermined histology|6|||
161393950|NCT00075946|582827286|FG000|Overall Study|Did not achieve response after induction|0|||
161393951|NCT00075946|582827287|FG001|Overall Study|Did not achieve response after induction|0|||
161393952|NCT00075946|582827288|FG002|Overall Study|Did not achieve response after induction|0|||
161393953|NCT00075946|582827289|FG003|Overall Study|Did not achieve response after induction|0|||
161393954|NCT00075946|582827290|FG004|Overall Study|Did not achieve response after induction|182|||
161393955|NCT00075946|582827286|FG000|Overall Study|Incorrectly randomized (no response)|5|||
161393956|NCT00075946|582827287|FG001|Overall Study|Incorrectly randomized (no response)|5|||
161393957|NCT00075946|582827288|FG002|Overall Study|Incorrectly randomized (no response)|5|||
161393958|NCT00075946|582827289|FG003|Overall Study|Incorrectly randomized (no response)|1|||
161393959|NCT00075946|582827290|FG004|Overall Study|Incorrectly randomized (no response)|0|||
161393960|NCT00075946|582827286|FG000|Overall Study|Adverse Event|2|||
161393961|NCT00075946|582827287|FG001|Overall Study|Adverse Event|10|||
161393962|NCT00075946|582827288|FG002|Overall Study|Adverse Event|0|||
161393963|NCT00075946|582827289|FG003|Overall Study|Adverse Event|2|||
161393964|NCT00075946|582827290|FG004|Overall Study|Adverse Event|0|||
161393965|NCT00075946|582827286|FG000|Overall Study|Death|0|||
161393966|NCT00075946|582827287|FG001|Overall Study|Death|1|||
161393967|NCT00075946|582827288|FG002|Overall Study|Death|0|||
161393968|NCT00075946|582827289|FG003|Overall Study|Death|0|||
161393969|NCT00075946|582827290|FG004|Overall Study|Death|0|||
161393970|NCT00075946|582827286|FG000|Overall Study|Withdrawal by Subject|23|||
161393971|NCT00075946|582827287|FG001|Overall Study|Withdrawal by Subject|58|||
161393972|NCT00075946|582827288|FG002|Overall Study|Withdrawal by Subject|4|||
161393973|NCT00075946|582827289|FG003|Overall Study|Withdrawal by Subject|9|||
161393974|NCT00075946|582827290|FG004|Overall Study|Withdrawal by Subject|0|||
161393975|NCT00075946|582827286|FG000|Overall Study|Alternative therapy|16|||
161393976|NCT00075946|582827287|FG001|Overall Study|Alternative therapy|2|||
161393977|NCT00075946|582827288|FG002|Overall Study|Alternative therapy|5|||
161393978|NCT00075946|582827289|FG003|Overall Study|Alternative therapy|0|||
161393979|NCT00075946|582827290|FG004|Overall Study|Alternative therapy|0|||
161393980|NCT00075946|582827286|FG000|Overall Study|Other complicating disease|7|||
161393981|NCT00075946|582827287|FG001|Overall Study|Other complicating disease|13|||
161393982|NCT00075946|582827288|FG002|Overall Study|Other complicating disease|1|||
161393983|NCT00075946|582827289|FG003|Overall Study|Other complicating disease|4|||
161393984|NCT00075946|582827290|FG004|Overall Study|Other complicating disease|0|||
161393985|NCT00075946|582827286|FG000|Overall Study|No response to retreatment|23|||
161393986|NCT00075946|582827287|FG001|Overall Study|No response to retreatment|0|||
161393987|NCT00075946|582827288|FG002|Overall Study|No response to retreatment|2|||
161393988|NCT00075946|582827289|FG003|Overall Study|No response to retreatment|0|||
161393989|NCT00075946|582827290|FG004|Overall Study|No response to retreatment|0|||
161393990|NCT00075946|582827286|FG000|Overall Study|Time to progression less than 6 months|15|||
161393991|NCT00075946|582827287|FG001|Overall Study|Time to progression less than 6 months|30|||
161393992|NCT00075946|582827288|FG002|Overall Study|Time to progression less than 6 months|8|||
161393993|NCT00075946|582827289|FG003|Overall Study|Time to progression less than 6 months|3|||
161393994|NCT00075946|582827290|FG004|Overall Study|Time to progression less than 6 months|0|||
161393995|NCT00075946|582827286|FG000|Overall Study|Other|57|||
161393996|NCT00075946|582827287|FG001|Overall Study|Other|32|||
161393997|NCT00075946|582827288|FG002|Overall Study|Other|3|||
161393998|NCT00075946|582827289|FG003|Overall Study|Other|11|||
161393999|NCT00075946|582827290|FG004|Overall Study|Other|0|||
161394000|NCT02231892|582827293|FG000|Overall Study|Lost to Follow-up|1|||
161394001|NCT02231892|582827294|FG001|Overall Study|Lost to Follow-up|0|||
161394002|NCT02231892|582827295|FG002|Overall Study|Lost to Follow-up|3|||
161394003|NCT02231892|582827293|FG000|Overall Study|Withdrawal by Subject|4|||
161394004|NCT02231892|582827294|FG001|Overall Study|Withdrawal by Subject|3|||
161394005|NCT02231892|582827295|FG002|Overall Study|Withdrawal by Subject|15|||
161394006|NCT02231892|582827293|FG000|Overall Study|Physician Decision|0|||
161394007|NCT02231892|582827294|FG001|Overall Study|Physician Decision|2|||
161394008|NCT02231892|582827295|FG002|Overall Study|Physician Decision|4|||
161394009|NCT02231892|582827293|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
161394010|NCT02231892|582827294|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
161394011|NCT02231892|582827295|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
161394012|NCT02231892|582827293|FG000|Overall Study|Participant motor threshold was >83%|0|||
161394013|NCT02231892|582827294|FG001|Overall Study|Participant motor threshold was >83%|0|||
161394014|NCT02231892|582827295|FG002|Overall Study|Participant motor threshold was >83%|9|||
161394015|NCT02231892|582827293|FG000|Overall Study|Could not find motor threshold|2|||
161394016|NCT02231892|582827294|FG001|Overall Study|Could not find motor threshold|0|||
161394017|NCT02231892|582827295|FG002|Overall Study|Could not find motor threshold|1|||
161394018|NCT02231892|582827293|FG000|Overall Study|Could not find reliable motor hotspot|0|||
161394019|NCT02231892|582827294|FG001|Overall Study|Could not find reliable motor hotspot|0|||
161394020|NCT02231892|582827295|FG002|Overall Study|Could not find reliable motor hotspot|1|||
161394021|NCT00223977|582827304|FG000|Overall Study|Adverse Event|7|||
161394022|NCT00223977|582827305|FG001|Overall Study|Adverse Event|10|||
161394023|NCT00223977|582827306|FG002|Overall Study|Adverse Event|0|||
161394024|NCT00223977|582827304|FG000|Overall Study|Protocol Violation|0|||
161394025|NCT00223977|582827305|FG001|Overall Study|Protocol Violation|0|||
161394026|NCT00223977|582827306|FG002|Overall Study|Protocol Violation|1|||
161394027|NCT00223977|582827304|FG000|Overall Study|Withdrawal by Subject|1|||
161394028|NCT00223977|582827305|FG001|Overall Study|Withdrawal by Subject|1|||
161394029|NCT00223977|582827306|FG002|Overall Study|Withdrawal by Subject|2|||
161394030|NCT00223977|582827304|FG000|Overall Study|Other|1|||
161394031|NCT00223977|582827305|FG001|Overall Study|Other|0|||
161394032|NCT00223977|582827306|FG002|Overall Study|Other|0|||
161394033|NCT02359045|582827307|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
161394034|NCT02359045|582827308|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161394035|NCT02359045|582827307|FG000|Overall Study|Lost to Follow-up|1|||
161394036|NCT02359045|582827308|FG001|Overall Study|Lost to Follow-up|1|||
161394037|NCT02359045|582827307|FG000|Overall Study|Adverse Event|0|||
161394038|NCT02359045|582827308|FG001|Overall Study|Adverse Event|1|||
161394039|NCT00503581|582827317|FG000|Overall Study|Study closed|3|||
161394040|NCT00503581|582827318|FG001|Overall Study|Study closed|4|||
161394041|NCT00503581|582827319|FG002|Overall Study|Study closed|2|||
161394042|NCT03099174|582827330|FG000|Overall Study|Withdrawal by Subject|0|||
161394043|NCT03099174|582827331|FG001|Overall Study|Withdrawal by Subject|0|||
161394044|NCT03099174|582827332|FG002|Overall Study|Withdrawal by Subject|1|||
161394045|NCT03099174|582827333|FG003|Overall Study|Withdrawal by Subject|0|||
161394046|NCT03099174|582827334|FG004|Overall Study|Withdrawal by Subject|2|||
161394047|NCT03099174|582827335|FG005|Overall Study|Withdrawal by Subject|2|||
161394048|NCT03099174|582827336|FG006|Overall Study|Withdrawal by Subject|1|||
161394049|NCT03099174|582827337|FG007|Overall Study|Withdrawal by Subject|4|||
161394050|NCT03099174|582827330|FG000|Overall Study|Adverse Event|0|||
161394051|NCT03099174|582827331|FG001|Overall Study|Adverse Event|1|||
161394052|NCT03099174|582827332|FG002|Overall Study|Adverse Event|1|||
161394053|NCT03099174|582827333|FG003|Overall Study|Adverse Event|2|||
161394054|NCT03099174|582827334|FG004|Overall Study|Adverse Event|5|||
161394055|NCT03099174|582827335|FG005|Overall Study|Adverse Event|3|||
161394056|NCT03099174|582827336|FG006|Overall Study|Adverse Event|6|||
161394057|NCT03099174|582827337|FG007|Overall Study|Adverse Event|4|||
161394058|NCT03099174|582827330|FG000|Overall Study|Other than listed|6|||
161394059|NCT03099174|582827331|FG001|Overall Study|Other than listed|6|||
161394060|NCT03099174|582827332|FG002|Overall Study|Other than listed|5|||
161394061|NCT03099174|582827333|FG003|Overall Study|Other than listed|6|||
161394062|NCT03099174|582827334|FG004|Overall Study|Other than listed|19|||
161394063|NCT03099174|582827335|FG005|Overall Study|Other than listed|10|||
161394064|NCT03099174|582827336|FG006|Overall Study|Other than listed|26|||
161394065|NCT03099174|582827337|FG007|Overall Study|Other than listed|23|||
161394066|NCT03219034|582827338|FG000|Overall Study|Lost to Follow-up|9|||
161394067|NCT03219034|582827339|FG001|Overall Study|Lost to Follow-up|13|||
161394068|NCT03219034|582827338|FG000|Overall Study|Additional dental work needed|1|||
161394069|NCT03219034|582827339|FG001|Overall Study|Additional dental work needed|0|||
161394070|NCT03219034|582827338|FG000|Overall Study|UPPP Surgery|1|||
161394071|NCT03219034|582827339|FG001|Overall Study|UPPP Surgery|0|||
161394072|NCT03219034|582827338|FG000|Overall Study|Dental sensitivity|0|||
161394073|NCT03219034|582827339|FG001|Overall Study|Dental sensitivity|1|||
161394074|NCT03219034|582827338|FG000|Overall Study|Death in family|0|||
161394075|NCT03219034|582827339|FG001|Overall Study|Death in family|1|||
161394076|NCT02438683|582827343|FG000|Overall Study|Adverse Event|1|||
161394077|NCT02438683|582827344|FG001|Overall Study|Adverse Event|0|||
161394078|NCT02438683|582827345|FG002|Overall Study|Adverse Event|0|||
161394079|NCT02438683|582827346|FG003|Overall Study|Adverse Event|0|||
161394080|NCT02438683|582827347|FG004|Overall Study|Adverse Event|0|||
161394081|NCT02438683|582827348|FG005|Overall Study|Adverse Event|0|||
161394082|NCT00721578|582827349|FG000|Overall Study|Death|1|||
161394083|NCT00721578|582827350|FG001|Overall Study|Death|1|||
161394084|NCT00721578|582827349|FG000|Overall Study|Withdrawal by Subject|1|||
161394085|NCT00721578|582827350|FG001|Overall Study|Withdrawal by Subject|1|||
161394086|NCT02226198|582829263|FG000|Lead-in Phase|Protocol Violation|1|||
161394087|NCT02226198|582829264|FG001|Lead-in Phase|Protocol Violation|0|||
161394088|NCT02226198|582829265|FG002|Lead-in Phase|Protocol Violation|0|||
161394089|NCT02226198|582829263|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
161394090|NCT02226198|582829264|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
161394091|NCT02226198|582829265|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
161394092|NCT01440517|582829269|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
161394093|NCT01288612|582829270|FG000|Overall Study|Unable to contact|11|||
161394094|NCT01288612|582829271|FG001|Overall Study|Unable to contact|16|||
161394095|NCT01288612|582829272|FG002|Overall Study|Unable to contact|20|||
161394096|NCT01288612|582829270|FG000|Overall Study|Declined|78|||
161394097|NCT01288612|582829271|FG001|Overall Study|Declined|63|||
161394098|NCT01288612|582829272|FG002|Overall Study|Declined|62|||
161394099|NCT01288612|582829270|FG000|Overall Study|Unable to intubate|0|||
161394100|NCT01288612|582829271|FG001|Overall Study|Unable to intubate|3|||
161394101|NCT01288612|582829272|FG002|Overall Study|Unable to intubate|0|||
161394102|NCT00871923|582829273|FG000|Overall Study|Death|1|||
161394103|NCT00871923|582829273|FG000|Overall Study|Withdrawal by Subject|1|||
161394104|NCT00496483|582829279|FG000|Overall Study|Not dosed|9|||
161394105|NCT00496483|582829279|FG000|Overall Study|Adverse Event|2|||
161394106|NCT00496483|582829279|FG000|Overall Study|Lack of Efficacy|1|||
161394107|NCT04258995|582829281|FG000|Overall Study|Lost to Follow-up|1|||
161394108|NCT04258995|582829282|FG001|Overall Study|Lost to Follow-up|1|||
161394109|NCT01145352|582829286|FG000|Overall Study|Found to have been registered twice|6|||
161394110|NCT01145352|582829286|FG000|Overall Study|Treated before marketing approval|4|||
161394111|NCT01145352|582829286|FG000|Overall Study|Syringe formulation was used|1|||
161394112|NCT03356977|582829287|FG000|Overall Study|Lost to Follow-up|3|||
161394113|NCT03356977|582829287|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161394114|NCT01728077|582829288|FG000|Overall Study|Lack of Efficacy|3|||
161394115|NCT01728077|582829289|FG001|Overall Study|Lack of Efficacy|1|||
161394116|NCT01728077|582829288|FG000|Overall Study|Lost to Follow-up|1|||
161394117|NCT01728077|582829289|FG001|Overall Study|Lost to Follow-up|0|||
161394118|NCT01728077|582829288|FG000|Overall Study|Subject choice|2|||
161394119|NCT01728077|582829289|FG001|Overall Study|Subject choice|3|||
161394120|NCT01728077|582829288|FG000|Overall Study|Death|0|||
161394121|NCT01728077|582829289|FG001|Overall Study|Death|1|||
161394122|NCT01728077|582829288|FG000|Overall Study|Patient moving|1|||
161394123|NCT01728077|582829289|FG001|Overall Study|Patient moving|0|||
161394124|NCT01728077|582829288|FG000|Overall Study|Non compliance|1|||
161394125|NCT01728077|582829289|FG001|Overall Study|Non compliance|0|||
161394126|NCT00378599|582829292|FG000|Overall Study|Adverse Event|38|||
161394127|NCT00378599|582829292|FG000|Overall Study|Protocol Violation|2|||
161394128|NCT00378599|582829292|FG000|Overall Study|Treatment failure|7|||
161394129|NCT00378599|582829292|FG000|Overall Study|Withdrawal by Subject|5|||
161394130|NCT03224507|582829293|FG000|Overall Study|Death|3|||
161394131|NCT03224507|582829294|FG001|Overall Study|Death|0|||
161394132|NCT03224507|582829293|FG000|Overall Study|Lack of Efficacy|6|||
161394133|NCT03224507|582829294|FG001|Overall Study|Lack of Efficacy|0|||
161394134|NCT03224507|582829293|FG000|Overall Study|Withdrawal by Subject|6|||
161394135|NCT03224507|582829294|FG001|Overall Study|Withdrawal by Subject|0|||
161394136|NCT00847665|582829295|FG000|Overall Study|Withdrawal by Subject|1|||
161394137|NCT00847665|582829296|FG001|Overall Study|Withdrawal by Subject|0|||
161394138|NCT00585546|582829297|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
161394139|NCT00585546|582829297|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
161394140|NCT02851797|582829298|FG000|Overall Study|Withdrawal by Subject|4|||
161394141|NCT02851797|582829299|FG001|Overall Study|Withdrawal by Subject|2|||
161394142|NCT02851797|582829298|FG000|Overall Study|Adverse Event|3|||
161394143|NCT02851797|582829299|FG001|Overall Study|Adverse Event|0|||
161394144|NCT03077438|582829300|FG000|Overall Study|Protocol Violation|3|||
161394145|NCT03077438|582829301|FG001|Overall Study|Protocol Violation|5|||
161394146|NCT03077438|582829300|FG000|Overall Study|Withdrawal by Subject|3|||
161394147|NCT03077438|582829301|FG001|Overall Study|Withdrawal by Subject|6|||
161394148|NCT03077438|582829300|FG000|Overall Study|Lost to Follow-up|6|||
161394149|NCT03077438|582829301|FG001|Overall Study|Lost to Follow-up|3|||
161394150|NCT00813865|582829302|FG000|Overall Study|Failure to Respond|3|||
161394151|NCT00813865|582829302|FG000|Overall Study|Lost to Follow-up|3|||
161394152|NCT00813865|582829302|FG000|Overall Study|Withdrawal by Subject|1|||
161394153|NCT00624585|582829306|FG000|Overall Study|Death|3|||
161394154|NCT00624585|582829306|FG000|Overall Study|Disease Progression|6|||
161394155|NCT00624585|582829306|FG000|Overall Study|Adverse Event|3|||
161394156|NCT04686084|582829313|FG000|Overall Study|Lost to Follow-up|1|||
161394157|NCT00676520|582829314|FG000|Overall Study|Withdrawal by Subject|163|||
161394158|NCT00676520|582829314|FG000|Overall Study|Lost to Follow-up|162|||
161394159|NCT00676520|582829314|FG000|Overall Study|Death|159|||
161394160|NCT00676520|582829314|FG000|Overall Study|Physician Decision|20|||
161394161|NCT00676520|582829314|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
161394162|NCT00676520|582829314|FG000|Overall Study|Other Reason|18|||
161394163|NCT01425359|582829315|FG000|Overall Study|Randomized but Not Treated|2|||
161394164|NCT01425359|582829316|FG001|Overall Study|Randomized but Not Treated|3|||
161394165|NCT01425359|582829315|FG000|Overall Study|Adverse Event|9|||
161394166|NCT01425359|582829316|FG001|Overall Study|Adverse Event|8|||
161394167|NCT01425359|582829315|FG000|Overall Study|Revascularization|0|||
161394168|NCT01425359|582829316|FG001|Overall Study|Revascularization|1|||
161394169|NCT01425359|582829315|FG000|Overall Study|Death|0|||
161394170|NCT01425359|582829316|FG001|Overall Study|Death|1|||
161394171|NCT01425359|582829315|FG000|Overall Study|Unsatisfactory Response|1|||
161394172|NCT01425359|582829316|FG001|Overall Study|Unsatisfactory Response|0|||
161394173|NCT01425359|582829315|FG000|Overall Study|Protocol Violation|1|||
161394174|NCT01425359|582829316|FG001|Overall Study|Protocol Violation|2|||
161394175|NCT01425359|582829315|FG000|Overall Study|Subject Withdrew Consent|1|||
161394176|NCT01425359|582829316|FG001|Overall Study|Subject Withdrew Consent|2|||
161394177|NCT01425359|582829315|FG000|Overall Study|Investigator's Discretion|2|||
161394178|NCT01425359|582829316|FG001|Overall Study|Investigator's Discretion|0|||
161394179|NCT01425359|582829315|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
161394180|NCT01425359|582829316|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
161394181|NCT02135029|582829320|FG000|Overall Study|Adverse Event|2|||
161394182|NCT02135029|582829321|FG001|Overall Study|Adverse Event|2|||
161394183|NCT02135029|582829322|FG002|Overall Study|Adverse Event|2|||
161394184|NCT02135029|582829320|FG000|Overall Study|Lost to Follow-up|0|||
161394185|NCT02135029|582829321|FG001|Overall Study|Lost to Follow-up|1|||
161394186|NCT02135029|582829322|FG002|Overall Study|Lost to Follow-up|0|||
161394187|NCT02135029|582829320|FG000|Overall Study|Withdrawal by Subject|2|||
161394188|NCT02135029|582829321|FG001|Overall Study|Withdrawal by Subject|0|||
161394189|NCT02135029|582829322|FG002|Overall Study|Withdrawal by Subject|1|||
161394190|NCT02135029|582829320|FG000|Overall Study|Other|0|||
161394191|NCT02135029|582829321|FG001|Overall Study|Other|1|||
161394192|NCT02135029|582829322|FG002|Overall Study|Other|0|||
161394193|NCT02135029|582829320|FG000|Overall Study|Death|0|||
161394194|NCT02135029|582829321|FG001|Overall Study|Death|1|||
161394195|NCT02135029|582829322|FG002|Overall Study|Death|0|||
161394196|NCT04043234|582829333|FG000|Overall Study|Lost to Follow-up|1|||
161394197|NCT04043234|582829333|FG000|Overall Study|Withdrawal by Subject|1|||
161394198|NCT00744978|582829339|FG000|Period 1|Lost to Follow-up|1|||
161394199|NCT00744978|582829340|FG001|Period 1|Lost to Follow-up|0|||
161394200|NCT00744978|582829339|FG000|Period 1|Withdrawal by Subject|0|||
161394201|NCT00744978|582829340|FG001|Period 1|Withdrawal by Subject|2|||
161394202|NCT00744978|582829339|FG000|Period 1|Other|0|||
161394203|NCT00744978|582829340|FG001|Period 1|Other|2|||
161394204|NCT00744978|582829339|FG000|Period 1|Adverse Event|4|||
161394205|NCT00744978|582829340|FG001|Period 1|Adverse Event|0|||
161394206|NCT00744978|582829339|FG000|Period 1|Randomized but not Treated|1|||
161394207|NCT00744978|582829340|FG001|Period 1|Randomized but not Treated|1|||
161394208|NCT00744978|582829339|FG000|Period 2|Adverse Event|0|||
161394209|NCT00744978|582829340|FG001|Period 2|Adverse Event|1|||
161394210|NCT03773133|582829341|FG000|Overall Study|Screen Failure|8|||
161394211|NCT00515294|582829342|FG000|Overall Study|Lost to Follow-up|3|||
161394212|NCT00515294|582829343|FG001|Overall Study|Lost to Follow-up|2|||
161394213|NCT00515294|582829344|FG002|Overall Study|Lost to Follow-up|3|||
161394214|NCT00515294|582829345|FG003|Overall Study|Lost to Follow-up|1|||
161394215|NCT00515294|582829342|FG000|Overall Study|Driver simulator problems|1|||
161394216|NCT00515294|582829343|FG001|Overall Study|Driver simulator problems|1|||
161394217|NCT00515294|582829344|FG002|Overall Study|Driver simulator problems|1|||
161394218|NCT00515294|582829345|FG003|Overall Study|Driver simulator problems|3|||
161394219|NCT00515294|582829342|FG000|Overall Study|Caffeine amount inaccurate|5|||
161394220|NCT00515294|582829343|FG001|Overall Study|Caffeine amount inaccurate|0|||
161394221|NCT00515294|582829344|FG002|Overall Study|Caffeine amount inaccurate|7|||
161394222|NCT00515294|582829345|FG003|Overall Study|Caffeine amount inaccurate|0|||
161394223|NCT01534260|582829350|FG000|Overall Study|Adverse Event|1|||
161394224|NCT01534260|582829351|FG001|Overall Study|Adverse Event|8|||
161394225|NCT01534260|582829350|FG000|Overall Study|Death|2|||
161394226|NCT01534260|582829351|FG001|Overall Study|Death|0|||
161394227|NCT01534260|582829350|FG000|Overall Study|Lack of Efficacy|1|||
161394228|NCT01534260|582829351|FG001|Overall Study|Lack of Efficacy|1|||
161394229|NCT01534260|582829350|FG000|Overall Study|Withdrawal by Subject|1|||
161394230|NCT01534260|582829351|FG001|Overall Study|Withdrawal by Subject|3|||
161394231|NCT01534260|582829350|FG000|Overall Study|Disease Progression|8|||
161394232|NCT01534260|582829351|FG001|Overall Study|Disease Progression|6|||
161394233|NCT01534260|582829350|FG000|Overall Study|Physician Decision|3|||
161394234|NCT01534260|582829351|FG001|Overall Study|Physician Decision|1|||
161394235|NCT01534260|582829350|FG000|Overall Study|No treatment, per protocol|0|||
161394236|NCT01534260|582829351|FG001|Overall Study|No treatment, per protocol|1|||
161394237|NCT01342965|582829352|FG000|Overall Study|Death|58|||
161394238|NCT01342965|582829353|FG001|Overall Study|Death|57|||
161394239|NCT01342965|582829352|FG000|Overall Study|Lost to Follow-up|5|||
161394240|NCT01342965|582829353|FG001|Overall Study|Lost to Follow-up|3|||
161394241|NCT01342965|582829352|FG000|Overall Study|Other Reasons- Unspecified|44|||
161394242|NCT01342965|582829353|FG001|Overall Study|Other Reasons- Unspecified|38|||
161394243|NCT01342965|582829352|FG000|Overall Study|Withdrawal by Subject|2|||
161394244|NCT01342965|582829353|FG001|Overall Study|Withdrawal by Subject|9|||
161394245|NCT00856206|582829354|FG000|Overall Study|Protocol Violation|6|||
161394246|NCT00856206|582829355|FG001|Overall Study|Protocol Violation|18|||
161394247|NCT00856206|582829354|FG000|Overall Study|Adverse Event|10|||
161394248|NCT00856206|582829355|FG001|Overall Study|Adverse Event|46|||
161394249|NCT00856206|582829354|FG000|Overall Study|Lack of Efficacy|1|||
161394250|NCT00856206|582829355|FG001|Overall Study|Lack of Efficacy|2|||
161394251|NCT00856206|582829354|FG000|Overall Study|Withdrawal by Subject|15|||
161394252|NCT00856206|582829355|FG001|Overall Study|Withdrawal by Subject|36|||
161394253|NCT00856206|582829354|FG000|Overall Study|Lost to Follow-up|13|||
161394254|NCT00856206|582829355|FG001|Overall Study|Lost to Follow-up|39|||
161394255|NCT00856206|582829354|FG000|Overall Study|Death|2|||
161394256|NCT00856206|582829355|FG001|Overall Study|Death|2|||
161394257|NCT00856206|582829354|FG000|Overall Study|Decision by the Sponsor|4|||
161394258|NCT00856206|582829355|FG001|Overall Study|Decision by the Sponsor|8|||
161394259|NCT00856206|582829354|FG000|Overall Study|Other than specified above|3|||
161394260|NCT00856206|582829355|FG001|Overall Study|Other than specified above|10|||
161394261|NCT02780856|582829360|FG000|Overall Study|Lost to Follow-up|1|||
161394262|NCT01301066|582829362|FG000|Overall Study|Lost to Follow-up|5|||
161394263|NCT01301066|582829363|FG001|Overall Study|Lost to Follow-up|11|||
161394264|NCT01301066|582829362|FG000|Overall Study|Protocol Violation|8|||
161394265|NCT01301066|582829363|FG001|Overall Study|Protocol Violation|7|||
161394266|NCT01301066|582829362|FG000|Overall Study|Withdrawal by Subject|4|||
161394267|NCT01301066|582829363|FG001|Overall Study|Withdrawal by Subject|9|||
161394268|NCT01301066|582829362|FG000|Overall Study|Adverse Event|6|||
161394269|NCT01301066|582829363|FG001|Overall Study|Adverse Event|6|||
161394270|NCT01301066|582829362|FG000|Overall Study|Sponsor Decision|2|||
161394271|NCT01301066|582829363|FG001|Overall Study|Sponsor Decision|1|||
161394272|NCT01301066|582829362|FG000|Overall Study|Physician Decision|0|||
161394273|NCT01301066|582829363|FG001|Overall Study|Physician Decision|1|||
161394274|NCT01301066|582829362|FG000|Overall Study|Other|2|||
161394275|NCT01301066|582829363|FG001|Overall Study|Other|0|||
161394276|NCT04003207|582829364|FG000|Overall Study|Protocol Violation|1|||
161394277|NCT03894969|582829365|FG000|Overall Study|Adverse Event|0|||
161394278|NCT03894969|582829366|FG001|Overall Study|Adverse Event|2|||
161394279|NCT03894969|582829367|FG002|Overall Study|Adverse Event|0|||
161394280|NCT03894969|582829368|FG003|Overall Study|Adverse Event|1|||
161394281|NCT03894969|582829369|FG004|Overall Study|Adverse Event|2|||
161394282|NCT03894969|582829365|FG000|Overall Study|Lost to Follow-up|3|||
161394283|NCT03894969|582829366|FG001|Overall Study|Lost to Follow-up|1|||
161394284|NCT03894969|582829367|FG002|Overall Study|Lost to Follow-up|1|||
161394285|NCT03894969|582829368|FG003|Overall Study|Lost to Follow-up|0|||
161394286|NCT03894969|582829369|FG004|Overall Study|Lost to Follow-up|0|||
161394287|NCT03894969|582829365|FG000|Overall Study|Withdrawal by Subject|2|||
161394288|NCT03894969|582829366|FG001|Overall Study|Withdrawal by Subject|1|||
161394289|NCT03894969|582829367|FG002|Overall Study|Withdrawal by Subject|3|||
161394290|NCT03894969|582829368|FG003|Overall Study|Withdrawal by Subject|4|||
161394291|NCT03894969|582829369|FG004|Overall Study|Withdrawal by Subject|8|||
161394292|NCT03894969|582829365|FG000|Overall Study|Other|0|||
161394293|NCT03894969|582829366|FG001|Overall Study|Other|0|||
161394294|NCT03894969|582829367|FG002|Overall Study|Other|0|||
161394295|NCT03894969|582829368|FG003|Overall Study|Other|0|||
161394296|NCT03894969|582829369|FG004|Overall Study|Other|3|||
161394297|NCT03894969|582829365|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
161394298|NCT03894969|582829366|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
161394299|NCT03894969|582829367|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
161394300|NCT03894969|582829368|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
161394301|NCT03894969|582829369|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
161394302|NCT03894969|582829365|FG000|Overall Study|Solicited Adverse Event|0|||
161394303|NCT03894969|582829366|FG001|Overall Study|Solicited Adverse Event|1|||
161394304|NCT03894969|582829367|FG002|Overall Study|Solicited Adverse Event|0|||
161394305|NCT03894969|582829368|FG003|Overall Study|Solicited Adverse Event|0|||
161394306|NCT03894969|582829369|FG004|Overall Study|Solicited Adverse Event|0|||
161394307|NCT00468676|582829370|FG000|Overall Study|Lost to Follow-up|14|||
161394308|NCT00468676|582829371|FG001|Overall Study|Lost to Follow-up|11|||
161394309|NCT00468676|582829370|FG000|Overall Study|Death|2|||
161394310|NCT00468676|582829371|FG001|Overall Study|Death|1|||
161394311|NCT02979093|582829372|FG000|First Scan Session|Scanning data problems|1|||
161394312|NCT02979093|582829373|FG001|First Scan Session|Scanning data problems|2|||
161394313|NCT02979093|582829374|FG002|First Scan Session|Scanning data problems|2|||
161394314|NCT02979093|582829375|FG003|First Scan Session|Scanning data problems|0|||
161394315|NCT02979093|582829372|FG000|Second Scan Session|Scanning data problems|3|||
161394316|NCT02979093|582829373|FG001|Second Scan Session|Scanning data problems|0|||
161394317|NCT02979093|582829374|FG002|Second Scan Session|Scanning data problems|1|||
161394318|NCT02979093|582829375|FG003|Second Scan Session|Scanning data problems|3|||
161394319|NCT02256384|582829381|FG000|Overall Study|Withdrawal by Subject|12|||
161394320|NCT02256384|582829381|FG000|Overall Study|Equipment not capturing data|2|||
161394321|NCT05032690|582829382|FG000|Period 1|Adverse Event|0|||
161394322|NCT05032690|582829383|FG001|Period 1|Adverse Event|1|||
161394323|NCT05032690|582829384|FG002|Period 1|Adverse Event|0|||
161394324|NCT05032690|582829385|FG003|Period 1|Adverse Event|0|||
161394325|NCT05032690|582829382|FG000|Period 1|Withdrawal by Subject|1|||
161394326|NCT05032690|582829383|FG001|Period 1|Withdrawal by Subject|0|||
161394327|NCT05032690|582829384|FG002|Period 1|Withdrawal by Subject|0|||
161394328|NCT05032690|582829385|FG003|Period 1|Withdrawal by Subject|0|||
161394329|NCT05032690|582829382|FG000|Period 1|No longer meets eligibility criteria|0|||
161394330|NCT05032690|582829383|FG001|Period 1|No longer meets eligibility criteria|1|||
161394331|NCT05032690|582829384|FG002|Period 1|No longer meets eligibility criteria|0|||
161394332|NCT05032690|582829385|FG003|Period 1|No longer meets eligibility criteria|0|||
161394333|NCT05032690|582829382|FG000|Period 2|Adverse Event|1|||
161394334|NCT05032690|582829383|FG001|Period 2|Adverse Event|0|||
161394335|NCT05032690|582829384|FG002|Period 2|Adverse Event|0|||
161394336|NCT05032690|582829385|FG003|Period 2|Adverse Event|0|||
161394337|NCT05032690|582829382|FG000|Period 2|Withdrawal by Subject|0|||
161394338|NCT05032690|582829383|FG001|Period 2|Withdrawal by Subject|1|||
161394339|NCT05032690|582829384|FG002|Period 2|Withdrawal by Subject|0|||
161394340|NCT05032690|582829385|FG003|Period 2|Withdrawal by Subject|0|||
161394341|NCT05032690|582829382|FG000|Period 2|No longer meets eligibility criteria|0|||
161394342|NCT05032690|582829383|FG001|Period 2|No longer meets eligibility criteria|1|||
161394343|NCT05032690|582829384|FG002|Period 2|No longer meets eligibility criteria|0|||
161394344|NCT05032690|582829385|FG003|Period 2|No longer meets eligibility criteria|0|||
161394345|NCT05032690|582829382|FG000|Period 3|Adverse Event|0|||
161394346|NCT05032690|582829383|FG001|Period 3|Adverse Event|1|||
161394347|NCT05032690|582829384|FG002|Period 3|Adverse Event|0|||
161394348|NCT05032690|582829385|FG003|Period 3|Adverse Event|0|||
161394349|NCT00487942|582829386|FG000|Overall Study|Adverse Event|1|||
161394350|NCT00487942|582829387|FG001|Overall Study|Adverse Event|1|||
161394351|NCT00487942|582829388|FG002|Overall Study|Adverse Event|1|||
161394352|NCT00487942|582829389|FG003|Overall Study|Adverse Event|1|||
161394353|NCT00487942|582829386|FG000|Overall Study|Lost to Follow-up|1|||
161394354|NCT00487942|582829387|FG001|Overall Study|Lost to Follow-up|0|||
161394355|NCT00487942|582829388|FG002|Overall Study|Lost to Follow-up|0|||
161394356|NCT00487942|582829389|FG003|Overall Study|Lost to Follow-up|1|||
161394357|NCT00487942|582829386|FG000|Overall Study|Protocol Violation|1|||
161394358|NCT00487942|582829387|FG001|Overall Study|Protocol Violation|1|||
161394359|NCT00487942|582829388|FG002|Overall Study|Protocol Violation|0|||
161394360|NCT00487942|582829389|FG003|Overall Study|Protocol Violation|0|||
161394361|NCT00487942|582829386|FG000|Overall Study|Withdrawal by Subject|0|||
161394362|NCT00487942|582829387|FG001|Overall Study|Withdrawal by Subject|1|||
161394363|NCT00487942|582829388|FG002|Overall Study|Withdrawal by Subject|2|||
161394364|NCT00487942|582829389|FG003|Overall Study|Withdrawal by Subject|0|||
161394365|NCT00211757|582829390|FG000|Overall Study|Withdrawal by Subject|1|||
161394366|NCT00211757|582829391|FG001|Overall Study|Withdrawal by Subject|1|||
161394367|NCT00211757|582829390|FG000|Overall Study|Lack of Efficacy|0|||
161394368|NCT00211757|582829391|FG001|Overall Study|Lack of Efficacy|1|||
161394369|NCT05151445|582829392|FG000|Overall Study|Withdrawal by Subject|3|||
161394370|NCT02298179|582829393|FG000|Overall Study|Lost to Follow-up|0|||
161394371|NCT02298179|582829394|FG001|Overall Study|Lost to Follow-up|0|||
161394372|NCT02298179|582829395|FG002|Overall Study|Lost to Follow-up|1|||
161394373|NCT02298179|582829396|FG003|Overall Study|Lost to Follow-up|0|||
161394374|NCT02298179|582829397|FG004|Overall Study|Lost to Follow-up|0|||
161394375|NCT02298179|582829398|FG005|Overall Study|Lost to Follow-up|0|||
161394376|NCT02298179|582829399|FG006|Overall Study|Lost to Follow-up|0|||
161394377|NCT02298179|582829400|FG007|Overall Study|Lost to Follow-up|1|||
161394378|NCT02298179|582829401|FG008|Overall Study|Lost to Follow-up|0|||
161394379|NCT02298179|582829402|FG009|Overall Study|Lost to Follow-up|0|||
161394380|NCT02298179|582829403|FG010|Overall Study|Lost to Follow-up|0|||
161394381|NCT02298179|582829404|FG011|Overall Study|Lost to Follow-up|0|||
161394382|NCT00082368|582829405|FG000|Overall Study|Not treated-pt had poor IV access|1|||
161394383|NCT02825420|582829407|FG000|Overall Study|Death|30|||
161394384|NCT02825420|582829408|FG001|Overall Study|Death|12|||
161394385|NCT02825420|582829407|FG000|Overall Study|Progressive disease|6|||
161394386|NCT02825420|582829408|FG001|Overall Study|Progressive disease|1|||
161394387|NCT02825420|582829407|FG000|Overall Study|Lost to Follow-up|2|||
161394388|NCT02825420|582829408|FG001|Overall Study|Lost to Follow-up|2|||
161394389|NCT02825420|582829407|FG000|Overall Study|Withdrawal by Subject|1|||
161394390|NCT02825420|582829408|FG001|Overall Study|Withdrawal by Subject|1|||
161394391|NCT02825420|582829407|FG000|Overall Study|Protocol amendment not signed|1|||
161394392|NCT02825420|582829408|FG001|Overall Study|Protocol amendment not signed|1|||
161394393|NCT02825420|582829407|FG000|Overall Study|Physician Decision|1|||
161394394|NCT02825420|582829408|FG001|Overall Study|Physician Decision|0|||
161394395|NCT02825420|582829407|FG000|Overall Study|Did not receive PLD|2|||
161394396|NCT02825420|582829408|FG001|Overall Study|Did not receive PLD|0|||
161394397|NCT01739933|582831313|FG000|Overall Study|Death|89|||
161394398|NCT01739933|582831314|FG001|Overall Study|Death|86|||
161394399|NCT01739933|582831313|FG000|Overall Study|Withdrawal by Subject|10|||
161394400|NCT01739933|582831314|FG001|Overall Study|Withdrawal by Subject|8|||
161394401|NCT01739933|582831313|FG000|Overall Study|Lost to Follow-up|3|||
161394402|NCT01739933|582831314|FG001|Overall Study|Lost to Follow-up|10|||
161394403|NCT01739933|582831313|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
161394404|NCT01739933|582831314|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
161394405|NCT01032291|582831315|FG000|Safety Lead-in|Adverse Event|1|||
161394406|NCT01032291|582831316|FG001|Safety Lead-in|Adverse Event|0|||
161394407|NCT01032291|582831317|FG002|Safety Lead-in|Adverse Event|0|||
161394408|NCT01032291|582831315|FG000|Safety Lead-in|Death|1|||
161394409|NCT01032291|582831316|FG001|Safety Lead-in|Death|0|||
161394410|NCT01032291|582831317|FG002|Safety Lead-in|Death|0|||
161394411|NCT01032291|582831315|FG000|Proof of Concept|Adverse Event|0|||
161394412|NCT01032291|582831316|FG001|Proof of Concept|Adverse Event|5|||
161394413|NCT01032291|582831317|FG002|Proof of Concept|Adverse Event|1|||
161394414|NCT01032291|582831315|FG000|Proof of Concept|Death|0|||
161394415|NCT01032291|582831316|FG001|Proof of Concept|Death|1|||
161394416|NCT01032291|582831317|FG002|Proof of Concept|Death|2|||
161394417|NCT01032291|582831315|FG000|Proof of Concept|Lack of Efficacy|0|||
161394418|NCT01032291|582831316|FG001|Proof of Concept|Lack of Efficacy|1|||
161394419|NCT01032291|582831317|FG002|Proof of Concept|Lack of Efficacy|0|||
161394420|NCT01032291|582831315|FG000|Proof of Concept|Never Received Study Drug|0|||
161394421|NCT01032291|582831316|FG001|Proof of Concept|Never Received Study Drug|1|||
161394422|NCT01032291|582831317|FG002|Proof of Concept|Never Received Study Drug|0|||
161394423|NCT00347438|582831318|FG000|Overall Study|Withdrawal by Subject|1|||
161394424|NCT00347438|582831318|FG000|Overall Study|Physician Decision|1|||
161394425|NCT01529515|582831319|FG000|TRANSITION PHASE|Adverse Event|16|||
161394426|NCT01529515|582831320|FG001|TRANSITION PHASE|Adverse Event|0|||
161394427|NCT01529515|582831321|FG002|TRANSITION PHASE|Adverse Event|0|||
161394428|NCT01529515|582831322|FG003|TRANSITION PHASE|Adverse Event|0|||
161394429|NCT01529515|582831319|FG000|TRANSITION PHASE|Death|1|||
161394430|NCT01529515|582831320|FG001|TRANSITION PHASE|Death|0|||
161394431|NCT01529515|582831321|FG002|TRANSITION PHASE|Death|0|||
161394432|NCT01529515|582831322|FG003|TRANSITION PHASE|Death|0|||
161394433|NCT01529515|582831319|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
161394434|NCT01529515|582831320|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
161394435|NCT01529515|582831321|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
161394436|NCT01529515|582831322|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
161394437|NCT01529515|582831319|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
161394438|NCT01529515|582831320|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
161394439|NCT01529515|582831321|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
161394440|NCT01529515|582831322|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
161394441|NCT01529515|582831319|FG000|TRANSITION PHASE|Protocol Violation|4|||
161394442|NCT01529515|582831320|FG001|TRANSITION PHASE|Protocol Violation|0|||
161394443|NCT01529515|582831321|FG002|TRANSITION PHASE|Protocol Violation|0|||
161394444|NCT01529515|582831322|FG003|TRANSITION PHASE|Protocol Violation|0|||
161394445|NCT01529515|582831319|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
161394446|NCT01529515|582831320|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
161394447|NCT01529515|582831321|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
161394448|NCT01529515|582831322|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
161394449|NCT01529515|582831319|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
161394450|NCT01529515|582831320|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
161394451|NCT01529515|582831321|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
161394452|NCT01529515|582831322|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
161394453|NCT01529515|582831319|FG000|TRANSITION PHASE|Other|9|||
161394454|NCT01529515|582831320|FG001|TRANSITION PHASE|Other|0|||
161394455|NCT01529515|582831321|FG002|TRANSITION PHASE|Other|0|||
161394456|NCT01529515|582831322|FG003|TRANSITION PHASE|Other|0|||
161394457|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Adverse Event|0|||
161394458|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Adverse Event|10|||
161394459|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Adverse Event|0|||
161394460|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Adverse Event|0|||
161394461|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
161394462|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
161394463|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
161394464|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
161394465|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
161394466|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
161394467|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
161394468|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
161394469|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
161394470|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
161394471|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
161394472|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
161394473|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
161394474|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
161394475|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
161394476|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
161394477|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
161394478|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
161394479|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
161394480|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
161394481|NCT01529515|582831319|FG000|MAINTENANCE PHASE|Other|0|||
161394482|NCT01529515|582831320|FG001|MAINTENANCE PHASE|Other|10|||
161394483|NCT01529515|582831321|FG002|MAINTENANCE PHASE|Other|0|||
161394484|NCT01529515|582831322|FG003|MAINTENANCE PHASE|Other|0|||
161394485|NCT01529515|582831319|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
161394486|NCT01529515|582831320|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
161394487|NCT01529515|582831321|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
161394488|NCT01529515|582831322|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
161394489|NCT01529515|582831319|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
161394490|NCT01529515|582831320|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
161394491|NCT01529515|582831321|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
161394492|NCT01529515|582831322|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
161394493|NCT01529515|582831319|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
161394494|NCT01529515|582831320|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
161394495|NCT01529515|582831321|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
161394496|NCT01529515|582831322|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
161394497|NCT01529515|582831319|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
161394498|NCT01529515|582831320|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
161394499|NCT01529515|582831321|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
161394500|NCT01529515|582831322|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
161394501|NCT01529515|582831319|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
161394502|NCT01529515|582831320|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
161394503|NCT01529515|582831321|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
161394504|NCT01529515|582831322|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
161394505|NCT01529515|582831319|FG000|DOUBLE BLIND PHASE|Other|0|||
161394506|NCT01529515|582831320|FG001|DOUBLE BLIND PHASE|Other|0|||
161394507|NCT01529515|582831321|FG002|DOUBLE BLIND PHASE|Other|9|||
161394508|NCT01529515|582831322|FG003|DOUBLE BLIND PHASE|Other|2|||
161394509|NCT00322023|582831326|FG000|Overall Study|various|0|||
161394510|NCT00322023|582831327|FG001|Overall Study|various|2|||
161394511|NCT00322023|582831328|FG002|Overall Study|various|6|||
161394512|NCT03327220|582831329|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
161394513|NCT03327220|582831330|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
161394514|NCT03327220|582831329|FG000|Overall Study|Investigator Decision|2|||
161394515|NCT03327220|582831330|FG001|Overall Study|Investigator Decision|0|||
161394516|NCT03327220|582831329|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
161394517|NCT03327220|582831330|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
161394518|NCT03327220|582831329|FG000|Overall Study|Fungal infection|1|||
161394519|NCT03327220|582831330|FG001|Overall Study|Fungal infection|0|||
161394520|NCT03327220|582831329|FG000|Overall Study|Discharged to Rehabilitation|0|||
161394521|NCT03327220|582831330|FG001|Overall Study|Discharged to Rehabilitation|1|||
161394522|NCT03327220|582831329|FG000|Overall Study|Missing|1|||
161394523|NCT03327220|582831330|FG001|Overall Study|Missing|0|||
161394524|NCT03920293|582831331|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
161394525|NCT03920293|582831332|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
161394526|NCT03920293|582831331|FG000|Randomized-Controlled Period|Physician Decision|1|||
161394527|NCT03920293|582831332|FG001|Randomized-Controlled Period|Physician Decision|2|||
161394528|NCT03920293|582831331|FG000|Randomized-Controlled Period|Adverse Event|0|||
161394529|NCT03920293|582831332|FG001|Randomized-Controlled Period|Adverse Event|2|||
161394530|NCT03920293|582831331|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
161394531|NCT03920293|582831332|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
161394532|NCT03920293|582831331|FG000|Randomized-Controlled Period|Death|2|||
161394533|NCT03920293|582831332|FG001|Randomized-Controlled Period|Death|0|||
161394534|NCT03920293|582831331|FG000|Randomized-Controlled Period|Protocol Violation|1|||
161394535|NCT03920293|582831332|FG001|Randomized-Controlled Period|Protocol Violation|0|||
161394536|NCT03920293|582831331|FG000|Randomized-Controlled Period|Noncompliance|1|||
161394537|NCT03920293|582831332|FG001|Randomized-Controlled Period|Noncompliance|0|||
161394538|NCT03920293|582831331|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
161394539|NCT03920293|582831332|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
161394540|NCT03920293|582831331|FG000|Open- Label Extension Period|Death|3|||
161394541|NCT03920293|582831332|FG001|Open- Label Extension Period|Death|3|||
161394542|NCT03920293|582831331|FG000|Open- Label Extension Period|Physician Decision|5|||
161394543|NCT03920293|582831332|FG001|Open- Label Extension Period|Physician Decision|3|||
161394544|NCT03920293|582831331|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
161394545|NCT03920293|582831332|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
161394546|NCT00523705|582831333|FG000|Overall Study|No time for study.|0|||
161394547|NCT00523705|582831334|FG001|Overall Study|No time for study.|1|||
161394548|NCT00693017|582831335|FG000|Overall Study|Sponsor Decision|2|||
161394549|NCT00693017|582831336|FG001|Overall Study|Sponsor Decision|1|||
161394550|NCT00693017|582831335|FG000|Overall Study|Death|0|||
161394551|NCT00693017|582831336|FG001|Overall Study|Death|1|||
161394552|NCT01691885|582831340|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
161394553|NCT01691885|582831341|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
161394554|NCT01691885|582831340|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
161394555|NCT01691885|582831341|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
161394556|NCT03555981|582831342|FG000|Overall Study|Lost to Follow-up|0|||
161394557|NCT03555981|582831343|FG001|Overall Study|Lost to Follow-up|2|||
161394558|NCT00688324|582831345|FG000|Overall Study|Withdrawal by Subject|2|||
161394559|NCT00688324|582831345|FG000|Overall Study|Physician Decision|5|||
161394560|NCT00688324|582831345|FG000|Overall Study|Lost to Follow-up|1|||
161394561|NCT01972308|582831346|FG000|Overall Study|Withdrawal by Subject|0|||
161394562|NCT01972308|582831347|FG001|Overall Study|Withdrawal by Subject|1|||
161394563|NCT01972308|582831346|FG000|Overall Study|Lost to Follow-up|4|||
161394564|NCT01972308|582831347|FG001|Overall Study|Lost to Follow-up|6|||
161394565|NCT01972308|582831346|FG000|Overall Study|Death|4|||
161394566|NCT01972308|582831347|FG001|Overall Study|Death|1|||
161394567|NCT04035564|582831349|FG000|Overall Study|Protocol Violation|1|||
161394568|NCT04035564|582831350|FG001|Overall Study|Protocol Violation|2|||
161394569|NCT04035564|582831349|FG000|Overall Study|No laboratory available|2|||
161394570|NCT04035564|582831350|FG001|Overall Study|No laboratory available|2|||
161394571|NCT04035564|582831349|FG000|Overall Study|Guardian declined consent|1|||
161394572|NCT04035564|582831350|FG001|Overall Study|Guardian declined consent|2|||
161394573|NCT01562314|582831351|FG000|Overall Study|Adverse Event|10|||
161394574|NCT01562314|582831352|FG001|Overall Study|Adverse Event|5|||
161394575|NCT01562314|582831351|FG000|Overall Study|Met Withdrawal Criteria|3|||
161394576|NCT01562314|582831352|FG001|Overall Study|Met Withdrawal Criteria|2|||
161394577|NCT01562314|582831351|FG000|Overall Study|Withdrawal by Subject|0|||
161394578|NCT01562314|582831352|FG001|Overall Study|Withdrawal by Subject|1|||
161394579|NCT01190475|582831359|FG000|Overall Study|Withdrawal by Subject|0|||
161394580|NCT01190475|582831360|FG001|Overall Study|Withdrawal by Subject|0|||
161394581|NCT01190475|582831361|FG002|Overall Study|Withdrawal by Subject|1|||
161394582|NCT00543803|582831362|FG000|Overall Study|Adverse Event|14|||
161394583|NCT00543803|582831362|FG000|Overall Study|Lack of Efficacy|22|||
161394584|NCT00543803|582831362|FG000|Overall Study|Lost to Follow-up|20|||
161394585|NCT00543803|582831362|FG000|Overall Study|Other|86|||
161394586|NCT04154345|582831365|FG000|Overall Study|Covid-19 pandemic|4|||
161394587|NCT03505788|582831366|FG000|Overall Study|Lost to Follow-up|2|||
161394588|NCT03505788|582831367|FG001|Overall Study|Lost to Follow-up|1|||
161394589|NCT03505788|582831366|FG000|Overall Study|Withdrawal by Subject|1|||
161394590|NCT03505788|582831367|FG001|Overall Study|Withdrawal by Subject|3|||
161394591|NCT03505788|582831366|FG000|Overall Study|Physician Decision|0|||
161394592|NCT03505788|582831367|FG001|Overall Study|Physician Decision|1|||
161394593|NCT03575065|582831368|FG000|Overall Study|Death|31|||
161394594|NCT03575065|582831369|FG001|Overall Study|Death|12|||
161394595|NCT03575065|582831368|FG000|Overall Study|Sponsor's Decision|28|||
161394596|NCT03575065|582831369|FG001|Overall Study|Sponsor's Decision|13|||
161394597|NCT03575065|582831368|FG000|Overall Study|Withdrawal by Subject|2|||
161394598|NCT03575065|582831369|FG001|Overall Study|Withdrawal by Subject|1|||
161394599|NCT03575065|582831368|FG000|Overall Study|Lost to Follow-up|1|||
161394600|NCT03575065|582831369|FG001|Overall Study|Lost to Follow-up|0|||
161394601|NCT02323126|582831374|FG000|Overall Study|Patient / guardian decision|0|||
161394602|NCT02323126|582831375|FG001|Overall Study|Patient / guardian decision|1|||
161394603|NCT02323126|582831376|FG002|Overall Study|Patient / guardian decision|2|||
161394604|NCT02323126|582831374|FG000|Overall Study|Progressive disease|14|||
161394605|NCT02323126|582831375|FG001|Overall Study|Progressive disease|8|||
161394606|NCT02323126|582831376|FG002|Overall Study|Progressive disease|14|||
161394607|NCT02323126|582831374|FG000|Overall Study|Physician Decision|0|||
161394608|NCT02323126|582831375|FG001|Overall Study|Physician Decision|1|||
161394609|NCT02323126|582831376|FG002|Overall Study|Physician Decision|3|||
161394610|NCT02323126|582831374|FG000|Overall Study|Death|1|||
161394611|NCT02323126|582831375|FG001|Overall Study|Death|1|||
161394612|NCT02323126|582831376|FG002|Overall Study|Death|4|||
161394613|NCT02323126|582831374|FG000|Overall Study|Adverse Event|3|||
161394614|NCT02323126|582831375|FG001|Overall Study|Adverse Event|5|||
161394615|NCT02323126|582831376|FG002|Overall Study|Adverse Event|7|||
161394616|NCT03333252|582831377|FG000|Overall Study|Adverse Event|10|||
161394617|NCT03333252|582831378|FG001|Overall Study|Adverse Event|6|||
161394618|NCT03333252|582831379|FG002|Overall Study|Adverse Event|5|||
161394619|NCT03333252|582831380|FG003|Overall Study|Adverse Event|2|||
161394620|NCT03333252|582831377|FG000|Overall Study|Death|1|||
161394621|NCT03333252|582831378|FG001|Overall Study|Death|3|||
161394622|NCT03333252|582831379|FG002|Overall Study|Death|0|||
161394623|NCT03333252|582831380|FG003|Overall Study|Death|0|||
161394624|NCT03333252|582831377|FG000|Overall Study|Lack of Efficacy|8|||
161394625|NCT03333252|582831378|FG001|Overall Study|Lack of Efficacy|4|||
161394626|NCT03333252|582831379|FG002|Overall Study|Lack of Efficacy|0|||
161394627|NCT03333252|582831380|FG003|Overall Study|Lack of Efficacy|7|||
161394628|NCT03333252|582831377|FG000|Overall Study|Lost to Follow-up|0|||
161394629|NCT03333252|582831378|FG001|Overall Study|Lost to Follow-up|5|||
161394630|NCT03333252|582831379|FG002|Overall Study|Lost to Follow-up|9|||
161394631|NCT03333252|582831380|FG003|Overall Study|Lost to Follow-up|3|||
161394632|NCT03333252|582831377|FG000|Overall Study|Withdrawal by Subject|14|||
161394633|NCT03333252|582831378|FG001|Overall Study|Withdrawal by Subject|24|||
161394634|NCT03333252|582831379|FG002|Overall Study|Withdrawal by Subject|11|||
161394635|NCT03333252|582831380|FG003|Overall Study|Withdrawal by Subject|17|||
161394636|NCT00939029|582831381|FG000|Overall Study|Withdrawal by Subject|3|||
161394637|NCT00939029|582831382|FG001|Overall Study|Withdrawal by Subject|7|||
161394638|NCT00939029|582831381|FG000|Overall Study|Lost to Follow-up|3|||
161394639|NCT00939029|582831382|FG001|Overall Study|Lost to Follow-up|4|||
161394640|NCT00939029|582831381|FG000|Overall Study|Adverse Event|0|||
161394641|NCT00939029|582831382|FG001|Overall Study|Adverse Event|1|||
161394642|NCT00396136|582831383|FG000|Overall Study|Death|43|||
161394643|NCT00396136|582831383|FG000|Overall Study|Withdrawal by Subject|59|||
161394644|NCT00396136|582831383|FG000|Overall Study|Lost to Follow-up|15|||
161394645|NCT00396136|582831383|FG000|Overall Study|Study device explanted|8|||
161394646|NCT01779856|582831385|FG000|Overall Study|Withdrawal by Subject|15|||
161394647|NCT01779856|582831385|FG000|Overall Study|Death|3|||
161394648|NCT01779856|582831385|FG000|Overall Study|Physician Decision|1|||
161394649|NCT01779856|582831385|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
161394650|NCT01779856|582831385|FG000|Overall Study|Delays in scheduling implant|1|||
161394651|NCT01779856|582831385|FG000|Overall Study|Subject ineligible for Implant|2|||
161394652|NCT01535599|582831386|FG000|Overall Study|Adverse Event|6|||
161394653|NCT01535599|582831387|FG001|Overall Study|Adverse Event|15|||
161394654|NCT01535599|582831386|FG000|Overall Study|Lost to Follow-up|3|||
161394655|NCT01535599|582831387|FG001|Overall Study|Lost to Follow-up|4|||
161394656|NCT01535599|582831386|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
161394657|NCT01535599|582831387|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
161394658|NCT01535599|582831386|FG000|Overall Study|Treatment Failure|33|||
161394659|NCT01535599|582831387|FG001|Overall Study|Treatment Failure|66|||
161394660|NCT01535599|582831386|FG000|Overall Study|BL Culture + for Group A Strep|0|||
161394661|NCT01535599|582831387|FG001|Overall Study|BL Culture + for Group A Strep|1|||
161394662|NCT01535599|582831386|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
161394663|NCT01535599|582831387|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
161394664|NCT01535599|582831386|FG000|Overall Study|Randomized in Error|2|||
161394665|NCT01535599|582831387|FG001|Overall Study|Randomized in Error|4|||
161394666|NCT01535599|582831386|FG000|Overall Study|Did not use product|1|||
161394667|NCT01535599|582831387|FG001|Overall Study|Did not use product|0|||
161394668|NCT01535599|582831386|FG000|Overall Study|Other|1|||
161394669|NCT01535599|582831387|FG001|Overall Study|Other|0|||
161394670|NCT01535599|582831386|FG000|Overall Study|Stopped medication|0|||
161394671|NCT01535599|582831387|FG001|Overall Study|Stopped medication|1|||
161394672|NCT01535599|582831386|FG000|Overall Study|Noncompliance|0|||
161394673|NCT01535599|582831387|FG001|Overall Study|Noncompliance|1|||
161394674|NCT03960580|582831391|FG000|Overall Study|Adverse Event|2|||
161394675|NCT03960580|582831392|FG001|Overall Study|Adverse Event|1|||
161394676|NCT03960580|582831393|FG002|Overall Study|Adverse Event|1|||
161394677|NCT03960580|582831391|FG000|Overall Study|Lost to Follow-up|1|||
161394678|NCT03960580|582831392|FG001|Overall Study|Lost to Follow-up|0|||
161394679|NCT03960580|582831393|FG002|Overall Study|Lost to Follow-up|0|||
161394680|NCT03960580|582831391|FG000|Overall Study|Lack of Efficacy|2|||
161394681|NCT03960580|582831392|FG001|Overall Study|Lack of Efficacy|1|||
161394682|NCT03960580|582831393|FG002|Overall Study|Lack of Efficacy|0|||
161394683|NCT03960580|582831391|FG000|Overall Study|Protocol Violation|0|||
161394684|NCT03960580|582831392|FG001|Overall Study|Protocol Violation|0|||
161394685|NCT03960580|582831393|FG002|Overall Study|Protocol Violation|1|||
161394686|NCT03960580|582831391|FG000|Overall Study|Withdrawal by Subject|1|||
161394687|NCT03960580|582831392|FG001|Overall Study|Withdrawal by Subject|1|||
161394688|NCT03960580|582831393|FG002|Overall Study|Withdrawal by Subject|1|||
161394689|NCT03960580|582831391|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
161394690|NCT03960580|582831392|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
161394691|NCT03960580|582831393|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
161394692|NCT03172325|582831398|FG000|Overall Study|Adverse Event|2|||
161394693|NCT03172325|582831399|FG001|Overall Study|Adverse Event|3|||
161394694|NCT03172325|582831398|FG000|Overall Study|Positive PPD|1|||
161394695|NCT03172325|582831399|FG001|Overall Study|Positive PPD|0|||
161394696|NCT03172325|582831398|FG000|Overall Study|Poor Compliance|1|||
161394697|NCT03172325|582831399|FG001|Overall Study|Poor Compliance|1|||
161394698|NCT00385944|582831403|FG000|1st Maintenance Dose Period|Physician Decision|1|||
161394699|NCT00385944|582831404|FG001|1st Maintenance Dose Period|Physician Decision|0|||
161394700|NCT00385944|582831405|FG002|1st Maintenance Dose Period|Physician Decision|0|||
161394701|NCT00385944|582831403|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
161394702|NCT00385944|582831404|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
161394703|NCT00385944|582831405|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
161394704|NCT00385944|582831403|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
161394705|NCT00385944|582831404|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
161394706|NCT00385944|582831405|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
161394707|NCT00385944|582831403|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
161394708|NCT00385944|582831404|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
161394709|NCT00385944|582831405|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
161394710|NCT00590824|582831406|FG000|Overall Study|Disease could not be resected|0|||
161394711|NCT00590824|582831407|FG001|Overall Study|Disease could not be resected|2|||
161394712|NCT00590824|582831408|FG002|Overall Study|Disease could not be resected|1|||
161394713|NCT00590824|582831409|FG003|Overall Study|Disease could not be resected|0|||
161394714|NCT00590824|582831406|FG000|Overall Study|Adverse Event|0|||
161394715|NCT00590824|582831407|FG001|Overall Study|Adverse Event|0|||
161394716|NCT00590824|582831408|FG002|Overall Study|Adverse Event|0|||
161394717|NCT00590824|582831409|FG003|Overall Study|Adverse Event|1|||
161394718|NCT03832322|582831411|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
161394719|NCT03832322|582831412|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
161394720|NCT01694121|582831414|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
161394721|NCT01694121|582831415|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
161394722|NCT01778049|582831419|FG000|Open Label Treatment Period|Adverse Event|5|||
161394723|NCT01778049|582831420|FG001|Open Label Treatment Period|Adverse Event|15|||
161394724|NCT01778049|582831421|FG002|Open Label Treatment Period|Adverse Event|0|||
161394725|NCT01778049|582831422|FG003|Open Label Treatment Period|Adverse Event|0|||
161394726|NCT01778049|582831423|FG004|Open Label Treatment Period|Adverse Event|0|||
161394727|NCT01778049|582831424|FG005|Open Label Treatment Period|Adverse Event|0|||
161394728|NCT01778049|582831419|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
161394729|NCT01778049|582831420|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
161394730|NCT01778049|582831421|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
161394731|NCT01778049|582831422|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
161394732|NCT01778049|582831423|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
161394733|NCT01778049|582831424|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
161394734|NCT01778049|582831419|FG000|Open Label Treatment Period|Protocol Violation|5|||
161394735|NCT01778049|582831420|FG001|Open Label Treatment Period|Protocol Violation|5|||
161394736|NCT01778049|582831421|FG002|Open Label Treatment Period|Protocol Violation|0|||
161394737|NCT01778049|582831422|FG003|Open Label Treatment Period|Protocol Violation|0|||
161394738|NCT01778049|582831423|FG004|Open Label Treatment Period|Protocol Violation|0|||
161394739|NCT01778049|582831424|FG005|Open Label Treatment Period|Protocol Violation|0|||
161394740|NCT01778049|582831419|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
161394741|NCT01778049|582831420|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
161394742|NCT01778049|582831421|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
161394743|NCT01778049|582831422|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
161394744|NCT01778049|582831423|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
161394745|NCT01778049|582831424|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
161394746|NCT01778049|582831419|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
161394747|NCT01778049|582831420|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
161394748|NCT01778049|582831421|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
161394749|NCT01778049|582831422|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
161394750|NCT01778049|582831423|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
161394751|NCT01778049|582831424|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
161394752|NCT01778049|582831419|FG000|Open Label Treatment Period|Not treated|2|||
161394753|NCT01778049|582831420|FG001|Open Label Treatment Period|Not treated|1|||
161394754|NCT01778049|582831421|FG002|Open Label Treatment Period|Not treated|0|||
161394755|NCT01778049|582831422|FG003|Open Label Treatment Period|Not treated|0|||
161394756|NCT01778049|582831423|FG004|Open Label Treatment Period|Not treated|0|||
161394757|NCT01778049|582831424|FG005|Open Label Treatment Period|Not treated|0|||
161394758|NCT01778049|582831419|FG000|Open Label Treatment Period|Other reason not defined above|77|||
161394759|NCT01778049|582831420|FG001|Open Label Treatment Period|Other reason not defined above|94|||
161394760|NCT01778049|582831421|FG002|Open Label Treatment Period|Other reason not defined above|0|||
161394761|NCT01778049|582831422|FG003|Open Label Treatment Period|Other reason not defined above|0|||
161394762|NCT01778049|582831423|FG004|Open Label Treatment Period|Other reason not defined above|0|||
161394763|NCT01778049|582831424|FG005|Open Label Treatment Period|Other reason not defined above|0|||
161394764|NCT01778049|582831419|FG000|Double Blind Treatment Period|Adverse Event|0|||
161394765|NCT01778049|582831420|FG001|Double Blind Treatment Period|Adverse Event|0|||
161394766|NCT01778049|582831421|FG002|Double Blind Treatment Period|Adverse Event|4|||
161394767|NCT01778049|582831422|FG003|Double Blind Treatment Period|Adverse Event|5|||
161394768|NCT01778049|582831423|FG004|Double Blind Treatment Period|Adverse Event|3|||
161394769|NCT01778049|582831424|FG005|Double Blind Treatment Period|Adverse Event|2|||
161394770|NCT01778049|582831419|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
161394771|NCT01778049|582831420|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161394772|NCT01778049|582831421|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161394773|NCT01778049|582831422|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
161394774|NCT01778049|582831423|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161394775|NCT01778049|582831424|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
161394776|NCT01778049|582831419|FG000|Double Blind Treatment Period|Protocol Violation|0|||
161394777|NCT01778049|582831420|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161394778|NCT01778049|582831421|FG002|Double Blind Treatment Period|Protocol Violation|2|||
161394779|NCT01778049|582831422|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161394780|NCT01778049|582831423|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161394781|NCT01778049|582831424|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161394782|NCT01778049|582831419|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161394783|NCT01778049|582831420|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161394784|NCT01778049|582831421|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
161394785|NCT01778049|582831422|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
161394786|NCT01778049|582831423|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
161394787|NCT01778049|582831424|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
161394788|NCT01778049|582831419|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161394789|NCT01778049|582831420|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161394790|NCT01778049|582831421|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
161394791|NCT01778049|582831422|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
161394792|NCT01778049|582831423|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161394793|NCT01778049|582831424|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
161394794|NCT01778049|582831419|FG000|Double Blind Treatment Period|Not treated|0|||
161394795|NCT01778049|582831420|FG001|Double Blind Treatment Period|Not treated|0|||
161394796|NCT01778049|582831421|FG002|Double Blind Treatment Period|Not treated|0|||
161394797|NCT01778049|582831422|FG003|Double Blind Treatment Period|Not treated|2|||
161394798|NCT01778049|582831423|FG004|Double Blind Treatment Period|Not treated|2|||
161394799|NCT01778049|582831424|FG005|Double Blind Treatment Period|Not treated|0|||
161394800|NCT01778049|582831419|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
161394801|NCT01778049|582831420|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
161394802|NCT01778049|582831421|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
161394803|NCT01778049|582831422|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
161394804|NCT01778049|582831423|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
161394805|NCT01778049|582831424|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
161394806|NCT02186652|582831425|FG000|Overall Study|Lost to Follow-up|2|||
161394807|NCT02186652|582831426|FG001|Overall Study|Lost to Follow-up|0|||
161394808|NCT03770728|582831430|FG000|Overall Study|Adverse Event|1|||
161394809|NCT03770728|582831431|FG001|Overall Study|Adverse Event|0|||
161394810|NCT03770728|582831432|FG002|Overall Study|Adverse Event|1|||
161394811|NCT03770728|582831433|FG003|Overall Study|Adverse Event|0|||
161394812|NCT03770728|582831430|FG000|Overall Study|Poor compliance to protocol|0|||
161394813|NCT03770728|582831431|FG001|Overall Study|Poor compliance to protocol|0|||
161394814|NCT03770728|582831432|FG002|Overall Study|Poor compliance to protocol|1|||
161394815|NCT03770728|582831433|FG003|Overall Study|Poor compliance to protocol|0|||
161394816|NCT03770728|582831430|FG000|Overall Study|Withdrawal by Subject|13|||
161394817|NCT03770728|582831431|FG001|Overall Study|Withdrawal by Subject|8|||
161394818|NCT03770728|582831432|FG002|Overall Study|Withdrawal by Subject|9|||
161394819|NCT03770728|582831433|FG003|Overall Study|Withdrawal by Subject|13|||
161394820|NCT03770728|582831430|FG000|Overall Study|Other than specified|24|||
161394821|NCT03770728|582831431|FG001|Overall Study|Other than specified|23|||
161394822|NCT03770728|582831432|FG002|Overall Study|Other than specified|21|||
161394823|NCT03770728|582831433|FG003|Overall Study|Other than specified|22|||
161394824|NCT00503776|582831434|FG000|Overall Study|Withdrawal by Subject|1|||
161394825|NCT00503776|582831435|FG001|Overall Study|Withdrawal by Subject|0|||
161394826|NCT00503776|582831436|FG002|Overall Study|Withdrawal by Subject|1|||
161394827|NCT00503776|582831437|FG003|Overall Study|Withdrawal by Subject|1|||
161394828|NCT00503776|582831434|FG000|Overall Study|Physician Decision|0|||
161394829|NCT00503776|582831435|FG001|Overall Study|Physician Decision|0|||
161394830|NCT00503776|582831436|FG002|Overall Study|Physician Decision|1|||
161394831|NCT00503776|582831437|FG003|Overall Study|Physician Decision|1|||
161394832|NCT02778555|582831438|FG000|Overall Study|Withdrawal by Subject|55|||
161394833|NCT02778555|582831439|FG001|Overall Study|Withdrawal by Subject|32|||
161394834|NCT02778555|582831440|FG002|Overall Study|Withdrawal by Subject|107|||
161394835|NCT02379988|582831441|FG000|Overall Study|Not eligible|1|||
161394836|NCT00107315|582831442|FG000|Overall Study|Disease Progression|9|||
161394837|NCT00107315|582831442|FG000|Overall Study|Adverse Event|4|||
161394838|NCT00107315|582831442|FG000|Overall Study|Withdrawal by Subject|2|||
161394839|NCT03943550|582831451|FG000|Overall Study|Adverse Event|0|||
161394840|NCT03943550|582831452|FG001|Overall Study|Adverse Event|0|||
161394841|NCT03943550|582831453|FG002|Overall Study|Adverse Event|1|||
161394842|NCT03943550|582831451|FG000|Overall Study|Lost to Follow-up|0|||
161394843|NCT03943550|582831452|FG001|Overall Study|Lost to Follow-up|0|||
161394844|NCT03943550|582831453|FG002|Overall Study|Lost to Follow-up|1|||
161394845|NCT03943550|582831451|FG000|Overall Study|Progressive Disease|0|||
161394846|NCT03943550|582831452|FG001|Overall Study|Progressive Disease|0|||
161394847|NCT03943550|582831453|FG002|Overall Study|Progressive Disease|2|||
161394848|NCT03943550|582831451|FG000|Overall Study|Participant Moved Out of the Country|0|||
161394849|NCT03943550|582831452|FG001|Overall Study|Participant Moved Out of the Country|1|||
161394850|NCT03943550|582831453|FG002|Overall Study|Participant Moved Out of the Country|0|||
161394851|NCT03359785|582831454|FG000|Overall Study|Protocol Violation|0|||
161394852|NCT03359785|582831455|FG001|Overall Study|Protocol Violation|1|||
161394853|NCT03359785|582831456|FG002|Overall Study|Protocol Violation|0|||
161394854|NCT03359785|582831457|FG003|Overall Study|Protocol Violation|0|||
161394855|NCT03359785|582831454|FG000|Overall Study|Early study termination due to study pause|0|||
161394856|NCT03359785|582831455|FG001|Overall Study|Early study termination due to study pause|0|||
161394857|NCT03359785|582831456|FG002|Overall Study|Early study termination due to study pause|2|||
161394858|NCT03359785|582831457|FG003|Overall Study|Early study termination due to study pause|0|||
161394859|NCT03359785|582831454|FG000|Overall Study|Withdrawal by Subject|2|||
161394860|NCT03359785|582831455|FG001|Overall Study|Withdrawal by Subject|2|||
161394861|NCT03359785|582831456|FG002|Overall Study|Withdrawal by Subject|0|||
161394862|NCT03359785|582831457|FG003|Overall Study|Withdrawal by Subject|0|||
161394863|NCT01895543|582831458|FG000|Overall Study|Withdrawal by Subject|43|||
161394864|NCT01895543|582831458|FG000|Overall Study|Lost to Follow-up|25|||
161394865|NCT01895543|582831458|FG000|Overall Study|Adverse Event|28|||
161394866|NCT01895543|582831458|FG000|Overall Study|Subject's substantial non-compliance|6|||
161394867|NCT01895543|582831458|FG000|Overall Study|Protocol Violation|1|||
161394868|NCT01895543|582831458|FG000|Overall Study|Physician Decision|2|||
161394869|NCT01895543|582831458|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
161394870|NCT03276026|582831459|FG000|Overall Study|Protocol Violation|1|||
161394871|NCT03276026|582831460|FG001|Overall Study|Protocol Violation|0|||
161394872|NCT00367744|582831461|FG000|Overall Study|Lost to Follow-up|4|||
161394873|NCT00367744|582831462|FG001|Overall Study|Lost to Follow-up|5|||
161394874|NCT03664674|582831464|FG000|Overall Study|Adverse Event|1|||
161394875|NCT03664674|582831465|FG001|Overall Study|Adverse Event|1|||
161394876|NCT03664674|582831464|FG000|Overall Study|Physician Decision|0|||
161394877|NCT03664674|582831465|FG001|Overall Study|Physician Decision|1|||
161394878|NCT03664674|582831464|FG000|Overall Study|Withdrawal by Subject|2|||
161394879|NCT03664674|582831465|FG001|Overall Study|Withdrawal by Subject|0|||
161394880|NCT04584346|582831471|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
161394881|NCT04584346|582831472|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
161394882|NCT04262882|582831475|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
161394883|NCT04262882|582831476|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
161394884|NCT04262882|582831475|FG000|Overall Study|Lost to Follow-up|1|||
161394885|NCT04262882|582831476|FG001|Overall Study|Lost to Follow-up|0|||
161394886|NCT04730635|582831478|FG000|Overall Study|Lost to Follow-up|1|||
161394887|NCT04730635|582831479|FG001|Overall Study|Lost to Follow-up|0|||
161394888|NCT04730635|582831478|FG000|Overall Study|Withdrawal by Subject|0|||
161394889|NCT04730635|582831479|FG001|Overall Study|Withdrawal by Subject|1|||
161394890|NCT03070223|582831480|FG000|Overall Study|Lost to Follow-up|34|||
161394891|NCT03070223|582831481|FG001|Overall Study|Lost to Follow-up|27|||
161394892|NCT03070223|582831480|FG000|Overall Study|Withdrawal by Subject|12|||
161394893|NCT03070223|582831481|FG001|Overall Study|Withdrawal by Subject|22|||
161394894|NCT03070223|582831480|FG000|Overall Study|Protocol Violation|0|||
161394895|NCT03070223|582831481|FG001|Overall Study|Protocol Violation|1|||
161394896|NCT00443053|582831483|FG000|Overall Study|Adverse Event|2|||
161394897|NCT00443053|582831484|FG001|Overall Study|Adverse Event|1|||
161394898|NCT00443053|582831483|FG000|Overall Study|Withdrawal by Subject|9|||
161394899|NCT00443053|582831484|FG001|Overall Study|Withdrawal by Subject|18|||
161394900|NCT00443053|582831483|FG000|Overall Study|Lost to Follow-up|4|||
161394901|NCT00443053|582831484|FG001|Overall Study|Lost to Follow-up|5|||
161394902|NCT00443053|582831483|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161394903|NCT00443053|582831484|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161394904|NCT00443053|582831483|FG000|Overall Study|Noncompliance|2|||
161394905|NCT00443053|582831484|FG001|Overall Study|Noncompliance|1|||
161394906|NCT00443053|582831483|FG000|Overall Study|Other|3|||
161394907|NCT00443053|582831484|FG001|Overall Study|Other|4|||
161394908|NCT00443053|582831483|FG000|Overall Study|Physician Decision|0|||
161394909|NCT00443053|582831484|FG001|Overall Study|Physician Decision|4|||
161394910|NCT00541866|582831485|FG000|Overall Study|Adverse Event|3|||
161394911|NCT00541866|582831486|FG001|Overall Study|Adverse Event|0|||
161394912|NCT00541866|582831487|FG002|Overall Study|Adverse Event|0|||
161394913|NCT00541866|582831488|FG003|Overall Study|Adverse Event|0|||
161394914|NCT00541866|582831489|FG004|Overall Study|Adverse Event|0|||
161394915|NCT00541866|582831485|FG000|Overall Study|Death|1|||
161394916|NCT00541866|582831486|FG001|Overall Study|Death|0|||
161394917|NCT00541866|582831487|FG002|Overall Study|Death|0|||
161394918|NCT00541866|582831488|FG003|Overall Study|Death|0|||
161394919|NCT00541866|582831489|FG004|Overall Study|Death|0|||
161394920|NCT00541866|582831485|FG000|Overall Study|Lack of Efficacy|19|||
161394921|NCT00541866|582831486|FG001|Overall Study|Lack of Efficacy|15|||
161394922|NCT00541866|582831487|FG002|Overall Study|Lack of Efficacy|10|||
161394923|NCT00541866|582831488|FG003|Overall Study|Lack of Efficacy|12|||
161394924|NCT00541866|582831489|FG004|Overall Study|Lack of Efficacy|14|||
161394925|NCT00541866|582831485|FG000|Overall Study|Not Reported or Other|11|||
161394926|NCT00541866|582831486|FG001|Overall Study|Not Reported or Other|3|||
161394927|NCT00541866|582831487|FG002|Overall Study|Not Reported or Other|3|||
161394928|NCT00541866|582831488|FG003|Overall Study|Not Reported or Other|3|||
161394929|NCT00541866|582831489|FG004|Overall Study|Not Reported or Other|1|||
161394930|NCT00541866|582831485|FG000|Overall Study|Physician Decision|0|||
161394931|NCT00541866|582831486|FG001|Overall Study|Physician Decision|0|||
161394932|NCT00541866|582831487|FG002|Overall Study|Physician Decision|2|||
161394933|NCT00541866|582831488|FG003|Overall Study|Physician Decision|1|||
161394934|NCT00541866|582831489|FG004|Overall Study|Physician Decision|0|||
161394935|NCT00522418|582831490|FG000|Overall Study|Local IRB Consent Violation|5|||
161394936|NCT00522418|582831491|FG001|Overall Study|Local IRB Consent Violation|5|||
161394937|NCT00522418|582831490|FG000|Overall Study|Early Study Termination|46|||
161394938|NCT00522418|582831491|FG001|Overall Study|Early Study Termination|47|||
161394939|NCT00522418|582831490|FG000|Overall Study|Noncompliance|2|||
161394940|NCT00522418|582831491|FG001|Overall Study|Noncompliance|2|||
161394941|NCT00522418|582831490|FG000|Overall Study|Reason Not Specified|3|||
161394942|NCT00522418|582831491|FG001|Overall Study|Reason Not Specified|1|||
161394943|NCT00522418|582831490|FG000|Overall Study|Consent Withdraw|1|||
161394944|NCT00522418|582831491|FG001|Overall Study|Consent Withdraw|2|||
161394945|NCT00522418|582831490|FG000|Overall Study|Lack of Efficacy|0|||
161394946|NCT00522418|582831491|FG001|Overall Study|Lack of Efficacy|1|||
161394947|NCT00578877|582831492|FG000|Overall Study|Lost to Follow-up|8|||
161394948|NCT00578877|582831493|FG001|Overall Study|Lost to Follow-up|10|||
161394949|NCT00578877|582831492|FG000|Overall Study|early discontinue|61|||
161394950|NCT00578877|582831493|FG001|Overall Study|early discontinue|101|||
161394951|NCT00578877|582831492|FG000|Overall Study|did not provide follow-up data|12|||
161394952|NCT00578877|582831493|FG001|Overall Study|did not provide follow-up data|17|||
161394953|NCT01202188|582831499|FG000|Overall Study|Protocol deviation|14|||
161394954|NCT01202188|582831500|FG001|Overall Study|Protocol deviation|8|||
161394955|NCT01202188|582831501|FG002|Overall Study|Protocol deviation|12|||
161394956|NCT01202188|582831502|FG003|Overall Study|Protocol deviation|10|||
161394957|NCT01202188|582831503|FG004|Overall Study|Protocol deviation|11|||
161394958|NCT01202188|582831499|FG000|Overall Study|Subject withdrew consent|12|||
161394959|NCT01202188|582831500|FG001|Overall Study|Subject withdrew consent|13|||
161394960|NCT01202188|582831501|FG002|Overall Study|Subject withdrew consent|22|||
161394961|NCT01202188|582831502|FG003|Overall Study|Subject withdrew consent|11|||
161394962|NCT01202188|582831503|FG004|Overall Study|Subject withdrew consent|13|||
161394963|NCT01202188|582831499|FG000|Overall Study|Adverse Event|5|||
161394964|NCT01202188|582831500|FG001|Overall Study|Adverse Event|23|||
161394965|NCT01202188|582831501|FG002|Overall Study|Adverse Event|13|||
161394966|NCT01202188|582831502|FG003|Overall Study|Adverse Event|10|||
161394967|NCT01202188|582831503|FG004|Overall Study|Adverse Event|10|||
161394968|NCT01202188|582831499|FG000|Overall Study|Administrative problems|3|||
161394969|NCT01202188|582831500|FG001|Overall Study|Administrative problems|2|||
161394970|NCT01202188|582831501|FG002|Overall Study|Administrative problems|1|||
161394971|NCT01202188|582831502|FG003|Overall Study|Administrative problems|1|||
161394972|NCT01202188|582831503|FG004|Overall Study|Administrative problems|2|||
161394973|NCT01202188|582831499|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161394974|NCT01202188|582831500|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161394975|NCT01202188|582831501|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161394976|NCT01202188|582831502|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
161394977|NCT01202188|582831503|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
161394978|NCT01202188|582831499|FG000|Overall Study|Lost to Follow-up|1|||
161394979|NCT01202188|582831500|FG001|Overall Study|Lost to Follow-up|1|||
161394980|NCT01202188|582831501|FG002|Overall Study|Lost to Follow-up|0|||
161394981|NCT01202188|582831502|FG003|Overall Study|Lost to Follow-up|4|||
161394982|NCT01202188|582831503|FG004|Overall Study|Lost to Follow-up|1|||
161394983|NCT01202188|582831499|FG000|Overall Study|Death|1|||
161394984|NCT01202188|582831500|FG001|Overall Study|Death|1|||
161394985|NCT01202188|582831501|FG002|Overall Study|Death|1|||
161394986|NCT01202188|582831502|FG003|Overall Study|Death|1|||
161394987|NCT01202188|582831503|FG004|Overall Study|Death|0|||
161394988|NCT01202188|582831499|FG000|Overall Study|Abnormal test procedure result (s)|0|||
161394989|NCT01202188|582831500|FG001|Overall Study|Abnormal test procedure result (s)|0|||
161394990|NCT01202188|582831501|FG002|Overall Study|Abnormal test procedure result (s)|2|||
161394991|NCT01202188|582831502|FG003|Overall Study|Abnormal test procedure result (s)|0|||
161394992|NCT01202188|582831503|FG004|Overall Study|Abnormal test procedure result (s)|0|||
161394993|NCT00642174|582833897|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
161394994|NCT00642174|582833898|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
161394995|NCT01730339|582833899|FG000|Overall Study|Withdrawal by Subject|3|||
161394996|NCT01730339|582833900|FG001|Overall Study|Withdrawal by Subject|2|||
161394997|NCT01730339|582833899|FG000|Overall Study|Lost to Follow-up|1|||
161394998|NCT01730339|582833900|FG001|Overall Study|Lost to Follow-up|1|||
161394999|NCT01730339|582833899|FG000|Overall Study|Un-specified|1|||
161395000|NCT01730339|582833900|FG001|Overall Study|Un-specified|0|||
161395001|NCT00896363|582833901|FG000|Overall Study|Adverse Event|3|||
161395002|NCT00896363|582833902|FG001|Overall Study|Adverse Event|4|||
161395003|NCT00896363|582833903|FG002|Overall Study|Adverse Event|2|||
161395004|NCT00896363|582833901|FG000|Overall Study|Lack of Efficacy|0|||
161395005|NCT00896363|582833902|FG001|Overall Study|Lack of Efficacy|2|||
161395006|NCT00896363|582833903|FG002|Overall Study|Lack of Efficacy|1|||
161395007|NCT00896363|582833901|FG000|Overall Study|Withdrawal by Subject|3|||
161395008|NCT00896363|582833902|FG001|Overall Study|Withdrawal by Subject|5|||
161395009|NCT00896363|582833903|FG002|Overall Study|Withdrawal by Subject|5|||
161395010|NCT03245736|582833904|FG000|Overall Study|Adverse Event|1|||
161395011|NCT03245736|582833904|FG000|Overall Study|Progressive Disease|4|||
161395012|NCT02251717|582833912|FG000|Overall Study|Adverse Event|0|||
161395013|NCT02251717|582833913|FG001|Overall Study|Adverse Event|1|||
161395014|NCT02251717|582833912|FG000|Overall Study|Withdrew Consent|1|||
161395015|NCT02251717|582833913|FG001|Overall Study|Withdrew Consent|0|||
161395016|NCT04098367|582833914|FG000|Overall Study|Adverse Event|0|||
161395017|NCT04098367|582833915|FG001|Overall Study|Adverse Event|0|||
161395018|NCT04098367|582833916|FG002|Overall Study|Adverse Event|1|||
161395019|NCT04098367|582833914|FG000|Overall Study|Lost to Follow-up|1|||
161395020|NCT04098367|582833915|FG001|Overall Study|Lost to Follow-up|5|||
161395021|NCT04098367|582833916|FG002|Overall Study|Lost to Follow-up|2|||
161395022|NCT04098367|582833914|FG000|Overall Study|Withdrawal by Subject|0|||
161395023|NCT04098367|582833915|FG001|Overall Study|Withdrawal by Subject|0|||
161395024|NCT04098367|582833916|FG002|Overall Study|Withdrawal by Subject|1|||
161395025|NCT04098367|582833914|FG000|Overall Study|Sick . Could not attend visit|1|||
161395026|NCT04098367|582833915|FG001|Overall Study|Sick . Could not attend visit|0|||
161395027|NCT04098367|582833916|FG002|Overall Study|Sick . Could not attend visit|0|||
161395028|NCT00445939|582833920|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
161395029|NCT00445939|582833921|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
161395030|NCT00445939|582833922|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
161395031|NCT00445939|582833923|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
161395032|NCT00445939|582833920|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
161395033|NCT00445939|582833921|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
161395034|NCT00445939|582833922|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
161395035|NCT00445939|582833923|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
161395036|NCT00416715|582833924|FG000|Overall Study|Not evaluable for joint aches|7|||
161395037|NCT00416715|582833924|FG000|Overall Study|Vitamin D levels not evaluable|8|||
161395038|NCT01007435|582833937|FG000|Overall Study|Adverse Event|16|||
161395039|NCT01007435|582833938|FG001|Overall Study|Adverse Event|25|||
161395040|NCT01007435|582833939|FG002|Overall Study|Adverse Event|47|||
161395041|NCT01007435|582833940|FG003|Overall Study|Adverse Event|31|||
161395042|NCT01007435|582833937|FG000|Overall Study|Death|2|||
161395043|NCT01007435|582833938|FG001|Overall Study|Death|4|||
161395044|NCT01007435|582833939|FG002|Overall Study|Death|2|||
161395045|NCT01007435|582833940|FG003|Overall Study|Death|1|||
161395046|NCT01007435|582833937|FG000|Overall Study|Insufficient Therapeutic Response|21|||
161395047|NCT01007435|582833938|FG001|Overall Study|Insufficient Therapeutic Response|7|||
161395048|NCT01007435|582833939|FG002|Overall Study|Insufficient Therapeutic Response|2|||
161395049|NCT01007435|582833940|FG003|Overall Study|Insufficient Therapeutic Response|9|||
161395050|NCT01007435|582833937|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
161395051|NCT01007435|582833938|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
161395052|NCT01007435|582833939|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
161395053|NCT01007435|582833940|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
161395054|NCT01007435|582833937|FG000|Overall Study|Other Protocol Violation|2|||
161395055|NCT01007435|582833938|FG001|Overall Study|Other Protocol Violation|0|||
161395056|NCT01007435|582833939|FG002|Overall Study|Other Protocol Violation|1|||
161395057|NCT01007435|582833940|FG003|Overall Study|Other Protocol Violation|0|||
161395058|NCT01007435|582833937|FG000|Overall Study|Refused Treatment|13|||
161395059|NCT01007435|582833938|FG001|Overall Study|Refused Treatment|13|||
161395060|NCT01007435|582833939|FG002|Overall Study|Refused Treatment|5|||
161395061|NCT01007435|582833940|FG003|Overall Study|Refused Treatment|8|||
161395062|NCT01007435|582833937|FG000|Overall Study|Failure to Return|5|||
161395063|NCT01007435|582833938|FG001|Overall Study|Failure to Return|4|||
161395064|NCT01007435|582833939|FG002|Overall Study|Failure to Return|3|||
161395065|NCT01007435|582833940|FG003|Overall Study|Failure to Return|6|||
161395066|NCT01007435|582833937|FG000|Overall Study|Reason not Specified|1|||
161395067|NCT01007435|582833938|FG001|Overall Study|Reason not Specified|1|||
161395068|NCT01007435|582833939|FG002|Overall Study|Reason not Specified|2|||
161395069|NCT01007435|582833940|FG003|Overall Study|Reason not Specified|1|||
161395070|NCT02576535|582833941|FG000|Overall Study|Withdrawal by Subject|2|||
161395071|NCT02545517|582833942|FG000|Overall Study|Death|2|||
161395072|NCT02545517|582833943|FG001|Overall Study|Death|2|||
161395073|NCT02545517|582833944|FG002|Overall Study|Death|1|||
161395074|NCT02545517|582833942|FG000|Overall Study|Lost to Follow-up|14|||
161395075|NCT02545517|582833943|FG001|Overall Study|Lost to Follow-up|13|||
161395076|NCT02545517|582833944|FG002|Overall Study|Lost to Follow-up|17|||
161395077|NCT02545517|582833942|FG000|Overall Study|Protocol Violation|0|||
161395078|NCT02545517|582833943|FG001|Overall Study|Protocol Violation|1|||
161395079|NCT02545517|582833944|FG002|Overall Study|Protocol Violation|1|||
161395080|NCT02545517|582833942|FG000|Overall Study|Withdrawal by Subject|5|||
161395081|NCT02545517|582833943|FG001|Overall Study|Withdrawal by Subject|8|||
161395082|NCT02545517|582833944|FG002|Overall Study|Withdrawal by Subject|9|||
161395083|NCT02545517|582833942|FG000|Overall Study|Administrative reason|5|||
161395084|NCT02545517|582833943|FG001|Overall Study|Administrative reason|6|||
161395085|NCT02545517|582833944|FG002|Overall Study|Administrative reason|10|||
161395086|NCT02545517|582833942|FG000|Overall Study|Other|2|||
161395087|NCT02545517|582833943|FG001|Overall Study|Other|4|||
161395088|NCT02545517|582833944|FG002|Overall Study|Other|3|||
161395089|NCT03334851|582833945|FG000|Overall Study|Other|0|||
161395090|NCT03334851|582833946|FG001|Overall Study|Other|0|||
161395091|NCT03334851|582833947|FG002|Overall Study|Other|0|||
161395092|NCT03334851|582833948|FG003|Overall Study|Other|0|||
161395093|NCT03334851|582833949|FG004|Overall Study|Other|0|||
161395094|NCT03334851|582833950|FG005|Overall Study|Other|0|||
161395095|NCT03334851|582833951|FG006|Overall Study|Other|0|||
161395096|NCT03334851|582833952|FG007|Overall Study|Other|1|||
161395097|NCT03334851|582833953|FG008|Overall Study|Other|0|||
161395098|NCT03334851|582833954|FG009|Overall Study|Other|0|||
161395099|NCT03334851|582833955|FG010|Overall Study|Other|0|||
161395100|NCT03334851|582833956|FG011|Overall Study|Other|0|||
161395101|NCT03334851|582833957|FG012|Overall Study|Other|0|||
161395102|NCT03334851|582833945|FG000|Overall Study|Adverse Event|0|||
161395103|NCT03334851|582833946|FG001|Overall Study|Adverse Event|0|||
161395104|NCT03334851|582833947|FG002|Overall Study|Adverse Event|0|||
161395105|NCT03334851|582833948|FG003|Overall Study|Adverse Event|0|||
161395106|NCT03334851|582833949|FG004|Overall Study|Adverse Event|0|||
161395107|NCT03334851|582833950|FG005|Overall Study|Adverse Event|0|||
161395108|NCT03334851|582833951|FG006|Overall Study|Adverse Event|0|||
161395109|NCT03334851|582833952|FG007|Overall Study|Adverse Event|1|||
161395110|NCT03334851|582833953|FG008|Overall Study|Adverse Event|0|||
161395111|NCT03334851|582833954|FG009|Overall Study|Adverse Event|0|||
161395112|NCT03334851|582833955|FG010|Overall Study|Adverse Event|0|||
161395113|NCT03334851|582833956|FG011|Overall Study|Adverse Event|0|||
161395114|NCT03334851|582833957|FG012|Overall Study|Adverse Event|0|||
161395115|NCT03334851|582833945|FG000|Overall Study|Withdrawal by Subject|0|||
161395116|NCT03334851|582833946|FG001|Overall Study|Withdrawal by Subject|0|||
161395117|NCT03334851|582833947|FG002|Overall Study|Withdrawal by Subject|0|||
161395118|NCT03334851|582833948|FG003|Overall Study|Withdrawal by Subject|0|||
161395119|NCT03334851|582833949|FG004|Overall Study|Withdrawal by Subject|0|||
161395120|NCT03334851|582833950|FG005|Overall Study|Withdrawal by Subject|0|||
161395121|NCT03334851|582833951|FG006|Overall Study|Withdrawal by Subject|0|||
161395122|NCT03334851|582833952|FG007|Overall Study|Withdrawal by Subject|0|||
161395123|NCT03334851|582833953|FG008|Overall Study|Withdrawal by Subject|0|||
161395124|NCT03334851|582833954|FG009|Overall Study|Withdrawal by Subject|0|||
161395125|NCT03334851|582833955|FG010|Overall Study|Withdrawal by Subject|1|||
161395126|NCT03334851|582833956|FG011|Overall Study|Withdrawal by Subject|0|||
161395127|NCT03334851|582833957|FG012|Overall Study|Withdrawal by Subject|1|||
161395128|NCT03334851|582833945|FG000|Overall Study|Lost to Follow-up|0|||
161395129|NCT03334851|582833946|FG001|Overall Study|Lost to Follow-up|0|||
161395130|NCT03334851|582833947|FG002|Overall Study|Lost to Follow-up|0|||
161395131|NCT03334851|582833948|FG003|Overall Study|Lost to Follow-up|0|||
161395132|NCT03334851|582833949|FG004|Overall Study|Lost to Follow-up|0|||
161395133|NCT03334851|582833950|FG005|Overall Study|Lost to Follow-up|0|||
161395134|NCT03334851|582833951|FG006|Overall Study|Lost to Follow-up|0|||
161395135|NCT03334851|582833952|FG007|Overall Study|Lost to Follow-up|0|||
161395136|NCT03334851|582833953|FG008|Overall Study|Lost to Follow-up|0|||
161395137|NCT03334851|582833954|FG009|Overall Study|Lost to Follow-up|0|||
161395138|NCT03334851|582833955|FG010|Overall Study|Lost to Follow-up|2|||
161395139|NCT03334851|582833956|FG011|Overall Study|Lost to Follow-up|1|||
161395140|NCT03334851|582833957|FG012|Overall Study|Lost to Follow-up|0|||
161395141|NCT00521599|582833960|FG000|Overall Study|Adverse Event|5|||
161395142|NCT00521599|582833961|FG001|Overall Study|Adverse Event|7|||
161395143|NCT00521599|582833962|FG002|Overall Study|Adverse Event|6|||
161395144|NCT00521599|582833960|FG000|Overall Study|Treatment Failure|8|||
161395145|NCT00521599|582833961|FG001|Overall Study|Treatment Failure|9|||
161395146|NCT00521599|582833962|FG002|Overall Study|Treatment Failure|22|||
161395147|NCT00521599|582833960|FG000|Overall Study|Lost to Follow-up|2|||
161395148|NCT00521599|582833961|FG001|Overall Study|Lost to Follow-up|1|||
161395149|NCT00521599|582833962|FG002|Overall Study|Lost to Follow-up|2|||
161395150|NCT00521599|582833960|FG000|Overall Study|Withdrawal by Subject|3|||
161395151|NCT00521599|582833961|FG001|Overall Study|Withdrawal by Subject|5|||
161395152|NCT00521599|582833962|FG002|Overall Study|Withdrawal by Subject|1|||
161395153|NCT00521599|582833960|FG000|Overall Study|Withdrawal by subject treatment related|3|||
161395154|NCT00521599|582833961|FG001|Overall Study|Withdrawal by subject treatment related|1|||
161395155|NCT00521599|582833962|FG002|Overall Study|Withdrawal by subject treatment related|2|||
161395156|NCT00521599|582833960|FG000|Overall Study|Protocol Violation|2|||
161395157|NCT00521599|582833961|FG001|Overall Study|Protocol Violation|4|||
161395158|NCT00521599|582833962|FG002|Overall Study|Protocol Violation|2|||
161395159|NCT00521599|582833960|FG000|Overall Study|Did not meet protocol eligibility|2|||
161395160|NCT00521599|582833961|FG001|Overall Study|Did not meet protocol eligibility|2|||
161395161|NCT00521599|582833962|FG002|Overall Study|Did not meet protocol eligibility|1|||
161395162|NCT00791479|582833963|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161395163|NCT00791479|582833964|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161395164|NCT00791479|582833965|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161395165|NCT00791479|582833966|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161395166|NCT00791479|582833967|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
161395167|NCT00791479|582833968|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161395168|NCT00791479|582833963|FG000|Overall Study|Adverse Event|0|||
161395169|NCT00791479|582833964|FG001|Overall Study|Adverse Event|1|||
161395170|NCT00791479|582833965|FG002|Overall Study|Adverse Event|0|||
161395171|NCT00791479|582833966|FG003|Overall Study|Adverse Event|2|||
161395172|NCT00791479|582833967|FG004|Overall Study|Adverse Event|0|||
161395173|NCT00791479|582833968|FG005|Overall Study|Adverse Event|1|||
161395174|NCT00791479|582833963|FG000|Overall Study|Lost to Follow-up|0|||
161395175|NCT00791479|582833964|FG001|Overall Study|Lost to Follow-up|1|||
161395176|NCT00791479|582833965|FG002|Overall Study|Lost to Follow-up|0|||
161395177|NCT00791479|582833966|FG003|Overall Study|Lost to Follow-up|0|||
161395178|NCT00791479|582833967|FG004|Overall Study|Lost to Follow-up|0|||
161395179|NCT00791479|582833968|FG005|Overall Study|Lost to Follow-up|1|||
161395180|NCT00791479|582833963|FG000|Overall Study|Protocol Violation|2|||
161395181|NCT00791479|582833964|FG001|Overall Study|Protocol Violation|1|||
161395182|NCT00791479|582833965|FG002|Overall Study|Protocol Violation|0|||
161395183|NCT00791479|582833966|FG003|Overall Study|Protocol Violation|1|||
161395184|NCT00791479|582833967|FG004|Overall Study|Protocol Violation|0|||
161395185|NCT00791479|582833968|FG005|Overall Study|Protocol Violation|0|||
161395186|NCT00791479|582833963|FG000|Overall Study|Withdrawal by Subject|0|||
161395187|NCT00791479|582833964|FG001|Overall Study|Withdrawal by Subject|0|||
161395188|NCT00791479|582833965|FG002|Overall Study|Withdrawal by Subject|0|||
161395189|NCT00791479|582833966|FG003|Overall Study|Withdrawal by Subject|1|||
161395190|NCT00791479|582833967|FG004|Overall Study|Withdrawal by Subject|0|||
161395191|NCT00791479|582833968|FG005|Overall Study|Withdrawal by Subject|1|||
161395192|NCT00496197|582833969|FG000|Overall Study|Discontinued study due to death|43|||
161395193|NCT00496197|582833969|FG000|Overall Study|Adverse Event|13|||
161395194|NCT00496197|582833969|FG000|Overall Study|Does not meet entrance criteria|5|||
161395195|NCT00496197|582833969|FG000|Overall Study|Insufficient clinical response|3|||
161395196|NCT00496197|582833969|FG000|Overall Study|Insufficient bacteriological response|10|||
161395197|NCT00496197|582833969|FG000|Overall Study|Lost to Follow-up|11|||
161395198|NCT00496197|582833969|FG000|Overall Study|Withdrawal by Subject|11|||
161395199|NCT00496197|582833969|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
161395200|NCT00496197|582833969|FG000|Overall Study|Other|14|||
161395201|NCT00496197|582833969|FG000|Overall Study|Protocol Violation|8|||
161395202|NCT00149994|582833970|FG000|Overall Study|Administrative problems:|1|||
161395203|NCT00149994|582833971|FG001|Overall Study|Administrative problems:|0|||
161395204|NCT00149994|582833970|FG000|Overall Study|Protocol Violation|0|||
161395205|NCT00149994|582833971|FG001|Overall Study|Protocol Violation|1|||
161395206|NCT01610713|582833972|FG000|Overall Study|Adverse Event|3|||
161395207|NCT01610713|582833973|FG001|Overall Study|Adverse Event|0|||
161395208|NCT01610713|582833972|FG000|Overall Study|Lack of Efficacy|1|||
161395209|NCT01610713|582833973|FG001|Overall Study|Lack of Efficacy|0|||
161395210|NCT01610713|582833972|FG000|Overall Study|low mood and poor motivation|1|||
161395211|NCT01610713|582833973|FG001|Overall Study|low mood and poor motivation|0|||
161395212|NCT01610713|582833972|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
161395213|NCT01610713|582833973|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
161395214|NCT01610713|582833972|FG000|Overall Study|Lost to Follow-up|0|||
161395215|NCT01610713|582833973|FG001|Overall Study|Lost to Follow-up|1|||
161395216|NCT02509039|582833978|FG000|Overall Study|Adverse Event|0|||
161395217|NCT02509039|582833979|FG001|Overall Study|Adverse Event|1|||
161395218|NCT02509039|582833980|FG002|Overall Study|Adverse Event|1|||
161395219|NCT02509039|582833981|FG003|Overall Study|Adverse Event|1|||
161395220|NCT02509039|582833978|FG000|Overall Study|Withdrawal by Subject|0|||
161395221|NCT02509039|582833979|FG001|Overall Study|Withdrawal by Subject|0|||
161395222|NCT02509039|582833980|FG002|Overall Study|Withdrawal by Subject|1|||
161395223|NCT02509039|582833981|FG003|Overall Study|Withdrawal by Subject|0|||
161395224|NCT02509039|582833978|FG000|Overall Study|Progressive disease|2|||
161395225|NCT02509039|582833979|FG001|Overall Study|Progressive disease|2|||
161395226|NCT02509039|582833980|FG002|Overall Study|Progressive disease|1|||
161395227|NCT02509039|582833981|FG003|Overall Study|Progressive disease|5|||
161395228|NCT02509039|582833978|FG000|Overall Study|Study terminated by Sponsor|1|||
161395229|NCT02509039|582833979|FG001|Overall Study|Study terminated by Sponsor|0|||
161395230|NCT02509039|582833980|FG002|Overall Study|Study terminated by Sponsor|0|||
161395231|NCT02509039|582833981|FG003|Overall Study|Study terminated by Sponsor|0|||
161395232|NCT03650803|582833987|FG000|Overall Study|Lost to Follow-up|6|||
161395233|NCT06107803|582833993|FG000|Overall Study|Adverse Event|1|||
161395234|NCT06107803|582833993|FG000|Overall Study|Withdrawal by Subject|2|||
161395235|NCT06107803|582833993|FG000|Overall Study|Protocol Violation|1|||
161395236|NCT04173260|582833994|FG000|Overall Study|Early termination|4|||
161395237|NCT02308163|582833997|FG000|Overall Study|Not fulfill eligible criteria|1|||
161395238|NCT02308163|582833998|FG001|Overall Study|Not fulfill eligible criteria|2|||
161395239|NCT02308163|582833999|FG002|Overall Study|Not fulfill eligible criteria|0|||
161395240|NCT02308163|582834000|FG003|Overall Study|Not fulfill eligible criteria|1|||
161395241|NCT02308163|582834001|FG004|Overall Study|Not fulfill eligible criteria|1|||
161395242|NCT02308163|582833997|FG000|Overall Study|Adverse Event|9|||
161395243|NCT02308163|582833998|FG001|Overall Study|Adverse Event|5|||
161395244|NCT02308163|582833999|FG002|Overall Study|Adverse Event|2|||
161395245|NCT02308163|582834000|FG003|Overall Study|Adverse Event|2|||
161395246|NCT02308163|582834001|FG004|Overall Study|Adverse Event|11|||
161395247|NCT02308163|582833997|FG000|Overall Study|Lack of Efficacy|11|||
161395248|NCT02308163|582833998|FG001|Overall Study|Lack of Efficacy|3|||
161395249|NCT02308163|582833999|FG002|Overall Study|Lack of Efficacy|8|||
161395250|NCT02308163|582834000|FG003|Overall Study|Lack of Efficacy|4|||
161395251|NCT02308163|582834001|FG004|Overall Study|Lack of Efficacy|6|||
161395252|NCT02308163|582833997|FG000|Overall Study|Withdrawal of consent|2|||
161395253|NCT02308163|582833998|FG001|Overall Study|Withdrawal of consent|3|||
161395254|NCT02308163|582833999|FG002|Overall Study|Withdrawal of consent|0|||
161395255|NCT02308163|582834000|FG003|Overall Study|Withdrawal of consent|2|||
161395256|NCT02308163|582834001|FG004|Overall Study|Withdrawal of consent|6|||
161395257|NCT02308163|582833997|FG000|Overall Study|Protocol Violation|3|||
161395258|NCT02308163|582833998|FG001|Overall Study|Protocol Violation|3|||
161395259|NCT02308163|582833999|FG002|Overall Study|Protocol Violation|3|||
161395260|NCT02308163|582834000|FG003|Overall Study|Protocol Violation|2|||
161395261|NCT02308163|582834001|FG004|Overall Study|Protocol Violation|5|||
161395262|NCT02308163|582833997|FG000|Overall Study|Lab data met discontinuation criteria|3|||
161395263|NCT02308163|582833998|FG001|Overall Study|Lab data met discontinuation criteria|0|||
161395264|NCT02308163|582833999|FG002|Overall Study|Lab data met discontinuation criteria|0|||
161395265|NCT02308163|582834000|FG003|Overall Study|Lab data met discontinuation criteria|2|||
161395266|NCT02308163|582834001|FG004|Overall Study|Lab data met discontinuation criteria|0|||
161395267|NCT02308163|582833997|FG000|Overall Study|Miscellaneous|2|||
161395268|NCT02308163|582833998|FG001|Overall Study|Miscellaneous|2|||
161395269|NCT02308163|582833999|FG002|Overall Study|Miscellaneous|1|||
161395270|NCT02308163|582834000|FG003|Overall Study|Miscellaneous|0|||
161395271|NCT02308163|582834001|FG004|Overall Study|Miscellaneous|5|||
161395272|NCT03006458|582834006|FG000|First Intervention|Unsatisfied Vision|0|||
161395273|NCT03006458|582834007|FG001|First Intervention|Unsatisfied Vision|3|||
161395274|NCT00118846|582834009|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
161395275|NCT00118846|582834010|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
161395276|NCT00118846|582834009|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
161395277|NCT00118846|582834010|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
161395278|NCT00118846|582834009|FG000|Overall Study|Physician Decision|1|||
161395279|NCT00118846|582834010|FG001|Overall Study|Physician Decision|0|||
161395280|NCT00118846|582834009|FG000|Overall Study|Medical condition|2|||
161395281|NCT00118846|582834010|FG001|Overall Study|Medical condition|2|||
161395282|NCT00118846|582834009|FG000|Overall Study|Lost to Follow-up|0|||
161395283|NCT00118846|582834010|FG001|Overall Study|Lost to Follow-up|2|||
161395284|NCT00118846|582834009|FG000|Overall Study|Personal reason|4|||
161395285|NCT00118846|582834010|FG001|Overall Study|Personal reason|5|||
161395286|NCT01468233|582834013|FG000|Treatment Period 1|Adverse Event|5|||
161395287|NCT01468233|582834014|FG001|Treatment Period 1|Adverse Event|3|||
161395288|NCT01468233|582834015|FG002|Treatment Period 1|Adverse Event|0|||
161395289|NCT01468233|582834016|FG003|Treatment Period 1|Adverse Event|0|||
161395290|NCT01468233|582834017|FG004|Treatment Period 1|Adverse Event|0|||
161395291|NCT01468233|582834018|FG005|Treatment Period 1|Adverse Event|0|||
161395292|NCT01468233|582834013|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161395293|NCT01468233|582834014|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161395294|NCT01468233|582834015|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161395295|NCT01468233|582834016|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161395296|NCT01468233|582834017|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161395297|NCT01468233|582834018|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161395298|NCT01468233|582834013|FG000|Treatment Period 1|Lost to Follow-up|3|||
161395299|NCT01468233|582834014|FG001|Treatment Period 1|Lost to Follow-up|0|||
161395300|NCT01468233|582834015|FG002|Treatment Period 1|Lost to Follow-up|0|||
161395301|NCT01468233|582834016|FG003|Treatment Period 1|Lost to Follow-up|0|||
161395302|NCT01468233|582834017|FG004|Treatment Period 1|Lost to Follow-up|0|||
161395303|NCT01468233|582834018|FG005|Treatment Period 1|Lost to Follow-up|0|||
161395304|NCT01468233|582834013|FG000|Treatment Period 1|Other|1|||
161395305|NCT01468233|582834014|FG001|Treatment Period 1|Other|1|||
161395306|NCT01468233|582834015|FG002|Treatment Period 1|Other|0|||
161395307|NCT01468233|582834016|FG003|Treatment Period 1|Other|0|||
161395308|NCT01468233|582834017|FG004|Treatment Period 1|Other|0|||
161395309|NCT01468233|582834018|FG005|Treatment Period 1|Other|0|||
161395310|NCT01468233|582834013|FG000|Treatment Period 2|Adverse Event|0|||
161395311|NCT01468233|582834014|FG001|Treatment Period 2|Adverse Event|0|||
161395312|NCT01468233|582834015|FG002|Treatment Period 2|Adverse Event|3|||
161395313|NCT01468233|582834016|FG003|Treatment Period 2|Adverse Event|0|||
161395314|NCT01468233|582834017|FG004|Treatment Period 2|Adverse Event|2|||
161395315|NCT01468233|582834018|FG005|Treatment Period 2|Adverse Event|1|||
161395316|NCT01468233|582834013|FG000|Treatment Period 2|Lack of Efficacy|0|||
161395317|NCT01468233|582834014|FG001|Treatment Period 2|Lack of Efficacy|0|||
161395318|NCT01468233|582834015|FG002|Treatment Period 2|Lack of Efficacy|9|||
161395319|NCT01468233|582834016|FG003|Treatment Period 2|Lack of Efficacy|2|||
161395320|NCT01468233|582834017|FG004|Treatment Period 2|Lack of Efficacy|0|||
161395321|NCT01468233|582834018|FG005|Treatment Period 2|Lack of Efficacy|1|||
161395322|NCT01468233|582834013|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161395323|NCT01468233|582834014|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161395324|NCT01468233|582834015|FG002|Treatment Period 2|Withdrawal by Subject|9|||
161395325|NCT01468233|582834016|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161395326|NCT01468233|582834017|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161395327|NCT01468233|582834018|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161395328|NCT01468233|582834013|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
161395329|NCT01468233|582834014|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
161395330|NCT01468233|582834015|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
161395331|NCT01468233|582834016|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
161395332|NCT01468233|582834017|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
161395333|NCT01468233|582834018|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
161395334|NCT01468233|582834013|FG000|Treatment Period 2|Lost to Follow-up|0|||
161395335|NCT01468233|582834014|FG001|Treatment Period 2|Lost to Follow-up|0|||
161395336|NCT01468233|582834015|FG002|Treatment Period 2|Lost to Follow-up|3|||
161395337|NCT01468233|582834016|FG003|Treatment Period 2|Lost to Follow-up|0|||
161395338|NCT01468233|582834017|FG004|Treatment Period 2|Lost to Follow-up|2|||
161395339|NCT01468233|582834018|FG005|Treatment Period 2|Lost to Follow-up|0|||
161395340|NCT01468233|582834013|FG000|Treatment Period 2|Other|0|||
161395341|NCT01468233|582834014|FG001|Treatment Period 2|Other|0|||
161395342|NCT01468233|582834015|FG002|Treatment Period 2|Other|3|||
161395343|NCT01468233|582834016|FG003|Treatment Period 2|Other|0|||
161395344|NCT01468233|582834017|FG004|Treatment Period 2|Other|1|||
161395345|NCT01468233|582834018|FG005|Treatment Period 2|Other|0|||
161395346|NCT01574157|582834019|FG000|Overall Study|Withdrawal by Subject|4|||
161395347|NCT01574157|582834020|FG001|Overall Study|Withdrawal by Subject|5|||
161395348|NCT01574157|582834019|FG000|Overall Study|Lost to Follow-up|0|||
161395349|NCT01574157|582834020|FG001|Overall Study|Lost to Follow-up|3|||
161395350|NCT01944098|582834024|FG000|Overall Study|Physician Decision|1|||
161395351|NCT01944098|582834025|FG001|Overall Study|Physician Decision|0|||
161395352|NCT02136680|582834026|FG000|Overall Study|No Longer Interested|1|||
161395353|NCT02136680|582834027|FG001|Overall Study|No Longer Interested|1|||
161395354|NCT02136680|582834026|FG000|Overall Study|No longer receiving care at clinic|3|||
161395355|NCT02136680|582834027|FG001|Overall Study|No longer receiving care at clinic|5|||
161395356|NCT02136680|582834026|FG000|Overall Study|Moved away|5|||
161395357|NCT02136680|582834027|FG001|Overall Study|Moved away|4|||
161395358|NCT02136680|582834026|FG000|Overall Study|Unable to schedule|17|||
161395359|NCT02136680|582834027|FG001|Overall Study|Unable to schedule|16|||
161395360|NCT02136680|582834026|FG000|Overall Study|Study ended before interview due|6|||
161395361|NCT02136680|582834027|FG001|Overall Study|Study ended before interview due|3|||
161395362|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
161395363|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
161395364|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
161395365|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
161395366|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
161395367|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
161395368|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
161395369|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
161395370|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
161395371|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
161395372|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
161395373|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
161395374|NCT01632241|582834028|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
161395375|NCT01632241|582834029|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
161395376|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
161395377|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
161395378|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
161395379|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
161395380|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
161395381|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
161395382|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
161395383|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
161395384|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
161395385|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
161395386|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
161395387|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
161395388|NCT01632241|582834028|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
161395389|NCT01632241|582834029|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
161395390|NCT03559517|582834035|FG000|Overall Study|Withdrawal by Subject|1|||
161395391|NCT03559517|582834036|FG001|Overall Study|Withdrawal by Subject|0|||
161395392|NCT03559517|582834037|FG002|Overall Study|Withdrawal by Subject|0|||
161395393|NCT01846299|582834038|FG000|Overall Study|Physician Decision|4|||
161395394|NCT01846299|582834039|FG001|Overall Study|Physician Decision|2|||
161395395|NCT01846299|582834038|FG000|Overall Study|Protocol deviation|1|||
161395396|NCT01846299|582834039|FG001|Overall Study|Protocol deviation|0|||
161395397|NCT01846299|582834038|FG000|Overall Study|Death|1|||
161395398|NCT01846299|582834039|FG001|Overall Study|Death|2|||
161395399|NCT01846299|582834038|FG000|Overall Study|Lost to Follow-up|3|||
161395400|NCT01846299|582834039|FG001|Overall Study|Lost to Follow-up|0|||
161395401|NCT01846299|582834038|FG000|Overall Study|Withdrawal by Subject|1|||
161395402|NCT01846299|582834039|FG001|Overall Study|Withdrawal by Subject|6|||
161395403|NCT01846299|582834038|FG000|Overall Study|Adverse Event|2|||
161395404|NCT01846299|582834039|FG001|Overall Study|Adverse Event|0|||
161395405|NCT01330628|582834040|FG000|Overall Study|Death|2|||
161395406|NCT01330628|582834041|FG001|Overall Study|Death|3|||
161395407|NCT01330628|582834040|FG000|Overall Study|Lost to Follow-up|5|||
161395408|NCT01330628|582834041|FG001|Overall Study|Lost to Follow-up|6|||
161395409|NCT01330628|582834040|FG000|Overall Study|Adverse Event|44|||
161395410|NCT01330628|582834041|FG001|Overall Study|Adverse Event|25|||
161395411|NCT01330628|582834040|FG000|Overall Study|Withdrawn|18|||
161395412|NCT01330628|582834041|FG001|Overall Study|Withdrawn|6|||
161395413|NCT01330628|582834040|FG000|Overall Study|Didn't receive study treatment|1|||
161395414|NCT01330628|582834041|FG001|Overall Study|Didn't receive study treatment|0|||
161395415|NCT03761394|582834042|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
161395416|NCT03761394|582834043|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
161395417|NCT03761394|582834044|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
161395418|NCT03761394|582834045|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
161395419|NCT03761394|582834042|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
161395420|NCT03761394|582834043|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
161395421|NCT03761394|582834044|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
161395422|NCT03761394|582834045|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
161395423|NCT03761394|582834042|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
161395424|NCT03761394|582834043|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
161395425|NCT03761394|582834044|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
161395426|NCT03761394|582834045|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
161395427|NCT03761394|582834042|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
161395428|NCT03761394|582834043|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
161395429|NCT03761394|582834044|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
161395430|NCT03761394|582834045|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
161395431|NCT01080768|582834055|FG000|Overall Study|Protocol Deviation|2|||
161395432|NCT01080768|582834056|FG001|Overall Study|Protocol Deviation|1|||
161395433|NCT00580034|582834067|FG000|Overall Study|Toxicity|10|||
161395434|NCT00580034|582834068|FG001|Overall Study|Toxicity|0|||
161395435|NCT01939002|582834069|FG000|Overall Study|Adverse Event|13|||
161395436|NCT01939002|582834070|FG001|Overall Study|Adverse Event|13|||
161395437|NCT01939002|582834069|FG000|Overall Study|Withdrawal by Subject|5|||
161395438|NCT01939002|582834070|FG001|Overall Study|Withdrawal by Subject|3|||
161395439|NCT01939002|582834069|FG000|Overall Study|Other|1|||
161395440|NCT01939002|582834070|FG001|Overall Study|Other|2|||
161395441|NCT00098748|582834074|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
161395442|NCT00098748|582834075|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
161395443|NCT00098748|582834076|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
161395444|NCT00098748|582834074|FG000|Received Study Treatment|Death|2|||
161395445|NCT00098748|582834075|FG001|Received Study Treatment|Death|1|||
161395446|NCT00098748|582834076|FG002|Received Study Treatment|Death|2|||
161395447|NCT00098748|582834074|FG000|Received Study Treatment|Adverse Event|1|||
161395448|NCT00098748|582834075|FG001|Received Study Treatment|Adverse Event|2|||
161395449|NCT00098748|582834076|FG002|Received Study Treatment|Adverse Event|5|||
161395450|NCT00098748|582834074|FG000|Received Study Treatment|Lack of Efficacy|40|||
161395451|NCT00098748|582834075|FG001|Received Study Treatment|Lack of Efficacy|27|||
161395452|NCT00098748|582834076|FG002|Received Study Treatment|Lack of Efficacy|27|||
161395453|NCT00098748|582834074|FG000|Received Study Treatment|Other|2|||
161395454|NCT00098748|582834075|FG001|Received Study Treatment|Other|2|||
161395455|NCT00098748|582834076|FG002|Received Study Treatment|Other|6|||
161395456|NCT00098748|582834074|FG000|Received Study Treatment|Subject defaulted|3|||
161395457|NCT00098748|582834075|FG001|Received Study Treatment|Subject defaulted|4|||
161395458|NCT00098748|582834076|FG002|Received Study Treatment|Subject defaulted|4|||
161395459|NCT00098748|582834074|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
161395460|NCT00098748|582834075|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
161395461|NCT00098748|582834076|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
161395462|NCT00098748|582834074|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
161395463|NCT00098748|582834075|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
161395464|NCT00098748|582834076|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
161395465|NCT00098748|582834074|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
161395466|NCT00098748|582834075|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
161395467|NCT00098748|582834076|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
161395468|NCT00098748|582834074|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
161395469|NCT00098748|582834075|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
161395470|NCT00098748|582834076|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
161395471|NCT00098748|582834074|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
161395472|NCT00098748|582834075|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
161395473|NCT00098748|582834076|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
161395474|NCT03095027|582835831|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
161395475|NCT03095027|582835832|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
161395476|NCT02982018|582835833|FG000|Overall Study|Incorrect Lens Dispensed|1|||
161395477|NCT02982018|582835834|FG001|Overall Study|Incorrect Lens Dispensed|0|||
161395478|NCT02982018|582835833|FG000|Overall Study|Protocol Violation|1|||
161395479|NCT02982018|582835834|FG001|Overall Study|Protocol Violation|1|||
161395480|NCT02982018|582835833|FG000|Overall Study|Adverse Event|1|||
161395481|NCT02982018|582835834|FG001|Overall Study|Adverse Event|1|||
161395482|NCT02982018|582835833|FG000|Overall Study|Lens Discomfort|2|||
161395483|NCT02982018|582835834|FG001|Overall Study|Lens Discomfort|0|||
161395484|NCT02982018|582835833|FG000|Overall Study|Withdrawal by Subject|0|||
161395485|NCT02982018|582835834|FG001|Overall Study|Withdrawal by Subject|1|||
161395486|NCT01942161|582835836|FG000|Overall Study|Adverse Event|1|||
161395487|NCT01942161|582835837|FG001|Overall Study|Adverse Event|2|||
161395488|NCT01942161|582835838|FG002|Overall Study|Adverse Event|5|||
161395489|NCT01942161|582835836|FG000|Overall Study|Physician Decision|3|||
161395490|NCT01942161|582835837|FG001|Overall Study|Physician Decision|1|||
161395491|NCT01942161|582835838|FG002|Overall Study|Physician Decision|0|||
161395492|NCT01942161|582835836|FG000|Overall Study|Protocol Violation|1|||
161395493|NCT01942161|582835837|FG001|Overall Study|Protocol Violation|0|||
161395494|NCT01942161|582835838|FG002|Overall Study|Protocol Violation|0|||
161395495|NCT01942161|582835836|FG000|Overall Study|Withdrawal by Subject|3|||
161395496|NCT01942161|582835837|FG001|Overall Study|Withdrawal by Subject|3|||
161395497|NCT01942161|582835838|FG002|Overall Study|Withdrawal by Subject|1|||
161395498|NCT01257568|582835841|FG000|Overall Study|Lost to Follow-up|2|||
161395499|NCT01257568|582835841|FG000|Overall Study|Withdrawal by Subject|6|||
161395500|NCT01257568|582835841|FG000|Overall Study|Terminated|1|||
161395501|NCT01257568|582835841|FG000|Overall Study|Component Revision|24|||
161395502|NCT00132691|582835843|FG000|Overall Study|Lost to Follow-up|5|||
161395503|NCT00132691|582835844|FG001|Overall Study|Lost to Follow-up|8|||
161395504|NCT00132691|582835843|FG000|Overall Study|Missed 2-year visit|4|||
161395505|NCT00132691|582835844|FG001|Overall Study|Missed 2-year visit|4|||
161395506|NCT00132691|582835843|FG000|Overall Study|Death|2|||
161395507|NCT00132691|582835844|FG001|Overall Study|Death|0|||
161395508|NCT03361189|582835847|FG000|Overall Study|Received heart transplant|1|||
161395509|NCT03361189|582835848|FG001|Overall Study|Received heart transplant|0|||
161395510|NCT03361189|582835847|FG000|Overall Study|Pacemake replacement|0|||
161395511|NCT03361189|582835848|FG001|Overall Study|Pacemake replacement|1|||
161395512|NCT03344549|582835849|FG000|Overall Study|Withdrawal by Subject|3|||
161395513|NCT03344549|582835850|FG001|Overall Study|Withdrawal by Subject|2|||
161395514|NCT03344549|582835849|FG000|Overall Study|Dialysis|2|||
161395515|NCT03344549|582835850|FG001|Overall Study|Dialysis|0|||
161395516|NCT03344549|582835849|FG000|Overall Study|Cancer|1|||
161395517|NCT03344549|582835850|FG001|Overall Study|Cancer|0|||
161395518|NCT03344549|582835849|FG000|Overall Study|Lack of electronic device|1|||
161395519|NCT03344549|582835850|FG001|Overall Study|Lack of electronic device|0|||
161395520|NCT03344549|582835849|FG000|Overall Study|Transportation difficulty|0|||
161395521|NCT03344549|582835850|FG001|Overall Study|Transportation difficulty|13|||
161395522|NCT00113399|582835851|FG000|Overall Study|Death|1|||
161395523|NCT00113399|582835852|FG001|Overall Study|Death|1|||
161395524|NCT00113399|582835851|FG000|Overall Study|Withdrawal by Subject|1|||
161395525|NCT00113399|582835852|FG001|Overall Study|Withdrawal by Subject|2|||
161395526|NCT00113399|582835851|FG000|Overall Study|Complete Response|0|||
161395527|NCT00113399|582835852|FG001|Overall Study|Complete Response|1|||
161395528|NCT00113399|582835851|FG000|Overall Study|Other|0|||
161395529|NCT00113399|582835852|FG001|Overall Study|Other|1|||
161395530|NCT04979897|582835857|FG000|Overall Study|Death|1|||
161395531|NCT04979897|582835858|FG001|Overall Study|Death|8|||
161395532|NCT04979897|582835857|FG000|Overall Study|Lost to Follow-up|111|||
161395533|NCT04979897|582835858|FG001|Overall Study|Lost to Follow-up|56|||
161395534|NCT04979897|582835857|FG000|Overall Study|Withdrawal by Subject|7|||
161395535|NCT04979897|582835858|FG001|Overall Study|Withdrawal by Subject|2|||
161395536|NCT01774097|582835859|FG000|Overall Study|Withdrawal by Subject|1|||
161395537|NCT01774097|582835860|FG001|Overall Study|Withdrawal by Subject|1|||
161395538|NCT01774097|582835859|FG000|Overall Study|Adverse Event|1|||
161395539|NCT01774097|582835860|FG001|Overall Study|Adverse Event|1|||
161395540|NCT00543296|582835861|FG000|Overall Study|Physician Decision|7|||
161395541|NCT00934947|582835864|FG000|Overall Study|Adverse Event|0|||
161395542|NCT00934947|582835865|FG001|Overall Study|Adverse Event|2|||
161395543|NCT04659174|582835870|FG000|Overall Study|Sponsor decision to discontinue study|0|||
161395544|NCT04659174|582835871|FG001|Overall Study|Sponsor decision to discontinue study|2|||
161395545|NCT04659174|582835870|FG000|Overall Study|Lost to Follow-up|9|||
161395546|NCT04659174|582835871|FG001|Overall Study|Lost to Follow-up|11|||
161395547|NCT04659174|582835870|FG000|Overall Study|Adverse Event|8|||
161395548|NCT04659174|582835871|FG001|Overall Study|Adverse Event|5|||
161395549|NCT04659174|582835870|FG000|Overall Study|Withdrawal by Subject|17|||
161395550|NCT04659174|582835871|FG001|Overall Study|Withdrawal by Subject|33|||
161395551|NCT04659174|582835870|FG000|Overall Study|Progressive disease|0|||
161395552|NCT04659174|582835871|FG001|Overall Study|Progressive disease|2|||
161395553|NCT04659174|582835870|FG000|Overall Study|Other reasons|0|||
161395554|NCT04659174|582835871|FG001|Overall Study|Other reasons|2|||
161395555|NCT04659174|582835870|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
161395556|NCT04659174|582835871|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
161395557|NCT04659174|582835870|FG000|Overall Study|Alcohol or illegal drug use|0|||
161395558|NCT04659174|582835871|FG001|Overall Study|Alcohol or illegal drug use|3|||
161395559|NCT04659174|582835870|FG000|Overall Study|Violation of entry criteria|1|||
161395560|NCT04659174|582835871|FG001|Overall Study|Violation of entry criteria|0|||
161395561|NCT04659174|582835870|FG000|Overall Study|Death|0|||
161395562|NCT04659174|582835871|FG001|Overall Study|Death|1|||
161395563|NCT02781792|582835872|FG000|Overall Study|Adverse Event|1|||
161395564|NCT02781792|582835873|FG001|Overall Study|Adverse Event|2|||
161395565|NCT02781792|582835872|FG000|Overall Study|Withdrawal by Subject|3|||
161395566|NCT02781792|582835873|FG001|Overall Study|Withdrawal by Subject|1|||
161395567|NCT02781792|582835872|FG000|Overall Study|Lack of Efficacy|1|||
161395568|NCT02781792|582835873|FG001|Overall Study|Lack of Efficacy|1|||
161395569|NCT02781792|582835872|FG000|Overall Study|Hospice|0|||
161395570|NCT02781792|582835873|FG001|Overall Study|Hospice|1|||
161395571|NCT03447314|582835878|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
161395572|NCT03447314|582835879|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
161395573|NCT03447314|582835880|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
161395574|NCT03447314|582835881|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
161395575|NCT03447314|582835882|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
161395576|NCT03447314|582835883|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
161395577|NCT03447314|582835884|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
161395578|NCT03447314|582835885|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395579|NCT03447314|582835886|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395580|NCT03447314|582835887|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395581|NCT03447314|582835888|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
161395582|NCT03447314|582835889|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
161395583|NCT03447314|582835890|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395584|NCT03447314|582835891|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395585|NCT03447314|582835892|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395586|NCT03447314|582835893|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395587|NCT03447314|582835894|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395588|NCT03447314|582835895|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161395589|NCT03447314|582835878|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161395590|NCT03447314|582835879|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395591|NCT03447314|582835880|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161395592|NCT03447314|582835881|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395593|NCT03447314|582835882|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395594|NCT03447314|582835883|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161395595|NCT03447314|582835884|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161395596|NCT03447314|582835885|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395597|NCT03447314|582835886|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395598|NCT03447314|582835887|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395599|NCT03447314|582835888|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395600|NCT03447314|582835889|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395601|NCT03447314|582835890|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395602|NCT03447314|582835891|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395603|NCT03447314|582835892|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395604|NCT03447314|582835893|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395605|NCT03447314|582835894|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395606|NCT03447314|582835895|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161395607|NCT03447314|582835878|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395608|NCT03447314|582835879|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395609|NCT03447314|582835880|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
161395610|NCT03447314|582835881|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395611|NCT03447314|582835882|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395612|NCT03447314|582835883|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395613|NCT03447314|582835884|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395614|NCT03447314|582835885|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395615|NCT03447314|582835886|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395616|NCT03447314|582835887|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395617|NCT03447314|582835888|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395618|NCT03447314|582835889|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395619|NCT03447314|582835890|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395620|NCT03447314|582835891|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395621|NCT03447314|582835892|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395622|NCT03447314|582835893|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395623|NCT03447314|582835894|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395624|NCT03447314|582835895|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161395625|NCT03447314|582835878|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395626|NCT03447314|582835879|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395627|NCT03447314|582835880|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
161395628|NCT03447314|582835881|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395629|NCT03447314|582835882|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395630|NCT03447314|582835883|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395631|NCT03447314|582835884|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395632|NCT03447314|582835885|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395633|NCT03447314|582835886|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395634|NCT03447314|582835887|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395635|NCT03447314|582835888|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395636|NCT03447314|582835889|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395637|NCT03447314|582835890|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395638|NCT03447314|582835891|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395639|NCT03447314|582835892|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395640|NCT03447314|582835893|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395641|NCT03447314|582835894|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395642|NCT03447314|582835895|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161395643|NCT03447314|582835878|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395644|NCT03447314|582835879|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395645|NCT03447314|582835880|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395646|NCT03447314|582835881|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395647|NCT03447314|582835882|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395648|NCT03447314|582835883|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395649|NCT03447314|582835884|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395650|NCT03447314|582835885|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395651|NCT03447314|582835886|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395652|NCT03447314|582835887|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395653|NCT03447314|582835888|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
161395654|NCT03447314|582835889|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395655|NCT03447314|582835890|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395656|NCT03447314|582835891|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395657|NCT03447314|582835892|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395658|NCT03447314|582835893|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395659|NCT03447314|582835894|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395660|NCT03447314|582835895|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161395661|NCT03447314|582835878|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395662|NCT03447314|582835879|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395663|NCT03447314|582835880|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395664|NCT03447314|582835881|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
161395665|NCT03447314|582835882|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395666|NCT03447314|582835883|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
161395667|NCT03447314|582835884|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395668|NCT03447314|582835885|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395669|NCT03447314|582835886|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395670|NCT03447314|582835887|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395671|NCT03447314|582835888|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395672|NCT03447314|582835889|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395673|NCT03447314|582835890|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395674|NCT03447314|582835891|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395675|NCT03447314|582835892|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395676|NCT03447314|582835893|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395677|NCT03447314|582835894|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395678|NCT03447314|582835895|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161395679|NCT01920568|582835897|FG000|Overall Study|Adverse Event|27|||
161395680|NCT01920568|582835898|FG001|Overall Study|Adverse Event|8|||
161395681|NCT01920568|582835897|FG000|Overall Study|Protocol Violation|5|||
161395682|NCT01920568|582835898|FG001|Overall Study|Protocol Violation|3|||
161395683|NCT01920568|582835897|FG000|Overall Study|Lost to Follow-up|2|||
161395684|NCT01920568|582835898|FG001|Overall Study|Lost to Follow-up|2|||
161395685|NCT01920568|582835897|FG000|Overall Study|Physician Decision|13|||
161395686|NCT01920568|582835898|FG001|Overall Study|Physician Decision|4|||
161395687|NCT01920568|582835897|FG000|Overall Study|Withdrawal by Subject|79|||
161395688|NCT01920568|582835898|FG001|Overall Study|Withdrawal by Subject|55|||
161395689|NCT01920568|582835897|FG000|Overall Study|Death due to disease progression|25|||
161395690|NCT01920568|582835898|FG001|Overall Study|Death due to disease progression|12|||
161395691|NCT04049266|582835902|FG000|Overall Study|Adverse Event|16|||
161395692|NCT04049266|582835903|FG001|Overall Study|Adverse Event|9|||
161395693|NCT04049266|582835902|FG000|Overall Study|Non-compliance with study drug|0|||
161395694|NCT04049266|582835903|FG001|Overall Study|Non-compliance with study drug|3|||
161395695|NCT04049266|582835902|FG000|Overall Study|Withdrawal by Subject|6|||
161395696|NCT04049266|582835903|FG001|Overall Study|Withdrawal by Subject|10|||
161395697|NCT04049266|582835902|FG000|Overall Study|Lost to Follow-up|2|||
161395698|NCT04049266|582835903|FG001|Overall Study|Lost to Follow-up|2|||
161395699|NCT04049266|582835902|FG000|Overall Study|Progressive disease|11|||
161395700|NCT04049266|582835903|FG001|Overall Study|Progressive disease|2|||
161395701|NCT04049266|582835902|FG000|Overall Study|Physician Decision|1|||
161395702|NCT04049266|582835903|FG001|Overall Study|Physician Decision|0|||
161395703|NCT04049266|582835902|FG000|Overall Study|Patient moved out of state|1|||
161395704|NCT04049266|582835903|FG001|Overall Study|Patient moved out of state|0|||
161395705|NCT01703208|582835904|FG000|Overall Study|Death|61|||
161395706|NCT01703208|582835905|FG001|Overall Study|Death|48|||
161395707|NCT01703208|582835904|FG000|Overall Study|Lack of Efficacy|1|||
161395708|NCT01703208|582835905|FG001|Overall Study|Lack of Efficacy|2|||
161395709|NCT01703208|582835904|FG000|Overall Study|Lost to Follow-up|68|||
161395710|NCT01703208|582835905|FG001|Overall Study|Lost to Follow-up|62|||
161395711|NCT01703208|582835904|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161395712|NCT01703208|582835905|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161395713|NCT01703208|582835904|FG000|Overall Study|Excluded Medication|1|||
161395714|NCT01703208|582835905|FG001|Overall Study|Excluded Medication|2|||
161395715|NCT01703208|582835904|FG000|Overall Study|Site Discontinued Study Participation|23|||
161395716|NCT01703208|582835905|FG001|Overall Study|Site Discontinued Study Participation|27|||
161395717|NCT01703208|582835904|FG000|Overall Study|Physician Decision|11|||
161395718|NCT01703208|582835905|FG001|Overall Study|Physician Decision|13|||
161395719|NCT01703208|582835904|FG000|Overall Study|Progressive disease|2|||
161395720|NCT01703208|582835905|FG001|Overall Study|Progressive disease|2|||
161395721|NCT01703208|582835904|FG000|Overall Study|Protocol Violation|1|||
161395722|NCT01703208|582835905|FG001|Overall Study|Protocol Violation|1|||
161395723|NCT01703208|582835904|FG000|Overall Study|Study Terminated by Sponsor|1710|||
161395724|NCT01703208|582835905|FG001|Overall Study|Study Terminated by Sponsor|1716|||
161395725|NCT01703208|582835904|FG000|Overall Study|Withdrawal by Subject|205|||
161395726|NCT01703208|582835905|FG001|Overall Study|Withdrawal by Subject|209|||
161395727|NCT01703208|582835904|FG000|Overall Study|Adverse Event|14|||
161395728|NCT01703208|582835905|FG001|Overall Study|Adverse Event|19|||
161395729|NCT01703208|582835904|FG000|Overall Study|Technical Problems|0|||
161395730|NCT01703208|582835905|FG001|Overall Study|Technical Problems|1|||
161395731|NCT01703208|582835904|FG000|Overall Study|Protocol Deviation|2|||
161395732|NCT01703208|582835905|FG001|Overall Study|Protocol Deviation|0|||
161395733|NCT00252694|582835911|FG000|Overall Study|Withdrawal by Subject|83|||
161395734|NCT00252694|582835912|FG001|Overall Study|Withdrawal by Subject|91|||
161395735|NCT00252694|582835911|FG000|Overall Study|Death|36|||
161395736|NCT00252694|582835912|FG001|Overall Study|Death|34|||
161395737|NCT00252694|582835911|FG000|Overall Study|Mostly Lost to Follow Up|8|||
161395738|NCT00252694|582835912|FG001|Overall Study|Mostly Lost to Follow Up|13|||
161395739|NCT00252694|582835911|FG000|Overall Study|Patient Moving|17|||
161395740|NCT00252694|582835912|FG001|Overall Study|Patient Moving|16|||
161395741|NCT00096226|582835914|FG000|Overall Study|Ineligible|2|||
161395742|NCT00096226|582835914|FG000|Overall Study|Protocol treatment not started|1|||
161395743|NCT02378298|582835917|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
161395744|NCT02378298|582835918|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
161395745|NCT02378298|582835919|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
161395746|NCT02378298|582835917|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
161395747|NCT02378298|582835918|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
161395748|NCT02378298|582835919|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
161395749|NCT02378298|582835917|FG000|Surveillance (19-68 Weeks)|Death|1|||
161395750|NCT02378298|582835918|FG001|Surveillance (19-68 Weeks)|Death|0|||
161395751|NCT02378298|582835919|FG002|Surveillance (19-68 Weeks)|Death|0|||
161395752|NCT04669262|582835921|FG000|Overall Study|Withdrawal by Subject|0|||
161395753|NCT04669262|582835922|FG001|Overall Study|Withdrawal by Subject|0|||
161395754|NCT04669262|582835923|FG002|Overall Study|Withdrawal by Subject|0|||
161395755|NCT04669262|582835924|FG003|Overall Study|Withdrawal by Subject|1|||
161395756|NCT04669262|582835921|FG000|Overall Study|Randomized but Not Treated|0|||
161395757|NCT04669262|582835922|FG001|Overall Study|Randomized but Not Treated|1|||
161395758|NCT04669262|582835923|FG002|Overall Study|Randomized but Not Treated|0|||
161395759|NCT04669262|582835924|FG003|Overall Study|Randomized but Not Treated|0|||
161395760|NCT01638013|582835925|FG000|Overall Study|Adverse Event|36|||
161395761|NCT01638013|582835926|FG001|Overall Study|Adverse Event|29|||
161395762|NCT01638013|582835927|FG002|Overall Study|Adverse Event|48|||
161395763|NCT01638013|582835925|FG000|Overall Study|Lack of Efficacy|39|||
161395764|NCT01638013|582835926|FG001|Overall Study|Lack of Efficacy|11|||
161395765|NCT01638013|582835927|FG002|Overall Study|Lack of Efficacy|14|||
161395766|NCT01638013|582835925|FG000|Overall Study|Protocol Violation|10|||
161395767|NCT01638013|582835926|FG001|Overall Study|Protocol Violation|7|||
161395768|NCT01638013|582835927|FG002|Overall Study|Protocol Violation|11|||
161395769|NCT01638013|582835925|FG000|Overall Study|Met discontinuation criteria|4|||
161395770|NCT01638013|582835926|FG001|Overall Study|Met discontinuation criteria|0|||
161395771|NCT01638013|582835927|FG002|Overall Study|Met discontinuation criteria|7|||
161395772|NCT01638013|582835925|FG000|Overall Study|Subject Lost to Follow up|1|||
161395773|NCT01638013|582835926|FG001|Overall Study|Subject Lost to Follow up|0|||
161395774|NCT01638013|582835927|FG002|Overall Study|Subject Lost to Follow up|1|||
161395775|NCT01638013|582835925|FG000|Overall Study|Miscellaneous|25|||
161395776|NCT01638013|582835926|FG001|Overall Study|Miscellaneous|19|||
161395777|NCT01638013|582835927|FG002|Overall Study|Miscellaneous|23|||
161395778|NCT01638013|582835925|FG000|Overall Study|Withdrawal of Consent|16|||
161395779|NCT01638013|582835926|FG001|Overall Study|Withdrawal of Consent|12|||
161395780|NCT01638013|582835927|FG002|Overall Study|Withdrawal of Consent|16|||
161395781|NCT01638013|582835925|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
161395782|NCT01638013|582835926|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
161395783|NCT01638013|582835927|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
161395784|NCT03549871|582835932|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
161395785|NCT03549871|582835933|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
161395786|NCT03549871|582835932|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
161395787|NCT03549871|582835933|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
161395788|NCT03549871|582835932|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
161395789|NCT03549871|582835933|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
161395790|NCT03549871|582835932|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
161395791|NCT03549871|582835933|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
161395792|NCT03549871|582835932|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
161395793|NCT03549871|582835933|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
161395794|NCT03549871|582835932|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
161395795|NCT03549871|582835933|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
161395796|NCT03549871|582835932|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
161395797|NCT03549871|582835933|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
161395798|NCT03549871|582835932|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
161395799|NCT03549871|582835933|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
161395800|NCT03549871|582835932|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
161395801|NCT03549871|582835933|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
161395802|NCT03549871|582835932|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
161395803|NCT03549871|582835933|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
161395804|NCT03549871|582835932|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
161395805|NCT03549871|582835933|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
161395806|NCT01133626|582835934|FG000|Overall Study|Adverse Event|0|||
161395807|NCT01133626|582835935|FG001|Overall Study|Adverse Event|1|||
161395808|NCT01133626|582835936|FG002|Overall Study|Adverse Event|0|||
161395809|NCT01133626|582835934|FG000|Overall Study|Withdrawal by Subject|1|||
161395810|NCT01133626|582835935|FG001|Overall Study|Withdrawal by Subject|2|||
161395811|NCT01133626|582835936|FG002|Overall Study|Withdrawal by Subject|2|||
161395812|NCT01133626|582835934|FG000|Overall Study|Other|0|||
161395813|NCT01133626|582835935|FG001|Overall Study|Other|2|||
161395814|NCT01133626|582835936|FG002|Overall Study|Other|0|||
161395815|NCT01960998|582835937|FG000|Overall Study|Lost to Follow-up|3|||
161395816|NCT01960998|582835938|FG001|Overall Study|Lost to Follow-up|7|||
161395817|NCT01960998|582835937|FG000|Overall Study|Death|0|||
161395818|NCT01960998|582835938|FG001|Overall Study|Death|1|||
161395819|NCT01960998|582835937|FG000|Overall Study|Withdrawal by Subject|8|||
161395820|NCT01960998|582835938|FG001|Overall Study|Withdrawal by Subject|2|||
161395821|NCT01960998|582835937|FG000|Overall Study|lost computer access|0|||
161395822|NCT01960998|582835938|FG001|Overall Study|lost computer access|1|||
161395823|NCT00772369|582835942|FG000|Overall Study|Did not return record release form|1|||
161395824|NCT01774253|582835943|FG000|Overall Study|Lack of Efficacy|4|||
161395825|NCT01774253|582835943|FG000|Overall Study|Physician Decision|2|||
161395826|NCT01774253|582835943|FG000|Overall Study|Withdrawal by Subject|2|||
161395827|NCT01774253|582835943|FG000|Overall Study|Death|1|||
161395828|NCT03510468|582835945|FG000|Overall Study|Lost to Follow-up|1|||
161395829|NCT03510468|582835945|FG000|Overall Study|Adverse Event|5|||
161395830|NCT03510468|582835945|FG000|Overall Study|Physician Decision|1|||
161395831|NCT03510468|582835945|FG000|Overall Study|non-compliant with treatment|2|||
161395832|NCT03510468|582835945|FG000|Overall Study|Missed visit|1|||
161395833|NCT00871117|582835946|FG000|Overall Study|Lost to Follow-up|5|||
161395834|NCT00871117|582835947|FG001|Overall Study|Lost to Follow-up|6|||
161395835|NCT00871117|582835946|FG000|Overall Study|Other|0|||
161395836|NCT00871117|582835947|FG001|Overall Study|Other|4|||
161395837|NCT02080481|582835948|FG000|Overall Study|Never received a block.|1|||
161395838|NCT02080481|582835949|FG001|Overall Study|Never received a block.|0|||
161395839|NCT04508751|582835955|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
161395840|NCT04508751|582835956|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
161395841|NCT04508751|582835957|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
161395842|NCT03551665|582835962|FG000|Overall Study|Lost to Follow-up|11|||
161395843|NCT03551665|582835963|FG001|Overall Study|Lost to Follow-up|2|||
161395844|NCT00798317|582837190|FG000|Overall Study|Physician Decision|0|||
161395845|NCT00798317|582837191|FG001|Overall Study|Physician Decision|1|||
161395846|NCT00798317|582837190|FG000|Overall Study|Withdrawal by Subject|5|||
161395847|NCT00798317|582837191|FG001|Overall Study|Withdrawal by Subject|4|||
161395848|NCT00798317|582837190|FG000|Overall Study|Lost to Follow-up|2|||
161395849|NCT00798317|582837191|FG001|Overall Study|Lost to Follow-up|2|||
161395850|NCT00798317|582837190|FG000|Overall Study|Adverse Event|2|||
161395851|NCT00798317|582837191|FG001|Overall Study|Adverse Event|0|||
161395852|NCT00798317|582837190|FG000|Overall Study|Death|1|||
161395853|NCT00798317|582837191|FG001|Overall Study|Death|0|||
161395854|NCT00919867|582837192|FG000|First Intervention|Withdrawal by Subject|0|||
161395855|NCT00919867|582837193|FG001|First Intervention|Withdrawal by Subject|0|||
161395856|NCT00919867|582837194|FG002|First Intervention|Withdrawal by Subject|1|||
161395857|NCT00919867|582837195|FG003|First Intervention|Withdrawal by Subject|0|||
161395858|NCT00919867|582837196|FG004|First Intervention|Withdrawal by Subject|0|||
161395859|NCT00919867|582837197|FG005|First Intervention|Withdrawal by Subject|0|||
161395860|NCT00919867|582837192|FG000|First Intervention|Physician Decision|0|||
161395861|NCT00919867|582837193|FG001|First Intervention|Physician Decision|0|||
161395862|NCT00919867|582837194|FG002|First Intervention|Physician Decision|0|||
161395863|NCT00919867|582837195|FG003|First Intervention|Physician Decision|0|||
161395864|NCT00919867|582837196|FG004|First Intervention|Physician Decision|0|||
161395865|NCT00919867|582837197|FG005|First Intervention|Physician Decision|1|||
161395866|NCT01685801|582837208|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
161395867|NCT01685801|582837209|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
161395868|NCT01685801|582837210|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
161395869|NCT01685801|582837211|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
161395870|NCT01685801|582837208|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
161395871|NCT01685801|582837209|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
161395872|NCT01685801|582837210|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
161395873|NCT01685801|582837211|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
161395874|NCT03350256|582837212|FG000|Overall Study|Inclusion/exclusion violation|4|||
161395875|NCT03350256|582837212|FG000|Overall Study|Recommended for other therapies|2|||
161395876|NCT03350256|582837212|FG000|Overall Study|Protocol Violation|3|||
161395877|NCT03350256|582837212|FG000|Overall Study|Non compliance|2|||
161395878|NCT03350256|582837212|FG000|Overall Study|Denial by insurance|1|||
161395879|NCT03350256|582837212|FG000|Overall Study|Adverse Event|2|||
161395880|NCT03350256|582837212|FG000|Overall Study|Trial failure|12|||
161395881|NCT03350256|582837212|FG000|Overall Study|Did not proceed to permanent implant|3|||
161395882|NCT03350256|582837212|FG000|Overall Study|Withdrawal by Subject|3|||
161395883|NCT03350256|582837212|FG000|Overall Study|Subject moving out of state|1|||
161395884|NCT03350256|582837212|FG000|Overall Study|Lost to Follow-up|1|||
161395885|NCT03350256|582837212|FG000|Overall Study|Lack of Efficacy|2|||
161395886|NCT00666588|582837213|FG000|Overall Study|ineligible|2|||
161395887|NCT00666588|582837214|FG001|Overall Study|ineligible|0|||
161395888|NCT00666588|582837215|FG002|Overall Study|ineligible|0|||
161395889|NCT00666588|582837216|FG003|Overall Study|ineligible|2|||
161395890|NCT00666588|582837213|FG000|Overall Study|inevaluable|2|||
161395891|NCT00666588|582837214|FG001|Overall Study|inevaluable|0|||
161395892|NCT00666588|582837215|FG002|Overall Study|inevaluable|0|||
161395893|NCT00666588|582837216|FG003|Overall Study|inevaluable|0|||
161395894|NCT01187446|582837219|FG000|Overall Study|Patient started non-protocol therapy|0|||
161395895|NCT01187446|582837220|FG001|Overall Study|Patient started non-protocol therapy|1|||
161395896|NCT00823212|582837222|FG000|Overall Study|Death|8|||
161395897|NCT00823212|582837223|FG001|Overall Study|Death|10|||
161395898|NCT00823212|582837222|FG000|Overall Study|Withdrawal by Subject|6|||
161395899|NCT00823212|582837223|FG001|Overall Study|Withdrawal by Subject|1|||
161395900|NCT00823212|582837222|FG000|Overall Study|Incarcerated|0|||
161395901|NCT00823212|582837223|FG001|Overall Study|Incarcerated|1|||
161395902|NCT00823212|582837222|FG000|Overall Study|Missed 12-month visit|21|||
161395903|NCT00823212|582837223|FG001|Overall Study|Missed 12-month visit|21|||
161395904|NCT03405935|582837233|FG000|Overall Study|Adverse Event|3|||
161395905|NCT03405935|582837233|FG000|Overall Study|Death|2|||
161395906|NCT03405935|582837233|FG000|Overall Study|Withdrawal by Subject|1|||
161395907|NCT03405935|582837233|FG000|Overall Study|Lost to Follow-up|2|||
161395908|NCT03136497|582837239|FG000|Overall Study|Screen Failure|1|||
161395909|NCT03136497|582837240|FG001|Overall Study|Screen Failure|0|||
161395910|NCT03136497|582837241|FG002|Overall Study|Screen Failure|0|||
161395911|NCT00557310|582837242|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
161395912|NCT00557310|582837242|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
161395913|NCT00557310|582837242|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
161395914|NCT00557310|582837242|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
161395915|NCT00557310|582837242|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
161395916|NCT00557310|582837242|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
161395917|NCT04600076|582837244|FG000|Overall Study|Lost to Follow-up|3|||
161395918|NCT01639339|582837245|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
161395919|NCT01639339|582837246|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
161395920|NCT01639339|582837245|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
161395921|NCT01639339|582837246|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
161395922|NCT01639339|582837245|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
161395923|NCT01639339|582837246|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
161395924|NCT01639339|582837245|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
161395925|NCT01639339|582837246|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
161395926|NCT01639339|582837245|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
161395927|NCT01639339|582837246|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
161395928|NCT01639339|582837245|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
161395929|NCT01639339|582837246|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
161395930|NCT01639339|582837245|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
161395931|NCT01639339|582837246|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
161395932|NCT01639339|582837245|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
161395933|NCT01639339|582837246|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
161395934|NCT01639339|582837245|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
161395935|NCT01639339|582837246|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
161395936|NCT01639339|582837245|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
161395937|NCT01639339|582837246|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
161395938|NCT02891681|582837247|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
161395939|NCT02891681|582837248|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
161395940|NCT02891681|582837249|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
161395941|NCT02891681|582837247|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
161395942|NCT02891681|582837248|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
161395943|NCT02891681|582837249|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
161395944|NCT02891681|582837247|FG000|Overall Study|Taken off study after first imaging appointment|1|||
161395945|NCT02891681|582837248|FG001|Overall Study|Taken off study after first imaging appointment|0|||
161395946|NCT02891681|582837249|FG002|Overall Study|Taken off study after first imaging appointment|0|||
161395947|NCT01170598|582837250|FG000|Overall Study|Withdrawal by Subject|1|||
161395948|NCT01170598|582837250|FG000|Overall Study|Death|3|||
161395949|NCT01170598|582837250|FG000|Overall Study|Lost to Follow-up|1|||
161395950|NCT01170598|582837250|FG000|Overall Study|Refused|1|||
161395951|NCT01271712|582837251|FG000|Double Blind Treatment|Death|2|||
161395952|NCT01271712|582837252|FG001|Double Blind Treatment|Death|0|||
161395953|NCT01271712|582837251|FG000|Double Blind Treatment|Lack of Efficacy|1|||
161395954|NCT01271712|582837252|FG001|Double Blind Treatment|Lack of Efficacy|0|||
161395955|NCT01271712|582837251|FG000|Double Blind Treatment|Adverse Event|9|||
161395956|NCT01271712|582837252|FG001|Double Blind Treatment|Adverse Event|4|||
161395957|NCT01271712|582837251|FG000|Double Blind Treatment|Progressive disease|23|||
161395958|NCT01271712|582837252|FG001|Double Blind Treatment|Progressive disease|3|||
161395959|NCT01271712|582837251|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
161395960|NCT01271712|582837252|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
161395961|NCT01271712|582837251|FG000|Double Blind Treatment|Non compliance with study drug|2|||
161395962|NCT01271712|582837252|FG001|Double Blind Treatment|Non compliance with study drug|0|||
161395963|NCT01271712|582837251|FG000|Double Blind Treatment|receive no study drug|1|||
161395964|NCT01271712|582837252|FG001|Double Blind Treatment|receive no study drug|0|||
161395965|NCT01271712|582837251|FG000|Open Label Treatment|Death|6|||
161395966|NCT01271712|582837252|FG001|Open Label Treatment|Death|5|||
161395967|NCT01271712|582837251|FG000|Open Label Treatment|Withdrawal by Subject|6|||
161395968|NCT01271712|582837252|FG001|Open Label Treatment|Withdrawal by Subject|11|||
161395969|NCT01271712|582837251|FG000|Open Label Treatment|Physician Decision|2|||
161395970|NCT01271712|582837252|FG001|Open Label Treatment|Physician Decision|0|||
161395971|NCT01271712|582837251|FG000|Open Label Treatment|Adverse Event|14|||
161395972|NCT01271712|582837252|FG001|Open Label Treatment|Adverse Event|8|||
161395973|NCT01271712|582837251|FG000|Open Label Treatment|Progressive disease|59|||
161395974|NCT01271712|582837252|FG001|Open Label Treatment|Progressive disease|32|||
161395975|NCT01271712|582837251|FG000|Open Label Treatment|transferred to rollover study|1|||
161395976|NCT01271712|582837252|FG001|Open Label Treatment|transferred to rollover study|0|||
161395977|NCT01271712|582837251|FG000|Open Label Treatment|Non-compliance with study drug|1|||
161395978|NCT01271712|582837252|FG001|Open Label Treatment|Non-compliance with study drug|0|||
161395979|NCT01271712|582837251|FG000|Open Label Treatment|Protocol Violation|0|||
161395980|NCT01271712|582837252|FG001|Open Label Treatment|Protocol Violation|1|||
161395981|NCT01271712|582837251|FG000|Open Label Treatment|Switching to other therapy|2|||
161395982|NCT01271712|582837252|FG001|Open Label Treatment|Switching to other therapy|1|||
161395983|NCT01271712|582837251|FG000|Safety Follow-up|Death|11|||
161395984|NCT01271712|582837252|FG001|Safety Follow-up|Death|7|||
161395985|NCT01271712|582837251|FG000|Safety Follow-up|Withdrawal by Subject|4|||
161395986|NCT01271712|582837252|FG001|Safety Follow-up|Withdrawal by Subject|2|||
161395987|NCT01271712|582837251|FG000|Safety Follow-up|Protocol Violation|1|||
161395988|NCT01271712|582837252|FG001|Safety Follow-up|Protocol Violation|1|||
161395989|NCT01271712|582837251|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
161395990|NCT01271712|582837252|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
161395991|NCT01271712|582837251|FG000|Safety Follow-up|No follow-up|1|||
161395992|NCT01271712|582837252|FG001|Safety Follow-up|No follow-up|1|||
161395993|NCT01271712|582837251|FG000|Safety Follow-up|Progressive disease|1|||
161395994|NCT01271712|582837252|FG001|Safety Follow-up|Progressive disease|0|||
161395995|NCT01271712|582837251|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
161395996|NCT01271712|582837252|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
161395997|NCT02685748|582837255|FG000|Overall Study|Withdrawal by Subject|3|||
161395998|NCT02685748|582837256|FG001|Overall Study|Withdrawal by Subject|2|||
161395999|NCT03941964|582837257|FG000|Overall Study|Adverse Event|1|||
161396000|NCT03941964|582837258|FG001|Overall Study|Adverse Event|8|||
161396001|NCT03941964|582837257|FG000|Overall Study|Progressive disease|7|||
161396002|NCT03941964|582837258|FG001|Overall Study|Progressive disease|3|||
161396003|NCT03941964|582837257|FG000|Overall Study|Lack of Efficacy|0|||
161396004|NCT03941964|582837258|FG001|Overall Study|Lack of Efficacy|1|||
161396005|NCT03941964|582837257|FG000|Overall Study|Death|3|||
161396006|NCT03941964|582837258|FG001|Overall Study|Death|1|||
161396007|NCT03941964|582837257|FG000|Overall Study|Withdrew consent|1|||
161396008|NCT03941964|582837258|FG001|Overall Study|Withdrew consent|3|||
161396009|NCT03941964|582837257|FG000|Overall Study|Physician Decision|9|||
161396010|NCT03941964|582837258|FG001|Overall Study|Physician Decision|2|||
161396011|NCT03941964|582837257|FG000|Overall Study|Other, not specified|2|||
161396012|NCT03941964|582837258|FG001|Overall Study|Other, not specified|1|||
161396013|NCT00737568|582837268|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
161396014|NCT00737568|582837269|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
161396015|NCT00737568|582837268|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
161396016|NCT00737568|582837269|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
161396017|NCT00737568|582837268|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
161396018|NCT00737568|582837269|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
161396019|NCT00737568|582837268|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
161396020|NCT00737568|582837269|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
161396021|NCT00737568|582837268|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
161396022|NCT00737568|582837269|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
161396023|NCT00737568|582837268|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
161396024|NCT00737568|582837269|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
161396025|NCT00737568|582837268|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
161396026|NCT00737568|582837269|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
161396027|NCT00737568|582837268|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
161396028|NCT00737568|582837269|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
161396029|NCT00737568|582837268|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
161396030|NCT00737568|582837269|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
161396031|NCT00855933|582837270|FG000|Overall Study|Withdrawal by Subject|0|||
161396032|NCT00855933|582837271|FG001|Overall Study|Withdrawal by Subject|1|||
161396033|NCT00951080|582837272|FG000|Overall Study|Adverse Event|3|||
161396034|NCT00951080|582837273|FG001|Overall Study|Adverse Event|3|||
161396035|NCT00951080|582837272|FG000|Overall Study|Lost to Follow-up|0|||
161396036|NCT00951080|582837273|FG001|Overall Study|Lost to Follow-up|1|||
161396037|NCT00951080|582837272|FG000|Overall Study|Physician Decision|4|||
161396038|NCT00951080|582837273|FG001|Overall Study|Physician Decision|1|||
161396039|NCT00951080|582837272|FG000|Overall Study|Other|19|||
161396040|NCT00951080|582837273|FG001|Overall Study|Other|22|||
161396041|NCT05463744|582837274|FG000|Treatment Period|Withdrawal by Subject|19|||
161396042|NCT05463744|582837275|FG001|Treatment Period|Withdrawal by Subject|16|||
161396043|NCT05463744|582837274|FG000|Treatment Period|Adverse Event|4|||
161396044|NCT05463744|582837275|FG001|Treatment Period|Adverse Event|4|||
161396045|NCT05463744|582837274|FG000|Treatment Period|Pregnancy|0|||
161396046|NCT05463744|582837275|FG001|Treatment Period|Pregnancy|3|||
161396047|NCT05463744|582837274|FG000|Treatment Period|Lost to Follow-up|1|||
161396048|NCT05463744|582837275|FG001|Treatment Period|Lost to Follow-up|3|||
161396049|NCT05463744|582837274|FG000|Treatment Period|Inadvertent enrollment|2|||
161396050|NCT05463744|582837275|FG001|Treatment Period|Inadvertent enrollment|1|||
161396051|NCT05463744|582837274|FG000|Treatment Period|Death|0|||
161396052|NCT05463744|582837275|FG001|Treatment Period|Death|1|||
161396053|NCT05463744|582837274|FG000|Treatment Period|Non-compliance with Study Drug|1|||
161396054|NCT05463744|582837275|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161396055|NCT05463744|582837274|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
161396056|NCT05463744|582837275|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
161396057|NCT05463744|582837274|FG000|Treatment Period|Physician Decision|0|||
161396058|NCT05463744|582837275|FG001|Treatment Period|Physician Decision|1|||
161396059|NCT05463744|582837274|FG000|Follow-Up Period|Withdrawal by Subject|3|||
161396060|NCT05463744|582837275|FG001|Follow-Up Period|Withdrawal by Subject|1|||
161396061|NCT05463744|582837274|FG000|Follow-Up Period|Lost to Follow-up|1|||
161396062|NCT05463744|582837275|FG001|Follow-Up Period|Lost to Follow-up|1|||
161396063|NCT01904149|582837279|FG000|Overall Study|Adverse Event|3|||
161396064|NCT01904149|582837280|FG001|Overall Study|Adverse Event|4|||
161396065|NCT01904149|582837281|FG002|Overall Study|Adverse Event|0|||
161396066|NCT01904149|582837282|FG003|Overall Study|Adverse Event|1|||
161396067|NCT01904149|582837283|FG004|Overall Study|Adverse Event|1|||
161396068|NCT01904149|582837284|FG005|Overall Study|Adverse Event|2|||
161396069|NCT01904149|582837279|FG000|Overall Study|Lack of Efficacy|0|||
161396070|NCT01904149|582837280|FG001|Overall Study|Lack of Efficacy|3|||
161396071|NCT01904149|582837281|FG002|Overall Study|Lack of Efficacy|1|||
161396072|NCT01904149|582837282|FG003|Overall Study|Lack of Efficacy|3|||
161396073|NCT01904149|582837283|FG004|Overall Study|Lack of Efficacy|3|||
161396074|NCT01904149|582837284|FG005|Overall Study|Lack of Efficacy|1|||
161396075|NCT01904149|582837279|FG000|Overall Study|Withdrawal by Subject|1|||
161396076|NCT01904149|582837280|FG001|Overall Study|Withdrawal by Subject|3|||
161396077|NCT01904149|582837281|FG002|Overall Study|Withdrawal by Subject|1|||
161396078|NCT01904149|582837282|FG003|Overall Study|Withdrawal by Subject|0|||
161396079|NCT01904149|582837283|FG004|Overall Study|Withdrawal by Subject|1|||
161396080|NCT01904149|582837284|FG005|Overall Study|Withdrawal by Subject|0|||
161396081|NCT01904149|582837279|FG000|Overall Study|Protocol Violation|0|||
161396082|NCT01904149|582837280|FG001|Overall Study|Protocol Violation|1|||
161396083|NCT01904149|582837281|FG002|Overall Study|Protocol Violation|0|||
161396084|NCT01904149|582837282|FG003|Overall Study|Protocol Violation|0|||
161396085|NCT01904149|582837283|FG004|Overall Study|Protocol Violation|0|||
161396086|NCT01904149|582837284|FG005|Overall Study|Protocol Violation|0|||
161396087|NCT01904149|582837279|FG000|Overall Study|non compliance with study drug|1|||
161396088|NCT01904149|582837280|FG001|Overall Study|non compliance with study drug|0|||
161396089|NCT01904149|582837281|FG002|Overall Study|non compliance with study drug|0|||
161396090|NCT01904149|582837282|FG003|Overall Study|non compliance with study drug|0|||
161396091|NCT01904149|582837283|FG004|Overall Study|non compliance with study drug|0|||
161396092|NCT01904149|582837284|FG005|Overall Study|non compliance with study drug|0|||
161396093|NCT01357161|582837285|FG000|Part 1 (Open Label Run-in)|Death|5|||
161396094|NCT01357161|582837286|FG001|Part 1 (Open Label Run-in)|Death|0|||
161396095|NCT01357161|582837287|FG002|Part 1 (Open Label Run-in)|Death|0|||
161396096|NCT01357161|582837285|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
161396097|NCT01357161|582837286|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
161396098|NCT01357161|582837287|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
161396099|NCT01357161|582837285|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
161396100|NCT01357161|582837286|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
161396101|NCT01357161|582837287|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
161396102|NCT01357161|582837285|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
161396103|NCT01357161|582837286|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
161396104|NCT01357161|582837287|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
161396105|NCT01357161|582837285|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
161396106|NCT01357161|582837286|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
161396107|NCT01357161|582837287|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
161396108|NCT01357161|582837285|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
161396109|NCT01357161|582837286|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
161396110|NCT01357161|582837287|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
161396111|NCT01357161|582837285|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
161396112|NCT01357161|582837286|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
161396113|NCT01357161|582837287|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
161396114|NCT01357161|582837285|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
161396115|NCT01357161|582837286|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
161396116|NCT01357161|582837287|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
161396117|NCT01357161|582837285|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
161396118|NCT01357161|582837286|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
161396119|NCT01357161|582837287|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
161396120|NCT01357161|582837285|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
161396121|NCT01357161|582837286|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
161396122|NCT01357161|582837287|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
161396123|NCT01357161|582837285|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
161396124|NCT01357161|582837286|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
161396125|NCT01357161|582837287|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
161396126|NCT01824823|582837288|FG000|Overall Study|Lack of Efficacy|1|||
161396127|NCT01824823|582837289|FG001|Overall Study|Lack of Efficacy|1|||
161396128|NCT01824823|582837288|FG000|Overall Study|Off-treatment reason not submitted|1|||
161396129|NCT01824823|582837289|FG001|Overall Study|Off-treatment reason not submitted|0|||
161396130|NCT03349645|582837292|FG000|Overall Study|Sponsor Terminated Study|75|||
161396131|NCT03349645|582837292|FG000|Overall Study|Withdrawal by Subject|4|||
161396132|NCT03349645|582837292|FG000|Overall Study|Protocol Violation|1|||
161396133|NCT03349645|582837292|FG000|Overall Study|Other|2|||
161396134|NCT02927925|582837293|FG000|Overall Study|Death|16|||
161396135|NCT02927925|582837293|FG000|Overall Study|Physician Decision|1|||
161396136|NCT02927925|582837293|FG000|Overall Study|Withdrawal by Subject|11|||
161396137|NCT02927925|582837293|FG000|Overall Study|Other|3|||
161396138|NCT02927925|582837293|FG000|Overall Study|Disease progression at clinical cutoff|1|||
161396139|NCT02910401|582837294|FG000|Overall Study|Study closure Study closure|0|||
161396140|NCT02910401|582837295|FG001|Overall Study|Study closure Study closure|0|||
161396141|NCT02910401|582837296|FG002|Overall Study|Study closure Study closure|2|||
161396142|NCT02910401|582837294|FG000|Overall Study|Physician Decision|1|||
161396143|NCT02910401|582837295|FG001|Overall Study|Physician Decision|0|||
161396144|NCT02910401|582837296|FG002|Overall Study|Physician Decision|0|||
161396145|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
161396146|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
161396147|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Death|0|||
161396148|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Death|0|||
161396149|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
161396150|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
161396151|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
161396152|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
161396153|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
161396154|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
161396155|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
161396156|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
161396157|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
161396158|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
161396159|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
161396160|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
161396161|NCT00433160|582837300|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
161396162|NCT00433160|582837301|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
161396163|NCT00433160|582837300|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
161396164|NCT00433160|582837301|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
161396165|NCT00433160|582837300|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
161396166|NCT00433160|582837301|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
161396167|NCT00433160|582837300|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
161396168|NCT00433160|582837301|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
161396169|NCT00433160|582837300|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
161396170|NCT00433160|582837301|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
161396171|NCT00433160|582837300|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
161396172|NCT00433160|582837301|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
161396173|NCT00433160|582837300|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
161396174|NCT00433160|582837301|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
161396175|NCT00433160|582837300|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
161396176|NCT00433160|582837301|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
161396177|NCT02240368|582837302|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
161396178|NCT02240368|582837303|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
161396179|NCT02240368|582837304|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
161396180|NCT02240368|582837302|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
161396181|NCT02240368|582837303|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
161396182|NCT02240368|582837304|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
161396183|NCT03372460|582837308|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
161396184|NCT03372460|582837309|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
161396185|NCT00916058|582837316|FG000|Phase 1|Screen Failure|0|||
161396186|NCT00916058|582837317|FG001|Phase 1|Screen Failure|0|||
161396187|NCT00916058|582837318|FG002|Phase 1|Screen Failure|0|||
161396188|NCT00916058|582837319|FG003|Phase 1|Screen Failure|0|||
161396189|NCT00916058|582837320|FG004|Phase 1|Screen Failure|0|||
161396190|NCT00916058|582837321|FG005|Phase 1|Screen Failure|1|||
161396191|NCT00916058|582837322|FG006|Phase 1|Screen Failure|0|||
161396192|NCT00916058|582837316|FG000|Phase 2|Screen Failure|0|||
161396193|NCT00916058|582837317|FG001|Phase 2|Screen Failure|0|||
161396194|NCT00916058|582837318|FG002|Phase 2|Screen Failure|0|||
161396195|NCT00916058|582837319|FG003|Phase 2|Screen Failure|0|||
161396196|NCT00916058|582837320|FG004|Phase 2|Screen Failure|0|||
161396197|NCT00916058|582837321|FG005|Phase 2|Screen Failure|0|||
161396198|NCT00916058|582837322|FG006|Phase 2|Screen Failure|3|||
161396199|NCT03222973|582837323|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
161396200|NCT03222973|582837324|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161396201|NCT03222973|582837325|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161396202|NCT03222973|582837326|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161396203|NCT03222973|582837323|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
161396204|NCT03222973|582837324|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
161396205|NCT03222973|582837325|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
161396206|NCT03222973|582837326|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
161396207|NCT03222973|582837323|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
161396208|NCT03222973|582837324|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
161396209|NCT03222973|582837325|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
161396210|NCT03222973|582837326|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
161396211|NCT03222973|582837323|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
161396212|NCT03222973|582837324|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
161396213|NCT03222973|582837325|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
161396214|NCT03222973|582837326|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
161396215|NCT03222973|582837323|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
161396216|NCT03222973|582837324|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
161396217|NCT03222973|582837325|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
161396218|NCT03222973|582837326|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
161396219|NCT03222973|582837323|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
161396220|NCT03222973|582837324|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
161396221|NCT03222973|582837325|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
161396222|NCT03222973|582837326|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
161396223|NCT03222973|582837323|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
161396224|NCT03222973|582837324|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
161396225|NCT03222973|582837325|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
161396226|NCT03222973|582837326|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
161396227|NCT03222973|582837323|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
161396228|NCT03222973|582837324|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
161396229|NCT03222973|582837325|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
161396230|NCT03222973|582837326|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
161396231|NCT03222973|582837323|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
161396232|NCT03222973|582837324|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
161396233|NCT03222973|582837325|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
161396234|NCT03222973|582837326|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
161396235|NCT03222973|582837323|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
161396236|NCT03222973|582837324|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
161396237|NCT03222973|582837325|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
161396238|NCT03222973|582837326|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
161396239|NCT03222973|582837323|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
161396240|NCT03222973|582837324|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
161396241|NCT03222973|582837325|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
161396242|NCT03222973|582837326|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
161396243|NCT03222973|582837323|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
161396244|NCT03222973|582837324|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
161396245|NCT03222973|582837325|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
161396246|NCT03222973|582837326|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
161396247|NCT00840060|582838959|FG000|Overall Study|Withdrawal by Subject|1|||
161396248|NCT00840060|582838960|FG001|Overall Study|Withdrawal by Subject|0|||
161396249|NCT00840060|582838959|FG000|Overall Study|Change in emotional/behavioral status|0|||
161396250|NCT00840060|582838960|FG001|Overall Study|Change in emotional/behavioral status|1|||
161396251|NCT01103063|582838961|FG000|Overall Study|Adverse Event|3|||
161396252|NCT01103063|582838962|FG001|Overall Study|Adverse Event|1|||
161396253|NCT01103063|582838961|FG000|Overall Study|Lost to Follow-up|68|||
161396254|NCT01103063|582838962|FG001|Overall Study|Lost to Follow-up|51|||
161396255|NCT01103063|582838961|FG000|Overall Study|Withdrawal by Subject|60|||
161396256|NCT01103063|582838962|FG001|Overall Study|Withdrawal by Subject|15|||
161396257|NCT01103063|582838961|FG000|Overall Study|Other|16|||
161396258|NCT01103063|582838962|FG001|Overall Study|Other|11|||
161396259|NCT01103063|582838961|FG000|Overall Study|Protocol Violation|1|||
161396260|NCT01103063|582838962|FG001|Overall Study|Protocol Violation|0|||
161396261|NCT01103063|582838961|FG000|Overall Study|Study terminated by Sponsor|326|||
161396262|NCT01103063|582838962|FG001|Overall Study|Study terminated by Sponsor|342|||
161396263|NCT01103063|582838961|FG000|Overall Study|Death|3|||
161396264|NCT01103063|582838962|FG001|Overall Study|Death|1|||
161396265|NCT03899064|582838965|FG000|Overall Study|Lost to Follow-up|1|||
161396266|NCT03899064|582838965|FG000|Overall Study|Protocol Violation|2|||
161396267|NCT03899064|582838965|FG000|Overall Study|Withdrawal by Subject|2|||
161396268|NCT03899064|582838965|FG000|Overall Study|Other|2|||
161396269|NCT03283098|582838966|FG000|Overall Study|Withdrawal by Subject|0|||
161396270|NCT03283098|582838967|FG001|Overall Study|Withdrawal by Subject|1|||
161396271|NCT01069861|582838973|FG000|Overall Study|Death|1|||
161396272|NCT01069861|582838973|FG000|Overall Study|Adverse Event|1|||
161396273|NCT01069861|582838973|FG000|Overall Study|Did not meet entrance criteria|1|||
161396274|NCT00354107|582838974|FG000|Overall Study|Adverse Event|2|||
161396275|NCT00354107|582838974|FG000|Overall Study|Physician Decision|2|||
161396276|NCT00354107|582838974|FG000|Overall Study|Withdrawal by Subject|1|||
161396277|NCT02351349|582838975|FG000|Overall Study|Withdrawal by Subject|2|||
161396278|NCT02351349|582838976|FG001|Overall Study|Withdrawal by Subject|3|||
161396279|NCT02649218|582838977|FG000|Overall Study|Adverse Event|8|||
161396280|NCT02649218|582838977|FG000|Overall Study|Lack of Efficacy|8|||
161396281|NCT02649218|582838977|FG000|Overall Study|Pregnancy|3|||
161396282|NCT02649218|582838977|FG000|Overall Study|Protocol Violation|3|||
161396283|NCT02649218|582838977|FG000|Overall Study|Physician Decision|1|||
161396284|NCT02649218|582838977|FG000|Overall Study|Withdrawal by Subject|2|||
161396285|NCT01224821|582838978|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
161396286|NCT01224821|582838978|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
161396287|NCT01224821|582838978|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
161396288|NCT01224821|582838978|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
161396289|NCT01224821|582838978|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
161396290|NCT01224821|582838978|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
161396291|NCT01224821|582838978|FG000|Long-Term Follow-Up|Death|2|||
161396292|NCT01224821|582838978|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
161396293|NCT02174523|582838979|FG000|Overall Study|Withdrawal by Subject|1|||
161396294|NCT02174523|582838980|FG001|Overall Study|Withdrawal by Subject|0|||
161396295|NCT00794365|582838981|FG000|Overall Study|Lost to Follow-up|38|||
161396296|NCT00794365|582838981|FG000|Overall Study|Other|17|||
161396297|NCT00794365|582838981|FG000|Overall Study|Poor Compliance|11|||
161396298|NCT00794365|582838981|FG000|Overall Study|Adverse Event|10|||
161396299|NCT00794365|582838981|FG000|Overall Study|Lack of Efficacy|3|||
161396300|NCT03538444|582838992|FG000|Overall Study|opioid withdrawal|1|||
161396301|NCT03538444|582838993|FG001|Overall Study|opioid withdrawal|0|||
161396302|NCT01451931|582838994|FG000|Overall Study|Lost to Follow-up|17|||
161396303|NCT01451931|582838995|FG001|Overall Study|Lost to Follow-up|36|||
161396304|NCT01451931|582838996|FG002|Overall Study|Lost to Follow-up|21|||
161396305|NCT01451931|582838994|FG000|Overall Study|Withdrawal by Subject|16|||
161396306|NCT01451931|582838995|FG001|Overall Study|Withdrawal by Subject|22|||
161396307|NCT01451931|582838996|FG002|Overall Study|Withdrawal by Subject|22|||
161396308|NCT04422561|582839002|FG000|Overall Study|Lost to Follow-up|25|||
161396309|NCT04422561|582839003|FG001|Overall Study|Lost to Follow-up|11|||
161396310|NCT03640052|582839004|FG000|Overall Study|Lost to Follow-up|0|||
161396311|NCT03640052|582839005|FG001|Overall Study|Lost to Follow-up|1|||
161396312|NCT03640052|582839006|FG002|Overall Study|Lost to Follow-up|0|||
161396313|NCT03640052|582839007|FG003|Overall Study|Lost to Follow-up|0|||
161396314|NCT03640052|582839008|FG004|Overall Study|Lost to Follow-up|0|||
161396315|NCT05479097|582839014|FG000|Overall Study|Withdrawal by Subject|2|||
161396316|NCT04126564|582839015|FG000|Overall Study|Withdrawal by Subject|0|||
161396317|NCT04126564|582839016|FG001|Overall Study|Withdrawal by Subject|2|||
161396318|NCT04126564|582839015|FG000|Overall Study|Lost to Follow-up|0|||
161396319|NCT04126564|582839016|FG001|Overall Study|Lost to Follow-up|1|||
161396320|NCT00457821|582839022|FG000|Part 2|Withdrawal by Subject|0|||
161396321|NCT00457821|582839023|FG001|Part 2|Withdrawal by Subject|0|||
161396322|NCT00457821|582839024|FG002|Part 2|Withdrawal by Subject|0|||
161396323|NCT00457821|582839025|FG003|Part 2|Withdrawal by Subject|0|||
161396324|NCT00457821|582839026|FG004|Part 2|Withdrawal by Subject|0|||
161396325|NCT00457821|582839027|FG005|Part 2|Withdrawal by Subject|0|||
161396326|NCT00457821|582839028|FG006|Part 2|Withdrawal by Subject|0|||
161396327|NCT00457821|582839029|FG007|Part 2|Withdrawal by Subject|1|||
161396328|NCT00790647|582839032|FG000|Overall Study|Adverse Event|1|||
161396329|NCT02437409|582839037|FG000|Overall Study|Withdrawal by Subject|3|||
161396330|NCT02437409|582839037|FG000|Overall Study|Screening failure|12|||
161396331|NCT00027378|582839038|FG000|Overall Study|Physician Decision|0|||
161396332|NCT00027378|582839039|FG001|Overall Study|Physician Decision|3|||
161396333|NCT02701777|582839041|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
161396334|NCT02701777|582839042|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
161396335|NCT02701777|582839043|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
161396336|NCT02701777|582839044|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
161396337|NCT02701777|582839041|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
161396338|NCT02701777|582839042|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
161396339|NCT02701777|582839043|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
161396340|NCT02701777|582839044|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
161396341|NCT01369680|582839045|FG000|Overall Study|Lost to Follow-up|0|||
161396342|NCT01369680|582839046|FG001|Overall Study|Lost to Follow-up|0|||
161396343|NCT01369680|582839047|FG002|Overall Study|Lost to Follow-up|1|||
161396344|NCT01369680|582839048|FG003|Overall Study|Lost to Follow-up|2|||
161396345|NCT02851407|582839051|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161396346|NCT02851407|582839052|FG001|Overall Study|Withdrawal by parent/guardian|7|||
161396347|NCT02851407|582839051|FG000|Overall Study|Protocol deviation|0|||
161396348|NCT02851407|582839052|FG001|Overall Study|Protocol deviation|1|||
161396349|NCT02851407|582839051|FG000|Overall Study|Transferred to another hospital to continue|1|||
161396350|NCT02851407|582839052|FG001|Overall Study|Transferred to another hospital to continue|0|||
161396351|NCT02851407|582839051|FG000|Overall Study|Other Death|30|||
161396352|NCT02851407|582839052|FG001|Overall Study|Other Death|20|||
161396353|NCT02851407|582839051|FG000|Overall Study|Adverse event, serious fatal|6|||
161396354|NCT02851407|582839052|FG001|Overall Study|Adverse event, serious fatal|8|||
161396355|NCT02851407|582839051|FG000|Overall Study|Consent withdrawn by participant|5|||
161396356|NCT02851407|582839052|FG001|Overall Study|Consent withdrawn by participant|3|||
161396357|NCT02851407|582839051|FG000|Overall Study|Screen failure|2|||
161396358|NCT02851407|582839052|FG001|Overall Study|Screen failure|1|||
161396359|NCT02851407|582839051|FG000|Overall Study|Disease relapse|9|||
161396360|NCT02851407|582839052|FG001|Overall Study|Disease relapse|6|||
161396361|NCT02851407|582839051|FG000|Overall Study|Physician Decision|7|||
161396362|NCT02851407|582839052|FG001|Overall Study|Physician Decision|6|||
161396363|NCT02851407|582839051|FG000|Overall Study|Transferred to hospital closer to home|0|||
161396364|NCT02851407|582839052|FG001|Overall Study|Transferred to hospital closer to home|1|||
161396365|NCT02851407|582839051|FG000|Overall Study|Enrolled in an investigational study|0|||
161396366|NCT02851407|582839052|FG001|Overall Study|Enrolled in an investigational study|1|||
161396367|NCT02851407|582839051|FG000|Overall Study|Early recovery|1|||
161396368|NCT02851407|582839052|FG001|Overall Study|Early recovery|0|||
161396369|NCT02851407|582839051|FG000|Overall Study|Adverse event, non-fatal|7|||
161396370|NCT02851407|582839052|FG001|Overall Study|Adverse event, non-fatal|5|||
161396371|NCT02851407|582839051|FG000|Overall Study|Lost to Follow-up|0|||
161396372|NCT02851407|582839052|FG001|Overall Study|Lost to Follow-up|2|||
161396373|NCT01713283|582839055|FG000|Overall Study|Lack of Efficacy|10|||
161396374|NCT01713283|582839056|FG001|Overall Study|Lack of Efficacy|2|||
161396375|NCT01713283|582839055|FG000|Overall Study|Lost to Follow-up|1|||
161396376|NCT01713283|582839056|FG001|Overall Study|Lost to Follow-up|1|||
161396377|NCT02585830|582839057|FG000|Overall Study|Withdrawal by Subject|3|||
161396378|NCT00835640|582839058|FG000|Second Intervention|Protocol Violation|1|||
161396379|NCT00835640|582839059|FG001|Second Intervention|Protocol Violation|0|||
161396380|NCT00350272|582839060|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
161396381|NCT00350272|582839061|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
161396382|NCT00350272|582839060|FG000|Blinded 12-Week Treatment|Death|1|||
161396383|NCT00350272|582839061|FG001|Blinded 12-Week Treatment|Death|0|||
161396384|NCT00350272|582839060|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
161396385|NCT00350272|582839061|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
161396386|NCT00350272|582839060|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
161396387|NCT00350272|582839061|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
161396388|NCT00350272|582839060|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
161396389|NCT00350272|582839061|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
161396390|NCT00350272|582839060|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
161396391|NCT00350272|582839061|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
161396392|NCT00350272|582839060|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
161396393|NCT00350272|582839061|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
161396394|NCT00350272|582839060|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
161396395|NCT00350272|582839061|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
161396396|NCT00350272|582839060|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
161396397|NCT00350272|582839061|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
161396398|NCT00350272|582839060|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
161396399|NCT00350272|582839061|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
161396400|NCT00350272|582839060|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
161396401|NCT00350272|582839061|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
161396402|NCT00068250|582839062|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
161396403|NCT00068250|582839063|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
161396404|NCT00068250|582839064|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
161396405|NCT00068250|582839065|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
161396406|NCT00812006|582839066|FG000|Overall Study|Lost to Follow-up|0|||
161396407|NCT00812006|582839067|FG001|Overall Study|Lost to Follow-up|0|||
161396408|NCT00812006|582839068|FG002|Overall Study|Lost to Follow-up|2|||
161396409|NCT00812006|582839066|FG000|Overall Study|Physician Decision|0|||
161396410|NCT00812006|582839067|FG001|Overall Study|Physician Decision|0|||
161396411|NCT00812006|582839068|FG002|Overall Study|Physician Decision|1|||
161396412|NCT00812006|582839066|FG000|Overall Study|Withdrawal by Subject|2|||
161396413|NCT00812006|582839067|FG001|Overall Study|Withdrawal by Subject|1|||
161396414|NCT00812006|582839068|FG002|Overall Study|Withdrawal by Subject|1|||
161396415|NCT00812006|582839066|FG000|Overall Study|Lack of Qualifying Event|4|||
161396416|NCT00812006|582839067|FG001|Overall Study|Lack of Qualifying Event|2|||
161396417|NCT00812006|582839068|FG002|Overall Study|Lack of Qualifying Event|2|||
161396418|NCT00235391|582839070|FG000|Overall Study|Adverse Event|4|||
161396419|NCT00235391|582839071|FG001|Overall Study|Adverse Event|5|||
161396420|NCT00235391|582839072|FG002|Overall Study|Adverse Event|10|||
161396421|NCT00235391|582839073|FG003|Overall Study|Adverse Event|72|||
161396422|NCT00235391|582839074|FG004|Overall Study|Adverse Event|5|||
161396423|NCT00235391|582839075|FG005|Overall Study|Adverse Event|2|||
161396424|NCT00235391|582839070|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161396425|NCT00235391|582839071|FG001|Overall Study|Abnormal laboratory value(s)|5|||
161396426|NCT00235391|582839072|FG002|Overall Study|Abnormal laboratory value(s)|4|||
161396427|NCT00235391|582839073|FG003|Overall Study|Abnormal laboratory value(s)|27|||
161396428|NCT00235391|582839074|FG004|Overall Study|Abnormal laboratory value(s)|1|||
161396429|NCT00235391|582839075|FG005|Overall Study|Abnormal laboratory value(s)|2|||
161396430|NCT00235391|582839070|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161396431|NCT00235391|582839071|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161396432|NCT00235391|582839072|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161396433|NCT00235391|582839073|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
161396434|NCT00235391|582839074|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161396435|NCT00235391|582839075|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161396436|NCT00235391|582839070|FG000|Overall Study|Condition no longer requires treatment|3|||
161396437|NCT00235391|582839071|FG001|Overall Study|Condition no longer requires treatment|0|||
161396438|NCT00235391|582839072|FG002|Overall Study|Condition no longer requires treatment|0|||
161396439|NCT00235391|582839073|FG003|Overall Study|Condition no longer requires treatment|11|||
161396440|NCT00235391|582839074|FG004|Overall Study|Condition no longer requires treatment|1|||
161396441|NCT00235391|582839075|FG005|Overall Study|Condition no longer requires treatment|0|||
161396442|NCT00235391|582839070|FG000|Overall Study|Protocol deviation|0|||
161396443|NCT00235391|582839071|FG001|Overall Study|Protocol deviation|0|||
161396444|NCT00235391|582839072|FG002|Overall Study|Protocol deviation|1|||
161396445|NCT00235391|582839073|FG003|Overall Study|Protocol deviation|11|||
161396446|NCT00235391|582839074|FG004|Overall Study|Protocol deviation|0|||
161396447|NCT00235391|582839075|FG005|Overall Study|Protocol deviation|0|||
161396448|NCT00235391|582839070|FG000|Overall Study|Withdrawal by Subject|2|||
161396449|NCT00235391|582839071|FG001|Overall Study|Withdrawal by Subject|3|||
161396450|NCT00235391|582839072|FG002|Overall Study|Withdrawal by Subject|3|||
161396451|NCT00235391|582839073|FG003|Overall Study|Withdrawal by Subject|61|||
161396452|NCT00235391|582839074|FG004|Overall Study|Withdrawal by Subject|5|||
161396453|NCT00235391|582839075|FG005|Overall Study|Withdrawal by Subject|0|||
161396454|NCT00235391|582839070|FG000|Overall Study|Lost to Follow-up|0|||
161396455|NCT00235391|582839071|FG001|Overall Study|Lost to Follow-up|3|||
161396456|NCT00235391|582839072|FG002|Overall Study|Lost to Follow-up|3|||
161396457|NCT00235391|582839073|FG003|Overall Study|Lost to Follow-up|16|||
161396458|NCT00235391|582839074|FG004|Overall Study|Lost to Follow-up|0|||
161396459|NCT00235391|582839075|FG005|Overall Study|Lost to Follow-up|0|||
161396460|NCT00235391|582839070|FG000|Overall Study|Administrative problems|0|||
161396461|NCT00235391|582839071|FG001|Overall Study|Administrative problems|0|||
161396462|NCT00235391|582839072|FG002|Overall Study|Administrative problems|0|||
161396463|NCT00235391|582839073|FG003|Overall Study|Administrative problems|1|||
161396464|NCT00235391|582839074|FG004|Overall Study|Administrative problems|0|||
161396465|NCT00235391|582839075|FG005|Overall Study|Administrative problems|0|||
161396466|NCT00235391|582839070|FG000|Overall Study|Death|0|||
161396467|NCT00235391|582839071|FG001|Overall Study|Death|0|||
161396468|NCT00235391|582839072|FG002|Overall Study|Death|1|||
161396469|NCT00235391|582839073|FG003|Overall Study|Death|4|||
161396470|NCT00235391|582839074|FG004|Overall Study|Death|0|||
161396471|NCT00235391|582839075|FG005|Overall Study|Death|0|||
161396472|NCT00075725|582839076|FG000|Overall Study|Adverse Event|6|||
161396473|NCT00075725|582839077|FG001|Overall Study|Adverse Event|6|||
161396474|NCT00075725|582839078|FG002|Overall Study|Adverse Event|20|||
161396475|NCT00075725|582839079|FG003|Overall Study|Adverse Event|8|||
161396476|NCT00075725|582839080|FG004|Overall Study|Adverse Event|4|||
161396477|NCT00075725|582839081|FG005|Overall Study|Adverse Event|38|||
161396478|NCT00075725|582839082|FG006|Overall Study|Adverse Event|3|||
161396479|NCT00075725|582839083|FG007|Overall Study|Adverse Event|51|||
161396480|NCT00075725|582839084|FG008|Overall Study|Adverse Event|15|||
161396481|NCT00075725|582839085|FG009|Overall Study|Adverse Event|4|||
161396482|NCT00075725|582839086|FG010|Overall Study|Adverse Event|2|||
161396483|NCT00075725|582839087|FG011|Overall Study|Adverse Event|2|||
161396484|NCT00075725|582839076|FG000|Overall Study|Death|3|||
161396485|NCT00075725|582839077|FG001|Overall Study|Death|5|||
161396486|NCT00075725|582839078|FG002|Overall Study|Death|10|||
161396487|NCT00075725|582839079|FG003|Overall Study|Death|2|||
161396488|NCT00075725|582839080|FG004|Overall Study|Death|3|||
161396489|NCT00075725|582839081|FG005|Overall Study|Death|25|||
161396490|NCT00075725|582839082|FG006|Overall Study|Death|4|||
161396491|NCT00075725|582839083|FG007|Overall Study|Death|22|||
161396492|NCT00075725|582839084|FG008|Overall Study|Death|14|||
161396493|NCT00075725|582839085|FG009|Overall Study|Death|4|||
161396494|NCT00075725|582839086|FG010|Overall Study|Death|3|||
161396495|NCT00075725|582839087|FG011|Overall Study|Death|0|||
161396496|NCT00075725|582839076|FG000|Overall Study|Lost to Follow-up|1|||
161396497|NCT00075725|582839077|FG001|Overall Study|Lost to Follow-up|1|||
161396498|NCT00075725|582839078|FG002|Overall Study|Lost to Follow-up|4|||
161396499|NCT00075725|582839079|FG003|Overall Study|Lost to Follow-up|1|||
161396500|NCT00075725|582839080|FG004|Overall Study|Lost to Follow-up|0|||
161396501|NCT00075725|582839081|FG005|Overall Study|Lost to Follow-up|13|||
161396502|NCT00075725|582839082|FG006|Overall Study|Lost to Follow-up|2|||
161396503|NCT00075725|582839083|FG007|Overall Study|Lost to Follow-up|4|||
161396504|NCT00075725|582839084|FG008|Overall Study|Lost to Follow-up|1|||
161396505|NCT00075725|582839085|FG009|Overall Study|Lost to Follow-up|0|||
161396506|NCT00075725|582839086|FG010|Overall Study|Lost to Follow-up|0|||
161396507|NCT00075725|582839087|FG011|Overall Study|Lost to Follow-up|0|||
161396508|NCT00075725|582839076|FG000|Overall Study|Physician Decision|2|||
161396509|NCT00075725|582839077|FG001|Overall Study|Physician Decision|6|||
161396510|NCT00075725|582839078|FG002|Overall Study|Physician Decision|5|||
161396511|NCT00075725|582839079|FG003|Overall Study|Physician Decision|8|||
161396512|NCT00075725|582839080|FG004|Overall Study|Physician Decision|4|||
161396513|NCT00075725|582839081|FG005|Overall Study|Physician Decision|19|||
161396514|NCT00075725|582839082|FG006|Overall Study|Physician Decision|3|||
161396515|NCT00075725|582839083|FG007|Overall Study|Physician Decision|17|||
161396516|NCT00075725|582839084|FG008|Overall Study|Physician Decision|5|||
161396517|NCT00075725|582839085|FG009|Overall Study|Physician Decision|0|||
161396518|NCT00075725|582839086|FG010|Overall Study|Physician Decision|1|||
161396519|NCT00075725|582839087|FG011|Overall Study|Physician Decision|0|||
161396520|NCT00075725|582839076|FG000|Overall Study|Pregnancy|0|||
161396521|NCT00075725|582839077|FG001|Overall Study|Pregnancy|0|||
161396522|NCT00075725|582839078|FG002|Overall Study|Pregnancy|0|||
161396523|NCT00075725|582839079|FG003|Overall Study|Pregnancy|0|||
161396524|NCT00075725|582839080|FG004|Overall Study|Pregnancy|0|||
161396525|NCT00075725|582839081|FG005|Overall Study|Pregnancy|1|||
161396526|NCT00075725|582839082|FG006|Overall Study|Pregnancy|0|||
161396527|NCT00075725|582839083|FG007|Overall Study|Pregnancy|1|||
161396528|NCT00075725|582839084|FG008|Overall Study|Pregnancy|0|||
161396529|NCT00075725|582839085|FG009|Overall Study|Pregnancy|0|||
161396530|NCT00075725|582839086|FG010|Overall Study|Pregnancy|0|||
161396531|NCT00075725|582839087|FG011|Overall Study|Pregnancy|0|||
161396532|NCT00075725|582839076|FG000|Overall Study|Protocol Violation|1|||
161396533|NCT00075725|582839077|FG001|Overall Study|Protocol Violation|1|||
161396534|NCT00075725|582839078|FG002|Overall Study|Protocol Violation|0|||
161396535|NCT00075725|582839079|FG003|Overall Study|Protocol Violation|3|||
161396536|NCT00075725|582839080|FG004|Overall Study|Protocol Violation|3|||
161396537|NCT00075725|582839081|FG005|Overall Study|Protocol Violation|2|||
161396538|NCT00075725|582839082|FG006|Overall Study|Protocol Violation|1|||
161396539|NCT00075725|582839083|FG007|Overall Study|Protocol Violation|2|||
161396540|NCT00075725|582839084|FG008|Overall Study|Protocol Violation|3|||
161396541|NCT00075725|582839085|FG009|Overall Study|Protocol Violation|0|||
161396542|NCT00075725|582839086|FG010|Overall Study|Protocol Violation|0|||
161396543|NCT00075725|582839087|FG011|Overall Study|Protocol Violation|1|||
161396544|NCT00075725|582839076|FG000|Overall Study|Withdrawal by Subject|12|||
161396545|NCT00075725|582839077|FG001|Overall Study|Withdrawal by Subject|3|||
161396546|NCT00075725|582839078|FG002|Overall Study|Withdrawal by Subject|6|||
161396547|NCT00075725|582839079|FG003|Overall Study|Withdrawal by Subject|10|||
161396548|NCT00075725|582839080|FG004|Overall Study|Withdrawal by Subject|6|||
161396549|NCT00075725|582839081|FG005|Overall Study|Withdrawal by Subject|27|||
161396550|NCT00075725|582839082|FG006|Overall Study|Withdrawal by Subject|7|||
161396551|NCT00075725|582839083|FG007|Overall Study|Withdrawal by Subject|31|||
161396552|NCT00075725|582839084|FG008|Overall Study|Withdrawal by Subject|10|||
161396553|NCT00075725|582839085|FG009|Overall Study|Withdrawal by Subject|2|||
161396554|NCT00075725|582839086|FG010|Overall Study|Withdrawal by Subject|0|||
161396555|NCT00075725|582839087|FG011|Overall Study|Withdrawal by Subject|0|||
161396556|NCT00075725|582839076|FG000|Overall Study|Disease Progression, all other reasons|17|||
161396557|NCT00075725|582839077|FG001|Overall Study|Disease Progression, all other reasons|5|||
161396558|NCT00075725|582839078|FG002|Overall Study|Disease Progression, all other reasons|33|||
161396559|NCT00075725|582839079|FG003|Overall Study|Disease Progression, all other reasons|6|||
161396560|NCT00075725|582839080|FG004|Overall Study|Disease Progression, all other reasons|21|||
161396561|NCT00075725|582839081|FG005|Overall Study|Disease Progression, all other reasons|59|||
161396562|NCT00075725|582839082|FG006|Overall Study|Disease Progression, all other reasons|20|||
161396563|NCT00075725|582839083|FG007|Overall Study|Disease Progression, all other reasons|46|||
161396564|NCT00075725|582839084|FG008|Overall Study|Disease Progression, all other reasons|21|||
161396565|NCT00075725|582839085|FG009|Overall Study|Disease Progression, all other reasons|4|||
161396566|NCT00075725|582839086|FG010|Overall Study|Disease Progression, all other reasons|0|||
161396567|NCT00075725|582839087|FG011|Overall Study|Disease Progression, all other reasons|5|||
161396568|NCT00075725|582839076|FG000|Overall Study|Patient off treatment|0|||
161396569|NCT00075725|582839077|FG001|Overall Study|Patient off treatment|0|||
161396570|NCT00075725|582839078|FG002|Overall Study|Patient off treatment|1|||
161396571|NCT00075725|582839079|FG003|Overall Study|Patient off treatment|2|||
161396572|NCT00075725|582839080|FG004|Overall Study|Patient off treatment|1|||
161396573|NCT00075725|582839081|FG005|Overall Study|Patient off treatment|0|||
161396574|NCT00075725|582839082|FG006|Overall Study|Patient off treatment|0|||
161396575|NCT00075725|582839083|FG007|Overall Study|Patient off treatment|2|||
161396576|NCT00075725|582839084|FG008|Overall Study|Patient off treatment|1|||
161396577|NCT00075725|582839085|FG009|Overall Study|Patient off treatment|0|||
161396578|NCT00075725|582839086|FG010|Overall Study|Patient off treatment|0|||
161396579|NCT00075725|582839087|FG011|Overall Study|Patient off treatment|0|||
161396580|NCT00075725|582839076|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
161396581|NCT00075725|582839077|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
161396582|NCT00075725|582839078|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
161396583|NCT00075725|582839079|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
161396584|NCT00075725|582839080|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
161396585|NCT00075725|582839081|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
161396586|NCT00075725|582839082|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
161396587|NCT00075725|582839083|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
161396588|NCT00075725|582839084|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
161396589|NCT00075725|582839085|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
161396590|NCT00075725|582839086|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
161396591|NCT00075725|582839087|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
161396592|NCT00075725|582839076|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
161396593|NCT00075725|582839077|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
161396594|NCT00075725|582839078|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
161396595|NCT00075725|582839079|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
161396596|NCT00075725|582839080|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
161396597|NCT00075725|582839081|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
161396598|NCT00075725|582839082|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
161396599|NCT00075725|582839083|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
161396600|NCT00075725|582839084|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
161396601|NCT00075725|582839085|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
161396602|NCT00075725|582839086|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
161396603|NCT00075725|582839087|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
161396604|NCT00075725|582839076|FG000|Overall Study|Pt non compliant with therapy|2|||
161396605|NCT00075725|582839077|FG001|Overall Study|Pt non compliant with therapy|1|||
161396606|NCT00075725|582839078|FG002|Overall Study|Pt non compliant with therapy|1|||
161396607|NCT00075725|582839079|FG003|Overall Study|Pt non compliant with therapy|0|||
161396608|NCT00075725|582839080|FG004|Overall Study|Pt non compliant with therapy|2|||
161396609|NCT00075725|582839081|FG005|Overall Study|Pt non compliant with therapy|14|||
161396610|NCT00075725|582839082|FG006|Overall Study|Pt non compliant with therapy|2|||
161396611|NCT00075725|582839083|FG007|Overall Study|Pt non compliant with therapy|5|||
161396612|NCT00075725|582839084|FG008|Overall Study|Pt non compliant with therapy|3|||
161396613|NCT00075725|582839085|FG009|Overall Study|Pt non compliant with therapy|0|||
161396614|NCT00075725|582839086|FG010|Overall Study|Pt non compliant with therapy|0|||
161396615|NCT00075725|582839087|FG011|Overall Study|Pt non compliant with therapy|0|||
161396616|NCT00075725|582839076|FG000|Overall Study|Pt age out of range for treatment|0|||
161396617|NCT00075725|582839077|FG001|Overall Study|Pt age out of range for treatment|1|||
161396618|NCT00075725|582839078|FG002|Overall Study|Pt age out of range for treatment|0|||
161396619|NCT00075725|582839079|FG003|Overall Study|Pt age out of range for treatment|0|||
161396620|NCT00075725|582839080|FG004|Overall Study|Pt age out of range for treatment|0|||
161396621|NCT00075725|582839081|FG005|Overall Study|Pt age out of range for treatment|1|||
161396622|NCT00075725|582839082|FG006|Overall Study|Pt age out of range for treatment|0|||
161396623|NCT00075725|582839083|FG007|Overall Study|Pt age out of range for treatment|1|||
161396624|NCT00075725|582839084|FG008|Overall Study|Pt age out of range for treatment|0|||
161396625|NCT00075725|582839085|FG009|Overall Study|Pt age out of range for treatment|0|||
161396626|NCT00075725|582839086|FG010|Overall Study|Pt age out of range for treatment|0|||
161396627|NCT00075725|582839087|FG011|Overall Study|Pt age out of range for treatment|0|||
161396628|NCT00075725|582839076|FG000|Overall Study|Insurance issues|0|||
161396629|NCT00075725|582839077|FG001|Overall Study|Insurance issues|1|||
161396630|NCT00075725|582839078|FG002|Overall Study|Insurance issues|0|||
161396631|NCT00075725|582839079|FG003|Overall Study|Insurance issues|1|||
161396632|NCT00075725|582839080|FG004|Overall Study|Insurance issues|1|||
161396633|NCT00075725|582839081|FG005|Overall Study|Insurance issues|1|||
161396634|NCT00075725|582839082|FG006|Overall Study|Insurance issues|0|||
161396635|NCT00075725|582839083|FG007|Overall Study|Insurance issues|1|||
161396636|NCT00075725|582839084|FG008|Overall Study|Insurance issues|0|||
161396637|NCT00075725|582839085|FG009|Overall Study|Insurance issues|0|||
161396638|NCT00075725|582839086|FG010|Overall Study|Insurance issues|0|||
161396639|NCT00075725|582839087|FG011|Overall Study|Insurance issues|0|||
161396640|NCT00075725|582839076|FG000|Overall Study|MRD positive after extended ind|0|||
161396641|NCT00075725|582839077|FG001|Overall Study|MRD positive after extended ind|1|||
161396642|NCT00075725|582839078|FG002|Overall Study|MRD positive after extended ind|1|||
161396643|NCT00075725|582839079|FG003|Overall Study|MRD positive after extended ind|0|||
161396644|NCT00075725|582839080|FG004|Overall Study|MRD positive after extended ind|1|||
161396645|NCT00075725|582839081|FG005|Overall Study|MRD positive after extended ind|2|||
161396646|NCT00075725|582839082|FG006|Overall Study|MRD positive after extended ind|0|||
161396647|NCT00075725|582839083|FG007|Overall Study|MRD positive after extended ind|1|||
161396648|NCT00075725|582839084|FG008|Overall Study|MRD positive after extended ind|0|||
161396649|NCT00075725|582839085|FG009|Overall Study|MRD positive after extended ind|0|||
161396650|NCT00075725|582839086|FG010|Overall Study|MRD positive after extended ind|0|||
161396651|NCT00075725|582839087|FG011|Overall Study|MRD positive after extended ind|0|||
161396652|NCT00075725|582839076|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
161396653|NCT00075725|582839077|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
161396654|NCT00075725|582839078|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
161396655|NCT00075725|582839079|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
161396656|NCT00075725|582839080|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
161396657|NCT00075725|582839081|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
161396658|NCT00075725|582839082|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
161396659|NCT00075725|582839083|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
161396660|NCT00075725|582839084|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
161396661|NCT00075725|582839085|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
161396662|NCT00075725|582839086|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
161396663|NCT00075725|582839087|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
161396664|NCT00075725|582839076|FG000|Overall Study|Inevaluable|1|||
161396665|NCT00075725|582839077|FG001|Overall Study|Inevaluable|1|||
161396666|NCT00075725|582839078|FG002|Overall Study|Inevaluable|4|||
161396667|NCT00075725|582839079|FG003|Overall Study|Inevaluable|2|||
161396668|NCT00075725|582839080|FG004|Overall Study|Inevaluable|2|||
161396669|NCT00075725|582839081|FG005|Overall Study|Inevaluable|9|||
161396670|NCT00075725|582839082|FG006|Overall Study|Inevaluable|1|||
161396671|NCT00075725|582839083|FG007|Overall Study|Inevaluable|11|||
161396672|NCT00075725|582839084|FG008|Overall Study|Inevaluable|2|||
161396673|NCT00075725|582839085|FG009|Overall Study|Inevaluable|0|||
161396674|NCT00075725|582839086|FG010|Overall Study|Inevaluable|1|||
161396675|NCT00075725|582839087|FG011|Overall Study|Inevaluable|0|||
161396676|NCT00075725|582839076|FG000|Overall Study|Other|4|||
161396677|NCT00075725|582839077|FG001|Overall Study|Other|2|||
161396678|NCT00075725|582839078|FG002|Overall Study|Other|1|||
161396679|NCT00075725|582839079|FG003|Overall Study|Other|1|||
161396680|NCT00075725|582839080|FG004|Overall Study|Other|1|||
161396681|NCT00075725|582839081|FG005|Overall Study|Other|4|||
161396682|NCT00075725|582839082|FG006|Overall Study|Other|2|||
161396683|NCT00075725|582839083|FG007|Overall Study|Other|9|||
161396684|NCT00075725|582839084|FG008|Overall Study|Other|2|||
161396685|NCT00075725|582839085|FG009|Overall Study|Other|1|||
161396686|NCT00075725|582839086|FG010|Overall Study|Other|0|||
161396687|NCT00075725|582839087|FG011|Overall Study|Other|3|||
161396688|NCT00075725|582839076|FG000|Overall Study|Pt trying to find a BM donor|0|||
161396689|NCT00075725|582839077|FG001|Overall Study|Pt trying to find a BM donor|1|||
161396690|NCT00075725|582839078|FG002|Overall Study|Pt trying to find a BM donor|0|||
161396691|NCT00075725|582839079|FG003|Overall Study|Pt trying to find a BM donor|0|||
161396692|NCT00075725|582839080|FG004|Overall Study|Pt trying to find a BM donor|0|||
161396693|NCT00075725|582839081|FG005|Overall Study|Pt trying to find a BM donor|0|||
161396694|NCT00075725|582839082|FG006|Overall Study|Pt trying to find a BM donor|0|||
161396695|NCT00075725|582839083|FG007|Overall Study|Pt trying to find a BM donor|0|||
161396696|NCT00075725|582839084|FG008|Overall Study|Pt trying to find a BM donor|0|||
161396697|NCT00075725|582839085|FG009|Overall Study|Pt trying to find a BM donor|0|||
161396698|NCT00075725|582839086|FG010|Overall Study|Pt trying to find a BM donor|0|||
161396699|NCT00075725|582839087|FG011|Overall Study|Pt trying to find a BM donor|0|||
161396700|NCT00075725|582839076|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
161396701|NCT00075725|582839077|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
161396702|NCT00075725|582839078|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
161396703|NCT00075725|582839079|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
161396704|NCT00075725|582839080|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
161396705|NCT00075725|582839081|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
161396706|NCT00075725|582839082|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
161396707|NCT00075725|582839083|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
161396708|NCT00075725|582839084|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
161396709|NCT00075725|582839085|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
161396710|NCT00075725|582839086|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
161396711|NCT00075725|582839087|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
161396712|NCT00075725|582839076|FG000|Overall Study|Unsuccessful institutional transfer|0|||
161396713|NCT00075725|582839077|FG001|Overall Study|Unsuccessful institutional transfer|0|||
161396714|NCT00075725|582839078|FG002|Overall Study|Unsuccessful institutional transfer|2|||
161396715|NCT00075725|582839079|FG003|Overall Study|Unsuccessful institutional transfer|0|||
161396716|NCT00075725|582839080|FG004|Overall Study|Unsuccessful institutional transfer|0|||
161396717|NCT00075725|582839081|FG005|Overall Study|Unsuccessful institutional transfer|0|||
161396718|NCT00075725|582839082|FG006|Overall Study|Unsuccessful institutional transfer|0|||
161396719|NCT00075725|582839083|FG007|Overall Study|Unsuccessful institutional transfer|0|||
161396720|NCT00075725|582839084|FG008|Overall Study|Unsuccessful institutional transfer|0|||
161396721|NCT00075725|582839085|FG009|Overall Study|Unsuccessful institutional transfer|1|||
161396722|NCT00075725|582839086|FG010|Overall Study|Unsuccessful institutional transfer|0|||
161396723|NCT00075725|582839087|FG011|Overall Study|Unsuccessful institutional transfer|0|||
161396724|NCT00075725|582839076|FG000|Overall Study|specimen(s) not submitted|0|||
161396725|NCT00075725|582839077|FG001|Overall Study|specimen(s) not submitted|0|||
161396726|NCT00075725|582839078|FG002|Overall Study|specimen(s) not submitted|2|||
161396727|NCT00075725|582839079|FG003|Overall Study|specimen(s) not submitted|0|||
161396728|NCT00075725|582839080|FG004|Overall Study|specimen(s) not submitted|0|||
161396729|NCT00075725|582839081|FG005|Overall Study|specimen(s) not submitted|0|||
161396730|NCT00075725|582839082|FG006|Overall Study|specimen(s) not submitted|0|||
161396731|NCT00075725|582839083|FG007|Overall Study|specimen(s) not submitted|0|||
161396732|NCT00075725|582839084|FG008|Overall Study|specimen(s) not submitted|0|||
161396733|NCT00075725|582839085|FG009|Overall Study|specimen(s) not submitted|0|||
161396734|NCT00075725|582839086|FG010|Overall Study|specimen(s) not submitted|0|||
161396735|NCT00075725|582839087|FG011|Overall Study|specimen(s) not submitted|0|||
161396736|NCT00075725|582839076|FG000|Overall Study|Pt went to transplant|0|||
161396737|NCT00075725|582839077|FG001|Overall Study|Pt went to transplant|0|||
161396738|NCT00075725|582839078|FG002|Overall Study|Pt went to transplant|0|||
161396739|NCT00075725|582839079|FG003|Overall Study|Pt went to transplant|1|||
161396740|NCT00075725|582839080|FG004|Overall Study|Pt went to transplant|0|||
161396741|NCT00075725|582839081|FG005|Overall Study|Pt went to transplant|1|||
161396742|NCT00075725|582839082|FG006|Overall Study|Pt went to transplant|0|||
161396743|NCT00075725|582839083|FG007|Overall Study|Pt went to transplant|0|||
161396744|NCT00075725|582839084|FG008|Overall Study|Pt went to transplant|0|||
161396745|NCT00075725|582839085|FG009|Overall Study|Pt went to transplant|0|||
161396746|NCT00075725|582839086|FG010|Overall Study|Pt went to transplant|0|||
161396747|NCT00075725|582839087|FG011|Overall Study|Pt went to transplant|0|||
161396748|NCT00075725|582839076|FG000|Overall Study|Pt received additional steroids|0|||
161396749|NCT00075725|582839077|FG001|Overall Study|Pt received additional steroids|0|||
161396750|NCT00075725|582839078|FG002|Overall Study|Pt received additional steroids|0|||
161396751|NCT00075725|582839079|FG003|Overall Study|Pt received additional steroids|1|||
161396752|NCT00075725|582839080|FG004|Overall Study|Pt received additional steroids|0|||
161396753|NCT00075725|582839081|FG005|Overall Study|Pt received additional steroids|0|||
161396754|NCT00075725|582839082|FG006|Overall Study|Pt received additional steroids|0|||
161396755|NCT00075725|582839083|FG007|Overall Study|Pt received additional steroids|0|||
161396756|NCT00075725|582839084|FG008|Overall Study|Pt received additional steroids|0|||
161396757|NCT00075725|582839085|FG009|Overall Study|Pt received additional steroids|0|||
161396758|NCT00075725|582839086|FG010|Overall Study|Pt received additional steroids|0|||
161396759|NCT00075725|582839087|FG011|Overall Study|Pt received additional steroids|0|||
161396760|NCT00075725|582839076|FG000|Overall Study|Pt relocated|0|||
161396761|NCT00075725|582839077|FG001|Overall Study|Pt relocated|0|||
161396762|NCT00075725|582839078|FG002|Overall Study|Pt relocated|0|||
161396763|NCT00075725|582839079|FG003|Overall Study|Pt relocated|2|||
161396764|NCT00075725|582839080|FG004|Overall Study|Pt relocated|0|||
161396765|NCT00075725|582839081|FG005|Overall Study|Pt relocated|1|||
161396766|NCT00075725|582839082|FG006|Overall Study|Pt relocated|1|||
161396767|NCT00075725|582839083|FG007|Overall Study|Pt relocated|2|||
161396768|NCT00075725|582839084|FG008|Overall Study|Pt relocated|1|||
161396769|NCT00075725|582839085|FG009|Overall Study|Pt relocated|0|||
161396770|NCT00075725|582839086|FG010|Overall Study|Pt relocated|0|||
161396771|NCT00075725|582839087|FG011|Overall Study|Pt relocated|0|||
161396772|NCT00075725|582839076|FG000|Overall Study|Institution Terminated|0|||
161396773|NCT00075725|582839077|FG001|Overall Study|Institution Terminated|0|||
161396774|NCT00075725|582839078|FG002|Overall Study|Institution Terminated|0|||
161396775|NCT00075725|582839079|FG003|Overall Study|Institution Terminated|0|||
161396776|NCT00075725|582839080|FG004|Overall Study|Institution Terminated|1|||
161396777|NCT00075725|582839081|FG005|Overall Study|Institution Terminated|0|||
161396778|NCT00075725|582839082|FG006|Overall Study|Institution Terminated|0|||
161396779|NCT00075725|582839083|FG007|Overall Study|Institution Terminated|3|||
161396780|NCT00075725|582839084|FG008|Overall Study|Institution Terminated|0|||
161396781|NCT00075725|582839085|FG009|Overall Study|Institution Terminated|0|||
161396782|NCT00075725|582839086|FG010|Overall Study|Institution Terminated|0|||
161396783|NCT00075725|582839087|FG011|Overall Study|Institution Terminated|0|||
161396784|NCT00075725|582839076|FG000|Overall Study|Study Closure|1|||
161396785|NCT00075725|582839077|FG001|Overall Study|Study Closure|0|||
161396786|NCT00075725|582839078|FG002|Overall Study|Study Closure|0|||
161396787|NCT00075725|582839079|FG003|Overall Study|Study Closure|0|||
161396788|NCT00075725|582839080|FG004|Overall Study|Study Closure|1|||
161396789|NCT00075725|582839081|FG005|Overall Study|Study Closure|3|||
161396790|NCT00075725|582839082|FG006|Overall Study|Study Closure|0|||
161396791|NCT00075725|582839083|FG007|Overall Study|Study Closure|1|||
161396792|NCT00075725|582839084|FG008|Overall Study|Study Closure|0|||
161396793|NCT00075725|582839085|FG009|Overall Study|Study Closure|0|||
161396794|NCT00075725|582839086|FG010|Overall Study|Study Closure|0|||
161396795|NCT00075725|582839087|FG011|Overall Study|Study Closure|0|||
161396796|NCT00075725|582839076|FG000|Overall Study|Other complications|0|||
161396797|NCT00075725|582839077|FG001|Overall Study|Other complications|0|||
161396798|NCT00075725|582839078|FG002|Overall Study|Other complications|0|||
161396799|NCT00075725|582839079|FG003|Overall Study|Other complications|0|||
161396800|NCT00075725|582839080|FG004|Overall Study|Other complications|0|||
161396801|NCT00075725|582839081|FG005|Overall Study|Other complications|1|||
161396802|NCT00075725|582839082|FG006|Overall Study|Other complications|0|||
161396803|NCT00075725|582839083|FG007|Overall Study|Other complications|0|||
161396804|NCT00075725|582839084|FG008|Overall Study|Other complications|0|||
161396805|NCT00075725|582839085|FG009|Overall Study|Other complications|0|||
161396806|NCT00075725|582839086|FG010|Overall Study|Other complications|0|||
161396807|NCT00075725|582839087|FG011|Overall Study|Other complications|0|||
161396808|NCT00075725|582839076|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
161396809|NCT00075725|582839077|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
161396810|NCT00075725|582839078|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
161396811|NCT00075725|582839079|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
161396812|NCT00075725|582839080|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
161396813|NCT00075725|582839081|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
161396814|NCT00075725|582839082|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
161396815|NCT00075725|582839083|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
161396816|NCT00075725|582839084|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
161396817|NCT00075725|582839085|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
161396818|NCT00075725|582839086|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
161396819|NCT00075725|582839087|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
161396820|NCT00075725|582839076|FG000|Overall Study|Pt incarcerated|0|||
161396821|NCT00075725|582839077|FG001|Overall Study|Pt incarcerated|0|||
161396822|NCT00075725|582839078|FG002|Overall Study|Pt incarcerated|0|||
161396823|NCT00075725|582839079|FG003|Overall Study|Pt incarcerated|0|||
161396824|NCT00075725|582839080|FG004|Overall Study|Pt incarcerated|0|||
161396825|NCT00075725|582839081|FG005|Overall Study|Pt incarcerated|0|||
161396826|NCT00075725|582839082|FG006|Overall Study|Pt incarcerated|0|||
161396827|NCT00075725|582839083|FG007|Overall Study|Pt incarcerated|1|||
161396828|NCT00075725|582839084|FG008|Overall Study|Pt incarcerated|0|||
161396829|NCT00075725|582839085|FG009|Overall Study|Pt incarcerated|0|||
161396830|NCT00075725|582839086|FG010|Overall Study|Pt incarcerated|0|||
161396831|NCT00075725|582839087|FG011|Overall Study|Pt incarcerated|0|||
161396832|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Death|1|||
161396833|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Death|1|||
161396834|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Death|0|||
161396835|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Death|0|||
161396836|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Death|1|||
161396837|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Death|0|||
161396838|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Death|0|||
161396839|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Death|0|||
161396840|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Death|0|||
161396841|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Death|0|||
161396842|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
161396843|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
161396844|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
161396845|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
161396846|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
161396847|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
161396848|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
161396849|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
161396850|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
161396851|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
161396852|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396853|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396854|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396855|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396856|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
161396857|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396858|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396859|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396860|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396861|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161396862|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
161396863|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396864|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396865|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396866|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396867|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396868|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396869|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396870|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396871|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161396872|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
161396873|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396874|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396875|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
161396876|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
161396877|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396878|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396879|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396880|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396881|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161396882|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
161396883|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396884|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396885|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
161396886|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396887|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396888|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396889|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396890|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396891|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161396892|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
161396893|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
161396894|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
161396895|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
161396896|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
161396897|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161396898|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161396899|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161396900|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161396901|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161396902|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
161396903|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
161396904|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
161396905|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161396906|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
161396907|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161396908|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161396909|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161396910|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161396911|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161396912|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
161396913|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396914|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396915|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
161396916|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
161396917|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396918|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396919|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396920|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396921|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161396922|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161396923|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161396924|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161396925|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161396926|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161396927|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161396928|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161396929|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161396930|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161396931|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161396932|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396933|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396934|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
161396935|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396936|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
161396937|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396938|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396939|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396940|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396941|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396942|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
161396943|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
161396944|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
161396945|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
161396946|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
161396947|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161396948|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161396949|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161396950|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161396951|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161396952|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396953|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396954|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396955|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
161396956|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
161396957|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396958|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396959|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396960|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396961|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161396962|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161396963|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161396964|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161396965|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161396966|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161396967|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161396968|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161396969|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161396970|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161396971|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161396972|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
161396973|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396974|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396975|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396976|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
161396977|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396978|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396979|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396980|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396981|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161396982|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396983|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396984|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396985|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396986|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
161396987|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396988|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396989|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396990|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396991|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161396992|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161396993|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
161396994|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161396995|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161396996|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
161396997|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161396998|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161396999|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161397000|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161397001|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161397002|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
161397003|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397004|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397005|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397006|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
161397007|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397008|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397009|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397010|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397011|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161397012|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
161397013|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397014|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
161397015|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397016|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
161397017|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397018|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397019|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397020|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397021|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161397022|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Other|5|||
161397023|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Other|1|||
161397024|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Other|0|||
161397025|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Other|3|||
161397026|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Other|0|||
161397027|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Other|0|||
161397028|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Other|0|||
161397029|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Other|0|||
161397030|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Other|0|||
161397031|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Other|0|||
161397032|NCT03352557|582839088|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397033|NCT03352557|582839089|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397034|NCT03352557|582839090|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397035|NCT03352557|582839091|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397036|NCT03352557|582839092|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
161397037|NCT03352557|582839093|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397038|NCT03352557|582839094|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397039|NCT03352557|582839095|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397040|NCT03352557|582839096|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397041|NCT03352557|582839097|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
161397042|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Death|0|||
161397043|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Death|0|||
161397044|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Death|0|||
161397045|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Death|0|||
161397046|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Death|0|||
161397047|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Death|1|||
161397048|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Death|0|||
161397049|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Death|1|||
161397050|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Death|1|||
161397051|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Death|1|||
161397052|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397053|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397054|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397055|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397056|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397057|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
161397058|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397059|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397060|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397061|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161397062|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397063|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397064|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397065|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397066|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397067|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397068|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397069|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397070|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
161397071|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161397072|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161397073|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161397074|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161397075|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161397076|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161397077|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
161397078|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
161397079|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
161397080|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
161397081|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
161397082|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161397083|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161397084|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161397085|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161397086|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161397087|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
161397088|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161397089|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
161397090|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
161397091|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
161397092|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397093|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397094|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397095|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397096|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397097|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161397098|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397099|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161397100|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161397101|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161397102|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161397103|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161397104|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161397105|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161397106|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161397107|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
161397108|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161397109|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
161397110|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
161397111|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
161397112|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397113|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397114|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397115|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397116|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397117|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397118|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397119|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161397120|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
161397121|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
161397122|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397123|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397124|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397125|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397126|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397127|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397128|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397129|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161397130|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397131|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161397132|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397133|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397134|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397135|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397136|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397137|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397138|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397139|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
161397140|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397141|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161397142|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397143|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397144|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397145|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397146|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397147|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397148|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397149|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
161397150|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
161397151|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161397152|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397153|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397154|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397155|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397156|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397157|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
161397158|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397159|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397160|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
161397161|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161397162|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397163|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397164|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397165|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397166|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397167|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397168|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397169|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397170|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161397171|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
161397172|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397173|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397174|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397175|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397176|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397177|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397178|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397179|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161397180|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
161397181|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
161397182|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397183|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397184|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397185|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397186|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397187|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397188|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397189|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
161397190|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
161397191|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161397192|NCT03352557|582839088|FG000|LTE Period: Week 80 to Week 173|Other|0|||
161397193|NCT03352557|582839089|FG001|LTE Period: Week 80 to Week 173|Other|0|||
161397194|NCT03352557|582839090|FG002|LTE Period: Week 80 to Week 173|Other|0|||
161397195|NCT03352557|582839091|FG003|LTE Period: Week 80 to Week 173|Other|0|||
161397196|NCT03352557|582839092|FG004|LTE Period: Week 80 to Week 173|Other|0|||
161397197|NCT03352557|582839093|FG005|LTE Period: Week 80 to Week 173|Other|0|||
161397198|NCT03352557|582839094|FG006|LTE Period: Week 80 to Week 173|Other|0|||
161397199|NCT03352557|582839095|FG007|LTE Period: Week 80 to Week 173|Other|1|||
161397200|NCT03352557|582839096|FG008|LTE Period: Week 80 to Week 173|Other|0|||
161397201|NCT03352557|582839097|FG009|LTE Period: Week 80 to Week 173|Other|0|||
161397202|NCT04677660|582839098|FG000|Overall Study|Lost to Follow-up|0|||
161397203|NCT04677660|582839099|FG001|Overall Study|Lost to Follow-up|2|||
161397204|NCT04677660|582839098|FG000|Overall Study|Withdrawal by Subject|0|||
161397205|NCT04677660|582839099|FG001|Overall Study|Withdrawal by Subject|1|||
161397206|NCT04677660|582839098|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
161397207|NCT04677660|582839099|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
161397208|NCT03242772|582839100|FG000|Overall Study|Lost to Follow-up|2|||
161397209|NCT03242772|582839101|FG001|Overall Study|Lost to Follow-up|0|||
161397210|NCT03242772|582839100|FG000|Overall Study|Physician Decision|0|||
161397211|NCT03242772|582839101|FG001|Overall Study|Physician Decision|1|||
161397212|NCT03242772|582839100|FG000|Overall Study|Withdrawal by Subject|1|||
161397213|NCT03242772|582839101|FG001|Overall Study|Withdrawal by Subject|0|||
161397214|NCT02499900|582839102|FG000|Core Study Period|Other|1|||
161397215|NCT02499900|582839103|FG001|Core Study Period|Other|4|||
161397216|NCT02499900|582839102|FG000|Core Study Period|Lost to Follow-up|1|||
161397217|NCT02499900|582839103|FG001|Core Study Period|Lost to Follow-up|2|||
161397218|NCT02499900|582839102|FG000|Core Study Period|Per sponsor request|0|||
161397219|NCT02499900|582839103|FG001|Core Study Period|Per sponsor request|1|||
161397220|NCT02499900|582839102|FG000|Core Study Period|Pregnancy|1|||
161397221|NCT02499900|582839103|FG001|Core Study Period|Pregnancy|0|||
161397222|NCT02499900|582839102|FG000|Core Study Period|Protocol Violation|3|||
161397223|NCT02499900|582839103|FG001|Core Study Period|Protocol Violation|0|||
161397224|NCT02499900|582839102|FG000|Core Study Period|Withdrawal by Subject|11|||
161397225|NCT02499900|582839103|FG001|Core Study Period|Withdrawal by Subject|10|||
161397226|NCT02499900|582839102|FG000|Core Study Period|Adverse Event|18|||
161397227|NCT02499900|582839103|FG001|Core Study Period|Adverse Event|14|||
161397228|NCT02499900|582839102|FG000|Core Study Period|Death|0|||
161397229|NCT02499900|582839103|FG001|Core Study Period|Death|1|||
161397230|NCT02499900|582839102|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
161397231|NCT02499900|582839103|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
161397232|NCT02499900|582839102|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
161397233|NCT02499900|582839103|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
161397234|NCT02499900|582839102|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
161397235|NCT02499900|582839103|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
161397236|NCT02499900|582839102|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
161397237|NCT02499900|582839103|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
161397238|NCT02499900|582839102|FG000|Extension Study Period|Adverse Event|2|||
161397239|NCT02499900|582839103|FG001|Extension Study Period|Adverse Event|4|||
161397240|NCT02499900|582839102|FG000|Extension Study Period|Withdrawal by Subject|5|||
161397241|NCT02499900|582839103|FG001|Extension Study Period|Withdrawal by Subject|2|||
161397242|NCT02499900|582839102|FG000|Extension Study Period|Physician Decision|2|||
161397243|NCT02499900|582839103|FG001|Extension Study Period|Physician Decision|5|||
161397244|NCT02499900|582839102|FG000|Extension Study Period|Pregnancy|1|||
161397245|NCT02499900|582839103|FG001|Extension Study Period|Pregnancy|2|||
161397246|NCT02499900|582839102|FG000|Extension Study Period|Lost to Follow-up|2|||
161397247|NCT02499900|582839103|FG001|Extension Study Period|Lost to Follow-up|5|||
161397248|NCT02499900|582839102|FG000|Extension Study Period|Other|0|||
161397249|NCT02499900|582839103|FG001|Extension Study Period|Other|2|||
161397250|NCT02439450|582839105|FG000|Overall Study|Adverse Event|4|||
161397251|NCT02439450|582839106|FG001|Overall Study|Adverse Event|1|||
161397252|NCT02439450|582839107|FG002|Overall Study|Adverse Event|0|||
161397253|NCT02439450|582839108|FG003|Overall Study|Adverse Event|0|||
161397254|NCT02439450|582839105|FG000|Overall Study|Withdrawal by Subject|1|||
161397255|NCT02439450|582839106|FG001|Overall Study|Withdrawal by Subject|2|||
161397256|NCT02439450|582839107|FG002|Overall Study|Withdrawal by Subject|0|||
161397257|NCT02439450|582839108|FG003|Overall Study|Withdrawal by Subject|0|||
161397258|NCT02439450|582839105|FG000|Overall Study|Death|3|||
161397259|NCT02439450|582839106|FG001|Overall Study|Death|0|||
161397260|NCT02439450|582839107|FG002|Overall Study|Death|0|||
161397261|NCT02439450|582839108|FG003|Overall Study|Death|1|||
161397262|NCT02439450|582839105|FG000|Overall Study|Progressive Disease|18|||
161397263|NCT02439450|582839106|FG001|Overall Study|Progressive Disease|41|||
161397264|NCT02439450|582839107|FG002|Overall Study|Progressive Disease|2|||
161397265|NCT02439450|582839108|FG003|Overall Study|Progressive Disease|3|||
161397266|NCT03730961|582839111|FG000|Overall Study|Adverse Event|0|||
161397267|NCT03730961|582839112|FG001|Overall Study|Adverse Event|1|||
161397268|NCT01646645|582839115|FG000|Overall Study|No Treated|1|||
161397269|NCT01646645|582839115|FG000|Overall Study|Inevaluable Donor|29|||
161397270|NCT00717522|582839116|FG000|Overall Study|Disease Progression|5|||
161397271|NCT00717522|582839116|FG000|Overall Study|Adverse Event|1|||
161397272|NCT00717522|582839116|FG000|Overall Study|Death|1|||
161397273|NCT01799239|582839117|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
161397274|NCT01799239|582839118|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
161397275|NCT01799239|582839117|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
161397276|NCT01799239|582839118|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
161397277|NCT01799239|582839117|FG000|Period 1 (7 Days)|Protocol Violation|0|||
161397278|NCT01799239|582839118|FG001|Period 1 (7 Days)|Protocol Violation|1|||
161397279|NCT01799239|582839117|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
161397280|NCT01799239|582839118|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
161397281|NCT01799239|582839117|FG000|Period 2 (7 Days)|Protocol Violation|1|||
161397282|NCT01799239|582839118|FG001|Period 2 (7 Days)|Protocol Violation|0|||
161397283|NCT04209114|582839119|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
161397284|NCT04209114|582839120|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
161397285|NCT04209114|582839121|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
161397286|NCT04209114|582839119|FG000|Pre-Treatment Phase|Other reasons|0|||
161397287|NCT04209114|582839120|FG001|Pre-Treatment Phase|Other reasons|0|||
161397288|NCT04209114|582839121|FG002|Pre-Treatment Phase|Other reasons|1|||
161397289|NCT04209114|582839119|FG000|Pre-Treatment Phase|Death|0|||
161397290|NCT04209114|582839120|FG001|Pre-Treatment Phase|Death|0|||
161397291|NCT04209114|582839121|FG002|Pre-Treatment Phase|Death|1|||
161397292|NCT04209114|582839119|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
161397293|NCT04209114|582839120|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
161397294|NCT04209114|582839121|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
161397295|NCT04209114|582839119|FG000|Treatment Phase|Other reasons|5|||
161397296|NCT04209114|582839120|FG001|Treatment Phase|Other reasons|3|||
161397297|NCT04209114|582839121|FG002|Treatment Phase|Other reasons|0|||
161397298|NCT04209114|582839119|FG000|Treatment Phase|Lost to Follow-up|1|||
161397299|NCT04209114|582839120|FG001|Treatment Phase|Lost to Follow-up|0|||
161397300|NCT04209114|582839121|FG002|Treatment Phase|Lost to Follow-up|0|||
161397301|NCT04209114|582839119|FG000|Treatment Phase|Participant withdrew consent|1|||
161397302|NCT04209114|582839120|FG001|Treatment Phase|Participant withdrew consent|0|||
161397303|NCT04209114|582839121|FG002|Treatment Phase|Participant withdrew consent|0|||
161397304|NCT04209114|582839119|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
161397305|NCT04209114|582839120|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
161397306|NCT04209114|582839121|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
161397307|NCT04209114|582839119|FG000|Treatment Phase|Death|4|||
161397308|NCT04209114|582839120|FG001|Treatment Phase|Death|1|||
161397309|NCT04209114|582839121|FG002|Treatment Phase|Death|0|||
161397310|NCT04209114|582839119|FG000|Treatment Phase|Study drug toxicity|4|||
161397311|NCT04209114|582839120|FG001|Treatment Phase|Study drug toxicity|6|||
161397312|NCT04209114|582839121|FG002|Treatment Phase|Study drug toxicity|0|||
161397313|NCT04209114|582839119|FG000|Treatment Phase|Disease progression|6|||
161397314|NCT04209114|582839120|FG001|Treatment Phase|Disease progression|9|||
161397315|NCT04209114|582839121|FG002|Treatment Phase|Disease progression|0|||
161397316|NCT01444027|582839134|FG000|Overall Study|Withdrawal by Subject|4|||
161397317|NCT01444027|582839135|FG001|Overall Study|Withdrawal by Subject|10|||
161397318|NCT01444027|582839136|FG002|Overall Study|Withdrawal by Subject|24|||
161397319|NCT01444027|582839134|FG000|Overall Study|Lost to Follow-up|26|||
161397320|NCT01444027|582839135|FG001|Overall Study|Lost to Follow-up|20|||
161397321|NCT01444027|582839136|FG002|Overall Study|Lost to Follow-up|14|||
161397322|NCT03966885|582840836|FG000|Overall Study|Death|1|||
161397323|NCT03966885|582840837|FG001|Overall Study|Death|0|||
161397324|NCT03966885|582840836|FG000|Overall Study|Lost to Follow-up|1|||
161397325|NCT03966885|582840837|FG001|Overall Study|Lost to Follow-up|2|||
161397326|NCT03966885|582840836|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
161397327|NCT03966885|582840837|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
161397328|NCT03966885|582840836|FG000|Overall Study|Moved from study area.|0|||
161397329|NCT03966885|582840837|FG001|Overall Study|Moved from study area.|2|||
161397330|NCT01514240|582840838|FG000|Overall Study|Adverse Event|4|||
161397331|NCT01514240|582840839|FG001|Overall Study|Adverse Event|4|||
161397332|NCT01514240|582840838|FG000|Overall Study|Subject Decision|2|||
161397333|NCT01514240|582840839|FG001|Overall Study|Subject Decision|7|||
161397334|NCT00509093|582840840|FG000|Overall Study|Adverse Event|10|||
161397335|NCT00509093|582840840|FG000|Overall Study|Disease Progression|9|||
161397336|NCT00509093|582840840|FG000|Overall Study|Transformed into MDS|1|||
161397337|NCT00509093|582840840|FG000|Overall Study|Withdrawal by Subject|3|||
161397338|NCT00509093|582840840|FG000|Overall Study|Physician Decision|1|||
161397339|NCT05013424|582840841|FG000|Overall Study|Lost to Follow-up|1|||
161397340|NCT05013424|582840842|FG001|Overall Study|Lost to Follow-up|1|||
161397341|NCT05013424|582840843|FG002|Overall Study|Lost to Follow-up|1|||
161397342|NCT05013424|582840841|FG000|Overall Study|Withdrawal by Subject|0|||
161397343|NCT05013424|582840842|FG001|Overall Study|Withdrawal by Subject|1|||
161397344|NCT05013424|582840843|FG002|Overall Study|Withdrawal by Subject|0|||
161397345|NCT04143217|582840850|FG000|Overall Study|Withdrawal by Subject|42|||
161397346|NCT04143217|582840850|FG000|Overall Study|Adverse Event|29|||
161397347|NCT04143217|582840850|FG000|Overall Study|Lost to Follow-up|29|||
161397348|NCT04143217|582840850|FG000|Overall Study|Lack of Efficacy|15|||
161397349|NCT04143217|582840850|FG000|Overall Study|Physician Decision|1|||
161397350|NCT04143217|582840850|FG000|Overall Study|Non-Compliance With Study Drug|6|||
161397351|NCT04143217|582840850|FG000|Overall Study|Other, Multiple Categories|11|||
161397352|NCT00471887|582840853|FG000|Overall Study|Adverse Event|9|||
161397353|NCT03710876|582840854|FG000|Overall Study|Death|0|||
161397354|NCT03710876|582840855|FG001|Overall Study|Death|2|||
161397355|NCT03710876|582840854|FG000|Overall Study|Withdrawal by Subject|0|||
161397356|NCT03710876|582840855|FG001|Overall Study|Withdrawal by Subject|2|||
161397357|NCT01460719|582840856|FG000|Overall Study|Adverse Event|1|||
161397358|NCT01460719|582840856|FG000|Overall Study|Withdrawal by Subject|1|||
161397359|NCT02285114|582840858|FG000|Main Phase|Investigator's Discretion|0|||
161397360|NCT02285114|582840859|FG001|Main Phase|Investigator's Discretion|2|||
161397361|NCT02285114|582840860|FG002|Main Phase|Investigator's Discretion|0|||
161397362|NCT02285114|582840861|FG003|Main Phase|Investigator's Discretion|0|||
161397363|NCT02285114|582840862|FG004|Main Phase|Investigator's Discretion|0|||
161397364|NCT02285114|582840863|FG005|Main Phase|Investigator's Discretion|0|||
161397365|NCT02285114|582840858|FG000|Main Phase|Enrolled but Never Treated|1|||
161397366|NCT02285114|582840859|FG001|Main Phase|Enrolled but Never Treated|0|||
161397367|NCT02285114|582840860|FG002|Main Phase|Enrolled but Never Treated|0|||
161397368|NCT02285114|582840861|FG003|Main Phase|Enrolled but Never Treated|0|||
161397369|NCT02285114|582840862|FG004|Main Phase|Enrolled but Never Treated|0|||
161397370|NCT02285114|582840863|FG005|Main Phase|Enrolled but Never Treated|0|||
161397371|NCT02285114|582840858|FG000|Main Phase|Withdrew Consent|0|||
161397372|NCT02285114|582840859|FG001|Main Phase|Withdrew Consent|0|||
161397373|NCT02285114|582840860|FG002|Main Phase|Withdrew Consent|1|||
161397374|NCT02285114|582840861|FG003|Main Phase|Withdrew Consent|0|||
161397375|NCT02285114|582840862|FG004|Main Phase|Withdrew Consent|0|||
161397376|NCT02285114|582840863|FG005|Main Phase|Withdrew Consent|0|||
161397377|NCT02285114|582840858|FG000|Extension Phase|Investigator's Discretion|0|||
161397378|NCT02285114|582840859|FG001|Extension Phase|Investigator's Discretion|0|||
161397379|NCT02285114|582840860|FG002|Extension Phase|Investigator's Discretion|0|||
161397380|NCT02285114|582840861|FG003|Extension Phase|Investigator's Discretion|14|||
161397381|NCT02285114|582840862|FG004|Extension Phase|Investigator's Discretion|1|||
161397382|NCT02285114|582840863|FG005|Extension Phase|Investigator's Discretion|0|||
161397383|NCT02285114|582840858|FG000|Extension Phase|Lost to Follow-up|0|||
161397384|NCT02285114|582840859|FG001|Extension Phase|Lost to Follow-up|0|||
161397385|NCT02285114|582840860|FG002|Extension Phase|Lost to Follow-up|0|||
161397386|NCT02285114|582840861|FG003|Extension Phase|Lost to Follow-up|1|||
161397387|NCT02285114|582840862|FG004|Extension Phase|Lost to Follow-up|1|||
161397388|NCT02285114|582840863|FG005|Extension Phase|Lost to Follow-up|0|||
161397389|NCT02285114|582840858|FG000|Extension Phase|Non-compliance with Study Drug|0|||
161397390|NCT02285114|582840859|FG001|Extension Phase|Non-compliance with Study Drug|0|||
161397391|NCT02285114|582840860|FG002|Extension Phase|Non-compliance with Study Drug|0|||
161397392|NCT02285114|582840861|FG003|Extension Phase|Non-compliance with Study Drug|2|||
161397393|NCT02285114|582840862|FG004|Extension Phase|Non-compliance with Study Drug|0|||
161397394|NCT02285114|582840863|FG005|Extension Phase|Non-compliance with Study Drug|0|||
161397395|NCT02285114|582840858|FG000|Extension Phase|Pregnancy|0|||
161397396|NCT02285114|582840859|FG001|Extension Phase|Pregnancy|0|||
161397397|NCT02285114|582840860|FG002|Extension Phase|Pregnancy|0|||
161397398|NCT02285114|582840861|FG003|Extension Phase|Pregnancy|1|||
161397399|NCT02285114|582840862|FG004|Extension Phase|Pregnancy|0|||
161397400|NCT02285114|582840863|FG005|Extension Phase|Pregnancy|0|||
161397401|NCT00320255|582840864|FG000|Overall Study|Lack of Efficacy|1|||
161397402|NCT00320255|582840865|FG001|Overall Study|Lack of Efficacy|0|||
161397403|NCT00320255|582840866|FG002|Overall Study|Lack of Efficacy|0|||
161397404|NCT00320255|582840867|FG003|Overall Study|Lack of Efficacy|0|||
161397405|NCT00320255|582840868|FG004|Overall Study|Lack of Efficacy|0|||
161397406|NCT00320255|582840869|FG005|Overall Study|Lack of Efficacy|0|||
161397407|NCT00320255|582840864|FG000|Overall Study|Adverse Event|5|||
161397408|NCT00320255|582840865|FG001|Overall Study|Adverse Event|2|||
161397409|NCT00320255|582840866|FG002|Overall Study|Adverse Event|3|||
161397410|NCT00320255|582840867|FG003|Overall Study|Adverse Event|2|||
161397411|NCT00320255|582840868|FG004|Overall Study|Adverse Event|0|||
161397412|NCT00320255|582840869|FG005|Overall Study|Adverse Event|0|||
161397413|NCT00320255|582840864|FG000|Overall Study|Withdrawal by Subject|1|||
161397414|NCT00320255|582840865|FG001|Overall Study|Withdrawal by Subject|2|||
161397415|NCT00320255|582840866|FG002|Overall Study|Withdrawal by Subject|2|||
161397416|NCT00320255|582840867|FG003|Overall Study|Withdrawal by Subject|4|||
161397417|NCT00320255|582840868|FG004|Overall Study|Withdrawal by Subject|0|||
161397418|NCT00320255|582840869|FG005|Overall Study|Withdrawal by Subject|0|||
161397419|NCT00320255|582840864|FG000|Overall Study|Poor compliance/noncompliance|1|||
161397420|NCT00320255|582840865|FG001|Overall Study|Poor compliance/noncompliance|1|||
161397421|NCT00320255|582840866|FG002|Overall Study|Poor compliance/noncompliance|0|||
161397422|NCT00320255|582840867|FG003|Overall Study|Poor compliance/noncompliance|1|||
161397423|NCT00320255|582840868|FG004|Overall Study|Poor compliance/noncompliance|0|||
161397424|NCT00320255|582840869|FG005|Overall Study|Poor compliance/noncompliance|0|||
161397425|NCT00320255|582840864|FG000|Overall Study|No longer meets study criteria|0|||
161397426|NCT00320255|582840865|FG001|Overall Study|No longer meets study criteria|0|||
161397427|NCT00320255|582840866|FG002|Overall Study|No longer meets study criteria|0|||
161397428|NCT00320255|582840867|FG003|Overall Study|No longer meets study criteria|1|||
161397429|NCT00320255|582840868|FG004|Overall Study|No longer meets study criteria|0|||
161397430|NCT00320255|582840869|FG005|Overall Study|No longer meets study criteria|0|||
161397431|NCT00320255|582840864|FG000|Overall Study|Other|3|||
161397432|NCT00320255|582840865|FG001|Overall Study|Other|2|||
161397433|NCT00320255|582840866|FG002|Overall Study|Other|1|||
161397434|NCT00320255|582840867|FG003|Overall Study|Other|0|||
161397435|NCT00320255|582840868|FG004|Overall Study|Other|0|||
161397436|NCT00320255|582840869|FG005|Overall Study|Other|0|||
161397437|NCT00683917|582840872|FG000|Overall Study|Study prematurely terminated|10|||
161397438|NCT03022097|582840878|FG000|Overall Study|Adverse Event|3|||
161397439|NCT03022097|582840879|FG001|Overall Study|Adverse Event|4|||
161397440|NCT03022097|582840880|FG002|Overall Study|Adverse Event|1|||
161397441|NCT03022097|582840881|FG003|Overall Study|Adverse Event|3|||
161397442|NCT03022097|582840878|FG000|Overall Study|Progressive Disease|2|||
161397443|NCT03022097|582840879|FG001|Overall Study|Progressive Disease|0|||
161397444|NCT03022097|582840880|FG002|Overall Study|Progressive Disease|5|||
161397445|NCT03022097|582840881|FG003|Overall Study|Progressive Disease|2|||
161397446|NCT03022097|582840878|FG000|Overall Study|Lack of Efficacy|0|||
161397447|NCT03022097|582840879|FG001|Overall Study|Lack of Efficacy|0|||
161397448|NCT03022097|582840880|FG002|Overall Study|Lack of Efficacy|3|||
161397449|NCT03022097|582840881|FG003|Overall Study|Lack of Efficacy|3|||
161397450|NCT03022097|582840878|FG000|Overall Study|Protocol Violation|1|||
161397451|NCT03022097|582840879|FG001|Overall Study|Protocol Violation|0|||
161397452|NCT03022097|582840880|FG002|Overall Study|Protocol Violation|1|||
161397453|NCT03022097|582840881|FG003|Overall Study|Protocol Violation|0|||
161397454|NCT03022097|582840878|FG000|Overall Study|Withdrawal by Subject|11|||
161397455|NCT03022097|582840879|FG001|Overall Study|Withdrawal by Subject|13|||
161397456|NCT03022097|582840880|FG002|Overall Study|Withdrawal by Subject|15|||
161397457|NCT03022097|582840881|FG003|Overall Study|Withdrawal by Subject|21|||
161397458|NCT03022097|582840878|FG000|Overall Study|Lost to Follow-up|0|||
161397459|NCT03022097|582840879|FG001|Overall Study|Lost to Follow-up|0|||
161397460|NCT03022097|582840880|FG002|Overall Study|Lost to Follow-up|1|||
161397461|NCT03022097|582840881|FG003|Overall Study|Lost to Follow-up|1|||
161397462|NCT03022097|582840878|FG000|Overall Study|Other|4|||
161397463|NCT03022097|582840879|FG001|Overall Study|Other|1|||
161397464|NCT03022097|582840880|FG002|Overall Study|Other|6|||
161397465|NCT03022097|582840881|FG003|Overall Study|Other|4|||
161397466|NCT03022097|582840878|FG000|Overall Study|Due to COVID-19 pandemic|0|||
161397467|NCT03022097|582840879|FG001|Overall Study|Due to COVID-19 pandemic|1|||
161397468|NCT03022097|582840880|FG002|Overall Study|Due to COVID-19 pandemic|0|||
161397469|NCT03022097|582840881|FG003|Overall Study|Due to COVID-19 pandemic|0|||
161397470|NCT00623545|582840882|FG000|Overall Study|Adverse Event|6|||
161397471|NCT00623545|582840882|FG000|Overall Study|Withdrawal by Subject|4|||
161397472|NCT04239222|582840883|FG000|Baseline|Withdrawal by Subject|0|||
161397473|NCT04239222|582840884|FG001|Baseline|Withdrawal by Subject|0|||
161397474|NCT04239222|582840885|FG002|Baseline|Withdrawal by Subject|1|||
161397475|NCT04239222|582840886|FG003|Baseline|Withdrawal by Subject|1|||
161397476|NCT04239222|582840883|FG000|First Foot Assignment|Withdrawal by Subject|0|||
161397477|NCT04239222|582840884|FG001|First Foot Assignment|Withdrawal by Subject|0|||
161397478|NCT04239222|582840885|FG002|First Foot Assignment|Withdrawal by Subject|1|||
161397479|NCT04239222|582840886|FG003|First Foot Assignment|Withdrawal by Subject|0|||
161397480|NCT04239222|582840883|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
161397481|NCT04239222|582840884|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
161397482|NCT04239222|582840885|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
161397483|NCT04239222|582840886|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
161397484|NCT00230282|582840890|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
161397485|NCT00230282|582840890|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
161397486|NCT00230282|582840890|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
161397487|NCT00230282|582840890|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
161397488|NCT01560637|582840895|FG000|Overall Study|Adverse Event|63|||
161397489|NCT01560637|582840895|FG000|Overall Study|Death|69|||
161397490|NCT01560637|582840895|FG000|Overall Study|Lost to Follow-up|8|||
161397491|NCT01560637|582840895|FG000|Overall Study|Protocol Violation|8|||
161397492|NCT01560637|582840895|FG000|Overall Study|Withdrawal by Subject|24|||
161397493|NCT01560637|582840895|FG000|Overall Study|Progressive Disease|20|||
161397494|NCT01560637|582840895|FG000|Overall Study|Other Reason Not Specified|6|||
161397495|NCT01089023|582840896|FG000|Overall Study|Lost to Follow-up|3|||
161397496|NCT01089023|582840896|FG000|Overall Study|Adverse Event|1|||
161397497|NCT01089023|582840896|FG000|Overall Study|Withdrawal by Subject|1|||
161397498|NCT01089023|582840896|FG000|Overall Study|Protocol Violation|1|||
161397499|NCT01089023|582840896|FG000|Overall Study|Lack of Efficacy|1|||
161397500|NCT02434354|582840901|FG000|Overall Study|screen fail|3|||
161397501|NCT01185964|582840903|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
161397502|NCT01185964|582840904|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
161397503|NCT01185964|582840905|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
161397504|NCT01185964|582840906|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
161397505|NCT01185964|582840903|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
161397506|NCT01185964|582840904|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
161397507|NCT01185964|582840905|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
161397508|NCT01185964|582840906|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
161397509|NCT01185964|582840903|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
161397510|NCT01185964|582840904|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
161397511|NCT01185964|582840905|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
161397512|NCT01185964|582840906|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
161397513|NCT01185964|582840903|FG000|Phase 1b and Phase 2|Adverse Event|1|||
161397514|NCT01185964|582840904|FG001|Phase 1b and Phase 2|Adverse Event|0|||
161397515|NCT01185964|582840905|FG002|Phase 1b and Phase 2|Adverse Event|2|||
161397516|NCT01185964|582840906|FG003|Phase 1b and Phase 2|Adverse Event|0|||
161397517|NCT01185964|582840903|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
161397518|NCT01185964|582840904|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
161397519|NCT01185964|582840905|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
161397520|NCT01185964|582840906|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
161397521|NCT01185964|582840903|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
161397522|NCT01185964|582840904|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
161397523|NCT01185964|582840905|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
161397524|NCT01185964|582840906|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
161397525|NCT01185964|582840903|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
161397526|NCT01185964|582840904|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
161397527|NCT01185964|582840905|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
161397528|NCT01185964|582840906|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
161397529|NCT01185964|582840903|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
161397530|NCT01185964|582840904|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
161397531|NCT01185964|582840905|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
161397532|NCT01185964|582840906|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
161397533|NCT03576755|582840920|FG000|Overall Study|Withdrawal by Subject|1|||
161397534|NCT03576755|582840921|FG001|Overall Study|Withdrawal by Subject|0|||
161397535|NCT03576755|582840922|FG002|Overall Study|Withdrawal by Subject|0|||
161397536|NCT03576755|582840923|FG003|Overall Study|Withdrawal by Subject|0|||
161397537|NCT04962230|582840924|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
161397538|NCT04962230|582840924|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
161397539|NCT02275117|582840925|FG000|Overall Study|Adverse Event|0|||
161397540|NCT02275117|582840926|FG001|Overall Study|Adverse Event|0|||
161397541|NCT02275117|582840927|FG002|Overall Study|Adverse Event|0|||
161397542|NCT02275117|582840928|FG003|Overall Study|Adverse Event|0|||
161397543|NCT02275117|582840929|FG004|Overall Study|Adverse Event|1|||
161397544|NCT02275117|582840925|FG000|Overall Study|Lack of Efficacy|6|||
161397545|NCT02275117|582840926|FG001|Overall Study|Lack of Efficacy|7|||
161397546|NCT02275117|582840927|FG002|Overall Study|Lack of Efficacy|5|||
161397547|NCT02275117|582840928|FG003|Overall Study|Lack of Efficacy|2|||
161397548|NCT02275117|582840929|FG004|Overall Study|Lack of Efficacy|10|||
161397549|NCT02275117|582840925|FG000|Overall Study|Lost to Follow-up|11|||
161397550|NCT02275117|582840926|FG001|Overall Study|Lost to Follow-up|16|||
161397551|NCT02275117|582840927|FG002|Overall Study|Lost to Follow-up|15|||
161397552|NCT02275117|582840928|FG003|Overall Study|Lost to Follow-up|16|||
161397553|NCT02275117|582840929|FG004|Overall Study|Lost to Follow-up|8|||
161397554|NCT02275117|582840925|FG000|Overall Study|Physician Decision|0|||
161397555|NCT02275117|582840926|FG001|Overall Study|Physician Decision|1|||
161397556|NCT02275117|582840927|FG002|Overall Study|Physician Decision|1|||
161397557|NCT02275117|582840928|FG003|Overall Study|Physician Decision|0|||
161397558|NCT02275117|582840929|FG004|Overall Study|Physician Decision|1|||
161397559|NCT02275117|582840925|FG000|Overall Study|Protocol Violation|1|||
161397560|NCT02275117|582840926|FG001|Overall Study|Protocol Violation|0|||
161397561|NCT02275117|582840927|FG002|Overall Study|Protocol Violation|1|||
161397562|NCT02275117|582840928|FG003|Overall Study|Protocol Violation|1|||
161397563|NCT02275117|582840929|FG004|Overall Study|Protocol Violation|0|||
161397564|NCT02275117|582840925|FG000|Overall Study|Withdrawal by Subject|6|||
161397565|NCT02275117|582840926|FG001|Overall Study|Withdrawal by Subject|4|||
161397566|NCT02275117|582840927|FG002|Overall Study|Withdrawal by Subject|7|||
161397567|NCT02275117|582840928|FG003|Overall Study|Withdrawal by Subject|3|||
161397568|NCT02275117|582840929|FG004|Overall Study|Withdrawal by Subject|3|||
161397569|NCT02275117|582840925|FG000|Overall Study|Terminated by Sponsor|4|||
161397570|NCT02275117|582840926|FG001|Overall Study|Terminated by Sponsor|4|||
161397571|NCT02275117|582840927|FG002|Overall Study|Terminated by Sponsor|4|||
161397572|NCT02275117|582840928|FG003|Overall Study|Terminated by Sponsor|6|||
161397573|NCT02275117|582840929|FG004|Overall Study|Terminated by Sponsor|4|||
161397574|NCT02275117|582840925|FG000|Overall Study|Worsening of Study Indication|0|||
161397575|NCT02275117|582840926|FG001|Overall Study|Worsening of Study Indication|1|||
161397576|NCT02275117|582840927|FG002|Overall Study|Worsening of Study Indication|2|||
161397577|NCT02275117|582840928|FG003|Overall Study|Worsening of Study Indication|0|||
161397578|NCT02275117|582840929|FG004|Overall Study|Worsening of Study Indication|0|||
161397579|NCT02275117|582840925|FG000|Overall Study|Study Burden|5|||
161397580|NCT02275117|582840926|FG001|Overall Study|Study Burden|4|||
161397581|NCT02275117|582840927|FG002|Overall Study|Study Burden|7|||
161397582|NCT02275117|582840928|FG003|Overall Study|Study Burden|5|||
161397583|NCT02275117|582840929|FG004|Overall Study|Study Burden|7|||
161397584|NCT02275117|582840925|FG000|Overall Study|Other|1|||
161397585|NCT02275117|582840926|FG001|Overall Study|Other|0|||
161397586|NCT02275117|582840927|FG002|Overall Study|Other|0|||
161397587|NCT02275117|582840928|FG003|Overall Study|Other|0|||
161397588|NCT02275117|582840929|FG004|Overall Study|Other|2|||
161397589|NCT01081301|582840933|FG000|Overall Study|Bereaved|3|||
161397590|NCT01081301|582840933|FG000|Overall Study|Too busy|5|||
161397591|NCT01081301|582840933|FG000|Overall Study|Patient too ill|2|||
161397592|NCT01081301|582840933|FG000|Overall Study|Lost to Follow-up|4|||
161397593|NCT02014480|582840934|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161397594|NCT02014480|582840935|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161397595|NCT02014480|582840936|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
161397596|NCT02014480|582840937|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161397597|NCT02014480|582840938|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161397598|NCT02014480|582840939|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161397599|NCT02014480|582840934|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161397600|NCT02014480|582840935|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161397601|NCT02014480|582840936|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161397602|NCT02014480|582840937|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
161397603|NCT02014480|582840938|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161397604|NCT02014480|582840939|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161397605|NCT02014480|582840934|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161397606|NCT02014480|582840935|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161397607|NCT02014480|582840936|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
161397608|NCT02014480|582840937|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161397609|NCT02014480|582840938|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161397610|NCT02014480|582840939|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161397611|NCT02014480|582840934|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161397612|NCT02014480|582840935|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161397613|NCT02014480|582840936|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
161397614|NCT02014480|582840937|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161397615|NCT02014480|582840938|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161397616|NCT02014480|582840939|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161397617|NCT02014480|582840934|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161397618|NCT02014480|582840935|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
161397619|NCT02014480|582840936|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161397620|NCT02014480|582840937|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161397621|NCT02014480|582840938|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161397622|NCT02014480|582840939|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161397623|NCT02014480|582840934|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
161397624|NCT02014480|582840935|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
161397625|NCT02014480|582840936|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
161397626|NCT02014480|582840937|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
161397627|NCT02014480|582840938|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
161397628|NCT02014480|582840939|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
161397629|NCT02014480|582840934|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161397630|NCT02014480|582840935|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161397631|NCT02014480|582840936|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161397632|NCT02014480|582840937|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161397633|NCT02014480|582840938|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161397634|NCT02014480|582840939|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
161397635|NCT01865812|582840940|FG000|Primary Treatment Phase|Adverse Event|2|||
161397636|NCT01865812|582840941|FG001|Primary Treatment Phase|Adverse Event|0|||
161397637|NCT01865812|582840940|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
161397638|NCT01865812|582840941|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
161397639|NCT01865812|582840940|FG000|Long-term Safety Extension Phase|Pruritus|0|||
161397640|NCT01865812|582840941|FG001|Long-term Safety Extension Phase|Pruritus|3|||
161397641|NCT01865812|582840940|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
161397642|NCT01865812|582840941|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
161397643|NCT01865812|582840940|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
161397644|NCT01865812|582840941|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
161397645|NCT00724854|582840942|FG000|Overall Study|Lack of Efficacy|187|||
161397646|NCT00724854|582840943|FG001|Overall Study|Lack of Efficacy|13|||
161397647|NCT00724854|582840942|FG000|Overall Study|Lost to Follow-up|87|||
161397648|NCT00724854|582840943|FG001|Overall Study|Lost to Follow-up|10|||
161397649|NCT00724854|582840942|FG000|Overall Study|Adverse Event|62|||
161397650|NCT00724854|582840943|FG001|Overall Study|Adverse Event|4|||
161397651|NCT00724854|582840942|FG000|Overall Study|Other|42|||
161397652|NCT00724854|582840943|FG001|Overall Study|Other|3|||
161397653|NCT00724854|582840942|FG000|Overall Study|Death|11|||
161397654|NCT00724854|582840943|FG001|Overall Study|Death|0|||
161397655|NCT00724854|582840942|FG000|Overall Study|Change of treatment|7|||
161397656|NCT00724854|582840943|FG001|Overall Study|Change of treatment|0|||
161397657|NCT00724854|582840942|FG000|Overall Study|Withdrawal by Subject|5|||
161397658|NCT00724854|582840943|FG001|Overall Study|Withdrawal by Subject|0|||
161397659|NCT00724854|582840942|FG000|Overall Study|Adverse event + lack of efficacy|2|||
161397660|NCT00724854|582840943|FG001|Overall Study|Adverse event + lack of efficacy|1|||
161397661|NCT01338610|582840944|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
161397662|NCT01338610|582840945|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
161397663|NCT01338610|582840946|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
161397664|NCT01338610|582840944|FG000|Overall Study|Protocol Violation|1|||
161397665|NCT01338610|582840945|FG001|Overall Study|Protocol Violation|0|||
161397666|NCT01338610|582840946|FG002|Overall Study|Protocol Violation|1|||
161397667|NCT01338610|582840944|FG000|Overall Study|Adverse Event|3|||
161397668|NCT01338610|582840945|FG001|Overall Study|Adverse Event|0|||
161397669|NCT01338610|582840946|FG002|Overall Study|Adverse Event|0|||
161397670|NCT02046226|582840947|FG000|Overall Study|Lost to Follow-up|7|||
161397671|NCT01095653|582840948|FG000|Overall Study|Lack of Efficacy|3|||
161397672|NCT01095653|582840949|FG001|Overall Study|Lack of Efficacy|0|||
161397673|NCT01095653|582840950|FG002|Overall Study|Lack of Efficacy|0|||
161397674|NCT01095653|582840948|FG000|Overall Study|Adverse Event|1|||
161397675|NCT01095653|582840949|FG001|Overall Study|Adverse Event|4|||
161397676|NCT01095653|582840950|FG002|Overall Study|Adverse Event|4|||
161397677|NCT01095653|582840948|FG000|Overall Study|Lost to Follow-up|1|||
161397678|NCT01095653|582840949|FG001|Overall Study|Lost to Follow-up|0|||
161397679|NCT01095653|582840950|FG002|Overall Study|Lost to Follow-up|4|||
161397680|NCT01095653|582840948|FG000|Overall Study|Withdrawal by Subject|4|||
161397681|NCT01095653|582840949|FG001|Overall Study|Withdrawal by Subject|5|||
161397682|NCT01095653|582840950|FG002|Overall Study|Withdrawal by Subject|3|||
161397683|NCT01095653|582840948|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
161397684|NCT01095653|582840949|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
161397685|NCT01095653|582840950|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
161397686|NCT02692040|582840951|FG000|Overall Study|Protocol Violation|0|||
161397687|NCT02692040|582840952|FG001|Overall Study|Protocol Violation|0|||
161397688|NCT02692040|582840953|FG002|Overall Study|Protocol Violation|0|||
161397689|NCT02692040|582840954|FG003|Overall Study|Protocol Violation|0|||
161397690|NCT02692040|582840955|FG004|Overall Study|Protocol Violation|0|||
161397691|NCT02692040|582840956|FG005|Overall Study|Protocol Violation|0|||
161397692|NCT02692040|582840957|FG006|Overall Study|Protocol Violation|0|||
161397693|NCT02692040|582840958|FG007|Overall Study|Protocol Violation|0|||
161397694|NCT02692040|582840959|FG008|Overall Study|Protocol Violation|0|||
161397695|NCT02692040|582840960|FG009|Overall Study|Protocol Violation|0|||
161397696|NCT02692040|582840961|FG010|Overall Study|Protocol Violation|0|||
161397697|NCT02692040|582840962|FG011|Overall Study|Protocol Violation|0|||
161397698|NCT02692040|582840963|FG012|Overall Study|Protocol Violation|1|||
161397699|NCT02692040|582840964|FG013|Overall Study|Protocol Violation|0|||
161397700|NCT02692040|582840965|FG014|Overall Study|Protocol Violation|0|||
161397701|NCT02692040|582840966|FG015|Overall Study|Protocol Violation|0|||
161397702|NCT02692040|582840967|FG016|Overall Study|Protocol Violation|0|||
161397703|NCT02692040|582840951|FG000|Overall Study|Adverse Event|0|||
161397704|NCT02692040|582840952|FG001|Overall Study|Adverse Event|0|||
161397705|NCT02692040|582840953|FG002|Overall Study|Adverse Event|0|||
161397706|NCT02692040|582840954|FG003|Overall Study|Adverse Event|0|||
161397707|NCT02692040|582840955|FG004|Overall Study|Adverse Event|0|||
161397708|NCT02692040|582840956|FG005|Overall Study|Adverse Event|0|||
161397709|NCT02692040|582840957|FG006|Overall Study|Adverse Event|0|||
161397710|NCT02692040|582840958|FG007|Overall Study|Adverse Event|0|||
161397711|NCT02692040|582840959|FG008|Overall Study|Adverse Event|0|||
161397712|NCT02692040|582840960|FG009|Overall Study|Adverse Event|0|||
161397713|NCT02692040|582840961|FG010|Overall Study|Adverse Event|0|||
161397714|NCT02692040|582840962|FG011|Overall Study|Adverse Event|0|||
161397715|NCT02692040|582840963|FG012|Overall Study|Adverse Event|0|||
161397716|NCT02692040|582840964|FG013|Overall Study|Adverse Event|3|||
161397717|NCT02692040|582840965|FG014|Overall Study|Adverse Event|1|||
161397718|NCT02692040|582840966|FG015|Overall Study|Adverse Event|1|||
161397719|NCT02692040|582840967|FG016|Overall Study|Adverse Event|0|||
161397720|NCT00171925|582840971|FG000|Overall Study|Adverse Event|10|||
161397721|NCT00171925|582840972|FG001|Overall Study|Adverse Event|6|||
161397722|NCT00171925|582840971|FG000|Overall Study|Protocol Violation|1|||
161397723|NCT00171925|582840972|FG001|Overall Study|Protocol Violation|1|||
161397724|NCT00171925|582840971|FG000|Overall Study|Withdrawal by Subject|6|||
161397725|NCT00171925|582840972|FG001|Overall Study|Withdrawal by Subject|9|||
161397726|NCT00171925|582840971|FG000|Overall Study|Lost to Follow-up|2|||
161397727|NCT00171925|582840972|FG001|Overall Study|Lost to Follow-up|2|||
161397728|NCT00171925|582840971|FG000|Overall Study|Administrative problems|10|||
161397729|NCT00171925|582840972|FG001|Overall Study|Administrative problems|11|||
161397730|NCT00171925|582840971|FG000|Overall Study|Death|1|||
161397731|NCT00171925|582840972|FG001|Overall Study|Death|2|||
161397732|NCT01819129|582840975|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
161397733|NCT01819129|582840976|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
161397734|NCT01819129|582840975|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
161397735|NCT01819129|582840976|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
161397736|NCT01819129|582840975|FG000|Overall Study|Other, Subject moved out of the country|0|||
161397737|NCT01819129|582840976|FG001|Overall Study|Other, Subject moved out of the country|1|||
161397738|NCT01819129|582840975|FG000|Overall Study|Withdrawal by Subject|15|||
161397739|NCT01819129|582840976|FG001|Overall Study|Withdrawal by Subject|15|||
161397740|NCT01819129|582840975|FG000|Overall Study|Lost to Follow-up|5|||
161397741|NCT01819129|582840976|FG001|Overall Study|Lost to Follow-up|2|||
161397742|NCT01819129|582840975|FG000|Overall Study|Lack of Efficacy|0|||
161397743|NCT01819129|582840976|FG001|Overall Study|Lack of Efficacy|1|||
161397744|NCT01819129|582840975|FG000|Overall Study|Adverse Event|1|||
161397745|NCT01819129|582840976|FG001|Overall Study|Adverse Event|4|||
161397746|NCT01819129|582840975|FG000|Overall Study|Death|1|||
161397747|NCT01819129|582840976|FG001|Overall Study|Death|1|||
161397748|NCT01819129|582840975|FG000|Overall Study|Withdrawal Criteria|20|||
161397749|NCT01819129|582840976|FG001|Overall Study|Withdrawal Criteria|15|||
161397750|NCT02752958|582840978|FG000|Overall Study|Adverse Event|3|||
161397751|NCT02752958|582840978|FG000|Overall Study|Lost to Follow-up|1|||
161397752|NCT02752958|582840978|FG000|Overall Study|Protocol Violation|1|||
161397753|NCT02752958|582840978|FG000|Overall Study|Withdrawal by Subject|2|||
161397754|NCT02752958|582840978|FG000|Overall Study|Other (Reason not specified)|2|||
161397755|NCT00054691|582840981|FG000|Overall Study|Unmeasurable Disease|2|||
161397756|NCT00054691|582840981|FG000|Overall Study|Noncompliant|1|||
161397757|NCT02836873|582840982|FG000|Overall Study|Protocol Violation|0|||
161397758|NCT02836873|582840983|FG001|Overall Study|Protocol Violation|1|||
161397759|NCT02836873|582840982|FG000|Overall Study|Adverse Event|1|||
161397760|NCT02836873|582840983|FG001|Overall Study|Adverse Event|4|||
161397761|NCT02836873|582840982|FG000|Overall Study|Withdrawal by Subject|2|||
161397762|NCT02836873|582840983|FG001|Overall Study|Withdrawal by Subject|2|||
161397763|NCT02836873|582840982|FG000|Overall Study|Lost to Follow-up|1|||
161397764|NCT02836873|582840983|FG001|Overall Study|Lost to Follow-up|3|||
161397765|NCT02836873|582840982|FG000|Overall Study|Physician Decision|0|||
161397766|NCT02836873|582840983|FG001|Overall Study|Physician Decision|1|||
161397767|NCT02836873|582840982|FG000|Overall Study|Other|1|||
161397768|NCT02836873|582840983|FG001|Overall Study|Other|0|||
161397769|NCT00853125|582840990|FG000|Overall Study|Study participant's donor was CMV +|1|||
161397770|NCT02914548|582840993|FG000|Overall Study|Adverse Event|15|||
161397771|NCT02914548|582840994|FG001|Overall Study|Adverse Event|7|||
161397772|NCT02914548|582840995|FG002|Overall Study|Adverse Event|15|||
161397773|NCT02914548|582840993|FG000|Overall Study|Physician Decision|2|||
161397774|NCT02914548|582840994|FG001|Overall Study|Physician Decision|2|||
161397775|NCT02914548|582840995|FG002|Overall Study|Physician Decision|0|||
161397776|NCT02914548|582840993|FG000|Overall Study|Protocol Violation|1|||
161397777|NCT02914548|582840994|FG001|Overall Study|Protocol Violation|0|||
161397778|NCT02914548|582840995|FG002|Overall Study|Protocol Violation|0|||
161397779|NCT02914548|582840993|FG000|Overall Study|Withdrawal by Subject|3|||
161397780|NCT02914548|582840994|FG001|Overall Study|Withdrawal by Subject|4|||
161397781|NCT02914548|582840995|FG002|Overall Study|Withdrawal by Subject|4|||
161397782|NCT02914548|582840993|FG000|Overall Study|>40% of body surface area|0|||
161397783|NCT02914548|582840994|FG001|Overall Study|>40% of body surface area|1|||
161397784|NCT02914548|582840995|FG002|Overall Study|>40% of body surface area|1|||
161397785|NCT03746600|582841000|FG000|Overall Study|Withdrawal by Subject|3|||
161397786|NCT03746600|582841001|FG001|Overall Study|Withdrawal by Subject|3|||
161397787|NCT03746600|582841000|FG000|Overall Study|dismissed from study|1|||
161397788|NCT03746600|582841001|FG001|Overall Study|dismissed from study|0|||
161397789|NCT03746600|582841000|FG000|Overall Study|Lost to Follow-up|1|||
161397790|NCT03746600|582841001|FG001|Overall Study|Lost to Follow-up|0|||
161397791|NCT02374814|582841009|FG000|Overall Study|Lost to Follow-up|1|||
161397792|NCT02374814|582841010|FG001|Overall Study|Lost to Follow-up|1|||
161397793|NCT02374814|582841011|FG002|Overall Study|Lost to Follow-up|0|||
161397794|NCT02374814|582841012|FG003|Overall Study|Lost to Follow-up|1|||
161397795|NCT02374814|582841013|FG004|Overall Study|Lost to Follow-up|0|||
161397796|NCT02374814|582841014|FG005|Overall Study|Lost to Follow-up|0|||
161397797|NCT02374814|582841009|FG000|Overall Study|Withdrawal by Subject|0|||
161397798|NCT02374814|582841010|FG001|Overall Study|Withdrawal by Subject|0|||
161397799|NCT02374814|582841011|FG002|Overall Study|Withdrawal by Subject|1|||
161397800|NCT02374814|582841012|FG003|Overall Study|Withdrawal by Subject|1|||
161397801|NCT02374814|582841013|FG004|Overall Study|Withdrawal by Subject|0|||
161397802|NCT02374814|582841014|FG005|Overall Study|Withdrawal by Subject|0|||
161397803|NCT00884039|582841015|FG000|Overall Study|Withdrawal by Subject|0|||
161397804|NCT00884039|582841016|FG001|Overall Study|Withdrawal by Subject|1|||
161397805|NCT00884039|582841015|FG000|Overall Study|Lack of Efficacy|2|||
161397806|NCT00884039|582841016|FG001|Overall Study|Lack of Efficacy|0|||
161397807|NCT05291936|582841017|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161397808|NCT05291936|582841018|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
161397809|NCT05291936|582841017|FG000|Period 1|Withdrew Consent during study|1|||
161397810|NCT05291936|582841018|FG001|Period 1|Withdrew Consent during study|0|||
161397811|NCT05291936|582841017|FG000|Period 2|Adverse Event|0|||
161397812|NCT05291936|582841018|FG001|Period 2|Adverse Event|1|||
161397813|NCT05291936|582841017|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
161397814|NCT05291936|582841018|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161397815|NCT01300819|582841019|FG000|Overall Study|Adverse Event|9|||
161397816|NCT01300819|582841020|FG001|Overall Study|Adverse Event|27|||
161397817|NCT01300819|582841019|FG000|Overall Study|Lack of Efficacy|2|||
161397818|NCT01300819|582841020|FG001|Overall Study|Lack of Efficacy|1|||
161397819|NCT01300819|582841019|FG000|Overall Study|Withdrawal by Subject|10|||
161397820|NCT01300819|582841020|FG001|Overall Study|Withdrawal by Subject|12|||
161397821|NCT01300819|582841019|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
161397822|NCT01300819|582841020|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
161397823|NCT01300819|582841019|FG000|Overall Study|Refusal to down titrate study drug|0|||
161397824|NCT01300819|582841020|FG001|Overall Study|Refusal to down titrate study drug|1|||
161397825|NCT01300819|582841019|FG000|Overall Study|Administrative reason|0|||
161397826|NCT01300819|582841020|FG001|Overall Study|Administrative reason|1|||
161397827|NCT01300819|582841019|FG000|Overall Study|Safety follow up not done by mistake|0|||
161397828|NCT01300819|582841020|FG001|Overall Study|Safety follow up not done by mistake|1|||
161397829|NCT01300819|582841019|FG000|Overall Study|Follow up call was not done|1|||
161397830|NCT01300819|582841020|FG001|Overall Study|Follow up call was not done|0|||
161397831|NCT00428220|582843113|FG000|Overall Study|Participant died|8|||
161397832|NCT00428220|582843113|FG000|Overall Study|Global deterioration of health status|7|||
161397833|NCT00428220|582843113|FG000|Overall Study|Lost to Follow-up|4|||
161397834|NCT00428220|582843113|FG000|Overall Study|Objective progression or relapse|123|||
161397835|NCT00428220|582843113|FG000|Overall Study|Participant refused continued treatment|7|||
161397836|NCT00428220|582843113|FG000|Overall Study|Adverse Event|51|||
161397837|NCT00428220|582843113|FG000|Overall Study|Other|23|||
161397838|NCT02210832|582843114|FG000|Overall Study|Pregnancy termination .|3|||
161397839|NCT02210832|582843115|FG001|Overall Study|Pregnancy termination .|4|||
161397840|NCT02210832|582843116|FG002|Overall Study|Pregnancy termination .|1|||
161397841|NCT02210832|582843114|FG000|Overall Study|Lost to Follow-up|26|||
161397842|NCT02210832|582843115|FG001|Overall Study|Lost to Follow-up|32|||
161397843|NCT02210832|582843116|FG002|Overall Study|Lost to Follow-up|17|||
161397844|NCT01278407|582843126|FG000|Confirmatory Phase|Adverse Event|5|||
161397845|NCT01278407|582843127|FG001|Confirmatory Phase|Adverse Event|10|||
161397846|NCT01278407|582843128|FG002|Confirmatory Phase|Adverse Event|1|||
161397847|NCT01278407|582843129|FG003|Confirmatory Phase|Adverse Event|0|||
161397848|NCT01278407|582843130|FG004|Confirmatory Phase|Adverse Event|0|||
161397849|NCT01278407|582843126|FG000|Confirmatory Phase|Participant's Choice|3|||
161397850|NCT01278407|582843127|FG001|Confirmatory Phase|Participant's Choice|5|||
161397851|NCT01278407|582843128|FG002|Confirmatory Phase|Participant's Choice|3|||
161397852|NCT01278407|582843129|FG003|Confirmatory Phase|Participant's Choice|0|||
161397853|NCT01278407|582843130|FG004|Confirmatory Phase|Participant's Choice|0|||
161397854|NCT01278407|582843126|FG000|Confirmatory Phase|Other|1|||
161397855|NCT01278407|582843127|FG001|Confirmatory Phase|Other|1|||
161397856|NCT01278407|582843128|FG002|Confirmatory Phase|Other|2|||
161397857|NCT01278407|582843129|FG003|Confirmatory Phase|Other|0|||
161397858|NCT01278407|582843130|FG004|Confirmatory Phase|Other|0|||
161397859|NCT01278407|582843126|FG000|Extension Phase|Adverse Event|0|||
161397860|NCT01278407|582843127|FG001|Extension Phase|Adverse Event|0|||
161397861|NCT01278407|582843128|FG002|Extension Phase|Adverse Event|0|||
161397862|NCT01278407|582843129|FG003|Extension Phase|Adverse Event|7|||
161397863|NCT01278407|582843130|FG004|Extension Phase|Adverse Event|16|||
161397864|NCT01278407|582843126|FG000|Extension Phase|Participant's Choice|0|||
161397865|NCT01278407|582843127|FG001|Extension Phase|Participant's Choice|0|||
161397866|NCT01278407|582843128|FG002|Extension Phase|Participant's Choice|0|||
161397867|NCT01278407|582843129|FG003|Extension Phase|Participant's Choice|4|||
161397868|NCT01278407|582843130|FG004|Extension Phase|Participant's Choice|11|||
161397869|NCT01278407|582843126|FG000|Extension Phase|Other|0|||
161397870|NCT01278407|582843127|FG001|Extension Phase|Other|0|||
161397871|NCT01278407|582843128|FG002|Extension Phase|Other|0|||
161397872|NCT01278407|582843129|FG003|Extension Phase|Other|1|||
161397873|NCT01278407|582843130|FG004|Extension Phase|Other|3|||
161397874|NCT02534935|582843132|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
161397875|NCT02534935|582843133|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
161397876|NCT02534935|582843134|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
161397877|NCT02534935|582843132|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
161397878|NCT02534935|582843133|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
161397879|NCT02534935|582843134|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
161397880|NCT02534935|582843132|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
161397881|NCT02534935|582843133|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
161397882|NCT02534935|582843134|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
161397883|NCT02534935|582843132|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
161397884|NCT02534935|582843133|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
161397885|NCT02534935|582843134|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
161397886|NCT02534935|582843132|FG000|Stage 1: 24 Months|Adverse Event|0|||
161397887|NCT02534935|582843133|FG001|Stage 1: 24 Months|Adverse Event|2|||
161397888|NCT02534935|582843134|FG002|Stage 1: 24 Months|Adverse Event|0|||
161397889|NCT02534935|582843132|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
161397890|NCT02534935|582843133|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
161397891|NCT02534935|582843134|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
161397892|NCT02534935|582843132|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
161397893|NCT02534935|582843133|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
161397894|NCT02534935|582843134|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
161397895|NCT03602885|582843139|FG000|Overall Study|Lost to Follow-up|3|||
161397896|NCT03602885|582843140|FG001|Overall Study|Lost to Follow-up|0|||
161397897|NCT01007123|582843145|FG000|Overall Study|Adverse Event|3|||
161397898|NCT01007123|582843146|FG001|Overall Study|Adverse Event|4|||
161397899|NCT01007123|582843147|FG002|Overall Study|Adverse Event|7|||
161397900|NCT01007123|582843148|FG003|Overall Study|Adverse Event|1|||
161397901|NCT01007123|582843145|FG000|Overall Study|Lack of Efficacy|1|||
161397902|NCT01007123|582843146|FG001|Overall Study|Lack of Efficacy|0|||
161397903|NCT01007123|582843147|FG002|Overall Study|Lack of Efficacy|1|||
161397904|NCT01007123|582843148|FG003|Overall Study|Lack of Efficacy|4|||
161397905|NCT01007123|582843145|FG000|Overall Study|Protocol Violation|1|||
161397906|NCT01007123|582843146|FG001|Overall Study|Protocol Violation|1|||
161397907|NCT01007123|582843147|FG002|Overall Study|Protocol Violation|2|||
161397908|NCT01007123|582843148|FG003|Overall Study|Protocol Violation|1|||
161397909|NCT01007123|582843145|FG000|Overall Study|Withdrawal by Subject|1|||
161397910|NCT01007123|582843146|FG001|Overall Study|Withdrawal by Subject|0|||
161397911|NCT01007123|582843147|FG002|Overall Study|Withdrawal by Subject|1|||
161397912|NCT01007123|582843148|FG003|Overall Study|Withdrawal by Subject|0|||
161397913|NCT01007123|582843145|FG000|Overall Study|Lost to Follow-up|0|||
161397914|NCT01007123|582843146|FG001|Overall Study|Lost to Follow-up|1|||
161397915|NCT01007123|582843147|FG002|Overall Study|Lost to Follow-up|0|||
161397916|NCT01007123|582843148|FG003|Overall Study|Lost to Follow-up|0|||
161397917|NCT02838901|582843149|FG000|Overall Study|Withdrawal by Subject|1|||
161397918|NCT02838901|582843150|FG001|Overall Study|Withdrawal by Subject|1|||
161397919|NCT02838901|582843149|FG000|Overall Study|Lost to Follow-up|1|||
161397920|NCT02838901|582843150|FG001|Overall Study|Lost to Follow-up|1|||
161397921|NCT04431713|582843151|FG000|Overall Study|Withdrawal by Subject|2|||
161397922|NCT04431713|582843152|FG001|Overall Study|Withdrawal by Subject|0|||
161397923|NCT04431713|582843151|FG000|Overall Study|Death|2|||
161397924|NCT04431713|582843152|FG001|Overall Study|Death|2|||
161397925|NCT01655381|582843154|FG000|Overall Study|Investigator Decision|1|||
161397926|NCT01655381|582843154|FG000|Overall Study|Moved to Another City|1|||
161397927|NCT01655381|582843154|FG000|Overall Study|Insufficient Treatment Response|1|||
161397928|NCT02324205|582843155|FG000|Overall Study|Withdrawal by Subject|37|||
161397929|NCT04195438|582843156|FG000|Overall Study|Withdrawal by Subject|1|||
161397930|NCT01156389|582843157|FG000|Overall Study|Elevated liver enzymes|4|||
161397931|NCT01156389|582843158|FG001|Overall Study|Elevated liver enzymes|0|||
161397932|NCT01156389|582843157|FG000|Overall Study|Vomiting|0|||
161397933|NCT01156389|582843158|FG001|Overall Study|Vomiting|1|||
161397934|NCT00937404|582843161|FG000|Overall Study|Protocol Violation|1|||
161397935|NCT00937404|582843161|FG000|Overall Study|Withdrawal by Subject|1|||
161397936|NCT00090233|582843162|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
161397937|NCT00090233|582843163|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
161397938|NCT00090233|582843162|FG000|Overall Study|Adverse Event|214|||
161397939|NCT00090233|582843163|FG001|Overall Study|Adverse Event|198|||
161397940|NCT00090233|582843162|FG000|Overall Study|Lost to Follow-up|68|||
161397941|NCT00090233|582843163|FG001|Overall Study|Lost to Follow-up|95|||
161397942|NCT00090233|582843162|FG000|Overall Study|Protocol Violation|960|||
161397943|NCT00090233|582843163|FG001|Overall Study|Protocol Violation|1022|||
161397944|NCT00090233|582843162|FG000|Overall Study|Withdrawal by Subject|182|||
161397945|NCT00090233|582843163|FG001|Overall Study|Withdrawal by Subject|211|||
161397946|NCT00090233|582843162|FG000|Overall Study|Moved|203|||
161397947|NCT00090233|582843163|FG001|Overall Study|Moved|189|||
161397948|NCT00090233|582843162|FG000|Overall Study|Other|1211|||
161397949|NCT00090233|582843163|FG001|Overall Study|Other|1160|||
161397950|NCT00090233|582843162|FG000|Overall Study|Data not available at data cut-off point|1552|||
161397951|NCT00090233|582843163|FG001|Overall Study|Data not available at data cut-off point|1563|||
161397952|NCT04863248|582843164|FG000|Overall Study|Sponsor Terminated|4|||
161397953|NCT04863248|582843165|FG001|Overall Study|Sponsor Terminated|1|||
161397954|NCT04863248|582843164|FG000|Overall Study|Death|0|||
161397955|NCT04863248|582843165|FG001|Overall Study|Death|1|||
161397956|NCT04863248|582843164|FG000|Overall Study|Withdrawal by Subject|0|||
161397957|NCT04863248|582843165|FG001|Overall Study|Withdrawal by Subject|1|||
161397958|NCT02536300|582843166|FG000|Overall Study|Investigator's Discretion|17|||
161397959|NCT02536300|582843167|FG001|Overall Study|Investigator's Discretion|11|||
161397960|NCT02536300|582843168|FG002|Overall Study|Investigator's Discretion|2|||
161397961|NCT02536300|582843166|FG000|Overall Study|Progressive Disease|11|||
161397962|NCT02536300|582843167|FG001|Overall Study|Progressive Disease|7|||
161397963|NCT02536300|582843168|FG002|Overall Study|Progressive Disease|6|||
161397964|NCT02536300|582843166|FG000|Overall Study|Study Terminated by Sponsor|6|||
161397965|NCT02536300|582843167|FG001|Overall Study|Study Terminated by Sponsor|4|||
161397966|NCT02536300|582843168|FG002|Overall Study|Study Terminated by Sponsor|7|||
161397967|NCT02536300|582843166|FG000|Overall Study|Death|7|||
161397968|NCT02536300|582843167|FG001|Overall Study|Death|0|||
161397969|NCT02536300|582843168|FG002|Overall Study|Death|5|||
161397970|NCT02536300|582843166|FG000|Overall Study|Withdrew Consent|4|||
161397971|NCT02536300|582843167|FG001|Overall Study|Withdrew Consent|2|||
161397972|NCT02536300|582843168|FG002|Overall Study|Withdrew Consent|0|||
161397973|NCT02536300|582843166|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
161397974|NCT02536300|582843167|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
161397975|NCT02536300|582843168|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
161397976|NCT02536300|582843166|FG000|Overall Study|Enrolled but Never Treated|0|||
161397977|NCT02536300|582843167|FG001|Overall Study|Enrolled but Never Treated|0|||
161397978|NCT02536300|582843168|FG002|Overall Study|Enrolled but Never Treated|1|||
161397979|NCT02536300|582843166|FG000|Overall Study|Non-compliance With Study Drug|1|||
161397980|NCT02536300|582843167|FG001|Overall Study|Non-compliance With Study Drug|0|||
161397981|NCT02536300|582843168|FG002|Overall Study|Non-compliance With Study Drug|0|||
161397982|NCT02536300|582843166|FG000|Overall Study|Protocol Violation|0|||
161397983|NCT02536300|582843167|FG001|Overall Study|Protocol Violation|1|||
161397984|NCT02536300|582843168|FG002|Overall Study|Protocol Violation|0|||
161397985|NCT01779869|582843169|FG000|Overall Study|Physician Decision|2|||
161397986|NCT01691105|582843177|FG000|1 Month Follow-up|Lost to Follow-up|41|||
161397987|NCT01691105|582843178|FG001|1 Month Follow-up|Lost to Follow-up|38|||
161397988|NCT01691105|582843177|FG000|1 Month Follow-up|Death|2|||
161397989|NCT01691105|582843178|FG001|1 Month Follow-up|Death|3|||
161397990|NCT01691105|582843177|FG000|6 Month Follow-up|Lost to Follow-up|39|||
161397991|NCT01691105|582843178|FG001|6 Month Follow-up|Lost to Follow-up|58|||
161397992|NCT01691105|582843177|FG000|6 Month Follow-up|Death|13|||
161397993|NCT01691105|582843178|FG001|6 Month Follow-up|Death|13|||
161397994|NCT01691105|582843177|FG000|12 Month Follow-up|Lost to Follow-up|50|||
161397995|NCT01691105|582843178|FG001|12 Month Follow-up|Lost to Follow-up|71|||
161397996|NCT01691105|582843177|FG000|12 Month Follow-up|Death|22|||
161397997|NCT01691105|582843178|FG001|12 Month Follow-up|Death|30|||
161397998|NCT01691105|582843177|FG000|12 Month Biochemical Verification|Death|22|||
161397999|NCT01691105|582843178|FG001|12 Month Biochemical Verification|Death|30|||
161398000|NCT01691105|582843177|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
161398001|NCT01691105|582843178|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
161398002|NCT01691105|582843177|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
161398003|NCT01691105|582843178|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
161398004|NCT00957944|582843179|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
161398005|NCT00957944|582843180|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
161398006|NCT01482169|582843182|FG000|Overall Study|Physician Decision|2|||
161398007|NCT00445848|582843185|FG000|Overall Study|Adverse Event|14|||
161398008|NCT00445848|582843185|FG000|Overall Study|Withdrawal by Subject|4|||
161398009|NCT00445848|582843185|FG000|Overall Study|Progression|62|||
161398010|NCT00445848|582843185|FG000|Overall Study|Other-Not protocol specified|5|||
161398011|NCT01777542|582843186|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
161398012|NCT01777542|582843187|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
161398013|NCT05605691|582843190|FG000|Overall Study|Lost to Follow-up|1|||
161398014|NCT01030874|582843191|FG000|Overall Study|Withdrawal by Subject|1|||
161398015|NCT01030874|582843192|FG001|Overall Study|Withdrawal by Subject|0|||
161398016|NCT01030874|582843191|FG000|Overall Study|Discharged in first 2 weeks|17|||
161398017|NCT01030874|582843192|FG001|Overall Study|Discharged in first 2 weeks|16|||
161398018|NCT02279719|582843193|FG000|Overall Study|Patients randomized but never treated|0|||
161398019|NCT02279719|582843194|FG001|Overall Study|Patients randomized but never treated|0|||
161398020|NCT02279719|582843195|FG002|Overall Study|Patients randomized but never treated|0|||
161398021|NCT02279719|582843196|FG003|Overall Study|Patients randomized but never treated|0|||
161398022|NCT02279719|582843197|FG004|Overall Study|Patients randomized but never treated|3|||
161398023|NCT02279719|582843198|FG005|Overall Study|Patients randomized but never treated|0|||
161398024|NCT02279719|582843199|FG006|Overall Study|Patients randomized but never treated|3|||
161398025|NCT04706273|582843200|FG000|Overall Study|Withdrawal by Subject|27|||
161398026|NCT04706273|582843200|FG000|Overall Study|Physician Decision|1|||
161398027|NCT04706273|582843200|FG000|Overall Study|Lost to Follow-up|42|||
161398028|NCT04706273|582843200|FG000|Overall Study|Death|85|||
161398029|NCT04706273|582843200|FG000|Overall Study|Amputation that removes study device|2|||
161398030|NCT04706273|582843200|FG000|Overall Study|Surgical bypass|3|||
161398031|NCT04706273|582843200|FG000|Overall Study|Changing hospital|23|||
161398032|NCT04706273|582843200|FG000|Overall Study|Unable to attend hospital|2|||
161398033|NCT03541187|582843203|FG000|Overall Study|Lost to Follow-up|2|||
161398034|NCT03541187|582843204|FG001|Overall Study|Lost to Follow-up|6|||
161398035|NCT03541187|582843203|FG000|Overall Study|Pregnancy|0|||
161398036|NCT03541187|582843204|FG001|Overall Study|Pregnancy|1|||
161398037|NCT03541187|582843203|FG000|Overall Study|Withdrawal by Subject|6|||
161398038|NCT03541187|582843204|FG001|Overall Study|Withdrawal by Subject|2|||
161398039|NCT03541187|582843203|FG000|Overall Study|Moved out of town|1|||
161398040|NCT03541187|582843204|FG001|Overall Study|Moved out of town|0|||
161398041|NCT03541187|582843203|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
161398042|NCT03541187|582843204|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
161398043|NCT03541187|582843203|FG000|Overall Study|Did not meet randomization criteria|1|||
161398044|NCT03541187|582843204|FG001|Overall Study|Did not meet randomization criteria|1|||
161398045|NCT03541187|582843203|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
161398046|NCT03541187|582843204|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
161398047|NCT03541187|582843203|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
161398048|NCT03541187|582843204|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
161398049|NCT00869050|582843208|FG000|Overall Study|Screen Failure|3|||
161398050|NCT03298984|582843215|FG000|Overall Study|Physician Decision|1|||
161398051|NCT03298984|582843216|FG001|Overall Study|Physician Decision|0|||
161398052|NCT03298984|582843217|FG002|Overall Study|Physician Decision|0|||
161398053|NCT03298984|582843218|FG003|Overall Study|Physician Decision|6|||
161398054|NCT03298984|582843215|FG000|Overall Study|Lack of Efficacy|0|||
161398055|NCT03298984|582843216|FG001|Overall Study|Lack of Efficacy|1|||
161398056|NCT03298984|582843217|FG002|Overall Study|Lack of Efficacy|1|||
161398057|NCT03298984|582843218|FG003|Overall Study|Lack of Efficacy|4|||
161398058|NCT03298984|582843215|FG000|Overall Study|Relapsed disease (following remission)|0|||
161398059|NCT03298984|582843216|FG001|Overall Study|Relapsed disease (following remission)|0|||
161398060|NCT03298984|582843217|FG002|Overall Study|Relapsed disease (following remission)|1|||
161398061|NCT03298984|582843218|FG003|Overall Study|Relapsed disease (following remission)|1|||
161398062|NCT03298984|582843215|FG000|Overall Study|Adverse Event|0|||
161398063|NCT03298984|582843216|FG001|Overall Study|Adverse Event|0|||
161398064|NCT03298984|582843217|FG002|Overall Study|Adverse Event|0|||
161398065|NCT03298984|582843218|FG003|Overall Study|Adverse Event|1|||
161398066|NCT03298984|582843215|FG000|Overall Study|Death|0|||
161398067|NCT03298984|582843216|FG001|Overall Study|Death|0|||
161398068|NCT03298984|582843217|FG002|Overall Study|Death|0|||
161398069|NCT03298984|582843218|FG003|Overall Study|Death|2|||
161398070|NCT03298984|582843215|FG000|Overall Study|Insurance Company Decision|0|||
161398071|NCT03298984|582843216|FG001|Overall Study|Insurance Company Decision|0|||
161398072|NCT03298984|582843217|FG002|Overall Study|Insurance Company Decision|0|||
161398073|NCT03298984|582843218|FG003|Overall Study|Insurance Company Decision|1|||
161398074|NCT01571284|582843219|FG000|Overall Study|Participant's decision|84|||
161398075|NCT01571284|582843219|FG000|Overall Study|Lost to Follow-up|3|||
161398076|NCT01571284|582843219|FG000|Overall Study|Enrolled but not treated|2|||
161398077|NCT01571284|582843219|FG000|Overall Study|Other than specified above|80|||
161398078|NCT03385265|582843223|FG000|Overall Study|Withdrawal by Subject|5|||
161398079|NCT03385265|582843224|FG001|Overall Study|Withdrawal by Subject|2|||
161398080|NCT03385265|582843225|FG002|Overall Study|Withdrawal by Subject|5|||
161398081|NCT03385265|582843226|FG003|Overall Study|Withdrawal by Subject|2|||
161398082|NCT04465877|582843229|FG000|Overall Study|Noncompliant with study requirements|0|||
161398083|NCT04465877|582843230|FG001|Overall Study|Noncompliant with study requirements|0|||
161398084|NCT04465877|582843231|FG002|Overall Study|Noncompliant with study requirements|1|||
161398085|NCT04465877|582843232|FG003|Overall Study|Noncompliant with study requirements|0|||
161398086|NCT02323204|582843239|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
161398087|NCT02323204|582843240|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
161398088|NCT02323204|582843241|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
161398089|NCT02323204|582843242|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
161398090|NCT02323204|582843239|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
161398091|NCT02323204|582843240|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
161398092|NCT02323204|582843241|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
161398093|NCT02323204|582843242|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
161398094|NCT02323204|582843239|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
161398095|NCT02323204|582843240|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
161398096|NCT02323204|582843241|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
161398097|NCT02323204|582843242|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
161398098|NCT02323204|582843239|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
161398099|NCT02323204|582843240|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
161398100|NCT02323204|582843241|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
161398101|NCT02323204|582843242|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
161398102|NCT02323204|582843239|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
161398103|NCT02323204|582843240|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
161398104|NCT02323204|582843241|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
161398105|NCT02323204|582843242|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
161398106|NCT02323204|582843239|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
161398107|NCT02323204|582843240|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
161398108|NCT02323204|582843241|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
161398109|NCT02323204|582843242|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
161398110|NCT02323204|582843239|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161398111|NCT02323204|582843240|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
161398112|NCT02323204|582843241|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161398113|NCT02323204|582843242|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
161398114|NCT02323204|582843239|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
161398115|NCT02323204|582843240|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
161398116|NCT02323204|582843241|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
161398117|NCT02323204|582843242|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
161398118|NCT02323204|582843239|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161398119|NCT02323204|582843240|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161398120|NCT02323204|582843241|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
161398121|NCT02323204|582843242|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
161398122|NCT03440918|582843243|FG000|Overall Study|Protocol Violation|0|||
161398123|NCT03440918|582843244|FG001|Overall Study|Protocol Violation|16|||
161398124|NCT01598753|582843245|FG000|Overall Study|Adverse Event|1|||
161398125|NCT01598753|582843246|FG001|Overall Study|Adverse Event|9|||
161398126|NCT01598753|582843247|FG002|Overall Study|Adverse Event|1|||
161398127|NCT01598753|582843248|FG003|Overall Study|Adverse Event|7|||
161398128|NCT01598753|582843245|FG000|Overall Study|Lost to Follow-up|4|||
161398129|NCT01598753|582843246|FG001|Overall Study|Lost to Follow-up|3|||
161398130|NCT01598753|582843247|FG002|Overall Study|Lost to Follow-up|7|||
161398131|NCT01598753|582843248|FG003|Overall Study|Lost to Follow-up|5|||
161398132|NCT01598753|582843245|FG000|Overall Study|Physician Decision|0|||
161398133|NCT01598753|582843246|FG001|Overall Study|Physician Decision|1|||
161398134|NCT01598753|582843247|FG002|Overall Study|Physician Decision|0|||
161398135|NCT01598753|582843248|FG003|Overall Study|Physician Decision|2|||
161398136|NCT01598753|582843245|FG000|Overall Study|Withdrawal by Subject|7|||
161398137|NCT01598753|582843246|FG001|Overall Study|Withdrawal by Subject|2|||
161398138|NCT01598753|582843247|FG002|Overall Study|Withdrawal by Subject|0|||
161398139|NCT01598753|582843248|FG003|Overall Study|Withdrawal by Subject|1|||
161398140|NCT04346108|582843249|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
161398141|NCT04346108|582843250|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
161398142|NCT04346108|582843251|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
161398143|NCT04346108|582843249|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
161398144|NCT04346108|582843250|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
161398145|NCT04346108|582843251|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
161398146|NCT02142283|582843252|FG000|Overall Study|Death|20|||
161398147|NCT02142283|582843253|FG001|Overall Study|Death|18|||
161398148|NCT02142283|582843252|FG000|Overall Study|Withdrawal by Subject|1|||
161398149|NCT02142283|582843253|FG001|Overall Study|Withdrawal by Subject|3|||
161398150|NCT02460783|582843254|FG000|Overall Study|Withdrawal by Subject|1|||
161398151|NCT02460783|582843255|FG001|Overall Study|Withdrawal by Subject|3|||
161398152|NCT02460783|582843254|FG000|Overall Study|Lost to Follow-up|1|||
161398153|NCT02460783|582843255|FG001|Overall Study|Lost to Follow-up|1|||
161398154|NCT00747344|582843256|FG000|Controlled Period|Adverse Event|3|||
161398155|NCT00747344|582843257|FG001|Controlled Period|Adverse Event|0|||
161398156|NCT00747344|582843258|FG002|Controlled Period|Adverse Event|0|||
161398157|NCT00747344|582843259|FG003|Controlled Period|Adverse Event|0|||
161398158|NCT00747344|582843256|FG000|Controlled Period|Lack of Efficacy|2|||
161398159|NCT00747344|582843257|FG001|Controlled Period|Lack of Efficacy|1|||
161398160|NCT00747344|582843258|FG002|Controlled Period|Lack of Efficacy|0|||
161398161|NCT00747344|582843259|FG003|Controlled Period|Lack of Efficacy|0|||
161398162|NCT00747344|582843256|FG000|Controlled Period|Other|0|||
161398163|NCT00747344|582843257|FG001|Controlled Period|Other|3|||
161398164|NCT00747344|582843258|FG002|Controlled Period|Other|0|||
161398165|NCT00747344|582843259|FG003|Controlled Period|Other|0|||
161398166|NCT00747344|582843256|FG000|After Controlled Period|Adverse Event|0|||
161398167|NCT00747344|582843257|FG001|After Controlled Period|Adverse Event|0|||
161398168|NCT00747344|582843258|FG002|After Controlled Period|Adverse Event|0|||
161398169|NCT00747344|582843259|FG003|After Controlled Period|Adverse Event|1|||
161398170|NCT01484834|582843260|FG000|Overall Study|Lost to Follow-up|5|||
161398171|NCT01484834|582843261|FG001|Overall Study|Lost to Follow-up|8|||
161398172|NCT01484834|582843262|FG002|Overall Study|Lost to Follow-up|1|||
161398173|NCT01484834|582843263|FG003|Overall Study|Lost to Follow-up|4|||
161398174|NCT01371643|582843264|FG000|Overall Study|Withdrawal by Subject|3|||
161398175|NCT01371643|582843265|FG001|Overall Study|Withdrawal by Subject|0|||
161398176|NCT03754582|582843266|FG000|Treatment Phase|Adverse Event|0|||
161398177|NCT03754582|582843267|FG001|Treatment Phase|Adverse Event|1|||
161398178|NCT03754582|582843268|FG002|Treatment Phase|Adverse Event|0|||
161398179|NCT03754582|582843266|FG000|Follow-up Phase|Other|0|||
161398180|NCT03754582|582843267|FG001|Follow-up Phase|Other|0|||
161398181|NCT03754582|582843268|FG002|Follow-up Phase|Other|1|||
161398182|NCT01561755|582843271|FG000|Overall Study|Lost to Follow-up|0|||
161398183|NCT01561755|582843272|FG001|Overall Study|Lost to Follow-up|1|||
161398184|NCT02847858|582843273|FG000|Overall Study|Lost to Follow-up|401|||
161398185|NCT02847858|582843274|FG001|Overall Study|Lost to Follow-up|269|||
161398186|NCT00624819|582843275|FG000|Follow-up Period: Year 4|Parents decision|0|||
161398187|NCT00624819|582843276|FG001|Follow-up Period: Year 4|Parents decision|0|||
161398188|NCT00624819|582843277|FG002|Follow-up Period: Year 4|Parents decision|1|||
161398189|NCT00624819|582843278|FG003|Follow-up Period: Year 4|Parents decision|0|||
161398190|NCT00624819|582843275|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
161398191|NCT00624819|582843276|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
161398192|NCT00624819|582843277|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
161398193|NCT00624819|582843278|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
161398194|NCT02826421|582843281|FG000|Overall Study|Adverse Event|1|||
161398195|NCT02826421|582843282|FG001|Overall Study|Adverse Event|0|||
161398196|NCT02826421|582843283|FG002|Overall Study|Adverse Event|0|||
161398197|NCT02826421|582843284|FG003|Overall Study|Adverse Event|1|||
161398198|NCT02826421|582843281|FG000|Overall Study|Withdrawal by Subject|1|||
161398199|NCT02826421|582843282|FG001|Overall Study|Withdrawal by Subject|3|||
161398200|NCT02826421|582843283|FG002|Overall Study|Withdrawal by Subject|1|||
161398201|NCT02826421|582843284|FG003|Overall Study|Withdrawal by Subject|1|||
161398202|NCT02826421|582843281|FG000|Overall Study|Reason not given|1|||
161398203|NCT02826421|582843282|FG001|Overall Study|Reason not given|0|||
161398204|NCT02826421|582843283|FG002|Overall Study|Reason not given|1|||
161398205|NCT02826421|582843284|FG003|Overall Study|Reason not given|0|||
161398206|NCT02210221|582843287|FG000|Overall Study|Lack of Efficacy|7|||
161398207|NCT02210221|582843287|FG000|Overall Study|Withdrawal by Subject|43|||
161398208|NCT02032407|582845206|FG000|Overall Study|Lost to Follow-up|2|||
161398209|NCT02032407|582845206|FG000|Overall Study|Pregnancy|1|||
161398210|NCT02032407|582845206|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161398211|NCT04411420|582845207|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
161398212|NCT04411420|582845208|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
161398213|NCT04411420|582845207|FG000|Survey Subset|Lost to Follow-up|134|||
161398214|NCT04411420|582845208|FG001|Survey Subset|Lost to Follow-up|120|||
161398215|NCT00549900|582845209|FG000|Overall Study|Adverse Event|1|||
161398216|NCT03187834|582845213|FG000|Overall Study|Lost to Follow-up|0|||
161398217|NCT03187834|582845214|FG001|Overall Study|Lost to Follow-up|1|||
161398218|NCT03187834|582845215|FG002|Overall Study|Lost to Follow-up|2|||
161398219|NCT03187834|582845216|FG003|Overall Study|Lost to Follow-up|2|||
161398220|NCT03187834|582845213|FG000|Overall Study|Had invalid anthropometric measurements|5|||
161398221|NCT03187834|582845214|FG001|Overall Study|Had invalid anthropometric measurements|3|||
161398222|NCT03187834|582845215|FG002|Overall Study|Had invalid anthropometric measurements|4|||
161398223|NCT03187834|582845216|FG003|Overall Study|Had invalid anthropometric measurements|2|||
161398224|NCT03559699|582845219|FG000|Overall Study|Withdrawal by Subject|6|||
161398225|NCT03559699|582845219|FG000|Overall Study|Lost to Follow-up|1|||
161398226|NCT00031460|582845220|FG000|Overall Study|Lost to Follow-up|0|||
161398227|NCT00031460|582845221|FG001|Overall Study|Lost to Follow-up|1|||
161398228|NCT00031460|582845220|FG000|Overall Study|Withdrawal by Subject|1|||
161398229|NCT00031460|582845221|FG001|Overall Study|Withdrawal by Subject|1|||
161398230|NCT00031460|582845220|FG000|Overall Study|Non-Compliant|1|||
161398231|NCT00031460|582845221|FG001|Overall Study|Non-Compliant|1|||
161398232|NCT00031460|582845220|FG000|Overall Study|Death|0|||
161398233|NCT00031460|582845221|FG001|Overall Study|Death|1|||
161398234|NCT00031460|582845220|FG000|Overall Study|Reactivation of Disease|5|||
161398235|NCT00031460|582845221|FG001|Overall Study|Reactivation of Disease|9|||
161398236|NCT00031460|582845220|FG000|Overall Study|Disruption of blinded drug supply|2|||
161398237|NCT00031460|582845221|FG001|Overall Study|Disruption of blinded drug supply|0|||
161398238|NCT00031460|582845220|FG000|Overall Study|Confirmed unevaluable|0|||
161398239|NCT00031460|582845221|FG001|Overall Study|Confirmed unevaluable|1|||
161398240|NCT01930890|582845222|FG000|Overall Study|Study Termination|14|||
161398241|NCT01930890|582845223|FG001|Overall Study|Study Termination|28|||
161398242|NCT01930890|582845224|FG002|Overall Study|Study Termination|13|||
161398243|NCT01930890|582845225|FG003|Overall Study|Study Termination|25|||
161398244|NCT01930890|582845222|FG000|Overall Study|Death|0|||
161398245|NCT01930890|582845223|FG001|Overall Study|Death|0|||
161398246|NCT01930890|582845224|FG002|Overall Study|Death|0|||
161398247|NCT01930890|582845225|FG003|Overall Study|Death|1|||
161398248|NCT01930890|582845222|FG000|Overall Study|Investigator Decision|0|||
161398249|NCT01930890|582845223|FG001|Overall Study|Investigator Decision|1|||
161398250|NCT01930890|582845224|FG002|Overall Study|Investigator Decision|0|||
161398251|NCT01930890|582845225|FG003|Overall Study|Investigator Decision|0|||
161398252|NCT01930890|582845222|FG000|Overall Study|Consent Withdrawn|0|||
161398253|NCT01930890|582845223|FG001|Overall Study|Consent Withdrawn|3|||
161398254|NCT01930890|582845224|FG002|Overall Study|Consent Withdrawn|0|||
161398255|NCT01930890|582845225|FG003|Overall Study|Consent Withdrawn|1|||
161398256|NCT01930890|582845222|FG000|Overall Study|Adverse Event|0|||
161398257|NCT01930890|582845223|FG001|Overall Study|Adverse Event|1|||
161398258|NCT01930890|582845224|FG002|Overall Study|Adverse Event|0|||
161398259|NCT01930890|582845225|FG003|Overall Study|Adverse Event|0|||
161398260|NCT01176565|582845228|FG000|Overall Study|Lost to Follow-up|12|||
161398261|NCT01176565|582845229|FG001|Overall Study|Lost to Follow-up|16|||
161398262|NCT01176565|582845228|FG000|Overall Study|Withdrawal by Subject|7|||
161398263|NCT01176565|582845229|FG001|Overall Study|Withdrawal by Subject|1|||
161398264|NCT01176565|582845228|FG000|Overall Study|Not Analyzed (any other reason)|1|||
161398265|NCT01176565|582845229|FG001|Overall Study|Not Analyzed (any other reason)|2|||
161398266|NCT02754141|582845230|FG000|Overall Study|Disease progression|11|||
161398267|NCT02754141|582845231|FG001|Overall Study|Disease progression|7|||
161398268|NCT02754141|582845232|FG002|Overall Study|Disease progression|8|||
161398269|NCT02754141|582845233|FG003|Overall Study|Disease progression|5|||
161398270|NCT02754141|582845234|FG004|Overall Study|Disease progression|7|||
161398271|NCT02754141|582845235|FG005|Overall Study|Disease progression|7|||
161398272|NCT02754141|582845236|FG006|Overall Study|Disease progression|7|||
161398273|NCT02754141|582845237|FG007|Overall Study|Disease progression|6|||
161398274|NCT02754141|582845238|FG008|Overall Study|Disease progression|11|||
161398275|NCT02754141|582845239|FG009|Overall Study|Disease progression|16|||
161398276|NCT02754141|582845240|FG010|Overall Study|Disease progression|18|||
161398277|NCT02754141|582845241|FG011|Overall Study|Disease progression|13|||
161398278|NCT02754141|582845242|FG012|Overall Study|Disease progression|10|||
161398279|NCT02754141|582845243|FG013|Overall Study|Disease progression|12|||
161398280|NCT02754141|582845244|FG014|Overall Study|Disease progression|12|||
161398281|NCT02754141|582845245|FG015|Overall Study|Disease progression|14|||
161398282|NCT02754141|582845246|FG016|Overall Study|Disease progression|0|||
161398283|NCT02754141|582845247|FG017|Overall Study|Disease progression|1|||
161398284|NCT02754141|582845230|FG000|Overall Study|Study drug toxicity|1|||
161398285|NCT02754141|582845231|FG001|Overall Study|Study drug toxicity|1|||
161398286|NCT02754141|582845232|FG002|Overall Study|Study drug toxicity|0|||
161398287|NCT02754141|582845233|FG003|Overall Study|Study drug toxicity|0|||
161398288|NCT02754141|582845234|FG004|Overall Study|Study drug toxicity|0|||
161398289|NCT02754141|582845235|FG005|Overall Study|Study drug toxicity|0|||
161398290|NCT02754141|582845236|FG006|Overall Study|Study drug toxicity|0|||
161398291|NCT02754141|582845237|FG007|Overall Study|Study drug toxicity|0|||
161398292|NCT02754141|582845238|FG008|Overall Study|Study drug toxicity|0|||
161398293|NCT02754141|582845239|FG009|Overall Study|Study drug toxicity|0|||
161398294|NCT02754141|582845240|FG010|Overall Study|Study drug toxicity|2|||
161398295|NCT02754141|582845241|FG011|Overall Study|Study drug toxicity|1|||
161398296|NCT02754141|582845242|FG012|Overall Study|Study drug toxicity|1|||
161398297|NCT02754141|582845243|FG013|Overall Study|Study drug toxicity|0|||
161398298|NCT02754141|582845244|FG014|Overall Study|Study drug toxicity|0|||
161398299|NCT02754141|582845245|FG015|Overall Study|Study drug toxicity|0|||
161398300|NCT02754141|582845246|FG016|Overall Study|Study drug toxicity|0|||
161398301|NCT02754141|582845247|FG017|Overall Study|Study drug toxicity|0|||
161398302|NCT02754141|582845230|FG000|Overall Study|AE unrelated to study drug|1|||
161398303|NCT02754141|582845231|FG001|Overall Study|AE unrelated to study drug|1|||
161398304|NCT02754141|582845232|FG002|Overall Study|AE unrelated to study drug|0|||
161398305|NCT02754141|582845233|FG003|Overall Study|AE unrelated to study drug|1|||
161398306|NCT02754141|582845234|FG004|Overall Study|AE unrelated to study drug|3|||
161398307|NCT02754141|582845235|FG005|Overall Study|AE unrelated to study drug|2|||
161398308|NCT02754141|582845236|FG006|Overall Study|AE unrelated to study drug|1|||
161398309|NCT02754141|582845237|FG007|Overall Study|AE unrelated to study drug|0|||
161398310|NCT02754141|582845238|FG008|Overall Study|AE unrelated to study drug|0|||
161398311|NCT02754141|582845239|FG009|Overall Study|AE unrelated to study drug|0|||
161398312|NCT02754141|582845240|FG010|Overall Study|AE unrelated to study drug|0|||
161398313|NCT02754141|582845241|FG011|Overall Study|AE unrelated to study drug|0|||
161398314|NCT02754141|582845242|FG012|Overall Study|AE unrelated to study drug|0|||
161398315|NCT02754141|582845243|FG013|Overall Study|AE unrelated to study drug|0|||
161398316|NCT02754141|582845244|FG014|Overall Study|AE unrelated to study drug|0|||
161398317|NCT02754141|582845245|FG015|Overall Study|AE unrelated to study drug|0|||
161398318|NCT02754141|582845246|FG016|Overall Study|AE unrelated to study drug|0|||
161398319|NCT02754141|582845247|FG017|Overall Study|AE unrelated to study drug|0|||
161398320|NCT02754141|582845230|FG000|Overall Study|Request to discontinue|0|||
161398321|NCT02754141|582845231|FG001|Overall Study|Request to discontinue|0|||
161398322|NCT02754141|582845232|FG002|Overall Study|Request to discontinue|0|||
161398323|NCT02754141|582845233|FG003|Overall Study|Request to discontinue|0|||
161398324|NCT02754141|582845234|FG004|Overall Study|Request to discontinue|0|||
161398325|NCT02754141|582845235|FG005|Overall Study|Request to discontinue|0|||
161398326|NCT02754141|582845236|FG006|Overall Study|Request to discontinue|0|||
161398327|NCT02754141|582845237|FG007|Overall Study|Request to discontinue|0|||
161398328|NCT02754141|582845238|FG008|Overall Study|Request to discontinue|1|||
161398329|NCT02754141|582845239|FG009|Overall Study|Request to discontinue|0|||
161398330|NCT02754141|582845240|FG010|Overall Study|Request to discontinue|0|||
161398331|NCT02754141|582845241|FG011|Overall Study|Request to discontinue|0|||
161398332|NCT02754141|582845242|FG012|Overall Study|Request to discontinue|0|||
161398333|NCT02754141|582845243|FG013|Overall Study|Request to discontinue|1|||
161398334|NCT02754141|582845244|FG014|Overall Study|Request to discontinue|1|||
161398335|NCT02754141|582845245|FG015|Overall Study|Request to discontinue|0|||
161398336|NCT02754141|582845246|FG016|Overall Study|Request to discontinue|0|||
161398337|NCT02754141|582845247|FG017|Overall Study|Request to discontinue|0|||
161398338|NCT02754141|582845230|FG000|Overall Study|Withdrew consent|0|||
161398339|NCT02754141|582845231|FG001|Overall Study|Withdrew consent|0|||
161398340|NCT02754141|582845232|FG002|Overall Study|Withdrew consent|0|||
161398341|NCT02754141|582845233|FG003|Overall Study|Withdrew consent|0|||
161398342|NCT02754141|582845234|FG004|Overall Study|Withdrew consent|0|||
161398343|NCT02754141|582845235|FG005|Overall Study|Withdrew consent|0|||
161398344|NCT02754141|582845236|FG006|Overall Study|Withdrew consent|0|||
161398345|NCT02754141|582845237|FG007|Overall Study|Withdrew consent|0|||
161398346|NCT02754141|582845238|FG008|Overall Study|Withdrew consent|0|||
161398347|NCT02754141|582845239|FG009|Overall Study|Withdrew consent|1|||
161398348|NCT02754141|582845240|FG010|Overall Study|Withdrew consent|0|||
161398349|NCT02754141|582845241|FG011|Overall Study|Withdrew consent|0|||
161398350|NCT02754141|582845242|FG012|Overall Study|Withdrew consent|0|||
161398351|NCT02754141|582845243|FG013|Overall Study|Withdrew consent|0|||
161398352|NCT02754141|582845244|FG014|Overall Study|Withdrew consent|0|||
161398353|NCT02754141|582845245|FG015|Overall Study|Withdrew consent|0|||
161398354|NCT02754141|582845246|FG016|Overall Study|Withdrew consent|0|||
161398355|NCT02754141|582845247|FG017|Overall Study|Withdrew consent|0|||
161398356|NCT02754141|582845230|FG000|Overall Study|Maximum clinical benefit|0|||
161398357|NCT02754141|582845231|FG001|Overall Study|Maximum clinical benefit|0|||
161398358|NCT02754141|582845232|FG002|Overall Study|Maximum clinical benefit|0|||
161398359|NCT02754141|582845233|FG003|Overall Study|Maximum clinical benefit|1|||
161398360|NCT02754141|582845234|FG004|Overall Study|Maximum clinical benefit|0|||
161398361|NCT02754141|582845235|FG005|Overall Study|Maximum clinical benefit|0|||
161398362|NCT02754141|582845236|FG006|Overall Study|Maximum clinical benefit|0|||
161398363|NCT02754141|582845237|FG007|Overall Study|Maximum clinical benefit|0|||
161398364|NCT02754141|582845238|FG008|Overall Study|Maximum clinical benefit|0|||
161398365|NCT02754141|582845239|FG009|Overall Study|Maximum clinical benefit|0|||
161398366|NCT02754141|582845240|FG010|Overall Study|Maximum clinical benefit|0|||
161398367|NCT02754141|582845241|FG011|Overall Study|Maximum clinical benefit|0|||
161398368|NCT02754141|582845242|FG012|Overall Study|Maximum clinical benefit|0|||
161398369|NCT02754141|582845243|FG013|Overall Study|Maximum clinical benefit|0|||
161398370|NCT02754141|582845244|FG014|Overall Study|Maximum clinical benefit|0|||
161398371|NCT02754141|582845245|FG015|Overall Study|Maximum clinical benefit|0|||
161398372|NCT02754141|582845246|FG016|Overall Study|Maximum clinical benefit|0|||
161398373|NCT02754141|582845247|FG017|Overall Study|Maximum clinical benefit|0|||
161398374|NCT02754141|582845230|FG000|Overall Study|No longer meets study criteria|0|||
161398375|NCT02754141|582845231|FG001|Overall Study|No longer meets study criteria|0|||
161398376|NCT02754141|582845232|FG002|Overall Study|No longer meets study criteria|0|||
161398377|NCT02754141|582845233|FG003|Overall Study|No longer meets study criteria|1|||
161398378|NCT02754141|582845234|FG004|Overall Study|No longer meets study criteria|0|||
161398379|NCT02754141|582845235|FG005|Overall Study|No longer meets study criteria|0|||
161398380|NCT02754141|582845236|FG006|Overall Study|No longer meets study criteria|0|||
161398381|NCT02754141|582845237|FG007|Overall Study|No longer meets study criteria|0|||
161398382|NCT02754141|582845238|FG008|Overall Study|No longer meets study criteria|0|||
161398383|NCT02754141|582845239|FG009|Overall Study|No longer meets study criteria|0|||
161398384|NCT02754141|582845240|FG010|Overall Study|No longer meets study criteria|0|||
161398385|NCT02754141|582845241|FG011|Overall Study|No longer meets study criteria|0|||
161398386|NCT02754141|582845242|FG012|Overall Study|No longer meets study criteria|0|||
161398387|NCT02754141|582845243|FG013|Overall Study|No longer meets study criteria|0|||
161398388|NCT02754141|582845244|FG014|Overall Study|No longer meets study criteria|0|||
161398389|NCT02754141|582845245|FG015|Overall Study|No longer meets study criteria|0|||
161398390|NCT02754141|582845246|FG016|Overall Study|No longer meets study criteria|0|||
161398391|NCT02754141|582845247|FG017|Overall Study|No longer meets study criteria|0|||
161398392|NCT02754141|582845230|FG000|Overall Study|Other reasons|0|||
161398393|NCT02754141|582845231|FG001|Overall Study|Other reasons|0|||
161398394|NCT02754141|582845232|FG002|Overall Study|Other reasons|0|||
161398395|NCT02754141|582845233|FG003|Overall Study|Other reasons|0|||
161398396|NCT02754141|582845234|FG004|Overall Study|Other reasons|0|||
161398397|NCT02754141|582845235|FG005|Overall Study|Other reasons|0|||
161398398|NCT02754141|582845236|FG006|Overall Study|Other reasons|0|||
161398399|NCT02754141|582845237|FG007|Overall Study|Other reasons|1|||
161398400|NCT02754141|582845238|FG008|Overall Study|Other reasons|0|||
161398401|NCT02754141|582845239|FG009|Overall Study|Other reasons|0|||
161398402|NCT02754141|582845240|FG010|Overall Study|Other reasons|0|||
161398403|NCT02754141|582845241|FG011|Overall Study|Other reasons|0|||
161398404|NCT02754141|582845242|FG012|Overall Study|Other reasons|2|||
161398405|NCT02754141|582845243|FG013|Overall Study|Other reasons|0|||
161398406|NCT02754141|582845244|FG014|Overall Study|Other reasons|0|||
161398407|NCT02754141|582845245|FG015|Overall Study|Other reasons|0|||
161398408|NCT02754141|582845246|FG016|Overall Study|Other reasons|0|||
161398409|NCT02754141|582845247|FG017|Overall Study|Other reasons|0|||
161398410|NCT02754141|582845230|FG000|Overall Study|Completed treatment as per protocol|0|||
161398411|NCT02754141|582845231|FG001|Overall Study|Completed treatment as per protocol|1|||
161398412|NCT02754141|582845232|FG002|Overall Study|Completed treatment as per protocol|0|||
161398413|NCT02754141|582845233|FG003|Overall Study|Completed treatment as per protocol|0|||
161398414|NCT02754141|582845234|FG004|Overall Study|Completed treatment as per protocol|0|||
161398415|NCT02754141|582845235|FG005|Overall Study|Completed treatment as per protocol|0|||
161398416|NCT02754141|582845236|FG006|Overall Study|Completed treatment as per protocol|0|||
161398417|NCT02754141|582845237|FG007|Overall Study|Completed treatment as per protocol|0|||
161398418|NCT02754141|582845238|FG008|Overall Study|Completed treatment as per protocol|0|||
161398419|NCT02754141|582845239|FG009|Overall Study|Completed treatment as per protocol|0|||
161398420|NCT02754141|582845240|FG010|Overall Study|Completed treatment as per protocol|0|||
161398421|NCT02754141|582845241|FG011|Overall Study|Completed treatment as per protocol|0|||
161398422|NCT02754141|582845242|FG012|Overall Study|Completed treatment as per protocol|1|||
161398423|NCT02754141|582845243|FG013|Overall Study|Completed treatment as per protocol|0|||
161398424|NCT02754141|582845244|FG014|Overall Study|Completed treatment as per protocol|0|||
161398425|NCT02754141|582845245|FG015|Overall Study|Completed treatment as per protocol|0|||
161398426|NCT02754141|582845246|FG016|Overall Study|Completed treatment as per protocol|0|||
161398427|NCT02754141|582845247|FG017|Overall Study|Completed treatment as per protocol|0|||
161398428|NCT02754141|582845230|FG000|Overall Study|Not completing monotherapy|0|||
161398429|NCT02754141|582845231|FG001|Overall Study|Not completing monotherapy|0|||
161398430|NCT02754141|582845232|FG002|Overall Study|Not completing monotherapy|0|||
161398431|NCT02754141|582845233|FG003|Overall Study|Not completing monotherapy|0|||
161398432|NCT02754141|582845234|FG004|Overall Study|Not completing monotherapy|0|||
161398433|NCT02754141|582845235|FG005|Overall Study|Not completing monotherapy|0|||
161398434|NCT02754141|582845236|FG006|Overall Study|Not completing monotherapy|0|||
161398435|NCT02754141|582845237|FG007|Overall Study|Not completing monotherapy|0|||
161398436|NCT02754141|582845238|FG008|Overall Study|Not completing monotherapy|0|||
161398437|NCT02754141|582845239|FG009|Overall Study|Not completing monotherapy|0|||
161398438|NCT02754141|582845240|FG010|Overall Study|Not completing monotherapy|0|||
161398439|NCT02754141|582845241|FG011|Overall Study|Not completing monotherapy|0|||
161398440|NCT02754141|582845242|FG012|Overall Study|Not completing monotherapy|0|||
161398441|NCT02754141|582845243|FG013|Overall Study|Not completing monotherapy|1|||
161398442|NCT02754141|582845244|FG014|Overall Study|Not completing monotherapy|0|||
161398443|NCT02754141|582845245|FG015|Overall Study|Not completing monotherapy|0|||
161398444|NCT02754141|582845246|FG016|Overall Study|Not completing monotherapy|0|||
161398445|NCT02754141|582845247|FG017|Overall Study|Not completing monotherapy|0|||
161398446|NCT02680041|582845251|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
161398447|NCT02680041|582845251|FG000|Overall Study|Lost to Follow-up|2|||
161398448|NCT01344538|582845252|FG000|Overall Study|Adverse Event|1|||
161398449|NCT01344538|582845253|FG001|Overall Study|Adverse Event|1|||
161398450|NCT01344538|582845252|FG000|Overall Study|Lost to Follow-up|1|||
161398451|NCT01344538|582845253|FG001|Overall Study|Lost to Follow-up|0|||
161398452|NCT00613925|582845257|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
161398453|NCT00613925|582845258|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
161398454|NCT00350623|582845261|FG000|Overall Study|Lost to Follow-up|8|||
161398455|NCT00350623|582845262|FG001|Overall Study|Lost to Follow-up|3|||
161398456|NCT00350623|582845263|FG002|Overall Study|Lost to Follow-up|4|||
161398457|NCT00350623|582845261|FG000|Overall Study|Withdrawal by Subject|0|||
161398458|NCT00350623|582845262|FG001|Overall Study|Withdrawal by Subject|1|||
161398459|NCT00350623|582845263|FG002|Overall Study|Withdrawal by Subject|1|||
161398460|NCT00350623|582845261|FG000|Overall Study|patient traveling outside the country|0|||
161398461|NCT00350623|582845262|FG001|Overall Study|patient traveling outside the country|0|||
161398462|NCT00350623|582845263|FG002|Overall Study|patient traveling outside the country|1|||
161398463|NCT03199053|582845281|FG000|ST Period|Withdrawal by Subject|2|||
161398464|NCT03199053|582845282|FG001|ST Period|Withdrawal by Subject|4|||
161398465|NCT03199053|582845283|FG002|ST Period|Withdrawal by Subject|6|||
161398466|NCT03199053|582845281|FG000|ST Period|Withdrawal by parent/guardian|1|||
161398467|NCT03199053|582845282|FG001|ST Period|Withdrawal by parent/guardian|1|||
161398468|NCT03199053|582845283|FG002|ST Period|Withdrawal by parent/guardian|1|||
161398469|NCT03199053|582845281|FG000|ST Period|Lost to Follow-up|2|||
161398470|NCT03199053|582845282|FG001|ST Period|Lost to Follow-up|0|||
161398471|NCT03199053|582845283|FG002|ST Period|Lost to Follow-up|1|||
161398472|NCT03199053|582845281|FG000|LT Period|Withdrawal by Subject|1|||
161398473|NCT03199053|582845282|FG001|LT Period|Withdrawal by Subject|3|||
161398474|NCT03199053|582845283|FG002|LT Period|Withdrawal by Subject|3|||
161398475|NCT03199053|582845281|FG000|LT Period|Withdrawal by parent/guardian|0|||
161398476|NCT03199053|582845282|FG001|LT Period|Withdrawal by parent/guardian|0|||
161398477|NCT03199053|582845283|FG002|LT Period|Withdrawal by parent/guardian|1|||
161398478|NCT03199053|582845281|FG000|LT Period|Lost to Follow-up|0|||
161398479|NCT03199053|582845282|FG001|LT Period|Lost to Follow-up|1|||
161398480|NCT03199053|582845283|FG002|LT Period|Lost to Follow-up|1|||
161398481|NCT03199053|582845281|FG000|LT Period|Miscellaneous|0|||
161398482|NCT03199053|582845282|FG001|LT Period|Miscellaneous|0|||
161398483|NCT03199053|582845283|FG002|LT Period|Miscellaneous|2|||
161398484|NCT03199053|582845281|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
161398485|NCT03199053|582845282|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
161398486|NCT03199053|582845283|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
161398487|NCT03199053|582845281|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
161398488|NCT03199053|582845282|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
161398489|NCT03199053|582845283|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
161398490|NCT03199053|582845281|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
161398491|NCT03199053|582845282|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
161398492|NCT03199053|582845283|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
161398493|NCT03199053|582845281|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
161398494|NCT03199053|582845282|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
161398495|NCT03199053|582845283|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
161398496|NCT03263923|582845285|FG000|Overall Study|Withdrawal by Subject|10|||
161398497|NCT03263923|582845286|FG001|Overall Study|Withdrawal by Subject|8|||
161398498|NCT03263923|582845285|FG000|Overall Study|Lost to Follow-up|15|||
161398499|NCT03263923|582845286|FG001|Overall Study|Lost to Follow-up|13|||
161398500|NCT01323270|582845287|FG000|Overall Study|Withdrawal by Subject|19|||
161398501|NCT01323270|582845288|FG001|Overall Study|Withdrawal by Subject|10|||
161398502|NCT01323270|582845287|FG000|Overall Study|Protocol Violation|9|||
161398503|NCT01323270|582845288|FG001|Overall Study|Protocol Violation|7|||
161398504|NCT01323270|582845287|FG000|Overall Study|Lost to Follow-up|4|||
161398505|NCT01323270|582845288|FG001|Overall Study|Lost to Follow-up|6|||
161398506|NCT01323270|582845287|FG000|Overall Study|Adverse Event|8|||
161398507|NCT01323270|582845288|FG001|Overall Study|Adverse Event|0|||
161398508|NCT01323270|582845287|FG000|Overall Study|Other|0|||
161398509|NCT01323270|582845288|FG001|Overall Study|Other|3|||
161398510|NCT01323270|582845287|FG000|Overall Study|Physician Decision|0|||
161398511|NCT01323270|582845288|FG001|Overall Study|Physician Decision|2|||
161398512|NCT01323270|582845287|FG000|Overall Study|Not eligible|1|||
161398513|NCT01323270|582845288|FG001|Overall Study|Not eligible|1|||
161398514|NCT01323270|582845287|FG000|Overall Study|Death|1|||
161398515|NCT01323270|582845288|FG001|Overall Study|Death|0|||
161398516|NCT01323270|582845287|FG000|Overall Study|Randomized, but not vaccinated|1|||
161398517|NCT01323270|582845288|FG001|Overall Study|Randomized, but not vaccinated|0|||
161398518|NCT01118520|582845289|FG000|Overall Study|AAA repair|9|||
161398519|NCT01118520|582845290|FG001|Overall Study|AAA repair|7|||
161398520|NCT01118520|582845291|FG002|Overall Study|AAA repair|9|||
161398521|NCT01118520|582845289|FG000|Overall Study|Adverse Event|3|||
161398522|NCT01118520|582845290|FG001|Overall Study|Adverse Event|3|||
161398523|NCT01118520|582845291|FG002|Overall Study|Adverse Event|3|||
161398524|NCT01118520|582845289|FG000|Overall Study|Withdrawal by Subject|8|||
161398525|NCT01118520|582845290|FG001|Overall Study|Withdrawal by Subject|13|||
161398526|NCT01118520|582845291|FG002|Overall Study|Withdrawal by Subject|8|||
161398527|NCT01071200|582845308|FG000|Overall Study|Lack of ovarian response|1|||
161398528|NCT01071200|582845309|FG001|Overall Study|Lack of ovarian response|1|||
161398529|NCT01071200|582845308|FG000|Overall Study|No fertilization|4|||
161398530|NCT01071200|582845309|FG001|Overall Study|No fertilization|0|||
161398531|NCT01071200|582845308|FG000|Overall Study|No oocytes retrieved|1|||
161398532|NCT01071200|582845309|FG001|Overall Study|No oocytes retrieved|1|||
161398533|NCT01071200|582845308|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
161398534|NCT01071200|582845309|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
161398535|NCT01071200|582845308|FG000|Overall Study|No viable embryos|0|||
161398536|NCT01071200|582845309|FG001|Overall Study|No viable embryos|1|||
161398537|NCT03883113|582845312|FG000|Overall Study|Physician Decision|4|||
161398538|NCT03883113|582845313|FG001|Overall Study|Physician Decision|2|||
161398539|NCT03883113|582845312|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
161398540|NCT03883113|582845313|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
161398541|NCT03883113|582845312|FG000|Overall Study|Pregnancy|1|||
161398542|NCT03883113|582845313|FG001|Overall Study|Pregnancy|0|||
161398543|NCT03883113|582845312|FG000|Overall Study|Adverse Event|0|||
161398544|NCT03883113|582845313|FG001|Overall Study|Adverse Event|1|||
161398545|NCT03883113|582845312|FG000|Overall Study|Withdrawal by Subject|1|||
161398546|NCT03883113|582845313|FG001|Overall Study|Withdrawal by Subject|2|||
161398547|NCT03883113|582845312|FG000|Overall Study|Lost to Follow-up|1|||
161398548|NCT03883113|582845313|FG001|Overall Study|Lost to Follow-up|0|||
161398549|NCT01396265|582845314|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
161398550|NCT01767493|582845315|FG000|Overall Study|screen failures|3|||
161398551|NCT03023826|582845317|FG000|Period 1|Withdrawal by Subject|0|||
161398552|NCT03023826|582845318|FG001|Period 1|Withdrawal by Subject|0|||
161398553|NCT03023826|582845319|FG002|Period 1|Withdrawal by Subject|0|||
161398554|NCT03023826|582845320|FG003|Period 1|Withdrawal by Subject|0|||
161398555|NCT03023826|582845321|FG004|Period 1|Withdrawal by Subject|1|||
161398556|NCT03023826|582845322|FG005|Period 1|Withdrawal by Subject|0|||
161398557|NCT00977938|582845323|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
161398558|NCT00977938|582845324|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
161398559|NCT00977938|582845325|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
161398560|NCT00977938|582845326|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
161398561|NCT00977938|582845323|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
161398562|NCT00977938|582845324|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
161398563|NCT00977938|582845325|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
161398564|NCT00977938|582845326|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
161398565|NCT00977938|582845323|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
161398566|NCT00977938|582845324|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
161398567|NCT00977938|582845325|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
161398568|NCT00977938|582845326|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
161398569|NCT00977938|582845323|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
161398570|NCT00977938|582845324|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
161398571|NCT00977938|582845325|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
161398572|NCT00977938|582845326|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
161398573|NCT00977938|582845323|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
161398574|NCT00977938|582845324|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
161398575|NCT00977938|582845325|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
161398576|NCT00977938|582845326|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
161398577|NCT00977938|582845323|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
161398578|NCT00977938|582845324|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
161398579|NCT00977938|582845325|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
161398580|NCT00977938|582845326|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
161398581|NCT02182440|582845337|FG000|Overall Study|Adverse Event|0|||
161398582|NCT02182440|582845338|FG001|Overall Study|Adverse Event|1|||
161398583|NCT02182440|582845339|FG002|Overall Study|Adverse Event|0|||
161398584|NCT02182440|582845340|FG003|Overall Study|Adverse Event|0|||
161398585|NCT02182440|582845337|FG000|Overall Study|Death|31|||
161398586|NCT02182440|582845338|FG001|Overall Study|Death|8|||
161398587|NCT02182440|582845339|FG002|Overall Study|Death|5|||
161398588|NCT02182440|582845340|FG003|Overall Study|Death|16|||
161398589|NCT02182440|582845337|FG000|Overall Study|Protocol Violation|0|||
161398590|NCT02182440|582845338|FG001|Overall Study|Protocol Violation|1|||
161398591|NCT02182440|582845339|FG002|Overall Study|Protocol Violation|0|||
161398592|NCT02182440|582845340|FG003|Overall Study|Protocol Violation|0|||
161398593|NCT02182440|582845337|FG000|Overall Study|Physician Decision|1|||
161398594|NCT02182440|582845338|FG001|Overall Study|Physician Decision|0|||
161398595|NCT02182440|582845339|FG002|Overall Study|Physician Decision|0|||
161398596|NCT02182440|582845340|FG003|Overall Study|Physician Decision|0|||
161398597|NCT02182440|582845337|FG000|Overall Study|Withdrawal by Subject|1|||
161398598|NCT02182440|582845338|FG001|Overall Study|Withdrawal by Subject|1|||
161398599|NCT02182440|582845339|FG002|Overall Study|Withdrawal by Subject|3|||
161398600|NCT02182440|582845340|FG003|Overall Study|Withdrawal by Subject|4|||
161398601|NCT02182440|582845337|FG000|Overall Study|different, e.g adm other hospital|12|||
161398602|NCT02182440|582845338|FG001|Overall Study|different, e.g adm other hospital|3|||
161398603|NCT02182440|582845339|FG002|Overall Study|different, e.g adm other hospital|3|||
161398604|NCT02182440|582845340|FG003|Overall Study|different, e.g adm other hospital|10|||
161398605|NCT00072293|582845341|FG000|Overall Study|Lost to Follow-up|1|||
161398606|NCT00072293|582845342|FG001|Overall Study|Lost to Follow-up|1|||
161398607|NCT00072293|582845341|FG000|Overall Study|Withdrawal by Subject|0|||
161398608|NCT00072293|582845342|FG001|Overall Study|Withdrawal by Subject|1|||
161398609|NCT01605227|582845343|FG000|Overall Study|Did not receive study treatment|2|||
161398610|NCT01605227|582845344|FG001|Overall Study|Did not receive study treatment|3|||
161398611|NCT01605227|582845343|FG000|Overall Study|Adverse Event|228|||
161398612|NCT01605227|582845344|FG001|Overall Study|Adverse Event|42|||
161398613|NCT01605227|582845343|FG000|Overall Study|Progressive Disease|132|||
161398614|NCT01605227|582845344|FG001|Overall Study|Progressive Disease|128|||
161398615|NCT01605227|582845343|FG000|Overall Study|Clinical Deterioration|227|||
161398616|NCT01605227|582845344|FG001|Overall Study|Clinical Deterioration|133|||
161398617|NCT01605227|582845343|FG000|Overall Study|Lost to Follow-up|1|||
161398618|NCT01605227|582845344|FG001|Overall Study|Lost to Follow-up|0|||
161398619|NCT01605227|582845343|FG000|Overall Study|Protocol Violation|1|||
161398620|NCT01605227|582845344|FG001|Overall Study|Protocol Violation|0|||
161398621|NCT01605227|582845343|FG000|Overall Study|Physician Decision|9|||
161398622|NCT01605227|582845344|FG001|Overall Study|Physician Decision|7|||
161398623|NCT01605227|582845343|FG000|Overall Study|Withdrawal by Subject|18|||
161398624|NCT01605227|582845344|FG001|Overall Study|Withdrawal by Subject|14|||
161398625|NCT01605227|582845343|FG000|Overall Study|Sponsor Decision|2|||
161398626|NCT01605227|582845344|FG001|Overall Study|Sponsor Decision|0|||
161398627|NCT01605227|582845343|FG000|Overall Study|Started New Therapy|1|||
161398628|NCT01605227|582845344|FG001|Overall Study|Started New Therapy|0|||
161398629|NCT01605227|582845343|FG000|Overall Study|Subject Decision|0|||
161398630|NCT01605227|582845344|FG001|Overall Study|Subject Decision|1|||
161398631|NCT01605227|582845343|FG000|Overall Study|Dose Held >6 weeks|0|||
161398632|NCT01605227|582845344|FG001|Overall Study|Dose Held >6 weeks|1|||
161398633|NCT01166958|582845345|FG000|Overall Study|Withdrawal by Subject|1|||
161398634|NCT01166958|582845346|FG001|Overall Study|Withdrawal by Subject|0|||
161398635|NCT01286987|582845347|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
161398636|NCT01286987|582845348|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
161398637|NCT01286987|582845349|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
161398638|NCT01286987|582845350|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
161398639|NCT01286987|582845351|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
161398640|NCT01286987|582845352|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
161398641|NCT01286987|582845353|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
161398642|NCT01286987|582845354|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
161398643|NCT01286987|582845355|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
161398644|NCT01286987|582845356|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
161398645|NCT01286987|582845357|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
161398646|NCT01286987|582845358|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
161398647|NCT01286987|582845359|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
161398648|NCT01286987|582845360|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
161398649|NCT01286987|582845361|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
161398650|NCT01286987|582845347|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
161398651|NCT01286987|582845348|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
161398652|NCT01286987|582845349|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
161398653|NCT01286987|582845350|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
161398654|NCT01286987|582845351|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
161398655|NCT01286987|582845352|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
161398656|NCT01286987|582845353|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
161398657|NCT01286987|582845354|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
161398658|NCT01286987|582845355|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
161398659|NCT01286987|582845356|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
161398660|NCT01286987|582845357|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
161398661|NCT01286987|582845358|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
161398662|NCT01286987|582845359|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
161398663|NCT01286987|582845360|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
161398664|NCT01286987|582845361|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
161398665|NCT01286987|582845347|FG000|Part 1: Dose Escalation|Physician Decision|0|||
161398666|NCT01286987|582845348|FG001|Part 1: Dose Escalation|Physician Decision|0|||
161398667|NCT01286987|582845349|FG002|Part 1: Dose Escalation|Physician Decision|0|||
161398668|NCT01286987|582845350|FG003|Part 1: Dose Escalation|Physician Decision|0|||
161398669|NCT01286987|582845351|FG004|Part 1: Dose Escalation|Physician Decision|1|||
161398670|NCT01286987|582845352|FG005|Part 1: Dose Escalation|Physician Decision|0|||
161398671|NCT01286987|582845353|FG006|Part 1: Dose Escalation|Physician Decision|0|||
161398672|NCT01286987|582845354|FG007|Part 1: Dose Escalation|Physician Decision|0|||
161398673|NCT01286987|582845355|FG008|Part 1: Dose Escalation|Physician Decision|0|||
161398674|NCT01286987|582845356|FG009|Part 1: Dose Escalation|Physician Decision|0|||
161398675|NCT01286987|582845357|FG010|Part 1: Dose Escalation|Physician Decision|0|||
161398676|NCT01286987|582845358|FG011|Part 1: Dose Escalation|Physician Decision|0|||
161398677|NCT01286987|582845359|FG012|Part 1: Dose Escalation|Physician Decision|0|||
161398678|NCT01286987|582845360|FG013|Part 1: Dose Escalation|Physician Decision|0|||
161398679|NCT01286987|582845361|FG014|Part 1: Dose Escalation|Physician Decision|0|||
161398680|NCT01286987|582845347|FG000|Part 2: Dose Expansion|Death|0|||
161398681|NCT01286987|582845348|FG001|Part 2: Dose Expansion|Death|0|||
161398682|NCT01286987|582845349|FG002|Part 2: Dose Expansion|Death|0|||
161398683|NCT01286987|582845350|FG003|Part 2: Dose Expansion|Death|0|||
161398684|NCT01286987|582845351|FG004|Part 2: Dose Expansion|Death|0|||
161398685|NCT01286987|582845352|FG005|Part 2: Dose Expansion|Death|0|||
161398686|NCT01286987|582845353|FG006|Part 2: Dose Expansion|Death|0|||
161398687|NCT01286987|582845354|FG007|Part 2: Dose Expansion|Death|0|||
161398688|NCT01286987|582845355|FG008|Part 2: Dose Expansion|Death|0|||
161398689|NCT01286987|582845356|FG009|Part 2: Dose Expansion|Death|0|||
161398690|NCT01286987|582845357|FG010|Part 2: Dose Expansion|Death|0|||
161398691|NCT01286987|582845358|FG011|Part 2: Dose Expansion|Death|0|||
161398692|NCT01286987|582845359|FG012|Part 2: Dose Expansion|Death|1|||
161398693|NCT01286987|582845360|FG013|Part 2: Dose Expansion|Death|1|||
161398694|NCT01286987|582845361|FG014|Part 2: Dose Expansion|Death|0|||
161398695|NCT01286987|582845347|FG000|Part 2: Dose Expansion|Physician Decision|0|||
161398696|NCT01286987|582845348|FG001|Part 2: Dose Expansion|Physician Decision|0|||
161398697|NCT01286987|582845349|FG002|Part 2: Dose Expansion|Physician Decision|0|||
161398698|NCT01286987|582845350|FG003|Part 2: Dose Expansion|Physician Decision|0|||
161398699|NCT01286987|582845351|FG004|Part 2: Dose Expansion|Physician Decision|0|||
161398700|NCT01286987|582845352|FG005|Part 2: Dose Expansion|Physician Decision|0|||
161398701|NCT01286987|582845353|FG006|Part 2: Dose Expansion|Physician Decision|0|||
161398702|NCT01286987|582845354|FG007|Part 2: Dose Expansion|Physician Decision|0|||
161398703|NCT01286987|582845355|FG008|Part 2: Dose Expansion|Physician Decision|0|||
161398704|NCT01286987|582845356|FG009|Part 2: Dose Expansion|Physician Decision|0|||
161398705|NCT01286987|582845357|FG010|Part 2: Dose Expansion|Physician Decision|1|||
161398706|NCT01286987|582845358|FG011|Part 2: Dose Expansion|Physician Decision|1|||
161398707|NCT01286987|582845359|FG012|Part 2: Dose Expansion|Physician Decision|0|||
161398708|NCT01286987|582845360|FG013|Part 2: Dose Expansion|Physician Decision|1|||
161398709|NCT01286987|582845361|FG014|Part 2: Dose Expansion|Physician Decision|0|||
161398710|NCT01286987|582845347|FG000|Part 2: Dose Expansion|Other|0|||
161398711|NCT01286987|582845348|FG001|Part 2: Dose Expansion|Other|0|||
161398712|NCT01286987|582845349|FG002|Part 2: Dose Expansion|Other|0|||
161398713|NCT01286987|582845350|FG003|Part 2: Dose Expansion|Other|0|||
161398714|NCT01286987|582845351|FG004|Part 2: Dose Expansion|Other|0|||
161398715|NCT01286987|582845352|FG005|Part 2: Dose Expansion|Other|0|||
161398716|NCT01286987|582845353|FG006|Part 2: Dose Expansion|Other|0|||
161398717|NCT01286987|582845354|FG007|Part 2: Dose Expansion|Other|0|||
161398718|NCT01286987|582845355|FG008|Part 2: Dose Expansion|Other|0|||
161398719|NCT01286987|582845356|FG009|Part 2: Dose Expansion|Other|0|||
161398720|NCT01286987|582845357|FG010|Part 2: Dose Expansion|Other|0|||
161398721|NCT01286987|582845358|FG011|Part 2: Dose Expansion|Other|0|||
161398722|NCT01286987|582845359|FG012|Part 2: Dose Expansion|Other|0|||
161398723|NCT01286987|582845360|FG013|Part 2: Dose Expansion|Other|1|||
161398724|NCT01286987|582845361|FG014|Part 2: Dose Expansion|Other|0|||
161398725|NCT01286987|582845347|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
161398726|NCT01286987|582845348|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
161398727|NCT01286987|582845349|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
161398728|NCT01286987|582845350|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
161398729|NCT01286987|582845351|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
161398730|NCT01286987|582845352|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
161398731|NCT01286987|582845353|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
161398732|NCT01286987|582845354|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
161398733|NCT01286987|582845355|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
161398734|NCT01286987|582845356|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
161398735|NCT01286987|582845357|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
161398736|NCT01286987|582845358|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
161398737|NCT01286987|582845359|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
161398738|NCT01286987|582845360|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
161398739|NCT01286987|582845361|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
161398740|NCT01286987|582845347|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
161398741|NCT01286987|582845348|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
161398742|NCT01286987|582845349|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
161398743|NCT01286987|582845350|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
161398744|NCT01286987|582845351|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
161398745|NCT01286987|582845352|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
161398746|NCT01286987|582845353|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
161398747|NCT01286987|582845354|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
161398748|NCT01286987|582845355|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
161398749|NCT01286987|582845356|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
161398750|NCT01286987|582845357|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
161398751|NCT01286987|582845358|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
161398752|NCT01286987|582845359|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
161398753|NCT01286987|582845360|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
161398754|NCT01286987|582845361|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
161398755|NCT01286987|582845347|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398756|NCT01286987|582845348|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398757|NCT01286987|582845349|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398758|NCT01286987|582845350|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398759|NCT01286987|582845351|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398760|NCT01286987|582845352|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398761|NCT01286987|582845353|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398762|NCT01286987|582845354|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398763|NCT01286987|582845355|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398764|NCT01286987|582845356|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398765|NCT01286987|582845357|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161398766|NCT01286987|582845358|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398767|NCT01286987|582845359|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398768|NCT01286987|582845360|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398769|NCT01286987|582845361|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161398770|NCT03093974|582845366|FG000|Overall Study|Withdrawal by Subject|32|||
161398771|NCT03093974|582845367|FG001|Overall Study|Withdrawal by Subject|27|||
161398772|NCT03093974|582845366|FG000|Overall Study|Adverse Event|17|||
161398773|NCT03093974|582845367|FG001|Overall Study|Adverse Event|24|||
161398774|NCT03093974|582845366|FG000|Overall Study|Death|0|||
161398775|NCT03093974|582845367|FG001|Overall Study|Death|1|||
161398776|NCT03093974|582845366|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161398777|NCT03093974|582845367|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161398778|NCT03093974|582845366|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
161398779|NCT03093974|582845367|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
161398780|NCT03093974|582845366|FG000|Overall Study|Lost to Follow-up|0|||
161398781|NCT03093974|582845367|FG001|Overall Study|Lost to Follow-up|1|||
161398782|NCT03093974|582845366|FG000|Overall Study|Other|1|||
161398783|NCT03093974|582845367|FG001|Overall Study|Other|2|||
161398784|NCT01009346|582845372|FG000|Overall Study|Adverse Event|4|||
161398785|NCT00033540|582845375|FG000|Overall Study|Adverse Event|14|||
161398786|NCT00033540|582845375|FG000|Overall Study|Death|1|||
161398787|NCT00033540|582845375|FG000|Overall Study|Progression|26|||
161398788|NCT00033540|582845375|FG000|Overall Study|Withdrawal by Subject|6|||
161398789|NCT00033540|582845375|FG000|Overall Study|Other|5|||
161398790|NCT00033540|582845375|FG000|Overall Study|Ineligible|3|||
161398791|NCT00033540|582845375|FG000|Overall Study|Never received treatment|2|||
161398792|NCT00405964|582845376|FG000|Overall Study|Treatment Failure|17|||
161398793|NCT00405964|582845377|FG001|Overall Study|Treatment Failure|45|||
161398794|NCT00405964|582845376|FG000|Overall Study|Adverse Event|7|||
161398795|NCT00405964|582845377|FG001|Overall Study|Adverse Event|16|||
161398796|NCT00405964|582845376|FG000|Overall Study|Lost to Follow-up|5|||
161398797|NCT00405964|582845377|FG001|Overall Study|Lost to Follow-up|5|||
161398798|NCT00405964|582845376|FG000|Overall Study|Withdrawal by Subject|19|||
161398799|NCT00405964|582845377|FG001|Overall Study|Withdrawal by Subject|23|||
161398800|NCT00405964|582845376|FG000|Overall Study|Protocol Violation|11|||
161398801|NCT00405964|582845377|FG001|Overall Study|Protocol Violation|6|||
161398802|NCT01253265|582845380|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
161398803|NCT01253265|582845381|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
161398804|NCT01253265|582845382|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
161398805|NCT01253265|582845383|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
161398806|NCT01253265|582845384|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
161398807|NCT01253265|582845380|FG000|Overall Study|Withdrawal by Subject|0|||
161398808|NCT01253265|582845381|FG001|Overall Study|Withdrawal by Subject|0|||
161398809|NCT01253265|582845382|FG002|Overall Study|Withdrawal by Subject|0|||
161398810|NCT01253265|582845383|FG003|Overall Study|Withdrawal by Subject|0|||
161398811|NCT01253265|582845384|FG004|Overall Study|Withdrawal by Subject|1|||
161398812|NCT00066469|582845387|FG000|Overall Study|Death|3|||
161398813|NCT00066469|582845387|FG000|Overall Study|Lack of Efficacy|9|||
161398814|NCT00066469|582845387|FG000|Overall Study|Lost to Follow-up|1|||
161398815|NCT00066469|582845387|FG000|Overall Study|Physician Decision|1|||
161398816|NCT00066469|582845387|FG000|Overall Study|Withdrawal by Subject|1|||
161398817|NCT00066469|582845387|FG000|Overall Study|ineligible|1|||
161398818|NCT03271047|582845388|FG000|Phase 1b: Dose Finding Period|Death|8|||
161398819|NCT03271047|582845389|FG001|Phase 1b: Dose Finding Period|Death|8|||
161398820|NCT03271047|582845390|FG002|Phase 1b: Dose Finding Period|Death|0|||
161398821|NCT03271047|582845391|FG003|Phase 1b: Dose Finding Period|Death|0|||
161398822|NCT03271047|582845388|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
161398823|NCT03271047|582845389|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
161398824|NCT03271047|582845390|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
161398825|NCT03271047|582845391|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
161398826|NCT03271047|582845388|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
161398827|NCT03271047|582845389|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
161398828|NCT03271047|582845390|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
161398829|NCT03271047|582845391|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
161398830|NCT03271047|582845388|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
161398831|NCT03271047|582845389|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
161398832|NCT03271047|582845390|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
161398833|NCT03271047|582845391|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
161398834|NCT03271047|582845388|FG000|Randomized Phase 2 Period|Other|0|||
161398835|NCT03271047|582845389|FG001|Randomized Phase 2 Period|Other|0|||
161398836|NCT03271047|582845390|FG002|Randomized Phase 2 Period|Other|0|||
161398837|NCT03271047|582845391|FG003|Randomized Phase 2 Period|Other|1|||
161398838|NCT03271047|582845388|FG000|Randomized Phase 2 Period|Death|0|||
161398839|NCT03271047|582845389|FG001|Randomized Phase 2 Period|Death|0|||
161398840|NCT03271047|582845390|FG002|Randomized Phase 2 Period|Death|20|||
161398841|NCT03271047|582845391|FG003|Randomized Phase 2 Period|Death|21|||
161398842|NCT03271047|582845388|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
161398843|NCT03271047|582845389|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
161398844|NCT03271047|582845390|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
161398845|NCT03271047|582845391|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
161398846|NCT03271047|582845388|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
161398847|NCT03271047|582845389|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
161398848|NCT03271047|582845390|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
161398849|NCT03271047|582845391|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
161398850|NCT03271047|582845388|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
161398851|NCT03271047|582845389|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
161398852|NCT03271047|582845390|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
161398853|NCT03271047|582845391|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
161398854|NCT00711802|582845392|FG000|Overall Study|Not treated (no further detail)|2|||
161398855|NCT00711802|582845393|FG001|Overall Study|Not treated (no further detail)|1|||
161398856|NCT00711802|582845394|FG002|Overall Study|Not treated (no further detail)|2|||
161398857|NCT00711802|582845395|FG003|Overall Study|Not treated (no further detail)|0|||
161398858|NCT00711802|582845396|FG004|Overall Study|Not treated (no further detail)|2|||
161398859|NCT00711802|582845397|FG005|Overall Study|Not treated (no further detail)|0|||
161398860|NCT00711802|582845398|FG006|Overall Study|Not treated (no further detail)|0|||
161398861|NCT00711802|582845399|FG007|Overall Study|Not treated (no further detail)|0|||
161398862|NCT00711802|582845392|FG000|Overall Study|Adverse Event|0|||
161398863|NCT00711802|582845393|FG001|Overall Study|Adverse Event|0|||
161398864|NCT00711802|582845394|FG002|Overall Study|Adverse Event|0|||
161398865|NCT00711802|582845395|FG003|Overall Study|Adverse Event|0|||
161398866|NCT00711802|582845396|FG004|Overall Study|Adverse Event|1|||
161398867|NCT00711802|582845397|FG005|Overall Study|Adverse Event|1|||
161398868|NCT00711802|582845398|FG006|Overall Study|Adverse Event|0|||
161398869|NCT00711802|582845399|FG007|Overall Study|Adverse Event|0|||
161398870|NCT00711802|582845392|FG000|Overall Study|Microbiological failure|0|||
161398871|NCT00711802|582845393|FG001|Overall Study|Microbiological failure|1|||
161398872|NCT00711802|582845394|FG002|Overall Study|Microbiological failure|0|||
161398873|NCT00711802|582845395|FG003|Overall Study|Microbiological failure|0|||
161398874|NCT00711802|582845396|FG004|Overall Study|Microbiological failure|0|||
161398875|NCT00711802|582845397|FG005|Overall Study|Microbiological failure|1|||
161398876|NCT00711802|582845398|FG006|Overall Study|Microbiological failure|0|||
161398877|NCT00711802|582845399|FG007|Overall Study|Microbiological failure|0|||
161398878|NCT00711802|582845392|FG000|Overall Study|Protocol Violation|0|||
161398879|NCT00711802|582845393|FG001|Overall Study|Protocol Violation|0|||
161398880|NCT00711802|582845394|FG002|Overall Study|Protocol Violation|0|||
161398881|NCT00711802|582845395|FG003|Overall Study|Protocol Violation|1|||
161398882|NCT00711802|582845396|FG004|Overall Study|Protocol Violation|0|||
161398883|NCT00711802|582845397|FG005|Overall Study|Protocol Violation|0|||
161398884|NCT00711802|582845398|FG006|Overall Study|Protocol Violation|0|||
161398885|NCT00711802|582845399|FG007|Overall Study|Protocol Violation|0|||
161398886|NCT00711802|582845392|FG000|Overall Study|Physician Decision|0|||
161398887|NCT00711802|582845393|FG001|Overall Study|Physician Decision|2|||
161398888|NCT00711802|582845394|FG002|Overall Study|Physician Decision|0|||
161398889|NCT00711802|582845395|FG003|Overall Study|Physician Decision|0|||
161398890|NCT00711802|582845396|FG004|Overall Study|Physician Decision|0|||
161398891|NCT00711802|582845397|FG005|Overall Study|Physician Decision|0|||
161398892|NCT00711802|582845398|FG006|Overall Study|Physician Decision|0|||
161398893|NCT00711802|582845399|FG007|Overall Study|Physician Decision|0|||
161398894|NCT00711802|582845392|FG000|Overall Study|Withdrawal by Subject|0|||
161398895|NCT00711802|582845393|FG001|Overall Study|Withdrawal by Subject|1|||
161398896|NCT00711802|582845394|FG002|Overall Study|Withdrawal by Subject|0|||
161398897|NCT00711802|582845395|FG003|Overall Study|Withdrawal by Subject|1|||
161398898|NCT00711802|582845396|FG004|Overall Study|Withdrawal by Subject|0|||
161398899|NCT00711802|582845397|FG005|Overall Study|Withdrawal by Subject|0|||
161398900|NCT00711802|582845398|FG006|Overall Study|Withdrawal by Subject|0|||
161398901|NCT00711802|582845399|FG007|Overall Study|Withdrawal by Subject|0|||
161398902|NCT00711802|582845392|FG000|Overall Study|Lost to Follow-up|0|||
161398903|NCT00711802|582845393|FG001|Overall Study|Lost to Follow-up|0|||
161398904|NCT00711802|582845394|FG002|Overall Study|Lost to Follow-up|3|||
161398905|NCT00711802|582845395|FG003|Overall Study|Lost to Follow-up|1|||
161398906|NCT00711802|582845396|FG004|Overall Study|Lost to Follow-up|10|||
161398907|NCT00711802|582845397|FG005|Overall Study|Lost to Follow-up|6|||
161398908|NCT00711802|582845398|FG006|Overall Study|Lost to Follow-up|4|||
161398909|NCT00711802|582845399|FG007|Overall Study|Lost to Follow-up|2|||
161398910|NCT00711802|582845392|FG000|Overall Study|Reason not reported|0|||
161398911|NCT00711802|582845393|FG001|Overall Study|Reason not reported|1|||
161398912|NCT00711802|582845394|FG002|Overall Study|Reason not reported|1|||
161398913|NCT00711802|582845395|FG003|Overall Study|Reason not reported|0|||
161398914|NCT00711802|582845396|FG004|Overall Study|Reason not reported|1|||
161398915|NCT00711802|582845397|FG005|Overall Study|Reason not reported|0|||
161398916|NCT00711802|582845398|FG006|Overall Study|Reason not reported|1|||
161398917|NCT00711802|582845399|FG007|Overall Study|Reason not reported|0|||
161398918|NCT03283150|582845401|FG000|Overall Study|Withdrawal by Subject|6|||
161398919|NCT03283150|582845402|FG001|Overall Study|Withdrawal by Subject|0|||
161398920|NCT03283150|582845403|FG002|Overall Study|Withdrawal by Subject|0|||
161398921|NCT02981407|582845404|FG000|Overall Study|Withdrawal by Subject|2|||
161398922|NCT02981407|582845405|FG001|Overall Study|Withdrawal by Subject|0|||
161398923|NCT02410824|582845408|FG000|First Intervention (One Week)|Headache|0|||
161398924|NCT02410824|582845409|FG001|First Intervention (One Week)|Headache|1|||
161398925|NCT00391391|582845410|FG000|Overall Study|Adverse Event|0|||
161398926|NCT00391391|582845411|FG001|Overall Study|Adverse Event|0|||
161398927|NCT00391391|582845412|FG002|Overall Study|Adverse Event|0|||
161398928|NCT00391391|582845413|FG003|Overall Study|Adverse Event|1|||
161398929|NCT00391391|582845410|FG000|Overall Study|Lost to Follow-up|1|||
161398930|NCT00391391|582845411|FG001|Overall Study|Lost to Follow-up|3|||
161398931|NCT00391391|582845412|FG002|Overall Study|Lost to Follow-up|7|||
161398932|NCT00391391|582845413|FG003|Overall Study|Lost to Follow-up|4|||
161398933|NCT00391391|582845410|FG000|Overall Study|Protocol Violation|2|||
161398934|NCT00391391|582845411|FG001|Overall Study|Protocol Violation|3|||
161398935|NCT00391391|582845412|FG002|Overall Study|Protocol Violation|6|||
161398936|NCT00391391|582845413|FG003|Overall Study|Protocol Violation|7|||
161398937|NCT00391391|582845410|FG000|Overall Study|Withdrawal by Subject|6|||
161398938|NCT00391391|582845411|FG001|Overall Study|Withdrawal by Subject|4|||
161398939|NCT00391391|582845412|FG002|Overall Study|Withdrawal by Subject|10|||
161398940|NCT00391391|582845413|FG003|Overall Study|Withdrawal by Subject|7|||
161398941|NCT02084238|582845414|FG000|Overall Study|Lost to Follow-up|2|||
161398942|NCT02649855|582845415|FG000|Overall Study|Refused further treatment|2|||
161398943|NCT02649855|582845416|FG001|Overall Study|Refused further treatment|1|||
161398944|NCT02649855|582845417|FG002|Overall Study|Refused further treatment|1|||
161398945|NCT02649855|582845415|FG000|Overall Study|Withdrew consent|0|||
161398946|NCT02649855|582845416|FG001|Overall Study|Withdrew consent|1|||
161398947|NCT02649855|582845417|FG002|Overall Study|Withdrew consent|0|||
161398948|NCT02649855|582845415|FG000|Overall Study|Switched to alternative treatment|0|||
161398949|NCT02649855|582845416|FG001|Overall Study|Switched to alternative treatment|1|||
161398950|NCT02649855|582845417|FG002|Overall Study|Switched to alternative treatment|1|||
161398951|NCT02649855|582845415|FG000|Overall Study|Principal investigator discretion|0|||
161398952|NCT02649855|582845416|FG001|Overall Study|Principal investigator discretion|1|||
161398953|NCT02649855|582845417|FG002|Overall Study|Principal investigator discretion|1|||
161398954|NCT02649855|582845415|FG000|Overall Study|No treatment, per protocol|1|||
161398955|NCT02649855|582845416|FG001|Overall Study|No treatment, per protocol|0|||
161398956|NCT02649855|582845417|FG002|Overall Study|No treatment, per protocol|0|||
161398957|NCT02649855|582845415|FG000|Overall Study|Initiate new treatment|1|||
161398958|NCT02649855|582845416|FG001|Overall Study|Initiate new treatment|0|||
161398959|NCT02649855|582845417|FG002|Overall Study|Initiate new treatment|0|||
161398960|NCT04030247|582847195|FG000|Overall Study|Withdrawal by Subject|4|||
161398961|NCT04030247|582847195|FG000|Overall Study|Lost to Follow-up|13|||
161398962|NCT02191605|582847196|FG000|Overall Study|Lost to Follow-up|9|||
161398963|NCT02191605|582847197|FG001|Overall Study|Lost to Follow-up|4|||
161398964|NCT02191605|582847198|FG002|Overall Study|Lost to Follow-up|7|||
161398965|NCT02191605|582847199|FG003|Overall Study|Lost to Follow-up|3|||
161398966|NCT02191605|582847200|FG004|Overall Study|Lost to Follow-up|4|||
161398967|NCT01309269|582847203|FG000|Overall Study|Adverse Event|56|||
161398968|NCT01309269|582847203|FG000|Overall Study|Withdrawal by Subject|25|||
161398969|NCT01309269|582847203|FG000|Overall Study|Lack of Acceptance|15|||
161398970|NCT01309269|582847203|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
161398971|NCT01309269|582847203|FG000|Overall Study|Kidney Transplant|25|||
161398972|NCT01309269|582847203|FG000|Overall Study|Administrative Problems|141|||
161398973|NCT01309269|582847203|FG000|Overall Study|Other|256|||
161398974|NCT01309269|582847203|FG000|Overall Study|Other|1|||
161398975|NCT01309269|582847203|FG000|Overall Study|Study Completion Data Not Recorded|95|||
161398976|NCT01309269|582847203|FG000|Overall Study|Enrolled but not Treated|107|||
161398977|NCT03647267|582847220|FG000|Overall Study|Lost to Follow-up|1|||
161398978|NCT03647267|582847221|FG001|Overall Study|Lost to Follow-up|0|||
161398979|NCT05079477|582847222|FG000|Overall Study|Lost to Follow-up|2|||
161398980|NCT05079477|582847223|FG001|Overall Study|Lost to Follow-up|0|||
161398981|NCT05079477|582847222|FG000|Overall Study|Withdrawal by Subject|1|||
161398982|NCT05079477|582847223|FG001|Overall Study|Withdrawal by Subject|0|||
161398983|NCT05079477|582847222|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
161398984|NCT05079477|582847223|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
161398985|NCT05079477|582847222|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
161398986|NCT05079477|582847223|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
161398987|NCT03131596|582847228|FG000|Overall Study|Protocol Violation|3|||
161398988|NCT03131596|582847229|FG001|Overall Study|Protocol Violation|3|||
161398989|NCT03131596|582847228|FG000|Overall Study|Lost to Follow-up|3|||
161398990|NCT03131596|582847229|FG001|Overall Study|Lost to Follow-up|0|||
161398991|NCT00734071|582847232|FG000|Overall Study|Adverse Event|4|||
161398992|NCT00734071|582847233|FG001|Overall Study|Adverse Event|3|||
161398993|NCT00734071|582847232|FG000|Overall Study|Lack of Efficacy|3|||
161398994|NCT00734071|582847233|FG001|Overall Study|Lack of Efficacy|1|||
161398995|NCT00734071|582847232|FG000|Overall Study|Noncompliance|2|||
161398996|NCT00734071|582847233|FG001|Overall Study|Noncompliance|2|||
161398997|NCT00734071|582847232|FG000|Overall Study|Protocol Deviations|3|||
161398998|NCT00734071|582847233|FG001|Overall Study|Protocol Deviations|4|||
161398999|NCT00734071|582847232|FG000|Overall Study|Voluntary Withdrawal|9|||
161399000|NCT00734071|582847233|FG001|Overall Study|Voluntary Withdrawal|7|||
161399001|NCT00734071|582847232|FG000|Overall Study|Lost to Follow-up|16|||
161399002|NCT00734071|582847233|FG001|Overall Study|Lost to Follow-up|8|||
161399003|NCT00734071|582847232|FG000|Overall Study|Other|1|||
161399004|NCT00734071|582847233|FG001|Overall Study|Other|2|||
161399005|NCT03654885|582847234|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
161399006|NCT03654885|582847235|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
161399007|NCT03654885|582847234|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
161399008|NCT03654885|582847235|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
161399009|NCT03654885|582847234|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
161399010|NCT03654885|582847235|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
161399011|NCT03654885|582847234|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
161399012|NCT03654885|582847235|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
161399013|NCT03654885|582847234|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
161399014|NCT03654885|582847235|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
161399015|NCT03654885|582847234|FG000|Overall Study|Adverse Event in Study Eye|3|||
161399016|NCT03654885|582847235|FG001|Overall Study|Adverse Event in Study Eye|0|||
161399017|NCT03654885|582847234|FG000|Overall Study|Consent Withdrawn|1|||
161399018|NCT03654885|582847235|FG001|Overall Study|Consent Withdrawn|0|||
161399019|NCT03654885|582847234|FG000|Overall Study|Death|3|||
161399020|NCT03654885|582847235|FG001|Overall Study|Death|1|||
161399021|NCT03654885|582847234|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
161399022|NCT03654885|582847235|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
161399023|NCT03654885|582847234|FG000|Overall Study|Lost to Follow-up|3|||
161399024|NCT03654885|582847235|FG001|Overall Study|Lost to Follow-up|3|||
161399025|NCT05275582|582847236|FG000|Overall Study|Lost to Follow-up|1|||
161399026|NCT05275582|582847237|FG001|Overall Study|Lost to Follow-up|0|||
161399027|NCT05275582|582847236|FG000|Overall Study|Withdrawal by Subject|0|||
161399028|NCT05275582|582847237|FG001|Overall Study|Withdrawal by Subject|2|||
161399029|NCT05275582|582847236|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
161399030|NCT05275582|582847237|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
161399031|NCT05275582|582847236|FG000|Overall Study|Death|1|||
161399032|NCT05275582|582847237|FG001|Overall Study|Death|0|||
161399033|NCT05275582|582847236|FG000|Overall Study|Protocol Violation|1|||
161399034|NCT05275582|582847237|FG001|Overall Study|Protocol Violation|0|||
161399035|NCT05320393|582847239|FG000|Overall Study|Withdrawal by Subject|1|||
161399036|NCT05320393|582847240|FG001|Overall Study|Withdrawal by Subject|0|||
161399037|NCT05320393|582847241|FG002|Overall Study|Withdrawal by Subject|2|||
161399038|NCT05320393|582847239|FG000|Overall Study|Lost to Follow-up|1|||
161399039|NCT05320393|582847240|FG001|Overall Study|Lost to Follow-up|2|||
161399040|NCT05320393|582847241|FG002|Overall Study|Lost to Follow-up|1|||
161399041|NCT05320393|582847239|FG000|Overall Study|Moved; too much driving|0|||
161399042|NCT05320393|582847240|FG001|Overall Study|Moved; too much driving|0|||
161399043|NCT05320393|582847241|FG002|Overall Study|Moved; too much driving|2|||
161399044|NCT05320393|582847239|FG000|Overall Study|Did not receive treatment|0|||
161399045|NCT05320393|582847240|FG001|Overall Study|Did not receive treatment|0|||
161399046|NCT05320393|582847241|FG002|Overall Study|Did not receive treatment|1|||
161399047|NCT02091284|582847243|FG000|Overall Study|Withdrawal by Subject|2|||
161399048|NCT02091284|582847244|FG001|Overall Study|Withdrawal by Subject|1|||
161399049|NCT02091284|582847243|FG000|Overall Study|unreliable data|1|||
161399050|NCT02091284|582847244|FG001|Overall Study|unreliable data|0|||
161399051|NCT01703117|582847250|FG000|Overall Study|Adverse Event|4|||
161399052|NCT01703117|582847251|FG001|Overall Study|Adverse Event|3|||
161399053|NCT01703117|582847250|FG000|Overall Study|Withdrawal by Subject|0|||
161399054|NCT01703117|582847251|FG001|Overall Study|Withdrawal by Subject|1|||
161399055|NCT03028480|582847252|FG000|Overall Study|No revisit after the first prescription date|2|||
161399056|NCT03028480|582847252|FG000|Overall Study|Did not use the drug|1|||
161399057|NCT03028480|582847252|FG000|Overall Study|Violation of the enrollment deadline|10|||
161399058|NCT03028480|582847252|FG000|Overall Study|Case report forms were not collected|21|||
161399059|NCT00759356|582847253|FG000|Overall Study|Adverse Event|0|||
161399060|NCT00759356|582847254|FG001|Overall Study|Adverse Event|1|||
161399061|NCT00759356|582847253|FG000|Overall Study|Withdrawal by Subject|0|||
161399062|NCT00759356|582847254|FG001|Overall Study|Withdrawal by Subject|2|||
161399063|NCT00759356|582847253|FG000|Overall Study|Subject was unable to return|1|||
161399064|NCT00759356|582847254|FG001|Overall Study|Subject was unable to return|0|||
161399065|NCT00585221|582847260|FG000|Overall Study|Protocol Violation|8|||
161399066|NCT02229214|582847269|FG000|Overall Study|Adverse Event|2|||
161399067|NCT02229214|582847270|FG001|Overall Study|Adverse Event|0|||
161399068|NCT02229214|582847269|FG000|Overall Study|Withdrawal by Subject|4|||
161399069|NCT02229214|582847270|FG001|Overall Study|Withdrawal by Subject|0|||
161399070|NCT00246025|582847271|FG000|Overall Study|Adverse Event|7|||
161399071|NCT00246025|582847272|FG001|Overall Study|Adverse Event|9|||
161399072|NCT00246025|582847273|FG002|Overall Study|Adverse Event|9|||
161399073|NCT00246025|582847274|FG003|Overall Study|Adverse Event|10|||
161399074|NCT00246025|582847271|FG000|Overall Study|Withdrawal by Subject|3|||
161399075|NCT00246025|582847272|FG001|Overall Study|Withdrawal by Subject|0|||
161399076|NCT00246025|582847273|FG002|Overall Study|Withdrawal by Subject|1|||
161399077|NCT00246025|582847274|FG003|Overall Study|Withdrawal by Subject|2|||
161399078|NCT00246025|582847271|FG000|Overall Study|unsuitable medical history was found|0|||
161399079|NCT00246025|582847272|FG001|Overall Study|unsuitable medical history was found|0|||
161399080|NCT00246025|582847273|FG002|Overall Study|unsuitable medical history was found|0|||
161399081|NCT00246025|582847274|FG003|Overall Study|unsuitable medical history was found|1|||
161399082|NCT03305081|582847283|FG000|Overall Study|Lost to Follow-up|10|||
161399083|NCT03305081|582847284|FG001|Overall Study|Lost to Follow-up|15|||
161399084|NCT00241631|582847285|FG000|Run in (2 Weeks)|Physician Decision|3|||
161399085|NCT00241631|582847286|FG001|Run in (2 Weeks)|Physician Decision|3|||
161399086|NCT00241631|582847285|FG000|Phase 1 (4 Weeks)|sore throat|1|||
161399087|NCT00241631|582847286|FG001|Phase 1 (4 Weeks)|sore throat|0|||
161399088|NCT00241631|582847285|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
161399089|NCT00241631|582847286|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
161399090|NCT00241631|582847285|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
161399091|NCT00241631|582847286|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
161399092|NCT00241631|582847285|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
161399093|NCT00241631|582847286|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
161399094|NCT01218100|582847287|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
161399095|NCT01218100|582847288|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
161399096|NCT01218100|582847289|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
161399097|NCT01218100|582847290|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
161399098|NCT01218100|582847287|FG000|Overall Study|Adverse Event|4|||
161399099|NCT01218100|582847288|FG001|Overall Study|Adverse Event|6|||
161399100|NCT01218100|582847289|FG002|Overall Study|Adverse Event|6|||
161399101|NCT01218100|582847290|FG003|Overall Study|Adverse Event|7|||
161399102|NCT01218100|582847287|FG000|Overall Study|Lack of Efficacy|9|||
161399103|NCT01218100|582847288|FG001|Overall Study|Lack of Efficacy|6|||
161399104|NCT01218100|582847289|FG002|Overall Study|Lack of Efficacy|5|||
161399105|NCT01218100|582847290|FG003|Overall Study|Lack of Efficacy|12|||
161399106|NCT01218100|582847287|FG000|Overall Study|Protocol Violation|0|||
161399107|NCT01218100|582847288|FG001|Overall Study|Protocol Violation|0|||
161399108|NCT01218100|582847289|FG002|Overall Study|Protocol Violation|1|||
161399109|NCT01218100|582847290|FG003|Overall Study|Protocol Violation|1|||
161399110|NCT01218100|582847287|FG000|Overall Study|Withdrawal by Subject|5|||
161399111|NCT01218100|582847288|FG001|Overall Study|Withdrawal by Subject|2|||
161399112|NCT01218100|582847289|FG002|Overall Study|Withdrawal by Subject|6|||
161399113|NCT01218100|582847290|FG003|Overall Study|Withdrawal by Subject|7|||
161399114|NCT01218100|582847287|FG000|Overall Study|Lost to Follow-up|3|||
161399115|NCT01218100|582847288|FG001|Overall Study|Lost to Follow-up|8|||
161399116|NCT01218100|582847289|FG002|Overall Study|Lost to Follow-up|2|||
161399117|NCT01218100|582847290|FG003|Overall Study|Lost to Follow-up|1|||
161399118|NCT01218100|582847287|FG000|Overall Study|Other Reason|2|||
161399119|NCT01218100|582847288|FG001|Overall Study|Other Reason|2|||
161399120|NCT01218100|582847289|FG002|Overall Study|Other Reason|6|||
161399121|NCT01218100|582847290|FG003|Overall Study|Other Reason|4|||
161399122|NCT02437305|582847291|FG000|Overall Study|Lost to Follow-up|18|||
161399123|NCT02437305|582847292|FG001|Overall Study|Lost to Follow-up|12|||
161399124|NCT01170065|582847293|FG000|Overall Study|Adverse Event|17|||
161399125|NCT01170065|582847294|FG001|Overall Study|Adverse Event|50|||
161399126|NCT01170065|582847295|FG002|Overall Study|Adverse Event|10|||
161399127|NCT01170065|582847293|FG000|Overall Study|Lost to Follow-up|1|||
161399128|NCT01170065|582847294|FG001|Overall Study|Lost to Follow-up|4|||
161399129|NCT01170065|582847295|FG002|Overall Study|Lost to Follow-up|1|||
161399130|NCT01170065|582847293|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
161399131|NCT01170065|582847294|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
161399132|NCT01170065|582847295|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
161399133|NCT01170065|582847293|FG000|Overall Study|Reason other than specified|3|||
161399134|NCT01170065|582847294|FG001|Overall Study|Reason other than specified|8|||
161399135|NCT01170065|582847295|FG002|Overall Study|Reason other than specified|3|||
161399136|NCT01170065|582847293|FG000|Overall Study|Ongoing after planned observation time|5|||
161399137|NCT01170065|582847294|FG001|Overall Study|Ongoing after planned observation time|26|||
161399138|NCT01170065|582847295|FG002|Overall Study|Ongoing after planned observation time|10|||
161399139|NCT03220581|582847297|FG000|Overall Study|Withdrawal by Subject|0|||
161399140|NCT03220581|582847298|FG001|Overall Study|Withdrawal by Subject|1|||
161399141|NCT03220581|582847297|FG000|Overall Study|Lost to Follow-up|3|||
161399142|NCT03220581|582847298|FG001|Overall Study|Lost to Follow-up|6|||
161399143|NCT01920893|582847299|FG000|Overall Study|Adverse Event|5|||
161399144|NCT01920893|582847300|FG001|Overall Study|Adverse Event|2|||
161399145|NCT01920893|582847299|FG000|Overall Study|Lack of Efficacy|2|||
161399146|NCT01920893|582847300|FG001|Overall Study|Lack of Efficacy|0|||
161399147|NCT03444766|582847301|FG000|Overall Study|Other Reasons|2|||
161399148|NCT03444766|582847301|FG000|Overall Study|Participant Withdrew Consent|5|||
161399149|NCT03444766|582847301|FG000|Overall Study|Lost to Follow-up|2|||
161399150|NCT03444766|582847301|FG000|Overall Study|Death|2|||
161399151|NCT03444766|582847301|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
161399152|NCT03444766|582847301|FG000|Overall Study|Disease Progression|49|||
161399153|NCT02446418|582847302|FG000|Overall Study|Adverse Event|4|||
161399154|NCT02446418|582847303|FG001|Overall Study|Adverse Event|8|||
161399155|NCT02446418|582847302|FG000|Overall Study|Physician Decision|5|||
161399156|NCT02446418|582847303|FG001|Overall Study|Physician Decision|1|||
161399157|NCT02446418|582847302|FG000|Overall Study|Withdrawal by Subject|3|||
161399158|NCT02446418|582847303|FG001|Overall Study|Withdrawal by Subject|3|||
161399159|NCT02446418|582847302|FG000|Overall Study|Lost to Follow-up|2|||
161399160|NCT02446418|582847303|FG001|Overall Study|Lost to Follow-up|2|||
161399161|NCT02446418|582847302|FG000|Overall Study|Protocol Violation|1|||
161399162|NCT02446418|582847303|FG001|Overall Study|Protocol Violation|2|||
161399163|NCT02446418|582847302|FG000|Overall Study|Lack of Efficacy|2|||
161399164|NCT02446418|582847303|FG001|Overall Study|Lack of Efficacy|0|||
161399165|NCT02446418|582847302|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
161399166|NCT02446418|582847303|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
161399167|NCT03421743|582847306|FG000|Overall Study|Lack of Efficacy|1|||
161399168|NCT03421743|582847307|FG001|Overall Study|Lack of Efficacy|0|||
161399169|NCT03421743|582847306|FG000|Overall Study|Adverse Event|2|||
161399170|NCT03421743|582847307|FG001|Overall Study|Adverse Event|1|||
161399171|NCT03421743|582847306|FG000|Overall Study|Withdrawal by Subject|0|||
161399172|NCT03421743|582847307|FG001|Overall Study|Withdrawal by Subject|1|||
161399173|NCT00435162|582847308|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
161399174|NCT00435162|582847309|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
161399175|NCT00435162|582847310|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
161399176|NCT00435162|582847311|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
161399177|NCT00435162|582847312|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
161399178|NCT00435162|582847313|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
161399179|NCT00694096|582847314|FG000|Overall Study|Withdrawal by Subject|5|||
161399180|NCT02680574|582847321|FG000|Overall Study|Death|137|||
161399181|NCT02680574|582847322|FG001|Overall Study|Death|137|||
161399182|NCT02680574|582847321|FG000|Overall Study|Withdrawal by Subject|17|||
161399183|NCT02680574|582847322|FG001|Overall Study|Withdrawal by Subject|9|||
161399184|NCT02680574|582847321|FG000|Overall Study|Lost to Follow-up|4|||
161399185|NCT02680574|582847322|FG001|Overall Study|Lost to Follow-up|6|||
161399186|NCT02078102|582847326|FG000|Overall Study|Adverse Event|1|||
161399187|NCT02078102|582847327|FG001|Overall Study|Adverse Event|0|||
161399188|NCT02078102|582847326|FG000|Overall Study|Withdrawal by Subject|1|||
161399189|NCT02078102|582847327|FG001|Overall Study|Withdrawal by Subject|0|||
161399190|NCT02078102|582847326|FG000|Overall Study|Physician Decision|0|||
161399191|NCT02078102|582847327|FG001|Overall Study|Physician Decision|1|||
161399192|NCT02185014|582847330|FG000|Overall Study|Adverse Event|18|||
161399193|NCT02185014|582847330|FG000|Overall Study|Withdrew Consent|8|||
161399194|NCT02185014|582847330|FG000|Overall Study|Lost to Follow-up|4|||
161399195|NCT02185014|582847330|FG000|Overall Study|Lack of Efficacy|14|||
161399196|NCT02185014|582847330|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
161399197|NCT02185014|582847330|FG000|Overall Study|Subject Noncompliance|1|||
161399198|NCT02185014|582847330|FG000|Overall Study|Other|4|||
161399199|NCT02141490|582847333|FG000|Overall Study|Screening failures|4|||
161399200|NCT02141490|582847334|FG001|Overall Study|Screening failures|0|||
161399201|NCT02141490|582847335|FG002|Overall Study|Screening failures|0|||
161399202|NCT01813721|582847336|FG000|Overall Study|Ineligibility determined|63|||
161399203|NCT01813721|582847336|FG000|Overall Study|Withdrawal by Subject|1|||
161399204|NCT02387164|582847337|FG000|Overall Study|Lost to Follow-up|2|||
161399205|NCT02387164|582847338|FG001|Overall Study|Lost to Follow-up|0|||
161399206|NCT02387164|582847337|FG000|Overall Study|Diagnosed|1|||
161399207|NCT02387164|582847338|FG001|Overall Study|Diagnosed|2|||
161399208|NCT02133664|582847341|FG000|Overall Study|Lost to Follow-up|2|||
161399209|NCT02133664|582847342|FG001|Overall Study|Lost to Follow-up|1|||
161399210|NCT02133664|582847341|FG000|Overall Study|Adverse Event|3|||
161399211|NCT02133664|582847342|FG001|Overall Study|Adverse Event|6|||
161399212|NCT00882908|582847344|FG000|Overall Study|Adverse Event|0|||
161399213|NCT00882908|582847345|FG001|Overall Study|Adverse Event|0|||
161399214|NCT00882908|582847346|FG002|Overall Study|Adverse Event|1|||
161399215|NCT00882908|582847347|FG003|Overall Study|Adverse Event|0|||
161399216|NCT00882908|582847348|FG004|Overall Study|Adverse Event|1|||
161399217|NCT00882908|582847344|FG000|Overall Study|Lost to Follow-up|3|||
161399218|NCT00882908|582847345|FG001|Overall Study|Lost to Follow-up|5|||
161399219|NCT00882908|582847346|FG002|Overall Study|Lost to Follow-up|3|||
161399220|NCT00882908|582847347|FG003|Overall Study|Lost to Follow-up|1|||
161399221|NCT00882908|582847348|FG004|Overall Study|Lost to Follow-up|2|||
161399222|NCT00882908|582847344|FG000|Overall Study|Protocol Violation|0|||
161399223|NCT00882908|582847345|FG001|Overall Study|Protocol Violation|1|||
161399224|NCT00882908|582847346|FG002|Overall Study|Protocol Violation|0|||
161399225|NCT00882908|582847347|FG003|Overall Study|Protocol Violation|0|||
161399226|NCT00882908|582847348|FG004|Overall Study|Protocol Violation|0|||
161399227|NCT00882908|582847344|FG000|Overall Study|Withdrawal by Subject|0|||
161399228|NCT00882908|582847345|FG001|Overall Study|Withdrawal by Subject|0|||
161399229|NCT00882908|582847346|FG002|Overall Study|Withdrawal by Subject|3|||
161399230|NCT00882908|582847347|FG003|Overall Study|Withdrawal by Subject|5|||
161399231|NCT00882908|582847348|FG004|Overall Study|Withdrawal by Subject|2|||
161399232|NCT00882908|582847344|FG000|Overall Study|Subject reached a virologic endpoint|0|||
161399233|NCT00882908|582847345|FG001|Overall Study|Subject reached a virologic endpoint|0|||
161399234|NCT00882908|582847346|FG002|Overall Study|Subject reached a virologic endpoint|0|||
161399235|NCT00882908|582847347|FG003|Overall Study|Subject reached a virologic endpoint|0|||
161399236|NCT00882908|582847348|FG004|Overall Study|Subject reached a virologic endpoint|1|||
161399237|NCT00882908|582847344|FG000|Overall Study|Study terminated in error|0|||
161399238|NCT00882908|582847345|FG001|Overall Study|Study terminated in error|0|||
161399239|NCT00882908|582847346|FG002|Overall Study|Study terminated in error|0|||
161399240|NCT00882908|582847347|FG003|Overall Study|Study terminated in error|1|||
161399241|NCT00882908|582847348|FG004|Overall Study|Study terminated in error|0|||
161399242|NCT00581828|582847349|FG000|Overall Study|Protocol Violation|1|||
161399243|NCT02436408|582847350|FG000|Overall Study|Death|1|||
161399244|NCT00392808|582847351|FG000|Overall Study|Lost to Follow-up|3|||
161399245|NCT00392808|582847352|FG001|Overall Study|Lost to Follow-up|2|||
161399246|NCT00392808|582847353|FG002|Overall Study|Lost to Follow-up|1|||
161399247|NCT00392808|582847354|FG003|Overall Study|Lost to Follow-up|2|||
161399248|NCT00392808|582847351|FG000|Overall Study|Unable to withdraw blood|3|||
161399249|NCT00392808|582847352|FG001|Overall Study|Unable to withdraw blood|1|||
161399250|NCT00392808|582847353|FG002|Overall Study|Unable to withdraw blood|1|||
161399251|NCT00392808|582847354|FG003|Overall Study|Unable to withdraw blood|2|||
161399252|NCT01038713|582847355|FG000|Overall Study|Patient to hospice|1|||
161399253|NCT01038713|582847356|FG001|Overall Study|Patient to hospice|1|||
161399254|NCT01038713|582847357|FG002|Overall Study|Patient to hospice|1|||
161399255|NCT01038713|582847355|FG000|Overall Study|Lost to Follow-up|3|||
161399256|NCT01038713|582847356|FG001|Overall Study|Lost to Follow-up|0|||
161399257|NCT01038713|582847357|FG002|Overall Study|Lost to Follow-up|0|||
161399258|NCT01038713|582847355|FG000|Overall Study|Neuroendocrine Tumor|0|||
161399259|NCT01038713|582847356|FG001|Overall Study|Neuroendocrine Tumor|1|||
161399260|NCT01038713|582847357|FG002|Overall Study|Neuroendocrine Tumor|0|||
161399261|NCT01038713|582847355|FG000|Overall Study|died from PEP|0|||
161399262|NCT01038713|582847356|FG001|Overall Study|died from PEP|1|||
161399263|NCT01038713|582847357|FG002|Overall Study|died from PEP|0|||
161399264|NCT01038713|582847355|FG000|Overall Study|Autoimmune Pancreatitis|1|||
161399265|NCT01038713|582847356|FG001|Overall Study|Autoimmune Pancreatitis|0|||
161399266|NCT01038713|582847357|FG002|Overall Study|Autoimmune Pancreatitis|0|||
161399267|NCT02818036|582847358|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
161399268|NCT02818036|582847359|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
161399269|NCT02818036|582847358|FG000|Overall Study|Withdrawal by Subject|1|||
161399270|NCT02818036|582847359|FG001|Overall Study|Withdrawal by Subject|0|||
161399271|NCT03777917|582847360|FG000|Overall Study|Withdrawal by Subject|1|||
161399272|NCT03777917|582847361|FG001|Overall Study|Withdrawal by Subject|0|||
161399273|NCT03777917|582847360|FG000|Overall Study|Physician Decision|1|||
161399274|NCT03777917|582847361|FG001|Overall Study|Physician Decision|0|||
161399275|NCT03777917|582847360|FG000|Overall Study|Lost to Follow-up|6|||
161399276|NCT03777917|582847361|FG001|Overall Study|Lost to Follow-up|2|||
161399277|NCT03777917|582847360|FG000|Overall Study|Other|1|||
161399278|NCT03777917|582847361|FG001|Overall Study|Other|0|||
161399279|NCT01154283|582847362|FG000|0-6 Weeks|Withdrawal by Subject|7|||
161399280|NCT01154283|582847363|FG001|0-6 Weeks|Withdrawal by Subject|2|||
161399281|NCT01154283|582847362|FG000|0-6 Weeks|Death|0|||
161399282|NCT01154283|582847363|FG001|0-6 Weeks|Death|1|||
161399283|NCT01154283|582847362|FG000|7-12 Weeks|Death|1|||
161399284|NCT01154283|582847363|FG001|7-12 Weeks|Death|0|||
161399285|NCT01154283|582847362|FG000|7-12 Weeks|Withdrawal by Subject|0|||
161399286|NCT01154283|582847363|FG001|7-12 Weeks|Withdrawal by Subject|1|||
161399287|NCT00320372|582847364|FG000|Overall Study|Physician Decision|4|||
161399288|NCT00320372|582847365|FG001|Overall Study|Physician Decision|7|||
161399289|NCT00320372|582847364|FG000|Overall Study|Death|7|||
161399290|NCT00320372|582847365|FG001|Overall Study|Death|8|||
161399291|NCT00320372|582847364|FG000|Overall Study|Withdrawal by Subject|55|||
161399292|NCT00320372|582847365|FG001|Overall Study|Withdrawal by Subject|37|||
161399293|NCT00320372|582847364|FG000|Overall Study|Non-Compliance|40|||
161399294|NCT00320372|582847365|FG001|Overall Study|Non-Compliance|39|||
161399295|NCT00320372|582847364|FG000|Overall Study|Did not Meet (I/E)|3|||
161399296|NCT00320372|582847365|FG001|Overall Study|Did not Meet (I/E)|1|||
161399297|NCT00320372|582847364|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
161399298|NCT00320372|582847365|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
161399299|NCT04063787|582847366|FG000|Overall Study|Inadequate Doppler data|4|||
161399300|NCT04063787|582847366|FG000|Overall Study|Lost to Follow-up|2|||
161399301|NCT04063787|582847366|FG000|Overall Study|Death|3|||
161399302|NCT01416441|582847367|FG000|Overall Study|Lost to Follow-up|5|||
161399303|NCT01416441|582847367|FG000|Overall Study|Adverse Event|6|||
161399304|NCT01416441|582847367|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
161399305|NCT01416441|582847367|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
161399306|NCT01416441|582847367|FG000|Overall Study|Investigator Withdrew Subject|2|||
161399307|NCT01416441|582847367|FG000|Overall Study|Subject Withdrew Consent|12|||
161399308|NCT01416441|582847367|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
161399309|NCT03515941|582847377|FG000|Overall Study|Adverse Event|1|||
161399310|NCT03515941|582847378|FG001|Overall Study|Adverse Event|0|||
161399311|NCT00240110|582849628|FG000|Overall Study|Lost to Follow-up|6|||
161399312|NCT00240110|582849629|FG001|Overall Study|Lost to Follow-up|7|||
161399313|NCT03747120|582849635|FG000|Overall Study|treatment related toxicity|3|||
161399314|NCT03747120|582849636|FG001|Overall Study|treatment related toxicity|0|||
161399315|NCT03747120|582849637|FG002|Overall Study|treatment related toxicity|0|||
161399316|NCT03747120|582849635|FG000|Overall Study|Withdrawal by Subject|0|||
161399317|NCT03747120|582849636|FG001|Overall Study|Withdrawal by Subject|1|||
161399318|NCT03747120|582849637|FG002|Overall Study|Withdrawal by Subject|2|||
161399319|NCT03383783|582849638|FG000|Overall Study|Withdrawal by Subject|2|||
161399320|NCT01340937|582849640|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
161399321|NCT01340937|582849641|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
161399322|NCT01340937|582849642|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
161399323|NCT01340937|582849643|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
161399324|NCT01340937|582849640|FG000|Period 1: Infant Series|Adverse Event|0|||
161399325|NCT01340937|582849641|FG001|Period 1: Infant Series|Adverse Event|1|||
161399326|NCT01340937|582849642|FG002|Period 1: Infant Series|Adverse Event|4|||
161399327|NCT01340937|582849643|FG003|Period 1: Infant Series|Adverse Event|0|||
161399328|NCT01340937|582849640|FG000|Period 1: Infant Series|Death|2|||
161399329|NCT01340937|582849641|FG001|Period 1: Infant Series|Death|0|||
161399330|NCT01340937|582849642|FG002|Period 1: Infant Series|Death|2|||
161399331|NCT01340937|582849643|FG003|Period 1: Infant Series|Death|0|||
161399332|NCT01340937|582849640|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
161399333|NCT01340937|582849641|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
161399334|NCT01340937|582849642|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
161399335|NCT01340937|582849643|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
161399336|NCT01340937|582849640|FG000|Period 1: Infant Series|Physician Decision|2|||
161399337|NCT01340937|582849641|FG001|Period 1: Infant Series|Physician Decision|3|||
161399338|NCT01340937|582849642|FG002|Period 1: Infant Series|Physician Decision|1|||
161399339|NCT01340937|582849643|FG003|Period 1: Infant Series|Physician Decision|0|||
161399340|NCT01340937|582849640|FG000|Period 1: Infant Series|Protocol Violation|1|||
161399341|NCT01340937|582849641|FG001|Period 1: Infant Series|Protocol Violation|4|||
161399342|NCT01340937|582849642|FG002|Period 1: Infant Series|Protocol Violation|4|||
161399343|NCT01340937|582849643|FG003|Period 1: Infant Series|Protocol Violation|3|||
161399344|NCT01340937|582849640|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
161399345|NCT01340937|582849641|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
161399346|NCT01340937|582849642|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
161399347|NCT01340937|582849643|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
161399348|NCT01340937|582849640|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
161399349|NCT01340937|582849641|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
161399350|NCT01340937|582849642|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
161399351|NCT01340937|582849643|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
161399352|NCT01340937|582849640|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
161399353|NCT01340937|582849641|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
161399354|NCT01340937|582849642|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
161399355|NCT01340937|582849643|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
161399356|NCT01340937|582849640|FG000|Period 2: Interim Period|Adverse Event|1|||
161399357|NCT01340937|582849641|FG001|Period 2: Interim Period|Adverse Event|0|||
161399358|NCT01340937|582849642|FG002|Period 2: Interim Period|Adverse Event|1|||
161399359|NCT01340937|582849643|FG003|Period 2: Interim Period|Adverse Event|0|||
161399360|NCT01340937|582849640|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
161399361|NCT01340937|582849641|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
161399362|NCT01340937|582849642|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
161399363|NCT01340937|582849643|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
161399364|NCT01340937|582849640|FG000|Period 2: Interim Period|Physician Decision|0|||
161399365|NCT01340937|582849641|FG001|Period 2: Interim Period|Physician Decision|1|||
161399366|NCT01340937|582849642|FG002|Period 2: Interim Period|Physician Decision|1|||
161399367|NCT01340937|582849643|FG003|Period 2: Interim Period|Physician Decision|0|||
161399368|NCT01340937|582849640|FG000|Period 2: Interim Period|Protocol Violation|5|||
161399369|NCT01340937|582849641|FG001|Period 2: Interim Period|Protocol Violation|3|||
161399370|NCT01340937|582849642|FG002|Period 2: Interim Period|Protocol Violation|6|||
161399371|NCT01340937|582849643|FG003|Period 2: Interim Period|Protocol Violation|3|||
161399372|NCT01340937|582849640|FG000|Period 2: Interim Period|Technical problems|4|||
161399373|NCT01340937|582849641|FG001|Period 2: Interim Period|Technical problems|4|||
161399374|NCT01340937|582849642|FG002|Period 2: Interim Period|Technical problems|6|||
161399375|NCT01340937|582849643|FG003|Period 2: Interim Period|Technical problems|3|||
161399376|NCT01340937|582849640|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
161399377|NCT01340937|582849641|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
161399378|NCT01340937|582849642|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
161399379|NCT01340937|582849643|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
161399380|NCT01340937|582849640|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
161399381|NCT01340937|582849641|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
161399382|NCT01340937|582849642|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
161399383|NCT01340937|582849643|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
161399384|NCT01340937|582849640|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
161399385|NCT01340937|582849641|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
161399386|NCT01340937|582849642|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
161399387|NCT01340937|582849643|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
161399388|NCT01340937|582849640|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
161399389|NCT01340937|582849641|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
161399390|NCT01340937|582849642|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
161399391|NCT01340937|582849643|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
161399392|NCT00440310|582849644|FG000|Overall Study|Lost to Follow-up|4|||
161399393|NCT00440310|582849645|FG001|Overall Study|Lost to Follow-up|5|||
161399394|NCT00440310|582849644|FG000|Overall Study|Protocol Violation|0|||
161399395|NCT00440310|582849645|FG001|Overall Study|Protocol Violation|1|||
161399396|NCT00440310|582849644|FG000|Overall Study|Withdrawal by Subject|15|||
161399397|NCT00440310|582849645|FG001|Overall Study|Withdrawal by Subject|14|||
161399398|NCT00440310|582849644|FG000|Overall Study|No Reply at EOS|7|||
161399399|NCT00440310|582849645|FG001|Overall Study|No Reply at EOS|7|||
161399400|NCT00440310|582849644|FG000|Overall Study|Other|1|||
161399401|NCT00440310|582849645|FG001|Overall Study|Other|0|||
161399402|NCT00440310|582849644|FG000|Overall Study|Status Unknown|1|||
161399403|NCT00440310|582849645|FG001|Overall Study|Status Unknown|3|||
161399404|NCT02469415|582849646|FG000|Overall Study|Withdrawal by Subject|1|||
161399405|NCT02469415|582849646|FG000|Overall Study|Investigational agent placed on hold|2|||
161399406|NCT02119156|582849647|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
161399407|NCT02119156|582849648|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
161399408|NCT02119156|582849649|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
161399409|NCT02119156|582849647|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
161399410|NCT02119156|582849648|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
161399411|NCT02119156|582849649|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
161399412|NCT02119156|582849647|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
161399413|NCT02119156|582849648|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
161399414|NCT02119156|582849649|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
161399415|NCT02119156|582849647|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
161399416|NCT02119156|582849648|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
161399417|NCT02119156|582849649|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
161399418|NCT02119156|582849647|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
161399419|NCT02119156|582849648|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
161399420|NCT02119156|582849649|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
161399421|NCT00096174|582849657|FG000|Overall Study|Lack of Efficacy|9|||
161399422|NCT00096174|582849657|FG000|Overall Study|Adverse Event|15|||
161399423|NCT00096174|582849657|FG000|Overall Study|Death|6|||
161399424|NCT00096174|582849657|FG000|Overall Study|Withdrawal by Subject|15|||
161399425|NCT00096174|582849657|FG000|Overall Study|Not started protocol therapy|3|||
161399426|NCT00096174|582849657|FG000|Overall Study|Ineligible|6|||
161399427|NCT00096174|582849657|FG000|Overall Study|other reason|8|||
161399428|NCT00330928|582849660|FG000|Overall Study|Lost to Follow-up|6|||
161399429|NCT00330928|582849660|FG000|Overall Study|Physician Decision|9|||
161399430|NCT00330928|582849660|FG000|Overall Study|Death|1|||
161399431|NCT00330928|582849660|FG000|Overall Study|IVUS could not be performed.|1|||
161399432|NCT02403635|582849667|FG000|Overall Study|Not eligible|9|||
161399433|NCT02509052|582849668|FG000|Overall Study|Non compliance|0|||
161399434|NCT02509052|582849669|FG001|Overall Study|Non compliance|0|||
161399435|NCT02509052|582849670|FG002|Overall Study|Non compliance|1|||
161399436|NCT03554772|582849673|FG000|Overall Study|Lost to Follow-up|0|||
161399437|NCT03554772|582849674|FG001|Overall Study|Lost to Follow-up|0|||
161399438|NCT03554772|582849675|FG002|Overall Study|Lost to Follow-up|0|||
161399439|NCT03554772|582849676|FG003|Overall Study|Lost to Follow-up|2|||
161399440|NCT03362931|582849678|FG000|Overall Study|Adverse Event|1|||
161399441|NCT03362931|582849678|FG000|Overall Study|Death|2|||
161399442|NCT01998893|582849679|FG000|Overall Study|Adverse Event|2|||
161399443|NCT01998893|582849679|FG000|Overall Study|Death|1|||
161399444|NCT01998893|582849679|FG000|Overall Study|Lost to Follow-up|8|||
161399445|NCT01998893|582849679|FG000|Overall Study|Physician Decision|2|||
161399446|NCT01998893|582849679|FG000|Overall Study|Protocol Violation|2|||
161399447|NCT01998893|582849679|FG000|Overall Study|Withdrawal by Subject|1|||
161399448|NCT01998893|582849679|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
161399449|NCT03276052|582849680|FG000|Overall Study|Withdrawal by Subject|5|||
161399450|NCT03276052|582849680|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
161399451|NCT01994863|582849685|FG000|Period 1|Adverse Event|4|||
161399452|NCT01994863|582849686|FG001|Period 1|Adverse Event|0|||
161399453|NCT01994863|582849685|FG000|Period 1|Withdrawal by Subject|1|||
161399454|NCT01994863|582849686|FG001|Period 1|Withdrawal by Subject|0|||
161399455|NCT01994863|582849685|FG000|Period 1|Trial stopped by sponsor|1|||
161399456|NCT01994863|582849686|FG001|Period 1|Trial stopped by sponsor|3|||
161399457|NCT01994863|582849685|FG000|Period 1|Lack of Efficacy|1|||
161399458|NCT01994863|582849686|FG001|Period 1|Lack of Efficacy|0|||
161399459|NCT01994863|582849685|FG000|Period 2|Adverse Event|0|||
161399460|NCT01994863|582849686|FG001|Period 2|Adverse Event|1|||
161399461|NCT01994863|582849685|FG000|Period 2|Lack of Efficacy|0|||
161399462|NCT01994863|582849686|FG001|Period 2|Lack of Efficacy|2|||
161399463|NCT01994863|582849685|FG000|Period 2|Withdrawal by Subject|1|||
161399464|NCT01994863|582849686|FG001|Period 2|Withdrawal by Subject|1|||
161399465|NCT05136898|582849687|FG000|Overall Study|Adverse Event|2|||
161399466|NCT03784846|582849690|FG000|Pre-COVID Study|Lost to Follow-up|3|||
161399467|NCT03784846|582849691|FG001|Pre-COVID Study|Lost to Follow-up|3|||
161399468|NCT03784846|582849692|FG002|Pre-COVID Study|Lost to Follow-up|2|||
161399469|NCT03784846|582849690|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
161399470|NCT03784846|582849691|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
161399471|NCT03784846|582849692|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
161399472|NCT03784846|582849690|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
161399473|NCT03784846|582849691|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
161399474|NCT03784846|582849692|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
161399475|NCT03784846|582849690|FG000|Post-COVID Study|Lost to Follow-up|3|||
161399476|NCT03784846|582849691|FG001|Post-COVID Study|Lost to Follow-up|5|||
161399477|NCT03784846|582849692|FG002|Post-COVID Study|Lost to Follow-up|1|||
161399478|NCT03784846|582849690|FG000|Post-COVID Study|Withdrawal by Subject|1|||
161399479|NCT03784846|582849691|FG001|Post-COVID Study|Withdrawal by Subject|2|||
161399480|NCT03784846|582849692|FG002|Post-COVID Study|Withdrawal by Subject|0|||
161399481|NCT03054350|582849693|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
161399482|NCT03054350|582849694|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
161399483|NCT03054350|582849695|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
161399484|NCT03054350|582849696|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
161399485|NCT03054350|582849697|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
161399486|NCT03054350|582849698|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
161399487|NCT03054350|582849693|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161399488|NCT03054350|582849694|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161399489|NCT03054350|582849695|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
161399490|NCT03054350|582849696|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161399491|NCT03054350|582849697|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161399492|NCT03054350|582849698|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161399493|NCT03054350|582849693|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
161399494|NCT03054350|582849694|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161399495|NCT03054350|582849695|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161399496|NCT03054350|582849696|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
161399497|NCT03054350|582849697|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161399498|NCT03054350|582849698|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161399499|NCT03054350|582849693|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161399500|NCT03054350|582849694|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161399501|NCT03054350|582849695|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
161399502|NCT03054350|582849696|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161399503|NCT03054350|582849697|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161399504|NCT03054350|582849698|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161399505|NCT01643850|582849699|FG000|Overall Study|Withdrawal by Subject|0|||
161399506|NCT01643850|582849700|FG001|Overall Study|Withdrawal by Subject|0|||
161399507|NCT01643850|582849701|FG002|Overall Study|Withdrawal by Subject|0|||
161399508|NCT01643850|582849702|FG003|Overall Study|Withdrawal by Subject|0|||
161399509|NCT01643850|582849703|FG004|Overall Study|Withdrawal by Subject|1|||
161399510|NCT01643850|582849704|FG005|Overall Study|Withdrawal by Subject|0|||
161399511|NCT01643850|582849705|FG006|Overall Study|Withdrawal by Subject|0|||
161399512|NCT01643850|582849706|FG007|Overall Study|Withdrawal by Subject|0|||
161399513|NCT01643850|582849707|FG008|Overall Study|Withdrawal by Subject|0|||
161399514|NCT01643850|582849699|FG000|Overall Study|Lost to Follow-up|0|||
161399515|NCT01643850|582849700|FG001|Overall Study|Lost to Follow-up|0|||
161399516|NCT01643850|582849701|FG002|Overall Study|Lost to Follow-up|0|||
161399517|NCT01643850|582849702|FG003|Overall Study|Lost to Follow-up|0|||
161399518|NCT01643850|582849703|FG004|Overall Study|Lost to Follow-up|0|||
161399519|NCT01643850|582849704|FG005|Overall Study|Lost to Follow-up|0|||
161399520|NCT01643850|582849705|FG006|Overall Study|Lost to Follow-up|1|||
161399521|NCT01643850|582849706|FG007|Overall Study|Lost to Follow-up|0|||
161399522|NCT01643850|582849707|FG008|Overall Study|Lost to Follow-up|1|||
161399523|NCT01643850|582849699|FG000|Overall Study|Adverse Event|0|||
161399524|NCT01643850|582849700|FG001|Overall Study|Adverse Event|0|||
161399525|NCT01643850|582849701|FG002|Overall Study|Adverse Event|0|||
161399526|NCT01643850|582849702|FG003|Overall Study|Adverse Event|0|||
161399527|NCT01643850|582849703|FG004|Overall Study|Adverse Event|1|||
161399528|NCT01643850|582849704|FG005|Overall Study|Adverse Event|0|||
161399529|NCT01643850|582849705|FG006|Overall Study|Adverse Event|0|||
161399530|NCT01643850|582849706|FG007|Overall Study|Adverse Event|0|||
161399531|NCT01643850|582849707|FG008|Overall Study|Adverse Event|0|||
161399532|NCT01643850|582849699|FG000|Overall Study|Administrative Problems|0|||
161399533|NCT01643850|582849700|FG001|Overall Study|Administrative Problems|0|||
161399534|NCT01643850|582849701|FG002|Overall Study|Administrative Problems|1|||
161399535|NCT01643850|582849702|FG003|Overall Study|Administrative Problems|0|||
161399536|NCT01643850|582849703|FG004|Overall Study|Administrative Problems|1|||
161399537|NCT01643850|582849704|FG005|Overall Study|Administrative Problems|0|||
161399538|NCT01643850|582849705|FG006|Overall Study|Administrative Problems|0|||
161399539|NCT01643850|582849706|FG007|Overall Study|Administrative Problems|0|||
161399540|NCT01643850|582849707|FG008|Overall Study|Administrative Problems|0|||
161399541|NCT00931723|582849708|FG000|Overall Study|Withdrawal by Subject|11|||
161399542|NCT00931723|582849709|FG001|Overall Study|Withdrawal by Subject|13|||
161399543|NCT00931723|582849708|FG000|Overall Study|Adverse Event|6|||
161399544|NCT00931723|582849709|FG001|Overall Study|Adverse Event|13|||
161399545|NCT00931723|582849708|FG000|Overall Study|Lithium found in blood|0|||
161399546|NCT00931723|582849709|FG001|Overall Study|Lithium found in blood|1|||
161399547|NCT00931723|582849708|FG000|Overall Study|Condition under investigation worsened|1|||
161399548|NCT00931723|582849709|FG001|Overall Study|Condition under investigation worsened|2|||
161399549|NCT00931723|582849708|FG000|Overall Study|Lost to Follow-up|1|||
161399550|NCT00931723|582849709|FG001|Overall Study|Lost to Follow-up|2|||
161399551|NCT00931723|582849708|FG000|Overall Study|Study-specific discontinuation criteria|1|||
161399552|NCT00931723|582849709|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161399553|NCT00931723|582849708|FG000|Overall Study|Severe non-compliance to protocol|2|||
161399554|NCT00931723|582849709|FG001|Overall Study|Severe non-compliance to protocol|0|||
161399555|NCT00931723|582849708|FG000|Overall Study|Safety reasons|0|||
161399556|NCT00931723|582849709|FG001|Overall Study|Safety reasons|1|||
161399557|NCT00931723|582849708|FG000|Overall Study|Took prohibited concomitant medication|0|||
161399558|NCT00931723|582849709|FG001|Overall Study|Took prohibited concomitant medication|1|||
161399559|NCT00931723|582849708|FG000|Overall Study|Lack or insufficient theraputic response|2|||
161399560|NCT00931723|582849709|FG001|Overall Study|Lack or insufficient theraputic response|5|||
161399561|NCT00931723|582849708|FG000|Overall Study|Sponsor decision|1|||
161399562|NCT00931723|582849709|FG001|Overall Study|Sponsor decision|0|||
161399563|NCT00931723|582849708|FG000|Overall Study|Late hospital discharge|1|||
161399564|NCT00931723|582849709|FG001|Overall Study|Late hospital discharge|0|||
161399565|NCT01133405|582849710|FG000|Period 1|Withdrawal by Subject|0|||
161399566|NCT01133405|582849711|FG001|Period 1|Withdrawal by Subject|1|||
161399567|NCT01133405|582849712|FG002|Period 1|Withdrawal by Subject|0|||
161399568|NCT01133405|582849713|FG003|Period 1|Withdrawal by Subject|1|||
161399569|NCT01133405|582849714|FG004|Period 1|Withdrawal by Subject|0|||
161399570|NCT01133405|582849715|FG005|Period 1|Withdrawal by Subject|1|||
161399571|NCT01133405|582849716|FG006|Period 1|Withdrawal by Subject|0|||
161399572|NCT01133405|582849717|FG007|Period 1|Withdrawal by Subject|0|||
161399573|NCT01133405|582849718|FG008|Period 1|Withdrawal by Subject|0|||
161399574|NCT01133405|582849719|FG009|Period 1|Withdrawal by Subject|0|||
161399575|NCT01133405|582849710|FG000|Period 1|Physician Decision|0|||
161399576|NCT01133405|582849711|FG001|Period 1|Physician Decision|0|||
161399577|NCT01133405|582849712|FG002|Period 1|Physician Decision|0|||
161399578|NCT01133405|582849713|FG003|Period 1|Physician Decision|1|||
161399579|NCT01133405|582849714|FG004|Period 1|Physician Decision|0|||
161399580|NCT01133405|582849715|FG005|Period 1|Physician Decision|0|||
161399581|NCT01133405|582849716|FG006|Period 1|Physician Decision|0|||
161399582|NCT01133405|582849717|FG007|Period 1|Physician Decision|0|||
161399583|NCT01133405|582849718|FG008|Period 1|Physician Decision|0|||
161399584|NCT01133405|582849719|FG009|Period 1|Physician Decision|0|||
161399585|NCT01133405|582849710|FG000|Period 1|Discontinued after randomization|1|||
161399586|NCT01133405|582849711|FG001|Period 1|Discontinued after randomization|0|||
161399587|NCT01133405|582849712|FG002|Period 1|Discontinued after randomization|0|||
161399588|NCT01133405|582849713|FG003|Period 1|Discontinued after randomization|0|||
161399589|NCT01133405|582849714|FG004|Period 1|Discontinued after randomization|0|||
161399590|NCT01133405|582849715|FG005|Period 1|Discontinued after randomization|0|||
161399591|NCT01133405|582849716|FG006|Period 1|Discontinued after randomization|1|||
161399592|NCT01133405|582849717|FG007|Period 1|Discontinued after randomization|0|||
161399593|NCT01133405|582849718|FG008|Period 1|Discontinued after randomization|0|||
161399594|NCT01133405|582849719|FG009|Period 1|Discontinued after randomization|0|||
161399595|NCT01133405|582849710|FG000|Period 1|Received drug only in period 2|0|||
161399596|NCT01133405|582849711|FG001|Period 1|Received drug only in period 2|1|||
161399597|NCT01133405|582849712|FG002|Period 1|Received drug only in period 2|0|||
161399598|NCT01133405|582849713|FG003|Period 1|Received drug only in period 2|2|||
161399599|NCT01133405|582849714|FG004|Period 1|Received drug only in period 2|0|||
161399600|NCT01133405|582849715|FG005|Period 1|Received drug only in period 2|1|||
161399601|NCT01133405|582849716|FG006|Period 1|Received drug only in period 2|0|||
161399602|NCT01133405|582849717|FG007|Period 1|Received drug only in period 2|0|||
161399603|NCT01133405|582849718|FG008|Period 1|Received drug only in period 2|0|||
161399604|NCT01133405|582849719|FG009|Period 1|Received drug only in period 2|0|||
161399605|NCT01133405|582849710|FG000|Period 1|Received drug only in period 3|0|||
161399606|NCT01133405|582849711|FG001|Period 1|Received drug only in period 3|1|||
161399607|NCT01133405|582849712|FG002|Period 1|Received drug only in period 3|1|||
161399608|NCT01133405|582849713|FG003|Period 1|Received drug only in period 3|0|||
161399609|NCT01133405|582849714|FG004|Period 1|Received drug only in period 3|0|||
161399610|NCT01133405|582849715|FG005|Period 1|Received drug only in period 3|0|||
161399611|NCT01133405|582849716|FG006|Period 1|Received drug only in period 3|0|||
161399612|NCT01133405|582849717|FG007|Period 1|Received drug only in period 3|0|||
161399613|NCT01133405|582849718|FG008|Period 1|Received drug only in period 3|0|||
161399614|NCT01133405|582849719|FG009|Period 1|Received drug only in period 3|0|||
161399615|NCT01133405|582849710|FG000|Period 2|Adverse Event|0|||
161399616|NCT01133405|582849711|FG001|Period 2|Adverse Event|0|||
161399617|NCT01133405|582849712|FG002|Period 2|Adverse Event|1|||
161399618|NCT01133405|582849713|FG003|Period 2|Adverse Event|0|||
161399619|NCT01133405|582849714|FG004|Period 2|Adverse Event|0|||
161399620|NCT01133405|582849715|FG005|Period 2|Adverse Event|0|||
161399621|NCT01133405|582849716|FG006|Period 2|Adverse Event|0|||
161399622|NCT01133405|582849717|FG007|Period 2|Adverse Event|0|||
161399623|NCT01133405|582849718|FG008|Period 2|Adverse Event|0|||
161399624|NCT01133405|582849719|FG009|Period 2|Adverse Event|0|||
161399625|NCT01133405|582849710|FG000|Period 2|Withdrawal by Subject|0|||
161399626|NCT01133405|582849711|FG001|Period 2|Withdrawal by Subject|0|||
161399627|NCT01133405|582849712|FG002|Period 2|Withdrawal by Subject|0|||
161399628|NCT01133405|582849713|FG003|Period 2|Withdrawal by Subject|1|||
161399629|NCT01133405|582849714|FG004|Period 2|Withdrawal by Subject|0|||
161399630|NCT01133405|582849715|FG005|Period 2|Withdrawal by Subject|1|||
161399631|NCT01133405|582849716|FG006|Period 2|Withdrawal by Subject|0|||
161399632|NCT01133405|582849717|FG007|Period 2|Withdrawal by Subject|0|||
161399633|NCT01133405|582849718|FG008|Period 2|Withdrawal by Subject|0|||
161399634|NCT01133405|582849719|FG009|Period 2|Withdrawal by Subject|0|||
161399635|NCT01133405|582849710|FG000|Period 2|Entry Criteria Not Met|0|||
161399636|NCT01133405|582849711|FG001|Period 2|Entry Criteria Not Met|1|||
161399637|NCT01133405|582849712|FG002|Period 2|Entry Criteria Not Met|0|||
161399638|NCT01133405|582849713|FG003|Period 2|Entry Criteria Not Met|0|||
161399639|NCT01133405|582849714|FG004|Period 2|Entry Criteria Not Met|0|||
161399640|NCT01133405|582849715|FG005|Period 2|Entry Criteria Not Met|0|||
161399641|NCT01133405|582849716|FG006|Period 2|Entry Criteria Not Met|0|||
161399642|NCT01133405|582849717|FG007|Period 2|Entry Criteria Not Met|0|||
161399643|NCT01133405|582849718|FG008|Period 2|Entry Criteria Not Met|0|||
161399644|NCT01133405|582849719|FG009|Period 2|Entry Criteria Not Met|0|||
161399645|NCT01133405|582849710|FG000|Period 2|Physician Decision|0|||
161399646|NCT01133405|582849711|FG001|Period 2|Physician Decision|0|||
161399647|NCT01133405|582849712|FG002|Period 2|Physician Decision|0|||
161399648|NCT01133405|582849713|FG003|Period 2|Physician Decision|0|||
161399649|NCT01133405|582849714|FG004|Period 2|Physician Decision|0|||
161399650|NCT01133405|582849715|FG005|Period 2|Physician Decision|1|||
161399651|NCT01133405|582849716|FG006|Period 2|Physician Decision|0|||
161399652|NCT01133405|582849717|FG007|Period 2|Physician Decision|0|||
161399653|NCT01133405|582849718|FG008|Period 2|Physician Decision|0|||
161399654|NCT01133405|582849719|FG009|Period 2|Physician Decision|0|||
161399655|NCT00867087|582849720|FG000|Overall Study|Other|1|||
161399656|NCT00867087|582849720|FG000|Overall Study|Withdrawal by Subject|4|||
161399657|NCT00867087|582849720|FG000|Overall Study|Death|37|||
161399658|NCT03300024|582849723|FG000|Overall Study|Physician Decision|4|||
161399659|NCT03300024|582849724|FG001|Overall Study|Physician Decision|6|||
161399660|NCT00681564|582849725|FG000|Overall Study|Lost to Follow-up|6|||
161399661|NCT00681564|582849726|FG001|Overall Study|Lost to Follow-up|6|||
161399662|NCT00681564|582849725|FG000|Overall Study|Withdrawal by Subject|0|||
161399663|NCT00681564|582849726|FG001|Overall Study|Withdrawal by Subject|1|||
161399664|NCT00681564|582849725|FG000|Overall Study|Death|0|||
161399665|NCT00681564|582849726|FG001|Overall Study|Death|1|||
161399666|NCT02370641|582849727|FG000|Overall Study|dropped study|4|||
161399667|NCT02370641|582849728|FG001|Overall Study|dropped study|2|||
161399668|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
161399669|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
161399670|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
161399671|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
161399672|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
161399673|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
161399674|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
161399675|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
161399676|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
161399677|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
161399678|NCT03906656|582849729|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
161399679|NCT03906656|582849730|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
161399680|NCT03906656|582849729|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
161399681|NCT03906656|582849730|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
161399682|NCT03906656|582849729|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
161399683|NCT03906656|582849730|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
161399684|NCT03906656|582849729|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
161399685|NCT03906656|582849730|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
161399686|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
161399687|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
161399688|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
161399689|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
161399690|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
161399691|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
161399692|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
161399693|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
161399694|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
161399695|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
161399696|NCT03906656|582849729|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
161399697|NCT03906656|582849730|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
161399698|NCT03906656|582849729|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
161399699|NCT03906656|582849730|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
161399700|NCT03906656|582849729|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
161399701|NCT03906656|582849730|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
161399702|NCT03906656|582849729|FG000|Home Use 2 (3 Months)|Death|2|||
161399703|NCT03906656|582849730|FG001|Home Use 2 (3 Months)|Death|0|||
161399704|NCT03906656|582849729|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
161399705|NCT03906656|582849730|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
161399706|NCT03906656|582849729|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
161399707|NCT03906656|582849730|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
161399708|NCT01036529|582849731|FG000|Overall Study|Adverse Event|0|||
161399709|NCT01036529|582849732|FG001|Overall Study|Adverse Event|1|||
161399710|NCT01036529|582849731|FG000|Overall Study|Lost to Follow-up|0|||
161399711|NCT01036529|582849732|FG001|Overall Study|Lost to Follow-up|1|||
161399712|NCT01036529|582849731|FG000|Overall Study|Physician Decision|1|||
161399713|NCT01036529|582849732|FG001|Overall Study|Physician Decision|0|||
161399714|NCT01036529|582849731|FG000|Overall Study|Withdrawal by Subject|1|||
161399715|NCT01036529|582849732|FG001|Overall Study|Withdrawal by Subject|1|||
161399716|NCT01036529|582849731|FG000|Overall Study|Sponsor study termination|11|||
161399717|NCT01036529|582849732|FG001|Overall Study|Sponsor study termination|12|||
161399718|NCT00343915|582849734|FG000|Primary Study|Withdrawal by Subject|1|||
161399719|NCT00343915|582849735|FG001|Primary Study|Withdrawal by Subject|0|||
161399720|NCT00343915|582849734|FG000|Primary Study|Lost to Follow-up|2|||
161399721|NCT00343915|582849735|FG001|Primary Study|Lost to Follow-up|3|||
161399722|NCT00343915|582849734|FG000|Primary Study|Other|1|||
161399723|NCT00343915|582849735|FG001|Primary Study|Other|0|||
161399724|NCT01719003|582849736|FG000|Overall Study|Non compliant with protocol|1|||
161399725|NCT01719003|582849737|FG001|Overall Study|Non compliant with protocol|1|||
161399726|NCT01719003|582849738|FG002|Overall Study|Non compliant with protocol|0|||
161399727|NCT01719003|582849739|FG003|Overall Study|Non compliant with protocol|1|||
161399728|NCT01719003|582849740|FG004|Overall Study|Non compliant with protocol|2|||
161399729|NCT01719003|582849741|FG005|Overall Study|Non compliant with protocol|1|||
161399730|NCT01719003|582849742|FG006|Overall Study|Non compliant with protocol|2|||
161399731|NCT01719003|582849743|FG007|Overall Study|Non compliant with protocol|3|||
161399732|NCT01719003|582849744|FG008|Overall Study|Non compliant with protocol|0|||
161399733|NCT01719003|582849736|FG000|Overall Study|Adverse Event|6|||
161399734|NCT01719003|582849737|FG001|Overall Study|Adverse Event|5|||
161399735|NCT01719003|582849738|FG002|Overall Study|Adverse Event|4|||
161399736|NCT01719003|582849739|FG003|Overall Study|Adverse Event|3|||
161399737|NCT01719003|582849740|FG004|Overall Study|Adverse Event|4|||
161399738|NCT01719003|582849741|FG005|Overall Study|Adverse Event|3|||
161399739|NCT01719003|582849742|FG006|Overall Study|Adverse Event|6|||
161399740|NCT01719003|582849743|FG007|Overall Study|Adverse Event|5|||
161399741|NCT01719003|582849744|FG008|Overall Study|Adverse Event|0|||
161399742|NCT01719003|582849736|FG000|Overall Study|Lost to Follow-up|0|||
161399743|NCT01719003|582849737|FG001|Overall Study|Lost to Follow-up|6|||
161399744|NCT01719003|582849738|FG002|Overall Study|Lost to Follow-up|7|||
161399745|NCT01719003|582849739|FG003|Overall Study|Lost to Follow-up|2|||
161399746|NCT01719003|582849740|FG004|Overall Study|Lost to Follow-up|3|||
161399747|NCT01719003|582849741|FG005|Overall Study|Lost to Follow-up|4|||
161399748|NCT01719003|582849742|FG006|Overall Study|Lost to Follow-up|3|||
161399749|NCT01719003|582849743|FG007|Overall Study|Lost to Follow-up|2|||
161399750|NCT01719003|582849744|FG008|Overall Study|Lost to Follow-up|2|||
161399751|NCT01719003|582849736|FG000|Overall Study|Refusal to continue, not due to AE|2|||
161399752|NCT01719003|582849737|FG001|Overall Study|Refusal to continue, not due to AE|5|||
161399753|NCT01719003|582849738|FG002|Overall Study|Refusal to continue, not due to AE|4|||
161399754|NCT01719003|582849739|FG003|Overall Study|Refusal to continue, not due to AE|4|||
161399755|NCT01719003|582849740|FG004|Overall Study|Refusal to continue, not due to AE|4|||
161399756|NCT01719003|582849741|FG005|Overall Study|Refusal to continue, not due to AE|3|||
161399757|NCT01719003|582849742|FG006|Overall Study|Refusal to continue, not due to AE|8|||
161399758|NCT01719003|582849743|FG007|Overall Study|Refusal to continue, not due to AE|7|||
161399759|NCT01719003|582849744|FG008|Overall Study|Refusal to continue, not due to AE|1|||
161399760|NCT01719003|582849736|FG000|Overall Study|Reason other than those specified|0|||
161399761|NCT01719003|582849737|FG001|Overall Study|Reason other than those specified|0|||
161399762|NCT01719003|582849738|FG002|Overall Study|Reason other than those specified|2|||
161399763|NCT01719003|582849739|FG003|Overall Study|Reason other than those specified|3|||
161399764|NCT01719003|582849740|FG004|Overall Study|Reason other than those specified|4|||
161399765|NCT01719003|582849741|FG005|Overall Study|Reason other than those specified|1|||
161399766|NCT01719003|582849742|FG006|Overall Study|Reason other than those specified|0|||
161399767|NCT01719003|582849743|FG007|Overall Study|Reason other than those specified|3|||
161399768|NCT01719003|582849744|FG008|Overall Study|Reason other than those specified|1|||
161399769|NCT01719003|582849736|FG000|Overall Study|Lack of Efficacy|0|||
161399770|NCT01719003|582849737|FG001|Overall Study|Lack of Efficacy|0|||
161399771|NCT01719003|582849738|FG002|Overall Study|Lack of Efficacy|0|||
161399772|NCT01719003|582849739|FG003|Overall Study|Lack of Efficacy|0|||
161399773|NCT01719003|582849740|FG004|Overall Study|Lack of Efficacy|0|||
161399774|NCT01719003|582849741|FG005|Overall Study|Lack of Efficacy|0|||
161399775|NCT01719003|582849742|FG006|Overall Study|Lack of Efficacy|1|||
161399776|NCT01719003|582849743|FG007|Overall Study|Lack of Efficacy|0|||
161399777|NCT01719003|582849744|FG008|Overall Study|Lack of Efficacy|0|||
161399778|NCT00700102|582849745|FG000|Overall Study|Died|394|||
161399779|NCT00700102|582849746|FG001|Overall Study|Died|385|||
161399780|NCT00700102|582849745|FG000|Overall Study|Lost to Follow-up|8|||
161399781|NCT00700102|582849746|FG001|Overall Study|Lost to Follow-up|10|||
161399782|NCT02525939|582849747|FG000|Overall Study|Lost to Follow-up|27|||
161399783|NCT02525939|582849748|FG001|Overall Study|Lost to Follow-up|24|||
161399784|NCT02525939|582849747|FG000|Overall Study|Physician Decision|0|||
161399785|NCT02525939|582849748|FG001|Overall Study|Physician Decision|1|||
161399786|NCT02525939|582849747|FG000|Overall Study|Withdrawal by Subject|24|||
161399787|NCT02525939|582849748|FG001|Overall Study|Withdrawal by Subject|39|||
161399788|NCT02525939|582849747|FG000|Overall Study|Death|180|||
161399789|NCT02525939|582849748|FG001|Overall Study|Death|179|||
161399790|NCT01667562|582849749|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
161399791|NCT01667562|582849750|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
161399792|NCT01667562|582849749|FG000|Erlotinib Phase|Lost to Follow-up|0|||
161399793|NCT01667562|582849750|FG001|Erlotinib Phase|Lost to Follow-up|1|||
161399794|NCT01667562|582849749|FG000|Erlotinib Phase|Adverse Event|0|||
161399795|NCT01667562|582849750|FG001|Erlotinib Phase|Adverse Event|1|||
161399796|NCT01667562|582849749|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
161399797|NCT01667562|582849750|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
161399798|NCT01028716|582849751|FG000|Overall Study|Physician Decision|1|||
161399799|NCT02130986|582849752|FG000|Overall Study|Withdrawal by Subject|4|||
161399800|NCT02130986|582849753|FG001|Overall Study|Withdrawal by Subject|4|||
161399801|NCT02130986|582849752|FG000|Overall Study|Lost to Follow-up|151|||
161399802|NCT02130986|582849753|FG001|Overall Study|Lost to Follow-up|160|||
161399803|NCT01129882|582849754|FG000|Overall Study|Adverse Event|39|||
161399804|NCT01129882|582849754|FG000|Overall Study|Death|6|||
161399805|NCT01129882|582849754|FG000|Overall Study|Lack of Efficacy|5|||
161399806|NCT01129882|582849754|FG000|Overall Study|Lost to Follow-up|13|||
161399807|NCT01129882|582849754|FG000|Overall Study|Physician Decision|27|||
161399808|NCT01129882|582849754|FG000|Overall Study|Protocol Deviation|3|||
161399809|NCT01129882|582849754|FG000|Overall Study|Withdrawal Criteria Met|19|||
161399810|NCT01129882|582849754|FG000|Overall Study|Trial Termination by Sponsor|6|||
161399811|NCT01129882|582849754|FG000|Overall Study|Withdrawal by Subject|160|||
161399812|NCT00536874|582849755|FG000|Overall Study|Adverse Event|1|||
161399813|NCT00536874|582849755|FG000|Overall Study|Death|2|||
161399814|NCT00536874|582849755|FG000|Overall Study|Withdrawal by Subject|1|||
161399815|NCT00762996|582849756|FG000|Period One|Protocol Violation|0|||
161399816|NCT00762996|582849757|FG001|Period One|Protocol Violation|0|||
161399817|NCT00762996|582849758|FG002|Period One|Protocol Violation|1|||
161399818|NCT00762996|582849759|FG003|Period One|Protocol Violation|0|||
161399819|NCT00762996|582849756|FG000|Period One|ineligible|0|||
161399820|NCT00762996|582849757|FG001|Period One|ineligible|0|||
161399821|NCT00762996|582849758|FG002|Period One|ineligible|1|||
161399822|NCT00762996|582849759|FG003|Period One|ineligible|1|||
161399823|NCT00762996|582849756|FG000|Period One|Adverse Event|0|||
161399824|NCT00762996|582849757|FG001|Period One|Adverse Event|0|||
161399825|NCT00762996|582849758|FG002|Period One|Adverse Event|1|||
161399826|NCT00762996|582849759|FG003|Period One|Adverse Event|0|||
161399827|NCT00762996|582849756|FG000|Period One|Withdrawal by Subject|0|||
161399828|NCT00762996|582849757|FG001|Period One|Withdrawal by Subject|0|||
161399829|NCT00762996|582849758|FG002|Period One|Withdrawal by Subject|1|||
161399830|NCT00762996|582849759|FG003|Period One|Withdrawal by Subject|0|||
161399831|NCT01853072|582849761|FG000|Overall Study|Adverse event prior to treatment|0|||
161399832|NCT01853072|582849762|FG001|Overall Study|Adverse event prior to treatment|1|||
161399833|NCT01853072|582849761|FG000|Overall Study|Adverse Event|0|||
161399834|NCT01853072|582849762|FG001|Overall Study|Adverse Event|3|||
161399835|NCT01853072|582849761|FG000|Overall Study|Death|1|||
161399836|NCT01853072|582849762|FG001|Overall Study|Death|4|||
161399837|NCT01853072|582849761|FG000|Overall Study|Lost to Follow-up|0|||
161399838|NCT01853072|582849762|FG001|Overall Study|Lost to Follow-up|3|||
161399839|NCT01853072|582849761|FG000|Overall Study|Non-compliance with study drug|0|||
161399840|NCT01853072|582849762|FG001|Overall Study|Non-compliance with study drug|1|||
161399841|NCT01853072|582849761|FG000|Overall Study|Physician Decision|1|||
161399842|NCT01853072|582849762|FG001|Overall Study|Physician Decision|1|||
161399843|NCT01853072|582849761|FG000|Overall Study|Withdrawal by Subject|1|||
161399844|NCT01853072|582849762|FG001|Overall Study|Withdrawal by Subject|2|||
161399845|NCT01853072|582849761|FG000|Overall Study|Reason not specified|9|||
161399846|NCT01853072|582849762|FG001|Overall Study|Reason not specified|6|||
161399847|NCT00930969|582849763|FG000|Overall Study|Death|5|||
161399848|NCT00930969|582849763|FG000|Overall Study|Lost to Follow-up|1|||
161399849|NCT00930969|582849763|FG000|Overall Study|Physician Decision|13|||
161399850|NCT00930969|582849763|FG000|Overall Study|Withdrawal by Subject|19|||
161399851|NCT01287221|582849764|FG000|Overall Study|Lack of Perceived Benefit|1|||
161399852|NCT01287221|582849765|FG001|Overall Study|Lack of Perceived Benefit|1|||
161399853|NCT01287221|582849764|FG000|Overall Study|Adverse Event|3|||
161399854|NCT01287221|582849765|FG001|Overall Study|Adverse Event|3|||
161399855|NCT01287221|582849764|FG000|Overall Study|Withdrawal by Subject|0|||
161399856|NCT01287221|582849765|FG001|Overall Study|Withdrawal by Subject|1|||
161399857|NCT00657150|582849766|FG000|Overall Study|Adverse Event|19|||
161399858|NCT00657150|582849767|FG001|Overall Study|Adverse Event|10|||
161399859|NCT00657150|582849766|FG000|Overall Study|Non-compliant with protocol|5|||
161399860|NCT00657150|582849767|FG001|Overall Study|Non-compliant with protocol|9|||
161399861|NCT00657150|582849766|FG000|Overall Study|Lost to Follow-up|2|||
161399862|NCT00657150|582849767|FG001|Overall Study|Lost to Follow-up|0|||
161399863|NCT00657150|582849766|FG000|Overall Study|Withdrawal by Subject|51|||
161399864|NCT00657150|582849767|FG001|Overall Study|Withdrawal by Subject|36|||
161399865|NCT00657150|582849766|FG000|Overall Study|Other|38|||
161399866|NCT00657150|582849767|FG001|Overall Study|Other|38|||
161399867|NCT00657150|582849766|FG000|Treatment|Adverse Event|60|||
161399868|NCT00657150|582849767|FG001|Treatment|Adverse Event|53|||
161399869|NCT00657150|582849766|FG000|Treatment|Non-compliant with protocol|10|||
161399870|NCT00657150|582849767|FG001|Treatment|Non-compliant with protocol|9|||
161399871|NCT00657150|582849766|FG000|Treatment|Lost to Follow-up|1|||
161399872|NCT00657150|582849767|FG001|Treatment|Lost to Follow-up|0|||
161399873|NCT00657150|582849766|FG000|Treatment|Withdrawal by Subject|23|||
161399874|NCT00657150|582849767|FG001|Treatment|Withdrawal by Subject|20|||
161399875|NCT00657150|582849766|FG000|Treatment|Other|13|||
161399876|NCT00657150|582849767|FG001|Treatment|Other|15|||
161399877|NCT02966795|582849768|FG000|Overall Study|Patient Left the Country|0|||
161399878|NCT02966795|582849769|FG001|Overall Study|Patient Left the Country|1|||
161399879|NCT00432744|582849770|FG000|Months 0-6|Withdrawal by Subject|4|||
161399880|NCT00432744|582849771|FG001|Months 0-6|Withdrawal by Subject|4|||
161399881|NCT00432744|582849770|FG000|Months 0-6|Too disabled to score|1|||
161399882|NCT00432744|582849771|FG001|Months 0-6|Too disabled to score|0|||
161399883|NCT00432744|582849770|FG000|Months 7 - 12|Withdrawal by Subject|1|||
161399884|NCT00432744|582849771|FG001|Months 7 - 12|Withdrawal by Subject|0|||
161399885|NCT00432744|582849770|FG000|Months 7 - 12|Too disabled to score|0|||
161399886|NCT00432744|582849771|FG001|Months 7 - 12|Too disabled to score|1|||
161399887|NCT01319721|582849779|FG000|Overall Study|Lost to Follow-up|1|||
161399888|NCT01319721|582849780|FG001|Overall Study|Lost to Follow-up|6|||
161399889|NCT02653495|582849781|FG000|Overall Study|Lost to Follow-up|2|||
161399890|NCT02653495|582849782|FG001|Overall Study|Lost to Follow-up|0|||
161399891|NCT02653495|582849781|FG000|Overall Study|Screening Failure|10|||
161399892|NCT02653495|582849782|FG001|Overall Study|Screening Failure|0|||
161399893|NCT00468845|582849783|FG000|Overall Study|Adverse Event|9|||
161399894|NCT00468845|582849784|FG001|Overall Study|Adverse Event|14|||
161399895|NCT00468845|582849785|FG002|Overall Study|Adverse Event|11|||
161399896|NCT00468845|582849783|FG000|Overall Study|Lost to Follow-up|2|||
161399897|NCT00468845|582849784|FG001|Overall Study|Lost to Follow-up|1|||
161399898|NCT00468845|582849785|FG002|Overall Study|Lost to Follow-up|2|||
161399899|NCT00468845|582849783|FG000|Overall Study|Other|4|||
161399900|NCT00468845|582849784|FG001|Overall Study|Other|9|||
161399901|NCT00468845|582849785|FG002|Overall Study|Other|5|||
161399902|NCT00468845|582849783|FG000|Overall Study|No longer willing to participate|5|||
161399903|NCT00468845|582849784|FG001|Overall Study|No longer willing to participate|6|||
161399904|NCT00468845|582849785|FG002|Overall Study|No longer willing to participate|10|||
161399905|NCT00468845|582849783|FG000|Overall Study|Randomized, not treated|1|||
161399906|NCT00468845|582849784|FG001|Overall Study|Randomized, not treated|4|||
161399907|NCT00468845|582849785|FG002|Overall Study|Randomized, not treated|2|||
161399908|NCT02761694|582849789|FG000|Overall Study|Lack of Efficacy|0|||
161399909|NCT02761694|582849790|FG001|Overall Study|Lack of Efficacy|0|||
161399910|NCT02761694|582849791|FG002|Overall Study|Lack of Efficacy|0|||
161399911|NCT02761694|582849792|FG003|Overall Study|Lack of Efficacy|0|||
161399912|NCT02761694|582849793|FG004|Overall Study|Lack of Efficacy|0|||
161399913|NCT02761694|582849794|FG005|Overall Study|Lack of Efficacy|0|||
161399914|NCT02761694|582849795|FG006|Overall Study|Lack of Efficacy|6|||
161399915|NCT02761694|582849796|FG007|Overall Study|Lack of Efficacy|0|||
161399916|NCT02761694|582849797|FG008|Overall Study|Lack of Efficacy|0|||
161399917|NCT02761694|582849798|FG009|Overall Study|Lack of Efficacy|1|||
161399918|NCT02761694|582849799|FG010|Overall Study|Lack of Efficacy|1|||
161399919|NCT02761694|582849800|FG011|Overall Study|Lack of Efficacy|4|||
161399920|NCT02761694|582849789|FG000|Overall Study|Death|0|||
161399921|NCT02761694|582849790|FG001|Overall Study|Death|0|||
161399922|NCT02761694|582849791|FG002|Overall Study|Death|0|||
161399923|NCT02761694|582849792|FG003|Overall Study|Death|0|||
161399924|NCT02761694|582849793|FG004|Overall Study|Death|0|||
161399925|NCT02761694|582849794|FG005|Overall Study|Death|0|||
161399926|NCT02761694|582849795|FG006|Overall Study|Death|2|||
161399927|NCT02761694|582849796|FG007|Overall Study|Death|0|||
161399928|NCT02761694|582849797|FG008|Overall Study|Death|2|||
161399929|NCT02761694|582849798|FG009|Overall Study|Death|2|||
161399930|NCT02761694|582849799|FG010|Overall Study|Death|1|||
161399931|NCT02761694|582849800|FG011|Overall Study|Death|0|||
161399932|NCT02761694|582849789|FG000|Overall Study|Physician Decision|0|||
161399933|NCT02761694|582849790|FG001|Overall Study|Physician Decision|0|||
161399934|NCT02761694|582849791|FG002|Overall Study|Physician Decision|0|||
161399935|NCT02761694|582849792|FG003|Overall Study|Physician Decision|0|||
161399936|NCT02761694|582849793|FG004|Overall Study|Physician Decision|0|||
161399937|NCT02761694|582849794|FG005|Overall Study|Physician Decision|0|||
161399938|NCT02761694|582849795|FG006|Overall Study|Physician Decision|1|||
161399939|NCT02761694|582849796|FG007|Overall Study|Physician Decision|0|||
161399940|NCT02761694|582849797|FG008|Overall Study|Physician Decision|0|||
161399941|NCT02761694|582849798|FG009|Overall Study|Physician Decision|0|||
161399942|NCT02761694|582849799|FG010|Overall Study|Physician Decision|0|||
161399943|NCT02761694|582849800|FG011|Overall Study|Physician Decision|0|||
161399944|NCT02761694|582849789|FG000|Overall Study|Withdrawal by Subject|0|||
161399945|NCT02761694|582849790|FG001|Overall Study|Withdrawal by Subject|0|||
161399946|NCT02761694|582849791|FG002|Overall Study|Withdrawal by Subject|0|||
161399947|NCT02761694|582849792|FG003|Overall Study|Withdrawal by Subject|1|||
161399948|NCT02761694|582849793|FG004|Overall Study|Withdrawal by Subject|0|||
161399949|NCT02761694|582849794|FG005|Overall Study|Withdrawal by Subject|0|||
161399950|NCT02761694|582849795|FG006|Overall Study|Withdrawal by Subject|4|||
161399951|NCT02761694|582849796|FG007|Overall Study|Withdrawal by Subject|0|||
161399952|NCT02761694|582849797|FG008|Overall Study|Withdrawal by Subject|2|||
161399953|NCT02761694|582849798|FG009|Overall Study|Withdrawal by Subject|1|||
161399954|NCT02761694|582849799|FG010|Overall Study|Withdrawal by Subject|0|||
161399955|NCT02761694|582849800|FG011|Overall Study|Withdrawal by Subject|0|||
161399956|NCT02761694|582849789|FG000|Overall Study|Lost to Follow-up|0|||
161399957|NCT02761694|582849790|FG001|Overall Study|Lost to Follow-up|0|||
161399958|NCT02761694|582849791|FG002|Overall Study|Lost to Follow-up|0|||
161399959|NCT02761694|582849792|FG003|Overall Study|Lost to Follow-up|0|||
161399960|NCT02761694|582849793|FG004|Overall Study|Lost to Follow-up|0|||
161399961|NCT02761694|582849794|FG005|Overall Study|Lost to Follow-up|0|||
161399962|NCT02761694|582849795|FG006|Overall Study|Lost to Follow-up|1|||
161399963|NCT02761694|582849796|FG007|Overall Study|Lost to Follow-up|0|||
161399964|NCT02761694|582849797|FG008|Overall Study|Lost to Follow-up|0|||
161399965|NCT02761694|582849798|FG009|Overall Study|Lost to Follow-up|0|||
161399966|NCT02761694|582849799|FG010|Overall Study|Lost to Follow-up|0|||
161399967|NCT02761694|582849800|FG011|Overall Study|Lost to Follow-up|1|||
161399968|NCT02761694|582849789|FG000|Overall Study|Adverse Event|0|||
161399969|NCT02761694|582849790|FG001|Overall Study|Adverse Event|0|||
161399970|NCT02761694|582849791|FG002|Overall Study|Adverse Event|0|||
161399971|NCT02761694|582849792|FG003|Overall Study|Adverse Event|0|||
161399972|NCT02761694|582849793|FG004|Overall Study|Adverse Event|0|||
161399973|NCT02761694|582849794|FG005|Overall Study|Adverse Event|0|||
161399974|NCT02761694|582849795|FG006|Overall Study|Adverse Event|1|||
161399975|NCT02761694|582849796|FG007|Overall Study|Adverse Event|0|||
161399976|NCT02761694|582849797|FG008|Overall Study|Adverse Event|1|||
161399977|NCT02761694|582849798|FG009|Overall Study|Adverse Event|0|||
161399978|NCT02761694|582849799|FG010|Overall Study|Adverse Event|0|||
161399979|NCT02761694|582849800|FG011|Overall Study|Adverse Event|1|||
161399980|NCT02761694|582849789|FG000|Overall Study|Other|4|||
161399981|NCT02761694|582849790|FG001|Overall Study|Other|4|||
161399982|NCT02761694|582849791|FG002|Overall Study|Other|1|||
161399983|NCT02761694|582849792|FG003|Overall Study|Other|2|||
161399984|NCT02761694|582849793|FG004|Overall Study|Other|3|||
161399985|NCT02761694|582849794|FG005|Overall Study|Other|3|||
161399986|NCT02761694|582849795|FG006|Overall Study|Other|18|||
161399987|NCT02761694|582849796|FG007|Overall Study|Other|8|||
161399988|NCT02761694|582849797|FG008|Overall Study|Other|0|||
161399989|NCT02761694|582849798|FG009|Overall Study|Other|1|||
161399990|NCT02761694|582849799|FG010|Overall Study|Other|1|||
161399991|NCT02761694|582849800|FG011|Overall Study|Other|0|||
161399992|NCT02395055|582849806|FG000|Overall Study|Withdrawal by Subject|7|||
161399993|NCT02395055|582849807|FG001|Overall Study|Withdrawal by Subject|3|||
161399994|NCT01896271|582849808|FG000|Overall Study|Physician Decision|10|||
161399995|NCT02743780|582849809|FG000|Part 3 (7 Days)|Adverse Event|0|||
161399996|NCT02743780|582849810|FG001|Part 3 (7 Days)|Adverse Event|0|||
161399997|NCT02743780|582849811|FG002|Part 3 (7 Days)|Adverse Event|1|||
161399998|NCT02743780|582849812|FG003|Part 3 (7 Days)|Adverse Event|0|||
161399999|NCT02743780|582849813|FG004|Part 3 (7 Days)|Adverse Event|0|||
161400000|NCT01294462|582849814|FG000|Overall Study|Lost to Follow-up|1|||
161400001|NCT01294462|582849815|FG001|Overall Study|Lost to Follow-up|0|||
161400002|NCT01294462|582849814|FG000|Overall Study|Withdrawal by Subject|65|||
161400003|NCT01294462|582849815|FG001|Overall Study|Withdrawal by Subject|63|||
161400004|NCT01460407|582849821|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
161400005|NCT01460407|582849822|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
161400006|NCT00526110|582849823|FG000|Overall Study|Adverse Event|2|||
161400007|NCT00526110|582849824|FG001|Overall Study|Adverse Event|9|||
161400008|NCT00526110|582849823|FG000|Overall Study|Disease Progression|0|||
161400009|NCT00526110|582849824|FG001|Overall Study|Disease Progression|19|||
161400010|NCT00526110|582849823|FG000|Overall Study|Maximal Response|0|||
161400011|NCT00526110|582849824|FG001|Overall Study|Maximal Response|6|||
161400012|NCT00526110|582849823|FG000|Overall Study|Withdrawal by Subject|0|||
161400013|NCT00526110|582849824|FG001|Overall Study|Withdrawal by Subject|2|||
161400014|NCT00526110|582849823|FG000|Overall Study|Poor Tolerance|0|||
161400015|NCT00526110|582849824|FG001|Overall Study|Poor Tolerance|5|||
161400016|NCT01400243|582849825|FG000|Overall Study|Protocol Violation|8|||
161400017|NCT01400243|582849826|FG001|Overall Study|Protocol Violation|11|||
161400018|NCT00953680|582849827|FG000|Period 1|Withdrawal by Subject|0|||
161400019|NCT00953680|582849828|FG001|Period 1|Withdrawal by Subject|1|||
161400020|NCT03762616|582849830|FG000|Overall Study|Protocol Violation|2|||
161400021|NCT03959982|582851789|FG000|Overall Study|Withdrawal by Subject|1|||
161400022|NCT03959982|582851790|FG001|Overall Study|Withdrawal by Subject|0|||
161400023|NCT03959982|582851789|FG000|Overall Study|Physician Decision|2|||
161400024|NCT03959982|582851790|FG001|Overall Study|Physician Decision|0|||
161400025|NCT03959982|582851789|FG000|Overall Study|Lost to Follow-up|1|||
161400026|NCT03959982|582851790|FG001|Overall Study|Lost to Follow-up|0|||
161400027|NCT00583791|582851792|FG000|Overall Study|Other|67|||
161400028|NCT00583791|582851792|FG000|Overall Study|Death|6|||
161400029|NCT00203021|582851793|FG000|Overall Study|Death|4|||
161400030|NCT00203021|582851794|FG001|Overall Study|Death|1|||
161400031|NCT00203021|582851793|FG000|Overall Study|Adverse Event|10|||
161400032|NCT00203021|582851794|FG001|Overall Study|Adverse Event|5|||
161400033|NCT00203021|582851793|FG000|Overall Study|Withdrawal by Subject|45|||
161400034|NCT00203021|582851794|FG001|Overall Study|Withdrawal by Subject|48|||
161400035|NCT00203021|582851793|FG000|Overall Study|Lost to Follow-up|9|||
161400036|NCT00203021|582851794|FG001|Overall Study|Lost to Follow-up|7|||
161400037|NCT00203021|582851793|FG000|Overall Study|Other than specified|11|||
161400038|NCT00203021|582851794|FG001|Overall Study|Other than specified|16|||
161400039|NCT02080260|582851795|FG000|Overall Study|Death|18|||
161400040|NCT02080260|582851795|FG000|Overall Study|Withdrawal by Subject|1|||
161400041|NCT05438602|582851796|FG000|Treatment (15 Days)|Adverse Event|2|||
161400042|NCT05438602|582851797|FG001|Treatment (15 Days)|Adverse Event|1|||
161400043|NCT05438602|582851798|FG002|Treatment (15 Days)|Adverse Event|3|||
161400044|NCT05438602|582851796|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
161400045|NCT05438602|582851797|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
161400046|NCT05438602|582851798|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
161400047|NCT05438602|582851796|FG000|Treatment (15 Days)|Other|0|||
161400048|NCT05438602|582851797|FG001|Treatment (15 Days)|Other|0|||
161400049|NCT05438602|582851798|FG002|Treatment (15 Days)|Other|1|||
161400050|NCT05438602|582851796|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
161400051|NCT05438602|582851797|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
161400052|NCT05438602|582851798|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
161400053|NCT05438602|582851796|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
161400054|NCT05438602|582851797|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
161400055|NCT05438602|582851798|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
161400056|NCT05438602|582851796|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
161400057|NCT05438602|582851797|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
161400058|NCT05438602|582851798|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
161400059|NCT05438602|582851796|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
161400060|NCT05438602|582851797|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
161400061|NCT05438602|582851798|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
161400062|NCT05438602|582851796|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
161400063|NCT05438602|582851797|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
161400064|NCT05438602|582851798|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
161400065|NCT05438602|582851796|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
161400066|NCT05438602|582851797|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
161400067|NCT05438602|582851798|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
161400068|NCT05438602|582851796|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
161400069|NCT05438602|582851797|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
161400070|NCT05438602|582851798|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
161400071|NCT02853435|582851799|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161400072|NCT02853435|582851800|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161400073|NCT02853435|582851801|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161400074|NCT02853435|582851802|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161400075|NCT02853435|582851803|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
161400076|NCT02853435|582851804|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161400077|NCT00046930|582851813|FG000|Overall Study|Ineligible|12|||
161400078|NCT00046930|582851814|FG001|Overall Study|Ineligible|4|||
161400079|NCT01657760|582851815|FG000|Overall Study|Withdrawal by Subject|0|||
161400080|NCT01657760|582851816|FG001|Overall Study|Withdrawal by Subject|0|||
161400081|NCT01657760|582851817|FG002|Overall Study|Withdrawal by Subject|0|||
161400082|NCT01657760|582851818|FG003|Overall Study|Withdrawal by Subject|1|||
161400083|NCT01657760|582851815|FG000|Overall Study|Physician Decision|1|||
161400084|NCT01657760|582851816|FG001|Overall Study|Physician Decision|1|||
161400085|NCT01657760|582851817|FG002|Overall Study|Physician Decision|1|||
161400086|NCT01657760|582851818|FG003|Overall Study|Physician Decision|2|||
161400087|NCT02317809|582851828|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
161400088|NCT02317809|582851829|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
161400089|NCT02317809|582851828|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
161400090|NCT02317809|582851829|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
161400091|NCT00953524|582851830|FG000|Overall Study|Adverse Event|2|||
161400092|NCT00953524|582851831|FG001|Overall Study|Adverse Event|0|||
161400093|NCT00953524|582851832|FG002|Overall Study|Adverse Event|1|||
161400094|NCT00953524|582851833|FG003|Overall Study|Adverse Event|2|||
161400095|NCT00953524|582851830|FG000|Overall Study|Protocol Violation|18|||
161400096|NCT00953524|582851831|FG001|Overall Study|Protocol Violation|10|||
161400097|NCT00953524|582851832|FG002|Overall Study|Protocol Violation|11|||
161400098|NCT00953524|582851833|FG003|Overall Study|Protocol Violation|6|||
161400099|NCT00953524|582851830|FG000|Overall Study|Lost to Follow-up|0|||
161400100|NCT00953524|582851831|FG001|Overall Study|Lost to Follow-up|1|||
161400101|NCT00953524|582851832|FG002|Overall Study|Lost to Follow-up|1|||
161400102|NCT00953524|582851833|FG003|Overall Study|Lost to Follow-up|0|||
161400103|NCT00953524|582851830|FG000|Overall Study|Withdrawal by Subject|2|||
161400104|NCT00953524|582851831|FG001|Overall Study|Withdrawal by Subject|4|||
161400105|NCT00953524|582851832|FG002|Overall Study|Withdrawal by Subject|1|||
161400106|NCT00953524|582851833|FG003|Overall Study|Withdrawal by Subject|0|||
161400107|NCT00294645|582851834|FG000|Overall Study|Death|10|||
161400108|NCT00294645|582851835|FG001|Overall Study|Death|18|||
161400109|NCT00294645|582851834|FG000|Overall Study|Lost to Follow-up|1|||
161400110|NCT00294645|582851835|FG001|Overall Study|Lost to Follow-up|10|||
161400111|NCT00294645|582851834|FG000|Overall Study|Withdrawal by Subject|18|||
161400112|NCT00294645|582851835|FG001|Overall Study|Withdrawal by Subject|34|||
161400113|NCT00294645|582851834|FG000|Overall Study|Physician Decision|15|||
161400114|NCT00294645|582851835|FG001|Overall Study|Physician Decision|20|||
161400115|NCT00294645|582851834|FG000|Overall Study|Other|4|||
161400116|NCT00294645|582851835|FG001|Overall Study|Other|10|||
161400117|NCT01238835|582851838|FG000|Overall Study|Death|124|||
161400118|NCT01238835|582851838|FG000|Overall Study|Withdrawal by Subject|9|||
161400119|NCT01238835|582851838|FG000|Overall Study|Lost to Follow-up|1|||
161400120|NCT01238835|582851838|FG000|Overall Study|Site early discontinuation|2|||
161400121|NCT00554619|582851839|FG000|Overall Study|Adverse Event|1|||
161400122|NCT00554619|582851839|FG000|Overall Study|Physician Decision|1|||
161400123|NCT00554619|582851839|FG000|Overall Study|Liver Function Test Abnormality|1|||
161400124|NCT02088073|582851841|FG000|Acute Phase|Withdrawal by Subject|5|||
161400125|NCT02088073|582851842|FG001|Acute Phase|Withdrawal by Subject|0|||
161400126|NCT02088073|582851843|FG002|Acute Phase|Withdrawal by Subject|0|||
161400127|NCT02088073|582851844|FG003|Acute Phase|Withdrawal by Subject|0|||
161400128|NCT02088073|582851845|FG004|Acute Phase|Withdrawal by Subject|0|||
161400129|NCT02088073|582851841|FG000|Acute Phase|Hyperkalemia|2|||
161400130|NCT02088073|582851842|FG001|Acute Phase|Hyperkalemia|0|||
161400131|NCT02088073|582851843|FG002|Acute Phase|Hyperkalemia|0|||
161400132|NCT02088073|582851844|FG003|Acute Phase|Hyperkalemia|0|||
161400133|NCT02088073|582851845|FG004|Acute Phase|Hyperkalemia|0|||
161400134|NCT02088073|582851841|FG000|Maintanance Phase|Withdrawal by Subject|0|||
161400135|NCT02088073|582851842|FG001|Maintanance Phase|Withdrawal by Subject|2|||
161400136|NCT02088073|582851843|FG002|Maintanance Phase|Withdrawal by Subject|0|||
161400137|NCT02088073|582851844|FG003|Maintanance Phase|Withdrawal by Subject|0|||
161400138|NCT02088073|582851845|FG004|Maintanance Phase|Withdrawal by Subject|0|||
161400139|NCT02088073|582851841|FG000|Maintanance Phase|Adverse Event|0|||
161400140|NCT02088073|582851842|FG001|Maintanance Phase|Adverse Event|0|||
161400141|NCT02088073|582851843|FG002|Maintanance Phase|Adverse Event|3|||
161400142|NCT02088073|582851844|FG003|Maintanance Phase|Adverse Event|0|||
161400143|NCT02088073|582851845|FG004|Maintanance Phase|Adverse Event|1|||
161400144|NCT02088073|582851841|FG000|Maintanance Phase|Physician Decision|0|||
161400145|NCT02088073|582851842|FG001|Maintanance Phase|Physician Decision|0|||
161400146|NCT02088073|582851843|FG002|Maintanance Phase|Physician Decision|0|||
161400147|NCT02088073|582851844|FG003|Maintanance Phase|Physician Decision|0|||
161400148|NCT02088073|582851845|FG004|Maintanance Phase|Physician Decision|1|||
161400149|NCT02088073|582851841|FG000|Maintanance Phase|Sponsor's decision|0|||
161400150|NCT02088073|582851842|FG001|Maintanance Phase|Sponsor's decision|2|||
161400151|NCT02088073|582851843|FG002|Maintanance Phase|Sponsor's decision|0|||
161400152|NCT02088073|582851844|FG003|Maintanance Phase|Sponsor's decision|2|||
161400153|NCT02088073|582851845|FG004|Maintanance Phase|Sponsor's decision|1|||
161400154|NCT02088073|582851841|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
161400155|NCT02088073|582851842|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
161400156|NCT02088073|582851843|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
161400157|NCT02088073|582851844|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
161400158|NCT02088073|582851845|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
161400159|NCT02088073|582851841|FG000|Maintanance Phase|Miscellaneous|0|||
161400160|NCT02088073|582851842|FG001|Maintanance Phase|Miscellaneous|2|||
161400161|NCT02088073|582851843|FG002|Maintanance Phase|Miscellaneous|1|||
161400162|NCT02088073|582851844|FG003|Maintanance Phase|Miscellaneous|2|||
161400163|NCT02088073|582851845|FG004|Maintanance Phase|Miscellaneous|1|||
161400164|NCT02088073|582851841|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
161400165|NCT02088073|582851842|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
161400166|NCT02088073|582851843|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
161400167|NCT02088073|582851844|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
161400168|NCT02088073|582851845|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
161400169|NCT02088073|582851841|FG000|Maintanance Phase|Subject compliance|0|||
161400170|NCT02088073|582851842|FG001|Maintanance Phase|Subject compliance|1|||
161400171|NCT02088073|582851843|FG002|Maintanance Phase|Subject compliance|0|||
161400172|NCT02088073|582851844|FG003|Maintanance Phase|Subject compliance|0|||
161400173|NCT02088073|582851845|FG004|Maintanance Phase|Subject compliance|0|||
161400174|NCT00907803|582851846|FG000|Overall Study|Withdrawal of consent - long commute|1|||
161400175|NCT00907803|582851847|FG001|Overall Study|Withdrawal of consent - long commute|0|||
161400176|NCT00907803|582851848|FG002|Overall Study|Withdrawal of consent - long commute|0|||
161400177|NCT00907803|582851846|FG000|Overall Study|Adverse Event|2|||
161400178|NCT00907803|582851847|FG001|Overall Study|Adverse Event|0|||
161400179|NCT00907803|582851848|FG002|Overall Study|Adverse Event|0|||
161400180|NCT00907803|582851846|FG000|Overall Study|Withdrawal by Subject|0|||
161400181|NCT00907803|582851847|FG001|Overall Study|Withdrawal by Subject|1|||
161400182|NCT00907803|582851848|FG002|Overall Study|Withdrawal by Subject|0|||
161400183|NCT00907803|582851846|FG000|Overall Study|Lost to Follow-up|0|||
161400184|NCT00907803|582851847|FG001|Overall Study|Lost to Follow-up|1|||
161400185|NCT00907803|582851848|FG002|Overall Study|Lost to Follow-up|0|||
161400186|NCT00907803|582851846|FG000|Overall Study|Protocol Violation|0|||
161400187|NCT00907803|582851847|FG001|Overall Study|Protocol Violation|1|||
161400188|NCT00907803|582851848|FG002|Overall Study|Protocol Violation|0|||
161400189|NCT04612842|582851853|FG000|Overall Study|Lost to Follow-up|20|||
161400190|NCT04612842|582851854|FG001|Overall Study|Lost to Follow-up|11|||
161400191|NCT04612842|582851853|FG000|Overall Study|Withdrawal by Subject|26|||
161400192|NCT04612842|582851854|FG001|Overall Study|Withdrawal by Subject|15|||
161400193|NCT04612842|582851853|FG000|Overall Study|Death|2|||
161400194|NCT04612842|582851854|FG001|Overall Study|Death|2|||
161400195|NCT02419131|582851855|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
161400196|NCT02419131|582851856|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
161400197|NCT02419131|582851857|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
161400198|NCT02419131|582851855|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
161400199|NCT02419131|582851856|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
161400200|NCT02419131|582851857|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
161400201|NCT05426031|582851858|FG000|Overall Study|Circulatory Arrest|3|||
161400202|NCT05426031|582851859|FG001|Overall Study|Circulatory Arrest|2|||
161400203|NCT03060512|582851860|FG000|Overall Study|Adverse Event|4|||
161400204|NCT03060512|582851861|FG001|Overall Study|Adverse Event|6|||
161400205|NCT03060512|582851860|FG000|Overall Study|Lost to Follow-up|1|||
161400206|NCT03060512|582851861|FG001|Overall Study|Lost to Follow-up|1|||
161400207|NCT03060512|582851860|FG000|Overall Study|Withdrawal by Subject|1|||
161400208|NCT03060512|582851861|FG001|Overall Study|Withdrawal by Subject|0|||
161400209|NCT03060512|582851860|FG000|Overall Study|Non-compliance with study medication|1|||
161400210|NCT03060512|582851861|FG001|Overall Study|Non-compliance with study medication|2|||
161400211|NCT00089986|582851862|FG000|Overall Study|Adverse Event|6|||
161400212|NCT00089986|582851863|FG001|Overall Study|Adverse Event|9|||
161400213|NCT00089986|582851864|FG002|Overall Study|Adverse Event|6|||
161400214|NCT00089986|582851862|FG000|Overall Study|Lost to Follow-up|3|||
161400215|NCT00089986|582851863|FG001|Overall Study|Lost to Follow-up|1|||
161400216|NCT00089986|582851864|FG002|Overall Study|Lost to Follow-up|1|||
161400217|NCT00089986|582851862|FG000|Overall Study|Protocol Violation|0|||
161400218|NCT00089986|582851863|FG001|Overall Study|Protocol Violation|1|||
161400219|NCT00089986|582851864|FG002|Overall Study|Protocol Violation|0|||
161400220|NCT00089986|582851862|FG000|Overall Study|Patient transferred to another hospital|2|||
161400221|NCT00089986|582851863|FG001|Overall Study|Patient transferred to another hospital|1|||
161400222|NCT00089986|582851864|FG002|Overall Study|Patient transferred to another hospital|0|||
161400223|NCT00089986|582851862|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
161400224|NCT00089986|582851863|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
161400225|NCT00089986|582851864|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
161400226|NCT00089986|582851862|FG000|Overall Study|Hemohlobin stopping rule|0|||
161400227|NCT00089986|582851863|FG001|Overall Study|Hemohlobin stopping rule|1|||
161400228|NCT00089986|582851864|FG002|Overall Study|Hemohlobin stopping rule|0|||
161400229|NCT00089986|582851862|FG000|Overall Study|Investigator decision to withdrew|0|||
161400230|NCT00089986|582851863|FG001|Overall Study|Investigator decision to withdrew|1|||
161400231|NCT00089986|582851864|FG002|Overall Study|Investigator decision to withdrew|0|||
161400232|NCT00089986|582851862|FG000|Overall Study|Enrollment in another study|0|||
161400233|NCT00089986|582851863|FG001|Overall Study|Enrollment in another study|1|||
161400234|NCT00089986|582851864|FG002|Overall Study|Enrollment in another study|0|||
161400235|NCT00089986|582851862|FG000|Overall Study|Family decision|0|||
161400236|NCT00089986|582851863|FG001|Overall Study|Family decision|1|||
161400237|NCT00089986|582851864|FG002|Overall Study|Family decision|0|||
161400238|NCT00089986|582851862|FG000|Overall Study|Do not resuscitate (DNR)|0|||
161400239|NCT00089986|582851863|FG001|Overall Study|Do not resuscitate (DNR)|0|||
161400240|NCT00089986|582851864|FG002|Overall Study|Do not resuscitate (DNR)|1|||
161400241|NCT00089986|582851862|FG000|Overall Study|Withdrawal by Subject|3|||
161400242|NCT00089986|582851863|FG001|Overall Study|Withdrawal by Subject|6|||
161400243|NCT00089986|582851864|FG002|Overall Study|Withdrawal by Subject|2|||
161400244|NCT04065074|582851868|FG000|Overall Study|Adverse Event|1|||
161400245|NCT04065074|582851868|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
161400246|NCT02334683|582851869|FG000|First 12 Week Period|Lost to Follow-up|1|||
161400247|NCT02334683|582851870|FG001|First 12 Week Period|Lost to Follow-up|0|||
161400248|NCT02334683|582851869|FG000|Second 12 Week Period|Adverse Event|0|||
161400249|NCT02334683|582851870|FG001|Second 12 Week Period|Adverse Event|1|||
161400250|NCT01062841|582851871|FG000|Overall Study|Indwelling Device Removed|41|||
161400251|NCT01062841|582851872|FG001|Overall Study|Indwelling Device Removed|48|||
161400252|NCT01062841|582851871|FG000|Overall Study|Death|3|||
161400253|NCT01062841|582851872|FG001|Overall Study|Death|5|||
161400254|NCT01062841|582851871|FG000|Overall Study|Withdrawal by Subject|2|||
161400255|NCT01062841|582851872|FG001|Overall Study|Withdrawal by Subject|0|||
161400256|NCT01062841|582851871|FG000|Overall Study|Withdrawal by Study|3|||
161400257|NCT01062841|582851872|FG001|Overall Study|Withdrawal by Study|0|||
161400258|NCT03831880|582851873|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
161400259|NCT03831880|582851874|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
161400260|NCT03831880|582851873|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
161400261|NCT03831880|582851874|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
161400262|NCT03958656|582851877|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
161400263|NCT03958656|582851878|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
161400264|NCT03958656|582851879|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
161400265|NCT03958656|582851880|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
161400266|NCT03958656|582851877|FG000|Overall Study|No longer meets eligibility criteria|0|||
161400267|NCT03958656|582851878|FG001|Overall Study|No longer meets eligibility criteria|0|||
161400268|NCT03958656|582851879|FG002|Overall Study|No longer meets eligibility criteria|1|||
161400269|NCT03958656|582851880|FG003|Overall Study|No longer meets eligibility criteria|0|||
161400270|NCT03958656|582851877|FG000|Overall Study|Started anti-cancer treatment|0|||
161400271|NCT03958656|582851878|FG001|Overall Study|Started anti-cancer treatment|0|||
161400272|NCT03958656|582851879|FG002|Overall Study|Started anti-cancer treatment|1|||
161400273|NCT03958656|582851880|FG003|Overall Study|Started anti-cancer treatment|0|||
161400274|NCT03158012|582851883|FG000|Overall Study|Withdrawal by Subject|0|||
161400275|NCT03158012|582851884|FG001|Overall Study|Withdrawal by Subject|1|||
161400276|NCT02788201|582851885|FG000|Overall Study|Death|1|||
161400277|NCT02788201|582851886|FG001|Overall Study|Death|1|||
161400278|NCT02788201|582851887|FG002|Overall Study|Death|1|||
161400279|NCT02788201|582851888|FG003|Overall Study|Death|1|||
161400280|NCT02788201|582851889|FG004|Overall Study|Death|0|||
161400281|NCT02788201|582851890|FG005|Overall Study|Death|1|||
161400282|NCT02788201|582851885|FG000|Overall Study|Ineligible|0|||
161400283|NCT02788201|582851886|FG001|Overall Study|Ineligible|0|||
161400284|NCT02788201|582851887|FG002|Overall Study|Ineligible|0|||
161400285|NCT02788201|582851888|FG003|Overall Study|Ineligible|0|||
161400286|NCT02788201|582851889|FG004|Overall Study|Ineligible|0|||
161400287|NCT02788201|582851890|FG005|Overall Study|Ineligible|1|||
161400288|NCT02788201|582851885|FG000|Overall Study|Withdrawal by Subject|0|||
161400289|NCT02788201|582851886|FG001|Overall Study|Withdrawal by Subject|0|||
161400290|NCT02788201|582851887|FG002|Overall Study|Withdrawal by Subject|0|||
161400291|NCT02788201|582851888|FG003|Overall Study|Withdrawal by Subject|0|||
161400292|NCT02788201|582851889|FG004|Overall Study|Withdrawal by Subject|0|||
161400293|NCT02788201|582851890|FG005|Overall Study|Withdrawal by Subject|1|||
161400294|NCT02969590|582851894|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
161400295|NCT02969590|582851895|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
161400296|NCT02969590|582851896|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
161400297|NCT01414205|582851897|FG000|Overall Study|Death|5|||
161400298|NCT01414205|582851898|FG001|Overall Study|Death|1|||
161400299|NCT01414205|582851897|FG000|Overall Study|Lost to Follow-up|1|||
161400300|NCT01414205|582851898|FG001|Overall Study|Lost to Follow-up|4|||
161400301|NCT01414205|582851897|FG000|Overall Study|Physician Decision|0|||
161400302|NCT01414205|582851898|FG001|Overall Study|Physician Decision|1|||
161400303|NCT01414205|582851897|FG000|Overall Study|Randomized but not Treated|1|||
161400304|NCT01414205|582851898|FG001|Overall Study|Randomized but not Treated|1|||
161400305|NCT01166373|582851899|FG000|Overall Study|Lost to Follow-up|3|||
161400306|NCT01166373|582851900|FG001|Overall Study|Lost to Follow-up|2|||
161400307|NCT01166373|582851901|FG002|Overall Study|Lost to Follow-up|2|||
161400308|NCT01166373|582851902|FG003|Overall Study|Lost to Follow-up|2|||
161400309|NCT01166373|582851899|FG000|Overall Study|Withdrawal by Subject|1|||
161400310|NCT01166373|582851900|FG001|Overall Study|Withdrawal by Subject|2|||
161400311|NCT01166373|582851901|FG002|Overall Study|Withdrawal by Subject|2|||
161400312|NCT01166373|582851902|FG003|Overall Study|Withdrawal by Subject|3|||
161400313|NCT01166373|582851899|FG000|Overall Study|Physician Decision|1|||
161400314|NCT01166373|582851900|FG001|Overall Study|Physician Decision|0|||
161400315|NCT01166373|582851901|FG002|Overall Study|Physician Decision|0|||
161400316|NCT01166373|582851902|FG003|Overall Study|Physician Decision|0|||
161400317|NCT02498067|582851903|FG000|Overall Study|Lost to Follow-up|22|||
161400318|NCT02498067|582851903|FG000|Overall Study|Did not meet inclusion criteria|11|||
161400319|NCT01874275|582851904|FG000|Overall Study|Lost to Follow-up|1|||
161400320|NCT01874275|582851905|FG001|Overall Study|Lost to Follow-up|0|||
161400321|NCT02214225|582851910|FG000|Overall Study|Lost to Follow-up|46|||
161400322|NCT02214225|582851911|FG001|Overall Study|Lost to Follow-up|18|||
161400323|NCT02214225|582851912|FG002|Overall Study|Lost to Follow-up|18|||
161400324|NCT02214225|582851910|FG000|Overall Study|Withdrawal by Subject|2|||
161400325|NCT02214225|582851911|FG001|Overall Study|Withdrawal by Subject|0|||
161400326|NCT02214225|582851912|FG002|Overall Study|Withdrawal by Subject|2|||
161400327|NCT02214225|582851910|FG000|Overall Study|Death|5|||
161400328|NCT02214225|582851911|FG001|Overall Study|Death|0|||
161400329|NCT02214225|582851912|FG002|Overall Study|Death|1|||
161400330|NCT02214225|582851910|FG000|Overall Study|randomized in error, not vaccinated|2|||
161400331|NCT02214225|582851911|FG001|Overall Study|randomized in error, not vaccinated|1|||
161400332|NCT02214225|582851912|FG002|Overall Study|randomized in error, not vaccinated|1|||
161400333|NCT03987932|582851913|FG000|Overall Study|Lost to Follow-up|2|||
161400334|NCT03987932|582851914|FG001|Overall Study|Lost to Follow-up|1|||
161400335|NCT03987932|582851915|FG002|Overall Study|Lost to Follow-up|1|||
161400336|NCT03987932|582851913|FG000|Overall Study|Non-study related elective surgery|0|||
161400337|NCT03987932|582851914|FG001|Overall Study|Non-study related elective surgery|0|||
161400338|NCT03987932|582851915|FG002|Overall Study|Non-study related elective surgery|1|||
161400339|NCT01669421|582851919|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
161400340|NCT01669421|582851919|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
161400341|NCT02813668|582851922|FG000|Overall Study|Death|4|||
161400342|NCT02813668|582851922|FG000|Overall Study|Lost to Follow-up|509|||
161400343|NCT02813668|582851922|FG000|Overall Study|Withdrawal by Subject|148|||
161400344|NCT02813668|582851922|FG000|Overall Study|No longer at worksite|85|||
161400345|NCT02813668|582851922|FG000|Overall Study|Medical reasons not related to the study|4|||
161400346|NCT02961790|582851923|FG000|Overall Study|Canceled|4|||
161400347|NCT02961790|582851924|FG001|Overall Study|Canceled|5|||
161400348|NCT02961790|582851925|FG002|Overall Study|Canceled|1|||
161400349|NCT02961790|582851926|FG003|Overall Study|Canceled|4|||
161400350|NCT02961790|582851923|FG000|Overall Study|without baseline data|4|||
161400351|NCT02961790|582851924|FG001|Overall Study|without baseline data|0|||
161400352|NCT02961790|582851925|FG002|Overall Study|without baseline data|1|||
161400353|NCT02961790|582851926|FG003|Overall Study|without baseline data|0|||
161400354|NCT02961790|582851923|FG000|Overall Study|without post baseline data|7|||
161400355|NCT02961790|582851924|FG001|Overall Study|without post baseline data|6|||
161400356|NCT02961790|582851925|FG002|Overall Study|without post baseline data|4|||
161400357|NCT02961790|582851926|FG003|Overall Study|without post baseline data|1|||
161400358|NCT02594098|582851929|FG000|Overall Study|Lack of Efficacy|17|||
161400359|NCT02594098|582851930|FG001|Overall Study|Lack of Efficacy|6|||
161400360|NCT02594098|582851929|FG000|Overall Study|Withdrawal by Subject|1|||
161400361|NCT02594098|582851930|FG001|Overall Study|Withdrawal by Subject|3|||
161400362|NCT02594098|582851929|FG000|Overall Study|Terminated participation|6|||
161400363|NCT02594098|582851930|FG001|Overall Study|Terminated participation|2|||
161400364|NCT02594098|582851929|FG000|Overall Study|Seek alternative treatment|2|||
161400365|NCT02594098|582851930|FG001|Overall Study|Seek alternative treatment|1|||
161400366|NCT02594098|582851929|FG000|Overall Study|Other|0|||
161400367|NCT02594098|582851930|FG001|Overall Study|Other|1|||
161400368|NCT01866423|582851931|FG000|Overall Study|Lack of Efficacy|3|||
161400369|NCT01866423|582851931|FG000|Overall Study|Sponsor Decision|1|||
161400370|NCT00541099|582851938|FG000|Overall Study|Ineligible|3|||
161400371|NCT02370095|582851943|FG000|Overall Study|Withdrawal by Subject|0|||
161400372|NCT02370095|582851944|FG001|Overall Study|Withdrawal by Subject|1|||
161400373|NCT00434759|582851945|FG000|Overall Study|Lack of Efficacy|5|||
161400374|NCT00434759|582851946|FG001|Overall Study|Lack of Efficacy|4|||
161400375|NCT00434759|582851945|FG000|Overall Study|Withdrawal by Subject|17|||
161400376|NCT00434759|582851946|FG001|Overall Study|Withdrawal by Subject|1|||
161400377|NCT00434759|582851945|FG000|Overall Study|family affairs|2|||
161400378|NCT00434759|582851946|FG001|Overall Study|family affairs|0|||
161400379|NCT00787930|582851951|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
161400380|NCT03002623|582851952|FG000|Overall Study|Lost to Follow-up|1|||
161400381|NCT03002623|582851953|FG001|Overall Study|Lost to Follow-up|0|||
161400382|NCT03002623|582851952|FG000|Overall Study|Physician Decision|1|||
161400383|NCT03002623|582851953|FG001|Overall Study|Physician Decision|1|||
161400384|NCT00758589|582854449|FG000|Overall Study|Adverse Event|3|||
161400385|NCT00758589|582854450|FG001|Overall Study|Adverse Event|2|||
161400386|NCT00758589|582854451|FG002|Overall Study|Adverse Event|5|||
161400387|NCT00758589|582854452|FG003|Overall Study|Adverse Event|4|||
161400388|NCT00758589|582854449|FG000|Overall Study|Withdrawal by Subject|0|||
161400389|NCT00758589|582854450|FG001|Overall Study|Withdrawal by Subject|1|||
161400390|NCT00758589|582854451|FG002|Overall Study|Withdrawal by Subject|1|||
161400391|NCT00758589|582854452|FG003|Overall Study|Withdrawal by Subject|1|||
161400392|NCT00758589|582854449|FG000|Overall Study|Palm stopped to work|0|||
161400393|NCT00758589|582854450|FG001|Overall Study|Palm stopped to work|0|||
161400394|NCT00758589|582854451|FG002|Overall Study|Palm stopped to work|0|||
161400395|NCT00758589|582854452|FG003|Overall Study|Palm stopped to work|1|||
161400396|NCT03204890|582854456|FG000|Overall Study|Withdrawal by Subject|1|||
161400397|NCT04524455|582854467|FG000|Overall Study|Death|3|||
161400398|NCT04524455|582854468|FG001|Overall Study|Death|3|||
161400399|NCT04524455|582854467|FG000|Overall Study|Decision by Sponsor|0|||
161400400|NCT04524455|582854468|FG001|Overall Study|Decision by Sponsor|2|||
161400401|NCT04524455|582854467|FG000|Overall Study|Withdrawal of Consent From Study|1|||
161400402|NCT04524455|582854468|FG001|Overall Study|Withdrawal of Consent From Study|0|||
161400403|NCT04524455|582854467|FG000|Overall Study|Lost to Follow-up|0|||
161400404|NCT04524455|582854468|FG001|Overall Study|Lost to Follow-up|1|||
161400405|NCT01688739|582854469|FG000|Overall Study|Administrative Decision|1|||
161400406|NCT01688739|582854470|FG001|Overall Study|Administrative Decision|0|||
161400407|NCT01688739|582854471|FG002|Overall Study|Administrative Decision|0|||
161400408|NCT01688739|582854472|FG003|Overall Study|Administrative Decision|0|||
161400409|NCT01688739|582854473|FG004|Overall Study|Administrative Decision|0|||
161400410|NCT01688739|582854474|FG005|Overall Study|Administrative Decision|0|||
161400411|NCT01688739|582854475|FG006|Overall Study|Administrative Decision|0|||
161400412|NCT01688739|582854476|FG007|Overall Study|Administrative Decision|0|||
161400413|NCT01688739|582854477|FG008|Overall Study|Administrative Decision|0|||
161400414|NCT01688739|582854478|FG009|Overall Study|Administrative Decision|0|||
161400415|NCT00490776|582854481|FG000|Overall Study|Withdrawal by Subject|1|||
161400416|NCT00490776|582854481|FG000|Overall Study|Administrative Problems|1|||
161400417|NCT00490776|582854481|FG000|Overall Study|Death|1|||
161400418|NCT00490776|582854481|FG000|Overall Study|New Cancer Therapy|1|||
161400419|NCT00490776|582854481|FG000|Overall Study|Disease Progression|5|||
161400420|NCT00940485|582854489|FG000|Overall Study|HBeAb positive at Baseline|3|||
161400421|NCT00940485|582854490|FG001|Overall Study|HBeAb positive at Baseline|2|||
161400422|NCT00940485|582854489|FG000|Overall Study|Lost to Follow-up|2|||
161400423|NCT00940485|582854490|FG001|Overall Study|Lost to Follow-up|3|||
161400424|NCT00940485|582854489|FG000|Overall Study|Adverse Event|8|||
161400425|NCT00940485|582854490|FG001|Overall Study|Adverse Event|0|||
161400426|NCT00940485|582854489|FG000|Overall Study|Withdrawal by Subject|1|||
161400427|NCT00940485|582854490|FG001|Overall Study|Withdrawal by Subject|1|||
161400428|NCT00940485|582854489|FG000|Overall Study|Others|1|||
161400429|NCT00940485|582854490|FG001|Overall Study|Others|1|||
161400430|NCT01113580|582854491|FG000|Overall Study|Protocol Violation|1|||
161400431|NCT01113580|582854492|FG001|Overall Study|Protocol Violation|0|||
161400432|NCT04599166|582854495|FG000|Overall Study|Technological failure connecting to study app|80|||
161400433|NCT01974752|582854496|FG000|Overall Study|Death|33|||
161400434|NCT01974752|582854497|FG001|Overall Study|Death|11|||
161400435|NCT01974752|582854496|FG000|Overall Study|Lost to Follow-up|2|||
161400436|NCT01974752|582854497|FG001|Overall Study|Lost to Follow-up|0|||
161400437|NCT01974752|582854496|FG000|Overall Study|Withdrawal by Subject|2|||
161400438|NCT01974752|582854497|FG001|Overall Study|Withdrawal by Subject|3|||
161400439|NCT01974752|582854496|FG000|Overall Study|Other Eligibility Criteria|0|||
161400440|NCT01974752|582854497|FG001|Overall Study|Other Eligibility Criteria|1|||
161400441|NCT02233738|582854498|FG000|Overall Study|Lost to Follow-up|5|||
161400442|NCT02233738|582854499|FG001|Overall Study|Lost to Follow-up|12|||
161400443|NCT02233738|582854498|FG000|Overall Study|Death|0|||
161400444|NCT02233738|582854499|FG001|Overall Study|Death|1|||
161400445|NCT02233738|582854498|FG000|Overall Study|Withdrawal by Subject|0|||
161400446|NCT02233738|582854499|FG001|Overall Study|Withdrawal by Subject|1|||
161400447|NCT02233738|582854498|FG000|Overall Study|Did not return after Baseline|3|||
161400448|NCT02233738|582854499|FG001|Overall Study|Did not return after Baseline|2|||
161400449|NCT02435680|582854500|FG000|Overall Study|Physician Decision|3|||
161400450|NCT02435680|582854501|FG001|Overall Study|Physician Decision|0|||
161400451|NCT02435680|582854502|FG002|Overall Study|Physician Decision|0|||
161400452|NCT02435680|582854500|FG000|Overall Study|subject / guardian decision|0|||
161400453|NCT02435680|582854501|FG001|Overall Study|subject / guardian decision|3|||
161400454|NCT02435680|582854502|FG002|Overall Study|subject / guardian decision|2|||
161400455|NCT02435680|582854500|FG000|Overall Study|Adverse Event|8|||
161400456|NCT02435680|582854501|FG001|Overall Study|Adverse Event|3|||
161400457|NCT02435680|582854502|FG002|Overall Study|Adverse Event|2|||
161400458|NCT02435680|582854500|FG000|Overall Study|progressive disease|10|||
161400459|NCT02435680|582854501|FG001|Overall Study|progressive disease|7|||
161400460|NCT02435680|582854502|FG002|Overall Study|progressive disease|11|||
161400461|NCT02435680|582854500|FG000|Overall Study|not treated|0|||
161400462|NCT02435680|582854501|FG001|Overall Study|not treated|0|||
161400463|NCT02435680|582854502|FG002|Overall Study|not treated|1|||
161400464|NCT00570037|582854504|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
161400465|NCT00570037|582854505|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
161400466|NCT03946124|582854506|FG000|Overall Study|Withdrawal by Subject|19|||
161400467|NCT02118597|582854515|FG000|Overall Study|Sponsor terminated the study|14|||
161400468|NCT02118597|582854515|FG000|Overall Study|Serious Adverse Event|1|||
161400469|NCT02118597|582854515|FG000|Overall Study|Investigator's decision|1|||
161400470|NCT01891344|582854516|FG000|Overall Study|Ongoing|6|||
161400471|NCT01891344|582854517|FG001|Overall Study|Ongoing|2|||
161400472|NCT01891344|582854518|FG002|Overall Study|Ongoing|0|||
161400473|NCT01891344|582854519|FG003|Overall Study|Ongoing|1|||
161400474|NCT01891344|582854520|FG004|Overall Study|Ongoing|4|||
161400475|NCT01891344|582854521|FG005|Overall Study|Ongoing|1|||
161400476|NCT01891344|582854522|FG006|Overall Study|Ongoing|0|||
161400477|NCT01891344|582854523|FG007|Overall Study|Ongoing|0|||
161400478|NCT01852825|582854524|FG000|Overall Study|Withdrawal by Subject|2|||
161400479|NCT01852825|582854525|FG001|Overall Study|Withdrawal by Subject|0|||
161400480|NCT01852825|582854526|FG002|Overall Study|Withdrawal by Subject|0|||
161400481|NCT02120365|582854532|FG000|Overall Study|Withdrawal by Subject|0|||
161400482|NCT02120365|582854533|FG001|Overall Study|Withdrawal by Subject|0|||
161400483|NCT02120365|582854534|FG002|Overall Study|Withdrawal by Subject|2|||
161400484|NCT02120365|582854535|FG003|Overall Study|Withdrawal by Subject|4|||
161400485|NCT02120365|582854536|FG004|Overall Study|Withdrawal by Subject|0|||
161400486|NCT02120365|582854537|FG005|Overall Study|Withdrawal by Subject|2|||
161400487|NCT02305849|582854538|FG000|Overall Study|Adverse Event|10|||
161400488|NCT02305849|582854539|FG001|Overall Study|Adverse Event|12|||
161400489|NCT02305849|582854540|FG002|Overall Study|Adverse Event|7|||
161400490|NCT02305849|582854541|FG003|Overall Study|Adverse Event|3|||
161400491|NCT02305849|582854538|FG000|Overall Study|Lack of Efficacy|10|||
161400492|NCT02305849|582854539|FG001|Overall Study|Lack of Efficacy|6|||
161400493|NCT02305849|582854540|FG002|Overall Study|Lack of Efficacy|3|||
161400494|NCT02305849|582854541|FG003|Overall Study|Lack of Efficacy|9|||
161400495|NCT02305849|582854538|FG000|Overall Study|Withdrawal by Subject|2|||
161400496|NCT02305849|582854539|FG001|Overall Study|Withdrawal by Subject|2|||
161400497|NCT02305849|582854540|FG002|Overall Study|Withdrawal by Subject|1|||
161400498|NCT02305849|582854541|FG003|Overall Study|Withdrawal by Subject|4|||
161400499|NCT02305849|582854538|FG000|Overall Study|Lost to Follow-up|0|||
161400500|NCT02305849|582854539|FG001|Overall Study|Lost to Follow-up|2|||
161400501|NCT02305849|582854540|FG002|Overall Study|Lost to Follow-up|0|||
161400502|NCT02305849|582854541|FG003|Overall Study|Lost to Follow-up|0|||
161400503|NCT02305849|582854538|FG000|Overall Study|Protocol Violation|3|||
161400504|NCT02305849|582854539|FG001|Overall Study|Protocol Violation|2|||
161400505|NCT02305849|582854540|FG002|Overall Study|Protocol Violation|1|||
161400506|NCT02305849|582854541|FG003|Overall Study|Protocol Violation|1|||
161400507|NCT02305849|582854538|FG000|Overall Study|Lab data met discontinuation criteria|0|||
161400508|NCT02305849|582854539|FG001|Overall Study|Lab data met discontinuation criteria|1|||
161400509|NCT02305849|582854540|FG002|Overall Study|Lab data met discontinuation criteria|2|||
161400510|NCT02305849|582854541|FG003|Overall Study|Lab data met discontinuation criteria|1|||
161400511|NCT02305849|582854538|FG000|Overall Study|Miscellaneous|1|||
161400512|NCT02305849|582854539|FG001|Overall Study|Miscellaneous|2|||
161400513|NCT02305849|582854540|FG002|Overall Study|Miscellaneous|4|||
161400514|NCT02305849|582854541|FG003|Overall Study|Miscellaneous|1|||
161400515|NCT02305849|582854538|FG000|Overall Study|Not fulfill eligibility criteria|1|||
161400516|NCT02305849|582854539|FG001|Overall Study|Not fulfill eligibility criteria|1|||
161400517|NCT02305849|582854540|FG002|Overall Study|Not fulfill eligibility criteria|0|||
161400518|NCT02305849|582854541|FG003|Overall Study|Not fulfill eligibility criteria|0|||
161400519|NCT00355342|582854542|FG000|Overall Study|Adverse Event|13|||
161400520|NCT00355342|582854543|FG001|Overall Study|Adverse Event|15|||
161400521|NCT00355342|582854542|FG000|Overall Study|Lost to Follow-up|4|||
161400522|NCT00355342|582854543|FG001|Overall Study|Lost to Follow-up|2|||
161400523|NCT00355342|582854542|FG000|Overall Study|Withdrawal by Subject|14|||
161400524|NCT00355342|582854543|FG001|Overall Study|Withdrawal by Subject|11|||
161400525|NCT00355342|582854542|FG000|Overall Study|Sponsor terminated study|2|||
161400526|NCT00355342|582854543|FG001|Overall Study|Sponsor terminated study|2|||
161400527|NCT00355342|582854542|FG000|Overall Study|Overcompliant-PI discretion|1|||
161400528|NCT00355342|582854543|FG001|Overall Study|Overcompliant-PI discretion|0|||
161400529|NCT00355342|582854542|FG000|Overall Study|Use of prohibited medication|1|||
161400530|NCT00355342|582854543|FG001|Overall Study|Use of prohibited medication|0|||
161400531|NCT00355342|582854542|FG000|Overall Study|COPD exacerbation|1|||
161400532|NCT00355342|582854543|FG001|Overall Study|COPD exacerbation|1|||
161400533|NCT00355342|582854542|FG000|Overall Study|Dispensed wrong study drug kit|1|||
161400534|NCT00355342|582854543|FG001|Overall Study|Dispensed wrong study drug kit|0|||
161400535|NCT00355342|582854542|FG000|Overall Study|Non-compliance with Dexa scans|1|||
161400536|NCT00355342|582854543|FG001|Overall Study|Non-compliance with Dexa scans|0|||
161400537|NCT00355342|582854542|FG000|Overall Study|Withdrawal by participant and physician|1|||
161400538|NCT00355342|582854543|FG001|Overall Study|Withdrawal by participant and physician|0|||
161400539|NCT00355342|582854542|FG000|Overall Study|Participant relocated|0|||
161400540|NCT00355342|582854543|FG001|Overall Study|Participant relocated|1|||
161400541|NCT00355342|582854542|FG000|Overall Study|Participant discontinued study drug|0|||
161400542|NCT00355342|582854543|FG001|Overall Study|Participant discontinued study drug|1|||
161400543|NCT00355342|582854542|FG000|Overall Study|Study management|0|||
161400544|NCT00355342|582854543|FG001|Overall Study|Study management|1|||
161400545|NCT00355342|582854542|FG000|Overall Study|Protocol Violation|0|||
161400546|NCT00355342|582854543|FG001|Overall Study|Protocol Violation|1|||
161400547|NCT00355342|582854542|FG000|Overall Study|Use of protocol excluded medication|0|||
161400548|NCT00355342|582854543|FG001|Overall Study|Use of protocol excluded medication|1|||
161400549|NCT00495521|582854544|FG000|Overall Study|Physician Decision|0|||
161400550|NCT00495521|582854545|FG001|Overall Study|Physician Decision|1|||
161400551|NCT02782325|582854546|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
161400552|NCT02782325|582854547|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
161400553|NCT02782325|582854548|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
161400554|NCT02782325|582854546|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
161400555|NCT02782325|582854547|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
161400556|NCT02782325|582854548|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
161400557|NCT00693472|582854549|FG000|Part 1|Adverse Event|1|||
161400558|NCT00693472|582854550|FG001|Part 1|Adverse Event|1|||
161400559|NCT00693472|582854551|FG002|Part 1|Adverse Event|0|||
161400560|NCT00693472|582854552|FG003|Part 1|Adverse Event|0|||
161400561|NCT00693472|582854549|FG000|Part 1|Lost to Follow-up|0|||
161400562|NCT00693472|582854550|FG001|Part 1|Lost to Follow-up|1|||
161400563|NCT00693472|582854551|FG002|Part 1|Lost to Follow-up|0|||
161400564|NCT00693472|582854552|FG003|Part 1|Lost to Follow-up|0|||
161400565|NCT00693472|582854549|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
161400566|NCT00693472|582854550|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
161400567|NCT00693472|582854551|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
161400568|NCT00693472|582854552|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
161400569|NCT00693472|582854549|FG000|Part 2|Adverse Event|0|||
161400570|NCT00693472|582854550|FG001|Part 2|Adverse Event|0|||
161400571|NCT00693472|582854551|FG002|Part 2|Adverse Event|1|||
161400572|NCT00693472|582854552|FG003|Part 2|Adverse Event|0|||
161400573|NCT00693472|582854549|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
161400574|NCT00693472|582854550|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
161400575|NCT00693472|582854551|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
161400576|NCT00693472|582854552|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
161400577|NCT01527383|582854553|FG000|Overall Study|Adverse Event|5|||
161400578|NCT01527383|582854554|FG001|Overall Study|Adverse Event|0|||
161400579|NCT01527383|582854553|FG000|Overall Study|Lost to Follow-up|3|||
161400580|NCT01527383|582854554|FG001|Overall Study|Lost to Follow-up|0|||
161400581|NCT01527383|582854553|FG000|Overall Study|Physician Decision|2|||
161400582|NCT01527383|582854554|FG001|Overall Study|Physician Decision|0|||
161400583|NCT01527383|582854553|FG000|Overall Study|Pregnancy|1|||
161400584|NCT01527383|582854554|FG001|Overall Study|Pregnancy|0|||
161400585|NCT01527383|582854553|FG000|Overall Study|Protocol Violation|1|||
161400586|NCT01527383|582854554|FG001|Overall Study|Protocol Violation|0|||
161400587|NCT01527383|582854553|FG000|Overall Study|Screen failure|1|||
161400588|NCT01527383|582854554|FG001|Overall Study|Screen failure|0|||
161400589|NCT01527383|582854553|FG000|Overall Study|Participant moved|0|||
161400590|NCT01527383|582854554|FG001|Overall Study|Participant moved|1|||
161400591|NCT01527383|582854553|FG000|Overall Study|Withdrawal by Subject|2|||
161400592|NCT01527383|582854554|FG001|Overall Study|Withdrawal by Subject|3|||
161400593|NCT00849875|582854555|FG000|Overall Study|Death|28|||
161400594|NCT00849875|582854555|FG000|Overall Study|Ongoing (unknown completion status)|11|||
161400595|NCT00849875|582854555|FG000|Overall Study|Others|6|||
161400596|NCT00849875|582854555|FG000|Overall Study|Lost to Follow-up|2|||
161400597|NCT00461305|582854556|FG000|Treatment|Adverse Event|26|||
161400598|NCT00461305|582854557|FG001|Treatment|Adverse Event|3|||
161400599|NCT00461305|582854556|FG000|Treatment|Lost to Follow-up|4|||
161400600|NCT00461305|582854557|FG001|Treatment|Lost to Follow-up|2|||
161400601|NCT00461305|582854556|FG000|Treatment|Protocol Violation|13|||
161400602|NCT00461305|582854557|FG001|Treatment|Protocol Violation|2|||
161400603|NCT00461305|582854556|FG000|Treatment|Withdrawal by Subject|48|||
161400604|NCT00461305|582854557|FG001|Treatment|Withdrawal by Subject|2|||
161400605|NCT00461305|582854556|FG000|Treatment|Never dispensed|5|||
161400606|NCT00461305|582854557|FG001|Treatment|Never dispensed|0|||
161400607|NCT00461305|582854556|FG000|Treatment|Study drug not taken|1|||
161400608|NCT00461305|582854557|FG001|Treatment|Study drug not taken|0|||
161400609|NCT00461305|582854556|FG000|Treatment|Partially missing diary|2|||
161400610|NCT00461305|582854557|FG001|Treatment|Partially missing diary|0|||
161400611|NCT00461305|582854556|FG000|Treatment|Other (missing drug etc)|2|||
161400612|NCT00461305|582854557|FG001|Treatment|Other (missing drug etc)|0|||
161400613|NCT00461305|582854556|FG000|Continued Treatment|Adverse Event|26|||
161400614|NCT00461305|582854557|FG001|Continued Treatment|Adverse Event|0|||
161400615|NCT00461305|582854556|FG000|Continued Treatment|Lost to Follow-up|4|||
161400616|NCT00461305|582854557|FG001|Continued Treatment|Lost to Follow-up|0|||
161400617|NCT00461305|582854556|FG000|Continued Treatment|Protocol Violation|13|||
161400618|NCT00461305|582854557|FG001|Continued Treatment|Protocol Violation|0|||
161400619|NCT00461305|582854556|FG000|Continued Treatment|Withdrawal by Subject|48|||
161400620|NCT00461305|582854557|FG001|Continued Treatment|Withdrawal by Subject|0|||
161400621|NCT00461305|582854556|FG000|Continued Treatment|Partially missing diary|2|||
161400622|NCT00461305|582854557|FG001|Continued Treatment|Partially missing diary|0|||
161400623|NCT00461305|582854556|FG000|Continued Treatment|Other (missing drug etc)|2|||
161400624|NCT00461305|582854557|FG001|Continued Treatment|Other (missing drug etc)|0|||
161400625|NCT02513823|582854558|FG000|Overall Study|Lost to Follow-up|4|||
161400626|NCT02513823|582854558|FG000|Overall Study|Physician Decision|1|||
161400627|NCT04342689|582854562|FG000|Overall Study|Withdrawal by Subject|32|||
161400628|NCT04342689|582854563|FG001|Overall Study|Withdrawal by Subject|33|||
161400629|NCT04342689|582854562|FG000|Overall Study|Lost to Follow-up|10|||
161400630|NCT04342689|582854563|FG001|Overall Study|Lost to Follow-up|12|||
161400631|NCT00844805|582854565|FG000|Treatment Phase|Adverse Event|5|||
161400632|NCT00844805|582854566|FG001|Treatment Phase|Adverse Event|1|||
161400633|NCT00844805|582854567|FG002|Treatment Phase|Adverse Event|0|||
161400634|NCT00844805|582854568|FG003|Treatment Phase|Adverse Event|0|||
161400635|NCT00844805|582854565|FG000|Treatment Phase|Withdrawal by Subject|3|||
161400636|NCT00844805|582854566|FG001|Treatment Phase|Withdrawal by Subject|4|||
161400637|NCT00844805|582854567|FG002|Treatment Phase|Withdrawal by Subject|0|||
161400638|NCT00844805|582854568|FG003|Treatment Phase|Withdrawal by Subject|0|||
161400639|NCT00844805|582854565|FG000|Treatment Phase|Noncompliance With Protocol|1|||
161400640|NCT00844805|582854566|FG001|Treatment Phase|Noncompliance With Protocol|0|||
161400641|NCT00844805|582854567|FG002|Treatment Phase|Noncompliance With Protocol|0|||
161400642|NCT00844805|582854568|FG003|Treatment Phase|Noncompliance With Protocol|0|||
161400643|NCT00844805|582854565|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
161400644|NCT00844805|582854566|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
161400645|NCT00844805|582854567|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
161400646|NCT00844805|582854568|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
161400647|NCT00844805|582854565|FG000|Follow-Up Phase|Adverse Event|0|||
161400648|NCT00844805|582854566|FG001|Follow-Up Phase|Adverse Event|0|||
161400649|NCT00844805|582854567|FG002|Follow-Up Phase|Adverse Event|1|||
161400650|NCT00844805|582854568|FG003|Follow-Up Phase|Adverse Event|0|||
161400651|NCT00844805|582854565|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161400652|NCT00844805|582854566|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
161400653|NCT00844805|582854567|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
161400654|NCT00844805|582854568|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
161400655|NCT00844805|582854565|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
161400656|NCT00844805|582854566|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
161400657|NCT00844805|582854567|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
161400658|NCT00844805|582854568|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
161400659|NCT00844805|582854565|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
161400660|NCT00844805|582854566|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
161400661|NCT00844805|582854567|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
161400662|NCT00844805|582854568|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
161400663|NCT00844805|582854565|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
161400664|NCT00844805|582854566|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
161400665|NCT00844805|582854567|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
161400666|NCT00844805|582854568|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
161400667|NCT00259298|582854572|FG000|Overall Study|Withdrawal by Subject|1|||
161400668|NCT00259298|582854572|FG000|Overall Study|Physician Decision|2|||
161400669|NCT01011933|582854573|FG000|Overall Study|Wrong cell type|1|||
161400670|NCT01011933|582854573|FG000|Overall Study|Improper pre-protocol Rx|1|||
161400671|NCT01011933|582854573|FG000|Overall Study|Inadequate pathology|1|||
161400672|NCT01011933|582854573|FG000|Overall Study|Never treated|1|||
161400673|NCT00475865|582854575|FG000|Overall Study|Adverse Event|0|||
161400674|NCT00475865|582854576|FG001|Overall Study|Adverse Event|3|||
161400675|NCT00475865|582854577|FG002|Overall Study|Adverse Event|4|||
161400676|NCT00475865|582854575|FG000|Overall Study|Lack of Efficacy|1|||
161400677|NCT00475865|582854576|FG001|Overall Study|Lack of Efficacy|0|||
161400678|NCT00475865|582854577|FG002|Overall Study|Lack of Efficacy|0|||
161400679|NCT00475865|582854575|FG000|Overall Study|Progressive disease|0|||
161400680|NCT00475865|582854576|FG001|Overall Study|Progressive disease|1|||
161400681|NCT00475865|582854577|FG002|Overall Study|Progressive disease|2|||
161400682|NCT00475865|582854575|FG000|Overall Study|Participant did not wish to continue|1|||
161400683|NCT00475865|582854576|FG001|Overall Study|Participant did not wish to continue|0|||
161400684|NCT00475865|582854577|FG002|Overall Study|Participant did not wish to continue|0|||
161400685|NCT00475865|582854575|FG000|Overall Study|Other than above|0|||
161400686|NCT00475865|582854576|FG001|Overall Study|Other than above|1|||
161400687|NCT00475865|582854577|FG002|Overall Study|Other than above|0|||
161400688|NCT04316741|582854578|FG000|Baseline Enrollment|Lost to Follow-up|1|||
161400689|NCT04316741|582854579|FG001|Baseline Enrollment|Lost to Follow-up|1|||
161400690|NCT04316741|582854578|FG000|Immediate Post-Test|Lost to Follow-up|5|||
161400691|NCT04316741|582854579|FG001|Immediate Post-Test|Lost to Follow-up|1|||
161400692|NCT04316741|582854578|FG000|1-month Post-test|Lost to Follow-up|7|||
161400693|NCT04316741|582854579|FG001|1-month Post-test|Lost to Follow-up|2|||
161400694|NCT04316741|582854578|FG000|3-month Follow-up|Lost to Follow-up|10|||
161400695|NCT04316741|582854579|FG001|3-month Follow-up|Lost to Follow-up|2|||
161400696|NCT02726880|582854580|FG000|Overall Study|Withdrawal by Subject|2|||
161400697|NCT02726880|582854581|FG001|Overall Study|Withdrawal by Subject|0|||
161400698|NCT02726880|582854580|FG000|Overall Study|Lost to Follow-up|1|||
161400699|NCT02726880|582854581|FG001|Overall Study|Lost to Follow-up|3|||
161400700|NCT00787202|582854582|FG000|Overall Study|Adverse Event|3|||
161400701|NCT00787202|582854583|FG001|Overall Study|Adverse Event|2|||
161400702|NCT00787202|582854584|FG002|Overall Study|Adverse Event|0|||
161400703|NCT00787202|582854585|FG003|Overall Study|Adverse Event|0|||
161400704|NCT00787202|582854586|FG004|Overall Study|Adverse Event|2|||
161400705|NCT00787202|582854582|FG000|Overall Study|Lack of Efficacy|5|||
161400706|NCT00787202|582854583|FG001|Overall Study|Lack of Efficacy|6|||
161400707|NCT00787202|582854584|FG002|Overall Study|Lack of Efficacy|5|||
161400708|NCT00787202|582854585|FG003|Overall Study|Lack of Efficacy|2|||
161400709|NCT00787202|582854586|FG004|Overall Study|Lack of Efficacy|1|||
161400710|NCT00787202|582854582|FG000|Overall Study|Lost to Follow-up|1|||
161400711|NCT00787202|582854583|FG001|Overall Study|Lost to Follow-up|0|||
161400712|NCT00787202|582854584|FG002|Overall Study|Lost to Follow-up|0|||
161400713|NCT00787202|582854585|FG003|Overall Study|Lost to Follow-up|0|||
161400714|NCT00787202|582854586|FG004|Overall Study|Lost to Follow-up|0|||
161400715|NCT00787202|582854582|FG000|Overall Study|Withdrawal by Subject|2|||
161400716|NCT00787202|582854583|FG001|Overall Study|Withdrawal by Subject|2|||
161400717|NCT00787202|582854584|FG002|Overall Study|Withdrawal by Subject|2|||
161400718|NCT00787202|582854585|FG003|Overall Study|Withdrawal by Subject|0|||
161400719|NCT00787202|582854586|FG004|Overall Study|Withdrawal by Subject|0|||
161400720|NCT00787202|582854582|FG000|Overall Study|Protocol Violation|2|||
161400721|NCT00787202|582854583|FG001|Overall Study|Protocol Violation|1|||
161400722|NCT00787202|582854584|FG002|Overall Study|Protocol Violation|0|||
161400723|NCT00787202|582854585|FG003|Overall Study|Protocol Violation|0|||
161400724|NCT00787202|582854586|FG004|Overall Study|Protocol Violation|1|||
161400725|NCT00787202|582854582|FG000|Overall Study|Randomized, not treated|1|||
161400726|NCT00787202|582854583|FG001|Overall Study|Randomized, not treated|0|||
161400727|NCT00787202|582854584|FG002|Overall Study|Randomized, not treated|0|||
161400728|NCT00787202|582854585|FG003|Overall Study|Randomized, not treated|0|||
161400729|NCT00787202|582854586|FG004|Overall Study|Randomized, not treated|0|||
161400730|NCT01510145|582854587|FG000|Overall Study|Adverse Event|6|||
161400731|NCT01510145|582854587|FG000|Overall Study|Lost to Follow-up|5|||
161400732|NCT01510145|582854587|FG000|Overall Study|Withdrawal by Subject|6|||
161400733|NCT01510145|582854587|FG000|Overall Study|Relative reported subject withdrew|1|||
161400734|NCT01442064|582854588|FG000|Overall Study|Adverse Event|2|||
161400735|NCT01442064|582854589|FG001|Overall Study|Adverse Event|2|||
161400736|NCT01442064|582854590|FG002|Overall Study|Adverse Event|2|||
161400737|NCT01442064|582854591|FG003|Overall Study|Adverse Event|1|||
161400738|NCT01442064|582854592|FG004|Overall Study|Adverse Event|2|||
161400739|NCT01442064|582854593|FG005|Overall Study|Adverse Event|0|||
161400740|NCT01442064|582854588|FG000|Overall Study|Death|0|||
161400741|NCT01442064|582854589|FG001|Overall Study|Death|1|||
161400742|NCT01442064|582854590|FG002|Overall Study|Death|3|||
161400743|NCT01442064|582854591|FG003|Overall Study|Death|3|||
161400744|NCT01442064|582854592|FG004|Overall Study|Death|1|||
161400745|NCT01442064|582854593|FG005|Overall Study|Death|3|||
161400746|NCT01442064|582854588|FG000|Overall Study|Lost to Follow-up|5|||
161400747|NCT01442064|582854589|FG001|Overall Study|Lost to Follow-up|5|||
161400748|NCT01442064|582854590|FG002|Overall Study|Lost to Follow-up|1|||
161400749|NCT01442064|582854591|FG003|Overall Study|Lost to Follow-up|1|||
161400750|NCT01442064|582854592|FG004|Overall Study|Lost to Follow-up|3|||
161400751|NCT01442064|582854593|FG005|Overall Study|Lost to Follow-up|3|||
161400752|NCT01442064|582854588|FG000|Overall Study|Physician Decision|1|||
161400753|NCT01442064|582854589|FG001|Overall Study|Physician Decision|1|||
161400754|NCT01442064|582854590|FG002|Overall Study|Physician Decision|2|||
161400755|NCT01442064|582854591|FG003|Overall Study|Physician Decision|3|||
161400756|NCT01442064|582854592|FG004|Overall Study|Physician Decision|3|||
161400757|NCT01442064|582854593|FG005|Overall Study|Physician Decision|1|||
161400758|NCT01442064|582854588|FG000|Overall Study|Withdrawal by Subject|6|||
161400759|NCT01442064|582854589|FG001|Overall Study|Withdrawal by Subject|3|||
161400760|NCT01442064|582854590|FG002|Overall Study|Withdrawal by Subject|2|||
161400761|NCT01442064|582854591|FG003|Overall Study|Withdrawal by Subject|2|||
161400762|NCT01442064|582854592|FG004|Overall Study|Withdrawal by Subject|2|||
161400763|NCT01442064|582854593|FG005|Overall Study|Withdrawal by Subject|1|||
161400764|NCT01442064|582854588|FG000|Overall Study|Sponsor decision|82|||
161400765|NCT01442064|582854589|FG001|Overall Study|Sponsor decision|88|||
161400766|NCT01442064|582854590|FG002|Overall Study|Sponsor decision|92|||
161400767|NCT01442064|582854591|FG003|Overall Study|Sponsor decision|88|||
161400768|NCT01442064|582854592|FG004|Overall Study|Sponsor decision|95|||
161400769|NCT01442064|582854593|FG005|Overall Study|Sponsor decision|87|||
161400770|NCT01442064|582854588|FG000|Overall Study|Subject non-compliance|0|||
161400771|NCT01442064|582854589|FG001|Overall Study|Subject non-compliance|0|||
161400772|NCT01442064|582854590|FG002|Overall Study|Subject non-compliance|0|||
161400773|NCT01442064|582854591|FG003|Overall Study|Subject non-compliance|0|||
161400774|NCT01442064|582854592|FG004|Overall Study|Subject non-compliance|0|||
161400775|NCT01442064|582854593|FG005|Overall Study|Subject non-compliance|2|||
161400776|NCT01442064|582854588|FG000|Overall Study|Condition mandated other intervention|1|||
161400777|NCT01442064|582854589|FG001|Overall Study|Condition mandated other intervention|1|||
161400778|NCT01442064|582854590|FG002|Overall Study|Condition mandated other intervention|2|||
161400779|NCT01442064|582854591|FG003|Overall Study|Condition mandated other intervention|0|||
161400780|NCT01442064|582854592|FG004|Overall Study|Condition mandated other intervention|0|||
161400781|NCT01442064|582854593|FG005|Overall Study|Condition mandated other intervention|2|||
161400782|NCT01360398|582854596|FG000|Overall Study|Withdrawal by Subject|14|||
161400783|NCT01360398|582854596|FG000|Overall Study|Other|7|||
161400784|NCT01360398|582854596|FG000|Overall Study|Migrated/moved from study area|1|||
161400785|NCT02153346|582854597|FG000|Overall Study|Lost to Follow-up|11|||
161400786|NCT01710527|582854598|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
161400787|NCT01710527|582854599|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
161400788|NCT01822535|582854600|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
161400789|NCT01822535|582854601|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
161400790|NCT01822535|582854600|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
161400791|NCT01822535|582854601|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
161400792|NCT01822535|582854600|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
161400793|NCT01822535|582854601|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
161400794|NCT02278614|582854604|FG000|Overall Study|Withdrawal by Subject|3|||
161400795|NCT02278614|582854605|FG001|Overall Study|Withdrawal by Subject|5|||
161400796|NCT02278614|582854604|FG000|Overall Study|Adverse Event|1|||
161400797|NCT02278614|582854605|FG001|Overall Study|Adverse Event|0|||
161400798|NCT02278614|582854604|FG000|Overall Study|left eye was not eligible|1|||
161400799|NCT02278614|582854605|FG001|Overall Study|left eye was not eligible|0|||
161400800|NCT02279498|582854606|FG000|Overall Study|Adverse Event|3|||
161400801|NCT02279498|582854607|FG001|Overall Study|Adverse Event|0|||
161400802|NCT02279498|582854606|FG000|Overall Study|Lack of Efficacy|4|||
161400803|NCT02279498|582854607|FG001|Overall Study|Lack of Efficacy|0|||
161400804|NCT02279498|582854606|FG000|Overall Study|Lost to Follow-up|0|||
161400805|NCT02279498|582854607|FG001|Overall Study|Lost to Follow-up|1|||
161400806|NCT02279498|582854606|FG000|Overall Study|Withdrawal by Subject|9|||
161400807|NCT02279498|582854607|FG001|Overall Study|Withdrawal by Subject|2|||
161400808|NCT02279498|582854606|FG000|Overall Study|Undefined|2|||
161400809|NCT02279498|582854607|FG001|Overall Study|Undefined|1|||
161400810|NCT00737711|582854610|FG000|Overall Study|Adverse Event|2|||
161400811|NCT00737711|582854610|FG000|Overall Study|Death|8|||
161400812|NCT00737711|582854610|FG000|Overall Study|Failure to return|4|||
161400813|NCT00737711|582854610|FG000|Overall Study|Protocol Violation|1|||
161400814|NCT00737711|582854610|FG000|Overall Study|Withdrawal by Subject|5|||
161400815|NCT00737711|582854610|FG000|Overall Study|Blood transfusion|6|||
161400816|NCT00737711|582854610|FG000|Overall Study|Other|5|||
161400817|NCT02739321|582854611|FG000|Overall Study|Lack of Efficacy|1|||
161400818|NCT02739321|582854612|FG001|Overall Study|Lack of Efficacy|1|||
161400819|NCT02739321|582854611|FG000|Overall Study|Lost to Follow-up|1|||
161400820|NCT02739321|582854612|FG001|Overall Study|Lost to Follow-up|1|||
161400821|NCT02739321|582854611|FG000|Overall Study|Withdrawal by Subject|1|||
161400822|NCT02739321|582854612|FG001|Overall Study|Withdrawal by Subject|2|||
161400823|NCT02558400|582854613|FG000|Overall Study|Adverse Event|47|||
161400824|NCT02558400|582854614|FG001|Overall Study|Adverse Event|53|||
161400825|NCT02558400|582854615|FG002|Overall Study|Adverse Event|4|||
161400826|NCT02558400|582854613|FG000|Overall Study|Withdrawal by Subject|13|||
161400827|NCT02558400|582854614|FG001|Overall Study|Withdrawal by Subject|9|||
161400828|NCT02558400|582854615|FG002|Overall Study|Withdrawal by Subject|8|||
161400829|NCT02558400|582854613|FG000|Overall Study|Non-Compliant|0|||
161400830|NCT02558400|582854614|FG001|Overall Study|Non-Compliant|1|||
161400831|NCT02558400|582854615|FG002|Overall Study|Non-Compliant|3|||
161400832|NCT02558400|582854613|FG000|Overall Study|Lost to Follow-up|5|||
161400833|NCT02558400|582854614|FG001|Overall Study|Lost to Follow-up|5|||
161400834|NCT02558400|582854615|FG002|Overall Study|Lost to Follow-up|4|||
161400835|NCT02558400|582854613|FG000|Overall Study|Lack of Efficacy|0|||
161400836|NCT02558400|582854614|FG001|Overall Study|Lack of Efficacy|13|||
161400837|NCT02558400|582854615|FG002|Overall Study|Lack of Efficacy|1|||
161400838|NCT02558400|582854613|FG000|Overall Study|Disallowed Concurrent Medication|6|||
161400839|NCT02558400|582854614|FG001|Overall Study|Disallowed Concurrent Medication|7|||
161400840|NCT02558400|582854615|FG002|Overall Study|Disallowed Concurrent Medication|5|||
161400841|NCT02558400|582854613|FG000|Overall Study|Physician Decision|2|||
161400842|NCT02558400|582854614|FG001|Overall Study|Physician Decision|2|||
161400843|NCT02558400|582854615|FG002|Overall Study|Physician Decision|0|||
161400844|NCT02558400|582854613|FG000|Overall Study|Protocol Violation|6|||
161400845|NCT02558400|582854614|FG001|Overall Study|Protocol Violation|3|||
161400846|NCT02558400|582854615|FG002|Overall Study|Protocol Violation|8|||
161400847|NCT02558400|582854613|FG000|Overall Study|Death|0|||
161400848|NCT02558400|582854614|FG001|Overall Study|Death|1|||
161400849|NCT02558400|582854615|FG002|Overall Study|Death|0|||
161400850|NCT02558400|582854613|FG000|Overall Study|Ineligible for the study|0|||
161400851|NCT02558400|582854614|FG001|Overall Study|Ineligible for the study|2|||
161400852|NCT02558400|582854615|FG002|Overall Study|Ineligible for the study|0|||
161400853|NCT02230683|582854619|FG000|Overall Study|Adverse Event|1|||
161400854|NCT00624780|582854620|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
161400855|NCT00624780|582854621|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
161400856|NCT00624780|582854622|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
161400857|NCT00624780|582854623|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
161400858|NCT00624780|582854624|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
161400859|NCT00624780|582854625|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
161400860|NCT00624780|582854620|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
161400861|NCT00624780|582854621|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
161400862|NCT00624780|582854622|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
161400863|NCT00624780|582854623|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
161400864|NCT00624780|582854624|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
161400865|NCT00624780|582854625|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
161400866|NCT00624780|582854620|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
161400867|NCT00624780|582854621|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
161400868|NCT00624780|582854622|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
161400869|NCT00624780|582854623|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
161400870|NCT00624780|582854624|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
161400871|NCT00624780|582854625|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
161400872|NCT00624780|582854620|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
161400873|NCT00624780|582854621|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
161400874|NCT00624780|582854622|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
161400875|NCT00624780|582854623|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
161400876|NCT00624780|582854624|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
161400877|NCT00624780|582854625|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
161400878|NCT00624780|582854620|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
161400879|NCT00624780|582854621|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
161400880|NCT00624780|582854622|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
161400881|NCT00624780|582854623|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
161400882|NCT00624780|582854624|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
161400883|NCT00624780|582854625|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
161400884|NCT00624780|582854620|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
161400885|NCT00624780|582854621|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
161400886|NCT00624780|582854622|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
161400887|NCT00624780|582854623|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
161400888|NCT00624780|582854624|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
161400889|NCT00624780|582854625|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
161400890|NCT00624780|582854620|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
161400891|NCT00624780|582854621|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
161400892|NCT00624780|582854622|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
161400893|NCT00624780|582854623|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
161400894|NCT00624780|582854624|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
161400895|NCT00624780|582854625|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
161400896|NCT00624780|582854620|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161400897|NCT00624780|582854621|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
161400898|NCT00624780|582854622|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161400899|NCT00624780|582854623|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
161400900|NCT00624780|582854624|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161400901|NCT00624780|582854625|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161400902|NCT00624780|582854620|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
161400903|NCT00624780|582854621|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
161400904|NCT00624780|582854622|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
161400905|NCT00624780|582854623|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
161400906|NCT00624780|582854624|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
161400907|NCT00624780|582854625|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
161400908|NCT00624780|582854620|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
161400909|NCT00624780|582854621|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
161400910|NCT00624780|582854622|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
161400911|NCT00624780|582854623|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
161400912|NCT00624780|582854624|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
161400913|NCT00624780|582854625|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
161400914|NCT00624780|582854620|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
161400915|NCT00624780|582854621|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
161400916|NCT00624780|582854622|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
161400917|NCT00624780|582854623|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
161400918|NCT00624780|582854624|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
161400919|NCT00624780|582854625|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
161400920|NCT00624780|582854620|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
161400921|NCT00624780|582854621|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161400922|NCT00624780|582854622|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161400923|NCT00624780|582854623|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161400924|NCT00624780|582854624|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161400925|NCT00624780|582854625|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161400926|NCT00624780|582854620|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161400927|NCT00624780|582854621|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161400928|NCT00624780|582854622|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
161400929|NCT00624780|582854623|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161400930|NCT00624780|582854624|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161400931|NCT00624780|582854625|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161400932|NCT00624780|582854620|FG000|Follow-up (Week 26)|Death|0|||
161400933|NCT00624780|582854621|FG001|Follow-up (Week 26)|Death|0|||
161400934|NCT00624780|582854622|FG002|Follow-up (Week 26)|Death|1|||
161400935|NCT00624780|582854623|FG003|Follow-up (Week 26)|Death|0|||
161400936|NCT00624780|582854624|FG004|Follow-up (Week 26)|Death|0|||
161400937|NCT00624780|582854625|FG005|Follow-up (Week 26)|Death|0|||
161400938|NCT00624780|582854620|FG000|Follow-up (Week 26)|Adverse Event|0|||
161400939|NCT00624780|582854621|FG001|Follow-up (Week 26)|Adverse Event|0|||
161400940|NCT00624780|582854622|FG002|Follow-up (Week 26)|Adverse Event|0|||
161400941|NCT00624780|582854623|FG003|Follow-up (Week 26)|Adverse Event|0|||
161400942|NCT00624780|582854624|FG004|Follow-up (Week 26)|Adverse Event|1|||
161400943|NCT00624780|582854625|FG005|Follow-up (Week 26)|Adverse Event|0|||
161400944|NCT00624780|582854620|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
161400945|NCT00624780|582854621|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
161400946|NCT00624780|582854622|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
161400947|NCT00624780|582854623|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
161400948|NCT00624780|582854624|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
161400949|NCT00624780|582854625|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
161400950|NCT00624780|582854620|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
161400951|NCT00624780|582854621|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
161400952|NCT00624780|582854622|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
161400953|NCT00624780|582854623|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
161400954|NCT00624780|582854624|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
161400955|NCT00624780|582854625|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
161400956|NCT00624780|582854620|FG000|Follow-up (Week 26)|Other|1|||
161400957|NCT00624780|582854621|FG001|Follow-up (Week 26)|Other|1|||
161400958|NCT00624780|582854622|FG002|Follow-up (Week 26)|Other|0|||
161400959|NCT00624780|582854623|FG003|Follow-up (Week 26)|Other|0|||
161400960|NCT00624780|582854624|FG004|Follow-up (Week 26)|Other|0|||
161400961|NCT00624780|582854625|FG005|Follow-up (Week 26)|Other|0|||
161400962|NCT04068519|582854627|FG000|Dose Verification|Death|15|||
161400963|NCT04068519|582854627|FG000|Dose Verification|Withdrawal by Subject|1|||
161400964|NCT04068519|582854627|FG000|Pharmacokinetic Sub-study|Death|35|||
161400965|NCT04068519|582854627|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
161400966|NCT04068519|582854627|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
161400967|NCT04068519|582854627|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
161400968|NCT04068519|582854627|FG000|Indication Expansion|Death|152|||
161400969|NCT04068519|582854627|FG000|Indication Expansion|Withdrawal by Subject|10|||
161400970|NCT04068519|582854627|FG000|Indication Expansion|Lost to Follow-up|7|||
161400971|NCT00969761|582854628|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161400972|NCT00969761|582854629|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400973|NCT00969761|582854630|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400974|NCT00969761|582854631|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161400975|NCT00969761|582854632|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400976|NCT00969761|582854633|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400977|NCT00969761|582854634|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400978|NCT00969761|582854635|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400979|NCT00969761|582854636|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161400980|NCT00969761|582854637|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161400981|NCT00969761|582854638|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400982|NCT00969761|582854639|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161400983|NCT00969761|582854628|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400984|NCT00969761|582854629|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400985|NCT00969761|582854630|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
161400986|NCT00969761|582854631|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400987|NCT00969761|582854632|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400988|NCT00969761|582854633|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400989|NCT00969761|582854634|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400990|NCT00969761|582854635|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400991|NCT00969761|582854636|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400992|NCT00969761|582854637|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400993|NCT00969761|582854638|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400994|NCT00969761|582854639|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161400995|NCT00969761|582854628|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161400996|NCT00969761|582854629|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161400997|NCT00969761|582854630|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
161400998|NCT00969761|582854631|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161400999|NCT00969761|582854632|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401000|NCT00969761|582854633|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401001|NCT00969761|582854634|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401002|NCT00969761|582854635|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401003|NCT00969761|582854636|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401004|NCT00969761|582854637|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401005|NCT00969761|582854638|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401006|NCT00969761|582854639|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161401007|NCT00969761|582854628|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401008|NCT00969761|582854629|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401009|NCT00969761|582854630|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401010|NCT00969761|582854631|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401011|NCT00969761|582854632|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401012|NCT00969761|582854633|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401013|NCT00969761|582854634|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401014|NCT00969761|582854635|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401015|NCT00969761|582854636|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
161401016|NCT00969761|582854637|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401017|NCT00969761|582854638|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401018|NCT00969761|582854639|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161401019|NCT00969761|582854628|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
161401020|NCT00969761|582854629|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161401021|NCT00969761|582854630|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
161401022|NCT00969761|582854631|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161401023|NCT00969761|582854632|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
161401024|NCT00969761|582854633|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161401025|NCT00969761|582854634|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161401026|NCT00969761|582854635|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
161401027|NCT00969761|582854636|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
161401028|NCT00969761|582854637|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
161401029|NCT00969761|582854638|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161401030|NCT00969761|582854639|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161401031|NCT00969761|582854628|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401032|NCT00969761|582854629|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401033|NCT00969761|582854630|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401034|NCT00969761|582854631|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
161401035|NCT00969761|582854632|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
161401036|NCT00969761|582854633|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401037|NCT00969761|582854634|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401038|NCT00969761|582854635|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401039|NCT00969761|582854636|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
161401040|NCT00969761|582854637|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401041|NCT00969761|582854638|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401042|NCT00969761|582854639|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161401043|NCT03081858|582856265|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
161401044|NCT03081858|582856266|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
161401045|NCT03081858|582856267|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
161401046|NCT03081858|582856268|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
161401047|NCT02936284|582856271|FG000|Overall Study|Withdrawal by Subject|3|||
161401048|NCT02936284|582856272|FG001|Overall Study|Withdrawal by Subject|1|||
161401049|NCT02936284|582856271|FG000|Overall Study|Lost to Follow-up|7|||
161401050|NCT02936284|582856272|FG001|Overall Study|Lost to Follow-up|8|||
161401051|NCT01610596|582856275|FG000|Overall Study|Lost to Follow-up|0|||
161401052|NCT01610596|582856276|FG001|Overall Study|Lost to Follow-up|1|||
161401053|NCT00799591|582856277|FG000|Overall Study|De-escalation of doses|20|||
161401054|NCT00799591|582856277|FG000|Overall Study|Death|14|||
161401055|NCT00799591|582856277|FG000|Overall Study|Technical failure|12|||
161401056|NCT00799591|582856277|FG000|Overall Study|Resistant germ|11|||
161401057|NCT00799591|582856277|FG000|Overall Study|New infection|4|||
161401058|NCT00799591|582856277|FG000|Overall Study|Resistance germ and technical failure|2|||
161401059|NCT00799591|582856277|FG000|Overall Study|Persistance of fever undetermined origin|1|||
161401060|NCT00799591|582856277|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
161401061|NCT00799591|582856277|FG000|Overall Study|Infectious origin not probable|1|||
161401062|NCT02098369|582856281|FG000|Overall Study|Withdrawal by Subject|1|||
161401063|NCT02098369|582856282|FG001|Overall Study|Withdrawal by Subject|5|||
161401064|NCT02098369|582856283|FG002|Overall Study|Withdrawal by Subject|0|||
161401065|NCT02098369|582856281|FG000|Overall Study|Lost to Follow-up|5|||
161401066|NCT02098369|582856282|FG001|Overall Study|Lost to Follow-up|1|||
161401067|NCT02098369|582856283|FG002|Overall Study|Lost to Follow-up|3|||
161401068|NCT02098369|582856281|FG000|Overall Study|Death|1|||
161401069|NCT02098369|582856282|FG001|Overall Study|Death|1|||
161401070|NCT02098369|582856283|FG002|Overall Study|Death|1|||
161401071|NCT02098369|582856281|FG000|Overall Study|Other|0|||
161401072|NCT02098369|582856282|FG001|Overall Study|Other|2|||
161401073|NCT02098369|582856283|FG002|Overall Study|Other|1|||
161401074|NCT02046174|582856286|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
161401075|NCT02046174|582856287|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
161401076|NCT00413920|582856288|FG000|Overall Study|Adverse Event|9|||
161401077|NCT00413920|582856289|FG001|Overall Study|Adverse Event|11|||
161401078|NCT00413920|582856288|FG000|Overall Study|Lack of Efficacy|11|||
161401079|NCT00413920|582856289|FG001|Overall Study|Lack of Efficacy|9|||
161401080|NCT00413920|582856288|FG000|Overall Study|Death|3|||
161401081|NCT00413920|582856289|FG001|Overall Study|Death|5|||
161401082|NCT00413920|582856288|FG000|Overall Study|Graft Loss|5|||
161401083|NCT00413920|582856289|FG001|Overall Study|Graft Loss|3|||
161401084|NCT00186537|582856292|FG000|Overall Study|Withdrawal by Subject|4|||
161401085|NCT00186537|582856293|FG001|Overall Study|Withdrawal by Subject|0|||
161401086|NCT00186537|582856294|FG002|Overall Study|Withdrawal by Subject|3|||
161401087|NCT00186537|582856292|FG000|Overall Study|ALT > 1.5 x ULN|3|||
161401088|NCT00186537|582856293|FG001|Overall Study|ALT > 1.5 x ULN|0|||
161401089|NCT00186537|582856294|FG002|Overall Study|ALT > 1.5 x ULN|0|||
161401090|NCT01765426|582856295|FG000|Overall Study|Lost to Follow-up|0|||
161401091|NCT01765426|582856296|FG001|Overall Study|Lost to Follow-up|1|||
161401092|NCT01765426|582856297|FG002|Overall Study|Lost to Follow-up|0|||
161401093|NCT01765426|582856298|FG003|Overall Study|Lost to Follow-up|0|||
161401094|NCT01665430|582856299|FG000|Overall Study|Adverse Event|1|||
161401095|NCT01665430|582856299|FG000|Overall Study|Withdrawal by Subject|6|||
161401096|NCT01665430|582856299|FG000|Overall Study|Other Unspecified|2|||
161401097|NCT02310230|582856300|FG000|Overall Study|Physician Decision|1|||
161401098|NCT02310230|582856301|FG001|Overall Study|Physician Decision|3|||
161401099|NCT02310230|582856300|FG000|Overall Study|monitor baseline taken after induction|2|||
161401100|NCT02310230|582856301|FG001|Overall Study|monitor baseline taken after induction|7|||
161401101|NCT02310230|582856300|FG000|Overall Study|Poor signal quality|5|||
161401102|NCT02310230|582856301|FG001|Overall Study|Poor signal quality|8|||
161401103|NCT02310230|582856300|FG000|Overall Study|Case cancelled|1|||
161401104|NCT02310230|582856301|FG001|Overall Study|Case cancelled|0|||
161401105|NCT03593681|582856302|FG000|Overall Study|Inadequate sample collected|12|||
161401106|NCT03593681|582856302|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
161401107|NCT03593681|582856302|FG000|Overall Study|Protocol Violation|3|||
161401108|NCT03593681|582856302|FG000|Overall Study|Withdrawal by Subject|3|||
161401109|NCT03593681|582856302|FG000|Overall Study|Procedure not attempted|3|||
161401110|NCT03593681|582856302|FG000|Overall Study|Adverse Event|2|||
161401111|NCT03593681|582856302|FG000|Overall Study|Physician Decision|1|||
161401112|NCT01149486|582856303|FG000|First Intervention|Adverse Event|0|||
161401113|NCT01149486|582856304|FG001|First Intervention|Adverse Event|1|||
161401114|NCT04662073|582856305|FG000|Overall Study|Withdrawal by Subject|1|||
161401115|NCT04662073|582856306|FG001|Overall Study|Withdrawal by Subject|0|||
161401116|NCT00598078|582856307|FG000|Period 2 (Day 2)|Adverse Event|1|||
161401117|NCT00598078|582856308|FG001|Period 2 (Day 2)|Adverse Event|0|||
161401118|NCT01479595|582856311|FG000|Overall Study|Protocol deviation|0|||
161401119|NCT01479595|582856312|FG001|Overall Study|Protocol deviation|1|||
161401120|NCT01479595|582856311|FG000|Overall Study|Adverse Event|2|||
161401121|NCT01479595|582856312|FG001|Overall Study|Adverse Event|1|||
161401122|NCT03366103|582856313|FG000|Overall Study|Disease Progression|3|||
161401123|NCT03366103|582856314|FG001|Overall Study|Disease Progression|1|||
161401124|NCT03366103|582856315|FG002|Overall Study|Disease Progression|0|||
161401125|NCT03366103|582856313|FG000|Overall Study|Adverse Event|0|||
161401126|NCT03366103|582856314|FG001|Overall Study|Adverse Event|1|||
161401127|NCT03366103|582856315|FG002|Overall Study|Adverse Event|0|||
161401128|NCT01344629|582856318|FG000|Crossover Period 2|Withdrawal by Subject|0|||
161401129|NCT01344629|582856319|FG001|Crossover Period 2|Withdrawal by Subject|1|||
161401130|NCT00900146|582856320|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
161401131|NCT00900146|582856321|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
161401132|NCT00900146|582856322|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
161401133|NCT00900146|582856323|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
161401134|NCT00900146|582856324|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
161401135|NCT00900146|582856320|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
161401136|NCT00900146|582856321|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
161401137|NCT00900146|582856322|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
161401138|NCT00900146|582856323|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
161401139|NCT00900146|582856324|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
161401140|NCT00900146|582856320|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
161401141|NCT00900146|582856321|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161401142|NCT00900146|582856322|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161401143|NCT00900146|582856323|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161401144|NCT00900146|582856324|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161401145|NCT00900146|582856320|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
161401146|NCT00900146|582856321|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
161401147|NCT00900146|582856322|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
161401148|NCT00900146|582856323|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
161401149|NCT00900146|582856324|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
161401150|NCT00900146|582856320|FG000|Intermediate: Period III|Lost to Follow-up|2|||
161401151|NCT00900146|582856321|FG001|Intermediate: Period III|Lost to Follow-up|0|||
161401152|NCT00900146|582856322|FG002|Intermediate: Period III|Lost to Follow-up|0|||
161401153|NCT00900146|582856323|FG003|Intermediate: Period III|Lost to Follow-up|0|||
161401154|NCT00900146|582856324|FG004|Intermediate: Period III|Lost to Follow-up|1|||
161401155|NCT00900146|582856320|FG000|Intermediate: Period III|Administrative problems|85|||
161401156|NCT00900146|582856321|FG001|Intermediate: Period III|Administrative problems|92|||
161401157|NCT00900146|582856322|FG002|Intermediate: Period III|Administrative problems|84|||
161401158|NCT00900146|582856323|FG003|Intermediate: Period III|Administrative problems|90|||
161401159|NCT00900146|582856324|FG004|Intermediate: Period III|Administrative problems|163|||
161401160|NCT05590000|582856328|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
161401161|NCT02689076|582856329|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
161401162|NCT02689076|582856330|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
161401163|NCT02689076|582856331|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
161401164|NCT02689076|582856329|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
161401165|NCT02689076|582856330|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
161401166|NCT02689076|582856331|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
161401167|NCT02689076|582856329|FG000|Overall Study|Did not have an HIE match|2|||
161401168|NCT02689076|582856330|FG001|Overall Study|Did not have an HIE match|0|||
161401169|NCT02689076|582856331|FG002|Overall Study|Did not have an HIE match|0|||
161401170|NCT02689076|582856329|FG000|Overall Study|Death during non-VA encounter|2|||
161401171|NCT02689076|582856330|FG001|Overall Study|Death during non-VA encounter|5|||
161401172|NCT02689076|582856331|FG002|Overall Study|Death during non-VA encounter|0|||
161401173|NCT02689076|582856329|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
161401174|NCT02689076|582856330|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
161401175|NCT02689076|582856331|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
161401176|NCT02689076|582856329|FG000|Overall Study|Participant no longer active in VA system|1|||
161401177|NCT02689076|582856330|FG001|Overall Study|Participant no longer active in VA system|0|||
161401178|NCT02689076|582856331|FG002|Overall Study|Participant no longer active in VA system|0|||
161401179|NCT02689076|582856329|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
161401180|NCT02689076|582856330|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
161401181|NCT02689076|582856331|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
161401182|NCT01174004|582856332|FG000|Overall Study|Adverse Event|2|||
161401183|NCT01174004|582856333|FG001|Overall Study|Adverse Event|10|||
161401184|NCT01174004|582856332|FG000|Overall Study|Withdrawal by Subject|2|||
161401185|NCT01174004|582856333|FG001|Overall Study|Withdrawal by Subject|3|||
161401186|NCT01174004|582856332|FG000|Overall Study|At Discretion of Sponsor|2|||
161401187|NCT01174004|582856333|FG001|Overall Study|At Discretion of Sponsor|2|||
161401188|NCT01174004|582856332|FG000|Overall Study|Protocol Violation|0|||
161401189|NCT01174004|582856333|FG001|Overall Study|Protocol Violation|1|||
161401190|NCT01174004|582856332|FG000|Overall Study|Physician Decision|1|||
161401191|NCT01174004|582856333|FG001|Overall Study|Physician Decision|0|||
161401192|NCT00933244|582856334|FG000|Overall Study|Withdrawal by Subject|5|||
161401193|NCT00933244|582856335|FG001|Overall Study|Withdrawal by Subject|1|||
161401194|NCT00933244|582856336|FG002|Overall Study|Withdrawal by Subject|3|||
161401195|NCT01143896|582856342|FG000|Overall Study|Did not complete Baseline Interview|5|||
161401196|NCT01143896|582856343|FG001|Overall Study|Did not complete Baseline Interview|4|||
161401197|NCT01143896|582856342|FG000|Overall Study|Lost to Follow-up|18|||
161401198|NCT01143896|582856343|FG001|Overall Study|Lost to Follow-up|13|||
161401199|NCT01143896|582856342|FG000|Overall Study|Withdrawal by Subject|13|||
161401200|NCT01143896|582856343|FG001|Overall Study|Withdrawal by Subject|5|||
161401201|NCT01143896|582856342|FG000|Overall Study|Death|6|||
161401202|NCT01143896|582856343|FG001|Overall Study|Death|3|||
161401203|NCT01318070|582856344|FG000|Overall Study|Adverse Event|1|||
161401204|NCT01318070|582856345|FG001|Overall Study|Adverse Event|1|||
161401205|NCT01318070|582856346|FG002|Overall Study|Adverse Event|5|||
161401206|NCT01318070|582856344|FG000|Overall Study|Withdrawal by Subject|0|||
161401207|NCT01318070|582856345|FG001|Overall Study|Withdrawal by Subject|1|||
161401208|NCT01318070|582856346|FG002|Overall Study|Withdrawal by Subject|1|||
161401209|NCT01318070|582856344|FG000|Overall Study|Lack of Efficacy|0|||
161401210|NCT01318070|582856345|FG001|Overall Study|Lack of Efficacy|0|||
161401211|NCT01318070|582856346|FG002|Overall Study|Lack of Efficacy|1|||
161401212|NCT01318070|582856344|FG000|Overall Study|Principal Investigator Discretion|1|||
161401213|NCT01318070|582856345|FG001|Overall Study|Principal Investigator Discretion|0|||
161401214|NCT01318070|582856346|FG002|Overall Study|Principal Investigator Discretion|0|||
161401215|NCT00042432|582856351|FG000|Overall Study|Adverse Event|4|||
161401216|NCT00042432|582856352|FG001|Overall Study|Adverse Event|1|||
161401217|NCT00042432|582856351|FG000|Overall Study|Withdrawal by Subject|1|||
161401218|NCT00042432|582856352|FG001|Overall Study|Withdrawal by Subject|3|||
161401219|NCT00042432|582856351|FG000|Overall Study|Death|0|||
161401220|NCT00042432|582856352|FG001|Overall Study|Death|2|||
161401221|NCT00042432|582856351|FG000|Overall Study|Ineligibility determined|1|||
161401222|NCT00042432|582856352|FG001|Overall Study|Ineligibility determined|0|||
161401223|NCT00042432|582856351|FG000|Overall Study|Initiation of maintenance dialysis|1|||
161401224|NCT00042432|582856352|FG001|Overall Study|Initiation of maintenance dialysis|1|||
161401225|NCT00042432|582856351|FG000|Overall Study|Other|2|||
161401226|NCT00042432|582856352|FG001|Overall Study|Other|0|||
161401227|NCT00334282|582856358|FG000|Overall Study|Lost to Follow-up|11|||
161401228|NCT00334282|582856359|FG001|Overall Study|Lost to Follow-up|5|||
161401229|NCT00334282|582856358|FG000|Overall Study|Withdrawal by Subject|17|||
161401230|NCT00334282|582856359|FG001|Overall Study|Withdrawal by Subject|3|||
161401231|NCT00334282|582856358|FG000|Overall Study|Death|194|||
161401232|NCT00334282|582856359|FG001|Overall Study|Death|100|||
161401233|NCT00276094|582856364|FG000|Overall Study|Adverse Event|15|||
161401234|NCT00276094|582856365|FG001|Overall Study|Adverse Event|13|||
161401235|NCT00276094|582856366|FG002|Overall Study|Adverse Event|11|||
161401236|NCT00276094|582856364|FG000|Overall Study|Withdrawal by Subject|14|||
161401237|NCT00276094|582856365|FG001|Overall Study|Withdrawal by Subject|14|||
161401238|NCT00276094|582856366|FG002|Overall Study|Withdrawal by Subject|12|||
161401239|NCT00276094|582856364|FG000|Overall Study|Protocol Violation|16|||
161401240|NCT00276094|582856365|FG001|Overall Study|Protocol Violation|7|||
161401241|NCT00276094|582856366|FG002|Overall Study|Protocol Violation|10|||
161401242|NCT00276094|582856364|FG000|Overall Study|Lost to Follow-up|8|||
161401243|NCT00276094|582856365|FG001|Overall Study|Lost to Follow-up|6|||
161401244|NCT00276094|582856366|FG002|Overall Study|Lost to Follow-up|4|||
161401245|NCT00276094|582856364|FG000|Overall Study|Other-Subject moved out of country|1|||
161401246|NCT00276094|582856365|FG001|Overall Study|Other-Subject moved out of country|0|||
161401247|NCT00276094|582856366|FG002|Overall Study|Other-Subject moved out of country|0|||
161401248|NCT00276094|582856364|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
161401249|NCT00276094|582856365|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
161401250|NCT00276094|582856366|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
161401251|NCT00276094|582856364|FG000|Overall Study|Other-Lack of efficacy|1|||
161401252|NCT00276094|582856365|FG001|Overall Study|Other-Lack of efficacy|0|||
161401253|NCT00276094|582856366|FG002|Overall Study|Other-Lack of efficacy|0|||
161401254|NCT00276094|582856364|FG000|Overall Study|Other-Refused follow-up visit|1|||
161401255|NCT00276094|582856365|FG001|Overall Study|Other-Refused follow-up visit|0|||
161401256|NCT00276094|582856366|FG002|Overall Study|Other-Refused follow-up visit|0|||
161401257|NCT00276094|582856364|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
161401258|NCT00276094|582856365|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
161401259|NCT00276094|582856366|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
161401260|NCT00276094|582856364|FG000|Overall Study|Other-Relocation|0|||
161401261|NCT00276094|582856365|FG001|Overall Study|Other-Relocation|1|||
161401262|NCT00276094|582856366|FG002|Overall Study|Other-Relocation|0|||
161401263|NCT00276094|582856364|FG000|Overall Study|Other-Study medication lost|0|||
161401264|NCT00276094|582856365|FG001|Overall Study|Other-Study medication lost|0|||
161401265|NCT00276094|582856366|FG002|Overall Study|Other-Study medication lost|1|||
161401266|NCT00787137|582856369|FG000|Overall Study|Study Termination|0|||
161401267|NCT00787137|582856370|FG001|Overall Study|Study Termination|0|||
161401268|NCT00787137|582856371|FG002|Overall Study|Study Termination|1|||
161401269|NCT00554099|582856373|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
161401270|NCT00554099|582856374|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
161401271|NCT00554099|582856375|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
161401272|NCT00554099|582856373|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
161401273|NCT00554099|582856374|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
161401274|NCT00554099|582856375|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
161401275|NCT00554099|582856373|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161401276|NCT00554099|582856374|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161401277|NCT00554099|582856375|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
161401278|NCT00554099|582856373|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
161401279|NCT00554099|582856374|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
161401280|NCT00554099|582856375|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
161401281|NCT00554099|582856373|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
161401282|NCT00554099|582856374|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
161401283|NCT00554099|582856375|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
161401284|NCT00554099|582856373|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161401285|NCT00554099|582856374|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161401286|NCT00554099|582856375|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161401287|NCT00554099|582856373|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
161401288|NCT00554099|582856374|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
161401289|NCT00554099|582856375|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
161401290|NCT00554099|582856373|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
161401291|NCT00554099|582856374|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
161401292|NCT00554099|582856375|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
161401293|NCT00554099|582856373|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
161401294|NCT00554099|582856374|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
161401295|NCT00554099|582856375|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
161401296|NCT02075632|582856376|FG000|Overall Study|Adverse Event|1|||
161401297|NCT02075632|582856377|FG001|Overall Study|Adverse Event|1|||
161401298|NCT02075632|582856376|FG000|Overall Study|Lost to Follow-up|0|||
161401299|NCT02075632|582856377|FG001|Overall Study|Lost to Follow-up|3|||
161401300|NCT02075632|582856376|FG000|Overall Study|Withdrawal by Subject|0|||
161401301|NCT02075632|582856377|FG001|Overall Study|Withdrawal by Subject|1|||
161401302|NCT04957758|582856385|FG000|Overall Study|Adverse Event|1|||
161401303|NCT04957758|582856386|FG001|Overall Study|Adverse Event|0|||
161401304|NCT04957758|582856385|FG000|Overall Study|Lost to Follow-up|0|||
161401305|NCT04957758|582856386|FG001|Overall Study|Lost to Follow-up|2|||
161401306|NCT04957758|582856385|FG000|Overall Study|Withdrawal by Subject|4|||
161401307|NCT04957758|582856386|FG001|Overall Study|Withdrawal by Subject|2|||
161401308|NCT04957758|582856385|FG000|Overall Study|Protocol Violation|0|||
161401309|NCT04957758|582856386|FG001|Overall Study|Protocol Violation|1|||
161401310|NCT03353922|582856387|FG000|Overall Study|Withdrawal by Subject|1|||
161401311|NCT03353922|582856388|FG001|Overall Study|Withdrawal by Subject|0|||
161401312|NCT03353922|582856389|FG002|Overall Study|Withdrawal by Subject|1|||
161401313|NCT03353922|582856390|FG003|Overall Study|Withdrawal by Subject|1|||
161401314|NCT03353922|582856391|FG004|Overall Study|Withdrawal by Subject|0|||
161401315|NCT03353922|582856392|FG005|Overall Study|Withdrawal by Subject|0|||
161401316|NCT03353922|582856387|FG000|Overall Study|Adverse Event|0|||
161401317|NCT03353922|582856388|FG001|Overall Study|Adverse Event|1|||
161401318|NCT03353922|582856389|FG002|Overall Study|Adverse Event|0|||
161401319|NCT03353922|582856390|FG003|Overall Study|Adverse Event|0|||
161401320|NCT03353922|582856391|FG004|Overall Study|Adverse Event|0|||
161401321|NCT03353922|582856392|FG005|Overall Study|Adverse Event|0|||
161401322|NCT00740714|582856393|FG000|Overall Study|Withdrawal by Subject|17|||
161401323|NCT00740714|582856394|FG001|Overall Study|Withdrawal by Subject|19|||
161401324|NCT00740714|582856395|FG002|Overall Study|Withdrawal by Subject|29|||
161401325|NCT03688555|582856396|FG000|Treatment Period|Adverse Event|0|||
161401326|NCT03688555|582856397|FG001|Treatment Period|Adverse Event|0|||
161401327|NCT03688555|582856398|FG002|Treatment Period|Adverse Event|1|||
161401328|NCT00886119|582856402|FG000|Period 1|Did not meet inclusion criteria|1|||
161401329|NCT00886119|582856403|FG001|Period 1|Did not meet inclusion criteria|0|||
161401330|NCT00394901|582856404|FG000|Baseline Phase|Protocol Violation|0|||
161401331|NCT00394901|582856405|FG001|Baseline Phase|Protocol Violation|0|||
161401332|NCT00394901|582856406|FG002|Baseline Phase|Protocol Violation|1|||
161401333|NCT00394901|582856407|FG003|Baseline Phase|Protocol Violation|0|||
161401334|NCT00394901|582856404|FG000|Double-blind Phase|Adverse Event|5|||
161401335|NCT00394901|582856405|FG001|Double-blind Phase|Adverse Event|7|||
161401336|NCT00394901|582856406|FG002|Double-blind Phase|Adverse Event|16|||
161401337|NCT00394901|582856407|FG003|Double-blind Phase|Adverse Event|20|||
161401338|NCT00394901|582856404|FG000|Double-blind Phase|Lack of Efficacy|6|||
161401339|NCT00394901|582856405|FG001|Double-blind Phase|Lack of Efficacy|4|||
161401340|NCT00394901|582856406|FG002|Double-blind Phase|Lack of Efficacy|1|||
161401341|NCT00394901|582856407|FG003|Double-blind Phase|Lack of Efficacy|3|||
161401342|NCT00394901|582856404|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161401343|NCT00394901|582856405|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161401344|NCT00394901|582856406|FG002|Double-blind Phase|Withdrawal by Subject|0|||
161401345|NCT00394901|582856407|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161401346|NCT00394901|582856404|FG000|Double-blind Phase|Lost to Follow-up|0|||
161401347|NCT00394901|582856405|FG001|Double-blind Phase|Lost to Follow-up|0|||
161401348|NCT00394901|582856406|FG002|Double-blind Phase|Lost to Follow-up|0|||
161401349|NCT00394901|582856407|FG003|Double-blind Phase|Lost to Follow-up|1|||
161401350|NCT00394901|582856404|FG000|Double-blind Phase|Protocol Violation|0|||
161401351|NCT00394901|582856405|FG001|Double-blind Phase|Protocol Violation|0|||
161401352|NCT00394901|582856406|FG002|Double-blind Phase|Protocol Violation|0|||
161401353|NCT00394901|582856407|FG003|Double-blind Phase|Protocol Violation|1|||
161401354|NCT00394901|582856404|FG000|Double-blind Phase|Death|1|||
161401355|NCT00394901|582856405|FG001|Double-blind Phase|Death|0|||
161401356|NCT00394901|582856406|FG002|Double-blind Phase|Death|0|||
161401357|NCT00394901|582856407|FG003|Double-blind Phase|Death|0|||
161401358|NCT00394901|582856404|FG000|Double-blind Phase|Subject's Personal Reason|1|||
161401359|NCT00394901|582856405|FG001|Double-blind Phase|Subject's Personal Reason|0|||
161401360|NCT00394901|582856406|FG002|Double-blind Phase|Subject's Personal Reason|0|||
161401361|NCT00394901|582856407|FG003|Double-blind Phase|Subject's Personal Reason|1|||
161401362|NCT00394901|582856404|FG000|Double-blind Phase|Lack of Compliance|0|||
161401363|NCT00394901|582856405|FG001|Double-blind Phase|Lack of Compliance|3|||
161401364|NCT00394901|582856406|FG002|Double-blind Phase|Lack of Compliance|0|||
161401365|NCT00394901|582856407|FG003|Double-blind Phase|Lack of Compliance|0|||
161401366|NCT00394901|582856404|FG000|Double-blind Phase|Entry into another study was found|0|||
161401367|NCT00394901|582856405|FG001|Double-blind Phase|Entry into another study was found|0|||
161401368|NCT00394901|582856406|FG002|Double-blind Phase|Entry into another study was found|1|||
161401369|NCT00394901|582856407|FG003|Double-blind Phase|Entry into another study was found|0|||
161401370|NCT00394901|582856404|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
161401371|NCT00394901|582856405|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
161401372|NCT00394901|582856406|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
161401373|NCT00394901|582856407|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
161401374|NCT01367704|582856413|FG000|Overall Study|Lost to Follow-up|47|||
161401375|NCT01367704|582856414|FG001|Overall Study|Lost to Follow-up|161|||
161401376|NCT03158272|582856419|FG000|Overall Study|Disease progression|3|||
161401377|NCT03158272|582856420|FG001|Overall Study|Disease progression|3|||
161401378|NCT03158272|582856421|FG002|Overall Study|Disease progression|4|||
161401379|NCT03158272|582856422|FG003|Overall Study|Disease progression|6|||
161401380|NCT03158272|582856419|FG000|Overall Study|Death|0|||
161401381|NCT03158272|582856420|FG001|Overall Study|Death|0|||
161401382|NCT03158272|582856421|FG002|Overall Study|Death|1|||
161401383|NCT03158272|582856422|FG003|Overall Study|Death|0|||
161401384|NCT03158272|582856419|FG000|Overall Study|Other reasons|0|||
161401385|NCT03158272|582856420|FG001|Overall Study|Other reasons|0|||
161401386|NCT03158272|582856421|FG002|Overall Study|Other reasons|1|||
161401387|NCT03158272|582856422|FG003|Overall Study|Other reasons|0|||
161401388|NCT03158272|582856419|FG000|Overall Study|Adverse event unrelated to the drug|0|||
161401389|NCT03158272|582856420|FG001|Overall Study|Adverse event unrelated to the drug|1|||
161401390|NCT03158272|582856421|FG002|Overall Study|Adverse event unrelated to the drug|0|||
161401391|NCT03158272|582856422|FG003|Overall Study|Adverse event unrelated to the drug|0|||
161401392|NCT01688921|582856423|FG000|Overall Study|Lost to Follow-up|7|||
161401393|NCT01688921|582856424|FG001|Overall Study|Lost to Follow-up|13|||
161401394|NCT01688921|582856423|FG000|Overall Study|Physician Decision|6|||
161401395|NCT01688921|582856424|FG001|Overall Study|Physician Decision|1|||
161401396|NCT01688921|582856423|FG000|Overall Study|Protocol Violation|0|||
161401397|NCT01688921|582856424|FG001|Overall Study|Protocol Violation|1|||
161401398|NCT01688921|582856423|FG000|Overall Study|informed consent|3|||
161401399|NCT01688921|582856424|FG001|Overall Study|informed consent|0|||
161401400|NCT00664326|582857942|FG000|Overall Study|Adverse Event|14|||
161401401|NCT00664326|582857942|FG000|Overall Study|Noncompliance with study medication|3|||
161401402|NCT00664326|582857942|FG000|Overall Study|Withdrawal by Subject|1|||
161401403|NCT00664326|582857942|FG000|Overall Study|Physician Decision|1|||
161401404|NCT00664326|582857942|FG000|Overall Study|Other Reasons|3|||
161401405|NCT00664326|582857942|FG000|Overall Study|Death|2|||
161401406|NCT00664326|582857942|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
161401407|NCT00262847|582857943|FG000|Overall Study|Disease Progression|309|||
161401408|NCT00262847|582857944|FG001|Overall Study|Disease Progression|274|||
161401409|NCT00262847|582857945|FG002|Overall Study|Disease Progression|195|||
161401410|NCT00262847|582857943|FG000|Overall Study|Patient Refusal|41|||
161401411|NCT00262847|582857944|FG001|Overall Study|Patient Refusal|52|||
161401412|NCT00262847|582857945|FG002|Overall Study|Patient Refusal|47|||
161401413|NCT00262847|582857943|FG000|Overall Study|Adverse Event|74|||
161401414|NCT00262847|582857944|FG001|Overall Study|Adverse Event|88|||
161401415|NCT00262847|582857945|FG002|Overall Study|Adverse Event|108|||
161401416|NCT00262847|582857943|FG000|Overall Study|Death|8|||
161401417|NCT00262847|582857944|FG001|Overall Study|Death|8|||
161401418|NCT00262847|582857945|FG002|Overall Study|Death|11|||
161401419|NCT00262847|582857943|FG000|Overall Study|Concomitant disease|3|||
161401420|NCT00262847|582857944|FG001|Overall Study|Concomitant disease|2|||
161401421|NCT00262847|582857945|FG002|Overall Study|Concomitant disease|4|||
161401422|NCT00262847|582857943|FG000|Overall Study|Other Reasons|79|||
161401423|NCT00262847|582857944|FG001|Overall Study|Other Reasons|88|||
161401424|NCT00262847|582857945|FG002|Overall Study|Other Reasons|27|||
161401425|NCT00262847|582857943|FG000|Overall Study|Did not receive study treatment|4|||
161401426|NCT00262847|582857944|FG001|Overall Study|Did not receive study treatment|1|||
161401427|NCT00262847|582857945|FG002|Overall Study|Did not receive study treatment|4|||
161401428|NCT00387647|582857946|FG000|Overall Study|Death|18|||
161401429|NCT05160766|582857947|FG000|Overall Study|Adverse Event|0|||
161401430|NCT05160766|582857948|FG001|Overall Study|Adverse Event|1|||
161401431|NCT05160766|582857949|FG002|Overall Study|Adverse Event|0|||
161401432|NCT05160766|582857950|FG003|Overall Study|Adverse Event|0|||
161401433|NCT05160766|582857947|FG000|Overall Study|COVID-19 infection|0|||
161401434|NCT05160766|582857948|FG001|Overall Study|COVID-19 infection|1|||
161401435|NCT05160766|582857949|FG002|Overall Study|COVID-19 infection|0|||
161401436|NCT05160766|582857950|FG003|Overall Study|COVID-19 infection|0|||
161401437|NCT05160766|582857947|FG000|Overall Study|travel time|1|||
161401438|NCT05160766|582857948|FG001|Overall Study|travel time|0|||
161401439|NCT05160766|582857949|FG002|Overall Study|travel time|0|||
161401440|NCT05160766|582857950|FG003|Overall Study|travel time|1|||
161401441|NCT05160766|582857947|FG000|Overall Study|Withdrawal by Subject|3|||
161401442|NCT05160766|582857948|FG001|Overall Study|Withdrawal by Subject|5|||
161401443|NCT05160766|582857949|FG002|Overall Study|Withdrawal by Subject|4|||
161401444|NCT05160766|582857950|FG003|Overall Study|Withdrawal by Subject|2|||
161401445|NCT05160766|582857947|FG000|Overall Study|Death|0|||
161401446|NCT05160766|582857948|FG001|Overall Study|Death|0|||
161401447|NCT05160766|582857949|FG002|Overall Study|Death|2|||
161401448|NCT05160766|582857950|FG003|Overall Study|Death|5|||
161401449|NCT05160766|582857947|FG000|Overall Study|Lost to Follow-up|0|||
161401450|NCT05160766|582857948|FG001|Overall Study|Lost to Follow-up|0|||
161401451|NCT05160766|582857949|FG002|Overall Study|Lost to Follow-up|1|||
161401452|NCT05160766|582857950|FG003|Overall Study|Lost to Follow-up|2|||
161401453|NCT05160766|582857947|FG000|Overall Study|No show|0|||
161401454|NCT05160766|582857948|FG001|Overall Study|No show|0|||
161401455|NCT05160766|582857949|FG002|Overall Study|No show|1|||
161401456|NCT05160766|582857950|FG003|Overall Study|No show|1|||
161401457|NCT05160766|582857947|FG000|Overall Study|Physician Decision|0|||
161401458|NCT05160766|582857948|FG001|Overall Study|Physician Decision|0|||
161401459|NCT05160766|582857949|FG002|Overall Study|Physician Decision|0|||
161401460|NCT05160766|582857950|FG003|Overall Study|Physician Decision|1|||
161401461|NCT05160766|582857947|FG000|Overall Study|Protocol Violation|0|||
161401462|NCT05160766|582857948|FG001|Overall Study|Protocol Violation|0|||
161401463|NCT05160766|582857949|FG002|Overall Study|Protocol Violation|1|||
161401464|NCT05160766|582857950|FG003|Overall Study|Protocol Violation|0|||
161401465|NCT02943915|582857951|FG000|Overall Study|Withdrawal by Subject|2|||
161401466|NCT02943915|582857952|FG001|Overall Study|Withdrawal by Subject|1|||
161401467|NCT02943915|582857953|FG002|Overall Study|Withdrawal by Subject|0|||
161401468|NCT02943915|582857954|FG003|Overall Study|Withdrawal by Subject|0|||
161401469|NCT02943915|582857951|FG000|Overall Study|Lost to Follow-up|3|||
161401470|NCT02943915|582857952|FG001|Overall Study|Lost to Follow-up|1|||
161401471|NCT02943915|582857953|FG002|Overall Study|Lost to Follow-up|0|||
161401472|NCT02943915|582857954|FG003|Overall Study|Lost to Follow-up|0|||
161401473|NCT02943915|582857951|FG000|Overall Study|excluded|0|||
161401474|NCT02943915|582857952|FG001|Overall Study|excluded|1|||
161401475|NCT02943915|582857953|FG002|Overall Study|excluded|0|||
161401476|NCT02943915|582857954|FG003|Overall Study|excluded|0|||
161401477|NCT03769311|582857955|FG000|Overall Study|Withdrawal by Subject|1|||
161401478|NCT03627065|582857956|FG000|Overall Study|Study Terminated by sponsor|1|||
161401479|NCT03627065|582857956|FG000|Overall Study|Withdrawal by Subject|2|||
161401480|NCT00076336|582857957|FG000|Overall Study|Death|13|||
161401481|NCT00076336|582857958|FG001|Overall Study|Death|17|||
161401482|NCT00076336|582857957|FG000|Overall Study|Adverse Event|4|||
161401483|NCT00076336|582857958|FG001|Overall Study|Adverse Event|4|||
161401484|NCT00076336|582857957|FG000|Overall Study|Lost to Follow-up|4|||
161401485|NCT00076336|582857958|FG001|Overall Study|Lost to Follow-up|4|||
161401486|NCT00076336|582857957|FG000|Overall Study|Non-Compliance|2|||
161401487|NCT00076336|582857958|FG001|Overall Study|Non-Compliance|0|||
161401488|NCT00076336|582857957|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
161401489|NCT00076336|582857958|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
161401490|NCT00076336|582857957|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
161401491|NCT00076336|582857958|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
161401492|NCT00076336|582857957|FG000|Overall Study|Liver Transplantation|3|||
161401493|NCT00076336|582857958|FG001|Overall Study|Liver Transplantation|3|||
161401494|NCT00076336|582857957|FG000|Overall Study|Virologic Breakthrough|14|||
161401495|NCT00076336|582857958|FG001|Overall Study|Virologic Breakthrough|16|||
161401496|NCT00076336|582857957|FG000|Overall Study|Treatment failure|4|||
161401497|NCT00076336|582857958|FG001|Overall Study|Treatment failure|5|||
161401498|NCT00524589|582857959|FG000|Overall Study|Withdrawal by Subject|2|||
161401499|NCT00524589|582857959|FG000|Overall Study|Disease Progression|16|||
161401500|NCT03351114|582857967|FG000|Overall Study|Withdrawal by Subject|1|||
161401501|NCT03249935|582857971|FG000|Overall Study|Discharged from facility early|36|||
161401502|NCT03249935|582857971|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
161401503|NCT03249935|582857971|FG000|Overall Study|Protocol Violation|5|||
161401504|NCT00989235|582857972|FG000|Overall Study|Death|0|||
161401505|NCT00989235|582857973|FG001|Overall Study|Death|1|||
161401506|NCT00989235|582857972|FG000|Overall Study|Adverse Event|0|||
161401507|NCT00989235|582857973|FG001|Overall Study|Adverse Event|1|||
161401508|NCT00989235|582857972|FG000|Overall Study|Lack of Efficacy|1|||
161401509|NCT00989235|582857973|FG001|Overall Study|Lack of Efficacy|0|||
161401510|NCT00989235|582857972|FG000|Overall Study|Withdrawal of Consent|1|||
161401511|NCT00989235|582857973|FG001|Overall Study|Withdrawal of Consent|1|||
161401512|NCT00989235|582857972|FG000|Overall Study|Desire to Become Pregnant|1|||
161401513|NCT00989235|582857973|FG001|Overall Study|Desire to Become Pregnant|0|||
161401514|NCT00989235|582857972|FG000|Overall Study|Randomized by Mistake|0|||
161401515|NCT00989235|582857973|FG001|Overall Study|Randomized by Mistake|2|||
161401516|NCT00989235|582857972|FG000|Overall Study|Lost to Follow-up|0|||
161401517|NCT00989235|582857973|FG001|Overall Study|Lost to Follow-up|1|||
161401518|NCT00545532|582857974|FG000|Overall Study|Withdrawal by Subject|1|||
161401519|NCT00545532|582857975|FG001|Overall Study|Withdrawal by Subject|3|||
161401520|NCT00545532|582857974|FG000|Overall Study|Lost to Follow-up|5|||
161401521|NCT00545532|582857975|FG001|Overall Study|Lost to Follow-up|6|||
161401522|NCT00545532|582857974|FG000|Overall Study|Death|0|||
161401523|NCT00545532|582857975|FG001|Overall Study|Death|1|||
161401524|NCT03630302|582857978|FG000|Surgery|hardware issue prevented LFP recordings|1|||
161401525|NCT03630302|582857978|FG000|3 Month Visit|Adverse Event|2|||
161401526|NCT03630302|582857978|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
161401527|NCT01135914|582857979|FG000|Overall Study|Withdrawal by Subject|1|||
161401528|NCT01135914|582857980|FG001|Overall Study|Withdrawal by Subject|3|||
161401529|NCT01135914|582857981|FG002|Overall Study|Withdrawal by Subject|6|||
161401530|NCT01135914|582857979|FG000|Overall Study|Lost to Follow-up|1|||
161401531|NCT01135914|582857980|FG001|Overall Study|Lost to Follow-up|0|||
161401532|NCT01135914|582857981|FG002|Overall Study|Lost to Follow-up|1|||
161401533|NCT01135914|582857979|FG000|Overall Study|Protocol Violation|0|||
161401534|NCT01135914|582857980|FG001|Overall Study|Protocol Violation|0|||
161401535|NCT01135914|582857981|FG002|Overall Study|Protocol Violation|3|||
161401536|NCT01135914|582857979|FG000|Overall Study|Lack of Efficacy|2|||
161401537|NCT01135914|582857980|FG001|Overall Study|Lack of Efficacy|1|||
161401538|NCT01135914|582857981|FG002|Overall Study|Lack of Efficacy|10|||
161401539|NCT01135914|582857979|FG000|Overall Study|Adverse Event|0|||
161401540|NCT01135914|582857980|FG001|Overall Study|Adverse Event|1|||
161401541|NCT01135914|582857981|FG002|Overall Study|Adverse Event|2|||
161401542|NCT01352741|582857986|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
161401543|NCT01352741|582857987|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
161401544|NCT01352741|582857986|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
161401545|NCT01352741|582857987|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
161401546|NCT01352741|582857986|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
161401547|NCT01352741|582857987|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
161401548|NCT01352741|582857986|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
161401549|NCT01352741|582857987|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
161401550|NCT01352741|582857986|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
161401551|NCT01352741|582857987|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
161401552|NCT01352741|582857986|FG000|Open-label Tapentadol Titration Period|Other|4|||
161401553|NCT01352741|582857987|FG001|Open-label Tapentadol Titration Period|Other|0|||
161401554|NCT01352741|582857986|FG000|Double-blind Comparative Period|Protocol Violation|2|||
161401555|NCT01352741|582857987|FG001|Double-blind Comparative Period|Protocol Violation|0|||
161401556|NCT01352741|582857986|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
161401557|NCT01352741|582857987|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
161401558|NCT01352741|582857986|FG000|Double-blind Comparative Period|Adverse Event|16|||
161401559|NCT01352741|582857987|FG001|Double-blind Comparative Period|Adverse Event|17|||
161401560|NCT01352741|582857986|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
161401561|NCT01352741|582857987|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
161401562|NCT01352741|582857986|FG000|Double-blind Comparative Period|Death|0|||
161401563|NCT01352741|582857987|FG001|Double-blind Comparative Period|Death|1|||
161401564|NCT01352741|582857986|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
161401565|NCT01352741|582857987|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
161401566|NCT01352741|582857986|FG000|Double-blind Comparative Period|Other|1|||
161401567|NCT01352741|582857987|FG001|Double-blind Comparative Period|Other|2|||
161401568|NCT01352741|582857986|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
161401569|NCT01352741|582857987|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
161401570|NCT01352741|582857986|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
161401571|NCT01352741|582857987|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
161401572|NCT01352741|582857986|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
161401573|NCT01352741|582857987|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
161401574|NCT01352741|582857986|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
161401575|NCT01352741|582857987|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
161401576|NCT00645528|582857988|FG000|Overall Study|Did not show up for Visit 2|7|||
161401577|NCT01886690|582857989|FG000|Overall Study|Protocol Violation|0|||
161401578|NCT01886690|582857990|FG001|Overall Study|Protocol Violation|1|||
161401579|NCT01886690|582857989|FG000|Overall Study|Personal Reasons|0|||
161401580|NCT01886690|582857990|FG001|Overall Study|Personal Reasons|1|||
161401581|NCT03618628|582857991|FG000|Overall Study|Death|1|||
161401582|NCT03618628|582857991|FG000|Overall Study|Lost to Follow-up|1|||
161401583|NCT01969500|582857992|FG000|Overall Study|Death|0|||
161401584|NCT01969500|582857993|FG001|Overall Study|Death|1|||
161401585|NCT01969500|582857992|FG000|Overall Study|extended hospitalization|1|||
161401586|NCT01969500|582857993|FG001|Overall Study|extended hospitalization|1|||
161401587|NCT02193087|582857994|FG000|Overall Study|Adverse Event|2|||
161401588|NCT02193087|582857995|FG001|Overall Study|Adverse Event|0|||
161401589|NCT02193087|582857996|FG002|Overall Study|Adverse Event|0|||
161401590|NCT02193087|582857997|FG003|Overall Study|Adverse Event|11|||
161401591|NCT02193087|582857994|FG000|Overall Study|Lost to Follow-up|14|||
161401592|NCT02193087|582857995|FG001|Overall Study|Lost to Follow-up|6|||
161401593|NCT02193087|582857996|FG002|Overall Study|Lost to Follow-up|4|||
161401594|NCT02193087|582857997|FG003|Overall Study|Lost to Follow-up|37|||
161401595|NCT02193087|582857994|FG000|Overall Study|Protocol Violation|2|||
161401596|NCT02193087|582857995|FG001|Overall Study|Protocol Violation|0|||
161401597|NCT02193087|582857996|FG002|Overall Study|Protocol Violation|1|||
161401598|NCT02193087|582857997|FG003|Overall Study|Protocol Violation|2|||
161401599|NCT02193087|582857994|FG000|Overall Study|Withdrawal by Subject|10|||
161401600|NCT02193087|582857995|FG001|Overall Study|Withdrawal by Subject|3|||
161401601|NCT02193087|582857996|FG002|Overall Study|Withdrawal by Subject|1|||
161401602|NCT02193087|582857997|FG003|Overall Study|Withdrawal by Subject|19|||
161401603|NCT02193087|582857994|FG000|Overall Study|Other Reason Not Specified|7|||
161401604|NCT02193087|582857995|FG001|Overall Study|Other Reason Not Specified|2|||
161401605|NCT02193087|582857996|FG002|Overall Study|Other Reason Not Specified|1|||
161401606|NCT02193087|582857997|FG003|Overall Study|Other Reason Not Specified|9|||
161401607|NCT02193087|582857994|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
161401608|NCT02193087|582857995|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
161401609|NCT02193087|582857996|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
161401610|NCT02193087|582857997|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
161401611|NCT04096820|582857998|FG000|Overall Study|Did not return for intervention|2|||
161401612|NCT04096820|582857998|FG000|Overall Study|Death|1|||
161401613|NCT02463032|582857999|FG000|Overall Study|Lack of Efficacy|61|||
161401614|NCT02463032|582858000|FG001|Overall Study|Lack of Efficacy|50|||
161401615|NCT02463032|582857999|FG000|Overall Study|Death|8|||
161401616|NCT02463032|582858000|FG001|Overall Study|Death|8|||
161401617|NCT02463032|582857999|FG000|Overall Study|Adverse Event|2|||
161401618|NCT02463032|582858000|FG001|Overall Study|Adverse Event|6|||
161401619|NCT00612508|582858001|FG000|Overall Study|Withdrawal by Subject|3|||
161401620|NCT00612508|582858002|FG001|Overall Study|Withdrawal by Subject|4|||
161401621|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
161401622|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
161401623|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
161401624|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
161401625|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
161401626|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
161401627|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
161401628|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
161401629|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
161401630|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
161401631|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
161401632|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
161401633|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
161401634|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
161401635|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
161401636|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
161401637|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
161401638|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
161401639|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
161401640|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
161401641|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
161401642|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
161401643|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
161401644|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
161401645|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
161401646|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
161401647|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
161401648|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
161401649|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
161401650|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
161401651|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
161401652|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
161401653|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
161401654|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
161401655|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
161401656|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
161401657|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
161401658|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
161401659|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
161401660|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
161401661|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
161401662|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
161401663|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
161401664|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
161401665|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
161401666|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
161401667|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
161435303|NCT00627393|582987983|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
161401668|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
161401669|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
161401670|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
161401671|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
161401672|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
161401673|NCT02008357|582858003|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
161401674|NCT02008357|582858004|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
161401675|NCT02008357|582858003|FG000|Open-label Extension Period|Adverse Event|8|||
161401676|NCT02008357|582858004|FG001|Open-label Extension Period|Adverse Event|7|||
161401677|NCT02008357|582858003|FG000|Open-label Extension Period|Death|7|||
161401678|NCT02008357|582858004|FG001|Open-label Extension Period|Death|4|||
161401679|NCT02008357|582858003|FG000|Open-label Extension Period|Lack of Efficacy|9|||
161401680|NCT02008357|582858004|FG001|Open-label Extension Period|Lack of Efficacy|5|||
161401681|NCT02008357|582858003|FG000|Open-label Extension Period|Lost to Follow-up|2|||
161401682|NCT02008357|582858004|FG001|Open-label Extension Period|Lost to Follow-up|2|||
161401683|NCT02008357|582858003|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
161401684|NCT02008357|582858004|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
161401685|NCT02008357|582858003|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
161401686|NCT02008357|582858004|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
161401687|NCT02008357|582858003|FG000|Open-label Extension Period|Safety Risk|2|||
161401688|NCT02008357|582858004|FG001|Open-label Extension Period|Safety Risk|1|||
161401689|NCT02008357|582858003|FG000|Open-label Extension Period|Non-Compliance|0|||
161401690|NCT02008357|582858004|FG001|Open-label Extension Period|Non-Compliance|1|||
161401691|NCT02008357|582858003|FG000|Open-label Extension Period|Investigator Recommendation|0|||
161401692|NCT02008357|582858004|FG001|Open-label Extension Period|Investigator Recommendation|1|||
161401693|NCT02008357|582858003|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
161401694|NCT02008357|582858004|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
161401695|NCT02008357|582858003|FG000|Open-label Extension Period|Coordinating Center Request|2|||
161401696|NCT02008357|582858004|FG001|Open-label Extension Period|Coordinating Center Request|4|||
161401697|NCT02008357|582858003|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
161401698|NCT02008357|582858004|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
161401699|NCT02008357|582858003|FG000|Open-label Extension Period|Study Ended|20|||
161401700|NCT02008357|582858004|FG001|Open-label Extension Period|Study Ended|25|||
161401701|NCT02008357|582858003|FG000|Open-label Extension Period|Personal Reasons|0|||
161401702|NCT02008357|582858004|FG001|Open-label Extension Period|Personal Reasons|1|||
161401703|NCT02008357|582858003|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
161401704|NCT02008357|582858004|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
161401705|NCT02008357|582858003|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
161401706|NCT02008357|582858004|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
161401707|NCT02008357|582858003|FG000|Open-label Extension Period|Other|2|||
161401708|NCT02008357|582858004|FG001|Open-label Extension Period|Other|0|||
161401709|NCT02312219|582858006|FG000|Overall Study|Withdrawal by Subject|1|||
161401710|NCT02312219|582858007|FG001|Overall Study|Withdrawal by Subject|2|||
161401711|NCT02312219|582858006|FG000|Overall Study|could not schedule imaging in time|0|||
161401712|NCT02312219|582858007|FG001|Overall Study|could not schedule imaging in time|2|||
161401713|NCT02312219|582858006|FG000|Overall Study|Other|0|||
161401714|NCT02312219|582858007|FG001|Overall Study|Other|1|||
161401715|NCT02312219|582858006|FG000|Overall Study|Not randomized. Ineligible|0|||
161401716|NCT02312219|582858007|FG001|Overall Study|Not randomized. Ineligible|1|||
161401717|NCT04941807|582858008|FG000|Overall Study|Lost to Follow-up|1|||
161401718|NCT04941807|582858009|FG001|Overall Study|Lost to Follow-up|1|||
161401719|NCT03553498|582858010|FG000|Overall Study|Missing primary outcome|1|||
161401720|NCT03553498|582858011|FG001|Overall Study|Missing primary outcome|2|||
161401721|NCT01100567|582858012|FG000|Overall Study|Withdrawal by Subject|5|||
161401722|NCT01100567|582858013|FG001|Overall Study|Withdrawal by Subject|8|||
161401723|NCT01100567|582858012|FG000|Overall Study|Early Hospital Discharge|6|||
161401724|NCT01100567|582858013|FG001|Overall Study|Early Hospital Discharge|4|||
161401725|NCT01100567|582858012|FG000|Overall Study|Lost to Follow-up|1|||
161401726|NCT01100567|582858013|FG001|Overall Study|Lost to Follow-up|2|||
161401727|NCT01100567|582858012|FG000|Overall Study|Physician Decision|0|||
161401728|NCT01100567|582858013|FG001|Overall Study|Physician Decision|1|||
161401729|NCT01100567|582858012|FG000|Overall Study|Deemed ineligible after consent|0|||
161401730|NCT01100567|582858013|FG001|Overall Study|Deemed ineligible after consent|1|||
161401731|NCT02741570|582858014|FG000|Pre-Treatment Period|Other reasons|0|||
161401732|NCT02741570|582858015|FG001|Pre-Treatment Period|Other reasons|3|||
161401733|NCT02741570|582858014|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
161401734|NCT02741570|582858015|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
161401735|NCT02741570|582858014|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
161401736|NCT02741570|582858015|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
161401737|NCT02741570|582858014|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
161401738|NCT02741570|582858015|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
161401739|NCT02741570|582858014|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161401740|NCT02741570|582858015|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
161401741|NCT02741570|582858014|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161401742|NCT02741570|582858015|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
161401743|NCT02741570|582858014|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161401744|NCT02741570|582858015|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161401745|NCT02741570|582858014|FG000|Pre-Treatment Period|Death|0|||
161401746|NCT02741570|582858015|FG001|Pre-Treatment Period|Death|1|||
161401747|NCT02741570|582858014|FG000|Pre-Treatment Period|Disease progression|0|||
161401748|NCT02741570|582858015|FG001|Pre-Treatment Period|Disease progression|1|||
161401749|NCT02741570|582858014|FG000|Treatment Period|Other reasons|47|||
161401750|NCT02741570|582858015|FG001|Treatment Period|Other reasons|12|||
161401751|NCT02741570|582858014|FG000|Treatment Period|Poor/non-compliance|0|||
161401752|NCT02741570|582858015|FG001|Treatment Period|Poor/non-compliance|2|||
161401753|NCT02741570|582858014|FG000|Treatment Period|Maximum clinical benefit|4|||
161401754|NCT02741570|582858015|FG001|Treatment Period|Maximum clinical benefit|6|||
161401755|NCT02741570|582858014|FG000|Treatment Period|Lost to Follow-up|1|||
161401756|NCT02741570|582858015|FG001|Treatment Period|Lost to Follow-up|3|||
161401757|NCT02741570|582858014|FG000|Treatment Period|Participant withdrew consent|9|||
161401758|NCT02741570|582858015|FG001|Treatment Period|Participant withdrew consent|13|||
161401759|NCT02741570|582858014|FG000|Treatment Period|Participant request to discontinue treatment|8|||
161401760|NCT02741570|582858015|FG001|Treatment Period|Participant request to discontinue treatment|23|||
161401761|NCT02741570|582858014|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
161401762|NCT02741570|582858015|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
161401763|NCT02741570|582858014|FG000|Treatment Period|Death|9|||
161401764|NCT02741570|582858015|FG001|Treatment Period|Death|7|||
161401765|NCT02741570|582858014|FG000|Treatment Period|Study drug toxicity|55|||
161401766|NCT02741570|582858015|FG001|Treatment Period|Study drug toxicity|47|||
161401767|NCT02741570|582858014|FG000|Treatment Period|Disease progression|294|||
161401768|NCT02741570|582858015|FG001|Treatment Period|Disease progression|301|||
161401769|NCT02741570|582858014|FG000|Treatment Period|Administrative reason by sponsor|0|||
161401770|NCT02741570|582858015|FG001|Treatment Period|Administrative reason by sponsor|1|||
161401771|NCT01498185|582858016|FG000|Overall Study|Adverse Event|0|||
161401772|NCT01498185|582858017|FG001|Overall Study|Adverse Event|0|||
161401773|NCT01498185|582858018|FG002|Overall Study|Adverse Event|0|||
161401774|NCT01498185|582858019|FG003|Overall Study|Adverse Event|1|||
161401775|NCT01498185|582858020|FG004|Overall Study|Adverse Event|0|||
161401776|NCT01498185|582858016|FG000|Overall Study|Withdrawal by Subject|1|||
161401777|NCT01498185|582858017|FG001|Overall Study|Withdrawal by Subject|1|||
161401778|NCT01498185|582858018|FG002|Overall Study|Withdrawal by Subject|0|||
161401779|NCT01498185|582858019|FG003|Overall Study|Withdrawal by Subject|2|||
161401780|NCT01498185|582858020|FG004|Overall Study|Withdrawal by Subject|1|||
161401781|NCT01498185|582858016|FG000|Overall Study|No longer met criteria, etc|0|||
161401782|NCT01498185|582858017|FG001|Overall Study|No longer met criteria, etc|0|||
161401783|NCT01498185|582858018|FG002|Overall Study|No longer met criteria, etc|0|||
161401784|NCT01498185|582858019|FG003|Overall Study|No longer met criteria, etc|0|||
161401785|NCT01498185|582858020|FG004|Overall Study|No longer met criteria, etc|2|||
161401786|NCT00946322|582858021|FG000|Pre-treatment|participant failure to follow up|1|||
161401787|NCT00946322|582858021|FG000|Post-treatment|participant failure to follow up|2|||
161401788|NCT01453946|582858022|FG000|Overall Study|Did not receive drug for the taper phase|1|||
161401789|NCT01453946|582858022|FG000|Overall Study|Protocol Violation|2|||
161401790|NCT01453946|582858022|FG000|Overall Study|Lack of Efficacy|3|||
161401791|NCT01453946|582858022|FG000|Overall Study|Adverse Event|3|||
161401792|NCT00846040|582858023|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
161401793|NCT00846040|582858024|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
161401794|NCT00846040|582858025|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
161401795|NCT00846040|582858023|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
161401796|NCT00846040|582858024|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
161401797|NCT00846040|582858025|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
161401798|NCT03352453|582858029|FG000|Overall Study|Miscellaneous Reasons|1|||
161401799|NCT03352453|582858030|FG001|Overall Study|Miscellaneous Reasons|2|||
161401800|NCT03352453|582858029|FG000|Overall Study|Lack of Efficacy|1|||
161401801|NCT03352453|582858030|FG001|Overall Study|Lack of Efficacy|0|||
161401802|NCT03352453|582858029|FG000|Overall Study|Withdrawal by Subject|8|||
161401803|NCT03352453|582858030|FG001|Overall Study|Withdrawal by Subject|14|||
161401804|NCT03352453|582858029|FG000|Overall Study|Study Terminated by Sponsor|2|||
161401805|NCT03352453|582858030|FG001|Overall Study|Study Terminated by Sponsor|1|||
161401806|NCT03352453|582858029|FG000|Overall Study|Protocol Deviation|1|||
161401807|NCT03352453|582858030|FG001|Overall Study|Protocol Deviation|0|||
161401808|NCT03352453|582858029|FG000|Overall Study|Lost to Follow-up|7|||
161401809|NCT03352453|582858030|FG001|Overall Study|Lost to Follow-up|6|||
161401810|NCT03352453|582858029|FG000|Overall Study|Adverse Event|2|||
161401811|NCT03352453|582858030|FG001|Overall Study|Adverse Event|9|||
161401812|NCT02827500|582858031|FG000|Overall Study|Death|7|||
161401813|NCT02827500|582858032|FG001|Overall Study|Death|3|||
161401814|NCT02827500|582858031|FG000|Overall Study|Lost to Follow-up|1|||
161401815|NCT02827500|582858032|FG001|Overall Study|Lost to Follow-up|1|||
161401816|NCT02827500|582858031|FG000|Overall Study|Withdrawal by Subject|3|||
161401817|NCT02827500|582858032|FG001|Overall Study|Withdrawal by Subject|1|||
161401818|NCT02827500|582858031|FG000|Overall Study|Missing primary endpoint data|3|||
161401819|NCT02827500|582858032|FG001|Overall Study|Missing primary endpoint data|1|||
161401820|NCT02827500|582858031|FG000|Overall Study|Other|5|||
161401821|NCT02827500|582858032|FG001|Overall Study|Other|1|||
161401822|NCT01241760|582858035|FG000|Overall Study|Adverse Event|1|||
161401823|NCT01241760|582858036|FG001|Overall Study|Adverse Event|0|||
161401824|NCT01241760|582858035|FG000|Overall Study|Lost to Follow-up|18|||
161401825|NCT01241760|582858036|FG001|Overall Study|Lost to Follow-up|22|||
161401826|NCT01241760|582858035|FG000|Overall Study|Withdrawal by Subject|13|||
161401827|NCT01241760|582858036|FG001|Overall Study|Withdrawal by Subject|13|||
161401828|NCT01241760|582858035|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
161401829|NCT01241760|582858036|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
161401830|NCT01241760|582858035|FG000|Overall Study|Other|1|||
161401831|NCT01241760|582858036|FG001|Overall Study|Other|1|||
161401832|NCT00514020|582858037|FG000|Overall Study|Adverse Event|6|||
161401833|NCT00514020|582858037|FG000|Overall Study|Withdrawal by Subject|3|||
161401834|NCT00514020|582858037|FG000|Overall Study|Physician Decision|1|||
161401835|NCT00514020|582858037|FG000|Overall Study|disease progression|9|||
161401836|NCT00514020|582858037|FG000|Overall Study|other complicating disease|2|||
161401837|NCT00514020|582858037|FG000|Overall Study|patient went to radiation treatment|1|||
161401838|NCT00514020|582858037|FG000|Overall Study|"patients moved to the no tx group"|6|||
161401839|NCT03697993|582858043|FG000|Overall Study|Became Ineligible after Enrollment|1|||
161401840|NCT03697993|582858044|FG001|Overall Study|Became Ineligible after Enrollment|3|||
161401841|NCT03697993|582858043|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
161401842|NCT03697993|582858044|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
161401843|NCT03697993|582858043|FG000|Overall Study|Lost to Follow-up|3|||
161401844|NCT03697993|582858044|FG001|Overall Study|Lost to Follow-up|0|||
161401845|NCT03697993|582858043|FG000|Overall Study|Physician Decision|4|||
161401846|NCT03697993|582858044|FG001|Overall Study|Physician Decision|0|||
161401847|NCT03697993|582858043|FG000|Overall Study|Initial Urine Culture Negative|0|||
161401848|NCT03697993|582858044|FG001|Overall Study|Initial Urine Culture Negative|1|||
161401849|NCT04384107|582858045|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
161401850|NCT04384107|582858046|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
161401851|NCT04384107|582858045|FG000|Overall Study|Lost to Follow-up|1|||
161401852|NCT04384107|582858046|FG001|Overall Study|Lost to Follow-up|0|||
161401853|NCT00276614|582858049|FG000|Overall Study|Progression of disease under study|3|||
161401854|NCT01048866|582858054|FG000|Overall Study|Adverse Event|1|||
161401855|NCT01048866|582858055|FG001|Overall Study|Adverse Event|0|||
161401856|NCT01048866|582858054|FG000|Overall Study|Protocol Violation|1|||
161401857|NCT01048866|582858055|FG001|Overall Study|Protocol Violation|0|||
161401858|NCT01048866|582858054|FG000|Overall Study|Physician Decision|1|||
161401859|NCT01048866|582858055|FG001|Overall Study|Physician Decision|0|||
161401860|NCT01048866|582858054|FG000|Overall Study|Withdrawal by Subject|0|||
161401861|NCT01048866|582858055|FG001|Overall Study|Withdrawal by Subject|2|||
161401862|NCT01048866|582858054|FG000|Overall Study|Lost to Follow-up|0|||
161401863|NCT01048866|582858055|FG001|Overall Study|Lost to Follow-up|2|||
161401864|NCT01048866|582858054|FG000|Overall Study|Other|1|||
161401865|NCT01048866|582858055|FG001|Overall Study|Other|1|||
161401866|NCT03582813|582858056|FG000|Overall Study|Lost to Follow-up|18|||
161401867|NCT03582813|582858057|FG001|Overall Study|Lost to Follow-up|21|||
161401868|NCT03582813|582858056|FG000|Overall Study|Withdrawal by Subject|1|||
161401869|NCT03582813|582858057|FG001|Overall Study|Withdrawal by Subject|0|||
161401870|NCT02525094|582858062|FG000|Overall Study|Lost to Follow-up|2|||
161401871|NCT02525094|582858063|FG001|Overall Study|Lost to Follow-up|1|||
161401872|NCT02525094|582858062|FG000|Overall Study|Withdrawal by Subject|5|||
161401873|NCT02525094|582858063|FG001|Overall Study|Withdrawal by Subject|6|||
161401874|NCT02525094|582858062|FG000|Overall Study|Not Treated|1|||
161401875|NCT02525094|582858063|FG001|Overall Study|Not Treated|1|||
161401876|NCT01591863|582858064|FG000|Overall Study|Adverse Event|3|||
161401877|NCT01591863|582858064|FG000|Overall Study|Withdrawal by Subject|1|||
161401878|NCT01591863|582858064|FG000|Overall Study|recurrence|9|||
161401879|NCT01591863|582858064|FG000|Overall Study|Lack of Efficacy|1|||
161401880|NCT01751776|582858067|FG000|Overall Study|Adverse Event|0|||
161401881|NCT01751776|582858068|FG001|Overall Study|Adverse Event|0|||
161401882|NCT01751776|582858069|FG002|Overall Study|Adverse Event|0|||
161401883|NCT01751776|582858070|FG003|Overall Study|Adverse Event|0|||
161401884|NCT01751776|582858071|FG004|Overall Study|Adverse Event|0|||
161401885|NCT01751776|582858072|FG005|Overall Study|Adverse Event|0|||
161401886|NCT01751776|582858073|FG006|Overall Study|Adverse Event|4|||
161401887|NCT01751776|582858074|FG007|Overall Study|Adverse Event|2|||
161401888|NCT01751776|582858067|FG000|Overall Study|Consent withdrawn|0|||
161401889|NCT01751776|582858068|FG001|Overall Study|Consent withdrawn|0|||
161401890|NCT01751776|582858069|FG002|Overall Study|Consent withdrawn|0|||
161401891|NCT01751776|582858070|FG003|Overall Study|Consent withdrawn|0|||
161401892|NCT01751776|582858071|FG004|Overall Study|Consent withdrawn|0|||
161401893|NCT01751776|582858072|FG005|Overall Study|Consent withdrawn|0|||
161401894|NCT01751776|582858073|FG006|Overall Study|Consent withdrawn|0|||
161401895|NCT01751776|582858074|FG007|Overall Study|Consent withdrawn|1|||
161401896|NCT01751776|582858067|FG000|Overall Study|Other reason not specified above|0|||
161401897|NCT01751776|582858068|FG001|Overall Study|Other reason not specified above|0|||
161401898|NCT01751776|582858069|FG002|Overall Study|Other reason not specified above|0|||
161401899|NCT01751776|582858070|FG003|Overall Study|Other reason not specified above|0|||
161401900|NCT01751776|582858071|FG004|Overall Study|Other reason not specified above|0|||
161401901|NCT01751776|582858072|FG005|Overall Study|Other reason not specified above|0|||
161401902|NCT01751776|582858073|FG006|Overall Study|Other reason not specified above|0|||
161401903|NCT01751776|582858074|FG007|Overall Study|Other reason not specified above|1|||
161401904|NCT00160654|582858075|FG000|Overall Study|Adverse Event|14|||
161401905|NCT00160654|582858075|FG000|Overall Study|Lack of Efficacy|4|||
161401906|NCT00160654|582858075|FG000|Overall Study|Lost to Follow-up|2|||
161401907|NCT00160654|582858075|FG000|Overall Study|Intake of expired drug|7|||
161401908|NCT00160654|582858075|FG000|Overall Study|Psychological trauma|1|||
161401909|NCT00160654|582858075|FG000|Overall Study|Sponsor decision|1|||
161401910|NCT00160654|582858075|FG000|Overall Study|Patient met exclusion criteria|1|||
161401911|NCT00160654|582858075|FG000|Overall Study|Patient decision|1|||
161401912|NCT00160654|582858075|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
161401913|NCT00160654|582858075|FG000|Overall Study|Met exclusion criteria|1|||
161401914|NCT00831701|582858076|FG000|Overall Study|Withdrawal by Subject|2|||
161401915|NCT00831701|582858077|FG001|Overall Study|Withdrawal by Subject|0|||
161401916|NCT00831701|582858076|FG000|Overall Study|Stone expulsion before first medication|2|||
161401917|NCT00831701|582858077|FG001|Overall Study|Stone expulsion before first medication|2|||
161401918|NCT00831701|582858076|FG000|Overall Study|Lost to Follow-up|1|||
161401919|NCT00831701|582858077|FG001|Overall Study|Lost to Follow-up|3|||
161401920|NCT02366767|582858078|FG000|Overall Study|left for home after 1 day at camp|1|||
161401921|NCT02366767|582858079|FG001|Overall Study|left for home after 1 day at camp|0|||
161401922|NCT02117349|582858080|FG000|Overall Study|Withdrawal by Subject|1|||
161401923|NCT02117349|582858081|FG001|Overall Study|Withdrawal by Subject|0|||
161401924|NCT02117349|582858080|FG000|Overall Study|Lost to Follow-up|1|||
161401925|NCT02117349|582858081|FG001|Overall Study|Lost to Follow-up|1|||
161401926|NCT02117349|582858080|FG000|Overall Study|Death|1|||
161401927|NCT02117349|582858081|FG001|Overall Study|Death|0|||
161401928|NCT00546260|582858084|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
161401929|NCT00546260|582858085|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
161401930|NCT03780959|582858086|FG000|Part 1|Adverse Event|1|||
161401931|NCT03780959|582858087|FG001|Part 1|Adverse Event|0|||
161401932|NCT03780959|582858088|FG002|Part 1|Adverse Event|0|||
161401933|NCT03780959|582858086|FG000|Part 1|Withdrawal by Subject|1|||
161401934|NCT03780959|582858087|FG001|Part 1|Withdrawal by Subject|0|||
161401935|NCT03780959|582858088|FG002|Part 1|Withdrawal by Subject|0|||
161401936|NCT03780959|582858086|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
161401937|NCT03780959|582858087|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
161401938|NCT03780959|582858088|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
161401939|NCT03780959|582858086|FG000|Part 1|Response Status|2|||
161401940|NCT03780959|582858087|FG001|Part 1|Response Status|0|||
161401941|NCT03780959|582858088|FG002|Part 1|Response Status|0|||
161401942|NCT03780959|582858086|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
161401943|NCT03780959|582858087|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
161401944|NCT03780959|582858088|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
161401945|NCT03780959|582858086|FG000|Part 2|Response Status|0|||
161401946|NCT03780959|582858087|FG001|Part 2|Response Status|18|||
161401947|NCT03780959|582858088|FG002|Part 2|Response Status|6|||
161401948|NCT03172130|582859742|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
161401949|NCT03172130|582859743|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
161401950|NCT01825941|582859747|FG000|Overall Study|Lost to Follow-up|4|||
161401951|NCT01825941|582859748|FG001|Overall Study|Lost to Follow-up|1|||
161401952|NCT00528996|582859749|FG000|Overall Study|Other reasons than listing|6|||
161401953|NCT00528996|582859750|FG001|Overall Study|Other reasons than listing|7|||
161401954|NCT00528996|582859751|FG002|Overall Study|Other reasons than listing|14|||
161401955|NCT00528996|582859752|FG003|Overall Study|Other reasons than listing|11|||
161401956|NCT00528996|582859753|FG004|Overall Study|Other reasons than listing|5|||
161401957|NCT00528996|582859749|FG000|Overall Study|Refused continue medication|16|||
161401958|NCT00528996|582859750|FG001|Overall Study|Refused continue medication|0|||
161401959|NCT00528996|582859751|FG002|Overall Study|Refused continue medication|3|||
161401960|NCT00528996|582859752|FG003|Overall Study|Refused continue medication|3|||
161401961|NCT00528996|582859753|FG004|Overall Study|Refused continue medication|6|||
161401962|NCT00528996|582859749|FG000|Overall Study|Lost to Follow-up|2|||
161401963|NCT00528996|582859750|FG001|Overall Study|Lost to Follow-up|0|||
161401964|NCT00528996|582859751|FG002|Overall Study|Lost to Follow-up|4|||
161401965|NCT00528996|582859752|FG003|Overall Study|Lost to Follow-up|1|||
161401966|NCT00528996|582859753|FG004|Overall Study|Lost to Follow-up|3|||
161401967|NCT00528996|582859749|FG000|Overall Study|Protocol Violation|1|||
161401968|NCT00528996|582859750|FG001|Overall Study|Protocol Violation|2|||
161401969|NCT00528996|582859751|FG002|Overall Study|Protocol Violation|3|||
161401970|NCT00528996|582859752|FG003|Overall Study|Protocol Violation|3|||
161401971|NCT00528996|582859753|FG004|Overall Study|Protocol Violation|2|||
161401972|NCT00528996|582859749|FG000|Overall Study|Lack of Efficacy|7|||
161401973|NCT00528996|582859750|FG001|Overall Study|Lack of Efficacy|2|||
161401974|NCT00528996|582859751|FG002|Overall Study|Lack of Efficacy|1|||
161401975|NCT00528996|582859752|FG003|Overall Study|Lack of Efficacy|3|||
161401976|NCT00528996|582859753|FG004|Overall Study|Lack of Efficacy|3|||
161401977|NCT00528996|582859749|FG000|Overall Study|Adverse Event|32|||
161401978|NCT00528996|582859750|FG001|Overall Study|Adverse Event|13|||
161401979|NCT00528996|582859751|FG002|Overall Study|Adverse Event|18|||
161401980|NCT00528996|582859752|FG003|Overall Study|Adverse Event|29|||
161401981|NCT00528996|582859753|FG004|Overall Study|Adverse Event|18|||
161401982|NCT02831933|582859755|FG000|Overall Study|Physician Decision|11|||
161401983|NCT03495102|582859756|FG000|Overall Study|Adverse Event|5|||
161401984|NCT03495102|582859757|FG001|Overall Study|Adverse Event|7|||
161401985|NCT03495102|582859758|FG002|Overall Study|Adverse Event|10|||
161401986|NCT03495102|582859756|FG000|Overall Study|Death|3|||
161401987|NCT03495102|582859757|FG001|Overall Study|Death|4|||
161401988|NCT03495102|582859758|FG002|Overall Study|Death|4|||
161401989|NCT03495102|582859756|FG000|Overall Study|Lost to Follow-up|15|||
161401990|NCT03495102|582859757|FG001|Overall Study|Lost to Follow-up|16|||
161401991|NCT03495102|582859758|FG002|Overall Study|Lost to Follow-up|17|||
161401992|NCT03495102|582859756|FG000|Overall Study|Physician Decision|2|||
161401993|NCT03495102|582859757|FG001|Overall Study|Physician Decision|0|||
161401994|NCT03495102|582859758|FG002|Overall Study|Physician Decision|2|||
161401995|NCT03495102|582859756|FG000|Overall Study|Withdrawal by Subject|25|||
161401996|NCT03495102|582859757|FG001|Overall Study|Withdrawal by Subject|36|||
161401997|NCT03495102|582859758|FG002|Overall Study|Withdrawal by Subject|18|||
161401998|NCT03495102|582859756|FG000|Overall Study|Protocol Violation|1|||
161401999|NCT03495102|582859757|FG001|Overall Study|Protocol Violation|1|||
161402000|NCT03495102|582859758|FG002|Overall Study|Protocol Violation|0|||
161402001|NCT03495102|582859756|FG000|Overall Study|Site Closure|3|||
161402002|NCT03495102|582859757|FG001|Overall Study|Site Closure|1|||
161402003|NCT03495102|582859758|FG002|Overall Study|Site Closure|2|||
161402004|NCT03495102|582859756|FG000|Overall Study|Non-compliance|1|||
161402005|NCT03495102|582859757|FG001|Overall Study|Non-compliance|0|||
161402006|NCT03495102|582859758|FG002|Overall Study|Non-compliance|0|||
161402007|NCT03495102|582859756|FG000|Overall Study|Participant Duplicated at Another Site|0|||
161402008|NCT03495102|582859757|FG001|Overall Study|Participant Duplicated at Another Site|0|||
161402009|NCT03495102|582859758|FG002|Overall Study|Participant Duplicated at Another Site|1|||
161402010|NCT03495102|582859756|FG000|Overall Study|Primary Care Physician Recommendation|0|||
161402011|NCT03495102|582859757|FG001|Overall Study|Primary Care Physician Recommendation|1|||
161402012|NCT03495102|582859758|FG002|Overall Study|Primary Care Physician Recommendation|0|||
161402013|NCT03495102|582859756|FG000|Overall Study|Relocated to Another Country|0|||
161402014|NCT03495102|582859757|FG001|Overall Study|Relocated to Another Country|1|||
161402015|NCT03495102|582859758|FG002|Overall Study|Relocated to Another Country|0|||
161402016|NCT03495102|582859756|FG000|Overall Study|Participant was in Rehabilitation|1|||
161402017|NCT03495102|582859757|FG001|Overall Study|Participant was in Rehabilitation|0|||
161402018|NCT03495102|582859758|FG002|Overall Study|Participant was in Rehabilitation|0|||
161402019|NCT01161537|582859761|FG000|Part B|Withdrawal by Subject|2|||
161402020|NCT00358436|582859766|FG000|Overall Study|Adverse Event|29|||
161402021|NCT00358436|582859767|FG001|Overall Study|Adverse Event|13|||
161402022|NCT00358436|582859766|FG000|Overall Study|Lack of Efficacy|34|||
161402023|NCT00358436|582859767|FG001|Overall Study|Lack of Efficacy|36|||
161402024|NCT00358436|582859766|FG000|Overall Study|Lost to Follow-up|11|||
161402025|NCT00358436|582859767|FG001|Overall Study|Lost to Follow-up|6|||
161402026|NCT00358436|582859766|FG000|Overall Study|Protocol Violation|8|||
161402027|NCT00358436|582859767|FG001|Overall Study|Protocol Violation|3|||
161402028|NCT00358436|582859766|FG000|Overall Study|Withdrawal by Subject|40|||
161402029|NCT00358436|582859767|FG001|Overall Study|Withdrawal by Subject|17|||
161402030|NCT00358436|582859766|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
161402031|NCT00358436|582859767|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
161402032|NCT00358436|582859766|FG000|Overall Study|COPD exacerbation|22|||
161402033|NCT00358436|582859767|FG001|Overall Study|COPD exacerbation|10|||
161402034|NCT00358436|582859766|FG000|Overall Study|Other|6|||
161402035|NCT00358436|582859767|FG001|Overall Study|Other|1|||
161402036|NCT05065190|582859769|FG000|Overall Study|Other than listed|2|||
161402037|NCT05065190|582859770|FG001|Overall Study|Other than listed|12|||
161402038|NCT05065190|582859769|FG000|Overall Study|Lack of Efficacy|4|||
161402039|NCT05065190|582859770|FG001|Overall Study|Lack of Efficacy|0|||
161402040|NCT05065190|582859769|FG000|Overall Study|Adverse Event|1|||
161402041|NCT05065190|582859770|FG001|Overall Study|Adverse Event|10|||
161402042|NCT03938324|582859778|FG000|Overall Study|Lost to Follow-up|42|||
161402043|NCT03938324|582859779|FG001|Overall Study|Lost to Follow-up|21|||
161402044|NCT03938324|582859778|FG000|Overall Study|Withdrawal by Subject|6|||
161402045|NCT03938324|582859779|FG001|Overall Study|Withdrawal by Subject|1|||
161402046|NCT02769962|582859780|FG000|Overall Study|Physician Decision|0|||
161402047|NCT02769962|582859781|FG001|Overall Study|Physician Decision|0|||
161402048|NCT02769962|582859782|FG002|Overall Study|Physician Decision|0|||
161402049|NCT02769962|582859783|FG003|Overall Study|Physician Decision|0|||
161402050|NCT02769962|582859784|FG004|Overall Study|Physician Decision|0|||
161402051|NCT02769962|582859785|FG005|Overall Study|Physician Decision|1|||
161402052|NCT02769962|582859786|FG006|Overall Study|Physician Decision|0|||
161402053|NCT02769962|582859787|FG007|Overall Study|Physician Decision|1|||
161402054|NCT02769962|582859780|FG000|Overall Study|Refused further treatment|0|||
161402055|NCT02769962|582859781|FG001|Overall Study|Refused further treatment|0|||
161402056|NCT02769962|582859782|FG002|Overall Study|Refused further treatment|0|||
161402057|NCT02769962|582859783|FG003|Overall Study|Refused further treatment|0|||
161402058|NCT02769962|582859784|FG004|Overall Study|Refused further treatment|0|||
161402059|NCT02769962|582859785|FG005|Overall Study|Refused further treatment|1|||
161402060|NCT02769962|582859786|FG006|Overall Study|Refused further treatment|1|||
161402061|NCT02769962|582859787|FG007|Overall Study|Refused further treatment|0|||
161402062|NCT02559414|582859794|FG000|Overall Study|Lost to Follow-up|0|||
161402063|NCT02559414|582859795|FG001|Overall Study|Lost to Follow-up|1|||
161402064|NCT02559414|582859796|FG002|Overall Study|Lost to Follow-up|0|||
161402065|NCT02559414|582859794|FG000|Overall Study|Withdrawal by Subject|1|||
161402066|NCT02559414|582859795|FG001|Overall Study|Withdrawal by Subject|0|||
161402067|NCT02559414|582859796|FG002|Overall Study|Withdrawal by Subject|1|||
161402068|NCT02559414|582859794|FG000|Overall Study|Other|0|||
161402069|NCT02559414|582859795|FG001|Overall Study|Other|1|||
161402070|NCT02559414|582859796|FG002|Overall Study|Other|1|||
161402071|NCT00004445|582859797|FG000|Overall Study|Physician Decision|2|||
161402072|NCT00004445|582859797|FG000|Overall Study|Withdrawal by Subject|1|||
161402073|NCT01266317|582859798|FG000|Overall Study|Withdrawal by Subject|2|||
161402074|NCT02753127|582859801|FG000|Overall Study|Lost to Follow-up|13|||
161402075|NCT02753127|582859802|FG001|Overall Study|Lost to Follow-up|11|||
161402076|NCT02753127|582859801|FG000|Overall Study|Withdrawal by Subject|37|||
161402077|NCT02753127|582859802|FG001|Overall Study|Withdrawal by Subject|47|||
161402078|NCT02753127|582859801|FG000|Overall Study|Other|3|||
161402079|NCT02753127|582859802|FG001|Overall Study|Other|8|||
161402080|NCT02753127|582859801|FG000|Overall Study|Hospice|0|||
161402081|NCT02753127|582859802|FG001|Overall Study|Hospice|2|||
161402082|NCT00098722|582859803|FG000|Double Blind Phase|Adverse Event|7|||
161402083|NCT00098722|582859804|FG001|Double Blind Phase|Adverse Event|7|||
161402084|NCT00098722|582859805|FG002|Double Blind Phase|Adverse Event|3|||
161402085|NCT00098722|582859806|FG003|Double Blind Phase|Adverse Event|0|||
161402086|NCT00098722|582859807|FG004|Double Blind Phase|Adverse Event|0|||
161402087|NCT00098722|582859808|FG005|Double Blind Phase|Adverse Event|0|||
161402088|NCT00098722|582859809|FG006|Double Blind Phase|Adverse Event|0|||
161402089|NCT00098722|582859803|FG000|Double Blind Phase|Death|2|||
161402090|NCT00098722|582859804|FG001|Double Blind Phase|Death|5|||
161402091|NCT00098722|582859805|FG002|Double Blind Phase|Death|0|||
161402092|NCT00098722|582859806|FG003|Double Blind Phase|Death|0|||
161402093|NCT00098722|582859807|FG004|Double Blind Phase|Death|0|||
161402094|NCT00098722|582859808|FG005|Double Blind Phase|Death|0|||
161402095|NCT00098722|582859809|FG006|Double Blind Phase|Death|0|||
161402096|NCT00098722|582859803|FG000|Double Blind Phase|Lack of Efficacy|21|||
161402097|NCT00098722|582859804|FG001|Double Blind Phase|Lack of Efficacy|23|||
161402098|NCT00098722|582859805|FG002|Double Blind Phase|Lack of Efficacy|15|||
161402099|NCT00098722|582859806|FG003|Double Blind Phase|Lack of Efficacy|0|||
161402100|NCT00098722|582859807|FG004|Double Blind Phase|Lack of Efficacy|0|||
161402101|NCT00098722|582859808|FG005|Double Blind Phase|Lack of Efficacy|0|||
161402102|NCT00098722|582859809|FG006|Double Blind Phase|Lack of Efficacy|0|||
161402103|NCT00098722|582859803|FG000|Double Blind Phase|Participant defaulted|16|||
161402104|NCT00098722|582859804|FG001|Double Blind Phase|Participant defaulted|11|||
161402105|NCT00098722|582859805|FG002|Double Blind Phase|Participant defaulted|9|||
161402106|NCT00098722|582859806|FG003|Double Blind Phase|Participant defaulted|0|||
161402107|NCT00098722|582859807|FG004|Double Blind Phase|Participant defaulted|0|||
161402108|NCT00098722|582859808|FG005|Double Blind Phase|Participant defaulted|0|||
161402109|NCT00098722|582859809|FG006|Double Blind Phase|Participant defaulted|0|||
161402110|NCT00098722|582859803|FG000|Double Blind Phase|Pregnancy|1|||
161402111|NCT00098722|582859804|FG001|Double Blind Phase|Pregnancy|0|||
161402112|NCT00098722|582859805|FG002|Double Blind Phase|Pregnancy|0|||
161402113|NCT00098722|582859806|FG003|Double Blind Phase|Pregnancy|0|||
161402114|NCT00098722|582859807|FG004|Double Blind Phase|Pregnancy|0|||
161402115|NCT00098722|582859808|FG005|Double Blind Phase|Pregnancy|0|||
161402116|NCT00098722|582859809|FG006|Double Blind Phase|Pregnancy|0|||
161402117|NCT00098722|582859803|FG000|Double Blind Phase|Randomized, not treated|4|||
161402118|NCT00098722|582859804|FG001|Double Blind Phase|Randomized, not treated|3|||
161402119|NCT00098722|582859805|FG002|Double Blind Phase|Randomized, not treated|3|||
161402120|NCT00098722|582859806|FG003|Double Blind Phase|Randomized, not treated|0|||
161402121|NCT00098722|582859807|FG004|Double Blind Phase|Randomized, not treated|0|||
161402122|NCT00098722|582859808|FG005|Double Blind Phase|Randomized, not treated|0|||
161402123|NCT00098722|582859809|FG006|Double Blind Phase|Randomized, not treated|0|||
161402124|NCT00098722|582859803|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
161402125|NCT00098722|582859804|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
161402126|NCT00098722|582859805|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
161402127|NCT00098722|582859806|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
161402128|NCT00098722|582859807|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
161402129|NCT00098722|582859808|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
161402130|NCT00098722|582859809|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
161402131|NCT00098722|582859803|FG000|Double Blind Phase|Other|7|||
161402132|NCT00098722|582859804|FG001|Double Blind Phase|Other|8|||
161402133|NCT00098722|582859805|FG002|Double Blind Phase|Other|7|||
161402134|NCT00098722|582859806|FG003|Double Blind Phase|Other|0|||
161402135|NCT00098722|582859807|FG004|Double Blind Phase|Other|0|||
161402136|NCT00098722|582859808|FG005|Double Blind Phase|Other|0|||
161402137|NCT00098722|582859809|FG006|Double Blind Phase|Other|0|||
161402138|NCT00098722|582859803|FG000|Open Label Phase|Adverse Event|0|||
161402139|NCT00098722|582859804|FG001|Open Label Phase|Adverse Event|0|||
161402140|NCT00098722|582859805|FG002|Open Label Phase|Adverse Event|0|||
161402141|NCT00098722|582859806|FG003|Open Label Phase|Adverse Event|5|||
161402142|NCT00098722|582859807|FG004|Open Label Phase|Adverse Event|0|||
161402143|NCT00098722|582859808|FG005|Open Label Phase|Adverse Event|0|||
161402144|NCT00098722|582859809|FG006|Open Label Phase|Adverse Event|0|||
161402145|NCT00098722|582859803|FG000|Open Label Phase|Death|0|||
161402146|NCT00098722|582859804|FG001|Open Label Phase|Death|0|||
161402147|NCT00098722|582859805|FG002|Open Label Phase|Death|0|||
161402148|NCT00098722|582859806|FG003|Open Label Phase|Death|2|||
161402149|NCT00098722|582859807|FG004|Open Label Phase|Death|0|||
161402150|NCT00098722|582859808|FG005|Open Label Phase|Death|0|||
161402151|NCT00098722|582859809|FG006|Open Label Phase|Death|0|||
161402152|NCT00098722|582859803|FG000|Open Label Phase|Lack of Efficacy|0|||
161402153|NCT00098722|582859804|FG001|Open Label Phase|Lack of Efficacy|0|||
161402154|NCT00098722|582859805|FG002|Open Label Phase|Lack of Efficacy|0|||
161402155|NCT00098722|582859806|FG003|Open Label Phase|Lack of Efficacy|8|||
161402156|NCT00098722|582859807|FG004|Open Label Phase|Lack of Efficacy|0|||
161402157|NCT00098722|582859808|FG005|Open Label Phase|Lack of Efficacy|0|||
161402158|NCT00098722|582859809|FG006|Open Label Phase|Lack of Efficacy|0|||
161402159|NCT00098722|582859803|FG000|Open Label Phase|Pregnancy|0|||
161402160|NCT00098722|582859804|FG001|Open Label Phase|Pregnancy|0|||
161402161|NCT00098722|582859805|FG002|Open Label Phase|Pregnancy|0|||
161402162|NCT00098722|582859806|FG003|Open Label Phase|Pregnancy|1|||
161402163|NCT00098722|582859807|FG004|Open Label Phase|Pregnancy|0|||
161402164|NCT00098722|582859808|FG005|Open Label Phase|Pregnancy|0|||
161402165|NCT00098722|582859809|FG006|Open Label Phase|Pregnancy|0|||
161402166|NCT00098722|582859803|FG000|Open Label Phase|Participant defaulted|0|||
161402167|NCT00098722|582859804|FG001|Open Label Phase|Participant defaulted|0|||
161402168|NCT00098722|582859805|FG002|Open Label Phase|Participant defaulted|0|||
161402169|NCT00098722|582859806|FG003|Open Label Phase|Participant defaulted|18|||
161402170|NCT00098722|582859807|FG004|Open Label Phase|Participant defaulted|0|||
161402171|NCT00098722|582859808|FG005|Open Label Phase|Participant defaulted|0|||
161402172|NCT00098722|582859809|FG006|Open Label Phase|Participant defaulted|0|||
161402173|NCT00098722|582859803|FG000|Open Label Phase|Ongoing at cut-off date|0|||
161402174|NCT00098722|582859804|FG001|Open Label Phase|Ongoing at cut-off date|0|||
161402175|NCT00098722|582859805|FG002|Open Label Phase|Ongoing at cut-off date|0|||
161402176|NCT00098722|582859806|FG003|Open Label Phase|Ongoing at cut-off date|220|||
161402177|NCT00098722|582859807|FG004|Open Label Phase|Ongoing at cut-off date|50|||
161402178|NCT00098722|582859808|FG005|Open Label Phase|Ongoing at cut-off date|0|||
161402179|NCT00098722|582859809|FG006|Open Label Phase|Ongoing at cut-off date|0|||
161402180|NCT00098722|582859803|FG000|Open Label Phase|Other|0|||
161402181|NCT00098722|582859804|FG001|Open Label Phase|Other|0|||
161402182|NCT00098722|582859805|FG002|Open Label Phase|Other|0|||
161402183|NCT00098722|582859806|FG003|Open Label Phase|Other|18|||
161402184|NCT00098722|582859807|FG004|Open Label Phase|Other|0|||
161402185|NCT00098722|582859808|FG005|Open Label Phase|Other|0|||
161402186|NCT00098722|582859809|FG006|Open Label Phase|Other|0|||
161402187|NCT00098722|582859803|FG000|Observation Phase|Death|0|||
161402188|NCT00098722|582859804|FG001|Observation Phase|Death|0|||
161402189|NCT00098722|582859805|FG002|Observation Phase|Death|0|||
161402190|NCT00098722|582859806|FG003|Observation Phase|Death|0|||
161402191|NCT00098722|582859807|FG004|Observation Phase|Death|0|||
161402192|NCT00098722|582859808|FG005|Observation Phase|Death|5|||
161402193|NCT00098722|582859809|FG006|Observation Phase|Death|3|||
161402194|NCT00098722|582859803|FG000|Observation Phase|Lack of Efficacy|0|||
161402195|NCT00098722|582859804|FG001|Observation Phase|Lack of Efficacy|0|||
161402196|NCT00098722|582859805|FG002|Observation Phase|Lack of Efficacy|0|||
161402197|NCT00098722|582859806|FG003|Observation Phase|Lack of Efficacy|0|||
161402198|NCT00098722|582859807|FG004|Observation Phase|Lack of Efficacy|0|||
161402199|NCT00098722|582859808|FG005|Observation Phase|Lack of Efficacy|2|||
161402200|NCT00098722|582859809|FG006|Observation Phase|Lack of Efficacy|0|||
161402201|NCT00098722|582859803|FG000|Observation Phase|Participant defaulted|0|||
161402202|NCT00098722|582859804|FG001|Observation Phase|Participant defaulted|0|||
161402203|NCT00098722|582859805|FG002|Observation Phase|Participant defaulted|0|||
161402204|NCT00098722|582859806|FG003|Observation Phase|Participant defaulted|0|||
161402205|NCT00098722|582859807|FG004|Observation Phase|Participant defaulted|0|||
161402206|NCT00098722|582859808|FG005|Observation Phase|Participant defaulted|17|||
161402207|NCT00098722|582859809|FG006|Observation Phase|Participant defaulted|4|||
161402208|NCT00098722|582859803|FG000|Observation Phase|Other|0|||
161402209|NCT00098722|582859804|FG001|Observation Phase|Other|0|||
161402210|NCT00098722|582859805|FG002|Observation Phase|Other|0|||
161402211|NCT00098722|582859806|FG003|Observation Phase|Other|0|||
161402212|NCT00098722|582859807|FG004|Observation Phase|Other|0|||
161402213|NCT00098722|582859808|FG005|Observation Phase|Other|21|||
161402214|NCT00098722|582859809|FG006|Observation Phase|Other|10|||
161402215|NCT01519674|582859812|FG000|Overall Study|Adverse Event|3|||
161402216|NCT01519674|582859813|FG001|Overall Study|Adverse Event|3|||
161402217|NCT01519674|582859814|FG002|Overall Study|Adverse Event|0|||
161402218|NCT01519674|582859812|FG000|Overall Study|Lack of Efficacy|1|||
161402219|NCT01519674|582859813|FG001|Overall Study|Lack of Efficacy|1|||
161402220|NCT01519674|582859814|FG002|Overall Study|Lack of Efficacy|1|||
161402221|NCT01519674|582859812|FG000|Overall Study|Protocol Violation|0|||
161402222|NCT01519674|582859813|FG001|Overall Study|Protocol Violation|3|||
161402223|NCT01519674|582859814|FG002|Overall Study|Protocol Violation|1|||
161402224|NCT01519674|582859812|FG000|Overall Study|Withdrawal Criteria|7|||
161402225|NCT01519674|582859813|FG001|Overall Study|Withdrawal Criteria|2|||
161402226|NCT01519674|582859814|FG002|Overall Study|Withdrawal Criteria|7|||
161402227|NCT01519674|582859812|FG000|Overall Study|Unsclassified|10|||
161402228|NCT01519674|582859813|FG001|Overall Study|Unsclassified|4|||
161402229|NCT01519674|582859814|FG002|Overall Study|Unsclassified|3|||
161402230|NCT01510184|582859819|FG000|Overall Study|Sponsor discretion|28|||
161402231|NCT01510184|582859820|FG001|Overall Study|Sponsor discretion|28|||
161402232|NCT01510184|582859819|FG000|Overall Study|Death|1|||
161402233|NCT01510184|582859820|FG001|Overall Study|Death|2|||
161402234|NCT01510184|582859819|FG000|Overall Study|Withdrawal by Subject|1|||
161402235|NCT01510184|582859820|FG001|Overall Study|Withdrawal by Subject|4|||
161402236|NCT01510184|582859819|FG000|Overall Study|Other|0|||
161402237|NCT01510184|582859820|FG001|Overall Study|Other|1|||
161402238|NCT01143051|582859822|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
161402239|NCT01143051|582859823|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
161402240|NCT01143051|582859824|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
161402241|NCT01143051|582859825|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
161402242|NCT01143051|582859826|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
161402243|NCT01143051|582859827|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
161402244|NCT01143051|582859822|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
161402245|NCT01143051|582859823|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
161402246|NCT01143051|582859824|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
161402247|NCT01143051|582859825|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
161402248|NCT01143051|582859826|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
161402249|NCT01143051|582859827|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
161402250|NCT01146288|582859828|FG000|First Intervention(1 Day)|Adverse Event|0|||
161402251|NCT01146288|582859829|FG001|First Intervention(1 Day)|Adverse Event|1|||
161402252|NCT00765882|582859830|FG000|Overall Study|Adverse Event|10|||
161402253|NCT00765882|582859831|FG001|Overall Study|Adverse Event|21|||
161402254|NCT00765882|582859832|FG002|Overall Study|Adverse Event|20|||
161402255|NCT00765882|582859830|FG000|Overall Study|Lack of Efficacy|4|||
161402256|NCT00765882|582859831|FG001|Overall Study|Lack of Efficacy|0|||
161402257|NCT00765882|582859832|FG002|Overall Study|Lack of Efficacy|1|||
161402258|NCT00765882|582859830|FG000|Overall Study|Protocol Violation|4|||
161402259|NCT00765882|582859831|FG001|Overall Study|Protocol Violation|3|||
161402260|NCT00765882|582859832|FG002|Overall Study|Protocol Violation|1|||
161402261|NCT00765882|582859830|FG000|Overall Study|Withdrawal by Subject|2|||
161402262|NCT00765882|582859831|FG001|Overall Study|Withdrawal by Subject|6|||
161402263|NCT00765882|582859832|FG002|Overall Study|Withdrawal by Subject|6|||
161402264|NCT00765882|582859830|FG000|Overall Study|Lost to Follow-up|1|||
161402265|NCT00765882|582859831|FG001|Overall Study|Lost to Follow-up|9|||
161402266|NCT00765882|582859832|FG002|Overall Study|Lost to Follow-up|6|||
161402267|NCT00765882|582859830|FG000|Overall Study|Other Reason|3|||
161402268|NCT00765882|582859831|FG001|Overall Study|Other Reason|1|||
161402269|NCT00765882|582859832|FG002|Overall Study|Other Reason|2|||
161402270|NCT03532932|582859833|FG000|Overall Study|Protocol Deviation|33|||
161402271|NCT03532932|582859834|FG001|Overall Study|Protocol Deviation|31|||
161402272|NCT03532932|582859833|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
161402273|NCT03532932|582859834|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
161402274|NCT03532932|582859833|FG000|Overall Study|Withdrawal by Subject|2|||
161402275|NCT03532932|582859834|FG001|Overall Study|Withdrawal by Subject|0|||
161402276|NCT03532932|582859833|FG000|Overall Study|Lost to Follow-up|15|||
161402277|NCT03532932|582859834|FG001|Overall Study|Lost to Follow-up|9|||
161402278|NCT03532932|582859833|FG000|Overall Study|Adverse Event|4|||
161402279|NCT03532932|582859834|FG001|Overall Study|Adverse Event|3|||
161402280|NCT03532932|582859833|FG000|Overall Study|Death|0|||
161402281|NCT03532932|582859834|FG001|Overall Study|Death|2|||
161402282|NCT03532932|582859833|FG000|Overall Study|Other|11|||
161402283|NCT03532932|582859834|FG001|Overall Study|Other|16|||
161402284|NCT02255565|582859835|FG000|Overall Study|Withdrawal by Subject|0|||
161402285|NCT02255565|582859836|FG001|Overall Study|Withdrawal by Subject|1|||
161402286|NCT02255565|582859837|FG002|Overall Study|Withdrawal by Subject|0|||
161402287|NCT00810901|582859838|FG000|Overall Study|Lost to Follow-up|88|||
161402288|NCT00810901|582859839|FG001|Overall Study|Lost to Follow-up|58|||
161402289|NCT00931801|582859840|FG000|Overall Study|Adverse Event|0|||
161402290|NCT00931801|582859841|FG001|Overall Study|Adverse Event|0|||
161402291|NCT00931801|582859842|FG002|Overall Study|Adverse Event|1|||
161402292|NCT00931801|582859840|FG000|Overall Study|Lost to Follow-up|0|||
161402293|NCT00931801|582859841|FG001|Overall Study|Lost to Follow-up|1|||
161402294|NCT00931801|582859842|FG002|Overall Study|Lost to Follow-up|0|||
161402295|NCT00931801|582859840|FG000|Overall Study|Withdrawal by Subject|1|||
161402296|NCT00931801|582859841|FG001|Overall Study|Withdrawal by Subject|0|||
161402297|NCT00931801|582859842|FG002|Overall Study|Withdrawal by Subject|0|||
161402298|NCT00931801|582859840|FG000|Overall Study|Confirmed Virologic Failure|0|||
161402299|NCT00931801|582859841|FG001|Overall Study|Confirmed Virologic Failure|0|||
161402300|NCT00931801|582859842|FG002|Overall Study|Confirmed Virologic Failure|3|||
161402301|NCT00746733|582859846|FG000|Second Intervention|Adverse Event|1|||
161402302|NCT00746733|582859847|FG001|Second Intervention|Adverse Event|0|||
161402303|NCT00746733|582859846|FG000|Third Intervention|Withdrawal by Subject|1|||
161402304|NCT00746733|582859847|FG001|Third Intervention|Withdrawal by Subject|1|||
161402305|NCT04375397|582859848|FG000|Overall Study|Death|1|||
161402306|NCT04375397|582859849|FG001|Overall Study|Death|1|||
161402307|NCT04375397|582859848|FG000|Overall Study|Withdrew consent|2|||
161402308|NCT04375397|582859849|FG001|Overall Study|Withdrew consent|0|||
161402309|NCT04375397|582859848|FG000|Overall Study|Lost to Follow-up|6|||
161402310|NCT04375397|582859849|FG001|Overall Study|Lost to Follow-up|4|||
161402311|NCT04375397|582859848|FG000|Overall Study|Other, not specified|0|||
161402312|NCT04375397|582859849|FG001|Overall Study|Other, not specified|1|||
161402313|NCT00610441|582859850|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
161402314|NCT00610441|582859851|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
161402315|NCT00610441|582859852|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
161402316|NCT00610441|582859853|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
161402317|NCT00610441|582859850|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
161402318|NCT00610441|582859851|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
161402319|NCT00610441|582859852|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
161402320|NCT00610441|582859853|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
161402321|NCT00610441|582859850|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
161402322|NCT00610441|582859851|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
161402323|NCT00610441|582859852|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
161402324|NCT00610441|582859853|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
161402325|NCT00610441|582859850|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
161402326|NCT00610441|582859851|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
161402327|NCT00610441|582859852|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
161402328|NCT00610441|582859853|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
161402329|NCT00610441|582859850|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
161402330|NCT00610441|582859851|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
161402331|NCT00610441|582859852|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
161402332|NCT00610441|582859853|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
161402333|NCT00610441|582859850|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161402334|NCT00610441|582859851|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
161402335|NCT00610441|582859852|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161402336|NCT00610441|582859853|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161402337|NCT00610441|582859850|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
161402338|NCT00610441|582859851|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
161402339|NCT00610441|582859852|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
161402340|NCT00610441|582859853|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
161402341|NCT00610441|582859850|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
161402342|NCT00610441|582859851|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
161402343|NCT00610441|582859852|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
161402344|NCT00610441|582859853|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
161402345|NCT00610441|582859850|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
161402346|NCT00610441|582859851|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
161402347|NCT00610441|582859852|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
161402348|NCT00610441|582859853|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
161402349|NCT01945775|582859855|FG000|Overall Study|Death|214|||
161402350|NCT01945775|582859856|FG001|Overall Study|Death|98|||
161402351|NCT01945775|582859855|FG000|Overall Study|Lost to Follow-up|12|||
161402352|NCT01945775|582859856|FG001|Overall Study|Lost to Follow-up|7|||
161402353|NCT01945775|582859855|FG000|Overall Study|Withdrawal by Subject|11|||
161402354|NCT01945775|582859856|FG001|Overall Study|Withdrawal by Subject|21|||
161402355|NCT01945775|582859855|FG000|Overall Study|Other|50|||
161402356|NCT01945775|582859856|FG001|Overall Study|Other|18|||
161402357|NCT02876328|582859857|FG000|Overall Study|Death|2|||
161402358|NCT02876328|582859858|FG001|Overall Study|Death|1|||
161402359|NCT02876328|582859859|FG002|Overall Study|Death|3|||
161402360|NCT02876328|582859860|FG003|Overall Study|Death|0|||
161402361|NCT02876328|582859861|FG004|Overall Study|Death|0|||
161402362|NCT02876328|582859862|FG005|Overall Study|Death|0|||
161402363|NCT02876328|582859863|FG006|Overall Study|Death|1|||
161402364|NCT02876328|582859864|FG007|Overall Study|Death|3|||
161402365|NCT02876328|582859865|FG008|Overall Study|Death|0|||
161402366|NCT02876328|582859866|FG009|Overall Study|Death|1|||
161402367|NCT02876328|582859867|FG010|Overall Study|Death|1|||
161402368|NCT02876328|582859868|FG011|Overall Study|Death|0|||
161402369|NCT02876328|582859869|FG012|Overall Study|Death|0|||
161402370|NCT02876328|582859870|FG013|Overall Study|Death|0|||
161402371|NCT02876328|582859871|FG014|Overall Study|Death|0|||
161402372|NCT02876328|582859872|FG015|Overall Study|Death|0|||
161402373|NCT02876328|582859873|FG016|Overall Study|Death|1|||
161402374|NCT02876328|582859874|FG017|Overall Study|Death|1|||
161402375|NCT02876328|582859875|FG018|Overall Study|Death|0|||
161402376|NCT02876328|582859876|FG019|Overall Study|Death|0|||
161402377|NCT02876328|582859877|FG020|Overall Study|Death|0|||
161402378|NCT02876328|582859878|FG021|Overall Study|Death|1|||
161402379|NCT02876328|582859879|FG022|Overall Study|Death|0|||
161402380|NCT02876328|582859880|FG023|Overall Study|Death|0|||
161402381|NCT02876328|582859857|FG000|Overall Study|Withdrawal by Subject|0|||
161402382|NCT02876328|582859858|FG001|Overall Study|Withdrawal by Subject|2|||
161402383|NCT02876328|582859859|FG002|Overall Study|Withdrawal by Subject|3|||
161402384|NCT02876328|582859860|FG003|Overall Study|Withdrawal by Subject|3|||
161402385|NCT02876328|582859861|FG004|Overall Study|Withdrawal by Subject|0|||
161402386|NCT02876328|582859862|FG005|Overall Study|Withdrawal by Subject|1|||
161402387|NCT02876328|582859863|FG006|Overall Study|Withdrawal by Subject|0|||
161402388|NCT02876328|582859864|FG007|Overall Study|Withdrawal by Subject|1|||
161402389|NCT02876328|582859865|FG008|Overall Study|Withdrawal by Subject|1|||
161402390|NCT02876328|582859866|FG009|Overall Study|Withdrawal by Subject|2|||
161402391|NCT02876328|582859867|FG010|Overall Study|Withdrawal by Subject|0|||
161402392|NCT02876328|582859868|FG011|Overall Study|Withdrawal by Subject|0|||
161402393|NCT02876328|582859869|FG012|Overall Study|Withdrawal by Subject|0|||
161402394|NCT02876328|582859870|FG013|Overall Study|Withdrawal by Subject|0|||
161402395|NCT02876328|582859871|FG014|Overall Study|Withdrawal by Subject|0|||
161402396|NCT02876328|582859872|FG015|Overall Study|Withdrawal by Subject|0|||
161402397|NCT02876328|582859873|FG016|Overall Study|Withdrawal by Subject|1|||
161402398|NCT02876328|582859874|FG017|Overall Study|Withdrawal by Subject|3|||
161402399|NCT02876328|582859875|FG018|Overall Study|Withdrawal by Subject|0|||
161402400|NCT02876328|582859876|FG019|Overall Study|Withdrawal by Subject|0|||
161402401|NCT02876328|582859877|FG020|Overall Study|Withdrawal by Subject|1|||
161402402|NCT02876328|582859878|FG021|Overall Study|Withdrawal by Subject|0|||
161402403|NCT02876328|582859879|FG022|Overall Study|Withdrawal by Subject|0|||
161402404|NCT02876328|582859880|FG023|Overall Study|Withdrawal by Subject|0|||
161402405|NCT02876328|582859857|FG000|Overall Study|Missed 12 Month Visit|15|||
161402406|NCT02876328|582859858|FG001|Overall Study|Missed 12 Month Visit|10|||
161402407|NCT02876328|582859859|FG002|Overall Study|Missed 12 Month Visit|11|||
161402408|NCT02876328|582859860|FG003|Overall Study|Missed 12 Month Visit|6|||
161402409|NCT02876328|582859861|FG004|Overall Study|Missed 12 Month Visit|10|||
161402410|NCT02876328|582859862|FG005|Overall Study|Missed 12 Month Visit|14|||
161402411|NCT02876328|582859863|FG006|Overall Study|Missed 12 Month Visit|3|||
161402412|NCT02876328|582859864|FG007|Overall Study|Missed 12 Month Visit|8|||
161402413|NCT02876328|582859865|FG008|Overall Study|Missed 12 Month Visit|9|||
161402414|NCT02876328|582859866|FG009|Overall Study|Missed 12 Month Visit|5|||
161402415|NCT02876328|582859867|FG010|Overall Study|Missed 12 Month Visit|4|||
161402416|NCT02876328|582859868|FG011|Overall Study|Missed 12 Month Visit|1|||
161402417|NCT02876328|582859869|FG012|Overall Study|Missed 12 Month Visit|5|||
161402418|NCT02876328|582859870|FG013|Overall Study|Missed 12 Month Visit|4|||
161402419|NCT02876328|582859871|FG014|Overall Study|Missed 12 Month Visit|4|||
161402420|NCT02876328|582859872|FG015|Overall Study|Missed 12 Month Visit|4|||
161402421|NCT02876328|582859873|FG016|Overall Study|Missed 12 Month Visit|3|||
161402422|NCT02876328|582859874|FG017|Overall Study|Missed 12 Month Visit|6|||
161402423|NCT02876328|582859875|FG018|Overall Study|Missed 12 Month Visit|2|||
161402424|NCT02876328|582859876|FG019|Overall Study|Missed 12 Month Visit|2|||
161402425|NCT02876328|582859877|FG020|Overall Study|Missed 12 Month Visit|11|||
161402426|NCT02876328|582859878|FG021|Overall Study|Missed 12 Month Visit|7|||
161402427|NCT02876328|582859879|FG022|Overall Study|Missed 12 Month Visit|1|||
161402428|NCT02876328|582859880|FG023|Overall Study|Missed 12 Month Visit|0|||
161402429|NCT00837876|582859884|FG000|Overall Study|Death|2|||
161402430|NCT00837876|582859884|FG000|Overall Study|Adverse Event|7|||
161402431|NCT00837876|582859884|FG000|Overall Study|Physician Decision|1|||
161402432|NCT00837876|582859884|FG000|Overall Study|Withdrawal by Subject|3|||
161402433|NCT00837876|582859884|FG000|Overall Study|disease progression|24|||
161402434|NCT03464422|582859888|FG000|Overall Study|Lost to Follow-up|2|||
161402435|NCT03464422|582859888|FG000|Overall Study|Withdrawal by Subject|2|||
161402436|NCT01628367|582859889|FG000|Overall Study|Adverse Event|1|||
161402437|NCT01628367|582859890|FG001|Overall Study|Adverse Event|0|||
161402438|NCT04070326|582859897|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
161402439|NCT04070326|582859898|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
161402440|NCT03461406|582859902|FG000|Overall Study|Death|1|||
161402441|NCT03461406|582859903|FG001|Overall Study|Death|2|||
161402442|NCT03461406|582859902|FG000|Overall Study|Consent Withdrawn by Participant|0|||
161402443|NCT03461406|582859903|FG001|Overall Study|Consent Withdrawn by Participant|1|||
161402444|NCT03461406|582859902|FG000|Overall Study|Screen Failure|3|||
161402445|NCT03461406|582859903|FG001|Overall Study|Screen Failure|1|||
161402446|NCT03461406|582859902|FG000|Overall Study|Reason not Specified|1|||
161402447|NCT03461406|582859903|FG001|Overall Study|Reason not Specified|3|||
161402448|NCT03461406|582859902|FG000|Overall Study|Lost to Follow-up|3|||
161402449|NCT03461406|582859903|FG001|Overall Study|Lost to Follow-up|0|||
161402450|NCT03077698|582859904|FG000|Progestin Monotherapy|Stable Disease|8|||
161402451|NCT03077698|582859905|FG001|Progestin Monotherapy|Stable Disease|0|||
161402452|NCT03077698|582859904|FG000|Progestin Monotherapy|Adverse Event|1|||
161402453|NCT03077698|582859905|FG001|Progestin Monotherapy|Adverse Event|0|||
161402454|NCT03077698|582859904|FG000|Progestin Monotherapy|Death|1|||
161402455|NCT03077698|582859905|FG001|Progestin Monotherapy|Death|0|||
161402456|NCT03077698|582859904|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
161402457|NCT03077698|582859905|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
161402458|NCT03077698|582859904|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
161402459|NCT03077698|582859905|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
161402460|NCT03077698|582859904|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
161402461|NCT03077698|582859905|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
161402462|NCT03077698|582859904|FG000|Safety Follow Up|Withdrawal by Subject|2|||
161402463|NCT03077698|582859905|FG001|Safety Follow Up|Withdrawal by Subject|1|||
161402464|NCT03077698|582859904|FG000|Safety Follow Up|Transfer of care to hospice|1|||
161402465|NCT03077698|582859905|FG001|Safety Follow Up|Transfer of care to hospice|0|||
161402466|NCT01439074|582859906|FG000|Overall Study|Lost to Follow-up|3|||
161402467|NCT01439074|582859907|FG001|Overall Study|Lost to Follow-up|4|||
161402468|NCT01439074|582859906|FG000|Overall Study|Subject shedding|1|||
161402469|NCT01439074|582859907|FG001|Overall Study|Subject shedding|0|||
161402470|NCT01439074|582859906|FG000|Overall Study|Withdrawal by Subject|1|||
161402471|NCT01439074|582859907|FG001|Overall Study|Withdrawal by Subject|5|||
161402472|NCT01439074|582859906|FG000|Overall Study|Other|4|||
161402473|NCT01439074|582859907|FG001|Overall Study|Other|4|||
161402474|NCT01140568|582859908|FG000|Overall Study|disease progression|31|||
161402475|NCT01140568|582859908|FG000|Overall Study|Withdrawal by Subject|1|||
161402476|NCT01140568|582859908|FG000|Overall Study|Screen Fail|4|||
161402477|NCT01636713|582859910|FG000|Overall Study|Adverse Event|16|||
161402478|NCT01636713|582859911|FG001|Overall Study|Adverse Event|16|||
161402479|NCT01636713|582859912|FG002|Overall Study|Adverse Event|7|||
161402480|NCT01636713|582859910|FG000|Overall Study|Lack of Efficacy|6|||
161402481|NCT01636713|582859911|FG001|Overall Study|Lack of Efficacy|6|||
161402482|NCT01636713|582859912|FG002|Overall Study|Lack of Efficacy|2|||
161402483|NCT01636713|582859910|FG000|Overall Study|Protocol Violation|3|||
161402484|NCT01636713|582859911|FG001|Overall Study|Protocol Violation|0|||
161402485|NCT01636713|582859912|FG002|Overall Study|Protocol Violation|1|||
161402486|NCT01636713|582859910|FG000|Overall Study|Lost to Follow-up|0|||
161402487|NCT01636713|582859911|FG001|Overall Study|Lost to Follow-up|0|||
161402488|NCT01636713|582859912|FG002|Overall Study|Lost to Follow-up|1|||
161402489|NCT01636713|582859910|FG000|Overall Study|Withdrawal by Subject|5|||
161402490|NCT01636713|582859911|FG001|Overall Study|Withdrawal by Subject|4|||
161402491|NCT01636713|582859912|FG002|Overall Study|Withdrawal by Subject|8|||
161402492|NCT01636713|582859910|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161402493|NCT01636713|582859911|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161402494|NCT01636713|582859912|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
161402495|NCT02242981|582859919|FG000|Overall Study|Withdrawal by Subject|1|||
161402496|NCT03474081|582859920|FG000|Overall Study|Adverse Event|6|||
161402497|NCT03474081|582859921|FG001|Overall Study|Adverse Event|3|||
161402498|NCT03474081|582859920|FG000|Overall Study|Lost to Follow-up|2|||
161402499|NCT03474081|582859921|FG001|Overall Study|Lost to Follow-up|1|||
161402500|NCT03474081|582859920|FG000|Overall Study|Physician Decision|3|||
161402501|NCT03474081|582859921|FG001|Overall Study|Physician Decision|2|||
161402502|NCT03474081|582859920|FG000|Overall Study|Withdrawal by Subject|5|||
161402503|NCT03474081|582859921|FG001|Overall Study|Withdrawal by Subject|7|||
161402504|NCT03474081|582859920|FG000|Overall Study|Investigator site closed|1|||
161402505|NCT03474081|582859921|FG001|Overall Study|Investigator site closed|0|||
161402506|NCT01977690|582859922|FG000|Overall Study|Withdrawal by Subject|0|||
161402507|NCT01977690|582859923|FG001|Overall Study|Withdrawal by Subject|4|||
161402508|NCT01711866|582859927|FG000|Overall Study|Noncompliant|3|||
161402509|NCT01711866|582859927|FG000|Overall Study|Withdrawal by Subject|3|||
161402510|NCT01711866|582859927|FG000|Overall Study|Adverse Event|2|||
161402511|NCT00459537|582859928|FG000|Overall Study|Adverse Event|1|||
161402512|NCT00459537|582859929|FG001|Overall Study|Adverse Event|6|||
161402513|NCT00459537|582859928|FG000|Overall Study|Lack of Efficacy|10|||
161402514|NCT00459537|582859929|FG001|Overall Study|Lack of Efficacy|11|||
161402515|NCT00459537|582859928|FG000|Overall Study|Withdrawal by Subject|20|||
161402516|NCT00459537|582859929|FG001|Overall Study|Withdrawal by Subject|26|||
161402517|NCT00459537|582859928|FG000|Overall Study|Lost to Follow-up|27|||
161402518|NCT00459537|582859929|FG001|Overall Study|Lost to Follow-up|30|||
161402519|NCT00459537|582859928|FG000|Overall Study|Administrative problems|3|||
161402520|NCT00459537|582859929|FG001|Overall Study|Administrative problems|0|||
161402521|NCT00459537|582859928|FG000|Overall Study|Protocol Violation|4|||
161402522|NCT00459537|582859929|FG001|Overall Study|Protocol Violation|3|||
161402523|NCT00459537|582859928|FG000|Overall Study|Missing|1|||
161402524|NCT00459537|582859929|FG001|Overall Study|Missing|0|||
161402525|NCT00456599|582859931|FG000|Overall Study|Non-compliance|1|||
161402526|NCT00456599|582859931|FG000|Overall Study|Withdrawal by Subject|2|||
161402527|NCT02198235|582859932|FG000|Overall Study|Lost to Follow-up|3|||
161402528|NCT02198235|582859933|FG001|Overall Study|Lost to Follow-up|2|||
161402529|NCT02198235|582859934|FG002|Overall Study|Lost to Follow-up|2|||
161402530|NCT00260065|582859935|FG000|Overall Study|Progressive Disease|22|||
161402531|NCT00260065|582859935|FG000|Overall Study|Adverse Event|17|||
161402532|NCT00260065|582859935|FG000|Overall Study|Death|13|||
161402533|NCT00260065|582859935|FG000|Overall Study|Withdrawal by Subject|13|||
161402534|NCT00260065|582859935|FG000|Overall Study|Physician Decision|19|||
161402535|NCT00260065|582859935|FG000|Overall Study|Not otherwise specified|8|||
161402536|NCT00260065|582859935|FG000|Overall Study|Medication Noncompliance|1|||
161402537|NCT05565937|582861796|FG000|Overall Study|Adverse Event|0|||
161402538|NCT05565937|582861797|FG001|Overall Study|Adverse Event|1|||
161402539|NCT05565937|582861796|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
161402540|NCT05565937|582861797|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
161402541|NCT05565937|582861796|FG000|Overall Study|Lost to Follow-up|2|||
161402542|NCT05565937|582861797|FG001|Overall Study|Lost to Follow-up|0|||
161402543|NCT05565937|582861796|FG000|Overall Study|Pregnancy|0|||
161402544|NCT05565937|582861797|FG001|Overall Study|Pregnancy|2|||
161402545|NCT05565937|582861796|FG000|Overall Study|Anisometropia|0|||
161402546|NCT05565937|582861797|FG001|Overall Study|Anisometropia|1|||
161402547|NCT04544683|582861798|FG000|Overall Study|Lost to Follow-up|2|||
161402548|NCT04544683|582861798|FG000|Overall Study|Underwent cervical spine surgery|6|||
161402549|NCT00151372|582861799|FG000|Overall Study|Death|12|||
161402550|NCT00151372|582861800|FG001|Overall Study|Death|11|||
161402551|NCT00151372|582861799|FG000|Overall Study|Lost to Follow-up|5|||
161402552|NCT00151372|582861800|FG001|Overall Study|Lost to Follow-up|5|||
161402553|NCT00151372|582861799|FG000|Overall Study|Too sick medically to continue|5|||
161402554|NCT00151372|582861800|FG001|Overall Study|Too sick medically to continue|6|||
161402555|NCT00151372|582861799|FG000|Overall Study|Withdrawal by Subject|7|||
161402556|NCT00151372|582861800|FG001|Overall Study|Withdrawal by Subject|7|||
161402557|NCT04732949|582861801|FG000|Overall Study|Withdrawal by Subject|23|||
161402558|NCT04732949|582861802|FG001|Overall Study|Withdrawal by Subject|27|||
161402559|NCT04732949|582861801|FG000|Overall Study|Protocol Violation|0|||
161402560|NCT04732949|582861802|FG001|Overall Study|Protocol Violation|1|||
161402561|NCT04732949|582861801|FG000|Overall Study|Non-compliance|0|||
161402562|NCT04732949|582861802|FG001|Overall Study|Non-compliance|2|||
161402563|NCT04732949|582861801|FG000|Overall Study|Physician Decision|2|||
161402564|NCT04732949|582861802|FG001|Overall Study|Physician Decision|1|||
161402565|NCT04732949|582861801|FG000|Overall Study|Serious adverse event (Fatal)|16|||
161402566|NCT04732949|582861802|FG001|Overall Study|Serious adverse event (Fatal)|18|||
161402567|NCT04732949|582861801|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
161402568|NCT04732949|582861802|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
161402569|NCT04732949|582861801|FG000|Overall Study|Non-serious adverse event|1|||
161402570|NCT04732949|582861802|FG001|Overall Study|Non-serious adverse event|3|||
161402571|NCT04732949|582861801|FG000|Overall Study|Lost to Follow-up|26|||
161402572|NCT04732949|582861802|FG001|Overall Study|Lost to Follow-up|27|||
161402573|NCT04732949|582861801|FG000|Overall Study|Other|6|||
161402574|NCT04732949|582861802|FG001|Overall Study|Other|3|||
161402575|NCT01023672|582861803|FG000|Overall Study|Worsening disease|2|||
161402576|NCT01023672|582861803|FG000|Overall Study|Death|1|||
161402577|NCT01286077|582861804|FG000|Overall Study|Adverse Event|2|||
161402578|NCT01286077|582861805|FG001|Overall Study|Adverse Event|0|||
161402579|NCT01286077|582861804|FG000|Overall Study|Death|1|||
161402580|NCT01286077|582861805|FG001|Overall Study|Death|0|||
161402581|NCT01286077|582861804|FG000|Overall Study|Protocol Violation|1|||
161402582|NCT01286077|582861805|FG001|Overall Study|Protocol Violation|1|||
161402583|NCT01286077|582861804|FG000|Overall Study|Withdrawal by Subject|0|||
161402584|NCT01286077|582861805|FG001|Overall Study|Withdrawal by Subject|2|||
161402585|NCT01286077|582861804|FG000|Overall Study|Intercurrent illness|1|||
161402586|NCT01286077|582861805|FG001|Overall Study|Intercurrent illness|0|||
161402587|NCT01286077|582861804|FG000|Overall Study|Non-compliance|1|||
161402588|NCT01286077|582861805|FG001|Overall Study|Non-compliance|0|||
161402589|NCT01286077|582861804|FG000|Overall Study|The subject starts with alternative MMY|0|||
161402590|NCT01286077|582861805|FG001|Overall Study|The subject starts with alternative MMY|3|||
161402591|NCT01286077|582861804|FG000|Overall Study|Patient's decision to stop treatment|3|||
161402592|NCT01286077|582861805|FG001|Overall Study|Patient's decision to stop treatment|0|||
161402593|NCT01286077|582861804|FG000|Overall Study|Progression of disease|0|||
161402594|NCT01286077|582861805|FG001|Overall Study|Progression of disease|1|||
161402595|NCT01286077|582861804|FG000|Overall Study|refill medication not received in time|1|||
161402596|NCT01286077|582861805|FG001|Overall Study|refill medication not received in time|0|||
161402597|NCT01282294|582861806|FG000|Overall Study|Lost to Follow-up|14|||
161402598|NCT01282294|582861806|FG000|Overall Study|Screening failure|1|||
161402599|NCT01282294|582861806|FG000|Overall Study|Adverse Event|1|||
161402600|NCT01282294|582861806|FG000|Overall Study|Patient non-compliance|2|||
161402601|NCT01282294|582861806|FG000|Overall Study|Physician Decision|1|||
161402602|NCT02408523|582861807|FG000|Overall Study|Adverse Event|4|||
161402603|NCT02408523|582861808|FG001|Overall Study|Adverse Event|10|||
161402604|NCT02408523|582861807|FG000|Overall Study|Lack of Efficacy|0|||
161402605|NCT02408523|582861808|FG001|Overall Study|Lack of Efficacy|1|||
161402606|NCT02408523|582861807|FG000|Overall Study|Protocol Violation|1|||
161402607|NCT02408523|582861808|FG001|Overall Study|Protocol Violation|2|||
161402608|NCT02408523|582861807|FG000|Overall Study|Lost to Follow-up|2|||
161402609|NCT02408523|582861808|FG001|Overall Study|Lost to Follow-up|3|||
161402610|NCT02408523|582861807|FG000|Overall Study|Withdrawal by Subject|3|||
161402611|NCT02408523|582861808|FG001|Overall Study|Withdrawal by Subject|1|||
161402612|NCT02408523|582861807|FG000|Overall Study|Sponsor request|1|||
161402613|NCT02408523|582861808|FG001|Overall Study|Sponsor request|0|||
161402614|NCT02408523|582861807|FG000|Overall Study|Did not satisfy extension conditions|0|||
161402615|NCT02408523|582861808|FG001|Overall Study|Did not satisfy extension conditions|1|||
161402616|NCT00996801|582861812|FG000|Overall Study|Adverse Event|6|||
161402617|NCT00996801|582861813|FG001|Overall Study|Adverse Event|4|||
161402618|NCT00996801|582861814|FG002|Overall Study|Adverse Event|12|||
161402619|NCT00996801|582861815|FG003|Overall Study|Adverse Event|17|||
161402620|NCT00996801|582861816|FG004|Overall Study|Adverse Event|31|||
161402621|NCT00996801|582861817|FG005|Overall Study|Adverse Event|3|||
161402622|NCT00996801|582861812|FG000|Overall Study|Lack of Efficacy|3|||
161402623|NCT00996801|582861813|FG001|Overall Study|Lack of Efficacy|0|||
161402624|NCT00996801|582861814|FG002|Overall Study|Lack of Efficacy|1|||
161402625|NCT00996801|582861815|FG003|Overall Study|Lack of Efficacy|3|||
161402626|NCT00996801|582861816|FG004|Overall Study|Lack of Efficacy|0|||
161402627|NCT00996801|582861817|FG005|Overall Study|Lack of Efficacy|1|||
161402628|NCT00996801|582861812|FG000|Overall Study|Lost to Follow-up|0|||
161402629|NCT00996801|582861813|FG001|Overall Study|Lost to Follow-up|0|||
161402630|NCT00996801|582861814|FG002|Overall Study|Lost to Follow-up|0|||
161402631|NCT00996801|582861815|FG003|Overall Study|Lost to Follow-up|3|||
161402632|NCT00996801|582861816|FG004|Overall Study|Lost to Follow-up|3|||
161402633|NCT00996801|582861817|FG005|Overall Study|Lost to Follow-up|2|||
161402634|NCT00996801|582861812|FG000|Overall Study|Physician Decision|0|||
161402635|NCT00996801|582861813|FG001|Overall Study|Physician Decision|0|||
161402636|NCT00996801|582861814|FG002|Overall Study|Physician Decision|0|||
161402637|NCT00996801|582861815|FG003|Overall Study|Physician Decision|1|||
161402638|NCT00996801|582861816|FG004|Overall Study|Physician Decision|0|||
161402639|NCT00996801|582861817|FG005|Overall Study|Physician Decision|0|||
161402640|NCT00996801|582861812|FG000|Overall Study|Progressive Disease|0|||
161402641|NCT00996801|582861813|FG001|Overall Study|Progressive Disease|1|||
161402642|NCT00996801|582861814|FG002|Overall Study|Progressive Disease|0|||
161402643|NCT00996801|582861815|FG003|Overall Study|Progressive Disease|0|||
161402644|NCT00996801|582861816|FG004|Overall Study|Progressive Disease|0|||
161402645|NCT00996801|582861817|FG005|Overall Study|Progressive Disease|0|||
161402646|NCT00996801|582861812|FG000|Overall Study|Protocol Violation|3|||
161402647|NCT00996801|582861813|FG001|Overall Study|Protocol Violation|4|||
161402648|NCT00996801|582861814|FG002|Overall Study|Protocol Violation|1|||
161402649|NCT00996801|582861815|FG003|Overall Study|Protocol Violation|2|||
161402650|NCT00996801|582861816|FG004|Overall Study|Protocol Violation|3|||
161402651|NCT00996801|582861817|FG005|Overall Study|Protocol Violation|4|||
161402652|NCT00996801|582861812|FG000|Overall Study|Study Terminated by Sponsor|0|||
161402653|NCT00996801|582861813|FG001|Overall Study|Study Terminated by Sponsor|1|||
161402654|NCT00996801|582861814|FG002|Overall Study|Study Terminated by Sponsor|0|||
161402655|NCT00996801|582861815|FG003|Overall Study|Study Terminated by Sponsor|0|||
161402656|NCT00996801|582861816|FG004|Overall Study|Study Terminated by Sponsor|46|||
161402657|NCT00996801|582861817|FG005|Overall Study|Study Terminated by Sponsor|0|||
161402658|NCT00996801|582861812|FG000|Overall Study|Withdrawal by Subject|8|||
161402659|NCT00996801|582861813|FG001|Overall Study|Withdrawal by Subject|6|||
161402660|NCT00996801|582861814|FG002|Overall Study|Withdrawal by Subject|9|||
161402661|NCT00996801|582861815|FG003|Overall Study|Withdrawal by Subject|5|||
161402662|NCT00996801|582861816|FG004|Overall Study|Withdrawal by Subject|5|||
161402663|NCT00996801|582861817|FG005|Overall Study|Withdrawal by Subject|9|||
161402664|NCT00289198|582861818|FG000|Overall Study|Adverse Event|0|||
161402665|NCT00289198|582861819|FG001|Overall Study|Adverse Event|2|||
161402666|NCT00289198|582861818|FG000|Overall Study|Protocol Violation|2|||
161402667|NCT00289198|582861819|FG001|Overall Study|Protocol Violation|1|||
161402668|NCT00289198|582861818|FG000|Overall Study|Withdrawal by Subject|4|||
161402669|NCT00289198|582861819|FG001|Overall Study|Withdrawal by Subject|1|||
161402670|NCT00289198|582861818|FG000|Overall Study|Lack of Efficacy|2|||
161402671|NCT00289198|582861819|FG001|Overall Study|Lack of Efficacy|0|||
161402672|NCT00289198|582861818|FG000|Overall Study|Other: Low compliance|0|||
161402673|NCT00289198|582861819|FG001|Overall Study|Other: Low compliance|1|||
161402674|NCT00289198|582861818|FG000|Overall Study|Other: Physician's decision|0|||
161402675|NCT00289198|582861819|FG001|Overall Study|Other: Physician's decision|1|||
161402676|NCT00289198|582861818|FG000|Overall Study|Other: Unable to attend on schedule|2|||
161402677|NCT00289198|582861819|FG001|Overall Study|Other: Unable to attend on schedule|1|||
161402678|NCT00289198|582861818|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
161402679|NCT00289198|582861819|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
161402680|NCT00289198|582861818|FG000|Overall Study|Other: Impossible to come on visit|0|||
161402681|NCT00289198|582861819|FG001|Overall Study|Other: Impossible to come on visit|1|||
161402682|NCT03369431|582861821|FG000|Overall Study|Lost to Follow-up|1|||
161402683|NCT03369431|582861822|FG001|Overall Study|Lost to Follow-up|3|||
161402684|NCT03369431|582861821|FG000|Overall Study|Withdrawal by Subject|2|||
161402685|NCT03369431|582861822|FG001|Overall Study|Withdrawal by Subject|3|||
161402686|NCT03369431|582861821|FG000|Overall Study|Protocol Violation|1|||
161402687|NCT03369431|582861822|FG001|Overall Study|Protocol Violation|1|||
161402688|NCT01062061|582861823|FG000|Overall Study|Enrolled more than once|2|||
161402689|NCT01062061|582861823|FG000|Overall Study|Investigated before study start|13|||
161402690|NCT01062061|582861823|FG000|Overall Study|Outside chief indications|10|||
161402691|NCT01062061|582861823|FG000|Overall Study|Failed to meet inclusion criteria|2|||
161402692|NCT02046070|582861832|FG000|Overall Study|Progressive Disease|18|||
161402693|NCT02046070|582861833|FG001|Overall Study|Progressive Disease|11|||
161402694|NCT02046070|582861834|FG002|Overall Study|Progressive Disease|40|||
161402695|NCT02046070|582861832|FG000|Overall Study|Adverse Event|8|||
161402696|NCT02046070|582861833|FG001|Overall Study|Adverse Event|10|||
161402697|NCT02046070|582861834|FG002|Overall Study|Adverse Event|17|||
161402698|NCT02046070|582861832|FG000|Overall Study|Withdrawal by Subject|1|||
161402699|NCT02046070|582861833|FG001|Overall Study|Withdrawal by Subject|2|||
161402700|NCT02046070|582861834|FG002|Overall Study|Withdrawal by Subject|6|||
161402701|NCT02046070|582861832|FG000|Overall Study|Study Terminated by Sponsor|1|||
161402702|NCT02046070|582861833|FG001|Overall Study|Study Terminated by Sponsor|1|||
161402703|NCT02046070|582861834|FG002|Overall Study|Study Terminated by Sponsor|1|||
161402704|NCT02046070|582861832|FG000|Overall Study|Reason not Specified|4|||
161402705|NCT02046070|582861833|FG001|Overall Study|Reason not Specified|4|||
161402706|NCT02046070|582861834|FG002|Overall Study|Reason not Specified|6|||
161402707|NCT04619004|582861835|FG000|Overall Study|Death|114|||
161402708|NCT04619004|582861836|FG001|Overall Study|Death|28|||
161402709|NCT04619004|582861835|FG000|Overall Study|Lost to Follow-up|1|||
161402710|NCT04619004|582861836|FG001|Overall Study|Lost to Follow-up|1|||
161402711|NCT04619004|582861835|FG000|Overall Study|Withdrawal by Subject|24|||
161402712|NCT04619004|582861836|FG001|Overall Study|Withdrawal by Subject|7|||
161402713|NCT04619004|582861835|FG000|Overall Study|Other - Not specified|0|||
161402714|NCT04619004|582861836|FG001|Overall Study|Other - Not specified|1|||
161402715|NCT05601102|582861840|FG000|Overall Study|Death|1|||
161402716|NCT05601102|582861841|FG001|Overall Study|Death|2|||
161402717|NCT05601102|582861840|FG000|Overall Study|Withdrawal by Subject|1|||
161402718|NCT05601102|582861841|FG001|Overall Study|Withdrawal by Subject|1|||
161402719|NCT05601102|582861840|FG000|Overall Study|Lost to Follow-up|0|||
161402720|NCT05601102|582861841|FG001|Overall Study|Lost to Follow-up|2|||
161402721|NCT04284813|582861846|FG000|Overall Study|Withdrawal by Subject|1|||
161402722|NCT01145053|582861852|FG000|Overall Study|Adverse Event|22|||
161402723|NCT01145053|582861852|FG000|Overall Study|Lost to Follow-up|28|||
161402724|NCT01145053|582861852|FG000|Overall Study|Withdrawal by Subject|25|||
161402725|NCT01145053|582861852|FG000|Overall Study|Other|18|||
161402726|NCT00293709|582861853|FG000|Overall Study|Other|47|||
161402727|NCT02785458|582861854|FG000|1 Month|Withdrawal by Subject|2|||
161402728|NCT02785458|582861855|FG001|1 Month|Withdrawal by Subject|1|||
161402729|NCT02785458|582861854|FG000|1 Month|Lost to Follow-up|38|||
161402730|NCT02785458|582861855|FG001|1 Month|Lost to Follow-up|31|||
161402731|NCT02785458|582861854|FG000|1 Month|Deemed Ineligible|1|||
161402732|NCT02785458|582861855|FG001|1 Month|Deemed Ineligible|0|||
161402733|NCT02785458|582861854|FG000|1 Month|Completed Evaluation by Baseline|42|||
161402734|NCT02785458|582861855|FG001|1 Month|Completed Evaluation by Baseline|39|||
161402735|NCT02785458|582861854|FG000|1 Month|Partial Interview|0|||
161402736|NCT02785458|582861855|FG001|1 Month|Partial Interview|4|||
161402737|NCT02785458|582861854|FG000|3 Months|Withdrawal by Subject|3|||
161402738|NCT02785458|582861855|FG001|3 Months|Withdrawal by Subject|1|||
161402739|NCT02785458|582861854|FG000|3 Months|Lost to Follow-up|25|||
161402740|NCT02785458|582861855|FG001|3 Months|Lost to Follow-up|21|||
161402741|NCT02785458|582861854|FG000|3 Months|Completed Evaluation at 1 Month|100|||
161402742|NCT02785458|582861855|FG001|3 Months|Completed Evaluation at 1 Month|89|||
161402743|NCT01146652|582861856|FG000|Overall Study|Adverse Event|506|||
161402744|NCT01146652|582861857|FG001|Overall Study|Adverse Event|15|||
161402745|NCT01146652|582861856|FG000|Overall Study|Lack of Efficacy|91|||
161402746|NCT01146652|582861857|FG001|Overall Study|Lack of Efficacy|7|||
161402747|NCT01146652|582861856|FG000|Overall Study|Poor compliance to protocol|38|||
161402748|NCT01146652|582861857|FG001|Overall Study|Poor compliance to protocol|1|||
161402749|NCT01146652|582861856|FG000|Overall Study|Other unspecified reasons|314|||
161402750|NCT01146652|582861857|FG001|Overall Study|Other unspecified reasons|22|||
161402751|NCT01146652|582861856|FG000|Overall Study|Enrolled but not treated|2|||
161402752|NCT01146652|582861857|FG001|Overall Study|Enrolled but not treated|0|||
161402753|NCT02590562|582861863|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
161402754|NCT01457950|582861864|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
161402755|NCT01457950|582861865|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
161402756|NCT01457950|582861866|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
161402757|NCT01457950|582861867|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
161402758|NCT01457950|582861864|FG000|Double-Blind Phase|Protocol Violation|2|||
161402759|NCT01457950|582861865|FG001|Double-Blind Phase|Protocol Violation|1|||
161402760|NCT01457950|582861866|FG002|Double-Blind Phase|Protocol Violation|0|||
161402761|NCT01457950|582861867|FG003|Double-Blind Phase|Protocol Violation|0|||
161402762|NCT01457950|582861864|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
161402763|NCT01457950|582861865|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161402764|NCT01457950|582861866|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161402765|NCT01457950|582861867|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161402766|NCT01457950|582861864|FG000|Open-Label Phase|Adverse Event|0|||
161402767|NCT01457950|582861865|FG001|Open-Label Phase|Adverse Event|0|||
161402768|NCT01457950|582861866|FG002|Open-Label Phase|Adverse Event|0|||
161402769|NCT01457950|582861867|FG003|Open-Label Phase|Adverse Event|1|||
161402770|NCT01457950|582861864|FG000|Open-Label Phase|Protocol Violation|0|||
161402771|NCT01457950|582861865|FG001|Open-Label Phase|Protocol Violation|0|||
161402772|NCT01457950|582861866|FG002|Open-Label Phase|Protocol Violation|0|||
161402773|NCT01457950|582861867|FG003|Open-Label Phase|Protocol Violation|1|||
161402774|NCT01457950|582861864|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161402775|NCT01457950|582861865|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161402776|NCT01457950|582861866|FG002|Open-Label Phase|Withdrawal by Subject|2|||
161402777|NCT01457950|582861867|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161402778|NCT03684304|582861868|FG000|Overall Study|Lost to Follow-up|19|||
161402779|NCT03684304|582861869|FG001|Overall Study|Lost to Follow-up|17|||
161402780|NCT00824005|582861870|FG000|Overall Study|Death|0|||
161402781|NCT00824005|582861871|FG001|Overall Study|Death|1|||
161402782|NCT00824005|582861870|FG000|Overall Study|Lost to Follow-up|0|||
161402783|NCT00824005|582861871|FG001|Overall Study|Lost to Follow-up|1|||
161402784|NCT02677844|582861872|FG000|Period 3|Withdrawal by Subject|0|||
161402785|NCT02677844|582861873|FG001|Period 3|Withdrawal by Subject|0|||
161402786|NCT02677844|582861874|FG002|Period 3|Withdrawal by Subject|0|||
161402787|NCT02677844|582861875|FG003|Period 3|Withdrawal by Subject|1|||
161402788|NCT02677844|582861876|FG004|Period 3|Withdrawal by Subject|0|||
161402789|NCT02677844|582861877|FG005|Period 3|Withdrawal by Subject|0|||
161402790|NCT02677844|582861878|FG006|Period 3|Withdrawal by Subject|0|||
161402791|NCT03458702|582861879|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
161402792|NCT03458702|582861880|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
161402793|NCT03458702|582861879|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
161402794|NCT03458702|582861880|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
161402795|NCT02231762|582861883|FG000|Combination Phase|Adverse Event|10|||
161402796|NCT02231762|582861884|FG001|Combination Phase|Adverse Event|0|||
161402797|NCT02231762|582861885|FG002|Combination Phase|Adverse Event|0|||
161402798|NCT02231762|582861886|FG003|Combination Phase|Adverse Event|0|||
161402799|NCT02231762|582861883|FG000|Combination Phase|Withdrawal by Subject|2|||
161402800|NCT02231762|582861884|FG001|Combination Phase|Withdrawal by Subject|0|||
161402801|NCT02231762|582861885|FG002|Combination Phase|Withdrawal by Subject|0|||
161402802|NCT02231762|582861886|FG003|Combination Phase|Withdrawal by Subject|0|||
161402803|NCT02231762|582861883|FG000|Combination Phase|Disease Progression|6|||
161402804|NCT02231762|582861884|FG001|Combination Phase|Disease Progression|0|||
161402805|NCT02231762|582861885|FG002|Combination Phase|Disease Progression|0|||
161402806|NCT02231762|582861886|FG003|Combination Phase|Disease Progression|0|||
161402807|NCT02231762|582861883|FG000|Combination Phase|Did not meet inclusion criteria|1|||
161402808|NCT02231762|582861884|FG001|Combination Phase|Did not meet inclusion criteria|0|||
161402809|NCT02231762|582861885|FG002|Combination Phase|Did not meet inclusion criteria|0|||
161402810|NCT02231762|582861886|FG003|Combination Phase|Did not meet inclusion criteria|0|||
161402811|NCT02231762|582861883|FG000|Combination Phase|Protocol Violation|1|||
161402812|NCT02231762|582861884|FG001|Combination Phase|Protocol Violation|0|||
161402813|NCT02231762|582861885|FG002|Combination Phase|Protocol Violation|0|||
161402814|NCT02231762|582861886|FG003|Combination Phase|Protocol Violation|0|||
161402815|NCT02231762|582861883|FG000|Maintenance Phase|Disease progression|0|||
161402816|NCT02231762|582861884|FG001|Maintenance Phase|Disease progression|3|||
161402817|NCT02231762|582861885|FG002|Maintenance Phase|Disease progression|4|||
161402818|NCT02231762|582861886|FG003|Maintenance Phase|Disease progression|3|||
161402819|NCT02231762|582861883|FG000|Maintenance Phase|Adverse Event|0|||
161402820|NCT02231762|582861884|FG001|Maintenance Phase|Adverse Event|0|||
161402821|NCT02231762|582861885|FG002|Maintenance Phase|Adverse Event|1|||
161402822|NCT02231762|582861886|FG003|Maintenance Phase|Adverse Event|2|||
161402823|NCT01697462|582861891|FG000|Overall Study|Disease Progression|1|||
161402824|NCT01697462|582861891|FG000|Overall Study|Adverse Event|6|||
161402825|NCT01697462|582861891|FG000|Overall Study|Lost to Follow-up|21|||
161402826|NCT01697462|582861891|FG000|Overall Study|Withdrawal by Subject|12|||
161402827|NCT01697462|582861891|FG000|Overall Study|Investigator Decision|21|||
161402828|NCT01697462|582861891|FG000|Overall Study|Death|1|||
161402829|NCT01697462|582861891|FG000|Overall Study|Other|10|||
161402830|NCT01697462|582861891|FG000|Overall Study|Missing|5|||
161402831|NCT02699450|582861893|FG000|Overall Study|Death|2|||
161402832|NCT02699450|582861894|FG001|Overall Study|Death|1|||
161402833|NCT02699450|582861895|FG002|Overall Study|Death|2|||
161402834|NCT02699450|582861893|FG000|Overall Study|Met Criteria for Study Exit|0|||
161402835|NCT02699450|582861894|FG001|Overall Study|Met Criteria for Study Exit|0|||
161402836|NCT02699450|582861895|FG002|Overall Study|Met Criteria for Study Exit|1|||
161402837|NCT02699450|582861893|FG000|Overall Study|Protocol Violation|4|||
161402838|NCT02699450|582861894|FG001|Overall Study|Protocol Violation|3|||
161402839|NCT02699450|582861895|FG002|Overall Study|Protocol Violation|5|||
161402840|NCT02699450|582861893|FG000|Overall Study|Lost to Follow-up|3|||
161402841|NCT02699450|582861894|FG001|Overall Study|Lost to Follow-up|0|||
161402842|NCT02699450|582861895|FG002|Overall Study|Lost to Follow-up|5|||
161402843|NCT02699450|582861893|FG000|Overall Study|Physician Decision|2|||
161402844|NCT02699450|582861894|FG001|Overall Study|Physician Decision|0|||
161402845|NCT02699450|582861895|FG002|Overall Study|Physician Decision|0|||
161402846|NCT02699450|582861893|FG000|Overall Study|Withdrawal by Subject|3|||
161402847|NCT02699450|582861894|FG001|Overall Study|Withdrawal by Subject|1|||
161402848|NCT02699450|582861895|FG002|Overall Study|Withdrawal by Subject|2|||
161402849|NCT02699450|582861893|FG000|Overall Study|Adverse Event|1|||
161402850|NCT02699450|582861894|FG001|Overall Study|Adverse Event|0|||
161402851|NCT02699450|582861895|FG002|Overall Study|Adverse Event|0|||
161402852|NCT03689712|582861896|FG000|Overall Study|Adverse Event|1|||
161402853|NCT03689712|582861897|FG001|Overall Study|Adverse Event|0|||
161402854|NCT03689712|582861896|FG000|Overall Study|Death|20|||
161402855|NCT03689712|582861897|FG001|Overall Study|Death|10|||
161402856|NCT03689712|582861896|FG000|Overall Study|Lost to Follow-up|6|||
161402857|NCT03689712|582861897|FG001|Overall Study|Lost to Follow-up|6|||
161402858|NCT03689712|582861896|FG000|Overall Study|Other|1|||
161402859|NCT03689712|582861897|FG001|Overall Study|Other|0|||
161402860|NCT03689712|582861896|FG000|Overall Study|Patient Non-Compliance|0|||
161402861|NCT03689712|582861897|FG001|Overall Study|Patient Non-Compliance|1|||
161402862|NCT03689712|582861896|FG000|Overall Study|Withdrawal by Subject|20|||
161402863|NCT03689712|582861897|FG001|Overall Study|Withdrawal by Subject|4|||
161402864|NCT03689712|582861896|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
161402865|NCT03689712|582861897|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
161402866|NCT03689712|582861896|FG000|Overall Study|Randomized but not Treated|13|||
161402867|NCT03689712|582861897|FG001|Overall Study|Randomized but not Treated|7|||
161402868|NCT03689712|582861896|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
161402869|NCT03689712|582861897|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
161402870|NCT01133275|582861898|FG000|Overall Study|Withdrawal by Subject|1|||
161402871|NCT01133275|582861898|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
161402872|NCT01635764|582861903|FG000|Overall Study|Adverse Event|46|||
161402873|NCT01635764|582861903|FG000|Overall Study|Lack of Efficacy|76|||
161402874|NCT01635764|582861903|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
161402875|NCT01635764|582861903|FG000|Overall Study|Protocol Deviation|1|||
161402876|NCT01635764|582861903|FG000|Overall Study|Withdrew Consent|67|||
161402877|NCT01635764|582861903|FG000|Overall Study|Lost to Follow-up|53|||
161402878|NCT01635764|582861903|FG000|Overall Study|Other|28|||
161402879|NCT02266875|582861905|FG000|Overall Study|Withdrawal by Subject|9|||
161402880|NCT02266875|582861906|FG001|Overall Study|Withdrawal by Subject|0|||
161402881|NCT02266875|582861905|FG000|Overall Study|Lost to Follow-up|2|||
161402882|NCT02266875|582861906|FG001|Overall Study|Lost to Follow-up|0|||
161402883|NCT01816906|582861907|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
161402884|NCT01816906|582861908|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
161402885|NCT01816906|582861907|FG000|Six Months|Lost to Follow-up|14|||
161402886|NCT01816906|582861908|FG001|Six Months|Lost to Follow-up|16|||
161402887|NCT01816906|582861907|FG000|12 Months|Adverse Event|2|||
161402888|NCT01816906|582861908|FG001|12 Months|Adverse Event|2|||
161402889|NCT01816906|582861907|FG000|12 Months|Death|0|||
161402890|NCT01816906|582861908|FG001|12 Months|Death|2|||
161402891|NCT01816906|582861907|FG000|12 Months|Lost to Follow-up|2|||
161402892|NCT01816906|582861908|FG001|12 Months|Lost to Follow-up|1|||
161402893|NCT00086502|582861909|FG000|Overall Study|Adverse Event|11|||
161402894|NCT00086502|582861910|FG001|Overall Study|Adverse Event|2|||
161402895|NCT00086502|582861909|FG000|Overall Study|Lack of Efficacy|0|||
161402896|NCT00086502|582861910|FG001|Overall Study|Lack of Efficacy|2|||
161402897|NCT00086502|582861909|FG000|Overall Study|Lost to Follow-up|3|||
161402898|NCT00086502|582861910|FG001|Overall Study|Lost to Follow-up|1|||
161402899|NCT00086502|582861909|FG000|Overall Study|Physician Decision|1|||
161402900|NCT00086502|582861910|FG001|Overall Study|Physician Decision|1|||
161402901|NCT00086502|582861909|FG000|Overall Study|Pregnancy|0|||
161402902|NCT00086502|582861910|FG001|Overall Study|Pregnancy|1|||
161402903|NCT00086502|582861909|FG000|Overall Study|Protocol Violation|3|||
161402904|NCT00086502|582861910|FG001|Overall Study|Protocol Violation|3|||
161402905|NCT00086502|582861909|FG000|Overall Study|Withdrawal by Subject|5|||
161402906|NCT00086502|582861910|FG001|Overall Study|Withdrawal by Subject|6|||
161402907|NCT00086502|582861909|FG000|Overall Study|Patient Moved|1|||
161402908|NCT00086502|582861910|FG001|Overall Study|Patient Moved|1|||
161402909|NCT00086502|582861909|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
161402910|NCT00086502|582861910|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
161402911|NCT00086502|582861909|FG000|Overall Study|Patient Accidentally Unblinded|1|||
161402912|NCT00086502|582861910|FG001|Overall Study|Patient Accidentally Unblinded|0|||
161402913|NCT01304329|582861911|FG000|Third Intervention (3 Days)|Adverse Event|0|||
161402914|NCT01304329|582861912|FG001|Third Intervention (3 Days)|Adverse Event|1|||
161402915|NCT01304329|582861913|FG002|Third Intervention (3 Days)|Adverse Event|0|||
161402916|NCT01304329|582861914|FG003|Third Intervention (3 Days)|Adverse Event|0|||
161402917|NCT01304329|582861915|FG004|Third Intervention (3 Days)|Adverse Event|0|||
161402918|NCT01304329|582861916|FG005|Third Intervention (3 Days)|Adverse Event|0|||
161402919|NCT05545644|582861921|FG000|Overall Study|Lost to Follow-up|4|||
161402920|NCT05545644|582861922|FG001|Overall Study|Lost to Follow-up|3|||
161402921|NCT01420627|582861925|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
161402922|NCT01490294|582861926|FG000|Overall Study|Prematurely discontinuation|4|||
161402923|NCT01490294|582861927|FG001|Overall Study|Prematurely discontinuation|0|||
161402924|NCT01490294|582861928|FG002|Overall Study|Prematurely discontinuation|1|||
161402925|NCT01490294|582861929|FG003|Overall Study|Prematurely discontinuation|1|||
161402926|NCT01490294|582861926|FG000|Overall Study|Adverse Event|1|||
161402927|NCT01490294|582861927|FG001|Overall Study|Adverse Event|0|||
161402928|NCT01490294|582861928|FG002|Overall Study|Adverse Event|0|||
161402929|NCT01490294|582861929|FG003|Overall Study|Adverse Event|0|||
161402930|NCT02210091|582861935|FG000|Overall Study|Physician Decision|0|||
161402931|NCT02210091|582861936|FG001|Overall Study|Physician Decision|1|||
161402932|NCT02210091|582861935|FG000|Overall Study|Withdrawal by Sponsor|0|||
161402933|NCT02210091|582861936|FG001|Overall Study|Withdrawal by Sponsor|1|||
161402934|NCT01831817|582861937|FG000|Overall Study|Lost to Follow-up|1|||
161402935|NCT01831817|582861938|FG001|Overall Study|Lost to Follow-up|0|||
161402936|NCT01831817|582861939|FG002|Overall Study|Lost to Follow-up|0|||
161402937|NCT01831817|582861940|FG003|Overall Study|Lost to Follow-up|0|||
161402938|NCT01831817|582861937|FG000|Overall Study|Withdrawl of Consent|3|||
161402939|NCT01831817|582861938|FG001|Overall Study|Withdrawl of Consent|0|||
161402940|NCT01831817|582861939|FG002|Overall Study|Withdrawl of Consent|0|||
161402941|NCT01831817|582861940|FG003|Overall Study|Withdrawl of Consent|0|||
161402942|NCT00958217|582861941|FG000|Overall Study|Death|2|||
161402943|NCT00958217|582861942|FG001|Overall Study|Death|1|||
161402944|NCT00958217|582861941|FG000|Overall Study|Withdrawal by Subject|4|||
161402945|NCT00958217|582861942|FG001|Overall Study|Withdrawal by Subject|3|||
161402946|NCT00958217|582861941|FG000|Overall Study|Lost to Follow-up|17|||
161402947|NCT00958217|582861942|FG001|Overall Study|Lost to Follow-up|19|||
161402948|NCT00958217|582861941|FG000|Overall Study|Moved out of area|1|||
161402949|NCT00958217|582861942|FG001|Overall Study|Moved out of area|1|||
161402950|NCT00958217|582861941|FG000|Overall Study|Inpatient hospitalization|0|||
161402951|NCT00958217|582861942|FG001|Overall Study|Inpatient hospitalization|1|||
161402952|NCT02440789|582861943|FG000|Overall Study|Withdrawal by Subject|3|||
161402953|NCT02440789|582861943|FG000|Overall Study|Not willing to adhere to reqs|1|||
161402954|NCT01999218|582861944|FG000|Overall Study|Hyperglycemia|18|||
161402955|NCT01999218|582861945|FG001|Overall Study|Hyperglycemia|17|||
161402956|NCT01999218|582861946|FG002|Overall Study|Hyperglycemia|17|||
161402957|NCT01999218|582861944|FG000|Overall Study|Lack of Efficacy|1|||
161402958|NCT01999218|582861945|FG001|Overall Study|Lack of Efficacy|0|||
161402959|NCT01999218|582861946|FG002|Overall Study|Lack of Efficacy|1|||
161402960|NCT01999218|582861944|FG000|Overall Study|Lost to Follow-up|22|||
161402961|NCT01999218|582861945|FG001|Overall Study|Lost to Follow-up|17|||
161402962|NCT01999218|582861946|FG002|Overall Study|Lost to Follow-up|18|||
161402963|NCT01999218|582861944|FG000|Overall Study|Non-Compliance With Study Drug|6|||
161402964|NCT01999218|582861945|FG001|Overall Study|Non-Compliance With Study Drug|4|||
161402965|NCT01999218|582861946|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161402966|NCT01999218|582861944|FG000|Overall Study|Physician Decision|1|||
161402967|NCT01999218|582861945|FG001|Overall Study|Physician Decision|4|||
161402968|NCT01999218|582861946|FG002|Overall Study|Physician Decision|6|||
161402969|NCT01999218|582861944|FG000|Overall Study|Protocol Violation|4|||
161402970|NCT01999218|582861945|FG001|Overall Study|Protocol Violation|5|||
161402971|NCT01999218|582861946|FG002|Overall Study|Protocol Violation|4|||
161402972|NCT01999218|582861944|FG000|Overall Study|Screen failure|0|||
161402973|NCT01999218|582861945|FG001|Overall Study|Screen failure|1|||
161402974|NCT01999218|582861946|FG002|Overall Study|Screen failure|0|||
161402975|NCT01999218|582861944|FG000|Overall Study|Study Terminated By Sponsor|7|||
161402976|NCT01999218|582861945|FG001|Overall Study|Study Terminated By Sponsor|5|||
161402977|NCT01999218|582861946|FG002|Overall Study|Study Terminated By Sponsor|12|||
161402978|NCT01999218|582861944|FG000|Overall Study|Participant moves|2|||
161402979|NCT01999218|582861945|FG001|Overall Study|Participant moves|5|||
161402980|NCT01999218|582861946|FG002|Overall Study|Participant moves|3|||
161402981|NCT01999218|582861944|FG000|Overall Study|Withdrawal by Subject|28|||
161402982|NCT01999218|582861945|FG001|Overall Study|Withdrawal by Subject|29|||
161402983|NCT01999218|582861946|FG002|Overall Study|Withdrawal by Subject|34|||
161402984|NCT01999218|582861944|FG000|Overall Study|Creatinine/eGFR|0|||
161402985|NCT01999218|582861945|FG001|Overall Study|Creatinine/eGFR|0|||
161402986|NCT01999218|582861946|FG002|Overall Study|Creatinine/eGFR|1|||
161402987|NCT01999218|582861944|FG000|Overall Study|Death|7|||
161402988|NCT01999218|582861945|FG001|Overall Study|Death|1|||
161402989|NCT01999218|582861946|FG002|Overall Study|Death|2|||
161402990|NCT01999218|582861944|FG000|Overall Study|Excluded Medication|1|||
161402991|NCT01999218|582861945|FG001|Overall Study|Excluded Medication|1|||
161402992|NCT01999218|582861946|FG002|Overall Study|Excluded Medication|2|||
161402993|NCT01999218|582861944|FG000|Overall Study|Adverse Event|9|||
161402994|NCT01999218|582861945|FG001|Overall Study|Adverse Event|7|||
161402995|NCT01999218|582861946|FG002|Overall Study|Adverse Event|7|||
161402996|NCT01999218|582861944|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
161402997|NCT01999218|582861945|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
161402998|NCT01999218|582861946|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
161402999|NCT01266590|582864081|FG000|Overall Study|Adverse Event|3|||
161403000|NCT01266590|582864081|FG000|Overall Study|Lost to Follow-up|1|||
161403001|NCT01266590|582864081|FG000|Overall Study|Withdrawal by Subject|1|||
161403002|NCT01266590|582864081|FG000|Overall Study|Physician Decision|1|||
161403003|NCT02654236|582864084|FG000|Overall Study|Withdrawal by Subject|0|||
161403004|NCT02654236|582864085|FG001|Overall Study|Withdrawal by Subject|0|||
161403005|NCT02654236|582864086|FG002|Overall Study|Withdrawal by Subject|2|||
161403006|NCT01549873|582864087|FG000|Overall Study|Physician Decision|0|||
161403007|NCT01549873|582864088|FG001|Overall Study|Physician Decision|1|||
161403008|NCT02905006|582864089|FG000|Overall Study|Adverse Event|1|||
161403009|NCT02905006|582864090|FG001|Overall Study|Adverse Event|1|||
161403010|NCT02905006|582864091|FG002|Overall Study|Adverse Event|1|||
161403011|NCT02905006|582864092|FG003|Overall Study|Adverse Event|1|||
161403012|NCT02905006|582864093|FG004|Overall Study|Adverse Event|0|||
161403013|NCT02905006|582864094|FG005|Overall Study|Adverse Event|1|||
161403014|NCT02905006|582864089|FG000|Overall Study|Lack of Efficacy|1|||
161403015|NCT02905006|582864090|FG001|Overall Study|Lack of Efficacy|0|||
161403016|NCT02905006|582864091|FG002|Overall Study|Lack of Efficacy|0|||
161403017|NCT02905006|582864092|FG003|Overall Study|Lack of Efficacy|0|||
161403018|NCT02905006|582864093|FG004|Overall Study|Lack of Efficacy|0|||
161403019|NCT02905006|582864094|FG005|Overall Study|Lack of Efficacy|0|||
161403020|NCT02905006|582864089|FG000|Overall Study|Protocol Violation|2|||
161403021|NCT02905006|582864090|FG001|Overall Study|Protocol Violation|0|||
161403022|NCT02905006|582864091|FG002|Overall Study|Protocol Violation|0|||
161403023|NCT02905006|582864092|FG003|Overall Study|Protocol Violation|0|||
161403024|NCT02905006|582864093|FG004|Overall Study|Protocol Violation|0|||
161403025|NCT02905006|582864094|FG005|Overall Study|Protocol Violation|0|||
161403026|NCT02905006|582864089|FG000|Overall Study|Lost to Follow-up|0|||
161403027|NCT02905006|582864090|FG001|Overall Study|Lost to Follow-up|0|||
161403028|NCT02905006|582864091|FG002|Overall Study|Lost to Follow-up|0|||
161403029|NCT02905006|582864092|FG003|Overall Study|Lost to Follow-up|1|||
161403030|NCT02905006|582864093|FG004|Overall Study|Lost to Follow-up|1|||
161403031|NCT02905006|582864094|FG005|Overall Study|Lost to Follow-up|0|||
161403032|NCT02905006|582864089|FG000|Overall Study|Withdrawal by Subject|0|||
161403033|NCT02905006|582864090|FG001|Overall Study|Withdrawal by Subject|0|||
161403034|NCT02905006|582864091|FG002|Overall Study|Withdrawal by Subject|1|||
161403035|NCT02905006|582864092|FG003|Overall Study|Withdrawal by Subject|1|||
161403036|NCT02905006|582864093|FG004|Overall Study|Withdrawal by Subject|0|||
161403037|NCT02905006|582864094|FG005|Overall Study|Withdrawal by Subject|1|||
161403038|NCT02905006|582864089|FG000|Overall Study|Screening exclusion criteria met|1|||
161403039|NCT02905006|582864090|FG001|Overall Study|Screening exclusion criteria met|0|||
161403040|NCT02905006|582864091|FG002|Overall Study|Screening exclusion criteria met|0|||
161403041|NCT02905006|582864092|FG003|Overall Study|Screening exclusion criteria met|0|||
161403042|NCT02905006|582864093|FG004|Overall Study|Screening exclusion criteria met|0|||
161403043|NCT02905006|582864094|FG005|Overall Study|Screening exclusion criteria met|0|||
161403044|NCT02905006|582864089|FG000|Overall Study|Lab withdrawal criterion met|0|||
161403045|NCT02905006|582864090|FG001|Overall Study|Lab withdrawal criterion met|1|||
161403046|NCT02905006|582864091|FG002|Overall Study|Lab withdrawal criterion met|2|||
161403047|NCT02905006|582864092|FG003|Overall Study|Lab withdrawal criterion met|2|||
161403048|NCT02905006|582864093|FG004|Overall Study|Lab withdrawal criterion met|2|||
161403049|NCT02905006|582864094|FG005|Overall Study|Lab withdrawal criterion met|1|||
161403050|NCT02905006|582864089|FG000|Overall Study|Positive for Tuberculosis|0|||
161403051|NCT02905006|582864090|FG001|Overall Study|Positive for Tuberculosis|1|||
161403052|NCT02905006|582864091|FG002|Overall Study|Positive for Tuberculosis|0|||
161403053|NCT02905006|582864092|FG003|Overall Study|Positive for Tuberculosis|0|||
161403054|NCT02905006|582864093|FG004|Overall Study|Positive for Tuberculosis|0|||
161403055|NCT02905006|582864094|FG005|Overall Study|Positive for Tuberculosis|0|||
161403056|NCT02905006|582864089|FG000|Overall Study|Subject positive for Hep B|0|||
161403057|NCT02905006|582864090|FG001|Overall Study|Subject positive for Hep B|0|||
161403058|NCT02905006|582864091|FG002|Overall Study|Subject positive for Hep B|1|||
161403059|NCT02905006|582864092|FG003|Overall Study|Subject positive for Hep B|0|||
161403060|NCT02905006|582864093|FG004|Overall Study|Subject positive for Hep B|0|||
161403061|NCT02905006|582864094|FG005|Overall Study|Subject positive for Hep B|0|||
161403062|NCT02905006|582864089|FG000|Overall Study|Patient moved abroad|0|||
161403063|NCT02905006|582864090|FG001|Overall Study|Patient moved abroad|0|||
161403064|NCT02905006|582864091|FG002|Overall Study|Patient moved abroad|0|||
161403065|NCT02905006|582864092|FG003|Overall Study|Patient moved abroad|1|||
161403066|NCT02905006|582864093|FG004|Overall Study|Patient moved abroad|0|||
161403067|NCT02905006|582864094|FG005|Overall Study|Patient moved abroad|0|||
161403068|NCT02905006|582864089|FG000|Overall Study|Patient randomized by mistake|0|||
161403069|NCT02905006|582864090|FG001|Overall Study|Patient randomized by mistake|0|||
161403070|NCT02905006|582864091|FG002|Overall Study|Patient randomized by mistake|0|||
161403071|NCT02905006|582864092|FG003|Overall Study|Patient randomized by mistake|0|||
161403072|NCT02905006|582864093|FG004|Overall Study|Patient randomized by mistake|0|||
161403073|NCT02905006|582864094|FG005|Overall Study|Patient randomized by mistake|1|||
161403074|NCT04435600|582864095|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403075|NCT04435600|582864096|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403076|NCT04435600|582864097|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
161403077|NCT04435600|582864098|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403078|NCT04435600|582864099|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403079|NCT04435600|582864100|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403080|NCT04435600|582864101|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403081|NCT04435600|582864102|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403082|NCT04435600|582864103|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403083|NCT04435600|582864104|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161403084|NCT04435600|582864095|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403085|NCT04435600|582864096|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403086|NCT04435600|582864097|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403087|NCT04435600|582864098|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403088|NCT04435600|582864099|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403089|NCT04435600|582864100|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403090|NCT04435600|582864101|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403091|NCT04435600|582864102|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403092|NCT04435600|582864103|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161403093|NCT04435600|582864104|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
161403094|NCT04435600|582864095|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403095|NCT04435600|582864096|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403096|NCT04435600|582864097|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403097|NCT04435600|582864098|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403098|NCT04435600|582864099|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403099|NCT04435600|582864100|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403100|NCT04435600|582864101|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403101|NCT04435600|582864102|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403102|NCT04435600|582864103|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161403103|NCT04435600|582864104|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
161403104|NCT04435600|582864095|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403105|NCT04435600|582864096|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403106|NCT04435600|582864097|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403107|NCT04435600|582864098|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403108|NCT04435600|582864099|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403109|NCT04435600|582864100|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403110|NCT04435600|582864101|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403111|NCT04435600|582864102|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403112|NCT04435600|582864103|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
161403113|NCT04435600|582864104|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
161403114|NCT02797184|582864109|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
161403115|NCT02797184|582864110|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
161403116|NCT05149313|582864111|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
161403117|NCT05149313|582864112|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
161403118|NCT05149313|582864113|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
161403119|NCT05149313|582864114|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
161403120|NCT05149313|582864111|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
161403121|NCT05149313|582864112|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
161403122|NCT05149313|582864113|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
161403123|NCT05149313|582864114|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
161403124|NCT05149313|582864111|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
161403125|NCT05149313|582864112|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
161403126|NCT05149313|582864113|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
161403127|NCT05149313|582864114|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
161403128|NCT05149313|582864111|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
161403129|NCT05149313|582864112|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
161403130|NCT05149313|582864113|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
161403131|NCT05149313|582864114|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
161403132|NCT05149313|582864111|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
161403133|NCT05149313|582864112|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
161403134|NCT05149313|582864113|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
161403135|NCT05149313|582864114|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
161403136|NCT05149313|582864111|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
161403137|NCT05149313|582864112|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
161403138|NCT05149313|582864113|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
161403139|NCT05149313|582864114|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
161403140|NCT05149313|582864111|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
161403141|NCT05149313|582864112|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
161403142|NCT05149313|582864113|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
161403143|NCT05149313|582864114|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
161403144|NCT05149313|582864111|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161403145|NCT05149313|582864112|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161403146|NCT05149313|582864113|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
161403147|NCT05149313|582864114|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
161403148|NCT05149313|582864111|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161403149|NCT05149313|582864112|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161403150|NCT05149313|582864113|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
161403151|NCT05149313|582864114|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
161403152|NCT05149313|582864111|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161403153|NCT05149313|582864112|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161403154|NCT05149313|582864113|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
161403155|NCT05149313|582864114|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161403156|NCT05149313|582864111|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
161403157|NCT05149313|582864112|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
161403158|NCT05149313|582864113|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
161403159|NCT05149313|582864114|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
161403160|NCT02212678|582864123|FG000|Overall Study|Adverse Event|1|||
161403161|NCT06250738|582864124|FG000|Overall Study|Lost to Follow-up|1|||
161403162|NCT04030962|582864126|FG000|Stage 2|Adverse Event|0|||
161403163|NCT04030962|582864127|FG001|Stage 2|Adverse Event|0|||
161403164|NCT04030962|582864128|FG002|Stage 2|Adverse Event|0|||
161403165|NCT04030962|582864129|FG003|Stage 2|Adverse Event|0|||
161403166|NCT04030962|582864130|FG004|Stage 2|Adverse Event|0|||
161403167|NCT04030962|582864131|FG005|Stage 2|Adverse Event|0|||
161403168|NCT04030962|582864132|FG006|Stage 2|Adverse Event|0|||
161403169|NCT04030962|582864133|FG007|Stage 2|Adverse Event|0|||
161403170|NCT04030962|582864134|FG008|Stage 2|Adverse Event|1|||
161403171|NCT04030962|582864135|FG009|Stage 2|Adverse Event|0|||
161403172|NCT04030962|582864136|FG010|Stage 2|Adverse Event|1|||
161403173|NCT04030962|582864137|FG011|Stage 2|Adverse Event|1|||
161403174|NCT04030962|582864138|FG012|Stage 2|Adverse Event|1|||
161403175|NCT04030962|582864126|FG000|Stage 2|Withdrawal by Subject|0|||
161403176|NCT04030962|582864127|FG001|Stage 2|Withdrawal by Subject|0|||
161403177|NCT04030962|582864128|FG002|Stage 2|Withdrawal by Subject|0|||
161403178|NCT04030962|582864129|FG003|Stage 2|Withdrawal by Subject|0|||
161403179|NCT04030962|582864130|FG004|Stage 2|Withdrawal by Subject|0|||
161403180|NCT04030962|582864131|FG005|Stage 2|Withdrawal by Subject|0|||
161403181|NCT04030962|582864132|FG006|Stage 2|Withdrawal by Subject|0|||
161403182|NCT04030962|582864133|FG007|Stage 2|Withdrawal by Subject|0|||
161403183|NCT04030962|582864134|FG008|Stage 2|Withdrawal by Subject|1|||
161403184|NCT04030962|582864135|FG009|Stage 2|Withdrawal by Subject|0|||
161403185|NCT04030962|582864136|FG010|Stage 2|Withdrawal by Subject|0|||
161403186|NCT04030962|582864137|FG011|Stage 2|Withdrawal by Subject|2|||
161403187|NCT04030962|582864138|FG012|Stage 2|Withdrawal by Subject|1|||
161403188|NCT04030962|582864126|FG000|Stage 2|Lost to Follow-up|0|||
161403189|NCT04030962|582864127|FG001|Stage 2|Lost to Follow-up|0|||
161403190|NCT04030962|582864128|FG002|Stage 2|Lost to Follow-up|0|||
161403191|NCT04030962|582864129|FG003|Stage 2|Lost to Follow-up|0|||
161403192|NCT04030962|582864130|FG004|Stage 2|Lost to Follow-up|0|||
161403193|NCT04030962|582864131|FG005|Stage 2|Lost to Follow-up|0|||
161403194|NCT04030962|582864132|FG006|Stage 2|Lost to Follow-up|0|||
161403195|NCT04030962|582864133|FG007|Stage 2|Lost to Follow-up|0|||
161403196|NCT04030962|582864134|FG008|Stage 2|Lost to Follow-up|1|||
161403197|NCT04030962|582864135|FG009|Stage 2|Lost to Follow-up|0|||
161403198|NCT04030962|582864136|FG010|Stage 2|Lost to Follow-up|0|||
161403199|NCT04030962|582864137|FG011|Stage 2|Lost to Follow-up|0|||
161403200|NCT04030962|582864138|FG012|Stage 2|Lost to Follow-up|0|||
161403201|NCT04030962|582864126|FG000|Stage 2|Technical Problems|0|||
161403202|NCT04030962|582864127|FG001|Stage 2|Technical Problems|0|||
161403203|NCT04030962|582864128|FG002|Stage 2|Technical Problems|0|||
161403204|NCT04030962|582864129|FG003|Stage 2|Technical Problems|0|||
161403205|NCT04030962|582864130|FG004|Stage 2|Technical Problems|0|||
161403206|NCT04030962|582864131|FG005|Stage 2|Technical Problems|0|||
161403207|NCT04030962|582864132|FG006|Stage 2|Technical Problems|0|||
161403208|NCT04030962|582864133|FG007|Stage 2|Technical Problems|0|||
161403209|NCT04030962|582864134|FG008|Stage 2|Technical Problems|0|||
161403210|NCT04030962|582864135|FG009|Stage 2|Technical Problems|0|||
161403211|NCT04030962|582864136|FG010|Stage 2|Technical Problems|0|||
161403212|NCT04030962|582864137|FG011|Stage 2|Technical Problems|1|||
161403213|NCT04030962|582864138|FG012|Stage 2|Technical Problems|0|||
161403214|NCT05288166|582864141|FG000|Overall Study|Adverse Event|1|||
161403215|NCT05288166|582864142|FG001|Overall Study|Adverse Event|0|||
161403216|NCT05288166|582864141|FG000|Overall Study|Lost to Follow-up|2|||
161403217|NCT05288166|582864142|FG001|Overall Study|Lost to Follow-up|0|||
161403218|NCT05288166|582864141|FG000|Overall Study|Physician Decision|0|||
161403219|NCT05288166|582864142|FG001|Overall Study|Physician Decision|2|||
161403220|NCT05288166|582864141|FG000|Overall Study|Screen Failure|1|||
161403221|NCT05288166|582864142|FG001|Overall Study|Screen Failure|1|||
161403222|NCT05288166|582864141|FG000|Overall Study|Withdrawal by Subject|4|||
161403223|NCT05288166|582864142|FG001|Overall Study|Withdrawal by Subject|2|||
161403224|NCT05288166|582864141|FG000|Overall Study|On Study Treatment|408|||
161403225|NCT05288166|582864142|FG001|Overall Study|On Study Treatment|418|||
161403226|NCT01114360|582864143|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
161403227|NCT01114360|582864144|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
161403228|NCT03007745|582864145|FG000|Overall Study|Sleep test negative for OSA|53|||
161403229|NCT03007745|582864146|FG001|Overall Study|Sleep test negative for OSA|49|||
161403230|NCT03007745|582864145|FG000|Overall Study|Physician Decision|6|||
161403231|NCT03007745|582864146|FG001|Overall Study|Physician Decision|9|||
161403232|NCT03007745|582864145|FG000|Overall Study|Withdrawal by Subject|38|||
161403233|NCT03007745|582864146|FG001|Overall Study|Withdrawal by Subject|16|||
161403234|NCT03007745|582864145|FG000|Overall Study|Lost to Follow-up|19|||
161403235|NCT03007745|582864146|FG001|Overall Study|Lost to Follow-up|25|||
161403236|NCT03007745|582864145|FG000|Overall Study|Unable to login to website|17|||
161403237|NCT03007745|582864146|FG001|Overall Study|Unable to login to website|4|||
161403238|NCT03344172|582864149|FG000|Overall Study|Received <1 dose of treatment|1|||
161403239|NCT03344172|582864150|FG001|Overall Study|Received <1 dose of treatment|0|||
161403240|NCT04912895|582864151|FG000|Overall Study|Unable to provide specimen|2|||
161403241|NCT04912895|582864152|FG001|Overall Study|Unable to provide specimen|0|||
161403242|NCT04912895|582864153|FG002|Overall Study|Unable to provide specimen|0|||
161403243|NCT03106415|582864154|FG000|Phase 1|Withdrawal by Subject|1|||
161403244|NCT03106415|582864155|FG001|Phase 1|Withdrawal by Subject|0|||
161403245|NCT03106415|582864156|FG002|Phase 1|Withdrawal by Subject|0|||
161403246|NCT03106415|582864154|FG000|Phase 1|Adverse Event|1|||
161403247|NCT03106415|582864155|FG001|Phase 1|Adverse Event|1|||
161403248|NCT03106415|582864156|FG002|Phase 1|Adverse Event|0|||
161403249|NCT03106415|582864154|FG000|Phase 1|Protocol Violation|0|||
161403250|NCT03106415|582864155|FG001|Phase 1|Protocol Violation|1|||
161403251|NCT03106415|582864156|FG002|Phase 1|Protocol Violation|0|||
161403252|NCT02981524|582864157|FG000|Overall Study|Progressive Disease|14|||
161403253|NCT02981524|582864157|FG000|Overall Study|Death (unrelated)|1|||
161403254|NCT02981524|582864157|FG000|Overall Study|Treatment Related Toxicity|1|||
161403255|NCT02981524|582864157|FG000|Overall Study|Withdrawal by Subject|1|||
161403256|NCT00520013|582864158|FG000|Overall Study|Withdrawal by Subject|0|||
161403257|NCT00520013|582864159|FG001|Overall Study|Withdrawal by Subject|0|||
161403258|NCT00520013|582864160|FG002|Overall Study|Withdrawal by Subject|1|||
161403259|NCT00520013|582864158|FG000|Overall Study|Adverse Event|2|||
161403260|NCT00520013|582864159|FG001|Overall Study|Adverse Event|10|||
161403261|NCT00520013|582864160|FG002|Overall Study|Adverse Event|7|||
161403262|NCT00520013|582864158|FG000|Overall Study|Progressive Disease|7|||
161403263|NCT00520013|582864159|FG001|Overall Study|Progressive Disease|3|||
161403264|NCT00520013|582864160|FG002|Overall Study|Progressive Disease|0|||
161403265|NCT00520013|582864158|FG000|Overall Study|Clinical Progression|3|||
161403266|NCT00520013|582864159|FG001|Overall Study|Clinical Progression|1|||
161403267|NCT00520013|582864160|FG002|Overall Study|Clinical Progression|0|||
161403268|NCT00520013|582864158|FG000|Overall Study|Death|0|||
161403269|NCT00520013|582864159|FG001|Overall Study|Death|1|||
161403270|NCT00520013|582864160|FG002|Overall Study|Death|0|||
161403271|NCT00520013|582864158|FG000|Overall Study|Physician Decision|0|||
161403272|NCT00520013|582864159|FG001|Overall Study|Physician Decision|0|||
161403273|NCT00520013|582864160|FG002|Overall Study|Physician Decision|3|||
161403274|NCT00159913|582864161|FG000|Overall Study|Adverse Event|1|||
161403275|NCT00159913|582864162|FG001|Overall Study|Adverse Event|0|||
161403276|NCT00159913|582864163|FG002|Overall Study|Adverse Event|1|||
161403277|NCT00159913|582864164|FG003|Overall Study|Adverse Event|0|||
161403278|NCT00159913|582864161|FG000|Overall Study|Withdrawal by Subject|0|||
161403279|NCT00159913|582864162|FG001|Overall Study|Withdrawal by Subject|0|||
161403280|NCT00159913|582864163|FG002|Overall Study|Withdrawal by Subject|0|||
161403281|NCT00159913|582864164|FG003|Overall Study|Withdrawal by Subject|1|||
161403282|NCT00159913|582864161|FG000|Overall Study|Lost to Follow-up|0|||
161403283|NCT00159913|582864162|FG001|Overall Study|Lost to Follow-up|0|||
161403284|NCT00159913|582864163|FG002|Overall Study|Lost to Follow-up|0|||
161403285|NCT00159913|582864164|FG003|Overall Study|Lost to Follow-up|1|||
161403286|NCT00159913|582864161|FG000|Overall Study|Protocol Violation|1|||
161403287|NCT00159913|582864162|FG001|Overall Study|Protocol Violation|0|||
161403288|NCT00159913|582864163|FG002|Overall Study|Protocol Violation|1|||
161403289|NCT00159913|582864164|FG003|Overall Study|Protocol Violation|0|||
161403290|NCT03294135|582864165|FG000|Overall Study|Serious Adverse Event|1|||
161403291|NCT03294135|582864166|FG001|Overall Study|Serious Adverse Event|0|||
161403292|NCT03294135|582864167|FG002|Overall Study|Serious Adverse Event|0|||
161403293|NCT03294135|582864165|FG000|Overall Study|Lost to Follow-up|1|||
161403294|NCT03294135|582864166|FG001|Overall Study|Lost to Follow-up|0|||
161403295|NCT03294135|582864167|FG002|Overall Study|Lost to Follow-up|1|||
161403296|NCT03294135|582864165|FG000|Overall Study|Withdrawal by Subject|0|||
161403297|NCT03294135|582864166|FG001|Overall Study|Withdrawal by Subject|0|||
161403298|NCT03294135|582864167|FG002|Overall Study|Withdrawal by Subject|1|||
161403299|NCT03294135|582864165|FG000|Overall Study|Other|2|||
161403300|NCT03294135|582864166|FG001|Overall Study|Other|0|||
161403301|NCT03294135|582864167|FG002|Overall Study|Other|0|||
161403302|NCT02763254|582864168|FG000|Overall Study|Adverse Event|1|||
161403303|NCT00431951|582864170|FG000|Overall Study|Inability to follow study procedures|1|||
161403304|NCT00431951|582864171|FG001|Overall Study|Inability to follow study procedures|0|||
161403305|NCT00431951|582864172|FG002|Overall Study|Inability to follow study procedures|1|||
161403306|NCT00431951|582864173|FG003|Overall Study|Inability to follow study procedures|2|||
161403307|NCT00431951|582864170|FG000|Overall Study|Lost to Follow-up|0|||
161403308|NCT00431951|582864171|FG001|Overall Study|Lost to Follow-up|1|||
161403309|NCT00431951|582864172|FG002|Overall Study|Lost to Follow-up|0|||
161403310|NCT00431951|582864173|FG003|Overall Study|Lost to Follow-up|0|||
161403311|NCT00431951|582864170|FG000|Overall Study|Withdrawal by Subject|0|||
161403312|NCT00431951|582864171|FG001|Overall Study|Withdrawal by Subject|1|||
161403313|NCT00431951|582864172|FG002|Overall Study|Withdrawal by Subject|0|||
161403314|NCT00431951|582864173|FG003|Overall Study|Withdrawal by Subject|0|||
161403315|NCT00431951|582864170|FG000|Overall Study|Adverse Event|0|||
161403316|NCT00431951|582864171|FG001|Overall Study|Adverse Event|0|||
161403317|NCT00431951|582864172|FG002|Overall Study|Adverse Event|1|||
161403318|NCT00431951|582864173|FG003|Overall Study|Adverse Event|0|||
161403319|NCT00385723|582864174|FG000|Overall Study|Lost to Follow-up|1|||
161403320|NCT00385723|582864175|FG001|Overall Study|Lost to Follow-up|1|||
161403321|NCT00385723|582864176|FG002|Overall Study|Lost to Follow-up|0|||
161403322|NCT00385723|582864174|FG000|Overall Study|Withdrawal by Subject|1|||
161403323|NCT00385723|582864175|FG001|Overall Study|Withdrawal by Subject|0|||
161403324|NCT00385723|582864176|FG002|Overall Study|Withdrawal by Subject|2|||
161403325|NCT01390779|582864177|FG000|Overall Study|Physician Decision|1|||
161403326|NCT00168103|582864178|FG000|Overall Study|Withdrawal by Subject|1|||
161403327|NCT00168103|582864179|FG001|Overall Study|Withdrawal by Subject|2|||
161403328|NCT00168103|582864180|FG002|Overall Study|Withdrawal by Subject|1|||
161403329|NCT00168103|582864181|FG003|Overall Study|Withdrawal by Subject|0|||
161403330|NCT00168103|582864178|FG000|Overall Study|Lost to Follow-up|1|||
161403331|NCT00168103|582864179|FG001|Overall Study|Lost to Follow-up|3|||
161403332|NCT00168103|582864180|FG002|Overall Study|Lost to Follow-up|0|||
161403333|NCT00168103|582864181|FG003|Overall Study|Lost to Follow-up|0|||
161403334|NCT00689793|582864188|FG000|Overall Study|Lost to Follow-up|4|||
161403335|NCT00689793|582864189|FG001|Overall Study|Lost to Follow-up|5|||
161403336|NCT02956850|582864195|FG000|Overall Study|Withdrawal by Subject|0|||
161403337|NCT02956850|582864196|FG001|Overall Study|Withdrawal by Subject|0|||
161403338|NCT02956850|582864197|FG002|Overall Study|Withdrawal by Subject|0|||
161403339|NCT02956850|582864198|FG003|Overall Study|Withdrawal by Subject|0|||
161403340|NCT02956850|582864199|FG004|Overall Study|Withdrawal by Subject|0|||
161403341|NCT02956850|582864200|FG005|Overall Study|Withdrawal by Subject|0|||
161403342|NCT02956850|582864201|FG006|Overall Study|Withdrawal by Subject|0|||
161403343|NCT02956850|582864202|FG007|Overall Study|Withdrawal by Subject|0|||
161403344|NCT02956850|582864203|FG008|Overall Study|Withdrawal by Subject|0|||
161403345|NCT02956850|582864204|FG009|Overall Study|Withdrawal by Subject|0|||
161403346|NCT02956850|582864205|FG010|Overall Study|Withdrawal by Subject|0|||
161403347|NCT02956850|582864206|FG011|Overall Study|Withdrawal by Subject|0|||
161403348|NCT02956850|582864207|FG012|Overall Study|Withdrawal by Subject|0|||
161403349|NCT02956850|582864208|FG013|Overall Study|Withdrawal by Subject|0|||
161403350|NCT02956850|582864209|FG014|Overall Study|Withdrawal by Subject|0|||
161403351|NCT02956850|582864210|FG015|Overall Study|Withdrawal by Subject|0|||
161403352|NCT02956850|582864211|FG016|Overall Study|Withdrawal by Subject|0|||
161403353|NCT02956850|582864212|FG017|Overall Study|Withdrawal by Subject|1|||
161403354|NCT01920152|582864213|FG000|Overall Study|Withdrawal by Subject|1|||
161403355|NCT01920152|582864214|FG001|Overall Study|Withdrawal by Subject|2|||
161403356|NCT00708734|582864215|FG000|Overall Study|scheduling conflict|2|||
161403357|NCT00708734|582864215|FG000|Overall Study|moved|1|||
161403358|NCT00708734|582864215|FG000|Overall Study|leg injury|1|||
161403359|NCT00708734|582864215|FG000|Overall Study|knee replacement|1|||
161403360|NCT00708734|582864215|FG000|Overall Study|vertigo|1|||
161403361|NCT00708734|582864215|FG000|Overall Study|leg fracture|1|||
161403362|NCT03412604|582864216|FG000|Overall Study|Withdrawal by Subject|1|||
161403363|NCT02634606|582864217|FG000|Overall Study|unable to obtain the drug at start|13|||
161403364|NCT01287195|582864227|FG000|Overall Study|Withdrawal by Subject|2|||
161403365|NCT01995552|582864228|FG000|Overall Study|Protocol Violation|1|||
161403366|NCT01995552|582864228|FG000|Overall Study|Lack of Efficacy|15|||
161403367|NCT01995552|582864228|FG000|Overall Study|Death|1|||
161403368|NCT02068118|582864231|FG000|18-month Comparative Study Period|Death|90|||
161403369|NCT02068118|582864232|FG001|18-month Comparative Study Period|Death|97|||
161403370|NCT02068118|582864231|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
161403371|NCT02068118|582864232|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
161403372|NCT02068118|582864231|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
161403373|NCT02068118|582864232|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
161403374|NCT02068118|582864231|FG000|18-month Comparative Study Period|Heart transplant|9|||
161403375|NCT02068118|582864232|FG001|18-month Comparative Study Period|Heart transplant|15|||
161403376|NCT02068118|582864231|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
161403377|NCT02068118|582864232|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
161403378|NCT02068118|582864231|FG000|18-month Comparative Study Period|Hemiplegia|0|||
161403379|NCT02068118|582864232|FG001|18-month Comparative Study Period|Hemiplegia|1|||
161403380|NCT02068118|582864231|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
161403381|NCT02068118|582864232|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
161403382|NCT02068118|582864231|FG000|18-month Comparative Study Period|Move|0|||
161403383|NCT02068118|582864232|FG001|18-month Comparative Study Period|Move|1|||
161403384|NCT02068118|582864231|FG000|18-month Comparative Study Period|Hearing loss|0|||
161403385|NCT02068118|582864232|FG001|18-month Comparative Study Period|Hearing loss|1|||
161403386|NCT02068118|582864231|FG000|Extension Period|Death|0|||
161403387|NCT02068118|582864232|FG001|Extension Period|Death|2|||
161403388|NCT02068118|582864231|FG000|Extension Period|Withdrawal by Subject|1|||
161403389|NCT02068118|582864232|FG001|Extension Period|Withdrawal by Subject|0|||
161403390|NCT02068118|582864231|FG000|Extension Period|Heart transplant|1|||
161403391|NCT02068118|582864232|FG001|Extension Period|Heart transplant|0|||
161403392|NCT02068118|582864231|FG000|Extension Period|Wrong device use|0|||
161403393|NCT02068118|582864232|FG001|Extension Period|Wrong device use|1|||
161403394|NCT00283868|582864237|FG000|Overall Study|Lost to Follow-up|7|||
161403395|NCT00283868|582864238|FG001|Overall Study|Lost to Follow-up|8|||
161403396|NCT00353873|582864239|FG000|Overall Study|Protocol Violation|1|||
161403397|NCT00353873|582864240|FG001|Overall Study|Protocol Violation|2|||
161403398|NCT00353873|582864239|FG000|Overall Study|Exacerbation|1|||
161403399|NCT00353873|582864240|FG001|Overall Study|Exacerbation|0|||
161403400|NCT00353873|582864239|FG000|Overall Study|Adverse Event|1|||
161403401|NCT00353873|582864240|FG001|Overall Study|Adverse Event|0|||
161403402|NCT00353873|582864239|FG000|Overall Study|Physician Decision|2|||
161403403|NCT00353873|582864240|FG001|Overall Study|Physician Decision|0|||
161403404|NCT00353873|582864239|FG000|Overall Study|Withdrawal by Subject|1|||
161403405|NCT00353873|582864240|FG001|Overall Study|Withdrawal by Subject|1|||
161403406|NCT01515475|582864241|FG000|Overall Study|Lost to Follow-up|20|||
161403407|NCT01515475|582864242|FG001|Overall Study|Lost to Follow-up|15|||
161403408|NCT01515475|582864243|FG002|Overall Study|Lost to Follow-up|12|||
161403409|NCT01515475|582864244|FG003|Overall Study|Lost to Follow-up|12|||
161403410|NCT00453973|582864247|FG000|Overall Study|Adverse Event|4|||
161403411|NCT00453973|582864248|FG001|Overall Study|Adverse Event|9|||
161403412|NCT00453973|582864247|FG000|Overall Study|Withdrawal by Subject|7|||
161403413|NCT00453973|582864248|FG001|Overall Study|Withdrawal by Subject|6|||
161403414|NCT00453973|582864247|FG000|Overall Study|PI Decision|0|||
161403415|NCT00453973|582864248|FG001|Overall Study|PI Decision|2|||
161403416|NCT00453973|582864247|FG000|Overall Study|Relocation|1|||
161403417|NCT00453973|582864248|FG001|Overall Study|Relocation|0|||
161403418|NCT00453973|582864247|FG000|Overall Study|Renal transplant|1|||
161403419|NCT00453973|582864248|FG001|Overall Study|Renal transplant|1|||
161403420|NCT00453973|582864247|FG000|Overall Study|Site closed by sponsor|3|||
161403421|NCT00453973|582864248|FG001|Overall Study|Site closed by sponsor|0|||
161403422|NCT00453973|582864247|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
161403423|NCT00453973|582864248|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
161403424|NCT03743064|582864253|FG000|Overall Study|Adverse Event|7|||
161403425|NCT03743064|582864254|FG001|Overall Study|Adverse Event|9|||
161403426|NCT03743064|582864253|FG000|Overall Study|Death|25|||
161403427|NCT03743064|582864254|FG001|Overall Study|Death|28|||
161403428|NCT03743064|582864253|FG000|Overall Study|Lost to Follow-up|3|||
161403429|NCT03743064|582864254|FG001|Overall Study|Lost to Follow-up|6|||
161403430|NCT03743064|582864253|FG000|Overall Study|Withdrawal by Subject|28|||
161403431|NCT03743064|582864254|FG001|Overall Study|Withdrawal by Subject|25|||
161403432|NCT03743064|582864253|FG000|Overall Study|Physician Decision|2|||
161403433|NCT03743064|582864254|FG001|Overall Study|Physician Decision|4|||
161403434|NCT03743064|582864253|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
161403435|NCT03743064|582864254|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
161403436|NCT02759315|582864255|FG000|Overall Study|Adverse Event|0|||
161403437|NCT02759315|582864256|FG001|Overall Study|Adverse Event|0|||
161403438|NCT02759315|582864257|FG002|Overall Study|Adverse Event|0|||
161403439|NCT02759315|582864258|FG003|Overall Study|Adverse Event|1|||
161403440|NCT02759315|582864259|FG004|Overall Study|Adverse Event|0|||
161403441|NCT02759315|582864255|FG000|Overall Study|Death|0|||
161403442|NCT02759315|582864256|FG001|Overall Study|Death|0|||
161403443|NCT02759315|582864257|FG002|Overall Study|Death|1|||
161403444|NCT02759315|582864258|FG003|Overall Study|Death|0|||
161403445|NCT02759315|582864259|FG004|Overall Study|Death|0|||
161403446|NCT02759315|582864255|FG000|Overall Study|Lost to Follow-up|2|||
161403447|NCT02759315|582864256|FG001|Overall Study|Lost to Follow-up|0|||
161403448|NCT02759315|582864257|FG002|Overall Study|Lost to Follow-up|4|||
161403449|NCT02759315|582864258|FG003|Overall Study|Lost to Follow-up|0|||
161403450|NCT02759315|582864259|FG004|Overall Study|Lost to Follow-up|0|||
161403451|NCT02759315|582864255|FG000|Overall Study|Protocol Violation|0|||
161403452|NCT02759315|582864256|FG001|Overall Study|Protocol Violation|1|||
161403453|NCT02759315|582864257|FG002|Overall Study|Protocol Violation|0|||
161403454|NCT02759315|582864258|FG003|Overall Study|Protocol Violation|0|||
161403455|NCT02759315|582864259|FG004|Overall Study|Protocol Violation|0|||
161403456|NCT02759315|582864255|FG000|Overall Study|Study terminated prior to completion|2|||
161403457|NCT02759315|582864256|FG001|Overall Study|Study terminated prior to completion|0|||
161403458|NCT02759315|582864257|FG002|Overall Study|Study terminated prior to completion|5|||
161403459|NCT02759315|582864258|FG003|Overall Study|Study terminated prior to completion|0|||
161403460|NCT02759315|582864259|FG004|Overall Study|Study terminated prior to completion|1|||
161403461|NCT01996592|582864260|FG000|Overall Study|no response to text/no diary entry|32|||
161403462|NCT01996592|582864260|FG000|Overall Study|change in surgical date|4|||
161403463|NCT01996592|582864260|FG000|Overall Study|Withdrawal by Subject|5|||
161403464|NCT01996592|582864260|FG000|Overall Study|change in mode of delivery|4|||
161403465|NCT00870194|582864261|FG000|Overall Study|Adverse Event|10|||
161403466|NCT00870194|582864262|FG001|Overall Study|Adverse Event|5|||
161403467|NCT00870194|582864261|FG000|Overall Study|Lack of Efficacy|0|||
161403468|NCT00870194|582864262|FG001|Overall Study|Lack of Efficacy|1|||
161403469|NCT00870194|582864261|FG000|Overall Study|Lost to Follow-up|2|||
161403470|NCT00870194|582864262|FG001|Overall Study|Lost to Follow-up|0|||
161403471|NCT00870194|582864261|FG000|Overall Study|Physician Decision|3|||
161403472|NCT00870194|582864262|FG001|Overall Study|Physician Decision|1|||
161403473|NCT00870194|582864261|FG000|Overall Study|Protocol Violation|3|||
161403474|NCT00870194|582864262|FG001|Overall Study|Protocol Violation|3|||
161403475|NCT00870194|582864261|FG000|Overall Study|Entry Criteria Not Met|1|||
161403476|NCT00870194|582864262|FG001|Overall Study|Entry Criteria Not Met|2|||
161403477|NCT00870194|582864261|FG000|Overall Study|Subject Decision|7|||
161403478|NCT00870194|582864262|FG001|Overall Study|Subject Decision|2|||
161403479|NCT01406015|582864263|FG000|Overall Study|Withdrawal by Subject|3|||
161403480|NCT01406015|582864264|FG001|Overall Study|Withdrawal by Subject|3|||
161403481|NCT00707746|582864266|FG000|Treatment Period|Adverse Event|2|||
161403482|NCT00707746|582864267|FG001|Treatment Period|Adverse Event|4|||
161403483|NCT00707746|582864266|FG000|Treatment Period|Ineligibility|0|||
161403484|NCT00707746|582864267|FG001|Treatment Period|Ineligibility|1|||
161403485|NCT02573246|582864275|FG000|Overall Study|Lost to Follow-up|2|||
161403486|NCT02573246|582864276|FG001|Overall Study|Lost to Follow-up|0|||
161403487|NCT02573246|582864277|FG002|Overall Study|Lost to Follow-up|0|||
161403488|NCT02573246|582864278|FG003|Overall Study|Lost to Follow-up|0|||
161403489|NCT02573246|582864279|FG004|Overall Study|Lost to Follow-up|1|||
161403490|NCT02573246|582864275|FG000|Overall Study|Withdrawal by Subject|0|||
161403491|NCT02573246|582864276|FG001|Overall Study|Withdrawal by Subject|0|||
161403492|NCT02573246|582864277|FG002|Overall Study|Withdrawal by Subject|0|||
161403493|NCT02573246|582864278|FG003|Overall Study|Withdrawal by Subject|0|||
161403494|NCT02573246|582864279|FG004|Overall Study|Withdrawal by Subject|1|||
161403495|NCT02573246|582864275|FG000|Overall Study|Physician Decision|1|||
161403496|NCT02573246|582864276|FG001|Overall Study|Physician Decision|1|||
161403497|NCT02573246|582864277|FG002|Overall Study|Physician Decision|3|||
161403498|NCT02573246|582864278|FG003|Overall Study|Physician Decision|2|||
161403499|NCT02573246|582864279|FG004|Overall Study|Physician Decision|2|||
161403500|NCT01219933|582864280|FG000|Overall Study|Adverse Event|8|||
161403501|NCT01219933|582864280|FG000|Overall Study|No LDA reached|5|||
161403502|NCT01219933|582864280|FG000|Overall Study|No LDA maintained|7|||
161403503|NCT01219933|582864280|FG000|Overall Study|Lost to Follow-up|3|||
161403504|NCT01219933|582864280|FG000|Overall Study|GC free|1|||
161403505|NCT01219933|582864280|FG000|Overall Study|Withdrawal by Subject|5|||
161403506|NCT01219933|582864280|FG000|Overall Study|Protocol Violation|8|||
161403507|NCT01219933|582864280|FG000|Overall Study|Lack of Efficacy|1|||
161403508|NCT00582738|582864281|FG000|Overall Study|Administrative Problems|7|||
161403509|NCT00582738|582864282|FG001|Overall Study|Administrative Problems|8|||
161403510|NCT00582738|582864281|FG000|Overall Study|Adverse Event|0|||
161403511|NCT00582738|582864282|FG001|Overall Study|Adverse Event|5|||
161403512|NCT00582738|582864281|FG000|Overall Study|Graft Lost|0|||
161403513|NCT00582738|582864282|FG001|Overall Study|Graft Lost|1|||
161403514|NCT00582738|582864281|FG000|Overall Study|Other|1|||
161403515|NCT00582738|582864282|FG001|Overall Study|Other|0|||
161403516|NCT00582738|582864281|FG000|Overall Study|Protocol Violation|1|||
161403517|NCT00582738|582864282|FG001|Overall Study|Protocol Violation|1|||
161403518|NCT00582738|582864281|FG000|Overall Study|Withdrawal by Subject|0|||
161403519|NCT00582738|582864282|FG001|Overall Study|Withdrawal by Subject|3|||
161403520|NCT01269385|582864283|FG000|Overall Study|Adverse Event|1|||
161403521|NCT01269385|582864284|FG001|Overall Study|Adverse Event|1|||
161403522|NCT01269385|582864285|FG002|Overall Study|Adverse Event|0|||
161403523|NCT01269385|582864286|FG003|Overall Study|Adverse Event|0|||
161403524|NCT01073930|582865647|FG000|Overall Study|Withdrawal by Subject|3|||
161403525|NCT01073930|582865648|FG001|Overall Study|Withdrawal by Subject|2|||
161403526|NCT01073930|582865647|FG000|Overall Study|Lost to Follow-up|0|||
161403527|NCT01073930|582865648|FG001|Overall Study|Lost to Follow-up|1|||
161403528|NCT01073930|582865647|FG000|Overall Study|Adverse Event|0|||
161403529|NCT01073930|582865648|FG001|Overall Study|Adverse Event|1|||
161403530|NCT01073930|582865647|FG000|Overall Study|Noncompliance with study drug|0|||
161403531|NCT01073930|582865648|FG001|Overall Study|Noncompliance with study drug|1|||
161403532|NCT01073930|582865647|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
161403533|NCT01073930|582865648|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
161403534|NCT00541346|582865649|FG000|Follow-up|Adverse Event|1|||
161403535|NCT02008773|582865650|FG000|Overall Study|Adverse Event|3|||
161403536|NCT02008773|582865651|FG001|Overall Study|Adverse Event|3|||
161403537|NCT02008773|582865652|FG002|Overall Study|Adverse Event|1|||
161403538|NCT02008773|582865653|FG003|Overall Study|Adverse Event|2|||
161403539|NCT02008773|582865650|FG000|Overall Study|Medication Non-compliance|2|||
161403540|NCT02008773|582865651|FG001|Overall Study|Medication Non-compliance|1|||
161403541|NCT02008773|582865652|FG002|Overall Study|Medication Non-compliance|3|||
161403542|NCT02008773|582865653|FG003|Overall Study|Medication Non-compliance|2|||
161403543|NCT02008773|582865650|FG000|Overall Study|Withdrawal by Subject|8|||
161403544|NCT02008773|582865651|FG001|Overall Study|Withdrawal by Subject|4|||
161403545|NCT02008773|582865652|FG002|Overall Study|Withdrawal by Subject|7|||
161403546|NCT02008773|582865653|FG003|Overall Study|Withdrawal by Subject|6|||
161403547|NCT02008773|582865650|FG000|Overall Study|Lost to Follow-up|0|||
161403548|NCT02008773|582865651|FG001|Overall Study|Lost to Follow-up|1|||
161403549|NCT02008773|582865652|FG002|Overall Study|Lost to Follow-up|3|||
161403550|NCT02008773|582865653|FG003|Overall Study|Lost to Follow-up|2|||
161403551|NCT03320330|582865656|FG000|Overall Study|Lack of Efficacy|5|||
161403552|NCT03320330|582865657|FG001|Overall Study|Lack of Efficacy|5|||
161403553|NCT03320330|582865658|FG002|Overall Study|Lack of Efficacy|14|||
161403554|NCT03320330|582865656|FG000|Overall Study|Physician Decision|1|||
161403555|NCT03320330|582865657|FG001|Overall Study|Physician Decision|0|||
161403556|NCT03320330|582865658|FG002|Overall Study|Physician Decision|0|||
161403557|NCT03323736|582865659|FG000|Overall Study|Screen Failure|14|||
161403558|NCT03323736|582865660|FG001|Overall Study|Screen Failure|9|||
161403559|NCT03323736|582865661|FG002|Overall Study|Screen Failure|1|||
161403560|NCT03323736|582865659|FG000|Overall Study|Withdrawal Before Treatment|3|||
161403561|NCT03323736|582865660|FG001|Overall Study|Withdrawal Before Treatment|1|||
161403562|NCT03323736|582865661|FG002|Overall Study|Withdrawal Before Treatment|1|||
161403563|NCT03323736|582865659|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
161403564|NCT03323736|582865660|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
161403565|NCT03323736|582865661|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
161403566|NCT00701805|582865664|FG000|Overall Study|Withdrawal by Subject|3|||
161403567|NCT00701805|582865665|FG001|Overall Study|Withdrawal by Subject|1|||
161403568|NCT00701805|582865666|FG002|Overall Study|Withdrawal by Subject|4|||
161403569|NCT00701805|582865667|FG003|Overall Study|Withdrawal by Subject|3|||
161403570|NCT00701805|582865664|FG000|Overall Study|Adverse Event|0|||
161403571|NCT00701805|582865665|FG001|Overall Study|Adverse Event|1|||
161403572|NCT00701805|582865666|FG002|Overall Study|Adverse Event|1|||
161403573|NCT00701805|582865667|FG003|Overall Study|Adverse Event|0|||
161403574|NCT00701805|582865664|FG000|Overall Study|Missed 7 consecutive doses|0|||
161403575|NCT00701805|582865665|FG001|Overall Study|Missed 7 consecutive doses|1|||
161403576|NCT00701805|582865666|FG002|Overall Study|Missed 7 consecutive doses|0|||
161403577|NCT00701805|582865667|FG003|Overall Study|Missed 7 consecutive doses|0|||
161403578|NCT00701805|582865664|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
161403579|NCT00701805|582865665|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
161403580|NCT00701805|582865666|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
161403581|NCT00701805|582865667|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
161403582|NCT00701805|582865664|FG000|Overall Study|Physician decision, change of therapy|0|||
161403583|NCT00701805|582865665|FG001|Overall Study|Physician decision, change of therapy|0|||
161403584|NCT00701805|582865666|FG002|Overall Study|Physician decision, change of therapy|0|||
161403585|NCT00701805|582865667|FG003|Overall Study|Physician decision, change of therapy|1|||
161403586|NCT00701805|582865664|FG000|Overall Study|Difficult to travel to dialysis site|0|||
161403587|NCT00701805|582865665|FG001|Overall Study|Difficult to travel to dialysis site|0|||
161403588|NCT00701805|582865666|FG002|Overall Study|Difficult to travel to dialysis site|1|||
161403589|NCT00701805|582865667|FG003|Overall Study|Difficult to travel to dialysis site|0|||
161403590|NCT00701805|582865664|FG000|Overall Study|Resumption criteria were not met|0|||
161403591|NCT00701805|582865665|FG001|Overall Study|Resumption criteria were not met|1|||
161403592|NCT00701805|582865666|FG002|Overall Study|Resumption criteria were not met|0|||
161403593|NCT00701805|582865667|FG003|Overall Study|Resumption criteria were not met|0|||
161403594|NCT03826342|582865674|FG000|Overall Study|Withdrawal by Subject|8|||
161403595|NCT03826342|582865675|FG001|Overall Study|Withdrawal by Subject|1|||
161403596|NCT03826342|582865674|FG000|Overall Study|Lost to Follow-up|7|||
161403597|NCT03826342|582865675|FG001|Overall Study|Lost to Follow-up|7|||
161403598|NCT03826342|582865674|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
161403599|NCT03826342|582865675|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
161403600|NCT03455829|582865676|FG000|Overall Study|Death|2|||
161403601|NCT03455829|582865677|FG001|Overall Study|Death|3|||
161403602|NCT03455829|582865678|FG002|Overall Study|Death|2|||
161403603|NCT03455829|582865679|FG003|Overall Study|Death|4|||
161403604|NCT03455829|582865680|FG004|Overall Study|Death|2|||
161403605|NCT03455829|582865676|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
161403606|NCT03455829|582865677|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
161403607|NCT03455829|582865678|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
161403608|NCT03455829|582865679|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
161403609|NCT03455829|582865680|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
161403610|NCT03455829|582865676|FG000|Overall Study|Disease progression|0|||
161403611|NCT03455829|582865677|FG001|Overall Study|Disease progression|0|||
161403612|NCT03455829|582865678|FG002|Overall Study|Disease progression|0|||
161403613|NCT03455829|582865679|FG003|Overall Study|Disease progression|1|||
161403614|NCT03455829|582865680|FG004|Overall Study|Disease progression|1|||
161403615|NCT02258529|582865687|FG000|Overall Study|Study Terminated by Sponsor|9|||
161403616|NCT02258529|582865687|FG000|Overall Study|Adverse Event|1|||
161403617|NCT00413010|582865688|FG000|Overall Study|Adverse Event|8|||
161403618|NCT00413010|582865689|FG001|Overall Study|Adverse Event|4|||
161403619|NCT00413010|582865688|FG000|Overall Study|Laboratory abnormality|0|||
161403620|NCT00413010|582865689|FG001|Overall Study|Laboratory abnormality|2|||
161403621|NCT00413010|582865688|FG000|Overall Study|Lack of Efficacy|0|||
161403622|NCT00413010|582865689|FG001|Overall Study|Lack of Efficacy|3|||
161403623|NCT00413010|582865688|FG000|Overall Study|Lost to Follow-up|3|||
161403624|NCT00413010|582865689|FG001|Overall Study|Lost to Follow-up|0|||
161403625|NCT00413010|582865688|FG000|Overall Study|Withdrawal by Subject|7|||
161403626|NCT00413010|582865689|FG001|Overall Study|Withdrawal by Subject|2|||
161403627|NCT00413010|582865688|FG000|Overall Study|Due to termination of the study|54|||
161403628|NCT00413010|582865689|FG001|Overall Study|Due to termination of the study|52|||
161403629|NCT01842581|582865693|FG000|Overall Study|Adverse Event|6|||
161403630|NCT01842581|582865694|FG001|Overall Study|Adverse Event|4|||
161403631|NCT01842581|582865693|FG000|Overall Study|HE breakthrough|26|||
161403632|NCT01842581|582865694|FG001|Overall Study|HE breakthrough|13|||
161403633|NCT01842581|582865693|FG000|Overall Study|Liver transplant|2|||
161403634|NCT01842581|582865694|FG001|Overall Study|Liver transplant|0|||
161403635|NCT01842581|582865693|FG000|Overall Study|Lost to Follow-up|2|||
161403636|NCT01842581|582865694|FG001|Overall Study|Lost to Follow-up|5|||
161403637|NCT01842581|582865693|FG000|Overall Study|Withdrawal by Subject|5|||
161403638|NCT01842581|582865694|FG001|Overall Study|Withdrawal by Subject|7|||
161403639|NCT01842581|582865693|FG000|Overall Study|Other than specified|3|||
161403640|NCT01842581|582865694|FG001|Overall Study|Other than specified|1|||
161403641|NCT00993499|582865697|FG000|Run-in Period (8 Days)|Adverse Event|0|||
161403642|NCT00993499|582865698|FG001|Run-in Period (8 Days)|Adverse Event|1|||
161403643|NCT00993499|582865699|FG002|Run-in Period (8 Days)|Adverse Event|0|||
161403644|NCT00993499|582865700|FG003|Run-in Period (8 Days)|Adverse Event|0|||
161403645|NCT00993499|582865701|FG004|Run-in Period (8 Days)|Adverse Event|0|||
161403646|NCT00993499|582865702|FG005|Run-in Period (8 Days)|Adverse Event|0|||
161403647|NCT00993499|582865697|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
161403648|NCT00993499|582865698|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161403649|NCT00993499|582865699|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161403650|NCT00993499|582865700|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161403651|NCT00993499|582865701|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161403652|NCT00993499|582865702|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161403653|NCT00993499|582865697|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
161403654|NCT00993499|582865698|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
161403655|NCT00993499|582865699|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
161403656|NCT00993499|582865700|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
161403657|NCT00993499|582865701|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
161403658|NCT00993499|582865702|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
161403659|NCT00993499|582865697|FG000|Run-in Period (8 Days)|Progressive disease|0|||
161403660|NCT00993499|582865698|FG001|Run-in Period (8 Days)|Progressive disease|1|||
161403661|NCT00993499|582865699|FG002|Run-in Period (8 Days)|Progressive disease|1|||
161403662|NCT00993499|582865700|FG003|Run-in Period (8 Days)|Progressive disease|0|||
161403663|NCT00993499|582865701|FG004|Run-in Period (8 Days)|Progressive disease|0|||
161403664|NCT00993499|582865702|FG005|Run-in Period (8 Days)|Progressive disease|0|||
161403665|NCT00993499|582865697|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
161403666|NCT00993499|582865698|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
161403667|NCT00993499|582865699|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
161403668|NCT00993499|582865700|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
161403669|NCT00993499|582865701|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
161403670|NCT00993499|582865702|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
161403671|NCT00993499|582865697|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
161403672|NCT00993499|582865698|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
161403673|NCT00993499|582865699|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161403674|NCT00993499|582865700|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161403675|NCT00993499|582865701|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161403676|NCT00993499|582865702|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161403677|NCT00993499|582865697|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161403678|NCT00993499|582865698|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161403679|NCT00993499|582865699|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
161403680|NCT00993499|582865700|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
161403681|NCT00993499|582865701|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161403682|NCT00993499|582865702|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161403683|NCT00993499|582865697|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161403684|NCT00993499|582865698|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161403685|NCT00993499|582865699|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
161403686|NCT00993499|582865700|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161403687|NCT00993499|582865701|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161403688|NCT00993499|582865702|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161403689|NCT00993499|582865697|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161403690|NCT00993499|582865698|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
161403691|NCT00993499|582865699|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161403692|NCT00993499|582865700|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161403693|NCT00993499|582865701|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161403694|NCT00993499|582865702|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161403695|NCT00993499|582865697|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
161403696|NCT00993499|582865698|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
161403697|NCT00993499|582865699|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
161403698|NCT00993499|582865700|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
161403699|NCT00993499|582865701|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
161403700|NCT00993499|582865702|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
161403701|NCT00993499|582865697|FG000|Discontinued After Starting Course 3|DLT|1|||
161403702|NCT00993499|582865698|FG001|Discontinued After Starting Course 3|DLT|0|||
161403703|NCT00993499|582865699|FG002|Discontinued After Starting Course 3|DLT|2|||
161403704|NCT00993499|582865700|FG003|Discontinued After Starting Course 3|DLT|1|||
161403705|NCT00993499|582865701|FG004|Discontinued After Starting Course 3|DLT|0|||
161403706|NCT00993499|582865702|FG005|Discontinued After Starting Course 3|DLT|0|||
161403707|NCT00993499|582865697|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
161403708|NCT00993499|582865698|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
161403709|NCT00993499|582865699|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
161403710|NCT00993499|582865700|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
161403711|NCT00993499|582865701|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
161403712|NCT00993499|582865702|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
161403713|NCT05432167|582865703|FG000|Overall Study|Adverse Event|0|||
161403714|NCT05432167|582865704|FG001|Overall Study|Adverse Event|2|||
161403715|NCT05432167|582865705|FG002|Overall Study|Adverse Event|1|||
161403716|NCT05432167|582865703|FG000|Overall Study|Lost to Follow-up|3|||
161403717|NCT05432167|582865704|FG001|Overall Study|Lost to Follow-up|3|||
161403718|NCT05432167|582865705|FG002|Overall Study|Lost to Follow-up|2|||
161403719|NCT05432167|582865703|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
161403720|NCT05432167|582865704|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161403721|NCT05432167|582865705|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
161403722|NCT05432167|582865703|FG000|Overall Study|Physician Decision|1|||
161403723|NCT05432167|582865704|FG001|Overall Study|Physician Decision|0|||
161403724|NCT05432167|582865705|FG002|Overall Study|Physician Decision|0|||
161403725|NCT05432167|582865703|FG000|Overall Study|Withdrawal by Subject|7|||
161403726|NCT05432167|582865704|FG001|Overall Study|Withdrawal by Subject|4|||
161403727|NCT05432167|582865705|FG002|Overall Study|Withdrawal by Subject|11|||
161403728|NCT05432167|582865703|FG000|Overall Study|Other|0|||
161403729|NCT05432167|582865704|FG001|Overall Study|Other|0|||
161403730|NCT05432167|582865705|FG002|Overall Study|Other|1|||
161403731|NCT00357656|582865708|FG000|Overall Study|Other, No surgery performed|0|||
161403732|NCT00357656|582865709|FG001|Overall Study|Other, No surgery performed|3|||
161403733|NCT01902888|582865710|FG000|Overall Study|Study Terminated|3|||
161403734|NCT02256267|582865711|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
161403735|NCT02256267|582865711|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
161403736|NCT03149003|582865712|FG000|Overall Study|Randomized but not treated|0|||
161403737|NCT03149003|582865713|FG001|Overall Study|Randomized but not treated|1|||
161403738|NCT03149003|582865714|FG002|Overall Study|Randomized but not treated|18|||
161403739|NCT01685983|582865715|FG000|Overall Study|Adverse Event|7|||
161403740|NCT01685983|582865715|FG000|Overall Study|Death|1|||
161403741|NCT01685983|582865715|FG000|Overall Study|Withdrawal by Subject|19|||
161403742|NCT01685983|582865715|FG000|Overall Study|Protocol Violation|2|||
161403743|NCT01685983|582865715|FG000|Overall Study|Physician Decision|13|||
161403744|NCT01685983|582865715|FG000|Overall Study|Other|7|||
161403745|NCT01685983|582865715|FG000|Overall Study|Progressive Disease|32|||
161403746|NCT01685983|582865715|FG000|Overall Study|Noncompliance with Study Drug|1|||
161403747|NCT01443130|582865716|FG000|Overall Study|Lost to Follow-up|44|||
161403748|NCT01443130|582865717|FG001|Overall Study|Lost to Follow-up|42|||
161403749|NCT01443130|582865718|FG002|Overall Study|Lost to Follow-up|50|||
161403750|NCT01443130|582865719|FG003|Overall Study|Lost to Follow-up|23|||
161403751|NCT01443130|582865720|FG004|Overall Study|Lost to Follow-up|25|||
161403752|NCT01443130|582865721|FG005|Overall Study|Lost to Follow-up|21|||
161403753|NCT01443130|582865716|FG000|Overall Study|Death|0|||
161403754|NCT01443130|582865717|FG001|Overall Study|Death|1|||
161403755|NCT01443130|582865718|FG002|Overall Study|Death|0|||
161403756|NCT01443130|582865719|FG003|Overall Study|Death|7|||
161403757|NCT01443130|582865720|FG004|Overall Study|Death|10|||
161403758|NCT01443130|582865721|FG005|Overall Study|Death|8|||
161403759|NCT01443130|582865716|FG000|Overall Study|Adverse Event|2|||
161403760|NCT01443130|582865717|FG001|Overall Study|Adverse Event|1|||
161403761|NCT01443130|582865718|FG002|Overall Study|Adverse Event|1|||
161403762|NCT01443130|582865719|FG003|Overall Study|Adverse Event|0|||
161403763|NCT01443130|582865720|FG004|Overall Study|Adverse Event|0|||
161403764|NCT01443130|582865721|FG005|Overall Study|Adverse Event|0|||
161403765|NCT01443130|582865716|FG000|Overall Study|Protocol Violation|2|||
161403766|NCT01443130|582865717|FG001|Overall Study|Protocol Violation|1|||
161403767|NCT01443130|582865718|FG002|Overall Study|Protocol Violation|3|||
161403768|NCT01443130|582865719|FG003|Overall Study|Protocol Violation|2|||
161403769|NCT01443130|582865720|FG004|Overall Study|Protocol Violation|2|||
161403770|NCT01443130|582865721|FG005|Overall Study|Protocol Violation|3|||
161403771|NCT01443130|582865716|FG000|Overall Study|Withdrawal by Subject|15|||
161403772|NCT01443130|582865717|FG001|Overall Study|Withdrawal by Subject|14|||
161403773|NCT01443130|582865718|FG002|Overall Study|Withdrawal by Subject|12|||
161403774|NCT01443130|582865719|FG003|Overall Study|Withdrawal by Subject|7|||
161403775|NCT01443130|582865720|FG004|Overall Study|Withdrawal by Subject|7|||
161403776|NCT01443130|582865721|FG005|Overall Study|Withdrawal by Subject|2|||
161403777|NCT01443130|582865716|FG000|Overall Study|Death of Subject's Infant|5|||
161403778|NCT01443130|582865717|FG001|Overall Study|Death of Subject's Infant|10|||
161403779|NCT01443130|582865718|FG002|Overall Study|Death of Subject's Infant|11|||
161403780|NCT01443130|582865719|FG003|Overall Study|Death of Subject's Infant|0|||
161403781|NCT01443130|582865720|FG004|Overall Study|Death of Subject's Infant|0|||
161403782|NCT01443130|582865721|FG005|Overall Study|Death of Subject's Infant|0|||
161403783|NCT00364533|582865725|FG000|Overall Study|Adverse Event|8|||
161403784|NCT00364533|582865726|FG001|Overall Study|Adverse Event|7|||
161403785|NCT00364533|582865727|FG002|Overall Study|Adverse Event|15|||
161403786|NCT00364533|582865728|FG003|Overall Study|Adverse Event|5|||
161403787|NCT00364533|582865729|FG004|Overall Study|Adverse Event|2|||
161403788|NCT00364533|582865725|FG000|Overall Study|Withdrawal by Subject|4|||
161403789|NCT00364533|582865726|FG001|Overall Study|Withdrawal by Subject|8|||
161403790|NCT00364533|582865727|FG002|Overall Study|Withdrawal by Subject|6|||
161403791|NCT00364533|582865728|FG003|Overall Study|Withdrawal by Subject|6|||
161403792|NCT00364533|582865729|FG004|Overall Study|Withdrawal by Subject|6|||
161403793|NCT00364533|582865725|FG000|Overall Study|Lack of Efficacy|22|||
161403794|NCT00364533|582865726|FG001|Overall Study|Lack of Efficacy|22|||
161403795|NCT00364533|582865727|FG002|Overall Study|Lack of Efficacy|21|||
161403796|NCT00364533|582865728|FG003|Overall Study|Lack of Efficacy|17|||
161403797|NCT00364533|582865729|FG004|Overall Study|Lack of Efficacy|42|||
161403798|NCT00364533|582865725|FG000|Overall Study|Subject discharged from hospital|4|||
161403799|NCT00364533|582865726|FG001|Overall Study|Subject discharged from hospital|1|||
161403800|NCT00364533|582865727|FG002|Overall Study|Subject discharged from hospital|2|||
161403801|NCT00364533|582865728|FG003|Overall Study|Subject discharged from hospital|3|||
161403802|NCT00364533|582865729|FG004|Overall Study|Subject discharged from hospital|1|||
161403803|NCT00364533|582865725|FG000|Overall Study|Variations in drug compliance|2|||
161403804|NCT00364533|582865726|FG001|Overall Study|Variations in drug compliance|1|||
161403805|NCT00364533|582865727|FG002|Overall Study|Variations in drug compliance|1|||
161403806|NCT00364533|582865728|FG003|Overall Study|Variations in drug compliance|0|||
161403807|NCT00364533|582865729|FG004|Overall Study|Variations in drug compliance|0|||
161403808|NCT00364533|582865725|FG000|Overall Study|Non-compliance|1|||
161403809|NCT00364533|582865726|FG001|Overall Study|Non-compliance|0|||
161403810|NCT00364533|582865727|FG002|Overall Study|Non-compliance|0|||
161403811|NCT00364533|582865728|FG003|Overall Study|Non-compliance|0|||
161403812|NCT00364533|582865729|FG004|Overall Study|Non-compliance|0|||
161403813|NCT00364533|582865725|FG000|Overall Study|Protocol Violation|1|||
161403814|NCT00364533|582865726|FG001|Overall Study|Protocol Violation|1|||
161403815|NCT00364533|582865727|FG002|Overall Study|Protocol Violation|0|||
161403816|NCT00364533|582865728|FG003|Overall Study|Protocol Violation|0|||
161403817|NCT00364533|582865729|FG004|Overall Study|Protocol Violation|0|||
161403818|NCT02758301|582865730|FG000|Overall Study|Death|12|||
161403819|NCT02758301|582865731|FG001|Overall Study|Death|0|||
161403820|NCT02758301|582865730|FG000|Overall Study|Physician Decision|10|||
161403821|NCT02758301|582865731|FG001|Overall Study|Physician Decision|1|||
161403822|NCT02758301|582865730|FG000|Overall Study|Withdrawal by Subject|5|||
161403823|NCT02758301|582865731|FG001|Overall Study|Withdrawal by Subject|6|||
161403824|NCT02758301|582865730|FG000|Overall Study|Lost to Follow-up|7|||
161403825|NCT02758301|582865731|FG001|Overall Study|Lost to Follow-up|0|||
161403826|NCT02758301|582865730|FG000|Overall Study|Protocol Violation|0|||
161403827|NCT02758301|582865731|FG001|Overall Study|Protocol Violation|1|||
161403828|NCT01167907|582865734|FG000|Overall Study|Protocol Violation|1|||
161403829|NCT01167907|582865735|FG001|Overall Study|Protocol Violation|0|||
161403830|NCT01167907|582865734|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
161403831|NCT01167907|582865735|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
161403832|NCT00815191|582865738|FG000|Overall Study|Protocol Violation|1|||
161403833|NCT00815191|582865739|FG001|Overall Study|Protocol Violation|1|||
161403834|NCT01814670|582865744|FG000|Overall Study|Protocol Violation|12|||
161403835|NCT01873729|582865745|FG000|Overall Study|Withdrawal by Subject|1|||
161403836|NCT01741532|582865746|FG000|Overall Study|Adverse Event|4|||
161403837|NCT01741532|582865747|FG001|Overall Study|Adverse Event|0|||
161403838|NCT01741532|582865746|FG000|Overall Study|Withdrawal by Subject|1|||
161403839|NCT01741532|582865747|FG001|Overall Study|Withdrawal by Subject|1|||
161403840|NCT01741532|582865746|FG000|Overall Study|Protocol Violation|0|||
161403841|NCT01741532|582865747|FG001|Overall Study|Protocol Violation|1|||
161403842|NCT01741532|582865746|FG000|Overall Study|Worsening of the disease|3|||
161403843|NCT01741532|582865747|FG001|Overall Study|Worsening of the disease|1|||
161403844|NCT01741532|582865746|FG000|Overall Study|Sponsor decision|1|||
161403845|NCT01741532|582865747|FG001|Overall Study|Sponsor decision|0|||
161403846|NCT01741532|582865746|FG000|Overall Study|Medical event|1|||
161403847|NCT01741532|582865747|FG001|Overall Study|Medical event|0|||
161403848|NCT00973102|582865748|FG000|Overall Study|Protocol Violation|1|||
161403849|NCT00973102|582865749|FG001|Overall Study|Protocol Violation|0|||
161403850|NCT00973102|582865748|FG000|Overall Study|Prisoner|0|||
161403851|NCT00973102|582865749|FG001|Overall Study|Prisoner|1|||
161403852|NCT00613080|582865750|FG000|Overall Study|Ineligible / no protocol treatment|11|||
161403853|NCT01066780|582865751|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
161403854|NCT01066780|582865752|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
161403855|NCT02360293|582865753|FG000|Overall Study|Lost to Follow-up|73|||
161403856|NCT02360293|582865754|FG001|Overall Study|Lost to Follow-up|95|||
161403857|NCT02360293|582865753|FG000|Overall Study|Withdrawal by Subject|2|||
161403858|NCT02360293|582865754|FG001|Overall Study|Withdrawal by Subject|1|||
161403859|NCT02360293|582865753|FG000|Overall Study|Excluded|1|||
161403860|NCT02360293|582865754|FG001|Overall Study|Excluded|0|||
161403861|NCT02226549|582865755|FG000|Overall Study|Randomized but Never Treated|1|||
161403862|NCT02226549|582865756|FG001|Overall Study|Randomized but Never Treated|0|||
161403863|NCT02226549|582865755|FG000|Overall Study|Lost to Follow-up|0|||
161403864|NCT02226549|582865756|FG001|Overall Study|Lost to Follow-up|1|||
161403865|NCT02012686|582865758|FG000|Overall Study|muscle contraction|0|||
161403866|NCT02012686|582865759|FG001|Overall Study|muscle contraction|1|||
161403867|NCT02012686|582865758|FG000|Overall Study|electrocardiography monitoring noise|0|||
161403868|NCT02012686|582865759|FG001|Overall Study|electrocardiography monitoring noise|1|||
161403869|NCT03099148|582865760|FG000|Wash-out|scheduling conflict|0|||
161403870|NCT03099148|582865761|FG001|Wash-out|scheduling conflict|1|||
161403871|NCT03099148|582865762|FG002|Wash-out|scheduling conflict|0|||
161403872|NCT03099148|582865763|FG003|Wash-out|scheduling conflict|0|||
161403873|NCT03099148|582865760|FG000|Wash-out|Adverse Event|0|||
161403874|NCT03099148|582865761|FG001|Wash-out|Adverse Event|1|||
161403875|NCT03099148|582865762|FG002|Wash-out|Adverse Event|0|||
161403876|NCT03099148|582865763|FG003|Wash-out|Adverse Event|0|||
161403877|NCT01703065|582865766|FG000|Overall Study|Lack of Efficacy|1|||
161403878|NCT01703065|582865767|FG001|Overall Study|Lack of Efficacy|0|||
161403879|NCT00687609|582865770|FG000|Overall Study|Physician Decision|1|||
161403880|NCT00687609|582865770|FG000|Overall Study|Withdrawal by Subject|2|||
161403881|NCT02713529|582865771|FG000|Overall Study|Withdrawal by Subject|3|||
161403882|NCT02713529|582865772|FG001|Overall Study|Withdrawal by Subject|1|||
161403883|NCT02713529|582865773|FG002|Overall Study|Withdrawal by Subject|4|||
161403884|NCT02713529|582865774|FG003|Overall Study|Withdrawal by Subject|2|||
161403885|NCT02713529|582865775|FG004|Overall Study|Withdrawal by Subject|0|||
161403886|NCT02713529|582865776|FG005|Overall Study|Withdrawal by Subject|1|||
161403887|NCT02713529|582865777|FG006|Overall Study|Withdrawal by Subject|1|||
161403888|NCT02713529|582865771|FG000|Overall Study|Lost to Follow-up|1|||
161403889|NCT02713529|582865772|FG001|Overall Study|Lost to Follow-up|0|||
161403890|NCT02713529|582865773|FG002|Overall Study|Lost to Follow-up|1|||
161403891|NCT02713529|582865774|FG003|Overall Study|Lost to Follow-up|0|||
161403892|NCT02713529|582865775|FG004|Overall Study|Lost to Follow-up|0|||
161403893|NCT02713529|582865776|FG005|Overall Study|Lost to Follow-up|0|||
161403894|NCT02713529|582865777|FG006|Overall Study|Lost to Follow-up|0|||
161403895|NCT02713529|582865771|FG000|Overall Study|Death|3|||
161403896|NCT02713529|582865772|FG001|Overall Study|Death|3|||
161403897|NCT02713529|582865773|FG002|Overall Study|Death|26|||
161403898|NCT02713529|582865774|FG003|Overall Study|Death|27|||
161403899|NCT02713529|582865775|FG004|Overall Study|Death|3|||
161403900|NCT02713529|582865776|FG005|Overall Study|Death|13|||
161403901|NCT02713529|582865777|FG006|Overall Study|Death|3|||
161403902|NCT02449018|582865783|FG000|Overall Study|Abnormal laboratory value|0|||
161403903|NCT02449018|582865784|FG001|Overall Study|Abnormal laboratory value|1|||
161403904|NCT02449018|582865783|FG000|Overall Study|Administrative problems|1|||
161403905|NCT02449018|582865784|FG001|Overall Study|Administrative problems|0|||
161403906|NCT02449018|582865783|FG000|Overall Study|Adverse Event|5|||
161403907|NCT02449018|582865784|FG001|Overall Study|Adverse Event|1|||
161403908|NCT02449018|582865783|FG000|Overall Study|Protocol deviation|4|||
161403909|NCT02449018|582865784|FG001|Overall Study|Protocol deviation|0|||
161403910|NCT02449018|582865783|FG000|Overall Study|Patient decision|2|||
161403911|NCT02449018|582865784|FG001|Overall Study|Patient decision|0|||
161403912|NCT02698371|582865792|FG000|All Participants Flow|Lost to Follow-up|3|||
161403913|NCT02698371|582865792|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
161403914|NCT02698371|582865792|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
161403915|NCT02698371|582865792|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
161403916|NCT02698371|582865792|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
161403917|NCT02698371|582865792|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
161403918|NCT02698371|582865792|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
161403919|NCT01949090|582866944|FG000|Overall Study|Serious Adverse Event|0|||
161403920|NCT01949090|582866945|FG001|Overall Study|Serious Adverse Event|1|||
161403921|NCT01949090|582866946|FG002|Overall Study|Serious Adverse Event|2|||
161403922|NCT01949090|582866947|FG003|Overall Study|Serious Adverse Event|0|||
161403923|NCT01949090|582866948|FG004|Overall Study|Serious Adverse Event|1|||
161403924|NCT01949090|582866944|FG000|Overall Study|Withdrawal by Subject|2|||
161403925|NCT01949090|582866945|FG001|Overall Study|Withdrawal by Subject|0|||
161403926|NCT01949090|582866946|FG002|Overall Study|Withdrawal by Subject|0|||
161403927|NCT01949090|582866947|FG003|Overall Study|Withdrawal by Subject|0|||
161403928|NCT01949090|582866948|FG004|Overall Study|Withdrawal by Subject|1|||
161403929|NCT01949090|582866944|FG000|Overall Study|Protocol non-compliance|0|||
161403930|NCT01949090|582866945|FG001|Overall Study|Protocol non-compliance|0|||
161403931|NCT01949090|582866946|FG002|Overall Study|Protocol non-compliance|0|||
161403932|NCT01949090|582866947|FG003|Overall Study|Protocol non-compliance|0|||
161403933|NCT01949090|582866948|FG004|Overall Study|Protocol non-compliance|1|||
161403934|NCT01949090|582866944|FG000|Overall Study|Lost to Follow-up|2|||
161403935|NCT01949090|582866945|FG001|Overall Study|Lost to Follow-up|1|||
161403936|NCT01949090|582866946|FG002|Overall Study|Lost to Follow-up|0|||
161403937|NCT01949090|582866947|FG003|Overall Study|Lost to Follow-up|1|||
161403938|NCT01949090|582866948|FG004|Overall Study|Lost to Follow-up|1|||
161403939|NCT02783170|582866949|FG000|Overall Study|Randomized but not Vaccinated|1|||
161403940|NCT02783170|582866950|FG001|Overall Study|Randomized but not Vaccinated|0|||
161403941|NCT04938037|582866951|FG000|Overall Study|Lost to Follow-up|4|||
161403942|NCT04938037|582866952|FG001|Overall Study|Lost to Follow-up|3|||
161403943|NCT01806064|582866953|FG000|Overall Study|Randomized Not Enrolled|0|||
161403944|NCT01806064|582866954|FG001|Overall Study|Randomized Not Enrolled|0|||
161403945|NCT01806064|582866955|FG002|Overall Study|Randomized Not Enrolled|0|||
161403946|NCT01806064|582866956|FG003|Overall Study|Randomized Not Enrolled|1|||
161403947|NCT01806064|582866957|FG004|Overall Study|Randomized Not Enrolled|2|||
161403948|NCT05063539|582866959|FG000|Overall Study|Adverse Event|1|||
161403949|NCT05063539|582866960|FG001|Overall Study|Adverse Event|2|||
161403950|NCT05063539|582866961|FG002|Overall Study|Adverse Event|1|||
161403951|NCT05063539|582866959|FG000|Overall Study|Death|0|||
161403952|NCT05063539|582866960|FG001|Overall Study|Death|1|||
161403953|NCT05063539|582866961|FG002|Overall Study|Death|1|||
161403954|NCT05063539|582866959|FG000|Overall Study|Lost to Follow-up|0|||
161403955|NCT05063539|582866960|FG001|Overall Study|Lost to Follow-up|1|||
161403956|NCT05063539|582866961|FG002|Overall Study|Lost to Follow-up|0|||
161403957|NCT05063539|582866959|FG000|Overall Study|Physician Decision|4|||
161403958|NCT05063539|582866960|FG001|Overall Study|Physician Decision|3|||
161403959|NCT05063539|582866961|FG002|Overall Study|Physician Decision|1|||
161403960|NCT05063539|582866959|FG000|Overall Study|Progressive Disease|0|||
161403961|NCT05063539|582866960|FG001|Overall Study|Progressive Disease|2|||
161403962|NCT05063539|582866961|FG002|Overall Study|Progressive Disease|0|||
161403963|NCT05063539|582866959|FG000|Overall Study|Withdrawal by Subject|17|||
161403964|NCT05063539|582866960|FG001|Overall Study|Withdrawal by Subject|26|||
161403965|NCT05063539|582866961|FG002|Overall Study|Withdrawal by Subject|14|||
161403966|NCT05063539|582866959|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
161403967|NCT05063539|582866960|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
161403968|NCT05063539|582866961|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
161403969|NCT05063539|582866959|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
161403970|NCT05063539|582866960|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
161403971|NCT05063539|582866961|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
161403972|NCT05063539|582866959|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
161403973|NCT05063539|582866960|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
161403974|NCT05063539|582866961|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
161403975|NCT05063539|582866959|FG000|Overall Study|Discontinued due to Common Close Design|0|||
161403976|NCT05063539|582866960|FG001|Overall Study|Discontinued due to Common Close Design|1|||
161403977|NCT05063539|582866961|FG002|Overall Study|Discontinued due to Common Close Design|0|||
161403978|NCT05063539|582866959|FG000|Overall Study|Participant not co-operative|0|||
161403979|NCT05063539|582866960|FG001|Overall Study|Participant not co-operative|1|||
161403980|NCT05063539|582866961|FG002|Overall Study|Participant not co-operative|0|||
161403981|NCT05063539|582866959|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
161403982|NCT05063539|582866960|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
161403983|NCT05063539|582866961|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
161403984|NCT05063539|582866959|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
161403985|NCT05063539|582866960|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
161403986|NCT05063539|582866961|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
161403987|NCT04256512|582866962|FG000|Overall Study|Withdrawal by Subject|1|||
161403988|NCT02804750|582866966|FG000|Period 1|Adverse Event|0|||
161403989|NCT02804750|582866967|FG001|Period 1|Adverse Event|2|||
161403990|NCT02804750|582866966|FG000|Period 1|Withdrawal by Subject|0|||
161403991|NCT02804750|582866967|FG001|Period 1|Withdrawal by Subject|1|||
161403992|NCT02804750|582866966|FG000|Period 2|Adverse Event|1|||
161403993|NCT02804750|582866967|FG001|Period 2|Adverse Event|0|||
161403994|NCT02804750|582866966|FG000|Period 3|Adverse Event|0|||
161403995|NCT02804750|582866967|FG001|Period 3|Adverse Event|2|||
161403996|NCT02804750|582866966|FG000|Period 4|Adverse Event|0|||
161403997|NCT02804750|582866967|FG001|Period 4|Adverse Event|5|||
161403998|NCT04692077|582866975|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
161403999|NCT01751139|582866980|FG000|Overall Study|Other|135|||
161404000|NCT01751139|582866980|FG000|Overall Study|Sponsor study termination|1609|||
161404001|NCT01751139|582866980|FG000|Overall Study|Lost to Follow-up|240|||
161404002|NCT01751139|582866980|FG000|Overall Study|Withdrawal by Subject|251|||
161404003|NCT01751139|582866980|FG000|Overall Study|Adverse Event|1|||
161404004|NCT01751139|582866980|FG000|Overall Study|Death|31|||
161404005|NCT03199391|582866981|FG000|Overall Study|Death|1|||
161404006|NCT03199391|582866981|FG000|Overall Study|Lost to Follow-up|3|||
161404007|NCT03199391|582866981|FG000|Overall Study|Adverse Event|2|||
161404008|NCT03199391|582866981|FG000|Overall Study|Withdrawal by Subject|10|||
161404009|NCT01867086|582866982|FG000|Overall Study|Disease Progression|1|||
161404010|NCT04271475|582866987|FG000|DB Period: Day 1 up to EODBT|Death|1|||
161404011|NCT04271475|582866988|FG001|DB Period: Day 1 up to EODBT|Death|0|||
161404012|NCT04271475|582866989|FG002|DB Period: Day 1 up to EODBT|Death|0|||
161404013|NCT04271475|582866990|FG003|DB Period: Day 1 up to EODBT|Death|0|||
161404014|NCT04271475|582866987|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
161404015|NCT04271475|582866988|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
161404016|NCT04271475|582866989|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
161404017|NCT04271475|582866990|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
161404018|NCT04271475|582866987|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
161404019|NCT04271475|582866988|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
161404020|NCT04271475|582866989|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
161404021|NCT04271475|582866990|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
161404022|NCT04271475|582866987|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
161404023|NCT04271475|582866988|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
161404024|NCT04271475|582866989|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
161404025|NCT04271475|582866990|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
161404026|NCT04271475|582866987|FG000|DB Period: Day 1 up to EODBT|Other|8|||
161404027|NCT04271475|582866988|FG001|DB Period: Day 1 up to EODBT|Other|5|||
161404028|NCT04271475|582866989|FG002|DB Period: Day 1 up to EODBT|Other|0|||
161404029|NCT04271475|582866990|FG003|DB Period: Day 1 up to EODBT|Other|0|||
161404030|NCT04271475|582866987|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
161404031|NCT04271475|582866988|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
161404032|NCT04271475|582866989|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
161404033|NCT04271475|582866990|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
161404034|NCT04271475|582866987|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
161404035|NCT04271475|582866988|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
161404036|NCT04271475|582866989|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
161404037|NCT04271475|582866990|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
161404038|NCT02337634|582866991|FG000|Overall Study|Protocol Violation|3|||
161404039|NCT02337634|582866992|FG001|Overall Study|Protocol Violation|1|||
161404040|NCT02337634|582866991|FG000|Overall Study|Lost to Follow-up|1|||
161404041|NCT02337634|582866992|FG001|Overall Study|Lost to Follow-up|0|||
161404042|NCT02428205|582866996|FG000|Overall Study|Lack of Efficacy|1|||
161404043|NCT02428205|582866997|FG001|Overall Study|Lack of Efficacy|0|||
161404044|NCT02428205|582866996|FG000|Overall Study|Lost to Follow-up|1|||
161404045|NCT02428205|582866997|FG001|Overall Study|Lost to Follow-up|1|||
161404046|NCT02428205|582866996|FG000|Overall Study|Worse behavior|0|||
161404047|NCT02428205|582866997|FG001|Overall Study|Worse behavior|1|||
161404048|NCT01818284|582866998|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
161404049|NCT01818284|582866999|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
161404050|NCT01818284|582866998|FG000|Overall Study|Death|0|||
161404051|NCT01818284|582866999|FG001|Overall Study|Death|2|||
161404052|NCT02888743|582867000|FG000|Overall Study|Withdrawal by Subject|1|||
161404053|NCT02888743|582867001|FG001|Overall Study|Withdrawal by Subject|2|||
161404054|NCT02888743|582867002|FG002|Overall Study|Withdrawal by Subject|2|||
161404055|NCT02888743|582867003|FG003|Overall Study|Withdrawal by Subject|0|||
161404056|NCT02888743|582867004|FG004|Overall Study|Withdrawal by Subject|1|||
161404057|NCT02888743|582867000|FG000|Overall Study|Disease progression before treatment|2|||
161404058|NCT02888743|582867001|FG001|Overall Study|Disease progression before treatment|0|||
161404059|NCT02888743|582867002|FG002|Overall Study|Disease progression before treatment|2|||
161404060|NCT02888743|582867003|FG003|Overall Study|Disease progression before treatment|0|||
161404061|NCT02888743|582867004|FG004|Overall Study|Disease progression before treatment|0|||
161404062|NCT02888743|582867000|FG000|Overall Study|Patient ineligible|1|||
161404063|NCT02888743|582867001|FG001|Overall Study|Patient ineligible|2|||
161404064|NCT02888743|582867002|FG002|Overall Study|Patient ineligible|0|||
161404065|NCT02888743|582867003|FG003|Overall Study|Patient ineligible|0|||
161404066|NCT02888743|582867004|FG004|Overall Study|Patient ineligible|0|||
161404067|NCT00527319|582867005|FG000|Overall Study|Withdrawal by Subject|5|||
161404068|NCT00527319|582867006|FG001|Overall Study|Withdrawal by Subject|0|||
161404069|NCT00527319|582867007|FG002|Overall Study|Withdrawal by Subject|1|||
161404070|NCT00527319|582867005|FG000|Overall Study|Lost to Follow-up|1|||
161404071|NCT00527319|582867006|FG001|Overall Study|Lost to Follow-up|0|||
161404072|NCT00527319|582867007|FG002|Overall Study|Lost to Follow-up|0|||
161404073|NCT00527319|582867005|FG000|Overall Study|Death|0|||
161404074|NCT00527319|582867006|FG001|Overall Study|Death|3|||
161404075|NCT00527319|582867007|FG002|Overall Study|Death|1|||
161404076|NCT00527319|582867005|FG000|Overall Study|Intercurrent Medical Illness|0|||
161404077|NCT00527319|582867006|FG001|Overall Study|Intercurrent Medical Illness|1|||
161404078|NCT00527319|582867007|FG002|Overall Study|Intercurrent Medical Illness|3|||
161404079|NCT00527319|582867005|FG000|Overall Study|Adverse Event|0|||
161404080|NCT00527319|582867006|FG001|Overall Study|Adverse Event|0|||
161404081|NCT00527319|582867007|FG002|Overall Study|Adverse Event|1|||
161404082|NCT01804582|582867011|FG000|Overall Study|Lost to Follow-up|47|||
161404083|NCT01804582|582867012|FG001|Overall Study|Lost to Follow-up|56|||
161404084|NCT01804582|582867011|FG000|Overall Study|Physician Decision|2|||
161404085|NCT01804582|582867012|FG001|Overall Study|Physician Decision|0|||
161404086|NCT01299571|582867018|FG000|Overall Study|Protocol Violation|107|||
161404087|NCT00875056|582867019|FG000|Overall Study|Adverse Event|6|||
161404088|NCT00875056|582867020|FG001|Overall Study|Adverse Event|1|||
161404089|NCT00875056|582867021|FG002|Overall Study|Adverse Event|2|||
161404090|NCT00875056|582867019|FG000|Overall Study|Progressive Disease|14|||
161404091|NCT00875056|582867020|FG001|Overall Study|Progressive Disease|8|||
161404092|NCT00875056|582867021|FG002|Overall Study|Progressive Disease|3|||
161404093|NCT00875056|582867019|FG000|Overall Study|Withdrawal by Subject|3|||
161404094|NCT00875056|582867020|FG001|Overall Study|Withdrawal by Subject|0|||
161404095|NCT00875056|582867021|FG002|Overall Study|Withdrawal by Subject|1|||
161404096|NCT02900170|582867026|FG000|Overall Study|Lost to Follow-up|8|||
161404097|NCT01739803|582867027|FG000|Overall Study|Lost to Follow-up|9|||
161404098|NCT01739803|582867028|FG001|Overall Study|Lost to Follow-up|6|||
161404099|NCT03759041|582867029|FG000|Overall Study|Withdrawal by Subject|4|||
161404100|NCT03759041|582867030|FG001|Overall Study|Withdrawal by Subject|10|||
161404101|NCT03759041|582867031|FG002|Overall Study|Withdrawal by Subject|10|||
161404102|NCT03759041|582867029|FG000|Overall Study|Adverse Event|1|||
161404103|NCT03759041|582867030|FG001|Overall Study|Adverse Event|3|||
161404104|NCT03759041|582867031|FG002|Overall Study|Adverse Event|4|||
161404105|NCT03759041|582867029|FG000|Overall Study|Lack of Efficacy|0|||
161404106|NCT03759041|582867030|FG001|Overall Study|Lack of Efficacy|0|||
161404107|NCT03759041|582867031|FG002|Overall Study|Lack of Efficacy|1|||
161404108|NCT03759041|582867029|FG000|Overall Study|Study Terminated by Sponsor|15|||
161404109|NCT03759041|582867030|FG001|Overall Study|Study Terminated by Sponsor|16|||
161404110|NCT03759041|582867031|FG002|Overall Study|Study Terminated by Sponsor|10|||
161404111|NCT03759041|582867029|FG000|Overall Study|Other reason for discontinuation|0|||
161404112|NCT03759041|582867030|FG001|Overall Study|Other reason for discontinuation|2|||
161404113|NCT03759041|582867031|FG002|Overall Study|Other reason for discontinuation|1|||
161404114|NCT03759041|582867029|FG000|Overall Study|Lost to Follow-up|7|||
161404115|NCT03759041|582867030|FG001|Overall Study|Lost to Follow-up|2|||
161404116|NCT03759041|582867031|FG002|Overall Study|Lost to Follow-up|2|||
161404117|NCT03759041|582867029|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
161404118|NCT03759041|582867030|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
161404119|NCT03759041|582867031|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
161404120|NCT00525824|582867033|FG000|Overall Study|Adverse Event|7|||
161404121|NCT00525824|582867034|FG001|Overall Study|Adverse Event|11|||
161404122|NCT00525824|582867035|FG002|Overall Study|Adverse Event|6|||
161404123|NCT00525824|582867036|FG003|Overall Study|Adverse Event|7|||
161404124|NCT00525824|582867033|FG000|Overall Study|Withdrawal by Subject|5|||
161404125|NCT00525824|582867034|FG001|Overall Study|Withdrawal by Subject|9|||
161404126|NCT00525824|582867035|FG002|Overall Study|Withdrawal by Subject|3|||
161404127|NCT00525824|582867036|FG003|Overall Study|Withdrawal by Subject|4|||
161404128|NCT00525824|582867033|FG000|Overall Study|Lost to Follow-up|4|||
161404129|NCT00525824|582867034|FG001|Overall Study|Lost to Follow-up|2|||
161404130|NCT00525824|582867035|FG002|Overall Study|Lost to Follow-up|4|||
161404131|NCT00525824|582867036|FG003|Overall Study|Lost to Follow-up|0|||
161404132|NCT00525824|582867033|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
161404133|NCT00525824|582867034|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
161404134|NCT00525824|582867035|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
161404135|NCT00525824|582867036|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
161404136|NCT00525824|582867033|FG000|Overall Study|Severe non-compliance|0|||
161404137|NCT00525824|582867034|FG001|Overall Study|Severe non-compliance|1|||
161404138|NCT00525824|582867035|FG002|Overall Study|Severe non-compliance|1|||
161404139|NCT00525824|582867036|FG003|Overall Study|Severe non-compliance|1|||
161404140|NCT00525824|582867033|FG000|Overall Study|Safety reasons|1|||
161404141|NCT00525824|582867034|FG001|Overall Study|Safety reasons|0|||
161404142|NCT00525824|582867035|FG002|Overall Study|Safety reasons|1|||
161404143|NCT00525824|582867036|FG003|Overall Study|Safety reasons|0|||
161404144|NCT00525824|582867033|FG000|Overall Study|Other|1|||
161404145|NCT00525824|582867034|FG001|Overall Study|Other|3|||
161404146|NCT00525824|582867035|FG002|Overall Study|Other|3|||
161404147|NCT00525824|582867036|FG003|Overall Study|Other|1|||
161404148|NCT01522404|582867037|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
161404149|NCT01522404|582867038|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
161404150|NCT01522404|582867037|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
161404151|NCT01522404|582867038|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
161404152|NCT01522404|582867037|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
161404153|NCT01522404|582867038|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
161404154|NCT00897390|582867046|FG000|Overall Study|Adverse Event|2|||
161404155|NCT00897390|582867046|FG000|Overall Study|No Longer Met Study Criteria|1|||
161404156|NCT00897390|582867046|FG000|Overall Study|Personal Reasons|1|||
161404157|NCT00897390|582867046|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
161404158|NCT03159104|582867047|FG000|Overall Study|Violation of inclusion criteria|1|||
161404159|NCT03159104|582867048|FG001|Overall Study|Violation of inclusion criteria|2|||
161404160|NCT01216683|582868362|FG000|Induction|Never started treatment|0|||
161404161|NCT01216683|582868363|FG001|Induction|Never started treatment|6|||
161404162|NCT01216683|582868364|FG002|Induction|Never started treatment|3|||
161404163|NCT01216683|582868362|FG000|Induction|Lack of Efficacy|4|||
161404164|NCT01216683|582868363|FG001|Induction|Lack of Efficacy|3|||
161404165|NCT01216683|582868364|FG002|Induction|Lack of Efficacy|7|||
161404166|NCT01216683|582868362|FG000|Induction|Adverse Event|0|||
161404167|NCT01216683|582868363|FG001|Induction|Adverse Event|5|||
161404168|NCT01216683|582868364|FG002|Induction|Adverse Event|5|||
161404169|NCT01216683|582868362|FG000|Induction|Death|0|||
161404170|NCT01216683|582868363|FG001|Induction|Death|0|||
161404171|NCT01216683|582868364|FG002|Induction|Death|2|||
161404172|NCT01216683|582868362|FG000|Induction|Withdrawal by Subject|0|||
161404173|NCT01216683|582868363|FG001|Induction|Withdrawal by Subject|4|||
161404174|NCT01216683|582868364|FG002|Induction|Withdrawal by Subject|2|||
161404175|NCT01216683|582868362|FG000|Induction|Other disease|0|||
161404176|NCT01216683|582868363|FG001|Induction|Other disease|1|||
161404177|NCT01216683|582868364|FG002|Induction|Other disease|2|||
161404178|NCT01216683|582868362|FG000|Continuation|Lack of Efficacy|3|||
161404179|NCT01216683|582868363|FG001|Continuation|Lack of Efficacy|2|||
161404180|NCT01216683|582868364|FG002|Continuation|Lack of Efficacy|7|||
161404181|NCT01216683|582868362|FG000|Continuation|Adverse Event|5|||
161404182|NCT01216683|582868363|FG001|Continuation|Adverse Event|3|||
161404183|NCT01216683|582868364|FG002|Continuation|Adverse Event|16|||
161404184|NCT01216683|582868362|FG000|Continuation|Death|1|||
161404185|NCT01216683|582868363|FG001|Continuation|Death|0|||
161404186|NCT01216683|582868364|FG002|Continuation|Death|2|||
161404187|NCT01216683|582868362|FG000|Continuation|Withdrawal by Subject|4|||
161404188|NCT01216683|582868363|FG001|Continuation|Withdrawal by Subject|5|||
161404189|NCT01216683|582868364|FG002|Continuation|Withdrawal by Subject|9|||
161404190|NCT01216683|582868362|FG000|Continuation|Other diseases|0|||
161404191|NCT01216683|582868363|FG001|Continuation|Other diseases|2|||
161404192|NCT01216683|582868364|FG002|Continuation|Other diseases|1|||
161404193|NCT01216683|582868362|FG000|Continuation|Physician Decision|1|||
161404194|NCT01216683|582868363|FG001|Continuation|Physician Decision|0|||
161404195|NCT01216683|582868364|FG002|Continuation|Physician Decision|1|||
161404196|NCT01216683|582868362|FG000|Continuation|Non-compliance|1|||
161404197|NCT01216683|582868363|FG001|Continuation|Non-compliance|0|||
161404198|NCT01216683|582868364|FG002|Continuation|Non-compliance|1|||
161404199|NCT01216683|582868362|FG000|Continuation|Insurance change|0|||
161404200|NCT01216683|582868363|FG001|Continuation|Insurance change|1|||
161404201|NCT01216683|582868364|FG002|Continuation|Insurance change|0|||
161404202|NCT01216683|582868362|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
161404203|NCT01216683|582868363|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
161404204|NCT01216683|582868364|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
161404205|NCT01216683|582868362|FG000|Continuation|Not reported|0|||
161404206|NCT01216683|582868363|FG001|Continuation|Not reported|0|||
161404207|NCT01216683|582868364|FG002|Continuation|Not reported|1|||
161404208|NCT01216683|582868362|FG000|Continuation|Never started treatment|0|||
161404209|NCT01216683|582868363|FG001|Continuation|Never started treatment|1|||
161404210|NCT01216683|582868364|FG002|Continuation|Never started treatment|5|||
161404211|NCT05011513|582868365|FG000|Overall Study|Death|0|||
161404212|NCT05011513|582868366|FG001|Overall Study|Death|1|||
161404213|NCT05011513|582868365|FG000|Overall Study|Lost to Follow-up|4|||
161404214|NCT05011513|582868366|FG001|Overall Study|Lost to Follow-up|0|||
161404215|NCT05011513|582868365|FG000|Overall Study|Withdrawal by Subject|18|||
161404216|NCT05011513|582868366|FG001|Overall Study|Withdrawal by Subject|17|||
161404217|NCT05011513|582868365|FG000|Overall Study|Other|4|||
161404218|NCT05011513|582868366|FG001|Overall Study|Other|2|||
161404219|NCT03667690|582868367|FG000|Overall Study|Adverse Event|0|||
161404220|NCT03667690|582868368|FG001|Overall Study|Adverse Event|3|||
161404221|NCT03667690|582868367|FG000|Overall Study|Death|22|||
161404222|NCT03667690|582868368|FG001|Overall Study|Death|21|||
161404223|NCT03667690|582868367|FG000|Overall Study|Lost to Follow-up|4|||
161404224|NCT03667690|582868368|FG001|Overall Study|Lost to Follow-up|5|||
161404225|NCT03667690|582868367|FG000|Overall Study|Withdrawal by Subject|7|||
161404226|NCT03667690|582868368|FG001|Overall Study|Withdrawal by Subject|8|||
161404227|NCT03667690|582868367|FG000|Overall Study|Subject could not return for additional investigational product|1|||
161404228|NCT03667690|582868368|FG001|Overall Study|Subject could not return for additional investigational product|0|||
161404229|NCT03667690|582868367|FG000|Overall Study|Subject discharged to hospice care|2|||
161404230|NCT03667690|582868368|FG001|Overall Study|Subject discharged to hospice care|0|||
161404231|NCT03667690|582868367|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
161404232|NCT03667690|582868368|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
161404233|NCT03667690|582868367|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
161404234|NCT03667690|582868368|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
161404235|NCT03667690|582868367|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
161404236|NCT03667690|582868368|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
161404237|NCT03667690|582868367|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
161404238|NCT03667690|582868368|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
161404239|NCT03667690|582868367|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
161404240|NCT03667690|582868368|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
161404241|NCT01350115|582868377|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
161404242|NCT01350115|582868378|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
161404243|NCT01350115|582868377|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
161404244|NCT01350115|582868378|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
161404245|NCT01350115|582868377|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
161404246|NCT01350115|582868378|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
161404247|NCT04327024|582868379|FG000|Overall Study|Death|1|||
161404248|NCT04327024|582868380|FG001|Overall Study|Death|2|||
161404249|NCT04327024|582868381|FG002|Overall Study|Death|1|||
161404250|NCT04327024|582868379|FG000|Overall Study|Non-compliance with study drug|0|||
161404251|NCT04327024|582868380|FG001|Overall Study|Non-compliance with study drug|1|||
161404252|NCT04327024|582868381|FG002|Overall Study|Non-compliance with study drug|0|||
161404253|NCT04327024|582868379|FG000|Overall Study|Withdrawal by Subject|1|||
161404254|NCT04327024|582868380|FG001|Overall Study|Withdrawal by Subject|1|||
161404255|NCT04327024|582868381|FG002|Overall Study|Withdrawal by Subject|2|||
161404256|NCT00837759|582868385|FG000|Overall Study|Protocol Violation|3|||
161404257|NCT00837759|582868385|FG000|Overall Study|Lost to Follow-up|1|||
161404258|NCT01597635|582868386|FG000|Part A|Adverse Event|3|||
161404259|NCT01597635|582868387|FG001|Part A|Adverse Event|0|||
161404260|NCT01597635|582868388|FG002|Part A|Adverse Event|0|||
161404261|NCT01597635|582868386|FG000|Part B|Adverse Event|0|||
161404262|NCT01597635|582868387|FG001|Part B|Adverse Event|0|||
161404263|NCT01597635|582868388|FG002|Part B|Adverse Event|1|||
161404264|NCT01597635|582868386|FG000|Part B|Protocol Violation|0|||
161404265|NCT01597635|582868387|FG001|Part B|Protocol Violation|1|||
161404266|NCT01597635|582868388|FG002|Part B|Protocol Violation|0|||
161404267|NCT01597635|582868386|FG000|Part B|Protocol-defined stopping criteria|0|||
161404268|NCT01597635|582868387|FG001|Part B|Protocol-defined stopping criteria|4|||
161404269|NCT01597635|582868388|FG002|Part B|Protocol-defined stopping criteria|3|||
161404270|NCT01597635|582868386|FG000|Part B|Withdrawal by Subject|0|||
161404271|NCT01597635|582868387|FG001|Part B|Withdrawal by Subject|1|||
161404272|NCT01597635|582868388|FG002|Part B|Withdrawal by Subject|0|||
161404273|NCT01192568|582868389|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
161404274|NCT01192568|582868390|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
161404275|NCT01192568|582868391|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
161404276|NCT01192568|582868392|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
161404277|NCT01192568|582868389|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
161404278|NCT01192568|582868390|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
161404279|NCT01192568|582868391|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
161404280|NCT01192568|582868392|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
161404281|NCT02593825|582868393|FG000|Intervention|Lost to Follow-up|10|||
161404282|NCT02593825|582868394|FG001|Intervention|Lost to Follow-up|12|||
161404283|NCT06359080|582868395|FG000|Overall Study|Withdrawal by Subject|3|||
161404284|NCT00511134|582868398|FG000|Overall Study|Withdrawal by Subject|0|||
161404285|NCT00511134|582868399|FG001|Overall Study|Withdrawal by Subject|2|||
161404286|NCT01300351|582868406|FG000|Overall Study|Did not receive treatment|2|||
161404287|NCT01300351|582868407|FG001|Overall Study|Did not receive treatment|0|||
161404288|NCT01300351|582868406|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
161404289|NCT01300351|582868407|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
161404290|NCT01300351|582868406|FG000|Overall Study|Lost to Follow-up|0|||
161404291|NCT01300351|582868407|FG001|Overall Study|Lost to Follow-up|1|||
161404292|NCT01300351|582868406|FG000|Overall Study|Adverse Event|0|||
161404293|NCT01300351|582868407|FG001|Overall Study|Adverse Event|4|||
161404294|NCT01300351|582868406|FG000|Overall Study|Withdrawal by Subject|7|||
161404295|NCT01300351|582868407|FG001|Overall Study|Withdrawal by Subject|10|||
161404296|NCT05824936|582868410|FG000|Overall Study|Lost to Follow-up|1|||
161404297|NCT00096018|582868411|FG000|Overall Study|Became Ineligible (not treated)|0|||
161404298|NCT00096018|582868412|FG001|Overall Study|Became Ineligible (not treated)|3|||
161404299|NCT00096018|582868411|FG000|Overall Study|Miscellaneous (not treated)|0|||
161404300|NCT00096018|582868412|FG001|Overall Study|Miscellaneous (not treated)|2|||
161404301|NCT00096018|582868411|FG000|Overall Study|Adverse Event|0|||
161404302|NCT00096018|582868412|FG001|Overall Study|Adverse Event|5|||
161404303|NCT00096018|582868411|FG000|Overall Study|Death|0|||
161404304|NCT00096018|582868412|FG001|Overall Study|Death|1|||
161404305|NCT00096018|582868411|FG000|Overall Study|Withdrawal by Subject|0|||
161404306|NCT00096018|582868412|FG001|Overall Study|Withdrawal by Subject|2|||
161404307|NCT00096018|582868411|FG000|Overall Study|Miscellaneous|2|||
161404308|NCT00096018|582868412|FG001|Overall Study|Miscellaneous|1|||
161404309|NCT00673881|582868413|FG000|Overall Study|Withdrawal by Subject|1|||
161404310|NCT00483041|582868414|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
161404311|NCT00483041|582868415|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
161404312|NCT03968159|582868416|FG000|Overall Study|Adverse Event|4|||
161404313|NCT03968159|582868417|FG001|Overall Study|Adverse Event|4|||
161404314|NCT03968159|582868416|FG000|Overall Study|Lost to Follow-up|1|||
161404315|NCT03968159|582868417|FG001|Overall Study|Lost to Follow-up|1|||
161404316|NCT03968159|582868416|FG000|Overall Study|Use of prohibited medication|0|||
161404317|NCT03968159|582868417|FG001|Overall Study|Use of prohibited medication|1|||
161404318|NCT03968159|582868416|FG000|Overall Study|Protocol Violation|2|||
161404319|NCT03968159|582868417|FG001|Overall Study|Protocol Violation|2|||
161404320|NCT03968159|582868416|FG000|Overall Study|Withdrawal by Subject|4|||
161404321|NCT03968159|582868417|FG001|Overall Study|Withdrawal by Subject|6|||
161404322|NCT03968159|582868416|FG000|Overall Study|Lack of Efficacy|0|||
161404323|NCT03968159|582868417|FG001|Overall Study|Lack of Efficacy|1|||
161404324|NCT03968159|582868416|FG000|Overall Study|Not further specified|2|||
161404325|NCT03968159|582868417|FG001|Overall Study|Not further specified|0|||
161404326|NCT00864851|582868418|FG000|Overall Study|Withdrawal by Subject|0|||
161404327|NCT00864851|582868419|FG001|Overall Study|Withdrawal by Subject|1|||
161404328|NCT00864851|582868420|FG002|Overall Study|Withdrawal by Subject|0|||
161404329|NCT00864851|582868418|FG000|Overall Study|Physician Decision|1|||
161404330|NCT00864851|582868419|FG001|Overall Study|Physician Decision|0|||
161404331|NCT00864851|582868420|FG002|Overall Study|Physician Decision|0|||
161404332|NCT00864851|582868418|FG000|Overall Study|Death|1|||
161404333|NCT00864851|582868419|FG001|Overall Study|Death|0|||
161404334|NCT00864851|582868420|FG002|Overall Study|Death|0|||
161404335|NCT00864851|582868418|FG000|Overall Study|Patient uncooperative|1|||
161404336|NCT00864851|582868419|FG001|Overall Study|Patient uncooperative|0|||
161404337|NCT00864851|582868420|FG002|Overall Study|Patient uncooperative|0|||
161404338|NCT00443781|582868421|FG000|Overall Study|Lost to Follow-up|10|||
161404339|NCT00443781|582868421|FG000|Overall Study|Physician Decision|2|||
161404340|NCT00443781|582868421|FG000|Overall Study|Protocol Violation|1|||
161404341|NCT00443781|582868421|FG000|Overall Study|Withdrawal by Subject|6|||
161404342|NCT00443781|582868421|FG000|Overall Study|Unable to comply with study follow up|2|||
161404343|NCT00443781|582868421|FG000|Overall Study|Investigator terminated participation|1|||
161404344|NCT00443781|582868421|FG000|Overall Study|Insurance not covered|2|||
161404345|NCT00443781|582868421|FG000|Overall Study|PD/FAD not done|1|||
161404346|NCT00430937|582868422|FG000|Overall Study|Adverse Event|3|||
161404347|NCT00430937|582868423|FG001|Overall Study|Adverse Event|8|||
161404348|NCT00430937|582868422|FG000|Overall Study|Death|0|||
161404349|NCT00430937|582868423|FG001|Overall Study|Death|1|||
161404350|NCT00430937|582868422|FG000|Overall Study|Lost to Follow-up|6|||
161404351|NCT00430937|582868423|FG001|Overall Study|Lost to Follow-up|6|||
161404352|NCT00430937|582868422|FG000|Overall Study|Withdrawal by Subject|5|||
161404353|NCT00430937|582868423|FG001|Overall Study|Withdrawal by Subject|2|||
161404354|NCT00430937|582868422|FG000|Overall Study|Protocol Violation|3|||
161404355|NCT00430937|582868423|FG001|Overall Study|Protocol Violation|2|||
161404356|NCT00430937|582868422|FG000|Overall Study|Lack of Efficacy|6|||
161404357|NCT00430937|582868423|FG001|Overall Study|Lack of Efficacy|5|||
161404358|NCT00430937|582868422|FG000|Overall Study|Inappropriate enrollment|2|||
161404359|NCT00430937|582868423|FG001|Overall Study|Inappropriate enrollment|1|||
161404360|NCT00430937|582868422|FG000|Overall Study|Administrative reasons|1|||
161404361|NCT00430937|582868423|FG001|Overall Study|Administrative reasons|0|||
161404362|NCT00430937|582868422|FG000|Overall Study|Protocol discontinuation criteria met|1|||
161404363|NCT00430937|582868423|FG001|Overall Study|Protocol discontinuation criteria met|2|||
161404364|NCT00430937|582868422|FG000|Overall Study|Unable to classify|0|||
161404365|NCT00430937|582868423|FG001|Overall Study|Unable to classify|1|||
161404366|NCT01533922|582868424|FG000|Overall Study|Adverse Event|5|||
161404367|NCT01533922|582868425|FG001|Overall Study|Adverse Event|8|||
161404368|NCT01533922|582868426|FG002|Overall Study|Adverse Event|6|||
161404369|NCT01533922|582868427|FG003|Overall Study|Adverse Event|3|||
161404370|NCT01533922|582868428|FG004|Overall Study|Adverse Event|4|||
161404371|NCT01533922|582868424|FG000|Overall Study|Lack of Efficacy|0|||
161404372|NCT01533922|582868425|FG001|Overall Study|Lack of Efficacy|0|||
161404373|NCT01533922|582868426|FG002|Overall Study|Lack of Efficacy|1|||
161404374|NCT01533922|582868427|FG003|Overall Study|Lack of Efficacy|0|||
161404375|NCT01533922|582868428|FG004|Overall Study|Lack of Efficacy|0|||
161404376|NCT01533922|582868424|FG000|Overall Study|Protocol Violation|0|||
161404377|NCT01533922|582868425|FG001|Overall Study|Protocol Violation|3|||
161404378|NCT01533922|582868426|FG002|Overall Study|Protocol Violation|0|||
161404379|NCT01533922|582868427|FG003|Overall Study|Protocol Violation|0|||
161404380|NCT01533922|582868428|FG004|Overall Study|Protocol Violation|1|||
161404381|NCT01533922|582868424|FG000|Overall Study|Withdrawal by Subject|3|||
161404382|NCT01533922|582868425|FG001|Overall Study|Withdrawal by Subject|1|||
161404383|NCT01533922|582868426|FG002|Overall Study|Withdrawal by Subject|2|||
161404384|NCT01533922|582868427|FG003|Overall Study|Withdrawal by Subject|2|||
161404385|NCT01533922|582868428|FG004|Overall Study|Withdrawal by Subject|1|||
161404386|NCT01533922|582868424|FG000|Overall Study|Other reason not defined above|2|||
161404387|NCT01533922|582868425|FG001|Overall Study|Other reason not defined above|0|||
161404388|NCT01533922|582868426|FG002|Overall Study|Other reason not defined above|1|||
161404389|NCT01533922|582868427|FG003|Overall Study|Other reason not defined above|0|||
161404390|NCT01533922|582868428|FG004|Overall Study|Other reason not defined above|0|||
161404391|NCT01267175|582868434|FG000|Overall Study|Withdrawal by Subject|1|||
161404392|NCT01267175|582868434|FG000|Overall Study|Lost to Follow-up|1|||
161404393|NCT00895661|582868436|FG000|Overall Study|Death|1|||
161404394|NCT00895661|582868436|FG000|Overall Study|reason unknown|2|||
161404395|NCT02006069|582868437|FG000|Overall Study|MPP other programming|239|||
161404396|NCT02006069|582868438|FG001|Overall Study|MPP other programming|0|||
161404397|NCT02006069|582868437|FG000|Overall Study|RV only pacing|0|||
161404398|NCT02006069|582868438|FG001|Overall Study|RV only pacing|3|||
161404399|NCT02989805|582868441|FG000|Overall Study|invalid consent|6|||
161404400|NCT02989805|582868442|FG001|Overall Study|invalid consent|4|||
161404401|NCT00286221|582868443|FG000|Overall Study|Protocol Violation|2|||
161404402|NCT00286221|582868444|FG001|Overall Study|Protocol Violation|1|||
161404403|NCT00286221|582868445|FG002|Overall Study|Protocol Violation|6|||
161404404|NCT00286221|582868446|FG003|Overall Study|Protocol Violation|4|||
161404405|NCT00286221|582868443|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
161404406|NCT00286221|582868444|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
161404407|NCT00286221|582868445|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
161404408|NCT00286221|582868446|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
161404409|NCT00286221|582868443|FG000|Overall Study|Inability to trigger PCA|2|||
161404410|NCT00286221|582868444|FG001|Overall Study|Inability to trigger PCA|0|||
161404411|NCT00286221|582868445|FG002|Overall Study|Inability to trigger PCA|0|||
161404412|NCT00286221|582868446|FG003|Overall Study|Inability to trigger PCA|0|||
161404413|NCT00286221|582868443|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
161404414|NCT00286221|582868444|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
161404415|NCT00286221|582868445|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
161404416|NCT00286221|582868446|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
161404417|NCT02648217|582868449|FG000|Overall Study|Adverse Event|0|||
161404418|NCT02648217|582868450|FG001|Overall Study|Adverse Event|1|||
161404419|NCT02648217|582868449|FG000|Overall Study|Lost to Follow-up|1|||
161404420|NCT02648217|582868450|FG001|Overall Study|Lost to Follow-up|1|||
161404421|NCT02648217|582868449|FG000|Overall Study|Withdrawal by Subject|4|||
161404422|NCT02648217|582868450|FG001|Overall Study|Withdrawal by Subject|3|||
161404423|NCT02648217|582868449|FG000|Overall Study|Unclassified|5|||
161404424|NCT02648217|582868450|FG001|Overall Study|Unclassified|0|||
161404425|NCT02553538|582868451|FG000|Overall Study|Could Not Reach by Telephone|133|||
161404426|NCT02553538|582868452|FG001|Overall Study|Could Not Reach by Telephone|0|||
161404427|NCT02553538|582868451|FG000|Overall Study|Died or Left Network|54|||
161404428|NCT02553538|582868452|FG001|Overall Study|Died or Left Network|56|||
161404429|NCT02066129|582868453|FG000|Overall Study|Lost to Follow-up|13|||
161404430|NCT02066129|582868454|FG001|Overall Study|Lost to Follow-up|12|||
161404431|NCT02066129|582868453|FG000|Overall Study|Withdrawal by Subject|7|||
161404432|NCT02066129|582868454|FG001|Overall Study|Withdrawal by Subject|10|||
161404433|NCT02066129|582868453|FG000|Overall Study|Lack of Efficacy|8|||
161404434|NCT02066129|582868454|FG001|Overall Study|Lack of Efficacy|10|||
161404435|NCT02066129|582868453|FG000|Overall Study|Physician Decision|1|||
161404436|NCT02066129|582868454|FG001|Overall Study|Physician Decision|1|||
161404437|NCT02776033|582868456|FG000|Overall Study|Withdrawal by Subject|0|||
161404438|NCT02776033|582868457|FG001|Overall Study|Withdrawal by Subject|0|||
161404439|NCT02776033|582868458|FG002|Overall Study|Withdrawal by Subject|2|||
161404440|NCT02776033|582868456|FG000|Overall Study|Physician Decision|2|||
161404441|NCT02776033|582868457|FG001|Overall Study|Physician Decision|0|||
161404442|NCT02776033|582868458|FG002|Overall Study|Physician Decision|0|||
161404443|NCT02776033|582868456|FG000|Overall Study|Lost to Follow-up|1|||
161404444|NCT02776033|582868457|FG001|Overall Study|Lost to Follow-up|0|||
161404445|NCT02776033|582868458|FG002|Overall Study|Lost to Follow-up|0|||
161404446|NCT02776033|582868456|FG000|Overall Study|Adverse Event|1|||
161404447|NCT02776033|582868457|FG001|Overall Study|Adverse Event|2|||
161404448|NCT02776033|582868458|FG002|Overall Study|Adverse Event|0|||
161404449|NCT00685373|582868462|FG000|Overall Study|Adverse Event|3|||
161404450|NCT00685373|582868462|FG000|Overall Study|Withdrawal by Subject|5|||
161404451|NCT00685373|582868462|FG000|Overall Study|Lack of Efficacy|3|||
161404452|NCT00685373|582868462|FG000|Overall Study|Condition no longer requires study drug|1|||
161404453|NCT00685373|582868462|FG000|Overall Study|Lost to Follow-up|2|||
161404454|NCT00685373|582868462|FG000|Overall Study|Protocol Violation|1|||
161404455|NCT02639338|582868463|FG000|Overall Study|Lost to Follow-up|2|||
161404456|NCT02639338|582868464|FG001|Overall Study|Lost to Follow-up|2|||
161404457|NCT02639338|582868463|FG000|Overall Study|Withdrew Consent|1|||
161404458|NCT02639338|582868464|FG001|Overall Study|Withdrew Consent|2|||
161404459|NCT02639338|582868463|FG000|Overall Study|Death|1|||
161404460|NCT02639338|582868464|FG001|Overall Study|Death|0|||
161404461|NCT02639338|582868463|FG000|Overall Study|Randomized but Not Treated|0|||
161404462|NCT02639338|582868464|FG001|Overall Study|Randomized but Not Treated|1|||
161404463|NCT00160199|582868470|FG000|Overall Study|Adverse Event|5|||
161404464|NCT00160199|582868471|FG001|Overall Study|Adverse Event|14|||
161404465|NCT00160199|582868470|FG000|Overall Study|Lack of Efficacy|0|||
161404466|NCT00160199|582868471|FG001|Overall Study|Lack of Efficacy|1|||
161404467|NCT00160199|582868470|FG000|Overall Study|Lost to Follow-up|7|||
161404468|NCT00160199|582868471|FG001|Overall Study|Lost to Follow-up|7|||
161404469|NCT00160199|582868470|FG000|Overall Study|Withdrawal by Subject|4|||
161404470|NCT00160199|582868471|FG001|Overall Study|Withdrawal by Subject|6|||
161404471|NCT00160199|582868470|FG000|Overall Study|Administrative|0|||
161404472|NCT00160199|582868471|FG001|Overall Study|Administrative|1|||
161404473|NCT00160199|582868470|FG000|Overall Study|Protocol Violation|8|||
161404474|NCT00160199|582868471|FG001|Overall Study|Protocol Violation|8|||
161404475|NCT02635347|582868472|FG000|Overall Study|Failed screening|20|||
161404476|NCT02635347|582868473|FG001|Overall Study|Failed screening|7|||
161404477|NCT02124772|582868474|FG000|Overall Study|Lack of Efficacy|2|||
161404478|NCT02124772|582868475|FG001|Overall Study|Lack of Efficacy|0|||
161404479|NCT02124772|582868476|FG002|Overall Study|Lack of Efficacy|0|||
161404480|NCT02124772|582868477|FG003|Overall Study|Lack of Efficacy|1|||
161404481|NCT02124772|582868478|FG004|Overall Study|Lack of Efficacy|2|||
161404482|NCT02124772|582868479|FG005|Overall Study|Lack of Efficacy|3|||
161404483|NCT02124772|582868480|FG006|Overall Study|Lack of Efficacy|0|||
161404484|NCT02124772|582868481|FG007|Overall Study|Lack of Efficacy|2|||
161404485|NCT02124772|582868482|FG008|Overall Study|Lack of Efficacy|0|||
161404486|NCT02124772|582868483|FG009|Overall Study|Lack of Efficacy|1|||
161404487|NCT02124772|582868484|FG010|Overall Study|Lack of Efficacy|0|||
161404488|NCT02124772|582868485|FG011|Overall Study|Lack of Efficacy|0|||
161404489|NCT02124772|582868486|FG012|Overall Study|Lack of Efficacy|1|||
161404490|NCT02124772|582868474|FG000|Overall Study|Adverse Event|1|||
161404491|NCT02124772|582868475|FG001|Overall Study|Adverse Event|4|||
161404492|NCT02124772|582868476|FG002|Overall Study|Adverse Event|1|||
161404493|NCT02124772|582868477|FG003|Overall Study|Adverse Event|5|||
161404494|NCT02124772|582868478|FG004|Overall Study|Adverse Event|2|||
161404495|NCT02124772|582868479|FG005|Overall Study|Adverse Event|1|||
161404496|NCT02124772|582868480|FG006|Overall Study|Adverse Event|1|||
161404497|NCT02124772|582868481|FG007|Overall Study|Adverse Event|5|||
161404498|NCT02124772|582868482|FG008|Overall Study|Adverse Event|0|||
161404499|NCT02124772|582868483|FG009|Overall Study|Adverse Event|3|||
161404500|NCT02124772|582868484|FG010|Overall Study|Adverse Event|1|||
161404501|NCT02124772|582868485|FG011|Overall Study|Adverse Event|3|||
161404502|NCT02124772|582868486|FG012|Overall Study|Adverse Event|1|||
161404503|NCT02124772|582868474|FG000|Overall Study|Withdrawal consent|0|||
161404504|NCT02124772|582868475|FG001|Overall Study|Withdrawal consent|1|||
161404505|NCT02124772|582868476|FG002|Overall Study|Withdrawal consent|1|||
161404506|NCT02124772|582868477|FG003|Overall Study|Withdrawal consent|1|||
161404507|NCT02124772|582868478|FG004|Overall Study|Withdrawal consent|0|||
161404508|NCT02124772|582868479|FG005|Overall Study|Withdrawal consent|1|||
161404509|NCT02124772|582868480|FG006|Overall Study|Withdrawal consent|1|||
161404510|NCT02124772|582868481|FG007|Overall Study|Withdrawal consent|0|||
161404511|NCT02124772|582868482|FG008|Overall Study|Withdrawal consent|0|||
161404512|NCT02124772|582868483|FG009|Overall Study|Withdrawal consent|1|||
161404513|NCT02124772|582868484|FG010|Overall Study|Withdrawal consent|0|||
161404514|NCT02124772|582868485|FG011|Overall Study|Withdrawal consent|1|||
161404515|NCT02124772|582868486|FG012|Overall Study|Withdrawal consent|0|||
161404516|NCT02124772|582868474|FG000|Overall Study|Investigator discretion|0|||
161404517|NCT02124772|582868475|FG001|Overall Study|Investigator discretion|2|||
161404518|NCT02124772|582868476|FG002|Overall Study|Investigator discretion|2|||
161404519|NCT02124772|582868477|FG003|Overall Study|Investigator discretion|1|||
161404520|NCT02124772|582868478|FG004|Overall Study|Investigator discretion|1|||
161404521|NCT02124772|582868479|FG005|Overall Study|Investigator discretion|0|||
161404522|NCT02124772|582868480|FG006|Overall Study|Investigator discretion|1|||
161404523|NCT02124772|582868481|FG007|Overall Study|Investigator discretion|0|||
161404524|NCT02124772|582868482|FG008|Overall Study|Investigator discretion|0|||
161404525|NCT02124772|582868483|FG009|Overall Study|Investigator discretion|1|||
161404526|NCT02124772|582868484|FG010|Overall Study|Investigator discretion|0|||
161404527|NCT02124772|582868485|FG011|Overall Study|Investigator discretion|1|||
161404528|NCT02124772|582868486|FG012|Overall Study|Investigator discretion|0|||
161404529|NCT02124772|582868474|FG000|Overall Study|Progressive disease|0|||
161404530|NCT02124772|582868475|FG001|Overall Study|Progressive disease|0|||
161404531|NCT02124772|582868476|FG002|Overall Study|Progressive disease|0|||
161404532|NCT02124772|582868477|FG003|Overall Study|Progressive disease|0|||
161404533|NCT02124772|582868478|FG004|Overall Study|Progressive disease|0|||
161404534|NCT02124772|582868479|FG005|Overall Study|Progressive disease|0|||
161404535|NCT02124772|582868480|FG006|Overall Study|Progressive disease|1|||
161404536|NCT02124772|582868481|FG007|Overall Study|Progressive disease|1|||
161404537|NCT02124772|582868482|FG008|Overall Study|Progressive disease|0|||
161404538|NCT02124772|582868483|FG009|Overall Study|Progressive disease|0|||
161404539|NCT02124772|582868484|FG010|Overall Study|Progressive disease|0|||
161404540|NCT02124772|582868485|FG011|Overall Study|Progressive disease|0|||
161404541|NCT02124772|582868486|FG012|Overall Study|Progressive disease|0|||
161404542|NCT02124772|582868474|FG000|Overall Study|Other|0|||
161404543|NCT02124772|582868475|FG001|Overall Study|Other|7|||
161404544|NCT02124772|582868476|FG002|Overall Study|Other|2|||
161404545|NCT02124772|582868477|FG003|Overall Study|Other|5|||
161404546|NCT02124772|582868478|FG004|Overall Study|Other|4|||
161404547|NCT02124772|582868479|FG005|Overall Study|Other|3|||
161404548|NCT02124772|582868480|FG006|Overall Study|Other|4|||
161404549|NCT02124772|582868481|FG007|Overall Study|Other|1|||
161404550|NCT02124772|582868482|FG008|Overall Study|Other|1|||
161404551|NCT02124772|582868483|FG009|Overall Study|Other|1|||
161404552|NCT02124772|582868484|FG010|Overall Study|Other|1|||
161404553|NCT02124772|582868485|FG011|Overall Study|Other|1|||
161404554|NCT02124772|582868486|FG012|Overall Study|Other|0|||
161404555|NCT01827332|582868487|FG000|Overall Study|Lost to Follow-up|2|||
161404556|NCT01827332|582868488|FG001|Overall Study|Lost to Follow-up|1|||
161404557|NCT02725593|582868489|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
161404558|NCT02725593|582868490|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
161404559|NCT02725593|582868489|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
161404560|NCT02725593|582868490|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
161404561|NCT02725593|582868489|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
161404562|NCT02725593|582868490|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
161404563|NCT02725593|582868489|FG000|Long Term Extension|Withdrawal by Subject|1|||
161404564|NCT02725593|582868490|FG001|Long Term Extension|Withdrawal by Subject|3|||
161404565|NCT01440881|582868495|FG000|Overall Study|Death|0|||
161404566|NCT01440881|582868496|FG001|Overall Study|Death|1|||
161404567|NCT02644356|582868498|FG000|Overall Study|Withdrawal by Subject|2|||
161404568|NCT02290938|582868499|FG000|Overall Study|Lost to Follow-up|14|||
161404569|NCT02290938|582868500|FG001|Overall Study|Lost to Follow-up|43|||
161404570|NCT02771626|582870117|FG000|Overall Study|Adverse Event|1|||
161404571|NCT02771626|582870118|FG001|Overall Study|Adverse Event|5|||
161404572|NCT02771626|582870119|FG002|Overall Study|Adverse Event|3|||
161404573|NCT02771626|582870120|FG003|Overall Study|Adverse Event|0|||
161404574|NCT02771626|582870121|FG004|Overall Study|Adverse Event|1|||
161404575|NCT02771626|582870122|FG005|Overall Study|Adverse Event|1|||
161404576|NCT02771626|582870117|FG000|Overall Study|Radiologic Disease Progression|6|||
161404577|NCT02771626|582870118|FG001|Overall Study|Radiologic Disease Progression|13|||
161404578|NCT02771626|582870119|FG002|Overall Study|Radiologic Disease Progression|10|||
161404579|NCT02771626|582870120|FG003|Overall Study|Radiologic Disease Progression|7|||
161404580|NCT02771626|582870121|FG004|Overall Study|Radiologic Disease Progression|28|||
161404581|NCT02771626|582870122|FG005|Overall Study|Radiologic Disease Progression|15|||
161404582|NCT02771626|582870117|FG000|Overall Study|Symptomatic Deterioration|0|||
161404583|NCT02771626|582870118|FG001|Overall Study|Symptomatic Deterioration|4|||
161404584|NCT02771626|582870119|FG002|Overall Study|Symptomatic Deterioration|2|||
161404585|NCT02771626|582870120|FG003|Overall Study|Symptomatic Deterioration|0|||
161404586|NCT02771626|582870121|FG004|Overall Study|Symptomatic Deterioration|5|||
161404587|NCT02771626|582870122|FG005|Overall Study|Symptomatic Deterioration|2|||
161404588|NCT02771626|582870117|FG000|Overall Study|Participant Request|0|||
161404589|NCT02771626|582870118|FG001|Overall Study|Participant Request|1|||
161404590|NCT02771626|582870119|FG002|Overall Study|Participant Request|0|||
161404591|NCT02771626|582870120|FG003|Overall Study|Participant Request|2|||
161404592|NCT02771626|582870121|FG004|Overall Study|Participant Request|0|||
161404593|NCT02771626|582870122|FG005|Overall Study|Participant Request|1|||
161404594|NCT02771626|582870117|FG000|Overall Study|Investigator Decision|0|||
161404595|NCT02771626|582870118|FG001|Overall Study|Investigator Decision|1|||
161404596|NCT02771626|582870119|FG002|Overall Study|Investigator Decision|0|||
161404597|NCT02771626|582870120|FG003|Overall Study|Investigator Decision|0|||
161404598|NCT02771626|582870121|FG004|Overall Study|Investigator Decision|1|||
161404599|NCT02771626|582870122|FG005|Overall Study|Investigator Decision|0|||
161404600|NCT02771626|582870117|FG000|Overall Study|Study Termination by Sponsor|0|||
161404601|NCT02771626|582870118|FG001|Overall Study|Study Termination by Sponsor|2|||
161404602|NCT02771626|582870119|FG002|Overall Study|Study Termination by Sponsor|1|||
161404603|NCT02771626|582870120|FG003|Overall Study|Study Termination by Sponsor|0|||
161404604|NCT02771626|582870121|FG004|Overall Study|Study Termination by Sponsor|1|||
161404605|NCT02771626|582870122|FG005|Overall Study|Study Termination by Sponsor|0|||
161404606|NCT02771626|582870117|FG000|Overall Study|Informed Consent Withdrawn|0|||
161404607|NCT02771626|582870118|FG001|Overall Study|Informed Consent Withdrawn|0|||
161404608|NCT02771626|582870119|FG002|Overall Study|Informed Consent Withdrawn|1|||
161404609|NCT02771626|582870120|FG003|Overall Study|Informed Consent Withdrawn|0|||
161404610|NCT02771626|582870121|FG004|Overall Study|Informed Consent Withdrawn|1|||
161404611|NCT02771626|582870122|FG005|Overall Study|Informed Consent Withdrawn|1|||
161404612|NCT02771626|582870117|FG000|Overall Study|Other, Not Specified|1|||
161404613|NCT02771626|582870118|FG001|Overall Study|Other, Not Specified|0|||
161404614|NCT02771626|582870119|FG002|Overall Study|Other, Not Specified|0|||
161404615|NCT02771626|582870120|FG003|Overall Study|Other, Not Specified|0|||
161404616|NCT02771626|582870121|FG004|Overall Study|Other, Not Specified|0|||
161404617|NCT02771626|582870122|FG005|Overall Study|Other, Not Specified|1|||
161404618|NCT04094584|582870123|FG000|Overall Study|No interest in study|88|||
161404619|NCT04094584|582870123|FG000|Overall Study|Unwilling to undergo screening tests|36|||
161404620|NCT04094584|582870123|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
161404621|NCT04094584|582870123|FG000|Overall Study|Opioid use|7|||
161404622|NCT04094584|582870123|FG000|Overall Study|Need for major surgery in study period|4|||
161404623|NCT04094584|582870123|FG000|Overall Study|eligible but declined enrollment|4|||
161404624|NCT04094584|582870123|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
161404625|NCT04094584|582870123|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
161404626|NCT04094584|582870123|FG000|Overall Study|Lost to Follow-up|3|||
161404627|NCT04094584|582870123|FG000|Overall Study|Withdrawal by Subject|2|||
161404628|NCT02690649|582870124|FG000|Overall Study|Withdrawal by Subject|1|||
161404629|NCT02690649|582870125|FG001|Overall Study|Withdrawal by Subject|1|||
161404630|NCT02690649|582870124|FG000|Overall Study|Protocol Violation|0|||
161404631|NCT02690649|582870125|FG001|Overall Study|Protocol Violation|3|||
161404632|NCT02276547|582870126|FG000|Overall Study|Death|2|||
161404633|NCT02276547|582870126|FG000|Overall Study|Explant|2|||
161404634|NCT02616393|582870127|FG000|Overall Study|Death|5|||
161404635|NCT02616393|582870128|FG001|Overall Study|Death|12|||
161404636|NCT02616393|582870129|FG002|Overall Study|Death|1|||
161404637|NCT02616393|582870127|FG000|Overall Study|Termination by Sponsor|4|||
161404638|NCT02616393|582870128|FG001|Overall Study|Termination by Sponsor|5|||
161404639|NCT02616393|582870129|FG002|Overall Study|Termination by Sponsor|2|||
161404640|NCT02616393|582870127|FG000|Overall Study|Other|3|||
161404641|NCT02616393|582870128|FG001|Overall Study|Other|0|||
161404642|NCT02616393|582870129|FG002|Overall Study|Other|0|||
161404643|NCT02616393|582870127|FG000|Overall Study|Withdrawal by Subject|1|||
161404644|NCT02616393|582870128|FG001|Overall Study|Withdrawal by Subject|1|||
161404645|NCT02616393|582870129|FG002|Overall Study|Withdrawal by Subject|0|||
161404646|NCT02616393|582870127|FG000|Overall Study|Lost to Follow-up|0|||
161404647|NCT02616393|582870128|FG001|Overall Study|Lost to Follow-up|2|||
161404648|NCT02616393|582870129|FG002|Overall Study|Lost to Follow-up|0|||
161404649|NCT02642965|582870130|FG000|Overall Study|Lack of Efficacy|4|||
161404650|NCT02642965|582870130|FG000|Overall Study|Physician Decision|9|||
161404651|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
161404652|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
161404653|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
161404654|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
161404655|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
161404656|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
161404657|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
161404658|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
161404659|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
161404660|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
161404661|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
161404662|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
161404663|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
161404664|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
161404665|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
161404666|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
161404667|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
161404668|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
161404669|NCT01302054|582870137|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
161404670|NCT01302054|582870138|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
161404671|NCT01302054|582870139|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
161404672|NCT01302054|582870137|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
161404673|NCT01302054|582870138|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
161404674|NCT01302054|582870139|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
161404675|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161404676|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
161404677|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
161404678|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161404679|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161404680|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161404681|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161404682|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
161404683|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
161404684|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
161404685|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
161404686|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
161404687|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161404688|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
161404689|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
161404690|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
161404691|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
161404692|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
161404693|NCT01302054|582870137|FG000|Double-Blind Treatment Phase|Other|0|||
161404694|NCT01302054|582870138|FG001|Double-Blind Treatment Phase|Other|4|||
161404695|NCT01302054|582870139|FG002|Double-Blind Treatment Phase|Other|9|||
161404696|NCT00857948|582870140|FG000|Overall Study|Withdrawal by Subject|2|||
161404697|NCT00857948|582870141|FG001|Overall Study|Withdrawal by Subject|0|||
161404698|NCT00857948|582870142|FG002|Overall Study|Withdrawal by Subject|0|||
161404699|NCT00857948|582870143|FG003|Overall Study|Withdrawal by Subject|0|||
161404700|NCT00857948|582870140|FG000|Overall Study|Protocol Violation|1|||
161404701|NCT00857948|582870141|FG001|Overall Study|Protocol Violation|0|||
161404702|NCT00857948|582870142|FG002|Overall Study|Protocol Violation|1|||
161404703|NCT00857948|582870143|FG003|Overall Study|Protocol Violation|0|||
161404704|NCT00493636|582870147|FG000|Overall Study|Withdrawal by Subject|1|||
161404705|NCT00493636|582870148|FG001|Overall Study|Withdrawal by Subject|0|||
161404706|NCT00493636|582870147|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
161404707|NCT00493636|582870148|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
161404708|NCT00493636|582870147|FG000|Overall Study|Mis-randomization|1|||
161404709|NCT00493636|582870148|FG001|Overall Study|Mis-randomization|1|||
161404710|NCT02715726|582870153|FG000|Overall Study|Adverse Event|2|||
161404711|NCT02715726|582870154|FG001|Overall Study|Adverse Event|6|||
161404712|NCT02715726|582870153|FG000|Overall Study|Protocol Violation|1|||
161404713|NCT02715726|582870154|FG001|Overall Study|Protocol Violation|0|||
161404714|NCT02715726|582870153|FG000|Overall Study|Death|2|||
161404715|NCT02715726|582870154|FG001|Overall Study|Death|1|||
161404716|NCT02715726|582870153|FG000|Overall Study|Participant moved|1|||
161404717|NCT02715726|582870154|FG001|Overall Study|Participant moved|3|||
161404718|NCT02715726|582870153|FG000|Overall Study|Other than specified above|11|||
161404719|NCT02715726|582870154|FG001|Overall Study|Other than specified above|15|||
161404720|NCT02715726|582870153|FG000|Overall Study|Randomized but not treated|1|||
161404721|NCT02715726|582870154|FG001|Overall Study|Randomized but not treated|2|||
161404722|NCT02445573|582870155|FG000|Overall Study|Withdrawal by Subject|1|||
161404723|NCT02445573|582870156|FG001|Overall Study|Withdrawal by Subject|1|||
161404724|NCT02445573|582870155|FG000|Overall Study|Lost to Follow-up|0|||
161404725|NCT02445573|582870156|FG001|Overall Study|Lost to Follow-up|1|||
161404726|NCT04047420|582870157|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
161404727|NCT04047420|582870157|FG000|Washout Period|Refused Participation|2|||
161404728|NCT03757130|582870158|FG000|Overall Study|Lost to Follow-up|0|||
161404729|NCT03757130|582870159|FG001|Overall Study|Lost to Follow-up|0|||
161404730|NCT03757130|582870160|FG002|Overall Study|Lost to Follow-up|0|||
161404731|NCT03757130|582870161|FG003|Overall Study|Lost to Follow-up|1|||
161404732|NCT03757130|582870162|FG004|Overall Study|Lost to Follow-up|0|||
161404733|NCT03757130|582870163|FG005|Overall Study|Lost to Follow-up|0|||
161404734|NCT03757130|582870164|FG006|Overall Study|Lost to Follow-up|0|||
161404735|NCT03757130|582870165|FG007|Overall Study|Lost to Follow-up|1|||
161404736|NCT03757130|582870158|FG000|Overall Study|Withdrawal by Subject|0|||
161404737|NCT03757130|582870159|FG001|Overall Study|Withdrawal by Subject|0|||
161404738|NCT03757130|582870160|FG002|Overall Study|Withdrawal by Subject|0|||
161404739|NCT03757130|582870161|FG003|Overall Study|Withdrawal by Subject|0|||
161404740|NCT03757130|582870162|FG004|Overall Study|Withdrawal by Subject|0|||
161404741|NCT03757130|582870163|FG005|Overall Study|Withdrawal by Subject|0|||
161404742|NCT03757130|582870164|FG006|Overall Study|Withdrawal by Subject|1|||
161404743|NCT03757130|582870165|FG007|Overall Study|Withdrawal by Subject|0|||
161404744|NCT01639755|582870166|FG000|Overall Study|Study Ongoing|15|||
161404745|NCT01639755|582870166|FG000|Overall Study|Patient had device explantation|4|||
161404746|NCT00966719|582870167|FG000|Overall Study|Lost to Follow-up|6|||
161404747|NCT00966719|582870168|FG001|Overall Study|Lost to Follow-up|11|||
161404748|NCT01439126|582870169|FG000|Overall Study|Adverse Event|2|||
161404749|NCT01439126|582870170|FG001|Overall Study|Adverse Event|0|||
161404750|NCT01439126|582870169|FG000|Overall Study|Withdrawal by Subject|5|||
161404751|NCT01439126|582870170|FG001|Overall Study|Withdrawal by Subject|21|||
161404752|NCT01439126|582870169|FG000|Overall Study|Protocol Violation|6|||
161404753|NCT01439126|582870170|FG001|Overall Study|Protocol Violation|4|||
161404754|NCT01439126|582870169|FG000|Overall Study|Lost to Follow-up|6|||
161404755|NCT01439126|582870170|FG001|Overall Study|Lost to Follow-up|3|||
161404756|NCT01439126|582870169|FG000|Overall Study|Other-Use of prohibited treatment|0|||
161404757|NCT01439126|582870170|FG001|Overall Study|Other-Use of prohibited treatment|2|||
161404758|NCT01439126|582870169|FG000|Overall Study|Other-Miscellaneous|12|||
161404759|NCT01439126|582870170|FG001|Overall Study|Other-Miscellaneous|12|||
161404760|NCT03242018|582870172|FG000|Overall Study|Adverse Event|7|||
161404761|NCT03242018|582870173|FG001|Overall Study|Adverse Event|7|||
161404762|NCT03242018|582870174|FG002|Overall Study|Adverse Event|6|||
161404763|NCT03242018|582870172|FG000|Overall Study|Lost to Follow-up|2|||
161404764|NCT03242018|582870173|FG001|Overall Study|Lost to Follow-up|2|||
161404765|NCT03242018|582870174|FG002|Overall Study|Lost to Follow-up|2|||
161404766|NCT03242018|582870172|FG000|Overall Study|At the Participant's Own Request|5|||
161404767|NCT03242018|582870173|FG001|Overall Study|At the Participant's Own Request|1|||
161404768|NCT03242018|582870174|FG002|Overall Study|At the Participant's Own Request|4|||
161404769|NCT03242018|582870172|FG000|Overall Study|Reason Not Specified|3|||
161404770|NCT03242018|582870173|FG001|Overall Study|Reason Not Specified|4|||
161404771|NCT03242018|582870174|FG002|Overall Study|Reason Not Specified|1|||
161404772|NCT03242018|582870172|FG000|Overall Study|Study Terminated by Sponsor|1|||
161404773|NCT03242018|582870173|FG001|Overall Study|Study Terminated by Sponsor|0|||
161404774|NCT03242018|582870174|FG002|Overall Study|Study Terminated by Sponsor|1|||
161404775|NCT00477269|582870178|FG000|Core Study|Adverse Event|6|||
161404776|NCT00477269|582870179|FG001|Core Study|Adverse Event|4|||
161404777|NCT00477269|582870180|FG002|Core Study|Adverse Event|0|||
161404778|NCT00477269|582870178|FG000|Core Study|Death|3|||
161404779|NCT00477269|582870179|FG001|Core Study|Death|3|||
161404780|NCT00477269|582870180|FG002|Core Study|Death|0|||
161404781|NCT00477269|582870178|FG000|Core Study|Withdrawn Consent|0|||
161404782|NCT00477269|582870179|FG001|Core Study|Withdrawn Consent|1|||
161404783|NCT00477269|582870180|FG002|Core Study|Withdrawn Consent|0|||
161404784|NCT00477269|582870178|FG000|Open Label Extension|Adverse Event|0|||
161404785|NCT00477269|582870179|FG001|Open Label Extension|Adverse Event|0|||
161404786|NCT00477269|582870180|FG002|Open Label Extension|Adverse Event|4|||
161404787|NCT00477269|582870178|FG000|Open Label Extension|Abnormal laboratory values|0|||
161404788|NCT00477269|582870179|FG001|Open Label Extension|Abnormal laboratory values|0|||
161404789|NCT00477269|582870180|FG002|Open Label Extension|Abnormal laboratory values|1|||
161404790|NCT00477269|582870178|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
161404791|NCT00477269|582870179|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
161404792|NCT00477269|582870180|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
161404793|NCT00477269|582870178|FG000|Open Label Extension|Adminiatrative problems|0|||
161404794|NCT00477269|582870179|FG001|Open Label Extension|Adminiatrative problems|0|||
161404795|NCT00477269|582870180|FG002|Open Label Extension|Adminiatrative problems|2|||
161404796|NCT00477269|582870178|FG000|Open Label Extension|Death|0|||
161404797|NCT00477269|582870179|FG001|Open Label Extension|Death|0|||
161404798|NCT00477269|582870180|FG002|Open Label Extension|Death|4|||
161404799|NCT03089944|582870181|FG000|Overall Study|Lost to Follow-up|8|||
161404800|NCT03089944|582870181|FG000|Overall Study|Withdrew Consent|2|||
161404801|NCT03089944|582870181|FG000|Overall Study|Adverse Event|1|||
161404802|NCT03089944|582870181|FG000|Overall Study|Other|1|||
161404803|NCT03689244|582870182|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
161404804|NCT03689244|582870183|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
161404805|NCT03689244|582870184|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
161404806|NCT03689244|582870185|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
161404807|NCT03689244|582870182|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
161404808|NCT03689244|582870183|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
161404809|NCT03689244|582870184|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
161404810|NCT03689244|582870185|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
161404811|NCT03689244|582870182|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
161404812|NCT03689244|582870183|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
161404813|NCT03689244|582870184|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
161404814|NCT03689244|582870185|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
161404815|NCT03689244|582870182|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
161404816|NCT03689244|582870183|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
161404817|NCT03689244|582870184|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
161404818|NCT03689244|582870185|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
161404819|NCT03689244|582870182|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
161404820|NCT03689244|582870183|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
161404821|NCT03689244|582870184|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
161404822|NCT03689244|582870185|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
161404823|NCT03689244|582870182|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
161404824|NCT03689244|582870183|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
161404825|NCT03689244|582870184|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
161404826|NCT03689244|582870185|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
161404827|NCT03689244|582870182|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
161404828|NCT03689244|582870183|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
161404829|NCT03689244|582870184|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
161404830|NCT03689244|582870185|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
161404831|NCT03689244|582870182|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
161404832|NCT03689244|582870183|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
161404833|NCT03689244|582870184|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
161404834|NCT03689244|582870185|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
161404835|NCT00806442|582870210|FG000|Overall Study|Lost to Follow-up|3|||
161404836|NCT00806442|582870211|FG001|Overall Study|Lost to Follow-up|2|||
161404837|NCT00806442|582870210|FG000|Overall Study|Withdrawal by Subject|1|||
161404838|NCT00806442|582870211|FG001|Overall Study|Withdrawal by Subject|5|||
161404839|NCT00654004|582870215|FG000|Overall Study|Lost to Follow-up|1|||
161404840|NCT00654004|582870216|FG001|Overall Study|Lost to Follow-up|0|||
161404841|NCT00444067|582870222|FG000|Overall Study|Lost to Follow-up|0|||
161404842|NCT00444067|582870223|FG001|Overall Study|Lost to Follow-up|1|||
161404843|NCT02528357|582870227|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404844|NCT02528357|582870228|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
161404845|NCT02528357|582870229|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404846|NCT02528357|582870230|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404847|NCT02528357|582870231|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404848|NCT02528357|582870232|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404849|NCT02528357|582870233|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404850|NCT02528357|582870234|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404851|NCT02528357|582870235|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404852|NCT02528357|582870236|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404853|NCT02528357|582870237|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404854|NCT02528357|582870238|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404855|NCT02528357|582870239|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404856|NCT02528357|582870240|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404857|NCT02528357|582870241|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404858|NCT02528357|582870242|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404859|NCT02528357|582870243|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404860|NCT02528357|582870244|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404861|NCT02528357|582870245|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161404862|NCT02528357|582870227|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404863|NCT02528357|582870228|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404864|NCT02528357|582870229|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404865|NCT02528357|582870230|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
161404866|NCT02528357|582870231|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404867|NCT02528357|582870232|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
161404868|NCT02528357|582870233|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404869|NCT02528357|582870234|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
161404870|NCT02528357|582870235|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404871|NCT02528357|582870236|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404872|NCT02528357|582870237|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404873|NCT02528357|582870238|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404874|NCT02528357|582870239|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404875|NCT02528357|582870240|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404876|NCT02528357|582870241|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404877|NCT02528357|582870242|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404878|NCT02528357|582870243|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404879|NCT02528357|582870244|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404880|NCT02528357|582870245|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161404881|NCT02528357|582870227|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404882|NCT02528357|582870228|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404883|NCT02528357|582870229|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
161404884|NCT02528357|582870230|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404885|NCT02528357|582870231|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
161404886|NCT02528357|582870232|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404887|NCT02528357|582870233|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
161404888|NCT02528357|582870234|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
161404889|NCT02528357|582870235|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404890|NCT02528357|582870236|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404891|NCT02528357|582870237|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404892|NCT02528357|582870238|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404893|NCT02528357|582870239|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404894|NCT02528357|582870240|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404895|NCT02528357|582870241|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404896|NCT02528357|582870242|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404897|NCT02528357|582870243|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404898|NCT02528357|582870244|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404899|NCT02528357|582870245|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161404900|NCT02528357|582870227|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404901|NCT02528357|582870228|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404902|NCT02528357|582870229|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404903|NCT02528357|582870230|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404904|NCT02528357|582870231|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161404905|NCT02528357|582870232|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404906|NCT02528357|582870233|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404907|NCT02528357|582870234|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404908|NCT02528357|582870235|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404909|NCT02528357|582870236|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404910|NCT02528357|582870237|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404911|NCT02528357|582870238|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404912|NCT02528357|582870239|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404913|NCT02528357|582870240|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404914|NCT02528357|582870241|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404915|NCT02528357|582870242|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404916|NCT02528357|582870243|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404917|NCT02528357|582870244|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404918|NCT02528357|582870245|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404919|NCT02528357|582870227|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404920|NCT02528357|582870228|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404921|NCT02528357|582870229|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404922|NCT02528357|582870230|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404923|NCT02528357|582870231|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404924|NCT02528357|582870232|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404925|NCT02528357|582870233|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404926|NCT02528357|582870234|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404927|NCT02528357|582870235|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404928|NCT02528357|582870236|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404929|NCT02528357|582870237|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404930|NCT02528357|582870238|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404931|NCT02528357|582870239|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404932|NCT02528357|582870240|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
161404933|NCT02528357|582870241|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
161404934|NCT02528357|582870242|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404935|NCT02528357|582870243|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404936|NCT02528357|582870244|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404937|NCT02528357|582870245|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161404938|NCT02528357|582870227|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404939|NCT02528357|582870228|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404940|NCT02528357|582870229|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404941|NCT02528357|582870230|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404942|NCT02528357|582870231|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404943|NCT02528357|582870232|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404944|NCT02528357|582870233|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404945|NCT02528357|582870234|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404946|NCT02528357|582870235|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404947|NCT02528357|582870236|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404948|NCT02528357|582870237|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404949|NCT02528357|582870238|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404950|NCT02528357|582870239|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404951|NCT02528357|582870240|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
161404952|NCT02528357|582870241|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404953|NCT02528357|582870242|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404954|NCT02528357|582870243|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404955|NCT02528357|582870244|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404956|NCT02528357|582870245|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161404957|NCT02528357|582870227|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404958|NCT02528357|582870228|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404959|NCT02528357|582870229|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404960|NCT02528357|582870230|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404961|NCT02528357|582870231|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404962|NCT02528357|582870232|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404963|NCT02528357|582870233|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404964|NCT02528357|582870234|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404965|NCT02528357|582870235|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404966|NCT02528357|582870236|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404967|NCT02528357|582870237|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
161404968|NCT02528357|582870238|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404969|NCT02528357|582870239|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
161404970|NCT02528357|582870240|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
161404971|NCT02528357|582870241|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
161404972|NCT02528357|582870242|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404973|NCT02528357|582870243|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404974|NCT02528357|582870244|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404975|NCT02528357|582870245|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161404976|NCT02528357|582870227|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404977|NCT02528357|582870228|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404978|NCT02528357|582870229|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404979|NCT02528357|582870230|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404980|NCT02528357|582870231|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404981|NCT02528357|582870232|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404982|NCT02528357|582870233|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404983|NCT02528357|582870234|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404984|NCT02528357|582870235|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161404985|NCT02528357|582870236|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161404986|NCT02528357|582870237|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404987|NCT02528357|582870238|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
161404988|NCT02528357|582870239|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
161404989|NCT02528357|582870240|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161404990|NCT02528357|582870241|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161404991|NCT02528357|582870242|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404992|NCT02528357|582870243|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404993|NCT02528357|582870244|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404994|NCT02528357|582870245|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161404995|NCT02528357|582870227|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161404996|NCT02528357|582870228|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161404997|NCT02528357|582870229|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161404998|NCT02528357|582870230|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161404999|NCT02528357|582870231|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405000|NCT02528357|582870232|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405001|NCT02528357|582870233|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405002|NCT02528357|582870234|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405003|NCT02528357|582870235|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405004|NCT02528357|582870236|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405005|NCT02528357|582870237|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405006|NCT02528357|582870238|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405007|NCT02528357|582870239|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405008|NCT02528357|582870240|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405009|NCT02528357|582870241|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405010|NCT02528357|582870242|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405011|NCT02528357|582870243|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
161405012|NCT02528357|582870244|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405013|NCT02528357|582870245|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161405014|NCT02528357|582870227|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405015|NCT02528357|582870228|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405016|NCT02528357|582870229|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405017|NCT02528357|582870230|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405018|NCT02528357|582870231|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405019|NCT02528357|582870232|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405020|NCT02528357|582870233|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405021|NCT02528357|582870234|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405022|NCT02528357|582870235|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405023|NCT02528357|582870236|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405024|NCT02528357|582870237|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405025|NCT02528357|582870238|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405026|NCT02528357|582870239|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405027|NCT02528357|582870240|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405028|NCT02528357|582870241|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405029|NCT02528357|582870242|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161405030|NCT02528357|582870243|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161405031|NCT02528357|582870244|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
161405032|NCT02528357|582870245|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
161405033|NCT01455220|582870249|FG000|Overall Study|screen fail|30|||
161405034|NCT00267150|582870250|FG000|Overall Study|Adverse Event|1|||
161405035|NCT00969436|582870255|FG000|Overall Study|Protocol Violation|1|||
161405036|NCT00969436|582870256|FG001|Overall Study|Protocol Violation|3|||
161405037|NCT00969436|582870257|FG002|Overall Study|Protocol Violation|0|||
161405038|NCT00969436|582870255|FG000|Overall Study|Migrated/moved from study area|12|||
161405039|NCT00969436|582870256|FG001|Overall Study|Migrated/moved from study area|10|||
161405040|NCT00969436|582870257|FG002|Overall Study|Migrated/moved from study area|2|||
161405041|NCT00969436|582870255|FG000|Overall Study|Father - serious health problem|0|||
161405042|NCT00969436|582870256|FG001|Overall Study|Father - serious health problem|0|||
161405043|NCT00969436|582870257|FG002|Overall Study|Father - serious health problem|1|||
161405044|NCT00969436|582870255|FG000|Overall Study|Parents personal problem|0|||
161405045|NCT00969436|582870256|FG001|Overall Study|Parents personal problem|0|||
161405046|NCT00969436|582870257|FG002|Overall Study|Parents personal problem|1|||
161405047|NCT00969436|582870255|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
161405048|NCT00969436|582870256|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
161405049|NCT00969436|582870257|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
161405050|NCT00969436|582870255|FG000|Overall Study|Withdrawal by Subject|3|||
161405051|NCT00969436|582870256|FG001|Overall Study|Withdrawal by Subject|0|||
161405052|NCT00969436|582870257|FG002|Overall Study|Withdrawal by Subject|2|||
161405053|NCT00969436|582870255|FG000|Overall Study|Lost to Follow-up|8|||
161405054|NCT00969436|582870256|FG001|Overall Study|Lost to Follow-up|8|||
161405055|NCT00969436|582870257|FG002|Overall Study|Lost to Follow-up|5|||
161405056|NCT00351273|582870258|FG000|Overall Study|Lost to Follow-up|1|||
161405057|NCT00351273|582870259|FG001|Overall Study|Lost to Follow-up|2|||
161405058|NCT00351273|582870260|FG002|Overall Study|Lost to Follow-up|5|||
161405059|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
161405060|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
161405061|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
161405062|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
161405063|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
161405064|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
161405065|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
161405066|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
161405067|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
161405068|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
161405069|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
161405070|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
161405071|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
161405072|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
161405073|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
161405074|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
161405075|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
161405076|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
161405077|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
161405078|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
161405079|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
161405080|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
161405081|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
161405082|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
161405083|NCT01672866|582870261|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
161405084|NCT01672866|582870262|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
161405085|NCT01672866|582870263|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
161405086|NCT01672866|582870261|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
161405087|NCT01672866|582870262|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
161405088|NCT01672866|582870263|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
161405089|NCT01672866|582870261|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
161405090|NCT01672866|582870262|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
161405091|NCT01672866|582870263|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
161405092|NCT01672866|582870261|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
161405093|NCT01672866|582870262|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
161405094|NCT01672866|582870263|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
161405095|NCT01672866|582870261|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
161405096|NCT01672866|582870262|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
161405097|NCT01672866|582870263|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
161405098|NCT02544373|582870266|FG000|Overall Study|Lost to Follow-up|5|||
161405099|NCT02544373|582870267|FG001|Overall Study|Lost to Follow-up|3|||
161405100|NCT02544373|582870266|FG000|Overall Study|Withdrawal by Subject|8|||
161405101|NCT02544373|582870267|FG001|Overall Study|Withdrawal by Subject|2|||
161405102|NCT04208087|582870268|FG000|Overall Study|Adverse Event|1|||
161405103|NCT04208087|582870269|FG001|Overall Study|Adverse Event|0|||
161405104|NCT04208087|582870270|FG002|Overall Study|Adverse Event|0|||
161405105|NCT04208087|582870271|FG003|Overall Study|Adverse Event|0|||
161405106|NCT04208087|582870272|FG004|Overall Study|Adverse Event|0|||
161405107|NCT04208087|582870268|FG000|Overall Study|Withdrawal by Subject|0|||
161405108|NCT04208087|582870269|FG001|Overall Study|Withdrawal by Subject|0|||
161405109|NCT04208087|582870270|FG002|Overall Study|Withdrawal by Subject|1|||
161405110|NCT04208087|582870271|FG003|Overall Study|Withdrawal by Subject|0|||
161405111|NCT04208087|582870272|FG004|Overall Study|Withdrawal by Subject|0|||
161405112|NCT04208087|582870268|FG000|Overall Study|Other|0|||
161405113|NCT04208087|582870269|FG001|Overall Study|Other|0|||
161405114|NCT04208087|582870270|FG002|Overall Study|Other|0|||
161405115|NCT04208087|582870271|FG003|Overall Study|Other|0|||
161405116|NCT04208087|582870272|FG004|Overall Study|Other|1|||
161405117|NCT01198509|582870273|FG000|Overall Study|Withdrawal by Subject|1|||
161405118|NCT01198509|582870274|FG001|Overall Study|Withdrawal by Subject|0|||
161405119|NCT01198509|582870275|FG002|Overall Study|Withdrawal by Subject|0|||
161405120|NCT01198509|582870276|FG003|Overall Study|Withdrawal by Subject|0|||
161405121|NCT01198509|582870277|FG004|Overall Study|Withdrawal by Subject|0|||
161405122|NCT01198509|582870278|FG005|Overall Study|Withdrawal by Subject|0|||
161405123|NCT01595581|582870279|FG000|Overall Study|Withdrawal by Subject|1|||
161405124|NCT01595581|582870280|FG001|Overall Study|Withdrawal by Subject|0|||
161405125|NCT02621073|582870290|FG000|Overall Study|Lost to Follow-up|0|||
161405126|NCT02621073|582870291|FG001|Overall Study|Lost to Follow-up|1|||
161405127|NCT02621073|582870290|FG000|Overall Study|Physician Decision|3|||
161405128|NCT02621073|582870291|FG001|Overall Study|Physician Decision|2|||
161405129|NCT01969721|582870292|FG000|Overall Study|Adverse Event|3|||
161405130|NCT01969721|582870293|FG001|Overall Study|Adverse Event|8|||
161405131|NCT01969721|582870294|FG002|Overall Study|Adverse Event|3|||
161405132|NCT01969721|582870295|FG003|Overall Study|Adverse Event|2|||
161405133|NCT01969721|582870292|FG000|Overall Study|Lack of Efficacy|0|||
161405134|NCT01969721|582870293|FG001|Overall Study|Lack of Efficacy|0|||
161405135|NCT01969721|582870294|FG002|Overall Study|Lack of Efficacy|1|||
161405136|NCT01969721|582870295|FG003|Overall Study|Lack of Efficacy|0|||
161405137|NCT01969721|582870292|FG000|Overall Study|Non compliant with protocol|1|||
161405138|NCT01969721|582870293|FG001|Overall Study|Non compliant with protocol|1|||
161405139|NCT01969721|582870294|FG002|Overall Study|Non compliant with protocol|0|||
161405140|NCT01969721|582870295|FG003|Overall Study|Non compliant with protocol|2|||
161405141|NCT01969721|582870292|FG000|Overall Study|Other not defined above|0|||
161405142|NCT01969721|582870293|FG001|Overall Study|Other not defined above|2|||
161405143|NCT01969721|582870294|FG002|Overall Study|Other not defined above|0|||
161405144|NCT01969721|582870295|FG003|Overall Study|Other not defined above|0|||
161405145|NCT01969721|582870292|FG000|Overall Study|Discontinued during washout periods.|0|||
161405146|NCT01969721|582870293|FG001|Overall Study|Discontinued during washout periods.|1|||
161405147|NCT01969721|582870294|FG002|Overall Study|Discontinued during washout periods.|1|||
161405148|NCT01969721|582870295|FG003|Overall Study|Discontinued during washout periods.|2|||
161405149|NCT02920957|582870297|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
161405150|NCT02920957|582870298|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
161405151|NCT02920957|582870297|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
161405152|NCT02920957|582870298|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
161405153|NCT02920957|582870297|FG000|First Intervention : 1 Month|Adverse Event|1|||
161405154|NCT02920957|582870298|FG001|First Intervention : 1 Month|Adverse Event|0|||
161405155|NCT02920957|582870297|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
161405156|NCT02920957|582870298|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
161405157|NCT01789606|582870299|FG000|Overall Study|Participant not Purchased the Product|0|||
161405158|NCT01789606|582870300|FG001|Overall Study|Participant not Purchased the Product|20|||
161405159|NCT01789606|582870299|FG000|Overall Study|Withdrawal by Subject|0|||
161405160|NCT01789606|582870300|FG001|Overall Study|Withdrawal by Subject|1|||
161405161|NCT01789606|582870299|FG000|Overall Study|Ineligible|6|||
161405162|NCT01789606|582870300|FG001|Overall Study|Ineligible|2|||
161405163|NCT01789606|582870299|FG000|Overall Study|Administrative Reasons|17|||
161405164|NCT01789606|582870300|FG001|Overall Study|Administrative Reasons|6|||
161405165|NCT01789606|582870299|FG000|Overall Study|No Study Medication Taken|0|||
161405166|NCT01789606|582870300|FG001|Overall Study|No Study Medication Taken|1|||
161405167|NCT01789606|582870299|FG000|Overall Study|Protocol Violation|0|||
161405168|NCT01789606|582870300|FG001|Overall Study|Protocol Violation|55|||
161405169|NCT01789606|582870299|FG000|Overall Study|Adverse Event|0|||
161405170|NCT01789606|582870300|FG001|Overall Study|Adverse Event|3|||
161405171|NCT01789606|582870299|FG000|Overall Study|Lost to Follow-up|0|||
161405172|NCT01789606|582870300|FG001|Overall Study|Lost to Follow-up|14|||
161405173|NCT01789606|582870299|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
161405174|NCT01789606|582870300|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
161405175|NCT03180307|582870301|FG000|Overall Study|Lost to Follow-up|2|||
161405176|NCT03180307|582870302|FG001|Overall Study|Lost to Follow-up|0|||
161405177|NCT03180307|582870301|FG000|Overall Study|Death|1|||
161405178|NCT03180307|582870302|FG001|Overall Study|Death|0|||
161405179|NCT03180307|582870301|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
161405180|NCT03180307|582870302|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
161405181|NCT01563172|582870308|FG000|Overall Study|Adverse Event|5|||
161405182|NCT01563172|582870308|FG000|Overall Study|Lost to Follow-up|2|||
161405183|NCT01563172|582870308|FG000|Overall Study|Other (Protocol deviation)|5|||
161405184|NCT01563172|582870308|FG000|Overall Study|Other (Not specified)|1|||
161405185|NCT00720343|582871951|FG000|Overall Study|Lost to Follow-up|1|||
161405186|NCT00720343|582871952|FG001|Overall Study|Lost to Follow-up|0|||
161405187|NCT00720343|582871951|FG000|Overall Study|Protocol Violation|0|||
161405188|NCT00720343|582871952|FG001|Overall Study|Protocol Violation|2|||
161405189|NCT03459365|582871955|FG000|Overall Study|Withdrawal by Subject|6|||
161405190|NCT03459365|582871955|FG000|Overall Study|Protocol Violation|8|||
161405191|NCT00344500|582871957|FG000|Overall Study|Adverse Event|6|||
161405192|NCT00344500|582871958|FG001|Overall Study|Adverse Event|2|||
161405193|NCT00344500|582871959|FG002|Overall Study|Adverse Event|0|||
161405194|NCT00344500|582871957|FG000|Overall Study|Lost to Follow-up|5|||
161405195|NCT00344500|582871958|FG001|Overall Study|Lost to Follow-up|13|||
161405196|NCT00344500|582871959|FG002|Overall Study|Lost to Follow-up|1|||
161405197|NCT00344500|582871957|FG000|Overall Study|Withdrawal by Subject|7|||
161405198|NCT00344500|582871958|FG001|Overall Study|Withdrawal by Subject|10|||
161405199|NCT00344500|582871959|FG002|Overall Study|Withdrawal by Subject|0|||
161405200|NCT00344500|582871957|FG000|Overall Study|Protocol Violation|4|||
161405201|NCT00344500|582871958|FG001|Overall Study|Protocol Violation|7|||
161405202|NCT00344500|582871959|FG002|Overall Study|Protocol Violation|1|||
161405203|NCT00344500|582871957|FG000|Overall Study|Not Noted|1|||
161405204|NCT00344500|582871958|FG001|Overall Study|Not Noted|3|||
161405205|NCT00344500|582871959|FG002|Overall Study|Not Noted|0|||
161405206|NCT00599755|582871960|FG000|Overall Study|Adverse Event|11|||
161405207|NCT00599755|582871960|FG000|Overall Study|Withdrawal by Subject|2|||
161405208|NCT00599755|582871960|FG000|Overall Study|Progression of Disease|3|||
161405209|NCT00599755|582871960|FG000|Overall Study|Other Reason|2|||
161405210|NCT00599755|582871960|FG000|Overall Study|No data available|1|||
161405211|NCT04037254|582871961|FG000|Overall Study|Protocol Violation|1|||
161405212|NCT04037254|582871962|FG001|Overall Study|Protocol Violation|0|||
161405213|NCT04037254|582871963|FG002|Overall Study|Protocol Violation|0|||
161405214|NCT04037254|582871964|FG003|Overall Study|Protocol Violation|0|||
161405215|NCT04037254|582871965|FG004|Overall Study|Protocol Violation|0|||
161405216|NCT04037254|582871961|FG000|Overall Study|Withdrawal by Subject|0|||
161405217|NCT04037254|582871962|FG001|Overall Study|Withdrawal by Subject|0|||
161405218|NCT04037254|582871963|FG002|Overall Study|Withdrawal by Subject|1|||
161405219|NCT04037254|582871964|FG003|Overall Study|Withdrawal by Subject|0|||
161405220|NCT04037254|582871965|FG004|Overall Study|Withdrawal by Subject|0|||
161405221|NCT04037254|582871961|FG000|Overall Study|Delayed or incomplete treatment|0|||
161405222|NCT04037254|582871962|FG001|Overall Study|Delayed or incomplete treatment|2|||
161405223|NCT04037254|582871963|FG002|Overall Study|Delayed or incomplete treatment|1|||
161405224|NCT04037254|582871964|FG003|Overall Study|Delayed or incomplete treatment|0|||
161405225|NCT04037254|582871965|FG004|Overall Study|Delayed or incomplete treatment|0|||
161405226|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
161405227|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
161405228|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
161405229|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
161405230|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
161405231|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
161405232|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
161405233|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
161405234|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
161405235|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
161405236|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
161405237|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
161405238|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
161405239|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
161405240|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
161405241|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
161405242|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
161405243|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
161405244|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
161405245|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
161405246|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
161405247|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
161405248|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
161405249|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
161405250|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
161405251|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
161405252|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
161405253|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
161405254|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
161405255|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
161405256|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
161405257|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
161405258|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
161405259|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
161405260|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
161405261|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
161405262|NCT02198794|582871966|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
161405263|NCT02198794|582871967|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
161405264|NCT02198794|582871968|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
161405265|NCT02198794|582871969|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
161405266|NCT02198794|582871966|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
161405267|NCT02198794|582871967|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
161405268|NCT02198794|582871968|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
161405269|NCT02198794|582871969|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
161405270|NCT02198794|582871966|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
161405271|NCT02198794|582871967|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
161405272|NCT02198794|582871968|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
161405273|NCT02198794|582871969|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
161405274|NCT02198794|582871966|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
161405275|NCT02198794|582871967|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
161405276|NCT02198794|582871968|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
161405277|NCT02198794|582871969|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
161405278|NCT02198794|582871966|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
161405279|NCT02198794|582871967|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
161405280|NCT02198794|582871968|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
161405281|NCT02198794|582871969|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
161405282|NCT02198794|582871966|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
161405283|NCT02198794|582871967|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
161405284|NCT02198794|582871968|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
161405285|NCT02198794|582871969|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
161405286|NCT01306656|582871970|FG000|Overall Study|Lost to Follow-up|1|||
161405287|NCT01306656|582871971|FG001|Overall Study|Lost to Follow-up|0|||
161405288|NCT01918332|582871975|FG000|Overall Study|Adverse Event|0|||
161405289|NCT01918332|582871976|FG001|Overall Study|Adverse Event|0|||
161405290|NCT01918332|582871977|FG002|Overall Study|Adverse Event|0|||
161405291|NCT01918332|582871978|FG003|Overall Study|Adverse Event|1|||
161405292|NCT01918332|582871975|FG000|Overall Study|Withdrawal by Subject|2|||
161405293|NCT01918332|582871976|FG001|Overall Study|Withdrawal by Subject|3|||
161405294|NCT01918332|582871977|FG002|Overall Study|Withdrawal by Subject|2|||
161405295|NCT01918332|582871978|FG003|Overall Study|Withdrawal by Subject|3|||
161405296|NCT01918332|582871975|FG000|Overall Study|Protocol Violation|6|||
161405297|NCT01918332|582871976|FG001|Overall Study|Protocol Violation|2|||
161405298|NCT01918332|582871977|FG002|Overall Study|Protocol Violation|6|||
161405299|NCT01918332|582871978|FG003|Overall Study|Protocol Violation|3|||
161405300|NCT01918332|582871975|FG000|Overall Study|lipid result by central lab did not meet|0|||
161405301|NCT01918332|582871976|FG001|Overall Study|lipid result by central lab did not meet|0|||
161405302|NCT01918332|582871977|FG002|Overall Study|lipid result by central lab did not meet|1|||
161405303|NCT01918332|582871978|FG003|Overall Study|lipid result by central lab did not meet|0|||
161405304|NCT00680368|582871985|FG000|Overall Study|not supervised, not eligible|15|||
161405305|NCT03779503|582871986|FG000|First Intervention|Adverse Event|0|||
161405306|NCT03779503|582871987|FG001|First Intervention|Adverse Event|1|||
161405307|NCT03779503|582871986|FG000|First Intervention|Withdrawal by Subject|1|||
161405308|NCT03779503|582871987|FG001|First Intervention|Withdrawal by Subject|0|||
161405309|NCT00106691|582871989|FG000|Overall Study|Adverse Event|60|||
161405310|NCT00106691|582871990|FG001|Overall Study|Adverse Event|64|||
161405311|NCT00106691|582871989|FG000|Overall Study|Lost to Follow-up|23|||
161405312|NCT00106691|582871990|FG001|Overall Study|Lost to Follow-up|18|||
161405313|NCT00106691|582871989|FG000|Overall Study|Physician Decision|18|||
161405314|NCT00106691|582871990|FG001|Overall Study|Physician Decision|21|||
161405315|NCT00106691|582871989|FG000|Overall Study|Protocol Violation|13|||
161405316|NCT00106691|582871990|FG001|Overall Study|Protocol Violation|18|||
161405317|NCT00106691|582871989|FG000|Overall Study|Withdrawal by Subject|75|||
161405318|NCT00106691|582871990|FG001|Overall Study|Withdrawal by Subject|70|||
161405319|NCT00106691|582871989|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
161405320|NCT00106691|582871990|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
161405321|NCT00106691|582871989|FG000|Overall Study|QTc>480|3|||
161405322|NCT00106691|582871990|FG001|Overall Study|QTc>480|1|||
161405323|NCT00106691|582871989|FG000|Overall Study|mililtary deployment|2|||
161405324|NCT00106691|582871990|FG001|Overall Study|mililtary deployment|0|||
161405325|NCT00106691|582871989|FG000|Overall Study|Study Site Closing/PI Moved|1|||
161405326|NCT00106691|582871990|FG001|Overall Study|Study Site Closing/PI Moved|2|||
161405327|NCT00106691|582871989|FG000|Overall Study|Cardiologist recommendation|1|||
161405328|NCT00106691|582871990|FG001|Overall Study|Cardiologist recommendation|0|||
161405329|NCT00106691|582871989|FG000|Overall Study|Pt. moved to another state|1|||
161405330|NCT00106691|582871990|FG001|Overall Study|Pt. moved to another state|0|||
161405331|NCT00106691|582871989|FG000|Overall Study|Taking exclusionary avodart|1|||
161405332|NCT00106691|582871990|FG001|Overall Study|Taking exclusionary avodart|0|||
161405333|NCT00106691|582871989|FG000|Overall Study|Not able to discontinue plavix|0|||
161405334|NCT00106691|582871990|FG001|Overall Study|Not able to discontinue plavix|1|||
161405335|NCT00530920|582871991|FG000|Overall Study|Randomized but not treated|0|||
161405336|NCT00530920|582871992|FG001|Overall Study|Randomized but not treated|2|||
161405337|NCT00530920|582871993|FG002|Overall Study|Randomized but not treated|0|||
161405338|NCT00530920|582871991|FG000|Overall Study|Adverse Event|0|||
161405339|NCT00530920|582871992|FG001|Overall Study|Adverse Event|0|||
161405340|NCT00530920|582871993|FG002|Overall Study|Adverse Event|3|||
161405341|NCT00530920|582871991|FG000|Overall Study|Withdrawal by Subject|0|||
161405342|NCT00530920|582871992|FG001|Overall Study|Withdrawal by Subject|0|||
161405343|NCT00530920|582871993|FG002|Overall Study|Withdrawal by Subject|1|||
161405344|NCT00907296|582871994|FG000|Overall Study|Ineligibility Determined|1|||
161405345|NCT00907296|582871995|FG001|Overall Study|Ineligibility Determined|0|||
161405346|NCT00907296|582871996|FG002|Overall Study|Ineligibility Determined|0|||
161405347|NCT00907296|582871997|FG003|Overall Study|Ineligibility Determined|1|||
161405348|NCT00907296|582871998|FG004|Overall Study|Ineligibility Determined|0|||
161405349|NCT00907296|582871999|FG005|Overall Study|Ineligibility Determined|0|||
161405350|NCT00907296|582872000|FG006|Overall Study|Ineligibility Determined|0|||
161405351|NCT00907296|582872001|FG007|Overall Study|Ineligibility Determined|1|||
161405352|NCT00907296|582872002|FG008|Overall Study|Ineligibility Determined|0|||
161405353|NCT00907296|582872003|FG009|Overall Study|Ineligibility Determined|0|||
161405354|NCT00907296|582871994|FG000|Overall Study|Protocol Deviation|0|||
161405355|NCT00907296|582871995|FG001|Overall Study|Protocol Deviation|1|||
161405356|NCT00907296|582871996|FG002|Overall Study|Protocol Deviation|0|||
161405357|NCT00907296|582871997|FG003|Overall Study|Protocol Deviation|0|||
161405358|NCT00907296|582871998|FG004|Overall Study|Protocol Deviation|0|||
161405359|NCT00907296|582871999|FG005|Overall Study|Protocol Deviation|0|||
161405360|NCT00907296|582872000|FG006|Overall Study|Protocol Deviation|0|||
161405361|NCT00907296|582872001|FG007|Overall Study|Protocol Deviation|0|||
161405362|NCT00907296|582872002|FG008|Overall Study|Protocol Deviation|0|||
161405363|NCT00907296|582872003|FG009|Overall Study|Protocol Deviation|0|||
161405364|NCT00907296|582871994|FG000|Overall Study|Noncompliance|1|||
161405365|NCT00907296|582871995|FG001|Overall Study|Noncompliance|1|||
161405366|NCT00907296|582871996|FG002|Overall Study|Noncompliance|1|||
161405367|NCT00907296|582871997|FG003|Overall Study|Noncompliance|0|||
161405368|NCT00907296|582871998|FG004|Overall Study|Noncompliance|0|||
161405369|NCT00907296|582871999|FG005|Overall Study|Noncompliance|1|||
161405370|NCT00907296|582872000|FG006|Overall Study|Noncompliance|0|||
161405371|NCT00907296|582872001|FG007|Overall Study|Noncompliance|2|||
161405372|NCT00907296|582872002|FG008|Overall Study|Noncompliance|0|||
161405373|NCT00907296|582872003|FG009|Overall Study|Noncompliance|0|||
161405374|NCT00907296|582871994|FG000|Overall Study|Adverse Event|2|||
161405375|NCT00907296|582871995|FG001|Overall Study|Adverse Event|0|||
161405376|NCT00907296|582871996|FG002|Overall Study|Adverse Event|0|||
161405377|NCT00907296|582871997|FG003|Overall Study|Adverse Event|0|||
161405378|NCT00907296|582871998|FG004|Overall Study|Adverse Event|0|||
161405379|NCT00907296|582871999|FG005|Overall Study|Adverse Event|0|||
161405380|NCT00907296|582872000|FG006|Overall Study|Adverse Event|1|||
161405381|NCT00907296|582872001|FG007|Overall Study|Adverse Event|0|||
161405382|NCT00907296|582872002|FG008|Overall Study|Adverse Event|0|||
161405383|NCT00907296|582872003|FG009|Overall Study|Adverse Event|1|||
161405384|NCT00907296|582871994|FG000|Overall Study|Withdrawal by Subject|7|||
161405385|NCT00907296|582871995|FG001|Overall Study|Withdrawal by Subject|2|||
161405386|NCT00907296|582871996|FG002|Overall Study|Withdrawal by Subject|1|||
161405387|NCT00907296|582871997|FG003|Overall Study|Withdrawal by Subject|1|||
161405388|NCT00907296|582871998|FG004|Overall Study|Withdrawal by Subject|1|||
161405389|NCT00907296|582871999|FG005|Overall Study|Withdrawal by Subject|5|||
161405390|NCT00907296|582872000|FG006|Overall Study|Withdrawal by Subject|3|||
161405391|NCT00907296|582872001|FG007|Overall Study|Withdrawal by Subject|2|||
161405392|NCT00907296|582872002|FG008|Overall Study|Withdrawal by Subject|4|||
161405393|NCT00907296|582872003|FG009|Overall Study|Withdrawal by Subject|2|||
161405394|NCT00907296|582871994|FG000|Overall Study|Lost to Follow-up|9|||
161405395|NCT00907296|582871995|FG001|Overall Study|Lost to Follow-up|1|||
161405396|NCT00907296|582871996|FG002|Overall Study|Lost to Follow-up|0|||
161405397|NCT00907296|582871997|FG003|Overall Study|Lost to Follow-up|2|||
161405398|NCT00907296|582871998|FG004|Overall Study|Lost to Follow-up|0|||
161405399|NCT00907296|582871999|FG005|Overall Study|Lost to Follow-up|3|||
161405400|NCT00907296|582872000|FG006|Overall Study|Lost to Follow-up|2|||
161405401|NCT00907296|582872001|FG007|Overall Study|Lost to Follow-up|2|||
161405402|NCT00907296|582872002|FG008|Overall Study|Lost to Follow-up|0|||
161405403|NCT00907296|582872003|FG009|Overall Study|Lost to Follow-up|4|||
161405404|NCT02392403|582872005|FG000|Overall Study|Adverse Event|1|||
161405405|NCT02392403|582872005|FG000|Overall Study|Death|1|||
161405406|NCT02392403|582872005|FG000|Overall Study|Withdrawal by Subject|1|||
161405407|NCT00316888|582872011|FG000|Overall Study|Adverse Event|4|||
161405408|NCT00316888|582872012|FG001|Overall Study|Adverse Event|5|||
161405409|NCT00316888|582872011|FG000|Overall Study|Withdrawal by Subject|2|||
161405410|NCT00316888|582872012|FG001|Overall Study|Withdrawal by Subject|2|||
161405411|NCT00316888|582872011|FG000|Overall Study|Not start protocol therapy|0|||
161405412|NCT00316888|582872012|FG001|Overall Study|Not start protocol therapy|1|||
161405413|NCT00657371|582872016|FG000|Overall Study|Poor bowel preparation|15|||
161405414|NCT00657371|582872016|FG000|Overall Study|Unable to intubate the cecum|5|||
161405415|NCT00657371|582872016|FG000|Overall Study|Protocol Violation|2|||
161405416|NCT00657371|582872016|FG000|Overall Study|Device- related reasons|13|||
161405417|NCT00657371|582872016|FG000|Overall Study|Pre-existing medical condition|4|||
161405418|NCT00652899|582872017|FG000|Overall Study|Death|1|||
161405419|NCT00652899|582872017|FG000|Overall Study|Treating physician decision|1|||
161405420|NCT02713867|582872018|FG000|Randomization|Other Reason|2|||
161405421|NCT02713867|582872019|FG001|Randomization|Other Reason|1|||
161405422|NCT02713867|582872018|FG000|Randomization|Participant Withdrew consent|0|||
161405423|NCT02713867|582872019|FG001|Randomization|Participant Withdrew consent|2|||
161405424|NCT02713867|582872018|FG000|Treatment Period|Other Reasons|22|||
161405425|NCT02713867|582872019|FG001|Treatment Period|Other Reasons|28|||
161405426|NCT02713867|582872018|FG000|Treatment Period|Administrative reason by sponsor|21|||
161405427|NCT02713867|582872019|FG001|Treatment Period|Administrative reason by sponsor|16|||
161405428|NCT02713867|582872018|FG000|Treatment Period|No longer meets study criteria|2|||
161405429|NCT02713867|582872019|FG001|Treatment Period|No longer meets study criteria|1|||
161405430|NCT02713867|582872018|FG000|Treatment Period|Poor/Non Compliance|1|||
161405431|NCT02713867|582872019|FG001|Treatment Period|Poor/Non Compliance|0|||
161405432|NCT02713867|582872018|FG000|Treatment Period|Maximum Clinical Benefit|5|||
161405433|NCT02713867|582872019|FG001|Treatment Period|Maximum Clinical Benefit|6|||
161405434|NCT02713867|582872018|FG000|Treatment Period|Withdrew consent|3|||
161405435|NCT02713867|582872019|FG001|Treatment Period|Withdrew consent|6|||
161405436|NCT02713867|582872018|FG000|Treatment Period|Requested to Discontinue|8|||
161405437|NCT02713867|582872019|FG001|Treatment Period|Requested to Discontinue|8|||
161405438|NCT02713867|582872018|FG000|Treatment Period|AE unrelated to Study Drug|11|||
161405439|NCT02713867|582872019|FG001|Treatment Period|AE unrelated to Study Drug|10|||
161405440|NCT02713867|582872018|FG000|Treatment Period|Death|7|||
161405441|NCT02713867|582872019|FG001|Treatment Period|Death|3|||
161405442|NCT02713867|582872018|FG000|Treatment Period|Study Drug Toxicity|16|||
161405443|NCT02713867|582872019|FG001|Treatment Period|Study Drug Toxicity|19|||
161405444|NCT02713867|582872018|FG000|Treatment Period|Disease Progression|82|||
161405445|NCT02713867|582872019|FG001|Treatment Period|Disease Progression|83|||
161405446|NCT04135859|582872022|FG000|Overall Study|Withdrawal by Subject|1|||
161405447|NCT04135859|582872023|FG001|Overall Study|Withdrawal by Subject|0|||
161405448|NCT04135859|582872022|FG000|Overall Study|Withdrawal due to screening failure|1|||
161405449|NCT04135859|582872023|FG001|Overall Study|Withdrawal due to screening failure|2|||
161405450|NCT04135859|582872022|FG000|Overall Study|Did not complete stress test|3|||
161405451|NCT04135859|582872023|FG001|Overall Study|Did not complete stress test|3|||
161405452|NCT04135859|582872022|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
161405453|NCT04135859|582872023|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
161405454|NCT01600053|582872024|FG000|Overall Study|Adverse Event|2|||
161405455|NCT01600053|582872024|FG000|Overall Study|trial will not meet the interim endpoint|9|||
161405456|NCT01565941|582872025|FG000|Overall Study|Withdrawn by parent/guardian|3|||
161405457|NCT01565941|582872026|FG001|Overall Study|Withdrawn by parent/guardian|2|||
161405458|NCT01565941|582872025|FG000|Overall Study|Randomized; did not receive intevention|8|||
161405459|NCT01565941|582872026|FG001|Overall Study|Randomized; did not receive intevention|2|||
161405460|NCT03230292|582872029|FG000|Overall Study|Adverse Event|1|||
161405461|NCT03230292|582872029|FG000|Overall Study|Protocol Violation|1|||
161405462|NCT03230292|582872029|FG000|Overall Study|Lost to Follow-up|1|||
161405463|NCT03230292|582872029|FG000|Overall Study|Withdrawal by Subject|3|||
161405464|NCT02855944|582872030|FG000|Period 1: Treatment|Ongoing|14|||
161405465|NCT02855944|582872031|FG001|Period 1: Treatment|Ongoing|0|||
161405466|NCT02855944|582872030|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
161405467|NCT02855944|582872031|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
161405468|NCT02855944|582872030|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
161405469|NCT02855944|582872031|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
161405470|NCT03629912|582872039|FG000|Overall Study|Lost to Follow-up|19|||
161405471|NCT03629912|582872040|FG001|Overall Study|Lost to Follow-up|7|||
161405472|NCT03629912|582872041|FG002|Overall Study|Lost to Follow-up|5|||
161405473|NCT03629912|582872042|FG003|Overall Study|Lost to Follow-up|1|||
161405474|NCT03629912|582872039|FG000|Overall Study|Withdrawal by Subject|6|||
161405475|NCT03629912|582872040|FG001|Overall Study|Withdrawal by Subject|0|||
161405476|NCT03629912|582872041|FG002|Overall Study|Withdrawal by Subject|1|||
161405477|NCT03629912|582872042|FG003|Overall Study|Withdrawal by Subject|2|||
161405478|NCT03629912|582872039|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
161405479|NCT03629912|582872040|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
161405480|NCT03629912|582872041|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
161405481|NCT03629912|582872042|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
161405482|NCT03629912|582872039|FG000|Overall Study|Death|1|||
161405483|NCT03629912|582872040|FG001|Overall Study|Death|0|||
161405484|NCT03629912|582872041|FG002|Overall Study|Death|0|||
161405485|NCT03629912|582872042|FG003|Overall Study|Death|0|||
161405486|NCT03262116|582872045|FG000|Overall Study|Physician Decision|0|||
161405487|NCT03262116|582872046|FG001|Overall Study|Physician Decision|2|||
161405488|NCT03262116|582872047|FG002|Overall Study|Physician Decision|1|||
161405489|NCT03262116|582872048|FG003|Overall Study|Physician Decision|1|||
161405490|NCT03262116|582872049|FG004|Overall Study|Physician Decision|1|||
161405491|NCT03262116|582872050|FG005|Overall Study|Physician Decision|2|||
161405492|NCT02365285|582872051|FG000|Overall Study|Physician Decision|0|||
161405493|NCT02365285|582872052|FG001|Overall Study|Physician Decision|1|||
161405494|NCT02365285|582872053|FG002|Overall Study|Physician Decision|1|||
161405495|NCT02365285|582872054|FG003|Overall Study|Physician Decision|0|||
161405496|NCT02365285|582872051|FG000|Overall Study|Adverse Event|0|||
161405497|NCT02365285|582872052|FG001|Overall Study|Adverse Event|0|||
161405498|NCT02365285|582872053|FG002|Overall Study|Adverse Event|0|||
161405499|NCT02365285|582872054|FG003|Overall Study|Adverse Event|2|||
161405500|NCT02608450|582872057|FG000|Overall Study|Lost to Follow-up|39|||
161405501|NCT02608450|582872058|FG001|Overall Study|Lost to Follow-up|32|||
161405502|NCT02608450|582872057|FG000|Overall Study|Withdrawal by Subject|21|||
161405503|NCT02608450|582872058|FG001|Overall Study|Withdrawal by Subject|15|||
161405504|NCT02608450|582872057|FG000|Overall Study|Adverse Event|3|||
161405505|NCT02608450|582872058|FG001|Overall Study|Adverse Event|6|||
161405506|NCT02608450|582872057|FG000|Overall Study|Withdrawal by parent|2|||
161405507|NCT02608450|582872058|FG001|Overall Study|Withdrawal by parent|3|||
161405508|NCT02608450|582872057|FG000|Overall Study|Lack of Efficacy|0|||
161405509|NCT02608450|582872058|FG001|Overall Study|Lack of Efficacy|3|||
161405510|NCT02608450|582872057|FG000|Overall Study|Noncompliance with study drug|0|||
161405511|NCT02608450|582872058|FG001|Overall Study|Noncompliance with study drug|2|||
161405512|NCT02608450|582872057|FG000|Overall Study|Physician Decision|0|||
161405513|NCT02608450|582872058|FG001|Overall Study|Physician Decision|1|||
161405514|NCT02608450|582872057|FG000|Overall Study|Pregnancy|0|||
161405515|NCT02608450|582872058|FG001|Overall Study|Pregnancy|1|||
161405516|NCT02608450|582872057|FG000|Overall Study|Progressive disease|1|||
161405517|NCT02608450|582872058|FG001|Overall Study|Progressive disease|0|||
161405518|NCT02608450|582872057|FG000|Overall Study|Multiple reasons|0|||
161405519|NCT02608450|582872058|FG001|Overall Study|Multiple reasons|2|||
161405520|NCT00635089|582872060|FG000|Overall Study|Adverse Event|7|||
161405521|NCT00635089|582872060|FG000|Overall Study|Lack of Efficacy|28|||
161405522|NCT00635089|582872060|FG000|Overall Study|Protocol Deviation|4|||
161405523|NCT00635089|582872060|FG000|Overall Study|Lost to Follow-up|8|||
161405524|NCT00635089|582872060|FG000|Overall Study|Other|31|||
161405525|NCT01617447|582872061|FG000|Overall Study|Adverse Event|0|||
161405526|NCT01617447|582872062|FG001|Overall Study|Adverse Event|1|||
161405527|NCT01617447|582872061|FG000|Overall Study|Physician Decision|0|||
161405528|NCT01617447|582872062|FG001|Overall Study|Physician Decision|2|||
161405529|NCT02636946|582872064|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
161405530|NCT02636946|582872065|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
161405531|NCT02636946|582872064|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
161405532|NCT02636946|582872065|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161405533|NCT02636946|582872064|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
161405534|NCT02636946|582872065|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
161405535|NCT02636946|582872064|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
161405536|NCT02636946|582872065|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
161405537|NCT02636946|582872064|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
161405538|NCT02636946|582872065|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
161405539|NCT02636946|582872064|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
161405540|NCT02636946|582872065|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
161405541|NCT01283542|582872066|FG000|Main Phase|Acute or progressive vision loss|1|||
161405542|NCT01283542|582872066|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
161405543|NCT01283542|582872066|FG000|Main Phase|abnormal laboratory values|5|||
161405544|NCT01283542|582872066|FG000|Extension Phase|Physician Decision|1|||
161405545|NCT01283542|582872066|FG000|Extension Phase|Adverse Event|1|||
161405546|NCT01283542|582872066|FG000|Extension Phase|Administrative problems|1|||
161405547|NCT05059977|582872067|FG000|Overall Study|Withdrawal by Subject|0|||
161405548|NCT05059977|582872068|FG001|Overall Study|Withdrawal by Subject|0|||
161405549|NCT05059977|582872069|FG002|Overall Study|Withdrawal by Subject|1|||
161405550|NCT04405245|582872070|FG000|Overall Study|Adverse Event|0|||
161405551|NCT04405245|582872071|FG001|Overall Study|Adverse Event|1|||
161405552|NCT04405245|582872072|FG002|Overall Study|Adverse Event|0|||
161405553|NCT00576472|582872073|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405554|NCT00576472|582872074|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405555|NCT00576472|582872075|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405556|NCT00576472|582872076|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
161405557|NCT00576472|582872077|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405558|NCT00576472|582872078|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405559|NCT00576472|582872079|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405560|NCT00576472|582872080|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405561|NCT00576472|582872081|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405562|NCT00576472|582872082|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405563|NCT00576472|582872083|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405564|NCT00576472|582872084|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405565|NCT00576472|582872085|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405566|NCT00576472|582872086|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405567|NCT00576472|582872087|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
161405568|NCT00576472|582872073|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
161405569|NCT00576472|582872074|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
161405570|NCT00576472|582872075|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
161405571|NCT00576472|582872076|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
161405572|NCT00576472|582872077|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
161405573|NCT00576472|582872078|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
161405574|NCT00576472|582872079|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
161405575|NCT00576472|582872080|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
161405576|NCT00576472|582872081|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
161405577|NCT00576472|582872082|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
161405578|NCT00576472|582872083|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
161405579|NCT00576472|582872084|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
161405580|NCT00576472|582872085|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
161405581|NCT00576472|582872086|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
161405582|NCT00576472|582872087|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
161405583|NCT00576472|582872073|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405584|NCT00576472|582872074|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405585|NCT00576472|582872075|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405586|NCT00576472|582872076|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
161405587|NCT00576472|582872077|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405588|NCT00576472|582872078|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405589|NCT00576472|582872079|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405590|NCT00576472|582872080|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405591|NCT00576472|582872081|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405592|NCT00576472|582872082|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405593|NCT00576472|582872083|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405594|NCT00576472|582872084|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405595|NCT00576472|582872085|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405596|NCT00576472|582872086|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405597|NCT00576472|582872087|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161405598|NCT00576472|582872073|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
161405599|NCT00576472|582872074|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
161405600|NCT00576472|582872075|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
161405601|NCT00576472|582872076|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
161405602|NCT00576472|582872077|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
161405603|NCT00576472|582872078|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
161405604|NCT00576472|582872079|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
161405605|NCT00576472|582872080|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
161405606|NCT00576472|582872081|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
161405607|NCT00576472|582872082|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
161405608|NCT00576472|582872083|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
161405609|NCT00576472|582872084|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
161405610|NCT00576472|582872085|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
161405611|NCT00576472|582872086|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
161405612|NCT00576472|582872087|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
161405613|NCT00576472|582872073|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405614|NCT00576472|582872074|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405615|NCT00576472|582872075|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405616|NCT00576472|582872076|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
161405617|NCT00576472|582872077|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405618|NCT00576472|582872078|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405619|NCT00576472|582872079|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405620|NCT00576472|582872080|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405621|NCT00576472|582872081|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405622|NCT00576472|582872082|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405623|NCT00576472|582872083|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405624|NCT00576472|582872084|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405625|NCT00576472|582872085|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405626|NCT00576472|582872086|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405627|NCT00576472|582872087|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
161405628|NCT00576472|582872073|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405629|NCT00576472|582872074|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405630|NCT00576472|582872075|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405631|NCT00576472|582872076|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405632|NCT00576472|582872077|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405633|NCT00576472|582872078|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405634|NCT00576472|582872079|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
161405635|NCT00576472|582872080|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405636|NCT00576472|582872081|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405637|NCT00576472|582872082|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405638|NCT00576472|582872083|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405639|NCT00576472|582872084|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405640|NCT00576472|582872085|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405641|NCT00576472|582872086|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405642|NCT00576472|582872087|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
161405643|NCT00576472|582872073|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
161405644|NCT00576472|582872074|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
161405645|NCT00576472|582872075|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
161405646|NCT00576472|582872076|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
161405647|NCT00576472|582872077|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
161405648|NCT00576472|582872078|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
161405649|NCT00576472|582872079|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
161405650|NCT00576472|582872080|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
161405651|NCT00576472|582872081|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
161405652|NCT00576472|582872082|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
161405653|NCT00576472|582872083|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
161405654|NCT00576472|582872084|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
161405655|NCT00576472|582872085|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
161405656|NCT00576472|582872086|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
161405657|NCT00576472|582872087|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
161405658|NCT00576472|582872073|FG000|MPH Cross Over Phase|Physician Decision|0|||
161405659|NCT00576472|582872074|FG001|MPH Cross Over Phase|Physician Decision|0|||
161405660|NCT00576472|582872075|FG002|MPH Cross Over Phase|Physician Decision|0|||
161405661|NCT00576472|582872076|FG003|MPH Cross Over Phase|Physician Decision|0|||
161405662|NCT00576472|582872077|FG004|MPH Cross Over Phase|Physician Decision|0|||
161405663|NCT00576472|582872078|FG005|MPH Cross Over Phase|Physician Decision|0|||
161405664|NCT00576472|582872079|FG006|MPH Cross Over Phase|Physician Decision|4|||
161405665|NCT00576472|582872080|FG007|MPH Cross Over Phase|Physician Decision|0|||
161405666|NCT00576472|582872081|FG008|MPH Cross Over Phase|Physician Decision|0|||
161405667|NCT00576472|582872082|FG009|MPH Cross Over Phase|Physician Decision|0|||
161405668|NCT00576472|582872083|FG010|MPH Cross Over Phase|Physician Decision|0|||
161405669|NCT00576472|582872084|FG011|MPH Cross Over Phase|Physician Decision|0|||
161405670|NCT00576472|582872085|FG012|MPH Cross Over Phase|Physician Decision|0|||
161405671|NCT00576472|582872086|FG013|MPH Cross Over Phase|Physician Decision|0|||
161405672|NCT00576472|582872087|FG014|MPH Cross Over Phase|Physician Decision|0|||
161405673|NCT00576472|582872073|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405674|NCT00576472|582872074|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405675|NCT00576472|582872075|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405676|NCT00576472|582872076|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405677|NCT00576472|582872077|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405678|NCT00576472|582872078|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405679|NCT00576472|582872079|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405680|NCT00576472|582872080|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405681|NCT00576472|582872081|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
161405682|NCT00576472|582872082|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405683|NCT00576472|582872083|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
161405684|NCT00576472|582872084|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
161405685|NCT00576472|582872085|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405686|NCT00576472|582872086|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405687|NCT00576472|582872087|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
161405688|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405689|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405690|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405691|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405692|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405693|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405694|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405695|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405696|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405697|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405698|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405699|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405700|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405701|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
161405702|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161405703|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
161405704|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
161405705|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
161405706|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
161405707|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
161405708|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
161405709|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
161405710|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
161405711|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
161405712|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
161405713|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
161405714|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
161405715|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
161405716|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
161405717|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
161405718|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
161405719|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
161405720|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
161405721|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
161405722|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
161405723|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
161405724|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
161405725|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
161405726|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
161405727|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
161405728|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
161405729|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
161405730|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
161405731|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
161405732|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
161405733|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Side effects|0|||
161405734|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Side effects|0|||
161405735|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Side effects|0|||
161405736|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Side effects|0|||
161405737|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Side effects|0|||
161405738|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Side effects|0|||
161405739|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Side effects|0|||
161405740|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Side effects|0|||
161405741|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Side effects|0|||
161405742|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Side effects|0|||
161405743|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Side effects|0|||
161405744|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Side effects|0|||
161405745|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Side effects|0|||
161405746|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Side effects|0|||
161405747|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Side effects|8|||
161405748|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405749|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405750|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405751|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405752|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405753|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405754|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405755|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405756|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405757|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405758|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405759|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405760|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405761|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161405762|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
161405763|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
161405764|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
161405765|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
161405766|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
161405767|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
161405768|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
161405769|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
161405770|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
161405771|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
161405772|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
161405773|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
161405774|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
161405775|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
161405776|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
161405777|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
161405778|NCT00576472|582872073|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405779|NCT00576472|582872074|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405780|NCT00576472|582872075|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405781|NCT00576472|582872076|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405782|NCT00576472|582872077|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405783|NCT00576472|582872078|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405784|NCT00576472|582872079|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405785|NCT00576472|582872080|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405786|NCT00576472|582872081|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405787|NCT00576472|582872082|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405788|NCT00576472|582872083|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405789|NCT00576472|582872084|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405790|NCT00576472|582872085|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405791|NCT00576472|582872086|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161405792|NCT00576472|582872087|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
161405793|NCT03443427|582872088|FG000|Overall Study|Adverse Event|2|||
161405794|NCT03443427|582872089|FG001|Overall Study|Adverse Event|3|||
161405795|NCT03443427|582872088|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
161405796|NCT03443427|582872089|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161405797|NCT03443427|582872088|FG000|Overall Study|Other|4|||
161405798|NCT03443427|582872089|FG001|Overall Study|Other|6|||
161405799|NCT00780273|582872093|FG000|Overall Study|Death|1|||
161405800|NCT00780273|582872093|FG000|Overall Study|Lost to Follow-up|1|||
161405801|NCT02576860|582872094|FG000|Overall Study|Adverse Event|6|||
161405802|NCT02576860|582872095|FG001|Overall Study|Adverse Event|6|||
161405803|NCT02576860|582872094|FG000|Overall Study|Lost to Follow-up|5|||
161405804|NCT02576860|582872095|FG001|Overall Study|Lost to Follow-up|7|||
161405805|NCT02576860|582872094|FG000|Overall Study|Physician Decision|0|||
161405806|NCT02576860|582872095|FG001|Overall Study|Physician Decision|1|||
161405807|NCT02576860|582872094|FG000|Overall Study|Protocol Violation|0|||
161405808|NCT02576860|582872095|FG001|Overall Study|Protocol Violation|2|||
161405809|NCT02576860|582872094|FG000|Overall Study|Withdrawal by Subject|13|||
161405810|NCT02576860|582872095|FG001|Overall Study|Withdrawal by Subject|8|||
161405811|NCT02576860|582872094|FG000|Overall Study|Disallowed medication|1|||
161405812|NCT02576860|582872095|FG001|Overall Study|Disallowed medication|0|||
161405813|NCT02391961|582872096|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
161405814|NCT02391961|582872097|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
161405815|NCT02391961|582872096|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161405816|NCT02391961|582872097|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
161405817|NCT02391961|582872096|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161405818|NCT02391961|582872097|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161405819|NCT02308488|582872100|FG000|Overall Study|Withdrawal by Subject|2|||
161405820|NCT01541917|582872101|FG000|Overall Study|Lost to Follow-up|2|||
161405821|NCT01541917|582872102|FG001|Overall Study|Lost to Follow-up|2|||
161405822|NCT01541917|582872101|FG000|Overall Study|Withdrawal by Subject|13|||
161405823|NCT01541917|582872102|FG001|Overall Study|Withdrawal by Subject|7|||
161405824|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
161405825|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
161405826|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
161405827|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
161405828|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
161405829|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
161405830|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
161405831|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
161405832|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
161405833|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
161405834|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
161405835|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
161405836|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
161405837|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
161405838|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
161405839|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
161405840|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
161405841|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
161405842|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
161405843|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
161405844|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
161405845|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
161405846|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
161405847|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
161405848|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
161405849|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
161405850|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
161405851|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
161405852|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
161405853|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
161405854|NCT00121641|582872103|FG000|24-week Short-term Treatment Period|Other Reason|1|||
161405855|NCT00121641|582872104|FG001|24-week Short-term Treatment Period|Other Reason|0|||
161405856|NCT00121641|582872105|FG002|24-week Short-term Treatment Period|Other Reason|0|||
161405857|NCT00121641|582872106|FG003|24-week Short-term Treatment Period|Other Reason|0|||
161405858|NCT00121641|582872107|FG004|24-week Short-term Treatment Period|Other Reason|0|||
161405859|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
161405860|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
161405861|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
161405862|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
161405863|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
161405864|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
161405865|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
161405866|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
161405867|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
161405868|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
161405869|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
161405870|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
161405871|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
161405872|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
161405873|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
161405874|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
161405875|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
161405876|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
161405877|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
161405878|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
161405879|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
161405880|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
161405881|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
161405882|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
161405883|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
161405884|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
161405885|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
161405886|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
161405887|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
161405888|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
161405889|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
161405890|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
161405891|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
161405892|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
161405893|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
161405894|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
161405895|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
161405896|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
161405897|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
161405898|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
161405899|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Death|0|||
161405900|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Death|0|||
161405901|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Death|0|||
161405902|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Death|1|||
161405903|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Death|0|||
161405904|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Missing|0|||
161405905|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Missing|0|||
161405906|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Missing|1|||
161405907|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Missing|0|||
161405908|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Missing|0|||
161405909|NCT00121641|582872103|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
161405910|NCT00121641|582872104|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
161405911|NCT00121641|582872105|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
161405912|NCT00121641|582872106|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
161405913|NCT00121641|582872107|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
161405914|NCT03263780|582872108|FG000|Overall Study|Withdrawal by Subject|3|||
161405915|NCT03263780|582872108|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
161405916|NCT01565564|582872119|FG000|Overall Study|Lost to Follow-up|5|||
161405917|NCT01565564|582872120|FG001|Overall Study|Lost to Follow-up|1|||
161405918|NCT00249613|582872121|FG000|12 Month Follow-up|Death|1|||
161405919|NCT00249613|582872122|FG001|12 Month Follow-up|Death|1|||
161405920|NCT00249613|582872121|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
161405921|NCT00249613|582872122|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
161405922|NCT00249613|582872121|FG000|12 Month Follow-up|Lost to Follow-up|10|||
161405923|NCT00249613|582872122|FG001|12 Month Follow-up|Lost to Follow-up|8|||
161405924|NCT00495755|582872123|FG000|Overall Study|Adverse Event|3|||
161405925|NCT03268941|582873866|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161405926|NCT03268941|582873867|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161405927|NCT03268941|582873868|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161405928|NCT03268941|582873869|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
161405929|NCT03268941|582873870|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161405930|NCT03268941|582873871|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161405931|NCT03268941|582873872|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161405932|NCT03268941|582873866|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
161405933|NCT03268941|582873867|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
161405934|NCT03268941|582873868|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
161405935|NCT03268941|582873869|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
161405936|NCT03268941|582873870|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
161405937|NCT03268941|582873871|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
161405938|NCT03268941|582873872|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
161405939|NCT03268941|582873866|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
161405940|NCT03268941|582873867|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161405941|NCT03268941|582873868|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161405942|NCT03268941|582873869|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161405943|NCT03268941|582873870|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161405944|NCT03268941|582873871|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161405945|NCT03268941|582873872|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161405946|NCT03268941|582873866|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
161405947|NCT03268941|582873867|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
161405948|NCT03268941|582873868|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
161405949|NCT03268941|582873869|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
161405950|NCT03268941|582873870|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
161405951|NCT03268941|582873871|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
161405952|NCT03268941|582873872|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
161405953|NCT03268941|582873866|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161405954|NCT03268941|582873867|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161405955|NCT03268941|582873868|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161405956|NCT03268941|582873869|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161405957|NCT03268941|582873870|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161405958|NCT03268941|582873871|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161405959|NCT03268941|582873872|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
161405960|NCT02720692|582873877|FG000|Overall Study|Withdrawal by Subject|3|||
161405961|NCT02720692|582873878|FG001|Overall Study|Withdrawal by Subject|0|||
161405962|NCT02720692|582873877|FG000|Overall Study|Physician Decision|1|||
161405963|NCT02720692|582873878|FG001|Overall Study|Physician Decision|0|||
161405964|NCT02720692|582873877|FG000|Overall Study|Lost to Follow-up|8|||
161405965|NCT02720692|582873878|FG001|Overall Study|Lost to Follow-up|3|||
161405966|NCT02720692|582873877|FG000|Overall Study|Subject unable to return for visit|1|||
161405967|NCT02720692|582873878|FG001|Overall Study|Subject unable to return for visit|0|||
161405968|NCT03878758|582873879|FG000|Overall Study|Withdrawal by Subject|1|||
161405969|NCT03878758|582873879|FG000|Overall Study|Protocol defined|2|||
161405970|NCT03878758|582873879|FG000|Overall Study|Improper consent documentation|1|||
161405971|NCT03614325|582873880|FG000|Overall Study|Withdrawal by Subject|0|||
161405972|NCT03614325|582873881|FG001|Overall Study|Withdrawal by Subject|2|||
161405973|NCT03614325|582873880|FG000|Overall Study|Surgery Cancelled|2|||
161405974|NCT03614325|582873881|FG001|Overall Study|Surgery Cancelled|1|||
161405975|NCT03614325|582873880|FG000|Overall Study|Lost to Follow-up|2|||
161405976|NCT03614325|582873881|FG001|Overall Study|Lost to Follow-up|1|||
161405977|NCT03614325|582873880|FG000|Overall Study|Surgery never scheduled|1|||
161405978|NCT03614325|582873881|FG001|Overall Study|Surgery never scheduled|0|||
161405979|NCT00652951|582873887|FG000|Booster Phase|Adverse event, non-fatal|0|||
161405980|NCT00652951|582873888|FG001|Booster Phase|Adverse event, non-fatal|1|||
161405981|NCT00652951|582873889|FG002|Booster Phase|Adverse event, non-fatal|0|||
161405982|NCT00652951|582873887|FG000|Booster Phase|Other|1|||
161405983|NCT00652951|582873888|FG001|Booster Phase|Other|0|||
161405984|NCT00652951|582873889|FG002|Booster Phase|Other|0|||
161405985|NCT01022424|582873890|FG000|Overall Study|Adverse Event|1|||
161405986|NCT01022424|582873890|FG000|Overall Study|Physician Decision|1|||
161405987|NCT01022424|582873890|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
161405988|NCT01206582|582873891|FG000|Overall Study|Withdrew prior to study|1|||
161405989|NCT01206582|582873892|FG001|Overall Study|Withdrew prior to study|0|||
161405990|NCT01206582|582873891|FG000|Overall Study|Discontinued intervention before week 8|1|||
161405991|NCT01206582|582873892|FG001|Overall Study|Discontinued intervention before week 8|2|||
161405992|NCT01939366|582873893|FG000|Overall Study|Adverse Event|8|||
161405993|NCT01939366|582873894|FG001|Overall Study|Adverse Event|17|||
161405994|NCT01939366|582873895|FG002|Overall Study|Adverse Event|30|||
161405995|NCT01939366|582873896|FG003|Overall Study|Adverse Event|8|||
161405996|NCT01939366|582873897|FG004|Overall Study|Adverse Event|5|||
161405997|NCT01939366|582873893|FG000|Overall Study|Lack of Efficacy|2|||
161405998|NCT01939366|582873894|FG001|Overall Study|Lack of Efficacy|1|||
161405999|NCT01939366|582873895|FG002|Overall Study|Lack of Efficacy|1|||
161406000|NCT01939366|582873896|FG003|Overall Study|Lack of Efficacy|1|||
161406001|NCT01939366|582873897|FG004|Overall Study|Lack of Efficacy|3|||
161406002|NCT01939366|582873893|FG000|Overall Study|Lost to Follow-up|1|||
161406003|NCT01939366|582873894|FG001|Overall Study|Lost to Follow-up|1|||
161406004|NCT01939366|582873895|FG002|Overall Study|Lost to Follow-up|0|||
161406005|NCT01939366|582873896|FG003|Overall Study|Lost to Follow-up|0|||
161406006|NCT01939366|582873897|FG004|Overall Study|Lost to Follow-up|0|||
161406007|NCT01939366|582873893|FG000|Overall Study|Withdrawal by Subject|1|||
161406008|NCT01939366|582873894|FG001|Overall Study|Withdrawal by Subject|0|||
161406009|NCT01939366|582873895|FG002|Overall Study|Withdrawal by Subject|2|||
161406010|NCT01939366|582873896|FG003|Overall Study|Withdrawal by Subject|2|||
161406011|NCT01939366|582873897|FG004|Overall Study|Withdrawal by Subject|3|||
161406012|NCT01939366|582873893|FG000|Overall Study|Inclusion criteria not met|0|||
161406013|NCT01939366|582873894|FG001|Overall Study|Inclusion criteria not met|1|||
161406014|NCT01939366|582873895|FG002|Overall Study|Inclusion criteria not met|1|||
161406015|NCT01939366|582873896|FG003|Overall Study|Inclusion criteria not met|0|||
161406016|NCT01939366|582873897|FG004|Overall Study|Inclusion criteria not met|1|||
161406017|NCT01939366|582873893|FG000|Overall Study|Other|0|||
161406018|NCT01939366|582873894|FG001|Overall Study|Other|0|||
161406019|NCT01939366|582873895|FG002|Overall Study|Other|2|||
161406020|NCT01939366|582873896|FG003|Overall Study|Other|2|||
161406021|NCT01939366|582873897|FG004|Overall Study|Other|1|||
161406022|NCT01939366|582873893|FG000|Overall Study|Protocol Violation|0|||
161406023|NCT01939366|582873894|FG001|Overall Study|Protocol Violation|0|||
161406024|NCT01939366|582873895|FG002|Overall Study|Protocol Violation|0|||
161406025|NCT01939366|582873896|FG003|Overall Study|Protocol Violation|1|||
161406026|NCT01939366|582873897|FG004|Overall Study|Protocol Violation|0|||
161406027|NCT01939366|582873893|FG000|Overall Study|Sponsor decision|0|||
161406028|NCT01939366|582873894|FG001|Overall Study|Sponsor decision|0|||
161406029|NCT01939366|582873895|FG002|Overall Study|Sponsor decision|0|||
161406030|NCT01939366|582873896|FG003|Overall Study|Sponsor decision|0|||
161406031|NCT01939366|582873897|FG004|Overall Study|Sponsor decision|2|||
161406032|NCT01939366|582873893|FG000|Overall Study|GCP non-compliance at site|2|||
161406033|NCT01939366|582873894|FG001|Overall Study|GCP non-compliance at site|3|||
161406034|NCT01939366|582873895|FG002|Overall Study|GCP non-compliance at site|2|||
161406035|NCT01939366|582873896|FG003|Overall Study|GCP non-compliance at site|3|||
161406036|NCT01939366|582873897|FG004|Overall Study|GCP non-compliance at site|3|||
161406037|NCT02252965|582873898|FG000|Overall Study|Adverse Event|9|||
161406038|NCT02252965|582873899|FG001|Overall Study|Adverse Event|14|||
161406039|NCT02252965|582873898|FG000|Overall Study|Lost to Follow-up|16|||
161406040|NCT02252965|582873899|FG001|Overall Study|Lost to Follow-up|8|||
161406041|NCT02252965|582873898|FG000|Overall Study|Protocol Violation|4|||
161406042|NCT02252965|582873899|FG001|Overall Study|Protocol Violation|5|||
161406043|NCT02252965|582873898|FG000|Overall Study|Lack of Efficacy|0|||
161406044|NCT02252965|582873899|FG001|Overall Study|Lack of Efficacy|2|||
161406045|NCT02252965|582873898|FG000|Overall Study|Withdrawal by Subject|7|||
161406046|NCT02252965|582873899|FG001|Overall Study|Withdrawal by Subject|9|||
161406047|NCT02252965|582873898|FG000|Overall Study|Other|4|||
161406048|NCT02252965|582873899|FG001|Overall Study|Other|5|||
161406049|NCT04736628|582873900|FG000|Overall Study|Not treated|0|||
161406050|NCT04736628|582873901|FG001|Overall Study|Not treated|0|||
161406051|NCT04736628|582873902|FG002|Overall Study|Not treated|0|||
161406052|NCT04736628|582873903|FG003|Overall Study|Not treated|2|||
161406053|NCT04736628|582873900|FG000|Overall Study|Other reason than listed|1|||
161406054|NCT04736628|582873901|FG001|Overall Study|Other reason than listed|2|||
161406055|NCT04736628|582873902|FG002|Overall Study|Other reason than listed|2|||
161406056|NCT04736628|582873903|FG003|Overall Study|Other reason than listed|3|||
161406057|NCT04736628|582873900|FG000|Overall Study|Protocol deviation|0|||
161406058|NCT04736628|582873901|FG001|Overall Study|Protocol deviation|0|||
161406059|NCT04736628|582873902|FG002|Overall Study|Protocol deviation|0|||
161406060|NCT04736628|582873903|FG003|Overall Study|Protocol deviation|1|||
161406061|NCT04736628|582873900|FG000|Overall Study|Burden of study procedures|1|||
161406062|NCT04736628|582873901|FG001|Overall Study|Burden of study procedures|0|||
161406063|NCT04736628|582873902|FG002|Overall Study|Burden of study procedures|0|||
161406064|NCT04736628|582873903|FG003|Overall Study|Burden of study procedures|1|||
161406065|NCT04736628|582873900|FG000|Overall Study|Change of residence|0|||
161406066|NCT04736628|582873901|FG001|Overall Study|Change of residence|1|||
161406067|NCT04736628|582873902|FG002|Overall Study|Change of residence|0|||
161406068|NCT04736628|582873903|FG003|Overall Study|Change of residence|0|||
161406069|NCT04736628|582873900|FG000|Overall Study|Perceived lack of efficacy|1|||
161406070|NCT04736628|582873901|FG001|Overall Study|Perceived lack of efficacy|0|||
161406071|NCT04736628|582873902|FG002|Overall Study|Perceived lack of efficacy|0|||
161406072|NCT04736628|582873903|FG003|Overall Study|Perceived lack of efficacy|1|||
161406073|NCT04736628|582873900|FG000|Overall Study|Adverse Event|3|||
161406074|NCT04736628|582873901|FG001|Overall Study|Adverse Event|2|||
161406075|NCT04736628|582873902|FG002|Overall Study|Adverse Event|4|||
161406076|NCT04736628|582873903|FG003|Overall Study|Adverse Event|3|||
161406077|NCT04279613|582873904|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161406078|NCT04279613|582873905|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161406079|NCT04279613|582873906|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161406080|NCT04279613|582873907|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161406081|NCT04279613|582873908|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
161406082|NCT04279613|582873904|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161406083|NCT04279613|582873905|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
161406084|NCT04279613|582873906|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161406085|NCT04279613|582873907|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161406086|NCT04279613|582873908|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161406087|NCT04279613|582873904|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161406088|NCT04279613|582873905|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161406089|NCT04279613|582873906|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
161406090|NCT04279613|582873907|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161406091|NCT04279613|582873908|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161406092|NCT04279613|582873904|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161406093|NCT04279613|582873905|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161406094|NCT04279613|582873906|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161406095|NCT04279613|582873907|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161406096|NCT04279613|582873908|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
161406097|NCT04279613|582873904|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161406098|NCT04279613|582873905|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161406099|NCT04279613|582873906|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161406100|NCT04279613|582873907|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
161406101|NCT04279613|582873908|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161406102|NCT02478164|582873909|FG000|Overall Study|Lack of Efficacy|13|||
161406103|NCT02478164|582873909|FG000|Overall Study|Adverse Event|1|||
161406104|NCT02478164|582873909|FG000|Overall Study|Withdrawal by Subject|1|||
161406105|NCT04051827|582873910|FG000|Overall Study|Death|1|||
161406106|NCT04051827|582873910|FG000|Overall Study|Withdrawal by Subject|4|||
161406107|NCT04051827|582873910|FG000|Overall Study|Progressive disease|16|||
161406108|NCT04051827|582873910|FG000|Overall Study|Physician Decision|1|||
161406109|NCT04051827|582873910|FG000|Overall Study|Other|4|||
161406110|NCT05779007|582873911|FG000|Overall Study|not meeting eligibility criteria|3517|||
161406111|NCT05779007|582873912|FG001|Overall Study|not meeting eligibility criteria|2009|||
161406112|NCT01424566|582873913|FG000|Single-blind Treatment|Adverse Event|71|||
161406113|NCT01424566|582873914|FG001|Single-blind Treatment|Adverse Event|0|||
161406114|NCT01424566|582873915|FG002|Single-blind Treatment|Adverse Event|0|||
161406115|NCT01424566|582873913|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
161406116|NCT01424566|582873914|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
161406117|NCT01424566|582873915|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
161406118|NCT01424566|582873913|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
161406119|NCT01424566|582873914|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
161406120|NCT01424566|582873915|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
161406121|NCT01424566|582873913|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
161406122|NCT01424566|582873914|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
161406123|NCT01424566|582873915|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
161406124|NCT01424566|582873913|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
161406125|NCT01424566|582873914|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
161406126|NCT01424566|582873915|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
161406127|NCT01424566|582873913|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
161406128|NCT01424566|582873914|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
161406129|NCT01424566|582873915|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
161406130|NCT01424566|582873913|FG000|Double-blind Treatment|Adverse Event|0|||
161406131|NCT01424566|582873914|FG001|Double-blind Treatment|Adverse Event|21|||
161406132|NCT01424566|582873915|FG002|Double-blind Treatment|Adverse Event|13|||
161406133|NCT01424566|582873913|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
161406134|NCT01424566|582873914|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
161406135|NCT01424566|582873915|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
161406136|NCT01424566|582873913|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
161406137|NCT01424566|582873914|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
161406138|NCT01424566|582873915|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
161406139|NCT01424566|582873913|FG000|Double-blind Treatment|Lack of Efficacy|0|||
161406140|NCT01424566|582873914|FG001|Double-blind Treatment|Lack of Efficacy|1|||
161406141|NCT01424566|582873915|FG002|Double-blind Treatment|Lack of Efficacy|1|||
161406142|NCT02708485|582873918|FG000|Overall Study|Withdrawal by Subject|3|||
161406143|NCT02708485|582873919|FG001|Overall Study|Withdrawal by Subject|2|||
161406144|NCT01100528|582873923|FG000|Overall Study|Death|1|||
161406145|NCT01100528|582873923|FG000|Overall Study|Withdrawal by Subject|2|||
161406146|NCT02066415|582873924|FG000|Overall Study|Decision by Sponsor|5|||
161406147|NCT02066415|582873925|FG001|Overall Study|Decision by Sponsor|4|||
161406148|NCT02066415|582873926|FG002|Overall Study|Decision by Sponsor|2|||
161406149|NCT02066415|582873924|FG000|Overall Study|Withdrawal by Subject|9|||
161406150|NCT02066415|582873925|FG001|Overall Study|Withdrawal by Subject|1|||
161406151|NCT02066415|582873926|FG002|Overall Study|Withdrawal by Subject|4|||
161406152|NCT02066415|582873924|FG000|Overall Study|Lost to Follow-up|7|||
161406153|NCT02066415|582873925|FG001|Overall Study|Lost to Follow-up|2|||
161406154|NCT02066415|582873926|FG002|Overall Study|Lost to Follow-up|2|||
161406155|NCT03242252|582873928|FG000|Overall Study|At the Participant's own Request|18|||
161406156|NCT03242252|582873929|FG001|Overall Study|At the Participant's own Request|10|||
161406157|NCT03242252|582873930|FG002|Overall Study|At the Participant's own Request|15|||
161406158|NCT03242252|582873928|FG000|Overall Study|Adverse Event|8|||
161406159|NCT03242252|582873929|FG001|Overall Study|Adverse Event|6|||
161406160|NCT03242252|582873930|FG002|Overall Study|Adverse Event|9|||
161406161|NCT03242252|582873928|FG000|Overall Study|Poor Compliance to Protocol|0|||
161406162|NCT03242252|582873929|FG001|Overall Study|Poor Compliance to Protocol|2|||
161406163|NCT03242252|582873930|FG002|Overall Study|Poor Compliance to Protocol|3|||
161406164|NCT03242252|582873928|FG000|Overall Study|Study Terminated by Sponsor|1|||
161406165|NCT03242252|582873929|FG001|Overall Study|Study Terminated by Sponsor|0|||
161406166|NCT03242252|582873930|FG002|Overall Study|Study Terminated by Sponsor|0|||
161406167|NCT03242252|582873928|FG000|Overall Study|Reason not Specified|4|||
161406168|NCT03242252|582873929|FG001|Overall Study|Reason not Specified|4|||
161406169|NCT03242252|582873930|FG002|Overall Study|Reason not Specified|1|||
161406170|NCT03242252|582873928|FG000|Overall Study|Lost to Follow-up|5|||
161406171|NCT03242252|582873929|FG001|Overall Study|Lost to Follow-up|1|||
161406172|NCT03242252|582873930|FG002|Overall Study|Lost to Follow-up|4|||
161406173|NCT01659255|582873931|FG000|Overall Study|Adverse Event|0|||
161406174|NCT01659255|582873932|FG001|Overall Study|Adverse Event|0|||
161406175|NCT01659255|582873933|FG002|Overall Study|Adverse Event|0|||
161406176|NCT01659255|582873934|FG003|Overall Study|Adverse Event|0|||
161406177|NCT01659255|582873935|FG004|Overall Study|Adverse Event|0|||
161406178|NCT01659255|582873936|FG005|Overall Study|Adverse Event|1|||
161406179|NCT01659255|582873937|FG006|Overall Study|Adverse Event|1|||
161406180|NCT01659255|582873938|FG007|Overall Study|Adverse Event|0|||
161406181|NCT01659255|582873939|FG008|Overall Study|Adverse Event|0|||
161406182|NCT01659255|582873940|FG009|Overall Study|Adverse Event|1|||
161406183|NCT01659255|582873941|FG010|Overall Study|Adverse Event|0|||
161406184|NCT01659255|582873942|FG011|Overall Study|Adverse Event|1|||
161406185|NCT01659255|582873943|FG012|Overall Study|Adverse Event|0|||
161406186|NCT01659255|582873944|FG013|Overall Study|Adverse Event|2|||
161406187|NCT01659255|582873945|FG014|Overall Study|Adverse Event|0|||
161406188|NCT01659255|582873946|FG015|Overall Study|Adverse Event|1|||
161406189|NCT01659255|582873947|FG016|Overall Study|Adverse Event|0|||
161406190|NCT01659255|582873931|FG000|Overall Study|Death|0|||
161406191|NCT01659255|582873932|FG001|Overall Study|Death|1|||
161406192|NCT01659255|582873933|FG002|Overall Study|Death|0|||
161406193|NCT01659255|582873934|FG003|Overall Study|Death|0|||
161406194|NCT01659255|582873935|FG004|Overall Study|Death|0|||
161406195|NCT01659255|582873936|FG005|Overall Study|Death|0|||
161406196|NCT01659255|582873937|FG006|Overall Study|Death|0|||
161406197|NCT01659255|582873938|FG007|Overall Study|Death|1|||
161406198|NCT01659255|582873939|FG008|Overall Study|Death|1|||
161406199|NCT01659255|582873940|FG009|Overall Study|Death|0|||
161406200|NCT01659255|582873941|FG010|Overall Study|Death|0|||
161406201|NCT01659255|582873942|FG011|Overall Study|Death|0|||
161406202|NCT01659255|582873943|FG012|Overall Study|Death|1|||
161406203|NCT01659255|582873944|FG013|Overall Study|Death|1|||
161406204|NCT01659255|582873945|FG014|Overall Study|Death|2|||
161406205|NCT01659255|582873946|FG015|Overall Study|Death|1|||
161406206|NCT01659255|582873947|FG016|Overall Study|Death|0|||
161406207|NCT01659255|582873931|FG000|Overall Study|Progressive Disease|2|||
161406208|NCT01659255|582873932|FG001|Overall Study|Progressive Disease|0|||
161406209|NCT01659255|582873933|FG002|Overall Study|Progressive Disease|0|||
161406210|NCT01659255|582873934|FG003|Overall Study|Progressive Disease|0|||
161406211|NCT01659255|582873935|FG004|Overall Study|Progressive Disease|0|||
161406212|NCT01659255|582873936|FG005|Overall Study|Progressive Disease|0|||
161406213|NCT01659255|582873937|FG006|Overall Study|Progressive Disease|0|||
161406214|NCT01659255|582873938|FG007|Overall Study|Progressive Disease|1|||
161406215|NCT01659255|582873939|FG008|Overall Study|Progressive Disease|0|||
161406216|NCT01659255|582873940|FG009|Overall Study|Progressive Disease|2|||
161406217|NCT01659255|582873941|FG010|Overall Study|Progressive Disease|2|||
161406218|NCT01659255|582873942|FG011|Overall Study|Progressive Disease|3|||
161406219|NCT01659255|582873943|FG012|Overall Study|Progressive Disease|5|||
161406220|NCT01659255|582873944|FG013|Overall Study|Progressive Disease|13|||
161406221|NCT01659255|582873945|FG014|Overall Study|Progressive Disease|6|||
161406222|NCT01659255|582873946|FG015|Overall Study|Progressive Disease|2|||
161406223|NCT01659255|582873947|FG016|Overall Study|Progressive Disease|3|||
161406224|NCT01659255|582873931|FG000|Overall Study|Withdrew Consent|0|||
161406225|NCT01659255|582873932|FG001|Overall Study|Withdrew Consent|0|||
161406226|NCT01659255|582873933|FG002|Overall Study|Withdrew Consent|0|||
161406227|NCT01659255|582873934|FG003|Overall Study|Withdrew Consent|0|||
161406228|NCT01659255|582873935|FG004|Overall Study|Withdrew Consent|0|||
161406229|NCT01659255|582873936|FG005|Overall Study|Withdrew Consent|0|||
161406230|NCT01659255|582873937|FG006|Overall Study|Withdrew Consent|0|||
161406231|NCT01659255|582873938|FG007|Overall Study|Withdrew Consent|0|||
161406232|NCT01659255|582873939|FG008|Overall Study|Withdrew Consent|0|||
161406233|NCT01659255|582873940|FG009|Overall Study|Withdrew Consent|0|||
161406234|NCT01659255|582873941|FG010|Overall Study|Withdrew Consent|1|||
161406235|NCT01659255|582873942|FG011|Overall Study|Withdrew Consent|0|||
161406236|NCT01659255|582873943|FG012|Overall Study|Withdrew Consent|0|||
161406237|NCT01659255|582873944|FG013|Overall Study|Withdrew Consent|1|||
161406238|NCT01659255|582873945|FG014|Overall Study|Withdrew Consent|0|||
161406239|NCT01659255|582873946|FG015|Overall Study|Withdrew Consent|0|||
161406240|NCT01659255|582873947|FG016|Overall Study|Withdrew Consent|0|||
161406241|NCT01659255|582873931|FG000|Overall Study|Investigator Decision|0|||
161406242|NCT01659255|582873932|FG001|Overall Study|Investigator Decision|0|||
161406243|NCT01659255|582873933|FG002|Overall Study|Investigator Decision|0|||
161406244|NCT01659255|582873934|FG003|Overall Study|Investigator Decision|0|||
161406245|NCT01659255|582873935|FG004|Overall Study|Investigator Decision|0|||
161406246|NCT01659255|582873936|FG005|Overall Study|Investigator Decision|0|||
161406247|NCT01659255|582873937|FG006|Overall Study|Investigator Decision|0|||
161406248|NCT01659255|582873938|FG007|Overall Study|Investigator Decision|0|||
161406249|NCT01659255|582873939|FG008|Overall Study|Investigator Decision|0|||
161406250|NCT01659255|582873940|FG009|Overall Study|Investigator Decision|0|||
161406251|NCT01659255|582873941|FG010|Overall Study|Investigator Decision|0|||
161406252|NCT01659255|582873942|FG011|Overall Study|Investigator Decision|0|||
161406253|NCT01659255|582873943|FG012|Overall Study|Investigator Decision|1|||
161406254|NCT01659255|582873944|FG013|Overall Study|Investigator Decision|1|||
161406255|NCT01659255|582873945|FG014|Overall Study|Investigator Decision|0|||
161406256|NCT01659255|582873946|FG015|Overall Study|Investigator Decision|0|||
161406257|NCT01659255|582873947|FG016|Overall Study|Investigator Decision|0|||
161406258|NCT01659255|582873931|FG000|Overall Study|Sponsor's Decision|0|||
161406259|NCT01659255|582873932|FG001|Overall Study|Sponsor's Decision|0|||
161406260|NCT01659255|582873933|FG002|Overall Study|Sponsor's Decision|0|||
161406261|NCT01659255|582873934|FG003|Overall Study|Sponsor's Decision|0|||
161406262|NCT01659255|582873935|FG004|Overall Study|Sponsor's Decision|0|||
161406263|NCT01659255|582873936|FG005|Overall Study|Sponsor's Decision|0|||
161406264|NCT01659255|582873937|FG006|Overall Study|Sponsor's Decision|1|||
161406265|NCT01659255|582873938|FG007|Overall Study|Sponsor's Decision|0|||
161406266|NCT01659255|582873939|FG008|Overall Study|Sponsor's Decision|0|||
161406267|NCT01659255|582873940|FG009|Overall Study|Sponsor's Decision|0|||
161406268|NCT01659255|582873941|FG010|Overall Study|Sponsor's Decision|0|||
161406269|NCT01659255|582873942|FG011|Overall Study|Sponsor's Decision|0|||
161406270|NCT01659255|582873943|FG012|Overall Study|Sponsor's Decision|0|||
161406271|NCT01659255|582873944|FG013|Overall Study|Sponsor's Decision|0|||
161406272|NCT01659255|582873945|FG014|Overall Study|Sponsor's Decision|0|||
161406273|NCT01659255|582873946|FG015|Overall Study|Sponsor's Decision|0|||
161406274|NCT01659255|582873947|FG016|Overall Study|Sponsor's Decision|0|||
161406275|NCT01659255|582873931|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406276|NCT01659255|582873932|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406277|NCT01659255|582873933|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406278|NCT01659255|582873934|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406279|NCT01659255|582873935|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406280|NCT01659255|582873936|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406281|NCT01659255|582873937|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406282|NCT01659255|582873938|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406283|NCT01659255|582873939|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406284|NCT01659255|582873940|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406285|NCT01659255|582873941|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406286|NCT01659255|582873942|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406287|NCT01659255|582873943|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406288|NCT01659255|582873944|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406289|NCT01659255|582873945|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406290|NCT01659255|582873946|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
161406291|NCT01659255|582873947|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161406292|NCT01659255|582873931|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
161406293|NCT01659255|582873932|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
161406294|NCT01659255|582873933|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
161406295|NCT01659255|582873934|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
161406296|NCT01659255|582873935|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
161406297|NCT01659255|582873936|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
161406298|NCT01659255|582873937|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
161406299|NCT01659255|582873938|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
161406300|NCT01659255|582873939|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
161406301|NCT01659255|582873940|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
161406302|NCT01659255|582873941|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
161406303|NCT01659255|582873942|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
161406304|NCT01659255|582873943|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
161406305|NCT01659255|582873944|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
161406306|NCT01659255|582873945|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
161406307|NCT01659255|582873946|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
161406308|NCT01659255|582873947|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
161406309|NCT01116427|582873948|FG000|Core Phase|Adverse Event|0|||
161406310|NCT01116427|582873949|FG001|Core Phase|Adverse Event|1|||
161406311|NCT01116427|582873948|FG000|Core Phase|Lost to Follow-up|1|||
161406312|NCT01116427|582873949|FG001|Core Phase|Lost to Follow-up|0|||
161406313|NCT01116427|582873948|FG000|Core Phase|Withdrawal by Subject|3|||
161406314|NCT01116427|582873949|FG001|Core Phase|Withdrawal by Subject|0|||
161406315|NCT01116427|582873948|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
161406316|NCT01116427|582873949|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
161406317|NCT01116427|582873948|FG000|Extension Phase|Adverse Event|1|||
161406318|NCT01116427|582873949|FG001|Extension Phase|Adverse Event|1|||
161406319|NCT01116427|582873948|FG000|Extension Phase|Lost to Follow-up|2|||
161406320|NCT01116427|582873949|FG001|Extension Phase|Lost to Follow-up|0|||
161406321|NCT01116427|582873948|FG000|Extension Phase|Withdrawal by Subject|5|||
161406322|NCT01116427|582873949|FG001|Extension Phase|Withdrawal by Subject|1|||
161406323|NCT01116427|582873948|FG000|Extension Phase|Not using appropriate birth control|1|||
161406324|NCT01116427|582873949|FG001|Extension Phase|Not using appropriate birth control|0|||
161406325|NCT02211313|582873952|FG000|Overall Study|Treatment Failure|5|||
161406326|NCT02211313|582873953|FG001|Overall Study|Treatment Failure|2|||
161406327|NCT02211313|582873952|FG000|Overall Study|No Follow up Questionnaires|1|||
161406328|NCT02211313|582873953|FG001|Overall Study|No Follow up Questionnaires|1|||
161406329|NCT01423916|582873954|FG000|Overall Study|Adverse Event|5|||
161406330|NCT01423916|582873955|FG001|Overall Study|Adverse Event|9|||
161406331|NCT01423916|582873956|FG002|Overall Study|Adverse Event|2|||
161406332|NCT01423916|582873954|FG000|Overall Study|Met Withdrawal Criteria|1|||
161406333|NCT01423916|582873955|FG001|Overall Study|Met Withdrawal Criteria|1|||
161406334|NCT01423916|582873956|FG002|Overall Study|Met Withdrawal Criteria|1|||
161406335|NCT01423916|582873954|FG000|Overall Study|Physician Decision|1|||
161406336|NCT01423916|582873955|FG001|Overall Study|Physician Decision|0|||
161406337|NCT01423916|582873956|FG002|Overall Study|Physician Decision|1|||
161406338|NCT01423916|582873954|FG000|Overall Study|Withdrawal by Subject|3|||
161406339|NCT01423916|582873955|FG001|Overall Study|Withdrawal by Subject|10|||
161406340|NCT01423916|582873956|FG002|Overall Study|Withdrawal by Subject|3|||
161406341|NCT01423916|582873954|FG000|Overall Study|Protocol Deviation|1|||
161406342|NCT01423916|582873955|FG001|Overall Study|Protocol Deviation|0|||
161406343|NCT01423916|582873956|FG002|Overall Study|Protocol Deviation|0|||
161406344|NCT03316950|582873957|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
161406345|NCT03316950|582873958|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
161406346|NCT03316950|582873959|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
161406347|NCT03316950|582873960|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
161406348|NCT03316950|582873957|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
161406349|NCT03316950|582873958|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
161406350|NCT03316950|582873959|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
161406351|NCT03316950|582873960|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
161406352|NCT03316950|582873957|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
161406353|NCT03316950|582873958|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
161406354|NCT03316950|582873959|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
161406355|NCT03316950|582873960|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
161406356|NCT01754194|582873961|FG000|Overall Study|Lost to Follow-up|39|||
161406357|NCT01754194|582873962|FG001|Overall Study|Lost to Follow-up|14|||
161406358|NCT01754194|582873961|FG000|Overall Study|Withdrawal by Subject|4|||
161406359|NCT01754194|582873962|FG001|Overall Study|Withdrawal by Subject|5|||
161406360|NCT01754194|582873961|FG000|Overall Study|Other|9|||
161406361|NCT01754194|582873962|FG001|Overall Study|Other|8|||
161406362|NCT00791557|582873963|FG000|Overall Study|Adverse Event|1|||
161406363|NCT01079936|582873964|FG000|Phase I: MTD|First Remission Status|2|||
161406364|NCT01079936|582873965|FG001|Phase I: MTD|First Remission Status|0|||
161406365|NCT01079936|582873966|FG002|Phase I: MTD|First Remission Status|0|||
161406366|NCT01079936|582873967|FG003|Phase I: MTD|First Remission Status|0|||
161406367|NCT01079936|582873968|FG004|Phase I: MTD|First Remission Status|0|||
161406368|NCT01079936|582873964|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
161406369|NCT01079936|582873965|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
161406370|NCT01079936|582873966|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
161406371|NCT01079936|582873967|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
161406372|NCT01079936|582873968|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
161406373|NCT01079936|582873964|FG000|Phase II|Adverse Event|0|||
161406374|NCT01079936|582873965|FG001|Phase II|Adverse Event|0|||
161406375|NCT01079936|582873966|FG002|Phase II|Adverse Event|1|||
161406376|NCT01079936|582873967|FG003|Phase II|Adverse Event|0|||
161406377|NCT01079936|582873968|FG004|Phase II|Adverse Event|0|||
161406378|NCT01079936|582873964|FG000|Phase II|Insurance Issue|0|||
161406379|NCT01079936|582873965|FG001|Phase II|Insurance Issue|0|||
161406380|NCT01079936|582873966|FG002|Phase II|Insurance Issue|0|||
161406381|NCT01079936|582873967|FG003|Phase II|Insurance Issue|0|||
161406382|NCT01079936|582873968|FG004|Phase II|Insurance Issue|1|||
161406383|NCT02322190|582873969|FG000|Overall Study|Death on study|1|||
161406384|NCT02322190|582873970|FG001|Overall Study|Death on study|0|||
161406385|NCT03344640|582873971|FG000|Overall Study|Adverse Event|1|||
161406386|NCT03344640|582873972|FG001|Overall Study|Adverse Event|0|||
161406387|NCT03344640|582873971|FG000|Overall Study|Physician Decision|1|||
161406388|NCT03344640|582873972|FG001|Overall Study|Physician Decision|1|||
161406389|NCT03344640|582873971|FG000|Overall Study|Withdrawal by Subject|1|||
161406390|NCT03344640|582873972|FG001|Overall Study|Withdrawal by Subject|2|||
161406391|NCT03344640|582873971|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
161406392|NCT03344640|582873972|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
161406393|NCT01177969|582873978|FG000|Overall Study|Protocol Violation|2|||
161406394|NCT01177969|582873979|FG001|Overall Study|Protocol Violation|1|||
161406395|NCT01177969|582873978|FG000|Overall Study|Withdrawal by Subject|1|||
161406396|NCT01177969|582873979|FG001|Overall Study|Withdrawal by Subject|2|||
161406397|NCT02565810|582873980|FG000|Overall Study|Withdrawal by Subject|1|||
161406398|NCT01792518|582873991|FG000|Overall Study|Adverse Event|3|||
161406399|NCT01792518|582873992|FG001|Overall Study|Adverse Event|4|||
161406400|NCT01792518|582873991|FG000|Overall Study|Protocol Violation|0|||
161406401|NCT01792518|582873992|FG001|Overall Study|Protocol Violation|1|||
161406402|NCT01792518|582873991|FG000|Overall Study|Lost to Follow-up|3|||
161406403|NCT01792518|582873992|FG001|Overall Study|Lost to Follow-up|1|||
161406404|NCT01792518|582873991|FG000|Overall Study|Withdrawal by Subject|2|||
161406405|NCT01792518|582873992|FG001|Overall Study|Withdrawal by Subject|0|||
161406406|NCT01792518|582873991|FG000|Overall Study|Other Reason|0|||
161406407|NCT01792518|582873992|FG001|Overall Study|Other Reason|1|||
161406408|NCT01504204|582873993|FG000|Overall Study|Lost to Follow-up|1|||
161406409|NCT01504204|582873994|FG001|Overall Study|Lost to Follow-up|1|||
161406410|NCT03995355|582873997|FG000|Overall Study|Adverse Event|1|||
161406411|NCT03995355|582873998|FG001|Overall Study|Adverse Event|0|||
161406412|NCT03995355|582873997|FG000|Overall Study|Withdrawal by Subject|1|||
161406413|NCT03995355|582873998|FG001|Overall Study|Withdrawal by Subject|0|||
161406414|NCT03995355|582873997|FG000|Overall Study|Scheduling Issues|0|||
161406415|NCT03995355|582873998|FG001|Overall Study|Scheduling Issues|1|||
161406416|NCT00094107|582873999|FG000|Overall Study|Lack of Efficacy|23|||
161406417|NCT00094107|582873999|FG000|Overall Study|Death|5|||
161406418|NCT00094107|582873999|FG000|Overall Study|Adverse Event|3|||
161406419|NCT00094107|582873999|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
161406420|NCT03869333|582874002|FG000|Overall Study|Lost to Follow-up|1|||
161406421|NCT03869333|582874003|FG001|Overall Study|Lost to Follow-up|0|||
161406422|NCT03869333|582874004|FG002|Overall Study|Lost to Follow-up|0|||
161406423|NCT03869333|582874005|FG003|Overall Study|Lost to Follow-up|0|||
161406424|NCT03869333|582874002|FG000|Overall Study|Pregnancy|1|||
161406425|NCT03869333|582874003|FG001|Overall Study|Pregnancy|0|||
161406426|NCT03869333|582874004|FG002|Overall Study|Pregnancy|0|||
161406427|NCT03869333|582874005|FG003|Overall Study|Pregnancy|0|||
161406428|NCT03869333|582874002|FG000|Overall Study|Physician Decision|0|||
161406429|NCT03869333|582874003|FG001|Overall Study|Physician Decision|1|||
161406430|NCT03869333|582874004|FG002|Overall Study|Physician Decision|0|||
161406431|NCT03869333|582874005|FG003|Overall Study|Physician Decision|0|||
161406432|NCT02241187|582874009|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
161406433|NCT02966015|582874010|FG000|Inclusion Visit|did not answer questionnaire|8|||
161406434|NCT02966015|582874011|FG001|Inclusion Visit|did not answer questionnaire|3|||
161406435|NCT02356887|582874012|FG000|Overall Study|poor compliance|2|||
161406436|NCT00199888|582874013|FG000|Overall Study|Lost to Follow-up|1|||
161406437|NCT02177838|582874014|FG000|Overall Study|Withdrawal by Subject|1|||
161406438|NCT02177838|582874014|FG000|Overall Study|Physician Decision|1|||
161406439|NCT02177838|582874014|FG000|Overall Study|Death|1|||
161406440|NCT01839656|582874015|FG000|Overall Study|Withdrawal by Subject|1|||
161406441|NCT01839656|582874016|FG001|Overall Study|Withdrawal by Subject|1|||
161406442|NCT01839656|582874015|FG000|Overall Study|Adverse event, serious fatal|1|||
161406443|NCT01839656|582874016|FG001|Overall Study|Adverse event, serious fatal|4|||
161406444|NCT01839656|582874015|FG000|Overall Study|Early study closure|0|||
161406445|NCT01839656|582874016|FG001|Overall Study|Early study closure|11|||
161406446|NCT01839656|582874015|FG000|Overall Study|Adverse Event|1|||
161406447|NCT01839656|582874016|FG001|Overall Study|Adverse Event|0|||
161406448|NCT02273960|582874019|FG000|Short Term Period|Lost to Follow-up|1|||
161406449|NCT02273960|582874020|FG001|Short Term Period|Lost to Follow-up|0|||
161406450|NCT02273960|582874021|FG002|Short Term Period|Lost to Follow-up|0|||
161406451|NCT02273960|582874022|FG003|Short Term Period|Lost to Follow-up|0|||
161406452|NCT02273960|582874019|FG000|Short Term Period|Lack of Efficacy|0|||
161406453|NCT02273960|582874020|FG001|Short Term Period|Lack of Efficacy|0|||
161406454|NCT02273960|582874021|FG002|Short Term Period|Lack of Efficacy|0|||
161406455|NCT02273960|582874022|FG003|Short Term Period|Lack of Efficacy|1|||
161406456|NCT02273960|582874019|FG000|Short Term Period|ST complete, not entering LTE|4|||
161406457|NCT02273960|582874020|FG001|Short Term Period|ST complete, not entering LTE|6|||
161406458|NCT02273960|582874021|FG002|Short Term Period|ST complete, not entering LTE|4|||
161406459|NCT02273960|582874022|FG003|Short Term Period|ST complete, not entering LTE|5|||
161406460|NCT02273960|582874019|FG000|Long Term Extension|Death|0|||
161406461|NCT02273960|582874020|FG001|Long Term Extension|Death|0|||
161406462|NCT02273960|582874021|FG002|Long Term Extension|Death|0|||
161406463|NCT02273960|582874022|FG003|Long Term Extension|Death|1|||
161406464|NCT00558272|582874025|FG000|Overall Study|Adverse Event|10|||
161406465|NCT00558272|582874026|FG001|Overall Study|Adverse Event|0|||
161406466|NCT00558272|582874025|FG000|Overall Study|Death|1|||
161406467|NCT00558272|582874026|FG001|Overall Study|Death|0|||
161406468|NCT00558272|582874025|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
161406469|NCT00558272|582874026|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
161406470|NCT00558272|582874025|FG000|Overall Study|AZ study team decision|0|||
161406471|NCT00558272|582874026|FG001|Overall Study|AZ study team decision|1|||
161406472|NCT00558272|582874025|FG000|Overall Study|Incorrectly enrolled|1|||
161406473|NCT00558272|582874026|FG001|Overall Study|Incorrectly enrolled|0|||
161406474|NCT00558272|582874025|FG000|Overall Study|Withdrawal by Subject|0|||
161406475|NCT00558272|582874026|FG001|Overall Study|Withdrawal by Subject|1|||
161406476|NCT03442296|582874033|FG000|3 Month Follow-up|Death|3|||
161406477|NCT03442296|582874034|FG001|3 Month Follow-up|Death|1|||
161406478|NCT03442296|582874033|FG000|3 Month Follow-up|Lost to Follow-up|1|||
161406479|NCT03442296|582874034|FG001|3 Month Follow-up|Lost to Follow-up|1|||
161406480|NCT03442296|582874033|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
161406481|NCT03442296|582874034|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
161406482|NCT03442296|582874033|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
161406483|NCT03442296|582874034|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
161406484|NCT03442296|582874033|FG000|12 Month Follow-up|Incomplete measurement|1|||
161406485|NCT03442296|582874034|FG001|12 Month Follow-up|Incomplete measurement|1|||
161406486|NCT00447122|582874035|FG000|Overall Study|worsening medical condition -came off|0|||
161406487|NCT00447122|582874036|FG001|Overall Study|worsening medical condition -came off|1|||
161406488|NCT00447122|582874037|FG002|Overall Study|worsening medical condition -came off|0|||
161406489|NCT00447122|582874038|FG003|Overall Study|worsening medical condition -came off|0|||
161406490|NCT02409342|582874039|FG000|Overall Study|Death|211|||
161406491|NCT02409342|582874040|FG001|Overall Study|Death|201|||
161406492|NCT02409342|582874039|FG000|Overall Study|Withdrawal by Subject|24|||
161406493|NCT02409342|582874040|FG001|Overall Study|Withdrawal by Subject|17|||
161406494|NCT02409342|582874039|FG000|Overall Study|Study Terminated By Sponsor|48|||
161406495|NCT02409342|582874040|FG001|Overall Study|Study Terminated By Sponsor|59|||
161406496|NCT02409342|582874039|FG000|Overall Study|Lost to Follow-up|3|||
161406497|NCT02409342|582874040|FG001|Overall Study|Lost to Follow-up|5|||
161406498|NCT02409342|582874039|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
161406499|NCT02409342|582874040|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
161406500|NCT02409342|582874039|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
161406501|NCT02409342|582874040|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
161406502|NCT02409342|582874039|FG000|Overall Study|Sponsor Decision|1|||
161406503|NCT02409342|582874040|FG001|Overall Study|Sponsor Decision|0|||
161406504|NCT00279812|582874041|FG000|Overall Study|Protocol Violation|1|||
161406505|NCT00279812|582874042|FG001|Overall Study|Protocol Violation|1|||
161406506|NCT00279812|582874043|FG002|Overall Study|Protocol Violation|0|||
161406507|NCT00279812|582874044|FG003|Overall Study|Protocol Violation|0|||
161406508|NCT00279812|582874045|FG004|Overall Study|Protocol Violation|1|||
161406509|NCT00279812|582874046|FG005|Overall Study|Protocol Violation|0|||
161406510|NCT00279812|582874041|FG000|Overall Study|Withdrawal by Subject|0|||
161406511|NCT00279812|582874042|FG001|Overall Study|Withdrawal by Subject|4|||
161406512|NCT00279812|582874043|FG002|Overall Study|Withdrawal by Subject|2|||
161406513|NCT00279812|582874044|FG003|Overall Study|Withdrawal by Subject|0|||
161406514|NCT00279812|582874045|FG004|Overall Study|Withdrawal by Subject|0|||
161406515|NCT00279812|582874046|FG005|Overall Study|Withdrawal by Subject|0|||
161406516|NCT00279812|582874041|FG000|Overall Study|Adverse Event|0|||
161406517|NCT00279812|582874042|FG001|Overall Study|Adverse Event|1|||
161406518|NCT00279812|582874043|FG002|Overall Study|Adverse Event|1|||
161406519|NCT00279812|582874044|FG003|Overall Study|Adverse Event|0|||
161406520|NCT00279812|582874045|FG004|Overall Study|Adverse Event|2|||
161406521|NCT00279812|582874046|FG005|Overall Study|Adverse Event|1|||
161406522|NCT04046250|582874054|FG000|Overall Study|Death|0|||
161406523|NCT04046250|582874055|FG001|Overall Study|Death|1|||
161406524|NCT04046250|582874054|FG000|Overall Study|Withdrawal by Subject|3|||
161406525|NCT04046250|582874055|FG001|Overall Study|Withdrawal by Subject|3|||
161406526|NCT03834220|582874060|FG000|Overall Study|Adverse Event|1|||
161406527|NCT03834220|582874061|FG001|Overall Study|Adverse Event|0|||
161406528|NCT03834220|582874062|FG002|Overall Study|Adverse Event|0|||
161406529|NCT03834220|582874060|FG000|Overall Study|Death|8|||
161406530|NCT03834220|582874061|FG001|Overall Study|Death|1|||
161406531|NCT03834220|582874062|FG002|Overall Study|Death|17|||
161406532|NCT03834220|582874060|FG000|Overall Study|Reason not Specified|9|||
161406533|NCT03834220|582874061|FG001|Overall Study|Reason not Specified|0|||
161406534|NCT03834220|582874062|FG002|Overall Study|Reason not Specified|6|||
161406535|NCT03834220|582874060|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
161406536|NCT03834220|582874061|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
161406537|NCT03834220|582874062|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
161406538|NCT03834220|582874060|FG000|Overall Study|Withdrawal of Consent|2|||
161406539|NCT03834220|582874061|FG001|Overall Study|Withdrawal of Consent|2|||
161406540|NCT03834220|582874062|FG002|Overall Study|Withdrawal of Consent|2|||
161406541|NCT00527332|582874064|FG000|Overall Study|Protocol Violation|4|||
161406542|NCT00527332|582874065|FG001|Overall Study|Protocol Violation|8|||
161406543|NCT00527332|582874064|FG000|Overall Study|Withdrew consent|5|||
161406544|NCT00527332|582874065|FG001|Overall Study|Withdrew consent|1|||
161406545|NCT03684694|582874068|FG000|Phase 1|Withdrawal by Subject|1|||
161406546|NCT03684694|582874069|FG001|Phase 1|Withdrawal by Subject|0|||
161406547|NCT03684694|582874070|FG002|Phase 1|Withdrawal by Subject|0|||
161406548|NCT03684694|582874071|FG003|Phase 1|Withdrawal by Subject|0|||
161406549|NCT03684694|582874072|FG004|Phase 1|Withdrawal by Subject|0|||
161406550|NCT03684694|582874073|FG005|Phase 1|Withdrawal by Subject|0|||
161406551|NCT03684694|582874068|FG000|Phase 1|Investigator/Sponsor Decision|12|||
161406552|NCT03684694|582874069|FG001|Phase 1|Investigator/Sponsor Decision|2|||
161406553|NCT03684694|582874070|FG002|Phase 1|Investigator/Sponsor Decision|1|||
161406554|NCT03684694|582874071|FG003|Phase 1|Investigator/Sponsor Decision|0|||
161406555|NCT03684694|582874072|FG004|Phase 1|Investigator/Sponsor Decision|0|||
161406556|NCT03684694|582874073|FG005|Phase 1|Investigator/Sponsor Decision|0|||
161406557|NCT03684694|582874068|FG000|Phase 1|Death|24|||
161406558|NCT03684694|582874069|FG001|Phase 1|Death|0|||
161406559|NCT03684694|582874070|FG002|Phase 1|Death|3|||
161406560|NCT03684694|582874071|FG003|Phase 1|Death|0|||
161406561|NCT03684694|582874072|FG004|Phase 1|Death|0|||
161406562|NCT03684694|582874073|FG005|Phase 1|Death|0|||
161406563|NCT03684694|582874068|FG000|Phase 1|Lost to Follow-up|0|||
161406564|NCT03684694|582874069|FG001|Phase 1|Lost to Follow-up|0|||
161406565|NCT03684694|582874070|FG002|Phase 1|Lost to Follow-up|1|||
161406566|NCT03684694|582874071|FG003|Phase 1|Lost to Follow-up|0|||
161406567|NCT03684694|582874072|FG004|Phase 1|Lost to Follow-up|0|||
161406568|NCT03684694|582874073|FG005|Phase 1|Lost to Follow-up|0|||
161406569|NCT03684694|582874068|FG000|Phase 1|Miscellaneous|0|||
161406570|NCT03684694|582874069|FG001|Phase 1|Miscellaneous|1|||
161406571|NCT03684694|582874070|FG002|Phase 1|Miscellaneous|0|||
161406572|NCT03684694|582874071|FG003|Phase 1|Miscellaneous|0|||
161406573|NCT03684694|582874072|FG004|Phase 1|Miscellaneous|0|||
161406574|NCT03684694|582874073|FG005|Phase 1|Miscellaneous|0|||
161406575|NCT03684694|582874068|FG000|Phase 2|Withdrawal by Subject|0|||
161406576|NCT03684694|582874069|FG001|Phase 2|Withdrawal by Subject|0|||
161406577|NCT03684694|582874070|FG002|Phase 2|Withdrawal by Subject|0|||
161406578|NCT03684694|582874071|FG003|Phase 2|Withdrawal by Subject|0|||
161406579|NCT03684694|582874072|FG004|Phase 2|Withdrawal by Subject|0|||
161406580|NCT03684694|582874073|FG005|Phase 2|Withdrawal by Subject|1|||
161406581|NCT03684694|582874068|FG000|Phase 2|Investigator/Sponsor Decision|0|||
161406582|NCT03684694|582874069|FG001|Phase 2|Investigator/Sponsor Decision|0|||
161406583|NCT03684694|582874070|FG002|Phase 2|Investigator/Sponsor Decision|0|||
161406584|NCT03684694|582874071|FG003|Phase 2|Investigator/Sponsor Decision|17|||
161406585|NCT03684694|582874072|FG004|Phase 2|Investigator/Sponsor Decision|16|||
161406586|NCT03684694|582874073|FG005|Phase 2|Investigator/Sponsor Decision|6|||
161406587|NCT03684694|582874068|FG000|Phase 2|Death|0|||
161406588|NCT03684694|582874069|FG001|Phase 2|Death|0|||
161406589|NCT03684694|582874070|FG002|Phase 2|Death|0|||
161406590|NCT03684694|582874071|FG003|Phase 2|Death|28|||
161406591|NCT03684694|582874072|FG004|Phase 2|Death|14|||
161406592|NCT03684694|582874073|FG005|Phase 2|Death|3|||
161406593|NCT03684694|582874068|FG000|Phase 2|Lost to Follow-up|0|||
161406594|NCT03684694|582874069|FG001|Phase 2|Lost to Follow-up|0|||
161406595|NCT03684694|582874070|FG002|Phase 2|Lost to Follow-up|0|||
161406596|NCT03684694|582874071|FG003|Phase 2|Lost to Follow-up|1|||
161406597|NCT03684694|582874072|FG004|Phase 2|Lost to Follow-up|0|||
161406598|NCT03684694|582874073|FG005|Phase 2|Lost to Follow-up|0|||
161406599|NCT03684694|582874068|FG000|Phase 2|Miscellaneous|0|||
161406600|NCT03684694|582874069|FG001|Phase 2|Miscellaneous|0|||
161406601|NCT03684694|582874070|FG002|Phase 2|Miscellaneous|0|||
161406602|NCT03684694|582874071|FG003|Phase 2|Miscellaneous|3|||
161406603|NCT03684694|582874072|FG004|Phase 2|Miscellaneous|0|||
161406604|NCT03684694|582874073|FG005|Phase 2|Miscellaneous|0|||
161406605|NCT02100475|582876241|FG000|Overall Study|Unclassified|1|||
161406606|NCT02100475|582876242|FG001|Overall Study|Unclassified|2|||
161406607|NCT02100475|582876241|FG000|Overall Study|Withdrawal criteria|1|||
161406608|NCT02100475|582876242|FG001|Overall Study|Withdrawal criteria|0|||
161406609|NCT02806960|582876243|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161406610|NCT02806960|582876244|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161406611|NCT02806960|582876245|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161406612|NCT02806960|582876246|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161406613|NCT01769196|582876247|FG000|Overall Study|Adverse Event|24|||
161406614|NCT01769196|582876248|FG001|Overall Study|Adverse Event|20|||
161406615|NCT01769196|582876247|FG000|Overall Study|Death|21|||
161406616|NCT01769196|582876248|FG001|Overall Study|Death|26|||
161406617|NCT01769196|582876247|FG000|Overall Study|Investigator Discretion|7|||
161406618|NCT01769196|582876248|FG001|Overall Study|Investigator Discretion|3|||
161406619|NCT01769196|582876247|FG000|Overall Study|Lack of Efficacy|3|||
161406620|NCT01769196|582876248|FG001|Overall Study|Lack of Efficacy|2|||
161406621|NCT01769196|582876247|FG000|Overall Study|Progressive disease|11|||
161406622|NCT01769196|582876248|FG001|Overall Study|Progressive disease|6|||
161406623|NCT01769196|582876247|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
161406624|NCT01769196|582876248|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
161406625|NCT01769196|582876247|FG000|Overall Study|Protocol Violation|0|||
161406626|NCT01769196|582876248|FG001|Overall Study|Protocol Violation|3|||
161406627|NCT01769196|582876247|FG000|Overall Study|Study terminated by sponsor|160|||
161406628|NCT01769196|582876248|FG001|Overall Study|Study terminated by sponsor|161|||
161406629|NCT01769196|582876247|FG000|Overall Study|Participant never dosed with study drug|1|||
161406630|NCT01769196|582876248|FG001|Overall Study|Participant never dosed with study drug|0|||
161406631|NCT01769196|582876247|FG000|Overall Study|Withdrew consent|36|||
161406632|NCT01769196|582876248|FG001|Overall Study|Withdrew consent|40|||
161406633|NCT00765063|582876249|FG000|Overall Study|Lack of Efficacy|5|||
161406634|NCT00765063|582876249|FG000|Overall Study|Withdrawal by Subject|1|||
161406635|NCT00765063|582876249|FG000|Overall Study|Other|16|||
161406636|NCT00765063|582876249|FG000|Overall Study|Protocol Violation|6|||
161406637|NCT00765063|582876249|FG000|Overall Study|Adverse Event|4|||
161406638|NCT00321464|582876250|FG000|Overall Study|Death|169|||
161406639|NCT00321464|582876251|FG001|Overall Study|Death|174|||
161406640|NCT00321464|582876250|FG000|Overall Study|Disease progression|124|||
161406641|NCT00321464|582876251|FG001|Overall Study|Disease progression|124|||
161406642|NCT00321464|582876250|FG000|Overall Study|Withdrawal by Subject|117|||
161406643|NCT00321464|582876251|FG001|Overall Study|Withdrawal by Subject|118|||
161406644|NCT00321464|582876250|FG000|Overall Study|Participant request|57|||
161406645|NCT00321464|582876251|FG001|Overall Study|Participant request|61|||
161406646|NCT00321464|582876250|FG000|Overall Study|Adverse Event|43|||
161406647|NCT00321464|582876251|FG001|Overall Study|Adverse Event|28|||
161406648|NCT00321464|582876250|FG000|Overall Study|Physician Decision|15|||
161406649|NCT00321464|582876251|FG001|Overall Study|Physician Decision|14|||
161406650|NCT00321464|582876250|FG000|Overall Study|Noncompliance|4|||
161406651|NCT00321464|582876251|FG001|Overall Study|Noncompliance|10|||
161406652|NCT00321464|582876250|FG000|Overall Study|Lost to Follow-up|7|||
161406653|NCT00321464|582876251|FG001|Overall Study|Lost to Follow-up|8|||
161406654|NCT00321464|582876250|FG000|Overall Study|Protocol deviation|0|||
161406655|NCT00321464|582876251|FG001|Overall Study|Protocol deviation|2|||
161406656|NCT00321464|582876250|FG000|Overall Study|Ineligibility determined|2|||
161406657|NCT00321464|582876251|FG001|Overall Study|Ineligibility determined|1|||
161406658|NCT00321464|582876250|FG000|Overall Study|Other|21|||
161406659|NCT00321464|582876251|FG001|Overall Study|Other|18|||
161406660|NCT01673620|582876252|FG000|Overall Study|Adverse Event|1|||
161406661|NCT01673620|582876253|FG001|Overall Study|Adverse Event|0|||
161406662|NCT02522325|582876255|FG000|Overall Study|Adverse Event|0|||
161406663|NCT02522325|582876256|FG001|Overall Study|Adverse Event|1|||
161406664|NCT02100969|582876257|FG000|Overall Study|Did not pass screening phase|1|||
161406665|NCT01629953|582876258|FG000|Overall Study|Death|3|||
161406666|NCT01629953|582876259|FG001|Overall Study|Death|1|||
161406667|NCT01629953|582876258|FG000|Overall Study|Lost to Follow-up|10|||
161406668|NCT01629953|582876259|FG001|Overall Study|Lost to Follow-up|14|||
161406669|NCT00528801|582876262|FG000|Overall Study|Withdrawal by Subject|1|||
161406670|NCT00528801|582876263|FG001|Overall Study|Withdrawal by Subject|1|||
161406671|NCT00528801|582876262|FG000|Overall Study|Protocol Violation|11|||
161406672|NCT00528801|582876263|FG001|Overall Study|Protocol Violation|5|||
161406673|NCT00528801|582876262|FG000|Overall Study|Lost to Follow-up|15|||
161406674|NCT00528801|582876263|FG001|Overall Study|Lost to Follow-up|4|||
161406675|NCT00528801|582876262|FG000|Overall Study|Administrative Reasons|0|||
161406676|NCT00528801|582876263|FG001|Overall Study|Administrative Reasons|1|||
161406677|NCT02207491|582876264|FG000|Overall Study|Adverse Event|20|||
161406678|NCT02207491|582876265|FG001|Overall Study|Adverse Event|4|||
161406679|NCT02207491|582876264|FG000|Overall Study|Withdrawal by Subject|3|||
161406680|NCT02207491|582876265|FG001|Overall Study|Withdrawal by Subject|2|||
161406681|NCT02207491|582876264|FG000|Overall Study|Non-compliant|0|||
161406682|NCT02207491|582876265|FG001|Overall Study|Non-compliant|1|||
161406683|NCT02207491|582876264|FG000|Overall Study|Lost to Follow-up|0|||
161406684|NCT02207491|582876265|FG001|Overall Study|Lost to Follow-up|1|||
161406685|NCT02207491|582876264|FG000|Overall Study|Lack of Efficacy|3|||
161406686|NCT02207491|582876265|FG001|Overall Study|Lack of Efficacy|0|||
161406687|NCT02207491|582876264|FG000|Overall Study|Physician Decision|2|||
161406688|NCT02207491|582876265|FG001|Overall Study|Physician Decision|0|||
161406689|NCT02207491|582876264|FG000|Overall Study|Protocol Violation|3|||
161406690|NCT02207491|582876265|FG001|Overall Study|Protocol Violation|5|||
161406691|NCT00477152|582876268|FG000|Overall Study|Parent withdrew consent|2|||
161406692|NCT00477152|582876268|FG000|Overall Study|Adverse Event|1|||
161406693|NCT00372697|582876269|FG000|Overall Study|Protocol Violation|1|||
161406694|NCT00372697|582876270|FG001|Overall Study|Protocol Violation|1|||
161406695|NCT03221842|582876271|FG000|Period 1 (Open-label)|Adverse Event|4|||
161406696|NCT03221842|582876272|FG001|Period 1 (Open-label)|Adverse Event|0|||
161406697|NCT03221842|582876271|FG000|Period 1 (Open-label)|Physician Decision|2|||
161406698|NCT03221842|582876272|FG001|Period 1 (Open-label)|Physician Decision|0|||
161406699|NCT03221842|582876271|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
161406700|NCT03221842|582876272|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
161406701|NCT03221842|582876271|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
161406702|NCT03221842|582876272|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
161406703|NCT03221842|582876271|FG000|Period 1 (Open-label)|Other|2|||
161406704|NCT03221842|582876272|FG001|Period 1 (Open-label)|Other|0|||
161406705|NCT03221842|582876271|FG000|Period 2 (Randomized, Blinded)|Death|0|||
161406706|NCT03221842|582876272|FG001|Period 2 (Randomized, Blinded)|Death|1|||
161406707|NCT03221842|582876271|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
161406708|NCT03221842|582876272|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
161406709|NCT02504580|582876273|FG000|Overall Study|Other|1|||
161406710|NCT02504580|582876274|FG001|Overall Study|Other|0|||
161406711|NCT02504580|582876275|FG002|Overall Study|Other|0|||
161406712|NCT02504580|582876276|FG003|Overall Study|Other|2|||
161406713|NCT02504580|582876277|FG004|Overall Study|Other|1|||
161406714|NCT02504580|582876278|FG005|Overall Study|Other|1|||
161406715|NCT02504580|582876279|FG006|Overall Study|Other|1|||
161406716|NCT02504580|582876280|FG007|Overall Study|Other|2|||
161406717|NCT02504580|582876281|FG008|Overall Study|Other|0|||
161406718|NCT02504580|582876282|FG009|Overall Study|Other|0|||
161406719|NCT02504580|582876283|FG010|Overall Study|Other|0|||
161406720|NCT02504580|582876284|FG011|Overall Study|Other|2|||
161406721|NCT02504580|582876273|FG000|Overall Study|Subject refusal to continue|0|||
161406722|NCT02504580|582876274|FG001|Overall Study|Subject refusal to continue|1|||
161406723|NCT02504580|582876275|FG002|Overall Study|Subject refusal to continue|0|||
161406724|NCT02504580|582876276|FG003|Overall Study|Subject refusal to continue|0|||
161406725|NCT02504580|582876277|FG004|Overall Study|Subject refusal to continue|0|||
161406726|NCT02504580|582876278|FG005|Overall Study|Subject refusal to continue|0|||
161406727|NCT02504580|582876279|FG006|Overall Study|Subject refusal to continue|0|||
161406728|NCT02504580|582876280|FG007|Overall Study|Subject refusal to continue|0|||
161406729|NCT02504580|582876281|FG008|Overall Study|Subject refusal to continue|0|||
161406730|NCT02504580|582876282|FG009|Overall Study|Subject refusal to continue|0|||
161406731|NCT02504580|582876283|FG010|Overall Study|Subject refusal to continue|0|||
161406732|NCT02504580|582876284|FG011|Overall Study|Subject refusal to continue|0|||
161406733|NCT00231413|582876287|FG000|Overall Study|Non-serious AE|0|||
161406734|NCT00231413|582876288|FG001|Overall Study|Non-serious AE|0|||
161406735|NCT00231413|582876289|FG002|Overall Study|Non-serious AE|1|||
161406736|NCT00231413|582876290|FG003|Overall Study|Non-serious AE|0|||
161406737|NCT00231413|582876291|FG004|Overall Study|Non-serious AE|0|||
161406738|NCT00231413|582876292|FG005|Overall Study|Non-serious AE|0|||
161406739|NCT00231413|582876293|FG006|Overall Study|Non-serious AE|1|||
161406740|NCT00231413|582876287|FG000|Overall Study|Withdrawal by Subject|3|||
161406741|NCT00231413|582876288|FG001|Overall Study|Withdrawal by Subject|1|||
161406742|NCT00231413|582876289|FG002|Overall Study|Withdrawal by Subject|4|||
161406743|NCT00231413|582876290|FG003|Overall Study|Withdrawal by Subject|2|||
161406744|NCT00231413|582876291|FG004|Overall Study|Withdrawal by Subject|2|||
161406745|NCT00231413|582876292|FG005|Overall Study|Withdrawal by Subject|0|||
161406746|NCT00231413|582876293|FG006|Overall Study|Withdrawal by Subject|3|||
161406747|NCT00231413|582876287|FG000|Overall Study|Migrated/moved from study area|0|||
161406748|NCT00231413|582876288|FG001|Overall Study|Migrated/moved from study area|0|||
161406749|NCT00231413|582876289|FG002|Overall Study|Migrated/moved from study area|1|||
161406750|NCT00231413|582876290|FG003|Overall Study|Migrated/moved from study area|0|||
161406751|NCT00231413|582876291|FG004|Overall Study|Migrated/moved from study area|0|||
161406752|NCT00231413|582876292|FG005|Overall Study|Migrated/moved from study area|1|||
161406753|NCT00231413|582876293|FG006|Overall Study|Migrated/moved from study area|0|||
161406754|NCT00231413|582876287|FG000|Overall Study|Lost to Follow-up|4|||
161406755|NCT00231413|582876288|FG001|Overall Study|Lost to Follow-up|4|||
161406756|NCT00231413|582876289|FG002|Overall Study|Lost to Follow-up|1|||
161406757|NCT00231413|582876290|FG003|Overall Study|Lost to Follow-up|1|||
161406758|NCT00231413|582876291|FG004|Overall Study|Lost to Follow-up|1|||
161406759|NCT00231413|582876292|FG005|Overall Study|Lost to Follow-up|4|||
161406760|NCT00231413|582876293|FG006|Overall Study|Lost to Follow-up|0|||
161406761|NCT00231413|582876287|FG000|Overall Study|Pregnancy|1|||
161406762|NCT00231413|582876288|FG001|Overall Study|Pregnancy|0|||
161406763|NCT00231413|582876289|FG002|Overall Study|Pregnancy|0|||
161406764|NCT00231413|582876290|FG003|Overall Study|Pregnancy|0|||
161406765|NCT00231413|582876291|FG004|Overall Study|Pregnancy|0|||
161406766|NCT00231413|582876292|FG005|Overall Study|Pregnancy|0|||
161406767|NCT00231413|582876293|FG006|Overall Study|Pregnancy|0|||
161406768|NCT01353911|582876296|FG000|Overall Study|Lost to Follow-up|2|||
161406769|NCT01353911|582876297|FG001|Overall Study|Lost to Follow-up|6|||
161406770|NCT01353911|582876298|FG002|Overall Study|Lost to Follow-up|4|||
161406771|NCT01353911|582876299|FG003|Overall Study|Lost to Follow-up|0|||
161406772|NCT01353911|582876300|FG004|Overall Study|Lost to Follow-up|4|||
161406773|NCT01353911|582876301|FG005|Overall Study|Lost to Follow-up|4|||
161406774|NCT01353911|582876302|FG006|Overall Study|Lost to Follow-up|3|||
161406775|NCT01353911|582876303|FG007|Overall Study|Lost to Follow-up|6|||
161406776|NCT01353911|582876296|FG000|Overall Study|Withdrawal by Subject|2|||
161406777|NCT01353911|582876297|FG001|Overall Study|Withdrawal by Subject|3|||
161406778|NCT01353911|582876298|FG002|Overall Study|Withdrawal by Subject|4|||
161406779|NCT01353911|582876299|FG003|Overall Study|Withdrawal by Subject|2|||
161406780|NCT01353911|582876300|FG004|Overall Study|Withdrawal by Subject|2|||
161406781|NCT01353911|582876301|FG005|Overall Study|Withdrawal by Subject|3|||
161406782|NCT01353911|582876302|FG006|Overall Study|Withdrawal by Subject|3|||
161406783|NCT01353911|582876303|FG007|Overall Study|Withdrawal by Subject|9|||
161406784|NCT01353911|582876296|FG000|Overall Study|Status Not Recorded|4|||
161406785|NCT01353911|582876297|FG001|Overall Study|Status Not Recorded|0|||
161406786|NCT01353911|582876298|FG002|Overall Study|Status Not Recorded|1|||
161406787|NCT01353911|582876299|FG003|Overall Study|Status Not Recorded|0|||
161406788|NCT01353911|582876300|FG004|Overall Study|Status Not Recorded|0|||
161406789|NCT01353911|582876301|FG005|Overall Study|Status Not Recorded|0|||
161406790|NCT01353911|582876302|FG006|Overall Study|Status Not Recorded|0|||
161406791|NCT01353911|582876303|FG007|Overall Study|Status Not Recorded|0|||
161406792|NCT02049138|582876306|FG000|Overall Study|Adverse Event|46|||
161406793|NCT02049138|582876307|FG001|Overall Study|Adverse Event|25|||
161406794|NCT02049138|582876308|FG002|Overall Study|Adverse Event|1|||
161406795|NCT02049138|582876306|FG000|Overall Study|Withdrawal by Subject|57|||
161406796|NCT02049138|582876307|FG001|Overall Study|Withdrawal by Subject|21|||
161406797|NCT02049138|582876308|FG002|Overall Study|Withdrawal by Subject|5|||
161406798|NCT02049138|582876306|FG000|Overall Study|Lost to Follow-up|18|||
161406799|NCT02049138|582876307|FG001|Overall Study|Lost to Follow-up|5|||
161406800|NCT02049138|582876308|FG002|Overall Study|Lost to Follow-up|1|||
161406801|NCT02049138|582876306|FG000|Overall Study|Lack of Efficacy|10|||
161406802|NCT02049138|582876307|FG001|Overall Study|Lack of Efficacy|26|||
161406803|NCT02049138|582876308|FG002|Overall Study|Lack of Efficacy|1|||
161406804|NCT02049138|582876306|FG000|Overall Study|Non-Compliance|15|||
161406805|NCT02049138|582876307|FG001|Overall Study|Non-Compliance|6|||
161406806|NCT02049138|582876308|FG002|Overall Study|Non-Compliance|0|||
161406807|NCT02049138|582876306|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
161406808|NCT02049138|582876307|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
161406809|NCT02049138|582876308|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
161406810|NCT02049138|582876306|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
161406811|NCT02049138|582876307|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161406812|NCT02049138|582876308|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161406813|NCT02049138|582876306|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161406814|NCT02049138|582876307|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
161406815|NCT02049138|582876308|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
161406816|NCT02049138|582876306|FG000|Overall Study|Other|15|||
161406817|NCT02049138|582876307|FG001|Overall Study|Other|13|||
161406818|NCT02049138|582876308|FG002|Overall Study|Other|0|||
161406819|NCT02049138|582876306|FG000|Overall Study|Missing|0|||
161406820|NCT02049138|582876307|FG001|Overall Study|Missing|1|||
161406821|NCT02049138|582876308|FG002|Overall Study|Missing|0|||
161406822|NCT05086510|582876309|FG000|Overall Study|Lost to Follow-up|0|||
161406823|NCT05086510|582876310|FG001|Overall Study|Lost to Follow-up|2|||
161406824|NCT05086510|582876309|FG000|Overall Study|Death|0|||
161406825|NCT05086510|582876310|FG001|Overall Study|Death|2|||
161406826|NCT00587847|582876311|FG000|Overall Study|Lack of Efficacy|5|||
161406827|NCT00587847|582876311|FG000|Overall Study|Adverse Event|2|||
161406828|NCT00343382|582876312|FG000|Overall Study|Adverse Event|2|||
161406829|NCT00343382|582876313|FG001|Overall Study|Adverse Event|10|||
161406830|NCT00343382|582876314|FG002|Overall Study|Adverse Event|7|||
161406831|NCT00343382|582876312|FG000|Overall Study|Withdrawal by Subject|1|||
161406832|NCT00343382|582876313|FG001|Overall Study|Withdrawal by Subject|2|||
161406833|NCT00343382|582876314|FG002|Overall Study|Withdrawal by Subject|6|||
161406834|NCT00343382|582876312|FG000|Overall Study|Other Reason Not Specified|1|||
161406835|NCT00343382|582876313|FG001|Overall Study|Other Reason Not Specified|2|||
161406836|NCT00343382|582876314|FG002|Overall Study|Other Reason Not Specified|4|||
161406837|NCT02337725|582876319|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
161406838|NCT02337725|582876320|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
161406839|NCT02337725|582876319|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
161406840|NCT02337725|582876320|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
161406841|NCT02337725|582876319|FG000|Overall Study|Major Protocol Deviation|0|||
161406842|NCT02337725|582876320|FG001|Overall Study|Major Protocol Deviation|1|||
161406843|NCT02337725|582876319|FG000|Overall Study|Voluntary Withdrawal|14|||
161406844|NCT02337725|582876320|FG001|Overall Study|Voluntary Withdrawal|3|||
161406845|NCT02337725|582876319|FG000|Overall Study|Lack of Efficacy|4|||
161406846|NCT02337725|582876320|FG001|Overall Study|Lack of Efficacy|0|||
161406847|NCT01571453|582876321|FG000|Overall Study|Adverse Event|14|||
161406848|NCT01571453|582876322|FG001|Overall Study|Adverse Event|32|||
161406849|NCT01571453|582876321|FG000|Overall Study|Lack of Efficacy|8|||
161406850|NCT01571453|582876322|FG001|Overall Study|Lack of Efficacy|3|||
161406851|NCT01571453|582876321|FG000|Overall Study|Non-compliance|2|||
161406852|NCT01571453|582876322|FG001|Overall Study|Non-compliance|4|||
161406853|NCT01571453|582876321|FG000|Overall Study|Protocol Violation|1|||
161406854|NCT01571453|582876322|FG001|Overall Study|Protocol Violation|5|||
161406855|NCT01571453|582876321|FG000|Overall Study|Withdrawal of consent|5|||
161406856|NCT01571453|582876322|FG001|Overall Study|Withdrawal of consent|13|||
161406857|NCT01571453|582876321|FG000|Overall Study|Lost to Follow-up|4|||
161406858|NCT01571453|582876322|FG001|Overall Study|Lost to Follow-up|2|||
161406859|NCT01571453|582876321|FG000|Overall Study|Administrative or other reason(s)|4|||
161406860|NCT01571453|582876322|FG001|Overall Study|Administrative or other reason(s)|3|||
161406861|NCT00500760|582876323|FG000|Overall Study|Death|32|||
161406862|NCT00500760|582876324|FG001|Overall Study|Death|15|||
161406863|NCT00500760|582876323|FG000|Overall Study|Withdrawal by Subject|5|||
161406864|NCT00500760|582876324|FG001|Overall Study|Withdrawal by Subject|7|||
161406865|NCT00500760|582876323|FG000|Overall Study|Administrative decision|2|||
161406866|NCT00500760|582876324|FG001|Overall Study|Administrative decision|0|||
161406867|NCT00500760|582876323|FG000|Overall Study|Lost to Follow-up|3|||
161406868|NCT00500760|582876324|FG001|Overall Study|Lost to Follow-up|0|||
161406869|NCT00500760|582876323|FG000|Overall Study|Other|1|||
161406870|NCT00500760|582876324|FG001|Overall Study|Other|2|||
161406871|NCT00129961|582876325|FG000|Overall Study|Adverse Event|1|||
161406872|NCT00129961|582876326|FG001|Overall Study|Adverse Event|0|||
161406873|NCT00129961|582876325|FG000|Overall Study|Death|1|||
161406874|NCT00129961|582876326|FG001|Overall Study|Death|1|||
161406875|NCT00129961|582876325|FG000|Overall Study|Withdrawal by Sponsor|14|||
161406876|NCT00129961|582876326|FG001|Overall Study|Withdrawal by Sponsor|20|||
161406877|NCT00129961|582876325|FG000|Overall Study|Physician Decision|1|||
161406878|NCT00129961|582876326|FG001|Overall Study|Physician Decision|0|||
161406879|NCT00129961|582876325|FG000|Overall Study|Withdrawal by Subject|2|||
161406880|NCT00129961|582876326|FG001|Overall Study|Withdrawal by Subject|1|||
161406881|NCT00129961|582876325|FG000|Overall Study|Missing Record|0|||
161406882|NCT00129961|582876326|FG001|Overall Study|Missing Record|1|||
161406883|NCT01264770|582876327|FG000|Overall Study|Not reported|0|||
161406884|NCT01264770|582876328|FG001|Overall Study|Not reported|0|||
161406885|NCT01264770|582876329|FG002|Overall Study|Not reported|1|||
161406886|NCT01264770|582876330|FG003|Overall Study|Not reported|0|||
161406887|NCT01264770|582876331|FG004|Overall Study|Not reported|0|||
161406888|NCT01264770|582876332|FG005|Overall Study|Not reported|0|||
161406889|NCT01264770|582876327|FG000|Overall Study|e.g., change in circumstances|8|||
161406890|NCT01264770|582876328|FG001|Overall Study|e.g., change in circumstances|3|||
161406891|NCT01264770|582876329|FG002|Overall Study|e.g., change in circumstances|3|||
161406892|NCT01264770|582876330|FG003|Overall Study|e.g., change in circumstances|3|||
161406893|NCT01264770|582876331|FG004|Overall Study|e.g., change in circumstances|4|||
161406894|NCT01264770|582876332|FG005|Overall Study|e.g., change in circumstances|4|||
161406895|NCT01264770|582876327|FG000|Overall Study|Severe non-compliance to protocol|0|||
161406896|NCT01264770|582876328|FG001|Overall Study|Severe non-compliance to protocol|0|||
161406897|NCT01264770|582876329|FG002|Overall Study|Severe non-compliance to protocol|1|||
161406898|NCT01264770|582876330|FG003|Overall Study|Severe non-compliance to protocol|1|||
161406899|NCT01264770|582876331|FG004|Overall Study|Severe non-compliance to protocol|0|||
161406900|NCT01264770|582876332|FG005|Overall Study|Severe non-compliance to protocol|0|||
161406901|NCT01264770|582876327|FG000|Overall Study|Lack of therapeutic response|1|||
161406902|NCT01264770|582876328|FG001|Overall Study|Lack of therapeutic response|0|||
161406903|NCT01264770|582876329|FG002|Overall Study|Lack of therapeutic response|2|||
161406904|NCT01264770|582876330|FG003|Overall Study|Lack of therapeutic response|1|||
161406905|NCT01264770|582876331|FG004|Overall Study|Lack of therapeutic response|1|||
161406906|NCT01264770|582876332|FG005|Overall Study|Lack of therapeutic response|0|||
161406907|NCT01264770|582876327|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
161406908|NCT01264770|582876328|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
161406909|NCT01264770|582876329|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
161406910|NCT01264770|582876330|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
161406911|NCT01264770|582876331|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
161406912|NCT01264770|582876332|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
161406913|NCT01264770|582876327|FG000|Overall Study|Lost to Follow-up|0|||
161406914|NCT01264770|582876328|FG001|Overall Study|Lost to Follow-up|0|||
161406915|NCT01264770|582876329|FG002|Overall Study|Lost to Follow-up|1|||
161406916|NCT01264770|582876330|FG003|Overall Study|Lost to Follow-up|1|||
161406917|NCT01264770|582876331|FG004|Overall Study|Lost to Follow-up|0|||
161406918|NCT01264770|582876332|FG005|Overall Study|Lost to Follow-up|0|||
161406919|NCT01264770|582876327|FG000|Overall Study|Adverse Event|7|||
161406920|NCT01264770|582876328|FG001|Overall Study|Adverse Event|7|||
161406921|NCT01264770|582876329|FG002|Overall Study|Adverse Event|8|||
161406922|NCT01264770|582876330|FG003|Overall Study|Adverse Event|0|||
161406923|NCT01264770|582876331|FG004|Overall Study|Adverse Event|2|||
161406924|NCT01264770|582876332|FG005|Overall Study|Adverse Event|1|||
161406925|NCT00084487|582876333|FG000|Overall Study|Death|1|||
161406926|NCT03691779|582876336|FG000|Part B (24 Weeks)|Adverse Event|0|||
161406927|NCT03691779|582876337|FG001|Part B (24 Weeks)|Adverse Event|1|||
161406928|NCT03691779|582876336|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
161406929|NCT03691779|582876337|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
161406930|NCT04881747|582876338|FG000|Period 2 Washout|Adverse Event|1|||
161406931|NCT04881747|582876339|FG001|Period 2 Washout|Adverse Event|0|||
161406932|NCT04881747|582876340|FG002|Period 2 Washout|Adverse Event|0|||
161406933|NCT04881747|582876341|FG003|Period 2 Washout|Adverse Event|0|||
161406934|NCT04881747|582876342|FG004|Period 2 Washout|Adverse Event|1|||
161406935|NCT04881747|582876343|FG005|Period 2 Washout|Adverse Event|0|||
161406936|NCT04881747|582876338|FG000|Period 2 Washout|Withdrawal by Subject|1|||
161406937|NCT04881747|582876339|FG001|Period 2 Washout|Withdrawal by Subject|0|||
161406938|NCT04881747|582876340|FG002|Period 2 Washout|Withdrawal by Subject|0|||
161406939|NCT04881747|582876341|FG003|Period 2 Washout|Withdrawal by Subject|1|||
161406940|NCT04881747|582876342|FG004|Period 2 Washout|Withdrawal by Subject|0|||
161406941|NCT04881747|582876343|FG005|Period 2 Washout|Withdrawal by Subject|0|||
161406942|NCT01927055|582876348|FG000|Open-label|Adverse Event|6|||
161406943|NCT01927055|582876349|FG001|Open-label|Adverse Event|0|||
161406944|NCT01927055|582876350|FG002|Open-label|Adverse Event|0|||
161406945|NCT01927055|582876348|FG000|Open-label|Withdrawal by Subject|1|||
161406946|NCT01927055|582876349|FG001|Open-label|Withdrawal by Subject|0|||
161406947|NCT01927055|582876350|FG002|Open-label|Withdrawal by Subject|0|||
161406948|NCT01927055|582876348|FG000|Open-label|Study Stopped|4|||
161406949|NCT01927055|582876349|FG001|Open-label|Study Stopped|0|||
161406950|NCT01927055|582876350|FG002|Open-label|Study Stopped|0|||
161406951|NCT01927055|582876348|FG000|Open-label|Supine Hypertension|4|||
161406952|NCT01927055|582876349|FG001|Open-label|Supine Hypertension|0|||
161406953|NCT01927055|582876350|FG002|Open-label|Supine Hypertension|0|||
161406954|NCT01927055|582876348|FG000|Open-label|Difficulty attending study visits|1|||
161406955|NCT01927055|582876349|FG001|Open-label|Difficulty attending study visits|0|||
161406956|NCT01927055|582876350|FG002|Open-label|Difficulty attending study visits|0|||
161406957|NCT01927055|582876348|FG000|Double-Blind|Adverse Event|0|||
161406958|NCT01927055|582876349|FG001|Double-Blind|Adverse Event|1|||
161406959|NCT01927055|582876350|FG002|Double-Blind|Adverse Event|1|||
161406960|NCT01927055|582876348|FG000|Double-Blind|Protocol Violation|0|||
161406961|NCT01927055|582876349|FG001|Double-Blind|Protocol Violation|0|||
161406962|NCT01927055|582876350|FG002|Double-Blind|Protocol Violation|1|||
161406963|NCT01927055|582876348|FG000|Double-Blind|Withdrawal by Subject|0|||
161406964|NCT01927055|582876349|FG001|Double-Blind|Withdrawal by Subject|2|||
161406965|NCT01927055|582876350|FG002|Double-Blind|Withdrawal by Subject|3|||
161406966|NCT01927055|582876348|FG000|Double-Blind|Study Stopped|0|||
161406967|NCT01927055|582876349|FG001|Double-Blind|Study Stopped|7|||
161406968|NCT01927055|582876350|FG002|Double-Blind|Study Stopped|7|||
161406969|NCT01927055|582876348|FG000|Double-Blind|Supine Hypertension|0|||
161406970|NCT01927055|582876349|FG001|Double-Blind|Supine Hypertension|0|||
161406971|NCT01927055|582876350|FG002|Double-Blind|Supine Hypertension|1|||
161406972|NCT01927055|582876348|FG000|Double-Blind|Extended Vacation|0|||
161406973|NCT01927055|582876349|FG001|Double-Blind|Extended Vacation|1|||
161406974|NCT01927055|582876350|FG002|Double-Blind|Extended Vacation|0|||
161406975|NCT02598128|582876351|FG000|Period A: Days -7 to -1|Adverse Event|1|||
161406976|NCT02598128|582876352|FG001|Period A: Days -7 to -1|Adverse Event|0|||
161406977|NCT02598128|582876353|FG002|Period A: Days -7 to -1|Adverse Event|0|||
161406978|NCT02598128|582876354|FG003|Period A: Days -7 to -1|Adverse Event|0|||
161406979|NCT01378429|582876355|FG000|Overall Study|Noncompliance with study drug|1|||
161406980|NCT01378429|582876356|FG001|Overall Study|Noncompliance with study drug|0|||
161406981|NCT01064687|582876358|FG000|Overall Study|Adverse Event|9|||
161406982|NCT01064687|582876359|FG001|Overall Study|Adverse Event|4|||
161406983|NCT01064687|582876360|FG002|Overall Study|Adverse Event|10|||
161406984|NCT01064687|582876361|FG003|Overall Study|Adverse Event|3|||
161406985|NCT01064687|582876358|FG000|Overall Study|Death|1|||
161406986|NCT01064687|582876359|FG001|Overall Study|Death|1|||
161406987|NCT01064687|582876360|FG002|Overall Study|Death|0|||
161406988|NCT01064687|582876361|FG003|Overall Study|Death|0|||
161406989|NCT01064687|582876358|FG000|Overall Study|Entry Criteria Not Met|3|||
161406990|NCT01064687|582876359|FG001|Overall Study|Entry Criteria Not Met|0|||
161406991|NCT01064687|582876360|FG002|Overall Study|Entry Criteria Not Met|0|||
161406992|NCT01064687|582876361|FG003|Overall Study|Entry Criteria Not Met|0|||
161406993|NCT01064687|582876358|FG000|Overall Study|Lack of Efficacy|1|||
161406994|NCT01064687|582876359|FG001|Overall Study|Lack of Efficacy|0|||
161406995|NCT01064687|582876360|FG002|Overall Study|Lack of Efficacy|2|||
161406996|NCT01064687|582876361|FG003|Overall Study|Lack of Efficacy|3|||
161406997|NCT01064687|582876358|FG000|Overall Study|Lost to Follow-up|7|||
161406998|NCT01064687|582876359|FG001|Overall Study|Lost to Follow-up|10|||
161406999|NCT01064687|582876360|FG002|Overall Study|Lost to Follow-up|13|||
161407000|NCT01064687|582876361|FG003|Overall Study|Lost to Follow-up|5|||
161407001|NCT01064687|582876358|FG000|Overall Study|Physician Decision|2|||
161407002|NCT01064687|582876359|FG001|Overall Study|Physician Decision|2|||
161407003|NCT01064687|582876360|FG002|Overall Study|Physician Decision|0|||
161407004|NCT01064687|582876361|FG003|Overall Study|Physician Decision|0|||
161407005|NCT01064687|582876358|FG000|Overall Study|Protocol Violation|1|||
161407006|NCT01064687|582876359|FG001|Overall Study|Protocol Violation|1|||
161407007|NCT01064687|582876360|FG002|Overall Study|Protocol Violation|0|||
161407008|NCT01064687|582876361|FG003|Overall Study|Protocol Violation|1|||
161407009|NCT01064687|582876358|FG000|Overall Study|Sponsor Decision|0|||
161407010|NCT01064687|582876359|FG001|Overall Study|Sponsor Decision|0|||
161407011|NCT01064687|582876360|FG002|Overall Study|Sponsor Decision|3|||
161407012|NCT01064687|582876361|FG003|Overall Study|Sponsor Decision|0|||
161407013|NCT01064687|582876358|FG000|Overall Study|Withdrawal by Subject|9|||
161407014|NCT01064687|582876359|FG001|Overall Study|Withdrawal by Subject|7|||
161407015|NCT01064687|582876360|FG002|Overall Study|Withdrawal by Subject|12|||
161407016|NCT01064687|582876361|FG003|Overall Study|Withdrawal by Subject|5|||
161407017|NCT01064687|582876358|FG000|Overall Study|Treatment Noncompliance|1|||
161407018|NCT01064687|582876359|FG001|Overall Study|Treatment Noncompliance|1|||
161407019|NCT01064687|582876360|FG002|Overall Study|Treatment Noncompliance|1|||
161407020|NCT01064687|582876361|FG003|Overall Study|Treatment Noncompliance|0|||
161407021|NCT00619489|582876362|FG000|Overall Study|Adverse Event|0|||
161407022|NCT00619489|582876363|FG001|Overall Study|Adverse Event|7|||
161407023|NCT00619489|582876362|FG000|Overall Study|Withdrawal by Subject|1|||
161407024|NCT00619489|582876363|FG001|Overall Study|Withdrawal by Subject|1|||
161407025|NCT00619489|582876362|FG000|Overall Study|Lack of Efficacy|0|||
161407026|NCT00619489|582876363|FG001|Overall Study|Lack of Efficacy|11|||
161407027|NCT00619489|582876362|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
161407028|NCT00619489|582876363|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
161407029|NCT05219669|582876368|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
161407030|NCT05219669|582876369|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
161407031|NCT05219669|582876370|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
161407032|NCT05219669|582876371|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
161407033|NCT05219669|582876372|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
161407034|NCT05219669|582876373|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
161407035|NCT03134183|582876375|FG000|Overall Study|Withdrawal by Subject|1|||
161407036|NCT03134183|582876376|FG001|Overall Study|Withdrawal by Subject|1|||
161407037|NCT02404649|582876380|FG000|Overall Study|Adverse Event|1|||
161407038|NCT02404649|582876381|FG001|Overall Study|Adverse Event|2|||
161407039|NCT00162266|582876385|FG000|Double-Blind Period|Adverse Event|5|||
161407040|NCT00162266|582876386|FG001|Double-Blind Period|Adverse Event|9|||
161407041|NCT00162266|582876387|FG002|Double-Blind Period|Adverse Event|11|||
161407042|NCT00162266|582876388|FG003|Double-Blind Period|Adverse Event|0|||
161407043|NCT00162266|582876385|FG000|Double-Blind Period|Death|0|||
161407044|NCT00162266|582876386|FG001|Double-Blind Period|Death|1|||
161407045|NCT00162266|582876387|FG002|Double-Blind Period|Death|0|||
161407046|NCT00162266|582876388|FG003|Double-Blind Period|Death|0|||
161407047|NCT00162266|582876385|FG000|Double-Blind Period|Lost to Follow-up|1|||
161407048|NCT00162266|582876386|FG001|Double-Blind Period|Lost to Follow-up|2|||
161407049|NCT00162266|582876387|FG002|Double-Blind Period|Lost to Follow-up|0|||
161407050|NCT00162266|582876388|FG003|Double-Blind Period|Lost to Follow-up|0|||
161407051|NCT00162266|582876385|FG000|Double-Blind Period|Other Reason|1|||
161407052|NCT00162266|582876386|FG001|Double-Blind Period|Other Reason|0|||
161407053|NCT00162266|582876387|FG002|Double-Blind Period|Other Reason|1|||
161407054|NCT00162266|582876388|FG003|Double-Blind Period|Other Reason|0|||
161407055|NCT00162266|582876385|FG000|Double-Blind Period|Lack of Efficacy|13|||
161407056|NCT00162266|582876386|FG001|Double-Blind Period|Lack of Efficacy|17|||
161407057|NCT00162266|582876387|FG002|Double-Blind Period|Lack of Efficacy|30|||
161407058|NCT00162266|582876388|FG003|Double-Blind Period|Lack of Efficacy|0|||
161407059|NCT00162266|582876385|FG000|Double-Blind Period|Withdrawal by Subject|5|||
161407060|NCT00162266|582876386|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161407061|NCT00162266|582876387|FG002|Double-Blind Period|Withdrawal by Subject|6|||
161407062|NCT00162266|582876388|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161407063|NCT00162266|582876385|FG000|Open-Label Period|Death|0|||
161407064|NCT00162266|582876386|FG001|Open-Label Period|Death|0|||
161407065|NCT00162266|582876387|FG002|Open-Label Period|Death|0|||
161407066|NCT00162266|582876388|FG003|Open-Label Period|Death|7|||
161407067|NCT00162266|582876385|FG000|Open-Label Period|Adverse Event|0|||
161407068|NCT00162266|582876386|FG001|Open-Label Period|Adverse Event|0|||
161407069|NCT00162266|582876387|FG002|Open-Label Period|Adverse Event|0|||
161407070|NCT00162266|582876388|FG003|Open-Label Period|Adverse Event|46|||
161407071|NCT00162266|582876385|FG000|Open-Label Period|Lack of Efficacy|0|||
161407072|NCT00162266|582876386|FG001|Open-Label Period|Lack of Efficacy|0|||
161407073|NCT00162266|582876387|FG002|Open-Label Period|Lack of Efficacy|0|||
161407074|NCT00162266|582876388|FG003|Open-Label Period|Lack of Efficacy|26|||
161407075|NCT00162266|582876385|FG000|Open-Label Period|Lost to Follow-up|0|||
161407076|NCT00162266|582876386|FG001|Open-Label Period|Lost to Follow-up|0|||
161407077|NCT00162266|582876387|FG002|Open-Label Period|Lost to Follow-up|0|||
161407078|NCT00162266|582876388|FG003|Open-Label Period|Lost to Follow-up|3|||
161407079|NCT00162266|582876385|FG000|Open-Label Period|Withdrawal by Subject|0|||
161407080|NCT00162266|582876386|FG001|Open-Label Period|Withdrawal by Subject|0|||
161407081|NCT00162266|582876387|FG002|Open-Label Period|Withdrawal by Subject|0|||
161407082|NCT00162266|582876388|FG003|Open-Label Period|Withdrawal by Subject|31|||
161407083|NCT00162266|582876385|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
161407084|NCT00162266|582876386|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
161407085|NCT00162266|582876387|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
161407086|NCT00162266|582876388|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
161407087|NCT00162266|582876385|FG000|Open-Label Period|Other Reasons|0|||
161407088|NCT00162266|582876386|FG001|Open-Label Period|Other Reasons|0|||
161407089|NCT00162266|582876387|FG002|Open-Label Period|Other Reasons|0|||
161407090|NCT00162266|582876388|FG003|Open-Label Period|Other Reasons|15|||
161407091|NCT02299076|582876389|FG000|Overall Study|Fraudulent Entries|20|||
161407092|NCT02299076|582876390|FG001|Overall Study|Fraudulent Entries|14|||
161407093|NCT00330668|582876391|FG000|BID Dosing Period|Adverse Event|1|||
161407094|NCT00330668|582876391|FG000|BID Dosing Period|Lost to Follow-up|7|||
161407095|NCT00330668|582876391|FG000|BID Dosing Period|Non-Compliance|5|||
161407096|NCT00330668|582876391|FG000|BID Dosing Period|Withdrawal by Subject|19|||
161407097|NCT00330668|582876391|FG000|BID Dosing Period|Sponsor's decision|1|||
161407098|NCT00330668|582876391|FG000|BID Dosing Period|Other|3|||
161407099|NCT00330668|582876391|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
161407100|NCT00330668|582876391|FG000|QD Dosing Period|Other|1|||
161407101|NCT00330668|582876391|FG000|QD Dosing Period|Withdrawal by Subject|1|||
161407102|NCT00330668|582876391|FG000|QD Dosing Period|Lost to Follow-up|2|||
161407103|NCT00499746|582876397|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
161407104|NCT00499746|582876397|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
161407105|NCT00499746|582876397|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
161407106|NCT00499746|582876397|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
161407107|NCT01012323|582876398|FG000|Overall Study|Investigator Judgment|1|||
161407108|NCT04311463|582876399|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
161407109|NCT04311463|582876400|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
161407110|NCT04311463|582876399|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
161407111|NCT04311463|582876400|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
161407112|NCT04311463|582876399|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
161407113|NCT04311463|582876400|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
161407114|NCT00737633|582876407|FG000|Overall Study|Study terminated by sponsor|44|||
161407115|NCT00737633|582876408|FG001|Overall Study|Study terminated by sponsor|55|||
161407116|NCT00737633|582876407|FG000|Overall Study|Lost to Follow-up|0|||
161407117|NCT00737633|582876408|FG001|Overall Study|Lost to Follow-up|1|||
161407118|NCT00737633|582876407|FG000|Overall Study|protocol non-compliance|0|||
161407119|NCT00737633|582876408|FG001|Overall Study|protocol non-compliance|1|||
161407120|NCT01105377|582876412|FG000|Overall Study|Withdrawal by Subject|0|||
161407121|NCT01105377|582876413|FG001|Overall Study|Withdrawal by Subject|1|||
161407122|NCT01638559|582876414|FG000|Overall Study|Lost to Follow-up|1|||
161407123|NCT01638559|582876414|FG000|Overall Study|Withdrawal by Subject|1|||
161407124|NCT01638559|582876414|FG000|Overall Study|Subject declined to travel for biopsy|1|||
161407125|NCT00483002|582876415|FG000|Overall Study|Adverse Event|68|||
161407126|NCT00483002|582876415|FG000|Overall Study|Lack of Efficacy|555|||
161407127|NCT00483002|582876415|FG000|Overall Study|Lost to Follow-up|962|||
161407128|NCT00483002|582876415|FG000|Overall Study|Other|2|||
161407129|NCT00483002|582876415|FG000|Overall Study|Other|967|||
161407130|NCT02651220|582876419|FG000|Overall Study|Adverse Event|1|||
161407131|NCT02651220|582876420|FG001|Overall Study|Adverse Event|5|||
161407132|NCT02651220|582876421|FG002|Overall Study|Adverse Event|1|||
161407133|NCT02651220|582876419|FG000|Overall Study|Lost to Follow-up|8|||
161407134|NCT02651220|582876420|FG001|Overall Study|Lost to Follow-up|14|||
161407135|NCT02651220|582876421|FG002|Overall Study|Lost to Follow-up|14|||
161407136|NCT02651220|582876419|FG000|Overall Study|Non-Compliance with Study Drug|4|||
161407137|NCT02651220|582876420|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161407138|NCT02651220|582876421|FG002|Overall Study|Non-Compliance with Study Drug|1|||
161407139|NCT02651220|582876419|FG000|Overall Study|Pregnancy|1|||
161407140|NCT02651220|582876420|FG001|Overall Study|Pregnancy|0|||
161407141|NCT02651220|582876421|FG002|Overall Study|Pregnancy|1|||
161407142|NCT02651220|582876419|FG000|Overall Study|Protocol Violation|0|||
161407143|NCT02651220|582876420|FG001|Overall Study|Protocol Violation|0|||
161407144|NCT02651220|582876421|FG002|Overall Study|Protocol Violation|1|||
161407145|NCT02651220|582876419|FG000|Overall Study|Withdrawal by Subject|5|||
161407146|NCT02651220|582876420|FG001|Overall Study|Withdrawal by Subject|6|||
161407147|NCT02651220|582876421|FG002|Overall Study|Withdrawal by Subject|8|||
161407148|NCT02651220|582876419|FG000|Overall Study|Miscellaneous|4|||
161407149|NCT02651220|582876420|FG001|Overall Study|Miscellaneous|1|||
161407150|NCT02651220|582876421|FG002|Overall Study|Miscellaneous|2|||
161407151|NCT02651220|582876419|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161407152|NCT02651220|582876420|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161407153|NCT02651220|582876421|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
161407154|NCT01274429|582876423|FG000|Overall Study|Study closed do to lack of funding|5|||
161407155|NCT01439373|582876424|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
161407156|NCT01439373|582876425|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
161407157|NCT01439373|582876424|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
161407158|NCT01439373|582876425|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
161407159|NCT04576897|582876428|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
161407160|NCT02593318|582876431|FG000|Overall Study|Withdrawal by Subject|1|||
161407161|NCT02593318|582876432|FG001|Overall Study|Withdrawal by Subject|1|||
161407162|NCT00448747|582878173|FG000|Overall Study|collapsed veins|1|||
161407163|NCT00448747|582878174|FG001|Overall Study|collapsed veins|0|||
161407164|NCT00387725|582878175|FG000|Overall Study|Adverse Event|0|||
161407165|NCT00387725|582878176|FG001|Overall Study|Adverse Event|0|||
161407166|NCT00387725|582878177|FG002|Overall Study|Adverse Event|0|||
161407167|NCT00387725|582878178|FG003|Overall Study|Adverse Event|1|||
161407168|NCT00387725|582878175|FG000|Overall Study|Protocol Violation|0|||
161407169|NCT00387725|582878176|FG001|Overall Study|Protocol Violation|1|||
161407170|NCT00387725|582878177|FG002|Overall Study|Protocol Violation|0|||
161407171|NCT00387725|582878178|FG003|Overall Study|Protocol Violation|0|||
161407172|NCT00387725|582878175|FG000|Overall Study|Withdrawal by Subject|1|||
161407173|NCT00387725|582878176|FG001|Overall Study|Withdrawal by Subject|0|||
161407174|NCT00387725|582878177|FG002|Overall Study|Withdrawal by Subject|1|||
161407175|NCT00387725|582878178|FG003|Overall Study|Withdrawal by Subject|0|||
161407176|NCT00387725|582878175|FG000|Overall Study|Parent/legal guardian request|0|||
161407177|NCT00387725|582878176|FG001|Overall Study|Parent/legal guardian request|0|||
161407178|NCT00387725|582878177|FG002|Overall Study|Parent/legal guardian request|1|||
161407179|NCT00387725|582878178|FG003|Overall Study|Parent/legal guardian request|1|||
161407180|NCT00568126|582878179|FG000|Overall Study|Adverse Event|3|||
161407181|NCT00568126|582878180|FG001|Overall Study|Adverse Event|0|||
161407182|NCT00568126|582878179|FG000|Overall Study|Withdrawal by Subject|2|||
161407183|NCT00568126|582878180|FG001|Overall Study|Withdrawal by Subject|3|||
161407184|NCT00568126|582878179|FG000|Overall Study|Lost to Follow-up|4|||
161407185|NCT00568126|582878180|FG001|Overall Study|Lost to Follow-up|3|||
161407186|NCT00568126|582878179|FG000|Overall Study|Lack of Efficacy|0|||
161407187|NCT00568126|582878180|FG001|Overall Study|Lack of Efficacy|1|||
161407188|NCT00568126|582878179|FG000|Overall Study|Physician Decision|2|||
161407189|NCT00568126|582878180|FG001|Overall Study|Physician Decision|2|||
161407190|NCT00527982|582878182|FG000|Overall Study|Physician Decision|1|||
161407191|NCT00527982|582878183|FG001|Overall Study|Physician Decision|0|||
161407192|NCT02429791|582878189|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
161407193|NCT02429791|582878190|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
161407194|NCT02429791|582878189|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
161407195|NCT02429791|582878190|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
161407196|NCT02429791|582878189|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
161407197|NCT02429791|582878190|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
161407198|NCT02429791|582878189|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161407199|NCT02429791|582878190|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
161407200|NCT02429791|582878189|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
161407201|NCT02429791|582878190|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
161407202|NCT02429791|582878189|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
161407203|NCT02429791|582878190|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
161407204|NCT02429791|582878189|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
161407205|NCT02429791|582878190|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
161407206|NCT02429791|582878189|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
161407207|NCT02429791|582878190|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
161407208|NCT02429791|582878189|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
161407209|NCT02429791|582878190|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
161407210|NCT02429791|582878189|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
161407211|NCT02429791|582878190|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
161407212|NCT02429791|582878189|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161407213|NCT02429791|582878190|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161407214|NCT02429791|582878189|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
161407215|NCT02429791|582878190|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
161407216|NCT02429791|582878189|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
161407217|NCT02429791|582878190|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
161407218|NCT02429791|582878189|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
161407219|NCT02429791|582878190|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
161407220|NCT02429791|582878189|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
161407221|NCT02429791|582878190|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
161407222|NCT02429791|582878189|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
161407223|NCT02429791|582878190|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
161407224|NCT02429791|582878189|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
161407225|NCT02429791|582878190|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
161407226|NCT02429791|582878189|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
161407227|NCT02429791|582878190|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
161407228|NCT02615691|582878191|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
161407229|NCT02615691|582878191|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
161407230|NCT02615691|582878191|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
161407231|NCT02615691|582878191|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
161407232|NCT04201093|582878192|FG000|Overall Study|Adverse Event|6|||
161407233|NCT04201093|582878193|FG001|Overall Study|Adverse Event|29|||
161407234|NCT04201093|582878194|FG002|Overall Study|Adverse Event|35|||
161407235|NCT04201093|582878192|FG000|Overall Study|Death|2|||
161407236|NCT04201093|582878193|FG001|Overall Study|Death|1|||
161407237|NCT04201093|582878194|FG002|Overall Study|Death|0|||
161407238|NCT04201093|582878192|FG000|Overall Study|Lack of Efficacy|5|||
161407239|NCT04201093|582878193|FG001|Overall Study|Lack of Efficacy|1|||
161407240|NCT04201093|582878194|FG002|Overall Study|Lack of Efficacy|2|||
161407241|NCT04201093|582878192|FG000|Overall Study|Lost to Follow-up|0|||
161407242|NCT04201093|582878193|FG001|Overall Study|Lost to Follow-up|0|||
161407243|NCT04201093|582878194|FG002|Overall Study|Lost to Follow-up|1|||
161407244|NCT04201093|582878192|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161407245|NCT04201093|582878193|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161407246|NCT04201093|582878194|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
161407247|NCT04201093|582878192|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161407248|NCT04201093|582878193|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161407249|NCT04201093|582878194|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
161407250|NCT04201093|582878192|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
161407251|NCT04201093|582878193|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
161407252|NCT04201093|582878194|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
161407253|NCT04201093|582878192|FG000|Overall Study|Physician Decision|1|||
161407254|NCT04201093|582878193|FG001|Overall Study|Physician Decision|0|||
161407255|NCT04201093|582878194|FG002|Overall Study|Physician Decision|0|||
161407256|NCT04201093|582878192|FG000|Overall Study|Protocol Deviation|1|||
161407257|NCT04201093|582878193|FG001|Overall Study|Protocol Deviation|0|||
161407258|NCT04201093|582878194|FG002|Overall Study|Protocol Deviation|0|||
161407259|NCT04201093|582878192|FG000|Overall Study|Site Terminated by Sponsor|5|||
161407260|NCT04201093|582878193|FG001|Overall Study|Site Terminated by Sponsor|3|||
161407261|NCT04201093|582878194|FG002|Overall Study|Site Terminated by Sponsor|1|||
161407262|NCT04201093|582878192|FG000|Overall Study|Withdrawal by Subject|7|||
161407263|NCT04201093|582878193|FG001|Overall Study|Withdrawal by Subject|8|||
161407264|NCT04201093|582878194|FG002|Overall Study|Withdrawal by Subject|15|||
161407265|NCT04201093|582878192|FG000|Overall Study|Other|0|||
161407266|NCT04201093|582878193|FG001|Overall Study|Other|1|||
161407267|NCT04201093|582878194|FG002|Overall Study|Other|2|||
161407268|NCT00007020|582878195|FG000|Overall Study|Death|16|||
161407269|NCT00007020|582878195|FG000|Overall Study|Lost to Follow-up|13|||
161407270|NCT00007020|582878195|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
161407271|NCT00007020|582878195|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
161407272|NCT00007020|582878195|FG000|Overall Study|Pt cared for by outside physician|4|||
161407273|NCT00007020|582878195|FG000|Overall Study|No evidence of treatment|6|||
161407274|NCT00881504|582878196|FG000|Overall Study|Withdrawal by Subject|1|||
161407275|NCT01276223|582878197|FG000|Overall Study|Adverse Event|7|||
161407276|NCT01276223|582878198|FG001|Overall Study|Adverse Event|4|||
161407277|NCT01276223|582878199|FG002|Overall Study|Adverse Event|1|||
161407278|NCT01276223|582878197|FG000|Overall Study|Lost to Follow-up|0|||
161407279|NCT01276223|582878198|FG001|Overall Study|Lost to Follow-up|0|||
161407280|NCT01276223|582878199|FG002|Overall Study|Lost to Follow-up|1|||
161407281|NCT01276223|582878197|FG000|Overall Study|Other|0|||
161407282|NCT01276223|582878198|FG001|Overall Study|Other|0|||
161407283|NCT01276223|582878199|FG002|Overall Study|Other|1|||
161407284|NCT01276223|582878197|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
161407285|NCT01276223|582878198|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
161407286|NCT01276223|582878199|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
161407287|NCT01276223|582878197|FG000|Overall Study|Protocol Violation|1|||
161407288|NCT01276223|582878198|FG001|Overall Study|Protocol Violation|0|||
161407289|NCT01276223|582878199|FG002|Overall Study|Protocol Violation|0|||
161407290|NCT02017522|582878200|FG000|Overall Study|Withdrawal by Subject|1|||
161407291|NCT02596230|582878201|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
161407292|NCT02596230|582878202|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
161407293|NCT02596230|582878203|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
161407294|NCT02596230|582878204|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
161407295|NCT02596230|582878205|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
161407296|NCT02596230|582878201|FG000|Objective 2, One Year|Lost to Follow-up|0|||
161407297|NCT02596230|582878202|FG001|Objective 2, One Year|Lost to Follow-up|41|||
161407298|NCT02596230|582878203|FG002|Objective 2, One Year|Lost to Follow-up|41|||
161407299|NCT02596230|582878204|FG003|Objective 2, One Year|Lost to Follow-up|32|||
161407300|NCT02596230|582878205|FG004|Objective 2, One Year|Lost to Follow-up|46|||
161407301|NCT02596230|582878201|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
161407302|NCT02596230|582878202|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
161407303|NCT02596230|582878203|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
161407304|NCT02596230|582878204|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
161407305|NCT02596230|582878205|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
161407306|NCT02596230|582878201|FG000|Objective 2, One Year|Adverse drug reaction|0|||
161407307|NCT02596230|582878202|FG001|Objective 2, One Year|Adverse drug reaction|1|||
161407308|NCT02596230|582878203|FG002|Objective 2, One Year|Adverse drug reaction|0|||
161407309|NCT02596230|582878204|FG003|Objective 2, One Year|Adverse drug reaction|0|||
161407310|NCT02596230|582878205|FG004|Objective 2, One Year|Adverse drug reaction|0|||
161407311|NCT02596230|582878201|FG000|Objective 2, One Year|Death|0|||
161407312|NCT02596230|582878202|FG001|Objective 2, One Year|Death|12|||
161407313|NCT02596230|582878203|FG002|Objective 2, One Year|Death|41|||
161407314|NCT02596230|582878204|FG003|Objective 2, One Year|Death|21|||
161407315|NCT02596230|582878205|FG004|Objective 2, One Year|Death|30|||
161407316|NCT02596230|582878201|FG000|Objective 2, One Year|Other|0|||
161407317|NCT02596230|582878202|FG001|Objective 2, One Year|Other|3|||
161407318|NCT02596230|582878203|FG002|Objective 2, One Year|Other|2|||
161407319|NCT02596230|582878204|FG003|Objective 2, One Year|Other|0|||
161407320|NCT02596230|582878205|FG004|Objective 2, One Year|Other|0|||
161407321|NCT00771615|582878206|FG000|Overall Study|Withdrawal by Subject|0|||
161407322|NCT00771615|582878207|FG001|Overall Study|Withdrawal by Subject|1|||
161407323|NCT00771615|582878208|FG002|Overall Study|Withdrawal by Subject|0|||
161407324|NCT00771615|582878209|FG003|Overall Study|Withdrawal by Subject|0|||
161407325|NCT00771615|582878210|FG004|Overall Study|Withdrawal by Subject|0|||
161407326|NCT00771615|582878211|FG005|Overall Study|Withdrawal by Subject|0|||
161407327|NCT00771615|582878212|FG006|Overall Study|Withdrawal by Subject|0|||
161407328|NCT00771615|582878213|FG007|Overall Study|Withdrawal by Subject|1|||
161407329|NCT00771615|582878214|FG008|Overall Study|Withdrawal by Subject|0|||
161407330|NCT00771615|582878206|FG000|Overall Study|Lost to Follow-up|1|||
161407331|NCT00771615|582878207|FG001|Overall Study|Lost to Follow-up|1|||
161407332|NCT00771615|582878208|FG002|Overall Study|Lost to Follow-up|1|||
161407333|NCT00771615|582878209|FG003|Overall Study|Lost to Follow-up|1|||
161407334|NCT00771615|582878210|FG004|Overall Study|Lost to Follow-up|0|||
161407335|NCT00771615|582878211|FG005|Overall Study|Lost to Follow-up|1|||
161407336|NCT00771615|582878212|FG006|Overall Study|Lost to Follow-up|1|||
161407337|NCT00771615|582878213|FG007|Overall Study|Lost to Follow-up|0|||
161407338|NCT00771615|582878214|FG008|Overall Study|Lost to Follow-up|0|||
161407339|NCT02704689|582878216|FG000|Overall Study|Physician Decision|1|||
161407340|NCT02704689|582878216|FG000|Overall Study|Study device not implanted|2|||
161407341|NCT00802893|582878217|FG000|Overall Study|study terminated|3|||
161407342|NCT00320424|582878218|FG000|Overall Study|Adverse Event|3|||
161407343|NCT00320424|582878218|FG000|Overall Study|Other|3|||
161407344|NCT02294734|582878222|FG000|Overall Study|Adverse Event|5|||
161407345|NCT02294734|582878223|FG001|Overall Study|Adverse Event|5|||
161407346|NCT02294734|582878222|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
161407347|NCT02294734|582878223|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
161407348|NCT02294734|582878222|FG000|Overall Study|Lost to Follow-up|2|||
161407349|NCT02294734|582878223|FG001|Overall Study|Lost to Follow-up|0|||
161407350|NCT02294734|582878222|FG000|Overall Study|Physician Decision|2|||
161407351|NCT02294734|582878223|FG001|Overall Study|Physician Decision|1|||
161407352|NCT02294734|582878222|FG000|Overall Study|Withdrawal by Subject|4|||
161407353|NCT02294734|582878223|FG001|Overall Study|Withdrawal by Subject|2|||
161407354|NCT03157583|582878224|FG000|Overall Study|Other (did not meet study criteria)|1|||
161407355|NCT02809053|582878228|FG000|Overall Study|Death|0|||
161407356|NCT02809053|582878229|FG001|Overall Study|Death|1|||
161407357|NCT02809053|582878228|FG000|Overall Study|Lost to Follow-up|3|||
161407358|NCT02809053|582878229|FG001|Overall Study|Lost to Follow-up|1|||
161407359|NCT02809053|582878228|FG000|Overall Study|Withdrawal by Subject|2|||
161407360|NCT02809053|582878229|FG001|Overall Study|Withdrawal by Subject|3|||
161407361|NCT02809053|582878228|FG000|Overall Study|Disease Progression|2|||
161407362|NCT02809053|582878229|FG001|Overall Study|Disease Progression|1|||
161407363|NCT01943552|582878231|FG000|Overall Study|Adverse Event|3|||
161407364|NCT01943552|582878232|FG001|Overall Study|Adverse Event|2|||
161407365|NCT01943552|582878231|FG000|Overall Study|Withdrawal by Subject|6|||
161407366|NCT01943552|582878232|FG001|Overall Study|Withdrawal by Subject|6|||
161407367|NCT01943552|582878231|FG000|Overall Study|Other Reasons|16|||
161407368|NCT01943552|582878232|FG001|Overall Study|Other Reasons|17|||
161407369|NCT00908037|582878234|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407370|NCT00908037|582878235|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407371|NCT00908037|582878236|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407372|NCT00908037|582878237|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407373|NCT00908037|582878238|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
161407374|NCT00908037|582878239|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407375|NCT00908037|582878240|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
161407376|NCT00908037|582878241|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407377|NCT00908037|582878242|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
161407378|NCT00908037|582878243|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407379|NCT00908037|582878244|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407380|NCT00908037|582878245|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161407381|NCT00908037|582878234|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407382|NCT00908037|582878235|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407383|NCT00908037|582878236|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407384|NCT00908037|582878237|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407385|NCT00908037|582878238|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
161407386|NCT00908037|582878239|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407387|NCT00908037|582878240|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407388|NCT00908037|582878241|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407389|NCT00908037|582878242|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
161407390|NCT00908037|582878243|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407391|NCT00908037|582878244|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407392|NCT00908037|582878245|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161407393|NCT00908037|582878234|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407394|NCT00908037|582878235|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407395|NCT00908037|582878236|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407396|NCT00908037|582878237|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
161407397|NCT00908037|582878238|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407398|NCT00908037|582878239|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407399|NCT00908037|582878240|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
161407400|NCT00908037|582878241|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407401|NCT00908037|582878242|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407402|NCT00908037|582878243|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407403|NCT00908037|582878244|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407404|NCT00908037|582878245|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161407405|NCT00908037|582878234|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407406|NCT00908037|582878235|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407407|NCT00908037|582878236|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407408|NCT00908037|582878237|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407409|NCT00908037|582878238|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407410|NCT00908037|582878239|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407411|NCT00908037|582878240|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407412|NCT00908037|582878241|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407413|NCT00908037|582878242|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407414|NCT00908037|582878243|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407415|NCT00908037|582878244|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161407416|NCT00908037|582878245|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
161407417|NCT00908037|582878234|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407418|NCT00908037|582878235|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407419|NCT00908037|582878236|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407420|NCT00908037|582878237|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407421|NCT00908037|582878238|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407422|NCT00908037|582878239|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407423|NCT00908037|582878240|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407424|NCT00908037|582878241|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407425|NCT00908037|582878242|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407426|NCT00908037|582878243|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
161407427|NCT00908037|582878244|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161407428|NCT00908037|582878245|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
161407429|NCT00908037|582878234|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407430|NCT00908037|582878235|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407431|NCT00908037|582878236|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407432|NCT00908037|582878237|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407433|NCT00908037|582878238|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407434|NCT00908037|582878239|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407435|NCT00908037|582878240|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407436|NCT00908037|582878241|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407437|NCT00908037|582878242|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407438|NCT00908037|582878243|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
161407439|NCT00908037|582878244|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407440|NCT00908037|582878245|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161407441|NCT00908037|582878234|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407442|NCT00908037|582878235|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407443|NCT00908037|582878236|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407444|NCT00908037|582878237|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407445|NCT00908037|582878238|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407446|NCT00908037|582878239|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407447|NCT00908037|582878240|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407448|NCT00908037|582878241|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407449|NCT00908037|582878242|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407450|NCT00908037|582878243|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407451|NCT00908037|582878244|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
161407452|NCT00908037|582878245|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161407453|NCT00908037|582878234|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407454|NCT00908037|582878235|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407455|NCT00908037|582878236|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407456|NCT00908037|582878237|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407457|NCT00908037|582878238|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407458|NCT00908037|582878239|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407459|NCT00908037|582878240|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407460|NCT00908037|582878241|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407461|NCT00908037|582878242|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407462|NCT00908037|582878243|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
161407463|NCT00908037|582878244|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407464|NCT00908037|582878245|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161407465|NCT00908037|582878234|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407466|NCT00908037|582878235|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407467|NCT00908037|582878236|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407468|NCT00908037|582878237|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407469|NCT00908037|582878238|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407470|NCT00908037|582878239|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407471|NCT00908037|582878240|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407472|NCT00908037|582878241|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407473|NCT00908037|582878242|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407474|NCT00908037|582878243|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407475|NCT00908037|582878244|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
161407476|NCT00908037|582878245|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161407477|NCT01147900|582878246|FG000|At Year 10|Lost to Follow-up|0|||
161407478|NCT01147900|582878247|FG001|At Year 10|Lost to Follow-up|1|||
161407479|NCT01147900|582878248|FG002|At Year 10|Lost to Follow-up|0|||
161407480|NCT04109976|582878250|FG000|Overall Study|Withdrawal by Subject|1|||
161407481|NCT04109976|582878251|FG001|Overall Study|Withdrawal by Subject|0|||
161407482|NCT00491608|582878252|FG000|Overall Study|Death|2|||
161407483|NCT00491608|582878252|FG000|Overall Study|Withdrawal by Subject|1|||
161407484|NCT00257660|582878253|FG000|Overall Study|Lack of Efficacy|5|||
161407485|NCT00257660|582878254|FG001|Overall Study|Lack of Efficacy|23|||
161407486|NCT00257660|582878253|FG000|Overall Study|Withdrawal by Subject|2|||
161407487|NCT00257660|582878254|FG001|Overall Study|Withdrawal by Subject|0|||
161407488|NCT00257660|582878253|FG000|Overall Study|Lost to Follow-up|1|||
161407489|NCT00257660|582878254|FG001|Overall Study|Lost to Follow-up|0|||
161407490|NCT00257660|582878253|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
161407491|NCT00257660|582878254|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
161407492|NCT00257660|582878253|FG000|Overall Study|No longer wanted to do blood draws|1|||
161407493|NCT00257660|582878254|FG001|Overall Study|No longer wanted to do blood draws|0|||
161407494|NCT00025155|582878255|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
161407495|NCT00025155|582878255|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
161407496|NCT03022981|582878258|FG000|Overall Study|Adverse Event|0|||
161407497|NCT03022981|582878259|FG001|Overall Study|Adverse Event|1|||
161407498|NCT03022981|582878260|FG002|Overall Study|Adverse Event|0|||
161407499|NCT03022981|582878258|FG000|Overall Study|Investigator's Discretion|0|||
161407500|NCT03022981|582878259|FG001|Overall Study|Investigator's Discretion|1|||
161407501|NCT03022981|582878260|FG002|Overall Study|Investigator's Discretion|2|||
161407502|NCT03022981|582878258|FG000|Overall Study|Lost to Follow-up|6|||
161407503|NCT03022981|582878259|FG001|Overall Study|Lost to Follow-up|2|||
161407504|NCT03022981|582878260|FG002|Overall Study|Lost to Follow-up|1|||
161407505|NCT03022981|582878258|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161407506|NCT03022981|582878259|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161407507|NCT03022981|582878260|FG002|Overall Study|Non-Compliance With Study Drug|2|||
161407508|NCT03022981|582878258|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
161407509|NCT03022981|582878259|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
161407510|NCT03022981|582878260|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
161407511|NCT02437084|582878261|FG000|Overall Study|Withdrawal by Subject|2|||
161407512|NCT02437084|582878261|FG000|Overall Study|Physician Decision|1|||
161407513|NCT00884832|582878262|FG000|Overall Study|Withdrawal by Subject|0|||
161407514|NCT00884832|582878263|FG001|Overall Study|Withdrawal by Subject|1|||
161407515|NCT01985360|582878267|FG000|Overall Study|Withdrawal by Subject|4|||
161407516|NCT01985360|582878268|FG001|Overall Study|Withdrawal by Subject|0|||
161407517|NCT01985360|582878267|FG000|Overall Study|Lost to Follow-up|5|||
161407518|NCT01985360|582878268|FG001|Overall Study|Lost to Follow-up|3|||
161407519|NCT00079677|582878269|FG000|Overall Study|Adverse Event|5|||
161407520|NCT00079677|582878270|FG001|Overall Study|Adverse Event|6|||
161407521|NCT00079677|582878269|FG000|Overall Study|Lack of Efficacy|1|||
161407522|NCT00079677|582878270|FG001|Overall Study|Lack of Efficacy|0|||
161407523|NCT00079677|582878269|FG000|Overall Study|Lost to Follow-up|2|||
161407524|NCT00079677|582878270|FG001|Overall Study|Lost to Follow-up|2|||
161407525|NCT00079677|582878269|FG000|Overall Study|Physician Decision|3|||
161407526|NCT00079677|582878270|FG001|Overall Study|Physician Decision|0|||
161407527|NCT00079677|582878269|FG000|Overall Study|Protocol Violation|2|||
161407528|NCT00079677|582878270|FG001|Overall Study|Protocol Violation|3|||
161407529|NCT00079677|582878269|FG000|Overall Study|Withdrawal by Subject|5|||
161407530|NCT00079677|582878270|FG001|Overall Study|Withdrawal by Subject|3|||
161407531|NCT00079677|582878269|FG000|Overall Study|Miscellaneous|2|||
161407532|NCT00079677|582878270|FG001|Overall Study|Miscellaneous|0|||
161407533|NCT00521222|582878273|FG000|Overall Study|Lost to Follow-up|0|||
161407534|NCT00521222|582878274|FG001|Overall Study|Lost to Follow-up|0|||
161407535|NCT00521222|582878275|FG002|Overall Study|Lost to Follow-up|1|||
161407536|NCT00521222|582878276|FG003|Overall Study|Lost to Follow-up|1|||
161407537|NCT00521222|582878273|FG000|Overall Study|Withdrawal by Subject|0|||
161407538|NCT00521222|582878274|FG001|Overall Study|Withdrawal by Subject|0|||
161407539|NCT00521222|582878275|FG002|Overall Study|Withdrawal by Subject|2|||
161407540|NCT00521222|582878276|FG003|Overall Study|Withdrawal by Subject|0|||
161407541|NCT00521222|582878273|FG000|Overall Study|Physician Decision|0|||
161407542|NCT00521222|582878274|FG001|Overall Study|Physician Decision|1|||
161407543|NCT00521222|582878275|FG002|Overall Study|Physician Decision|0|||
161407544|NCT00521222|582878276|FG003|Overall Study|Physician Decision|1|||
161407545|NCT04598269|582878277|FG000|Overall Study|Adverse Event|0|||
161407546|NCT04598269|582878278|FG001|Overall Study|Adverse Event|3|||
161407547|NCT04598269|582878277|FG000|Overall Study|Withdrawal by Subject|1|||
161407548|NCT04598269|582878278|FG001|Overall Study|Withdrawal by Subject|4|||
161407549|NCT04598269|582878277|FG000|Overall Study|Lost to Follow-up|1|||
161407550|NCT04598269|582878278|FG001|Overall Study|Lost to Follow-up|0|||
161407551|NCT04598269|582878277|FG000|Overall Study|Not Treated|2|||
161407552|NCT04598269|582878278|FG001|Overall Study|Not Treated|0|||
161407553|NCT00424190|582878279|FG000|Overall Study|Withdrew consent|3|||
161407554|NCT00424190|582878280|FG001|Overall Study|Withdrew consent|4|||
161407555|NCT00424190|582878279|FG000|Overall Study|Death|3|||
161407556|NCT00424190|582878280|FG001|Overall Study|Death|0|||
161407557|NCT00424190|582878279|FG000|Overall Study|Noncompliance|1|||
161407558|NCT00424190|582878280|FG001|Overall Study|Noncompliance|2|||
161407559|NCT00424190|582878279|FG000|Overall Study|Request of sponsor or investigator|0|||
161407560|NCT00424190|582878280|FG001|Overall Study|Request of sponsor or investigator|2|||
161407561|NCT00424190|582878279|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
161407562|NCT00424190|582878280|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
161407563|NCT00424190|582878279|FG000|Overall Study|Other|15|||
161407564|NCT00424190|582878280|FG001|Overall Study|Other|21|||
161407565|NCT02265796|582878282|FG000|Overall Study|Death|1|||
161407566|NCT02265796|582878283|FG001|Overall Study|Death|0|||
161407567|NCT02265796|582878282|FG000|Overall Study|started on excluded medication|1|||
161407568|NCT02265796|582878283|FG001|Overall Study|started on excluded medication|0|||
161407569|NCT02265796|582878282|FG000|Overall Study|Withdrawal by Subject|1|||
161407570|NCT02265796|582878283|FG001|Overall Study|Withdrawal by Subject|1|||
161407571|NCT02477553|582878284|FG000|Overall Study|Screening up-to-date|12|||
161407572|NCT02477553|582878285|FG001|Overall Study|Screening up-to-date|13|||
161407573|NCT02477553|582878284|FG000|Overall Study|No MD visit|1|||
161407574|NCT02477553|582878285|FG001|Overall Study|No MD visit|1|||
161407575|NCT02477553|582878284|FG000|Overall Study|Workup consistent w/CRC|1|||
161407576|NCT02477553|582878285|FG001|Overall Study|Workup consistent w/CRC|1|||
161407577|NCT02477553|582878284|FG000|Overall Study|Technical issues with intervention|2|||
161407578|NCT02477553|582878285|FG001|Overall Study|Technical issues with intervention|0|||
161407579|NCT02477553|582878284|FG000|Overall Study|Elevated risk for CRC|2|||
161407580|NCT02477553|582878285|FG001|Overall Study|Elevated risk for CRC|2|||
161407581|NCT02477553|582878284|FG000|Overall Study|MD advised against screening|1|||
161407582|NCT02477553|582878285|FG001|Overall Study|MD advised against screening|3|||
161407583|NCT02477553|582878284|FG000|Overall Study|patient deceased|1|||
161407584|NCT02477553|582878285|FG001|Overall Study|patient deceased|0|||
161407585|NCT04023682|582878286|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
161407586|NCT00454649|582878287|FG000|Overall Study|Lack of Efficacy|2|||
161407587|NCT00454649|582878288|FG001|Overall Study|Lack of Efficacy|2|||
161407588|NCT00454649|582878289|FG002|Overall Study|Lack of Efficacy|10|||
161407589|NCT00454649|582878290|FG003|Overall Study|Lack of Efficacy|3|||
161407590|NCT00454649|582878291|FG004|Overall Study|Lack of Efficacy|0|||
161407591|NCT00454649|582878292|FG005|Overall Study|Lack of Efficacy|4|||
161407592|NCT00454649|582878293|FG006|Overall Study|Lack of Efficacy|5|||
161407593|NCT00454649|582878294|FG007|Overall Study|Lack of Efficacy|13|||
161407594|NCT00454649|582878295|FG008|Overall Study|Lack of Efficacy|10|||
161407595|NCT00454649|582878296|FG009|Overall Study|Lack of Efficacy|2|||
161407596|NCT00454649|582878287|FG000|Overall Study|Adverse Event|0|||
161407597|NCT00454649|582878288|FG001|Overall Study|Adverse Event|1|||
161407598|NCT00454649|582878289|FG002|Overall Study|Adverse Event|3|||
161407599|NCT00454649|582878290|FG003|Overall Study|Adverse Event|0|||
161407600|NCT00454649|582878291|FG004|Overall Study|Adverse Event|1|||
161407601|NCT00454649|582878292|FG005|Overall Study|Adverse Event|2|||
161407602|NCT00454649|582878293|FG006|Overall Study|Adverse Event|3|||
161407603|NCT00454649|582878294|FG007|Overall Study|Adverse Event|4|||
161407604|NCT00454649|582878295|FG008|Overall Study|Adverse Event|6|||
161407605|NCT00454649|582878296|FG009|Overall Study|Adverse Event|2|||
161407606|NCT00454649|582878287|FG000|Overall Study|Lost to Follow-up|0|||
161407607|NCT00454649|582878288|FG001|Overall Study|Lost to Follow-up|0|||
161407608|NCT00454649|582878289|FG002|Overall Study|Lost to Follow-up|1|||
161407609|NCT00454649|582878290|FG003|Overall Study|Lost to Follow-up|0|||
161407610|NCT00454649|582878291|FG004|Overall Study|Lost to Follow-up|0|||
161407611|NCT00454649|582878292|FG005|Overall Study|Lost to Follow-up|0|||
161407612|NCT00454649|582878293|FG006|Overall Study|Lost to Follow-up|1|||
161407613|NCT00454649|582878294|FG007|Overall Study|Lost to Follow-up|0|||
161407614|NCT00454649|582878295|FG008|Overall Study|Lost to Follow-up|0|||
161407615|NCT00454649|582878296|FG009|Overall Study|Lost to Follow-up|0|||
161407616|NCT00454649|582878287|FG000|Overall Study|Other|1|||
161407617|NCT00454649|582878288|FG001|Overall Study|Other|1|||
161407618|NCT00454649|582878289|FG002|Overall Study|Other|5|||
161407619|NCT00454649|582878290|FG003|Overall Study|Other|3|||
161407620|NCT00454649|582878291|FG004|Overall Study|Other|0|||
161407621|NCT00454649|582878292|FG005|Overall Study|Other|0|||
161407622|NCT00454649|582878293|FG006|Overall Study|Other|0|||
161407623|NCT00454649|582878294|FG007|Overall Study|Other|0|||
161407624|NCT00454649|582878295|FG008|Overall Study|Other|3|||
161407625|NCT00454649|582878296|FG009|Overall Study|Other|1|||
161407626|NCT00454649|582878287|FG000|Overall Study|Withdrawal by Subject|0|||
161407627|NCT00454649|582878288|FG001|Overall Study|Withdrawal by Subject|0|||
161407628|NCT00454649|582878289|FG002|Overall Study|Withdrawal by Subject|0|||
161407629|NCT00454649|582878290|FG003|Overall Study|Withdrawal by Subject|0|||
161407630|NCT00454649|582878291|FG004|Overall Study|Withdrawal by Subject|0|||
161407631|NCT00454649|582878292|FG005|Overall Study|Withdrawal by Subject|1|||
161407632|NCT00454649|582878293|FG006|Overall Study|Withdrawal by Subject|0|||
161407633|NCT00454649|582878294|FG007|Overall Study|Withdrawal by Subject|2|||
161407634|NCT00454649|582878295|FG008|Overall Study|Withdrawal by Subject|1|||
161407635|NCT00454649|582878296|FG009|Overall Study|Withdrawal by Subject|0|||
161407636|NCT02745535|582878298|FG000|Overall Study|Death|1|||
161407637|NCT02745535|582878298|FG000|Overall Study|Adverse Event|3|||
161407638|NCT02745535|582878298|FG000|Overall Study|Lost to Follow-up|2|||
161407639|NCT01291277|582878303|FG000|Overall Study|Death|2|||
161407640|NCT01291277|582878304|FG001|Overall Study|Death|2|||
161407641|NCT01291277|582878303|FG000|Overall Study|Lost to Follow-up|3|||
161407642|NCT01291277|582878304|FG001|Overall Study|Lost to Follow-up|1|||
161407643|NCT00377364|582878305|FG000|Overall Study|Lost to Follow-up|1|||
161407644|NCT00377364|582878306|FG001|Overall Study|Lost to Follow-up|0|||
161407645|NCT00377364|582878305|FG000|Overall Study|Withdrawal by Subject|1|||
161407646|NCT00377364|582878306|FG001|Overall Study|Withdrawal by Subject|0|||
161407647|NCT03480009|582878310|FG000|Overall Study|Lost to Follow-up|4|||
161407648|NCT03480009|582878311|FG001|Overall Study|Lost to Follow-up|5|||
161407649|NCT03480009|582878312|FG002|Overall Study|Lost to Follow-up|4|||
161407650|NCT03480009|582878313|FG003|Overall Study|Lost to Follow-up|0|||
161407651|NCT02014584|582878314|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161407652|NCT02014584|582878315|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
161407653|NCT02014584|582878316|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161407654|NCT02014584|582878317|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161407655|NCT02014584|582878318|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161407656|NCT02014584|582878319|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161407657|NCT02014584|582878314|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
161407658|NCT02014584|582878315|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
161407659|NCT02014584|582878316|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161407660|NCT02014584|582878317|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161407661|NCT02014584|582878318|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161407662|NCT02014584|582878319|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161407663|NCT02014584|582878314|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161407664|NCT02014584|582878315|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161407665|NCT02014584|582878316|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
161407666|NCT02014584|582878317|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161407667|NCT02014584|582878318|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161407668|NCT02014584|582878319|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161407669|NCT02014584|582878314|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161407670|NCT02014584|582878315|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161407671|NCT02014584|582878316|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
161407672|NCT02014584|582878317|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
161407673|NCT02014584|582878318|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161407674|NCT02014584|582878319|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161407675|NCT02014584|582878314|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161407676|NCT02014584|582878315|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161407677|NCT02014584|582878316|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161407678|NCT02014584|582878317|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161407679|NCT02014584|582878318|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
161407680|NCT02014584|582878319|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161407681|NCT03109184|582879845|FG000|Overall Study|Lost to Follow-up|6|||
161407682|NCT03109184|582879846|FG001|Overall Study|Lost to Follow-up|6|||
161407683|NCT03109184|582879845|FG000|Overall Study|Withdrawal by Subject|1|||
161407684|NCT03109184|582879846|FG001|Overall Study|Withdrawal by Subject|1|||
161407685|NCT00602420|582879847|FG000|Overall Study|Death|1|||
161407686|NCT00602420|582879848|FG001|Overall Study|Death|4|||
161407687|NCT00602420|582879847|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
161407688|NCT00602420|582879848|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
161407689|NCT00602420|582879847|FG000|Overall Study|Withdrawal by Subject|18|||
161407690|NCT00602420|582879848|FG001|Overall Study|Withdrawal by Subject|17|||
161407691|NCT00602420|582879847|FG000|Overall Study|Adverse Event|1|||
161407692|NCT00602420|582879848|FG001|Overall Study|Adverse Event|0|||
161407693|NCT01209078|582879860|FG000|Overall Study|Adverse Event|5|||
161407694|NCT01209078|582879861|FG001|Overall Study|Adverse Event|0|||
161407695|NCT01209078|582879860|FG000|Overall Study|Lost to Follow-up|4|||
161407696|NCT01209078|582879861|FG001|Overall Study|Lost to Follow-up|0|||
161407697|NCT01209078|582879860|FG000|Overall Study|Physician Decision|5|||
161407698|NCT01209078|582879861|FG001|Overall Study|Physician Decision|2|||
161407699|NCT01209078|582879860|FG000|Overall Study|Withdrawal by Subject|2|||
161407700|NCT01209078|582879861|FG001|Overall Study|Withdrawal by Subject|1|||
161407701|NCT03270891|582879862|FG000|Overall Study|Lost to Follow-up|3|||
161407702|NCT03270891|582879863|FG001|Overall Study|Lost to Follow-up|6|||
161407703|NCT03270891|582879864|FG002|Overall Study|Lost to Follow-up|0|||
161407704|NCT03270891|582879862|FG000|Overall Study|Withdrawal by Subject|1|||
161407705|NCT03270891|582879863|FG001|Overall Study|Withdrawal by Subject|0|||
161407706|NCT03270891|582879864|FG002|Overall Study|Withdrawal by Subject|0|||
161407707|NCT03270891|582879862|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
161407708|NCT03270891|582879863|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
161407709|NCT03270891|582879864|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
161407710|NCT02540668|582879865|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
161407711|NCT02540668|582879866|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
161407712|NCT00849108|582879867|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
161407713|NCT00849108|582879868|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
161407714|NCT00849108|582879867|FG000|Cohort 2 Efficacy|Adverse Event|0|||
161407715|NCT00849108|582879868|FG001|Cohort 2 Efficacy|Adverse Event|1|||
161407716|NCT00849108|582879867|FG000|Cohort 2 Efficacy|Other|0|||
161407717|NCT00849108|582879868|FG001|Cohort 2 Efficacy|Other|9|||
161407718|NCT01475162|582879869|FG000|Overall Study|Physician Decision|1|||
161407719|NCT01475162|582879869|FG000|Overall Study|Death|10|||
161407720|NCT01475162|582879869|FG000|Overall Study|Study closed for safety|3|||
161407721|NCT00545103|582879870|FG000|Overall Study|Lack of Efficacy|48|||
161407722|NCT00545103|582879871|FG001|Overall Study|Lack of Efficacy|45|||
161407723|NCT00545103|582879872|FG002|Overall Study|Lack of Efficacy|31|||
161407724|NCT00545103|582879873|FG003|Overall Study|Lack of Efficacy|27|||
161407725|NCT00545103|582879870|FG000|Overall Study|Withdrawal by Subject|6|||
161407726|NCT00545103|582879871|FG001|Overall Study|Withdrawal by Subject|10|||
161407727|NCT00545103|582879872|FG002|Overall Study|Withdrawal by Subject|18|||
161407728|NCT00545103|582879873|FG003|Overall Study|Withdrawal by Subject|22|||
161407729|NCT00545103|582879870|FG000|Overall Study|Adverse Event|11|||
161407730|NCT00545103|582879871|FG001|Overall Study|Adverse Event|12|||
161407731|NCT00545103|582879872|FG002|Overall Study|Adverse Event|17|||
161407732|NCT00545103|582879873|FG003|Overall Study|Adverse Event|10|||
161407733|NCT00545103|582879870|FG000|Overall Study|Lost to Follow-up|4|||
161407734|NCT00545103|582879871|FG001|Overall Study|Lost to Follow-up|6|||
161407735|NCT00545103|582879872|FG002|Overall Study|Lost to Follow-up|3|||
161407736|NCT00545103|582879873|FG003|Overall Study|Lost to Follow-up|4|||
161407737|NCT00545103|582879870|FG000|Overall Study|Protocol Violation|1|||
161407738|NCT00545103|582879871|FG001|Overall Study|Protocol Violation|2|||
161407739|NCT00545103|582879872|FG002|Overall Study|Protocol Violation|3|||
161407740|NCT00545103|582879873|FG003|Overall Study|Protocol Violation|0|||
161407741|NCT00545103|582879870|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
161407742|NCT00545103|582879871|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
161407743|NCT00545103|582879872|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
161407744|NCT00545103|582879873|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
161407745|NCT00545103|582879870|FG000|Overall Study|Difficult to open package|0|||
161407746|NCT00545103|582879871|FG001|Overall Study|Difficult to open package|0|||
161407747|NCT00545103|582879872|FG002|Overall Study|Difficult to open package|0|||
161407748|NCT00545103|582879873|FG003|Overall Study|Difficult to open package|1|||
161407749|NCT00545103|582879870|FG000|Overall Study|Investigational product not taken|1|||
161407750|NCT00545103|582879871|FG001|Overall Study|Investigational product not taken|0|||
161407751|NCT00545103|582879872|FG002|Overall Study|Investigational product not taken|0|||
161407752|NCT00545103|582879873|FG003|Overall Study|Investigational product not taken|1|||
161407753|NCT00545103|582879870|FG000|Overall Study|Wish to start a family|0|||
161407754|NCT00545103|582879871|FG001|Overall Study|Wish to start a family|0|||
161407755|NCT00545103|582879872|FG002|Overall Study|Wish to start a family|0|||
161407756|NCT00545103|582879873|FG003|Overall Study|Wish to start a family|1|||
161407757|NCT00545103|582879870|FG000|Overall Study|Diverticulitis crisis|0|||
161407758|NCT00545103|582879871|FG001|Overall Study|Diverticulitis crisis|0|||
161407759|NCT00545103|582879872|FG002|Overall Study|Diverticulitis crisis|0|||
161407760|NCT00545103|582879873|FG003|Overall Study|Diverticulitis crisis|1|||
161407761|NCT00545103|582879870|FG000|Overall Study|Personal reasons|1|||
161407762|NCT00545103|582879871|FG001|Overall Study|Personal reasons|0|||
161407763|NCT00545103|582879872|FG002|Overall Study|Personal reasons|0|||
161407764|NCT00545103|582879873|FG003|Overall Study|Personal reasons|0|||
161407765|NCT00545103|582879870|FG000|Overall Study|Subject's decision|1|||
161407766|NCT00545103|582879871|FG001|Overall Study|Subject's decision|0|||
161407767|NCT00545103|582879872|FG002|Overall Study|Subject's decision|0|||
161407768|NCT00545103|582879873|FG003|Overall Study|Subject's decision|0|||
161407769|NCT00545103|582879870|FG000|Overall Study|Noncompliance|0|||
161407770|NCT00545103|582879871|FG001|Overall Study|Noncompliance|1|||
161407771|NCT00545103|582879872|FG002|Overall Study|Noncompliance|0|||
161407772|NCT00545103|582879873|FG003|Overall Study|Noncompliance|0|||
161407773|NCT00545103|582879870|FG000|Overall Study|Investigator decision|0|||
161407774|NCT00545103|582879871|FG001|Overall Study|Investigator decision|0|||
161407775|NCT00545103|582879872|FG002|Overall Study|Investigator decision|1|||
161407776|NCT00545103|582879873|FG003|Overall Study|Investigator decision|0|||
161407777|NCT00545103|582879870|FG000|Overall Study|Subject moved|0|||
161407778|NCT00545103|582879871|FG001|Overall Study|Subject moved|1|||
161407779|NCT00545103|582879872|FG002|Overall Study|Subject moved|0|||
161407780|NCT00545103|582879873|FG003|Overall Study|Subject moved|0|||
161407781|NCT00545103|582879870|FG000|Overall Study|Use of prohibited medication|0|||
161407782|NCT00545103|582879871|FG001|Overall Study|Use of prohibited medication|0|||
161407783|NCT00545103|582879872|FG002|Overall Study|Use of prohibited medication|1|||
161407784|NCT00545103|582879873|FG003|Overall Study|Use of prohibited medication|0|||
161407785|NCT00545103|582879870|FG000|Overall Study|Does not want to take study drug anymore|1|||
161407786|NCT00545103|582879871|FG001|Overall Study|Does not want to take study drug anymore|0|||
161407787|NCT00545103|582879872|FG002|Overall Study|Does not want to take study drug anymore|1|||
161407788|NCT00545103|582879873|FG003|Overall Study|Does not want to take study drug anymore|0|||
161407789|NCT00545103|582879870|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
161407790|NCT00545103|582879871|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
161407791|NCT00545103|582879872|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
161407792|NCT00545103|582879873|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
161407793|NCT00545103|582879870|FG000|Overall Study|Death|0|||
161407794|NCT00545103|582879871|FG001|Overall Study|Death|1|||
161407795|NCT00545103|582879872|FG002|Overall Study|Death|0|||
161407796|NCT00545103|582879873|FG003|Overall Study|Death|0|||
161407797|NCT05026853|582879874|FG000|Overall Study|Cancelled appointment|1|||
161407798|NCT05026853|582879875|FG001|Overall Study|Cancelled appointment|0|||
161407799|NCT05026853|582879874|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
161407800|NCT05026853|582879875|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
161407801|NCT05026853|582879874|FG000|Overall Study|Did not complete 12-week survey|16|||
161407802|NCT05026853|582879875|FG001|Overall Study|Did not complete 12-week survey|16|||
161407803|NCT02358044|582879876|FG000|Overall Study|Adverse Event|0|||
161407804|NCT02358044|582879877|FG001|Overall Study|Adverse Event|1|||
161407805|NCT02358044|582879876|FG000|Overall Study|Lost to Follow-up|2|||
161407806|NCT02358044|582879877|FG001|Overall Study|Lost to Follow-up|1|||
161407807|NCT02358044|582879876|FG000|Overall Study|Physician Decision|0|||
161407808|NCT02358044|582879877|FG001|Overall Study|Physician Decision|1|||
161407809|NCT02358044|582879876|FG000|Overall Study|Withdrawal by Subject|0|||
161407810|NCT02358044|582879877|FG001|Overall Study|Withdrawal by Subject|4|||
161407811|NCT01732913|582879878|FG000|Overall Study|Study Terminated by Sponsor|105|||
161407812|NCT01732913|582879879|FG001|Overall Study|Study Terminated by Sponsor|55|||
161407813|NCT01732913|582879878|FG000|Overall Study|Withdrawal by Subject|27|||
161407814|NCT01732913|582879879|FG001|Overall Study|Withdrawal by Subject|4|||
161407815|NCT01732913|582879878|FG000|Overall Study|Physician Decision|14|||
161407816|NCT01732913|582879879|FG001|Overall Study|Physician Decision|7|||
161407817|NCT01732913|582879878|FG000|Overall Study|Other|7|||
161407818|NCT01732913|582879879|FG001|Overall Study|Other|1|||
161407819|NCT01732913|582879878|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
161407820|NCT01732913|582879879|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
161407821|NCT00903331|582879880|FG000|Overall Study|Death|4|||
161407822|NCT00903331|582879881|FG001|Overall Study|Death|8|||
161407823|NCT00903331|582879880|FG000|Overall Study|Withdrawal of consent|1|||
161407824|NCT00903331|582879881|FG001|Overall Study|Withdrawal of consent|8|||
161407825|NCT00903331|582879880|FG000|Overall Study|Lung transplant|0|||
161407826|NCT00903331|582879881|FG001|Overall Study|Lung transplant|2|||
161407827|NCT02723175|582879882|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
161407828|NCT02723175|582879883|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
161407829|NCT02723175|582879882|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
161407830|NCT02723175|582879883|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
161407831|NCT03233438|582879884|FG000|Overall Study|Lost to Follow-up|4|||
161407832|NCT03233438|582879885|FG001|Overall Study|Lost to Follow-up|9|||
161407833|NCT03233438|582879884|FG000|Overall Study|Withdrawal by Subject|2|||
161407834|NCT03233438|582879885|FG001|Overall Study|Withdrawal by Subject|1|||
161407835|NCT03233438|582879884|FG000|Overall Study|No recording of dalbavancin|0|||
161407836|NCT03233438|582879885|FG001|Overall Study|No recording of dalbavancin|1|||
161407837|NCT00413374|582879893|FG000|Overall Study|Ineligible due to screening criteria.|3|||
161407838|NCT00413374|582879894|FG001|Overall Study|Ineligible due to screening criteria.|0|||
161407839|NCT00413374|582879893|FG000|Overall Study|Adverse Event|1|||
161407840|NCT00413374|582879894|FG001|Overall Study|Adverse Event|0|||
161407841|NCT00413374|582879893|FG000|Overall Study|Lost to Follow-up|1|||
161407842|NCT00413374|582879894|FG001|Overall Study|Lost to Follow-up|0|||
161407843|NCT00413374|582879893|FG000|Overall Study|Surgery|1|||
161407844|NCT00413374|582879894|FG001|Overall Study|Surgery|0|||
161407845|NCT00552760|582879895|FG000|Overall Study|Adverse Event|3|||
161407846|NCT00552760|582879896|FG001|Overall Study|Adverse Event|5|||
161407847|NCT00552760|582879895|FG000|Overall Study|Relapsed- Depressed Event|10|||
161407848|NCT00552760|582879896|FG001|Overall Study|Relapsed- Depressed Event|16|||
161407849|NCT00552760|582879895|FG000|Overall Study|Relapse- Manic Event|3|||
161407850|NCT00552760|582879896|FG001|Overall Study|Relapse- Manic Event|3|||
161407851|NCT00552760|582879895|FG000|Overall Study|Relapsed- Mixed Event|3|||
161407852|NCT00552760|582879896|FG001|Overall Study|Relapsed- Mixed Event|5|||
161407853|NCT00552760|582879895|FG000|Overall Study|Protocol Violation|0|||
161407854|NCT00552760|582879896|FG001|Overall Study|Protocol Violation|1|||
161407855|NCT00552760|582879895|FG000|Overall Study|Lost to Follow-up|1|||
161407856|NCT00552760|582879896|FG001|Overall Study|Lost to Follow-up|1|||
161407857|NCT00552760|582879895|FG000|Overall Study|Non-compliance|1|||
161407858|NCT00552760|582879896|FG001|Overall Study|Non-compliance|1|||
161407859|NCT00552760|582879895|FG000|Overall Study|Medical Condition|1|||
161407860|NCT00552760|582879896|FG001|Overall Study|Medical Condition|1|||
161407861|NCT00552760|582879895|FG000|Overall Study|Withdrawal by Subject|3|||
161407862|NCT00552760|582879896|FG001|Overall Study|Withdrawal by Subject|0|||
161407863|NCT00552760|582879895|FG000|Overall Study|Medication Change|1|||
161407864|NCT00552760|582879896|FG001|Overall Study|Medication Change|0|||
161407865|NCT03615066|582879898|FG000|Main Study|Withdrew Consent|0|||
161407866|NCT03615066|582879899|FG001|Main Study|Withdrew Consent|1|||
161407867|NCT03615066|582879900|FG002|Main Study|Withdrew Consent|1|||
161407868|NCT03615066|582879898|FG000|Main Study|Lost to Follow-up|0|||
161407869|NCT03615066|582879899|FG001|Main Study|Lost to Follow-up|0|||
161407870|NCT03615066|582879900|FG002|Main Study|Lost to Follow-up|1|||
161407871|NCT03615066|582879898|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
161407872|NCT03615066|582879899|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
161407873|NCT03615066|582879900|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
161407874|NCT03615066|582879898|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
161407875|NCT03615066|582879899|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
161407876|NCT03615066|582879900|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
161407877|NCT03615066|582879898|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
161407878|NCT03615066|582879899|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
161407879|NCT03615066|582879900|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
161407880|NCT00494507|582879901|FG000|Double-Blind Phase|Adverse Event|2|||
161407881|NCT00494507|582879902|FG001|Double-Blind Phase|Adverse Event|0|||
161407882|NCT00494507|582879903|FG002|Double-Blind Phase|Adverse Event|1|||
161407883|NCT00494507|582879904|FG003|Double-Blind Phase|Adverse Event|0|||
161407884|NCT00494507|582879901|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
161407885|NCT00494507|582879902|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
161407886|NCT00494507|582879903|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161407887|NCT00494507|582879904|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161407888|NCT00494507|582879901|FG000|Double-Blind Phase|Subject Non-compliance|0|||
161407889|NCT00494507|582879902|FG001|Double-Blind Phase|Subject Non-compliance|0|||
161407890|NCT00494507|582879903|FG002|Double-Blind Phase|Subject Non-compliance|1|||
161407891|NCT00494507|582879904|FG003|Double-Blind Phase|Subject Non-compliance|0|||
161407892|NCT00494507|582879901|FG000|Double-Blind Phase|Negative DNA test|0|||
161407893|NCT00494507|582879902|FG001|Double-Blind Phase|Negative DNA test|0|||
161407894|NCT00494507|582879903|FG002|Double-Blind Phase|Negative DNA test|0|||
161407895|NCT00494507|582879904|FG003|Double-Blind Phase|Negative DNA test|1|||
161407896|NCT00494507|582879901|FG000|Open-Label Phase|Adverse Event|0|||
161407897|NCT00494507|582879902|FG001|Open-Label Phase|Adverse Event|1|||
161407898|NCT00494507|582879903|FG002|Open-Label Phase|Adverse Event|5|||
161407899|NCT00494507|582879904|FG003|Open-Label Phase|Adverse Event|3|||
161407900|NCT00494507|582879901|FG000|Open-Label Phase|Worsening Disease|0|||
161407901|NCT00494507|582879902|FG001|Open-Label Phase|Worsening Disease|0|||
161407902|NCT00494507|582879903|FG002|Open-Label Phase|Worsening Disease|0|||
161407903|NCT00494507|582879904|FG003|Open-Label Phase|Worsening Disease|2|||
161407904|NCT00924404|582879907|FG000|Overall Study|Lost to Follow-up|6|||
161407905|NCT00924404|582879908|FG001|Overall Study|Lost to Follow-up|4|||
161407906|NCT03426631|582879911|FG000|Overall Study|Lost to Follow-up|0|||
161407907|NCT03426631|582879912|FG001|Overall Study|Lost to Follow-up|1|||
161407908|NCT03831945|582879913|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
161407909|NCT03831945|582879914|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
161407910|NCT03831945|582879913|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
161407911|NCT03831945|582879914|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
161407912|NCT03831945|582879913|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
161407913|NCT03831945|582879914|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
161407914|NCT00454181|582879917|FG000|Overall Study|Adverse Event|1|||
161407915|NCT00454181|582879918|FG001|Overall Study|Adverse Event|1|||
161407916|NCT00454181|582879917|FG000|Overall Study|Lost to Follow-up|11|||
161407917|NCT00454181|582879918|FG001|Overall Study|Lost to Follow-up|1|||
161407918|NCT00454181|582879917|FG000|Overall Study|Protocol Violation|1|||
161407919|NCT00454181|582879918|FG001|Overall Study|Protocol Violation|1|||
161407920|NCT00454181|582879917|FG000|Overall Study|Withdrawal by Subject|2|||
161407921|NCT00454181|582879918|FG001|Overall Study|Withdrawal by Subject|0|||
161407922|NCT02613169|582879919|FG000|Overall Study|Withdrawal by Subject|4|||
161407923|NCT02613169|582879920|FG001|Overall Study|Withdrawal by Subject|1|||
161407924|NCT02613169|582879919|FG000|Overall Study|Lost to Follow-up|0|||
161407925|NCT02613169|582879920|FG001|Overall Study|Lost to Follow-up|5|||
161407926|NCT02613169|582879919|FG000|Overall Study|HIV|0|||
161407927|NCT02613169|582879920|FG001|Overall Study|HIV|2|||
161407928|NCT02613169|582879919|FG000|Overall Study|No TB infection endpoint|14|||
161407929|NCT02613169|582879920|FG001|Overall Study|No TB infection endpoint|9|||
161407930|NCT03729245|582879921|FG000|Overall Study|Lost to Follow-up|5|||
161407931|NCT03729245|582879922|FG001|Overall Study|Lost to Follow-up|6|||
161407932|NCT03729245|582879921|FG000|Overall Study|Withdrawal by Subject|16|||
161407933|NCT03729245|582879922|FG001|Overall Study|Withdrawal by Subject|19|||
161407934|NCT03729245|582879921|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
161407935|NCT03729245|582879922|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
161407936|NCT04032080|582879923|FG000|Overall Study|Death|6|||
161407937|NCT02096263|582879924|FG000|Overall Study|Adverse Event|1|||
161407938|NCT02096263|582879925|FG001|Overall Study|Adverse Event|0|||
161407939|NCT02096263|582879926|FG002|Overall Study|Adverse Event|1|||
161407940|NCT02096263|582879924|FG000|Overall Study|Lost to Follow-up|14|||
161407941|NCT02096263|582879925|FG001|Overall Study|Lost to Follow-up|18|||
161407942|NCT02096263|582879926|FG002|Overall Study|Lost to Follow-up|15|||
161407943|NCT02096263|582879924|FG000|Overall Study|Other|7|||
161407944|NCT02096263|582879925|FG001|Overall Study|Other|9|||
161407945|NCT02096263|582879926|FG002|Overall Study|Other|6|||
161407946|NCT02096263|582879924|FG000|Overall Study|Sponsor study termination|0|||
161407947|NCT02096263|582879925|FG001|Overall Study|Sponsor study termination|0|||
161407948|NCT02096263|582879926|FG002|Overall Study|Sponsor study termination|1|||
161407949|NCT02096263|582879924|FG000|Overall Study|Protocol Violation|7|||
161407950|NCT02096263|582879925|FG001|Overall Study|Protocol Violation|2|||
161407951|NCT02096263|582879926|FG002|Overall Study|Protocol Violation|8|||
161407952|NCT02096263|582879924|FG000|Overall Study|Withdrawal by Subject|5|||
161407953|NCT02096263|582879925|FG001|Overall Study|Withdrawal by Subject|7|||
161407954|NCT02096263|582879926|FG002|Overall Study|Withdrawal by Subject|8|||
161407955|NCT00845065|582879939|FG000|Overall Study|Adverse Event|3|||
161407956|NCT00845065|582879940|FG001|Overall Study|Adverse Event|23|||
161407957|NCT00845065|582879939|FG000|Overall Study|Lack of Efficacy|43|||
161407958|NCT00845065|582879940|FG001|Overall Study|Lack of Efficacy|21|||
161407959|NCT00845065|582879939|FG000|Overall Study|Non-Medical Reasons|1|||
161407960|NCT00845065|582879940|FG001|Overall Study|Non-Medical Reasons|11|||
161407961|NCT02963701|582879942|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
161407962|NCT02963701|582879943|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
161407963|NCT01345682|582879946|FG000|Overall Study|Progressive disease per RECIST|226|||
161407964|NCT01345682|582879947|FG001|Overall Study|Progressive disease per RECIST|93|||
161407965|NCT01345682|582879946|FG000|Overall Study|Worsening of underlying cancer disease|23|||
161407966|NCT01345682|582879947|FG001|Overall Study|Worsening of underlying cancer disease|12|||
161407967|NCT01345682|582879946|FG000|Overall Study|Adverse Event|51|||
161407968|NCT01345682|582879947|FG001|Overall Study|Adverse Event|41|||
161407969|NCT01345682|582879946|FG000|Overall Study|Non-compliance with protocol|0|||
161407970|NCT01345682|582879947|FG001|Overall Study|Non-compliance with protocol|1|||
161407971|NCT01345682|582879946|FG000|Overall Study|Lost to Follow-up|0|||
161407972|NCT01345682|582879947|FG001|Overall Study|Lost to Follow-up|1|||
161407973|NCT01345682|582879946|FG000|Overall Study|Refused to continue trial medication|16|||
161407974|NCT01345682|582879947|FG001|Overall Study|Refused to continue trial medication|9|||
161407975|NCT01345682|582879946|FG000|Overall Study|Not treated|2|||
161407976|NCT01345682|582879947|FG001|Overall Study|Not treated|1|||
161407977|NCT01345682|582879946|FG000|Overall Study|Reason other than those specified above|4|||
161407978|NCT01345682|582879947|FG001|Overall Study|Reason other than those specified above|3|||
161407979|NCT00637572|582879948|FG000|Overall Study|Adverse Event|1|||
161407980|NCT00637572|582879949|FG001|Overall Study|Adverse Event|2|||
161407981|NCT00637572|582879948|FG000|Overall Study|Death|0|||
161407982|NCT00637572|582879949|FG001|Overall Study|Death|1|||
161407983|NCT00637572|582879948|FG000|Overall Study|Lost to Follow-up|0|||
161407984|NCT00637572|582879949|FG001|Overall Study|Lost to Follow-up|1|||
161407985|NCT00637572|582879948|FG000|Overall Study|Physician Decision|1|||
161407986|NCT00637572|582879949|FG001|Overall Study|Physician Decision|1|||
161407987|NCT00637572|582879948|FG000|Overall Study|Withdrawal by Subject|0|||
161407988|NCT00637572|582879949|FG001|Overall Study|Withdrawal by Subject|2|||
161407989|NCT00637572|582879948|FG000|Overall Study|Illicit Drug Use|1|||
161407990|NCT00637572|582879949|FG001|Overall Study|Illicit Drug Use|0|||
161407991|NCT00896649|582879950|FG000|Overall Study|Physician Decision|1|||
161407992|NCT00896649|582879950|FG000|Overall Study|Pregnancy|1|||
161407993|NCT00896649|582879950|FG000|Overall Study|missing documentation|1|||
161407994|NCT00896649|582879950|FG000|Overall Study|technical difficulties|2|||
161407995|NCT03652675|582879954|FG000|Overall Study|Lost to Follow-up|4|||
161407996|NCT03652675|582879955|FG001|Overall Study|Lost to Follow-up|4|||
161407997|NCT00695864|582879957|FG000|Placebo|Withdrawal by Subject|1|||
161407998|NCT00695864|582879957|FG000|Placebo|Physician Decision|4|||
161407999|NCT00752726|582879958|FG000|Overall Study|Lost to Follow-up|2|||
161408000|NCT00752726|582879959|FG001|Overall Study|Lost to Follow-up|1|||
161408001|NCT00752726|582879958|FG000|Overall Study|Adverse Event|3|||
161408002|NCT00752726|582879959|FG001|Overall Study|Adverse Event|0|||
161408003|NCT00752726|582879958|FG000|Overall Study|Withdrawal by Subject|5|||
161408004|NCT00752726|582879959|FG001|Overall Study|Withdrawal by Subject|10|||
161408005|NCT00752726|582879958|FG000|Overall Study|Other Reason|1|||
161408006|NCT00752726|582879959|FG001|Overall Study|Other Reason|2|||
161408007|NCT04232215|582879960|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161408008|NCT04232215|582879961|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161408009|NCT01555125|582879964|FG000|Induction Period|Lost to Follow-up|0|||
161408010|NCT01555125|582879965|FG001|Induction Period|Lost to Follow-up|2|||
161408011|NCT01555125|582879966|FG002|Induction Period|Lost to Follow-up|0|||
161408012|NCT01555125|582879967|FG003|Induction Period|Lost to Follow-up|0|||
161408013|NCT01555125|582879968|FG004|Induction Period|Lost to Follow-up|0|||
161408014|NCT01555125|582879964|FG000|Induction Period|Adverse Event|0|||
161408015|NCT01555125|582879965|FG001|Induction Period|Adverse Event|1|||
161408016|NCT01555125|582879966|FG002|Induction Period|Adverse Event|0|||
161408017|NCT01555125|582879967|FG003|Induction Period|Adverse Event|0|||
161408018|NCT01555125|582879968|FG004|Induction Period|Adverse Event|1|||
161408019|NCT01555125|582879964|FG000|Induction Period|Subject / guardian decision|0|||
161408020|NCT01555125|582879965|FG001|Induction Period|Subject / guardian decision|0|||
161408021|NCT01555125|582879966|FG002|Induction Period|Subject / guardian decision|0|||
161408022|NCT01555125|582879967|FG003|Induction Period|Subject / guardian decision|0|||
161408023|NCT01555125|582879968|FG004|Induction Period|Subject / guardian decision|2|||
161408024|NCT01555125|582879964|FG000|Induction Period|Death|1|||
161408025|NCT01555125|582879965|FG001|Induction Period|Death|0|||
161408026|NCT01555125|582879966|FG002|Induction Period|Death|0|||
161408027|NCT01555125|582879967|FG003|Induction Period|Death|0|||
161408028|NCT01555125|582879968|FG004|Induction Period|Death|0|||
161408029|NCT01555125|582879964|FG000|Maintenance Period|Adverse Event|1|||
161408030|NCT01555125|582879965|FG001|Maintenance Period|Adverse Event|1|||
161408031|NCT01555125|582879966|FG002|Maintenance Period|Adverse Event|0|||
161408032|NCT01555125|582879967|FG003|Maintenance Period|Adverse Event|0|||
161408033|NCT01555125|582879968|FG004|Maintenance Period|Adverse Event|0|||
161408034|NCT01555125|582879964|FG000|Maintenance Period|Subject / guardian decision|1|||
161408035|NCT01555125|582879965|FG001|Maintenance Period|Subject / guardian decision|2|||
161408036|NCT01555125|582879966|FG002|Maintenance Period|Subject / guardian decision|0|||
161408037|NCT01555125|582879967|FG003|Maintenance Period|Subject / guardian decision|0|||
161408038|NCT01555125|582879968|FG004|Maintenance Period|Subject / guardian decision|0|||
161408039|NCT01555125|582879964|FG000|Maintenance Period|Lost to Follow-up|2|||
161408040|NCT01555125|582879965|FG001|Maintenance Period|Lost to Follow-up|0|||
161408041|NCT01555125|582879966|FG002|Maintenance Period|Lost to Follow-up|0|||
161408042|NCT01555125|582879967|FG003|Maintenance Period|Lost to Follow-up|1|||
161408043|NCT01555125|582879968|FG004|Maintenance Period|Lost to Follow-up|0|||
161408044|NCT01555125|582879964|FG000|Maintenance Period|Lack of Efficacy|6|||
161408045|NCT01555125|582879965|FG001|Maintenance Period|Lack of Efficacy|1|||
161408046|NCT01555125|582879966|FG002|Maintenance Period|Lack of Efficacy|3|||
161408047|NCT01555125|582879967|FG003|Maintenance Period|Lack of Efficacy|0|||
161408048|NCT01555125|582879968|FG004|Maintenance Period|Lack of Efficacy|0|||
161408049|NCT01555125|582879964|FG000|Maintenance Period|Physician Decision|0|||
161408050|NCT01555125|582879965|FG001|Maintenance Period|Physician Decision|0|||
161408051|NCT01555125|582879966|FG002|Maintenance Period|Physician Decision|1|||
161408052|NCT01555125|582879967|FG003|Maintenance Period|Physician Decision|0|||
161408053|NCT01555125|582879968|FG004|Maintenance Period|Physician Decision|0|||
161408054|NCT01555125|582879964|FG000|Maintenance Period|Death|0|||
161408055|NCT01555125|582879965|FG001|Maintenance Period|Death|0|||
161408056|NCT01555125|582879966|FG002|Maintenance Period|Death|0|||
161408057|NCT01555125|582879967|FG003|Maintenance Period|Death|1|||
161408058|NCT01555125|582879968|FG004|Maintenance Period|Death|0|||
161408059|NCT01555125|582879964|FG000|Extension|Adverse Event|1|||
161408060|NCT01555125|582879965|FG001|Extension|Adverse Event|2|||
161408061|NCT01555125|582879966|FG002|Extension|Adverse Event|1|||
161408062|NCT01555125|582879967|FG003|Extension|Adverse Event|1|||
161408063|NCT01555125|582879968|FG004|Extension|Adverse Event|0|||
161408064|NCT01555125|582879964|FG000|Extension|Protocol deviation|1|||
161408065|NCT01555125|582879965|FG001|Extension|Protocol deviation|0|||
161408066|NCT01555125|582879966|FG002|Extension|Protocol deviation|0|||
161408067|NCT01555125|582879967|FG003|Extension|Protocol deviation|0|||
161408068|NCT01555125|582879968|FG004|Extension|Protocol deviation|0|||
161408069|NCT01555125|582879964|FG000|Extension|Lack of Efficacy|7|||
161408070|NCT01555125|582879965|FG001|Extension|Lack of Efficacy|6|||
161408071|NCT01555125|582879966|FG002|Extension|Lack of Efficacy|3|||
161408072|NCT01555125|582879967|FG003|Extension|Lack of Efficacy|0|||
161408073|NCT01555125|582879968|FG004|Extension|Lack of Efficacy|0|||
161408074|NCT01555125|582879964|FG000|Extension|Lost to Follow-up|2|||
161408075|NCT01555125|582879965|FG001|Extension|Lost to Follow-up|1|||
161408076|NCT01555125|582879966|FG002|Extension|Lost to Follow-up|2|||
161408077|NCT01555125|582879967|FG003|Extension|Lost to Follow-up|0|||
161408078|NCT01555125|582879968|FG004|Extension|Lost to Follow-up|0|||
161408079|NCT01555125|582879964|FG000|Extension|Study terminated by sponsor|32|||
161408080|NCT01555125|582879965|FG001|Extension|Study terminated by sponsor|33|||
161408081|NCT01555125|582879966|FG002|Extension|Study terminated by sponsor|16|||
161408082|NCT01555125|582879967|FG003|Extension|Study terminated by sponsor|20|||
161408083|NCT01555125|582879968|FG004|Extension|Study terminated by sponsor|0|||
161408084|NCT01555125|582879964|FG000|Extension|Subject/guardian decision|1|||
161408085|NCT01555125|582879965|FG001|Extension|Subject/guardian decision|9|||
161408086|NCT01555125|582879966|FG002|Extension|Subject/guardian decision|1|||
161408087|NCT01555125|582879967|FG003|Extension|Subject/guardian decision|0|||
161408088|NCT01555125|582879968|FG004|Extension|Subject/guardian decision|0|||
161408089|NCT01555125|582879964|FG000|Extension|Technical Problems|1|||
161408090|NCT01555125|582879965|FG001|Extension|Technical Problems|0|||
161408091|NCT01555125|582879966|FG002|Extension|Technical Problems|0|||
161408092|NCT01555125|582879967|FG003|Extension|Technical Problems|1|||
161408093|NCT01555125|582879968|FG004|Extension|Technical Problems|0|||
161408094|NCT01555125|582879964|FG000|Follow-Up Period|Lost to Follow-up|1|||
161408095|NCT01555125|582879965|FG001|Follow-Up Period|Lost to Follow-up|0|||
161408096|NCT01555125|582879966|FG002|Follow-Up Period|Lost to Follow-up|0|||
161408097|NCT01555125|582879967|FG003|Follow-Up Period|Lost to Follow-up|0|||
161408098|NCT01555125|582879968|FG004|Follow-Up Period|Lost to Follow-up|0|||
161408099|NCT01555125|582879964|FG000|Follow-Up Period|Subject / guardian decision|3|||
161408100|NCT01555125|582879965|FG001|Follow-Up Period|Subject / guardian decision|1|||
161408101|NCT01555125|582879966|FG002|Follow-Up Period|Subject / guardian decision|1|||
161408102|NCT01555125|582879967|FG003|Follow-Up Period|Subject / guardian decision|1|||
161408103|NCT01555125|582879968|FG004|Follow-Up Period|Subject / guardian decision|0|||
161408104|NCT04268745|582879969|FG000|Overall Study|Lost to Follow-up|2|||
161408105|NCT04268745|582879970|FG001|Overall Study|Lost to Follow-up|3|||
161408106|NCT04268745|582879969|FG000|Overall Study|Withdrawal by Subject|4|||
161408107|NCT04268745|582879970|FG001|Overall Study|Withdrawal by Subject|2|||
161408108|NCT04268745|582879969|FG000|Overall Study|Death in the family|1|||
161408109|NCT04268745|582879970|FG001|Overall Study|Death in the family|0|||
161408110|NCT01887353|582879972|FG000|Overall Study|Study stopped early|4|||
161408111|NCT01887353|582879973|FG001|Overall Study|Study stopped early|3|||
161408112|NCT02039856|582879974|FG000|Overall Study|Death|5|||
161408113|NCT02039856|582879975|FG001|Overall Study|Death|3|||
161408114|NCT02039856|582879974|FG000|Overall Study|Partial survey completion|61|||
161408115|NCT02039856|582879975|FG001|Overall Study|Partial survey completion|26|||
161408116|NCT02039856|582879974|FG000|Overall Study|Lost to Follow-up|388|||
161408117|NCT02039856|582879975|FG001|Overall Study|Lost to Follow-up|206|||
161408118|NCT02039856|582879974|FG000|Overall Study|Withdrawal by Subject|1573|||
161408119|NCT02039856|582879975|FG001|Overall Study|Withdrawal by Subject|618|||
161408120|NCT05327361|582879989|FG000|Overall Study|Lost to Follow-up|4|||
161408121|NCT00626405|582879990|FG000|Overall Study|Deemed Ineligible|1|||
161408122|NCT00626405|582879991|FG001|Overall Study|Deemed Ineligible|0|||
161408123|NCT00626405|582879990|FG000|Overall Study|Withdrawal by Subject|0|||
161408124|NCT00626405|582879991|FG001|Overall Study|Withdrawal by Subject|1|||
161408125|NCT01174173|582879992|FG000|Overall Study|drug-drug interaction|1|||
161408126|NCT00649428|582882436|FG000|Overall Study|Adverse Event|2|||
161408127|NCT00649428|582882437|FG001|Overall Study|Adverse Event|2|||
161408128|NCT00649428|582882436|FG000|Overall Study|Withdrawal by Subject|6|||
161408129|NCT00649428|582882437|FG001|Overall Study|Withdrawal by Subject|6|||
161408130|NCT00649428|582882436|FG000|Overall Study|Lost to Follow-up|1|||
161408131|NCT00649428|582882437|FG001|Overall Study|Lost to Follow-up|3|||
161408132|NCT00649428|582882436|FG000|Overall Study|Insufficient manufacturing yield|5|||
161408133|NCT00649428|582882437|FG001|Overall Study|Insufficient manufacturing yield|1|||
161408134|NCT00649428|582882436|FG000|Overall Study|Protocol Violation|6|||
161408135|NCT00649428|582882437|FG001|Overall Study|Protocol Violation|2|||
161408136|NCT00649428|582882436|FG000|Overall Study|Physician Decision|0|||
161408137|NCT00649428|582882437|FG001|Overall Study|Physician Decision|1|||
161408138|NCT02503501|582882438|FG000|Overall Study|Physician Decision|1|||
161408139|NCT02503501|582882439|FG001|Overall Study|Physician Decision|0|||
161408140|NCT02503501|582882438|FG000|Overall Study|Protocol Violation|0|||
161408141|NCT02503501|582882439|FG001|Overall Study|Protocol Violation|1|||
161408142|NCT02503501|582882438|FG000|Overall Study|Withdrawal by Subject|0|||
161408143|NCT02503501|582882439|FG001|Overall Study|Withdrawal by Subject|2|||
161408144|NCT01740401|582882440|FG000|Overall Study|Progression of disease|6|||
161408145|NCT01740401|582882440|FG000|Overall Study|Adverse Event|2|||
161408146|NCT01740401|582882440|FG000|Overall Study|Did not reach primary endpoint|2|||
161408147|NCT02315560|582882441|FG000|Overall Study|noncompliance by subjects|3|||
161408148|NCT02008227|582882442|FG000|Overall Study|Lost to Follow-up|7|||
161408149|NCT02008227|582882443|FG001|Overall Study|Lost to Follow-up|9|||
161408150|NCT02008227|582882442|FG000|Overall Study|Death|494|||
161408151|NCT02008227|582882443|FG001|Overall Study|Death|485|||
161408152|NCT02008227|582882442|FG000|Overall Study|Withdrawal by Subject|67|||
161408153|NCT02008227|582882443|FG001|Overall Study|Withdrawal by Subject|36|||
161408154|NCT02008227|582882442|FG000|Overall Study|Study Terminated By Sponsor|44|||
161408155|NCT02008227|582882443|FG001|Overall Study|Study Terminated By Sponsor|83|||
161408156|NCT04599465|582882444|FG000|Overall Study|Physician Decision|1|||
161408157|NCT04599465|582882444|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
161408158|NCT04566601|582882445|FG000|Overall Study|Other than listed|13|||
161408159|NCT04566601|582882446|FG001|Overall Study|Other than listed|4|||
161408160|NCT04566601|582882447|FG002|Overall Study|Other than listed|2|||
161408161|NCT04566601|582882448|FG003|Overall Study|Other than listed|1|||
161408162|NCT04566601|582882449|FG004|Overall Study|Other than listed|4|||
161408163|NCT04566601|582882445|FG000|Overall Study|Protocol deviation|3|||
161408164|NCT04566601|582882446|FG001|Overall Study|Protocol deviation|0|||
161408165|NCT04566601|582882447|FG002|Overall Study|Protocol deviation|1|||
161408166|NCT04566601|582882448|FG003|Overall Study|Protocol deviation|1|||
161408167|NCT04566601|582882449|FG004|Overall Study|Protocol deviation|1|||
161408168|NCT04566601|582882445|FG000|Overall Study|Technical problems|0|||
161408169|NCT04566601|582882446|FG001|Overall Study|Technical problems|0|||
161408170|NCT04566601|582882447|FG002|Overall Study|Technical problems|1|||
161408171|NCT04566601|582882448|FG003|Overall Study|Technical problems|0|||
161408172|NCT04566601|582882449|FG004|Overall Study|Technical problems|0|||
161408173|NCT04566601|582882445|FG000|Overall Study|No reason available|3|||
161408174|NCT04566601|582882446|FG001|Overall Study|No reason available|2|||
161408175|NCT04566601|582882447|FG002|Overall Study|No reason available|7|||
161408176|NCT04566601|582882448|FG003|Overall Study|No reason available|1|||
161408177|NCT04566601|582882449|FG004|Overall Study|No reason available|5|||
161408178|NCT04566601|582882445|FG000|Overall Study|Burden of study procedures|3|||
161408179|NCT04566601|582882446|FG001|Overall Study|Burden of study procedures|0|||
161408180|NCT04566601|582882447|FG002|Overall Study|Burden of study procedures|0|||
161408181|NCT04566601|582882448|FG003|Overall Study|Burden of study procedures|3|||
161408182|NCT04566601|582882449|FG004|Overall Study|Burden of study procedures|1|||
161408183|NCT04566601|582882445|FG000|Overall Study|Change of residence|2|||
161408184|NCT04566601|582882446|FG001|Overall Study|Change of residence|2|||
161408185|NCT04566601|582882447|FG002|Overall Study|Change of residence|0|||
161408186|NCT04566601|582882448|FG003|Overall Study|Change of residence|1|||
161408187|NCT04566601|582882449|FG004|Overall Study|Change of residence|2|||
161408188|NCT04566601|582882445|FG000|Overall Study|Perceived lack of efficacy|2|||
161408189|NCT04566601|582882446|FG001|Overall Study|Perceived lack of efficacy|0|||
161408190|NCT04566601|582882447|FG002|Overall Study|Perceived lack of efficacy|1|||
161408191|NCT04566601|582882448|FG003|Overall Study|Perceived lack of efficacy|1|||
161408192|NCT04566601|582882449|FG004|Overall Study|Perceived lack of efficacy|2|||
161408193|NCT04566601|582882445|FG000|Overall Study|Adverse Event|7|||
161408194|NCT04566601|582882446|FG001|Overall Study|Adverse Event|4|||
161408195|NCT04566601|582882447|FG002|Overall Study|Adverse Event|6|||
161408196|NCT04566601|582882448|FG003|Overall Study|Adverse Event|5|||
161408197|NCT04566601|582882449|FG004|Overall Study|Adverse Event|12|||
161408198|NCT01272635|582882452|FG000|Overall Study|Lost to Follow-up|31|||
161408199|NCT01272635|582882453|FG001|Overall Study|Lost to Follow-up|20|||
161408200|NCT01272635|582882454|FG002|Overall Study|Lost to Follow-up|31|||
161408201|NCT01272635|582882455|FG003|Overall Study|Lost to Follow-up|23|||
161408202|NCT00306527|582882458|FG000|Overall Study|Lost to Follow-up|3|||
161408203|NCT00306527|582882459|FG001|Overall Study|Lost to Follow-up|4|||
161408204|NCT00306527|582882460|FG002|Overall Study|Lost to Follow-up|3|||
161408205|NCT00306527|582882461|FG003|Overall Study|Lost to Follow-up|0|||
161408206|NCT00306527|582882458|FG000|Overall Study|Withdrawal by Subject|2|||
161408207|NCT00306527|582882459|FG001|Overall Study|Withdrawal by Subject|3|||
161408208|NCT00306527|582882460|FG002|Overall Study|Withdrawal by Subject|0|||
161408209|NCT00306527|582882461|FG003|Overall Study|Withdrawal by Subject|3|||
161408210|NCT00306527|582882458|FG000|Overall Study|Adverse Event|0|||
161408211|NCT00306527|582882459|FG001|Overall Study|Adverse Event|0|||
161408212|NCT00306527|582882460|FG002|Overall Study|Adverse Event|1|||
161408213|NCT00306527|582882461|FG003|Overall Study|Adverse Event|1|||
161408214|NCT00306527|582882458|FG000|Overall Study|Death|1|||
161408215|NCT00306527|582882459|FG001|Overall Study|Death|0|||
161408216|NCT00306527|582882460|FG002|Overall Study|Death|1|||
161408217|NCT00306527|582882461|FG003|Overall Study|Death|2|||
161408218|NCT02702180|582882462|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161408219|NCT02702180|582882463|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161408220|NCT02702180|582882464|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161408221|NCT02702180|582882462|FG000|Double-blind Treatment Period|Adverse Event|0|||
161408222|NCT02702180|582882463|FG001|Double-blind Treatment Period|Adverse Event|0|||
161408223|NCT02702180|582882464|FG002|Double-blind Treatment Period|Adverse Event|1|||
161408224|NCT02702180|582882462|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161408225|NCT02702180|582882463|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161408226|NCT02702180|582882464|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161408227|NCT02702180|582882462|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161408228|NCT02702180|582882463|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161408229|NCT02702180|582882464|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161408230|NCT02702180|582882462|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161408231|NCT02702180|582882463|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
161408232|NCT02702180|582882464|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
161408233|NCT02702180|582882462|FG000|Open-label Treatment Period|Withdrawn in error|0|||
161408234|NCT02702180|582882463|FG001|Open-label Treatment Period|Withdrawn in error|0|||
161408235|NCT02702180|582882464|FG002|Open-label Treatment Period|Withdrawn in error|1|||
161408236|NCT00785980|582882465|FG000|7 Day Washout Period|Protocol Violation|3|||
161408237|NCT02352753|582882466|FG000|6-Month Dosing Period|Decision by sponsor|2|||
161408238|NCT02352753|582882466|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
161408239|NCT02352753|582882466|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
161408240|NCT02352753|582882466|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
161408241|NCT02352753|582882466|FG000|3-Month Dosing Period|Decision by sponsor|14|||
161408242|NCT02352753|582882466|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
161408243|NCT00539305|582882467|FG000|Overall Study|Adverse Event|1|||
161408244|NCT00539305|582882468|FG001|Overall Study|Adverse Event|0|||
161408245|NCT00539305|582882467|FG000|Overall Study|Substance Use|0|||
161408246|NCT00539305|582882468|FG001|Overall Study|Substance Use|1|||
161408247|NCT00539305|582882467|FG000|Overall Study|Withdrawal by Subject|0|||
161408248|NCT00539305|582882468|FG001|Overall Study|Withdrawal by Subject|1|||
161408249|NCT00126776|582882470|FG000|Overall Study|follow up complete on all patients|0|||
161408250|NCT00126776|582882471|FG001|Overall Study|follow up complete on all patients|0|||
161408251|NCT00679172|582882475|FG000|Overall Study|Non-compliance|1|||
161408252|NCT00679172|582882476|FG001|Overall Study|Non-compliance|1|||
161408253|NCT00679172|582882477|FG002|Overall Study|Non-compliance|0|||
161408254|NCT00679172|582882478|FG003|Overall Study|Non-compliance|1|||
161408255|NCT00679172|582882479|FG004|Overall Study|Non-compliance|0|||
161408256|NCT00679172|582882475|FG000|Overall Study|Other not specified|0|||
161408257|NCT00679172|582882476|FG001|Overall Study|Other not specified|0|||
161408258|NCT00679172|582882477|FG002|Overall Study|Other not specified|1|||
161408259|NCT00679172|582882478|FG003|Overall Study|Other not specified|0|||
161408260|NCT00679172|582882479|FG004|Overall Study|Other not specified|0|||
161408261|NCT00417963|582882491|FG000|Overall Study|Lost to Follow-up|3|||
161408262|NCT00417963|582882491|FG000|Overall Study|Withdrawal by Subject|18|||
161408263|NCT00417963|582882491|FG000|Overall Study|Death|17|||
161408264|NCT00417963|582882491|FG000|Overall Study|Study device could not be deployed|3|||
161408265|NCT01815840|582882493|FG000|Overall Study|Missing|1|||
161408266|NCT01815840|582882494|FG001|Overall Study|Missing|0|||
161408267|NCT01815840|582882493|FG000|Overall Study|Withdrew Consent|31|||
161408268|NCT01815840|582882494|FG001|Overall Study|Withdrew Consent|30|||
161408269|NCT01815840|582882493|FG000|Overall Study|Administrative/Other|1|||
161408270|NCT01815840|582882494|FG001|Overall Study|Administrative/Other|3|||
161408271|NCT01815840|582882493|FG000|Overall Study|Adverse Event|10|||
161408272|NCT01815840|582882494|FG001|Overall Study|Adverse Event|16|||
161408273|NCT01815840|582882493|FG000|Overall Study|Death|2|||
161408274|NCT01815840|582882494|FG001|Overall Study|Death|2|||
161408275|NCT01815840|582882493|FG000|Overall Study|Disease progression|3|||
161408276|NCT01815840|582882494|FG001|Overall Study|Disease progression|2|||
161408277|NCT01815840|582882493|FG000|Overall Study|Investigators Decision|2|||
161408278|NCT01815840|582882494|FG001|Overall Study|Investigators Decision|3|||
161408279|NCT01815840|582882493|FG000|Overall Study|Lost to Follow-up|3|||
161408280|NCT01815840|582882494|FG001|Overall Study|Lost to Follow-up|6|||
161408281|NCT01815840|582882493|FG000|Overall Study|Refused Treatment|5|||
161408282|NCT01815840|582882494|FG001|Overall Study|Refused Treatment|1|||
161408283|NCT01815840|582882493|FG000|Overall Study|Sponsor Termination Treatment|1|||
161408284|NCT01815840|582882494|FG001|Overall Study|Sponsor Termination Treatment|0|||
161408285|NCT00434642|582882495|FG000|Blinded Treatment Phase|Adverse Event|12|||
161408286|NCT00434642|582882496|FG001|Blinded Treatment Phase|Adverse Event|58|||
161408287|NCT00434642|582882495|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
161408288|NCT00434642|582882496|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
161408289|NCT00434642|582882495|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
161408290|NCT00434642|582882496|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
161408291|NCT00434642|582882495|FG000|Blinded Treatment Phase|Physician Decision|19|||
161408292|NCT00434642|582882496|FG001|Blinded Treatment Phase|Physician Decision|27|||
161408293|NCT00434642|582882495|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
161408294|NCT00434642|582882496|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
161408295|NCT00434642|582882495|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
161408296|NCT00434642|582882496|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
161408297|NCT00434642|582882495|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
161408298|NCT00434642|582882496|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
161408299|NCT00434642|582882495|FG000|Open-label Treatment Phase|Adverse Event|0|||
161408300|NCT00434642|582882496|FG001|Open-label Treatment Phase|Adverse Event|5|||
161408301|NCT00434642|582882495|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
161408302|NCT00434642|582882496|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
161408303|NCT02241343|582882499|FG000|Overall Study|Adverse Event|1|||
161408304|NCT04680975|582882500|FG000|Overall Study|Adverse Event|3|||
161408305|NCT04680975|582882500|FG000|Overall Study|Death|1|||
161408306|NCT04680975|582882500|FG000|Overall Study|Progressive Disease|1|||
161408307|NCT04680975|582882500|FG000|Overall Study|Withdrawal by Subject|1|||
161408308|NCT00753454|582882501|FG000|Overall Study|Adverse Event|4|||
161408309|NCT00753454|582882501|FG000|Overall Study|Lack of Efficacy|1|||
161408310|NCT00753454|582882501|FG000|Overall Study|Lost to Follow-up|3|||
161408311|NCT00753454|582882501|FG000|Overall Study|Withdrawal by Subject|5|||
161408312|NCT00753454|582882501|FG000|Overall Study|Investigator Decision|1|||
161408313|NCT05856227|582882504|FG000|Overall Study|Adverse Event|0|||
161408314|NCT05856227|582882505|FG001|Overall Study|Adverse Event|1|||
161408315|NCT05856227|582882504|FG000|Overall Study|Due to Investigator absence|1|||
161408316|NCT05856227|582882505|FG001|Overall Study|Due to Investigator absence|0|||
161408317|NCT05856227|582882504|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
161408318|NCT05856227|582882505|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
161408319|NCT05011058|582882506|FG000|Overall Study|Sponsor Decision|2|||
161408320|NCT05011058|582882507|FG001|Overall Study|Sponsor Decision|0|||
161408321|NCT05011058|582882508|FG002|Overall Study|Sponsor Decision|14|||
161408322|NCT05011058|582882509|FG003|Overall Study|Sponsor Decision|0|||
161408323|NCT05011058|582882510|FG004|Overall Study|Sponsor Decision|0|||
161408324|NCT05011058|582882511|FG005|Overall Study|Sponsor Decision|1|||
161408325|NCT05011058|582882512|FG006|Overall Study|Sponsor Decision|0|||
161408326|NCT05011058|582882513|FG007|Overall Study|Sponsor Decision|5|||
161408327|NCT01571232|582882514|FG000|Overall Study|Lost to Follow-up|0|||
161408328|NCT01571232|582882515|FG001|Overall Study|Lost to Follow-up|1|||
161408329|NCT01571232|582882514|FG000|Overall Study|Withdrawal by Subject|1|||
161408330|NCT01571232|582882515|FG001|Overall Study|Withdrawal by Subject|0|||
161408331|NCT01272869|582882516|FG000|Period 2 (14 Days)|Adverse Event|1|||
161408332|NCT01272869|582882517|FG001|Period 2 (14 Days)|Adverse Event|0|||
161408333|NCT02271945|582882518|FG000|Overall Study|Death|3|||
161408334|NCT02271945|582882519|FG001|Overall Study|Death|3|||
161408335|NCT02271945|582882518|FG000|Overall Study|Withdrawal by Subject|1|||
161408336|NCT02271945|582882519|FG001|Overall Study|Withdrawal by Subject|1|||
161408337|NCT02271945|582882518|FG000|Overall Study|Other|1|||
161408338|NCT02271945|582882519|FG001|Overall Study|Other|1|||
161408339|NCT02455076|582882520|FG000|Inpatient|Withdrawal by Subject|1|||
161408340|NCT02455076|582882521|FG001|Inpatient|Withdrawal by Subject|0|||
161408341|NCT02455076|582882522|FG002|Inpatient|Withdrawal by Subject|0|||
161408342|NCT02455076|582882523|FG003|Inpatient|Withdrawal by Subject|0|||
161408343|NCT02455076|582882524|FG004|Inpatient|Withdrawal by Subject|0|||
161408344|NCT02455076|582882520|FG000|Inpatient|Discharged <24 h after admission|0|||
161408345|NCT02455076|582882521|FG001|Inpatient|Discharged <24 h after admission|1|||
161408346|NCT02455076|582882522|FG002|Inpatient|Discharged <24 h after admission|0|||
161408347|NCT02455076|582882523|FG003|Inpatient|Discharged <24 h after admission|0|||
161408348|NCT02455076|582882524|FG004|Inpatient|Discharged <24 h after admission|0|||
161408349|NCT02455076|582882520|FG000|Inpatient|Adverse Event|3|||
161408350|NCT02455076|582882521|FG001|Inpatient|Adverse Event|0|||
161408351|NCT02455076|582882522|FG002|Inpatient|Adverse Event|0|||
161408352|NCT02455076|582882523|FG003|Inpatient|Adverse Event|0|||
161408353|NCT02455076|582882524|FG004|Inpatient|Adverse Event|0|||
161408354|NCT02455076|582882520|FG000|Outpatient|Adverse Event|0|||
161408355|NCT02455076|582882521|FG001|Outpatient|Adverse Event|0|||
161408356|NCT02455076|582882522|FG002|Outpatient|Adverse Event|0|||
161408357|NCT02455076|582882523|FG003|Outpatient|Adverse Event|5|||
161408358|NCT02455076|582882524|FG004|Outpatient|Adverse Event|0|||
161408359|NCT02455076|582882520|FG000|Outpatient|Lost to Follow-up|0|||
161408360|NCT02455076|582882521|FG001|Outpatient|Lost to Follow-up|0|||
161408361|NCT02455076|582882522|FG002|Outpatient|Lost to Follow-up|0|||
161408362|NCT02455076|582882523|FG003|Outpatient|Lost to Follow-up|1|||
161408363|NCT02455076|582882524|FG004|Outpatient|Lost to Follow-up|12|||
161408364|NCT03908476|582882526|FG000|Overall Study|Death|3|||
161408365|NCT03908476|582882527|FG001|Overall Study|Death|0|||
161408366|NCT03908476|582882526|FG000|Overall Study|Lost to Follow-up|3|||
161408367|NCT03908476|582882527|FG001|Overall Study|Lost to Follow-up|1|||
161408368|NCT03908476|582882526|FG000|Overall Study|Withdrawal by Subject|7|||
161408369|NCT03908476|582882527|FG001|Overall Study|Withdrawal by Subject|1|||
161408370|NCT03908476|582882526|FG000|Overall Study|Physician Decision|2|||
161408371|NCT03908476|582882527|FG001|Overall Study|Physician Decision|0|||
161408372|NCT03908476|582882526|FG000|Overall Study|System Explanted and not Replaced|4|||
161408373|NCT03908476|582882527|FG001|Overall Study|System Explanted and not Replaced|0|||
161408374|NCT03908476|582882526|FG000|Overall Study|Intrathecal Pump|1|||
161408375|NCT03908476|582882527|FG001|Overall Study|Intrathecal Pump|0|||
161408376|NCT03908476|582882526|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
161408377|NCT03908476|582882527|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
161408378|NCT05194267|582882528|FG000|Overall Study|Withdrawal by Subject|2|||
161408379|NCT02868229|582882529|FG000|Overall Study|Adverse Event|1|||
161408380|NCT02868229|582882530|FG001|Overall Study|Adverse Event|0|||
161408381|NCT02868229|582882531|FG002|Overall Study|Adverse Event|0|||
161408382|NCT02868229|582882532|FG003|Overall Study|Adverse Event|1|||
161408383|NCT02868229|582882529|FG000|Overall Study|Death|0|||
161408384|NCT02868229|582882530|FG001|Overall Study|Death|0|||
161408385|NCT02868229|582882531|FG002|Overall Study|Death|1|||
161408386|NCT02868229|582882532|FG003|Overall Study|Death|1|||
161408387|NCT02868229|582882529|FG000|Overall Study|Missed dose|0|||
161408388|NCT02868229|582882530|FG001|Overall Study|Missed dose|0|||
161408389|NCT02868229|582882531|FG002|Overall Study|Missed dose|0|||
161408390|NCT02868229|582882532|FG003|Overall Study|Missed dose|3|||
161408391|NCT06151288|582882533|FG000|Overall Study|Lost to Follow-up|4|||
161408392|NCT06151288|582882534|FG001|Overall Study|Lost to Follow-up|2|||
161408393|NCT06151288|582882535|FG002|Overall Study|Lost to Follow-up|4|||
161408394|NCT06151288|582882536|FG003|Overall Study|Lost to Follow-up|3|||
161408395|NCT06151288|582882533|FG000|Overall Study|Withdrawal by Subject|4|||
161408396|NCT06151288|582882534|FG001|Overall Study|Withdrawal by Subject|5|||
161408397|NCT06151288|582882535|FG002|Overall Study|Withdrawal by Subject|1|||
161408398|NCT06151288|582882536|FG003|Overall Study|Withdrawal by Subject|1|||
161408399|NCT01646203|582882541|FG000|Overall Study|Adverse Event|2|||
161408400|NCT01646203|582882542|FG001|Overall Study|Adverse Event|0|||
161408401|NCT01646203|582882543|FG002|Overall Study|Adverse Event|1|||
161408402|NCT01646203|582882541|FG000|Overall Study|Withdrawal by Subject|0|||
161408403|NCT01646203|582882542|FG001|Overall Study|Withdrawal by Subject|1|||
161408404|NCT01646203|582882543|FG002|Overall Study|Withdrawal by Subject|0|||
161408405|NCT01646203|582882541|FG000|Overall Study|Physician's Decision|0|||
161408406|NCT01646203|582882542|FG001|Overall Study|Physician's Decision|1|||
161408407|NCT01646203|582882543|FG002|Overall Study|Physician's Decision|0|||
161408408|NCT04676867|582882544|FG000|Overall Study|Screen failure|0|||
161408409|NCT04676867|582882545|FG001|Overall Study|Screen failure|0|||
161408410|NCT04676867|582882546|FG002|Overall Study|Screen failure|6|||
161408411|NCT04676867|582882547|FG003|Overall Study|Screen failure|2|||
161408412|NCT04676867|582882544|FG000|Overall Study|Death|0|||
161408413|NCT04676867|582882545|FG001|Overall Study|Death|0|||
161408414|NCT04676867|582882546|FG002|Overall Study|Death|1|||
161408415|NCT04676867|582882547|FG003|Overall Study|Death|0|||
161408416|NCT04676867|582882544|FG000|Overall Study|Withdrawal by Subject|2|||
161408417|NCT04676867|582882545|FG001|Overall Study|Withdrawal by Subject|2|||
161408418|NCT04676867|582882546|FG002|Overall Study|Withdrawal by Subject|4|||
161408419|NCT04676867|582882547|FG003|Overall Study|Withdrawal by Subject|4|||
161408420|NCT04676867|582882544|FG000|Overall Study|Lost to Follow-up|1|||
161408421|NCT04676867|582882545|FG001|Overall Study|Lost to Follow-up|0|||
161408422|NCT04676867|582882546|FG002|Overall Study|Lost to Follow-up|0|||
161408423|NCT04676867|582882547|FG003|Overall Study|Lost to Follow-up|0|||
161408424|NCT02717130|582882551|FG000|Overall Study|Withdrawal by Subject|1|||
161408425|NCT02717130|582882551|FG000|Overall Study|Adverse Event|1|||
161408426|NCT02717130|582882551|FG000|Overall Study|Physician Decision|1|||
161408427|NCT02717130|582882551|FG000|Overall Study|Study Closure|4|||
161408428|NCT00548717|582882554|FG000|Overall Study|Death|5|||
161408429|NCT00548717|582882555|FG001|Overall Study|Death|2|||
161408430|NCT00548717|582882554|FG000|Overall Study|Relapse|3|||
161408431|NCT00548717|582882555|FG001|Overall Study|Relapse|0|||
161408432|NCT00548717|582882554|FG000|Overall Study|Alternative treatment for GVHD|1|||
161408433|NCT00548717|582882555|FG001|Overall Study|Alternative treatment for GVHD|0|||
161408434|NCT00551291|582882559|FG000|Overall Study|Physician Decision|1|||
161408435|NCT04268173|582882560|FG000|Overall Study|Lost to Follow-up|75|||
161408436|NCT04268173|582882561|FG001|Overall Study|Lost to Follow-up|108|||
161408437|NCT01953913|582882562|FG000|Overall Study|Disease Progression|349|||
161408438|NCT01953913|582882562|FG000|Overall Study|Worsening of underlying cancer|22|||
161408439|NCT01953913|582882562|FG000|Overall Study|Adverse Event|20|||
161408440|NCT01953913|582882562|FG000|Overall Study|Protocol Violation|6|||
161408441|NCT01953913|582882562|FG000|Overall Study|Lost to Follow-up|4|||
161408442|NCT01953913|582882562|FG000|Overall Study|Withdrawal by Subject|32|||
161408443|NCT01953913|582882562|FG000|Overall Study|Other than listed|108|||
161408444|NCT01953913|582882562|FG000|Overall Study|Not Treated|1|||
161408445|NCT02925741|582882563|FG000|Overall Study|Withdrawal by Subject|11|||
161408446|NCT02925741|582882564|FG001|Overall Study|Withdrawal by Subject|0|||
161408447|NCT00710385|582882565|FG000|Overall Study|Did not qualify|1|||
161408448|NCT00710385|582882565|FG000|Overall Study|Withdrawal by Subject|1|||
161408449|NCT00710385|582882565|FG000|Overall Study|Undisclosed back pain|1|||
161408450|NCT00710385|582882565|FG000|Overall Study|Physician Decision|1|||
161408451|NCT00710385|582882565|FG000|Overall Study|Undisclosed excessive methadone use|1|||
161408452|NCT01600092|582882566|FG000|Overall Study|Adverse Event|2|||
161408453|NCT01600092|582882567|FG001|Overall Study|Adverse Event|0|||
161408454|NCT01600092|582882566|FG000|Overall Study|Lost to Follow-up|4|||
161408455|NCT01600092|582882567|FG001|Overall Study|Lost to Follow-up|6|||
161408456|NCT01600092|582882566|FG000|Overall Study|Withdrawal by parent/guardian|8|||
161408457|NCT01600092|582882567|FG001|Overall Study|Withdrawal by parent/guardian|6|||
161408458|NCT01600092|582882566|FG000|Overall Study|Physician Decision|1|||
161408459|NCT01600092|582882567|FG001|Overall Study|Physician Decision|1|||
161408460|NCT01600092|582882566|FG000|Overall Study|Randomized but not vaccinated|3|||
161408461|NCT01600092|582882567|FG001|Overall Study|Randomized but not vaccinated|3|||
161408462|NCT02976103|582882568|FG000|Overall Study|Withdrawal by Subject|1|||
161408463|NCT02976103|582882569|FG001|Overall Study|Withdrawal by Subject|0|||
161408464|NCT02976103|582882568|FG000|Overall Study|Lost to Follow-up|12|||
161408465|NCT02976103|582882569|FG001|Overall Study|Lost to Follow-up|8|||
161408466|NCT01561963|582882570|FG000|Overall Study|Adverse Event|1|||
161408467|NCT03040986|582882571|FG000|Overall Study|Hospice|1|||
161408468|NCT03040986|582882572|FG001|Overall Study|Hospice|0|||
161408469|NCT03040986|582882571|FG000|Overall Study|Adverse Event|2|||
161408470|NCT03040986|582882572|FG001|Overall Study|Adverse Event|1|||
161408471|NCT03040986|582882571|FG000|Overall Study|Disease progression on study|3|||
161408472|NCT03040986|582882572|FG001|Overall Study|Disease progression on study|1|||
161408473|NCT02228096|582882576|FG000|Overall Study|Study terminated by Sponsor|24|||
161408474|NCT02228096|582882576|FG000|Overall Study|Lack of Efficacy|18|||
161408475|NCT02228096|582882576|FG000|Overall Study|Death|12|||
161408476|NCT02228096|582882576|FG000|Overall Study|Physician Decision|3|||
161408477|NCT02228096|582882576|FG000|Overall Study|Subject/guardian decision|2|||
161408478|NCT02228096|582882576|FG000|Overall Study|New therapy for study indication|1|||
161408479|NCT02228096|582882576|FG000|Overall Study|Enrolled, not infused|11|||
161408480|NCT02383433|582882577|FG000|Overall Study|Disease progression|2|||
161408481|NCT00952614|582882580|FG000|Overall Study|Death|3|||
161408482|NCT00952614|582882580|FG000|Overall Study|Lost to Follow-up|3|||
161408483|NCT00952614|582882580|FG000|Overall Study|other reason|1|||
161408484|NCT02925728|582882581|FG000|Overall Study|Death|3|||
161408485|NCT02925728|582882582|FG001|Overall Study|Death|5|||
161408486|NCT02925728|582882581|FG000|Overall Study|Physician Decision|1|||
161408487|NCT02925728|582882582|FG001|Overall Study|Physician Decision|0|||
161408488|NCT02925728|582882581|FG000|Overall Study|Withdrawal by Subject|1|||
161408489|NCT02925728|582882582|FG001|Overall Study|Withdrawal by Subject|0|||
161408490|NCT01075984|582882583|FG000|Treatment Phase|Adverse Event|0|||
161408491|NCT01075984|582882584|FG001|Treatment Phase|Adverse Event|1|||
161408492|NCT01075984|582882585|FG002|Treatment Phase|Adverse Event|3|||
161408493|NCT01075984|582882586|FG003|Treatment Phase|Adverse Event|7|||
161408494|NCT01075984|582882587|FG004|Treatment Phase|Adverse Event|35|||
161408495|NCT01075984|582882583|FG000|Treatment Phase|Protocol Violation|0|||
161408496|NCT01075984|582882584|FG001|Treatment Phase|Protocol Violation|0|||
161408497|NCT01075984|582882585|FG002|Treatment Phase|Protocol Violation|1|||
161408498|NCT01075984|582882586|FG003|Treatment Phase|Protocol Violation|0|||
161408499|NCT01075984|582882587|FG004|Treatment Phase|Protocol Violation|3|||
161408500|NCT01075984|582882583|FG000|Treatment Phase|Withdrawal by Subject|0|||
161408501|NCT01075984|582882584|FG001|Treatment Phase|Withdrawal by Subject|0|||
161408502|NCT01075984|582882585|FG002|Treatment Phase|Withdrawal by Subject|2|||
161408503|NCT01075984|582882586|FG003|Treatment Phase|Withdrawal by Subject|0|||
161408504|NCT01075984|582882587|FG004|Treatment Phase|Withdrawal by Subject|15|||
161408505|NCT01075984|582882583|FG000|Treatment Phase|Treatment Failure|0|||
161408506|NCT01075984|582882584|FG001|Treatment Phase|Treatment Failure|0|||
161408507|NCT01075984|582882585|FG002|Treatment Phase|Treatment Failure|1|||
161408508|NCT01075984|582882586|FG003|Treatment Phase|Treatment Failure|0|||
161408509|NCT01075984|582882587|FG004|Treatment Phase|Treatment Failure|5|||
161408510|NCT01075984|582882583|FG000|Treatment Phase|Progression of disease|0|||
161408511|NCT01075984|582882584|FG001|Treatment Phase|Progression of disease|0|||
161408512|NCT01075984|582882585|FG002|Treatment Phase|Progression of disease|0|||
161408513|NCT01075984|582882586|FG003|Treatment Phase|Progression of disease|0|||
161408514|NCT01075984|582882587|FG004|Treatment Phase|Progression of disease|2|||
161408515|NCT01075984|582882583|FG000|Follow-up Phase|Protocol Violation|0|||
161408516|NCT01075984|582882584|FG001|Follow-up Phase|Protocol Violation|0|||
161408517|NCT01075984|582882585|FG002|Follow-up Phase|Protocol Violation|1|||
161408518|NCT01075984|582882586|FG003|Follow-up Phase|Protocol Violation|0|||
161408519|NCT01075984|582882587|FG004|Follow-up Phase|Protocol Violation|3|||
161408520|NCT01075984|582882583|FG000|Follow-up Phase|Adverse Event|0|||
161408521|NCT01075984|582882584|FG001|Follow-up Phase|Adverse Event|0|||
161408522|NCT01075984|582882585|FG002|Follow-up Phase|Adverse Event|0|||
161408523|NCT01075984|582882586|FG003|Follow-up Phase|Adverse Event|2|||
161408524|NCT01075984|582882587|FG004|Follow-up Phase|Adverse Event|27|||
161408525|NCT01075984|582882583|FG000|Follow-up Phase|Administrative|0|||
161408526|NCT01075984|582882584|FG001|Follow-up Phase|Administrative|0|||
161408527|NCT01075984|582882585|FG002|Follow-up Phase|Administrative|0|||
161408528|NCT01075984|582882586|FG003|Follow-up Phase|Administrative|0|||
161408529|NCT01075984|582882587|FG004|Follow-up Phase|Administrative|1|||
161408530|NCT01075984|582882583|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161408531|NCT01075984|582882584|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161408532|NCT01075984|582882585|FG002|Follow-up Phase|Withdrawal by Subject|0|||
161408533|NCT01075984|582882586|FG003|Follow-up Phase|Withdrawal by Subject|0|||
161408534|NCT01075984|582882587|FG004|Follow-up Phase|Withdrawal by Subject|10|||
161408535|NCT01075984|582882583|FG000|Follow-up Phase|Progression of disease|0|||
161408536|NCT01075984|582882584|FG001|Follow-up Phase|Progression of disease|0|||
161408537|NCT01075984|582882585|FG002|Follow-up Phase|Progression of disease|0|||
161408538|NCT01075984|582882586|FG003|Follow-up Phase|Progression of disease|0|||
161408539|NCT01075984|582882587|FG004|Follow-up Phase|Progression of disease|2|||
161408540|NCT01075984|582882583|FG000|Follow-up Phase|Treatment failure|0|||
161408541|NCT01075984|582882584|FG001|Follow-up Phase|Treatment failure|0|||
161408542|NCT01075984|582882585|FG002|Follow-up Phase|Treatment failure|0|||
161408543|NCT01075984|582882586|FG003|Follow-up Phase|Treatment failure|0|||
161408544|NCT01075984|582882587|FG004|Follow-up Phase|Treatment failure|4|||
161408545|NCT03101085|582882588|FG000|Overall Study|Lost to Follow-up|0|||
161408546|NCT03101085|582882589|FG001|Overall Study|Lost to Follow-up|1|||
161408547|NCT02986854|582882590|FG000|Overall Study|Withdrawal by Subject|0|||
161408548|NCT02986854|582882591|FG001|Overall Study|Withdrawal by Subject|1|||
161408549|NCT02986854|582882592|FG002|Overall Study|Withdrawal by Subject|1|||
161408550|NCT02986854|582882590|FG000|Overall Study|Lost to Follow-up|3|||
161408551|NCT02986854|582882591|FG001|Overall Study|Lost to Follow-up|11|||
161408552|NCT02986854|582882592|FG002|Overall Study|Lost to Follow-up|2|||
161408553|NCT00086411|582882597|FG000|Overall Study|Lost to Follow-up|11|||
161408554|NCT00086411|582882598|FG001|Overall Study|Lost to Follow-up|11|||
161408555|NCT00086411|582882599|FG002|Overall Study|Lost to Follow-up|13|||
161408556|NCT00086411|582882600|FG003|Overall Study|Lost to Follow-up|12|||
161408557|NCT01624090|582882608|FG000|Overall Study|DLT, taken off therapy|0|||
161408558|NCT01624090|582882609|FG001|Overall Study|DLT, taken off therapy|1|||
161408559|NCT01624090|582882610|FG002|Overall Study|DLT, taken off therapy|0|||
161408560|NCT01624090|582882611|FG003|Overall Study|DLT, taken off therapy|0|||
161408561|NCT01624090|582882608|FG000|Overall Study|Withdrew prior to treatment|0|||
161408562|NCT01624090|582882609|FG001|Overall Study|Withdrew prior to treatment|1|||
161408563|NCT01624090|582882610|FG002|Overall Study|Withdrew prior to treatment|0|||
161408564|NCT01624090|582882611|FG003|Overall Study|Withdrew prior to treatment|0|||
161408565|NCT01624090|582882608|FG000|Overall Study|Died on study|0|||
161408566|NCT01624090|582882609|FG001|Overall Study|Died on study|0|||
161408567|NCT01624090|582882610|FG002|Overall Study|Died on study|2|||
161408568|NCT01624090|582882611|FG003|Overall Study|Died on study|0|||
161408569|NCT01624090|582882608|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
161408570|NCT01624090|582882609|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
161408571|NCT01624090|582882610|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
161408572|NCT01624090|582882611|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
161408573|NCT01624090|582882608|FG000|Overall Study|Dose escalated|0|||
161408574|NCT01624090|582882609|FG001|Overall Study|Dose escalated|0|||
161408575|NCT01624090|582882610|FG002|Overall Study|Dose escalated|3|||
161408576|NCT01624090|582882611|FG003|Overall Study|Dose escalated|0|||
161408577|NCT01403116|582882612|FG000|Overall Study|Adverse Event|7|||
161408578|NCT01403116|582882613|FG001|Overall Study|Adverse Event|4|||
161408579|NCT01403116|582882612|FG000|Overall Study|Lost to Follow-up|7|||
161408580|NCT01403116|582882613|FG001|Overall Study|Lost to Follow-up|5|||
161408581|NCT01403116|582882612|FG000|Overall Study|Withdrawal by Subject|12|||
161408582|NCT01403116|582882613|FG001|Overall Study|Withdrawal by Subject|15|||
161408583|NCT01403116|582882612|FG000|Overall Study|Non-compliance of study drug|3|||
161408584|NCT01403116|582882613|FG001|Overall Study|Non-compliance of study drug|0|||
161408585|NCT01403116|582882612|FG000|Overall Study|Protocol Violation|0|||
161408586|NCT01403116|582882613|FG001|Overall Study|Protocol Violation|1|||
161408587|NCT01403116|582882612|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
161408588|NCT01403116|582882613|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
161408589|NCT01403116|582882612|FG000|Overall Study|Hct >54%|2|||
161408590|NCT01403116|582882613|FG001|Overall Study|Hct >54%|0|||
161408591|NCT01403116|582882612|FG000|Overall Study|unable to keep appointments|0|||
161408592|NCT01403116|582882613|FG001|Overall Study|unable to keep appointments|2|||
161408593|NCT01895309|582882614|FG000|Overall Study|Adverse Event|13|||
161408594|NCT01895309|582882615|FG001|Overall Study|Adverse Event|17|||
161408595|NCT01895309|582882614|FG000|Overall Study|Protocol Violation|1|||
161408596|NCT01895309|582882615|FG001|Overall Study|Protocol Violation|0|||
161408597|NCT01895309|582882614|FG000|Overall Study|Lack of Efficacy|1|||
161408598|NCT01895309|582882615|FG001|Overall Study|Lack of Efficacy|3|||
161408599|NCT01895309|582882614|FG000|Overall Study|Lost to Follow-up|1|||
161408600|NCT01895309|582882615|FG001|Overall Study|Lost to Follow-up|3|||
161408601|NCT01895309|582882614|FG000|Overall Study|Physician Decision|15|||
161408602|NCT01895309|582882615|FG001|Overall Study|Physician Decision|10|||
161408603|NCT01895309|582882614|FG000|Overall Study|Withdrawal by Subject|9|||
161408604|NCT01895309|582882615|FG001|Overall Study|Withdrawal by Subject|18|||
161408605|NCT00042666|582882616|FG000|Overall Study|Adverse Event|2|||
161408606|NCT00042666|582882616|FG000|Overall Study|Death|4|||
161408607|NCT00042666|582882616|FG000|Overall Study|Protocol Violation|1|||
161408608|NCT00042666|582882616|FG000|Overall Study|Participant/Physician Perception|1|||
161408609|NCT00042666|582882616|FG000|Overall Study|Progressive Disease|41|||
161408610|NCT00042666|582882616|FG000|Overall Study|Other|1|||
161408611|NCT00042666|582882616|FG000|Overall Study|Other|4|||
161435304|NCT00627393|582987982|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
161435305|NCT00627393|582987983|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
161435306|NCT00627393|582987982|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
161435307|NCT00627393|582987983|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
161435308|NCT00627393|582987982|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
161435309|NCT00627393|582987983|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
161435310|NCT03337308|582987986|FG000|Overall Study|Adverse Event|2|||
161435311|NCT03337308|582987987|FG001|Overall Study|Adverse Event|3|||
161435312|NCT03337308|582987988|FG002|Overall Study|Adverse Event|3|||
161435313|NCT03337308|582987989|FG003|Overall Study|Adverse Event|1|||
161435314|NCT03337308|582987986|FG000|Overall Study|Lost to Follow-up|1|||
161435315|NCT03337308|582987987|FG001|Overall Study|Lost to Follow-up|2|||
161435316|NCT03337308|582987988|FG002|Overall Study|Lost to Follow-up|0|||
161435317|NCT03337308|582987989|FG003|Overall Study|Lost to Follow-up|0|||
161435318|NCT03337308|582987986|FG000|Overall Study|Withdrawal by Subject|2|||
161435319|NCT03337308|582987987|FG001|Overall Study|Withdrawal by Subject|1|||
161435320|NCT03337308|582987988|FG002|Overall Study|Withdrawal by Subject|2|||
161435321|NCT03337308|582987989|FG003|Overall Study|Withdrawal by Subject|1|||
161435322|NCT03337308|582987986|FG000|Overall Study|Protocol Violation|0|||
161435323|NCT03337308|582987987|FG001|Overall Study|Protocol Violation|1|||
161435324|NCT03337308|582987988|FG002|Overall Study|Protocol Violation|0|||
161435325|NCT03337308|582987989|FG003|Overall Study|Protocol Violation|0|||
161435326|NCT00283296|582987991|FG000|Overall Study|in-home trial not completed|5|||
161435327|NCT03558737|582987992|FG000|Overall Study|Death|1|||
161435328|NCT03558737|582987993|FG001|Overall Study|Death|1|||
161435329|NCT01294553|582987994|FG000|Overall Study|Duplicated Participants|1|||
161435330|NCT01294553|582987994|FG000|Overall Study|Protocol Violation|268|||
161435331|NCT00795535|582987995|FG000|Overall Study|incomplete data and technical problems|20|||
161435332|NCT01903460|582987996|FG000|Overall Study|Adverse Event|0|||
161435333|NCT01903460|582987997|FG001|Overall Study|Adverse Event|0|||
161435334|NCT01903460|582987998|FG002|Overall Study|Adverse Event|0|||
161435335|NCT01903460|582987999|FG003|Overall Study|Adverse Event|1|||
161435336|NCT03104868|582988000|FG000|6 Week Follow up|Lost to Follow-up|5|||
161408612|NCT03343626|582884462|FG000|Overall Study|Lost to Follow-up|4|||
161408613|NCT03343626|582884463|FG001|Overall Study|Lost to Follow-up|3|||
161408614|NCT03343626|582884464|FG002|Overall Study|Lost to Follow-up|2|||
161408615|NCT03343626|582884465|FG003|Overall Study|Lost to Follow-up|5|||
161408616|NCT03343626|582884466|FG004|Overall Study|Lost to Follow-up|4|||
161408617|NCT03343626|582884467|FG005|Overall Study|Lost to Follow-up|4|||
161408618|NCT03343626|582884468|FG006|Overall Study|Lost to Follow-up|4|||
161408619|NCT03343626|582884469|FG007|Overall Study|Lost to Follow-up|7|||
161408620|NCT03343626|582884462|FG000|Overall Study|Withdrawal of Consent|2|||
161408621|NCT03343626|582884463|FG001|Overall Study|Withdrawal of Consent|1|||
161408622|NCT03343626|582884464|FG002|Overall Study|Withdrawal of Consent|0|||
161408623|NCT03343626|582884465|FG003|Overall Study|Withdrawal of Consent|3|||
161408624|NCT03343626|582884466|FG004|Overall Study|Withdrawal of Consent|3|||
161408625|NCT03343626|582884467|FG005|Overall Study|Withdrawal of Consent|1|||
161408626|NCT03343626|582884468|FG006|Overall Study|Withdrawal of Consent|1|||
161408627|NCT03343626|582884469|FG007|Overall Study|Withdrawal of Consent|2|||
161408628|NCT03343626|582884462|FG000|Overall Study|Reason not Specified|0|||
161408629|NCT03343626|582884463|FG001|Overall Study|Reason not Specified|1|||
161408630|NCT03343626|582884464|FG002|Overall Study|Reason not Specified|0|||
161408631|NCT03343626|582884465|FG003|Overall Study|Reason not Specified|0|||
161408632|NCT03343626|582884466|FG004|Overall Study|Reason not Specified|0|||
161408633|NCT03343626|582884467|FG005|Overall Study|Reason not Specified|0|||
161408634|NCT03343626|582884468|FG006|Overall Study|Reason not Specified|0|||
161408635|NCT03343626|582884469|FG007|Overall Study|Reason not Specified|1|||
161408636|NCT03343626|582884462|FG000|Overall Study|Data Entry Error|0|||
161408637|NCT03343626|582884463|FG001|Overall Study|Data Entry Error|0|||
161408638|NCT03343626|582884464|FG002|Overall Study|Data Entry Error|0|||
161408639|NCT03343626|582884465|FG003|Overall Study|Data Entry Error|0|||
161408640|NCT03343626|582884466|FG004|Overall Study|Data Entry Error|0|||
161408641|NCT03343626|582884467|FG005|Overall Study|Data Entry Error|0|||
161408642|NCT03343626|582884468|FG006|Overall Study|Data Entry Error|0|||
161408643|NCT03343626|582884469|FG007|Overall Study|Data Entry Error|1|||
161408644|NCT00742417|582884472|FG000|Randomized|Withdrawal by legal representative|0|||
161408645|NCT00742417|582884473|FG001|Randomized|Withdrawal by legal representative|1|||
161408646|NCT00742417|582884472|FG000|Randomized|Withdrawal by Subject|1|||
161408647|NCT00742417|582884473|FG001|Randomized|Withdrawal by Subject|0|||
161408648|NCT00742417|582884472|FG000|Randomized|Physician Decision|1|||
161408649|NCT00742417|582884473|FG001|Randomized|Physician Decision|0|||
161408650|NCT00742417|582884472|FG000|Intensive Period|Withdrawal by Subject|1|||
161408651|NCT00742417|582884473|FG001|Intensive Period|Withdrawal by Subject|1|||
161408652|NCT00742417|582884472|FG000|Intensive Period|Adverse Event|2|||
161408653|NCT00742417|582884473|FG001|Intensive Period|Adverse Event|0|||
161408654|NCT00965575|582884478|FG000|Overall Study|subject unwillingness to swallow study c|1|||
161408655|NCT00965575|582884479|FG001|Overall Study|subject unwillingness to swallow study c|0|||
161408656|NCT01041287|582884482|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
161408657|NCT01041287|582884483|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
161408658|NCT01041287|582884482|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
161408659|NCT01041287|582884483|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
161408660|NCT03775512|582884491|FG000|Overall Study|Death|1|||
161408661|NCT03775512|582884492|FG001|Overall Study|Death|1|||
161408662|NCT03775512|582884491|FG000|Overall Study|Withdrawal by Subject|7|||
161408663|NCT03775512|582884492|FG001|Overall Study|Withdrawal by Subject|4|||
161408664|NCT03775512|582884491|FG000|Overall Study|Lost to Follow-up|5|||
161408665|NCT03775512|582884492|FG001|Overall Study|Lost to Follow-up|5|||
161408666|NCT03775512|582884491|FG000|Overall Study|Excluded before Catheter insertion|14|||
161408667|NCT03775512|582884492|FG001|Overall Study|Excluded before Catheter insertion|5|||
161408668|NCT03775512|582884491|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
161408669|NCT03775512|582884492|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
161408670|NCT03775512|582884491|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
161408671|NCT03775512|582884492|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
161408672|NCT02629822|582884493|FG000|Base Study|Lost to Follow-up|2|||
161408673|NCT02629822|582884493|FG000|Base Study|Non-Compliance With Study Drug|1|||
161408674|NCT02629822|582884493|FG000|Extension Study|Adverse Event|1|||
161408675|NCT02629822|582884493|FG000|Extension Study|Lost to Follow-up|1|||
161408676|NCT01610336|582884494|FG000|Overall Study|Progressive Disease|4|||
161408677|NCT01610336|582884495|FG001|Overall Study|Progressive Disease|6|||
161408678|NCT01610336|582884496|FG002|Overall Study|Progressive Disease|6|||
161408679|NCT01610336|582884497|FG003|Overall Study|Progressive Disease|5|||
161408680|NCT01610336|582884498|FG004|Overall Study|Progressive Disease|3|||
161408681|NCT01610336|582884499|FG005|Overall Study|Progressive Disease|10|||
161408682|NCT01610336|582884500|FG006|Overall Study|Progressive Disease|1|||
161408683|NCT01610336|582884501|FG007|Overall Study|Progressive Disease|6|||
161408684|NCT01610336|582884502|FG008|Overall Study|Progressive Disease|6|||
161408685|NCT01610336|582884503|FG009|Overall Study|Progressive Disease|40|||
161408686|NCT01610336|582884504|FG010|Overall Study|Progressive Disease|36|||
161408687|NCT01610336|582884494|FG000|Overall Study|Adverse Event|0|||
161408688|NCT01610336|582884495|FG001|Overall Study|Adverse Event|0|||
161408689|NCT01610336|582884496|FG002|Overall Study|Adverse Event|0|||
161408690|NCT01610336|582884497|FG003|Overall Study|Adverse Event|1|||
161408691|NCT01610336|582884498|FG004|Overall Study|Adverse Event|1|||
161408692|NCT01610336|582884499|FG005|Overall Study|Adverse Event|1|||
161408693|NCT01610336|582884500|FG006|Overall Study|Adverse Event|0|||
161408694|NCT01610336|582884501|FG007|Overall Study|Adverse Event|0|||
161408695|NCT01610336|582884502|FG008|Overall Study|Adverse Event|2|||
161408696|NCT01610336|582884503|FG009|Overall Study|Adverse Event|8|||
161408697|NCT01610336|582884504|FG010|Overall Study|Adverse Event|6|||
161408698|NCT01610336|582884494|FG000|Overall Study|Subject/Guardian decision|1|||
161408699|NCT01610336|582884495|FG001|Overall Study|Subject/Guardian decision|1|||
161408700|NCT01610336|582884496|FG002|Overall Study|Subject/Guardian decision|0|||
161408701|NCT01610336|582884497|FG003|Overall Study|Subject/Guardian decision|1|||
161408702|NCT01610336|582884498|FG004|Overall Study|Subject/Guardian decision|0|||
161408703|NCT01610336|582884499|FG005|Overall Study|Subject/Guardian decision|0|||
161408704|NCT01610336|582884500|FG006|Overall Study|Subject/Guardian decision|0|||
161408705|NCT01610336|582884501|FG007|Overall Study|Subject/Guardian decision|1|||
161408706|NCT01610336|582884502|FG008|Overall Study|Subject/Guardian decision|0|||
161408707|NCT01610336|582884503|FG009|Overall Study|Subject/Guardian decision|2|||
161408708|NCT01610336|582884504|FG010|Overall Study|Subject/Guardian decision|2|||
161408709|NCT01610336|582884494|FG000|Overall Study|Death|0|||
161408710|NCT01610336|582884495|FG001|Overall Study|Death|0|||
161408711|NCT01610336|582884496|FG002|Overall Study|Death|0|||
161408712|NCT01610336|582884497|FG003|Overall Study|Death|0|||
161408713|NCT01610336|582884498|FG004|Overall Study|Death|0|||
161408714|NCT01610336|582884499|FG005|Overall Study|Death|1|||
161408715|NCT01610336|582884500|FG006|Overall Study|Death|3|||
161408716|NCT01610336|582884501|FG007|Overall Study|Death|0|||
161408717|NCT01610336|582884502|FG008|Overall Study|Death|0|||
161408718|NCT01610336|582884503|FG009|Overall Study|Death|1|||
161408719|NCT01610336|582884504|FG010|Overall Study|Death|2|||
161408720|NCT01610336|582884494|FG000|Overall Study|Non-Compliance with study treatment|0|||
161408721|NCT01610336|582884495|FG001|Overall Study|Non-Compliance with study treatment|0|||
161408722|NCT01610336|582884496|FG002|Overall Study|Non-Compliance with study treatment|0|||
161408723|NCT01610336|582884497|FG003|Overall Study|Non-Compliance with study treatment|0|||
161408724|NCT01610336|582884498|FG004|Overall Study|Non-Compliance with study treatment|0|||
161408725|NCT01610336|582884499|FG005|Overall Study|Non-Compliance with study treatment|0|||
161408726|NCT01610336|582884500|FG006|Overall Study|Non-Compliance with study treatment|0|||
161408727|NCT01610336|582884501|FG007|Overall Study|Non-Compliance with study treatment|0|||
161408728|NCT01610336|582884502|FG008|Overall Study|Non-Compliance with study treatment|0|||
161408729|NCT01610336|582884503|FG009|Overall Study|Non-Compliance with study treatment|1|||
161408730|NCT01610336|582884504|FG010|Overall Study|Non-Compliance with study treatment|0|||
161408731|NCT01610336|582884494|FG000|Overall Study|Physician Decision|0|||
161408732|NCT01610336|582884495|FG001|Overall Study|Physician Decision|0|||
161408733|NCT01610336|582884496|FG002|Overall Study|Physician Decision|0|||
161408734|NCT01610336|582884497|FG003|Overall Study|Physician Decision|0|||
161408735|NCT01610336|582884498|FG004|Overall Study|Physician Decision|0|||
161408736|NCT01610336|582884499|FG005|Overall Study|Physician Decision|0|||
161408737|NCT01610336|582884500|FG006|Overall Study|Physician Decision|1|||
161408738|NCT01610336|582884501|FG007|Overall Study|Physician Decision|0|||
161408739|NCT01610336|582884502|FG008|Overall Study|Physician Decision|0|||
161408740|NCT01610336|582884503|FG009|Overall Study|Physician Decision|0|||
161408741|NCT01610336|582884504|FG010|Overall Study|Physician Decision|0|||
161408742|NCT01610336|582884494|FG000|Overall Study|Protocol Deviation|0|||
161408743|NCT01610336|582884495|FG001|Overall Study|Protocol Deviation|0|||
161408744|NCT01610336|582884496|FG002|Overall Study|Protocol Deviation|0|||
161408745|NCT01610336|582884497|FG003|Overall Study|Protocol Deviation|0|||
161408746|NCT01610336|582884498|FG004|Overall Study|Protocol Deviation|0|||
161408747|NCT01610336|582884499|FG005|Overall Study|Protocol Deviation|0|||
161408748|NCT01610336|582884500|FG006|Overall Study|Protocol Deviation|0|||
161408749|NCT01610336|582884501|FG007|Overall Study|Protocol Deviation|0|||
161408750|NCT01610336|582884502|FG008|Overall Study|Protocol Deviation|0|||
161408751|NCT01610336|582884503|FG009|Overall Study|Protocol Deviation|1|||
161408752|NCT01610336|582884504|FG010|Overall Study|Protocol Deviation|0|||
161408753|NCT01610336|582884494|FG000|Overall Study|Transfer to another trial|0|||
161408754|NCT01610336|582884495|FG001|Overall Study|Transfer to another trial|0|||
161408755|NCT01610336|582884496|FG002|Overall Study|Transfer to another trial|0|||
161408756|NCT01610336|582884497|FG003|Overall Study|Transfer to another trial|0|||
161408757|NCT01610336|582884498|FG004|Overall Study|Transfer to another trial|0|||
161408758|NCT01610336|582884499|FG005|Overall Study|Transfer to another trial|0|||
161408759|NCT01610336|582884500|FG006|Overall Study|Transfer to another trial|0|||
161408760|NCT01610336|582884501|FG007|Overall Study|Transfer to another trial|0|||
161408761|NCT01610336|582884502|FG008|Overall Study|Transfer to another trial|0|||
161408762|NCT01610336|582884503|FG009|Overall Study|Transfer to another trial|0|||
161408763|NCT01610336|582884504|FG010|Overall Study|Transfer to another trial|1|||
161408764|NCT00082407|582884505|FG000|Overall Study|Adverse Event|20|||
161408765|NCT00082407|582884506|FG001|Overall Study|Adverse Event|0|||
161408766|NCT00082407|582884505|FG000|Overall Study|Protocol Violation|14|||
161408767|NCT00082407|582884506|FG001|Overall Study|Protocol Violation|12|||
161408768|NCT00082407|582884505|FG000|Overall Study|Patient Decision|13|||
161408769|NCT00082407|582884506|FG001|Overall Study|Patient Decision|6|||
161408770|NCT00082407|582884505|FG000|Overall Study|Physician Decision|5|||
161408771|NCT00082407|582884506|FG001|Overall Study|Physician Decision|3|||
161408772|NCT00082407|582884505|FG000|Overall Study|Loss of Glucose Control|2|||
161408773|NCT00082407|582884506|FG001|Overall Study|Loss of Glucose Control|2|||
161408774|NCT00082407|582884505|FG000|Overall Study|Death|2|||
161408775|NCT00082407|582884506|FG001|Overall Study|Death|1|||
161408776|NCT00082407|582884505|FG000|Overall Study|Lost to Follow-up|0|||
161408777|NCT00082407|582884506|FG001|Overall Study|Lost to Follow-up|3|||
161408778|NCT03464019|582884507|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
161408779|NCT03464019|582884508|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
161408780|NCT03464019|582884509|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
161408781|NCT03464019|582884507|FG000|NODE-301 Part 1|Ablation|0|||
161408782|NCT03464019|582884508|FG001|NODE-301 Part 1|Ablation|0|||
161408783|NCT03464019|582884509|FG002|NODE-301 Part 1|Ablation|16|||
161408784|NCT03464019|582884507|FG000|NODE-301 Part 1|Test Dose Failure|0|||
161408785|NCT03464019|582884508|FG001|NODE-301 Part 1|Test Dose Failure|0|||
161408786|NCT03464019|582884509|FG002|NODE-301 Part 1|Test Dose Failure|8|||
161408787|NCT03464019|582884507|FG000|NODE-301 Part 1|Adverse Event|0|||
161408788|NCT03464019|582884508|FG001|NODE-301 Part 1|Adverse Event|0|||
161408789|NCT03464019|582884509|FG002|NODE-301 Part 1|Adverse Event|5|||
161408790|NCT03464019|582884507|FG000|NODE-301 Part 1|Physician Decision|0|||
161408791|NCT03464019|582884508|FG001|NODE-301 Part 1|Physician Decision|0|||
161408792|NCT03464019|582884509|FG002|NODE-301 Part 1|Physician Decision|4|||
161408793|NCT03464019|582884507|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
161408794|NCT03464019|582884508|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
161408795|NCT03464019|582884509|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
161408796|NCT03464019|582884507|FG000|NODE-301 Part 1|Protocol Violation|0|||
161408797|NCT03464019|582884508|FG001|NODE-301 Part 1|Protocol Violation|0|||
161408798|NCT03464019|582884509|FG002|NODE-301 Part 1|Protocol Violation|2|||
161408799|NCT03464019|582884507|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
161408800|NCT03464019|582884508|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
161408801|NCT03464019|582884509|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
161408802|NCT03464019|582884507|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
161408803|NCT03464019|582884508|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
161408804|NCT03464019|582884509|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
161408805|NCT03464019|582884507|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
161408806|NCT03464019|582884508|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
161408807|NCT03464019|582884509|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
161408808|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
161408809|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
161408810|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
161408811|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
161408812|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
161408813|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
161408814|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
161408815|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
161408816|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
161408817|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
161408818|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
161408819|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
161408820|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
161408821|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
161408822|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
161408823|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
161408824|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
161408825|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
161408826|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
161408827|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
161408828|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
161408829|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
161408830|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
161408831|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
161408832|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
161408833|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
161408834|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
161408835|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
161408836|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
161408837|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
161408838|NCT03464019|582884507|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
161408839|NCT03464019|582884508|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
161408840|NCT03464019|582884509|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
161408841|NCT00767806|582884510|FG000|Overall Study|Adverse Event|30|||
161408842|NCT00767806|582884511|FG001|Overall Study|Adverse Event|11|||
161408843|NCT00767806|582884510|FG000|Overall Study|Withdrawal by Subject|8|||
161408844|NCT00767806|582884511|FG001|Overall Study|Withdrawal by Subject|13|||
161408845|NCT00767806|582884510|FG000|Overall Study|Protocol Violation|6|||
161408846|NCT00767806|582884511|FG001|Overall Study|Protocol Violation|5|||
161408847|NCT00767806|582884510|FG000|Overall Study|Lack of Efficacy|1|||
161408848|NCT00767806|582884511|FG001|Overall Study|Lack of Efficacy|9|||
161408849|NCT00767806|582884510|FG000|Overall Study|Physician Decision|4|||
161408850|NCT00767806|582884511|FG001|Overall Study|Physician Decision|3|||
161408851|NCT00767806|582884510|FG000|Overall Study|Lost to Follow-up|1|||
161408852|NCT00767806|582884511|FG001|Overall Study|Lost to Follow-up|4|||
161408853|NCT00767806|582884510|FG000|Overall Study|Entry Criteria Not Met|1|||
161408854|NCT00767806|582884511|FG001|Overall Study|Entry Criteria Not Met|1|||
161408855|NCT00767806|582884510|FG000|Overall Study|Sponsor Decision|0|||
161408856|NCT00767806|582884511|FG001|Overall Study|Sponsor Decision|1|||
161408857|NCT02489942|582884512|FG000|Overall Study|Request by patient|602|||
161408858|NCT02489942|582884512|FG000|Overall Study|Improvement/remission|157|||
161408859|NCT02489942|582884512|FG000|Overall Study|No change/Progressive disease|263|||
161408860|NCT02489942|582884512|FG000|Overall Study|Adverse Event|522|||
161408861|NCT02489942|582884512|FG000|Overall Study|Other personal reasons|1218|||
161408862|NCT02489942|582884512|FG000|Overall Study|Lost to Follow-up|456|||
161408863|NCT02489942|582884512|FG000|Overall Study|Not continuously investigated|7|||
161408864|NCT02489942|582884512|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
161408865|NCT02489942|582884512|FG000|Overall Study|Multiple registration|1|||
161408866|NCT02489942|582884512|FG000|Overall Study|No patient visit after entry|100|||
161408867|NCT02489942|582884512|FG000|Overall Study|No treatment with Jardiance|2|||
161408868|NCT02489942|582884512|FG000|Overall Study|Patient received Jardiance before registration|1|||
161408869|NCT02489942|582884512|FG000|Overall Study|No CRF collected|86|||
161408870|NCT00858208|582884513|FG000|Overall Study|Adverse Event|3|||
161408871|NCT00858208|582884513|FG000|Overall Study|Lost to Follow-up|26|||
161408872|NCT00858208|582884513|FG000|Overall Study|Participant refused|40|||
161408873|NCT00858208|582884513|FG000|Overall Study|Other|10|||
161408874|NCT01543776|582884514|FG000|Overall Study|Withdrawal by Subject|2|||
161408875|NCT01543776|582884515|FG001|Overall Study|Withdrawal by Subject|2|||
161408876|NCT00567359|582884516|FG000|Overall Study|Withdrawal by Subject|1|||
161408877|NCT02397057|582884517|FG000|Overall Study|Withdrawal by Subject|6|||
161408878|NCT02397057|582884518|FG001|Overall Study|Withdrawal by Subject|7|||
161408879|NCT02397057|582884517|FG000|Overall Study|Lost to Follow-up|4|||
161408880|NCT02397057|582884518|FG001|Overall Study|Lost to Follow-up|3|||
161408881|NCT02397057|582884517|FG000|Overall Study|Death|1|||
161408882|NCT02397057|582884518|FG001|Overall Study|Death|0|||
161408883|NCT02397057|582884517|FG000|Overall Study|Adverse Event|0|||
161408884|NCT02397057|582884518|FG001|Overall Study|Adverse Event|1|||
161408885|NCT02397057|582884517|FG000|Overall Study|Physician Decision|0|||
161408886|NCT02397057|582884518|FG001|Overall Study|Physician Decision|1|||
161408887|NCT02397057|582884517|FG000|Overall Study|Subject did not receive study drug|0|||
161408888|NCT02397057|582884518|FG001|Overall Study|Subject did not receive study drug|1|||
161408889|NCT00704288|582884520|FG000|Overall Treatment Period|Adverse Event|11|||
161408890|NCT00704288|582884521|FG001|Overall Treatment Period|Adverse Event|8|||
161408891|NCT00704288|582884522|FG002|Overall Treatment Period|Adverse Event|22|||
161408892|NCT00704288|582884520|FG000|Overall Treatment Period|Death|0|||
161408893|NCT00704288|582884521|FG001|Overall Treatment Period|Death|0|||
161408894|NCT00704288|582884522|FG002|Overall Treatment Period|Death|1|||
161408895|NCT00704288|582884520|FG000|Overall Treatment Period|Physician Decision|0|||
161408896|NCT00704288|582884521|FG001|Overall Treatment Period|Physician Decision|2|||
161408897|NCT00704288|582884522|FG002|Overall Treatment Period|Physician Decision|0|||
161408898|NCT00704288|582884520|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
161408899|NCT00704288|582884521|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
161408900|NCT00704288|582884522|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
161408901|NCT00704288|582884520|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
161408902|NCT00704288|582884521|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
161408903|NCT00704288|582884522|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
161408904|NCT00704288|582884520|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
161408905|NCT00704288|582884521|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
161408906|NCT00704288|582884522|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
161408907|NCT00704288|582884520|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
161408908|NCT00704288|582884521|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
161408909|NCT00704288|582884522|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
161408910|NCT00704288|582884520|FG000|Overall Treatment Period|Roll-over to another study|1|||
161408911|NCT00704288|582884521|FG001|Overall Treatment Period|Roll-over to another study|0|||
161408912|NCT00704288|582884522|FG002|Overall Treatment Period|Roll-over to another study|4|||
161408913|NCT00704288|582884520|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
161408914|NCT00704288|582884521|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
161408915|NCT00704288|582884522|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
161408916|NCT00704288|582884520|FG000|Extended Post Treatment Follow Up Period|Death|41|||
161408917|NCT00704288|582884521|FG001|Extended Post Treatment Follow Up Period|Death|50|||
161408918|NCT00704288|582884522|FG002|Extended Post Treatment Follow Up Period|Death|93|||
161408919|NCT00704288|582884520|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
161408920|NCT00704288|582884521|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
161408921|NCT00704288|582884522|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
161408922|NCT00704288|582884520|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
161408923|NCT00704288|582884521|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
161408924|NCT00704288|582884522|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
161408925|NCT00704288|582884520|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
161408926|NCT00704288|582884521|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
161408927|NCT00704288|582884522|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
161408928|NCT01055314|582884523|FG000|Overall Study|Adverse Event|7|||
161408929|NCT01055314|582884524|FG001|Overall Study|Adverse Event|4|||
161408930|NCT01055314|582884523|FG000|Overall Study|Death|2|||
161408931|NCT01055314|582884524|FG001|Overall Study|Death|1|||
161408932|NCT01055314|582884523|FG000|Overall Study|Lack of Efficacy|11|||
161408933|NCT01055314|582884524|FG001|Overall Study|Lack of Efficacy|19|||
161408934|NCT01055314|582884523|FG000|Overall Study|Physician Decision|10|||
161408935|NCT01055314|582884524|FG001|Overall Study|Physician Decision|5|||
161408936|NCT01055314|582884523|FG000|Overall Study|Withdrawal by Subject|1|||
161408937|NCT01055314|582884524|FG001|Overall Study|Withdrawal by Subject|0|||
161408938|NCT01055314|582884523|FG000|Overall Study|Ineligible|3|||
161408939|NCT01055314|582884524|FG001|Overall Study|Ineligible|5|||
161408940|NCT01055314|582884523|FG000|Overall Study|Refusal of further protocol therapy|10|||
161408941|NCT01055314|582884524|FG001|Overall Study|Refusal of further protocol therapy|4|||
161408942|NCT01055314|582884523|FG000|Overall Study|No treatment|1|||
161408943|NCT01055314|582884524|FG001|Overall Study|No treatment|0|||
161408944|NCT04395690|582884525|FG000|Overall Study|Lost to Follow-up|1|||
161408945|NCT04395690|582884526|FG001|Overall Study|Lost to Follow-up|1|||
161408946|NCT03927144|582884527|FG000|Core Phase|Adverse Event|9|||
161408947|NCT03927144|582884528|FG001|Core Phase|Adverse Event|5|||
161408948|NCT03927144|582884527|FG000|Core Phase|Lost to Follow-up|3|||
161408949|NCT03927144|582884528|FG001|Core Phase|Lost to Follow-up|2|||
161408950|NCT03927144|582884527|FG000|Core Phase|New Therapy for Study Indication|0|||
161408951|NCT03927144|582884528|FG001|Core Phase|New Therapy for Study Indication|1|||
161408952|NCT03927144|582884527|FG000|Core Phase|No Longer Clinically Benefiting|4|||
161408953|NCT03927144|582884528|FG001|Core Phase|No Longer Clinically Benefiting|4|||
161408954|NCT03927144|582884527|FG000|Core Phase|Physician Decision|2|||
161408955|NCT03927144|582884528|FG001|Core Phase|Physician Decision|8|||
161408956|NCT03927144|582884527|FG000|Core Phase|Protocol Violation|2|||
161408957|NCT03927144|582884528|FG001|Core Phase|Protocol Violation|2|||
161408958|NCT03927144|582884527|FG000|Core Phase|Withdrawal by Subject|16|||
161408959|NCT03927144|582884528|FG001|Core Phase|Withdrawal by Subject|40|||
161408960|NCT03927144|582884527|FG000|Extension Phase|Adverse Event|2|||
161408961|NCT03927144|582884528|FG001|Extension Phase|Adverse Event|1|||
161408962|NCT03927144|582884527|FG000|Extension Phase|No longer clinically benefiting|4|||
161408963|NCT03927144|582884528|FG001|Extension Phase|No longer clinically benefiting|5|||
161408964|NCT03927144|582884527|FG000|Extension Phase|Pregnancy|1|||
161408965|NCT03927144|582884528|FG001|Extension Phase|Pregnancy|0|||
161408966|NCT03927144|582884527|FG000|Extension Phase|Protocol Violation|0|||
161408967|NCT03927144|582884528|FG001|Extension Phase|Protocol Violation|1|||
161408968|NCT03927144|582884527|FG000|Extension Phase|Withdrawal by Subject|8|||
161408969|NCT03927144|582884528|FG001|Extension Phase|Withdrawal by Subject|3|||
161408970|NCT03909152|582884529|FG000|Overall Study|Adverse Event|14|||
161408971|NCT03909152|582884530|FG001|Overall Study|Adverse Event|5|||
161408972|NCT03909152|582884531|FG002|Overall Study|Adverse Event|1|||
161408973|NCT03909152|582884532|FG003|Overall Study|Adverse Event|14|||
161408974|NCT00719680|582884537|FG000|Overall Study|Adverse Event|1|||
161408975|NCT00719680|582884537|FG000|Overall Study|Lost to Follow-up|1|||
161408976|NCT00719680|582884537|FG000|Overall Study|Withdrawal by Subject|3|||
161408977|NCT04071158|582884539|FG000|Overall Study|Lost to Follow-up|1|||
161408978|NCT04071158|582884540|FG001|Overall Study|Lost to Follow-up|2|||
161408979|NCT04071158|582884541|FG002|Overall Study|Lost to Follow-up|3|||
161408980|NCT04071158|582884542|FG003|Overall Study|Lost to Follow-up|3|||
161408981|NCT04071158|582884543|FG004|Overall Study|Lost to Follow-up|5|||
161408982|NCT04071158|582884539|FG000|Overall Study|Randomized but not treated|2|||
161408983|NCT04071158|582884540|FG001|Overall Study|Randomized but not treated|2|||
161408984|NCT04071158|582884541|FG002|Overall Study|Randomized but not treated|0|||
161408985|NCT04071158|582884542|FG003|Overall Study|Randomized but not treated|0|||
161408986|NCT04071158|582884543|FG004|Overall Study|Randomized but not treated|0|||
161408987|NCT01178099|582884544|FG000|Overall Study|Physician Decision|0|||
161408988|NCT01178099|582884545|FG001|Overall Study|Physician Decision|1|||
161408989|NCT02473367|582884546|FG000|Wait 1|Withdrawal by Subject|1|||
161408990|NCT02473367|582884546|FG000|Period 4|Lost to Follow-up|1|||
161408991|NCT04816721|582884547|FG000|Overall Study|Withdrawal by Subject|0|||
161408992|NCT04816721|582884548|FG001|Overall Study|Withdrawal by Subject|2|||
161408993|NCT04816721|582884549|FG002|Overall Study|Withdrawal by Subject|0|||
161408994|NCT04816721|582884550|FG003|Overall Study|Withdrawal by Subject|1|||
161408995|NCT04816721|582884551|FG004|Overall Study|Withdrawal by Subject|1|||
161408996|NCT04816721|582884552|FG005|Overall Study|Withdrawal by Subject|0|||
161408997|NCT04816721|582884553|FG006|Overall Study|Withdrawal by Subject|0|||
161408998|NCT04816721|582884554|FG007|Overall Study|Withdrawal by Subject|0|||
161408999|NCT04816721|582884547|FG000|Overall Study|Miscellaneous|0|||
161409000|NCT04816721|582884548|FG001|Overall Study|Miscellaneous|0|||
161409001|NCT04816721|582884549|FG002|Overall Study|Miscellaneous|0|||
161409002|NCT04816721|582884550|FG003|Overall Study|Miscellaneous|0|||
161409003|NCT04816721|582884551|FG004|Overall Study|Miscellaneous|0|||
161409004|NCT04816721|582884552|FG005|Overall Study|Miscellaneous|1|||
161409005|NCT04816721|582884553|FG006|Overall Study|Miscellaneous|0|||
161409006|NCT04816721|582884554|FG007|Overall Study|Miscellaneous|0|||
161409007|NCT04816721|582884547|FG000|Overall Study|Lost to Follow-up|0|||
161409008|NCT04816721|582884548|FG001|Overall Study|Lost to Follow-up|0|||
161409009|NCT04816721|582884549|FG002|Overall Study|Lost to Follow-up|0|||
161409010|NCT04816721|582884550|FG003|Overall Study|Lost to Follow-up|1|||
161409011|NCT04816721|582884551|FG004|Overall Study|Lost to Follow-up|0|||
161409012|NCT04816721|582884552|FG005|Overall Study|Lost to Follow-up|0|||
161409013|NCT04816721|582884553|FG006|Overall Study|Lost to Follow-up|0|||
161409014|NCT04816721|582884554|FG007|Overall Study|Lost to Follow-up|0|||
161409015|NCT03194438|582884568|FG000|Overall Study|Withdrawal by Subject|2|||
161409016|NCT01286740|582884569|FG000|Overall Study|Enrolled but not treated|1|||
161409017|NCT01286740|582884569|FG000|Overall Study|Protocol Violation|1|||
161409018|NCT02335424|582884572|FG000|Overall Study|Withdrawal by Subject|19|||
161409019|NCT02335424|582884572|FG000|Overall Study|Adverse Event|25|||
161409020|NCT02335424|582884572|FG000|Overall Study|Death|273|||
161409021|NCT02335424|582884572|FG000|Overall Study|Lost to Follow-up|3|||
161409022|NCT02335424|582884572|FG000|Overall Study|Physician Decision|13|||
161409023|NCT02335424|582884572|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
161409024|NCT02335424|582884572|FG000|Overall Study|Protocol Violation|1|||
161409025|NCT02335424|582884572|FG000|Overall Study|Screen failure|1|||
161409026|NCT01141478|582884573|FG000|Overall Study|Withdrawal by Subject|1|||
161409027|NCT01141478|582884574|FG001|Overall Study|Withdrawal by Subject|1|||
161409028|NCT01581619|582884577|FG000|Overall Study|Withdrawal by Subject|1|||
161409029|NCT01581619|582884577|FG000|Overall Study|Lost to Follow-up|1|||
161409030|NCT00290498|582884578|FG000|Overall Study|Death|2|||
161409031|NCT00290498|582884579|FG001|Overall Study|Death|0|||
161409032|NCT00290498|582884578|FG000|Overall Study|Physician Decision|1|||
161409033|NCT00290498|582884579|FG001|Overall Study|Physician Decision|0|||
161409034|NCT00290498|582884578|FG000|Overall Study|Withdrawal by Subject|1|||
161409035|NCT00290498|582884579|FG001|Overall Study|Withdrawal by Subject|0|||
161409036|NCT00290498|582884578|FG000|Overall Study|Ineligible|3|||
161409037|NCT00290498|582884579|FG001|Overall Study|Ineligible|0|||
161409038|NCT00290498|582884578|FG000|Overall Study|Non-Compliance|1|||
161409039|NCT00290498|582884579|FG001|Overall Study|Non-Compliance|0|||
161409040|NCT03847909|582884582|FG000|Overall Study|Withdrawal by Subject|1|||
161409041|NCT03847909|582884583|FG001|Overall Study|Withdrawal by Subject|1|||
161409042|NCT01375608|582884584|FG000|Overall Study|Withdrawal by Subject|2|||
161409043|NCT00694304|582884585|FG000|Overall Study|Adverse Event|42|||
161409044|NCT00694304|582884585|FG000|Overall Study|Lack of Efficacy|35|||
161409045|NCT00694304|582884585|FG000|Overall Study|Non-compliance With Study Product|16|||
161409046|NCT00694304|582884585|FG000|Overall Study|Protocol Violation|6|||
161409047|NCT00694304|582884585|FG000|Overall Study|Withdrawal of Consent|61|||
161409048|NCT00694304|582884585|FG000|Overall Study|Lost to Follow-up|15|||
161409049|NCT00694304|582884585|FG000|Overall Study|Administrative or Other Reasons|32|||
161409050|NCT02102399|582884593|FG000|Overall Study|Withdrawal by Subject|6|||
161409051|NCT02102399|582884594|FG001|Overall Study|Withdrawal by Subject|4|||
161409052|NCT00772109|582884597|FG000|Overall Study|Serious adverse event|1|||
161409053|NCT00772109|582884598|FG001|Overall Study|Serious adverse event|0|||
161409054|NCT00772109|582884599|FG002|Overall Study|Serious adverse event|1|||
161409055|NCT00772109|582884600|FG003|Overall Study|Serious adverse event|0|||
161409056|NCT00772109|582884597|FG000|Overall Study|Protocol Violation|5|||
161409057|NCT00772109|582884598|FG001|Overall Study|Protocol Violation|8|||
161409058|NCT00772109|582884599|FG002|Overall Study|Protocol Violation|7|||
161409059|NCT00772109|582884600|FG003|Overall Study|Protocol Violation|6|||
161409060|NCT00772109|582884597|FG000|Overall Study|Lost to Follow-up|7|||
161409061|NCT00772109|582884598|FG001|Overall Study|Lost to Follow-up|3|||
161409062|NCT00772109|582884599|FG002|Overall Study|Lost to Follow-up|5|||
161409063|NCT00772109|582884600|FG003|Overall Study|Lost to Follow-up|9|||
161409064|NCT00772109|582884597|FG000|Overall Study|Withdrawal by Subject|8|||
161409065|NCT00772109|582884598|FG001|Overall Study|Withdrawal by Subject|8|||
161409066|NCT00772109|582884599|FG002|Overall Study|Withdrawal by Subject|6|||
161409067|NCT00772109|582884600|FG003|Overall Study|Withdrawal by Subject|16|||
161409068|NCT00410605|582884601|FG000|Overall Study|Adverse Event|12|||
161409069|NCT00410605|582884601|FG000|Overall Study|Physician Decision|3|||
161409070|NCT00410605|582884601|FG000|Overall Study|Withdrawal by Subject|5|||
161409071|NCT00410605|582884601|FG000|Overall Study|Started Non-Protocol Therapy|3|||
161409072|NCT00410605|582884601|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
161409073|NCT00410605|582884601|FG000|Overall Study|Transferred to another Institution|1|||
161409074|NCT04667104|582884605|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
161409075|NCT04667104|582884606|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
161409076|NCT04667104|582884607|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
161409077|NCT01078168|582884608|FG000|Overall Study|Physician Decision|0|||
161409078|NCT01078168|582884609|FG001|Overall Study|Physician Decision|1|||
161409079|NCT05066165|582886514|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
161409080|NCT05066165|582886515|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
161409081|NCT05066165|582886514|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
161409082|NCT05066165|582886515|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
161409083|NCT03210961|582886516|FG000|Overall Study|Adverse Event|0|||
161409084|NCT03210961|582886517|FG001|Overall Study|Adverse Event|0|||
161409085|NCT03210961|582886518|FG002|Overall Study|Adverse Event|0|||
161409086|NCT03210961|582886519|FG003|Overall Study|Adverse Event|0|||
161409087|NCT03210961|582886520|FG004|Overall Study|Adverse Event|0|||
161409088|NCT03210961|582886521|FG005|Overall Study|Adverse Event|0|||
161409089|NCT03210961|582886522|FG006|Overall Study|Adverse Event|0|||
161409090|NCT03210961|582886523|FG007|Overall Study|Adverse Event|0|||
161409091|NCT03210961|582886524|FG008|Overall Study|Adverse Event|0|||
161409092|NCT03210961|582886525|FG009|Overall Study|Adverse Event|0|||
161409093|NCT03210961|582886526|FG010|Overall Study|Adverse Event|0|||
161409094|NCT03210961|582886527|FG011|Overall Study|Adverse Event|0|||
161409095|NCT03210961|582886528|FG012|Overall Study|Adverse Event|0|||
161409096|NCT03210961|582886529|FG013|Overall Study|Adverse Event|1|||
161409097|NCT03210961|582886530|FG014|Overall Study|Adverse Event|0|||
161409098|NCT03210961|582886516|FG000|Overall Study|Lost to Follow-up|0|||
161409099|NCT03210961|582886517|FG001|Overall Study|Lost to Follow-up|0|||
161409100|NCT03210961|582886518|FG002|Overall Study|Lost to Follow-up|0|||
161409101|NCT03210961|582886519|FG003|Overall Study|Lost to Follow-up|0|||
161409102|NCT03210961|582886520|FG004|Overall Study|Lost to Follow-up|0|||
161409103|NCT03210961|582886521|FG005|Overall Study|Lost to Follow-up|0|||
161409104|NCT03210961|582886522|FG006|Overall Study|Lost to Follow-up|0|||
161409105|NCT03210961|582886523|FG007|Overall Study|Lost to Follow-up|0|||
161409106|NCT03210961|582886524|FG008|Overall Study|Lost to Follow-up|0|||
161409107|NCT03210961|582886525|FG009|Overall Study|Lost to Follow-up|0|||
161409108|NCT03210961|582886526|FG010|Overall Study|Lost to Follow-up|0|||
161409109|NCT03210961|582886527|FG011|Overall Study|Lost to Follow-up|0|||
161409110|NCT03210961|582886528|FG012|Overall Study|Lost to Follow-up|0|||
161409111|NCT03210961|582886529|FG013|Overall Study|Lost to Follow-up|0|||
161409112|NCT03210961|582886530|FG014|Overall Study|Lost to Follow-up|1|||
161409113|NCT03210961|582886516|FG000|Overall Study|Withdrawal by Subject|0|||
161409114|NCT03210961|582886517|FG001|Overall Study|Withdrawal by Subject|0|||
161409115|NCT03210961|582886518|FG002|Overall Study|Withdrawal by Subject|0|||
161409116|NCT03210961|582886519|FG003|Overall Study|Withdrawal by Subject|0|||
161409117|NCT03210961|582886520|FG004|Overall Study|Withdrawal by Subject|0|||
161409118|NCT03210961|582886521|FG005|Overall Study|Withdrawal by Subject|0|||
161409119|NCT03210961|582886522|FG006|Overall Study|Withdrawal by Subject|0|||
161409120|NCT03210961|582886523|FG007|Overall Study|Withdrawal by Subject|0|||
161409121|NCT03210961|582886524|FG008|Overall Study|Withdrawal by Subject|0|||
161409122|NCT03210961|582886525|FG009|Overall Study|Withdrawal by Subject|0|||
161409123|NCT03210961|582886526|FG010|Overall Study|Withdrawal by Subject|0|||
161409124|NCT03210961|582886527|FG011|Overall Study|Withdrawal by Subject|0|||
161409125|NCT03210961|582886528|FG012|Overall Study|Withdrawal by Subject|0|||
161409126|NCT03210961|582886529|FG013|Overall Study|Withdrawal by Subject|0|||
161409127|NCT03210961|582886530|FG014|Overall Study|Withdrawal by Subject|1|||
161409128|NCT03210961|582886516|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409129|NCT03210961|582886517|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409130|NCT03210961|582886518|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409131|NCT03210961|582886519|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409132|NCT03210961|582886520|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409133|NCT03210961|582886521|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409134|NCT03210961|582886522|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409135|NCT03210961|582886523|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409136|NCT03210961|582886524|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409137|NCT03210961|582886525|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409138|NCT03210961|582886526|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409139|NCT03210961|582886527|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409140|NCT03210961|582886528|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409141|NCT03210961|582886529|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
161409142|NCT03210961|582886530|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
161409143|NCT03210961|582886516|FG000|Overall Study|Other|0|||
161409144|NCT03210961|582886517|FG001|Overall Study|Other|0|||
161409145|NCT03210961|582886518|FG002|Overall Study|Other|0|||
161409146|NCT03210961|582886519|FG003|Overall Study|Other|1|||
161409147|NCT03210961|582886520|FG004|Overall Study|Other|0|||
161409148|NCT03210961|582886521|FG005|Overall Study|Other|0|||
161409149|NCT03210961|582886522|FG006|Overall Study|Other|1|||
161409150|NCT03210961|582886523|FG007|Overall Study|Other|0|||
161409151|NCT03210961|582886524|FG008|Overall Study|Other|0|||
161409152|NCT03210961|582886525|FG009|Overall Study|Other|0|||
161409153|NCT03210961|582886526|FG010|Overall Study|Other|1|||
161409154|NCT03210961|582886527|FG011|Overall Study|Other|0|||
161409155|NCT03210961|582886528|FG012|Overall Study|Other|2|||
161409156|NCT03210961|582886529|FG013|Overall Study|Other|2|||
161409157|NCT03210961|582886530|FG014|Overall Study|Other|0|||
161409158|NCT02467582|582886531|FG000|Allocation|Withdrawal by Subject|1|||
161409159|NCT02467582|582886532|FG001|Allocation|Withdrawal by Subject|0|||
161409160|NCT02467582|582886531|FG000|Follow-up|Death|5|||
161409161|NCT02467582|582886532|FG001|Follow-up|Death|4|||
161409162|NCT02467582|582886531|FG000|Follow-up|Lost to Follow-up|6|||
161409163|NCT02467582|582886532|FG001|Follow-up|Lost to Follow-up|5|||
161409164|NCT03047031|582886536|FG000|Overall Study|Other than listed|1|||
161409165|NCT03047031|582886537|FG001|Overall Study|Other than listed|0|||
161409166|NCT03047031|582886538|FG002|Overall Study|Other than listed|0|||
161409167|NCT03047031|582886536|FG000|Overall Study|Lost to Follow-up|4|||
161409168|NCT03047031|582886537|FG001|Overall Study|Lost to Follow-up|0|||
161409169|NCT03047031|582886538|FG002|Overall Study|Lost to Follow-up|0|||
161409170|NCT03047031|582886536|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
161409171|NCT03047031|582886537|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
161409172|NCT03047031|582886538|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
161409173|NCT03047031|582886536|FG000|Overall Study|Adverse Event|1|||
161409174|NCT03047031|582886537|FG001|Overall Study|Adverse Event|0|||
161409175|NCT03047031|582886538|FG002|Overall Study|Adverse Event|0|||
161409176|NCT03047031|582886536|FG000|Overall Study|Withdrawal by Subject|2|||
161409177|NCT03047031|582886537|FG001|Overall Study|Withdrawal by Subject|0|||
161409178|NCT03047031|582886538|FG002|Overall Study|Withdrawal by Subject|0|||
161409179|NCT03047031|582886536|FG000|Overall Study|Change to other medication|2|||
161409180|NCT03047031|582886537|FG001|Overall Study|Change to other medication|0|||
161409181|NCT03047031|582886538|FG002|Overall Study|Change to other medication|0|||
161409182|NCT03047031|582886536|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
161409183|NCT03047031|582886537|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
161409184|NCT03047031|582886538|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
161409185|NCT02814175|582886539|FG000|Part 1|Adverse Event|2|||
161409186|NCT02814175|582886540|FG001|Part 1|Adverse Event|3|||
161409187|NCT02814175|582886541|FG002|Part 1|Adverse Event|0|||
161409188|NCT02814175|582886542|FG003|Part 1|Adverse Event|0|||
161409189|NCT02814175|582886543|FG004|Part 1|Adverse Event|0|||
161409190|NCT02814175|582886544|FG005|Part 1|Adverse Event|0|||
161409191|NCT02814175|582886539|FG000|Part 1|Withdrawal Consent|8|||
161409192|NCT02814175|582886540|FG001|Part 1|Withdrawal Consent|1|||
161409193|NCT02814175|582886541|FG002|Part 1|Withdrawal Consent|0|||
161409194|NCT02814175|582886542|FG003|Part 1|Withdrawal Consent|0|||
161409195|NCT02814175|582886543|FG004|Part 1|Withdrawal Consent|0|||
161409196|NCT02814175|582886544|FG005|Part 1|Withdrawal Consent|0|||
161409197|NCT02814175|582886539|FG000|Part 1|Lost to Follow-up|1|||
161409198|NCT02814175|582886540|FG001|Part 1|Lost to Follow-up|0|||
161409199|NCT02814175|582886541|FG002|Part 1|Lost to Follow-up|0|||
161409200|NCT02814175|582886542|FG003|Part 1|Lost to Follow-up|0|||
161409201|NCT02814175|582886543|FG004|Part 1|Lost to Follow-up|0|||
161409202|NCT02814175|582886544|FG005|Part 1|Lost to Follow-up|0|||
161409203|NCT02814175|582886539|FG000|Part 1|Lack of Efficacy|1|||
161409204|NCT02814175|582886540|FG001|Part 1|Lack of Efficacy|2|||
161409205|NCT02814175|582886541|FG002|Part 1|Lack of Efficacy|0|||
161409206|NCT02814175|582886542|FG003|Part 1|Lack of Efficacy|0|||
161409207|NCT02814175|582886543|FG004|Part 1|Lack of Efficacy|0|||
161409208|NCT02814175|582886544|FG005|Part 1|Lack of Efficacy|0|||
161409209|NCT02814175|582886539|FG000|Part 2|Adverse Event|0|||
161409210|NCT02814175|582886540|FG001|Part 2|Adverse Event|0|||
161409211|NCT02814175|582886541|FG002|Part 2|Adverse Event|0|||
161409212|NCT02814175|582886542|FG003|Part 2|Adverse Event|1|||
161409213|NCT02814175|582886543|FG004|Part 2|Adverse Event|1|||
161409214|NCT02814175|582886544|FG005|Part 2|Adverse Event|2|||
161409215|NCT02814175|582886539|FG000|Part 2|Withdrawal Consent|0|||
161409216|NCT02814175|582886540|FG001|Part 2|Withdrawal Consent|0|||
161409217|NCT02814175|582886541|FG002|Part 2|Withdrawal Consent|0|||
161409218|NCT02814175|582886542|FG003|Part 2|Withdrawal Consent|2|||
161409219|NCT02814175|582886543|FG004|Part 2|Withdrawal Consent|1|||
161409220|NCT02814175|582886544|FG005|Part 2|Withdrawal Consent|1|||
161409221|NCT02814175|582886539|FG000|Part 2|Lost to Follow-up|0|||
161409222|NCT02814175|582886540|FG001|Part 2|Lost to Follow-up|0|||
161409223|NCT02814175|582886541|FG002|Part 2|Lost to Follow-up|0|||
161409224|NCT02814175|582886542|FG003|Part 2|Lost to Follow-up|1|||
161409225|NCT02814175|582886543|FG004|Part 2|Lost to Follow-up|0|||
161409226|NCT02814175|582886544|FG005|Part 2|Lost to Follow-up|0|||
161409227|NCT02814175|582886539|FG000|Part 2|Lack of Efficacy|0|||
161409228|NCT02814175|582886540|FG001|Part 2|Lack of Efficacy|0|||
161409229|NCT02814175|582886541|FG002|Part 2|Lack of Efficacy|0|||
161409230|NCT02814175|582886542|FG003|Part 2|Lack of Efficacy|0|||
161409231|NCT02814175|582886543|FG004|Part 2|Lack of Efficacy|0|||
161409232|NCT02814175|582886544|FG005|Part 2|Lack of Efficacy|3|||
161409233|NCT02702414|582886555|FG000|Overall Study|Death|96|||
161409234|NCT02702414|582886556|FG001|Overall Study|Death|42|||
161409235|NCT02702414|582886555|FG000|Overall Study|Lost to Follow-up|0|||
161409236|NCT02702414|582886556|FG001|Overall Study|Lost to Follow-up|1|||
161409237|NCT02702414|582886555|FG000|Overall Study|Withdrawal by Subject|0|||
161409238|NCT02702414|582886556|FG001|Overall Study|Withdrawal by Subject|1|||
161409239|NCT02702414|582886555|FG000|Overall Study|Protocol Violation|1|||
161409240|NCT02702414|582886556|FG001|Overall Study|Protocol Violation|0|||
161409241|NCT02702414|582886555|FG000|Overall Study|Sponsor Decision|8|||
161409242|NCT02702414|582886556|FG001|Overall Study|Sponsor Decision|7|||
161409243|NCT04541628|582886557|FG000|Overall Study|Study Terminated|1|||
161409244|NCT04541628|582886558|FG001|Overall Study|Study Terminated|1|||
161409245|NCT04541628|582886559|FG002|Overall Study|Study Terminated|1|||
161409246|NCT00859937|582886563|FG000|Overall Study|Protocol Violation|1|||
161409247|NCT00859937|582886564|FG001|Overall Study|Protocol Violation|0|||
161409248|NCT00615030|582886565|FG000|Period I|Administrative problem|0|||
161409249|NCT00615030|582886566|FG001|Period I|Administrative problem|0|||
161409250|NCT00615030|582886567|FG002|Period I|Administrative problem|0|||
161409251|NCT00615030|582886568|FG003|Period I|Administrative problem|0|||
161409252|NCT00615030|582886569|FG004|Period I|Administrative problem|1|||
161409253|NCT00615030|582886570|FG005|Period I|Administrative problem|0|||
161409254|NCT00615030|582886571|FG006|Period I|Administrative problem|0|||
161409255|NCT00615030|582886572|FG007|Period I|Administrative problem|0|||
161409256|NCT00615030|582886573|FG008|Period I|Administrative problem|0|||
161409257|NCT00615030|582886574|FG009|Period I|Administrative problem|0|||
161409258|NCT00615030|582886575|FG010|Period I|Administrative problem|0|||
161409259|NCT00615030|582886576|FG011|Period I|Administrative problem|0|||
161409260|NCT00615030|582886565|FG000|Period I|Protocol deviation|1|||
161409261|NCT00615030|582886566|FG001|Period I|Protocol deviation|0|||
161409262|NCT00615030|582886567|FG002|Period I|Protocol deviation|0|||
161409263|NCT00615030|582886568|FG003|Period I|Protocol deviation|0|||
161409264|NCT00615030|582886569|FG004|Period I|Protocol deviation|0|||
161409265|NCT00615030|582886570|FG005|Period I|Protocol deviation|0|||
161409266|NCT00615030|582886571|FG006|Period I|Protocol deviation|0|||
161409267|NCT00615030|582886572|FG007|Period I|Protocol deviation|0|||
161409268|NCT00615030|582886573|FG008|Period I|Protocol deviation|0|||
161409269|NCT00615030|582886574|FG009|Period I|Protocol deviation|0|||
161409270|NCT00615030|582886575|FG010|Period I|Protocol deviation|0|||
161409271|NCT00615030|582886576|FG011|Period I|Protocol deviation|0|||
161409272|NCT00615030|582886565|FG000|Period I|Subject withdrew consent|0|||
161409273|NCT00615030|582886566|FG001|Period I|Subject withdrew consent|0|||
161409274|NCT00615030|582886567|FG002|Period I|Subject withdrew consent|0|||
161409275|NCT00615030|582886568|FG003|Period I|Subject withdrew consent|0|||
161409276|NCT00615030|582886569|FG004|Period I|Subject withdrew consent|0|||
161409277|NCT00615030|582886570|FG005|Period I|Subject withdrew consent|0|||
161409278|NCT00615030|582886571|FG006|Period I|Subject withdrew consent|0|||
161409279|NCT00615030|582886572|FG007|Period I|Subject withdrew consent|0|||
161409280|NCT00615030|582886573|FG008|Period I|Subject withdrew consent|1|||
161409281|NCT00615030|582886574|FG009|Period I|Subject withdrew consent|0|||
161409282|NCT00615030|582886575|FG010|Period I|Subject withdrew consent|1|||
161409283|NCT00615030|582886576|FG011|Period I|Subject withdrew consent|1|||
161409284|NCT00615030|582886565|FG000|Period I|Abnormal laboratory value(s)|0|||
161409285|NCT00615030|582886566|FG001|Period I|Abnormal laboratory value(s)|0|||
161409286|NCT00615030|582886567|FG002|Period I|Abnormal laboratory value(s)|0|||
161409287|NCT00615030|582886568|FG003|Period I|Abnormal laboratory value(s)|0|||
161409288|NCT00615030|582886569|FG004|Period I|Abnormal laboratory value(s)|0|||
161409289|NCT00615030|582886570|FG005|Period I|Abnormal laboratory value(s)|1|||
161409290|NCT00615030|582886571|FG006|Period I|Abnormal laboratory value(s)|0|||
161409291|NCT00615030|582886572|FG007|Period I|Abnormal laboratory value(s)|0|||
161409292|NCT00615030|582886573|FG008|Period I|Abnormal laboratory value(s)|0|||
161409293|NCT00615030|582886574|FG009|Period I|Abnormal laboratory value(s)|0|||
161409294|NCT00615030|582886575|FG010|Period I|Abnormal laboratory value(s)|0|||
161409295|NCT00615030|582886576|FG011|Period I|Abnormal laboratory value(s)|0|||
161409296|NCT00615030|582886565|FG000|Period II|Adverse Event|0|||
161409297|NCT00615030|582886566|FG001|Period II|Adverse Event|0|||
161409298|NCT00615030|582886567|FG002|Period II|Adverse Event|1|||
161409299|NCT00615030|582886568|FG003|Period II|Adverse Event|0|||
161409300|NCT00615030|582886569|FG004|Period II|Adverse Event|0|||
161409301|NCT00615030|582886570|FG005|Period II|Adverse Event|0|||
161409302|NCT00615030|582886571|FG006|Period II|Adverse Event|0|||
161409303|NCT00615030|582886572|FG007|Period II|Adverse Event|0|||
161409304|NCT00615030|582886573|FG008|Period II|Adverse Event|1|||
161409305|NCT00615030|582886574|FG009|Period II|Adverse Event|0|||
161409306|NCT00615030|582886575|FG010|Period II|Adverse Event|0|||
161409307|NCT00615030|582886576|FG011|Period II|Adverse Event|0|||
161409308|NCT00615030|582886565|FG000|Period II|Subject withdrew consent|0|||
161409309|NCT00615030|582886566|FG001|Period II|Subject withdrew consent|0|||
161409310|NCT00615030|582886567|FG002|Period II|Subject withdrew consent|0|||
161409311|NCT00615030|582886568|FG003|Period II|Subject withdrew consent|1|||
161409312|NCT00615030|582886569|FG004|Period II|Subject withdrew consent|0|||
161409313|NCT00615030|582886570|FG005|Period II|Subject withdrew consent|0|||
161409314|NCT00615030|582886571|FG006|Period II|Subject withdrew consent|1|||
161409315|NCT00615030|582886572|FG007|Period II|Subject withdrew consent|0|||
161409316|NCT00615030|582886573|FG008|Period II|Subject withdrew consent|0|||
161409317|NCT00615030|582886574|FG009|Period II|Subject withdrew consent|0|||
161409318|NCT00615030|582886575|FG010|Period II|Subject withdrew consent|0|||
161409319|NCT00615030|582886576|FG011|Period II|Subject withdrew consent|0|||
161409320|NCT00615030|582886565|FG000|Period III|Administrative problems|1|||
161409321|NCT00615030|582886566|FG001|Period III|Administrative problems|0|||
161409322|NCT00615030|582886567|FG002|Period III|Administrative problems|0|||
161409323|NCT00615030|582886568|FG003|Period III|Administrative problems|1|||
161409324|NCT00615030|582886569|FG004|Period III|Administrative problems|0|||
161409325|NCT00615030|582886570|FG005|Period III|Administrative problems|0|||
161409326|NCT00615030|582886571|FG006|Period III|Administrative problems|0|||
161409327|NCT00615030|582886572|FG007|Period III|Administrative problems|0|||
161409328|NCT00615030|582886573|FG008|Period III|Administrative problems|0|||
161409329|NCT00615030|582886574|FG009|Period III|Administrative problems|0|||
161409330|NCT00615030|582886575|FG010|Period III|Administrative problems|0|||
161409331|NCT00615030|582886576|FG011|Period III|Administrative problems|0|||
161409332|NCT00151476|582886577|FG000|FAP Identified Subjects|Protocol Violation|0|||
161409333|NCT00151476|582886578|FG001|FAP Identified Subjects|Protocol Violation|1|||
161409334|NCT00151476|582886577|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
161409335|NCT00151476|582886578|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
161409336|NCT00151476|582886577|FG000|FAP Analyzed Subjects|Other study participation|0|||
161409337|NCT00151476|582886578|FG001|FAP Analyzed Subjects|Other study participation|1|||
161409338|NCT03446456|582886579|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
161409339|NCT03446456|582886580|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
161409340|NCT03446456|582886579|FG000|Overall Study|Lost to Follow-up|1|||
161409341|NCT03446456|582886580|FG001|Overall Study|Lost to Follow-up|3|||
161409342|NCT03446456|582886579|FG000|Overall Study|Participant failed the toxicology test|1|||
161409343|NCT03446456|582886580|FG001|Overall Study|Participant failed the toxicology test|0|||
161409344|NCT03446456|582886579|FG000|Overall Study|Break down of the experimental equipment|1|||
161409345|NCT03446456|582886580|FG001|Overall Study|Break down of the experimental equipment|0|||
161409346|NCT00308074|582886595|FG000|Overall Study|Withdrawal by Subject|1|||
161409347|NCT03002311|582886596|FG000|Overall Study|Lost to Follow-up|13|||
161409348|NCT03002311|582886597|FG001|Overall Study|Lost to Follow-up|26|||
161409349|NCT03002311|582886596|FG000|Overall Study|Referral provider called to schedule app|3|||
161409350|NCT03002311|582886597|FG001|Overall Study|Referral provider called to schedule app|3|||
161409351|NCT03002311|582886596|FG000|Overall Study|Physician Decision|3|||
161409352|NCT03002311|582886597|FG001|Overall Study|Physician Decision|1|||
161409353|NCT01329939|582886601|FG000|Overall Study|Lost to Follow-up|3|||
161409354|NCT01329939|582886602|FG001|Overall Study|Lost to Follow-up|0|||
161409355|NCT01329939|582886603|FG002|Overall Study|Lost to Follow-up|1|||
161409356|NCT01329939|582886604|FG003|Overall Study|Lost to Follow-up|2|||
161409357|NCT01329939|582886601|FG000|Overall Study|Withdrawal by Subject|0|||
161409358|NCT01329939|582886602|FG001|Overall Study|Withdrawal by Subject|1|||
161409359|NCT01329939|582886603|FG002|Overall Study|Withdrawal by Subject|0|||
161409360|NCT01329939|582886604|FG003|Overall Study|Withdrawal by Subject|0|||
161409361|NCT01329939|582886601|FG000|Overall Study|Adverse Event|0|||
161409362|NCT01329939|582886602|FG001|Overall Study|Adverse Event|0|||
161409363|NCT01329939|582886603|FG002|Overall Study|Adverse Event|0|||
161409364|NCT01329939|582886604|FG003|Overall Study|Adverse Event|3|||
161409365|NCT03722524|582886605|FG000|Overall Study|Protocol Violation|86|||
161409366|NCT03722524|582886605|FG000|Overall Study|Adverse Event|7|||
161409367|NCT03722524|582886605|FG000|Overall Study|Lost to Follow-up|1|||
161409368|NCT03722524|582886605|FG000|Overall Study|Reason is not stated|1|||
161409369|NCT03722524|582886605|FG000|Overall Study|Physician Decision|1|||
161409370|NCT03722524|582886605|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
161409371|NCT04369950|582886607|FG000|Overall Study|Protocol Violation|2|||
161409372|NCT04369950|582886608|FG001|Overall Study|Protocol Violation|2|||
161409373|NCT00989963|582886609|FG000|Overall Study|Adverse Event|1|||
161409374|NCT00989963|582886610|FG001|Overall Study|Adverse Event|1|||
161409375|NCT00989963|582886611|FG002|Overall Study|Adverse Event|1|||
161409376|NCT01240200|582886618|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
161409377|NCT01240200|582886619|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
161409378|NCT00549770|582886622|FG000|Overall Study|Protocol deviation|1|||
161409379|NCT00549770|582886623|FG001|Overall Study|Protocol deviation|1|||
161409380|NCT00549770|582886624|FG002|Overall Study|Protocol deviation|1|||
161409381|NCT00549770|582886625|FG003|Overall Study|Protocol deviation|2|||
161409382|NCT00549770|582886626|FG004|Overall Study|Protocol deviation|2|||
161409383|NCT00549770|582886627|FG005|Overall Study|Protocol deviation|2|||
161409384|NCT00549770|582886628|FG006|Overall Study|Protocol deviation|1|||
161409385|NCT00549770|582886629|FG007|Overall Study|Protocol deviation|2|||
161409386|NCT00549770|582886622|FG000|Overall Study|Administrative problems|0|||
161409387|NCT00549770|582886623|FG001|Overall Study|Administrative problems|1|||
161409388|NCT00549770|582886624|FG002|Overall Study|Administrative problems|0|||
161409389|NCT00549770|582886625|FG003|Overall Study|Administrative problems|0|||
161409390|NCT00549770|582886626|FG004|Overall Study|Administrative problems|0|||
161409391|NCT00549770|582886627|FG005|Overall Study|Administrative problems|0|||
161409392|NCT00549770|582886628|FG006|Overall Study|Administrative problems|0|||
161409393|NCT00549770|582886629|FG007|Overall Study|Administrative problems|1|||
161409394|NCT00549770|582886622|FG000|Overall Study|Lost to Follow-up|0|||
161409395|NCT00549770|582886623|FG001|Overall Study|Lost to Follow-up|0|||
161409396|NCT00549770|582886624|FG002|Overall Study|Lost to Follow-up|2|||
161409397|NCT00549770|582886625|FG003|Overall Study|Lost to Follow-up|2|||
161409398|NCT00549770|582886626|FG004|Overall Study|Lost to Follow-up|3|||
161409399|NCT00549770|582886627|FG005|Overall Study|Lost to Follow-up|2|||
161409400|NCT00549770|582886628|FG006|Overall Study|Lost to Follow-up|0|||
161409401|NCT00549770|582886629|FG007|Overall Study|Lost to Follow-up|0|||
161409402|NCT00549770|582886622|FG000|Overall Study|Withdrawal by Subject|4|||
161409403|NCT00549770|582886623|FG001|Overall Study|Withdrawal by Subject|6|||
161409404|NCT00549770|582886624|FG002|Overall Study|Withdrawal by Subject|4|||
161409405|NCT00549770|582886625|FG003|Overall Study|Withdrawal by Subject|5|||
161409406|NCT00549770|582886626|FG004|Overall Study|Withdrawal by Subject|6|||
161409407|NCT00549770|582886627|FG005|Overall Study|Withdrawal by Subject|6|||
161409408|NCT00549770|582886628|FG006|Overall Study|Withdrawal by Subject|4|||
161409409|NCT00549770|582886629|FG007|Overall Study|Withdrawal by Subject|9|||
161409410|NCT00549770|582886622|FG000|Overall Study|Lack of Efficacy|1|||
161409411|NCT00549770|582886623|FG001|Overall Study|Lack of Efficacy|0|||
161409412|NCT00549770|582886624|FG002|Overall Study|Lack of Efficacy|2|||
161409413|NCT00549770|582886625|FG003|Overall Study|Lack of Efficacy|3|||
161409414|NCT00549770|582886626|FG004|Overall Study|Lack of Efficacy|5|||
161409415|NCT00549770|582886627|FG005|Overall Study|Lack of Efficacy|1|||
161409416|NCT00549770|582886628|FG006|Overall Study|Lack of Efficacy|3|||
161409417|NCT00549770|582886629|FG007|Overall Study|Lack of Efficacy|8|||
161409418|NCT00549770|582886622|FG000|Overall Study|Abnormal test procedure results|0|||
161409419|NCT00549770|582886623|FG001|Overall Study|Abnormal test procedure results|0|||
161409420|NCT00549770|582886624|FG002|Overall Study|Abnormal test procedure results|0|||
161409421|NCT00549770|582886625|FG003|Overall Study|Abnormal test procedure results|2|||
161409422|NCT00549770|582886626|FG004|Overall Study|Abnormal test procedure results|0|||
161409423|NCT00549770|582886627|FG005|Overall Study|Abnormal test procedure results|1|||
161409424|NCT00549770|582886628|FG006|Overall Study|Abnormal test procedure results|1|||
161409425|NCT00549770|582886629|FG007|Overall Study|Abnormal test procedure results|1|||
161409426|NCT00549770|582886622|FG000|Overall Study|Abnormal laboratory values|0|||
161409427|NCT00549770|582886623|FG001|Overall Study|Abnormal laboratory values|0|||
161409428|NCT00549770|582886624|FG002|Overall Study|Abnormal laboratory values|0|||
161409429|NCT00549770|582886625|FG003|Overall Study|Abnormal laboratory values|0|||
161409430|NCT00549770|582886626|FG004|Overall Study|Abnormal laboratory values|0|||
161409431|NCT00549770|582886627|FG005|Overall Study|Abnormal laboratory values|1|||
161409432|NCT00549770|582886628|FG006|Overall Study|Abnormal laboratory values|0|||
161409433|NCT00549770|582886629|FG007|Overall Study|Abnormal laboratory values|0|||
161409434|NCT00549770|582886622|FG000|Overall Study|Adverse Event|1|||
161409435|NCT00549770|582886623|FG001|Overall Study|Adverse Event|3|||
161409436|NCT00549770|582886624|FG002|Overall Study|Adverse Event|1|||
161409437|NCT00549770|582886625|FG003|Overall Study|Adverse Event|2|||
161409438|NCT00549770|582886626|FG004|Overall Study|Adverse Event|1|||
161409439|NCT00549770|582886627|FG005|Overall Study|Adverse Event|0|||
161409440|NCT00549770|582886628|FG006|Overall Study|Adverse Event|5|||
161409441|NCT00549770|582886629|FG007|Overall Study|Adverse Event|4|||
161409442|NCT02712424|582886630|FG000|Overall Study|Lost to Follow-up|34|||
161409443|NCT02712424|582886631|FG001|Overall Study|Lost to Follow-up|32|||
161409444|NCT02760810|582886634|FG000|Overall Study|Protocol Violation|1|||
161409445|NCT00490022|582886637|FG000|Overall Study|Adverse Event|0|||
161409446|NCT00490022|582886638|FG001|Overall Study|Adverse Event|2|||
161409447|NCT00490022|582886637|FG000|Overall Study|Withdrawal by Subject|1|||
161409448|NCT00490022|582886638|FG001|Overall Study|Withdrawal by Subject|0|||
161409449|NCT00490022|582886637|FG000|Overall Study|Subject failed to disclose concommitant|0|||
161409450|NCT00490022|582886638|FG001|Overall Study|Subject failed to disclose concommitant|1|||
161409451|NCT00869401|582886639|FG000|Overall Study|Withdrawal by Subject|0|||
161409452|NCT00869401|582886640|FG001|Overall Study|Withdrawal by Subject|0|||
161409453|NCT00869401|582886641|FG002|Overall Study|Withdrawal by Subject|0|||
161409454|NCT00869401|582886642|FG003|Overall Study|Withdrawal by Subject|5|||
161409455|NCT00869401|582886643|FG004|Overall Study|Withdrawal by Subject|3|||
161409456|NCT00975143|582886646|FG000|Overall Study|Adverse Event|19|||
161409457|NCT00975143|582886647|FG001|Overall Study|Adverse Event|15|||
161409458|NCT00975143|582886646|FG000|Overall Study|Withdrawal by Subject|15|||
161409459|NCT00975143|582886647|FG001|Overall Study|Withdrawal by Subject|15|||
161409460|NCT00975143|582886646|FG000|Overall Study|Lost to Follow-up|20|||
161409461|NCT00975143|582886647|FG001|Overall Study|Lost to Follow-up|16|||
161409462|NCT00975143|582886646|FG000|Overall Study|Non-compliance|5|||
161409463|NCT00975143|582886647|FG001|Overall Study|Non-compliance|8|||
161409464|NCT00975143|582886646|FG000|Overall Study|Physician Decision|1|||
161409465|NCT00975143|582886647|FG001|Overall Study|Physician Decision|2|||
161409466|NCT00975143|582886646|FG000|Overall Study|Details not available|10|||
161409467|NCT00975143|582886647|FG001|Overall Study|Details not available|4|||
161409468|NCT01753401|582886648|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
161409469|NCT01753401|582886649|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
161409470|NCT01753401|582886650|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
161409471|NCT01753401|582886651|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
161409472|NCT01753401|582886648|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
161409473|NCT01753401|582886649|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
161409474|NCT01753401|582886650|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161409475|NCT01753401|582886651|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161409476|NCT01753401|582886648|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
161409477|NCT01753401|582886649|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
161409478|NCT01753401|582886650|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
161409479|NCT01753401|582886651|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
161409480|NCT01753401|582886648|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
161409481|NCT01753401|582886649|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
161409482|NCT01753401|582886650|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
161409483|NCT01753401|582886651|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
161409484|NCT01753401|582886648|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
161409485|NCT01753401|582886649|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
161409486|NCT01753401|582886650|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
161409487|NCT01753401|582886651|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
161409488|NCT01753401|582886648|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
161409489|NCT01753401|582886649|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
161409490|NCT01753401|582886650|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
161409491|NCT01753401|582886651|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
161409492|NCT01753401|582886648|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
161409493|NCT01753401|582886649|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
161409494|NCT01753401|582886650|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
161409495|NCT01753401|582886651|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
161409496|NCT00581360|582886652|FG000|Overall Study|Withdrawal by Subject|1|||
161409497|NCT03129360|582886653|FG000|Overall Study|Did not meet entry criteria|0|||
161409498|NCT03129360|582886654|FG001|Overall Study|Did not meet entry criteria|2|||
161409499|NCT03129360|582886655|FG002|Overall Study|Did not meet entry criteria|1|||
161409500|NCT03129360|582886653|FG000|Overall Study|Excluded due to motion in scanner|1|||
161409501|NCT03129360|582886654|FG001|Overall Study|Excluded due to motion in scanner|0|||
161409502|NCT03129360|582886655|FG002|Overall Study|Excluded due to motion in scanner|0|||
161409503|NCT00599638|582886656|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
161409504|NCT00599638|582886657|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
161409505|NCT00599638|582886658|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
161409506|NCT00599638|582886659|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
161409507|NCT00599638|582886656|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
161409508|NCT00599638|582886657|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
161409509|NCT00599638|582886658|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
161409510|NCT00599638|582886659|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
161409511|NCT00599638|582886656|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
161409512|NCT00599638|582886657|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
161409513|NCT00599638|582886658|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
161409514|NCT00599638|582886659|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
161409515|NCT00599638|582886656|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
161409516|NCT00599638|582886657|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
161409517|NCT00599638|582886658|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
161409518|NCT00599638|582886659|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
161409519|NCT00599638|582886656|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161409520|NCT00599638|582886657|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
161409521|NCT00599638|582886658|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
161409522|NCT00599638|582886659|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161409523|NCT00599638|582886656|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
161409524|NCT00599638|582886657|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
161409525|NCT00599638|582886658|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
161409526|NCT00599638|582886659|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
161409527|NCT00599638|582886656|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
161409528|NCT00599638|582886657|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
161409529|NCT00599638|582886658|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
161409530|NCT00599638|582886659|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
161409531|NCT00599638|582886656|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
161409532|NCT00599638|582886657|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
161409533|NCT00599638|582886658|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
161409534|NCT00599638|582886659|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
161409535|NCT00599638|582886656|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
161409536|NCT00599638|582886657|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
161409537|NCT00599638|582886658|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
161409538|NCT00599638|582886659|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
161409539|NCT03006887|582886663|FG000|Overall Study|Adverse Event|1|||
161409540|NCT03836677|582886664|FG000|Period 1|Adverse Event|0|||
161409541|NCT03836677|582886665|FG001|Period 1|Adverse Event|1|||
161409542|NCT03836677|582886664|FG000|Period 2|Severe non-compliance to protocol|1|||
161409543|NCT03836677|582886665|FG001|Period 2|Severe non-compliance to protocol|0|||
161409544|NCT02895945|582886666|FG000|Overall Study|Physician Decision|2|||
161409545|NCT02895945|582886667|FG001|Overall Study|Physician Decision|1|||
161409546|NCT00462748|582886668|FG000|Overall Study|Adverse Event|7|||
161409547|NCT00462748|582886669|FG001|Overall Study|Adverse Event|5|||
161409548|NCT00462748|582886670|FG002|Overall Study|Adverse Event|9|||
161409549|NCT00462748|582886668|FG000|Overall Study|Protocol Violation|0|||
161409550|NCT00462748|582886669|FG001|Overall Study|Protocol Violation|2|||
161409551|NCT00462748|582886670|FG002|Overall Study|Protocol Violation|1|||
161409552|NCT00462748|582886668|FG000|Overall Study|Withdrew consent|3|||
161409553|NCT00462748|582886669|FG001|Overall Study|Withdrew consent|3|||
161409554|NCT00462748|582886670|FG002|Overall Study|Withdrew consent|0|||
161409555|NCT00462748|582886668|FG000|Overall Study|Lost to Follow-up|1|||
161409556|NCT00462748|582886669|FG001|Overall Study|Lost to Follow-up|1|||
161409557|NCT00462748|582886670|FG002|Overall Study|Lost to Follow-up|1|||
161409558|NCT00462748|582886668|FG000|Overall Study|Discontinued after 41 days Rx|1|||
161409559|NCT00462748|582886669|FG001|Overall Study|Discontinued after 41 days Rx|0|||
161409560|NCT00462748|582886670|FG002|Overall Study|Discontinued after 41 days Rx|0|||
161409561|NCT03429543|582886671|FG000|Overall Study|Adverse Event|1|||
161409562|NCT03429543|582886672|FG001|Overall Study|Adverse Event|1|||
161409563|NCT03429543|582886673|FG002|Overall Study|Adverse Event|0|||
161409564|NCT03429543|582886674|FG003|Overall Study|Adverse Event|0|||
161409565|NCT03429543|582886675|FG004|Overall Study|Adverse Event|0|||
161409566|NCT03429543|582886676|FG005|Overall Study|Adverse Event|2|||
161409567|NCT03429543|582886677|FG006|Overall Study|Adverse Event|0|||
161409568|NCT03429543|582886671|FG000|Overall Study|Lost to Follow-up|1|||
161409569|NCT03429543|582886672|FG001|Overall Study|Lost to Follow-up|0|||
161409570|NCT03429543|582886673|FG002|Overall Study|Lost to Follow-up|0|||
161409571|NCT03429543|582886674|FG003|Overall Study|Lost to Follow-up|0|||
161409572|NCT03429543|582886675|FG004|Overall Study|Lost to Follow-up|1|||
161409573|NCT03429543|582886676|FG005|Overall Study|Lost to Follow-up|0|||
161409574|NCT03429543|582886677|FG006|Overall Study|Lost to Follow-up|0|||
161409575|NCT03429543|582886671|FG000|Overall Study|Withdrawal by Subject|5|||
161409576|NCT03429543|582886672|FG001|Overall Study|Withdrawal by Subject|0|||
161409577|NCT03429543|582886673|FG002|Overall Study|Withdrawal by Subject|1|||
161409578|NCT03429543|582886674|FG003|Overall Study|Withdrawal by Subject|2|||
161409579|NCT03429543|582886675|FG004|Overall Study|Withdrawal by Subject|6|||
161409580|NCT03429543|582886676|FG005|Overall Study|Withdrawal by Subject|3|||
161409581|NCT03429543|582886677|FG006|Overall Study|Withdrawal by Subject|1|||
161409582|NCT03429543|582886671|FG000|Overall Study|Other reason than listed|0|||
161409583|NCT03429543|582886672|FG001|Overall Study|Other reason than listed|1|||
161409584|NCT03429543|582886673|FG002|Overall Study|Other reason than listed|0|||
161409585|NCT03429543|582886674|FG003|Overall Study|Other reason than listed|0|||
161409586|NCT03429543|582886675|FG004|Overall Study|Other reason than listed|4|||
161409587|NCT03429543|582886676|FG005|Overall Study|Other reason than listed|4|||
161409588|NCT03429543|582886677|FG006|Overall Study|Other reason than listed|0|||
161409589|NCT03429543|582886671|FG000|Overall Study|Not treated|0|||
161409590|NCT03429543|582886672|FG001|Overall Study|Not treated|0|||
161409591|NCT03429543|582886673|FG002|Overall Study|Not treated|0|||
161409592|NCT03429543|582886674|FG003|Overall Study|Not treated|0|||
161409593|NCT03429543|582886675|FG004|Overall Study|Not treated|1|||
161409594|NCT03429543|582886676|FG005|Overall Study|Not treated|0|||
161409595|NCT03429543|582886677|FG006|Overall Study|Not treated|0|||
161409596|NCT01729208|582886678|FG000|Baseline|Physician Decision|5|||
161409597|NCT01729208|582886679|FG001|Baseline|Physician Decision|4|||
161409598|NCT01729208|582886678|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
161409599|NCT01729208|582886679|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
161409600|NCT01729208|582886678|FG000|12 Months Follow-up|Lost to Follow-up|3|||
161409601|NCT01729208|582886679|FG001|12 Months Follow-up|Lost to Follow-up|3|||
161409602|NCT01729208|582886678|FG000|24 Months Follow-up|Lost to Follow-up|3|||
161409603|NCT01729208|582886679|FG001|24 Months Follow-up|Lost to Follow-up|0|||
161409604|NCT01729208|582886678|FG000|36 Months Follow-up|Physician Decision|1|||
161409605|NCT01729208|582886679|FG001|36 Months Follow-up|Physician Decision|0|||
161409606|NCT01729208|582886678|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
161409607|NCT01729208|582886679|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
161409608|NCT00082381|582886680|FG000|Overall Study|Adverse Event|27|||
161409609|NCT00082381|582886681|FG001|Overall Study|Adverse Event|2|||
161409610|NCT00082381|582886680|FG000|Overall Study|Lost to Follow-up|5|||
161409611|NCT00082381|582886681|FG001|Overall Study|Lost to Follow-up|7|||
161409612|NCT00082381|582886680|FG000|Overall Study|Patient Decision|8|||
161409613|NCT00082381|582886681|FG001|Overall Study|Patient Decision|4|||
161409614|NCT00082381|582886680|FG000|Overall Study|Physician Decision|1|||
161409615|NCT00082381|582886681|FG001|Overall Study|Physician Decision|2|||
161409616|NCT00082381|582886680|FG000|Overall Study|Protocol Violation|10|||
161409617|NCT00082381|582886681|FG001|Overall Study|Protocol Violation|11|||
161409618|NCT00082381|582886680|FG000|Overall Study|Loss of Glucose Control|4|||
161409619|NCT00082381|582886681|FG001|Overall Study|Loss of Glucose Control|0|||
161409620|NCT02428413|582886682|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
161409621|NCT02428413|582886683|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
161409622|NCT02428413|582886682|FG000|Overall Study|Protocol Violation|1|||
161409623|NCT02428413|582886683|FG001|Overall Study|Protocol Violation|2|||
161409624|NCT02428413|582886682|FG000|Overall Study|Case Cancelled|2|||
161409625|NCT02428413|582886683|FG001|Overall Study|Case Cancelled|0|||
161409626|NCT02428413|582886682|FG000|Overall Study|Missed Cases|1|||
161409627|NCT02428413|582886683|FG001|Overall Study|Missed Cases|2|||
161409628|NCT02428413|582886682|FG000|Overall Study|Nurse Refusal|1|||
161409629|NCT02428413|582886683|FG001|Overall Study|Nurse Refusal|0|||
161409630|NCT02345330|582886687|FG000|Overall Study|Death|1|||
161409631|NCT02345330|582886687|FG000|Overall Study|Progressive Disease|2|||
161409632|NCT00295932|582886688|FG000|Overall Study|Not Treated|0|||
161409633|NCT00295932|582886689|FG001|Overall Study|Not Treated|0|||
161409634|NCT00295932|582886690|FG002|Overall Study|Not Treated|0|||
161409635|NCT00295932|582886691|FG003|Overall Study|Not Treated|0|||
161409636|NCT00295932|582886692|FG004|Overall Study|Not Treated|0|||
161409637|NCT00295932|582886693|FG005|Overall Study|Not Treated|0|||
161409638|NCT00295932|582886694|FG006|Overall Study|Not Treated|0|||
161409639|NCT00295932|582886695|FG007|Overall Study|Not Treated|0|||
161409640|NCT00295932|582886696|FG008|Overall Study|Not Treated|0|||
161409641|NCT00295932|582886697|FG009|Overall Study|Not Treated|0|||
161409642|NCT00295932|582886698|FG010|Overall Study|Not Treated|1|||
161409643|NCT00109577|582886699|FG000|Overall Study|Withdrawal by Subject|3|||
161409644|NCT00109577|582886700|FG001|Overall Study|Withdrawal by Subject|3|||
161409645|NCT03322423|582886701|FG000|Period 1|Subject no longer eligible|0|||
161409646|NCT03322423|582886702|FG001|Period 1|Subject no longer eligible|1|||
161409647|NCT03322423|582886701|FG000|Period 1|Withdrawal by Subject|0|||
161409648|NCT03322423|582886702|FG001|Period 1|Withdrawal by Subject|1|||
161409649|NCT03322423|582886701|FG000|Period 1|Incorrect Lens Dispensed|1|||
161409650|NCT03322423|582886702|FG001|Period 1|Incorrect Lens Dispensed|0|||
161409651|NCT03322423|582886701|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
161409652|NCT03322423|582886702|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
161409653|NCT03322423|582886701|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
161409654|NCT03322423|582886702|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
161409655|NCT03322423|582886701|FG000|Period 2|Protocol Violation|1|||
161409656|NCT03322423|582886702|FG001|Period 2|Protocol Violation|0|||
161409657|NCT03322423|582886701|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
161409658|NCT03322423|582886702|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
161409659|NCT04891107|582886703|FG000|Overall Study|Physician Decision|1|||
161409660|NCT04891107|582886703|FG000|Overall Study|Withdrawal by Subject|1|||
161409661|NCT04891107|582886703|FG000|Overall Study|Screen failure after consent|1|||
161409662|NCT02453555|582886704|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
161409663|NCT02453555|582886705|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
161409664|NCT02453555|582886706|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
161409665|NCT02453555|582886707|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
161409666|NCT02453555|582886708|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
161409667|NCT02453555|582886709|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
161409668|NCT02453555|582886704|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
161409669|NCT02453555|582886705|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161409670|NCT02453555|582886706|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161409671|NCT02453555|582886707|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161409672|NCT02453555|582886708|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161409673|NCT02453555|582886709|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161409674|NCT02453555|582886704|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
161409675|NCT02453555|582886705|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
161409676|NCT02453555|582886706|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161409677|NCT02453555|582886707|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161409678|NCT02453555|582886708|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161409679|NCT02453555|582886709|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161409680|NCT02453555|582886704|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
161409681|NCT02453555|582886705|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
161409682|NCT02453555|582886706|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
161409683|NCT02453555|582886707|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
161409684|NCT02453555|582886708|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
161409685|NCT02453555|582886709|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
161409686|NCT02453555|582886704|FG000|Extension Period|Adverse Event|0|||
161409687|NCT02453555|582886705|FG001|Extension Period|Adverse Event|0|||
161409688|NCT02453555|582886706|FG002|Extension Period|Adverse Event|1|||
161409689|NCT02453555|582886707|FG003|Extension Period|Adverse Event|2|||
161409690|NCT02453555|582886708|FG004|Extension Period|Adverse Event|1|||
161409691|NCT02453555|582886709|FG005|Extension Period|Adverse Event|1|||
161409692|NCT02453555|582886704|FG000|Extension Period|Protocol Violation|0|||
161409693|NCT02453555|582886705|FG001|Extension Period|Protocol Violation|0|||
161409694|NCT02453555|582886706|FG002|Extension Period|Protocol Violation|1|||
161409695|NCT02453555|582886707|FG003|Extension Period|Protocol Violation|0|||
161409696|NCT02453555|582886708|FG004|Extension Period|Protocol Violation|0|||
161409697|NCT02453555|582886709|FG005|Extension Period|Protocol Violation|0|||
161409698|NCT02453555|582886704|FG000|Extension Period|Withdrawal by Subject|0|||
161409699|NCT02453555|582886705|FG001|Extension Period|Withdrawal by Subject|0|||
161409700|NCT02453555|582886706|FG002|Extension Period|Withdrawal by Subject|1|||
161409701|NCT02453555|582886707|FG003|Extension Period|Withdrawal by Subject|0|||
161409702|NCT02453555|582886708|FG004|Extension Period|Withdrawal by Subject|0|||
161409703|NCT02453555|582886709|FG005|Extension Period|Withdrawal by Subject|0|||
161409704|NCT03689855|582886714|FG000|Overall Study|Adverse Event|3|||
161409705|NCT03689855|582886714|FG000|Overall Study|Withdrawal by Subject|1|||
161409706|NCT03178669|582886715|FG000|Overall Study|Adverse Event|4|||
161409707|NCT03178669|582886716|FG001|Overall Study|Adverse Event|1|||
161409708|NCT03178669|582886717|FG002|Overall Study|Adverse Event|4|||
161409709|NCT03178669|582886718|FG003|Overall Study|Adverse Event|2|||
161409710|NCT03178669|582886719|FG004|Overall Study|Adverse Event|2|||
161409711|NCT03178669|582886715|FG000|Overall Study|Lack of Efficacy|0|||
161409712|NCT03178669|582886716|FG001|Overall Study|Lack of Efficacy|0|||
161409713|NCT03178669|582886717|FG002|Overall Study|Lack of Efficacy|2|||
161409714|NCT03178669|582886718|FG003|Overall Study|Lack of Efficacy|0|||
161409715|NCT03178669|582886719|FG004|Overall Study|Lack of Efficacy|1|||
161409716|NCT03178669|582886715|FG000|Overall Study|Physician Decision|0|||
161409717|NCT03178669|582886716|FG001|Overall Study|Physician Decision|0|||
161409718|NCT03178669|582886717|FG002|Overall Study|Physician Decision|0|||
161409719|NCT03178669|582886718|FG003|Overall Study|Physician Decision|0|||
161409720|NCT03178669|582886719|FG004|Overall Study|Physician Decision|1|||
161409721|NCT03178669|582886715|FG000|Overall Study|Withdrawal by Subject|1|||
161409722|NCT03178669|582886716|FG001|Overall Study|Withdrawal by Subject|0|||
161409723|NCT03178669|582886717|FG002|Overall Study|Withdrawal by Subject|1|||
161409724|NCT03178669|582886718|FG003|Overall Study|Withdrawal by Subject|1|||
161409725|NCT03178669|582886719|FG004|Overall Study|Withdrawal by Subject|0|||
161409726|NCT03178669|582886715|FG000|Overall Study|Lost to Follow-up|0|||
161409727|NCT03178669|582886716|FG001|Overall Study|Lost to Follow-up|0|||
161409728|NCT03178669|582886717|FG002|Overall Study|Lost to Follow-up|0|||
161409729|NCT03178669|582886718|FG003|Overall Study|Lost to Follow-up|1|||
161409730|NCT03178669|582886719|FG004|Overall Study|Lost to Follow-up|0|||
161409731|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
161409732|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
161409733|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
161409734|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
161409735|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
161409736|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
161409737|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161409738|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161409739|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161409740|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161409741|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161409742|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
161409743|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
161409744|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
161409745|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161409746|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
161409747|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
161409748|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161409749|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161409750|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161409751|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161409752|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161409753|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161409754|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
161409755|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
161409756|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
161409757|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
161409758|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
161409759|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161409760|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161409761|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161409762|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161409763|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161409764|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
161409765|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
161409766|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
161409767|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161409768|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
161409769|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
161409770|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161409771|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161409772|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161409773|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161409774|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161409775|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409776|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409777|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
161409778|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409779|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409780|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
161409781|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409782|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409783|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409784|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409785|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161409786|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
161409787|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409788|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409789|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409790|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409791|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409792|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409793|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409794|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409795|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409796|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161409797|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409798|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409799|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
161409800|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409801|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409802|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409803|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409804|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409805|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409806|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409807|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161409808|NCT02914561|582886721|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
161409809|NCT02914561|582886722|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161409810|NCT02914561|582886723|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161409811|NCT02914561|582886724|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161409812|NCT02914561|582886725|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161409813|NCT02914561|582886726|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161409814|NCT02914561|582886727|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161409815|NCT02914561|582886728|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161409816|NCT02914561|582886729|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161409817|NCT02914561|582886730|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161409818|NCT02914561|582886731|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161409819|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161409820|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161409821|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161409822|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161409823|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161409824|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161409825|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
161409826|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
161409827|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
161409828|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
161409829|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
161409830|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161409831|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161409832|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161409833|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161409834|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161409835|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161409836|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
161409837|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
161409838|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
161409839|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
161409840|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
161409841|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161409842|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161409843|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161409844|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161409845|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161409846|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161409847|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
161409848|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
161409849|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
161409850|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
161409851|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
161409852|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409853|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409854|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409855|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409856|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409857|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409858|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
161409859|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409860|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
161409861|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161409862|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
161409863|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409864|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409865|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409866|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409867|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409868|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409869|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
161409870|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161409871|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
161409872|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
161409873|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
161409874|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409875|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409876|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409877|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409878|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409879|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409880|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
161409881|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409882|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
161409883|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409884|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161409885|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409886|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409887|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409888|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409889|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409890|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409891|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409892|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409893|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
161409894|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409895|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161409896|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409897|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409898|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409899|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409900|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409901|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409902|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
161409903|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409904|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409905|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409906|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161409907|NCT02914561|582886721|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409908|NCT02914561|582886722|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409909|NCT02914561|582886723|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409910|NCT02914561|582886724|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409911|NCT02914561|582886725|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409912|NCT02914561|582886726|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409913|NCT02914561|582886727|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409914|NCT02914561|582886728|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161409915|NCT02914561|582886729|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
161409916|NCT02914561|582886730|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
161409917|NCT02914561|582886731|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
161409918|NCT01300455|582886732|FG000|Washout|Withdrawal by Subject|1|||
161409919|NCT01300455|582886733|FG001|Washout|Withdrawal by Subject|0|||
161409920|NCT00565136|582886734|FG000|Overall Study|Lost to Follow-up|1|||
161409921|NCT00565136|582886734|FG000|Overall Study|Withdrawal by Subject|1|||
161409922|NCT00565136|582886734|FG000|Overall Study|Protocol Violation|1|||
161409923|NCT03332160|582886745|FG000|Overall Study|Withdrawal by Subject|1|||
161409924|NCT03332160|582886746|FG001|Overall Study|Withdrawal by Subject|1|||
161409925|NCT03332160|582886745|FG000|Overall Study|Adverse Event|0|||
161409926|NCT03332160|582886746|FG001|Overall Study|Adverse Event|1|||
161409927|NCT03332160|582886745|FG000|Overall Study|Developed Exclusion Criteria|0|||
161409928|NCT03332160|582886746|FG001|Overall Study|Developed Exclusion Criteria|1|||
161409929|NCT03332160|582886745|FG000|Overall Study|Non-adherence to treatment|0|||
161409930|NCT03332160|582886746|FG001|Overall Study|Non-adherence to treatment|2|||
161409931|NCT01370265|582888348|FG000|First Intervention|Adverse Event|1|||
161409932|NCT01370265|582888349|FG001|First Intervention|Adverse Event|1|||
161409933|NCT00703924|582888350|FG000|Overall Study|Withdrawal by Subject|1|||
161409934|NCT00703924|582888351|FG001|Overall Study|Withdrawal by Subject|1|||
161409935|NCT01031979|582888352|FG000|Overall Study|Lost to Follow-up|5|||
161409936|NCT01031979|582888353|FG001|Overall Study|Lost to Follow-up|4|||
161409937|NCT03592368|582888355|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
161409938|NCT03592368|582888356|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
161409939|NCT03592368|582888357|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
161409940|NCT03592368|582888358|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
161409941|NCT03592368|582888355|FG000|Overall Study|Adverse Event|0|||
161409942|NCT03592368|582888356|FG001|Overall Study|Adverse Event|0|||
161409943|NCT03592368|582888357|FG002|Overall Study|Adverse Event|0|||
161409944|NCT03592368|582888358|FG003|Overall Study|Adverse Event|1|||
161409945|NCT03592368|582888355|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
161409946|NCT03592368|582888356|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
161409947|NCT03592368|582888357|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
161409948|NCT03592368|582888358|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
161409949|NCT03831100|582888359|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
161409950|NCT03831100|582888360|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
161409951|NCT02454478|582888366|FG000|Overall Study|Incomplete DLT Evaluation|1|||
161409952|NCT01732770|582888370|FG000|Overall Study|Lost to Follow-up|2|||
161409953|NCT01732770|582888371|FG001|Overall Study|Lost to Follow-up|3|||
161409954|NCT01732770|582888370|FG000|Overall Study|Withdrawal by Subject|5|||
161409955|NCT01732770|582888371|FG001|Overall Study|Withdrawal by Subject|3|||
161409956|NCT01732770|582888370|FG000|Overall Study|Decision by Sponsor|2|||
161409957|NCT01732770|582888371|FG001|Overall Study|Decision by Sponsor|2|||
161409958|NCT01732770|582888370|FG000|Overall Study|Death|1|||
161409959|NCT01732770|582888371|FG001|Overall Study|Death|0|||
161409960|NCT01959841|582888375|FG000|Overall Study|Adverse Event|1|||
161409961|NCT01959841|582888376|FG001|Overall Study|Adverse Event|3|||
161409962|NCT01959841|582888377|FG002|Overall Study|Adverse Event|2|||
161409963|NCT01959841|582888375|FG000|Overall Study|Lack of Efficacy|5|||
161409964|NCT01959841|582888376|FG001|Overall Study|Lack of Efficacy|0|||
161409965|NCT01959841|582888377|FG002|Overall Study|Lack of Efficacy|0|||
161409966|NCT01959841|582888375|FG000|Overall Study|Lost to Follow-up|1|||
161409967|NCT01959841|582888376|FG001|Overall Study|Lost to Follow-up|1|||
161409968|NCT01959841|582888377|FG002|Overall Study|Lost to Follow-up|0|||
161409969|NCT01959841|582888375|FG000|Overall Study|Physician Decision|0|||
161409970|NCT01959841|582888376|FG001|Overall Study|Physician Decision|2|||
161409971|NCT01959841|582888377|FG002|Overall Study|Physician Decision|3|||
161409972|NCT01959841|582888375|FG000|Overall Study|Protocol Violation|16|||
161409973|NCT01959841|582888376|FG001|Overall Study|Protocol Violation|23|||
161409974|NCT01959841|582888377|FG002|Overall Study|Protocol Violation|16|||
161409975|NCT01959841|582888375|FG000|Overall Study|Withdrawal by Subject|7|||
161409976|NCT01959841|582888376|FG001|Overall Study|Withdrawal by Subject|7|||
161409977|NCT01959841|582888377|FG002|Overall Study|Withdrawal by Subject|5|||
161409978|NCT01959841|582888375|FG000|Overall Study|Clinical laboratory value|2|||
161409979|NCT01959841|582888376|FG001|Overall Study|Clinical laboratory value|6|||
161409980|NCT01959841|582888377|FG002|Overall Study|Clinical laboratory value|6|||
161409981|NCT01959841|582888375|FG000|Overall Study|Platelet count below on day1 or 4|11|||
161409982|NCT01959841|582888376|FG001|Overall Study|Platelet count below on day1 or 4|15|||
161409983|NCT01959841|582888377|FG002|Overall Study|Platelet count below on day1 or 4|11|||
161409984|NCT01450098|582888378|FG000|Period 3|Protocol Violation|0|||
161409985|NCT01450098|582888379|FG001|Period 3|Protocol Violation|1|||
161409986|NCT01450098|582888378|FG000|Period 3|Withdrawal by Subject|0|||
161409987|NCT01450098|582888379|FG001|Period 3|Withdrawal by Subject|2|||
161409988|NCT04207749|582888386|FG000|Overall Study|Lost to Follow-up|0|||
161409989|NCT04207749|582888387|FG001|Overall Study|Lost to Follow-up|2|||
161409990|NCT04207749|582888386|FG000|Overall Study|Protocol Violation|0|||
161409991|NCT04207749|582888387|FG001|Overall Study|Protocol Violation|1|||
161409992|NCT04207749|582888386|FG000|Overall Study|Withdrawal by Subject|3|||
161409993|NCT04207749|582888387|FG001|Overall Study|Withdrawal by Subject|0|||
161409994|NCT04207749|582888386|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
161409995|NCT04207749|582888387|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
161409996|NCT00655629|582888388|FG000|Overall Study|Adverse Event|4|||
161409997|NCT00655629|582888389|FG001|Overall Study|Adverse Event|1|||
161409998|NCT00655629|582888388|FG000|Overall Study|Lack of Efficacy|2|||
161409999|NCT00655629|582888389|FG001|Overall Study|Lack of Efficacy|12|||
161410000|NCT00655629|582888388|FG000|Overall Study|Lost to Follow-up|4|||
161410001|NCT00655629|582888389|FG001|Overall Study|Lost to Follow-up|3|||
161410002|NCT00655629|582888388|FG000|Overall Study|Protocol Violation|5|||
161410003|NCT00655629|582888389|FG001|Overall Study|Protocol Violation|3|||
161410004|NCT00655629|582888388|FG000|Overall Study|consent withdrawn|6|||
161410005|NCT00655629|582888389|FG001|Overall Study|consent withdrawn|4|||
161410006|NCT01971008|582888390|FG000|Overall Study|Protocol Violation|2|||
161410007|NCT01971008|582888391|FG001|Overall Study|Protocol Violation|1|||
161410008|NCT03416127|582888392|FG000|Overall Study|Withdrawal by Subject|0|||
161410009|NCT03416127|582888393|FG001|Overall Study|Withdrawal by Subject|1|||
161410010|NCT03416127|582888394|FG002|Overall Study|Withdrawal by Subject|1|||
161410011|NCT00924508|582888395|FG000|Overall Study|Withdrawal by Subject|3|||
161410012|NCT00495625|582888396|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
161410013|NCT03679624|582888397|FG000|Overall Study|Adverse Event|1|||
161410014|NCT03679624|582888398|FG001|Overall Study|Adverse Event|0|||
161410015|NCT01912339|582888399|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
161410016|NCT01912339|582888400|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
161410017|NCT01912339|582888401|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
161410018|NCT01912339|582888399|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
161410019|NCT01912339|582888400|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
161410020|NCT01912339|582888401|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
161410021|NCT01912339|582888399|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
161410022|NCT01912339|582888400|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
161410023|NCT01912339|582888401|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
161410024|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
161410025|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
161410026|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
161410027|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
161410028|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
161410029|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
161410030|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
161410031|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
161410032|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
161410033|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
161410034|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
161410035|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
161410036|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
161410037|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
161410038|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
161410039|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
161410040|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
161410041|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
161410042|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
161410043|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
161410044|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
161410045|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
161410046|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
161410047|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
161410048|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
161410049|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
161410050|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
161410051|NCT01912339|582888399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
161410052|NCT01912339|582888400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
161410053|NCT01912339|582888401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
161410054|NCT00741013|582888402|FG000|Overall Study|Adverse Event|1|||
161410055|NCT00741013|582888403|FG001|Overall Study|Adverse Event|0|||
161410056|NCT00741013|582888404|FG002|Overall Study|Adverse Event|0|||
161410057|NCT00741013|582888402|FG000|Overall Study|Withdrawal by Subject|0|||
161410058|NCT00741013|582888403|FG001|Overall Study|Withdrawal by Subject|0|||
161410059|NCT00741013|582888404|FG002|Overall Study|Withdrawal by Subject|1|||
161410060|NCT00741013|582888402|FG000|Overall Study|Discovered failed screen after enrolled|0|||
161410061|NCT00741013|582888403|FG001|Overall Study|Discovered failed screen after enrolled|2|||
161410062|NCT00741013|582888404|FG002|Overall Study|Discovered failed screen after enrolled|0|||
161410063|NCT01754493|582888406|FG000|Overall Study|Adverse Event|1|||
161410064|NCT01754493|582888406|FG000|Overall Study|Lost to Follow-up|3|||
161410065|NCT01754493|582888406|FG000|Overall Study|Withdrawal by Subject|1|||
161410066|NCT01754493|582888406|FG000|Overall Study|Moved out of town|1|||
161410067|NCT01754493|582888406|FG000|Overall Study|Scheduling conflict|1|||
161410068|NCT04512976|582888407|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161410069|NCT04512976|582888408|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161410070|NCT04512976|582888409|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161410071|NCT04512976|582888410|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161410072|NCT04512976|582888411|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161410073|NCT04512976|582888412|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
161410074|NCT05249569|582888417|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
161410075|NCT01452919|582888419|FG000|Open-Label Treatment|Adverse Event|5|||
161410076|NCT01452919|582888420|FG001|Open-Label Treatment|Adverse Event|0|||
161410077|NCT01452919|582888421|FG002|Open-Label Treatment|Adverse Event|0|||
161410078|NCT01452919|582888419|FG000|Open-Label Treatment|Lost to Follow-up|4|||
161410079|NCT01452919|582888420|FG001|Open-Label Treatment|Lost to Follow-up|0|||
161410080|NCT01452919|582888421|FG002|Open-Label Treatment|Lost to Follow-up|0|||
161410081|NCT01452919|582888419|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
161410082|NCT01452919|582888420|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
161410083|NCT01452919|582888421|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
161410084|NCT01452919|582888419|FG000|Open-Label Treatment|Protocol Violation|4|||
161410085|NCT01452919|582888420|FG001|Open-Label Treatment|Protocol Violation|0|||
161410086|NCT01452919|582888421|FG002|Open-Label Treatment|Protocol Violation|0|||
161410087|NCT01452919|582888419|FG000|Open-Label Treatment|Sponsor Decision|1|||
161410088|NCT01452919|582888420|FG001|Open-Label Treatment|Sponsor Decision|0|||
161410089|NCT01452919|582888421|FG002|Open-Label Treatment|Sponsor Decision|0|||
161410090|NCT01452919|582888419|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
161410091|NCT01452919|582888420|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161410092|NCT01452919|582888421|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
161410093|NCT01452919|582888419|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
161410094|NCT01452919|582888420|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
161410095|NCT01452919|582888421|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
161410096|NCT01452919|582888419|FG000|Randomization Treatment|Adverse Event|0|||
161410097|NCT01452919|582888420|FG001|Randomization Treatment|Adverse Event|0|||
161410098|NCT01452919|582888421|FG002|Randomization Treatment|Adverse Event|2|||
161410099|NCT01452919|582888419|FG000|Randomization Treatment|Sponsor Decision|0|||
161410100|NCT01452919|582888420|FG001|Randomization Treatment|Sponsor Decision|1|||
161410101|NCT01452919|582888421|FG002|Randomization Treatment|Sponsor Decision|0|||
161410102|NCT01452919|582888419|FG000|Randomization Treatment|Withdrawal by Subject|0|||
161410103|NCT01452919|582888420|FG001|Randomization Treatment|Withdrawal by Subject|1|||
161410104|NCT01452919|582888421|FG002|Randomization Treatment|Withdrawal by Subject|0|||
161410105|NCT01452919|582888419|FG000|Randomization Treatment|Subject is moving or has moved|0|||
161410106|NCT01452919|582888420|FG001|Randomization Treatment|Subject is moving or has moved|1|||
161410107|NCT01452919|582888421|FG002|Randomization Treatment|Subject is moving or has moved|0|||
161410108|NCT00658814|582888422|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
161410109|NCT00658814|582888423|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
161410110|NCT00658814|582888422|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
161410111|NCT00658814|582888423|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
161410112|NCT00658814|582888422|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
161410113|NCT00658814|582888423|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
161410114|NCT00658814|582888422|FG000|Remission Induction Chemotherapy|Death|1|||
161410115|NCT00658814|582888423|FG001|Remission Induction Chemotherapy|Death|4|||
161410116|NCT00658814|582888422|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
161410117|NCT00658814|582888423|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
161410118|NCT00658814|582888422|FG000|Remission Induction Chemotherapy|Not eligible|1|||
161410119|NCT00658814|582888423|FG001|Remission Induction Chemotherapy|Not eligible|2|||
161410120|NCT00658814|582888422|FG000|Consolidation Therapy|Not protocol specified|0|||
161410121|NCT00658814|582888423|FG001|Consolidation Therapy|Not protocol specified|1|||
161410122|NCT00658814|582888422|FG000|Consolidation Therapy|Not eligible|2|||
161410123|NCT00658814|582888423|FG001|Consolidation Therapy|Not eligible|2|||
161410124|NCT00658814|582888422|FG000|Maintenance Therapy|Adverse Event|1|||
161410125|NCT00658814|582888423|FG001|Maintenance Therapy|Adverse Event|1|||
161410126|NCT00658814|582888422|FG000|Maintenance Therapy|Not protocol specified|1|||
161410127|NCT00658814|582888423|FG001|Maintenance Therapy|Not protocol specified|0|||
161410128|NCT00658814|582888422|FG000|Maintenance Therapy|Not eligible|1|||
161410129|NCT00658814|582888423|FG001|Maintenance Therapy|Not eligible|0|||
161410130|NCT00455143|582888429|FG000|Overall Study|Physician Decision|1|||
161410131|NCT00455143|582888429|FG000|Overall Study|Withdrawal by Subject|1|||
161410132|NCT00455143|582888429|FG000|Overall Study|Staff was not avail to follow patient|2|||
161410133|NCT00455143|582888429|FG000|Overall Study|No longer met Inclusion Criteria|1|||
161410134|NCT00455143|582888429|FG000|Overall Study|Surgical time, staff not available|1|||
161410143|NCT04856904|582888436|FG000|Overall Study|Physician Decision|1|||
161410144|NCT04856904|582888437|FG001|Overall Study|Physician Decision|1|||
161410145|NCT04856904|582888436|FG000|Overall Study|Withdrawal by Subject|13|||
161410146|NCT04856904|582888437|FG001|Overall Study|Withdrawal by Subject|13|||
161410147|NCT04856904|582888436|FG000|Overall Study|Adverse Event|1|||
161410148|NCT04856904|582888437|FG001|Overall Study|Adverse Event|1|||
161410149|NCT04856904|582888436|FG000|Overall Study|Non-compliance with study drug|1|||
161410150|NCT04856904|582888437|FG001|Overall Study|Non-compliance with study drug|1|||
161410151|NCT04856904|582888436|FG000|Overall Study|Lost to Follow-up|4|||
161410152|NCT04856904|582888437|FG001|Overall Study|Lost to Follow-up|4|||
161410153|NCT04856904|582888436|FG000|Overall Study|Withdrawal by Subject|1|||
161410154|NCT04856904|582888437|FG001|Overall Study|Withdrawal by Subject|1|||
161410155|NCT04856904|582888436|FG000|Overall Study|Protocol Violation|1|||
161410156|NCT04856904|582888437|FG001|Overall Study|Protocol Violation|1|||
161410157|NCT00847015|582888438|FG000|Overall Study|Withdrawal by Subject|1|||
161410158|NCT00847015|582888438|FG000|Overall Study|declined any surgery|1|||
161410159|NCT00847015|582888438|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
161410160|NCT01641822|582888439|FG000|Run-in Phase|Noncompliance with study drug|1|||
161410161|NCT01641822|582888440|FG001|Run-in Phase|Noncompliance with study drug|0|||
161410162|NCT01641822|582888441|FG002|Run-in Phase|Noncompliance with study drug|0|||
161410163|NCT01641822|582888439|FG000|Run-in Phase|Adverse Event|3|||
161410164|NCT01641822|582888440|FG001|Run-in Phase|Adverse Event|0|||
161410165|NCT01641822|582888441|FG002|Run-in Phase|Adverse Event|0|||
161410166|NCT01641822|582888439|FG000|Run-in Phase|Withdrew consent|1|||
161410167|NCT01641822|582888440|FG001|Run-in Phase|Withdrew consent|0|||
161410168|NCT01641822|582888441|FG002|Run-in Phase|Withdrew consent|0|||
161410169|NCT01641822|582888439|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
161410170|NCT01641822|582888440|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
161410171|NCT01641822|582888441|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
161410172|NCT01641822|582888439|FG000|Comparative Phase|Noncompliance with study drug|0|||
161410173|NCT01641822|582888440|FG001|Comparative Phase|Noncompliance with study drug|1|||
161410174|NCT01641822|582888441|FG002|Comparative Phase|Noncompliance with study drug|0|||
161410175|NCT01641822|582888439|FG000|Comparative Phase|Investigator's discretion|0|||
161410176|NCT01641822|582888440|FG001|Comparative Phase|Investigator's discretion|0|||
161410177|NCT01641822|582888441|FG002|Comparative Phase|Investigator's discretion|1|||
161410178|NCT01641822|582888439|FG000|Comparative Phase|Pregnancy|0|||
161410179|NCT01641822|582888440|FG001|Comparative Phase|Pregnancy|0|||
161410180|NCT01641822|582888441|FG002|Comparative Phase|Pregnancy|1|||
161410181|NCT01641822|582888439|FG000|Comparative Phase|Adverse event, serious fatal|0|||
161410182|NCT01641822|582888440|FG001|Comparative Phase|Adverse event, serious fatal|1|||
161410183|NCT01641822|582888441|FG002|Comparative Phase|Adverse event, serious fatal|0|||
161410184|NCT01641822|582888439|FG000|Comparative Phase|Withdrew consent|0|||
161410185|NCT01641822|582888440|FG001|Comparative Phase|Withdrew consent|3|||
161410186|NCT01641822|582888441|FG002|Comparative Phase|Withdrew consent|7|||
161410187|NCT01641822|582888439|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
161410188|NCT01641822|582888440|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
161410189|NCT01641822|582888441|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
161410190|NCT00454584|582888442|FG000|Controlled Period|Adverse Event|5|||
161410191|NCT00454584|582888443|FG001|Controlled Period|Adverse Event|2|||
161410192|NCT00454584|582888444|FG002|Controlled Period|Adverse Event|1|||
161410193|NCT00454584|582888445|FG003|Controlled Period|Adverse Event|0|||
161410194|NCT00454584|582888446|FG004|Controlled Period|Adverse Event|0|||
161410195|NCT00454584|582888447|FG005|Controlled Period|Adverse Event|0|||
161410196|NCT00454584|582888442|FG000|Controlled Period|Lost to Follow-up|1|||
161410197|NCT00454584|582888443|FG001|Controlled Period|Lost to Follow-up|2|||
161410198|NCT00454584|582888444|FG002|Controlled Period|Lost to Follow-up|2|||
161410199|NCT00454584|582888445|FG003|Controlled Period|Lost to Follow-up|0|||
161410200|NCT00454584|582888446|FG004|Controlled Period|Lost to Follow-up|0|||
161410201|NCT00454584|582888447|FG005|Controlled Period|Lost to Follow-up|0|||
161410202|NCT00454584|582888442|FG000|Controlled Period|Other|5|||
161410203|NCT00454584|582888443|FG001|Controlled Period|Other|4|||
161410204|NCT00454584|582888444|FG002|Controlled Period|Other|2|||
161410205|NCT00454584|582888445|FG003|Controlled Period|Other|0|||
161410206|NCT00454584|582888446|FG004|Controlled Period|Other|0|||
161410207|NCT00454584|582888447|FG005|Controlled Period|Other|0|||
161410208|NCT00454584|582888442|FG000|After Controlled Period|Adverse Event|0|||
161410209|NCT00454584|582888443|FG001|After Controlled Period|Adverse Event|0|||
161410210|NCT00454584|582888444|FG002|After Controlled Period|Adverse Event|0|||
161410211|NCT00454584|582888445|FG003|After Controlled Period|Adverse Event|9|||
161410212|NCT00454584|582888446|FG004|After Controlled Period|Adverse Event|3|||
161410213|NCT00454584|582888447|FG005|After Controlled Period|Adverse Event|9|||
161410214|NCT00454584|582888442|FG000|After Controlled Period|Lack of Efficacy|0|||
161410215|NCT00454584|582888443|FG001|After Controlled Period|Lack of Efficacy|0|||
161410216|NCT00454584|582888444|FG002|After Controlled Period|Lack of Efficacy|0|||
161410217|NCT00454584|582888445|FG003|After Controlled Period|Lack of Efficacy|1|||
161410218|NCT00454584|582888446|FG004|After Controlled Period|Lack of Efficacy|0|||
161410219|NCT00454584|582888447|FG005|After Controlled Period|Lack of Efficacy|0|||
161410220|NCT00454584|582888442|FG000|After Controlled Period|Lost to Follow-up|0|||
161410221|NCT00454584|582888443|FG001|After Controlled Period|Lost to Follow-up|0|||
161410222|NCT00454584|582888444|FG002|After Controlled Period|Lost to Follow-up|0|||
161410223|NCT00454584|582888445|FG003|After Controlled Period|Lost to Follow-up|2|||
161410224|NCT00454584|582888446|FG004|After Controlled Period|Lost to Follow-up|4|||
161410225|NCT00454584|582888447|FG005|After Controlled Period|Lost to Follow-up|6|||
161410226|NCT00454584|582888442|FG000|After Controlled Period|Other|0|||
161410227|NCT00454584|582888443|FG001|After Controlled Period|Other|0|||
161410228|NCT00454584|582888444|FG002|After Controlled Period|Other|0|||
161410229|NCT00454584|582888445|FG003|After Controlled Period|Other|1|||
161410230|NCT00454584|582888446|FG004|After Controlled Period|Other|0|||
161410231|NCT00454584|582888447|FG005|After Controlled Period|Other|0|||
161410232|NCT00454584|582888442|FG000|After Controlled Period|Other|0|||
161410233|NCT00454584|582888443|FG001|After Controlled Period|Other|0|||
161410234|NCT00454584|582888444|FG002|After Controlled Period|Other|0|||
161410235|NCT00454584|582888445|FG003|After Controlled Period|Other|13|||
161410236|NCT00454584|582888446|FG004|After Controlled Period|Other|5|||
161410237|NCT00454584|582888447|FG005|After Controlled Period|Other|17|||
161410238|NCT02421601|582888448|FG000|Overall Study|Adverse Event|4|||
161410239|NCT02421601|582888448|FG000|Overall Study|Lack of Efficacy|5|||
161410240|NCT02421601|582888448|FG000|Overall Study|Physician Decision|1|||
161410241|NCT02421601|582888448|FG000|Overall Study|Withdrawal by Subject|31|||
161410242|NCT02421601|582888448|FG000|Overall Study|Others|41|||
161410243|NCT02250664|582888449|FG000|Overall Study|Lost to Follow-up|18|||
161410244|NCT02250664|582888450|FG001|Overall Study|Lost to Follow-up|28|||
161410245|NCT02250664|582888451|FG002|Overall Study|Lost to Follow-up|33|||
161410246|NCT02250664|582888449|FG000|Overall Study|Personal Reasons|7|||
161410247|NCT02250664|582888450|FG001|Overall Study|Personal Reasons|8|||
161410248|NCT02250664|582888451|FG002|Overall Study|Personal Reasons|14|||
161410249|NCT02250664|582888449|FG000|Overall Study|Adverse Event|6|||
161410250|NCT02250664|582888450|FG001|Overall Study|Adverse Event|3|||
161410251|NCT02250664|582888451|FG002|Overall Study|Adverse Event|8|||
161410252|NCT02250664|582888449|FG000|Overall Study|Incarcerated|2|||
161410253|NCT02250664|582888450|FG001|Overall Study|Incarcerated|1|||
161410254|NCT02250664|582888451|FG002|Overall Study|Incarcerated|2|||
161410255|NCT02250664|582888449|FG000|Overall Study|Withdrawal by Subject|0|||
161410256|NCT02250664|582888450|FG001|Overall Study|Withdrawal by Subject|1|||
161410257|NCT02250664|582888451|FG002|Overall Study|Withdrawal by Subject|2|||
161410258|NCT02250664|582888449|FG000|Overall Study|Death|0|||
161410259|NCT02250664|582888450|FG001|Overall Study|Death|1|||
161410260|NCT02250664|582888451|FG002|Overall Study|Death|1|||
161410261|NCT02250664|582888449|FG000|Overall Study|Physician Decision|1|||
161410262|NCT02250664|582888450|FG001|Overall Study|Physician Decision|3|||
161410263|NCT02250664|582888451|FG002|Overall Study|Physician Decision|1|||
161410264|NCT02250664|582888449|FG000|Overall Study|Protocol Violation|1|||
161410265|NCT02250664|582888450|FG001|Overall Study|Protocol Violation|0|||
161410266|NCT02250664|582888451|FG002|Overall Study|Protocol Violation|1|||
161410267|NCT02250664|582888449|FG000|Overall Study|Reason unknown|1|||
161410268|NCT02250664|582888450|FG001|Overall Study|Reason unknown|0|||
161410269|NCT02250664|582888451|FG002|Overall Study|Reason unknown|0|||
161410270|NCT00778895|582888460|FG000|Active Phase|Adverse Event|3|||
161410271|NCT00778895|582888461|FG001|Active Phase|Adverse Event|1|||
161410272|NCT00778895|582888462|FG002|Active Phase|Adverse Event|0|||
161410273|NCT00778895|582888460|FG000|Active Phase|Withdrawal by Subject|1|||
161410274|NCT00778895|582888461|FG001|Active Phase|Withdrawal by Subject|4|||
161410275|NCT00778895|582888462|FG002|Active Phase|Withdrawal by Subject|0|||
161410276|NCT00778895|582888460|FG000|Active Phase|Lost to Follow-up|1|||
161410277|NCT00778895|582888461|FG001|Active Phase|Lost to Follow-up|1|||
161410278|NCT00778895|582888462|FG002|Active Phase|Lost to Follow-up|0|||
161410279|NCT00778895|582888460|FG000|Active Phase|Other|2|||
161410280|NCT00778895|582888461|FG001|Active Phase|Other|0|||
161410281|NCT00778895|582888462|FG002|Active Phase|Other|0|||
161410282|NCT00778895|582888460|FG000|ESFU Phase|Adverse Event|2|||
161410283|NCT00778895|582888461|FG001|ESFU Phase|Adverse Event|1|||
161410284|NCT00778895|582888462|FG002|ESFU Phase|Adverse Event|0|||
161410285|NCT00778895|582888460|FG000|ESFU Phase|Withdrawal by Subject|1|||
161410286|NCT00778895|582888461|FG001|ESFU Phase|Withdrawal by Subject|4|||
161410287|NCT00778895|582888462|FG002|ESFU Phase|Withdrawal by Subject|0|||
161410288|NCT00778895|582888460|FG000|ESFU Phase|Lost to Follow-up|6|||
161410289|NCT00778895|582888461|FG001|ESFU Phase|Lost to Follow-up|7|||
161410290|NCT00778895|582888462|FG002|ESFU Phase|Lost to Follow-up|2|||
161410291|NCT00778895|582888460|FG000|ESFU Phase|Other|2|||
161410292|NCT00778895|582888461|FG001|ESFU Phase|Other|0|||
161410293|NCT00778895|582888462|FG002|ESFU Phase|Other|0|||
161410294|NCT01459913|582888464|FG000|Overall Study|Adverse Event|0|||
161410295|NCT01459913|582888465|FG001|Overall Study|Adverse Event|0|||
161410296|NCT01459913|582888466|FG002|Overall Study|Adverse Event|0|||
161410297|NCT01459913|582888467|FG003|Overall Study|Adverse Event|3|||
161410298|NCT01459913|582888464|FG000|Overall Study|Withdrawal by Subject|4|||
161410299|NCT01459913|582888465|FG001|Overall Study|Withdrawal by Subject|0|||
161410300|NCT01459913|582888466|FG002|Overall Study|Withdrawal by Subject|0|||
161410301|NCT01459913|582888467|FG003|Overall Study|Withdrawal by Subject|5|||
161410302|NCT01459913|582888464|FG000|Overall Study|Lost to Follow-up|7|||
161410303|NCT01459913|582888465|FG001|Overall Study|Lost to Follow-up|4|||
161410304|NCT01459913|582888466|FG002|Overall Study|Lost to Follow-up|1|||
161410305|NCT01459913|582888467|FG003|Overall Study|Lost to Follow-up|8|||
161410306|NCT01459913|582888464|FG000|Overall Study|Death|0|||
161410307|NCT01459913|582888465|FG001|Overall Study|Death|0|||
161410308|NCT01459913|582888466|FG002|Overall Study|Death|0|||
161410309|NCT01459913|582888467|FG003|Overall Study|Death|1|||
161410310|NCT01459913|582888464|FG000|Overall Study|Non- Compliance|0|||
161410311|NCT01459913|582888465|FG001|Overall Study|Non- Compliance|0|||
161410312|NCT01459913|582888466|FG002|Overall Study|Non- Compliance|0|||
161410313|NCT01459913|582888467|FG003|Overall Study|Non- Compliance|3|||
161410314|NCT01459913|582888464|FG000|Overall Study|Physician Decision|0|||
161410315|NCT01459913|582888465|FG001|Overall Study|Physician Decision|1|||
161410316|NCT01459913|582888466|FG002|Overall Study|Physician Decision|0|||
161410317|NCT01459913|582888467|FG003|Overall Study|Physician Decision|0|||
161410318|NCT01459913|582888464|FG000|Overall Study|Study Terminated by Sponsor|30|||
161410319|NCT01459913|582888465|FG001|Overall Study|Study Terminated by Sponsor|15|||
161410320|NCT01459913|582888466|FG002|Overall Study|Study Terminated by Sponsor|9|||
161410321|NCT01459913|582888467|FG003|Overall Study|Study Terminated by Sponsor|11|||
161410322|NCT01459913|582888464|FG000|Overall Study|Other|0|||
161410323|NCT01459913|582888465|FG001|Overall Study|Other|0|||
161410324|NCT01459913|582888466|FG002|Overall Study|Other|3|||
161410325|NCT01459913|582888467|FG003|Overall Study|Other|1|||
161410326|NCT01459913|582888464|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
161410327|NCT01459913|582888465|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
161410328|NCT01459913|582888466|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
161410329|NCT01459913|582888467|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
161410330|NCT00576576|582888470|FG000|Overall Study|Lost to Follow-up|6|||
161410331|NCT00576576|582888470|FG000|Overall Study|Protocol Violation|1|||
161410332|NCT05096312|582888471|FG000|Overall Study|Lost to Follow-up|2|||
161410333|NCT05096312|582888472|FG001|Overall Study|Lost to Follow-up|4|||
161410334|NCT05096312|582888471|FG000|Overall Study|Adverse Event|1|||
161410335|NCT05096312|582888472|FG001|Overall Study|Adverse Event|0|||
161410336|NCT03135210|582888473|FG000|Overall Study|Death|0|||
161410337|NCT03135210|582888474|FG001|Overall Study|Death|1|||
161410338|NCT03517566|582888477|FG000|Overall Study|Adverse Event|5|||
161410339|NCT03517566|582888478|FG001|Overall Study|Adverse Event|2|||
161410340|NCT03517566|582888479|FG002|Overall Study|Adverse Event|2|||
161410341|NCT03517566|582888480|FG003|Overall Study|Adverse Event|8|||
161410342|NCT03517566|582888481|FG004|Overall Study|Adverse Event|7|||
161410343|NCT03517566|582888477|FG000|Overall Study|Lack of Efficacy|3|||
161410344|NCT03517566|582888478|FG001|Overall Study|Lack of Efficacy|2|||
161410345|NCT03517566|582888479|FG002|Overall Study|Lack of Efficacy|1|||
161410346|NCT03517566|582888480|FG003|Overall Study|Lack of Efficacy|1|||
161410347|NCT03517566|582888481|FG004|Overall Study|Lack of Efficacy|4|||
161410348|NCT03517566|582888477|FG000|Overall Study|Lost to Follow-up|3|||
161410349|NCT03517566|582888478|FG001|Overall Study|Lost to Follow-up|1|||
161410350|NCT03517566|582888479|FG002|Overall Study|Lost to Follow-up|1|||
161410351|NCT03517566|582888480|FG003|Overall Study|Lost to Follow-up|1|||
161410352|NCT03517566|582888481|FG004|Overall Study|Lost to Follow-up|0|||
161410353|NCT03517566|582888477|FG000|Overall Study|Physician Decision|1|||
161410354|NCT03517566|582888478|FG001|Overall Study|Physician Decision|1|||
161410355|NCT03517566|582888479|FG002|Overall Study|Physician Decision|0|||
161410356|NCT03517566|582888480|FG003|Overall Study|Physician Decision|1|||
161410357|NCT03517566|582888481|FG004|Overall Study|Physician Decision|0|||
161410358|NCT03517566|582888477|FG000|Overall Study|Pregnancy|0|||
161410359|NCT03517566|582888478|FG001|Overall Study|Pregnancy|1|||
161410360|NCT03517566|582888479|FG002|Overall Study|Pregnancy|0|||
161410361|NCT03517566|582888480|FG003|Overall Study|Pregnancy|0|||
161410362|NCT03517566|582888481|FG004|Overall Study|Pregnancy|0|||
161410363|NCT03517566|582888477|FG000|Overall Study|Protocol Deviation|0|||
161410364|NCT03517566|582888478|FG001|Overall Study|Protocol Deviation|1|||
161410365|NCT03517566|582888479|FG002|Overall Study|Protocol Deviation|0|||
161410366|NCT03517566|582888480|FG003|Overall Study|Protocol Deviation|1|||
161410367|NCT03517566|582888481|FG004|Overall Study|Protocol Deviation|1|||
161410368|NCT03517566|582888477|FG000|Overall Study|Study terminated by Sponsor|11|||
161410369|NCT03517566|582888478|FG001|Overall Study|Study terminated by Sponsor|5|||
161410370|NCT03517566|582888479|FG002|Overall Study|Study terminated by Sponsor|6|||
161410371|NCT03517566|582888480|FG003|Overall Study|Study terminated by Sponsor|14|||
161410372|NCT03517566|582888481|FG004|Overall Study|Study terminated by Sponsor|12|||
161410373|NCT03517566|582888477|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
161410374|NCT03517566|582888478|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
161410375|NCT03517566|582888479|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
161410376|NCT03517566|582888480|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
161410377|NCT03517566|582888481|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
161410378|NCT00671437|582888482|FG000|Overall Study|Progressive disease before C1 week 8|8|||
161410379|NCT00671437|582888482|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
161410380|NCT00671437|582888482|FG000|Overall Study|Adverse Event|3|||
161410381|NCT00671437|582888482|FG000|Overall Study|Ineligible post-hoc|1|||
161410382|NCT04349033|582888487|FG000|Overall Study|Lost to Follow-up|3|||
161410383|NCT04349033|582888488|FG001|Overall Study|Lost to Follow-up|1|||
161410384|NCT04349033|582888489|FG002|Overall Study|Lost to Follow-up|1|||
161410385|NCT00718770|582888493|FG000|Overall Study|Adverse Event|1|||
161410386|NCT00718770|582888493|FG000|Overall Study|Lack of Efficacy|1|||
161410387|NCT00718770|582888493|FG000|Overall Study|Lack of Efficacy|1|||
161410388|NCT00718770|582888493|FG000|Overall Study|Adverse Event|1|||
161410389|NCT00718770|582888493|FG000|Overall Study|Lack of Efficacy|1|||
161410390|NCT00718770|582888493|FG000|Overall Study|Adverse Event|1|||
161410391|NCT00718770|582888493|FG000|Overall Study|Lack of Efficacy|1|||
161410392|NCT00718770|582888493|FG000|Overall Study|Adverse Event|1|||
161410393|NCT01704456|582888494|FG000|Overall Study|Lost to Follow-up|8|||
161410394|NCT01704456|582888495|FG001|Overall Study|Lost to Follow-up|14|||
161410395|NCT04583956|582888496|FG000|Overall Study|Death|9|||
161410396|NCT04583956|582888497|FG001|Overall Study|Death|11|||
161410397|NCT04583956|582888496|FG000|Overall Study|Lost to Follow-up|7|||
161410398|NCT04583956|582888497|FG001|Overall Study|Lost to Follow-up|9|||
161410399|NCT04583956|582888496|FG000|Overall Study|Protocol Violation|2|||
161410400|NCT04583956|582888497|FG001|Overall Study|Protocol Violation|0|||
161410401|NCT04583956|582888496|FG000|Overall Study|Withdrawal by Subject|0|||
161410402|NCT04583956|582888497|FG001|Overall Study|Withdrawal by Subject|2|||
161410403|NCT04583956|582888496|FG000|Overall Study|Randomized but not dosed|2|||
161410404|NCT04583956|582888497|FG001|Overall Study|Randomized but not dosed|3|||
161410405|NCT04583956|582888496|FG000|Overall Study|Withdrawal of consent before product administration|1|||
161410406|NCT04583956|582888497|FG001|Overall Study|Withdrawal of consent before product administration|0|||
161410407|NCT00915551|582888503|FG000|Overall Study|Withdrawal by Subject|0|||
161410408|NCT00915551|582888504|FG001|Overall Study|Withdrawal by Subject|1|||
161410409|NCT02540291|582888505|FG000|Overall Study|Death|7|||
161410410|NCT02540291|582888506|FG001|Overall Study|Death|7|||
161410411|NCT02540291|582888507|FG002|Overall Study|Death|5|||
161410412|NCT02540291|582888508|FG003|Overall Study|Death|7|||
161410413|NCT02540291|582888505|FG000|Overall Study|Lost to Follow-up|0|||
161410414|NCT02540291|582888506|FG001|Overall Study|Lost to Follow-up|0|||
161410415|NCT02540291|582888507|FG002|Overall Study|Lost to Follow-up|1|||
161410416|NCT02540291|582888508|FG003|Overall Study|Lost to Follow-up|0|||
161410417|NCT02540291|582888505|FG000|Overall Study|Withdrawal Of Consent|0|||
161410418|NCT02540291|582888506|FG001|Overall Study|Withdrawal Of Consent|1|||
161410419|NCT02540291|582888507|FG002|Overall Study|Withdrawal Of Consent|0|||
161410420|NCT02540291|582888508|FG003|Overall Study|Withdrawal Of Consent|0|||
161410421|NCT02540291|582888505|FG000|Overall Study|Study Terminated By Sponsor|1|||
161410422|NCT02540291|582888506|FG001|Overall Study|Study Terminated By Sponsor|0|||
161410423|NCT02540291|582888507|FG002|Overall Study|Study Terminated By Sponsor|0|||
161410424|NCT02540291|582888508|FG003|Overall Study|Study Terminated By Sponsor|0|||
161410425|NCT02540291|582888505|FG000|Overall Study|Other|0|||
161410426|NCT02540291|582888506|FG001|Overall Study|Other|0|||
161410427|NCT02540291|582888507|FG002|Overall Study|Other|1|||
161410428|NCT02540291|582888508|FG003|Overall Study|Other|0|||
161410429|NCT01879072|582888510|FG000|Overall Study|Withdrawal by Subject|121|||
161410430|NCT01879072|582888510|FG000|Overall Study|Not Transplanted|30|||
161410431|NCT02666105|582888525|FG000|Overall Study|Death|1|||
161410432|NCT01264419|582888526|FG000|Overall Study|Lost to Follow-up|3|||
161410433|NCT01900054|582890125|FG000|Overall Study|Physician Decision|1|||
161410434|NCT01900054|582890125|FG000|Overall Study|Withdrawal by Subject|1|||
161410435|NCT03229109|582890135|FG000|Overall Study|Withdrawal by Subject|0|||
161410436|NCT03229109|582890136|FG001|Overall Study|Withdrawal by Subject|0|||
161410437|NCT03229109|582890137|FG002|Overall Study|Withdrawal by Subject|0|||
161410438|NCT03229109|582890138|FG003|Overall Study|Withdrawal by Subject|1|||
161410439|NCT01835223|582890141|FG000|Overall Study|Adverse Event|1|||
161410440|NCT01835223|582890142|FG001|Overall Study|Adverse Event|0|||
161410441|NCT01835223|582890141|FG000|Overall Study|Withdrawal by Subject|2|||
161410442|NCT01835223|582890142|FG001|Overall Study|Withdrawal by Subject|0|||
161410443|NCT01835223|582890141|FG000|Overall Study|Disease progression|2|||
161410444|NCT01835223|582890142|FG001|Overall Study|Disease progression|1|||
161410445|NCT01835223|582890141|FG000|Overall Study|Became Inelligible|4|||
161410446|NCT01835223|582890142|FG001|Overall Study|Became Inelligible|0|||
161410447|NCT03329196|582890146|FG000|Overall Study|Adverse Event|10|||
161410448|NCT03329196|582890147|FG001|Overall Study|Adverse Event|5|||
161410449|NCT03329196|582890146|FG000|Overall Study|Physician Decision|2|||
161410450|NCT03329196|582890147|FG001|Overall Study|Physician Decision|2|||
161410451|NCT03329196|582890146|FG000|Overall Study|Withdrawal by Subject|11|||
161410452|NCT03329196|582890147|FG001|Overall Study|Withdrawal by Subject|3|||
161410453|NCT03329196|582890146|FG000|Overall Study|Hepatic function abnormalities|0|||
161410454|NCT03329196|582890147|FG001|Overall Study|Hepatic function abnormalities|1|||
161410455|NCT03329196|582890146|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
161410456|NCT03329196|582890147|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
161410457|NCT03329196|582890146|FG000|Overall Study|Difficult to control Hb|2|||
161410458|NCT03329196|582890147|FG001|Overall Study|Difficult to control Hb|3|||
161410459|NCT03329196|582890146|FG000|Overall Study|Dialysis or renal transplant|13|||
161410460|NCT03329196|582890147|FG001|Overall Study|Dialysis or renal transplant|15|||
161410461|NCT04481750|582890151|FG000|Period 1 (Fasted)|Adverse Event|0|||
161410462|NCT04481750|582890152|FG001|Period 1 (Fasted)|Adverse Event|0|||
161410463|NCT04481750|582890153|FG002|Period 1 (Fasted)|Adverse Event|1|||
161410464|NCT04481750|582890154|FG003|Period 1 (Fasted)|Adverse Event|0|||
161410465|NCT04481750|582890155|FG004|Period 1 (Fasted)|Adverse Event|0|||
161410466|NCT04481750|582890156|FG005|Period 1 (Fasted)|Adverse Event|0|||
161410467|NCT04481750|582890157|FG006|Period 1 (Fasted)|Adverse Event|0|||
161410468|NCT04481750|582890158|FG007|Period 1 (Fasted)|Adverse Event|0|||
161410469|NCT04481750|582890159|FG008|Period 1 (Fasted)|Adverse Event|0|||
161410470|NCT04481750|582890160|FG009|Period 1 (Fasted)|Adverse Event|0|||
161410471|NCT04481750|582890161|FG010|Period 1 (Fasted)|Adverse Event|0|||
161410472|NCT03176771|582890162|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
161410473|NCT03176771|582890163|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
161410474|NCT03176771|582890164|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
161410475|NCT03176771|582890165|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
161410476|NCT03176771|582890166|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
161410477|NCT03176771|582890162|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161410478|NCT03176771|582890163|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
161410479|NCT03176771|582890164|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161410480|NCT03176771|582890165|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161410481|NCT03176771|582890166|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161410482|NCT03176771|582890162|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
161410483|NCT03176771|582890163|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
161410484|NCT03176771|582890164|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
161410485|NCT03176771|582890165|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161410486|NCT03176771|582890166|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161410487|NCT03176771|582890162|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161410488|NCT03176771|582890163|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161410489|NCT03176771|582890164|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
161410490|NCT03176771|582890165|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161410491|NCT03176771|582890166|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161410492|NCT03176771|582890162|FG000|Double-Blind Extension Period|Adverse Event|0|||
161410493|NCT03176771|582890163|FG001|Double-Blind Extension Period|Adverse Event|0|||
161410494|NCT03176771|582890164|FG002|Double-Blind Extension Period|Adverse Event|0|||
161410495|NCT03176771|582890165|FG003|Double-Blind Extension Period|Adverse Event|15|||
161410496|NCT03176771|582890166|FG004|Double-Blind Extension Period|Adverse Event|18|||
161410497|NCT03176771|582890162|FG000|Double-Blind Extension Period|Death|0|||
161410498|NCT03176771|582890163|FG001|Double-Blind Extension Period|Death|0|||
161410499|NCT03176771|582890164|FG002|Double-Blind Extension Period|Death|0|||
161410500|NCT03176771|582890165|FG003|Double-Blind Extension Period|Death|3|||
161410501|NCT03176771|582890166|FG004|Double-Blind Extension Period|Death|4|||
161410502|NCT03176771|582890162|FG000|Double-Blind Extension Period|Physician Decision|0|||
161410503|NCT03176771|582890163|FG001|Double-Blind Extension Period|Physician Decision|0|||
161410504|NCT03176771|582890164|FG002|Double-Blind Extension Period|Physician Decision|0|||
161410505|NCT03176771|582890165|FG003|Double-Blind Extension Period|Physician Decision|3|||
161410506|NCT03176771|582890166|FG004|Double-Blind Extension Period|Physician Decision|1|||
161410507|NCT03176771|582890162|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
161410508|NCT03176771|582890163|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
161410509|NCT03176771|582890164|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
161410510|NCT03176771|582890165|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
161410511|NCT03176771|582890166|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
161410512|NCT03439137|582890167|FG000|Overall Study|Adverse Event|16|||
161410513|NCT03439137|582890168|FG001|Overall Study|Adverse Event|12|||
161410514|NCT03439137|582890167|FG000|Overall Study|Physician Decision|0|||
161410515|NCT03439137|582890168|FG001|Overall Study|Physician Decision|5|||
161410516|NCT03439137|582890167|FG000|Overall Study|Withdrawal by Subject|14|||
161410517|NCT03439137|582890168|FG001|Overall Study|Withdrawal by Subject|4|||
161410518|NCT03439137|582890167|FG000|Overall Study|Conducting rescue therapy|2|||
161410519|NCT03439137|582890168|FG001|Overall Study|Conducting rescue therapy|1|||
161410520|NCT03439137|582890167|FG000|Overall Study|Difficult to control Hb|10|||
161410521|NCT03439137|582890168|FG001|Overall Study|Difficult to control Hb|2|||
161410522|NCT03439137|582890167|FG000|Overall Study|Initiation of a renal transplant|0|||
161410523|NCT03439137|582890168|FG001|Overall Study|Initiation of a renal transplant|2|||
161410524|NCT04097379|582890169|FG000|Overall Study|Adverse Event|1|||
161410525|NCT04097379|582890170|FG001|Overall Study|Adverse Event|0|||
161410526|NCT04097379|582890171|FG002|Overall Study|Adverse Event|0|||
161410527|NCT04097379|582890172|FG003|Overall Study|Adverse Event|0|||
161410528|NCT04097379|582890169|FG000|Overall Study|Physician Decision|0|||
161410529|NCT04097379|582890170|FG001|Overall Study|Physician Decision|1|||
161410530|NCT04097379|582890171|FG002|Overall Study|Physician Decision|0|||
161410531|NCT04097379|582890172|FG003|Overall Study|Physician Decision|0|||
161410532|NCT03387020|582890173|FG000|Overall Study|Adverse Event|0|||
161410533|NCT03387020|582890174|FG001|Overall Study|Adverse Event|2|||
161410534|NCT03387020|582890175|FG002|Overall Study|Adverse Event|0|||
161410535|NCT03387020|582890173|FG000|Overall Study|Withdrawal by Subject|2|||
161410536|NCT03387020|582890174|FG001|Overall Study|Withdrawal by Subject|0|||
161410537|NCT03387020|582890175|FG002|Overall Study|Withdrawal by Subject|0|||
161410538|NCT01425632|582890176|FG000|Overall Study|Adverse Event|0|||
161410539|NCT01425632|582890177|FG001|Overall Study|Adverse Event|1|||
161410540|NCT01425632|582890178|FG002|Overall Study|Adverse Event|1|||
161410541|NCT01425632|582890176|FG000|Overall Study|Physician Decision|1|||
161410542|NCT01425632|582890177|FG001|Overall Study|Physician Decision|0|||
161410543|NCT01425632|582890178|FG002|Overall Study|Physician Decision|0|||
161410544|NCT01425632|582890176|FG000|Overall Study|Protocol Violation|0|||
161410545|NCT01425632|582890177|FG001|Overall Study|Protocol Violation|0|||
161410546|NCT01425632|582890178|FG002|Overall Study|Protocol Violation|2|||
161410547|NCT01425632|582890176|FG000|Overall Study|Withdrawal by Subject|0|||
161410548|NCT01425632|582890177|FG001|Overall Study|Withdrawal by Subject|0|||
161410549|NCT01425632|582890178|FG002|Overall Study|Withdrawal by Subject|1|||
161410550|NCT03461146|582890182|FG000|Overall Study|Adverse Event|2|||
161410551|NCT03461146|582890182|FG000|Overall Study|Physician Decision|1|||
161410552|NCT02140047|582890183|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161410553|NCT02140047|582890184|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161410554|NCT02140047|582890185|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161410555|NCT04617496|582890186|FG000|Overall Study|Death|2|||
161410556|NCT04617496|582890187|FG001|Overall Study|Death|1|||
161410557|NCT04617496|582890186|FG000|Overall Study|Lost to Follow-up|3|||
161410558|NCT04617496|582890187|FG001|Overall Study|Lost to Follow-up|3|||
161410559|NCT00200356|582890192|FG000|Overall Study|Lack of Efficacy|3|||
161410560|NCT00200356|582890193|FG001|Overall Study|Lack of Efficacy|3|||
161410561|NCT00200356|582890192|FG000|Overall Study|Protocol Violation|4|||
161410562|NCT00200356|582890193|FG001|Overall Study|Protocol Violation|4|||
161410563|NCT00200356|582890192|FG000|Overall Study|Nontreatment|1|||
161410564|NCT00200356|582890193|FG001|Overall Study|Nontreatment|0|||
161410565|NCT04530552|582890196|FG000|Overall Study|Physician Decision|0|||
161410566|NCT04530552|582890197|FG001|Overall Study|Physician Decision|1|||
161410567|NCT04530552|582890196|FG000|Overall Study|Withdrawal by Subject|0|||
161410568|NCT04530552|582890197|FG001|Overall Study|Withdrawal by Subject|1|||
161410569|NCT04530552|582890196|FG000|Overall Study|Adverse Event|0|||
161410570|NCT04530552|582890197|FG001|Overall Study|Adverse Event|1|||
161410571|NCT04530552|582890196|FG000|Overall Study|No surgery|0|||
161410572|NCT04530552|582890197|FG001|Overall Study|No surgery|1|||
161410573|NCT03703856|582890200|FG000|Enrolled in study|Withdrawal by Subject|23|||
161410574|NCT03703856|582890200|FG000|Titrated to full dose|Withdrawal by Subject|5|||
161410575|NCT03703856|582890200|FG000|16 week assessment|Withdrawal by Subject|1|||
161410576|NCT03703856|582890200|FG000|24 week assessment|Withdrawal by Subject|1|||
161410577|NCT01596335|582890201|FG000|Overall Study|exacerbation of primary disease|5|||
161410578|NCT01596335|582890202|FG001|Overall Study|exacerbation of primary disease|9|||
161410579|NCT01532570|582890206|FG000|Overall Study|Lack of Efficacy|1|||
161410580|NCT01532570|582890207|FG001|Overall Study|Lack of Efficacy|0|||
161410581|NCT01532570|582890208|FG002|Overall Study|Lack of Efficacy|0|||
161410582|NCT01532570|582890209|FG003|Overall Study|Lack of Efficacy|0|||
161410583|NCT01532570|582890206|FG000|Overall Study|Withdrawal by Subject|0|||
161410584|NCT01532570|582890207|FG001|Overall Study|Withdrawal by Subject|1|||
161410585|NCT01532570|582890208|FG002|Overall Study|Withdrawal by Subject|0|||
161410586|NCT01532570|582890209|FG003|Overall Study|Withdrawal by Subject|0|||
161410587|NCT01585155|582890210|FG000|Overall Study|Adverse Event|1|||
161410588|NCT01585155|582890210|FG000|Overall Study|Lack of Efficacy|2|||
161410589|NCT01585155|582890210|FG000|Overall Study|Worsening ulcerative colitis|2|||
161410590|NCT01192412|582890212|FG000|Overall Study|Lost to Follow-up|2|||
161410591|NCT01192412|582890213|FG001|Overall Study|Lost to Follow-up|1|||
161410592|NCT01192412|582890212|FG000|Overall Study|Withdrawal by Subject|2|||
161410593|NCT01192412|582890213|FG001|Overall Study|Withdrawal by Subject|1|||
161410594|NCT02421588|582890214|FG000|Overall Study|Non-treatment-related AE|8|||
161410595|NCT02421588|582890215|FG001|Overall Study|Non-treatment-related AE|8|||
161410596|NCT02421588|582890214|FG000|Overall Study|Progressive disease|152|||
161410597|NCT02421588|582890215|FG001|Overall Study|Progressive disease|135|||
161410598|NCT02421588|582890214|FG000|Overall Study|Death|11|||
161410599|NCT02421588|582890215|FG001|Overall Study|Death|3|||
161410600|NCT02421588|582890214|FG000|Overall Study|Physician Decision|8|||
161410601|NCT02421588|582890215|FG001|Overall Study|Physician Decision|17|||
161410602|NCT02421588|582890214|FG000|Overall Study|Other reason not specified|3|||
161410603|NCT02421588|582890215|FG001|Overall Study|Other reason not specified|1|||
161410604|NCT02421588|582890214|FG000|Overall Study|Symptomatic deterioration|13|||
161410605|NCT02421588|582890215|FG001|Overall Study|Symptomatic deterioration|19|||
161410606|NCT02421588|582890214|FG000|Overall Study|Treatment-related AE|10|||
161410607|NCT02421588|582890215|FG001|Overall Study|Treatment-related AE|14|||
161410608|NCT02421588|582890214|FG000|Overall Study|Withdrawal by Subject|14|||
161410609|NCT02421588|582890215|FG001|Overall Study|Withdrawal by Subject|16|||
161410610|NCT02421588|582890214|FG000|Overall Study|Not treated|2|||
161410611|NCT02421588|582890215|FG001|Overall Study|Not treated|8|||
161410612|NCT01359943|582890216|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
161410613|NCT01359943|582890217|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
161410614|NCT01359943|582890218|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
161410615|NCT01359943|582890216|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
161410616|NCT01359943|582890217|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
161410617|NCT01359943|582890218|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
161410618|NCT01359943|582890216|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
161410619|NCT01359943|582890217|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
161410620|NCT01359943|582890218|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
161410621|NCT01359943|582890216|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
161410622|NCT01359943|582890217|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
161410623|NCT01359943|582890218|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
161410624|NCT01359943|582890216|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
161410625|NCT01359943|582890217|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
161410626|NCT01359943|582890218|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
161410627|NCT01359943|582890216|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
161410628|NCT01359943|582890217|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
161410629|NCT01359943|582890218|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
161410630|NCT01359943|582890216|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161410631|NCT01359943|582890217|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161410632|NCT01359943|582890218|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161410633|NCT01359943|582890216|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
161410634|NCT01359943|582890217|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
161410635|NCT01359943|582890218|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
161410636|NCT01359943|582890216|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
161410637|NCT01359943|582890217|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
161410638|NCT01359943|582890218|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
161410639|NCT01359943|582890216|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
161410640|NCT01359943|582890217|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
161410641|NCT01359943|582890218|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
161410642|NCT01359943|582890216|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
161410643|NCT01359943|582890217|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
161410644|NCT01359943|582890218|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
161410645|NCT01359943|582890216|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
161410646|NCT01359943|582890217|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
161410647|NCT01359943|582890218|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
161410648|NCT01359943|582890216|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
161410649|NCT01359943|582890217|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
161410650|NCT01359943|582890218|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
161410651|NCT01359943|582890216|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
161410652|NCT01359943|582890217|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
161410653|NCT01359943|582890218|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
161410654|NCT01359943|582890216|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
161410655|NCT01359943|582890217|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
161410656|NCT01359943|582890218|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
161410657|NCT01529034|582890219|FG000|Overall Study|Discontinued prior to study treatment|14|||
161410658|NCT01529034|582890219|FG000|Overall Study|Site closure|62|||
161410659|NCT01529034|582890219|FG000|Overall Study|Study termination|29|||
161410660|NCT01529034|582890219|FG000|Overall Study|Withdrawal by Subject|25|||
161410661|NCT01529034|582890219|FG000|Overall Study|No treated SCs within protocol window|13|||
161410662|NCT01529034|582890219|FG000|Overall Study|Noncompliance|8|||
161410663|NCT01529034|582890219|FG000|Overall Study|Caregiver no longer available|7|||
161410664|NCT01529034|582890219|FG000|Overall Study|Adverse Event|4|||
161410665|NCT01529034|582890219|FG000|Overall Study|Protocol Violation|4|||
161410666|NCT01529034|582890219|FG000|Overall Study|Lack of Efficacy|4|||
161410667|NCT01529034|582890219|FG000|Overall Study|Investigator no longer available|2|||
161410668|NCT01529034|582890219|FG000|Overall Study|Study drug not available|2|||
161410669|NCT02911142|582890220|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
161410670|NCT02911142|582890220|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
161410671|NCT02911142|582890220|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
161410672|NCT02911142|582890220|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
161410673|NCT02678923|582890221|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
161410674|NCT02678923|582890222|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
161410675|NCT02678923|582890221|FG000|Overall Study|Withdrawal by Subject|3|||
161410676|NCT02678923|582890222|FG001|Overall Study|Withdrawal by Subject|2|||
161410677|NCT02678923|582890221|FG000|Overall Study|Lost to Follow-up|1|||
161410678|NCT02678923|582890222|FG001|Overall Study|Lost to Follow-up|0|||
161410679|NCT02678923|582890221|FG000|Overall Study|Did Not Return for Study Visits|1|||
161410680|NCT02678923|582890222|FG001|Overall Study|Did Not Return for Study Visits|0|||
161410681|NCT03266172|582890223|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
161410682|NCT03266172|582890224|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
161410683|NCT03266172|582890225|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
161410684|NCT03266172|582890223|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
161410685|NCT03266172|582890224|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
161410686|NCT03266172|582890225|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
161410687|NCT03266172|582890223|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
161410688|NCT03266172|582890224|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
161410689|NCT03266172|582890225|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
161410690|NCT03266172|582890223|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
161410691|NCT03266172|582890224|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
161410692|NCT03266172|582890225|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
161410693|NCT03266172|582890223|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161410694|NCT03266172|582890224|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161410695|NCT03266172|582890225|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
161410696|NCT03266172|582890223|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161410697|NCT03266172|582890224|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161410698|NCT03266172|582890225|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
161410699|NCT01554514|582890226|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
161410700|NCT01554514|582890226|FG000|Overall Study|Physician Decision|1|||
161410701|NCT01374178|582890229|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
161410702|NCT01374178|582890230|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
161410703|NCT01374178|582890229|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
161410704|NCT01374178|582890230|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
161410705|NCT01422824|582890231|FG000|Overall Study|Case record form not evaluated|1|||
161410706|NCT01422824|582890231|FG000|Overall Study|Lost to Follow-up|37|||
161410707|NCT01716104|582890232|FG000|Overall Study|Do not meet inclusion criteria|6|||
161410708|NCT01716104|582890233|FG001|Overall Study|Do not meet inclusion criteria|7|||
161410709|NCT00117793|582890234|FG000|Overall Study|Withdrawal by Subject|12|||
161410710|NCT00470418|582890235|FG000|Overall Study|Withdrawal by Subject|1|||
161410711|NCT00470418|582890236|FG001|Overall Study|Withdrawal by Subject|0|||
161410712|NCT01818492|582890237|FG000|Overall Study|Adverse Event|2|||
161410713|NCT01818492|582890237|FG000|Overall Study|Death|3|||
161410714|NCT01818492|582890237|FG000|Overall Study|Withdrawal by Subject|1|||
161410715|NCT01818492|582890237|FG000|Overall Study|Additional therapy when not allowed PP|4|||
161410716|NCT02409719|582890240|FG000|Overall Study|Lost to Follow-up|3|||
161410717|NCT02409719|582890241|FG001|Overall Study|Lost to Follow-up|3|||
161410718|NCT02438813|582890242|FG000|Overall Study|Patient Decision|59|||
161410719|NCT02438813|582890242|FG000|Overall Study|Patient Lost to Follow-Up|137|||
161410720|NCT02438813|582890242|FG000|Overall Study|Study Ended by Sponsor|80|||
161410721|NCT02438813|582890242|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
161410722|NCT01026220|582890243|FG000|Induction|Death|1|||
161410723|NCT01026220|582890244|FG001|Induction|Death|0|||
161410724|NCT01026220|582890245|FG002|Induction|Death|0|||
161410725|NCT01026220|582890243|FG000|Induction|Lack of Efficacy|2|||
161410726|NCT01026220|582890244|FG001|Induction|Lack of Efficacy|0|||
161410727|NCT01026220|582890245|FG002|Induction|Lack of Efficacy|0|||
161410728|NCT01026220|582890243|FG000|Induction|Physician Decision|12|||
161410729|NCT01026220|582890244|FG001|Induction|Physician Decision|0|||
161410730|NCT01026220|582890245|FG002|Induction|Physician Decision|0|||
161410731|NCT01026220|582890243|FG000|Induction|Withdrawal by Subject|9|||
161410732|NCT01026220|582890244|FG001|Induction|Withdrawal by Subject|0|||
161410733|NCT01026220|582890245|FG002|Induction|Withdrawal by Subject|0|||
161410734|NCT01026220|582890243|FG000|Induction|Ineligible|1|||
161410735|NCT01026220|582890244|FG001|Induction|Ineligible|0|||
161410736|NCT01026220|582890245|FG002|Induction|Ineligible|0|||
161410737|NCT01026220|582890243|FG000|Consolidation Maintenance|Death|0|||
161410738|NCT01026220|582890244|FG001|Consolidation Maintenance|Death|1|||
161410739|NCT01026220|582890245|FG002|Consolidation Maintenance|Death|0|||
161410740|NCT01026220|582890243|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
161410741|NCT01026220|582890244|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
161410742|NCT01026220|582890245|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
161410743|NCT01026220|582890243|FG000|Consolidation Maintenance|Physician Decision|0|||
161410744|NCT01026220|582890244|FG001|Consolidation Maintenance|Physician Decision|2|||
161410745|NCT01026220|582890245|FG002|Consolidation Maintenance|Physician Decision|7|||
161410746|NCT01026220|582890243|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
161410747|NCT01026220|582890244|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
161410748|NCT01026220|582890245|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
161410749|NCT02879578|582890249|FG000|Overall Study|Adverse Event|1|||
161410750|NCT02879578|582890250|FG001|Overall Study|Adverse Event|2|||
161410751|NCT02879578|582890251|FG002|Overall Study|Adverse Event|14|||
161410752|NCT02879578|582890249|FG000|Overall Study|Protocol Violation|0|||
161410753|NCT02879578|582890250|FG001|Overall Study|Protocol Violation|1|||
161410754|NCT02879578|582890251|FG002|Overall Study|Protocol Violation|1|||
161410755|NCT02879578|582890249|FG000|Overall Study|Withdrawal by Subject|8|||
161410756|NCT02879578|582890250|FG001|Overall Study|Withdrawal by Subject|6|||
161410757|NCT02879578|582890251|FG002|Overall Study|Withdrawal by Subject|9|||
161410758|NCT02879578|582890249|FG000|Overall Study|Lost to Follow-up|1|||
161410759|NCT02879578|582890250|FG001|Overall Study|Lost to Follow-up|0|||
161410760|NCT02879578|582890251|FG002|Overall Study|Lost to Follow-up|4|||
161410761|NCT02879578|582890249|FG000|Overall Study|Physician Decision|0|||
161410762|NCT02879578|582890250|FG001|Overall Study|Physician Decision|0|||
161410763|NCT02879578|582890251|FG002|Overall Study|Physician Decision|4|||
161410764|NCT04390841|582890257|FG000|Overall Study|Withdrawal by Subject|2|||
161410765|NCT00411632|582890258|FG000|Overall Study|Death|1|||
161410766|NCT00659230|582890259|FG000|Overall Study|Lost to Follow-up|2|||
161410767|NCT00659230|582890260|FG001|Overall Study|Lost to Follow-up|5|||
161410768|NCT00659230|582890259|FG000|Overall Study|Lost source documentation|5|||
161410769|NCT00659230|582890260|FG001|Overall Study|Lost source documentation|4|||
161410770|NCT00659230|582890259|FG000|Overall Study|Did not return post-randomization|2|||
161410771|NCT00659230|582890260|FG001|Overall Study|Did not return post-randomization|3|||
161410772|NCT00691028|582891401|FG000|Open-label Period|Adverse Event|0|||
161410773|NCT00691028|582891402|FG001|Open-label Period|Adverse Event|0|||
161410774|NCT00691028|582891403|FG002|Open-label Period|Adverse Event|0|||
161410775|NCT00691028|582891404|FG003|Open-label Period|Adverse Event|16|||
161410776|NCT00691028|582891401|FG000|Open-label Period|Withdrawal by Subject|0|||
161410777|NCT00691028|582891402|FG001|Open-label Period|Withdrawal by Subject|0|||
161410778|NCT00691028|582891403|FG002|Open-label Period|Withdrawal by Subject|0|||
161410779|NCT00691028|582891404|FG003|Open-label Period|Withdrawal by Subject|3|||
161410780|NCT00691028|582891401|FG000|Open-label Period|not come to a hospital|0|||
161410781|NCT00691028|582891402|FG001|Open-label Period|not come to a hospital|0|||
161410782|NCT00691028|582891403|FG002|Open-label Period|not come to a hospital|0|||
161410783|NCT00691028|582891404|FG003|Open-label Period|not come to a hospital|1|||
161410784|NCT00691028|582891401|FG000|Double-blind Period|Adverse Event|8|||
161410785|NCT00691028|582891402|FG001|Double-blind Period|Adverse Event|9|||
161410786|NCT00691028|582891403|FG002|Double-blind Period|Adverse Event|6|||
161410787|NCT00691028|582891404|FG003|Double-blind Period|Adverse Event|0|||
161410788|NCT00691028|582891401|FG000|Double-blind Period|Lack of Efficacy|4|||
161410789|NCT00691028|582891402|FG001|Double-blind Period|Lack of Efficacy|3|||
161410790|NCT00691028|582891403|FG002|Double-blind Period|Lack of Efficacy|2|||
161410791|NCT00691028|582891404|FG003|Double-blind Period|Lack of Efficacy|0|||
161410792|NCT00691028|582891401|FG000|Double-blind Period|Withdrawal by Subject|1|||
161410793|NCT00691028|582891402|FG001|Double-blind Period|Withdrawal by Subject|0|||
161410794|NCT00691028|582891403|FG002|Double-blind Period|Withdrawal by Subject|1|||
161410795|NCT00691028|582891404|FG003|Double-blind Period|Withdrawal by Subject|0|||
161410796|NCT00691028|582891401|FG000|Double-blind Period|not come to a hospital.|0|||
161410797|NCT00691028|582891402|FG001|Double-blind Period|not come to a hospital.|1|||
161410798|NCT00691028|582891403|FG002|Double-blind Period|not come to a hospital.|0|||
161410799|NCT00691028|582891404|FG003|Double-blind Period|not come to a hospital.|0|||
161410800|NCT03402386|582891407|FG000|Overall Study|Adverse Event|3|||
161410801|NCT03402386|582891407|FG000|Overall Study|Physician Decision|1|||
161410802|NCT03402386|582891407|FG000|Overall Study|Difficult to control Hb|2|||
161410803|NCT05138419|582891408|FG000|Overall Study|Study terminated before participant completed.|0|||
161410804|NCT05138419|582891409|FG001|Overall Study|Study terminated before participant completed.|0|||
161410805|NCT05138419|582891410|FG002|Overall Study|Study terminated before participant completed.|1|||
161410806|NCT01048853|582891411|FG000|Overall Study|Death|1|||
161410807|NCT01048853|582891412|FG001|Overall Study|Death|0|||
161410808|NCT01048853|582891413|FG002|Overall Study|Death|0|||
161410809|NCT01048853|582891411|FG000|Overall Study|Lost to Follow-up|1|||
161410810|NCT01048853|582891412|FG001|Overall Study|Lost to Follow-up|4|||
161410811|NCT01048853|582891413|FG002|Overall Study|Lost to Follow-up|0|||
161410812|NCT00805766|582891420|FG000|Screening Period|Adverse Event|1|||
161410813|NCT00805766|582891420|FG000|Screening Period|Lack of Efficacy|2|||
161410814|NCT00805766|582891420|FG000|Screening Period|Pregnancy|1|||
161410815|NCT00805766|582891420|FG000|Screening Period|Responder|2|||
161410816|NCT00805766|582891420|FG000|Increased Dose Period|Adverse Event|4|||
161410817|NCT00805766|582891420|FG000|Increased Dose Period|Lack of Efficacy|7|||
161410818|NCT00805766|582891420|FG000|Increased Dose Period|Pregnancy|1|||
161410819|NCT00805766|582891420|FG000|Increased Dose Period|Withdrawal by Subject|1|||
161410820|NCT04254913|582891421|FG000|Overall Study|Adverse Event|1|||
161410821|NCT00971243|582891422|FG000|Double Blind Period|Adverse Event|2|||
161410822|NCT00971243|582891423|FG001|Double Blind Period|Adverse Event|3|||
161410823|NCT00971243|582891424|FG002|Double Blind Period|Adverse Event|2|||
161410824|NCT00971243|582891425|FG003|Double Blind Period|Adverse Event|2|||
161410825|NCT00971243|582891426|FG004|Double Blind Period|Adverse Event|3|||
161410826|NCT00971243|582891422|FG000|Double Blind Period|Lost to Follow-up|0|||
161410827|NCT00971243|582891423|FG001|Double Blind Period|Lost to Follow-up|1|||
161410828|NCT00971243|582891424|FG002|Double Blind Period|Lost to Follow-up|1|||
161410829|NCT00971243|582891425|FG003|Double Blind Period|Lost to Follow-up|0|||
161410830|NCT00971243|582891426|FG004|Double Blind Period|Lost to Follow-up|1|||
161410831|NCT00971243|582891422|FG000|Double Blind Period|Physician Decision|10|||
161410832|NCT00971243|582891423|FG001|Double Blind Period|Physician Decision|6|||
161410833|NCT00971243|582891424|FG002|Double Blind Period|Physician Decision|7|||
161410834|NCT00971243|582891425|FG003|Double Blind Period|Physician Decision|6|||
161410835|NCT00971243|582891426|FG004|Double Blind Period|Physician Decision|7|||
161410836|NCT00971243|582891422|FG000|Double Blind Period|Protocol Violation|2|||
161410837|NCT00971243|582891423|FG001|Double Blind Period|Protocol Violation|0|||
161410838|NCT00971243|582891424|FG002|Double Blind Period|Protocol Violation|3|||
161410839|NCT00971243|582891425|FG003|Double Blind Period|Protocol Violation|2|||
161410840|NCT00971243|582891426|FG004|Double Blind Period|Protocol Violation|2|||
161410841|NCT00971243|582891422|FG000|Double Blind Period|Withdrawal by Subject|4|||
161410842|NCT00971243|582891423|FG001|Double Blind Period|Withdrawal by Subject|1|||
161410843|NCT00971243|582891424|FG002|Double Blind Period|Withdrawal by Subject|4|||
161410844|NCT00971243|582891425|FG003|Double Blind Period|Withdrawal by Subject|4|||
161410845|NCT00971243|582891426|FG004|Double Blind Period|Withdrawal by Subject|4|||
161410846|NCT00971243|582891422|FG000|Double Blind Period|Other reasons|1|||
161410847|NCT00971243|582891423|FG001|Double Blind Period|Other reasons|0|||
161410848|NCT00971243|582891424|FG002|Double Blind Period|Other reasons|2|||
161410849|NCT00971243|582891425|FG003|Double Blind Period|Other reasons|0|||
161410850|NCT00971243|582891426|FG004|Double Blind Period|Other reasons|1|||
161410851|NCT00971243|582891422|FG000|Open-label Period|Adverse Event|1|||
161410852|NCT00971243|582891423|FG001|Open-label Period|Adverse Event|0|||
161410853|NCT00971243|582891424|FG002|Open-label Period|Adverse Event|1|||
161410854|NCT00971243|582891425|FG003|Open-label Period|Adverse Event|1|||
161410855|NCT00971243|582891426|FG004|Open-label Period|Adverse Event|0|||
161410856|NCT00971243|582891422|FG000|Open-label Period|Physician Decision|5|||
161410857|NCT00971243|582891423|FG001|Open-label Period|Physician Decision|9|||
161410858|NCT00971243|582891424|FG002|Open-label Period|Physician Decision|3|||
161410859|NCT00971243|582891425|FG003|Open-label Period|Physician Decision|7|||
161410860|NCT00971243|582891426|FG004|Open-label Period|Physician Decision|2|||
161410861|NCT00971243|582891422|FG000|Open-label Period|Protocol Violation|1|||
161410862|NCT00971243|582891423|FG001|Open-label Period|Protocol Violation|1|||
161410863|NCT00971243|582891424|FG002|Open-label Period|Protocol Violation|1|||
161410864|NCT00971243|582891425|FG003|Open-label Period|Protocol Violation|0|||
161410865|NCT00971243|582891426|FG004|Open-label Period|Protocol Violation|1|||
161410866|NCT00971243|582891422|FG000|Open-label Period|Withdrawal by Subject|1|||
161410867|NCT00971243|582891423|FG001|Open-label Period|Withdrawal by Subject|0|||
161410868|NCT00971243|582891424|FG002|Open-label Period|Withdrawal by Subject|0|||
161410869|NCT00971243|582891425|FG003|Open-label Period|Withdrawal by Subject|2|||
161410870|NCT00971243|582891426|FG004|Open-label Period|Withdrawal by Subject|1|||
161410871|NCT00971243|582891422|FG000|Open-label Period|Other reason|0|||
161410872|NCT00971243|582891423|FG001|Open-label Period|Other reason|0|||
161410873|NCT00971243|582891424|FG002|Open-label Period|Other reason|0|||
161410874|NCT00971243|582891425|FG003|Open-label Period|Other reason|0|||
161410875|NCT00971243|582891426|FG004|Open-label Period|Other reason|2|||
161410876|NCT01004952|582891427|FG000|Overall Study|Lost to Follow-up|0|||
161410877|NCT01004952|582891428|FG001|Overall Study|Lost to Follow-up|11|||
161410878|NCT01004952|582891427|FG000|Overall Study|Withdrawal by Subject|0|||
161410879|NCT01004952|582891428|FG001|Overall Study|Withdrawal by Subject|5|||
161410880|NCT02354222|582891432|FG000|Overall Study|Adverse Event|0|||
161410881|NCT02354222|582891433|FG001|Overall Study|Adverse Event|3|||
161410882|NCT02354222|582891432|FG000|Overall Study|Physician Decision|1|||
161410883|NCT02354222|582891433|FG001|Overall Study|Physician Decision|1|||
161410884|NCT02354222|582891432|FG000|Overall Study|Pregnancy|1|||
161410885|NCT02354222|582891433|FG001|Overall Study|Pregnancy|0|||
161410886|NCT02354222|582891432|FG000|Overall Study|Withdrawal by Subject|2|||
161410887|NCT02354222|582891433|FG001|Overall Study|Withdrawal by Subject|3|||
161410888|NCT02354222|582891432|FG000|Overall Study|Conflict with the stopping criteria|0|||
161410889|NCT02354222|582891433|FG001|Overall Study|Conflict with the stopping criteria|4|||
161410890|NCT04300218|582891434|FG000|Overall Study|Lost to Follow-up|6|||
161410891|NCT04300218|582891435|FG001|Overall Study|Lost to Follow-up|8|||
161410892|NCT04099511|582891436|FG000|Overall Study|Lost to Follow-up|2|||
161410893|NCT04099511|582891437|FG001|Overall Study|Lost to Follow-up|2|||
161410894|NCT04099511|582891436|FG000|Overall Study|Withdrawal by Subject|8|||
161410895|NCT04099511|582891437|FG001|Overall Study|Withdrawal by Subject|4|||
161410896|NCT06581094|582891440|FG000|Overall Study|Lost to Follow-up|1|||
161410897|NCT06581094|582891441|FG001|Overall Study|Lost to Follow-up|1|||
161410898|NCT05740618|582891442|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
161410899|NCT05740618|582891442|FG000|Overall Study|Physician Decision|1|||
161410900|NCT04588389|582891443|FG000|Overall Study|Issues with anesthesia during surgery|2|||
161410901|NCT04588389|582891444|FG001|Overall Study|Issues with anesthesia during surgery|0|||
161410902|NCT04588389|582891445|FG002|Overall Study|Issues with anesthesia during surgery|0|||
161410903|NCT02354235|582891451|FG000|Overall Study|Adverse Event|2|||
161410904|NCT02354235|582891452|FG001|Overall Study|Adverse Event|2|||
161410905|NCT02354235|582891451|FG000|Overall Study|Physician Decision|0|||
161410906|NCT02354235|582891452|FG001|Overall Study|Physician Decision|1|||
161410907|NCT02354235|582891451|FG000|Overall Study|Withdrawal by Subject|1|||
161410908|NCT02354235|582891452|FG001|Overall Study|Withdrawal by Subject|3|||
161410909|NCT02354235|582891451|FG000|Overall Study|Conflict with the stopping criteria|0|||
161410910|NCT02354235|582891452|FG001|Overall Study|Conflict with the stopping criteria|1|||
161410911|NCT05451940|582891453|FG000|Treatment Period|Physician Decision|1|||
161410912|NCT03436693|582891454|FG000|Overall Study|Adverse Event|22|||
161410913|NCT03436693|582891455|FG001|Overall Study|Adverse Event|10|||
161410914|NCT03436693|582891454|FG000|Overall Study|Physician Decision|3|||
161410915|NCT03436693|582891455|FG001|Overall Study|Physician Decision|3|||
161410916|NCT03436693|582891454|FG000|Overall Study|Withdrawal by Subject|4|||
161410917|NCT03436693|582891455|FG001|Overall Study|Withdrawal by Subject|13|||
161410918|NCT03436693|582891454|FG000|Overall Study|Progressive Disease|1|||
161410919|NCT03436693|582891455|FG001|Overall Study|Progressive Disease|1|||
161410920|NCT04481789|582891456|FG000|Period 1|Withdrawal by Subject|1|||
161410921|NCT04481789|582891457|FG001|Period 1|Withdrawal by Subject|0|||
161410922|NCT04481789|582891458|FG002|Period 1|Withdrawal by Subject|0|||
161410923|NCT04481789|582891459|FG003|Period 1|Withdrawal by Subject|0|||
161410924|NCT04481789|582891460|FG004|Period 1|Withdrawal by Subject|0|||
161410925|NCT04481789|582891461|FG005|Period 1|Withdrawal by Subject|0|||
161410926|NCT05216224|582891462|FG000|Overall Study|Adverse Event|6|||
161410927|NCT05216224|582891463|FG001|Overall Study|Adverse Event|3|||
161410928|NCT05216224|582891462|FG000|Overall Study|Lack of Efficacy|1|||
161410929|NCT05216224|582891463|FG001|Overall Study|Lack of Efficacy|0|||
161410930|NCT05216224|582891462|FG000|Overall Study|Lost to Follow-up|8|||
161410931|NCT05216224|582891463|FG001|Overall Study|Lost to Follow-up|6|||
161410932|NCT05216224|582891462|FG000|Overall Study|Protocol Violation|1|||
161410933|NCT05216224|582891463|FG001|Overall Study|Protocol Violation|1|||
161410934|NCT05216224|582891462|FG000|Overall Study|Withdrawal by Subject|6|||
161410935|NCT05216224|582891463|FG001|Overall Study|Withdrawal by Subject|5|||
161410936|NCT05216224|582891462|FG000|Overall Study|Other than specified|1|||
161410937|NCT05216224|582891463|FG001|Overall Study|Other than specified|0|||
161410938|NCT03245008|582891464|FG000|Overall Study|Adverse Event|15|||
161410939|NCT03245008|582891465|FG001|Overall Study|Adverse Event|18|||
161410940|NCT03245008|582891466|FG002|Overall Study|Adverse Event|15|||
161410941|NCT03245008|582891467|FG003|Overall Study|Adverse Event|0|||
161410942|NCT03245008|582891468|FG004|Overall Study|Adverse Event|1|||
161410943|NCT03245008|582891464|FG000|Overall Study|Lack of Efficacy|0|||
161410944|NCT03245008|582891465|FG001|Overall Study|Lack of Efficacy|1|||
161410945|NCT03245008|582891466|FG002|Overall Study|Lack of Efficacy|0|||
161410946|NCT03245008|582891467|FG003|Overall Study|Lack of Efficacy|0|||
161410947|NCT03245008|582891468|FG004|Overall Study|Lack of Efficacy|0|||
161410948|NCT03245008|582891464|FG000|Overall Study|Lost to Follow-up|4|||
161410949|NCT03245008|582891465|FG001|Overall Study|Lost to Follow-up|1|||
161410950|NCT03245008|582891466|FG002|Overall Study|Lost to Follow-up|0|||
161410951|NCT03245008|582891467|FG003|Overall Study|Lost to Follow-up|0|||
161410952|NCT03245008|582891468|FG004|Overall Study|Lost to Follow-up|1|||
161410953|NCT03245008|582891464|FG000|Overall Study|Physician Decision|1|||
161410954|NCT03245008|582891465|FG001|Overall Study|Physician Decision|3|||
161410955|NCT03245008|582891466|FG002|Overall Study|Physician Decision|4|||
161410956|NCT03245008|582891467|FG003|Overall Study|Physician Decision|0|||
161410957|NCT03245008|582891468|FG004|Overall Study|Physician Decision|0|||
161410958|NCT03245008|582891464|FG000|Overall Study|Protocol Violation|0|||
161410959|NCT03245008|582891465|FG001|Overall Study|Protocol Violation|1|||
161410960|NCT03245008|582891466|FG002|Overall Study|Protocol Violation|0|||
161410961|NCT03245008|582891467|FG003|Overall Study|Protocol Violation|0|||
161410962|NCT03245008|582891468|FG004|Overall Study|Protocol Violation|0|||
161410963|NCT03245008|582891464|FG000|Overall Study|Withdrawal by Subject|20|||
161410964|NCT03245008|582891465|FG001|Overall Study|Withdrawal by Subject|19|||
161410965|NCT03245008|582891466|FG002|Overall Study|Withdrawal by Subject|11|||
161410966|NCT03245008|582891467|FG003|Overall Study|Withdrawal by Subject|0|||
161410967|NCT03245008|582891468|FG004|Overall Study|Withdrawal by Subject|0|||
161410968|NCT03245008|582891464|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
161410969|NCT03245008|582891465|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
161410970|NCT03245008|582891466|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
161410971|NCT03245008|582891467|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
161410972|NCT03245008|582891468|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
161410973|NCT03245008|582891464|FG000|Overall Study|Failure to meet randomization criteria|0|||
161410974|NCT03245008|582891465|FG001|Overall Study|Failure to meet randomization criteria|1|||
161410975|NCT03245008|582891466|FG002|Overall Study|Failure to meet randomization criteria|0|||
161410976|NCT03245008|582891467|FG003|Overall Study|Failure to meet randomization criteria|1|||
161410977|NCT03245008|582891468|FG004|Overall Study|Failure to meet randomization criteria|0|||
161410978|NCT04655144|582891474|FG000|Overall Study|Consumed THC|1|||
161410979|NCT04655144|582891475|FG001|Overall Study|Consumed THC|0|||
161410980|NCT04655144|582891474|FG000|Overall Study|Unilateral embolization|0|||
161410981|NCT04655144|582891475|FG001|Overall Study|Unilateral embolization|1|||
161410982|NCT04317742|582891476|FG000|Overall Study|Lost to Follow-up|57|||
161410983|NCT04317742|582891477|FG001|Overall Study|Lost to Follow-up|59|||
161410984|NCT04317742|582891476|FG000|Overall Study|Pregnancy|1|||
161410985|NCT04317742|582891477|FG001|Overall Study|Pregnancy|1|||
161410986|NCT04317742|582891476|FG000|Overall Study|Withdrawal by Subject|46|||
161410987|NCT04317742|582891477|FG001|Overall Study|Withdrawal by Subject|24|||
161410988|NCT03645863|582891478|FG000|Overall Study|Withdrawal by Subject|1|||
161410989|NCT03645863|582891479|FG001|Overall Study|Withdrawal by Subject|0|||
161410990|NCT03645863|582891480|FG002|Overall Study|Withdrawal by Subject|0|||
161410991|NCT01580670|582891481|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
161410992|NCT01580670|582891481|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
161410993|NCT02220907|582891482|FG000|Overall Study|Adverse Event|7|||
161410994|NCT02220907|582891482|FG000|Overall Study|Physician Decision|1|||
161410995|NCT02220907|582891482|FG000|Overall Study|Withdrawal by Subject|2|||
161410996|NCT02220907|582891482|FG000|Overall Study|Conflict with the stopping criteria|1|||
161410997|NCT00542815|582891483|FG000|Overall Study|Adverse Event|19|||
161410998|NCT00542815|582891484|FG001|Overall Study|Adverse Event|6|||
161410999|NCT00542815|582891485|FG002|Overall Study|Adverse Event|9|||
161411000|NCT00542815|582891483|FG000|Overall Study|Death|10|||
161411001|NCT00542815|582891484|FG001|Overall Study|Death|7|||
161411002|NCT00542815|582891485|FG002|Overall Study|Death|3|||
161411003|NCT00542815|582891483|FG000|Overall Study|Lack of Efficacy|9|||
161411004|NCT00542815|582891484|FG001|Overall Study|Lack of Efficacy|2|||
161411005|NCT00542815|582891485|FG002|Overall Study|Lack of Efficacy|0|||
161411006|NCT00542815|582891483|FG000|Overall Study|Physician Decision|2|||
161411007|NCT00542815|582891484|FG001|Overall Study|Physician Decision|1|||
161411008|NCT00542815|582891485|FG002|Overall Study|Physician Decision|0|||
161411009|NCT00542815|582891483|FG000|Overall Study|Protocol Violation|1|||
161411010|NCT00542815|582891484|FG001|Overall Study|Protocol Violation|1|||
161411011|NCT00542815|582891485|FG002|Overall Study|Protocol Violation|2|||
161411012|NCT00542815|582891483|FG000|Overall Study|Withdrawal by Subject|41|||
161411013|NCT00542815|582891484|FG001|Overall Study|Withdrawal by Subject|5|||
161411014|NCT00542815|582891485|FG002|Overall Study|Withdrawal by Subject|8|||
161411015|NCT00542815|582891483|FG000|Overall Study|Other reasons|24|||
161411016|NCT00542815|582891484|FG001|Overall Study|Other reasons|10|||
161411017|NCT00542815|582891485|FG002|Overall Study|Other reasons|10|||
161411018|NCT01966445|582891486|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161411019|NCT01966445|582891487|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161411020|NCT01966445|582891488|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161411021|NCT01966445|582891489|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
161411022|NCT01966445|582891490|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161411023|NCT01966445|582891491|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
161411024|NCT01966445|582891492|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161411025|NCT01966445|582891486|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161411026|NCT01966445|582891487|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
161411027|NCT01966445|582891488|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161411028|NCT01966445|582891489|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
161411029|NCT01966445|582891490|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
161411030|NCT01966445|582891491|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161411031|NCT01966445|582891492|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161411032|NCT01966445|582891486|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161411033|NCT01966445|582891487|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
161411034|NCT01966445|582891488|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
161411035|NCT01966445|582891489|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161411036|NCT01966445|582891490|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
161411037|NCT01966445|582891491|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161411038|NCT01966445|582891492|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161411039|NCT01966445|582891486|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161411040|NCT01966445|582891487|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161411041|NCT01966445|582891488|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161411042|NCT01966445|582891489|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161411043|NCT01966445|582891490|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161411044|NCT01966445|582891491|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161411045|NCT01966445|582891492|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
161411046|NCT01966445|582891486|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161411047|NCT01966445|582891487|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161411048|NCT01966445|582891488|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161411049|NCT01966445|582891489|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161411050|NCT01966445|582891490|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161411051|NCT01966445|582891491|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161411052|NCT01966445|582891492|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
161411053|NCT00409344|582891497|FG000|Overall Study|no enrollment|0|||
161411054|NCT00409344|582891498|FG001|Overall Study|no enrollment|0|||
161411055|NCT06045507|582892175|FG000|Overall Study|Death|0|||
161411056|NCT06045507|582892176|FG001|Overall Study|Death|0|||
161411057|NCT06045507|582892177|FG002|Overall Study|Death|1|||
161411058|NCT06045507|582892178|FG003|Overall Study|Death|0|||
161411059|NCT06045507|582892175|FG000|Overall Study|Lost to Follow-up|3|||
161411060|NCT06045507|582892176|FG001|Overall Study|Lost to Follow-up|3|||
161411061|NCT06045507|582892177|FG002|Overall Study|Lost to Follow-up|0|||
161411062|NCT06045507|582892178|FG003|Overall Study|Lost to Follow-up|0|||
161411063|NCT06045507|582892175|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
161411064|NCT06045507|582892176|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
161411065|NCT06045507|582892177|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
161411066|NCT06045507|582892178|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
161411067|NCT06045507|582892175|FG000|Overall Study|Withdrawal by Subject|4|||
161411068|NCT06045507|582892176|FG001|Overall Study|Withdrawal by Subject|1|||
161411069|NCT06045507|582892177|FG002|Overall Study|Withdrawal by Subject|0|||
161411070|NCT06045507|582892178|FG003|Overall Study|Withdrawal by Subject|2|||
161411071|NCT06045507|582892175|FG000|Overall Study|Miscellaneous|2|||
161411072|NCT06045507|582892176|FG001|Overall Study|Miscellaneous|0|||
161411073|NCT06045507|582892177|FG002|Overall Study|Miscellaneous|0|||
161411074|NCT06045507|582892178|FG003|Overall Study|Miscellaneous|1|||
161411075|NCT03688100|582892183|FG000|Overall Study|Lost to Follow-up|21|||
161411076|NCT03688100|582892184|FG001|Overall Study|Lost to Follow-up|15|||
161411077|NCT03688100|582892185|FG002|Overall Study|Lost to Follow-up|15|||
161411078|NCT03688100|582892186|FG003|Overall Study|Lost to Follow-up|18|||
161411079|NCT03688100|582892183|FG000|Overall Study|Withdrawal by Subject|19|||
161411080|NCT03688100|582892184|FG001|Overall Study|Withdrawal by Subject|16|||
161411081|NCT03688100|582892185|FG002|Overall Study|Withdrawal by Subject|0|||
161411082|NCT03688100|582892186|FG003|Overall Study|Withdrawal by Subject|0|||
161411083|NCT03688100|582892183|FG000|Overall Study|Death|36|||
161411084|NCT03688100|582892184|FG001|Overall Study|Death|27|||
161411085|NCT03688100|582892185|FG002|Overall Study|Death|0|||
161411086|NCT03688100|582892186|FG003|Overall Study|Death|0|||
161411087|NCT02479139|582892192|FG000|Overall Study|Lost to Follow-up|2|||
161411088|NCT02479139|582892193|FG001|Overall Study|Lost to Follow-up|4|||
161411089|NCT02479139|582892194|FG002|Overall Study|Lost to Follow-up|4|||
161411090|NCT02479139|582892195|FG003|Overall Study|Lost to Follow-up|2|||
161411091|NCT02479139|582892196|FG004|Overall Study|Lost to Follow-up|3|||
161411092|NCT02479139|582892197|FG005|Overall Study|Lost to Follow-up|5|||
161411093|NCT02479139|582892192|FG000|Overall Study|Withdrew Consent|5|||
161411094|NCT02479139|582892193|FG001|Overall Study|Withdrew Consent|6|||
161411095|NCT02479139|582892194|FG002|Overall Study|Withdrew Consent|1|||
161411096|NCT02479139|582892195|FG003|Overall Study|Withdrew Consent|4|||
161411097|NCT02479139|582892196|FG004|Overall Study|Withdrew Consent|1|||
161411098|NCT02479139|582892197|FG005|Overall Study|Withdrew Consent|1|||
161411099|NCT02479139|582892192|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161411100|NCT02479139|582892193|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161411101|NCT02479139|582892194|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
161411102|NCT02479139|582892195|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161411103|NCT02479139|582892196|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161411104|NCT02479139|582892197|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161411105|NCT02479139|582892192|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161411106|NCT02479139|582892193|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161411107|NCT02479139|582892194|FG002|Overall Study|Other Miscellaneous Reasons|1|||
161411108|NCT02479139|582892195|FG003|Overall Study|Other Miscellaneous Reasons|1|||
161411109|NCT02479139|582892196|FG004|Overall Study|Other Miscellaneous Reasons|1|||
161411110|NCT02479139|582892197|FG005|Overall Study|Other Miscellaneous Reasons|0|||
161411111|NCT00885482|582892198|FG000|Overall Study|Pregnancy|1|||
161411112|NCT00885482|582892198|FG000|Overall Study|Lack of Efficacy|1|||
161411113|NCT00885482|582892198|FG000|Overall Study|Death|1|||
161411114|NCT00885482|582892198|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
161411115|NCT00084656|582892199|FG000|Overall Study|Other reasons|0|||
161411116|NCT00084656|582892200|FG001|Overall Study|Other reasons|12|||
161411117|NCT00084656|582892201|FG002|Overall Study|Other reasons|11|||
161411118|NCT00084656|582892199|FG000|Overall Study|Withdrawal by Subject|15|||
161411119|NCT00084656|582892200|FG001|Overall Study|Withdrawal by Subject|4|||
161411120|NCT00084656|582892201|FG002|Overall Study|Withdrawal by Subject|4|||
161411121|NCT00084656|582892199|FG000|Overall Study|Disease relapse|0|||
161411122|NCT00084656|582892200|FG001|Overall Study|Disease relapse|9|||
161411123|NCT00084656|582892201|FG002|Overall Study|Disease relapse|10|||
161411124|NCT00084656|582892199|FG000|Overall Study|Disease progression|9|||
161411125|NCT00084656|582892200|FG001|Overall Study|Disease progression|0|||
161411126|NCT00084656|582892201|FG002|Overall Study|Disease progression|0|||
161411127|NCT00084656|582892199|FG000|Overall Study|Lost to Follow-up|1|||
161411128|NCT00084656|582892200|FG001|Overall Study|Lost to Follow-up|0|||
161411129|NCT00084656|582892201|FG002|Overall Study|Lost to Follow-up|1|||
161411130|NCT02772978|582892202|FG000|Overall Study|Withdrawal by Subject|1|||
161411131|NCT02772978|582892203|FG001|Overall Study|Withdrawal by Subject|1|||
161411132|NCT00989781|582892204|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
161411133|NCT00989781|582892205|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
161411134|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
161411135|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
161411136|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
161411137|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
161411138|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
161411139|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
161411140|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
161411141|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
161411142|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
161411143|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
161411144|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
161411145|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
161411146|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
161411147|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
161411148|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
161411149|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
161411150|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
161411151|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
161411152|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
161411153|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
161411154|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
161411155|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
161411156|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
161411157|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
161411158|NCT01532869|582892206|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
161411159|NCT01532869|582892207|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
161411160|NCT01532869|582892206|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
161411161|NCT01532869|582892207|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
161411162|NCT01532869|582892206|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
161411163|NCT01532869|582892207|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
161411164|NCT01532869|582892206|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
161411165|NCT01532869|582892207|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
161411166|NCT01532869|582892206|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
161411167|NCT01532869|582892207|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
161411168|NCT01069705|582892211|FG000|Overall Study|Adverse Event|1|||
161411169|NCT01069705|582892211|FG000|Overall Study|Withdrawal by Subject|2|||
161411170|NCT03624127|582892212|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
161411171|NCT03624127|582892213|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
161411172|NCT03624127|582892214|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
161411173|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
161411174|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
161411175|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
161411176|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Death|0|||
161411177|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Death|1|||
161411178|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Death|0|||
161411179|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
161411180|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
161411181|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
161411182|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
161411183|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
161411184|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
161411185|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
161411186|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
161411187|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
161411188|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
161411189|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
161411190|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
161411191|NCT03624127|582892212|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
161411192|NCT03624127|582892213|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
161411193|NCT03624127|582892214|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
161411194|NCT03624127|582892212|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
161411195|NCT03624127|582892213|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
161411196|NCT03624127|582892214|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
161411197|NCT03624127|582892212|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
161411198|NCT03624127|582892213|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161411199|NCT03624127|582892214|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161411200|NCT03624127|582892212|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161411201|NCT03624127|582892213|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161411202|NCT03624127|582892214|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
161411203|NCT03624127|582892212|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
161411204|NCT03624127|582892213|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
161411205|NCT03624127|582892214|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
161411206|NCT03624127|582892212|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
161411207|NCT03624127|582892213|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
161411208|NCT03624127|582892214|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
161411209|NCT03624127|582892212|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
161411210|NCT03624127|582892213|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
161411211|NCT03624127|582892214|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
161411212|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
161411213|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
161411214|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
161411215|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
161411216|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161411217|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161411218|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
161411219|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
161411220|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
161411221|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
161411222|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
161411223|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
161411224|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
161411225|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
161411226|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
161411227|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
161411228|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161411229|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161411230|NCT03624127|582892212|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
161411231|NCT03624127|582892213|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
161411232|NCT03624127|582892214|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
161411233|NCT01817959|582892215|FG000|Overall Study|Graft loss|1|||
161411234|NCT01817959|582892216|FG001|Overall Study|Graft loss|1|||
161411235|NCT01817959|582892215|FG000|Overall Study|forbidden medication|1|||
161411236|NCT01817959|582892216|FG001|Overall Study|forbidden medication|1|||
161411237|NCT01817959|582892215|FG000|Overall Study|Adverse Event|1|||
161411238|NCT01817959|582892216|FG001|Overall Study|Adverse Event|0|||
161411239|NCT01817959|582892215|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
161411240|NCT01817959|582892216|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
161411241|NCT01123707|582892217|FG000|Overall Study|Lost to Follow-up|3|||
161411242|NCT01123707|582892218|FG001|Overall Study|Lost to Follow-up|1|||
161411243|NCT01123707|582892219|FG002|Overall Study|Lost to Follow-up|3|||
161411244|NCT01123707|582892220|FG003|Overall Study|Lost to Follow-up|2|||
161411245|NCT01123707|582892217|FG000|Overall Study|Adverse Event|5|||
161411246|NCT01123707|582892218|FG001|Overall Study|Adverse Event|7|||
161411247|NCT01123707|582892219|FG002|Overall Study|Adverse Event|5|||
161411248|NCT01123707|582892220|FG003|Overall Study|Adverse Event|3|||
161411249|NCT01123707|582892217|FG000|Overall Study|Sponsor Discontinued Study|30|||
161411250|NCT01123707|582892218|FG001|Overall Study|Sponsor Discontinued Study|24|||
161411251|NCT01123707|582892219|FG002|Overall Study|Sponsor Discontinued Study|25|||
161411252|NCT01123707|582892220|FG003|Overall Study|Sponsor Discontinued Study|40|||
161411253|NCT01123707|582892217|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161411254|NCT01123707|582892218|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161411255|NCT01123707|582892219|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
161411256|NCT01123707|582892220|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161411257|NCT01123707|582892217|FG000|Overall Study|Investigator Withdrew Participant|0|||
161411258|NCT01123707|582892218|FG001|Overall Study|Investigator Withdrew Participant|1|||
161411259|NCT01123707|582892219|FG002|Overall Study|Investigator Withdrew Participant|1|||
161411260|NCT01123707|582892220|FG003|Overall Study|Investigator Withdrew Participant|1|||
161411261|NCT01123707|582892217|FG000|Overall Study|Subject Withdrew Consent|4|||
161411262|NCT01123707|582892218|FG001|Overall Study|Subject Withdrew Consent|5|||
161411263|NCT01123707|582892219|FG002|Overall Study|Subject Withdrew Consent|1|||
161411264|NCT01123707|582892220|FG003|Overall Study|Subject Withdrew Consent|2|||
161411265|NCT01123707|582892217|FG000|Overall Study|Lack of Efficacy|1|||
161411266|NCT01123707|582892218|FG001|Overall Study|Lack of Efficacy|2|||
161411267|NCT01123707|582892219|FG002|Overall Study|Lack of Efficacy|1|||
161411268|NCT01123707|582892220|FG003|Overall Study|Lack of Efficacy|0|||
161411269|NCT01123707|582892217|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
161411270|NCT01123707|582892218|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
161411271|NCT01123707|582892219|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
161411272|NCT01123707|582892220|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
161411273|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
161411274|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
161411275|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
161411276|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
161411277|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
161411278|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
161411279|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
161411280|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
161411281|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Death|0|||
161411282|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Death|1|||
161411283|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
161411284|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
161411285|NCT03281304|582892223|FG000|Treatment Phase (up to 42 Months)|Other|0|||
161411286|NCT03281304|582892224|FG001|Treatment Phase (up to 42 Months)|Other|2|||
161411287|NCT03281304|582892223|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
161411288|NCT03281304|582892224|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
161411289|NCT00858637|582892225|FG000|Active Comparison Phase|Adverse Event|14|||
161411290|NCT00858637|582892226|FG001|Active Comparison Phase|Adverse Event|0|||
161411291|NCT00858637|582892227|FG002|Active Comparison Phase|Adverse Event|0|||
161411292|NCT00858637|582892228|FG003|Active Comparison Phase|Adverse Event|9|||
161411293|NCT00858637|582892229|FG004|Active Comparison Phase|Adverse Event|0|||
161411294|NCT00858637|582892230|FG005|Active Comparison Phase|Adverse Event|0|||
161411295|NCT00858637|582892225|FG000|Active Comparison Phase|Death|1|||
161411296|NCT00858637|582892226|FG001|Active Comparison Phase|Death|0|||
161411297|NCT00858637|582892227|FG002|Active Comparison Phase|Death|0|||
161411298|NCT00858637|582892228|FG003|Active Comparison Phase|Death|1|||
161411299|NCT00858637|582892229|FG004|Active Comparison Phase|Death|0|||
161411300|NCT00858637|582892230|FG005|Active Comparison Phase|Death|0|||
161411301|NCT00858637|582892225|FG000|Active Comparison Phase|Physician Decision|1|||
161411302|NCT00858637|582892226|FG001|Active Comparison Phase|Physician Decision|0|||
161411303|NCT00858637|582892227|FG002|Active Comparison Phase|Physician Decision|0|||
161411304|NCT00858637|582892228|FG003|Active Comparison Phase|Physician Decision|1|||
161411305|NCT00858637|582892229|FG004|Active Comparison Phase|Physician Decision|0|||
161411306|NCT00858637|582892230|FG005|Active Comparison Phase|Physician Decision|0|||
161411307|NCT00858637|582892225|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
161411308|NCT00858637|582892226|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
161411309|NCT00858637|582892227|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
161411310|NCT00858637|582892228|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
161411311|NCT00858637|582892229|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
161411312|NCT00858637|582892230|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
161411313|NCT00858637|582892225|FG000|Active Comparison Phase|Other Reasons|1|||
161411314|NCT00858637|582892226|FG001|Active Comparison Phase|Other Reasons|0|||
161411315|NCT00858637|582892227|FG002|Active Comparison Phase|Other Reasons|0|||
161411316|NCT00858637|582892228|FG003|Active Comparison Phase|Other Reasons|1|||
161411317|NCT00858637|582892229|FG004|Active Comparison Phase|Other Reasons|0|||
161411318|NCT00858637|582892230|FG005|Active Comparison Phase|Other Reasons|0|||
161411319|NCT00858637|582892225|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
161411320|NCT00858637|582892226|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
161411321|NCT00858637|582892227|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
161411322|NCT00858637|582892228|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
161411323|NCT00858637|582892229|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
161411324|NCT00858637|582892230|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
161411325|NCT00858637|582892225|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161411326|NCT00858637|582892226|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161411327|NCT00858637|582892227|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161411328|NCT00858637|582892228|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161411329|NCT00858637|582892229|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161411330|NCT00858637|582892230|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
161411331|NCT00605345|582892233|FG000|Overall Study|Withdrawal by Subject|1|||
161411332|NCT00605345|582892234|FG001|Overall Study|Withdrawal by Subject|0|||
161411333|NCT00605345|582892233|FG000|Overall Study|Adverse Event|0|||
161411334|NCT00605345|582892234|FG001|Overall Study|Adverse Event|1|||
161411335|NCT00605345|582892233|FG000|Overall Study|Protocol Violation|0|||
161411336|NCT00605345|582892234|FG001|Overall Study|Protocol Violation|2|||
161411337|NCT02577016|582892235|FG000|Overall Study|Adverse Event|2|||
161411338|NCT02577016|582892236|FG001|Overall Study|Adverse Event|1|||
161411339|NCT02577016|582892235|FG000|Overall Study|Physician Decision|0|||
161411340|NCT02577016|582892236|FG001|Overall Study|Physician Decision|1|||
161411341|NCT02126839|582892237|FG000|Overall Study|Adverse Event|0|||
161411342|NCT02126839|582892238|FG001|Overall Study|Adverse Event|1|||
161411343|NCT02126839|582892237|FG000|Overall Study|Withdrawal by Subject|1|||
161411344|NCT02126839|582892238|FG001|Overall Study|Withdrawal by Subject|0|||
161411345|NCT02126839|582892237|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161411346|NCT02126839|582892238|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161411347|NCT02126839|582892237|FG000|Overall Study|Protocol Violation|2|||
161411348|NCT02126839|582892238|FG001|Overall Study|Protocol Violation|3|||
161411349|NCT02126839|582892237|FG000|Overall Study|Sponsor request|0|||
161411350|NCT02126839|582892238|FG001|Overall Study|Sponsor request|1|||
161411351|NCT02126839|582892237|FG000|Overall Study|Lost to Follow-up|1|||
161411352|NCT02126839|582892238|FG001|Overall Study|Lost to Follow-up|4|||
161411353|NCT02126839|582892237|FG000|Overall Study|Other|5|||
161411354|NCT02126839|582892238|FG001|Overall Study|Other|5|||
161411355|NCT00687531|582892241|FG000|Overall Study|Did not meet protocol eligibility|104|||
161411356|NCT00687531|582892241|FG000|Overall Study|Adverse Event|5|||
161411357|NCT00687531|582892241|FG000|Overall Study|Lost to Follow-up|26|||
161411358|NCT00666224|582893915|FG000|Double-Blind|Adverse Event|15|||
161411359|NCT00666224|582893916|FG001|Double-Blind|Adverse Event|5|||
161411360|NCT00666224|582893915|FG000|Double-Blind|Lost to Follow-up|2|||
161411361|NCT00666224|582893916|FG001|Double-Blind|Lost to Follow-up|2|||
161411362|NCT00666224|582893915|FG000|Double-Blind|Withdrawal by Subject|18|||
161411363|NCT00666224|582893916|FG001|Double-Blind|Withdrawal by Subject|14|||
161411364|NCT00666224|582893915|FG000|Double-Blind|Physician Decision|0|||
161411365|NCT00666224|582893916|FG001|Double-Blind|Physician Decision|3|||
161411366|NCT00666224|582893915|FG000|Double-Blind|Sponsor decision|1|||
161411367|NCT00666224|582893916|FG001|Double-Blind|Sponsor decision|0|||
161411368|NCT00666224|582893915|FG000|Double-Blind|Pregnancy|3|||
161411369|NCT00666224|582893916|FG001|Double-Blind|Pregnancy|2|||
161411370|NCT00666224|582893915|FG000|Double-Blind|Noncompliance|1|||
161411371|NCT00666224|582893916|FG001|Double-Blind|Noncompliance|0|||
161411372|NCT00666224|582893915|FG000|Double-Blind|Death|1|||
161411373|NCT00666224|582893916|FG001|Double-Blind|Death|0|||
161411374|NCT00666224|582893915|FG000|Double-Blind|Undefined/Unknown|4|||
161411375|NCT00666224|582893916|FG001|Double-Blind|Undefined/Unknown|1|||
161411376|NCT00666224|582893915|FG000|Open-Label|Adverse Event|8|||
161411377|NCT00666224|582893916|FG001|Open-Label|Adverse Event|43|||
161411378|NCT00666224|582893915|FG000|Open-Label|Lost to Follow-up|4|||
161411379|NCT00666224|582893916|FG001|Open-Label|Lost to Follow-up|5|||
161411380|NCT00666224|582893915|FG000|Open-Label|Withdrawal by Subject|12|||
161411381|NCT00666224|582893916|FG001|Open-Label|Withdrawal by Subject|25|||
161411382|NCT00666224|582893915|FG000|Open-Label|Physician Decision|7|||
161411383|NCT00666224|582893916|FG001|Open-Label|Physician Decision|5|||
161411384|NCT00666224|582893915|FG000|Open-Label|Pregnancy|1|||
161411385|NCT00666224|582893916|FG001|Open-Label|Pregnancy|5|||
161411386|NCT00666224|582893915|FG000|Open-Label|Noncompliance|2|||
161411387|NCT00666224|582893916|FG001|Open-Label|Noncompliance|1|||
161411388|NCT00666224|582893915|FG000|Open-Label|Undefined/Unknown|1|||
161411389|NCT00666224|582893916|FG001|Open-Label|Undefined/Unknown|1|||
161411390|NCT03521141|582893917|FG000|Overall Study|Death|1|||
161411391|NCT03521141|582893918|FG001|Overall Study|Death|0|||
161411392|NCT03521141|582893919|FG002|Overall Study|Death|1|||
161411393|NCT03828617|582893921|FG000|Overall Study|Lost to Follow-up|22|||
161411394|NCT03828617|582893922|FG001|Overall Study|Lost to Follow-up|12|||
161411395|NCT03828617|582893923|FG002|Overall Study|Lost to Follow-up|23|||
161411396|NCT03828617|582893924|FG003|Overall Study|Lost to Follow-up|7|||
161411397|NCT03828617|582893921|FG000|Overall Study|No longer met eligibility criteria|0|||
161411398|NCT03828617|582893922|FG001|Overall Study|No longer met eligibility criteria|1|||
161411399|NCT03828617|582893923|FG002|Overall Study|No longer met eligibility criteria|1|||
161411400|NCT03828617|582893924|FG003|Overall Study|No longer met eligibility criteria|3|||
161411401|NCT03828617|582893921|FG000|Overall Study|Protocol Violation|0|||
161411402|NCT03828617|582893922|FG001|Overall Study|Protocol Violation|2|||
161411403|NCT03828617|582893923|FG002|Overall Study|Protocol Violation|0|||
161411404|NCT03828617|582893924|FG003|Overall Study|Protocol Violation|0|||
161411405|NCT03828617|582893921|FG000|Overall Study|Withdrawal by Subject|2|||
161411406|NCT03828617|582893922|FG001|Overall Study|Withdrawal by Subject|0|||
161411407|NCT03828617|582893923|FG002|Overall Study|Withdrawal by Subject|2|||
161411408|NCT03828617|582893924|FG003|Overall Study|Withdrawal by Subject|0|||
161411409|NCT03354273|582893925|FG000|Overall Study|Adverse Event|5|||
161411410|NCT03354273|582893925|FG000|Overall Study|Screen Failure|21|||
161411411|NCT03354273|582893925|FG000|Overall Study|Withdrawal by Subject|34|||
161411412|NCT03354273|582893925|FG000|Overall Study|Technical Problems|30|||
161411413|NCT03354273|582893925|FG000|Overall Study|Lost to Follow-up|4|||
161411414|NCT03354273|582893925|FG000|Overall Study|Investigator Decision|3|||
161411415|NCT03354273|582893925|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
161411416|NCT03354273|582893925|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
161411417|NCT03354273|582893925|FG000|Overall Study|COVID-19 Restrictions|9|||
161411418|NCT03354273|582893925|FG000|Overall Study|Other|5|||
161411419|NCT00303485|582893926|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
161411420|NCT00303485|582893927|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
161411421|NCT00303485|582893926|FG000|Overall Study|Failure to return|0|||
161411422|NCT00303485|582893927|FG001|Overall Study|Failure to return|1|||
161411423|NCT00303485|582893926|FG000|Overall Study|Withdrawal by Subject|1|||
161411424|NCT00303485|582893927|FG001|Overall Study|Withdrawal by Subject|0|||
161411425|NCT00902174|582893933|FG000|Overall Study|Adverse Event|27|||
161411426|NCT00902174|582893934|FG001|Overall Study|Adverse Event|7|||
161411427|NCT00902174|582893933|FG000|Overall Study|Lack of Efficacy|1|||
161411428|NCT00902174|582893934|FG001|Overall Study|Lack of Efficacy|5|||
161411429|NCT00902174|582893933|FG000|Overall Study|Death|2|||
161411430|NCT00902174|582893934|FG001|Overall Study|Death|2|||
161411431|NCT00902174|582893933|FG000|Overall Study|Withdrawal by Subject|2|||
161411432|NCT00902174|582893934|FG001|Overall Study|Withdrawal by Subject|1|||
161411433|NCT00902174|582893933|FG000|Overall Study|Abnormal labs|1|||
161411434|NCT00902174|582893934|FG001|Overall Study|Abnormal labs|1|||
161411435|NCT00902174|582893933|FG000|Overall Study|Protocol Violation|1|||
161411436|NCT00902174|582893934|FG001|Overall Study|Protocol Violation|1|||
161411437|NCT00902174|582893933|FG000|Overall Study|Administration problem|0|||
161411438|NCT00902174|582893934|FG001|Overall Study|Administration problem|1|||
161411439|NCT00764673|582893935|FG000|Overall Study|Death|1|||
161411440|NCT00764673|582893935|FG000|Overall Study|Lost to Follow-up|3|||
161411441|NCT00764673|582893935|FG000|Overall Study|Withdrawal by Subject|6|||
161411442|NCT00764673|582893935|FG000|Overall Study|Revision of Device|2|||
161411443|NCT01331291|582893936|FG000|Overall Study|Lack of Efficacy|2|||
161411444|NCT01331291|582893937|FG001|Overall Study|Lack of Efficacy|8|||
161411445|NCT01331291|582893936|FG000|Overall Study|Death|0|||
161411446|NCT01331291|582893937|FG001|Overall Study|Death|1|||
161411447|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
161411448|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
161411449|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
161411450|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
161411451|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
161411452|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
161411453|NCT01389323|582893943|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
161411454|NCT01389323|582893943|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
161411455|NCT01389323|582893943|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
161411456|NCT01389323|582893943|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
161411457|NCT01389323|582893943|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
161411458|NCT01805037|582893945|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
161411459|NCT01805037|582893946|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
161411460|NCT01805037|582893945|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
161411461|NCT01805037|582893946|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
161411462|NCT01805037|582893945|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
161411463|NCT01805037|582893946|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
161411464|NCT01805037|582893945|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
161411465|NCT01805037|582893946|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
161411466|NCT01805037|582893945|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
161411467|NCT01805037|582893946|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
161411468|NCT01805037|582893945|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
161411469|NCT01805037|582893946|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
161411470|NCT01805037|582893945|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
161411471|NCT01805037|582893946|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
161411472|NCT01805037|582893945|FG000|Follow Up (up to 3 Years)|Death|0|||
161411473|NCT01805037|582893946|FG001|Follow Up (up to 3 Years)|Death|2|||
161411474|NCT01805037|582893945|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
161411475|NCT01805037|582893946|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
161411476|NCT01805037|582893945|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
161411477|NCT01805037|582893946|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
161411478|NCT01270256|582893947|FG000|Overall Study|Withdrawal by Subject|1|||
161411479|NCT01270256|582893948|FG001|Overall Study|Withdrawal by Subject|0|||
161411480|NCT04566692|582893952|FG000|Overall Study|Adverse Event|2|||
161411481|NCT04566692|582893953|FG001|Overall Study|Adverse Event|0|||
161411482|NCT04566692|582893952|FG000|Overall Study|Withdrawal by Subject|1|||
161411483|NCT04566692|582893953|FG001|Overall Study|Withdrawal by Subject|1|||
161411484|NCT01183468|582893954|FG000|Overall Study|Lost to Follow-up|2|||
161411485|NCT01183468|582893955|FG001|Overall Study|Lost to Follow-up|1|||
161411486|NCT01183468|582893956|FG002|Overall Study|Lost to Follow-up|0|||
161411487|NCT01183468|582893957|FG003|Overall Study|Lost to Follow-up|0|||
161411488|NCT01183468|582893954|FG000|Overall Study|Physician Decision|1|||
161411489|NCT01183468|582893955|FG001|Overall Study|Physician Decision|0|||
161411490|NCT01183468|582893956|FG002|Overall Study|Physician Decision|0|||
161411491|NCT01183468|582893957|FG003|Overall Study|Physician Decision|0|||
161411492|NCT01183468|582893954|FG000|Overall Study|Withdrawal by Subject|0|||
161411493|NCT01183468|582893955|FG001|Overall Study|Withdrawal by Subject|1|||
161411494|NCT01183468|582893956|FG002|Overall Study|Withdrawal by Subject|0|||
161411495|NCT01183468|582893957|FG003|Overall Study|Withdrawal by Subject|0|||
161411496|NCT00590577|582893958|FG000|Overall Study|Lack of Efficacy|31|||
161411497|NCT00590577|582893959|FG001|Overall Study|Lack of Efficacy|28|||
161411498|NCT00590577|582893960|FG002|Overall Study|Lack of Efficacy|23|||
161411499|NCT00590577|582893961|FG003|Overall Study|Lack of Efficacy|45|||
161411500|NCT00590577|582893958|FG000|Overall Study|Withdrawal by Subject|23|||
161411501|NCT00590577|582893959|FG001|Overall Study|Withdrawal by Subject|28|||
161411502|NCT00590577|582893960|FG002|Overall Study|Withdrawal by Subject|30|||
161411503|NCT00590577|582893961|FG003|Overall Study|Withdrawal by Subject|26|||
161411504|NCT00590577|582893958|FG000|Overall Study|Adverse Event|10|||
161411505|NCT00590577|582893959|FG001|Overall Study|Adverse Event|10|||
161411506|NCT00590577|582893960|FG002|Overall Study|Adverse Event|13|||
161411507|NCT00590577|582893961|FG003|Overall Study|Adverse Event|11|||
161411508|NCT00590577|582893958|FG000|Overall Study|Lost to Follow-up|12|||
161411509|NCT00590577|582893959|FG001|Overall Study|Lost to Follow-up|6|||
161411510|NCT00590577|582893960|FG002|Overall Study|Lost to Follow-up|6|||
161411511|NCT00590577|582893961|FG003|Overall Study|Lost to Follow-up|9|||
161411512|NCT00590577|582893958|FG000|Overall Study|Pregnancy|0|||
161411513|NCT00590577|582893959|FG001|Overall Study|Pregnancy|1|||
161411514|NCT00590577|582893960|FG002|Overall Study|Pregnancy|0|||
161411515|NCT00590577|582893961|FG003|Overall Study|Pregnancy|0|||
161411516|NCT00590577|582893958|FG000|Overall Study|Various reasons|1|||
161411517|NCT00590577|582893959|FG001|Overall Study|Various reasons|3|||
161411518|NCT00590577|582893960|FG002|Overall Study|Various reasons|1|||
161411519|NCT00590577|582893961|FG003|Overall Study|Various reasons|2|||
161411520|NCT03927404|582893963|FG000|Overall Study|Withdrawal by Subject|1|||
161411521|NCT01229449|582893964|FG000|Overall Study|Withdrawal by Subject|0|||
161411522|NCT01229449|582893965|FG001|Overall Study|Withdrawal by Subject|3|||
161411523|NCT01229449|582893966|FG002|Overall Study|Withdrawal by Subject|0|||
161411524|NCT01229449|582893967|FG003|Overall Study|Withdrawal by Subject|1|||
161411525|NCT01229449|582893968|FG004|Overall Study|Withdrawal by Subject|1|||
161411526|NCT01229449|582893964|FG000|Overall Study|Lost to Follow-up|1|||
161411527|NCT01229449|582893965|FG001|Overall Study|Lost to Follow-up|1|||
161411528|NCT01229449|582893966|FG002|Overall Study|Lost to Follow-up|1|||
161411529|NCT01229449|582893967|FG003|Overall Study|Lost to Follow-up|0|||
161411530|NCT01229449|582893968|FG004|Overall Study|Lost to Follow-up|0|||
161411531|NCT01229449|582893964|FG000|Overall Study|Physician Decision|0|||
161411532|NCT01229449|582893965|FG001|Overall Study|Physician Decision|0|||
161411533|NCT01229449|582893966|FG002|Overall Study|Physician Decision|1|||
161411534|NCT01229449|582893967|FG003|Overall Study|Physician Decision|0|||
161411535|NCT01229449|582893968|FG004|Overall Study|Physician Decision|0|||
161411536|NCT03203291|582893972|FG000|Overall Study|Withdrawal by Subject|1|||
161411537|NCT01300260|582893973|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
161411538|NCT01300260|582893974|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
161411539|NCT01300260|582893973|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
161411540|NCT01300260|582893974|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
161411541|NCT01300260|582893973|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
161411542|NCT01300260|582893974|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
161411543|NCT05098509|582893980|FG000|Overall Study|Withdrawal by Subject|0|||
161411544|NCT05098509|582893981|FG001|Overall Study|Withdrawal by Subject|0|||
161411545|NCT05098509|582893982|FG002|Overall Study|Withdrawal by Subject|1|||
161411546|NCT05098509|582893983|FG003|Overall Study|Withdrawal by Subject|0|||
161411547|NCT05098509|582893980|FG000|Overall Study|Early study termination|1|||
161411548|NCT05098509|582893981|FG001|Overall Study|Early study termination|1|||
161411549|NCT05098509|582893982|FG002|Overall Study|Early study termination|1|||
161411550|NCT05098509|582893983|FG003|Overall Study|Early study termination|0|||
161411551|NCT01147848|582893984|FG000|Run-in Period|Screen Failure|623|||
161411552|NCT01147848|582893985|FG001|Run-in Period|Screen Failure|0|||
161411553|NCT01147848|582893986|FG002|Run-in Period|Screen Failure|0|||
161411554|NCT01147848|582893984|FG000|Run-in Period|Run-in Failure|135|||
161411555|NCT01147848|582893985|FG001|Run-in Period|Run-in Failure|0|||
161411556|NCT01147848|582893986|FG002|Run-in Period|Run-in Failure|0|||
161411557|NCT01147848|582893984|FG000|Randomized Phase|Adverse Event|0|||
161411558|NCT01147848|582893985|FG001|Randomized Phase|Adverse Event|6|||
161411559|NCT01147848|582893986|FG002|Randomized Phase|Adverse Event|8|||
161411560|NCT01147848|582893984|FG000|Randomized Phase|Lack of Efficacy|0|||
161411561|NCT01147848|582893985|FG001|Randomized Phase|Lack of Efficacy|20|||
161411562|NCT01147848|582893986|FG002|Randomized Phase|Lack of Efficacy|11|||
161411563|NCT01147848|582893984|FG000|Randomized Phase|Protocol Violation|0|||
161411564|NCT01147848|582893985|FG001|Randomized Phase|Protocol Violation|7|||
161411565|NCT01147848|582893986|FG002|Randomized Phase|Protocol Violation|10|||
161411566|NCT01147848|582893984|FG000|Randomized Phase|Lost to Follow-up|0|||
161411567|NCT01147848|582893985|FG001|Randomized Phase|Lost to Follow-up|5|||
161411568|NCT01147848|582893986|FG002|Randomized Phase|Lost to Follow-up|7|||
161411569|NCT01147848|582893984|FG000|Randomized Phase|Physician Decision|0|||
161411570|NCT01147848|582893985|FG001|Randomized Phase|Physician Decision|0|||
161411571|NCT01147848|582893986|FG002|Randomized Phase|Physician Decision|1|||
161411572|NCT01147848|582893984|FG000|Randomized Phase|Withdrawal by Subject|0|||
161411573|NCT01147848|582893985|FG001|Randomized Phase|Withdrawal by Subject|7|||
161411574|NCT01147848|582893986|FG002|Randomized Phase|Withdrawal by Subject|9|||
161411575|NCT04033068|582893987|FG000|Overall Study|Withdrawal by Subject|0|||
161411576|NCT04033068|582893988|FG001|Overall Study|Withdrawal by Subject|0|||
161411577|NCT04033068|582893989|FG002|Overall Study|Withdrawal by Subject|1|||
161411578|NCT04033068|582893990|FG003|Overall Study|Withdrawal by Subject|0|||
161411579|NCT04033068|582893987|FG000|Overall Study|Lost to Follow-up|0|||
161411580|NCT04033068|582893988|FG001|Overall Study|Lost to Follow-up|1|||
161411581|NCT04033068|582893989|FG002|Overall Study|Lost to Follow-up|0|||
161411582|NCT04033068|582893990|FG003|Overall Study|Lost to Follow-up|0|||
161411583|NCT04033068|582893987|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161411584|NCT04033068|582893988|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161411585|NCT04033068|582893989|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161411586|NCT04033068|582893990|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
161411587|NCT03157037|582893993|FG000|Overall Study|Death|1|||
161411588|NCT00324233|582893994|FG000|First Period|unable to insert catheter|1|||
161411589|NCT00324233|582893995|FG001|First Period|unable to insert catheter|0|||
161411590|NCT00324233|582893994|FG000|Second Period|unable to insert catheter|1|||
161411591|NCT00324233|582893995|FG001|Second Period|unable to insert catheter|1|||
161411592|NCT00324233|582893994|FG000|Second Period|Protocol Violation|4|||
161411593|NCT00324233|582893995|FG001|Second Period|Protocol Violation|6|||
161411594|NCT01972789|582893996|FG000|Overall Study|Adverse Event|11|||
161411595|NCT01972789|582893997|FG001|Overall Study|Adverse Event|4|||
161411596|NCT01972789|582893996|FG000|Overall Study|Subject withdrew consent|14|||
161411597|NCT01972789|582893997|FG001|Overall Study|Subject withdrew consent|12|||
161411598|NCT01972789|582893996|FG000|Overall Study|Lost to Follow-up|4|||
161411599|NCT01972789|582893997|FG001|Overall Study|Lost to Follow-up|7|||
161411600|NCT01972789|582893996|FG000|Overall Study|Death|7|||
161411601|NCT01972789|582893997|FG001|Overall Study|Death|5|||
161411602|NCT01972789|582893996|FG000|Overall Study|Protocol deviation|1|||
161411603|NCT01972789|582893997|FG001|Overall Study|Protocol deviation|0|||
161411604|NCT01972789|582893996|FG000|Overall Study|Physician Decision|3|||
161411605|NCT01972789|582893997|FG001|Overall Study|Physician Decision|2|||
161411606|NCT03596450|582894003|FG000|Overall Study|Death|9|||
161411607|NCT03596450|582894004|FG001|Overall Study|Death|9|||
161411608|NCT03596450|582894003|FG000|Overall Study|Protocol Violation|18|||
161411609|NCT03596450|582894004|FG001|Overall Study|Protocol Violation|26|||
161411610|NCT03596450|582894003|FG000|Overall Study|Lost to Follow-up|50|||
161411611|NCT03596450|582894004|FG001|Overall Study|Lost to Follow-up|56|||
161411612|NCT03596450|582894003|FG000|Overall Study|Adverse Event|14|||
161411613|NCT03596450|582894004|FG001|Overall Study|Adverse Event|7|||
161411614|NCT03596450|582894003|FG000|Overall Study|Withdrawal by Subject|38|||
161411615|NCT03596450|582894004|FG001|Overall Study|Withdrawal by Subject|36|||
161411616|NCT03596450|582894003|FG000|Overall Study|Accidentally Randomized|2|||
161411617|NCT03596450|582894004|FG001|Overall Study|Accidentally Randomized|0|||
161411618|NCT03596450|582894003|FG000|Overall Study|Other reasons|48|||
161411619|NCT03596450|582894004|FG001|Overall Study|Other reasons|53|||
161411620|NCT03596450|582894003|FG000|Overall Study|Pregnancy|2|||
161411621|NCT03596450|582894004|FG001|Overall Study|Pregnancy|0|||
161411622|NCT00498355|582894005|FG000|Overall Study|Lost to Follow-up|1|||
161411623|NCT03262441|582894016|FG000|Overall Study|Withdrawal by Subject|1|||
161411624|NCT02607228|582894017|FG000|Overall Study|Progressive Disease|4|||
161411625|NCT02607228|582894018|FG001|Overall Study|Progressive Disease|3|||
161411626|NCT02607228|582894019|FG002|Overall Study|Progressive Disease|1|||
161411627|NCT02607228|582894020|FG003|Overall Study|Progressive Disease|5|||
161411628|NCT02607228|582894021|FG004|Overall Study|Progressive Disease|4|||
161411629|NCT02607228|582894022|FG005|Overall Study|Progressive Disease|3|||
161411630|NCT02607228|582894023|FG006|Overall Study|Progressive Disease|1|||
161411631|NCT02607228|582894017|FG000|Overall Study|Adverse Event|1|||
161411632|NCT02607228|582894018|FG001|Overall Study|Adverse Event|0|||
161411633|NCT02607228|582894019|FG002|Overall Study|Adverse Event|1|||
161411634|NCT02607228|582894020|FG003|Overall Study|Adverse Event|0|||
161411635|NCT02607228|582894021|FG004|Overall Study|Adverse Event|1|||
161411636|NCT02607228|582894022|FG005|Overall Study|Adverse Event|1|||
161411637|NCT02607228|582894023|FG006|Overall Study|Adverse Event|1|||
161411638|NCT02607228|582894017|FG000|Overall Study|Investigator's Discretion|0|||
161411639|NCT02607228|582894018|FG001|Overall Study|Investigator's Discretion|0|||
161411640|NCT02607228|582894019|FG002|Overall Study|Investigator's Discretion|1|||
161411641|NCT02607228|582894020|FG003|Overall Study|Investigator's Discretion|0|||
161411642|NCT02607228|582894021|FG004|Overall Study|Investigator's Discretion|0|||
161411643|NCT02607228|582894022|FG005|Overall Study|Investigator's Discretion|1|||
161411644|NCT02607228|582894023|FG006|Overall Study|Investigator's Discretion|0|||
161411645|NCT02607228|582894017|FG000|Overall Study|Withdrew Consent|0|||
161411646|NCT02607228|582894018|FG001|Overall Study|Withdrew Consent|1|||
161411647|NCT02607228|582894019|FG002|Overall Study|Withdrew Consent|0|||
161411648|NCT02607228|582894020|FG003|Overall Study|Withdrew Consent|0|||
161411649|NCT02607228|582894021|FG004|Overall Study|Withdrew Consent|0|||
161411650|NCT02607228|582894022|FG005|Overall Study|Withdrew Consent|1|||
161411651|NCT02607228|582894023|FG006|Overall Study|Withdrew Consent|0|||
161411652|NCT02607228|582894017|FG000|Overall Study|Study Terminated by Sponsor|0|||
161411653|NCT02607228|582894018|FG001|Overall Study|Study Terminated by Sponsor|0|||
161411654|NCT02607228|582894019|FG002|Overall Study|Study Terminated by Sponsor|0|||
161411655|NCT02607228|582894020|FG003|Overall Study|Study Terminated by Sponsor|1|||
161411656|NCT02607228|582894021|FG004|Overall Study|Study Terminated by Sponsor|0|||
161411657|NCT02607228|582894022|FG005|Overall Study|Study Terminated by Sponsor|0|||
161411658|NCT02607228|582894023|FG006|Overall Study|Study Terminated by Sponsor|0|||
161411659|NCT03235089|582894024|FG000|Overall Study|Lost to Follow-up|1|||
161411660|NCT03235089|582894025|FG001|Overall Study|Lost to Follow-up|1|||
161411661|NCT03235089|582894024|FG000|Overall Study|Physician Decision|2|||
161411662|NCT03235089|582894025|FG001|Overall Study|Physician Decision|2|||
161411663|NCT03238924|582894035|FG000|Overall Study|Withdrawal by Subject|2|||
161411664|NCT03238924|582894036|FG001|Overall Study|Withdrawal by Subject|2|||
161411665|NCT03576716|582894039|FG000|Overall Study|Withdrawal by Subject|0|||
161411666|NCT03576716|582894040|FG001|Overall Study|Withdrawal by Subject|1|||
161411667|NCT00559988|582894041|FG000|Overall Study|Death|147|||
161411668|NCT00559988|582894042|FG001|Overall Study|Death|140|||
161411669|NCT00559988|582894041|FG000|Overall Study|Withdrawal by Subject|152|||
161411670|NCT00559988|582894042|FG001|Overall Study|Withdrawal by Subject|139|||
161411671|NCT00559988|582894041|FG000|Overall Study|Lost to Follow-up|42|||
161411672|NCT00559988|582894042|FG001|Overall Study|Lost to Follow-up|56|||
161411673|NCT00559988|582894041|FG000|Overall Study|ICD device explanted|10|||
161411674|NCT00559988|582894042|FG001|Overall Study|ICD device explanted|17|||
161411675|NCT02891382|582894043|FG000|Overall Study|Lost to Follow-up|3|||
161411676|NCT02891382|582894044|FG001|Overall Study|Lost to Follow-up|4|||
161411677|NCT02891382|582894045|FG002|Overall Study|Lost to Follow-up|5|||
161411678|NCT02891382|582894046|FG003|Overall Study|Lost to Follow-up|3|||
161411679|NCT02891382|582894047|FG004|Overall Study|Lost to Follow-up|4|||
161411680|NCT02516228|582894048|FG000|Overall Study|Lost to Follow-up|1|||
161411681|NCT02516228|582894048|FG000|Overall Study|Withdrawal by Subject|1|||
161411682|NCT02516228|582894048|FG000|Overall Study|Physician Decision|1|||
161411683|NCT03916484|582894049|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161411684|NCT03916484|582894050|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
161411685|NCT03916484|582894051|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161411686|NCT03916484|582894052|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161411687|NCT03916484|582894049|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
161411688|NCT03916484|582894050|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
161411689|NCT03916484|582894051|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
161411690|NCT03916484|582894052|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
161411691|NCT02292706|582894054|FG000|Overall Study|Lost to Follow-up|20|||
161411692|NCT02292706|582894055|FG001|Overall Study|Lost to Follow-up|44|||
161411693|NCT02292706|582894056|FG002|Overall Study|Lost to Follow-up|24|||
161411694|NCT02292706|582894057|FG003|Overall Study|Lost to Follow-up|61|||
161411695|NCT02292706|582894058|FG004|Overall Study|Lost to Follow-up|21|||
161411696|NCT02292706|582894059|FG005|Overall Study|Lost to Follow-up|52|||
161411697|NCT02292706|582894060|FG006|Overall Study|Lost to Follow-up|25|||
161411698|NCT02292706|582894061|FG007|Overall Study|Lost to Follow-up|0|||
161411699|NCT02292706|582894054|FG000|Overall Study|Withdrew consent|15|||
161411700|NCT02292706|582894055|FG001|Overall Study|Withdrew consent|56|||
161411701|NCT02292706|582894056|FG002|Overall Study|Withdrew consent|43|||
161411702|NCT02292706|582894057|FG003|Overall Study|Withdrew consent|36|||
161411703|NCT02292706|582894058|FG004|Overall Study|Withdrew consent|13|||
161411704|NCT02292706|582894059|FG005|Overall Study|Withdrew consent|51|||
161411705|NCT02292706|582894060|FG006|Overall Study|Withdrew consent|20|||
161411706|NCT02292706|582894061|FG007|Overall Study|Withdrew consent|0|||
161411707|NCT02292706|582894054|FG000|Overall Study|Death|3|||
161411708|NCT02292706|582894055|FG001|Overall Study|Death|11|||
161411709|NCT02292706|582894056|FG002|Overall Study|Death|16|||
161411710|NCT02292706|582894057|FG003|Overall Study|Death|22|||
161411711|NCT02292706|582894058|FG004|Overall Study|Death|8|||
161411712|NCT02292706|582894059|FG005|Overall Study|Death|17|||
161411713|NCT02292706|582894060|FG006|Overall Study|Death|3|||
161411714|NCT02292706|582894061|FG007|Overall Study|Death|0|||
161411715|NCT02292706|582894054|FG000|Overall Study|Study terminated by sponsor|0|||
161411716|NCT02292706|582894055|FG001|Overall Study|Study terminated by sponsor|9|||
161411717|NCT02292706|582894056|FG002|Overall Study|Study terminated by sponsor|4|||
161411718|NCT02292706|582894057|FG003|Overall Study|Study terminated by sponsor|21|||
161411719|NCT02292706|582894058|FG004|Overall Study|Study terminated by sponsor|11|||
161411720|NCT02292706|582894059|FG005|Overall Study|Study terminated by sponsor|13|||
161411721|NCT02292706|582894060|FG006|Overall Study|Study terminated by sponsor|3|||
161411722|NCT02292706|582894061|FG007|Overall Study|Study terminated by sponsor|0|||
161411723|NCT02292706|582894054|FG000|Overall Study|Investigator's discretion|4|||
161411724|NCT02292706|582894055|FG001|Overall Study|Investigator's discretion|9|||
161411725|NCT02292706|582894056|FG002|Overall Study|Investigator's discretion|7|||
161411726|NCT02292706|582894057|FG003|Overall Study|Investigator's discretion|11|||
161411727|NCT02292706|582894058|FG004|Overall Study|Investigator's discretion|4|||
161411728|NCT02292706|582894059|FG005|Overall Study|Investigator's discretion|10|||
161411729|NCT02292706|582894060|FG006|Overall Study|Investigator's discretion|1|||
161411730|NCT02292706|582894061|FG007|Overall Study|Investigator's discretion|0|||
161411731|NCT02292706|582894054|FG000|Overall Study|Liver transplant|1|||
161411732|NCT02292706|582894055|FG001|Overall Study|Liver transplant|1|||
161411733|NCT02292706|582894056|FG002|Overall Study|Liver transplant|11|||
161411734|NCT02292706|582894057|FG003|Overall Study|Liver transplant|16|||
161411735|NCT02292706|582894058|FG004|Overall Study|Liver transplant|5|||
161411736|NCT02292706|582894059|FG005|Overall Study|Liver transplant|6|||
161411737|NCT02292706|582894060|FG006|Overall Study|Liver transplant|5|||
161411738|NCT02292706|582894061|FG007|Overall Study|Liver transplant|0|||
161411739|NCT02292706|582894054|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
161411740|NCT02292706|582894055|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
161411741|NCT02292706|582894056|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
161411742|NCT02292706|582894057|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
161411743|NCT02292706|582894058|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
161411744|NCT02292706|582894059|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
161411745|NCT02292706|582894060|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
161411746|NCT02292706|582894061|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
161411747|NCT02292706|582894054|FG000|Overall Study|Subject terminated by sponsor|1|||
161411748|NCT02292706|582894055|FG001|Overall Study|Subject terminated by sponsor|0|||
161411749|NCT02292706|582894056|FG002|Overall Study|Subject terminated by sponsor|0|||
161411750|NCT02292706|582894057|FG003|Overall Study|Subject terminated by sponsor|2|||
161411751|NCT02292706|582894058|FG004|Overall Study|Subject terminated by sponsor|1|||
161411752|NCT02292706|582894059|FG005|Overall Study|Subject terminated by sponsor|0|||
161411753|NCT02292706|582894060|FG006|Overall Study|Subject terminated by sponsor|0|||
161411754|NCT02292706|582894061|FG007|Overall Study|Subject terminated by sponsor|0|||
161411755|NCT02292706|582894054|FG000|Overall Study|Missing|0|||
161411756|NCT02292706|582894055|FG001|Overall Study|Missing|0|||
161411757|NCT02292706|582894056|FG002|Overall Study|Missing|1|||
161411758|NCT02292706|582894057|FG003|Overall Study|Missing|1|||
161411759|NCT02292706|582894058|FG004|Overall Study|Missing|0|||
161411760|NCT02292706|582894059|FG005|Overall Study|Missing|1|||
161411761|NCT02292706|582894060|FG006|Overall Study|Missing|0|||
161411762|NCT02292706|582894061|FG007|Overall Study|Missing|0|||
161411763|NCT02292706|582894054|FG000|Overall Study|Virologic relapse or reinfection|1|||
161411764|NCT02292706|582894055|FG001|Overall Study|Virologic relapse or reinfection|0|||
161411765|NCT02292706|582894056|FG002|Overall Study|Virologic relapse or reinfection|0|||
161411766|NCT02292706|582894057|FG003|Overall Study|Virologic relapse or reinfection|1|||
161411767|NCT02292706|582894058|FG004|Overall Study|Virologic relapse or reinfection|0|||
161411768|NCT02292706|582894059|FG005|Overall Study|Virologic relapse or reinfection|1|||
161411769|NCT02292706|582894060|FG006|Overall Study|Virologic relapse or reinfection|0|||
161411770|NCT02292706|582894061|FG007|Overall Study|Virologic relapse or reinfection|0|||
161411771|NCT01990612|582894066|FG000|Overall Study|Lost to Follow-up|2|||
161411772|NCT01990612|582894067|FG001|Overall Study|Lost to Follow-up|1|||
161411773|NCT01990612|582894066|FG000|Overall Study|Withdrawal by Subject|5|||
161411774|NCT01990612|582894067|FG001|Overall Study|Withdrawal by Subject|2|||
161411775|NCT02725866|582894068|FG000|Overall Study|Failure to return|6|||
161411776|NCT02725866|582894068|FG000|Overall Study|Withdrew consent|3|||
161411777|NCT02725866|582894068|FG000|Overall Study|Insufficient virological response|1|||
161411778|NCT02725866|582894068|FG000|Overall Study|Other, not specified|4|||
161411779|NCT02188849|582894071|FG000|Overall Study|Lost to Follow-up|3|||
161411780|NCT02188849|582894072|FG001|Overall Study|Lost to Follow-up|8|||
161411781|NCT02980133|582894074|FG000|Overall Study|Other than specified|1|||
161411782|NCT02980133|582894075|FG001|Overall Study|Other than specified|1|||
161411783|NCT02980133|582894076|FG002|Overall Study|Other than specified|2|||
161411784|NCT02980133|582894077|FG003|Overall Study|Other than specified|2|||
161411785|NCT02980133|582894074|FG000|Overall Study|Lost to Follow-up|0|||
161411786|NCT02980133|582894075|FG001|Overall Study|Lost to Follow-up|0|||
161411787|NCT02980133|582894076|FG002|Overall Study|Lost to Follow-up|1|||
161411788|NCT02980133|582894077|FG003|Overall Study|Lost to Follow-up|3|||
161411789|NCT02980133|582894074|FG000|Overall Study|Protocol Violation|0|||
161411790|NCT02980133|582894075|FG001|Overall Study|Protocol Violation|1|||
161411791|NCT02980133|582894076|FG002|Overall Study|Protocol Violation|0|||
161411792|NCT02980133|582894077|FG003|Overall Study|Protocol Violation|0|||
161411793|NCT02980133|582894074|FG000|Overall Study|Withdrawal by parent/guardian|6|||
161411794|NCT02980133|582894075|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161411795|NCT02980133|582894076|FG002|Overall Study|Withdrawal by parent/guardian|3|||
161411796|NCT02980133|582894077|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161411797|NCT02980133|582894074|FG000|Overall Study|Withdrawal by Subject|0|||
161411798|NCT02980133|582894075|FG001|Overall Study|Withdrawal by Subject|0|||
161411799|NCT02980133|582894076|FG002|Overall Study|Withdrawal by Subject|1|||
161411800|NCT02980133|582894077|FG003|Overall Study|Withdrawal by Subject|0|||
161411801|NCT03208088|582894085|FG000|Period 2|Withdrawal by Subject|0|||
161411802|NCT03208088|582894086|FG001|Period 2|Withdrawal by Subject|0|||
161411803|NCT03208088|582894087|FG002|Period 2|Withdrawal by Subject|0|||
161411804|NCT03208088|582894088|FG003|Period 2|Withdrawal by Subject|0|||
161411805|NCT03208088|582894089|FG004|Period 2|Withdrawal by Subject|0|||
161411806|NCT03208088|582894090|FG005|Period 2|Withdrawal by Subject|0|||
161411807|NCT03208088|582894091|FG006|Period 2|Withdrawal by Subject|0|||
161411808|NCT03208088|582894092|FG007|Period 2|Withdrawal by Subject|0|||
161411809|NCT03208088|582894093|FG008|Period 2|Withdrawal by Subject|1|||
161411810|NCT03208088|582894094|FG009|Period 2|Withdrawal by Subject|0|||
161411811|NCT03208088|582894085|FG000|Period 3|Unsatisfactory Test Article|0|||
161411812|NCT03208088|582894086|FG001|Period 3|Unsatisfactory Test Article|0|||
161411813|NCT03208088|582894087|FG002|Period 3|Unsatisfactory Test Article|0|||
161411814|NCT03208088|582894088|FG003|Period 3|Unsatisfactory Test Article|1|||
161411815|NCT03208088|582894089|FG004|Period 3|Unsatisfactory Test Article|0|||
161411816|NCT03208088|582894090|FG005|Period 3|Unsatisfactory Test Article|0|||
161411817|NCT03208088|582894091|FG006|Period 3|Unsatisfactory Test Article|0|||
161411818|NCT03208088|582894092|FG007|Period 3|Unsatisfactory Test Article|0|||
161411819|NCT03208088|582894093|FG008|Period 3|Unsatisfactory Test Article|0|||
161411820|NCT03208088|582894094|FG009|Period 3|Unsatisfactory Test Article|0|||
161411821|NCT03208088|582894085|FG000|Period 4|Unsatisfactory Test Article|0|||
161411822|NCT03208088|582894086|FG001|Period 4|Unsatisfactory Test Article|0|||
161411823|NCT03208088|582894087|FG002|Period 4|Unsatisfactory Test Article|0|||
161411824|NCT03208088|582894088|FG003|Period 4|Unsatisfactory Test Article|1|||
161411825|NCT03208088|582894089|FG004|Period 4|Unsatisfactory Test Article|0|||
161411826|NCT03208088|582894090|FG005|Period 4|Unsatisfactory Test Article|0|||
161411827|NCT03208088|582894091|FG006|Period 4|Unsatisfactory Test Article|0|||
161411828|NCT03208088|582894092|FG007|Period 4|Unsatisfactory Test Article|0|||
161411829|NCT03208088|582894093|FG008|Period 4|Unsatisfactory Test Article|0|||
161411830|NCT03208088|582894094|FG009|Period 4|Unsatisfactory Test Article|0|||
161411831|NCT01108523|582894099|FG000|Overall Study|Protocol Violation|4|||
161411832|NCT00547521|582894100|FG000|Short Term Study (4 Months)|Adverse Event|1|||
161411833|NCT00547521|582894101|FG001|Short Term Study (4 Months)|Adverse Event|0|||
161411834|NCT00547521|582894100|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
161411835|NCT00547521|582894101|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
161411836|NCT00547521|582894100|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
161411837|NCT00547521|582894101|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
161411838|NCT00547521|582894100|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
161411839|NCT00547521|582894101|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
161411840|NCT00547521|582894100|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
161411841|NCT00547521|582894101|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
161411842|NCT00547521|582894100|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
161411843|NCT00547521|582894101|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
161411844|NCT00547521|582894100|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
161411845|NCT00547521|582894101|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
161411846|NCT00547521|582894100|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
161411847|NCT00547521|582894101|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
161411848|NCT00547521|582894100|FG000|Long Term Extension (LTE) Study|Other|0|||
161411849|NCT00547521|582894101|FG001|Long Term Extension (LTE) Study|Other|2|||
161411850|NCT00547521|582894100|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
161411851|NCT00547521|582894101|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
161411852|NCT00705367|582896054|FG000|Long-term Extension Period|Adverse Event|2|||
161411853|NCT00705367|582896055|FG001|Long-term Extension Period|Adverse Event|0|||
161411854|NCT00705367|582896054|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
161411855|NCT00705367|582896055|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
161411856|NCT00705367|582896054|FG000|Long-term Extension Period|Lack of Efficacy|1|||
161411857|NCT00705367|582896055|FG001|Long-term Extension Period|Lack of Efficacy|0|||
161411858|NCT00705367|582896054|FG000|Long-term Extension Period|No longer met study criteria|1|||
161411859|NCT00705367|582896055|FG001|Long-term Extension Period|No longer met study criteria|0|||
161411860|NCT00705367|582896054|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
161411861|NCT00705367|582896055|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
161411862|NCT01832155|582896059|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
161411863|NCT01832155|582896060|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
161411864|NCT01832155|582896059|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
161411865|NCT01832155|582896060|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
161411866|NCT01279616|582896061|FG000|Overall Study|donor could not be located|5|||
161411867|NCT01279616|582896061|FG000|Overall Study|no signs of sickle cell disease|2|||
161411868|NCT00842543|582896064|FG000|Overall Study|Withdrawal by Subject|2|||
161411869|NCT00842543|582896065|FG001|Overall Study|Withdrawal by Subject|0|||
161411870|NCT00842543|582896066|FG002|Overall Study|Withdrawal by Subject|3|||
161411871|NCT00842543|582896067|FG003|Overall Study|Withdrawal by Subject|4|||
161411872|NCT01483183|582896072|FG000|Overall Study|Physician Decision|0|||
161411873|NCT01483183|582896073|FG001|Overall Study|Physician Decision|0|||
161411874|NCT01483183|582896074|FG002|Overall Study|Physician Decision|0|||
161411875|NCT01483183|582896075|FG003|Overall Study|Physician Decision|0|||
161411876|NCT01483183|582896076|FG004|Overall Study|Physician Decision|0|||
161411877|NCT01483183|582896077|FG005|Overall Study|Physician Decision|0|||
161411878|NCT01483183|582896078|FG006|Overall Study|Physician Decision|2|||
161411879|NCT01483183|582896079|FG007|Overall Study|Physician Decision|0|||
161411880|NCT01483183|582896080|FG008|Overall Study|Physician Decision|0|||
161411881|NCT01483183|582896081|FG009|Overall Study|Physician Decision|0|||
161411882|NCT01483183|582896072|FG000|Overall Study|Withdrawal by Subject|0|||
161411883|NCT01483183|582896073|FG001|Overall Study|Withdrawal by Subject|0|||
161411884|NCT01483183|582896074|FG002|Overall Study|Withdrawal by Subject|0|||
161411885|NCT01483183|582896075|FG003|Overall Study|Withdrawal by Subject|0|||
161411886|NCT01483183|582896076|FG004|Overall Study|Withdrawal by Subject|0|||
161411887|NCT01483183|582896077|FG005|Overall Study|Withdrawal by Subject|0|||
161411888|NCT01483183|582896078|FG006|Overall Study|Withdrawal by Subject|0|||
161411889|NCT01483183|582896079|FG007|Overall Study|Withdrawal by Subject|0|||
161411890|NCT01483183|582896080|FG008|Overall Study|Withdrawal by Subject|0|||
161411891|NCT01483183|582896081|FG009|Overall Study|Withdrawal by Subject|1|||
161411892|NCT00239928|582896082|FG000|Overall Study|Lack of Efficacy|1|||
161411893|NCT00239928|582896082|FG000|Overall Study|Adverse Event|4|||
161411894|NCT00239928|582896082|FG000|Overall Study|Not need to continue study|3|||
161411895|NCT00239928|582896082|FG000|Overall Study|Withdrawal by Subject|2|||
161411896|NCT02942485|582896084|FG000|Overall Study|Lost to Follow-up|1|||
161411897|NCT02942485|582896085|FG001|Overall Study|Lost to Follow-up|0|||
161411898|NCT04302545|582896094|FG000|Overall Study|Lost to Follow-up|3|||
161411899|NCT04302545|582896095|FG001|Overall Study|Lost to Follow-up|4|||
161411900|NCT02516592|582896096|FG000|Overall Study|Patient withdrew consent|5|||
161411901|NCT02516592|582896097|FG001|Overall Study|Patient withdrew consent|2|||
161411902|NCT02516592|582896096|FG000|Overall Study|Protocol deviation|4|||
161411903|NCT02516592|582896097|FG001|Overall Study|Protocol deviation|4|||
161411904|NCT02516592|582896096|FG000|Overall Study|Lost to Follow-up|2|||
161411905|NCT02516592|582896097|FG001|Overall Study|Lost to Follow-up|3|||
161411906|NCT02516592|582896096|FG000|Overall Study|Patient/guardian decision|2|||
161411907|NCT02516592|582896097|FG001|Overall Study|Patient/guardian decision|1|||
161411908|NCT02516592|582896096|FG000|Overall Study|Adverse Event|1|||
161411909|NCT02516592|582896097|FG001|Overall Study|Adverse Event|2|||
161411910|NCT02516592|582896096|FG000|Overall Study|Abnormal test procedure result|1|||
161411911|NCT02516592|582896097|FG001|Overall Study|Abnormal test procedure result|0|||
161411912|NCT02516592|582896096|FG000|Overall Study|Death|1|||
161411913|NCT02516592|582896097|FG001|Overall Study|Death|1|||
161411914|NCT00300365|582896101|FG000|Overall Study|Lost to Follow-up|1|||
161411915|NCT00300365|582896102|FG001|Overall Study|Lost to Follow-up|0|||
161411916|NCT00300365|582896101|FG000|Overall Study|Physician Decision|2|||
161411917|NCT00300365|582896102|FG001|Overall Study|Physician Decision|0|||
161411918|NCT00300365|582896101|FG000|Overall Study|Withdrawal by Subject|1|||
161411919|NCT00300365|582896102|FG001|Overall Study|Withdrawal by Subject|0|||
161411920|NCT00300365|582896101|FG000|Overall Study|Adverse Event|0|||
161411921|NCT00300365|582896102|FG001|Overall Study|Adverse Event|2|||
161411922|NCT01438177|582896104|FG000|Overall Study|Withdrawal by Subject|1|||
161411923|NCT01438177|582896104|FG000|Overall Study|Initiation of new therapy|1|||
161411924|NCT01727336|582896105|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161411925|NCT01727336|582896106|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
161411926|NCT01727336|582896107|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
161411927|NCT01727336|582896108|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161411928|NCT01727336|582896109|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161411929|NCT01727336|582896110|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161411930|NCT01727336|582896105|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
161411931|NCT01727336|582896106|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
161411932|NCT01727336|582896107|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
161411933|NCT01727336|582896108|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
161411934|NCT01727336|582896109|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
161411935|NCT01727336|582896110|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
161411936|NCT01727336|582896105|FG000|Part 2 Blinded|Death|0|||
161411937|NCT01727336|582896106|FG001|Part 2 Blinded|Death|0|||
161411938|NCT01727336|582896107|FG002|Part 2 Blinded|Death|0|||
161411939|NCT01727336|582896108|FG003|Part 2 Blinded|Death|0|||
161411940|NCT01727336|582896109|FG004|Part 2 Blinded|Death|20|||
161411941|NCT01727336|582896110|FG005|Part 2 Blinded|Death|16|||
161411942|NCT01727336|582896105|FG000|Part 2 Blinded|Lack of Efficacy|0|||
161411943|NCT01727336|582896106|FG001|Part 2 Blinded|Lack of Efficacy|0|||
161411944|NCT01727336|582896107|FG002|Part 2 Blinded|Lack of Efficacy|0|||
161411945|NCT01727336|582896108|FG003|Part 2 Blinded|Lack of Efficacy|0|||
161411946|NCT01727336|582896109|FG004|Part 2 Blinded|Lack of Efficacy|42|||
161411947|NCT01727336|582896110|FG005|Part 2 Blinded|Lack of Efficacy|44|||
161411948|NCT01727336|582896105|FG000|Part 2 Blinded|Lost to Follow-up|0|||
161411949|NCT01727336|582896106|FG001|Part 2 Blinded|Lost to Follow-up|0|||
161411950|NCT01727336|582896107|FG002|Part 2 Blinded|Lost to Follow-up|0|||
161411951|NCT01727336|582896108|FG003|Part 2 Blinded|Lost to Follow-up|0|||
161411952|NCT01727336|582896109|FG004|Part 2 Blinded|Lost to Follow-up|0|||
161411953|NCT01727336|582896110|FG005|Part 2 Blinded|Lost to Follow-up|1|||
161411954|NCT01727336|582896105|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
161411955|NCT01727336|582896106|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
161411956|NCT01727336|582896107|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
161411957|NCT01727336|582896108|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
161411958|NCT01727336|582896109|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
161411959|NCT01727336|582896110|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
161411960|NCT01727336|582896105|FG000|Part 2 Blinded|use of prohibited medications|0|||
161411961|NCT01727336|582896106|FG001|Part 2 Blinded|use of prohibited medications|0|||
161411962|NCT01727336|582896107|FG002|Part 2 Blinded|use of prohibited medications|0|||
161411963|NCT01727336|582896108|FG003|Part 2 Blinded|use of prohibited medications|0|||
161411964|NCT01727336|582896109|FG004|Part 2 Blinded|use of prohibited medications|1|||
161411965|NCT01727336|582896110|FG005|Part 2 Blinded|use of prohibited medications|3|||
161411966|NCT00619099|582896113|FG000|Overall Study|Progressive Disease|7|||
161411967|NCT00619099|582896114|FG001|Overall Study|Progressive Disease|5|||
161411968|NCT00619099|582896113|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
161411969|NCT00619099|582896114|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
161411970|NCT00619099|582896113|FG000|Overall Study|Adverse Event|4|||
161411971|NCT00619099|582896114|FG001|Overall Study|Adverse Event|3|||
161411972|NCT00619099|582896113|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
161411973|NCT00619099|582896114|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
161411974|NCT00619099|582896113|FG000|Overall Study|Withdrawal by Subject|10|||
161411975|NCT00619099|582896114|FG001|Overall Study|Withdrawal by Subject|2|||
161411976|NCT00619099|582896113|FG000|Overall Study|Physician Decision|9|||
161411977|NCT00619099|582896114|FG001|Overall Study|Physician Decision|6|||
161411978|NCT02540265|582896115|FG000|Overall Study|Lost to Follow-up|0|||
161411979|NCT02540265|582896116|FG001|Overall Study|Lost to Follow-up|0|||
161411980|NCT02540265|582896117|FG002|Overall Study|Lost to Follow-up|1|||
161411981|NCT00666965|582896118|FG000|Overall Study|Adverse Event|0|||
161411982|NCT00666965|582896119|FG001|Overall Study|Adverse Event|2|||
161411983|NCT00666965|582896120|FG002|Overall Study|Adverse Event|1|||
161411984|NCT00666965|582896121|FG003|Overall Study|Adverse Event|9|||
161411985|NCT00666965|582896118|FG000|Overall Study|Lack of Efficacy|1|||
161411986|NCT00666965|582896119|FG001|Overall Study|Lack of Efficacy|1|||
161411987|NCT00666965|582896120|FG002|Overall Study|Lack of Efficacy|0|||
161411988|NCT00666965|582896121|FG003|Overall Study|Lack of Efficacy|0|||
161411989|NCT00666965|582896118|FG000|Overall Study|Protocol Violation|0|||
161411990|NCT00666965|582896119|FG001|Overall Study|Protocol Violation|0|||
161411991|NCT00666965|582896120|FG002|Overall Study|Protocol Violation|0|||
161411992|NCT00666965|582896121|FG003|Overall Study|Protocol Violation|2|||
161411993|NCT00666965|582896118|FG000|Overall Study|Discontinuation criteria|2|||
161411994|NCT00666965|582896119|FG001|Overall Study|Discontinuation criteria|1|||
161411995|NCT00666965|582896120|FG002|Overall Study|Discontinuation criteria|1|||
161411996|NCT00666965|582896121|FG003|Overall Study|Discontinuation criteria|2|||
161411997|NCT00666965|582896118|FG000|Overall Study|Withdrawal by Subject|0|||
161411998|NCT00666965|582896119|FG001|Overall Study|Withdrawal by Subject|0|||
161411999|NCT00666965|582896120|FG002|Overall Study|Withdrawal by Subject|0|||
161412000|NCT00666965|582896121|FG003|Overall Study|Withdrawal by Subject|2|||
161412001|NCT01455194|582896124|FG000|Overall Study|Screen Failure|20|||
161412002|NCT01455194|582896125|FG001|Overall Study|Screen Failure|0|||
161412003|NCT01455194|582896126|FG002|Overall Study|Screen Failure|0|||
161412004|NCT01455194|582896127|FG003|Overall Study|Screen Failure|0|||
161412005|NCT01455194|582896124|FG000|Overall Study|Randomisation Failure|90|||
161412006|NCT01455194|582896125|FG001|Overall Study|Randomisation Failure|0|||
161412007|NCT01455194|582896126|FG002|Overall Study|Randomisation Failure|0|||
161412008|NCT01455194|582896127|FG003|Overall Study|Randomisation Failure|0|||
161412009|NCT01455194|582896124|FG000|Overall Study|Deterioration in asthma|12|||
161412010|NCT01455194|582896125|FG001|Overall Study|Deterioration in asthma|6|||
161412011|NCT01455194|582896126|FG002|Overall Study|Deterioration in asthma|14|||
161412012|NCT01455194|582896127|FG003|Overall Study|Deterioration in asthma|9|||
161412013|NCT01455194|582896124|FG000|Overall Study|Adverse Event|1|||
161412014|NCT01455194|582896125|FG001|Overall Study|Adverse Event|1|||
161412015|NCT01455194|582896126|FG002|Overall Study|Adverse Event|1|||
161412016|NCT01455194|582896127|FG003|Overall Study|Adverse Event|3|||
161412017|NCT01455194|582896124|FG000|Overall Study|Withdrawal by Subject|21|||
161412018|NCT01455194|582896125|FG001|Overall Study|Withdrawal by Subject|16|||
161412019|NCT01455194|582896126|FG002|Overall Study|Withdrawal by Subject|12|||
161412020|NCT01455194|582896127|FG003|Overall Study|Withdrawal by Subject|9|||
161412021|NCT01455194|582896124|FG000|Overall Study|Lost to Follow-up|2|||
161412022|NCT01455194|582896125|FG001|Overall Study|Lost to Follow-up|0|||
161412023|NCT01455194|582896126|FG002|Overall Study|Lost to Follow-up|1|||
161412024|NCT01455194|582896127|FG003|Overall Study|Lost to Follow-up|1|||
161412025|NCT01455194|582896124|FG000|Overall Study|Pregnancy|0|||
161412026|NCT01455194|582896125|FG001|Overall Study|Pregnancy|1|||
161412027|NCT01455194|582896126|FG002|Overall Study|Pregnancy|1|||
161412028|NCT01455194|582896127|FG003|Overall Study|Pregnancy|0|||
161412029|NCT01455194|582896124|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
161412030|NCT01455194|582896125|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
161412031|NCT01455194|582896126|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
161412032|NCT01455194|582896127|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
161412033|NCT01455194|582896124|FG000|Overall Study|Miscellaneous|4|||
161412034|NCT01455194|582896125|FG001|Overall Study|Miscellaneous|5|||
161412035|NCT01455194|582896126|FG002|Overall Study|Miscellaneous|1|||
161412036|NCT01455194|582896127|FG003|Overall Study|Miscellaneous|4|||
161412037|NCT01196416|582896128|FG000|Overall Study|Withdrawal by Subject|2|||
161412038|NCT05090852|582896129|FG000|Overall Study|Physician Decision|5|||
161412039|NCT00504894|582896130|FG000|Overall Study|fMRI technical problems|1|||
161412040|NCT00504894|582896131|FG001|Overall Study|fMRI technical problems|1|||
161412041|NCT00504894|582896132|FG002|Overall Study|fMRI technical problems|0|||
161412042|NCT00504894|582896130|FG000|Overall Study|Withdrawal by Subject|0|||
161412043|NCT00504894|582896131|FG001|Overall Study|Withdrawal by Subject|1|||
161412044|NCT00504894|582896132|FG002|Overall Study|Withdrawal by Subject|0|||
161412045|NCT00504894|582896130|FG000|Overall Study|Infusion technical problems|0|||
161412046|NCT00504894|582896131|FG001|Overall Study|Infusion technical problems|1|||
161412047|NCT00504894|582896132|FG002|Overall Study|Infusion technical problems|0|||
161412048|NCT00504894|582896130|FG000|Overall Study|poor subject data|2|||
161412049|NCT00504894|582896131|FG001|Overall Study|poor subject data|0|||
161412050|NCT00504894|582896132|FG002|Overall Study|poor subject data|0|||
161412051|NCT00148941|582896133|FG000|Overall Study|Lost to Follow-up|17|||
161412052|NCT00148941|582896134|FG001|Overall Study|Lost to Follow-up|24|||
161412053|NCT00148941|582896135|FG002|Overall Study|Lost to Follow-up|18|||
161412054|NCT00148941|582896136|FG003|Overall Study|Lost to Follow-up|22|||
161412055|NCT00148941|582896133|FG000|Overall Study|Withdrawal by Subject|1|||
161412056|NCT00148941|582896134|FG001|Overall Study|Withdrawal by Subject|0|||
161412057|NCT00148941|582896135|FG002|Overall Study|Withdrawal by Subject|1|||
161412058|NCT00148941|582896136|FG003|Overall Study|Withdrawal by Subject|0|||
161412059|NCT00148941|582896133|FG000|Overall Study|Other|0|||
161412060|NCT00148941|582896134|FG001|Overall Study|Other|0|||
161412061|NCT00148941|582896135|FG002|Overall Study|Other|1|||
161412062|NCT00148941|582896136|FG003|Overall Study|Other|2|||
161412063|NCT02673684|582896139|FG000|Overall Study|Study not completed d/t loss of funding|9|||
161412064|NCT02673684|582896140|FG001|Overall Study|Study not completed d/t loss of funding|8|||
161412065|NCT01092663|582896141|FG000|Overall Study|Withdrawal by Subject|3|||
161412066|NCT01092663|582896142|FG001|Overall Study|Withdrawal by Subject|2|||
161412067|NCT01092663|582896141|FG000|Overall Study|Glucose >300mg/dL|1|||
161412068|NCT01092663|582896142|FG001|Overall Study|Glucose >300mg/dL|0|||
161412069|NCT01092663|582896141|FG000|Overall Study|High fasting triglyceride|2|||
161412070|NCT01092663|582896142|FG001|Overall Study|High fasting triglyceride|0|||
161412071|NCT01092663|582896141|FG000|Overall Study|Adverse Event|1|||
161412072|NCT01092663|582896142|FG001|Overall Study|Adverse Event|1|||
161412073|NCT01092663|582896141|FG000|Overall Study|Protocol Violation|0|||
161412074|NCT01092663|582896142|FG001|Overall Study|Protocol Violation|1|||
161412075|NCT00788710|582896143|FG000|Overall Study|Adverse Event|1|||
161412076|NCT00788710|582896144|FG001|Overall Study|Adverse Event|3|||
161412077|NCT00788710|582896145|FG002|Overall Study|Adverse Event|4|||
161412078|NCT00788710|582896143|FG000|Overall Study|Lack of Efficacy|0|||
161412079|NCT00788710|582896144|FG001|Overall Study|Lack of Efficacy|0|||
161412080|NCT00788710|582896145|FG002|Overall Study|Lack of Efficacy|1|||
161412081|NCT00788710|582896143|FG000|Overall Study|Lost to Follow-up|0|||
161412082|NCT00788710|582896144|FG001|Overall Study|Lost to Follow-up|1|||
161412083|NCT00788710|582896145|FG002|Overall Study|Lost to Follow-up|0|||
161412084|NCT00788710|582896143|FG000|Overall Study|Physician Decision|2|||
161412085|NCT00788710|582896144|FG001|Overall Study|Physician Decision|1|||
161412086|NCT00788710|582896145|FG002|Overall Study|Physician Decision|0|||
161412087|NCT00788710|582896143|FG000|Overall Study|Protocol Violation|0|||
161412088|NCT00788710|582896144|FG001|Overall Study|Protocol Violation|1|||
161412089|NCT00788710|582896145|FG002|Overall Study|Protocol Violation|1|||
161412090|NCT00788710|582896143|FG000|Overall Study|Withdrawal by Subject|2|||
161412091|NCT00788710|582896144|FG001|Overall Study|Withdrawal by Subject|2|||
161412092|NCT00788710|582896145|FG002|Overall Study|Withdrawal by Subject|0|||
161412093|NCT01008904|582896146|FG000|Overall Study|Lost to Follow-up|1|||
161412094|NCT01008904|582896146|FG000|Overall Study|Adverse Event|2|||
161412095|NCT01008904|582896146|FG000|Overall Study|unexpected unrelated surgery|1|||
161412096|NCT03908970|582896147|FG000|Overall Study|Adverse Event|7|||
161412097|NCT03908970|582896148|FG001|Overall Study|Adverse Event|21|||
161412098|NCT03908970|582896147|FG000|Overall Study|Physician Decision|1|||
161412099|NCT03908970|582896148|FG001|Overall Study|Physician Decision|4|||
161412100|NCT03908970|582896147|FG000|Overall Study|Withdrawal by Subject|9|||
161412101|NCT03908970|582896148|FG001|Overall Study|Withdrawal by Subject|22|||
161412102|NCT04407234|582896149|FG000|Overall Study|Adverse Event|3|||
161412103|NCT04407234|582896150|FG001|Overall Study|Adverse Event|3|||
161412104|NCT00727558|582896156|FG000|Overall Study|Lens issue|0|||
161412105|NCT00727558|582896157|FG001|Overall Study|Lens issue|1|||
161412106|NCT00727558|582896156|FG000|Overall Study|Adverse Event|0|||
161412107|NCT00727558|582896157|FG001|Overall Study|Adverse Event|1|||
161412108|NCT00727558|582896156|FG000|Overall Study|Subject unable to return for follow-up|1|||
161412109|NCT00727558|582896157|FG001|Overall Study|Subject unable to return for follow-up|1|||
161412110|NCT00727558|582896156|FG000|Overall Study|Lost to Follow-up|1|||
161412111|NCT00727558|582896157|FG001|Overall Study|Lost to Follow-up|0|||
161412112|NCT01717326|582896164|FG000|Overall Study|Death|0|||
161412113|NCT01717326|582896165|FG001|Overall Study|Death|0|||
161412114|NCT01717326|582896166|FG002|Overall Study|Death|0|||
161412115|NCT01717326|582896167|FG003|Overall Study|Death|0|||
161412116|NCT01717326|582896168|FG004|Overall Study|Death|0|||
161412117|NCT01717326|582896169|FG005|Overall Study|Death|0|||
161412118|NCT01717326|582896170|FG006|Overall Study|Death|0|||
161412119|NCT01717326|582896171|FG007|Overall Study|Death|0|||
161412120|NCT01717326|582896172|FG008|Overall Study|Death|0|||
161412121|NCT01717326|582896173|FG009|Overall Study|Death|0|||
161412122|NCT01717326|582896174|FG010|Overall Study|Death|1|||
161412123|NCT01717326|582896175|FG011|Overall Study|Death|0|||
161412124|NCT01717326|582896176|FG012|Overall Study|Death|0|||
161412125|NCT01717326|582896177|FG013|Overall Study|Death|0|||
161412126|NCT01717326|582896178|FG014|Overall Study|Death|0|||
161412127|NCT01717326|582896179|FG015|Overall Study|Death|0|||
161412128|NCT01717326|582896180|FG016|Overall Study|Death|0|||
161412129|NCT01717326|582896181|FG017|Overall Study|Death|0|||
161412130|NCT01717326|582896182|FG018|Overall Study|Death|0|||
161412131|NCT01717326|582896183|FG019|Overall Study|Death|0|||
161412132|NCT01717326|582896164|FG000|Overall Study|Lost to Follow-up|3|||
161412133|NCT01717326|582896165|FG001|Overall Study|Lost to Follow-up|0|||
161412134|NCT01717326|582896166|FG002|Overall Study|Lost to Follow-up|0|||
161412135|NCT01717326|582896167|FG003|Overall Study|Lost to Follow-up|2|||
161412136|NCT01717326|582896168|FG004|Overall Study|Lost to Follow-up|1|||
161412137|NCT01717326|582896169|FG005|Overall Study|Lost to Follow-up|0|||
161412138|NCT01717326|582896170|FG006|Overall Study|Lost to Follow-up|1|||
161412139|NCT01717326|582896171|FG007|Overall Study|Lost to Follow-up|0|||
161412140|NCT01717326|582896172|FG008|Overall Study|Lost to Follow-up|0|||
161412141|NCT01717326|582896173|FG009|Overall Study|Lost to Follow-up|0|||
161412142|NCT01717326|582896174|FG010|Overall Study|Lost to Follow-up|1|||
161412143|NCT01717326|582896175|FG011|Overall Study|Lost to Follow-up|0|||
161412144|NCT01717326|582896176|FG012|Overall Study|Lost to Follow-up|0|||
161412145|NCT01717326|582896177|FG013|Overall Study|Lost to Follow-up|0|||
161412146|NCT01717326|582896178|FG014|Overall Study|Lost to Follow-up|0|||
161412147|NCT01717326|582896179|FG015|Overall Study|Lost to Follow-up|2|||
161412148|NCT01717326|582896180|FG016|Overall Study|Lost to Follow-up|1|||
161412149|NCT01717326|582896181|FG017|Overall Study|Lost to Follow-up|0|||
161412150|NCT01717326|582896182|FG018|Overall Study|Lost to Follow-up|2|||
161412151|NCT01717326|582896183|FG019|Overall Study|Lost to Follow-up|3|||
161412152|NCT01717326|582896164|FG000|Overall Study|Physician Decision|0|||
161412153|NCT01717326|582896165|FG001|Overall Study|Physician Decision|0|||
161412154|NCT01717326|582896166|FG002|Overall Study|Physician Decision|0|||
161412155|NCT01717326|582896167|FG003|Overall Study|Physician Decision|0|||
161412156|NCT01717326|582896168|FG004|Overall Study|Physician Decision|0|||
161412157|NCT01717326|582896169|FG005|Overall Study|Physician Decision|0|||
161412158|NCT01717326|582896170|FG006|Overall Study|Physician Decision|0|||
161412159|NCT01717326|582896171|FG007|Overall Study|Physician Decision|0|||
161412160|NCT01717326|582896172|FG008|Overall Study|Physician Decision|0|||
161412161|NCT01717326|582896173|FG009|Overall Study|Physician Decision|1|||
161412162|NCT01717326|582896174|FG010|Overall Study|Physician Decision|0|||
161412163|NCT01717326|582896175|FG011|Overall Study|Physician Decision|0|||
161412164|NCT01717326|582896176|FG012|Overall Study|Physician Decision|0|||
161412165|NCT01717326|582896177|FG013|Overall Study|Physician Decision|0|||
161412166|NCT01717326|582896178|FG014|Overall Study|Physician Decision|0|||
161412167|NCT01717326|582896179|FG015|Overall Study|Physician Decision|0|||
161412168|NCT01717326|582896180|FG016|Overall Study|Physician Decision|0|||
161412169|NCT01717326|582896181|FG017|Overall Study|Physician Decision|0|||
161412170|NCT01717326|582896182|FG018|Overall Study|Physician Decision|0|||
161412171|NCT01717326|582896183|FG019|Overall Study|Physician Decision|0|||
161412172|NCT01717326|582896164|FG000|Overall Study|Protocol Violation|0|||
161412173|NCT01717326|582896165|FG001|Overall Study|Protocol Violation|0|||
161412174|NCT01717326|582896166|FG002|Overall Study|Protocol Violation|0|||
161412175|NCT01717326|582896167|FG003|Overall Study|Protocol Violation|0|||
161412176|NCT01717326|582896168|FG004|Overall Study|Protocol Violation|1|||
161412177|NCT01717326|582896169|FG005|Overall Study|Protocol Violation|0|||
161412178|NCT01717326|582896170|FG006|Overall Study|Protocol Violation|0|||
161412179|NCT01717326|582896171|FG007|Overall Study|Protocol Violation|0|||
161412180|NCT01717326|582896172|FG008|Overall Study|Protocol Violation|0|||
161412181|NCT01717326|582896173|FG009|Overall Study|Protocol Violation|0|||
161412182|NCT01717326|582896174|FG010|Overall Study|Protocol Violation|0|||
161412183|NCT01717326|582896175|FG011|Overall Study|Protocol Violation|0|||
161412184|NCT01717326|582896176|FG012|Overall Study|Protocol Violation|0|||
161412185|NCT01717326|582896177|FG013|Overall Study|Protocol Violation|0|||
161412186|NCT01717326|582896178|FG014|Overall Study|Protocol Violation|0|||
161412187|NCT01717326|582896179|FG015|Overall Study|Protocol Violation|0|||
161412188|NCT01717326|582896180|FG016|Overall Study|Protocol Violation|0|||
161412189|NCT01717326|582896181|FG017|Overall Study|Protocol Violation|0|||
161412190|NCT01717326|582896182|FG018|Overall Study|Protocol Violation|0|||
161412191|NCT01717326|582896183|FG019|Overall Study|Protocol Violation|0|||
161412192|NCT01717326|582896164|FG000|Overall Study|Withdrawal by Subject|0|||
161412193|NCT01717326|582896165|FG001|Overall Study|Withdrawal by Subject|1|||
161412194|NCT01717326|582896166|FG002|Overall Study|Withdrawal by Subject|0|||
161412195|NCT01717326|582896167|FG003|Overall Study|Withdrawal by Subject|0|||
161412196|NCT01717326|582896168|FG004|Overall Study|Withdrawal by Subject|0|||
161412197|NCT01717326|582896169|FG005|Overall Study|Withdrawal by Subject|0|||
161412198|NCT01717326|582896170|FG006|Overall Study|Withdrawal by Subject|0|||
161412199|NCT01717326|582896171|FG007|Overall Study|Withdrawal by Subject|0|||
161412200|NCT01717326|582896172|FG008|Overall Study|Withdrawal by Subject|0|||
161412201|NCT01717326|582896173|FG009|Overall Study|Withdrawal by Subject|1|||
161412202|NCT01717326|582896174|FG010|Overall Study|Withdrawal by Subject|0|||
161412203|NCT01717326|582896175|FG011|Overall Study|Withdrawal by Subject|0|||
161412204|NCT01717326|582896176|FG012|Overall Study|Withdrawal by Subject|1|||
161412205|NCT01717326|582896177|FG013|Overall Study|Withdrawal by Subject|0|||
161412206|NCT01717326|582896178|FG014|Overall Study|Withdrawal by Subject|0|||
161412207|NCT01717326|582896179|FG015|Overall Study|Withdrawal by Subject|1|||
161412208|NCT01717326|582896180|FG016|Overall Study|Withdrawal by Subject|0|||
161412209|NCT01717326|582896181|FG017|Overall Study|Withdrawal by Subject|0|||
161412210|NCT01717326|582896182|FG018|Overall Study|Withdrawal by Subject|2|||
161412211|NCT01717326|582896183|FG019|Overall Study|Withdrawal by Subject|3|||
161412212|NCT02262754|582896185|FG000|Overall Study|Adverse Event|3|||
161412213|NCT02262754|582896186|FG001|Overall Study|Adverse Event|4|||
161412214|NCT02262754|582896187|FG002|Overall Study|Adverse Event|0|||
161412215|NCT02262754|582896185|FG000|Overall Study|Lack of Efficacy|2|||
161412216|NCT02262754|582896186|FG001|Overall Study|Lack of Efficacy|0|||
161412217|NCT02262754|582896187|FG002|Overall Study|Lack of Efficacy|1|||
161412218|NCT02262754|582896185|FG000|Overall Study|Lost to Follow-up|0|||
161412219|NCT02262754|582896186|FG001|Overall Study|Lost to Follow-up|0|||
161412220|NCT02262754|582896187|FG002|Overall Study|Lost to Follow-up|1|||
161412221|NCT02262754|582896185|FG000|Overall Study|No longer meets eligibility criteria|0|||
161412222|NCT02262754|582896186|FG001|Overall Study|No longer meets eligibility criteria|1|||
161412223|NCT02262754|582896187|FG002|Overall Study|No longer meets eligibility criteria|0|||
161412224|NCT02262754|582896185|FG000|Overall Study|Study terminated by sponsor|5|||
161412225|NCT02262754|582896186|FG001|Overall Study|Study terminated by sponsor|4|||
161412226|NCT02262754|582896187|FG002|Overall Study|Study terminated by sponsor|4|||
161412227|NCT02262754|582896185|FG000|Overall Study|Protocol Violation|1|||
161412228|NCT02262754|582896186|FG001|Overall Study|Protocol Violation|0|||
161412229|NCT02262754|582896187|FG002|Overall Study|Protocol Violation|0|||
161412230|NCT02262754|582896185|FG000|Overall Study|Withdrawal by Subject|1|||
161412231|NCT02262754|582896186|FG001|Overall Study|Withdrawal by Subject|0|||
161412232|NCT02262754|582896187|FG002|Overall Study|Withdrawal by Subject|1|||
161412233|NCT02262754|582896185|FG000|Overall Study|Other|4|||
161412234|NCT02262754|582896186|FG001|Overall Study|Other|0|||
161412235|NCT02262754|582896187|FG002|Overall Study|Other|2|||
161412236|NCT01299116|582896191|FG000|Overall Study|Lost to Follow-up|65|||
161412237|NCT01299116|582896192|FG001|Overall Study|Lost to Follow-up|9|||
161412238|NCT01299116|582896193|FG002|Overall Study|Lost to Follow-up|11|||
161412239|NCT04079114|582896198|FG000|Overall Study|Study prematuely terminated.|166|||
161412240|NCT00629798|582896201|FG000|Overall Study|Not Treated|4|||
161412241|NCT01114438|582896202|FG000|Overall Study|Adverse Event|10|||
161412242|NCT01114438|582896202|FG000|Overall Study|concomitant medication|1|||
161412243|NCT01114438|582896202|FG000|Overall Study|Physician Decision|1|||
161412244|NCT01114438|582896202|FG000|Overall Study|Withdrawal by Subject|2|||
161412245|NCT00428844|582896207|FG000|Completed Study Drug Treatment|Adverse Event|2|||
161412246|NCT00428844|582896208|FG001|Completed Study Drug Treatment|Adverse Event|4|||
161412247|NCT00428844|582896209|FG002|Completed Study Drug Treatment|Adverse Event|4|||
161412248|NCT00428844|582896207|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
161412249|NCT00428844|582896208|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
161412250|NCT00428844|582896209|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
161412251|NCT00428844|582896207|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
161412252|NCT00428844|582896208|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
161412253|NCT00428844|582896209|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
161412254|NCT00428844|582896207|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
161412255|NCT00428844|582896208|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
161412256|NCT00428844|582896209|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
161412257|NCT00428844|582896207|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
161412258|NCT00428844|582896208|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
161412259|NCT00428844|582896209|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
161412260|NCT00428844|582896207|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
161412261|NCT00428844|582896208|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
161412262|NCT00428844|582896209|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
161412263|NCT00428844|582896207|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
161412264|NCT00428844|582896208|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
161412265|NCT00428844|582896209|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
161412266|NCT00428844|582896207|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
161412267|NCT00428844|582896208|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
161412268|NCT00428844|582896209|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
161412269|NCT00428844|582896207|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
161412270|NCT00428844|582896208|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
161412271|NCT00428844|582896209|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
161412272|NCT00488826|582896210|FG000|Overall Study|Withdrawal by Subject|40|||
161412273|NCT00488826|582896211|FG001|Overall Study|Withdrawal by Subject|35|||
161412274|NCT00488826|582896212|FG002|Overall Study|Withdrawal by Subject|19|||
161412275|NCT00488826|582896210|FG000|Overall Study|Protocol Violation|0|||
161412276|NCT00488826|582896211|FG001|Overall Study|Protocol Violation|0|||
161412277|NCT00488826|582896212|FG002|Overall Study|Protocol Violation|2|||
161412278|NCT00488826|582896210|FG000|Overall Study|Adverse Event|9|||
161412279|NCT00488826|582896211|FG001|Overall Study|Adverse Event|15|||
161412280|NCT00488826|582896212|FG002|Overall Study|Adverse Event|4|||
161412281|NCT00488826|582896210|FG000|Overall Study|Lost to Follow-up|5|||
161412282|NCT00488826|582896211|FG001|Overall Study|Lost to Follow-up|1|||
161412283|NCT00488826|582896212|FG002|Overall Study|Lost to Follow-up|0|||
161412284|NCT00488826|582896210|FG000|Overall Study|Protocol Deviations|2|||
161412285|NCT00488826|582896211|FG001|Overall Study|Protocol Deviations|1|||
161412286|NCT00488826|582896212|FG002|Overall Study|Protocol Deviations|1|||
161412287|NCT00812565|582896217|FG000|Overall Study|Did Not Receive Study Medication|1|||
161412288|NCT00812565|582896218|FG001|Overall Study|Did Not Receive Study Medication|1|||
161412289|NCT00812565|582896219|FG002|Overall Study|Did Not Receive Study Medication|0|||
161412290|NCT00812565|582896220|FG003|Overall Study|Did Not Receive Study Medication|0|||
161412291|NCT00812565|582896221|FG004|Overall Study|Did Not Receive Study Medication|0|||
161412292|NCT00812565|582896222|FG005|Overall Study|Did Not Receive Study Medication|0|||
161412293|NCT00812565|582896223|FG006|Overall Study|Did Not Receive Study Medication|0|||
161412294|NCT00812565|582896224|FG007|Overall Study|Did Not Receive Study Medication|0|||
161412295|NCT00812565|582896217|FG000|Overall Study|Adverse Event|0|||
161412296|NCT00812565|582896218|FG001|Overall Study|Adverse Event|0|||
161412297|NCT00812565|582896219|FG002|Overall Study|Adverse Event|0|||
161412298|NCT00812565|582896220|FG003|Overall Study|Adverse Event|2|||
161412299|NCT00812565|582896221|FG004|Overall Study|Adverse Event|0|||
161412300|NCT00812565|582896222|FG005|Overall Study|Adverse Event|0|||
161412301|NCT00812565|582896223|FG006|Overall Study|Adverse Event|0|||
161412302|NCT00812565|582896224|FG007|Overall Study|Adverse Event|1|||
161412303|NCT00812565|582896217|FG000|Overall Study|Did Not Come to Study Visit|1|||
161412304|NCT00812565|582896218|FG001|Overall Study|Did Not Come to Study Visit|0|||
161412305|NCT00812565|582896219|FG002|Overall Study|Did Not Come to Study Visit|0|||
161412306|NCT00812565|582896220|FG003|Overall Study|Did Not Come to Study Visit|0|||
161412307|NCT00812565|582896221|FG004|Overall Study|Did Not Come to Study Visit|0|||
161412308|NCT00812565|582896222|FG005|Overall Study|Did Not Come to Study Visit|0|||
161412309|NCT00812565|582896223|FG006|Overall Study|Did Not Come to Study Visit|0|||
161412310|NCT00812565|582896224|FG007|Overall Study|Did Not Come to Study Visit|0|||
161412311|NCT00812565|582896217|FG000|Overall Study|Withdrawal of Consent|1|||
161412312|NCT00812565|582896218|FG001|Overall Study|Withdrawal of Consent|0|||
161412313|NCT00812565|582896219|FG002|Overall Study|Withdrawal of Consent|0|||
161412314|NCT00812565|582896220|FG003|Overall Study|Withdrawal of Consent|0|||
161412315|NCT00812565|582896221|FG004|Overall Study|Withdrawal of Consent|1|||
161412316|NCT00812565|582896222|FG005|Overall Study|Withdrawal of Consent|0|||
161412317|NCT00812565|582896223|FG006|Overall Study|Withdrawal of Consent|0|||
161412318|NCT00812565|582896224|FG007|Overall Study|Withdrawal of Consent|0|||
161412319|NCT00812565|582896217|FG000|Overall Study|Reason Not Specified|0|||
161412320|NCT00812565|582896218|FG001|Overall Study|Reason Not Specified|0|||
161412321|NCT00812565|582896219|FG002|Overall Study|Reason Not Specified|0|||
161412322|NCT00812565|582896220|FG003|Overall Study|Reason Not Specified|0|||
161412323|NCT00812565|582896221|FG004|Overall Study|Reason Not Specified|0|||
161412324|NCT00812565|582896222|FG005|Overall Study|Reason Not Specified|1|||
161412325|NCT00812565|582896223|FG006|Overall Study|Reason Not Specified|0|||
161412326|NCT00812565|582896224|FG007|Overall Study|Reason Not Specified|0|||
161412327|NCT00422383|582896227|FG000|Overall Study|Adverse Event|5|||
161412328|NCT00422383|582896228|FG001|Overall Study|Adverse Event|3|||
161412329|NCT00422383|582896229|FG002|Overall Study|Adverse Event|1|||
161412330|NCT00422383|582896230|FG003|Overall Study|Adverse Event|1|||
161412331|NCT00422383|582896231|FG004|Overall Study|Adverse Event|0|||
161412332|NCT00422383|582896227|FG000|Overall Study|Lack of Efficacy|4|||
161412333|NCT00422383|582896228|FG001|Overall Study|Lack of Efficacy|4|||
161412334|NCT00422383|582896229|FG002|Overall Study|Lack of Efficacy|2|||
161412335|NCT00422383|582896230|FG003|Overall Study|Lack of Efficacy|1|||
161412336|NCT00422383|582896231|FG004|Overall Study|Lack of Efficacy|1|||
161412337|NCT00422383|582896227|FG000|Overall Study|Lost to Follow-up|0|||
161412338|NCT00422383|582896228|FG001|Overall Study|Lost to Follow-up|1|||
161412339|NCT00422383|582896229|FG002|Overall Study|Lost to Follow-up|0|||
161412340|NCT00422383|582896230|FG003|Overall Study|Lost to Follow-up|0|||
161412341|NCT00422383|582896231|FG004|Overall Study|Lost to Follow-up|1|||
161412342|NCT00422383|582896227|FG000|Overall Study|Protocol Violation|1|||
161412343|NCT00422383|582896228|FG001|Overall Study|Protocol Violation|1|||
161412344|NCT00422383|582896229|FG002|Overall Study|Protocol Violation|1|||
161412345|NCT00422383|582896230|FG003|Overall Study|Protocol Violation|0|||
161412346|NCT00422383|582896231|FG004|Overall Study|Protocol Violation|0|||
161412347|NCT00422383|582896227|FG000|Overall Study|Withdrawal by Subject|5|||
161412348|NCT00422383|582896228|FG001|Overall Study|Withdrawal by Subject|5|||
161412349|NCT00422383|582896229|FG002|Overall Study|Withdrawal by Subject|0|||
161412350|NCT00422383|582896230|FG003|Overall Study|Withdrawal by Subject|0|||
161412351|NCT00422383|582896231|FG004|Overall Study|Withdrawal by Subject|1|||
161412352|NCT00566254|582896232|FG000|Overall Study|Adverse Event|3|||
161412353|NCT00566254|582896233|FG001|Overall Study|Adverse Event|1|||
161412354|NCT00566254|582896232|FG000|Overall Study|Protocol Violation|1|||
161412355|NCT00566254|582896233|FG001|Overall Study|Protocol Violation|3|||
161412356|NCT00566254|582896232|FG000|Overall Study|Withdrawal by Subject|1|||
161412357|NCT00566254|582896233|FG001|Overall Study|Withdrawal by Subject|2|||
161412358|NCT00566254|582896232|FG000|Overall Study|Lack of Efficacy|5|||
161412359|NCT00566254|582896233|FG001|Overall Study|Lack of Efficacy|6|||
161412360|NCT00566254|582896232|FG000|Overall Study|Other|0|||
161412361|NCT00566254|582896233|FG001|Overall Study|Other|2|||
161412362|NCT00238238|582896234|FG000|Overall Study|Withdrawal by Subject|0|||
161412363|NCT00238238|582896235|FG001|Overall Study|Withdrawal by Subject|3|||
161412364|NCT00238238|582896236|FG002|Overall Study|Withdrawal by Subject|0|||
161412365|NCT01007838|582896237|FG000|Overall Study|Withdrawal by Subject|1|||
161412366|NCT01007838|582896238|FG001|Overall Study|Withdrawal by Subject|0|||
161412367|NCT01007838|582896239|FG002|Overall Study|Withdrawal by Subject|0|||
161412368|NCT01007838|582896240|FG003|Overall Study|Withdrawal by Subject|0|||
161412369|NCT01007838|582896237|FG000|Overall Study|Physician Decision|1|||
161412370|NCT01007838|582896238|FG001|Overall Study|Physician Decision|0|||
161412371|NCT01007838|582896239|FG002|Overall Study|Physician Decision|0|||
161412372|NCT01007838|582896240|FG003|Overall Study|Physician Decision|0|||
161412373|NCT01007838|582896237|FG000|Overall Study|Started home haemodialysis|1|||
161412374|NCT01007838|582896238|FG001|Overall Study|Started home haemodialysis|0|||
161412375|NCT01007838|582896239|FG002|Overall Study|Started home haemodialysis|0|||
161412376|NCT01007838|582896240|FG003|Overall Study|Started home haemodialysis|0|||
161412377|NCT02277119|582896244|FG000|Overall Study|Lack of Efficacy|1|||
161412378|NCT02277119|582896245|FG001|Overall Study|Lack of Efficacy|1|||
161412379|NCT02277119|582896246|FG002|Overall Study|Lack of Efficacy|1|||
161412380|NCT02277119|582896244|FG000|Overall Study|Protocol Violation|2|||
161412381|NCT02277119|582896245|FG001|Overall Study|Protocol Violation|3|||
161412382|NCT02277119|582896246|FG002|Overall Study|Protocol Violation|7|||
161412383|NCT01345669|582896247|FG000|Overall Study|Primary tumour recurrence|53|||
161412384|NCT01345669|582896248|FG001|Overall Study|Primary tumour recurrence|32|||
161412385|NCT01345669|582896247|FG000|Overall Study|Second primary tumour|4|||
161412386|NCT01345669|582896248|FG001|Overall Study|Second primary tumour|3|||
161412387|NCT01345669|582896247|FG000|Overall Study|Adverse Event|63|||
161412388|NCT01345669|582896248|FG001|Overall Study|Adverse Event|9|||
161412389|NCT01345669|582896247|FG000|Overall Study|Protocol Violation|3|||
161412390|NCT01345669|582896248|FG001|Overall Study|Protocol Violation|1|||
161412391|NCT01345669|582896247|FG000|Overall Study|Lost to Follow-up|1|||
161412392|NCT01345669|582896248|FG001|Overall Study|Lost to Follow-up|1|||
161412393|NCT01345669|582896247|FG000|Overall Study|Withdrawal by Subject|52|||
161412394|NCT01345669|582896248|FG001|Overall Study|Withdrawal by Subject|13|||
161412395|NCT01345669|582896247|FG000|Overall Study|Other Reasons|111|||
161412396|NCT01345669|582896248|FG001|Overall Study|Other Reasons|60|||
161412397|NCT01793883|582896249|FG000|Overall Study|Withdrawal by Subject|3|||
161412398|NCT01793883|582896250|FG001|Overall Study|Withdrawal by Subject|7|||
161412399|NCT01793883|582896251|FG002|Overall Study|Withdrawal by Subject|3|||
161412400|NCT01793883|582896249|FG000|Overall Study|Subject noncompliance|0|||
161412401|NCT01793883|582896250|FG001|Overall Study|Subject noncompliance|1|||
161412402|NCT01793883|582896251|FG002|Overall Study|Subject noncompliance|1|||
161412403|NCT01793883|582896249|FG000|Overall Study|Lost to Follow-up|5|||
161412404|NCT01793883|582896250|FG001|Overall Study|Lost to Follow-up|1|||
161412405|NCT01793883|582896251|FG002|Overall Study|Lost to Follow-up|3|||
161412406|NCT01793883|582896249|FG000|Overall Study|Randomized in error|1|||
161412407|NCT01793883|582896250|FG001|Overall Study|Randomized in error|0|||
161412408|NCT01793883|582896251|FG002|Overall Study|Randomized in error|0|||
161412409|NCT01793883|582896249|FG000|Overall Study|Unable to complete spriometry|1|||
161412410|NCT01793883|582896250|FG001|Overall Study|Unable to complete spriometry|0|||
161412411|NCT01793883|582896251|FG002|Overall Study|Unable to complete spriometry|0|||
161412412|NCT01793883|582896249|FG000|Overall Study|Unable to complete measurements|1|||
161412413|NCT01793883|582896250|FG001|Overall Study|Unable to complete measurements|0|||
161412414|NCT01793883|582896251|FG002|Overall Study|Unable to complete measurements|0|||
161412415|NCT01793883|582896249|FG000|Overall Study|Met exclusion criteria|1|||
161412416|NCT01793883|582896250|FG001|Overall Study|Met exclusion criteria|0|||
161412417|NCT01793883|582896251|FG002|Overall Study|Met exclusion criteria|0|||
161412418|NCT01793883|582896249|FG000|Overall Study|Dosing error|0|||
161412419|NCT01793883|582896250|FG001|Overall Study|Dosing error|1|||
161412420|NCT01793883|582896251|FG002|Overall Study|Dosing error|0|||
161412421|NCT01793883|582896249|FG000|Overall Study|Respiratory distress during spirometry|0|||
161412422|NCT01793883|582896250|FG001|Overall Study|Respiratory distress during spirometry|0|||
161412423|NCT01793883|582896251|FG002|Overall Study|Respiratory distress during spirometry|1|||
161412424|NCT00761527|582896252|FG000|Overall Study|Adverse Event|3|||
161412425|NCT00761527|582896252|FG000|Overall Study|Poor Compliance|8|||
161412426|NCT00761527|582896252|FG000|Overall Study|Lost to Follow-up|9|||
161412427|NCT00761527|582896252|FG000|Overall Study|Unknown reason|2|||
161412428|NCT02353728|582896253|FG000|Overall Study|Subject non-compliance|1|||
161412429|NCT02301624|582896254|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
161412430|NCT02301624|582896255|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
161412431|NCT02301624|582896254|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
161412432|NCT02301624|582896255|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
161412433|NCT02301624|582896254|FG000|Open-label Maintenance Phase|Adverse Event|2|||
161412434|NCT02301624|582896255|FG001|Open-label Maintenance Phase|Adverse Event|5|||
161412435|NCT02301624|582896254|FG000|Open-label Maintenance Phase|Physician Decision|3|||
161412436|NCT02301624|582896255|FG001|Open-label Maintenance Phase|Physician Decision|3|||
161412437|NCT02301624|582896254|FG000|Open-label Maintenance Phase|Death|2|||
161412438|NCT02301624|582896255|FG001|Open-label Maintenance Phase|Death|1|||
161412439|NCT02301624|582896254|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
161412440|NCT02301624|582896255|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
161412441|NCT00895310|582896256|FG000|Overall Study|Withdrawal by Subject|1|||
161412442|NCT02611817|582897877|FG000|Open-label Induction Phase|Reason not Specified|9|||
161412443|NCT02611817|582897878|FG001|Open-label Induction Phase|Reason not Specified|0|||
161412444|NCT02611817|582897879|FG002|Open-label Induction Phase|Reason not Specified|0|||
161412445|NCT02611817|582897877|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
161412446|NCT02611817|582897878|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
161412447|NCT02611817|582897879|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
161412448|NCT02611817|582897877|FG000|Open-label Induction Phase|Pregnancy|1|||
161412449|NCT02611817|582897878|FG001|Open-label Induction Phase|Pregnancy|0|||
161412450|NCT02611817|582897879|FG002|Open-label Induction Phase|Pregnancy|0|||
161412451|NCT02611817|582897877|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
161412452|NCT02611817|582897878|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
161412453|NCT02611817|582897879|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
161412454|NCT02611817|582897877|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
161412455|NCT02611817|582897878|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
161412456|NCT02611817|582897879|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
161412457|NCT02611817|582897877|FG000|Open-label Induction Phase|Protocol Violation|5|||
161412458|NCT02611817|582897878|FG001|Open-label Induction Phase|Protocol Violation|0|||
161412459|NCT02611817|582897879|FG002|Open-label Induction Phase|Protocol Violation|0|||
161412460|NCT02611817|582897877|FG000|Open-label Induction Phase|Adverse Event|16|||
161412461|NCT02611817|582897878|FG001|Open-label Induction Phase|Adverse Event|0|||
161412462|NCT02611817|582897879|FG002|Open-label Induction Phase|Adverse Event|0|||
161412463|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
161412464|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
161412465|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
161412466|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
161412467|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
161412468|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
161412469|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
161412470|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
161412471|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
161412472|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
161412473|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
161412474|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
161412475|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
161412476|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
161412477|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
161412478|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
161412479|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
161412480|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
161412481|NCT02611817|582897877|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
161412482|NCT02611817|582897878|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
161412483|NCT02611817|582897879|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
161412484|NCT03077919|582897880|FG000|Overall Study|Lost to Follow-up|4|||
161412485|NCT03077919|582897881|FG001|Overall Study|Lost to Follow-up|1|||
161412486|NCT03738618|582897882|FG000|Overall Study|Protocol deviation|23|||
161412487|NCT03738618|582897883|FG001|Overall Study|Protocol deviation|0|||
161412488|NCT03738618|582897882|FG000|Overall Study|Adverse Event|4|||
161412489|NCT03738618|582897883|FG001|Overall Study|Adverse Event|0|||
161412490|NCT03738618|582897882|FG000|Overall Study|Lost to Follow-up|2|||
161412491|NCT03738618|582897883|FG001|Overall Study|Lost to Follow-up|0|||
161412492|NCT03738618|582897882|FG000|Overall Study|Randomization failure|1|||
161412493|NCT03738618|582897883|FG001|Overall Study|Randomization failure|0|||
161412494|NCT03738618|582897882|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
161412495|NCT03738618|582897883|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
161412496|NCT03738618|582897882|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
161412497|NCT03738618|582897883|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
161412498|NCT00826618|582897884|FG000|Overall Study|Withdrawal by Subject|1|||
161412499|NCT01487265|582897889|FG000|Overall Study|Adverse Event|8|||
161412500|NCT01487265|582897889|FG000|Overall Study|Withdrawal by Subject|5|||
161412501|NCT01487265|582897889|FG000|Overall Study|Disease Progression|21|||
161412502|NCT01487265|582897889|FG000|Overall Study|Death|2|||
161412503|NCT01487265|582897889|FG000|Overall Study|Still on Treatment|1|||
161412504|NCT01016600|582897890|FG000|Overall Study|Did not start treatment|1|||
161412505|NCT01016600|582897891|FG001|Overall Study|Did not start treatment|0|||
161412506|NCT01016600|582897892|FG002|Overall Study|Did not start treatment|0|||
161412507|NCT01016600|582897893|FG003|Overall Study|Did not start treatment|0|||
161412508|NCT01271725|582897896|FG000|Part A|Progressive disease according to RECIST|8|||
161412509|NCT01271725|582897897|FG001|Part A|Progressive disease according to RECIST|0|||
161412510|NCT01271725|582897896|FG000|Part A|Clinical signs/symptoms of progression|2|||
161412511|NCT01271725|582897897|FG001|Part A|Clinical signs/symptoms of progression|0|||
161412512|NCT01271725|582897896|FG000|Part A|Other Adverse Event|8|||
161412513|NCT01271725|582897897|FG001|Part A|Other Adverse Event|0|||
161412514|NCT01271725|582897896|FG000|Part A|Lost to Follow-up|1|||
161412515|NCT01271725|582897897|FG001|Part A|Lost to Follow-up|0|||
161412516|NCT01271725|582897896|FG000|Part A|Withdrawal by Subject|12|||
161412517|NCT01271725|582897897|FG001|Part A|Withdrawal by Subject|0|||
161412518|NCT01271725|582897896|FG000|Part A|Other than specified|3|||
161412519|NCT01271725|582897897|FG001|Part A|Other than specified|0|||
161412520|NCT01271725|582897896|FG000|Part A|Protocol Violation|1|||
161412521|NCT01271725|582897897|FG001|Part A|Protocol Violation|0|||
161412522|NCT01271725|582897896|FG000|Part B|Other than specified|0|||
161412523|NCT01271725|582897897|FG001|Part B|Other than specified|2|||
161412524|NCT01271725|582897896|FG000|Part B|Clinical signs/symptoms of progression|0|||
161412525|NCT01271725|582897897|FG001|Part B|Clinical signs/symptoms of progression|2|||
161412526|NCT01271725|582897896|FG000|Part B|Other Adverse Event|0|||
161412527|NCT01271725|582897897|FG001|Part B|Other Adverse Event|1|||
161412528|NCT01271725|582897896|FG000|Part B|Protocol Violation|0|||
161412529|NCT01271725|582897897|FG001|Part B|Protocol Violation|1|||
161412530|NCT01271725|582897896|FG000|Part B|Withdrawal by Subject|0|||
161412531|NCT01271725|582897897|FG001|Part B|Withdrawal by Subject|6|||
161412532|NCT00801229|582897898|FG000|Signed Consent|Withdrawal by Subject|2|||
161412533|NCT00801229|582897899|FG001|Signed Consent|Withdrawal by Subject|2|||
161412534|NCT00801229|582897898|FG000|Signed Consent|Found Ineligible|1|||
161412535|NCT00801229|582897899|FG001|Signed Consent|Found Ineligible|1|||
161412536|NCT00801229|582897898|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
161412537|NCT00801229|582897899|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
161412538|NCT00801229|582897898|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
161412539|NCT00801229|582897899|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
161412540|NCT00801229|582897898|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
161412541|NCT00801229|582897899|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
161412542|NCT00801229|582897898|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
161412543|NCT00801229|582897899|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
161412544|NCT00801229|582897898|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
161412545|NCT00801229|582897899|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
161412546|NCT00801229|582897898|FG000|Received Study Drug/Placebo|Adverse Event|1|||
161412547|NCT00801229|582897899|FG001|Received Study Drug/Placebo|Adverse Event|1|||
161412548|NCT03826186|582897900|FG000|Overall Study|Protocol Violation|2|||
161412549|NCT03826186|582897901|FG001|Overall Study|Protocol Violation|0|||
161412550|NCT03826186|582897900|FG000|Overall Study|Withdrawal by Subject|1|||
161412551|NCT03826186|582897901|FG001|Overall Study|Withdrawal by Subject|0|||
161412552|NCT02950480|582897904|FG000|Overall Study|Withdrawal by Subject|1|||
161412553|NCT02950480|582897905|FG001|Overall Study|Withdrawal by Subject|0|||
161412554|NCT01363661|582897906|FG000|Overall Study|Adverse Event|9|||
161412555|NCT01363661|582897907|FG001|Overall Study|Adverse Event|2|||
161412556|NCT01363661|582897906|FG000|Overall Study|Withdrawal by Subject|1|||
161412557|NCT01363661|582897907|FG001|Overall Study|Withdrawal by Subject|1|||
161412558|NCT01363661|582897906|FG000|Overall Study|Protocol Violation|1|||
161412559|NCT01363661|582897907|FG001|Overall Study|Protocol Violation|0|||
161412560|NCT01363661|582897906|FG000|Overall Study|Lost to Follow-up|3|||
161412561|NCT01363661|582897907|FG001|Overall Study|Lost to Follow-up|1|||
161412562|NCT01959139|582897910|FG000|Phase II|Disease progression|0|||
161412563|NCT01959139|582897911|FG001|Phase II|Disease progression|0|||
161412564|NCT01959139|582897912|FG002|Phase II|Disease progression|26|||
161412565|NCT01959139|582897913|FG003|Phase II|Disease progression|34|||
161412566|NCT01959139|582897910|FG000|Phase II|Adverse Event|0|||
161412567|NCT01959139|582897911|FG001|Phase II|Adverse Event|0|||
161412568|NCT01959139|582897912|FG002|Phase II|Adverse Event|10|||
161412569|NCT01959139|582897913|FG003|Phase II|Adverse Event|11|||
161412570|NCT01959139|582897910|FG000|Phase II|Patient Refusal|0|||
161412571|NCT01959139|582897911|FG001|Phase II|Patient Refusal|0|||
161412572|NCT01959139|582897912|FG002|Phase II|Patient Refusal|5|||
161412573|NCT01959139|582897913|FG003|Phase II|Patient Refusal|4|||
161412574|NCT01959139|582897910|FG000|Phase II|Death|0|||
161412575|NCT01959139|582897911|FG001|Phase II|Death|0|||
161412576|NCT01959139|582897912|FG002|Phase II|Death|3|||
161412577|NCT01959139|582897913|FG003|Phase II|Death|1|||
161412578|NCT01959139|582897910|FG000|Phase II|Other/Unknown|0|||
161412579|NCT01959139|582897911|FG001|Phase II|Other/Unknown|0|||
161412580|NCT01959139|582897912|FG002|Phase II|Other/Unknown|8|||
161412581|NCT01959139|582897913|FG003|Phase II|Other/Unknown|5|||
161412582|NCT01959139|582897910|FG000|Phase II|On treatment|0|||
161412583|NCT01959139|582897911|FG001|Phase II|On treatment|0|||
161412584|NCT01959139|582897912|FG002|Phase II|On treatment|4|||
161412585|NCT01959139|582897913|FG003|Phase II|On treatment|0|||
161412586|NCT01378325|582897916|FG000|Overall Study|Protocol Violation|0|||
161412587|NCT01378325|582897917|FG001|Overall Study|Protocol Violation|1|||
161412588|NCT01559675|582897918|FG000|Overall Study|Protocol Violation|1|||
161412589|NCT01559675|582897919|FG001|Overall Study|Protocol Violation|2|||
161412590|NCT01559675|582897918|FG000|Overall Study|2nd operation on same patient excluded|14|||
161412591|NCT01559675|582897919|FG001|Overall Study|2nd operation on same patient excluded|12|||
161412592|NCT01496469|582897920|FG000|Overall Study|Adverse Event|1|||
161412593|NCT01496469|582897921|FG001|Overall Study|Adverse Event|0|||
161412594|NCT01496469|582897920|FG000|Overall Study|Protocol Violation|2|||
161412595|NCT01496469|582897921|FG001|Overall Study|Protocol Violation|0|||
161412596|NCT01496469|582897920|FG000|Overall Study|Lost to Follow-up|1|||
161412597|NCT01496469|582897921|FG001|Overall Study|Lost to Follow-up|1|||
161412598|NCT01496469|582897920|FG000|Overall Study|Withdrawal by Subject|4|||
161412599|NCT01496469|582897921|FG001|Overall Study|Withdrawal by Subject|4|||
161412600|NCT01496469|582897920|FG000|Overall Study|BP exceeds protocol limits|1|||
161412601|NCT01496469|582897921|FG001|Overall Study|BP exceeds protocol limits|2|||
161412602|NCT01496469|582897920|FG000|Overall Study|Other|1|||
161412603|NCT01496469|582897921|FG001|Overall Study|Other|1|||
161412604|NCT00193180|582897925|FG000|Overall Study|Lack of Efficacy|1|||
161412605|NCT00193180|582897925|FG000|Overall Study|Adverse Event|8|||
161412606|NCT00193180|582897925|FG000|Overall Study|Protocol Violation|1|||
161412607|NCT02219334|582897926|FG000|Overall Study|Withdrawal by Subject|1|||
161412608|NCT02219334|582897927|FG001|Overall Study|Withdrawal by Subject|0|||
161412609|NCT02219334|582897926|FG000|Overall Study|Protocol Violation|7|||
161412610|NCT02219334|582897927|FG001|Overall Study|Protocol Violation|3|||
161412611|NCT00891228|582897929|FG000|Overall Study|Adverse Event|0|||
161412612|NCT00891228|582897930|FG001|Overall Study|Adverse Event|2|||
161412613|NCT00891228|582897931|FG002|Overall Study|Adverse Event|3|||
161412614|NCT00891228|582897929|FG000|Overall Study|Withdrawal by Subject|2|||
161412615|NCT00891228|582897930|FG001|Overall Study|Withdrawal by Subject|4|||
161412616|NCT00891228|582897931|FG002|Overall Study|Withdrawal by Subject|5|||
161412617|NCT00891228|582897929|FG000|Overall Study|Protocol Violation|3|||
161412618|NCT00891228|582897930|FG001|Overall Study|Protocol Violation|1|||
161412619|NCT00891228|582897931|FG002|Overall Study|Protocol Violation|2|||
161412620|NCT00891228|582897929|FG000|Overall Study|Physician Decision|2|||
161412621|NCT00891228|582897930|FG001|Overall Study|Physician Decision|1|||
161412622|NCT00891228|582897931|FG002|Overall Study|Physician Decision|0|||
161412623|NCT00891228|582897929|FG000|Overall Study|Lost to Follow-up|4|||
161412624|NCT00891228|582897930|FG001|Overall Study|Lost to Follow-up|4|||
161412625|NCT00891228|582897931|FG002|Overall Study|Lost to Follow-up|5|||
161412626|NCT00891228|582897929|FG000|Overall Study|Pregnancy|0|||
161412627|NCT00891228|582897930|FG001|Overall Study|Pregnancy|1|||
161412628|NCT00891228|582897931|FG002|Overall Study|Pregnancy|0|||
161412629|NCT02688985|582897940|FG000|Overall Study|Adverse Event|1|||
161412630|NCT02688985|582897941|FG001|Overall Study|Adverse Event|2|||
161412631|NCT02688985|582897942|FG002|Overall Study|Adverse Event|2|||
161412632|NCT02688985|582897943|FG003|Overall Study|Adverse Event|0|||
161412633|NCT02688985|582897944|FG004|Overall Study|Adverse Event|0|||
161412634|NCT02688985|582897940|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
161412635|NCT02688985|582897941|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
161412636|NCT02688985|582897942|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
161412637|NCT02688985|582897943|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
161412638|NCT02688985|582897944|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
161412639|NCT02688985|582897940|FG000|Overall Study|Death|0|||
161412640|NCT02688985|582897941|FG001|Overall Study|Death|0|||
161412641|NCT02688985|582897942|FG002|Overall Study|Death|0|||
161412642|NCT02688985|582897943|FG003|Overall Study|Death|0|||
161412643|NCT02688985|582897944|FG004|Overall Study|Death|1|||
161412644|NCT02688985|582897940|FG000|Overall Study|Lack of Efficacy|0|||
161412645|NCT02688985|582897941|FG001|Overall Study|Lack of Efficacy|0|||
161412646|NCT02688985|582897942|FG002|Overall Study|Lack of Efficacy|0|||
161412647|NCT02688985|582897943|FG003|Overall Study|Lack of Efficacy|0|||
161412648|NCT02688985|582897944|FG004|Overall Study|Lack of Efficacy|1|||
161412649|NCT02688985|582897940|FG000|Overall Study|Lost to Follow-up|2|||
161412650|NCT02688985|582897941|FG001|Overall Study|Lost to Follow-up|0|||
161412651|NCT02688985|582897942|FG002|Overall Study|Lost to Follow-up|1|||
161412652|NCT02688985|582897943|FG003|Overall Study|Lost to Follow-up|1|||
161412653|NCT02688985|582897944|FG004|Overall Study|Lost to Follow-up|1|||
161412654|NCT02688985|582897940|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161412655|NCT02688985|582897941|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161412656|NCT02688985|582897942|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161412657|NCT02688985|582897943|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161412658|NCT02688985|582897944|FG004|Overall Study|Non-Compliance With Study Drug|1|||
161412659|NCT02688985|582897940|FG000|Overall Study|Other|3|||
161412660|NCT02688985|582897941|FG001|Overall Study|Other|4|||
161412661|NCT02688985|582897942|FG002|Overall Study|Other|1|||
161412662|NCT02688985|582897943|FG003|Overall Study|Other|0|||
161412663|NCT02688985|582897944|FG004|Overall Study|Other|0|||
161412664|NCT02688985|582897940|FG000|Overall Study|Physician Decision|2|||
161412665|NCT02688985|582897941|FG001|Overall Study|Physician Decision|2|||
161412666|NCT02688985|582897942|FG002|Overall Study|Physician Decision|0|||
161412667|NCT02688985|582897943|FG003|Overall Study|Physician Decision|0|||
161412668|NCT02688985|582897944|FG004|Overall Study|Physician Decision|1|||
161412669|NCT02688985|582897940|FG000|Overall Study|Pregnancy|0|||
161412670|NCT02688985|582897941|FG001|Overall Study|Pregnancy|0|||
161412671|NCT02688985|582897942|FG002|Overall Study|Pregnancy|2|||
161412672|NCT02688985|582897943|FG003|Overall Study|Pregnancy|1|||
161412673|NCT02688985|582897944|FG004|Overall Study|Pregnancy|0|||
161412674|NCT02688985|582897940|FG000|Overall Study|Study Terminated By Sponsor|0|||
161412675|NCT02688985|582897941|FG001|Overall Study|Study Terminated By Sponsor|0|||
161412676|NCT02688985|582897942|FG002|Overall Study|Study Terminated By Sponsor|0|||
161412677|NCT02688985|582897943|FG003|Overall Study|Study Terminated By Sponsor|1|||
161412678|NCT02688985|582897944|FG004|Overall Study|Study Terminated By Sponsor|0|||
161412679|NCT02688985|582897940|FG000|Overall Study|Withdrawal by Subject|2|||
161412680|NCT02688985|582897941|FG001|Overall Study|Withdrawal by Subject|8|||
161412681|NCT02688985|582897942|FG002|Overall Study|Withdrawal by Subject|7|||
161412682|NCT02688985|582897943|FG003|Overall Study|Withdrawal by Subject|1|||
161412683|NCT02688985|582897944|FG004|Overall Study|Withdrawal by Subject|4|||
161412684|NCT01964963|582897947|FG000|Overall Study|Case Report Forms Uncollected|888|||
161412685|NCT01964963|582897947|FG000|Overall Study|Protocol Deviation|50|||
161412686|NCT01964963|582897947|FG000|Overall Study|Data Reliability was not Assured|5|||
161412687|NCT00930553|582897948|FG000|Overall Study|Adverse Event|1|||
161412688|NCT00930553|582897948|FG000|Overall Study|Lack of Efficacy|7|||
161412689|NCT00930553|582897948|FG000|Overall Study|Physician Decision|39|||
161412690|NCT00930553|582897948|FG000|Overall Study|Protocol Violation|1|||
161412691|NCT00930553|582897948|FG000|Overall Study|Pregnancy|1|||
161412692|NCT00930553|582897948|FG000|Overall Study|Withdrawal by Subject|88|||
161412693|NCT00930553|582897948|FG000|Overall Study|Lost to Follow-up|25|||
161412694|NCT00930553|582897948|FG000|Overall Study|Death|9|||
161412695|NCT00930553|582897948|FG000|Overall Study|Study terminated by sponsor|24|||
161412696|NCT00930553|582897948|FG000|Overall Study|Other than specified above|28|||
161412697|NCT01235234|582897949|FG000|Overall Study|Adverse Event|2|||
161412698|NCT01235234|582897950|FG001|Overall Study|Adverse Event|2|||
161412699|NCT01235234|582897951|FG002|Overall Study|Adverse Event|1|||
161412700|NCT01726582|582897952|FG000|Overall Study|Physician Decision|99|||
161412701|NCT01726582|582897952|FG000|Overall Study|Death|85|||
161412702|NCT02630472|582897953|FG000|Overall Study|Physician Decision|10|||
161412703|NCT02630472|582897954|FG001|Overall Study|Physician Decision|0|||
161412704|NCT03704688|582897963|FG000|Overall Study|Adverse Event|0|||
161412705|NCT03704688|582897964|FG001|Overall Study|Adverse Event|0|||
161412706|NCT03704688|582897965|FG002|Overall Study|Adverse Event|0|||
161412707|NCT03704688|582897966|FG003|Overall Study|Adverse Event|4|||
161412708|NCT03704688|582897967|FG004|Overall Study|Adverse Event|1|||
161412709|NCT03704688|582897968|FG005|Overall Study|Adverse Event|0|||
161412710|NCT03704688|582897963|FG000|Overall Study|Disease Progression|0|||
161412711|NCT03704688|582897964|FG001|Overall Study|Disease Progression|0|||
161412712|NCT03704688|582897965|FG002|Overall Study|Disease Progression|0|||
161412713|NCT03704688|582897966|FG003|Overall Study|Disease Progression|3|||
161412714|NCT03704688|582897967|FG004|Overall Study|Disease Progression|1|||
161412715|NCT03704688|582897968|FG005|Overall Study|Disease Progression|0|||
161412716|NCT03704688|582897963|FG000|Overall Study|Death|0|||
161412717|NCT03704688|582897964|FG001|Overall Study|Death|0|||
161412718|NCT03704688|582897965|FG002|Overall Study|Death|0|||
161412719|NCT03704688|582897966|FG003|Overall Study|Death|0|||
161412720|NCT03704688|582897967|FG004|Overall Study|Death|3|||
161412721|NCT03704688|582897968|FG005|Overall Study|Death|0|||
161412722|NCT00787189|582897970|FG000|Overall Study|Lost to Follow-up|2|||
161412723|NCT00787189|582897971|FG001|Overall Study|Lost to Follow-up|2|||
161412724|NCT00847886|582897972|FG000|Overall Study|Adverse Event|0|||
161412725|NCT00847886|582897973|FG001|Overall Study|Adverse Event|1|||
161412726|NCT00413036|582897974|FG000|Overall Study|Adverse Event|44|||
161412727|NCT00413036|582897974|FG000|Overall Study|Lack of Efficacy|129|||
161412728|NCT00413036|582897974|FG000|Overall Study|Withdrawal by Subject|7|||
161412729|NCT00413036|582897974|FG000|Overall Study|Death|9|||
161412730|NCT00413036|582897974|FG000|Overall Study|Other|26|||
161412731|NCT00413036|582897974|FG000|Overall Study|Missing|2|||
161412732|NCT00183625|582897975|FG000|Overall Study|Withdrawal by Subject|18|||
161412733|NCT00183625|582897976|FG001|Overall Study|Withdrawal by Subject|18|||
161412734|NCT00183625|582897977|FG002|Overall Study|Withdrawal by Subject|19|||
161412735|NCT00183625|582897978|FG003|Overall Study|Withdrawal by Subject|14|||
161412736|NCT01369641|582897979|FG000|Overall Study|Withdrawal by Subject|1|||
161412737|NCT02524158|582897980|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
161412738|NCT02524158|582897981|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
161412739|NCT02524158|582897980|FG000|12-weeks Assessment|Lost to Follow-up|18|||
161412740|NCT02524158|582897981|FG001|12-weeks Assessment|Lost to Follow-up|12|||
161412741|NCT02524158|582897980|FG000|6-month Assessment|Withdrawal by Subject|1|||
161412742|NCT02524158|582897981|FG001|6-month Assessment|Withdrawal by Subject|1|||
161412743|NCT02524158|582897980|FG000|6-month Assessment|Lost to Follow-up|21|||
161412744|NCT02524158|582897981|FG001|6-month Assessment|Lost to Follow-up|20|||
161412745|NCT00887926|582897982|FG000|Overall Study|Withdrawal by Subject|0|||
161412746|NCT00887926|582897983|FG001|Overall Study|Withdrawal by Subject|1|||
161412747|NCT00887926|582897984|FG002|Overall Study|Withdrawal by Subject|0|||
161412748|NCT00887926|582897985|FG003|Overall Study|Withdrawal by Subject|0|||
161412749|NCT01110382|582897986|FG000|Overall Study|Withdrawal by Subject|0|||
161412750|NCT01110382|582897987|FG001|Overall Study|Withdrawal by Subject|1|||
161412751|NCT01110382|582897986|FG000|Overall Study|Protocol Violation|0|||
161412752|NCT01110382|582897987|FG001|Overall Study|Protocol Violation|1|||
161412753|NCT00077649|582897988|FG000|Overall Study|Adverse Event|5|||
161412754|NCT00077649|582897989|FG001|Overall Study|Adverse Event|1|||
161412755|NCT00077649|582897990|FG002|Overall Study|Adverse Event|7|||
161412756|NCT00077649|582897991|FG003|Overall Study|Adverse Event|9|||
161412757|NCT00077649|582897988|FG000|Overall Study|Lack of Efficacy|5|||
161412758|NCT00077649|582897989|FG001|Overall Study|Lack of Efficacy|3|||
161412759|NCT00077649|582897990|FG002|Overall Study|Lack of Efficacy|3|||
161412760|NCT00077649|582897991|FG003|Overall Study|Lack of Efficacy|2|||
161412761|NCT00077649|582897988|FG000|Overall Study|Withdrawal by Subject|0|||
161412762|NCT00077649|582897989|FG001|Overall Study|Withdrawal by Subject|1|||
161412763|NCT00077649|582897990|FG002|Overall Study|Withdrawal by Subject|1|||
161412764|NCT00077649|582897991|FG003|Overall Study|Withdrawal by Subject|2|||
161412765|NCT00077649|582897988|FG000|Overall Study|Lost to Follow-up|2|||
161412766|NCT00077649|582897989|FG001|Overall Study|Lost to Follow-up|2|||
161412767|NCT00077649|582897990|FG002|Overall Study|Lost to Follow-up|3|||
161412768|NCT00077649|582897991|FG003|Overall Study|Lost to Follow-up|2|||
161412769|NCT00077649|582897988|FG000|Overall Study|Abnormality of Laboratory Test|1|||
161412770|NCT00077649|582897989|FG001|Overall Study|Abnormality of Laboratory Test|2|||
161412771|NCT00077649|582897990|FG002|Overall Study|Abnormality of Laboratory Test|1|||
161412772|NCT00077649|582897991|FG003|Overall Study|Abnormality of Laboratory Test|2|||
161412773|NCT00077649|582897988|FG000|Overall Study|Randomized but never dosed|1|||
161412774|NCT00077649|582897989|FG001|Overall Study|Randomized but never dosed|0|||
161412775|NCT00077649|582897990|FG002|Overall Study|Randomized but never dosed|0|||
161412776|NCT00077649|582897991|FG003|Overall Study|Randomized but never dosed|0|||
161412777|NCT00293020|582897994|FG000|Overall Study|Withdrawal by Subject|34|||
161412778|NCT00293020|582897994|FG000|Overall Study|Adverse Event|30|||
161412779|NCT00293020|582897994|FG000|Overall Study|Death|32|||
161412780|NCT00293020|582897994|FG000|Overall Study|Lack of Efficacy|12|||
161412781|NCT00293020|582897994|FG000|Overall Study|Lost to Follow-up|4|||
161412782|NCT00293020|582897994|FG000|Overall Study|Protocol Violation|6|||
161412783|NCT00293020|582897994|FG000|Overall Study|Physician Decision|21|||
161412784|NCT00293020|582897994|FG000|Overall Study|Other Reason|22|||
161412785|NCT00293020|582897994|FG000|Overall Study|No dose taken|1|||
161412786|NCT01336023|582897995|FG000|Week 0 to Week 26|Adverse Event|8|||
161412787|NCT01336023|582897996|FG001|Week 0 to Week 26|Adverse Event|10|||
161412788|NCT01336023|582897997|FG002|Week 0 to Week 26|Adverse Event|24|||
161412789|NCT01336023|582897995|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
161412790|NCT01336023|582897996|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
161412791|NCT01336023|582897997|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
161412792|NCT01336023|582897995|FG000|Week 0 to Week 26|Protocol Violation|1|||
161412793|NCT01336023|582897996|FG001|Week 0 to Week 26|Protocol Violation|2|||
161412794|NCT01336023|582897997|FG002|Week 0 to Week 26|Protocol Violation|0|||
161412795|NCT01336023|582897995|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
161412796|NCT01336023|582897996|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
161412797|NCT01336023|582897997|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
161412798|NCT01336023|582897995|FG000|Week 0 to Week 26|Unclassified|5|||
161412799|NCT01336023|582897996|FG001|Week 0 to Week 26|Unclassified|16|||
161412800|NCT01336023|582897997|FG002|Week 0 to Week 26|Unclassified|9|||
161412801|NCT01336023|582897995|FG000|Week 27 to 52|Adverse Event|1|||
161412802|NCT01336023|582897996|FG001|Week 27 to 52|Adverse Event|5|||
161412803|NCT01336023|582897997|FG002|Week 27 to 52|Adverse Event|2|||
161412804|NCT01336023|582897995|FG000|Week 27 to 52|Protocol Violation|0|||
161412805|NCT01336023|582897996|FG001|Week 27 to 52|Protocol Violation|2|||
161412806|NCT01336023|582897997|FG002|Week 27 to 52|Protocol Violation|1|||
161412807|NCT01336023|582897995|FG000|Week 27 to 52|Withdrawal Criteria|14|||
161412808|NCT01336023|582897996|FG001|Week 27 to 52|Withdrawal Criteria|19|||
161412809|NCT01336023|582897997|FG002|Week 27 to 52|Withdrawal Criteria|16|||
161412810|NCT01336023|582897995|FG000|Week 27 to 52|Unclassified|13|||
161412811|NCT01336023|582897996|FG001|Week 27 to 52|Unclassified|18|||
161412812|NCT01336023|582897997|FG002|Week 27 to 52|Unclassified|9|||
161412813|NCT04058886|582898002|FG000|Overall Study|Withdrawal by Subject|4|||
161412814|NCT04058886|582898002|FG000|Overall Study|Inadequate deafness interpreter service|1|||
161412815|NCT00699335|582898008|FG000|Overall Study|Combination of multiple reasons|176|||
161412816|NCT00699335|582898008|FG000|Overall Study|Missing data|52|||
161412817|NCT03043651|582898009|FG000|Overall Study|Death|1|||
161412818|NCT03043651|582898009|FG000|Overall Study|Progressive Disease|2|||
161412819|NCT03043651|582898009|FG000|Overall Study|Adverse Event|2|||
161412820|NCT03043651|582898009|FG000|Overall Study|Withdrawal by Subject|4|||
161412821|NCT03043651|582898009|FG000|Overall Study|Study Terminated by Sponsor|39|||
161412822|NCT02974842|582898010|FG000|Overall Study|Withdrawal by Subject|4|||
161412823|NCT02974842|582898010|FG000|Overall Study|Screen failures|4|||
161412824|NCT01959243|582898011|FG000|Overall Study|Investigator Decision|3|||
161412825|NCT01959243|582898012|FG001|Overall Study|Investigator Decision|0|||
161412826|NCT01959243|582898011|FG000|Overall Study|Adverse Event|5|||
161412827|NCT01959243|582898012|FG001|Overall Study|Adverse Event|2|||
161412828|NCT01959243|582898011|FG000|Overall Study|Administrative reasons|2|||
161412829|NCT01959243|582898012|FG001|Overall Study|Administrative reasons|1|||
161412830|NCT01959243|582898011|FG000|Overall Study|Lost to Follow-up|3|||
161412831|NCT01959243|582898012|FG001|Overall Study|Lost to Follow-up|1|||
161412832|NCT02596945|582898013|FG000|Overall Study|No documentation of study drug dosing|3|||
161412833|NCT02596945|582898013|FG000|Overall Study|Other|32|||
161412834|NCT02596945|582898013|FG000|Overall Study|Change to hemodialysis|15|||
161412835|NCT02596945|582898013|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
161412836|NCT02596945|582898013|FG000|Overall Study|Withdrawal by Subject|1|||
161412837|NCT02596945|582898013|FG000|Overall Study|Missing|1|||
161412838|NCT04699461|582898014|FG000|Overall Study|Withdrawal by Subject|1|||
161412839|NCT04699461|582898015|FG001|Overall Study|Withdrawal by Subject|0|||
161412840|NCT04699461|582898014|FG000|Overall Study|Study termination by sponsor|2|||
161412841|NCT04699461|582898015|FG001|Overall Study|Study termination by sponsor|1|||
161412842|NCT04699461|582898014|FG000|Overall Study|Death|1|||
161412843|NCT04699461|582898015|FG001|Overall Study|Death|0|||
161412844|NCT04699461|582898014|FG000|Overall Study|Radiographic progression|0|||
161412845|NCT04699461|582898015|FG001|Overall Study|Radiographic progression|1|||
161412846|NCT02478255|582898016|FG000|Overall Study|Physician Decision|6|||
161412847|NCT02478255|582898017|FG001|Overall Study|Physician Decision|0|||
161412848|NCT02478255|582898016|FG000|Overall Study|Withdrawal by Subject|2|||
161412849|NCT02478255|582898017|FG001|Overall Study|Withdrawal by Subject|0|||
161412850|NCT03068767|582898024|FG000|Overall Study|Lost to Follow-up|7|||
161412851|NCT03068767|582898025|FG001|Overall Study|Lost to Follow-up|3|||
161412852|NCT03068767|582898024|FG000|Overall Study|Protocol Violation|3|||
161412853|NCT03068767|582898025|FG001|Overall Study|Protocol Violation|0|||
161412854|NCT00061633|582898028|FG000|Overall Study|Adverse Event|1|||
161412855|NCT00061633|582898029|FG001|Overall Study|Adverse Event|2|||
161412856|NCT00061633|582898028|FG000|Overall Study|Withdrawal by Subject|2|||
161412857|NCT00061633|582898029|FG001|Overall Study|Withdrawal by Subject|2|||
161412858|NCT00061633|582898028|FG000|Overall Study|Lost to Follow-up|1|||
161412859|NCT00061633|582898029|FG001|Overall Study|Lost to Follow-up|4|||
161412860|NCT00061633|582898028|FG000|Overall Study|Other|1|||
161412861|NCT00061633|582898029|FG001|Overall Study|Other|1|||
161412862|NCT00061633|582898028|FG000|Overall Study|Never received study treatment|0|||
161412863|NCT00061633|582898029|FG001|Overall Study|Never received study treatment|2|||
161412864|NCT01431963|582898030|FG000|Overall Study|Adverse Event|18|||
161412865|NCT01431963|582898030|FG000|Overall Study|Lack of Efficacy|7|||
161412866|NCT01431963|582898030|FG000|Overall Study|Protocol Violation|1|||
161412867|NCT01431963|582898030|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
161412868|NCT01431963|582898030|FG000|Overall Study|Physician Decision|4|||
161412869|NCT01431963|582898030|FG000|Overall Study|Withdrawal by Subject|3|||
161412870|NCT02737475|582900671|FG000|Overall Study|Other reasons|0|||
161412871|NCT02737475|582900672|FG001|Overall Study|Other reasons|0|||
161412872|NCT02737475|582900673|FG002|Overall Study|Other reasons|0|||
161412873|NCT02737475|582900674|FG003|Overall Study|Other reasons|0|||
161412874|NCT02737475|582900675|FG004|Overall Study|Other reasons|1|||
161412875|NCT02737475|582900676|FG005|Overall Study|Other reasons|1|||
161412876|NCT02737475|582900677|FG006|Overall Study|Other reasons|0|||
161412877|NCT02737475|582900678|FG007|Overall Study|Other reasons|0|||
161412878|NCT02737475|582900679|FG008|Overall Study|Other reasons|1|||
161412879|NCT02737475|582900680|FG009|Overall Study|Other reasons|0|||
161412880|NCT02737475|582900681|FG010|Overall Study|Other reasons|1|||
161412881|NCT02737475|582900682|FG011|Overall Study|Other reasons|0|||
161412882|NCT02737475|582900683|FG012|Overall Study|Other reasons|0|||
161412883|NCT02737475|582900684|FG013|Overall Study|Other reasons|0|||
161412884|NCT02737475|582900685|FG014|Overall Study|Other reasons|0|||
161412885|NCT02737475|582900686|FG015|Overall Study|Other reasons|0|||
161412886|NCT02737475|582900687|FG016|Overall Study|Other reasons|0|||
161412887|NCT02737475|582900688|FG017|Overall Study|Other reasons|0|||
161412888|NCT02737475|582900689|FG018|Overall Study|Other reasons|0|||
161412889|NCT02737475|582900690|FG019|Overall Study|Other reasons|0|||
161412890|NCT02737475|582900691|FG020|Overall Study|Other reasons|0|||
161412891|NCT02737475|582900692|FG021|Overall Study|Other reasons|1|||
161412892|NCT02737475|582900693|FG022|Overall Study|Other reasons|0|||
161412893|NCT02737475|582900694|FG023|Overall Study|Other reasons|1|||
161412894|NCT02737475|582900695|FG024|Overall Study|Other reasons|1|||
161412895|NCT02737475|582900696|FG025|Overall Study|Other reasons|1|||
161412896|NCT02737475|582900697|FG026|Overall Study|Other reasons|0|||
161412897|NCT02737475|582900671|FG000|Overall Study|Death|1|||
161412898|NCT02737475|582900672|FG001|Overall Study|Death|0|||
161412899|NCT02737475|582900673|FG002|Overall Study|Death|0|||
161412900|NCT02737475|582900674|FG003|Overall Study|Death|1|||
161412901|NCT02737475|582900675|FG004|Overall Study|Death|0|||
161412902|NCT02737475|582900676|FG005|Overall Study|Death|0|||
161412903|NCT02737475|582900677|FG006|Overall Study|Death|0|||
161412904|NCT02737475|582900678|FG007|Overall Study|Death|2|||
161412905|NCT02737475|582900679|FG008|Overall Study|Death|0|||
161412906|NCT02737475|582900680|FG009|Overall Study|Death|0|||
161412907|NCT02737475|582900681|FG010|Overall Study|Death|0|||
161412908|NCT02737475|582900682|FG011|Overall Study|Death|4|||
161412909|NCT02737475|582900683|FG012|Overall Study|Death|2|||
161412910|NCT02737475|582900684|FG013|Overall Study|Death|2|||
161412911|NCT02737475|582900685|FG014|Overall Study|Death|0|||
161412912|NCT02737475|582900686|FG015|Overall Study|Death|2|||
161412913|NCT02737475|582900687|FG016|Overall Study|Death|2|||
161412914|NCT02737475|582900688|FG017|Overall Study|Death|2|||
161412915|NCT02737475|582900689|FG018|Overall Study|Death|1|||
161412916|NCT02737475|582900690|FG019|Overall Study|Death|0|||
161412917|NCT02737475|582900691|FG020|Overall Study|Death|0|||
161412918|NCT02737475|582900692|FG021|Overall Study|Death|0|||
161412919|NCT02737475|582900693|FG022|Overall Study|Death|0|||
161412920|NCT02737475|582900694|FG023|Overall Study|Death|0|||
161412921|NCT02737475|582900695|FG024|Overall Study|Death|0|||
161412922|NCT02737475|582900696|FG025|Overall Study|Death|0|||
161412923|NCT02737475|582900697|FG026|Overall Study|Death|0|||
161412924|NCT02737475|582900671|FG000|Overall Study|Participant withdrew consent|0|||
161412925|NCT02737475|582900672|FG001|Overall Study|Participant withdrew consent|0|||
161412926|NCT02737475|582900673|FG002|Overall Study|Participant withdrew consent|0|||
161412927|NCT02737475|582900674|FG003|Overall Study|Participant withdrew consent|0|||
161412928|NCT02737475|582900675|FG004|Overall Study|Participant withdrew consent|0|||
161412929|NCT02737475|582900676|FG005|Overall Study|Participant withdrew consent|2|||
161412930|NCT02737475|582900677|FG006|Overall Study|Participant withdrew consent|0|||
161412931|NCT02737475|582900678|FG007|Overall Study|Participant withdrew consent|0|||
161412932|NCT02737475|582900679|FG008|Overall Study|Participant withdrew consent|0|||
161412933|NCT02737475|582900680|FG009|Overall Study|Participant withdrew consent|0|||
161412934|NCT02737475|582900681|FG010|Overall Study|Participant withdrew consent|0|||
161412935|NCT02737475|582900682|FG011|Overall Study|Participant withdrew consent|0|||
161412936|NCT02737475|582900683|FG012|Overall Study|Participant withdrew consent|0|||
161412937|NCT02737475|582900684|FG013|Overall Study|Participant withdrew consent|0|||
161412938|NCT02737475|582900685|FG014|Overall Study|Participant withdrew consent|1|||
161412939|NCT02737475|582900686|FG015|Overall Study|Participant withdrew consent|0|||
161412940|NCT02737475|582900687|FG016|Overall Study|Participant withdrew consent|0|||
161412941|NCT02737475|582900688|FG017|Overall Study|Participant withdrew consent|2|||
161412942|NCT02737475|582900689|FG018|Overall Study|Participant withdrew consent|1|||
161412943|NCT02737475|582900690|FG019|Overall Study|Participant withdrew consent|0|||
161412944|NCT02737475|582900691|FG020|Overall Study|Participant withdrew consent|2|||
161412945|NCT02737475|582900692|FG021|Overall Study|Participant withdrew consent|0|||
161412946|NCT02737475|582900693|FG022|Overall Study|Participant withdrew consent|0|||
161412947|NCT02737475|582900694|FG023|Overall Study|Participant withdrew consent|0|||
161412948|NCT02737475|582900695|FG024|Overall Study|Participant withdrew consent|0|||
161412949|NCT02737475|582900696|FG025|Overall Study|Participant withdrew consent|0|||
161412950|NCT02737475|582900697|FG026|Overall Study|Participant withdrew consent|0|||
161412951|NCT02737475|582900671|FG000|Overall Study|Lost to Follow-up|0|||
161412952|NCT02737475|582900672|FG001|Overall Study|Lost to Follow-up|0|||
161412953|NCT02737475|582900673|FG002|Overall Study|Lost to Follow-up|0|||
161412954|NCT02737475|582900674|FG003|Overall Study|Lost to Follow-up|0|||
161412955|NCT02737475|582900675|FG004|Overall Study|Lost to Follow-up|0|||
161412956|NCT02737475|582900676|FG005|Overall Study|Lost to Follow-up|0|||
161412957|NCT02737475|582900677|FG006|Overall Study|Lost to Follow-up|0|||
161412958|NCT02737475|582900678|FG007|Overall Study|Lost to Follow-up|0|||
161412959|NCT02737475|582900679|FG008|Overall Study|Lost to Follow-up|0|||
161412960|NCT02737475|582900680|FG009|Overall Study|Lost to Follow-up|0|||
161412961|NCT02737475|582900681|FG010|Overall Study|Lost to Follow-up|0|||
161412962|NCT02737475|582900682|FG011|Overall Study|Lost to Follow-up|0|||
161412963|NCT02737475|582900683|FG012|Overall Study|Lost to Follow-up|0|||
161412964|NCT02737475|582900684|FG013|Overall Study|Lost to Follow-up|0|||
161412965|NCT02737475|582900685|FG014|Overall Study|Lost to Follow-up|0|||
161412966|NCT02737475|582900686|FG015|Overall Study|Lost to Follow-up|1|||
161412967|NCT02737475|582900687|FG016|Overall Study|Lost to Follow-up|0|||
161412968|NCT02737475|582900688|FG017|Overall Study|Lost to Follow-up|0|||
161412969|NCT02737475|582900689|FG018|Overall Study|Lost to Follow-up|0|||
161412970|NCT02737475|582900690|FG019|Overall Study|Lost to Follow-up|0|||
161412971|NCT02737475|582900691|FG020|Overall Study|Lost to Follow-up|0|||
161412972|NCT02737475|582900692|FG021|Overall Study|Lost to Follow-up|0|||
161412973|NCT02737475|582900693|FG022|Overall Study|Lost to Follow-up|0|||
161412974|NCT02737475|582900694|FG023|Overall Study|Lost to Follow-up|0|||
161412975|NCT02737475|582900695|FG024|Overall Study|Lost to Follow-up|0|||
161412976|NCT02737475|582900696|FG025|Overall Study|Lost to Follow-up|0|||
161412977|NCT02737475|582900697|FG026|Overall Study|Lost to Follow-up|0|||
161412978|NCT02737475|582900671|FG000|Overall Study|Disease Progression|0|||
161412979|NCT02737475|582900672|FG001|Overall Study|Disease Progression|0|||
161412980|NCT02737475|582900673|FG002|Overall Study|Disease Progression|0|||
161412981|NCT02737475|582900674|FG003|Overall Study|Disease Progression|0|||
161412982|NCT02737475|582900675|FG004|Overall Study|Disease Progression|0|||
161412983|NCT02737475|582900676|FG005|Overall Study|Disease Progression|0|||
161412984|NCT02737475|582900677|FG006|Overall Study|Disease Progression|0|||
161412985|NCT02737475|582900678|FG007|Overall Study|Disease Progression|0|||
161412986|NCT02737475|582900679|FG008|Overall Study|Disease Progression|0|||
161412987|NCT02737475|582900680|FG009|Overall Study|Disease Progression|0|||
161412988|NCT02737475|582900681|FG010|Overall Study|Disease Progression|0|||
161412989|NCT02737475|582900682|FG011|Overall Study|Disease Progression|0|||
161412990|NCT02737475|582900683|FG012|Overall Study|Disease Progression|0|||
161412991|NCT02737475|582900684|FG013|Overall Study|Disease Progression|0|||
161412992|NCT02737475|582900685|FG014|Overall Study|Disease Progression|0|||
161412993|NCT02737475|582900686|FG015|Overall Study|Disease Progression|0|||
161412994|NCT02737475|582900687|FG016|Overall Study|Disease Progression|0|||
161412995|NCT02737475|582900688|FG017|Overall Study|Disease Progression|0|||
161412996|NCT02737475|582900689|FG018|Overall Study|Disease Progression|0|||
161412997|NCT02737475|582900690|FG019|Overall Study|Disease Progression|0|||
161412998|NCT02737475|582900691|FG020|Overall Study|Disease Progression|0|||
161412999|NCT02737475|582900692|FG021|Overall Study|Disease Progression|0|||
161413000|NCT02737475|582900693|FG022|Overall Study|Disease Progression|0|||
161413001|NCT02737475|582900694|FG023|Overall Study|Disease Progression|0|||
161413002|NCT02737475|582900695|FG024|Overall Study|Disease Progression|0|||
161413003|NCT02737475|582900696|FG025|Overall Study|Disease Progression|0|||
161413004|NCT02737475|582900697|FG026|Overall Study|Disease Progression|1|||
161413005|NCT02255461|582900708|FG000|Overall Study|Adverse Event|0|||
161413006|NCT02255461|582900709|FG001|Overall Study|Adverse Event|1|||
161413007|NCT02255461|582900710|FG002|Overall Study|Adverse Event|0|||
161413008|NCT02255461|582900711|FG003|Overall Study|Adverse Event|0|||
161413009|NCT02255461|582900712|FG004|Overall Study|Adverse Event|1|||
161413010|NCT02255461|582900708|FG000|Overall Study|Withdrawal by Subject|0|||
161413011|NCT02255461|582900709|FG001|Overall Study|Withdrawal by Subject|0|||
161413012|NCT02255461|582900710|FG002|Overall Study|Withdrawal by Subject|1|||
161413013|NCT02255461|582900711|FG003|Overall Study|Withdrawal by Subject|0|||
161413014|NCT02255461|582900712|FG004|Overall Study|Withdrawal by Subject|1|||
161413015|NCT02255461|582900708|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
161413016|NCT02255461|582900709|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
161413017|NCT02255461|582900710|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
161413018|NCT02255461|582900711|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
161413019|NCT02255461|582900712|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
161413020|NCT01357551|582900715|FG000|Overall Study|Withdrawal by Subject|6|||
161413021|NCT01357551|582900716|FG001|Overall Study|Withdrawal by Subject|4|||
161413022|NCT01357551|582900715|FG000|Overall Study|Death|0|||
161413023|NCT01357551|582900716|FG001|Overall Study|Death|1|||
161413024|NCT01357551|582900715|FG000|Overall Study|Lost to Follow-up|16|||
161413025|NCT01357551|582900716|FG001|Overall Study|Lost to Follow-up|6|||
161413026|NCT00711971|582900728|FG000|Overall Study|Lost to Follow-up|3|||
161413027|NCT00711971|582900729|FG001|Overall Study|Lost to Follow-up|4|||
161413028|NCT00711971|582900730|FG002|Overall Study|Lost to Follow-up|1|||
161413029|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413030|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413031|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
161413032|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
161413033|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
161413034|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413035|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
161413036|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
161413037|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
161413038|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413039|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413040|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413041|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161413042|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
161413043|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
161413044|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
161413045|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
161413046|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
161413047|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
161413048|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
161413049|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
161413050|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
161413051|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161413052|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161413053|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161413054|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161413055|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413056|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161413057|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161413058|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413059|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413060|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161413061|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161413062|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413063|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413064|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413065|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413066|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413067|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161413068|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413069|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161413070|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161413071|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413072|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413073|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413074|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161413075|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413076|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161413077|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413078|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413079|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413080|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161413081|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413082|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413083|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413084|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
161413085|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413086|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413087|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413088|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
161413089|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413090|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413091|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413092|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413093|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161413094|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413095|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413096|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413097|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
161413098|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413099|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413100|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
161413101|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413102|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413103|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413104|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413105|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413106|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161413107|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413108|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
161413109|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413110|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413111|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413112|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413113|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413114|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413115|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413116|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413117|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413118|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413119|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161413120|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
161413121|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413122|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413123|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413124|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413125|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413126|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413127|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413128|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413129|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413130|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413131|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413132|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161413133|NCT03100058|582900735|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413134|NCT03100058|582900736|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413135|NCT03100058|582900737|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413136|NCT03100058|582900738|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413137|NCT03100058|582900739|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413138|NCT03100058|582900740|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413139|NCT03100058|582900741|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
161413140|NCT03100058|582900742|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413141|NCT03100058|582900743|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413142|NCT03100058|582900744|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413143|NCT03100058|582900745|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413144|NCT03100058|582900746|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413145|NCT03100058|582900747|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161413146|NCT03100058|582900735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413147|NCT03100058|582900736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413148|NCT03100058|582900737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413149|NCT03100058|582900738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413150|NCT03100058|582900739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413151|NCT03100058|582900740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413152|NCT03100058|582900741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413153|NCT03100058|582900742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413154|NCT03100058|582900743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413155|NCT03100058|582900744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161413156|NCT03100058|582900745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
161413157|NCT03100058|582900746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
161413158|NCT03100058|582900747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
161413159|NCT03100058|582900735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413160|NCT03100058|582900736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413161|NCT03100058|582900737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413162|NCT03100058|582900738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413163|NCT03100058|582900739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413164|NCT03100058|582900740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413165|NCT03100058|582900741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413166|NCT03100058|582900742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413167|NCT03100058|582900743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413168|NCT03100058|582900744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413169|NCT03100058|582900745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
161413170|NCT03100058|582900746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
161413171|NCT03100058|582900747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161413172|NCT03100058|582900735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413173|NCT03100058|582900736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413174|NCT03100058|582900737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413175|NCT03100058|582900738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413176|NCT03100058|582900739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413177|NCT03100058|582900740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413178|NCT03100058|582900741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413179|NCT03100058|582900742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413180|NCT03100058|582900743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413181|NCT03100058|582900744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
161413182|NCT03100058|582900745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
161413183|NCT03100058|582900746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161413184|NCT03100058|582900747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
161413185|NCT03100058|582900735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413186|NCT03100058|582900736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413187|NCT03100058|582900737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413188|NCT03100058|582900738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413189|NCT03100058|582900739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413190|NCT03100058|582900740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413191|NCT03100058|582900741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413192|NCT03100058|582900742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413193|NCT03100058|582900743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413194|NCT03100058|582900744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413195|NCT03100058|582900745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
161413196|NCT03100058|582900746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413197|NCT03100058|582900747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161413198|NCT03100058|582900735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413199|NCT03100058|582900736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413200|NCT03100058|582900737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413201|NCT03100058|582900738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413202|NCT03100058|582900739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413203|NCT03100058|582900740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413204|NCT03100058|582900741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413205|NCT03100058|582900742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413206|NCT03100058|582900743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413207|NCT03100058|582900744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413208|NCT03100058|582900745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413209|NCT03100058|582900746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161413210|NCT03100058|582900747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
161413211|NCT03100058|582900735|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413212|NCT03100058|582900736|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413213|NCT03100058|582900737|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413214|NCT03100058|582900738|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413215|NCT03100058|582900739|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413216|NCT03100058|582900740|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413217|NCT03100058|582900741|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413218|NCT03100058|582900742|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413219|NCT03100058|582900743|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413220|NCT03100058|582900744|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
161413221|NCT03100058|582900745|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413222|NCT03100058|582900746|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413223|NCT03100058|582900747|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161413224|NCT01067144|582900750|FG000|Treatment|Did not receive allocated intervention|4|||
161413225|NCT01067144|582900751|FG001|Treatment|Did not receive allocated intervention|7|||
161413226|NCT01067144|582900750|FG000|Follow-up|Lost to Follow-up|22|||
161413227|NCT01067144|582900751|FG001|Follow-up|Lost to Follow-up|12|||
161413228|NCT01067144|582900750|FG000|Follow-up|Censored owing to second surgery|19|||
161413229|NCT01067144|582900751|FG001|Follow-up|Censored owing to second surgery|28|||
161413230|NCT01067144|582900750|FG000|Follow-up|Withdrawal by Subject|18|||
161413231|NCT01067144|582900751|FG001|Follow-up|Withdrawal by Subject|14|||
161413232|NCT01067144|582900750|FG000|Follow-up|Surgery cancelled|0|||
161413233|NCT01067144|582900751|FG001|Follow-up|Surgery cancelled|1|||
161413234|NCT01067144|582900750|FG000|Follow-up|Death|0|||
161413235|NCT01067144|582900751|FG001|Follow-up|Death|1|||
161413236|NCT02718716|582900753|FG000|Overall Study|Lack of Efficacy|1|||
161413237|NCT02718716|582900754|FG001|Overall Study|Lack of Efficacy|0|||
161413238|NCT02718716|582900755|FG002|Overall Study|Lack of Efficacy|0|||
161413239|NCT02718716|582900756|FG003|Overall Study|Lack of Efficacy|0|||
161413240|NCT02718716|582900757|FG004|Overall Study|Lack of Efficacy|0|||
161413241|NCT01835158|582900758|FG000|Overall Study|Withdrawal by Subject|1|||
161413242|NCT01835158|582900759|FG001|Overall Study|Withdrawal by Subject|6|||
161413243|NCT00596830|582900762|FG000|Overall Study|Death|258|||
161413244|NCT00596830|582900763|FG001|Overall Study|Death|247|||
161413245|NCT00596830|582900762|FG000|Overall Study|Lost to Follow-up|7|||
161413246|NCT00596830|582900763|FG001|Overall Study|Lost to Follow-up|11|||
161413247|NCT00596830|582900762|FG000|Overall Study|Withdrawal by Subject|22|||
161413248|NCT00596830|582900763|FG001|Overall Study|Withdrawal by Subject|12|||
161413249|NCT00596830|582900762|FG000|Overall Study|Study terminated by sponsor|51|||
161413250|NCT00596830|582900763|FG001|Overall Study|Study terminated by sponsor|62|||
161413251|NCT00596830|582900762|FG000|Overall Study|Follow-up was discontinued|1|||
161413252|NCT00596830|582900763|FG001|Overall Study|Follow-up was discontinued|0|||
161413253|NCT00596830|582900762|FG000|Overall Study|Randomized but not treated|3|||
161413254|NCT00596830|582900763|FG001|Overall Study|Randomized but not treated|7|||
161413255|NCT01919801|582900766|FG000|Overall Study|Withdrawal by Subject|1|||
161413256|NCT01919801|582900767|FG001|Overall Study|Withdrawal by Subject|0|||
161413257|NCT01919801|582900766|FG000|Overall Study|Physician Decision|0|||
161413258|NCT01919801|582900767|FG001|Overall Study|Physician Decision|1|||
161413259|NCT01919801|582900766|FG000|Overall Study|Lost to Follow-up|0|||
161413260|NCT01919801|582900767|FG001|Overall Study|Lost to Follow-up|1|||
161413261|NCT01919801|582900766|FG000|Overall Study|Other|0|||
161413262|NCT01919801|582900767|FG001|Overall Study|Other|1|||
161413263|NCT01677858|582900772|FG000|Overall Study|Adverse Event|0|||
161413264|NCT01677858|582900773|FG001|Overall Study|Adverse Event|0|||
161413265|NCT01677858|582900774|FG002|Overall Study|Adverse Event|2|||
161413266|NCT01677858|582900775|FG003|Overall Study|Adverse Event|3|||
161413267|NCT01677858|582900776|FG004|Overall Study|Adverse Event|13|||
161413268|NCT01677858|582900772|FG000|Overall Study|Death|0|||
161413269|NCT01677858|582900773|FG001|Overall Study|Death|0|||
161413270|NCT01677858|582900774|FG002|Overall Study|Death|0|||
161413271|NCT01677858|582900775|FG003|Overall Study|Death|0|||
161413272|NCT01677858|582900776|FG004|Overall Study|Death|1|||
161413273|NCT01677858|582900772|FG000|Overall Study|Physician Decision|1|||
161413274|NCT01677858|582900773|FG001|Overall Study|Physician Decision|0|||
161413275|NCT01677858|582900774|FG002|Overall Study|Physician Decision|2|||
161413276|NCT01677858|582900775|FG003|Overall Study|Physician Decision|0|||
161413277|NCT01677858|582900776|FG004|Overall Study|Physician Decision|12|||
161413278|NCT01677858|582900772|FG000|Overall Study|Progressive Disease|2|||
161413279|NCT01677858|582900773|FG001|Overall Study|Progressive Disease|1|||
161413280|NCT01677858|582900774|FG002|Overall Study|Progressive Disease|9|||
161413281|NCT01677858|582900775|FG003|Overall Study|Progressive Disease|3|||
161413282|NCT01677858|582900776|FG004|Overall Study|Progressive Disease|43|||
161413283|NCT01677858|582900772|FG000|Overall Study|Withdrawal by Subject|0|||
161413284|NCT01677858|582900773|FG001|Overall Study|Withdrawal by Subject|1|||
161413285|NCT01677858|582900774|FG002|Overall Study|Withdrawal by Subject|1|||
161413286|NCT01677858|582900775|FG003|Overall Study|Withdrawal by Subject|0|||
161413287|NCT01677858|582900776|FG004|Overall Study|Withdrawal by Subject|15|||
161413288|NCT01677858|582900772|FG000|Overall Study|Lost to Follow-up|0|||
161413289|NCT01677858|582900773|FG001|Overall Study|Lost to Follow-up|0|||
161413290|NCT01677858|582900774|FG002|Overall Study|Lost to Follow-up|0|||
161413291|NCT01677858|582900775|FG003|Overall Study|Lost to Follow-up|0|||
161413292|NCT01677858|582900776|FG004|Overall Study|Lost to Follow-up|1|||
161413293|NCT00988091|582900777|FG000|Double-blind Period|Withdrawal by Subject|15|||
161413294|NCT00988091|582900778|FG001|Double-blind Period|Withdrawal by Subject|13|||
161413295|NCT00988091|582900777|FG000|Double-blind Period|Lost to Follow-up|12|||
161413296|NCT00988091|582900778|FG001|Double-blind Period|Lost to Follow-up|14|||
161413297|NCT00988091|582900777|FG000|Double-blind Period|Other|8|||
161413298|NCT00988091|582900778|FG001|Double-blind Period|Other|8|||
161413299|NCT00988091|582900777|FG000|Double-blind Period|Adverse Event|6|||
161413300|NCT00988091|582900778|FG001|Double-blind Period|Adverse Event|9|||
161413301|NCT00988091|582900777|FG000|Double-blind Period|Use of exclusionary medication|2|||
161413302|NCT00988091|582900778|FG001|Double-blind Period|Use of exclusionary medication|3|||
161413303|NCT00988091|582900777|FG000|Open-label Period|Adverse Event|4|||
161413304|NCT00988091|582900778|FG001|Open-label Period|Adverse Event|7|||
161413305|NCT00988091|582900777|FG000|Open-label Period|Use of exclusionary medication|1|||
161413306|NCT00988091|582900778|FG001|Open-label Period|Use of exclusionary medication|1|||
161413307|NCT00988091|582900777|FG000|Open-label Period|Protocol Violation|1|||
161413308|NCT00988091|582900778|FG001|Open-label Period|Protocol Violation|1|||
161413309|NCT00988091|582900777|FG000|Open-label Period|Withdrawal by Subject|10|||
161413310|NCT00988091|582900778|FG001|Open-label Period|Withdrawal by Subject|16|||
161413311|NCT00988091|582900777|FG000|Open-label Period|Lost to Follow-up|3|||
161413312|NCT00988091|582900778|FG001|Open-label Period|Lost to Follow-up|5|||
161413313|NCT00988091|582900777|FG000|Open-label Period|Other|2|||
161413314|NCT00988091|582900778|FG001|Open-label Period|Other|3|||
161413315|NCT03078855|582900782|FG000|Overall Study|Lack of Efficacy|62|||
161413316|NCT03078855|582900783|FG001|Overall Study|Lack of Efficacy|31|||
161413317|NCT03078855|582900782|FG000|Overall Study|Death|1|||
161413318|NCT03078855|582900783|FG001|Overall Study|Death|0|||
161413319|NCT03078855|582900782|FG000|Overall Study|Withdrawal by Subject|12|||
161413320|NCT03078855|582900783|FG001|Overall Study|Withdrawal by Subject|6|||
161413321|NCT03078855|582900782|FG000|Overall Study|Physician Decision|3|||
161413322|NCT03078855|582900783|FG001|Overall Study|Physician Decision|2|||
161413323|NCT03078855|582900782|FG000|Overall Study|Second Malignancy|4|||
161413324|NCT03078855|582900783|FG001|Overall Study|Second Malignancy|0|||
161413325|NCT03078855|582900782|FG000|Overall Study|Ineligible|2|||
161413326|NCT03078855|582900783|FG001|Overall Study|Ineligible|0|||
161413327|NCT03078855|582900782|FG000|Overall Study|Withdrew before day 1 treatment|2|||
161413328|NCT03078855|582900783|FG001|Overall Study|Withdrew before day 1 treatment|1|||
161413329|NCT03194646|582900784|FG000|Overall Study|Adverse Event|24|||
161413330|NCT03194646|582900785|FG001|Overall Study|Adverse Event|25|||
161413331|NCT03194646|582900786|FG002|Overall Study|Adverse Event|14|||
161413332|NCT03194646|582900787|FG003|Overall Study|Adverse Event|17|||
161413333|NCT03194646|582900784|FG000|Overall Study|Lack of Efficacy|4|||
161413334|NCT03194646|582900785|FG001|Overall Study|Lack of Efficacy|2|||
161413335|NCT03194646|582900786|FG002|Overall Study|Lack of Efficacy|2|||
161413336|NCT03194646|582900787|FG003|Overall Study|Lack of Efficacy|12|||
161413337|NCT03194646|582900784|FG000|Overall Study|Lost to Follow-up|30|||
161413338|NCT03194646|582900785|FG001|Overall Study|Lost to Follow-up|22|||
161413339|NCT03194646|582900786|FG002|Overall Study|Lost to Follow-up|12|||
161413340|NCT03194646|582900787|FG003|Overall Study|Lost to Follow-up|35|||
161413341|NCT03194646|582900784|FG000|Overall Study|Non-compliance with study drug|4|||
161413342|NCT03194646|582900785|FG001|Overall Study|Non-compliance with study drug|0|||
161413343|NCT03194646|582900786|FG002|Overall Study|Non-compliance with study drug|1|||
161413344|NCT03194646|582900787|FG003|Overall Study|Non-compliance with study drug|1|||
161413345|NCT03194646|582900784|FG000|Overall Study|Other|89|||
161413346|NCT03194646|582900785|FG001|Overall Study|Other|68|||
161413347|NCT03194646|582900786|FG002|Overall Study|Other|34|||
161413348|NCT03194646|582900787|FG003|Overall Study|Other|31|||
161413349|NCT03194646|582900784|FG000|Overall Study|Physician Decision|7|||
161413350|NCT03194646|582900785|FG001|Overall Study|Physician Decision|9|||
161413351|NCT03194646|582900786|FG002|Overall Study|Physician Decision|5|||
161413352|NCT03194646|582900787|FG003|Overall Study|Physician Decision|4|||
161413353|NCT03194646|582900784|FG000|Overall Study|Pregnancy|4|||
161413354|NCT03194646|582900785|FG001|Overall Study|Pregnancy|5|||
161413355|NCT03194646|582900786|FG002|Overall Study|Pregnancy|1|||
161413356|NCT03194646|582900787|FG003|Overall Study|Pregnancy|2|||
161413357|NCT03194646|582900784|FG000|Overall Study|Protocol Violation|4|||
161413358|NCT03194646|582900785|FG001|Overall Study|Protocol Violation|2|||
161413359|NCT03194646|582900786|FG002|Overall Study|Protocol Violation|1|||
161413360|NCT03194646|582900787|FG003|Overall Study|Protocol Violation|1|||
161413361|NCT03194646|582900784|FG000|Overall Study|Site terminated by sponsor|0|||
161413362|NCT03194646|582900785|FG001|Overall Study|Site terminated by sponsor|0|||
161413363|NCT03194646|582900786|FG002|Overall Study|Site terminated by sponsor|2|||
161413364|NCT03194646|582900787|FG003|Overall Study|Site terminated by sponsor|0|||
161413365|NCT03194646|582900784|FG000|Overall Study|Study terminated by sponsor|62|||
161413366|NCT03194646|582900785|FG001|Overall Study|Study terminated by sponsor|61|||
161413367|NCT03194646|582900786|FG002|Overall Study|Study terminated by sponsor|30|||
161413368|NCT03194646|582900787|FG003|Overall Study|Study terminated by sponsor|34|||
161413369|NCT03194646|582900784|FG000|Overall Study|Withdrawal by Subject|75|||
161413370|NCT03194646|582900785|FG001|Overall Study|Withdrawal by Subject|74|||
161413371|NCT03194646|582900786|FG002|Overall Study|Withdrawal by Subject|36|||
161413372|NCT03194646|582900787|FG003|Overall Study|Withdrawal by Subject|131|||
161413373|NCT03194646|582900784|FG000|Overall Study|Missing|1|||
161413374|NCT03194646|582900785|FG001|Overall Study|Missing|0|||
161413375|NCT03194646|582900786|FG002|Overall Study|Missing|1|||
161413376|NCT03194646|582900787|FG003|Overall Study|Missing|12|||
161413377|NCT04869358|582900788|FG000|Overall Study|Wish to have children.|1|||
161413378|NCT04869358|582900789|FG001|Overall Study|Wish to have children.|0|||
161413379|NCT04869358|582900790|FG002|Overall Study|Wish to have children.|0|||
161413380|NCT04869358|582900791|FG003|Overall Study|Wish to have children.|0|||
161413381|NCT04427072|582900792|FG000|Randomized Treatment Phase|Progressive disease|9|||
161413382|NCT04427072|582900793|FG001|Randomized Treatment Phase|Progressive disease|4|||
161413383|NCT04427072|582900792|FG000|Randomized Treatment Phase|Adverse Event|3|||
161413384|NCT04427072|582900793|FG001|Randomized Treatment Phase|Adverse Event|1|||
161413385|NCT04427072|582900792|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
161413386|NCT04427072|582900793|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
161413387|NCT04427072|582900792|FG000|Randomized Treatment Phase|Death|0|||
161413388|NCT04427072|582900793|FG001|Randomized Treatment Phase|Death|1|||
161413389|NCT04427072|582900792|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
161413390|NCT04427072|582900793|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
161413391|NCT04427072|582900792|FG000|Extension Treatment Phase|Progressive disease|0|||
161413392|NCT04427072|582900793|FG001|Extension Treatment Phase|Progressive disease|5|||
161413393|NCT00098306|582900798|FG000|Double Blind|Randomized, not treated|9|||
161413394|NCT00098306|582900799|FG001|Double Blind|Randomized, not treated|5|||
161413395|NCT00098306|582900800|FG002|Double Blind|Randomized, not treated|2|||
161413396|NCT00098306|582900801|FG003|Double Blind|Randomized, not treated|0|||
161413397|NCT00098306|582900802|FG004|Double Blind|Randomized, not treated|0|||
161413398|NCT00098306|582900803|FG005|Double Blind|Randomized, not treated|0|||
161413399|NCT00098306|582900804|FG006|Double Blind|Randomized, not treated|0|||
161413400|NCT00098306|582900798|FG000|Double Blind|Ongoing at cut-off date|151|||
161413401|NCT00098306|582900799|FG001|Double Blind|Ongoing at cut-off date|166|||
161413402|NCT00098306|582900800|FG002|Double Blind|Ongoing at cut-off date|72|||
161413403|NCT00098306|582900801|FG003|Double Blind|Ongoing at cut-off date|0|||
161413404|NCT00098306|582900802|FG004|Double Blind|Ongoing at cut-off date|0|||
161413405|NCT00098306|582900803|FG005|Double Blind|Ongoing at cut-off date|0|||
161413406|NCT00098306|582900804|FG006|Double Blind|Ongoing at cut-off date|0|||
161413407|NCT00098306|582900798|FG000|Double Blind|Adverse Event|11|||
161413408|NCT00098306|582900799|FG001|Double Blind|Adverse Event|10|||
161413409|NCT00098306|582900800|FG002|Double Blind|Adverse Event|6|||
161413410|NCT00098306|582900801|FG003|Double Blind|Adverse Event|0|||
161413411|NCT00098306|582900802|FG004|Double Blind|Adverse Event|0|||
161413412|NCT00098306|582900803|FG005|Double Blind|Adverse Event|0|||
161413413|NCT00098306|582900804|FG006|Double Blind|Adverse Event|0|||
161413414|NCT00098306|582900798|FG000|Double Blind|Lack of Efficacy|43|||
161413415|NCT00098306|582900799|FG001|Double Blind|Lack of Efficacy|34|||
161413416|NCT00098306|582900800|FG002|Double Blind|Lack of Efficacy|17|||
161413417|NCT00098306|582900801|FG003|Double Blind|Lack of Efficacy|0|||
161413418|NCT00098306|582900802|FG004|Double Blind|Lack of Efficacy|0|||
161413419|NCT00098306|582900803|FG005|Double Blind|Lack of Efficacy|0|||
161413420|NCT00098306|582900804|FG006|Double Blind|Lack of Efficacy|0|||
161413421|NCT00098306|582900798|FG000|Double Blind|Death|1|||
161413422|NCT00098306|582900799|FG001|Double Blind|Death|4|||
161413423|NCT00098306|582900800|FG002|Double Blind|Death|1|||
161413424|NCT00098306|582900801|FG003|Double Blind|Death|0|||
161413425|NCT00098306|582900802|FG004|Double Blind|Death|0|||
161413426|NCT00098306|582900803|FG005|Double Blind|Death|0|||
161413427|NCT00098306|582900804|FG006|Double Blind|Death|0|||
161413428|NCT00098306|582900798|FG000|Double Blind|Participant defaulted|19|||
161413429|NCT00098306|582900799|FG001|Double Blind|Participant defaulted|18|||
161413430|NCT00098306|582900800|FG002|Double Blind|Participant defaulted|11|||
161413431|NCT00098306|582900801|FG003|Double Blind|Participant defaulted|0|||
161413432|NCT00098306|582900802|FG004|Double Blind|Participant defaulted|0|||
161413433|NCT00098306|582900803|FG005|Double Blind|Participant defaulted|0|||
161413434|NCT00098306|582900804|FG006|Double Blind|Participant defaulted|0|||
161413435|NCT00098306|582900798|FG000|Double Blind|Un-specified|7|||
161413436|NCT00098306|582900799|FG001|Double Blind|Un-specified|3|||
161413437|NCT00098306|582900800|FG002|Double Blind|Un-specified|11|||
161413438|NCT00098306|582900801|FG003|Double Blind|Un-specified|0|||
161413439|NCT00098306|582900802|FG004|Double Blind|Un-specified|0|||
161413440|NCT00098306|582900803|FG005|Double Blind|Un-specified|0|||
161413441|NCT00098306|582900804|FG006|Double Blind|Un-specified|0|||
161413442|NCT00098306|582900798|FG000|Open Label|Lack of Efficacy|0|||
161413443|NCT00098306|582900799|FG001|Open Label|Lack of Efficacy|0|||
161413444|NCT00098306|582900800|FG002|Open Label|Lack of Efficacy|0|||
161413445|NCT00098306|582900801|FG003|Open Label|Lack of Efficacy|13|||
161413446|NCT00098306|582900802|FG004|Open Label|Lack of Efficacy|0|||
161413447|NCT00098306|582900803|FG005|Open Label|Lack of Efficacy|0|||
161413448|NCT00098306|582900804|FG006|Open Label|Lack of Efficacy|0|||
161413449|NCT00098306|582900798|FG000|Open Label|Adverse Event|0|||
161413450|NCT00098306|582900799|FG001|Open Label|Adverse Event|0|||
161413451|NCT00098306|582900800|FG002|Open Label|Adverse Event|0|||
161413452|NCT00098306|582900801|FG003|Open Label|Adverse Event|2|||
161413453|NCT00098306|582900802|FG004|Open Label|Adverse Event|0|||
161413454|NCT00098306|582900803|FG005|Open Label|Adverse Event|0|||
161413455|NCT00098306|582900804|FG006|Open Label|Adverse Event|0|||
161413456|NCT00098306|582900798|FG000|Open Label|Death|0|||
161413457|NCT00098306|582900799|FG001|Open Label|Death|0|||
161413458|NCT00098306|582900800|FG002|Open Label|Death|0|||
161413459|NCT00098306|582900801|FG003|Open Label|Death|4|||
161413460|NCT00098306|582900802|FG004|Open Label|Death|0|||
161413461|NCT00098306|582900803|FG005|Open Label|Death|0|||
161413462|NCT00098306|582900804|FG006|Open Label|Death|0|||
161413463|NCT00098306|582900798|FG000|Open Label|Participant defaulted|0|||
161413464|NCT00098306|582900799|FG001|Open Label|Participant defaulted|0|||
161413465|NCT00098306|582900800|FG002|Open Label|Participant defaulted|0|||
161413466|NCT00098306|582900801|FG003|Open Label|Participant defaulted|24|||
161413467|NCT00098306|582900802|FG004|Open Label|Participant defaulted|0|||
161413468|NCT00098306|582900803|FG005|Open Label|Participant defaulted|0|||
161413469|NCT00098306|582900804|FG006|Open Label|Participant defaulted|0|||
161413470|NCT00098306|582900798|FG000|Open Label|Un-specified|0|||
161413471|NCT00098306|582900799|FG001|Open Label|Un-specified|0|||
161413472|NCT00098306|582900800|FG002|Open Label|Un-specified|0|||
161413473|NCT00098306|582900801|FG003|Open Label|Un-specified|15|||
161413474|NCT00098306|582900802|FG004|Open Label|Un-specified|0|||
161413475|NCT00098306|582900803|FG005|Open Label|Un-specified|0|||
161413476|NCT00098306|582900804|FG006|Open Label|Un-specified|0|||
161413477|NCT00098306|582900798|FG000|Open Label|Ongoing at cut-off date|0|||
161413478|NCT00098306|582900799|FG001|Open Label|Ongoing at cut-off date|0|||
161413479|NCT00098306|582900800|FG002|Open Label|Ongoing at cut-off date|0|||
161413480|NCT00098306|582900801|FG003|Open Label|Ongoing at cut-off date|269|||
161413481|NCT00098306|582900802|FG004|Open Label|Ongoing at cut-off date|62|||
161413482|NCT00098306|582900803|FG005|Open Label|Ongoing at cut-off date|0|||
161413483|NCT00098306|582900804|FG006|Open Label|Ongoing at cut-off date|0|||
161413484|NCT00098306|582900798|FG000|Observational Phase|Death|0|||
161413485|NCT00098306|582900799|FG001|Observational Phase|Death|0|||
161413486|NCT00098306|582900800|FG002|Observational Phase|Death|0|||
161413487|NCT00098306|582900801|FG003|Observational Phase|Death|0|||
161413488|NCT00098306|582900802|FG004|Observational Phase|Death|0|||
161413489|NCT00098306|582900803|FG005|Observational Phase|Death|5|||
161413490|NCT00098306|582900804|FG006|Observational Phase|Death|4|||
161413491|NCT00098306|582900798|FG000|Observational Phase|Participant defaulted|0|||
161413492|NCT00098306|582900799|FG001|Observational Phase|Participant defaulted|0|||
161413493|NCT00098306|582900800|FG002|Observational Phase|Participant defaulted|0|||
161413494|NCT00098306|582900801|FG003|Observational Phase|Participant defaulted|0|||
161413495|NCT00098306|582900802|FG004|Observational Phase|Participant defaulted|0|||
161413496|NCT00098306|582900803|FG005|Observational Phase|Participant defaulted|34|||
161413497|NCT00098306|582900804|FG006|Observational Phase|Participant defaulted|18|||
161413498|NCT00098306|582900798|FG000|Observational Phase|Un-specified|0|||
161413499|NCT00098306|582900799|FG001|Observational Phase|Un-specified|0|||
161413500|NCT00098306|582900800|FG002|Observational Phase|Un-specified|0|||
161413501|NCT00098306|582900801|FG003|Observational Phase|Un-specified|0|||
161413502|NCT00098306|582900802|FG004|Observational Phase|Un-specified|0|||
161413503|NCT00098306|582900803|FG005|Observational Phase|Un-specified|7|||
161413504|NCT00098306|582900804|FG006|Observational Phase|Un-specified|4|||
161413505|NCT03550404|582900805|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
161413506|NCT03550404|582900806|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
161413507|NCT03550404|582900807|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
161413508|NCT03550404|582900805|FG000|Phase 2|Vacated position|1|||
161413509|NCT03550404|582900806|FG001|Phase 2|Vacated position|0|||
161413510|NCT03550404|582900807|FG002|Phase 2|Vacated position|0|||
161413511|NCT00820222|582900810|FG000|Overall Study|Lost to Follow-up|10|||
161413512|NCT00820222|582900811|FG001|Overall Study|Lost to Follow-up|9|||
161413513|NCT00820222|582900810|FG000|Overall Study|Withdrawal by Subject|19|||
161413514|NCT00820222|582900811|FG001|Overall Study|Withdrawal by Subject|21|||
161413515|NCT00820222|582900810|FG000|Overall Study|Physician Decision|93|||
161413516|NCT00820222|582900811|FG001|Overall Study|Physician Decision|88|||
161413517|NCT00820222|582900810|FG000|Overall Study|Sponsor Terminated Study|43|||
161413518|NCT00820222|582900811|FG001|Overall Study|Sponsor Terminated Study|65|||
161413519|NCT00820222|582900810|FG000|Overall Study|Unkown|11|||
161413520|NCT00820222|582900811|FG001|Overall Study|Unkown|7|||
161413521|NCT02690714|582900812|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
161413522|NCT02690714|582900812|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
161413523|NCT01894022|582900823|FG000|Overall Study|Death|1|||
161413524|NCT01894022|582900824|FG001|Overall Study|Death|0|||
161413525|NCT01894022|582900823|FG000|Overall Study|Adverse Event, non-fatal|1|||
161413526|NCT01894022|582900824|FG001|Overall Study|Adverse Event, non-fatal|0|||
161413527|NCT01894022|582900823|FG000|Overall Study|Study Closed/terminated|7|||
161413528|NCT01894022|582900824|FG001|Overall Study|Study Closed/terminated|10|||
161413529|NCT02202538|582900826|FG000|Overall Study|Withdrawal by Subject|5|||
161413530|NCT02202538|582900826|FG000|Overall Study|Did not meet all inclusion criteria|2|||
161413531|NCT02202538|582900826|FG000|Overall Study|Investigator Decision|1|||
161413532|NCT04496453|582900827|FG000|Overall Study|Lost to Follow-up|6|||
161413533|NCT00767819|582900828|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
161413534|NCT00767819|582900829|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
161413535|NCT00767819|582900830|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161413536|NCT00767819|582900828|FG000|Overall Study|Withdrawal by Subject|1|||
161413537|NCT00767819|582900829|FG001|Overall Study|Withdrawal by Subject|1|||
161413538|NCT00767819|582900830|FG002|Overall Study|Withdrawal by Subject|0|||
161413539|NCT00767819|582900828|FG000|Overall Study|Administrative problems|0|||
161413540|NCT00767819|582900829|FG001|Overall Study|Administrative problems|1|||
161413541|NCT00767819|582900830|FG002|Overall Study|Administrative problems|0|||
161413542|NCT00767819|582900828|FG000|Overall Study|Death|2|||
161413543|NCT00767819|582900829|FG001|Overall Study|Death|3|||
161413544|NCT00767819|582900830|FG002|Overall Study|Death|0|||
161413545|NCT00767819|582900828|FG000|Overall Study|Adverse Event|2|||
161413546|NCT00767819|582900829|FG001|Overall Study|Adverse Event|0|||
161413547|NCT00767819|582900830|FG002|Overall Study|Adverse Event|0|||
161413548|NCT00767819|582900828|FG000|Overall Study|Abnormal lab values|1|||
161413549|NCT00767819|582900829|FG001|Overall Study|Abnormal lab values|0|||
161413550|NCT00767819|582900830|FG002|Overall Study|Abnormal lab values|0|||
161413551|NCT00767819|582900828|FG000|Overall Study|Lost to Follow-up|1|||
161413552|NCT00767819|582900829|FG001|Overall Study|Lost to Follow-up|0|||
161413553|NCT00767819|582900830|FG002|Overall Study|Lost to Follow-up|0|||
161413554|NCT03916081|582900831|FG000|Overall Study|Adverse Event|1|||
161413555|NCT03916081|582900832|FG001|Overall Study|Adverse Event|0|||
161413556|NCT03916081|582900833|FG002|Overall Study|Adverse Event|0|||
161413557|NCT03916081|582900831|FG000|Overall Study|Physician Decision|0|||
161413558|NCT03916081|582900832|FG001|Overall Study|Physician Decision|0|||
161413559|NCT03916081|582900833|FG002|Overall Study|Physician Decision|1|||
161413560|NCT03916081|582900831|FG000|Overall Study|Lost to Follow-up|0|||
161413561|NCT03916081|582900832|FG001|Overall Study|Lost to Follow-up|1|||
161413562|NCT03916081|582900833|FG002|Overall Study|Lost to Follow-up|0|||
161413563|NCT03916081|582900831|FG000|Overall Study|Withdrawal by Subject|3|||
161413564|NCT03916081|582900832|FG001|Overall Study|Withdrawal by Subject|0|||
161413565|NCT03916081|582900833|FG002|Overall Study|Withdrawal by Subject|1|||
161413566|NCT03916081|582900831|FG000|Overall Study|Worsening of AD|0|||
161413567|NCT03916081|582900832|FG001|Overall Study|Worsening of AD|0|||
161413568|NCT03916081|582900833|FG002|Overall Study|Worsening of AD|1|||
161413569|NCT01371305|582900837|FG000|Overall Study|Adverse Event|0|||
161413570|NCT01371305|582900838|FG001|Overall Study|Adverse Event|0|||
161413571|NCT01371305|582900839|FG002|Overall Study|Adverse Event|0|||
161413572|NCT01371305|582900840|FG003|Overall Study|Adverse Event|2|||
161413573|NCT01371305|582900841|FG004|Overall Study|Adverse Event|1|||
161413574|NCT01371305|582900842|FG005|Overall Study|Adverse Event|0|||
161413575|NCT01371305|582900837|FG000|Overall Study|Study terminated by sponsor|0|||
161413576|NCT01371305|582900838|FG001|Overall Study|Study terminated by sponsor|0|||
161413577|NCT01371305|582900839|FG002|Overall Study|Study terminated by sponsor|0|||
161413578|NCT01371305|582900840|FG003|Overall Study|Study terminated by sponsor|0|||
161413579|NCT01371305|582900841|FG004|Overall Study|Study terminated by sponsor|3|||
161413580|NCT01371305|582900842|FG005|Overall Study|Study terminated by sponsor|1|||
161413581|NCT01371305|582900837|FG000|Overall Study|Subject request|0|||
161413582|NCT01371305|582900838|FG001|Overall Study|Subject request|0|||
161413583|NCT01371305|582900839|FG002|Overall Study|Subject request|0|||
161413584|NCT01371305|582900840|FG003|Overall Study|Subject request|0|||
161413585|NCT01371305|582900841|FG004|Overall Study|Subject request|0|||
161413586|NCT01371305|582900842|FG005|Overall Study|Subject request|1|||
161413587|NCT00235716|582900843|FG000|Overall Study|Death|26|||
161413588|NCT00235716|582900844|FG001|Overall Study|Death|39|||
161413589|NCT00235716|582900845|FG002|Overall Study|Death|32|||
161413590|NCT00235716|582900846|FG003|Overall Study|Death|31|||
161413591|NCT00235716|582900843|FG000|Overall Study|Withdrawal by Subject|23|||
161413592|NCT00235716|582900844|FG001|Overall Study|Withdrawal by Subject|19|||
161413593|NCT00235716|582900845|FG002|Overall Study|Withdrawal by Subject|17|||
161413594|NCT00235716|582900846|FG003|Overall Study|Withdrawal by Subject|18|||
161413595|NCT00235716|582900843|FG000|Overall Study|Lost to Follow-up|12|||
161413596|NCT00235716|582900844|FG001|Overall Study|Lost to Follow-up|7|||
161413597|NCT00235716|582900845|FG002|Overall Study|Lost to Follow-up|14|||
161413598|NCT00235716|582900846|FG003|Overall Study|Lost to Follow-up|10|||
161413599|NCT00235716|582900843|FG000|Overall Study|Adverse Event|1|||
161413600|NCT00235716|582900844|FG001|Overall Study|Adverse Event|1|||
161413601|NCT00235716|582900845|FG002|Overall Study|Adverse Event|1|||
161413602|NCT00235716|582900846|FG003|Overall Study|Adverse Event|0|||
161413603|NCT00235716|582900843|FG000|Overall Study|Physician Decision|0|||
161413604|NCT00235716|582900844|FG001|Overall Study|Physician Decision|1|||
161413605|NCT00235716|582900845|FG002|Overall Study|Physician Decision|1|||
161413606|NCT00235716|582900846|FG003|Overall Study|Physician Decision|3|||
161413607|NCT01545050|582900847|FG000|Overall Study|Lack of Efficacy|0|||
161413608|NCT01545050|582900848|FG001|Overall Study|Lack of Efficacy|0|||
161413609|NCT01545050|582900849|FG002|Overall Study|Lack of Efficacy|0|||
161413610|NCT01545050|582900850|FG003|Overall Study|Lack of Efficacy|3|||
161413611|NCT01545050|582900851|FG004|Overall Study|Lack of Efficacy|2|||
161413612|NCT01545050|582900847|FG000|Overall Study|Adverse Event|1|||
161413613|NCT01545050|582900848|FG001|Overall Study|Adverse Event|1|||
161413614|NCT01545050|582900849|FG002|Overall Study|Adverse Event|2|||
161413615|NCT01545050|582900850|FG003|Overall Study|Adverse Event|2|||
161413616|NCT01545050|582900851|FG004|Overall Study|Adverse Event|0|||
161413617|NCT01545050|582900847|FG000|Overall Study|Discontinued study treatment|1|||
161413618|NCT01545050|582900848|FG001|Overall Study|Discontinued study treatment|0|||
161413619|NCT01545050|582900849|FG002|Overall Study|Discontinued study treatment|0|||
161413620|NCT01545050|582900850|FG003|Overall Study|Discontinued study treatment|0|||
161413621|NCT01545050|582900851|FG004|Overall Study|Discontinued study treatment|0|||
161413622|NCT01545050|582900847|FG000|Overall Study|Withdrawal by Subject|1|||
161413623|NCT01545050|582900848|FG001|Overall Study|Withdrawal by Subject|0|||
161413624|NCT01545050|582900849|FG002|Overall Study|Withdrawal by Subject|0|||
161413625|NCT01545050|582900850|FG003|Overall Study|Withdrawal by Subject|2|||
161413626|NCT01545050|582900851|FG004|Overall Study|Withdrawal by Subject|1|||
161413627|NCT01545050|582900847|FG000|Overall Study|Participant no longer meets study criteria|0|||
161413628|NCT01545050|582900848|FG001|Overall Study|Participant no longer meets study criteria|2|||
161413629|NCT01545050|582900849|FG002|Overall Study|Participant no longer meets study criteria|0|||
161413630|NCT01545050|582900850|FG003|Overall Study|Participant no longer meets study criteria|0|||
161413631|NCT01545050|582900851|FG004|Overall Study|Participant no longer meets study criteria|1|||
161413632|NCT01545050|582900847|FG000|Overall Study|Administrative reason by sponsor|4|||
161413633|NCT01545050|582900848|FG001|Overall Study|Administrative reason by sponsor|2|||
161413634|NCT01545050|582900849|FG002|Overall Study|Administrative reason by sponsor|3|||
161413635|NCT01545050|582900850|FG003|Overall Study|Administrative reason by sponsor|5|||
161413636|NCT01545050|582900851|FG004|Overall Study|Administrative reason by sponsor|5|||
161413637|NCT02249182|582900852|FG000|Treatment Phase|Lost to Follow-up|4|||
161413638|NCT02249182|582900853|FG001|Treatment Phase|Lost to Follow-up|0|||
161413639|NCT02249182|582900854|FG002|Treatment Phase|Lost to Follow-up|0|||
161413640|NCT02249182|582900855|FG003|Treatment Phase|Lost to Follow-up|0|||
161413641|NCT02249182|582900856|FG004|Treatment Phase|Lost to Follow-up|0|||
161413642|NCT03244826|582900863|FG000|Overall Study|Withdrawal by Subject|2|||
161413643|NCT03244826|582900864|FG001|Overall Study|Withdrawal by Subject|0|||
161413644|NCT03244826|582900863|FG000|Overall Study|Transplant delayed or withdrawn|12|||
161413645|NCT03244826|582900864|FG001|Overall Study|Transplant delayed or withdrawn|10|||
161413646|NCT04356040|582900865|FG000|Overall Study|Death|2|||
161413647|NCT04356040|582900866|FG001|Overall Study|Death|0|||
161413648|NCT04356040|582900865|FG000|Overall Study|Lost to Follow-up|1|||
161413649|NCT04356040|582900866|FG001|Overall Study|Lost to Follow-up|0|||
161413650|NCT04356040|582900865|FG000|Overall Study|Physician Decision|0|||
161413651|NCT04356040|582900866|FG001|Overall Study|Physician Decision|1|||
161413652|NCT04356040|582900865|FG000|Overall Study|Withdrawal by Subject|13|||
161413653|NCT04356040|582900866|FG001|Overall Study|Withdrawal by Subject|1|||
161413654|NCT04356040|582900865|FG000|Overall Study|Enrollment Pause|10|||
161413655|NCT04356040|582900866|FG001|Overall Study|Enrollment Pause|0|||
161413656|NCT04356040|582900865|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
161413657|NCT04356040|582900866|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
161413658|NCT04356040|582900865|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
161413659|NCT04356040|582900866|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
161413660|NCT04356040|582900865|FG000|Overall Study|PI left institution|3|||
161413661|NCT04356040|582900866|FG001|Overall Study|PI left institution|0|||
161413662|NCT00416455|582900867|FG000|Overall Study|PET / CT not done|3|||
161413663|NCT00416455|582900868|FG001|Overall Study|PET / CT not done|5|||
161413664|NCT00416455|582900867|FG000|Overall Study|PET / CT poor quality|2|||
161413665|NCT00416455|582900868|FG001|Overall Study|PET / CT poor quality|1|||
161413666|NCT00416455|582900867|FG000|Overall Study|Inadequate pathology|11|||
161413667|NCT00416455|582900868|FG001|Overall Study|Inadequate pathology|2|||
161413668|NCT02456857|582900869|FG000|Overall Study|Disease Progression|4|||
161413669|NCT00781859|582900870|FG000|Overall Study|Adverse Event|2|||
161413670|NCT00781859|582900871|FG001|Overall Study|Adverse Event|2|||
161413671|NCT00781859|582900870|FG000|Overall Study|Withdrawal by Subject|8|||
161413672|NCT00781859|582900871|FG001|Overall Study|Withdrawal by Subject|4|||
161413673|NCT00781859|582900870|FG000|Overall Study|Lost to Follow-up|6|||
161413674|NCT00781859|582900871|FG001|Overall Study|Lost to Follow-up|3|||
161413675|NCT00781859|582900870|FG000|Overall Study|Death|3|||
161413676|NCT00781859|582900871|FG001|Overall Study|Death|0|||
161413677|NCT01138501|582900872|FG000|Overall Study|Protocol Violation|2|||
161413678|NCT01138501|582900872|FG000|Overall Study|Withdrawal by Subject|3|||
161413679|NCT00360568|582900873|FG000|Overall Study|Adverse Event|1|||
161413680|NCT00360568|582900874|FG001|Overall Study|Adverse Event|2|||
161413681|NCT00360568|582900873|FG000|Overall Study|Lack of Efficacy|1|||
161413682|NCT00360568|582900874|FG001|Overall Study|Lack of Efficacy|0|||
161413683|NCT00360568|582900873|FG000|Overall Study|Withdrawal by Subject|0|||
161413684|NCT00360568|582900874|FG001|Overall Study|Withdrawal by Subject|3|||
161413685|NCT01008449|582900875|FG000|Overall Study|Lost to Follow-up|29|||
161413686|NCT01008449|582900876|FG001|Overall Study|Lost to Follow-up|19|||
161413687|NCT01220180|582900877|FG000|Overall Study|Lost to Follow-up|76|||
161413688|NCT01220180|582900877|FG000|Overall Study|Other|72|||
161413689|NCT01220180|582900877|FG000|Overall Study|Adverse Event|35|||
161413690|NCT01220180|582900877|FG000|Overall Study|Lack of Efficacy|22|||
161413691|NCT01220180|582900877|FG000|Overall Study|Death|1|||
161413692|NCT01220180|582900877|FG000|Overall Study|Randomized but not treated|1|||
161413693|NCT00348309|582900878|FG000|Overall Study|Adverse Event|56|||
161413694|NCT00348309|582900879|FG001|Overall Study|Adverse Event|28|||
161413695|NCT00348309|582900880|FG002|Overall Study|Adverse Event|63|||
161413696|NCT00348309|582900878|FG000|Overall Study|Lost to Follow-up|6|||
161413697|NCT00348309|582900879|FG001|Overall Study|Lost to Follow-up|7|||
161413698|NCT00348309|582900880|FG002|Overall Study|Lost to Follow-up|4|||
161413699|NCT00348309|582900878|FG000|Overall Study|Protocol Violation|7|||
161413700|NCT00348309|582900879|FG001|Overall Study|Protocol Violation|12|||
161413701|NCT00348309|582900880|FG002|Overall Study|Protocol Violation|7|||
161413702|NCT00348309|582900878|FG000|Overall Study|Withdrawal by Subject|33|||
161413703|NCT00348309|582900879|FG001|Overall Study|Withdrawal by Subject|37|||
161413704|NCT00348309|582900880|FG002|Overall Study|Withdrawal by Subject|40|||
161413705|NCT00348309|582900878|FG000|Overall Study|Non-compliance|8|||
161413706|NCT00348309|582900879|FG001|Overall Study|Non-compliance|6|||
161413707|NCT00348309|582900880|FG002|Overall Study|Non-compliance|8|||
161413708|NCT00348309|582900878|FG000|Overall Study|Death of caregiver|1|||
161413709|NCT00348309|582900879|FG001|Overall Study|Death of caregiver|0|||
161413710|NCT00348309|582900880|FG002|Overall Study|Death of caregiver|1|||
161413711|NCT00348309|582900878|FG000|Overall Study|Lack of insight, dementia|1|||
161413712|NCT00348309|582900879|FG001|Overall Study|Lack of insight, dementia|0|||
161413713|NCT00348309|582900880|FG002|Overall Study|Lack of insight, dementia|0|||
161413714|NCT00348309|582900878|FG000|Overall Study|Wrong bottle allocated|1|||
161413715|NCT00348309|582900879|FG001|Overall Study|Wrong bottle allocated|0|||
161413716|NCT00348309|582900880|FG002|Overall Study|Wrong bottle allocated|0|||
161413717|NCT00348309|582900878|FG000|Overall Study|Caregiver sick|1|||
161413718|NCT00348309|582900879|FG001|Overall Study|Caregiver sick|0|||
161413719|NCT00348309|582900880|FG002|Overall Study|Caregiver sick|0|||
161413720|NCT00348309|582900878|FG000|Overall Study|Use of prohibited medication|5|||
161413721|NCT00348309|582900879|FG001|Overall Study|Use of prohibited medication|2|||
161413722|NCT00348309|582900880|FG002|Overall Study|Use of prohibited medication|2|||
161413723|NCT00348309|582900878|FG000|Overall Study|Caregiver withdrawal|3|||
161413724|NCT00348309|582900879|FG001|Overall Study|Caregiver withdrawal|0|||
161413725|NCT00348309|582900880|FG002|Overall Study|Caregiver withdrawal|7|||
161413726|NCT00348309|582900878|FG000|Overall Study|Unable to complete ET visit|1|||
161413727|NCT00348309|582900879|FG001|Overall Study|Unable to complete ET visit|0|||
161413728|NCT00348309|582900880|FG002|Overall Study|Unable to complete ET visit|0|||
161413729|NCT00348309|582900878|FG000|Overall Study|PI closing medical practice|1|||
161413730|NCT00348309|582900879|FG001|Overall Study|PI closing medical practice|0|||
161413731|NCT00348309|582900880|FG002|Overall Study|PI closing medical practice|0|||
161413732|NCT00348309|582900878|FG000|Overall Study|Principal investigator's decision|1|||
161413733|NCT00348309|582900879|FG001|Overall Study|Principal investigator's decision|0|||
161413734|NCT00348309|582900880|FG002|Overall Study|Principal investigator's decision|0|||
161413735|NCT00348309|582900878|FG000|Overall Study|No disponibility of medication|1|||
161413736|NCT00348309|582900879|FG001|Overall Study|No disponibility of medication|0|||
161413737|NCT00348309|582900880|FG002|Overall Study|No disponibility of medication|0|||
161413738|NCT00348309|582900878|FG000|Overall Study|Worsened neurodegenerative disease|1|||
161413739|NCT00348309|582900879|FG001|Overall Study|Worsened neurodegenerative disease|0|||
161413740|NCT00348309|582900880|FG002|Overall Study|Worsened neurodegenerative disease|0|||
161413741|NCT00348309|582900878|FG000|Overall Study|Cognitive and behaviour worsening|2|||
161413742|NCT00348309|582900879|FG001|Overall Study|Cognitive and behaviour worsening|0|||
161413743|NCT00348309|582900880|FG002|Overall Study|Cognitive and behaviour worsening|0|||
161413744|NCT00348309|582900878|FG000|Overall Study|Worsening of alzheimer|1|||
161413745|NCT00348309|582900879|FG001|Overall Study|Worsening of alzheimer|0|||
161413746|NCT00348309|582900880|FG002|Overall Study|Worsening of alzheimer|1|||
161413747|NCT00348309|582900878|FG000|Overall Study|Did not appear in time for Visit 3|1|||
161413748|NCT00348309|582900879|FG001|Overall Study|Did not appear in time for Visit 3|0|||
161413749|NCT00348309|582900880|FG002|Overall Study|Did not appear in time for Visit 3|0|||
161413750|NCT00348309|582900878|FG000|Overall Study|Participant died|2|||
161413751|NCT00348309|582900879|FG001|Overall Study|Participant died|1|||
161413752|NCT00348309|582900880|FG002|Overall Study|Participant died|1|||
161413753|NCT00348309|582900878|FG000|Overall Study|Decision of sponsor|1|||
161413754|NCT00348309|582900879|FG001|Overall Study|Decision of sponsor|0|||
161413755|NCT00348309|582900880|FG002|Overall Study|Decision of sponsor|0|||
161413756|NCT00348309|582900878|FG000|Overall Study|Ineffectiveness of treatment|0|||
161413757|NCT00348309|582900879|FG001|Overall Study|Ineffectiveness of treatment|1|||
161413758|NCT00348309|582900880|FG002|Overall Study|Ineffectiveness of treatment|0|||
161413759|NCT00348309|582900878|FG000|Overall Study|A foul of exclusion criteria|0|||
161413760|NCT00348309|582900879|FG001|Overall Study|A foul of exclusion criteria|1|||
161413761|NCT00348309|582900880|FG002|Overall Study|A foul of exclusion criteria|0|||
161413762|NCT00348309|582900878|FG000|Overall Study|Participant was hospitalized|0|||
161413763|NCT00348309|582900879|FG001|Overall Study|Participant was hospitalized|1|||
161413764|NCT00348309|582900880|FG002|Overall Study|Participant was hospitalized|0|||
161413765|NCT00348309|582900878|FG000|Overall Study|Sponsor refuseal|0|||
161413766|NCT00348309|582900879|FG001|Overall Study|Sponsor refuseal|1|||
161413767|NCT00348309|582900880|FG002|Overall Study|Sponsor refuseal|1|||
161413768|NCT00348309|582900878|FG000|Overall Study|Forgot often medication|0|||
161413769|NCT00348309|582900879|FG001|Overall Study|Forgot often medication|1|||
161413770|NCT00348309|582900880|FG002|Overall Study|Forgot often medication|0|||
161413771|NCT00348309|582900878|FG000|Overall Study|Medical Monitor decision|0|||
161413772|NCT00348309|582900879|FG001|Overall Study|Medical Monitor decision|0|||
161413773|NCT00348309|582900880|FG002|Overall Study|Medical Monitor decision|1|||
161413774|NCT00348309|582900878|FG000|Overall Study|Increased dose of Aricept|0|||
161413775|NCT00348309|582900879|FG001|Overall Study|Increased dose of Aricept|0|||
161413776|NCT00348309|582900880|FG002|Overall Study|Increased dose of Aricept|1|||
161413777|NCT00348309|582900878|FG000|Overall Study|Site closure|0|||
161413778|NCT00348309|582900879|FG001|Overall Study|Site closure|0|||
161413779|NCT00348309|582900880|FG002|Overall Study|Site closure|1|||
161413780|NCT00348309|582900878|FG000|Overall Study|Adverse event not attended|0|||
161413781|NCT00348309|582900879|FG001|Overall Study|Adverse event not attended|0|||
161413782|NCT00348309|582900880|FG002|Overall Study|Adverse event not attended|1|||
161413783|NCT00348309|582900878|FG000|Overall Study|ECG abnormal|0|||
161413784|NCT00348309|582900879|FG001|Overall Study|ECG abnormal|0|||
161413785|NCT00348309|582900880|FG002|Overall Study|ECG abnormal|2|||
161413786|NCT00348309|582900878|FG000|Overall Study|Cardiologist recommendations|0|||
161413787|NCT00348309|582900879|FG001|Overall Study|Cardiologist recommendations|0|||
161413788|NCT00348309|582900880|FG002|Overall Study|Cardiologist recommendations|1|||
161413789|NCT00348309|582900878|FG000|Overall Study|HCV career|0|||
161413790|NCT00348309|582900879|FG001|Overall Study|HCV career|0|||
161413791|NCT00348309|582900880|FG002|Overall Study|HCV career|1|||
161413792|NCT01364389|582900883|FG000|Overall Study|Withdrawal by Subject|0|||
161413793|NCT01364389|582900884|FG001|Overall Study|Withdrawal by Subject|1|||
161413794|NCT01364389|582900885|FG002|Overall Study|Withdrawal by Subject|0|||
161413795|NCT01364389|582900883|FG000|Overall Study|Protocol deviation|0|||
161413796|NCT01364389|582900884|FG001|Overall Study|Protocol deviation|0|||
161413797|NCT01364389|582900885|FG002|Overall Study|Protocol deviation|1|||
161413798|NCT01364389|582900883|FG000|Overall Study|Administrative problems|1|||
161413799|NCT01364389|582900884|FG001|Overall Study|Administrative problems|0|||
161413800|NCT01364389|582900885|FG002|Overall Study|Administrative problems|0|||
161413801|NCT01364389|582900883|FG000|Overall Study|Adverse Event|1|||
161413802|NCT01364389|582900884|FG001|Overall Study|Adverse Event|0|||
161413803|NCT01364389|582900885|FG002|Overall Study|Adverse Event|0|||
161413804|NCT01534195|582900886|FG000|Overall Study|Withdrawal by Subject|1|||
161413805|NCT01534195|582900887|FG001|Overall Study|Withdrawal by Subject|1|||
161413806|NCT02554981|582900888|FG000|Overall Study|Adverse Event|1|||
161413807|NCT02554981|582900888|FG000|Overall Study|Administrative Reasons|1|||
161413808|NCT02554981|582900888|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161413809|NCT01630889|582900889|FG000|Overall Study|Death|2|||
161413810|NCT01630889|582900889|FG000|Overall Study|Withdrawal by Subject|1|||
161413811|NCT01630889|582900889|FG000|Overall Study|Other than Specified|2|||
161413812|NCT01630889|582900889|FG000|Overall Study|Lost to Follow-up|4|||
161413813|NCT01630889|582900889|FG000|Overall Study|Other|1|||
161413814|NCT02475278|582903215|FG000|Overall Study|Lost to Follow-up|1|||
161413815|NCT02475278|582903215|FG000|Overall Study|Reason Not Specified|1|||
161413816|NCT01946152|582903216|FG000|Overall Study|Adverse Event|1|||
161413817|NCT01946152|582903217|FG001|Overall Study|Adverse Event|0|||
161413818|NCT01946152|582903218|FG002|Overall Study|Adverse Event|0|||
161413819|NCT01946152|582903219|FG003|Overall Study|Adverse Event|0|||
161413820|NCT01946152|582903216|FG000|Overall Study|Withdrawal by Subject|0|||
161413821|NCT01946152|582903217|FG001|Overall Study|Withdrawal by Subject|2|||
161413822|NCT01946152|582903218|FG002|Overall Study|Withdrawal by Subject|0|||
161413823|NCT01946152|582903219|FG003|Overall Study|Withdrawal by Subject|0|||
161413824|NCT01946152|582903216|FG000|Overall Study|Progression|0|||
161413825|NCT01946152|582903217|FG001|Overall Study|Progression|1|||
161413826|NCT01946152|582903218|FG002|Overall Study|Progression|4|||
161413827|NCT01946152|582903219|FG003|Overall Study|Progression|7|||
161413828|NCT01946152|582903216|FG000|Overall Study|Physician Decision|0|||
161413829|NCT01946152|582903217|FG001|Overall Study|Physician Decision|0|||
161413830|NCT01946152|582903218|FG002|Overall Study|Physician Decision|1|||
161413831|NCT01946152|582903219|FG003|Overall Study|Physician Decision|0|||
161413832|NCT01946152|582903216|FG000|Overall Study|Second malignancy|0|||
161413833|NCT01946152|582903217|FG001|Overall Study|Second malignancy|0|||
161413834|NCT01946152|582903218|FG002|Overall Study|Second malignancy|1|||
161413835|NCT01946152|582903219|FG003|Overall Study|Second malignancy|0|||
161413836|NCT01946152|582903216|FG000|Overall Study|Adverse Event|0|||
161413837|NCT01946152|582903217|FG001|Overall Study|Adverse Event|0|||
161413838|NCT01946152|582903218|FG002|Overall Study|Adverse Event|0|||
161413839|NCT01946152|582903219|FG003|Overall Study|Adverse Event|1|||
161413840|NCT03712787|582903220|FG000|Overall Study|Adverse Event|2|||
161413841|NCT03712787|582903221|FG001|Overall Study|Adverse Event|3|||
161413842|NCT03712787|582903222|FG002|Overall Study|Adverse Event|0|||
161413843|NCT03712787|582903223|FG003|Overall Study|Adverse Event|4|||
161413844|NCT03712787|582903220|FG000|Overall Study|Withdrawal by Subject|4|||
161413845|NCT03712787|582903221|FG001|Overall Study|Withdrawal by Subject|14|||
161413846|NCT03712787|582903222|FG002|Overall Study|Withdrawal by Subject|12|||
161413847|NCT03712787|582903223|FG003|Overall Study|Withdrawal by Subject|8|||
161413848|NCT03712787|582903220|FG000|Overall Study|Lost to Follow-up|1|||
161413849|NCT03712787|582903221|FG001|Overall Study|Lost to Follow-up|1|||
161413850|NCT03712787|582903222|FG002|Overall Study|Lost to Follow-up|2|||
161413851|NCT03712787|582903223|FG003|Overall Study|Lost to Follow-up|1|||
161413852|NCT03712787|582903220|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161413853|NCT03712787|582903221|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161413854|NCT03712787|582903222|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
161413855|NCT03712787|582903223|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
161413856|NCT03712787|582903220|FG000|Overall Study|COVID-19 Infection|0|||
161413857|NCT03712787|582903221|FG001|Overall Study|COVID-19 Infection|1|||
161413858|NCT03712787|582903222|FG002|Overall Study|COVID-19 Infection|0|||
161413859|NCT03712787|582903223|FG003|Overall Study|COVID-19 Infection|0|||
161413860|NCT03712787|582903220|FG000|Overall Study|Other, Not Specified|79|||
161413861|NCT03712787|582903221|FG001|Overall Study|Other, Not Specified|77|||
161413862|NCT03712787|582903222|FG002|Overall Study|Other, Not Specified|74|||
161413863|NCT03712787|582903223|FG003|Overall Study|Other, Not Specified|78|||
161413864|NCT01865448|582903224|FG000|Overall Study|Adverse Event|1|||
161413865|NCT01865448|582903225|FG001|Overall Study|Adverse Event|1|||
161413866|NCT01865448|582903224|FG000|Overall Study|Pregnancy|0|||
161413867|NCT01865448|582903225|FG001|Overall Study|Pregnancy|1|||
161413868|NCT01865448|582903224|FG000|Overall Study|dropout unrelated to study|1|||
161413869|NCT01865448|582903225|FG001|Overall Study|dropout unrelated to study|1|||
161413870|NCT03499314|582903226|FG000|Overall Study|Time Commitment|1|||
161413871|NCT03499314|582903227|FG001|Overall Study|Time Commitment|2|||
161413872|NCT03499314|582903226|FG000|Overall Study|Medical issue unrelated to research study|1|||
161413873|NCT03499314|582903227|FG001|Overall Study|Medical issue unrelated to research study|1|||
161413874|NCT01618695|582903228|FG000|Core Phase|Adverse Event|4|||
161413875|NCT01618695|582903229|FG001|Core Phase|Adverse Event|5|||
161413876|NCT01618695|582903230|FG002|Core Phase|Adverse Event|15|||
161413877|NCT01618695|582903231|FG003|Core Phase|Adverse Event|20|||
161413878|NCT01618695|582903228|FG000|Core Phase|Lost to Follow-up|0|||
161413879|NCT01618695|582903229|FG001|Core Phase|Lost to Follow-up|0|||
161413880|NCT01618695|582903230|FG002|Core Phase|Lost to Follow-up|1|||
161413881|NCT01618695|582903231|FG003|Core Phase|Lost to Follow-up|0|||
161413882|NCT01618695|582903228|FG000|Core Phase|Withdrawal by Subject|16|||
161413883|NCT01618695|582903229|FG001|Core Phase|Withdrawal by Subject|11|||
161413884|NCT01618695|582903230|FG002|Core Phase|Withdrawal by Subject|9|||
161413885|NCT01618695|582903231|FG003|Core Phase|Withdrawal by Subject|13|||
161413886|NCT01618695|582903228|FG000|Core Phase|Pregnancy|2|||
161413887|NCT01618695|582903229|FG001|Core Phase|Pregnancy|0|||
161413888|NCT01618695|582903230|FG002|Core Phase|Pregnancy|0|||
161413889|NCT01618695|582903231|FG003|Core Phase|Pregnancy|0|||
161413890|NCT01618695|582903228|FG000|Core Phase|Lack of Efficacy|1|||
161413891|NCT01618695|582903229|FG001|Core Phase|Lack of Efficacy|2|||
161413892|NCT01618695|582903230|FG002|Core Phase|Lack of Efficacy|1|||
161413893|NCT01618695|582903231|FG003|Core Phase|Lack of Efficacy|1|||
161413894|NCT01618695|582903228|FG000|Core Phase|Other than specified|1|||
161413895|NCT01618695|582903229|FG001|Core Phase|Other than specified|2|||
161413896|NCT01618695|582903230|FG002|Core Phase|Other than specified|2|||
161413897|NCT01618695|582903231|FG003|Core Phase|Other than specified|2|||
161413898|NCT01618695|582903228|FG000|Core Phase|Not treated|1|||
161413899|NCT01618695|582903229|FG001|Core Phase|Not treated|0|||
161413900|NCT01618695|582903230|FG002|Core Phase|Not treated|2|||
161413901|NCT01618695|582903231|FG003|Core Phase|Not treated|0|||
161413902|NCT01618695|582903228|FG000|Extension Phase|Lack of Efficacy|17|||
161413903|NCT01618695|582903229|FG001|Extension Phase|Lack of Efficacy|33|||
161413904|NCT01618695|582903230|FG002|Extension Phase|Lack of Efficacy|26|||
161413905|NCT01618695|582903231|FG003|Extension Phase|Lack of Efficacy|24|||
161413906|NCT01618695|582903228|FG000|Extension Phase|Pregnancy|2|||
161413907|NCT01618695|582903229|FG001|Extension Phase|Pregnancy|0|||
161413908|NCT01618695|582903230|FG002|Extension Phase|Pregnancy|1|||
161413909|NCT01618695|582903231|FG003|Extension Phase|Pregnancy|1|||
161413910|NCT01618695|582903228|FG000|Extension Phase|Withdrawal by Subject|43|||
161413911|NCT01618695|582903229|FG001|Extension Phase|Withdrawal by Subject|48|||
161413912|NCT01618695|582903230|FG002|Extension Phase|Withdrawal by Subject|42|||
161413913|NCT01618695|582903231|FG003|Extension Phase|Withdrawal by Subject|33|||
161413914|NCT01618695|582903228|FG000|Extension Phase|Adverse Event|18|||
161413915|NCT01618695|582903229|FG001|Extension Phase|Adverse Event|16|||
161413916|NCT01618695|582903230|FG002|Extension Phase|Adverse Event|9|||
161413917|NCT01618695|582903231|FG003|Extension Phase|Adverse Event|20|||
161413918|NCT01618695|582903228|FG000|Extension Phase|Lost to Follow-up|2|||
161413919|NCT01618695|582903229|FG001|Extension Phase|Lost to Follow-up|1|||
161413920|NCT01618695|582903230|FG002|Extension Phase|Lost to Follow-up|1|||
161413921|NCT01618695|582903231|FG003|Extension Phase|Lost to Follow-up|1|||
161413922|NCT01618695|582903228|FG000|Extension Phase|Other than specified|13|||
161413923|NCT01618695|582903229|FG001|Extension Phase|Other than specified|18|||
161413924|NCT01618695|582903230|FG002|Extension Phase|Other than specified|13|||
161413925|NCT01618695|582903231|FG003|Extension Phase|Other than specified|18|||
161413926|NCT02291419|582903235|FG000|Overall Study|Early study termination|1|||
161413927|NCT02291419|582903236|FG001|Overall Study|Early study termination|5|||
161413928|NCT00931606|582903237|FG000|Overall Study|Death|1|||
161413929|NCT00931606|582903238|FG001|Overall Study|Death|3|||
161413930|NCT00931606|582903239|FG002|Overall Study|Death|2|||
161413931|NCT00931606|582903240|FG003|Overall Study|Death|0|||
161413932|NCT00931606|582903237|FG000|Overall Study|Lost to Follow-up|0|||
161413933|NCT00931606|582903238|FG001|Overall Study|Lost to Follow-up|1|||
161413934|NCT00931606|582903239|FG002|Overall Study|Lost to Follow-up|0|||
161413935|NCT00931606|582903240|FG003|Overall Study|Lost to Follow-up|0|||
161413936|NCT00931606|582903237|FG000|Overall Study|Physician Decision|0|||
161413937|NCT00931606|582903238|FG001|Overall Study|Physician Decision|0|||
161413938|NCT00931606|582903239|FG002|Overall Study|Physician Decision|3|||
161413939|NCT00931606|582903240|FG003|Overall Study|Physician Decision|0|||
161413940|NCT00931606|582903237|FG000|Overall Study|Sponsor Decision|1|||
161413941|NCT00931606|582903238|FG001|Overall Study|Sponsor Decision|4|||
161413942|NCT00931606|582903239|FG002|Overall Study|Sponsor Decision|0|||
161413943|NCT00931606|582903240|FG003|Overall Study|Sponsor Decision|2|||
161413944|NCT00931606|582903237|FG000|Overall Study|Withdrawal by Subject|3|||
161413945|NCT00931606|582903238|FG001|Overall Study|Withdrawal by Subject|1|||
161413946|NCT00931606|582903239|FG002|Overall Study|Withdrawal by Subject|1|||
161413947|NCT00931606|582903240|FG003|Overall Study|Withdrawal by Subject|1|||
161413948|NCT00871338|582903241|FG000|Prior to Booster|Withdrawal by Subject|1|||
161413949|NCT00871338|582903242|FG001|Prior to Booster|Withdrawal by Subject|3|||
161413950|NCT00871338|582903241|FG000|Prior to Booster|Lost to Follow-up|1|||
161413951|NCT00871338|582903242|FG001|Prior to Booster|Lost to Follow-up|0|||
161413952|NCT02391363|582903243|FG000|Overall Study|Lost to Follow-up|5|||
161413953|NCT02391363|582903244|FG001|Overall Study|Lost to Follow-up|5|||
161413954|NCT02391363|582903243|FG000|Overall Study|Withdrawal by Subject|6|||
161413955|NCT02391363|582903244|FG001|Overall Study|Withdrawal by Subject|3|||
161413956|NCT00799266|582903245|FG000|Overall Study|Adverse Event|0|||
161413957|NCT00799266|582903246|FG001|Overall Study|Adverse Event|1|||
161413958|NCT00799266|582903245|FG000|Overall Study|Subject withdrew consent|3|||
161413959|NCT00799266|582903246|FG001|Overall Study|Subject withdrew consent|0|||
161413960|NCT00872599|582903247|FG000|Second Washout Period|Adverse Event|1|||
161413961|NCT00872599|582903248|FG001|Second Washout Period|Adverse Event|1|||
161413962|NCT04794270|582903249|FG000|Period 1|Non Compliance|1|||
161413963|NCT04794270|582903250|FG001|Period 1|Non Compliance|0|||
161413964|NCT04794270|582903249|FG000|Period 1|Adverse Event|1|||
161413965|NCT04794270|582903250|FG001|Period 1|Adverse Event|0|||
161413966|NCT04794270|582903249|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
161413967|NCT04794270|582903250|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
161413968|NCT00265317|582903254|FG000|Lead-In|Objective progression or relapse|6|||
161413969|NCT00265317|582903255|FG001|Lead-In|Objective progression or relapse|11|||
161413970|NCT00265317|582903256|FG002|Lead-In|Objective progression or relapse|0|||
161413971|NCT00265317|582903257|FG003|Lead-In|Objective progression or relapse|0|||
161413972|NCT00265317|582903254|FG000|Lead-In|Adverse Event|2|||
161413973|NCT00265317|582903255|FG001|Lead-In|Adverse Event|1|||
161413974|NCT00265317|582903256|FG002|Lead-In|Adverse Event|0|||
161413975|NCT00265317|582903257|FG003|Lead-In|Adverse Event|0|||
161413976|NCT00265317|582903254|FG000|Lead-In|Death|3|||
161413977|NCT00265317|582903255|FG001|Lead-In|Death|5|||
161413978|NCT00265317|582903256|FG002|Lead-In|Death|0|||
161413979|NCT00265317|582903257|FG003|Lead-In|Death|0|||
161413980|NCT00265317|582903254|FG000|Lead-In|Withdrawal/other than adverse event|1|||
161413981|NCT00265317|582903255|FG001|Lead-In|Withdrawal/other than adverse event|0|||
161413982|NCT00265317|582903256|FG002|Lead-In|Withdrawal/other than adverse event|0|||
161413983|NCT00265317|582903257|FG003|Lead-In|Withdrawal/other than adverse event|0|||
161413984|NCT00265317|582903254|FG000|Phase 2|Objective progression or relapse|0|||
161413985|NCT00265317|582903255|FG001|Phase 2|Objective progression or relapse|0|||
161413986|NCT00265317|582903256|FG002|Phase 2|Objective progression or relapse|37|||
161413987|NCT00265317|582903257|FG003|Phase 2|Objective progression or relapse|38|||
161413988|NCT00265317|582903254|FG000|Phase 2|Global deterioration of health status|0|||
161413989|NCT00265317|582903255|FG001|Phase 2|Global deterioration of health status|0|||
161413990|NCT00265317|582903256|FG002|Phase 2|Global deterioration of health status|3|||
161413991|NCT00265317|582903257|FG003|Phase 2|Global deterioration of health status|0|||
161413992|NCT00265317|582903254|FG000|Phase 2|Adverse Event|0|||
161413993|NCT00265317|582903255|FG001|Phase 2|Adverse Event|0|||
161413994|NCT00265317|582903256|FG002|Phase 2|Adverse Event|7|||
161413995|NCT00265317|582903257|FG003|Phase 2|Adverse Event|5|||
161413996|NCT00265317|582903254|FG000|Phase 2|Death|0|||
161413997|NCT00265317|582903255|FG001|Phase 2|Death|0|||
161413998|NCT00265317|582903256|FG002|Phase 2|Death|12|||
161413999|NCT00265317|582903257|FG003|Phase 2|Death|15|||
161414000|NCT00265317|582903254|FG000|Phase 2|Protocol Violation|0|||
161414001|NCT00265317|582903255|FG001|Phase 2|Protocol Violation|0|||
161414002|NCT00265317|582903256|FG002|Phase 2|Protocol Violation|1|||
161414003|NCT00265317|582903257|FG003|Phase 2|Protocol Violation|4|||
161414004|NCT00265317|582903254|FG000|Phase 2|Lost to Follow-up|0|||
161414005|NCT00265317|582903255|FG001|Phase 2|Lost to Follow-up|0|||
161414006|NCT00265317|582903256|FG002|Phase 2|Lost to Follow-up|0|||
161414007|NCT00265317|582903257|FG003|Phase 2|Lost to Follow-up|1|||
161414008|NCT00265317|582903254|FG000|Phase 2|Withdrawal/other than adverse event|0|||
161414009|NCT00265317|582903255|FG001|Phase 2|Withdrawal/other than adverse event|0|||
161414010|NCT00265317|582903256|FG002|Phase 2|Withdrawal/other than adverse event|2|||
161414011|NCT00265317|582903257|FG003|Phase 2|Withdrawal/other than adverse event|1|||
161414012|NCT00265317|582903254|FG000|Phase 2|Study terminated by sponsor|0|||
161414013|NCT00265317|582903255|FG001|Phase 2|Study terminated by sponsor|0|||
161414014|NCT00265317|582903256|FG002|Phase 2|Study terminated by sponsor|1|||
161414015|NCT00265317|582903257|FG003|Phase 2|Study terminated by sponsor|0|||
161414016|NCT00265317|582903254|FG000|Phase 2|Other|0|||
161414017|NCT00265317|582903255|FG001|Phase 2|Other|0|||
161414018|NCT00265317|582903256|FG002|Phase 2|Other|1|||
161414019|NCT00265317|582903257|FG003|Phase 2|Other|1|||
161414020|NCT00732875|582903260|FG000|Overall Study|Adverse Event|16|||
161414021|NCT00732875|582903260|FG000|Overall Study|Withdrawal by Subject|6|||
161414022|NCT00732875|582903260|FG000|Overall Study|Lack of Efficacy|13|||
161414023|NCT02300259|582903261|FG000|Period 1|Adverse Event|0|||
161414024|NCT02300259|582903262|FG001|Period 1|Adverse Event|0|||
161414025|NCT02300259|582903263|FG002|Period 1|Adverse Event|1|||
161414026|NCT02300259|582903261|FG000|Period 1|Withdrawal by Subject|0|||
161414027|NCT02300259|582903262|FG001|Period 1|Withdrawal by Subject|0|||
161414028|NCT02300259|582903263|FG002|Period 1|Withdrawal by Subject|1|||
161414029|NCT02300259|582903261|FG000|Period 2|Adverse Event|1|||
161414030|NCT02300259|582903262|FG001|Period 2|Adverse Event|0|||
161414031|NCT02300259|582903263|FG002|Period 2|Adverse Event|0|||
161414032|NCT02300259|582903261|FG000|Period 2|Withdrawal by Subject|0|||
161414033|NCT02300259|582903262|FG001|Period 2|Withdrawal by Subject|0|||
161414034|NCT02300259|582903263|FG002|Period 2|Withdrawal by Subject|1|||
161414035|NCT02510001|582903264|FG000|Overall Study|Early disease progression|0|||
161414036|NCT02510001|582903265|FG001|Overall Study|Early disease progression|0|||
161414037|NCT02510001|582903266|FG002|Overall Study|Early disease progression|0|||
161414038|NCT02510001|582903267|FG003|Overall Study|Early disease progression|1|||
161414039|NCT02510001|582903268|FG004|Overall Study|Early disease progression|1|||
161414040|NCT02510001|582903269|FG005|Overall Study|Early disease progression|1|||
161414041|NCT02510001|582903270|FG006|Overall Study|Early disease progression|0|||
161414042|NCT02510001|582903271|FG007|Overall Study|Early disease progression|0|||
161414043|NCT02510001|582903264|FG000|Overall Study|Adverse Event|0|||
161414044|NCT02510001|582903265|FG001|Overall Study|Adverse Event|0|||
161414045|NCT02510001|582903266|FG002|Overall Study|Adverse Event|0|||
161414046|NCT02510001|582903267|FG003|Overall Study|Adverse Event|1|||
161414047|NCT02510001|582903268|FG004|Overall Study|Adverse Event|2|||
161414048|NCT02510001|582903269|FG005|Overall Study|Adverse Event|1|||
161414049|NCT02510001|582903270|FG006|Overall Study|Adverse Event|2|||
161414050|NCT02510001|582903271|FG007|Overall Study|Adverse Event|5|||
161414051|NCT02510001|582903264|FG000|Overall Study|Physician Decision|0|||
161414052|NCT02510001|582903265|FG001|Overall Study|Physician Decision|0|||
161414053|NCT02510001|582903266|FG002|Overall Study|Physician Decision|0|||
161414054|NCT02510001|582903267|FG003|Overall Study|Physician Decision|0|||
161414055|NCT02510001|582903268|FG004|Overall Study|Physician Decision|1|||
161414056|NCT02510001|582903269|FG005|Overall Study|Physician Decision|0|||
161414057|NCT02510001|582903270|FG006|Overall Study|Physician Decision|0|||
161414058|NCT02510001|582903271|FG007|Overall Study|Physician Decision|0|||
161414059|NCT02510001|582903264|FG000|Overall Study|Withdrawal by Subject|0|||
161414060|NCT02510001|582903265|FG001|Overall Study|Withdrawal by Subject|0|||
161414061|NCT02510001|582903266|FG002|Overall Study|Withdrawal by Subject|0|||
161414062|NCT02510001|582903267|FG003|Overall Study|Withdrawal by Subject|0|||
161414063|NCT02510001|582903268|FG004|Overall Study|Withdrawal by Subject|0|||
161414064|NCT02510001|582903269|FG005|Overall Study|Withdrawal by Subject|0|||
161414065|NCT02510001|582903270|FG006|Overall Study|Withdrawal by Subject|0|||
161414066|NCT02510001|582903271|FG007|Overall Study|Withdrawal by Subject|2|||
161414067|NCT01504841|582903278|FG000|Overall Study|Withdrawal by Subject|1|||
161414068|NCT01504841|582903279|FG001|Overall Study|Withdrawal by Subject|1|||
161414069|NCT01504841|582903280|FG002|Overall Study|Withdrawal by Subject|0|||
161414070|NCT03149055|582903287|FG000|Overall Study|Not treated|4|||
161414071|NCT04440813|582903288|FG000|Overall Study|Lost to Follow-up|5|||
161414072|NCT04440813|582903289|FG001|Overall Study|Lost to Follow-up|5|||
161414073|NCT00660179|582903290|FG000|Overall Study|Death|44|||
161414074|NCT00660179|582903291|FG001|Overall Study|Death|47|||
161414075|NCT00660179|582903292|FG002|Overall Study|Death|34|||
161414076|NCT00660179|582903290|FG000|Overall Study|Withdrawal of consent|4|||
161414077|NCT00660179|582903291|FG001|Overall Study|Withdrawal of consent|6|||
161414078|NCT00660179|582903292|FG002|Overall Study|Withdrawal of consent|4|||
161414079|NCT00660179|582903290|FG000|Overall Study|Lost to Follow-up|7|||
161414080|NCT00660179|582903291|FG001|Overall Study|Lost to Follow-up|5|||
161414081|NCT00660179|582903292|FG002|Overall Study|Lost to Follow-up|2|||
161414082|NCT00660179|582903290|FG000|Overall Study|Administrative reason|0|||
161414083|NCT00660179|582903291|FG001|Overall Study|Administrative reason|0|||
161414084|NCT00660179|582903292|FG002|Overall Study|Administrative reason|1|||
161414085|NCT00660179|582903290|FG000|Overall Study|Incorrect randomization|1|||
161414086|NCT00660179|582903291|FG001|Overall Study|Incorrect randomization|0|||
161414087|NCT00660179|582903292|FG002|Overall Study|Incorrect randomization|0|||
161414088|NCT00291018|582903299|FG000|Overall Study|Not Consented or Declined PAS|12|||
161414089|NCT00291018|582903300|FG001|Overall Study|Not Consented or Declined PAS|15|||
161414090|NCT00291018|582903301|FG002|Overall Study|Not Consented or Declined PAS|15|||
161414091|NCT00291018|582903299|FG000|Overall Study|Death|3|||
161414092|NCT00291018|582903300|FG001|Overall Study|Death|3|||
161414093|NCT00291018|582903301|FG002|Overall Study|Death|4|||
161414094|NCT00291018|582903299|FG000|Overall Study|Withdrawal by Subject|2|||
161414095|NCT00291018|582903300|FG001|Overall Study|Withdrawal by Subject|8|||
161414096|NCT00291018|582903301|FG002|Overall Study|Withdrawal by Subject|1|||
161414097|NCT00291018|582903299|FG000|Overall Study|Failures|5|||
161414098|NCT00291018|582903300|FG001|Overall Study|Failures|12|||
161414099|NCT00291018|582903301|FG002|Overall Study|Failures|5|||
161414100|NCT00291018|582903299|FG000|Overall Study|Lost to Follow-up|3|||
161414101|NCT00291018|582903300|FG001|Overall Study|Lost to Follow-up|4|||
161414102|NCT00291018|582903301|FG002|Overall Study|Lost to Follow-up|18|||
161414103|NCT05362058|582903306|FG000|Treatment Period|Adverse Event|3|||
161414104|NCT05362058|582903307|FG001|Treatment Period|Adverse Event|3|||
161414105|NCT05362058|582903306|FG000|Treatment Period|Assigned treatment by mistake|3|||
161414106|NCT05362058|582903307|FG001|Treatment Period|Assigned treatment by mistake|4|||
161414107|NCT05362058|582903306|FG000|Treatment Period|Death|1|||
161414108|NCT05362058|582903307|FG001|Treatment Period|Death|1|||
161414109|NCT05362058|582903306|FG000|Treatment Period|Lost to Follow-up|6|||
161414110|NCT05362058|582903307|FG001|Treatment Period|Lost to Follow-up|3|||
161414111|NCT05362058|582903306|FG000|Treatment Period|Non-compliance with study drug|0|||
161414112|NCT05362058|582903307|FG001|Treatment Period|Non-compliance with study drug|1|||
161414113|NCT05362058|582903306|FG000|Treatment Period|Physician Decision|1|||
161414114|NCT05362058|582903307|FG001|Treatment Period|Physician Decision|0|||
161414115|NCT05362058|582903306|FG000|Treatment Period|Protocol deviation|1|||
161414116|NCT05362058|582903307|FG001|Treatment Period|Protocol deviation|0|||
161414117|NCT05362058|582903306|FG000|Treatment Period|Withdrawal by Subject|10|||
161414118|NCT05362058|582903307|FG001|Treatment Period|Withdrawal by Subject|11|||
161414119|NCT05362058|582903306|FG000|Follow-Up Period|Death|1|||
161414120|NCT05362058|582903307|FG001|Follow-Up Period|Death|0|||
161414121|NCT05362058|582903306|FG000|Follow-Up Period|Lost to Follow-up|2|||
161414122|NCT05362058|582903307|FG001|Follow-Up Period|Lost to Follow-up|1|||
161414123|NCT05362058|582903306|FG000|Follow-Up Period|Protocol deviation|1|||
161414124|NCT05362058|582903307|FG001|Follow-Up Period|Protocol deviation|1|||
161414125|NCT05362058|582903306|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161414126|NCT05362058|582903307|FG001|Follow-Up Period|Withdrawal by Subject|3|||
161414127|NCT00887549|582903310|FG000|Induction Therapy|Adverse Event|8|||
161414128|NCT00887549|582903310|FG000|Induction Therapy|Physician Decision|1|||
161414129|NCT00887549|582903310|FG000|Induction Therapy|Progressive Disease|13|||
161414130|NCT00887549|582903310|FG000|Induction Therapy|Death due to Study Disease|4|||
161414131|NCT00887549|582903310|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
161414132|NCT00887549|582903310|FG000|Maintenance Therapy|Adverse Event|16|||
161414133|NCT00887549|582903310|FG000|Maintenance Therapy|Physician Decision|1|||
161414134|NCT00887549|582903310|FG000|Maintenance Therapy|Progressive Disease|25|||
161414135|NCT00887549|582903310|FG000|Maintenance Therapy|Death due to adverse event|1|||
161414136|NCT01858740|582903311|FG000|Overall Study|Death|4|||
161414137|NCT03671304|582903312|FG000|Overall Study|study terminated|7|||
161414138|NCT02097030|582903317|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
161414139|NCT02097030|582903318|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
161414140|NCT02097030|582903317|FG000|First Intervention (3 Days)|Visual Acuity|0|||
161414141|NCT02097030|582903318|FG001|First Intervention (3 Days)|Visual Acuity|1|||
161414142|NCT00391027|582903319|FG000|Overall Study|Adverse Event|8|||
161414143|NCT00391027|582903320|FG001|Overall Study|Adverse Event|8|||
161414144|NCT00391027|582903319|FG000|Overall Study|Lack of Efficacy|3|||
161414145|NCT00391027|582903320|FG001|Overall Study|Lack of Efficacy|0|||
161414146|NCT00391027|582903319|FG000|Overall Study|Withdrawal by Subject|10|||
161414147|NCT00391027|582903320|FG001|Overall Study|Withdrawal by Subject|1|||
161414148|NCT00391027|582903319|FG000|Overall Study|Other|4|||
161414149|NCT00391027|582903320|FG001|Overall Study|Other|3|||
161414150|NCT05232864|582903321|FG000|Overall Study|Adverse Event|0|||
161414151|NCT05232864|582903322|FG001|Overall Study|Adverse Event|1|||
161414152|NCT05232864|582903321|FG000|Overall Study|Study terminated by sponsor|16|||
161414153|NCT05232864|582903322|FG001|Overall Study|Study terminated by sponsor|14|||
161414154|NCT04765202|582903326|FG000|Overall Study|Lost to Follow-up|1|||
161414155|NCT04765202|582903327|FG001|Overall Study|Lost to Follow-up|1|||
161414156|NCT04765202|582903328|FG002|Overall Study|Lost to Follow-up|2|||
161414157|NCT04765202|582903329|FG003|Overall Study|Lost to Follow-up|2|||
161414158|NCT04765202|582903326|FG000|Overall Study|Physician Decision|0|||
161414159|NCT04765202|582903327|FG001|Overall Study|Physician Decision|0|||
161414160|NCT04765202|582903328|FG002|Overall Study|Physician Decision|1|||
161414161|NCT04765202|582903329|FG003|Overall Study|Physician Decision|1|||
161414162|NCT04929249|582903330|FG000|Overall Study|Adverse Event|2|||
161414163|NCT04929249|582903331|FG001|Overall Study|Adverse Event|1|||
161414164|NCT04929249|582903330|FG000|Overall Study|Death|2|||
161414165|NCT04929249|582903331|FG001|Overall Study|Death|1|||
161414166|NCT04929249|582903330|FG000|Overall Study|Lost to Follow-up|3|||
161414167|NCT04929249|582903331|FG001|Overall Study|Lost to Follow-up|11|||
161414168|NCT04929249|582903330|FG000|Overall Study|Technical problems|0|||
161414169|NCT04929249|582903331|FG001|Overall Study|Technical problems|1|||
161414170|NCT04929249|582903330|FG000|Overall Study|Subject decision|6|||
161414171|NCT04929249|582903331|FG001|Overall Study|Subject decision|8|||
161414172|NCT04929249|582903330|FG000|Overall Study|Withdrew consent|0|||
161414173|NCT04929249|582903331|FG001|Overall Study|Withdrew consent|8|||
161414174|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
161414175|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
161414176|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
161414177|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
161414178|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Death|2|||
161414179|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Death|2|||
161414180|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Death|0|||
161414181|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Death|0|||
161414182|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
161414183|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
161414184|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
161414185|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
161414186|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
161414187|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
161414188|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
161414189|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
161414190|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
161414191|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
161414192|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
161414193|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
161414194|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
161414195|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
161414196|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
161414197|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
161414198|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
161414199|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
161414200|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
161414201|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
161414202|NCT03068754|582903332|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
161414203|NCT03068754|582903333|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
161414204|NCT03068754|582903334|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
161414205|NCT03068754|582903335|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
161414206|NCT03068754|582903332|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
161414207|NCT03068754|582903333|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
161414208|NCT03068754|582903334|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
161414209|NCT03068754|582903335|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
161414210|NCT03068754|582903332|FG000|Open Label Extension Period (OLE)|Death|0|||
161414211|NCT03068754|582903333|FG001|Open Label Extension Period (OLE)|Death|0|||
161414212|NCT03068754|582903334|FG002|Open Label Extension Period (OLE)|Death|0|||
161414213|NCT03068754|582903335|FG003|Open Label Extension Period (OLE)|Death|1|||
161414214|NCT03068754|582903332|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
161414215|NCT03068754|582903333|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
161414216|NCT03068754|582903334|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
161414217|NCT03068754|582903335|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
161414218|NCT03068754|582903332|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
161414219|NCT03068754|582903333|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
161414220|NCT03068754|582903334|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
161414221|NCT03068754|582903335|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
161414222|NCT03068754|582903332|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
161414223|NCT03068754|582903333|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
161414224|NCT03068754|582903334|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
161414225|NCT03068754|582903335|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
161414226|NCT03068754|582903332|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
161414227|NCT03068754|582903333|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
161414228|NCT03068754|582903334|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
161414229|NCT03068754|582903335|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
161414230|NCT00129467|582903336|FG000|Received Intervention|Death|1|||
161414231|NCT00129467|582903337|FG001|Received Intervention|Death|1|||
161414232|NCT00129467|582903336|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
161414233|NCT00129467|582903337|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
161414234|NCT00129467|582903336|FG000|Received Intervention|Delirium|2|||
161414235|NCT00129467|582903337|FG001|Received Intervention|Delirium|0|||
161414236|NCT00129467|582903336|FG000|Received Intervention|Withdrawal by Subject|1|||
161414237|NCT00129467|582903337|FG001|Received Intervention|Withdrawal by Subject|0|||
161414238|NCT00129467|582903336|FG000|Received Intervention|Nausea|1|||
161414239|NCT00129467|582903337|FG001|Received Intervention|Nausea|0|||
161414240|NCT00129467|582903336|FG000|Received Intervention|Intolerance to citalopram|0|||
161414241|NCT00129467|582903337|FG001|Received Intervention|Intolerance to citalopram|1|||
161414242|NCT00129467|582903336|FG000|Received Intervention|Dizzyness, fatigue|0|||
161414243|NCT00129467|582903337|FG001|Received Intervention|Dizzyness, fatigue|1|||
161414244|NCT00129467|582903336|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
161414245|NCT00129467|582903337|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
161414246|NCT00129467|582903336|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
161414247|NCT00129467|582903337|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
161414248|NCT01009086|582903338|FG000|Overall Study|Lack of Efficacy|16|||
161414249|NCT01009086|582903339|FG001|Overall Study|Lack of Efficacy|15|||
161414250|NCT01009086|582903340|FG002|Overall Study|Lack of Efficacy|9|||
161414251|NCT01009086|582903338|FG000|Overall Study|Lost to Follow-up|4|||
161414252|NCT01009086|582903339|FG001|Overall Study|Lost to Follow-up|5|||
161414253|NCT01009086|582903340|FG002|Overall Study|Lost to Follow-up|3|||
161414254|NCT01009086|582903338|FG000|Overall Study|Adverse Event|12|||
161414255|NCT01009086|582903339|FG001|Overall Study|Adverse Event|11|||
161414256|NCT01009086|582903340|FG002|Overall Study|Adverse Event|8|||
161414257|NCT01009086|582903338|FG000|Overall Study|Withdrawal by Subject|9|||
161414258|NCT01009086|582903339|FG001|Overall Study|Withdrawal by Subject|11|||
161414259|NCT01009086|582903340|FG002|Overall Study|Withdrawal by Subject|13|||
161414260|NCT01009086|582903338|FG000|Overall Study|Other|3|||
161414261|NCT01009086|582903339|FG001|Overall Study|Other|5|||
161414262|NCT01009086|582903340|FG002|Overall Study|Other|1|||
161414263|NCT01853878|582903341|FG000|Overall Study|Recurrence|2|||
161414264|NCT01853878|582903342|FG001|Overall Study|Recurrence|0|||
161414265|NCT01853878|582903341|FG000|Overall Study|Adverse Event|2|||
161414266|NCT01853878|582903342|FG001|Overall Study|Adverse Event|0|||
161414267|NCT01853878|582903341|FG000|Overall Study|Withdrawal by Subject|3|||
161414268|NCT01853878|582903342|FG001|Overall Study|Withdrawal by Subject|1|||
161414269|NCT01853878|582903341|FG000|Overall Study|Migrated/moved from the study area|1|||
161414270|NCT01853878|582903342|FG001|Overall Study|Migrated/moved from the study area|0|||
161414271|NCT01853878|582903341|FG000|Overall Study|Other|55|||
161414272|NCT01853878|582903342|FG001|Overall Study|Other|43|||
161414273|NCT01846741|582903343|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
161414274|NCT01361178|582903344|FG000|Overall Study|Death|13|||
161414275|NCT01361178|582903345|FG001|Overall Study|Death|0|||
161414276|NCT04294147|582903348|FG000|Overall Study|Protocol Violation|2|||
161414277|NCT04294147|582903349|FG001|Overall Study|Protocol Violation|0|||
161414278|NCT04038567|582903354|FG000|Overall Study|Lost to Follow-up|6|||
161414279|NCT04038567|582903355|FG001|Overall Study|Lost to Follow-up|4|||
161414280|NCT04038567|582903356|FG002|Overall Study|Lost to Follow-up|5|||
161414281|NCT04038567|582903357|FG003|Overall Study|Lost to Follow-up|4|||
161414282|NCT04038567|582903358|FG004|Overall Study|Lost to Follow-up|6|||
161414283|NCT04038567|582903359|FG005|Overall Study|Lost to Follow-up|4|||
161414284|NCT04038567|582903360|FG006|Overall Study|Lost to Follow-up|4|||
161414285|NCT04038567|582903361|FG007|Overall Study|Lost to Follow-up|1|||
161414286|NCT04038567|582903354|FG000|Overall Study|Withdrawal by Subject|2|||
161414287|NCT04038567|582903355|FG001|Overall Study|Withdrawal by Subject|1|||
161414288|NCT04038567|582903356|FG002|Overall Study|Withdrawal by Subject|1|||
161414289|NCT04038567|582903357|FG003|Overall Study|Withdrawal by Subject|1|||
161414290|NCT04038567|582903358|FG004|Overall Study|Withdrawal by Subject|4|||
161414291|NCT04038567|582903359|FG005|Overall Study|Withdrawal by Subject|1|||
161414292|NCT04038567|582903360|FG006|Overall Study|Withdrawal by Subject|1|||
161414293|NCT04038567|582903361|FG007|Overall Study|Withdrawal by Subject|1|||
161414294|NCT04038567|582903354|FG000|Overall Study|missed survey window|1|||
161414295|NCT04038567|582903355|FG001|Overall Study|missed survey window|2|||
161414296|NCT04038567|582903356|FG002|Overall Study|missed survey window|0|||
161414297|NCT04038567|582903357|FG003|Overall Study|missed survey window|0|||
161414298|NCT04038567|582903358|FG004|Overall Study|missed survey window|1|||
161414299|NCT04038567|582903359|FG005|Overall Study|missed survey window|1|||
161414300|NCT04038567|582903360|FG006|Overall Study|missed survey window|2|||
161414301|NCT04038567|582903361|FG007|Overall Study|missed survey window|2|||
161414302|NCT04038567|582903354|FG000|Overall Study|technical issues|0|||
161414303|NCT04038567|582903355|FG001|Overall Study|technical issues|0|||
161414304|NCT04038567|582903356|FG002|Overall Study|technical issues|0|||
161414305|NCT04038567|582903357|FG003|Overall Study|technical issues|0|||
161414306|NCT04038567|582903358|FG004|Overall Study|technical issues|0|||
161414307|NCT04038567|582903359|FG005|Overall Study|technical issues|0|||
161414308|NCT04038567|582903360|FG006|Overall Study|technical issues|1|||
161414309|NCT04038567|582903361|FG007|Overall Study|technical issues|0|||
161414310|NCT04038567|582903354|FG000|Overall Study|Medical issues (i.e., illness)|0|||
161414311|NCT04038567|582903355|FG001|Overall Study|Medical issues (i.e., illness)|1|||
161414312|NCT04038567|582903356|FG002|Overall Study|Medical issues (i.e., illness)|2|||
161414313|NCT04038567|582903357|FG003|Overall Study|Medical issues (i.e., illness)|1|||
161414314|NCT04038567|582903358|FG004|Overall Study|Medical issues (i.e., illness)|1|||
161414315|NCT04038567|582903359|FG005|Overall Study|Medical issues (i.e., illness)|1|||
161414316|NCT04038567|582903360|FG006|Overall Study|Medical issues (i.e., illness)|0|||
161414317|NCT04038567|582903361|FG007|Overall Study|Medical issues (i.e., illness)|0|||
161414318|NCT04038567|582903354|FG000|Overall Study|Death|0|||
161414319|NCT04038567|582903355|FG001|Overall Study|Death|0|||
161414320|NCT04038567|582903356|FG002|Overall Study|Death|0|||
161414321|NCT04038567|582903357|FG003|Overall Study|Death|1|||
161414322|NCT04038567|582903358|FG004|Overall Study|Death|1|||
161414323|NCT04038567|582903359|FG005|Overall Study|Death|0|||
161414324|NCT04038567|582903360|FG006|Overall Study|Death|0|||
161414325|NCT04038567|582903361|FG007|Overall Study|Death|1|||
161414326|NCT02726022|582903362|FG000|Overall Study|Adverse Event|14|||
161414327|NCT02726022|582903362|FG000|Overall Study|Treatment Failure|8|||
161414328|NCT02726022|582903362|FG000|Overall Study|Poor Compliance|13|||
161414329|NCT02726022|582903362|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
161414330|NCT02999633|582903363|FG000|Overall Study|Adverse Event|2|||
161414331|NCT02999633|582903363|FG000|Overall Study|Progressive disease|12|||
161414332|NCT01990859|582903369|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
161414333|NCT01990859|582903369|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
161414334|NCT00622388|582903370|FG000|Overall Study|Disease Progression|47|||
161414335|NCT00622388|582903370|FG000|Overall Study|Adverse Event|6|||
161414336|NCT00622388|582903370|FG000|Overall Study|Protocol Violation|3|||
161414337|NCT00622388|582903370|FG000|Overall Study|Participant Refusal|1|||
161414338|NCT00622388|582903370|FG000|Overall Study|Death|3|||
161414339|NCT00622388|582903370|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
161414340|NCT00622388|582903370|FG000|Overall Study|Took Prohibited Medication|2|||
161414341|NCT00622388|582903370|FG000|Overall Study|Withdrew Consent|1|||
161414342|NCT00622388|582903370|FG000|Overall Study|Insurance Expired|1|||
161414343|NCT01068158|582903371|FG000|Overall Study|Withdrawal by Subject|1|||
161414344|NCT01068158|582903372|FG001|Overall Study|Withdrawal by Subject|2|||
161414345|NCT01068158|582903371|FG000|Overall Study|Lost to Follow-up|7|||
161414346|NCT01068158|582903372|FG001|Overall Study|Lost to Follow-up|0|||
161414347|NCT01068158|582903371|FG000|Overall Study|Protocol Violation|0|||
161414348|NCT01068158|582903372|FG001|Overall Study|Protocol Violation|2|||
161414349|NCT01300572|582903379|FG000|Overall Study|HAMA + post dosimetry|1|||
161414350|NCT01368081|582903380|FG000|Overall Study|Adverse Event|4|||
161414351|NCT01368081|582903381|FG001|Overall Study|Adverse Event|4|||
161414352|NCT01368081|582903382|FG002|Overall Study|Adverse Event|3|||
161414353|NCT01368081|582903383|FG003|Overall Study|Adverse Event|2|||
161414354|NCT01368081|582903384|FG004|Overall Study|Adverse Event|2|||
161414355|NCT01368081|582903385|FG005|Overall Study|Adverse Event|5|||
161414356|NCT01368081|582903386|FG006|Overall Study|Adverse Event|6|||
161414357|NCT01368081|582903387|FG007|Overall Study|Adverse Event|2|||
161414358|NCT01368081|582903388|FG008|Overall Study|Adverse Event|3|||
161414359|NCT01368081|582903389|FG009|Overall Study|Adverse Event|5|||
161414360|NCT01368081|582903390|FG010|Overall Study|Adverse Event|6|||
161414361|NCT01368081|582903391|FG011|Overall Study|Adverse Event|1|||
161414362|NCT01368081|582903392|FG012|Overall Study|Adverse Event|3|||
161414363|NCT01368081|582903380|FG000|Overall Study|Lack of Efficacy|0|||
161414364|NCT01368081|582903381|FG001|Overall Study|Lack of Efficacy|1|||
161414365|NCT01368081|582903382|FG002|Overall Study|Lack of Efficacy|0|||
161414366|NCT01368081|582903383|FG003|Overall Study|Lack of Efficacy|1|||
161414367|NCT01368081|582903384|FG004|Overall Study|Lack of Efficacy|0|||
161414368|NCT01368081|582903385|FG005|Overall Study|Lack of Efficacy|0|||
161414369|NCT01368081|582903386|FG006|Overall Study|Lack of Efficacy|0|||
161414370|NCT01368081|582903387|FG007|Overall Study|Lack of Efficacy|2|||
161414371|NCT01368081|582903388|FG008|Overall Study|Lack of Efficacy|0|||
161414372|NCT01368081|582903389|FG009|Overall Study|Lack of Efficacy|0|||
161414373|NCT01368081|582903390|FG010|Overall Study|Lack of Efficacy|0|||
161414374|NCT01368081|582903391|FG011|Overall Study|Lack of Efficacy|0|||
161414375|NCT01368081|582903392|FG012|Overall Study|Lack of Efficacy|0|||
161414376|NCT01368081|582903380|FG000|Overall Study|Protocol Violation|0|||
161414377|NCT01368081|582903381|FG001|Overall Study|Protocol Violation|0|||
161414378|NCT01368081|582903382|FG002|Overall Study|Protocol Violation|0|||
161414379|NCT01368081|582903383|FG003|Overall Study|Protocol Violation|0|||
161414380|NCT01368081|582903384|FG004|Overall Study|Protocol Violation|0|||
161414381|NCT01368081|582903385|FG005|Overall Study|Protocol Violation|1|||
161414382|NCT01368081|582903386|FG006|Overall Study|Protocol Violation|0|||
161414383|NCT01368081|582903387|FG007|Overall Study|Protocol Violation|1|||
161414384|NCT01368081|582903388|FG008|Overall Study|Protocol Violation|0|||
161414385|NCT01368081|582903389|FG009|Overall Study|Protocol Violation|0|||
161414386|NCT01368081|582903390|FG010|Overall Study|Protocol Violation|0|||
161414387|NCT01368081|582903391|FG011|Overall Study|Protocol Violation|0|||
161414388|NCT01368081|582903392|FG012|Overall Study|Protocol Violation|0|||
161414389|NCT01368081|582903380|FG000|Overall Study|Lost to Follow-up|0|||
161414390|NCT01368081|582903381|FG001|Overall Study|Lost to Follow-up|0|||
161414391|NCT01368081|582903382|FG002|Overall Study|Lost to Follow-up|0|||
161414392|NCT01368081|582903383|FG003|Overall Study|Lost to Follow-up|0|||
161414393|NCT01368081|582903384|FG004|Overall Study|Lost to Follow-up|0|||
161414394|NCT01368081|582903385|FG005|Overall Study|Lost to Follow-up|0|||
161414395|NCT01368081|582903386|FG006|Overall Study|Lost to Follow-up|0|||
161414396|NCT01368081|582903387|FG007|Overall Study|Lost to Follow-up|0|||
161414397|NCT01368081|582903388|FG008|Overall Study|Lost to Follow-up|0|||
161414398|NCT01368081|582903389|FG009|Overall Study|Lost to Follow-up|0|||
161414399|NCT01368081|582903390|FG010|Overall Study|Lost to Follow-up|0|||
161414400|NCT01368081|582903391|FG011|Overall Study|Lost to Follow-up|0|||
161414401|NCT01368081|582903392|FG012|Overall Study|Lost to Follow-up|1|||
161414402|NCT01368081|582903380|FG000|Overall Study|Withdrawal by Subject|4|||
161414403|NCT01368081|582903381|FG001|Overall Study|Withdrawal by Subject|4|||
161414404|NCT01368081|582903382|FG002|Overall Study|Withdrawal by Subject|1|||
161414405|NCT01368081|582903383|FG003|Overall Study|Withdrawal by Subject|1|||
161414406|NCT01368081|582903384|FG004|Overall Study|Withdrawal by Subject|0|||
161414407|NCT01368081|582903385|FG005|Overall Study|Withdrawal by Subject|3|||
161414408|NCT01368081|582903386|FG006|Overall Study|Withdrawal by Subject|4|||
161414409|NCT01368081|582903387|FG007|Overall Study|Withdrawal by Subject|2|||
161414410|NCT01368081|582903388|FG008|Overall Study|Withdrawal by Subject|5|||
161414411|NCT01368081|582903389|FG009|Overall Study|Withdrawal by Subject|4|||
161414412|NCT01368081|582903390|FG010|Overall Study|Withdrawal by Subject|3|||
161414413|NCT01368081|582903391|FG011|Overall Study|Withdrawal by Subject|2|||
161414414|NCT01368081|582903392|FG012|Overall Study|Withdrawal by Subject|0|||
161414415|NCT01368081|582903380|FG000|Overall Study|Other reason not defined above|2|||
161414416|NCT01368081|582903381|FG001|Overall Study|Other reason not defined above|0|||
161414417|NCT01368081|582903382|FG002|Overall Study|Other reason not defined above|0|||
161414418|NCT01368081|582903383|FG003|Overall Study|Other reason not defined above|1|||
161414419|NCT01368081|582903384|FG004|Overall Study|Other reason not defined above|0|||
161414420|NCT01368081|582903385|FG005|Overall Study|Other reason not defined above|1|||
161414421|NCT01368081|582903386|FG006|Overall Study|Other reason not defined above|2|||
161414422|NCT01368081|582903387|FG007|Overall Study|Other reason not defined above|0|||
161414423|NCT01368081|582903388|FG008|Overall Study|Other reason not defined above|0|||
161414424|NCT01368081|582903389|FG009|Overall Study|Other reason not defined above|1|||
161414425|NCT01368081|582903390|FG010|Overall Study|Other reason not defined above|0|||
161414426|NCT01368081|582903391|FG011|Overall Study|Other reason not defined above|0|||
161414427|NCT01368081|582903392|FG012|Overall Study|Other reason not defined above|3|||
161414428|NCT01504412|582905721|FG000|Overall Study|Adverse Event|1|||
161414429|NCT01504412|582905722|FG001|Overall Study|Adverse Event|8|||
161414430|NCT01504412|582905723|FG002|Overall Study|Adverse Event|1|||
161414431|NCT01504412|582905724|FG003|Overall Study|Adverse Event|7|||
161414432|NCT01504412|582905725|FG004|Overall Study|Adverse Event|10|||
161414433|NCT01504412|582905721|FG000|Overall Study|Withdrawal by Subject|2|||
161414434|NCT01504412|582905722|FG001|Overall Study|Withdrawal by Subject|1|||
161414435|NCT01504412|582905723|FG002|Overall Study|Withdrawal by Subject|1|||
161414436|NCT01504412|582905724|FG003|Overall Study|Withdrawal by Subject|5|||
161414437|NCT01504412|582905725|FG004|Overall Study|Withdrawal by Subject|1|||
161414438|NCT01504412|582905721|FG000|Overall Study|Other|2|||
161414439|NCT01504412|582905722|FG001|Overall Study|Other|1|||
161414440|NCT01504412|582905723|FG002|Overall Study|Other|1|||
161414441|NCT01504412|582905724|FG003|Overall Study|Other|6|||
161414442|NCT01504412|582905725|FG004|Overall Study|Other|1|||
161414443|NCT01504412|582905721|FG000|Overall Study|Lost to Follow-up|0|||
161414444|NCT01504412|582905722|FG001|Overall Study|Lost to Follow-up|2|||
161414445|NCT01504412|582905723|FG002|Overall Study|Lost to Follow-up|0|||
161414446|NCT01504412|582905724|FG003|Overall Study|Lost to Follow-up|0|||
161414447|NCT01504412|582905725|FG004|Overall Study|Lost to Follow-up|0|||
161414448|NCT01504412|582905721|FG000|Overall Study|Lack of Efficacy|0|||
161414449|NCT01504412|582905722|FG001|Overall Study|Lack of Efficacy|0|||
161414450|NCT01504412|582905723|FG002|Overall Study|Lack of Efficacy|1|||
161414451|NCT01504412|582905724|FG003|Overall Study|Lack of Efficacy|0|||
161414452|NCT01504412|582905725|FG004|Overall Study|Lack of Efficacy|1|||
161414453|NCT01504412|582905721|FG000|Overall Study|Death|0|||
161414454|NCT01504412|582905722|FG001|Overall Study|Death|0|||
161414455|NCT01504412|582905723|FG002|Overall Study|Death|0|||
161414456|NCT01504412|582905724|FG003|Overall Study|Death|1|||
161414457|NCT01504412|582905725|FG004|Overall Study|Death|0|||
161414458|NCT00630344|582905726|FG000|Overall Study|Adverse Event|5|||
161414459|NCT00630344|582905726|FG000|Overall Study|Progressive Disease|19|||
161414460|NCT00630344|582905726|FG000|Overall Study|Physician Decision|9|||
161414461|NCT00630344|582905726|FG000|Overall Study|Withdrawal by Subject|1|||
161414462|NCT00630344|582905726|FG000|Overall Study|Intercurrent Illness|1|||
161414463|NCT00630344|582905726|FG000|Overall Study|Other|1|||
161414464|NCT04774926|582905727|FG000|Overall Study|Adverse Event|15|||
161414465|NCT04774926|582905727|FG000|Overall Study|Lost to Follow-up|3|||
161414466|NCT04774926|582905727|FG000|Overall Study|Physician Decision|6|||
161414467|NCT04774926|582905727|FG000|Overall Study|Withdrawal by Subject|3|||
161414468|NCT04774926|582905727|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
161414469|NCT01393639|582905728|FG000|Overall Study|Protocol Violation|0|||
161414470|NCT01393639|582905729|FG001|Overall Study|Protocol Violation|0|||
161414471|NCT01393639|582905730|FG002|Overall Study|Protocol Violation|0|||
161414472|NCT01393639|582905731|FG003|Overall Study|Protocol Violation|1|||
161414473|NCT01393639|582905732|FG004|Overall Study|Protocol Violation|0|||
161414474|NCT01393639|582905733|FG005|Overall Study|Protocol Violation|0|||
161414475|NCT01393639|582905734|FG006|Overall Study|Protocol Violation|0|||
161414476|NCT01393639|582905728|FG000|Overall Study|Other|0|||
161414477|NCT01393639|582905729|FG001|Overall Study|Other|2|||
161414478|NCT01393639|582905730|FG002|Overall Study|Other|0|||
161414479|NCT01393639|582905731|FG003|Overall Study|Other|2|||
161414480|NCT01393639|582905732|FG004|Overall Study|Other|1|||
161414481|NCT01393639|582905733|FG005|Overall Study|Other|0|||
161414482|NCT01393639|582905734|FG006|Overall Study|Other|1|||
161414483|NCT01393639|582905728|FG000|Overall Study|Withdrawal by Subject|1|||
161414484|NCT01393639|582905729|FG001|Overall Study|Withdrawal by Subject|1|||
161414485|NCT01393639|582905730|FG002|Overall Study|Withdrawal by Subject|0|||
161414486|NCT01393639|582905731|FG003|Overall Study|Withdrawal by Subject|0|||
161414487|NCT01393639|582905732|FG004|Overall Study|Withdrawal by Subject|0|||
161414488|NCT01393639|582905733|FG005|Overall Study|Withdrawal by Subject|0|||
161414489|NCT01393639|582905734|FG006|Overall Study|Withdrawal by Subject|1|||
161414490|NCT01393639|582905728|FG000|Overall Study|Medication error without associated AE|0|||
161414491|NCT01393639|582905729|FG001|Overall Study|Medication error without associated AE|0|||
161414492|NCT01393639|582905730|FG002|Overall Study|Medication error without associated AE|0|||
161414493|NCT01393639|582905731|FG003|Overall Study|Medication error without associated AE|0|||
161414494|NCT01393639|582905732|FG004|Overall Study|Medication error without associated AE|0|||
161414495|NCT01393639|582905733|FG005|Overall Study|Medication error without associated AE|0|||
161414496|NCT01393639|582905734|FG006|Overall Study|Medication error without associated AE|1|||
161414497|NCT01393639|582905728|FG000|Overall Study|Lost to Follow-up|0|||
161414498|NCT01393639|582905729|FG001|Overall Study|Lost to Follow-up|1|||
161414499|NCT01393639|582905730|FG002|Overall Study|Lost to Follow-up|0|||
161414500|NCT01393639|582905731|FG003|Overall Study|Lost to Follow-up|0|||
161414501|NCT01393639|582905732|FG004|Overall Study|Lost to Follow-up|0|||
161414502|NCT01393639|582905733|FG005|Overall Study|Lost to Follow-up|0|||
161414503|NCT01393639|582905734|FG006|Overall Study|Lost to Follow-up|1|||
161414504|NCT01393639|582905728|FG000|Overall Study|Lack of Efficacy|0|||
161414505|NCT01393639|582905729|FG001|Overall Study|Lack of Efficacy|0|||
161414506|NCT01393639|582905730|FG002|Overall Study|Lack of Efficacy|0|||
161414507|NCT01393639|582905731|FG003|Overall Study|Lack of Efficacy|0|||
161414508|NCT01393639|582905732|FG004|Overall Study|Lack of Efficacy|0|||
161414509|NCT01393639|582905733|FG005|Overall Study|Lack of Efficacy|0|||
161414510|NCT01393639|582905734|FG006|Overall Study|Lack of Efficacy|1|||
161414511|NCT01393639|582905728|FG000|Overall Study|Adverse Event|2|||
161414512|NCT01393639|582905729|FG001|Overall Study|Adverse Event|3|||
161414513|NCT01393639|582905730|FG002|Overall Study|Adverse Event|1|||
161414514|NCT01393639|582905731|FG003|Overall Study|Adverse Event|2|||
161414515|NCT01393639|582905732|FG004|Overall Study|Adverse Event|0|||
161414516|NCT01393639|582905733|FG005|Overall Study|Adverse Event|2|||
161414517|NCT01393639|582905734|FG006|Overall Study|Adverse Event|3|||
161414518|NCT03626545|582905735|FG000|Overall Study|Progressive disease|3|||
161414519|NCT03626545|582905736|FG001|Overall Study|Progressive disease|82|||
161414520|NCT03626545|582905737|FG002|Overall Study|Progressive disease|85|||
161414521|NCT03626545|582905735|FG000|Overall Study|Adverse Event|3|||
161414522|NCT03626545|582905736|FG001|Overall Study|Adverse Event|13|||
161414523|NCT03626545|582905737|FG002|Overall Study|Adverse Event|10|||
161414524|NCT03626545|582905735|FG000|Overall Study|Physician Decision|1|||
161414525|NCT03626545|582905736|FG001|Overall Study|Physician Decision|18|||
161414526|NCT03626545|582905737|FG002|Overall Study|Physician Decision|14|||
161414527|NCT03626545|582905735|FG000|Overall Study|Subject Decision|0|||
161414528|NCT03626545|582905736|FG001|Overall Study|Subject Decision|5|||
161414529|NCT03626545|582905737|FG002|Overall Study|Subject Decision|5|||
161414530|NCT03626545|582905735|FG000|Overall Study|Death|1|||
161414531|NCT03626545|582905736|FG001|Overall Study|Death|1|||
161414532|NCT03626545|582905737|FG002|Overall Study|Death|1|||
161414533|NCT03626545|582905735|FG000|Overall Study|Protocol Deviation|0|||
161414534|NCT03626545|582905736|FG001|Overall Study|Protocol Deviation|1|||
161414535|NCT03626545|582905737|FG002|Overall Study|Protocol Deviation|1|||
161414536|NCT03626545|582905735|FG000|Overall Study|Guardian Decision|0|||
161414537|NCT03626545|582905736|FG001|Overall Study|Guardian Decision|0|||
161414538|NCT03626545|582905737|FG002|Overall Study|Guardian Decision|1|||
161414539|NCT00793325|582905739|FG000|Overall Study|Protocol Violation|18|||
161414540|NCT00793325|582905739|FG000|Overall Study|Lost to Follow-up|1|||
161414541|NCT01440816|582905740|FG000|Overall Study|Disease Progression|0|||
161414542|NCT01440816|582905741|FG001|Overall Study|Disease Progression|9|||
161414543|NCT01440816|582905740|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
161414544|NCT01440816|582905741|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
161414545|NCT02462720|582905745|FG000|Part 2|Withdrawal by Subject|1|||
161414546|NCT02462720|582905746|FG001|Part 2|Withdrawal by Subject|0|||
161414547|NCT02462720|582905745|FG000|Part 2|Protocol Violation|0|||
161414548|NCT02462720|582905746|FG001|Part 2|Protocol Violation|1|||
161414549|NCT03250182|582905751|FG000|Overall Study|Withdrawal by Subject|1|||
161414550|NCT05173012|582905754|FG000|Overall Study|Adverse Event|2|||
161414551|NCT05173012|582905755|FG001|Overall Study|Adverse Event|3|||
161414552|NCT05173012|582905756|FG002|Overall Study|Adverse Event|4|||
161414553|NCT05173012|582905757|FG003|Overall Study|Adverse Event|13|||
161414554|NCT05173012|582905758|FG004|Overall Study|Adverse Event|0|||
161414555|NCT05173012|582905759|FG005|Overall Study|Adverse Event|0|||
161414556|NCT05173012|582905760|FG006|Overall Study|Adverse Event|2|||
161414557|NCT05173012|582905761|FG007|Overall Study|Adverse Event|4|||
161414558|NCT05173012|582905754|FG000|Overall Study|Lost to Follow-up|0|||
161414559|NCT05173012|582905755|FG001|Overall Study|Lost to Follow-up|0|||
161414560|NCT05173012|582905756|FG002|Overall Study|Lost to Follow-up|0|||
161414561|NCT05173012|582905757|FG003|Overall Study|Lost to Follow-up|1|||
161414562|NCT05173012|582905758|FG004|Overall Study|Lost to Follow-up|0|||
161414563|NCT05173012|582905759|FG005|Overall Study|Lost to Follow-up|0|||
161414564|NCT05173012|582905760|FG006|Overall Study|Lost to Follow-up|0|||
161414565|NCT05173012|582905761|FG007|Overall Study|Lost to Follow-up|0|||
161414566|NCT05173012|582905754|FG000|Overall Study|Withdrawal by Subject|1|||
161414567|NCT05173012|582905755|FG001|Overall Study|Withdrawal by Subject|0|||
161414568|NCT05173012|582905756|FG002|Overall Study|Withdrawal by Subject|1|||
161414569|NCT05173012|582905757|FG003|Overall Study|Withdrawal by Subject|3|||
161414570|NCT05173012|582905758|FG004|Overall Study|Withdrawal by Subject|1|||
161414571|NCT05173012|582905759|FG005|Overall Study|Withdrawal by Subject|0|||
161414572|NCT05173012|582905760|FG006|Overall Study|Withdrawal by Subject|1|||
161414573|NCT05173012|582905761|FG007|Overall Study|Withdrawal by Subject|0|||
161414574|NCT05173012|582905754|FG000|Overall Study|Protocol Deviation|0|||
161414575|NCT05173012|582905755|FG001|Overall Study|Protocol Deviation|0|||
161414576|NCT05173012|582905756|FG002|Overall Study|Protocol Deviation|0|||
161414577|NCT05173012|582905757|FG003|Overall Study|Protocol Deviation|1|||
161414578|NCT05173012|582905758|FG004|Overall Study|Protocol Deviation|0|||
161414579|NCT05173012|582905759|FG005|Overall Study|Protocol Deviation|0|||
161414580|NCT05173012|582905760|FG006|Overall Study|Protocol Deviation|0|||
161414581|NCT05173012|582905761|FG007|Overall Study|Protocol Deviation|0|||
161414582|NCT05173012|582905754|FG000|Overall Study|Other|0|||
161414583|NCT05173012|582905755|FG001|Overall Study|Other|0|||
161414584|NCT05173012|582905756|FG002|Overall Study|Other|0|||
161414585|NCT05173012|582905757|FG003|Overall Study|Other|2|||
161414586|NCT05173012|582905758|FG004|Overall Study|Other|0|||
161414587|NCT05173012|582905759|FG005|Overall Study|Other|0|||
161414588|NCT05173012|582905760|FG006|Overall Study|Other|0|||
161414589|NCT05173012|582905761|FG007|Overall Study|Other|0|||
161414590|NCT03472950|582905762|FG000|Overall Study|Lost to Follow-up|0|||
161414591|NCT03472950|582905763|FG001|Overall Study|Lost to Follow-up|1|||
161414592|NCT03472950|582905762|FG000|Overall Study|Adverse Event|0|||
161414593|NCT03472950|582905763|FG001|Overall Study|Adverse Event|3|||
161414594|NCT03668613|582905764|FG000|Overall Study|Adverse Event|1|||
161414595|NCT03668613|582905765|FG001|Overall Study|Adverse Event|2|||
161414596|NCT03668613|582905764|FG000|Overall Study|Lack of Efficacy|5|||
161414597|NCT03668613|582905765|FG001|Overall Study|Lack of Efficacy|1|||
161414598|NCT03668613|582905764|FG000|Overall Study|Pregnancy|0|||
161414599|NCT03668613|582905765|FG001|Overall Study|Pregnancy|2|||
161414600|NCT03668613|582905764|FG000|Overall Study|Protocol Violation|1|||
161414601|NCT03668613|582905765|FG001|Overall Study|Protocol Violation|0|||
161414602|NCT03668613|582905764|FG000|Overall Study|Physician Decision|1|||
161414603|NCT03668613|582905765|FG001|Overall Study|Physician Decision|0|||
161414604|NCT03668613|582905764|FG000|Overall Study|Withdrawal by Subject|2|||
161414605|NCT03668613|582905765|FG001|Overall Study|Withdrawal by Subject|1|||
161414606|NCT03668613|582905764|FG000|Overall Study|Guardian decision|1|||
161414607|NCT03668613|582905765|FG001|Overall Study|Guardian decision|0|||
161414608|NCT03386487|582905768|FG000|Overall Study|Lost to Follow-up|5|||
161414609|NCT03386487|582905769|FG001|Overall Study|Lost to Follow-up|6|||
161414610|NCT03386487|582905768|FG000|Overall Study|Withdrawal by Subject|11|||
161414611|NCT03386487|582905769|FG001|Overall Study|Withdrawal by Subject|7|||
161414612|NCT03386487|582905768|FG000|Overall Study|Physician Decision|11|||
161414613|NCT03386487|582905769|FG001|Overall Study|Physician Decision|8|||
161414614|NCT01068769|582905770|FG000|Overall Study|Ineligible|1|||
161414615|NCT00894361|582905775|FG000|Overall Study|deaths and less than 2 years followup|24|||
161414616|NCT00894361|582905776|FG001|Overall Study|deaths and less than 2 years followup|64|||
161414617|NCT00286494|582905777|FG000|Overall Study|Hyperglycemic rescue|12|||
161414618|NCT00286494|582905778|FG001|Overall Study|Hyperglycemic rescue|19|||
161414619|NCT00286494|582905779|FG002|Overall Study|Hyperglycemic rescue|18|||
161414620|NCT00286494|582905777|FG000|Overall Study|Withdrawal by Subject|2|||
161414621|NCT00286494|582905778|FG001|Overall Study|Withdrawal by Subject|10|||
161414622|NCT00286494|582905779|FG002|Overall Study|Withdrawal by Subject|9|||
161414623|NCT00286494|582905777|FG000|Overall Study|Adverse Event|3|||
161414624|NCT00286494|582905778|FG001|Overall Study|Adverse Event|8|||
161414625|NCT00286494|582905779|FG002|Overall Study|Adverse Event|6|||
161414626|NCT00286494|582905777|FG000|Overall Study|Physician Decision|5|||
161414627|NCT00286494|582905778|FG001|Overall Study|Physician Decision|5|||
161414628|NCT00286494|582905779|FG002|Overall Study|Physician Decision|1|||
161414629|NCT00286494|582905777|FG000|Overall Study|Lost to Follow-up|3|||
161414630|NCT00286494|582905778|FG001|Overall Study|Lost to Follow-up|1|||
161414631|NCT00286494|582905779|FG002|Overall Study|Lost to Follow-up|3|||
161414632|NCT00286494|582905777|FG000|Overall Study|Protocol Violation|1|||
161414633|NCT00286494|582905778|FG001|Overall Study|Protocol Violation|1|||
161414634|NCT00286494|582905779|FG002|Overall Study|Protocol Violation|2|||
161414635|NCT04776317|582905780|FG000|Overall Study|Physician Decision|0|||
161414636|NCT04776317|582905781|FG001|Overall Study|Physician Decision|1|||
161414637|NCT04776317|582905782|FG002|Overall Study|Physician Decision|0|||
161414638|NCT04776317|582905783|FG003|Overall Study|Physician Decision|0|||
161414639|NCT04776317|582905784|FG004|Overall Study|Physician Decision|0|||
161414640|NCT04776317|582905785|FG005|Overall Study|Physician Decision|0|||
161414641|NCT04776317|582905786|FG006|Overall Study|Physician Decision|0|||
161414642|NCT04776317|582905787|FG007|Overall Study|Physician Decision|0|||
161414643|NCT04776317|582905788|FG008|Overall Study|Physician Decision|0|||
161414644|NCT04776317|582905789|FG009|Overall Study|Physician Decision|0|||
161414645|NCT04776317|582905790|FG010|Overall Study|Physician Decision|0|||
161414646|NCT04776317|582905791|FG011|Overall Study|Physician Decision|0|||
161414647|NCT04776317|582905792|FG012|Overall Study|Physician Decision|0|||
161414648|NCT04776317|582905793|FG013|Overall Study|Physician Decision|0|||
161414649|NCT04776317|582905794|FG014|Overall Study|Physician Decision|0|||
161414650|NCT04776317|582905780|FG000|Overall Study|Protocol Violation|0|||
161414651|NCT04776317|582905781|FG001|Overall Study|Protocol Violation|0|||
161414652|NCT04776317|582905782|FG002|Overall Study|Protocol Violation|1|||
161414653|NCT04776317|582905783|FG003|Overall Study|Protocol Violation|0|||
161414654|NCT04776317|582905784|FG004|Overall Study|Protocol Violation|0|||
161414655|NCT04776317|582905785|FG005|Overall Study|Protocol Violation|0|||
161414656|NCT04776317|582905786|FG006|Overall Study|Protocol Violation|0|||
161414657|NCT04776317|582905787|FG007|Overall Study|Protocol Violation|0|||
161414658|NCT04776317|582905788|FG008|Overall Study|Protocol Violation|0|||
161414659|NCT04776317|582905789|FG009|Overall Study|Protocol Violation|0|||
161414660|NCT04776317|582905790|FG010|Overall Study|Protocol Violation|0|||
161414661|NCT04776317|582905791|FG011|Overall Study|Protocol Violation|0|||
161414662|NCT04776317|582905792|FG012|Overall Study|Protocol Violation|0|||
161414663|NCT04776317|582905793|FG013|Overall Study|Protocol Violation|0|||
161414664|NCT04776317|582905794|FG014|Overall Study|Protocol Violation|0|||
161414665|NCT04776317|582905780|FG000|Overall Study|Withdrawal by Subject|0|||
161414666|NCT04776317|582905781|FG001|Overall Study|Withdrawal by Subject|0|||
161414667|NCT04776317|582905782|FG002|Overall Study|Withdrawal by Subject|0|||
161414668|NCT04776317|582905783|FG003|Overall Study|Withdrawal by Subject|0|||
161414669|NCT04776317|582905784|FG004|Overall Study|Withdrawal by Subject|1|||
161414670|NCT04776317|582905785|FG005|Overall Study|Withdrawal by Subject|0|||
161414671|NCT04776317|582905786|FG006|Overall Study|Withdrawal by Subject|0|||
161414672|NCT04776317|582905787|FG007|Overall Study|Withdrawal by Subject|0|||
161414673|NCT04776317|582905788|FG008|Overall Study|Withdrawal by Subject|0|||
161414674|NCT04776317|582905789|FG009|Overall Study|Withdrawal by Subject|0|||
161414675|NCT04776317|582905790|FG010|Overall Study|Withdrawal by Subject|0|||
161414676|NCT04776317|582905791|FG011|Overall Study|Withdrawal by Subject|0|||
161414677|NCT04776317|582905792|FG012|Overall Study|Withdrawal by Subject|0|||
161414678|NCT04776317|582905793|FG013|Overall Study|Withdrawal by Subject|0|||
161414679|NCT04776317|582905794|FG014|Overall Study|Withdrawal by Subject|0|||
161414680|NCT04207060|582905795|FG000|Overall Study|Lost to Follow-up|2|||
161414681|NCT04207060|582905796|FG001|Overall Study|Lost to Follow-up|0|||
161414682|NCT00774800|582905797|FG000|Intervention 4|Withdrawal by Subject|1|||
161414683|NCT00532298|582905798|FG000|Overall Study|Adverse Event|1|||
161414684|NCT00532298|582905799|FG001|Overall Study|Adverse Event|0|||
161414685|NCT00532298|582905800|FG002|Overall Study|Adverse Event|0|||
161414686|NCT00532298|582905801|FG003|Overall Study|Adverse Event|0|||
161414687|NCT00532298|582905802|FG004|Overall Study|Adverse Event|1|||
161414688|NCT00532298|582905803|FG005|Overall Study|Adverse Event|1|||
161414689|NCT00532298|582905798|FG000|Overall Study|Lost to Follow-up|1|||
161414690|NCT00532298|582905799|FG001|Overall Study|Lost to Follow-up|1|||
161414691|NCT00532298|582905800|FG002|Overall Study|Lost to Follow-up|1|||
161414692|NCT00532298|582905801|FG003|Overall Study|Lost to Follow-up|0|||
161414693|NCT00532298|582905802|FG004|Overall Study|Lost to Follow-up|0|||
161414694|NCT00532298|582905803|FG005|Overall Study|Lost to Follow-up|1|||
161414695|NCT00479856|582905804|FG000|Overall Study|Adverse Event|1|||
161414696|NCT00479856|582905804|FG000|Overall Study|Withdrawal by Subject|1|||
161414697|NCT00479856|582905804|FG000|Overall Study|Physician Decision|1|||
161414698|NCT04164732|582905809|FG000|Treatment run-in Period|Adverse Event|4|||
161414699|NCT04164732|582905810|FG001|Treatment run-in Period|Adverse Event|0|||
161414700|NCT04164732|582905811|FG002|Treatment run-in Period|Adverse Event|0|||
161414701|NCT04164732|582905809|FG000|Treatment run-in Period|Physician Decision|1|||
161414702|NCT04164732|582905810|FG001|Treatment run-in Period|Physician Decision|0|||
161414703|NCT04164732|582905811|FG002|Treatment run-in Period|Physician Decision|0|||
161414704|NCT04164732|582905809|FG000|Treatment run-in Period|Screen Failure|1|||
161414705|NCT04164732|582905810|FG001|Treatment run-in Period|Screen Failure|0|||
161414706|NCT04164732|582905811|FG002|Treatment run-in Period|Screen Failure|0|||
161414707|NCT04164732|582905809|FG000|Randomized Treatment Period|Adverse Event|0|||
161414708|NCT04164732|582905810|FG001|Randomized Treatment Period|Adverse Event|1|||
161414709|NCT04164732|582905811|FG002|Randomized Treatment Period|Adverse Event|0|||
161414710|NCT04164732|582905809|FG000|Randomized Treatment Period|Protocol Deviation|0|||
161414711|NCT04164732|582905810|FG001|Randomized Treatment Period|Protocol Deviation|1|||
161414712|NCT04164732|582905811|FG002|Randomized Treatment Period|Protocol Deviation|1|||
161414713|NCT04164732|582905809|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
161414714|NCT04164732|582905810|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
161414715|NCT04164732|582905811|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
161414716|NCT02141360|582905812|FG000|Overall Study|Withdrawal by Subject|6|||
161414717|NCT02141360|582905813|FG001|Overall Study|Withdrawal by Subject|0|||
161414718|NCT02141360|582905814|FG002|Overall Study|Withdrawal by Subject|0|||
161414719|NCT02141360|582905812|FG000|Overall Study|Study Terminated before Visit|1|||
161414720|NCT02141360|582905813|FG001|Overall Study|Study Terminated before Visit|0|||
161414721|NCT02141360|582905814|FG002|Overall Study|Study Terminated before Visit|0|||
161414722|NCT00646399|582905815|FG000|Overall Study|Death|63|||
161414723|NCT00646399|582905816|FG001|Overall Study|Death|53|||
161414724|NCT00646399|582905815|FG000|Overall Study|Withdrawal by Subject|9|||
161414725|NCT00646399|582905816|FG001|Overall Study|Withdrawal by Subject|10|||
161414726|NCT00646399|582905815|FG000|Overall Study|Other Reason|11|||
161414727|NCT00646399|582905816|FG001|Overall Study|Other Reason|11|||
161414728|NCT00661622|582905817|FG000|Overall Study|Protocol Violation|1|||
161414729|NCT00661622|582905818|FG001|Overall Study|Protocol Violation|0|||
161414730|NCT02332291|582905823|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
161414731|NCT02332291|582905824|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
161414732|NCT02332291|582905823|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
161414733|NCT02332291|582905824|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
161414734|NCT02332291|582905823|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
161414735|NCT02332291|582905824|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
161414736|NCT02332291|582905823|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
161414737|NCT02332291|582905824|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
161414738|NCT02332291|582905823|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
161414739|NCT02332291|582905824|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
161414740|NCT02332291|582905823|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
161414741|NCT02332291|582905824|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
161414742|NCT00395850|582905831|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
161414743|NCT00395850|582905832|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
161414744|NCT00395850|582905833|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
161414745|NCT00395850|582905834|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
161414746|NCT00395850|582905831|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
161414747|NCT00395850|582905832|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
161414748|NCT00395850|582905833|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
161414749|NCT00395850|582905834|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
161414750|NCT00395850|582905831|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
161414751|NCT00395850|582905832|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
161414752|NCT00395850|582905833|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
161414753|NCT00395850|582905834|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
161414754|NCT00395850|582905831|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
161414755|NCT00395850|582905832|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
161414756|NCT00395850|582905833|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
161414757|NCT00395850|582905834|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
161414758|NCT00395850|582905831|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
161414759|NCT00395850|582905832|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
161414760|NCT00395850|582905833|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
161414761|NCT00395850|582905834|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
161414762|NCT00395850|582905831|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
161414763|NCT00395850|582905832|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
161414764|NCT00395850|582905833|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
161414765|NCT00395850|582905834|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
161414766|NCT00395850|582905831|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
161414767|NCT00395850|582905832|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
161414768|NCT00395850|582905833|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
161414769|NCT00395850|582905834|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
161414770|NCT01424228|582905837|FG000|Overall Study|Withdrawal by Subject|27|||
161414771|NCT01424228|582905838|FG001|Overall Study|Withdrawal by Subject|11|||
161414772|NCT01424228|582905837|FG000|Overall Study|Adverse Event|10|||
161414773|NCT01424228|582905838|FG001|Overall Study|Adverse Event|14|||
161414774|NCT01424228|582905837|FG000|Overall Study|Sponsor's decision|9|||
161414775|NCT01424228|582905838|FG001|Overall Study|Sponsor's decision|12|||
161414776|NCT01424228|582905837|FG000|Overall Study|Lack of Efficacy|5|||
161414777|NCT01424228|582905838|FG001|Overall Study|Lack of Efficacy|7|||
161414778|NCT01424228|582905837|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
161414779|NCT01424228|582905838|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
161414780|NCT01424228|582905837|FG000|Overall Study|Non-compliance|2|||
161414781|NCT01424228|582905838|FG001|Overall Study|Non-compliance|0|||
161414782|NCT01424228|582905837|FG000|Overall Study|Worsening of symptoms|1|||
161414783|NCT01424228|582905838|FG001|Overall Study|Worsening of symptoms|0|||
161414784|NCT01424228|582905837|FG000|Overall Study|Unplanned journey|0|||
161414785|NCT01424228|582905838|FG001|Overall Study|Unplanned journey|1|||
161414786|NCT00844558|582905839|FG000|Overall Study|Withdrawal by Subject|9|||
161414787|NCT00844558|582905840|FG001|Overall Study|Withdrawal by Subject|2|||
161414788|NCT00844558|582905839|FG000|Overall Study|Death|1|||
161414789|NCT00844558|582905840|FG001|Overall Study|Death|0|||
161414790|NCT00844558|582905839|FG000|Overall Study|Protocol Violation|1|||
161414791|NCT00844558|582905840|FG001|Overall Study|Protocol Violation|1|||
161414792|NCT00844558|582905839|FG000|Overall Study|Lost to Follow-up|0|||
161414793|NCT00844558|582905840|FG001|Overall Study|Lost to Follow-up|1|||
161414794|NCT00844558|582905839|FG000|Overall Study|Physician Decision|1|||
161414795|NCT00844558|582905840|FG001|Overall Study|Physician Decision|0|||
161414796|NCT00588094|582905841|FG000|Overall Study|Adverse Event|3|||
161414797|NCT00588094|582905841|FG000|Overall Study|Progression of Disease|2|||
161414798|NCT02951429|582905848|FG000|Overall Study|Adverse Event|3|||
161414799|NCT02951429|582905849|FG001|Overall Study|Adverse Event|7|||
161414800|NCT02951429|582905848|FG000|Overall Study|Death|28|||
161414801|NCT02951429|582905849|FG001|Overall Study|Death|36|||
161414802|NCT02951429|582905848|FG000|Overall Study|Lack of Efficacy|0|||
161414803|NCT02951429|582905849|FG001|Overall Study|Lack of Efficacy|1|||
161414804|NCT02951429|582905848|FG000|Overall Study|Lost to Follow-up|0|||
161414805|NCT02951429|582905849|FG001|Overall Study|Lost to Follow-up|1|||
161414806|NCT02951429|582905848|FG000|Overall Study|Lung Transplantation|9|||
161414807|NCT02951429|582905849|FG001|Overall Study|Lung Transplantation|6|||
161414808|NCT02951429|582905848|FG000|Overall Study|Other|1|||
161414809|NCT02951429|582905849|FG001|Overall Study|Other|3|||
161414810|NCT02951429|582905848|FG000|Overall Study|Progressive Disease|1|||
161414811|NCT02951429|582905849|FG001|Overall Study|Progressive Disease|1|||
161414812|NCT02951429|582905848|FG000|Overall Study|Withdrawal by Subject|7|||
161414813|NCT02951429|582905849|FG001|Overall Study|Withdrawal by Subject|11|||
161414814|NCT02951429|582905848|FG000|Overall Study|Participant ongoing in the study|23|||
161414815|NCT02951429|582905849|FG001|Overall Study|Participant ongoing in the study|17|||
161414816|NCT03997825|582905858|FG000|Overall Study|Death|3|||
161414817|NCT03997825|582905858|FG000|Overall Study|Lost to Follow-up|10|||
161414818|NCT03997825|582905858|FG000|Overall Study|Withdrawal by Subject|3|||
161414819|NCT03997825|582905858|FG000|Overall Study|Refused participation|1|||
161414820|NCT01153698|582905859|FG000|Overall Study|Adverse Event|12|||
161414821|NCT01153698|582905859|FG000|Overall Study|Lost to Follow-up|4|||
161414822|NCT01153698|582905859|FG000|Overall Study|Withdrawal by Subject|2|||
161414823|NCT01153698|582905859|FG000|Overall Study|Switch to other anticoagulants|4|||
161414824|NCT01153698|582905859|FG000|Overall Study|Other|2|||
161414825|NCT01153698|582905859|FG000|Overall Study|Not treated with Pradaxa|5|||
161414826|NCT00465647|582905861|FG000|Overall Study|Administrative|2|||
161414827|NCT00465647|582905862|FG001|Overall Study|Administrative|2|||
161414828|NCT00465647|582905863|FG002|Overall Study|Administrative|3|||
161414829|NCT00465647|582905864|FG003|Overall Study|Administrative|2|||
161414830|NCT00465647|582905861|FG000|Overall Study|Adverse Event|2|||
161414831|NCT00465647|582905862|FG001|Overall Study|Adverse Event|0|||
161414832|NCT00465647|582905863|FG002|Overall Study|Adverse Event|3|||
161414833|NCT00465647|582905864|FG003|Overall Study|Adverse Event|2|||
161414834|NCT00465647|582905861|FG000|Overall Study|Withdrawal by Subject|1|||
161414835|NCT00465647|582905862|FG001|Overall Study|Withdrawal by Subject|2|||
161414836|NCT00465647|582905863|FG002|Overall Study|Withdrawal by Subject|2|||
161414837|NCT00465647|582905864|FG003|Overall Study|Withdrawal by Subject|7|||
161414838|NCT00465647|582905861|FG000|Overall Study|"The other reasons included loss of IV"|8|||
161414839|NCT00465647|582905862|FG001|Overall Study|"The other reasons included loss of IV"|4|||
161414840|NCT00465647|582905863|FG002|Overall Study|"The other reasons included loss of IV"|3|||
161414841|NCT00465647|582905864|FG003|Overall Study|"The other reasons included loss of IV"|2|||
161414842|NCT01240135|582905865|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
161414843|NCT01240135|582905866|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
161414844|NCT01240135|582905865|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
161414845|NCT01240135|582905866|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
161414846|NCT02220712|582905867|FG000|Overall Study|Adverse Event|1|||
161414847|NCT02220712|582905867|FG000|Overall Study|Withdrawal by Subject|2|||
161414848|NCT02220712|582905867|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
161414849|NCT00760838|582905868|FG000|Overall Study|Adverse Event|1|||
161414850|NCT00760838|582905869|FG001|Overall Study|Adverse Event|1|||
161414851|NCT00760838|582905868|FG000|Overall Study|Lack of Efficacy|1|||
161414852|NCT00760838|582905869|FG001|Overall Study|Lack of Efficacy|0|||
161414853|NCT00760838|582905868|FG000|Overall Study|Lost to Follow-up|2|||
161414854|NCT00760838|582905869|FG001|Overall Study|Lost to Follow-up|0|||
161414855|NCT00760838|582905868|FG000|Overall Study|Withdrawal by Subject|1|||
161414856|NCT00760838|582905869|FG001|Overall Study|Withdrawal by Subject|1|||
161414857|NCT01628965|582905870|FG000|Overall Study|Adverse Event|30|||
161414858|NCT01628965|582905870|FG000|Overall Study|Lack of Efficacy|7|||
161414859|NCT01628965|582905870|FG000|Overall Study|Withdrawal by Subject|3|||
161414860|NCT01628965|582905870|FG000|Overall Study|Lost to Follow-up|1|||
161414861|NCT01628965|582905870|FG000|Overall Study|Discontinuation criteria|8|||
161414862|NCT04356352|582905875|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
161414863|NCT04356352|582905876|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
161414864|NCT04356352|582905877|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
161414865|NCT04356352|582905875|FG000|Overall Study|Protocol Violation|0|||
161414866|NCT04356352|582905876|FG001|Overall Study|Protocol Violation|3|||
161414867|NCT04356352|582905877|FG002|Overall Study|Protocol Violation|1|||
161414868|NCT01983774|582905883|FG000|Overall Study|Lung Transplant|0|||
161414869|NCT01983774|582905884|FG001|Overall Study|Lung Transplant|1|||
161414870|NCT01983774|582905883|FG000|Overall Study|Lost to Follow-up|1|||
161414871|NCT01983774|582905884|FG001|Overall Study|Lost to Follow-up|0|||
161414872|NCT01339897|582905885|FG000|Overall Study|Adverse Event|1|||
161414873|NCT01339897|582905886|FG001|Overall Study|Adverse Event|0|||
161414874|NCT01339897|582905887|FG002|Overall Study|Adverse Event|0|||
161414875|NCT01339897|582905888|FG003|Overall Study|Adverse Event|1|||
161414876|NCT00847197|582905889|FG000|Overall Study|Adverse Event|21|||
161414877|NCT00847197|582905890|FG001|Overall Study|Adverse Event|3|||
161414878|NCT00847197|582905889|FG000|Overall Study|Protocol Violation|0|||
161414879|NCT00847197|582905890|FG001|Overall Study|Protocol Violation|1|||
161414880|NCT00847197|582905889|FG000|Overall Study|Withdrawal by Subject|3|||
161414881|NCT00847197|582905890|FG001|Overall Study|Withdrawal by Subject|1|||
161414882|NCT01743040|582905893|FG000|Overall Study|Death|1|||
161414883|NCT01743040|582905893|FG000|Overall Study|Lost to Follow-up|66|||
161414884|NCT01743040|582905893|FG000|Overall Study|Physician Decision|40|||
161414885|NCT01743040|582905893|FG000|Overall Study|Protocol Violation|1|||
161414886|NCT01743040|582905893|FG000|Overall Study|Withdrawal by Subject|121|||
161414887|NCT03824587|582905894|FG000|Run-in Period|Screen Failure|0|||
161414888|NCT03824587|582905895|FG001|Run-in Period|Screen Failure|275|||
161414889|NCT03824587|582905894|FG000|Treatment Period|Adverse Event|4|||
161414890|NCT03824587|582905895|FG001|Treatment Period|Adverse Event|1|||
161414891|NCT03824587|582905894|FG000|Treatment Period|Withdrawal by Subject|0|||
161414892|NCT03824587|582905895|FG001|Treatment Period|Withdrawal by Subject|1|||
161414893|NCT03824587|582905894|FG000|Treatment Period|Kidney Transplant|1|||
161414894|NCT03824587|582905895|FG001|Treatment Period|Kidney Transplant|1|||
161414895|NCT02813889|582907968|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
161414896|NCT02813889|582907969|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
161414897|NCT05128578|582907970|FG000|Overall Study|Withdrawal by Subject|9|||
161414898|NCT05128578|582907970|FG000|Overall Study|Lost to Follow-up|5|||
161414899|NCT01128244|582907974|FG000|Overall Study|Adverse Event|1|||
161414900|NCT01128244|582907974|FG000|Overall Study|Scheduling conflict|2|||
161414901|NCT02974257|582907975|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
161414902|NCT02974257|582907976|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
161414903|NCT02974257|582907975|FG000|Overall Study|Clinical indication for thiamine|1|||
161414904|NCT02974257|582907976|FG001|Overall Study|Clinical indication for thiamine|0|||
161414905|NCT02974257|582907975|FG000|Overall Study|Already on thiamine|1|||
161414906|NCT02974257|582907976|FG001|Overall Study|Already on thiamine|0|||
161414907|NCT02974257|582907975|FG000|Overall Study|Extubated prior to study drug|0|||
161414908|NCT02974257|582907976|FG001|Overall Study|Extubated prior to study drug|1|||
161414909|NCT02974257|582907975|FG000|Overall Study|Death|0|||
161414910|NCT02974257|582907976|FG001|Overall Study|Death|1|||
161414911|NCT00398567|582907977|FG000|Overall Study|Disease Progression|3|||
161414912|NCT00398567|582907978|FG001|Overall Study|Disease Progression|4|||
161414913|NCT00398567|582907979|FG002|Overall Study|Disease Progression|27|||
161414914|NCT00398567|582907977|FG000|Overall Study|Withdrawal by Subject|1|||
161414915|NCT00398567|582907978|FG001|Overall Study|Withdrawal by Subject|0|||
161414916|NCT00398567|582907979|FG002|Overall Study|Withdrawal by Subject|4|||
161414917|NCT00398567|582907977|FG000|Overall Study|Adverse Event|0|||
161414918|NCT00398567|582907978|FG001|Overall Study|Adverse Event|0|||
161414919|NCT00398567|582907979|FG002|Overall Study|Adverse Event|2|||
161414920|NCT00398567|582907977|FG000|Overall Study|Protocol Violation|0|||
161414921|NCT00398567|582907978|FG001|Overall Study|Protocol Violation|0|||
161414922|NCT00398567|582907979|FG002|Overall Study|Protocol Violation|1|||
161414923|NCT03437577|582907982|FG000|Pre-Randomization|Withdrawal by Subject|0|||
161414924|NCT03437577|582907983|FG001|Pre-Randomization|Withdrawal by Subject|0|||
161414925|NCT03437577|582907984|FG002|Pre-Randomization|Withdrawal by Subject|10|||
161414926|NCT03437577|582907982|FG000|Post-Randomization|Physician Decision|0|||
161414927|NCT03437577|582907983|FG001|Post-Randomization|Physician Decision|2|||
161414928|NCT03437577|582907984|FG002|Post-Randomization|Physician Decision|0|||
161414929|NCT04273893|582907985|FG000|Overall Study|Withdrawal by Subject|0|||
161414930|NCT04273893|582907986|FG001|Overall Study|Withdrawal by Subject|2|||
161414931|NCT04273893|582907985|FG000|Overall Study|Treatment of Disease Progression|0|||
161414932|NCT04273893|582907986|FG001|Overall Study|Treatment of Disease Progression|2|||
161414933|NCT04273893|582907985|FG000|Overall Study|Death|1|||
161414934|NCT04273893|582907986|FG001|Overall Study|Death|2|||
161414935|NCT04273893|582907985|FG000|Overall Study|Lost to Follow-up|0|||
161414936|NCT04273893|582907986|FG001|Overall Study|Lost to Follow-up|2|||
161414937|NCT04273893|582907985|FG000|Overall Study|Physician Decision|1|||
161414938|NCT04273893|582907986|FG001|Overall Study|Physician Decision|0|||
161414939|NCT00100789|582907994|FG000|Overall Study|Adverse Event|10|||
161414940|NCT00100789|582907994|FG000|Overall Study|Withdrawal by Subject|1|||
161414941|NCT00100789|582907994|FG000|Overall Study|Progression/relapse|42|||
161414942|NCT00100789|582907994|FG000|Overall Study|Death|2|||
161414943|NCT00100789|582907994|FG000|Overall Study|Not protocol specified|5|||
161414944|NCT00100789|582907994|FG000|Overall Study|Ineligible|3|||
161414945|NCT00100789|582907994|FG000|Overall Study|Never received treatment|1|||
161414946|NCT02936843|582907995|FG000|Overall Study|Lost to Follow-up|3|||
161414947|NCT02936843|582907996|FG001|Overall Study|Lost to Follow-up|1|||
161414948|NCT02936843|582907995|FG000|Overall Study|Withdrawal by Subject|1|||
161414949|NCT02936843|582907996|FG001|Overall Study|Withdrawal by Subject|1|||
161414950|NCT01393821|582907997|FG000|Overall Study|Cancel|1|||
161414951|NCT01393821|582907998|FG001|Overall Study|Cancel|1|||
161414952|NCT01393821|582907997|FG000|Overall Study|not evaluable for primary endpoint|4|||
161414953|NCT01393821|582907998|FG001|Overall Study|not evaluable for primary endpoint|2|||
161414954|NCT00517361|582908010|FG000|Overall Study|Death|6|||
161414955|NCT00517361|582908010|FG000|Overall Study|The study was terminated|5|||
161414956|NCT01948063|582908011|FG000|Overall Study|Boston MCI halted research protocol|0|||
161414957|NCT01948063|582908012|FG001|Overall Study|Boston MCI halted research protocol|1|||
161414958|NCT01948063|582908011|FG000|Overall Study|Discovered an enrollment in other study|0|||
161414959|NCT01948063|582908012|FG001|Overall Study|Discovered an enrollment in other study|1|||
161414960|NCT01948063|582908011|FG000|Overall Study|Blood samples were accidentally thawed|1|||
161414961|NCT01948063|582908012|FG001|Overall Study|Blood samples were accidentally thawed|0|||
161414962|NCT01858766|582908013|FG000|Overall Study|Randomized but Never Treated|0|||
161414963|NCT01858766|582908014|FG001|Overall Study|Randomized but Never Treated|0|||
161414964|NCT01858766|582908015|FG002|Overall Study|Randomized but Never Treated|0|||
161414965|NCT01858766|582908016|FG003|Overall Study|Randomized but Never Treated|0|||
161414966|NCT01858766|582908017|FG004|Overall Study|Randomized but Never Treated|0|||
161414967|NCT01858766|582908018|FG005|Overall Study|Randomized but Never Treated|1|||
161414968|NCT01858766|582908019|FG006|Overall Study|Randomized but Never Treated|0|||
161414969|NCT01858766|582908020|FG007|Overall Study|Randomized but Never Treated|0|||
161414970|NCT01858766|582908021|FG008|Overall Study|Randomized but Never Treated|0|||
161414971|NCT01858766|582908022|FG009|Overall Study|Randomized but Never Treated|0|||
161414972|NCT01858766|582908023|FG010|Overall Study|Randomized but Never Treated|0|||
161414973|NCT01858766|582908024|FG011|Overall Study|Randomized but Never Treated|0|||
161414974|NCT01858766|582908025|FG012|Overall Study|Randomized but Never Treated|0|||
161414975|NCT01858766|582908026|FG013|Overall Study|Randomized but Never Treated|0|||
161414976|NCT01858766|582908027|FG014|Overall Study|Randomized but Never Treated|0|||
161414977|NCT01858766|582908028|FG015|Overall Study|Randomized but Never Treated|0|||
161414978|NCT01858766|582908029|FG016|Overall Study|Randomized but Never Treated|0|||
161414979|NCT01858766|582908030|FG017|Overall Study|Randomized but Never Treated|1|||
161414980|NCT01858766|582908031|FG018|Overall Study|Randomized but Never Treated|0|||
161414981|NCT01858766|582908013|FG000|Overall Study|Death|0|||
161414982|NCT01858766|582908014|FG001|Overall Study|Death|0|||
161414983|NCT01858766|582908015|FG002|Overall Study|Death|1|||
161414984|NCT01858766|582908016|FG003|Overall Study|Death|0|||
161414985|NCT01858766|582908017|FG004|Overall Study|Death|0|||
161414986|NCT01858766|582908018|FG005|Overall Study|Death|0|||
161414987|NCT01858766|582908019|FG006|Overall Study|Death|0|||
161414988|NCT01858766|582908020|FG007|Overall Study|Death|0|||
161414989|NCT01858766|582908021|FG008|Overall Study|Death|0|||
161414990|NCT01858766|582908022|FG009|Overall Study|Death|0|||
161414991|NCT01858766|582908023|FG010|Overall Study|Death|0|||
161414992|NCT01858766|582908024|FG011|Overall Study|Death|0|||
161414993|NCT01858766|582908025|FG012|Overall Study|Death|0|||
161414994|NCT01858766|582908026|FG013|Overall Study|Death|0|||
161414995|NCT01858766|582908027|FG014|Overall Study|Death|0|||
161414996|NCT01858766|582908028|FG015|Overall Study|Death|0|||
161414997|NCT01858766|582908029|FG016|Overall Study|Death|0|||
161414998|NCT01858766|582908030|FG017|Overall Study|Death|0|||
161414999|NCT01858766|582908031|FG018|Overall Study|Death|0|||
161415000|NCT01858766|582908013|FG000|Overall Study|Lack of Efficacy|1|||
161415001|NCT01858766|582908014|FG001|Overall Study|Lack of Efficacy|0|||
161415002|NCT01858766|582908015|FG002|Overall Study|Lack of Efficacy|0|||
161415003|NCT01858766|582908016|FG003|Overall Study|Lack of Efficacy|0|||
161415004|NCT01858766|582908017|FG004|Overall Study|Lack of Efficacy|1|||
161415005|NCT01858766|582908018|FG005|Overall Study|Lack of Efficacy|2|||
161415006|NCT01858766|582908019|FG006|Overall Study|Lack of Efficacy|0|||
161415007|NCT01858766|582908020|FG007|Overall Study|Lack of Efficacy|0|||
161415008|NCT01858766|582908021|FG008|Overall Study|Lack of Efficacy|0|||
161415009|NCT01858766|582908022|FG009|Overall Study|Lack of Efficacy|0|||
161415010|NCT01858766|582908023|FG010|Overall Study|Lack of Efficacy|0|||
161415011|NCT01858766|582908024|FG011|Overall Study|Lack of Efficacy|3|||
161415012|NCT01858766|582908025|FG012|Overall Study|Lack of Efficacy|5|||
161415013|NCT01858766|582908026|FG013|Overall Study|Lack of Efficacy|3|||
161415014|NCT01858766|582908027|FG014|Overall Study|Lack of Efficacy|5|||
161415015|NCT01858766|582908028|FG015|Overall Study|Lack of Efficacy|5|||
161415016|NCT01858766|582908029|FG016|Overall Study|Lack of Efficacy|2|||
161415017|NCT01858766|582908030|FG017|Overall Study|Lack of Efficacy|3|||
161415018|NCT01858766|582908031|FG018|Overall Study|Lack of Efficacy|3|||
161415019|NCT01858766|582908013|FG000|Overall Study|Lost to Follow-up|0|||
161415020|NCT01858766|582908014|FG001|Overall Study|Lost to Follow-up|0|||
161415021|NCT01858766|582908015|FG002|Overall Study|Lost to Follow-up|0|||
161415022|NCT01858766|582908016|FG003|Overall Study|Lost to Follow-up|0|||
161415023|NCT01858766|582908017|FG004|Overall Study|Lost to Follow-up|0|||
161415024|NCT01858766|582908018|FG005|Overall Study|Lost to Follow-up|1|||
161415025|NCT01858766|582908019|FG006|Overall Study|Lost to Follow-up|0|||
161415026|NCT01858766|582908020|FG007|Overall Study|Lost to Follow-up|2|||
161415027|NCT01858766|582908021|FG008|Overall Study|Lost to Follow-up|0|||
161415028|NCT01858766|582908022|FG009|Overall Study|Lost to Follow-up|0|||
161415029|NCT01858766|582908023|FG010|Overall Study|Lost to Follow-up|0|||
161415030|NCT01858766|582908024|FG011|Overall Study|Lost to Follow-up|1|||
161415031|NCT01858766|582908025|FG012|Overall Study|Lost to Follow-up|0|||
161415032|NCT01858766|582908026|FG013|Overall Study|Lost to Follow-up|0|||
161415033|NCT01858766|582908027|FG014|Overall Study|Lost to Follow-up|3|||
161415034|NCT01858766|582908028|FG015|Overall Study|Lost to Follow-up|1|||
161415035|NCT01858766|582908029|FG016|Overall Study|Lost to Follow-up|1|||
161415036|NCT01858766|582908030|FG017|Overall Study|Lost to Follow-up|0|||
161415037|NCT01858766|582908031|FG018|Overall Study|Lost to Follow-up|1|||
161415038|NCT01858766|582908013|FG000|Overall Study|Withdrew Consent|0|||
161415039|NCT01858766|582908014|FG001|Overall Study|Withdrew Consent|0|||
161415040|NCT01858766|582908015|FG002|Overall Study|Withdrew Consent|0|||
161415041|NCT01858766|582908016|FG003|Overall Study|Withdrew Consent|0|||
161415042|NCT01858766|582908017|FG004|Overall Study|Withdrew Consent|0|||
161415043|NCT01858766|582908018|FG005|Overall Study|Withdrew Consent|0|||
161415044|NCT01858766|582908019|FG006|Overall Study|Withdrew Consent|0|||
161415045|NCT01858766|582908020|FG007|Overall Study|Withdrew Consent|0|||
161415046|NCT01858766|582908021|FG008|Overall Study|Withdrew Consent|0|||
161415047|NCT01858766|582908022|FG009|Overall Study|Withdrew Consent|0|||
161415048|NCT01858766|582908023|FG010|Overall Study|Withdrew Consent|0|||
161415049|NCT01858766|582908024|FG011|Overall Study|Withdrew Consent|1|||
161415050|NCT01858766|582908025|FG012|Overall Study|Withdrew Consent|0|||
161415051|NCT01858766|582908026|FG013|Overall Study|Withdrew Consent|0|||
161415052|NCT01858766|582908027|FG014|Overall Study|Withdrew Consent|0|||
161415053|NCT01858766|582908028|FG015|Overall Study|Withdrew Consent|0|||
161415054|NCT01858766|582908029|FG016|Overall Study|Withdrew Consent|0|||
161415055|NCT01858766|582908030|FG017|Overall Study|Withdrew Consent|0|||
161415056|NCT01858766|582908031|FG018|Overall Study|Withdrew Consent|0|||
161415057|NCT05438576|582908046|FG000|Overall Study|Death|1|||
161415058|NCT05438576|582908047|FG001|Overall Study|Death|1|||
161415059|NCT05438576|582908046|FG000|Overall Study|Withdrawal by Subject|4|||
161415060|NCT05438576|582908047|FG001|Overall Study|Withdrawal by Subject|2|||
161415061|NCT05438576|582908046|FG000|Overall Study|Not Eligible|2|||
161415062|NCT05438576|582908047|FG001|Overall Study|Not Eligible|1|||
161415063|NCT05438576|582908046|FG000|Overall Study|Did not complete baseline testing|22|||
161415064|NCT05438576|582908047|FG001|Overall Study|Did not complete baseline testing|4|||
161415065|NCT02881762|582908050|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161415066|NCT02881762|582908051|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161415067|NCT00245037|582908052|FG000|Overall Study|Death|17|||
161415068|NCT00296140|582908054|FG000|Overall Study|Lost to Follow-up|1|||
161415069|NCT00296140|582908055|FG001|Overall Study|Lost to Follow-up|0|||
161415070|NCT00296140|582908054|FG000|Overall Study|Withdrawal by Subject|1|||
161415071|NCT00296140|582908055|FG001|Overall Study|Withdrawal by Subject|0|||
161415072|NCT00296140|582908054|FG000|Overall Study|Discharge to Nursing Home|1|||
161415073|NCT00296140|582908055|FG001|Overall Study|Discharge to Nursing Home|0|||
161415074|NCT00880191|582908062|FG000|Overall Study|Refused further treatment|4|||
161415075|NCT00880191|582908063|FG001|Overall Study|Refused further treatment|1|||
161415076|NCT00880191|582908062|FG000|Overall Study|Adverse Event|8|||
161415077|NCT00880191|582908063|FG001|Overall Study|Adverse Event|6|||
161415078|NCT00880191|582908062|FG000|Overall Study|Hospitalization/efficacy|1|||
161415079|NCT00880191|582908063|FG001|Overall Study|Hospitalization/efficacy|1|||
161415080|NCT01843062|582908065|FG000|Overall Study|Protocol Violation|1|||
161415081|NCT01843062|582908066|FG001|Overall Study|Protocol Violation|0|||
161415082|NCT01843062|582908065|FG000|Overall Study|New treatment following progression|2|||
161415083|NCT01843062|582908066|FG001|Overall Study|New treatment following progression|0|||
161415084|NCT01843062|582908065|FG000|Overall Study|Pregnancy|1|||
161415085|NCT01843062|582908066|FG001|Overall Study|Pregnancy|0|||
161415086|NCT01843062|582908065|FG000|Overall Study|Adverse Event|2|||
161415087|NCT01843062|582908066|FG001|Overall Study|Adverse Event|0|||
161415088|NCT01843062|582908065|FG000|Overall Study|Incorrect randomisation|1|||
161415089|NCT01843062|582908066|FG001|Overall Study|Incorrect randomisation|0|||
161415090|NCT01843062|582908065|FG000|Overall Study|Withdrawal by Subject|12|||
161415091|NCT01843062|582908066|FG001|Overall Study|Withdrawal by Subject|3|||
161415092|NCT01843062|582908065|FG000|Overall Study|Death|1|||
161415093|NCT01843062|582908066|FG001|Overall Study|Death|2|||
161415094|NCT01843062|582908065|FG000|Overall Study|Lost to Follow-up|2|||
161415095|NCT01843062|582908066|FG001|Overall Study|Lost to Follow-up|4|||
161415096|NCT00994422|582908070|FG000|Overall Study|Lost to Follow-up|7|||
161415097|NCT00994422|582908071|FG001|Overall Study|Lost to Follow-up|1|||
161415098|NCT02669212|582908072|FG000|Overall Study|Lost to Follow-up|1|||
161415099|NCT02669212|582908073|FG001|Overall Study|Lost to Follow-up|0|||
161415100|NCT02669212|582908072|FG000|Overall Study|Medical Condition|3|||
161415101|NCT02669212|582908073|FG001|Overall Study|Medical Condition|4|||
161415102|NCT02669212|582908072|FG000|Overall Study|Withdrawal by Subject|0|||
161415103|NCT02669212|582908073|FG001|Overall Study|Withdrawal by Subject|2|||
161415104|NCT02669212|582908072|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
161415105|NCT02669212|582908073|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
161415106|NCT03549104|582908076|FG000|Overall Study|Withdrawal by Subject|5|||
161415107|NCT03549104|582908077|FG001|Overall Study|Withdrawal by Subject|2|||
161415108|NCT03549104|582908076|FG000|Overall Study|Covid shelter in place|1|||
161415109|NCT03549104|582908077|FG001|Overall Study|Covid shelter in place|2|||
161415110|NCT04124705|582908078|FG000|Titration Period|Adverse Event|9|||
161415111|NCT04124705|582908079|FG001|Titration Period|Adverse Event|5|||
161415112|NCT04124705|582908078|FG000|Titration Period|Withdrawal by Subject|6|||
161415113|NCT04124705|582908079|FG001|Titration Period|Withdrawal by Subject|3|||
161415114|NCT04124705|582908078|FG000|Titration Period|Lost to Follow-up|0|||
161415115|NCT04124705|582908079|FG001|Titration Period|Lost to Follow-up|1|||
161415116|NCT04124705|582908078|FG000|Titration Period|Death|1|||
161415117|NCT04124705|582908079|FG001|Titration Period|Death|1|||
161415118|NCT04124705|582908078|FG000|Titration Period|Lack of Efficacy|2|||
161415119|NCT04124705|582908079|FG001|Titration Period|Lack of Efficacy|0|||
161415120|NCT04124705|582908078|FG000|Titration Period|Physician Decision|2|||
161415121|NCT04124705|582908079|FG001|Titration Period|Physician Decision|0|||
161415122|NCT04124705|582908078|FG000|Titration Period|Non-compliance with Study Drug|2|||
161415123|NCT04124705|582908079|FG001|Titration Period|Non-compliance with Study Drug|0|||
161415124|NCT04124705|582908078|FG000|Titration Period|Other|4|||
161415125|NCT04124705|582908079|FG001|Titration Period|Other|9|||
161415126|NCT04124705|582908078|FG000|Stabilization Period|Adverse Event|4|||
161415127|NCT04124705|582908079|FG001|Stabilization Period|Adverse Event|2|||
161415128|NCT04124705|582908078|FG000|Stabilization Period|Withdrawal by Subject|1|||
161415129|NCT04124705|582908079|FG001|Stabilization Period|Withdrawal by Subject|1|||
161415130|NCT04124705|582908078|FG000|Stabilization Period|Lost to Follow-up|0|||
161415131|NCT04124705|582908079|FG001|Stabilization Period|Lost to Follow-up|1|||
161415132|NCT04124705|582908078|FG000|Stabilization Period|Lack of Efficacy|4|||
161415133|NCT04124705|582908079|FG001|Stabilization Period|Lack of Efficacy|2|||
161415134|NCT04124705|582908078|FG000|Stabilization Period|Protocol Deviation|0|||
161415135|NCT04124705|582908079|FG001|Stabilization Period|Protocol Deviation|2|||
161415136|NCT04124705|582908078|FG000|Stabilization Period|Other|2|||
161415137|NCT04124705|582908079|FG001|Stabilization Period|Other|2|||
161415138|NCT03422536|582908080|FG000|Randomized|Physician Decision|1|||
161415139|NCT03422536|582908081|FG001|Randomized|Physician Decision|1|||
161415140|NCT03422536|582908080|FG000|Allocation - Received Intervention|Disease progression|19|||
161415141|NCT03422536|582908081|FG001|Allocation - Received Intervention|Disease progression|25|||
161415142|NCT03422536|582908080|FG000|Allocation - Received Intervention|Death|1|||
161415143|NCT03422536|582908081|FG001|Allocation - Received Intervention|Death|3|||
161415144|NCT03422536|582908080|FG000|Allocation - Received Intervention|Adverse Event|1|||
161415145|NCT03422536|582908081|FG001|Allocation - Received Intervention|Adverse Event|0|||
161415146|NCT03422536|582908080|FG000|Allocation - Received Intervention|Physician Decision|1|||
161415147|NCT03422536|582908081|FG001|Allocation - Received Intervention|Physician Decision|1|||
161415148|NCT03422536|582908080|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
161415149|NCT03422536|582908081|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
161415150|NCT03422536|582908080|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
161415151|NCT03422536|582908081|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
161415152|NCT01973998|582908082|FG000|Overall Study|Death|2|||
161415153|NCT01973998|582908083|FG001|Overall Study|Death|2|||
161415154|NCT02540993|582908090|FG000|Overall Study|Lost to Follow-up|5|||
161415155|NCT02540993|582908091|FG001|Overall Study|Lost to Follow-up|3|||
161415156|NCT02540993|582908090|FG000|Overall Study|Withdrawal by Subject|4|||
161415157|NCT02540993|582908091|FG001|Overall Study|Withdrawal by Subject|6|||
161415158|NCT02540993|582908090|FG000|Overall Study|GCP violations|33|||
161415159|NCT02540993|582908091|FG001|Overall Study|GCP violations|27|||
161415160|NCT00932165|582908094|FG000|Overall Study|Lost to Follow-up|1|||
161415161|NCT01620528|582908095|FG000|Treatment Period|Did Not Receive Study Drug|0|||
161415162|NCT01620528|582908096|FG001|Treatment Period|Did Not Receive Study Drug|0|||
161415163|NCT01620528|582908097|FG002|Treatment Period|Did Not Receive Study Drug|1|||
161415164|NCT01620528|582908095|FG000|Treatment Period|Withdrawal by Subject|35|||
161415165|NCT01620528|582908096|FG001|Treatment Period|Withdrawal by Subject|21|||
161415166|NCT01620528|582908097|FG002|Treatment Period|Withdrawal by Subject|16|||
161415167|NCT01620528|582908095|FG000|Treatment Period|Adverse Event|17|||
161415168|NCT01620528|582908096|FG001|Treatment Period|Adverse Event|13|||
161415169|NCT01620528|582908097|FG002|Treatment Period|Adverse Event|21|||
161415170|NCT01620528|582908095|FG000|Treatment Period|Lost to Follow-up|16|||
161415171|NCT01620528|582908096|FG001|Treatment Period|Lost to Follow-up|8|||
161415172|NCT01620528|582908097|FG002|Treatment Period|Lost to Follow-up|14|||
161415173|NCT01620528|582908095|FG000|Treatment Period|Other|9|||
161415174|NCT01620528|582908096|FG001|Treatment Period|Other|5|||
161415175|NCT01620528|582908097|FG002|Treatment Period|Other|7|||
161415176|NCT01620528|582908095|FG000|Treatment Period|Subject Noncompliant|11|||
161415177|NCT01620528|582908096|FG001|Treatment Period|Subject Noncompliant|2|||
161415178|NCT01620528|582908097|FG002|Treatment Period|Subject Noncompliant|2|||
161415179|NCT01620528|582908095|FG000|Treatment Period|Pregnancy|7|||
161415180|NCT01620528|582908096|FG001|Treatment Period|Pregnancy|2|||
161415181|NCT01620528|582908097|FG002|Treatment Period|Pregnancy|2|||
161415182|NCT01620528|582908095|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
161415183|NCT01620528|582908096|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
161415184|NCT01620528|582908097|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
161415185|NCT01620528|582908095|FG000|Treatment Period|Exclusionary Medication Received|0|||
161415186|NCT01620528|582908096|FG001|Treatment Period|Exclusionary Medication Received|1|||
161415187|NCT01620528|582908097|FG002|Treatment Period|Exclusionary Medication Received|0|||
161415188|NCT01620528|582908095|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161415189|NCT01620528|582908096|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
161415190|NCT01620528|582908097|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161415191|NCT01620528|582908095|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161415192|NCT01620528|582908096|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161415193|NCT01620528|582908097|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
161415194|NCT01620528|582908095|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
161415195|NCT01620528|582908096|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
161415196|NCT01620528|582908097|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
161415197|NCT01620528|582908095|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
161415198|NCT01620528|582908096|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
161415199|NCT01620528|582908097|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
161415200|NCT01620528|582908095|FG000|Post-Treatment Follow-Up Period|Other|6|||
161415201|NCT01620528|582908096|FG001|Post-Treatment Follow-Up Period|Other|4|||
161415202|NCT01620528|582908097|FG002|Post-Treatment Follow-Up Period|Other|2|||
161415203|NCT01457846|582908098|FG000|Overall Study|Death before treatment|1|||
161415204|NCT01457846|582908099|FG001|Overall Study|Death before treatment|2|||
161415205|NCT01457846|582908098|FG000|Overall Study|Did not receive treatment|0|||
161415206|NCT01457846|582908099|FG001|Overall Study|Did not receive treatment|1|||
161415207|NCT01457846|582908098|FG000|Overall Study|Death|27|||
161415208|NCT01457846|582908099|FG001|Overall Study|Death|16|||
161415209|NCT01457846|582908098|FG000|Overall Study|Unclassified reason for not completed|11|||
161415210|NCT01457846|582908099|FG001|Overall Study|Unclassified reason for not completed|10|||
161415211|NCT01457846|582908098|FG000|Overall Study|Withdrawal by Subject|1|||
161415212|NCT01457846|582908099|FG001|Overall Study|Withdrawal by Subject|1|||
161415213|NCT01457846|582908098|FG000|Overall Study|Lost to Follow-up|1|||
161415214|NCT01457846|582908099|FG001|Overall Study|Lost to Follow-up|0|||
161415215|NCT03688620|582908104|FG000|Overall Study|Other|0|||
161415216|NCT03688620|582908105|FG001|Overall Study|Other|0|||
161415217|NCT03688620|582908106|FG002|Overall Study|Other|1|||
161415218|NCT03688620|582908104|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
161415219|NCT03688620|582908105|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
161415220|NCT03688620|582908106|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
161415221|NCT03688620|582908104|FG000|Overall Study|Lost to Follow-up|16|||
161415222|NCT03688620|582908105|FG001|Overall Study|Lost to Follow-up|0|||
161415223|NCT03688620|582908106|FG002|Overall Study|Lost to Follow-up|1|||
161415224|NCT03688620|582908104|FG000|Overall Study|Withdrawal by Subject|0|||
161415225|NCT03688620|582908105|FG001|Overall Study|Withdrawal by Subject|0|||
161415226|NCT03688620|582908106|FG002|Overall Study|Withdrawal by Subject|6|||
161415227|NCT02828020|582908107|FG000|Treatment Period|Adverse Event|3|||
161415228|NCT02828020|582908108|FG001|Treatment Period|Adverse Event|1|||
161415229|NCT02828020|582908109|FG002|Treatment Period|Adverse Event|1|||
161415230|NCT02828020|582908107|FG000|Treatment Period|Withdrawal of Consent|10|||
161415231|NCT02828020|582908108|FG001|Treatment Period|Withdrawal of Consent|14|||
161415232|NCT02828020|582908109|FG002|Treatment Period|Withdrawal of Consent|9|||
161415233|NCT02828020|582908107|FG000|Treatment Period|Lost to Follow-up|21|||
161415234|NCT02828020|582908108|FG001|Treatment Period|Lost to Follow-up|24|||
161415235|NCT02828020|582908109|FG002|Treatment Period|Lost to Follow-up|18|||
161415236|NCT02828020|582908107|FG000|Treatment Period|Lack of Qualifying Event|44|||
161415237|NCT02828020|582908108|FG001|Treatment Period|Lack of Qualifying Event|53|||
161415238|NCT02828020|582908109|FG002|Treatment Period|Lack of Qualifying Event|43|||
161415239|NCT02828020|582908107|FG000|Treatment Period|Pregnancy|0|||
161415240|NCT02828020|582908108|FG001|Treatment Period|Pregnancy|2|||
161415241|NCT02828020|582908109|FG002|Treatment Period|Pregnancy|0|||
161415242|NCT02828020|582908107|FG000|Treatment Period|Protocol Violation|2|||
161415243|NCT02828020|582908108|FG001|Treatment Period|Protocol Violation|4|||
161415244|NCT02828020|582908109|FG002|Treatment Period|Protocol Violation|7|||
161415245|NCT02828020|582908107|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161415246|NCT02828020|582908108|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
161415247|NCT02828020|582908109|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
161415248|NCT02828020|582908107|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
161415249|NCT02828020|582908108|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
161415250|NCT02828020|582908109|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
161415251|NCT02828020|582908107|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
161415252|NCT02828020|582908108|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
161415253|NCT02828020|582908109|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
161415254|NCT02828020|582908107|FG000|Safety Follow-up Period|Protocol Violation|0|||
161415255|NCT02828020|582908108|FG001|Safety Follow-up Period|Protocol Violation|2|||
161415256|NCT02828020|582908109|FG002|Safety Follow-up Period|Protocol Violation|1|||
161415257|NCT02828020|582908107|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
161415258|NCT02828020|582908108|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161415259|NCT02828020|582908109|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161415260|NCT03657095|582908110|FG000|Overall Study|Withdrawal by Subject|1|||
161415261|NCT03657095|582908111|FG001|Overall Study|Withdrawal by Subject|1|||
161415262|NCT03657095|582908110|FG000|Overall Study|Adverse Event|0|||
161415263|NCT03657095|582908111|FG001|Overall Study|Adverse Event|3|||
161415264|NCT03657095|582908110|FG000|Overall Study|Study Terminated by Sponsor|58|||
161415265|NCT03657095|582908111|FG001|Overall Study|Study Terminated by Sponsor|49|||
161415266|NCT00828750|582908112|FG000|Overall Study|Lack of Efficacy|3|||
161415267|NCT00828750|582908112|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
161415268|NCT01067469|582908113|FG000|Overall Study|Withdrawal by Subject|0|||
161415269|NCT01067469|582908114|FG001|Overall Study|Withdrawal by Subject|1|||
161415270|NCT01067469|582908113|FG000|Overall Study|Disease Progression|0|||
161415271|NCT01067469|582908114|FG001|Overall Study|Disease Progression|1|||
161415272|NCT04006392|582908115|FG000|Overall Study|Lost to Follow-up|0|||
161415273|NCT04006392|582908116|FG001|Overall Study|Lost to Follow-up|1|||
161415274|NCT04378114|582908117|FG000|Overall Study|Withdrawal by Subject|5|||
161415275|NCT00830180|582908118|FG000|Overall Study|Adverse Event|6|||
161415276|NCT00830180|582908118|FG000|Overall Study|Death|11|||
161415277|NCT00830180|582908118|FG000|Overall Study|Insufficient clinical response|1|||
161415278|NCT00830180|582908118|FG000|Overall Study|Withdrawal by Subject|5|||
161415279|NCT00830180|582908118|FG000|Overall Study|Progressive disease|2|||
161415280|NCT00830180|582908118|FG000|Overall Study|Other - Unspecified|1|||
161415281|NCT01832532|582908119|FG000|Overall Study|Withdrawal by Subject|5|||
161415282|NCT01832532|582908120|FG001|Overall Study|Withdrawal by Subject|2|||
161415283|NCT01736618|582908125|FG000|Overall Study|Death|294|||
161415284|NCT01736618|582908125|FG000|Overall Study|Lost to Follow-up|193|||
161415285|NCT01736618|582908125|FG000|Overall Study|Withdrawal by Subject|54|||
161415286|NCT01736618|582908125|FG000|Overall Study|Subject unable to be followed at study location|223|||
161415287|NCT01736618|582908125|FG000|Overall Study|Physician Decision|33|||
161415288|NCT01736618|582908125|FG000|Overall Study|Transplant or removal of target organ|19|||
161415289|NCT01736618|582908125|FG000|Overall Study|Change in indication or condition|78|||
161415290|NCT01736618|582908125|FG000|Overall Study|Study device explant|103|||
161415291|NCT01736618|582908125|FG000|Overall Study|Unable to complete implant|2|||
161415292|NCT01748825|582908129|FG000|Dose Escalation|Refused further treatment|2|||
161415293|NCT01748825|582908130|FG001|Dose Escalation|Refused further treatment|2|||
161415294|NCT01748825|582908131|FG002|Dose Escalation|Refused further treatment|0|||
161415295|NCT01748825|582908132|FG003|Dose Escalation|Refused further treatment|0|||
161415296|NCT01748825|582908133|FG004|Dose Escalation|Refused further treatment|1|||
161415297|NCT01748825|582908134|FG005|Dose Escalation|Refused further treatment|2|||
161415298|NCT01748825|582908135|FG006|Dose Escalation|Refused further treatment|0|||
161415299|NCT01748825|582908136|FG007|Dose Escalation|Refused further treatment|0|||
161415300|NCT01748825|582908137|FG008|Dose Escalation|Refused further treatment|0|||
161415301|NCT01748825|582908138|FG009|Dose Escalation|Refused further treatment|0|||
161415302|NCT01748825|582908129|FG000|Dose Escalation|Switched to alternative treatment|0|||
161415303|NCT01748825|582908130|FG001|Dose Escalation|Switched to alternative treatment|0|||
161415304|NCT01748825|582908131|FG002|Dose Escalation|Switched to alternative treatment|0|||
161415305|NCT01748825|582908132|FG003|Dose Escalation|Switched to alternative treatment|1|||
161415306|NCT01748825|582908133|FG004|Dose Escalation|Switched to alternative treatment|0|||
161415307|NCT01748825|582908134|FG005|Dose Escalation|Switched to alternative treatment|0|||
161415308|NCT01748825|582908135|FG006|Dose Escalation|Switched to alternative treatment|0|||
161415309|NCT01748825|582908136|FG007|Dose Escalation|Switched to alternative treatment|0|||
161415310|NCT01748825|582908137|FG008|Dose Escalation|Switched to alternative treatment|0|||
161415311|NCT01748825|582908138|FG009|Dose Escalation|Switched to alternative treatment|0|||
161415312|NCT01748825|582908129|FG000|Dose Escalation|Adverse Event|0|||
161415313|NCT01748825|582908130|FG001|Dose Escalation|Adverse Event|0|||
161415314|NCT01748825|582908131|FG002|Dose Escalation|Adverse Event|0|||
161415315|NCT01748825|582908132|FG003|Dose Escalation|Adverse Event|0|||
161415316|NCT01748825|582908133|FG004|Dose Escalation|Adverse Event|0|||
161415317|NCT01748825|582908134|FG005|Dose Escalation|Adverse Event|0|||
161415318|NCT01748825|582908135|FG006|Dose Escalation|Adverse Event|1|||
161415319|NCT01748825|582908136|FG007|Dose Escalation|Adverse Event|0|||
161415320|NCT01748825|582908137|FG008|Dose Escalation|Adverse Event|0|||
161415321|NCT01748825|582908138|FG009|Dose Escalation|Adverse Event|0|||
161415322|NCT01748825|582908129|FG000|Dose Expansion|Refused further treatment|0|||
161415323|NCT01748825|582908130|FG001|Dose Expansion|Refused further treatment|0|||
161415324|NCT01748825|582908131|FG002|Dose Expansion|Refused further treatment|0|||
161415325|NCT01748825|582908132|FG003|Dose Expansion|Refused further treatment|0|||
161415326|NCT01748825|582908133|FG004|Dose Expansion|Refused further treatment|0|||
161415327|NCT01748825|582908134|FG005|Dose Expansion|Refused further treatment|0|||
161415328|NCT01748825|582908135|FG006|Dose Expansion|Refused further treatment|0|||
161415329|NCT01748825|582908136|FG007|Dose Expansion|Refused further treatment|0|||
161415330|NCT01748825|582908137|FG008|Dose Expansion|Refused further treatment|1|||
161415331|NCT01748825|582908138|FG009|Dose Expansion|Refused further treatment|1|||
161415332|NCT01748825|582908129|FG000|Dose Expansion|Switched to alternative treatment|0|||
161415333|NCT01748825|582908130|FG001|Dose Expansion|Switched to alternative treatment|0|||
161415334|NCT01748825|582908131|FG002|Dose Expansion|Switched to alternative treatment|0|||
161415335|NCT01748825|582908132|FG003|Dose Expansion|Switched to alternative treatment|0|||
161415336|NCT01748825|582908133|FG004|Dose Expansion|Switched to alternative treatment|0|||
161415337|NCT01748825|582908134|FG005|Dose Expansion|Switched to alternative treatment|0|||
161415338|NCT01748825|582908135|FG006|Dose Expansion|Switched to alternative treatment|0|||
161415339|NCT01748825|582908136|FG007|Dose Expansion|Switched to alternative treatment|0|||
161415340|NCT01748825|582908137|FG008|Dose Expansion|Switched to alternative treatment|0|||
161415341|NCT01748825|582908138|FG009|Dose Expansion|Switched to alternative treatment|1|||
161415342|NCT01748825|582908129|FG000|Dose Expansion|Adverse Event|0|||
161415343|NCT01748825|582908130|FG001|Dose Expansion|Adverse Event|0|||
161415344|NCT01748825|582908131|FG002|Dose Expansion|Adverse Event|0|||
161415345|NCT01748825|582908132|FG003|Dose Expansion|Adverse Event|0|||
161415346|NCT01748825|582908133|FG004|Dose Expansion|Adverse Event|0|||
161415347|NCT01748825|582908134|FG005|Dose Expansion|Adverse Event|0|||
161415348|NCT01748825|582908135|FG006|Dose Expansion|Adverse Event|0|||
161415349|NCT01748825|582908136|FG007|Dose Expansion|Adverse Event|0|||
161415350|NCT01748825|582908137|FG008|Dose Expansion|Adverse Event|0|||
161415351|NCT01748825|582908138|FG009|Dose Expansion|Adverse Event|3|||
161415352|NCT01748825|582908129|FG000|Dose Expansion|Physician Decision|0|||
161415353|NCT01748825|582908130|FG001|Dose Expansion|Physician Decision|0|||
161415354|NCT01748825|582908131|FG002|Dose Expansion|Physician Decision|0|||
161415355|NCT01748825|582908132|FG003|Dose Expansion|Physician Decision|0|||
161415356|NCT01748825|582908133|FG004|Dose Expansion|Physician Decision|0|||
161415357|NCT01748825|582908134|FG005|Dose Expansion|Physician Decision|0|||
161415358|NCT01748825|582908135|FG006|Dose Expansion|Physician Decision|0|||
161415359|NCT01748825|582908136|FG007|Dose Expansion|Physician Decision|0|||
161415360|NCT01748825|582908137|FG008|Dose Expansion|Physician Decision|1|||
161415361|NCT01748825|582908138|FG009|Dose Expansion|Physician Decision|0|||
161415362|NCT01730586|582908142|FG000|Overall Study|Progressive Disease|2|||
161415363|NCT01730586|582908142|FG000|Overall Study|Inadequate Trial|8|||
161415364|NCT01730586|582908142|FG000|Overall Study|Adverse Event|2|||
161415365|NCT01730586|582908142|FG000|Overall Study|Hospice|1|||
161415366|NCT02461745|582908143|FG000|Overall Study|Lack of Efficacy|9|||
161415367|NCT02461745|582908144|FG001|Overall Study|Lack of Efficacy|1|||
161415368|NCT02461745|582908143|FG000|Overall Study|Lost to Follow-up|2|||
161415369|NCT02461745|582908144|FG001|Overall Study|Lost to Follow-up|2|||
161415370|NCT02461745|582908143|FG000|Overall Study|Withdrawal by Subject|3|||
161415371|NCT02461745|582908144|FG001|Overall Study|Withdrawal by Subject|1|||
161415372|NCT02921087|582908145|FG000|Overall Study|Withdrawal by Subject|0|||
161415373|NCT02921087|582908146|FG001|Overall Study|Withdrawal by Subject|1|||
161415374|NCT05111249|582909800|FG000|Overall Study|Lost to Follow-up|0|||
161415375|NCT05111249|582909801|FG001|Overall Study|Lost to Follow-up|2|||
161415376|NCT05111249|582909800|FG000|Overall Study|Physician Decision|0|||
161415377|NCT05111249|582909801|FG001|Overall Study|Physician Decision|1|||
161415378|NCT05111249|582909800|FG000|Overall Study|Participant decision|1|||
161415379|NCT05111249|582909801|FG001|Overall Study|Participant decision|5|||
161415380|NCT02610777|582909807|FG000|Overall Study|Lost to Follow-up|1|||
161415381|NCT02610777|582909808|FG001|Overall Study|Lost to Follow-up|0|||
161415382|NCT02610777|582909807|FG000|Overall Study|Site Terminated by Sponsor|9|||
161415383|NCT02610777|582909808|FG001|Overall Study|Site Terminated by Sponsor|8|||
161415384|NCT02610777|582909807|FG000|Overall Study|Withdrawal by Subject|2|||
161415385|NCT02610777|582909808|FG001|Overall Study|Withdrawal by Subject|2|||
161415386|NCT02610777|582909807|FG000|Overall Study|Reason not Specified|0|||
161415387|NCT02610777|582909808|FG001|Overall Study|Reason not Specified|1|||
161415388|NCT02610777|582909807|FG000|Overall Study|Death|50|||
161415389|NCT02610777|582909808|FG001|Overall Study|Death|47|||
161415390|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
161415391|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161415392|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161415393|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161415394|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161415395|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
161415396|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161415397|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161415398|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161415399|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161415400|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
161415401|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161415402|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161415403|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161415404|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161415405|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
161415406|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161415407|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161415408|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161415409|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161415410|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
161415411|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161415412|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161415413|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161415414|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161415415|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
161415416|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161415417|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161415418|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161415419|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161415420|NCT01173601|582909811|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
161415421|NCT01173601|582909812|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161415422|NCT01173601|582909813|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161415423|NCT01173601|582909814|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161415424|NCT01173601|582909815|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161415425|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
161415426|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
161415427|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
161415428|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
161415429|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
161415430|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
161415431|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
161415432|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
161415433|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
161415434|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
161415435|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161415436|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
161415437|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161415438|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
161415439|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
161415440|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161415441|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161415442|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161415443|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161415444|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161415445|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
161415446|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
161415447|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161415448|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
161415449|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161415450|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
161415451|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
161415452|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
161415453|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
161415454|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
161415455|NCT01173601|582909811|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161415456|NCT01173601|582909812|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161415457|NCT01173601|582909813|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161415458|NCT01173601|582909814|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161415459|NCT01173601|582909815|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
161415460|NCT04737278|582909816|FG000|Overall Study|Lost to Follow-up|1|||
161415461|NCT04737278|582909817|FG001|Overall Study|Lost to Follow-up|1|||
161415462|NCT04737278|582909816|FG000|Overall Study|Withdrawal by Subject|1|||
161415463|NCT04737278|582909817|FG001|Overall Study|Withdrawal by Subject|0|||
161415464|NCT04737278|582909816|FG000|Overall Study|Protocol Violation|1|||
161415465|NCT04737278|582909817|FG001|Overall Study|Protocol Violation|1|||
161415466|NCT04737278|582909816|FG000|Overall Study|failure to complete questionnaire|1|||
161415467|NCT04737278|582909817|FG001|Overall Study|failure to complete questionnaire|1|||
161415468|NCT02828436|582909826|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
161415469|NCT02828436|582909827|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
161415470|NCT02828436|582909826|FG000|Period 1|Lost to Follow-up|0|||
161415471|NCT02828436|582909827|FG001|Period 1|Lost to Follow-up|1|||
161415472|NCT02828436|582909826|FG000|Period 2|Withdrawal by Subject|4|||
161415473|NCT02828436|582909827|FG001|Period 2|Withdrawal by Subject|0|||
161415474|NCT02828436|582909826|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
161415475|NCT02828436|582909827|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
161415476|NCT02828436|582909826|FG000|Period 2|Lost to Follow-up|1|||
161415477|NCT02828436|582909827|FG001|Period 2|Lost to Follow-up|0|||
161415478|NCT02837029|582909828|FG000|Screening|Failed to meet screening requirements.|7|||
161415479|NCT02837029|582909829|FG001|Screening|Failed to meet screening requirements.|3|||
161415480|NCT02837029|582909830|FG002|Screening|Failed to meet screening requirements.|0|||
161415481|NCT02837029|582909828|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
161415482|NCT02837029|582909829|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
161415483|NCT02837029|582909830|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
161415484|NCT02837029|582909828|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
161415485|NCT02837029|582909829|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
161415486|NCT02837029|582909830|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
161415487|NCT02837029|582909828|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
161415488|NCT02837029|582909829|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
161415489|NCT02837029|582909830|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
161415490|NCT02837029|582909828|FG000|Cycle 2 and Beyond|Adverse Event|1|||
161415491|NCT02837029|582909829|FG001|Cycle 2 and Beyond|Adverse Event|0|||
161415492|NCT02837029|582909830|FG002|Cycle 2 and Beyond|Adverse Event|0|||
161415493|NCT02837029|582909828|FG000|2 Year Follow-up|Death|6|||
161415494|NCT02837029|582909829|FG001|2 Year Follow-up|Death|7|||
161415495|NCT02837029|582909830|FG002|2 Year Follow-up|Death|0|||
161415496|NCT01363908|582909831|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
161415497|NCT01363908|582909832|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
161415498|NCT01363908|582909831|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
161415499|NCT01363908|582909832|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
161415500|NCT01363908|582909831|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
161415501|NCT01363908|582909832|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
161415502|NCT01363908|582909831|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
161415503|NCT01363908|582909832|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
161415504|NCT02644343|582909833|FG000|Overall Study|Withdrawal by Subject|1|||
161415505|NCT05258149|582909834|FG000|Period 1|Protocol Deviation|1|||
161415506|NCT05258149|582909835|FG001|Period 1|Protocol Deviation|0|||
161415507|NCT05258149|582909834|FG000|Period 1|Adverse Event|0|||
161415508|NCT05258149|582909835|FG001|Period 1|Adverse Event|1|||
161415509|NCT05258149|582909834|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
161415510|NCT05258149|582909835|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161415511|NCT05258149|582909834|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
161415512|NCT05258149|582909835|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
161415513|NCT05258149|582909834|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
161415514|NCT05258149|582909835|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
161415515|NCT00536471|582909838|FG000|Overall Study|Lost to Follow-up|48|||
161415516|NCT00536471|582909839|FG001|Overall Study|Lost to Follow-up|23|||
161415517|NCT00536471|582909840|FG002|Overall Study|Lost to Follow-up|48|||
161415518|NCT00536471|582909841|FG003|Overall Study|Lost to Follow-up|22|||
161415519|NCT00536471|582909838|FG000|Overall Study|Adverse Event|32|||
161415520|NCT00536471|582909839|FG001|Overall Study|Adverse Event|16|||
161415521|NCT00536471|582909840|FG002|Overall Study|Adverse Event|28|||
161415522|NCT00536471|582909841|FG003|Overall Study|Adverse Event|13|||
161415523|NCT00536471|582909838|FG000|Overall Study|Withdrawal by Subject|40|||
161415524|NCT00536471|582909839|FG001|Overall Study|Withdrawal by Subject|24|||
161415525|NCT00536471|582909840|FG002|Overall Study|Withdrawal by Subject|43|||
161415526|NCT00536471|582909841|FG003|Overall Study|Withdrawal by Subject|21|||
161415527|NCT00536471|582909838|FG000|Overall Study|Lack of Efficacy|17|||
161415528|NCT00536471|582909839|FG001|Overall Study|Lack of Efficacy|18|||
161415529|NCT00536471|582909840|FG002|Overall Study|Lack of Efficacy|11|||
161415530|NCT00536471|582909841|FG003|Overall Study|Lack of Efficacy|9|||
161415531|NCT00536471|582909838|FG000|Overall Study|Protocol Violation|8|||
161415532|NCT00536471|582909839|FG001|Overall Study|Protocol Violation|1|||
161415533|NCT00536471|582909840|FG002|Overall Study|Protocol Violation|2|||
161415534|NCT00536471|582909841|FG003|Overall Study|Protocol Violation|3|||
161415535|NCT00536471|582909838|FG000|Overall Study|Physician Decision|11|||
161415536|NCT00536471|582909839|FG001|Overall Study|Physician Decision|1|||
161415537|NCT00536471|582909840|FG002|Overall Study|Physician Decision|3|||
161415538|NCT00536471|582909841|FG003|Overall Study|Physician Decision|2|||
161415539|NCT00536471|582909838|FG000|Overall Study|Death|0|||
161415540|NCT00536471|582909839|FG001|Overall Study|Death|0|||
161415541|NCT00536471|582909840|FG002|Overall Study|Death|1|||
161415542|NCT00536471|582909841|FG003|Overall Study|Death|2|||
161415543|NCT00536471|582909838|FG000|Overall Study|Sponsor Decision|0|||
161415544|NCT00536471|582909839|FG001|Overall Study|Sponsor Decision|1|||
161415545|NCT00536471|582909840|FG002|Overall Study|Sponsor Decision|3|||
161415546|NCT00536471|582909841|FG003|Overall Study|Sponsor Decision|2|||
161415547|NCT01442714|582909844|FG000|Overall Study|Death|11|||
161415548|NCT01442714|582909844|FG000|Overall Study|Withdrawal by Subject|1|||
161415549|NCT01979952|582909860|FG000|Overall Study|Adverse Event|4|||
161415550|NCT01979952|582909861|FG001|Overall Study|Adverse Event|5|||
161415551|NCT01979952|582909860|FG000|Overall Study|Protocol Violation|1|||
161415552|NCT01979952|582909861|FG001|Overall Study|Protocol Violation|0|||
161415553|NCT01979952|582909860|FG000|Overall Study|Withdrawal by Subject|2|||
161415554|NCT01979952|582909861|FG001|Overall Study|Withdrawal by Subject|1|||
161415555|NCT01979952|582909860|FG000|Overall Study|Other than specified above|1|||
161415556|NCT01979952|582909861|FG001|Overall Study|Other than specified above|0|||
161415557|NCT00203424|582909863|FG000|Treatment Period|Withdrawal by Subject|4|||
161415558|NCT00203424|582909863|FG000|Treatment Period|Adverse Event|5|||
161415559|NCT00203424|582909863|FG000|Treatment Period|progressive disease|2|||
161415560|NCT00203424|582909863|FG000|Follow-up Period|Withdrawal by Subject|1|||
161415561|NCT00203424|582909863|FG000|Follow-up Period|progressive disease|4|||
161415562|NCT00203424|582909863|FG000|Follow-up Period|Lost to Follow-up|1|||
161415563|NCT01053988|582909864|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
161415564|NCT01053988|582909865|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161415565|NCT01053988|582909866|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161415566|NCT01053988|582909867|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161415567|NCT01053988|582909868|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161415568|NCT01053988|582909869|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161415569|NCT01053988|582909864|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
161415570|NCT01053988|582909865|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161415571|NCT01053988|582909866|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161415572|NCT01053988|582909867|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161415573|NCT01053988|582909868|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161415574|NCT01053988|582909869|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161415575|NCT01053988|582909864|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
161415576|NCT01053988|582909865|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161415577|NCT01053988|582909866|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161415578|NCT01053988|582909867|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161415579|NCT01053988|582909868|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161415580|NCT01053988|582909869|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161415581|NCT01053988|582909864|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
161415582|NCT01053988|582909865|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
161415583|NCT01053988|582909866|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
161415584|NCT01053988|582909867|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161415585|NCT01053988|582909868|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
161415586|NCT01053988|582909869|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
161415587|NCT01053988|582909864|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
161415588|NCT01053988|582909865|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
161415589|NCT01053988|582909866|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
161415590|NCT01053988|582909867|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
161415591|NCT01053988|582909868|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
161415592|NCT01053988|582909869|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
161415593|NCT01053988|582909864|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
161415594|NCT01053988|582909865|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161415595|NCT01053988|582909866|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161415596|NCT01053988|582909867|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161415597|NCT01053988|582909868|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161415598|NCT01053988|582909869|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161415599|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161415600|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
161415601|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
161415602|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
161415603|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
161415604|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
161415605|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161415606|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
161415607|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161415608|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161415609|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
161415610|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161415611|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
161415612|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
161415613|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
161415614|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161415615|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
161415616|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
161415617|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161415618|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161415619|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161415620|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161415621|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
161415622|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161415623|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161415624|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
161415625|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
161415626|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
161415627|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161415628|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
161415629|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161415630|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
161415631|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161415632|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161415633|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161415634|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
161415635|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161415636|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
161415637|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
161415638|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
161415639|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
161415640|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
161415641|NCT01053988|582909864|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161415642|NCT01053988|582909865|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
161415643|NCT01053988|582909866|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161415644|NCT01053988|582909867|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
161415645|NCT01053988|582909868|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
161415646|NCT01053988|582909869|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161415647|NCT01922271|582909871|FG000|WASHOUT Period|Withdrawal by Subject|1|||
161415648|NCT01922271|582909872|FG001|WASHOUT Period|Withdrawal by Subject|0|||
161415649|NCT00719355|582909873|FG000|Overall Study|Death|0|||
161415650|NCT00719355|582909874|FG001|Overall Study|Death|1|||
161415651|NCT00719355|582909873|FG000|Overall Study|Medical|14|||
161415652|NCT00719355|582909874|FG001|Overall Study|Medical|5|||
161415653|NCT00719355|582909873|FG000|Overall Study|Compliance|4|||
161415654|NCT00719355|582909874|FG001|Overall Study|Compliance|6|||
161415655|NCT00719355|582909873|FG000|Overall Study|Moved|0|||
161415656|NCT00719355|582909874|FG001|Overall Study|Moved|1|||
161415657|NCT01856582|582909875|FG000|Overall Study|Died prior to Boost infusion|1|||
161415658|NCT01824355|582909876|FG000|Overall Study|Adverse Event|2|||
161415659|NCT01824355|582909876|FG000|Overall Study|unevaluable reference method results per|1|||
161415660|NCT01331109|582909877|FG000|Overall Study|Adverse Event|6|||
161415661|NCT01331109|582909877|FG000|Overall Study|Lack of Efficacy|2|||
161415662|NCT01331109|582909877|FG000|Overall Study|Protocol Violation|3|||
161415663|NCT01331109|582909877|FG000|Overall Study|Withdrawal by Subject|7|||
161415664|NCT01331109|582909877|FG000|Overall Study|Lost to Follow-up|1|||
161415665|NCT01331109|582909877|FG000|Overall Study|Study Terminated by Sponsor|38|||
161415666|NCT00773747|582909878|FG000|Overall Study|Lack of Efficacy|112|||
161415667|NCT00773747|582909879|FG001|Overall Study|Lack of Efficacy|144|||
161415668|NCT00773747|582909878|FG000|Overall Study|Physician Decision|26|||
161415669|NCT00773747|582909879|FG001|Overall Study|Physician Decision|18|||
161415670|NCT00773747|582909878|FG000|Overall Study|Lost to Follow-up|0|||
161415671|NCT00773747|582909879|FG001|Overall Study|Lost to Follow-up|1|||
161415672|NCT00773747|582909878|FG000|Overall Study|Protocol Violation|2|||
161415673|NCT00773747|582909879|FG001|Overall Study|Protocol Violation|2|||
161415674|NCT00773747|582909878|FG000|Overall Study|Withdrawal by Subject|89|||
161415675|NCT00773747|582909879|FG001|Overall Study|Withdrawal by Subject|61|||
161415676|NCT00773747|582909878|FG000|Overall Study|Adverse Event|61|||
161415677|NCT00773747|582909879|FG001|Overall Study|Adverse Event|62|||
161415678|NCT00773747|582909878|FG000|Overall Study|Death|5|||
161415679|NCT00773747|582909879|FG001|Overall Study|Death|8|||
161415680|NCT00773747|582909878|FG000|Overall Study|Not Treated|2|||
161415681|NCT00773747|582909879|FG001|Overall Study|Not Treated|0|||
161415682|NCT00836186|582909882|FG000|Overall Study|Blood could not be drawn|1|||
161415683|NCT04079816|582909883|FG000|Overall Study|Request of Subject|2|||
161415684|NCT04079816|582909883|FG000|Overall Study|Unable to draw samples|1|||
161415685|NCT01636986|582909884|FG000|Overall Study|Withdrawal by Subject|0|||
161415686|NCT01636986|582909885|FG001|Overall Study|Withdrawal by Subject|1|||
161415687|NCT01636986|582909884|FG000|Overall Study|Corneal Staining|0|||
161415688|NCT01636986|582909885|FG001|Overall Study|Corneal Staining|1|||
161415689|NCT02160145|582909888|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
161415690|NCT02160145|582909889|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
161415691|NCT02160145|582909890|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
161415692|NCT02160145|582909888|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
161415693|NCT02160145|582909889|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
161415694|NCT02160145|582909890|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
161415695|NCT02160145|582909888|FG000|Randomized Double-blind Period|Subject decision|0|||
161415696|NCT02160145|582909889|FG001|Randomized Double-blind Period|Subject decision|21|||
161415697|NCT02160145|582909890|FG002|Randomized Double-blind Period|Subject decision|20|||
161415698|NCT02160145|582909888|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
161415699|NCT02160145|582909889|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
161415700|NCT02160145|582909890|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
161415701|NCT02160145|582909888|FG000|Randomized Double-blind Period|Physician Decision|0|||
161415702|NCT02160145|582909889|FG001|Randomized Double-blind Period|Physician Decision|7|||
161415703|NCT02160145|582909890|FG002|Randomized Double-blind Period|Physician Decision|5|||
161415704|NCT00705146|582909892|FG000|Overall Study|Lost to Follow-up|1|||
161415705|NCT00705146|582909893|FG001|Overall Study|Lost to Follow-up|1|||
161415706|NCT00383162|582909894|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
161415707|NCT00383162|582909895|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
161415708|NCT00383162|582909894|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
161415709|NCT00383162|582909895|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
161415710|NCT00383162|582909894|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
161415711|NCT00383162|582909895|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
161415712|NCT00383162|582909894|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
161415713|NCT00383162|582909895|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
161415714|NCT00383162|582909894|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
161415715|NCT00383162|582909895|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
161415716|NCT00383162|582909894|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
161415717|NCT00383162|582909895|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
161415718|NCT00383162|582909894|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
161415719|NCT00383162|582909895|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
161415720|NCT00383162|582909894|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
161415721|NCT00383162|582909895|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
161415722|NCT00383162|582909894|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
161415723|NCT00383162|582909895|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
161415724|NCT05392803|582909898|FG000|Overall Study|Lost to Follow-up|0|||
161415725|NCT05392803|582909899|FG001|Overall Study|Lost to Follow-up|2|||
161415726|NCT00923845|582909903|FG000|Induction Therapy|Poor performance status|0|||
161415727|NCT00923845|582909904|FG001|Induction Therapy|Poor performance status|2|||
161415728|NCT01183065|582909906|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
161415729|NCT02578186|582909907|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
161415730|NCT02578186|582909908|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
161415731|NCT02578186|582909907|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
161415732|NCT02578186|582909908|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
161415733|NCT01894243|582909909|FG000|Overall Study|Adverse Event|0|||
161415734|NCT01894243|582909910|FG001|Overall Study|Adverse Event|1|||
161415735|NCT01894243|582909911|FG002|Overall Study|Adverse Event|2|||
161415736|NCT01894243|582909909|FG000|Overall Study|Death|0|||
161415737|NCT01894243|582909910|FG001|Overall Study|Death|0|||
161415738|NCT01894243|582909911|FG002|Overall Study|Death|3|||
161415739|NCT01894243|582909909|FG000|Overall Study|Lack of Efficacy|3|||
161415740|NCT01894243|582909910|FG001|Overall Study|Lack of Efficacy|3|||
161415741|NCT01894243|582909911|FG002|Overall Study|Lack of Efficacy|1|||
161415742|NCT01894243|582909909|FG000|Overall Study|Condition under investigation worsened|8|||
161415743|NCT01894243|582909910|FG001|Overall Study|Condition under investigation worsened|6|||
161415744|NCT01894243|582909911|FG002|Overall Study|Condition under investigation worsened|2|||
161415745|NCT01894243|582909909|FG000|Overall Study|Subject decision|1|||
161415746|NCT01894243|582909910|FG001|Overall Study|Subject decision|0|||
161415747|NCT01894243|582909911|FG002|Overall Study|Subject decision|0|||
161415748|NCT01894243|582909909|FG000|Overall Study|Other|1|||
161415749|NCT01894243|582909910|FG001|Overall Study|Other|0|||
161415750|NCT01894243|582909911|FG002|Overall Study|Other|0|||
161415751|NCT01620944|582909914|FG000|Overall Study|Early termination of Study|2|||
161415752|NCT01620944|582909915|FG001|Overall Study|Early termination of Study|1|||
161415753|NCT00392990|582909916|FG000|Treatment on Study|Adverse Event|3|||
161415754|NCT00392990|582909917|FG001|Treatment on Study|Adverse Event|1|||
161415755|NCT00392990|582909916|FG000|Follow up for 2 Years|Death|4|||
161415756|NCT00392990|582909917|FG001|Follow up for 2 Years|Death|0|||
161415757|NCT00825812|582909918|FG000|Overall Study|Never entered follow up|0|||
161415758|NCT00825812|582909919|FG001|Overall Study|Never entered follow up|0|||
161415759|NCT00825812|582909920|FG002|Overall Study|Never entered follow up|0|||
161415760|NCT00825812|582909921|FG003|Overall Study|Never entered follow up|1|||
161415761|NCT00825812|582909918|FG000|Overall Study|Adverse Event|0|||
161415762|NCT00825812|582909919|FG001|Overall Study|Adverse Event|0|||
161415763|NCT00825812|582909920|FG002|Overall Study|Adverse Event|0|||
161415764|NCT00825812|582909921|FG003|Overall Study|Adverse Event|1|||
161415765|NCT00825812|582909918|FG000|Overall Study|Subject withdrew consent|0|||
161415766|NCT00825812|582909919|FG001|Overall Study|Subject withdrew consent|0|||
161415767|NCT00825812|582909920|FG002|Overall Study|Subject withdrew consent|3|||
161415768|NCT00825812|582909921|FG003|Overall Study|Subject withdrew consent|2|||
161415769|NCT00825812|582909918|FG000|Overall Study|Non-compliance with protocol|0|||
161415770|NCT00825812|582909919|FG001|Overall Study|Non-compliance with protocol|0|||
161415771|NCT00825812|582909920|FG002|Overall Study|Non-compliance with protocol|0|||
161415772|NCT00825812|582909921|FG003|Overall Study|Non-compliance with protocol|1|||
161415773|NCT00825812|582909918|FG000|Overall Study|Administrative|0|||
161415774|NCT00825812|582909919|FG001|Overall Study|Administrative|1|||
161415775|NCT00825812|582909920|FG002|Overall Study|Administrative|3|||
161415776|NCT00825812|582909921|FG003|Overall Study|Administrative|5|||
161415777|NCT00991406|582909923|FG000|Overall Study|One participant did not respond to FES.|1|||
161415778|NCT00986362|582909924|FG000|Overall Study|Death|2|||
161415779|NCT00986362|582909925|FG001|Overall Study|Death|0|||
161415780|NCT00986362|582909924|FG000|Overall Study|Lost to Follow-up|0|||
161415781|NCT00986362|582909925|FG001|Overall Study|Lost to Follow-up|1|||
161415782|NCT03597061|582909926|FG000|Overall Study|Lost to Follow-up|1|||
161415783|NCT03597061|582909927|FG001|Overall Study|Lost to Follow-up|0|||
161415784|NCT03597061|582909926|FG000|Overall Study|Protocol Violation|0|||
161415785|NCT03597061|582909927|FG001|Overall Study|Protocol Violation|1|||
161415786|NCT03755661|582909932|FG000|Overall Study|Lost to Follow-up|1|||
161415787|NCT03755661|582909933|FG001|Overall Study|Lost to Follow-up|0|||
161415788|NCT02038075|582909934|FG000|Overall Study|Withdrawal by Subject|3|||
161415789|NCT02038075|582909935|FG001|Overall Study|Withdrawal by Subject|0|||
161415790|NCT04000581|582909936|FG000|Overall Study|Withdrawal by Subject|0|||
161415791|NCT04000581|582909937|FG001|Overall Study|Withdrawal by Subject|1|||
161415792|NCT00895453|582909938|FG000|Overall Study|Lost to Follow-up|25|||
161415793|NCT00895453|582909939|FG001|Overall Study|Lost to Follow-up|25|||
161415794|NCT00895453|582909940|FG002|Overall Study|Lost to Follow-up|23|||
161415795|NCT02519595|582909944|FG000|Overall Study|Protocol Violation|8|||
161415796|NCT02519595|582909945|FG001|Overall Study|Protocol Violation|22|||
161415797|NCT02519595|582909946|FG002|Overall Study|Protocol Violation|16|||
161415798|NCT03188510|582909949|FG000|Overall Study|Inappropriate behavior with site staff|0|||
161415799|NCT03188510|582909950|FG001|Overall Study|Inappropriate behavior with site staff|1|||
161415800|NCT03188510|582909951|FG002|Overall Study|Inappropriate behavior with site staff|0|||
161415801|NCT04167137|582909954|FG000|Overall Study|Disease progression|1|||
161415802|NCT04167137|582909955|FG001|Overall Study|Disease progression|1|||
161415803|NCT04167137|582909956|FG002|Overall Study|Disease progression|3|||
161415804|NCT04167137|582909957|FG003|Overall Study|Disease progression|3|||
161415805|NCT04167137|582909958|FG004|Overall Study|Disease progression|2|||
161415806|NCT04167137|582909959|FG005|Overall Study|Disease progression|3|||
161415807|NCT04167137|582909960|FG006|Overall Study|Disease progression|2|||
161415808|NCT04167137|582909961|FG007|Overall Study|Disease progression|2|||
161415809|NCT04167137|582909954|FG000|Overall Study|Withdrawal by Subject|1|||
161415810|NCT04167137|582909955|FG001|Overall Study|Withdrawal by Subject|0|||
161415811|NCT04167137|582909956|FG002|Overall Study|Withdrawal by Subject|0|||
161415812|NCT04167137|582909957|FG003|Overall Study|Withdrawal by Subject|1|||
161415813|NCT04167137|582909958|FG004|Overall Study|Withdrawal by Subject|0|||
161415814|NCT04167137|582909959|FG005|Overall Study|Withdrawal by Subject|2|||
161415815|NCT04167137|582909960|FG006|Overall Study|Withdrawal by Subject|1|||
161415816|NCT04167137|582909961|FG007|Overall Study|Withdrawal by Subject|0|||
161415817|NCT04167137|582909954|FG000|Overall Study|Adverse Event|0|||
161415818|NCT04167137|582909955|FG001|Overall Study|Adverse Event|0|||
161415819|NCT04167137|582909956|FG002|Overall Study|Adverse Event|0|||
161415820|NCT04167137|582909957|FG003|Overall Study|Adverse Event|0|||
161415821|NCT04167137|582909958|FG004|Overall Study|Adverse Event|0|||
161415822|NCT04167137|582909959|FG005|Overall Study|Adverse Event|1|||
161415823|NCT04167137|582909960|FG006|Overall Study|Adverse Event|0|||
161415824|NCT04167137|582909961|FG007|Overall Study|Adverse Event|1|||
161415825|NCT04167137|582909954|FG000|Overall Study|Physician Decision|0|||
161415826|NCT04167137|582909955|FG001|Overall Study|Physician Decision|0|||
161415827|NCT04167137|582909956|FG002|Overall Study|Physician Decision|0|||
161415828|NCT04167137|582909957|FG003|Overall Study|Physician Decision|1|||
161415829|NCT04167137|582909958|FG004|Overall Study|Physician Decision|0|||
161415830|NCT04167137|582909959|FG005|Overall Study|Physician Decision|0|||
161415831|NCT04167137|582909960|FG006|Overall Study|Physician Decision|1|||
161415832|NCT04167137|582909961|FG007|Overall Study|Physician Decision|0|||
161415833|NCT04167137|582909954|FG000|Overall Study|Death|0|||
161415834|NCT04167137|582909955|FG001|Overall Study|Death|1|||
161415835|NCT04167137|582909956|FG002|Overall Study|Death|0|||
161415836|NCT04167137|582909957|FG003|Overall Study|Death|0|||
161415837|NCT04167137|582909958|FG004|Overall Study|Death|0|||
161415838|NCT04167137|582909959|FG005|Overall Study|Death|0|||
161415839|NCT04167137|582909960|FG006|Overall Study|Death|0|||
161415840|NCT04167137|582909961|FG007|Overall Study|Death|0|||
161415841|NCT04167137|582909954|FG000|Overall Study|Study terminated by Sponsor|0|||
161415842|NCT04167137|582909955|FG001|Overall Study|Study terminated by Sponsor|0|||
161415843|NCT04167137|582909956|FG002|Overall Study|Study terminated by Sponsor|0|||
161415844|NCT04167137|582909957|FG003|Overall Study|Study terminated by Sponsor|0|||
161415845|NCT04167137|582909958|FG004|Overall Study|Study terminated by Sponsor|0|||
161415846|NCT04167137|582909959|FG005|Overall Study|Study terminated by Sponsor|0|||
161415847|NCT04167137|582909960|FG006|Overall Study|Study terminated by Sponsor|0|||
161415848|NCT04167137|582909961|FG007|Overall Study|Study terminated by Sponsor|1|||
161415849|NCT00211887|582909962|FG000|Overall Study|Adverse Event|8|||
161415850|NCT00211887|582909963|FG001|Overall Study|Adverse Event|4|||
161415851|NCT00211887|582909964|FG002|Overall Study|Adverse Event|6|||
161415852|NCT00211887|582909962|FG000|Overall Study|Death|1|||
161415853|NCT00211887|582909963|FG001|Overall Study|Death|1|||
161415854|NCT00211887|582909964|FG002|Overall Study|Death|1|||
161415855|NCT00211887|582909962|FG000|Overall Study|Lost to Follow-up|28|||
161415856|NCT00211887|582909963|FG001|Overall Study|Lost to Follow-up|13|||
161415857|NCT00211887|582909964|FG002|Overall Study|Lost to Follow-up|9|||
161415858|NCT00211887|582909962|FG000|Overall Study|Non-medical reason|31|||
161415859|NCT00211887|582909963|FG001|Overall Study|Non-medical reason|14|||
161415860|NCT00211887|582909964|FG002|Overall Study|Non-medical reason|8|||
161415861|NCT00211887|582909962|FG000|Overall Study|Other medical reason|15|||
161415862|NCT00211887|582909963|FG001|Overall Study|Other medical reason|11|||
161415863|NCT00211887|582909964|FG002|Overall Study|Other medical reason|7|||
161415864|NCT00211887|582909962|FG000|Overall Study|Side effects|19|||
161415865|NCT00211887|582909963|FG001|Overall Study|Side effects|13|||
161415866|NCT00211887|582909964|FG002|Overall Study|Side effects|5|||
161415867|NCT03058692|582911465|FG000|Overall Study|Lost to Follow-up|2|||
161415868|NCT03058692|582911466|FG001|Overall Study|Lost to Follow-up|1|||
161415869|NCT03058692|582911465|FG000|Overall Study|Withdrawal by Subject|1|||
161415870|NCT03058692|582911466|FG001|Overall Study|Withdrawal by Subject|1|||
161415871|NCT01702025|582911469|FG000|Overall Study|Equipment failure|1|||
161415872|NCT01702025|582911470|FG001|Overall Study|Equipment failure|0|||
161415873|NCT01702025|582911471|FG002|Overall Study|Equipment failure|0|||
161415874|NCT01702025|582911472|FG003|Overall Study|Equipment failure|0|||
161415875|NCT01702025|582911469|FG000|Overall Study|Adverse Event|1|||
161415876|NCT01702025|582911470|FG001|Overall Study|Adverse Event|1|||
161415877|NCT01702025|582911471|FG002|Overall Study|Adverse Event|1|||
161415878|NCT01702025|582911472|FG003|Overall Study|Adverse Event|0|||
161415879|NCT02679755|582911473|FG000|Overall Study|Death|0|||
161415880|NCT02679755|582911474|FG001|Overall Study|Death|3|||
161415881|NCT02679755|582911473|FG000|Overall Study|Global deterioration of health status|1|||
161415882|NCT02679755|582911474|FG001|Overall Study|Global deterioration of health status|8|||
161415883|NCT02679755|582911473|FG000|Overall Study|Lost to Follow-up|1|||
161415884|NCT02679755|582911474|FG001|Overall Study|Lost to Follow-up|0|||
161415885|NCT02679755|582911473|FG000|Overall Study|Objective progression or relapse|24|||
161415886|NCT02679755|582911474|FG001|Overall Study|Objective progression or relapse|83|||
161415887|NCT02679755|582911473|FG000|Overall Study|Not defined|0|||
161415888|NCT02679755|582911474|FG001|Overall Study|Not defined|2|||
161415889|NCT02679755|582911473|FG000|Overall Study|Withdrawal by participant|6|||
161415890|NCT02679755|582911474|FG001|Overall Study|Withdrawal by participant|3|||
161415891|NCT02679755|582911473|FG000|Overall Study|Adverse Event|1|||
161415892|NCT02679755|582911474|FG001|Overall Study|Adverse Event|4|||
161415893|NCT02679755|582911473|FG000|Overall Study|Adverse events not related to study drug|1|||
161415894|NCT02679755|582911474|FG001|Overall Study|Adverse events not related to study drug|2|||
161415895|NCT01061359|582911475|FG000|Overall Study|Death|32|||
161415896|NCT01061359|582911475|FG000|Overall Study|Lost to Follow-up|1072|||
161415897|NCT01061359|582911475|FG000|Overall Study|Relapse|187|||
161415898|NCT01061359|582911475|FG000|Overall Study|Secondary neoplasm|11|||
161415899|NCT03038126|582911477|FG000|Overall Study|Death|1|||
161415900|NCT03038126|582911478|FG001|Overall Study|Death|1|||
161415901|NCT03038126|582911477|FG000|Overall Study|Withdrawal by Subject|5|||
161415902|NCT03038126|582911478|FG001|Overall Study|Withdrawal by Subject|0|||
161415903|NCT03038126|582911477|FG000|Overall Study|Lost to Follow-up|0|||
161415904|NCT03038126|582911478|FG001|Overall Study|Lost to Follow-up|1|||
161415905|NCT03038126|582911477|FG000|Overall Study|Long Term Hospitalization|2|||
161415906|NCT03038126|582911478|FG001|Overall Study|Long Term Hospitalization|0|||
161415907|NCT03038126|582911477|FG000|Overall Study|Too Ill to Participate|1|||
161415908|NCT03038126|582911478|FG001|Overall Study|Too Ill to Participate|2|||
161415909|NCT01724866|582911479|FG000|Overall Study|Adverse Event|0|||
161415910|NCT01724866|582911480|FG001|Overall Study|Adverse Event|0|||
161415911|NCT01724866|582911481|FG002|Overall Study|Adverse Event|1|||
161415912|NCT01724866|582911482|FG003|Overall Study|Adverse Event|1|||
161415913|NCT01724866|582911479|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
161415914|NCT01724866|582911480|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
161415915|NCT01724866|582911481|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
161415916|NCT01724866|582911482|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
161415917|NCT01724866|582911479|FG000|Overall Study|Investigator's Discretion|0|||
161415918|NCT01724866|582911480|FG001|Overall Study|Investigator's Discretion|1|||
161415919|NCT01724866|582911481|FG002|Overall Study|Investigator's Discretion|1|||
161415920|NCT01724866|582911482|FG003|Overall Study|Investigator's Discretion|0|||
161415921|NCT01724866|582911479|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
161415922|NCT01724866|582911480|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
161415923|NCT01724866|582911481|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
161415924|NCT01724866|582911482|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
161415925|NCT01724866|582911479|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
161415926|NCT01724866|582911480|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
161415927|NCT01724866|582911481|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
161415928|NCT01724866|582911482|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
161415929|NCT00411671|582911485|FG000|Overall Study|Adverse Event|15|||
161415930|NCT00411671|582911485|FG000|Overall Study|Death|2|||
161415931|NCT00411671|582911485|FG000|Overall Study|Lost to Follow-up|3|||
161415932|NCT00546000|582911490|FG000|Overall Study|Adverse Event|1|||
161415933|NCT00546000|582911490|FG000|Overall Study|Lost to Follow-up|1|||
161415934|NCT00546000|582911490|FG000|Overall Study|Baseline HPA Axis Supression|2|||
161415935|NCT03688074|582911495|FG000|Overall Study|Adverse Event|0|||
161415936|NCT03688074|582911496|FG001|Overall Study|Adverse Event|1|||
161415937|NCT03688074|582911495|FG000|Overall Study|Other|1|||
161415938|NCT03688074|582911496|FG001|Overall Study|Other|0|||
161415939|NCT01362608|582911497|FG000|Overall Study|Protocol Violation|0|||
161415940|NCT01362608|582911498|FG001|Overall Study|Protocol Violation|1|||
161415941|NCT01362608|582911497|FG000|Overall Study|Lost to Follow-up|3|||
161415942|NCT01362608|582911498|FG001|Overall Study|Lost to Follow-up|1|||
161415943|NCT01362608|582911497|FG000|Overall Study|Withdrawal by Subject|1|||
161415944|NCT01362608|582911498|FG001|Overall Study|Withdrawal by Subject|2|||
161415945|NCT01362608|582911497|FG000|Overall Study|Lack of Efficacy|0|||
161415946|NCT01362608|582911498|FG001|Overall Study|Lack of Efficacy|2|||
161415947|NCT01362608|582911497|FG000|Overall Study|Adverse Event|0|||
161415948|NCT01362608|582911498|FG001|Overall Study|Adverse Event|2|||
161415949|NCT03056339|582911501|FG000|Overall Study|Failed Requirements|0|||
161415950|NCT03056339|582911502|FG001|Overall Study|Failed Requirements|2|||
161415951|NCT03056339|582911503|FG002|Overall Study|Failed Requirements|7|||
161415952|NCT03056339|582911504|FG003|Overall Study|Failed Requirements|1|||
161415953|NCT04171219|582911507|FG000|Overall Study|Adverse Event|1|||
161415954|NCT04171219|582911508|FG001|Overall Study|Adverse Event|0|||
161415955|NCT04171219|582911507|FG000|Overall Study|Death|0|||
161415956|NCT04171219|582911508|FG001|Overall Study|Death|1|||
161415957|NCT04171219|582911507|FG000|Overall Study|Lack of Efficacy|9|||
161415958|NCT04171219|582911508|FG001|Overall Study|Lack of Efficacy|13|||
161415959|NCT04171219|582911507|FG000|Overall Study|Withdrawal by Subject|1|||
161415960|NCT04171219|582911508|FG001|Overall Study|Withdrawal by Subject|2|||
161415961|NCT04171219|582911507|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
161415962|NCT04171219|582911508|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
161415963|NCT04171219|582911507|FG000|Overall Study|Clinical PD/Patient choice|1|||
161415964|NCT04171219|582911508|FG001|Overall Study|Clinical PD/Patient choice|0|||
161415965|NCT04171219|582911507|FG000|Overall Study|Toxicity/ Patient choice|1|||
161415966|NCT04171219|582911508|FG001|Overall Study|Toxicity/ Patient choice|0|||
161415967|NCT04809285|582911509|FG000|Phase 1|Lost to Follow-up|6|||
161415968|NCT04809285|582911509|FG000|Phase 1|Protocol Violation|2|||
161415969|NCT04809285|582911509|FG000|Phase 1|Physician Decision|3|||
161415970|NCT04809285|582911509|FG000|Phase 1|Withdrawal by Subject|29|||
161415971|NCT04809285|582911509|FG000|Phase 2|Protocol Violation|3|||
161415972|NCT04809285|582911509|FG000|Phase 2|Withdrawal by Subject|4|||
161415973|NCT03350815|582911511|FG000|Period 1|Adverse Event|10|||
161415974|NCT03350815|582911512|FG001|Period 1|Adverse Event|0|||
161415975|NCT03350815|582911513|FG002|Period 1|Adverse Event|0|||
161415976|NCT03350815|582911514|FG003|Period 1|Adverse Event|0|||
161415977|NCT03350815|582911511|FG000|Period 1|Technical problems|1|||
161415978|NCT03350815|582911512|FG001|Period 1|Technical problems|0|||
161415979|NCT03350815|582911513|FG002|Period 1|Technical problems|0|||
161415980|NCT03350815|582911514|FG003|Period 1|Technical problems|0|||
161415981|NCT03350815|582911511|FG000|Period 1|Lost to Follow-up|3|||
161415982|NCT03350815|582911512|FG001|Period 1|Lost to Follow-up|0|||
161415983|NCT03350815|582911513|FG002|Period 1|Lost to Follow-up|0|||
161415984|NCT03350815|582911514|FG003|Period 1|Lost to Follow-up|0|||
161415985|NCT03350815|582911511|FG000|Period 1|Physician Decision|1|||
161415986|NCT03350815|582911512|FG001|Period 1|Physician Decision|0|||
161415987|NCT03350815|582911513|FG002|Period 1|Physician Decision|0|||
161415988|NCT03350815|582911514|FG003|Period 1|Physician Decision|0|||
161415989|NCT03350815|582911511|FG000|Period 1|Withdrawal by Subject|8|||
161415990|NCT03350815|582911512|FG001|Period 1|Withdrawal by Subject|0|||
161415991|NCT03350815|582911513|FG002|Period 1|Withdrawal by Subject|0|||
161415992|NCT03350815|582911514|FG003|Period 1|Withdrawal by Subject|0|||
161415993|NCT03350815|582911511|FG000|Period 1|Lack of Efficacy|15|||
161415994|NCT03350815|582911512|FG001|Period 1|Lack of Efficacy|0|||
161415995|NCT03350815|582911513|FG002|Period 1|Lack of Efficacy|0|||
161415996|NCT03350815|582911514|FG003|Period 1|Lack of Efficacy|0|||
161415997|NCT03350815|582911511|FG000|Period 1|Non-compliance with study treatment|2|||
161415998|NCT03350815|582911512|FG001|Period 1|Non-compliance with study treatment|0|||
161415999|NCT03350815|582911513|FG002|Period 1|Non-compliance with study treatment|0|||
161416000|NCT03350815|582911514|FG003|Period 1|Non-compliance with study treatment|0|||
161416001|NCT03350815|582911511|FG000|Period 1|Protocol Violation|3|||
161416002|NCT03350815|582911512|FG001|Period 1|Protocol Violation|0|||
161416003|NCT03350815|582911513|FG002|Period 1|Protocol Violation|0|||
161416004|NCT03350815|582911514|FG003|Period 1|Protocol Violation|0|||
161416005|NCT03350815|582911511|FG000|Period 2|Adverse Event|0|||
161416006|NCT03350815|582911512|FG001|Period 2|Adverse Event|3|||
161416007|NCT03350815|582911513|FG002|Period 2|Adverse Event|5|||
161416008|NCT03350815|582911514|FG003|Period 2|Adverse Event|0|||
161416009|NCT03350815|582911511|FG000|Period 2|Technical problem|0|||
161416010|NCT03350815|582911512|FG001|Period 2|Technical problem|1|||
161416011|NCT03350815|582911513|FG002|Period 2|Technical problem|0|||
161416012|NCT03350815|582911514|FG003|Period 2|Technical problem|0|||
161416013|NCT03350815|582911511|FG000|Period 2|Lost to Follow-up|0|||
161416014|NCT03350815|582911512|FG001|Period 2|Lost to Follow-up|3|||
161416015|NCT03350815|582911513|FG002|Period 2|Lost to Follow-up|3|||
161416016|NCT03350815|582911514|FG003|Period 2|Lost to Follow-up|0|||
161416017|NCT03350815|582911511|FG000|Period 2|Physician Decision|0|||
161416018|NCT03350815|582911512|FG001|Period 2|Physician Decision|0|||
161416019|NCT03350815|582911513|FG002|Period 2|Physician Decision|1|||
161416020|NCT03350815|582911514|FG003|Period 2|Physician Decision|0|||
161416021|NCT03350815|582911511|FG000|Period 2|Withdrawal by Subject|0|||
161416022|NCT03350815|582911512|FG001|Period 2|Withdrawal by Subject|3|||
161416023|NCT03350815|582911513|FG002|Period 2|Withdrawal by Subject|4|||
161416024|NCT03350815|582911514|FG003|Period 2|Withdrawal by Subject|0|||
161416025|NCT03350815|582911511|FG000|Period 2|Lack of Efficacy|0|||
161416026|NCT03350815|582911512|FG001|Period 2|Lack of Efficacy|6|||
161416027|NCT03350815|582911513|FG002|Period 2|Lack of Efficacy|2|||
161416028|NCT03350815|582911514|FG003|Period 2|Lack of Efficacy|0|||
161416029|NCT03350815|582911511|FG000|Period 2|Protocol Violation|0|||
161416030|NCT03350815|582911512|FG001|Period 2|Protocol Violation|0|||
161416031|NCT03350815|582911513|FG002|Period 2|Protocol Violation|1|||
161416032|NCT03350815|582911514|FG003|Period 2|Protocol Violation|0|||
161416033|NCT03350815|582911511|FG000|Period 2|New therapy for study indication|0|||
161416034|NCT03350815|582911512|FG001|Period 2|New therapy for study indication|0|||
161416035|NCT03350815|582911513|FG002|Period 2|New therapy for study indication|1|||
161416036|NCT03350815|582911514|FG003|Period 2|New therapy for study indication|0|||
161416037|NCT03526146|582911515|FG000|Overall Study|Lost to Follow-up|5|||
161416038|NCT03526146|582911515|FG000|Overall Study|Withdrawal by Subject|6|||
161416039|NCT03526146|582911515|FG000|Overall Study|class canceled due to COVID-19|4|||
161416040|NCT02517541|582911520|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
161416041|NCT02517541|582911520|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
161416042|NCT02517541|582911520|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
161416043|NCT02517541|582911520|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
161416044|NCT02517541|582911520|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
161416045|NCT02517541|582911520|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
161416046|NCT00699608|582911521|FG000|First Intervention|Withdrawal by Subject|0|||
161416047|NCT00699608|582911522|FG001|First Intervention|Withdrawal by Subject|0|||
161416048|NCT00699608|582911523|FG002|First Intervention|Withdrawal by Subject|1|||
161416049|NCT00699608|582911524|FG003|First Intervention|Withdrawal by Subject|0|||
161416050|NCT00699608|582911525|FG004|First Intervention|Withdrawal by Subject|0|||
161416051|NCT00699608|582911526|FG005|First Intervention|Withdrawal by Subject|0|||
161416052|NCT00699608|582911521|FG000|First Intervention|Protocol Violation|0|||
161416053|NCT00699608|582911522|FG001|First Intervention|Protocol Violation|0|||
161416054|NCT00699608|582911523|FG002|First Intervention|Protocol Violation|0|||
161416055|NCT00699608|582911524|FG003|First Intervention|Protocol Violation|0|||
161416056|NCT00699608|582911525|FG004|First Intervention|Protocol Violation|1|||
161416057|NCT00699608|582911526|FG005|First Intervention|Protocol Violation|0|||
161416058|NCT00699608|582911521|FG000|Second Intervention|Adverse Event|0|||
161416059|NCT00699608|582911522|FG001|Second Intervention|Adverse Event|0|||
161416060|NCT00699608|582911523|FG002|Second Intervention|Adverse Event|1|||
161416061|NCT00699608|582911524|FG003|Second Intervention|Adverse Event|0|||
161416062|NCT00699608|582911525|FG004|Second Intervention|Adverse Event|0|||
161416063|NCT00699608|582911526|FG005|Second Intervention|Adverse Event|0|||
161416064|NCT00699608|582911521|FG000|Second Intervention|Withdrawal by Subject|0|||
161416065|NCT00699608|582911522|FG001|Second Intervention|Withdrawal by Subject|0|||
161416066|NCT00699608|582911523|FG002|Second Intervention|Withdrawal by Subject|0|||
161416067|NCT00699608|582911524|FG003|Second Intervention|Withdrawal by Subject|1|||
161416068|NCT00699608|582911525|FG004|Second Intervention|Withdrawal by Subject|0|||
161416069|NCT00699608|582911526|FG005|Second Intervention|Withdrawal by Subject|0|||
161416070|NCT02034877|582911527|FG000|Overall Study|Lost to Follow-up|0|||
161416071|NCT02034877|582911528|FG001|Overall Study|Lost to Follow-up|3|||
161416072|NCT02034877|582911527|FG000|Overall Study|No Longer Willing to Participate|0|||
161416073|NCT02034877|582911528|FG001|Overall Study|No Longer Willing to Participate|3|||
161416074|NCT01036321|582911532|FG000|Overall Study|Ineligible after randomization|0|||
161416075|NCT01036321|582911533|FG001|Overall Study|Ineligible after randomization|1|||
161416076|NCT01036321|582911532|FG000|Overall Study|Withdrawal by Subject|3|||
161416077|NCT01036321|582911533|FG001|Overall Study|Withdrawal by Subject|2|||
161416078|NCT01036321|582911532|FG000|Overall Study|Adverse Event|2|||
161416079|NCT01036321|582911533|FG001|Overall Study|Adverse Event|1|||
161416080|NCT00381693|582911534|FG000|Overall Study|Death|1|||
161416081|NCT00381693|582911534|FG000|Overall Study|Adverse Event|4|||
161416082|NCT00381693|582911534|FG000|Overall Study|Patient Choice|1|||
161416083|NCT00381693|582911534|FG000|Overall Study|Progression|2|||
161416084|NCT02598297|582911535|FG000|Overall Study|Study terminated by Sponsor|21|||
161416085|NCT02598297|582911536|FG001|Overall Study|Study terminated by Sponsor|23|||
161416086|NCT02598297|582911535|FG000|Overall Study|Adverse Event|1|||
161416087|NCT02598297|582911536|FG001|Overall Study|Adverse Event|1|||
161416088|NCT02598297|582911535|FG000|Overall Study|Physician Decision|1|||
161416089|NCT02598297|582911536|FG001|Overall Study|Physician Decision|0|||
161416090|NCT02598297|582911535|FG000|Overall Study|Subject/guardian decision|1|||
161416091|NCT02598297|582911536|FG001|Overall Study|Subject/guardian decision|0|||
161416092|NCT02598297|582911535|FG000|Overall Study|Followed for survival|1|||
161416093|NCT02598297|582911536|FG001|Overall Study|Followed for survival|0|||
161416094|NCT04112303|582911540|FG000|Overall Study|Death|1|||
161416095|NCT01685697|582911541|FG000|Overall Study|Protocol Violation|3|||
161416096|NCT01685697|582911542|FG001|Overall Study|Protocol Violation|3|||
161416097|NCT02703324|582911543|FG000|Period Two|Withdrawal by Subject|0|||
161416098|NCT02703324|582911544|FG001|Period Two|Withdrawal by Subject|0|||
161416099|NCT02703324|582911545|FG002|Period Two|Withdrawal by Subject|1|||
161416100|NCT02703324|582911546|FG003|Period Two|Withdrawal by Subject|0|||
161416101|NCT02703324|582911547|FG004|Period Two|Withdrawal by Subject|0|||
161416102|NCT02703324|582911548|FG005|Period Two|Withdrawal by Subject|0|||
161416103|NCT04303572|582911551|FG000|Overall Study|Study closed due to poor enrollment|1|||
161416104|NCT06312592|582911552|FG000|Overall Study|Lost to Follow-up|29|||
161416105|NCT06312592|582911553|FG001|Overall Study|Lost to Follow-up|13|||
161416106|NCT03517228|582911556|FG000|Overall Study|Withdrawal by Subject|2|||
161416107|NCT03517228|582911556|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
161416108|NCT03517228|582911556|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
161416109|NCT03517228|582911556|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
161416110|NCT03517228|582911556|FG000|Overall Study|Canceled due to device being updated|1|||
161416111|NCT03517228|582911556|FG000|Overall Study|No V Cares in stock|1|||
161416112|NCT03517228|582911556|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
161416113|NCT03781414|582911561|FG000|Overall Study|Study terminated by sponsor|39|||
161416114|NCT03781414|582911562|FG001|Overall Study|Study terminated by sponsor|34|||
161416115|NCT03781414|582911563|FG002|Overall Study|Study terminated by sponsor|25|||
161416116|NCT03781414|582911561|FG000|Overall Study|Adverse Event|3|||
161416117|NCT03781414|582911562|FG001|Overall Study|Adverse Event|6|||
161416118|NCT03781414|582911563|FG002|Overall Study|Adverse Event|3|||
161416119|NCT03781414|582911561|FG000|Overall Study|Physician Decision|2|||
161416120|NCT03781414|582911562|FG001|Overall Study|Physician Decision|0|||
161416121|NCT03781414|582911563|FG002|Overall Study|Physician Decision|1|||
161416122|NCT03781414|582911561|FG000|Overall Study|Withdrawal by Subject|2|||
161416123|NCT03781414|582911562|FG001|Overall Study|Withdrawal by Subject|3|||
161416124|NCT03781414|582911563|FG002|Overall Study|Withdrawal by Subject|3|||
161416125|NCT03781414|582911561|FG000|Overall Study|Death|1|||
161416126|NCT03781414|582911562|FG001|Overall Study|Death|4|||
161416127|NCT03781414|582911563|FG002|Overall Study|Death|0|||
161416128|NCT03781414|582911561|FG000|Overall Study|Lost to Follow-up|1|||
161416129|NCT03781414|582911562|FG001|Overall Study|Lost to Follow-up|1|||
161416130|NCT03781414|582911563|FG002|Overall Study|Lost to Follow-up|0|||
161416131|NCT01620762|582911570|FG000|Overall Study|Protocol Violation|1|||
161416132|NCT01620762|582911571|FG001|Overall Study|Protocol Violation|1|||
161416133|NCT01620762|582911572|FG002|Overall Study|Protocol Violation|1|||
161416134|NCT01620762|582911570|FG000|Overall Study|Adverse Event|9|||
161416135|NCT01620762|582911571|FG001|Overall Study|Adverse Event|5|||
161416136|NCT01620762|582911572|FG002|Overall Study|Adverse Event|2|||
161416137|NCT01620762|582911570|FG000|Overall Study|Withdrawal by Subject|23|||
161416138|NCT01620762|582911571|FG001|Overall Study|Withdrawal by Subject|26|||
161416139|NCT01620762|582911572|FG002|Overall Study|Withdrawal by Subject|27|||
161416140|NCT01620762|582911570|FG000|Overall Study|Lost to Follow-up|11|||
161416141|NCT01620762|582911571|FG001|Overall Study|Lost to Follow-up|17|||
161416142|NCT01620762|582911572|FG002|Overall Study|Lost to Follow-up|10|||
161416143|NCT01620762|582911570|FG000|Overall Study|Protocol deviation|1|||
161416144|NCT01620762|582911571|FG001|Overall Study|Protocol deviation|1|||
161416145|NCT01620762|582911572|FG002|Overall Study|Protocol deviation|6|||
161416146|NCT01620762|582911570|FG000|Overall Study|Subject deterioration|0|||
161416147|NCT01620762|582911571|FG001|Overall Study|Subject deterioration|1|||
161416148|NCT01620762|582911572|FG002|Overall Study|Subject deterioration|1|||
161416149|NCT01620762|582911570|FG000|Overall Study|Non-specified|3|||
161416150|NCT01620762|582911571|FG001|Overall Study|Non-specified|6|||
161416151|NCT01620762|582911572|FG002|Overall Study|Non-specified|5|||
161416152|NCT01620762|582911570|FG000|Overall Study|Use of prohibted therapies|0|||
161416153|NCT01620762|582911571|FG001|Overall Study|Use of prohibted therapies|1|||
161416154|NCT01620762|582911572|FG002|Overall Study|Use of prohibted therapies|1|||
161416155|NCT03664765|582911577|FG000|Overall Study|Withdrawal by Subject|4|||
161416156|NCT03664765|582911578|FG001|Overall Study|Withdrawal by Subject|1|||
161416157|NCT03664765|582911577|FG000|Overall Study|Lost to Follow-up|0|||
161416158|NCT03664765|582911578|FG001|Overall Study|Lost to Follow-up|1|||
161416159|NCT01496846|582911579|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
161416160|NCT01496846|582911580|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
161416161|NCT01496846|582911581|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161416162|NCT01496846|582911582|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161416163|NCT01496846|582911583|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161416164|NCT01496846|582911584|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161416165|NCT01772576|582911587|FG000|Overall Study|Death|15|||
161416166|NCT01772576|582911587|FG000|Overall Study|Protocol Violation|1|||
161416167|NCT01772576|582911587|FG000|Overall Study|Lost to Follow-up|3|||
161416168|NCT01772576|582911587|FG000|Overall Study|Study device not used|3|||
161416169|NCT01772576|582911587|FG000|Overall Study|Adverse Event|6|||
161416170|NCT01772576|582911587|FG000|Overall Study|Withdrawal by Subject|6|||
161416171|NCT00527904|582911589|FG000|Overall Study|Adverse Event|45|||
161416172|NCT00527904|582911589|FG000|Overall Study|Withdrawal by Subject|21|||
161416173|NCT00527904|582911589|FG000|Overall Study|Lost to Follow-up|8|||
161416174|NCT00527904|582911589|FG000|Overall Study|misc|22|||
161416175|NCT02873338|582911593|FG000|Overall Study|Adverse Event|0|||
161416176|NCT02873338|582911594|FG001|Overall Study|Adverse Event|2|||
161416177|NCT02873338|582911595|FG002|Overall Study|Adverse Event|1|||
161416178|NCT02873338|582911593|FG000|Overall Study|Death|2|||
161416179|NCT02873338|582911594|FG001|Overall Study|Death|1|||
161416180|NCT02873338|582911595|FG002|Overall Study|Death|1|||
161416181|NCT02873338|582911593|FG000|Overall Study|Withdrawal by Subject|2|||
161416182|NCT02873338|582911594|FG001|Overall Study|Withdrawal by Subject|1|||
161416183|NCT02873338|582911595|FG002|Overall Study|Withdrawal by Subject|3|||
161416184|NCT02873338|582911593|FG000|Overall Study|Lack of Efficacy|0|||
161416185|NCT02873338|582911594|FG001|Overall Study|Lack of Efficacy|2|||
161416186|NCT02873338|582911595|FG002|Overall Study|Lack of Efficacy|0|||
161416187|NCT02873338|582911593|FG000|Overall Study|Other or Missing|14|||
161416188|NCT02873338|582911594|FG001|Overall Study|Other or Missing|15|||
161416189|NCT02873338|582911595|FG002|Overall Study|Other or Missing|13|||
161416190|NCT03477838|582911605|FG000|Overall Study|Lost to Follow-up|14|||
161416191|NCT00850538|582911606|FG000|Overall Study|unable/unwilling to complete MRI|13|||
161416192|NCT00850538|582911606|FG000|Overall Study|specimen missed due to scheduling error|14|||
161416193|NCT00850538|582911606|FG000|Overall Study|specimen unusable|7|||
161416194|NCT00850538|582911606|FG000|Overall Study|Withdrawal by Subject|3|||
161416195|NCT00850538|582911606|FG000|Overall Study|radiology error|2|||
161416196|NCT00850538|582911606|FG000|Overall Study|Protocol Violation|2|||
161416197|NCT01088399|582911612|FG000|Overall Study|Adverse Event|211|||
161416198|NCT01088399|582911613|FG001|Overall Study|Adverse Event|16|||
161416199|NCT01088399|582911614|FG002|Overall Study|Adverse Event|0|||
161416200|NCT01088399|582911612|FG000|Overall Study|Death|204|||
161416201|NCT01088399|582911613|FG001|Overall Study|Death|45|||
161416202|NCT01088399|582911614|FG002|Overall Study|Death|0|||
161416203|NCT01088399|582911612|FG000|Overall Study|Lack of Efficacy|298|||
161416204|NCT01088399|582911613|FG001|Overall Study|Lack of Efficacy|7|||
161416205|NCT01088399|582911614|FG002|Overall Study|Lack of Efficacy|5|||
161416206|NCT01088399|582911612|FG000|Overall Study|Lost to Follow-up|1070|||
161416207|NCT01088399|582911613|FG001|Overall Study|Lost to Follow-up|278|||
161416208|NCT01088399|582911614|FG002|Overall Study|Lost to Follow-up|58|||
161416209|NCT01088399|582911612|FG000|Overall Study|Physician Decision|531|||
161416210|NCT01088399|582911613|FG001|Overall Study|Physician Decision|88|||
161416211|NCT01088399|582911614|FG002|Overall Study|Physician Decision|16|||
161416212|NCT01088399|582911612|FG000|Overall Study|Withdrawal by Subject|544|||
161416213|NCT01088399|582911613|FG001|Overall Study|Withdrawal by Subject|195|||
161416214|NCT01088399|582911614|FG002|Overall Study|Withdrawal by Subject|33|||
161416215|NCT01088399|582911612|FG000|Overall Study|Change to or start of somatropin therapy|234|||
161416216|NCT01088399|582911613|FG001|Overall Study|Change to or start of somatropin therapy|17|||
161416217|NCT01088399|582911614|FG002|Overall Study|Change to or start of somatropin therapy|12|||
161416218|NCT01088399|582911612|FG000|Overall Study|Sponsor decision|1573|||
161416219|NCT01088399|582911613|FG001|Overall Study|Sponsor decision|298|||
161416220|NCT01088399|582911614|FG002|Overall Study|Sponsor decision|7|||
161416221|NCT01088399|582911612|FG000|Overall Study|Protocol Violation|10|||
161416222|NCT01088399|582911613|FG001|Overall Study|Protocol Violation|1|||
161416223|NCT01088399|582911614|FG002|Overall Study|Protocol Violation|0|||
161416224|NCT01088399|582911612|FG000|Overall Study|Enrollment criteria not met|48|||
161416225|NCT01088399|582911613|FG001|Overall Study|Enrollment criteria not met|119|||
161416226|NCT01088399|582911614|FG002|Overall Study|Enrollment criteria not met|70|||
161416227|NCT01088399|582911612|FG000|Overall Study|Study summary visit not completed|2398|||
161416228|NCT01088399|582911613|FG001|Overall Study|Study summary visit not completed|283|||
161416229|NCT01088399|582911614|FG002|Overall Study|Study summary visit not completed|80|||
161416230|NCT03193736|582911615|FG000|Overall Study|Death|2|||
161416231|NCT03193736|582911615|FG000|Overall Study|Withdrawal by Subject|1|||
161416232|NCT03193736|582911615|FG000|Overall Study|Lost to Follow-up|1|||
161416233|NCT03193736|582911615|FG000|Overall Study|implant not received|1|||
161416234|NCT00852241|582911616|FG000|Overall Study|Physician Decision|18|||
161416235|NCT00534976|582911619|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
161416236|NCT00534976|582911620|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
161416237|NCT00534976|582911619|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
161416238|NCT00534976|582911620|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
161416239|NCT00534976|582911619|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
161416240|NCT00534976|582911620|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
161416241|NCT00269633|582911623|FG000|Overall Study|Withdrawal by Subject|1|||
161416242|NCT00269633|582911624|FG001|Overall Study|Withdrawal by Subject|0|||
161416243|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
161416244|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
161416245|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
161416246|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
161416247|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
161416248|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
161416249|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
161416250|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
161416251|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
161416252|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
161416253|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
161416254|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
161416255|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
161416256|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
161416257|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
161416258|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
161416259|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
161416260|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
161416261|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
161416262|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
161416263|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
161416264|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
161416265|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
161416266|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
161416267|NCT03777059|582913700|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
161416268|NCT03777059|582913701|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
161416269|NCT03777059|582913702|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
161416270|NCT03777059|582913703|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
161416271|NCT03777059|582913700|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
161416272|NCT03777059|582913701|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
161416273|NCT03777059|582913702|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
161416274|NCT03777059|582913703|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
161416275|NCT03777059|582913700|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
161416276|NCT03777059|582913701|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
161416277|NCT03777059|582913702|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
161416278|NCT03777059|582913703|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
161416279|NCT03777059|582913700|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
161416280|NCT03777059|582913701|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
161416281|NCT03777059|582913702|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
161416282|NCT03777059|582913703|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
161416283|NCT03777059|582913700|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
161416284|NCT03777059|582913701|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
161416285|NCT03777059|582913702|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
161416286|NCT03777059|582913703|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
161416287|NCT04506502|582913704|FG000|Overall Study|Withdrawal by Subject|1|||
161416288|NCT04506502|582913704|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
161416289|NCT01449006|582913705|FG000|Overall Study|Lost to Follow-up|1|||
161416290|NCT01449006|582913706|FG001|Overall Study|Lost to Follow-up|0|||
161416291|NCT01449006|582913705|FG000|Overall Study|Withdrawal by Subject|1|||
161416292|NCT01449006|582913706|FG001|Overall Study|Withdrawal by Subject|0|||
161416293|NCT01449006|582913705|FG000|Overall Study|Protocol Violation|1|||
161416294|NCT01449006|582913706|FG001|Overall Study|Protocol Violation|0|||
161416295|NCT04720417|582913711|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
161416296|NCT03574779|582913712|FG000|Overall Study|Screening failure|13|||
161416297|NCT03574779|582913713|FG001|Overall Study|Screening failure|83|||
161416298|NCT03755882|582913719|FG000|Period 1|Protocol Violation|1|||
161416299|NCT03755882|582913720|FG001|Period 1|Protocol Violation|0|||
161416300|NCT03755882|582913719|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
161416301|NCT03755882|582913720|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
161416302|NCT01687101|582913721|FG000|Overall Study|Lost to Follow-up|7|||
161416303|NCT02003534|582913724|FG000|Overall Study|Lost to Follow-up|47|||
161416304|NCT02206035|582913725|FG000|Overall Study|Physician Decision|10|||
161416305|NCT02206035|582913726|FG001|Overall Study|Physician Decision|0|||
161416306|NCT02206035|582913727|FG002|Overall Study|Physician Decision|175|||
161416307|NCT01934010|582913728|FG000|Overall Study|Adverse Event|1|||
161416308|NCT01934010|582913729|FG001|Overall Study|Adverse Event|1|||
161416309|NCT01934010|582913730|FG002|Overall Study|Adverse Event|0|||
161416310|NCT01934010|582913728|FG000|Overall Study|Withdrawal by Subject|15|||
161416311|NCT01934010|582913729|FG001|Overall Study|Withdrawal by Subject|6|||
161416312|NCT01934010|582913730|FG002|Overall Study|Withdrawal by Subject|2|||
161416313|NCT01934010|582913728|FG000|Overall Study|Lost to Follow-up|7|||
161416314|NCT01934010|582913729|FG001|Overall Study|Lost to Follow-up|4|||
161416315|NCT01934010|582913730|FG002|Overall Study|Lost to Follow-up|0|||
161416316|NCT00377858|582913731|FG000|Overall Study|Withdrawal by Subject|12|||
161416317|NCT00377858|582913732|FG001|Overall Study|Withdrawal by Subject|11|||
161416318|NCT00377858|582913731|FG000|Overall Study|Lost to Follow-up|6|||
161416319|NCT00377858|582913732|FG001|Overall Study|Lost to Follow-up|1|||
161416320|NCT00377858|582913731|FG000|Overall Study|Physician Decision|5|||
161416321|NCT00377858|582913732|FG001|Overall Study|Physician Decision|5|||
161416322|NCT00377858|582913731|FG000|Overall Study|Protocol Violation|3|||
161416323|NCT00377858|582913732|FG001|Overall Study|Protocol Violation|4|||
161416324|NCT00377858|582913731|FG000|Overall Study|Adverse Event|2|||
161416325|NCT00377858|582913732|FG001|Overall Study|Adverse Event|1|||
161416326|NCT00377858|582913731|FG000|Overall Study|Entry Criteria Not Met|2|||
161416327|NCT00377858|582913732|FG001|Overall Study|Entry Criteria Not Met|0|||
161416328|NCT00377858|582913731|FG000|Overall Study|Sponsor Decision|1|||
161416329|NCT00377858|582913732|FG001|Overall Study|Sponsor Decision|2|||
161416330|NCT00377858|582913731|FG000|Overall Study|Death|0|||
161416331|NCT00377858|582913732|FG001|Overall Study|Death|3|||
161416332|NCT03534141|582913733|FG000|Overall Study|Enrolled in other clinical trial|1|||
161416333|NCT03534141|582913734|FG001|Overall Study|Enrolled in other clinical trial|0|||
161416334|NCT03534141|582913733|FG000|Overall Study|Liver transplant aborted after randomization|0|||
161416335|NCT03534141|582913734|FG001|Overall Study|Liver transplant aborted after randomization|2|||
161416336|NCT03534141|582913733|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
161416337|NCT03534141|582913734|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
161416338|NCT03785405|582913736|FG000|Overall Study|Adverse Event|16|||
161416339|NCT03785405|582913737|FG001|Overall Study|Adverse Event|1|||
161416340|NCT03785405|582913736|FG000|Overall Study|Death|6|||
161416341|NCT03785405|582913737|FG001|Overall Study|Death|4|||
161416342|NCT03785405|582913736|FG000|Overall Study|Guardian decision|4|||
161416343|NCT03785405|582913737|FG001|Overall Study|Guardian decision|1|||
161416344|NCT03785405|582913736|FG000|Overall Study|Lost to Follow-up|1|||
161416345|NCT03785405|582913737|FG001|Overall Study|Lost to Follow-up|0|||
161416346|NCT03785405|582913736|FG000|Overall Study|Physician Decision|8|||
161416347|NCT03785405|582913737|FG001|Overall Study|Physician Decision|5|||
161416348|NCT03785405|582913736|FG000|Overall Study|Participant decision|2|||
161416349|NCT03785405|582913737|FG001|Overall Study|Participant decision|0|||
161416350|NCT03785405|582913736|FG000|Overall Study|Other|1|||
161416351|NCT03785405|582913737|FG001|Overall Study|Other|0|||
161416352|NCT03785405|582913736|FG000|Overall Study|No treatment was received|0|||
161416353|NCT03785405|582913737|FG001|Overall Study|No treatment was received|1|||
161416354|NCT06041919|582913743|FG000|Overall Study|Lost to Follow-up|1|||
161416355|NCT06041919|582913744|FG001|Overall Study|Lost to Follow-up|0|||
161416356|NCT06041919|582913745|FG002|Overall Study|Lost to Follow-up|0|||
161416357|NCT06041919|582913746|FG003|Overall Study|Lost to Follow-up|0|||
161416358|NCT06041919|582913747|FG004|Overall Study|Lost to Follow-up|0|||
161416359|NCT06041919|582913743|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
161416360|NCT06041919|582913744|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
161416361|NCT06041919|582913745|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
161416362|NCT06041919|582913746|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
161416363|NCT06041919|582913747|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
161416364|NCT01147055|582913748|FG000|First Intervention Period|Lost to Follow-up|1|||
161416365|NCT01147055|582913749|FG001|First Intervention Period|Lost to Follow-up|0|||
161416366|NCT03724890|582913750|FG000|Overall Study|Death|2|||
161416367|NCT03724890|582913751|FG001|Overall Study|Death|6|||
161416368|NCT03724890|582913752|FG002|Overall Study|Death|3|||
161416369|NCT03724890|582913753|FG003|Overall Study|Death|5|||
161416370|NCT03724890|582913754|FG004|Overall Study|Death|2|||
161416371|NCT03724890|582913755|FG005|Overall Study|Death|0|||
161416372|NCT03724890|582913756|FG006|Overall Study|Death|2|||
161416373|NCT03724890|582913757|FG007|Overall Study|Death|3|||
161416374|NCT03724890|582913758|FG008|Overall Study|Death|4|||
161416375|NCT03724890|582913759|FG009|Overall Study|Death|2|||
161416376|NCT03724890|582913760|FG010|Overall Study|Death|2|||
161416377|NCT03724890|582913750|FG000|Overall Study|Lost to Follow-up|0|||
161416378|NCT03724890|582913751|FG001|Overall Study|Lost to Follow-up|3|||
161416379|NCT03724890|582913752|FG002|Overall Study|Lost to Follow-up|0|||
161416380|NCT03724890|582913753|FG003|Overall Study|Lost to Follow-up|1|||
161416381|NCT03724890|582913754|FG004|Overall Study|Lost to Follow-up|2|||
161416382|NCT03724890|582913755|FG005|Overall Study|Lost to Follow-up|2|||
161416383|NCT03724890|582913756|FG006|Overall Study|Lost to Follow-up|1|||
161416384|NCT03724890|582913757|FG007|Overall Study|Lost to Follow-up|0|||
161416385|NCT03724890|582913758|FG008|Overall Study|Lost to Follow-up|2|||
161416386|NCT03724890|582913759|FG009|Overall Study|Lost to Follow-up|0|||
161416387|NCT03724890|582913760|FG010|Overall Study|Lost to Follow-up|0|||
161416388|NCT03724890|582913750|FG000|Overall Study|Withdrawal by Subject|1|||
161416389|NCT03724890|582913751|FG001|Overall Study|Withdrawal by Subject|2|||
161416390|NCT03724890|582913752|FG002|Overall Study|Withdrawal by Subject|1|||
161416391|NCT03724890|582913753|FG003|Overall Study|Withdrawal by Subject|0|||
161416392|NCT03724890|582913754|FG004|Overall Study|Withdrawal by Subject|0|||
161416393|NCT03724890|582913755|FG005|Overall Study|Withdrawal by Subject|1|||
161416394|NCT03724890|582913756|FG006|Overall Study|Withdrawal by Subject|0|||
161416395|NCT03724890|582913757|FG007|Overall Study|Withdrawal by Subject|0|||
161416396|NCT03724890|582913758|FG008|Overall Study|Withdrawal by Subject|2|||
161416397|NCT03724890|582913759|FG009|Overall Study|Withdrawal by Subject|2|||
161416398|NCT03724890|582913760|FG010|Overall Study|Withdrawal by Subject|1|||
161416399|NCT03724890|582913750|FG000|Overall Study|Other|1|||
161416400|NCT03724890|582913751|FG001|Overall Study|Other|0|||
161416401|NCT03724890|582913752|FG002|Overall Study|Other|0|||
161416402|NCT03724890|582913753|FG003|Overall Study|Other|0|||
161416403|NCT03724890|582913754|FG004|Overall Study|Other|0|||
161416404|NCT03724890|582913755|FG005|Overall Study|Other|0|||
161416405|NCT03724890|582913756|FG006|Overall Study|Other|0|||
161416406|NCT03724890|582913757|FG007|Overall Study|Other|1|||
161416407|NCT03724890|582913758|FG008|Overall Study|Other|1|||
161416408|NCT03724890|582913759|FG009|Overall Study|Other|0|||
161416409|NCT03724890|582913760|FG010|Overall Study|Other|2|||
161416410|NCT02123823|582913762|FG000|Overall Study|Lack of Efficacy|0|||
161416411|NCT02123823|582913763|FG001|Overall Study|Lack of Efficacy|2|||
161416412|NCT02123823|582913764|FG002|Overall Study|Lack of Efficacy|8|||
161416413|NCT02123823|582913765|FG003|Overall Study|Lack of Efficacy|10|||
161416414|NCT02123823|582913762|FG000|Overall Study|Progressive disease|3|||
161416415|NCT02123823|582913763|FG001|Overall Study|Progressive disease|19|||
161416416|NCT02123823|582913764|FG002|Overall Study|Progressive disease|52|||
161416417|NCT02123823|582913765|FG003|Overall Study|Progressive disease|53|||
161416418|NCT02123823|582913762|FG000|Overall Study|Withdrawal by Subject|0|||
161416419|NCT02123823|582913763|FG001|Overall Study|Withdrawal by Subject|0|||
161416420|NCT02123823|582913764|FG002|Overall Study|Withdrawal by Subject|7|||
161416421|NCT02123823|582913765|FG003|Overall Study|Withdrawal by Subject|2|||
161416422|NCT02123823|582913762|FG000|Overall Study|Adverse Event|0|||
161416423|NCT02123823|582913763|FG001|Overall Study|Adverse Event|0|||
161416424|NCT02123823|582913764|FG002|Overall Study|Adverse Event|3|||
161416425|NCT02123823|582913765|FG003|Overall Study|Adverse Event|5|||
161416426|NCT01635855|582913800|FG000|Overall Study|Withdrawal by Subject|4|||
161416427|NCT01844778|582913803|FG000|Overall Study|Protocol deviation|0|||
161416428|NCT01844778|582913804|FG001|Overall Study|Protocol deviation|1|||
161416429|NCT01844778|582913805|FG002|Overall Study|Protocol deviation|2|||
161416430|NCT01844778|582913803|FG000|Overall Study|Withdrawal by Subject|2|||
161416431|NCT01844778|582913804|FG001|Overall Study|Withdrawal by Subject|0|||
161416432|NCT01844778|582913805|FG002|Overall Study|Withdrawal by Subject|0|||
161416433|NCT01844778|582913803|FG000|Overall Study|Adverse Event|0|||
161416434|NCT01844778|582913804|FG001|Overall Study|Adverse Event|2|||
161416435|NCT01844778|582913805|FG002|Overall Study|Adverse Event|2|||
161416436|NCT00095173|582913806|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
161416437|NCT00095173|582913807|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161416438|NCT00095173|582913808|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161416439|NCT00095173|582913809|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161416440|NCT00095173|582913810|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161416441|NCT00095173|582913811|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161416442|NCT00095173|582913806|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
161416443|NCT00095173|582913807|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161416444|NCT00095173|582913808|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161416445|NCT00095173|582913809|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161416446|NCT00095173|582913810|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161416447|NCT00095173|582913811|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161416448|NCT00095173|582913806|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
161416449|NCT00095173|582913807|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161416450|NCT00095173|582913808|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161416451|NCT00095173|582913809|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161416452|NCT00095173|582913810|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161416453|NCT00095173|582913811|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161416454|NCT00095173|582913806|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
161416455|NCT00095173|582913807|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
161416456|NCT00095173|582913808|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
161416457|NCT00095173|582913809|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
161416458|NCT00095173|582913810|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
161416459|NCT00095173|582913811|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
161416460|NCT00095173|582913806|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161416461|NCT00095173|582913807|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
161416462|NCT00095173|582913808|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
161416463|NCT00095173|582913809|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161416464|NCT00095173|582913810|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161416465|NCT00095173|582913811|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161416466|NCT00095173|582913806|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161416467|NCT00095173|582913807|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
161416468|NCT00095173|582913808|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161416469|NCT00095173|582913809|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161416470|NCT00095173|582913810|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161416471|NCT00095173|582913811|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161416472|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Death|0|||
161416473|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Death|0|||
161416474|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Death|0|||
161416475|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Death|0|||
161416476|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Death|0|||
161416477|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Death|1|||
161416478|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
161416479|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
161416480|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
161416481|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
161416482|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
161416483|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
161416484|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
161416485|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
161416486|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
161416487|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
161416488|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
161416489|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
161416490|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
161416491|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
161416492|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
161416493|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
161416494|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
161416495|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
161416496|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161416497|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161416498|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161416499|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
161416500|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
161416501|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161416502|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161416503|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161416504|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161416505|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161416506|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
161416507|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
161416508|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161416509|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161416510|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161416511|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161416512|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
161416513|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
161416514|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
161416515|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
161416516|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
161416517|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
161416518|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
161416519|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
161416520|NCT00095173|582913806|FG000|Open-Label Extension Phase (Period C)|Other|0|||
161416521|NCT00095173|582913807|FG001|Open-Label Extension Phase (Period C)|Other|0|||
161416522|NCT00095173|582913808|FG002|Open-Label Extension Phase (Period C)|Other|0|||
161416523|NCT00095173|582913809|FG003|Open-Label Extension Phase (Period C)|Other|4|||
161416524|NCT00095173|582913810|FG004|Open-Label Extension Phase (Period C)|Other|6|||
161416525|NCT00095173|582913811|FG005|Open-Label Extension Phase (Period C)|Other|8|||
161416526|NCT02161757|582913818|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
161416527|NCT02161757|582913819|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
161416528|NCT02161757|582913820|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
161416529|NCT02161757|582913818|FG000|Treatment Through Study Completion|Adverse Event|1|||
161416530|NCT02161757|582913819|FG001|Treatment Through Study Completion|Adverse Event|1|||
161416531|NCT02161757|582913820|FG002|Treatment Through Study Completion|Adverse Event|0|||
161416532|NCT02161757|582913818|FG000|Treatment Through Study Completion|Protocol Violation|0|||
161416533|NCT02161757|582913819|FG001|Treatment Through Study Completion|Protocol Violation|1|||
161416534|NCT02161757|582913820|FG002|Treatment Through Study Completion|Protocol Violation|2|||
161416535|NCT02161757|582913818|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
161416536|NCT02161757|582913819|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
161416537|NCT02161757|582913820|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
161416538|NCT02161757|582913818|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
161416539|NCT02161757|582913819|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
161416540|NCT02161757|582913820|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
161416541|NCT02161757|582913818|FG000|Treatment Through Study Completion|Other|20|||
161416542|NCT02161757|582913819|FG001|Treatment Through Study Completion|Other|19|||
161416543|NCT02161757|582913820|FG002|Treatment Through Study Completion|Other|12|||
161416544|NCT02161757|582913818|FG000|Treatment Through Study Completion|Death|2|||
161416545|NCT02161757|582913819|FG001|Treatment Through Study Completion|Death|1|||
161416546|NCT02161757|582913820|FG002|Treatment Through Study Completion|Death|1|||
161416547|NCT00391625|582913821|FG000|Month 14|Withdrawal by Subject|1|||
161416548|NCT00391625|582913821|FG000|Month 50|Physician Decision|1|||
161416549|NCT02106403|582913828|FG000|Follow-Up Visit 3|Other Reason|0|||
161416550|NCT02106403|582913829|FG001|Follow-Up Visit 3|Other Reason|0|||
161416551|NCT02106403|582913830|FG002|Follow-Up Visit 3|Other Reason|0|||
161416552|NCT02106403|582913831|FG003|Follow-Up Visit 3|Other Reason|0|||
161416553|NCT02106403|582913832|FG004|Follow-Up Visit 3|Other Reason|0|||
161416554|NCT02106403|582913833|FG005|Follow-Up Visit 3|Other Reason|1|||
161416555|NCT01128946|582913846|FG000|Period I|Protocol Violation|0|||
161416556|NCT01128946|582913847|FG001|Period I|Protocol Violation|1|||
161416557|NCT01128946|582913848|FG002|Period I|Protocol Violation|0|||
161416558|NCT01128946|582913849|FG003|Period I|Protocol Violation|0|||
161416559|NCT01128946|582913846|FG000|Period I|Withdrawal by Subject|0|||
161416560|NCT01128946|582913847|FG001|Period I|Withdrawal by Subject|0|||
161416561|NCT01128946|582913848|FG002|Period I|Withdrawal by Subject|1|||
161416562|NCT01128946|582913849|FG003|Period I|Withdrawal by Subject|1|||
161416563|NCT01128946|582913846|FG000|Period II|Protocol Violation|0|||
161416564|NCT01128946|582913847|FG001|Period II|Protocol Violation|1|||
161416565|NCT01128946|582913848|FG002|Period II|Protocol Violation|0|||
161416566|NCT01128946|582913849|FG003|Period II|Protocol Violation|0|||
161416567|NCT01128946|582913846|FG000|Period II|Withdrawal by Subject|0|||
161416568|NCT01128946|582913847|FG001|Period II|Withdrawal by Subject|0|||
161416569|NCT01128946|582913848|FG002|Period II|Withdrawal by Subject|0|||
161416570|NCT01128946|582913849|FG003|Period II|Withdrawal by Subject|1|||
161416571|NCT01128946|582913846|FG000|Period III|Protocol Violation|1|||
161416572|NCT01128946|582913847|FG001|Period III|Protocol Violation|0|||
161416573|NCT01128946|582913848|FG002|Period III|Protocol Violation|0|||
161416574|NCT01128946|582913849|FG003|Period III|Protocol Violation|0|||
161416575|NCT00379912|582913850|FG000|Overall Study|Lack of Efficacy|1|||
161416576|NCT00379912|582913851|FG001|Overall Study|Lack of Efficacy|0|||
161416577|NCT04698993|582913852|FG000|Overall Study|PCR results not accessible|2|||
161416578|NCT04698993|582913853|FG001|Overall Study|PCR results not accessible|7|||
161416579|NCT04698993|582913852|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
161416580|NCT04698993|582913853|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
161416581|NCT01371734|582913854|FG000|Overall Study|Other|2|||
161416582|NCT01371734|582913855|FG001|Overall Study|Other|1|||
161416583|NCT01371734|582913856|FG002|Overall Study|Other|2|||
161416584|NCT01371734|582913854|FG000|Overall Study|Withdrawal by Subject|3|||
161416585|NCT01371734|582913855|FG001|Overall Study|Withdrawal by Subject|4|||
161416586|NCT01371734|582913856|FG002|Overall Study|Withdrawal by Subject|9|||
161416587|NCT01371734|582913854|FG000|Overall Study|Lost to Follow-up|5|||
161416588|NCT01371734|582913855|FG001|Overall Study|Lost to Follow-up|3|||
161416589|NCT01371734|582913856|FG002|Overall Study|Lost to Follow-up|1|||
161416590|NCT01371734|582913854|FG000|Overall Study|Protocol Violation|3|||
161416591|NCT01371734|582913855|FG001|Overall Study|Protocol Violation|1|||
161416592|NCT01371734|582913856|FG002|Overall Study|Protocol Violation|2|||
161416593|NCT01371734|582913854|FG000|Overall Study|Adverse Event|8|||
161416594|NCT01371734|582913855|FG001|Overall Study|Adverse Event|8|||
161416595|NCT01371734|582913856|FG002|Overall Study|Adverse Event|3|||
161416596|NCT01371734|582913854|FG000|Overall Study|Lack of Efficacy|2|||
161416597|NCT01371734|582913855|FG001|Overall Study|Lack of Efficacy|2|||
161416598|NCT01371734|582913856|FG002|Overall Study|Lack of Efficacy|0|||
161416599|NCT00206440|582913857|FG000|Overall Study|Protocol Violation|1|||
161416600|NCT00206440|582913858|FG001|Overall Study|Protocol Violation|2|||
161416601|NCT00206440|582913857|FG000|Overall Study|Adverse Event|4|||
161416602|NCT00206440|582913858|FG001|Overall Study|Adverse Event|2|||
161416603|NCT01140061|582913861|FG000|Part I|Adverse Event|1|||
161416604|NCT01140061|582913862|FG001|Part I|Adverse Event|0|||
161416605|NCT01140061|582913863|FG002|Part I|Adverse Event|0|||
161416606|NCT01140061|582913864|FG003|Part I|Adverse Event|0|||
161416607|NCT01140061|582913865|FG004|Part I|Adverse Event|0|||
161416608|NCT01140061|582913866|FG005|Part I|Adverse Event|0|||
161416609|NCT01140061|582913867|FG006|Part I|Adverse Event|0|||
161416610|NCT01140061|582913868|FG007|Part I|Adverse Event|0|||
161416611|NCT01140061|582913869|FG008|Part I|Adverse Event|0|||
161416612|NCT01140061|582913870|FG009|Part I|Adverse Event|0|||
161416613|NCT01140061|582913861|FG000|Extension|Laboratory Adverse Event|0|||
161416614|NCT01140061|582913862|FG001|Extension|Laboratory Adverse Event|0|||
161416615|NCT01140061|582913863|FG002|Extension|Laboratory Adverse Event|0|||
161416616|NCT01140061|582913864|FG003|Extension|Laboratory Adverse Event|0|||
161416617|NCT01140061|582913865|FG004|Extension|Laboratory Adverse Event|0|||
161416618|NCT01140061|582913866|FG005|Extension|Laboratory Adverse Event|0|||
161416619|NCT01140061|582913867|FG006|Extension|Laboratory Adverse Event|0|||
161416620|NCT01140061|582913868|FG007|Extension|Laboratory Adverse Event|0|||
161416621|NCT01140061|582913869|FG008|Extension|Laboratory Adverse Event|0|||
161416622|NCT01140061|582913870|FG009|Extension|Laboratory Adverse Event|1|||
161416623|NCT00766051|582913872|FG000|Overall Study|Withdrawal by Subject|2|||
161416624|NCT00766051|582913873|FG001|Overall Study|Withdrawal by Subject|0|||
161416625|NCT02669121|582913874|FG000|Overall Study|Adverse Event|4|||
161416626|NCT02669121|582913875|FG001|Overall Study|Adverse Event|5|||
161416627|NCT02669121|582913874|FG000|Overall Study|Lost to Follow-up|15|||
161416628|NCT02669121|582913875|FG001|Overall Study|Lost to Follow-up|27|||
161416629|NCT02669121|582913874|FG000|Overall Study|Withdrawal by Subject|132|||
161416630|NCT02669121|582913875|FG001|Overall Study|Withdrawal by Subject|140|||
161416631|NCT02669121|582913874|FG000|Overall Study|Pregnancy|0|||
161416632|NCT02669121|582913875|FG001|Overall Study|Pregnancy|1|||
161416633|NCT02669121|582913874|FG000|Overall Study|Discharged from US Military Active Service|117|||
161416634|NCT02669121|582913875|FG001|Overall Study|Discharged from US Military Active Service|91|||
161416635|NCT02669121|582913874|FG000|Overall Study|Reason not Specified|22|||
161416636|NCT02669121|582913875|FG001|Overall Study|Reason not Specified|18|||
161416637|NCT02708355|582913876|FG000|Overall Study|Adverse Event|1|||
161416638|NCT02708355|582913877|FG001|Overall Study|Adverse Event|0|||
161416639|NCT02708355|582913878|FG002|Overall Study|Adverse Event|0|||
161416640|NCT04384523|582913879|FG000|Overall Study|Lost to Follow-up|0|||
161416641|NCT04384523|582913880|FG001|Overall Study|Lost to Follow-up|0|||
161416642|NCT04384523|582913881|FG002|Overall Study|Lost to Follow-up|0|||
161416643|NCT04384523|582913882|FG003|Overall Study|Lost to Follow-up|0|||
161416644|NCT04384523|582913883|FG004|Overall Study|Lost to Follow-up|0|||
161416645|NCT04384523|582913884|FG005|Overall Study|Lost to Follow-up|1|||
161416646|NCT04384523|582913879|FG000|Overall Study|Protocol Violation|0|||
161416647|NCT04384523|582913880|FG001|Overall Study|Protocol Violation|1|||
161416648|NCT04384523|582913881|FG002|Overall Study|Protocol Violation|0|||
161416649|NCT04384523|582913882|FG003|Overall Study|Protocol Violation|0|||
161416650|NCT04384523|582913883|FG004|Overall Study|Protocol Violation|0|||
161416651|NCT04384523|582913884|FG005|Overall Study|Protocol Violation|0|||
161416652|NCT04384523|582913879|FG000|Overall Study|Withdrawal by Subject|1|||
161416653|NCT04384523|582913880|FG001|Overall Study|Withdrawal by Subject|0|||
161416654|NCT04384523|582913881|FG002|Overall Study|Withdrawal by Subject|0|||
161416655|NCT04384523|582913882|FG003|Overall Study|Withdrawal by Subject|0|||
161416656|NCT04384523|582913883|FG004|Overall Study|Withdrawal by Subject|0|||
161416657|NCT04384523|582913884|FG005|Overall Study|Withdrawal by Subject|0|||
161416658|NCT03216746|582913885|FG000|Overall Study|Lost to Follow-up|6|||
161416659|NCT03216746|582913886|FG001|Overall Study|Lost to Follow-up|8|||
161416660|NCT03216746|582913887|FG002|Overall Study|Lost to Follow-up|5|||
161416661|NCT03216746|582913888|FG003|Overall Study|Lost to Follow-up|6|||
161416662|NCT01320202|582913889|FG000|Overall Study|Adverse Event|5|||
161416663|NCT01320202|582913890|FG001|Overall Study|Adverse Event|5|||
161416664|NCT01320202|582913889|FG000|Overall Study|Death|5|||
161416665|NCT01320202|582913890|FG001|Overall Study|Death|3|||
161416666|NCT01320202|582913889|FG000|Overall Study|Lost to Follow-up|1|||
161416667|NCT01320202|582913890|FG001|Overall Study|Lost to Follow-up|0|||
161416668|NCT01320202|582913889|FG000|Overall Study|Physician Decision|3|||
161416669|NCT01320202|582913890|FG001|Overall Study|Physician Decision|1|||
161416670|NCT01320202|582913889|FG000|Overall Study|Protocol Violation|2|||
161416671|NCT01320202|582913890|FG001|Overall Study|Protocol Violation|1|||
161416672|NCT01320202|582913889|FG000|Overall Study|Withdrawal by Subject|10|||
161416673|NCT01320202|582913890|FG001|Overall Study|Withdrawal by Subject|3|||
161416674|NCT01320202|582913889|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
161416675|NCT01320202|582913890|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
161416676|NCT01320202|582913889|FG000|Overall Study|kidney transplant|1|||
161416677|NCT01320202|582913890|FG001|Overall Study|kidney transplant|2|||
161416678|NCT01320202|582913889|FG000|Overall Study|blood transfusion|1|||
161416679|NCT01320202|582913890|FG001|Overall Study|blood transfusion|7|||
161416680|NCT01320202|582913889|FG000|Overall Study|moved/changed dialysis|5|||
161416681|NCT01320202|582913890|FG001|Overall Study|moved/changed dialysis|2|||
161416682|NCT01320202|582913889|FG000|Overall Study|sponsor request|2|||
161416683|NCT01320202|582913890|FG001|Overall Study|sponsor request|0|||
161416684|NCT01320202|582913889|FG000|Overall Study|ineligible|3|||
161416685|NCT01320202|582913890|FG001|Overall Study|ineligible|0|||
161416686|NCT01320202|582913889|FG000|Overall Study|regained renal function|1|||
161416687|NCT01320202|582913890|FG001|Overall Study|regained renal function|0|||
161416688|NCT00635882|582913891|FG000|Overall Study|Protocol Violation|1|||
161416689|NCT00635882|582913892|FG001|Overall Study|Protocol Violation|0|||
161416690|NCT00635882|582913893|FG002|Overall Study|Protocol Violation|0|||
161416691|NCT00635882|582913894|FG003|Overall Study|Protocol Violation|0|||
161416692|NCT00635882|582913895|FG004|Overall Study|Protocol Violation|0|||
161416693|NCT00635882|582913896|FG005|Overall Study|Protocol Violation|0|||
161416694|NCT02006979|582913898|FG000|Overall Study|Withdrawal by Subject|1|||
161416695|NCT02006979|582913899|FG001|Overall Study|Withdrawal by Subject|1|||
161416696|NCT02006979|582913898|FG000|Overall Study|Protocol Violation|0|||
161416697|NCT02006979|582913899|FG001|Overall Study|Protocol Violation|1|||
161416698|NCT03848949|582913906|FG000|Overall Study|Lost to Follow-up|5|||
161416699|NCT03848949|582913907|FG001|Overall Study|Lost to Follow-up|7|||
161416700|NCT02697435|582913908|FG000|Overall Study|Withdrawal by Subject|1|||
161416701|NCT02697435|582913909|FG001|Overall Study|Withdrawal by Subject|0|||
161416702|NCT02697435|582913908|FG000|Overall Study|Physician Decision|0|||
161416703|NCT02697435|582913909|FG001|Overall Study|Physician Decision|4|||
161416704|NCT04230213|582913914|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
161416705|NCT04230213|582913915|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
161416706|NCT04230213|582913916|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
161416707|NCT04230213|582913914|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
161416708|NCT04230213|582913915|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
161416709|NCT04230213|582913916|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
161416710|NCT04230213|582913914|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
161416711|NCT04230213|582913915|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
161416712|NCT04230213|582913916|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
161416713|NCT04230213|582913914|FG000|TP2: Week 10 to Week 16|Other|0|||
161416714|NCT04230213|582913915|FG001|TP2: Week 10 to Week 16|Other|2|||
161416715|NCT04230213|582913916|FG002|TP2: Week 10 to Week 16|Other|1|||
161416716|NCT04230213|582913914|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
161416717|NCT04230213|582913915|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
161416718|NCT04230213|582913916|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
161416719|NCT04230213|582913914|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
161416720|NCT04230213|582913915|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
161416721|NCT04230213|582913916|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
161416722|NCT04230213|582913914|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
161416723|NCT04230213|582913915|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
161416724|NCT04230213|582913916|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
161416725|NCT04230213|582913914|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
161416726|NCT04230213|582913915|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
161416727|NCT04230213|582913916|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
161416728|NCT04230213|582913914|FG000|TP3: Week 16 to Week 22|Other|0|||
161416729|NCT04230213|582913915|FG001|TP3: Week 16 to Week 22|Other|1|||
161416730|NCT04230213|582913916|FG002|TP3: Week 16 to Week 22|Other|3|||
161416731|NCT04230213|582913914|FG000|TP4: Week 22 to Week 32|Other|0|||
161416732|NCT04230213|582913915|FG001|TP4: Week 22 to Week 32|Other|5|||
161416733|NCT04230213|582913916|FG002|TP4: Week 22 to Week 32|Other|5|||
161416734|NCT04230213|582913914|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
161416735|NCT04230213|582913915|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
161416736|NCT04230213|582913916|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
161416737|NCT04230213|582913914|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
161416738|NCT04230213|582913915|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
161416739|NCT04230213|582913916|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
161416740|NCT04230213|582913914|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
161416741|NCT04230213|582913915|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
161416742|NCT04230213|582913916|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
161416743|NCT04230213|582913914|FG000|Follow up: Week 32 to Week 36|Other|0|||
161416744|NCT04230213|582913915|FG001|Follow up: Week 32 to Week 36|Other|1|||
161416745|NCT04230213|582913916|FG002|Follow up: Week 32 to Week 36|Other|1|||
161416746|NCT00619307|582913926|FG000|Overall Study|Adverse Event|0|||
161416747|NCT00619307|582913927|FG001|Overall Study|Adverse Event|1|||
161416748|NCT00619307|582913926|FG000|Overall Study|Lost to Follow-up|0|||
161416749|NCT00619307|582913927|FG001|Overall Study|Lost to Follow-up|1|||
161416750|NCT00619307|582913926|FG000|Overall Study|Protocol Violation|3|||
161416751|NCT00619307|582913927|FG001|Overall Study|Protocol Violation|0|||
161416752|NCT00619307|582913926|FG000|Overall Study|Withdrew consent|1|||
161416753|NCT00619307|582913927|FG001|Overall Study|Withdrew consent|0|||
161416754|NCT00619307|582913926|FG000|Overall Study|Severe migraine|0|||
161416755|NCT00619307|582913927|FG001|Overall Study|Severe migraine|1|||
161416756|NCT00619307|582913926|FG000|Overall Study|MS attack plus steroids|0|||
161416757|NCT00619307|582913927|FG001|Overall Study|MS attack plus steroids|1|||
161416758|NCT00118430|582913936|FG000|Overall Study|Withdrawal by Subject|6|||
161416759|NCT00118430|582913937|FG001|Overall Study|Withdrawal by Subject|2|||
161416760|NCT00118430|582913938|FG002|Overall Study|Withdrawal by Subject|0|||
161416761|NCT00118430|582913936|FG000|Overall Study|Lost to Follow-up|15|||
161416762|NCT00118430|582913937|FG001|Overall Study|Lost to Follow-up|22|||
161416763|NCT00118430|582913938|FG002|Overall Study|Lost to Follow-up|28|||
161416764|NCT02147288|582913939|FG000|Overall Study|post-operative hematoma|1|||
161416765|NCT02147288|582913940|FG001|Overall Study|post-operative hematoma|1|||
161416766|NCT02147288|582913941|FG002|Overall Study|post-operative hematoma|0|||
161416767|NCT02147288|582913942|FG003|Overall Study|post-operative hematoma|0|||
161416768|NCT02147288|582913943|FG004|Overall Study|post-operative hematoma|0|||
161416769|NCT02147288|582913944|FG005|Overall Study|post-operative hematoma|0|||
161416770|NCT02147288|582913945|FG006|Overall Study|post-operative hematoma|0|||
161416771|NCT02147288|582913946|FG007|Overall Study|post-operative hematoma|0|||
161416772|NCT02147288|582913947|FG008|Overall Study|post-operative hematoma|0|||
161416773|NCT02147288|582913948|FG009|Overall Study|post-operative hematoma|0|||
161416774|NCT02147288|582913939|FG000|Overall Study|complications from concurrent hernia rep|0|||
161416775|NCT02147288|582913940|FG001|Overall Study|complications from concurrent hernia rep|1|||
161416776|NCT02147288|582913941|FG002|Overall Study|complications from concurrent hernia rep|0|||
161416777|NCT02147288|582913942|FG003|Overall Study|complications from concurrent hernia rep|0|||
161416778|NCT02147288|582913943|FG004|Overall Study|complications from concurrent hernia rep|0|||
161416779|NCT02147288|582913944|FG005|Overall Study|complications from concurrent hernia rep|0|||
161416780|NCT02147288|582913945|FG006|Overall Study|complications from concurrent hernia rep|0|||
161416781|NCT02147288|582913946|FG007|Overall Study|complications from concurrent hernia rep|0|||
161416782|NCT02147288|582913947|FG008|Overall Study|complications from concurrent hernia rep|0|||
161416783|NCT02147288|582913948|FG009|Overall Study|complications from concurrent hernia rep|0|||
161416784|NCT00861471|582913949|FG000|Overall Study|Withdrawal by Subject|1|||
161416785|NCT00861471|582913949|FG000|Overall Study|Adverse Event|2|||
161416786|NCT00861471|582913949|FG000|Overall Study|Lack of Efficacy|3|||
161416787|NCT00861471|582913949|FG000|Overall Study|treatment for lumbar laminectomy|1|||
161416788|NCT00861471|582913949|FG000|Overall Study|Physician Decision|2|||
161416789|NCT02069392|582913950|FG000|Overall Study|Withdrawal by Subject|4|||
161416790|NCT02069392|582913951|FG001|Overall Study|Withdrawal by Subject|2|||
161416791|NCT01574651|582913952|FG000|Overall Study|Lost to Follow-up|2|||
161416792|NCT01574651|582913953|FG001|Overall Study|Lost to Follow-up|4|||
161416793|NCT01574651|582913952|FG000|Overall Study|Administrative problems|0|||
161416794|NCT01574651|582913953|FG001|Overall Study|Administrative problems|1|||
161416795|NCT01574651|582913952|FG000|Overall Study|Death|3|||
161416796|NCT01574651|582913953|FG001|Overall Study|Death|3|||
161416797|NCT01574651|582913952|FG000|Overall Study|Patient's inability to use the device|0|||
161416798|NCT01574651|582913953|FG001|Overall Study|Patient's inability to use the device|1|||
161416799|NCT01574651|582913952|FG000|Overall Study|Adverse Event|36|||
161416800|NCT01574651|582913953|FG001|Overall Study|Adverse Event|27|||
161416801|NCT01574651|582913952|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161416802|NCT01574651|582913953|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161416803|NCT01574651|582913952|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161416804|NCT01574651|582913953|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161416805|NCT01574651|582913952|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161416806|NCT01574651|582913953|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161416807|NCT01574651|582913952|FG000|Overall Study|Protocol Violation|3|||
161416808|NCT01574651|582913953|FG001|Overall Study|Protocol Violation|5|||
161416809|NCT01574651|582913952|FG000|Overall Study|Withdrawal by Subject|9|||
161416810|NCT01574651|582913953|FG001|Overall Study|Withdrawal by Subject|10|||
161416811|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Adverse Event|33|||
161416812|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
161416813|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
161416814|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
161416815|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Physician Decision|6|||
161416816|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
161416817|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
161416818|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
161416819|NCT00965419|582913954|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
161416820|NCT00965419|582913954|FG000|Follow-up Phase|Adverse Event|9|||
161416821|NCT00965419|582913954|FG000|Follow-up Phase|Protocol Violation|4|||
161416822|NCT00965419|582913954|FG000|Follow-up Phase|Withdrawal by Subject|8|||
161416823|NCT00965419|582913954|FG000|Follow-up Phase|Physician Decision|4|||
161416824|NCT00965419|582913954|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
161416825|NCT00965419|582913954|FG000|Follow-up Phase|Lack of Efficacy|28|||
161416826|NCT04412707|582913955|FG000|Cycle 1|Death|0|||
161416827|NCT04412707|582913956|FG001|Cycle 1|Death|3|||
161416828|NCT04412707|582913955|FG000|Cycle 1|Disease progression|1|||
161416829|NCT04412707|582913956|FG001|Cycle 1|Disease progression|2|||
161416830|NCT04412707|582913955|FG000|Cycle 2|Death|0|||
161416831|NCT04412707|582913956|FG001|Cycle 2|Death|1|||
161416832|NCT04412707|582913955|FG000|Cycle 2|Disease progression|3|||
161416833|NCT04412707|582913956|FG001|Cycle 2|Disease progression|0|||
161416834|NCT04412707|582913955|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
161416835|NCT04412707|582913956|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
161416836|NCT04412707|582913955|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
161416837|NCT04412707|582913956|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
161416838|NCT04412707|582913955|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
161416839|NCT04412707|582913956|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
161416840|NCT04412707|582913955|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
161416841|NCT04412707|582913956|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
161416842|NCT00264537|582913957|FG000|Overall Study|Death|0|||
161416843|NCT00264537|582913958|FG001|Overall Study|Death|3|||
161416844|NCT00264537|582913959|FG002|Overall Study|Death|3|||
161416845|NCT00264537|582913960|FG003|Overall Study|Death|2|||
161416846|NCT00264537|582913957|FG000|Overall Study|Lost to Follow-up|3|||
161416847|NCT00264537|582913958|FG001|Overall Study|Lost to Follow-up|4|||
161416848|NCT00264537|582913959|FG002|Overall Study|Lost to Follow-up|7|||
161416849|NCT00264537|582913960|FG003|Overall Study|Lost to Follow-up|6|||
161416850|NCT00264537|582913957|FG000|Overall Study|Adverse Event|21|||
161416851|NCT00264537|582913958|FG001|Overall Study|Adverse Event|32|||
161416852|NCT00264537|582913959|FG002|Overall Study|Adverse Event|24|||
161416853|NCT00264537|582913960|FG003|Overall Study|Adverse Event|34|||
161416854|NCT00264537|582913957|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161416855|NCT00264537|582913958|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161416856|NCT00264537|582913959|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
161416857|NCT00264537|582913960|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
161416858|NCT00264537|582913957|FG000|Overall Study|Other|21|||
161416859|NCT00264537|582913958|FG001|Overall Study|Other|11|||
161416860|NCT00264537|582913959|FG002|Overall Study|Other|10|||
161416861|NCT00264537|582913960|FG003|Overall Study|Other|11|||
161416862|NCT00264537|582913957|FG000|Overall Study|Not treated|0|||
161416863|NCT00264537|582913958|FG001|Overall Study|Not treated|2|||
161416864|NCT00264537|582913959|FG002|Overall Study|Not treated|1|||
161416865|NCT00264537|582913960|FG003|Overall Study|Not treated|0|||
161416866|NCT00615017|582916152|FG000|Overall Study|Adverse Event|0|||
161416867|NCT00615017|582916153|FG001|Overall Study|Adverse Event|1|||
161416868|NCT00615017|582916154|FG002|Overall Study|Adverse Event|2|||
161416869|NCT00615017|582916155|FG003|Overall Study|Adverse Event|0|||
161416870|NCT00615017|582916156|FG004|Overall Study|Adverse Event|0|||
161416871|NCT00615017|582916157|FG005|Overall Study|Adverse Event|1|||
161416872|NCT00615017|582916152|FG000|Overall Study|Death|0|||
161416873|NCT00615017|582916153|FG001|Overall Study|Death|0|||
161416874|NCT00615017|582916154|FG002|Overall Study|Death|2|||
161416875|NCT00615017|582916155|FG003|Overall Study|Death|0|||
161416876|NCT00615017|582916156|FG004|Overall Study|Death|1|||
161416877|NCT00615017|582916157|FG005|Overall Study|Death|1|||
161416878|NCT00615017|582916152|FG000|Overall Study|Sepsis resolved|0|||
161416879|NCT00615017|582916153|FG001|Overall Study|Sepsis resolved|0|||
161416880|NCT00615017|582916154|FG002|Overall Study|Sepsis resolved|1|||
161416881|NCT00615017|582916155|FG003|Overall Study|Sepsis resolved|0|||
161416882|NCT00615017|582916156|FG004|Overall Study|Sepsis resolved|0|||
161416883|NCT00615017|582916157|FG005|Overall Study|Sepsis resolved|0|||
161416884|NCT00615017|582916152|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
161416885|NCT00615017|582916153|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
161416886|NCT00615017|582916154|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
161416887|NCT00615017|582916155|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
161416888|NCT00615017|582916156|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
161416889|NCT00615017|582916157|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
161416890|NCT00615017|582916152|FG000|Overall Study|Physician discontinued drug|0|||
161416891|NCT00615017|582916153|FG001|Overall Study|Physician discontinued drug|0|||
161416892|NCT00615017|582916154|FG002|Overall Study|Physician discontinued drug|0|||
161416893|NCT00615017|582916155|FG003|Overall Study|Physician discontinued drug|0|||
161416894|NCT00615017|582916156|FG004|Overall Study|Physician discontinued drug|0|||
161416895|NCT00615017|582916157|FG005|Overall Study|Physician discontinued drug|1|||
161416896|NCT00855959|582916158|FG000|Overall Study|Adverse Event|2|||
161416897|NCT00855959|582916158|FG000|Overall Study|Lost to Follow-up|2|||
161416898|NCT00855959|582916158|FG000|Overall Study|Withdrawal by Subject|3|||
161416899|NCT00855959|582916158|FG000|Overall Study|Pregnancy|1|||
161416900|NCT00855959|582916158|FG000|Overall Study|Incorrect enrolment|1|||
161416901|NCT04014062|582916159|FG000|Period I: Dosing|Medical Grounds|4|||
161416902|NCT04014062|582916160|FG001|Period I: Dosing|Medical Grounds|5|||
161416903|NCT04014062|582916159|FG000|Period I: Dosing|Withdrawal by Subject|3|||
161416904|NCT04014062|582916160|FG001|Period I: Dosing|Withdrawal by Subject|1|||
161416905|NCT04306510|582916161|FG000|Overall Study|Voluntarily withdrawal|1|||
161416906|NCT04306510|582916161|FG000|Overall Study|Enrolled but Not Treated|1|||
161416907|NCT03329092|582916162|FG000|Overall Study|Other|2|||
161416908|NCT03329092|582916163|FG001|Overall Study|Other|2|||
161416909|NCT03329092|582916162|FG000|Overall Study|Withdrawal by Subject|16|||
161416910|NCT03329092|582916163|FG001|Overall Study|Withdrawal by Subject|3|||
161416911|NCT03329092|582916162|FG000|Overall Study|Physician Decision|1|||
161416912|NCT03329092|582916163|FG001|Overall Study|Physician Decision|0|||
161416913|NCT03329092|582916162|FG000|Overall Study|Death|17|||
161416914|NCT03329092|582916163|FG001|Overall Study|Death|11|||
161416915|NCT03329092|582916162|FG000|Overall Study|Adverse Event|3|||
161416916|NCT03329092|582916163|FG001|Overall Study|Adverse Event|1|||
161416917|NCT03329092|582916162|FG000|Overall Study|Lost to Follow-up|1|||
161416918|NCT03329092|582916163|FG001|Overall Study|Lost to Follow-up|1|||
161416919|NCT04878211|582916164|FG000|Overall Study|Lost to Follow-up|0|||
161416920|NCT04878211|582916165|FG001|Overall Study|Lost to Follow-up|0|||
161416921|NCT04878211|582916166|FG002|Overall Study|Lost to Follow-up|0|||
161416922|NCT04878211|582916167|FG003|Overall Study|Lost to Follow-up|1|||
161416923|NCT04878211|582916168|FG004|Overall Study|Lost to Follow-up|0|||
161416924|NCT04878211|582916169|FG005|Overall Study|Lost to Follow-up|1|||
161416925|NCT04878211|582916164|FG000|Overall Study|Protocol deviation|1|||
161416926|NCT04878211|582916165|FG001|Overall Study|Protocol deviation|0|||
161416927|NCT04878211|582916166|FG002|Overall Study|Protocol deviation|0|||
161416928|NCT04878211|582916167|FG003|Overall Study|Protocol deviation|0|||
161416929|NCT04878211|582916168|FG004|Overall Study|Protocol deviation|0|||
161416930|NCT04878211|582916169|FG005|Overall Study|Protocol deviation|0|||
161416931|NCT04878211|582916164|FG000|Overall Study|Study terminated by sponsor|0|||
161416932|NCT04878211|582916165|FG001|Overall Study|Study terminated by sponsor|0|||
161416933|NCT04878211|582916166|FG002|Overall Study|Study terminated by sponsor|0|||
161416934|NCT04878211|582916167|FG003|Overall Study|Study terminated by sponsor|0|||
161416935|NCT04878211|582916168|FG004|Overall Study|Study terminated by sponsor|9|||
161416936|NCT04878211|582916169|FG005|Overall Study|Study terminated by sponsor|4|||
161416937|NCT04878211|582916164|FG000|Overall Study|Subject decision|0|||
161416938|NCT04878211|582916165|FG001|Overall Study|Subject decision|0|||
161416939|NCT04878211|582916166|FG002|Overall Study|Subject decision|0|||
161416940|NCT04878211|582916167|FG003|Overall Study|Subject decision|0|||
161416941|NCT04878211|582916168|FG004|Overall Study|Subject decision|1|||
161416942|NCT04878211|582916169|FG005|Overall Study|Subject decision|0|||
161416943|NCT02783599|582916176|FG000|Overall Study|Progressive disease|23|||
161416944|NCT02783599|582916176|FG000|Overall Study|Surgical Resection|10|||
161416945|NCT02783599|582916176|FG000|Overall Study|Adverse Event|4|||
161416946|NCT02783599|582916176|FG000|Overall Study|Physician Decision|2|||
161416947|NCT02783599|582916176|FG000|Overall Study|Death|1|||
161416948|NCT00856544|582916177|FG000|Overall Study|Randomized but not treated|3|||
161416949|NCT00856544|582916178|FG001|Overall Study|Randomized but not treated|0|||
161416950|NCT00856544|582916179|FG002|Overall Study|Randomized but not treated|0|||
161416951|NCT00856544|582916180|FG003|Overall Study|Randomized but not treated|0|||
161416952|NCT00856544|582916177|FG000|Overall Study|Death|0|||
161416953|NCT00856544|582916178|FG001|Overall Study|Death|2|||
161416954|NCT00856544|582916179|FG002|Overall Study|Death|0|||
161416955|NCT00856544|582916180|FG003|Overall Study|Death|0|||
161416956|NCT00856544|582916177|FG000|Overall Study|Adverse Event|20|||
161416957|NCT00856544|582916178|FG001|Overall Study|Adverse Event|29|||
161416958|NCT00856544|582916179|FG002|Overall Study|Adverse Event|2|||
161416959|NCT00856544|582916180|FG003|Overall Study|Adverse Event|3|||
161416960|NCT00856544|582916177|FG000|Overall Study|Lack of Efficacy|16|||
161416961|NCT00856544|582916178|FG001|Overall Study|Lack of Efficacy|12|||
161416962|NCT00856544|582916179|FG002|Overall Study|Lack of Efficacy|3|||
161416963|NCT00856544|582916180|FG003|Overall Study|Lack of Efficacy|3|||
161416964|NCT00856544|582916177|FG000|Overall Study|Other|9|||
161416965|NCT00856544|582916178|FG001|Overall Study|Other|16|||
161416966|NCT00856544|582916179|FG002|Overall Study|Other|1|||
161416967|NCT00856544|582916180|FG003|Overall Study|Other|6|||
161416968|NCT00856544|582916177|FG000|Overall Study|Lost to Follow-up|1|||
161416969|NCT00856544|582916178|FG001|Overall Study|Lost to Follow-up|2|||
161416970|NCT00856544|582916179|FG002|Overall Study|Lost to Follow-up|2|||
161416971|NCT00856544|582916180|FG003|Overall Study|Lost to Follow-up|0|||
161416972|NCT00856544|582916177|FG000|Overall Study|Withdrawal by Subject|8|||
161416973|NCT00856544|582916178|FG001|Overall Study|Withdrawal by Subject|5|||
161416974|NCT00856544|582916179|FG002|Overall Study|Withdrawal by Subject|0|||
161416975|NCT00856544|582916180|FG003|Overall Study|Withdrawal by Subject|1|||
161416976|NCT01564732|582916181|FG000|Overall Study|Early termination by the study sponsor|6|||
161416977|NCT01564732|582916182|FG001|Overall Study|Early termination by the study sponsor|5|||
161416978|NCT00394706|582916188|FG000|Overall Study|Withdrawal by Subject|2|||
161416979|NCT00394706|582916189|FG001|Overall Study|Withdrawal by Subject|0|||
161416980|NCT00394706|582916190|FG002|Overall Study|Withdrawal by Subject|1|||
161416981|NCT00394706|582916191|FG003|Overall Study|Withdrawal by Subject|0|||
161416982|NCT00394706|582916192|FG004|Overall Study|Withdrawal by Subject|0|||
161416983|NCT00394706|582916193|FG005|Overall Study|Withdrawal by Subject|2|||
161416984|NCT00394706|582916194|FG006|Overall Study|Withdrawal by Subject|1|||
161416985|NCT00394706|582916195|FG007|Overall Study|Withdrawal by Subject|0|||
161416986|NCT00394706|582916188|FG000|Overall Study|Lost to Follow-up|2|||
161416987|NCT00394706|582916189|FG001|Overall Study|Lost to Follow-up|2|||
161416988|NCT00394706|582916190|FG002|Overall Study|Lost to Follow-up|8|||
161416989|NCT00394706|582916191|FG003|Overall Study|Lost to Follow-up|1|||
161416990|NCT00394706|582916192|FG004|Overall Study|Lost to Follow-up|2|||
161416991|NCT00394706|582916193|FG005|Overall Study|Lost to Follow-up|5|||
161416992|NCT00394706|582916194|FG006|Overall Study|Lost to Follow-up|2|||
161416993|NCT00394706|582916195|FG007|Overall Study|Lost to Follow-up|0|||
161416994|NCT03040674|582916197|FG000|Overall Study|Lost to Follow-up|225|||
161416995|NCT03040674|582916197|FG000|Overall Study|Death|23|||
161416996|NCT01746368|582916200|FG000|Overall Study|Lost to Follow-up|2|||
161416997|NCT01746368|582916201|FG001|Overall Study|Lost to Follow-up|0|||
161416998|NCT01746368|582916200|FG000|Overall Study|Withdrawal by Subject|0|||
161416999|NCT01746368|582916201|FG001|Overall Study|Withdrawal by Subject|1|||
161417000|NCT02506192|582916202|FG000|Overall Study|Withdrawal by Subject|1|||
161417001|NCT02506192|582916203|FG001|Overall Study|Withdrawal by Subject|1|||
161417002|NCT04042909|582916204|FG000|Overall Study|Withdrawal by Subject|1|||
161417003|NCT04042909|582916205|FG001|Overall Study|Withdrawal by Subject|0|||
161417004|NCT04042909|582916206|FG002|Overall Study|Withdrawal by Subject|0|||
161417005|NCT04042909|582916204|FG000|Overall Study|duplicate cases|2|||
161417006|NCT04042909|582916205|FG001|Overall Study|duplicate cases|0|||
161417007|NCT04042909|582916206|FG002|Overall Study|duplicate cases|0|||
161417008|NCT04042909|582916204|FG000|Overall Study|technical problem|0|||
161417009|NCT04042909|582916205|FG001|Overall Study|technical problem|1|||
161417010|NCT04042909|582916206|FG002|Overall Study|technical problem|0|||
161417011|NCT03705559|582916207|FG000|Overall Study|COVID Shut down|1|||
161417012|NCT02576795|582916208|FG000|Overall Study|Lost to Follow-up|0|||
161417013|NCT02576795|582916209|FG001|Overall Study|Lost to Follow-up|0|||
161417014|NCT02576795|582916210|FG002|Overall Study|Lost to Follow-up|1|||
161417015|NCT02576795|582916211|FG003|Overall Study|Lost to Follow-up|0|||
161417016|NCT02362464|582916212|FG000|Overall Study|Switched to alternative therapy|1|||
161417017|NCT02362464|582916212|FG000|Overall Study|Refused further treatment|1|||
161417018|NCT02362464|582916212|FG000|Overall Study|Physician Decision|4|||
161417019|NCT02104947|582916213|FG000|Overall Study|Withdrawal by Subject|10|||
161417020|NCT02104947|582916214|FG001|Overall Study|Withdrawal by Subject|3|||
161417021|NCT02104947|582916213|FG000|Overall Study|Lost to Follow-up|4|||
161417022|NCT02104947|582916214|FG001|Overall Study|Lost to Follow-up|4|||
161417023|NCT02104947|582916213|FG000|Overall Study|Protocol Violation|6|||
161417024|NCT02104947|582916214|FG001|Overall Study|Protocol Violation|8|||
161417025|NCT02104947|582916213|FG000|Overall Study|Adverse Event|57|||
161417026|NCT02104947|582916214|FG001|Overall Study|Adverse Event|38|||
161417027|NCT02104947|582916213|FG000|Overall Study|Other than stated above|2|||
161417028|NCT02104947|582916214|FG001|Overall Study|Other than stated above|3|||
161417029|NCT02343406|582916215|FG000|Overall Study|Progressive disease|72|||
161417030|NCT02343406|582916216|FG001|Overall Study|Progressive disease|70|||
161417031|NCT02343406|582916217|FG002|Overall Study|Progressive disease|43|||
161417032|NCT02343406|582916218|FG003|Overall Study|Progressive disease|15|||
161417033|NCT02343406|582916219|FG004|Overall Study|Progressive disease|5|||
161417034|NCT02343406|582916215|FG000|Overall Study|Adverse Event|6|||
161417035|NCT02343406|582916216|FG001|Overall Study|Adverse Event|8|||
161417036|NCT02343406|582916217|FG002|Overall Study|Adverse Event|6|||
161417037|NCT02343406|582916218|FG003|Overall Study|Adverse Event|3|||
161417038|NCT02343406|582916219|FG004|Overall Study|Adverse Event|0|||
161417039|NCT02343406|582916215|FG000|Overall Study|Withdrawal by Subject|6|||
161417040|NCT02343406|582916216|FG001|Overall Study|Withdrawal by Subject|4|||
161417041|NCT02343406|582916217|FG002|Overall Study|Withdrawal by Subject|8|||
161417042|NCT02343406|582916218|FG003|Overall Study|Withdrawal by Subject|3|||
161417043|NCT02343406|582916219|FG004|Overall Study|Withdrawal by Subject|0|||
161417044|NCT02343406|582916215|FG000|Overall Study|Death|2|||
161417045|NCT02343406|582916216|FG001|Overall Study|Death|1|||
161417046|NCT02343406|582916217|FG002|Overall Study|Death|0|||
161417047|NCT02343406|582916218|FG003|Overall Study|Death|0|||
161417048|NCT02343406|582916219|FG004|Overall Study|Death|0|||
161417049|NCT02343406|582916215|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
161417050|NCT02343406|582916216|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
161417051|NCT02343406|582916217|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
161417052|NCT02343406|582916218|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
161417053|NCT02343406|582916219|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
161417054|NCT02343406|582916215|FG000|Overall Study|Other primary malignancy|0|||
161417055|NCT02343406|582916216|FG001|Overall Study|Other primary malignancy|1|||
161417056|NCT02343406|582916217|FG002|Overall Study|Other primary malignancy|0|||
161417057|NCT02343406|582916218|FG003|Overall Study|Other primary malignancy|0|||
161417058|NCT02343406|582916219|FG004|Overall Study|Other primary malignancy|0|||
161417059|NCT02343406|582916215|FG000|Overall Study|Other, not specified|2|||
161417060|NCT02343406|582916216|FG001|Overall Study|Other, not specified|1|||
161417061|NCT02343406|582916217|FG002|Overall Study|Other, not specified|1|||
161417062|NCT02343406|582916218|FG003|Overall Study|Other, not specified|4|||
161417063|NCT02343406|582916219|FG004|Overall Study|Other, not specified|0|||
161417064|NCT00548145|582916220|FG000|Overall Study|Death|0|||
161417065|NCT00548145|582916221|FG001|Overall Study|Death|1|||
161417066|NCT00548145|582916220|FG000|Overall Study|Withdrawal by Subject|0|||
161417067|NCT00548145|582916221|FG001|Overall Study|Withdrawal by Subject|2|||
161417068|NCT00548145|582916220|FG000|Overall Study|Physician Decision|1|||
161417069|NCT00548145|582916221|FG001|Overall Study|Physician Decision|1|||
161417070|NCT00874848|582916222|FG000|Overall Study|Adverse Event|13|||
161417071|NCT00874848|582916223|FG001|Overall Study|Adverse Event|2|||
161417072|NCT00874848|582916222|FG000|Overall Study|Progressive neoplastic disease|38|||
161417073|NCT00874848|582916223|FG001|Overall Study|Progressive neoplastic disease|18|||
161417074|NCT00874848|582916222|FG000|Overall Study|Withdrawal by Subject|7|||
161417075|NCT00874848|582916223|FG001|Overall Study|Withdrawal by Subject|4|||
161417076|NCT00874848|582916222|FG000|Overall Study|Noncompliance|1|||
161417077|NCT00874848|582916223|FG001|Overall Study|Noncompliance|1|||
161417078|NCT00874848|582916222|FG000|Overall Study|Failure to comply with protocol|0|||
161417079|NCT00874848|582916223|FG001|Overall Study|Failure to comply with protocol|1|||
161417080|NCT00874848|582916222|FG000|Overall Study|Physician Decision|0|||
161417081|NCT00874848|582916223|FG001|Overall Study|Physician Decision|2|||
161417082|NCT03301350|582916230|FG000|Overall Study|Withdrawal by Subject|4|||
161417083|NCT03301350|582916230|FG000|Overall Study|Adverse Event|1|||
161417084|NCT03301350|582916230|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
161417085|NCT03301350|582916230|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
161417086|NCT03301350|582916230|FG000|Overall Study|no detail provided|1|||
161417087|NCT00621140|582916231|FG000|Overall Study|Adverse Event|4|||
161417088|NCT00621140|582916232|FG001|Overall Study|Adverse Event|5|||
161417089|NCT00621140|582916231|FG000|Overall Study|Lost to Follow-up|1|||
161417090|NCT00621140|582916232|FG001|Overall Study|Lost to Follow-up|2|||
161417091|NCT00621140|582916231|FG000|Overall Study|Withdrawal by Subject|4|||
161417092|NCT00621140|582916232|FG001|Overall Study|Withdrawal by Subject|6|||
161417093|NCT00621140|582916231|FG000|Overall Study|Other incl. lack of efficacy|6|||
161417094|NCT00621140|582916232|FG001|Overall Study|Other incl. lack of efficacy|5|||
161417095|NCT00958165|582916233|FG000|Overall Study|Lost to Follow-up|5|||
161417096|NCT00958165|582916233|FG000|Overall Study|Not eligible|9|||
161417097|NCT00145574|582916234|FG000|Double Blind|Adverse Event|0|||
161417098|NCT00145574|582916235|FG001|Double Blind|Adverse Event|3|||
161417099|NCT00145574|582916236|FG002|Double Blind|Adverse Event|1|||
161417100|NCT00145574|582916234|FG000|Double Blind|Withdrawal by Subject|1|||
161417101|NCT00145574|582916235|FG001|Double Blind|Withdrawal by Subject|1|||
161417102|NCT00145574|582916236|FG002|Double Blind|Withdrawal by Subject|1|||
161417103|NCT00145574|582916234|FG000|Double Blind|required restricted medicine|0|||
161417104|NCT00145574|582916235|FG001|Double Blind|required restricted medicine|1|||
161417105|NCT00145574|582916236|FG002|Double Blind|required restricted medicine|0|||
161417106|NCT00145574|582916234|FG000|Open Label Long-term Extension|Adverse Event|0|||
161417107|NCT00145574|582916235|FG001|Open Label Long-term Extension|Adverse Event|0|||
161417108|NCT00145574|582916236|FG002|Open Label Long-term Extension|Adverse Event|5|||
161417109|NCT00145574|582916234|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
161417110|NCT00145574|582916235|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
161417111|NCT00145574|582916236|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
161417112|NCT00145574|582916234|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
161417113|NCT00145574|582916235|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
161417114|NCT00145574|582916236|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
161417115|NCT00145574|582916234|FG000|Open Label Long-term Extension|required restricted medicine|0|||
161417116|NCT00145574|582916235|FG001|Open Label Long-term Extension|required restricted medicine|0|||
161417117|NCT00145574|582916236|FG002|Open Label Long-term Extension|required restricted medicine|1|||
161417118|NCT01298765|582916238|FG000|Titration Period|Adverse Event|26|||
161417119|NCT01298765|582916238|FG000|Titration Period|Death|1|||
161417120|NCT01298765|582916238|FG000|Titration Period|Lack of Efficacy|21|||
161417121|NCT01298765|582916238|FG000|Titration Period|Lost to Follow-up|9|||
161417122|NCT01298765|582916238|FG000|Titration Period|Physician Decision|1|||
161417123|NCT01298765|582916238|FG000|Titration Period|Withdrawal by Subject|10|||
161417124|NCT01298765|582916238|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
161417125|NCT01298765|582916238|FG000|Long-Term Treatment Period|Adverse Event|19|||
161417126|NCT01298765|582916238|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
161417127|NCT01298765|582916238|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
161417128|NCT01298765|582916238|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
161417129|NCT01298765|582916238|FG000|Long-Term Treatment Period|Physician Decision|1|||
161417130|NCT01298765|582916238|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
161417131|NCT03565237|582916239|FG000|Overall Study|Non-compliance of Investigational Product|1|||
161417132|NCT03565237|582916239|FG000|Overall Study|Physician Decision|1|||
161417133|NCT00428389|582916240|FG000|Core Phase|Adverse Event|6|||
161417134|NCT00428389|582916241|FG001|Core Phase|Adverse Event|4|||
161417135|NCT00428389|582916240|FG000|Core Phase|Lack of Efficacy|2|||
161417136|NCT00428389|582916241|FG001|Core Phase|Lack of Efficacy|0|||
161417137|NCT00428389|582916240|FG000|Core Phase|Abnormal test procedure result(s)|0|||
161417138|NCT00428389|582916241|FG001|Core Phase|Abnormal test procedure result(s)|1|||
161417139|NCT00428389|582916240|FG000|Core Phase|Withdrawal by Subject|3|||
161417140|NCT00428389|582916241|FG001|Core Phase|Withdrawal by Subject|4|||
161417141|NCT00428389|582916240|FG000|Core Phase|Protocol deviation|0|||
161417142|NCT00428389|582916241|FG001|Core Phase|Protocol deviation|2|||
161417143|NCT00428389|582916240|FG000|Extension Phase|Adverse Event|17|||
161417144|NCT00428389|582916241|FG001|Extension Phase|Adverse Event|11|||
161417145|NCT00428389|582916240|FG000|Extension Phase|Lack of Efficacy|4|||
161417146|NCT00428389|582916241|FG001|Extension Phase|Lack of Efficacy|3|||
161417147|NCT00428389|582916240|FG000|Extension Phase|Withdrawal by Subject|6|||
161417148|NCT00428389|582916241|FG001|Extension Phase|Withdrawal by Subject|6|||
161417149|NCT00428389|582916240|FG000|Extension Phase|Lost to Follow-up|0|||
161417150|NCT00428389|582916241|FG001|Extension Phase|Lost to Follow-up|3|||
161417151|NCT00428389|582916240|FG000|Extension Phase|Death|1|||
161417152|NCT00428389|582916241|FG001|Extension Phase|Death|0|||
161417153|NCT00428389|582916240|FG000|Extension Phase|Protocol Violation|3|||
161417154|NCT00428389|582916241|FG001|Extension Phase|Protocol Violation|2|||
161417155|NCT00428389|582916240|FG000|Extension Phase|Administrative problems|1|||
161417156|NCT00428389|582916241|FG001|Extension Phase|Administrative problems|1|||
161417157|NCT04090242|582916242|FG000|Overall Study|Withdrawal by Subject|1|||
161417158|NCT04090242|582916243|FG001|Overall Study|Withdrawal by Subject|0|||
161417159|NCT02687581|582916244|FG000|Overall Study|Withdrawal by Subject|1|||
161417160|NCT02687581|582916245|FG001|Overall Study|Withdrawal by Subject|0|||
161417161|NCT02687581|582916246|FG002|Overall Study|Withdrawal by Subject|0|||
161417162|NCT02687581|582916247|FG003|Overall Study|Withdrawal by Subject|1|||
161417163|NCT02687581|582916244|FG000|Overall Study|Lost to Follow-up|2|||
161417164|NCT02687581|582916245|FG001|Overall Study|Lost to Follow-up|2|||
161417165|NCT02687581|582916246|FG002|Overall Study|Lost to Follow-up|0|||
161417166|NCT02687581|582916247|FG003|Overall Study|Lost to Follow-up|0|||
161417167|NCT02687581|582916244|FG000|Overall Study|the device is too small for the patient.|1|||
161417168|NCT02687581|582916245|FG001|Overall Study|the device is too small for the patient.|0|||
161417169|NCT02687581|582916246|FG002|Overall Study|the device is too small for the patient.|0|||
161417170|NCT02687581|582916247|FG003|Overall Study|the device is too small for the patient.|0|||
161417171|NCT00835341|582916248|FG000|Overall Study|Lost to Follow-up|3|||
161417172|NCT00835341|582916249|FG001|Overall Study|Lost to Follow-up|12|||
161417173|NCT04405076|582916250|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
161417174|NCT04405076|582916251|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
161417175|NCT04405076|582916252|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
161417176|NCT04405076|582916253|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
161417177|NCT04405076|582916254|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
161417178|NCT04405076|582916255|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
161417179|NCT04405076|582916256|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
161417180|NCT04405076|582916257|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
161417181|NCT04405076|582916258|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
161417182|NCT04405076|582916250|FG000|Part A (Blinded Phase)|Physician Decision|1|||
161417183|NCT04405076|582916251|FG001|Part A (Blinded Phase)|Physician Decision|2|||
161417184|NCT04405076|582916252|FG002|Part A (Blinded Phase)|Physician Decision|0|||
161417185|NCT04405076|582916253|FG003|Part A (Blinded Phase)|Physician Decision|0|||
161417186|NCT04405076|582916254|FG004|Part A (Blinded Phase)|Physician Decision|0|||
161417187|NCT04405076|582916255|FG005|Part A (Blinded Phase)|Physician Decision|0|||
161417188|NCT04405076|582916256|FG006|Part A (Blinded Phase)|Physician Decision|0|||
161417189|NCT04405076|582916257|FG007|Part A (Blinded Phase)|Physician Decision|0|||
161417190|NCT04405076|582916258|FG008|Part A (Blinded Phase)|Physician Decision|0|||
161417191|NCT04405076|582916250|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
161417192|NCT04405076|582916251|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
161417193|NCT04405076|582916252|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
161417194|NCT04405076|582916253|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
161417195|NCT04405076|582916254|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
161417196|NCT04405076|582916255|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
161417197|NCT04405076|582916256|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
161417198|NCT04405076|582916257|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
161417199|NCT04405076|582916258|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
161417200|NCT04405076|582916250|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
161417201|NCT04405076|582916251|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417202|NCT04405076|582916252|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417203|NCT04405076|582916253|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417204|NCT04405076|582916254|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417205|NCT04405076|582916255|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417206|NCT04405076|582916256|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417207|NCT04405076|582916257|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417208|NCT04405076|582916258|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161417209|NCT04405076|582916250|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
161417210|NCT04405076|582916251|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
161417211|NCT04405076|582916252|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417212|NCT04405076|582916253|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417213|NCT04405076|582916254|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417214|NCT04405076|582916255|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417215|NCT04405076|582916256|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417216|NCT04405076|582916257|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417217|NCT04405076|582916258|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161417218|NCT04405076|582916250|FG000|Part A (Blinded Phase)|Other than Specified|0|||
161417219|NCT04405076|582916251|FG001|Part A (Blinded Phase)|Other than Specified|0|||
161417220|NCT04405076|582916252|FG002|Part A (Blinded Phase)|Other than Specified|3|||
161417221|NCT04405076|582916253|FG003|Part A (Blinded Phase)|Other than Specified|0|||
161417222|NCT04405076|582916254|FG004|Part A (Blinded Phase)|Other than Specified|0|||
161417223|NCT04405076|582916255|FG005|Part A (Blinded Phase)|Other than Specified|0|||
161417224|NCT04405076|582916256|FG006|Part A (Blinded Phase)|Other than Specified|0|||
161417225|NCT04405076|582916257|FG007|Part A (Blinded Phase)|Other than Specified|0|||
161417226|NCT04405076|582916258|FG008|Part A (Blinded Phase)|Other than Specified|0|||
161417227|NCT04405076|582916250|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161417228|NCT04405076|582916251|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161417229|NCT04405076|582916252|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161417230|NCT04405076|582916253|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
161417231|NCT04405076|582916254|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
161417232|NCT04405076|582916255|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
161417233|NCT04405076|582916256|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161417234|NCT04405076|582916257|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161417235|NCT04405076|582916258|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161417236|NCT04405076|582916250|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417237|NCT04405076|582916251|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417238|NCT04405076|582916252|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417239|NCT04405076|582916253|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417240|NCT04405076|582916254|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
161417241|NCT04405076|582916255|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417242|NCT04405076|582916256|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417243|NCT04405076|582916257|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417244|NCT04405076|582916258|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161417245|NCT04405076|582916250|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161417246|NCT04405076|582916251|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161417247|NCT04405076|582916252|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161417248|NCT04405076|582916253|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
161417249|NCT04405076|582916254|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
161417250|NCT04405076|582916255|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
161417251|NCT04405076|582916256|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161417252|NCT04405076|582916257|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161417253|NCT04405076|582916258|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161417254|NCT04405076|582916250|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417255|NCT04405076|582916251|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417256|NCT04405076|582916252|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417257|NCT04405076|582916253|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417258|NCT04405076|582916254|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417259|NCT04405076|582916255|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417260|NCT04405076|582916256|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161417261|NCT04405076|582916257|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
161417262|NCT04405076|582916258|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
161417263|NCT04405076|582916250|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417264|NCT04405076|582916251|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417265|NCT04405076|582916252|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417266|NCT04405076|582916253|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417267|NCT04405076|582916254|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417268|NCT04405076|582916255|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417269|NCT04405076|582916256|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
161417270|NCT04405076|582916257|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417271|NCT04405076|582916258|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161417272|NCT02513472|582916259|FG000|Overall Study|Radiological Disease Progression|45|||
161417273|NCT02513472|582916260|FG001|Overall Study|Radiological Disease Progression|57|||
161417274|NCT02513472|582916259|FG000|Overall Study|Clinical Disease Progression|5|||
161417275|NCT02513472|582916260|FG001|Overall Study|Clinical Disease Progression|13|||
161417276|NCT02513472|582916259|FG000|Overall Study|Adverse Event|8|||
161417277|NCT02513472|582916260|FG001|Overall Study|Adverse Event|11|||
161417278|NCT02513472|582916259|FG000|Overall Study|Withdrawal by Subject|0|||
161417279|NCT02513472|582916260|FG001|Overall Study|Withdrawal by Subject|4|||
161417280|NCT02513472|582916259|FG000|Overall Study|Subject Choice|2|||
161417281|NCT02513472|582916260|FG001|Overall Study|Subject Choice|7|||
161417282|NCT02513472|582916259|FG000|Overall Study|Treatment Completed as per Protocol|3|||
161417283|NCT02513472|582916260|FG001|Overall Study|Treatment Completed as per Protocol|3|||
161417284|NCT02513472|582916259|FG000|Overall Study|Other|3|||
161417285|NCT02513472|582916260|FG001|Overall Study|Other|6|||
161417286|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
161417287|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
161417288|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
161417289|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Death|0|||
161417290|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Death|2|||
161417291|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Death|0|||
161417292|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
161417293|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
161417294|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
161417295|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
161417296|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
161417297|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
161417298|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
161417299|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
161417300|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
161417301|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
161417302|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
161417303|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
161417304|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
161417305|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
161417306|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
161417307|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Recovery|1|||
161417308|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Recovery|0|||
161417309|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Recovery|1|||
161417310|NCT00195663|582916261|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
161417311|NCT00195663|582916262|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
161417312|NCT00195663|582916263|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
161417313|NCT00195663|582916261|FG000|Open-Label Extension Period|Adverse Event|21|||
161417314|NCT00195663|582916262|FG001|Open-Label Extension Period|Adverse Event|32|||
161417315|NCT00195663|582916263|FG002|Open-Label Extension Period|Adverse Event|36|||
161417316|NCT00195663|582916261|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
161417317|NCT00195663|582916262|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
161417318|NCT00195663|582916263|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
161417319|NCT00195663|582916261|FG000|Open-Label Extension Period|Recovery|0|||
161417320|NCT00195663|582916262|FG001|Open-Label Extension Period|Recovery|2|||
161417321|NCT00195663|582916263|FG002|Open-Label Extension Period|Recovery|2|||
161417322|NCT00195663|582916261|FG000|Open-Label Extension Period|Protocol Violation|3|||
161417323|NCT00195663|582916262|FG001|Open-Label Extension Period|Protocol Violation|4|||
161417324|NCT00195663|582916263|FG002|Open-Label Extension Period|Protocol Violation|4|||
161417325|NCT00195663|582916261|FG000|Open-Label Extension Period|Death|2|||
161417326|NCT00195663|582916262|FG001|Open-Label Extension Period|Death|2|||
161417327|NCT00195663|582916263|FG002|Open-Label Extension Period|Death|2|||
161417328|NCT00195663|582916261|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
161417329|NCT00195663|582916262|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
161417330|NCT00195663|582916263|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
161417331|NCT00195663|582916261|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
161417332|NCT00195663|582916262|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
161417333|NCT00195663|582916263|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
161417334|NCT00195663|582916261|FG000|Open-Label Extension Period|Administrative reasons|11|||
161417335|NCT00195663|582916262|FG001|Open-Label Extension Period|Administrative reasons|11|||
161417336|NCT00195663|582916263|FG002|Open-Label Extension Period|Administrative reasons|13|||
161417337|NCT01380834|582916264|FG000|Overall Study|Physician Decision|1|||
161417338|NCT01380834|582916265|FG001|Overall Study|Physician Decision|0|||
161417339|NCT03214406|582916266|FG000|Overall Study|did not meet enrollment criteria|9|||
161417340|NCT03214406|582916267|FG001|Overall Study|did not meet enrollment criteria|13|||
161417341|NCT03214406|582916266|FG000|Overall Study|Withdrawal by Subject|1|||
161417342|NCT03214406|582916267|FG001|Overall Study|Withdrawal by Subject|0|||
161417343|NCT03214406|582916266|FG000|Overall Study|Lost to Follow-up|0|||
161417344|NCT03214406|582916267|FG001|Overall Study|Lost to Follow-up|2|||
161417345|NCT01098305|582916269|FG000|Overall Study|Lost to Follow-up|31|||
161417346|NCT01098305|582916270|FG001|Overall Study|Lost to Follow-up|33|||
161417347|NCT04677504|582916277|FG000|Overall Study|Death|51|||
161417348|NCT04677504|582916278|FG001|Overall Study|Death|49|||
161417349|NCT04677504|582916277|FG000|Overall Study|Progressive Disease|1|||
161417350|NCT04677504|582916278|FG001|Overall Study|Progressive Disease|0|||
161417351|NCT04677504|582916277|FG000|Overall Study|Symptomatic Deterioration|1|||
161417352|NCT04677504|582916278|FG001|Overall Study|Symptomatic Deterioration|0|||
161417353|NCT04677504|582916277|FG000|Overall Study|Withdrawal by Subject|2|||
161417354|NCT04677504|582916278|FG001|Overall Study|Withdrawal by Subject|5|||
161417355|NCT04677504|582916277|FG000|Overall Study|Study Terminated By Sponsor|28|||
161417356|NCT04677504|582916278|FG001|Overall Study|Study Terminated By Sponsor|24|||
161417357|NCT04677504|582916277|FG000|Overall Study|Adverse Event|0|||
161417358|NCT04677504|582916278|FG001|Overall Study|Adverse Event|1|||
161417359|NCT03182907|582916279|FG000|Overall Study|Death|3|||
161417360|NCT03182907|582916280|FG001|Overall Study|Death|0|||
161417361|NCT03182907|582916279|FG000|Overall Study|Protocol Violation|4|||
161417362|NCT03182907|582916280|FG001|Overall Study|Protocol Violation|0|||
161417363|NCT03182907|582916279|FG000|Overall Study|Lost to Follow-up|1|||
161417364|NCT03182907|582916280|FG001|Overall Study|Lost to Follow-up|0|||
161417365|NCT03182907|582916279|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161417366|NCT03182907|582916280|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161417367|NCT01711645|582916283|FG000|Overall Study|Withdrawal by Subject|8|||
161417368|NCT01711645|582916283|FG000|Overall Study|Lost to Follow-up|6|||
161417369|NCT01711645|582916283|FG000|Overall Study|Physician Decision|5|||
161417370|NCT01746173|582916288|FG000|Overall Study|Disease Progression|2|||
161417371|NCT00375518|582916289|FG000|Overall Study|Withdrawal by Subject|2|||
161417372|NCT00375518|582916290|FG001|Overall Study|Withdrawal by Subject|10|||
161417373|NCT00375518|582916289|FG000|Overall Study|Patient Not Treated|6|||
161417374|NCT00375518|582916290|FG001|Overall Study|Patient Not Treated|6|||
161417375|NCT00375518|582916289|FG000|Overall Study|Death|0|||
161417376|NCT00375518|582916290|FG001|Overall Study|Death|1|||
161417377|NCT03170193|582916291|FG000|Overall Study|Withdrawal by Subject|0|||
161417378|NCT03170193|582916292|FG001|Overall Study|Withdrawal by Subject|0|||
161417379|NCT03170193|582916293|FG002|Overall Study|Withdrawal by Subject|0|||
161417380|NCT03170193|582916294|FG003|Overall Study|Withdrawal by Subject|1|||
161417381|NCT03170193|582916295|FG004|Overall Study|Withdrawal by Subject|0|||
161417382|NCT03170193|582916296|FG005|Overall Study|Withdrawal by Subject|0|||
161417383|NCT03170193|582916297|FG006|Overall Study|Withdrawal by Subject|0|||
161417384|NCT03170193|582916291|FG000|Overall Study|Lost to Follow-up|1|||
161417385|NCT03170193|582916292|FG001|Overall Study|Lost to Follow-up|1|||
161417386|NCT03170193|582916293|FG002|Overall Study|Lost to Follow-up|0|||
161417387|NCT03170193|582916294|FG003|Overall Study|Lost to Follow-up|0|||
161417388|NCT03170193|582916295|FG004|Overall Study|Lost to Follow-up|0|||
161417389|NCT03170193|582916296|FG005|Overall Study|Lost to Follow-up|0|||
161417390|NCT03170193|582916297|FG006|Overall Study|Lost to Follow-up|0|||
161417391|NCT02560012|582916298|FG000|Overall Study|Study Terminated|2|||
161417392|NCT03052816|582916299|FG000|Overall Study|Withdrawal by Subject|1|||
161417393|NCT03052816|582916300|FG001|Overall Study|Withdrawal by Subject|0|||
161417394|NCT03052816|582916299|FG000|Overall Study|Desired opioids|2|||
161417395|NCT03052816|582916300|FG001|Overall Study|Desired opioids|0|||
161417396|NCT02218008|582916301|FG000|Stage 1 (S1)|Adverse Event|6|||
161417397|NCT02218008|582916302|FG001|Stage 1 (S1)|Adverse Event|5|||
161417398|NCT02218008|582916303|FG002|Stage 1 (S1)|Adverse Event|11|||
161417399|NCT02218008|582916304|FG003|Stage 1 (S1)|Adverse Event|0|||
161417400|NCT02218008|582916305|FG004|Stage 1 (S1)|Adverse Event|0|||
161417401|NCT02218008|582916306|FG005|Stage 1 (S1)|Adverse Event|0|||
161417402|NCT02218008|582916301|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
161417403|NCT02218008|582916302|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
161417404|NCT02218008|582916303|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
161417405|NCT02218008|582916304|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
161417406|NCT02218008|582916305|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
161417407|NCT02218008|582916306|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
161417408|NCT02218008|582916301|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
161417409|NCT02218008|582916302|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
161417410|NCT02218008|582916303|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
161417411|NCT02218008|582916304|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
161417412|NCT02218008|582916305|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
161417413|NCT02218008|582916306|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
161417414|NCT02218008|582916301|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
161417415|NCT02218008|582916302|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
161417416|NCT02218008|582916303|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
161417417|NCT02218008|582916304|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
161417418|NCT02218008|582916305|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
161417419|NCT02218008|582916306|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
161417420|NCT02218008|582916301|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
161417421|NCT02218008|582916302|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
161417422|NCT02218008|582916303|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161417423|NCT02218008|582916304|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161417424|NCT02218008|582916305|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161417425|NCT02218008|582916306|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161417426|NCT02218008|582916301|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
161417427|NCT02218008|582916302|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
161417428|NCT02218008|582916303|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
161417429|NCT02218008|582916304|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
161417430|NCT02218008|582916305|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
161417431|NCT02218008|582916306|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
161417432|NCT02218008|582916301|FG000|Stage 1 (S1)|Pregnancy|0|||
161417433|NCT02218008|582916302|FG001|Stage 1 (S1)|Pregnancy|0|||
161417434|NCT02218008|582916303|FG002|Stage 1 (S1)|Pregnancy|1|||
161417435|NCT02218008|582916304|FG003|Stage 1 (S1)|Pregnancy|0|||
161417436|NCT02218008|582916305|FG004|Stage 1 (S1)|Pregnancy|0|||
161417437|NCT02218008|582916306|FG005|Stage 1 (S1)|Pregnancy|0|||
161417438|NCT02218008|582916301|FG000|Stage 1 (S1)|Protocol Violation|0|||
161417439|NCT02218008|582916302|FG001|Stage 1 (S1)|Protocol Violation|0|||
161417440|NCT02218008|582916303|FG002|Stage 1 (S1)|Protocol Violation|1|||
161417441|NCT02218008|582916304|FG003|Stage 1 (S1)|Protocol Violation|0|||
161417442|NCT02218008|582916305|FG004|Stage 1 (S1)|Protocol Violation|0|||
161417443|NCT02218008|582916306|FG005|Stage 1 (S1)|Protocol Violation|0|||
161417444|NCT02218008|582916301|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
161417445|NCT02218008|582916302|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161417446|NCT02218008|582916303|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161417447|NCT02218008|582916304|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161417448|NCT02218008|582916305|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161417449|NCT02218008|582916306|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161417450|NCT02218008|582916301|FG000|Stage 2 (S2)|Adverse Event|0|||
161417451|NCT02218008|582916302|FG001|Stage 2 (S2)|Adverse Event|0|||
161417452|NCT02218008|582916303|FG002|Stage 2 (S2)|Adverse Event|0|||
161417453|NCT02218008|582916304|FG003|Stage 2 (S2)|Adverse Event|2|||
161417454|NCT02218008|582916305|FG004|Stage 2 (S2)|Adverse Event|3|||
161417455|NCT02218008|582916306|FG005|Stage 2 (S2)|Adverse Event|3|||
161417456|NCT02218008|582916301|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
161417457|NCT02218008|582916302|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
161417458|NCT02218008|582916303|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
161417459|NCT02218008|582916304|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
161417460|NCT02218008|582916305|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
161417461|NCT02218008|582916306|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
161417462|NCT02218008|582916301|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
161417463|NCT02218008|582916302|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
161417464|NCT02218008|582916303|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
161417465|NCT02218008|582916304|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
161417466|NCT02218008|582916305|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
161417467|NCT02218008|582916306|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
161417468|NCT02218008|582916301|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161417469|NCT02218008|582916302|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161417470|NCT02218008|582916303|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161417471|NCT02218008|582916304|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
161417472|NCT02218008|582916305|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161417473|NCT02218008|582916306|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161417474|NCT02218008|582916301|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
161417475|NCT02218008|582916302|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
161417476|NCT02218008|582916303|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
161417477|NCT02218008|582916304|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
161417478|NCT02218008|582916305|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
161417479|NCT02218008|582916306|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
161417480|NCT00408434|582916307|FG000|Overall Study|Adverse Event|0|||
161417481|NCT00408434|582916308|FG001|Overall Study|Adverse Event|0|||
161417482|NCT00408434|582916309|FG002|Overall Study|Adverse Event|1|||
161417483|NCT00408434|582916310|FG003|Overall Study|Adverse Event|0|||
161417484|NCT00408434|582916311|FG004|Overall Study|Adverse Event|0|||
161417485|NCT00408434|582916312|FG005|Overall Study|Adverse Event|0|||
161417486|NCT00408434|582916313|FG006|Overall Study|Adverse Event|0|||
161417487|NCT00408434|582916307|FG000|Overall Study|Progressive disease|6|||
161417488|NCT00408434|582916308|FG001|Overall Study|Progressive disease|3|||
161417489|NCT00408434|582916309|FG002|Overall Study|Progressive disease|4|||
161417490|NCT00408434|582916310|FG003|Overall Study|Progressive disease|3|||
161417491|NCT00408434|582916311|FG004|Overall Study|Progressive disease|3|||
161417492|NCT00408434|582916312|FG005|Overall Study|Progressive disease|1|||
161417493|NCT00408434|582916313|FG006|Overall Study|Progressive disease|4|||
161417494|NCT00408434|582916307|FG000|Overall Study|Other|0|||
161417495|NCT00408434|582916308|FG001|Overall Study|Other|0|||
161417496|NCT00408434|582916309|FG002|Overall Study|Other|1|||
161417497|NCT00408434|582916310|FG003|Overall Study|Other|0|||
161417498|NCT00408434|582916311|FG004|Overall Study|Other|2|||
161417499|NCT00408434|582916312|FG005|Overall Study|Other|1|||
161417500|NCT00408434|582916313|FG006|Overall Study|Other|0|||
161417501|NCT00408434|582916307|FG000|Overall Study|Terminated by Investigator|0|||
161417502|NCT00408434|582916308|FG001|Overall Study|Terminated by Investigator|0|||
161417503|NCT00408434|582916309|FG002|Overall Study|Terminated by Investigator|0|||
161417504|NCT00408434|582916310|FG003|Overall Study|Terminated by Investigator|0|||
161417505|NCT00408434|582916311|FG004|Overall Study|Terminated by Investigator|1|||
161417506|NCT00408434|582916312|FG005|Overall Study|Terminated by Investigator|1|||
161417507|NCT00408434|582916313|FG006|Overall Study|Terminated by Investigator|0|||
161417508|NCT03304873|582916314|FG000|Overall Study|Lost to Follow-up|1|||
161417509|NCT03304873|582916315|FG001|Overall Study|Lost to Follow-up|8|||
161417510|NCT00400569|582916316|FG000|Overall Study|Death|1|||
161417511|NCT00620113|582916319|FG000|Overall Study|Adverse Event|3|||
161417512|NCT00620113|582916320|FG001|Overall Study|Adverse Event|2|||
161417513|NCT00620113|582916321|FG002|Overall Study|Adverse Event|2|||
161417514|NCT00620113|582916322|FG003|Overall Study|Adverse Event|1|||
161417515|NCT00620113|582916319|FG000|Overall Study|Lack of Efficacy|2|||
161417516|NCT00620113|582916320|FG001|Overall Study|Lack of Efficacy|3|||
161417517|NCT00620113|582916321|FG002|Overall Study|Lack of Efficacy|0|||
161417518|NCT00620113|582916322|FG003|Overall Study|Lack of Efficacy|2|||
161417519|NCT00620113|582916319|FG000|Overall Study|Physician Decision|1|||
161417520|NCT00620113|582916320|FG001|Overall Study|Physician Decision|0|||
161417521|NCT00620113|582916321|FG002|Overall Study|Physician Decision|0|||
161417522|NCT00620113|582916322|FG003|Overall Study|Physician Decision|2|||
161417523|NCT00620113|582916319|FG000|Overall Study|Protocol Violation|2|||
161417524|NCT00620113|582916320|FG001|Overall Study|Protocol Violation|1|||
161417525|NCT00620113|582916321|FG002|Overall Study|Protocol Violation|0|||
161417526|NCT00620113|582916322|FG003|Overall Study|Protocol Violation|0|||
161417527|NCT00620113|582916319|FG000|Overall Study|Withdrawal by Subject|5|||
161417528|NCT00620113|582916320|FG001|Overall Study|Withdrawal by Subject|1|||
161417529|NCT00620113|582916321|FG002|Overall Study|Withdrawal by Subject|3|||
161417530|NCT00620113|582916322|FG003|Overall Study|Withdrawal by Subject|5|||
161417531|NCT00042991|582916323|FG000|Overall Study|Adverse Event|1|||
161417532|NCT00042991|582916324|FG001|Overall Study|Adverse Event|4|||
161417533|NCT00042991|582916325|FG002|Overall Study|Adverse Event|2|||
161417534|NCT00042991|582916326|FG003|Overall Study|Adverse Event|0|||
161417535|NCT00042991|582916327|FG004|Overall Study|Adverse Event|0|||
161417536|NCT00042991|582916328|FG005|Overall Study|Adverse Event|1|||
161417537|NCT00042991|582916329|FG006|Overall Study|Adverse Event|0|||
161417538|NCT00042991|582916323|FG000|Overall Study|Withdrawal by Subject|0|||
161417539|NCT00042991|582916324|FG001|Overall Study|Withdrawal by Subject|7|||
161417540|NCT00042991|582916325|FG002|Overall Study|Withdrawal by Subject|2|||
161417541|NCT00042991|582916326|FG003|Overall Study|Withdrawal by Subject|0|||
161417542|NCT00042991|582916327|FG004|Overall Study|Withdrawal by Subject|1|||
161417543|NCT00042991|582916328|FG005|Overall Study|Withdrawal by Subject|0|||
161417544|NCT00042991|582916329|FG006|Overall Study|Withdrawal by Subject|0|||
161417545|NCT00042991|582916323|FG000|Overall Study|Disease Progression|5|||
161417546|NCT00042991|582916324|FG001|Overall Study|Disease Progression|29|||
161417547|NCT00042991|582916325|FG002|Overall Study|Disease Progression|2|||
161417548|NCT00042991|582916326|FG003|Overall Study|Disease Progression|2|||
161417549|NCT00042991|582916327|FG004|Overall Study|Disease Progression|1|||
161417550|NCT00042991|582916328|FG005|Overall Study|Disease Progression|4|||
161417551|NCT00042991|582916329|FG006|Overall Study|Disease Progression|2|||
161417552|NCT00042991|582916323|FG000|Overall Study|Alternative Therapy|0|||
161417553|NCT00042991|582916324|FG001|Overall Study|Alternative Therapy|0|||
161417554|NCT00042991|582916325|FG002|Overall Study|Alternative Therapy|0|||
161417555|NCT00042991|582916326|FG003|Overall Study|Alternative Therapy|0|||
161417556|NCT00042991|582916327|FG004|Overall Study|Alternative Therapy|1|||
161417557|NCT00042991|582916328|FG005|Overall Study|Alternative Therapy|0|||
161417558|NCT00042991|582916329|FG006|Overall Study|Alternative Therapy|0|||
161417559|NCT00856297|582916332|FG000|Overall Study|Unable to classify|2|||
161417560|NCT00856297|582916333|FG001|Overall Study|Unable to classify|0|||
161417561|NCT00856297|582916334|FG002|Overall Study|Unable to classify|0|||
161417562|NCT00856297|582916335|FG003|Overall Study|Unable to classify|0|||
161417563|NCT00856297|582916336|FG004|Overall Study|Unable to classify|0|||
161417564|NCT03369236|582916339|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
161417565|NCT03369236|582916340|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
161417566|NCT03369236|582916339|FG000|Open-label Extension Period|Lack of Efficacy|2|||
161417567|NCT03369236|582916340|FG001|Open-label Extension Period|Lack of Efficacy|1|||
161417568|NCT03369236|582916339|FG000|Open-label Extension Period|Adverse Event|0|||
161417569|NCT03369236|582916340|FG001|Open-label Extension Period|Adverse Event|1|||
161417570|NCT03369236|582916339|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
161417571|NCT03369236|582916340|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
161417572|NCT02508428|582916346|FG000|Overall Study|Death|32|||
161417573|NCT02508428|582916347|FG001|Overall Study|Death|33|||
161417574|NCT02508428|582916346|FG000|Overall Study|Liner revised|3|||
161417575|NCT02508428|582916347|FG001|Overall Study|Liner revised|19|||
161417576|NCT02508428|582916346|FG000|Overall Study|Incomplete follow-up|17|||
161417577|NCT02508428|582916347|FG001|Overall Study|Incomplete follow-up|15|||
161417578|NCT00806988|582917893|FG000|Overall Study|Death|15|||
161417579|NCT00806988|582917894|FG001|Overall Study|Death|16|||
161417580|NCT00806988|582917893|FG000|Overall Study|Withdrawal by Subject|8|||
161417581|NCT00806988|582917894|FG001|Overall Study|Withdrawal by Subject|8|||
161417582|NCT00806988|582917893|FG000|Overall Study|Lost to Follow-up|4|||
161417583|NCT00806988|582917894|FG001|Overall Study|Lost to Follow-up|19|||
161417584|NCT04775953|582917896|FG000|Overall Study|Lost to Follow-up|6|||
161417585|NCT04775953|582917897|FG001|Overall Study|Lost to Follow-up|11|||
161417586|NCT04775953|582917896|FG000|Overall Study|Death|5|||
161417587|NCT04775953|582917897|FG001|Overall Study|Death|4|||
161417588|NCT04775953|582917896|FG000|Overall Study|Withdrawal by Subject|3|||
161417589|NCT04775953|582917897|FG001|Overall Study|Withdrawal by Subject|3|||
161417590|NCT04775953|582917896|FG000|Overall Study|Protocol Violation|2|||
161417591|NCT04775953|582917897|FG001|Overall Study|Protocol Violation|0|||
161417592|NCT04775953|582917896|FG000|Overall Study|Participant non-compliance|0|||
161417593|NCT04775953|582917897|FG001|Overall Study|Participant non-compliance|1|||
161417594|NCT01698814|582917898|FG000|Overall Study|Adverse Event|0|||
161417595|NCT01698814|582917899|FG001|Overall Study|Adverse Event|2|||
161417596|NCT01698814|582917898|FG000|Overall Study|Lost to Follow-up|0|||
161417597|NCT01698814|582917899|FG001|Overall Study|Lost to Follow-up|1|||
161417598|NCT01698814|582917898|FG000|Overall Study|Pregnancy|1|||
161417599|NCT01698814|582917899|FG001|Overall Study|Pregnancy|0|||
161417600|NCT01698814|582917898|FG000|Overall Study|Randomized in error|1|||
161417601|NCT01698814|582917899|FG001|Overall Study|Randomized in error|0|||
161417602|NCT00368641|582917902|FG000|Overall Study|Adverse Event|2|||
161417603|NCT00368641|582917903|FG001|Overall Study|Adverse Event|1|||
161417604|NCT00368641|582917902|FG000|Overall Study|Death|1|||
161417605|NCT00368641|582917903|FG001|Overall Study|Death|0|||
161417606|NCT00368641|582917902|FG000|Overall Study|Withdrawal by Subject|1|||
161417607|NCT00368641|582917903|FG001|Overall Study|Withdrawal by Subject|0|||
161417608|NCT00368641|582917902|FG000|Overall Study|Sponsor decision to terminate study|2|||
161417609|NCT00368641|582917903|FG001|Overall Study|Sponsor decision to terminate study|5|||
161417610|NCT01424501|582917904|FG000|Overall Study|Withdrawal by Subject|1|||
161417611|NCT01424501|582917905|FG001|Overall Study|Withdrawal by Subject|0|||
161417612|NCT01424501|582917906|FG002|Overall Study|Withdrawal by Subject|1|||
161417613|NCT01424501|582917907|FG003|Overall Study|Withdrawal by Subject|0|||
161417614|NCT01424501|582917908|FG004|Overall Study|Withdrawal by Subject|0|||
161417615|NCT01424501|582917909|FG005|Overall Study|Withdrawal by Subject|0|||
161417616|NCT01424501|582917904|FG000|Overall Study|Lost to Follow-up|0|||
161417617|NCT01424501|582917905|FG001|Overall Study|Lost to Follow-up|1|||
161417618|NCT01424501|582917906|FG002|Overall Study|Lost to Follow-up|1|||
161417619|NCT01424501|582917907|FG003|Overall Study|Lost to Follow-up|0|||
161417620|NCT01424501|582917908|FG004|Overall Study|Lost to Follow-up|0|||
161417621|NCT01424501|582917909|FG005|Overall Study|Lost to Follow-up|0|||
161417622|NCT01980095|582917910|FG000|Overall Study|Lost to Follow-up|6|||
161417623|NCT01980095|582917911|FG001|Overall Study|Lost to Follow-up|7|||
161417624|NCT01980095|582917910|FG000|Overall Study|Withdrawal by Subject|2|||
161417625|NCT01980095|582917911|FG001|Overall Study|Withdrawal by Subject|3|||
161417626|NCT01980095|582917910|FG000|Overall Study|Poor compliance|5|||
161417627|NCT01980095|582917911|FG001|Overall Study|Poor compliance|0|||
161417628|NCT01980095|582917910|FG000|Overall Study|Safety issue|0|||
161417629|NCT01980095|582917911|FG001|Overall Study|Safety issue|1|||
161417630|NCT01980095|582917910|FG000|Overall Study|Study drug discontinued|1|||
161417631|NCT01980095|582917911|FG001|Overall Study|Study drug discontinued|0|||
161417632|NCT01980095|582917910|FG000|Overall Study|Randomized by mistake|1|||
161417633|NCT01980095|582917911|FG001|Overall Study|Randomized by mistake|0|||
161417634|NCT03920254|582917912|FG000|Overall Study|Adverse Event|1|||
161417635|NCT03920254|582917913|FG001|Overall Study|Adverse Event|0|||
161417636|NCT03920254|582917914|FG002|Overall Study|Adverse Event|0|||
161417637|NCT03920254|582917912|FG000|Overall Study|Physician Decision|0|||
161417638|NCT03920254|582917913|FG001|Overall Study|Physician Decision|1|||
161417639|NCT03920254|582917914|FG002|Overall Study|Physician Decision|2|||
161417640|NCT03920254|582917912|FG000|Overall Study|Study Terminated By Sponsor|12|||
161417641|NCT03920254|582917913|FG001|Overall Study|Study Terminated By Sponsor|17|||
161417642|NCT03920254|582917914|FG002|Overall Study|Study Terminated By Sponsor|12|||
161417643|NCT03920254|582917912|FG000|Overall Study|Withdrawal by Subject|0|||
161417644|NCT03920254|582917913|FG001|Overall Study|Withdrawal by Subject|0|||
161417645|NCT03920254|582917914|FG002|Overall Study|Withdrawal by Subject|1|||
161417646|NCT05274269|582917915|FG000|Overall Study|Adverse Event|0|||
161417647|NCT05274269|582917916|FG001|Overall Study|Adverse Event|3|||
161417648|NCT05274269|582917915|FG000|Overall Study|Death|0|||
161417649|NCT05274269|582917916|FG001|Overall Study|Death|1|||
161417650|NCT05274269|582917915|FG000|Overall Study|Other|0|||
161417651|NCT05274269|582917916|FG001|Overall Study|Other|2|||
161417652|NCT05274269|582917915|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161417653|NCT05274269|582917916|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161417654|NCT05636852|582917917|FG000|Overall Study|Withdrawal by Subject|1|||
161417655|NCT05636852|582917917|FG000|Overall Study|Other than specified|1|||
161417656|NCT00709618|582917918|FG000|Overall Study|Withdrawal by Subject|4|||
161417657|NCT00709618|582917918|FG000|Overall Study|Lost to Follow-up|1|||
161417658|NCT00709618|582917918|FG000|Overall Study|Study Closed/Terminated|25|||
161417659|NCT01415401|582917926|FG000|Overall Study|Adverse Event|5|||
161417660|NCT01415401|582917926|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
161417661|NCT01415401|582917926|FG000|Overall Study|Terminated by Sponsor|1|||
161417662|NCT01746225|582917929|FG000|Overall Study|Death|1|||
161417663|NCT01746225|582917930|FG001|Overall Study|Death|0|||
161417664|NCT01746225|582917931|FG002|Overall Study|Death|1|||
161417665|NCT01746225|582917929|FG000|Overall Study|Withdrawal by Subject|5|||
161417666|NCT01746225|582917930|FG001|Overall Study|Withdrawal by Subject|15|||
161417667|NCT01746225|582917931|FG002|Overall Study|Withdrawal by Subject|19|||
161417668|NCT01746225|582917929|FG000|Overall Study|Physician Decision|14|||
161417669|NCT01746225|582917930|FG001|Overall Study|Physician Decision|11|||
161417670|NCT01746225|582917931|FG002|Overall Study|Physician Decision|3|||
161417671|NCT01746225|582917929|FG000|Overall Study|Adverse Event|15|||
161417672|NCT01746225|582917930|FG001|Overall Study|Adverse Event|12|||
161417673|NCT01746225|582917931|FG002|Overall Study|Adverse Event|17|||
161417674|NCT01746225|582917929|FG000|Overall Study|Continuing Treatment|5|||
161417675|NCT01746225|582917930|FG001|Overall Study|Continuing Treatment|8|||
161417676|NCT01746225|582917931|FG002|Overall Study|Continuing Treatment|3|||
161417677|NCT00595478|582917932|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
161417678|NCT00595478|582917933|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
161417679|NCT00595478|582917932|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
161417680|NCT00595478|582917933|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
161417681|NCT02713828|582917936|FG000|Overall Study|Death|2|||
161417682|NCT02713828|582917937|FG001|Overall Study|Death|0|||
161417683|NCT02713828|582917936|FG000|Overall Study|Withdrawal by Subject|1|||
161417684|NCT02713828|582917937|FG001|Overall Study|Withdrawal by Subject|0|||
161417685|NCT02713828|582917936|FG000|Overall Study|study terminated but patient allowed to|2|||
161417686|NCT02713828|582917937|FG001|Overall Study|study terminated but patient allowed to|0|||
161417687|NCT03302247|582917938|FG000|Overall Study|the study has closed prematurely|2|||
161417688|NCT03302247|582917938|FG000|Overall Study|Death|1|||
161417689|NCT02305238|582917939|FG000|Overall Study|Death|2|||
161417690|NCT02305238|582917940|FG001|Overall Study|Death|1|||
161417691|NCT02305238|582917941|FG002|Overall Study|Death|0|||
161417692|NCT02305238|582917939|FG000|Overall Study|Progressive disease|4|||
161417693|NCT02305238|582917940|FG001|Overall Study|Progressive disease|4|||
161417694|NCT02305238|582917941|FG002|Overall Study|Progressive disease|0|||
161417695|NCT02305238|582917939|FG000|Overall Study|Logistical difficulties|1|||
161417696|NCT02305238|582917940|FG001|Overall Study|Logistical difficulties|3|||
161417697|NCT02305238|582917941|FG002|Overall Study|Logistical difficulties|0|||
161417698|NCT02305238|582917939|FG000|Overall Study|Protocol Violation|0|||
161417699|NCT02305238|582917940|FG001|Overall Study|Protocol Violation|3|||
161417700|NCT02305238|582917941|FG002|Overall Study|Protocol Violation|0|||
161417701|NCT02305238|582917939|FG000|Overall Study|Physician Decision|2|||
161417702|NCT02305238|582917940|FG001|Overall Study|Physician Decision|1|||
161417703|NCT02305238|582917941|FG002|Overall Study|Physician Decision|0|||
161417704|NCT02305238|582917939|FG000|Overall Study|Adverse Event|4|||
161417705|NCT02305238|582917940|FG001|Overall Study|Adverse Event|2|||
161417706|NCT02305238|582917941|FG002|Overall Study|Adverse Event|0|||
161417707|NCT02305238|582917939|FG000|Overall Study|Withdrawal by Subject|3|||
161417708|NCT02305238|582917940|FG001|Overall Study|Withdrawal by Subject|4|||
161417709|NCT02305238|582917941|FG002|Overall Study|Withdrawal by Subject|0|||
161417710|NCT02305238|582917939|FG000|Overall Study|Randomized failure|0|||
161417711|NCT02305238|582917940|FG001|Overall Study|Randomized failure|0|||
161417712|NCT02305238|582917941|FG002|Overall Study|Randomized failure|8|||
161417713|NCT02305238|582917939|FG000|Overall Study|Required procedure failed|0|||
161417714|NCT02305238|582917940|FG001|Overall Study|Required procedure failed|1|||
161417715|NCT02305238|582917941|FG002|Overall Study|Required procedure failed|0|||
161417716|NCT01019369|582917942|FG000|Overall Study|Lost to Follow-up|10|||
161417717|NCT01019369|582917943|FG001|Overall Study|Lost to Follow-up|6|||
161417718|NCT01019369|582917942|FG000|Overall Study|Withdrawal by Subject|0|||
161417719|NCT01019369|582917943|FG001|Overall Study|Withdrawal by Subject|1|||
161417720|NCT00604695|582917944|FG000|Overall Study|Did not receive first bolus.|0|||
161417721|NCT00604695|582917945|FG001|Overall Study|Did not receive first bolus.|4|||
161417722|NCT04310566|582917948|FG000|Period 1|Study Termination due to COVID-19|15|||
161417723|NCT04310566|582917949|FG001|Period 1|Study Termination due to COVID-19|17|||
161417724|NCT04310566|582917948|FG000|Period 1|Protocol Violation|0|||
161417725|NCT04310566|582917949|FG001|Period 1|Protocol Violation|1|||
161417726|NCT04310566|582917948|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
161417727|NCT04310566|582917949|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
161417728|NCT04310566|582917948|FG000|Period 1|Lost to Follow-up|1|||
161417729|NCT04310566|582917949|FG001|Period 1|Lost to Follow-up|0|||
161417730|NCT04310566|582917948|FG000|Period 1|Withdrawal by Subject|0|||
161417731|NCT04310566|582917949|FG001|Period 1|Withdrawal by Subject|1|||
161417732|NCT04310566|582917948|FG000|Period 2|Study Termination|7|||
161417733|NCT04310566|582917949|FG001|Period 2|Study Termination|5|||
161417734|NCT00172042|582917951|FG000|Overall Study|Adverse Event|27|||
161417735|NCT00172042|582917952|FG001|Overall Study|Adverse Event|13|||
161417736|NCT00172042|582917951|FG000|Overall Study|Abnormal laboratory value(s)|5|||
161417737|NCT00172042|582917952|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161417738|NCT00172042|582917951|FG000|Overall Study|Abnormal test procedure(s)|0|||
161417739|NCT00172042|582917952|FG001|Overall Study|Abnormal test procedure(s)|3|||
161417740|NCT00172042|582917951|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
161417741|NCT00172042|582917952|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
161417742|NCT00172042|582917951|FG000|Overall Study|Patient no longer requires study drug|10|||
161417743|NCT00172042|582917952|FG001|Overall Study|Patient no longer requires study drug|8|||
161417744|NCT00172042|582917951|FG000|Overall Study|Protocol Violation|8|||
161417745|NCT00172042|582917952|FG001|Overall Study|Protocol Violation|7|||
161417746|NCT00172042|582917951|FG000|Overall Study|Withdrawal by Subject|37|||
161417747|NCT00172042|582917952|FG001|Overall Study|Withdrawal by Subject|25|||
161417748|NCT00172042|582917951|FG000|Overall Study|Lost to Follow-up|3|||
161417749|NCT00172042|582917952|FG001|Overall Study|Lost to Follow-up|5|||
161417750|NCT00172042|582917951|FG000|Overall Study|Administrative problems|13|||
161417751|NCT00172042|582917952|FG001|Overall Study|Administrative problems|10|||
161417752|NCT00172042|582917951|FG000|Overall Study|Death|42|||
161417753|NCT00172042|582917952|FG001|Overall Study|Death|42|||
161417754|NCT00384332|582917953|FG000|Overall Study|Lost to Follow-up|4|||
161417755|NCT00384332|582917954|FG001|Overall Study|Lost to Follow-up|0|||
161417756|NCT01771250|582917955|FG000|Period 1|Met exclusion criteria|1|||
161417757|NCT01771250|582917956|FG001|Period 1|Met exclusion criteria|0|||
161417758|NCT02058563|582917957|FG000|Overall Study|Lost to Follow-up|26|||
161417759|NCT02058563|582917958|FG001|Overall Study|Lost to Follow-up|22|||
161417760|NCT02058563|582917957|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
161417761|NCT02058563|582917958|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
161417762|NCT02058563|582917957|FG000|Overall Study|Consent Withdrawal|1|||
161417763|NCT02058563|582917958|FG001|Overall Study|Consent Withdrawal|1|||
161417764|NCT02058563|582917957|FG000|Overall Study|Other (patient incarcerated)|0|||
161417765|NCT02058563|582917958|FG001|Overall Study|Other (patient incarcerated)|1|||
161417766|NCT00166439|582917959|FG000|Overall Study|Ineligible|5|||
161417767|NCT01180296|582917960|FG000|Overall Study|Protocol Violation|1|||
161417768|NCT01180296|582917961|FG001|Overall Study|Protocol Violation|2|||
161417769|NCT00483938|582917962|FG000|Overall Study|Protocol Violation|0|||
161417770|NCT00483938|582917963|FG001|Overall Study|Protocol Violation|0|||
161417771|NCT00483938|582917964|FG002|Overall Study|Protocol Violation|0|||
161417772|NCT00483938|582917965|FG003|Overall Study|Protocol Violation|0|||
161417773|NCT00483938|582917966|FG004|Overall Study|Protocol Violation|0|||
161417774|NCT00483938|582917967|FG005|Overall Study|Protocol Violation|0|||
161417775|NCT00483938|582917968|FG006|Overall Study|Protocol Violation|3|||
161417776|NCT00483938|582917962|FG000|Overall Study|Withdrawal by Subject|1|||
161417777|NCT00483938|582917963|FG001|Overall Study|Withdrawal by Subject|6|||
161417778|NCT00483938|582917964|FG002|Overall Study|Withdrawal by Subject|0|||
161417779|NCT00483938|582917965|FG003|Overall Study|Withdrawal by Subject|0|||
161417780|NCT00483938|582917966|FG004|Overall Study|Withdrawal by Subject|1|||
161417781|NCT00483938|582917967|FG005|Overall Study|Withdrawal by Subject|3|||
161417782|NCT00483938|582917968|FG006|Overall Study|Withdrawal by Subject|2|||
161417783|NCT00483938|582917962|FG000|Overall Study|Lost to Follow-up|1|||
161417784|NCT00483938|582917963|FG001|Overall Study|Lost to Follow-up|2|||
161417785|NCT00483938|582917964|FG002|Overall Study|Lost to Follow-up|0|||
161417786|NCT00483938|582917965|FG003|Overall Study|Lost to Follow-up|2|||
161417787|NCT00483938|582917966|FG004|Overall Study|Lost to Follow-up|1|||
161417788|NCT00483938|582917967|FG005|Overall Study|Lost to Follow-up|1|||
161417789|NCT00483938|582917968|FG006|Overall Study|Lost to Follow-up|3|||
161417790|NCT00483938|582917962|FG000|Overall Study|Death|0|||
161417791|NCT00483938|582917963|FG001|Overall Study|Death|2|||
161417792|NCT00483938|582917964|FG002|Overall Study|Death|0|||
161417793|NCT00483938|582917965|FG003|Overall Study|Death|0|||
161417794|NCT00483938|582917966|FG004|Overall Study|Death|0|||
161417795|NCT00483938|582917967|FG005|Overall Study|Death|0|||
161417796|NCT00483938|582917968|FG006|Overall Study|Death|0|||
161417797|NCT00483938|582917962|FG000|Overall Study|Other|3|||
161417798|NCT00483938|582917963|FG001|Overall Study|Other|9|||
161417799|NCT00483938|582917964|FG002|Overall Study|Other|0|||
161417800|NCT00483938|582917965|FG003|Overall Study|Other|4|||
161417801|NCT00483938|582917966|FG004|Overall Study|Other|0|||
161417802|NCT00483938|582917967|FG005|Overall Study|Other|4|||
161417803|NCT00483938|582917968|FG006|Overall Study|Other|32|||
161417804|NCT00106353|582917975|FG000|Part 1|Disease progression|3|||
161417805|NCT00106353|582917976|FG001|Part 1|Disease progression|4|||
161417806|NCT00106353|582917977|FG002|Part 1|Disease progression|1|||
161417807|NCT00106353|582917978|FG003|Part 1|Disease progression|3|||
161417808|NCT00106353|582917979|FG004|Part 1|Disease progression|0|||
161417809|NCT00106353|582917980|FG005|Part 1|Disease progression|0|||
161417810|NCT00106353|582917981|FG006|Part 1|Disease progression|0|||
161417811|NCT00106353|582917975|FG000|Part 1|Withdrawal by Subject|0|||
161417812|NCT00106353|582917976|FG001|Part 1|Withdrawal by Subject|0|||
161417813|NCT00106353|582917977|FG002|Part 1|Withdrawal by Subject|1|||
161417814|NCT00106353|582917978|FG003|Part 1|Withdrawal by Subject|2|||
161417815|NCT00106353|582917979|FG004|Part 1|Withdrawal by Subject|0|||
161417816|NCT00106353|582917980|FG005|Part 1|Withdrawal by Subject|0|||
161417817|NCT00106353|582917981|FG006|Part 1|Withdrawal by Subject|0|||
161417818|NCT00106353|582917975|FG000|Part 1|Symptomatic deterioration|0|||
161417819|NCT00106353|582917976|FG001|Part 1|Symptomatic deterioration|0|||
161417820|NCT00106353|582917977|FG002|Part 1|Symptomatic deterioration|1|||
161417821|NCT00106353|582917978|FG003|Part 1|Symptomatic deterioration|0|||
161417822|NCT00106353|582917979|FG004|Part 1|Symptomatic deterioration|0|||
161417823|NCT00106353|582917980|FG005|Part 1|Symptomatic deterioration|0|||
161417824|NCT00106353|582917981|FG006|Part 1|Symptomatic deterioration|0|||
161417825|NCT00106353|582917975|FG000|Part 1|Entered follow-up phase|1|||
161417826|NCT00106353|582917976|FG001|Part 1|Entered follow-up phase|1|||
161417827|NCT00106353|582917977|FG002|Part 1|Entered follow-up phase|0|||
161417828|NCT00106353|582917978|FG003|Part 1|Entered follow-up phase|1|||
161417829|NCT00106353|582917979|FG004|Part 1|Entered follow-up phase|0|||
161417830|NCT00106353|582917980|FG005|Part 1|Entered follow-up phase|0|||
161417831|NCT00106353|582917981|FG006|Part 1|Entered follow-up phase|0|||
161417832|NCT00106353|582917975|FG000|Part 1|Adverse Event|0|||
161417833|NCT00106353|582917976|FG001|Part 1|Adverse Event|0|||
161417834|NCT00106353|582917977|FG002|Part 1|Adverse Event|0|||
161417835|NCT00106353|582917978|FG003|Part 1|Adverse Event|1|||
161417836|NCT00106353|582917979|FG004|Part 1|Adverse Event|0|||
161417837|NCT00106353|582917980|FG005|Part 1|Adverse Event|0|||
161417838|NCT00106353|582917981|FG006|Part 1|Adverse Event|0|||
161417839|NCT00106353|582917975|FG000|Part 2|Disease progression|0|||
161417840|NCT00106353|582917976|FG001|Part 2|Disease progression|0|||
161417841|NCT00106353|582917977|FG002|Part 2|Disease progression|0|||
161417842|NCT00106353|582917978|FG003|Part 2|Disease progression|0|||
161417843|NCT00106353|582917979|FG004|Part 2|Disease progression|8|||
161417844|NCT00106353|582917980|FG005|Part 2|Disease progression|14|||
161417845|NCT00106353|582917981|FG006|Part 2|Disease progression|13|||
161417846|NCT00106353|582917975|FG000|Part 2|Death|0|||
161417847|NCT00106353|582917976|FG001|Part 2|Death|0|||
161417848|NCT00106353|582917977|FG002|Part 2|Death|0|||
161417849|NCT00106353|582917978|FG003|Part 2|Death|0|||
161417850|NCT00106353|582917979|FG004|Part 2|Death|3|||
161417851|NCT00106353|582917980|FG005|Part 2|Death|0|||
161417852|NCT00106353|582917981|FG006|Part 2|Death|1|||
161417853|NCT00106353|582917975|FG000|Part 2|Symptomatic deterioration|0|||
161417854|NCT00106353|582917976|FG001|Part 2|Symptomatic deterioration|0|||
161417855|NCT00106353|582917977|FG002|Part 2|Symptomatic deterioration|0|||
161417856|NCT00106353|582917978|FG003|Part 2|Symptomatic deterioration|0|||
161417857|NCT00106353|582917979|FG004|Part 2|Symptomatic deterioration|3|||
161417858|NCT00106353|582917980|FG005|Part 2|Symptomatic deterioration|0|||
161417859|NCT00106353|582917981|FG006|Part 2|Symptomatic deterioration|0|||
161417860|NCT00106353|582917975|FG000|Part 2|Adverse Event|0|||
161417861|NCT00106353|582917976|FG001|Part 2|Adverse Event|0|||
161417862|NCT00106353|582917977|FG002|Part 2|Adverse Event|0|||
161417863|NCT00106353|582917978|FG003|Part 2|Adverse Event|0|||
161417864|NCT00106353|582917979|FG004|Part 2|Adverse Event|0|||
161417865|NCT00106353|582917980|FG005|Part 2|Adverse Event|2|||
161417866|NCT00106353|582917981|FG006|Part 2|Adverse Event|1|||
161417867|NCT00106353|582917975|FG000|Part 2|Other|0|||
161417868|NCT00106353|582917976|FG001|Part 2|Other|0|||
161417869|NCT00106353|582917977|FG002|Part 2|Other|0|||
161417870|NCT00106353|582917978|FG003|Part 2|Other|0|||
161417871|NCT00106353|582917979|FG004|Part 2|Other|1|||
161417872|NCT00106353|582917980|FG005|Part 2|Other|1|||
161417873|NCT00106353|582917981|FG006|Part 2|Other|1|||
161417874|NCT00106353|582917975|FG000|Part 2|Withdrawal by Subject|0|||
161417875|NCT00106353|582917976|FG001|Part 2|Withdrawal by Subject|0|||
161417876|NCT00106353|582917977|FG002|Part 2|Withdrawal by Subject|0|||
161417877|NCT00106353|582917978|FG003|Part 2|Withdrawal by Subject|0|||
161417878|NCT00106353|582917979|FG004|Part 2|Withdrawal by Subject|1|||
161417879|NCT00106353|582917980|FG005|Part 2|Withdrawal by Subject|0|||
161417880|NCT00106353|582917981|FG006|Part 2|Withdrawal by Subject|0|||
161417881|NCT00106353|582917975|FG000|Part 2|Physician Decision|0|||
161417882|NCT00106353|582917976|FG001|Part 2|Physician Decision|0|||
161417883|NCT00106353|582917977|FG002|Part 2|Physician Decision|0|||
161417884|NCT00106353|582917978|FG003|Part 2|Physician Decision|0|||
161417885|NCT00106353|582917979|FG004|Part 2|Physician Decision|0|||
161417886|NCT00106353|582917980|FG005|Part 2|Physician Decision|1|||
161417887|NCT00106353|582917981|FG006|Part 2|Physician Decision|0|||
161417888|NCT04039217|582917982|FG000|Overall Study|Lost to Follow-up|1|||
161417889|NCT01278797|582917983|FG000|Period 1|Adverse Event|0|||
161417890|NCT01278797|582917984|FG001|Period 1|Adverse Event|1|||
161417891|NCT01278797|582917983|FG000|Period 1|Protocol Violation|1|||
161417892|NCT01278797|582917984|FG001|Period 1|Protocol Violation|0|||
161417893|NCT00588354|582917985|FG000|Baseline to 2 Weeks|Adverse Event|1|||
161417894|NCT00588354|582917986|FG001|Baseline to 2 Weeks|Adverse Event|0|||
161417895|NCT00588354|582917985|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
161417896|NCT00588354|582917986|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
161417897|NCT00588354|582917985|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
161417898|NCT00588354|582917986|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
161417899|NCT03364309|582917987|FG000|Induction Period|Adverse Event|4|||
161417900|NCT03364309|582917988|FG001|Induction Period|Adverse Event|0|||
161417901|NCT03364309|582917989|FG002|Induction Period|Adverse Event|1|||
161417902|NCT03364309|582917990|FG003|Induction Period|Adverse Event|0|||
161417903|NCT03364309|582917991|FG004|Induction Period|Adverse Event|0|||
161417904|NCT03364309|582917992|FG005|Induction Period|Adverse Event|0|||
161417905|NCT03364309|582917993|FG006|Induction Period|Adverse Event|0|||
161417906|NCT03364309|582917994|FG007|Induction Period|Adverse Event|0|||
161417907|NCT03364309|582917995|FG008|Induction Period|Adverse Event|0|||
161417908|NCT03364309|582917996|FG009|Induction Period|Adverse Event|0|||
161417909|NCT03364309|582917997|FG010|Induction Period|Adverse Event|0|||
161417910|NCT03364309|582917998|FG011|Induction Period|Adverse Event|0|||
161417911|NCT03364309|582917999|FG012|Induction Period|Adverse Event|0|||
161417912|NCT03364309|582918000|FG013|Induction Period|Adverse Event|0|||
161417913|NCT03364309|582918001|FG014|Induction Period|Adverse Event|0|||
161417914|NCT03364309|582918002|FG015|Induction Period|Adverse Event|0|||
161417915|NCT03364309|582918003|FG016|Induction Period|Adverse Event|0|||
161417916|NCT03364309|582918004|FG017|Induction Period|Adverse Event|0|||
161417917|NCT03364309|582918005|FG018|Induction Period|Adverse Event|0|||
161417918|NCT03364309|582917987|FG000|Induction Period|Withdrawal by Subject|1|||
161417919|NCT03364309|582917988|FG001|Induction Period|Withdrawal by Subject|3|||
161417920|NCT03364309|582917989|FG002|Induction Period|Withdrawal by Subject|0|||
161417921|NCT03364309|582917990|FG003|Induction Period|Withdrawal by Subject|0|||
161417922|NCT03364309|582917991|FG004|Induction Period|Withdrawal by Subject|0|||
161417923|NCT03364309|582917992|FG005|Induction Period|Withdrawal by Subject|0|||
161417924|NCT03364309|582917993|FG006|Induction Period|Withdrawal by Subject|0|||
161417925|NCT03364309|582917994|FG007|Induction Period|Withdrawal by Subject|0|||
161417926|NCT03364309|582917995|FG008|Induction Period|Withdrawal by Subject|0|||
161417927|NCT03364309|582917996|FG009|Induction Period|Withdrawal by Subject|0|||
161417928|NCT03364309|582917997|FG010|Induction Period|Withdrawal by Subject|0|||
161417929|NCT03364309|582917998|FG011|Induction Period|Withdrawal by Subject|0|||
161417930|NCT03364309|582917999|FG012|Induction Period|Withdrawal by Subject|0|||
161417931|NCT03364309|582918000|FG013|Induction Period|Withdrawal by Subject|0|||
161417932|NCT03364309|582918001|FG014|Induction Period|Withdrawal by Subject|0|||
161417933|NCT03364309|582918002|FG015|Induction Period|Withdrawal by Subject|0|||
161417934|NCT03364309|582918003|FG016|Induction Period|Withdrawal by Subject|0|||
161417935|NCT03364309|582918004|FG017|Induction Period|Withdrawal by Subject|0|||
161417936|NCT03364309|582918005|FG018|Induction Period|Withdrawal by Subject|0|||
161417937|NCT03364309|582917987|FG000|Induction Period|Lost to Follow-up|1|||
161417938|NCT03364309|582917988|FG001|Induction Period|Lost to Follow-up|0|||
161417939|NCT03364309|582917989|FG002|Induction Period|Lost to Follow-up|0|||
161417940|NCT03364309|582917990|FG003|Induction Period|Lost to Follow-up|0|||
161417941|NCT03364309|582917991|FG004|Induction Period|Lost to Follow-up|0|||
161417942|NCT03364309|582917992|FG005|Induction Period|Lost to Follow-up|0|||
161417943|NCT03364309|582917993|FG006|Induction Period|Lost to Follow-up|0|||
161417944|NCT03364309|582917994|FG007|Induction Period|Lost to Follow-up|0|||
161417945|NCT03364309|582917995|FG008|Induction Period|Lost to Follow-up|0|||
161417946|NCT03364309|582917996|FG009|Induction Period|Lost to Follow-up|0|||
161417947|NCT03364309|582917997|FG010|Induction Period|Lost to Follow-up|0|||
161417948|NCT03364309|582917998|FG011|Induction Period|Lost to Follow-up|0|||
161417949|NCT03364309|582917999|FG012|Induction Period|Lost to Follow-up|0|||
161417950|NCT03364309|582918000|FG013|Induction Period|Lost to Follow-up|0|||
161417951|NCT03364309|582918001|FG014|Induction Period|Lost to Follow-up|0|||
161417952|NCT03364309|582918002|FG015|Induction Period|Lost to Follow-up|0|||
161417953|NCT03364309|582918003|FG016|Induction Period|Lost to Follow-up|0|||
161417954|NCT03364309|582918004|FG017|Induction Period|Lost to Follow-up|0|||
161417955|NCT03364309|582918005|FG018|Induction Period|Lost to Follow-up|0|||
161417956|NCT03364309|582917987|FG000|Induction Period|Physician Decision|0|||
161417957|NCT03364309|582917988|FG001|Induction Period|Physician Decision|1|||
161417958|NCT03364309|582917989|FG002|Induction Period|Physician Decision|0|||
161417959|NCT03364309|582917990|FG003|Induction Period|Physician Decision|0|||
161417960|NCT03364309|582917991|FG004|Induction Period|Physician Decision|0|||
161417961|NCT03364309|582917992|FG005|Induction Period|Physician Decision|0|||
161417962|NCT03364309|582917993|FG006|Induction Period|Physician Decision|0|||
161417963|NCT03364309|582917994|FG007|Induction Period|Physician Decision|0|||
161417964|NCT03364309|582917995|FG008|Induction Period|Physician Decision|0|||
161417965|NCT03364309|582917996|FG009|Induction Period|Physician Decision|0|||
161417966|NCT03364309|582917997|FG010|Induction Period|Physician Decision|0|||
161417967|NCT03364309|582917998|FG011|Induction Period|Physician Decision|0|||
161417968|NCT03364309|582917999|FG012|Induction Period|Physician Decision|0|||
161417969|NCT03364309|582918000|FG013|Induction Period|Physician Decision|0|||
161417970|NCT03364309|582918001|FG014|Induction Period|Physician Decision|0|||
161417971|NCT03364309|582918002|FG015|Induction Period|Physician Decision|0|||
161417972|NCT03364309|582918003|FG016|Induction Period|Physician Decision|0|||
161417973|NCT03364309|582918004|FG017|Induction Period|Physician Decision|0|||
161417974|NCT03364309|582918005|FG018|Induction Period|Physician Decision|0|||
161417975|NCT03364309|582917987|FG000|Maintenance Period|Withdrawal by Subject|0|||
161417976|NCT03364309|582917988|FG001|Maintenance Period|Withdrawal by Subject|0|||
161417977|NCT03364309|582917989|FG002|Maintenance Period|Withdrawal by Subject|0|||
161417978|NCT03364309|582917990|FG003|Maintenance Period|Withdrawal by Subject|1|||
161417979|NCT03364309|582917991|FG004|Maintenance Period|Withdrawal by Subject|3|||
161417980|NCT03364309|582917992|FG005|Maintenance Period|Withdrawal by Subject|1|||
161417981|NCT03364309|582917993|FG006|Maintenance Period|Withdrawal by Subject|3|||
161417982|NCT03364309|582917994|FG007|Maintenance Period|Withdrawal by Subject|0|||
161417983|NCT03364309|582917995|FG008|Maintenance Period|Withdrawal by Subject|1|||
161417984|NCT03364309|582917996|FG009|Maintenance Period|Withdrawal by Subject|1|||
161417985|NCT03364309|582917997|FG010|Maintenance Period|Withdrawal by Subject|2|||
161417986|NCT03364309|582917998|FG011|Maintenance Period|Withdrawal by Subject|0|||
161417987|NCT03364309|582917999|FG012|Maintenance Period|Withdrawal by Subject|0|||
161417988|NCT03364309|582918000|FG013|Maintenance Period|Withdrawal by Subject|0|||
161417989|NCT03364309|582918001|FG014|Maintenance Period|Withdrawal by Subject|0|||
161417990|NCT03364309|582918002|FG015|Maintenance Period|Withdrawal by Subject|0|||
161417991|NCT03364309|582918003|FG016|Maintenance Period|Withdrawal by Subject|0|||
161417992|NCT03364309|582918004|FG017|Maintenance Period|Withdrawal by Subject|0|||
161417993|NCT03364309|582918005|FG018|Maintenance Period|Withdrawal by Subject|0|||
161417994|NCT03364309|582917987|FG000|Maintenance Period|Adverse Event|0|||
161417995|NCT03364309|582917988|FG001|Maintenance Period|Adverse Event|0|||
161417996|NCT03364309|582917989|FG002|Maintenance Period|Adverse Event|0|||
161417997|NCT03364309|582917990|FG003|Maintenance Period|Adverse Event|0|||
161417998|NCT03364309|582917991|FG004|Maintenance Period|Adverse Event|2|||
161417999|NCT03364309|582917992|FG005|Maintenance Period|Adverse Event|0|||
161418000|NCT03364309|582917993|FG006|Maintenance Period|Adverse Event|3|||
161418001|NCT03364309|582917994|FG007|Maintenance Period|Adverse Event|0|||
161418002|NCT03364309|582917995|FG008|Maintenance Period|Adverse Event|1|||
161418003|NCT03364309|582917996|FG009|Maintenance Period|Adverse Event|0|||
161418004|NCT03364309|582917997|FG010|Maintenance Period|Adverse Event|2|||
161418005|NCT03364309|582917998|FG011|Maintenance Period|Adverse Event|0|||
161418006|NCT03364309|582917999|FG012|Maintenance Period|Adverse Event|0|||
161418007|NCT03364309|582918000|FG013|Maintenance Period|Adverse Event|0|||
161418008|NCT03364309|582918001|FG014|Maintenance Period|Adverse Event|0|||
161418009|NCT03364309|582918002|FG015|Maintenance Period|Adverse Event|0|||
161418010|NCT03364309|582918003|FG016|Maintenance Period|Adverse Event|0|||
161418011|NCT03364309|582918004|FG017|Maintenance Period|Adverse Event|0|||
161418012|NCT03364309|582918005|FG018|Maintenance Period|Adverse Event|0|||
161418013|NCT03364309|582917987|FG000|Maintenance Period|Relapsed|0|||
161418014|NCT03364309|582917988|FG001|Maintenance Period|Relapsed|0|||
161418015|NCT03364309|582917989|FG002|Maintenance Period|Relapsed|0|||
161418016|NCT03364309|582917990|FG003|Maintenance Period|Relapsed|43|||
161418017|NCT03364309|582917991|FG004|Maintenance Period|Relapsed|7|||
161418018|NCT03364309|582917992|FG005|Maintenance Period|Relapsed|45|||
161418019|NCT03364309|582917993|FG006|Maintenance Period|Relapsed|10|||
161418020|NCT03364309|582917994|FG007|Maintenance Period|Relapsed|2|||
161418021|NCT03364309|582917995|FG008|Maintenance Period|Relapsed|0|||
161418022|NCT03364309|582917996|FG009|Maintenance Period|Relapsed|0|||
161418023|NCT03364309|582917997|FG010|Maintenance Period|Relapsed|0|||
161418024|NCT03364309|582917998|FG011|Maintenance Period|Relapsed|0|||
161418025|NCT03364309|582917999|FG012|Maintenance Period|Relapsed|0|||
161418026|NCT03364309|582918000|FG013|Maintenance Period|Relapsed|0|||
161418027|NCT03364309|582918001|FG014|Maintenance Period|Relapsed|0|||
161418028|NCT03364309|582918002|FG015|Maintenance Period|Relapsed|0|||
161418029|NCT03364309|582918003|FG016|Maintenance Period|Relapsed|0|||
161418030|NCT03364309|582918004|FG017|Maintenance Period|Relapsed|0|||
161418031|NCT03364309|582918005|FG018|Maintenance Period|Relapsed|0|||
161418032|NCT03364309|582917987|FG000|Maintenance Period|Lack of Efficacy|0|||
161418033|NCT03364309|582917988|FG001|Maintenance Period|Lack of Efficacy|0|||
161418034|NCT03364309|582917989|FG002|Maintenance Period|Lack of Efficacy|0|||
161418035|NCT03364309|582917990|FG003|Maintenance Period|Lack of Efficacy|0|||
161418036|NCT03364309|582917991|FG004|Maintenance Period|Lack of Efficacy|0|||
161418037|NCT03364309|582917992|FG005|Maintenance Period|Lack of Efficacy|0|||
161418038|NCT03364309|582917993|FG006|Maintenance Period|Lack of Efficacy|0|||
161418039|NCT03364309|582917994|FG007|Maintenance Period|Lack of Efficacy|0|||
161418040|NCT03364309|582917995|FG008|Maintenance Period|Lack of Efficacy|1|||
161418041|NCT03364309|582917996|FG009|Maintenance Period|Lack of Efficacy|3|||
161418042|NCT03364309|582917997|FG010|Maintenance Period|Lack of Efficacy|2|||
161418043|NCT03364309|582917998|FG011|Maintenance Period|Lack of Efficacy|0|||
161418044|NCT03364309|582917999|FG012|Maintenance Period|Lack of Efficacy|0|||
161418045|NCT03364309|582918000|FG013|Maintenance Period|Lack of Efficacy|0|||
161418046|NCT03364309|582918001|FG014|Maintenance Period|Lack of Efficacy|0|||
161418047|NCT03364309|582918002|FG015|Maintenance Period|Lack of Efficacy|0|||
161418048|NCT03364309|582918003|FG016|Maintenance Period|Lack of Efficacy|0|||
161418049|NCT03364309|582918004|FG017|Maintenance Period|Lack of Efficacy|0|||
161418050|NCT03364309|582918005|FG018|Maintenance Period|Lack of Efficacy|0|||
161418051|NCT03364309|582917987|FG000|Maintenance Period|Death|0|||
161418052|NCT03364309|582917988|FG001|Maintenance Period|Death|0|||
161418053|NCT03364309|582917989|FG002|Maintenance Period|Death|0|||
161418054|NCT03364309|582917990|FG003|Maintenance Period|Death|0|||
161418055|NCT03364309|582917991|FG004|Maintenance Period|Death|0|||
161418056|NCT03364309|582917992|FG005|Maintenance Period|Death|0|||
161418057|NCT03364309|582917993|FG006|Maintenance Period|Death|0|||
161418058|NCT03364309|582917994|FG007|Maintenance Period|Death|0|||
161418059|NCT03364309|582917995|FG008|Maintenance Period|Death|1|||
161418060|NCT03364309|582917996|FG009|Maintenance Period|Death|0|||
161418061|NCT03364309|582917997|FG010|Maintenance Period|Death|0|||
161418062|NCT03364309|582917998|FG011|Maintenance Period|Death|0|||
161418063|NCT03364309|582917999|FG012|Maintenance Period|Death|0|||
161418064|NCT03364309|582918000|FG013|Maintenance Period|Death|0|||
161418065|NCT03364309|582918001|FG014|Maintenance Period|Death|0|||
161418066|NCT03364309|582918002|FG015|Maintenance Period|Death|0|||
161418067|NCT03364309|582918003|FG016|Maintenance Period|Death|0|||
161418068|NCT03364309|582918004|FG017|Maintenance Period|Death|0|||
161418069|NCT03364309|582918005|FG018|Maintenance Period|Death|0|||
161418070|NCT03364309|582917987|FG000|Maintenance Period|Lost to Follow-up|0|||
161418071|NCT03364309|582917988|FG001|Maintenance Period|Lost to Follow-up|0|||
161418072|NCT03364309|582917989|FG002|Maintenance Period|Lost to Follow-up|0|||
161418073|NCT03364309|582917990|FG003|Maintenance Period|Lost to Follow-up|0|||
161418074|NCT03364309|582917991|FG004|Maintenance Period|Lost to Follow-up|0|||
161418075|NCT03364309|582917992|FG005|Maintenance Period|Lost to Follow-up|0|||
161418076|NCT03364309|582917993|FG006|Maintenance Period|Lost to Follow-up|0|||
161418077|NCT03364309|582917994|FG007|Maintenance Period|Lost to Follow-up|0|||
161418078|NCT03364309|582917995|FG008|Maintenance Period|Lost to Follow-up|1|||
161418079|NCT03364309|582917996|FG009|Maintenance Period|Lost to Follow-up|0|||
161418080|NCT03364309|582917997|FG010|Maintenance Period|Lost to Follow-up|0|||
161418081|NCT03364309|582917998|FG011|Maintenance Period|Lost to Follow-up|0|||
161418082|NCT03364309|582917999|FG012|Maintenance Period|Lost to Follow-up|0|||
161418083|NCT03364309|582918000|FG013|Maintenance Period|Lost to Follow-up|0|||
161418084|NCT03364309|582918001|FG014|Maintenance Period|Lost to Follow-up|0|||
161418085|NCT03364309|582918002|FG015|Maintenance Period|Lost to Follow-up|0|||
161418086|NCT03364309|582918003|FG016|Maintenance Period|Lost to Follow-up|0|||
161418087|NCT03364309|582918004|FG017|Maintenance Period|Lost to Follow-up|0|||
161418088|NCT03364309|582918005|FG018|Maintenance Period|Lost to Follow-up|0|||
161418089|NCT03364309|582917987|FG000|Maintenance Period|Miscellaneous|0|||
161418090|NCT03364309|582917988|FG001|Maintenance Period|Miscellaneous|0|||
161418091|NCT03364309|582917989|FG002|Maintenance Period|Miscellaneous|0|||
161418092|NCT03364309|582917990|FG003|Maintenance Period|Miscellaneous|0|||
161418093|NCT03364309|582917991|FG004|Maintenance Period|Miscellaneous|0|||
161418094|NCT03364309|582917992|FG005|Maintenance Period|Miscellaneous|0|||
161418095|NCT03364309|582917993|FG006|Maintenance Period|Miscellaneous|0|||
161418096|NCT03364309|582917994|FG007|Maintenance Period|Miscellaneous|0|||
161418097|NCT03364309|582917995|FG008|Maintenance Period|Miscellaneous|1|||
161418098|NCT03364309|582917996|FG009|Maintenance Period|Miscellaneous|0|||
161418099|NCT03364309|582917997|FG010|Maintenance Period|Miscellaneous|0|||
161418100|NCT03364309|582917998|FG011|Maintenance Period|Miscellaneous|0|||
161418101|NCT03364309|582917999|FG012|Maintenance Period|Miscellaneous|0|||
161418102|NCT03364309|582918000|FG013|Maintenance Period|Miscellaneous|0|||
161418103|NCT03364309|582918001|FG014|Maintenance Period|Miscellaneous|0|||
161418104|NCT03364309|582918002|FG015|Maintenance Period|Miscellaneous|0|||
161418105|NCT03364309|582918003|FG016|Maintenance Period|Miscellaneous|0|||
161418106|NCT03364309|582918004|FG017|Maintenance Period|Miscellaneous|0|||
161418107|NCT03364309|582918005|FG018|Maintenance Period|Miscellaneous|0|||
161418108|NCT03364309|582917987|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418109|NCT03364309|582917988|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418110|NCT03364309|582917989|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418111|NCT03364309|582917990|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418112|NCT03364309|582917991|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418113|NCT03364309|582917992|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418114|NCT03364309|582917993|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418115|NCT03364309|582917994|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418116|NCT03364309|582917995|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418117|NCT03364309|582917996|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418118|NCT03364309|582917997|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418119|NCT03364309|582917998|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418120|NCT03364309|582917999|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418121|NCT03364309|582918000|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
161418122|NCT03364309|582918001|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
161418123|NCT03364309|582918002|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
161418124|NCT03364309|582918003|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418125|NCT03364309|582918004|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418126|NCT03364309|582918005|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161418127|NCT03364309|582917987|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418128|NCT03364309|582917988|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418129|NCT03364309|582917989|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418130|NCT03364309|582917990|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418131|NCT03364309|582917991|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418132|NCT03364309|582917992|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418133|NCT03364309|582917993|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418134|NCT03364309|582917994|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418135|NCT03364309|582917995|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418136|NCT03364309|582917996|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418137|NCT03364309|582917997|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418138|NCT03364309|582917998|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418139|NCT03364309|582917999|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418140|NCT03364309|582918000|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418141|NCT03364309|582918001|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
161418142|NCT03364309|582918002|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418143|NCT03364309|582918003|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418144|NCT03364309|582918004|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418145|NCT03364309|582918005|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
161418146|NCT03364309|582917987|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
161418147|NCT03364309|582917988|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
161418148|NCT03364309|582917989|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
161418149|NCT03364309|582917990|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
161418150|NCT03364309|582917991|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
161418151|NCT03364309|582917992|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
161418152|NCT03364309|582917993|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
161418153|NCT03364309|582917994|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
161418154|NCT03364309|582917995|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
161418155|NCT03364309|582917996|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
161418156|NCT03364309|582917997|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
161418157|NCT03364309|582917998|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
161418158|NCT03364309|582917999|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
161418159|NCT03364309|582918000|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
161418160|NCT03364309|582918001|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
161418161|NCT03364309|582918002|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
161418162|NCT03364309|582918003|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
161418163|NCT03364309|582918004|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
161418164|NCT03364309|582918005|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
161418165|NCT03364309|582917987|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418166|NCT03364309|582917988|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418167|NCT03364309|582917989|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418168|NCT03364309|582917990|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418169|NCT03364309|582917991|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418170|NCT03364309|582917992|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418171|NCT03364309|582917993|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418172|NCT03364309|582917994|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418173|NCT03364309|582917995|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418174|NCT03364309|582917996|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418175|NCT03364309|582917997|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418176|NCT03364309|582917998|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418177|NCT03364309|582917999|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418178|NCT03364309|582918000|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418179|NCT03364309|582918001|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418180|NCT03364309|582918002|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161418181|NCT03364309|582918003|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
161418182|NCT03364309|582918004|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
161418183|NCT03364309|582918005|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
161418184|NCT03364309|582917987|FG000|Post-Treatment Followup Period|Adverse Event|0|||
161418185|NCT03364309|582917988|FG001|Post-Treatment Followup Period|Adverse Event|0|||
161418186|NCT03364309|582917989|FG002|Post-Treatment Followup Period|Adverse Event|0|||
161418187|NCT03364309|582917990|FG003|Post-Treatment Followup Period|Adverse Event|0|||
161418188|NCT03364309|582917991|FG004|Post-Treatment Followup Period|Adverse Event|0|||
161418189|NCT03364309|582917992|FG005|Post-Treatment Followup Period|Adverse Event|0|||
161418190|NCT03364309|582917993|FG006|Post-Treatment Followup Period|Adverse Event|0|||
161418191|NCT03364309|582917994|FG007|Post-Treatment Followup Period|Adverse Event|0|||
161418192|NCT03364309|582917995|FG008|Post-Treatment Followup Period|Adverse Event|0|||
161418193|NCT03364309|582917996|FG009|Post-Treatment Followup Period|Adverse Event|0|||
161418194|NCT03364309|582917997|FG010|Post-Treatment Followup Period|Adverse Event|0|||
161418195|NCT03364309|582917998|FG011|Post-Treatment Followup Period|Adverse Event|0|||
161418196|NCT03364309|582917999|FG012|Post-Treatment Followup Period|Adverse Event|0|||
161418197|NCT03364309|582918000|FG013|Post-Treatment Followup Period|Adverse Event|0|||
161418198|NCT03364309|582918001|FG014|Post-Treatment Followup Period|Adverse Event|0|||
161418199|NCT03364309|582918002|FG015|Post-Treatment Followup Period|Adverse Event|0|||
161418200|NCT03364309|582918003|FG016|Post-Treatment Followup Period|Adverse Event|2|||
161418201|NCT03364309|582918004|FG017|Post-Treatment Followup Period|Adverse Event|6|||
161418202|NCT03364309|582918005|FG018|Post-Treatment Followup Period|Adverse Event|1|||
161418203|NCT03364309|582917987|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418204|NCT03364309|582917988|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418205|NCT03364309|582917989|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418206|NCT03364309|582917990|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418207|NCT03364309|582917991|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418208|NCT03364309|582917992|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418209|NCT03364309|582917993|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418210|NCT03364309|582917994|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418211|NCT03364309|582917995|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418212|NCT03364309|582917996|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418213|NCT03364309|582917997|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418214|NCT03364309|582917998|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418215|NCT03364309|582917999|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418216|NCT03364309|582918000|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418217|NCT03364309|582918001|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418218|NCT03364309|582918002|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418219|NCT03364309|582918003|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418220|NCT03364309|582918004|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
161418221|NCT03364309|582918005|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
161418222|NCT03364309|582917987|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
161418223|NCT03364309|582917988|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
161418224|NCT03364309|582917989|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
161418225|NCT03364309|582917990|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
161418226|NCT03364309|582917991|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
161418227|NCT03364309|582917992|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
161418228|NCT03364309|582917993|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
161418229|NCT03364309|582917994|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
161418230|NCT03364309|582917995|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
161418231|NCT03364309|582917996|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
161418232|NCT03364309|582917997|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
161418233|NCT03364309|582917998|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
161418234|NCT03364309|582917999|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
161418235|NCT03364309|582918000|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
161418236|NCT03364309|582918001|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
161418237|NCT03364309|582918002|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
161418238|NCT03364309|582918003|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
161418239|NCT03364309|582918004|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
161418240|NCT03364309|582918005|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
161418241|NCT01371552|582918006|FG000|Part 1, First 3 Days|Inconvenience|0|||
161418242|NCT01371552|582918007|FG001|Part 1, First 3 Days|Inconvenience|0|||
161418243|NCT01371552|582918008|FG002|Part 1, First 3 Days|Inconvenience|1|||
161418244|NCT01371552|582918009|FG003|Part 1, First 3 Days|Inconvenience|0|||
161418245|NCT01371552|582918010|FG004|Part 1, First 3 Days|Inconvenience|0|||
161418246|NCT01371552|582918011|FG005|Part 1, First 3 Days|Inconvenience|0|||
161418247|NCT00167310|582918012|FG000|Overall Study|Protocol Violation|5|||
161418248|NCT00167310|582918013|FG001|Overall Study|Protocol Violation|3|||
161418249|NCT00167310|582918012|FG000|Overall Study|Withdrawal by Subject|3|||
161418250|NCT00167310|582918013|FG001|Overall Study|Withdrawal by Subject|7|||
161418251|NCT00615992|582918014|FG000|Overall Study|Protocol Violation|67|||
161418252|NCT04522141|582918016|FG000|Overall Study|Withdrawal by Subject|1|||
161418253|NCT04522141|582918017|FG001|Overall Study|Withdrawal by Subject|0|||
161418254|NCT03052049|582918018|FG000|Overall Study|Withdrawal by Subject|2|||
161418255|NCT02328027|582918019|FG000|Overall Study|Withdrawal by Subject|0|||
161418256|NCT02328027|582918020|FG001|Overall Study|Withdrawal by Subject|1|||
161418257|NCT03319212|582918021|FG000|Overall Study|Discontinued as moving out of local area|0|||
161418258|NCT03319212|582918022|FG001|Overall Study|Discontinued as moving out of local area|1|||
161418259|NCT03319212|582918021|FG000|Overall Study|Adverse Event|2|||
161418260|NCT03319212|582918022|FG001|Overall Study|Adverse Event|2|||
161418261|NCT03319212|582918021|FG000|Overall Study|Withdrawal by Subject|0|||
161418262|NCT03319212|582918022|FG001|Overall Study|Withdrawal by Subject|1|||
161418263|NCT03319212|582918021|FG000|Overall Study|Lost to Follow-up|0|||
161418264|NCT03319212|582918022|FG001|Overall Study|Lost to Follow-up|1|||
161418265|NCT03319212|582918021|FG000|Overall Study|Physician Decision|1|||
161418266|NCT03319212|582918022|FG001|Overall Study|Physician Decision|0|||
161418267|NCT01868477|582918023|FG000|Overall Study|Adverse Event|2|||
161418268|NCT01868477|582918024|FG001|Overall Study|Adverse Event|4|||
161418269|NCT01868477|582918023|FG000|Overall Study|Disease progression|1|||
161418270|NCT01868477|582918024|FG001|Overall Study|Disease progression|1|||
161418271|NCT01868477|582918023|FG000|Overall Study|Withdrawal by Subject|1|||
161418272|NCT01868477|582918024|FG001|Overall Study|Withdrawal by Subject|0|||
161418273|NCT02465203|582918025|FG000|Overall Study|Protocol Violation|1|||
161418274|NCT02465203|582918026|FG001|Overall Study|Protocol Violation|1|||
161418275|NCT02465203|582918027|FG002|Overall Study|Protocol Violation|1|||
161418276|NCT02465203|582918025|FG000|Overall Study|Study terminated by sponsor|50|||
161418277|NCT02465203|582918026|FG001|Overall Study|Study terminated by sponsor|34|||
161418278|NCT02465203|582918027|FG002|Overall Study|Study terminated by sponsor|11|||
161418279|NCT02465203|582918025|FG000|Overall Study|New therapy for study indication|4|||
161418280|NCT02465203|582918026|FG001|Overall Study|New therapy for study indication|0|||
161418281|NCT02465203|582918027|FG002|Overall Study|New therapy for study indication|0|||
161418282|NCT02465203|582918025|FG000|Overall Study|Patient/guardian decision|1|||
161418283|NCT02465203|582918026|FG001|Overall Study|Patient/guardian decision|1|||
161418284|NCT02465203|582918027|FG002|Overall Study|Patient/guardian decision|1|||
161418285|NCT04072887|582918032|FG000|Overall Study|Withdrawal by Subject|3|||
161418286|NCT04072887|582918033|FG001|Overall Study|Withdrawal by Subject|8|||
161418287|NCT04072887|582918034|FG002|Overall Study|Withdrawal by Subject|1|||
161418288|NCT04072887|582918035|FG003|Overall Study|Withdrawal by Subject|3|||
161418289|NCT04072887|582918036|FG004|Overall Study|Withdrawal by Subject|3|||
161418290|NCT04072887|582918037|FG005|Overall Study|Withdrawal by Subject|13|||
161418291|NCT04072887|582918032|FG000|Overall Study|Adverse Event|2|||
161418292|NCT04072887|582918033|FG001|Overall Study|Adverse Event|4|||
161418293|NCT04072887|582918034|FG002|Overall Study|Adverse Event|1|||
161418294|NCT04072887|582918035|FG003|Overall Study|Adverse Event|4|||
161418295|NCT04072887|582918036|FG004|Overall Study|Adverse Event|0|||
161418296|NCT04072887|582918037|FG005|Overall Study|Adverse Event|1|||
161418297|NCT04072887|582918032|FG000|Overall Study|Physician Decision|2|||
161418298|NCT04072887|582918033|FG001|Overall Study|Physician Decision|0|||
161418299|NCT04072887|582918034|FG002|Overall Study|Physician Decision|0|||
161418300|NCT04072887|582918035|FG003|Overall Study|Physician Decision|0|||
161418301|NCT04072887|582918036|FG004|Overall Study|Physician Decision|0|||
161418302|NCT04072887|582918037|FG005|Overall Study|Physician Decision|1|||
161418303|NCT04072887|582918032|FG000|Overall Study|Lost to Follow-up|1|||
161418304|NCT04072887|582918033|FG001|Overall Study|Lost to Follow-up|3|||
161418305|NCT04072887|582918034|FG002|Overall Study|Lost to Follow-up|0|||
161418306|NCT04072887|582918035|FG003|Overall Study|Lost to Follow-up|0|||
161418307|NCT04072887|582918036|FG004|Overall Study|Lost to Follow-up|0|||
161418308|NCT04072887|582918037|FG005|Overall Study|Lost to Follow-up|0|||
161418309|NCT04072887|582918032|FG000|Overall Study|Death|0|||
161418310|NCT04072887|582918033|FG001|Overall Study|Death|2|||
161418311|NCT04072887|582918034|FG002|Overall Study|Death|0|||
161418312|NCT04072887|582918035|FG003|Overall Study|Death|2|||
161418313|NCT04072887|582918036|FG004|Overall Study|Death|3|||
161418314|NCT04072887|582918037|FG005|Overall Study|Death|0|||
161418315|NCT01153724|582918040|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161418316|NCT01153724|582918040|FG000|Treatment Period 2|Adverse Event|1|||
161418317|NCT01153724|582918040|FG000|Treatment Period 2|Other reason not defined above|1|||
161418318|NCT04371666|582918045|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
161418319|NCT04371666|582918046|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
161418320|NCT04371666|582918045|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
161418321|NCT04371666|582918046|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
161418322|NCT04371666|582918045|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
161418323|NCT04371666|582918046|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
161418324|NCT04371666|582918045|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
161418325|NCT04371666|582918046|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
161418326|NCT04371666|582918045|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
161418327|NCT04371666|582918046|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
161418328|NCT04371666|582918045|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
161418329|NCT04371666|582918046|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
161418330|NCT00445770|582918047|FG000|Overall Study|Adverse Event|9|||
161418331|NCT00445770|582918048|FG001|Overall Study|Adverse Event|15|||
161418332|NCT00445770|582918049|FG002|Overall Study|Adverse Event|19|||
161418333|NCT00445770|582918047|FG000|Overall Study|Lack of Efficacy|38|||
161418334|NCT00445770|582918048|FG001|Overall Study|Lack of Efficacy|13|||
161418335|NCT00445770|582918049|FG002|Overall Study|Lack of Efficacy|6|||
161418336|NCT00445770|582918047|FG000|Overall Study|Lost to Follow-up|0|||
161418337|NCT00445770|582918048|FG001|Overall Study|Lost to Follow-up|2|||
161418338|NCT00445770|582918049|FG002|Overall Study|Lost to Follow-up|0|||
161418339|NCT00445770|582918047|FG000|Overall Study|Other|6|||
161418340|NCT00445770|582918048|FG001|Overall Study|Other|5|||
161418341|NCT00445770|582918049|FG002|Overall Study|Other|6|||
161418342|NCT02092025|582918050|FG000|Overall Study|Case Report Forms Uncollected|44|||
161418343|NCT02092025|582918050|FG000|Overall Study|Protocol Deviation|24|||
161418344|NCT02927938|582918051|FG000|Overall Study|Death|0|||
161418345|NCT02927938|582918052|FG001|Overall Study|Death|1|||
161418346|NCT02927938|582918053|FG002|Overall Study|Death|0|||
161418347|NCT02927938|582918054|FG003|Overall Study|Death|4|||
161418348|NCT02927938|582918051|FG000|Overall Study|Early Study Termination|1|||
161418349|NCT02927938|582918052|FG001|Overall Study|Early Study Termination|5|||
161418350|NCT02927938|582918053|FG002|Overall Study|Early Study Termination|4|||
161418351|NCT02927938|582918054|FG003|Overall Study|Early Study Termination|3|||
161418352|NCT00934128|582918055|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
161418353|NCT00934128|582918056|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
161418354|NCT00934128|582918055|FG000|First Intervention (2 Hours)|Adverse Event|4|||
161418355|NCT00934128|582918056|FG001|First Intervention (2 Hours)|Adverse Event|1|||
161418356|NCT00934128|582918055|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
161418357|NCT00934128|582918056|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
161418358|NCT00934128|582918055|FG000|Washout Period (1 Hour)|Patient preference|1|||
161418359|NCT00934128|582918056|FG001|Washout Period (1 Hour)|Patient preference|3|||
161418360|NCT00934128|582918055|FG000|Washout Period (1 Hour)|Pain|1|||
161418361|NCT00934128|582918056|FG001|Washout Period (1 Hour)|Pain|0|||
161418362|NCT00934128|582918055|FG000|Washout Period (1 Hour)|Too tired|1|||
161418363|NCT00934128|582918056|FG001|Washout Period (1 Hour)|Too tired|0|||
161418364|NCT00934128|582918055|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
161418365|NCT00934128|582918056|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
161418366|NCT00934128|582918055|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
161418367|NCT00934128|582918056|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
161418368|NCT02834247|582918057|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
161418369|NCT02834247|582918058|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
161418370|NCT02834247|582918059|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
161418371|NCT02834247|582918060|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
161418372|NCT02834247|582918057|FG000|Dose Escalation Phase|Death|5|||
161418373|NCT02834247|582918058|FG001|Dose Escalation Phase|Death|6|||
161418374|NCT02834247|582918059|FG002|Dose Escalation Phase|Death|5|||
161418375|NCT02834247|582918060|FG003|Dose Escalation Phase|Death|0|||
161418376|NCT02834247|582918057|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
161418377|NCT02834247|582918058|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
161418378|NCT02834247|582918059|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
161418379|NCT02834247|582918060|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
161418380|NCT02834247|582918057|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
161418381|NCT02834247|582918058|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
161418382|NCT02834247|582918059|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161418383|NCT02834247|582918060|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161418384|NCT02834247|582918057|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
161418385|NCT02834247|582918058|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
161418386|NCT02834247|582918059|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
161418387|NCT02834247|582918060|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
161418388|NCT02834247|582918057|FG000|Dose Expansion Phase|Death|0|||
161418389|NCT02834247|582918058|FG001|Dose Expansion Phase|Death|0|||
161418390|NCT02834247|582918059|FG002|Dose Expansion Phase|Death|0|||
161418391|NCT02834247|582918060|FG003|Dose Expansion Phase|Death|8|||
161418392|NCT02834247|582918057|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
161418393|NCT02834247|582918058|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
161418394|NCT02834247|582918059|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
161418395|NCT02834247|582918060|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
161418396|NCT02834247|582918057|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
161418397|NCT02834247|582918058|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
161418398|NCT02834247|582918059|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
161418399|NCT02834247|582918060|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
161418400|NCT02476006|582918061|FG000|Overall Study|Death|4|||
161418401|NCT02476006|582918061|FG000|Overall Study|Lack of treatment efficacy|2|||
161418402|NCT02476006|582918061|FG000|Overall Study|Pregnancy|1|||
161418403|NCT02476006|582918061|FG000|Overall Study|Participant did not wish to continue|39|||
161418404|NCT02476006|582918061|FG000|Overall Study|Adverse Event|41|||
161418405|NCT02476006|582918061|FG000|Overall Study|Poor compliance to study protocol|3|||
161418406|NCT02476006|582918061|FG000|Overall Study|Sponsor decision|6|||
161418407|NCT02476006|582918061|FG000|Overall Study|Lost to Follow-up|5|||
161418408|NCT02476006|582918061|FG000|Overall Study|Physician Decision|5|||
161418409|NCT02476006|582918061|FG000|Overall Study|Study ended treatment not available|4|||
161418410|NCT02476006|582918061|FG000|Overall Study|Switched to commercial drug|4|||
161418411|NCT02476006|582918061|FG000|Overall Study|Excluded from study|1|||
161418412|NCT02476006|582918061|FG000|Overall Study|Protocol Violation|1|||
161418413|NCT02476006|582918061|FG000|Overall Study|Enrolled but not treated|4|||
161418414|NCT01807299|582918068|FG000|Overall Study|Protocol Violation|3|||
161418415|NCT01807299|582918069|FG001|Overall Study|Protocol Violation|1|||
161418416|NCT01807299|582918070|FG002|Overall Study|Protocol Violation|0|||
161418417|NCT01807299|582918071|FG003|Overall Study|Protocol Violation|2|||
161418418|NCT00811174|582918072|FG000|Overall Study|Protocol Violation|2|||
161418419|NCT00811174|582918072|FG000|Overall Study|Sponsors Decision|1|||
161418420|NCT01410890|582919368|FG000|Overall Study|Withdrawal by Subject|0|||
161418421|NCT01410890|582919369|FG001|Overall Study|Withdrawal by Subject|1|||
161418422|NCT00412893|582919370|FG000|Overall Study|Adverse Event|31|||
161418423|NCT00412893|582919371|FG001|Overall Study|Adverse Event|53|||
161418424|NCT00412893|582919370|FG000|Overall Study|Death|17|||
161418425|NCT00412893|582919371|FG001|Overall Study|Death|21|||
161418426|NCT00412893|582919370|FG000|Overall Study|Insufficient Therapeutic Response|39|||
161418427|NCT00412893|582919371|FG001|Overall Study|Insufficient Therapeutic Response|23|||
161418428|NCT00412893|582919370|FG000|Overall Study|Lost to Follow-up|2|||
161418429|NCT00412893|582919371|FG001|Overall Study|Lost to Follow-up|1|||
161418430|NCT00412893|582919370|FG000|Overall Study|Violation of Selection at Entry|17|||
161418431|NCT00412893|582919371|FG001|Overall Study|Violation of Selection at Entry|10|||
161418432|NCT00412893|582919370|FG000|Overall Study|Other Protocol Violation|10|||
161418433|NCT00412893|582919371|FG001|Overall Study|Other Protocol Violation|6|||
161418434|NCT00412893|582919370|FG000|Overall Study|Did Not Cooperate|12|||
161418435|NCT00412893|582919371|FG001|Overall Study|Did Not Cooperate|9|||
161418436|NCT00412893|582919370|FG000|Overall Study|Administrative Reason|12|||
161418437|NCT00412893|582919371|FG001|Overall Study|Administrative Reason|15|||
161418438|NCT00412893|582919370|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
161418439|NCT00412893|582919371|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
161418440|NCT03951077|582919372|FG000|Overall Study|Adverse Event|1|||
161418441|NCT03951077|582919373|FG001|Overall Study|Adverse Event|0|||
161418442|NCT03951077|582919374|FG002|Overall Study|Adverse Event|0|||
161418443|NCT03951077|582919375|FG003|Overall Study|Adverse Event|0|||
161418444|NCT03951077|582919376|FG004|Overall Study|Adverse Event|0|||
161418445|NCT03951077|582919377|FG005|Overall Study|Adverse Event|0|||
161418446|NCT03951077|582919372|FG000|Overall Study|Withdrawal by Subject|3|||
161418447|NCT03951077|582919373|FG001|Overall Study|Withdrawal by Subject|3|||
161418448|NCT03951077|582919374|FG002|Overall Study|Withdrawal by Subject|0|||
161418449|NCT03951077|582919375|FG003|Overall Study|Withdrawal by Subject|3|||
161418450|NCT03951077|582919376|FG004|Overall Study|Withdrawal by Subject|3|||
161418451|NCT03951077|582919377|FG005|Overall Study|Withdrawal by Subject|2|||
161418452|NCT03951077|582919372|FG000|Overall Study|Lost to Follow-up|1|||
161418453|NCT03951077|582919373|FG001|Overall Study|Lost to Follow-up|1|||
161418454|NCT03951077|582919374|FG002|Overall Study|Lost to Follow-up|2|||
161418455|NCT03951077|582919375|FG003|Overall Study|Lost to Follow-up|3|||
161418456|NCT03951077|582919376|FG004|Overall Study|Lost to Follow-up|2|||
161418457|NCT03951077|582919377|FG005|Overall Study|Lost to Follow-up|3|||
161418458|NCT03951077|582919372|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
161418459|NCT03951077|582919373|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
161418460|NCT03951077|582919374|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
161418461|NCT03951077|582919375|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
161418462|NCT03951077|582919376|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
161418463|NCT03951077|582919377|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
161418464|NCT03951077|582919372|FG000|Overall Study|Other, Not Specified|12|||
161418465|NCT03951077|582919373|FG001|Overall Study|Other, Not Specified|10|||
161418466|NCT03951077|582919374|FG002|Overall Study|Other, Not Specified|10|||
161418467|NCT03951077|582919375|FG003|Overall Study|Other, Not Specified|5|||
161418468|NCT03951077|582919376|FG004|Overall Study|Other, Not Specified|9|||
161418469|NCT03951077|582919377|FG005|Overall Study|Other, Not Specified|6|||
161418470|NCT03951077|582919372|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
161418471|NCT03951077|582919373|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
161418472|NCT03951077|582919374|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
161418473|NCT03951077|582919375|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
161418474|NCT03951077|582919376|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
161418475|NCT03951077|582919377|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
161418476|NCT03579940|582919380|FG000|Period 2|Withdrawal by Subject|0|||
161418477|NCT03579940|582919381|FG001|Period 2|Withdrawal by Subject|0|||
161418478|NCT03579940|582919382|FG002|Period 2|Withdrawal by Subject|1|||
161418479|NCT03579940|582919383|FG003|Period 2|Withdrawal by Subject|0|||
161418480|NCT03579940|582919384|FG004|Period 2|Withdrawal by Subject|0|||
161418481|NCT03579940|582919385|FG005|Period 2|Withdrawal by Subject|0|||
161418482|NCT03579940|582919386|FG006|Period 2|Withdrawal by Subject|0|||
161418483|NCT03579940|582919387|FG007|Period 2|Withdrawal by Subject|0|||
161418484|NCT03579940|582919388|FG008|Period 2|Withdrawal by Subject|0|||
161418485|NCT03579940|582919389|FG009|Period 2|Withdrawal by Subject|0|||
161418486|NCT03579940|582919390|FG010|Period 2|Withdrawal by Subject|0|||
161418487|NCT01217944|582919391|FG000|Overall Study|Protocol Violation|1|||
161418488|NCT01217944|582919392|FG001|Overall Study|Protocol Violation|1|||
161418489|NCT01217944|582919393|FG002|Overall Study|Protocol Violation|0|||
161418490|NCT01217944|582919391|FG000|Overall Study|Lost to Follow-up|3|||
161418491|NCT01217944|582919392|FG001|Overall Study|Lost to Follow-up|1|||
161418492|NCT01217944|582919393|FG002|Overall Study|Lost to Follow-up|0|||
161418493|NCT01217944|582919391|FG000|Overall Study|Withdrawal by Subject|1|||
161418494|NCT01217944|582919392|FG001|Overall Study|Withdrawal by Subject|2|||
161418495|NCT01217944|582919393|FG002|Overall Study|Withdrawal by Subject|0|||
161418496|NCT01217944|582919391|FG000|Overall Study|Lack of Efficacy|1|||
161418497|NCT01217944|582919392|FG001|Overall Study|Lack of Efficacy|0|||
161418498|NCT01217944|582919393|FG002|Overall Study|Lack of Efficacy|0|||
161418499|NCT02274792|582919394|FG000|Overall Study|Withdrawal by Subject|13|||
161418500|NCT02274792|582919394|FG000|Overall Study|Lost to Follow-up|8|||
161418501|NCT02274792|582919394|FG000|Overall Study|Protocol Specified Criteria|2|||
161418502|NCT02274792|582919394|FG000|Overall Study|Sponsor Decision|2|||
161418503|NCT02751580|582919395|FG000|Overall Study|Lost to Follow-up|4|||
161418504|NCT02751580|582919395|FG000|Overall Study|Death|2|||
161418505|NCT04343755|582919400|FG000|Overall Study|Death|11|||
161418506|NCT04343755|582919400|FG000|Overall Study|Screen Failure|1|||
161418507|NCT00108862|582919405|FG000|Overall Study|Death|31|||
161418508|NCT00108862|582919406|FG001|Overall Study|Death|37|||
161418509|NCT00108862|582919405|FG000|Overall Study|Withdrawal by Subject|10|||
161418510|NCT00108862|582919406|FG001|Overall Study|Withdrawal by Subject|6|||
161418511|NCT00108862|582919405|FG000|Overall Study|Lost to Follow-up|27|||
161418512|NCT00108862|582919406|FG001|Overall Study|Lost to Follow-up|19|||
161418513|NCT04854551|582919411|FG000|Overall Study|Withdrawal by Subject|1|||
161418514|NCT04854551|582919412|FG001|Overall Study|Withdrawal by Subject|1|||
161418515|NCT01076036|582919415|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
161418516|NCT00687804|582919416|FG000|Core Study|Adverse Event|5|||
161418517|NCT00687804|582919417|FG001|Core Study|Adverse Event|3|||
161418518|NCT00687804|582919418|FG002|Core Study|Adverse Event|3|||
161418519|NCT00687804|582919416|FG000|Core Study|Abnormal laboratory value(s)|1|||
161418520|NCT00687804|582919417|FG001|Core Study|Abnormal laboratory value(s)|0|||
161418521|NCT00687804|582919418|FG002|Core Study|Abnormal laboratory value(s)|0|||
161418522|NCT00687804|582919416|FG000|Core Study|Lack of Efficacy|1|||
161418523|NCT00687804|582919417|FG001|Core Study|Lack of Efficacy|1|||
161418524|NCT00687804|582919418|FG002|Core Study|Lack of Efficacy|1|||
161418525|NCT00687804|582919416|FG000|Core Study|Withdrawal by Subject|4|||
161418526|NCT00687804|582919417|FG001|Core Study|Withdrawal by Subject|7|||
161418527|NCT00687804|582919418|FG002|Core Study|Withdrawal by Subject|7|||
161418528|NCT00687804|582919416|FG000|Core Study|Lost to Follow-up|0|||
161418529|NCT00687804|582919417|FG001|Core Study|Lost to Follow-up|1|||
161418530|NCT00687804|582919418|FG002|Core Study|Lost to Follow-up|0|||
161418531|NCT00687804|582919416|FG000|Core Study|Death|2|||
161418532|NCT00687804|582919417|FG001|Core Study|Death|2|||
161418533|NCT00687804|582919418|FG002|Core Study|Death|2|||
161418534|NCT00687804|582919416|FG000|Core Study|Protocol Violation|1|||
161418535|NCT00687804|582919417|FG001|Core Study|Protocol Violation|1|||
161418536|NCT00687804|582919418|FG002|Core Study|Protocol Violation|0|||
161418537|NCT00687804|582919416|FG000|Open-Label Extension Study|Adverse Event|2|||
161418538|NCT00687804|582919417|FG001|Open-Label Extension Study|Adverse Event|2|||
161418539|NCT00687804|582919418|FG002|Open-Label Extension Study|Adverse Event|2|||
161418540|NCT00687804|582919416|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
161418541|NCT00687804|582919417|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
161418542|NCT00687804|582919418|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
161418543|NCT00687804|582919416|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
161418544|NCT00687804|582919417|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
161418545|NCT00687804|582919418|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
161418546|NCT00687804|582919416|FG000|Open-Label Extension Study|Administrative problems|1|||
161418547|NCT00687804|582919417|FG001|Open-Label Extension Study|Administrative problems|1|||
161418548|NCT00687804|582919418|FG002|Open-Label Extension Study|Administrative problems|0|||
161418549|NCT00687804|582919416|FG000|Open-Label Extension Study|Death|2|||
161418550|NCT00687804|582919417|FG001|Open-Label Extension Study|Death|3|||
161418551|NCT00687804|582919418|FG002|Open-Label Extension Study|Death|3|||
161418552|NCT02221674|582919419|FG000|Overall Study|Lost to Follow-up|1|||
161418553|NCT02221674|582919420|FG001|Overall Study|Lost to Follow-up|0|||
161418554|NCT02221674|582919421|FG002|Overall Study|Lost to Follow-up|0|||
161418555|NCT05292131|582919422|FG000|Overall Study|Lost to Follow-up|1|||
161418556|NCT05292131|582919423|FG001|Overall Study|Lost to Follow-up|1|||
161418557|NCT05292131|582919422|FG000|Overall Study|Withdrawal by Subject|0|||
161418558|NCT05292131|582919423|FG001|Overall Study|Withdrawal by Subject|1|||
161418559|NCT04390880|582919424|FG000|Overall Study|Withdrawal by Subject|1|||
161418560|NCT02557542|582919425|FG000|Overall Study|Poor recruitment|3|||
161418561|NCT02557542|582919426|FG001|Overall Study|Poor recruitment|0|||
161418562|NCT00195091|582919427|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
161418563|NCT01345188|582919428|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
161418564|NCT01345188|582919428|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
161418565|NCT00475709|582919432|FG000|Overall Study|Did not meet eligibility criteria|8|||
161418566|NCT00475709|582919432|FG000|Overall Study|Death|41|||
161418567|NCT00475709|582919432|FG000|Overall Study|Device Explant|6|||
161418568|NCT00475709|582919432|FG000|Overall Study|Lost to Follow-up|21|||
161418569|NCT04752358|582919433|FG000|Overall Study|Death|2|||
161418570|NCT04752358|582919434|FG001|Overall Study|Death|1|||
161418571|NCT00555672|582919437|FG000|Overall Study|Death|0|||
161418572|NCT00555672|582919438|FG001|Overall Study|Death|2|||
161418573|NCT00555672|582919437|FG000|Overall Study|Adverse Event|8|||
161418574|NCT00555672|582919438|FG001|Overall Study|Adverse Event|2|||
161418575|NCT00555672|582919437|FG000|Overall Study|Objective progression or relapse|11|||
161418576|NCT00555672|582919438|FG001|Overall Study|Objective progression or relapse|5|||
161418577|NCT00555672|582919437|FG000|Overall Study|Other|3|||
161418578|NCT00555672|582919438|FG001|Overall Study|Other|1|||
161418579|NCT00555672|582919437|FG000|Overall Study|Participant refused|2|||
161418580|NCT00555672|582919438|FG001|Overall Study|Participant refused|0|||
161418581|NCT04526145|582919439|FG000|Overall Study|Withdrawal by Subject|5|||
161418582|NCT05236257|582919442|FG000|Overall Study|Ongoing with study treatment|29|||
161418583|NCT05236257|582919443|FG001|Overall Study|Ongoing with study treatment|1|||
161418584|NCT05236257|582919442|FG000|Overall Study|Discontinued study treatment|22|||
161418585|NCT05236257|582919443|FG001|Overall Study|Discontinued study treatment|41|||
161418586|NCT05870865|582919444|FG000|Randomized|Did not receive study treatment|2|||
161418587|NCT05870865|582919445|FG001|Randomized|Did not receive study treatment|4|||
161418588|NCT05870865|582919446|FG002|Randomized|Did not receive study treatment|4|||
161418589|NCT05870865|582919447|FG003|Randomized|Did not receive study treatment|3|||
161418590|NCT05870865|582919444|FG000|Treatment Period|Adverse Event|1|||
161418591|NCT05870865|582919445|FG001|Treatment Period|Adverse Event|1|||
161418592|NCT05870865|582919446|FG002|Treatment Period|Adverse Event|1|||
161418593|NCT05870865|582919447|FG003|Treatment Period|Adverse Event|1|||
161418594|NCT05870865|582919444|FG000|Treatment Period|Lost to Follow-up|0|||
161418595|NCT05870865|582919445|FG001|Treatment Period|Lost to Follow-up|1|||
161418596|NCT05870865|582919446|FG002|Treatment Period|Lost to Follow-up|2|||
161418597|NCT05870865|582919447|FG003|Treatment Period|Lost to Follow-up|0|||
161418598|NCT05870865|582919444|FG000|Treatment Period|Protocol Violation|0|||
161418599|NCT05870865|582919445|FG001|Treatment Period|Protocol Violation|0|||
161418600|NCT05870865|582919446|FG002|Treatment Period|Protocol Violation|0|||
161418601|NCT05870865|582919447|FG003|Treatment Period|Protocol Violation|1|||
161418602|NCT05870865|582919444|FG000|Treatment Period|Withdrawal by Subject|0|||
161418603|NCT05870865|582919445|FG001|Treatment Period|Withdrawal by Subject|1|||
161418604|NCT05870865|582919446|FG002|Treatment Period|Withdrawal by Subject|1|||
161418605|NCT05870865|582919447|FG003|Treatment Period|Withdrawal by Subject|1|||
161418606|NCT03828019|582919450|FG000|Overall Study|Withdrawal by Subject|3|||
161418607|NCT03828019|582919451|FG001|Overall Study|Withdrawal by Subject|8|||
161418608|NCT03828019|582919450|FG000|Overall Study|Lost to Follow-up|1|||
161418609|NCT03828019|582919451|FG001|Overall Study|Lost to Follow-up|6|||
161418610|NCT03828019|582919450|FG000|Overall Study|Incarcerated|1|||
161418611|NCT03828019|582919451|FG001|Overall Study|Incarcerated|0|||
161418612|NCT03828019|582919450|FG000|Overall Study|Adverse Event|0|||
161418613|NCT03828019|582919451|FG001|Overall Study|Adverse Event|1|||
161418614|NCT05715242|582919452|FG000|Overall Study|Lost to Follow-up|0|||
161418615|NCT05715242|582919453|FG001|Overall Study|Lost to Follow-up|0|||
161418616|NCT05715242|582919454|FG002|Overall Study|Lost to Follow-up|1|||
161418617|NCT05715242|582919455|FG003|Overall Study|Lost to Follow-up|0|||
161418618|NCT05715242|582919456|FG004|Overall Study|Lost to Follow-up|0|||
161418619|NCT05715242|582919457|FG005|Overall Study|Lost to Follow-up|1|||
161418620|NCT05715242|582919458|FG006|Overall Study|Lost to Follow-up|0|||
161418621|NCT05715242|582919459|FG007|Overall Study|Lost to Follow-up|0|||
161418622|NCT05715242|582919460|FG008|Overall Study|Lost to Follow-up|0|||
161418623|NCT05715242|582919461|FG009|Overall Study|Lost to Follow-up|0|||
161418624|NCT05715242|582919462|FG010|Overall Study|Lost to Follow-up|0|||
161418625|NCT05715242|582919463|FG011|Overall Study|Lost to Follow-up|0|||
161418626|NCT05715242|582919464|FG012|Overall Study|Lost to Follow-up|0|||
161418627|NCT05715242|582919465|FG013|Overall Study|Lost to Follow-up|0|||
161418628|NCT05715242|582919466|FG014|Overall Study|Lost to Follow-up|0|||
161418629|NCT05715242|582919467|FG015|Overall Study|Lost to Follow-up|0|||
161418630|NCT03400176|582919468|FG000|Dose Escalation|Progressive disease|1|||
161418631|NCT03400176|582919469|FG001|Dose Escalation|Progressive disease|1|||
161418632|NCT03400176|582919470|FG002|Dose Escalation|Progressive disease|0|||
161418633|NCT03400176|582919471|FG003|Dose Escalation|Progressive disease|0|||
161418634|NCT03400176|582919472|FG004|Dose Escalation|Progressive disease|1|||
161418635|NCT03400176|582919468|FG000|Dose Escalation|Patient decision|0|||
161418636|NCT03400176|582919469|FG001|Dose Escalation|Patient decision|0|||
161418637|NCT03400176|582919470|FG002|Dose Escalation|Patient decision|0|||
161418638|NCT03400176|582919471|FG003|Dose Escalation|Patient decision|0|||
161418639|NCT03400176|582919472|FG004|Dose Escalation|Patient decision|1|||
161418640|NCT03400176|582919468|FG000|Dose Expansion|Patient decision|0|||
161418641|NCT03400176|582919469|FG001|Dose Expansion|Patient decision|0|||
161418642|NCT03400176|582919470|FG002|Dose Expansion|Patient decision|0|||
161418643|NCT03400176|582919471|FG003|Dose Expansion|Patient decision|1|||
161418644|NCT03400176|582919472|FG004|Dose Expansion|Patient decision|0|||
161418645|NCT03400176|582919468|FG000|Dose Expansion|Adverse Event|0|||
161418646|NCT03400176|582919469|FG001|Dose Expansion|Adverse Event|0|||
161418647|NCT03400176|582919470|FG002|Dose Expansion|Adverse Event|0|||
161418648|NCT03400176|582919471|FG003|Dose Expansion|Adverse Event|1|||
161418649|NCT03400176|582919472|FG004|Dose Expansion|Adverse Event|0|||
161418650|NCT03400176|582919468|FG000|Dose Expansion|Physician Decision|0|||
161418651|NCT03400176|582919469|FG001|Dose Expansion|Physician Decision|0|||
161418652|NCT03400176|582919470|FG002|Dose Expansion|Physician Decision|0|||
161418653|NCT03400176|582919471|FG003|Dose Expansion|Physician Decision|1|||
161418654|NCT03400176|582919472|FG004|Dose Expansion|Physician Decision|0|||
161418655|NCT03400176|582919468|FG000|Dose Expansion|Progressive disease|0|||
161418656|NCT03400176|582919469|FG001|Dose Expansion|Progressive disease|0|||
161418657|NCT03400176|582919470|FG002|Dose Expansion|Progressive disease|1|||
161418658|NCT03400176|582919471|FG003|Dose Expansion|Progressive disease|1|||
161418659|NCT03400176|582919472|FG004|Dose Expansion|Progressive disease|0|||
161418660|NCT01090063|582919480|FG000|Screen|Screen Failed|4|||
161418661|NCT01090063|582919480|FG000|Treatment|Withdrawal by Subject|4|||
161418662|NCT00048347|582919481|FG000|Overall Study|Screen failure|2|||
161418663|NCT02863328|582919482|FG000|Overall Study|Lost to Follow-up|4|||
161418664|NCT02863328|582919483|FG001|Overall Study|Lost to Follow-up|10|||
161418665|NCT02863328|582919482|FG000|Overall Study|Withdrawal by Subject|7|||
161418666|NCT02863328|582919483|FG001|Overall Study|Withdrawal by Subject|12|||
161418667|NCT02863328|582919482|FG000|Overall Study|Died|0|||
161418668|NCT02863328|582919483|FG001|Overall Study|Died|1|||
161418669|NCT04565951|582919486|FG000|Overall Study|Lost to Follow-up|66|||
161418670|NCT04565951|582919487|FG001|Overall Study|Lost to Follow-up|38|||
161418671|NCT04565951|582919486|FG000|Overall Study|Withdrawal by Subject|14|||
161418672|NCT04565951|582919487|FG001|Overall Study|Withdrawal by Subject|7|||
161418673|NCT04565951|582919486|FG000|Overall Study|Death|0|||
161418674|NCT04565951|582919487|FG001|Overall Study|Death|1|||
161418675|NCT00429169|582919488|FG000|Overall Study|Lost to Follow-up|0|||
161418676|NCT00429169|582919489|FG001|Overall Study|Lost to Follow-up|1|||
161418677|NCT00429169|582919488|FG000|Overall Study|Ineligibility discovered after entry|2|||
161418678|NCT00429169|582919489|FG001|Overall Study|Ineligibility discovered after entry|1|||
161418679|NCT03508609|582919493|FG000|Overall Study|Withdrawal by Subject|1|||
161418680|NCT00423449|582919494|FG000|Overall Study|Clinical Adverse Event|1|||
161418681|NCT00423449|582919495|FG001|Overall Study|Clinical Adverse Event|0|||
161418682|NCT00423449|582919496|FG002|Overall Study|Clinical Adverse Event|1|||
161418683|NCT00423449|582919497|FG003|Overall Study|Clinical Adverse Event|8|||
161418684|NCT00423449|582919498|FG004|Overall Study|Clinical Adverse Event|2|||
161418685|NCT00423449|582919494|FG000|Overall Study|Death|1|||
161418686|NCT00423449|582919495|FG001|Overall Study|Death|0|||
161418687|NCT00423449|582919496|FG002|Overall Study|Death|2|||
161418688|NCT00423449|582919497|FG003|Overall Study|Death|1|||
161418689|NCT00423449|582919498|FG004|Overall Study|Death|1|||
161418690|NCT00423449|582919494|FG000|Overall Study|Progressive Disease|1|||
161418691|NCT00423449|582919495|FG001|Overall Study|Progressive Disease|3|||
161418692|NCT00423449|582919496|FG002|Overall Study|Progressive Disease|8|||
161418693|NCT00423449|582919497|FG003|Overall Study|Progressive Disease|11|||
161418694|NCT00423449|582919498|FG004|Overall Study|Progressive Disease|4|||
161418695|NCT00423449|582919494|FG000|Overall Study|Laboratory Adverse Event|0|||
161418696|NCT00423449|582919495|FG001|Overall Study|Laboratory Adverse Event|1|||
161418697|NCT00423449|582919496|FG002|Overall Study|Laboratory Adverse Event|2|||
161418698|NCT00423449|582919497|FG003|Overall Study|Laboratory Adverse Event|0|||
161418699|NCT00423449|582919498|FG004|Overall Study|Laboratory Adverse Event|0|||
161418700|NCT00423449|582919494|FG000|Overall Study|Other|0|||
161418701|NCT00423449|582919495|FG001|Overall Study|Other|0|||
161418702|NCT00423449|582919496|FG002|Overall Study|Other|0|||
161418703|NCT00423449|582919497|FG003|Overall Study|Other|1|||
161418704|NCT00423449|582919498|FG004|Overall Study|Other|0|||
161418705|NCT00423449|582919494|FG000|Overall Study|Protocol Violation|0|||
161418706|NCT00423449|582919495|FG001|Overall Study|Protocol Violation|0|||
161418707|NCT00423449|582919496|FG002|Overall Study|Protocol Violation|2|||
161418708|NCT00423449|582919497|FG003|Overall Study|Protocol Violation|1|||
161418709|NCT00423449|582919498|FG004|Overall Study|Protocol Violation|0|||
161418710|NCT00947115|582919499|FG000|Overall Study|Missed reporting interval|3|||
161418711|NCT00947115|582919500|FG001|Overall Study|Missed reporting interval|4|||
161418712|NCT00947115|582919501|FG002|Overall Study|Missed reporting interval|2|||
161418713|NCT00947115|582919499|FG000|Overall Study|Physician Decision|0|||
161418714|NCT00947115|582919500|FG001|Overall Study|Physician Decision|2|||
161418715|NCT00947115|582919501|FG002|Overall Study|Physician Decision|0|||
161418716|NCT00947115|582919499|FG000|Overall Study|Death|0|||
161418717|NCT00947115|582919500|FG001|Overall Study|Death|1|||
161418718|NCT00947115|582919501|FG002|Overall Study|Death|1|||
161418719|NCT00947115|582919499|FG000|Overall Study|Migrated from study area|2|||
161418720|NCT00947115|582919500|FG001|Overall Study|Migrated from study area|0|||
161418721|NCT00947115|582919501|FG002|Overall Study|Migrated from study area|0|||
161418722|NCT00947115|582919499|FG000|Overall Study|Withdrawal by Subject|1|||
161418723|NCT00947115|582919500|FG001|Overall Study|Withdrawal by Subject|3|||
161418724|NCT00947115|582919501|FG002|Overall Study|Withdrawal by Subject|4|||
161418725|NCT00947115|582919499|FG000|Overall Study|Lost to Follow-up|11|||
161418726|NCT00947115|582919500|FG001|Overall Study|Lost to Follow-up|12|||
161418727|NCT00947115|582919501|FG002|Overall Study|Lost to Follow-up|8|||
161418728|NCT03228212|582919504|FG000|Period 1|Adverse Event|1|||
161418729|NCT03228212|582919505|FG001|Period 1|Adverse Event|0|||
161418730|NCT03228212|582919504|FG000|Period 1|no longer meets eligibility criteria|0|||
161418731|NCT03228212|582919505|FG001|Period 1|no longer meets eligibility criteria|1|||
161418732|NCT03228212|582919504|FG000|Period 2|Lost to Follow-up|1|||
161418733|NCT03228212|582919505|FG001|Period 2|Lost to Follow-up|0|||
161418734|NCT00447226|582921163|FG000|12-Week Open-label Phase|Adverse Event|0|||
161418735|NCT00447226|582921164|FG001|12-Week Open-label Phase|Adverse Event|3|||
161418736|NCT00447226|582921163|FG000|12-Week Open-label Phase|Protocol Violation|0|||
161418737|NCT00447226|582921164|FG001|12-Week Open-label Phase|Protocol Violation|1|||
161418738|NCT00447226|582921163|FG000|12-Week Open-label Phase|Disease Progression|0|||
161418739|NCT00447226|582921164|FG001|12-Week Open-label Phase|Disease Progression|20|||
161418740|NCT00447226|582921163|FG000|12-Week Open-label Phase|Physician Decision|0|||
161418741|NCT00447226|582921164|FG001|12-Week Open-label Phase|Physician Decision|1|||
161418742|NCT00447226|582921163|FG000|Double-blind Phase|Disease Progression|4|||
161418743|NCT00447226|582921164|FG001|Double-blind Phase|Disease Progression|3|||
161418744|NCT03449758|582921172|FG000|Overall Study|Major protocol deviation|1|||
161418745|NCT03449758|582921172|FG000|Overall Study|Treatment inefficacy|5|||
161418746|NCT03449758|582921172|FG000|Overall Study|Adverse Event|9|||
161418747|NCT03449758|582921172|FG000|Overall Study|Consent withdrawal|1|||
161418748|NCT03449758|582921172|FG000|Overall Study|Other unspecified reason|3|||
161418749|NCT01478971|582921181|FG000|Standard of Care Period|Adverse Event|1|||
161418750|NCT01478971|582921181|FG000|Standard of Care Period|Withdrawal by Subject|3|||
161418751|NCT01478971|582921181|FG000|Standard of Care Period|Death|8|||
161418752|NCT01478971|582921181|FG000|Standard of Care Period|Lost to Follow-up|9|||
161418753|NCT01478971|582921181|FG000|Standard of Care Period|Other|4|||
161418754|NCT01478971|582921181|FG000|Peginesatide Treatment Period|Adverse Event|1|||
161418755|NCT01478971|582921181|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
161418756|NCT01478971|582921181|FG000|Peginesatide Treatment Period|Death|4|||
161418757|NCT01478971|582921181|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
161418758|NCT01478971|582921181|FG000|Peginesatide Treatment Period|Other|4|||
161418759|NCT00584012|582921182|FG000|Overall Study|Withdrawal by Subject|1|||
161418760|NCT04404556|582921183|FG000|Intervention|Withdrawal by Subject|15|||
161418761|NCT04404556|582921184|FG001|Intervention|Withdrawal by Subject|3|||
161418762|NCT04404556|582921183|FG000|Intervention|Did not complete all intervention sessions|2|||
161418763|NCT04404556|582921184|FG001|Intervention|Did not complete all intervention sessions|1|||
161418764|NCT04404556|582921183|FG000|Post-Intervention|Missing Data|1|||
161418765|NCT04404556|582921184|FG001|Post-Intervention|Missing Data|2|||
161418766|NCT04404556|582921183|FG000|Follow-up 1|Withdrawal by Subject|5|||
161418767|NCT04404556|582921184|FG001|Follow-up 1|Withdrawal by Subject|1|||
161418768|NCT04404556|582921183|FG000|Follow-up 1|Missing Data|4|||
161418769|NCT04404556|582921184|FG001|Follow-up 1|Missing Data|7|||
161418770|NCT04404556|582921183|FG000|Follow-up 2|Withdrawal by Subject|1|||
161418771|NCT04404556|582921184|FG001|Follow-up 2|Withdrawal by Subject|1|||
161418772|NCT04404556|582921183|FG000|Follow-up 2|Missing Data|6|||
161418773|NCT04404556|582921184|FG001|Follow-up 2|Missing Data|5|||
161418774|NCT02451943|582921185|FG000|Overall Study|Withdrawal by Subject|13|||
161418775|NCT02451943|582921186|FG001|Overall Study|Withdrawal by Subject|16|||
161418776|NCT02451943|582921185|FG000|Overall Study|Lost to Follow-up|3|||
161418777|NCT02451943|582921186|FG001|Overall Study|Lost to Follow-up|4|||
161418778|NCT02451943|582921185|FG000|Overall Study|Sponsor Decision|0|||
161418779|NCT02451943|582921186|FG001|Overall Study|Sponsor Decision|4|||
161418780|NCT03937713|582921187|FG000|Overall Study|Withdrawal by Subject|3|||
161418781|NCT03937713|582921188|FG001|Overall Study|Withdrawal by Subject|6|||
161418782|NCT03937713|582921187|FG000|Overall Study|Lost to Follow-up|1|||
161418783|NCT03937713|582921188|FG001|Overall Study|Lost to Follow-up|0|||
161418784|NCT00763386|582921194|FG000|Overall Study|Adverse Event|43|||
161418785|NCT00763386|582921195|FG001|Overall Study|Adverse Event|33|||
161418786|NCT00763386|582921194|FG000|Overall Study|Death|1|||
161418787|NCT00763386|582921195|FG001|Overall Study|Death|2|||
161418788|NCT00763386|582921194|FG000|Overall Study|Lost to Follow-up|3|||
161418789|NCT00763386|582921195|FG001|Overall Study|Lost to Follow-up|3|||
161418790|NCT00763386|582921194|FG000|Overall Study|Withdrawal by Subject|0|||
161418791|NCT00763386|582921195|FG001|Overall Study|Withdrawal by Subject|1|||
161418792|NCT00763386|582921194|FG000|Overall Study|CRF missing|0|||
161418793|NCT00763386|582921195|FG001|Overall Study|CRF missing|1|||
161418794|NCT00763386|582921194|FG000|Overall Study|Study Prosthesis Removed|1|||
161418795|NCT00763386|582921195|FG001|Overall Study|Study Prosthesis Removed|0|||
161418796|NCT00922623|582921196|FG000|Overall Study|Other|4|||
161418797|NCT00922623|582921196|FG000|Overall Study|Lost to Follow-up|1|||
161418798|NCT02451917|582921197|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
161418799|NCT02451917|582921198|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
161418800|NCT02451917|582921197|FG000|First Intervention (24 Weeks)|Death|0|||
161418801|NCT02451917|582921198|FG001|First Intervention (24 Weeks)|Death|1|||
161418802|NCT02451917|582921197|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
161418803|NCT02451917|582921198|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
161418804|NCT02871635|582921199|FG000|Overall Study|Primary lack of efficacy|4|||
161418805|NCT02871635|582921200|FG001|Overall Study|Primary lack of efficacy|4|||
161418806|NCT02871635|582921199|FG000|Overall Study|Protocol Violation|3|||
161418807|NCT02871635|582921200|FG001|Overall Study|Protocol Violation|1|||
161418808|NCT02871635|582921199|FG000|Overall Study|Lost to Follow-up|1|||
161418809|NCT02871635|582921200|FG001|Overall Study|Lost to Follow-up|2|||
161418810|NCT02871635|582921199|FG000|Overall Study|Pregnancy|0|||
161418811|NCT02871635|582921200|FG001|Overall Study|Pregnancy|2|||
161418812|NCT02871635|582921199|FG000|Overall Study|Physician Decision|1|||
161418813|NCT02871635|582921200|FG001|Overall Study|Physician Decision|1|||
161418814|NCT02871635|582921199|FG000|Overall Study|Withdrawal by Subject|3|||
161418815|NCT02871635|582921200|FG001|Overall Study|Withdrawal by Subject|4|||
161418816|NCT02871635|582921199|FG000|Overall Study|Adverse Event|4|||
161418817|NCT02871635|582921200|FG001|Overall Study|Adverse Event|4|||
161418818|NCT02871635|582921199|FG000|Overall Study|Secondary lack of efficacy|2|||
161418819|NCT02871635|582921200|FG001|Overall Study|Secondary lack of efficacy|1|||
161418820|NCT02420379|582921201|FG000|Overall Study|Withdrawal by Subject|0|||
161418821|NCT02420379|582921202|FG001|Overall Study|Withdrawal by Subject|3|||
161418822|NCT02420379|582921201|FG000|Overall Study|Unable to complete due to schooling|0|||
161418823|NCT02420379|582921202|FG001|Overall Study|Unable to complete due to schooling|1|||
161418824|NCT02420379|582921201|FG000|Overall Study|Transitioned to commercial drug|1|||
161418825|NCT02420379|582921202|FG001|Overall Study|Transitioned to commercial drug|0|||
161418826|NCT00502671|582921203|FG000|Overall Study|Disease Progression|13|||
161418827|NCT00502671|582921203|FG000|Overall Study|Personal Reasons|22|||
161418828|NCT00502671|582921203|FG000|Overall Study|Lost to Follow-up|7|||
161418829|NCT00502671|582921203|FG000|Overall Study|Protocol Violation|16|||
161418830|NCT00502671|582921203|FG000|Overall Study|Adverse Event|19|||
161418831|NCT01402817|582921204|FG000|Overall Study|Withdrawal by Subject|3|||
161418832|NCT01402817|582921204|FG000|Overall Study|Study Suspended by FDA|8|||
161418833|NCT00681629|582921211|FG000|Overall Study|Study termination|4|||
161418834|NCT00681629|582921212|FG001|Overall Study|Study termination|2|||
161418835|NCT00681629|582921211|FG000|Overall Study|Adverse Event|1|||
161418836|NCT00681629|582921212|FG001|Overall Study|Adverse Event|0|||
161418837|NCT00086047|582921213|FG000|Overall Study|Lost to Follow-up|7|||
161418838|NCT00086047|582921214|FG001|Overall Study|Lost to Follow-up|6|||
161418839|NCT00086047|582921213|FG000|Overall Study|Physician Decision|0|||
161418840|NCT00086047|582921214|FG001|Overall Study|Physician Decision|1|||
161418841|NCT01395901|582921215|FG000|Overall Study|Lost to Follow-up|4|||
161418842|NCT01395901|582921216|FG001|Overall Study|Lost to Follow-up|0|||
161418843|NCT01395901|582921215|FG000|Overall Study|Randomized but not received study drug|5|||
161418844|NCT01395901|582921216|FG001|Overall Study|Randomized but not received study drug|4|||
161418845|NCT01395901|582921215|FG000|Overall Study|Adverse Event|0|||
161418846|NCT01395901|582921216|FG001|Overall Study|Adverse Event|1|||
161418847|NCT01395901|582921215|FG000|Overall Study|Withdrawal of consent|1|||
161418848|NCT01395901|582921216|FG001|Overall Study|Withdrawal of consent|0|||
161418849|NCT00853151|582921221|FG000|Overall Study|Adverse Event|1|||
161418850|NCT00853151|582921222|FG001|Overall Study|Adverse Event|4|||
161418851|NCT00853151|582921223|FG002|Overall Study|Adverse Event|2|||
161418852|NCT00853151|582921224|FG003|Overall Study|Adverse Event|0|||
161418853|NCT00853151|582921221|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161418854|NCT00853151|582921222|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161418855|NCT00853151|582921223|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161418856|NCT00853151|582921224|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161418857|NCT00853151|582921221|FG000|Overall Study|Lost to Follow-up|2|||
161418858|NCT00853151|582921222|FG001|Overall Study|Lost to Follow-up|0|||
161418859|NCT00853151|582921223|FG002|Overall Study|Lost to Follow-up|3|||
161418860|NCT00853151|582921224|FG003|Overall Study|Lost to Follow-up|0|||
161418861|NCT00853151|582921221|FG000|Overall Study|Death|1|||
161418862|NCT00853151|582921222|FG001|Overall Study|Death|0|||
161418863|NCT00853151|582921223|FG002|Overall Study|Death|0|||
161418864|NCT00853151|582921224|FG003|Overall Study|Death|1|||
161418865|NCT00853151|582921221|FG000|Overall Study|Protocol Violation|0|||
161418866|NCT00853151|582921222|FG001|Overall Study|Protocol Violation|0|||
161418867|NCT00853151|582921223|FG002|Overall Study|Protocol Violation|0|||
161418868|NCT00853151|582921224|FG003|Overall Study|Protocol Violation|1|||
161418869|NCT00853151|582921221|FG000|Overall Study|Withdrawal by Subject|5|||
161418870|NCT00853151|582921222|FG001|Overall Study|Withdrawal by Subject|4|||
161418871|NCT00853151|582921223|FG002|Overall Study|Withdrawal by Subject|2|||
161418872|NCT00853151|582921224|FG003|Overall Study|Withdrawal by Subject|1|||
161418873|NCT00853151|582921221|FG000|Overall Study|Physician Decision|0|||
161418874|NCT00853151|582921222|FG001|Overall Study|Physician Decision|2|||
161418875|NCT00853151|582921223|FG002|Overall Study|Physician Decision|1|||
161418876|NCT00853151|582921224|FG003|Overall Study|Physician Decision|0|||
161418877|NCT00853151|582921221|FG000|Overall Study|Sponsor Decision|0|||
161418878|NCT00853151|582921222|FG001|Overall Study|Sponsor Decision|3|||
161418879|NCT00853151|582921223|FG002|Overall Study|Sponsor Decision|0|||
161418880|NCT00853151|582921224|FG003|Overall Study|Sponsor Decision|0|||
161418881|NCT01751984|582921225|FG000|Overall Study|Adverse Event|5|||
161418882|NCT01751984|582921226|FG001|Overall Study|Adverse Event|3|||
161418883|NCT01751984|582921225|FG000|Overall Study|Withdrawal by Subject|0|||
161418884|NCT01751984|582921226|FG001|Overall Study|Withdrawal by Subject|1|||
161418885|NCT01751984|582921225|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
161418886|NCT01751984|582921226|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161418887|NCT00587158|582921227|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
161418888|NCT00587158|582921228|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
161418889|NCT00587158|582921227|FG000|Overall Study|Physician Decision|0|||
161418890|NCT00587158|582921228|FG001|Overall Study|Physician Decision|1|||
161418891|NCT00587158|582921227|FG000|Overall Study|Lost to Follow-up|1|||
161418892|NCT00587158|582921228|FG001|Overall Study|Lost to Follow-up|2|||
161418893|NCT00587158|582921227|FG000|Overall Study|Death|0|||
161418894|NCT00587158|582921228|FG001|Overall Study|Death|1|||
161418895|NCT00587158|582921227|FG000|Overall Study|Subject did not want to take study med|0|||
161418896|NCT00587158|582921228|FG001|Overall Study|Subject did not want to take study med|1|||
161418897|NCT01136408|582921229|FG000|Overall Study|Adverse Event|4|||
161418898|NCT01136408|582921230|FG001|Overall Study|Adverse Event|8|||
161418899|NCT01136408|582921231|FG002|Overall Study|Adverse Event|4|||
161418900|NCT01136408|582921229|FG000|Overall Study|Protocol Violation|1|||
161418901|NCT01136408|582921230|FG001|Overall Study|Protocol Violation|1|||
161418902|NCT01136408|582921231|FG002|Overall Study|Protocol Violation|1|||
161418903|NCT01510158|582921232|FG000|Overall Study|Adverse Event|7|||
161418904|NCT01510158|582921233|FG001|Overall Study|Adverse Event|8|||
161418905|NCT01510158|582921234|FG002|Overall Study|Adverse Event|5|||
161418906|NCT01510158|582921232|FG000|Overall Study|Gout flare|1|||
161418907|NCT01510158|582921233|FG001|Overall Study|Gout flare|0|||
161418908|NCT01510158|582921234|FG002|Overall Study|Gout flare|0|||
161418909|NCT01510158|582921232|FG000|Overall Study|Protocol Violation|17|||
161418910|NCT01510158|582921233|FG001|Overall Study|Protocol Violation|16|||
161418911|NCT01510158|582921234|FG002|Overall Study|Protocol Violation|24|||
161418912|NCT01510158|582921232|FG000|Overall Study|Sponsor terminated study.|2|||
161418913|NCT01510158|582921233|FG001|Overall Study|Sponsor terminated study.|0|||
161418914|NCT01510158|582921234|FG002|Overall Study|Sponsor terminated study.|2|||
161418915|NCT01510158|582921232|FG000|Overall Study|Lost to Follow-up|13|||
161418916|NCT01510158|582921233|FG001|Overall Study|Lost to Follow-up|16|||
161418917|NCT01510158|582921234|FG002|Overall Study|Lost to Follow-up|9|||
161418918|NCT01510158|582921232|FG000|Overall Study|Withdrawal by Subject|10|||
161418919|NCT01510158|582921233|FG001|Overall Study|Withdrawal by Subject|13|||
161418920|NCT01510158|582921234|FG002|Overall Study|Withdrawal by Subject|10|||
161418921|NCT01510158|582921232|FG000|Overall Study|Death|1|||
161418922|NCT01510158|582921233|FG001|Overall Study|Death|0|||
161418923|NCT01510158|582921234|FG002|Overall Study|Death|0|||
161418924|NCT03078556|582921235|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
161418925|NCT03078556|582921236|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
161418926|NCT03078556|582921237|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
161418927|NCT03078556|582921238|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
161418928|NCT03078556|582921235|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
161418929|NCT03078556|582921236|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
161418930|NCT03078556|582921237|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
161418931|NCT03078556|582921238|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
161418932|NCT03078556|582921235|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
161418933|NCT03078556|582921236|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
161418934|NCT03078556|582921237|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
161418935|NCT03078556|582921238|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
161418936|NCT03078556|582921235|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
161418937|NCT03078556|582921236|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
161418938|NCT03078556|582921237|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
161418939|NCT03078556|582921238|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
161418940|NCT00832416|582921245|FG000|Overall Study|Lack of Efficacy|17|||
161418941|NCT00832416|582921246|FG001|Overall Study|Lack of Efficacy|15|||
161418942|NCT00832416|582921247|FG002|Overall Study|Lack of Efficacy|13|||
161418943|NCT00832416|582921248|FG003|Overall Study|Lack of Efficacy|52|||
161418944|NCT00832416|582921245|FG000|Overall Study|Withdrawal by Subject|5|||
161418945|NCT00832416|582921246|FG001|Overall Study|Withdrawal by Subject|7|||
161418946|NCT00832416|582921247|FG002|Overall Study|Withdrawal by Subject|2|||
161418947|NCT00832416|582921248|FG003|Overall Study|Withdrawal by Subject|10|||
161418948|NCT00832416|582921245|FG000|Overall Study|Physician Decision|2|||
161418949|NCT00832416|582921246|FG001|Overall Study|Physician Decision|12|||
161418950|NCT00832416|582921247|FG002|Overall Study|Physician Decision|5|||
161418951|NCT00832416|582921248|FG003|Overall Study|Physician Decision|10|||
161418952|NCT00832416|582921245|FG000|Overall Study|Administrative|0|||
161418953|NCT00832416|582921246|FG001|Overall Study|Administrative|0|||
161418954|NCT00832416|582921247|FG002|Overall Study|Administrative|0|||
161418955|NCT00832416|582921248|FG003|Overall Study|Administrative|1|||
161418956|NCT00832416|582921245|FG000|Overall Study|Adverse Event|21|||
161418957|NCT00832416|582921246|FG001|Overall Study|Adverse Event|19|||
161418958|NCT00832416|582921247|FG002|Overall Study|Adverse Event|41|||
161418959|NCT00832416|582921248|FG003|Overall Study|Adverse Event|10|||
161418960|NCT00832416|582921245|FG000|Overall Study|Death|1|||
161418961|NCT00832416|582921246|FG001|Overall Study|Death|0|||
161418962|NCT00832416|582921247|FG002|Overall Study|Death|0|||
161418963|NCT00832416|582921248|FG003|Overall Study|Death|0|||
161418964|NCT04421482|582921255|FG000|Overall Study|Physician Decision|1|||
161418965|NCT00571038|582921258|FG000|Overall Study|Lost to Follow-up|1|||
161418966|NCT00571038|582921259|FG001|Overall Study|Lost to Follow-up|4|||
161418967|NCT00571038|582921258|FG000|Overall Study|Death|7|||
161418968|NCT00571038|582921259|FG001|Overall Study|Death|5|||
161418969|NCT00571038|582921258|FG000|Overall Study|Withdrawal by Subject|1|||
161418970|NCT00571038|582921259|FG001|Overall Study|Withdrawal by Subject|3|||
161418971|NCT00571038|582921258|FG000|Overall Study|Moved out of state|2|||
161418972|NCT00571038|582921259|FG001|Overall Study|Moved out of state|2|||
161418973|NCT05786508|582921260|FG000|Overall Study|Withdrawal by Subject|2|||
161418974|NCT05786508|582921261|FG001|Overall Study|Withdrawal by Subject|0|||
161418975|NCT02588261|582921264|FG000|Overall Study|Study Terminated by Sponsor|157|||
161418976|NCT02588261|582921265|FG001|Overall Study|Study Terminated by Sponsor|142|||
161418977|NCT02588261|582921264|FG000|Overall Study|Protocol Deviation|1|||
161418978|NCT02588261|582921265|FG001|Overall Study|Protocol Deviation|0|||
161418979|NCT02588261|582921264|FG000|Overall Study|Death|1|||
161418980|NCT02588261|582921265|FG001|Overall Study|Death|2|||
161418981|NCT02588261|582921264|FG000|Overall Study|Withdrawal by Subject|12|||
161418982|NCT02588261|582921265|FG001|Overall Study|Withdrawal by Subject|8|||
161418983|NCT02588261|582921264|FG000|Overall Study|Noncompliance with Study Drug|0|||
161418984|NCT02588261|582921265|FG001|Overall Study|Noncompliance with Study Drug|1|||
161418985|NCT02588261|582921264|FG000|Overall Study|Miscellaneous|5|||
161418986|NCT02588261|582921265|FG001|Overall Study|Miscellaneous|4|||
161418987|NCT02588261|582921264|FG000|Overall Study|Progressive Disease|61|||
161418988|NCT02588261|582921265|FG001|Overall Study|Progressive Disease|82|||
161418989|NCT02588261|582921264|FG000|Overall Study|Adverse Event|29|||
161418990|NCT02588261|582921265|FG001|Overall Study|Adverse Event|24|||
161418991|NCT02588261|582921264|FG000|Overall Study|Lost to Follow-up|1|||
161418992|NCT02588261|582921265|FG001|Overall Study|Lost to Follow-up|0|||
161418993|NCT02652156|582921268|FG000|Overall Study|Physician Decision|1|||
161418994|NCT02652156|582921269|FG001|Overall Study|Physician Decision|0|||
161418995|NCT02652156|582921270|FG002|Overall Study|Physician Decision|0|||
161418996|NCT03329846|582921271|FG000|Overall Study|Disease progression|4|||
161418997|NCT03329846|582921272|FG001|Overall Study|Disease progression|6|||
161418998|NCT03329846|582921271|FG000|Overall Study|Study drug toxicity|1|||
161418999|NCT03329846|582921272|FG001|Overall Study|Study drug toxicity|0|||
161419000|NCT03329846|582921271|FG000|Overall Study|Participant request to discontinue treatment|0|||
161419001|NCT03329846|582921272|FG001|Overall Study|Participant request to discontinue treatment|1|||
161419002|NCT03329846|582921271|FG000|Overall Study|Participant withdrew consent|1|||
161419003|NCT03329846|582921272|FG001|Overall Study|Participant withdrew consent|0|||
161419004|NCT03329846|582921271|FG000|Overall Study|Other reasons|2|||
161419005|NCT03329846|582921272|FG001|Overall Study|Other reasons|2|||
161419006|NCT03066193|582921273|FG000|Overall Study|Withdrawal by Subject|1|||
161419007|NCT04034004|582921277|FG000|Overall Study|Withdrawal by Subject|1|||
161419008|NCT04034004|582921278|FG001|Overall Study|Withdrawal by Subject|2|||
161419009|NCT04034004|582921279|FG002|Overall Study|Withdrawal by Subject|2|||
161419010|NCT04034004|582921280|FG003|Overall Study|Withdrawal by Subject|3|||
161419011|NCT04034004|582921277|FG000|Overall Study|could not find vein to administer IV|2|||
161419012|NCT04034004|582921278|FG001|Overall Study|could not find vein to administer IV|1|||
161419013|NCT04034004|582921279|FG002|Overall Study|could not find vein to administer IV|0|||
161419014|NCT04034004|582921280|FG003|Overall Study|could not find vein to administer IV|0|||
161419015|NCT04034004|582921277|FG000|Overall Study|nurse accidentally unblinded subject|0|||
161419016|NCT04034004|582921278|FG001|Overall Study|nurse accidentally unblinded subject|0|||
161419017|NCT04034004|582921279|FG002|Overall Study|nurse accidentally unblinded subject|0|||
161419018|NCT04034004|582921280|FG003|Overall Study|nurse accidentally unblinded subject|1|||
161419019|NCT01397461|582921281|FG000|Overall Study|Withdrawal by Subject|2|||
161419020|NCT01397461|582921282|FG001|Overall Study|Withdrawal by Subject|1|||
161419021|NCT01397461|582921283|FG002|Overall Study|Withdrawal by Subject|0|||
161419022|NCT01397461|582921281|FG000|Overall Study|Lost to Follow-up|0|||
161419023|NCT01397461|582921282|FG001|Overall Study|Lost to Follow-up|2|||
161419024|NCT01397461|582921283|FG002|Overall Study|Lost to Follow-up|1|||
161419025|NCT01397461|582921281|FG000|Overall Study|Lack of Efficacy|0|||
161419026|NCT01397461|582921282|FG001|Overall Study|Lack of Efficacy|3|||
161419027|NCT01397461|582921283|FG002|Overall Study|Lack of Efficacy|0|||
161419028|NCT01397461|582921281|FG000|Overall Study|Not treated|0|||
161419029|NCT01397461|582921282|FG001|Overall Study|Not treated|0|||
161419030|NCT01397461|582921283|FG002|Overall Study|Not treated|1|||
161419031|NCT03364738|582921304|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
161419032|NCT03364738|582921304|FG000|Overall Study|Withdrawal by Subject|1|||
161419033|NCT03364738|582921304|FG000|Overall Study|Adverse Event|1|||
161419034|NCT03245398|582921305|FG000|Overall Study|Travelled to another island|1|||
161419035|NCT03245398|582921306|FG001|Overall Study|Travelled to another island|0|||
161419036|NCT02735343|582921308|FG000|Overall Study|screen fail|0|||
161419037|NCT02735343|582921309|FG001|Overall Study|screen fail|2|||
161419038|NCT04531241|582921319|FG000|Period 1|Withdrawal by Subject|2|||
161419039|NCT04531241|582921320|FG001|Period 1|Withdrawal by Subject|0|||
161419040|NCT04531241|582921319|FG000|Period 1|Dispesed incorrect lens power|1|||
161419041|NCT04531241|582921320|FG001|Period 1|Dispesed incorrect lens power|0|||
161419042|NCT04531241|582921319|FG000|Period 1|Protocol Violation|1|||
161419043|NCT04531241|582921320|FG001|Period 1|Protocol Violation|0|||
161419044|NCT04531241|582921319|FG000|Period 1|No longer eligible|0|||
161419045|NCT04531241|582921320|FG001|Period 1|No longer eligible|1|||
161419046|NCT04531241|582921319|FG000|Period 1|Lens Discomfort|0|||
161419047|NCT04531241|582921320|FG001|Period 1|Lens Discomfort|1|||
161419048|NCT04531241|582921319|FG000|Period 2|Covid-19 Related|1|||
161419049|NCT04531241|582921320|FG001|Period 2|Covid-19 Related|1|||
161419050|NCT03983304|582921321|FG000|Overall Study|Withdrawal by Subject|5|||
161419051|NCT03983304|582921321|FG000|Overall Study|Lost to Follow-up|2|||
161419052|NCT01702246|582921322|FG000|Overall Study|Lost to Follow-up|2|||
161419053|NCT01702246|582921322|FG000|Overall Study|Withdrawal by Subject|2|||
161419054|NCT01702246|582921322|FG000|Overall Study|Physician Decision|1|||
161419055|NCT01518374|582921325|FG000|Overall Study|Withdrawal by Subject|2|||
161419056|NCT01518374|582921325|FG000|Overall Study|Protocol Violation|3|||
161419057|NCT01518374|582921325|FG000|Overall Study|Lost to Follow-up|2|||
161419058|NCT04607837|582921326|FG000|Overall Study|Adverse Event|8|||
161419059|NCT04607837|582921327|FG001|Overall Study|Adverse Event|2|||
161419060|NCT04607837|582921326|FG000|Overall Study|Withdrawal by Subject|8|||
161419061|NCT04607837|582921327|FG001|Overall Study|Withdrawal by Subject|7|||
161419062|NCT04607837|582921326|FG000|Overall Study|Physician Decision|2|||
161419063|NCT04607837|582921327|FG001|Overall Study|Physician Decision|0|||
161419064|NCT04607837|582921326|FG000|Overall Study|Lack of Efficacy|2|||
161419065|NCT04607837|582921327|FG001|Overall Study|Lack of Efficacy|0|||
161419066|NCT04607837|582921326|FG000|Overall Study|Participant terminated by sponsor|1|||
161419067|NCT04607837|582921327|FG001|Overall Study|Participant terminated by sponsor|0|||
161419068|NCT04607837|582921326|FG000|Overall Study|Disease worsening|36|||
161419069|NCT04607837|582921327|FG001|Overall Study|Disease worsening|36|||
161419070|NCT04607837|582921326|FG000|Overall Study|Other|1|||
161419071|NCT04607837|582921327|FG001|Overall Study|Other|0|||
161419072|NCT02023996|582921337|FG000|Overall Study|Protocol Violation|6|||
161419073|NCT00465452|582921338|FG000|Overall Study|Adverse Event|1|||
161419074|NCT04209205|582921342|FG000|Overall Study|Adverse Event|2|||
161419075|NCT04209205|582921343|FG001|Overall Study|Adverse Event|3|||
161419076|NCT04209205|582921342|FG000|Overall Study|Lost to Follow-up|3|||
161419077|NCT04209205|582921343|FG001|Overall Study|Lost to Follow-up|1|||
161419078|NCT04209205|582921342|FG000|Overall Study|Physician Decision|1|||
161419079|NCT04209205|582921343|FG001|Overall Study|Physician Decision|1|||
161419080|NCT04209205|582921342|FG000|Overall Study|Subject decision|10|||
161419081|NCT04209205|582921343|FG001|Overall Study|Subject decision|10|||
161419082|NCT04209205|582921342|FG000|Overall Study|Progressive disease|1|||
161419083|NCT04209205|582921343|FG001|Overall Study|Progressive disease|0|||
161419084|NCT04209205|582921342|FG000|Overall Study|Protocol deviation|0|||
161419085|NCT04209205|582921343|FG001|Overall Study|Protocol deviation|1|||
161419086|NCT04209205|582921342|FG000|Overall Study|New therapy for study indication|1|||
161419087|NCT04209205|582921343|FG001|Overall Study|New therapy for study indication|0|||
161419088|NCT04209205|582921342|FG000|Overall Study|Adverse event - placebo not switched|0|||
161419089|NCT04209205|582921343|FG001|Overall Study|Adverse event - placebo not switched|1|||
161419090|NCT04209205|582921342|FG000|Overall Study|Subject decision - placebo not switched|0|||
161419091|NCT04209205|582921343|FG001|Overall Study|Subject decision - placebo not switched|5|||
161419092|NCT04209205|582921342|FG000|Overall Study|Death - placebo not switched|0|||
161419093|NCT04209205|582921343|FG001|Overall Study|Death - placebo not switched|1|||
161419094|NCT00999544|582923266|FG000|Overall Study|Withdrawal by Subject|1|||
161419095|NCT01392547|582923267|FG000|Overall Study|Adverse Event|2|||
161419096|NCT01392547|582923267|FG000|Overall Study|Non-compliance|2|||
161419097|NCT01392547|582923267|FG000|Overall Study|Withdrawal criteria|3|||
161419098|NCT01392547|582923267|FG000|Overall Study|Unclassified|1|||
161419099|NCT02936635|582923269|FG000|Overall Study|Adverse Event|43|||
161419100|NCT02936635|582923270|FG001|Overall Study|Adverse Event|25|||
161419101|NCT02936635|582923269|FG000|Overall Study|Progressive Disease|10|||
161419102|NCT02936635|582923270|FG001|Overall Study|Progressive Disease|18|||
161419103|NCT02936635|582923269|FG000|Overall Study|Sponsor Discretion|10|||
161419104|NCT02936635|582923270|FG001|Overall Study|Sponsor Discretion|16|||
161419105|NCT02936635|582923269|FG000|Overall Study|Death|9|||
161419106|NCT02936635|582923270|FG001|Overall Study|Death|15|||
161419107|NCT02936635|582923269|FG000|Overall Study|Withdrawal by Subject|8|||
161419108|NCT02936635|582923270|FG001|Overall Study|Withdrawal by Subject|15|||
161419109|NCT02936635|582923269|FG000|Overall Study|Physician Decision|2|||
161419110|NCT02936635|582923270|FG001|Overall Study|Physician Decision|9|||
161419111|NCT02936635|582923269|FG000|Overall Study|Lost to Follow-up|1|||
161419112|NCT02936635|582923270|FG001|Overall Study|Lost to Follow-up|2|||
161419113|NCT02936635|582923269|FG000|Overall Study|Protocol Violation|1|||
161419114|NCT02936635|582923270|FG001|Overall Study|Protocol Violation|0|||
161419115|NCT02936635|582923269|FG000|Overall Study|Lack of effect/Entry into other study|31|||
161419116|NCT02936635|582923270|FG001|Overall Study|Lack of effect/Entry into other study|65|||
161419117|NCT02407223|582923271|FG000|Overall Study|Adverse Event|1|||
161419118|NCT02407223|582923272|FG001|Overall Study|Adverse Event|0|||
161419119|NCT02407223|582923273|FG002|Overall Study|Adverse Event|1|||
161419120|NCT02407223|582923271|FG000|Overall Study|Lack of Efficacy|6|||
161419121|NCT02407223|582923272|FG001|Overall Study|Lack of Efficacy|6|||
161419122|NCT02407223|582923273|FG002|Overall Study|Lack of Efficacy|4|||
161419123|NCT02407223|582923271|FG000|Overall Study|Lost to Follow-up|1|||
161419124|NCT02407223|582923272|FG001|Overall Study|Lost to Follow-up|0|||
161419125|NCT02407223|582923273|FG002|Overall Study|Lost to Follow-up|2|||
161419126|NCT02407223|582923271|FG000|Overall Study|Withdrawal by Subject|2|||
161419127|NCT02407223|582923272|FG001|Overall Study|Withdrawal by Subject|4|||
161419128|NCT02407223|582923273|FG002|Overall Study|Withdrawal by Subject|4|||
161419129|NCT02407223|582923271|FG000|Overall Study|Study Terminated by Sponsor|77|||
161419130|NCT02407223|582923272|FG001|Overall Study|Study Terminated by Sponsor|80|||
161419131|NCT02407223|582923273|FG002|Overall Study|Study Terminated by Sponsor|86|||
161419132|NCT02407223|582923271|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
161419133|NCT02407223|582923272|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
161419134|NCT02407223|582923273|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
161419135|NCT02407223|582923271|FG000|Overall Study|Other|29|||
161419136|NCT02407223|582923272|FG001|Overall Study|Other|27|||
161419137|NCT02407223|582923273|FG002|Overall Study|Other|25|||
161419138|NCT00950846|582923275|FG000|Overall Study|Death|6|||
161419139|NCT00950846|582923275|FG000|Overall Study|Lost to Follow-up|3|||
161419140|NCT00950846|582923275|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
161419141|NCT04426318|582923276|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
161419142|NCT04426318|582923277|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
161419143|NCT04829916|582923278|FG000|Overall Study|Withdrawal by Subject|1|||
161419144|NCT04829916|582923279|FG001|Overall Study|Withdrawal by Subject|0|||
161419145|NCT02287467|582923281|FG000|Overall Study|Protocol Violation|12|||
161419146|NCT02287467|582923282|FG001|Overall Study|Protocol Violation|9|||
161419147|NCT03781778|582923283|FG000|Overall Study|Withdrawal by Subject|2|||
161419148|NCT03781778|582923284|FG001|Overall Study|Withdrawal by Subject|2|||
161419149|NCT01456169|582923286|FG000|Overall Study|Adverse Event|1|||
161419150|NCT01456169|582923287|FG001|Overall Study|Adverse Event|2|||
161419151|NCT01456169|582923288|FG002|Overall Study|Adverse Event|7|||
161419152|NCT01456169|582923286|FG000|Overall Study|Major Protocol Deviation|3|||
161419153|NCT01456169|582923287|FG001|Overall Study|Major Protocol Deviation|2|||
161419154|NCT01456169|582923288|FG002|Overall Study|Major Protocol Deviation|3|||
161419155|NCT01456169|582923286|FG000|Overall Study|Voluntary Withdrawal|3|||
161419156|NCT01456169|582923287|FG001|Overall Study|Voluntary Withdrawal|0|||
161419157|NCT01456169|582923288|FG002|Overall Study|Voluntary Withdrawal|2|||
161419158|NCT01456169|582923286|FG000|Overall Study|Lack of Efficacy|2|||
161419159|NCT01456169|582923287|FG001|Overall Study|Lack of Efficacy|0|||
161419160|NCT01456169|582923288|FG002|Overall Study|Lack of Efficacy|0|||
161419161|NCT01456169|582923286|FG000|Overall Study|Other|1|||
161419162|NCT01456169|582923287|FG001|Overall Study|Other|1|||
161419163|NCT01456169|582923288|FG002|Overall Study|Other|0|||
161419164|NCT02292446|582923289|FG000|Overall Study|Adverse Event|12|||
161419165|NCT02292446|582923289|FG000|Overall Study|Death|1|||
161419166|NCT02292446|582923289|FG000|Overall Study|Disease progression|2|||
161419167|NCT02292446|582923289|FG000|Overall Study|Subject/guardian decision|2|||
161419168|NCT02292446|582923289|FG000|Overall Study|Withdrawal by Subject|3|||
161419169|NCT00496080|582923294|FG000|Overall Study|Lost to Follow-up|9|||
161419170|NCT00496080|582923294|FG000|Overall Study|Surgical re-intervention|7|||
161419171|NCT00496080|582923294|FG000|Overall Study|Withdrawal by Subject|5|||
161419172|NCT00496080|582923294|FG000|Overall Study|Physician Decision|6|||
161419173|NCT04098809|582923295|FG000|Overall Study|Withdrawal by Subject|1|||
161419174|NCT04098809|582923296|FG001|Overall Study|Withdrawal by Subject|3|||
161419175|NCT04098809|582923295|FG000|Overall Study|Physician Decision|2|||
161419176|NCT04098809|582923296|FG001|Overall Study|Physician Decision|1|||
161419177|NCT00570310|582923301|FG000|Overall Study|Adverse Event|1|||
161419178|NCT00570310|582923302|FG001|Overall Study|Adverse Event|2|||
161419179|NCT00570310|582923301|FG000|Overall Study|Lack of Efficacy|1|||
161419180|NCT00570310|582923302|FG001|Overall Study|Lack of Efficacy|4|||
161419181|NCT02741596|582923305|FG000|Overall Study|Adverse Event|1|||
161419182|NCT02741596|582923306|FG001|Overall Study|Adverse Event|5|||
161419183|NCT02741596|582923305|FG000|Overall Study|Lost to Follow-up|1|||
161419184|NCT02741596|582923306|FG001|Overall Study|Lost to Follow-up|1|||
161419185|NCT02741596|582923305|FG000|Overall Study|Physician Decision|2|||
161419186|NCT02741596|582923306|FG001|Overall Study|Physician Decision|1|||
161419187|NCT02741596|582923305|FG000|Overall Study|Pregnancy|3|||
161419188|NCT02741596|582923306|FG001|Overall Study|Pregnancy|1|||
161419189|NCT02741596|582923305|FG000|Overall Study|Other (Unspecified)|0|||
161419190|NCT02741596|582923306|FG001|Overall Study|Other (Unspecified)|3|||
161419191|NCT02741596|582923305|FG000|Overall Study|Subject withdrawn-Other|17|||
161419192|NCT02741596|582923306|FG001|Overall Study|Subject withdrawn-Other|4|||
161419193|NCT02741596|582923305|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
161419194|NCT02741596|582923306|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
161419195|NCT00479336|582923307|FG000|Overall Study|Adverse Event|1|||
161419196|NCT00479336|582923308|FG001|Overall Study|Adverse Event|1|||
161419197|NCT00479336|582923309|FG002|Overall Study|Adverse Event|1|||
161419198|NCT00479336|582923310|FG003|Overall Study|Adverse Event|3|||
161419199|NCT00479336|582923307|FG000|Overall Study|Lack of Efficacy|1|||
161419200|NCT00479336|582923308|FG001|Overall Study|Lack of Efficacy|0|||
161419201|NCT00479336|582923309|FG002|Overall Study|Lack of Efficacy|0|||
161419202|NCT00479336|582923310|FG003|Overall Study|Lack of Efficacy|0|||
161419203|NCT00479336|582923307|FG000|Overall Study|Protocol Violation|0|||
161419204|NCT00479336|582923308|FG001|Overall Study|Protocol Violation|1|||
161419205|NCT00479336|582923309|FG002|Overall Study|Protocol Violation|0|||
161419206|NCT00479336|582923310|FG003|Overall Study|Protocol Violation|0|||
161419207|NCT00479336|582923307|FG000|Overall Study|Withdrawal by Subject|1|||
161419208|NCT00479336|582923308|FG001|Overall Study|Withdrawal by Subject|2|||
161419209|NCT00479336|582923309|FG002|Overall Study|Withdrawal by Subject|0|||
161419210|NCT00479336|582923310|FG003|Overall Study|Withdrawal by Subject|0|||
161419211|NCT00479336|582923307|FG000|Overall Study|Physician Decision|0|||
161419212|NCT00479336|582923308|FG001|Overall Study|Physician Decision|1|||
161419213|NCT00479336|582923309|FG002|Overall Study|Physician Decision|0|||
161419214|NCT00479336|582923310|FG003|Overall Study|Physician Decision|2|||
161419215|NCT00479336|582923307|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
161419216|NCT00479336|582923308|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
161419217|NCT00479336|582923309|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
161419218|NCT00479336|582923310|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
161419219|NCT02021643|582923311|FG000|Overall Study|Enrolled but Never Treated|1|||
161419220|NCT02021643|582923312|FG001|Overall Study|Enrolled but Never Treated|0|||
161419221|NCT02021643|582923313|FG002|Overall Study|Enrolled but Never Treated|0|||
161419222|NCT02021643|582923314|FG003|Overall Study|Enrolled but Never Treated|0|||
161419223|NCT02021643|582923311|FG000|Overall Study|Adverse Event|0|||
161419224|NCT02021643|582923312|FG001|Overall Study|Adverse Event|1|||
161419225|NCT02021643|582923313|FG002|Overall Study|Adverse Event|0|||
161419226|NCT02021643|582923314|FG003|Overall Study|Adverse Event|0|||
161419227|NCT02021643|582923311|FG000|Overall Study|Death|0|||
161419228|NCT02021643|582923312|FG001|Overall Study|Death|1|||
161419229|NCT02021643|582923313|FG002|Overall Study|Death|0|||
161419230|NCT02021643|582923314|FG003|Overall Study|Death|0|||
161419231|NCT02021643|582923311|FG000|Overall Study|Investigator's Discretion|1|||
161419232|NCT02021643|582923312|FG001|Overall Study|Investigator's Discretion|0|||
161419233|NCT02021643|582923313|FG002|Overall Study|Investigator's Discretion|0|||
161419234|NCT02021643|582923314|FG003|Overall Study|Investigator's Discretion|0|||
161419235|NCT02021643|582923311|FG000|Overall Study|Lack of Efficacy|7|||
161419236|NCT02021643|582923312|FG001|Overall Study|Lack of Efficacy|6|||
161419237|NCT02021643|582923313|FG002|Overall Study|Lack of Efficacy|0|||
161419238|NCT02021643|582923314|FG003|Overall Study|Lack of Efficacy|12|||
161419239|NCT02021643|582923311|FG000|Overall Study|Lost to Follow-up|0|||
161419240|NCT02021643|582923312|FG001|Overall Study|Lost to Follow-up|1|||
161419241|NCT02021643|582923313|FG002|Overall Study|Lost to Follow-up|0|||
161419242|NCT02021643|582923314|FG003|Overall Study|Lost to Follow-up|0|||
161419243|NCT02021643|582923311|FG000|Overall Study|Withdrew Consent|0|||
161419244|NCT02021643|582923312|FG001|Overall Study|Withdrew Consent|1|||
161419245|NCT02021643|582923313|FG002|Overall Study|Withdrew Consent|0|||
161419246|NCT02021643|582923314|FG003|Overall Study|Withdrew Consent|0|||
161419247|NCT02631551|582923315|FG000|Overall Study|Adverse Event|1|||
161419248|NCT02631551|582923316|FG001|Overall Study|Adverse Event|2|||
161419249|NCT02631551|582923317|FG002|Overall Study|Adverse Event|4|||
161419250|NCT02631551|582923318|FG003|Overall Study|Adverse Event|0|||
161419251|NCT02631551|582923315|FG000|Overall Study|Lack of Efficacy|0|||
161419252|NCT02631551|582923316|FG001|Overall Study|Lack of Efficacy|0|||
161419253|NCT02631551|582923317|FG002|Overall Study|Lack of Efficacy|1|||
161419254|NCT02631551|582923318|FG003|Overall Study|Lack of Efficacy|0|||
161419255|NCT02631551|582923315|FG000|Overall Study|Lost to Follow-up|1|||
161419256|NCT02631551|582923316|FG001|Overall Study|Lost to Follow-up|2|||
161419257|NCT02631551|582923317|FG002|Overall Study|Lost to Follow-up|0|||
161419258|NCT02631551|582923318|FG003|Overall Study|Lost to Follow-up|3|||
161419259|NCT02631551|582923315|FG000|Overall Study|Withdrawal by Subject|2|||
161419260|NCT02631551|582923316|FG001|Overall Study|Withdrawal by Subject|2|||
161419261|NCT02631551|582923317|FG002|Overall Study|Withdrawal by Subject|0|||
161419262|NCT02631551|582923318|FG003|Overall Study|Withdrawal by Subject|5|||
161419263|NCT02631551|582923315|FG000|Overall Study|Protocol deviation|3|||
161419264|NCT02631551|582923316|FG001|Overall Study|Protocol deviation|6|||
161419265|NCT02631551|582923317|FG002|Overall Study|Protocol deviation|3|||
161419266|NCT02631551|582923318|FG003|Overall Study|Protocol deviation|0|||
161419267|NCT02631551|582923315|FG000|Overall Study|Non-compliance with study procedures|0|||
161419268|NCT02631551|582923316|FG001|Overall Study|Non-compliance with study procedures|0|||
161419269|NCT02631551|582923317|FG002|Overall Study|Non-compliance with study procedures|1|||
161419270|NCT02631551|582923318|FG003|Overall Study|Non-compliance with study procedures|1|||
161419271|NCT02631551|582923315|FG000|Overall Study|Non-compliance with study drug|1|||
161419272|NCT02631551|582923316|FG001|Overall Study|Non-compliance with study drug|0|||
161419273|NCT02631551|582923317|FG002|Overall Study|Non-compliance with study drug|0|||
161419274|NCT02631551|582923318|FG003|Overall Study|Non-compliance with study drug|0|||
161419275|NCT02631551|582923315|FG000|Overall Study|Other, specific reasons not collected|5|||
161419276|NCT02631551|582923316|FG001|Overall Study|Other, specific reasons not collected|7|||
161419277|NCT02631551|582923317|FG002|Overall Study|Other, specific reasons not collected|2|||
161419278|NCT02631551|582923318|FG003|Overall Study|Other, specific reasons not collected|2|||
161419279|NCT04390243|582923321|FG000|Overall Study|Death|1|||
161419280|NCT04390243|582923321|FG000|Overall Study|Disease Progression|4|||
161419281|NCT04390243|582923321|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
161419282|NCT01521507|582923328|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
161419283|NCT01521507|582923329|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
161419284|NCT01521507|582923328|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
161419285|NCT01521507|582923329|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
161419286|NCT01521507|582923328|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
161419287|NCT01521507|582923329|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
161419288|NCT01521507|582923328|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
161419289|NCT01521507|582923329|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
161419290|NCT01521507|582923328|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
161419291|NCT01521507|582923329|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
161419292|NCT01521507|582923328|FG000|Stage 2: Observational Design|Physician Decision|1|||
161419293|NCT01521507|582923329|FG001|Stage 2: Observational Design|Physician Decision|0|||
161419294|NCT04317040|582923330|FG000|Overall Study|Lost to Follow-up|2|||
161419295|NCT04317040|582923331|FG001|Overall Study|Lost to Follow-up|0|||
161419296|NCT04317040|582923330|FG000|Overall Study|Death|16|||
161419297|NCT04317040|582923331|FG001|Overall Study|Death|18|||
161419298|NCT04317040|582923330|FG000|Overall Study|Withdrawal by Subject|0|||
161419299|NCT04317040|582923331|FG001|Overall Study|Withdrawal by Subject|1|||
161419300|NCT04317040|582923330|FG000|Overall Study|Incomplete assessments|0|||
161419301|NCT04317040|582923331|FG001|Overall Study|Incomplete assessments|1|||
161419302|NCT03672292|582923332|FG000|Overall Study|Adverse Event|3|||
161419303|NCT03672292|582923333|FG001|Overall Study|Adverse Event|1|||
161419304|NCT03672292|582923332|FG000|Overall Study|Physician Decision|0|||
161419305|NCT03672292|582923333|FG001|Overall Study|Physician Decision|1|||
161419306|NCT03672292|582923332|FG000|Overall Study|Withdrawal by Subject|1|||
161419307|NCT03672292|582923333|FG001|Overall Study|Withdrawal by Subject|2|||
161419308|NCT00799903|582923334|FG000|Overall Study|Investigator Site Closed|25|||
161419309|NCT00799903|582923335|FG001|Overall Study|Investigator Site Closed|23|||
161419310|NCT00799903|582923334|FG000|Overall Study|Withdrawal by Subject|179|||
161419311|NCT00799903|582923335|FG001|Overall Study|Withdrawal by Subject|175|||
161419312|NCT00799903|582923334|FG000|Overall Study|Lost to Follow-up|69|||
161419313|NCT00799903|582923335|FG001|Overall Study|Lost to Follow-up|80|||
161419314|NCT02518971|582923336|FG000|Overall Study|Lost to Follow-up|0|||
161419315|NCT02518971|582923337|FG001|Overall Study|Lost to Follow-up|1|||
161419316|NCT02518971|582923336|FG000|Overall Study|Physician Decision|6|||
161419317|NCT02518971|582923337|FG001|Overall Study|Physician Decision|6|||
161419318|NCT02518971|582923336|FG000|Overall Study|Protocol Violation|6|||
161419319|NCT02518971|582923337|FG001|Overall Study|Protocol Violation|4|||
161419320|NCT02518971|582923336|FG000|Overall Study|Withdrawal by Subject|4|||
161419321|NCT02518971|582923337|FG001|Overall Study|Withdrawal by Subject|5|||
161419322|NCT02518971|582923336|FG000|Overall Study|Side effects|1|||
161419323|NCT02518971|582923337|FG001|Overall Study|Side effects|0|||
161419324|NCT02518971|582923336|FG000|Overall Study|medication lost in mail|0|||
161419325|NCT02518971|582923337|FG001|Overall Study|medication lost in mail|1|||
161419326|NCT02518971|582923336|FG000|Overall Study|eligibility criteria no longer met|6|||
161419327|NCT02518971|582923337|FG001|Overall Study|eligibility criteria no longer met|3|||
161419328|NCT03088917|582923338|FG000|Overall Study|In care/cured elsewhere|15|||
161419329|NCT03088917|582923338|FG000|Overall Study|Refuse re-evaluation|13|||
161419330|NCT03088917|582923338|FG000|Overall Study|Contact not established|13|||
161419331|NCT03088917|582923338|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
161419332|NCT03088917|582923338|FG000|Overall Study|Moved outside study region|50|||
161419333|NCT00757237|582923339|FG000|Overall Study|Lost to Follow-up|0|||
161419334|NCT00757237|582923340|FG001|Overall Study|Lost to Follow-up|1|||
161419335|NCT00757237|582923339|FG000|Overall Study|Protocol Violation|0|||
161419336|NCT00757237|582923340|FG001|Overall Study|Protocol Violation|2|||
161419337|NCT00757237|582923339|FG000|Overall Study|Physician Decision|2|||
161419338|NCT00757237|582923340|FG001|Overall Study|Physician Decision|3|||
161419339|NCT00757237|582923339|FG000|Overall Study|Withdrawal by Subject|8|||
161419340|NCT00757237|582923340|FG001|Overall Study|Withdrawal by Subject|12|||
161419341|NCT00757237|582923339|FG000|Overall Study|Safety or Tolerability|3|||
161419342|NCT00757237|582923340|FG001|Overall Study|Safety or Tolerability|5|||
161419343|NCT00757237|582923339|FG000|Overall Study|Other|0|||
161419344|NCT00757237|582923340|FG001|Overall Study|Other|2|||
161419345|NCT05150990|582923345|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
161419346|NCT05150990|582923346|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
161419347|NCT05150990|582923345|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
161419348|NCT05150990|582923346|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
161419349|NCT05150990|582923345|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
161419350|NCT05150990|582923346|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
161419351|NCT05150990|582923345|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
161419352|NCT05150990|582923346|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
161419353|NCT05150990|582923345|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
161419354|NCT05150990|582923346|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
161419355|NCT05150990|582923345|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
161419356|NCT05150990|582923346|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
161419357|NCT05150990|582923345|FG000|Overall Study|Death (unrelated to the intervention)|1|||
161419358|NCT05150990|582923346|FG001|Overall Study|Death (unrelated to the intervention)|2|||
161419359|NCT01843023|582923347|FG000|Overall Study|Death|1|||
161419360|NCT01843023|582923348|FG001|Overall Study|Death|0|||
161419361|NCT01843023|582923347|FG000|Overall Study|Lost to Follow-up|24|||
161419362|NCT01843023|582923348|FG001|Overall Study|Lost to Follow-up|29|||
161419363|NCT01843023|582923347|FG000|Overall Study|Withdrawal by Subject|8|||
161419364|NCT01843023|582923348|FG001|Overall Study|Withdrawal by Subject|6|||
161419365|NCT04980612|582923350|FG000|Overall Study|Withdrawal by Subject|7|||
161419366|NCT04980612|582923351|FG001|Overall Study|Withdrawal by Subject|5|||
161419367|NCT01514201|582923354|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
161419368|NCT01514201|582923355|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161419369|NCT01514201|582923356|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161419370|NCT01514201|582923357|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161419371|NCT01514201|582923354|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161419372|NCT01514201|582923355|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
161419373|NCT01514201|582923356|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
161419374|NCT01514201|582923357|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161419375|NCT01514201|582923354|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
161419376|NCT01514201|582923355|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
161419377|NCT01514201|582923356|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
161419378|NCT01514201|582923357|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161419379|NCT01514201|582923354|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
161419380|NCT01514201|582923355|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
161419381|NCT01514201|582923356|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161419382|NCT01514201|582923357|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161419383|NCT01514201|582923354|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
161419384|NCT01514201|582923355|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
161419385|NCT01514201|582923356|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
161419386|NCT01514201|582923357|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
161419387|NCT01514201|582923354|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
161419388|NCT01514201|582923355|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
161419389|NCT01514201|582923356|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
161419390|NCT01514201|582923357|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
161419391|NCT01514201|582923354|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
161419392|NCT01514201|582923355|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
161419393|NCT01514201|582923356|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
161419394|NCT01514201|582923357|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
161419395|NCT01514201|582923354|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161419396|NCT01514201|582923355|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161419397|NCT01514201|582923356|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161419398|NCT01514201|582923357|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
161419399|NCT01514201|582923354|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
161419400|NCT01514201|582923355|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
161419401|NCT01514201|582923356|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
161419402|NCT01514201|582923357|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
161419403|NCT01514201|582923354|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161419404|NCT01514201|582923355|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161419405|NCT01514201|582923356|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161419406|NCT01514201|582923357|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
161419407|NCT01514201|582923354|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161419408|NCT01514201|582923355|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161419409|NCT01514201|582923356|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161419410|NCT01514201|582923357|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
161419411|NCT01514201|582923354|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161419412|NCT01514201|582923355|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161419413|NCT01514201|582923356|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161419414|NCT01514201|582923357|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
161419415|NCT00566852|582923362|FG000|Overall Study|Protocol Violation|22|||
161419416|NCT00566852|582923363|FG001|Overall Study|Protocol Violation|24|||
161419417|NCT00566852|582923362|FG000|Overall Study|Death|95|||
161419418|NCT00566852|582923363|FG001|Overall Study|Death|78|||
161419419|NCT00566852|582923362|FG000|Overall Study|Withdrawal by Subject|30|||
161419420|NCT00566852|582923363|FG001|Overall Study|Withdrawal by Subject|25|||
161419421|NCT00566852|582923362|FG000|Overall Study|Patient refusal|37|||
161419422|NCT00566852|582923363|FG001|Overall Study|Patient refusal|37|||
161419423|NCT00566852|582923362|FG000|Overall Study|Not tested due to disability|6|||
161419424|NCT00566852|582923363|FG001|Overall Study|Not tested due to disability|12|||
161419425|NCT00566852|582923362|FG000|Overall Study|Missing reason not specified|1|||
161419426|NCT00566852|582923363|FG001|Overall Study|Missing reason not specified|2|||
161419427|NCT00566852|582923362|FG000|Overall Study|Missing reason not reported|16|||
161419428|NCT00566852|582923363|FG001|Overall Study|Missing reason not reported|20|||
161419429|NCT02715609|582923367|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
161419430|NCT02715609|582923368|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
161419431|NCT02715609|582923369|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
161419432|NCT02715609|582923367|FG000|Overall Study|Withdrawal by Subject|0|||
161419433|NCT02715609|582923368|FG001|Overall Study|Withdrawal by Subject|0|||
161419434|NCT02715609|582923369|FG002|Overall Study|Withdrawal by Subject|1|||
161419435|NCT00286429|582923372|FG000|Overall Study|Adverse Event|4|||
161419436|NCT00286429|582923373|FG001|Overall Study|Adverse Event|1|||
161419437|NCT00286429|582923374|FG002|Overall Study|Adverse Event|6|||
161419438|NCT00286429|582923372|FG000|Overall Study|Lack of Efficacy|52|||
161419439|NCT00286429|582923373|FG001|Overall Study|Lack of Efficacy|27|||
161419440|NCT00286429|582923374|FG002|Overall Study|Lack of Efficacy|25|||
161419441|NCT00286429|582923372|FG000|Overall Study|Lost to Follow-up|2|||
161419442|NCT00286429|582923373|FG001|Overall Study|Lost to Follow-up|4|||
161419443|NCT00286429|582923374|FG002|Overall Study|Lost to Follow-up|3|||
161419444|NCT00286429|582923372|FG000|Overall Study|Physician Decision|10|||
161419445|NCT00286429|582923373|FG001|Overall Study|Physician Decision|7|||
161419446|NCT00286429|582923374|FG002|Overall Study|Physician Decision|7|||
161419447|NCT00286429|582923372|FG000|Overall Study|Protocol Violation|3|||
161419448|NCT00286429|582923373|FG001|Overall Study|Protocol Violation|5|||
161419449|NCT00286429|582923374|FG002|Overall Study|Protocol Violation|4|||
161419450|NCT00286429|582923372|FG000|Overall Study|Withdrawal by Subject|3|||
161419451|NCT00286429|582923373|FG001|Overall Study|Withdrawal by Subject|2|||
161419452|NCT00286429|582923374|FG002|Overall Study|Withdrawal by Subject|6|||
161419453|NCT00286429|582923372|FG000|Overall Study|Administrative Error|1|||
161419454|NCT00286429|582923373|FG001|Overall Study|Administrative Error|1|||
161419455|NCT00286429|582923374|FG002|Overall Study|Administrative Error|1|||
161419456|NCT00286429|582923372|FG000|Overall Study|Administrative Decision|0|||
161419457|NCT00286429|582923373|FG001|Overall Study|Administrative Decision|1|||
161419458|NCT00286429|582923374|FG002|Overall Study|Administrative Decision|0|||
161419459|NCT03197376|582923378|FG000|Primary and Booster Phase|Adverse Event|0|||
161419460|NCT03197376|582923379|FG001|Primary and Booster Phase|Adverse Event|0|||
161419461|NCT03197376|582923380|FG002|Primary and Booster Phase|Adverse Event|0|||
161419462|NCT03197376|582923381|FG003|Primary and Booster Phase|Adverse Event|1|||
161419463|NCT03197376|582923378|FG000|Primary and Booster Phase|Death|1|||
161419464|NCT03197376|582923379|FG001|Primary and Booster Phase|Death|0|||
161419465|NCT03197376|582923380|FG002|Primary and Booster Phase|Death|0|||
161419466|NCT03197376|582923381|FG003|Primary and Booster Phase|Death|2|||
161419467|NCT03197376|582923378|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
161419468|NCT03197376|582923379|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
161419469|NCT03197376|582923380|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
161419470|NCT03197376|582923381|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
161419471|NCT03197376|582923378|FG000|Primary and Booster Phase|Physician Decision|1|||
161419472|NCT03197376|582923379|FG001|Primary and Booster Phase|Physician Decision|0|||
161419473|NCT03197376|582923380|FG002|Primary and Booster Phase|Physician Decision|1|||
161419474|NCT03197376|582923381|FG003|Primary and Booster Phase|Physician Decision|3|||
161419475|NCT03197376|582923378|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
161419476|NCT03197376|582923379|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
161419477|NCT03197376|582923380|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
161419478|NCT03197376|582923381|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
161419479|NCT03197376|582923378|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
161419480|NCT03197376|582923379|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
161419481|NCT03197376|582923380|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
161419482|NCT03197376|582923381|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
161419483|NCT03197376|582923378|FG000|Primary and Booster Phase|Not vaccine related|1|||
161419484|NCT03197376|582923379|FG001|Primary and Booster Phase|Not vaccine related|2|||
161419485|NCT03197376|582923380|FG002|Primary and Booster Phase|Not vaccine related|0|||
161419486|NCT03197376|582923381|FG003|Primary and Booster Phase|Not vaccine related|6|||
161419487|NCT03197376|582923378|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
161419488|NCT03197376|582923379|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
161419489|NCT03197376|582923380|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
161419490|NCT03197376|582923381|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
161419491|NCT03197376|582923378|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
161419492|NCT03197376|582923379|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
161419493|NCT03197376|582923380|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
161419494|NCT03197376|582923381|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
161419495|NCT03197376|582923378|FG000|Immune Persistence Phase|Not vaccine related|1|||
161419496|NCT03197376|582923379|FG001|Immune Persistence Phase|Not vaccine related|0|||
161419497|NCT03197376|582923380|FG002|Immune Persistence Phase|Not vaccine related|1|||
161419498|NCT03197376|582923381|FG003|Immune Persistence Phase|Not vaccine related|1|||
161419499|NCT00999518|582923383|FG000|Overall Study|Adverse Event|1|||
161419500|NCT00999518|582923384|FG001|Overall Study|Adverse Event|6|||
161419501|NCT00999518|582923385|FG002|Overall Study|Adverse Event|3|||
161419502|NCT00999518|582923386|FG003|Overall Study|Adverse Event|1|||
161419503|NCT00999518|582923387|FG004|Overall Study|Adverse Event|2|||
161419504|NCT00999518|582923383|FG000|Overall Study|Lack of Efficacy|2|||
161419505|NCT00999518|582923384|FG001|Overall Study|Lack of Efficacy|0|||
161419506|NCT00999518|582923385|FG002|Overall Study|Lack of Efficacy|0|||
161419507|NCT00999518|582923386|FG003|Overall Study|Lack of Efficacy|2|||
161419508|NCT00999518|582923387|FG004|Overall Study|Lack of Efficacy|2|||
161419509|NCT00999518|582923383|FG000|Overall Study|Lost to Follow-up|0|||
161419510|NCT00999518|582923384|FG001|Overall Study|Lost to Follow-up|0|||
161419511|NCT00999518|582923385|FG002|Overall Study|Lost to Follow-up|0|||
161419512|NCT00999518|582923386|FG003|Overall Study|Lost to Follow-up|4|||
161419513|NCT00999518|582923387|FG004|Overall Study|Lost to Follow-up|1|||
161419514|NCT00999518|582923383|FG000|Overall Study|Did not meet entrance criteria|0|||
161419515|NCT00999518|582923384|FG001|Overall Study|Did not meet entrance criteria|0|||
161419516|NCT00999518|582923385|FG002|Overall Study|Did not meet entrance criteria|0|||
161419517|NCT00999518|582923386|FG003|Overall Study|Did not meet entrance criteria|0|||
161419518|NCT00999518|582923387|FG004|Overall Study|Did not meet entrance criteria|1|||
161419519|NCT00999518|582923383|FG000|Overall Study|Study terminated by sponsor|10|||
161419520|NCT00999518|582923384|FG001|Overall Study|Study terminated by sponsor|6|||
161419521|NCT00999518|582923385|FG002|Overall Study|Study terminated by sponsor|5|||
161419522|NCT00999518|582923386|FG003|Overall Study|Study terminated by sponsor|5|||
161419523|NCT00999518|582923387|FG004|Overall Study|Study terminated by sponsor|9|||
161419524|NCT00999518|582923383|FG000|Overall Study|Pregnancy|0|||
161419525|NCT00999518|582923384|FG001|Overall Study|Pregnancy|0|||
161419526|NCT00999518|582923385|FG002|Overall Study|Pregnancy|1|||
161419527|NCT00999518|582923386|FG003|Overall Study|Pregnancy|0|||
161419528|NCT00999518|582923387|FG004|Overall Study|Pregnancy|0|||
161419529|NCT00999518|582923383|FG000|Overall Study|Protocol Violation|0|||
161419530|NCT00999518|582923384|FG001|Overall Study|Protocol Violation|1|||
161419531|NCT00999518|582923385|FG002|Overall Study|Protocol Violation|0|||
161419532|NCT00999518|582923386|FG003|Overall Study|Protocol Violation|0|||
161419533|NCT00999518|582923387|FG004|Overall Study|Protocol Violation|2|||
161419534|NCT00999518|582923383|FG000|Overall Study|Withdrawal by Subject|5|||
161419535|NCT00999518|582923384|FG001|Overall Study|Withdrawal by Subject|4|||
161419536|NCT00999518|582923385|FG002|Overall Study|Withdrawal by Subject|10|||
161419537|NCT00999518|582923386|FG003|Overall Study|Withdrawal by Subject|6|||
161419538|NCT00999518|582923387|FG004|Overall Study|Withdrawal by Subject|1|||
161419539|NCT00999518|582923383|FG000|Overall Study|Other|5|||
161419540|NCT00999518|582923384|FG001|Overall Study|Other|7|||
161419541|NCT00999518|582923385|FG002|Overall Study|Other|1|||
161419542|NCT00999518|582923386|FG003|Overall Study|Other|4|||
161419543|NCT00999518|582923387|FG004|Overall Study|Other|5|||
161419544|NCT00999518|582923383|FG000|Overall Study|Randomized but not Treated|1|||
161419545|NCT00999518|582923384|FG001|Overall Study|Randomized but not Treated|1|||
161419546|NCT00999518|582923385|FG002|Overall Study|Randomized but not Treated|2|||
161419547|NCT00999518|582923386|FG003|Overall Study|Randomized but not Treated|0|||
161419548|NCT00999518|582923387|FG004|Overall Study|Randomized but not Treated|1|||
161419549|NCT01811186|582923391|FG000|Overall Study|Adverse Event|54|||
161419550|NCT01811186|582923392|FG001|Overall Study|Adverse Event|38|||
161419551|NCT01811186|582923391|FG000|Overall Study|Protocol Violation|5|||
161419552|NCT01811186|582923392|FG001|Overall Study|Protocol Violation|6|||
161419553|NCT01811186|582923391|FG000|Overall Study|Withdrawal by Subject|5|||
161419554|NCT01811186|582923392|FG001|Overall Study|Withdrawal by Subject|10|||
161419555|NCT01811186|582923391|FG000|Overall Study|Lack of Efficacy|3|||
161419556|NCT01811186|582923392|FG001|Overall Study|Lack of Efficacy|6|||
161419557|NCT01811186|582923391|FG000|Overall Study|Lost to Follow-up|4|||
161419558|NCT01811186|582923392|FG001|Overall Study|Lost to Follow-up|2|||
161419559|NCT01445080|582923400|FG000|Overall Study|Adverse Event|5|||
161419560|NCT01445080|582923401|FG001|Overall Study|Adverse Event|3|||
161419561|NCT01445080|582923402|FG002|Overall Study|Adverse Event|11|||
161419562|NCT01445080|582923403|FG003|Overall Study|Adverse Event|6|||
161419563|NCT01445080|582923404|FG004|Overall Study|Adverse Event|2|||
161419564|NCT01445080|582923405|FG005|Overall Study|Adverse Event|3|||
161419565|NCT01445080|582923406|FG006|Overall Study|Adverse Event|0|||
161419566|NCT01445080|582923407|FG007|Overall Study|Adverse Event|3|||
161419567|NCT01445080|582923408|FG008|Overall Study|Adverse Event|10|||
161419568|NCT01445080|582923400|FG000|Overall Study|Physician Decision|0|||
161419569|NCT01445080|582923401|FG001|Overall Study|Physician Decision|0|||
161419570|NCT01445080|582923402|FG002|Overall Study|Physician Decision|1|||
161419571|NCT01445080|582923403|FG003|Overall Study|Physician Decision|0|||
161419572|NCT01445080|582923404|FG004|Overall Study|Physician Decision|0|||
161419573|NCT01445080|582923405|FG005|Overall Study|Physician Decision|3|||
161419574|NCT01445080|582923406|FG006|Overall Study|Physician Decision|2|||
161419575|NCT01445080|582923407|FG007|Overall Study|Physician Decision|2|||
161419576|NCT01445080|582923408|FG008|Overall Study|Physician Decision|0|||
161419577|NCT01445080|582923400|FG000|Overall Study|Withdrawal by Subject|1|||
161419578|NCT01445080|582923401|FG001|Overall Study|Withdrawal by Subject|0|||
161419579|NCT01445080|582923402|FG002|Overall Study|Withdrawal by Subject|0|||
161419580|NCT01445080|582923403|FG003|Overall Study|Withdrawal by Subject|1|||
161419581|NCT01445080|582923404|FG004|Overall Study|Withdrawal by Subject|0|||
161419582|NCT01445080|582923405|FG005|Overall Study|Withdrawal by Subject|0|||
161419583|NCT01445080|582923406|FG006|Overall Study|Withdrawal by Subject|0|||
161419584|NCT01445080|582923407|FG007|Overall Study|Withdrawal by Subject|0|||
161419585|NCT01445080|582923408|FG008|Overall Study|Withdrawal by Subject|2|||
161419586|NCT01445080|582923400|FG000|Overall Study|Ineligible/Inevaluable|1|||
161419587|NCT01445080|582923401|FG001|Overall Study|Ineligible/Inevaluable|2|||
161419588|NCT01445080|582923402|FG002|Overall Study|Ineligible/Inevaluable|0|||
161419589|NCT01445080|582923403|FG003|Overall Study|Ineligible/Inevaluable|1|||
161419590|NCT01445080|582923404|FG004|Overall Study|Ineligible/Inevaluable|2|||
161419591|NCT01445080|582923405|FG005|Overall Study|Ineligible/Inevaluable|3|||
161419592|NCT01445080|582923406|FG006|Overall Study|Ineligible/Inevaluable|0|||
161419593|NCT01445080|582923407|FG007|Overall Study|Ineligible/Inevaluable|0|||
161419594|NCT01445080|582923408|FG008|Overall Study|Ineligible/Inevaluable|6|||
161419595|NCT03887221|582923409|FG000|Overall Study|Protocol Violation|1|||
161419596|NCT03887221|582923410|FG001|Overall Study|Protocol Violation|0|||
161419597|NCT02487030|582923411|FG000|Overall Study|Lack of Efficacy|2|||
161419598|NCT02487030|582923412|FG001|Overall Study|Lack of Efficacy|4|||
161419599|NCT02487030|582923413|FG002|Overall Study|Lack of Efficacy|1|||
161419600|NCT02487030|582923414|FG003|Overall Study|Lack of Efficacy|0|||
161419601|NCT02487030|582923415|FG004|Overall Study|Lack of Efficacy|1|||
161419602|NCT02487030|582923416|FG005|Overall Study|Lack of Efficacy|0|||
161419603|NCT02487030|582923417|FG006|Overall Study|Lack of Efficacy|0|||
161419604|NCT02487030|582923411|FG000|Overall Study|Lost to Follow-up|0|||
161419605|NCT02487030|582923412|FG001|Overall Study|Lost to Follow-up|0|||
161419606|NCT02487030|582923413|FG002|Overall Study|Lost to Follow-up|1|||
161419607|NCT02487030|582923414|FG003|Overall Study|Lost to Follow-up|1|||
161419608|NCT02487030|582923415|FG004|Overall Study|Lost to Follow-up|0|||
161419609|NCT02487030|582923416|FG005|Overall Study|Lost to Follow-up|1|||
161419610|NCT02487030|582923417|FG006|Overall Study|Lost to Follow-up|0|||
161419611|NCT02487030|582923411|FG000|Overall Study|Adverse Event|0|||
161419612|NCT02487030|582923412|FG001|Overall Study|Adverse Event|0|||
161419613|NCT02487030|582923413|FG002|Overall Study|Adverse Event|0|||
161419614|NCT02487030|582923414|FG003|Overall Study|Adverse Event|1|||
161419615|NCT02487030|582923415|FG004|Overall Study|Adverse Event|0|||
161419616|NCT02487030|582923416|FG005|Overall Study|Adverse Event|0|||
161419617|NCT02487030|582923417|FG006|Overall Study|Adverse Event|0|||
161419618|NCT02487030|582923411|FG000|Overall Study|Death|0|||
161419619|NCT02487030|582923412|FG001|Overall Study|Death|0|||
161419620|NCT02487030|582923413|FG002|Overall Study|Death|0|||
161419621|NCT02487030|582923414|FG003|Overall Study|Death|0|||
161419622|NCT02487030|582923415|FG004|Overall Study|Death|1|||
161419623|NCT02487030|582923416|FG005|Overall Study|Death|0|||
161419624|NCT02487030|582923417|FG006|Overall Study|Death|0|||
161419625|NCT03857542|582923418|FG000|Overall Study|Adverse Event|1|||
161419626|NCT03857542|582923419|FG001|Overall Study|Adverse Event|3|||
161419627|NCT03857542|582923418|FG000|Overall Study|Withdrawal by Subject|2|||
161419628|NCT03857542|582923419|FG001|Overall Study|Withdrawal by Subject|1|||
161419629|NCT03857542|582923418|FG000|Overall Study|Lost to Follow-up|2|||
161419630|NCT03857542|582923419|FG001|Overall Study|Lost to Follow-up|1|||
161419631|NCT03857542|582923418|FG000|Overall Study|Reason not Specified|1|||
161419632|NCT03857542|582923419|FG001|Overall Study|Reason not Specified|0|||
161419633|NCT02123576|582923420|FG000|Overall Study|Adverse Event|1|||
161419634|NCT02123576|582923421|FG001|Overall Study|Adverse Event|0|||
161419635|NCT04864639|582924873|FG000|Overall Study|Death|1|||
161419636|NCT04864639|582924873|FG000|Overall Study|Lost to Follow-up|1|||
161419637|NCT00713544|582924889|FG000|Overall Study|Adverse Event|5|||
161419638|NCT00713544|582924890|FG001|Overall Study|Adverse Event|3|||
161419639|NCT00713544|582924891|FG002|Overall Study|Adverse Event|7|||
161419640|NCT00713544|582924892|FG003|Overall Study|Adverse Event|7|||
161419641|NCT00713544|582924893|FG004|Overall Study|Adverse Event|3|||
161419642|NCT00713544|582924894|FG005|Overall Study|Adverse Event|5|||
161419643|NCT00713544|582924889|FG000|Overall Study|Withdrawal by Subject|2|||
161419644|NCT00713544|582924890|FG001|Overall Study|Withdrawal by Subject|0|||
161419645|NCT00713544|582924891|FG002|Overall Study|Withdrawal by Subject|3|||
161419646|NCT00713544|582924892|FG003|Overall Study|Withdrawal by Subject|2|||
161419647|NCT00713544|582924893|FG004|Overall Study|Withdrawal by Subject|3|||
161419648|NCT00713544|582924894|FG005|Overall Study|Withdrawal by Subject|1|||
161419649|NCT00713544|582924889|FG000|Overall Study|Protocol Violation|0|||
161419650|NCT00713544|582924890|FG001|Overall Study|Protocol Violation|0|||
161419651|NCT00713544|582924891|FG002|Overall Study|Protocol Violation|0|||
161419652|NCT00713544|582924892|FG003|Overall Study|Protocol Violation|0|||
161419653|NCT00713544|582924893|FG004|Overall Study|Protocol Violation|0|||
161419654|NCT00713544|582924894|FG005|Overall Study|Protocol Violation|1|||
161419655|NCT00713544|582924889|FG000|Overall Study|Physician Decision|0|||
161419656|NCT00713544|582924890|FG001|Overall Study|Physician Decision|0|||
161419657|NCT00713544|582924891|FG002|Overall Study|Physician Decision|0|||
161419658|NCT00713544|582924892|FG003|Overall Study|Physician Decision|0|||
161419659|NCT00713544|582924893|FG004|Overall Study|Physician Decision|0|||
161419660|NCT00713544|582924894|FG005|Overall Study|Physician Decision|2|||
161419661|NCT00713544|582924889|FG000|Overall Study|Lack of Efficacy|0|||
161419662|NCT00713544|582924890|FG001|Overall Study|Lack of Efficacy|1|||
161419663|NCT00713544|582924891|FG002|Overall Study|Lack of Efficacy|0|||
161419664|NCT00713544|582924892|FG003|Overall Study|Lack of Efficacy|1|||
161419665|NCT00713544|582924893|FG004|Overall Study|Lack of Efficacy|1|||
161419666|NCT00713544|582924894|FG005|Overall Study|Lack of Efficacy|0|||
161419667|NCT00713544|582924889|FG000|Overall Study|Lost to Follow-up|0|||
161419668|NCT00713544|582924890|FG001|Overall Study|Lost to Follow-up|0|||
161419669|NCT00713544|582924891|FG002|Overall Study|Lost to Follow-up|1|||
161419670|NCT00713544|582924892|FG003|Overall Study|Lost to Follow-up|0|||
161419671|NCT00713544|582924893|FG004|Overall Study|Lost to Follow-up|0|||
161419672|NCT00713544|582924894|FG005|Overall Study|Lost to Follow-up|0|||
161419673|NCT00713544|582924889|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161419674|NCT00713544|582924890|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
161419675|NCT00713544|582924891|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161419676|NCT00713544|582924892|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161419677|NCT00713544|582924893|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161419678|NCT00713544|582924894|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161419679|NCT00713544|582924889|FG000|Overall Study|Incorrect enrollment|0|||
161419680|NCT00713544|582924890|FG001|Overall Study|Incorrect enrollment|1|||
161419681|NCT00713544|582924891|FG002|Overall Study|Incorrect enrollment|0|||
161419682|NCT00713544|582924892|FG003|Overall Study|Incorrect enrollment|0|||
161419683|NCT00713544|582924893|FG004|Overall Study|Incorrect enrollment|0|||
161419684|NCT00713544|582924894|FG005|Overall Study|Incorrect enrollment|0|||
161419685|NCT00713544|582924889|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
161419686|NCT00713544|582924890|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
161419687|NCT00713544|582924891|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
161419688|NCT00713544|582924892|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
161419689|NCT00713544|582924893|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
161419690|NCT00713544|582924894|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
161419691|NCT00269919|582924895|FG000|Overall Study|Other|26|||
161419692|NCT00269919|582924895|FG000|Overall Study|Started but not treated|1|||
161419693|NCT00786799|582924898|FG000|Overall Study|Lost to Follow-up|1|||
161419694|NCT00786799|582924899|FG001|Overall Study|Lost to Follow-up|1|||
161419695|NCT02544503|582924900|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
161419696|NCT02544503|582924901|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
161419697|NCT02544503|582924900|FG000|Overall Study|Lost to Follow-up|9|||
161419698|NCT02544503|582924901|FG001|Overall Study|Lost to Follow-up|0|||
161419699|NCT02544503|582924900|FG000|Overall Study|Withdrawal by Subject|1|||
161419700|NCT02544503|582924901|FG001|Overall Study|Withdrawal by Subject|0|||
161419701|NCT04640311|582924902|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
161419702|NCT04640311|582924903|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419703|NCT04640311|582924904|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419704|NCT04640311|582924905|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419705|NCT04640311|582924906|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419706|NCT04640311|582924907|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419707|NCT04640311|582924908|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419708|NCT04640311|582924909|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419709|NCT04640311|582924910|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419710|NCT04640311|582924911|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419711|NCT04640311|582924912|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419712|NCT04640311|582924913|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419713|NCT04640311|582924914|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419714|NCT04640311|582924902|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419715|NCT04640311|582924903|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
161419716|NCT04640311|582924904|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419717|NCT04640311|582924905|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419718|NCT04640311|582924906|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419719|NCT04640311|582924907|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419720|NCT04640311|582924908|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419721|NCT04640311|582924909|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419722|NCT04640311|582924910|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419723|NCT04640311|582924911|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419724|NCT04640311|582924912|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419725|NCT04640311|582924913|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419726|NCT04640311|582924914|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161419727|NCT04640311|582924902|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419728|NCT04640311|582924903|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
161419729|NCT04640311|582924904|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419730|NCT04640311|582924905|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419731|NCT04640311|582924906|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419732|NCT04640311|582924907|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419733|NCT04640311|582924908|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161435337|NCT03104868|582988001|FG001|6 Week Follow up|Lost to Follow-up|8|||
161419734|NCT04640311|582924909|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419735|NCT04640311|582924910|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419736|NCT04640311|582924911|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419737|NCT04640311|582924912|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419738|NCT04640311|582924913|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419739|NCT04640311|582924914|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419740|NCT04640311|582924902|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
161419741|NCT04640311|582924903|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
161419742|NCT04640311|582924904|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
161419743|NCT04640311|582924905|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419744|NCT04640311|582924906|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419745|NCT04640311|582924907|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419746|NCT04640311|582924908|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419747|NCT04640311|582924909|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419748|NCT04640311|582924910|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419749|NCT04640311|582924911|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419750|NCT04640311|582924912|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419751|NCT04640311|582924913|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419752|NCT04640311|582924914|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161419753|NCT04640311|582924902|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419754|NCT04640311|582924903|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419755|NCT04640311|582924904|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
161419756|NCT04640311|582924905|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419757|NCT04640311|582924906|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419758|NCT04640311|582924907|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419759|NCT04640311|582924908|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419760|NCT04640311|582924909|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419761|NCT04640311|582924910|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419762|NCT04640311|582924911|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419763|NCT04640311|582924912|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419764|NCT04640311|582924913|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419765|NCT04640311|582924914|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161419766|NCT04640311|582924902|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419767|NCT04640311|582924903|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419768|NCT04640311|582924904|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419769|NCT04640311|582924905|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
161419770|NCT04640311|582924906|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419771|NCT04640311|582924907|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419772|NCT04640311|582924908|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
161419773|NCT04640311|582924909|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419774|NCT04640311|582924910|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419775|NCT04640311|582924911|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419776|NCT04640311|582924912|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419777|NCT04640311|582924913|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419778|NCT04640311|582924914|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161419779|NCT04640311|582924902|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419780|NCT04640311|582924903|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419781|NCT04640311|582924904|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419782|NCT04640311|582924905|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419783|NCT04640311|582924906|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419784|NCT04640311|582924907|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
161419785|NCT04640311|582924908|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419786|NCT04640311|582924909|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419787|NCT04640311|582924910|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
161419788|NCT04640311|582924911|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419789|NCT04640311|582924912|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161435338|NCT03104868|582988000|FG000|6 Week Follow up|Death|1|||
161419790|NCT04640311|582924913|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419791|NCT04640311|582924914|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161419792|NCT04640311|582924902|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419793|NCT04640311|582924903|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419794|NCT04640311|582924904|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419795|NCT04640311|582924905|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419796|NCT04640311|582924906|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419797|NCT04640311|582924907|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419798|NCT04640311|582924908|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
161419799|NCT04640311|582924909|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419800|NCT04640311|582924910|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419801|NCT04640311|582924911|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419802|NCT04640311|582924912|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
161419803|NCT04640311|582924913|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419804|NCT04640311|582924914|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161419805|NCT04640311|582924902|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419806|NCT04640311|582924903|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419807|NCT04640311|582924904|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419808|NCT04640311|582924905|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419809|NCT04640311|582924906|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419810|NCT04640311|582924907|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419811|NCT04640311|582924908|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419812|NCT04640311|582924909|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419813|NCT04640311|582924910|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419814|NCT04640311|582924911|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419815|NCT04640311|582924912|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419816|NCT04640311|582924913|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
161419817|NCT04640311|582924914|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161419818|NCT01641601|582924915|FG000|Overall Study|Study discontinued.|3|||
161419819|NCT01641601|582924916|FG001|Overall Study|Study discontinued.|5|||
161419820|NCT01799226|582924920|FG000|Overall Study|Withdrawal by Subject|1|||
161419821|NCT01799226|582924921|FG001|Overall Study|Withdrawal by Subject|0|||
161419822|NCT01799226|582924920|FG000|Overall Study|Disqualified at Day 14|1|||
161419823|NCT01799226|582924921|FG001|Overall Study|Disqualified at Day 14|0|||
161419824|NCT02178995|582924922|FG000|Double Blind|Adverse Event|0|||
161419825|NCT02178995|582924923|FG001|Double Blind|Adverse Event|0|||
161419826|NCT02178995|582924924|FG002|Double Blind|Adverse Event|0|||
161419827|NCT02178995|582924925|FG003|Double Blind|Adverse Event|0|||
161419828|NCT02178995|582924926|FG004|Double Blind|Adverse Event|0|||
161419829|NCT02178995|582924927|FG005|Double Blind|Adverse Event|1|||
161419830|NCT02178995|582924928|FG006|Double Blind|Adverse Event|0|||
161419831|NCT02178995|582924929|FG007|Double Blind|Adverse Event|1|||
161419832|NCT02178995|582924930|FG008|Double Blind|Adverse Event|1|||
161419833|NCT02178995|582924922|FG000|Double Blind|Lost to Follow-up|0|||
161419834|NCT02178995|582924923|FG001|Double Blind|Lost to Follow-up|1|||
161419835|NCT02178995|582924924|FG002|Double Blind|Lost to Follow-up|0|||
161419836|NCT02178995|582924925|FG003|Double Blind|Lost to Follow-up|0|||
161419837|NCT02178995|582924926|FG004|Double Blind|Lost to Follow-up|0|||
161419838|NCT02178995|582924927|FG005|Double Blind|Lost to Follow-up|0|||
161419839|NCT02178995|582924928|FG006|Double Blind|Lost to Follow-up|0|||
161419840|NCT02178995|582924929|FG007|Double Blind|Lost to Follow-up|1|||
161419841|NCT02178995|582924930|FG008|Double Blind|Lost to Follow-up|0|||
161419842|NCT02178995|582924922|FG000|Open Label|Adverse Event|2|||
161419843|NCT02178995|582924923|FG001|Open Label|Adverse Event|0|||
161419844|NCT02178995|582924924|FG002|Open Label|Adverse Event|0|||
161419845|NCT02178995|582924925|FG003|Open Label|Adverse Event|0|||
161419846|NCT02178995|582924926|FG004|Open Label|Adverse Event|0|||
161419847|NCT02178995|582924927|FG005|Open Label|Adverse Event|0|||
161419848|NCT02178995|582924928|FG006|Open Label|Adverse Event|0|||
161419849|NCT02178995|582924929|FG007|Open Label|Adverse Event|0|||
161419850|NCT02178995|582924930|FG008|Open Label|Adverse Event|0|||
161419851|NCT02114606|582924932|FG000|Overall Study|Unable to swallow Cytosponge|6|||
161419852|NCT00981461|582924933|FG000|Overall Study|Lost to Follow-up|5|||
161419853|NCT00981461|582924934|FG001|Overall Study|Lost to Follow-up|2|||
161419854|NCT01388907|582924935|FG000|Overall Study|Adverse Event|2|||
161419855|NCT01388907|582924936|FG001|Overall Study|Adverse Event|0|||
161419856|NCT03361293|582924937|FG000|Overall Study|Lost to Follow-up|0|||
161419857|NCT03361293|582924938|FG001|Overall Study|Lost to Follow-up|2|||
161419858|NCT03361293|582924937|FG000|Overall Study|Withdrawal by Subject|1|||
161419859|NCT03361293|582924938|FG001|Overall Study|Withdrawal by Subject|3|||
161419860|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
161419861|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
161419862|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
161419863|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
161419864|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
161419865|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
161419866|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
161419867|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
161419868|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
161419869|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
161419870|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
161419871|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
161419872|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
161419873|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
161419874|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
161419875|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
161419876|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
161419877|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
161419878|NCT01910402|582924939|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
161419879|NCT01910402|582924940|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
161419880|NCT01910402|582924941|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
161419881|NCT01910402|582924939|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
161419882|NCT01910402|582924940|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
161419883|NCT01910402|582924941|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
161419884|NCT01910402|582924939|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
161419885|NCT01910402|582924940|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
161419886|NCT01910402|582924941|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
161419887|NCT01910402|582924939|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
161419888|NCT01910402|582924940|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
161419889|NCT01910402|582924941|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
161419890|NCT01910402|582924939|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
161419891|NCT01910402|582924940|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
161419892|NCT01910402|582924941|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
161419893|NCT01910402|582924939|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
161419894|NCT01910402|582924940|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
161419895|NCT01910402|582924941|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
161419896|NCT01910402|582924939|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
161419897|NCT01910402|582924940|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
161419898|NCT01910402|582924941|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
161419899|NCT00483405|582924942|FG000|Overall Study|Adverse Event|8|||
161419900|NCT00483405|582924942|FG000|Overall Study|Lack of Efficacy|14|||
161419901|NCT00483405|582924942|FG000|Overall Study|Death|3|||
161419902|NCT00483405|582924942|FG000|Overall Study|Withdrawal by Subject|2|||
161419903|NCT00483405|582924942|FG000|Overall Study|Other complicating disease|1|||
161419904|NCT03010319|582924943|FG000|Overall Study|Adverse Event|15|||
161419905|NCT03010319|582924944|FG001|Overall Study|Adverse Event|9|||
161419906|NCT03010319|582924943|FG000|Overall Study|Withdrawal by Subject|1|||
161419907|NCT03010319|582924944|FG001|Overall Study|Withdrawal by Subject|6|||
161419908|NCT03010319|582924943|FG000|Overall Study|Physician Decision|2|||
161419909|NCT03010319|582924944|FG001|Overall Study|Physician Decision|4|||
161419910|NCT03010319|582924943|FG000|Overall Study|Sponsor requested withdrawal|2|||
161419911|NCT03010319|582924944|FG001|Overall Study|Sponsor requested withdrawal|2|||
161419912|NCT03010319|582924943|FG000|Overall Study|Death|1|||
161419913|NCT03010319|582924944|FG001|Overall Study|Death|0|||
161419914|NCT03010319|582924943|FG000|Overall Study|Lost to Follow-up|0|||
161419915|NCT03010319|582924944|FG001|Overall Study|Lost to Follow-up|1|||
161419916|NCT03010319|582924943|FG000|Overall Study|Other Reason|5|||
161419917|NCT03010319|582924944|FG001|Overall Study|Other Reason|7|||
161419918|NCT02128724|582924945|FG000|Overall Study|Death|1|||
161419919|NCT02128724|582924946|FG001|Overall Study|Death|0|||
161419920|NCT02128724|582924947|FG002|Overall Study|Death|0|||
161419921|NCT02128724|582924948|FG003|Overall Study|Death|0|||
161419922|NCT02128724|582924945|FG000|Overall Study|Adverse Event|0|||
161419923|NCT02128724|582924946|FG001|Overall Study|Adverse Event|1|||
161419924|NCT02128724|582924947|FG002|Overall Study|Adverse Event|0|||
161419925|NCT02128724|582924948|FG003|Overall Study|Adverse Event|0|||
161419926|NCT02128724|582924945|FG000|Overall Study|Physician Decision|0|||
161419927|NCT02128724|582924946|FG001|Overall Study|Physician Decision|0|||
161419928|NCT02128724|582924947|FG002|Overall Study|Physician Decision|0|||
161419929|NCT02128724|582924948|FG003|Overall Study|Physician Decision|2|||
161419930|NCT02128724|582924945|FG000|Overall Study|Withdrawal by Subject|0|||
161419931|NCT02128724|582924946|FG001|Overall Study|Withdrawal by Subject|0|||
161419932|NCT02128724|582924947|FG002|Overall Study|Withdrawal by Subject|0|||
161435339|NCT03104868|582988001|FG001|6 Week Follow up|Death|1|||
161419933|NCT02128724|582924948|FG003|Overall Study|Withdrawal by Subject|1|||
161419934|NCT01957202|582924950|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419935|NCT01957202|582924951|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
161419936|NCT01957202|582924952|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419937|NCT01957202|582924953|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419938|NCT01957202|582924954|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419939|NCT01957202|582924955|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419940|NCT01957202|582924956|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419941|NCT01957202|582924957|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419942|NCT01957202|582924958|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419943|NCT01957202|582924959|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419944|NCT01957202|582924960|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419945|NCT01957202|582924961|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419946|NCT01957202|582924962|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419947|NCT01957202|582924963|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419948|NCT01957202|582924964|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419949|NCT01957202|582924965|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419950|NCT01957202|582924966|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
161419951|NCT01957202|582924967|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161419952|NCT01957202|582924950|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419953|NCT01957202|582924951|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419954|NCT01957202|582924952|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419955|NCT01957202|582924953|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419956|NCT01957202|582924954|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419957|NCT01957202|582924955|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419958|NCT01957202|582924956|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419959|NCT01957202|582924957|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419960|NCT01957202|582924958|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419961|NCT01957202|582924959|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419962|NCT01957202|582924960|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419963|NCT01957202|582924961|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419964|NCT01957202|582924962|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419965|NCT01957202|582924963|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419966|NCT01957202|582924964|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419967|NCT01957202|582924965|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419968|NCT01957202|582924966|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
161419969|NCT01957202|582924967|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
161419970|NCT03594773|582924969|FG000|Overall Study|Withdrawal by Subject|3|||
161419971|NCT03594773|582924970|FG001|Overall Study|Withdrawal by Subject|2|||
161419972|NCT03594773|582924969|FG000|Overall Study|Lost to Follow-up|3|||
161419973|NCT03594773|582924970|FG001|Overall Study|Lost to Follow-up|4|||
161419974|NCT02640547|582924971|FG000|Overall Study|Failure to Return|1|||
161419975|NCT02640547|582924971|FG000|Overall Study|Withdrawal by Subject|1|||
161419976|NCT02640547|582924971|FG000|Overall Study|Death|6|||
161419977|NCT02640547|582924971|FG000|Overall Study|Miscellaneous|3|||
161419978|NCT00193206|582924972|FG000|Preoperative Therapy|Lack of Efficacy|2|||
161419979|NCT00193206|582924972|FG000|Preoperative Therapy|Adverse Event|2|||
161419980|NCT00193206|582924972|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
161419981|NCT00193206|582924972|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
161419982|NCT00193206|582924972|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
161419983|NCT00193206|582924972|FG000|Postoperative Therapy|Physician Decision|3|||
161419984|NCT00193206|582924972|FG000|Postoperative Therapy|Intercurrent Illness|2|||
161419985|NCT00193206|582924972|FG000|Postoperative Therapy|Lack of Efficacy|1|||
161419986|NCT00193206|582924972|FG000|Postoperative Therapy|Protocol Violation|1|||
161419987|NCT01200368|582924974|FG000|Infant Series|Adverse Event|2|||
161419988|NCT01200368|582924975|FG001|Infant Series|Adverse Event|2|||
161419989|NCT01200368|582924976|FG002|Infant Series|Adverse Event|3|||
161419990|NCT01200368|582924974|FG000|Infant Series|Withdrawal by Subject|0|||
161419991|NCT01200368|582924975|FG001|Infant Series|Withdrawal by Subject|2|||
161419992|NCT01200368|582924976|FG002|Infant Series|Withdrawal by Subject|2|||
161419993|NCT01200368|582924974|FG000|Infant Series|Did not meet entrance criteria|0|||
161419994|NCT01200368|582924975|FG001|Infant Series|Did not meet entrance criteria|1|||
161419995|NCT01200368|582924976|FG002|Infant Series|Did not meet entrance criteria|0|||
161419996|NCT01200368|582924974|FG000|Infant Series|Randomized, not vaccinated|0|||
161419997|NCT01200368|582924975|FG001|Infant Series|Randomized, not vaccinated|1|||
161419998|NCT01200368|582924976|FG002|Infant Series|Randomized, not vaccinated|1|||
161419999|NCT01200368|582924974|FG000|Infant Series|Other|1|||
161420000|NCT01200368|582924975|FG001|Infant Series|Other|0|||
161420001|NCT01200368|582924976|FG002|Infant Series|Other|0|||
161420002|NCT01200368|582924974|FG000|After Infant Series|Adverse Event|6|||
161420003|NCT01200368|582924975|FG001|After Infant Series|Adverse Event|6|||
161420004|NCT01200368|582924976|FG002|After Infant Series|Adverse Event|3|||
161420005|NCT01200368|582924974|FG000|After Infant Series|Withdrawal by Subject|10|||
161420006|NCT01200368|582924975|FG001|After Infant Series|Withdrawal by Subject|8|||
161420007|NCT01200368|582924976|FG002|After Infant Series|Withdrawal by Subject|4|||
161420008|NCT01200368|582924974|FG000|After Infant Series|Lost to Follow-up|1|||
161420009|NCT01200368|582924975|FG001|After Infant Series|Lost to Follow-up|0|||
161420010|NCT01200368|582924976|FG002|After Infant Series|Lost to Follow-up|0|||
161420011|NCT01200368|582924974|FG000|After Infant Series|Other|1|||
161420012|NCT01200368|582924975|FG001|After Infant Series|Other|2|||
161420013|NCT01200368|582924976|FG002|After Infant Series|Other|2|||
161420014|NCT01200368|582924974|FG000|Toddler Dose|Adverse Event|0|||
161420015|NCT01200368|582924975|FG001|Toddler Dose|Adverse Event|3|||
161420016|NCT01200368|582924976|FG002|Toddler Dose|Adverse Event|1|||
161420017|NCT01290757|582924977|FG000|Overall Study|Adverse Event|1|||
161420018|NCT01290757|582924978|FG001|Overall Study|Adverse Event|0|||
161420019|NCT01290757|582924977|FG000|Overall Study|Protocol Violation|1|||
161420020|NCT01290757|582924978|FG001|Overall Study|Protocol Violation|1|||
161420021|NCT01290757|582924977|FG000|Overall Study|Other|0|||
161420022|NCT01290757|582924978|FG001|Overall Study|Other|1|||
161420023|NCT00080301|582924980|FG000|Overall Study|Randomized but Never Treated|5|||
161420024|NCT00080301|582924981|FG001|Overall Study|Randomized but Never Treated|10|||
161420025|NCT00080301|582924980|FG000|Overall Study|Still on Treatment as of CSR date|0|||
161420026|NCT00080301|582924981|FG001|Overall Study|Still on Treatment as of CSR date|1|||
161420027|NCT00991939|582924982|FG000|Overall Study|Lost to Follow-up|0|||
161420028|NCT00991939|582924983|FG001|Overall Study|Lost to Follow-up|1|||
161420029|NCT00991939|582924982|FG000|Overall Study|Withdrawal by Subject|1|||
161420030|NCT00991939|582924983|FG001|Overall Study|Withdrawal by Subject|0|||
161420031|NCT00991939|582924982|FG000|Overall Study|Entire study terminated|4|||
161420032|NCT00991939|582924983|FG001|Overall Study|Entire study terminated|1|||
161420033|NCT00181766|582924993|FG000|Overall Study|Lost to Follow-up|6|||
161420034|NCT00181766|582924993|FG000|Overall Study|Adverse Event|4|||
161420035|NCT00181766|582924993|FG000|Overall Study|non-compliance|2|||
161420036|NCT01965704|582924996|FG000|Overall Study|Withdrawal by Subject|2|||
161420037|NCT01965704|582924997|FG001|Overall Study|Withdrawal by Subject|2|||
161420038|NCT01965704|582924998|FG002|Overall Study|Withdrawal by Subject|1|||
161420039|NCT01965704|582924999|FG003|Overall Study|Withdrawal by Subject|1|||
161420040|NCT01965704|582924996|FG000|Overall Study|Delivered at home|1|||
161420041|NCT01965704|582924997|FG001|Overall Study|Delivered at home|1|||
161420042|NCT01965704|582924998|FG002|Overall Study|Delivered at home|0|||
161420043|NCT01965704|582924999|FG003|Overall Study|Delivered at home|0|||
161420044|NCT01965704|582924996|FG000|Overall Study|Experienced complications|0|||
161420045|NCT01965704|582924997|FG001|Overall Study|Experienced complications|0|||
161420046|NCT01965704|582924998|FG002|Overall Study|Experienced complications|2|||
161420047|NCT01965704|582924999|FG003|Overall Study|Experienced complications|2|||
161420048|NCT01965704|582924996|FG000|Overall Study|Adverse Event|0|||
161420049|NCT01965704|582924997|FG001|Overall Study|Adverse Event|0|||
161420050|NCT01965704|582924998|FG002|Overall Study|Adverse Event|1|||
161420051|NCT01965704|582924999|FG003|Overall Study|Adverse Event|1|||
161420052|NCT01965704|582924996|FG000|Overall Study|Did not meet inclusion criteria|0|||
161420053|NCT01965704|582924997|FG001|Overall Study|Did not meet inclusion criteria|0|||
161420054|NCT01965704|582924998|FG002|Overall Study|Did not meet inclusion criteria|1|||
161420055|NCT01965704|582924999|FG003|Overall Study|Did not meet inclusion criteria|1|||
161420056|NCT02524171|582925003|FG000|6-month Follow-up|Lost to Follow-up|53|||
161420057|NCT02524171|582925004|FG001|6-month Follow-up|Lost to Follow-up|45|||
161420058|NCT02524171|582925003|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
161420059|NCT02524171|582925004|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
161420060|NCT01502228|582925005|FG000|Overall Study|Death|1|||
161420061|NCT05730387|582925006|FG000|Overall Study|Stillbirth|0|||
161420062|NCT05730387|582925007|FG001|Overall Study|Stillbirth|262|||
161420063|NCT05730387|582925006|FG000|Overall Study|Died during or after delivery|2|||
161420064|NCT05730387|582925007|FG001|Overall Study|Died during or after delivery|85|||
161420065|NCT05730387|582925006|FG000|Overall Study|Died after being admitted|0|||
161420066|NCT05730387|582925007|FG001|Overall Study|Died after being admitted|44|||
161420067|NCT05730387|582925006|FG000|Overall Study|Lost to Follow-up|69|||
161420068|NCT05730387|582925007|FG001|Overall Study|Lost to Follow-up|77|||
161420069|NCT00637416|582925013|FG000|Overall Study|Lost to Follow-up|1|||
161420070|NCT00637416|582925014|FG001|Overall Study|Lost to Follow-up|1|||
161420071|NCT00637416|582925013|FG000|Overall Study|Unable to take study drug|0|||
161420072|NCT00637416|582925014|FG001|Overall Study|Unable to take study drug|1|||
161420073|NCT04137731|582925017|FG000|Overall Study|Surgery Cancellation|1|||
161420074|NCT04137731|582925018|FG001|Overall Study|Surgery Cancellation|2|||
161420075|NCT04137731|582925017|FG000|Overall Study|Withdrawal by Subject|2|||
161420076|NCT04137731|582925018|FG001|Overall Study|Withdrawal by Subject|0|||
161420077|NCT04137731|582925017|FG000|Overall Study|Protocol Violation|0|||
161420078|NCT04137731|582925018|FG001|Overall Study|Protocol Violation|1|||
161420079|NCT02204072|582925020|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
161420080|NCT02204072|582925021|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
161420081|NCT02204072|582925022|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
161420082|NCT02204072|582925023|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
161420083|NCT02204072|582925024|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
161420084|NCT02204072|582925020|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
161420085|NCT02204072|582925021|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
161420086|NCT02204072|582925022|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
161420087|NCT02204072|582925023|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
161420088|NCT02204072|582925024|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
161420089|NCT02204072|582925020|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
161420090|NCT02204072|582925021|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
161420091|NCT02204072|582925022|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
161420092|NCT02204072|582925023|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
161420093|NCT02204072|582925024|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
161420094|NCT02204072|582925020|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161420095|NCT02204072|582925021|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161420096|NCT02204072|582925022|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
161420097|NCT02204072|582925023|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161420098|NCT02204072|582925024|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161420099|NCT00310817|582925025|FG000|Overall Study|AE or Death|3|||
161420100|NCT00310817|582925026|FG001|Overall Study|AE or Death|1|||
161420101|NCT00310817|582925027|FG002|Overall Study|AE or Death|0|||
161420102|NCT00310817|582925028|FG003|Overall Study|AE or Death|0|||
161420103|NCT00310817|582925025|FG000|Overall Study|Withdrawal by Subject|1|||
161420104|NCT00310817|582925026|FG001|Overall Study|Withdrawal by Subject|4|||
161420105|NCT00310817|582925027|FG002|Overall Study|Withdrawal by Subject|6|||
161420106|NCT00310817|582925028|FG003|Overall Study|Withdrawal by Subject|7|||
161420107|NCT00310817|582925025|FG000|Overall Study|Lost to Follow-up|2|||
161420108|NCT00310817|582925026|FG001|Overall Study|Lost to Follow-up|1|||
161420109|NCT00310817|582925027|FG002|Overall Study|Lost to Follow-up|0|||
161420110|NCT00310817|582925028|FG003|Overall Study|Lost to Follow-up|0|||
161420111|NCT00310817|582925025|FG000|Overall Study|Inappropriate Enrollment|1|||
161420112|NCT00310817|582925026|FG001|Overall Study|Inappropriate Enrollment|0|||
161420113|NCT00310817|582925027|FG002|Overall Study|Inappropriate Enrollment|1|||
161420114|NCT00310817|582925028|FG003|Overall Study|Inappropriate Enrollment|0|||
161420115|NCT00310817|582925025|FG000|Overall Study|Protocol Violation|1|||
161420116|NCT00310817|582925026|FG001|Overall Study|Protocol Violation|1|||
161420117|NCT00310817|582925027|FG002|Overall Study|Protocol Violation|1|||
161420118|NCT00310817|582925028|FG003|Overall Study|Protocol Violation|1|||
161420119|NCT00310817|582925025|FG000|Overall Study|Unable to classify|3|||
161420120|NCT00310817|582925026|FG001|Overall Study|Unable to classify|1|||
161420121|NCT00310817|582925027|FG002|Overall Study|Unable to classify|0|||
161420122|NCT00310817|582925028|FG003|Overall Study|Unable to classify|0|||
161420123|NCT01587040|582925034|FG000|Overall Study|Protocol Violation|0|||
161420124|NCT01587040|582925035|FG001|Overall Study|Protocol Violation|0|||
161420125|NCT01587040|582925036|FG002|Overall Study|Protocol Violation|1|||
161420126|NCT01587040|582925037|FG003|Overall Study|Protocol Violation|0|||
161420127|NCT01587040|582925034|FG000|Overall Study|Adverse Event|0|||
161420128|NCT01587040|582925035|FG001|Overall Study|Adverse Event|1|||
161420129|NCT01587040|582925036|FG002|Overall Study|Adverse Event|10|||
161420130|NCT01587040|582925037|FG003|Overall Study|Adverse Event|0|||
161420131|NCT01587040|582925034|FG000|Overall Study|Disease progression|12|||
161420132|NCT01587040|582925035|FG001|Overall Study|Disease progression|1|||
161420133|NCT01587040|582925036|FG002|Overall Study|Disease progression|15|||
161420134|NCT01587040|582925037|FG003|Overall Study|Disease progression|3|||
161420135|NCT01587040|582925034|FG000|Overall Study|Other than specified|5|||
161420136|NCT01587040|582925035|FG001|Overall Study|Other than specified|1|||
161420137|NCT01587040|582925036|FG002|Overall Study|Other than specified|11|||
161420138|NCT01587040|582925037|FG003|Overall Study|Other than specified|1|||
161420139|NCT00367835|582925041|FG000|Overall Study|Adverse Event|14|||
161420140|NCT00367835|582925042|FG001|Overall Study|Adverse Event|1|||
161420141|NCT00367835|582925041|FG000|Overall Study|Protocol Violation|1|||
161420142|NCT00367835|582925042|FG001|Overall Study|Protocol Violation|7|||
161420143|NCT00367835|582925041|FG000|Overall Study|Withdrawal by Subject|7|||
161420144|NCT00367835|582925042|FG001|Overall Study|Withdrawal by Subject|6|||
161420145|NCT00367835|582925041|FG000|Overall Study|Lost to Follow-up|1|||
161420146|NCT00367835|582925042|FG001|Overall Study|Lost to Follow-up|4|||
161420147|NCT00367835|582925041|FG000|Overall Study|Lack of Efficacy|3|||
161420148|NCT00367835|582925042|FG001|Overall Study|Lack of Efficacy|12|||
161420149|NCT00367835|582925041|FG000|Overall Study|Subject in juvenile detention center|1|||
161420150|NCT00367835|582925042|FG001|Overall Study|Subject in juvenile detention center|0|||
161420151|NCT00367835|582925041|FG000|Overall Study|refused blood collection|1|||
161420152|NCT00367835|582925042|FG001|Overall Study|refused blood collection|0|||
161420153|NCT00367835|582925041|FG000|Overall Study|Did not respond to calls|1|||
161420154|NCT00367835|582925042|FG001|Overall Study|Did not respond to calls|0|||
161420155|NCT00367835|582925041|FG000|Overall Study|History of lead poisoning|0|||
161420156|NCT00367835|582925042|FG001|Overall Study|History of lead poisoning|1|||
161420157|NCT04346654|582925044|FG000|Overall Study|Adverse Event|2|||
161420158|NCT04346654|582925045|FG001|Overall Study|Adverse Event|0|||
161420159|NCT04346654|582925044|FG000|Overall Study|Non-response|1|||
161420160|NCT04346654|582925045|FG001|Overall Study|Non-response|1|||
161420161|NCT04346654|582925044|FG000|Overall Study|Withdrawal by Subject|2|||
161420162|NCT04346654|582925045|FG001|Overall Study|Withdrawal by Subject|0|||
161420163|NCT04346654|582925044|FG000|Overall Study|Lost to Follow-up|0|||
161420164|NCT04346654|582925045|FG001|Overall Study|Lost to Follow-up|1|||
161420165|NCT04346654|582925044|FG000|Overall Study|Pregnancy|0|||
161420166|NCT04346654|582925045|FG001|Overall Study|Pregnancy|1|||
161420167|NCT01525615|582926872|FG000|Overall Study|Adverse Event|11|||
161420168|NCT01525615|582926873|FG001|Overall Study|Adverse Event|7|||
161420169|NCT01525615|582926874|FG002|Overall Study|Adverse Event|5|||
161420170|NCT01525615|582926872|FG000|Overall Study|Lost to Follow-up|1|||
161420171|NCT01525615|582926873|FG001|Overall Study|Lost to Follow-up|0|||
161420172|NCT01525615|582926874|FG002|Overall Study|Lost to Follow-up|0|||
161420173|NCT01525615|582926872|FG000|Overall Study|Withdrawal by Subject|1|||
161420174|NCT01525615|582926873|FG001|Overall Study|Withdrawal by Subject|0|||
161420175|NCT01525615|582926874|FG002|Overall Study|Withdrawal by Subject|0|||
161420176|NCT01525615|582926872|FG000|Overall Study|Other reason not described above|1|||
161420177|NCT01525615|582926873|FG001|Overall Study|Other reason not described above|0|||
161420178|NCT01525615|582926874|FG002|Overall Study|Other reason not described above|1|||
161420179|NCT04050618|582926875|FG000|First Intervention|Withdrawal by Subject|2|||
161420180|NCT04050618|582926876|FG001|First Intervention|Withdrawal by Subject|0|||
161420181|NCT04050618|582926875|FG000|Second Intervention|Withdrawal by Subject|1|||
161420182|NCT04050618|582926876|FG001|Second Intervention|Withdrawal by Subject|0|||
161420183|NCT01101035|582926877|FG000|Overall Study|Adverse Event|191|||
161420184|NCT01101035|582926878|FG001|Overall Study|Adverse Event|172|||
161420185|NCT01101035|582926877|FG000|Overall Study|Major Protocol Deviation|52|||
161420186|NCT01101035|582926878|FG001|Overall Study|Major Protocol Deviation|46|||
161420187|NCT01101035|582926877|FG000|Overall Study|Lost to Follow-up|226|||
161420188|NCT01101035|582926878|FG001|Overall Study|Lost to Follow-up|223|||
161420189|NCT01101035|582926877|FG000|Overall Study|Voluntary Withdrawal|595|||
161420190|NCT01101035|582926878|FG001|Overall Study|Voluntary Withdrawal|587|||
161420191|NCT01101035|582926877|FG000|Overall Study|Reason not Specified|333|||
161420192|NCT01101035|582926878|FG001|Overall Study|Reason not Specified|363|||
161420193|NCT00217425|582926879|FG000|Overall Study|Never started treatment|2|||
161420194|NCT00217425|582926879|FG000|Overall Study|Patient ineligible|5|||
161420195|NCT00217425|582926879|FG000|Overall Study|Lack of Efficacy|13|||
161420196|NCT00217425|582926879|FG000|Overall Study|Adverse Event|8|||
161420197|NCT00217425|582926879|FG000|Overall Study|Withdrawal by Subject|4|||
161420198|NCT00217425|582926879|FG000|Overall Study|Other complicating disease|1|||
161420199|NCT00217425|582926879|FG000|Overall Study|Other|4|||
161420200|NCT00671034|582926881|FG000|Overall Study|Adverse Event|5|||
161420201|NCT00671034|582926882|FG001|Overall Study|Adverse Event|7|||
161420202|NCT00671034|582926883|FG002|Overall Study|Adverse Event|1|||
161420203|NCT00671034|582926881|FG000|Overall Study|Death|3|||
161420204|NCT00671034|582926882|FG001|Overall Study|Death|2|||
161420205|NCT00671034|582926883|FG002|Overall Study|Death|1|||
161420206|NCT00671034|582926881|FG000|Overall Study|Physician Decision|12|||
161420207|NCT00671034|582926882|FG001|Overall Study|Physician Decision|4|||
161420208|NCT00671034|582926883|FG002|Overall Study|Physician Decision|5|||
161420209|NCT00671034|582926881|FG000|Overall Study|VHR ALL feature|8|||
161420210|NCT00671034|582926882|FG001|Overall Study|VHR ALL feature|3|||
161420211|NCT00671034|582926883|FG002|Overall Study|VHR ALL feature|5|||
161420212|NCT00671034|582926881|FG000|Overall Study|Refusal|5|||
161420213|NCT00671034|582926882|FG001|Overall Study|Refusal|3|||
161420214|NCT00671034|582926883|FG002|Overall Study|Refusal|5|||
161420215|NCT00671034|582926881|FG000|Overall Study|includes Alternative therapy, etc.|6|||
161420216|NCT00671034|582926882|FG001|Overall Study|includes Alternative therapy, etc.|1|||
161420217|NCT00671034|582926883|FG002|Overall Study|includes Alternative therapy, etc.|7|||
161420218|NCT00330759|582926884|FG000|Overall Study|Death|316|||
161420219|NCT00330759|582926885|FG001|Overall Study|Death|310|||
161420220|NCT00330759|582926884|FG000|Overall Study|Disease progression|104|||
161420221|NCT00330759|582926885|FG001|Overall Study|Disease progression|126|||
161420222|NCT00330759|582926884|FG000|Overall Study|Withdrawal by Subject|143|||
161420223|NCT00330759|582926885|FG001|Overall Study|Withdrawal by Subject|124|||
161420224|NCT00330759|582926884|FG000|Overall Study|Adverse Event|48|||
161420225|NCT00330759|582926885|FG001|Overall Study|Adverse Event|36|||
161420226|NCT00330759|582926884|FG000|Overall Study|Participant request|31|||
161420227|NCT00330759|582926885|FG001|Overall Study|Participant request|22|||
161420228|NCT00330759|582926884|FG000|Overall Study|Lost to Follow-up|16|||
161420229|NCT00330759|582926885|FG001|Overall Study|Lost to Follow-up|22|||
161420230|NCT00330759|582926884|FG000|Overall Study|Noncompliance|15|||
161420231|NCT00330759|582926885|FG001|Overall Study|Noncompliance|17|||
161420232|NCT00330759|582926884|FG000|Overall Study|Physician Decision|1|||
161420233|NCT00330759|582926885|FG001|Overall Study|Physician Decision|2|||
161420234|NCT00330759|582926884|FG000|Overall Study|Protocol deviation|0|||
161420235|NCT00330759|582926885|FG001|Overall Study|Protocol deviation|2|||
161420236|NCT00330759|582926884|FG000|Overall Study|Ineligibility determined|2|||
161420237|NCT00330759|582926885|FG001|Overall Study|Ineligibility determined|1|||
161420238|NCT00330759|582926884|FG000|Overall Study|Other|36|||
161420239|NCT00330759|582926885|FG001|Overall Study|Other|44|||
161420240|NCT02380287|582926886|FG000|Overall Study|Adverse Event|0|||
161420241|NCT02380287|582926887|FG001|Overall Study|Adverse Event|0|||
161420242|NCT02380287|582926888|FG002|Overall Study|Adverse Event|1|||
161420243|NCT02380287|582926889|FG003|Overall Study|Adverse Event|0|||
161420244|NCT02380287|582926890|FG004|Overall Study|Adverse Event|0|||
161420245|NCT02380287|582926891|FG005|Overall Study|Adverse Event|0|||
161420246|NCT02380287|582926892|FG006|Overall Study|Adverse Event|0|||
161420247|NCT02380287|582926893|FG007|Overall Study|Adverse Event|0|||
161420248|NCT04473963|582926894|FG000|Overall Study|Withdrawal by Subject|1|||
161420249|NCT04473963|582926895|FG001|Overall Study|Withdrawal by Subject|1|||
161420250|NCT04473963|582926896|FG002|Overall Study|Withdrawal by Subject|0|||
161420251|NCT04473963|582926894|FG000|Overall Study|Not inducible in AF|0|||
161420252|NCT04473963|582926895|FG001|Overall Study|Not inducible in AF|0|||
161420253|NCT04473963|582926896|FG002|Overall Study|Not inducible in AF|2|||
161420254|NCT04685798|582926897|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
161420255|NCT02152761|582926902|FG000|Epoch: Treatment Epoch|Technical problems|0|||
161420256|NCT02152761|582926903|FG001|Epoch: Treatment Epoch|Technical problems|0|||
161420257|NCT02152761|582926904|FG002|Epoch: Treatment Epoch|Technical problems|0|||
161420258|NCT02152761|582926905|FG003|Epoch: Treatment Epoch|Technical problems|1|||
161420259|NCT02152761|582926902|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
161420260|NCT02152761|582926903|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
161420261|NCT02152761|582926904|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
161420262|NCT02152761|582926905|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
161420263|NCT02152761|582926902|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
161420264|NCT02152761|582926903|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
161420265|NCT02152761|582926904|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
161420266|NCT02152761|582926905|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
161420267|NCT02152761|582926902|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
161420268|NCT02152761|582926903|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
161420269|NCT02152761|582926904|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
161420270|NCT02152761|582926905|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
161420271|NCT02152761|582926902|FG000|Epoch: Treatment Epoch|Death|0|||
161420272|NCT02152761|582926903|FG001|Epoch: Treatment Epoch|Death|3|||
161420273|NCT02152761|582926904|FG002|Epoch: Treatment Epoch|Death|1|||
161420274|NCT02152761|582926905|FG003|Epoch: Treatment Epoch|Death|0|||
161420275|NCT02152761|582926902|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
161420276|NCT02152761|582926903|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
161420277|NCT02152761|582926904|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
161420278|NCT02152761|582926905|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
161420279|NCT02152761|582926902|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
161420280|NCT02152761|582926903|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
161420281|NCT02152761|582926904|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
161420282|NCT02152761|582926905|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
161420283|NCT02152761|582926902|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
161420284|NCT02152761|582926903|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
161420285|NCT02152761|582926904|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
161420286|NCT02152761|582926905|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
161420287|NCT02152761|582926902|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
161420288|NCT02152761|582926903|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161420289|NCT02152761|582926904|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161420290|NCT02152761|582926905|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161420291|NCT02152761|582926902|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
161420292|NCT02152761|582926903|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
161420293|NCT02152761|582926904|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
161420294|NCT02152761|582926905|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
161420295|NCT01797263|582926906|FG000|Overall Study|Withdrawal by Subject|21|||
161420296|NCT01797263|582926907|FG001|Overall Study|Withdrawal by Subject|25|||
161420297|NCT01797263|582926906|FG000|Overall Study|Death|1|||
161420298|NCT01797263|582926907|FG001|Overall Study|Death|0|||
161420299|NCT01797263|582926906|FG000|Overall Study|Lost to Follow-up|15|||
161420300|NCT01797263|582926907|FG001|Overall Study|Lost to Follow-up|15|||
161420301|NCT01550757|582926908|FG000|Overall Study|Lost to Follow-up|21|||
161420302|NCT01550757|582926909|FG001|Overall Study|Lost to Follow-up|14|||
161420303|NCT01550757|582926910|FG002|Overall Study|Lost to Follow-up|42|||
161420304|NCT01550757|582926911|FG003|Overall Study|Lost to Follow-up|53|||
161420305|NCT01550757|582926908|FG000|Overall Study|Withdrawal by Subject|2|||
161420306|NCT01550757|582926909|FG001|Overall Study|Withdrawal by Subject|0|||
161420307|NCT01550757|582926910|FG002|Overall Study|Withdrawal by Subject|3|||
161420308|NCT01550757|582926911|FG003|Overall Study|Withdrawal by Subject|1|||
161420309|NCT02342223|582926912|FG000|Overall Study|Lost to Follow-up|1|||
161420310|NCT03018691|582926913|FG000|Overall Study|Adverse Event|1|||
161420311|NCT03018691|582926914|FG001|Overall Study|Adverse Event|1|||
161420312|NCT03018691|582926915|FG002|Overall Study|Adverse Event|4|||
161420313|NCT03018691|582926913|FG000|Overall Study|Lack of Efficacy|0|||
161420314|NCT03018691|582926914|FG001|Overall Study|Lack of Efficacy|0|||
161420315|NCT03018691|582926915|FG002|Overall Study|Lack of Efficacy|1|||
161420316|NCT03018691|582926913|FG000|Overall Study|Withdrawal by Subject|0|||
161420317|NCT03018691|582926914|FG001|Overall Study|Withdrawal by Subject|0|||
161420318|NCT03018691|582926915|FG002|Overall Study|Withdrawal by Subject|1|||
161420319|NCT03018691|582926913|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161420320|NCT03018691|582926914|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161420321|NCT03018691|582926915|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161420322|NCT03369418|582926916|FG000|Overall Study|Withdrawal by Subject|3|||
161420323|NCT03369418|582926917|FG001|Overall Study|Withdrawal by Subject|3|||
161420324|NCT01485094|582926918|FG000|Overall Study|Adverse Event|1|||
161420325|NCT01485094|582926919|FG001|Overall Study|Adverse Event|1|||
161420326|NCT01485094|582926920|FG002|Overall Study|Adverse Event|1|||
161420327|NCT01485094|582926918|FG000|Overall Study|Lost to Follow-up|1|||
161420328|NCT01485094|582926919|FG001|Overall Study|Lost to Follow-up|0|||
161420329|NCT01485094|582926920|FG002|Overall Study|Lost to Follow-up|0|||
161420330|NCT01485094|582926918|FG000|Overall Study|Withdrawal by Subject|1|||
161420331|NCT01485094|582926919|FG001|Overall Study|Withdrawal by Subject|1|||
161420332|NCT01485094|582926920|FG002|Overall Study|Withdrawal by Subject|0|||
161420333|NCT01426958|582926921|FG000|Overall Study|Adverse Event|2|||
161420334|NCT02859246|582926927|FG000|Overall Study|Screen fails|3|||
161420335|NCT02859246|582926927|FG000|Overall Study|Adverse Event|1|||
161420336|NCT02859246|582926927|FG000|Overall Study|Withdrawal by Subject|1|||
161420337|NCT05280717|582926928|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
161420338|NCT05280717|582926929|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
161420339|NCT05280717|582926930|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
161420340|NCT05280717|582926931|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161420341|NCT05280717|582926932|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161420342|NCT05280717|582926933|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161420343|NCT05280717|582926934|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161420344|NCT05280717|582926928|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
161420345|NCT05280717|582926929|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161420346|NCT05280717|582926930|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161420347|NCT05280717|582926931|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161420348|NCT05280717|582926932|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161420349|NCT05280717|582926933|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161420350|NCT05280717|582926934|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161420351|NCT05280717|582926928|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161420352|NCT05280717|582926929|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
161420353|NCT05280717|582926930|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161420354|NCT05280717|582926931|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161420355|NCT05280717|582926932|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161420356|NCT05280717|582926933|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161420357|NCT05280717|582926934|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161420358|NCT05280717|582926928|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161420359|NCT05280717|582926929|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161420360|NCT05280717|582926930|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
161420361|NCT05280717|582926931|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161420362|NCT05280717|582926932|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161420363|NCT05280717|582926933|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161420364|NCT05280717|582926934|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161420365|NCT05280717|582926928|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161420366|NCT05280717|582926929|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161420367|NCT05280717|582926930|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161420368|NCT05280717|582926931|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161420369|NCT05280717|582926932|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161420370|NCT05280717|582926933|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
161420371|NCT05280717|582926934|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161420372|NCT05280717|582926928|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161420373|NCT05280717|582926929|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161420374|NCT05280717|582926930|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161420375|NCT05280717|582926931|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161420376|NCT05280717|582926932|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161420377|NCT05280717|582926933|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
161420378|NCT05280717|582926934|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161420379|NCT00740584|582926937|FG000|Overall Study|Withdrawal by Subject|1|||
161420380|NCT00855816|582926938|FG000|Overall Study|Withdrawal by Subject|22|||
161420381|NCT00855816|582926939|FG001|Overall Study|Withdrawal by Subject|15|||
161420382|NCT00855816|582926938|FG000|Overall Study|Lost to Follow-up|3|||
161420383|NCT00855816|582926939|FG001|Overall Study|Lost to Follow-up|5|||
161420384|NCT00855816|582926938|FG000|Overall Study|Death|1|||
161420385|NCT00855816|582926939|FG001|Overall Study|Death|0|||
161420386|NCT00855816|582926938|FG000|Overall Study|Became ineligible|0|||
161420387|NCT00855816|582926939|FG001|Overall Study|Became ineligible|1|||
161420388|NCT03188432|582926946|FG000|Overall Study|Death|3|||
161420389|NCT03188432|582926946|FG000|Overall Study|Withdrawal by Subject|15|||
161420390|NCT03188432|582926946|FG000|Overall Study|Did not complete protocol treatment|9|||
161420391|NCT01196026|582926949|FG000|Overall Study|Withdrawal by Subject|1|||
161420392|NCT01196026|582926950|FG001|Overall Study|Withdrawal by Subject|4|||
161420393|NCT01196026|582926951|FG002|Overall Study|Withdrawal by Subject|0|||
161420394|NCT01196026|582926952|FG003|Overall Study|Withdrawal by Subject|0|||
161420395|NCT01196026|582926953|FG004|Overall Study|Withdrawal by Subject|0|||
161420396|NCT01196026|582926954|FG005|Overall Study|Withdrawal by Subject|0|||
161420397|NCT01196026|582926949|FG000|Overall Study|Lost to Follow-up|0|||
161420398|NCT01196026|582926950|FG001|Overall Study|Lost to Follow-up|3|||
161420399|NCT01196026|582926951|FG002|Overall Study|Lost to Follow-up|0|||
161420400|NCT01196026|582926952|FG003|Overall Study|Lost to Follow-up|0|||
161420401|NCT01196026|582926953|FG004|Overall Study|Lost to Follow-up|1|||
161420402|NCT01196026|582926954|FG005|Overall Study|Lost to Follow-up|0|||
161420403|NCT01196026|582926949|FG000|Overall Study|Other|0|||
161420404|NCT01196026|582926950|FG001|Overall Study|Other|1|||
161420405|NCT01196026|582926951|FG002|Overall Study|Other|0|||
161420406|NCT01196026|582926952|FG003|Overall Study|Other|0|||
161420407|NCT01196026|582926953|FG004|Overall Study|Other|0|||
161420408|NCT01196026|582926954|FG005|Overall Study|Other|0|||
161420409|NCT02868554|582926955|FG000|Overall Study|Lost to Follow-up|3|||
161420410|NCT02868554|582926956|FG001|Overall Study|Lost to Follow-up|0|||
161420411|NCT02868554|582926957|FG002|Overall Study|Lost to Follow-up|1|||
161420412|NCT05447663|582926962|FG000|Overall Study|Study terminated by Sponsor|5|||
161420413|NCT05447663|582926962|FG000|Overall Study|Death|2|||
161420414|NCT05447663|582926962|FG000|Overall Study|Withdrawal by Subject|1|||
161420415|NCT01100320|582926963|FG000|Period 1|Withdrawal by Subject|2|||
161420416|NCT01100320|582926964|FG001|Period 1|Withdrawal by Subject|4|||
161420417|NCT01100320|582926963|FG000|Period 1|Positive Drug Screen|1|||
161420418|NCT01100320|582926964|FG001|Period 1|Positive Drug Screen|1|||
161420419|NCT01100320|582926963|FG000|Period 1|Adverse Event|2|||
161420420|NCT01100320|582926964|FG001|Period 1|Adverse Event|2|||
161420421|NCT01100320|582926963|FG000|Period 2|Withdrawal by Subject|1|||
161420422|NCT01100320|582926964|FG001|Period 2|Withdrawal by Subject|1|||
161420423|NCT04181762|582926965|FG000|Overall Study|Adverse Event|1|||
161420424|NCT04181762|582926966|FG001|Overall Study|Adverse Event|3|||
161420425|NCT04181762|582926965|FG000|Overall Study|Lost to Follow-up|1|||
161420426|NCT04181762|582926966|FG001|Overall Study|Lost to Follow-up|1|||
161420427|NCT04181762|582926965|FG000|Overall Study|Physician Decision|1|||
161420428|NCT04181762|582926966|FG001|Overall Study|Physician Decision|3|||
161420429|NCT04181762|582926965|FG000|Overall Study|Pregnancy|0|||
161420430|NCT04181762|582926966|FG001|Overall Study|Pregnancy|1|||
161420431|NCT04181762|582926965|FG000|Overall Study|Lack of Efficacy|2|||
161420432|NCT04181762|582926966|FG001|Overall Study|Lack of Efficacy|2|||
161420433|NCT04181762|582926965|FG000|Overall Study|Study terminated by sponsor|95|||
161420434|NCT04181762|582926966|FG001|Overall Study|Study terminated by sponsor|97|||
161420435|NCT04181762|582926965|FG000|Overall Study|Subject decision|11|||
161420436|NCT04181762|582926966|FG001|Overall Study|Subject decision|4|||
161420437|NCT04181762|582926965|FG000|Overall Study|Death|1|||
161420438|NCT04181762|582926966|FG001|Overall Study|Death|1|||
161420439|NCT04181762|582926965|FG000|Overall Study|Protocol deviation|1|||
161420440|NCT04181762|582926966|FG001|Overall Study|Protocol deviation|0|||
161420441|NCT04181762|582926965|FG000|Overall Study|Withdrawal of informed consent|1|||
161420442|NCT04181762|582926966|FG001|Overall Study|Withdrawal of informed consent|3|||
161420443|NCT04669301|582926967|FG000|Overall Study|Lost to Follow-up|0|||
161420444|NCT04669301|582926968|FG001|Overall Study|Lost to Follow-up|1|||
161420445|NCT04669301|582926969|FG002|Overall Study|Lost to Follow-up|0|||
161420446|NCT04669301|582926967|FG000|Overall Study|Withdrawal by Subject|3|||
161420447|NCT04669301|582926968|FG001|Overall Study|Withdrawal by Subject|2|||
161420448|NCT04669301|582926969|FG002|Overall Study|Withdrawal by Subject|0|||
161420449|NCT02586727|582926970|FG000|Overall Study|Lost to Follow-up|1|||
161420450|NCT02586727|582926971|FG001|Overall Study|Lost to Follow-up|0|||
161420451|NCT05888181|582926972|FG000|Overall Study|Lost to Follow-up|1|||
161420452|NCT05888181|582926973|FG001|Overall Study|Lost to Follow-up|1|||
161420453|NCT05888181|582926974|FG002|Overall Study|Lost to Follow-up|0|||
161420454|NCT02534909|582926977|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
161420455|NCT02326597|582926980|FG000|Overall Study|Lost to Follow-up|42|||
161420456|NCT02326597|582926981|FG001|Overall Study|Lost to Follow-up|32|||
161420457|NCT00132808|582926982|FG000|Stratum I|Adverse Event|2|||
161420458|NCT00132808|582926983|FG001|Stratum I|Adverse Event|1|||
161420459|NCT00132808|582926984|FG002|Stratum I|Adverse Event|0|||
161420460|NCT00132808|582926982|FG000|Stratum I|Lost to Follow-up|3|||
161420461|NCT00132808|582926983|FG001|Stratum I|Lost to Follow-up|4|||
161420462|NCT00132808|582926984|FG002|Stratum I|Lost to Follow-up|1|||
161420463|NCT00132808|582926982|FG000|Stratum I|Withdrawal by Subject|4|||
161420464|NCT00132808|582926983|FG001|Stratum I|Withdrawal by Subject|7|||
161420465|NCT00132808|582926984|FG002|Stratum I|Withdrawal by Subject|3|||
161420466|NCT00132808|582926982|FG000|Stratum I|Abnormal test procedure result (s)|0|||
161420467|NCT00132808|582926983|FG001|Stratum I|Abnormal test procedure result (s)|0|||
161420468|NCT00132808|582926984|FG002|Stratum I|Abnormal test procedure result (s)|1|||
161420469|NCT00132808|582926982|FG000|Stratum II|Adverse Event|1|||
161420470|NCT00132808|582926983|FG001|Stratum II|Adverse Event|2|||
161420471|NCT00132808|582926984|FG002|Stratum II|Adverse Event|1|||
161420472|NCT00132808|582926982|FG000|Stratum II|Death|1|||
161420473|NCT00132808|582926983|FG001|Stratum II|Death|0|||
161420474|NCT00132808|582926984|FG002|Stratum II|Death|0|||
161420475|NCT00132808|582926982|FG000|Stratum II|Lost to Follow-up|2|||
161420476|NCT00132808|582926983|FG001|Stratum II|Lost to Follow-up|2|||
161420477|NCT00132808|582926984|FG002|Stratum II|Lost to Follow-up|1|||
161420478|NCT00132808|582926982|FG000|Stratum II|Protocol Violation|0|||
161420479|NCT00132808|582926983|FG001|Stratum II|Protocol Violation|2|||
161420480|NCT00132808|582926984|FG002|Stratum II|Protocol Violation|1|||
161420481|NCT00132808|582926982|FG000|Stratum II|Withdrawal by Subject|4|||
161420482|NCT00132808|582926983|FG001|Stratum II|Withdrawal by Subject|9|||
161420483|NCT00132808|582926984|FG002|Stratum II|Withdrawal by Subject|6|||
161420484|NCT00428948|582926988|FG000|Overall Study|Lost to Follow-up|15|||
161420485|NCT00428948|582926989|FG001|Overall Study|Lost to Follow-up|8|||
161420486|NCT00428948|582926988|FG000|Overall Study|Adverse Event|148|||
161420487|NCT00428948|582926989|FG001|Overall Study|Adverse Event|24|||
161420488|NCT00428948|582926988|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
161420489|NCT00428948|582926989|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
161420490|NCT00428948|582926988|FG000|Overall Study|Investigator Withdrew Subject|3|||
161420491|NCT00428948|582926989|FG001|Overall Study|Investigator Withdrew Subject|4|||
161420492|NCT00428948|582926988|FG000|Overall Study|Subject Withdrew Consent|50|||
161420493|NCT00428948|582926989|FG001|Overall Study|Subject Withdrew Consent|30|||
161420494|NCT00428948|582926988|FG000|Overall Study|Protocol Deviation|1|||
161420495|NCT00428948|582926989|FG001|Overall Study|Protocol Deviation|1|||
161420496|NCT00577824|582926990|FG000|Overall Study|Adverse Event|6|||
161420497|NCT00577824|582926991|FG001|Overall Study|Adverse Event|18|||
161420498|NCT00577824|582926992|FG002|Overall Study|Adverse Event|1|||
161420499|NCT00577824|582926990|FG000|Overall Study|Patient decision|0|||
161420500|NCT00577824|582926991|FG001|Overall Study|Patient decision|1|||
161420501|NCT00577824|582926992|FG002|Overall Study|Patient decision|1|||
161420502|NCT00577824|582926990|FG000|Overall Study|Protocol Violation|1|||
161420503|NCT00577824|582926991|FG001|Overall Study|Protocol Violation|1|||
161420504|NCT00577824|582926992|FG002|Overall Study|Protocol Violation|0|||
161420505|NCT00362648|582926993|FG000|Overall Study|Adverse Event|12|||
161420506|NCT00362648|582926994|FG001|Overall Study|Adverse Event|21|||
161420507|NCT00362648|582926995|FG002|Overall Study|Adverse Event|1|||
161420508|NCT00362648|582926996|FG003|Overall Study|Adverse Event|0|||
161420509|NCT00362648|582926993|FG000|Overall Study|Lost to Follow-up|62|||
161420510|NCT00362648|582926994|FG001|Overall Study|Lost to Follow-up|69|||
161420511|NCT00362648|582926995|FG002|Overall Study|Lost to Follow-up|4|||
161420512|NCT00362648|582926996|FG003|Overall Study|Lost to Follow-up|3|||
161420513|NCT00362648|582926993|FG000|Overall Study|Protocol Violation|4|||
161420514|NCT00362648|582926994|FG001|Overall Study|Protocol Violation|2|||
161420515|NCT00362648|582926995|FG002|Overall Study|Protocol Violation|2|||
161420516|NCT00362648|582926996|FG003|Overall Study|Protocol Violation|2|||
161420517|NCT00362648|582926993|FG000|Overall Study|Withdrawal by Subject|48|||
161420518|NCT00362648|582926994|FG001|Overall Study|Withdrawal by Subject|42|||
161420519|NCT00362648|582926995|FG002|Overall Study|Withdrawal by Subject|2|||
161420520|NCT00362648|582926996|FG003|Overall Study|Withdrawal by Subject|6|||
161420521|NCT04752332|582926997|FG000|Overall Study|Adverse Event|3|||
161420522|NCT04752332|582926998|FG001|Overall Study|Adverse Event|1|||
161420523|NCT04752332|582926997|FG000|Overall Study|Disease Relapse|1|||
161420524|NCT04752332|582926998|FG001|Overall Study|Disease Relapse|0|||
161420525|NCT04752332|582926997|FG000|Overall Study|Non-compliance With Study Drug|2|||
161420526|NCT04752332|582926998|FG001|Overall Study|Non-compliance With Study Drug|0|||
161420527|NCT04752332|582926997|FG000|Overall Study|Physician Decision|2|||
161420528|NCT04752332|582926998|FG001|Overall Study|Physician Decision|1|||
161420529|NCT04752332|582926997|FG000|Overall Study|Protocol Violation|1|||
161420530|NCT04752332|582926998|FG001|Overall Study|Protocol Violation|1|||
161420531|NCT04752332|582926997|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
161420532|NCT04752332|582926998|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
161420533|NCT04752332|582926997|FG000|Overall Study|Study Terminated by Sponsor|10|||
161420534|NCT04752332|582926998|FG001|Overall Study|Study Terminated by Sponsor|48|||
161420535|NCT04752332|582926997|FG000|Overall Study|Withdrawal by Subject|11|||
161420536|NCT04752332|582926998|FG001|Overall Study|Withdrawal by Subject|3|||
161420537|NCT00924443|582926999|FG000|Overall Study|Physician Decision|2|||
161420538|NCT00924443|582926999|FG000|Overall Study|Protocol Violation|1|||
161420539|NCT02978833|582927002|FG000|Overall Study|Study terminated|1|||
161420540|NCT02978833|582927003|FG001|Overall Study|Study terminated|1|||
161420541|NCT01123395|582927006|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
161420542|NCT01123395|582927007|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
161420543|NCT00186901|582927008|FG000|Overall Study|Pregnancy|6|||
161420544|NCT00186901|582927009|FG001|Overall Study|Pregnancy|3|||
161420545|NCT00186901|582927010|FG002|Overall Study|Pregnancy|0|||
161420546|NCT00186901|582927008|FG000|Overall Study|Lost to Follow-up|6|||
161420547|NCT00186901|582927009|FG001|Overall Study|Lost to Follow-up|3|||
161420548|NCT00186901|582927010|FG002|Overall Study|Lost to Follow-up|0|||
161420549|NCT00186901|582927008|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
161420550|NCT00186901|582927009|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
161420551|NCT00186901|582927010|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
161420552|NCT00186901|582927008|FG000|Overall Study|ALL relapse or second malignancy|1|||
161420553|NCT00186901|582927009|FG001|Overall Study|ALL relapse or second malignancy|2|||
161420554|NCT00186901|582927010|FG002|Overall Study|ALL relapse or second malignancy|0|||
161420555|NCT00186901|582927008|FG000|Overall Study|Withdrawal by Subject|4|||
161420556|NCT00186901|582927009|FG001|Overall Study|Withdrawal by Subject|5|||
161420557|NCT00186901|582927010|FG002|Overall Study|Withdrawal by Subject|0|||
161420558|NCT00186901|582927008|FG000|Overall Study|Open label|3|||
161420559|NCT00186901|582927009|FG001|Overall Study|Open label|2|||
161420560|NCT00186901|582927010|FG002|Overall Study|Open label|0|||
161420561|NCT00186901|582927008|FG000|Overall Study|Limited adherence to study requirements|20|||
161420562|NCT00186901|582927009|FG001|Overall Study|Limited adherence to study requirements|23|||
161420563|NCT00186901|582927010|FG002|Overall Study|Limited adherence to study requirements|0|||
161420564|NCT00186901|582927008|FG000|Overall Study|Bone Mineral Density > 0|0|||
161420565|NCT00186901|582927009|FG001|Overall Study|Bone Mineral Density > 0|0|||
161420566|NCT00186901|582927010|FG002|Overall Study|Bone Mineral Density > 0|149|||
161420567|NCT00782483|582927013|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
161420568|NCT01052077|582927014|FG000|Phase A|Lost to Follow-up|22|||
161420569|NCT01052077|582927015|FG001|Phase A|Lost to Follow-up|0|||
161420570|NCT01052077|582927016|FG002|Phase A|Lost to Follow-up|0|||
161420571|NCT01052077|582927017|FG003|Phase A|Lost to Follow-up|0|||
161420572|NCT01052077|582927014|FG000|Phase A|Adverse Event|32|||
161420573|NCT01052077|582927015|FG001|Phase A|Adverse Event|0|||
161420574|NCT01052077|582927016|FG002|Phase A|Adverse Event|0|||
161420575|NCT01052077|582927017|FG003|Phase A|Adverse Event|0|||
161420576|NCT01052077|582927014|FG000|Phase A|Met Withdrawal Criteria|26|||
161420577|NCT01052077|582927015|FG001|Phase A|Met Withdrawal Criteria|0|||
161420578|NCT01052077|582927016|FG002|Phase A|Met Withdrawal Criteria|0|||
161420579|NCT01052077|582927017|FG003|Phase A|Met Withdrawal Criteria|0|||
161420580|NCT01052077|582927014|FG000|Phase A|Physician Decision|10|||
161420581|NCT01052077|582927015|FG001|Phase A|Physician Decision|0|||
161420582|NCT01052077|582927016|FG002|Phase A|Physician Decision|0|||
161420583|NCT01052077|582927017|FG003|Phase A|Physician Decision|0|||
161420584|NCT01052077|582927014|FG000|Phase A|Withdrawal by Subject|29|||
161420585|NCT01052077|582927015|FG001|Phase A|Withdrawal by Subject|0|||
161420586|NCT01052077|582927016|FG002|Phase A|Withdrawal by Subject|0|||
161420587|NCT01052077|582927017|FG003|Phase A|Withdrawal by Subject|0|||
161420588|NCT01052077|582927014|FG000|Phase A|Protocol Deviation|27|||
161420589|NCT01052077|582927015|FG001|Phase A|Protocol Deviation|0|||
161420590|NCT01052077|582927016|FG002|Phase A|Protocol Deviation|0|||
161420591|NCT01052077|582927017|FG003|Phase A|Protocol Deviation|0|||
161420592|NCT01052077|582927014|FG000|Phase B|Lost to Follow-up|0|||
161420593|NCT01052077|582927015|FG001|Phase B|Lost to Follow-up|2|||
161420594|NCT01052077|582927016|FG002|Phase B|Lost to Follow-up|3|||
161420595|NCT01052077|582927017|FG003|Phase B|Lost to Follow-up|0|||
161420596|NCT01052077|582927014|FG000|Phase B|Adverse Event|0|||
161420597|NCT01052077|582927015|FG001|Phase B|Adverse Event|9|||
161420598|NCT01052077|582927016|FG002|Phase B|Adverse Event|2|||
161420599|NCT01052077|582927017|FG003|Phase B|Adverse Event|0|||
161420600|NCT01052077|582927014|FG000|Phase B|Met Withdrawal Criteria|0|||
161420601|NCT01052077|582927015|FG001|Phase B|Met Withdrawal Criteria|2|||
161420602|NCT01052077|582927016|FG002|Phase B|Met Withdrawal Criteria|1|||
161420603|NCT01052077|582927017|FG003|Phase B|Met Withdrawal Criteria|0|||
161420604|NCT01052077|582927014|FG000|Phase B|Physician Decision|0|||
161420605|NCT01052077|582927015|FG001|Phase B|Physician Decision|1|||
161420606|NCT01052077|582927016|FG002|Phase B|Physician Decision|1|||
161420607|NCT01052077|582927017|FG003|Phase B|Physician Decision|0|||
161420608|NCT01052077|582927014|FG000|Phase B|Withdrawal by Subject|0|||
161420609|NCT01052077|582927015|FG001|Phase B|Withdrawal by Subject|0|||
161420610|NCT01052077|582927016|FG002|Phase B|Withdrawal by Subject|5|||
161420611|NCT01052077|582927017|FG003|Phase B|Withdrawal by Subject|0|||
161420612|NCT01052077|582927014|FG000|Phase B|Protocol Deviation|0|||
161420613|NCT01052077|582927015|FG001|Phase B|Protocol Deviation|3|||
161420614|NCT01052077|582927016|FG002|Phase B|Protocol Deviation|4|||
161420615|NCT01052077|582927017|FG003|Phase B|Protocol Deviation|0|||
161420616|NCT01052077|582927014|FG000|Phase B|Lack of Efficacy|0|||
161420617|NCT01052077|582927015|FG001|Phase B|Lack of Efficacy|1|||
161420618|NCT01052077|582927016|FG002|Phase B|Lack of Efficacy|0|||
161420619|NCT01052077|582927017|FG003|Phase B|Lack of Efficacy|0|||
161420620|NCT01052077|582927014|FG000|Phase A+|Lost to Follow-up|0|||
161420621|NCT01052077|582927015|FG001|Phase A+|Lost to Follow-up|0|||
161420622|NCT01052077|582927016|FG002|Phase A+|Lost to Follow-up|0|||
161420623|NCT01052077|582927017|FG003|Phase A+|Lost to Follow-up|8|||
161420624|NCT01052077|582927014|FG000|Phase A+|Adverse Event|0|||
161420625|NCT01052077|582927015|FG001|Phase A+|Adverse Event|0|||
161420626|NCT01052077|582927016|FG002|Phase A+|Adverse Event|0|||
161420627|NCT01052077|582927017|FG003|Phase A+|Adverse Event|4|||
161420628|NCT01052077|582927014|FG000|Phase A+|Met Withdrawal Criteria|0|||
161420629|NCT01052077|582927015|FG001|Phase A+|Met Withdrawal Criteria|0|||
161420630|NCT01052077|582927016|FG002|Phase A+|Met Withdrawal Criteria|0|||
161420631|NCT01052077|582927017|FG003|Phase A+|Met Withdrawal Criteria|2|||
161420632|NCT01052077|582927014|FG000|Phase A+|Withdrawal by Subject|0|||
161420633|NCT01052077|582927015|FG001|Phase A+|Withdrawal by Subject|0|||
161420634|NCT01052077|582927016|FG002|Phase A+|Withdrawal by Subject|0|||
161420635|NCT01052077|582927017|FG003|Phase A+|Withdrawal by Subject|7|||
161420636|NCT00003199|582927022|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
161420637|NCT00003199|582927022|FG000|Overall Study|Lack of insurance clearance|2|||
161420638|NCT00003199|582927022|FG000|Overall Study|Screen fail|15|||
161420639|NCT00940498|582927023|FG000|Overall Study|Death|2|||
161420640|NCT00940498|582927024|FG001|Overall Study|Death|0|||
161420641|NCT00940498|582927025|FG002|Overall Study|Death|0|||
161420642|NCT00940498|582927026|FG003|Overall Study|Death|1|||
161420643|NCT00940498|582927027|FG004|Overall Study|Death|5|||
161420644|NCT00940498|582927028|FG005|Overall Study|Death|0|||
161420645|NCT00940498|582927029|FG006|Overall Study|Death|1|||
161420646|NCT00940498|582927030|FG007|Overall Study|Death|0|||
161420647|NCT00940498|582927023|FG000|Overall Study|Lost to Follow-up|1|||
161420648|NCT00940498|582927024|FG001|Overall Study|Lost to Follow-up|1|||
161420649|NCT00940498|582927025|FG002|Overall Study|Lost to Follow-up|2|||
161420650|NCT00940498|582927026|FG003|Overall Study|Lost to Follow-up|0|||
161420651|NCT00940498|582927027|FG004|Overall Study|Lost to Follow-up|1|||
161420652|NCT00940498|582927028|FG005|Overall Study|Lost to Follow-up|0|||
161420653|NCT00940498|582927029|FG006|Overall Study|Lost to Follow-up|0|||
161420654|NCT00940498|582927030|FG007|Overall Study|Lost to Follow-up|1|||
161420655|NCT00940498|582927023|FG000|Overall Study|Disease Progression|0|||
161420656|NCT00940498|582927024|FG001|Overall Study|Disease Progression|0|||
161420657|NCT00940498|582927025|FG002|Overall Study|Disease Progression|1|||
161420658|NCT00940498|582927026|FG003|Overall Study|Disease Progression|1|||
161420659|NCT00940498|582927027|FG004|Overall Study|Disease Progression|0|||
161420660|NCT00940498|582927028|FG005|Overall Study|Disease Progression|1|||
161420661|NCT00940498|582927029|FG006|Overall Study|Disease Progression|0|||
161420662|NCT00940498|582927030|FG007|Overall Study|Disease Progression|0|||
161420663|NCT00940498|582927023|FG000|Overall Study|Physician Decision|0|||
161420664|NCT00940498|582927024|FG001|Overall Study|Physician Decision|0|||
161420665|NCT00940498|582927025|FG002|Overall Study|Physician Decision|0|||
161420666|NCT00940498|582927026|FG003|Overall Study|Physician Decision|0|||
161420667|NCT00940498|582927027|FG004|Overall Study|Physician Decision|2|||
161420668|NCT00940498|582927028|FG005|Overall Study|Physician Decision|0|||
161420669|NCT00940498|582927029|FG006|Overall Study|Physician Decision|0|||
161420670|NCT00940498|582927030|FG007|Overall Study|Physician Decision|0|||
161420671|NCT00940498|582927023|FG000|Overall Study|Not treated due to disease related pain|0|||
161420672|NCT00940498|582927024|FG001|Overall Study|Not treated due to disease related pain|0|||
161420673|NCT00940498|582927025|FG002|Overall Study|Not treated due to disease related pain|0|||
161420674|NCT00940498|582927026|FG003|Overall Study|Not treated due to disease related pain|0|||
161420675|NCT00940498|582927027|FG004|Overall Study|Not treated due to disease related pain|1|||
161420676|NCT00940498|582927028|FG005|Overall Study|Not treated due to disease related pain|0|||
161420677|NCT00940498|582927029|FG006|Overall Study|Not treated due to disease related pain|0|||
161420678|NCT00940498|582927030|FG007|Overall Study|Not treated due to disease related pain|0|||
161420679|NCT00900029|582927031|FG000|Overall Study|Lost to Follow-up|0|||
161420680|NCT00900029|582927032|FG001|Overall Study|Lost to Follow-up|2|||
161420681|NCT00900029|582927033|FG002|Overall Study|Lost to Follow-up|1|||
161420682|NCT00900029|582927034|FG003|Overall Study|Lost to Follow-up|4|||
161420683|NCT00900029|582927035|FG004|Overall Study|Lost to Follow-up|4|||
161420684|NCT00900029|582927031|FG000|Overall Study|Withdrawal by Subject|2|||
161420685|NCT00900029|582927032|FG001|Overall Study|Withdrawal by Subject|2|||
161420686|NCT00900029|582927033|FG002|Overall Study|Withdrawal by Subject|1|||
161420687|NCT00900029|582927034|FG003|Overall Study|Withdrawal by Subject|1|||
161420688|NCT00900029|582927035|FG004|Overall Study|Withdrawal by Subject|1|||
161420689|NCT00900029|582927031|FG000|Overall Study|Adverse Event|0|||
161420690|NCT00900029|582927032|FG001|Overall Study|Adverse Event|0|||
161420691|NCT00900029|582927033|FG002|Overall Study|Adverse Event|1|||
161420692|NCT00900029|582927034|FG003|Overall Study|Adverse Event|1|||
161420693|NCT00900029|582927035|FG004|Overall Study|Adverse Event|1|||
161420694|NCT00900029|582927031|FG000|Overall Study|Death|1|||
161420695|NCT00900029|582927032|FG001|Overall Study|Death|0|||
161420696|NCT00900029|582927033|FG002|Overall Study|Death|0|||
161420697|NCT00900029|582927034|FG003|Overall Study|Death|1|||
161420698|NCT00900029|582927035|FG004|Overall Study|Death|0|||
161420699|NCT02709330|582927036|FG000|Overall Study|Death|5|||
161420700|NCT02709330|582927037|FG001|Overall Study|Death|0|||
161420701|NCT02709330|582927036|FG000|Overall Study|Lost to Follow-up|2|||
161420702|NCT02709330|582927037|FG001|Overall Study|Lost to Follow-up|0|||
161420703|NCT02709330|582927036|FG000|Overall Study|Physician Decision|2|||
161420704|NCT02709330|582927037|FG001|Overall Study|Physician Decision|0|||
161420705|NCT02709330|582927036|FG000|Overall Study|Withdrawal by Subject|4|||
161420706|NCT02709330|582927037|FG001|Overall Study|Withdrawal by Subject|0|||
161420707|NCT02587819|582927040|FG000|Overall Study|Adverse Event|1|||
161420708|NCT02587819|582927040|FG000|Overall Study|Lost to Follow-up|1|||
161420709|NCT01594931|582929917|FG000|Overall Study|Adverse Event|3|||
161420710|NCT01594931|582929918|FG001|Overall Study|Adverse Event|1|||
161420711|NCT01594931|582929919|FG002|Overall Study|Adverse Event|1|||
161420712|NCT01594931|582929917|FG000|Overall Study|Withdrawal by Subject|2|||
161420713|NCT01594931|582929918|FG001|Overall Study|Withdrawal by Subject|1|||
161420714|NCT01594931|582929919|FG002|Overall Study|Withdrawal by Subject|1|||
161420715|NCT01594931|582929917|FG000|Overall Study|Lack of Efficacy|7|||
161420716|NCT01594931|582929918|FG001|Overall Study|Lack of Efficacy|2|||
161420717|NCT01594931|582929919|FG002|Overall Study|Lack of Efficacy|2|||
161420718|NCT01594931|582929917|FG000|Overall Study|Lost to Follow-up|4|||
161420719|NCT01594931|582929918|FG001|Overall Study|Lost to Follow-up|3|||
161420720|NCT01594931|582929919|FG002|Overall Study|Lost to Follow-up|3|||
161420721|NCT01594931|582929917|FG000|Overall Study|Protocol Violation|2|||
161420722|NCT01594931|582929918|FG001|Overall Study|Protocol Violation|1|||
161420723|NCT01594931|582929919|FG002|Overall Study|Protocol Violation|0|||
161420724|NCT01594931|582929917|FG000|Overall Study|No defiined|11|||
161420725|NCT01594931|582929918|FG001|Overall Study|No defiined|4|||
161420726|NCT01594931|582929919|FG002|Overall Study|No defiined|7|||
161420727|NCT01929226|582929924|FG000|Overall Study|Lost to Follow-up|4|||
161420728|NCT01929226|582929925|FG001|Overall Study|Lost to Follow-up|0|||
161420729|NCT01929226|582929924|FG000|Overall Study|Withdrawal by Subject|1|||
161420730|NCT01929226|582929925|FG001|Overall Study|Withdrawal by Subject|1|||
161420731|NCT00859547|582929926|FG000|Overall Study|Lost to Follow-up|1|||
161420732|NCT00859547|582929926|FG000|Overall Study|Parent withdrew consent|1|||
161420733|NCT01473732|582929929|FG000|Overall Study|Adverse Event|1|||
161420734|NCT01473732|582929930|FG001|Overall Study|Adverse Event|0|||
161420735|NCT01473732|582929929|FG000|Overall Study|Death|1|||
161420736|NCT01473732|582929930|FG001|Overall Study|Death|0|||
161420737|NCT00592904|582929951|FG000|Overall Study|Adverse Event|15|||
161420738|NCT00592904|582929952|FG001|Overall Study|Adverse Event|25|||
161420739|NCT00592904|582929953|FG002|Overall Study|Adverse Event|13|||
161420740|NCT00592904|582929954|FG003|Overall Study|Adverse Event|5|||
161420741|NCT00592904|582929951|FG000|Overall Study|Protocol Violation|1|||
161420742|NCT00592904|582929952|FG001|Overall Study|Protocol Violation|1|||
161420743|NCT00592904|582929953|FG002|Overall Study|Protocol Violation|0|||
161420744|NCT00592904|582929954|FG003|Overall Study|Protocol Violation|1|||
161420745|NCT00592904|582929951|FG000|Overall Study|Withdrawal by Subject|4|||
161420746|NCT00592904|582929952|FG001|Overall Study|Withdrawal by Subject|16|||
161420747|NCT00592904|582929953|FG002|Overall Study|Withdrawal by Subject|1|||
161420748|NCT00592904|582929954|FG003|Overall Study|Withdrawal by Subject|2|||
161420749|NCT00592904|582929951|FG000|Overall Study|Lack of Efficacy|2|||
161420750|NCT00592904|582929952|FG001|Overall Study|Lack of Efficacy|7|||
161420751|NCT00592904|582929953|FG002|Overall Study|Lack of Efficacy|2|||
161420752|NCT00592904|582929954|FG003|Overall Study|Lack of Efficacy|3|||
161420753|NCT00592904|582929951|FG000|Overall Study|Physician Decision|0|||
161420754|NCT00592904|582929952|FG001|Overall Study|Physician Decision|3|||
161420755|NCT00592904|582929953|FG002|Overall Study|Physician Decision|1|||
161420756|NCT00592904|582929954|FG003|Overall Study|Physician Decision|0|||
161420757|NCT00592904|582929951|FG000|Overall Study|Other|3|||
161420758|NCT00592904|582929952|FG001|Overall Study|Other|3|||
161420759|NCT00592904|582929953|FG002|Overall Study|Other|0|||
161420760|NCT00592904|582929954|FG003|Overall Study|Other|0|||
161420761|NCT00824473|582929957|FG000|Overall Study|Adverse Event|4|||
161420762|NCT00824473|582929958|FG001|Overall Study|Adverse Event|5|||
161420763|NCT00824473|582929957|FG000|Overall Study|Lack of Efficacy|2|||
161420764|NCT00824473|582929958|FG001|Overall Study|Lack of Efficacy|2|||
161420765|NCT00824473|582929957|FG000|Overall Study|Protocol Violation|2|||
161420766|NCT00824473|582929958|FG001|Overall Study|Protocol Violation|0|||
161420767|NCT00824473|582929957|FG000|Overall Study|Non-Compliance|4|||
161420768|NCT00824473|582929958|FG001|Overall Study|Non-Compliance|2|||
161420769|NCT00824473|582929957|FG000|Overall Study|Withdrawal by Subject|2|||
161420770|NCT00824473|582929958|FG001|Overall Study|Withdrawal by Subject|3|||
161420771|NCT00824473|582929957|FG000|Overall Study|Other|1|||
161420772|NCT00824473|582929958|FG001|Overall Study|Other|1|||
161420773|NCT03906071|582929959|FG000|Overall Study|Death|180|||
161420774|NCT03906071|582929960|FG001|Overall Study|Death|185|||
161420775|NCT03906071|582929959|FG000|Overall Study|Lost to Follow-up|3|||
161420776|NCT03906071|582929960|FG001|Overall Study|Lost to Follow-up|3|||
161420777|NCT03906071|582929959|FG000|Overall Study|Withdrawal by Subject|15|||
161420778|NCT03906071|582929960|FG001|Overall Study|Withdrawal by Subject|27|||
161420779|NCT03906071|582929959|FG000|Overall Study|Other|2|||
161420780|NCT03906071|582929960|FG001|Overall Study|Other|1|||
161420781|NCT01359904|582929961|FG000|Overall Study|Withdrawal by Subject|1|||
161420782|NCT01359904|582929962|FG001|Overall Study|Withdrawal by Subject|0|||
161420783|NCT01172535|582929965|FG000|Overall Study|Death|3|||
161420784|NCT01172535|582929965|FG000|Overall Study|Withdrawal by Subject|2|||
161420785|NCT01172535|582929965|FG000|Overall Study|Lost to Follow-up|1|||
161420786|NCT01172535|582929965|FG000|Overall Study|Ineligible at study entry|1|||
161420787|NCT01172535|582929965|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161420788|NCT01461707|582929966|FG000|Overall Study|Withdrawal by Subject|1|||
161420789|NCT01461707|582929967|FG001|Overall Study|Withdrawal by Subject|0|||
161420790|NCT00337207|582929968|FG000|Overall Study|Withdrawal by Subject|3|||
161420791|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
161420792|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
161420793|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
161420794|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
161420795|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
161420796|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
161420797|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
161420798|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
161420799|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
161420800|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
161420801|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
161420802|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
161420803|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
161420804|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
161420805|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
161420806|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
161420807|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
161420808|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
161420809|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
161420810|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
161420811|NCT03573323|582929969|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
161420812|NCT03573323|582929970|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
161420813|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
161420814|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
161420815|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
161420816|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
161420817|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
161420818|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
161420819|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
161420820|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
161420821|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
161420822|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
161420823|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
161420824|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
161420825|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
161420826|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
161420827|NCT03573323|582929969|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
161420828|NCT03573323|582929970|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
161420829|NCT00413218|582929972|FG000|Overall Study|Randomized but didn't receive study drug|2|||
161420830|NCT00413218|582929973|FG001|Overall Study|Randomized but didn't receive study drug|8|||
161420831|NCT00413218|582929972|FG000|Overall Study|Death|57|||
161420832|NCT00413218|582929973|FG001|Overall Study|Death|56|||
161420833|NCT00413218|582929972|FG000|Overall Study|Lost to Follow-up|14|||
161420834|NCT00413218|582929973|FG001|Overall Study|Lost to Follow-up|17|||
161420835|NCT00413218|582929972|FG000|Overall Study|Admin|20|||
161420836|NCT00413218|582929973|FG001|Overall Study|Admin|14|||
161420837|NCT00413218|582929972|FG000|Overall Study|Missing|1|||
161420838|NCT00413218|582929973|FG001|Overall Study|Missing|0|||
161420839|NCT00413218|582929972|FG000|Overall Study|Withdrawal by Subject|9|||
161420840|NCT00413218|582929973|FG001|Overall Study|Withdrawal by Subject|1|||
161420841|NCT00837213|582929976|FG000|Overall Study|Lost to Follow-up|3|||
161420842|NCT00837213|582929977|FG001|Overall Study|Lost to Follow-up|2|||
161420843|NCT00837213|582929976|FG000|Overall Study|Withdrawal by Subject|2|||
161420844|NCT00837213|582929977|FG001|Overall Study|Withdrawal by Subject|2|||
161420845|NCT00837213|582929976|FG000|Overall Study|not stated|1|||
161420846|NCT00837213|582929977|FG001|Overall Study|not stated|1|||
161420847|NCT02562716|582929985|FG000|Overall Study|Adverse Event|7|||
161420848|NCT02562716|582929986|FG001|Overall Study|Adverse Event|14|||
161420849|NCT02562716|582929985|FG000|Overall Study|Withdrawal unrelated to AE|7|||
161420850|NCT02562716|582929986|FG001|Overall Study|Withdrawal unrelated to AE|1|||
161420851|NCT02562716|582929985|FG000|Overall Study|Progression|8|||
161420852|NCT02562716|582929986|FG001|Overall Study|Progression|10|||
161420853|NCT02562716|582929985|FG000|Overall Study|Death|2|||
161420854|NCT02562716|582929986|FG001|Overall Study|Death|1|||
161420855|NCT02562716|582929985|FG000|Overall Study|Not protocol specified|4|||
161420856|NCT02562716|582929986|FG001|Overall Study|Not protocol specified|2|||
161420857|NCT02753946|582929987|FG000|Overall Study|Adverse Event|7|||
161420858|NCT02753946|582929988|FG001|Overall Study|Adverse Event|6|||
161420859|NCT02753946|582929987|FG000|Overall Study|Withdrawal by Subject|6|||
161420860|NCT02753946|582929988|FG001|Overall Study|Withdrawal by Subject|1|||
161420861|NCT02753946|582929987|FG000|Overall Study|Lack of Efficacy|1|||
161420862|NCT02753946|582929988|FG001|Overall Study|Lack of Efficacy|0|||
161420863|NCT02753946|582929987|FG000|Overall Study|Physician Decision|0|||
161420864|NCT02753946|582929988|FG001|Overall Study|Physician Decision|2|||
161420865|NCT02175017|582929989|FG000|Overall Study|Did not receive the investigational product|1|||
161420866|NCT02175017|582929990|FG001|Overall Study|Did not receive the investigational product|2|||
161420867|NCT02175017|582929989|FG000|Overall Study|Withdrawal by Subject|6|||
161420868|NCT02175017|582929990|FG001|Overall Study|Withdrawal by Subject|3|||
161420869|NCT02175017|582929989|FG000|Overall Study|Met an exclusion criteria|0|||
161420870|NCT02175017|582929990|FG001|Overall Study|Met an exclusion criteria|1|||
161420871|NCT02175017|582929989|FG000|Overall Study|Adverse Event|3|||
161420872|NCT02175017|582929990|FG001|Overall Study|Adverse Event|10|||
161420873|NCT02175017|582929989|FG000|Overall Study|Disease progression|20|||
161420874|NCT02175017|582929990|FG001|Overall Study|Disease progression|27|||
161420875|NCT02175017|582929989|FG000|Overall Study|Other than above reasons|3|||
161420876|NCT02175017|582929990|FG001|Overall Study|Other than above reasons|0|||
161420877|NCT00216671|582929991|FG000|Overall Study|Adverse Event|4|||
161420878|NCT00216671|582929992|FG001|Overall Study|Adverse Event|9|||
161420879|NCT00216671|582929991|FG000|Overall Study|Pregnancy|0|||
161420880|NCT00216671|582929992|FG001|Overall Study|Pregnancy|1|||
161420881|NCT00216671|582929991|FG000|Overall Study|Withdrawal by Subject|4|||
161420882|NCT00216671|582929992|FG001|Overall Study|Withdrawal by Subject|2|||
161420883|NCT00216671|582929991|FG000|Overall Study|Refused Injections|3|||
161420884|NCT00216671|582929992|FG001|Overall Study|Refused Injections|13|||
161420885|NCT00216671|582929991|FG000|Overall Study|No Need to Continue Medication|1|||
161420886|NCT00216671|582929992|FG001|Overall Study|No Need to Continue Medication|1|||
161420887|NCT00216671|582929991|FG000|Overall Study|Insufficient Response|9|||
161420888|NCT00216671|582929992|FG001|Overall Study|Insufficient Response|4|||
161420889|NCT00216671|582929991|FG000|Overall Study|Lost to Follow-up|3|||
161420890|NCT00216671|582929992|FG001|Overall Study|Lost to Follow-up|5|||
161420891|NCT00216671|582929991|FG000|Overall Study|Non compliant|2|||
161420892|NCT00216671|582929992|FG001|Overall Study|Non compliant|2|||
161420893|NCT00216671|582929991|FG000|Overall Study|Ineligible|0|||
161420894|NCT00216671|582929992|FG001|Overall Study|Ineligible|2|||
161420895|NCT00216671|582929991|FG000|Overall Study|Physician Decision|1|||
161420896|NCT00216671|582929992|FG001|Overall Study|Physician Decision|1|||
161420897|NCT00216671|582929991|FG000|Overall Study|Protocol Violation|3|||
161420898|NCT00216671|582929992|FG001|Overall Study|Protocol Violation|5|||
161420899|NCT00216671|582929991|FG000|Overall Study|Relapse|1|||
161420900|NCT00216671|582929992|FG001|Overall Study|Relapse|0|||
161420901|NCT00216671|582929991|FG000|Overall Study|Investigator Illness|0|||
161420902|NCT00216671|582929992|FG001|Overall Study|Investigator Illness|1|||
161420903|NCT00216671|582929991|FG000|Overall Study|Patient Moved|0|||
161420904|NCT00216671|582929992|FG001|Overall Study|Patient Moved|1|||
161420905|NCT00216671|582929991|FG000|Overall Study|Ineligible, no efficacy data|2|||
161420906|NCT00216671|582929992|FG001|Overall Study|Ineligible, no efficacy data|2|||
161420907|NCT00216671|582929991|FG000|Overall Study|Insufficient Response Adverse Event|2|||
161420908|NCT00216671|582929992|FG001|Overall Study|Insufficient Response Adverse Event|1|||
161420909|NCT02714569|582929993|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
161420910|NCT02714569|582929994|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
161420911|NCT02714569|582929995|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
161420912|NCT02714569|582929996|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
161420913|NCT02714569|582929997|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
161420914|NCT02714569|582929998|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
161420915|NCT02714569|582929999|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
161420916|NCT02714569|582930000|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
161420917|NCT02714569|582930001|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
161420918|NCT02714569|582930002|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
161420919|NCT02714569|582930003|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
161420920|NCT02714569|582929993|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420921|NCT02714569|582929994|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420922|NCT02714569|582929995|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420923|NCT02714569|582929996|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
161420924|NCT02714569|582929997|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420925|NCT02714569|582929998|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420926|NCT02714569|582929999|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420927|NCT02714569|582930000|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420928|NCT02714569|582930001|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420929|NCT02714569|582930002|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420930|NCT02714569|582930003|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161420931|NCT02714569|582929993|FG000|Part A Third Intervention|Adverse Event|0|||
161420932|NCT02714569|582929994|FG001|Part A Third Intervention|Adverse Event|0|||
161420933|NCT02714569|582929995|FG002|Part A Third Intervention|Adverse Event|1|||
161420934|NCT02714569|582929996|FG003|Part A Third Intervention|Adverse Event|0|||
161420935|NCT02714569|582929997|FG004|Part A Third Intervention|Adverse Event|0|||
161420936|NCT02714569|582929998|FG005|Part A Third Intervention|Adverse Event|0|||
161420937|NCT02714569|582929999|FG006|Part A Third Intervention|Adverse Event|0|||
161420938|NCT02714569|582930000|FG007|Part A Third Intervention|Adverse Event|0|||
161420939|NCT02714569|582930001|FG008|Part A Third Intervention|Adverse Event|0|||
161420940|NCT02714569|582930002|FG009|Part A Third Intervention|Adverse Event|0|||
161420941|NCT02714569|582930003|FG010|Part A Third Intervention|Adverse Event|0|||
161420942|NCT02714569|582929993|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
161420943|NCT02714569|582929994|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420944|NCT02714569|582929995|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420945|NCT02714569|582929996|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420946|NCT02714569|582929997|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420947|NCT02714569|582929998|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
161420948|NCT02714569|582929999|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420949|NCT02714569|582930000|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420950|NCT02714569|582930001|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420951|NCT02714569|582930002|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420952|NCT02714569|582930003|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161420953|NCT02714569|582929993|FG000|Part B (Overall)|Lost to Follow-up|0|||
161420954|NCT02714569|582929994|FG001|Part B (Overall)|Lost to Follow-up|0|||
161420955|NCT02714569|582929995|FG002|Part B (Overall)|Lost to Follow-up|0|||
161420956|NCT02714569|582929996|FG003|Part B (Overall)|Lost to Follow-up|0|||
161420957|NCT02714569|582929997|FG004|Part B (Overall)|Lost to Follow-up|0|||
161420958|NCT02714569|582929998|FG005|Part B (Overall)|Lost to Follow-up|0|||
161420959|NCT02714569|582929999|FG006|Part B (Overall)|Lost to Follow-up|1|||
161420960|NCT02714569|582930000|FG007|Part B (Overall)|Lost to Follow-up|0|||
161420961|NCT02714569|582930001|FG008|Part B (Overall)|Lost to Follow-up|0|||
161420962|NCT02714569|582930002|FG009|Part B (Overall)|Lost to Follow-up|0|||
161420963|NCT02714569|582930003|FG010|Part B (Overall)|Lost to Follow-up|0|||
161420964|NCT02714569|582929993|FG000|Part B (Overall)|Withdrawal by Subject|0|||
161420965|NCT02714569|582929994|FG001|Part B (Overall)|Withdrawal by Subject|0|||
161420966|NCT02714569|582929995|FG002|Part B (Overall)|Withdrawal by Subject|0|||
161420967|NCT02714569|582929996|FG003|Part B (Overall)|Withdrawal by Subject|0|||
161420968|NCT02714569|582929997|FG004|Part B (Overall)|Withdrawal by Subject|0|||
161420969|NCT02714569|582929998|FG005|Part B (Overall)|Withdrawal by Subject|0|||
161420970|NCT02714569|582929999|FG006|Part B (Overall)|Withdrawal by Subject|0|||
161420971|NCT02714569|582930000|FG007|Part B (Overall)|Withdrawal by Subject|1|||
161420972|NCT02714569|582930001|FG008|Part B (Overall)|Withdrawal by Subject|0|||
161420973|NCT02714569|582930002|FG009|Part B (Overall)|Withdrawal by Subject|1|||
161420974|NCT02714569|582930003|FG010|Part B (Overall)|Withdrawal by Subject|0|||
161420975|NCT02714569|582929993|FG000|Part B (Overall)|Adverse Event|0|||
161420976|NCT02714569|582929994|FG001|Part B (Overall)|Adverse Event|0|||
161420977|NCT02714569|582929995|FG002|Part B (Overall)|Adverse Event|0|||
161420978|NCT02714569|582929996|FG003|Part B (Overall)|Adverse Event|0|||
161420979|NCT02714569|582929997|FG004|Part B (Overall)|Adverse Event|0|||
161420980|NCT02714569|582929998|FG005|Part B (Overall)|Adverse Event|0|||
161420981|NCT02714569|582929999|FG006|Part B (Overall)|Adverse Event|0|||
161420982|NCT02714569|582930000|FG007|Part B (Overall)|Adverse Event|0|||
161420983|NCT02714569|582930001|FG008|Part B (Overall)|Adverse Event|0|||
161420984|NCT02714569|582930002|FG009|Part B (Overall)|Adverse Event|1|||
161420985|NCT02714569|582930003|FG010|Part B (Overall)|Adverse Event|0|||
161420986|NCT04915729|582930004|FG000|Overall Study|Lost to Follow-up|20|||
161420987|NCT04915729|582930005|FG001|Overall Study|Lost to Follow-up|10|||
161420988|NCT04915729|582930004|FG000|Overall Study|Withdrawal by Subject|12|||
161420989|NCT04915729|582930005|FG001|Overall Study|Withdrawal by Subject|5|||
161420990|NCT04915729|582930004|FG000|Overall Study|Death|34|||
161420991|NCT04915729|582930005|FG001|Overall Study|Death|44|||
161420992|NCT04915729|582930004|FG000|Overall Study|not treated|3|||
161420993|NCT04915729|582930005|FG001|Overall Study|not treated|6|||
161420994|NCT04915729|582930004|FG000|Overall Study|Investigator removed subject|1|||
161420995|NCT04915729|582930005|FG001|Overall Study|Investigator removed subject|2|||
161420996|NCT04915729|582930004|FG000|Overall Study|questionnaire result not evaluated|1|||
161420997|NCT04915729|582930005|FG001|Overall Study|questionnaire result not evaluated|0|||
161420998|NCT04915729|582930004|FG000|Overall Study|refuse of hospital visit|1|||
161420999|NCT04915729|582930005|FG001|Overall Study|refuse of hospital visit|3|||
161421000|NCT04915729|582930004|FG000|Overall Study|Subject withdrew|1|||
161421001|NCT04915729|582930005|FG001|Overall Study|Subject withdrew|0|||
161421002|NCT04961541|582930006|FG000|Overall Study|Adverse Event|0|||
161421003|NCT04961541|582930007|FG001|Overall Study|Adverse Event|0|||
161421004|NCT04961541|582930008|FG002|Overall Study|Adverse Event|0|||
161421005|NCT04961541|582930009|FG003|Overall Study|Adverse Event|0|||
161421006|NCT04961541|582930010|FG004|Overall Study|Adverse Event|0|||
161421007|NCT04961541|582930011|FG005|Overall Study|Adverse Event|1|||
161421008|NCT04961541|582930012|FG006|Overall Study|Adverse Event|0|||
161421009|NCT04961541|582930013|FG007|Overall Study|Adverse Event|0|||
161421010|NCT04961541|582930014|FG008|Overall Study|Adverse Event|0|||
161421011|NCT04961541|582930015|FG009|Overall Study|Adverse Event|0|||
161421012|NCT04961541|582930016|FG010|Overall Study|Adverse Event|0|||
161421013|NCT04961541|582930017|FG011|Overall Study|Adverse Event|0|||
161421014|NCT04961541|582930018|FG012|Overall Study|Adverse Event|0|||
161421015|NCT04961541|582930019|FG013|Overall Study|Adverse Event|0|||
161421016|NCT04961541|582930006|FG000|Overall Study|Lost to Follow-up|0|||
161421017|NCT04961541|582930007|FG001|Overall Study|Lost to Follow-up|0|||
161421018|NCT04961541|582930008|FG002|Overall Study|Lost to Follow-up|3|||
161421019|NCT04961541|582930009|FG003|Overall Study|Lost to Follow-up|0|||
161421020|NCT04961541|582930010|FG004|Overall Study|Lost to Follow-up|0|||
161421021|NCT04961541|582930011|FG005|Overall Study|Lost to Follow-up|0|||
161421022|NCT04961541|582930012|FG006|Overall Study|Lost to Follow-up|1|||
161421023|NCT04961541|582930013|FG007|Overall Study|Lost to Follow-up|1|||
161421024|NCT04961541|582930014|FG008|Overall Study|Lost to Follow-up|0|||
161421025|NCT04961541|582930015|FG009|Overall Study|Lost to Follow-up|1|||
161421026|NCT04961541|582930016|FG010|Overall Study|Lost to Follow-up|0|||
161421027|NCT04961541|582930017|FG011|Overall Study|Lost to Follow-up|0|||
161421028|NCT04961541|582930018|FG012|Overall Study|Lost to Follow-up|1|||
161421029|NCT04961541|582930019|FG013|Overall Study|Lost to Follow-up|0|||
161421030|NCT04961541|582930006|FG000|Overall Study|Withdrawal by Subject|0|||
161421031|NCT04961541|582930007|FG001|Overall Study|Withdrawal by Subject|0|||
161421032|NCT04961541|582930008|FG002|Overall Study|Withdrawal by Subject|1|||
161421033|NCT04961541|582930009|FG003|Overall Study|Withdrawal by Subject|1|||
161421034|NCT04961541|582930010|FG004|Overall Study|Withdrawal by Subject|0|||
161421035|NCT04961541|582930011|FG005|Overall Study|Withdrawal by Subject|0|||
161421036|NCT04961541|582930012|FG006|Overall Study|Withdrawal by Subject|0|||
161421037|NCT04961541|582930013|FG007|Overall Study|Withdrawal by Subject|0|||
161421038|NCT04961541|582930014|FG008|Overall Study|Withdrawal by Subject|0|||
161421039|NCT04961541|582930015|FG009|Overall Study|Withdrawal by Subject|1|||
161421040|NCT04961541|582930016|FG010|Overall Study|Withdrawal by Subject|0|||
161421041|NCT04961541|582930017|FG011|Overall Study|Withdrawal by Subject|0|||
161421042|NCT04961541|582930018|FG012|Overall Study|Withdrawal by Subject|0|||
161421043|NCT04961541|582930019|FG013|Overall Study|Withdrawal by Subject|0|||
161421044|NCT01684202|582930020|FG000|Dose-escalation Period|Adverse Event|0|||
161421045|NCT01684202|582930021|FG001|Dose-escalation Period|Adverse Event|1|||
161421046|NCT01684202|582930022|FG002|Dose-escalation Period|Adverse Event|0|||
161421047|NCT01684202|582930023|FG003|Dose-escalation Period|Adverse Event|0|||
161421048|NCT01684202|582930020|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
161421049|NCT01684202|582930021|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
161421050|NCT01684202|582930022|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
161421051|NCT01684202|582930023|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
161421052|NCT01684202|582930020|FG000|Maintenance Period|Adverse Event|1|||
161421053|NCT01684202|582930021|FG001|Maintenance Period|Adverse Event|1|||
161421054|NCT01684202|582930022|FG002|Maintenance Period|Adverse Event|1|||
161421055|NCT01684202|582930023|FG003|Maintenance Period|Adverse Event|1|||
161421056|NCT01684202|582930020|FG000|Maintenance Period|Physician Decision|0|||
161421057|NCT01684202|582930021|FG001|Maintenance Period|Physician Decision|1|||
161421058|NCT01684202|582930022|FG002|Maintenance Period|Physician Decision|0|||
161421059|NCT01684202|582930023|FG003|Maintenance Period|Physician Decision|0|||
161421060|NCT01684202|582930020|FG000|Maintenance Period|Withdrawal by Subject|0|||
161421061|NCT01684202|582930021|FG001|Maintenance Period|Withdrawal by Subject|1|||
161421062|NCT01684202|582930022|FG002|Maintenance Period|Withdrawal by Subject|0|||
161421063|NCT01684202|582930023|FG003|Maintenance Period|Withdrawal by Subject|0|||
161421064|NCT00191308|582930024|FG000|Overall Study|Adverse Event|1|||
161421065|NCT00466921|582930025|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
161421066|NCT00466921|582930025|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
161421067|NCT00466921|582930025|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
161421068|NCT00466921|582930025|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
161421069|NCT00466921|582930025|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
161421070|NCT00466921|582930025|FG000|Follow up for a Minimum of 1 Year|Death|6|||
161421071|NCT00779025|582930026|FG000|Overall Study|Withdrawal by Subject|1|||
161421072|NCT03305770|582930027|FG000|Overall Study|Physician Decision - prior to dispense|0|||
161421073|NCT03305770|582930028|FG001|Overall Study|Physician Decision - prior to dispense|1|||
161421074|NCT03305770|582930027|FG000|Overall Study|Subject moved|1|||
161421075|NCT03305770|582930028|FG001|Overall Study|Subject moved|0|||
161421076|NCT03539601|582930029|FG000|Overall Study|Withdraw by parent/guardian|1|||
161421077|NCT03539601|582930030|FG001|Overall Study|Withdraw by parent/guardian|0|||
161421078|NCT03539601|582930031|FG002|Overall Study|Withdraw by parent/guardian|1|||
161421079|NCT03539601|582930032|FG003|Overall Study|Withdraw by parent/guardian|0|||
161421080|NCT03539601|582930029|FG000|Overall Study|Adverse Event|0|||
161421081|NCT03539601|582930030|FG001|Overall Study|Adverse Event|2|||
161421082|NCT03539601|582930031|FG002|Overall Study|Adverse Event|0|||
161421083|NCT03539601|582930032|FG003|Overall Study|Adverse Event|0|||
161421084|NCT03539601|582930029|FG000|Overall Study|Lost to Follow-up|2|||
161421085|NCT03539601|582930030|FG001|Overall Study|Lost to Follow-up|4|||
161421086|NCT03539601|582930031|FG002|Overall Study|Lost to Follow-up|5|||
161421087|NCT03539601|582930032|FG003|Overall Study|Lost to Follow-up|0|||
161421088|NCT03539601|582930029|FG000|Overall Study|Withdrawal by Subject|2|||
161421089|NCT03539601|582930030|FG001|Overall Study|Withdrawal by Subject|0|||
161421090|NCT03539601|582930031|FG002|Overall Study|Withdrawal by Subject|0|||
161421091|NCT03539601|582930032|FG003|Overall Study|Withdrawal by Subject|1|||
161421092|NCT03539601|582930029|FG000|Overall Study|Randomized but not treated|1|||
161421093|NCT03539601|582930030|FG001|Overall Study|Randomized but not treated|1|||
161421094|NCT03539601|582930031|FG002|Overall Study|Randomized but not treated|0|||
161421095|NCT03539601|582930032|FG003|Overall Study|Randomized but not treated|0|||
161421096|NCT03710642|582930033|FG000|Overall Study|Adverse Event|5|||
161421097|NCT03710642|582930034|FG001|Overall Study|Adverse Event|1|||
161421098|NCT03710642|582930033|FG000|Overall Study|non-site physician recommendation|1|||
161421099|NCT03710642|582930034|FG001|Overall Study|non-site physician recommendation|0|||
161421100|NCT03710642|582930033|FG000|Overall Study|Participant unwilling or unable to participate|1|||
161421101|NCT03710642|582930034|FG001|Overall Study|Participant unwilling or unable to participate|1|||
161421102|NCT03710642|582930033|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
161421103|NCT03710642|582930034|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
161421104|NCT03710642|582930033|FG000|Overall Study|NA-no code provided|1|||
161421105|NCT03710642|582930034|FG001|Overall Study|NA-no code provided|0|||
161421106|NCT03710642|582930033|FG000|Overall Study|Withdrawal by Subject|1|||
161421107|NCT03710642|582930034|FG001|Overall Study|Withdrawal by Subject|0|||
161421108|NCT00226811|582930035|FG000|Overall Study|Death|8|||
161421109|NCT00226811|582930035|FG000|Overall Study|Adverse Event|11|||
161421110|NCT00226811|582930035|FG000|Overall Study|Lack of Efficacy|55|||
161421111|NCT00226811|582930035|FG000|Overall Study|Withdrawal by Subject|2|||
161421112|NCT01633541|582930039|FG000|Overall Study|Death|1|||
161421113|NCT01633541|582930040|FG001|Overall Study|Death|0|||
161421114|NCT01010971|582930041|FG000|Overall Study|Adverse Event|2|||
161421115|NCT01010971|582930042|FG001|Overall Study|Adverse Event|4|||
161421116|NCT01010971|582930043|FG002|Overall Study|Adverse Event|3|||
161421117|NCT01010971|582930041|FG000|Overall Study|Withdrawal by Subject|0|||
161421118|NCT01010971|582930042|FG001|Overall Study|Withdrawal by Subject|2|||
161421119|NCT01010971|582930043|FG002|Overall Study|Withdrawal by Subject|5|||
161421120|NCT01010971|582930041|FG000|Overall Study|Lost to Follow-up|0|||
161421121|NCT01010971|582930042|FG001|Overall Study|Lost to Follow-up|2|||
161421122|NCT01010971|582930043|FG002|Overall Study|Lost to Follow-up|3|||
161421123|NCT01010971|582930041|FG000|Overall Study|Other|1|||
161421124|NCT01010971|582930042|FG001|Overall Study|Other|0|||
161421125|NCT01010971|582930043|FG002|Overall Study|Other|2|||
161421126|NCT00773513|582930045|FG000|Overall Study|Renal Transplant|254|||
161421127|NCT00773513|582930046|FG001|Overall Study|Renal Transplant|263|||
161421128|NCT00773513|582930045|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
161421129|NCT00773513|582930046|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
161421130|NCT00773513|582930045|FG000|Overall Study|Withdrew Consent|68|||
161421131|NCT00773513|582930046|FG001|Overall Study|Withdrew Consent|69|||
161421132|NCT00773513|582930045|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
161421133|NCT00773513|582930046|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
161421134|NCT00773513|582930045|FG000|Overall Study|Failure to Return|22|||
161421135|NCT00773513|582930046|FG001|Overall Study|Failure to Return|8|||
161421136|NCT00773513|582930045|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161421137|NCT00773513|582930046|FG001|Overall Study|Insufficient Therapeutic Response|18|||
161421138|NCT00773513|582930045|FG000|Overall Study|Reason Not Specified|159|||
161421139|NCT00773513|582930046|FG001|Overall Study|Reason Not Specified|126|||
161421140|NCT00773513|582930045|FG000|Overall Study|Death|531|||
161421141|NCT00773513|582930046|FG001|Overall Study|Death|545|||
161421142|NCT00700713|582930048|FG000|Overall Study|Protocol Violation|1|||
161421143|NCT00700713|582930049|FG001|Overall Study|Protocol Violation|0|||
161421144|NCT00700713|582930050|FG002|Overall Study|Protocol Violation|1|||
161421145|NCT00700713|582930048|FG000|Overall Study|Withdrawal by Subject|0|||
161421146|NCT00700713|582930049|FG001|Overall Study|Withdrawal by Subject|0|||
161421147|NCT00700713|582930050|FG002|Overall Study|Withdrawal by Subject|1|||
161421148|NCT02330055|582930051|FG000|Overall Study|technical issues|2|||
161421149|NCT02330055|582930052|FG001|Overall Study|technical issues|0|||
161421150|NCT02330055|582930051|FG000|Overall Study|participant forgot to wear device|5|||
161421151|NCT02330055|582930052|FG001|Overall Study|participant forgot to wear device|5|||
161421152|NCT02330055|582930051|FG000|Overall Study|data for less than 60 minutes|3|||
161421153|NCT02330055|582930052|FG001|Overall Study|data for less than 60 minutes|3|||
161421154|NCT02330055|582930051|FG000|Overall Study|participant did not sleep|0|||
161421155|NCT02330055|582930052|FG001|Overall Study|participant did not sleep|1|||
161421156|NCT05729568|582930054|FG000|Overall Study|Still on Study|52|||
161421157|NCT05729568|582930055|FG001|Overall Study|Still on Study|26|||
161421158|NCT05729568|582930054|FG000|Overall Study|Randomized but Never Treated|3|||
161421159|NCT05729568|582930055|FG001|Overall Study|Randomized but Never Treated|0|||
161421160|NCT05729568|582930054|FG000|Overall Study|Adverse Event|0|||
161421161|NCT05729568|582930055|FG001|Overall Study|Adverse Event|1|||
161421162|NCT05729568|582930054|FG000|Overall Study|Investigator's Discretion|1|||
161421163|NCT05729568|582930055|FG001|Overall Study|Investigator's Discretion|0|||
161421164|NCT00550953|582930056|FG000|Overall Study|Adverse Event|4|||
161421165|NCT00550953|582930057|FG001|Overall Study|Adverse Event|3|||
161421166|NCT00550953|582930056|FG000|Overall Study|Not able to visit the site|2|||
161421167|NCT00550953|582930057|FG001|Overall Study|Not able to visit the site|3|||
161421168|NCT02728089|582930058|FG000|Overall Study|Physician Decision|2|||
161421169|NCT02728089|582930058|FG000|Overall Study|Withdrawal by Subject|1|||
161421170|NCT01221350|582930059|FG000|Overall Study|Discontinued intervention (GERD)|1|||
161421171|NCT01221350|582930060|FG001|Overall Study|Discontinued intervention (GERD)|0|||
161421172|NCT01221350|582930059|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
161421173|NCT01221350|582930060|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
161421174|NCT01221350|582930059|FG000|Overall Study|Withdrawal by Subject|4|||
161421175|NCT01221350|582930060|FG001|Overall Study|Withdrawal by Subject|2|||
161421176|NCT04739436|582930063|FG000|Overall Study|Lost to Follow-up|21|||
161421177|NCT04739436|582930064|FG001|Overall Study|Lost to Follow-up|23|||
161421178|NCT04739436|582930063|FG000|Overall Study|Withdrawal by Subject|4|||
161421179|NCT04739436|582930064|FG001|Overall Study|Withdrawal by Subject|6|||
161421180|NCT04739436|582930063|FG000|Overall Study|not randomized properly|1|||
161421181|NCT04739436|582930064|FG001|Overall Study|not randomized properly|0|||
161421182|NCT02915978|582930068|FG000|Overall Study|Adverse Event|2|||
161421183|NCT02915978|582930069|FG001|Overall Study|Adverse Event|1|||
161421184|NCT02915978|582930070|FG002|Overall Study|Adverse Event|0|||
161421185|NCT02119663|582930075|FG000|Overall Study|Disease progression|26|||
161421186|NCT02119663|582930076|FG001|Overall Study|Disease progression|27|||
161421187|NCT02119663|582930075|FG000|Overall Study|Adverse Event|5|||
161421188|NCT02119663|582930076|FG001|Overall Study|Adverse Event|5|||
161421189|NCT02119663|582930075|FG000|Overall Study|Death|3|||
161421190|NCT02119663|582930076|FG001|Overall Study|Death|2|||
161421191|NCT02119663|582930075|FG000|Overall Study|Physician Decision|1|||
161421192|NCT02119663|582930076|FG001|Overall Study|Physician Decision|2|||
161421193|NCT02119663|582930075|FG000|Overall Study|Other unspecified|2|||
161421194|NCT02119663|582930076|FG001|Overall Study|Other unspecified|0|||
161421195|NCT02119663|582930075|FG000|Overall Study|Subject decision|0|||
161421196|NCT02119663|582930076|FG001|Overall Study|Subject decision|1|||
161421197|NCT02119663|582930075|FG000|Overall Study|Study Terminated by the Sponsor|3|||
161421198|NCT02119663|582930076|FG001|Overall Study|Study Terminated by the Sponsor|4|||
161421199|NCT01248949|582930077|FG000|Overall Study|Lost to Follow-up|2|||
161421200|NCT01248949|582930078|FG001|Overall Study|Lost to Follow-up|2|||
161421201|NCT01248949|582930079|FG002|Overall Study|Lost to Follow-up|2|||
161421202|NCT01248949|582930080|FG003|Overall Study|Lost to Follow-up|1|||
161421203|NCT01248949|582930081|FG004|Overall Study|Lost to Follow-up|0|||
161421204|NCT01248949|582930077|FG000|Overall Study|Withdrawal by Subject|5|||
161421205|NCT01248949|582930078|FG001|Overall Study|Withdrawal by Subject|3|||
161421206|NCT01248949|582930079|FG002|Overall Study|Withdrawal by Subject|11|||
161421207|NCT01248949|582930080|FG003|Overall Study|Withdrawal by Subject|3|||
161421208|NCT01248949|582930081|FG004|Overall Study|Withdrawal by Subject|1|||
161421209|NCT01248949|582930077|FG000|Overall Study|Death|22|||
161421210|NCT01248949|582930078|FG001|Overall Study|Death|7|||
161421211|NCT01248949|582930079|FG002|Overall Study|Death|21|||
161421212|NCT01248949|582930080|FG003|Overall Study|Death|6|||
161421213|NCT01248949|582930081|FG004|Overall Study|Death|2|||
161421214|NCT01248949|582930077|FG000|Overall Study|Alternative Therapy|1|||
161421215|NCT01248949|582930078|FG001|Overall Study|Alternative Therapy|0|||
161421216|NCT01248949|582930079|FG002|Overall Study|Alternative Therapy|0|||
161421217|NCT01248949|582930080|FG003|Overall Study|Alternative Therapy|0|||
161421218|NCT01248949|582930081|FG004|Overall Study|Alternative Therapy|0|||
161421219|NCT01248949|582930077|FG000|Overall Study|Alternative Therapy.|1|||
161421220|NCT01248949|582930078|FG001|Overall Study|Alternative Therapy.|0|||
161421221|NCT01248949|582930079|FG002|Overall Study|Alternative Therapy.|0|||
161421222|NCT01248949|582930080|FG003|Overall Study|Alternative Therapy.|0|||
161421223|NCT01248949|582930081|FG004|Overall Study|Alternative Therapy.|0|||
161421224|NCT01248949|582930077|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
161421225|NCT01248949|582930078|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
161421226|NCT01248949|582930079|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
161421227|NCT01248949|582930080|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
161421228|NCT01248949|582930081|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
161421229|NCT01248949|582930077|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
161421230|NCT01248949|582930078|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
161421231|NCT01248949|582930079|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
161421232|NCT01248949|582930080|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
161421233|NCT01248949|582930081|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
161421234|NCT01248949|582930077|FG000|Overall Study|Participant Went To Hospice|0|||
161421235|NCT01248949|582930078|FG001|Overall Study|Participant Went To Hospice|0|||
161421236|NCT01248949|582930079|FG002|Overall Study|Participant Went To Hospice|1|||
161421237|NCT01248949|582930080|FG003|Overall Study|Participant Went To Hospice|0|||
161421238|NCT01248949|582930081|FG004|Overall Study|Participant Went To Hospice|0|||
161421239|NCT01248949|582930077|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
161421240|NCT01248949|582930078|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161421241|NCT01248949|582930079|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161421242|NCT01248949|582930080|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161421243|NCT01248949|582930081|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161421244|NCT01248949|582930077|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
161421245|NCT01248949|582930078|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
161421246|NCT01248949|582930079|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
161421247|NCT01248949|582930080|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
161421248|NCT01248949|582930081|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
161421249|NCT01248949|582930077|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161421250|NCT01248949|582930078|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
161421251|NCT01248949|582930079|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161421252|NCT01248949|582930080|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161421253|NCT01248949|582930081|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161421254|NCT01248949|582930077|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161421255|NCT01248949|582930078|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161421256|NCT01248949|582930079|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
161421257|NCT01248949|582930080|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161421258|NCT01248949|582930081|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161421259|NCT03245775|582930084|FG000|Overall Study|Lost to Follow-up|25|||
161421260|NCT03245775|582930085|FG001|Overall Study|Lost to Follow-up|26|||
161421261|NCT03245775|582930086|FG002|Overall Study|Lost to Follow-up|16|||
161421262|NCT03245775|582930087|FG003|Overall Study|Lost to Follow-up|16|||
161421263|NCT01099397|582930089|FG000|Overall Study|Lost to Follow-up|4|||
161421264|NCT01099397|582930089|FG000|Overall Study|Protocol Violation|4|||
161421265|NCT01099397|582930089|FG000|Overall Study|Withdrawal by Subject|5|||
161421266|NCT02363959|582930090|FG000|Overall Study|Medical instability|1|||
161421267|NCT02363959|582930091|FG001|Overall Study|Medical instability|0|||
161421268|NCT00950248|582930094|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
161421269|NCT00950248|582930095|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
161421270|NCT00950248|582930096|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
161421271|NCT00950248|582930094|FG000|Year 1: Baseline|worsening of symptoms|2|||
161421272|NCT00950248|582930095|FG001|Year 1: Baseline|worsening of symptoms|0|||
161421273|NCT00950248|582930096|FG002|Year 1: Baseline|worsening of symptoms|0|||
161421274|NCT00950248|582930094|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
161421275|NCT00950248|582930095|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
161421276|NCT00950248|582930096|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
161421277|NCT00950248|582930094|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
161421278|NCT00950248|582930095|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
161421279|NCT00950248|582930096|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
161421280|NCT00950248|582930094|FG000|Year 2&3 Treatment Randomization|Death|0|||
161421281|NCT00950248|582930095|FG001|Year 2&3 Treatment Randomization|Death|0|||
161421282|NCT00950248|582930096|FG002|Year 2&3 Treatment Randomization|Death|1|||
161421283|NCT00950248|582930094|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
161421284|NCT00950248|582930095|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
161421285|NCT00950248|582930096|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
161421286|NCT00650845|582930101|FG000|Overall Study|Withdrawal by Subject|5|||
161421287|NCT00650845|582930102|FG001|Overall Study|Withdrawal by Subject|0|||
161421288|NCT00650845|582930101|FG000|Overall Study|Protocol Violation|0|||
161421289|NCT00650845|582930102|FG001|Overall Study|Protocol Violation|13|||
161421290|NCT01479868|582931945|FG000|Overall Study|Adverse Event|1|||
161421291|NCT01479868|582931945|FG000|Overall Study|Lost to Follow-up|4|||
161421292|NCT01479868|582931945|FG000|Overall Study|Protocol Violation|1|||
161421293|NCT01479868|582931945|FG000|Overall Study|Withdrawal by Subject|1|||
161421294|NCT01479868|582931945|FG000|Overall Study|Sponsor's Decision|1|||
161421295|NCT01479868|582931945|FG000|Overall Study|Initiation of new HCV Therapy|1|||
161421296|NCT01618669|582931946|FG000|Overall Study|Lost to Follow-up|1|||
161421297|NCT01618669|582931947|FG001|Overall Study|Lost to Follow-up|1|||
161421298|NCT01618669|582931946|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
161421299|NCT01618669|582931947|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
161421300|NCT01618669|582931946|FG000|Overall Study|Adverse Event|16|||
161421301|NCT01618669|582931947|FG001|Overall Study|Adverse Event|7|||
161421302|NCT01618669|582931946|FG000|Overall Study|Protocol Violation|5|||
161421303|NCT01618669|582931947|FG001|Overall Study|Protocol Violation|3|||
161421304|NCT01618669|582931946|FG000|Overall Study|Withdrawal by Subject|9|||
161421305|NCT01618669|582931947|FG001|Overall Study|Withdrawal by Subject|9|||
161421306|NCT01618669|582931946|FG000|Overall Study|Miscellaneous Reason|0|||
161421307|NCT01618669|582931947|FG001|Overall Study|Miscellaneous Reason|1|||
161421308|NCT01508169|582931948|FG000|Overall Study|Adverse Event|1|||
161421309|NCT01508169|582931949|FG001|Overall Study|Adverse Event|0|||
161421310|NCT01508169|582931948|FG000|Overall Study|Withdrawal by Subject|1|||
161421311|NCT01508169|582931949|FG001|Overall Study|Withdrawal by Subject|0|||
161421312|NCT01508169|582931948|FG000|Overall Study|Lost to Follow-up|1|||
161421313|NCT01508169|582931949|FG001|Overall Study|Lost to Follow-up|2|||
161421314|NCT03600740|582931957|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
161421315|NCT02336230|582931962|FG000|Overall Study|Adverse Event|1|||
161421316|NCT02336230|582931962|FG000|Overall Study|Withdrawal of consent|1|||
161421317|NCT02336230|582931962|FG000|Overall Study|Death|9|||
161421318|NCT02336230|582931962|FG000|Overall Study|Dose not received due to shipping delay|1|||
161421319|NCT02336230|582931962|FG000|Overall Study|Discontinuation of MSC infusion|1|||
161421320|NCT01620086|582931967|FG000|Overall Study|Withdrawal by Subject|3|||
161421321|NCT01620086|582931968|FG001|Overall Study|Withdrawal by Subject|3|||
161421322|NCT01620086|582931969|FG002|Overall Study|Withdrawal by Subject|0|||
161421323|NCT01620086|582931967|FG000|Overall Study|failed study criteria|1|||
161421324|NCT01620086|582931968|FG001|Overall Study|failed study criteria|4|||
161421325|NCT01620086|582931969|FG002|Overall Study|failed study criteria|0|||
161421326|NCT01620086|582931967|FG000|Overall Study|Physician Decision|1|||
161421327|NCT01620086|582931968|FG001|Overall Study|Physician Decision|0|||
161421328|NCT01620086|582931969|FG002|Overall Study|Physician Decision|0|||
161421329|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Progressive disease|50|||
161421330|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Progressive disease|110|||
161421331|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Progressive disease|0|||
161421332|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Progressive disease|0|||
161421333|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
161421334|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
161421335|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161421336|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161421337|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Adverse Event|7|||
161421338|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Adverse Event|7|||
161421339|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Adverse Event|0|||
161421340|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Adverse Event|0|||
161421341|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Other|1|||
161421342|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Other|3|||
161421343|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Other|0|||
161421344|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Other|0|||
161421345|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Physician Decision|6|||
161421346|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Physician Decision|3|||
161421347|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Physician Decision|0|||
161421348|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Physician Decision|0|||
161421349|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Death|1|||
161421350|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Death|1|||
161421351|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Death|0|||
161421352|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Death|0|||
161421353|NCT01695135|582931970|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
161421354|NCT01695135|582931971|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
161421355|NCT01695135|582931972|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
161421356|NCT01695135|582931973|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
161421357|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
161421358|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
161421359|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
161421360|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
161421361|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
161421362|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
161421363|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
161421364|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
161421365|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
161421366|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
161421367|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
161421368|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
161421369|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Other|0|||
161421370|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Other|0|||
161421371|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Other|4|||
161421372|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Other|7|||
161421373|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
161421374|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
161421375|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
161421376|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
161421377|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Death|0|||
161421378|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Death|0|||
161421379|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Death|2|||
161421380|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Death|7|||
161421381|NCT01695135|582931970|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
161421382|NCT01695135|582931971|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
161421383|NCT01695135|582931972|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
161421384|NCT01695135|582931973|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
161421385|NCT00580723|582931979|FG000|Overall Study|Did not want to participate in extension|3|||
161421386|NCT00580723|582931979|FG000|Overall Study|Lost to Follow-up|5|||
161421387|NCT00684996|582931980|FG000|Overall Study|Adverse Event|1|||
161421388|NCT00684996|582931980|FG000|Overall Study|Refusal unrelated to adverse event|1|||
161421389|NCT00684996|582931980|FG000|Overall Study|Progression/relapse|2|||
161421390|NCT00684996|582931980|FG000|Overall Study|Other reasons not protocol specified|1|||
161421391|NCT00556998|582931981|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
161421392|NCT00556998|582931981|FG000|Voriconazole Intravenous (IV)|Other|4|||
161421393|NCT00556998|582931981|FG000|Voriconazole Oral|Adverse Event|1|||
161421394|NCT00556998|582931981|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
161421395|NCT02519439|582931984|FG000|Overall Study|Study Termination|19|||
161421396|NCT02519439|582931984|FG000|Overall Study|Withdrawal by Subject|1|||
161421397|NCT02519439|582931984|FG000|Overall Study|Adverse Event|1|||
161421398|NCT03030417|582931991|FG000|Dose Expansion|Disease progression before treatment|0|||
161421399|NCT03030417|582931992|FG001|Dose Expansion|Disease progression before treatment|0|||
161421400|NCT03030417|582931993|FG002|Dose Expansion|Disease progression before treatment|0|||
161421401|NCT03030417|582931994|FG003|Dose Expansion|Disease progression before treatment|0|||
161421402|NCT03030417|582931995|FG004|Dose Expansion|Disease progression before treatment|0|||
161421403|NCT03030417|582931996|FG005|Dose Expansion|Disease progression before treatment|0|||
161421404|NCT03030417|582931997|FG006|Dose Expansion|Disease progression before treatment|0|||
161421405|NCT03030417|582931998|FG007|Dose Expansion|Disease progression before treatment|0|||
161421406|NCT03030417|582931999|FG008|Dose Expansion|Disease progression before treatment|0|||
161421407|NCT03030417|582932000|FG009|Dose Expansion|Disease progression before treatment|0|||
161421408|NCT03030417|582932001|FG010|Dose Expansion|Disease progression before treatment|0|||
161421409|NCT03030417|582932002|FG011|Dose Expansion|Disease progression before treatment|0|||
161421410|NCT03030417|582932003|FG012|Dose Expansion|Disease progression before treatment|1|||
161421411|NCT01078441|582932004|FG000|Overall Study|Withdrawal by Subject|1|||
161421412|NCT01970306|582932008|FG000|Overall Study|Not eligible|3|||
161421413|NCT01970306|582932008|FG000|Overall Study|Not able to be treated|9|||
161421414|NCT02741635|582932009|FG000|Overall Study|Withdrawal by Subject|1|||
161421415|NCT01427933|582932010|FG000|Overall Study|Withdrawal by Subject|5|||
161421416|NCT01427933|582932011|FG001|Overall Study|Withdrawal by Subject|8|||
161421417|NCT01427933|582932010|FG000|Overall Study|Lost to Follow-up|1|||
161421418|NCT01427933|582932011|FG001|Overall Study|Lost to Follow-up|5|||
161421419|NCT01427933|582932010|FG000|Overall Study|Other|1|||
161421420|NCT01427933|582932011|FG001|Overall Study|Other|0|||
161421421|NCT01427933|582932010|FG000|Overall Study|Investigator's Decision|1|||
161421422|NCT01427933|582932011|FG001|Overall Study|Investigator's Decision|0|||
161421423|NCT03472326|582932012|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
161421424|NCT03472326|582932013|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
161421425|NCT03472326|582932014|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
161421426|NCT03472326|582932015|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
161421427|NCT03472326|582932012|FG000|Part 2: Combination Therapy|Pregnancy|0|||
161421428|NCT03472326|582932013|FG001|Part 2: Combination Therapy|Pregnancy|0|||
161421429|NCT03472326|582932014|FG002|Part 2: Combination Therapy|Pregnancy|0|||
161421430|NCT03472326|582932015|FG003|Part 2: Combination Therapy|Pregnancy|1|||
161421431|NCT03386721|582932016|FG000|Overall Study|Death|12|||
161421432|NCT03386721|582932017|FG001|Overall Study|Death|21|||
161421433|NCT03386721|582932018|FG002|Overall Study|Death|2|||
161421434|NCT03386721|582932019|FG003|Overall Study|Death|5|||
161421435|NCT03386721|582932020|FG004|Overall Study|Death|1|||
161421436|NCT03386721|582932021|FG005|Overall Study|Death|12|||
161421437|NCT03386721|582932022|FG006|Overall Study|Death|1|||
161421438|NCT03386721|582932023|FG007|Overall Study|Death|1|||
161421439|NCT03386721|582932024|FG008|Overall Study|Death|12|||
161421440|NCT03386721|582932025|FG009|Overall Study|Death|20|||
161421441|NCT03386721|582932026|FG010|Overall Study|Death|21|||
161421442|NCT03386721|582932027|FG011|Overall Study|Death|21|||
161421443|NCT03386721|582932028|FG012|Overall Study|Death|14|||
161421444|NCT03386721|582932029|FG013|Overall Study|Death|2|||
161421445|NCT03386721|582932030|FG014|Overall Study|Death|1|||
161421446|NCT03386721|582932016|FG000|Overall Study|Lost to Follow-up|1|||
161421447|NCT03386721|582932017|FG001|Overall Study|Lost to Follow-up|3|||
161421448|NCT03386721|582932018|FG002|Overall Study|Lost to Follow-up|0|||
161421449|NCT03386721|582932019|FG003|Overall Study|Lost to Follow-up|0|||
161421450|NCT03386721|582932020|FG004|Overall Study|Lost to Follow-up|0|||
161421451|NCT03386721|582932021|FG005|Overall Study|Lost to Follow-up|2|||
161421452|NCT03386721|582932022|FG006|Overall Study|Lost to Follow-up|1|||
161421453|NCT03386721|582932023|FG007|Overall Study|Lost to Follow-up|0|||
161421454|NCT03386721|582932024|FG008|Overall Study|Lost to Follow-up|1|||
161421455|NCT03386721|582932025|FG009|Overall Study|Lost to Follow-up|2|||
161421456|NCT03386721|582932026|FG010|Overall Study|Lost to Follow-up|1|||
161421457|NCT03386721|582932027|FG011|Overall Study|Lost to Follow-up|0|||
161421458|NCT03386721|582932028|FG012|Overall Study|Lost to Follow-up|0|||
161421459|NCT03386721|582932029|FG013|Overall Study|Lost to Follow-up|0|||
161421460|NCT03386721|582932030|FG014|Overall Study|Lost to Follow-up|0|||
161421461|NCT03386721|582932016|FG000|Overall Study|Reason not specified|3|||
161421462|NCT03386721|582932017|FG001|Overall Study|Reason not specified|0|||
161421463|NCT03386721|582932018|FG002|Overall Study|Reason not specified|0|||
161421464|NCT03386721|582932019|FG003|Overall Study|Reason not specified|0|||
161421465|NCT03386721|582932020|FG004|Overall Study|Reason not specified|0|||
161421466|NCT03386721|582932021|FG005|Overall Study|Reason not specified|3|||
161421467|NCT03386721|582932022|FG006|Overall Study|Reason not specified|1|||
161421468|NCT03386721|582932023|FG007|Overall Study|Reason not specified|0|||
161421469|NCT03386721|582932024|FG008|Overall Study|Reason not specified|0|||
161421470|NCT03386721|582932025|FG009|Overall Study|Reason not specified|1|||
161421471|NCT03386721|582932026|FG010|Overall Study|Reason not specified|2|||
161421472|NCT03386721|582932027|FG011|Overall Study|Reason not specified|6|||
161421473|NCT03386721|582932028|FG012|Overall Study|Reason not specified|1|||
161421474|NCT03386721|582932029|FG013|Overall Study|Reason not specified|0|||
161421475|NCT03386721|582932030|FG014|Overall Study|Reason not specified|0|||
161421476|NCT03386721|582932016|FG000|Overall Study|Progressive Disease|0|||
161421477|NCT03386721|582932017|FG001|Overall Study|Progressive Disease|0|||
161421478|NCT03386721|582932018|FG002|Overall Study|Progressive Disease|1|||
161421479|NCT03386721|582932019|FG003|Overall Study|Progressive Disease|0|||
161421480|NCT03386721|582932020|FG004|Overall Study|Progressive Disease|0|||
161421481|NCT03386721|582932021|FG005|Overall Study|Progressive Disease|1|||
161421482|NCT03386721|582932022|FG006|Overall Study|Progressive Disease|0|||
161421483|NCT03386721|582932023|FG007|Overall Study|Progressive Disease|0|||
161421484|NCT03386721|582932024|FG008|Overall Study|Progressive Disease|2|||
161421485|NCT03386721|582932025|FG009|Overall Study|Progressive Disease|1|||
161421486|NCT03386721|582932026|FG010|Overall Study|Progressive Disease|1|||
161421487|NCT03386721|582932027|FG011|Overall Study|Progressive Disease|0|||
161421488|NCT03386721|582932028|FG012|Overall Study|Progressive Disease|1|||
161421489|NCT03386721|582932029|FG013|Overall Study|Progressive Disease|0|||
161421490|NCT03386721|582932030|FG014|Overall Study|Progressive Disease|0|||
161421491|NCT03386721|582932016|FG000|Overall Study|Site Terminated by Sponsor|5|||
161421492|NCT03386721|582932017|FG001|Overall Study|Site Terminated by Sponsor|5|||
161421493|NCT03386721|582932018|FG002|Overall Study|Site Terminated by Sponsor|0|||
161421494|NCT03386721|582932019|FG003|Overall Study|Site Terminated by Sponsor|0|||
161421495|NCT03386721|582932020|FG004|Overall Study|Site Terminated by Sponsor|1|||
161421496|NCT03386721|582932021|FG005|Overall Study|Site Terminated by Sponsor|3|||
161421497|NCT03386721|582932022|FG006|Overall Study|Site Terminated by Sponsor|0|||
161421498|NCT03386721|582932023|FG007|Overall Study|Site Terminated by Sponsor|1|||
161421499|NCT03386721|582932024|FG008|Overall Study|Site Terminated by Sponsor|4|||
161421500|NCT03386721|582932025|FG009|Overall Study|Site Terminated by Sponsor|5|||
161421501|NCT03386721|582932026|FG010|Overall Study|Site Terminated by Sponsor|3|||
161421502|NCT03386721|582932027|FG011|Overall Study|Site Terminated by Sponsor|11|||
161421503|NCT03386721|582932028|FG012|Overall Study|Site Terminated by Sponsor|6|||
161421504|NCT03386721|582932029|FG013|Overall Study|Site Terminated by Sponsor|0|||
161421505|NCT03386721|582932030|FG014|Overall Study|Site Terminated by Sponsor|0|||
161421506|NCT03386721|582932016|FG000|Overall Study|Symptomatic Deterioration|0|||
161421507|NCT03386721|582932017|FG001|Overall Study|Symptomatic Deterioration|0|||
161421508|NCT03386721|582932018|FG002|Overall Study|Symptomatic Deterioration|0|||
161421509|NCT03386721|582932019|FG003|Overall Study|Symptomatic Deterioration|0|||
161421510|NCT03386721|582932020|FG004|Overall Study|Symptomatic Deterioration|0|||
161421511|NCT03386721|582932021|FG005|Overall Study|Symptomatic Deterioration|0|||
161421512|NCT03386721|582932022|FG006|Overall Study|Symptomatic Deterioration|0|||
161421513|NCT03386721|582932023|FG007|Overall Study|Symptomatic Deterioration|0|||
161421514|NCT03386721|582932024|FG008|Overall Study|Symptomatic Deterioration|1|||
161421515|NCT03386721|582932025|FG009|Overall Study|Symptomatic Deterioration|0|||
161421516|NCT03386721|582932026|FG010|Overall Study|Symptomatic Deterioration|0|||
161421517|NCT03386721|582932027|FG011|Overall Study|Symptomatic Deterioration|1|||
161421518|NCT03386721|582932028|FG012|Overall Study|Symptomatic Deterioration|0|||
161421519|NCT03386721|582932029|FG013|Overall Study|Symptomatic Deterioration|0|||
161421520|NCT03386721|582932030|FG014|Overall Study|Symptomatic Deterioration|0|||
161421521|NCT03386721|582932016|FG000|Overall Study|Withdrawal by Subject|1|||
161421522|NCT03386721|582932017|FG001|Overall Study|Withdrawal by Subject|2|||
161421523|NCT03386721|582932018|FG002|Overall Study|Withdrawal by Subject|0|||
161421524|NCT03386721|582932019|FG003|Overall Study|Withdrawal by Subject|0|||
161421525|NCT03386721|582932020|FG004|Overall Study|Withdrawal by Subject|0|||
161421526|NCT03386721|582932021|FG005|Overall Study|Withdrawal by Subject|0|||
161421527|NCT03386721|582932022|FG006|Overall Study|Withdrawal by Subject|0|||
161421528|NCT03386721|582932023|FG007|Overall Study|Withdrawal by Subject|0|||
161421529|NCT03386721|582932024|FG008|Overall Study|Withdrawal by Subject|2|||
161421530|NCT03386721|582932025|FG009|Overall Study|Withdrawal by Subject|1|||
161421531|NCT03386721|582932026|FG010|Overall Study|Withdrawal by Subject|3|||
161421532|NCT03386721|582932027|FG011|Overall Study|Withdrawal by Subject|2|||
161421533|NCT03386721|582932028|FG012|Overall Study|Withdrawal by Subject|3|||
161421534|NCT03386721|582932029|FG013|Overall Study|Withdrawal by Subject|0|||
161421535|NCT03386721|582932030|FG014|Overall Study|Withdrawal by Subject|0|||
161421536|NCT03359174|582932033|FG000|Overall Study|Adverse Event|1|||
161421537|NCT02680665|582932034|FG000|Overall Study|No visit after the first prescription|5|||
161421538|NCT02905266|582932035|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
161421539|NCT02905266|582932036|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
161421540|NCT02905266|582932035|FG000|Treatment Phase Part 1|Disease Progression|6|||
161421541|NCT02905266|582932036|FG001|Treatment Phase Part 1|Disease Progression|7|||
161421542|NCT02905266|582932035|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
161421543|NCT02905266|582932036|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
161421544|NCT02905266|582932035|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
161421545|NCT02905266|582932036|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
161421546|NCT02905266|582932035|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
161421547|NCT02905266|582932036|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
161421548|NCT02905266|582932035|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
161421549|NCT02905266|582932036|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
161421550|NCT02905266|582932035|FG000|Transition From Part 1 to Part 2|Death|0|||
161421551|NCT02905266|582932036|FG001|Transition From Part 1 to Part 2|Death|1|||
161421552|NCT02905266|582932035|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
161421553|NCT02905266|582932036|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
161421554|NCT02905266|582932035|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
161421555|NCT02905266|582932036|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
161421556|NCT02905266|582932035|FG000|Maintenance Phase Part 2|Disease Progression|9|||
161421557|NCT02905266|582932036|FG001|Maintenance Phase Part 2|Disease Progression|2|||
161421558|NCT02905266|582932035|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
161421559|NCT02905266|582932036|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
161421560|NCT02905266|582932035|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
161421561|NCT02905266|582932036|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
161421562|NCT00596752|582932039|FG000|Overall Study|Other Reason|44|||
161421563|NCT00596752|582932040|FG001|Overall Study|Other Reason|49|||
161421564|NCT00596752|582932039|FG000|Overall Study|Adverse Event|34|||
161421565|NCT00596752|582932040|FG001|Overall Study|Adverse Event|34|||
161421566|NCT00596752|582932039|FG000|Overall Study|Lost to Follow-up|22|||
161421567|NCT00596752|582932040|FG001|Overall Study|Lost to Follow-up|38|||
161421568|NCT00596752|582932039|FG000|Overall Study|Withdrawal by Subject|12|||
161421569|NCT00596752|582932040|FG001|Overall Study|Withdrawal by Subject|9|||
161421570|NCT00596752|582932039|FG000|Overall Study|Unsatisfactory Compliance|9|||
161421571|NCT00596752|582932040|FG001|Overall Study|Unsatisfactory Compliance|6|||
161421572|NCT00596752|582932039|FG000|Overall Study|Lack of Efficacy|4|||
161421573|NCT00596752|582932040|FG001|Overall Study|Lack of Efficacy|7|||
161421574|NCT00596752|582932039|FG000|Overall Study|Protocol Violation|1|||
161421575|NCT00596752|582932040|FG001|Overall Study|Protocol Violation|0|||
161421576|NCT04445662|582932043|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
161421577|NCT04445662|582932044|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
161421578|NCT04445662|582932043|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
161421579|NCT04445662|582932044|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
161421580|NCT04445662|582932043|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
161421581|NCT04445662|582932044|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
161421582|NCT04445662|582932043|FG000|Post-treatment (12-24 weeks)|Death|1|||
161421583|NCT04445662|582932044|FG001|Post-treatment (12-24 weeks)|Death|0|||
161421584|NCT02451124|582932055|FG000|Overall Study|Withdrawal by Subject|1|||
161421585|NCT01870726|582932056|FG000|Overall Study|Withdrawal of informed consent|0|||
161421586|NCT01870726|582932057|FG001|Overall Study|Withdrawal of informed consent|0|||
161421587|NCT01870726|582932058|FG002|Overall Study|Withdrawal of informed consent|0|||
161421588|NCT01870726|582932059|FG003|Overall Study|Withdrawal of informed consent|1|||
161421589|NCT01870726|582932060|FG004|Overall Study|Withdrawal of informed consent|0|||
161421590|NCT01870726|582932061|FG005|Overall Study|Withdrawal of informed consent|0|||
161421591|NCT01870726|582932062|FG006|Overall Study|Withdrawal of informed consent|0|||
161421592|NCT01870726|582932056|FG000|Overall Study|Withdrawal by Subject|0|||
161421593|NCT01870726|582932057|FG001|Overall Study|Withdrawal by Subject|1|||
161421594|NCT01870726|582932058|FG002|Overall Study|Withdrawal by Subject|0|||
161421595|NCT01870726|582932059|FG003|Overall Study|Withdrawal by Subject|0|||
161421596|NCT01870726|582932060|FG004|Overall Study|Withdrawal by Subject|0|||
161421597|NCT01870726|582932061|FG005|Overall Study|Withdrawal by Subject|0|||
161421598|NCT01870726|582932062|FG006|Overall Study|Withdrawal by Subject|0|||
161421599|NCT01870726|582932056|FG000|Overall Study|Adverse Event|0|||
161421600|NCT01870726|582932057|FG001|Overall Study|Adverse Event|0|||
161421601|NCT01870726|582932058|FG002|Overall Study|Adverse Event|0|||
161421602|NCT01870726|582932059|FG003|Overall Study|Adverse Event|0|||
161421603|NCT01870726|582932060|FG004|Overall Study|Adverse Event|1|||
161421604|NCT01870726|582932061|FG005|Overall Study|Adverse Event|1|||
161421605|NCT01870726|582932062|FG006|Overall Study|Adverse Event|0|||
161421606|NCT01870726|582932056|FG000|Overall Study|Progressive disease|5|||
161421607|NCT01870726|582932057|FG001|Overall Study|Progressive disease|5|||
161421608|NCT01870726|582932058|FG002|Overall Study|Progressive disease|4|||
161421609|NCT01870726|582932059|FG003|Overall Study|Progressive disease|5|||
161421610|NCT01870726|582932060|FG004|Overall Study|Progressive disease|6|||
161421611|NCT01870726|582932061|FG005|Overall Study|Progressive disease|4|||
161421612|NCT01870726|582932062|FG006|Overall Study|Progressive disease|10|||
161421613|NCT00103740|582932065|FG000|Period 1 - Core|Adverse Event|1|||
161421614|NCT00103740|582932066|FG001|Period 1 - Core|Adverse Event|0|||
161421615|NCT00103740|582932065|FG000|Period 1 - Core|Protocol Violation|3|||
161421616|NCT00103740|582932066|FG001|Period 1 - Core|Protocol Violation|2|||
161421617|NCT00103740|582932065|FG000|Period 1 - Core|Patient withdrew consent|3|||
161421618|NCT00103740|582932066|FG001|Period 1 - Core|Patient withdrew consent|2|||
161421619|NCT00103740|582932065|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
161421620|NCT00103740|582932066|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
161421621|NCT00103740|582932065|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
161421622|NCT00103740|582932066|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
161421623|NCT00103740|582932065|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
161421624|NCT00103740|582932066|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
161421625|NCT00103740|582932065|FG000|Period 2 - Extended Observation Period|Death|6|||
161421626|NCT00103740|582932066|FG001|Period 2 - Extended Observation Period|Death|2|||
161421627|NCT00103740|582932065|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
161421628|NCT00103740|582932066|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
161421629|NCT03691571|582932067|FG000|Overall Study|Withdrawal by Subject|9|||
161421630|NCT03691571|582932068|FG001|Overall Study|Withdrawal by Subject|2|||
161421631|NCT01463306|582932069|FG000|Overall Study|Adverse Event|6|||
161421632|NCT01463306|582932070|FG001|Overall Study|Adverse Event|9|||
161421633|NCT01463306|582932071|FG002|Overall Study|Adverse Event|3|||
161421634|NCT01463306|582932069|FG000|Overall Study|Death|3|||
161421635|NCT01463306|582932070|FG001|Overall Study|Death|3|||
161421636|NCT01463306|582932071|FG002|Overall Study|Death|0|||
161421637|NCT01463306|582932069|FG000|Overall Study|Lack of Efficacy|22|||
161421638|NCT01463306|582932070|FG001|Overall Study|Lack of Efficacy|16|||
161421639|NCT01463306|582932071|FG002|Overall Study|Lack of Efficacy|1|||
161421640|NCT01463306|582932069|FG000|Overall Study|Lost to Follow-up|5|||
161421641|NCT01463306|582932070|FG001|Overall Study|Lost to Follow-up|2|||
161421642|NCT01463306|582932071|FG002|Overall Study|Lost to Follow-up|0|||
161421643|NCT01463306|582932069|FG000|Overall Study|Protocol Violation|4|||
161421644|NCT01463306|582932070|FG001|Overall Study|Protocol Violation|0|||
161421645|NCT01463306|582932071|FG002|Overall Study|Protocol Violation|0|||
161421646|NCT01463306|582932069|FG000|Overall Study|Withdrawal by Subject|19|||
161421647|NCT01463306|582932070|FG001|Overall Study|Withdrawal by Subject|9|||
161421648|NCT01463306|582932071|FG002|Overall Study|Withdrawal by Subject|1|||
161421649|NCT01463306|582932069|FG000|Overall Study|Other|26|||
161421650|NCT01463306|582932070|FG001|Overall Study|Other|13|||
161421651|NCT01463306|582932071|FG002|Overall Study|Other|0|||
161421652|NCT01463306|582932069|FG000|Overall Study|Approval expiry at site|1|||
161421653|NCT01463306|582932070|FG001|Overall Study|Approval expiry at site|0|||
161421654|NCT01463306|582932071|FG002|Overall Study|Approval expiry at site|0|||
161421655|NCT00250276|582932076|FG000|Overall Study|Serious Adverse Event|0|||
161421656|NCT00250276|582932077|FG001|Overall Study|Serious Adverse Event|0|||
161421657|NCT00250276|582932078|FG002|Overall Study|Serious Adverse Event|1|||
161421658|NCT00250276|582932079|FG003|Overall Study|Serious Adverse Event|0|||
161421659|NCT00250276|582932076|FG000|Overall Study|Non-serious Adverse Event|2|||
161421660|NCT00250276|582932077|FG001|Overall Study|Non-serious Adverse Event|0|||
161421661|NCT00250276|582932078|FG002|Overall Study|Non-serious Adverse Event|0|||
161421662|NCT00250276|582932079|FG003|Overall Study|Non-serious Adverse Event|2|||
161421663|NCT00250276|582932076|FG000|Overall Study|Protocol Violation|0|||
161421664|NCT00250276|582932077|FG001|Overall Study|Protocol Violation|1|||
161421665|NCT00250276|582932078|FG002|Overall Study|Protocol Violation|0|||
161421666|NCT00250276|582932079|FG003|Overall Study|Protocol Violation|0|||
161421667|NCT00250276|582932076|FG000|Overall Study|Withdrawal by Subject|1|||
161421668|NCT00250276|582932077|FG001|Overall Study|Withdrawal by Subject|2|||
161421669|NCT00250276|582932078|FG002|Overall Study|Withdrawal by Subject|3|||
161421670|NCT00250276|582932079|FG003|Overall Study|Withdrawal by Subject|2|||
161421671|NCT00250276|582932076|FG000|Overall Study|Migrated/moved from study area|3|||
161421672|NCT00250276|582932077|FG001|Overall Study|Migrated/moved from study area|0|||
161421673|NCT00250276|582932078|FG002|Overall Study|Migrated/moved from study area|2|||
161421674|NCT00250276|582932079|FG003|Overall Study|Migrated/moved from study area|7|||
161421675|NCT00250276|582932076|FG000|Overall Study|Lost to Follow-up|11|||
161421676|NCT00250276|582932077|FG001|Overall Study|Lost to Follow-up|18|||
161421677|NCT00250276|582932078|FG002|Overall Study|Lost to Follow-up|13|||
161421678|NCT00250276|582932079|FG003|Overall Study|Lost to Follow-up|8|||
161421679|NCT00555217|582932080|FG000|Overall Study|Withdrawal by Subject|35|||
161421680|NCT00555217|582932081|FG001|Overall Study|Withdrawal by Subject|31|||
161421681|NCT00555217|582932080|FG000|Overall Study|Lost to Follow-up|19|||
161421682|NCT00555217|582932081|FG001|Overall Study|Lost to Follow-up|20|||
161421683|NCT00555217|582932080|FG000|Overall Study|close out sites|21|||
161421684|NCT00555217|582932081|FG001|Overall Study|close out sites|17|||
161421685|NCT01546688|582932082|FG000|Overall Study|Adverse Event|0|||
161421686|NCT01546688|582932083|FG001|Overall Study|Adverse Event|4|||
161421687|NCT01546688|582932082|FG000|Overall Study|Withdrawal by Subject|2|||
161421688|NCT01546688|582932083|FG001|Overall Study|Withdrawal by Subject|1|||
161421689|NCT01546688|582932082|FG000|Overall Study|Lack of Efficacy|1|||
161421690|NCT01546688|582932083|FG001|Overall Study|Lack of Efficacy|0|||
161421691|NCT03543137|582932084|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
161421692|NCT03543137|582932085|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
161421693|NCT03543137|582932084|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
161421694|NCT03543137|582932085|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
161421695|NCT03543137|582932084|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
161421696|NCT03543137|582932085|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
161421697|NCT01045694|582932091|FG000|Overall Study|Withdrawal by Subject|2|||
161421698|NCT01657292|582932092|FG000|Overall Study|Adverse Event|6|||
161421699|NCT01657292|582932092|FG000|Overall Study|Withdrawal by Subject|2|||
161421700|NCT01657292|582932092|FG000|Overall Study|Violation of eligibility criteria|1|||
161421701|NCT01657292|582932092|FG000|Overall Study|Change of therapy|1|||
161421702|NCT01900652|582932093|FG000|Overall Study|Progressive Disease|1|||
161421703|NCT01900652|582932094|FG001|Overall Study|Progressive Disease|0|||
161421704|NCT01900652|582932093|FG000|Overall Study|Consent withdrawn by subject|1|||
161421705|NCT01900652|582932094|FG001|Overall Study|Consent withdrawn by subject|1|||
161421706|NCT01900652|582932093|FG000|Overall Study|Death|3|||
161421707|NCT01900652|582932094|FG001|Overall Study|Death|0|||
161421708|NCT01900652|582932093|FG000|Overall Study|Adverse Event|2|||
161421709|NCT01900652|582932094|FG001|Overall Study|Adverse Event|1|||
161421710|NCT01900652|582932093|FG000|Overall Study|Physician Decision|1|||
161421711|NCT01900652|582932094|FG001|Overall Study|Physician Decision|1|||
161421712|NCT03761810|582932095|FG000|Overall Study|Adverse Event|12|||
161421713|NCT03761810|582932096|FG001|Overall Study|Adverse Event|0|||
161421714|NCT03761810|582932095|FG000|Overall Study|Lost to Follow-up|15|||
161421715|NCT03761810|582932096|FG001|Overall Study|Lost to Follow-up|7|||
161421716|NCT03761810|582932095|FG000|Overall Study|Pregnancy|1|||
161421717|NCT03761810|582932096|FG001|Overall Study|Pregnancy|0|||
161421718|NCT03761810|582932095|FG000|Overall Study|Withdrawal by Subject|14|||
161421719|NCT03761810|582932096|FG001|Overall Study|Withdrawal by Subject|5|||
161421720|NCT03761810|582932095|FG000|Overall Study|Physician Decision|1|||
161421721|NCT03761810|582932096|FG001|Overall Study|Physician Decision|0|||
161421722|NCT03761810|582932095|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
161421723|NCT03761810|582932096|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161421724|NCT03761810|582932095|FG000|Overall Study|Other Than Specified|1|||
161421725|NCT03761810|582932096|FG001|Overall Study|Other Than Specified|0|||
161421726|NCT03566082|582932097|FG000|Overall Study|Death|7|||
161421727|NCT03566082|582932097|FG000|Overall Study|Failures (revision required)|2|||
161421728|NCT03566082|582932097|FG000|Overall Study|Lost to Follow-up|8|||
161421729|NCT00983385|582932098|FG000|Observation Period|Not eligible to be dosed|20|||
161421730|NCT00983385|582932098|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
161421731|NCT02663622|582932099|FG000|Overall Study|Death|3|||
161421732|NCT02663622|582932100|FG001|Overall Study|Death|1|||
161421733|NCT02663622|582932101|FG002|Overall Study|Death|1|||
161421734|NCT02663622|582932102|FG003|Overall Study|Death|8|||
161421735|NCT02663622|582932099|FG000|Overall Study|Protocol Violation|0|||
161421736|NCT02663622|582932100|FG001|Overall Study|Protocol Violation|0|||
161421737|NCT02663622|582932101|FG002|Overall Study|Protocol Violation|0|||
161421738|NCT02663622|582932102|FG003|Overall Study|Protocol Violation|1|||
161421739|NCT00930930|582932104|FG000|Overall Study|Death|1|||
161421740|NCT00930930|582932105|FG001|Overall Study|Death|0|||
161421741|NCT00930930|582932104|FG000|Overall Study|Physician Decision|1|||
161421742|NCT00930930|582932105|FG001|Overall Study|Physician Decision|0|||
161421743|NCT00930930|582932104|FG000|Overall Study|Adverse Event|13|||
161421744|NCT00930930|582932105|FG001|Overall Study|Adverse Event|3|||
161421745|NCT00930930|582932104|FG000|Overall Study|Withdrawal by Subject|3|||
161421746|NCT00930930|582932105|FG001|Overall Study|Withdrawal by Subject|1|||
161421747|NCT00930930|582932104|FG000|Overall Study|Disease progression|2|||
161421748|NCT00930930|582932105|FG001|Overall Study|Disease progression|3|||
161421749|NCT00930930|582932104|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
161421750|NCT00930930|582932105|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
161421751|NCT00930930|582932104|FG000|Overall Study|patients not compliant|1|||
161421752|NCT00930930|582932105|FG001|Overall Study|patients not compliant|1|||
161421753|NCT00511238|582932106|FG000|Overall Study|Adverse Event|13|||
161421754|NCT00511238|582932107|FG001|Overall Study|Adverse Event|33|||
161421755|NCT00511238|582932106|FG000|Overall Study|Withdrawal by Subject|2|||
161421756|NCT00511238|582932107|FG001|Overall Study|Withdrawal by Subject|22|||
161421757|NCT00511238|582932106|FG000|Overall Study|Progressive Disease|23|||
161421758|NCT00511238|582932107|FG001|Overall Study|Progressive Disease|157|||
161421759|NCT00511238|582932106|FG000|Overall Study|various reasons|4|||
161421760|NCT00511238|582932107|FG001|Overall Study|various reasons|14|||
161421761|NCT00163020|582932108|FG000|Overall Study|Lost to Follow-up|0|||
161421762|NCT00163020|582932109|FG001|Overall Study|Lost to Follow-up|2|||
161421763|NCT03790111|582933848|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
161421764|NCT00997035|582933852|FG000|3-week Followup Visit|Lost to Follow-up|9|||
161421765|NCT00997035|582933853|FG001|3-week Followup Visit|Lost to Follow-up|6|||
161421766|NCT00997035|582933852|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
161421767|NCT00997035|582933853|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
161421768|NCT02471014|582933854|FG000|Overall Study|Lost to Follow-up|2|||
161421769|NCT02471014|582933855|FG001|Overall Study|Lost to Follow-up|2|||
161421770|NCT00936702|582933858|FG000|Overall Study|Disease progression|34|||
161421771|NCT00936702|582933858|FG000|Overall Study|Adverse Event|8|||
161421772|NCT00936702|582933858|FG000|Overall Study|Withdrawal by Subject|2|||
161421773|NCT00936702|582933858|FG000|Overall Study|Alternative Treatment|1|||
161421774|NCT00936702|582933858|FG000|Overall Study|Other|1|||
161421775|NCT00354679|582933859|FG000|Overall Study|Patient Not Treated|1|||
161421776|NCT03456076|582933860|FG000|Overall Study|Withdrawal by Subject|5|||
161421777|NCT03456076|582933861|FG001|Overall Study|Withdrawal by Subject|9|||
161421778|NCT03456076|582933860|FG000|Overall Study|Protocol deviation|0|||
161421779|NCT03456076|582933861|FG001|Overall Study|Protocol deviation|1|||
161421780|NCT03456076|582933860|FG000|Overall Study|Lost to Follow-up|0|||
161421781|NCT03456076|582933861|FG001|Overall Study|Lost to Follow-up|1|||
161421782|NCT03456076|582933860|FG000|Overall Study|Death|2|||
161421783|NCT03456076|582933861|FG001|Overall Study|Death|5|||
161421784|NCT03456076|582933860|FG000|Overall Study|Study ongoing|123|||
161421785|NCT03456076|582933861|FG001|Overall Study|Study ongoing|111|||
161421786|NCT03187132|582933864|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
161421787|NCT03187132|582933865|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
161421788|NCT03187132|582933864|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
161421789|NCT03187132|582933865|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
161421790|NCT03187132|582933864|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
161421791|NCT03187132|582933865|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
161421792|NCT03187132|582933864|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
161421793|NCT03187132|582933865|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
161421794|NCT03187132|582933864|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
161421795|NCT03187132|582933865|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
161421796|NCT03187132|582933864|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
161421797|NCT03187132|582933865|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
161421798|NCT03187132|582933864|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
161421799|NCT03187132|582933865|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
161421800|NCT03187132|582933864|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
161421801|NCT03187132|582933865|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
161421802|NCT03187132|582933864|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
161421803|NCT03187132|582933865|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
161421804|NCT03187132|582933864|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
161421805|NCT03187132|582933865|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
161421806|NCT03187132|582933864|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
161421807|NCT03187132|582933865|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
161421808|NCT02045095|582933866|FG000|Overall Study|Other|0|||
161421809|NCT02045095|582933867|FG001|Overall Study|Other|0|||
161421810|NCT02045095|582933868|FG002|Overall Study|Other|1|||
161421811|NCT02045095|582933869|FG003|Overall Study|Other|0|||
161421812|NCT02045095|582933870|FG004|Overall Study|Other|0|||
161421813|NCT02045095|582933871|FG005|Overall Study|Other|2|||
161421814|NCT02045095|582933872|FG006|Overall Study|Other|0|||
161421815|NCT02045095|582933866|FG000|Overall Study|Progressive Disease|3|||
161421816|NCT02045095|582933867|FG001|Overall Study|Progressive Disease|3|||
161421817|NCT02045095|582933868|FG002|Overall Study|Progressive Disease|2|||
161421818|NCT02045095|582933869|FG003|Overall Study|Progressive Disease|4|||
161421819|NCT02045095|582933870|FG004|Overall Study|Progressive Disease|2|||
161421820|NCT02045095|582933871|FG005|Overall Study|Progressive Disease|4|||
161421821|NCT02045095|582933872|FG006|Overall Study|Progressive Disease|1|||
161421822|NCT02045095|582933866|FG000|Overall Study|Withdrawal by Subject|0|||
161421823|NCT02045095|582933867|FG001|Overall Study|Withdrawal by Subject|0|||
161421824|NCT02045095|582933868|FG002|Overall Study|Withdrawal by Subject|0|||
161421825|NCT02045095|582933869|FG003|Overall Study|Withdrawal by Subject|0|||
161421826|NCT02045095|582933870|FG004|Overall Study|Withdrawal by Subject|3|||
161421827|NCT02045095|582933871|FG005|Overall Study|Withdrawal by Subject|0|||
161421828|NCT02045095|582933872|FG006|Overall Study|Withdrawal by Subject|0|||
161421829|NCT02045095|582933866|FG000|Overall Study|Adverse Event|0|||
161421830|NCT02045095|582933867|FG001|Overall Study|Adverse Event|1|||
161421831|NCT02045095|582933868|FG002|Overall Study|Adverse Event|1|||
161421832|NCT02045095|582933869|FG003|Overall Study|Adverse Event|0|||
161421833|NCT02045095|582933870|FG004|Overall Study|Adverse Event|0|||
161421834|NCT02045095|582933871|FG005|Overall Study|Adverse Event|2|||
161421835|NCT02045095|582933872|FG006|Overall Study|Adverse Event|0|||
161421836|NCT02525588|582933873|FG000|Overall Study|Death|3|||
161421837|NCT02525588|582933874|FG001|Overall Study|Death|1|||
161421838|NCT02525588|582933873|FG000|Overall Study|Lost to Follow-up|2|||
161421839|NCT02525588|582933874|FG001|Overall Study|Lost to Follow-up|0|||
161421840|NCT02525588|582933873|FG000|Overall Study|Withdrawal by Subject|1|||
161421841|NCT02525588|582933874|FG001|Overall Study|Withdrawal by Subject|1|||
161421842|NCT02525588|582933873|FG000|Overall Study|Adverse Event|0|||
161421843|NCT02525588|582933874|FG001|Overall Study|Adverse Event|1|||
161421844|NCT01450761|582933878|FG000|Randomization|Subject no longer meets study criteria|1|||
161421845|NCT01450761|582933879|FG001|Randomization|Subject no longer meets study criteria|2|||
161421846|NCT01450761|582933878|FG000|Randomization|Withdrawal by Subject|2|||
161421847|NCT01450761|582933879|FG001|Randomization|Withdrawal by Subject|0|||
161421848|NCT01450761|582933878|FG000|Randomization|Disease progression|0|||
161421849|NCT01450761|582933879|FG001|Randomization|Disease progression|2|||
161421850|NCT01450761|582933878|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161421851|NCT01450761|582933879|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161421852|NCT01450761|582933878|FG000|Randomization|Other|0|||
161421853|NCT01450761|582933879|FG001|Randomization|Other|1|||
161421854|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Disease progression|33|||
161421855|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Disease progression|32|||
161421856|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
161421857|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
161421858|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
161421859|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
161421860|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
161421861|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
161421862|NCT01450761|582933878|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
161421863|NCT01450761|582933879|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
161421864|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Death|3|||
161421865|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Death|3|||
161421866|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Other|2|||
161421867|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Other|2|||
161421868|NCT01450761|582933878|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
161421869|NCT01450761|582933879|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
161421870|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
161421871|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
161421872|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
161421873|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
161421874|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
161421875|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
161421876|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
161421877|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
161421878|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
161421879|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
161421880|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Death|5|||
161421881|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Death|6|||
161421882|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
161421883|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
161421884|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
161421885|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
161421886|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
161421887|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
161421888|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
161421889|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
161421890|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
161421891|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
161421892|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
161421893|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
161421894|NCT01450761|582933878|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
161421895|NCT01450761|582933879|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
161421896|NCT03801174|582933880|FG000|Overall Study|Withdrawal by Subject|14|||
161421897|NCT03801174|582933881|FG001|Overall Study|Withdrawal by Subject|15|||
161421898|NCT03801174|582933880|FG000|Overall Study|Death|1|||
161421899|NCT03801174|582933881|FG001|Overall Study|Death|0|||
161421900|NCT03801174|582933880|FG000|Overall Study|Pregnancy|2|||
161421901|NCT03801174|582933881|FG001|Overall Study|Pregnancy|2|||
161421902|NCT03801174|582933880|FG000|Overall Study|Lost to Follow-up|19|||
161421903|NCT03801174|582933881|FG001|Overall Study|Lost to Follow-up|10|||
161421904|NCT03801174|582933880|FG000|Overall Study|Other|4|||
161421905|NCT03801174|582933881|FG001|Overall Study|Other|3|||
161421906|NCT03801174|582933880|FG000|Overall Study|Lack of Efficacy|4|||
161421907|NCT03801174|582933881|FG001|Overall Study|Lack of Efficacy|0|||
161421908|NCT03801174|582933880|FG000|Overall Study|Unwilling to complete activities|5|||
161421909|NCT03801174|582933881|FG001|Overall Study|Unwilling to complete activities|6|||
161421910|NCT03801174|582933880|FG000|Overall Study|Moved out of area|3|||
161421911|NCT03801174|582933881|FG001|Overall Study|Moved out of area|0|||
161421912|NCT04435366|582933882|FG000|Year 1 (12 Months)|Adverse Event|3|||
161421913|NCT04435366|582933883|FG001|Year 1 (12 Months)|Adverse Event|0|||
161421914|NCT04435366|582933884|FG002|Year 1 (12 Months)|Adverse Event|2|||
161421915|NCT04435366|582933882|FG000|Year 1 (12 Months)|Death|2|||
161421916|NCT04435366|582933883|FG001|Year 1 (12 Months)|Death|0|||
161421917|NCT04435366|582933884|FG002|Year 1 (12 Months)|Death|1|||
161421918|NCT04435366|582933882|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
161421919|NCT04435366|582933883|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
161421920|NCT04435366|582933884|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
161421921|NCT04435366|582933882|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
161421922|NCT04435366|582933883|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
161421923|NCT04435366|582933884|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
161421924|NCT04435366|582933882|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
161421925|NCT04435366|582933883|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
161421926|NCT04435366|582933884|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
161421927|NCT04435366|582933882|FG000|Year 1 (12 Months)|Not treated|0|||
161421928|NCT04435366|582933883|FG001|Year 1 (12 Months)|Not treated|0|||
161421929|NCT04435366|582933884|FG002|Year 1 (12 Months)|Not treated|1|||
161421930|NCT04435366|582933882|FG000|Year 2 (12 Months)|Death|1|||
161421931|NCT04435366|582933883|FG001|Year 2 (12 Months)|Death|4|||
161421932|NCT04435366|582933884|FG002|Year 2 (12 Months)|Death|6|||
161421933|NCT04435366|582933882|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
161421934|NCT04435366|582933883|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
161421935|NCT04435366|582933884|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
161421936|NCT04435366|582933882|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
161421937|NCT04435366|582933883|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
161421938|NCT04435366|582933884|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
161421939|NCT04435366|582933882|FG000|Year 2 (12 Months)|Adverse Event|2|||
161421940|NCT04435366|582933883|FG001|Year 2 (12 Months)|Adverse Event|1|||
161421941|NCT04435366|582933884|FG002|Year 2 (12 Months)|Adverse Event|6|||
161421942|NCT05963022|582933889|FG000|Overall Study|Adverse Event|0|||
161421943|NCT05963022|582933890|FG001|Overall Study|Adverse Event|1|||
161421944|NCT05963022|582933891|FG002|Overall Study|Adverse Event|1|||
161421945|NCT05963022|582933892|FG003|Overall Study|Adverse Event|0|||
161421946|NCT05963022|582933889|FG000|Overall Study|Protocol Violation|0|||
161421947|NCT05963022|582933890|FG001|Overall Study|Protocol Violation|3|||
161421948|NCT05963022|582933891|FG002|Overall Study|Protocol Violation|0|||
161421949|NCT05963022|582933892|FG003|Overall Study|Protocol Violation|0|||
161421950|NCT05963022|582933889|FG000|Overall Study|Pregnancy|0|||
161421951|NCT05963022|582933890|FG001|Overall Study|Pregnancy|1|||
161421952|NCT05963022|582933891|FG002|Overall Study|Pregnancy|1|||
161421953|NCT05963022|582933892|FG003|Overall Study|Pregnancy|1|||
161421954|NCT05963022|582933889|FG000|Overall Study|Withdrawal by Subject|0|||
161421955|NCT05963022|582933890|FG001|Overall Study|Withdrawal by Subject|0|||
161421956|NCT05963022|582933891|FG002|Overall Study|Withdrawal by Subject|2|||
161421957|NCT05963022|582933892|FG003|Overall Study|Withdrawal by Subject|1|||
161421958|NCT05963022|582933889|FG000|Overall Study|Lost to Follow-up|0|||
161421959|NCT05963022|582933890|FG001|Overall Study|Lost to Follow-up|0|||
161421960|NCT05963022|582933891|FG002|Overall Study|Lost to Follow-up|0|||
161421961|NCT05963022|582933892|FG003|Overall Study|Lost to Follow-up|1|||
161421962|NCT05963022|582933889|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
161421963|NCT05963022|582933890|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
161421964|NCT05963022|582933891|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
161421965|NCT05963022|582933892|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
161421966|NCT02478463|582933897|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
161421967|NCT02478463|582933897|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
161421968|NCT02478463|582933897|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
161421969|NCT01177007|582933899|FG000|Overall Study|Lost to Follow-up|2|||
161421970|NCT01177007|582933899|FG000|Overall Study|Death|4|||
161421971|NCT01177007|582933899|FG000|Overall Study|Entered hospice care|5|||
161421972|NCT01177007|582933899|FG000|Overall Study|Required additional Y90 treatment|6|||
161421973|NCT01177007|582933899|FG000|Overall Study|Change in treatment modality|21|||
161421974|NCT01702558|582933901|FG000|Overall Study|Withdrawal by Subject|0|||
161421975|NCT01702558|582933902|FG001|Overall Study|Withdrawal by Subject|0|||
161421976|NCT01702558|582933903|FG002|Overall Study|Withdrawal by Subject|0|||
161421977|NCT01702558|582933904|FG003|Overall Study|Withdrawal by Subject|12|||
161421978|NCT01702558|582933905|FG004|Overall Study|Withdrawal by Subject|4|||
161421979|NCT01702558|582933901|FG000|Overall Study|Lost to Follow-up|0|||
161421980|NCT01702558|582933902|FG001|Overall Study|Lost to Follow-up|0|||
161421981|NCT01702558|582933903|FG002|Overall Study|Lost to Follow-up|0|||
161421982|NCT01702558|582933904|FG003|Overall Study|Lost to Follow-up|3|||
161421983|NCT01702558|582933905|FG004|Overall Study|Lost to Follow-up|0|||
161421984|NCT01702558|582933901|FG000|Overall Study|Death|4|||
161421985|NCT01702558|582933902|FG001|Overall Study|Death|3|||
161421986|NCT01702558|582933903|FG002|Overall Study|Death|3|||
161421987|NCT01702558|582933904|FG003|Overall Study|Death|16|||
161421988|NCT01702558|582933905|FG004|Overall Study|Death|20|||
161421989|NCT01702558|582933901|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
161421990|NCT01702558|582933902|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
161421991|NCT01702558|582933903|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
161421992|NCT01702558|582933904|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
161421993|NCT01702558|582933905|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
161421994|NCT01702558|582933901|FG000|Overall Study|Study Terminated by Sponsor|0|||
161421995|NCT01702558|582933902|FG001|Overall Study|Study Terminated by Sponsor|1|||
161421996|NCT01702558|582933903|FG002|Overall Study|Study Terminated by Sponsor|0|||
161421997|NCT01702558|582933904|FG003|Overall Study|Study Terminated by Sponsor|0|||
161421998|NCT01702558|582933905|FG004|Overall Study|Study Terminated by Sponsor|1|||
161421999|NCT01702558|582933901|FG000|Overall Study|Other|0|||
161422000|NCT01702558|582933902|FG001|Overall Study|Other|0|||
161422001|NCT01702558|582933903|FG002|Overall Study|Other|0|||
161422002|NCT01702558|582933904|FG003|Overall Study|Other|16|||
161422003|NCT01702558|582933905|FG004|Overall Study|Other|17|||
161422004|NCT03259087|582933911|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161422005|NCT03259087|582933912|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161422006|NCT03259087|582933913|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161422007|NCT03259087|582933914|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161422008|NCT03259087|582933915|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
161422009|NCT03259087|582933911|FG000|Period 2 of Part 2|Adverse Event|0|||
161422010|NCT03259087|582933912|FG001|Period 2 of Part 2|Adverse Event|0|||
161422011|NCT03259087|582933913|FG002|Period 2 of Part 2|Adverse Event|0|||
161422012|NCT03259087|582933914|FG003|Period 2 of Part 2|Adverse Event|0|||
161422013|NCT03259087|582933915|FG004|Period 2 of Part 2|Adverse Event|1|||
161422014|NCT04524858|582933916|FG000|Overall Study|Adverse Event|1|||
161422015|NCT03571204|582933917|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
161422016|NCT03571204|582933918|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
161422017|NCT03571204|582933919|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
161422018|NCT03571204|582933917|FG000|Overall Study|Physician Decision|0|||
161422019|NCT03571204|582933918|FG001|Overall Study|Physician Decision|1|||
161422020|NCT03571204|582933919|FG002|Overall Study|Physician Decision|0|||
161422021|NCT02396212|582933920|FG000|Overall Study|Adverse Event|1|||
161422022|NCT02396212|582933920|FG000|Overall Study|Lack of Efficacy|2|||
161422023|NCT01623115|582933921|FG000|Overall Study|Randomized but not treated|0|||
161422024|NCT01623115|582933922|FG001|Overall Study|Randomized but not treated|1|||
161422025|NCT01623115|582933921|FG000|Overall Study|Physician Decision|1|||
161422026|NCT01623115|582933922|FG001|Overall Study|Physician Decision|0|||
161422027|NCT01623115|582933921|FG000|Overall Study|Participants moved|1|||
161422028|NCT01623115|582933922|FG001|Overall Study|Participants moved|5|||
161422029|NCT01623115|582933921|FG000|Overall Study|Adverse Event|10|||
161422030|NCT01623115|582933922|FG001|Overall Study|Adverse Event|13|||
161422031|NCT01623115|582933921|FG000|Overall Study|Poor compliance to protocol|4|||
161422032|NCT01623115|582933922|FG001|Overall Study|Poor compliance to protocol|10|||
161422033|NCT01623115|582933921|FG000|Overall Study|Consent withdrawn by participant|2|||
161422034|NCT01623115|582933922|FG001|Overall Study|Consent withdrawn by participant|6|||
161422035|NCT01623115|582933921|FG000|Overall Study|Related to study drug administration|0|||
161422036|NCT01623115|582933922|FG001|Overall Study|Related to study drug administration|2|||
161422037|NCT01623115|582933921|FG000|Overall Study|Last visit outside protocol visit window|14|||
161422038|NCT01623115|582933922|FG001|Overall Study|Last visit outside protocol visit window|26|||
161422039|NCT01623115|582933921|FG000|Overall Study|Site closure|1|||
161422040|NCT01623115|582933922|FG001|Overall Study|Site closure|7|||
161422041|NCT01623115|582933921|FG000|Overall Study|Death|0|||
161422042|NCT01623115|582933922|FG001|Overall Study|Death|4|||
161422043|NCT01623115|582933921|FG000|Overall Study|Other than specified above|0|||
161422044|NCT01623115|582933922|FG001|Overall Study|Other than specified above|3|||
161422045|NCT04950465|582933923|FG000|Overall Study|Lost to Follow-up|1|||
161422046|NCT04950465|582933924|FG001|Overall Study|Lost to Follow-up|0|||
161422047|NCT04950465|582933925|FG002|Overall Study|Lost to Follow-up|0|||
161422048|NCT02721875|582933930|FG000|Overall Study|Progressive disease/relapse|1|||
161422049|NCT02721875|582933931|FG001|Overall Study|Progressive disease/relapse|0|||
161422050|NCT02888106|582933932|FG000|Overall Study|Withdrawal by Subject|1|||
161422051|NCT02888106|582933933|FG001|Overall Study|Withdrawal by Subject|2|||
161422052|NCT02888106|582933934|FG002|Overall Study|Withdrawal by Subject|0|||
161422053|NCT02888106|582933935|FG003|Overall Study|Withdrawal by Subject|1|||
161422054|NCT02888106|582933936|FG004|Overall Study|Withdrawal by Subject|0|||
161422055|NCT02888106|582933937|FG005|Overall Study|Withdrawal by Subject|0|||
161422056|NCT02888106|582933932|FG000|Overall Study|Lost to Follow-up|1|||
161422057|NCT02888106|582933933|FG001|Overall Study|Lost to Follow-up|0|||
161422058|NCT02888106|582933934|FG002|Overall Study|Lost to Follow-up|0|||
161422059|NCT02888106|582933935|FG003|Overall Study|Lost to Follow-up|1|||
161422060|NCT02888106|582933936|FG004|Overall Study|Lost to Follow-up|0|||
161422061|NCT02888106|582933937|FG005|Overall Study|Lost to Follow-up|1|||
161422062|NCT02888106|582933932|FG000|Overall Study|Adverse Event|2|||
161422063|NCT02888106|582933933|FG001|Overall Study|Adverse Event|0|||
161422064|NCT02888106|582933934|FG002|Overall Study|Adverse Event|0|||
161422065|NCT02888106|582933935|FG003|Overall Study|Adverse Event|0|||
161422066|NCT02888106|582933936|FG004|Overall Study|Adverse Event|0|||
161422067|NCT02888106|582933937|FG005|Overall Study|Adverse Event|0|||
161422068|NCT02888106|582933932|FG000|Overall Study|Withdrawal of consent|0|||
161422069|NCT02888106|582933933|FG001|Overall Study|Withdrawal of consent|0|||
161422070|NCT02888106|582933934|FG002|Overall Study|Withdrawal of consent|0|||
161422071|NCT02888106|582933935|FG003|Overall Study|Withdrawal of consent|0|||
161422072|NCT02888106|582933936|FG004|Overall Study|Withdrawal of consent|1|||
161422073|NCT02888106|582933937|FG005|Overall Study|Withdrawal of consent|0|||
161422074|NCT02888106|582933932|FG000|Overall Study|Pregnancy|1|||
161422075|NCT02888106|582933933|FG001|Overall Study|Pregnancy|0|||
161422076|NCT02888106|582933934|FG002|Overall Study|Pregnancy|0|||
161422077|NCT02888106|582933935|FG003|Overall Study|Pregnancy|0|||
161422078|NCT02888106|582933936|FG004|Overall Study|Pregnancy|0|||
161422079|NCT02888106|582933937|FG005|Overall Study|Pregnancy|0|||
161422080|NCT01425801|582933943|FG000|Period 1|Withdrawal by Subject|0|||
161422081|NCT01425801|582933944|FG001|Period 1|Withdrawal by Subject|0|||
161422082|NCT01425801|582933945|FG002|Period 1|Withdrawal by Subject|0|||
161422083|NCT01425801|582933946|FG003|Period 1|Withdrawal by Subject|0|||
161422084|NCT01425801|582933947|FG004|Period 1|Withdrawal by Subject|1|||
161422085|NCT01425801|582933948|FG005|Period 1|Withdrawal by Subject|0|||
161422086|NCT01425801|582933943|FG000|Period 2|Withdrawal by Subject|0|||
161422087|NCT01425801|582933944|FG001|Period 2|Withdrawal by Subject|0|||
161422088|NCT01425801|582933945|FG002|Period 2|Withdrawal by Subject|0|||
161422089|NCT01425801|582933946|FG003|Period 2|Withdrawal by Subject|0|||
161422090|NCT01425801|582933947|FG004|Period 2|Withdrawal by Subject|1|||
161422091|NCT01425801|582933948|FG005|Period 2|Withdrawal by Subject|0|||
161422092|NCT01425801|582933943|FG000|Period 3|Stability criteria not fullfilled|0|||
161422093|NCT01425801|582933944|FG001|Period 3|Stability criteria not fullfilled|0|||
161422094|NCT01425801|582933945|FG002|Period 3|Stability criteria not fullfilled|1|||
161422095|NCT01425801|582933946|FG003|Period 3|Stability criteria not fullfilled|0|||
161422096|NCT01425801|582933947|FG004|Period 3|Stability criteria not fullfilled|0|||
161422097|NCT01425801|582933948|FG005|Period 3|Stability criteria not fullfilled|0|||
161422098|NCT01425801|582933943|FG000|Period 4|Not able to maintain visit schedule|0|||
161422099|NCT01425801|582933944|FG001|Period 4|Not able to maintain visit schedule|0|||
161422100|NCT01425801|582933945|FG002|Period 4|Not able to maintain visit schedule|1|||
161422101|NCT01425801|582933946|FG003|Period 4|Not able to maintain visit schedule|0|||
161422102|NCT01425801|582933947|FG004|Period 4|Not able to maintain visit schedule|0|||
161422103|NCT01425801|582933948|FG005|Period 4|Not able to maintain visit schedule|0|||
161422104|NCT03066596|582933949|FG000|Overall Study|Withdrawal by Subject|4|||
161422105|NCT03066596|582933950|FG001|Overall Study|Withdrawal by Subject|2|||
161422106|NCT03066596|582933949|FG000|Overall Study|Lost to Follow-up|14|||
161422107|NCT03066596|582933950|FG001|Overall Study|Lost to Follow-up|10|||
161422108|NCT03797586|582933951|FG000|Overall Study|Lost to Follow-up|3|||
161422109|NCT03797586|582933952|FG001|Overall Study|Lost to Follow-up|6|||
161422110|NCT03797586|582933951|FG000|Overall Study|Death|1|||
161422111|NCT03797586|582933952|FG001|Overall Study|Death|1|||
161422112|NCT03797586|582933951|FG000|Overall Study|Adverse Event|0|||
161422113|NCT03797586|582933952|FG001|Overall Study|Adverse Event|2|||
161422114|NCT02959437|582933953|FG000|Overall Study|Death|33|||
161422115|NCT02959437|582933954|FG001|Overall Study|Death|3|||
161422116|NCT02959437|582933955|FG002|Overall Study|Death|0|||
161422117|NCT02959437|582933956|FG003|Overall Study|Death|0|||
161422118|NCT02959437|582933953|FG000|Overall Study|Lost to Follow-up|3|||
161422119|NCT02959437|582933954|FG001|Overall Study|Lost to Follow-up|1|||
161422120|NCT02959437|582933955|FG002|Overall Study|Lost to Follow-up|0|||
161422121|NCT02959437|582933956|FG003|Overall Study|Lost to Follow-up|0|||
161422122|NCT02959437|582933953|FG000|Overall Study|Withdrawal by Subject|11|||
161422123|NCT02959437|582933954|FG001|Overall Study|Withdrawal by Subject|3|||
161422124|NCT02959437|582933955|FG002|Overall Study|Withdrawal by Subject|0|||
161422125|NCT02959437|582933956|FG003|Overall Study|Withdrawal by Subject|0|||
161422126|NCT02959437|582933953|FG000|Overall Study|Progressive Disease|9|||
161422127|NCT02959437|582933954|FG001|Overall Study|Progressive Disease|1|||
161422128|NCT02959437|582933955|FG002|Overall Study|Progressive Disease|0|||
161422129|NCT02959437|582933956|FG003|Overall Study|Progressive Disease|0|||
161422130|NCT02959437|582933953|FG000|Overall Study|Study Terminated by Sponsor|4|||
161422131|NCT02959437|582933954|FG001|Overall Study|Study Terminated by Sponsor|0|||
161422132|NCT02959437|582933955|FG002|Overall Study|Study Terminated by Sponsor|0|||
161422133|NCT02959437|582933956|FG003|Overall Study|Study Terminated by Sponsor|0|||
161422134|NCT02959437|582933953|FG000|Overall Study|Other Unspecified|2|||
161422135|NCT02959437|582933954|FG001|Overall Study|Other Unspecified|0|||
161422136|NCT02959437|582933955|FG002|Overall Study|Other Unspecified|0|||
161422137|NCT02959437|582933956|FG003|Overall Study|Other Unspecified|0|||
161422138|NCT02864901|582933957|FG000|Overall Study|Withdrawal by Subject|1|||
161422139|NCT02864901|582933958|FG001|Overall Study|Withdrawal by Subject|0|||
161422140|NCT01369784|582933963|FG000|Overall Study|Protocol Violation|12|||
161422141|NCT01219985|582933964|FG000|Overall Study|Physician Decision|20|||
161422142|NCT04797780|582933967|FG000|Overall Study|Lost to Follow-up|1|||
161422143|NCT04797780|582933968|FG001|Overall Study|Lost to Follow-up|1|||
161422144|NCT04797780|582933967|FG000|Overall Study|Withdrawal by Subject|14|||
161422145|NCT04797780|582933968|FG001|Overall Study|Withdrawal by Subject|9|||
161422146|NCT04797780|582933967|FG000|Overall Study|Death|49|||
161422147|NCT04797780|582933968|FG001|Overall Study|Death|20|||
161422148|NCT02940496|582933969|FG000|Overall Study|Adverse Event|1|||
161422149|NCT02940496|582933970|FG001|Overall Study|Adverse Event|0|||
161422150|NCT02940496|582933969|FG000|Overall Study|Death|2|||
161422151|NCT02940496|582933970|FG001|Overall Study|Death|0|||
161422152|NCT02940496|582933969|FG000|Overall Study|Hospice Care|1|||
161422153|NCT02940496|582933970|FG001|Overall Study|Hospice Care|0|||
161422154|NCT02940496|582933969|FG000|Overall Study|No MRE Done|1|||
161422155|NCT02940496|582933970|FG001|Overall Study|No MRE Done|0|||
161422156|NCT02940496|582933969|FG000|Overall Study|MRE Failure|1|||
161422157|NCT02940496|582933970|FG001|Overall Study|MRE Failure|0|||
161422158|NCT05973006|582933971|FG000|Overall Study|Early termination|3|||
161422159|NCT05973006|582933972|FG001|Overall Study|Early termination|9|||
161422160|NCT05167825|582933973|FG000|Overall Study|Ongoing|3|||
161422161|NCT01807598|582933974|FG000|Overall Study|Withdrawal by Subject|4|||
161422162|NCT01807598|582933974|FG000|Overall Study|Adverse Event|1|||
161422163|NCT01807598|582933974|FG000|Overall Study|Other Physician Decision|1|||
161422164|NCT04089761|582933977|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
161422165|NCT04089761|582933977|FG000|"Run In Phase"|Lost to Follow-up|1|||
161422166|NCT04089761|582933977|FG000|"Treatment Phase"|No evaluable data|5|||
161422167|NCT04089761|582933977|FG000|"Treatment Phase"|Lost to Follow-up|1|||
161422168|NCT03622814|582933978|FG000|Overall Study|Lost to Follow-up|8|||
161422169|NCT03622814|582933979|FG001|Overall Study|Lost to Follow-up|14|||
161422170|NCT04417361|582933980|FG000|Overall Study|Withdrawal by Subject|1|||
161422171|NCT04417361|582933981|FG001|Overall Study|Withdrawal by Subject|0|||
161422172|NCT04417361|582933980|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
161422173|NCT04417361|582933981|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
161422174|NCT00165672|582933982|FG000|Overall Study|Adverse Event|0|||
161422175|NCT00165672|582933983|FG001|Overall Study|Adverse Event|1|||
161422176|NCT03868943|582933984|FG000|Overall Study|Adverse Event|1|||
161422177|NCT04896593|582933987|FG000|Overall Study|Withdrawal by Subject|2|||
161422178|NCT04896593|582933987|FG000|Overall Study|Lost to Follow-up|1|||
161422179|NCT04896593|582933987|FG000|Overall Study|Did not complete onboarding|2|||
161422180|NCT00892775|582933988|FG000|Overall Study|Protocol Violation|1|||
161422181|NCT00892775|582933989|FG001|Overall Study|Protocol Violation|0|||
161422182|NCT00892775|582933988|FG000|Overall Study|Subject difficulties with blood drawing|1|||
161422183|NCT00892775|582933989|FG001|Overall Study|Subject difficulties with blood drawing|0|||
161422184|NCT00892775|582933988|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
161422185|NCT00892775|582933989|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
161422186|NCT00892775|582933988|FG000|Overall Study|Migrated/ moved from study area|1|||
161422187|NCT00892775|582933989|FG001|Overall Study|Migrated/ moved from study area|0|||
161422188|NCT00892775|582933988|FG000|Overall Study|Withdrawal by Subject|0|||
161422189|NCT00892775|582933989|FG001|Overall Study|Withdrawal by Subject|1|||
161422190|NCT00892775|582933988|FG000|Overall Study|Lost to Follow-up|1|||
161422191|NCT00892775|582933989|FG001|Overall Study|Lost to Follow-up|0|||
161422192|NCT00869518|582933992|FG000|Overall Study|Lost to Follow-up|1|||
161422193|NCT00869518|582933993|FG001|Overall Study|Lost to Follow-up|1|||
161422194|NCT04178720|582933994|FG000|Overall Study|Withdrawal by Subject|2|||
161422195|NCT04178720|582933995|FG001|Overall Study|Withdrawal by Subject|0|||
161422196|NCT04178720|582933994|FG000|Overall Study|Relocation|0|||
161422197|NCT04178720|582933995|FG001|Overall Study|Relocation|1|||
161422198|NCT03922620|582933996|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
161422199|NCT03922620|582933997|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
161422200|NCT01633788|582935986|FG000|Overall Study|Adverse Event|1|||
161422201|NCT01633788|582935987|FG001|Overall Study|Adverse Event|3|||
161422202|NCT01633788|582935988|FG002|Overall Study|Adverse Event|3|||
161422203|NCT01633788|582935989|FG003|Overall Study|Adverse Event|3|||
161422204|NCT01633788|582935986|FG000|Overall Study|Lost to Follow-up|2|||
161422205|NCT01633788|582935987|FG001|Overall Study|Lost to Follow-up|2|||
161422206|NCT01633788|582935988|FG002|Overall Study|Lost to Follow-up|2|||
161422207|NCT01633788|582935989|FG003|Overall Study|Lost to Follow-up|0|||
161422208|NCT01633788|582935986|FG000|Overall Study|Personal Reasons|3|||
161422209|NCT01633788|582935987|FG001|Overall Study|Personal Reasons|1|||
161422210|NCT01633788|582935988|FG002|Overall Study|Personal Reasons|1|||
161422211|NCT01633788|582935989|FG003|Overall Study|Personal Reasons|3|||
161422212|NCT01633788|582935986|FG000|Overall Study|Protocol Violation|1|||
161422213|NCT01633788|582935987|FG001|Overall Study|Protocol Violation|0|||
161422214|NCT01633788|582935988|FG002|Overall Study|Protocol Violation|1|||
161422215|NCT01633788|582935989|FG003|Overall Study|Protocol Violation|0|||
161422216|NCT01633788|582935986|FG000|Overall Study|Other Reasons|0|||
161422217|NCT01633788|582935987|FG001|Overall Study|Other Reasons|2|||
161422218|NCT01633788|582935988|FG002|Overall Study|Other Reasons|3|||
161422219|NCT01633788|582935989|FG003|Overall Study|Other Reasons|7|||
161422220|NCT01389882|582935994|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
161422221|NCT01389882|582935995|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
161422222|NCT01389882|582935994|FG000|Overall Study|Withdrawal by Subject|0|||
161422223|NCT01389882|582935995|FG001|Overall Study|Withdrawal by Subject|1|||
161422224|NCT03811340|582935996|FG000|Overall Study|subjects did not complete the survey.|90|||
161422225|NCT01045967|582935997|FG000|Second Intervention|Protocol Violation|0|||
161422226|NCT01045967|582935998|FG001|Second Intervention|Protocol Violation|1|||
161422227|NCT00985673|582935999|FG000|Overall Study|Lost to Follow-up|6|||
161422228|NCT00985673|582936000|FG001|Overall Study|Lost to Follow-up|7|||
161422229|NCT00985673|582936001|FG002|Overall Study|Lost to Follow-up|6|||
161422230|NCT00985673|582936002|FG003|Overall Study|Lost to Follow-up|10|||
161422231|NCT00985673|582936003|FG004|Overall Study|Lost to Follow-up|5|||
161422232|NCT00985673|582936004|FG005|Overall Study|Lost to Follow-up|3|||
161422233|NCT00985673|582935999|FG000|Overall Study|Withdrawal by Subject|0|||
161422234|NCT00985673|582936000|FG001|Overall Study|Withdrawal by Subject|4|||
161422235|NCT00985673|582936001|FG002|Overall Study|Withdrawal by Subject|5|||
161422236|NCT00985673|582936002|FG003|Overall Study|Withdrawal by Subject|2|||
161422237|NCT00985673|582936003|FG004|Overall Study|Withdrawal by Subject|2|||
161422238|NCT00985673|582936004|FG005|Overall Study|Withdrawal by Subject|3|||
161422239|NCT00985673|582935999|FG000|Overall Study|Other|1|||
161422240|NCT00985673|582936000|FG001|Overall Study|Other|0|||
161422241|NCT00985673|582936001|FG002|Overall Study|Other|1|||
161422242|NCT00985673|582936002|FG003|Overall Study|Other|0|||
161422243|NCT00985673|582936003|FG004|Overall Study|Other|1|||
161422244|NCT00985673|582936004|FG005|Overall Study|Other|0|||
161422245|NCT02252146|582936005|FG000|Overall Study|Lack of Efficacy|4|||
161422246|NCT02252146|582936005|FG000|Overall Study|Entered hospice care|1|||
161422247|NCT02252146|582936005|FG000|Overall Study|Inability to travel to study site|1|||
161422248|NCT00531284|582936006|FG000|Overall Study|Progressive Disease|1|||
161422249|NCT00531284|582936007|FG001|Overall Study|Progressive Disease|3|||
161422250|NCT00531284|582936008|FG002|Overall Study|Progressive Disease|5|||
161422251|NCT00531284|582936009|FG003|Overall Study|Progressive Disease|42|||
161422252|NCT00531284|582936010|FG004|Overall Study|Progressive Disease|4|||
161422253|NCT00531284|582936011|FG005|Overall Study|Progressive Disease|4|||
161422254|NCT00531284|582936012|FG006|Overall Study|Progressive Disease|3|||
161422255|NCT00531284|582936013|FG007|Overall Study|Progressive Disease|8|||
161422256|NCT00531284|582936014|FG008|Overall Study|Progressive Disease|6|||
161422257|NCT00531284|582936015|FG009|Overall Study|Progressive Disease|3|||
161422258|NCT00531284|582936016|FG010|Overall Study|Progressive Disease|3|||
161422259|NCT00531284|582936017|FG011|Overall Study|Progressive Disease|14|||
161422260|NCT00531284|582936018|FG012|Overall Study|Progressive Disease|2|||
161422261|NCT00531284|582936019|FG013|Overall Study|Progressive Disease|1|||
161422262|NCT00531284|582936020|FG014|Overall Study|Progressive Disease|2|||
161422263|NCT00531284|582936021|FG015|Overall Study|Progressive Disease|11|||
161422264|NCT00531284|582936022|FG016|Overall Study|Progressive Disease|5|||
161422265|NCT00531284|582936006|FG000|Overall Study|Adverse Event|0|||
161422266|NCT00531284|582936007|FG001|Overall Study|Adverse Event|1|||
161422267|NCT00531284|582936008|FG002|Overall Study|Adverse Event|1|||
161422268|NCT00531284|582936009|FG003|Overall Study|Adverse Event|7|||
161422269|NCT00531284|582936010|FG004|Overall Study|Adverse Event|0|||
161422270|NCT00531284|582936011|FG005|Overall Study|Adverse Event|2|||
161422271|NCT00531284|582936012|FG006|Overall Study|Adverse Event|3|||
161422272|NCT00531284|582936013|FG007|Overall Study|Adverse Event|2|||
161422273|NCT00531284|582936014|FG008|Overall Study|Adverse Event|3|||
161422274|NCT00531284|582936015|FG009|Overall Study|Adverse Event|0|||
161422275|NCT00531284|582936016|FG010|Overall Study|Adverse Event|0|||
161422276|NCT00531284|582936017|FG011|Overall Study|Adverse Event|5|||
161422277|NCT00531284|582936018|FG012|Overall Study|Adverse Event|0|||
161422278|NCT00531284|582936019|FG013|Overall Study|Adverse Event|1|||
161422279|NCT00531284|582936020|FG014|Overall Study|Adverse Event|1|||
161422280|NCT00531284|582936021|FG015|Overall Study|Adverse Event|0|||
161422281|NCT00531284|582936022|FG016|Overall Study|Adverse Event|2|||
161422282|NCT00531284|582936006|FG000|Overall Study|Withdrawal by Subject|1|||
161422283|NCT00531284|582936007|FG001|Overall Study|Withdrawal by Subject|0|||
161422284|NCT00531284|582936008|FG002|Overall Study|Withdrawal by Subject|0|||
161422285|NCT00531284|582936009|FG003|Overall Study|Withdrawal by Subject|4|||
161422286|NCT00531284|582936010|FG004|Overall Study|Withdrawal by Subject|0|||
161422287|NCT00531284|582936011|FG005|Overall Study|Withdrawal by Subject|0|||
161422288|NCT00531284|582936012|FG006|Overall Study|Withdrawal by Subject|0|||
161422289|NCT00531284|582936013|FG007|Overall Study|Withdrawal by Subject|0|||
161422290|NCT00531284|582936014|FG008|Overall Study|Withdrawal by Subject|0|||
161422291|NCT00531284|582936015|FG009|Overall Study|Withdrawal by Subject|0|||
161422292|NCT00531284|582936016|FG010|Overall Study|Withdrawal by Subject|0|||
161422293|NCT00531284|582936017|FG011|Overall Study|Withdrawal by Subject|3|||
161422294|NCT00531284|582936018|FG012|Overall Study|Withdrawal by Subject|0|||
161422295|NCT00531284|582936019|FG013|Overall Study|Withdrawal by Subject|1|||
161422296|NCT00531284|582936020|FG014|Overall Study|Withdrawal by Subject|0|||
161422297|NCT00531284|582936021|FG015|Overall Study|Withdrawal by Subject|1|||
161422298|NCT00531284|582936022|FG016|Overall Study|Withdrawal by Subject|1|||
161422299|NCT00531284|582936006|FG000|Overall Study|Other|1|||
161422300|NCT00531284|582936007|FG001|Overall Study|Other|0|||
161422301|NCT00531284|582936008|FG002|Overall Study|Other|0|||
161422302|NCT00531284|582936009|FG003|Overall Study|Other|10|||
161422303|NCT00531284|582936010|FG004|Overall Study|Other|2|||
161422304|NCT00531284|582936011|FG005|Overall Study|Other|1|||
161422305|NCT00531284|582936012|FG006|Overall Study|Other|0|||
161422306|NCT00531284|582936013|FG007|Overall Study|Other|0|||
161422307|NCT00531284|582936014|FG008|Overall Study|Other|2|||
161422308|NCT00531284|582936015|FG009|Overall Study|Other|1|||
161422309|NCT00531284|582936016|FG010|Overall Study|Other|0|||
161422310|NCT00531284|582936017|FG011|Overall Study|Other|2|||
161422311|NCT00531284|582936018|FG012|Overall Study|Other|0|||
161422312|NCT00531284|582936019|FG013|Overall Study|Other|0|||
161422313|NCT00531284|582936020|FG014|Overall Study|Other|1|||
161422314|NCT00531284|582936021|FG015|Overall Study|Other|0|||
161422315|NCT00531284|582936022|FG016|Overall Study|Other|0|||
161422316|NCT03057496|582936023|FG000|Overall Study|Withdrawal by Subject|8|||
161422317|NCT03057496|582936023|FG000|Overall Study|Lost to Follow-up|5|||
161422318|NCT03057496|582936023|FG000|Overall Study|Did not use device during home trial|3|||
161422319|NCT03057496|582936023|FG000|Overall Study|Device failure|2|||
161422320|NCT00280917|582936024|FG000|Overall Study|Adverse Event|1|||
161422321|NCT00280917|582936025|FG001|Overall Study|Adverse Event|1|||
161422322|NCT00280917|582936026|FG002|Overall Study|Adverse Event|4|||
161422323|NCT00280917|582936027|FG003|Overall Study|Adverse Event|1|||
161422324|NCT00280917|582936024|FG000|Overall Study|Change Therapy|1|||
161422325|NCT00280917|582936025|FG001|Overall Study|Change Therapy|2|||
161422326|NCT00280917|582936026|FG002|Overall Study|Change Therapy|0|||
161422327|NCT00280917|582936027|FG003|Overall Study|Change Therapy|0|||
161422328|NCT00280917|582936024|FG000|Overall Study|Withdrawal by Subject|0|||
161422329|NCT00280917|582936025|FG001|Overall Study|Withdrawal by Subject|2|||
161422330|NCT00280917|582936026|FG002|Overall Study|Withdrawal by Subject|0|||
161422331|NCT00280917|582936027|FG003|Overall Study|Withdrawal by Subject|1|||
161422332|NCT00280917|582936024|FG000|Overall Study|Noncompliance|0|||
161422333|NCT00280917|582936025|FG001|Overall Study|Noncompliance|1|||
161422334|NCT00280917|582936026|FG002|Overall Study|Noncompliance|2|||
161422335|NCT00280917|582936027|FG003|Overall Study|Noncompliance|0|||
161422336|NCT03310723|582936032|FG000|Overall Study|Withdrawal by Subject|0|||
161422337|NCT03310723|582936033|FG001|Overall Study|Withdrawal by Subject|1|||
161422338|NCT03310723|582936032|FG000|Overall Study|Protocol Violation|0|||
161422339|NCT03310723|582936033|FG001|Overall Study|Protocol Violation|2|||
161422340|NCT02098746|582936034|FG000|Overall Study|Changes of Investigator|2|||
161422341|NCT02098746|582936034|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161422342|NCT02098746|582936034|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
161422343|NCT02098746|582936034|FG000|Overall Study|Data Not Available After Treatment|1|||
161422344|NCT01508312|582936037|FG000|Overall Study|Lost to Follow-up|1|||
161422345|NCT01508312|582936038|FG001|Overall Study|Lost to Follow-up|0|||
161422346|NCT01508312|582936039|FG002|Overall Study|Lost to Follow-up|0|||
161422347|NCT01508312|582936040|FG003|Overall Study|Lost to Follow-up|0|||
161422348|NCT01508312|582936037|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
161422349|NCT01508312|582936038|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
161422350|NCT01508312|582936039|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
161422351|NCT01508312|582936040|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
161422352|NCT01508312|582936037|FG000|Overall Study|Adverse Event|0|||
161422353|NCT01508312|582936038|FG001|Overall Study|Adverse Event|0|||
161422354|NCT01508312|582936039|FG002|Overall Study|Adverse Event|2|||
161422355|NCT01508312|582936040|FG003|Overall Study|Adverse Event|0|||
161422356|NCT01508312|582936037|FG000|Overall Study|Lack of Efficacy|0|||
161422357|NCT01508312|582936038|FG001|Overall Study|Lack of Efficacy|0|||
161422358|NCT01508312|582936039|FG002|Overall Study|Lack of Efficacy|1|||
161422359|NCT01508312|582936040|FG003|Overall Study|Lack of Efficacy|0|||
161422360|NCT01508312|582936037|FG000|Overall Study|Withdrawal by Subject|0|||
161422361|NCT01508312|582936038|FG001|Overall Study|Withdrawal by Subject|0|||
161422362|NCT01508312|582936039|FG002|Overall Study|Withdrawal by Subject|1|||
161422363|NCT01508312|582936040|FG003|Overall Study|Withdrawal by Subject|0|||
161422364|NCT02222558|582936041|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
161422365|NCT02222558|582936042|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
161422366|NCT02222558|582936043|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
161422367|NCT02222558|582936044|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
161422368|NCT02222558|582936045|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
161422369|NCT02222558|582936046|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
161422370|NCT02222558|582936041|FG000|Period 3|Withdrawal by Subject|0|||
161422371|NCT02222558|582936042|FG001|Period 3|Withdrawal by Subject|0|||
161422372|NCT02222558|582936043|FG002|Period 3|Withdrawal by Subject|0|||
161422373|NCT02222558|582936044|FG003|Period 3|Withdrawal by Subject|0|||
161422374|NCT02222558|582936045|FG004|Period 3|Withdrawal by Subject|0|||
161422375|NCT02222558|582936046|FG005|Period 3|Withdrawal by Subject|1|||
161422376|NCT02322281|582936049|FG000|Overall Study|Progressive Disease|42|||
161422377|NCT02322281|582936050|FG001|Overall Study|Progressive Disease|14|||
161422378|NCT02322281|582936051|FG002|Overall Study|Progressive Disease|49|||
161422379|NCT02322281|582936049|FG000|Overall Study|Adverse Event|3|||
161422380|NCT02322281|582936050|FG001|Overall Study|Adverse Event|4|||
161422381|NCT02322281|582936051|FG002|Overall Study|Adverse Event|6|||
161422382|NCT02322281|582936049|FG000|Overall Study|Death|3|||
161422383|NCT02322281|582936050|FG001|Overall Study|Death|3|||
161422384|NCT02322281|582936051|FG002|Overall Study|Death|3|||
161422385|NCT02322281|582936049|FG000|Overall Study|Withdrawal by Subject|1|||
161422386|NCT02322281|582936050|FG001|Overall Study|Withdrawal by Subject|1|||
161422387|NCT02322281|582936051|FG002|Overall Study|Withdrawal by Subject|6|||
161422388|NCT02322281|582936049|FG000|Overall Study|Physician Decision|2|||
161422389|NCT02322281|582936050|FG001|Overall Study|Physician Decision|0|||
161422390|NCT02322281|582936051|FG002|Overall Study|Physician Decision|5|||
161422391|NCT02322281|582936049|FG000|Overall Study|Study Terminated by Sponsor|2|||
161422392|NCT02322281|582936050|FG001|Overall Study|Study Terminated by Sponsor|0|||
161422393|NCT02322281|582936051|FG002|Overall Study|Study Terminated by Sponsor|0|||
161422394|NCT02322281|582936049|FG000|Overall Study|Missing|0|||
161422395|NCT02322281|582936050|FG001|Overall Study|Missing|0|||
161422396|NCT02322281|582936051|FG002|Overall Study|Missing|1|||
161422397|NCT02322281|582936049|FG000|Overall Study|Miscellaneous|0|||
161422398|NCT02322281|582936050|FG001|Overall Study|Miscellaneous|0|||
161422399|NCT02322281|582936051|FG002|Overall Study|Miscellaneous|4|||
161422400|NCT02532465|582936052|FG000|Overall Study|Protocol Violation|1|||
161422401|NCT02532465|582936053|FG001|Overall Study|Protocol Violation|0|||
161422402|NCT02532465|582936052|FG000|Overall Study|Lack of Efficacy|0|||
161422403|NCT02532465|582936053|FG001|Overall Study|Lack of Efficacy|1|||
161422404|NCT00466440|582936058|FG000|Overall Study|Adverse Event|0|||
161422405|NCT00466440|582936059|FG001|Overall Study|Adverse Event|3|||
161422406|NCT00466440|582936060|FG002|Overall Study|Adverse Event|1|||
161422407|NCT00466440|582936058|FG000|Overall Study|Death|1|||
161422408|NCT00466440|582936059|FG001|Overall Study|Death|1|||
161422409|NCT00466440|582936060|FG002|Overall Study|Death|0|||
161422410|NCT00466440|582936058|FG000|Overall Study|Progressive disease|13|||
161422411|NCT00466440|582936059|FG001|Overall Study|Progressive disease|5|||
161422412|NCT00466440|582936060|FG002|Overall Study|Progressive disease|4|||
161422413|NCT00466440|582936058|FG000|Overall Study|Lost to Follow-up|0|||
161422414|NCT00466440|582936059|FG001|Overall Study|Lost to Follow-up|1|||
161422415|NCT00466440|582936060|FG002|Overall Study|Lost to Follow-up|0|||
161422416|NCT00466440|582936058|FG000|Overall Study|Physician Decision|0|||
161422417|NCT00466440|582936059|FG001|Overall Study|Physician Decision|1|||
161422418|NCT00466440|582936060|FG002|Overall Study|Physician Decision|2|||
161422419|NCT00466440|582936058|FG000|Overall Study|Protocol entry criteria not met|0|||
161422420|NCT00466440|582936059|FG001|Overall Study|Protocol entry criteria not met|0|||
161422421|NCT00466440|582936060|FG002|Overall Study|Protocol entry criteria not met|4|||
161422422|NCT00466440|582936058|FG000|Overall Study|Withdrawal by Subject|0|||
161422423|NCT00466440|582936059|FG001|Overall Study|Withdrawal by Subject|1|||
161422424|NCT00466440|582936060|FG002|Overall Study|Withdrawal by Subject|0|||
161422425|NCT00466440|582936058|FG000|Overall Study|Sponsor decision|0|||
161422426|NCT00466440|582936059|FG001|Overall Study|Sponsor decision|0|||
161422427|NCT00466440|582936060|FG002|Overall Study|Sponsor decision|1|||
161422428|NCT03191630|582936066|FG000|Overall Study|Lost to Follow-up|7|||
161422429|NCT03191630|582936067|FG001|Overall Study|Lost to Follow-up|7|||
161422430|NCT00714415|582936076|FG000|Overall Study|Lack of Efficacy|1|||
161422431|NCT00714415|582936077|FG001|Overall Study|Lack of Efficacy|0|||
161422432|NCT00714415|582936076|FG000|Overall Study|Death|1|||
161422433|NCT00714415|582936077|FG001|Overall Study|Death|0|||
161422434|NCT01818596|582936086|FG000|Overall Study|Enrolled but Not Treated|4|||
161422435|NCT01818596|582936087|FG001|Overall Study|Enrolled but Not Treated|0|||
161422436|NCT01818596|582936086|FG000|Overall Study|Adverse Event|7|||
161422437|NCT01818596|582936087|FG001|Overall Study|Adverse Event|0|||
161422438|NCT01818596|582936086|FG000|Overall Study|Death|3|||
161422439|NCT01818596|582936087|FG001|Overall Study|Death|0|||
161422440|NCT01818596|582936086|FG000|Overall Study|Investigator's Discretion|4|||
161422441|NCT01818596|582936087|FG001|Overall Study|Investigator's Discretion|0|||
161422442|NCT01818596|582936086|FG000|Overall Study|Protocol Violation|1|||
161422443|NCT01818596|582936087|FG001|Overall Study|Protocol Violation|0|||
161422444|NCT01818596|582936086|FG000|Overall Study|Withdrew Consent|5|||
161422445|NCT01818596|582936087|FG001|Overall Study|Withdrew Consent|0|||
161422446|NCT01818596|582936086|FG000|Overall Study|Lost to Follow-up|7|||
161422447|NCT01818596|582936087|FG001|Overall Study|Lost to Follow-up|0|||
161422448|NCT02073682|582936096|FG000|Overall Study|Low Creatinine Clearance|1|||
161422449|NCT02073682|582936097|FG001|Overall Study|Low Creatinine Clearance|2|||
161422450|NCT02073682|582936096|FG000|Overall Study|Death|86|||
161422451|NCT02073682|582936097|FG001|Overall Study|Death|100|||
161422452|NCT02073682|582936096|FG000|Overall Study|Cancer Cured|10|||
161422453|NCT02073682|582936097|FG001|Overall Study|Cancer Cured|15|||
161422454|NCT02073682|582936096|FG000|Overall Study|ID: Patient Noncompliance|1|||
161422455|NCT02073682|582936097|FG001|Overall Study|ID: Patient Noncompliance|2|||
161422456|NCT02073682|582936096|FG000|Overall Study|ID: Palliative Treatment Only|10|||
161422457|NCT02073682|582936097|FG001|Overall Study|ID: Palliative Treatment Only|7|||
161422458|NCT02073682|582936096|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
161422459|NCT02073682|582936097|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
161422460|NCT02073682|582936096|FG000|Overall Study|Platelet Count <50,000/mL|1|||
161422461|NCT02073682|582936097|FG001|Overall Study|Platelet Count <50,000/mL|2|||
161422462|NCT02073682|582936096|FG000|Overall Study|Surgery/Medical Procedure|3|||
161422463|NCT02073682|582936097|FG001|Overall Study|Surgery/Medical Procedure|1|||
161422464|NCT02073682|582936096|FG000|Overall Study|Withdrawal by Subject|6|||
161422465|NCT02073682|582936097|FG001|Overall Study|Withdrawal by Subject|8|||
161422466|NCT02073682|582936096|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
161422467|NCT02073682|582936097|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
161422468|NCT02073682|582936096|FG000|Overall Study|Cancer Progression|53|||
161422469|NCT02073682|582936097|FG001|Overall Study|Cancer Progression|33|||
161422470|NCT02073682|582936096|FG000|Overall Study|Protocol Violation|1|||
161422471|NCT02073682|582936097|FG001|Overall Study|Protocol Violation|0|||
161422472|NCT02073682|582936096|FG000|Overall Study|Adverse Event|79|||
161422473|NCT02073682|582936097|FG001|Overall Study|Adverse Event|62|||
161422474|NCT02073682|582936096|FG000|Overall Study|No reason provided|11|||
161422475|NCT02073682|582936097|FG001|Overall Study|No reason provided|9|||
161422476|NCT02073682|582936096|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
161422477|NCT02073682|582936097|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
161422478|NCT02073682|582936096|FG000|Overall Study|Lost to Follow-up|1|||
161422479|NCT02073682|582936097|FG001|Overall Study|Lost to Follow-up|1|||
161422480|NCT02073682|582936096|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
161422481|NCT02073682|582936097|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
161422482|NCT04112810|582936103|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
161422483|NCT01687296|582936105|FG000|Overall Study|Lack of Efficacy|1|||
161422484|NCT01687296|582936106|FG001|Overall Study|Lack of Efficacy|1|||
161422485|NCT01687296|582936105|FG000|Overall Study|Protocol Violation|0|||
161422486|NCT01687296|582936106|FG001|Overall Study|Protocol Violation|1|||
161422487|NCT01687296|582936105|FG000|Overall Study|Withdrawal by Subject|6|||
161422488|NCT01687296|582936106|FG001|Overall Study|Withdrawal by Subject|3|||
161422489|NCT04497116|582936107|FG000|Overall Study|Lost to Follow-up|1|||
161422490|NCT04497116|582936108|FG001|Overall Study|Lost to Follow-up|0|||
161422491|NCT04497116|582936109|FG002|Overall Study|Lost to Follow-up|0|||
161422492|NCT04497116|582936110|FG003|Overall Study|Lost to Follow-up|0|||
161422493|NCT04497116|582936111|FG004|Overall Study|Lost to Follow-up|0|||
161422494|NCT04497116|582936112|FG005|Overall Study|Lost to Follow-up|0|||
161422495|NCT04497116|582936113|FG006|Overall Study|Lost to Follow-up|0|||
161422496|NCT04497116|582936114|FG007|Overall Study|Lost to Follow-up|3|||
161422497|NCT04497116|582936115|FG008|Overall Study|Lost to Follow-up|3|||
161422498|NCT04497116|582936116|FG009|Overall Study|Lost to Follow-up|0|||
161422499|NCT04497116|582936117|FG010|Overall Study|Lost to Follow-up|0|||
161422500|NCT04497116|582936118|FG011|Overall Study|Lost to Follow-up|0|||
161422501|NCT04497116|582936119|FG012|Overall Study|Lost to Follow-up|0|||
161422502|NCT04497116|582936120|FG013|Overall Study|Lost to Follow-up|0|||
161422503|NCT04497116|582936121|FG014|Overall Study|Lost to Follow-up|0|||
161422504|NCT04497116|582936122|FG015|Overall Study|Lost to Follow-up|0|||
161422505|NCT04497116|582936123|FG016|Overall Study|Lost to Follow-up|0|||
161422506|NCT04497116|582936124|FG017|Overall Study|Lost to Follow-up|0|||
161422507|NCT04497116|582936125|FG018|Overall Study|Lost to Follow-up|0|||
161422508|NCT04497116|582936126|FG019|Overall Study|Lost to Follow-up|0|||
161422509|NCT04497116|582936127|FG020|Overall Study|Lost to Follow-up|0|||
161422510|NCT04497116|582936128|FG021|Overall Study|Lost to Follow-up|0|||
161422511|NCT04497116|582936129|FG022|Overall Study|Lost to Follow-up|1|||
161422512|NCT04497116|582936130|FG023|Overall Study|Lost to Follow-up|0|||
161422513|NCT04497116|582936131|FG024|Overall Study|Lost to Follow-up|0|||
161422514|NCT04497116|582936107|FG000|Overall Study|Sponsor decision to terminate study|0|||
161422515|NCT04497116|582936108|FG001|Overall Study|Sponsor decision to terminate study|0|||
161422516|NCT04497116|582936109|FG002|Overall Study|Sponsor decision to terminate study|0|||
161422517|NCT04497116|582936110|FG003|Overall Study|Sponsor decision to terminate study|0|||
161422518|NCT04497116|582936111|FG004|Overall Study|Sponsor decision to terminate study|0|||
161422519|NCT04497116|582936112|FG005|Overall Study|Sponsor decision to terminate study|0|||
161422520|NCT04497116|582936113|FG006|Overall Study|Sponsor decision to terminate study|1|||
161422521|NCT04497116|582936114|FG007|Overall Study|Sponsor decision to terminate study|0|||
161422522|NCT04497116|582936115|FG008|Overall Study|Sponsor decision to terminate study|0|||
161422523|NCT04497116|582936116|FG009|Overall Study|Sponsor decision to terminate study|1|||
161422524|NCT04497116|582936117|FG010|Overall Study|Sponsor decision to terminate study|0|||
161422525|NCT04497116|582936118|FG011|Overall Study|Sponsor decision to terminate study|0|||
161422526|NCT04497116|582936119|FG012|Overall Study|Sponsor decision to terminate study|0|||
161422527|NCT04497116|582936120|FG013|Overall Study|Sponsor decision to terminate study|0|||
161422528|NCT04497116|582936121|FG014|Overall Study|Sponsor decision to terminate study|0|||
161422529|NCT04497116|582936122|FG015|Overall Study|Sponsor decision to terminate study|0|||
161422530|NCT04497116|582936123|FG016|Overall Study|Sponsor decision to terminate study|0|||
161422531|NCT04497116|582936124|FG017|Overall Study|Sponsor decision to terminate study|0|||
161422532|NCT04497116|582936125|FG018|Overall Study|Sponsor decision to terminate study|0|||
161422533|NCT04497116|582936126|FG019|Overall Study|Sponsor decision to terminate study|1|||
161422534|NCT04497116|582936127|FG020|Overall Study|Sponsor decision to terminate study|0|||
161422535|NCT04497116|582936128|FG021|Overall Study|Sponsor decision to terminate study|0|||
161422536|NCT04497116|582936129|FG022|Overall Study|Sponsor decision to terminate study|0|||
161422537|NCT04497116|582936130|FG023|Overall Study|Sponsor decision to terminate study|0|||
161422538|NCT04497116|582936131|FG024|Overall Study|Sponsor decision to terminate study|0|||
161422539|NCT04497116|582936107|FG000|Overall Study|Death|4|||
161422540|NCT04497116|582936108|FG001|Overall Study|Death|5|||
161422541|NCT04497116|582936109|FG002|Overall Study|Death|2|||
161422542|NCT04497116|582936110|FG003|Overall Study|Death|2|||
161422543|NCT04497116|582936111|FG004|Overall Study|Death|1|||
161422544|NCT04497116|582936112|FG005|Overall Study|Death|1|||
161422545|NCT04497116|582936113|FG006|Overall Study|Death|3|||
161422546|NCT04497116|582936114|FG007|Overall Study|Death|10|||
161422547|NCT04497116|582936115|FG008|Overall Study|Death|37|||
161422548|NCT04497116|582936116|FG009|Overall Study|Death|17|||
161422549|NCT04497116|582936117|FG010|Overall Study|Death|2|||
161422550|NCT04497116|582936118|FG011|Overall Study|Death|1|||
161422551|NCT04497116|582936119|FG012|Overall Study|Death|1|||
161422552|NCT04497116|582936120|FG013|Overall Study|Death|3|||
161422553|NCT04497116|582936121|FG014|Overall Study|Death|18|||
161422554|NCT04497116|582936122|FG015|Overall Study|Death|3|||
161422555|NCT04497116|582936123|FG016|Overall Study|Death|2|||
161422556|NCT04497116|582936124|FG017|Overall Study|Death|1|||
161422557|NCT04497116|582936125|FG018|Overall Study|Death|4|||
161422558|NCT04497116|582936126|FG019|Overall Study|Death|17|||
161422559|NCT04497116|582936127|FG020|Overall Study|Death|1|||
161422560|NCT04497116|582936128|FG021|Overall Study|Death|0|||
161422561|NCT04497116|582936129|FG022|Overall Study|Death|3|||
161422562|NCT04497116|582936130|FG023|Overall Study|Death|5|||
161422563|NCT04497116|582936131|FG024|Overall Study|Death|4|||
161422564|NCT04497116|582936107|FG000|Overall Study|Withdrawal by Subject|1|||
161422565|NCT04497116|582936108|FG001|Overall Study|Withdrawal by Subject|0|||
161422566|NCT04497116|582936109|FG002|Overall Study|Withdrawal by Subject|1|||
161422567|NCT04497116|582936110|FG003|Overall Study|Withdrawal by Subject|0|||
161422568|NCT04497116|582936111|FG004|Overall Study|Withdrawal by Subject|0|||
161422569|NCT04497116|582936112|FG005|Overall Study|Withdrawal by Subject|0|||
161422570|NCT04497116|582936113|FG006|Overall Study|Withdrawal by Subject|0|||
161422571|NCT04497116|582936114|FG007|Overall Study|Withdrawal by Subject|7|||
161422572|NCT04497116|582936115|FG008|Overall Study|Withdrawal by Subject|14|||
161422573|NCT04497116|582936116|FG009|Overall Study|Withdrawal by Subject|3|||
161422574|NCT04497116|582936117|FG010|Overall Study|Withdrawal by Subject|3|||
161422575|NCT04497116|582936118|FG011|Overall Study|Withdrawal by Subject|0|||
161422576|NCT04497116|582936119|FG012|Overall Study|Withdrawal by Subject|1|||
161422577|NCT04497116|582936120|FG013|Overall Study|Withdrawal by Subject|0|||
161422578|NCT04497116|582936121|FG014|Overall Study|Withdrawal by Subject|7|||
161422579|NCT04497116|582936122|FG015|Overall Study|Withdrawal by Subject|1|||
161422580|NCT04497116|582936123|FG016|Overall Study|Withdrawal by Subject|3|||
161422581|NCT04497116|582936124|FG017|Overall Study|Withdrawal by Subject|1|||
161422582|NCT04497116|582936125|FG018|Overall Study|Withdrawal by Subject|1|||
161422583|NCT04497116|582936126|FG019|Overall Study|Withdrawal by Subject|5|||
161422584|NCT04497116|582936127|FG020|Overall Study|Withdrawal by Subject|2|||
161422585|NCT04497116|582936128|FG021|Overall Study|Withdrawal by Subject|2|||
161422586|NCT04497116|582936129|FG022|Overall Study|Withdrawal by Subject|2|||
161422587|NCT04497116|582936130|FG023|Overall Study|Withdrawal by Subject|4|||
161422588|NCT04497116|582936131|FG024|Overall Study|Withdrawal by Subject|3|||
161422589|NCT04497116|582936107|FG000|Overall Study|Physician Decision|0|||
161422590|NCT04497116|582936108|FG001|Overall Study|Physician Decision|0|||
161422591|NCT04497116|582936109|FG002|Overall Study|Physician Decision|0|||
161422592|NCT04497116|582936110|FG003|Overall Study|Physician Decision|0|||
161422593|NCT04497116|582936111|FG004|Overall Study|Physician Decision|0|||
161422594|NCT04497116|582936112|FG005|Overall Study|Physician Decision|0|||
161422595|NCT04497116|582936113|FG006|Overall Study|Physician Decision|0|||
161422596|NCT04497116|582936114|FG007|Overall Study|Physician Decision|0|||
161422597|NCT04497116|582936115|FG008|Overall Study|Physician Decision|0|||
161422598|NCT04497116|582936116|FG009|Overall Study|Physician Decision|0|||
161422599|NCT04497116|582936117|FG010|Overall Study|Physician Decision|0|||
161422600|NCT04497116|582936118|FG011|Overall Study|Physician Decision|0|||
161422601|NCT04497116|582936119|FG012|Overall Study|Physician Decision|0|||
161422602|NCT04497116|582936120|FG013|Overall Study|Physician Decision|0|||
161422603|NCT04497116|582936121|FG014|Overall Study|Physician Decision|0|||
161422604|NCT04497116|582936122|FG015|Overall Study|Physician Decision|0|||
161422605|NCT04497116|582936123|FG016|Overall Study|Physician Decision|0|||
161422606|NCT04497116|582936124|FG017|Overall Study|Physician Decision|0|||
161422607|NCT04497116|582936125|FG018|Overall Study|Physician Decision|0|||
161422608|NCT04497116|582936126|FG019|Overall Study|Physician Decision|0|||
161422609|NCT04497116|582936127|FG020|Overall Study|Physician Decision|0|||
161422610|NCT04497116|582936128|FG021|Overall Study|Physician Decision|0|||
161422611|NCT04497116|582936129|FG022|Overall Study|Physician Decision|0|||
161422612|NCT04497116|582936130|FG023|Overall Study|Physician Decision|1|||
161422613|NCT04497116|582936131|FG024|Overall Study|Physician Decision|0|||
161422614|NCT04497116|582936107|FG000|Overall Study|Clinical Progression Related|0|||
161422615|NCT04497116|582936108|FG001|Overall Study|Clinical Progression Related|0|||
161422616|NCT04497116|582936109|FG002|Overall Study|Clinical Progression Related|0|||
161422617|NCT04497116|582936110|FG003|Overall Study|Clinical Progression Related|0|||
161422618|NCT04497116|582936111|FG004|Overall Study|Clinical Progression Related|0|||
161422619|NCT04497116|582936112|FG005|Overall Study|Clinical Progression Related|0|||
161422620|NCT04497116|582936113|FG006|Overall Study|Clinical Progression Related|0|||
161422621|NCT04497116|582936114|FG007|Overall Study|Clinical Progression Related|0|||
161422622|NCT04497116|582936115|FG008|Overall Study|Clinical Progression Related|0|||
161422623|NCT04497116|582936116|FG009|Overall Study|Clinical Progression Related|1|||
161422624|NCT04497116|582936117|FG010|Overall Study|Clinical Progression Related|0|||
161422625|NCT04497116|582936118|FG011|Overall Study|Clinical Progression Related|0|||
161422626|NCT04497116|582936119|FG012|Overall Study|Clinical Progression Related|0|||
161422627|NCT04497116|582936120|FG013|Overall Study|Clinical Progression Related|0|||
161422628|NCT04497116|582936121|FG014|Overall Study|Clinical Progression Related|0|||
161422629|NCT04497116|582936122|FG015|Overall Study|Clinical Progression Related|0|||
161422630|NCT04497116|582936123|FG016|Overall Study|Clinical Progression Related|0|||
161422631|NCT04497116|582936124|FG017|Overall Study|Clinical Progression Related|0|||
161422632|NCT04497116|582936125|FG018|Overall Study|Clinical Progression Related|0|||
161422633|NCT04497116|582936126|FG019|Overall Study|Clinical Progression Related|0|||
161422634|NCT04497116|582936127|FG020|Overall Study|Clinical Progression Related|0|||
161422635|NCT04497116|582936128|FG021|Overall Study|Clinical Progression Related|0|||
161422636|NCT04497116|582936129|FG022|Overall Study|Clinical Progression Related|0|||
161422637|NCT04497116|582936130|FG023|Overall Study|Clinical Progression Related|0|||
161422638|NCT04497116|582936131|FG024|Overall Study|Clinical Progression Related|0|||
161422639|NCT02698826|582936132|FG000|Overall Study|Death|13|||
161422640|NCT02698826|582936132|FG000|Overall Study|Adverse Event|1|||
161422641|NCT02915263|582936135|FG000|Overall Study|Covid|3|||
161422642|NCT02915263|582936136|FG001|Overall Study|Covid|2|||
161422643|NCT01358825|582936137|FG000|Overall Study|Blood sample not drawn|0|||
161422644|NCT01358825|582936138|FG001|Overall Study|Blood sample not drawn|1|||
161422645|NCT01788566|582936141|FG000|Overall Study|Death|4|||
161422646|NCT01788566|582936141|FG000|Overall Study|Adverse Event|1|||
161422647|NCT01788566|582936141|FG000|Overall Study|Clinical Progressive Disease|3|||
161422648|NCT00857285|582936144|FG000|Overall Study|Adverse Event|4|||
161422649|NCT00857285|582936145|FG001|Overall Study|Adverse Event|2|||
161422650|NCT00857285|582936144|FG000|Overall Study|Lack of Efficacy|0|||
161422651|NCT00857285|582936145|FG001|Overall Study|Lack of Efficacy|2|||
161422652|NCT00857285|582936144|FG000|Overall Study|Protocol Violation|3|||
161422653|NCT00857285|582936145|FG001|Overall Study|Protocol Violation|1|||
161422654|NCT00857285|582936144|FG000|Overall Study|Withdrawal by Subject|4|||
161422655|NCT00857285|582936145|FG001|Overall Study|Withdrawal by Subject|0|||
161422656|NCT00857285|582936144|FG000|Overall Study|Randomization criteria not met|1|||
161422657|NCT00857285|582936145|FG001|Overall Study|Randomization criteria not met|1|||
161422658|NCT01539759|582936146|FG000|Overall Study|Lost to Follow-up|6|||
161422659|NCT01539759|582936147|FG001|Overall Study|Lost to Follow-up|8|||
161422660|NCT01076959|582936148|FG000|Overall Study|Adverse Event|767|||
161422661|NCT01076959|582936148|FG000|Overall Study|Lack of Efficacy|849|||
161422662|NCT01076959|582936148|FG000|Overall Study|Non-compliance|274|||
161422663|NCT01076959|582936148|FG000|Overall Study|Lost to Follow-up|241|||
161422664|NCT01076959|582936148|FG000|Overall Study|Other|119|||
161422665|NCT02491983|582936149|FG000|Overall Study|Physician Decision|1|||
161422666|NCT02491983|582936150|FG001|Overall Study|Physician Decision|0|||
161422667|NCT02491983|582936149|FG000|Overall Study|Not meet selection criteria|1|||
161422668|NCT02491983|582936150|FG001|Overall Study|Not meet selection criteria|0|||
161422669|NCT02491983|582936149|FG000|Overall Study|Withdrawal by Subject|0|||
161422670|NCT02491983|582936150|FG001|Overall Study|Withdrawal by Subject|1|||
161422671|NCT04378270|582936152|FG000|Overall Study|Lack of Efficacy|1|||
161422672|NCT04378270|582936152|FG000|Overall Study|Withdrawal by Subject|1|||
161422673|NCT04378270|582936152|FG000|Overall Study|Screen Failure|1|||
161422674|NCT04378270|582936152|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
161422675|NCT01132313|582936153|FG000|Overall Study|Lack of Efficacy|1|||
161422676|NCT01132313|582936154|FG001|Overall Study|Lack of Efficacy|0|||
161422677|NCT01132313|582936155|FG002|Overall Study|Lack of Efficacy|0|||
161422678|NCT01132313|582936156|FG003|Overall Study|Lack of Efficacy|0|||
161422679|NCT01132313|582936157|FG004|Overall Study|Lack of Efficacy|0|||
161422680|NCT01132313|582936158|FG005|Overall Study|Lack of Efficacy|0|||
161422681|NCT01132313|582936159|FG006|Overall Study|Lack of Efficacy|0|||
161422682|NCT01132313|582936160|FG007|Overall Study|Lack of Efficacy|3|||
161422683|NCT01132313|582936161|FG008|Overall Study|Lack of Efficacy|14|||
161422684|NCT01132313|582936162|FG009|Overall Study|Lack of Efficacy|16|||
161422685|NCT01132313|582936163|FG010|Overall Study|Lack of Efficacy|0|||
161422686|NCT01132313|582936164|FG011|Overall Study|Lack of Efficacy|0|||
161422687|NCT01132313|582936153|FG000|Overall Study|Not treated|2|||
161422688|NCT01132313|582936154|FG001|Overall Study|Not treated|0|||
161422689|NCT01132313|582936155|FG002|Overall Study|Not treated|0|||
161422690|NCT01132313|582936156|FG003|Overall Study|Not treated|0|||
161422691|NCT01132313|582936157|FG004|Overall Study|Not treated|2|||
161422692|NCT01132313|582936158|FG005|Overall Study|Not treated|1|||
161422693|NCT01132313|582936159|FG006|Overall Study|Not treated|3|||
161422694|NCT01132313|582936160|FG007|Overall Study|Not treated|0|||
161422695|NCT01132313|582936161|FG008|Overall Study|Not treated|0|||
161422696|NCT01132313|582936162|FG009|Overall Study|Not treated|0|||
161422697|NCT01132313|582936163|FG010|Overall Study|Not treated|0|||
161422698|NCT01132313|582936164|FG011|Overall Study|Not treated|0|||
161422699|NCT01132313|582936153|FG000|Overall Study|Adverse Event|0|||
161422700|NCT01132313|582936154|FG001|Overall Study|Adverse Event|0|||
161422701|NCT01132313|582936155|FG002|Overall Study|Adverse Event|4|||
161422702|NCT01132313|582936156|FG003|Overall Study|Adverse Event|10|||
161422703|NCT01132313|582936157|FG004|Overall Study|Adverse Event|19|||
161422704|NCT01132313|582936158|FG005|Overall Study|Adverse Event|6|||
161422705|NCT01132313|582936159|FG006|Overall Study|Adverse Event|5|||
161422706|NCT01132313|582936160|FG007|Overall Study|Adverse Event|3|||
161422707|NCT01132313|582936161|FG008|Overall Study|Adverse Event|7|||
161422708|NCT01132313|582936162|FG009|Overall Study|Adverse Event|2|||
161422709|NCT01132313|582936163|FG010|Overall Study|Adverse Event|0|||
161422710|NCT01132313|582936164|FG011|Overall Study|Adverse Event|0|||
161422711|NCT01132313|582936153|FG000|Overall Study|Protocol Violation|0|||
161422712|NCT01132313|582936154|FG001|Overall Study|Protocol Violation|0|||
161422713|NCT01132313|582936155|FG002|Overall Study|Protocol Violation|0|||
161422714|NCT01132313|582936156|FG003|Overall Study|Protocol Violation|1|||
161422715|NCT01132313|582936157|FG004|Overall Study|Protocol Violation|0|||
161422716|NCT01132313|582936158|FG005|Overall Study|Protocol Violation|0|||
161422717|NCT01132313|582936159|FG006|Overall Study|Protocol Violation|0|||
161422718|NCT01132313|582936160|FG007|Overall Study|Protocol Violation|0|||
161422719|NCT01132313|582936161|FG008|Overall Study|Protocol Violation|0|||
161422720|NCT01132313|582936162|FG009|Overall Study|Protocol Violation|0|||
161422721|NCT01132313|582936163|FG010|Overall Study|Protocol Violation|0|||
161422722|NCT01132313|582936164|FG011|Overall Study|Protocol Violation|0|||
161422723|NCT01132313|582936153|FG000|Overall Study|Lost to Follow-up|0|||
161422724|NCT01132313|582936154|FG001|Overall Study|Lost to Follow-up|0|||
161422725|NCT01132313|582936155|FG002|Overall Study|Lost to Follow-up|1|||
161422726|NCT01132313|582936156|FG003|Overall Study|Lost to Follow-up|0|||
161422727|NCT01132313|582936157|FG004|Overall Study|Lost to Follow-up|0|||
161422728|NCT01132313|582936158|FG005|Overall Study|Lost to Follow-up|0|||
161422729|NCT01132313|582936159|FG006|Overall Study|Lost to Follow-up|0|||
161422730|NCT01132313|582936160|FG007|Overall Study|Lost to Follow-up|1|||
161422731|NCT01132313|582936161|FG008|Overall Study|Lost to Follow-up|0|||
161422732|NCT01132313|582936162|FG009|Overall Study|Lost to Follow-up|0|||
161422733|NCT01132313|582936163|FG010|Overall Study|Lost to Follow-up|0|||
161422734|NCT01132313|582936164|FG011|Overall Study|Lost to Follow-up|0|||
161422735|NCT01132313|582936153|FG000|Overall Study|Withdrawal by Subject|0|||
161422736|NCT01132313|582936154|FG001|Overall Study|Withdrawal by Subject|0|||
161422737|NCT01132313|582936155|FG002|Overall Study|Withdrawal by Subject|3|||
161422738|NCT01132313|582936156|FG003|Overall Study|Withdrawal by Subject|3|||
161422739|NCT01132313|582936157|FG004|Overall Study|Withdrawal by Subject|6|||
161422740|NCT01132313|582936158|FG005|Overall Study|Withdrawal by Subject|0|||
161422741|NCT01132313|582936159|FG006|Overall Study|Withdrawal by Subject|1|||
161422742|NCT01132313|582936160|FG007|Overall Study|Withdrawal by Subject|0|||
161422743|NCT01132313|582936161|FG008|Overall Study|Withdrawal by Subject|0|||
161422744|NCT01132313|582936162|FG009|Overall Study|Withdrawal by Subject|2|||
161422745|NCT01132313|582936163|FG010|Overall Study|Withdrawal by Subject|0|||
161422746|NCT01132313|582936164|FG011|Overall Study|Withdrawal by Subject|0|||
161422747|NCT01132313|582936153|FG000|Overall Study|Lack of antiviral response|0|||
161422748|NCT01132313|582936154|FG001|Overall Study|Lack of antiviral response|0|||
161422749|NCT01132313|582936155|FG002|Overall Study|Lack of antiviral response|12|||
161422750|NCT01132313|582936156|FG003|Overall Study|Lack of antiviral response|18|||
161422751|NCT01132313|582936157|FG004|Overall Study|Lack of antiviral response|18|||
161422752|NCT01132313|582936158|FG005|Overall Study|Lack of antiviral response|18|||
161422753|NCT01132313|582936159|FG006|Overall Study|Lack of antiviral response|21|||
161422754|NCT01132313|582936160|FG007|Overall Study|Lack of antiviral response|0|||
161422755|NCT01132313|582936161|FG008|Overall Study|Lack of antiviral response|0|||
161422756|NCT01132313|582936162|FG009|Overall Study|Lack of antiviral response|0|||
161422757|NCT01132313|582936163|FG010|Overall Study|Lack of antiviral response|1|||
161422758|NCT01132313|582936164|FG011|Overall Study|Lack of antiviral response|0|||
161422759|NCT01132313|582936153|FG000|Overall Study|Other reason not defined above|0|||
161422760|NCT01132313|582936154|FG001|Overall Study|Other reason not defined above|0|||
161422761|NCT01132313|582936155|FG002|Overall Study|Other reason not defined above|0|||
161422762|NCT01132313|582936156|FG003|Overall Study|Other reason not defined above|0|||
161422763|NCT01132313|582936157|FG004|Overall Study|Other reason not defined above|0|||
161422764|NCT01132313|582936158|FG005|Overall Study|Other reason not defined above|0|||
161422765|NCT01132313|582936159|FG006|Overall Study|Other reason not defined above|0|||
161422766|NCT01132313|582936160|FG007|Overall Study|Other reason not defined above|1|||
161422767|NCT01132313|582936161|FG008|Overall Study|Other reason not defined above|0|||
161422768|NCT01132313|582936162|FG009|Overall Study|Other reason not defined above|0|||
161422769|NCT01132313|582936163|FG010|Overall Study|Other reason not defined above|0|||
161422770|NCT01132313|582936164|FG011|Overall Study|Other reason not defined above|0|||
161422771|NCT03201419|582936167|FG000|Overall Study|Adverse Event|3|||
161422772|NCT03201419|582936168|FG001|Overall Study|Adverse Event|1|||
161422773|NCT03201419|582936169|FG002|Overall Study|Adverse Event|0|||
161422774|NCT03201419|582936170|FG003|Overall Study|Adverse Event|0|||
161422775|NCT03201419|582936171|FG004|Overall Study|Adverse Event|1|||
161422776|NCT03201419|582936172|FG005|Overall Study|Adverse Event|1|||
161422777|NCT03201419|582936173|FG006|Overall Study|Adverse Event|5|||
161422778|NCT03201419|582936174|FG007|Overall Study|Adverse Event|0|||
161422779|NCT03201419|582936175|FG008|Overall Study|Adverse Event|0|||
161422780|NCT03201419|582936167|FG000|Overall Study|Lost to Follow-up|1|||
161422781|NCT03201419|582936168|FG001|Overall Study|Lost to Follow-up|0|||
161422782|NCT03201419|582936169|FG002|Overall Study|Lost to Follow-up|0|||
161422783|NCT03201419|582936170|FG003|Overall Study|Lost to Follow-up|0|||
161422784|NCT03201419|582936171|FG004|Overall Study|Lost to Follow-up|0|||
161422785|NCT03201419|582936172|FG005|Overall Study|Lost to Follow-up|0|||
161422786|NCT03201419|582936173|FG006|Overall Study|Lost to Follow-up|0|||
161422787|NCT03201419|582936174|FG007|Overall Study|Lost to Follow-up|0|||
161422788|NCT03201419|582936175|FG008|Overall Study|Lost to Follow-up|0|||
161422789|NCT03201419|582936167|FG000|Overall Study|Protocol Deviation|0|||
161422790|NCT03201419|582936168|FG001|Overall Study|Protocol Deviation|0|||
161422791|NCT03201419|582936169|FG002|Overall Study|Protocol Deviation|0|||
161422792|NCT03201419|582936170|FG003|Overall Study|Protocol Deviation|0|||
161422793|NCT03201419|582936171|FG004|Overall Study|Protocol Deviation|0|||
161422794|NCT03201419|582936172|FG005|Overall Study|Protocol Deviation|0|||
161422795|NCT03201419|582936173|FG006|Overall Study|Protocol Deviation|1|||
161422796|NCT03201419|582936174|FG007|Overall Study|Protocol Deviation|0|||
161422797|NCT03201419|582936175|FG008|Overall Study|Protocol Deviation|0|||
161422798|NCT03201419|582936167|FG000|Overall Study|Withdrawal by Subject|4|||
161422799|NCT03201419|582936168|FG001|Overall Study|Withdrawal by Subject|2|||
161422800|NCT03201419|582936169|FG002|Overall Study|Withdrawal by Subject|1|||
161422801|NCT03201419|582936170|FG003|Overall Study|Withdrawal by Subject|0|||
161422802|NCT03201419|582936171|FG004|Overall Study|Withdrawal by Subject|0|||
161422803|NCT03201419|582936172|FG005|Overall Study|Withdrawal by Subject|0|||
161422804|NCT03201419|582936173|FG006|Overall Study|Withdrawal by Subject|0|||
161422805|NCT03201419|582936174|FG007|Overall Study|Withdrawal by Subject|1|||
161422806|NCT03201419|582936175|FG008|Overall Study|Withdrawal by Subject|2|||
161422807|NCT03201419|582936167|FG000|Overall Study|Other|0|||
161422808|NCT03201419|582936168|FG001|Overall Study|Other|0|||
161422809|NCT03201419|582936169|FG002|Overall Study|Other|1|||
161422810|NCT03201419|582936170|FG003|Overall Study|Other|0|||
161422811|NCT03201419|582936171|FG004|Overall Study|Other|0|||
161422812|NCT03201419|582936172|FG005|Overall Study|Other|0|||
161422813|NCT03201419|582936173|FG006|Overall Study|Other|0|||
161422814|NCT03201419|582936174|FG007|Overall Study|Other|0|||
161422815|NCT03201419|582936175|FG008|Overall Study|Other|0|||
161422816|NCT04965688|582936181|FG000|Overall Study|Withdrawal by Subject|2|||
161422817|NCT00369577|582936182|FG000|Overall Study|Withdrawal by Subject|0|||
161422818|NCT00369577|582936183|FG001|Overall Study|Withdrawal by Subject|0|||
161422819|NCT00369577|582936184|FG002|Overall Study|Withdrawal by Subject|1|||
161422820|NCT00699660|582936185|FG000|Overall Study|Lost to Follow-up|4|||
161422821|NCT00699660|582936186|FG001|Overall Study|Lost to Follow-up|2|||
161422822|NCT00699660|582936185|FG000|Overall Study|missing reports and recording failures|10|||
161422823|NCT00699660|582936186|FG001|Overall Study|missing reports and recording failures|6|||
161422824|NCT03915470|582936187|FG000|Overall Study|Death|3|||
161422825|NCT03915470|582936188|FG001|Overall Study|Death|1|||
161422826|NCT03915470|582936187|FG000|Overall Study|Adverse Event|1|||
161422827|NCT03915470|582936188|FG001|Overall Study|Adverse Event|0|||
161422828|NCT03915470|582936187|FG000|Overall Study|Physician Decision|1|||
161422829|NCT03915470|582936188|FG001|Overall Study|Physician Decision|0|||
161422830|NCT03915470|582936187|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
161422831|NCT03915470|582936188|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
161422832|NCT03160898|582936189|FG000|Overall Study|Adverse Event|4|||
161422833|NCT03160898|582936190|FG001|Overall Study|Adverse Event|8|||
161422834|NCT03160898|582936191|FG002|Overall Study|Adverse Event|7|||
161422835|NCT03160898|582936192|FG003|Overall Study|Adverse Event|10|||
161422836|NCT03160898|582936189|FG000|Overall Study|Death|1|||
161422837|NCT03160898|582936190|FG001|Overall Study|Death|0|||
161422838|NCT03160898|582936191|FG002|Overall Study|Death|0|||
161422839|NCT03160898|582936192|FG003|Overall Study|Death|1|||
161422840|NCT03160898|582936189|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
161422841|NCT03160898|582936190|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
161422842|NCT03160898|582936191|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
161422843|NCT03160898|582936192|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
161422844|NCT03160898|582936189|FG000|Overall Study|Lost to Follow-up|1|||
161422845|NCT03160898|582936190|FG001|Overall Study|Lost to Follow-up|1|||
161422846|NCT03160898|582936191|FG002|Overall Study|Lost to Follow-up|1|||
161422847|NCT03160898|582936192|FG003|Overall Study|Lost to Follow-up|2|||
161422848|NCT03160898|582936189|FG000|Overall Study|Physician Decision|1|||
161422849|NCT03160898|582936190|FG001|Overall Study|Physician Decision|0|||
161422850|NCT03160898|582936191|FG002|Overall Study|Physician Decision|0|||
161422851|NCT03160898|582936192|FG003|Overall Study|Physician Decision|1|||
161422852|NCT03160898|582936189|FG000|Overall Study|Progressive Disease|4|||
161422853|NCT03160898|582936190|FG001|Overall Study|Progressive Disease|1|||
161422854|NCT03160898|582936191|FG002|Overall Study|Progressive Disease|2|||
161422855|NCT03160898|582936192|FG003|Overall Study|Progressive Disease|1|||
161422856|NCT03160898|582936189|FG000|Overall Study|Protocol Violation|1|||
161422857|NCT03160898|582936190|FG001|Overall Study|Protocol Violation|0|||
161422858|NCT03160898|582936191|FG002|Overall Study|Protocol Violation|2|||
161422859|NCT03160898|582936192|FG003|Overall Study|Protocol Violation|0|||
161422860|NCT03160898|582936189|FG000|Overall Study|Sponsor Discretion|2|||
161422861|NCT03160898|582936190|FG001|Overall Study|Sponsor Discretion|0|||
161422862|NCT03160898|582936191|FG002|Overall Study|Sponsor Discretion|0|||
161422863|NCT03160898|582936192|FG003|Overall Study|Sponsor Discretion|0|||
161422864|NCT03160898|582936189|FG000|Overall Study|Withdrawal by Subject|1|||
161422865|NCT03160898|582936190|FG001|Overall Study|Withdrawal by Subject|3|||
161422866|NCT03160898|582936191|FG002|Overall Study|Withdrawal by Subject|2|||
161422867|NCT03160898|582936192|FG003|Overall Study|Withdrawal by Subject|1|||
161422868|NCT03160898|582936189|FG000|Overall Study|Other|2|||
161422869|NCT03160898|582936190|FG001|Overall Study|Other|0|||
161422870|NCT03160898|582936191|FG002|Overall Study|Other|2|||
161422871|NCT03160898|582936192|FG003|Overall Study|Other|2|||
161422872|NCT03405818|582936195|FG000|Overall Study|Withdrawal by Subject|4|||
161422873|NCT03405818|582936195|FG000|Overall Study|Lost to Follow-up|4|||
161422874|NCT00434109|582936196|FG000|Overall Study|Physician Decision|9|||
161422875|NCT00434109|582936196|FG000|Overall Study|Adverse Event|5|||
161422876|NCT00434109|582936196|FG000|Overall Study|Protocol Violation|1|||
161422877|NCT00434109|582936196|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
161422878|NCT04186871|582936197|FG000|Overall Study|Lack of Efficacy|0|||
161422879|NCT04186871|582936198|FG001|Overall Study|Lack of Efficacy|1|||
161422880|NCT04186871|582936199|FG002|Overall Study|Lack of Efficacy|0|||
161422881|NCT04186871|582936200|FG003|Overall Study|Lack of Efficacy|0|||
161422882|NCT04186871|582936201|FG004|Overall Study|Lack of Efficacy|1|||
161422883|NCT04186871|582936202|FG005|Overall Study|Lack of Efficacy|1|||
161422884|NCT04186871|582936197|FG000|Overall Study|Adverse Event|1|||
161422885|NCT04186871|582936198|FG001|Overall Study|Adverse Event|1|||
161422886|NCT04186871|582936199|FG002|Overall Study|Adverse Event|0|||
161422887|NCT04186871|582936200|FG003|Overall Study|Adverse Event|0|||
161422888|NCT04186871|582936201|FG004|Overall Study|Adverse Event|0|||
161422889|NCT04186871|582936202|FG005|Overall Study|Adverse Event|2|||
161422890|NCT04186871|582936197|FG000|Overall Study|Study terminated by sponsor|1|||
161422891|NCT04186871|582936198|FG001|Overall Study|Study terminated by sponsor|2|||
161422892|NCT04186871|582936199|FG002|Overall Study|Study terminated by sponsor|0|||
161422893|NCT04186871|582936200|FG003|Overall Study|Study terminated by sponsor|1|||
161422894|NCT04186871|582936201|FG004|Overall Study|Study terminated by sponsor|0|||
161422895|NCT04186871|582936202|FG005|Overall Study|Study terminated by sponsor|0|||
161422896|NCT04186871|582936197|FG000|Overall Study|Other reasons|0|||
161422897|NCT04186871|582936198|FG001|Overall Study|Other reasons|0|||
161422898|NCT04186871|582936199|FG002|Overall Study|Other reasons|0|||
161422899|NCT04186871|582936200|FG003|Overall Study|Other reasons|0|||
161422900|NCT04186871|582936201|FG004|Overall Study|Other reasons|0|||
161422901|NCT04186871|582936202|FG005|Overall Study|Other reasons|1|||
161422902|NCT04186871|582936197|FG000|Overall Study|Withdrawal by Subject|0|||
161422903|NCT04186871|582936198|FG001|Overall Study|Withdrawal by Subject|0|||
161422904|NCT04186871|582936199|FG002|Overall Study|Withdrawal by Subject|0|||
161422905|NCT04186871|582936200|FG003|Overall Study|Withdrawal by Subject|0|||
161422906|NCT04186871|582936201|FG004|Overall Study|Withdrawal by Subject|0|||
161422907|NCT04186871|582936202|FG005|Overall Study|Withdrawal by Subject|1|||
161422908|NCT04186871|582936197|FG000|Overall Study|Lost to Follow-up|0|||
161422909|NCT04186871|582936198|FG001|Overall Study|Lost to Follow-up|0|||
161422910|NCT04186871|582936199|FG002|Overall Study|Lost to Follow-up|0|||
161422911|NCT04186871|582936200|FG003|Overall Study|Lost to Follow-up|0|||
161422912|NCT04186871|582936201|FG004|Overall Study|Lost to Follow-up|0|||
161422913|NCT04186871|582936202|FG005|Overall Study|Lost to Follow-up|1|||
161422914|NCT00549445|582936208|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
161422915|NCT00549445|582936209|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
161422916|NCT01467505|582937709|FG000|Overall Study|Adverse Event|1|||
161422917|NCT01467505|582937710|FG001|Overall Study|Adverse Event|0|||
161422918|NCT01467505|582937709|FG000|Overall Study|Withdrawal by Subject|4|||
161422919|NCT01467505|582937710|FG001|Overall Study|Withdrawal by Subject|0|||
161422920|NCT01467505|582937709|FG000|Overall Study|Study Terminated by Sponsor|28|||
161422921|NCT01467505|582937710|FG001|Overall Study|Study Terminated by Sponsor|3|||
161422922|NCT00227721|582937711|FG000|Overall Study|On study, but never treated.|1|||
161422923|NCT00984256|582937715|FG000|Overall Study|Withdrawal by Subject|0|||
161422924|NCT00984256|582937716|FG001|Overall Study|Withdrawal by Subject|1|||
161422925|NCT03529110|582937722|FG000|Overall Study|Progressive Disease|66|||
161422926|NCT03529110|582937723|FG001|Overall Study|Progressive Disease|158|||
161422927|NCT03529110|582937722|FG000|Overall Study|Clinical Progression|4|||
161422928|NCT03529110|582937723|FG001|Overall Study|Clinical Progression|12|||
161422929|NCT03529110|582937722|FG000|Overall Study|Adverse Event|35|||
161422930|NCT03529110|582937723|FG001|Overall Study|Adverse Event|17|||
161422931|NCT03529110|582937722|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
161422932|NCT03529110|582937723|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
161422933|NCT03529110|582937722|FG000|Overall Study|Lack of Efficacy|3|||
161422934|NCT03529110|582937723|FG001|Overall Study|Lack of Efficacy|3|||
161422935|NCT03529110|582937722|FG000|Overall Study|Physician Decision|2|||
161422936|NCT03529110|582937723|FG001|Overall Study|Physician Decision|8|||
161422937|NCT03529110|582937722|FG000|Overall Study|Miscellaneous|2|||
161422938|NCT03529110|582937723|FG001|Overall Study|Miscellaneous|5|||
161422939|NCT03493945|582937724|FG000|Phase I Dose Escalation|Ineligible|0|||
161422940|NCT03493945|582937725|FG001|Phase I Dose Escalation|Ineligible|0|||
161422941|NCT03493945|582937726|FG002|Phase I Dose Escalation|Ineligible|1|||
161422942|NCT03493945|582937727|FG003|Phase I Dose Escalation|Ineligible|0|||
161422943|NCT03493945|582937728|FG004|Phase I Dose Escalation|Ineligible|0|||
161422944|NCT03493945|582937729|FG005|Phase I Dose Escalation|Ineligible|0|||
161422945|NCT03493945|582937730|FG006|Phase I Dose Escalation|Ineligible|0|||
161422946|NCT03493945|582937724|FG000|Phase I Dose Escalation|New therapy|0|||
161422947|NCT03493945|582937725|FG001|Phase I Dose Escalation|New therapy|1|||
161422948|NCT03493945|582937726|FG002|Phase I Dose Escalation|New therapy|0|||
161422949|NCT03493945|582937727|FG003|Phase I Dose Escalation|New therapy|0|||
161422950|NCT03493945|582937728|FG004|Phase I Dose Escalation|New therapy|0|||
161422951|NCT03493945|582937729|FG005|Phase I Dose Escalation|New therapy|0|||
161422952|NCT03493945|582937730|FG006|Phase I Dose Escalation|New therapy|0|||
161422953|NCT03493945|582937724|FG000|Phase II Dose Expansion|Refused further treatment|0|||
161422954|NCT03493945|582937725|FG001|Phase II Dose Expansion|Refused further treatment|0|||
161422955|NCT03493945|582937726|FG002|Phase II Dose Expansion|Refused further treatment|0|||
161422956|NCT03493945|582937727|FG003|Phase II Dose Expansion|Refused further treatment|0|||
161422957|NCT03493945|582937728|FG004|Phase II Dose Expansion|Refused further treatment|1|||
161422958|NCT03493945|582937729|FG005|Phase II Dose Expansion|Refused further treatment|1|||
161422959|NCT03493945|582937730|FG006|Phase II Dose Expansion|Refused further treatment|0|||
161422960|NCT03493945|582937724|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
161422961|NCT03493945|582937725|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
161422962|NCT03493945|582937726|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
161422963|NCT03493945|582937727|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
161422964|NCT03493945|582937728|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
161422965|NCT03493945|582937729|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
161422966|NCT03493945|582937730|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
161422967|NCT05104450|582937731|FG000|Overall Study|Death|1|||
161422968|NCT05104450|582937732|FG001|Overall Study|Death|2|||
161422969|NCT05104450|582937731|FG000|Overall Study|Withdrawal by Subject|3|||
161422970|NCT05104450|582937732|FG001|Overall Study|Withdrawal by Subject|1|||
161422971|NCT01584232|582937733|FG000|Overall Study|Adverse Event|3|||
161422972|NCT01584232|582937734|FG001|Overall Study|Adverse Event|1|||
161422973|NCT01584232|582937733|FG000|Overall Study|Withdrawal by Subject|2|||
161422974|NCT01584232|582937734|FG001|Overall Study|Withdrawal by Subject|1|||
161422975|NCT01584232|582937733|FG000|Overall Study|Physician Decision|2|||
161422976|NCT01584232|582937734|FG001|Overall Study|Physician Decision|1|||
161422977|NCT01584232|582937733|FG000|Overall Study|Lost to Follow-up|1|||
161422978|NCT01584232|582937734|FG001|Overall Study|Lost to Follow-up|0|||
161422979|NCT01307319|582937735|FG000|Overall Study|Adverse Event|2|||
161422980|NCT01307319|582937736|FG001|Overall Study|Adverse Event|2|||
161422981|NCT01307319|582937737|FG002|Overall Study|Adverse Event|1|||
161422982|NCT01307319|582937735|FG000|Overall Study|Lost to Follow-up|1|||
161422983|NCT01307319|582937736|FG001|Overall Study|Lost to Follow-up|0|||
161422984|NCT01307319|582937737|FG002|Overall Study|Lost to Follow-up|1|||
161422985|NCT01307319|582937735|FG000|Overall Study|Protocol Violation|1|||
161422986|NCT01307319|582937736|FG001|Overall Study|Protocol Violation|1|||
161422987|NCT01307319|582937737|FG002|Overall Study|Protocol Violation|0|||
161422988|NCT01307319|582937735|FG000|Overall Study|Withdrawal by Subject|0|||
161422989|NCT01307319|582937736|FG001|Overall Study|Withdrawal by Subject|1|||
161422990|NCT01307319|582937737|FG002|Overall Study|Withdrawal by Subject|2|||
161422991|NCT01307319|582937735|FG000|Overall Study|Other|0|||
161422992|NCT01307319|582937736|FG001|Overall Study|Other|4|||
161422993|NCT01307319|582937737|FG002|Overall Study|Other|3|||
161422994|NCT02735239|582937739|FG000|Overall Study|Adverse Event|0|||
161422995|NCT02735239|582937740|FG001|Overall Study|Adverse Event|0|||
161422996|NCT02735239|582937741|FG002|Overall Study|Adverse Event|4|||
161422997|NCT02735239|582937742|FG003|Overall Study|Adverse Event|0|||
161422998|NCT02735239|582937743|FG004|Overall Study|Adverse Event|0|||
161422999|NCT02735239|582937744|FG005|Overall Study|Adverse Event|0|||
161423000|NCT02735239|582937739|FG000|Overall Study|Death|1|||
161423001|NCT02735239|582937740|FG001|Overall Study|Death|1|||
161423002|NCT02735239|582937741|FG002|Overall Study|Death|0|||
161423003|NCT02735239|582937742|FG003|Overall Study|Death|0|||
161423004|NCT02735239|582937743|FG004|Overall Study|Death|0|||
161423005|NCT02735239|582937744|FG005|Overall Study|Death|0|||
161423006|NCT02735239|582937739|FG000|Overall Study|Physician Decision|0|||
161423007|NCT02735239|582937740|FG001|Overall Study|Physician Decision|0|||
161423008|NCT02735239|582937741|FG002|Overall Study|Physician Decision|1|||
161423009|NCT02735239|582937742|FG003|Overall Study|Physician Decision|0|||
161423010|NCT02735239|582937743|FG004|Overall Study|Physician Decision|0|||
161423011|NCT02735239|582937744|FG005|Overall Study|Physician Decision|0|||
161423012|NCT02735239|582937739|FG000|Overall Study|Progressive disease|3|||
161423013|NCT02735239|582937740|FG001|Overall Study|Progressive disease|1|||
161423014|NCT02735239|582937741|FG002|Overall Study|Progressive disease|3|||
161423015|NCT02735239|582937742|FG003|Overall Study|Progressive disease|0|||
161423016|NCT02735239|582937743|FG004|Overall Study|Progressive disease|0|||
161423017|NCT02735239|582937744|FG005|Overall Study|Progressive disease|2|||
161423018|NCT02735239|582937739|FG000|Overall Study|Withdrawal by Subject|0|||
161423019|NCT02735239|582937740|FG001|Overall Study|Withdrawal by Subject|1|||
161423020|NCT02735239|582937741|FG002|Overall Study|Withdrawal by Subject|0|||
161423021|NCT02735239|582937742|FG003|Overall Study|Withdrawal by Subject|0|||
161423022|NCT02735239|582937743|FG004|Overall Study|Withdrawal by Subject|0|||
161423023|NCT02735239|582937744|FG005|Overall Study|Withdrawal by Subject|0|||
161423024|NCT02152631|582937752|FG000|Overall Study|Adverse Event|32|||
161423025|NCT02152631|582937753|FG001|Overall Study|Adverse Event|4|||
161423026|NCT02152631|582937752|FG000|Overall Study|Withdrawal by Subject|13|||
161423027|NCT02152631|582937753|FG001|Overall Study|Withdrawal by Subject|16|||
161423028|NCT02152631|582937752|FG000|Overall Study|Noncompliance with study drug|1|||
161423029|NCT02152631|582937753|FG001|Overall Study|Noncompliance with study drug|0|||
161423030|NCT02152631|582937752|FG000|Overall Study|Physician Decision|1|||
161423031|NCT02152631|582937753|FG001|Overall Study|Physician Decision|2|||
161423032|NCT02152631|582937752|FG000|Overall Study|Lost to Follow-up|0|||
161423033|NCT02152631|582937753|FG001|Overall Study|Lost to Follow-up|1|||
161423034|NCT02152631|582937752|FG000|Overall Study|On Treatment|19|||
161423035|NCT02152631|582937753|FG001|Overall Study|On Treatment|3|||
161423036|NCT00404651|582937757|FG000|Overall Study|Serious Adverse Event|0|||
161423037|NCT00404651|582937758|FG001|Overall Study|Serious Adverse Event|0|||
161423038|NCT00404651|582937759|FG002|Overall Study|Serious Adverse Event|2|||
161423039|NCT00404651|582937760|FG003|Overall Study|Serious Adverse Event|0|||
161423040|NCT00404651|582937757|FG000|Overall Study|Protocol Violation|10|||
161423041|NCT00404651|582937758|FG001|Overall Study|Protocol Violation|5|||
161423042|NCT00404651|582937759|FG002|Overall Study|Protocol Violation|14|||
161423043|NCT00404651|582937760|FG003|Overall Study|Protocol Violation|5|||
161423044|NCT00404651|582937757|FG000|Overall Study|Lost to Follow-up|15|||
161423045|NCT00404651|582937758|FG001|Overall Study|Lost to Follow-up|11|||
161423046|NCT00404651|582937759|FG002|Overall Study|Lost to Follow-up|13|||
161423047|NCT00404651|582937760|FG003|Overall Study|Lost to Follow-up|10|||
161423048|NCT00404651|582937757|FG000|Overall Study|Withdrawal by Subject|14|||
161423049|NCT00404651|582937758|FG001|Overall Study|Withdrawal by Subject|12|||
161423050|NCT00404651|582937759|FG002|Overall Study|Withdrawal by Subject|16|||
161423051|NCT00404651|582937760|FG003|Overall Study|Withdrawal by Subject|6|||
161423052|NCT01121146|582937769|FG000|Overall Study|Death|17|||
161423053|NCT01121146|582937770|FG001|Overall Study|Death|15|||
161423054|NCT01121146|582937769|FG000|Overall Study|Adverse Event|2|||
161423055|NCT01121146|582937770|FG001|Overall Study|Adverse Event|11|||
161423056|NCT01121146|582937769|FG000|Overall Study|Lost to Follow-up|7|||
161423057|NCT01121146|582937770|FG001|Overall Study|Lost to Follow-up|16|||
161423058|NCT03922581|582937779|FG000|Overall Study|Lost to Follow-up|20|||
161423059|NCT03922581|582937780|FG001|Overall Study|Lost to Follow-up|9|||
161423060|NCT03922581|582937779|FG000|Overall Study|Physician Decision|1|||
161423061|NCT03922581|582937780|FG001|Overall Study|Physician Decision|1|||
161423062|NCT03922581|582937779|FG000|Overall Study|Withdrawal by Subject|1|||
161423063|NCT03922581|582937780|FG001|Overall Study|Withdrawal by Subject|0|||
161423064|NCT00764699|582937783|FG000|Overall Study|PI left and study terminated|3|||
161423065|NCT02223715|582937789|FG000|Overall Study|Death|31|||
161423066|NCT02223715|582937789|FG000|Overall Study|Lost to Follow-up|73|||
161423067|NCT01745367|582937790|FG000|Overall Study|Death|1|||
161423068|NCT01745367|582937791|FG001|Overall Study|Death|0|||
161423069|NCT01745367|582937790|FG000|Overall Study|Withdrawal by Subject|1|||
161423070|NCT01745367|582937791|FG001|Overall Study|Withdrawal by Subject|2|||
161423071|NCT01745367|582937790|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
161423072|NCT01745367|582937791|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
161423073|NCT01745367|582937790|FG000|Overall Study|Other Reasons Unspecified|0|||
161423074|NCT01745367|582937791|FG001|Overall Study|Other Reasons Unspecified|2|||
161423075|NCT00965081|582937793|FG000|Overall Study|Adverse Event|14|||
161423076|NCT00965081|582937794|FG001|Overall Study|Adverse Event|9|||
161423077|NCT00965081|582937793|FG000|Overall Study|Lack of Efficacy|2|||
161423078|NCT00965081|582937794|FG001|Overall Study|Lack of Efficacy|5|||
161423079|NCT00965081|582937793|FG000|Overall Study|Lost to Follow-up|4|||
161423080|NCT00965081|582937794|FG001|Overall Study|Lost to Follow-up|5|||
161423081|NCT00965081|582937793|FG000|Overall Study|Physician Decision|2|||
161423082|NCT00965081|582937794|FG001|Overall Study|Physician Decision|0|||
161423083|NCT00965081|582937793|FG000|Overall Study|Protocol Violation|2|||
161423084|NCT00965081|582937794|FG001|Overall Study|Protocol Violation|5|||
161423085|NCT00965081|582937793|FG000|Overall Study|Sponsor Decision|1|||
161423086|NCT00965081|582937794|FG001|Overall Study|Sponsor Decision|0|||
161423087|NCT00965081|582937793|FG000|Overall Study|Withdrawal by Subject|4|||
161423088|NCT00965081|582937794|FG001|Overall Study|Withdrawal by Subject|7|||
161423089|NCT00965081|582937793|FG000|Overall Study|Switched to Rescue Arm|5|||
161423090|NCT00965081|582937794|FG001|Overall Study|Switched to Rescue Arm|12|||
161423091|NCT01020786|582937797|FG000|Induction Period|Entry Criteria Not Met|2|||
161423092|NCT01020786|582937797|FG000|Induction Period|Adverse Event|10|||
161423093|NCT01020786|582937797|FG000|Induction Period|Progressive Disease|31|||
161423094|NCT01020786|582937797|FG000|Induction Period|Investigator Decision|3|||
161423095|NCT01020786|582937797|FG000|Induction Period|Withdrawal by Subject|3|||
161423096|NCT01020786|582937797|FG000|Maintenance Period|Adverse Event|8|||
161423097|NCT01020786|582937797|FG000|Maintenance Period|Progressive Disease|43|||
161423098|NCT01020786|582937797|FG000|Maintenance Period|Withdrawal by Subject|8|||
161423099|NCT01020786|582937797|FG000|Maintenance Period|Sponsor Decision|1|||
161423100|NCT02292719|582937800|FG000|Overall Study|Withdrawal by Subject|0|||
161423101|NCT02292719|582937801|FG001|Overall Study|Withdrawal by Subject|0|||
161423102|NCT02292719|582937802|FG002|Overall Study|Withdrawal by Subject|0|||
161423103|NCT02292719|582937803|FG003|Overall Study|Withdrawal by Subject|1|||
161423104|NCT02292719|582937804|FG004|Overall Study|Withdrawal by Subject|1|||
161423105|NCT02292719|582937805|FG005|Overall Study|Withdrawal by Subject|0|||
161423106|NCT02292719|582937800|FG000|Overall Study|Subject enrolled in new study.|0|||
161423107|NCT02292719|582937801|FG001|Overall Study|Subject enrolled in new study.|0|||
161423108|NCT02292719|582937802|FG002|Overall Study|Subject enrolled in new study.|1|||
161423109|NCT02292719|582937803|FG003|Overall Study|Subject enrolled in new study.|0|||
161423110|NCT02292719|582937804|FG004|Overall Study|Subject enrolled in new study.|0|||
161423111|NCT02292719|582937805|FG005|Overall Study|Subject enrolled in new study.|0|||
161423112|NCT04170543|582937811|FG000|Overall Study|Death|1|||
161423113|NCT04170543|582937812|FG001|Overall Study|Death|1|||
161423114|NCT04170543|582937813|FG002|Overall Study|Death|1|||
161423115|NCT04170543|582937814|FG003|Overall Study|Death|1|||
161423116|NCT04170543|582937815|FG004|Overall Study|Death|1|||
161423117|NCT04170543|582937811|FG000|Overall Study|Lost to Follow-up|3|||
161423118|NCT04170543|582937812|FG001|Overall Study|Lost to Follow-up|3|||
161423119|NCT04170543|582937813|FG002|Overall Study|Lost to Follow-up|0|||
161423120|NCT04170543|582937814|FG003|Overall Study|Lost to Follow-up|3|||
161423121|NCT04170543|582937815|FG004|Overall Study|Lost to Follow-up|1|||
161423122|NCT04170543|582937811|FG000|Overall Study|Withdrawal by Subject|13|||
161423123|NCT04170543|582937812|FG001|Overall Study|Withdrawal by Subject|6|||
161423124|NCT04170543|582937813|FG002|Overall Study|Withdrawal by Subject|5|||
161423125|NCT04170543|582937814|FG003|Overall Study|Withdrawal by Subject|4|||
161423126|NCT04170543|582937815|FG004|Overall Study|Withdrawal by Subject|9|||
161423127|NCT04170543|582937811|FG000|Overall Study|Not able to transition to phase 2b|8|||
161423128|NCT04170543|582937812|FG001|Overall Study|Not able to transition to phase 2b|0|||
161423129|NCT04170543|582937813|FG002|Overall Study|Not able to transition to phase 2b|10|||
161423130|NCT04170543|582937814|FG003|Overall Study|Not able to transition to phase 2b|0|||
161423131|NCT04170543|582937815|FG004|Overall Study|Not able to transition to phase 2b|6|||
161423132|NCT04170543|582937811|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
161423133|NCT04170543|582937812|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
161423134|NCT04170543|582937813|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
161423135|NCT04170543|582937814|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
161423136|NCT04170543|582937815|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
161423137|NCT04170543|582937811|FG000|Overall Study|Not Treated|0|||
161423138|NCT04170543|582937812|FG001|Overall Study|Not Treated|0|||
161423139|NCT04170543|582937813|FG002|Overall Study|Not Treated|0|||
161423140|NCT04170543|582937814|FG003|Overall Study|Not Treated|0|||
161423141|NCT04170543|582937815|FG004|Overall Study|Not Treated|2|||
161423142|NCT04170543|582937811|FG000|Overall Study|(CRF)|16|||
161423143|NCT04170543|582937812|FG001|Overall Study|(CRF)|15|||
161423144|NCT04170543|582937813|FG002|Overall Study|(CRF)|12|||
161423145|NCT04170543|582937814|FG003|Overall Study|(CRF)|17|||
161423146|NCT04170543|582937815|FG004|Overall Study|(CRF)|17|||
161423147|NCT04170543|582937811|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
161423148|NCT04170543|582937812|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
161423149|NCT04170543|582937813|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
161423150|NCT04170543|582937814|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
161423151|NCT04170543|582937815|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
161423152|NCT00770601|582937816|FG000|Overall Study|Withdrawal by Subject|1|||
161423153|NCT04628780|582937817|FG000|Overall Study|Death|0|||
161423154|NCT04628780|582937818|FG001|Overall Study|Death|1|||
161423155|NCT04628780|582937819|FG002|Overall Study|Death|0|||
161423156|NCT04628780|582937820|FG003|Overall Study|Death|0|||
161423157|NCT04628780|582937821|FG004|Overall Study|Death|1|||
161423158|NCT04628780|582937822|FG005|Overall Study|Death|0|||
161423159|NCT04628780|582937817|FG000|Overall Study|Physician Decision|2|||
161423160|NCT04628780|582937818|FG001|Overall Study|Physician Decision|0|||
161423161|NCT04628780|582937819|FG002|Overall Study|Physician Decision|0|||
161423162|NCT04628780|582937820|FG003|Overall Study|Physician Decision|0|||
161423163|NCT04628780|582937821|FG004|Overall Study|Physician Decision|2|||
161423164|NCT04628780|582937822|FG005|Overall Study|Physician Decision|0|||
161423165|NCT04628780|582937817|FG000|Overall Study|Progressive disease|2|||
161423166|NCT04628780|582937818|FG001|Overall Study|Progressive disease|2|||
161423167|NCT04628780|582937819|FG002|Overall Study|Progressive disease|2|||
161423168|NCT04628780|582937820|FG003|Overall Study|Progressive disease|3|||
161423169|NCT04628780|582937821|FG004|Overall Study|Progressive disease|9|||
161423170|NCT04628780|582937822|FG005|Overall Study|Progressive disease|4|||
161423171|NCT04628780|582937817|FG000|Overall Study|Withdrawal by Subject|0|||
161423172|NCT04628780|582937818|FG001|Overall Study|Withdrawal by Subject|1|||
161423173|NCT04628780|582937819|FG002|Overall Study|Withdrawal by Subject|2|||
161423174|NCT04628780|582937820|FG003|Overall Study|Withdrawal by Subject|0|||
161423175|NCT04628780|582937821|FG004|Overall Study|Withdrawal by Subject|3|||
161423176|NCT04628780|582937822|FG005|Overall Study|Withdrawal by Subject|1|||
161423177|NCT04628780|582937817|FG000|Overall Study|Global deterioration of health status|0|||
161423178|NCT04628780|582937818|FG001|Overall Study|Global deterioration of health status|0|||
161423179|NCT04628780|582937819|FG002|Overall Study|Global deterioration of health status|0|||
161423180|NCT04628780|582937820|FG003|Overall Study|Global deterioration of health status|0|||
161423181|NCT04628780|582937821|FG004|Overall Study|Global deterioration of health status|1|||
161423182|NCT04628780|582937822|FG005|Overall Study|Global deterioration of health status|1|||
161423183|NCT01987102|582937827|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
161423184|NCT01987102|582937828|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
161423185|NCT01987102|582937827|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
161423186|NCT01987102|582937828|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
161423187|NCT01987102|582937827|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
161423188|NCT01987102|582937828|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
161423189|NCT01987102|582937827|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
161423190|NCT01987102|582937828|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
161423191|NCT01987102|582937827|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
161423192|NCT01987102|582937828|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
161423193|NCT01987102|582937827|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
161423194|NCT01987102|582937828|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
161423195|NCT01327599|582937829|FG000|Overall Study|Adverse Event|1|||
161423196|NCT01327599|582937829|FG000|Overall Study|Could Not Attend Visit|1|||
161423197|NCT01327599|582937829|FG000|Overall Study|Withdrawal of Consent|1|||
161423198|NCT01236521|582937830|FG000|Overall Study|Withdrawal by Subject|12|||
161423199|NCT01236521|582937831|FG001|Overall Study|Withdrawal by Subject|17|||
161423200|NCT01236521|582937830|FG000|Overall Study|Death|2|||
161423201|NCT01236521|582937831|FG001|Overall Study|Death|1|||
161423202|NCT01236521|582937830|FG000|Overall Study|Lost to Follow-up|9|||
161423203|NCT01236521|582937831|FG001|Overall Study|Lost to Follow-up|7|||
161423204|NCT04661150|582937837|FG000|Overall Study|Ongoing in study|19|||
161423205|NCT04661150|582937838|FG001|Overall Study|Ongoing in study|20|||
161423206|NCT04661150|582937837|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
161423207|NCT04661150|582937838|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
161423208|NCT04661150|582937837|FG000|Overall Study|Death|2|||
161423209|NCT04661150|582937838|FG001|Overall Study|Death|0|||
161423210|NCT05864586|582937839|FG000|Overall Study|Ineligible|4|||
161423211|NCT05864586|582937840|FG001|Overall Study|Ineligible|12|||
161423212|NCT05864586|582937839|FG000|Overall Study|Pregnancy|0|||
161423213|NCT05864586|582937840|FG001|Overall Study|Pregnancy|1|||
161423214|NCT05864586|582937839|FG000|Overall Study|Withdrawal by Subject|0|||
161423215|NCT05864586|582937840|FG001|Overall Study|Withdrawal by Subject|1|||
161423216|NCT03635424|582937841|FG000|Overall Study|Adverse Event|1|||
161423217|NCT03635424|582937841|FG000|Overall Study|Death|1|||
161423218|NCT03635424|582937841|FG000|Overall Study|Device not implanted|1|||
161423219|NCT02701283|582937842|FG000|Overall Study|Death|25|||
161423220|NCT02701283|582937843|FG001|Overall Study|Death|29|||
161423221|NCT02701283|582937844|FG002|Overall Study|Death|19|||
161423222|NCT02701283|582937842|FG000|Overall Study|Lost to Follow-up|3|||
161423223|NCT02701283|582937843|FG001|Overall Study|Lost to Follow-up|8|||
161423224|NCT02701283|582937844|FG002|Overall Study|Lost to Follow-up|1|||
161423225|NCT02701283|582937842|FG000|Overall Study|Withdrawal by Subject|12|||
161423226|NCT02701283|582937843|FG001|Overall Study|Withdrawal by Subject|41|||
161423227|NCT02701283|582937844|FG002|Overall Study|Withdrawal by Subject|1|||
161423228|NCT02701283|582937842|FG000|Overall Study|Missed 2-year visit|22|||
161423229|NCT02701283|582937843|FG001|Overall Study|Missed 2-year visit|27|||
161423230|NCT02701283|582937844|FG002|Overall Study|Missed 2-year visit|0|||
161423231|NCT02701283|582937842|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
161423232|NCT02701283|582937843|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
161423233|NCT02701283|582937844|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
161423234|NCT04544956|582937845|FG000|Overall Study|Withdrawal by Subject|1|||
161423235|NCT04266795|582937846|FG000|Overall Study|Adverse Event|10|||
161423236|NCT04266795|582937847|FG001|Overall Study|Adverse Event|19|||
161423237|NCT04266795|582937846|FG000|Overall Study|Death|7|||
161423238|NCT04266795|582937847|FG001|Overall Study|Death|8|||
161423239|NCT04266795|582937846|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
161423240|NCT04266795|582937847|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
161423241|NCT04266795|582937846|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161423242|NCT04266795|582937847|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161423243|NCT04266795|582937846|FG000|Overall Study|Progressive Disease|12|||
161423244|NCT04266795|582937847|FG001|Overall Study|Progressive Disease|9|||
161423245|NCT04266795|582937846|FG000|Overall Study|Withdrawal by Patient|5|||
161423246|NCT04266795|582937847|FG001|Overall Study|Withdrawal by Patient|6|||
161423247|NCT04266795|582937846|FG000|Overall Study|Disease Relapse|3|||
161423248|NCT04266795|582937847|FG001|Overall Study|Disease Relapse|6|||
161423249|NCT04266795|582937846|FG000|Overall Study|Reason not Specified|12|||
161423250|NCT04266795|582937847|FG001|Overall Study|Reason not Specified|10|||
161423251|NCT04266795|582937846|FG000|Overall Study|Participants Ongoing on Treatment|25|||
161423252|NCT04266795|582937847|FG001|Overall Study|Participants Ongoing on Treatment|23|||
161423253|NCT03932760|582937853|FG000|Overall Study|Became Ineligible|2|||
161423254|NCT03932760|582937854|FG001|Overall Study|Became Ineligible|5|||
161423255|NCT03932760|582937853|FG000|Overall Study|Withdrawal by Subject|6|||
161423256|NCT03932760|582937854|FG001|Overall Study|Withdrawal by Subject|6|||
161423257|NCT04725500|582937855|FG000|Screening|Screen Failure|26|||
161423258|NCT04725500|582937855|FG000|Screening|Withdrawal by Subject|1|||
161423259|NCT04725500|582937855|FG000|2 Week Take Home|Screen Fail|5|||
161423260|NCT04618744|582937858|FG000|Overall Study|Adverse Event|0|||
161423261|NCT04618744|582937859|FG001|Overall Study|Adverse Event|1|||
161423262|NCT04618744|582937858|FG000|Overall Study|Withdrawal by Subject|0|||
161423263|NCT04618744|582937859|FG001|Overall Study|Withdrawal by Subject|1|||
161423264|NCT03553758|582939681|FG000|Overall Study|Lost to Follow-up|1|||
161423265|NCT02807623|582939682|FG000|Overall Study|Lost to Follow-up|23|||
161423266|NCT02807623|582939683|FG001|Overall Study|Lost to Follow-up|18|||
161423267|NCT02807623|582939684|FG002|Overall Study|Lost to Follow-up|22|||
161423268|NCT02807623|582939682|FG000|Overall Study|Drug intolerance|0|||
161423269|NCT02807623|582939683|FG001|Overall Study|Drug intolerance|1|||
161423270|NCT02807623|582939684|FG002|Overall Study|Drug intolerance|0|||
161423271|NCT02807623|582939682|FG000|Overall Study|incomplete blood draw|0|||
161423272|NCT02807623|582939683|FG001|Overall Study|incomplete blood draw|2|||
161423273|NCT02807623|582939684|FG002|Overall Study|incomplete blood draw|1|||
161423274|NCT02614729|582939685|FG000|Overall Study|Withdrawal by Subject|1|||
161423275|NCT02614729|582939686|FG001|Overall Study|Withdrawal by Subject|0|||
161423276|NCT04002960|582939691|FG000|Overall Study|Withdrawn prior to Completion|2|||
161423277|NCT00383786|582939694|FG000|Overall Study|Protocol Violation|2|||
161423278|NCT00383786|582939695|FG001|Overall Study|Protocol Violation|6|||
161423279|NCT00383786|582939694|FG000|Overall Study|Withdrawal by Subject|2|||
161423280|NCT00383786|582939695|FG001|Overall Study|Withdrawal by Subject|5|||
161423281|NCT00383786|582939694|FG000|Overall Study|Physician Decision|0|||
161423282|NCT00383786|582939695|FG001|Overall Study|Physician Decision|1|||
161423283|NCT02219464|582939699|FG000|Overall Study|Withdrawal by Subject|1|||
161423284|NCT02219464|582939700|FG001|Overall Study|Withdrawal by Subject|0|||
161423285|NCT02219464|582939699|FG000|Overall Study|case cancelled|1|||
161423286|NCT02219464|582939700|FG001|Overall Study|case cancelled|0|||
161423287|NCT02219464|582939699|FG000|Overall Study|catheter malfunction|1|||
161423288|NCT02219464|582939700|FG001|Overall Study|catheter malfunction|0|||
161423289|NCT02544321|582939701|FG000|Overall Study|Withdrawal by Subject|1|||
161423290|NCT02544321|582939702|FG001|Overall Study|Withdrawal by Subject|2|||
161423291|NCT02544321|582939701|FG000|Overall Study|Adverse Event|1|||
161423292|NCT02544321|582939702|FG001|Overall Study|Adverse Event|1|||
161423293|NCT02544321|582939701|FG000|Overall Study|Protocol Violation|0|||
161423294|NCT02544321|582939702|FG001|Overall Study|Protocol Violation|1|||
161423295|NCT00527735|582939704|FG000|Overall Study|Disease progression|47|||
161423296|NCT00527735|582939705|FG001|Overall Study|Disease progression|61|||
161423297|NCT00527735|582939706|FG002|Overall Study|Disease progression|53|||
161423298|NCT00527735|582939704|FG000|Overall Study|Death|23|||
161423299|NCT00527735|582939705|FG001|Overall Study|Death|13|||
161423300|NCT00527735|582939706|FG002|Overall Study|Death|15|||
161423301|NCT00527735|582939704|FG000|Overall Study|Completed treatment in treatment phase|14|||
161423302|NCT00527735|582939705|FG001|Overall Study|Completed treatment in treatment phase|13|||
161423303|NCT00527735|582939706|FG002|Overall Study|Completed treatment in treatment phase|18|||
161423304|NCT00527735|582939704|FG000|Overall Study|Adverse Event|10|||
161423305|NCT00527735|582939705|FG001|Overall Study|Adverse Event|6|||
161423306|NCT00527735|582939706|FG002|Overall Study|Adverse Event|7|||
161423307|NCT00527735|582939704|FG000|Overall Study|Not identified|5|||
161423308|NCT00527735|582939705|FG001|Overall Study|Not identified|5|||
161423309|NCT00527735|582939706|FG002|Overall Study|Not identified|5|||
161423310|NCT00527735|582939704|FG000|Overall Study|Withdrawal by Subject|5|||
161423311|NCT00527735|582939705|FG001|Overall Study|Withdrawal by Subject|4|||
161423312|NCT00527735|582939706|FG002|Overall Study|Withdrawal by Subject|3|||
161423313|NCT00527735|582939704|FG000|Overall Study|No longer met study criteria|2|||
161423314|NCT00527735|582939705|FG001|Overall Study|No longer met study criteria|2|||
161423315|NCT00527735|582939706|FG002|Overall Study|No longer met study criteria|1|||
161423316|NCT00527735|582939704|FG000|Overall Study|Lost to Follow-up|0|||
161423317|NCT00527735|582939705|FG001|Overall Study|Lost to Follow-up|0|||
161423318|NCT00527735|582939706|FG002|Overall Study|Lost to Follow-up|3|||
161423319|NCT00527735|582939704|FG000|Overall Study|Poor compliance or noncompliance|0|||
161423320|NCT00527735|582939705|FG001|Overall Study|Poor compliance or noncompliance|1|||
161423321|NCT00527735|582939706|FG002|Overall Study|Poor compliance or noncompliance|1|||
161423322|NCT00527735|582939704|FG000|Overall Study|Completed treatment during maintenance|2|||
161423323|NCT00527735|582939705|FG001|Overall Study|Completed treatment during maintenance|2|||
161423324|NCT00527735|582939706|FG002|Overall Study|Completed treatment during maintenance|1|||
161423325|NCT01080807|582939707|FG000|Overall Study|Adverse Event|9|||
161423326|NCT01080807|582939708|FG001|Overall Study|Adverse Event|1|||
161423327|NCT01080807|582939707|FG000|Overall Study|Lack of Efficacy|0|||
161423328|NCT01080807|582939708|FG001|Overall Study|Lack of Efficacy|1|||
161423329|NCT01080807|582939707|FG000|Overall Study|Withdrawal by Subject|7|||
161423330|NCT01080807|582939708|FG001|Overall Study|Withdrawal by Subject|2|||
161423331|NCT01080807|582939707|FG000|Overall Study|Protocol Violation|7|||
161423332|NCT01080807|582939708|FG001|Overall Study|Protocol Violation|6|||
161423333|NCT01080807|582939707|FG000|Overall Study|Lost to Follow-up|6|||
161423334|NCT01080807|582939708|FG001|Overall Study|Lost to Follow-up|4|||
161423335|NCT01080807|582939707|FG000|Overall Study|Noncompliance with drug administration|1|||
161423336|NCT01080807|582939708|FG001|Overall Study|Noncompliance with drug administration|1|||
161423337|NCT01080807|582939707|FG000|Overall Study|Noncompliance to study procedures|1|||
161423338|NCT01080807|582939708|FG001|Overall Study|Noncompliance to study procedures|1|||
161423339|NCT01080807|582939707|FG000|Overall Study|Began working day shift|0|||
161423340|NCT01080807|582939708|FG001|Overall Study|Began working day shift|2|||
161423341|NCT01080807|582939707|FG000|Overall Study|Laid off or terminated from job|1|||
161423342|NCT01080807|582939708|FG001|Overall Study|Laid off or terminated from job|2|||
161423343|NCT01080807|582939707|FG000|Overall Study|Stopped working consistent night shifts|0|||
161423344|NCT01080807|582939708|FG001|Overall Study|Stopped working consistent night shifts|1|||
161423345|NCT01080807|582939707|FG000|Overall Study|Work schedule changing|1|||
161423346|NCT01080807|582939708|FG001|Overall Study|Work schedule changing|1|||
161423347|NCT01080807|582939707|FG000|Overall Study|Work schedule and travel|0|||
161423348|NCT01080807|582939708|FG001|Overall Study|Work schedule and travel|1|||
161423349|NCT01080807|582939707|FG000|Overall Study|Switched to first shift|1|||
161423350|NCT01080807|582939708|FG001|Overall Study|Switched to first shift|0|||
161423351|NCT01080807|582939707|FG000|Overall Study|Moved away without notifying center|1|||
161423352|NCT01080807|582939708|FG001|Overall Study|Moved away without notifying center|0|||
161423353|NCT02107703|582939715|FG000|Overall Study|Withdrawal by Subject|46|||
161423354|NCT02107703|582939716|FG001|Overall Study|Withdrawal by Subject|21|||
161423355|NCT02107703|582939715|FG000|Overall Study|Lost to Follow-up|20|||
161423356|NCT02107703|582939716|FG001|Overall Study|Lost to Follow-up|9|||
161423357|NCT02107703|582939715|FG000|Overall Study|On study treatment/follow up|48|||
161423358|NCT02107703|582939716|FG001|Overall Study|On study treatment/follow up|5|||
161423359|NCT02366312|582939717|FG000|Overall Study|Lost to Follow-up|0|||
161423360|NCT02366312|582939718|FG001|Overall Study|Lost to Follow-up|1|||
161423361|NCT01879683|582939725|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
161423362|NCT01338818|582939733|FG000|Overall Study|Adverse Event|8|||
161423363|NCT01338818|582939733|FG000|Overall Study|Lack of Efficacy|5|||
161423364|NCT01338818|582939733|FG000|Overall Study|no longer require study drug|1|||
161423365|NCT01338818|582939733|FG000|Overall Study|Withdrawal by Subject|11|||
161423366|NCT01338818|582939733|FG000|Overall Study|Lost to Follow-up|4|||
161423367|NCT01338818|582939733|FG000|Overall Study|Administrative problems|3|||
161423368|NCT01338818|582939733|FG000|Overall Study|Protocol Deviation|4|||
161423369|NCT05202418|582939734|FG000|Overall Study|Withdrawal by Subject|2|||
161423370|NCT05202418|582939735|FG001|Overall Study|Withdrawal by Subject|1|||
161423371|NCT05202418|582939734|FG000|Overall Study|Lost to Follow-up|1|||
161423372|NCT05202418|582939735|FG001|Overall Study|Lost to Follow-up|1|||
161423373|NCT03901144|582939740|FG000|Overall Study|Lost to Follow-up|1|||
161423374|NCT03901144|582939741|FG001|Overall Study|Lost to Follow-up|1|||
161423375|NCT03901144|582939742|FG002|Overall Study|Lost to Follow-up|1|||
161423376|NCT03901144|582939743|FG003|Overall Study|Lost to Follow-up|1|||
161423377|NCT02021565|582939744|FG000|Baseline Through Intervention|Death|0|||
161423378|NCT02021565|582939745|FG001|Baseline Through Intervention|Death|1|||
161423379|NCT02021565|582939744|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
161423380|NCT02021565|582939745|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
161423381|NCT02021565|582939744|FG000|Baseline Through Intervention|Protocol Violation|0|||
161423382|NCT02021565|582939745|FG001|Baseline Through Intervention|Protocol Violation|7|||
161423383|NCT02021565|582939744|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
161423384|NCT02021565|582939745|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
161423385|NCT02021565|582939744|FG000|3-month Follow-up|Death|3|||
161423386|NCT02021565|582939745|FG001|3-month Follow-up|Death|0|||
161423387|NCT02021565|582939744|FG000|3-month Follow-up|Withdrawal by Subject|4|||
161423388|NCT02021565|582939745|FG001|3-month Follow-up|Withdrawal by Subject|0|||
161423389|NCT02021565|582939744|FG000|3-month Follow-up|Protocol Violation|3|||
161423390|NCT02021565|582939745|FG001|3-month Follow-up|Protocol Violation|2|||
161423391|NCT03575403|582939746|FG000|Overall Study|Adverse Event|1|||
161423392|NCT03575403|582939747|FG001|Overall Study|Adverse Event|0|||
161423393|NCT03575403|582939748|FG002|Overall Study|Adverse Event|0|||
161423394|NCT03575403|582939746|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
161423395|NCT03575403|582939747|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
161423396|NCT03575403|582939748|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
161423397|NCT01332994|582939750|FG000|Overall Study|Adverse Event|34|||
161423398|NCT01332994|582939750|FG000|Overall Study|Death|1|||
161423399|NCT01332994|582939750|FG000|Overall Study|Lack of Efficacy|1|||
161423400|NCT01332994|582939750|FG000|Overall Study|Lost to Follow-up|4|||
161423401|NCT01332994|582939750|FG000|Overall Study|Protocol Violation|6|||
161423402|NCT01332994|582939750|FG000|Overall Study|Withdrawal by Subject|15|||
161423403|NCT01332994|582939750|FG000|Overall Study|Administrative Problem|2|||
161423404|NCT01332994|582939750|FG000|Overall Study|Other|8|||
161423405|NCT00279916|582939751|FG000|Overall Study|Withdrawal by Subject|4|||
161423406|NCT00279916|582939752|FG001|Overall Study|Withdrawal by Subject|3|||
161423407|NCT00279916|582939751|FG000|Overall Study|Lost to Follow-up|3|||
161423408|NCT00279916|582939752|FG001|Overall Study|Lost to Follow-up|2|||
161423409|NCT00731679|582939754|FG000|Overall Study|Adverse Event|7|||
161423410|NCT00731679|582939755|FG001|Overall Study|Adverse Event|8|||
161423411|NCT00731679|582939754|FG000|Overall Study|Withdrawal by Subject|8|||
161423412|NCT00731679|582939755|FG001|Overall Study|Withdrawal by Subject|8|||
161423413|NCT00731679|582939754|FG000|Overall Study|Lost to Follow-up|7|||
161423414|NCT00731679|582939755|FG001|Overall Study|Lost to Follow-up|8|||
161423415|NCT00731679|582939754|FG000|Overall Study|Noncompliance|0|||
161423416|NCT00731679|582939755|FG001|Overall Study|Noncompliance|1|||
161423417|NCT00731679|582939754|FG000|Overall Study|Pregnancy|0|||
161423418|NCT00731679|582939755|FG001|Overall Study|Pregnancy|1|||
161423419|NCT02488005|582939758|FG000|Overall Study|Lost to Follow-up|2|||
161423420|NCT03384940|582939765|FG000|Overall Study|Progressive disease|36|||
161423421|NCT03384940|582939766|FG001|Overall Study|Progressive disease|11|||
161423422|NCT03384940|582939767|FG002|Overall Study|Progressive disease|13|||
161423423|NCT03384940|582939765|FG000|Overall Study|Clinical progression|4|||
161423424|NCT03384940|582939766|FG001|Overall Study|Clinical progression|0|||
161423425|NCT03384940|582939767|FG002|Overall Study|Clinical progression|3|||
161423426|NCT03384940|582939765|FG000|Overall Study|Adverse Event|7|||
161423427|NCT03384940|582939766|FG001|Overall Study|Adverse Event|1|||
161423428|NCT03384940|582939767|FG002|Overall Study|Adverse Event|1|||
161423429|NCT03384940|582939765|FG000|Overall Study|Withdrawal by Subject|3|||
161423430|NCT03384940|582939766|FG001|Overall Study|Withdrawal by Subject|1|||
161423431|NCT03384940|582939767|FG002|Overall Study|Withdrawal by Subject|0|||
161423432|NCT03384940|582939765|FG000|Overall Study|Physician Decision|1|||
161423433|NCT03384940|582939766|FG001|Overall Study|Physician Decision|1|||
161423434|NCT03384940|582939767|FG002|Overall Study|Physician Decision|0|||
161423435|NCT03384940|582939765|FG000|Overall Study|Death|2|||
161423436|NCT03384940|582939766|FG001|Overall Study|Death|1|||
161423437|NCT03384940|582939767|FG002|Overall Study|Death|0|||
161423438|NCT03384940|582939765|FG000|Overall Study|Other|0|||
161423439|NCT03384940|582939766|FG001|Overall Study|Other|0|||
161423440|NCT03384940|582939767|FG002|Overall Study|Other|1|||
161423441|NCT03089580|582939770|FG000|Overall Study|Lost to Follow-up|2|||
161423442|NCT03087513|582939771|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
161423443|NCT03269994|582939772|FG000|Overall Study|Withdrawal by Subject|4|||
161423444|NCT03269994|582939773|FG001|Overall Study|Withdrawal by Subject|5|||
161423445|NCT03269994|582939772|FG000|Overall Study|Unresectable at surgery|39|||
161423446|NCT03269994|582939773|FG001|Overall Study|Unresectable at surgery|58|||
161423447|NCT03269994|582939772|FG000|Overall Study|Patient canceled surgery|5|||
161423448|NCT03269994|582939773|FG001|Overall Study|Patient canceled surgery|14|||
161423449|NCT03269994|582939772|FG000|Overall Study|Preoperative progression|14|||
161423450|NCT03269994|582939773|FG001|Overall Study|Preoperative progression|9|||
161423451|NCT03269994|582939772|FG000|Overall Study|Preoperative infection|10|||
161423452|NCT03269994|582939773|FG001|Overall Study|Preoperative infection|4|||
161423453|NCT03269994|582939772|FG000|Overall Study|Kidney insufficiency|1|||
161423454|NCT03269994|582939773|FG001|Overall Study|Kidney insufficiency|0|||
161423455|NCT03269994|582939772|FG000|Overall Study|Drug allergy|0|||
161423456|NCT03269994|582939773|FG001|Overall Study|Drug allergy|2|||
161423457|NCT03269994|582939772|FG000|Overall Study|Operation changed to different resection|9|||
161423458|NCT03269994|582939773|FG001|Overall Study|Operation changed to different resection|0|||
161423459|NCT03269994|582939772|FG000|Overall Study|Preoperative steroid|0|||
161423460|NCT03269994|582939773|FG001|Overall Study|Preoperative steroid|3|||
161423461|NCT03269994|582939772|FG000|Overall Study|Accrual Closed|2|||
161423462|NCT03269994|582939773|FG001|Overall Study|Accrual Closed|0|||
161423463|NCT03269994|582939772|FG000|Overall Study|Operation changed to different resection|0|||
161423464|NCT03269994|582939773|FG001|Overall Study|Operation changed to different resection|10|||
161423465|NCT04303559|582939774|FG000|Overall Study|Study closed due to poor enrollment.|1|||
161423466|NCT01288989|582939777|FG000|Overall Study|Death|0|||
161423467|NCT01288989|582939778|FG001|Overall Study|Death|0|||
161423468|NCT01288989|582939779|FG002|Overall Study|Death|0|||
161423469|NCT01288989|582939780|FG003|Overall Study|Death|1|||
161423470|NCT01288989|582939781|FG004|Overall Study|Death|0|||
161423471|NCT01288989|582939777|FG000|Overall Study|Dose limiting toxicity|1|||
161423472|NCT01288989|582939778|FG001|Overall Study|Dose limiting toxicity|0|||
161423473|NCT01288989|582939779|FG002|Overall Study|Dose limiting toxicity|0|||
161423474|NCT01288989|582939780|FG003|Overall Study|Dose limiting toxicity|0|||
161423475|NCT01288989|582939781|FG004|Overall Study|Dose limiting toxicity|0|||
161423476|NCT01288989|582939777|FG000|Overall Study|Adverse Event|0|||
161423477|NCT01288989|582939778|FG001|Overall Study|Adverse Event|0|||
161423478|NCT01288989|582939779|FG002|Overall Study|Adverse Event|0|||
161423479|NCT01288989|582939780|FG003|Overall Study|Adverse Event|0|||
161423480|NCT01288989|582939781|FG004|Overall Study|Adverse Event|2|||
161423481|NCT01288989|582939777|FG000|Overall Study|Physician Decision|0|||
161423482|NCT01288989|582939778|FG001|Overall Study|Physician Decision|0|||
161423483|NCT01288989|582939779|FG002|Overall Study|Physician Decision|0|||
161423484|NCT01288989|582939780|FG003|Overall Study|Physician Decision|0|||
161423485|NCT01288989|582939781|FG004|Overall Study|Physician Decision|1|||
161423486|NCT01288989|582939777|FG000|Overall Study|Withdrawal by Subject|0|||
161423487|NCT01288989|582939778|FG001|Overall Study|Withdrawal by Subject|0|||
161423488|NCT01288989|582939779|FG002|Overall Study|Withdrawal by Subject|0|||
161423489|NCT01288989|582939780|FG003|Overall Study|Withdrawal by Subject|0|||
161423490|NCT01288989|582939781|FG004|Overall Study|Withdrawal by Subject|3|||
161423491|NCT01156714|582939782|FG000|Overall Study|Withdrawal by Subject|9|||
161423492|NCT01156714|582939783|FG001|Overall Study|Withdrawal by Subject|4|||
161423493|NCT01156714|582939784|FG002|Overall Study|Withdrawal by Subject|3|||
161423494|NCT05907395|582939789|FG000|Period 1|No longer met eligibility criteria|0|||
161423495|NCT05907395|582939790|FG001|Period 1|No longer met eligibility criteria|1|||
161423496|NCT05907395|582939791|FG002|Period 1|No longer met eligibility criteria|0|||
161423497|NCT05907395|582939792|FG003|Period 1|No longer met eligibility criteria|0|||
161423498|NCT05907395|582939793|FG004|Period 1|No longer met eligibility criteria|0|||
161423499|NCT05907395|582939794|FG005|Period 1|No longer met eligibility criteria|1|||
161423500|NCT05907395|582939795|FG006|Period 1|No longer met eligibility criteria|1|||
161423501|NCT05907395|582939796|FG007|Period 1|No longer met eligibility criteria|0|||
161423502|NCT05907395|582939797|FG008|Period 1|No longer met eligibility criteria|0|||
161423503|NCT05907395|582939798|FG009|Period 1|No longer met eligibility criteria|0|||
161423504|NCT05907395|582939799|FG010|Period 1|No longer met eligibility criteria|0|||
161423505|NCT05907395|582939800|FG011|Period 1|No longer met eligibility criteria|0|||
161423506|NCT05907395|582939789|FG000|Period 2|Adverse Event|0|||
161423507|NCT05907395|582939790|FG001|Period 2|Adverse Event|0|||
161423508|NCT05907395|582939791|FG002|Period 2|Adverse Event|0|||
161423509|NCT05907395|582939792|FG003|Period 2|Adverse Event|1|||
161423510|NCT05907395|582939793|FG004|Period 2|Adverse Event|0|||
161423511|NCT05907395|582939794|FG005|Period 2|Adverse Event|0|||
161423512|NCT05907395|582939795|FG006|Period 2|Adverse Event|0|||
161423513|NCT05907395|582939796|FG007|Period 2|Adverse Event|1|||
161423514|NCT05907395|582939797|FG008|Period 2|Adverse Event|0|||
161423515|NCT05907395|582939798|FG009|Period 2|Adverse Event|0|||
161423516|NCT05907395|582939799|FG010|Period 2|Adverse Event|0|||
161423517|NCT05907395|582939800|FG011|Period 2|Adverse Event|0|||
161423518|NCT05907395|582939789|FG000|Period 2|Personal reason|0|||
161423519|NCT05907395|582939790|FG001|Period 2|Personal reason|0|||
161423520|NCT05907395|582939791|FG002|Period 2|Personal reason|0|||
161423521|NCT05907395|582939792|FG003|Period 2|Personal reason|0|||
161423522|NCT05907395|582939793|FG004|Period 2|Personal reason|0|||
161423523|NCT05907395|582939794|FG005|Period 2|Personal reason|0|||
161423524|NCT05907395|582939795|FG006|Period 2|Personal reason|0|||
161423525|NCT05907395|582939796|FG007|Period 2|Personal reason|0|||
161423526|NCT05907395|582939797|FG008|Period 2|Personal reason|0|||
161423527|NCT05907395|582939798|FG009|Period 2|Personal reason|1|||
161423528|NCT05907395|582939799|FG010|Period 2|Personal reason|0|||
161423529|NCT05907395|582939800|FG011|Period 2|Personal reason|0|||
161423530|NCT05907395|582939789|FG000|Period 3|Adverse Event|0|||
161423531|NCT05907395|582939790|FG001|Period 3|Adverse Event|0|||
161423532|NCT05907395|582939791|FG002|Period 3|Adverse Event|0|||
161423533|NCT05907395|582939792|FG003|Period 3|Adverse Event|0|||
161423534|NCT05907395|582939793|FG004|Period 3|Adverse Event|1|||
161423535|NCT05907395|582939794|FG005|Period 3|Adverse Event|0|||
161423536|NCT05907395|582939795|FG006|Period 3|Adverse Event|0|||
161423537|NCT05907395|582939796|FG007|Period 3|Adverse Event|0|||
161423538|NCT05907395|582939797|FG008|Period 3|Adverse Event|0|||
161423539|NCT05907395|582939798|FG009|Period 3|Adverse Event|0|||
161423540|NCT05907395|582939799|FG010|Period 3|Adverse Event|0|||
161423541|NCT05907395|582939800|FG011|Period 3|Adverse Event|0|||
161423542|NCT03043872|582939801|FG000|Overall Study|Withdrawal by Subject|6|||
161423543|NCT03043872|582939802|FG001|Overall Study|Withdrawal by Subject|6|||
161423544|NCT03043872|582939803|FG002|Overall Study|Withdrawal by Subject|15|||
161423545|NCT03043872|582939801|FG000|Overall Study|Lost to Follow-up|2|||
161423546|NCT03043872|582939802|FG001|Overall Study|Lost to Follow-up|1|||
161423547|NCT03043872|582939803|FG002|Overall Study|Lost to Follow-up|1|||
161423548|NCT03043872|582939801|FG000|Overall Study|Death|270|||
161423549|NCT03043872|582939802|FG001|Overall Study|Death|269|||
161423550|NCT03043872|582939803|FG002|Overall Study|Death|296|||
161423551|NCT02777827|582939804|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
161423552|NCT02777827|582939805|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
161423553|NCT02777827|582939806|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
161423554|NCT02777827|582939807|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
161423555|NCT02777827|582939808|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
161423556|NCT02777827|582939809|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
161423557|NCT04551066|582939810|FG000|Overall Study|Death|5|||
161423558|NCT04551066|582939811|FG001|Overall Study|Death|3|||
161423559|NCT04551066|582939810|FG000|Overall Study|Lost to Follow-up|1|||
161423560|NCT04551066|582939811|FG001|Overall Study|Lost to Follow-up|0|||
161423561|NCT04551066|582939810|FG000|Overall Study|Sponsor Decision|104|||
161423562|NCT04551066|582939811|FG001|Overall Study|Sponsor Decision|117|||
161423563|NCT04551066|582939810|FG000|Overall Study|Withdrawal by Subject|8|||
161423564|NCT04551066|582939811|FG001|Overall Study|Withdrawal by Subject|2|||
161423565|NCT04551066|582939810|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
161423566|NCT04551066|582939811|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
161423567|NCT04551066|582939810|FG000|Overall Study|Adverse Event|2|||
161423568|NCT04551066|582939811|FG001|Overall Study|Adverse Event|0|||
161423569|NCT04551066|582939810|FG000|Overall Study|Physician Decision|2|||
161423570|NCT04551066|582939811|FG001|Overall Study|Physician Decision|0|||
161423571|NCT04551066|582939810|FG000|Overall Study|Protocol Violation|1|||
161423572|NCT04551066|582939811|FG001|Overall Study|Protocol Violation|0|||
161423573|NCT04551066|582939810|FG000|Overall Study|Lack of Efficacy|0|||
161423574|NCT04551066|582939811|FG001|Overall Study|Lack of Efficacy|1|||
161423575|NCT04551066|582939810|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
161423576|NCT04551066|582939811|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
161423577|NCT04491136|582939812|FG000|Overall Study|Patient withdraw informed consent|9|||
161423578|NCT04491136|582939812|FG000|Overall Study|Adverse Event|2|||
161423579|NCT04491136|582939812|FG000|Overall Study|Death|3|||
161423580|NCT04491136|582939812|FG000|Overall Study|Lost to Follow-up|3|||
161423581|NCT04491136|582939812|FG000|Overall Study|Physician Decision|45|||
161423582|NCT04491136|582939812|FG000|Overall Study|sponsor terminated the study early|16|||
161423583|NCT04491136|582939812|FG000|Overall Study|Patient/guardian's decision|1|||
161423584|NCT00398320|582939813|FG000|Overall Study|Death|1|||
161423585|NCT00398320|582939813|FG000|Overall Study|Adverse Event|4|||
161423586|NCT00398320|582939813|FG000|Overall Study|Physician Decision|1|||
161423587|NCT00064792|582939814|FG000|Overall Study|Withdrawal by Subject|2|||
161423588|NCT00064792|582939815|FG001|Overall Study|Withdrawal by Subject|0|||
161423589|NCT00064792|582939814|FG000|Overall Study|Adverse Event|3|||
161423590|NCT00064792|582939815|FG001|Overall Study|Adverse Event|0|||
161423591|NCT00319254|582939820|FG000|Overall Study|Withdrawal by Subject|4|||
161423592|NCT00319254|582939820|FG000|Overall Study|Death|46|||
161423593|NCT00319254|582939820|FG000|Overall Study|Lost to Follow-up|2|||
161423594|NCT00319254|582939820|FG000|Overall Study|Enrolled, Not Treated|2|||
161423595|NCT01712204|582939824|FG000|Overall Study|Adverse Event|3|||
161423596|NCT01712204|582939825|FG001|Overall Study|Adverse Event|1|||
161423597|NCT01712204|582939824|FG000|Overall Study|Withdrawal by Subject|3|||
161423598|NCT01712204|582939825|FG001|Overall Study|Withdrawal by Subject|3|||
161423599|NCT01712204|582939824|FG000|Overall Study|Lost to Follow-up|1|||
161423600|NCT01712204|582939825|FG001|Overall Study|Lost to Follow-up|0|||
161423601|NCT01712204|582939824|FG000|Overall Study|Protocol Violation|1|||
161423602|NCT01712204|582939825|FG001|Overall Study|Protocol Violation|1|||
161423603|NCT02452424|582939826|FG000|Overall Study|Death|2|||
161423604|NCT02452424|582939827|FG001|Overall Study|Death|2|||
161423605|NCT02452424|582939828|FG002|Overall Study|Death|2|||
161423606|NCT02452424|582939829|FG003|Overall Study|Death|6|||
161423607|NCT02452424|582939830|FG004|Overall Study|Death|2|||
161423608|NCT02452424|582939831|FG005|Overall Study|Death|0|||
161423609|NCT02452424|582939832|FG006|Overall Study|Death|5|||
161423610|NCT02452424|582939833|FG007|Overall Study|Death|1|||
161423611|NCT02452424|582939834|FG008|Overall Study|Death|3|||
161423612|NCT02452424|582939835|FG009|Overall Study|Death|1|||
161423613|NCT02452424|582939836|FG010|Overall Study|Death|0|||
161423614|NCT02452424|582939826|FG000|Overall Study|Lost to Follow-up|0|||
161423615|NCT02452424|582939827|FG001|Overall Study|Lost to Follow-up|1|||
161423616|NCT02452424|582939828|FG002|Overall Study|Lost to Follow-up|1|||
161423617|NCT02452424|582939829|FG003|Overall Study|Lost to Follow-up|0|||
161423618|NCT02452424|582939830|FG004|Overall Study|Lost to Follow-up|0|||
161423619|NCT02452424|582939831|FG005|Overall Study|Lost to Follow-up|0|||
161423620|NCT02452424|582939832|FG006|Overall Study|Lost to Follow-up|0|||
161423621|NCT02452424|582939833|FG007|Overall Study|Lost to Follow-up|0|||
161423622|NCT02452424|582939834|FG008|Overall Study|Lost to Follow-up|0|||
161423623|NCT02452424|582939835|FG009|Overall Study|Lost to Follow-up|0|||
161423624|NCT02452424|582939836|FG010|Overall Study|Lost to Follow-up|0|||
161423625|NCT02452424|582939826|FG000|Overall Study|Withdrawal by Subject|0|||
161423626|NCT02452424|582939827|FG001|Overall Study|Withdrawal by Subject|0|||
161423627|NCT02452424|582939828|FG002|Overall Study|Withdrawal by Subject|3|||
161423628|NCT02452424|582939829|FG003|Overall Study|Withdrawal by Subject|2|||
161423629|NCT02452424|582939830|FG004|Overall Study|Withdrawal by Subject|0|||
161423630|NCT02452424|582939831|FG005|Overall Study|Withdrawal by Subject|0|||
161423631|NCT02452424|582939832|FG006|Overall Study|Withdrawal by Subject|1|||
161423632|NCT02452424|582939833|FG007|Overall Study|Withdrawal by Subject|0|||
161423633|NCT02452424|582939834|FG008|Overall Study|Withdrawal by Subject|1|||
161423634|NCT02452424|582939835|FG009|Overall Study|Withdrawal by Subject|1|||
161423635|NCT02452424|582939836|FG010|Overall Study|Withdrawal by Subject|0|||
161423636|NCT02452424|582939826|FG000|Overall Study|Other|0|||
161423637|NCT02452424|582939827|FG001|Overall Study|Other|0|||
161423638|NCT02452424|582939828|FG002|Overall Study|Other|1|||
161423639|NCT02452424|582939829|FG003|Overall Study|Other|0|||
161423640|NCT02452424|582939830|FG004|Overall Study|Other|0|||
161423641|NCT02452424|582939831|FG005|Overall Study|Other|1|||
161423642|NCT02452424|582939832|FG006|Overall Study|Other|4|||
161423643|NCT02452424|582939833|FG007|Overall Study|Other|3|||
161423644|NCT02452424|582939834|FG008|Overall Study|Other|0|||
161423645|NCT02452424|582939835|FG009|Overall Study|Other|0|||
161423646|NCT02452424|582939836|FG010|Overall Study|Other|1|||
161423647|NCT02452424|582939826|FG000|Overall Study|Progressive disease (per RECIST)|0|||
161423648|NCT02452424|582939827|FG001|Overall Study|Progressive disease (per RECIST)|0|||
161423649|NCT02452424|582939828|FG002|Overall Study|Progressive disease (per RECIST)|0|||
161423650|NCT02452424|582939829|FG003|Overall Study|Progressive disease (per RECIST)|0|||
161423651|NCT02452424|582939830|FG004|Overall Study|Progressive disease (per RECIST)|0|||
161423652|NCT02452424|582939831|FG005|Overall Study|Progressive disease (per RECIST)|0|||
161423653|NCT02452424|582939832|FG006|Overall Study|Progressive disease (per RECIST)|0|||
161423654|NCT02452424|582939833|FG007|Overall Study|Progressive disease (per RECIST)|0|||
161423655|NCT02452424|582939834|FG008|Overall Study|Progressive disease (per RECIST)|2|||
161423656|NCT02452424|582939835|FG009|Overall Study|Progressive disease (per RECIST)|0|||
161423657|NCT02452424|582939836|FG010|Overall Study|Progressive disease (per RECIST)|0|||
161423658|NCT02452424|582939826|FG000|Overall Study|Adverse Event|0|||
161423659|NCT02452424|582939827|FG001|Overall Study|Adverse Event|0|||
161423660|NCT02452424|582939828|FG002|Overall Study|Adverse Event|0|||
161423661|NCT02452424|582939829|FG003|Overall Study|Adverse Event|0|||
161423662|NCT02452424|582939830|FG004|Overall Study|Adverse Event|0|||
161423663|NCT02452424|582939831|FG005|Overall Study|Adverse Event|0|||
161423664|NCT02452424|582939832|FG006|Overall Study|Adverse Event|0|||
161423665|NCT02452424|582939833|FG007|Overall Study|Adverse Event|0|||
161423666|NCT02452424|582939834|FG008|Overall Study|Adverse Event|0|||
161423667|NCT02452424|582939835|FG009|Overall Study|Adverse Event|0|||
161423668|NCT02452424|582939836|FG010|Overall Study|Adverse Event|1|||
161423669|NCT01059318|582939837|FG000|Core Study (26 Week)|Adverse Event|3|||
161423670|NCT01059318|582939837|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
161423671|NCT01059318|582939837|FG000|Extension (36 Week)|Adverse Event|3|||
161423672|NCT03790917|582939838|FG000|Overall Study|Death|1|||
161423673|NCT01150097|582939842|FG000|Months 24 to 36 Post-transplantation|Death|2|||
161423674|NCT01150097|582939843|FG001|Months 24 to 36 Post-transplantation|Death|0|||
161423675|NCT01150097|582939844|FG002|Months 24 to 36 Post-transplantation|Death|0|||
161423676|NCT01150097|582939842|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
161423677|NCT01150097|582939843|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
161423678|NCT01150097|582939844|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
161423679|NCT01150097|582939842|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
161423680|NCT01150097|582939843|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
161423681|NCT01150097|582939844|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
161423682|NCT01150097|582939842|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
161423683|NCT01150097|582939843|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
161423684|NCT01150097|582939844|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
161423685|NCT01150097|582939842|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
161423686|NCT01150097|582939843|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
161423687|NCT01150097|582939844|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
161423688|NCT01150097|582939842|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
161423689|NCT01150097|582939843|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
161423690|NCT01150097|582939844|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
161423691|NCT01150097|582939842|FG000|Months 24 to 48 Post-transplantation|Death|2|||
161423692|NCT01150097|582939843|FG001|Months 24 to 48 Post-transplantation|Death|0|||
161423693|NCT01150097|582939844|FG002|Months 24 to 48 Post-transplantation|Death|0|||
161423694|NCT00992459|582939845|FG000|Overall Study|Withdrawal by Subject|0|||
161423695|NCT00992459|582939846|FG001|Overall Study|Withdrawal by Subject|1|||
161423696|NCT00992459|582939845|FG000|Overall Study|Adverse Event|1|||
161423697|NCT00992459|582939846|FG001|Overall Study|Adverse Event|0|||
161423698|NCT01408459|582939847|FG000|Overall Study|Withdrawal by Subject|1|||
161423699|NCT01408459|582939848|FG001|Overall Study|Withdrawal by Subject|1|||
161423700|NCT00543387|582939853|FG000|Panel 1 + Panel 2|Adverse Event|0|||
161423701|NCT00543387|582939854|FG001|Panel 1 + Panel 2|Adverse Event|1|||
161423702|NCT00543387|582939855|FG002|Panel 1 + Panel 2|Adverse Event|0|||
161423703|NCT00543387|582939856|FG003|Panel 1 + Panel 2|Adverse Event|0|||
161423704|NCT00543387|582939857|FG004|Panel 1 + Panel 2|Adverse Event|0|||
161423705|NCT00543387|582939858|FG005|Panel 1 + Panel 2|Adverse Event|0|||
161423706|NCT00543387|582939859|FG006|Panel 1 + Panel 2|Adverse Event|0|||
161423707|NCT00543387|582939860|FG007|Panel 1 + Panel 2|Adverse Event|1|||
161423708|NCT00543387|582939861|FG008|Panel 1 + Panel 2|Adverse Event|1|||
161423709|NCT00543387|582939862|FG009|Panel 1 + Panel 2|Adverse Event|0|||
161423710|NCT00543387|582939863|FG010|Panel 1 + Panel 2|Adverse Event|0|||
161423711|NCT00543387|582939853|FG000|Panel 1 + Panel 2|Physician Decision|0|||
161423712|NCT00543387|582939854|FG001|Panel 1 + Panel 2|Physician Decision|0|||
161423713|NCT00543387|582939855|FG002|Panel 1 + Panel 2|Physician Decision|1|||
161423714|NCT00543387|582939856|FG003|Panel 1 + Panel 2|Physician Decision|0|||
161423715|NCT00543387|582939857|FG004|Panel 1 + Panel 2|Physician Decision|0|||
161423716|NCT00543387|582939858|FG005|Panel 1 + Panel 2|Physician Decision|0|||
161423717|NCT00543387|582939859|FG006|Panel 1 + Panel 2|Physician Decision|0|||
161423718|NCT00543387|582939860|FG007|Panel 1 + Panel 2|Physician Decision|1|||
161423719|NCT00543387|582939861|FG008|Panel 1 + Panel 2|Physician Decision|0|||
161423720|NCT00543387|582939862|FG009|Panel 1 + Panel 2|Physician Decision|0|||
161423721|NCT00543387|582939863|FG010|Panel 1 + Panel 2|Physician Decision|0|||
161423722|NCT00543387|582939853|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161423723|NCT00543387|582939854|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
161423724|NCT00543387|582939855|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
161423725|NCT00543387|582939856|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161423726|NCT00543387|582939857|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161423727|NCT00543387|582939858|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161423728|NCT00543387|582939859|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
161423729|NCT00543387|582939860|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
161423730|NCT00543387|582939861|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
161423731|NCT00543387|582939862|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
161423732|NCT00543387|582939863|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
161423733|NCT00543387|582939853|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423734|NCT00543387|582939854|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423735|NCT00543387|582939855|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423736|NCT00543387|582939856|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423737|NCT00543387|582939857|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423738|NCT00543387|582939858|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423739|NCT00543387|582939859|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
161423740|NCT00543387|582939860|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423741|NCT00543387|582939861|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423742|NCT00543387|582939862|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423743|NCT00543387|582939863|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161423744|NCT00543387|582939853|FG000|Crossover Participants|Progressive Disease|0|||
161423745|NCT00543387|582939854|FG001|Crossover Participants|Progressive Disease|0|||
161423746|NCT00543387|582939855|FG002|Crossover Participants|Progressive Disease|0|||
161423747|NCT00543387|582939856|FG003|Crossover Participants|Progressive Disease|0|||
161423748|NCT00543387|582939857|FG004|Crossover Participants|Progressive Disease|0|||
161423749|NCT00543387|582939858|FG005|Crossover Participants|Progressive Disease|0|||
161423750|NCT00543387|582939859|FG006|Crossover Participants|Progressive Disease|0|||
161423751|NCT00543387|582939860|FG007|Crossover Participants|Progressive Disease|0|||
161423752|NCT00543387|582939861|FG008|Crossover Participants|Progressive Disease|0|||
161423753|NCT00543387|582939862|FG009|Crossover Participants|Progressive Disease|1|||
161423754|NCT00543387|582939863|FG010|Crossover Participants|Progressive Disease|2|||
161423755|NCT00543387|582939853|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
161423756|NCT00543387|582939854|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
161423757|NCT00543387|582939855|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
161423758|NCT00543387|582939856|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
161423759|NCT00543387|582939857|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
161423760|NCT00543387|582939858|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
161423761|NCT00543387|582939859|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
161423762|NCT00543387|582939860|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
161423763|NCT00543387|582939861|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
161423764|NCT00543387|582939862|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
161423765|NCT00543387|582939863|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
161423766|NCT01223183|582939869|FG000|Imaging Day 1|Physician Decision|0|||
161423767|NCT01223183|582939870|FG001|Imaging Day 1|Physician Decision|1|||
161423768|NCT01223183|582939869|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
161423769|NCT01223183|582939870|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
161423770|NCT01223183|582939869|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
161423771|NCT01223183|582939870|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
161423772|NCT03772665|582939871|FG000|Overall Study|Protocol Violation|1|||
161423773|NCT03772665|582939872|FG001|Overall Study|Protocol Violation|0|||
161423774|NCT02719171|582941837|FG000|Overall Study|Adverse Event|1|||
161423775|NCT02719171|582941838|FG001|Overall Study|Adverse Event|2|||
161423776|NCT02719171|582941839|FG002|Overall Study|Adverse Event|0|||
161423777|NCT02719171|582941840|FG003|Overall Study|Adverse Event|0|||
161423778|NCT02719171|582941841|FG004|Overall Study|Adverse Event|2|||
161423779|NCT02719171|582941837|FG000|Overall Study|Lost to Follow-up|0|||
161423780|NCT02719171|582941838|FG001|Overall Study|Lost to Follow-up|0|||
161423781|NCT02719171|582941839|FG002|Overall Study|Lost to Follow-up|1|||
161423782|NCT02719171|582941840|FG003|Overall Study|Lost to Follow-up|0|||
161423783|NCT02719171|582941841|FG004|Overall Study|Lost to Follow-up|0|||
161423784|NCT02719171|582941837|FG000|Overall Study|Subject Withdrawal|0|||
161423785|NCT02719171|582941838|FG001|Overall Study|Subject Withdrawal|2|||
161423786|NCT02719171|582941839|FG002|Overall Study|Subject Withdrawal|2|||
161423787|NCT02719171|582941840|FG003|Overall Study|Subject Withdrawal|1|||
161423788|NCT02719171|582941841|FG004|Overall Study|Subject Withdrawal|0|||
161423789|NCT02719171|582941837|FG000|Overall Study|Other|0|||
161423790|NCT02719171|582941838|FG001|Overall Study|Other|0|||
161423791|NCT02719171|582941839|FG002|Overall Study|Other|0|||
161423792|NCT02719171|582941840|FG003|Overall Study|Other|1|||
161423793|NCT02719171|582941841|FG004|Overall Study|Other|0|||
161423794|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161423795|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
161423796|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161423797|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161423798|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161423799|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
161423800|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
161423801|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
161423802|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
161423803|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
161423804|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
161423805|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
161423806|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
161423807|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
161423808|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
161423809|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
161423810|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
161423811|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
161423812|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
161423813|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
161423814|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
161423815|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
161423816|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
161423817|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
161423818|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
161423819|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
161423820|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
161423821|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
161423822|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
161423823|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
161423824|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
161423825|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
161423826|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
161423827|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
161423828|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
161423829|NCT02831764|582941845|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161423830|NCT02831764|582941846|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
161423831|NCT02831764|582941847|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161423832|NCT02831764|582941848|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161423833|NCT02831764|582941849|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161423834|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161423835|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161423836|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
161423837|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
161423838|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161423839|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161423840|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161423841|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
161423842|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161423843|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161423844|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161423845|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161423846|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
161423847|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
161423848|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161423849|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161423850|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161423851|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
161423852|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161423853|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161423854|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161423855|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161423856|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
161423857|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
161423858|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161423859|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161423860|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161423861|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
161423862|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
161423863|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161423864|NCT02831764|582941845|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161423865|NCT02831764|582941846|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161423866|NCT02831764|582941847|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
161423867|NCT02831764|582941848|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
161423868|NCT02831764|582941849|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161423869|NCT02831764|582941845|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161423870|NCT02831764|582941846|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161423871|NCT02831764|582941847|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161423872|NCT02831764|582941848|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161423873|NCT02831764|582941849|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
161423874|NCT02831764|582941845|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161423875|NCT02831764|582941846|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161423876|NCT02831764|582941847|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161423877|NCT02831764|582941848|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161423878|NCT02831764|582941849|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
161423879|NCT02831764|582941845|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161423880|NCT02831764|582941846|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161423881|NCT02831764|582941847|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161423882|NCT02831764|582941848|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161423883|NCT02831764|582941849|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
161423884|NCT02831764|582941845|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161423885|NCT02831764|582941846|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161423886|NCT02831764|582941847|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161423887|NCT02831764|582941848|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161423888|NCT02831764|582941849|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
161423889|NCT02539797|582941850|FG000|Overall Study|Lost to Follow-up|0|||
161423890|NCT02539797|582941851|FG001|Overall Study|Lost to Follow-up|1|||
161423891|NCT02539797|582941852|FG002|Overall Study|Lost to Follow-up|0|||
161423892|NCT02796677|582941858|FG000|Overall Study|Adverse Event|11|||
161423893|NCT02796677|582941859|FG001|Overall Study|Adverse Event|22|||
161423894|NCT02796677|582941860|FG002|Overall Study|Adverse Event|14|||
161423895|NCT02796677|582941861|FG003|Overall Study|Adverse Event|14|||
161423896|NCT02796677|582941858|FG000|Overall Study|Protocol Violation|7|||
161423897|NCT02796677|582941859|FG001|Overall Study|Protocol Violation|5|||
161423898|NCT02796677|582941860|FG002|Overall Study|Protocol Violation|4|||
161423899|NCT02796677|582941861|FG003|Overall Study|Protocol Violation|8|||
161423900|NCT02796677|582941858|FG000|Overall Study|Lost to Follow-up|1|||
161423901|NCT02796677|582941859|FG001|Overall Study|Lost to Follow-up|5|||
161423902|NCT02796677|582941860|FG002|Overall Study|Lost to Follow-up|2|||
161423903|NCT02796677|582941861|FG003|Overall Study|Lost to Follow-up|2|||
161423904|NCT02796677|582941858|FG000|Overall Study|Lack of Efficacy|7|||
161423905|NCT02796677|582941859|FG001|Overall Study|Lack of Efficacy|9|||
161423906|NCT02796677|582941860|FG002|Overall Study|Lack of Efficacy|14|||
161423907|NCT02796677|582941861|FG003|Overall Study|Lack of Efficacy|20|||
161423908|NCT02796677|582941858|FG000|Overall Study|Withdrawal by Subject|4|||
161423909|NCT02796677|582941859|FG001|Overall Study|Withdrawal by Subject|14|||
161423910|NCT02796677|582941860|FG002|Overall Study|Withdrawal by Subject|6|||
161423911|NCT02796677|582941861|FG003|Overall Study|Withdrawal by Subject|7|||
161423912|NCT02796677|582941858|FG000|Overall Study|Progressive disease|6|||
161423913|NCT02796677|582941859|FG001|Overall Study|Progressive disease|15|||
161423914|NCT02796677|582941860|FG002|Overall Study|Progressive disease|13|||
161423915|NCT02796677|582941861|FG003|Overall Study|Progressive disease|18|||
161423916|NCT02796677|582941858|FG000|Overall Study|Reason not mentioned|2|||
161423917|NCT02796677|582941859|FG001|Overall Study|Reason not mentioned|3|||
161423918|NCT02796677|582941860|FG002|Overall Study|Reason not mentioned|0|||
161423919|NCT02796677|582941861|FG003|Overall Study|Reason not mentioned|5|||
161423920|NCT00961181|582941862|FG000|Overall Study|Death|2|||
161423921|NCT00961181|582941862|FG000|Overall Study|Withdrawal by Subject|2|||
161423922|NCT00961181|582941862|FG000|Overall Study|Lost to Follow-up|1|||
161423923|NCT01777308|582941865|FG000|Overall Study|Withdrawal by Subject|5|||
161423924|NCT01777308|582941866|FG001|Overall Study|Withdrawal by Subject|1|||
161423925|NCT01777308|582941865|FG000|Overall Study|Migrated/moved from study area|1|||
161423926|NCT01777308|582941866|FG001|Overall Study|Migrated/moved from study area|0|||
161423927|NCT01777308|582941865|FG000|Overall Study|Lost to Follow-up|7|||
161423928|NCT01777308|582941866|FG001|Overall Study|Lost to Follow-up|2|||
161423929|NCT01777308|582941865|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
161423930|NCT01777308|582941866|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
161423931|NCT03212326|582941868|FG000|Overall Study|Physician Decision|4|||
161423932|NCT01517750|582941880|FG000|Overall Study|Lost to Follow-up|1|||
161423933|NCT01517750|582941881|FG001|Overall Study|Lost to Follow-up|2|||
161423934|NCT01517750|582941882|FG002|Overall Study|Lost to Follow-up|4|||
161423935|NCT01517750|582941883|FG003|Overall Study|Lost to Follow-up|1|||
161423936|NCT01855412|582941884|FG000|Overall Study|Death|77|||
161423937|NCT01855412|582941885|FG001|Overall Study|Death|123|||
161423938|NCT01855412|582941886|FG002|Overall Study|Death|30|||
161423939|NCT01855412|582941884|FG000|Overall Study|Lost to Follow-up|28|||
161423940|NCT01855412|582941885|FG001|Overall Study|Lost to Follow-up|46|||
161423941|NCT01855412|582941886|FG002|Overall Study|Lost to Follow-up|15|||
161423942|NCT01855412|582941884|FG000|Overall Study|Withdrawal by Subject|77|||
161423943|NCT01855412|582941885|FG001|Overall Study|Withdrawal by Subject|123|||
161423944|NCT01855412|582941886|FG002|Overall Study|Withdrawal by Subject|24|||
161423945|NCT01855412|582941884|FG000|Overall Study|Physician Decision|25|||
161423946|NCT01855412|582941885|FG001|Overall Study|Physician Decision|31|||
161423947|NCT01855412|582941886|FG002|Overall Study|Physician Decision|3|||
161423948|NCT01855412|582941884|FG000|Overall Study|Site Closure|4|||
161423949|NCT01855412|582941885|FG001|Overall Study|Site Closure|18|||
161423950|NCT01855412|582941886|FG002|Overall Study|Site Closure|1|||
161423951|NCT01855412|582941884|FG000|Overall Study|Reason not Specified|1|||
161423952|NCT01855412|582941885|FG001|Overall Study|Reason not Specified|2|||
161423953|NCT01855412|582941886|FG002|Overall Study|Reason not Specified|3|||
161423954|NCT03347123|582941890|FG000|Overall Study|Death|1|||
161423955|NCT03347123|582941891|FG001|Overall Study|Death|2|||
161423956|NCT03347123|582941892|FG002|Overall Study|Death|0|||
161423957|NCT03347123|582941893|FG003|Overall Study|Death|0|||
161423958|NCT03347123|582941894|FG004|Overall Study|Death|0|||
161423959|NCT03347123|582941895|FG005|Overall Study|Death|0|||
161423960|NCT03347123|582941896|FG006|Overall Study|Death|0|||
161423961|NCT03347123|582941890|FG000|Overall Study|Withdrawal by Subject|1|||
161423962|NCT03347123|582941891|FG001|Overall Study|Withdrawal by Subject|0|||
161423963|NCT03347123|582941892|FG002|Overall Study|Withdrawal by Subject|0|||
161423964|NCT03347123|582941893|FG003|Overall Study|Withdrawal by Subject|0|||
161423965|NCT03347123|582941894|FG004|Overall Study|Withdrawal by Subject|0|||
161423966|NCT03347123|582941895|FG005|Overall Study|Withdrawal by Subject|0|||
161423967|NCT03347123|582941896|FG006|Overall Study|Withdrawal by Subject|0|||
161423968|NCT03347123|582941890|FG000|Overall Study|Reason not Specified|3|||
161423969|NCT03347123|582941891|FG001|Overall Study|Reason not Specified|4|||
161423970|NCT03347123|582941892|FG002|Overall Study|Reason not Specified|0|||
161423971|NCT03347123|582941893|FG003|Overall Study|Reason not Specified|0|||
161423972|NCT03347123|582941894|FG004|Overall Study|Reason not Specified|0|||
161423973|NCT03347123|582941895|FG005|Overall Study|Reason not Specified|0|||
161423974|NCT03347123|582941896|FG006|Overall Study|Reason not Specified|0|||
161423975|NCT01276639|582941901|FG000|Week 0 to 16|Death|1|||
161423976|NCT01276639|582941902|FG001|Week 0 to 16|Death|0|||
161423977|NCT01276639|582941903|FG002|Week 0 to 16|Death|0|||
161423978|NCT01276639|582941904|FG003|Week 0 to 16|Death|0|||
161423979|NCT01276639|582941905|FG004|Week 0 to 16|Death|0|||
161423980|NCT01276639|582941901|FG000|Week 0 to 16|Adverse Event|11|||
161423981|NCT01276639|582941902|FG001|Week 0 to 16|Adverse Event|8|||
161423982|NCT01276639|582941903|FG002|Week 0 to 16|Adverse Event|11|||
161423983|NCT01276639|582941904|FG003|Week 0 to 16|Adverse Event|0|||
161423984|NCT01276639|582941905|FG004|Week 0 to 16|Adverse Event|0|||
161423985|NCT01276639|582941901|FG000|Week 0 to 16|Lack of Efficacy|20|||
161423986|NCT01276639|582941902|FG001|Week 0 to 16|Lack of Efficacy|15|||
161423987|NCT01276639|582941903|FG002|Week 0 to 16|Lack of Efficacy|25|||
161423988|NCT01276639|582941904|FG003|Week 0 to 16|Lack of Efficacy|0|||
161423989|NCT01276639|582941905|FG004|Week 0 to 16|Lack of Efficacy|0|||
161423990|NCT01276639|582941901|FG000|Week 0 to 16|Lost to Follow-up|3|||
161423991|NCT01276639|582941902|FG001|Week 0 to 16|Lost to Follow-up|5|||
161423992|NCT01276639|582941903|FG002|Week 0 to 16|Lost to Follow-up|3|||
161423993|NCT01276639|582941904|FG003|Week 0 to 16|Lost to Follow-up|0|||
161423994|NCT01276639|582941905|FG004|Week 0 to 16|Lost to Follow-up|0|||
161423995|NCT01276639|582941901|FG000|Week 0 to 16|Withdrawal by Subject|8|||
161423996|NCT01276639|582941902|FG001|Week 0 to 16|Withdrawal by Subject|5|||
161423997|NCT01276639|582941903|FG002|Week 0 to 16|Withdrawal by Subject|4|||
161423998|NCT01276639|582941904|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161423999|NCT01276639|582941905|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161424000|NCT01276639|582941901|FG000|Week 0 to 16|Other|7|||
161424001|NCT01276639|582941902|FG001|Week 0 to 16|Other|7|||
161424002|NCT01276639|582941903|FG002|Week 0 to 16|Other|2|||
161424003|NCT01276639|582941904|FG003|Week 0 to 16|Other|0|||
161424004|NCT01276639|582941905|FG004|Week 0 to 16|Other|0|||
161424005|NCT01276639|582941901|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
161424006|NCT01276639|582941902|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
161424007|NCT01276639|582941903|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
161424008|NCT01276639|582941904|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
161424009|NCT01276639|582941905|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
161424010|NCT01276639|582941901|FG000|Week 16 to 52|Death|1|||
161424011|NCT01276639|582941902|FG001|Week 16 to 52|Death|0|||
161424012|NCT01276639|582941903|FG002|Week 16 to 52|Death|0|||
161424013|NCT01276639|582941904|FG003|Week 16 to 52|Death|0|||
161424014|NCT01276639|582941905|FG004|Week 16 to 52|Death|0|||
161424015|NCT01276639|582941901|FG000|Week 16 to 52|Adverse Event|10|||
161424016|NCT01276639|582941902|FG001|Week 16 to 52|Adverse Event|13|||
161424017|NCT01276639|582941903|FG002|Week 16 to 52|Adverse Event|0|||
161424018|NCT01276639|582941904|FG003|Week 16 to 52|Adverse Event|1|||
161424019|NCT01276639|582941905|FG004|Week 16 to 52|Adverse Event|3|||
161424020|NCT01276639|582941901|FG000|Week 16 to 52|Lack of Efficacy|99|||
161424021|NCT01276639|582941902|FG001|Week 16 to 52|Lack of Efficacy|71|||
161424022|NCT01276639|582941903|FG002|Week 16 to 52|Lack of Efficacy|0|||
161424023|NCT01276639|582941904|FG003|Week 16 to 52|Lack of Efficacy|14|||
161424024|NCT01276639|582941905|FG004|Week 16 to 52|Lack of Efficacy|13|||
161424025|NCT01276639|582941901|FG000|Week 16 to 52|Lost to Follow-up|3|||
161424026|NCT01276639|582941902|FG001|Week 16 to 52|Lost to Follow-up|1|||
161424027|NCT01276639|582941903|FG002|Week 16 to 52|Lost to Follow-up|0|||
161424028|NCT01276639|582941904|FG003|Week 16 to 52|Lost to Follow-up|0|||
161424029|NCT01276639|582941905|FG004|Week 16 to 52|Lost to Follow-up|1|||
161424030|NCT01276639|582941901|FG000|Week 16 to 52|Withdrawal by Subject|4|||
161424031|NCT01276639|582941902|FG001|Week 16 to 52|Withdrawal by Subject|4|||
161424032|NCT01276639|582941903|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161424033|NCT01276639|582941904|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161424034|NCT01276639|582941905|FG004|Week 16 to 52|Withdrawal by Subject|1|||
161424035|NCT01276639|582941901|FG000|Week 16 to 52|Other|10|||
161424036|NCT01276639|582941902|FG001|Week 16 to 52|Other|12|||
161424037|NCT01276639|582941903|FG002|Week 16 to 52|Other|0|||
161424038|NCT01276639|582941904|FG003|Week 16 to 52|Other|1|||
161424039|NCT01276639|582941905|FG004|Week 16 to 52|Other|3|||
161424040|NCT01132807|582941910|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
161424041|NCT01132807|582941911|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
161424042|NCT01132807|582941912|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
161424043|NCT01132807|582941910|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
161424044|NCT01132807|582941911|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
161424045|NCT01132807|582941912|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
161424046|NCT01380769|582941913|FG000|Overall Study|Withdrawal by Subject|7|||
161424047|NCT01380769|582941914|FG001|Overall Study|Withdrawal by Subject|11|||
161424048|NCT01380769|582941913|FG000|Overall Study|Physician Decision|1|||
161424049|NCT01380769|582941914|FG001|Overall Study|Physician Decision|1|||
161424050|NCT01380769|582941913|FG000|Overall Study|Adverse Event|1|||
161424051|NCT01380769|582941914|FG001|Overall Study|Adverse Event|1|||
161424052|NCT01380769|582941913|FG000|Overall Study|Protocol Violation|0|||
161424053|NCT01380769|582941914|FG001|Overall Study|Protocol Violation|1|||
161424054|NCT03654690|582941916|FG000|Overall Study|Withdrawal by Subject|1|||
161424055|NCT03654690|582941917|FG001|Overall Study|Withdrawal by Subject|0|||
161424056|NCT03654690|582941918|FG002|Overall Study|Withdrawal by Subject|0|||
161424057|NCT00742183|582941921|FG000|Overall Study|Adverse Event|2|||
161424058|NCT00742183|582941922|FG001|Overall Study|Adverse Event|2|||
161424059|NCT00742183|582941921|FG000|Overall Study|Death|1|||
161424060|NCT00742183|582941922|FG001|Overall Study|Death|0|||
161424061|NCT00742183|582941921|FG000|Overall Study|Physician Decision|0|||
161424062|NCT00742183|582941922|FG001|Overall Study|Physician Decision|2|||
161424063|NCT00742183|582941921|FG000|Overall Study|Lost to Follow-up|4|||
161424064|NCT00742183|582941922|FG001|Overall Study|Lost to Follow-up|4|||
161424065|NCT00742183|582941921|FG000|Overall Study|Required skin-graft|1|||
161424066|NCT00742183|582941922|FG001|Overall Study|Required skin-graft|1|||
161424067|NCT00742183|582941921|FG000|Overall Study|Withdrawal by Subject|1|||
161424068|NCT00742183|582941922|FG001|Overall Study|Withdrawal by Subject|0|||
161424069|NCT00742183|582941921|FG000|Overall Study|Lack of Efficacy|0|||
161424070|NCT00742183|582941922|FG001|Overall Study|Lack of Efficacy|3|||
161424071|NCT01176058|582941934|FG000|Overall Study|Adverse Event|1|||
161424072|NCT01176058|582941935|FG001|Overall Study|Adverse Event|0|||
161424073|NCT01176058|582941934|FG000|Overall Study|Insufficient clinical response|2|||
161424074|NCT01176058|582941935|FG001|Overall Study|Insufficient clinical response|2|||
161424075|NCT01176058|582941934|FG000|Overall Study|Insufficient mycological response|0|||
161424076|NCT01176058|582941935|FG001|Overall Study|Insufficient mycological response|1|||
161424077|NCT01176058|582941934|FG000|Overall Study|Withdrawal by Subject|1|||
161424078|NCT01176058|582941935|FG001|Overall Study|Withdrawal by Subject|0|||
161424079|NCT00256724|582941938|FG000|Overall Study|Physician Decision|2|||
161424080|NCT00256724|582941939|FG001|Overall Study|Physician Decision|5|||
161424081|NCT00256724|582941938|FG000|Overall Study|Protocol Violation|3|||
161424082|NCT00256724|582941939|FG001|Overall Study|Protocol Violation|3|||
161424083|NCT01217463|582941940|FG000|Overall Study|Adverse Event|8|||
161424084|NCT01217463|582941941|FG001|Overall Study|Adverse Event|5|||
161424085|NCT01217463|582941940|FG000|Overall Study|Physician Decision|0|||
161424086|NCT01217463|582941941|FG001|Overall Study|Physician Decision|1|||
161424087|NCT01217463|582941940|FG000|Overall Study|Withdrawal by Subject|3|||
161424088|NCT01217463|582941941|FG001|Overall Study|Withdrawal by Subject|0|||
161424089|NCT01217463|582941940|FG000|Overall Study|Surgery on the Target Limb|0|||
161424090|NCT01217463|582941941|FG001|Overall Study|Surgery on the Target Limb|1|||
161424091|NCT01217463|582941940|FG000|Overall Study|Patient Non-compliant|1|||
161424092|NCT01217463|582941941|FG001|Overall Study|Patient Non-compliant|0|||
161424093|NCT01217463|582941940|FG000|Overall Study|Other|1|||
161424094|NCT01217463|582941941|FG001|Overall Study|Other|1|||
161424095|NCT01569841|582941942|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
161424096|NCT01569841|582941943|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
161424097|NCT05114473|582941946|FG000|Overall Study|Lost to Follow-up|2|||
161424098|NCT05114473|582941947|FG001|Overall Study|Lost to Follow-up|2|||
161424099|NCT05114473|582941948|FG002|Overall Study|Lost to Follow-up|0|||
161424100|NCT00782717|582941950|FG000|Overall Study|Adverse Event|2|||
161424101|NCT00782717|582941951|FG001|Overall Study|Adverse Event|5|||
161424102|NCT00782717|582941950|FG000|Overall Study|Patient decision unrelated to AE|6|||
161424103|NCT00782717|582941951|FG001|Overall Study|Patient decision unrelated to AE|3|||
161424104|NCT00782717|582941950|FG000|Overall Study|Noncompliance|2|||
161424105|NCT00782717|582941951|FG001|Overall Study|Noncompliance|1|||
161424106|NCT00782717|582941950|FG000|Overall Study|Treatment failure|3|||
161424107|NCT00782717|582941951|FG001|Overall Study|Treatment failure|14|||
161424108|NCT00782717|582941950|FG000|Overall Study|Enrollment close prior to surgery|1|||
161424109|NCT00782717|582941951|FG001|Overall Study|Enrollment close prior to surgery|0|||
161424110|NCT00782717|582941950|FG000|Overall Study|Did not meet entrance criteria|1|||
161424111|NCT00782717|582941951|FG001|Overall Study|Did not meet entrance criteria|3|||
161424112|NCT00782717|582941950|FG000|Overall Study|Exited in error|0|||
161424113|NCT00782717|582941951|FG001|Overall Study|Exited in error|2|||
161424114|NCT02446717|582941952|FG000|Overall Study|Adverse Event|0|||
161424115|NCT02446717|582941953|FG001|Overall Study|Adverse Event|0|||
161424116|NCT02446717|582941954|FG002|Overall Study|Adverse Event|1|||
161424117|NCT02446717|582941955|FG003|Overall Study|Adverse Event|0|||
161424118|NCT02446717|582941956|FG004|Overall Study|Adverse Event|0|||
161424119|NCT02446717|582941952|FG000|Overall Study|Lost to Follow-up|0|||
161424120|NCT02446717|582941953|FG001|Overall Study|Lost to Follow-up|1|||
161424121|NCT02446717|582941954|FG002|Overall Study|Lost to Follow-up|1|||
161424122|NCT02446717|582941955|FG003|Overall Study|Lost to Follow-up|0|||
161424123|NCT02446717|582941956|FG004|Overall Study|Lost to Follow-up|1|||
161424124|NCT02446717|582941952|FG000|Overall Study|Withdrew consent|0|||
161424125|NCT02446717|582941953|FG001|Overall Study|Withdrew consent|0|||
161424126|NCT02446717|582941954|FG002|Overall Study|Withdrew consent|0|||
161424127|NCT02446717|582941955|FG003|Overall Study|Withdrew consent|1|||
161424128|NCT02446717|582941956|FG004|Overall Study|Withdrew consent|0|||
161424129|NCT00650767|582941965|FG000|Overall Study|Adverse Event|0|||
161424130|NCT00650767|582941966|FG001|Overall Study|Adverse Event|3|||
161424131|NCT00650767|582941967|FG002|Overall Study|Adverse Event|10|||
161424132|NCT00650767|582941968|FG003|Overall Study|Adverse Event|8|||
161424133|NCT00650767|582941965|FG000|Overall Study|Death|1|||
161424134|NCT00650767|582941966|FG001|Overall Study|Death|0|||
161424135|NCT00650767|582941967|FG002|Overall Study|Death|0|||
161424136|NCT00650767|582941968|FG003|Overall Study|Death|0|||
161424137|NCT00650767|582941965|FG000|Overall Study|Withdrawal by Subject|2|||
161424138|NCT00650767|582941966|FG001|Overall Study|Withdrawal by Subject|4|||
161424139|NCT00650767|582941967|FG002|Overall Study|Withdrawal by Subject|3|||
161424140|NCT00650767|582941968|FG003|Overall Study|Withdrawal by Subject|3|||
161424141|NCT00650767|582941965|FG000|Overall Study|Lost to Follow-up|1|||
161424142|NCT00650767|582941966|FG001|Overall Study|Lost to Follow-up|1|||
161424143|NCT00650767|582941967|FG002|Overall Study|Lost to Follow-up|1|||
161424144|NCT00650767|582941968|FG003|Overall Study|Lost to Follow-up|0|||
161424145|NCT00650767|582941965|FG000|Overall Study|Other|1|||
161424146|NCT00650767|582941966|FG001|Overall Study|Other|1|||
161424147|NCT00650767|582941967|FG002|Overall Study|Other|0|||
161424148|NCT00650767|582941968|FG003|Overall Study|Other|0|||
161424149|NCT03649074|582941969|FG000|Overall Study|Lost to Follow-up|2|||
161424150|NCT03649074|582941970|FG001|Overall Study|Lost to Follow-up|1|||
161424151|NCT03649074|582941969|FG000|Overall Study|Adverse Event|1|||
161424152|NCT03649074|582941970|FG001|Overall Study|Adverse Event|0|||
161424153|NCT03649074|582941969|FG000|Overall Study|Physician Decision|1|||
161424154|NCT03649074|582941970|FG001|Overall Study|Physician Decision|0|||
161424155|NCT03649074|582941969|FG000|Overall Study|Withdrawal by Subject|0|||
161424156|NCT03649074|582941970|FG001|Overall Study|Withdrawal by Subject|2|||
161424157|NCT03649074|582941969|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161424158|NCT03649074|582941970|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
161424159|NCT03649074|582941969|FG000|Overall Study|Other|1|||
161424160|NCT03649074|582941970|FG001|Overall Study|Other|0|||
161424161|NCT03775486|582941971|FG000|Initial Therapy Phase|Other reason provided|0|||
161424162|NCT03775486|582941972|FG001|Initial Therapy Phase|Other reason provided|15|||
161424163|NCT03775486|582941971|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
161424164|NCT03775486|582941972|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
161424165|NCT03775486|582941971|FG000|Initial Therapy Phase|Protocol Violation|0|||
161424166|NCT03775486|582941972|FG001|Initial Therapy Phase|Protocol Violation|2|||
161424167|NCT03775486|582941971|FG000|Initial Therapy Phase|Adverse Event|0|||
161424168|NCT03775486|582941972|FG001|Initial Therapy Phase|Adverse Event|34|||
161424169|NCT03775486|582941971|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
161424170|NCT03775486|582941972|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
161424171|NCT03775486|582941971|FG000|Maintenance Phase|Withdrawal by Subject|13|||
161424172|NCT03775486|582941972|FG001|Maintenance Phase|Withdrawal by Subject|12|||
161424173|NCT03775486|582941971|FG000|Maintenance Phase|Death|44|||
161424174|NCT03775486|582941972|FG001|Maintenance Phase|Death|45|||
161424175|NCT00801216|582941973|FG000|Overall Study|Screening Failure|2|||
161424176|NCT05214768|582941974|FG000|Induction Period|Withdrawal by Subject|1|||
161424177|NCT05214768|582941975|FG001|Induction Period|Withdrawal by Subject|0|||
161424178|NCT05214768|582941976|FG002|Induction Period|Withdrawal by Subject|0|||
161424179|NCT05214768|582941977|FG003|Induction Period|Withdrawal by Subject|0|||
161424180|NCT05214768|582941978|FG004|Induction Period|Withdrawal by Subject|0|||
161424181|NCT05214768|582941979|FG005|Induction Period|Withdrawal by Subject|0|||
161424182|NCT05214768|582941974|FG000|Induction Period|Physician Decision|1|||
161424183|NCT05214768|582941975|FG001|Induction Period|Physician Decision|0|||
161424184|NCT05214768|582941976|FG002|Induction Period|Physician Decision|0|||
161424185|NCT05214768|582941977|FG003|Induction Period|Physician Decision|0|||
161424186|NCT05214768|582941978|FG004|Induction Period|Physician Decision|0|||
161424187|NCT05214768|582941979|FG005|Induction Period|Physician Decision|0|||
161424188|NCT05214768|582941974|FG000|Maintenance Period|Other Reasons|0|||
161424189|NCT05214768|582941975|FG001|Maintenance Period|Other Reasons|0|||
161424190|NCT05214768|582941976|FG002|Maintenance Period|Other Reasons|1|||
161424191|NCT05214768|582941977|FG003|Maintenance Period|Other Reasons|1|||
161424192|NCT05214768|582941978|FG004|Maintenance Period|Other Reasons|0|||
161424193|NCT05214768|582941979|FG005|Maintenance Period|Other Reasons|0|||
161424194|NCT05214768|582941974|FG000|Maintenance Period|Withdrawal by Subject|0|||
161424195|NCT05214768|582941975|FG001|Maintenance Period|Withdrawal by Subject|0|||
161424196|NCT05214768|582941976|FG002|Maintenance Period|Withdrawal by Subject|0|||
161424197|NCT05214768|582941977|FG003|Maintenance Period|Withdrawal by Subject|1|||
161424198|NCT05214768|582941978|FG004|Maintenance Period|Withdrawal by Subject|0|||
161424199|NCT05214768|582941979|FG005|Maintenance Period|Withdrawal by Subject|0|||
161424200|NCT05214768|582941974|FG000|Maintenance Period|Lack of Efficacy|0|||
161424201|NCT05214768|582941975|FG001|Maintenance Period|Lack of Efficacy|0|||
161424202|NCT05214768|582941976|FG002|Maintenance Period|Lack of Efficacy|1|||
161424203|NCT05214768|582941977|FG003|Maintenance Period|Lack of Efficacy|0|||
161424204|NCT05214768|582941978|FG004|Maintenance Period|Lack of Efficacy|1|||
161424205|NCT05214768|582941979|FG005|Maintenance Period|Lack of Efficacy|0|||
161424206|NCT05214768|582941974|FG000|Open Label Extension Period|Physician Decision|0|||
161424207|NCT05214768|582941975|FG001|Open Label Extension Period|Physician Decision|0|||
161424208|NCT05214768|582941976|FG002|Open Label Extension Period|Physician Decision|0|||
161424209|NCT05214768|582941977|FG003|Open Label Extension Period|Physician Decision|0|||
161424210|NCT05214768|582941978|FG004|Open Label Extension Period|Physician Decision|0|||
161424211|NCT05214768|582941979|FG005|Open Label Extension Period|Physician Decision|1|||
161424212|NCT05214768|582941974|FG000|Open Label Extension Period|Lack of Efficacy|0|||
161424213|NCT05214768|582941975|FG001|Open Label Extension Period|Lack of Efficacy|0|||
161424214|NCT05214768|582941976|FG002|Open Label Extension Period|Lack of Efficacy|0|||
161424215|NCT05214768|582941977|FG003|Open Label Extension Period|Lack of Efficacy|0|||
161424216|NCT05214768|582941978|FG004|Open Label Extension Period|Lack of Efficacy|0|||
161424217|NCT05214768|582941979|FG005|Open Label Extension Period|Lack of Efficacy|1|||
161424218|NCT05214768|582941974|FG000|Open Label Extension Period|Ongoing Study|0|||
161424219|NCT05214768|582941975|FG001|Open Label Extension Period|Ongoing Study|0|||
161424220|NCT05214768|582941976|FG002|Open Label Extension Period|Ongoing Study|0|||
161424221|NCT05214768|582941977|FG003|Open Label Extension Period|Ongoing Study|0|||
161424222|NCT05214768|582941978|FG004|Open Label Extension Period|Ongoing Study|0|||
161424223|NCT05214768|582941979|FG005|Open Label Extension Period|Ongoing Study|42|||
161424224|NCT05481359|582941980|FG000|Overall Study|Lost to Follow-up|3|||
161424225|NCT05481359|582941980|FG000|Overall Study|Withdrawal by Subject|1|||
161424226|NCT00291486|582941986|FG000|Overall Study|Adverse Event|0|||
161424227|NCT00291486|582941987|FG001|Overall Study|Adverse Event|3|||
161424228|NCT00291486|582941988|FG002|Overall Study|Adverse Event|0|||
161424229|NCT00291486|582941989|FG003|Overall Study|Adverse Event|1|||
161424230|NCT00291486|582941990|FG004|Overall Study|Adverse Event|0|||
161424231|NCT00291486|582941986|FG000|Overall Study|Withdrawal by Subject|0|||
161424232|NCT00291486|582941987|FG001|Overall Study|Withdrawal by Subject|0|||
161424233|NCT00291486|582941988|FG002|Overall Study|Withdrawal by Subject|0|||
161424234|NCT00291486|582941989|FG003|Overall Study|Withdrawal by Subject|0|||
161424235|NCT00291486|582941990|FG004|Overall Study|Withdrawal by Subject|1|||
161424236|NCT00291486|582941986|FG000|Overall Study|Disease progression|1|||
161424237|NCT00291486|582941987|FG001|Overall Study|Disease progression|0|||
161424238|NCT00291486|582941988|FG002|Overall Study|Disease progression|1|||
161424239|NCT00291486|582941989|FG003|Overall Study|Disease progression|0|||
161424240|NCT00291486|582941990|FG004|Overall Study|Disease progression|0|||
161424241|NCT01232868|582943069|FG000|Overall Study|Lost to Follow-up|2|||
161424242|NCT01232868|582943070|FG001|Overall Study|Lost to Follow-up|4|||
161424243|NCT04481243|582943071|FG000|Overall Study|Withdrawal by Subject|4|||
161424244|NCT01131507|582943074|FG000|Overall Study|Adverse Event|1|||
161424245|NCT01131507|582943074|FG000|Overall Study|Lost to Follow-up|1|||
161424246|NCT01131507|582943074|FG000|Overall Study|Withdrawal by Subject|1|||
161424247|NCT00346216|582943078|FG000|Overall Study|Other|181|||
161424248|NCT00346216|582943079|FG001|Overall Study|Other|231|||
161424249|NCT00346216|582943080|FG002|Overall Study|Other|205|||
161424250|NCT00346216|582943078|FG000|Overall Study|No longer willing to participate|600|||
161424251|NCT00346216|582943079|FG001|Overall Study|No longer willing to participate|606|||
161424252|NCT00346216|582943080|FG002|Overall Study|No longer willing to participate|585|||
161424253|NCT00346216|582943078|FG000|Overall Study|Withdrawal by Subject|661|||
161424254|NCT00346216|582943079|FG001|Overall Study|Withdrawal by Subject|692|||
161424255|NCT00346216|582943080|FG002|Overall Study|Withdrawal by Subject|651|||
161424256|NCT00346216|582943078|FG000|Overall Study|Lost to Follow-up|611|||
161424257|NCT00346216|582943079|FG001|Overall Study|Lost to Follow-up|588|||
161424258|NCT00346216|582943080|FG002|Overall Study|Lost to Follow-up|542|||
161424259|NCT00346216|582943078|FG000|Overall Study|Physician Decision|80|||
161424260|NCT00346216|582943079|FG001|Overall Study|Physician Decision|76|||
161424261|NCT00346216|582943080|FG002|Overall Study|Physician Decision|59|||
161424262|NCT00346216|582943078|FG000|Overall Study|Does not meet entrance criteria|13|||
161424263|NCT00346216|582943079|FG001|Overall Study|Does not meet entrance criteria|10|||
161424264|NCT00346216|582943080|FG002|Overall Study|Does not meet entrance criteria|8|||
161424265|NCT00346216|582943078|FG000|Overall Study|Death|189|||
161424266|NCT00346216|582943079|FG001|Overall Study|Death|192|||
161424267|NCT00346216|582943080|FG002|Overall Study|Death|228|||
161424268|NCT00346216|582943078|FG000|Overall Study|Study terminated by sponsor|11|||
161424269|NCT00346216|582943079|FG001|Overall Study|Study terminated by sponsor|4|||
161424270|NCT00346216|582943080|FG002|Overall Study|Study terminated by sponsor|8|||
161424271|NCT00346216|582943078|FG000|Overall Study|Missing Subject Summary Status|62|||
161424272|NCT00346216|582943079|FG001|Overall Study|Missing Subject Summary Status|61|||
161424273|NCT00346216|582943080|FG002|Overall Study|Missing Subject Summary Status|62|||
161424274|NCT03431441|582943081|FG000|Overall Study|Withdrawal by Subject|2|||
161424275|NCT03431441|582943081|FG000|Overall Study|Adverse Event|2|||
161424276|NCT03431441|582943081|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
161424277|NCT05030350|582943085|FG000|Overall Study|Adverse Event|13|||
161424278|NCT05030350|582943085|FG000|Overall Study|Lack of Efficacy|8|||
161424279|NCT05030350|582943085|FG000|Overall Study|Lost to Follow-up|35|||
161424280|NCT05030350|582943085|FG000|Overall Study|Pregnancy|2|||
161424281|NCT05030350|582943085|FG000|Overall Study|Protocol Violation|2|||
161424282|NCT05030350|582943085|FG000|Overall Study|Withdrawal by Subject|60|||
161424283|NCT05030350|582943085|FG000|Overall Study|Study terminated by sponsor|349|||
161424284|NCT05030350|582943085|FG000|Overall Study|Positive Drug Screen|4|||
161424285|NCT05030350|582943085|FG000|Overall Study|Other|8|||
161424286|NCT03985761|582943089|FG000|Overall Study|Withdrawal by Subject|2|||
161424287|NCT03985761|582943090|FG001|Overall Study|Withdrawal by Subject|3|||
161424288|NCT01858363|582943096|FG000|Overall Study|Death|35|||
161424289|NCT01858363|582943097|FG001|Overall Study|Death|9|||
161424290|NCT01858363|582943096|FG000|Overall Study|Withdrawal by Subject|28|||
161424291|NCT01858363|582943097|FG001|Overall Study|Withdrawal by Subject|14|||
161424292|NCT01858363|582943096|FG000|Overall Study|Lost to Follow-up|13|||
161424293|NCT01858363|582943097|FG001|Overall Study|Lost to Follow-up|3|||
161424294|NCT01859923|582943103|FG000|Overall Study|Adverse Event|0|||
161424295|NCT01859923|582943104|FG001|Overall Study|Adverse Event|0|||
161424296|NCT01859923|582943105|FG002|Overall Study|Adverse Event|1|||
161424297|NCT01859923|582943106|FG003|Overall Study|Adverse Event|1|||
161424298|NCT00764361|582943112|FG000|Overall Study|Withdrawal by Subject|2|||
161424299|NCT00764361|582943113|FG001|Overall Study|Withdrawal by Subject|3|||
161424300|NCT00764361|582943112|FG000|Overall Study|Adverse Event|0|||
161424301|NCT00764361|582943113|FG001|Overall Study|Adverse Event|1|||
161424302|NCT02090426|582943114|FG000|Overall Study|Lost to Follow-up|12|||
161424303|NCT02090426|582943115|FG001|Overall Study|Lost to Follow-up|6|||
161424304|NCT01141712|582943119|FG000|Overall Study|Disease progression|3|||
161424305|NCT01308736|582943126|FG000|Overall Study|Did not attend a single session|6|||
161424306|NCT01308736|582943127|FG001|Overall Study|Did not attend a single session|5|||
161424307|NCT03634085|582943128|FG000|Overall Study|Adverse Event|1|||
161424308|NCT03634085|582943129|FG001|Overall Study|Adverse Event|0|||
161424309|NCT03634085|582943128|FG000|Overall Study|Withdrawal by Subject|0|||
161424310|NCT03634085|582943129|FG001|Overall Study|Withdrawal by Subject|2|||
161424311|NCT01054456|582943136|FG000|Overall Study|Other|1|||
161424312|NCT04701333|582943137|FG000|Overall Study|Lost to Follow-up|3|||
161424313|NCT04701333|582943138|FG001|Overall Study|Lost to Follow-up|7|||
161424314|NCT04701333|582943137|FG000|Overall Study|Withdrawal by Subject|0|||
161424315|NCT04701333|582943138|FG001|Overall Study|Withdrawal by Subject|1|||
161424316|NCT01012258|582943139|FG000|Overall Study|Death|14|||
161424317|NCT01012258|582943139|FG000|Overall Study|Lost to Follow-up|1|||
161424318|NCT01012258|582943139|FG000|Overall Study|Adverse Event|1|||
161424319|NCT01012258|582943139|FG000|Overall Study|Progressive Disease (PD)|18|||
161424320|NCT01012258|582943139|FG000|Overall Study|Symptomatic Deterioration|1|||
161424321|NCT01012258|582943139|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
161424322|NCT01012258|582943139|FG000|Overall Study|Another Tumor Discovered|1|||
161424323|NCT01012258|582943139|FG000|Overall Study|Ongoing|29|||
161424324|NCT01292187|582943140|FG000|Overall Study|Adverse Event|10|||
161424325|NCT01292187|582943141|FG001|Overall Study|Adverse Event|5|||
161424326|NCT01292187|582943140|FG000|Overall Study|Withdrawal by Subject|6|||
161424327|NCT01292187|582943141|FG001|Overall Study|Withdrawal by Subject|5|||
161424328|NCT01292187|582943140|FG000|Overall Study|All other reasons|1|||
161424329|NCT01292187|582943141|FG001|Overall Study|All other reasons|3|||
161424330|NCT01814527|582943143|FG000|Overall Study|RTP greater than 30 days|6|||
161424331|NCT01814527|582943144|FG001|Overall Study|RTP greater than 30 days|1|||
161424332|NCT00687401|582943145|FG000|Overall Study|Protocol Violation|7|||
161424333|NCT00687401|582943145|FG000|Overall Study|Adverse Event|6|||
161424334|NCT00687401|582943145|FG000|Overall Study|Lack of Efficacy|6|||
161424335|NCT00687401|582943145|FG000|Overall Study|Withdrawal by Subject|4|||
161424336|NCT00687401|582943145|FG000|Overall Study|Did not return for visit|3|||
161424337|NCT00687401|582943145|FG000|Overall Study|For reasons different from those above|4|||
161424338|NCT02366195|582943146|FG000|Overall Study|Protocol-specified criteria|3|||
161424339|NCT02366195|582943146|FG000|Overall Study|Withdrawal by Subject|9|||
161424340|NCT02366195|582943146|FG000|Overall Study|Lost to Follow-up|1|||
161424341|NCT02366195|582943146|FG000|Overall Study|Death|41|||
161424342|NCT00113841|582943147|FG000|Overall Study|Disease progression|0|||
161424343|NCT00113841|582943148|FG001|Overall Study|Disease progression|2|||
161424344|NCT00113841|582943147|FG000|Overall Study|Non-compliant|1|||
161424345|NCT00113841|582943148|FG001|Overall Study|Non-compliant|0|||
161424346|NCT02520726|582943149|FG000|Overall Study|Lost to Follow-up|3|||
161424347|NCT02520726|582943150|FG001|Overall Study|Lost to Follow-up|2|||
161424348|NCT00721396|582943151|FG000|Overall Study|Adverse Event|4|||
161424349|NCT00721396|582943152|FG001|Overall Study|Adverse Event|7|||
161424350|NCT00721396|582943153|FG002|Overall Study|Adverse Event|2|||
161424351|NCT00721396|582943154|FG003|Overall Study|Adverse Event|0|||
161424352|NCT00721396|582943151|FG000|Overall Study|Withdrawal by Subject|12|||
161424353|NCT00721396|582943152|FG001|Overall Study|Withdrawal by Subject|15|||
161424354|NCT00721396|582943153|FG002|Overall Study|Withdrawal by Subject|3|||
161424355|NCT00721396|582943154|FG003|Overall Study|Withdrawal by Subject|7|||
161424356|NCT00721396|582943151|FG000|Overall Study|Lost to Follow-up|7|||
161424357|NCT00721396|582943152|FG001|Overall Study|Lost to Follow-up|9|||
161424358|NCT00721396|582943153|FG002|Overall Study|Lost to Follow-up|3|||
161424359|NCT00721396|582943154|FG003|Overall Study|Lost to Follow-up|3|||
161424360|NCT00721396|582943151|FG000|Overall Study|Protocol Violation|4|||
161424361|NCT00721396|582943152|FG001|Overall Study|Protocol Violation|3|||
161424362|NCT00721396|582943153|FG002|Overall Study|Protocol Violation|1|||
161424363|NCT00721396|582943154|FG003|Overall Study|Protocol Violation|0|||
161424364|NCT00721396|582943151|FG000|Overall Study|Inappropriate enrollment|0|||
161424365|NCT00721396|582943152|FG001|Overall Study|Inappropriate enrollment|2|||
161424366|NCT00721396|582943153|FG002|Overall Study|Inappropriate enrollment|0|||
161424367|NCT00721396|582943154|FG003|Overall Study|Inappropriate enrollment|0|||
161424368|NCT00721396|582943151|FG000|Overall Study|Administrative reason|3|||
161424369|NCT00721396|582943152|FG001|Overall Study|Administrative reason|0|||
161424370|NCT00721396|582943153|FG002|Overall Study|Administrative reason|1|||
161424371|NCT00721396|582943154|FG003|Overall Study|Administrative reason|0|||
161424372|NCT00148759|582943155|FG000|Overall Study|Withdrawal by Subject|1|||
161424373|NCT00148759|582943156|FG001|Overall Study|Withdrawal by Subject|1|||
161424374|NCT00148759|582943155|FG000|Overall Study|Lost to Follow-up|1|||
161424375|NCT00148759|582943156|FG001|Overall Study|Lost to Follow-up|0|||
161424376|NCT00430716|582943158|FG000|Double Blind Phase|Death|1|||
161424377|NCT00430716|582943159|FG001|Double Blind Phase|Death|0|||
161424378|NCT00430716|582943160|FG002|Double Blind Phase|Death|0|||
161424379|NCT00430716|582943158|FG000|Double Blind Phase|No longer willing to participate|2|||
161424380|NCT00430716|582943159|FG001|Double Blind Phase|No longer willing to participate|1|||
161424381|NCT00430716|582943160|FG002|Double Blind Phase|No longer willing to participate|1|||
161424382|NCT00430716|582943158|FG000|Double Blind Phase|Other|0|||
161424383|NCT00430716|582943159|FG001|Double Blind Phase|Other|2|||
161424384|NCT00430716|582943160|FG002|Double Blind Phase|Other|0|||
161424385|NCT00430716|582943158|FG000|Double Blind Phase|Study terminated by sponsor|1|||
161424386|NCT00430716|582943159|FG001|Double Blind Phase|Study terminated by sponsor|1|||
161424387|NCT00430716|582943160|FG002|Double Blind Phase|Study terminated by sponsor|2|||
161424388|NCT00430716|582943158|FG000|Double Blind Phase|Adverse Event|1|||
161424389|NCT00430716|582943159|FG001|Double Blind Phase|Adverse Event|1|||
161424390|NCT00430716|582943160|FG002|Double Blind Phase|Adverse Event|3|||
161424391|NCT00430716|582943158|FG000|Double Blind Phase|Not treated|1|||
161424392|NCT00430716|582943159|FG001|Double Blind Phase|Not treated|0|||
161424393|NCT00430716|582943160|FG002|Double Blind Phase|Not treated|0|||
161424394|NCT00430716|582943158|FG000|Open Label Phase|Lost to Follow-up|1|||
161424395|NCT00430716|582943159|FG001|Open Label Phase|Lost to Follow-up|0|||
161424396|NCT00430716|582943160|FG002|Open Label Phase|Lost to Follow-up|1|||
161424397|NCT00430716|582943158|FG000|Open Label Phase|No longer willing to participate|0|||
161424398|NCT00430716|582943159|FG001|Open Label Phase|No longer willing to participate|1|||
161424399|NCT00430716|582943160|FG002|Open Label Phase|No longer willing to participate|1|||
161424400|NCT00430716|582943158|FG000|Open Label Phase|Other|3|||
161424401|NCT00430716|582943159|FG001|Open Label Phase|Other|1|||
161424402|NCT00430716|582943160|FG002|Open Label Phase|Other|1|||
161424403|NCT00430716|582943158|FG000|Open Label Phase|Protocol Violation|1|||
161424404|NCT00430716|582943159|FG001|Open Label Phase|Protocol Violation|0|||
161424405|NCT00430716|582943160|FG002|Open Label Phase|Protocol Violation|0|||
161424406|NCT00430716|582943158|FG000|Open Label Phase|Study terminated by sponsor|4|||
161424407|NCT00430716|582943159|FG001|Open Label Phase|Study terminated by sponsor|5|||
161424408|NCT00430716|582943160|FG002|Open Label Phase|Study terminated by sponsor|4|||
161424409|NCT03948334|582943161|FG000|Overall Study|Adverse Event|1|||
161424410|NCT03948334|582943162|FG001|Overall Study|Adverse Event|4|||
161424411|NCT03948334|582943161|FG000|Overall Study|Lack of Efficacy|2|||
161424412|NCT03948334|582943162|FG001|Overall Study|Lack of Efficacy|0|||
161424413|NCT03948334|582943161|FG000|Overall Study|Lost to Follow-up|1|||
161424414|NCT03948334|582943162|FG001|Overall Study|Lost to Follow-up|0|||
161424415|NCT03948334|582943161|FG000|Overall Study|Physician Decision|1|||
161424416|NCT03948334|582943162|FG001|Overall Study|Physician Decision|0|||
161424417|NCT03948334|582943161|FG000|Overall Study|Pregnancy|0|||
161424418|NCT03948334|582943162|FG001|Overall Study|Pregnancy|1|||
161424419|NCT03948334|582943161|FG000|Overall Study|Protocol Deviation|1|||
161424420|NCT03948334|582943162|FG001|Overall Study|Protocol Deviation|0|||
161424421|NCT03948334|582943161|FG000|Overall Study|Study terminated by Sponsor|50|||
161424422|NCT03948334|582943162|FG001|Overall Study|Study terminated by Sponsor|51|||
161424423|NCT03948334|582943161|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
161424424|NCT03948334|582943162|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
161424425|NCT00154297|582943165|FG000|Overall Study|Death|5|||
161424426|NCT00154297|582943166|FG001|Overall Study|Death|2|||
161424427|NCT00154297|582943165|FG000|Overall Study|Withdrawal by Subject|0|||
161424428|NCT00154297|582943166|FG001|Overall Study|Withdrawal by Subject|5|||
161424429|NCT00154297|582943165|FG000|Overall Study|Lost to Follow-up|3|||
161424430|NCT00154297|582943166|FG001|Overall Study|Lost to Follow-up|0|||
161424431|NCT04332107|582943167|FG000|Day 3|Lost to Follow-up|23|||
161424432|NCT04332107|582943168|FG001|Day 3|Lost to Follow-up|14|||
161424433|NCT04332107|582943167|FG000|Day 3|Missing outcome data|3|||
161424434|NCT04332107|582943168|FG001|Day 3|Missing outcome data|6|||
161424435|NCT04332107|582943167|FG000|Day 14|Lost to Follow-up|13|||
161424436|NCT04332107|582943168|FG001|Day 14|Lost to Follow-up|4|||
161424437|NCT04332107|582943167|FG000|Day 14|Missing outcome data|4|||
161424438|NCT04332107|582943168|FG001|Day 14|Missing outcome data|4|||
161424439|NCT04332107|582943167|FG000|Day 21|Lost to Follow-up|10|||
161424440|NCT04332107|582943168|FG001|Day 21|Lost to Follow-up|2|||
161424441|NCT03116685|582943171|FG000|Overall Study|Physician Decision|0|||
161424442|NCT03116685|582943172|FG001|Overall Study|Physician Decision|1|||
161424443|NCT06235905|582943174|FG000|Overall Study|Adverse Event|1|||
161424444|NCT06235905|582943174|FG000|Overall Study|Non-compliant with protocol procedures|1|||
161424445|NCT01505374|582943178|FG000|Overall Study|Lost to Follow-up|1|||
161424446|NCT01505374|582943179|FG001|Overall Study|Lost to Follow-up|0|||
161424447|NCT00176462|582943182|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
161424448|NCT00176462|582943183|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
161424449|NCT00176462|582943182|FG000|Induction (4 Weeks)|Death|1|||
161424450|NCT00176462|582943183|FG001|Induction (4 Weeks)|Death|2|||
161424451|NCT00176462|582943182|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
161424452|NCT00176462|582943183|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
161424453|NCT00176462|582943182|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
161424454|NCT00176462|582943183|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
161424455|NCT00176462|582943182|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
161424456|NCT00176462|582943183|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
161424457|NCT00176462|582943182|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
161424458|NCT00176462|582943183|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
161424459|NCT00176462|582943182|FG000|Consolidation (12 Weeks)|Not documented|0|||
161424460|NCT00176462|582943183|FG001|Consolidation (12 Weeks)|Not documented|1|||
161424461|NCT00176462|582943182|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
161424462|NCT00176462|582943183|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
161424463|NCT00176462|582943182|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
161424464|NCT00176462|582943183|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
161424465|NCT00320515|582943188|FG000|Overall Study|Death|33|||
161424466|NCT00320515|582943188|FG000|Overall Study|Lost to Follow-up|6|||
161424467|NCT00320515|582943188|FG000|Overall Study|Physician Decision|2|||
161424468|NCT00320515|582943188|FG000|Overall Study|Withdrawal by Subject|8|||
161424469|NCT01114828|582943189|FG000|Overall Study|Adverse Event|1|||
161424470|NCT01114828|582943190|FG001|Overall Study|Adverse Event|1|||
161424471|NCT01114828|582943189|FG000|Overall Study|Lack of Efficacy|0|||
161424472|NCT01114828|582943190|FG001|Overall Study|Lack of Efficacy|2|||
161424473|NCT01114828|582943189|FG000|Overall Study|Protocol Violation|2|||
161424474|NCT01114828|582943190|FG001|Overall Study|Protocol Violation|0|||
161424475|NCT01114828|582943189|FG000|Overall Study|Withdrawal by Subject|0|||
161424476|NCT01114828|582943190|FG001|Overall Study|Withdrawal by Subject|1|||
161424477|NCT00794950|582943191|FG000|BCG Induction|Withdrawal by Subject|2|||
161424478|NCT00794950|582943191|FG000|BCG Induction|ineligible|3|||
161424479|NCT00794950|582943191|FG000|BCG Induction|noncompliant w. BCG|1|||
161424480|NCT00794950|582943191|FG000|BCG Induction|Adverse Event|1|||
161424481|NCT00794950|582943191|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
161424482|NCT00794950|582943191|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
161424483|NCT00794950|582943191|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
161424484|NCT00794950|582943191|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
161424485|NCT02485704|582943192|FG000|Overall Study|Lost to Follow-up|4|||
161424486|NCT02485704|582943193|FG001|Overall Study|Lost to Follow-up|5|||
161424487|NCT02485704|582943192|FG000|Overall Study|Withdrawal by Subject|0|||
161424488|NCT02485704|582943193|FG001|Overall Study|Withdrawal by Subject|3|||
161424489|NCT02485704|582943192|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
161424490|NCT02485704|582943193|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
161424491|NCT00851786|582943196|FG000|Overall Study|Withdrawal by Subject|0|||
161424492|NCT00851786|582943197|FG001|Overall Study|Withdrawal by Subject|1|||
161424493|NCT00851786|582943196|FG000|Overall Study|Protocol Violation|0|||
161424494|NCT00851786|582943197|FG001|Overall Study|Protocol Violation|1|||
161424495|NCT00851786|582943196|FG000|Overall Study|Lost to Follow-up|1|||
161424496|NCT00851786|582943197|FG001|Overall Study|Lost to Follow-up|0|||
161424497|NCT00851786|582943196|FG000|Overall Study|Incarceration|1|||
161424498|NCT00851786|582943197|FG001|Overall Study|Incarceration|0|||
161424499|NCT00851786|582943196|FG000|Overall Study|Site Closure|1|||
161424500|NCT00851786|582943197|FG001|Overall Study|Site Closure|0|||
161424501|NCT00851786|582943196|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
161424502|NCT00851786|582943197|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
161424503|NCT04177212|582943201|FG000|Overall Study|Withdrawal by Subject|9|||
161424504|NCT04177212|582943202|FG001|Overall Study|Withdrawal by Subject|7|||
161424505|NCT04177212|582943201|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
161424506|NCT04177212|582943202|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
161424507|NCT04177212|582943201|FG000|Overall Study|Physician Decision|1|||
161424508|NCT04177212|582943202|FG001|Overall Study|Physician Decision|0|||
161424509|NCT04177212|582943201|FG000|Overall Study|Lost to Follow-up|0|||
161424510|NCT04177212|582943202|FG001|Overall Study|Lost to Follow-up|3|||
161424511|NCT04177212|582943201|FG000|Overall Study|Adverse Event|0|||
161424512|NCT04177212|582943202|FG001|Overall Study|Adverse Event|1|||
161424513|NCT04177212|582943201|FG000|Overall Study|Other|1|||
161424514|NCT04177212|582943202|FG001|Overall Study|Other|2|||
161424515|NCT01792115|582943203|FG000|Overall Study|Lost to Follow-up|0|||
161424516|NCT01792115|582943204|FG001|Overall Study|Lost to Follow-up|1|||
161424517|NCT01792115|582943205|FG002|Overall Study|Lost to Follow-up|0|||
161424518|NCT01279681|582943206|FG000|Overall Study|Disease Progression|9|||
161424519|NCT01279681|582943207|FG001|Overall Study|Disease Progression|6|||
161424520|NCT01279681|582943206|FG000|Overall Study|Withdrawal by Subject|3|||
161424521|NCT01279681|582943207|FG001|Overall Study|Withdrawal by Subject|4|||
161424522|NCT01279681|582943206|FG000|Overall Study|Adverse Event|2|||
161424523|NCT01279681|582943207|FG001|Overall Study|Adverse Event|3|||
161424524|NCT01279681|582943206|FG000|Overall Study|Death|0|||
161424525|NCT01279681|582943207|FG001|Overall Study|Death|1|||
161424526|NCT01279681|582943206|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
161424527|NCT01279681|582943207|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
161424528|NCT01279681|582943206|FG000|Overall Study|Physician Decision|1|||
161424529|NCT01279681|582943207|FG001|Overall Study|Physician Decision|0|||
161424530|NCT01279681|582943206|FG000|Overall Study|Other Reason|0|||
161424531|NCT01279681|582943207|FG001|Overall Study|Other Reason|2|||
161424532|NCT01943591|582943208|FG000|Overall Study|Lost to Follow-up|3|||
161424533|NCT01943591|582943209|FG001|Overall Study|Lost to Follow-up|4|||
161424534|NCT01943591|582943208|FG000|Overall Study|Death|2|||
161424535|NCT01943591|582943209|FG001|Overall Study|Death|7|||
161424536|NCT01790594|582944598|FG000|Overall Study|Death|1|||
161424537|NCT01790594|582944599|FG001|Overall Study|Death|0|||
161424538|NCT01790594|582944600|FG002|Overall Study|Death|0|||
161424539|NCT01790594|582944598|FG000|Overall Study|Physician Decision|2|||
161424540|NCT01790594|582944599|FG001|Overall Study|Physician Decision|1|||
161424541|NCT01790594|582944600|FG002|Overall Study|Physician Decision|0|||
161424542|NCT01790594|582944598|FG000|Overall Study|Withdrawal by Subject|2|||
161424543|NCT01790594|582944599|FG001|Overall Study|Withdrawal by Subject|0|||
161424544|NCT01790594|582944600|FG002|Overall Study|Withdrawal by Subject|0|||
161424545|NCT01790594|582944598|FG000|Overall Study|Transplant was not done|0|||
161424546|NCT01790594|582944599|FG001|Overall Study|Transplant was not done|0|||
161424547|NCT01790594|582944600|FG002|Overall Study|Transplant was not done|3|||
161424548|NCT01790594|582944598|FG000|Overall Study|Terminated prior to week 76|0|||
161424549|NCT01790594|582944599|FG001|Overall Study|Terminated prior to week 76|2|||
161424550|NCT01790594|582944600|FG002|Overall Study|Terminated prior to week 76|0|||
161424551|NCT02711137|582944601|FG000|Overall Study|Death|1|||
161424552|NCT02711137|582944602|FG001|Overall Study|Death|4|||
161424553|NCT02711137|582944603|FG002|Overall Study|Death|5|||
161424554|NCT02711137|582944604|FG003|Overall Study|Death|5|||
161424555|NCT02711137|582944605|FG004|Overall Study|Death|3|||
161424556|NCT02711137|582944606|FG005|Overall Study|Death|1|||
161424557|NCT02711137|582944607|FG006|Overall Study|Death|61|||
161424558|NCT02711137|582944608|FG007|Overall Study|Death|3|||
161424559|NCT02711137|582944609|FG008|Overall Study|Death|0|||
161424560|NCT02711137|582944610|FG009|Overall Study|Death|1|||
161424561|NCT02711137|582944611|FG010|Overall Study|Death|1|||
161424562|NCT02711137|582944612|FG011|Overall Study|Death|1|||
161424563|NCT02711137|582944613|FG012|Overall Study|Death|0|||
161424564|NCT02711137|582944614|FG013|Overall Study|Death|0|||
161424565|NCT02711137|582944615|FG014|Overall Study|Death|0|||
161424566|NCT02711137|582944601|FG000|Overall Study|Study Terminated by Sponsor|0|||
161424567|NCT02711137|582944602|FG001|Overall Study|Study Terminated by Sponsor|0|||
161424568|NCT02711137|582944603|FG002|Overall Study|Study Terminated by Sponsor|1|||
161424569|NCT02711137|582944604|FG003|Overall Study|Study Terminated by Sponsor|0|||
161424570|NCT02711137|582944605|FG004|Overall Study|Study Terminated by Sponsor|0|||
161424571|NCT02711137|582944606|FG005|Overall Study|Study Terminated by Sponsor|0|||
161424572|NCT02711137|582944607|FG006|Overall Study|Study Terminated by Sponsor|1|||
161424573|NCT02711137|582944608|FG007|Overall Study|Study Terminated by Sponsor|0|||
161424574|NCT02711137|582944609|FG008|Overall Study|Study Terminated by Sponsor|0|||
161424575|NCT02711137|582944610|FG009|Overall Study|Study Terminated by Sponsor|0|||
161424576|NCT02711137|582944611|FG010|Overall Study|Study Terminated by Sponsor|0|||
161424577|NCT02711137|582944612|FG011|Overall Study|Study Terminated by Sponsor|0|||
161424578|NCT02711137|582944613|FG012|Overall Study|Study Terminated by Sponsor|0|||
161424579|NCT02711137|582944614|FG013|Overall Study|Study Terminated by Sponsor|0|||
161424580|NCT02711137|582944615|FG014|Overall Study|Study Terminated by Sponsor|0|||
161424581|NCT02711137|582944601|FG000|Overall Study|Physician Decision|1|||
161424582|NCT02711137|582944602|FG001|Overall Study|Physician Decision|0|||
161424583|NCT02711137|582944603|FG002|Overall Study|Physician Decision|2|||
161424584|NCT02711137|582944604|FG003|Overall Study|Physician Decision|1|||
161424585|NCT02711137|582944605|FG004|Overall Study|Physician Decision|1|||
161424586|NCT02711137|582944606|FG005|Overall Study|Physician Decision|0|||
161424587|NCT02711137|582944607|FG006|Overall Study|Physician Decision|12|||
161424588|NCT02711137|582944608|FG007|Overall Study|Physician Decision|2|||
161424589|NCT02711137|582944609|FG008|Overall Study|Physician Decision|1|||
161424590|NCT02711137|582944610|FG009|Overall Study|Physician Decision|1|||
161424591|NCT02711137|582944611|FG010|Overall Study|Physician Decision|3|||
161424592|NCT02711137|582944612|FG011|Overall Study|Physician Decision|2|||
161424593|NCT02711137|582944613|FG012|Overall Study|Physician Decision|1|||
161424594|NCT02711137|582944614|FG013|Overall Study|Physician Decision|1|||
161424595|NCT02711137|582944615|FG014|Overall Study|Physician Decision|2|||
161424596|NCT02711137|582944601|FG000|Overall Study|Other|0|||
161424597|NCT02711137|582944602|FG001|Overall Study|Other|1|||
161424598|NCT02711137|582944603|FG002|Overall Study|Other|0|||
161424599|NCT02711137|582944604|FG003|Overall Study|Other|0|||
161424600|NCT02711137|582944605|FG004|Overall Study|Other|0|||
161424601|NCT02711137|582944606|FG005|Overall Study|Other|0|||
161424602|NCT02711137|582944607|FG006|Overall Study|Other|3|||
161424603|NCT02711137|582944608|FG007|Overall Study|Other|0|||
161424604|NCT02711137|582944609|FG008|Overall Study|Other|0|||
161424605|NCT02711137|582944610|FG009|Overall Study|Other|0|||
161424606|NCT02711137|582944611|FG010|Overall Study|Other|0|||
161424607|NCT02711137|582944612|FG011|Overall Study|Other|0|||
161424608|NCT02711137|582944613|FG012|Overall Study|Other|0|||
161424609|NCT02711137|582944614|FG013|Overall Study|Other|0|||
161424610|NCT02711137|582944615|FG014|Overall Study|Other|1|||
161424611|NCT02711137|582944601|FG000|Overall Study|Withdrawal by Subject|1|||
161424612|NCT02711137|582944602|FG001|Overall Study|Withdrawal by Subject|0|||
161424613|NCT02711137|582944603|FG002|Overall Study|Withdrawal by Subject|0|||
161424614|NCT02711137|582944604|FG003|Overall Study|Withdrawal by Subject|1|||
161424615|NCT02711137|582944605|FG004|Overall Study|Withdrawal by Subject|1|||
161424616|NCT02711137|582944606|FG005|Overall Study|Withdrawal by Subject|0|||
161424617|NCT02711137|582944607|FG006|Overall Study|Withdrawal by Subject|7|||
161424618|NCT02711137|582944608|FG007|Overall Study|Withdrawal by Subject|0|||
161424619|NCT02711137|582944609|FG008|Overall Study|Withdrawal by Subject|0|||
161424620|NCT02711137|582944610|FG009|Overall Study|Withdrawal by Subject|0|||
161424621|NCT02711137|582944611|FG010|Overall Study|Withdrawal by Subject|0|||
161424622|NCT02711137|582944612|FG011|Overall Study|Withdrawal by Subject|0|||
161424623|NCT02711137|582944613|FG012|Overall Study|Withdrawal by Subject|0|||
161424624|NCT02711137|582944614|FG013|Overall Study|Withdrawal by Subject|1|||
161424625|NCT02711137|582944615|FG014|Overall Study|Withdrawal by Subject|0|||
161424626|NCT02711137|582944601|FG000|Overall Study|Lost to Follow-up|1|||
161424627|NCT02711137|582944602|FG001|Overall Study|Lost to Follow-up|0|||
161424628|NCT02711137|582944603|FG002|Overall Study|Lost to Follow-up|0|||
161424629|NCT02711137|582944604|FG003|Overall Study|Lost to Follow-up|0|||
161424630|NCT02711137|582944605|FG004|Overall Study|Lost to Follow-up|0|||
161424631|NCT02711137|582944606|FG005|Overall Study|Lost to Follow-up|0|||
161424632|NCT02711137|582944607|FG006|Overall Study|Lost to Follow-up|2|||
161424633|NCT02711137|582944608|FG007|Overall Study|Lost to Follow-up|0|||
161424634|NCT02711137|582944609|FG008|Overall Study|Lost to Follow-up|0|||
161424635|NCT02711137|582944610|FG009|Overall Study|Lost to Follow-up|0|||
161424636|NCT02711137|582944611|FG010|Overall Study|Lost to Follow-up|0|||
161424637|NCT02711137|582944612|FG011|Overall Study|Lost to Follow-up|0|||
161424638|NCT02711137|582944613|FG012|Overall Study|Lost to Follow-up|0|||
161424639|NCT02711137|582944614|FG013|Overall Study|Lost to Follow-up|0|||
161424640|NCT02711137|582944615|FG014|Overall Study|Lost to Follow-up|0|||
161424641|NCT01285401|582944616|FG000|Overall Study|Prematurely withdrawn from the study|17|||
161424642|NCT01285401|582944617|FG001|Overall Study|Prematurely withdrawn from the study|29|||
161424643|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
161424644|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
161424645|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Death|1|||
161424646|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Death|2|||
161424647|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
161424648|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
161424649|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
161424650|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
161424651|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
161424652|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
161424653|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
161424654|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
161424655|NCT01794000|582944624|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
161424656|NCT01794000|582944625|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
161424657|NCT01794000|582944624|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
161424658|NCT01794000|582944625|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161424659|NCT00796666|582944626|FG000|Overall Study|Death|2|||
161424660|NCT00796666|582944627|FG001|Overall Study|Death|4|||
161424661|NCT00796666|582944626|FG000|Overall Study|Withdrawal by Subject|2|||
161424662|NCT00796666|582944627|FG001|Overall Study|Withdrawal by Subject|0|||
161424663|NCT00796666|582944626|FG000|Overall Study|Adverse Event|7|||
161424664|NCT00796666|582944627|FG001|Overall Study|Adverse Event|5|||
161424665|NCT00796666|582944626|FG000|Overall Study|Protocol Violation|1|||
161424666|NCT00796666|582944627|FG001|Overall Study|Protocol Violation|0|||
161424667|NCT00796666|582944626|FG000|Overall Study|Other|1|||
161424668|NCT00796666|582944627|FG001|Overall Study|Other|0|||
161424669|NCT00796666|582944626|FG000|Overall Study|Terminated by sponsor|53|||
161424670|NCT00796666|582944627|FG001|Overall Study|Terminated by sponsor|55|||
161424671|NCT00796666|582944626|FG000|Overall Study|Randomized and not treated|1|||
161424672|NCT00796666|582944627|FG001|Overall Study|Randomized and not treated|0|||
161424673|NCT01367834|582944628|FG000|Overall Study|Withdrawal by Subject|2|||
161424674|NCT01367834|582944629|FG001|Overall Study|Withdrawal by Subject|2|||
161424675|NCT01367834|582944628|FG000|Overall Study|Study was ended.|0|||
161424676|NCT01367834|582944629|FG001|Overall Study|Study was ended.|1|||
161424677|NCT00255190|582944630|FG000|Overall Study|Adverse Event|17|||
161424678|NCT00255190|582944631|FG001|Overall Study|Adverse Event|36|||
161424679|NCT00255190|582944630|FG000|Overall Study|Protocol Violation|2|||
161424680|NCT00255190|582944631|FG001|Overall Study|Protocol Violation|2|||
161424681|NCT00255190|582944630|FG000|Overall Study|Lost to Follow-up|10|||
161424682|NCT00255190|582944631|FG001|Overall Study|Lost to Follow-up|27|||
161424683|NCT00255190|582944630|FG000|Overall Study|Withdrew Consent|17|||
161424684|NCT00255190|582944631|FG001|Overall Study|Withdrew Consent|48|||
161424685|NCT00255190|582944630|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161424686|NCT00255190|582944631|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
161424687|NCT00255190|582944630|FG000|Overall Study|Erosive esophagitis not healed|0|||
161424688|NCT00255190|582944631|FG001|Overall Study|Erosive esophagitis not healed|20|||
161424689|NCT00255190|582944630|FG000|Overall Study|Various|4|||
161424690|NCT00255190|582944631|FG001|Overall Study|Various|23|||
161424691|NCT00628030|582944632|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
161424692|NCT00628030|582944633|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
161424693|NCT00628030|582944632|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
161424694|NCT00628030|582944633|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
161424695|NCT00628030|582944632|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
161424696|NCT00628030|582944633|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
161424697|NCT01156480|582944634|FG000|Overall Study|change in diagnosis|0|||
161424698|NCT01156480|582944635|FG001|Overall Study|change in diagnosis|1|||
161424699|NCT04537793|582944636|FG000|Part B (24 Weeks)|Adverse Event|0|||
161424700|NCT04537793|582944637|FG001|Part B (24 Weeks)|Adverse Event|1|||
161424701|NCT05470387|582944638|FG000|Overall Study|Protocol Violation|0|||
161424702|NCT05470387|582944639|FG001|Overall Study|Protocol Violation|3|||
161424703|NCT01255423|582944640|FG000|Overall Study|Abnormal Laboratory value|3|||
161424704|NCT01255423|582944641|FG001|Overall Study|Abnormal Laboratory value|2|||
161424705|NCT01255423|582944640|FG000|Overall Study|Use of prohibited medications|0|||
161424706|NCT01255423|582944641|FG001|Overall Study|Use of prohibited medications|1|||
161424707|NCT00988598|582944642|FG000|Overall Study|Withdrawal by Subject|2|||
161424708|NCT00988598|582944643|FG001|Overall Study|Withdrawal by Subject|0|||
161424709|NCT03367858|582944644|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
161424710|NCT03367858|582944645|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
161424711|NCT03367858|582944644|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
161424712|NCT03367858|582944645|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
161424713|NCT03367858|582944644|FG000|3 Month Follow Up|Lost to Follow-up|8|||
161424714|NCT03367858|582944645|FG001|3 Month Follow Up|Lost to Follow-up|3|||
161424715|NCT03367858|582944644|FG000|3 Month Follow Up|Moved out of study area|2|||
161424716|NCT03367858|582944645|FG001|3 Month Follow Up|Moved out of study area|6|||
161424717|NCT03367858|582944644|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
161424718|NCT03367858|582944645|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
161424719|NCT03367858|582944644|FG000|3 Month Follow Up|MRI contraindication|2|||
161424720|NCT03367858|582944645|FG001|3 Month Follow Up|MRI contraindication|1|||
161424721|NCT03367858|582944644|FG000|3 Month Follow Up|Incarcerated|0|||
161424722|NCT03367858|582944645|FG001|3 Month Follow Up|Incarcerated|1|||
161424723|NCT03367858|582944644|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
161424724|NCT03367858|582944645|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
161424725|NCT03367858|582944644|FG000|6 Month Follow Up|Lost to Follow-up|5|||
161424726|NCT03367858|582944645|FG001|6 Month Follow Up|Lost to Follow-up|2|||
161424727|NCT03367858|582944644|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
161424728|NCT03367858|582944645|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
161424729|NCT03367858|582944644|FG000|12 Month Follow Up|Lost to Follow-up|3|||
161424730|NCT03367858|582944645|FG001|12 Month Follow Up|Lost to Follow-up|3|||
161424731|NCT03367858|582944644|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
161424732|NCT03367858|582944645|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
161424733|NCT00057863|582944663|FG000|Overall Study|Death|1|||
161424734|NCT00057863|582944663|FG000|Overall Study|Withdrawal by Subject|2|||
161424735|NCT02079038|582944665|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
161424736|NCT02079038|582944666|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
161424737|NCT02079038|582944665|FG000|Modified Intent to Treat Population|Death|1|||
161424738|NCT02079038|582944666|FG001|Modified Intent to Treat Population|Death|0|||
161424739|NCT02079038|582944665|FG000|Completed 6 Months|Lost to Follow-up|2|||
161424740|NCT02079038|582944666|FG001|Completed 6 Months|Lost to Follow-up|1|||
161424741|NCT03480152|582944667|FG000|Phase I|Signed consent. Died before treatment.|1|||
161424742|NCT03480152|582944668|FG001|Phase I|Signed consent. Died before treatment.|0|||
161424743|NCT03480152|582944669|FG002|Phase I|Signed consent. Died before treatment.|0|||
161424744|NCT04276233|582944670|FG000|Overall Study|Adverse Event|1|||
161424745|NCT04276233|582944670|FG000|Overall Study|Lost to Follow-up|3|||
161424746|NCT04276233|582944670|FG000|Overall Study|Physician Decision|4|||
161424747|NCT04276233|582944670|FG000|Overall Study|Withdrawal by Subject|2|||
161424748|NCT01946139|582944671|FG000|Overall Study|Withdrawal by Subject|8|||
161424749|NCT01946139|582944671|FG000|Overall Study|ineligible|8|||
161424750|NCT01946139|582944671|FG000|Overall Study|Specimens not available|4|||
161424751|NCT00101686|582944678|FG000|Overall Study|Progressive Disease|37|||
161424752|NCT00101686|582944679|FG001|Overall Study|Progressive Disease|28|||
161424753|NCT00101686|582944680|FG002|Overall Study|Progressive Disease|37|||
161424754|NCT00101686|582944681|FG003|Overall Study|Progressive Disease|38|||
161424755|NCT00101686|582944682|FG004|Overall Study|Progressive Disease|28|||
161424756|NCT00101686|582944683|FG005|Overall Study|Progressive Disease|25|||
161424757|NCT00101686|582944684|FG006|Overall Study|Progressive Disease|5|||
161424758|NCT00101686|582944685|FG007|Overall Study|Progressive Disease|7|||
161424759|NCT00101686|582944686|FG008|Overall Study|Progressive Disease|10|||
161424760|NCT00101686|582944687|FG009|Overall Study|Progressive Disease|8|||
161424761|NCT00101686|582944678|FG000|Overall Study|initiation other anti-cancer treatment|4|||
161424762|NCT00101686|582944679|FG001|Overall Study|initiation other anti-cancer treatment|3|||
161424763|NCT00101686|582944680|FG002|Overall Study|initiation other anti-cancer treatment|4|||
161424764|NCT00101686|582944681|FG003|Overall Study|initiation other anti-cancer treatment|3|||
161424765|NCT00101686|582944682|FG004|Overall Study|initiation other anti-cancer treatment|1|||
161424766|NCT00101686|582944683|FG005|Overall Study|initiation other anti-cancer treatment|1|||
161424767|NCT00101686|582944684|FG006|Overall Study|initiation other anti-cancer treatment|2|||
161424768|NCT00101686|582944685|FG007|Overall Study|initiation other anti-cancer treatment|2|||
161424769|NCT00101686|582944686|FG008|Overall Study|initiation other anti-cancer treatment|3|||
161424770|NCT00101686|582944687|FG009|Overall Study|initiation other anti-cancer treatment|3|||
161424771|NCT00101686|582944678|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
161424772|NCT00101686|582944679|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
161424773|NCT00101686|582944680|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
161424774|NCT00101686|582944681|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
161424775|NCT00101686|582944682|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
161424776|NCT00101686|582944683|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
161424777|NCT00101686|582944684|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
161424778|NCT00101686|582944685|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
161424779|NCT00101686|582944686|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
161424780|NCT00101686|582944687|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
161424781|NCT00101686|582944678|FG000|Overall Study|unacceptable toxicity|3|||
161424782|NCT00101686|582944679|FG001|Overall Study|unacceptable toxicity|9|||
161424783|NCT00101686|582944680|FG002|Overall Study|unacceptable toxicity|10|||
161424784|NCT00101686|582944681|FG003|Overall Study|unacceptable toxicity|6|||
161424785|NCT00101686|582944682|FG004|Overall Study|unacceptable toxicity|16|||
161424786|NCT00101686|582944683|FG005|Overall Study|unacceptable toxicity|10|||
161424787|NCT00101686|582944684|FG006|Overall Study|unacceptable toxicity|4|||
161424788|NCT00101686|582944685|FG007|Overall Study|unacceptable toxicity|2|||
161424789|NCT00101686|582944686|FG008|Overall Study|unacceptable toxicity|1|||
161424790|NCT00101686|582944687|FG009|Overall Study|unacceptable toxicity|4|||
161424791|NCT00101686|582944678|FG000|Overall Study|Randomized but did not receive treament|1|||
161424792|NCT00101686|582944679|FG001|Overall Study|Randomized but did not receive treament|6|||
161424793|NCT00101686|582944680|FG002|Overall Study|Randomized but did not receive treament|2|||
161424794|NCT00101686|582944681|FG003|Overall Study|Randomized but did not receive treament|2|||
161424795|NCT00101686|582944682|FG004|Overall Study|Randomized but did not receive treament|2|||
161424796|NCT00101686|582944683|FG005|Overall Study|Randomized but did not receive treament|2|||
161424797|NCT00101686|582944684|FG006|Overall Study|Randomized but did not receive treament|0|||
161424798|NCT00101686|582944685|FG007|Overall Study|Randomized but did not receive treament|1|||
161424799|NCT00101686|582944686|FG008|Overall Study|Randomized but did not receive treament|0|||
161424800|NCT00101686|582944687|FG009|Overall Study|Randomized but did not receive treament|1|||
161424801|NCT00101686|582944678|FG000|Overall Study|intercurrent non-cancer related illness|0|||
161424802|NCT00101686|582944679|FG001|Overall Study|intercurrent non-cancer related illness|0|||
161424803|NCT00101686|582944680|FG002|Overall Study|intercurrent non-cancer related illness|2|||
161424804|NCT00101686|582944681|FG003|Overall Study|intercurrent non-cancer related illness|0|||
161424805|NCT00101686|582944682|FG004|Overall Study|intercurrent non-cancer related illness|1|||
161424806|NCT00101686|582944683|FG005|Overall Study|intercurrent non-cancer related illness|3|||
161424807|NCT00101686|582944684|FG006|Overall Study|intercurrent non-cancer related illness|1|||
161424808|NCT00101686|582944685|FG007|Overall Study|intercurrent non-cancer related illness|0|||
161424809|NCT00101686|582944686|FG008|Overall Study|intercurrent non-cancer related illness|1|||
161424810|NCT00101686|582944687|FG009|Overall Study|intercurrent non-cancer related illness|1|||
161424811|NCT00101686|582944678|FG000|Overall Study|Physician Decision|10|||
161424812|NCT00101686|582944679|FG001|Overall Study|Physician Decision|13|||
161424813|NCT00101686|582944680|FG002|Overall Study|Physician Decision|6|||
161424814|NCT00101686|582944681|FG003|Overall Study|Physician Decision|7|||
161424815|NCT00101686|582944682|FG004|Overall Study|Physician Decision|8|||
161424816|NCT00101686|582944683|FG005|Overall Study|Physician Decision|9|||
161424817|NCT00101686|582944684|FG006|Overall Study|Physician Decision|5|||
161424818|NCT00101686|582944685|FG007|Overall Study|Physician Decision|5|||
161424819|NCT00101686|582944686|FG008|Overall Study|Physician Decision|1|||
161424820|NCT00101686|582944687|FG009|Overall Study|Physician Decision|1|||
161424821|NCT00101686|582944678|FG000|Overall Study|Other|1|||
161424822|NCT00101686|582944679|FG001|Overall Study|Other|4|||
161424823|NCT00101686|582944680|FG002|Overall Study|Other|1|||
161424824|NCT00101686|582944681|FG003|Overall Study|Other|6|||
161424825|NCT00101686|582944682|FG004|Overall Study|Other|2|||
161424826|NCT00101686|582944683|FG005|Overall Study|Other|12|||
161424827|NCT00101686|582944684|FG006|Overall Study|Other|1|||
161424828|NCT00101686|582944685|FG007|Overall Study|Other|5|||
161424829|NCT00101686|582944686|FG008|Overall Study|Other|3|||
161424830|NCT00101686|582944687|FG009|Overall Study|Other|3|||
161424831|NCT00101686|582944678|FG000|Overall Study|Withdrawal by Subject|9|||
161424832|NCT00101686|582944679|FG001|Overall Study|Withdrawal by Subject|8|||
161424833|NCT00101686|582944680|FG002|Overall Study|Withdrawal by Subject|6|||
161424834|NCT00101686|582944681|FG003|Overall Study|Withdrawal by Subject|8|||
161424835|NCT00101686|582944682|FG004|Overall Study|Withdrawal by Subject|8|||
161424836|NCT00101686|582944683|FG005|Overall Study|Withdrawal by Subject|7|||
161424837|NCT00101686|582944684|FG006|Overall Study|Withdrawal by Subject|7|||
161424838|NCT00101686|582944685|FG007|Overall Study|Withdrawal by Subject|7|||
161424839|NCT00101686|582944686|FG008|Overall Study|Withdrawal by Subject|8|||
161424840|NCT00101686|582944687|FG009|Overall Study|Withdrawal by Subject|9|||
161424841|NCT00296816|582944688|FG000|Overall Study|Disease Progression|37|||
161424842|NCT00296816|582944688|FG000|Overall Study|Adverse Event|18|||
161424843|NCT00296816|582944688|FG000|Overall Study|Investigator/Participant request|5|||
161424844|NCT00296816|582944688|FG000|Overall Study|Non-compliance|1|||
161424845|NCT00296816|582944688|FG000|Overall Study|Missing for end of treatment|4|||
161424846|NCT00296816|582944688|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
161424847|NCT00296816|582944688|FG000|Overall Study|Poor performance status|1|||
161424848|NCT00296816|582944688|FG000|Overall Study|Relocation to Florida|1|||
161424849|NCT00296816|582944688|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
161424850|NCT00296816|582944688|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
161424851|NCT00296816|582944688|FG000|Overall Study|Neuropathy/patient preference|1|||
161424852|NCT00296816|582944688|FG000|Overall Study|Proteinuria|1|||
161424853|NCT00296816|582944688|FG000|Overall Study|ineligibility due to radiation treatment|1|||
161424854|NCT00985465|582944689|FG000|Overall Study|Withdrawal by Subject|1|||
161424855|NCT00985465|582944690|FG001|Overall Study|Withdrawal by Subject|2|||
161424856|NCT00985465|582944689|FG000|Overall Study|Considered to be part of the other group|0|||
161424857|NCT00985465|582944690|FG001|Overall Study|Considered to be part of the other group|1|||
161424858|NCT01454596|582944695|FG000|Overall Study|Death|0|||
161424859|NCT01454596|582944696|FG001|Overall Study|Death|0|||
161424860|NCT01454596|582944697|FG002|Overall Study|Death|0|||
161424861|NCT01454596|582944698|FG003|Overall Study|Death|0|||
161424862|NCT01454596|582944699|FG004|Overall Study|Death|0|||
161424863|NCT01454596|582944700|FG005|Overall Study|Death|0|||
161424864|NCT01454596|582944701|FG006|Overall Study|Death|0|||
161424865|NCT01454596|582944702|FG007|Overall Study|Death|0|||
161424866|NCT01454596|582944703|FG008|Overall Study|Death|0|||
161424867|NCT01454596|582944704|FG009|Overall Study|Death|1|||
161424868|NCT01454596|582944705|FG010|Overall Study|Death|1|||
161424869|NCT01454596|582944706|FG011|Overall Study|Death|0|||
161424870|NCT02800863|582944712|FG000|Overall Study|Adverse Event|14|||
161424871|NCT02800863|582944712|FG000|Overall Study|Another Device Implanted|1|||
161424872|NCT02800863|582944712|FG000|Overall Study|Device Explanted|1|||
161424873|NCT02800863|582944712|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
161424874|NCT02800863|582944712|FG000|Overall Study|Health Issues|1|||
161424875|NCT02800863|582944712|FG000|Overall Study|Insurance Denial|8|||
161424876|NCT02800863|582944712|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
161424877|NCT02800863|582944712|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
161424878|NCT02800863|582944712|FG000|Overall Study|Screen Failure|1|||
161424879|NCT02800863|582944712|FG000|Overall Study|Sponsor Request|6|||
161424880|NCT02800863|582944712|FG000|Overall Study|Death|3|||
161424881|NCT02800863|582944712|FG000|Overall Study|Subject Implant at Another Facility|1|||
161424882|NCT02800863|582944712|FG000|Overall Study|Lost to Follow-up|26|||
161424883|NCT02800863|582944712|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
161424884|NCT02800863|582944712|FG000|Overall Study|Subject and/or Family Request|64|||
161424885|NCT02800863|582944712|FG000|Overall Study|Trial Failure|81|||
161424886|NCT02800863|582944712|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
161424887|NCT00717249|582944713|FG000|Overall Study|Lens Discomfort|4|||
161424888|NCT00717249|582944714|FG001|Overall Study|Lens Discomfort|1|||
161424889|NCT00717249|582944713|FG000|Overall Study|Unsatisfactory visual Response|0|||
161424890|NCT00717249|582944714|FG001|Overall Study|Unsatisfactory visual Response|2|||
161424891|NCT00717249|582944713|FG000|Overall Study|Adverse Event|4|||
161424892|NCT00717249|582944714|FG001|Overall Study|Adverse Event|2|||
161424893|NCT00717249|582944713|FG000|Overall Study|Lost to Follow-up|2|||
161424894|NCT00717249|582944714|FG001|Overall Study|Lost to Follow-up|0|||
161424895|NCT00717249|582944713|FG000|Overall Study|Withdrawal by Subject|1|||
161424896|NCT00717249|582944714|FG001|Overall Study|Withdrawal by Subject|2|||
161424897|NCT00717249|582944713|FG000|Overall Study|Pregnancy|6|||
161424898|NCT00717249|582944714|FG001|Overall Study|Pregnancy|3|||
161424899|NCT00717249|582944713|FG000|Overall Study|Protocol Violation|0|||
161424900|NCT00717249|582944714|FG001|Overall Study|Protocol Violation|2|||
161424901|NCT00717249|582944713|FG000|Overall Study|Subject became Ineligible|1|||
161424902|NCT00717249|582944714|FG001|Overall Study|Subject became Ineligible|1|||
161424903|NCT00717249|582944713|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
161424904|NCT00717249|582944714|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
161424905|NCT00717249|582944713|FG000|Overall Study|Gastric Surgery|0|||
161424906|NCT00717249|582944714|FG001|Overall Study|Gastric Surgery|1|||
161424907|NCT00717249|582944713|FG000|Overall Study|Diagnosed with Diabetes|1|||
161424908|NCT00717249|582944714|FG001|Overall Study|Diagnosed with Diabetes|0|||
161424909|NCT00717249|582944713|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
161424910|NCT00717249|582944714|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
161424911|NCT00717249|582944713|FG000|Overall Study|Subject relocated|1|||
161424912|NCT00717249|582944714|FG001|Overall Study|Subject relocated|0|||
161424913|NCT00717249|582944713|FG000|Overall Study|Headaches|1|||
161424914|NCT00717249|582944714|FG001|Overall Study|Headaches|0|||
161424915|NCT01808196|582944718|FG000|Overall Study|Lost to Follow-up|1|||
161424916|NCT03370718|582944719|FG000|Overall Study|Withdrawal by Subject|1|||
161424917|NCT00479713|582944720|FG000|Overall Study|Adverse Event|8|||
161424918|NCT00479713|582944721|FG001|Overall Study|Adverse Event|6|||
161424919|NCT00479713|582944720|FG000|Overall Study|Death|1|||
161424920|NCT00479713|582944721|FG001|Overall Study|Death|0|||
161424921|NCT00479713|582944720|FG000|Overall Study|Lost to Follow-up|0|||
161424922|NCT00479713|582944721|FG001|Overall Study|Lost to Follow-up|1|||
161424923|NCT00479713|582944720|FG000|Overall Study|Protocol Violation|0|||
161424924|NCT00479713|582944721|FG001|Overall Study|Protocol Violation|1|||
161424925|NCT00479713|582944720|FG000|Overall Study|Withdrawal by Subject|4|||
161424926|NCT00479713|582944721|FG001|Overall Study|Withdrawal by Subject|1|||
161424927|NCT01670721|582944726|FG000|Overall Study|Participant's decision|15|||
161424928|NCT01670721|582944726|FG000|Overall Study|Other than specified above|38|||
161424929|NCT00141102|582944727|FG000|Overall Study|Adverse Event|233|||
161424930|NCT00141102|582944728|FG001|Overall Study|Adverse Event|305|||
161424931|NCT00141102|582944727|FG000|Overall Study|Laboratory Abnormality|9|||
161424932|NCT00141102|582944728|FG001|Overall Study|Laboratory Abnormality|33|||
161424933|NCT00141102|582944727|FG000|Overall Study|Lack of Efficacy|21|||
161424934|NCT00141102|582944728|FG001|Overall Study|Lack of Efficacy|26|||
161424935|NCT00141102|582944727|FG000|Overall Study|Lost to Follow-up|29|||
161424936|NCT00141102|582944728|FG001|Overall Study|Lost to Follow-up|32|||
161424937|NCT00141102|582944727|FG000|Overall Study|Other|87|||
161424938|NCT00141102|582944728|FG001|Overall Study|Other|76|||
161424939|NCT00141102|582944727|FG000|Overall Study|Withdrawal by Subject|112|||
161424940|NCT00141102|582944728|FG001|Overall Study|Withdrawal by Subject|142|||
161424941|NCT00141102|582944727|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
161424942|NCT00141102|582944728|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
161424943|NCT00141102|582944727|FG000|Overall Study|Death|2|||
161424944|NCT00141102|582944728|FG001|Overall Study|Death|2|||
161424945|NCT05477485|582944729|FG000|Overall Study|Lost to Follow-up|0|||
161424946|NCT05477485|582944730|FG001|Overall Study|Lost to Follow-up|4|||
161424947|NCT03061201|582944731|FG000|Overall Study|Participants Terminated at Month 36|0|||
161424948|NCT03061201|582944732|FG001|Overall Study|Participants Terminated at Month 36|1|||
161424949|NCT03061201|582944733|FG002|Overall Study|Participants Terminated at Month 36|0|||
161424950|NCT03061201|582944734|FG003|Overall Study|Participants Terminated at Month 36|1|||
161424951|NCT03061201|582944731|FG000|Overall Study|Lost to Follow-up|1|||
161424952|NCT03061201|582944732|FG001|Overall Study|Lost to Follow-up|0|||
161424953|NCT03061201|582944733|FG002|Overall Study|Lost to Follow-up|0|||
161424954|NCT03061201|582944734|FG003|Overall Study|Lost to Follow-up|0|||
161424955|NCT01572480|582944735|FG000|Participants Enrolled|Withdrawal by Subject|1|||
161424956|NCT01572480|582944735|FG000|Drug Administration|Discontinued drug/Off Study|1|||
161424957|NCT01572480|582944735|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
161424958|NCT01572480|582944735|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
161424959|NCT05081219|582944736|FG000|Overall Study|Withdrawal by Subject|4|||
161424960|NCT05081219|582944737|FG001|Overall Study|Withdrawal by Subject|0|||
161424961|NCT05081219|582944738|FG002|Overall Study|Withdrawal by Subject|0|||
161424962|NCT05081219|582944739|FG003|Overall Study|Withdrawal by Subject|1|||
161424963|NCT03446313|582944740|FG000|Overall Study|Lost to Follow-up|1|||
161424964|NCT03446313|582944741|FG001|Overall Study|Lost to Follow-up|2|||
161424965|NCT03446313|582944740|FG000|Overall Study|Failed primary screening|3|||
161424966|NCT03446313|582944741|FG001|Overall Study|Failed primary screening|0|||
161424967|NCT03446313|582944740|FG000|Overall Study|Diagnosed with terminal cancer|1|||
161424968|NCT03446313|582944741|FG001|Overall Study|Diagnosed with terminal cancer|0|||
161424969|NCT03446313|582944740|FG000|Overall Study|Excluded from analysis|1|||
161424970|NCT03446313|582944741|FG001|Overall Study|Excluded from analysis|1|||
161424971|NCT05274958|582944742|FG000|Overall Study|Only completed 1 set of PROMs|22|||
161424972|NCT05274958|582944743|FG001|Overall Study|Only completed 1 set of PROMs|35|||
161424973|NCT00866814|582944744|FG000|Overall Study|Lost to Follow-up|12|||
161424974|NCT00866814|582944744|FG000|Overall Study|Adverse Event|2|||
161424975|NCT00866814|582944744|FG000|Overall Study|Physician Decision|1|||
161424976|NCT00866814|582944744|FG000|Overall Study|Death|1|||
161424977|NCT00866814|582944744|FG000|Overall Study|No longer wished to participate|1|||
161424978|NCT00866814|582944744|FG000|Overall Study|Unable to meet follow-up requirements|2|||
161424979|NCT00866814|582944744|FG000|Overall Study|Moved to area without study site|1|||
161424980|NCT02679287|582944749|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
161424981|NCT02679287|582944750|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
161424982|NCT02679287|582944749|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
161424983|NCT02679287|582944750|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
161424984|NCT02679287|582944749|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
161424985|NCT02679287|582944750|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
161424986|NCT02679287|582944749|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
161424987|NCT02679287|582944750|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
161424988|NCT02679287|582944749|FG000|Period 2|Work/Scheduling Conflict|1|||
161424989|NCT02679287|582944750|FG001|Period 2|Work/Scheduling Conflict|0|||
161424990|NCT02679287|582944749|FG000|Period 2|Disliked Mobile System|2|||
161424991|NCT02679287|582944750|FG001|Period 2|Disliked Mobile System|0|||
161424992|NCT02679287|582944749|FG000|Period 3|Work/Scheduling Conflict|0|||
161424993|NCT02679287|582944750|FG001|Period 3|Work/Scheduling Conflict|1|||
161424994|NCT03956550|582946938|FG000|Overall Study|Sponsor decision|65|||
161424995|NCT03956550|582946939|FG001|Overall Study|Sponsor decision|66|||
161424996|NCT03956550|582946940|FG002|Overall Study|Sponsor decision|64|||
161424997|NCT03956550|582946938|FG000|Overall Study|Adverse Event|0|||
161424998|NCT03956550|582946939|FG001|Overall Study|Adverse Event|1|||
161424999|NCT03956550|582946940|FG002|Overall Study|Adverse Event|0|||
161425000|NCT03956550|582946938|FG000|Overall Study|Withdrawal by Subject|5|||
161425001|NCT03956550|582946939|FG001|Overall Study|Withdrawal by Subject|5|||
161425002|NCT03956550|582946940|FG002|Overall Study|Withdrawal by Subject|6|||
161425003|NCT03400852|582946941|FG000|Blinded Treatment Period|Physician Decision|0|||
161425004|NCT03400852|582946942|FG001|Blinded Treatment Period|Physician Decision|1|||
161425005|NCT03400852|582946943|FG002|Blinded Treatment Period|Physician Decision|0|||
161425006|NCT03400852|582946941|FG000|Blinded Treatment Period|Adverse Event|1|||
161425007|NCT03400852|582946942|FG001|Blinded Treatment Period|Adverse Event|1|||
161425008|NCT03400852|582946943|FG002|Blinded Treatment Period|Adverse Event|0|||
161425009|NCT03400852|582946941|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
161425010|NCT03400852|582946942|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
161425011|NCT03400852|582946943|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
161425012|NCT03400852|582946941|FG000|Open Label Period|Physician Decision|0|||
161425013|NCT03400852|582946942|FG001|Open Label Period|Physician Decision|0|||
161425014|NCT03400852|582946943|FG002|Open Label Period|Physician Decision|1|||
161425015|NCT03400852|582946941|FG000|Open Label Period|Study terminated by sponsor|0|||
161425016|NCT03400852|582946942|FG001|Open Label Period|Study terminated by sponsor|0|||
161425017|NCT03400852|582946943|FG002|Open Label Period|Study terminated by sponsor|21|||
161425018|NCT00248495|582946944|FG000|Overall Study|Withdrawal by Subject|1|||
161425019|NCT03719131|582946946|FG000|Overall Study|Death|1|||
161425020|NCT03719131|582946947|FG001|Overall Study|Death|2|||
161425021|NCT04244253|582946948|FG000|Overall Study|Adverse Event|2|||
161425022|NCT04244253|582946949|FG001|Overall Study|Adverse Event|2|||
161425023|NCT04244253|582946950|FG002|Overall Study|Adverse Event|4|||
161425024|NCT04244253|582946948|FG000|Overall Study|Protocol Violation|1|||
161425025|NCT04244253|582946949|FG001|Overall Study|Protocol Violation|2|||
161425026|NCT04244253|582946950|FG002|Overall Study|Protocol Violation|1|||
161425027|NCT04244253|582946948|FG000|Overall Study|Withdrawal by Subject|0|||
161425028|NCT04244253|582946949|FG001|Overall Study|Withdrawal by Subject|1|||
161425029|NCT04244253|582946950|FG002|Overall Study|Withdrawal by Subject|6|||
161425030|NCT04244253|582946948|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161425031|NCT04244253|582946949|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161425032|NCT04244253|582946950|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161425033|NCT01544920|582946951|FG000|Overall Study|Adverse Event|0|||
161425034|NCT01544920|582946952|FG001|Overall Study|Adverse Event|3|||
161425035|NCT01544920|582946951|FG000|Overall Study|Death|0|||
161425036|NCT01544920|582946952|FG001|Overall Study|Death|1|||
161425037|NCT01544920|582946951|FG000|Overall Study|Lost to Follow-up|11|||
161425038|NCT01544920|582946952|FG001|Overall Study|Lost to Follow-up|12|||
161425039|NCT01544920|582946951|FG000|Overall Study|Protocol Violation|0|||
161425040|NCT01544920|582946952|FG001|Overall Study|Protocol Violation|2|||
161425041|NCT01544920|582946951|FG000|Overall Study|Physician Decision|4|||
161425042|NCT01544920|582946952|FG001|Overall Study|Physician Decision|1|||
161425043|NCT01544920|582946951|FG000|Overall Study|Withdrawal by Subject|4|||
161425044|NCT01544920|582946952|FG001|Overall Study|Withdrawal by Subject|4|||
161425045|NCT02420093|582946953|FG000|Overall Study|Withdrawal by Subject|1|||
161425046|NCT02420093|582946954|FG001|Overall Study|Withdrawal by Subject|1|||
161425047|NCT03244917|582946958|FG000|Overall Study|Lost to Follow-up|2|||
161425048|NCT03244917|582946959|FG001|Overall Study|Lost to Follow-up|2|||
161425049|NCT03001557|582946961|FG000|Core Phase|Randomized but not treated|0|||
161425050|NCT03001557|582946962|FG001|Core Phase|Randomized but not treated|0|||
161425051|NCT03001557|582946963|FG002|Core Phase|Randomized but not treated|1|||
161425052|NCT03001557|582946964|FG003|Core Phase|Randomized but not treated|0|||
161425053|NCT03001557|582946965|FG004|Core Phase|Randomized but not treated|0|||
161425054|NCT03001557|582946966|FG005|Core Phase|Randomized but not treated|0|||
161425055|NCT03001557|582946967|FG006|Core Phase|Randomized but not treated|0|||
161425056|NCT03001557|582946968|FG007|Core Phase|Randomized but not treated|0|||
161425057|NCT03001557|582946961|FG000|Extension Phase|Adverse Event|0|||
161425058|NCT03001557|582946962|FG001|Extension Phase|Adverse Event|0|||
161425059|NCT03001557|582946963|FG002|Extension Phase|Adverse Event|0|||
161425060|NCT03001557|582946964|FG003|Extension Phase|Adverse Event|0|||
161425061|NCT03001557|582946965|FG004|Extension Phase|Adverse Event|0|||
161425062|NCT03001557|582946966|FG005|Extension Phase|Adverse Event|2|||
161425063|NCT03001557|582946967|FG006|Extension Phase|Adverse Event|0|||
161425064|NCT03001557|582946968|FG007|Extension Phase|Adverse Event|0|||
161425065|NCT03001557|582946961|FG000|Extension Phase|Withdrawal by Subject|0|||
161425066|NCT03001557|582946962|FG001|Extension Phase|Withdrawal by Subject|0|||
161425067|NCT03001557|582946963|FG002|Extension Phase|Withdrawal by Subject|0|||
161425068|NCT03001557|582946964|FG003|Extension Phase|Withdrawal by Subject|0|||
161425069|NCT03001557|582946965|FG004|Extension Phase|Withdrawal by Subject|0|||
161425070|NCT03001557|582946966|FG005|Extension Phase|Withdrawal by Subject|1|||
161425071|NCT03001557|582946967|FG006|Extension Phase|Withdrawal by Subject|5|||
161425072|NCT03001557|582946968|FG007|Extension Phase|Withdrawal by Subject|2|||
161425073|NCT03001557|582946961|FG000|Extension Phase|Lost to Follow-up|0|||
161425074|NCT03001557|582946962|FG001|Extension Phase|Lost to Follow-up|0|||
161425075|NCT03001557|582946963|FG002|Extension Phase|Lost to Follow-up|0|||
161425076|NCT03001557|582946964|FG003|Extension Phase|Lost to Follow-up|0|||
161425077|NCT03001557|582946965|FG004|Extension Phase|Lost to Follow-up|0|||
161425078|NCT03001557|582946966|FG005|Extension Phase|Lost to Follow-up|0|||
161425079|NCT03001557|582946967|FG006|Extension Phase|Lost to Follow-up|2|||
161425080|NCT03001557|582946968|FG007|Extension Phase|Lost to Follow-up|1|||
161425081|NCT03001557|582946961|FG000|Extension Phase|Administrative Reason|0|||
161425082|NCT03001557|582946962|FG001|Extension Phase|Administrative Reason|0|||
161425083|NCT03001557|582946963|FG002|Extension Phase|Administrative Reason|0|||
161425084|NCT03001557|582946964|FG003|Extension Phase|Administrative Reason|0|||
161425085|NCT03001557|582946965|FG004|Extension Phase|Administrative Reason|0|||
161425086|NCT03001557|582946966|FG005|Extension Phase|Administrative Reason|1|||
161425087|NCT03001557|582946967|FG006|Extension Phase|Administrative Reason|3|||
161425088|NCT03001557|582946968|FG007|Extension Phase|Administrative Reason|3|||
161425089|NCT03001557|582946961|FG000|Extension Phase|Loss of caregiver|0|||
161425090|NCT03001557|582946962|FG001|Extension Phase|Loss of caregiver|0|||
161425091|NCT03001557|582946963|FG002|Extension Phase|Loss of caregiver|0|||
161425092|NCT03001557|582946964|FG003|Extension Phase|Loss of caregiver|0|||
161425093|NCT03001557|582946965|FG004|Extension Phase|Loss of caregiver|0|||
161425094|NCT03001557|582946966|FG005|Extension Phase|Loss of caregiver|0|||
161425095|NCT03001557|582946967|FG006|Extension Phase|Loss of caregiver|1|||
161425096|NCT03001557|582946968|FG007|Extension Phase|Loss of caregiver|0|||
161425097|NCT03001557|582946961|FG000|Extension Phase|Others|0|||
161425098|NCT03001557|582946962|FG001|Extension Phase|Others|0|||
161425099|NCT03001557|582946963|FG002|Extension Phase|Others|0|||
161425100|NCT03001557|582946964|FG003|Extension Phase|Others|0|||
161425101|NCT03001557|582946965|FG004|Extension Phase|Others|0|||
161425102|NCT03001557|582946966|FG005|Extension Phase|Others|1|||
161425103|NCT03001557|582946967|FG006|Extension Phase|Others|3|||
161425104|NCT03001557|582946968|FG007|Extension Phase|Others|0|||
161425105|NCT01272232|582946969|FG000|Weeks 0-56|Adverse Event|39|||
161425106|NCT01272232|582946970|FG001|Weeks 0-56|Adverse Event|18|||
161425107|NCT01272232|582946971|FG002|Weeks 0-56|Adverse Event|7|||
161425108|NCT01272232|582946969|FG000|Weeks 0-56|Lack of Efficacy|0|||
161425109|NCT01272232|582946970|FG001|Weeks 0-56|Lack of Efficacy|0|||
161425110|NCT01272232|582946971|FG002|Weeks 0-56|Lack of Efficacy|3|||
161425111|NCT01272232|582946969|FG000|Weeks 0-56|Protocol Violation|12|||
161425112|NCT01272232|582946970|FG001|Weeks 0-56|Protocol Violation|8|||
161425113|NCT01272232|582946971|FG002|Weeks 0-56|Protocol Violation|13|||
161425114|NCT01272232|582946969|FG000|Weeks 0-56|Withdrawal criteria|32|||
161425115|NCT01272232|582946970|FG001|Weeks 0-56|Withdrawal criteria|14|||
161425116|NCT01272232|582946971|FG002|Weeks 0-56|Withdrawal criteria|37|||
161425117|NCT01272232|582946969|FG000|Weeks 0-56|Unclassified|16|||
161425118|NCT01272232|582946970|FG001|Weeks 0-56|Unclassified|7|||
161425119|NCT01272232|582946971|FG002|Weeks 0-56|Unclassified|12|||
161425120|NCT01272232|582946969|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
161425121|NCT01272232|582946970|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
161425122|NCT01272232|582946971|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
161425123|NCT01272232|582946969|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
161425124|NCT01272232|582946970|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
161425125|NCT01272232|582946971|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
161425126|NCT01272232|582946969|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
161425127|NCT01272232|582946970|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
161425128|NCT01272232|582946971|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
161425129|NCT01272232|582946969|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
161425130|NCT01272232|582946970|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
161425131|NCT01272232|582946971|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
161425132|NCT01272232|582946969|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
161425133|NCT01272232|582946970|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
161425134|NCT01272232|582946971|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
161425135|NCT02159066|582946972|FG000|Part I|Adverse Event|7|||
161425136|NCT02159066|582946973|FG001|Part I|Adverse Event|5|||
161425137|NCT02159066|582946974|FG002|Part I|Adverse Event|0|||
161425138|NCT02159066|582946975|FG003|Part I|Adverse Event|0|||
161425139|NCT02159066|582946976|FG004|Part I|Adverse Event|0|||
161425140|NCT02159066|582946977|FG005|Part I|Adverse Event|0|||
161425141|NCT02159066|582946972|FG000|Part I|Death|11|||
161425142|NCT02159066|582946973|FG001|Part I|Death|9|||
161425143|NCT02159066|582946974|FG002|Part I|Death|0|||
161425144|NCT02159066|582946975|FG003|Part I|Death|0|||
161425145|NCT02159066|582946976|FG004|Part I|Death|0|||
161425146|NCT02159066|582946977|FG005|Part I|Death|0|||
161425147|NCT02159066|582946972|FG000|Part I|Progressive Disease|37|||
161425148|NCT02159066|582946973|FG001|Part I|Progressive Disease|46|||
161425149|NCT02159066|582946974|FG002|Part I|Progressive Disease|0|||
161425150|NCT02159066|582946975|FG003|Part I|Progressive Disease|0|||
161425151|NCT02159066|582946976|FG004|Part I|Progressive Disease|0|||
161425152|NCT02159066|582946977|FG005|Part I|Progressive Disease|0|||
161425153|NCT02159066|582946972|FG000|Part I|New Therapy for Study Indication|5|||
161425154|NCT02159066|582946973|FG001|Part I|New Therapy for Study Indication|4|||
161425155|NCT02159066|582946974|FG002|Part I|New Therapy for Study Indication|0|||
161425156|NCT02159066|582946975|FG003|Part I|New Therapy for Study Indication|0|||
161425157|NCT02159066|582946976|FG004|Part I|New Therapy for Study Indication|0|||
161425158|NCT02159066|582946977|FG005|Part I|New Therapy for Study Indication|0|||
161425159|NCT02159066|582946972|FG000|Part I|Termination of participants from the study|3|||
161425160|NCT02159066|582946973|FG001|Part I|Termination of participants from the study|3|||
161425161|NCT02159066|582946974|FG002|Part I|Termination of participants from the study|0|||
161425162|NCT02159066|582946975|FG003|Part I|Termination of participants from the study|0|||
161425163|NCT02159066|582946976|FG004|Part I|Termination of participants from the study|0|||
161425164|NCT02159066|582946977|FG005|Part I|Termination of participants from the study|0|||
161425165|NCT02159066|582946972|FG000|Part I|Physician Decision|2|||
161425166|NCT02159066|582946973|FG001|Part I|Physician Decision|9|||
161425167|NCT02159066|582946974|FG002|Part I|Physician Decision|0|||
161425168|NCT02159066|582946975|FG003|Part I|Physician Decision|0|||
161425169|NCT02159066|582946976|FG004|Part I|Physician Decision|0|||
161425170|NCT02159066|582946977|FG005|Part I|Physician Decision|0|||
161425171|NCT02159066|582946972|FG000|Part I|Participant/Guardian Decision|9|||
161425172|NCT02159066|582946973|FG001|Part I|Participant/Guardian Decision|3|||
161425173|NCT02159066|582946974|FG002|Part I|Participant/Guardian Decision|0|||
161425174|NCT02159066|582946975|FG003|Part I|Participant/Guardian Decision|0|||
161425175|NCT02159066|582946976|FG004|Part I|Participant/Guardian Decision|0|||
161425176|NCT02159066|582946977|FG005|Part I|Participant/Guardian Decision|0|||
161425177|NCT02159066|582946972|FG000|Part I|Missing Data|1|||
161425178|NCT02159066|582946973|FG001|Part I|Missing Data|0|||
161425179|NCT02159066|582946974|FG002|Part I|Missing Data|0|||
161425180|NCT02159066|582946975|FG003|Part I|Missing Data|0|||
161425181|NCT02159066|582946976|FG004|Part I|Missing Data|0|||
161425182|NCT02159066|582946977|FG005|Part I|Missing Data|0|||
161425183|NCT02159066|582946972|FG000|Part II|Adverse Event|0|||
161425184|NCT02159066|582946973|FG001|Part II|Adverse Event|0|||
161425185|NCT02159066|582946974|FG002|Part II|Adverse Event|1|||
161425186|NCT02159066|582946975|FG003|Part II|Adverse Event|0|||
161425187|NCT02159066|582946976|FG004|Part II|Adverse Event|1|||
161425188|NCT02159066|582946977|FG005|Part II|Adverse Event|1|||
161425189|NCT02159066|582946972|FG000|Part II|Death|0|||
161425190|NCT02159066|582946973|FG001|Part II|Death|0|||
161425191|NCT02159066|582946974|FG002|Part II|Death|1|||
161425192|NCT02159066|582946975|FG003|Part II|Death|0|||
161425193|NCT02159066|582946976|FG004|Part II|Death|2|||
161425194|NCT02159066|582946977|FG005|Part II|Death|1|||
161425195|NCT02159066|582946972|FG000|Part II|Progressive Disease|0|||
161425196|NCT02159066|582946973|FG001|Part II|Progressive Disease|0|||
161425197|NCT02159066|582946974|FG002|Part II|Progressive Disease|35|||
161425198|NCT02159066|582946975|FG003|Part II|Progressive Disease|1|||
161425199|NCT02159066|582946976|FG004|Part II|Progressive Disease|7|||
161425200|NCT02159066|582946977|FG005|Part II|Progressive Disease|4|||
161425201|NCT02159066|582946972|FG000|Part II|New Therapy for Study Indication|0|||
161425202|NCT02159066|582946973|FG001|Part II|New Therapy for Study Indication|0|||
161425203|NCT02159066|582946974|FG002|Part II|New Therapy for Study Indication|0|||
161425204|NCT02159066|582946975|FG003|Part II|New Therapy for Study Indication|0|||
161425205|NCT02159066|582946976|FG004|Part II|New Therapy for Study Indication|1|||
161425206|NCT02159066|582946977|FG005|Part II|New Therapy for Study Indication|0|||
161425207|NCT02159066|582946972|FG000|Part II|Physician Decision|0|||
161425208|NCT02159066|582946973|FG001|Part II|Physician Decision|0|||
161425209|NCT02159066|582946974|FG002|Part II|Physician Decision|1|||
161425210|NCT02159066|582946975|FG003|Part II|Physician Decision|0|||
161425211|NCT02159066|582946976|FG004|Part II|Physician Decision|0|||
161425212|NCT02159066|582946977|FG005|Part II|Physician Decision|0|||
161425213|NCT02159066|582946972|FG000|Part II|Participant/Guardian Decision|0|||
161425214|NCT02159066|582946973|FG001|Part II|Participant/Guardian Decision|0|||
161425215|NCT02159066|582946974|FG002|Part II|Participant/Guardian Decision|0|||
161425216|NCT02159066|582946975|FG003|Part II|Participant/Guardian Decision|0|||
161425217|NCT02159066|582946976|FG004|Part II|Participant/Guardian Decision|2|||
161425218|NCT02159066|582946977|FG005|Part II|Participant/Guardian Decision|0|||
161425219|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161425220|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161425221|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161425222|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425223|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425224|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425225|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425226|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425227|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425228|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425229|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425230|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425231|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161425232|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425233|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161425234|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425235|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161425236|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425237|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425238|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
161425239|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161425240|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
161425241|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
161425242|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425243|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161425244|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425245|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425246|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161425247|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161425248|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
161425249|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
161425250|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
161425251|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
161425252|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
161425253|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
161425254|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
161425255|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
161425256|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
161425257|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
161425258|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
161425259|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
161425260|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
161425261|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
161425262|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
161425263|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
161425264|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
161425265|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425266|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425267|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
161425268|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425269|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425270|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425271|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425272|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425273|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425274|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
161425275|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425276|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425277|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425278|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161425279|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425280|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425281|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425282|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425283|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161425284|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161425285|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425286|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161425287|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425288|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161425289|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425290|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161425291|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425292|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161425293|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161425294|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425295|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425296|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425297|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
161425298|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425299|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425300|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425301|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425302|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425303|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425304|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
161425305|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425306|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425307|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425308|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161425309|NCT01147666|582946978|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425310|NCT01147666|582946979|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425311|NCT01147666|582946980|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425312|NCT01147666|582946981|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425313|NCT01147666|582946982|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425314|NCT01147666|582946983|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425315|NCT01147666|582946984|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425316|NCT01147666|582946985|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425317|NCT01147666|582946986|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425318|NCT01147666|582946987|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425319|NCT01147666|582946988|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425320|NCT01147666|582946989|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
161425321|NCT01147666|582946990|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
161425322|NCT01147666|582946991|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161425323|NCT01147666|582946992|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
161425324|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
161425325|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
161425326|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
161425327|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
161425328|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
161425329|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
161425330|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
161425331|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
161425332|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
161425333|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
161425334|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
161425335|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
161425336|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
161425337|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
161425338|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
161425339|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425340|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425341|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425342|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425343|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
161425344|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
161425345|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
161425346|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
161425347|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425348|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
161425349|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425350|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425351|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
161425352|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161425353|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
161425354|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425355|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425356|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425357|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
161425358|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425359|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425360|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425361|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425362|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425363|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425364|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425365|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425366|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425367|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425368|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161425369|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425370|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425371|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425372|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425373|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161425374|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161425375|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425376|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161425377|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425378|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161425379|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425380|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425381|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425382|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161425383|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161425384|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425385|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425386|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425387|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
161425388|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425389|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425390|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425391|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425392|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425393|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425394|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
161425395|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425396|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425397|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425398|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161425399|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425400|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425401|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425402|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425403|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425404|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425405|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425406|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425407|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425408|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425409|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425410|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425411|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
161425412|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425413|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161425414|NCT01147666|582946978|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425415|NCT01147666|582946979|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425416|NCT01147666|582946980|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425417|NCT01147666|582946981|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425418|NCT01147666|582946982|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425419|NCT01147666|582946983|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425420|NCT01147666|582946984|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425421|NCT01147666|582946985|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425422|NCT01147666|582946986|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425423|NCT01147666|582946987|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425424|NCT01147666|582946988|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425425|NCT01147666|582946989|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425426|NCT01147666|582946990|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
161425427|NCT01147666|582946991|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161425428|NCT01147666|582946992|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
161425429|NCT02748863|582946993|FG000|Treatment Period 1|Adverse Event|0|||
161425430|NCT02748863|582946994|FG001|Treatment Period 1|Adverse Event|1|||
161425431|NCT02748863|582946995|FG002|Treatment Period 1|Adverse Event|0|||
161425432|NCT02748863|582946996|FG003|Treatment Period 1|Adverse Event|0|||
161425433|NCT02748863|582946997|FG004|Treatment Period 1|Adverse Event|0|||
161425434|NCT02748863|582946993|FG000|Treatment Period 1|Lack of Efficacy|0|||
161425435|NCT02748863|582946994|FG001|Treatment Period 1|Lack of Efficacy|0|||
161425436|NCT02748863|582946995|FG002|Treatment Period 1|Lack of Efficacy|1|||
161425437|NCT02748863|582946996|FG003|Treatment Period 1|Lack of Efficacy|0|||
161425438|NCT02748863|582946997|FG004|Treatment Period 1|Lack of Efficacy|0|||
161425439|NCT02748863|582946993|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161425440|NCT02748863|582946994|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161425441|NCT02748863|582946995|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161425442|NCT02748863|582946996|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161425443|NCT02748863|582946997|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161425444|NCT02748863|582946993|FG000|Treatment Period 2|Lost to Follow-up|2|||
161425445|NCT02748863|582946994|FG001|Treatment Period 2|Lost to Follow-up|0|||
161425446|NCT02748863|582946995|FG002|Treatment Period 2|Lost to Follow-up|0|||
161425447|NCT02748863|582946996|FG003|Treatment Period 2|Lost to Follow-up|0|||
161425448|NCT02748863|582946997|FG004|Treatment Period 2|Lost to Follow-up|0|||
161425449|NCT02748863|582946993|FG000|Treatment Period 2|Adverse Event|3|||
161425450|NCT02748863|582946994|FG001|Treatment Period 2|Adverse Event|2|||
161425451|NCT02748863|582946995|FG002|Treatment Period 2|Adverse Event|0|||
161425452|NCT02748863|582946996|FG003|Treatment Period 2|Adverse Event|2|||
161425453|NCT02748863|582946997|FG004|Treatment Period 2|Adverse Event|0|||
161425454|NCT02748863|582946993|FG000|Treatment Period 2|Lack of Efficacy|0|||
161425455|NCT02748863|582946994|FG001|Treatment Period 2|Lack of Efficacy|1|||
161425456|NCT02748863|582946995|FG002|Treatment Period 2|Lack of Efficacy|0|||
161425457|NCT02748863|582946996|FG003|Treatment Period 2|Lack of Efficacy|0|||
161425458|NCT02748863|582946997|FG004|Treatment Period 2|Lack of Efficacy|0|||
161425459|NCT02748863|582946993|FG000|Treatment Period 2|Pregnancy|0|||
161425460|NCT02748863|582946994|FG001|Treatment Period 2|Pregnancy|0|||
161425461|NCT02748863|582946995|FG002|Treatment Period 2|Pregnancy|0|||
161425462|NCT02748863|582946996|FG003|Treatment Period 2|Pregnancy|0|||
161425463|NCT02748863|582946997|FG004|Treatment Period 2|Pregnancy|1|||
161425464|NCT02576639|582946999|FG000|Overall Study|Withdrawal by Subject|1|||
161425465|NCT02576639|582947000|FG001|Overall Study|Withdrawal by Subject|2|||
161425466|NCT02576639|582947001|FG002|Overall Study|Withdrawal by Subject|1|||
161425467|NCT02576639|582947002|FG003|Overall Study|Withdrawal by Subject|0|||
161425468|NCT02576639|582947003|FG004|Overall Study|Withdrawal by Subject|1|||
161425469|NCT02576639|582946999|FG000|Overall Study|Adverse Event|1|||
161425470|NCT02576639|582947000|FG001|Overall Study|Adverse Event|0|||
161425471|NCT02576639|582947001|FG002|Overall Study|Adverse Event|1|||
161425472|NCT02576639|582947002|FG003|Overall Study|Adverse Event|1|||
161425473|NCT02576639|582947003|FG004|Overall Study|Adverse Event|2|||
161425474|NCT02576639|582946999|FG000|Overall Study|Physician Decision|0|||
161425475|NCT02576639|582947000|FG001|Overall Study|Physician Decision|0|||
161425476|NCT02576639|582947001|FG002|Overall Study|Physician Decision|0|||
161425477|NCT02576639|582947002|FG003|Overall Study|Physician Decision|0|||
161425478|NCT02576639|582947003|FG004|Overall Study|Physician Decision|1|||
161425479|NCT01135134|582947004|FG000|Overall Study|Adverse Event|1|||
161425480|NCT01135134|582947005|FG001|Overall Study|Adverse Event|1|||
161425481|NCT01135134|582947004|FG000|Overall Study|Did not meet protocol eligibility|1|||
161425482|NCT01135134|582947005|FG001|Overall Study|Did not meet protocol eligibility|0|||
161425483|NCT01329978|582947011|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
161425484|NCT01329978|582947012|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
161425485|NCT01329978|582947013|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
161425486|NCT01329978|582947014|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
161425487|NCT01329978|582947015|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
161425488|NCT01329978|582947011|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
161425489|NCT01329978|582947012|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
161425490|NCT01329978|582947013|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
161425491|NCT01329978|582947014|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
161425492|NCT01329978|582947015|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
161425493|NCT01329978|582947011|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
161425494|NCT01329978|582947012|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
161425495|NCT01329978|582947013|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
161425496|NCT01329978|582947014|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
161425497|NCT01329978|582947015|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
161425498|NCT01329978|582947011|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161425499|NCT01329978|582947012|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
161425500|NCT01329978|582947013|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161425501|NCT01329978|582947014|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161425502|NCT01329978|582947015|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161425503|NCT01329978|582947011|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161425504|NCT01329978|582947012|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
161425505|NCT01329978|582947013|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161425506|NCT01329978|582947014|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161425507|NCT01329978|582947015|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161425508|NCT01329978|582947011|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
161425509|NCT01329978|582947012|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
161425510|NCT01329978|582947013|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
161425511|NCT01329978|582947014|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
161425512|NCT01329978|582947015|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
161425513|NCT01329978|582947011|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161425514|NCT01329978|582947012|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161425515|NCT01329978|582947013|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161425516|NCT01329978|582947014|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161425517|NCT01329978|582947015|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
161425518|NCT01188772|582947019|FG000|Overall Study|Randomized but Not Treated|0|||
161425519|NCT01188772|582947020|FG001|Overall Study|Randomized but Not Treated|1|||
161425520|NCT01188772|582947021|FG002|Overall Study|Randomized but Not Treated|0|||
161425521|NCT01188772|582947022|FG003|Overall Study|Randomized but Not Treated|0|||
161425522|NCT01188772|582947019|FG000|Overall Study|Adverse Event|0|||
161425523|NCT01188772|582947020|FG001|Overall Study|Adverse Event|1|||
161425524|NCT01188772|582947021|FG002|Overall Study|Adverse Event|2|||
161425525|NCT01188772|582947022|FG003|Overall Study|Adverse Event|0|||
161425526|NCT01188772|582947019|FG000|Overall Study|Lost to Follow-up|4|||
161425527|NCT01188772|582947020|FG001|Overall Study|Lost to Follow-up|1|||
161425528|NCT01188772|582947021|FG002|Overall Study|Lost to Follow-up|1|||
161425529|NCT01188772|582947022|FG003|Overall Study|Lost to Follow-up|1|||
161425530|NCT01188772|582947019|FG000|Overall Study|Non-responder|0|||
161425531|NCT01188772|582947020|FG001|Overall Study|Non-responder|0|||
161425532|NCT01188772|582947021|FG002|Overall Study|Non-responder|3|||
161425533|NCT01188772|582947022|FG003|Overall Study|Non-responder|0|||
161425534|NCT01188772|582947019|FG000|Overall Study|Physician Decision|0|||
161425535|NCT01188772|582947020|FG001|Overall Study|Physician Decision|0|||
161425536|NCT01188772|582947021|FG002|Overall Study|Physician Decision|1|||
161425537|NCT01188772|582947022|FG003|Overall Study|Physician Decision|0|||
161425538|NCT01188772|582947019|FG000|Overall Study|Terminated by Sponsor|0|||
161425539|NCT01188772|582947020|FG001|Overall Study|Terminated by Sponsor|0|||
161425540|NCT01188772|582947021|FG002|Overall Study|Terminated by Sponsor|1|||
161425541|NCT01188772|582947022|FG003|Overall Study|Terminated by Sponsor|0|||
161425542|NCT01188772|582947019|FG000|Overall Study|Treatment Failure|0|||
161425543|NCT01188772|582947020|FG001|Overall Study|Treatment Failure|0|||
161425544|NCT01188772|582947021|FG002|Overall Study|Treatment Failure|1|||
161425545|NCT01188772|582947022|FG003|Overall Study|Treatment Failure|0|||
161425546|NCT01188772|582947019|FG000|Overall Study|Virologic Failure|1|||
161425547|NCT01188772|582947020|FG001|Overall Study|Virologic Failure|0|||
161425548|NCT01188772|582947021|FG002|Overall Study|Virologic Failure|0|||
161425549|NCT01188772|582947022|FG003|Overall Study|Virologic Failure|0|||
161425550|NCT01188772|582947019|FG000|Overall Study|Withdrawal by Subject|0|||
161425551|NCT01188772|582947020|FG001|Overall Study|Withdrawal by Subject|0|||
161425552|NCT01188772|582947021|FG002|Overall Study|Withdrawal by Subject|2|||
161425553|NCT01188772|582947022|FG003|Overall Study|Withdrawal by Subject|0|||
161425554|NCT03081884|582947026|FG000|Overall Study|deferred prostate cancer treatment|1|||
161425555|NCT03081884|582947026|FG000|Overall Study|metastasis managed with systemic therapy|3|||
161425556|NCT02294058|582947027|FG000|Overall Study|Adverse Event|16|||
161425557|NCT02294058|582947028|FG001|Overall Study|Adverse Event|7|||
161425558|NCT02294058|582947029|FG002|Overall Study|Adverse Event|13|||
161425559|NCT02294058|582947027|FG000|Overall Study|Lack of Efficacy|3|||
161425560|NCT02294058|582947028|FG001|Overall Study|Lack of Efficacy|3|||
161425561|NCT02294058|582947029|FG002|Overall Study|Lack of Efficacy|0|||
161425562|NCT02294058|582947027|FG000|Overall Study|Lost to Follow-up|1|||
161425563|NCT02294058|582947028|FG001|Overall Study|Lost to Follow-up|0|||
161425564|NCT02294058|582947029|FG002|Overall Study|Lost to Follow-up|2|||
161425565|NCT02294058|582947027|FG000|Overall Study|Withdrawal by Subject|10|||
161425566|NCT02294058|582947028|FG001|Overall Study|Withdrawal by Subject|14|||
161425567|NCT02294058|582947029|FG002|Overall Study|Withdrawal by Subject|13|||
161425568|NCT02294058|582947027|FG000|Overall Study|Physician Decision|2|||
161425569|NCT02294058|582947028|FG001|Overall Study|Physician Decision|1|||
161425570|NCT02294058|582947029|FG002|Overall Study|Physician Decision|0|||
161425571|NCT02294058|582947027|FG000|Overall Study|Miscellaneous|4|||
161425572|NCT02294058|582947028|FG001|Overall Study|Miscellaneous|1|||
161425573|NCT02294058|582947029|FG002|Overall Study|Miscellaneous|1|||
161425574|NCT01894607|582947031|FG000|Overall Study|Ineligible|1|||
161425575|NCT01787461|582947044|FG000|Overall Study|Adverse Event|4|||
161425576|NCT01787461|582947045|FG001|Overall Study|Adverse Event|3|||
161425577|NCT01787461|582947044|FG000|Overall Study|Lost to Follow-up|3|||
161425578|NCT01787461|582947045|FG001|Overall Study|Lost to Follow-up|2|||
161425579|NCT01787461|582947044|FG000|Overall Study|No longer met eligibility criteria|1|||
161425580|NCT01787461|582947045|FG001|Overall Study|No longer met eligibility criteria|0|||
161425581|NCT01787461|582947044|FG000|Overall Study|Withdrawal by Subject|3|||
161425582|NCT01787461|582947045|FG001|Overall Study|Withdrawal by Subject|4|||
161425583|NCT01787461|582947044|FG000|Overall Study|Protocol Violation|3|||
161425584|NCT01787461|582947045|FG001|Overall Study|Protocol Violation|0|||
161425585|NCT00152503|582947046|FG000|Overall Study|Adverse Event|4|||
161425586|NCT03259555|582947047|FG000|Overall Study|Adverse Event|6|||
161425587|NCT03259555|582947048|FG001|Overall Study|Adverse Event|4|||
161425588|NCT03259555|582947047|FG000|Overall Study|Lack of Efficacy|6|||
161425589|NCT03259555|582947048|FG001|Overall Study|Lack of Efficacy|4|||
161425590|NCT03259555|582947047|FG000|Overall Study|Lost to Follow-up|0|||
161425591|NCT03259555|582947048|FG001|Overall Study|Lost to Follow-up|2|||
161425592|NCT03259555|582947047|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161425593|NCT03259555|582947048|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161425594|NCT03259555|582947047|FG000|Overall Study|Progressive Disease|0|||
161425595|NCT03259555|582947048|FG001|Overall Study|Progressive Disease|2|||
161425596|NCT03259555|582947047|FG000|Overall Study|Withdrawal by Subject|19|||
161425597|NCT03259555|582947048|FG001|Overall Study|Withdrawal by Subject|16|||
161425598|NCT03259555|582947047|FG000|Overall Study|Physician Decision|1|||
161425599|NCT03259555|582947048|FG001|Overall Study|Physician Decision|2|||
161425600|NCT03259555|582947047|FG000|Overall Study|Other|1|||
161425601|NCT03259555|582947048|FG001|Overall Study|Other|0|||
161425602|NCT03957551|582947049|FG000|Overall Study|Adverse Event|2|||
161425603|NCT03957551|582947050|FG001|Overall Study|Adverse Event|2|||
161425604|NCT03957551|582947051|FG002|Overall Study|Adverse Event|6|||
161425605|NCT03957551|582947049|FG000|Overall Study|Physician Decision|1|||
161425606|NCT03957551|582947050|FG001|Overall Study|Physician Decision|0|||
161425607|NCT03957551|582947051|FG002|Overall Study|Physician Decision|2|||
161425608|NCT03957551|582947049|FG000|Overall Study|Withdrawal by Subject|1|||
161425609|NCT03957551|582947050|FG001|Overall Study|Withdrawal by Subject|0|||
161425610|NCT03957551|582947051|FG002|Overall Study|Withdrawal by Subject|2|||
161425611|NCT03957551|582947049|FG000|Overall Study|Disease progression|1|||
161425612|NCT03957551|582947050|FG001|Overall Study|Disease progression|0|||
161425613|NCT03957551|582947051|FG002|Overall Study|Disease progression|8|||
161425614|NCT00607087|582947052|FG000|Overall Study|Withdrawal by Subject|9|||
161425615|NCT00607087|582947053|FG001|Overall Study|Withdrawal by Subject|4|||
161425616|NCT00607087|582947054|FG002|Overall Study|Withdrawal by Subject|4|||
161425617|NCT00607087|582947052|FG000|Overall Study|Adverse Event|3|||
161425618|NCT00607087|582947053|FG001|Overall Study|Adverse Event|2|||
161425619|NCT00607087|582947054|FG002|Overall Study|Adverse Event|3|||
161425620|NCT00607087|582947052|FG000|Overall Study|Other reason|1|||
161425621|NCT00607087|582947053|FG001|Overall Study|Other reason|5|||
161425622|NCT00607087|582947054|FG002|Overall Study|Other reason|2|||
161425623|NCT00607087|582947052|FG000|Overall Study|Poor compliance to protocol|1|||
161425624|NCT00607087|582947053|FG001|Overall Study|Poor compliance to protocol|0|||
161425625|NCT00607087|582947054|FG002|Overall Study|Poor compliance to protocol|1|||
161425626|NCT00607087|582947052|FG000|Overall Study|Lost to Follow-up|1|||
161425627|NCT00607087|582947053|FG001|Overall Study|Lost to Follow-up|0|||
161425628|NCT00607087|582947054|FG002|Overall Study|Lost to Follow-up|0|||
161425629|NCT00607087|582947052|FG000|Period 1|Withdrawal by Subject|7|||
161425630|NCT00607087|582947053|FG001|Period 1|Withdrawal by Subject|2|||
161425631|NCT00607087|582947054|FG002|Period 1|Withdrawal by Subject|3|||
161425632|NCT00607087|582947052|FG000|Period 1|Adverse Event|3|||
161425633|NCT00607087|582947053|FG001|Period 1|Adverse Event|0|||
161425634|NCT00607087|582947054|FG002|Period 1|Adverse Event|0|||
161425635|NCT00607087|582947052|FG000|Period 1|Poor compliance to protocol|1|||
161425636|NCT00607087|582947053|FG001|Period 1|Poor compliance to protocol|0|||
161425637|NCT00607087|582947054|FG002|Period 1|Poor compliance to protocol|0|||
161425638|NCT00607087|582947052|FG000|Period 1|Lost to Follow-up|1|||
161425639|NCT00607087|582947053|FG001|Period 1|Lost to Follow-up|0|||
161425640|NCT00607087|582947054|FG002|Period 1|Lost to Follow-up|0|||
161425641|NCT00607087|582947052|FG000|Period 1|Other reason|0|||
161425642|NCT00607087|582947053|FG001|Period 1|Other reason|4|||
161425643|NCT00607087|582947054|FG002|Period 1|Other reason|2|||
161425644|NCT00607087|582947052|FG000|Period 2|Withdrawal by Subject|0|||
161425645|NCT00607087|582947053|FG001|Period 2|Withdrawal by Subject|1|||
161425646|NCT00607087|582947054|FG002|Period 2|Withdrawal by Subject|1|||
161425647|NCT00607087|582947052|FG000|Period 2|Other reason|1|||
161425648|NCT00607087|582947053|FG001|Period 2|Other reason|1|||
161425649|NCT00607087|582947054|FG002|Period 2|Other reason|0|||
161425650|NCT00607087|582947052|FG000|Period 2|Adverse Event|0|||
161425651|NCT00607087|582947053|FG001|Period 2|Adverse Event|1|||
161425652|NCT00607087|582947054|FG002|Period 2|Adverse Event|3|||
161425653|NCT00607087|582947052|FG000|Period 2|Poor compliance to protocol|0|||
161425654|NCT00607087|582947053|FG001|Period 2|Poor compliance to protocol|0|||
161425655|NCT00607087|582947054|FG002|Period 2|Poor compliance to protocol|1|||
161425656|NCT00607087|582947052|FG000|Period 3|Withdrawal by Subject|2|||
161425657|NCT00607087|582947053|FG001|Period 3|Withdrawal by Subject|1|||
161425658|NCT00607087|582947054|FG002|Period 3|Withdrawal by Subject|0|||
161425659|NCT00607087|582947052|FG000|Period 3|Adverse Event|0|||
161425660|NCT00607087|582947053|FG001|Period 3|Adverse Event|1|||
161425661|NCT00607087|582947054|FG002|Period 3|Adverse Event|0|||
161425662|NCT02717494|582947057|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
161425663|NCT02717494|582947058|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
161425664|NCT02717494|582947059|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
161425665|NCT02717494|582947057|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
161425666|NCT02717494|582947058|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
161425667|NCT02717494|582947059|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
161425668|NCT02717494|582947057|FG000|First Intervention (Step 1)|Death|0|||
161425669|NCT02717494|582947058|FG001|First Intervention (Step 1)|Death|0|||
161425670|NCT02717494|582947059|FG002|First Intervention (Step 1)|Death|1|||
161425671|NCT02717494|582947057|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
161425672|NCT02717494|582947058|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
161425673|NCT02717494|582947059|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
161425674|NCT01774799|582947065|FG000|Overall Study|Lost to Follow-up|1|||
161425675|NCT01774799|582947066|FG001|Overall Study|Lost to Follow-up|1|||
161425676|NCT01774799|582947067|FG002|Overall Study|Lost to Follow-up|0|||
161425677|NCT01774799|582947068|FG003|Overall Study|Lost to Follow-up|0|||
161425678|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
161425679|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
161425680|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
161425681|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
161425682|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
161425683|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
161425684|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
161425685|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
161425686|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
161425687|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
161425688|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
161425689|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
161425690|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
161425691|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
161425692|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
161425693|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
161425694|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
161425695|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
161425696|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
161425697|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
161425698|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
161425699|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
161425700|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
161425701|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
161425702|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
161425703|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
161425704|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
161425705|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
161425706|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
161425707|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
161425708|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
161425709|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
161425710|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
161425711|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
161425712|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
161425713|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
161425714|NCT02586623|582947069|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
161425715|NCT02586623|582947070|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
161425716|NCT02586623|582947071|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
161425717|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
161425718|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
161425719|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
161425720|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
161425721|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
161425722|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
161425723|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
161425724|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
161425725|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
161425726|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
161425727|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
161425728|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
161425729|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
161425730|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
161425731|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
161425732|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
161425733|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
161425734|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
161425735|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
161425736|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
161425737|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
161425738|NCT02586623|582947069|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
161425739|NCT02586623|582947070|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
161425740|NCT02586623|582947071|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
161425741|NCT04393493|582947074|FG000|First 4 Days of Intervention|Early improvement|5|||
161425742|NCT04393493|582947075|FG001|First 4 Days of Intervention|Early improvement|7|||
161425743|NCT02910466|582947076|FG000|Overall Study|Adverse Event|1|||
161425744|NCT02910466|582947076|FG000|Overall Study|Withdrawal by Subject|3|||
161425745|NCT02910466|582947076|FG000|Overall Study|Lost to Follow-up|5|||
161425746|NCT02910466|582947076|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
161425747|NCT02910466|582947076|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
161425748|NCT01125800|582947078|FG000|Phase I|Protocol Violation|0|||
161425749|NCT01125800|582947079|FG001|Phase I|Protocol Violation|3|||
161425750|NCT01125800|582947080|FG002|Phase I|Protocol Violation|1|||
161425751|NCT01125800|582947081|FG003|Phase I|Protocol Violation|1|||
161425752|NCT01125800|582947082|FG004|Phase I|Protocol Violation|0|||
161425753|NCT01125800|582947078|FG000|Phase I|Adverse Event|2|||
161425754|NCT01125800|582947079|FG001|Phase I|Adverse Event|2|||
161425755|NCT01125800|582947080|FG002|Phase I|Adverse Event|1|||
161425756|NCT01125800|582947081|FG003|Phase I|Adverse Event|7|||
161425757|NCT01125800|582947082|FG004|Phase I|Adverse Event|0|||
161425758|NCT01125800|582947078|FG000|Phase I|Administrative problems|1|||
161425759|NCT01125800|582947079|FG001|Phase I|Administrative problems|0|||
161425760|NCT01125800|582947080|FG002|Phase I|Administrative problems|0|||
161425761|NCT01125800|582947081|FG003|Phase I|Administrative problems|0|||
161425762|NCT01125800|582947082|FG004|Phase I|Administrative problems|0|||
161425763|NCT01125800|582947078|FG000|Phase I|Withdrawal by Subject|0|||
161425764|NCT01125800|582947079|FG001|Phase I|Withdrawal by Subject|0|||
161425765|NCT01125800|582947080|FG002|Phase I|Withdrawal by Subject|1|||
161425766|NCT01125800|582947081|FG003|Phase I|Withdrawal by Subject|0|||
161425767|NCT01125800|582947082|FG004|Phase I|Withdrawal by Subject|0|||
161425768|NCT01125800|582947078|FG000|Phase I|Disease progression|5|||
161425769|NCT01125800|582947079|FG001|Phase I|Disease progression|4|||
161425770|NCT01125800|582947080|FG002|Phase I|Disease progression|1|||
161425771|NCT01125800|582947081|FG003|Phase I|Disease progression|3|||
161425772|NCT01125800|582947082|FG004|Phase I|Disease progression|0|||
161425773|NCT01125800|582947078|FG000|Phase II|Protocol Violation|0|||
161425774|NCT01125800|582947079|FG001|Phase II|Protocol Violation|0|||
161425775|NCT01125800|582947080|FG002|Phase II|Protocol Violation|0|||
161425776|NCT01125800|582947081|FG003|Phase II|Protocol Violation|0|||
161425777|NCT01125800|582947082|FG004|Phase II|Protocol Violation|1|||
161425778|NCT01125800|582947078|FG000|Phase II|Adverse Event|0|||
161425779|NCT01125800|582947079|FG001|Phase II|Adverse Event|0|||
161425780|NCT01125800|582947080|FG002|Phase II|Adverse Event|0|||
161425781|NCT01125800|582947081|FG003|Phase II|Adverse Event|0|||
161425782|NCT01125800|582947082|FG004|Phase II|Adverse Event|2|||
161425783|NCT01125800|582947078|FG000|Phase II|Disease progression|0|||
161425784|NCT01125800|582947079|FG001|Phase II|Disease progression|0|||
161425785|NCT01125800|582947080|FG002|Phase II|Disease progression|0|||
161425786|NCT01125800|582947081|FG003|Phase II|Disease progression|1|||
161425787|NCT01125800|582947082|FG004|Phase II|Disease progression|8|||
161425788|NCT05051579|582947086|FG000|Overall Study|Withdrawal by Subject|3|||
161425789|NCT05051579|582947087|FG001|Overall Study|Withdrawal by Subject|5|||
161425790|NCT05051579|582947088|FG002|Overall Study|Withdrawal by Subject|2|||
161425791|NCT05051579|582947089|FG003|Overall Study|Withdrawal by Subject|1|||
161425792|NCT05051579|582947090|FG004|Overall Study|Withdrawal by Subject|4|||
161425793|NCT05051579|582947091|FG005|Overall Study|Withdrawal by Subject|0|||
161425794|NCT05051579|582947092|FG006|Overall Study|Withdrawal by Subject|4|||
161425795|NCT05051579|582947086|FG000|Overall Study|Lost to Follow-up|1|||
161425796|NCT05051579|582947087|FG001|Overall Study|Lost to Follow-up|0|||
161425797|NCT05051579|582947088|FG002|Overall Study|Lost to Follow-up|0|||
161425798|NCT05051579|582947089|FG003|Overall Study|Lost to Follow-up|0|||
161425799|NCT05051579|582947090|FG004|Overall Study|Lost to Follow-up|1|||
161425800|NCT05051579|582947091|FG005|Overall Study|Lost to Follow-up|0|||
161425801|NCT05051579|582947092|FG006|Overall Study|Lost to Follow-up|1|||
161425802|NCT05051579|582947086|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161425803|NCT05051579|582947087|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161425804|NCT05051579|582947088|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161425805|NCT05051579|582947089|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161425806|NCT05051579|582947090|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161425807|NCT05051579|582947091|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161425808|NCT05051579|582947092|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
161425809|NCT05051579|582947086|FG000|Overall Study|Adverse Event|2|||
161425810|NCT05051579|582947087|FG001|Overall Study|Adverse Event|1|||
161425811|NCT05051579|582947088|FG002|Overall Study|Adverse Event|0|||
161425812|NCT05051579|582947089|FG003|Overall Study|Adverse Event|4|||
161425813|NCT05051579|582947090|FG004|Overall Study|Adverse Event|1|||
161425814|NCT05051579|582947091|FG005|Overall Study|Adverse Event|2|||
161425815|NCT05051579|582947092|FG006|Overall Study|Adverse Event|0|||
161425816|NCT05051579|582947086|FG000|Overall Study|Inadvertent Enrollment|0|||
161425817|NCT05051579|582947087|FG001|Overall Study|Inadvertent Enrollment|0|||
161425818|NCT05051579|582947088|FG002|Overall Study|Inadvertent Enrollment|0|||
161425819|NCT05051579|582947089|FG003|Overall Study|Inadvertent Enrollment|0|||
161425820|NCT05051579|582947090|FG004|Overall Study|Inadvertent Enrollment|0|||
161425821|NCT05051579|582947091|FG005|Overall Study|Inadvertent Enrollment|0|||
161425822|NCT05051579|582947092|FG006|Overall Study|Inadvertent Enrollment|1|||
161425823|NCT05051579|582947086|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161425824|NCT05051579|582947087|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
161425825|NCT05051579|582947088|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161425826|NCT05051579|582947089|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161425827|NCT05051579|582947090|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161425828|NCT05051579|582947091|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161425829|NCT05051579|582947092|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161425830|NCT05051579|582947086|FG000|Overall Study|Sponsor Decision|0|||
161425831|NCT05051579|582947087|FG001|Overall Study|Sponsor Decision|0|||
161425832|NCT05051579|582947088|FG002|Overall Study|Sponsor Decision|0|||
161425833|NCT05051579|582947089|FG003|Overall Study|Sponsor Decision|0|||
161425834|NCT05051579|582947090|FG004|Overall Study|Sponsor Decision|1|||
161425835|NCT05051579|582947091|FG005|Overall Study|Sponsor Decision|0|||
161425836|NCT05051579|582947092|FG006|Overall Study|Sponsor Decision|0|||
161425837|NCT05051579|582947086|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161425838|NCT05051579|582947087|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161435340|NCT03104868|582988000|FG000|6 Week Follow up|Withdrawal by Subject|7|||
161425839|NCT05051579|582947088|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161425840|NCT05051579|582947089|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161425841|NCT05051579|582947090|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
161425842|NCT05051579|582947091|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161425843|NCT05051579|582947092|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161425844|NCT06172348|582947097|FG000|Treatment Period 2|Adverse Event|0|||
161425845|NCT06172348|582947098|FG001|Treatment Period 2|Adverse Event|0|||
161425846|NCT06172348|582947099|FG002|Treatment Period 2|Adverse Event|1|||
161425847|NCT06172348|582947100|FG003|Treatment Period 2|Adverse Event|0|||
161425848|NCT06172348|582947101|FG004|Treatment Period 2|Adverse Event|0|||
161425849|NCT06172348|582947102|FG005|Treatment Period 2|Adverse Event|0|||
161425850|NCT03799341|582947103|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
161425851|NCT03799341|582947104|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
161425852|NCT03799341|582947105|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
161425853|NCT03799341|582947103|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
161425854|NCT03799341|582947104|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
161425855|NCT03799341|582947105|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
161425856|NCT03799341|582947103|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
161425857|NCT03799341|582947104|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
161425858|NCT03799341|582947105|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
161425859|NCT03799341|582947103|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
161425860|NCT03799341|582947104|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
161425861|NCT03799341|582947105|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
161425862|NCT03799341|582947103|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
161425863|NCT03799341|582947104|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
161425864|NCT03799341|582947105|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
161425865|NCT03799341|582947103|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
161425866|NCT03799341|582947104|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
161425867|NCT03799341|582947105|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
161425868|NCT04539938|582947106|FG000|Overall Study|Death|30|||
161425869|NCT04539938|582947106|FG000|Overall Study|Withdrawal by Subject|4|||
161425870|NCT04037891|582947107|FG000|Open-label Period|Withdrawal by Subject|1|||
161425871|NCT04037891|582947108|FG001|Open-label Period|Withdrawal by Subject|0|||
161425872|NCT04037891|582947109|FG002|Open-label Period|Withdrawal by Subject|0|||
161425873|NCT04037891|582947107|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
161425874|NCT04037891|582947108|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
161425875|NCT04037891|582947109|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
161425876|NCT00990106|582947110|FG000|Overall Study|"too busy to continue"|1|||
161425877|NCT00990106|582947111|FG001|Overall Study|"too busy to continue"|2|||
161425878|NCT00990106|582947110|FG000|Overall Study|Lost to Follow-up|1|||
161425879|NCT00990106|582947111|FG001|Overall Study|Lost to Follow-up|3|||
161425880|NCT00990106|582947110|FG000|Overall Study|Withdrawal by Subject|2|||
161425881|NCT00990106|582947111|FG001|Overall Study|Withdrawal by Subject|1|||
161425882|NCT00990106|582947110|FG000|Overall Study|opted for open label prazosin|1|||
161425883|NCT00990106|582947111|FG001|Overall Study|opted for open label prazosin|1|||
161425884|NCT00990106|582947110|FG000|Overall Study|relocation/deployment|4|||
161425885|NCT00990106|582947111|FG001|Overall Study|relocation/deployment|1|||
161425886|NCT00990106|582947110|FG000|Overall Study|started exclusionary medication|0|||
161425887|NCT00990106|582947111|FG001|Overall Study|started exclusionary medication|1|||
161425888|NCT00990106|582947110|FG000|Overall Study|planned major surgery|0|||
161425889|NCT00990106|582947111|FG001|Overall Study|planned major surgery|1|||
161425890|NCT00990106|582947110|FG000|Overall Study|scheduling conflicts|0|||
161425891|NCT00990106|582947111|FG001|Overall Study|scheduling conflicts|2|||
161425892|NCT04194944|582947112|FG000|Overall Study|Lost to Follow-up|3|||
161425893|NCT04194944|582947113|FG001|Overall Study|Lost to Follow-up|0|||
161425894|NCT04194944|582947112|FG000|Overall Study|Withdrawal by Subject|2|||
161425895|NCT04194944|582947113|FG001|Overall Study|Withdrawal by Subject|2|||
161425896|NCT04194944|582947112|FG000|Overall Study|On Treatment|93|||
161425897|NCT04194944|582947113|FG001|Overall Study|On Treatment|30|||
161425898|NCT00348673|582947116|FG000|Stage 1|Randomized but not Treated|0|||
161425899|NCT00348673|582947117|FG001|Stage 1|Randomized but not Treated|0|||
161425900|NCT00348673|582947118|FG002|Stage 1|Randomized but not Treated|1|||
161425901|NCT00348673|582947119|FG003|Stage 1|Randomized but not Treated|0|||
161425902|NCT00348673|582947120|FG004|Stage 1|Randomized but not Treated|0|||
161425903|NCT00348673|582947121|FG005|Stage 1|Randomized but not Treated|0|||
161425904|NCT00348673|582947122|FG006|Stage 1|Randomized but not Treated|0|||
161425905|NCT00348673|582947123|FG007|Stage 1|Randomized but not Treated|0|||
161425906|NCT00348673|582947124|FG008|Stage 1|Randomized but not Treated|0|||
161425907|NCT03798717|582949434|FG000|Overall Study|Failed Screening|0|||
161425908|NCT03798717|582949435|FG001|Overall Study|Failed Screening|0|||
161425909|NCT03798717|582949436|FG002|Overall Study|Failed Screening|0|||
161425910|NCT03798717|582949437|FG003|Overall Study|Failed Screening|0|||
161425911|NCT03798717|582949438|FG004|Overall Study|Failed Screening|0|||
161425912|NCT03798717|582949439|FG005|Overall Study|Failed Screening|1|||
161425913|NCT03798717|582949434|FG000|Overall Study|Physician Decision|1|||
161425914|NCT03798717|582949435|FG001|Overall Study|Physician Decision|0|||
161425915|NCT03798717|582949436|FG002|Overall Study|Physician Decision|1|||
161425916|NCT03798717|582949437|FG003|Overall Study|Physician Decision|0|||
161425917|NCT03798717|582949438|FG004|Overall Study|Physician Decision|0|||
161425918|NCT03798717|582949439|FG005|Overall Study|Physician Decision|0|||
161425919|NCT03798717|582949434|FG000|Overall Study|Withdrawal by Subject|0|||
161425920|NCT03798717|582949435|FG001|Overall Study|Withdrawal by Subject|0|||
161425921|NCT03798717|582949436|FG002|Overall Study|Withdrawal by Subject|0|||
161425922|NCT03798717|582949437|FG003|Overall Study|Withdrawal by Subject|1|||
161425923|NCT03798717|582949438|FG004|Overall Study|Withdrawal by Subject|0|||
161425924|NCT03798717|582949439|FG005|Overall Study|Withdrawal by Subject|0|||
161425925|NCT03798717|582949434|FG000|Overall Study|Lost to Follow-up|1|||
161425926|NCT03798717|582949435|FG001|Overall Study|Lost to Follow-up|0|||
161425927|NCT03798717|582949436|FG002|Overall Study|Lost to Follow-up|0|||
161425928|NCT03798717|582949437|FG003|Overall Study|Lost to Follow-up|1|||
161425929|NCT03798717|582949438|FG004|Overall Study|Lost to Follow-up|0|||
161425930|NCT03798717|582949439|FG005|Overall Study|Lost to Follow-up|0|||
161425931|NCT03798717|582949434|FG000|Overall Study|Adverse Event|0|||
161425932|NCT03798717|582949435|FG001|Overall Study|Adverse Event|1|||
161425933|NCT03798717|582949436|FG002|Overall Study|Adverse Event|0|||
161425934|NCT03798717|582949437|FG003|Overall Study|Adverse Event|0|||
161425935|NCT03798717|582949438|FG004|Overall Study|Adverse Event|0|||
161425936|NCT03798717|582949439|FG005|Overall Study|Adverse Event|0|||
161425937|NCT03798717|582949434|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161425938|NCT03798717|582949435|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161425939|NCT03798717|582949436|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161425940|NCT03798717|582949437|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161425941|NCT03798717|582949438|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
161425942|NCT03798717|582949439|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161425943|NCT00445549|582949440|FG000|Overall Study|progressive disease|12|||
161425944|NCT03858049|582949443|FG000|Overall Study|Adverse Event|16|||
161425945|NCT03858049|582949444|FG001|Overall Study|Adverse Event|9|||
161425946|NCT03858049|582949443|FG000|Overall Study|Other|1|||
161425947|NCT03858049|582949444|FG001|Overall Study|Other|1|||
161425948|NCT01600326|582949445|FG000|Overall Study|Lost to Follow-up|1|||
161425949|NCT01600326|582949446|FG001|Overall Study|Lost to Follow-up|1|||
161425950|NCT02079740|582949447|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
161425951|NCT02079740|582949448|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
161425952|NCT02079740|582949449|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
161425953|NCT02079740|582949450|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
161425954|NCT02079740|582949451|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
161425955|NCT02079740|582949452|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
161425956|NCT02079740|582949453|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
161425957|NCT02079740|582949454|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
161425958|NCT02079740|582949455|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
161425959|NCT02079740|582949456|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
161425960|NCT02079740|582949457|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
161425961|NCT02079740|582949458|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
161425962|NCT02079740|582949459|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
161425963|NCT02079740|582949447|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
161425964|NCT02079740|582949448|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
161425965|NCT02079740|582949449|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
161425966|NCT02079740|582949450|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
161425967|NCT02079740|582949451|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
161425968|NCT02079740|582949452|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
161425969|NCT02079740|582949453|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
161425970|NCT02079740|582949454|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
161425971|NCT02079740|582949455|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
161425972|NCT02079740|582949456|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
161425973|NCT02079740|582949457|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
161425974|NCT02079740|582949458|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
161425975|NCT02079740|582949459|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
161425976|NCT02079740|582949447|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425977|NCT02079740|582949448|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425978|NCT02079740|582949449|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425979|NCT02079740|582949450|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425980|NCT02079740|582949451|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425981|NCT02079740|582949452|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425982|NCT02079740|582949453|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425983|NCT02079740|582949454|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
161425984|NCT02079740|582949455|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425985|NCT02079740|582949456|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425986|NCT02079740|582949457|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425987|NCT02079740|582949458|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425988|NCT02079740|582949459|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
161425989|NCT02079740|582949447|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425990|NCT02079740|582949448|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425991|NCT02079740|582949449|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425992|NCT02079740|582949450|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425993|NCT02079740|582949451|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425994|NCT02079740|582949452|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425995|NCT02079740|582949453|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425996|NCT02079740|582949454|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
161425997|NCT02079740|582949455|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425998|NCT02079740|582949456|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161425999|NCT02079740|582949457|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161426000|NCT02079740|582949458|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161426001|NCT02079740|582949459|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161426002|NCT02079740|582949447|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426003|NCT02079740|582949448|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426004|NCT02079740|582949449|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426005|NCT02079740|582949450|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426006|NCT02079740|582949451|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426007|NCT02079740|582949452|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426008|NCT02079740|582949453|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426009|NCT02079740|582949454|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426010|NCT02079740|582949455|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426011|NCT02079740|582949456|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
161426012|NCT02079740|582949457|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161426013|NCT02079740|582949458|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
161426014|NCT02079740|582949459|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
161426015|NCT04617782|582949460|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
161426016|NCT04617782|582949460|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
161426017|NCT04617782|582949460|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
161426018|NCT04617782|582949460|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
161426019|NCT04617782|582949460|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
161426020|NCT04617782|582949460|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
161426021|NCT01405768|582949473|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
161426022|NCT01405768|582949474|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
161426023|NCT04388111|582949477|FG000|Overall Study|Lost to Follow-up|5|||
161426024|NCT04388111|582949478|FG001|Overall Study|Lost to Follow-up|3|||
161426025|NCT04388111|582949477|FG000|Overall Study|Adverse Event|1|||
161426026|NCT04388111|582949478|FG001|Overall Study|Adverse Event|1|||
161426027|NCT04388111|582949477|FG000|Overall Study|Protocol Violation|2|||
161426028|NCT04388111|582949478|FG001|Overall Study|Protocol Violation|4|||
161426029|NCT04388111|582949477|FG000|Overall Study|Withdrawal by Subject|1|||
161426030|NCT04388111|582949478|FG001|Overall Study|Withdrawal by Subject|0|||
161426031|NCT01474317|582949486|FG000|Overall Study|Adverse Event|1|||
161426032|NCT01474317|582949486|FG000|Overall Study|Subject ineligible for study|1|||
161426033|NCT00387881|582949489|FG000|Overall Study|Lost to Follow-up|23|||
161426034|NCT00387881|582949490|FG001|Overall Study|Lost to Follow-up|23|||
161426035|NCT00387881|582949489|FG000|Overall Study|Protocol Violation|2|||
161426036|NCT00387881|582949490|FG001|Overall Study|Protocol Violation|12|||
161426037|NCT00387881|582949489|FG000|Overall Study|Withdrawal by Subject|15|||
161426038|NCT00387881|582949490|FG001|Overall Study|Withdrawal by Subject|18|||
161426039|NCT00387881|582949489|FG000|Overall Study|Sponsor terminated Study|0|||
161426040|NCT00387881|582949490|FG001|Overall Study|Sponsor terminated Study|1|||
161426041|NCT00387881|582949489|FG000|Overall Study|Not eligible|6|||
161426042|NCT00387881|582949490|FG001|Overall Study|Not eligible|7|||
161426043|NCT00387881|582949489|FG000|Overall Study|No opportunity to treat headache|32|||
161426044|NCT00387881|582949490|FG001|Overall Study|No opportunity to treat headache|34|||
161426045|NCT00387881|582949489|FG000|Overall Study|Not otherwise specified|11|||
161426046|NCT00387881|582949490|FG001|Overall Study|Not otherwise specified|7|||
161426047|NCT00453154|582949491|FG000|Double BIind Maintenance|Adverse Event|0|||
161426048|NCT00453154|582949492|FG001|Double BIind Maintenance|Adverse Event|0|||
161426049|NCT00453154|582949493|FG002|Double BIind Maintenance|Adverse Event|3|||
161426050|NCT00453154|582949494|FG003|Double BIind Maintenance|Adverse Event|12|||
161426051|NCT00453154|582949491|FG000|Double BIind Maintenance|Death|0|||
161426052|NCT00453154|582949492|FG001|Double BIind Maintenance|Death|0|||
161426053|NCT00453154|582949493|FG002|Double BIind Maintenance|Death|2|||
161426054|NCT00453154|582949494|FG003|Double BIind Maintenance|Death|1|||
161426055|NCT00453154|582949491|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
161426056|NCT00453154|582949492|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
161426057|NCT00453154|582949493|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
161426058|NCT00453154|582949494|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
161426059|NCT00453154|582949491|FG000|Double BIind Maintenance|Progression|0|||
161426060|NCT00453154|582949492|FG001|Double BIind Maintenance|Progression|0|||
161426061|NCT00453154|582949493|FG002|Double BIind Maintenance|Progression|29|||
161426062|NCT00453154|582949494|FG003|Double BIind Maintenance|Progression|26|||
161426063|NCT00453154|582949491|FG000|Double BIind Maintenance|Medical Issues|0|||
161426064|NCT00453154|582949492|FG001|Double BIind Maintenance|Medical Issues|0|||
161426065|NCT00453154|582949493|FG002|Double BIind Maintenance|Medical Issues|3|||
161426066|NCT00453154|582949494|FG003|Double BIind Maintenance|Medical Issues|1|||
161426067|NCT00453154|582949491|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
161426068|NCT00453154|582949492|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
161426069|NCT00453154|582949493|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
161426070|NCT00453154|582949494|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
161426071|NCT03629886|582949496|FG000|Overall Study|Migrated / moved from the study area|0|||
161426072|NCT03629886|582949497|FG001|Overall Study|Migrated / moved from the study area|55|||
161426073|NCT03629886|582949496|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
161426074|NCT03629886|582949497|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
161426075|NCT03629886|582949496|FG000|Overall Study|Study vaccine not administrated|0|||
161426076|NCT03629886|582949497|FG001|Overall Study|Study vaccine not administrated|3|||
161426077|NCT03629886|582949496|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
161426078|NCT03629886|582949497|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
161426079|NCT03629886|582949496|FG000|Overall Study|Refused vaccination step of the study|0|||
161426080|NCT03629886|582949497|FG001|Overall Study|Refused vaccination step of the study|44|||
161426081|NCT05473026|582949499|FG000|Overall Study|Lost to Follow-up|5|||
161426082|NCT05473026|582949500|FG001|Overall Study|Lost to Follow-up|2|||
161426083|NCT02038153|582949501|FG000|Overall Study|Withdrawal by Subject|1|||
161426084|NCT03683173|582949502|FG000|Completed Follow-up|Unavailable|235|||
161426085|NCT03683173|582949503|FG001|Completed Follow-up|Unavailable|217|||
161426086|NCT03683173|582949502|FG000|Completed Follow-up|Refused|69|||
161426087|NCT03683173|582949503|FG001|Completed Follow-up|Refused|59|||
161426088|NCT03683173|582949502|FG000|Completed Follow-up|Disconnected phone|65|||
161426089|NCT03683173|582949503|FG001|Completed Follow-up|Disconnected phone|95|||
161426090|NCT03683173|582949502|FG000|Completed Follow-up|Health issue/deceased|10|||
161426091|NCT03683173|582949503|FG001|Completed Follow-up|Health issue/deceased|4|||
161426092|NCT03683173|582949502|FG000|Completed Follow-up|Moved away|8|||
161426093|NCT03683173|582949503|FG001|Completed Follow-up|Moved away|1|||
161426094|NCT02647281|582949504|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426095|NCT02647281|582949505|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426096|NCT02647281|582949506|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426097|NCT02647281|582949507|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426098|NCT02647281|582949508|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426099|NCT02647281|582949509|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426100|NCT02647281|582949510|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426101|NCT02647281|582949511|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161426102|NCT02647281|582949512|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
161426103|NCT01050634|582949513|FG000|Overall Study|Enrolled, but Not Treated|56|||
161426104|NCT01050634|582949513|FG000|Overall Study|Death|2|||
161426105|NCT01050634|582949513|FG000|Overall Study|Adverse Event|42|||
161426106|NCT01050634|582949513|FG000|Overall Study|Lost to Follow-up|2|||
161426107|NCT01050634|582949513|FG000|Overall Study|Other|21|||
161426108|NCT01050634|582949513|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
161426109|NCT00496015|582949514|FG000|Overall Study|Other|1|||
161426110|NCT00496015|582949515|FG001|Overall Study|Other|0|||
161426111|NCT00496015|582949516|FG002|Overall Study|Other|0|||
161426112|NCT00496015|582949517|FG003|Overall Study|Other|1|||
161426113|NCT00496015|582949518|FG004|Overall Study|Other|0|||
161426114|NCT02730728|582949521|FG000|Overall Study|Withdrawal by Subject|0|||
161426115|NCT02730728|582949522|FG001|Overall Study|Withdrawal by Subject|1|||
161426116|NCT02730728|582949523|FG002|Overall Study|Withdrawal by Subject|0|||
161426117|NCT02730728|582949521|FG000|Overall Study|Lack of Efficacy|0|||
161426118|NCT02730728|582949522|FG001|Overall Study|Lack of Efficacy|1|||
161426119|NCT02730728|582949523|FG002|Overall Study|Lack of Efficacy|1|||
161426120|NCT03360682|582949542|FG000|Overall Study|Adverse Event|3|||
161426121|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426122|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426123|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426124|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
161426125|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426126|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426127|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426128|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426129|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426130|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
161426131|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
161426132|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
161426133|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
161426134|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
161426135|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
161426136|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
161426137|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
161426138|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
161426139|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
161426140|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
161426141|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
161426142|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
161426143|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
161426144|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
161426145|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
161426146|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
161426147|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
161426148|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
161426149|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
161426150|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
161426151|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
161426152|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
161426153|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
161426154|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
161426155|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
161426156|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
161426157|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
161426158|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
161426159|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
161426160|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
161426161|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
161426162|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426163|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
161426164|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426165|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
161426166|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426167|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426168|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426169|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426170|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
161426171|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
161426172|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426173|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426174|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426175|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
161426176|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
161426177|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426178|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426179|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426180|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
161426181|NCT02365649|582949552|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426182|NCT02365649|582949553|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426183|NCT02365649|582949554|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
161426184|NCT02365649|582949555|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426185|NCT02365649|582949556|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426186|NCT02365649|582949557|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426187|NCT02365649|582949558|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426188|NCT02365649|582949559|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426189|NCT02365649|582949560|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426190|NCT02365649|582949561|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
161426191|NCT02365649|582949552|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426192|NCT02365649|582949553|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426193|NCT02365649|582949554|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426194|NCT02365649|582949555|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426195|NCT02365649|582949556|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426196|NCT02365649|582949557|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426197|NCT02365649|582949558|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
161426198|NCT02365649|582949559|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426199|NCT02365649|582949560|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426200|NCT02365649|582949561|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
161426201|NCT02365649|582949552|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426202|NCT02365649|582949553|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426203|NCT02365649|582949554|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426204|NCT02365649|582949555|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426205|NCT02365649|582949556|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426206|NCT02365649|582949557|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426207|NCT02365649|582949558|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
161426208|NCT02365649|582949559|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
161426209|NCT02365649|582949560|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
161426210|NCT02365649|582949561|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
161426211|NCT02365649|582949552|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
161426212|NCT02365649|582949553|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
161426213|NCT02365649|582949554|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
161426214|NCT02365649|582949555|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
161426215|NCT02365649|582949556|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
161426216|NCT02365649|582949557|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
161426217|NCT02365649|582949558|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
161426218|NCT02365649|582949559|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
161426219|NCT02365649|582949560|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
161426220|NCT02365649|582949561|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
161426221|NCT02365649|582949552|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426222|NCT02365649|582949553|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426223|NCT02365649|582949554|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426224|NCT02365649|582949555|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426225|NCT02365649|582949556|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426226|NCT02365649|582949557|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426227|NCT02365649|582949558|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
161426228|NCT02365649|582949559|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
161426229|NCT02365649|582949560|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
161426230|NCT02365649|582949561|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
161426231|NCT02365649|582949552|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426232|NCT02365649|582949553|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426233|NCT02365649|582949554|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426234|NCT02365649|582949555|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426235|NCT02365649|582949556|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426236|NCT02365649|582949557|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426237|NCT02365649|582949558|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
161426238|NCT02365649|582949559|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426239|NCT02365649|582949560|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
161426240|NCT02365649|582949561|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
161426241|NCT01433172|582949574|FG000|Overall Study|Withdrawal by Subject|0|||
161426242|NCT01433172|582949575|FG001|Overall Study|Withdrawal by Subject|1|||
161426243|NCT01433172|582949576|FG002|Overall Study|Withdrawal by Subject|0|||
161426244|NCT01433172|582949574|FG000|Overall Study|Disease Progression|0|||
161426245|NCT01433172|582949575|FG001|Overall Study|Disease Progression|0|||
161426246|NCT01433172|582949576|FG002|Overall Study|Disease Progression|1|||
161426247|NCT01433172|582949574|FG000|Overall Study|Death|0|||
161426248|NCT01433172|582949575|FG001|Overall Study|Death|2|||
161426249|NCT01433172|582949576|FG002|Overall Study|Death|0|||
161426250|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
161426251|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
161426252|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
161426253|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
161426254|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
161426255|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
161426256|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Death|7|||
161426257|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Death|5|||
161426258|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Death|6|||
161426259|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
161426260|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
161426261|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
161426262|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
161426263|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
161426264|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
161426265|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Other|1|||
161426266|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Other|0|||
161426267|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Other|0|||
161426268|NCT00104650|582949577|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
161426269|NCT00104650|582949578|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
161426270|NCT00104650|582949579|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
161426271|NCT00104650|582949577|FG000|Follow-up Period|Physician Decision|1|||
161426272|NCT00104650|582949578|FG001|Follow-up Period|Physician Decision|1|||
161426273|NCT00104650|582949579|FG002|Follow-up Period|Physician Decision|0|||
161426274|NCT00104650|582949577|FG000|Follow-up Period|Adverse Event|1|||
161426275|NCT00104650|582949578|FG001|Follow-up Period|Adverse Event|0|||
161426276|NCT00104650|582949579|FG002|Follow-up Period|Adverse Event|1|||
161426277|NCT00104650|582949577|FG000|Follow-up Period|Withdrawal by Subject|0|||
161426278|NCT00104650|582949578|FG001|Follow-up Period|Withdrawal by Subject|3|||
161426279|NCT00104650|582949579|FG002|Follow-up Period|Withdrawal by Subject|3|||
161426280|NCT00104650|582949577|FG000|Follow-up Period|Death|6|||
161426281|NCT00104650|582949578|FG001|Follow-up Period|Death|6|||
161426282|NCT00104650|582949579|FG002|Follow-up Period|Death|4|||
161426283|NCT00104650|582949577|FG000|Follow-up Period|Disease progression|3|||
161426284|NCT00104650|582949578|FG001|Follow-up Period|Disease progression|1|||
161426285|NCT00104650|582949579|FG002|Follow-up Period|Disease progression|0|||
161426286|NCT00104650|582949577|FG000|Follow-up Period|Lost to Follow-up|0|||
161426287|NCT00104650|582949578|FG001|Follow-up Period|Lost to Follow-up|1|||
161426288|NCT00104650|582949579|FG002|Follow-up Period|Lost to Follow-up|2|||
161426289|NCT00104650|582949577|FG000|Follow-up Period|Other|0|||
161426290|NCT00104650|582949578|FG001|Follow-up Period|Other|1|||
161426291|NCT00104650|582949579|FG002|Follow-up Period|Other|0|||
161426292|NCT01391663|582949580|FG000|Overall Study|Withdrawal by Subject|0|||
161426293|NCT01391663|582949581|FG001|Overall Study|Withdrawal by Subject|0|||
161426294|NCT01391663|582949582|FG002|Overall Study|Withdrawal by Subject|1|||
161426295|NCT01391663|582949583|FG003|Overall Study|Withdrawal by Subject|0|||
161426296|NCT03515824|582949584|FG000|Overall Study|Death|3|||
161426297|NCT03515824|582949585|FG001|Overall Study|Death|2|||
161426298|NCT03515824|582949586|FG002|Overall Study|Death|6|||
161426299|NCT03515824|582949587|FG003|Overall Study|Death|0|||
161426300|NCT03515824|582949584|FG000|Overall Study|Lost to Follow-up|0|||
161426301|NCT03515824|582949585|FG001|Overall Study|Lost to Follow-up|1|||
161426302|NCT03515824|582949586|FG002|Overall Study|Lost to Follow-up|1|||
161426303|NCT03515824|582949587|FG003|Overall Study|Lost to Follow-up|0|||
161426304|NCT03515824|582949584|FG000|Overall Study|Study terminated by sponsor|0|||
161426305|NCT03515824|582949585|FG001|Overall Study|Study terminated by sponsor|1|||
161426306|NCT03515824|582949586|FG002|Overall Study|Study terminated by sponsor|6|||
161426307|NCT03515824|582949587|FG003|Overall Study|Study terminated by sponsor|0|||
161426308|NCT03515824|582949584|FG000|Overall Study|Status not recorded|0|||
161426309|NCT03515824|582949585|FG001|Overall Study|Status not recorded|0|||
161426310|NCT03515824|582949586|FG002|Overall Study|Status not recorded|2|||
161426311|NCT03515824|582949587|FG003|Overall Study|Status not recorded|0|||
161426312|NCT00920855|582949588|FG000|Overall Study|Adverse Event|1|||
161426313|NCT00920855|582949589|FG001|Overall Study|Adverse Event|1|||
161426314|NCT00920855|582949590|FG002|Overall Study|Adverse Event|4|||
161426315|NCT00920855|582949588|FG000|Overall Study|Withdrawal by Subject|2|||
161426316|NCT00920855|582949589|FG001|Overall Study|Withdrawal by Subject|1|||
161426317|NCT00920855|582949590|FG002|Overall Study|Withdrawal by Subject|6|||
161426318|NCT00920855|582949588|FG000|Overall Study|Disease progression|2|||
161426319|NCT00920855|582949589|FG001|Overall Study|Disease progression|1|||
161426320|NCT00920855|582949590|FG002|Overall Study|Disease progression|10|||
161426321|NCT00920855|582949588|FG000|Overall Study|Noncompliance to study medication|0|||
161426322|NCT00920855|582949589|FG001|Overall Study|Noncompliance to study medication|0|||
161426323|NCT00920855|582949590|FG002|Overall Study|Noncompliance to study medication|1|||
161426324|NCT00920855|582949588|FG000|Overall Study|Response plateau; started maintenance|0|||
161426325|NCT00920855|582949589|FG001|Overall Study|Response plateau; started maintenance|0|||
161426326|NCT00920855|582949590|FG002|Overall Study|Response plateau; started maintenance|1|||
161426327|NCT00539994|582949591|FG000|Overall Study|Lost to Follow-up|2|||
161426328|NCT00539994|582949592|FG001|Overall Study|Lost to Follow-up|1|||
161426329|NCT00539994|582949593|FG002|Overall Study|Lost to Follow-up|0|||
161426330|NCT00539994|582949591|FG000|Overall Study|Withdrawal by Subject|1|||
161426331|NCT00539994|582949592|FG001|Overall Study|Withdrawal by Subject|0|||
161426332|NCT00539994|582949593|FG002|Overall Study|Withdrawal by Subject|1|||
161426333|NCT00539994|582949591|FG000|Overall Study|Physician Decision|0|||
161426334|NCT00539994|582949592|FG001|Overall Study|Physician Decision|0|||
161426335|NCT00539994|582949593|FG002|Overall Study|Physician Decision|1|||
161426336|NCT03084796|582949594|FG000|Overall Study|Adverse Event|4|||
161426337|NCT03084796|582949595|FG001|Overall Study|Adverse Event|5|||
161426338|NCT03084796|582949596|FG002|Overall Study|Adverse Event|6|||
161426339|NCT03084796|582949597|FG003|Overall Study|Adverse Event|2|||
161426340|NCT03084796|582949598|FG004|Overall Study|Adverse Event|3|||
161426341|NCT03084796|582949599|FG005|Overall Study|Adverse Event|5|||
161426342|NCT03084796|582949594|FG000|Overall Study|Withdrawal by Subject|3|||
161426343|NCT03084796|582949595|FG001|Overall Study|Withdrawal by Subject|5|||
161426344|NCT03084796|582949596|FG002|Overall Study|Withdrawal by Subject|2|||
161426345|NCT03084796|582949597|FG003|Overall Study|Withdrawal by Subject|1|||
161426346|NCT03084796|582949598|FG004|Overall Study|Withdrawal by Subject|3|||
161426347|NCT03084796|582949599|FG005|Overall Study|Withdrawal by Subject|0|||
161426348|NCT03084796|582949594|FG000|Overall Study|Protocol Violation|0|||
161426349|NCT03084796|582949595|FG001|Overall Study|Protocol Violation|0|||
161426350|NCT03084796|582949596|FG002|Overall Study|Protocol Violation|1|||
161426351|NCT03084796|582949597|FG003|Overall Study|Protocol Violation|0|||
161426352|NCT03084796|582949598|FG004|Overall Study|Protocol Violation|1|||
161426353|NCT03084796|582949599|FG005|Overall Study|Protocol Violation|1|||
161426354|NCT03084796|582949594|FG000|Overall Study|Lack of Efficacy|0|||
161426355|NCT03084796|582949595|FG001|Overall Study|Lack of Efficacy|0|||
161426356|NCT03084796|582949596|FG002|Overall Study|Lack of Efficacy|1|||
161426357|NCT03084796|582949597|FG003|Overall Study|Lack of Efficacy|0|||
161426358|NCT03084796|582949598|FG004|Overall Study|Lack of Efficacy|1|||
161426359|NCT03084796|582949599|FG005|Overall Study|Lack of Efficacy|0|||
161426360|NCT03084796|582949594|FG000|Overall Study|Lost to Follow-up|0|||
161426361|NCT03084796|582949595|FG001|Overall Study|Lost to Follow-up|0|||
161426362|NCT03084796|582949596|FG002|Overall Study|Lost to Follow-up|1|||
161426363|NCT03084796|582949597|FG003|Overall Study|Lost to Follow-up|1|||
161426364|NCT03084796|582949598|FG004|Overall Study|Lost to Follow-up|3|||
161426365|NCT03084796|582949599|FG005|Overall Study|Lost to Follow-up|1|||
161426366|NCT03084796|582949594|FG000|Overall Study|Randomization error|0|||
161426367|NCT03084796|582949595|FG001|Overall Study|Randomization error|0|||
161426368|NCT03084796|582949596|FG002|Overall Study|Randomization error|1|||
161426369|NCT03084796|582949597|FG003|Overall Study|Randomization error|0|||
161426370|NCT03084796|582949598|FG004|Overall Study|Randomization error|0|||
161426371|NCT03084796|582949599|FG005|Overall Study|Randomization error|0|||
161426372|NCT05470985|582949600|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
161426373|NCT05470985|582949601|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
161426374|NCT05470985|582949600|FG000|Double Blind Treatment Period|Physician Decision|0|||
161426375|NCT05470985|582949601|FG001|Double Blind Treatment Period|Physician Decision|1|||
161426376|NCT05470985|582949600|FG000|Long Term Extension|Adverse Event|0|||
161426377|NCT05470985|582949601|FG001|Long Term Extension|Adverse Event|1|||
161426378|NCT05470985|582949600|FG000|Long Term Extension|Study terminated by sponsor|2|||
161426379|NCT05470985|582949601|FG001|Long Term Extension|Study terminated by sponsor|0|||
161426380|NCT02741245|582949611|FG000|Overall Study|Adverse Event|0|||
161426381|NCT02741245|582949612|FG001|Overall Study|Adverse Event|0|||
161426382|NCT02741245|582949613|FG002|Overall Study|Adverse Event|0|||
161426383|NCT02741245|582949614|FG003|Overall Study|Adverse Event|2|||
161426384|NCT02741245|582949615|FG004|Overall Study|Adverse Event|2|||
161426385|NCT02741245|582949611|FG000|Overall Study|Protocol Violation|0|||
161426386|NCT02741245|582949612|FG001|Overall Study|Protocol Violation|1|||
161426387|NCT02741245|582949613|FG002|Overall Study|Protocol Violation|0|||
161426388|NCT02741245|582949614|FG003|Overall Study|Protocol Violation|1|||
161426389|NCT02741245|582949615|FG004|Overall Study|Protocol Violation|0|||
161426390|NCT02741245|582949611|FG000|Overall Study|Withdrawal by Subject|0|||
161426391|NCT02741245|582949612|FG001|Overall Study|Withdrawal by Subject|0|||
161426392|NCT02741245|582949613|FG002|Overall Study|Withdrawal by Subject|0|||
161426393|NCT02741245|582949614|FG003|Overall Study|Withdrawal by Subject|1|||
161426394|NCT02741245|582949615|FG004|Overall Study|Withdrawal by Subject|0|||
161426395|NCT01116648|582949616|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
161426396|NCT01116648|582949617|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
161426397|NCT01116648|582949618|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
161426398|NCT01116648|582949619|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
161426399|NCT01116648|582949620|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
161426400|NCT01116648|582949621|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
161426401|NCT01116648|582949622|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
161426402|NCT01116648|582949623|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
161426403|NCT01116648|582949624|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
161426404|NCT01116648|582949625|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
161426405|NCT01116648|582949626|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
161426406|NCT01116648|582949627|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
161426407|NCT01116648|582949628|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
161426408|NCT01116648|582949629|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
161426409|NCT01116648|582949630|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
161426410|NCT01519323|582951480|FG000|Overall Study|Death|3|||
161426411|NCT01519323|582951481|FG001|Overall Study|Death|2|||
161426412|NCT01519323|582951480|FG000|Overall Study|Study terminated by sponsor|0|||
161426413|NCT01519323|582951481|FG001|Overall Study|Study terminated by sponsor|1|||
161426414|NCT03096834|582951498|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
161426415|NCT03096834|582951499|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
161426416|NCT03096834|582951500|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
161426417|NCT03096834|582951501|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
161426418|NCT03096834|582951498|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
161426419|NCT03096834|582951499|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
161426420|NCT03096834|582951500|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
161426421|NCT03096834|582951501|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
161426422|NCT03096834|582951498|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
161426423|NCT03096834|582951499|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
161426424|NCT03096834|582951500|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
161426425|NCT03096834|582951501|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
161426426|NCT03096834|582951498|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
161426427|NCT03096834|582951499|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
161426428|NCT03096834|582951500|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
161426429|NCT03096834|582951501|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
161426430|NCT03096834|582951498|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
161426431|NCT03096834|582951499|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
161426432|NCT03096834|582951500|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
161426433|NCT03096834|582951501|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
161426434|NCT03096834|582951498|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
161426435|NCT03096834|582951499|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
161426436|NCT03096834|582951500|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
161426437|NCT03096834|582951501|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
161426438|NCT03096834|582951498|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
161426439|NCT03096834|582951499|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
161426440|NCT03096834|582951500|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
161426441|NCT03096834|582951501|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
161426442|NCT03096834|582951498|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
161426443|NCT03096834|582951499|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
161426444|NCT03096834|582951500|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
161426445|NCT03096834|582951501|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
161426446|NCT03096834|582951498|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
161426447|NCT03096834|582951499|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
161426448|NCT03096834|582951500|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
161426449|NCT03096834|582951501|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
161426450|NCT03096834|582951498|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
161426451|NCT03096834|582951499|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
161426452|NCT03096834|582951500|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
161426453|NCT03096834|582951501|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
161426454|NCT03096834|582951498|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
161426455|NCT03096834|582951499|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
161426456|NCT03096834|582951500|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
161426457|NCT03096834|582951501|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
161426458|NCT03096834|582951498|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
161426459|NCT03096834|582951499|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
161426460|NCT03096834|582951500|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
161426461|NCT03096834|582951501|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
161426462|NCT02313766|582951506|FG000|Overall Study|surgery cancelled|1|||
161426463|NCT02313766|582951507|FG001|Overall Study|surgery cancelled|0|||
161426464|NCT02313766|582951508|FG002|Overall Study|surgery cancelled|0|||
161426465|NCT02313766|582951506|FG000|Overall Study|Lost to Follow-up|0|||
161426466|NCT02313766|582951507|FG001|Overall Study|Lost to Follow-up|2|||
161426467|NCT02313766|582951508|FG002|Overall Study|Lost to Follow-up|0|||
161426468|NCT02313766|582951506|FG000|Overall Study|Adverse Event|0|||
161426469|NCT02313766|582951507|FG001|Overall Study|Adverse Event|1|||
161426470|NCT02313766|582951508|FG002|Overall Study|Adverse Event|0|||
161426471|NCT01005251|582951509|FG000|Overall Study|Withdrawal by Subject|2|||
161426472|NCT01005251|582951510|FG001|Overall Study|Withdrawal by Subject|5|||
161426473|NCT01005251|582951511|FG002|Overall Study|Withdrawal by Subject|3|||
161426474|NCT01005251|582951512|FG003|Overall Study|Withdrawal by Subject|4|||
161426475|NCT01005251|582951513|FG004|Overall Study|Withdrawal by Subject|9|||
161426476|NCT01005251|582951509|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
161426477|NCT01005251|582951510|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161426478|NCT01005251|582951511|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
161426479|NCT01005251|582951512|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161426480|NCT01005251|582951513|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161426481|NCT01005251|582951509|FG000|Overall Study|Adverse Event|2|||
161426482|NCT01005251|582951510|FG001|Overall Study|Adverse Event|6|||
161426483|NCT01005251|582951511|FG002|Overall Study|Adverse Event|8|||
161426484|NCT01005251|582951512|FG003|Overall Study|Adverse Event|5|||
161426485|NCT01005251|582951513|FG004|Overall Study|Adverse Event|4|||
161426486|NCT01005251|582951509|FG000|Overall Study|Protocol Violation|1|||
161426487|NCT01005251|582951510|FG001|Overall Study|Protocol Violation|0|||
161426488|NCT01005251|582951511|FG002|Overall Study|Protocol Violation|0|||
161426489|NCT01005251|582951512|FG003|Overall Study|Protocol Violation|0|||
161426490|NCT01005251|582951513|FG004|Overall Study|Protocol Violation|2|||
161426491|NCT01005251|582951509|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
161426492|NCT01005251|582951510|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
161426493|NCT01005251|582951511|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
161426494|NCT01005251|582951512|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
161426495|NCT01005251|582951513|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
161426496|NCT01005251|582951509|FG000|Overall Study|Lost to Follow-up|1|||
161426497|NCT01005251|582951510|FG001|Overall Study|Lost to Follow-up|4|||
161426498|NCT01005251|582951511|FG002|Overall Study|Lost to Follow-up|2|||
161426499|NCT01005251|582951512|FG003|Overall Study|Lost to Follow-up|0|||
161426500|NCT01005251|582951513|FG004|Overall Study|Lost to Follow-up|0|||
161426501|NCT01005251|582951509|FG000|Overall Study|Physician Decision|0|||
161426502|NCT01005251|582951510|FG001|Overall Study|Physician Decision|0|||
161426503|NCT01005251|582951511|FG002|Overall Study|Physician Decision|0|||
161426504|NCT01005251|582951512|FG003|Overall Study|Physician Decision|0|||
161426505|NCT01005251|582951513|FG004|Overall Study|Physician Decision|2|||
161426506|NCT01005251|582951509|FG000|Overall Study|Patient moved|1|||
161426507|NCT01005251|582951510|FG001|Overall Study|Patient moved|0|||
161426508|NCT01005251|582951511|FG002|Overall Study|Patient moved|0|||
161426509|NCT01005251|582951512|FG003|Overall Study|Patient moved|0|||
161426510|NCT01005251|582951513|FG004|Overall Study|Patient moved|0|||
161426511|NCT01005251|582951509|FG000|Overall Study|Wrong drug dispensed|0|||
161426512|NCT01005251|582951510|FG001|Overall Study|Wrong drug dispensed|1|||
161426513|NCT01005251|582951511|FG002|Overall Study|Wrong drug dispensed|0|||
161426514|NCT01005251|582951512|FG003|Overall Study|Wrong drug dispensed|0|||
161426515|NCT01005251|582951513|FG004|Overall Study|Wrong drug dispensed|0|||
161426516|NCT01005251|582951509|FG000|Overall Study|Randomized in error|0|||
161426517|NCT01005251|582951510|FG001|Overall Study|Randomized in error|0|||
161426518|NCT01005251|582951511|FG002|Overall Study|Randomized in error|1|||
161426519|NCT01005251|582951512|FG003|Overall Study|Randomized in error|1|||
161426520|NCT01005251|582951513|FG004|Overall Study|Randomized in error|0|||
161426521|NCT01005251|582951509|FG000|Overall Study|Lack of Efficacy|0|||
161426522|NCT01005251|582951510|FG001|Overall Study|Lack of Efficacy|0|||
161426523|NCT01005251|582951511|FG002|Overall Study|Lack of Efficacy|1|||
161426524|NCT01005251|582951512|FG003|Overall Study|Lack of Efficacy|1|||
161426525|NCT01005251|582951513|FG004|Overall Study|Lack of Efficacy|0|||
161426526|NCT01702844|582951514|FG000|Overall Study|Adverse Event|9|||
161426527|NCT01702844|582951514|FG000|Overall Study|Death|1|||
161426528|NCT01702844|582951514|FG000|Overall Study|Withdrawal by Subject|3|||
161426529|NCT01702844|582951514|FG000|Overall Study|Physician Decision|6|||
161426530|NCT02193776|582951515|FG000|Overall Study|Consent withdrawn|1|||
161426531|NCT02193776|582951516|FG001|Overall Study|Consent withdrawn|0|||
161426532|NCT02193776|582951517|FG002|Overall Study|Consent withdrawn|0|||
161426533|NCT02193776|582951518|FG003|Overall Study|Consent withdrawn|0|||
161426534|NCT02193776|582951515|FG000|Overall Study|Failure to comply with protocol|0|||
161426535|NCT02193776|582951516|FG001|Overall Study|Failure to comply with protocol|1|||
161426536|NCT02193776|582951517|FG002|Overall Study|Failure to comply with protocol|0|||
161426537|NCT02193776|582951518|FG003|Overall Study|Failure to comply with protocol|0|||
161426538|NCT02193776|582951515|FG000|Overall Study|Investigator/Sponsor decision|1|||
161426539|NCT02193776|582951516|FG001|Overall Study|Investigator/Sponsor decision|1|||
161426540|NCT02193776|582951517|FG002|Overall Study|Investigator/Sponsor decision|0|||
161426541|NCT02193776|582951518|FG003|Overall Study|Investigator/Sponsor decision|0|||
161426542|NCT02193776|582951515|FG000|Overall Study|Death|1|||
161426543|NCT02193776|582951516|FG001|Overall Study|Death|0|||
161426544|NCT02193776|582951517|FG002|Overall Study|Death|0|||
161426545|NCT02193776|582951518|FG003|Overall Study|Death|0|||
161426546|NCT02193776|582951515|FG000|Overall Study|Adverse event/Specific toxicity|5|||
161426547|NCT02193776|582951516|FG001|Overall Study|Adverse event/Specific toxicity|5|||
161426548|NCT02193776|582951517|FG002|Overall Study|Adverse event/Specific toxicity|2|||
161426549|NCT02193776|582951518|FG003|Overall Study|Adverse event/Specific toxicity|2|||
161426550|NCT02995980|582951519|FG000|Overall Study|Lost to Follow-up|14|||
161426551|NCT01169103|582951520|FG000|Overall Study|Lost to Follow-up|3|||
161426552|NCT01169103|582951521|FG001|Overall Study|Lost to Follow-up|3|||
161426553|NCT01169103|582951520|FG000|Overall Study|Withdrawal by Subject|3|||
161426554|NCT01169103|582951521|FG001|Overall Study|Withdrawal by Subject|1|||
161426555|NCT06039579|582951522|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426556|NCT06039579|582951523|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426557|NCT06039579|582951524|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426558|NCT06039579|582951525|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426559|NCT06039579|582951526|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426560|NCT06039579|582951527|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426561|NCT06039579|582951528|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
161426562|NCT06039579|582951529|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
161426563|NCT00981149|582951537|FG000|Overall Study|Lost to Follow-up|1|||
161426564|NCT00981149|582951538|FG001|Overall Study|Lost to Follow-up|2|||
161426565|NCT00981149|582951537|FG000|Overall Study|Withdrawal by Subject|1|||
161426566|NCT00981149|582951538|FG001|Overall Study|Withdrawal by Subject|1|||
161426567|NCT02634333|582951542|FG000|Overall Study|Completed out of Window|3|||
161426568|NCT02634333|582951543|FG001|Overall Study|Completed out of Window|2|||
161426569|NCT02634333|582951542|FG000|Overall Study|Missed Visit|5|||
161426570|NCT02634333|582951543|FG001|Overall Study|Missed Visit|2|||
161426571|NCT02634333|582951542|FG000|Overall Study|Lost to Follow-up|12|||
161426572|NCT02634333|582951543|FG001|Overall Study|Lost to Follow-up|7|||
161426573|NCT02634333|582951542|FG000|Overall Study|Withdrawal by Subject|9|||
161426574|NCT02634333|582951543|FG001|Overall Study|Withdrawal by Subject|13|||
161426575|NCT02634333|582951542|FG000|Overall Study|Death|11|||
161426576|NCT02634333|582951543|FG001|Overall Study|Death|8|||
161426577|NCT00657046|582951546|FG000|Overall Study|Adverse Event|1|||
161426578|NCT00657046|582951547|FG001|Overall Study|Adverse Event|1|||
161426579|NCT00657046|582951548|FG002|Overall Study|Adverse Event|0|||
161426580|NCT00657046|582951546|FG000|Overall Study|Protocol Violation|2|||
161426581|NCT00657046|582951547|FG001|Overall Study|Protocol Violation|2|||
161426582|NCT00657046|582951548|FG002|Overall Study|Protocol Violation|0|||
161426583|NCT00657046|582951546|FG000|Overall Study|Withdrawal by Subject|1|||
161426584|NCT00657046|582951547|FG001|Overall Study|Withdrawal by Subject|0|||
161426585|NCT00657046|582951548|FG002|Overall Study|Withdrawal by Subject|0|||
161426586|NCT00657046|582951546|FG000|Overall Study|Death|0|||
161426587|NCT00657046|582951547|FG001|Overall Study|Death|0|||
161426588|NCT00657046|582951548|FG002|Overall Study|Death|1|||
161426589|NCT00657046|582951546|FG000|Overall Study|Surgery|0|||
161426590|NCT00657046|582951547|FG001|Overall Study|Surgery|0|||
161426591|NCT00657046|582951548|FG002|Overall Study|Surgery|1|||
161426592|NCT03827655|582951549|FG000|Overall Study|Death|0|||
161426593|NCT03827655|582951550|FG001|Overall Study|Death|0|||
161426594|NCT03827655|582951551|FG002|Overall Study|Death|0|||
161426595|NCT03827655|582951552|FG003|Overall Study|Death|0|||
161426596|NCT03827655|582951553|FG004|Overall Study|Death|1|||
161426597|NCT03827655|582951549|FG000|Overall Study|Protocol Deviation|1|||
161426598|NCT03827655|582951550|FG001|Overall Study|Protocol Deviation|0|||
161426599|NCT03827655|582951551|FG002|Overall Study|Protocol Deviation|1|||
161426600|NCT03827655|582951552|FG003|Overall Study|Protocol Deviation|1|||
161426601|NCT03827655|582951553|FG004|Overall Study|Protocol Deviation|0|||
161426602|NCT03827655|582951549|FG000|Overall Study|Withdrawal by Subject|3|||
161426603|NCT03827655|582951550|FG001|Overall Study|Withdrawal by Subject|2|||
161426604|NCT03827655|582951551|FG002|Overall Study|Withdrawal by Subject|2|||
161426605|NCT03827655|582951552|FG003|Overall Study|Withdrawal by Subject|0|||
161426606|NCT03827655|582951553|FG004|Overall Study|Withdrawal by Subject|1|||
161426607|NCT03827655|582951549|FG000|Overall Study|Reason not Specified|3|||
161426608|NCT03827655|582951550|FG001|Overall Study|Reason not Specified|1|||
161426609|NCT03827655|582951551|FG002|Overall Study|Reason not Specified|1|||
161426610|NCT03827655|582951552|FG003|Overall Study|Reason not Specified|1|||
161426611|NCT03827655|582951553|FG004|Overall Study|Reason not Specified|1|||
161426612|NCT03935126|582951556|FG000|Overall Study|Study termination by sponsor|3|||
161426613|NCT01092728|582951557|FG000|Overall Study|Withdrawal by Subject|2|||
161426614|NCT01092728|582951558|FG001|Overall Study|Withdrawal by Subject|0|||
161426615|NCT01092728|582951557|FG000|Overall Study|Adverse Event|0|||
161426616|NCT01092728|582951558|FG001|Overall Study|Adverse Event|1|||
161426617|NCT01092728|582951557|FG000|Overall Study|Disease Progression|1|||
161426618|NCT01092728|582951558|FG001|Overall Study|Disease Progression|13|||
161426619|NCT01092728|582951557|FG000|Overall Study|Prohibited Concomitant Medications|1|||
161426620|NCT01092728|582951558|FG001|Overall Study|Prohibited Concomitant Medications|0|||
161426621|NCT02336607|582951559|FG000|Overall Study|Physician Decision|1|||
161426622|NCT02336607|582951560|FG001|Overall Study|Physician Decision|4|||
161426623|NCT02336607|582951561|FG002|Overall Study|Physician Decision|3|||
161426624|NCT02336607|582951562|FG003|Overall Study|Physician Decision|15|||
161426625|NCT02336607|582951559|FG000|Overall Study|Lack of Efficacy|1|||
161426626|NCT02336607|582951560|FG001|Overall Study|Lack of Efficacy|0|||
161426627|NCT02336607|582951561|FG002|Overall Study|Lack of Efficacy|0|||
161426628|NCT02336607|582951562|FG003|Overall Study|Lack of Efficacy|2|||
161426629|NCT02336607|582951559|FG000|Overall Study|Lost to Follow-up|2|||
161426630|NCT02336607|582951560|FG001|Overall Study|Lost to Follow-up|1|||
161426631|NCT02336607|582951561|FG002|Overall Study|Lost to Follow-up|0|||
161426632|NCT02336607|582951562|FG003|Overall Study|Lost to Follow-up|21|||
161426633|NCT02336607|582951559|FG000|Overall Study|Protocol Violation|0|||
161426634|NCT02336607|582951560|FG001|Overall Study|Protocol Violation|1|||
161426635|NCT02336607|582951561|FG002|Overall Study|Protocol Violation|1|||
161426636|NCT02336607|582951562|FG003|Overall Study|Protocol Violation|3|||
161426637|NCT02336607|582951559|FG000|Overall Study|Adverse Event|0|||
161426638|NCT02336607|582951560|FG001|Overall Study|Adverse Event|2|||
161426639|NCT02336607|582951561|FG002|Overall Study|Adverse Event|2|||
161426640|NCT02336607|582951562|FG003|Overall Study|Adverse Event|26|||
161426641|NCT02336607|582951559|FG000|Overall Study|Withdrawal by Subject|0|||
161426642|NCT02336607|582951560|FG001|Overall Study|Withdrawal by Subject|2|||
161426643|NCT02336607|582951561|FG002|Overall Study|Withdrawal by Subject|0|||
161426644|NCT02336607|582951562|FG003|Overall Study|Withdrawal by Subject|20|||
161426645|NCT02552966|582951563|FG000|Overall Study|Lost to Follow-up|2|||
161426646|NCT02552966|582951563|FG000|Overall Study|Withdrawal by Subject|3|||
161426647|NCT01506271|582951575|FG000|Overall Study|Progressive disease|0|||
161426648|NCT01506271|582951576|FG001|Overall Study|Progressive disease|1|||
161426649|NCT01506271|582951577|FG002|Overall Study|Progressive disease|0|||
161426650|NCT01506271|582951575|FG000|Overall Study|Protocol Violation|3|||
161426651|NCT01506271|582951576|FG001|Overall Study|Protocol Violation|1|||
161426652|NCT01506271|582951577|FG002|Overall Study|Protocol Violation|0|||
161426653|NCT01506271|582951575|FG000|Overall Study|Death|0|||
161426654|NCT01506271|582951576|FG001|Overall Study|Death|1|||
161426655|NCT01506271|582951577|FG002|Overall Study|Death|0|||
161426656|NCT01506271|582951575|FG000|Overall Study|Adverse Event|0|||
161426657|NCT01506271|582951576|FG001|Overall Study|Adverse Event|2|||
161426658|NCT01506271|582951577|FG002|Overall Study|Adverse Event|0|||
161426659|NCT01506271|582951575|FG000|Overall Study|Insufficient supply of study drug|1|||
161426660|NCT01506271|582951576|FG001|Overall Study|Insufficient supply of study drug|0|||
161426661|NCT01506271|582951577|FG002|Overall Study|Insufficient supply of study drug|0|||
161426662|NCT01506271|582951575|FG000|Overall Study|Withdrawal by Subject|0|||
161426663|NCT01506271|582951576|FG001|Overall Study|Withdrawal by Subject|1|||
161426664|NCT01506271|582951577|FG002|Overall Study|Withdrawal by Subject|1|||
161426665|NCT01506271|582951575|FG000|Overall Study|Lost to Follow-up|0|||
161426666|NCT01506271|582951576|FG001|Overall Study|Lost to Follow-up|1|||
161426667|NCT01506271|582951577|FG002|Overall Study|Lost to Follow-up|2|||
161426668|NCT00689390|582951578|FG000|Overall Study|Adverse Event|19|||
161426669|NCT00689390|582951579|FG001|Overall Study|Adverse Event|0|||
161426670|NCT00689390|582951578|FG000|Overall Study|Lost to Follow-up|179|||
161426671|NCT00689390|582951579|FG001|Overall Study|Lost to Follow-up|7|||
161426672|NCT00689390|582951578|FG000|Overall Study|Withdrawal by Subject|117|||
161426673|NCT00689390|582951579|FG001|Overall Study|Withdrawal by Subject|3|||
161426674|NCT00689390|582951578|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
161426675|NCT00689390|582951579|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
161426676|NCT00689390|582951578|FG000|Overall Study|Non-Compliance With Protocol|21|||
161426677|NCT00689390|582951579|FG001|Overall Study|Non-Compliance With Protocol|0|||
161426678|NCT00689390|582951578|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
161426679|NCT00689390|582951579|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161426680|NCT00689390|582951578|FG000|Overall Study|Administrative|37|||
161426681|NCT00689390|582951579|FG001|Overall Study|Administrative|0|||
161426682|NCT03318549|582951580|FG000|Overall Study|Withdrawal by Subject|5|||
161426683|NCT03318549|582951581|FG001|Overall Study|Withdrawal by Subject|19|||
161426684|NCT03318549|582951582|FG002|Overall Study|Withdrawal by Subject|2|||
161426685|NCT03318549|582951583|FG003|Overall Study|Withdrawal by Subject|0|||
161426686|NCT03318549|582951584|FG004|Overall Study|Withdrawal by Subject|0|||
161426687|NCT03318549|582951585|FG005|Overall Study|Withdrawal by Subject|0|||
161426688|NCT03318549|582951586|FG006|Overall Study|Withdrawal by Subject|0|||
161426689|NCT03318549|582951580|FG000|Overall Study|Physician Decision|0|||
161426690|NCT03318549|582951581|FG001|Overall Study|Physician Decision|4|||
161426691|NCT03318549|582951582|FG002|Overall Study|Physician Decision|1|||
161426692|NCT03318549|582951583|FG003|Overall Study|Physician Decision|0|||
161426693|NCT03318549|582951584|FG004|Overall Study|Physician Decision|0|||
161426694|NCT03318549|582951585|FG005|Overall Study|Physician Decision|0|||
161426695|NCT03318549|582951586|FG006|Overall Study|Physician Decision|0|||
161426696|NCT03318549|582951580|FG000|Overall Study|Lost to Follow-up|0|||
161426697|NCT03318549|582951581|FG001|Overall Study|Lost to Follow-up|3|||
161426698|NCT03318549|582951582|FG002|Overall Study|Lost to Follow-up|3|||
161426699|NCT03318549|582951583|FG003|Overall Study|Lost to Follow-up|0|||
161426700|NCT03318549|582951584|FG004|Overall Study|Lost to Follow-up|0|||
161426701|NCT03318549|582951585|FG005|Overall Study|Lost to Follow-up|0|||
161426702|NCT03318549|582951586|FG006|Overall Study|Lost to Follow-up|0|||
161426703|NCT00510835|582951588|FG000|Overall Study|Withdrawal by Subject|6|||
161426704|NCT00510835|582951589|FG001|Overall Study|Withdrawal by Subject|2|||
161426705|NCT00510835|582951590|FG002|Overall Study|Withdrawal by Subject|2|||
161426706|NCT01917747|582951591|FG000|Overall Study|Withdrawal by Subject|1|||
161426707|NCT01917747|582951592|FG001|Overall Study|Withdrawal by Subject|2|||
161426708|NCT01917747|582951591|FG000|Overall Study|Lost to Follow-up|18|||
161426709|NCT01917747|582951592|FG001|Overall Study|Lost to Follow-up|9|||
161426710|NCT03064490|582951594|FG000|Overall Study|Physician Decision|5|||
161426711|NCT05579977|582951599|FG000|Treatment Phase|Other|0|||
161426712|NCT05579977|582951600|FG001|Treatment Phase|Other|0|||
161426713|NCT05579977|582951601|FG002|Treatment Phase|Other|0|||
161426714|NCT05579977|582951602|FG003|Treatment Phase|Other|2|||
161426715|NCT05579977|582951603|FG004|Treatment Phase|Other|1|||
161426716|NCT05579977|582951604|FG005|Treatment Phase|Other|2|||
161426717|NCT05579977|582951605|FG006|Treatment Phase|Other|1|||
161426718|NCT05579977|582951606|FG007|Treatment Phase|Other|2|||
161426719|NCT05579977|582951607|FG008|Treatment Phase|Other|2|||
161426720|NCT05579977|582951608|FG009|Treatment Phase|Other|1|||
161426721|NCT05579977|582951609|FG010|Treatment Phase|Other|0|||
161426722|NCT05579977|582951610|FG011|Treatment Phase|Other|0|||
161426723|NCT05579977|582951611|FG012|Treatment Phase|Other|3|||
161426724|NCT05579977|582951599|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
161426725|NCT05579977|582951600|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
161426726|NCT05579977|582951601|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
161426727|NCT05579977|582951602|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
161426728|NCT05579977|582951603|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
161426729|NCT05579977|582951604|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
161426730|NCT05579977|582951605|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
161426731|NCT05579977|582951606|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
161426732|NCT05579977|582951607|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
161426733|NCT05579977|582951608|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
161426734|NCT05579977|582951609|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
161426735|NCT05579977|582951610|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
161426736|NCT05579977|582951611|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
161426737|NCT05579977|582951599|FG000|Treatment Phase|Withdrawal by Subject|2|||
161426738|NCT05579977|582951600|FG001|Treatment Phase|Withdrawal by Subject|0|||
161426739|NCT05579977|582951601|FG002|Treatment Phase|Withdrawal by Subject|0|||
161426740|NCT05579977|582951602|FG003|Treatment Phase|Withdrawal by Subject|1|||
161426741|NCT05579977|582951603|FG004|Treatment Phase|Withdrawal by Subject|2|||
161426742|NCT05579977|582951604|FG005|Treatment Phase|Withdrawal by Subject|0|||
161426743|NCT05579977|582951605|FG006|Treatment Phase|Withdrawal by Subject|1|||
161426744|NCT05579977|582951606|FG007|Treatment Phase|Withdrawal by Subject|8|||
161426745|NCT05579977|582951607|FG008|Treatment Phase|Withdrawal by Subject|3|||
161426746|NCT05579977|582951608|FG009|Treatment Phase|Withdrawal by Subject|3|||
161426747|NCT05579977|582951609|FG010|Treatment Phase|Withdrawal by Subject|5|||
161426748|NCT05579977|582951610|FG011|Treatment Phase|Withdrawal by Subject|1|||
161426749|NCT05579977|582951611|FG012|Treatment Phase|Withdrawal by Subject|3|||
161426750|NCT05579977|582951599|FG000|Treatment Phase|Study terminated by sponsor|70|||
161426751|NCT05579977|582951600|FG001|Treatment Phase|Study terminated by sponsor|70|||
161426752|NCT05579977|582951601|FG002|Treatment Phase|Study terminated by sponsor|61|||
161426753|NCT05579977|582951602|FG003|Treatment Phase|Study terminated by sponsor|59|||
161426754|NCT05579977|582951603|FG004|Treatment Phase|Study terminated by sponsor|63|||
161426755|NCT05579977|582951604|FG005|Treatment Phase|Study terminated by sponsor|53|||
161426756|NCT05579977|582951605|FG006|Treatment Phase|Study terminated by sponsor|66|||
161426757|NCT05579977|582951606|FG007|Treatment Phase|Study terminated by sponsor|48|||
161426758|NCT05579977|582951607|FG008|Treatment Phase|Study terminated by sponsor|47|||
161426759|NCT05579977|582951608|FG009|Treatment Phase|Study terminated by sponsor|37|||
161426760|NCT05579977|582951609|FG010|Treatment Phase|Study terminated by sponsor|44|||
161426761|NCT05579977|582951610|FG011|Treatment Phase|Study terminated by sponsor|36|||
161426762|NCT05579977|582951611|FG012|Treatment Phase|Study terminated by sponsor|32|||
161426763|NCT05579977|582951599|FG000|Treatment Phase|Pregnancy|0|||
161426764|NCT05579977|582951600|FG001|Treatment Phase|Pregnancy|0|||
161426765|NCT05579977|582951601|FG002|Treatment Phase|Pregnancy|0|||
161426766|NCT05579977|582951602|FG003|Treatment Phase|Pregnancy|0|||
161426767|NCT05579977|582951603|FG004|Treatment Phase|Pregnancy|0|||
161426768|NCT05579977|582951604|FG005|Treatment Phase|Pregnancy|0|||
161426769|NCT05579977|582951605|FG006|Treatment Phase|Pregnancy|0|||
161426770|NCT05579977|582951606|FG007|Treatment Phase|Pregnancy|0|||
161426771|NCT05579977|582951607|FG008|Treatment Phase|Pregnancy|0|||
161426772|NCT05579977|582951608|FG009|Treatment Phase|Pregnancy|1|||
161426773|NCT05579977|582951609|FG010|Treatment Phase|Pregnancy|0|||
161426774|NCT05579977|582951610|FG011|Treatment Phase|Pregnancy|0|||
161426775|NCT05579977|582951611|FG012|Treatment Phase|Pregnancy|0|||
161426776|NCT05579977|582951599|FG000|Treatment Phase|Physician Decision|0|||
161426777|NCT05579977|582951600|FG001|Treatment Phase|Physician Decision|0|||
161426778|NCT05579977|582951601|FG002|Treatment Phase|Physician Decision|0|||
161426779|NCT05579977|582951602|FG003|Treatment Phase|Physician Decision|0|||
161426780|NCT05579977|582951603|FG004|Treatment Phase|Physician Decision|0|||
161426781|NCT05579977|582951604|FG005|Treatment Phase|Physician Decision|0|||
161426782|NCT05579977|582951605|FG006|Treatment Phase|Physician Decision|0|||
161426783|NCT05579977|582951606|FG007|Treatment Phase|Physician Decision|0|||
161426784|NCT05579977|582951607|FG008|Treatment Phase|Physician Decision|0|||
161426785|NCT05579977|582951608|FG009|Treatment Phase|Physician Decision|0|||
161426786|NCT05579977|582951609|FG010|Treatment Phase|Physician Decision|0|||
161426787|NCT05579977|582951610|FG011|Treatment Phase|Physician Decision|1|||
161426788|NCT05579977|582951611|FG012|Treatment Phase|Physician Decision|0|||
161426789|NCT05579977|582951599|FG000|Treatment Phase|Lost to Follow-up|0|||
161426790|NCT05579977|582951600|FG001|Treatment Phase|Lost to Follow-up|0|||
161426791|NCT05579977|582951601|FG002|Treatment Phase|Lost to Follow-up|0|||
161426792|NCT05579977|582951602|FG003|Treatment Phase|Lost to Follow-up|1|||
161426793|NCT05579977|582951603|FG004|Treatment Phase|Lost to Follow-up|1|||
161426794|NCT05579977|582951604|FG005|Treatment Phase|Lost to Follow-up|1|||
161426795|NCT05579977|582951605|FG006|Treatment Phase|Lost to Follow-up|0|||
161426796|NCT05579977|582951606|FG007|Treatment Phase|Lost to Follow-up|1|||
161426797|NCT05579977|582951607|FG008|Treatment Phase|Lost to Follow-up|2|||
161426798|NCT05579977|582951608|FG009|Treatment Phase|Lost to Follow-up|2|||
161426799|NCT05579977|582951609|FG010|Treatment Phase|Lost to Follow-up|1|||
161426800|NCT05579977|582951610|FG011|Treatment Phase|Lost to Follow-up|4|||
161426801|NCT05579977|582951611|FG012|Treatment Phase|Lost to Follow-up|3|||
161426802|NCT05579977|582951599|FG000|Treatment Phase|Death|1|||
161426803|NCT05579977|582951600|FG001|Treatment Phase|Death|0|||
161426804|NCT05579977|582951601|FG002|Treatment Phase|Death|0|||
161426805|NCT05579977|582951602|FG003|Treatment Phase|Death|0|||
161426806|NCT05579977|582951603|FG004|Treatment Phase|Death|0|||
161426807|NCT05579977|582951604|FG005|Treatment Phase|Death|0|||
161426808|NCT05579977|582951605|FG006|Treatment Phase|Death|0|||
161426809|NCT05579977|582951606|FG007|Treatment Phase|Death|0|||
161426810|NCT05579977|582951607|FG008|Treatment Phase|Death|0|||
161426811|NCT05579977|582951608|FG009|Treatment Phase|Death|0|||
161426812|NCT05579977|582951609|FG010|Treatment Phase|Death|0|||
161426813|NCT05579977|582951610|FG011|Treatment Phase|Death|0|||
161426814|NCT05579977|582951611|FG012|Treatment Phase|Death|0|||
161426815|NCT05579977|582951599|FG000|Treatment Phase|Adverse Event|0|||
161426816|NCT05579977|582951600|FG001|Treatment Phase|Adverse Event|3|||
161426817|NCT05579977|582951601|FG002|Treatment Phase|Adverse Event|11|||
161426818|NCT05579977|582951602|FG003|Treatment Phase|Adverse Event|10|||
161426819|NCT05579977|582951603|FG004|Treatment Phase|Adverse Event|5|||
161426820|NCT05579977|582951604|FG005|Treatment Phase|Adverse Event|17|||
161426821|NCT05579977|582951605|FG006|Treatment Phase|Adverse Event|5|||
161426822|NCT05579977|582951606|FG007|Treatment Phase|Adverse Event|5|||
161426823|NCT05579977|582951607|FG008|Treatment Phase|Adverse Event|12|||
161426824|NCT05579977|582951608|FG009|Treatment Phase|Adverse Event|20|||
161426825|NCT05579977|582951609|FG010|Treatment Phase|Adverse Event|15|||
161426826|NCT05579977|582951610|FG011|Treatment Phase|Adverse Event|24|||
161426827|NCT05579977|582951611|FG012|Treatment Phase|Adverse Event|23|||
161426828|NCT05579977|582951599|FG000|Treatment Phase|Randomized not treated|0|||
161426829|NCT05579977|582951600|FG001|Treatment Phase|Randomized not treated|0|||
161426830|NCT05579977|582951601|FG002|Treatment Phase|Randomized not treated|0|||
161426831|NCT05579977|582951602|FG003|Treatment Phase|Randomized not treated|0|||
161426832|NCT05579977|582951603|FG004|Treatment Phase|Randomized not treated|1|||
161426833|NCT05579977|582951604|FG005|Treatment Phase|Randomized not treated|0|||
161426834|NCT05579977|582951605|FG006|Treatment Phase|Randomized not treated|0|||
161426835|NCT05579977|582951606|FG007|Treatment Phase|Randomized not treated|0|||
161426836|NCT05579977|582951607|FG008|Treatment Phase|Randomized not treated|0|||
161426837|NCT05579977|582951608|FG009|Treatment Phase|Randomized not treated|0|||
161426838|NCT05579977|582951609|FG010|Treatment Phase|Randomized not treated|0|||
161426839|NCT05579977|582951610|FG011|Treatment Phase|Randomized not treated|0|||
161426840|NCT05579977|582951611|FG012|Treatment Phase|Randomized not treated|0|||
161426841|NCT05579977|582951599|FG000|Follow up|Death|1|||
161426842|NCT05579977|582951600|FG001|Follow up|Death|0|||
161426843|NCT05579977|582951601|FG002|Follow up|Death|0|||
161426844|NCT05579977|582951602|FG003|Follow up|Death|0|||
161426845|NCT05579977|582951603|FG004|Follow up|Death|0|||
161426846|NCT05579977|582951604|FG005|Follow up|Death|0|||
161426847|NCT05579977|582951605|FG006|Follow up|Death|0|||
161426848|NCT05579977|582951606|FG007|Follow up|Death|0|||
161426849|NCT05579977|582951607|FG008|Follow up|Death|0|||
161426850|NCT05579977|582951608|FG009|Follow up|Death|0|||
161426851|NCT05579977|582951609|FG010|Follow up|Death|0|||
161426852|NCT05579977|582951610|FG011|Follow up|Death|0|||
161426853|NCT05579977|582951611|FG012|Follow up|Death|0|||
161426854|NCT05579977|582951599|FG000|Follow up|Lost to Follow-up|0|||
161426855|NCT05579977|582951600|FG001|Follow up|Lost to Follow-up|0|||
161426856|NCT05579977|582951601|FG002|Follow up|Lost to Follow-up|0|||
161426857|NCT05579977|582951602|FG003|Follow up|Lost to Follow-up|1|||
161426858|NCT05579977|582951603|FG004|Follow up|Lost to Follow-up|1|||
161426859|NCT05579977|582951604|FG005|Follow up|Lost to Follow-up|2|||
161426860|NCT05579977|582951605|FG006|Follow up|Lost to Follow-up|1|||
161426861|NCT05579977|582951606|FG007|Follow up|Lost to Follow-up|1|||
161426862|NCT05579977|582951607|FG008|Follow up|Lost to Follow-up|3|||
161426863|NCT05579977|582951608|FG009|Follow up|Lost to Follow-up|2|||
161426864|NCT05579977|582951609|FG010|Follow up|Lost to Follow-up|2|||
161426865|NCT05579977|582951610|FG011|Follow up|Lost to Follow-up|4|||
161426866|NCT05579977|582951611|FG012|Follow up|Lost to Follow-up|4|||
161426867|NCT05579977|582951599|FG000|Follow up|Withdrawal by Subject|2|||
161426868|NCT05579977|582951600|FG001|Follow up|Withdrawal by Subject|0|||
161426869|NCT05579977|582951601|FG002|Follow up|Withdrawal by Subject|0|||
161426870|NCT05579977|582951602|FG003|Follow up|Withdrawal by Subject|0|||
161426871|NCT05579977|582951603|FG004|Follow up|Withdrawal by Subject|1|||
161426872|NCT05579977|582951604|FG005|Follow up|Withdrawal by Subject|0|||
161426873|NCT05579977|582951605|FG006|Follow up|Withdrawal by Subject|1|||
161426874|NCT05579977|582951606|FG007|Follow up|Withdrawal by Subject|4|||
161426875|NCT05579977|582951607|FG008|Follow up|Withdrawal by Subject|2|||
161426876|NCT05579977|582951608|FG009|Follow up|Withdrawal by Subject|3|||
161426877|NCT05579977|582951609|FG010|Follow up|Withdrawal by Subject|3|||
161426878|NCT05579977|582951610|FG011|Follow up|Withdrawal by Subject|1|||
161426879|NCT05579977|582951611|FG012|Follow up|Withdrawal by Subject|3|||
161426880|NCT01611194|582951615|FG000|Overall Study|Lost to Follow-up|0|||
161426881|NCT01611194|582951616|FG001|Overall Study|Lost to Follow-up|1|||
161426882|NCT01611194|582951615|FG000|Overall Study|Withdrawal by Subject|0|||
161426883|NCT01611194|582951616|FG001|Overall Study|Withdrawal by Subject|1|||
161426884|NCT01611194|582951615|FG000|Overall Study|drug use|0|||
161426885|NCT01611194|582951616|FG001|Overall Study|drug use|1|||
161426886|NCT00452790|582951617|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
161426887|NCT00452790|582951618|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
161426888|NCT00452790|582951617|FG000|Infant Series|Parent/legal guardian request|8|||
161426889|NCT00452790|582951618|FG001|Infant Series|Parent/legal guardian request|6|||
161426890|NCT00452790|582951617|FG000|Infant Series|Failed to return|4|||
161426891|NCT00452790|582951618|FG001|Infant Series|Failed to return|1|||
161426892|NCT00452790|582951617|FG000|Infant Series|Protocol Violation|1|||
161426893|NCT00452790|582951618|FG001|Infant Series|Protocol Violation|3|||
161426894|NCT00452790|582951617|FG000|Infant Series|Lost to Follow-up|2|||
161426895|NCT00452790|582951618|FG001|Infant Series|Lost to Follow-up|2|||
161426896|NCT00452790|582951617|FG000|Infant Series|Adverse Event|1|||
161426897|NCT00452790|582951618|FG001|Infant Series|Adverse Event|2|||
161426898|NCT00452790|582951617|FG000|Infant Series|Other reasons|1|||
161426899|NCT00452790|582951618|FG001|Infant Series|Other reasons|2|||
161426900|NCT00452790|582951617|FG000|Infant Series|Investigator request|0|||
161426901|NCT00452790|582951618|FG001|Infant Series|Investigator request|1|||
161426902|NCT00452790|582951617|FG000|Infant Series|Death|0|||
161426903|NCT00452790|582951618|FG001|Infant Series|Death|1|||
161426904|NCT00452790|582951617|FG000|After Infant Series|Investigator request|10|||
161426905|NCT00452790|582951618|FG001|After Infant Series|Investigator request|10|||
161426906|NCT00452790|582951617|FG000|After Infant Series|Adverse Event|4|||
161426907|NCT00452790|582951618|FG001|After Infant Series|Adverse Event|1|||
161426908|NCT00452790|582951617|FG000|After Infant Series|Parent/legal guardian request|1|||
161426909|NCT00452790|582951618|FG001|After Infant Series|Parent/legal guardian request|3|||
161426910|NCT00452790|582951617|FG000|After Infant Series|Lost to Follow-up|4|||
161426911|NCT00452790|582951618|FG001|After Infant Series|Lost to Follow-up|0|||
161426912|NCT00452790|582951617|FG000|After Infant Series|Failed to return|1|||
161426913|NCT00452790|582951618|FG001|After Infant Series|Failed to return|0|||
161426914|NCT00452790|582951617|FG000|After Infant Series|Other reasons|1|||
161426915|NCT00452790|582951618|FG001|After Infant Series|Other reasons|0|||
161426916|NCT00452790|582951617|FG000|Toddler Dose|Failed to return|0|||
161426917|NCT00452790|582951618|FG001|Toddler Dose|Failed to return|1|||
161426918|NCT00452790|582951617|FG000|Toddler Dose|Parent/legal guardian request|0|||
161426919|NCT00452790|582951618|FG001|Toddler Dose|Parent/legal guardian request|1|||
161426920|NCT02926638|582951634|FG000|Overall Study|Progression|2|||
161426921|NCT02926638|582951635|FG001|Overall Study|Progression|5|||
161426922|NCT02926638|582951634|FG000|Overall Study|Ineligible|1|||
161426923|NCT02926638|582951635|FG001|Overall Study|Ineligible|0|||
161426924|NCT02926638|582951634|FG000|Overall Study|Not protocol specified|1|||
161426925|NCT02926638|582951635|FG001|Overall Study|Not protocol specified|0|||
161426926|NCT02464410|582951637|FG000|Overall Study|Death|3|||
161426927|NCT02464410|582951638|FG001|Overall Study|Death|4|||
161426928|NCT02464410|582951637|FG000|Overall Study|Lost to Follow-up|7|||
161426929|NCT02464410|582951638|FG001|Overall Study|Lost to Follow-up|9|||
161426930|NCT02464410|582951637|FG000|Overall Study|Withdrawal by Subject|12|||
161426931|NCT02464410|582951638|FG001|Overall Study|Withdrawal by Subject|3|||
161426932|NCT01928927|582951639|FG000|Overall Study|Lost to Follow-up|1|||
161426933|NCT01928927|582951640|FG001|Overall Study|Lost to Follow-up|0|||
161426934|NCT01928927|582951639|FG000|Overall Study|Withdrawal by Subject|1|||
161426935|NCT01928927|582951640|FG001|Overall Study|Withdrawal by Subject|1|||
161426936|NCT01871519|582951645|FG000|Overall Study|Death|26|||
161426937|NCT01871519|582951645|FG000|Overall Study|Lost to Follow-up|15|||
161426938|NCT01871519|582951645|FG000|Overall Study|Withdrawal by Subject|49|||
161426939|NCT01777776|582951646|FG000|Overall Study|Adverse Event|2|||
161426940|NCT01777776|582951647|FG001|Overall Study|Adverse Event|4|||
161426941|NCT01777776|582951648|FG002|Overall Study|Adverse Event|0|||
161426942|NCT01777776|582951649|FG003|Overall Study|Adverse Event|0|||
161426943|NCT01777776|582951646|FG000|Overall Study|Disease Progression|4|||
161426944|NCT01777776|582951647|FG001|Overall Study|Disease Progression|8|||
161426945|NCT01777776|582951648|FG002|Overall Study|Disease Progression|6|||
161426946|NCT01777776|582951649|FG003|Overall Study|Disease Progression|3|||
161426947|NCT01777776|582951646|FG000|Overall Study|Withdrawal by Subject|0|||
161426948|NCT01777776|582951647|FG001|Overall Study|Withdrawal by Subject|0|||
161426949|NCT01777776|582951648|FG002|Overall Study|Withdrawal by Subject|0|||
161426950|NCT01777776|582951649|FG003|Overall Study|Withdrawal by Subject|1|||
161426951|NCT01420926|582951652|FG000|Overall Study|Adverse Event|6|||
161426952|NCT01420926|582951653|FG001|Overall Study|Adverse Event|4|||
161426953|NCT01420926|582951652|FG000|Overall Study|Death|18|||
161426954|NCT01420926|582951653|FG001|Overall Study|Death|17|||
161426955|NCT01420926|582951652|FG000|Overall Study|Withdrawal by Subject|11|||
161426956|NCT01420926|582951653|FG001|Overall Study|Withdrawal by Subject|17|||
161426957|NCT01420926|582951652|FG000|Overall Study|Non-protocol treatment|17|||
161426958|NCT01420926|582951653|FG001|Overall Study|Non-protocol treatment|20|||
161426959|NCT01420926|582951652|FG000|Overall Study|Physician Decision|8|||
161426960|NCT01420926|582951653|FG001|Overall Study|Physician Decision|5|||
161426961|NCT04564846|582953118|FG000|Overall Study|Withdrawal by Subject|2|||
161426962|NCT04564846|582953119|FG001|Overall Study|Withdrawal by Subject|1|||
161426963|NCT04564846|582953118|FG000|Overall Study|Physician Decision|0|||
161426964|NCT04564846|582953119|FG001|Overall Study|Physician Decision|1|||
161426965|NCT04564846|582953118|FG000|Overall Study|Lost to Follow-up|0|||
161426966|NCT04564846|582953119|FG001|Overall Study|Lost to Follow-up|1|||
161426967|NCT04564846|582953118|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
161426968|NCT04564846|582953119|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
161426969|NCT04564846|582953118|FG000|Overall Study|Subject non-compliance|1|||
161426970|NCT04564846|582953119|FG001|Overall Study|Subject non-compliance|0|||
161426971|NCT00179621|582953120|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
161426972|NCT00179621|582953121|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
161426973|NCT00179621|582953122|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
161426974|NCT00179621|582953123|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
161426975|NCT00179621|582953120|FG000|Double-Blind Period|Adverse Event|2|||
161426976|NCT00179621|582953121|FG001|Double-Blind Period|Adverse Event|7|||
161426977|NCT00179621|582953122|FG002|Double-Blind Period|Adverse Event|4|||
161426978|NCT00179621|582953123|FG003|Double-Blind Period|Adverse Event|0|||
161426979|NCT00179621|582953120|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161426980|NCT00179621|582953121|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161426981|NCT00179621|582953122|FG002|Double-Blind Period|Withdrawal by Subject|3|||
161426982|NCT00179621|582953123|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161426983|NCT00179621|582953120|FG000|Double-Blind Period|Death|0|||
161426984|NCT00179621|582953121|FG001|Double-Blind Period|Death|1|||
161426985|NCT00179621|582953122|FG002|Double-Blind Period|Death|2|||
161426986|NCT00179621|582953123|FG003|Double-Blind Period|Death|0|||
161426987|NCT00179621|582953120|FG000|Double-Blind Period|Protocol Violation|1|||
161426988|NCT00179621|582953121|FG001|Double-Blind Period|Protocol Violation|0|||
161426989|NCT00179621|582953122|FG002|Double-Blind Period|Protocol Violation|0|||
161426990|NCT00179621|582953123|FG003|Double-Blind Period|Protocol Violation|0|||
161426991|NCT00179621|582953120|FG000|Double-Blind Period|Other|0|||
161426992|NCT00179621|582953121|FG001|Double-Blind Period|Other|2|||
161426993|NCT00179621|582953122|FG002|Double-Blind Period|Other|2|||
161426994|NCT00179621|582953123|FG003|Double-Blind Period|Other|0|||
161426995|NCT00179621|582953120|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
161426996|NCT00179621|582953121|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
161426997|NCT00179621|582953122|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
161426998|NCT00179621|582953123|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
161426999|NCT00179621|582953120|FG000|Open-Label Period|Adverse Event|0|||
161427000|NCT00179621|582953121|FG001|Open-Label Period|Adverse Event|6|||
161427001|NCT00179621|582953122|FG002|Open-Label Period|Adverse Event|5|||
161427002|NCT00179621|582953123|FG003|Open-Label Period|Adverse Event|6|||
161427003|NCT00179621|582953120|FG000|Open-Label Period|Withdrawal by Subject|0|||
161427004|NCT00179621|582953121|FG001|Open-Label Period|Withdrawal by Subject|2|||
161427005|NCT00179621|582953122|FG002|Open-Label Period|Withdrawal by Subject|2|||
161427006|NCT00179621|582953123|FG003|Open-Label Period|Withdrawal by Subject|2|||
161427007|NCT00179621|582953120|FG000|Open-Label Period|Death|0|||
161427008|NCT00179621|582953121|FG001|Open-Label Period|Death|0|||
161427009|NCT00179621|582953122|FG002|Open-Label Period|Death|1|||
161427010|NCT00179621|582953123|FG003|Open-Label Period|Death|2|||
161427011|NCT00179621|582953120|FG000|Open-Label Period|Other|0|||
161427012|NCT00179621|582953121|FG001|Open-Label Period|Other|1|||
161427013|NCT00179621|582953122|FG002|Open-Label Period|Other|1|||
161427014|NCT00179621|582953123|FG003|Open-Label Period|Other|2|||
161427015|NCT00865345|582953125|FG000|Overall Study|Withdrawal by Subject|2|||
161427016|NCT03737123|582953126|FG000|Study Treatment|Adverse Event|2|||
161427017|NCT03737123|582953127|FG001|Study Treatment|Adverse Event|0|||
161427018|NCT03737123|582953126|FG000|Study Treatment|Disease Progression|2|||
161427019|NCT03737123|582953127|FG001|Study Treatment|Disease Progression|0|||
161427020|NCT03737123|582953126|FG000|Study Treatment|Withdrawal by Subject|2|||
161427021|NCT03737123|582953127|FG001|Study Treatment|Withdrawal by Subject|0|||
161427022|NCT03737123|582953126|FG000|Follow up|Death|1|||
161427023|NCT03737123|582953127|FG001|Follow up|Death|0|||
161427024|NCT03737123|582953126|FG000|Follow up|Withdrawal by Subject|1|||
161427025|NCT03737123|582953127|FG001|Follow up|Withdrawal by Subject|0|||
161427026|NCT03737123|582953126|FG000|Follow up|Termination of study|4|||
161427027|NCT03737123|582953127|FG001|Follow up|Termination of study|0|||
161427028|NCT00383552|582953128|FG000|Overall Study|Adverse Event|7|||
161427029|NCT00383552|582953129|FG001|Overall Study|Adverse Event|6|||
161427030|NCT00383552|582953130|FG002|Overall Study|Adverse Event|9|||
161427031|NCT00383552|582953131|FG003|Overall Study|Adverse Event|6|||
161427032|NCT00383552|582953128|FG000|Overall Study|Lack of Efficacy|4|||
161427033|NCT00383552|582953129|FG001|Overall Study|Lack of Efficacy|13|||
161427034|NCT00383552|582953130|FG002|Overall Study|Lack of Efficacy|29|||
161427035|NCT00383552|582953131|FG003|Overall Study|Lack of Efficacy|42|||
161427036|NCT00383552|582953128|FG000|Overall Study|Lost to Follow-up|0|||
161427037|NCT00383552|582953129|FG001|Overall Study|Lost to Follow-up|1|||
161427038|NCT00383552|582953130|FG002|Overall Study|Lost to Follow-up|5|||
161427039|NCT00383552|582953131|FG003|Overall Study|Lost to Follow-up|1|||
161427040|NCT00383552|582953128|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
161427041|NCT00383552|582953129|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
161427042|NCT00383552|582953130|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
161427043|NCT00383552|582953131|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
161427044|NCT00383552|582953128|FG000|Overall Study|Did not wish to continue (related)|1|||
161427045|NCT00383552|582953129|FG001|Overall Study|Did not wish to continue (related)|0|||
161427046|NCT00383552|582953130|FG002|Overall Study|Did not wish to continue (related)|2|||
161427047|NCT00383552|582953131|FG003|Overall Study|Did not wish to continue (related)|3|||
161427048|NCT00383552|582953128|FG000|Overall Study|Noncompliance with the protocol|11|||
161427049|NCT00383552|582953129|FG001|Overall Study|Noncompliance with the protocol|6|||
161427050|NCT00383552|582953130|FG002|Overall Study|Noncompliance with the protocol|8|||
161427051|NCT00383552|582953131|FG003|Overall Study|Noncompliance with the protocol|10|||
161427052|NCT00383552|582953128|FG000|Overall Study|Did not meet protocol eligibility|8|||
161427053|NCT00383552|582953129|FG001|Overall Study|Did not meet protocol eligibility|6|||
161427054|NCT00383552|582953130|FG002|Overall Study|Did not meet protocol eligibility|2|||
161427055|NCT00383552|582953131|FG003|Overall Study|Did not meet protocol eligibility|3|||
161427056|NCT00383552|582953128|FG000|Overall Study|Administrative|1|||
161427057|NCT00383552|582953129|FG001|Overall Study|Administrative|0|||
161427058|NCT00383552|582953130|FG002|Overall Study|Administrative|1|||
161427059|NCT00383552|582953131|FG003|Overall Study|Administrative|1|||
161427060|NCT00966654|582953132|FG000|Overall Study|Study was terminated,PI left institution|12|||
161427061|NCT00762359|582953135|FG000|Overall Study|Adverse Event|20|||
161427062|NCT00762359|582953136|FG001|Overall Study|Adverse Event|23|||
161427063|NCT00762359|582953135|FG000|Overall Study|Protocol Violation|21|||
161427064|NCT00762359|582953136|FG001|Overall Study|Protocol Violation|13|||
161427065|NCT00762359|582953135|FG000|Overall Study|Withdrawal by Subject|13|||
161427066|NCT00762359|582953136|FG001|Overall Study|Withdrawal by Subject|10|||
161427067|NCT00762359|582953135|FG000|Overall Study|Lack of Efficacy|0|||
161427068|NCT00762359|582953136|FG001|Overall Study|Lack of Efficacy|4|||
161427069|NCT00762359|582953135|FG000|Overall Study|Institution closed|2|||
161427070|NCT00762359|582953136|FG001|Overall Study|Institution closed|3|||
161427071|NCT00762359|582953135|FG000|Overall Study|Physician Decision|2|||
161427072|NCT00762359|582953136|FG001|Overall Study|Physician Decision|3|||
161427073|NCT00762359|582953135|FG000|Overall Study|Removal|0|||
161427074|NCT00762359|582953136|FG001|Overall Study|Removal|1|||
161427075|NCT00762359|582953135|FG000|Overall Study|Withdrew consent|1|||
161427076|NCT00762359|582953136|FG001|Overall Study|Withdrew consent|0|||
161427077|NCT00882440|582953137|FG000|Overall Study|Adverse Event|2|||
161427078|NCT00882440|582953138|FG001|Overall Study|Adverse Event|2|||
161427079|NCT00882440|582953139|FG002|Overall Study|Adverse Event|2|||
161427080|NCT00882440|582953140|FG003|Overall Study|Adverse Event|1|||
161427081|NCT00882440|582953141|FG004|Overall Study|Adverse Event|1|||
161427082|NCT00882440|582953142|FG005|Overall Study|Adverse Event|4|||
161427083|NCT00882440|582953143|FG006|Overall Study|Adverse Event|2|||
161427084|NCT00882440|582953137|FG000|Overall Study|Lack of Efficacy|3|||
161427085|NCT00882440|582953138|FG001|Overall Study|Lack of Efficacy|5|||
161427086|NCT00882440|582953139|FG002|Overall Study|Lack of Efficacy|2|||
161427087|NCT00882440|582953140|FG003|Overall Study|Lack of Efficacy|0|||
161427088|NCT00882440|582953141|FG004|Overall Study|Lack of Efficacy|0|||
161427089|NCT00882440|582953142|FG005|Overall Study|Lack of Efficacy|3|||
161427090|NCT00882440|582953143|FG006|Overall Study|Lack of Efficacy|0|||
161427091|NCT00882440|582953137|FG000|Overall Study|Lost to Follow-up|2|||
161427092|NCT00882440|582953138|FG001|Overall Study|Lost to Follow-up|0|||
161427093|NCT00882440|582953139|FG002|Overall Study|Lost to Follow-up|1|||
161427094|NCT00882440|582953140|FG003|Overall Study|Lost to Follow-up|1|||
161427095|NCT00882440|582953141|FG004|Overall Study|Lost to Follow-up|1|||
161427096|NCT00882440|582953142|FG005|Overall Study|Lost to Follow-up|0|||
161427097|NCT00882440|582953143|FG006|Overall Study|Lost to Follow-up|1|||
161427098|NCT00882440|582953137|FG000|Overall Study|Protocol Violation|0|||
161427099|NCT00882440|582953138|FG001|Overall Study|Protocol Violation|0|||
161427100|NCT00882440|582953139|FG002|Overall Study|Protocol Violation|1|||
161427101|NCT00882440|582953140|FG003|Overall Study|Protocol Violation|1|||
161427102|NCT00882440|582953141|FG004|Overall Study|Protocol Violation|1|||
161427103|NCT00882440|582953142|FG005|Overall Study|Protocol Violation|0|||
161427104|NCT00882440|582953143|FG006|Overall Study|Protocol Violation|0|||
161427105|NCT00882440|582953137|FG000|Overall Study|Withdrawal by Subject|2|||
161427106|NCT00882440|582953138|FG001|Overall Study|Withdrawal by Subject|1|||
161427107|NCT00882440|582953139|FG002|Overall Study|Withdrawal by Subject|1|||
161427108|NCT00882440|582953140|FG003|Overall Study|Withdrawal by Subject|0|||
161427109|NCT00882440|582953141|FG004|Overall Study|Withdrawal by Subject|6|||
161427110|NCT00882440|582953142|FG005|Overall Study|Withdrawal by Subject|0|||
161427111|NCT00882440|582953143|FG006|Overall Study|Withdrawal by Subject|1|||
161427112|NCT00882440|582953137|FG000|Overall Study|Patient Uncooperative|2|||
161427113|NCT00882440|582953138|FG001|Overall Study|Patient Uncooperative|0|||
161427114|NCT00882440|582953139|FG002|Overall Study|Patient Uncooperative|0|||
161427115|NCT00882440|582953140|FG003|Overall Study|Patient Uncooperative|0|||
161427116|NCT00882440|582953141|FG004|Overall Study|Patient Uncooperative|1|||
161427117|NCT00882440|582953142|FG005|Overall Study|Patient Uncooperative|0|||
161427118|NCT00882440|582953143|FG006|Overall Study|Patient Uncooperative|0|||
161427119|NCT05482308|582953147|FG000|Overall Study|Withdrawal by Subject|1|||
161427120|NCT05482308|582953148|FG001|Overall Study|Withdrawal by Subject|0|||
161427121|NCT05482308|582953147|FG000|Overall Study|No longer meets eligibility criteria|0|||
161427122|NCT05482308|582953148|FG001|Overall Study|No longer meets eligibility criteria|1|||
161427123|NCT03016312|582953149|FG000|Overall Study|discontinued before the treatment started|0|||
161427124|NCT03016312|582953150|FG001|Overall Study|discontinued before the treatment started|1|||
161427125|NCT03016312|582953149|FG000|Overall Study|Withdrawal by Subject|37|||
161427126|NCT03016312|582953150|FG001|Overall Study|Withdrawal by Subject|44|||
161427127|NCT03016312|582953149|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
161427128|NCT03016312|582953150|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
161427129|NCT03016312|582953149|FG000|Overall Study|Physician Decision|1|||
161427130|NCT03016312|582953150|FG001|Overall Study|Physician Decision|3|||
161427131|NCT03016312|582953149|FG000|Overall Study|Lost to Follow-up|12|||
161427132|NCT03016312|582953150|FG001|Overall Study|Lost to Follow-up|12|||
161427133|NCT03016312|582953149|FG000|Overall Study|Death|210|||
161427134|NCT03016312|582953150|FG001|Overall Study|Death|184|||
161427135|NCT03016312|582953149|FG000|Overall Study|loss to contact|1|||
161427136|NCT03016312|582953150|FG001|Overall Study|loss to contact|0|||
161427137|NCT03016312|582953149|FG000|Overall Study|started a new cancer therapy|1|||
161427138|NCT03016312|582953150|FG001|Overall Study|started a new cancer therapy|0|||
161427139|NCT01631435|582953153|FG000|Overall Study|Adverse Event|2|||
161427140|NCT01631435|582953153|FG000|Overall Study|Withdrawal by Subject|2|||
161427141|NCT01631435|582953153|FG000|Overall Study|incomplete study procedure|5|||
161427142|NCT01421017|582953154|FG000|Overall Study|Withdrawal by Subject|2|||
161427143|NCT01421017|582953155|FG001|Overall Study|Withdrawal by Subject|0|||
161427144|NCT01421017|582953156|FG002|Overall Study|Withdrawal by Subject|0|||
161427145|NCT01421017|582953154|FG000|Overall Study|POD|0|||
161427146|NCT01421017|582953155|FG001|Overall Study|POD|6|||
161427147|NCT01421017|582953156|FG002|Overall Study|POD|3|||
161427148|NCT00416624|582953159|FG000|Overall Study|Withdrawal by Subject|1|||
161427149|NCT00416624|582953160|FG001|Overall Study|Withdrawal by Subject|6|||
161427150|NCT00416624|582953161|FG002|Overall Study|Withdrawal by Subject|4|||
161427151|NCT00416624|582953162|FG003|Overall Study|Withdrawal by Subject|9|||
161427152|NCT00416624|582953159|FG000|Overall Study|Death|4|||
161427153|NCT00416624|582953160|FG001|Overall Study|Death|7|||
161427154|NCT00416624|582953161|FG002|Overall Study|Death|7|||
161427155|NCT00416624|582953162|FG003|Overall Study|Death|1|||
161427156|NCT00416624|582953159|FG000|Overall Study|Adverse Event|8|||
161427157|NCT00416624|582953160|FG001|Overall Study|Adverse Event|3|||
161427158|NCT00416624|582953161|FG002|Overall Study|Adverse Event|2|||
161427159|NCT00416624|582953162|FG003|Overall Study|Adverse Event|2|||
161427160|NCT00416624|582953159|FG000|Overall Study|Other|8|||
161427161|NCT00416624|582953160|FG001|Overall Study|Other|11|||
161427162|NCT00416624|582953161|FG002|Overall Study|Other|5|||
161427163|NCT00416624|582953162|FG003|Overall Study|Other|5|||
161427164|NCT00416624|582953159|FG000|Overall Study|Cancel|1|||
161427165|NCT00416624|582953160|FG001|Overall Study|Cancel|0|||
161427166|NCT00416624|582953161|FG002|Overall Study|Cancel|0|||
161427167|NCT00416624|582953162|FG003|Overall Study|Cancel|0|||
161427168|NCT01458639|582953169|FG000|Overall Study|Physician Decision|4|||
161427169|NCT01458639|582953169|FG000|Overall Study|Equipment issue|1|||
161427170|NCT01458639|582953169|FG000|Overall Study|Inability to obtain subject blood sample|1|||
161427171|NCT04245111|582953170|FG000|Overall Study|Lost to Follow-up|5|||
161427172|NCT04245111|582953171|FG001|Overall Study|Lost to Follow-up|1|||
161427173|NCT04245111|582953172|FG002|Overall Study|Lost to Follow-up|1|||
161427174|NCT02792231|582953173|FG000|Overall Study|Patient/guardian decision|32|||
161427175|NCT02792231|582953174|FG001|Overall Study|Patient/guardian decision|42|||
161427176|NCT02792231|582953173|FG000|Overall Study|Adverse Event|15|||
161427177|NCT02792231|582953174|FG001|Overall Study|Adverse Event|11|||
161427178|NCT02792231|582953173|FG000|Overall Study|Physician Decision|14|||
161427179|NCT02792231|582953174|FG001|Overall Study|Physician Decision|12|||
161427180|NCT02792231|582953173|FG000|Overall Study|Lack of Efficacy|7|||
161427181|NCT02792231|582953174|FG001|Overall Study|Lack of Efficacy|9|||
161427182|NCT02792231|582953173|FG000|Overall Study|Lost to Follow-up|9|||
161427183|NCT02792231|582953174|FG001|Overall Study|Lost to Follow-up|5|||
161427184|NCT02792231|582953173|FG000|Overall Study|Pregnancy|1|||
161427185|NCT02792231|582953174|FG001|Overall Study|Pregnancy|3|||
161427186|NCT02792231|582953173|FG000|Overall Study|Non-compliance with study treatment|2|||
161427187|NCT02792231|582953174|FG001|Overall Study|Non-compliance with study treatment|1|||
161427188|NCT02792231|582953173|FG000|Overall Study|Protocol deviation|2|||
161427189|NCT02792231|582953174|FG001|Overall Study|Protocol deviation|0|||
161427190|NCT02792231|582953173|FG000|Overall Study|Technical problems|0|||
161427191|NCT02792231|582953174|FG001|Overall Study|Technical problems|1|||
161427192|NCT03309878|582953175|FG000|Overall Study|Adverse Event|1|||
161427193|NCT03309878|582953176|FG001|Overall Study|Adverse Event|0|||
161427194|NCT03309878|582953177|FG002|Overall Study|Adverse Event|0|||
161427195|NCT03309878|582953178|FG003|Overall Study|Adverse Event|0|||
161427196|NCT03309878|582953175|FG000|Overall Study|Did not maintain eligibility|2|||
161427197|NCT03309878|582953176|FG001|Overall Study|Did not maintain eligibility|1|||
161427198|NCT03309878|582953177|FG002|Overall Study|Did not maintain eligibility|0|||
161427199|NCT03309878|582953178|FG003|Overall Study|Did not maintain eligibility|0|||
161427200|NCT03309878|582953175|FG000|Overall Study|Withdrawal by Subject|0|||
161427201|NCT03309878|582953176|FG001|Overall Study|Withdrawal by Subject|1|||
161427202|NCT03309878|582953177|FG002|Overall Study|Withdrawal by Subject|0|||
161427203|NCT03309878|582953178|FG003|Overall Study|Withdrawal by Subject|0|||
161427204|NCT01884077|582953179|FG000|Overall Study|screen fail|0|||
161427205|NCT01884077|582953180|FG001|Overall Study|screen fail|2|||
161427206|NCT01884077|582953179|FG000|Overall Study|canceled surgery|2|||
161427207|NCT01884077|582953180|FG001|Overall Study|canceled surgery|0|||
161427208|NCT01884077|582953179|FG000|Overall Study|Lost to Follow-up|0|||
161427209|NCT01884077|582953180|FG001|Overall Study|Lost to Follow-up|4|||
161427210|NCT01884077|582953179|FG000|Overall Study|study closed|6|||
161427211|NCT01884077|582953180|FG001|Overall Study|study closed|4|||
161427212|NCT01755234|582953181|FG000|Overall Study|Lost to Follow-up|11|||
161427213|NCT01755234|582953182|FG001|Overall Study|Lost to Follow-up|6|||
161427214|NCT01755234|582953181|FG000|Overall Study|Change in surgical case|2|||
161427215|NCT01755234|582953182|FG001|Overall Study|Change in surgical case|1|||
161427216|NCT01755234|582953181|FG000|Overall Study|case cancelled|1|||
161427217|NCT01755234|582953182|FG001|Overall Study|case cancelled|0|||
161427218|NCT01755234|582953181|FG000|Overall Study|Withdrawal by Subject|0|||
161427219|NCT01755234|582953182|FG001|Overall Study|Withdrawal by Subject|1|||
161427220|NCT01755234|582953181|FG000|Overall Study|unblinded|1|||
161427221|NCT01755234|582953182|FG001|Overall Study|unblinded|0|||
161427222|NCT03812380|582953183|FG000|Overall Study|Protocol Violation|3|||
161427223|NCT03812380|582953184|FG001|Overall Study|Protocol Violation|3|||
161427224|NCT03812380|582953183|FG000|Overall Study|Withdrawal by Subject|5|||
161427225|NCT03812380|582953184|FG001|Overall Study|Withdrawal by Subject|4|||
161427226|NCT03812380|582953183|FG000|Overall Study|Early termination of study|14|||
161427227|NCT03812380|582953184|FG001|Overall Study|Early termination of study|14|||
161427228|NCT02836652|582953185|FG000|Overall Study|Death|3|||
161427229|NCT02836652|582953186|FG001|Overall Study|Death|3|||
161427230|NCT02836652|582953185|FG000|Overall Study|Transplant/Explant|3|||
161427231|NCT02836652|582953186|FG001|Overall Study|Transplant/Explant|4|||
161427232|NCT02836652|582953185|FG000|Overall Study|Withdrawn|9|||
161427233|NCT02836652|582953186|FG001|Overall Study|Withdrawn|9|||
161427234|NCT02836652|582953185|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
161427235|NCT02836652|582953186|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
161427236|NCT01220167|582953187|FG000|Period 3|Urine positive for substance abuse|0|||
161427237|NCT01220167|582953188|FG001|Period 3|Urine positive for substance abuse|1|||
161427238|NCT01220167|582953189|FG002|Period 3|Urine positive for substance abuse|0|||
161427239|NCT01008943|582953190|FG000|Overall Study|Withdrawal by Subject|1|||
161427240|NCT00861705|582953191|FG000|Overall Study|Never Began Treatment|7|||
161427241|NCT00861705|582953192|FG001|Overall Study|Never Began Treatment|3|||
161427242|NCT00861705|582953193|FG002|Overall Study|Never Began Treatment|0|||
161427243|NCT00861705|582953194|FG003|Overall Study|Never Began Treatment|1|||
161427244|NCT02611479|582953195|FG000|Baseline Enrollment|Exited study|13|||
161427245|NCT02611479|582953195|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
161427246|NCT02611479|582953195|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
161427247|NCT02611479|582953195|FG000|Data Cleaning|No baseline function or pain metrics|2|||
161427248|NCT00743249|582953196|FG000|Overall Study|Adverse Event|0|||
161427249|NCT00743249|582953197|FG001|Overall Study|Adverse Event|4|||
161427250|NCT00743249|582953196|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
161427251|NCT00743249|582953197|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
161427252|NCT00743249|582953196|FG000|Overall Study|Unsuccessful insertion of stent|2|||
161427253|NCT00743249|582953197|FG001|Overall Study|Unsuccessful insertion of stent|1|||
161427254|NCT02314052|582953200|FG000|Cycle One|Adverse Event|0|||
161427255|NCT02314052|582953201|FG001|Cycle One|Adverse Event|0|||
161427256|NCT02314052|582953202|FG002|Cycle One|Adverse Event|0|||
161427257|NCT02314052|582953203|FG003|Cycle One|Adverse Event|1|||
161427258|NCT02314052|582953204|FG004|Cycle One|Adverse Event|0|||
161427259|NCT02314052|582953205|FG005|Cycle One|Adverse Event|0|||
161427260|NCT01960140|582953207|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
161427261|NCT00686777|582953211|FG000|Overall Study|Adverse Event|2|||
161427262|NCT00686777|582953211|FG000|Overall Study|Pregnancy|1|||
161427263|NCT00686777|582953211|FG000|Overall Study|Withdrawal by Subject|2|||
161427264|NCT00686777|582953211|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
161427265|NCT00686777|582953211|FG000|Overall Study|No Visit|1|||
161427266|NCT00883779|582953212|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
161427267|NCT00883779|582953213|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
161427268|NCT00883779|582953212|FG000|Primary Study Treatment Phase|Disease progression|75|||
161427269|NCT00883779|582953213|FG001|Primary Study Treatment Phase|Disease progression|59|||
161427270|NCT00883779|582953212|FG000|Primary Study Treatment Phase|Adverse Event|16|||
161427271|NCT00883779|582953213|FG001|Primary Study Treatment Phase|Adverse Event|16|||
161427272|NCT00883779|582953212|FG000|Primary Study Treatment Phase|Death|2|||
161427273|NCT00883779|582953213|FG001|Primary Study Treatment Phase|Death|3|||
161427274|NCT00883779|582953212|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
161427275|NCT00883779|582953213|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
161427276|NCT00883779|582953212|FG000|Primary Study Treatment Phase|Other|3|||
161427277|NCT00883779|582953213|FG001|Primary Study Treatment Phase|Other|0|||
161427278|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Adverse Event|2|||
161427279|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Adverse Event|3|||
161427280|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Death|1|||
161427281|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Death|3|||
161427282|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
161427283|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
161427284|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
161427285|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
161427286|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Disease progression|103|||
161427287|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Disease progression|122|||
161427288|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Other|3|||
161427289|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Other|0|||
161427290|NCT00883779|582953212|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
161427291|NCT00883779|582953213|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
161427292|NCT00883779|582953212|FG000|Off-study Phase|Death|185|||
161427293|NCT00883779|582953213|FG001|Off-study Phase|Death|174|||
161427294|NCT00883779|582953212|FG000|Off-study Phase|Refused treatment|1|||
161427295|NCT00883779|582953213|FG001|Off-study Phase|Refused treatment|1|||
161427296|NCT00883779|582953212|FG000|Off-study Phase|Failure to return|5|||
161427297|NCT00883779|582953213|FG001|Off-study Phase|Failure to return|6|||
161427298|NCT00883779|582953212|FG000|Off-study Phase|Other|18|||
161427299|NCT00883779|582953213|FG001|Off-study Phase|Other|21|||
161427300|NCT00499681|582953214|FG000|Overall Study|toxicity|0|||
161427301|NCT00499681|582953215|FG001|Overall Study|toxicity|1|||
161427302|NCT00499681|582953214|FG000|Overall Study|disease progression|0|||
161427303|NCT00499681|582953215|FG001|Overall Study|disease progression|1|||
161427304|NCT00739401|582953216|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
161427305|NCT00739401|582953216|FG000|Overall Study|Death|3|||
161427306|NCT00739401|582953216|FG000|Overall Study|Withdrawal by Subject|4|||
161427307|NCT01239381|582953217|FG000|Overall Study|Protocol Violation|1|||
161427308|NCT01239381|582953217|FG000|Overall Study|Withdrawal by Subject|1|||
161427309|NCT06237049|582953218|FG000|Overall Study|Death|0|||
161427310|NCT06237049|582953219|FG001|Overall Study|Death|0|||
161427311|NCT06237049|582953220|FG002|Overall Study|Death|0|||
161427312|NCT06237049|582953221|FG003|Overall Study|Death|1|||
161427313|NCT06237049|582953218|FG000|Overall Study|Lost to Follow-up|11|||
161427314|NCT06237049|582953219|FG001|Overall Study|Lost to Follow-up|5|||
161427315|NCT06237049|582953220|FG002|Overall Study|Lost to Follow-up|8|||
161427316|NCT06237049|582953221|FG003|Overall Study|Lost to Follow-up|8|||
161427317|NCT06237049|582953218|FG000|Overall Study|Protocol Violation|0|||
161427318|NCT06237049|582953219|FG001|Overall Study|Protocol Violation|1|||
161427319|NCT06237049|582953220|FG002|Overall Study|Protocol Violation|0|||
161427320|NCT06237049|582953221|FG003|Overall Study|Protocol Violation|1|||
161427321|NCT06237049|582953218|FG000|Overall Study|Withdrawal by Subject|4|||
161427322|NCT06237049|582953219|FG001|Overall Study|Withdrawal by Subject|2|||
161427323|NCT06237049|582953220|FG002|Overall Study|Withdrawal by Subject|1|||
161427324|NCT06237049|582953221|FG003|Overall Study|Withdrawal by Subject|0|||
161427325|NCT03748823|582953222|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
161427326|NCT03748823|582953223|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
161427327|NCT03748823|582953222|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
161427328|NCT03748823|582953223|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
161427329|NCT03748823|582953222|FG000|Extension Period|Withdrawal by Subject|9|||
161427330|NCT03748823|582953223|FG001|Extension Period|Withdrawal by Subject|12|||
161427331|NCT03748823|582953222|FG000|Extension Period|Death|2|||
161427332|NCT03748823|582953223|FG001|Extension Period|Death|2|||
161427333|NCT03748823|582953222|FG000|Extension Period|Other than Specified|0|||
161427334|NCT03748823|582953223|FG001|Extension Period|Other than Specified|1|||
161427335|NCT03748823|582953222|FG000|Extension Period|Protocol Violation|1|||
161427336|NCT03748823|582953223|FG001|Extension Period|Protocol Violation|0|||
161427337|NCT03748823|582953222|FG000|Extension Period|Lost to Follow-up|0|||
161427338|NCT03748823|582953223|FG001|Extension Period|Lost to Follow-up|1|||
161427339|NCT03748823|582953222|FG000|Extension Period|Lack of Efficacy|0|||
161427340|NCT03748823|582953223|FG001|Extension Period|Lack of Efficacy|1|||
161427341|NCT03748823|582953222|FG000|Extension Period|Physician Decision|1|||
161427342|NCT03748823|582953223|FG001|Extension Period|Physician Decision|2|||
161427343|NCT04678115|582953224|FG000|Overall Study|Lost to Follow-up|1|||
161427344|NCT04678115|582953225|FG001|Overall Study|Lost to Follow-up|0|||
161427345|NCT00890825|582953226|FG000|Overall Study|Withdrawal by Subject|1|||
161427346|NCT00890825|582953227|FG001|Overall Study|Withdrawal by Subject|0|||
161427347|NCT00890825|582953226|FG000|Overall Study|Alive at data cut off (DCO)|13|||
161427348|NCT00890825|582953227|FG001|Overall Study|Alive at data cut off (DCO)|14|||
161427349|NCT01363700|582953228|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
161427350|NCT01363700|582953229|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
161427351|NCT01363700|582953230|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
161427352|NCT01363700|582953231|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
161427353|NCT01363700|582953232|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
161427354|NCT03649217|582953233|FG000|Overall Study|subject had severe ataxia not initially found|1|||
161427355|NCT03649217|582953233|FG000|Overall Study|subject had cognitive issues not initially found|1|||
161427356|NCT01721161|582953234|FG000|Overall Study|Adverse Event|2|||
161427357|NCT01721161|582953235|FG001|Overall Study|Adverse Event|3|||
161427358|NCT01721161|582953234|FG000|Overall Study|Lost to Follow-up|1|||
161427359|NCT01721161|582953235|FG001|Overall Study|Lost to Follow-up|2|||
161427360|NCT01721161|582953234|FG000|Overall Study|Withdrawal by Subject|1|||
161427361|NCT01721161|582953235|FG001|Overall Study|Withdrawal by Subject|1|||
161427362|NCT01721161|582953234|FG000|Overall Study|Other|0|||
161427363|NCT01721161|582953235|FG001|Overall Study|Other|1|||
161427364|NCT01216202|582953236|FG000|Overall Study|Withdrawal by Subject|8|||
161427365|NCT01216202|582953237|FG001|Overall Study|Withdrawal by Subject|0|||
161427366|NCT01216202|582953236|FG000|Overall Study|Death|0|||
161427367|NCT01216202|582953237|FG001|Overall Study|Death|2|||
161427368|NCT01216202|582953236|FG000|Overall Study|Lost to Follow-up|14|||
161427369|NCT01216202|582953237|FG001|Overall Study|Lost to Follow-up|0|||
161427370|NCT01091675|582953240|FG000|Overall Study|Adverse Event|7|||
161427371|NCT01091675|582953240|FG000|Overall Study|Lack of Efficacy|27|||
161427372|NCT00614380|582953243|FG000|Overall Study|Adverse Event|14|||
161427373|NCT00614380|582953244|FG001|Overall Study|Adverse Event|4|||
161427374|NCT00614380|582953245|FG002|Overall Study|Adverse Event|0|||
161427375|NCT00614380|582953246|FG003|Overall Study|Adverse Event|0|||
161427376|NCT00614380|582953243|FG000|Overall Study|Lost to Follow-up|6|||
161427377|NCT00614380|582953244|FG001|Overall Study|Lost to Follow-up|1|||
161427378|NCT00614380|582953245|FG002|Overall Study|Lost to Follow-up|0|||
161427379|NCT00614380|582953246|FG003|Overall Study|Lost to Follow-up|0|||
161427380|NCT00614380|582953243|FG000|Overall Study|Non compliant with the protocol|12|||
161427381|NCT00614380|582953244|FG001|Overall Study|Non compliant with the protocol|2|||
161427382|NCT00614380|582953245|FG002|Overall Study|Non compliant with the protocol|1|||
161427383|NCT00614380|582953246|FG003|Overall Study|Non compliant with the protocol|2|||
161427384|NCT00614380|582953243|FG000|Overall Study|Consent withdrawn|3|||
161427385|NCT00614380|582953244|FG001|Overall Study|Consent withdrawn|1|||
161427386|NCT00614380|582953245|FG002|Overall Study|Consent withdrawn|0|||
161427387|NCT00614380|582953246|FG003|Overall Study|Consent withdrawn|0|||
161427388|NCT04908397|582953251|FG000|Overall Study|Withdrawal by Subject|2|||
161427389|NCT00462306|582953252|FG000|Overall Study|insufficient data|0|||
161427390|NCT00462306|582953253|FG001|Overall Study|insufficient data|13|||
161427391|NCT02360228|582953254|FG000|Overall Study|Withdrawal by Subject|1|||
161427392|NCT02360228|582953255|FG001|Overall Study|Withdrawal by Subject|0|||
161427393|NCT02360228|582953256|FG002|Overall Study|Withdrawal by Subject|0|||
161427394|NCT02360228|582953254|FG000|Overall Study|Self-discontinued medication|0|||
161427395|NCT02360228|582953255|FG001|Overall Study|Self-discontinued medication|1|||
161427396|NCT02360228|582953256|FG002|Overall Study|Self-discontinued medication|0|||
161427397|NCT02360228|582953254|FG000|Overall Study|Unstable symptoms during screening|0|||
161427398|NCT02360228|582953255|FG001|Overall Study|Unstable symptoms during screening|0|||
161427399|NCT02360228|582953256|FG002|Overall Study|Unstable symptoms during screening|1|||
161427400|NCT01063153|582953257|FG000|Overall Study|Found Ineligible During Screening|2|||
161427401|NCT01063153|582953258|FG001|Overall Study|Found Ineligible During Screening|0|||
161427402|NCT01063153|582953257|FG000|Overall Study|Lost to Follow-up|0|||
161427403|NCT01063153|582953258|FG001|Overall Study|Lost to Follow-up|7|||
161427404|NCT01063153|582953257|FG000|Overall Study|Withdrawal by Subject|0|||
161427405|NCT01063153|582953258|FG001|Overall Study|Withdrawal by Subject|1|||
161427406|NCT01063153|582953257|FG000|Overall Study|Physician Decision|0|||
161427407|NCT01063153|582953258|FG001|Overall Study|Physician Decision|4|||
161427408|NCT00350844|582953259|FG000|Overall Study|Lost to Follow-up|1|||
161427409|NCT02775916|582953260|FG000|Overall Study|Adverse Event|1|||
161427410|NCT02775916|582953261|FG001|Overall Study|Adverse Event|0|||
161427411|NCT02775916|582953260|FG000|Overall Study|Subject/Guardian Decision|2|||
161427412|NCT02775916|582953261|FG001|Overall Study|Subject/Guardian Decision|0|||
161427413|NCT01693029|582954821|FG000|Overall Study|Withdrawal by Subject|15|||
161427414|NCT01693029|582954822|FG001|Overall Study|Withdrawal by Subject|22|||
161427415|NCT01693029|582954821|FG000|Overall Study|Kidney transplantation|7|||
161427416|NCT01693029|582954822|FG001|Overall Study|Kidney transplantation|7|||
161427417|NCT01693029|582954821|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
161427418|NCT01693029|582954822|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
161427419|NCT01693029|582954821|FG000|Overall Study|Protocol Violation|6|||
161427420|NCT01693029|582954822|FG001|Overall Study|Protocol Violation|7|||
161427421|NCT01693029|582954821|FG000|Overall Study|Change in dialysis modality|2|||
161427422|NCT01693029|582954822|FG001|Overall Study|Change in dialysis modality|1|||
161427423|NCT01693029|582954821|FG000|Overall Study|Physician Decision|0|||
161427424|NCT01693029|582954822|FG001|Overall Study|Physician Decision|2|||
161427425|NCT01693029|582954821|FG000|Overall Study|Lost to Follow-up|0|||
161427426|NCT01693029|582954822|FG001|Overall Study|Lost to Follow-up|1|||
161427427|NCT01693029|582954821|FG000|Overall Study|Adverse Event|1|||
161427428|NCT01693029|582954822|FG001|Overall Study|Adverse Event|6|||
161427429|NCT01693029|582954821|FG000|Overall Study|Death|5|||
161427430|NCT01693029|582954822|FG001|Overall Study|Death|8|||
161427431|NCT01693029|582954821|FG000|Overall Study|Non-compliance|2|||
161427432|NCT01693029|582954822|FG001|Overall Study|Non-compliance|1|||
161427433|NCT01838694|582954823|FG000|Overall Study|Adverse Event|0|||
161427434|NCT01838694|582954824|FG001|Overall Study|Adverse Event|1|||
161427435|NCT01535807|582954825|FG000|Overall Study|Withdrawal by Subject|1|||
161427436|NCT01535807|582954826|FG001|Overall Study|Withdrawal by Subject|1|||
161427437|NCT01535807|582954825|FG000|Overall Study|Data collection error|1|||
161427438|NCT01535807|582954826|FG001|Overall Study|Data collection error|1|||
161427439|NCT01329263|582954827|FG000|Overall Study|Lost to Follow-up|4|||
161427440|NCT01329263|582954828|FG001|Overall Study|Lost to Follow-up|21|||
161427441|NCT01329263|582954827|FG000|Overall Study|Withdrawal by Subject|1|||
161427442|NCT01329263|582954828|FG001|Overall Study|Withdrawal by Subject|2|||
161427443|NCT02123134|582954830|FG000|Overall Study|Withdrawal of consent|3|||
161427444|NCT02123134|582954831|FG001|Overall Study|Withdrawal of consent|2|||
161427445|NCT02123134|582954830|FG000|Overall Study|Administrative decision|0|||
161427446|NCT02123134|582954831|FG001|Overall Study|Administrative decision|1|||
161427447|NCT00657540|582954832|FG000|Overall Study|Lost to Follow-up|1|||
161427448|NCT00657540|582954833|FG001|Overall Study|Lost to Follow-up|4|||
161427449|NCT00141453|582954834|FG000|Overall Study|Protocol Violation|6|||
161427450|NCT00141453|582954835|FG001|Overall Study|Protocol Violation|5|||
161427451|NCT02043938|582954836|FG000|Overall Study|Withdrawal by Subject|7|||
161427452|NCT02043938|582954836|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
161427453|NCT02043938|582954836|FG000|Overall Study|No show by subject|1|||
161427454|NCT02043938|582954836|FG000|Overall Study|Investigator decision|1|||
161427455|NCT02656017|582954839|FG000|Overall Study|Study burden|3|||
161427456|NCT02656017|582954840|FG001|Overall Study|Study burden|3|||
161427457|NCT02656017|582954839|FG000|Overall Study|Adverse Event|2|||
161427458|NCT02656017|582954840|FG001|Overall Study|Adverse Event|1|||
161427459|NCT02656017|582954839|FG000|Overall Study|Unable/unwilling to take study medication|2|||
161427460|NCT02656017|582954840|FG001|Overall Study|Unable/unwilling to take study medication|1|||
161427461|NCT02656017|582954839|FG000|Overall Study|Began Tolvaptan|1|||
161427462|NCT02656017|582954840|FG001|Overall Study|Began Tolvaptan|1|||
161427463|NCT02656017|582954839|FG000|Overall Study|Withdrawal by Subject|1|||
161427464|NCT02656017|582954840|FG001|Overall Study|Withdrawal by Subject|0|||
161427465|NCT02349633|582954843|FG000|Overall Study|Death|0|||
161427466|NCT02349633|582954844|FG001|Overall Study|Death|1|||
161427467|NCT02349633|582954845|FG002|Overall Study|Death|0|||
161427468|NCT02349633|582954846|FG003|Overall Study|Death|0|||
161427469|NCT02349633|582954847|FG004|Overall Study|Death|0|||
161427470|NCT02349633|582954848|FG005|Overall Study|Death|1|||
161427471|NCT02349633|582954849|FG006|Overall Study|Death|1|||
161427472|NCT02349633|582954850|FG007|Overall Study|Death|1|||
161427473|NCT02349633|582954851|FG008|Overall Study|Death|0|||
161427474|NCT02349633|582954852|FG009|Overall Study|Death|1|||
161427475|NCT02349633|582954853|FG010|Overall Study|Death|0|||
161427476|NCT02349633|582954854|FG011|Overall Study|Death|0|||
161427477|NCT02349633|582954855|FG012|Overall Study|Death|0|||
161427478|NCT02349633|582954856|FG013|Overall Study|Death|0|||
161427479|NCT02349633|582954843|FG000|Overall Study|Withdrawal by Subject|0|||
161427480|NCT02349633|582954844|FG001|Overall Study|Withdrawal by Subject|0|||
161427481|NCT02349633|582954845|FG002|Overall Study|Withdrawal by Subject|0|||
161427482|NCT02349633|582954846|FG003|Overall Study|Withdrawal by Subject|1|||
161427483|NCT02349633|582954847|FG004|Overall Study|Withdrawal by Subject|0|||
161427484|NCT02349633|582954848|FG005|Overall Study|Withdrawal by Subject|0|||
161427485|NCT02349633|582954849|FG006|Overall Study|Withdrawal by Subject|0|||
161427486|NCT02349633|582954850|FG007|Overall Study|Withdrawal by Subject|2|||
161427487|NCT02349633|582954851|FG008|Overall Study|Withdrawal by Subject|2|||
161427488|NCT02349633|582954852|FG009|Overall Study|Withdrawal by Subject|1|||
161427489|NCT02349633|582954853|FG010|Overall Study|Withdrawal by Subject|0|||
161427490|NCT02349633|582954854|FG011|Overall Study|Withdrawal by Subject|0|||
161427491|NCT02349633|582954855|FG012|Overall Study|Withdrawal by Subject|0|||
161427492|NCT02349633|582954856|FG013|Overall Study|Withdrawal by Subject|0|||
161427493|NCT02349633|582954843|FG000|Overall Study|Withdrawal of informed consent|0|||
161427494|NCT02349633|582954844|FG001|Overall Study|Withdrawal of informed consent|0|||
161427495|NCT02349633|582954845|FG002|Overall Study|Withdrawal of informed consent|0|||
161427496|NCT02349633|582954846|FG003|Overall Study|Withdrawal of informed consent|1|||
161427497|NCT02349633|582954847|FG004|Overall Study|Withdrawal of informed consent|1|||
161427498|NCT02349633|582954848|FG005|Overall Study|Withdrawal of informed consent|0|||
161427499|NCT02349633|582954849|FG006|Overall Study|Withdrawal of informed consent|0|||
161427500|NCT02349633|582954850|FG007|Overall Study|Withdrawal of informed consent|3|||
161427501|NCT02349633|582954851|FG008|Overall Study|Withdrawal of informed consent|0|||
161427502|NCT02349633|582954852|FG009|Overall Study|Withdrawal of informed consent|0|||
161427503|NCT02349633|582954853|FG010|Overall Study|Withdrawal of informed consent|0|||
161427504|NCT02349633|582954854|FG011|Overall Study|Withdrawal of informed consent|0|||
161427505|NCT02349633|582954855|FG012|Overall Study|Withdrawal of informed consent|0|||
161427506|NCT02349633|582954856|FG013|Overall Study|Withdrawal of informed consent|0|||
161427507|NCT02349633|582954843|FG000|Overall Study|Transition to compassionate use|0|||
161427508|NCT02349633|582954844|FG001|Overall Study|Transition to compassionate use|0|||
161427509|NCT02349633|582954845|FG002|Overall Study|Transition to compassionate use|0|||
161427510|NCT02349633|582954846|FG003|Overall Study|Transition to compassionate use|0|||
161427511|NCT02349633|582954847|FG004|Overall Study|Transition to compassionate use|1|||
161427512|NCT02349633|582954848|FG005|Overall Study|Transition to compassionate use|0|||
161427513|NCT02349633|582954849|FG006|Overall Study|Transition to compassionate use|0|||
161427514|NCT02349633|582954850|FG007|Overall Study|Transition to compassionate use|3|||
161427515|NCT02349633|582954851|FG008|Overall Study|Transition to compassionate use|0|||
161427516|NCT02349633|582954852|FG009|Overall Study|Transition to compassionate use|1|||
161427517|NCT02349633|582954853|FG010|Overall Study|Transition to compassionate use|0|||
161427518|NCT02349633|582954854|FG011|Overall Study|Transition to compassionate use|0|||
161427519|NCT02349633|582954855|FG012|Overall Study|Transition to compassionate use|0|||
161427520|NCT02349633|582954856|FG013|Overall Study|Transition to compassionate use|0|||
161427521|NCT02349633|582954843|FG000|Overall Study|Early termination of survival follow-up|0|||
161427522|NCT02349633|582954844|FG001|Overall Study|Early termination of survival follow-up|0|||
161427523|NCT02349633|582954845|FG002|Overall Study|Early termination of survival follow-up|0|||
161427524|NCT02349633|582954846|FG003|Overall Study|Early termination of survival follow-up|0|||
161427525|NCT02349633|582954847|FG004|Overall Study|Early termination of survival follow-up|0|||
161427526|NCT02349633|582954848|FG005|Overall Study|Early termination of survival follow-up|0|||
161427527|NCT02349633|582954849|FG006|Overall Study|Early termination of survival follow-up|0|||
161427528|NCT02349633|582954850|FG007|Overall Study|Early termination of survival follow-up|4|||
161427529|NCT02349633|582954851|FG008|Overall Study|Early termination of survival follow-up|0|||
161427530|NCT02349633|582954852|FG009|Overall Study|Early termination of survival follow-up|0|||
161427531|NCT02349633|582954853|FG010|Overall Study|Early termination of survival follow-up|0|||
161427532|NCT02349633|582954854|FG011|Overall Study|Early termination of survival follow-up|0|||
161427533|NCT02349633|582954855|FG012|Overall Study|Early termination of survival follow-up|0|||
161427534|NCT02349633|582954856|FG013|Overall Study|Early termination of survival follow-up|0|||
161427535|NCT02349633|582954843|FG000|Overall Study|Termination by sponsor|0|||
161427536|NCT02349633|582954844|FG001|Overall Study|Termination by sponsor|0|||
161427537|NCT02349633|582954845|FG002|Overall Study|Termination by sponsor|0|||
161427538|NCT02349633|582954846|FG003|Overall Study|Termination by sponsor|0|||
161427539|NCT02349633|582954847|FG004|Overall Study|Termination by sponsor|0|||
161427540|NCT02349633|582954848|FG005|Overall Study|Termination by sponsor|0|||
161427541|NCT02349633|582954849|FG006|Overall Study|Termination by sponsor|0|||
161427542|NCT02349633|582954850|FG007|Overall Study|Termination by sponsor|1|||
161427543|NCT02349633|582954851|FG008|Overall Study|Termination by sponsor|0|||
161427544|NCT02349633|582954852|FG009|Overall Study|Termination by sponsor|2|||
161427545|NCT02349633|582954853|FG010|Overall Study|Termination by sponsor|0|||
161427546|NCT02349633|582954854|FG011|Overall Study|Termination by sponsor|0|||
161427547|NCT02349633|582954855|FG012|Overall Study|Termination by sponsor|0|||
161427548|NCT02349633|582954856|FG013|Overall Study|Termination by sponsor|0|||
161427549|NCT02349633|582954843|FG000|Overall Study|Other|0|||
161427550|NCT02349633|582954844|FG001|Overall Study|Other|0|||
161427551|NCT02349633|582954845|FG002|Overall Study|Other|0|||
161427552|NCT02349633|582954846|FG003|Overall Study|Other|0|||
161427553|NCT02349633|582954847|FG004|Overall Study|Other|0|||
161427554|NCT02349633|582954848|FG005|Overall Study|Other|0|||
161427555|NCT02349633|582954849|FG006|Overall Study|Other|0|||
161427556|NCT02349633|582954850|FG007|Overall Study|Other|2|||
161427557|NCT02349633|582954851|FG008|Overall Study|Other|0|||
161427558|NCT02349633|582954852|FG009|Overall Study|Other|0|||
161427559|NCT02349633|582954853|FG010|Overall Study|Other|0|||
161427560|NCT02349633|582954854|FG011|Overall Study|Other|0|||
161427561|NCT02349633|582954855|FG012|Overall Study|Other|0|||
161427562|NCT02349633|582954856|FG013|Overall Study|Other|0|||
161427563|NCT00667628|582954858|FG000|Overall Study|Lost to Follow-up|1|||
161427564|NCT00667628|582954859|FG001|Overall Study|Lost to Follow-up|0|||
161427565|NCT00667628|582954858|FG000|Overall Study|Death|6|||
161427566|NCT00667628|582954859|FG001|Overall Study|Death|6|||
161427567|NCT00667628|582954858|FG000|Overall Study|Investigator Considers in Best Interest|1|||
161427568|NCT00667628|582954859|FG001|Overall Study|Investigator Considers in Best Interest|0|||
161427569|NCT00667628|582954858|FG000|Overall Study|Sponsor Terminated Study|17|||
161427570|NCT00667628|582954859|FG001|Overall Study|Sponsor Terminated Study|21|||
161427571|NCT05789745|582954860|FG000|Overall Study|Withdrawal by Subject|0|||
161427572|NCT05789745|582954861|FG001|Overall Study|Withdrawal by Subject|0|||
161427573|NCT05789745|582954862|FG002|Overall Study|Withdrawal by Subject|0|||
161427574|NCT05789745|582954863|FG003|Overall Study|Withdrawal by Subject|0|||
161427575|NCT05789745|582954864|FG004|Overall Study|Withdrawal by Subject|1|||
161427576|NCT04663321|582954865|FG000|Overall Study|Study terminated by Sponsor|2|||
161427577|NCT04663321|582954866|FG001|Overall Study|Study terminated by Sponsor|1|||
161427578|NCT04663321|582954867|FG002|Overall Study|Study terminated by Sponsor|2|||
161427579|NCT04663321|582954865|FG000|Overall Study|Withdrawal by Subject|10|||
161427580|NCT04663321|582954866|FG001|Overall Study|Withdrawal by Subject|3|||
161427581|NCT04663321|582954867|FG002|Overall Study|Withdrawal by Subject|2|||
161427582|NCT04663321|582954865|FG000|Overall Study|Not provided|0|||
161427583|NCT04663321|582954866|FG001|Overall Study|Not provided|0|||
161427584|NCT04663321|582954867|FG002|Overall Study|Not provided|1|||
161427585|NCT00622505|582954868|FG000|Overall Study|Adverse Event|9|||
161427586|NCT00622505|582954869|FG001|Overall Study|Adverse Event|7|||
161427587|NCT00622505|582954868|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
161427588|NCT00622505|582954869|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
161427589|NCT00622505|582954868|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
161427590|NCT00622505|582954869|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161427591|NCT00622505|582954868|FG000|Overall Study|Withdrawal by Subject|12|||
161427592|NCT00622505|582954869|FG001|Overall Study|Withdrawal by Subject|5|||
161427593|NCT00622505|582954868|FG000|Overall Study|Administrative Problems|2|||
161427594|NCT00622505|582954869|FG001|Overall Study|Administrative Problems|4|||
161427595|NCT00622505|582954868|FG000|Overall Study|Death|2|||
161427596|NCT00622505|582954869|FG001|Overall Study|Death|2|||
161427597|NCT00619515|582954870|FG000|Overall Study|Study Termination by IRB|73|||
161427598|NCT03294590|582954873|FG000|Overall Study|Lost to Follow-up|105|||
161427599|NCT03294590|582954874|FG001|Overall Study|Lost to Follow-up|107|||
161427600|NCT01962441|582954877|FG000|Randomized Period|Randomized but Never Treated|4|||
161427601|NCT01962441|582954878|FG001|Randomized Period|Randomized but Never Treated|2|||
161427602|NCT01962441|582954879|FG002|Randomized Period|Randomized but Never Treated|3|||
161427603|NCT01962441|582954877|FG000|Randomized Period|Lost to Follow-up|2|||
161427604|NCT01962441|582954878|FG001|Randomized Period|Lost to Follow-up|4|||
161427605|NCT01962441|582954879|FG002|Randomized Period|Lost to Follow-up|4|||
161427606|NCT01962441|582954877|FG000|Randomized Period|Withdrew Consent|3|||
161427607|NCT01962441|582954878|FG001|Randomized Period|Withdrew Consent|3|||
161427608|NCT01962441|582954879|FG002|Randomized Period|Withdrew Consent|2|||
161427609|NCT01962441|582954877|FG000|Randomized Period|Adverse Event|1|||
161427610|NCT01962441|582954878|FG001|Randomized Period|Adverse Event|1|||
161427611|NCT01962441|582954879|FG002|Randomized Period|Adverse Event|0|||
161427612|NCT01962441|582954877|FG000|Randomized Period|Death|0|||
161427613|NCT01962441|582954878|FG001|Randomized Period|Death|0|||
161427614|NCT01962441|582954879|FG002|Randomized Period|Death|2|||
161427615|NCT01962441|582954877|FG000|Randomized Period|Protocol Violation|0|||
161427616|NCT01962441|582954878|FG001|Randomized Period|Protocol Violation|1|||
161427617|NCT01962441|582954879|FG002|Randomized Period|Protocol Violation|0|||
161427618|NCT01962441|582954877|FG000|Retreatment Substudy|Lack of Efficacy|1|||
161427619|NCT01962441|582954878|FG001|Retreatment Substudy|Lack of Efficacy|0|||
161427620|NCT01962441|582954879|FG002|Retreatment Substudy|Lack of Efficacy|0|||
161427621|NCT01962441|582954877|FG000|Retreatment Substudy|Lost to Follow-up|1|||
161427622|NCT01962441|582954878|FG001|Retreatment Substudy|Lost to Follow-up|0|||
161427623|NCT01962441|582954879|FG002|Retreatment Substudy|Lost to Follow-up|0|||
161427624|NCT04862065|582954880|FG000|Screening|Protocol Violation|54|||
161427625|NCT04862065|582954881|FG001|Screening|Protocol Violation|0|||
161427626|NCT04862065|582954882|FG002|Screening|Protocol Violation|0|||
161427627|NCT04862065|582954880|FG000|Screening|Insufficient Sample|1|||
161427628|NCT04862065|582954881|FG001|Screening|Insufficient Sample|0|||
161427629|NCT04862065|582954882|FG002|Screening|Insufficient Sample|0|||
161427630|NCT04862065|582954880|FG000|Follow-Up|Lost to Follow-up|3|||
161427631|NCT04862065|582954881|FG001|Follow-Up|Lost to Follow-up|0|||
161427632|NCT04862065|582954882|FG002|Follow-Up|Lost to Follow-up|0|||
161427633|NCT01453140|582954883|FG000|Overall Study|Adverse Event|3|||
161427634|NCT00474955|582954885|FG000|Overall Study|Adverse Event|2|||
161427635|NCT00474955|582954885|FG000|Overall Study|Drug unavailability|1|||
161427636|NCT00474955|582954885|FG000|Overall Study|Personal reasons|5|||
161427637|NCT02653326|582954886|FG000|Overall Study|Lost to Follow-up|10|||
161427638|NCT02653326|582954887|FG001|Overall Study|Lost to Follow-up|7|||
161427639|NCT02422498|582954888|FG000|Overall Study|Inevaluable|4|||
161427640|NCT01620060|582954890|FG000|Overall Study|Adverse Event|9|||
161427641|NCT01620060|582954890|FG000|Overall Study|Protocol Violation|1|||
161427642|NCT01620060|582954890|FG000|Overall Study|Withdrawal by Subject|1|||
161427643|NCT01620060|582954890|FG000|Overall Study|Did not comply with Study Produre|1|||
161427644|NCT01620060|582954890|FG000|Overall Study|Family emergency|1|||
161427645|NCT01620060|582954890|FG000|Overall Study|Per Sponsor Decision|2|||
161427646|NCT03452540|582954891|FG000|Overall Study|Adverse Event|1|||
161427647|NCT03452540|582954891|FG000|Overall Study|Withdrawal by Subject|1|||
161427648|NCT03452540|582954891|FG000|Overall Study|Other SAE and AE|2|||
161427649|NCT04664153|582954892|FG000|Overall Study|Lack of Efficacy|0|||
161427650|NCT04664153|582954893|FG001|Overall Study|Lack of Efficacy|0|||
161427651|NCT04664153|582954894|FG002|Overall Study|Lack of Efficacy|1|||
161427652|NCT04664153|582954895|FG003|Overall Study|Lack of Efficacy|0|||
161427653|NCT04664153|582954892|FG000|Overall Study|Physician Decision|0|||
161427654|NCT04664153|582954893|FG001|Overall Study|Physician Decision|0|||
161427655|NCT04664153|582954894|FG002|Overall Study|Physician Decision|1|||
161427656|NCT04664153|582954895|FG003|Overall Study|Physician Decision|0|||
161427657|NCT04664153|582954892|FG000|Overall Study|Withdrawal by Subject|3|||
161427658|NCT04664153|582954893|FG001|Overall Study|Withdrawal by Subject|2|||
161427659|NCT04664153|582954894|FG002|Overall Study|Withdrawal by Subject|1|||
161427660|NCT04664153|582954895|FG003|Overall Study|Withdrawal by Subject|2|||
161427661|NCT04664153|582954892|FG000|Overall Study|Other|0|||
161427662|NCT04664153|582954893|FG001|Overall Study|Other|1|||
161427663|NCT04664153|582954894|FG002|Overall Study|Other|0|||
161427664|NCT04664153|582954895|FG003|Overall Study|Other|0|||
161427665|NCT04664153|582954892|FG000|Overall Study|Adverse Event|4|||
161427666|NCT04664153|582954893|FG001|Overall Study|Adverse Event|0|||
161427667|NCT04664153|582954894|FG002|Overall Study|Adverse Event|1|||
161427668|NCT04664153|582954895|FG003|Overall Study|Adverse Event|0|||
161427669|NCT00231777|582954897|FG000|Overall Study|Lost to Follow-up|3|||
161427670|NCT00231777|582954898|FG001|Overall Study|Lost to Follow-up|0|||
161427671|NCT00231777|582954897|FG000|Overall Study|Other|3|||
161427672|NCT00231777|582954898|FG001|Overall Study|Other|2|||
161427673|NCT00524485|582954899|FG000|Overall Study|Withdrawal by Subject|5|||
161427674|NCT01600885|582954902|FG000|First Period|Adverse Event|1|||
161427675|NCT01600885|582954903|FG001|First Period|Adverse Event|1|||
161427676|NCT01600885|582954902|FG000|First Period|moved out of area|1|||
161427677|NCT01600885|582954903|FG001|First Period|moved out of area|0|||
161427678|NCT00642356|582954915|FG000|Overall Study|Adverse Event|1|||
161427679|NCT00642356|582954916|FG001|Overall Study|Adverse Event|0|||
161427680|NCT00642356|582954915|FG000|Overall Study|Protocol Violation|0|||
161427681|NCT00642356|582954916|FG001|Overall Study|Protocol Violation|3|||
161427682|NCT00642356|582954915|FG000|Overall Study|Lack of Efficacy|1|||
161427683|NCT00642356|582954916|FG001|Overall Study|Lack of Efficacy|0|||
161427684|NCT01009060|582954919|FG000|Overall Study|Adverse Event|1|||
161427685|NCT01009060|582954920|FG001|Overall Study|Adverse Event|2|||
161427686|NCT01009060|582954919|FG000|Overall Study|Protocol Violation|0|||
161427687|NCT01009060|582954920|FG001|Overall Study|Protocol Violation|1|||
161427688|NCT01009060|582954919|FG000|Overall Study|Lost to Follow-up|1|||
161427689|NCT01009060|582954920|FG001|Overall Study|Lost to Follow-up|0|||
161427690|NCT01009060|582954919|FG000|Overall Study|Physician Decision|1|||
161427691|NCT01009060|582954920|FG001|Overall Study|Physician Decision|1|||
161427692|NCT01009060|582954919|FG000|Overall Study|Withdrawal by Subject|1|||
161427693|NCT01009060|582954920|FG001|Overall Study|Withdrawal by Subject|1|||
161427694|NCT00005906|582954921|FG000|Overall Study|Lack of Efficacy|3|||
161427695|NCT04551989|582954922|FG000|Overall Study|Adverse Event|4|||
161427696|NCT04551989|582954922|FG000|Overall Study|Protocol Violation|3|||
161427697|NCT04551989|582954922|FG000|Overall Study|Lost to Follow-up|1|||
161427698|NCT04551989|582954922|FG000|Overall Study|Physician Decision|3|||
161427699|NCT04201431|582954923|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
161427700|NCT04201431|582954924|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
161427701|NCT04201431|582954925|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
161427702|NCT00088530|582954930|FG000|Overall Study|Progressive/Relapsed Disease|28|||
161427703|NCT00088530|582954931|FG001|Overall Study|Progressive/Relapsed Disease|39|||
161427704|NCT00088530|582954930|FG000|Overall Study|Adverse Event|15|||
161427705|NCT00088530|582954931|FG001|Overall Study|Adverse Event|9|||
161427706|NCT00088530|582954930|FG000|Overall Study|Withdrawal by Subject|2|||
161427707|NCT00088530|582954931|FG001|Overall Study|Withdrawal by Subject|5|||
161427708|NCT00088530|582954930|FG000|Overall Study|Lost to Follow-up|2|||
161427709|NCT00088530|582954931|FG001|Overall Study|Lost to Follow-up|0|||
161427710|NCT00088530|582954930|FG000|Overall Study|Physician Decision|2|||
161427711|NCT00088530|582954931|FG001|Overall Study|Physician Decision|0|||
161427712|NCT00088530|582954930|FG000|Overall Study|Sponsor decision|0|||
161427713|NCT00088530|582954931|FG001|Overall Study|Sponsor decision|1|||
161427714|NCT00088530|582954930|FG000|Overall Study|Patient never treated|1|||
161427715|NCT00088530|582954931|FG001|Overall Study|Patient never treated|0|||
161427716|NCT00300755|582954932|FG000|Overall Study|Adverse Event|1|||
161427717|NCT00300755|582954933|FG001|Overall Study|Adverse Event|2|||
161427718|NCT00300755|582954934|FG002|Overall Study|Adverse Event|1|||
161427719|NCT00300755|582954932|FG000|Overall Study|Withdrawal by Subject|0|||
161427720|NCT00300755|582954933|FG001|Overall Study|Withdrawal by Subject|2|||
161427721|NCT00300755|582954934|FG002|Overall Study|Withdrawal by Subject|0|||
161427722|NCT00300755|582954932|FG000|Overall Study|Protocol Violation|0|||
161427723|NCT00300755|582954933|FG001|Overall Study|Protocol Violation|0|||
161427724|NCT00300755|582954934|FG002|Overall Study|Protocol Violation|1|||
161427725|NCT04571944|582954935|FG000|Overall Study|Death|1|||
161427726|NCT04571944|582954936|FG001|Overall Study|Death|0|||
161427727|NCT04571944|582954935|FG000|Overall Study|Withdrawal by Subject|3|||
161427728|NCT04571944|582954936|FG001|Overall Study|Withdrawal by Subject|0|||
161427729|NCT04571944|582954935|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
161427730|NCT04571944|582954936|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
161427731|NCT02694744|582954942|FG000|Overall Study|Adverse Event|2|||
161427732|NCT02694744|582954943|FG001|Overall Study|Adverse Event|1|||
161427733|NCT02694744|582954942|FG000|Overall Study|Withdrawal by Subject|2|||
161427734|NCT02694744|582954943|FG001|Overall Study|Withdrawal by Subject|1|||
161427735|NCT02694744|582954942|FG000|Overall Study|Physician Decision|1|||
161427736|NCT02694744|582954943|FG001|Overall Study|Physician Decision|2|||
161427737|NCT02694744|582954942|FG000|Overall Study|Lost to Follow-up|1|||
161427738|NCT02694744|582954943|FG001|Overall Study|Lost to Follow-up|0|||
161427739|NCT02694744|582954942|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
161427740|NCT02694744|582954943|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
161427741|NCT00667888|582954944|FG000|Overall Study|Death|1|||
161427742|NCT00667888|582954945|FG001|Overall Study|Death|1|||
161427743|NCT00667888|582954944|FG000|Overall Study|Withdrawal by Subject|6|||
161427744|NCT00667888|582954945|FG001|Overall Study|Withdrawal by Subject|3|||
161427745|NCT00667888|582954944|FG000|Overall Study|Proceed with other treatment|3|||
161427746|NCT00667888|582954945|FG001|Overall Study|Proceed with other treatment|3|||
161427747|NCT00667888|582954944|FG000|Overall Study|Ineligible after SIM|0|||
161427748|NCT00667888|582954945|FG001|Overall Study|Ineligible after SIM|2|||
161427749|NCT01945021|582954946|FG000|Overall Study|Adverse Event|1|||
161427750|NCT01945021|582954946|FG000|Overall Study|Withdrawal of consent|12|||
161427751|NCT01945021|582954946|FG000|Overall Study|Lost to Follow-up|5|||
161427752|NCT01945021|582954946|FG000|Overall Study|Death|65|||
161427753|NCT04575155|582954947|FG000|2 Month|Withdrawal by Subject|1|||
161427754|NCT04575155|582954948|FG001|2 Month|Withdrawal by Subject|1|||
161427755|NCT04575155|582954947|FG000|2 Month|Lost to Follow-up|5|||
161427756|NCT04575155|582954948|FG001|2 Month|Lost to Follow-up|3|||
161427757|NCT04575155|582954947|FG000|2 Month|Ineligible|1|||
161427758|NCT04575155|582954948|FG001|2 Month|Ineligible|0|||
161427759|NCT02920892|582954950|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
161427760|NCT02920892|582954951|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
161427761|NCT02920892|582954952|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
161427762|NCT02920892|582954950|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
161427763|NCT02920892|582954951|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
161427764|NCT02920892|582954952|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
161427765|NCT02920892|582954950|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
161427766|NCT02920892|582954951|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
161427767|NCT02920892|582954952|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
161427768|NCT02920892|582954950|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
161427769|NCT02920892|582954951|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
161427770|NCT02920892|582954952|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
161427771|NCT02920892|582954950|FG000|Placebo-Controlled Period|Physician Decision|0|||
161427772|NCT02920892|582954951|FG001|Placebo-Controlled Period|Physician Decision|0|||
161427773|NCT02920892|582954952|FG002|Placebo-Controlled Period|Physician Decision|1|||
161427774|NCT02920892|582954950|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
161427775|NCT02920892|582954951|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
161427776|NCT02920892|582954952|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
161427777|NCT02920892|582954950|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161427778|NCT02920892|582954951|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
161427779|NCT02920892|582954952|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161427780|NCT02920892|582954950|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
161427781|NCT02920892|582954951|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
161427782|NCT02920892|582954952|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
161427783|NCT00360412|582954957|FG000|Overall Study|Adverse Event|37|||
161427784|NCT00360412|582954958|FG001|Overall Study|Adverse Event|65|||
161427785|NCT00360412|582954957|FG000|Overall Study|Protocol Violation|2|||
161427786|NCT00360412|582954958|FG001|Overall Study|Protocol Violation|5|||
161427787|NCT00360412|582954957|FG000|Overall Study|Patient withdrew consent|27|||
161427788|NCT00360412|582954958|FG001|Overall Study|Patient withdrew consent|52|||
161427789|NCT00360412|582954957|FG000|Overall Study|Lack of therapeutic efficacy|46|||
161427790|NCT00360412|582954958|FG001|Overall Study|Lack of therapeutic efficacy|61|||
161427791|NCT00360412|582954957|FG000|Overall Study|Physician Decision|2|||
161427792|NCT00360412|582954958|FG001|Overall Study|Physician Decision|4|||
161427793|NCT00360412|582954957|FG000|Overall Study|Other|5|||
161427794|NCT00360412|582954958|FG001|Overall Study|Other|6|||
161427795|NCT00360412|582954957|FG000|Overall Study|Study termination by Sponsor|214|||
161427796|NCT00360412|582954958|FG001|Overall Study|Study termination by Sponsor|469|||
161427797|NCT03863509|582954959|FG000|Overall Study|COVID-19 shutdown period|0|||
161427798|NCT03863509|582954960|FG001|Overall Study|COVID-19 shutdown period|4|||
161427799|NCT03863509|582954961|FG002|Overall Study|COVID-19 shutdown period|0|||
161427800|NCT03863509|582954959|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
161427801|NCT03863509|582954960|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
161427802|NCT03863509|582954961|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
161427803|NCT03863509|582954959|FG000|Overall Study|Lost to Follow-up|8|||
161427804|NCT03863509|582954960|FG001|Overall Study|Lost to Follow-up|0|||
161427805|NCT03863509|582954961|FG002|Overall Study|Lost to Follow-up|2|||
161427806|NCT03863509|582954959|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
161427807|NCT03863509|582954960|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
161427808|NCT03863509|582954961|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
161427809|NCT03863509|582954959|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
161427810|NCT03863509|582954960|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
161427811|NCT03863509|582954961|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
161427812|NCT03861273|582954962|FG000|Screening Phase (3 Weeks)|Other|1|||
161427813|NCT03861273|582954962|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
161427814|NCT03861273|582954962|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
161427815|NCT03861273|582954962|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
161427816|NCT03861273|582954962|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
161427817|NCT00191334|582954965|FG000|Overall Study|Adverse Event|4|||
161427818|NCT00191334|582954965|FG000|Overall Study|Disease Progression or Relapse|8|||
161427819|NCT00191334|582954965|FG000|Overall Study|Physician Decision|1|||
161427820|NCT00191334|582954965|FG000|Overall Study|Withdrawal by Subject|4|||
161427821|NCT00770653|582956043|FG000|Overall Study|Adverse Event|13|||
161427822|NCT00770653|582956044|FG001|Overall Study|Adverse Event|5|||
161427823|NCT00770653|582956043|FG000|Overall Study|Protocol Violation|8|||
161427824|NCT00770653|582956044|FG001|Overall Study|Protocol Violation|6|||
161427825|NCT00770653|582956043|FG000|Overall Study|Withdrawal by Subject|4|||
161427826|NCT00770653|582956044|FG001|Overall Study|Withdrawal by Subject|7|||
161427827|NCT00770653|582956043|FG000|Overall Study|Lack of Compliance|1|||
161427828|NCT00770653|582956044|FG001|Overall Study|Lack of Compliance|4|||
161427829|NCT00770653|582956043|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
161427830|NCT00770653|582956044|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
161427831|NCT00770653|582956043|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
161427832|NCT00770653|582956044|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
161427833|NCT00770653|582956043|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
161427834|NCT00770653|582956044|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
161427835|NCT00770653|582956043|FG000|Overall Study|Lost to Follow-up|1|||
161427836|NCT00770653|582956044|FG001|Overall Study|Lost to Follow-up|2|||
161427837|NCT00770653|582956043|FG000|Overall Study|Physician Decision|1|||
161427838|NCT00770653|582956044|FG001|Overall Study|Physician Decision|0|||
161427839|NCT01908426|582956047|FG000|Overall Study|Adverse Event|98|||
161427840|NCT01908426|582956048|FG001|Overall Study|Adverse Event|11|||
161427841|NCT01908426|582956047|FG000|Overall Study|Clinical Deterioration|72|||
161427842|NCT01908426|582956048|FG001|Overall Study|Clinical Deterioration|38|||
161427843|NCT01908426|582956047|FG000|Overall Study|Lack of Efficacy|3|||
161427844|NCT01908426|582956048|FG001|Overall Study|Lack of Efficacy|0|||
161427845|NCT01908426|582956047|FG000|Overall Study|Lost to Follow-up|0|||
161427846|NCT01908426|582956048|FG001|Overall Study|Lost to Follow-up|1|||
161427847|NCT01908426|582956047|FG000|Overall Study|Physician Decision|3|||
161427848|NCT01908426|582956048|FG001|Overall Study|Physician Decision|3|||
161427849|NCT01908426|582956047|FG000|Overall Study|Withdrawal by Subject|11|||
161427850|NCT01908426|582956048|FG001|Overall Study|Withdrawal by Subject|6|||
161427851|NCT01908426|582956047|FG000|Overall Study|Progressive Disease|206|||
161427852|NCT01908426|582956048|FG001|Overall Study|Progressive Disease|152|||
161427853|NCT01908426|582956047|FG000|Overall Study|Protocol Violation|1|||
161427854|NCT01908426|582956048|FG001|Overall Study|Protocol Violation|0|||
161427855|NCT01908426|582956047|FG000|Overall Study|No Study Treatment Given|3|||
161427856|NCT01908426|582956048|FG001|Overall Study|No Study Treatment Given|0|||
161427857|NCT02973100|582956056|FG000|Overall Study|Adverse Event|1|||
161427858|NCT02973100|582956057|FG001|Overall Study|Adverse Event|2|||
161427859|NCT02973100|582956058|FG002|Overall Study|Adverse Event|1|||
161427860|NCT02973100|582956059|FG003|Overall Study|Adverse Event|2|||
161427861|NCT02973100|582956056|FG000|Overall Study|Lost to Follow-up|3|||
161427862|NCT02973100|582956057|FG001|Overall Study|Lost to Follow-up|1|||
161427863|NCT02973100|582956058|FG002|Overall Study|Lost to Follow-up|1|||
161427864|NCT02973100|582956059|FG003|Overall Study|Lost to Follow-up|0|||
161427865|NCT02973100|582956056|FG000|Overall Study|Withdrawal by Subject|3|||
161427866|NCT02973100|582956057|FG001|Overall Study|Withdrawal by Subject|5|||
161427867|NCT02973100|582956058|FG002|Overall Study|Withdrawal by Subject|1|||
161427868|NCT02973100|582956059|FG003|Overall Study|Withdrawal by Subject|4|||
161427869|NCT02973100|582956056|FG000|Overall Study|Notification of change in address|0|||
161427870|NCT02973100|582956057|FG001|Overall Study|Notification of change in address|0|||
161427871|NCT02973100|582956058|FG002|Overall Study|Notification of change in address|0|||
161427872|NCT02973100|582956059|FG003|Overall Study|Notification of change in address|1|||
161427873|NCT02973100|582956056|FG000|Overall Study|Failed to attend Safety followup period|0|||
161427874|NCT02973100|582956057|FG001|Overall Study|Failed to attend Safety followup period|0|||
161427875|NCT02973100|582956058|FG002|Overall Study|Failed to attend Safety followup period|1|||
161427876|NCT02973100|582956059|FG003|Overall Study|Failed to attend Safety followup period|0|||
161427877|NCT02426580|582956060|FG000|Overall Study|Death|2|||
161427878|NCT02426580|582956061|FG001|Overall Study|Death|2|||
161427879|NCT02426580|582956060|FG000|Overall Study|Lost to Follow-up|0|||
161427880|NCT02426580|582956061|FG001|Overall Study|Lost to Follow-up|9|||
161427881|NCT02426580|582956060|FG000|Overall Study|transfer to hemodialysis|5|||
161427882|NCT02426580|582956061|FG001|Overall Study|transfer to hemodialysis|5|||
161427883|NCT02426580|582956060|FG000|Overall Study|Kidney transplant|3|||
161427884|NCT02426580|582956061|FG001|Overall Study|Kidney transplant|0|||
161427885|NCT02426580|582956060|FG000|Overall Study|Allergic to egg white|1|||
161427886|NCT02426580|582956061|FG001|Overall Study|Allergic to egg white|0|||
161427887|NCT04456504|582956064|FG000|Overall Study|Lost to Follow-up|2|||
161427888|NCT01342913|582956065|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
161427889|NCT01342913|582956066|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161427890|NCT01342913|582956067|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161427891|NCT01342913|582956065|FG000|2-week Run-in Period|Physician Decision|6|||
161427892|NCT01342913|582956066|FG001|2-week Run-in Period|Physician Decision|0|||
161427893|NCT01342913|582956067|FG002|2-week Run-in Period|Physician Decision|0|||
161427894|NCT01342913|582956065|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
161427895|NCT01342913|582956066|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161427896|NCT01342913|582956067|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161427897|NCT01342913|582956065|FG000|2-week Run-in Period|Adverse Event|2|||
161427898|NCT01342913|582956066|FG001|2-week Run-in Period|Adverse Event|0|||
161427899|NCT01342913|582956067|FG002|2-week Run-in Period|Adverse Event|0|||
161427900|NCT01342913|582956065|FG000|2-week Run-in Period|Protocol Violation|5|||
161427901|NCT01342913|582956066|FG001|2-week Run-in Period|Protocol Violation|0|||
161427902|NCT01342913|582956067|FG002|2-week Run-in Period|Protocol Violation|0|||
161427903|NCT01342913|582956065|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
161427904|NCT01342913|582956066|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
161427905|NCT01342913|582956067|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
161427906|NCT01342913|582956065|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161427907|NCT01342913|582956066|FG001|Double-Blind Treatment Period|Adverse Event|3|||
161427908|NCT01342913|582956067|FG002|Double-Blind Treatment Period|Adverse Event|6|||
161427909|NCT01342913|582956065|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161427910|NCT01342913|582956066|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
161427911|NCT01342913|582956067|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
161427912|NCT01342913|582956065|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161427913|NCT01342913|582956066|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
161427914|NCT01342913|582956067|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
161427915|NCT01342913|582956065|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161427916|NCT01342913|582956066|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161427917|NCT01342913|582956067|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
161427918|NCT01342913|582956065|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161427919|NCT01342913|582956066|FG001|Double-Blind Treatment Period|Physician Decision|2|||
161427920|NCT01342913|582956067|FG002|Double-Blind Treatment Period|Physician Decision|0|||
161427921|NCT01342913|582956065|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161427922|NCT01342913|582956066|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161427923|NCT01342913|582956067|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161427924|NCT02869633|582956071|FG000|Overall Study|Death|2|||
161427925|NCT02869633|582956072|FG001|Overall Study|Death|1|||
161427926|NCT02869633|582956071|FG000|Overall Study|Patient refused follow-up|1|||
161427927|NCT02869633|582956072|FG001|Overall Study|Patient refused follow-up|0|||
161427928|NCT02869633|582956071|FG000|Overall Study|Provider discretion|1|||
161427929|NCT02869633|582956072|FG001|Overall Study|Provider discretion|0|||
161427930|NCT02869633|582956071|FG000|Overall Study|Investigator decision|1|||
161427931|NCT02869633|582956072|FG001|Overall Study|Investigator decision|0|||
161427932|NCT02869633|582956071|FG000|Overall Study|Lost to Follow-up|0|||
161427933|NCT02869633|582956072|FG001|Overall Study|Lost to Follow-up|1|||
161427934|NCT02869633|582956071|FG000|Overall Study|Not eligible|6|||
161427935|NCT02869633|582956072|FG001|Overall Study|Not eligible|1|||
161427936|NCT02869633|582956071|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
161427937|NCT02869633|582956072|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
161427938|NCT02869633|582956071|FG000|Overall Study|Withdrawal by Subject|0|||
161427939|NCT02869633|582956072|FG001|Overall Study|Withdrawal by Subject|1|||
161427940|NCT03287791|582956074|FG000|Overall Study|Insufficient Therapeutic Response|0|||
161427941|NCT03287791|582956075|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161427942|NCT03287791|582956076|FG002|Overall Study|Insufficient Therapeutic Response|1|||
161427943|NCT03287791|582956074|FG000|Overall Study|Adverse Event|0|||
161427944|NCT03287791|582956075|FG001|Overall Study|Adverse Event|4|||
161427945|NCT03287791|582956076|FG002|Overall Study|Adverse Event|3|||
161427946|NCT03287791|582956074|FG000|Overall Study|Withdrawal by Subject|12|||
161427947|NCT03287791|582956075|FG001|Overall Study|Withdrawal by Subject|12|||
161427948|NCT03287791|582956076|FG002|Overall Study|Withdrawal by Subject|17|||
161427949|NCT03287791|582956074|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
161435559|NCT00107653|582988055|FG000|Overall Study|Protocol Violation|1|||
161427950|NCT03287791|582956075|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
161427951|NCT03287791|582956076|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
161427952|NCT03287791|582956074|FG000|Overall Study|Lost to Follow-up|8|||
161427953|NCT03287791|582956075|FG001|Overall Study|Lost to Follow-up|14|||
161427954|NCT03287791|582956076|FG002|Overall Study|Lost to Follow-up|11|||
161427955|NCT03287791|582956074|FG000|Overall Study|Protocol Violation|7|||
161427956|NCT03287791|582956075|FG001|Overall Study|Protocol Violation|2|||
161427957|NCT03287791|582956076|FG002|Overall Study|Protocol Violation|1|||
161427958|NCT03287791|582956074|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
161427959|NCT03287791|582956075|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
161427960|NCT03287791|582956076|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
161427961|NCT03287791|582956074|FG000|Overall Study|Too much time between 2 visits|0|||
161427962|NCT03287791|582956075|FG001|Overall Study|Too much time between 2 visits|1|||
161427963|NCT03287791|582956076|FG002|Overall Study|Too much time between 2 visits|0|||
161427964|NCT03287791|582956074|FG000|Overall Study|Non-compliance|0|||
161427965|NCT03287791|582956075|FG001|Overall Study|Non-compliance|1|||
161427966|NCT03287791|582956076|FG002|Overall Study|Non-compliance|0|||
161427967|NCT03287791|582956074|FG000|Overall Study|Did not meet inclusion criteria|1|||
161427968|NCT03287791|582956075|FG001|Overall Study|Did not meet inclusion criteria|0|||
161427969|NCT03287791|582956076|FG002|Overall Study|Did not meet inclusion criteria|0|||
161427970|NCT01381016|582956078|FG000|Overall Study|Lost to Follow-up|1|||
161427971|NCT01381016|582956079|FG001|Overall Study|Lost to Follow-up|1|||
161427972|NCT01381016|582956078|FG000|Overall Study|Screen Failure|2|||
161427973|NCT01381016|582956079|FG001|Overall Study|Screen Failure|2|||
161427974|NCT01381016|582956078|FG000|Overall Study|Withdrawal by Subject|0|||
161427975|NCT01381016|582956079|FG001|Overall Study|Withdrawal by Subject|1|||
161427976|NCT01381016|582956078|FG000|Overall Study|Physician Decision|0|||
161427977|NCT01381016|582956079|FG001|Overall Study|Physician Decision|2|||
161427978|NCT03598036|582956085|FG000|Overall Study|Withdrawal by Subject|1|||
161427979|NCT03598036|582956086|FG001|Overall Study|Withdrawal by Subject|0|||
161427980|NCT02891174|582956087|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
161427981|NCT02891174|582956088|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
161427982|NCT02891174|582956087|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
161427983|NCT02891174|582956088|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
161427984|NCT02891174|582956087|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
161427985|NCT02891174|582956088|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
161427986|NCT02891174|582956087|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
161427987|NCT02891174|582956088|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
161427988|NCT02891174|582956087|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
161427989|NCT02891174|582956088|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
161427990|NCT02891174|582956087|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
161427991|NCT02891174|582956088|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
161427992|NCT02891174|582956087|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
161427993|NCT02891174|582956088|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
161427994|NCT04319198|582956091|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
161427995|NCT04319198|582956092|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
161427996|NCT04319198|582956093|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
161427997|NCT04319198|582956091|FG000|Overall Study|Death|0|||
161427998|NCT04319198|582956092|FG001|Overall Study|Death|3|||
161427999|NCT04319198|582956093|FG002|Overall Study|Death|3|||
161428000|NCT04319198|582956091|FG000|Overall Study|Reason Not Specified|0|||
161428001|NCT04319198|582956092|FG001|Overall Study|Reason Not Specified|2|||
161428002|NCT04319198|582956093|FG002|Overall Study|Reason Not Specified|4|||
161428003|NCT04319198|582956091|FG000|Overall Study|Withdrawal of Consent|0|||
161428004|NCT04319198|582956092|FG001|Overall Study|Withdrawal of Consent|0|||
161428005|NCT04319198|582956093|FG002|Overall Study|Withdrawal of Consent|5|||
161428006|NCT04319198|582956091|FG000|Overall Study|Site Terminated by Sponsor|0|||
161428007|NCT04319198|582956092|FG001|Overall Study|Site Terminated by Sponsor|1|||
161428008|NCT04319198|582956093|FG002|Overall Study|Site Terminated by Sponsor|0|||
161428009|NCT04607668|582956095|FG000|Overall Study|Death|49|||
161428010|NCT04607668|582956096|FG001|Overall Study|Death|26|||
161428011|NCT04607668|582956095|FG000|Overall Study|Lost to Follow-up|3|||
161428012|NCT04607668|582956096|FG001|Overall Study|Lost to Follow-up|4|||
161428013|NCT04607668|582956095|FG000|Overall Study|Study terminated by Sponsor|92|||
161428014|NCT04607668|582956096|FG001|Overall Study|Study terminated by Sponsor|114|||
161428015|NCT04607668|582956095|FG000|Overall Study|Withdrawal by Subject|12|||
161428016|NCT04607668|582956096|FG001|Overall Study|Withdrawal by Subject|11|||
161428017|NCT04607668|582956095|FG000|Overall Study|Other, unspecified|8|||
161428018|NCT04607668|582956096|FG001|Overall Study|Other, unspecified|7|||
161428019|NCT02250326|582956097|FG000|Treatment|Death|1|||
161428020|NCT02250326|582956098|FG001|Treatment|Death|13|||
161428021|NCT02250326|582956099|FG002|Treatment|Death|2|||
161428022|NCT02250326|582956097|FG000|Treatment|Adverse Event|8|||
161428023|NCT02250326|582956098|FG001|Treatment|Adverse Event|8|||
161428024|NCT02250326|582956099|FG002|Treatment|Adverse Event|9|||
161428025|NCT02250326|582956097|FG000|Treatment|Progressive Disease|42|||
161428026|NCT02250326|582956098|FG001|Treatment|Progressive Disease|40|||
161428027|NCT02250326|582956099|FG002|Treatment|Progressive Disease|47|||
161428028|NCT02250326|582956097|FG000|Treatment|Symptomatic Deterioration|9|||
161428029|NCT02250326|582956098|FG001|Treatment|Symptomatic Deterioration|4|||
161428030|NCT02250326|582956099|FG002|Treatment|Symptomatic Deterioration|10|||
161428031|NCT02250326|582956097|FG000|Treatment|Withdrawal by Subject|11|||
161428032|NCT02250326|582956098|FG001|Treatment|Withdrawal by Subject|6|||
161428033|NCT02250326|582956099|FG002|Treatment|Withdrawal by Subject|4|||
161428034|NCT02250326|582956097|FG000|Treatment|Other reasons|8|||
161428035|NCT02250326|582956098|FG001|Treatment|Other reasons|7|||
161428036|NCT02250326|582956099|FG002|Treatment|Other reasons|7|||
161428037|NCT02250326|582956097|FG000|Extension Period|Progressive Disease|0|||
161428038|NCT02250326|582956098|FG001|Extension Period|Progressive Disease|2|||
161428039|NCT02250326|582956099|FG002|Extension Period|Progressive Disease|0|||
161428040|NCT02250326|582956097|FG000|Extension Period|Withdrawal by Subject|0|||
161428041|NCT02250326|582956098|FG001|Extension Period|Withdrawal by Subject|1|||
161428042|NCT02250326|582956099|FG002|Extension Period|Withdrawal by Subject|0|||
161428043|NCT02250326|582956097|FG000|Extension Period|Withdrawal by investigator|0|||
161428044|NCT02250326|582956098|FG001|Extension Period|Withdrawal by investigator|1|||
161428045|NCT02250326|582956099|FG002|Extension Period|Withdrawal by investigator|0|||
161428046|NCT05801991|582956100|FG000|Overall Study|Lost to Follow-up|1|||
161428047|NCT05801991|582956101|FG001|Overall Study|Lost to Follow-up|0|||
161428048|NCT04235140|582956102|FG000|Overall Study|Adverse Event|2|||
161428049|NCT04235140|582956102|FG000|Overall Study|Lost to Follow-up|1|||
161428050|NCT04235140|582956102|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
161428051|NCT04235140|582956102|FG000|Overall Study|Commercial drug is available for participants|7|||
161428052|NCT01451723|582956104|FG000|Overall Study|study halted|6|||
161428053|NCT01451723|582956105|FG001|Overall Study|study halted|5|||
161428054|NCT02210000|582956106|FG000|Overall Study|Study Terminated|11|||
161428055|NCT02210000|582956107|FG001|Overall Study|Study Terminated|12|||
161428056|NCT02210000|582956106|FG000|Overall Study|Withdrawal by Subject|7|||
161428057|NCT02210000|582956107|FG001|Overall Study|Withdrawal by Subject|1|||
161428058|NCT02210000|582956106|FG000|Overall Study|Adverse Event|1|||
161428059|NCT02210000|582956107|FG001|Overall Study|Adverse Event|5|||
161428060|NCT02210000|582956106|FG000|Overall Study|Lost to Follow-up|0|||
161428061|NCT02210000|582956107|FG001|Overall Study|Lost to Follow-up|2|||
161428062|NCT02210000|582956106|FG000|Overall Study|Physician Decision|0|||
161428063|NCT02210000|582956107|FG001|Overall Study|Physician Decision|1|||
161428064|NCT00833040|582956108|FG000|Overall Study|Adverse Event|0|||
161428065|NCT00833040|582956109|FG001|Overall Study|Adverse Event|0|||
161428066|NCT00833040|582956110|FG002|Overall Study|Adverse Event|0|||
161428067|NCT00833040|582956111|FG003|Overall Study|Adverse Event|0|||
161428068|NCT00833040|582956112|FG004|Overall Study|Adverse Event|0|||
161428069|NCT00833040|582956113|FG005|Overall Study|Adverse Event|1|||
161428070|NCT00962208|582956118|FG000|Overall Study|Could not achieve good vision|9|||
161428071|NCT00962208|582956119|FG001|Overall Study|Could not achieve good vision|0|||
161428072|NCT00962208|582956118|FG000|Overall Study|Contraindicated to continue study|5|||
161428073|NCT00962208|582956119|FG001|Overall Study|Contraindicated to continue study|1|||
161428074|NCT00962208|582956118|FG000|Overall Study|Lost to Follow-up|0|||
161428075|NCT00962208|582956119|FG001|Overall Study|Lost to Follow-up|9|||
161428076|NCT01731912|582956120|FG000|Overall Study|noncompliance|2|||
161428077|NCT00443040|582956123|FG000|Overall Study|Withdrawal by Subject|1|||
161428078|NCT00443040|582956124|FG001|Overall Study|Withdrawal by Subject|0|||
161428079|NCT00443040|582956125|FG002|Overall Study|Withdrawal by Subject|0|||
161428080|NCT00443040|582956123|FG000|Overall Study|Converted to an open laparotomy|3|||
161428081|NCT00443040|582956124|FG001|Overall Study|Converted to an open laparotomy|0|||
161428082|NCT00443040|582956125|FG002|Overall Study|Converted to an open laparotomy|1|||
161428083|NCT00718510|582956128|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161428084|NCT00718510|582956129|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161428085|NCT00718510|582956128|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161428086|NCT00718510|582956129|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161428087|NCT00423657|582956130|FG000|Overall Study|Withdrew consent|10|||
161428088|NCT00423657|582956131|FG001|Overall Study|Withdrew consent|8|||
161428089|NCT00423657|582956130|FG000|Overall Study|Non-compliance|0|||
161428090|NCT00423657|582956131|FG001|Overall Study|Non-compliance|1|||
161428091|NCT00423657|582956130|FG000|Overall Study|Other|15|||
161428092|NCT00423657|582956131|FG001|Overall Study|Other|16|||
161428093|NCT00423657|582956130|FG000|Overall Study|Request of sponsor/investigator|1|||
161428094|NCT00423657|582956131|FG001|Overall Study|Request of sponsor/investigator|0|||
161428095|NCT02269124|582956133|FG000|Overall Study|Lost to Follow-up|1|||
161428096|NCT02269124|582956134|FG001|Overall Study|Lost to Follow-up|0|||
161428097|NCT02269124|582956133|FG000|Overall Study|Withdrawal by Subject|0|||
161428098|NCT02269124|582956134|FG001|Overall Study|Withdrawal by Subject|2|||
161428099|NCT01045460|582956137|FG000|Overall Study|Physician Decision|3|||
161428100|NCT01045460|582956138|FG001|Overall Study|Physician Decision|2|||
161428101|NCT01045460|582956137|FG000|Overall Study|Lost to Follow-up|0|||
161428102|NCT01045460|582956138|FG001|Overall Study|Lost to Follow-up|1|||
161428103|NCT01045460|582956137|FG000|Overall Study|Lack of Efficacy|3|||
161428104|NCT01045460|582956138|FG001|Overall Study|Lack of Efficacy|0|||
161428105|NCT00097500|582956139|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
161428106|NCT00097500|582956140|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
161428107|NCT00097500|582956139|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
161428108|NCT00097500|582956140|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
161428109|NCT00097500|582956139|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
161428110|NCT00097500|582956140|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
161428111|NCT00097500|582956139|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161428112|NCT00097500|582956140|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
161428113|NCT00097500|582956139|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
161428114|NCT00097500|582956140|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
161428115|NCT00097500|582956139|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
161428116|NCT00097500|582956140|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
161428117|NCT00097500|582956139|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
161428118|NCT00097500|582956140|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
161428119|NCT02163902|582956143|FG000|Overall Study|Subject's Request|3|||
161428120|NCT02163902|582956144|FG001|Overall Study|Subject's Request|4|||
161428121|NCT02163902|582956143|FG000|Overall Study|Lost to Follow-up|6|||
161428122|NCT02163902|582956144|FG001|Overall Study|Lost to Follow-up|7|||
161428123|NCT02163902|582956143|FG000|Overall Study|Administrative Decision|2|||
161428124|NCT02163902|582956144|FG001|Overall Study|Administrative Decision|2|||
161428125|NCT00844376|582956148|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
161428126|NCT00844376|582956149|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
161428127|NCT01300234|582956150|FG000|Overall Study|Adverse Event|1|||
161428128|NCT01300234|582956151|FG001|Overall Study|Adverse Event|1|||
161428129|NCT01300234|582956150|FG000|Overall Study|Protocol Violation|2|||
161428130|NCT01300234|582956151|FG001|Overall Study|Protocol Violation|3|||
161428131|NCT01300234|582956150|FG000|Overall Study|Withdrawal by Subject|5|||
161428132|NCT01300234|582956151|FG001|Overall Study|Withdrawal by Subject|9|||
161428133|NCT01300234|582956150|FG000|Overall Study|Lost to Follow-up|14|||
161428134|NCT01300234|582956151|FG001|Overall Study|Lost to Follow-up|12|||
161428135|NCT01300234|582956150|FG000|Overall Study|Pregnancy|2|||
161428136|NCT01300234|582956151|FG001|Overall Study|Pregnancy|1|||
161428137|NCT01300234|582956150|FG000|Overall Study|Participant reached stopping critera|2|||
161428138|NCT01300234|582956151|FG001|Overall Study|Participant reached stopping critera|0|||
161428139|NCT01300234|582956150|FG000|Overall Study|Participant stopped medication|1|||
161428140|NCT01300234|582956151|FG001|Overall Study|Participant stopped medication|1|||
161428141|NCT01300234|582956150|FG000|Overall Study|Participant refused return to hospital|1|||
161428142|NCT01300234|582956151|FG001|Overall Study|Participant refused return to hospital|0|||
161428143|NCT03253679|582956152|FG000|Overall Study|Screen Failure|1|||
161428144|NCT04816214|582956153|FG000|Overall Study|Progressive Disease|4|||
161428145|NCT04816214|582956154|FG001|Overall Study|Progressive Disease|0|||
161428146|NCT04816214|582956155|FG002|Overall Study|Progressive Disease|0|||
161428147|NCT04816214|582956153|FG000|Overall Study|Death|1|||
161428148|NCT04816214|582956154|FG001|Overall Study|Death|0|||
161428149|NCT04816214|582956155|FG002|Overall Study|Death|0|||
161428150|NCT04816214|582956153|FG000|Overall Study|Study Terminated by Sponsor|1|||
161428151|NCT04816214|582956154|FG001|Overall Study|Study Terminated by Sponsor|0|||
161428152|NCT04816214|582956155|FG002|Overall Study|Study Terminated by Sponsor|0|||
161428153|NCT04879628|582956156|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
161428154|NCT04879628|582956157|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
161428155|NCT04879628|582956158|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
161428156|NCT04879628|582956159|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
161428157|NCT04879628|582956156|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
161428158|NCT04879628|582956157|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
161428159|NCT04879628|582956158|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
161428160|NCT04879628|582956159|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
161428161|NCT04879628|582956156|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
161428162|NCT04879628|582956157|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
161428163|NCT04879628|582956158|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
161428164|NCT04879628|582956159|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
161428165|NCT04879628|582956156|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
161428166|NCT04879628|582956157|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
161428167|NCT04879628|582956158|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
161428168|NCT04879628|582956159|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
161428169|NCT00948064|582957507|FG000|Phase I|No treatment received|1|||
161428170|NCT00948064|582957508|FG001|Phase I|No treatment received|0|||
161428171|NCT00948064|582957509|FG002|Phase I|No treatment received|0|||
161428172|NCT00948064|582957507|FG000|Phase II|Physician Decision|0|||
161428173|NCT00948064|582957508|FG001|Phase II|Physician Decision|0|||
161428174|NCT00948064|582957509|FG002|Phase II|Physician Decision|1|||
161428175|NCT00948064|582957507|FG000|Phase II|Withdrawal by Subject|0|||
161428176|NCT00948064|582957508|FG001|Phase II|Withdrawal by Subject|1|||
161428177|NCT00948064|582957509|FG002|Phase II|Withdrawal by Subject|0|||
161428178|NCT03409796|582957523|FG000|Overall Study|Adverse Event|2|||
161428179|NCT03409796|582957524|FG001|Overall Study|Adverse Event|0|||
161428180|NCT03409796|582957523|FG000|Overall Study|Other|0|||
161428181|NCT03409796|582957524|FG001|Overall Study|Other|1|||
161428182|NCT00740220|582957525|FG000|Overall Study|screen failures (non-COPD patients)|9|||
161428183|NCT04416204|582957538|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
161428184|NCT04416204|582957539|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
161428185|NCT04416204|582957540|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
161428186|NCT04416204|582957541|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
161428187|NCT01959503|582957542|FG000|Overall Study|Death|2|||
161428188|NCT01959503|582957543|FG001|Overall Study|Death|1|||
161428189|NCT01959503|582957542|FG000|Overall Study|Randomized but not treated|1|||
161428190|NCT01959503|582957543|FG001|Overall Study|Randomized but not treated|1|||
161428191|NCT01419236|582957544|FG000|Overall Study|Adverse Event|1|||
161428192|NCT01419236|582957545|FG001|Overall Study|Adverse Event|0|||
161428193|NCT01419236|582957544|FG000|Overall Study|Lack of Efficacy|0|||
161428194|NCT01419236|582957545|FG001|Overall Study|Lack of Efficacy|1|||
161428195|NCT01419236|582957544|FG000|Overall Study|Lost to Follow-up|1|||
161428196|NCT01419236|582957545|FG001|Overall Study|Lost to Follow-up|0|||
161428197|NCT01419236|582957544|FG000|Overall Study|Physician Decision|1|||
161428198|NCT01419236|582957545|FG001|Overall Study|Physician Decision|0|||
161428199|NCT01419236|582957544|FG000|Overall Study|Withdrawal by Subject|1|||
161428200|NCT01419236|582957545|FG001|Overall Study|Withdrawal by Subject|4|||
161428201|NCT01419236|582957544|FG000|Overall Study|Entry Criteria Not Met|1|||
161428202|NCT01419236|582957545|FG001|Overall Study|Entry Criteria Not Met|0|||
161428203|NCT01393158|582957547|FG000|Overall Study|Adverse Event|1|||
161428204|NCT01393158|582957548|FG001|Overall Study|Adverse Event|0|||
161428205|NCT04233801|582957550|FG000|Overall Study|Other than listed|0|||
161428206|NCT04233801|582957551|FG001|Overall Study|Other than listed|0|||
161428207|NCT04233801|582957552|FG002|Overall Study|Other than listed|1|||
161428208|NCT04233801|582957550|FG000|Overall Study|Withdrawal by Subject|0|||
161428209|NCT04233801|582957551|FG001|Overall Study|Withdrawal by Subject|2|||
161428210|NCT04233801|582957552|FG002|Overall Study|Withdrawal by Subject|3|||
161428211|NCT02173769|582957553|FG000|Overall Study|Protocol Violation|4|||
161428212|NCT00683878|582957566|FG000|Overall Study|Lack of Efficacy|3|||
161428213|NCT00683878|582957567|FG001|Overall Study|Lack of Efficacy|0|||
161428214|NCT00683878|582957568|FG002|Overall Study|Lack of Efficacy|1|||
161428215|NCT00683878|582957566|FG000|Overall Study|Adverse Event|4|||
161428216|NCT00683878|582957567|FG001|Overall Study|Adverse Event|3|||
161428217|NCT00683878|582957568|FG002|Overall Study|Adverse Event|3|||
161428218|NCT00683878|582957566|FG000|Overall Study|Withdrawal by Subject|9|||
161428219|NCT00683878|582957567|FG001|Overall Study|Withdrawal by Subject|8|||
161428220|NCT00683878|582957568|FG002|Overall Study|Withdrawal by Subject|6|||
161428221|NCT00683878|582957566|FG000|Overall Study|Death|0|||
161428222|NCT00683878|582957567|FG001|Overall Study|Death|1|||
161428223|NCT00683878|582957568|FG002|Overall Study|Death|0|||
161428224|NCT00683878|582957566|FG000|Overall Study|Lost to Follow-up|4|||
161428225|NCT00683878|582957567|FG001|Overall Study|Lost to Follow-up|2|||
161428226|NCT00683878|582957568|FG002|Overall Study|Lost to Follow-up|4|||
161428227|NCT00683878|582957566|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
161428228|NCT00683878|582957567|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
161428229|NCT00683878|582957568|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
161428230|NCT04024891|582957569|FG000|Overall Study|Pregnancy|0|||
161428231|NCT04024891|582957570|FG001|Overall Study|Pregnancy|1|||
161428232|NCT03010527|582957584|FG000|Overall Study|Death|0|||
161428233|NCT03010527|582957585|FG001|Overall Study|Death|0|||
161428234|NCT03010527|582957586|FG002|Overall Study|Death|1|||
161428235|NCT03010527|582957584|FG000|Overall Study|Adverse Event|0|||
161428236|NCT03010527|582957585|FG001|Overall Study|Adverse Event|4|||
161428237|NCT03010527|582957586|FG002|Overall Study|Adverse Event|2|||
161428238|NCT03010527|582957584|FG000|Overall Study|Protocol Violation|0|||
161428239|NCT03010527|582957585|FG001|Overall Study|Protocol Violation|1|||
161428240|NCT03010527|582957586|FG002|Overall Study|Protocol Violation|0|||
161428241|NCT03010527|582957584|FG000|Overall Study|Lost to Follow-up|0|||
161428242|NCT03010527|582957585|FG001|Overall Study|Lost to Follow-up|2|||
161428243|NCT03010527|582957586|FG002|Overall Study|Lost to Follow-up|1|||
161428244|NCT03010527|582957584|FG000|Overall Study|Withdrawal by Subject|0|||
161428245|NCT03010527|582957585|FG001|Overall Study|Withdrawal by Subject|3|||
161428246|NCT03010527|582957586|FG002|Overall Study|Withdrawal by Subject|4|||
161428247|NCT03010527|582957584|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
161428248|NCT03010527|582957585|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
161428249|NCT03010527|582957586|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
161428250|NCT03010527|582957584|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
161428251|NCT03010527|582957585|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
161428252|NCT03010527|582957586|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
161428253|NCT03010527|582957584|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
161428254|NCT03010527|582957585|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
161428255|NCT03010527|582957586|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
161428256|NCT02469623|582957587|FG000|Overall Study|Not consented for long-term follow-up|4|||
161428257|NCT02469623|582957587|FG000|Overall Study|Lost to Follow-up|4|||
161428258|NCT02469623|582957587|FG000|Overall Study|Withdrawal by Subject|2|||
161428259|NCT02469623|582957587|FG000|Overall Study|Death|3|||
161428260|NCT04073186|582957588|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
161428261|NCT04073186|582957588|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
161428262|NCT04073186|582957588|FG000|First Wearing Cycle|Protocol Violation|1|||
161428263|NCT04073186|582957588|FG000|First Wearing Cycle|Lens Discomfort|2|||
161428264|NCT04073186|582957588|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
161428265|NCT04073186|582957588|FG000|Second Wearing Cycle|Adverse Event|1|||
161428266|NCT01096316|582957589|FG000|Overall Study|Lost to Follow-up|15|||
161428267|NCT01096316|582957590|FG001|Overall Study|Lost to Follow-up|9|||
161428268|NCT00473434|582957591|FG000|Overall Study|Physician Decision|3|||
161428269|NCT00473434|582957591|FG000|Overall Study|Withdrawal by Subject|9|||
161428270|NCT00473434|582957591|FG000|Overall Study|Compliance|3|||
161428271|NCT00473434|582957591|FG000|Overall Study|Lack of Efficacy|3|||
161428272|NCT00473434|582957591|FG000|Overall Study|Adverse Event|3|||
161428273|NCT00473434|582957591|FG000|Overall Study|Patient was selling medication to others|1|||
161428274|NCT00473434|582957591|FG000|Overall Study|Safety evaluation|1|||
161428275|NCT00473434|582957591|FG000|Overall Study|Reason not specified|6|||
161428276|NCT00473434|582957591|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
161428277|NCT00473434|582957591|FG000|Overall Study|Switching to trial medication|1|||
161428278|NCT00473434|582957591|FG000|Overall Study|No longer required|1|||
161428279|NCT06418152|582957593|FG000|Overall Study|Frequent DBS setting changes|1|||
161428280|NCT06418152|582957593|FG000|Overall Study|Withdrawal by Subject|2|||
161428281|NCT02529852|582957596|FG000|Overall Study|Withdrawal by Subject|2|||
161428282|NCT02055898|582957597|FG000|First Intervention (5 Days)|Physician Decision|2|||
161428283|NCT02055898|582957598|FG001|First Intervention (5 Days)|Physician Decision|0|||
161428284|NCT02055898|582957597|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
161428285|NCT02055898|582957598|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
161428286|NCT02201524|582957600|FG000|Overall Study|Adverse Event|0|||
161428287|NCT02201524|582957601|FG001|Overall Study|Adverse Event|2|||
161428288|NCT02201524|582957602|FG002|Overall Study|Adverse Event|1|||
161428289|NCT02201524|582957603|FG003|Overall Study|Adverse Event|0|||
161428290|NCT02201524|582957600|FG000|Overall Study|Insufficient clinical response|1|||
161428291|NCT02201524|582957601|FG001|Overall Study|Insufficient clinical response|0|||
161428292|NCT02201524|582957602|FG002|Overall Study|Insufficient clinical response|0|||
161428293|NCT02201524|582957603|FG003|Overall Study|Insufficient clinical response|0|||
161428294|NCT02201524|582957600|FG000|Overall Study|Lost to Follow-up|0|||
161428295|NCT02201524|582957601|FG001|Overall Study|Lost to Follow-up|0|||
161428296|NCT02201524|582957602|FG002|Overall Study|Lost to Follow-up|2|||
161428297|NCT02201524|582957603|FG003|Overall Study|Lost to Follow-up|0|||
161428298|NCT02201524|582957600|FG000|Overall Study|No longer meets eligibility criteria|0|||
161428299|NCT02201524|582957601|FG001|Overall Study|No longer meets eligibility criteria|0|||
161428300|NCT02201524|582957602|FG002|Overall Study|No longer meets eligibility criteria|0|||
161428301|NCT02201524|582957603|FG003|Overall Study|No longer meets eligibility criteria|2|||
161428302|NCT02201524|582957600|FG000|Overall Study|Protocol Violation|0|||
161428303|NCT02201524|582957601|FG001|Overall Study|Protocol Violation|0|||
161428304|NCT02201524|582957602|FG002|Overall Study|Protocol Violation|0|||
161428305|NCT02201524|582957603|FG003|Overall Study|Protocol Violation|1|||
161428306|NCT02201524|582957600|FG000|Overall Study|Withdrawal by Subject|0|||
161428307|NCT02201524|582957601|FG001|Overall Study|Withdrawal by Subject|0|||
161428308|NCT02201524|582957602|FG002|Overall Study|Withdrawal by Subject|1|||
161428309|NCT02201524|582957603|FG003|Overall Study|Withdrawal by Subject|1|||
161428310|NCT02201524|582957600|FG000|Overall Study|Other|1|||
161428311|NCT02201524|582957601|FG001|Overall Study|Other|1|||
161428312|NCT02201524|582957602|FG002|Overall Study|Other|0|||
161428313|NCT02201524|582957603|FG003|Overall Study|Other|0|||
161428314|NCT03206216|582957608|FG000|Overall Study|Withdrawal by Subject|0|||
161428315|NCT03206216|582957609|FG001|Overall Study|Withdrawal by Subject|1|||
161428316|NCT00265564|582957615|FG000|Overall Study|Lost to Follow-up|5|||
161428317|NCT00265564|582957616|FG001|Overall Study|Lost to Follow-up|7|||
161428318|NCT00265564|582957615|FG000|Overall Study|met exclusion criteria|5|||
161428319|NCT00265564|582957616|FG001|Overall Study|met exclusion criteria|2|||
161428320|NCT01553084|582957617|FG000|Overall Study|Withdrawal by Subject|15|||
161428321|NCT01553084|582957618|FG001|Overall Study|Withdrawal by Subject|13|||
161428322|NCT01553084|582957619|FG002|Overall Study|Withdrawal by Subject|35|||
161428323|NCT03119259|582957621|FG000|Overall Study|Withdrawn as no longer eligible|1|||
161428324|NCT03119259|582957622|FG001|Overall Study|Withdrawn as no longer eligible|0|||
161428325|NCT03119259|582957621|FG000|Overall Study|Withdrawal by Subject|4|||
161428326|NCT03119259|582957622|FG001|Overall Study|Withdrawal by Subject|2|||
161428327|NCT03119259|582957621|FG000|Overall Study|Lost to Follow-up|0|||
161428328|NCT03119259|582957622|FG001|Overall Study|Lost to Follow-up|1|||
161428329|NCT00539981|582957629|FG000|Overall Study|Adverse events (AE)|3|||
161428330|NCT00539981|582957630|FG001|Overall Study|Adverse events (AE)|3|||
161428331|NCT00539981|582957629|FG000|Overall Study|Lost to Follow-up|260|||
161428332|NCT00539981|582957630|FG001|Overall Study|Lost to Follow-up|251|||
161428333|NCT00539981|582957629|FG000|Overall Study|Withdrew consent|22|||
161428334|NCT00539981|582957630|FG001|Overall Study|Withdrew consent|14|||
161428335|NCT00539981|582957629|FG000|Overall Study|Death|1|||
161428336|NCT00539981|582957630|FG001|Overall Study|Death|1|||
161428337|NCT00539981|582957629|FG000|Overall Study|Other reason-unspecified|9|||
161428338|NCT00539981|582957630|FG001|Overall Study|Other reason-unspecified|13|||
161428339|NCT01759420|582957631|FG000|Overall Study|Screen failure|5|||
161428340|NCT01759420|582957631|FG000|Overall Study|Inaccurate EKG machine readings|1|||
161428341|NCT01129622|582957632|FG000|Overall Study|Withdrawal by Subject|2|||
161428342|NCT02051764|582957633|FG000|Overall Study|Study terminated by sponsor|0|||
161428343|NCT02051764|582957634|FG001|Overall Study|Study terminated by sponsor|7|||
161428344|NCT00591006|582957635|FG000|Overall Study|Withdrawal by Subject|0|||
161428345|NCT00591006|582957636|FG001|Overall Study|Withdrawal by Subject|0|||
161428346|NCT00591006|582957637|FG002|Overall Study|Withdrawal by Subject|0|||
161428347|NCT00591006|582957638|FG003|Overall Study|Withdrawal by Subject|0|||
161428348|NCT00591006|582957639|FG004|Overall Study|Withdrawal by Subject|0|||
161428349|NCT00591006|582957640|FG005|Overall Study|Withdrawal by Subject|0|||
161428350|NCT00591006|582957641|FG006|Overall Study|Withdrawal by Subject|0|||
161428351|NCT00591006|582957642|FG007|Overall Study|Withdrawal by Subject|0|||
161428352|NCT00591006|582957643|FG008|Overall Study|Withdrawal by Subject|0|||
161428353|NCT00591006|582957644|FG009|Overall Study|Withdrawal by Subject|0|||
161428354|NCT00591006|582957645|FG010|Overall Study|Withdrawal by Subject|0|||
161428355|NCT00591006|582957646|FG011|Overall Study|Withdrawal by Subject|0|||
161428356|NCT00591006|582957647|FG012|Overall Study|Withdrawal by Subject|0|||
161428357|NCT00591006|582957648|FG013|Overall Study|Withdrawal by Subject|0|||
161428358|NCT00591006|582957649|FG014|Overall Study|Withdrawal by Subject|0|||
161428359|NCT00591006|582957650|FG015|Overall Study|Withdrawal by Subject|1|||
161428360|NCT00591006|582957651|FG016|Overall Study|Withdrawal by Subject|0|||
161428361|NCT00591006|582957652|FG017|Overall Study|Withdrawal by Subject|0|||
161428362|NCT00591006|582957653|FG018|Overall Study|Withdrawal by Subject|0|||
161428363|NCT00591006|582957654|FG019|Overall Study|Withdrawal by Subject|0|||
161428364|NCT00591006|582957655|FG020|Overall Study|Withdrawal by Subject|0|||
161428365|NCT00591006|582957656|FG021|Overall Study|Withdrawal by Subject|0|||
161428366|NCT00591006|582957657|FG022|Overall Study|Withdrawal by Subject|0|||
161428367|NCT00591006|582957658|FG023|Overall Study|Withdrawal by Subject|1|||
161428368|NCT00591006|582957635|FG000|Overall Study|Adverse Event|0|||
161428369|NCT00591006|582957636|FG001|Overall Study|Adverse Event|0|||
161428370|NCT00591006|582957637|FG002|Overall Study|Adverse Event|0|||
161428371|NCT00591006|582957638|FG003|Overall Study|Adverse Event|0|||
161428372|NCT00591006|582957639|FG004|Overall Study|Adverse Event|0|||
161428373|NCT00591006|582957640|FG005|Overall Study|Adverse Event|0|||
161428374|NCT00591006|582957641|FG006|Overall Study|Adverse Event|0|||
161428375|NCT00591006|582957642|FG007|Overall Study|Adverse Event|0|||
161428376|NCT00591006|582957643|FG008|Overall Study|Adverse Event|0|||
161428377|NCT00591006|582957644|FG009|Overall Study|Adverse Event|0|||
161428378|NCT00591006|582957645|FG010|Overall Study|Adverse Event|0|||
161428379|NCT00591006|582957646|FG011|Overall Study|Adverse Event|0|||
161428380|NCT00591006|582957647|FG012|Overall Study|Adverse Event|0|||
161428381|NCT00591006|582957648|FG013|Overall Study|Adverse Event|0|||
161428382|NCT00591006|582957649|FG014|Overall Study|Adverse Event|0|||
161428383|NCT00591006|582957650|FG015|Overall Study|Adverse Event|0|||
161428384|NCT00591006|582957651|FG016|Overall Study|Adverse Event|0|||
161428385|NCT00591006|582957652|FG017|Overall Study|Adverse Event|0|||
161428386|NCT00591006|582957653|FG018|Overall Study|Adverse Event|0|||
161428387|NCT00591006|582957654|FG019|Overall Study|Adverse Event|0|||
161428388|NCT00591006|582957655|FG020|Overall Study|Adverse Event|0|||
161428389|NCT00591006|582957656|FG021|Overall Study|Adverse Event|0|||
161428390|NCT00591006|582957657|FG022|Overall Study|Adverse Event|1|||
161428391|NCT00591006|582957658|FG023|Overall Study|Adverse Event|0|||
161428392|NCT01384734|582957660|FG000|Overall Study|Adverse Event|0|||
161428393|NCT01384734|582957661|FG001|Overall Study|Adverse Event|3|||
161428394|NCT01384734|582957662|FG002|Overall Study|Adverse Event|0|||
161428395|NCT01384734|582957663|FG003|Overall Study|Adverse Event|2|||
161428396|NCT01384734|582957664|FG004|Overall Study|Adverse Event|7|||
161428397|NCT01384734|582957660|FG000|Overall Study|Death|1|||
161428398|NCT01384734|582957661|FG001|Overall Study|Death|0|||
161428399|NCT01384734|582957662|FG002|Overall Study|Death|1|||
161428400|NCT01384734|582957663|FG003|Overall Study|Death|0|||
161428401|NCT01384734|582957664|FG004|Overall Study|Death|0|||
161428402|NCT01384734|582957660|FG000|Overall Study|Continuation criteria not met|0|||
161428403|NCT01384734|582957661|FG001|Overall Study|Continuation criteria not met|0|||
161428404|NCT01384734|582957662|FG002|Overall Study|Continuation criteria not met|1|||
161428405|NCT01384734|582957663|FG003|Overall Study|Continuation criteria not met|1|||
161428406|NCT01384734|582957664|FG004|Overall Study|Continuation criteria not met|0|||
161428407|NCT01384734|582957660|FG000|Overall Study|Lack of Efficacy|3|||
161428408|NCT01384734|582957661|FG001|Overall Study|Lack of Efficacy|7|||
161428409|NCT01384734|582957662|FG002|Overall Study|Lack of Efficacy|4|||
161428410|NCT01384734|582957663|FG003|Overall Study|Lack of Efficacy|4|||
161428411|NCT01384734|582957664|FG004|Overall Study|Lack of Efficacy|2|||
161428412|NCT01384734|582957660|FG000|Overall Study|Lost to Follow-up|5|||
161428413|NCT01384734|582957661|FG001|Overall Study|Lost to Follow-up|3|||
161428414|NCT01384734|582957662|FG002|Overall Study|Lost to Follow-up|3|||
161428415|NCT01384734|582957663|FG003|Overall Study|Lost to Follow-up|8|||
161428416|NCT01384734|582957664|FG004|Overall Study|Lost to Follow-up|5|||
161428417|NCT01384734|582957660|FG000|Overall Study|Non-compliance with study drug|1|||
161428418|NCT01384734|582957661|FG001|Overall Study|Non-compliance with study drug|2|||
161428419|NCT01384734|582957662|FG002|Overall Study|Non-compliance with study drug|6|||
161428420|NCT01384734|582957663|FG003|Overall Study|Non-compliance with study drug|0|||
161428421|NCT01384734|582957664|FG004|Overall Study|Non-compliance with study drug|2|||
161428422|NCT01384734|582957660|FG000|Overall Study|Pregnancy|0|||
161428423|NCT01384734|582957661|FG001|Overall Study|Pregnancy|1|||
161428424|NCT01384734|582957662|FG002|Overall Study|Pregnancy|0|||
161428425|NCT01384734|582957663|FG003|Overall Study|Pregnancy|0|||
161428426|NCT01384734|582957664|FG004|Overall Study|Pregnancy|1|||
161428427|NCT01384734|582957660|FG000|Overall Study|Sponsor terminated|0|||
161428428|NCT01384734|582957661|FG001|Overall Study|Sponsor terminated|0|||
161428429|NCT01384734|582957662|FG002|Overall Study|Sponsor terminated|0|||
161428430|NCT01384734|582957663|FG003|Overall Study|Sponsor terminated|0|||
161428431|NCT01384734|582957664|FG004|Overall Study|Sponsor terminated|1|||
161428432|NCT01384734|582957660|FG000|Overall Study|Withdrawal by Subject|5|||
161428433|NCT01384734|582957661|FG001|Overall Study|Withdrawal by Subject|5|||
161428434|NCT01384734|582957662|FG002|Overall Study|Withdrawal by Subject|6|||
161428435|NCT01384734|582957663|FG003|Overall Study|Withdrawal by Subject|7|||
161428436|NCT01384734|582957664|FG004|Overall Study|Withdrawal by Subject|9|||
161428437|NCT01384734|582957660|FG000|Overall Study|Investigator relocating|0|||
161428438|NCT01384734|582957661|FG001|Overall Study|Investigator relocating|2|||
161428439|NCT01384734|582957662|FG002|Overall Study|Investigator relocating|0|||
161428440|NCT01384734|582957663|FG003|Overall Study|Investigator relocating|3|||
161428441|NCT01384734|582957664|FG004|Overall Study|Investigator relocating|1|||
161428442|NCT01384734|582957660|FG000|Overall Study|Unable to come back for visit|1|||
161428443|NCT01384734|582957661|FG001|Overall Study|Unable to come back for visit|0|||
161428444|NCT01384734|582957662|FG002|Overall Study|Unable to come back for visit|1|||
161428445|NCT01384734|582957663|FG003|Overall Study|Unable to come back for visit|1|||
161428446|NCT01384734|582957664|FG004|Overall Study|Unable to come back for visit|0|||
161428447|NCT01384734|582957660|FG000|Overall Study|Prison|0|||
161428448|NCT01384734|582957661|FG001|Overall Study|Prison|0|||
161428449|NCT01384734|582957662|FG002|Overall Study|Prison|1|||
161428450|NCT01384734|582957663|FG003|Overall Study|Prison|0|||
161428451|NCT01384734|582957664|FG004|Overall Study|Prison|0|||
161428452|NCT01384734|582957660|FG000|Overall Study|As per Exclusion criteria|0|||
161428453|NCT01384734|582957661|FG001|Overall Study|As per Exclusion criteria|1|||
161428454|NCT01384734|582957662|FG002|Overall Study|As per Exclusion criteria|0|||
161428455|NCT01384734|582957663|FG003|Overall Study|As per Exclusion criteria|0|||
161428456|NCT01384734|582957664|FG004|Overall Study|As per Exclusion criteria|0|||
161428457|NCT01384734|582957660|FG000|Overall Study|Missed End of treatment visit|0|||
161428458|NCT01384734|582957661|FG001|Overall Study|Missed End of treatment visit|0|||
161428459|NCT01384734|582957662|FG002|Overall Study|Missed End of treatment visit|0|||
161428460|NCT01384734|582957663|FG003|Overall Study|Missed End of treatment visit|1|||
161428461|NCT01384734|582957664|FG004|Overall Study|Missed End of treatment visit|0|||
161428462|NCT01384734|582957660|FG000|Overall Study|Adhesion problem|0|||
161428463|NCT01384734|582957661|FG001|Overall Study|Adhesion problem|0|||
161428464|NCT01384734|582957662|FG002|Overall Study|Adhesion problem|0|||
161428465|NCT01384734|582957663|FG003|Overall Study|Adhesion problem|1|||
161428466|NCT01384734|582957664|FG004|Overall Study|Adhesion problem|0|||
161428467|NCT01384734|582957660|FG000|Overall Study|Early termination|0|||
161428468|NCT01384734|582957661|FG001|Overall Study|Early termination|0|||
161428469|NCT01384734|582957662|FG002|Overall Study|Early termination|0|||
161428470|NCT01384734|582957663|FG003|Overall Study|Early termination|0|||
161428471|NCT01384734|582957664|FG004|Overall Study|Early termination|1|||
161428472|NCT01384734|582957660|FG000|Overall Study|Physician Decision|1|||
161428473|NCT01384734|582957661|FG001|Overall Study|Physician Decision|0|||
161428474|NCT01384734|582957662|FG002|Overall Study|Physician Decision|0|||
161428475|NCT01384734|582957663|FG003|Overall Study|Physician Decision|0|||
161428476|NCT01384734|582957664|FG004|Overall Study|Physician Decision|0|||
161428477|NCT03071263|582957665|FG000|Overall Study|Adverse Event|1|||
161428478|NCT03071263|582957666|FG001|Overall Study|Adverse Event|3|||
161428479|NCT03071263|582957665|FG000|Overall Study|Withdrawal by Subject|1|||
161428480|NCT03071263|582957666|FG001|Overall Study|Withdrawal by Subject|3|||
161428481|NCT03071263|582957665|FG000|Overall Study|Physician Decision|1|||
161428482|NCT03071263|582957666|FG001|Overall Study|Physician Decision|0|||
161428483|NCT03071263|582957665|FG000|Overall Study|Participant moved to another city|0|||
161428484|NCT03071263|582957666|FG001|Overall Study|Participant moved to another city|1|||
161428485|NCT00647296|582957671|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
161428486|NCT00647296|582957672|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
161428487|NCT00647296|582957673|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
161428488|NCT00647296|582957674|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
161428489|NCT00647296|582957671|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
161428490|NCT00647296|582957672|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
161428491|NCT00647296|582957673|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
161428492|NCT00647296|582957674|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
161428493|NCT00647296|582957671|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
161428494|NCT00647296|582957672|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
161428495|NCT00647296|582957673|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
161428496|NCT00647296|582957674|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
161428497|NCT00647296|582957671|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
161428498|NCT00647296|582957672|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
161428499|NCT00647296|582957673|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
161428500|NCT00647296|582957674|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
161428501|NCT00647296|582957671|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
161428502|NCT00647296|582957672|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
161428503|NCT00647296|582957673|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
161428504|NCT00647296|582957674|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
161428505|NCT00647296|582957671|FG000|Part 2: 4-week Placebo Washout|Death|3|||
161428506|NCT00647296|582957672|FG001|Part 2: 4-week Placebo Washout|Death|0|||
161428507|NCT00647296|582957673|FG002|Part 2: 4-week Placebo Washout|Death|0|||
161428508|NCT00647296|582957674|FG003|Part 2: 4-week Placebo Washout|Death|0|||
161428509|NCT00647296|582957671|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
161428510|NCT00647296|582957672|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
161428511|NCT00647296|582957673|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
161428512|NCT00647296|582957674|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
161428513|NCT00647296|582957671|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
161428514|NCT00647296|582957672|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
161428515|NCT00647296|582957673|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
161428516|NCT00647296|582957674|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
161428517|NCT00647296|582957671|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
161428518|NCT00647296|582957672|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
161428519|NCT00647296|582957673|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
161428520|NCT00647296|582957674|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
161428521|NCT00647296|582957671|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
161428522|NCT00647296|582957672|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
161428523|NCT00647296|582957673|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
161428524|NCT00647296|582957674|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
161428525|NCT00647296|582957671|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
161428526|NCT00647296|582957672|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
161428527|NCT00647296|582957673|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
161428528|NCT00647296|582957674|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
161428529|NCT02922725|582957675|FG000|Overall Study|Withdrawal by Subject|1|||
161428530|NCT02922725|582957676|FG001|Overall Study|Withdrawal by Subject|0|||
161428531|NCT02922725|582957677|FG002|Overall Study|Withdrawal by Subject|0|||
161428532|NCT00871871|582957678|FG000|Part I|Adverse Event|0|||
161428533|NCT00871871|582957679|FG001|Part I|Adverse Event|2|||
161428534|NCT00871871|582957680|FG002|Part I|Adverse Event|0|||
161428535|NCT00871871|582957681|FG003|Part I|Adverse Event|0|||
161428536|NCT00871871|582957678|FG000|Part I|Withdrawal by Subject|3|||
161428537|NCT00871871|582957679|FG001|Part I|Withdrawal by Subject|0|||
161428538|NCT00871871|582957680|FG002|Part I|Withdrawal by Subject|0|||
161428539|NCT00871871|582957681|FG003|Part I|Withdrawal by Subject|0|||
161428540|NCT00871871|582957678|FG000|Part I|Laboratory abnormality|0|||
161428541|NCT00871871|582957679|FG001|Part I|Laboratory abnormality|1|||
161428542|NCT00871871|582957680|FG002|Part I|Laboratory abnormality|0|||
161428543|NCT00871871|582957681|FG003|Part I|Laboratory abnormality|0|||
161428544|NCT00871871|582957678|FG000|Part II|Lack of Efficacy|0|||
161428545|NCT00871871|582957679|FG001|Part II|Lack of Efficacy|0|||
161428546|NCT00871871|582957680|FG002|Part II|Lack of Efficacy|1|||
161428547|NCT00871871|582957681|FG003|Part II|Lack of Efficacy|0|||
161428548|NCT00871871|582957678|FG000|Part II|Withdrawal by Subject|0|||
161428549|NCT00871871|582957679|FG001|Part II|Withdrawal by Subject|0|||
161428550|NCT00871871|582957680|FG002|Part II|Withdrawal by Subject|2|||
161428551|NCT00871871|582957681|FG003|Part II|Withdrawal by Subject|1|||
161428552|NCT00871871|582957678|FG000|Part II|Adverse Event|0|||
161428553|NCT00871871|582957679|FG001|Part II|Adverse Event|0|||
161428554|NCT00871871|582957680|FG002|Part II|Adverse Event|1|||
161428555|NCT00871871|582957681|FG003|Part II|Adverse Event|2|||
161428556|NCT00871871|582957678|FG000|Part II|Protocol Violation|0|||
161428557|NCT00871871|582957679|FG001|Part II|Protocol Violation|0|||
161428558|NCT00871871|582957680|FG002|Part II|Protocol Violation|0|||
161428559|NCT00871871|582957681|FG003|Part II|Protocol Violation|1|||
161428560|NCT04612725|582957682|FG000|Overall Study|Adverse Event|1|||
161428561|NCT04612725|582957683|FG001|Overall Study|Adverse Event|3|||
161428562|NCT04612725|582957684|FG002|Overall Study|Adverse Event|1|||
161428563|NCT04612725|582957685|FG003|Overall Study|Adverse Event|0|||
161428564|NCT04612725|582957686|FG004|Overall Study|Adverse Event|1|||
161428565|NCT04612725|582957682|FG000|Overall Study|Lost to Follow-up|0|||
161428566|NCT04612725|582957683|FG001|Overall Study|Lost to Follow-up|1|||
161428567|NCT04612725|582957684|FG002|Overall Study|Lost to Follow-up|0|||
161428568|NCT04612725|582957685|FG003|Overall Study|Lost to Follow-up|0|||
161428569|NCT04612725|582957686|FG004|Overall Study|Lost to Follow-up|0|||
161428570|NCT04612725|582957682|FG000|Overall Study|Physician Decision|2|||
161428571|NCT04612725|582957683|FG001|Overall Study|Physician Decision|0|||
161428572|NCT04612725|582957684|FG002|Overall Study|Physician Decision|0|||
161428573|NCT04612725|582957685|FG003|Overall Study|Physician Decision|0|||
161428574|NCT04612725|582957686|FG004|Overall Study|Physician Decision|0|||
161428575|NCT04612725|582957682|FG000|Overall Study|Study terminated by sponsor|3|||
161428576|NCT04612725|582957683|FG001|Overall Study|Study terminated by sponsor|1|||
161428577|NCT04612725|582957684|FG002|Overall Study|Study terminated by sponsor|2|||
161428578|NCT04612725|582957685|FG003|Overall Study|Study terminated by sponsor|4|||
161428579|NCT04612725|582957686|FG004|Overall Study|Study terminated by sponsor|5|||
161428580|NCT04612725|582957682|FG000|Overall Study|Withdrawal by Subject|8|||
161428581|NCT04612725|582957683|FG001|Overall Study|Withdrawal by Subject|3|||
161428582|NCT04612725|582957684|FG002|Overall Study|Withdrawal by Subject|5|||
161428583|NCT04612725|582957685|FG003|Overall Study|Withdrawal by Subject|1|||
161428584|NCT04612725|582957686|FG004|Overall Study|Withdrawal by Subject|9|||
161428585|NCT04612725|582957682|FG000|Overall Study|Other|0|||
161428586|NCT04612725|582957683|FG001|Overall Study|Other|0|||
161428587|NCT04612725|582957684|FG002|Overall Study|Other|0|||
161428588|NCT04612725|582957685|FG003|Overall Study|Other|0|||
161428589|NCT04612725|582957686|FG004|Overall Study|Other|1|||
161428590|NCT03069352|582957687|FG000|Overall Study|Ongoing|12|||
161428591|NCT03069352|582957688|FG001|Overall Study|Ongoing|40|||
161428592|NCT02621424|582957689|FG000|Overall Study|Withdrawal by Subject|1|||
161428593|NCT02621424|582957690|FG001|Overall Study|Withdrawal by Subject|2|||
161428594|NCT05148234|582957692|FG000|Phase I|Ineligible|0|||
161428595|NCT05148234|582957693|FG001|Phase I|Ineligible|0|||
161428596|NCT05148234|582957694|FG002|Phase I|Ineligible|0|||
161428597|NCT05148234|582957695|FG003|Phase I|Ineligible|0|||
161428598|NCT05148234|582957696|FG004|Phase I|Ineligible|0|||
161428599|NCT05148234|582957697|FG005|Phase I|Ineligible|0|||
161428600|NCT05148234|582957698|FG006|Phase I|Ineligible|0|||
161428601|NCT05148234|582957699|FG007|Phase I|Ineligible|1|||
161428602|NCT05148234|582957692|FG000|Phase I|Company closed the trial.|0|||
161428603|NCT05148234|582957693|FG001|Phase I|Company closed the trial.|1|||
161428604|NCT05148234|582957694|FG002|Phase I|Company closed the trial.|0|||
161428605|NCT05148234|582957695|FG003|Phase I|Company closed the trial.|0|||
161428606|NCT05148234|582957696|FG004|Phase I|Company closed the trial.|0|||
161428607|NCT05148234|582957697|FG005|Phase I|Company closed the trial.|0|||
161428608|NCT05148234|582957698|FG006|Phase I|Company closed the trial.|0|||
161428609|NCT05148234|582957699|FG007|Phase I|Company closed the trial.|0|||
161428610|NCT04750642|582957700|FG000|Overall Study|Adverse Event|1|||
161428611|NCT04750642|582957701|FG001|Overall Study|Adverse Event|0|||
161428612|NCT04750642|582957700|FG000|Overall Study|Withdrawal by Subject|0|||
161428613|NCT04750642|582957701|FG001|Overall Study|Withdrawal by Subject|1|||
161428614|NCT04750642|582957700|FG000|Overall Study|Protocol Violation|0|||
161428615|NCT04750642|582957701|FG001|Overall Study|Protocol Violation|1|||
161428616|NCT03095651|582960731|FG000|Overall Study|Lost to Follow-up|1|||
161428617|NCT03095651|582960732|FG001|Overall Study|Lost to Follow-up|1|||
161428618|NCT03095651|582960733|FG002|Overall Study|Lost to Follow-up|0|||
161428619|NCT03095651|582960734|FG003|Overall Study|Lost to Follow-up|1|||
161428620|NCT03095651|582960735|FG004|Overall Study|Lost to Follow-up|0|||
161428621|NCT03095651|582960736|FG005|Overall Study|Lost to Follow-up|0|||
161428622|NCT03095651|582960737|FG006|Overall Study|Lost to Follow-up|0|||
161428623|NCT03095651|582960738|FG007|Overall Study|Lost to Follow-up|0|||
161428624|NCT03095651|582960731|FG000|Overall Study|Withdrawal by Subject|0|||
161428625|NCT03095651|582960732|FG001|Overall Study|Withdrawal by Subject|0|||
161428626|NCT03095651|582960733|FG002|Overall Study|Withdrawal by Subject|0|||
161428627|NCT03095651|582960734|FG003|Overall Study|Withdrawal by Subject|0|||
161428628|NCT03095651|582960735|FG004|Overall Study|Withdrawal by Subject|0|||
161428629|NCT03095651|582960736|FG005|Overall Study|Withdrawal by Subject|1|||
161428630|NCT03095651|582960737|FG006|Overall Study|Withdrawal by Subject|0|||
161428631|NCT03095651|582960738|FG007|Overall Study|Withdrawal by Subject|0|||
161428632|NCT04124939|582960739|FG000|Overall Study|Lost to Follow-up|1|||
161428633|NCT04124939|582960740|FG001|Overall Study|Lost to Follow-up|3|||
161428634|NCT00308139|582960743|FG000|Overall Study|Adverse Event|20|||
161428635|NCT00308139|582960744|FG001|Overall Study|Adverse Event|14|||
161428636|NCT00308139|582960743|FG000|Overall Study|Lost to Follow-up|13|||
161428637|NCT00308139|582960744|FG001|Overall Study|Lost to Follow-up|8|||
161428638|NCT00308139|582960743|FG000|Overall Study|Protocol Violation|3|||
161428639|NCT00308139|582960744|FG001|Overall Study|Protocol Violation|2|||
161428640|NCT00308139|582960743|FG000|Overall Study|Withdrawal of Consent|40|||
161428641|NCT00308139|582960744|FG001|Overall Study|Withdrawal of Consent|42|||
161428642|NCT00308139|582960743|FG000|Overall Study|Investigator Decision|11|||
161428643|NCT00308139|582960744|FG001|Overall Study|Investigator Decision|10|||
161428644|NCT00308139|582960743|FG000|Overall Study|Loss of Glucose Control|5|||
161428645|NCT00308139|582960744|FG001|Overall Study|Loss of Glucose Control|7|||
161428646|NCT00308139|582960743|FG000|Overall Study|Administrative|1|||
161428647|NCT00308139|582960744|FG001|Overall Study|Administrative|4|||
161428648|NCT00308139|582960743|FG000|Overall Study|Other|1|||
161428649|NCT00308139|582960744|FG001|Overall Study|Other|0|||
161428650|NCT00791388|582960749|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
161428651|NCT00791388|582960750|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
161428652|NCT00791388|582960751|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
161428653|NCT00791388|582960752|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
161428654|NCT00791388|582960753|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
161428655|NCT00791388|582960749|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
161428656|NCT00791388|582960750|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
161428657|NCT00791388|582960751|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
161428658|NCT00791388|582960752|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
161428659|NCT00791388|582960753|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
161428660|NCT00791388|582960749|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
161428661|NCT00791388|582960750|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
161428662|NCT00791388|582960751|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
161428663|NCT00791388|582960752|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
161428664|NCT00791388|582960753|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
161428665|NCT00435409|582960762|FG000|Overall Study|Protocol Violation|1|||
161428666|NCT00435409|582960763|FG001|Overall Study|Protocol Violation|2|||
161428667|NCT00435409|582960764|FG002|Overall Study|Protocol Violation|0|||
161428668|NCT00435409|582960762|FG000|Overall Study|Lost to Follow-up|1|||
161428669|NCT00435409|582960763|FG001|Overall Study|Lost to Follow-up|2|||
161428670|NCT00435409|582960764|FG002|Overall Study|Lost to Follow-up|0|||
161428671|NCT00435409|582960762|FG000|Overall Study|Death|8|||
161428672|NCT00435409|582960763|FG001|Overall Study|Death|6|||
161428673|NCT00435409|582960764|FG002|Overall Study|Death|6|||
161428674|NCT00435409|582960762|FG000|Overall Study|Objective progression or relapse|158|||
161428675|NCT00435409|582960763|FG001|Overall Study|Objective progression or relapse|93|||
161428676|NCT00435409|582960764|FG002|Overall Study|Objective progression or relapse|58|||
161428677|NCT00435409|582960762|FG000|Overall Study|Global deterioration of health status|0|||
161428678|NCT00435409|582960763|FG001|Overall Study|Global deterioration of health status|0|||
161428679|NCT00435409|582960764|FG002|Overall Study|Global deterioration of health status|4|||
161428680|NCT00435409|582960762|FG000|Overall Study|Withdrawal by Subject|8|||
161428681|NCT00435409|582960763|FG001|Overall Study|Withdrawal by Subject|7|||
161428682|NCT00435409|582960764|FG002|Overall Study|Withdrawal by Subject|1|||
161428683|NCT00435409|582960762|FG000|Overall Study|Other|45|||
161428684|NCT00435409|582960763|FG001|Overall Study|Other|30|||
161428685|NCT00435409|582960764|FG002|Overall Study|Other|1|||
161428686|NCT00435409|582960762|FG000|Overall Study|Adverse Event|0|||
161428687|NCT00435409|582960763|FG001|Overall Study|Adverse Event|0|||
161428688|NCT00435409|582960764|FG002|Overall Study|Adverse Event|8|||
161428689|NCT00435409|582960762|FG000|Overall Study|Sponsor decision|0|||
161428690|NCT00435409|582960763|FG001|Overall Study|Sponsor decision|3|||
161428691|NCT00435409|582960764|FG002|Overall Study|Sponsor decision|0|||
161428692|NCT04750824|582960765|FG000|Overall Study|Toxicity/intolerability|3|||
161428693|NCT04750824|582960766|FG001|Overall Study|Toxicity/intolerability|1|||
161428694|NCT04750824|582960765|FG000|Overall Study|Death|1|||
161428695|NCT04750824|582960766|FG001|Overall Study|Death|3|||
161428696|NCT04750824|582960765|FG000|Overall Study|Scheduled duration of therapy complete|1|||
161428697|NCT04750824|582960766|FG001|Overall Study|Scheduled duration of therapy complete|9|||
161428698|NCT04750824|582960765|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
161428699|NCT04750824|582960766|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
161428700|NCT05196828|582960767|FG000|Overall Study|Withdrawal by Subject|2|||
161428701|NCT05196828|582960768|FG001|Overall Study|Withdrawal by Subject|0|||
161428702|NCT05196828|582960767|FG000|Overall Study|Lost to Follow-up|0|||
161428703|NCT05196828|582960768|FG001|Overall Study|Lost to Follow-up|4|||
161428704|NCT05196828|582960767|FG000|Overall Study|Adverse Event|1|||
161428705|NCT05196828|582960768|FG001|Overall Study|Adverse Event|0|||
161428706|NCT02763644|582960769|FG000|Overall Study|Patient/guardian decision|1|||
161428707|NCT02763644|582960770|FG001|Overall Study|Patient/guardian decision|0|||
161428708|NCT02763644|582960769|FG000|Overall Study|Death|1|||
161428709|NCT02763644|582960770|FG001|Overall Study|Death|1|||
161428710|NCT02763644|582960769|FG000|Overall Study|Adverse Event|1|||
161428711|NCT02763644|582960770|FG001|Overall Study|Adverse Event|1|||
161428712|NCT02356159|582960771|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
161428713|NCT02356159|582960772|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
161428714|NCT02356159|582960773|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
161428715|NCT02356159|582960774|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
161428716|NCT02356159|582960775|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
161428717|NCT02356159|582960776|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
161428718|NCT03192176|582960777|FG000|Overall Study|Adverse Event|1|||
161428719|NCT03192176|582960778|FG001|Overall Study|Adverse Event|0|||
161428720|NCT03192176|582960779|FG002|Overall Study|Adverse Event|4|||
161428721|NCT03192176|582960780|FG003|Overall Study|Adverse Event|5|||
161428722|NCT03192176|582960781|FG004|Overall Study|Adverse Event|3|||
161428723|NCT03192176|582960782|FG005|Overall Study|Adverse Event|2|||
161428724|NCT03192176|582960783|FG006|Overall Study|Adverse Event|3|||
161428725|NCT03192176|582960784|FG007|Overall Study|Adverse Event|3|||
161428726|NCT03192176|582960777|FG000|Overall Study|Lost to Follow-up|0|||
161428727|NCT03192176|582960778|FG001|Overall Study|Lost to Follow-up|0|||
161428728|NCT03192176|582960779|FG002|Overall Study|Lost to Follow-up|1|||
161428729|NCT03192176|582960780|FG003|Overall Study|Lost to Follow-up|2|||
161428730|NCT03192176|582960781|FG004|Overall Study|Lost to Follow-up|3|||
161428731|NCT03192176|582960782|FG005|Overall Study|Lost to Follow-up|1|||
161428732|NCT03192176|582960783|FG006|Overall Study|Lost to Follow-up|1|||
161428733|NCT03192176|582960784|FG007|Overall Study|Lost to Follow-up|1|||
161428734|NCT03192176|582960777|FG000|Overall Study|Physician Decision|1|||
161428735|NCT03192176|582960778|FG001|Overall Study|Physician Decision|0|||
161428736|NCT03192176|582960779|FG002|Overall Study|Physician Decision|0|||
161428737|NCT03192176|582960780|FG003|Overall Study|Physician Decision|0|||
161428738|NCT03192176|582960781|FG004|Overall Study|Physician Decision|0|||
161428739|NCT03192176|582960782|FG005|Overall Study|Physician Decision|2|||
161428740|NCT03192176|582960783|FG006|Overall Study|Physician Decision|1|||
161428741|NCT03192176|582960784|FG007|Overall Study|Physician Decision|0|||
161428742|NCT03192176|582960777|FG000|Overall Study|Protocol Deviation|1|||
161428743|NCT03192176|582960778|FG001|Overall Study|Protocol Deviation|1|||
161428744|NCT03192176|582960779|FG002|Overall Study|Protocol Deviation|0|||
161428745|NCT03192176|582960780|FG003|Overall Study|Protocol Deviation|0|||
161428746|NCT03192176|582960781|FG004|Overall Study|Protocol Deviation|2|||
161428747|NCT03192176|582960782|FG005|Overall Study|Protocol Deviation|0|||
161428748|NCT03192176|582960783|FG006|Overall Study|Protocol Deviation|0|||
161428749|NCT03192176|582960784|FG007|Overall Study|Protocol Deviation|0|||
161428750|NCT03192176|582960777|FG000|Overall Study|Withdrawal by Subject|3|||
161428751|NCT03192176|582960778|FG001|Overall Study|Withdrawal by Subject|4|||
161428752|NCT03192176|582960779|FG002|Overall Study|Withdrawal by Subject|0|||
161428753|NCT03192176|582960780|FG003|Overall Study|Withdrawal by Subject|4|||
161428754|NCT03192176|582960781|FG004|Overall Study|Withdrawal by Subject|3|||
161428755|NCT03192176|582960782|FG005|Overall Study|Withdrawal by Subject|4|||
161428756|NCT03192176|582960783|FG006|Overall Study|Withdrawal by Subject|4|||
161428757|NCT03192176|582960784|FG007|Overall Study|Withdrawal by Subject|2|||
161428758|NCT03192176|582960777|FG000|Overall Study|Miscellaneous|1|||
161428759|NCT03192176|582960778|FG001|Overall Study|Miscellaneous|0|||
161428760|NCT03192176|582960779|FG002|Overall Study|Miscellaneous|1|||
161428761|NCT03192176|582960780|FG003|Overall Study|Miscellaneous|1|||
161428762|NCT03192176|582960781|FG004|Overall Study|Miscellaneous|1|||
161428763|NCT03192176|582960782|FG005|Overall Study|Miscellaneous|2|||
161428764|NCT03192176|582960783|FG006|Overall Study|Miscellaneous|0|||
161428765|NCT03192176|582960784|FG007|Overall Study|Miscellaneous|1|||
161428766|NCT00836589|582960789|FG000|Overall Study|Lost to Follow-up|246|||
161428767|NCT00836589|582960789|FG000|Overall Study|Death|429|||
161428768|NCT00836589|582960789|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
161428769|NCT00117637|582960790|FG000|First Intervention (Period 1)|Adverse Event|11|||
161428770|NCT00117637|582960791|FG001|First Intervention (Period 1)|Adverse Event|16|||
161428771|NCT00117637|582960790|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
161428772|NCT00117637|582960791|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
161428773|NCT00117637|582960790|FG000|First Intervention (Period 1)|Protocol Violation|1|||
161428774|NCT00117637|582960791|FG001|First Intervention (Period 1)|Protocol Violation|0|||
161428775|NCT00117637|582960790|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
161428776|NCT00117637|582960791|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
161428777|NCT00117637|582960790|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
161428778|NCT00117637|582960791|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
161428779|NCT00117637|582960790|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
161428780|NCT00117637|582960791|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
161428781|NCT00117637|582960790|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
161428782|NCT00117637|582960791|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
161428783|NCT00117637|582960790|FG000|First Intervention (Period 1)|reason not reported|0|||
161428784|NCT00117637|582960791|FG001|First Intervention (Period 1)|reason not reported|1|||
161428785|NCT00117637|582960790|FG000|Second Intervention (Period 2)|Adverse Event|0|||
161428786|NCT00117637|582960791|FG001|Second Intervention (Period 2)|Adverse Event|9|||
161428787|NCT00117637|582960790|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
161428788|NCT00117637|582960791|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
161428789|NCT00117637|582960790|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
161428790|NCT00117637|582960791|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
161428791|NCT00117637|582960790|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
161428792|NCT00117637|582960791|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
161428793|NCT00117637|582960790|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
161428794|NCT00117637|582960791|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
161428795|NCT00117637|582960790|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
161428796|NCT00117637|582960791|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
161428797|NCT00117637|582960790|FG000|Second Intervention (Period 2)|reason not reported|1|||
161428798|NCT00117637|582960791|FG001|Second Intervention (Period 2)|reason not reported|0|||
161428799|NCT02914639|582960794|FG000|Overall Study|Withdrawal by Subject|0|||
161428800|NCT02914639|582960795|FG001|Overall Study|Withdrawal by Subject|2|||
161428801|NCT01582061|582960796|FG000|Overall Study|Lack of Efficacy|3|||
161428802|NCT01582061|582960797|FG001|Overall Study|Lack of Efficacy|23|||
161428803|NCT01582061|582960796|FG000|Overall Study|Adverse Event|12|||
161428804|NCT01582061|582960797|FG001|Overall Study|Adverse Event|8|||
161428805|NCT01582061|582960796|FG000|Overall Study|Withdrawal by Subject|10|||
161428806|NCT01582061|582960797|FG001|Overall Study|Withdrawal by Subject|4|||
161428807|NCT01582061|582960796|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161428808|NCT01582061|582960797|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161428809|NCT01582061|582960796|FG000|Overall Study|Death|0|||
161428810|NCT01582061|582960797|FG001|Overall Study|Death|1|||
161428811|NCT01582061|582960796|FG000|Overall Study|condition no longer requires study drug|1|||
161428812|NCT01582061|582960797|FG001|Overall Study|condition no longer requires study drug|0|||
161428813|NCT01582061|582960796|FG000|Overall Study|Lost to Follow-up|1|||
161428814|NCT01582061|582960797|FG001|Overall Study|Lost to Follow-up|0|||
161428815|NCT00436332|582960801|FG000|Overall Study|Adverse Event|9|||
161428816|NCT00436332|582960801|FG000|Overall Study|Withdrawal by Subject|2|||
161428817|NCT00436332|582960801|FG000|Overall Study|Progression|59|||
161428818|NCT00436332|582960801|FG000|Overall Study|Death|2|||
161428819|NCT00436332|582960801|FG000|Overall Study|Not Protocol Specified|6|||
161428820|NCT00436332|582960801|FG000|Overall Study|Ineligible|2|||
161428821|NCT00436332|582960801|FG000|Overall Study|Never Received Treatment|3|||
161428822|NCT01924845|582960802|FG000|Overall Study|Adverse Event|3|||
161428823|NCT01924845|582960802|FG000|Overall Study|Withdrawal by Subject|2|||
161428824|NCT01924845|582960802|FG000|Overall Study|Protocol Violation|1|||
161428825|NCT00062439|582960803|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
161428826|NCT00062439|582960803|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
161428827|NCT00062439|582960803|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
161428828|NCT00062439|582960803|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
161428829|NCT00062439|582960803|FG000|Post Chemoradiation Assessment|Death|1|||
161428830|NCT00062439|582960803|FG000|Post Chemoradiation Assessment|Disease progression|2|||
161428831|NCT00062439|582960803|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
161428832|NCT00062439|582960803|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
161428833|NCT00062439|582960803|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
161428834|NCT00062439|582960803|FG000|Surgery|Physician Decision|4|||
161428835|NCT00062439|582960803|FG000|Surgery|Death|1|||
161428836|NCT00062439|582960803|FG000|Surgery|Adverse Event|2|||
161428837|NCT00062439|582960803|FG000|Consolidation Chemotherapy|Adverse Event|2|||
161428838|NCT03780452|582960804|FG000|Overall Study|Screening failure|2|||
161428839|NCT02388269|582960805|FG000|Overall Study|Adverse Event|2|||
161428840|NCT02388269|582960806|FG001|Overall Study|Adverse Event|0|||
161428841|NCT02388269|582960807|FG002|Overall Study|Adverse Event|0|||
161428842|NCT02388269|582960805|FG000|Overall Study|Withdrawal by Subject|1|||
161428843|NCT02388269|582960806|FG001|Overall Study|Withdrawal by Subject|2|||
161428844|NCT02388269|582960807|FG002|Overall Study|Withdrawal by Subject|0|||
161428845|NCT02388269|582960805|FG000|Overall Study|less than 50% stimulations|1|||
161428846|NCT02388269|582960806|FG001|Overall Study|less than 50% stimulations|0|||
161428847|NCT02388269|582960807|FG002|Overall Study|less than 50% stimulations|0|||
161428848|NCT02388269|582960805|FG000|Overall Study|no diary data|3|||
161428849|NCT02388269|582960806|FG001|Overall Study|no diary data|0|||
161428850|NCT02388269|582960807|FG002|Overall Study|no diary data|0|||
161428851|NCT02388269|582960805|FG000|Overall Study|Protocol Violation|2|||
161428852|NCT02388269|582960806|FG001|Overall Study|Protocol Violation|0|||
161428853|NCT02388269|582960807|FG002|Overall Study|Protocol Violation|0|||
161428854|NCT02388269|582960805|FG000|Overall Study|Screen Failure|0|||
161428855|NCT02388269|582960806|FG001|Overall Study|Screen Failure|0|||
161428856|NCT02388269|582960807|FG002|Overall Study|Screen Failure|10|||
161428857|NCT04698343|582960810|FG000|Overall Study|Withdrawal by Subject|6|||
161428858|NCT04698343|582960810|FG000|Overall Study|Physician Decision|2|||
161428859|NCT04698343|582960810|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
161428860|NCT04698343|582960810|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
161428861|NCT04698343|582960810|FG000|Overall Study|Personal reasons|3|||
161428862|NCT04698343|582960810|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
161428863|NCT00325897|582960814|FG000|Overall Study|Lost to Follow-up|12|||
161428864|NCT00325897|582960815|FG001|Overall Study|Lost to Follow-up|13|||
161428865|NCT03915717|582960818|FG000|Overall Study|EchoMark Not Implanted|6|||
161428866|NCT04079296|582960819|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
161428867|NCT04079296|582960820|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
161428868|NCT04079296|582960821|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
161428869|NCT04079296|582960822|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
161428870|NCT04079296|582960823|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
161428871|NCT04079296|582960819|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
161428872|NCT04079296|582960820|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
161428873|NCT04079296|582960821|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
161428874|NCT04079296|582960822|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
161428875|NCT04079296|582960823|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
161428876|NCT04079296|582960819|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
161428877|NCT04079296|582960820|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
161428878|NCT04079296|582960821|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
161428879|NCT04079296|582960822|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
161428880|NCT04079296|582960823|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
161428881|NCT04079296|582960819|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
161428882|NCT04079296|582960820|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
161428883|NCT04079296|582960821|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
161428884|NCT04079296|582960822|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
161428885|NCT04079296|582960823|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
161428886|NCT04079296|582960819|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
161428887|NCT04079296|582960820|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
161428888|NCT04079296|582960821|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
161428889|NCT04079296|582960822|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
161428890|NCT04079296|582960823|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
161428891|NCT04079296|582960819|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
161428892|NCT04079296|582960820|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
161428893|NCT04079296|582960821|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
161428894|NCT04079296|582960822|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
161428895|NCT04079296|582960823|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
161428896|NCT04079296|582960819|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
161428897|NCT04079296|582960820|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
161428898|NCT04079296|582960821|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
161428899|NCT04079296|582960822|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
161428900|NCT04079296|582960823|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
161428901|NCT04079296|582960819|FG000|Dose Expansion Phase (168 Days)|Death|0|||
161428902|NCT04079296|582960820|FG001|Dose Expansion Phase (168 Days)|Death|0|||
161428903|NCT04079296|582960821|FG002|Dose Expansion Phase (168 Days)|Death|0|||
161428904|NCT04079296|582960822|FG003|Dose Expansion Phase (168 Days)|Death|1|||
161428905|NCT04079296|582960823|FG004|Dose Expansion Phase (168 Days)|Death|0|||
161428906|NCT00467740|582960824|FG000|Overall Study|Adverse Event|0|||
161428907|NCT00467740|582960825|FG001|Overall Study|Adverse Event|0|||
161428908|NCT00467740|582960826|FG002|Overall Study|Adverse Event|1|||
161428909|NCT00467740|582960827|FG003|Overall Study|Adverse Event|0|||
161428910|NCT00467740|582960828|FG004|Overall Study|Adverse Event|0|||
161428911|NCT00467740|582960824|FG000|Overall Study|Protocol Violation|0|||
161428912|NCT00467740|582960825|FG001|Overall Study|Protocol Violation|0|||
161428913|NCT00467740|582960826|FG002|Overall Study|Protocol Violation|1|||
161428914|NCT00467740|582960827|FG003|Overall Study|Protocol Violation|0|||
161428915|NCT00467740|582960828|FG004|Overall Study|Protocol Violation|0|||
161428916|NCT00467740|582960824|FG000|Overall Study|Lost to Follow-up|0|||
161428917|NCT00467740|582960825|FG001|Overall Study|Lost to Follow-up|1|||
161428918|NCT00467740|582960826|FG002|Overall Study|Lost to Follow-up|0|||
161428919|NCT00467740|582960827|FG003|Overall Study|Lost to Follow-up|0|||
161428920|NCT00467740|582960828|FG004|Overall Study|Lost to Follow-up|0|||
161428921|NCT00467740|582960824|FG000|Overall Study|Withdrawal by Subject|1|||
161428922|NCT00467740|582960825|FG001|Overall Study|Withdrawal by Subject|1|||
161428923|NCT00467740|582960826|FG002|Overall Study|Withdrawal by Subject|0|||
161428924|NCT00467740|582960827|FG003|Overall Study|Withdrawal by Subject|1|||
161428925|NCT00467740|582960828|FG004|Overall Study|Withdrawal by Subject|0|||
161428926|NCT00467740|582960824|FG000|Overall Study|Lack of Efficacy|0|||
161428927|NCT00467740|582960825|FG001|Overall Study|Lack of Efficacy|1|||
161428928|NCT00467740|582960826|FG002|Overall Study|Lack of Efficacy|0|||
161428929|NCT00467740|582960827|FG003|Overall Study|Lack of Efficacy|0|||
161428930|NCT00467740|582960828|FG004|Overall Study|Lack of Efficacy|0|||
161428931|NCT02903160|582960829|FG000|Overall Study|Adverse Event|2|||
161428932|NCT02903160|582960829|FG000|Overall Study|Death|1|||
161428933|NCT02903160|582960829|FG000|Overall Study|Lost to Follow-up|2|||
161428934|NCT02903160|582960829|FG000|Overall Study|Withdrawal by Subject|1|||
161428935|NCT02903160|582960829|FG000|Overall Study|Medical Insurance Barriers|1|||
161428936|NCT01664910|582960832|FG000|Overall Study|Adverse Event|0|||
161428937|NCT01664910|582960833|FG001|Overall Study|Adverse Event|0|||
161428938|NCT01664910|582960834|FG002|Overall Study|Adverse Event|1|||
161428939|NCT02240485|582960835|FG000|3 Months Post-admission|Lost to Follow-up|1|||
161428940|NCT02240485|582960836|FG001|3 Months Post-admission|Lost to Follow-up|5|||
161428941|NCT02240485|582960835|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
161428942|NCT02240485|582960836|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
161428943|NCT02240485|582960835|FG000|9 Months Post-admission|Lost to Follow-up|3|||
161428944|NCT02240485|582960836|FG001|9 Months Post-admission|Lost to Follow-up|1|||
161428945|NCT02240485|582960835|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
161428946|NCT02240485|582960836|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
161428947|NCT02240485|582960835|FG000|18 Months Post-admission|Lost to Follow-up|1|||
161428948|NCT02240485|582960836|FG001|18 Months Post-admission|Lost to Follow-up|1|||
161428949|NCT02240485|582960835|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
161428950|NCT02240485|582960836|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
161428951|NCT02525471|582960837|FG000|Overall Study|Screen Failure|6|||
161428952|NCT02525471|582960837|FG000|Overall Study|Withdrawal by Subject|4|||
161428953|NCT02525471|582960837|FG000|Overall Study|Death|1|||
161428954|NCT00867165|582960841|FG000|Overall Study|Adverse Event|3|||
161428955|NCT00867165|582960842|FG001|Overall Study|Adverse Event|0|||
161428956|NCT00867165|582960841|FG000|Overall Study|Withdrawal by Subject|1|||
161428957|NCT00867165|582960842|FG001|Overall Study|Withdrawal by Subject|0|||
161428958|NCT03275740|582960843|FG000|Overall Study|Adverse Event|0|||
161428959|NCT03275740|582960844|FG001|Overall Study|Adverse Event|0|||
161428960|NCT03275740|582960845|FG002|Overall Study|Adverse Event|0|||
161428961|NCT03275740|582960846|FG003|Overall Study|Adverse Event|0|||
161428962|NCT03275740|582960847|FG004|Overall Study|Adverse Event|1|||
161428963|NCT03275740|582960848|FG005|Overall Study|Adverse Event|0|||
161428964|NCT03275740|582960849|FG006|Overall Study|Adverse Event|0|||
161428965|NCT03275740|582960850|FG007|Overall Study|Adverse Event|0|||
161428966|NCT03275740|582960851|FG008|Overall Study|Adverse Event|0|||
161428967|NCT03275740|582960852|FG009|Overall Study|Adverse Event|0|||
161428968|NCT03275740|582960853|FG010|Overall Study|Adverse Event|0|||
161428969|NCT03275740|582960854|FG011|Overall Study|Adverse Event|0|||
161428970|NCT03275740|582960843|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428971|NCT03275740|582960844|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428972|NCT03275740|582960845|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428973|NCT03275740|582960846|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428974|NCT03275740|582960847|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428975|NCT03275740|582960848|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
161428976|NCT03275740|582960849|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428977|NCT03275740|582960850|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428978|NCT03275740|582960851|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428979|NCT03275740|582960852|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428980|NCT03275740|582960853|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428981|NCT03275740|582960854|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
161428982|NCT03275740|582960843|FG000|Overall Study|Withdrawal by Subject|0|||
161428983|NCT03275740|582960844|FG001|Overall Study|Withdrawal by Subject|0|||
161428984|NCT03275740|582960845|FG002|Overall Study|Withdrawal by Subject|0|||
161428985|NCT03275740|582960846|FG003|Overall Study|Withdrawal by Subject|0|||
161428986|NCT03275740|582960847|FG004|Overall Study|Withdrawal by Subject|0|||
161428987|NCT03275740|582960848|FG005|Overall Study|Withdrawal by Subject|0|||
161428988|NCT03275740|582960849|FG006|Overall Study|Withdrawal by Subject|0|||
161428989|NCT03275740|582960850|FG007|Overall Study|Withdrawal by Subject|0|||
161428990|NCT03275740|582960851|FG008|Overall Study|Withdrawal by Subject|1|||
161428991|NCT03275740|582960852|FG009|Overall Study|Withdrawal by Subject|1|||
161428992|NCT03275740|582960853|FG010|Overall Study|Withdrawal by Subject|0|||
161428993|NCT03275740|582960854|FG011|Overall Study|Withdrawal by Subject|0|||
161428994|NCT00988884|582960855|FG000|Overall Study|Adverse Event|0|||
161428995|NCT00988884|582960856|FG001|Overall Study|Adverse Event|1|||
161428996|NCT00988884|582960855|FG000|Overall Study|Lost to Follow-up|20|||
161428997|NCT00988884|582960856|FG001|Overall Study|Lost to Follow-up|16|||
161428998|NCT00988884|582960855|FG000|Overall Study|Protocol Violation|0|||
161428999|NCT00988884|582960856|FG001|Overall Study|Protocol Violation|1|||
161429000|NCT00988884|582960855|FG000|Overall Study|Withdrawal by Subject|15|||
161429001|NCT00988884|582960856|FG001|Overall Study|Withdrawal by Subject|18|||
161429002|NCT04621448|582960858|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
161429003|NCT04621448|582960859|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
161429004|NCT04621448|582960860|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
161429005|NCT04621448|582960861|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
161429006|NCT04621448|582960858|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
161429007|NCT04621448|582960859|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
161429008|NCT04621448|582960860|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
161429009|NCT04621448|582960861|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
161429010|NCT04621448|582960858|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
161429011|NCT04621448|582960859|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
161429012|NCT04621448|582960860|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
161429013|NCT04621448|582960861|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
161429014|NCT04621448|582960858|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
161429015|NCT04621448|582960859|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
161429016|NCT04621448|582960860|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
161429017|NCT04621448|582960861|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
161429018|NCT00549640|582960862|FG000|Overall Study|Withdrawal by Subject|6|||
161429019|NCT00549640|582960863|FG001|Overall Study|Withdrawal by Subject|12|||
161429020|NCT00549640|582960862|FG000|Overall Study|Adverse Event|5|||
161429021|NCT00549640|582960863|FG001|Overall Study|Adverse Event|0|||
161429022|NCT00549640|582960862|FG000|Overall Study|Lost to Follow-up|7|||
161429023|NCT00549640|582960863|FG001|Overall Study|Lost to Follow-up|4|||
161429024|NCT03550378|582960870|FG000|Overall Study|Death|0|||
161429025|NCT03550378|582960871|FG001|Overall Study|Death|1|||
161429026|NCT04486235|582960872|FG000|Overall Study|Pregnancy|1|||
161429027|NCT04486235|582960873|FG001|Overall Study|Pregnancy|0|||
161429028|NCT04486235|582960872|FG000|Overall Study|Lost to Follow-up|1|||
161429029|NCT04486235|582960873|FG001|Overall Study|Lost to Follow-up|0|||
161429030|NCT00626275|582960874|FG000|Part A - Treatment Period 1|Adverse Event|1|||
161429031|NCT00626275|582960875|FG001|Part A - Treatment Period 1|Adverse Event|0|||
161429032|NCT00626275|582960876|FG002|Part A - Treatment Period 1|Adverse Event|0|||
161429033|NCT00626275|582960877|FG003|Part A - Treatment Period 1|Adverse Event|0|||
161429034|NCT00626275|582960878|FG004|Part A - Treatment Period 1|Adverse Event|0|||
161429035|NCT00626275|582960879|FG005|Part A - Treatment Period 1|Adverse Event|0|||
161429036|NCT00626275|582960880|FG006|Part A - Treatment Period 1|Adverse Event|0|||
161429037|NCT00626275|582960881|FG007|Part A - Treatment Period 1|Adverse Event|0|||
161429038|NCT00626275|582960874|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429039|NCT00626275|582960875|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429040|NCT00626275|582960876|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
161429041|NCT00626275|582960877|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429042|NCT00626275|582960878|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429043|NCT00626275|582960879|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429044|NCT00626275|582960880|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429045|NCT00626275|582960881|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
161429046|NCT00626275|582960874|FG000|Part B|Lost to Follow-up|0|||
161429047|NCT00626275|582960875|FG001|Part B|Lost to Follow-up|0|||
161429048|NCT00626275|582960876|FG002|Part B|Lost to Follow-up|0|||
161429049|NCT00626275|582960877|FG003|Part B|Lost to Follow-up|0|||
161429050|NCT00626275|582960878|FG004|Part B|Lost to Follow-up|0|||
161429051|NCT00626275|582960879|FG005|Part B|Lost to Follow-up|0|||
161429052|NCT00626275|582960880|FG006|Part B|Lost to Follow-up|1|||
161429053|NCT00626275|582960881|FG007|Part B|Lost to Follow-up|0|||
161429054|NCT00626275|582960874|FG000|Part B|Withdrawal by Subject|0|||
161429055|NCT00626275|582960875|FG001|Part B|Withdrawal by Subject|0|||
161429056|NCT00626275|582960876|FG002|Part B|Withdrawal by Subject|0|||
161429057|NCT00626275|582960877|FG003|Part B|Withdrawal by Subject|0|||
161429058|NCT00626275|582960878|FG004|Part B|Withdrawal by Subject|0|||
161429059|NCT00626275|582960879|FG005|Part B|Withdrawal by Subject|0|||
161429060|NCT00626275|582960880|FG006|Part B|Withdrawal by Subject|0|||
161429061|NCT00626275|582960881|FG007|Part B|Withdrawal by Subject|1|||
161429062|NCT04590014|582960882|FG000|Overall Study|Withdrawal by Subject|1|||
161429063|NCT04590014|582960883|FG001|Overall Study|Withdrawal by Subject|0|||
161429064|NCT00468299|582960884|FG000|Overall Study|Withdrawal by Subject|0|||
161429065|NCT00468299|582960885|FG001|Overall Study|Withdrawal by Subject|1|||
161429066|NCT04999839|582960886|FG000|Overall Study|Adverse Event|1|||
161429067|NCT04999839|582960887|FG001|Overall Study|Adverse Event|1|||
161429068|NCT04999839|582960888|FG002|Overall Study|Adverse Event|1|||
161429069|NCT04999839|582960889|FG003|Overall Study|Adverse Event|1|||
161429070|NCT04999839|582960890|FG004|Overall Study|Adverse Event|1|||
161429071|NCT04999839|582960886|FG000|Overall Study|Lost to Follow-up|2|||
161429072|NCT04999839|582960887|FG001|Overall Study|Lost to Follow-up|0|||
161429073|NCT04999839|582960888|FG002|Overall Study|Lost to Follow-up|2|||
161429074|NCT04999839|582960889|FG003|Overall Study|Lost to Follow-up|4|||
161429075|NCT04999839|582960890|FG004|Overall Study|Lost to Follow-up|1|||
161429076|NCT04999839|582960886|FG000|Overall Study|Withdrawal by Subject|6|||
161429077|NCT04999839|582960887|FG001|Overall Study|Withdrawal by Subject|5|||
161429078|NCT04999839|582960888|FG002|Overall Study|Withdrawal by Subject|3|||
161429079|NCT04999839|582960889|FG003|Overall Study|Withdrawal by Subject|2|||
161429080|NCT04999839|582960890|FG004|Overall Study|Withdrawal by Subject|2|||
161429081|NCT04999839|582960886|FG000|Overall Study|Lack of Efficacy|0|||
161429082|NCT04999839|582960887|FG001|Overall Study|Lack of Efficacy|1|||
161429083|NCT04999839|582960888|FG002|Overall Study|Lack of Efficacy|0|||
161429084|NCT04999839|582960889|FG003|Overall Study|Lack of Efficacy|0|||
161429085|NCT04999839|582960890|FG004|Overall Study|Lack of Efficacy|0|||
161429086|NCT04999839|582960886|FG000|Overall Study|Physician Decision|0|||
161429087|NCT04999839|582960887|FG001|Overall Study|Physician Decision|0|||
161429088|NCT04999839|582960888|FG002|Overall Study|Physician Decision|0|||
161429089|NCT04999839|582960889|FG003|Overall Study|Physician Decision|0|||
161429090|NCT04999839|582960890|FG004|Overall Study|Physician Decision|1|||
161429091|NCT04999839|582960886|FG000|Overall Study|Sponsor request|0|||
161429092|NCT04999839|582960887|FG001|Overall Study|Sponsor request|1|||
161429093|NCT04999839|582960888|FG002|Overall Study|Sponsor request|0|||
161429094|NCT04999839|582960889|FG003|Overall Study|Sponsor request|0|||
161429095|NCT04999839|582960890|FG004|Overall Study|Sponsor request|0|||
161429096|NCT04999839|582960886|FG000|Overall Study|Other|0|||
161429097|NCT04999839|582960887|FG001|Overall Study|Other|0|||
161429098|NCT04999839|582960888|FG002|Overall Study|Other|1|||
161429099|NCT04999839|582960889|FG003|Overall Study|Other|0|||
161429100|NCT04999839|582960890|FG004|Overall Study|Other|0|||
161429101|NCT01362348|582960891|FG000|Overall Study|Protocol-defined stopping criteria|9|||
161429102|NCT01362348|582960891|FG000|Overall Study|Study closed/terminated|5|||
161429103|NCT00399516|582960892|FG000|Overall Study|Lost to Follow-up|2|||
161429104|NCT03546621|582960893|FG000|Overall Study|Withdrawal by Subject|0|||
161429105|NCT03546621|582960894|FG001|Overall Study|Withdrawal by Subject|1|||
161429106|NCT03546621|582960895|FG002|Overall Study|Withdrawal by Subject|2|||
161429107|NCT03546621|582960896|FG003|Overall Study|Withdrawal by Subject|1|||
161429108|NCT03546621|582960893|FG000|Overall Study|Lost to Follow-up|0|||
161429109|NCT03546621|582960894|FG001|Overall Study|Lost to Follow-up|1|||
161429110|NCT03546621|582960895|FG002|Overall Study|Lost to Follow-up|0|||
161429111|NCT03546621|582960896|FG003|Overall Study|Lost to Follow-up|0|||
161429112|NCT03546621|582960893|FG000|Overall Study|Adverse Event|0|||
161429113|NCT03546621|582960894|FG001|Overall Study|Adverse Event|1|||
161429114|NCT03546621|582960895|FG002|Overall Study|Adverse Event|0|||
161429115|NCT03546621|582960896|FG003|Overall Study|Adverse Event|1|||
161429116|NCT03546621|582960893|FG000|Overall Study|Progressive disease|0|||
161429117|NCT03546621|582960894|FG001|Overall Study|Progressive disease|0|||
161429118|NCT03546621|582960895|FG002|Overall Study|Progressive disease|0|||
161429119|NCT03546621|582960896|FG003|Overall Study|Progressive disease|1|||
161429120|NCT00660192|582960897|FG000|Overall Study|Lost to Follow-up|2|||
161429121|NCT00660192|582960898|FG001|Overall Study|Lost to Follow-up|3|||
161429122|NCT00377520|582960899|FG000|Overall Study|Ineligible (Prior radiation)|1|||
161429123|NCT00982735|582960900|FG000|Overall Study|Lost to Follow-up|6|||
161429124|NCT00982735|582960900|FG000|Overall Study|Patient ineligible for trial|224|||
161429125|NCT00651924|582960903|FG000|Overall Study|Withdrawal by PI|0|||
161429126|NCT00651924|582960904|FG001|Overall Study|Withdrawal by PI|2|||
161429127|NCT00651924|582960903|FG000|Overall Study|Withdrawal by Subject|0|||
161429128|NCT00651924|582960904|FG001|Overall Study|Withdrawal by Subject|5|||
161429129|NCT00758771|582960905|FG000|Overall Study|Withdrawal by Subject|1|||
161429130|NCT00758771|582960906|FG001|Overall Study|Withdrawal by Subject|1|||
161429131|NCT00758771|582960905|FG000|Overall Study|Did not meet eligibility criteria|2|||
161429132|NCT00758771|582960906|FG001|Overall Study|Did not meet eligibility criteria|4|||
161429133|NCT00960063|582960907|FG000|Overall Study|Adverse Event|1|||
161429134|NCT00960063|582960908|FG001|Overall Study|Adverse Event|0|||
161429135|NCT00960063|582960909|FG002|Overall Study|Adverse Event|0|||
161429136|NCT00960063|582960907|FG000|Overall Study|Progression of Disease|0|||
161429137|NCT00960063|582960908|FG001|Overall Study|Progression of Disease|0|||
161429138|NCT00960063|582960909|FG002|Overall Study|Progression of Disease|3|||
161429139|NCT02898454|582960916|FG000|Overall Study|Adverse Event|4|||
161429140|NCT02898454|582960917|FG001|Overall Study|Adverse Event|1|||
161429141|NCT02898454|582960918|FG002|Overall Study|Adverse Event|2|||
161429142|NCT02898454|582960916|FG000|Overall Study|Protocol Violation|1|||
161429143|NCT02898454|582960917|FG001|Overall Study|Protocol Violation|0|||
161429144|NCT02898454|582960918|FG002|Overall Study|Protocol Violation|1|||
161429145|NCT02898454|582960916|FG000|Overall Study|Lack of Efficacy|4|||
161429146|NCT02898454|582960917|FG001|Overall Study|Lack of Efficacy|1|||
161429147|NCT02898454|582960918|FG002|Overall Study|Lack of Efficacy|0|||
161429148|NCT02898454|582960916|FG000|Overall Study|Withdrawal by Subject|6|||
161429149|NCT02898454|582960917|FG001|Overall Study|Withdrawal by Subject|3|||
161429150|NCT02898454|582960918|FG002|Overall Study|Withdrawal by Subject|3|||
161429151|NCT02898454|582960916|FG000|Overall Study|Lost to Follow-up|1|||
161429152|NCT02898454|582960917|FG001|Overall Study|Lost to Follow-up|0|||
161429153|NCT02898454|582960918|FG002|Overall Study|Lost to Follow-up|0|||
161429154|NCT02898454|582960916|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
161429155|NCT02898454|582960917|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
161429156|NCT02898454|582960918|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
161429157|NCT02343263|582960919|FG000|Overall Study|Physician Decision|5|||
161429158|NCT02343263|582960920|FG001|Overall Study|Physician Decision|3|||
161429159|NCT02343263|582960921|FG002|Overall Study|Physician Decision|1|||
161429160|NCT03040141|582960922|FG000|Overall Study|Death|1|||
161429161|NCT03040141|582960923|FG001|Overall Study|Death|2|||
161429162|NCT03040141|582960924|FG002|Overall Study|Death|3|||
161429163|NCT03040141|582960922|FG000|Overall Study|Withdrawal by Subject|3|||
161429164|NCT03040141|582960923|FG001|Overall Study|Withdrawal by Subject|1|||
161429165|NCT03040141|582960924|FG002|Overall Study|Withdrawal by Subject|1|||
161429166|NCT03040141|582960922|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
161429167|NCT03040141|582960923|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
161429168|NCT03040141|582960924|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
161429169|NCT03040141|582960922|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
161429170|NCT03040141|582960923|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
161429171|NCT03040141|582960924|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
161429172|NCT01400698|582960926|FG000|Overall Study|Lost to Follow-up|2|||
161429173|NCT01400698|582960927|FG001|Overall Study|Lost to Follow-up|5|||
161429174|NCT01400698|582960928|FG002|Overall Study|Lost to Follow-up|2|||
161429175|NCT01400698|582960929|FG003|Overall Study|Lost to Follow-up|1|||
161429176|NCT01400698|582960930|FG004|Overall Study|Lost to Follow-up|4|||
161429177|NCT01400698|582960931|FG005|Overall Study|Lost to Follow-up|3|||
161429178|NCT01400698|582960926|FG000|Overall Study|Withdrawal by Subject|8|||
161429179|NCT01400698|582960927|FG001|Overall Study|Withdrawal by Subject|2|||
161429180|NCT01400698|582960928|FG002|Overall Study|Withdrawal by Subject|0|||
161429181|NCT01400698|582960929|FG003|Overall Study|Withdrawal by Subject|4|||
161429182|NCT01400698|582960930|FG004|Overall Study|Withdrawal by Subject|1|||
161429183|NCT01400698|582960931|FG005|Overall Study|Withdrawal by Subject|3|||
161429184|NCT01400698|582960926|FG000|Overall Study|Protocol Violation|0|||
161429185|NCT01400698|582960927|FG001|Overall Study|Protocol Violation|1|||
161429186|NCT01400698|582960928|FG002|Overall Study|Protocol Violation|0|||
161429187|NCT01400698|582960929|FG003|Overall Study|Protocol Violation|0|||
161429188|NCT01400698|582960930|FG004|Overall Study|Protocol Violation|1|||
161429189|NCT01400698|582960931|FG005|Overall Study|Protocol Violation|0|||
161429190|NCT01400698|582960926|FG000|Overall Study|Non-compliance|0|||
161429191|NCT01400698|582960927|FG001|Overall Study|Non-compliance|1|||
161429192|NCT01400698|582960928|FG002|Overall Study|Non-compliance|0|||
161429193|NCT01400698|582960929|FG003|Overall Study|Non-compliance|1|||
161429194|NCT01400698|582960930|FG004|Overall Study|Non-compliance|0|||
161429195|NCT01400698|582960931|FG005|Overall Study|Non-compliance|0|||
161429196|NCT01400698|582960926|FG000|Overall Study|Adverse Event|1|||
161429197|NCT01400698|582960927|FG001|Overall Study|Adverse Event|0|||
161429198|NCT01400698|582960928|FG002|Overall Study|Adverse Event|0|||
161429199|NCT01400698|582960929|FG003|Overall Study|Adverse Event|0|||
161429200|NCT01400698|582960930|FG004|Overall Study|Adverse Event|0|||
161429201|NCT01400698|582960931|FG005|Overall Study|Adverse Event|0|||
161429202|NCT01400698|582960926|FG000|Overall Study|Other|4|||
161429203|NCT01400698|582960927|FG001|Overall Study|Other|2|||
161429204|NCT01400698|582960928|FG002|Overall Study|Other|0|||
161429205|NCT01400698|582960929|FG003|Overall Study|Other|2|||
161429206|NCT01400698|582960930|FG004|Overall Study|Other|1|||
161429207|NCT01400698|582960931|FG005|Overall Study|Other|0|||
161429208|NCT01650194|582960932|FG000|Overall Study|Progressive Disease (PD)|35|||
161429209|NCT01650194|582960932|FG000|Overall Study|Withdrawal by Subject|2|||
161429210|NCT01650194|582960932|FG000|Overall Study|Miscellaneous|10|||
161429211|NCT00633477|582962912|FG000|Overall Study|Death|1|||
161429212|NCT00633477|582962913|FG001|Overall Study|Death|0|||
161429213|NCT00633477|582962912|FG000|Overall Study|Randomized but not treated|1|||
161429214|NCT00633477|582962913|FG001|Overall Study|Randomized but not treated|0|||
161429215|NCT04906499|582962915|FG000|Overall Study|Lack of time|1|||
161429216|NCT00644423|582962916|FG000|Overall Study|Lost to Follow-up|1|||
161429217|NCT00644423|582962917|FG001|Overall Study|Lost to Follow-up|1|||
161429218|NCT03346434|582962918|FG000|Overall Study|Randomized in Error|0|||
161429219|NCT03346434|582962919|FG001|Overall Study|Randomized in Error|0|||
161429220|NCT03346434|582962920|FG002|Overall Study|Randomized in Error|0|||
161429221|NCT03346434|582962921|FG003|Overall Study|Randomized in Error|0|||
161429222|NCT03346434|582962922|FG004|Overall Study|Randomized in Error|1|||
161429223|NCT03346434|582962923|FG005|Overall Study|Randomized in Error|0|||
161429224|NCT03346434|582962918|FG000|Overall Study|Withdrawal by Subject|0|||
161429225|NCT03346434|582962919|FG001|Overall Study|Withdrawal by Subject|0|||
161429226|NCT03346434|582962920|FG002|Overall Study|Withdrawal by Subject|1|||
161429227|NCT03346434|582962921|FG003|Overall Study|Withdrawal by Subject|0|||
161429228|NCT03346434|582962922|FG004|Overall Study|Withdrawal by Subject|1|||
161429229|NCT03346434|582962923|FG005|Overall Study|Withdrawal by Subject|0|||
161429230|NCT03346434|582962918|FG000|Overall Study|Lost to Follow-up|0|||
161429231|NCT03346434|582962919|FG001|Overall Study|Lost to Follow-up|0|||
161429232|NCT03346434|582962920|FG002|Overall Study|Lost to Follow-up|0|||
161429233|NCT03346434|582962921|FG003|Overall Study|Lost to Follow-up|0|||
161429234|NCT03346434|582962922|FG004|Overall Study|Lost to Follow-up|1|||
161429235|NCT03346434|582962923|FG005|Overall Study|Lost to Follow-up|1|||
161429236|NCT03346434|582962918|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
161429237|NCT03346434|582962919|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
161429238|NCT03346434|582962920|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
161429239|NCT03346434|582962921|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
161429240|NCT03346434|582962922|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
161429241|NCT03346434|582962923|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
161429242|NCT03525444|582962924|FG000|Overall Study|Adverse Event|0|||
161429243|NCT03525444|582962925|FG001|Overall Study|Adverse Event|1|||
161429244|NCT03525444|582962924|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161429245|NCT03525444|582962925|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
161429246|NCT03525444|582962924|FG000|Overall Study|Other|0|||
161429247|NCT03525444|582962925|FG001|Overall Study|Other|1|||
161429248|NCT00262860|582962927|FG000|Overall Study|Adverse Event|2|||
161429249|NCT02741128|582962928|FG000|Overall Study|Protocol Violation|4|||
161429250|NCT02741128|582962929|FG001|Overall Study|Protocol Violation|1|||
161429251|NCT02741128|582962928|FG000|Overall Study|Withdrawal by Subject|2|||
161429252|NCT02741128|582962929|FG001|Overall Study|Withdrawal by Subject|0|||
161429253|NCT02741128|582962928|FG000|Overall Study|Lost to Follow-up|1|||
161429254|NCT02741128|582962929|FG001|Overall Study|Lost to Follow-up|0|||
161429255|NCT02081677|582962930|FG000|Overall Study|Adverse Event|0|||
161429256|NCT02081677|582962931|FG001|Overall Study|Adverse Event|0|||
161429257|NCT02081677|582962932|FG002|Overall Study|Adverse Event|1|||
161429258|NCT02081677|582962933|FG003|Overall Study|Adverse Event|0|||
161429259|NCT02081677|582962930|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161429260|NCT02081677|582962931|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161429261|NCT02081677|582962932|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
161429262|NCT02081677|582962933|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161429263|NCT02081677|582962930|FG000|Overall Study|Not comfortable with lens care system|1|||
161429264|NCT02081677|582962931|FG001|Overall Study|Not comfortable with lens care system|0|||
161429265|NCT02081677|582962932|FG002|Overall Study|Not comfortable with lens care system|0|||
161429266|NCT02081677|582962933|FG003|Overall Study|Not comfortable with lens care system|0|||
161429267|NCT02081677|582962930|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
161429268|NCT02081677|582962931|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
161429269|NCT02081677|582962932|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
161429270|NCT02081677|582962933|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
161429271|NCT01419769|582962934|FG000|Overall Study|Did not receive the AXIOS stent|3|||
161429272|NCT01419769|582962934|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
161429273|NCT00878501|582962943|FG000|Overall Study|Adverse Event|11|||
161429274|NCT00878501|582962944|FG001|Overall Study|Adverse Event|3|||
161429275|NCT00878501|582962945|FG002|Overall Study|Adverse Event|3|||
161429276|NCT00878501|582962943|FG000|Overall Study|Lack of Efficacy|2|||
161429277|NCT00878501|582962944|FG001|Overall Study|Lack of Efficacy|1|||
161429278|NCT00878501|582962945|FG002|Overall Study|Lack of Efficacy|0|||
161429279|NCT00878501|582962943|FG000|Overall Study|Withdrawal by Subject|2|||
161429280|NCT00878501|582962944|FG001|Overall Study|Withdrawal by Subject|1|||
161429281|NCT00878501|582962945|FG002|Overall Study|Withdrawal by Subject|2|||
161429282|NCT00878501|582962943|FG000|Overall Study|Protocol Violation|0|||
161429283|NCT00878501|582962944|FG001|Overall Study|Protocol Violation|0|||
161429284|NCT00878501|582962945|FG002|Overall Study|Protocol Violation|1|||
161429285|NCT00878501|582962943|FG000|Overall Study|Incorrect enrolment|1|||
161429286|NCT00878501|582962944|FG001|Overall Study|Incorrect enrolment|2|||
161429287|NCT00878501|582962945|FG002|Overall Study|Incorrect enrolment|0|||
161429288|NCT00878501|582962943|FG000|Overall Study|Intake of prohibited concom. medication|0|||
161429289|NCT00878501|582962944|FG001|Overall Study|Intake of prohibited concom. medication|0|||
161429290|NCT00878501|582962945|FG002|Overall Study|Intake of prohibited concom. medication|1|||
161429291|NCT00878501|582962943|FG000|Overall Study|Mis-randomisation of patient|1|||
161429292|NCT00878501|582962944|FG001|Overall Study|Mis-randomisation of patient|0|||
161429293|NCT00878501|582962945|FG002|Overall Study|Mis-randomisation of patient|0|||
161429294|NCT00878501|582962943|FG000|Overall Study|Administrative|0|||
161429295|NCT00878501|582962944|FG001|Overall Study|Administrative|0|||
161429296|NCT00878501|582962945|FG002|Overall Study|Administrative|1|||
161429297|NCT03224130|582962948|FG000|Overall Study|consent issue|0|||
161429298|NCT03224130|582962949|FG001|Overall Study|consent issue|1|||
161429299|NCT01690052|582962950|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
161429300|NCT01690052|582962951|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
161429301|NCT01453049|582962952|FG000|Overall Study|Protocol Violation|2|||
161429302|NCT01453049|582962953|FG001|Overall Study|Protocol Violation|5|||
161429303|NCT01453049|582962952|FG000|Overall Study|Lost to Follow-up|2|||
161429304|NCT01453049|582962953|FG001|Overall Study|Lost to Follow-up|1|||
161429305|NCT01453049|582962952|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
161429306|NCT01453049|582962953|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
161429307|NCT01453049|582962952|FG000|Overall Study|Withdrawal by Subject|1|||
161429308|NCT01453049|582962953|FG001|Overall Study|Withdrawal by Subject|0|||
161429309|NCT01453049|582962952|FG000|Overall Study|Randomized in Error|1|||
161429310|NCT01453049|582962953|FG001|Overall Study|Randomized in Error|0|||
161429311|NCT02421172|582962954|FG000|Period 1|Adverse Event|1|||
161429312|NCT02421172|582962955|FG001|Period 1|Adverse Event|0|||
161429313|NCT02421172|582962956|FG002|Period 1|Adverse Event|0|||
161429314|NCT02421172|582962957|FG003|Period 1|Adverse Event|0|||
161429315|NCT02421172|582962958|FG004|Period 1|Adverse Event|0|||
161429316|NCT02421172|582962954|FG000|Period 1|Lost to Follow-up|3|||
161429317|NCT02421172|582962955|FG001|Period 1|Lost to Follow-up|1|||
161429318|NCT02421172|582962956|FG002|Period 1|Lost to Follow-up|0|||
161429319|NCT02421172|582962957|FG003|Period 1|Lost to Follow-up|0|||
161429320|NCT02421172|582962958|FG004|Period 1|Lost to Follow-up|0|||
161429321|NCT02421172|582962954|FG000|Period 1|Patient/guardian decision|0|||
161429322|NCT02421172|582962955|FG001|Period 1|Patient/guardian decision|1|||
161429323|NCT02421172|582962956|FG002|Period 1|Patient/guardian decision|0|||
161429324|NCT02421172|582962957|FG003|Period 1|Patient/guardian decision|0|||
161429325|NCT02421172|582962958|FG004|Period 1|Patient/guardian decision|0|||
161429326|NCT02421172|582962954|FG000|Period 2|Adverse Event|0|||
161429327|NCT02421172|582962955|FG001|Period 2|Adverse Event|0|||
161429328|NCT02421172|582962956|FG002|Period 2|Adverse Event|4|||
161429329|NCT02421172|582962957|FG003|Period 2|Adverse Event|0|||
161429330|NCT02421172|582962958|FG004|Period 2|Adverse Event|0|||
161429331|NCT02421172|582962954|FG000|Period 2|Lost to Follow-up|0|||
161429332|NCT02421172|582962955|FG001|Period 2|Lost to Follow-up|0|||
161429333|NCT02421172|582962956|FG002|Period 2|Lost to Follow-up|0|||
161429334|NCT02421172|582962957|FG003|Period 2|Lost to Follow-up|1|||
161429335|NCT02421172|582962958|FG004|Period 2|Lost to Follow-up|0|||
161429336|NCT02421172|582962954|FG000|Period 2|Patient/guardian decision|0|||
161429337|NCT02421172|582962955|FG001|Period 2|Patient/guardian decision|0|||
161429338|NCT02421172|582962956|FG002|Period 2|Patient/guardian decision|3|||
161429339|NCT02421172|582962957|FG003|Period 2|Patient/guardian decision|2|||
161429340|NCT02421172|582962958|FG004|Period 2|Patient/guardian decision|1|||
161429341|NCT00928486|582962959|FG000|Overall Study|Adverse Event|2|||
161429342|NCT00928486|582962959|FG000|Overall Study|Disease Progression|7|||
161429343|NCT00928486|582962959|FG000|Overall Study|Withdrawal by Subject|1|||
161429344|NCT03489863|582962963|FG000|Overall Study|Withdrawal by Subject|0|||
161429345|NCT03489863|582962964|FG001|Overall Study|Withdrawal by Subject|1|||
161429346|NCT01751061|582962965|FG000|Overall Study|Death|1|||
161429347|NCT01751061|582962966|FG001|Overall Study|Death|0|||
161429348|NCT01751061|582962965|FG000|Overall Study|patient death|5|||
161429349|NCT01751061|582962966|FG001|Overall Study|patient death|0|||
161429350|NCT01751061|582962965|FG000|Overall Study|Lost to Follow-up|40|||
161429351|NCT01751061|582962966|FG001|Overall Study|Lost to Follow-up|25|||
161429352|NCT01751061|582962965|FG000|Overall Study|patient regained decisional capacity|4|||
161429353|NCT01751061|582962966|FG001|Overall Study|patient regained decisional capacity|8|||
161429354|NCT01751061|582962965|FG000|Overall Study|Withdrawal by Subject|4|||
161429355|NCT01751061|582962966|FG001|Overall Study|Withdrawal by Subject|1|||
161429356|NCT01751061|582962965|FG000|Overall Study|Physician Decision|2|||
161429357|NCT01751061|582962966|FG001|Overall Study|Physician Decision|0|||
161429358|NCT00768989|582962969|FG000|Prior to Week 24|Withdrawal by Subject|1|||
161429359|NCT00768989|582962970|FG001|Prior to Week 24|Withdrawal by Subject|0|||
161429360|NCT00768989|582962969|FG000|Prior to Week 24|Adverse Event|3|||
161429361|NCT00768989|582962970|FG001|Prior to Week 24|Adverse Event|0|||
161429362|NCT00768989|582962969|FG000|Prior to Week 24|Lost to Follow-up|0|||
161429363|NCT00768989|582962970|FG001|Prior to Week 24|Lost to Follow-up|1|||
161429364|NCT00768989|582962969|FG000|Prior to Week 24|Protocol Violation|0|||
161429365|NCT00768989|582962970|FG001|Prior to Week 24|Protocol Violation|2|||
161429366|NCT00768989|582962969|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
161429367|NCT00768989|582962970|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
161429368|NCT00768989|582962969|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
161429369|NCT00768989|582962970|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
161429370|NCT00768989|582962969|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
161429371|NCT00768989|582962970|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
161429372|NCT00768989|582962969|FG000|On or After Week 36|Lack of Efficacy|1|||
161429373|NCT00768989|582962970|FG001|On or After Week 36|Lack of Efficacy|0|||
161429374|NCT00768989|582962969|FG000|On or After Week 36|Adverse Event|0|||
161429375|NCT00768989|582962970|FG001|On or After Week 36|Adverse Event|1|||
161429376|NCT00768989|582962969|FG000|On or After Week 36|Lost to Follow-up|1|||
161429377|NCT00768989|582962970|FG001|On or After Week 36|Lost to Follow-up|0|||
161429378|NCT00768989|582962969|FG000|On or After Week 36|Poor Compliance|1|||
161429379|NCT00768989|582962970|FG001|On or After Week 36|Poor Compliance|0|||
161429380|NCT00768989|582962969|FG000|On or After Week 36|Protocol Violation|1|||
161429381|NCT00768989|582962970|FG001|On or After Week 36|Protocol Violation|0|||
161429382|NCT00768989|582962969|FG000|On or After Week 36|Did not attend termination visit|2|||
161429383|NCT00768989|582962970|FG001|On or After Week 36|Did not attend termination visit|0|||
161429384|NCT00768989|582962969|FG000|On or After Week 36|Sponsor Termination|45|||
161429385|NCT00768989|582962970|FG001|On or After Week 36|Sponsor Termination|26|||
161429386|NCT02153086|582962971|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
161429387|NCT02153086|582962971|FG000|Overall Study|Other|2|||
161429388|NCT01194830|582962972|FG000|Overall Study|Adverse Event|3|||
161429389|NCT01194830|582962973|FG001|Overall Study|Adverse Event|2|||
161429390|NCT01194830|582962972|FG000|Overall Study|Protocol Violation|5|||
161429391|NCT01194830|582962973|FG001|Overall Study|Protocol Violation|4|||
161429392|NCT01194830|582962972|FG000|Overall Study|Lost to Follow-up|9|||
161429393|NCT01194830|582962973|FG001|Overall Study|Lost to Follow-up|7|||
161429394|NCT01194830|582962972|FG000|Overall Study|Withdrawal by Subject|2|||
161429395|NCT01194830|582962973|FG001|Overall Study|Withdrawal by Subject|1|||
161429396|NCT01194830|582962972|FG000|Overall Study|Lack of Efficacy|1|||
161429397|NCT01194830|582962973|FG001|Overall Study|Lack of Efficacy|1|||
161429398|NCT01194830|582962972|FG000|Overall Study|Non-compliance issues|4|||
161429399|NCT01194830|582962973|FG001|Overall Study|Non-compliance issues|4|||
161429400|NCT01194830|582962972|FG000|Overall Study|Other Reason|12|||
161429401|NCT01194830|582962973|FG001|Overall Study|Other Reason|8|||
161429402|NCT03115359|582962974|FG000|Overall Study|Withdrawal by Subject|29|||
161429403|NCT03115359|582962975|FG001|Overall Study|Withdrawal by Subject|39|||
161429404|NCT03115359|582962974|FG000|Overall Study|Scheduling conflict|25|||
161429405|NCT03115359|582962975|FG001|Overall Study|Scheduling conflict|23|||
161429406|NCT03115359|582962974|FG000|Overall Study|Personal reasons including health|12|||
161429407|NCT03115359|582962975|FG001|Overall Study|Personal reasons including health|9|||
161429408|NCT03115359|582962974|FG000|Overall Study|Transportation barriers|3|||
161429409|NCT03115359|582962975|FG001|Overall Study|Transportation barriers|0|||
161429410|NCT03115359|582962974|FG000|Overall Study|No longer interested|5|||
161429411|NCT03115359|582962975|FG001|Overall Study|No longer interested|4|||
161429412|NCT03115359|582962974|FG000|Overall Study|No reason provided|45|||
161429413|NCT03115359|582962975|FG001|Overall Study|No reason provided|47|||
161429414|NCT01815918|582962976|FG000|Overall Study|Patient samples not analyzable|3|||
161429415|NCT01815918|582962977|FG001|Overall Study|Patient samples not analyzable|4|||
161429416|NCT01815918|582962976|FG000|Overall Study|Lack of Efficacy|15|||
161429417|NCT01815918|582962977|FG001|Overall Study|Lack of Efficacy|15|||
161429418|NCT02412306|582962980|FG000|Overall Study|Lost to Follow-up|0|||
161429419|NCT02412306|582962981|FG001|Overall Study|Lost to Follow-up|1|||
161429420|NCT02412306|582962982|FG002|Overall Study|Lost to Follow-up|0|||
161429421|NCT02412306|582962983|FG003|Overall Study|Lost to Follow-up|0|||
161429422|NCT02412306|582962984|FG004|Overall Study|Lost to Follow-up|0|||
161429423|NCT02412306|582962980|FG000|Overall Study|Withdrawal by Subject|0|||
161429424|NCT02412306|582962981|FG001|Overall Study|Withdrawal by Subject|0|||
161429425|NCT02412306|582962982|FG002|Overall Study|Withdrawal by Subject|1|||
161429426|NCT02412306|582962983|FG003|Overall Study|Withdrawal by Subject|0|||
161429427|NCT02412306|582962984|FG004|Overall Study|Withdrawal by Subject|0|||
161429428|NCT02412306|582962980|FG000|Overall Study|Death|5|||
161429429|NCT02412306|582962981|FG001|Overall Study|Death|7|||
161429430|NCT02412306|582962982|FG002|Overall Study|Death|15|||
161429431|NCT02412306|582962983|FG003|Overall Study|Death|0|||
161429432|NCT02412306|582962984|FG004|Overall Study|Death|2|||
161429433|NCT00866177|582962987|FG000|Overall Study|Withdrawal by Subject|1|||
161429434|NCT00866177|582962987|FG000|Overall Study|Not Treated|151|||
161429435|NCT05635461|582962988|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
161429436|NCT05635461|582962989|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
161429437|NCT05635461|582962990|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
161429438|NCT05635461|582962991|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
161429439|NCT05635461|582962992|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
161429440|NCT05635461|582962993|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
161429441|NCT05635461|582962988|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
161429442|NCT05635461|582962989|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
161429443|NCT05635461|582962990|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
161429444|NCT05635461|582962991|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
161429445|NCT05635461|582962992|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
161429446|NCT05635461|582962993|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
161429447|NCT05635461|582962988|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
161429448|NCT05635461|582962989|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
161429449|NCT05635461|582962990|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
161429450|NCT05635461|582962991|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
161429451|NCT05635461|582962992|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
161429452|NCT05635461|582962993|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
161429453|NCT03661723|582962994|FG000|Overall Study|Disease Progression|4|||
161429454|NCT03661723|582962995|FG001|Overall Study|Disease Progression|24|||
161429455|NCT03661723|582962996|FG002|Overall Study|Disease Progression|4|||
161429456|NCT03661723|582962997|FG003|Overall Study|Disease Progression|19|||
161429457|NCT03661723|582962994|FG000|Overall Study|Withdrawal by Subject|1|||
161429458|NCT03661723|582962995|FG001|Overall Study|Withdrawal by Subject|0|||
161429459|NCT03661723|582962996|FG002|Overall Study|Withdrawal by Subject|2|||
161429460|NCT03661723|582962997|FG003|Overall Study|Withdrawal by Subject|4|||
161429461|NCT03661723|582962994|FG000|Overall Study|Physician Decision|1|||
161429462|NCT03661723|582962995|FG001|Overall Study|Physician Decision|0|||
161429463|NCT03661723|582962996|FG002|Overall Study|Physician Decision|0|||
161429464|NCT03661723|582962997|FG003|Overall Study|Physician Decision|0|||
161429465|NCT03661723|582962994|FG000|Overall Study|Clinical Deterioration|0|||
161429466|NCT03661723|582962995|FG001|Overall Study|Clinical Deterioration|0|||
161429467|NCT03661723|582962996|FG002|Overall Study|Clinical Deterioration|0|||
161429468|NCT03661723|582962997|FG003|Overall Study|Clinical Deterioration|1|||
161429469|NCT00807911|582963002|FG000|Overall Study|Withdrawal by Subject|12|||
161429470|NCT00807911|582963003|FG001|Overall Study|Withdrawal by Subject|10|||
161429471|NCT00807911|582963002|FG000|Overall Study|Ineligible|0|||
161429472|NCT00807911|582963003|FG001|Overall Study|Ineligible|4|||
161429473|NCT02648204|582963008|FG000|Overall Study|Withdrawal by Subject|12|||
161429474|NCT02648204|582963009|FG001|Overall Study|Withdrawal by Subject|8|||
161429475|NCT02648204|582963010|FG002|Overall Study|Withdrawal by Subject|2|||
161429476|NCT02648204|582963011|FG003|Overall Study|Withdrawal by Subject|6|||
161429477|NCT02648204|582963008|FG000|Overall Study|Lost to Follow-up|5|||
161429478|NCT02648204|582963009|FG001|Overall Study|Lost to Follow-up|8|||
161429479|NCT02648204|582963010|FG002|Overall Study|Lost to Follow-up|4|||
161429480|NCT02648204|582963011|FG003|Overall Study|Lost to Follow-up|6|||
161429481|NCT02648204|582963008|FG000|Overall Study|Missing follow-up information|4|||
161429482|NCT02648204|582963009|FG001|Overall Study|Missing follow-up information|4|||
161429483|NCT02648204|582963010|FG002|Overall Study|Missing follow-up information|4|||
161429484|NCT02648204|582963011|FG003|Overall Study|Missing follow-up information|2|||
161429485|NCT02648204|582963008|FG000|Overall Study|Death|1|||
161429486|NCT02648204|582963009|FG001|Overall Study|Death|1|||
161429487|NCT02648204|582963010|FG002|Overall Study|Death|2|||
161429488|NCT02648204|582963011|FG003|Overall Study|Death|2|||
161429489|NCT02648204|582963008|FG000|Overall Study|Adverse Event|0|||
161429490|NCT02648204|582963009|FG001|Overall Study|Adverse Event|0|||
161429491|NCT02648204|582963010|FG002|Overall Study|Adverse Event|1|||
161429492|NCT02648204|582963011|FG003|Overall Study|Adverse Event|0|||
161429493|NCT03532542|582963012|FG000|Overall Study|Death|1|||
161429494|NCT03532542|582963013|FG001|Overall Study|Death|0|||
161429495|NCT03532542|582963012|FG000|Overall Study|Study Terminated by Sponsor|41|||
161429496|NCT03532542|582963013|FG001|Overall Study|Study Terminated by Sponsor|65|||
161429497|NCT03532542|582963012|FG000|Overall Study|Withdrawal by Subject|6|||
161429498|NCT03532542|582963013|FG001|Overall Study|Withdrawal by Subject|5|||
161429499|NCT00614575|582963014|FG000|Overall Study|Adverse Event|106|||
161429500|NCT00614575|582963014|FG000|Overall Study|Lost to Follow-up|55|||
161429501|NCT00614575|582963014|FG000|Overall Study|Lack of Efficacy|14|||
161429502|NCT00614575|582963014|FG000|Overall Study|Withdrawal by Subject|6|||
161429503|NCT00614575|582963014|FG000|Overall Study|Death|3|||
161429504|NCT00614575|582963014|FG000|Overall Study|Physician Decision|2|||
161429505|NCT00614575|582963014|FG000|Overall Study|No data were collected.|18|||
161429506|NCT00614575|582963014|FG000|Overall Study|Irregularly enrolled patients|23|||
161429507|NCT00614575|582963014|FG000|Overall Study|No treatment|1|||
161429508|NCT00472108|582963015|FG000|Overall Study|Lost to Follow-up|0|||
161429509|NCT00472108|582963016|FG001|Overall Study|Lost to Follow-up|1|||
161429510|NCT00189540|582963017|FG000|Overall Study|Withdrawal by Subject|3|||
161429511|NCT00189540|582963018|FG001|Overall Study|Withdrawal by Subject|0|||
161429512|NCT00189540|582963017|FG000|Overall Study|Death|4|||
161429513|NCT00189540|582963018|FG001|Overall Study|Death|1|||
161429514|NCT03882021|582963019|FG000|Enrollment|Procedure aborted/cancelled|2|||
161429515|NCT03882021|582963019|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
161429516|NCT03882021|582963019|FG000|Enrollment to 3-Month|Death|1|||
161429517|NCT03882021|582963019|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
161429518|NCT03882021|582963019|FG000|Enrollment to 3-Month|Missed Visit|4|||
161429519|NCT03882021|582963019|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
161429520|NCT03882021|582963019|FG000|6-Month to 12-Month Visit|Death|1|||
161429521|NCT03882021|582963019|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
161429522|NCT00286442|582963020|FG000|Overall Study|Hyperglycemic Rescue|19|||
161429523|NCT00286442|582963021|FG001|Overall Study|Hyperglycemic Rescue|17|||
161429524|NCT00286442|582963022|FG002|Overall Study|Hyperglycemic Rescue|25|||
161429525|NCT00286442|582963020|FG000|Overall Study|Adverse Event|7|||
161429526|NCT00286442|582963021|FG001|Overall Study|Adverse Event|6|||
161429527|NCT00286442|582963022|FG002|Overall Study|Adverse Event|1|||
161429528|NCT00286442|582963020|FG000|Overall Study|Protocol Violation|2|||
161429529|NCT00286442|582963021|FG001|Overall Study|Protocol Violation|4|||
161429530|NCT00286442|582963022|FG002|Overall Study|Protocol Violation|2|||
161429531|NCT00286442|582963020|FG000|Overall Study|Lost to Follow-up|5|||
161429532|NCT00286442|582963021|FG001|Overall Study|Lost to Follow-up|2|||
161429533|NCT00286442|582963022|FG002|Overall Study|Lost to Follow-up|1|||
161429534|NCT00286442|582963020|FG000|Overall Study|Physician Decision|1|||
161429535|NCT00286442|582963021|FG001|Overall Study|Physician Decision|1|||
161429536|NCT00286442|582963022|FG002|Overall Study|Physician Decision|1|||
161429537|NCT00286442|582963020|FG000|Overall Study|Administrative Error|1|||
161429538|NCT00286442|582963021|FG001|Overall Study|Administrative Error|1|||
161429539|NCT00286442|582963022|FG002|Overall Study|Administrative Error|0|||
161429540|NCT00286442|582963020|FG000|Overall Study|Withdrawal by Subject|2|||
161429541|NCT00286442|582963021|FG001|Overall Study|Withdrawal by Subject|14|||
161429542|NCT00286442|582963022|FG002|Overall Study|Withdrawal by Subject|2|||
161429543|NCT03582215|582963025|FG000|Overall Study|Adverse Event|1|||
161429544|NCT03582215|582963026|FG001|Overall Study|Adverse Event|0|||
161429545|NCT03582215|582963027|FG002|Overall Study|Adverse Event|0|||
161429546|NCT03582215|582963028|FG003|Overall Study|Adverse Event|0|||
161429547|NCT03582215|582963029|FG004|Overall Study|Adverse Event|0|||
161429548|NCT03582215|582963030|FG005|Overall Study|Adverse Event|0|||
161429549|NCT03582215|582963031|FG006|Overall Study|Adverse Event|2|||
161429550|NCT03582215|582963032|FG007|Overall Study|Adverse Event|2|||
161429551|NCT02174731|582963033|FG000|Overall Study|Participant decision|67|||
161429552|NCT02174731|582963034|FG001|Overall Study|Participant decision|64|||
161429553|NCT02174731|582963033|FG000|Overall Study|Incorrect enrolment before randomization|0|||
161429554|NCT02174731|582963034|FG001|Overall Study|Incorrect enrolment before randomization|1|||
161429555|NCT02174731|582963033|FG000|Overall Study|Missing|2|||
161429556|NCT02174731|582963034|FG001|Overall Study|Missing|0|||
161429557|NCT00079040|582963035|FG000|Overall Study|Withdrew before treatment|1|||
161429558|NCT00079040|582963035|FG000|Overall Study|Ineligible|1|||
161429559|NCT01046565|582963053|FG000|Overall Study|Adverse Event|2|||
161429560|NCT01046565|582963053|FG000|Overall Study|Withdrawal by Subject|7|||
161429561|NCT03740048|582963054|FG000|Overall Study|Withdrawal by Subject|1|||
161429562|NCT03740048|582963055|FG001|Overall Study|Withdrawal by Subject|1|||
161429563|NCT03740048|582963054|FG000|Overall Study|Death|1|||
161429564|NCT03740048|582963055|FG001|Overall Study|Death|6|||
161429565|NCT03740048|582963054|FG000|Overall Study|Switched to thrice-weekly HD|2|||
161429566|NCT03740048|582963055|FG001|Overall Study|Switched to thrice-weekly HD|0|||
161429567|NCT03740048|582963054|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
161429568|NCT03740048|582963055|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
161429569|NCT03740048|582963054|FG000|Overall Study|Lost to Follow-up|0|||
161429570|NCT03740048|582963055|FG001|Overall Study|Lost to Follow-up|1|||
161429571|NCT03740048|582963054|FG000|Overall Study|Non-compliance with HD|0|||
161429572|NCT03740048|582963055|FG001|Overall Study|Non-compliance with HD|1|||
161429573|NCT03261336|582963056|FG000|Overall Study|Adverse Event|1|||
161429574|NCT01069484|582963057|FG000|Overall Study|Death-in-near-family|1|||
161429575|NCT01069484|582963058|FG001|Overall Study|Death-in-near-family|0|||
161429576|NCT01069484|582963057|FG000|Overall Study|No specific reason|8|||
161429577|NCT01069484|582963058|FG001|Overall Study|No specific reason|2|||
161429578|NCT01069484|582963057|FG000|Overall Study|Illness mother or child|3|||
161429579|NCT01069484|582963058|FG001|Overall Study|Illness mother or child|1|||
161429580|NCT00292942|582963059|FG000|Overall Study|Withdrawal by Subject|0|||
161429581|NCT00292942|582963060|FG001|Overall Study|Withdrawal by Subject|0|||
161429582|NCT00292942|582963061|FG002|Overall Study|Withdrawal by Subject|1|||
161429583|NCT00292942|582963062|FG003|Overall Study|Withdrawal by Subject|0|||
161429584|NCT00292942|582963059|FG000|Overall Study|Adverse Event|0|||
161429585|NCT00292942|582963060|FG001|Overall Study|Adverse Event|0|||
161429586|NCT00292942|582963061|FG002|Overall Study|Adverse Event|0|||
161429587|NCT00292942|582963062|FG003|Overall Study|Adverse Event|1|||
161429588|NCT00644358|582963063|FG000|Overall Study|Adverse Event|124|||
161429589|NCT00644358|582963063|FG000|Overall Study|Lost to Follow-up|105|||
161429590|NCT00644358|582963063|FG000|Overall Study|Consent Withdrawal|64|||
161429591|NCT00644358|582963063|FG000|Overall Study|Lack of Effectiveness|39|||
161429592|NCT00644358|582963063|FG000|Overall Study|Protocol Violation|5|||
161429593|NCT00644358|582963063|FG000|Overall Study|Noncompliance|14|||
161429594|NCT00644358|582963063|FG000|Overall Study|Other Unspecified|11|||
161429595|NCT01290523|582963066|FG000|Overall Study|Death|3|||
161429596|NCT04158583|582963069|FG000|Overall Study|Withdrawal by Subject|1|||
161429597|NCT04158583|582963070|FG001|Overall Study|Withdrawal by Subject|1|||
161429598|NCT04158583|582963071|FG002|Overall Study|Withdrawal by Subject|0|||
161429599|NCT04158583|582963072|FG003|Overall Study|Withdrawal by Subject|0|||
161429600|NCT04158583|582963073|FG004|Overall Study|Withdrawal by Subject|1|||
161429601|NCT04158583|582963074|FG005|Overall Study|Withdrawal by Subject|0|||
161429602|NCT04158583|582963075|FG006|Overall Study|Withdrawal by Subject|0|||
161429603|NCT04158583|582963076|FG007|Overall Study|Withdrawal by Subject|0|||
161429604|NCT04158583|582963077|FG008|Overall Study|Withdrawal by Subject|2|||
161429605|NCT04158583|582963078|FG009|Overall Study|Withdrawal by Subject|0|||
161429606|NCT04158583|582963069|FG000|Overall Study|Study Terminated by Sponsor|0|||
161429607|NCT04158583|582963070|FG001|Overall Study|Study Terminated by Sponsor|0|||
161429608|NCT04158583|582963071|FG002|Overall Study|Study Terminated by Sponsor|0|||
161429609|NCT04158583|582963072|FG003|Overall Study|Study Terminated by Sponsor|1|||
161429610|NCT04158583|582963073|FG004|Overall Study|Study Terminated by Sponsor|0|||
161429611|NCT04158583|582963074|FG005|Overall Study|Study Terminated by Sponsor|0|||
161429612|NCT04158583|582963075|FG006|Overall Study|Study Terminated by Sponsor|0|||
161429613|NCT04158583|582963076|FG007|Overall Study|Study Terminated by Sponsor|0|||
161429614|NCT04158583|582963077|FG008|Overall Study|Study Terminated by Sponsor|0|||
161429615|NCT04158583|582963078|FG009|Overall Study|Study Terminated by Sponsor|0|||
161429616|NCT04158583|582963069|FG000|Overall Study|Progressive Disease|1|||
161429617|NCT04158583|582963070|FG001|Overall Study|Progressive Disease|0|||
161429618|NCT04158583|582963071|FG002|Overall Study|Progressive Disease|3|||
161429619|NCT04158583|582963072|FG003|Overall Study|Progressive Disease|5|||
161429620|NCT04158583|582963073|FG004|Overall Study|Progressive Disease|0|||
161429621|NCT04158583|582963074|FG005|Overall Study|Progressive Disease|1|||
161429622|NCT04158583|582963075|FG006|Overall Study|Progressive Disease|6|||
161429623|NCT04158583|582963076|FG007|Overall Study|Progressive Disease|2|||
161429624|NCT04158583|582963077|FG008|Overall Study|Progressive Disease|1|||
161429625|NCT04158583|582963078|FG009|Overall Study|Progressive Disease|2|||
161429626|NCT04158583|582963069|FG000|Overall Study|Lost to Follow-up|0|||
161429627|NCT04158583|582963070|FG001|Overall Study|Lost to Follow-up|0|||
161429628|NCT04158583|582963071|FG002|Overall Study|Lost to Follow-up|1|||
161429629|NCT04158583|582963072|FG003|Overall Study|Lost to Follow-up|1|||
161429630|NCT04158583|582963073|FG004|Overall Study|Lost to Follow-up|1|||
161429631|NCT04158583|582963074|FG005|Overall Study|Lost to Follow-up|0|||
161429632|NCT04158583|582963075|FG006|Overall Study|Lost to Follow-up|0|||
161429633|NCT04158583|582963076|FG007|Overall Study|Lost to Follow-up|0|||
161429634|NCT04158583|582963077|FG008|Overall Study|Lost to Follow-up|0|||
161429635|NCT04158583|582963078|FG009|Overall Study|Lost to Follow-up|0|||
161429636|NCT04158583|582963069|FG000|Overall Study|Due To Patient Status|0|||
161429637|NCT04158583|582963070|FG001|Overall Study|Due To Patient Status|0|||
161429638|NCT04158583|582963071|FG002|Overall Study|Due To Patient Status|0|||
161429639|NCT04158583|582963072|FG003|Overall Study|Due To Patient Status|0|||
161429640|NCT04158583|582963073|FG004|Overall Study|Due To Patient Status|0|||
161429641|NCT04158583|582963074|FG005|Overall Study|Due To Patient Status|0|||
161429642|NCT04158583|582963075|FG006|Overall Study|Due To Patient Status|0|||
161429643|NCT04158583|582963076|FG007|Overall Study|Due To Patient Status|0|||
161429644|NCT04158583|582963077|FG008|Overall Study|Due To Patient Status|1|||
161429645|NCT04158583|582963078|FG009|Overall Study|Due To Patient Status|0|||
161429646|NCT04158583|582963069|FG000|Overall Study|Death|3|||
161429647|NCT04158583|582963070|FG001|Overall Study|Death|4|||
161429648|NCT04158583|582963071|FG002|Overall Study|Death|2|||
161429649|NCT04158583|582963072|FG003|Overall Study|Death|2|||
161429650|NCT04158583|582963073|FG004|Overall Study|Death|4|||
161429651|NCT04158583|582963074|FG005|Overall Study|Death|3|||
161429652|NCT04158583|582963075|FG006|Overall Study|Death|5|||
161429653|NCT04158583|582963076|FG007|Overall Study|Death|2|||
161429654|NCT04158583|582963077|FG008|Overall Study|Death|0|||
161429655|NCT04158583|582963078|FG009|Overall Study|Death|1|||
161429656|NCT04158583|582963069|FG000|Overall Study|Clinical Progression Disease|0|||
161429657|NCT04158583|582963070|FG001|Overall Study|Clinical Progression Disease|0|||
161429658|NCT04158583|582963071|FG002|Overall Study|Clinical Progression Disease|0|||
161429659|NCT04158583|582963072|FG003|Overall Study|Clinical Progression Disease|1|||
161429660|NCT04158583|582963073|FG004|Overall Study|Clinical Progression Disease|0|||
161429661|NCT04158583|582963074|FG005|Overall Study|Clinical Progression Disease|0|||
161429662|NCT04158583|582963075|FG006|Overall Study|Clinical Progression Disease|0|||
161429663|NCT04158583|582963076|FG007|Overall Study|Clinical Progression Disease|0|||
161429664|NCT04158583|582963077|FG008|Overall Study|Clinical Progression Disease|0|||
161429665|NCT04158583|582963078|FG009|Overall Study|Clinical Progression Disease|0|||
161429666|NCT04158583|582963069|FG000|Overall Study|Clinical Progression|0|||
161429667|NCT04158583|582963070|FG001|Overall Study|Clinical Progression|0|||
161429668|NCT04158583|582963071|FG002|Overall Study|Clinical Progression|0|||
161429669|NCT04158583|582963072|FG003|Overall Study|Clinical Progression|0|||
161429670|NCT04158583|582963073|FG004|Overall Study|Clinical Progression|1|||
161429671|NCT04158583|582963074|FG005|Overall Study|Clinical Progression|0|||
161429672|NCT04158583|582963075|FG006|Overall Study|Clinical Progression|2|||
161429673|NCT04158583|582963076|FG007|Overall Study|Clinical Progression|0|||
161429674|NCT04158583|582963077|FG008|Overall Study|Clinical Progression|0|||
161429675|NCT04158583|582963078|FG009|Overall Study|Clinical Progression|0|||
161429676|NCT04158583|582963069|FG000|Overall Study|Clinical Deterioration|0|||
161429677|NCT04158583|582963070|FG001|Overall Study|Clinical Deterioration|0|||
161429678|NCT04158583|582963071|FG002|Overall Study|Clinical Deterioration|0|||
161429679|NCT04158583|582963072|FG003|Overall Study|Clinical Deterioration|1|||
161429680|NCT04158583|582963073|FG004|Overall Study|Clinical Deterioration|0|||
161429681|NCT04158583|582963074|FG005|Overall Study|Clinical Deterioration|0|||
161429682|NCT04158583|582963075|FG006|Overall Study|Clinical Deterioration|0|||
161429683|NCT04158583|582963076|FG007|Overall Study|Clinical Deterioration|0|||
161429684|NCT04158583|582963077|FG008|Overall Study|Clinical Deterioration|0|||
161429685|NCT04158583|582963078|FG009|Overall Study|Clinical Deterioration|1|||
161429686|NCT01602224|582964742|FG000|Overall Study|Adverse Event|0|||
161429687|NCT01602224|582964743|FG001|Overall Study|Adverse Event|1|||
161429688|NCT01602224|582964744|FG002|Overall Study|Adverse Event|0|||
161429689|NCT01602224|582964742|FG000|Overall Study|Investigator Decison|1|||
161429690|NCT01602224|582964743|FG001|Overall Study|Investigator Decison|0|||
161429691|NCT01602224|582964744|FG002|Overall Study|Investigator Decison|0|||
161429692|NCT01602224|582964742|FG000|Overall Study|Lost to Follow-up|0|||
161429693|NCT01602224|582964743|FG001|Overall Study|Lost to Follow-up|0|||
161429694|NCT01602224|582964744|FG002|Overall Study|Lost to Follow-up|1|||
161429695|NCT01602224|582964742|FG000|Overall Study|Protocol Violation|0|||
161429696|NCT01602224|582964743|FG001|Overall Study|Protocol Violation|1|||
161429697|NCT01602224|582964744|FG002|Overall Study|Protocol Violation|0|||
161429698|NCT01602224|582964742|FG000|Overall Study|Sponsor Decision|2|||
161429699|NCT01602224|582964743|FG001|Overall Study|Sponsor Decision|3|||
161429700|NCT01602224|582964744|FG002|Overall Study|Sponsor Decision|2|||
161429701|NCT01602224|582964742|FG000|Overall Study|Withdrawal by Subject|5|||
161429702|NCT01602224|582964743|FG001|Overall Study|Withdrawal by Subject|3|||
161429703|NCT01602224|582964744|FG002|Overall Study|Withdrawal by Subject|3|||
161429704|NCT01352117|582964745|FG000|Overall Study|Death|15|||
161429705|NCT01352117|582964746|FG001|Overall Study|Death|16|||
161429706|NCT01352117|582964745|FG000|Overall Study|Withdrawal by Subject|1|||
161429707|NCT01352117|582964746|FG001|Overall Study|Withdrawal by Subject|0|||
161429708|NCT01352117|582964745|FG000|Overall Study|Lost to Follow-up|2|||
161429709|NCT01352117|582964746|FG001|Overall Study|Lost to Follow-up|7|||
161429710|NCT01352117|582964745|FG000|Overall Study|Non-adherent to study requirements|1|||
161429711|NCT01352117|582964746|FG001|Overall Study|Non-adherent to study requirements|1|||
161429712|NCT01352117|582964745|FG000|Overall Study|Did not initiate study treatment|1|||
161429713|NCT01352117|582964746|FG001|Overall Study|Did not initiate study treatment|0|||
161429714|NCT01352117|582964745|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
161429715|NCT01352117|582964746|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
161429716|NCT01317472|582964755|FG000|Overall Study|Withdrawal by Subject|1|||
161429717|NCT01317472|582964756|FG001|Overall Study|Withdrawal by Subject|0|||
161429718|NCT01317472|582964755|FG000|Overall Study|Unrelated hospitalization|1|||
161429719|NCT01317472|582964756|FG001|Overall Study|Unrelated hospitalization|0|||
161429720|NCT03585660|582964765|FG000|Overall Study|operator error|1|||
161429721|NCT03585660|582964765|FG000|Overall Study|technical error|2|||
161429722|NCT03585660|582964765|FG000|Overall Study|hip prosthesis|2|||
161429723|NCT03585660|582964765|FG000|Overall Study|did not undergo biopsy|8|||
161429724|NCT03585660|582964765|FG000|Overall Study|scanner problem|2|||
161429725|NCT04349891|582964770|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
161429726|NCT04349891|582964771|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
161429727|NCT04349891|582964770|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
161429728|NCT04349891|582964771|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
161429729|NCT04349891|582964770|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
161429730|NCT04349891|582964771|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
161429731|NCT04349891|582964770|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
161429732|NCT04349891|582964771|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
161429733|NCT01018030|582964774|FG000|Overall Study|Adverse Event|10|||
161429734|NCT01018030|582964775|FG001|Overall Study|Adverse Event|5|||
161429735|NCT01018030|582964776|FG002|Overall Study|Adverse Event|5|||
161429736|NCT01018030|582964774|FG000|Overall Study|Withdrawal by Subject|2|||
161429737|NCT01018030|582964775|FG001|Overall Study|Withdrawal by Subject|2|||
161429738|NCT01018030|582964776|FG002|Overall Study|Withdrawal by Subject|4|||
161429739|NCT01018030|582964774|FG000|Overall Study|Lost to Follow-up|2|||
161429740|NCT01018030|582964775|FG001|Overall Study|Lost to Follow-up|0|||
161429741|NCT01018030|582964776|FG002|Overall Study|Lost to Follow-up|3|||
161429742|NCT01018030|582964774|FG000|Overall Study|Protocol Violation|2|||
161429743|NCT01018030|582964775|FG001|Overall Study|Protocol Violation|1|||
161429744|NCT01018030|582964776|FG002|Overall Study|Protocol Violation|0|||
161429745|NCT01018030|582964774|FG000|Overall Study|Physician Decision|1|||
161429746|NCT01018030|582964775|FG001|Overall Study|Physician Decision|0|||
161429747|NCT01018030|582964776|FG002|Overall Study|Physician Decision|1|||
161429748|NCT01018030|582964774|FG000|Overall Study|Lack of Efficacy|1|||
161429749|NCT01018030|582964775|FG001|Overall Study|Lack of Efficacy|0|||
161429750|NCT01018030|582964776|FG002|Overall Study|Lack of Efficacy|0|||
161429751|NCT01018030|582964774|FG000|Overall Study|Did Not Receive Study Drug|1|||
161429752|NCT01018030|582964775|FG001|Overall Study|Did Not Receive Study Drug|3|||
161429753|NCT01018030|582964776|FG002|Overall Study|Did Not Receive Study Drug|0|||
161429754|NCT02399215|582964787|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
161429755|NCT02399215|582964787|FG000|Overall Study|Withdrawal by Subject|1|||
161429756|NCT01903356|582964790|FG000|Overall Study|Lost to Follow-up|7|||
161429757|NCT01903356|582964790|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
161429758|NCT01903356|582964790|FG000|Overall Study|Violated the dosage and administration|3|||
161429759|NCT00713609|582964791|FG000|Overall Study|Adverse Event|2|||
161429760|NCT00713609|582964792|FG001|Overall Study|Adverse Event|0|||
161429761|NCT00713609|582964793|FG002|Overall Study|Adverse Event|2|||
161429762|NCT00713609|582964794|FG003|Overall Study|Adverse Event|2|||
161429763|NCT00713609|582964795|FG004|Overall Study|Adverse Event|3|||
161429764|NCT00713609|582964796|FG005|Overall Study|Adverse Event|1|||
161429765|NCT00713609|582964791|FG000|Overall Study|Lost to Follow-up|5|||
161429766|NCT00713609|582964792|FG001|Overall Study|Lost to Follow-up|7|||
161429767|NCT00713609|582964793|FG002|Overall Study|Lost to Follow-up|5|||
161429768|NCT00713609|582964794|FG003|Overall Study|Lost to Follow-up|5|||
161429769|NCT00713609|582964795|FG004|Overall Study|Lost to Follow-up|7|||
161429770|NCT00713609|582964796|FG005|Overall Study|Lost to Follow-up|0|||
161429771|NCT00713609|582964791|FG000|Overall Study|Lack of Efficacy|1|||
161429772|NCT00713609|582964792|FG001|Overall Study|Lack of Efficacy|3|||
161429773|NCT00713609|582964793|FG002|Overall Study|Lack of Efficacy|0|||
161429774|NCT00713609|582964794|FG003|Overall Study|Lack of Efficacy|0|||
161429775|NCT00713609|582964795|FG004|Overall Study|Lack of Efficacy|1|||
161429776|NCT00713609|582964796|FG005|Overall Study|Lack of Efficacy|0|||
161429777|NCT00713609|582964791|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
161429778|NCT00713609|582964792|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
161429779|NCT00713609|582964793|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
161429780|NCT00713609|582964794|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
161429781|NCT00713609|582964795|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
161429782|NCT00713609|582964796|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
161429783|NCT00713609|582964791|FG000|Overall Study|Withdrawal by Subject|6|||
161429784|NCT00713609|582964792|FG001|Overall Study|Withdrawal by Subject|1|||
161429785|NCT00713609|582964793|FG002|Overall Study|Withdrawal by Subject|5|||
161429786|NCT00713609|582964794|FG003|Overall Study|Withdrawal by Subject|1|||
161429787|NCT00713609|582964795|FG004|Overall Study|Withdrawal by Subject|5|||
161429788|NCT00713609|582964796|FG005|Overall Study|Withdrawal by Subject|7|||
161429789|NCT00713609|582964791|FG000|Overall Study|Protocol Violation|6|||
161429790|NCT00713609|582964792|FG001|Overall Study|Protocol Violation|3|||
161429791|NCT00713609|582964793|FG002|Overall Study|Protocol Violation|1|||
161429792|NCT00713609|582964794|FG003|Overall Study|Protocol Violation|1|||
161429793|NCT00713609|582964795|FG004|Overall Study|Protocol Violation|2|||
161429794|NCT00713609|582964796|FG005|Overall Study|Protocol Violation|0|||
161429795|NCT01791244|582964800|FG000|Overall Study|Adverse Event|5|||
161429796|NCT01791244|582964801|FG001|Overall Study|Adverse Event|7|||
161429797|NCT01791244|582964800|FG000|Overall Study|Insufficient clinical response|10|||
161429798|NCT01791244|582964801|FG001|Overall Study|Insufficient clinical response|10|||
161429799|NCT01791244|582964800|FG000|Overall Study|Laboratory Abnormality|0|||
161429800|NCT01791244|582964801|FG001|Overall Study|Laboratory Abnormality|1|||
161429801|NCT02358473|582964803|FG000|Overall Study|Disease Progession|6|||
161429802|NCT02358473|582964803|FG000|Overall Study|Adverse Event|3|||
161429803|NCT02358473|582964803|FG000|Overall Study|Withdrawal by Subject|2|||
161429804|NCT02358473|582964803|FG000|Overall Study|Physician Decision|2|||
161429805|NCT00703014|582964806|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
161429806|NCT00703014|582964807|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
161429807|NCT00703014|582964808|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
161429808|NCT00703014|582964809|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
161429809|NCT00703014|582964806|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
161429810|NCT00703014|582964807|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
161429811|NCT00703014|582964808|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
161429812|NCT00703014|582964809|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
161429813|NCT04949191|582964810|FG000|Overall Study|Non-compliance with Study Drug|1|||
161429814|NCT04949191|582964811|FG001|Overall Study|Non-compliance with Study Drug|0|||
161429815|NCT04949191|582964812|FG002|Overall Study|Non-compliance with Study Drug|0|||
161429816|NCT04949191|582964813|FG003|Overall Study|Non-compliance with Study Drug|0|||
161429817|NCT04949191|582964810|FG000|Overall Study|Progressive Disease|0|||
161429818|NCT04949191|582964811|FG001|Overall Study|Progressive Disease|1|||
161429819|NCT04949191|582964812|FG002|Overall Study|Progressive Disease|0|||
161429820|NCT04949191|582964813|FG003|Overall Study|Progressive Disease|0|||
161429821|NCT04949191|582964810|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
161429822|NCT04949191|582964811|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
161429823|NCT04949191|582964812|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
161429824|NCT04949191|582964813|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
161429825|NCT04949191|582964810|FG000|Overall Study|Sponsor Terminated Study|0|||
161429826|NCT04949191|582964811|FG001|Overall Study|Sponsor Terminated Study|0|||
161429827|NCT04949191|582964812|FG002|Overall Study|Sponsor Terminated Study|1|||
161429828|NCT04949191|582964813|FG003|Overall Study|Sponsor Terminated Study|1|||
161429829|NCT00730158|582964814|FG000|Overall Study|Withdrawal by Subject|1|||
161429830|NCT00730158|582964815|FG001|Overall Study|Withdrawal by Subject|1|||
161429831|NCT03535974|582964817|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
161429832|NCT03535974|582964818|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
161429833|NCT03535974|582964819|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
161429834|NCT03535974|582964817|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
161429835|NCT03535974|582964818|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
161429836|NCT03535974|582964819|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
161429837|NCT04059549|582964820|FG000|Overall Study|Withdrawal by Subject|2|||
161429838|NCT04059549|582964821|FG001|Overall Study|Withdrawal by Subject|0|||
161429839|NCT02678351|582964822|FG000|Overall Study|Withdrawal by Subject|1|||
161429840|NCT02913482|582964823|FG000|Overall Study|Death|0|||
161429841|NCT02913482|582964824|FG001|Overall Study|Death|2|||
161429842|NCT02913482|582964825|FG002|Overall Study|Death|2|||
161429843|NCT02913482|582964823|FG000|Overall Study|Progressive Disease|1|||
161429844|NCT02913482|582964824|FG001|Overall Study|Progressive Disease|1|||
161429845|NCT02913482|582964825|FG002|Overall Study|Progressive Disease|1|||
161429846|NCT02913482|582964823|FG000|Overall Study|Reason not specified|0|||
161429847|NCT02913482|582964824|FG001|Overall Study|Reason not specified|0|||
161429848|NCT02913482|582964825|FG002|Overall Study|Reason not specified|1|||
161429849|NCT02913482|582964823|FG000|Overall Study|Withdrawal by Subject|0|||
161429850|NCT02913482|582964824|FG001|Overall Study|Withdrawal by Subject|1|||
161429851|NCT02913482|582964825|FG002|Overall Study|Withdrawal by Subject|1|||
161429852|NCT01919229|582964826|FG000|Overall Study|Subject/guardian decision|0|||
161429853|NCT01919229|582964827|FG001|Overall Study|Subject/guardian decision|0|||
161429854|NCT01919229|582964828|FG002|Overall Study|Subject/guardian decision|1|||
161429855|NCT01011673|582964829|FG000|Randomized|Secondary headache|2|||
161429856|NCT01011673|582964830|FG001|Randomized|Secondary headache|1|||
161429857|NCT01011673|582964829|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
161429858|NCT01011673|582964830|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
161429859|NCT04716426|582964835|FG000|Overall Study|Vaccination|1|||
161429860|NCT04716426|582964836|FG001|Overall Study|Vaccination|1|||
161429861|NCT04716426|582964835|FG000|Overall Study|Contamination|1|||
161429862|NCT04716426|582964836|FG001|Overall Study|Contamination|0|||
161429863|NCT01650558|582964837|FG000|Overall Study|Migration out of study area|61|||
161429864|NCT01650558|582964838|FG001|Overall Study|Migration out of study area|71|||
161429865|NCT01650558|582964839|FG002|Overall Study|Migration out of study area|56|||
161429866|NCT01650558|582964837|FG000|Overall Study|Lost to Follow-up|10|||
161429867|NCT01650558|582964838|FG001|Overall Study|Lost to Follow-up|13|||
161429868|NCT01650558|582964839|FG002|Overall Study|Lost to Follow-up|6|||
161429869|NCT01650558|582964837|FG000|Overall Study|Death|10|||
161429870|NCT01650558|582964838|FG001|Overall Study|Death|6|||
161429871|NCT01650558|582964839|FG002|Overall Study|Death|8|||
161429872|NCT01650558|582964837|FG000|Overall Study|Withdrawal by Subject|1|||
161429873|NCT01650558|582964838|FG001|Overall Study|Withdrawal by Subject|1|||
161429874|NCT01650558|582964839|FG002|Overall Study|Withdrawal by Subject|3|||
161429875|NCT01650558|582964837|FG000|Overall Study|Non-compliant participant|1|||
161429876|NCT01650558|582964838|FG001|Overall Study|Non-compliant participant|0|||
161429877|NCT01650558|582964839|FG002|Overall Study|Non-compliant participant|2|||
161429878|NCT01650558|582964837|FG000|Overall Study|Physician Decision|0|||
161429879|NCT01650558|582964838|FG001|Overall Study|Physician Decision|1|||
161429880|NCT01650558|582964839|FG002|Overall Study|Physician Decision|0|||
161429881|NCT02960217|582964840|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
161429882|NCT02960217|582964841|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
161429883|NCT02960217|582964840|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
161429884|NCT02960217|582964841|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
161429885|NCT02960217|582964840|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
161429886|NCT02960217|582964841|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
161429887|NCT02960217|582964840|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
161429888|NCT02960217|582964841|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
161429889|NCT02960217|582964840|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
161429890|NCT02960217|582964841|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
161429891|NCT02960217|582964840|FG000|Open-Label Extension Phase|Adverse Event|1|||
161429892|NCT02960217|582964841|FG001|Open-Label Extension Phase|Adverse Event|0|||
161429893|NCT02960217|582964840|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
161429894|NCT02960217|582964841|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
161429895|NCT02960217|582964840|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
161429896|NCT02960217|582964841|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
161429897|NCT02960217|582964840|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
161429898|NCT02960217|582964841|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
161429899|NCT02734693|582964842|FG000|Overall Study|Adverse Event|1|||
161429900|NCT02734693|582964843|FG001|Overall Study|Adverse Event|3|||
161429901|NCT02734693|582964844|FG002|Overall Study|Adverse Event|3|||
161429902|NCT02734693|582964842|FG000|Overall Study|Lack of Efficacy|1|||
161429903|NCT02734693|582964843|FG001|Overall Study|Lack of Efficacy|0|||
161429904|NCT02734693|582964844|FG002|Overall Study|Lack of Efficacy|0|||
161429905|NCT02734693|582964842|FG000|Overall Study|Lost to Follow-up|2|||
161429906|NCT02734693|582964843|FG001|Overall Study|Lost to Follow-up|0|||
161429907|NCT02734693|582964844|FG002|Overall Study|Lost to Follow-up|0|||
161429908|NCT02734693|582964842|FG000|Overall Study|Protocol Violation|1|||
161429909|NCT02734693|582964843|FG001|Overall Study|Protocol Violation|0|||
161429910|NCT02734693|582964844|FG002|Overall Study|Protocol Violation|0|||
161429911|NCT02734693|582964842|FG000|Overall Study|Withdrawal by Subject|1|||
161429912|NCT02734693|582964843|FG001|Overall Study|Withdrawal by Subject|0|||
161429913|NCT02734693|582964844|FG002|Overall Study|Withdrawal by Subject|0|||
161429914|NCT00625131|582964846|FG000|Overall Study|Lost to Follow-up|3|||
161429915|NCT00625131|582964847|FG001|Overall Study|Lost to Follow-up|2|||
161429916|NCT00625131|582964848|FG002|Overall Study|Lost to Follow-up|0|||
161429917|NCT00625131|582964846|FG000|Overall Study|Withdrawal by Subject|1|||
161429918|NCT00625131|582964847|FG001|Overall Study|Withdrawal by Subject|0|||
161429919|NCT00625131|582964848|FG002|Overall Study|Withdrawal by Subject|5|||
161429920|NCT05083351|582964852|FG000|Overall Study|Adverse Event|3|||
161429921|NCT05083351|582964852|FG000|Overall Study|Did not meet data inclusion criteria|8|||
161429922|NCT05083351|582964852|FG000|Overall Study|Did not meet eligibility criteria|19|||
161429923|NCT05083351|582964852|FG000|Overall Study|Study Staff Decision|19|||
161429924|NCT00849940|582964861|FG000|Overall Study|Physician Decision|4|||
161429925|NCT03353675|582964865|FG000|Overall Study|Adverse Event|4|||
161429926|NCT00402168|582964866|FG000|Randomized|Lost to Follow-up|1|||
161429927|NCT00402168|582964867|FG001|Randomized|Lost to Follow-up|0|||
161429928|NCT00402168|582964866|FG000|Randomized|Withdrawal by Subject|0|||
161429929|NCT00402168|582964867|FG001|Randomized|Withdrawal by Subject|1|||
161429930|NCT00402168|582964866|FG000|Treatment (up to 12 Months)|Death|0|||
161429931|NCT00402168|582964867|FG001|Treatment (up to 12 Months)|Death|1|||
161429932|NCT00402168|582964866|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
161429933|NCT00402168|582964867|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
161429934|NCT00402168|582964866|FG000|Treatment (up to 12 Months)|non-specified|0|||
161429935|NCT00402168|582964867|FG001|Treatment (up to 12 Months)|non-specified|1|||
161429936|NCT00402168|582964866|FG000|Long Term (LT)|Adverse Event|1|||
161429937|NCT00402168|582964867|FG001|Long Term (LT)|Adverse Event|5|||
161429938|NCT00402168|582964866|FG000|Long Term (LT)|Withdrawal by Subject|4|||
161429939|NCT00402168|582964867|FG001|Long Term (LT)|Withdrawal by Subject|7|||
161429940|NCT00402168|582964866|FG000|Long Term (LT)|Pregnancy|0|||
161429941|NCT00402168|582964867|FG001|Long Term (LT)|Pregnancy|1|||
161429942|NCT00402168|582964866|FG000|Long Term (LT)|Lost to Follow-up|1|||
161429943|NCT00402168|582964867|FG001|Long Term (LT)|Lost to Follow-up|0|||
161429944|NCT00402168|582964866|FG000|Long Term (LT)|Death|4|||
161429945|NCT00402168|582964867|FG001|Long Term (LT)|Death|0|||
161429946|NCT00402168|582964866|FG000|Long Term (LT)|Lack of Efficacy|0|||
161429947|NCT00402168|582964867|FG001|Long Term (LT)|Lack of Efficacy|2|||
161429948|NCT00402168|582964866|FG000|Long Term (LT)|non-specified|1|||
161429949|NCT00402168|582964867|FG001|Long Term (LT)|non-specified|2|||
161429950|NCT00402168|582964866|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
161429951|NCT00402168|582964867|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
161429952|NCT00402168|582964866|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
161429953|NCT00402168|582964867|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
161429954|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
161429955|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
161429956|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
161429957|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
161429958|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
161429959|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
161429960|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
161429961|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
161429962|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
161429963|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
161429964|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
161429965|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
161429966|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
161429967|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
161429968|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
161429969|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
161429970|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
161429971|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
161429972|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
161429973|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
161429974|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
161429975|NCT00550407|582964870|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
161429976|NCT00550407|582964871|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
161429977|NCT00550407|582964872|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
161429978|NCT00550407|582964870|FG000|26-Week Randomized Phase|Adverse Event|0|||
161429979|NCT00550407|582964871|FG001|26-Week Randomized Phase|Adverse Event|5|||
161429980|NCT00550407|582964872|FG002|26-Week Randomized Phase|Adverse Event|2|||
161429981|NCT00550407|582964870|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
161429982|NCT00550407|582964871|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
161429983|NCT00550407|582964872|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
161429984|NCT00550407|582964870|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
161429985|NCT00550407|582964871|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
161429986|NCT00550407|582964872|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
161429987|NCT00550407|582964870|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
161429988|NCT00550407|582964871|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
161429989|NCT00550407|582964872|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
161429990|NCT00584415|582964873|FG000|Overall Study|Adverse Event|7|||
161429991|NCT02370420|582964874|FG000|Overall Study|Physician Decision|3|||
161429992|NCT02370420|582964875|FG001|Overall Study|Physician Decision|3|||
161429993|NCT02370420|582964874|FG000|Overall Study|Lost to Follow-up|11|||
161429994|NCT02370420|582964875|FG001|Overall Study|Lost to Follow-up|9|||
161429995|NCT00556894|582964876|FG000|Overall Study|Adverse Event|2|||
161429996|NCT00556894|582964877|FG001|Overall Study|Adverse Event|3|||
161429997|NCT00556894|582964878|FG002|Overall Study|Adverse Event|3|||
161429998|NCT00556894|582964876|FG000|Overall Study|Death|1|||
161429999|NCT00556894|582964877|FG001|Overall Study|Death|0|||
161430000|NCT00556894|582964878|FG002|Overall Study|Death|0|||
161430001|NCT00556894|582964876|FG000|Overall Study|regulatory decision in Bulgaria|10|||
161430002|NCT00556894|582964877|FG001|Overall Study|regulatory decision in Bulgaria|14|||
161430003|NCT00556894|582964878|FG002|Overall Study|regulatory decision in Bulgaria|13|||
161430004|NCT00556894|582964876|FG000|Overall Study|Change in therapy|2|||
161430005|NCT00556894|582964877|FG001|Overall Study|Change in therapy|1|||
161430006|NCT00556894|582964878|FG002|Overall Study|Change in therapy|2|||
161430007|NCT00556894|582964876|FG000|Overall Study|Withdrawal by Subject|1|||
161430008|NCT00556894|582964877|FG001|Overall Study|Withdrawal by Subject|1|||
161430009|NCT00556894|582964878|FG002|Overall Study|Withdrawal by Subject|1|||
161430010|NCT03883581|582964879|FG000|Overall Study|Withdrawal by Subject|4|||
161430011|NCT05190120|582964883|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
161430012|NCT05190120|582964884|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
161430013|NCT05190120|582964885|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
161430014|NCT05190120|582964886|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
161430015|NCT05190120|582964883|FG000|Overall Study|Lost to Follow-up|5|||
161430016|NCT05190120|582964884|FG001|Overall Study|Lost to Follow-up|0|||
161430017|NCT05190120|582964885|FG002|Overall Study|Lost to Follow-up|2|||
161430018|NCT05190120|582964886|FG003|Overall Study|Lost to Follow-up|3|||
161430019|NCT05893862|582964887|FG000|Overall Study|Physician Decision|0|||
161430020|NCT05893862|582964888|FG001|Overall Study|Physician Decision|1|||
161430021|NCT05893862|582964889|FG002|Overall Study|Physician Decision|0|||
161430022|NCT05893862|582964890|FG003|Overall Study|Physician Decision|0|||
161430023|NCT05893862|582964891|FG004|Overall Study|Physician Decision|1|||
161430024|NCT05893862|582964892|FG005|Overall Study|Physician Decision|0|||
161430025|NCT05893862|582964887|FG000|Overall Study|Withdrawal by Subject|1|||
161430026|NCT05893862|582964888|FG001|Overall Study|Withdrawal by Subject|7|||
161430027|NCT05893862|582964889|FG002|Overall Study|Withdrawal by Subject|1|||
161430028|NCT05893862|582964890|FG003|Overall Study|Withdrawal by Subject|3|||
161430029|NCT05893862|582964891|FG004|Overall Study|Withdrawal by Subject|3|||
161430030|NCT05893862|582964892|FG005|Overall Study|Withdrawal by Subject|2|||
161430031|NCT05893862|582964887|FG000|Overall Study|Adverse Event|1|||
161430032|NCT05893862|582964888|FG001|Overall Study|Adverse Event|4|||
161430033|NCT05893862|582964889|FG002|Overall Study|Adverse Event|2|||
161430034|NCT05893862|582964890|FG003|Overall Study|Adverse Event|2|||
161430035|NCT05893862|582964891|FG004|Overall Study|Adverse Event|1|||
161430036|NCT05893862|582964892|FG005|Overall Study|Adverse Event|0|||
161430037|NCT00410956|582964893|FG000|Overall Study|Adverse Event|1|||
161430038|NCT00410956|582964893|FG000|Overall Study|Death|2|||
161430039|NCT00410956|582964893|FG000|Overall Study|Lack of Efficacy|10|||
161430040|NCT00410956|582964893|FG000|Overall Study|Physician Decision|6|||
161430041|NCT01097668|582967042|FG000|Overall Study|Withdrawal by Subject|1|||
161430042|NCT01097668|582967043|FG001|Overall Study|Withdrawal by Subject|2|||
161430043|NCT01097668|582967042|FG000|Overall Study|Lost to Follow-up|1|||
161430044|NCT01097668|582967043|FG001|Overall Study|Lost to Follow-up|0|||
161430045|NCT00755183|582967044|FG000|Overall Study|Adverse Event|5|||
161430046|NCT00755183|582967045|FG001|Overall Study|Adverse Event|2|||
161430047|NCT00755183|582967044|FG000|Overall Study|Protocol Violation|0|||
161430048|NCT00755183|582967045|FG001|Overall Study|Protocol Violation|1|||
161430049|NCT00755183|582967044|FG000|Overall Study|Withdrawal by Subject|0|||
161430050|NCT00755183|582967045|FG001|Overall Study|Withdrawal by Subject|2|||
161430051|NCT00755183|582967044|FG000|Overall Study|Administrative|2|||
161430052|NCT00755183|582967045|FG001|Overall Study|Administrative|1|||
161430053|NCT02587520|582967046|FG000|Overall Study|Protocol Violation|2|||
161430054|NCT02587520|582967047|FG001|Overall Study|Protocol Violation|0|||
161430055|NCT02587520|582967048|FG002|Overall Study|Protocol Violation|0|||
161430056|NCT02587520|582967049|FG003|Overall Study|Protocol Violation|2|||
161430057|NCT02587520|582967050|FG004|Overall Study|Protocol Violation|0|||
161430058|NCT02587520|582967051|FG005|Overall Study|Protocol Violation|1|||
161430059|NCT02587520|582967052|FG006|Overall Study|Protocol Violation|1|||
161430060|NCT02587520|582967053|FG007|Overall Study|Protocol Violation|1|||
161430061|NCT02587520|582967054|FG008|Overall Study|Protocol Violation|3|||
161430062|NCT02587520|582967055|FG009|Overall Study|Protocol Violation|3|||
161430063|NCT02587520|582967056|FG010|Overall Study|Protocol Violation|1|||
161430064|NCT02587520|582967057|FG011|Overall Study|Protocol Violation|2|||
161430065|NCT02587520|582967058|FG012|Overall Study|Protocol Violation|0|||
161430066|NCT02587520|582967059|FG013|Overall Study|Protocol Violation|0|||
161430067|NCT02587520|582967060|FG014|Overall Study|Protocol Violation|0|||
161430068|NCT02587520|582967061|FG015|Overall Study|Protocol Violation|0|||
161430069|NCT02587520|582967062|FG016|Overall Study|Protocol Violation|0|||
161430070|NCT02587520|582967063|FG017|Overall Study|Protocol Violation|0|||
161430071|NCT02587520|582967046|FG000|Overall Study|Adverse Event|0|||
161430072|NCT02587520|582967047|FG001|Overall Study|Adverse Event|0|||
161430073|NCT02587520|582967048|FG002|Overall Study|Adverse Event|0|||
161430074|NCT02587520|582967049|FG003|Overall Study|Adverse Event|0|||
161430075|NCT02587520|582967050|FG004|Overall Study|Adverse Event|0|||
161430076|NCT02587520|582967051|FG005|Overall Study|Adverse Event|0|||
161430077|NCT02587520|582967052|FG006|Overall Study|Adverse Event|0|||
161430078|NCT02587520|582967053|FG007|Overall Study|Adverse Event|0|||
161430079|NCT02587520|582967054|FG008|Overall Study|Adverse Event|0|||
161430080|NCT02587520|582967055|FG009|Overall Study|Adverse Event|0|||
161430081|NCT02587520|582967056|FG010|Overall Study|Adverse Event|0|||
161430082|NCT02587520|582967057|FG011|Overall Study|Adverse Event|1|||
161430083|NCT02587520|582967058|FG012|Overall Study|Adverse Event|0|||
161430084|NCT02587520|582967059|FG013|Overall Study|Adverse Event|0|||
161430085|NCT02587520|582967060|FG014|Overall Study|Adverse Event|0|||
161430086|NCT02587520|582967061|FG015|Overall Study|Adverse Event|0|||
161430087|NCT02587520|582967062|FG016|Overall Study|Adverse Event|0|||
161430088|NCT02587520|582967063|FG017|Overall Study|Adverse Event|0|||
161430089|NCT02587520|582967046|FG000|Overall Study|Withdrawal by Subject|0|||
161430090|NCT02587520|582967047|FG001|Overall Study|Withdrawal by Subject|0|||
161430091|NCT02587520|582967048|FG002|Overall Study|Withdrawal by Subject|1|||
161430092|NCT02587520|582967049|FG003|Overall Study|Withdrawal by Subject|1|||
161430093|NCT02587520|582967050|FG004|Overall Study|Withdrawal by Subject|0|||
161430094|NCT02587520|582967051|FG005|Overall Study|Withdrawal by Subject|1|||
161430095|NCT02587520|582967052|FG006|Overall Study|Withdrawal by Subject|1|||
161430096|NCT02587520|582967053|FG007|Overall Study|Withdrawal by Subject|0|||
161430097|NCT02587520|582967054|FG008|Overall Study|Withdrawal by Subject|0|||
161430098|NCT02587520|582967055|FG009|Overall Study|Withdrawal by Subject|0|||
161430099|NCT02587520|582967056|FG010|Overall Study|Withdrawal by Subject|0|||
161430100|NCT02587520|582967057|FG011|Overall Study|Withdrawal by Subject|0|||
161430101|NCT02587520|582967058|FG012|Overall Study|Withdrawal by Subject|0|||
161430102|NCT02587520|582967059|FG013|Overall Study|Withdrawal by Subject|1|||
161430103|NCT02587520|582967060|FG014|Overall Study|Withdrawal by Subject|0|||
161430104|NCT02587520|582967061|FG015|Overall Study|Withdrawal by Subject|0|||
161430105|NCT02587520|582967062|FG016|Overall Study|Withdrawal by Subject|0|||
161430106|NCT02587520|582967063|FG017|Overall Study|Withdrawal by Subject|0|||
161430107|NCT02587520|582967046|FG000|Overall Study|Lost to Follow-up|0|||
161430108|NCT02587520|582967047|FG001|Overall Study|Lost to Follow-up|2|||
161430109|NCT02587520|582967048|FG002|Overall Study|Lost to Follow-up|0|||
161430110|NCT02587520|582967049|FG003|Overall Study|Lost to Follow-up|2|||
161430111|NCT02587520|582967050|FG004|Overall Study|Lost to Follow-up|0|||
161430112|NCT02587520|582967051|FG005|Overall Study|Lost to Follow-up|1|||
161430113|NCT02587520|582967052|FG006|Overall Study|Lost to Follow-up|1|||
161430114|NCT02587520|582967053|FG007|Overall Study|Lost to Follow-up|1|||
161430115|NCT02587520|582967054|FG008|Overall Study|Lost to Follow-up|0|||
161430116|NCT02587520|582967055|FG009|Overall Study|Lost to Follow-up|2|||
161430117|NCT02587520|582967056|FG010|Overall Study|Lost to Follow-up|2|||
161430118|NCT02587520|582967057|FG011|Overall Study|Lost to Follow-up|1|||
161430119|NCT02587520|582967058|FG012|Overall Study|Lost to Follow-up|0|||
161430120|NCT02587520|582967059|FG013|Overall Study|Lost to Follow-up|0|||
161430121|NCT02587520|582967060|FG014|Overall Study|Lost to Follow-up|0|||
161430122|NCT02587520|582967061|FG015|Overall Study|Lost to Follow-up|0|||
161430123|NCT02587520|582967062|FG016|Overall Study|Lost to Follow-up|0|||
161430124|NCT02587520|582967063|FG017|Overall Study|Lost to Follow-up|0|||
161430125|NCT00672555|582967064|FG000|Overall Study|Lost to Follow-up|4|||
161430126|NCT00672555|582967064|FG000|Overall Study|Did not want to answer questionnaire|2|||
161430127|NCT04516746|582967067|FG000|Overall Study|Randomized but not Treated|51|||
161430128|NCT04516746|582967068|FG001|Overall Study|Randomized but not Treated|19|||
161430129|NCT04516746|582967067|FG000|Overall Study|Adverse Event|0|||
161430130|NCT04516746|582967068|FG001|Overall Study|Adverse Event|1|||
161430131|NCT04516746|582967067|FG000|Overall Study|Death|62|||
161430132|NCT04516746|582967068|FG001|Overall Study|Death|32|||
161430133|NCT04516746|582967067|FG000|Overall Study|Lost to Follow-up|3431|||
161430134|NCT04516746|582967068|FG001|Overall Study|Lost to Follow-up|1831|||
161430135|NCT04516746|582967067|FG000|Overall Study|Withdrawal by Subject|1946|||
161430136|NCT04516746|582967068|FG001|Overall Study|Withdrawal by Subject|1696|||
161430137|NCT04516746|582967067|FG000|Overall Study|Physician Decision|10|||
161430138|NCT04516746|582967068|FG001|Overall Study|Physician Decision|8|||
161430139|NCT04516746|582967067|FG000|Overall Study|Other|35|||
161430140|NCT04516746|582967068|FG001|Overall Study|Other|16|||
161430141|NCT00446849|582967070|FG000|Acute Phase|Lack of Efficacy|64|||
161430142|NCT00446849|582967070|FG000|Acute Phase|Protocol Violation|10|||
161430143|NCT00446849|582967070|FG000|Acute Phase|Consent withdrawn|4|||
161430144|NCT00446849|582967070|FG000|Acute Phase|Lost to Follow-up|2|||
161430145|NCT00446849|582967070|FG000|Acute Phase|Physician Decision|1|||
161430146|NCT00446849|582967070|FG000|Acute Phase|noncompliance|1|||
161430147|NCT00446849|582967070|FG000|Maintenance Phase|Lack of Efficacy|40|||
161430148|NCT00446849|582967070|FG000|Maintenance Phase|Protocol Violation|7|||
161430149|NCT00446849|582967070|FG000|Maintenance Phase|Adverse Event|6|||
161430150|NCT00446849|582967070|FG000|Maintenance Phase|Consent withdrawn|5|||
161430151|NCT00446849|582967070|FG000|Maintenance Phase|Lost to Follow-up|3|||
161430152|NCT00446849|582967070|FG000|Maintenance Phase|Pregnancy|1|||
161430153|NCT00446849|582967070|FG000|Maintenance Phase|noncompliance|2|||
161430154|NCT00446849|582967070|FG000|Maintenance Phase|prohibited medication use|2|||
161430155|NCT00446849|582967070|FG000|Maintenance Phase|antibiotic use|1|||
161430156|NCT00446849|582967070|FG000|Maintenance Phase|study closure|1|||
161430157|NCT00446849|582967070|FG000|Maintenance Phase|hydrocodone use|1|||
161430158|NCT00446849|582967070|FG000|Maintenance Phase|concomitant medication use|1|||
161430159|NCT05546476|582967071|FG000|Period 1: Part A|Adverse Event|2|||
161430160|NCT05546476|582967072|FG001|Period 1: Part A|Adverse Event|0|||
161430161|NCT05546476|582967073|FG002|Period 1: Part A|Adverse Event|0|||
161430162|NCT05546476|582967074|FG003|Period 1: Part A|Adverse Event|1|||
161430163|NCT05546476|582967071|FG000|Period 1: Part A|Death|4|||
161430164|NCT05546476|582967072|FG001|Period 1: Part A|Death|4|||
161430165|NCT05546476|582967073|FG002|Period 1: Part A|Death|5|||
161430166|NCT05546476|582967074|FG003|Period 1: Part A|Death|6|||
161430167|NCT05546476|582967071|FG000|Period 1: Part A|Lack of Efficacy|0|||
161430168|NCT05546476|582967072|FG001|Period 1: Part A|Lack of Efficacy|0|||
161430169|NCT05546476|582967073|FG002|Period 1: Part A|Lack of Efficacy|0|||
161430170|NCT05546476|582967074|FG003|Period 1: Part A|Lack of Efficacy|1|||
161430171|NCT05546476|582967071|FG000|Period 1: Part A|Lost to Follow-up|0|||
161430172|NCT05546476|582967072|FG001|Period 1: Part A|Lost to Follow-up|0|||
161430173|NCT05546476|582967073|FG002|Period 1: Part A|Lost to Follow-up|0|||
161430174|NCT05546476|582967074|FG003|Period 1: Part A|Lost to Follow-up|1|||
161430175|NCT05546476|582967071|FG000|Period 1: Part A|Physician Decision|1|||
161430176|NCT05546476|582967072|FG001|Period 1: Part A|Physician Decision|0|||
161430177|NCT05546476|582967073|FG002|Period 1: Part A|Physician Decision|0|||
161430178|NCT05546476|582967074|FG003|Period 1: Part A|Physician Decision|0|||
161430179|NCT05546476|582967071|FG000|Period 1: Part A|Progressive disease|3|||
161430180|NCT05546476|582967072|FG001|Period 1: Part A|Progressive disease|5|||
161430181|NCT05546476|582967073|FG002|Period 1: Part A|Progressive disease|0|||
161430182|NCT05546476|582967074|FG003|Period 1: Part A|Progressive disease|1|||
161430183|NCT05546476|582967071|FG000|Period 1: Part A|Withdrawal by Subject|1|||
161430184|NCT05546476|582967072|FG001|Period 1: Part A|Withdrawal by Subject|1|||
161430185|NCT05546476|582967073|FG002|Period 1: Part A|Withdrawal by Subject|1|||
161430186|NCT05546476|582967074|FG003|Period 1: Part A|Withdrawal by Subject|2|||
161430187|NCT05546476|582967071|FG000|Period 1: Part A|Global deterioration of health status|2|||
161430188|NCT05546476|582967072|FG001|Period 1: Part A|Global deterioration of health status|2|||
161430189|NCT05546476|582967073|FG002|Period 1: Part A|Global deterioration of health status|1|||
161430190|NCT05546476|582967074|FG003|Period 1: Part A|Global deterioration of health status|4|||
161430191|NCT05546476|582967071|FG000|Period 1: Part A|Other: Unspecified|0|||
161430192|NCT05546476|582967072|FG001|Period 1: Part A|Other: Unspecified|2|||
161430193|NCT05546476|582967073|FG002|Period 1: Part A|Other: Unspecified|0|||
161430194|NCT05546476|582967074|FG003|Period 1: Part A|Other: Unspecified|0|||
161430195|NCT05546476|582967071|FG000|Period 2: Part B|Ongoing|26|||
161430196|NCT05546476|582967072|FG001|Period 2: Part B|Ongoing|27|||
161430197|NCT05546476|582967073|FG002|Period 2: Part B|Ongoing|35|||
161430198|NCT05546476|582967074|FG003|Period 2: Part B|Ongoing|29|||
161430199|NCT03760029|582967082|FG000|Overall Study|Death|1|||
161430200|NCT03760029|582967083|FG001|Overall Study|Death|0|||
161430201|NCT03760029|582967084|FG002|Overall Study|Death|0|||
161430202|NCT03760029|582967082|FG000|Overall Study|Lost to Follow-up|0|||
161430203|NCT03760029|582967083|FG001|Overall Study|Lost to Follow-up|2|||
161430204|NCT03760029|582967084|FG002|Overall Study|Lost to Follow-up|1|||
161430205|NCT03760029|582967082|FG000|Overall Study|Withdrawal by Subject|1|||
161430206|NCT03760029|582967083|FG001|Overall Study|Withdrawal by Subject|4|||
161430207|NCT03760029|582967084|FG002|Overall Study|Withdrawal by Subject|1|||
161430208|NCT03760029|582967082|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161430209|NCT03760029|582967083|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161430210|NCT03760029|582967084|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161430211|NCT03760029|582967082|FG000|Overall Study|Other|2|||
161430212|NCT03760029|582967083|FG001|Overall Study|Other|1|||
161430213|NCT03760029|582967084|FG002|Overall Study|Other|0|||
161430214|NCT04890652|582967090|FG000|Overall Study|Withdrawal by Subject|2|||
161430215|NCT00772538|582967098|FG000|Overall Study|Adverse Event|6|||
161430216|NCT00772538|582967099|FG001|Overall Study|Adverse Event|6|||
161430217|NCT00772538|582967098|FG000|Overall Study|Protocol Violation|3|||
161430218|NCT00772538|582967099|FG001|Overall Study|Protocol Violation|3|||
161430219|NCT00772538|582967098|FG000|Overall Study|Lost to Follow-up|1|||
161430220|NCT00772538|582967099|FG001|Overall Study|Lost to Follow-up|1|||
161430221|NCT00772538|582967098|FG000|Overall Study|Withdrawal by Subject|3|||
161430222|NCT00772538|582967099|FG001|Overall Study|Withdrawal by Subject|8|||
161430223|NCT00772538|582967098|FG000|Overall Study|Lack of Efficacy|0|||
161430224|NCT00772538|582967099|FG001|Overall Study|Lack of Efficacy|1|||
161430225|NCT00772538|582967098|FG000|Overall Study|Other|7|||
161430226|NCT00772538|582967099|FG001|Overall Study|Other|7|||
161430227|NCT01089504|582967100|FG000|Overall Study|Lost to Follow-up|1|||
161430228|NCT01089504|582967101|FG001|Overall Study|Lost to Follow-up|1|||
161430229|NCT01089504|582967100|FG000|Overall Study|Withdrawal by Subject|2|||
161430230|NCT01089504|582967101|FG001|Overall Study|Withdrawal by Subject|0|||
161430231|NCT00001832|582967102|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
161430232|NCT00001832|582967103|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
161430233|NCT00001832|582967104|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
161430234|NCT00001832|582967105|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
161430235|NCT00001832|582967106|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
161430236|NCT00001832|582967107|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
161430237|NCT00001832|582967108|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
161430238|NCT00001832|582967109|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
161430239|NCT00001832|582967110|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
161430240|NCT00001832|582967111|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
161430241|NCT00001832|582967112|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
161430242|NCT00001832|582967113|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
161430243|NCT00001832|582967114|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
161430244|NCT00001832|582967115|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
161430245|NCT00001832|582967116|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
161430246|NCT00001832|582967102|FG000|Treatment Period|Death during treatment|0|||
161430247|NCT00001832|582967103|FG001|Treatment Period|Death during treatment|0|||
161430248|NCT00001832|582967104|FG002|Treatment Period|Death during treatment|0|||
161430249|NCT00001832|582967105|FG003|Treatment Period|Death during treatment|0|||
161430250|NCT00001832|582967106|FG004|Treatment Period|Death during treatment|0|||
161430251|NCT00001832|582967107|FG005|Treatment Period|Death during treatment|1|||
161430252|NCT00001832|582967108|FG006|Treatment Period|Death during treatment|0|||
161430253|NCT00001832|582967109|FG007|Treatment Period|Death during treatment|0|||
161430254|NCT00001832|582967110|FG008|Treatment Period|Death during treatment|0|||
161430255|NCT00001832|582967111|FG009|Treatment Period|Death during treatment|0|||
161430256|NCT00001832|582967112|FG010|Treatment Period|Death during treatment|0|||
161430257|NCT00001832|582967113|FG011|Treatment Period|Death during treatment|0|||
161430258|NCT00001832|582967114|FG012|Treatment Period|Death during treatment|0|||
161430259|NCT00001832|582967115|FG013|Treatment Period|Death during treatment|0|||
161430260|NCT00001832|582967116|FG014|Treatment Period|Death during treatment|0|||
161430261|NCT00001832|582967102|FG000|Treatment Period|Not treated|0|||
161430262|NCT00001832|582967103|FG001|Treatment Period|Not treated|0|||
161430263|NCT00001832|582967104|FG002|Treatment Period|Not treated|0|||
161430264|NCT00001832|582967105|FG003|Treatment Period|Not treated|0|||
161430265|NCT00001832|582967106|FG004|Treatment Period|Not treated|0|||
161430266|NCT00001832|582967107|FG005|Treatment Period|Not treated|0|||
161430267|NCT00001832|582967108|FG006|Treatment Period|Not treated|0|||
161430268|NCT00001832|582967109|FG007|Treatment Period|Not treated|1|||
161430269|NCT00001832|582967110|FG008|Treatment Period|Not treated|0|||
161430270|NCT00001832|582967111|FG009|Treatment Period|Not treated|0|||
161430271|NCT00001832|582967112|FG010|Treatment Period|Not treated|0|||
161430272|NCT00001832|582967113|FG011|Treatment Period|Not treated|0|||
161430273|NCT00001832|582967114|FG012|Treatment Period|Not treated|0|||
161430274|NCT00001832|582967115|FG013|Treatment Period|Not treated|0|||
161430275|NCT00001832|582967116|FG014|Treatment Period|Not treated|0|||
161430276|NCT04529083|582967117|FG000|Overall Study|Withdrawal by Subject|3|||
161430277|NCT03305666|582967122|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
161430278|NCT03305666|582967123|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
161430279|NCT04196686|582967124|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
161430280|NCT04196686|582967125|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
161430281|NCT00914849|582967128|FG000|Overall Study|Withdrawal by Subject|1|||
161430282|NCT00914849|582967129|FG001|Overall Study|Withdrawal by Subject|0|||
161430283|NCT00914849|582967128|FG000|Overall Study|Not eligible|0|||
161430284|NCT00914849|582967129|FG001|Overall Study|Not eligible|1|||
161430285|NCT01001221|582967130|FG000|Overall Study|Adverse Event|1|||
161430286|NCT01001221|582967131|FG001|Overall Study|Adverse Event|2|||
161430287|NCT01001221|582967132|FG002|Overall Study|Adverse Event|0|||
161430288|NCT01001221|582967133|FG003|Overall Study|Adverse Event|2|||
161430289|NCT01001221|582967134|FG004|Overall Study|Adverse Event|0|||
161430290|NCT01001221|582967130|FG000|Overall Study|Disease progression|3|||
161430291|NCT01001221|582967131|FG001|Overall Study|Disease progression|2|||
161430292|NCT01001221|582967132|FG002|Overall Study|Disease progression|2|||
161430293|NCT01001221|582967133|FG003|Overall Study|Disease progression|4|||
161430294|NCT01001221|582967134|FG004|Overall Study|Disease progression|0|||
161430295|NCT01001221|582967130|FG000|Overall Study|Other|1|||
161430296|NCT01001221|582967131|FG001|Overall Study|Other|1|||
161430297|NCT01001221|582967132|FG002|Overall Study|Other|0|||
161430298|NCT01001221|582967133|FG003|Overall Study|Other|0|||
161430299|NCT01001221|582967134|FG004|Overall Study|Other|0|||
161430300|NCT01001221|582967130|FG000|Overall Study|Not treated; protocol exclusion|0|||
161430301|NCT01001221|582967131|FG001|Overall Study|Not treated; protocol exclusion|0|||
161430302|NCT01001221|582967132|FG002|Overall Study|Not treated; protocol exclusion|1|||
161430303|NCT01001221|582967133|FG003|Overall Study|Not treated; protocol exclusion|0|||
161430304|NCT01001221|582967134|FG004|Overall Study|Not treated; protocol exclusion|0|||
161430305|NCT05106959|582967135|FG000|Overall Study|Lost to Follow-up|1|||
161430306|NCT03448406|582967136|FG000|Overall Study|Noncompliance of scheduled visits|1|||
161430307|NCT03448406|582967137|FG001|Overall Study|Noncompliance of scheduled visits|2|||
161430308|NCT03448406|582967136|FG000|Overall Study|Withdrawal by Subject|1|||
161430309|NCT03448406|582967137|FG001|Overall Study|Withdrawal by Subject|2|||
161430310|NCT03448406|582967136|FG000|Overall Study|Protocol Violation|1|||
161430311|NCT03448406|582967137|FG001|Overall Study|Protocol Violation|0|||
161430312|NCT03448406|582967136|FG000|Overall Study|Adverse Event|8|||
161430313|NCT03448406|582967137|FG001|Overall Study|Adverse Event|9|||
161430314|NCT00087152|582967138|FG000|Overall Study|Ineligible|6|||
161430315|NCT01292486|582967139|FG000|Overall Study|Protocol Violation|2|||
161430316|NCT01292486|582967139|FG000|Overall Study|Did not meet screening criteria|2|||
161430317|NCT01292486|582967139|FG000|Overall Study|Adverse Event|1|||
161430318|NCT01292486|582967139|FG000|Overall Study|Physician Decision|1|||
161430319|NCT04602390|582967146|FG000|Overall Study|Withdrawal by Subject|0|||
161430320|NCT04602390|582967147|FG001|Overall Study|Withdrawal by Subject|0|||
161430321|NCT04602390|582967148|FG002|Overall Study|Withdrawal by Subject|0|||
161430322|NCT04602390|582967149|FG003|Overall Study|Withdrawal by Subject|0|||
161430323|NCT04602390|582967150|FG004|Overall Study|Withdrawal by Subject|1|||
161430324|NCT04602390|582967151|FG005|Overall Study|Withdrawal by Subject|0|||
161430325|NCT04602390|582967146|FG000|Overall Study|Adverse Event|0|||
161430326|NCT04602390|582967147|FG001|Overall Study|Adverse Event|0|||
161430327|NCT04602390|582967148|FG002|Overall Study|Adverse Event|0|||
161430328|NCT04602390|582967149|FG003|Overall Study|Adverse Event|0|||
161430329|NCT04602390|582967150|FG004|Overall Study|Adverse Event|0|||
161430330|NCT04602390|582967151|FG005|Overall Study|Adverse Event|1|||
161430331|NCT02756338|582967152|FG000|Overall Study|Withdrawn by Investigator|1|||
161430332|NCT02756338|582967152|FG000|Overall Study|Device Replaced with Pacemaker|4|||
161430333|NCT01546857|582967153|FG000|Overall Study|Withdrawal by Subject|2|||
161430334|NCT01546857|582967154|FG001|Overall Study|Withdrawal by Subject|3|||
161430335|NCT02542865|582967155|FG000|Overall Study|Identified as screen failure|1|||
161430336|NCT02542865|582967156|FG001|Overall Study|Identified as screen failure|0|||
161430337|NCT02542865|582967155|FG000|Overall Study|Withdrawal by Subject|16|||
161430338|NCT02542865|582967156|FG001|Overall Study|Withdrawal by Subject|0|||
161430339|NCT01339689|582967157|FG000|Overall Study|Adverse Event|1|||
161430340|NCT01339689|582967158|FG001|Overall Study|Adverse Event|2|||
161430341|NCT01339689|582967157|FG000|Overall Study|Lost to Follow-up|9|||
161430342|NCT01339689|582967158|FG001|Overall Study|Lost to Follow-up|3|||
161430343|NCT01339689|582967157|FG000|Overall Study|Withdrawal by Subject|3|||
161430344|NCT01339689|582967158|FG001|Overall Study|Withdrawal by Subject|0|||
161430345|NCT01339689|582967157|FG000|Overall Study|Noncompliance|1|||
161430346|NCT01339689|582967158|FG001|Overall Study|Noncompliance|0|||
161430347|NCT01339689|582967157|FG000|Overall Study|Relocated out of area|0|||
161430348|NCT01339689|582967158|FG001|Overall Study|Relocated out of area|1|||
161430349|NCT01339689|582967157|FG000|Overall Study|Other|2|||
161430350|NCT01339689|582967158|FG001|Overall Study|Other|2|||
161430351|NCT01339689|582967157|FG000|Overall Study|multiple reasons|1|||
161430352|NCT01339689|582967158|FG001|Overall Study|multiple reasons|1|||
161430353|NCT00659061|582967159|FG000|Overall Study|Migration due to political unrest|21|||
161430354|NCT00659061|582967160|FG001|Overall Study|Migration due to political unrest|15|||
161430355|NCT01277744|582967169|FG000|Overall Study|Physician Decision|2|||
161430356|NCT05121766|582967172|FG000|Overall Study|Covid reinfection|3|||
161430357|NCT05121766|582967173|FG001|Overall Study|Covid reinfection|0|||
161430358|NCT05121766|582967172|FG000|Overall Study|Withdrawal by Subject|3|||
161430359|NCT05121766|582967173|FG001|Overall Study|Withdrawal by Subject|1|||
161430360|NCT05121766|582967172|FG000|Overall Study|Adverse Event|2|||
161430361|NCT05121766|582967173|FG001|Overall Study|Adverse Event|4|||
161430362|NCT05121766|582967172|FG000|Overall Study|Lost to Follow-up|0|||
161430363|NCT05121766|582967173|FG001|Overall Study|Lost to Follow-up|1|||
161430364|NCT03259230|582967174|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
161430365|NCT03259230|582967175|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
161430366|NCT01632020|582967176|FG000|Overall Study|Withdrawal by Subject|1|||
161430367|NCT01632020|582967177|FG001|Overall Study|Withdrawal by Subject|0|||
161430368|NCT01632020|582967176|FG000|Overall Study|Adverse Event|1|||
161430369|NCT01632020|582967177|FG001|Overall Study|Adverse Event|0|||
161430370|NCT05468814|582967178|FG000|Overall Study|Lost to Follow-up|5|||
161430371|NCT05468814|582967179|FG001|Overall Study|Lost to Follow-up|6|||
161430372|NCT00528957|582967184|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
161430373|NCT00528957|582967185|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
161430374|NCT00528957|582967184|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
161430375|NCT00528957|582967185|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
161430376|NCT00528957|582967184|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
161430377|NCT00528957|582967185|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
161430378|NCT00528957|582967184|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
161430379|NCT00528957|582967185|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
161430380|NCT00528957|582967184|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
161430381|NCT00528957|582967185|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
161430382|NCT00528957|582967184|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
161430383|NCT00528957|582967185|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
161430384|NCT00528957|582967184|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
161430385|NCT00528957|582967185|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
161430386|NCT00528957|582967184|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
161430387|NCT00528957|582967185|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
161430388|NCT00528957|582967184|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
161430389|NCT00528957|582967185|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
161430390|NCT00528957|582967184|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
161430391|NCT00528957|582967185|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
161430392|NCT00528957|582967184|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
161430393|NCT00528957|582967185|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
161430394|NCT00528957|582967184|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
161430395|NCT00528957|582967185|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
161430396|NCT00528957|582967184|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
161430397|NCT00528957|582967185|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
161430398|NCT00528957|582967184|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
161430399|NCT00528957|582967185|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
161430400|NCT00528957|582967184|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
161430401|NCT00528957|582967185|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
161430402|NCT00528957|582967184|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
161430403|NCT00528957|582967185|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
161430404|NCT01611792|582967188|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
161430405|NCT01611792|582967189|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
161430406|NCT01611792|582967188|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
161430407|NCT01611792|582967189|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
161430408|NCT03416868|582967190|FG000|Overall Study|Withdrawal by Subject|2|||
161430409|NCT03416868|582967190|FG000|Overall Study|Lost to Follow-up|1|||
161430410|NCT00083889|582967193|FG000|Overall Study|Adverse Event|76|||
161430411|NCT00083889|582967194|FG001|Overall Study|Adverse Event|86|||
161430412|NCT00083889|582967193|FG000|Overall Study|Protocol Violation|2|||
161430413|NCT00083889|582967194|FG001|Overall Study|Protocol Violation|2|||
161430414|NCT00083889|582967193|FG000|Overall Study|Withdrawal by Subject|22|||
161430415|NCT00083889|582967194|FG001|Overall Study|Withdrawal by Subject|24|||
161430416|NCT00083889|582967193|FG000|Overall Study|Lack of Efficacy|240|||
161430417|NCT00083889|582967194|FG001|Overall Study|Lack of Efficacy|219|||
161430418|NCT00083889|582967193|FG000|Overall Study|Decision of sponsor|32|||
161430419|NCT00083889|582967194|FG001|Overall Study|Decision of sponsor|4|||
161430420|NCT00083889|582967193|FG000|Overall Study|Randomized: did not take study drug|0|||
161430421|NCT00083889|582967194|FG001|Overall Study|Randomized: did not take study drug|15|||
161430422|NCT00083889|582967193|FG000|Overall Study|Completed on marketed sunitinub|3|||
161430423|NCT00083889|582967194|FG001|Overall Study|Completed on marketed sunitinub|0|||
161430424|NCT00083889|582967193|FG000|Overall Study|Crossover to SU011248|0|||
161430425|NCT00083889|582967194|FG001|Overall Study|Crossover to SU011248|25|||
161430426|NCT00960375|582967195|FG000|Overall Study|Lost to Follow-up|20|||
161430427|NCT00960375|582967196|FG001|Overall Study|Lost to Follow-up|22|||
161430428|NCT03624881|582967197|FG000|Overall Study|Screen Failure|14|||
161430429|NCT03624881|582967198|FG001|Overall Study|Screen Failure|0|||
161430430|NCT03624881|582967197|FG000|Overall Study|No Catheter Inserted|6|||
161430431|NCT03624881|582967198|FG001|Overall Study|No Catheter Inserted|1|||
161430432|NCT03624881|582967197|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
161430433|NCT03624881|582967198|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
161430434|NCT03624881|582967197|FG000|Overall Study|Death|2|||
161430435|NCT03624881|582967198|FG001|Overall Study|Death|0|||
161430436|NCT03624881|582967197|FG000|Overall Study|Lost to Follow-up|10|||
161430437|NCT03624881|582967198|FG001|Overall Study|Lost to Follow-up|4|||
161430438|NCT03624881|582967197|FG000|Overall Study|Withdrawal by Subject|12|||
161430439|NCT03624881|582967198|FG001|Overall Study|Withdrawal by Subject|1|||
161430440|NCT03473236|582967199|FG000|Overall Study|Withdrawal by Subject|0|||
161430441|NCT03473236|582967200|FG001|Overall Study|Withdrawal by Subject|0|||
161430442|NCT03473236|582967201|FG002|Overall Study|Withdrawal by Subject|0|||
161430443|NCT03473236|582967202|FG003|Overall Study|Withdrawal by Subject|0|||
161430444|NCT03473236|582967203|FG004|Overall Study|Withdrawal by Subject|0|||
161430445|NCT03473236|582967204|FG005|Overall Study|Withdrawal by Subject|1|||
161430446|NCT03473236|582967205|FG006|Overall Study|Withdrawal by Subject|0|||
161430447|NCT03473236|582967206|FG007|Overall Study|Withdrawal by Subject|0|||
161430448|NCT03473236|582967207|FG008|Overall Study|Withdrawal by Subject|1|||
161430449|NCT03473236|582967208|FG009|Overall Study|Withdrawal by Subject|0|||
161430450|NCT04264442|582967209|FG000|Overall Study|Lack of Efficacy|6|||
161430451|NCT04264442|582967209|FG000|Overall Study|Lost to Follow-up|2|||
161430452|NCT04264442|582967209|FG000|Overall Study|Sponsor Decision|23|||
161430453|NCT04264442|582967209|FG000|Overall Study|Withdrawal by Subject|11|||
161430454|NCT04264442|582967209|FG000|Overall Study|Study Termination|5|||
161430455|NCT03062358|582967212|FG000|Overall Study|Death|269|||
161430456|NCT03062358|582967213|FG001|Overall Study|Death|145|||
161430457|NCT03062358|582967212|FG000|Overall Study|Withdrawal by Subject|2|||
161430458|NCT03062358|582967213|FG001|Overall Study|Withdrawal by Subject|1|||
161430459|NCT03062358|582967212|FG000|Overall Study|Sponsor Decision|29|||
161430460|NCT03062358|582967213|FG001|Overall Study|Sponsor Decision|7|||
161430461|NCT00880698|582967214|FG000|Overall Study|Death|0|||
161430462|NCT00880698|582967215|FG001|Overall Study|Death|0|||
161430463|NCT00880698|582967216|FG002|Overall Study|Death|1|||
161430464|NCT00880698|582967217|FG003|Overall Study|Death|2|||
161430465|NCT00880698|582967214|FG000|Overall Study|Lost to Follow-up|1|||
161430466|NCT00880698|582967215|FG001|Overall Study|Lost to Follow-up|3|||
161430467|NCT00880698|582967216|FG002|Overall Study|Lost to Follow-up|0|||
161430468|NCT00880698|582967217|FG003|Overall Study|Lost to Follow-up|1|||
161430469|NCT01766050|582969102|FG000|Overall Study|Adverse Event|1|||
161430470|NCT01766050|582969102|FG000|Overall Study|Lost to Follow-up|1|||
161430471|NCT01766050|582969102|FG000|Overall Study|Withdrawal by Subject|2|||
161430472|NCT00812708|582969103|FG000|Overall Study|Device could not be implanted|2|||
161430473|NCT00812708|582969103|FG000|Overall Study|Lack of medical insurance|1|||
161430474|NCT00812708|582969103|FG000|Overall Study|Switched to another study|1|||
161430475|NCT00812708|582969103|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
161430476|NCT00812708|582969103|FG000|Overall Study|Signed consent but later withdrew|3|||
161430477|NCT01021020|582969105|FG000|Period I|Protocol Violation|1|||
161430478|NCT01021020|582969105|FG000|Period I|Withdrawal by Subject|1|||
161430479|NCT01021020|582969105|FG000|14 Day Washout Period A|Physician Decision|1|||
161430480|NCT00948246|582969106|FG000|Overall Study|Lost to Follow-up|11|||
161430481|NCT00948246|582969106|FG000|Overall Study|Adverse Event|11|||
161430482|NCT00948246|582969106|FG000|Overall Study|Death|1|||
161430483|NCT00948246|582969106|FG000|Overall Study|Withdrawal by Subject|1|||
161430484|NCT01706458|582969109|FG000|Overall Study|Physician Decision|3|||
161430485|NCT01706458|582969110|FG001|Overall Study|Physician Decision|4|||
161430486|NCT03547518|582969114|FG000|Overall Study|Lost to Follow-up|2|||
161430487|NCT03547518|582969115|FG001|Overall Study|Lost to Follow-up|0|||
161430488|NCT02766023|582969117|FG000|Overall Study|Lost to Follow-up|23|||
161430489|NCT02766023|582969118|FG001|Overall Study|Lost to Follow-up|11|||
161430490|NCT02766023|582969117|FG000|Overall Study|Pregnancy|1|||
161430491|NCT02766023|582969118|FG001|Overall Study|Pregnancy|0|||
161430492|NCT02766023|582969117|FG000|Overall Study|Adverse Event|1|||
161430493|NCT02766023|582969118|FG001|Overall Study|Adverse Event|0|||
161430494|NCT02766023|582969117|FG000|Overall Study|Withdrawal by Subject|4|||
161430495|NCT02766023|582969118|FG001|Overall Study|Withdrawal by Subject|5|||
161430496|NCT02766023|582969117|FG000|Overall Study|Physician Decision|1|||
161430497|NCT02766023|582969118|FG001|Overall Study|Physician Decision|0|||
161430498|NCT02766023|582969117|FG000|Overall Study|Not Eligible at Enrollment|0|||
161430499|NCT02766023|582969118|FG001|Overall Study|Not Eligible at Enrollment|1|||
161430500|NCT00286468|582969119|FG000|Overall Study|Hyperglycemic Rescue|28|||
161430501|NCT00286468|582969120|FG001|Overall Study|Hyperglycemic Rescue|30|||
161430502|NCT00286468|582969121|FG002|Overall Study|Hyperglycemic Rescue|31|||
161430503|NCT00286468|582969119|FG000|Overall Study|Adverse Event|2|||
161430504|NCT00286468|582969120|FG001|Overall Study|Adverse Event|6|||
161430505|NCT00286468|582969121|FG002|Overall Study|Adverse Event|4|||
161430506|NCT00286468|582969119|FG000|Overall Study|Protocol Violation|0|||
161430507|NCT00286468|582969120|FG001|Overall Study|Protocol Violation|3|||
161430508|NCT00286468|582969121|FG002|Overall Study|Protocol Violation|1|||
161430509|NCT00286468|582969119|FG000|Overall Study|Lost to Follow-up|1|||
161430510|NCT00286468|582969120|FG001|Overall Study|Lost to Follow-up|1|||
161430511|NCT00286468|582969121|FG002|Overall Study|Lost to Follow-up|2|||
161430512|NCT00286468|582969119|FG000|Overall Study|Withdrawal by Subject|3|||
161430513|NCT00286468|582969120|FG001|Overall Study|Withdrawal by Subject|8|||
161430514|NCT00286468|582969121|FG002|Overall Study|Withdrawal by Subject|11|||
161430515|NCT00286468|582969119|FG000|Overall Study|Physician Decision|3|||
161430516|NCT00286468|582969120|FG001|Overall Study|Physician Decision|2|||
161430517|NCT00286468|582969121|FG002|Overall Study|Physician Decision|1|||
161430518|NCT02953652|582969122|FG000|Overall Study|Adverse Event|18|||
161430519|NCT02953652|582969122|FG000|Overall Study|Withdrawal by Subject|6|||
161430520|NCT02953652|582969122|FG000|Overall Study|Protocol Violation|1|||
161430521|NCT02953652|582969122|FG000|Overall Study|Disease Progression|27|||
161430522|NCT02384551|582969126|FG000|Overall Study|Lost to Follow-up|13|||
161430523|NCT02384551|582969127|FG001|Overall Study|Lost to Follow-up|14|||
161430524|NCT02384551|582969128|FG002|Overall Study|Lost to Follow-up|14|||
161430525|NCT02384551|582969129|FG003|Overall Study|Lost to Follow-up|14|||
161430526|NCT04742556|582969134|FG000|Overall Study|Withdrawal by Subject|0|||
161430527|NCT04742556|582969135|FG001|Overall Study|Withdrawal by Subject|1|||
161430528|NCT04742556|582969136|FG002|Overall Study|Withdrawal by Subject|0|||
161430529|NCT04742556|582969134|FG000|Overall Study|Adverse Event|0|||
161430530|NCT04742556|582969135|FG001|Overall Study|Adverse Event|0|||
161430531|NCT04742556|582969136|FG002|Overall Study|Adverse Event|2|||
161430532|NCT04742556|582969134|FG000|Overall Study|Clinical disease progression|0|||
161430533|NCT04742556|582969135|FG001|Overall Study|Clinical disease progression|1|||
161430534|NCT04742556|582969136|FG002|Overall Study|Clinical disease progression|2|||
161430535|NCT04742556|582969134|FG000|Overall Study|Objective disease progression|3|||
161430536|NCT04742556|582969135|FG001|Overall Study|Objective disease progression|2|||
161430537|NCT04742556|582969136|FG002|Overall Study|Objective disease progression|4|||
161430538|NCT04247347|582969137|FG000|Overall Study|Withdrawal by Subject|2|||
161430539|NCT04247347|582969138|FG001|Overall Study|Withdrawal by Subject|3|||
161430540|NCT04247347|582969139|FG002|Overall Study|Withdrawal by Subject|3|||
161430541|NCT04247347|582969137|FG000|Overall Study|Lost to Follow-up|1|||
161430542|NCT04247347|582969138|FG001|Overall Study|Lost to Follow-up|1|||
161430543|NCT04247347|582969139|FG002|Overall Study|Lost to Follow-up|1|||
161430544|NCT03035032|582969140|FG000|Overall Study|Adverse Event|2|||
161430545|NCT03035032|582969140|FG000|Overall Study|Death|9|||
161430546|NCT03035032|582969140|FG000|Overall Study|Lost to Follow-up|1|||
161430547|NCT03035032|582969140|FG000|Overall Study|Progressive Disease|22|||
161430548|NCT03035032|582969140|FG000|Overall Study|Protocol Violation|2|||
161430549|NCT03035032|582969140|FG000|Overall Study|Withdrawal by Subject|2|||
161430550|NCT03035032|582969140|FG000|Overall Study|Physician Decision|5|||
161430551|NCT03562195|582969141|FG000|Overall Study|Adverse Event|0|||
161430552|NCT03562195|582969142|FG001|Overall Study|Adverse Event|6|||
161430553|NCT03562195|582969141|FG000|Overall Study|Lack of Efficacy|0|||
161430554|NCT03562195|582969142|FG001|Overall Study|Lack of Efficacy|5|||
161430555|NCT03562195|582969141|FG000|Overall Study|Protocol Violation|0|||
161430556|NCT03562195|582969142|FG001|Overall Study|Protocol Violation|1|||
161430557|NCT03562195|582969141|FG000|Overall Study|Lost to Follow-up|0|||
161430558|NCT03562195|582969142|FG001|Overall Study|Lost to Follow-up|1|||
161430559|NCT03562195|582969141|FG000|Overall Study|Physician Decision|1|||
161430560|NCT03562195|582969142|FG001|Overall Study|Physician Decision|0|||
161430561|NCT03562195|582969141|FG000|Overall Study|Withdrawal by Subject|3|||
161430562|NCT03562195|582969142|FG001|Overall Study|Withdrawal by Subject|0|||
161430563|NCT02923726|582969143|FG000|Overall Study|Death|196|||
161430564|NCT02923726|582969144|FG001|Overall Study|Death|175|||
161430565|NCT02923726|582969143|FG000|Overall Study|Withdrawal by Subject|337|||
161430566|NCT02923726|582969144|FG001|Overall Study|Withdrawal by Subject|307|||
161430567|NCT01176032|582969159|FG000|Overall Study|Adverse Event|1|||
161430568|NCT01176032|582969160|FG001|Overall Study|Adverse Event|0|||
161430569|NCT01176032|582969159|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161430570|NCT01176032|582969160|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161430571|NCT01176032|582969159|FG000|Overall Study|Protocol Violation|1|||
161430572|NCT01176032|582969160|FG001|Overall Study|Protocol Violation|0|||
161430573|NCT01176032|582969159|FG000|Overall Study|Informed consent withdrawn|3|||
161430574|NCT01176032|582969160|FG001|Overall Study|Informed consent withdrawn|0|||
161430575|NCT01176032|582969159|FG000|Overall Study|Other|1|||
161430576|NCT01176032|582969160|FG001|Overall Study|Other|0|||
161430577|NCT01469221|582969161|FG000|Double Blind Phase|Protocol Violation|1|||
161430578|NCT01469221|582969162|FG001|Double Blind Phase|Protocol Violation|0|||
161430579|NCT01469221|582969163|FG002|Double Blind Phase|Protocol Violation|0|||
161430580|NCT01469221|582969161|FG000|Double Blind Phase|Physician Decision|1|||
161430581|NCT01469221|582969162|FG001|Double Blind Phase|Physician Decision|1|||
161430582|NCT01469221|582969163|FG002|Double Blind Phase|Physician Decision|0|||
161430583|NCT01469221|582969161|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
161430584|NCT01469221|582969162|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
161430585|NCT01469221|582969163|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
161430586|NCT04038359|582969165|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
161430587|NCT04038359|582969166|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
161430588|NCT04038359|582969165|FG000|Overall Study|Death|8|||
161430589|NCT04038359|582969166|FG001|Overall Study|Death|7|||
161430590|NCT04038359|582969165|FG000|Overall Study|Lost to Follow-up|3|||
161430591|NCT04038359|582969166|FG001|Overall Study|Lost to Follow-up|0|||
161430592|NCT04038359|582969165|FG000|Overall Study|Participant Moved|1|||
161430593|NCT04038359|582969166|FG001|Overall Study|Participant Moved|0|||
161430594|NCT04038359|582969165|FG000|Overall Study|Withdrawal by Subject|4|||
161430595|NCT04038359|582969166|FG001|Overall Study|Withdrawal by Subject|3|||
161430596|NCT04038359|582969165|FG000|Overall Study|Physician Decision|3|||
161430597|NCT04038359|582969166|FG001|Overall Study|Physician Decision|2|||
161430598|NCT04038359|582969165|FG000|Overall Study|Adverse Event|0|||
161430599|NCT04038359|582969166|FG001|Overall Study|Adverse Event|2|||
161430600|NCT04038359|582969165|FG000|Overall Study|Progressive Disease|0|||
161430601|NCT04038359|582969166|FG001|Overall Study|Progressive Disease|1|||
161430602|NCT00475670|582969167|FG000|Overall Study|Death|0|||
161430603|NCT00475670|582969168|FG001|Overall Study|Death|1|||
161430604|NCT00475670|582969167|FG000|Overall Study|Lack of Efficacy|3|||
161430605|NCT00475670|582969168|FG001|Overall Study|Lack of Efficacy|34|||
161430606|NCT00475670|582969167|FG000|Overall Study|Refused treatment|0|||
161430607|NCT00475670|582969168|FG001|Overall Study|Refused treatment|2|||
161430608|NCT00475670|582969167|FG000|Overall Study|Failure to Return|0|||
161430609|NCT00475670|582969168|FG001|Overall Study|Failure to Return|1|||
161430610|NCT00475670|582969167|FG000|Overall Study|Other|0|||
161430611|NCT00475670|582969168|FG001|Overall Study|Other|3|||
161430612|NCT01168349|582969169|FG000|Overall Study|Death|157|||
161430613|NCT01168349|582969169|FG000|Overall Study|Lost to Follow-up|34|||
161430614|NCT01168349|582969169|FG000|Overall Study|Withdrawal by Subject|9|||
161430615|NCT01168349|582969169|FG000|Overall Study|Kidney transplantation|3|||
161430616|NCT01168349|582969169|FG000|Overall Study|Other|22|||
161430617|NCT01168349|582969169|FG000|Overall Study|Protocol Violation|76|||
161430618|NCT01033240|582969170|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
161430619|NCT01033240|582969171|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
161430620|NCT01033240|582969172|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
161430621|NCT01033240|582969170|FG000|Overall Study|Death|2|||
161430622|NCT01033240|582969171|FG001|Overall Study|Death|0|||
161430623|NCT01033240|582969172|FG002|Overall Study|Death|0|||
161430624|NCT01033240|582969170|FG000|Overall Study|Withdrew Consent|2|||
161430625|NCT01033240|582969171|FG001|Overall Study|Withdrew Consent|9|||
161430626|NCT01033240|582969172|FG002|Overall Study|Withdrew Consent|2|||
161430627|NCT01033240|582969170|FG000|Overall Study|Disease Progression|35|||
161430628|NCT01033240|582969171|FG001|Overall Study|Disease Progression|32|||
161430629|NCT01033240|582969172|FG002|Overall Study|Disease Progression|41|||
161430630|NCT01033240|582969170|FG000|Overall Study|Investigator Discretion|0|||
161430631|NCT01033240|582969171|FG001|Overall Study|Investigator Discretion|0|||
161430632|NCT01033240|582969172|FG002|Overall Study|Investigator Discretion|2|||
161430633|NCT01033240|582969170|FG000|Overall Study|Other|0|||
161430634|NCT01033240|582969171|FG001|Overall Study|Other|1|||
161430635|NCT01033240|582969172|FG002|Overall Study|Other|2|||
161430636|NCT00918385|582969176|FG000|Monotherapy|Adverse Event|1|||
161430637|NCT00918385|582969177|FG001|Monotherapy|Adverse Event|6|||
161430638|NCT00918385|582969176|FG000|Monotherapy|Complicating illness|1|||
161430639|NCT00918385|582969177|FG001|Monotherapy|Complicating illness|0|||
161430640|NCT00918385|582969176|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
161430641|NCT00918385|582969177|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
161430642|NCT00918385|582969176|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
161430643|NCT00918385|582969177|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
161430644|NCT00918385|582969176|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
161430645|NCT00918385|582969177|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
161430646|NCT00918385|582969176|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
161430647|NCT00918385|582969177|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
161430648|NCT01476722|582969180|FG000|Overall Study|Adverse Event|1|||
161430649|NCT02978417|582969184|FG000|Overall Study|Lost to Follow-up|2|||
161430650|NCT02978417|582969185|FG001|Overall Study|Lost to Follow-up|2|||
161430651|NCT02675907|582969188|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
161430652|NCT02675907|582969189|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
161430653|NCT02675907|582969188|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
161430654|NCT02675907|582969189|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
161430655|NCT02675907|582969188|FG000|Study Overall|Lack of Efficacy|1|||
161430656|NCT02675907|582969189|FG001|Study Overall|Lack of Efficacy|0|||
161430657|NCT02675907|582969188|FG000|Study Overall|Withdrawal by Subject|2|||
161430658|NCT02675907|582969189|FG001|Study Overall|Withdrawal by Subject|2|||
161430659|NCT02675907|582969188|FG000|Study Overall|Lost to Follow-up|0|||
161430660|NCT02675907|582969189|FG001|Study Overall|Lost to Follow-up|2|||
161430661|NCT01323582|582969190|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
161430662|NCT01323582|582969191|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
161430663|NCT01323582|582969190|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
161430664|NCT01323582|582969191|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
161430665|NCT01323582|582969190|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
161430666|NCT01323582|582969191|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
161430667|NCT00168844|582969192|FG000|Overall Study|Adverse Event|31|||
161430668|NCT00168844|582969193|FG001|Overall Study|Adverse Event|32|||
161430669|NCT00168844|582969194|FG002|Overall Study|Adverse Event|48|||
161430670|NCT00168844|582969192|FG000|Overall Study|Lost to Follow-up|4|||
161430671|NCT00168844|582969193|FG001|Overall Study|Lost to Follow-up|5|||
161430672|NCT00168844|582969194|FG002|Overall Study|Lost to Follow-up|11|||
161430673|NCT00168844|582969192|FG000|Overall Study|Withdrawal by Subject|12|||
161430674|NCT00168844|582969193|FG001|Overall Study|Withdrawal by Subject|9|||
161430675|NCT00168844|582969194|FG002|Overall Study|Withdrawal by Subject|19|||
161430676|NCT00168844|582969192|FG000|Overall Study|Protocol Violation|2|||
161430677|NCT00168844|582969193|FG001|Overall Study|Protocol Violation|2|||
161430678|NCT00168844|582969194|FG002|Overall Study|Protocol Violation|4|||
161430679|NCT00168844|582969192|FG000|Overall Study|Other|6|||
161430680|NCT00168844|582969193|FG001|Overall Study|Other|7|||
161430681|NCT00168844|582969194|FG002|Overall Study|Other|9|||
161430682|NCT00525512|582969205|FG000|Double-Blind Phase|Adverse Event|48|||
161430683|NCT00525512|582969206|FG001|Double-Blind Phase|Adverse Event|28|||
161430684|NCT00525512|582969207|FG002|Double-Blind Phase|Adverse Event|0|||
161430685|NCT00525512|582969208|FG003|Double-Blind Phase|Adverse Event|0|||
161430686|NCT00525512|582969205|FG000|Double-Blind Phase|Protocol Violation|3|||
161430687|NCT00525512|582969206|FG001|Double-Blind Phase|Protocol Violation|1|||
161430688|NCT00525512|582969207|FG002|Double-Blind Phase|Protocol Violation|0|||
161430689|NCT00525512|582969208|FG003|Double-Blind Phase|Protocol Violation|0|||
161430690|NCT00525512|582969205|FG000|Double-Blind Phase|Lost to Follow-up|3|||
161430691|NCT00525512|582969206|FG001|Double-Blind Phase|Lost to Follow-up|7|||
161430692|NCT00525512|582969207|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161430693|NCT00525512|582969208|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161430694|NCT00525512|582969205|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
161430695|NCT00525512|582969206|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
161430696|NCT00525512|582969207|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161430697|NCT00525512|582969208|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161430698|NCT00525512|582969205|FG000|Double-Blind Phase|Lack of Efficacy|13|||
161430699|NCT00525512|582969206|FG001|Double-Blind Phase|Lack of Efficacy|5|||
161430700|NCT00525512|582969207|FG002|Double-Blind Phase|Lack of Efficacy|0|||
161430701|NCT00525512|582969208|FG003|Double-Blind Phase|Lack of Efficacy|0|||
161430702|NCT00525512|582969205|FG000|Double-Blind Phase|Other reason (not specified)|12|||
161430703|NCT00525512|582969206|FG001|Double-Blind Phase|Other reason (not specified)|13|||
161430704|NCT00525512|582969207|FG002|Double-Blind Phase|Other reason (not specified)|0|||
161430705|NCT00525512|582969208|FG003|Double-Blind Phase|Other reason (not specified)|0|||
161430706|NCT00525512|582969205|FG000|Open-Label Phase|Adverse Event|0|||
161430707|NCT00525512|582969206|FG001|Open-Label Phase|Adverse Event|0|||
161430708|NCT00525512|582969207|FG002|Open-Label Phase|Adverse Event|1|||
161430709|NCT00525512|582969208|FG003|Open-Label Phase|Adverse Event|0|||
161430710|NCT00525512|582969205|FG000|Open-Label Phase|Lost to Follow-up|0|||
161430711|NCT00525512|582969206|FG001|Open-Label Phase|Lost to Follow-up|0|||
161430712|NCT00525512|582969207|FG002|Open-Label Phase|Lost to Follow-up|1|||
161430713|NCT00525512|582969208|FG003|Open-Label Phase|Lost to Follow-up|0|||
161430714|NCT00525512|582969205|FG000|Open-Label Phase|Other reason (not specified)|0|||
161430715|NCT00525512|582969206|FG001|Open-Label Phase|Other reason (not specified)|0|||
161430716|NCT00525512|582969207|FG002|Open-Label Phase|Other reason (not specified)|4|||
161430717|NCT00525512|582969208|FG003|Open-Label Phase|Other reason (not specified)|5|||
161430718|NCT01601535|582969209|FG000|Phase 1|Adverse Event|1|||
161430719|NCT01601535|582969210|FG001|Phase 1|Adverse Event|0|||
161430720|NCT01601535|582969211|FG002|Phase 1|Adverse Event|2|||
161430721|NCT01601535|582969212|FG003|Phase 1|Adverse Event|1|||
161430722|NCT01601535|582969213|FG004|Phase 1|Adverse Event|0|||
161430723|NCT01601535|582969214|FG005|Phase 1|Adverse Event|0|||
161430724|NCT01601535|582969209|FG000|Phase 1|Withdrawal by Subject|2|||
161430725|NCT01601535|582969210|FG001|Phase 1|Withdrawal by Subject|1|||
161430726|NCT01601535|582969211|FG002|Phase 1|Withdrawal by Subject|1|||
161430727|NCT01601535|582969212|FG003|Phase 1|Withdrawal by Subject|2|||
161430728|NCT01601535|582969213|FG004|Phase 1|Withdrawal by Subject|0|||
161430729|NCT01601535|582969214|FG005|Phase 1|Withdrawal by Subject|0|||
161430730|NCT01601535|582969209|FG000|Phase 1|Progressive Disease|2|||
161430731|NCT01601535|582969210|FG001|Phase 1|Progressive Disease|3|||
161430732|NCT01601535|582969211|FG002|Phase 1|Progressive Disease|2|||
161430733|NCT01601535|582969212|FG003|Phase 1|Progressive Disease|1|||
161430734|NCT01601535|582969213|FG004|Phase 1|Progressive Disease|0|||
161430735|NCT01601535|582969214|FG005|Phase 1|Progressive Disease|0|||
161430736|NCT01601535|582969209|FG000|Phase 1|Started Another Treatment|1|||
161430737|NCT01601535|582969210|FG001|Phase 1|Started Another Treatment|2|||
161430738|NCT01601535|582969211|FG002|Phase 1|Started Another Treatment|0|||
161430739|NCT01601535|582969212|FG003|Phase 1|Started Another Treatment|0|||
161430740|NCT01601535|582969213|FG004|Phase 1|Started Another Treatment|0|||
161430741|NCT01601535|582969214|FG005|Phase 1|Started Another Treatment|0|||
161430742|NCT01601535|582969209|FG000|Phase 2|Adverse Event|0|||
161430743|NCT01601535|582969210|FG001|Phase 2|Adverse Event|0|||
161430744|NCT01601535|582969211|FG002|Phase 2|Adverse Event|0|||
161430745|NCT01601535|582969212|FG003|Phase 2|Adverse Event|0|||
161430746|NCT01601535|582969213|FG004|Phase 2|Adverse Event|5|||
161430747|NCT01601535|582969214|FG005|Phase 2|Adverse Event|1|||
161430748|NCT01601535|582969209|FG000|Phase 2|Withdrawal by Subject|0|||
161430749|NCT01601535|582969210|FG001|Phase 2|Withdrawal by Subject|0|||
161430750|NCT01601535|582969211|FG002|Phase 2|Withdrawal by Subject|0|||
161430751|NCT01601535|582969212|FG003|Phase 2|Withdrawal by Subject|0|||
161430752|NCT01601535|582969213|FG004|Phase 2|Withdrawal by Subject|8|||
161430753|NCT01601535|582969214|FG005|Phase 2|Withdrawal by Subject|2|||
161430754|NCT01601535|582969209|FG000|Phase 2|Progressive Disease|0|||
161430755|NCT01601535|582969210|FG001|Phase 2|Progressive Disease|0|||
161430756|NCT01601535|582969211|FG002|Phase 2|Progressive Disease|0|||
161430757|NCT01601535|582969212|FG003|Phase 2|Progressive Disease|0|||
161430758|NCT01601535|582969213|FG004|Phase 2|Progressive Disease|5|||
161430759|NCT01601535|582969214|FG005|Phase 2|Progressive Disease|7|||
161430760|NCT01601535|582969209|FG000|Phase 2|Started Another Treatment|0|||
161430761|NCT01601535|582969210|FG001|Phase 2|Started Another Treatment|0|||
161430762|NCT01601535|582969211|FG002|Phase 2|Started Another Treatment|0|||
161430763|NCT01601535|582969212|FG003|Phase 2|Started Another Treatment|0|||
161430764|NCT01601535|582969213|FG004|Phase 2|Started Another Treatment|1|||
161430765|NCT01601535|582969214|FG005|Phase 2|Started Another Treatment|2|||
161430766|NCT03600909|582969217|FG000|Overall Study|Not treated|0|||
161430767|NCT03600909|582969218|FG001|Overall Study|Not treated|3|||
161430768|NCT03600909|582969219|FG002|Overall Study|Not treated|0|||
161430769|NCT04576988|582969220|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
161430770|NCT04576988|582969221|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
161430771|NCT04576988|582969220|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
161430772|NCT04576988|582969221|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
161430773|NCT04576988|582969220|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
161430774|NCT04576988|582969221|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
161430775|NCT04576988|582969220|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
161430776|NCT04576988|582969221|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
161430777|NCT04576988|582969220|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
161430778|NCT04576988|582969221|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
161430779|NCT04576988|582969220|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
161430780|NCT04576988|582969221|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
161430781|NCT04576988|582969220|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
161430782|NCT04576988|582969221|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
161430783|NCT04576988|582969220|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
161430784|NCT04576988|582969221|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
161430785|NCT04576988|582969220|FG000|Long Term Double Blind (LTDB)|Death|2|||
161430786|NCT04576988|582969221|FG001|Long Term Double Blind (LTDB)|Death|1|||
161430787|NCT04576988|582969220|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
161430788|NCT04576988|582969221|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
161430789|NCT03309020|582969222|FG000|Overall Study|Death|1|||
161430790|NCT03309020|582969223|FG001|Overall Study|Death|0|||
161430791|NCT03309020|582969222|FG000|Overall Study|Did not undergo surgery|2|||
161430792|NCT03309020|582969223|FG001|Overall Study|Did not undergo surgery|1|||
161430793|NCT02362724|582969232|FG000|Overall Study|Withdrawal by Subject|3|||
161430794|NCT02362724|582969233|FG001|Overall Study|Withdrawal by Subject|1|||
161430795|NCT02362724|582969232|FG000|Overall Study|Adverse Event|3|||
161430796|NCT02362724|582969233|FG001|Overall Study|Adverse Event|0|||
161430797|NCT02919761|582969241|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
161430798|NCT02919761|582969242|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
161430799|NCT02919761|582969243|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
161430800|NCT02919761|582969241|FG000|Part 1: Open Label|Adverse Event|1|||
161430801|NCT02919761|582969242|FG001|Part 1: Open Label|Adverse Event|0|||
161430802|NCT02919761|582969243|FG002|Part 1: Open Label|Adverse Event|0|||
161430803|NCT02919761|582969241|FG000|Part 1: Open Label|Lost to Follow-up|1|||
161430804|NCT02919761|582969242|FG001|Part 1: Open Label|Lost to Follow-up|0|||
161430805|NCT02919761|582969243|FG002|Part 1: Open Label|Lost to Follow-up|0|||
161430806|NCT02919761|582969241|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
161430807|NCT02919761|582969242|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
161430808|NCT02919761|582969243|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
161430809|NCT02919761|582969241|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
161430810|NCT02919761|582969242|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
161430811|NCT02919761|582969243|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
161430812|NCT02919761|582969241|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
161430813|NCT02919761|582969242|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
161430814|NCT02919761|582969243|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
161430815|NCT02919761|582969241|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
161430816|NCT02919761|582969242|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
161430817|NCT02919761|582969243|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
161430818|NCT02919761|582969241|FG000|Part 1: Open Label|Termination by Sponsor|1|||
161430819|NCT02919761|582969242|FG001|Part 1: Open Label|Termination by Sponsor|0|||
161430820|NCT02919761|582969243|FG002|Part 1: Open Label|Termination by Sponsor|0|||
161430821|NCT02919761|582969241|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
161430822|NCT02919761|582969242|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
161430823|NCT02919761|582969243|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
161430824|NCT02919761|582969241|FG000|Part 2: Double-blind|Adverse Event|0|||
161430825|NCT02919761|582969242|FG001|Part 2: Double-blind|Adverse Event|1|||
161430826|NCT02919761|582969243|FG002|Part 2: Double-blind|Adverse Event|0|||
161430827|NCT02919761|582969241|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
161430828|NCT02919761|582969242|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
161430829|NCT02919761|582969243|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
161430830|NCT02919761|582969241|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
161430831|NCT02919761|582969242|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
161430832|NCT02919761|582969243|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
161430833|NCT02919761|582969241|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
161430834|NCT02919761|582969242|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
161430835|NCT02919761|582969243|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
161430836|NCT02919761|582969241|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
161430837|NCT02919761|582969242|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
161430838|NCT02919761|582969243|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
161430839|NCT02919761|582969241|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
161430840|NCT02919761|582969242|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
161430841|NCT02919761|582969243|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
161430842|NCT02919761|582969241|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
161430843|NCT02919761|582969242|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
161430844|NCT02919761|582969243|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
161430845|NCT03724942|582969244|FG000|Overall Study|Adverse Event|20|||
161430846|NCT03724942|582969245|FG001|Overall Study|Adverse Event|14|||
161430847|NCT03724942|582969244|FG000|Overall Study|Lack of Efficacy|0|||
161430848|NCT03724942|582969245|FG001|Overall Study|Lack of Efficacy|1|||
161430849|NCT03724942|582969244|FG000|Overall Study|Physician Decision|5|||
161430850|NCT03724942|582969245|FG001|Overall Study|Physician Decision|2|||
161430851|NCT03724942|582969244|FG000|Overall Study|Protocol Violation|1|||
161430852|NCT03724942|582969245|FG001|Overall Study|Protocol Violation|0|||
161430853|NCT03724942|582969244|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
161430854|NCT03724942|582969245|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
161430855|NCT03724942|582969244|FG000|Overall Study|Withdrawal by Legal Representative|3|||
161430856|NCT03724942|582969245|FG001|Overall Study|Withdrawal by Legal Representative|0|||
161430857|NCT02994108|582971167|FG000|Intervention Messages|Withdrawal by Subject|2|||
161430858|NCT02994108|582971168|FG001|Intervention Messages|Withdrawal by Subject|0|||
161430859|NCT02994108|582971167|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
161430860|NCT02994108|582971168|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
161430861|NCT02994108|582971167|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
161430862|NCT02994108|582971168|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
161430863|NCT02994108|582971167|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
161430864|NCT02994108|582971168|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
161430865|NCT00089297|582971169|FG000|Overall Study|Adverse Event|9|||
161430866|NCT00089297|582971169|FG000|Overall Study|Death|1|||
161430867|NCT00089297|582971169|FG000|Overall Study|Withdrawal by Subject|12|||
161430868|NCT00089297|582971169|FG000|Overall Study|Disease progression|2|||
161430869|NCT00089297|582971169|FG000|Overall Study|Ineligible|11|||
161430870|NCT00089297|582971169|FG000|Overall Study|Secondary malignancy|1|||
161430871|NCT00089297|582971169|FG000|Overall Study|IRB approval not ready|1|||
161430872|NCT00089297|582971169|FG000|Overall Study|Non-compliance|1|||
161430873|NCT00904969|582971170|FG000|Overall Study|Lost to Follow-up|4|||
161430874|NCT00904969|582971170|FG000|Overall Study|Withdrawal by Subject|3|||
161430875|NCT00904969|582971170|FG000|Overall Study|Additional Treatments|11|||
161430876|NCT00904969|582971170|FG000|Overall Study|Case Aborted; Subject Exited|1|||
161430877|NCT01295814|582971177|FG000|Overall Study|Lack of Efficacy|0|||
161430878|NCT01295814|582971178|FG001|Overall Study|Lack of Efficacy|2|||
161430879|NCT01295814|582971177|FG000|Overall Study|Withdrawal by Subject|2|||
161430880|NCT01295814|582971178|FG001|Overall Study|Withdrawal by Subject|0|||
161430881|NCT03414983|582971179|FG000|Pre-Treatment|Other reasons|1|||
161430882|NCT03414983|582971180|FG001|Pre-Treatment|Other reasons|0|||
161430883|NCT03414983|582971179|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
161430884|NCT03414983|582971180|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
161430885|NCT03414983|582971179|FG000|Pre-Treatment|Participant withdrew consent|1|||
161430886|NCT03414983|582971180|FG001|Pre-Treatment|Participant withdrew consent|3|||
161430887|NCT03414983|582971179|FG000|Treatment|Participant withdrew consent|4|||
161430888|NCT03414983|582971180|FG001|Treatment|Participant withdrew consent|3|||
161430889|NCT03414983|582971179|FG000|Treatment|Participant request to discontinue study treatment|8|||
161430890|NCT03414983|582971180|FG001|Treatment|Participant request to discontinue study treatment|10|||
161430891|NCT03414983|582971179|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
161430892|NCT03414983|582971180|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
161430893|NCT03414983|582971179|FG000|Treatment|Death|0|||
161430894|NCT03414983|582971180|FG001|Treatment|Death|1|||
161430895|NCT03414983|582971179|FG000|Treatment|Study Drug Toxicity|10|||
161430896|NCT03414983|582971180|FG001|Treatment|Study Drug Toxicity|5|||
161430897|NCT03414983|582971179|FG000|Treatment|Disease Progression|75|||
161430898|NCT03414983|582971180|FG001|Treatment|Disease Progression|29|||
161430899|NCT03414983|582971179|FG000|Treatment|Not reported|1|||
161430900|NCT03414983|582971180|FG001|Treatment|Not reported|0|||
161430901|NCT03414983|582971179|FG000|Treatment|Other reasons|3|||
161430902|NCT03414983|582971180|FG001|Treatment|Other reasons|2|||
161430903|NCT03414983|582971179|FG000|Treatment|Poor/non-compliance|2|||
161430904|NCT03414983|582971180|FG001|Treatment|Poor/non-compliance|0|||
161430905|NCT03414983|582971179|FG000|Treatment|Maximum clinical benefit|5|||
161430906|NCT03414983|582971180|FG001|Treatment|Maximum clinical benefit|9|||
161430907|NCT03414983|582971179|FG000|Treatment|Lost to Follow-up|0|||
161430908|NCT03414983|582971180|FG001|Treatment|Lost to Follow-up|1|||
161430909|NCT03414983|582971179|FG000|Treatment|Administrative reasons by sponsor|1|||
161430910|NCT03414983|582971180|FG001|Treatment|Administrative reasons by sponsor|0|||
161430911|NCT04515771|582971188|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
161430912|NCT04515771|582971189|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
161430913|NCT04515771|582971188|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
161430914|NCT04515771|582971189|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
161430915|NCT04515771|582971188|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
161430916|NCT04515771|582971189|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
161430917|NCT00148317|582971193|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
161430918|NCT00148317|582971193|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
161430919|NCT00148317|582971193|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
161430920|NCT04199351|582971196|FG000|Overall Study|Decision by sponsor|0|||
161430921|NCT04199351|582971197|FG001|Overall Study|Decision by sponsor|0|||
161430922|NCT04199351|582971198|FG002|Overall Study|Decision by sponsor|0|||
161430923|NCT04199351|582971199|FG003|Overall Study|Decision by sponsor|2|||
161430924|NCT04199351|582971200|FG004|Overall Study|Decision by sponsor|0|||
161430925|NCT04199351|582971201|FG005|Overall Study|Decision by sponsor|0|||
161430926|NCT04199351|582971202|FG006|Overall Study|Decision by sponsor|0|||
161430927|NCT04199351|582971203|FG007|Overall Study|Decision by sponsor|0|||
161430928|NCT04199351|582971204|FG008|Overall Study|Decision by sponsor|0|||
161430929|NCT04199351|582971205|FG009|Overall Study|Decision by sponsor|6|||
161430930|NCT04199351|582971196|FG000|Overall Study|Lost to Follow-up|0|||
161430931|NCT04199351|582971197|FG001|Overall Study|Lost to Follow-up|0|||
161430932|NCT04199351|582971198|FG002|Overall Study|Lost to Follow-up|1|||
161430933|NCT04199351|582971199|FG003|Overall Study|Lost to Follow-up|0|||
161430934|NCT04199351|582971200|FG004|Overall Study|Lost to Follow-up|0|||
161430935|NCT04199351|582971201|FG005|Overall Study|Lost to Follow-up|1|||
161430936|NCT04199351|582971202|FG006|Overall Study|Lost to Follow-up|0|||
161430937|NCT04199351|582971203|FG007|Overall Study|Lost to Follow-up|0|||
161430938|NCT04199351|582971204|FG008|Overall Study|Lost to Follow-up|0|||
161430939|NCT04199351|582971205|FG009|Overall Study|Lost to Follow-up|0|||
161430940|NCT04199351|582971196|FG000|Overall Study|Withdrawal by Subject|0|||
161430941|NCT04199351|582971197|FG001|Overall Study|Withdrawal by Subject|1|||
161430942|NCT04199351|582971198|FG002|Overall Study|Withdrawal by Subject|0|||
161430943|NCT04199351|582971199|FG003|Overall Study|Withdrawal by Subject|0|||
161430944|NCT04199351|582971200|FG004|Overall Study|Withdrawal by Subject|1|||
161430945|NCT04199351|582971201|FG005|Overall Study|Withdrawal by Subject|4|||
161430946|NCT04199351|582971202|FG006|Overall Study|Withdrawal by Subject|2|||
161430947|NCT04199351|582971203|FG007|Overall Study|Withdrawal by Subject|0|||
161430948|NCT04199351|582971204|FG008|Overall Study|Withdrawal by Subject|3|||
161430949|NCT04199351|582971205|FG009|Overall Study|Withdrawal by Subject|0|||
161430950|NCT03623243|582971208|FG000|Overall Study|Adverse Event|15|||
161430951|NCT03623243|582971208|FG000|Overall Study|Guardian Decision|1|||
161430952|NCT03623243|582971208|FG000|Overall Study|New Therapy for Study Indication|1|||
161430953|NCT03623243|582971208|FG000|Overall Study|Protocol Deviation|3|||
161430954|NCT03623243|582971208|FG000|Overall Study|Physician Decision|4|||
161430955|NCT03623243|582971208|FG000|Overall Study|Patient Decision|15|||
161430956|NCT03007966|582971209|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
161430957|NCT03007966|582971210|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
161430958|NCT00979901|582971214|FG000|Overall Study|Adverse Event|1|||
161430959|NCT00979901|582971215|FG001|Overall Study|Adverse Event|3|||
161430960|NCT00979901|582971216|FG002|Overall Study|Adverse Event|9|||
161430961|NCT00979901|582971217|FG003|Overall Study|Adverse Event|2|||
161430962|NCT00979901|582971214|FG000|Overall Study|Lack of Efficacy|8|||
161430963|NCT00979901|582971215|FG001|Overall Study|Lack of Efficacy|4|||
161430964|NCT00979901|582971216|FG002|Overall Study|Lack of Efficacy|9|||
161430965|NCT00979901|582971217|FG003|Overall Study|Lack of Efficacy|0|||
161430966|NCT00979901|582971214|FG000|Overall Study|Lost to Follow-up|1|||
161430967|NCT00979901|582971215|FG001|Overall Study|Lost to Follow-up|1|||
161430968|NCT00979901|582971216|FG002|Overall Study|Lost to Follow-up|2|||
161430969|NCT00979901|582971217|FG003|Overall Study|Lost to Follow-up|0|||
161430970|NCT00979901|582971214|FG000|Overall Study|Protocol Violation|2|||
161430971|NCT00979901|582971215|FG001|Overall Study|Protocol Violation|2|||
161430972|NCT00979901|582971216|FG002|Overall Study|Protocol Violation|7|||
161430973|NCT00979901|582971217|FG003|Overall Study|Protocol Violation|1|||
161430974|NCT00979901|582971214|FG000|Overall Study|Withdrawal by Subject|2|||
161430975|NCT00979901|582971215|FG001|Overall Study|Withdrawal by Subject|1|||
161430976|NCT00979901|582971216|FG002|Overall Study|Withdrawal by Subject|1|||
161435560|NCT00107653|582988056|FG001|Overall Study|Protocol Violation|0|||
161430977|NCT00979901|582971217|FG003|Overall Study|Withdrawal by Subject|1|||
161430978|NCT00979901|582971214|FG000|Overall Study|Noncompliance|1|||
161430979|NCT00979901|582971215|FG001|Overall Study|Noncompliance|0|||
161430980|NCT00979901|582971216|FG002|Overall Study|Noncompliance|0|||
161430981|NCT00979901|582971217|FG003|Overall Study|Noncompliance|0|||
161430982|NCT00979901|582971214|FG000|Overall Study|out-of-state|1|||
161430983|NCT00979901|582971215|FG001|Overall Study|out-of-state|0|||
161430984|NCT00979901|582971216|FG002|Overall Study|out-of-state|0|||
161430985|NCT00979901|582971217|FG003|Overall Study|out-of-state|0|||
161430986|NCT00979901|582971214|FG000|Overall Study|vacation|1|||
161430987|NCT00979901|582971215|FG001|Overall Study|vacation|0|||
161430988|NCT00979901|582971216|FG002|Overall Study|vacation|0|||
161430989|NCT00979901|582971217|FG003|Overall Study|vacation|0|||
161430990|NCT00979901|582971214|FG000|Overall Study|elevated lab values pre-randomization|1|||
161430991|NCT00979901|582971215|FG001|Overall Study|elevated lab values pre-randomization|0|||
161430992|NCT00979901|582971216|FG002|Overall Study|elevated lab values pre-randomization|0|||
161430993|NCT00979901|582971217|FG003|Overall Study|elevated lab values pre-randomization|0|||
161430994|NCT00979901|582971214|FG000|Overall Study|Discontinued in Error|0|||
161430995|NCT00979901|582971215|FG001|Overall Study|Discontinued in Error|1|||
161430996|NCT00979901|582971216|FG002|Overall Study|Discontinued in Error|0|||
161430997|NCT00979901|582971217|FG003|Overall Study|Discontinued in Error|0|||
161430998|NCT00979901|582971214|FG000|Overall Study|Left Country|0|||
161430999|NCT00979901|582971215|FG001|Overall Study|Left Country|0|||
161431000|NCT00979901|582971216|FG002|Overall Study|Left Country|1|||
161431001|NCT00979901|582971217|FG003|Overall Study|Left Country|0|||
161431002|NCT00979901|582971214|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
161431003|NCT00979901|582971215|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
161431004|NCT00979901|582971216|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
161431005|NCT00979901|582971217|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
161431006|NCT00248625|582971218|FG000|Overall Study|Withdrawal by Subject|0|||
161431007|NCT00248625|582971219|FG001|Overall Study|Withdrawal by Subject|2|||
161431008|NCT03284710|582971224|FG000|Overall Study|Withdrawal by Subject|1|||
161431009|NCT03284710|582971225|FG001|Overall Study|Withdrawal by Subject|0|||
161431010|NCT03284710|582971226|FG002|Overall Study|Withdrawal by Subject|1|||
161431011|NCT03284710|582971227|FG003|Overall Study|Withdrawal by Subject|6|||
161431012|NCT03284710|582971224|FG000|Overall Study|Lost to Follow-up|3|||
161431013|NCT03284710|582971225|FG001|Overall Study|Lost to Follow-up|3|||
161431014|NCT03284710|582971226|FG002|Overall Study|Lost to Follow-up|1|||
161431015|NCT03284710|582971227|FG003|Overall Study|Lost to Follow-up|0|||
161431016|NCT03284710|582971224|FG000|Overall Study|Physician Decision|1|||
161431017|NCT03284710|582971225|FG001|Overall Study|Physician Decision|0|||
161431018|NCT03284710|582971226|FG002|Overall Study|Physician Decision|0|||
161431019|NCT03284710|582971227|FG003|Overall Study|Physician Decision|0|||
161431020|NCT03284710|582971224|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161431021|NCT03284710|582971225|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161431022|NCT03284710|582971226|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161431023|NCT03284710|582971227|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161431024|NCT03284710|582971224|FG000|Overall Study|HIV Infection|0|||
161431025|NCT03284710|582971225|FG001|Overall Study|HIV Infection|2|||
161431026|NCT03284710|582971226|FG002|Overall Study|HIV Infection|2|||
161431027|NCT03284710|582971227|FG003|Overall Study|HIV Infection|1|||
161431028|NCT02814916|582971229|FG000|Overall Study|Withdrawal of consent|0|||
161431029|NCT02814916|582971230|FG001|Overall Study|Withdrawal of consent|2|||
161431030|NCT02814916|582971231|FG002|Overall Study|Withdrawal of consent|0|||
161431031|NCT02814916|582971229|FG000|Overall Study|Lost to Follow-up|0|||
161431032|NCT02814916|582971230|FG001|Overall Study|Lost to Follow-up|1|||
161431033|NCT02814916|582971231|FG002|Overall Study|Lost to Follow-up|0|||
161431034|NCT02814916|582971229|FG000|Overall Study|Other, not specified|0|||
161431035|NCT02814916|582971230|FG001|Overall Study|Other, not specified|1|||
161431036|NCT02814916|582971231|FG002|Overall Study|Other, not specified|0|||
161431037|NCT05316597|582971236|FG000|First Session|Withdrawal by Subject|0|||
161431038|NCT05316597|582971237|FG001|First Session|Withdrawal by Subject|1|||
161431039|NCT05316597|582971236|FG000|Washout Period|Lost to Follow-up|1|||
161431040|NCT05316597|582971237|FG001|Washout Period|Lost to Follow-up|2|||
161431041|NCT05316597|582971236|FG000|Washout Period|Physician Decision|1|||
161431042|NCT05316597|582971237|FG001|Washout Period|Physician Decision|1|||
161431043|NCT05316597|582971236|FG000|Washout Period|Excluded before second session|1|||
161431044|NCT05316597|582971237|FG001|Washout Period|Excluded before second session|1|||
161431045|NCT05316597|582971236|FG000|Washout Period|Withdrawal by Subject|0|||
161431046|NCT05316597|582971237|FG001|Washout Period|Withdrawal by Subject|4|||
161431047|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
161431048|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
161431049|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
161431050|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Death|9|||
161435939|NCT04780061|582989734|FG001|Overall Study|Lost to Follow-up|5|||
161431051|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Death|0|||
161431052|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Death|0|||
161435940|NCT04050553|582989735|FG000|Period 1|Physician Decision|2|||
161431053|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
161431054|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
161435941|NCT04050553|582989736|FG001|Period 1|Physician Decision|2|||
161435942|NCT04050553|582989735|FG000|Period 1|Adverse Event|1|||
161431055|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
161431056|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
161431057|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
161431058|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
161431059|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Other|135|||
161431060|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Other|0|||
161431061|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Other|0|||
161431062|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
161431063|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
161431064|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
161431065|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
161431066|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
161431067|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
161431068|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
161431069|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
161431070|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
161431071|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Other|3|||
161431072|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Other|0|||
161431073|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Other|0|||
161431074|NCT02118584|582971238|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
161431075|NCT02118584|582971239|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
161431076|NCT02118584|582971240|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
161431077|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
161431078|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
161431079|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
161431080|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
161431081|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
161431082|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
161431083|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
161431084|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
161431085|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
161431086|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
161431087|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
161431088|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
161431089|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
161431090|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
161431091|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
161431092|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
161431093|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
161431094|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
161431095|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161431096|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
161431097|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161431098|NCT02118584|582971238|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
161431099|NCT02118584|582971239|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
161431100|NCT02118584|582971240|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
161431101|NCT03103542|582971241|FG000|Overall Study|Physician Decision|2|||
161431102|NCT03103542|582971241|FG000|Overall Study|Adverse Event|2|||
161431103|NCT03103542|582971241|FG000|Overall Study|Other|2|||
161431104|NCT03103542|582971241|FG000|Overall Study|Withdrawal by Subject|1|||
161431105|NCT02927301|582971243|FG000|Overall Study|Death|39|||
161431106|NCT02927301|582971243|FG000|Overall Study|Lost to Follow-up|8|||
161431107|NCT02927301|582971243|FG000|Overall Study|Physician Decision|2|||
161431108|NCT02927301|582971243|FG000|Overall Study|Withdrawal by Subject|12|||
161431109|NCT02927301|582971243|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
161431110|NCT02903771|582971244|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
161431111|NCT02903771|582971245|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
161431112|NCT02903771|582971246|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
161431113|NCT02903771|582971247|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
161431114|NCT02903771|582971248|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
161431115|NCT02903771|582971249|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
161431116|NCT02903771|582971250|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
161431117|NCT02903771|582971244|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
161431118|NCT02903771|582971245|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
161431119|NCT02903771|582971246|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
161431120|NCT02903771|582971247|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
161431121|NCT02903771|582971248|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
161431122|NCT02903771|582971249|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
161431123|NCT02903771|582971250|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
161431124|NCT02903771|582971244|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
161431125|NCT02903771|582971245|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
161431126|NCT02903771|582971246|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
161431127|NCT02903771|582971247|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
161431128|NCT02903771|582971248|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
161431129|NCT02903771|582971249|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
161431130|NCT02903771|582971250|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
161431131|NCT02903771|582971244|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
161431132|NCT02903771|582971245|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
161431133|NCT02903771|582971246|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
161431134|NCT02903771|582971247|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
161431135|NCT02903771|582971248|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
161431136|NCT02903771|582971249|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
161431137|NCT02903771|582971250|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
161431138|NCT02903771|582971244|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
161431139|NCT02903771|582971245|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
161431140|NCT02903771|582971246|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
161431141|NCT02903771|582971247|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
161431142|NCT02903771|582971248|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
161431143|NCT02903771|582971249|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
161431144|NCT02903771|582971250|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
161431145|NCT02903771|582971244|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
161431146|NCT02903771|582971245|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
161431147|NCT02903771|582971246|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
161431148|NCT02903771|582971247|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
161431149|NCT02903771|582971248|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
161431150|NCT02903771|582971249|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
161431151|NCT02903771|582971250|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
161431152|NCT02903771|582971244|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
161431153|NCT02903771|582971245|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
161431154|NCT02903771|582971246|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
161431155|NCT02903771|582971247|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
161431156|NCT02903771|582971248|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
161431157|NCT02903771|582971249|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
161431158|NCT02903771|582971250|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
161431159|NCT02903771|582971244|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
161431160|NCT02903771|582971245|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
161431161|NCT02903771|582971246|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
161431162|NCT02903771|582971247|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
161431163|NCT02903771|582971248|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
161431164|NCT02903771|582971249|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
161431165|NCT02903771|582971250|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
161431166|NCT02903771|582971244|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
161431167|NCT02903771|582971245|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
161431168|NCT02903771|582971246|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
161431169|NCT02903771|582971247|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
161431170|NCT02903771|582971248|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
161431171|NCT02903771|582971249|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
161431172|NCT02903771|582971250|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
161431173|NCT02903771|582971244|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
161431174|NCT02903771|582971245|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
161431175|NCT02903771|582971246|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
161431176|NCT02903771|582971247|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
161431177|NCT02903771|582971248|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
161431178|NCT02903771|582971249|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
161431179|NCT02903771|582971250|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
161431180|NCT02903771|582971244|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161431181|NCT02903771|582971245|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161431182|NCT02903771|582971246|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161431183|NCT02903771|582971247|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161431184|NCT02903771|582971248|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
161431185|NCT02903771|582971249|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161431186|NCT02903771|582971250|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161431187|NCT02218372|582971251|FG000|Overall Study|Adverse Event|1|||
161431188|NCT02218372|582971252|FG001|Overall Study|Adverse Event|1|||
161431189|NCT02218372|582971251|FG000|Overall Study|Miscellaneous|2|||
161431190|NCT02218372|582971252|FG001|Overall Study|Miscellaneous|1|||
161431191|NCT02218372|582971251|FG000|Overall Study|Randomized but did not receive treatment|2|||
161431192|NCT02218372|582971252|FG001|Overall Study|Randomized but did not receive treatment|3|||
161431193|NCT02218372|582971251|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161431194|NCT02218372|582971252|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161431195|NCT03406780|582971257|FG000|Overall Study|Withdrawal by Subject|1|||
161431196|NCT03406780|582971258|FG001|Overall Study|Withdrawal by Subject|1|||
161431197|NCT03406780|582971257|FG000|Overall Study|Other|0|||
161431198|NCT03406780|582971258|FG001|Overall Study|Other|2|||
161431199|NCT02546609|582971259|FG000|Overall Study|Withdrawal by Subject|0|||
161431200|NCT02546609|582971260|FG001|Overall Study|Withdrawal by Subject|1|||
161431201|NCT02546609|582971261|FG002|Overall Study|Withdrawal by Subject|2|||
161431202|NCT02546609|582971259|FG000|Overall Study|Adverse Event|0|||
161431203|NCT02546609|582971260|FG001|Overall Study|Adverse Event|6|||
161431204|NCT02546609|582971261|FG002|Overall Study|Adverse Event|1|||
161431205|NCT02546609|582971259|FG000|Overall Study|Protocol Violation|0|||
161431206|NCT02546609|582971260|FG001|Overall Study|Protocol Violation|1|||
161431207|NCT02546609|582971261|FG002|Overall Study|Protocol Violation|1|||
161431208|NCT02546609|582971259|FG000|Overall Study|Lost to Follow-up|2|||
161431209|NCT02546609|582971260|FG001|Overall Study|Lost to Follow-up|3|||
161431210|NCT02546609|582971261|FG002|Overall Study|Lost to Follow-up|1|||
161431211|NCT02546609|582971259|FG000|Overall Study|travel or work schedule restriction|0|||
161431212|NCT02546609|582971260|FG001|Overall Study|travel or work schedule restriction|0|||
161431213|NCT02546609|582971261|FG002|Overall Study|travel or work schedule restriction|2|||
161431214|NCT02004236|582971270|FG000|Overall Study|Lack of Efficacy|0|||
161431215|NCT02004236|582971271|FG001|Overall Study|Lack of Efficacy|0|||
161431216|NCT02004236|582971272|FG002|Overall Study|Lack of Efficacy|16|||
161431217|NCT00918281|582971275|FG000|Overall Study|Physician Decision|29|||
161431218|NCT03557970|582971280|FG000|Overall Study|Study closure|1|||
161431219|NCT03557970|582971281|FG001|Overall Study|Study closure|0|||
161431220|NCT03557970|582971280|FG000|Overall Study|Physician Decision|0|||
161431221|NCT03557970|582971281|FG001|Overall Study|Physician Decision|1|||
161431222|NCT03557970|582971280|FG000|Overall Study|Death|0|||
161431223|NCT03557970|582971281|FG001|Overall Study|Death|1|||
161431224|NCT00112736|582971282|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
161431225|NCT00112736|582971283|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
161431226|NCT00004563|582971285|FG000|Overall Study|Withdrawal by Subject|20|||
161431227|NCT00004563|582971286|FG001|Overall Study|Withdrawal by Subject|16|||
161431228|NCT00004563|582971285|FG000|Overall Study|Lack of Efficacy|3|||
161431229|NCT00004563|582971286|FG001|Overall Study|Lack of Efficacy|5|||
161431230|NCT00004563|582971285|FG000|Overall Study|Death|2|||
161431231|NCT00004563|582971286|FG001|Overall Study|Death|3|||
161431232|NCT05135871|582971289|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
161431233|NCT05135871|582971290|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
161431234|NCT05135871|582971291|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
161431235|NCT05135871|582971292|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
161431236|NCT04258423|582971293|FG000|Overall Study|Study Closure|2|||
161431237|NCT04258423|582971294|FG001|Overall Study|Study Closure|2|||
161431238|NCT03980730|582971295|FG000|Overall Study|Study Terminated by Sponsor|0|||
161431239|NCT03980730|582971296|FG001|Overall Study|Study Terminated by Sponsor|3|||
161431240|NCT03980730|582971295|FG000|Overall Study|Adverse Event|2|||
161431241|NCT03980730|582971296|FG001|Overall Study|Adverse Event|0|||
161431242|NCT03980730|582971295|FG000|Overall Study|Sponsor Request|0|||
161431243|NCT03980730|582971296|FG001|Overall Study|Sponsor Request|1|||
161431244|NCT00880620|582971304|FG000|Overall Study|Adverse Event|4|||
161431245|NCT00880620|582971305|FG001|Overall Study|Adverse Event|5|||
161431246|NCT00880620|582971306|FG002|Overall Study|Adverse Event|15|||
161431247|NCT00880620|582971307|FG003|Overall Study|Adverse Event|15|||
161431248|NCT00880620|582971304|FG000|Overall Study|Death|0|||
161431249|NCT00880620|582971305|FG001|Overall Study|Death|0|||
161431250|NCT00880620|582971306|FG002|Overall Study|Death|1|||
161431251|NCT00880620|582971307|FG003|Overall Study|Death|0|||
161431252|NCT00880620|582971304|FG000|Overall Study|Lack of Efficacy|12|||
161431253|NCT00880620|582971305|FG001|Overall Study|Lack of Efficacy|4|||
161431254|NCT00880620|582971306|FG002|Overall Study|Lack of Efficacy|0|||
161431255|NCT00880620|582971307|FG003|Overall Study|Lack of Efficacy|1|||
161431256|NCT00880620|582971304|FG000|Overall Study|Lost to Follow-up|0|||
161431257|NCT00880620|582971305|FG001|Overall Study|Lost to Follow-up|1|||
161431258|NCT00880620|582971306|FG002|Overall Study|Lost to Follow-up|1|||
161431259|NCT00880620|582971307|FG003|Overall Study|Lost to Follow-up|0|||
161431260|NCT00880620|582971304|FG000|Overall Study|Protocol Violation|0|||
161431261|NCT00880620|582971305|FG001|Overall Study|Protocol Violation|1|||
161431262|NCT00880620|582971306|FG002|Overall Study|Protocol Violation|0|||
161431263|NCT00880620|582971307|FG003|Overall Study|Protocol Violation|2|||
161431264|NCT00880620|582971304|FG000|Overall Study|Withdrawal by Subject|4|||
161431265|NCT00880620|582971305|FG001|Overall Study|Withdrawal by Subject|3|||
161431266|NCT00880620|582971306|FG002|Overall Study|Withdrawal by Subject|1|||
161431267|NCT00880620|582971307|FG003|Overall Study|Withdrawal by Subject|3|||
161431268|NCT00880620|582971304|FG000|Overall Study|Noncompliance|0|||
161431269|NCT00880620|582971305|FG001|Overall Study|Noncompliance|0|||
161431270|NCT00880620|582971306|FG002|Overall Study|Noncompliance|1|||
161431271|NCT00880620|582971307|FG003|Overall Study|Noncompliance|1|||
161431272|NCT00880620|582971304|FG000|Overall Study|Other|1|||
161431273|NCT00880620|582971305|FG001|Overall Study|Other|1|||
161431274|NCT00880620|582971306|FG002|Overall Study|Other|2|||
161431275|NCT00880620|582971307|FG003|Overall Study|Other|2|||
161431276|NCT02016781|582971314|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
161431277|NCT02016781|582971315|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
161431278|NCT02016781|582971314|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
161431279|NCT02016781|582971315|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
161431280|NCT02016781|582971314|FG000|Final Database Lock|Withdrawal by Subject|2|||
161431281|NCT02016781|582971315|FG001|Final Database Lock|Withdrawal by Subject|1|||
161431282|NCT02016781|582971314|FG000|Final Database Lock|Lost to Follow-up|11|||
161431283|NCT02016781|582971315|FG001|Final Database Lock|Lost to Follow-up|4|||
161431284|NCT02016781|582971314|FG000|Final Database Lock|Missing data|0|||
161431285|NCT02016781|582971315|FG001|Final Database Lock|Missing data|3|||
161431286|NCT00945009|582971316|FG000|Overall Study|Lack of Efficacy|10|||
161431287|NCT00945009|582971317|FG001|Overall Study|Lack of Efficacy|0|||
161431288|NCT00945009|582971318|FG002|Overall Study|Lack of Efficacy|0|||
161431289|NCT00945009|582971316|FG000|Overall Study|Physician Decision|21|||
161431290|NCT00945009|582971317|FG001|Overall Study|Physician Decision|4|||
161431291|NCT00945009|582971318|FG002|Overall Study|Physician Decision|3|||
161431292|NCT00945009|582971316|FG000|Overall Study|Protocol Violation|6|||
161431293|NCT00945009|582971317|FG001|Overall Study|Protocol Violation|1|||
161431294|NCT00945009|582971318|FG002|Overall Study|Protocol Violation|0|||
161431295|NCT00945009|582971316|FG000|Overall Study|Withdrawal by Subject|1|||
161431296|NCT00945009|582971317|FG001|Overall Study|Withdrawal by Subject|0|||
161431297|NCT00945009|582971318|FG002|Overall Study|Withdrawal by Subject|0|||
161431298|NCT00945009|582971316|FG000|Overall Study|Ineligible|6|||
161431299|NCT00945009|582971317|FG001|Overall Study|Ineligible|1|||
161431300|NCT00945009|582971318|FG002|Overall Study|Ineligible|0|||
161431301|NCT00945009|582971316|FG000|Overall Study|Inevaluable|0|||
161431302|NCT00945009|582971317|FG001|Overall Study|Inevaluable|1|||
161431303|NCT00945009|582971318|FG002|Overall Study|Inevaluable|0|||
161431304|NCT00945009|582971316|FG000|Overall Study|Refusal of further protocol|1|||
161431305|NCT00945009|582971317|FG001|Overall Study|Refusal of further protocol|0|||
161431306|NCT00945009|582971318|FG002|Overall Study|Refusal of further protocol|0|||
161431307|NCT04875975|582971319|FG000|Overall Study|Adverse Event|1|||
161431308|NCT04875975|582971320|FG001|Overall Study|Adverse Event|2|||
161431309|NCT04875975|582971319|FG000|Overall Study|Lack of Efficacy|2|||
161431310|NCT04875975|582971320|FG001|Overall Study|Lack of Efficacy|2|||
161431311|NCT04875975|582971319|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
161431312|NCT04875975|582971320|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
161431313|NCT04875975|582971319|FG000|Overall Study|Relapse With Insults|0|||
161431314|NCT04875975|582971320|FG001|Overall Study|Relapse With Insults|1|||
161431315|NCT04875975|582971319|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
161431316|NCT04875975|582971320|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
161431317|NCT04972162|582971325|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
161431318|NCT04972162|582971326|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
161431319|NCT02429830|582971327|FG000|Overall Study|Lost to Follow-up|1|||
161431320|NCT02429830|582971327|FG000|Overall Study|Device Explant|2|||
161431321|NCT00474487|582972909|FG000|Overall Study|Withdrawal by Subject|6|||
161431322|NCT00474487|582972910|FG001|Overall Study|Withdrawal by Subject|0|||
161431323|NCT00474487|582972911|FG002|Overall Study|Withdrawal by Subject|0|||
161431324|NCT00474487|582972912|FG003|Overall Study|Withdrawal by Subject|0|||
161431325|NCT00474487|582972909|FG000|Overall Study|Lost to Follow-up|20|||
161431326|NCT00474487|582972910|FG001|Overall Study|Lost to Follow-up|1|||
161431327|NCT00474487|582972911|FG002|Overall Study|Lost to Follow-up|7|||
161431328|NCT00474487|582972912|FG003|Overall Study|Lost to Follow-up|0|||
161431329|NCT00474487|582972909|FG000|Overall Study|Inappropriate enrollment|4|||
161431330|NCT00474487|582972910|FG001|Overall Study|Inappropriate enrollment|0|||
161431331|NCT00474487|582972911|FG002|Overall Study|Inappropriate enrollment|7|||
161431332|NCT00474487|582972912|FG003|Overall Study|Inappropriate enrollment|0|||
161431333|NCT00474487|582972909|FG000|Overall Study|Death|0|||
161431334|NCT00474487|582972910|FG001|Overall Study|Death|1|||
161431335|NCT00474487|582972911|FG002|Overall Study|Death|0|||
161431336|NCT00474487|582972912|FG003|Overall Study|Death|0|||
161431337|NCT03924622|582972913|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
161431338|NCT03924622|582972914|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
161431339|NCT03924622|582972915|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
161431340|NCT03924622|582972916|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
161431341|NCT03924622|582972917|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
161431342|NCT03924622|582972918|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
161431343|NCT03085095|582972919|FG000|Overall Study|Adverse Event|23|||
161431344|NCT03085095|582972920|FG001|Overall Study|Adverse Event|8|||
161431345|NCT03085095|582972919|FG000|Overall Study|Protocol Violation|0|||
161431346|NCT03085095|582972920|FG001|Overall Study|Protocol Violation|1|||
161431347|NCT03085095|582972919|FG000|Overall Study|Lost to Follow-up|2|||
161431348|NCT03085095|582972920|FG001|Overall Study|Lost to Follow-up|1|||
161431349|NCT03085095|582972919|FG000|Overall Study|Withdrawal by Subject|17|||
161431350|NCT03085095|582972920|FG001|Overall Study|Withdrawal by Subject|6|||
161431351|NCT03085095|582972919|FG000|Overall Study|Physician Decision|9|||
161431352|NCT03085095|582972920|FG001|Overall Study|Physician Decision|3|||
161431353|NCT03085095|582972919|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
161431354|NCT03085095|582972920|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
161431355|NCT03085095|582972919|FG000|Overall Study|Did not Receive Study Drug|2|||
161431356|NCT03085095|582972920|FG001|Overall Study|Did not Receive Study Drug|2|||
161431357|NCT03085095|582972919|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
161431358|NCT03085095|582972920|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
161431359|NCT05176314|582972923|FG000|Overall Study|Lost to Follow-up|2|||
161431360|NCT05176314|582972923|FG000|Overall Study|Physician Decision|1|||
161431361|NCT05176314|582972923|FG000|Overall Study|Adverse Event|1|||
161431362|NCT05543265|582972925|FG000|Overall Study|Lost to Follow-up|3|||
161431363|NCT05543265|582972926|FG001|Overall Study|Lost to Follow-up|3|||
161431364|NCT05543265|582972925|FG000|Overall Study|Withdrawal by Subject|0|||
161431365|NCT05543265|582972926|FG001|Overall Study|Withdrawal by Subject|1|||
161431366|NCT02182895|582972927|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
161431367|NCT02182895|582972928|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
161431368|NCT01488045|582972938|FG000|Overall Study|Withdrawal by Subject|6|||
161431369|NCT01488045|582972939|FG001|Overall Study|Withdrawal by Subject|11|||
161431370|NCT01488045|582972938|FG000|Overall Study|Failure to present for colonoscopy|3|||
161431371|NCT01488045|582972939|FG001|Overall Study|Failure to present for colonoscopy|6|||
161431372|NCT01488045|582972938|FG000|Overall Study|Failure to report exclusion criteria|0|||
161431373|NCT01488045|582972939|FG001|Overall Study|Failure to report exclusion criteria|1|||
161431374|NCT00671658|582972941|FG000|Overall Study|Physician Decision|5|||
161431375|NCT03617172|582972944|FG000|Overall Study|Lost to Follow-up|1|||
161431376|NCT03617172|582972945|FG001|Overall Study|Lost to Follow-up|0|||
161431377|NCT01680341|582972946|FG000|Overall Study|Adverse Event|3|||
161431378|NCT01680341|582972947|FG001|Overall Study|Adverse Event|2|||
161431379|NCT01680341|582972946|FG000|Overall Study|Unclassified|18|||
161431380|NCT01680341|582972947|FG001|Overall Study|Unclassified|15|||
161431381|NCT02587221|582972949|FG000|Overall Study|Adverse Event|3|||
161431382|NCT02587221|582972950|FG001|Overall Study|Adverse Event|3|||
161431383|NCT02587221|582972949|FG000|Overall Study|Death|33|||
161431384|NCT02587221|582972950|FG001|Overall Study|Death|34|||
161431385|NCT02587221|582972949|FG000|Overall Study|Withdrawal by Subject|66|||
161431386|NCT02587221|582972950|FG001|Overall Study|Withdrawal by Subject|61|||
161431387|NCT02587221|582972949|FG000|Overall Study|Lost to Follow-up|21|||
161431388|NCT02587221|582972950|FG001|Overall Study|Lost to Follow-up|19|||
161431389|NCT02587221|582972949|FG000|Overall Study|Protocol Violation|6|||
161431390|NCT02587221|582972950|FG001|Overall Study|Protocol Violation|5|||
161431391|NCT02587221|582972949|FG000|Overall Study|Other Reason or Unspecified|2|||
161431392|NCT02587221|582972950|FG001|Overall Study|Other Reason or Unspecified|1|||
161431393|NCT03988400|582972951|FG000|Overall Study|Adverse Event|1|||
161431394|NCT03988400|582972952|FG001|Overall Study|Adverse Event|0|||
161431395|NCT03988400|582972951|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
161435943|NCT04050553|582989736|FG001|Period 1|Adverse Event|1|||
161431396|NCT03988400|582972952|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
161431397|NCT03988400|582972951|FG000|Overall Study|Lost to Follow-up|0|||
161431398|NCT03988400|582972952|FG001|Overall Study|Lost to Follow-up|1|||
161431399|NCT04913610|582972953|FG000|Randomized Participants|Did Not Receive Treatment|0|||
161431400|NCT04913610|582972954|FG001|Randomized Participants|Did Not Receive Treatment|0|||
161431401|NCT04913610|582972955|FG002|Randomized Participants|Did Not Receive Treatment|1|||
161431402|NCT04913610|582972956|FG003|Randomized Participants|Did Not Receive Treatment|1|||
161431403|NCT04913610|582972957|FG004|Randomized Participants|Did Not Receive Treatment|0|||
161431404|NCT04913610|582972953|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
161431405|NCT04913610|582972954|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
161431406|NCT04913610|582972955|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
161431407|NCT04913610|582972956|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
161431408|NCT04913610|582972957|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
161431409|NCT03186209|582972958|FG000|Overall Study|Withdrawal by Subject|11|||
161431410|NCT03186209|582972959|FG001|Overall Study|Withdrawal by Subject|22|||
161431411|NCT03186209|582972958|FG000|Overall Study|Pregnancy|1|||
161431412|NCT03186209|582972959|FG001|Overall Study|Pregnancy|0|||
161431413|NCT03186209|582972958|FG000|Overall Study|Adverse Event|4|||
161431414|NCT03186209|582972959|FG001|Overall Study|Adverse Event|0|||
161431415|NCT03186209|582972958|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
161431416|NCT03186209|582972959|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
161431417|NCT03186209|582972958|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
161431418|NCT03186209|582972959|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
161431419|NCT03186209|582972958|FG000|Overall Study|Fail to meet randomization criteria|0|||
161431420|NCT03186209|582972959|FG001|Overall Study|Fail to meet randomization criteria|1|||
161431421|NCT03186209|582972958|FG000|Overall Study|Lost to Follow-up|0|||
161431422|NCT03186209|582972959|FG001|Overall Study|Lost to Follow-up|1|||
161431423|NCT00953667|582972962|FG000|Overall Study|Lost to Follow-up|11|||
161431424|NCT00953667|582972962|FG000|Overall Study|Physician Decision|35|||
161431425|NCT00953667|582972962|FG000|Overall Study|Withdrawal by Subject|63|||
161431426|NCT00953667|582972962|FG000|Overall Study|Adverse Event|10|||
161431427|NCT00953667|582972962|FG000|Overall Study|poor venous access,unable to draw blood|4|||
161431428|NCT00551759|582972963|FG000|Overall Study|Adverse Event|7|||
161431429|NCT00551759|582972963|FG000|Overall Study|Death|5|||
161431430|NCT00551759|582972963|FG000|Overall Study|Ineligible|1|||
161431431|NCT03521570|582972964|FG000|Overall Study|Not eligible|11|||
161431432|NCT00322881|582972966|FG000|Overall Study|Death|2|||
161431433|NCT00322881|582972966|FG000|Overall Study|Adverse Event|1|||
161431434|NCT00322881|582972966|FG000|Overall Study|Disease Progression|2|||
161431435|NCT02138890|582972973|FG000|Overall Study|Adverse Event|1|||
161431436|NCT02138890|582972974|FG001|Overall Study|Adverse Event|0|||
161431437|NCT05435339|582972975|FG000|Overall Study|Death|1|||
161431438|NCT05435339|582972976|FG001|Overall Study|Death|0|||
161431439|NCT05435339|582972977|FG002|Overall Study|Death|3|||
161431440|NCT05435339|582972978|FG003|Overall Study|Death|1|||
161431441|NCT05435339|582972979|FG004|Overall Study|Death|3|||
161431442|NCT05435339|582972980|FG005|Overall Study|Death|2|||
161431443|NCT05435339|582972981|FG006|Overall Study|Death|4|||
161431444|NCT05435339|582972982|FG007|Overall Study|Death|6|||
161431445|NCT05435339|582972975|FG000|Overall Study|Sponsor Decision|0|||
161431446|NCT05435339|582972976|FG001|Overall Study|Sponsor Decision|1|||
161431447|NCT05435339|582972977|FG002|Overall Study|Sponsor Decision|0|||
161431448|NCT05435339|582972978|FG003|Overall Study|Sponsor Decision|0|||
161431449|NCT05435339|582972979|FG004|Overall Study|Sponsor Decision|2|||
161431450|NCT05435339|582972980|FG005|Overall Study|Sponsor Decision|1|||
161431451|NCT05435339|582972981|FG006|Overall Study|Sponsor Decision|2|||
161431452|NCT05435339|582972982|FG007|Overall Study|Sponsor Decision|2|||
161431453|NCT05435339|582972975|FG000|Overall Study|Withdrawal by Subject|0|||
161431454|NCT05435339|582972976|FG001|Overall Study|Withdrawal by Subject|0|||
161431455|NCT05435339|582972977|FG002|Overall Study|Withdrawal by Subject|0|||
161431456|NCT05435339|582972978|FG003|Overall Study|Withdrawal by Subject|0|||
161431457|NCT05435339|582972979|FG004|Overall Study|Withdrawal by Subject|1|||
161431458|NCT05435339|582972980|FG005|Overall Study|Withdrawal by Subject|0|||
161431459|NCT05435339|582972981|FG006|Overall Study|Withdrawal by Subject|1|||
161431460|NCT05435339|582972982|FG007|Overall Study|Withdrawal by Subject|1|||
161431461|NCT01446159|582972983|FG000|Overall Study|Withdrawal by Subject|1|||
161431462|NCT01446159|582972984|FG001|Overall Study|Withdrawal by Subject|0|||
161431463|NCT01446159|582972985|FG002|Overall Study|Withdrawal by Subject|14|||
161431464|NCT01446159|582972986|FG003|Overall Study|Withdrawal by Subject|11|||
161431465|NCT01446159|582972983|FG000|Overall Study|Lost to Follow-up|0|||
161431466|NCT01446159|582972984|FG001|Overall Study|Lost to Follow-up|0|||
161431467|NCT01446159|582972985|FG002|Overall Study|Lost to Follow-up|1|||
161431468|NCT01446159|582972986|FG003|Overall Study|Lost to Follow-up|2|||
161431469|NCT01446159|582972983|FG000|Overall Study|Death|2|||
161431470|NCT01446159|582972984|FG001|Overall Study|Death|3|||
161431471|NCT01446159|582972985|FG002|Overall Study|Death|43|||
161431472|NCT01446159|582972986|FG003|Overall Study|Death|36|||
161431473|NCT01446159|582972983|FG000|Overall Study|Other|0|||
161431474|NCT01446159|582972984|FG001|Overall Study|Other|0|||
161431475|NCT01446159|582972985|FG002|Overall Study|Other|13|||
161431476|NCT01446159|582972986|FG003|Overall Study|Other|13|||
161431477|NCT00537394|582972993|FG000|First Year of Follow-up|Death|7|||
161431478|NCT00537394|582972994|FG001|First Year of Follow-up|Death|0|||
161431479|NCT00537394|582972995|FG002|First Year of Follow-up|Death|0|||
161431480|NCT00537394|582972993|FG000|First Year of Follow-up|Severe debilitation|1|||
161431481|NCT00537394|582972994|FG001|First Year of Follow-up|Severe debilitation|0|||
161431482|NCT00537394|582972995|FG002|First Year of Follow-up|Severe debilitation|1|||
161431483|NCT00537394|582972993|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
161431484|NCT00537394|582972994|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
161431485|NCT00537394|582972995|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
161431486|NCT00537394|582972993|FG000|First Year of Follow-up|Lost to Follow-up|1|||
161431487|NCT00537394|582972994|FG001|First Year of Follow-up|Lost to Follow-up|5|||
161431488|NCT00537394|582972995|FG002|First Year of Follow-up|Lost to Follow-up|1|||
161431489|NCT00537394|582972993|FG000|2nd Year of Follow-up|Death|4|||
161431490|NCT00537394|582972994|FG001|2nd Year of Follow-up|Death|1|||
161431491|NCT00537394|582972995|FG002|2nd Year of Follow-up|Death|2|||
161431492|NCT00537394|582972993|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
161431493|NCT00537394|582972994|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
161431494|NCT00537394|582972995|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
161431495|NCT00537394|582972993|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
161431496|NCT00537394|582972994|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
161431497|NCT00537394|582972995|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
161431498|NCT00537394|582972993|FG000|2nd Year of Follow-up|Clinic site closure|1|||
161431499|NCT00537394|582972994|FG001|2nd Year of Follow-up|Clinic site closure|0|||
161431500|NCT00537394|582972995|FG002|2nd Year of Follow-up|Clinic site closure|0|||
161431501|NCT01056822|582973000|FG000|Overall Study|Adverse Event|0|||
161431502|NCT01056822|582973001|FG001|Overall Study|Adverse Event|1|||
161431503|NCT01056822|582973000|FG000|Overall Study|Protocol Violation|6|||
161431504|NCT01056822|582973001|FG001|Overall Study|Protocol Violation|5|||
161431505|NCT01056822|582973000|FG000|Overall Study|Withdrawal by Subject|1|||
161431506|NCT01056822|582973001|FG001|Overall Study|Withdrawal by Subject|1|||
161431507|NCT01056822|582973000|FG000|Overall Study|Lost to Follow-up|1|||
161431508|NCT01056822|582973001|FG001|Overall Study|Lost to Follow-up|0|||
161431509|NCT01927497|582973002|FG000|Overall Study|Death|0|||
161431510|NCT01927497|582973003|FG001|Overall Study|Death|1|||
161431511|NCT01927497|582973002|FG000|Overall Study|Protocol Violation|2|||
161431512|NCT01927497|582973003|FG001|Overall Study|Protocol Violation|0|||
161431513|NCT00395746|582973004|FG000|Overall Study|Adverse Event|5|||
161431514|NCT00395746|582973005|FG001|Overall Study|Adverse Event|2|||
161431515|NCT00395746|582973006|FG002|Overall Study|Adverse Event|2|||
161431516|NCT00395746|582973004|FG000|Overall Study|Protocol Violation|0|||
161431517|NCT00395746|582973005|FG001|Overall Study|Protocol Violation|1|||
161431518|NCT00395746|582973006|FG002|Overall Study|Protocol Violation|0|||
161431519|NCT00395746|582973004|FG000|Overall Study|Lack of Efficacy|2|||
161431520|NCT00395746|582973005|FG001|Overall Study|Lack of Efficacy|0|||
161431521|NCT00395746|582973006|FG002|Overall Study|Lack of Efficacy|17|||
161431522|NCT00395746|582973004|FG000|Overall Study|Hypoglycaemia|2|||
161431523|NCT00395746|582973005|FG001|Overall Study|Hypoglycaemia|1|||
161431524|NCT00395746|582973006|FG002|Overall Study|Hypoglycaemia|0|||
161431525|NCT00395746|582973004|FG000|Overall Study|Subject decision|0|||
161431526|NCT00395746|582973005|FG001|Overall Study|Subject decision|0|||
161431527|NCT00395746|582973006|FG002|Overall Study|Subject decision|1|||
161431528|NCT00395746|582973004|FG000|Overall Study|Withdrawal of consent|0|||
161431529|NCT00395746|582973005|FG001|Overall Study|Withdrawal of consent|0|||
161431530|NCT00395746|582973006|FG002|Overall Study|Withdrawal of consent|1|||
161431531|NCT00395746|582973004|FG000|Overall Study|Difficultulty in use of device|0|||
161431532|NCT00395746|582973005|FG001|Overall Study|Difficultulty in use of device|0|||
161431533|NCT00395746|582973006|FG002|Overall Study|Difficultulty in use of device|1|||
161431534|NCT00395746|582973004|FG000|Overall Study|Unable to visit site on schedule|1|||
161431535|NCT00395746|582973005|FG001|Overall Study|Unable to visit site on schedule|0|||
161431536|NCT00395746|582973006|FG002|Overall Study|Unable to visit site on schedule|0|||
161431537|NCT04528641|582973007|FG000|Overall Study|Withdrawal by Subject|0|||
161431538|NCT04528641|582973008|FG001|Overall Study|Withdrawal by Subject|0|||
161431539|NCT04528641|582973009|FG002|Overall Study|Withdrawal by Subject|0|||
161431540|NCT04528641|582973010|FG003|Overall Study|Withdrawal by Subject|1|||
161431541|NCT04528641|582973011|FG004|Overall Study|Withdrawal by Subject|0|||
161431542|NCT04528641|582973012|FG005|Overall Study|Withdrawal by Subject|1|||
161431543|NCT03914417|582973013|FG000|Overall Study|Withdrawal by Subject|2|||
161431544|NCT00517296|582973018|FG000|Overall Study|Withdrawal by Subject|1|||
161431545|NCT00517296|582973019|FG001|Overall Study|Withdrawal by Subject|0|||
161431546|NCT00795704|582973022|FG000|Overall Study|Withdrawal by Subject|3|||
161431547|NCT00795704|582973023|FG001|Overall Study|Withdrawal by Subject|2|||
161431548|NCT00795704|582973022|FG000|Overall Study|Adverse Event|1|||
161431549|NCT00795704|582973023|FG001|Overall Study|Adverse Event|1|||
161431550|NCT01300728|582973024|FG000|Overall Study|Withdrawal by Subject|1|||
161431551|NCT01300728|582973025|FG001|Overall Study|Withdrawal by Subject|1|||
161431552|NCT01300728|582973024|FG000|Overall Study|Physician Decision|1|||
161431553|NCT01300728|582973025|FG001|Overall Study|Physician Decision|0|||
161431554|NCT01247324|582973026|FG000|Overall Study|Death|6|||
161431555|NCT01247324|582973027|FG001|Overall Study|Death|10|||
161431556|NCT01247324|582973026|FG000|Overall Study|Physician Decision|2|||
161431557|NCT01247324|582973027|FG001|Overall Study|Physician Decision|3|||
161431558|NCT01247324|582973026|FG000|Overall Study|Non-compliance with study drug|3|||
161431559|NCT01247324|582973027|FG001|Overall Study|Non-compliance with study drug|0|||
161431560|NCT01247324|582973026|FG000|Overall Study|Lack of Efficacy|24|||
161431561|NCT01247324|582973027|FG001|Overall Study|Lack of Efficacy|14|||
161431562|NCT01247324|582973026|FG000|Overall Study|Non-compliance|3|||
161431563|NCT01247324|582973027|FG001|Overall Study|Non-compliance|2|||
161431564|NCT01247324|582973026|FG000|Overall Study|Pregnancy|5|||
161431565|NCT01247324|582973027|FG001|Overall Study|Pregnancy|10|||
161431566|NCT01247324|582973026|FG000|Overall Study|Protocol Violation|1|||
161431567|NCT01247324|582973027|FG001|Overall Study|Protocol Violation|1|||
161431568|NCT01247324|582973026|FG000|Overall Study|Reason not specified|42|||
161431569|NCT01247324|582973027|FG001|Overall Study|Reason not specified|32|||
161431570|NCT01247324|582973026|FG000|Overall Study|Consent withdrawn by participant|41|||
161431571|NCT01247324|582973027|FG001|Overall Study|Consent withdrawn by participant|56|||
161431572|NCT01247324|582973026|FG000|Overall Study|Adverse Event|49|||
161431573|NCT01247324|582973027|FG001|Overall Study|Adverse Event|35|||
161431574|NCT01247324|582973026|FG000|Overall Study|Lost to Follow-up|3|||
161431575|NCT01247324|582973027|FG001|Overall Study|Lost to Follow-up|6|||
161431576|NCT01247324|582973026|FG000|Overall Study|Study Terminated by Sponsor|4|||
161431577|NCT01247324|582973027|FG001|Overall Study|Study Terminated by Sponsor|1|||
161431578|NCT01247324|582973026|FG000|Overall Study|Missing|2|||
161431579|NCT01247324|582973027|FG001|Overall Study|Missing|1|||
161431580|NCT00506350|582973028|FG000|Overall Study|Serious Adverse Event|1|||
161431581|NCT00506350|582973029|FG001|Overall Study|Serious Adverse Event|0|||
161431582|NCT00506350|582973030|FG002|Overall Study|Serious Adverse Event|0|||
161431583|NCT00506350|582973031|FG003|Overall Study|Serious Adverse Event|0|||
161431584|NCT00506350|582973032|FG004|Overall Study|Serious Adverse Event|0|||
161431585|NCT00506350|582973033|FG005|Overall Study|Serious Adverse Event|0|||
161431586|NCT00506350|582973034|FG006|Overall Study|Serious Adverse Event|0|||
161431587|NCT00506350|582973035|FG007|Overall Study|Serious Adverse Event|0|||
161431588|NCT00506350|582973036|FG008|Overall Study|Serious Adverse Event|0|||
161431589|NCT00506350|582973028|FG000|Overall Study|Adverse Event|0|||
161431590|NCT00506350|582973029|FG001|Overall Study|Adverse Event|0|||
161431591|NCT00506350|582973030|FG002|Overall Study|Adverse Event|0|||
161431592|NCT00506350|582973031|FG003|Overall Study|Adverse Event|0|||
161431593|NCT00506350|582973032|FG004|Overall Study|Adverse Event|0|||
161431594|NCT00506350|582973033|FG005|Overall Study|Adverse Event|0|||
161431595|NCT00506350|582973034|FG006|Overall Study|Adverse Event|0|||
161431596|NCT00506350|582973035|FG007|Overall Study|Adverse Event|1|||
161431597|NCT00506350|582973036|FG008|Overall Study|Adverse Event|1|||
161431598|NCT00506350|582973028|FG000|Overall Study|Protocol Violation|0|||
161431599|NCT00506350|582973029|FG001|Overall Study|Protocol Violation|0|||
161431600|NCT00506350|582973030|FG002|Overall Study|Protocol Violation|1|||
161431601|NCT00506350|582973031|FG003|Overall Study|Protocol Violation|0|||
161431602|NCT00506350|582973032|FG004|Overall Study|Protocol Violation|0|||
161431603|NCT00506350|582973033|FG005|Overall Study|Protocol Violation|0|||
161431604|NCT00506350|582973034|FG006|Overall Study|Protocol Violation|1|||
161431605|NCT00506350|582973035|FG007|Overall Study|Protocol Violation|0|||
161431606|NCT00506350|582973036|FG008|Overall Study|Protocol Violation|0|||
161431607|NCT00506350|582973028|FG000|Overall Study|Withdrawal by Subject|0|||
161431608|NCT00506350|582973029|FG001|Overall Study|Withdrawal by Subject|1|||
161431609|NCT00506350|582973030|FG002|Overall Study|Withdrawal by Subject|1|||
161431610|NCT00506350|582973031|FG003|Overall Study|Withdrawal by Subject|1|||
161431611|NCT00506350|582973032|FG004|Overall Study|Withdrawal by Subject|4|||
161431612|NCT00506350|582973033|FG005|Overall Study|Withdrawal by Subject|1|||
161431613|NCT00506350|582973034|FG006|Overall Study|Withdrawal by Subject|1|||
161431614|NCT00506350|582973035|FG007|Overall Study|Withdrawal by Subject|2|||
161431615|NCT00506350|582973036|FG008|Overall Study|Withdrawal by Subject|0|||
161431616|NCT00506350|582973028|FG000|Overall Study|Lost to Follow-up|1|||
161431617|NCT00506350|582973029|FG001|Overall Study|Lost to Follow-up|1|||
161431618|NCT00506350|582973030|FG002|Overall Study|Lost to Follow-up|1|||
161431619|NCT00506350|582973031|FG003|Overall Study|Lost to Follow-up|1|||
161431620|NCT00506350|582973032|FG004|Overall Study|Lost to Follow-up|2|||
161431621|NCT00506350|582973033|FG005|Overall Study|Lost to Follow-up|1|||
161431622|NCT00506350|582973034|FG006|Overall Study|Lost to Follow-up|0|||
161431623|NCT00506350|582973035|FG007|Overall Study|Lost to Follow-up|0|||
161431624|NCT00506350|582973036|FG008|Overall Study|Lost to Follow-up|2|||
161431625|NCT00506350|582973028|FG000|Overall Study|Medical Reason|0|||
161431626|NCT00506350|582973029|FG001|Overall Study|Medical Reason|0|||
161431627|NCT00506350|582973030|FG002|Overall Study|Medical Reason|0|||
161431628|NCT00506350|582973031|FG003|Overall Study|Medical Reason|0|||
161431629|NCT00506350|582973032|FG004|Overall Study|Medical Reason|1|||
161431630|NCT00506350|582973033|FG005|Overall Study|Medical Reason|0|||
161431631|NCT00506350|582973034|FG006|Overall Study|Medical Reason|0|||
161431632|NCT00506350|582973035|FG007|Overall Study|Medical Reason|0|||
161431633|NCT00506350|582973036|FG008|Overall Study|Medical Reason|0|||
161431634|NCT00506350|582973028|FG000|Overall Study|Other|1|||
161431635|NCT00506350|582973029|FG001|Overall Study|Other|1|||
161431636|NCT00506350|582973030|FG002|Overall Study|Other|3|||
161431637|NCT00506350|582973031|FG003|Overall Study|Other|0|||
161431638|NCT00506350|582973032|FG004|Overall Study|Other|3|||
161431639|NCT00506350|582973033|FG005|Overall Study|Other|0|||
161431640|NCT00506350|582973034|FG006|Overall Study|Other|0|||
161431641|NCT00506350|582973035|FG007|Overall Study|Other|2|||
161431642|NCT00506350|582973036|FG008|Overall Study|Other|2|||
161431643|NCT03474588|582973037|FG000|Overall Study|Withdrawal by Subject|4|||
161431644|NCT03474588|582973038|FG001|Overall Study|Withdrawal by Subject|3|||
161431645|NCT03474588|582973037|FG000|Overall Study|Death|0|||
161431646|NCT03474588|582973038|FG001|Overall Study|Death|1|||
161431647|NCT01607957|582973039|FG000|Overall Study|Not treated|1|||
161431648|NCT01607957|582973040|FG001|Overall Study|Not treated|1|||
161431649|NCT01607957|582973039|FG000|Overall Study|Death|367|||
161431650|NCT01607957|582973040|FG001|Overall Study|Death|211|||
161431651|NCT01607957|582973039|FG000|Overall Study|Lost to Follow-up|3|||
161431652|NCT01607957|582973040|FG001|Overall Study|Lost to Follow-up|3|||
161431653|NCT01607957|582973039|FG000|Overall Study|Participant refusal|1|||
161431654|NCT01607957|582973040|FG001|Overall Study|Participant refusal|0|||
161431655|NCT01691794|582973041|FG000|Overall Study|Poor/Non-Compliance|1|||
161431656|NCT01691794|582973042|FG001|Overall Study|Poor/Non-Compliance|4|||
161431657|NCT01691794|582973043|FG002|Overall Study|Poor/Non-Compliance|1|||
161431658|NCT01691794|582973041|FG000|Overall Study|Death|0|||
161431659|NCT01691794|582973042|FG001|Overall Study|Death|0|||
161431660|NCT01691794|582973043|FG002|Overall Study|Death|1|||
161431661|NCT01691794|582973041|FG000|Overall Study|Lack of Efficacy|0|||
161431662|NCT01691794|582973042|FG001|Overall Study|Lack of Efficacy|7|||
161431663|NCT01691794|582973043|FG002|Overall Study|Lack of Efficacy|1|||
161431664|NCT01691794|582973041|FG000|Overall Study|Participant request to discontinue|0|||
161431665|NCT01691794|582973042|FG001|Overall Study|Participant request to discontinue|1|||
161431666|NCT01691794|582973043|FG002|Overall Study|Participant request to discontinue|0|||
161431667|NCT01691794|582973041|FG000|Overall Study|Adverse Event|0|||
161431668|NCT01691794|582973042|FG001|Overall Study|Adverse Event|1|||
161431669|NCT01691794|582973043|FG002|Overall Study|Adverse Event|1|||
161431670|NCT01691794|582973041|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
161431671|NCT01691794|582973042|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
161431672|NCT01691794|582973043|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
161431673|NCT01691794|582973041|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
161431674|NCT01691794|582973042|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
161431675|NCT01691794|582973043|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
161431676|NCT04972786|582973044|FG000|First Intervention (1 Day)|Adverse Event|1|||
161431677|NCT04972786|582973045|FG001|First Intervention (1 Day)|Adverse Event|0|||
161431678|NCT03905096|582973046|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
161431679|NCT03905096|582973047|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
161431680|NCT00385671|582975130|FG000|Overall Study|Adverse Event|14|||
161431681|NCT00385671|582975131|FG001|Overall Study|Adverse Event|27|||
161431682|NCT00385671|582975132|FG002|Overall Study|Adverse Event|18|||
161431683|NCT00385671|582975130|FG000|Overall Study|Lack of Efficacy|5|||
161431684|NCT00385671|582975131|FG001|Overall Study|Lack of Efficacy|9|||
161431685|NCT00385671|582975132|FG002|Overall Study|Lack of Efficacy|5|||
161431686|NCT00385671|582975130|FG000|Overall Study|Lost to Follow-up|6|||
161431687|NCT00385671|582975131|FG001|Overall Study|Lost to Follow-up|6|||
161431688|NCT00385671|582975132|FG002|Overall Study|Lost to Follow-up|5|||
161431689|NCT00385671|582975130|FG000|Overall Study|Physician Decision|2|||
161431690|NCT00385671|582975131|FG001|Overall Study|Physician Decision|1|||
161431691|NCT00385671|582975132|FG002|Overall Study|Physician Decision|2|||
161431692|NCT00385671|582975130|FG000|Overall Study|Protocol Violation|5|||
161431693|NCT00385671|582975131|FG001|Overall Study|Protocol Violation|2|||
161431694|NCT00385671|582975132|FG002|Overall Study|Protocol Violation|1|||
161431695|NCT00385671|582975130|FG000|Overall Study|Sponsor Decision|2|||
161431696|NCT00385671|582975131|FG001|Overall Study|Sponsor Decision|2|||
161431697|NCT00385671|582975132|FG002|Overall Study|Sponsor Decision|1|||
161431698|NCT00385671|582975130|FG000|Overall Study|Withdrawal by Subject|4|||
161431699|NCT00385671|582975131|FG001|Overall Study|Withdrawal by Subject|4|||
161431700|NCT00385671|582975132|FG002|Overall Study|Withdrawal by Subject|4|||
161431701|NCT02608684|582975133|FG000|Overall Study|Physician Decision|2|||
161431702|NCT02608684|582975133|FG000|Overall Study|Withdrawal by Subject|1|||
161431703|NCT01775501|582975136|FG000|Overall Study|Discontinued prior to treatment|1|||
161431704|NCT03037385|582975137|FG000|Overall Study|Adverse Event|0|||
161431705|NCT03037385|582975138|FG001|Overall Study|Adverse Event|0|||
161431706|NCT03037385|582975139|FG002|Overall Study|Adverse Event|1|||
161431707|NCT03037385|582975140|FG003|Overall Study|Adverse Event|0|||
161431708|NCT03037385|582975141|FG004|Overall Study|Adverse Event|0|||
161431709|NCT03037385|582975142|FG005|Overall Study|Adverse Event|0|||
161431710|NCT03037385|582975143|FG006|Overall Study|Adverse Event|0|||
161431711|NCT03037385|582975144|FG007|Overall Study|Adverse Event|0|||
161431712|NCT03037385|582975145|FG008|Overall Study|Adverse Event|0|||
161431713|NCT03037385|582975146|FG009|Overall Study|Adverse Event|6|||
161431714|NCT03037385|582975137|FG000|Overall Study|Death|1|||
161431715|NCT03037385|582975138|FG001|Overall Study|Death|4|||
161431716|NCT03037385|582975139|FG002|Overall Study|Death|2|||
161431717|NCT03037385|582975140|FG003|Overall Study|Death|2|||
161431718|NCT03037385|582975141|FG004|Overall Study|Death|5|||
161431719|NCT03037385|582975142|FG005|Overall Study|Death|2|||
161431720|NCT03037385|582975143|FG006|Overall Study|Death|1|||
161431721|NCT03037385|582975144|FG007|Overall Study|Death|4|||
161431722|NCT03037385|582975145|FG008|Overall Study|Death|3|||
161431723|NCT03037385|582975146|FG009|Overall Study|Death|240|||
161431724|NCT03037385|582975137|FG000|Overall Study|Initiation of Another Therapy|1|||
161431725|NCT03037385|582975138|FG001|Overall Study|Initiation of Another Therapy|0|||
161431726|NCT03037385|582975139|FG002|Overall Study|Initiation of Another Therapy|0|||
161431727|NCT03037385|582975140|FG003|Overall Study|Initiation of Another Therapy|0|||
161431728|NCT03037385|582975141|FG004|Overall Study|Initiation of Another Therapy|0|||
161431729|NCT03037385|582975142|FG005|Overall Study|Initiation of Another Therapy|0|||
161431730|NCT03037385|582975143|FG006|Overall Study|Initiation of Another Therapy|0|||
161431731|NCT03037385|582975144|FG007|Overall Study|Initiation of Another Therapy|1|||
161431732|NCT03037385|582975145|FG008|Overall Study|Initiation of Another Therapy|0|||
161431733|NCT03037385|582975146|FG009|Overall Study|Initiation of Another Therapy|2|||
161431734|NCT03037385|582975137|FG000|Overall Study|Lost to Follow-up|0|||
161431735|NCT03037385|582975138|FG001|Overall Study|Lost to Follow-up|0|||
161431736|NCT03037385|582975139|FG002|Overall Study|Lost to Follow-up|0|||
161431737|NCT03037385|582975140|FG003|Overall Study|Lost to Follow-up|0|||
161431738|NCT03037385|582975141|FG004|Overall Study|Lost to Follow-up|0|||
161431739|NCT03037385|582975142|FG005|Overall Study|Lost to Follow-up|1|||
161431740|NCT03037385|582975143|FG006|Overall Study|Lost to Follow-up|0|||
161431741|NCT03037385|582975144|FG007|Overall Study|Lost to Follow-up|0|||
161431742|NCT03037385|582975145|FG008|Overall Study|Lost to Follow-up|0|||
161431743|NCT03037385|582975146|FG009|Overall Study|Lost to Follow-up|16|||
161431744|NCT03037385|582975137|FG000|Overall Study|Physician Decision|0|||
161431745|NCT03037385|582975138|FG001|Overall Study|Physician Decision|0|||
161431746|NCT03037385|582975139|FG002|Overall Study|Physician Decision|0|||
161431747|NCT03037385|582975140|FG003|Overall Study|Physician Decision|0|||
161431748|NCT03037385|582975141|FG004|Overall Study|Physician Decision|0|||
161431749|NCT03037385|582975142|FG005|Overall Study|Physician Decision|0|||
161431750|NCT03037385|582975143|FG006|Overall Study|Physician Decision|0|||
161431751|NCT03037385|582975144|FG007|Overall Study|Physician Decision|0|||
161431752|NCT03037385|582975145|FG008|Overall Study|Physician Decision|0|||
161431753|NCT03037385|582975146|FG009|Overall Study|Physician Decision|1|||
161431754|NCT03037385|582975137|FG000|Overall Study|Progressive Disease|0|||
161431755|NCT03037385|582975138|FG001|Overall Study|Progressive Disease|1|||
161431756|NCT03037385|582975139|FG002|Overall Study|Progressive Disease|1|||
161431757|NCT03037385|582975140|FG003|Overall Study|Progressive Disease|5|||
161431758|NCT03037385|582975141|FG004|Overall Study|Progressive Disease|2|||
161431759|NCT03037385|582975142|FG005|Overall Study|Progressive Disease|0|||
161431760|NCT03037385|582975143|FG006|Overall Study|Progressive Disease|1|||
161431761|NCT03037385|582975144|FG007|Overall Study|Progressive Disease|0|||
161431762|NCT03037385|582975145|FG008|Overall Study|Progressive Disease|0|||
161431763|NCT03037385|582975146|FG009|Overall Study|Progressive Disease|30|||
161431764|NCT03037385|582975137|FG000|Overall Study|Withdrawal by Subject|0|||
161431765|NCT03037385|582975138|FG001|Overall Study|Withdrawal by Subject|0|||
161431766|NCT03037385|582975139|FG002|Overall Study|Withdrawal by Subject|1|||
161431767|NCT03037385|582975140|FG003|Overall Study|Withdrawal by Subject|2|||
161431768|NCT03037385|582975141|FG004|Overall Study|Withdrawal by Subject|1|||
161431769|NCT03037385|582975142|FG005|Overall Study|Withdrawal by Subject|3|||
161431770|NCT03037385|582975143|FG006|Overall Study|Withdrawal by Subject|0|||
161431771|NCT03037385|582975144|FG007|Overall Study|Withdrawal by Subject|0|||
161431772|NCT03037385|582975145|FG008|Overall Study|Withdrawal by Subject|0|||
161431773|NCT03037385|582975146|FG009|Overall Study|Withdrawal by Subject|52|||
161431774|NCT03037385|582975137|FG000|Overall Study|Reason Not Specified|0|||
161431775|NCT03037385|582975138|FG001|Overall Study|Reason Not Specified|1|||
161431776|NCT03037385|582975139|FG002|Overall Study|Reason Not Specified|0|||
161431777|NCT03037385|582975140|FG003|Overall Study|Reason Not Specified|4|||
161431778|NCT03037385|582975141|FG004|Overall Study|Reason Not Specified|3|||
161431779|NCT03037385|582975142|FG005|Overall Study|Reason Not Specified|6|||
161431780|NCT03037385|582975143|FG006|Overall Study|Reason Not Specified|2|||
161431781|NCT03037385|582975144|FG007|Overall Study|Reason Not Specified|0|||
161431782|NCT03037385|582975145|FG008|Overall Study|Reason Not Specified|1|||
161431783|NCT03037385|582975146|FG009|Overall Study|Reason Not Specified|181|||
161431784|NCT02318706|582975147|FG000|Double-blind Phase|Adverse Event|7|||
161431785|NCT02318706|582975148|FG001|Double-blind Phase|Adverse Event|4|||
161431786|NCT02318706|582975149|FG002|Double-blind Phase|Adverse Event|3|||
161431787|NCT02318706|582975150|FG003|Double-blind Phase|Adverse Event|10|||
161431788|NCT02318706|582975151|FG004|Double-blind Phase|Adverse Event|0|||
161431789|NCT02318706|582975147|FG000|Double-blind Phase|Lost to Follow-up|1|||
161431790|NCT02318706|582975148|FG001|Double-blind Phase|Lost to Follow-up|0|||
161431791|NCT02318706|582975149|FG002|Double-blind Phase|Lost to Follow-up|0|||
161431792|NCT02318706|582975150|FG003|Double-blind Phase|Lost to Follow-up|0|||
161431793|NCT02318706|582975151|FG004|Double-blind Phase|Lost to Follow-up|0|||
161431794|NCT02318706|582975147|FG000|Double-blind Phase|Protocol Violation|4|||
161431795|NCT02318706|582975148|FG001|Double-blind Phase|Protocol Violation|2|||
161431796|NCT02318706|582975149|FG002|Double-blind Phase|Protocol Violation|4|||
161431797|NCT02318706|582975150|FG003|Double-blind Phase|Protocol Violation|3|||
161431798|NCT02318706|582975151|FG004|Double-blind Phase|Protocol Violation|0|||
161431799|NCT02318706|582975147|FG000|Double-blind Phase|Withdrawal by Subject|9|||
161431800|NCT02318706|582975148|FG001|Double-blind Phase|Withdrawal by Subject|5|||
161431801|NCT02318706|582975149|FG002|Double-blind Phase|Withdrawal by Subject|7|||
161431802|NCT02318706|582975150|FG003|Double-blind Phase|Withdrawal by Subject|10|||
161431803|NCT02318706|582975151|FG004|Double-blind Phase|Withdrawal by Subject|0|||
161431804|NCT02318706|582975147|FG000|Double-blind Phase|Other|4|||
161431805|NCT02318706|582975148|FG001|Double-blind Phase|Other|1|||
161431806|NCT02318706|582975149|FG002|Double-blind Phase|Other|2|||
161431807|NCT02318706|582975150|FG003|Double-blind Phase|Other|1|||
161431808|NCT02318706|582975151|FG004|Double-blind Phase|Other|0|||
161431809|NCT02318706|582975147|FG000|Double-blind Phase|Death|0|||
161431810|NCT02318706|582975148|FG001|Double-blind Phase|Death|0|||
161431811|NCT02318706|582975149|FG002|Double-blind Phase|Death|2|||
161431812|NCT02318706|582975150|FG003|Double-blind Phase|Death|0|||
161431813|NCT02318706|582975151|FG004|Double-blind Phase|Death|0|||
161431814|NCT02318706|582975147|FG000|Open-label Extension Phase|Adverse Event|0|||
161431815|NCT02318706|582975148|FG001|Open-label Extension Phase|Adverse Event|0|||
161431816|NCT02318706|582975149|FG002|Open-label Extension Phase|Adverse Event|0|||
161431817|NCT02318706|582975150|FG003|Open-label Extension Phase|Adverse Event|0|||
161431818|NCT02318706|582975151|FG004|Open-label Extension Phase|Adverse Event|21|||
161431819|NCT02318706|582975147|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
161431820|NCT02318706|582975148|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
161431821|NCT02318706|582975149|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
161431822|NCT02318706|582975150|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
161431823|NCT02318706|582975151|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
161431824|NCT02318706|582975147|FG000|Open-label Extension Phase|Death|0|||
161431825|NCT02318706|582975148|FG001|Open-label Extension Phase|Death|0|||
161431826|NCT02318706|582975149|FG002|Open-label Extension Phase|Death|0|||
161431827|NCT02318706|582975150|FG003|Open-label Extension Phase|Death|0|||
161431828|NCT02318706|582975151|FG004|Open-label Extension Phase|Death|1|||
161431829|NCT02318706|582975147|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
161431830|NCT02318706|582975148|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
161431831|NCT02318706|582975149|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
161431832|NCT02318706|582975150|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
161431833|NCT02318706|582975151|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
161431834|NCT04328077|582975152|FG000|Overall Study|Lost to Follow-up|0|||
161431835|NCT04328077|582975153|FG001|Overall Study|Lost to Follow-up|1|||
161431836|NCT04328077|582975154|FG002|Overall Study|Lost to Follow-up|0|||
161431837|NCT04328077|582975155|FG003|Overall Study|Lost to Follow-up|0|||
161431838|NCT04328077|582975152|FG000|Overall Study|Withdrawal by Subject|0|||
161431839|NCT04328077|582975153|FG001|Overall Study|Withdrawal by Subject|1|||
161431840|NCT04328077|582975154|FG002|Overall Study|Withdrawal by Subject|1|||
161431841|NCT04328077|582975155|FG003|Overall Study|Withdrawal by Subject|3|||
161431842|NCT01456039|582975156|FG000|Phase 1 (First Step)|Disease Progression|1|||
161431843|NCT01456039|582975157|FG001|Phase 1 (First Step)|Disease Progression|1|||
161431844|NCT01456039|582975158|FG002|Phase 1 (First Step)|Disease Progression|0|||
161431845|NCT01456039|582975156|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
161431846|NCT01456039|582975157|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
161431847|NCT01456039|582975158|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
161431848|NCT01456039|582975156|FG000|Phase 1 (First Step)|Adverse Event|0|||
161431849|NCT01456039|582975157|FG001|Phase 1 (First Step)|Adverse Event|3|||
161431850|NCT01456039|582975158|FG002|Phase 1 (First Step)|Adverse Event|0|||
161431851|NCT01456039|582975156|FG000|Phase 1 (First Step)|Other|0|||
161431852|NCT01456039|582975157|FG001|Phase 1 (First Step)|Other|1|||
161431853|NCT01456039|582975158|FG002|Phase 1 (First Step)|Other|0|||
161431854|NCT01456039|582975156|FG000|Phase 2 (Second Step)|Disease Progression|0|||
161431855|NCT01456039|582975157|FG001|Phase 2 (Second Step)|Disease Progression|0|||
161431856|NCT01456039|582975158|FG002|Phase 2 (Second Step)|Disease Progression|17|||
161431857|NCT01456039|582975156|FG000|Phase 2 (Second Step)|Adverse Event|0|||
161431858|NCT01456039|582975157|FG001|Phase 2 (Second Step)|Adverse Event|0|||
161431859|NCT01456039|582975158|FG002|Phase 2 (Second Step)|Adverse Event|10|||
161431860|NCT01456039|582975156|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
161431861|NCT01456039|582975157|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
161431862|NCT01456039|582975158|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
161431863|NCT01456039|582975156|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
161431864|NCT01456039|582975157|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
161431865|NCT01456039|582975158|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
161431866|NCT01456039|582975156|FG000|Phase 2 (Second Step)|Other|0|||
161431867|NCT01456039|582975157|FG001|Phase 2 (Second Step)|Other|0|||
161431868|NCT01456039|582975158|FG002|Phase 2 (Second Step)|Other|1|||
161431869|NCT01702311|582975162|FG000|Overall Study|Withdrawal by Subject|3|||
161431870|NCT01702311|582975163|FG001|Overall Study|Withdrawal by Subject|2|||
161431871|NCT01702311|582975162|FG000|Overall Study|Discharge less than 24 hours|10|||
161431872|NCT01702311|582975163|FG001|Overall Study|Discharge less than 24 hours|7|||
161431873|NCT01702311|582975162|FG000|Overall Study|Physician Decision|3|||
161431874|NCT01702311|582975163|FG001|Overall Study|Physician Decision|4|||
161431875|NCT04106557|582975170|FG000|Overall Study|Physician Decision|0|||
161431876|NCT04106557|582975171|FG001|Overall Study|Physician Decision|1|||
161431877|NCT04106557|582975172|FG002|Overall Study|Physician Decision|0|||
161431878|NCT04106557|582975170|FG000|Overall Study|Protocol Violation|0|||
161431879|NCT04106557|582975171|FG001|Overall Study|Protocol Violation|1|||
161431880|NCT04106557|582975172|FG002|Overall Study|Protocol Violation|0|||
161431881|NCT02326155|582975173|FG000|Overall Study|Adverse Event|21|||
161431882|NCT02326155|582975174|FG001|Overall Study|Adverse Event|5|||
161431883|NCT02326155|582975173|FG000|Overall Study|Death|3|||
161431884|NCT02326155|582975174|FG001|Overall Study|Death|0|||
161431885|NCT02326155|582975173|FG000|Overall Study|Lack of Efficacy|49|||
161431886|NCT02326155|582975174|FG001|Overall Study|Lack of Efficacy|5|||
161431887|NCT02326155|582975173|FG000|Overall Study|Lost to Follow-up|14|||
161431888|NCT02326155|582975174|FG001|Overall Study|Lost to Follow-up|3|||
161431889|NCT02326155|582975173|FG000|Overall Study|Protocol Violation|2|||
161431890|NCT02326155|582975174|FG001|Overall Study|Protocol Violation|0|||
161431891|NCT02326155|582975173|FG000|Overall Study|Withdrawal by Subject|34|||
161431892|NCT02326155|582975174|FG001|Overall Study|Withdrawal by Subject|11|||
161431893|NCT02326155|582975173|FG000|Overall Study|Disease progression|37|||
161431894|NCT02326155|582975174|FG001|Overall Study|Disease progression|4|||
161431895|NCT02326155|582975173|FG000|Overall Study|Study close|188|||
161431896|NCT02326155|582975174|FG001|Overall Study|Study close|21|||
161431897|NCT02326155|582975173|FG000|Overall Study|except for study close|46|||
161431898|NCT02326155|582975174|FG001|Overall Study|except for study close|13|||
161431899|NCT00313014|582975175|FG000|Overall Study|Withdrawal by Subject|11|||
161431900|NCT00313014|582975176|FG001|Overall Study|Withdrawal by Subject|7|||
161431901|NCT00313014|582975177|FG002|Overall Study|Withdrawal by Subject|5|||
161431902|NCT00313014|582975175|FG000|Overall Study|Adverse Event|14|||
161431903|NCT00313014|582975176|FG001|Overall Study|Adverse Event|29|||
161431904|NCT00313014|582975177|FG002|Overall Study|Adverse Event|16|||
161431905|NCT00313014|582975175|FG000|Overall Study|Lost to Follow-up|7|||
161431906|NCT00313014|582975176|FG001|Overall Study|Lost to Follow-up|6|||
161431907|NCT00313014|582975177|FG002|Overall Study|Lost to Follow-up|10|||
161431908|NCT00313014|582975175|FG000|Overall Study|Administrative|9|||
161431909|NCT00313014|582975176|FG001|Overall Study|Administrative|6|||
161431910|NCT00313014|582975177|FG002|Overall Study|Administrative|14|||
161431911|NCT00313014|582975175|FG000|Overall Study|Lack of Efficacy|52|||
161431912|NCT00313014|582975176|FG001|Overall Study|Lack of Efficacy|25|||
161431913|NCT00313014|582975177|FG002|Overall Study|Lack of Efficacy|16|||
161431914|NCT01428258|582975183|FG000|Intervention 1|Withdrawal by Subject|2|||
161431915|NCT01428258|582975184|FG001|Intervention 1|Withdrawal by Subject|0|||
161431916|NCT00419393|582975185|FG000|Overall Study|Adverse Event|5|||
161431917|NCT00419393|582975185|FG000|Overall Study|Protocol Violation|5|||
161431918|NCT00419393|582975185|FG000|Overall Study|Withdrawal by Subject|7|||
161431919|NCT00419393|582975185|FG000|Overall Study|Other: Sponsor request|3|||
161431920|NCT00419393|582975185|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
161431921|NCT00419393|582975185|FG000|Overall Study|Other: Site closure|1|||
161431922|NCT00419393|582975185|FG000|Overall Study|Other: Other health problems|1|||
161431923|NCT00419393|582975185|FG000|Overall Study|Other: Investigator decision|1|||
161431924|NCT01231984|582975190|FG000|Study Period 1|Withdrawal by Subject|0|||
161431925|NCT01231984|582975191|FG001|Study Period 1|Withdrawal by Subject|0|||
161431926|NCT01231984|582975192|FG002|Study Period 1|Withdrawal by Subject|0|||
161431927|NCT01231984|582975193|FG003|Study Period 1|Withdrawal by Subject|1|||
161431928|NCT01231984|582975190|FG000|Study Period 1|Lost to Follow-up|1|||
161431929|NCT01231984|582975191|FG001|Study Period 1|Lost to Follow-up|1|||
161431930|NCT01231984|582975192|FG002|Study Period 1|Lost to Follow-up|1|||
161431931|NCT01231984|582975193|FG003|Study Period 1|Lost to Follow-up|0|||
161431932|NCT01231984|582975190|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
161431933|NCT01231984|582975191|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
161431934|NCT01231984|582975192|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
161431935|NCT01231984|582975193|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
161431936|NCT01231984|582975190|FG000|Study Period 1|Screen Failure|0|||
161431937|NCT01231984|582975191|FG001|Study Period 1|Screen Failure|0|||
161431938|NCT01231984|582975192|FG002|Study Period 1|Screen Failure|0|||
161431939|NCT01231984|582975193|FG003|Study Period 1|Screen Failure|1|||
161431940|NCT01231984|582975190|FG000|Study Period 1|Non-compliance with study requirements|5|||
161431941|NCT01231984|582975191|FG001|Study Period 1|Non-compliance with study requirements|0|||
161431942|NCT01231984|582975192|FG002|Study Period 1|Non-compliance with study requirements|2|||
161431943|NCT01231984|582975193|FG003|Study Period 1|Non-compliance with study requirements|1|||
161431944|NCT01231984|582975190|FG000|Study Period 1|Protocol Violation|3|||
161431945|NCT01231984|582975191|FG001|Study Period 1|Protocol Violation|4|||
161431946|NCT01231984|582975192|FG002|Study Period 1|Protocol Violation|2|||
161431947|NCT01231984|582975193|FG003|Study Period 1|Protocol Violation|3|||
161431948|NCT01231984|582975190|FG000|Study Period 1|Adverse Event|1|||
161431949|NCT01231984|582975191|FG001|Study Period 1|Adverse Event|0|||
161431950|NCT01231984|582975192|FG002|Study Period 1|Adverse Event|0|||
161431951|NCT01231984|582975193|FG003|Study Period 1|Adverse Event|0|||
161431952|NCT01231984|582975190|FG000|Study Period 1|Other|0|||
161431953|NCT01231984|582975191|FG001|Study Period 1|Other|0|||
161431954|NCT01231984|582975192|FG002|Study Period 1|Other|0|||
161431955|NCT01231984|582975193|FG003|Study Period 1|Other|1|||
161431956|NCT01231984|582975190|FG000|Study Period 2|Withdrawal by Subject|1|||
161431957|NCT01231984|582975191|FG001|Study Period 2|Withdrawal by Subject|1|||
161431958|NCT01231984|582975192|FG002|Study Period 2|Withdrawal by Subject|0|||
161431959|NCT01231984|582975193|FG003|Study Period 2|Withdrawal by Subject|0|||
161431960|NCT01231984|582975190|FG000|Study Period 2|Lost to Follow-up|1|||
161431961|NCT01231984|582975191|FG001|Study Period 2|Lost to Follow-up|0|||
161431962|NCT01231984|582975192|FG002|Study Period 2|Lost to Follow-up|0|||
161431963|NCT01231984|582975193|FG003|Study Period 2|Lost to Follow-up|3|||
161431964|NCT01231984|582975190|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
161431965|NCT01231984|582975191|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
161431966|NCT01231984|582975192|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
161431967|NCT01231984|582975193|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
161431968|NCT02939287|582975196|FG000|Overall Study|met exclusion criteria|1|||
161431969|NCT02939287|582975197|FG001|Overall Study|met exclusion criteria|1|||
161431970|NCT02939287|582975198|FG002|Overall Study|met exclusion criteria|1|||
161431971|NCT02939287|582975196|FG000|Overall Study|Did not complete survey|2|||
161431972|NCT02939287|582975197|FG001|Overall Study|Did not complete survey|2|||
161431973|NCT02939287|582975198|FG002|Overall Study|Did not complete survey|0|||
161431974|NCT02939287|582975196|FG000|Overall Study|Withdrawal by Subject|1|||
161431975|NCT02939287|582975197|FG001|Overall Study|Withdrawal by Subject|1|||
161431976|NCT02939287|582975198|FG002|Overall Study|Withdrawal by Subject|0|||
161431977|NCT00333775|582975199|FG000|Overall Study|Death|144|||
161431978|NCT00333775|582975200|FG001|Overall Study|Death|149|||
161431979|NCT00333775|582975201|FG002|Overall Study|Death|143|||
161431980|NCT00333775|582975199|FG000|Overall Study|In Follow-up When Study Stopped|87|||
161431981|NCT00333775|582975200|FG001|Overall Study|In Follow-up When Study Stopped|92|||
161431982|NCT00333775|582975201|FG002|Overall Study|In Follow-up When Study Stopped|96|||
161431983|NCT00333775|582975199|FG000|Overall Study|Lost to Follow-up|10|||
161431984|NCT00333775|582975200|FG001|Overall Study|Lost to Follow-up|7|||
161431985|NCT00333775|582975201|FG002|Overall Study|Lost to Follow-up|8|||
161431986|NCT02476617|582975203|FG000|Overall Study|Adverse Event|1|||
161431987|NCT02476617|582975203|FG000|Overall Study|Lost to Follow-up|1|||
161431988|NCT01383928|582975204|FG000|Overall Study|Initiation of ASCT|2|||
161431989|NCT01383928|582975205|FG001|Overall Study|Initiation of ASCT|1|||
161431990|NCT01383928|582975206|FG002|Overall Study|Initiation of ASCT|18|||
161431991|NCT01383928|582975204|FG000|Overall Study|Adverse Event|1|||
161431992|NCT01383928|582975205|FG001|Overall Study|Adverse Event|2|||
161431993|NCT01383928|582975206|FG002|Overall Study|Adverse Event|8|||
161431994|NCT01383928|582975204|FG000|Overall Study|Other|1|||
161431995|NCT01383928|582975205|FG001|Overall Study|Other|3|||
161431996|NCT01383928|582975206|FG002|Overall Study|Other|4|||
161431997|NCT01383928|582975204|FG000|Overall Study|Progressive Disease|1|||
161431998|NCT01383928|582975205|FG001|Overall Study|Progressive Disease|1|||
161431999|NCT01383928|582975206|FG002|Overall Study|Progressive Disease|5|||
161432000|NCT01383928|582975204|FG000|Overall Study|Withdrawal by Subject|0|||
161432001|NCT01383928|582975205|FG001|Overall Study|Withdrawal by Subject|0|||
161432002|NCT01383928|582975206|FG002|Overall Study|Withdrawal by Subject|4|||
161432003|NCT01383928|582975204|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
161432004|NCT01383928|582975205|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
161432005|NCT01383928|582975206|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
161432006|NCT03486912|582975207|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
161432007|NCT03486912|582975208|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
161432008|NCT03486912|582975209|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
161432009|NCT03486912|582975210|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
161432010|NCT03486912|582975207|FG000|Treatment Period|Withdrawal by Subject|3|||
161432011|NCT03486912|582975208|FG001|Treatment Period|Withdrawal by Subject|3|||
161432012|NCT03486912|582975209|FG002|Treatment Period|Withdrawal by Subject|3|||
161432013|NCT03486912|582975210|FG003|Treatment Period|Withdrawal by Subject|2|||
161432014|NCT03486912|582975207|FG000|Treatment Period|Other Reasons|0|||
161432015|NCT03486912|582975208|FG001|Treatment Period|Other Reasons|2|||
161432016|NCT03486912|582975209|FG002|Treatment Period|Other Reasons|1|||
161432017|NCT03486912|582975210|FG003|Treatment Period|Other Reasons|1|||
161432018|NCT03486912|582975207|FG000|Treatment Period|Adverse Event|0|||
161432019|NCT03486912|582975208|FG001|Treatment Period|Adverse Event|1|||
161432020|NCT03486912|582975209|FG002|Treatment Period|Adverse Event|1|||
161432021|NCT03486912|582975210|FG003|Treatment Period|Adverse Event|0|||
161432022|NCT03486912|582975207|FG000|Treatment Period|Lost to Follow-up|1|||
161432023|NCT03486912|582975208|FG001|Treatment Period|Lost to Follow-up|0|||
161432024|NCT03486912|582975209|FG002|Treatment Period|Lost to Follow-up|0|||
161432025|NCT03486912|582975210|FG003|Treatment Period|Lost to Follow-up|2|||
161432026|NCT02491684|582975211|FG000|Treatment Phase|Adverse Event|2|||
161432027|NCT02491684|582975212|FG001|Treatment Phase|Adverse Event|2|||
161432028|NCT02491684|582975211|FG000|Treatment Phase|Incorrect randomisation|1|||
161432029|NCT02491684|582975212|FG001|Treatment Phase|Incorrect randomisation|0|||
161432030|NCT02491684|582975211|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
161432031|NCT02491684|582975212|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
161432032|NCT01499940|582975213|FG000|Overall Study|Study was withdrawn before completion.|9|||
161432033|NCT04739982|582975215|FG000|Overall Study|Lost to Follow-up|176|||
161432034|NCT04739982|582975216|FG001|Overall Study|Lost to Follow-up|65|||
161432035|NCT04739982|582975215|FG000|Overall Study|Withdrawal by Subject|19|||
161432036|NCT04739982|582975216|FG001|Overall Study|Withdrawal by Subject|0|||
161432037|NCT04739982|582975215|FG000|Overall Study|Protocol Violation|0|||
161432038|NCT04739982|582975216|FG001|Overall Study|Protocol Violation|5|||
161432039|NCT04914364|582975218|FG000|Overall Study|No longer eligible for study|1|||
161432040|NCT04914364|582975218|FG000|Overall Study|Lost to Follow-up|2|||
161432041|NCT01283139|582975219|FG000|Overall Study|Lost to Follow-up|5|||
161432042|NCT01283139|582975220|FG001|Overall Study|Lost to Follow-up|2|||
161432043|NCT01283139|582975221|FG002|Overall Study|Lost to Follow-up|3|||
161432044|NCT01283139|582975222|FG003|Overall Study|Lost to Follow-up|1|||
161432045|NCT01283139|582975219|FG000|Overall Study|Withdrawal by Subject|8|||
161432046|NCT01283139|582975220|FG001|Overall Study|Withdrawal by Subject|8|||
161432047|NCT01283139|582975221|FG002|Overall Study|Withdrawal by Subject|6|||
161432048|NCT01283139|582975222|FG003|Overall Study|Withdrawal by Subject|8|||
161432049|NCT01283139|582975219|FG000|Overall Study|Death|2|||
161432050|NCT01283139|582975220|FG001|Overall Study|Death|0|||
161432051|NCT01283139|582975221|FG002|Overall Study|Death|2|||
161432052|NCT01283139|582975222|FG003|Overall Study|Death|2|||
161432053|NCT01283139|582975219|FG000|Overall Study|Lack of Efficacy|1|||
161432054|NCT01283139|582975220|FG001|Overall Study|Lack of Efficacy|2|||
161432055|NCT01283139|582975221|FG002|Overall Study|Lack of Efficacy|2|||
161432056|NCT01283139|582975222|FG003|Overall Study|Lack of Efficacy|1|||
161432057|NCT01283139|582975219|FG000|Overall Study|Early termination due to AE/SAE|1|||
161432058|NCT01283139|582975220|FG001|Overall Study|Early termination due to AE/SAE|1|||
161432059|NCT01283139|582975221|FG002|Overall Study|Early termination due to AE/SAE|0|||
161432060|NCT01283139|582975222|FG003|Overall Study|Early termination due to AE/SAE|0|||
161432061|NCT01283139|582975219|FG000|Overall Study|Participant's refusal to continue|0|||
161432062|NCT01283139|582975220|FG001|Overall Study|Participant's refusal to continue|3|||
161432063|NCT01283139|582975221|FG002|Overall Study|Participant's refusal to continue|1|||
161432064|NCT01283139|582975222|FG003|Overall Study|Participant's refusal to continue|1|||
161432065|NCT01283139|582975219|FG000|Overall Study|Pregnancy|0|||
161432066|NCT01283139|582975220|FG001|Overall Study|Pregnancy|1|||
161432067|NCT01283139|582975221|FG002|Overall Study|Pregnancy|1|||
161432068|NCT01283139|582975222|FG003|Overall Study|Pregnancy|0|||
161432069|NCT01283139|582975219|FG000|Overall Study|Missed follow-up visit|0|||
161432070|NCT01283139|582975220|FG001|Overall Study|Missed follow-up visit|1|||
161432071|NCT01283139|582975221|FG002|Overall Study|Missed follow-up visit|2|||
161432072|NCT01283139|582975222|FG003|Overall Study|Missed follow-up visit|2|||
161432073|NCT01283139|582975219|FG000|Overall Study|Participant randomized in error|0|||
161432074|NCT01283139|582975220|FG001|Overall Study|Participant randomized in error|0|||
161432075|NCT01283139|582975221|FG002|Overall Study|Participant randomized in error|1|||
161432076|NCT01283139|582975222|FG003|Overall Study|Participant randomized in error|0|||
161432077|NCT01844765|582975228|FG000|Overall Study|Adverse Event|6|||
161432078|NCT01844765|582975229|FG001|Overall Study|Adverse Event|8|||
161432079|NCT01844765|582975228|FG000|Overall Study|Withdrawal by Subject|2|||
161432080|NCT01844765|582975229|FG001|Overall Study|Withdrawal by Subject|3|||
161432081|NCT01844765|582975228|FG000|Overall Study|Disease progression|1|||
161432082|NCT01844765|582975229|FG001|Overall Study|Disease progression|0|||
161432083|NCT01844765|582975228|FG000|Overall Study|Administrative problems|3|||
161432084|NCT01844765|582975229|FG001|Overall Study|Administrative problems|4|||
161432085|NCT01844765|582975228|FG000|Overall Study|Protocol deviation|2|||
161432086|NCT01844765|582975229|FG001|Overall Study|Protocol deviation|0|||
161432087|NCT01844765|582975228|FG000|Overall Study|Untreated|1|||
161432088|NCT01844765|582975229|FG001|Overall Study|Untreated|0|||
161432089|NCT02025179|582975230|FG000|Overall Study|Lost to Follow-up|0|||
161432090|NCT02025179|582975231|FG001|Overall Study|Lost to Follow-up|0|||
161432091|NCT02025179|582975232|FG002|Overall Study|Lost to Follow-up|1|||
161432092|NCT00556075|582975233|FG000|Overall Study|Lost to Follow-up|3|||
161432093|NCT00556075|582975234|FG001|Overall Study|Lost to Follow-up|0|||
161432094|NCT00556075|582975235|FG002|Overall Study|Lost to Follow-up|3|||
161432095|NCT00556075|582975233|FG000|Overall Study|Withdrawal by Subject|3|||
161432096|NCT00556075|582975234|FG001|Overall Study|Withdrawal by Subject|3|||
161432097|NCT00556075|582975235|FG002|Overall Study|Withdrawal by Subject|0|||
161432098|NCT00556075|582975233|FG000|Overall Study|Protocol Violation|1|||
161432099|NCT00556075|582975234|FG001|Overall Study|Protocol Violation|1|||
161432100|NCT00556075|582975235|FG002|Overall Study|Protocol Violation|3|||
161432101|NCT00556075|582975233|FG000|Overall Study|Not eligible|1|||
161432102|NCT00556075|582975234|FG001|Overall Study|Not eligible|1|||
161432103|NCT00556075|582975235|FG002|Overall Study|Not eligible|2|||
161432104|NCT00556075|582975233|FG000|Overall Study|Adverse Event|1|||
161432105|NCT00556075|582975234|FG001|Overall Study|Adverse Event|2|||
161432106|NCT00556075|582975235|FG002|Overall Study|Adverse Event|0|||
161432107|NCT00556075|582975233|FG000|Overall Study|Personal issues|4|||
161432108|NCT00556075|582975234|FG001|Overall Study|Personal issues|1|||
161432109|NCT00556075|582975235|FG002|Overall Study|Personal issues|0|||
161432110|NCT00556075|582975233|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
161432111|NCT00556075|582975234|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
161432112|NCT00556075|582975235|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
161432113|NCT00601835|582975236|FG000|Overall Study|Withdrawal by Subject|9|||
161432114|NCT00601835|582975237|FG001|Overall Study|Withdrawal by Subject|6|||
161432115|NCT00601835|582975236|FG000|Overall Study|Physician Decision|1|||
161432116|NCT00601835|582975237|FG001|Overall Study|Physician Decision|0|||
161432117|NCT00601835|582975236|FG000|Overall Study|Lost to Follow-up|37|||
161432118|NCT00601835|582975237|FG001|Overall Study|Lost to Follow-up|5|||
161432119|NCT00601835|582975236|FG000|Overall Study|Adverse Event|1|||
161432120|NCT00601835|582975237|FG001|Overall Study|Adverse Event|1|||
161432121|NCT00601835|582975236|FG000|Overall Study|Relocate|12|||
161432122|NCT00601835|582975237|FG001|Overall Study|Relocate|2|||
161432123|NCT03836625|582975238|FG000|Overall Study|Lost to Follow-up|9|||
161432124|NCT03836625|582975239|FG001|Overall Study|Lost to Follow-up|9|||
161432125|NCT03836625|582975238|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
161432126|NCT03836625|582975239|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
161432127|NCT03836625|582975238|FG000|Overall Study|Death|0|||
161432128|NCT03836625|582975239|FG001|Overall Study|Death|1|||
161432129|NCT03836625|582975238|FG000|Overall Study|Refused follow-up|0|||
161432130|NCT03836625|582975239|FG001|Overall Study|Refused follow-up|1|||
161432131|NCT04764162|582975242|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
161432132|NCT04764162|582975243|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
161432133|NCT03077542|582975248|FG000|Overall Study|Death|4|||
161432134|NCT03077542|582975249|FG001|Overall Study|Death|0|||
161432135|NCT03077542|582975248|FG000|Overall Study|Physician Decision|6|||
161432136|NCT03077542|582975249|FG001|Overall Study|Physician Decision|1|||
161432137|NCT03077542|582975248|FG000|Overall Study|Withdrawal by Subject|0|||
161432138|NCT03077542|582975249|FG001|Overall Study|Withdrawal by Subject|1|||
161432139|NCT00301808|582975250|FG000|Overall Study|Adverse Event|5|||
161432140|NCT00301808|582975250|FG000|Overall Study|Death|3|||
161432141|NCT00301808|582975250|FG000|Overall Study|Lack of Efficacy|4|||
161432142|NCT00844844|582975251|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
161432143|NCT00844844|582975251|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
161432144|NCT00844844|582975251|FG000|Extension Treatment Period|Adverse Event|2|||
161432145|NCT00844844|582975251|FG000|Post Treatment Period|Withdrawal by Subject|1|||
161432146|NCT04886154|582975254|FG000|Overall Study|Adverse Event|0|||
161432147|NCT04886154|582975255|FG001|Overall Study|Adverse Event|0|||
161432148|NCT04886154|582975256|FG002|Overall Study|Adverse Event|0|||
161432149|NCT04886154|582975257|FG003|Overall Study|Adverse Event|0|||
161432150|NCT04886154|582975258|FG004|Overall Study|Adverse Event|1|||
161432151|NCT04886154|582975259|FG005|Overall Study|Adverse Event|0|||
161432152|NCT04886154|582975260|FG006|Overall Study|Adverse Event|0|||
161432153|NCT04886154|582975261|FG007|Overall Study|Adverse Event|1|||
161432154|NCT04886154|582975262|FG008|Overall Study|Adverse Event|1|||
161432155|NCT04886154|582975263|FG009|Overall Study|Adverse Event|0|||
161432156|NCT04886154|582975264|FG010|Overall Study|Adverse Event|0|||
161432157|NCT04886154|582975265|FG011|Overall Study|Adverse Event|1|||
161432158|NCT04886154|582975266|FG012|Overall Study|Adverse Event|0|||
161432159|NCT04886154|582975267|FG013|Overall Study|Adverse Event|0|||
161432160|NCT04886154|582975268|FG014|Overall Study|Adverse Event|3|||
161432161|NCT04886154|582975254|FG000|Overall Study|Lost to Follow-up|1|||
161432162|NCT04886154|582975255|FG001|Overall Study|Lost to Follow-up|0|||
161432163|NCT04886154|582975256|FG002|Overall Study|Lost to Follow-up|2|||
161432164|NCT04886154|582975257|FG003|Overall Study|Lost to Follow-up|0|||
161432165|NCT04886154|582975258|FG004|Overall Study|Lost to Follow-up|17|||
161432166|NCT04886154|582975259|FG005|Overall Study|Lost to Follow-up|7|||
161432167|NCT04886154|582975260|FG006|Overall Study|Lost to Follow-up|8|||
161432168|NCT04886154|582975261|FG007|Overall Study|Lost to Follow-up|7|||
161432169|NCT04886154|582975262|FG008|Overall Study|Lost to Follow-up|8|||
161432170|NCT04886154|582975263|FG009|Overall Study|Lost to Follow-up|0|||
161432171|NCT04886154|582975264|FG010|Overall Study|Lost to Follow-up|2|||
161432172|NCT04886154|582975265|FG011|Overall Study|Lost to Follow-up|0|||
161432173|NCT04886154|582975266|FG012|Overall Study|Lost to Follow-up|0|||
161432174|NCT04886154|582975267|FG013|Overall Study|Lost to Follow-up|0|||
161432175|NCT04886154|582975268|FG014|Overall Study|Lost to Follow-up|0|||
161432176|NCT04886154|582975254|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432177|NCT04886154|582975255|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432178|NCT04886154|582975256|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432179|NCT04886154|582975257|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432180|NCT04886154|582975258|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432181|NCT04886154|582975259|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432182|NCT04886154|582975260|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
161432183|NCT04886154|582975261|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432184|NCT04886154|582975262|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432185|NCT04886154|582975263|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432186|NCT04886154|582975264|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432187|NCT04886154|582975265|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432188|NCT04886154|582975266|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432189|NCT04886154|582975267|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432190|NCT04886154|582975268|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
161432191|NCT04886154|582975254|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432192|NCT04886154|582975255|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432193|NCT04886154|582975256|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432194|NCT04886154|582975257|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432195|NCT04886154|582975258|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161432196|NCT04886154|582975259|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432197|NCT04886154|582975260|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161432198|NCT04886154|582975261|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161432199|NCT04886154|582975262|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432200|NCT04886154|582975263|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432201|NCT04886154|582975264|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432202|NCT04886154|582975265|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432203|NCT04886154|582975266|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432204|NCT04886154|582975267|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161432205|NCT04886154|582975268|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161432206|NCT04886154|582975254|FG000|Overall Study|Other, Not Specified|0|||
161432207|NCT04886154|582975255|FG001|Overall Study|Other, Not Specified|0|||
161432208|NCT04886154|582975256|FG002|Overall Study|Other, Not Specified|0|||
161432209|NCT04886154|582975257|FG003|Overall Study|Other, Not Specified|0|||
161432210|NCT04886154|582975258|FG004|Overall Study|Other, Not Specified|11|||
161432211|NCT04886154|582975259|FG005|Overall Study|Other, Not Specified|8|||
161432212|NCT04886154|582975260|FG006|Overall Study|Other, Not Specified|9|||
161432213|NCT04886154|582975261|FG007|Overall Study|Other, Not Specified|10|||
161432214|NCT04886154|582975262|FG008|Overall Study|Other, Not Specified|6|||
161432215|NCT04886154|582975263|FG009|Overall Study|Other, Not Specified|1|||
161432216|NCT04886154|582975264|FG010|Overall Study|Other, Not Specified|1|||
161432217|NCT04886154|582975265|FG011|Overall Study|Other, Not Specified|2|||
161432218|NCT04886154|582975266|FG012|Overall Study|Other, Not Specified|1|||
161432219|NCT04886154|582975267|FG013|Overall Study|Other, Not Specified|2|||
161432220|NCT04886154|582975268|FG014|Overall Study|Other, Not Specified|3|||
161432221|NCT03919773|582975277|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
161432222|NCT03919773|582975278|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
161432223|NCT03919773|582975277|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
161432224|NCT03919773|582975278|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
161432225|NCT04659044|582975281|FG000|Induction|Physician Decision|1|||
161432226|NCT04659044|582975281|FG000|Induction|Adverse Event|2|||
161432227|NCT04966013|582975283|FG000|Overall Study|Withdrawal by Subject|0|||
161432228|NCT04966013|582975284|FG001|Overall Study|Withdrawal by Subject|2|||
161432229|NCT04966013|582975285|FG002|Overall Study|Withdrawal by Subject|1|||
161432230|NCT04966013|582975283|FG000|Overall Study|Adverse Event|2|||
161432231|NCT04966013|582975284|FG001|Overall Study|Adverse Event|1|||
161432232|NCT04966013|582975285|FG002|Overall Study|Adverse Event|1|||
161432233|NCT02702492|582975289|FG000|Overall Study|Disease progression|3|||
161432234|NCT02702492|582975290|FG001|Overall Study|Disease progression|3|||
161432235|NCT02702492|582975291|FG002|Overall Study|Disease progression|2|||
161432236|NCT02702492|582975292|FG003|Overall Study|Disease progression|4|||
161432237|NCT02702492|582975293|FG004|Overall Study|Disease progression|4|||
161432238|NCT02702492|582975294|FG005|Overall Study|Disease progression|1|||
161432239|NCT02702492|582975295|FG006|Overall Study|Disease progression|2|||
161432240|NCT02702492|582975296|FG007|Overall Study|Disease progression|8|||
161432241|NCT02702492|582975297|FG008|Overall Study|Disease progression|5|||
161432242|NCT02702492|582975298|FG009|Overall Study|Disease progression|1|||
161432243|NCT02702492|582975299|FG010|Overall Study|Disease progression|0|||
161432244|NCT02702492|582975300|FG011|Overall Study|Disease progression|3|||
161432245|NCT02702492|582975301|FG012|Overall Study|Disease progression|2|||
161432246|NCT02702492|582975289|FG000|Overall Study|Clinical progression|0|||
161432247|NCT02702492|582975290|FG001|Overall Study|Clinical progression|0|||
161432248|NCT02702492|582975291|FG002|Overall Study|Clinical progression|2|||
161432249|NCT02702492|582975292|FG003|Overall Study|Clinical progression|1|||
161432250|NCT02702492|582975293|FG004|Overall Study|Clinical progression|0|||
161432251|NCT02702492|582975294|FG005|Overall Study|Clinical progression|2|||
161432252|NCT02702492|582975295|FG006|Overall Study|Clinical progression|1|||
161432253|NCT02702492|582975296|FG007|Overall Study|Clinical progression|4|||
161432254|NCT02702492|582975297|FG008|Overall Study|Clinical progression|0|||
161432255|NCT02702492|582975298|FG009|Overall Study|Clinical progression|0|||
161432256|NCT02702492|582975299|FG010|Overall Study|Clinical progression|1|||
161432257|NCT02702492|582975300|FG011|Overall Study|Clinical progression|2|||
161432258|NCT02702492|582975301|FG012|Overall Study|Clinical progression|0|||
161432259|NCT02702492|582975289|FG000|Overall Study|Adverse Event|0|||
161432260|NCT02702492|582975290|FG001|Overall Study|Adverse Event|0|||
161432261|NCT02702492|582975291|FG002|Overall Study|Adverse Event|1|||
161432262|NCT02702492|582975292|FG003|Overall Study|Adverse Event|2|||
161432263|NCT02702492|582975293|FG004|Overall Study|Adverse Event|1|||
161432264|NCT02702492|582975294|FG005|Overall Study|Adverse Event|0|||
161432265|NCT02702492|582975295|FG006|Overall Study|Adverse Event|1|||
161432266|NCT02702492|582975296|FG007|Overall Study|Adverse Event|0|||
161432267|NCT02702492|582975297|FG008|Overall Study|Adverse Event|2|||
161432268|NCT02702492|582975298|FG009|Overall Study|Adverse Event|0|||
161432269|NCT02702492|582975299|FG010|Overall Study|Adverse Event|0|||
161432270|NCT02702492|582975300|FG011|Overall Study|Adverse Event|0|||
161432271|NCT02702492|582975301|FG012|Overall Study|Adverse Event|1|||
161432272|NCT02702492|582975289|FG000|Overall Study|Other|0|||
161432273|NCT02702492|582975290|FG001|Overall Study|Other|0|||
161432274|NCT02702492|582975291|FG002|Overall Study|Other|0|||
161432275|NCT02702492|582975292|FG003|Overall Study|Other|0|||
161432276|NCT02702492|582975293|FG004|Overall Study|Other|0|||
161432277|NCT02702492|582975294|FG005|Overall Study|Other|0|||
161432278|NCT02702492|582975295|FG006|Overall Study|Other|0|||
161432279|NCT02702492|582975296|FG007|Overall Study|Other|0|||
161432280|NCT02702492|582975297|FG008|Overall Study|Other|0|||
161432281|NCT02702492|582975298|FG009|Overall Study|Other|0|||
161432282|NCT02702492|582975299|FG010|Overall Study|Other|0|||
161432283|NCT02702492|582975300|FG011|Overall Study|Other|0|||
161432284|NCT02702492|582975301|FG012|Overall Study|Other|1|||
161432285|NCT01910298|582975302|FG000|Overall Study|Adverse Event|1|||
161432286|NCT01910298|582975303|FG001|Overall Study|Adverse Event|0|||
161432287|NCT01910298|582975302|FG000|Overall Study|Withdrawal by Subject|2|||
161432288|NCT01910298|582975303|FG001|Overall Study|Withdrawal by Subject|7|||
161432289|NCT01910298|582975302|FG000|Overall Study|Protocol Deviation|0|||
161432290|NCT01910298|582975303|FG001|Overall Study|Protocol Deviation|5|||
161432291|NCT01910298|582975302|FG000|Overall Study|Lost to Follow-up|1|||
161432292|NCT01910298|582975303|FG001|Overall Study|Lost to Follow-up|1|||
161432293|NCT01910298|582975302|FG000|Overall Study|Study Terminated by Sponsor|1|||
161432294|NCT01910298|582975303|FG001|Overall Study|Study Terminated by Sponsor|17|||
161432295|NCT01910298|582975302|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161432296|NCT01910298|582975303|FG001|Overall Study|Other Miscellaneous Reasons|2|||
161432297|NCT00781768|582976971|FG000|Overall Study|Not transplanted.|0|||
161432298|NCT00781768|582976972|FG001|Overall Study|Not transplanted.|2|||
161432299|NCT02458313|582976981|FG000|Overall Study|Withdrawal by Subject|6|||
161432300|NCT02458313|582976982|FG001|Overall Study|Withdrawal by Subject|8|||
161432301|NCT02458313|582976981|FG000|Overall Study|Excluded for motion during MRI|1|||
161432302|NCT02458313|582976982|FG001|Overall Study|Excluded for motion during MRI|2|||
161432303|NCT00199381|582976983|FG000|Overall Study|Withdrawal by Subject|38|||
161432304|NCT00199381|582976983|FG000|Overall Study|Adverse Event|73|||
161432305|NCT00199381|582976983|FG000|Overall Study|Protocol Violation|6|||
161432306|NCT00199381|582976983|FG000|Overall Study|Lack of Efficacy|27|||
161432307|NCT00199381|582976983|FG000|Overall Study|Not including due to early termination|37|||
161432308|NCT00199381|582976983|FG000|Overall Study|Study termination by Sponsor|323|||
161432309|NCT00751296|582976984|FG000|Overall Study|Adverse Event|2|||
161432310|NCT01972217|582976985|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
161432311|NCT01972217|582976986|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
161432312|NCT01972217|582976987|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
161432313|NCT01972217|582976988|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
161432314|NCT01972217|582976985|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
161432315|NCT01972217|582976986|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
161432316|NCT01972217|582976987|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
161432317|NCT01972217|582976988|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
161432318|NCT01972217|582976985|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
161432319|NCT01972217|582976986|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
161432320|NCT01972217|582976987|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
161432321|NCT01972217|582976988|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
161432322|NCT01972217|582976985|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
161432323|NCT01972217|582976986|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
161432324|NCT01972217|582976987|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
161432325|NCT01972217|582976988|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
161432326|NCT01972217|582976985|FG000|Part B Double-blind, Randomised Period|Death|0|||
161432327|NCT01972217|582976986|FG001|Part B Double-blind, Randomised Period|Death|0|||
161432328|NCT01972217|582976987|FG002|Part B Double-blind, Randomised Period|Death|43|||
161432329|NCT01972217|582976988|FG003|Part B Double-blind, Randomised Period|Death|44|||
161432330|NCT01972217|582976985|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
161432331|NCT01972217|582976986|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
161432332|NCT01972217|582976987|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
161432333|NCT01972217|582976988|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
161432334|NCT01972217|582976985|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
161432335|NCT01972217|582976986|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
161432336|NCT01972217|582976987|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
161432337|NCT01972217|582976988|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
161432338|NCT01972217|582976985|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
161432339|NCT01972217|582976986|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
161432340|NCT01972217|582976987|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
161432341|NCT01972217|582976988|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
161432342|NCT01972217|582976985|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
161432343|NCT01972217|582976986|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
161432344|NCT01972217|582976987|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
161432345|NCT01972217|582976988|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
161432346|NCT03714672|582976992|FG000|Overall Study|Adverse Event|0|||
161432347|NCT03714672|582976993|FG001|Overall Study|Adverse Event|0|||
161432348|NCT03714672|582976994|FG002|Overall Study|Adverse Event|3|||
161432349|NCT03714672|582976995|FG003|Overall Study|Adverse Event|0|||
161432350|NCT03714672|582976992|FG000|Overall Study|Physician Decision|0|||
161432351|NCT03714672|582976993|FG001|Overall Study|Physician Decision|1|||
161432352|NCT03714672|582976994|FG002|Overall Study|Physician Decision|0|||
161432353|NCT03714672|582976995|FG003|Overall Study|Physician Decision|0|||
161432354|NCT03714672|582976992|FG000|Overall Study|Other Reason|1|||
161432355|NCT03714672|582976993|FG001|Overall Study|Other Reason|2|||
161432356|NCT03714672|582976994|FG002|Overall Study|Other Reason|1|||
161432357|NCT03714672|582976995|FG003|Overall Study|Other Reason|1|||
161432358|NCT03714672|582976992|FG000|Overall Study|Lost to Follow-up|1|||
161432359|NCT03714672|582976993|FG001|Overall Study|Lost to Follow-up|1|||
161432360|NCT03714672|582976994|FG002|Overall Study|Lost to Follow-up|0|||
161432361|NCT03714672|582976995|FG003|Overall Study|Lost to Follow-up|0|||
161432362|NCT01074502|582976996|FG000|Overall Study|Withdrawal by Subject|1|||
161432363|NCT00674817|582977004|FG000|Period 1|Withdrawal by Subject|2|||
161432364|NCT00674817|582977004|FG000|Period 1|Protocol Violation|1|||
161432365|NCT00674817|582977004|FG000|Period 3|Adverse Event|1|||
161432366|NCT00674817|582977004|FG000|Period 3|Protocol Violation|1|||
161432367|NCT00674817|582977004|FG000|Period 4|Adverse Event|1|||
161432368|NCT04945733|582977007|FG000|Overall Study|Physician Decision|1|||
161432369|NCT04945733|582977008|FG001|Overall Study|Physician Decision|3|||
161432370|NCT04945733|582977009|FG002|Overall Study|Physician Decision|0|||
161432371|NCT04945733|582977007|FG000|Overall Study|Withdrawal by Subject|3|||
161432372|NCT04945733|582977008|FG001|Overall Study|Withdrawal by Subject|3|||
161432373|NCT04945733|582977009|FG002|Overall Study|Withdrawal by Subject|0|||
161432374|NCT03566511|582977016|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
161432375|NCT03566511|582977017|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
161432376|NCT00687596|582977018|FG000|Overall Study|Adverse Event (AE)|10|||
161432377|NCT00687596|582977019|FG001|Overall Study|Adverse Event (AE)|3|||
161432378|NCT00687596|582977018|FG000|Overall Study|Radiological Disease Progression|6|||
161432379|NCT00687596|582977019|FG001|Overall Study|Radiological Disease Progression|2|||
161432380|NCT00687596|582977018|FG000|Overall Study|Clinical Disease Progression|1|||
161432381|NCT00687596|582977019|FG001|Overall Study|Clinical Disease Progression|3|||
161432382|NCT00687596|582977018|FG000|Overall Study|Investigator Discretion|3|||
161432383|NCT00687596|582977019|FG001|Overall Study|Investigator Discretion|1|||
161432384|NCT00687596|582977018|FG000|Overall Study|Sponsor Terminated Study|6|||
161432385|NCT00687596|582977019|FG001|Overall Study|Sponsor Terminated Study|17|||
161432386|NCT00499486|582977021|FG000|Overall Study|Withdrawal by Subject|16|||
161432387|NCT03796728|582977023|FG000|Overall Study|Lost to Follow-up|8|||
161432388|NCT03796728|582977023|FG000|Overall Study|Reason not Specified|16|||
161432389|NCT05236270|582977024|FG000|Overall Study|Lost to Follow-up|3|||
161432390|NCT05236270|582977025|FG001|Overall Study|Lost to Follow-up|2|||
161432391|NCT05236270|582977026|FG002|Overall Study|Lost to Follow-up|0|||
161432392|NCT05236270|582977027|FG003|Overall Study|Lost to Follow-up|0|||
161432393|NCT05236270|582977028|FG004|Overall Study|Lost to Follow-up|2|||
161432394|NCT05236270|582977029|FG005|Overall Study|Lost to Follow-up|0|||
161432395|NCT05236270|582977030|FG006|Overall Study|Lost to Follow-up|1|||
161432396|NCT05236270|582977031|FG007|Overall Study|Lost to Follow-up|3|||
161432397|NCT01149096|582977032|FG000|Overall Study|Lost to Follow-up|0|||
161432398|NCT01149096|582977033|FG001|Overall Study|Lost to Follow-up|1|||
161432399|NCT03651765|582977034|FG000|Overall Study|Adverse Event|6|||
161432400|NCT03651765|582977034|FG000|Overall Study|Lack of Efficacy|18|||
161432401|NCT03651765|582977034|FG000|Overall Study|Lost to Follow-up|5|||
161432402|NCT03651765|582977034|FG000|Overall Study|Non-Compliance with Study Drug|4|||
161432403|NCT03651765|582977034|FG000|Overall Study|Physician Decision|6|||
161432404|NCT03651765|582977034|FG000|Overall Study|Pregnancy|1|||
161432405|NCT03651765|582977034|FG000|Overall Study|Discontinued by Sponsor|40|||
161432406|NCT03651765|582977034|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
161432407|NCT03651765|582977034|FG000|Overall Study|Withdrawal by Subject|24|||
161432408|NCT03651765|582977034|FG000|Overall Study|Miscellaneous|6|||
161432409|NCT01263769|582977037|FG000|Overall Study|Non-Compliant with treatment|1|||
161432410|NCT03267277|582977038|FG000|Overall Study|Withdrawal by Subject|1|||
161432411|NCT01346358|582977039|FG000|Overall Study|Withdrawal by Subject|1|||
161432412|NCT01346358|582977040|FG001|Overall Study|Withdrawal by Subject|0|||
161432413|NCT01346358|582977041|FG002|Overall Study|Withdrawal by Subject|1|||
161432414|NCT01346358|582977042|FG003|Overall Study|Withdrawal by Subject|1|||
161432415|NCT01346358|582977043|FG004|Overall Study|Withdrawal by Subject|0|||
161432416|NCT01346358|582977044|FG005|Overall Study|Withdrawal by Subject|2|||
161432417|NCT01346358|582977045|FG006|Overall Study|Withdrawal by Subject|1|||
161432418|NCT01346358|582977046|FG007|Overall Study|Withdrawal by Subject|1|||
161432419|NCT01346358|582977047|FG008|Overall Study|Withdrawal by Subject|1|||
161432420|NCT01346358|582977039|FG000|Overall Study|Adverse Event|1|||
161432421|NCT01346358|582977040|FG001|Overall Study|Adverse Event|0|||
161432422|NCT01346358|582977041|FG002|Overall Study|Adverse Event|0|||
161432423|NCT01346358|582977042|FG003|Overall Study|Adverse Event|0|||
161432424|NCT01346358|582977043|FG004|Overall Study|Adverse Event|1|||
161432425|NCT01346358|582977044|FG005|Overall Study|Adverse Event|0|||
161432426|NCT01346358|582977045|FG006|Overall Study|Adverse Event|0|||
161432427|NCT01346358|582977046|FG007|Overall Study|Adverse Event|0|||
161432428|NCT01346358|582977047|FG008|Overall Study|Adverse Event|1|||
161432429|NCT01346358|582977039|FG000|Overall Study|Non-Compliance|0|||
161432430|NCT01346358|582977040|FG001|Overall Study|Non-Compliance|0|||
161432431|NCT01346358|582977041|FG002|Overall Study|Non-Compliance|0|||
161432432|NCT01346358|582977042|FG003|Overall Study|Non-Compliance|0|||
161432433|NCT01346358|582977043|FG004|Overall Study|Non-Compliance|0|||
161432434|NCT01346358|582977044|FG005|Overall Study|Non-Compliance|0|||
161432435|NCT01346358|582977045|FG006|Overall Study|Non-Compliance|0|||
161432436|NCT01346358|582977046|FG007|Overall Study|Non-Compliance|2|||
161432437|NCT01346358|582977047|FG008|Overall Study|Non-Compliance|0|||
161432438|NCT01346358|582977039|FG000|Overall Study|Physician Decision|0|||
161432439|NCT01346358|582977040|FG001|Overall Study|Physician Decision|1|||
161432440|NCT01346358|582977041|FG002|Overall Study|Physician Decision|0|||
161432441|NCT01346358|582977042|FG003|Overall Study|Physician Decision|0|||
161432442|NCT01346358|582977043|FG004|Overall Study|Physician Decision|0|||
161432443|NCT01346358|582977044|FG005|Overall Study|Physician Decision|0|||
161432444|NCT01346358|582977045|FG006|Overall Study|Physician Decision|0|||
161432445|NCT01346358|582977046|FG007|Overall Study|Physician Decision|1|||
161432446|NCT01346358|582977047|FG008|Overall Study|Physician Decision|1|||
161432447|NCT05058365|582977050|FG000|Overall Study|Migration|1|||
161432448|NCT05058365|582977051|FG001|Overall Study|Migration|1|||
161432449|NCT00702702|582977052|FG000|Overall Study|Study prematurely terminated|56|||
161432450|NCT00468169|582977053|FG000|Overall Study|Withdrawal by Subject|1|||
161432451|NCT00468169|582977054|FG001|Overall Study|Withdrawal by Subject|0|||
161432452|NCT01126749|582977059|FG000|Phase 1b|Other|0|||
161432453|NCT01126749|582977060|FG001|Phase 1b|Other|1|||
161432454|NCT01126749|582977061|FG002|Phase 1b|Other|0|||
161432455|NCT01126749|582977062|FG003|Phase 1b|Other|0|||
161432456|NCT01126749|582977059|FG000|Phase 1b|Withdrawal by Subject|0|||
161432457|NCT01126749|582977060|FG001|Phase 1b|Withdrawal by Subject|1|||
161432458|NCT01126749|582977061|FG002|Phase 1b|Withdrawal by Subject|0|||
161432459|NCT01126749|582977062|FG003|Phase 1b|Withdrawal by Subject|0|||
161432460|NCT01126749|582977059|FG000|Phase 1b|Death|3|||
161432461|NCT01126749|582977060|FG001|Phase 1b|Death|4|||
161432462|NCT01126749|582977061|FG002|Phase 1b|Death|0|||
161432463|NCT01126749|582977062|FG003|Phase 1b|Death|0|||
161432464|NCT01126749|582977059|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
161432465|NCT01126749|582977060|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
161432466|NCT01126749|582977061|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
161432467|NCT01126749|582977062|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
161432468|NCT01126749|582977059|FG000|Phase 2|Study Termination by Sponsor|0|||
161432469|NCT01126749|582977060|FG001|Phase 2|Study Termination by Sponsor|0|||
161432470|NCT01126749|582977061|FG002|Phase 2|Study Termination by Sponsor|12|||
161432471|NCT01126749|582977062|FG003|Phase 2|Study Termination by Sponsor|6|||
161432472|NCT01126749|582977059|FG000|Phase 2|Other|0|||
161432473|NCT01126749|582977060|FG001|Phase 2|Other|0|||
161432474|NCT01126749|582977061|FG002|Phase 2|Other|4|||
161432475|NCT01126749|582977062|FG003|Phase 2|Other|2|||
161432476|NCT01126749|582977059|FG000|Phase 2|Withdrawal by Subject|0|||
161432477|NCT01126749|582977060|FG001|Phase 2|Withdrawal by Subject|0|||
161432478|NCT01126749|582977061|FG002|Phase 2|Withdrawal by Subject|0|||
161432479|NCT01126749|582977062|FG003|Phase 2|Withdrawal by Subject|2|||
161432480|NCT01126749|582977059|FG000|Phase 2|Lost to Follow-up|0|||
161432481|NCT01126749|582977060|FG001|Phase 2|Lost to Follow-up|0|||
161432482|NCT01126749|582977061|FG002|Phase 2|Lost to Follow-up|0|||
161432483|NCT01126749|582977062|FG003|Phase 2|Lost to Follow-up|1|||
161432484|NCT01126749|582977059|FG000|Phase 2|Death|0|||
161432485|NCT01126749|582977060|FG001|Phase 2|Death|0|||
161432486|NCT01126749|582977061|FG002|Phase 2|Death|22|||
161432487|NCT01126749|582977062|FG003|Phase 2|Death|22|||
161432488|NCT01126749|582977059|FG000|Phase 2|Adverse Event|0|||
161432489|NCT01126749|582977060|FG001|Phase 2|Adverse Event|0|||
161432490|NCT01126749|582977061|FG002|Phase 2|Adverse Event|0|||
161432491|NCT01126749|582977062|FG003|Phase 2|Adverse Event|1|||
161432492|NCT03668873|582977063|FG000|Overall Study|Lost to Follow-up|6|||
161432493|NCT03668873|582977064|FG001|Overall Study|Lost to Follow-up|3|||
161432494|NCT02183675|582977065|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
161432495|NCT02183675|582977066|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
161432496|NCT02183675|582977067|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
161432497|NCT02183675|582977068|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
161432498|NCT02183675|582977069|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
161432499|NCT02183675|582977070|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
161432500|NCT01521117|582977071|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
161432501|NCT01521117|582977072|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
161432502|NCT01521117|582977071|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
161432503|NCT01521117|582977072|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
161432504|NCT01521117|582977071|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
161432505|NCT01521117|582977072|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
161432506|NCT00784563|582977075|FG000|Years 1 & 2|Withdrawal by Subject|3|||
161432507|NCT00784563|582977076|FG001|Years 1 & 2|Withdrawal by Subject|2|||
161432508|NCT00784563|582977077|FG002|Years 1 & 2|Withdrawal by Subject|0|||
161432509|NCT00784563|582977075|FG000|Years 1 & 2|Adverse Event|0|||
161432510|NCT00784563|582977076|FG001|Years 1 & 2|Adverse Event|3|||
161432511|NCT00784563|582977077|FG002|Years 1 & 2|Adverse Event|0|||
161432512|NCT00784563|582977075|FG000|Year 3|Withdrawal by Subject|0|||
161432513|NCT00784563|582977076|FG001|Year 3|Withdrawal by Subject|0|||
161432514|NCT00784563|582977077|FG002|Year 3|Withdrawal by Subject|2|||
161432515|NCT00784563|582977075|FG000|Year 3|Adverse Event|0|||
161432516|NCT00784563|582977076|FG001|Year 3|Adverse Event|0|||
161432517|NCT00784563|582977077|FG002|Year 3|Adverse Event|1|||
161432518|NCT00762164|582977078|FG000|Overall Study|Lost to Follow-up|1|||
161432519|NCT00762164|582977079|FG001|Overall Study|Lost to Follow-up|1|||
161432520|NCT00762164|582977078|FG000|Overall Study|Discontinued medication|2|||
161432521|NCT00762164|582977079|FG001|Overall Study|Discontinued medication|0|||
161432522|NCT00762164|582977078|FG000|Overall Study|Withdrawal by Subject|0|||
161432523|NCT00762164|582977079|FG001|Overall Study|Withdrawal by Subject|1|||
161432524|NCT02657889|582977084|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
161432525|NCT02657889|582977085|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
161432526|NCT02657889|582977086|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
161432527|NCT02657889|582977087|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
161432528|NCT02657889|582977084|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
161432529|NCT02657889|582977085|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
161432530|NCT02657889|582977086|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
161432531|NCT02657889|582977087|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
161432532|NCT02657889|582977084|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
161432533|NCT02657889|582977085|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
161432534|NCT02657889|582977086|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
161432535|NCT02657889|582977087|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
161432536|NCT02657889|582977084|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
161432537|NCT02657889|582977085|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
161432538|NCT02657889|582977086|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
161432539|NCT02657889|582977087|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
161432540|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
161432541|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
161432542|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
161432543|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
161432544|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
161432545|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
161432546|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
161432547|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
161432548|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
161432549|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
161432550|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
161432551|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
161432552|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
161432553|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
161432554|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
161432555|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
161432556|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
161432557|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
161432558|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
161432559|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
161432560|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
161432561|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
161432562|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
161432563|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
161432564|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
161432565|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
161432566|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
161432567|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
161432568|NCT02657889|582977084|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
161432569|NCT02657889|582977085|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
161432570|NCT02657889|582977086|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
161432571|NCT02657889|582977087|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
161432572|NCT00685165|582977088|FG000|Washout Period of 14 Days|Adverse Event|1|||
161432573|NCT00685165|582977089|FG001|Washout Period of 14 Days|Adverse Event|0|||
161432574|NCT03155724|582977091|FG000|Overall Study|Death|3|||
161432575|NCT03155724|582977091|FG000|Overall Study|Physician Decision|1|||
161432576|NCT03155724|582977091|FG000|Overall Study|Study closure|7|||
161432577|NCT00321789|582977100|FG000|Overall Study|Lost to Follow-up|4|||
161432578|NCT00321789|582977101|FG001|Overall Study|Lost to Follow-up|7|||
161432579|NCT00321789|582977100|FG000|Overall Study|Withdrawal by Subject|6|||
161432580|NCT00321789|582977101|FG001|Overall Study|Withdrawal by Subject|6|||
161432581|NCT00321789|582977100|FG000|Overall Study|Protocol Violation|5|||
161432582|NCT00321789|582977101|FG001|Overall Study|Protocol Violation|3|||
161432583|NCT03050801|582977102|FG000|Experiment 1|Lost to Follow-up|0|||
161432584|NCT03050801|582977103|FG001|Experiment 1|Lost to Follow-up|1|||
161432585|NCT03050801|582977104|FG002|Experiment 1|Lost to Follow-up|0|||
161432586|NCT03050801|582977105|FG003|Experiment 1|Lost to Follow-up|0|||
161432587|NCT03050801|582977106|FG004|Experiment 1|Lost to Follow-up|0|||
161432588|NCT03050801|582977107|FG005|Experiment 1|Lost to Follow-up|0|||
161432589|NCT03050801|582977102|FG000|Experiment 1|Physician Decision|0|||
161432590|NCT03050801|582977103|FG001|Experiment 1|Physician Decision|3|||
161432591|NCT03050801|582977104|FG002|Experiment 1|Physician Decision|0|||
161432592|NCT03050801|582977105|FG003|Experiment 1|Physician Decision|0|||
161432593|NCT03050801|582977106|FG004|Experiment 1|Physician Decision|0|||
161432594|NCT03050801|582977107|FG005|Experiment 1|Physician Decision|0|||
161432595|NCT03050801|582977102|FG000|Experiment 1|Change of experimental design|0|||
161432596|NCT03050801|582977103|FG001|Experiment 1|Change of experimental design|3|||
161432597|NCT03050801|582977104|FG002|Experiment 1|Change of experimental design|0|||
161432598|NCT03050801|582977105|FG003|Experiment 1|Change of experimental design|0|||
161432599|NCT03050801|582977106|FG004|Experiment 1|Change of experimental design|0|||
161432600|NCT03050801|582977107|FG005|Experiment 1|Change of experimental design|0|||
161432601|NCT03050801|582977102|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
161432602|NCT03050801|582977103|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
161432603|NCT03050801|582977104|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
161432604|NCT03050801|582977105|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
161432605|NCT03050801|582977106|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
161432606|NCT03050801|582977107|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
161432607|NCT03050801|582977102|FG000|Experiment 2|Lost to Follow-up|0|||
161432608|NCT03050801|582977103|FG001|Experiment 2|Lost to Follow-up|0|||
161432609|NCT03050801|582977104|FG002|Experiment 2|Lost to Follow-up|0|||
161432610|NCT03050801|582977105|FG003|Experiment 2|Lost to Follow-up|1|||
161432611|NCT03050801|582977106|FG004|Experiment 2|Lost to Follow-up|1|||
161432612|NCT03050801|582977107|FG005|Experiment 2|Lost to Follow-up|0|||
161432613|NCT03050801|582977102|FG000|Experiment 2|Physician Decision|0|||
161432614|NCT03050801|582977103|FG001|Experiment 2|Physician Decision|0|||
161432615|NCT03050801|582977104|FG002|Experiment 2|Physician Decision|0|||
161432616|NCT03050801|582977105|FG003|Experiment 2|Physician Decision|0|||
161432617|NCT03050801|582977106|FG004|Experiment 2|Physician Decision|1|||
161432618|NCT03050801|582977107|FG005|Experiment 2|Physician Decision|0|||
161432619|NCT03050801|582977102|FG000|Experiment 2|Pregnancy|0|||
161432620|NCT03050801|582977103|FG001|Experiment 2|Pregnancy|0|||
161432621|NCT03050801|582977104|FG002|Experiment 2|Pregnancy|0|||
161432622|NCT03050801|582977105|FG003|Experiment 2|Pregnancy|0|||
161432623|NCT03050801|582977106|FG004|Experiment 2|Pregnancy|1|||
161432624|NCT03050801|582977107|FG005|Experiment 2|Pregnancy|0|||
161432625|NCT03050801|582977102|FG000|Experiment 2|Withdrawal by Subject|0|||
161432626|NCT03050801|582977103|FG001|Experiment 2|Withdrawal by Subject|0|||
161432627|NCT03050801|582977104|FG002|Experiment 2|Withdrawal by Subject|0|||
161432628|NCT03050801|582977105|FG003|Experiment 2|Withdrawal by Subject|1|||
161432629|NCT03050801|582977106|FG004|Experiment 2|Withdrawal by Subject|0|||
161432630|NCT03050801|582977107|FG005|Experiment 2|Withdrawal by Subject|0|||
161432631|NCT03050801|582977102|FG000|Experiment 2|Poor data quality|0|||
161432632|NCT03050801|582977103|FG001|Experiment 2|Poor data quality|0|||
161432633|NCT03050801|582977104|FG002|Experiment 2|Poor data quality|0|||
161432634|NCT03050801|582977105|FG003|Experiment 2|Poor data quality|4|||
161432635|NCT03050801|582977106|FG004|Experiment 2|Poor data quality|1|||
161432636|NCT03050801|582977107|FG005|Experiment 2|Poor data quality|0|||
161432637|NCT03050801|582977102|FG000|Experiment 2|Discomfort during stimulation|0|||
161432638|NCT03050801|582977103|FG001|Experiment 2|Discomfort during stimulation|0|||
161432639|NCT03050801|582977104|FG002|Experiment 2|Discomfort during stimulation|0|||
161432640|NCT03050801|582977105|FG003|Experiment 2|Discomfort during stimulation|0|||
161432641|NCT03050801|582977106|FG004|Experiment 2|Discomfort during stimulation|0|||
161432642|NCT03050801|582977107|FG005|Experiment 2|Discomfort during stimulation|2|||
161432643|NCT01576341|582977108|FG000|Overall Study|Withdrawal by Subject|24|||
161432644|NCT01576341|582977108|FG000|Overall Study|Adverse Event|10|||
161432645|NCT01576341|582977108|FG000|Overall Study|Death|21|||
161432646|NCT01576341|582977108|FG000|Overall Study|Physician Decision|2|||
161432647|NCT01576341|582977108|FG000|Overall Study|Lost to Follow-up|2|||
161432648|NCT01576341|582977108|FG000|Overall Study|Kidney transplantation|10|||
161432649|NCT01576341|582977108|FG000|Overall Study|Protocol Violation|12|||
161432650|NCT01576341|582977108|FG000|Overall Study|Other|12|||
161432651|NCT00617734|582977109|FG000|Overall Study|Withdrew Consent|2|||
161432652|NCT00617734|582977110|FG001|Overall Study|Withdrew Consent|0|||
161432653|NCT00617734|582977109|FG000|Overall Study|Adverse Event|4|||
161432654|NCT00617734|582977110|FG001|Overall Study|Adverse Event|1|||
161432655|NCT00617734|582977109|FG000|Overall Study|Protocol Violation|1|||
161432656|NCT00617734|582977110|FG001|Overall Study|Protocol Violation|0|||
161432657|NCT00617734|582977109|FG000|Overall Study|Found Ineligible After Randomization|1|||
161432658|NCT00617734|582977110|FG001|Overall Study|Found Ineligible After Randomization|4|||
161432659|NCT00617734|582977109|FG000|Overall Study|Lost to Follow-up|0|||
161432660|NCT00617734|582977110|FG001|Overall Study|Lost to Follow-up|1|||
161432661|NCT02485691|582977111|FG000|Overall Study|Adverse Event|25|||
161432662|NCT02485691|582977112|FG001|Overall Study|Adverse Event|11|||
161432663|NCT02485691|582977111|FG000|Overall Study|Poor compliance to protocol|0|||
161432664|NCT02485691|582977112|FG001|Overall Study|Poor compliance to protocol|1|||
161432665|NCT02485691|582977111|FG000|Overall Study|Disease progression|57|||
161432666|NCT02485691|582977112|FG001|Overall Study|Disease progression|92|||
161432667|NCT02485691|582977111|FG000|Overall Study|Investigator's decision|23|||
161432668|NCT02485691|582977112|FG001|Overall Study|Investigator's decision|5|||
161432669|NCT02485691|582977111|FG000|Overall Study|Participant's request|13|||
161432670|NCT02485691|582977112|FG001|Overall Study|Participant's request|6|||
161432671|NCT02485691|582977111|FG000|Overall Study|Other reason|8|||
161432672|NCT02485691|582977112|FG001|Overall Study|Other reason|9|||
161432673|NCT02485691|582977111|FG000|Overall Study|Randomized and not treated|3|||
161432674|NCT02485691|582977112|FG001|Overall Study|Randomized and not treated|2|||
161432675|NCT04292535|582977113|FG000|Overall Study|Withdrawal by Subject|0|||
161432676|NCT04292535|582977114|FG001|Overall Study|Withdrawal by Subject|0|||
161432677|NCT04292535|582977115|FG002|Overall Study|Withdrawal by Subject|0|||
161432678|NCT04292535|582977116|FG003|Overall Study|Withdrawal by Subject|0|||
161432679|NCT04292535|582977117|FG004|Overall Study|Withdrawal by Subject|0|||
161432680|NCT04292535|582977118|FG005|Overall Study|Withdrawal by Subject|0|||
161432681|NCT04292535|582977119|FG006|Overall Study|Withdrawal by Subject|0|||
161432682|NCT04292535|582977120|FG007|Overall Study|Withdrawal by Subject|1|||
161432683|NCT04292535|582977121|FG008|Overall Study|Withdrawal by Subject|0|||
161432684|NCT04292535|582977122|FG009|Overall Study|Withdrawal by Subject|0|||
161432685|NCT04292535|582977123|FG010|Overall Study|Withdrawal by Subject|0|||
161432686|NCT04292535|582977124|FG011|Overall Study|Withdrawal by Subject|0|||
161432687|NCT04292535|582977125|FG012|Overall Study|Withdrawal by Subject|0|||
161432688|NCT04292535|582977126|FG013|Overall Study|Withdrawal by Subject|0|||
161432689|NCT04292535|582977113|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432690|NCT04292535|582977114|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432691|NCT04292535|582977115|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432692|NCT04292535|582977116|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432693|NCT04292535|582977117|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432694|NCT04292535|582977118|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432695|NCT04292535|582977119|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432696|NCT04292535|582977120|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
161432697|NCT04292535|582977121|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432698|NCT04292535|582977122|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432699|NCT04292535|582977123|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432700|NCT04292535|582977124|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
161432701|NCT04292535|582977125|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
161432702|NCT04292535|582977126|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
161432703|NCT04292535|582977113|FG000|Overall Study|Report of Dizziness|0|||
161432704|NCT04292535|582977114|FG001|Overall Study|Report of Dizziness|0|||
161432705|NCT04292535|582977115|FG002|Overall Study|Report of Dizziness|0|||
161432706|NCT04292535|582977116|FG003|Overall Study|Report of Dizziness|0|||
161432707|NCT04292535|582977117|FG004|Overall Study|Report of Dizziness|0|||
161432708|NCT04292535|582977118|FG005|Overall Study|Report of Dizziness|0|||
161432709|NCT04292535|582977119|FG006|Overall Study|Report of Dizziness|0|||
161432710|NCT04292535|582977120|FG007|Overall Study|Report of Dizziness|0|||
161432711|NCT04292535|582977121|FG008|Overall Study|Report of Dizziness|0|||
161432712|NCT04292535|582977122|FG009|Overall Study|Report of Dizziness|0|||
161432713|NCT04292535|582977123|FG010|Overall Study|Report of Dizziness|0|||
161432714|NCT04292535|582977124|FG011|Overall Study|Report of Dizziness|0|||
161432715|NCT04292535|582977125|FG012|Overall Study|Report of Dizziness|0|||
161432716|NCT04292535|582977126|FG013|Overall Study|Report of Dizziness|1|||
161432717|NCT04292535|582977113|FG000|Overall Study|Equipment Failure|0|||
161432718|NCT04292535|582977114|FG001|Overall Study|Equipment Failure|0|||
161432719|NCT04292535|582977115|FG002|Overall Study|Equipment Failure|0|||
161432720|NCT04292535|582977116|FG003|Overall Study|Equipment Failure|0|||
161432721|NCT04292535|582977117|FG004|Overall Study|Equipment Failure|0|||
161432722|NCT04292535|582977118|FG005|Overall Study|Equipment Failure|0|||
161432723|NCT04292535|582977119|FG006|Overall Study|Equipment Failure|0|||
161432724|NCT04292535|582977120|FG007|Overall Study|Equipment Failure|0|||
161432725|NCT04292535|582977121|FG008|Overall Study|Equipment Failure|0|||
161432726|NCT04292535|582977122|FG009|Overall Study|Equipment Failure|0|||
161432727|NCT04292535|582977123|FG010|Overall Study|Equipment Failure|0|||
161432728|NCT04292535|582977124|FG011|Overall Study|Equipment Failure|1|||
161432729|NCT04292535|582977125|FG012|Overall Study|Equipment Failure|0|||
161432730|NCT04292535|582977126|FG013|Overall Study|Equipment Failure|0|||
161432731|NCT01420861|582977127|FG000|Overall Study|Adverse Event|2|||
161432732|NCT01420861|582977127|FG000|Overall Study|Study terminated by Sponsor|7|||
161432733|NCT01420861|582977127|FG000|Overall Study|Screen failure|7|||
161432734|NCT01420861|582977127|FG000|Overall Study|Randomized not Treated|2|||
161432735|NCT03361137|582977128|FG000|Overall Study|Reason not specified|1|||
161432736|NCT03361137|582977129|FG001|Overall Study|Reason not specified|0|||
161432737|NCT03361137|582977130|FG002|Overall Study|Reason not specified|0|||
161432738|NCT03361137|582977131|FG003|Overall Study|Reason not specified|0|||
161432739|NCT03361137|582977132|FG004|Overall Study|Reason not specified|0|||
161432740|NCT00791934|582977133|FG000|Overall Study|Withdrawal by Subject|2|||
161432741|NCT00791934|582977133|FG000|Overall Study|Did not consent for extended follow-up|13|||
161432742|NCT03413891|582977135|FG000|Overall Study|Lost to Follow-up|2|||
161432743|NCT03413891|582977136|FG001|Overall Study|Lost to Follow-up|1|||
161432744|NCT03413891|582977135|FG000|Overall Study|Protocol Violation|0|||
161432745|NCT03413891|582977136|FG001|Overall Study|Protocol Violation|1|||
161432746|NCT04905134|582977137|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
161432747|NCT04905134|582977137|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
161432748|NCT03009058|582977138|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
161432749|NCT05556265|582977139|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
161432750|NCT05556265|582977140|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
161432751|NCT05556265|582977141|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
161432752|NCT05556265|582977142|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
161432753|NCT05556265|582977143|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
161432754|NCT05556265|582977139|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
161432755|NCT05556265|582977140|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
161432756|NCT05556265|582977141|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
161432757|NCT05556265|582977142|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
161432758|NCT05556265|582977143|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
161432759|NCT05556265|582977139|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
161432760|NCT05556265|582977140|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
161432761|NCT05556265|582977141|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
161432762|NCT05556265|582977142|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
161432763|NCT05556265|582977143|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
161432764|NCT05556265|582977139|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
161432765|NCT05556265|582977140|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
161432766|NCT05556265|582977141|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
161432767|NCT05556265|582977142|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
161435944|NCT04050553|582989735|FG000|Period 1|Withdrawal by Subject|0|||
161432768|NCT05556265|582977143|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
161432769|NCT05556265|582977139|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
161432770|NCT05556265|582977140|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
161432771|NCT05556265|582977141|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
161432772|NCT05556265|582977142|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
161432773|NCT05556265|582977143|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
161432774|NCT05556265|582977139|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
161432775|NCT05556265|582977140|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
161432776|NCT05556265|582977141|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
161432777|NCT05556265|582977142|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
161432778|NCT05556265|582977143|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
161432779|NCT05556265|582977139|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
161432780|NCT05556265|582977140|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
161432781|NCT05556265|582977141|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
161432782|NCT05556265|582977142|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
161432783|NCT05556265|582977143|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
161432784|NCT05556265|582977139|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
161432785|NCT05556265|582977140|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
161432786|NCT05556265|582977141|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
161432787|NCT05556265|582977142|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
161432788|NCT05556265|582977143|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
161432789|NCT05556265|582977139|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
161432790|NCT05556265|582977140|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
161432791|NCT05556265|582977141|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
161432792|NCT05556265|582977142|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
161432793|NCT05556265|582977143|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
161432794|NCT00079417|582978780|FG000|Overall Study|Physician Decision|2|||
161432795|NCT00079417|582978780|FG000|Overall Study|Ineligible|7|||
161432796|NCT01615939|582978781|FG000|Overall Study|Lost to Follow-up|5|||
161432797|NCT01615939|582978782|FG001|Overall Study|Lost to Follow-up|0|||
161432798|NCT05366738|582978786|FG000|Overall Study|Adverse Event|0|||
161432799|NCT05366738|582978787|FG001|Overall Study|Adverse Event|1|||
161432800|NCT05366738|582978788|FG002|Overall Study|Adverse Event|0|||
161432801|NCT05024032|582978789|FG000|Overall Study|Withdrawal by Subject|0|||
161432802|NCT05024032|582978790|FG001|Overall Study|Withdrawal by Subject|3|||
161432803|NCT05024032|582978791|FG002|Overall Study|Withdrawal by Subject|4|||
161432804|NCT05024032|582978789|FG000|Overall Study|Adverse Event|0|||
161432805|NCT05024032|582978790|FG001|Overall Study|Adverse Event|1|||
161432806|NCT05024032|582978791|FG002|Overall Study|Adverse Event|0|||
161432807|NCT05024032|582978789|FG000|Overall Study|Protocol Deviation|1|||
161432808|NCT05024032|582978790|FG001|Overall Study|Protocol Deviation|0|||
161432809|NCT05024032|582978791|FG002|Overall Study|Protocol Deviation|0|||
161432810|NCT00939393|582978792|FG000|Overall Study|Withdrawal by Subject|1|||
161432811|NCT00939393|582978793|FG001|Overall Study|Withdrawal by Subject|0|||
161432812|NCT00939393|582978792|FG000|Overall Study|Lost to Follow-up|3|||
161432813|NCT00939393|582978793|FG001|Overall Study|Lost to Follow-up|0|||
161432814|NCT01054885|582978794|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
161432815|NCT01054885|582978795|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161432816|NCT01054885|582978796|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161432817|NCT01054885|582978797|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161432818|NCT01054885|582978798|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161432819|NCT01054885|582978799|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161432820|NCT01054885|582978800|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161432821|NCT01054885|582978794|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
161432822|NCT01054885|582978795|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
161432823|NCT01054885|582978796|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
161432824|NCT01054885|582978797|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
161432825|NCT01054885|582978798|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
161432826|NCT01054885|582978799|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
161432827|NCT01054885|582978800|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
161432828|NCT01054885|582978794|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
161432829|NCT01054885|582978795|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161432830|NCT01054885|582978796|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161432831|NCT01054885|582978797|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161432832|NCT01054885|582978798|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161432833|NCT01054885|582978799|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161435945|NCT04050553|582989736|FG001|Period 1|Withdrawal by Subject|1|||
161432834|NCT01054885|582978800|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161432835|NCT01054885|582978794|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
161432836|NCT01054885|582978795|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161432837|NCT01054885|582978796|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161432838|NCT01054885|582978797|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161432839|NCT01054885|582978798|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161432840|NCT01054885|582978799|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161432841|NCT01054885|582978800|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161432842|NCT01054885|582978794|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
161432843|NCT01054885|582978795|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
161432844|NCT01054885|582978796|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
161432845|NCT01054885|582978797|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161432846|NCT01054885|582978798|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
161432847|NCT01054885|582978799|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
161432848|NCT01054885|582978800|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
161432849|NCT01054885|582978794|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
161432850|NCT01054885|582978795|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161432851|NCT01054885|582978796|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161432852|NCT01054885|582978797|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161432853|NCT01054885|582978798|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161432854|NCT01054885|582978799|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161432855|NCT01054885|582978800|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161432856|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161432857|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
161432858|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
161432859|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
161432860|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
161432861|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
161432862|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
161432863|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161432864|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161432865|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
161432866|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
161432867|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161432868|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
161432869|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161432870|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
161432871|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
161432872|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
161432873|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
161432874|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
161432875|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
161432876|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
161432877|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161432878|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
161432879|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
161432880|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161432881|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161432882|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
161432883|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161432884|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
161432885|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
161432886|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
161432887|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
161432888|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
161432889|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
161432890|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
161432891|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
161432892|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
161432893|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
161432894|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
161432895|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
161432896|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
161432897|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
161432898|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161432899|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
161432900|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161432901|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161432902|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161432903|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161432904|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161432905|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161432906|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
161432907|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161432908|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
161432909|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
161432910|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
161432911|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
161432912|NCT01054885|582978794|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161432913|NCT01054885|582978795|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
161432914|NCT01054885|582978796|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161432915|NCT01054885|582978797|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
161432916|NCT01054885|582978798|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
161432917|NCT01054885|582978799|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161432918|NCT01054885|582978800|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
161432919|NCT00804908|582978801|FG000|Overall Study|Other|115|||
161432920|NCT00804908|582978802|FG001|Overall Study|Other|116|||
161432921|NCT00804908|582978803|FG002|Overall Study|Other|114|||
161432922|NCT01280903|582978804|FG000|Overall Study|Lost to Follow-up|23|||
161432923|NCT01280903|582978805|FG001|Overall Study|Lost to Follow-up|16|||
161432924|NCT03453164|582978806|FG000|Overall Study|Lack of Efficacy|16|||
161432925|NCT03453164|582978806|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
161432926|NCT03829228|582978807|FG000|Overall Study|Protocol Violation|1|||
161432927|NCT02177695|582978808|FG000|ITT Analysis|Ineligible|5|||
161432928|NCT02177695|582978809|FG001|ITT Analysis|Ineligible|5|||
161432929|NCT02177695|582978808|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
161432930|NCT02177695|582978809|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
161432931|NCT02177695|582978808|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
161432932|NCT02177695|582978809|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
161432933|NCT02177695|582978808|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
161432934|NCT02177695|582978809|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
161432935|NCT00744497|582978812|FG000|Overall Study|Withdrawal by Subject|21|||
161432936|NCT00744497|582978813|FG001|Overall Study|Withdrawal by Subject|18|||
161432937|NCT00744497|582978812|FG000|Overall Study|Death|11|||
161432938|NCT00744497|582978813|FG001|Overall Study|Death|9|||
161432939|NCT00744497|582978812|FG000|Overall Study|Lost to Follow-up|4|||
161432940|NCT00744497|582978813|FG001|Overall Study|Lost to Follow-up|2|||
161432941|NCT00744497|582978812|FG000|Overall Study|Poor compliance/noncompliance|9|||
161432942|NCT00744497|582978813|FG001|Overall Study|Poor compliance/noncompliance|5|||
161432943|NCT00744497|582978812|FG000|Overall Study|No longer meets study criteria|7|||
161432944|NCT00744497|582978813|FG001|Overall Study|No longer meets study criteria|3|||
161432945|NCT00744497|582978812|FG000|Overall Study|Administrative Reason By Sponsor|25|||
161432946|NCT00744497|582978813|FG001|Overall Study|Administrative Reason By Sponsor|8|||
161432947|NCT00744497|582978812|FG000|Overall Study|Disease progression|312|||
161432948|NCT00744497|582978813|FG001|Overall Study|Disease progression|219|||
161432949|NCT00744497|582978812|FG000|Overall Study|Study drug toxicity|68|||
161432950|NCT00744497|582978813|FG001|Overall Study|Study drug toxicity|141|||
161432951|NCT00744497|582978812|FG000|Overall Study|Adverse event unrelated to study drug|78|||
161432952|NCT00744497|582978813|FG001|Overall Study|Adverse event unrelated to study drug|122|||
161432953|NCT00744497|582978812|FG000|Overall Study|Patient requested to stop study drug|65|||
161432954|NCT00744497|582978813|FG001|Overall Study|Patient requested to stop study drug|80|||
161432955|NCT00744497|582978812|FG000|Overall Study|Maximum clinical benefit|141|||
161432956|NCT00744497|582978813|FG001|Overall Study|Maximum clinical benefit|142|||
161432957|NCT00744497|582978812|FG000|Overall Study|Not defined|19|||
161432958|NCT00744497|582978813|FG001|Overall Study|Not defined|13|||
161432959|NCT02443688|582978814|FG000|Overall Study|Adverse Event|2|||
161432960|NCT02443688|582978815|FG001|Overall Study|Adverse Event|3|||
161432961|NCT02443688|582978816|FG002|Overall Study|Adverse Event|2|||
161432962|NCT02443688|582978814|FG000|Overall Study|Lost to Follow-up|1|||
161432963|NCT02443688|582978815|FG001|Overall Study|Lost to Follow-up|0|||
161432964|NCT02443688|582978816|FG002|Overall Study|Lost to Follow-up|0|||
161432965|NCT02443688|582978814|FG000|Overall Study|Physician Decision|3|||
161432966|NCT02443688|582978815|FG001|Overall Study|Physician Decision|0|||
161432967|NCT02443688|582978816|FG002|Overall Study|Physician Decision|1|||
161432968|NCT02443688|582978814|FG000|Overall Study|Pregnancy|0|||
161432969|NCT02443688|582978815|FG001|Overall Study|Pregnancy|0|||
161432970|NCT02443688|582978816|FG002|Overall Study|Pregnancy|1|||
161432971|NCT02443688|582978814|FG000|Overall Study|Withdrawal by Subject|3|||
161432972|NCT02443688|582978815|FG001|Overall Study|Withdrawal by Subject|3|||
161432973|NCT02443688|582978816|FG002|Overall Study|Withdrawal by Subject|4|||
161432974|NCT02443688|582978814|FG000|Overall Study|Non-compliance with study drug|1|||
161432975|NCT02443688|582978815|FG001|Overall Study|Non-compliance with study drug|2|||
161432976|NCT02443688|582978816|FG002|Overall Study|Non-compliance with study drug|4|||
161432977|NCT02443688|582978814|FG000|Overall Study|Sponsor Request|2|||
161432978|NCT02443688|582978815|FG001|Overall Study|Sponsor Request|1|||
161432979|NCT02443688|582978816|FG002|Overall Study|Sponsor Request|0|||
161432980|NCT03459079|582978818|FG000|Overall Study|Adverse Event|4|||
161432981|NCT03459079|582978819|FG001|Overall Study|Adverse Event|2|||
161432982|NCT03459079|582978820|FG002|Overall Study|Adverse Event|0|||
161432983|NCT03459079|582978818|FG000|Overall Study|Withdrawal by Subject|2|||
161432984|NCT03459079|582978819|FG001|Overall Study|Withdrawal by Subject|2|||
161432985|NCT03459079|582978820|FG002|Overall Study|Withdrawal by Subject|0|||
161432986|NCT00726063|582978822|FG000|Overall Study|Adverse Event|9|||
161432987|NCT00726063|582978823|FG001|Overall Study|Adverse Event|7|||
161432988|NCT02007096|582978824|FG000|Overall Study|medication not available|2|||
161432989|NCT02007096|582978825|FG001|Overall Study|medication not available|0|||
161432990|NCT02007096|582978824|FG000|Overall Study|did not inject saline|0|||
161432991|NCT02007096|582978825|FG001|Overall Study|did not inject saline|3|||
161432992|NCT02007096|582978824|FG000|Overall Study|did not follow postoperative protocol|8|||
161432993|NCT02007096|582978825|FG001|Overall Study|did not follow postoperative protocol|11|||
161432994|NCT02007096|582978824|FG000|Overall Study|converted to open surgery|1|||
161432995|NCT02007096|582978825|FG001|Overall Study|converted to open surgery|1|||
161432996|NCT02007096|582978824|FG000|Overall Study|no mesh placed|0|||
161432997|NCT02007096|582978825|FG001|Overall Study|no mesh placed|1|||
161432998|NCT05660577|582978826|FG000|Overall Study|Discontinued|9|||
161432999|NCT03363841|582978827|FG000|Overall Study|Adverse Event|1|||
161433000|NCT03363841|582978827|FG000|Overall Study|Withdrawal by Subject|1|||
161433001|NCT03363841|582978827|FG000|Overall Study|Death|7|||
161433002|NCT03363841|582978827|FG000|Overall Study|Physician Decision|1|||
161433003|NCT02156076|582978830|FG000|Treatment Period|no longer meets study criteria|0|||
161433004|NCT02156076|582978831|FG001|Treatment Period|no longer meets study criteria|0|||
161433005|NCT02156076|582978832|FG002|Treatment Period|no longer meets study criteria|1|||
161433006|NCT02156076|582978833|FG003|Treatment Period|no longer meets study criteria|0|||
161433007|NCT02156076|582978830|FG000|Treatment Period|Poor/non-compliance|0|||
161433008|NCT02156076|582978831|FG001|Treatment Period|Poor/non-compliance|1|||
161433009|NCT02156076|582978832|FG002|Treatment Period|Poor/non-compliance|0|||
161433010|NCT02156076|582978833|FG003|Treatment Period|Poor/non-compliance|0|||
161433011|NCT02156076|582978830|FG000|Treatment Period|Lost to Follow-up|0|||
161433012|NCT02156076|582978831|FG001|Treatment Period|Lost to Follow-up|0|||
161433013|NCT02156076|582978832|FG002|Treatment Period|Lost to Follow-up|0|||
161433014|NCT02156076|582978833|FG003|Treatment Period|Lost to Follow-up|1|||
161433015|NCT02156076|582978830|FG000|Treatment Period|Withdrawal by Subject|0|||
161433016|NCT02156076|582978831|FG001|Treatment Period|Withdrawal by Subject|0|||
161433017|NCT02156076|582978832|FG002|Treatment Period|Withdrawal by Subject|1|||
161433018|NCT02156076|582978833|FG003|Treatment Period|Withdrawal by Subject|0|||
161433019|NCT02156076|582978830|FG000|Treatment Period|Subject request to discontinue treatment|0|||
161433020|NCT02156076|582978831|FG001|Treatment Period|Subject request to discontinue treatment|1|||
161433021|NCT02156076|582978832|FG002|Treatment Period|Subject request to discontinue treatment|0|||
161433022|NCT02156076|582978833|FG003|Treatment Period|Subject request to discontinue treatment|0|||
161433023|NCT02156076|582978830|FG000|Treatment Period|Adverse Event|0|||
161433024|NCT02156076|582978831|FG001|Treatment Period|Adverse Event|0|||
161433025|NCT02156076|582978832|FG002|Treatment Period|Adverse Event|0|||
161433026|NCT02156076|582978833|FG003|Treatment Period|Adverse Event|1|||
161433027|NCT02156076|582978830|FG000|Follow-up Period|Withdrawal by Subject|1|||
161433028|NCT02156076|582978831|FG001|Follow-up Period|Withdrawal by Subject|0|||
161433029|NCT02156076|582978832|FG002|Follow-up Period|Withdrawal by Subject|0|||
161433030|NCT02156076|582978833|FG003|Follow-up Period|Withdrawal by Subject|0|||
161433031|NCT00981656|582978842|FG000|Overall Study|Protocol Violation|1|||
161433032|NCT00981656|582978842|FG000|Overall Study|Did not start protocol treatment|2|||
161433033|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
161433034|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
161433035|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161433036|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
161433037|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
161433038|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
161433039|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161433040|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
161433041|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
161433042|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161433043|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161433044|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161433045|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
161433046|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
161433047|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
161433048|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
161433049|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
161433050|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
161433051|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
161433052|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
161433053|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
161433054|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
161433055|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161433056|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161433057|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
161433058|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
161433059|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
161433060|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
161433061|NCT04026113|582978843|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161433062|NCT04026113|582978844|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
161433063|NCT04026113|582978845|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161433064|NCT04026113|582978846|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161433065|NCT04026113|582978843|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
161433066|NCT04026113|582978844|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
161433067|NCT04026113|582978845|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
161433068|NCT04026113|582978846|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
161433069|NCT00837434|582978848|FG000|Overall Study|Physician Decision|3|||
161433070|NCT00837434|582978849|FG001|Overall Study|Physician Decision|0|||
161433071|NCT00837434|582978848|FG000|Overall Study|Lost to Follow-up|1|||
161433072|NCT00837434|582978849|FG001|Overall Study|Lost to Follow-up|1|||
161433073|NCT00837434|582978848|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
161433074|NCT00837434|582978849|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
161433075|NCT00837434|582978848|FG000|Overall Study|Noncompliant|2|||
161433076|NCT00837434|582978849|FG001|Overall Study|Noncompliant|0|||
161433077|NCT00837434|582978848|FG000|Overall Study|Baseline assessments not done in time|1|||
161433078|NCT00837434|582978849|FG001|Overall Study|Baseline assessments not done in time|0|||
161433079|NCT00837434|582978848|FG000|Overall Study|Unable to obtain study drug|1|||
161433080|NCT00837434|582978849|FG001|Overall Study|Unable to obtain study drug|0|||
161433081|NCT01527149|582978850|FG000|Overall Study|Death|2|||
161433082|NCT01709721|582978851|FG000|Open Label Phase|Withdrawal by Subject|0|||
161433083|NCT01709721|582978852|FG001|Open Label Phase|Withdrawal by Subject|0|||
161433084|NCT01709721|582978853|FG002|Open Label Phase|Withdrawal by Subject|5|||
161433085|NCT01709721|582978851|FG000|Open Label Phase|Adverse Event|0|||
161433086|NCT01709721|582978852|FG001|Open Label Phase|Adverse Event|0|||
161433087|NCT01709721|582978853|FG002|Open Label Phase|Adverse Event|8|||
161433088|NCT01709721|582978851|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
161433089|NCT01709721|582978852|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
161433090|NCT01709721|582978853|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
161433091|NCT01709721|582978851|FG000|Open Label Phase|Investigator Decision|0|||
161433092|NCT01709721|582978852|FG001|Open Label Phase|Investigator Decision|0|||
161433093|NCT01709721|582978853|FG002|Open Label Phase|Investigator Decision|1|||
161433094|NCT01709721|582978851|FG000|Open Label Phase|Sponsor Decision|0|||
161433095|NCT01709721|582978852|FG001|Open Label Phase|Sponsor Decision|0|||
161433096|NCT01709721|582978853|FG002|Open Label Phase|Sponsor Decision|2|||
161433097|NCT01709721|582978851|FG000|Open Label Phase|Protocol Violation|0|||
161433098|NCT01709721|582978852|FG001|Open Label Phase|Protocol Violation|0|||
161433099|NCT01709721|582978853|FG002|Open Label Phase|Protocol Violation|1|||
161433100|NCT01709721|582978851|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
161433101|NCT01709721|582978852|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
161433102|NCT01709721|582978853|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
161433103|NCT01709721|582978851|FG000|Open Label Phase|Inadequate Pain Control|0|||
161433104|NCT01709721|582978852|FG001|Open Label Phase|Inadequate Pain Control|0|||
161433105|NCT01709721|582978853|FG002|Open Label Phase|Inadequate Pain Control|37|||
161433106|NCT01709721|582978851|FG000|Open Label Phase|Other, Specify in text field in database|0|||
161433107|NCT01709721|582978852|FG001|Open Label Phase|Other, Specify in text field in database|0|||
161433108|NCT01709721|582978853|FG002|Open Label Phase|Other, Specify in text field in database|14|||
161433109|NCT01709721|582978851|FG000|Randomized Phase|Adverse Event|0|||
161433110|NCT01709721|582978852|FG001|Randomized Phase|Adverse Event|1|||
161433111|NCT01709721|582978853|FG002|Randomized Phase|Adverse Event|0|||
161433112|NCT01709721|582978851|FG000|Randomized Phase|Lost to Follow-up|1|||
161433113|NCT01709721|582978852|FG001|Randomized Phase|Lost to Follow-up|0|||
161433114|NCT01709721|582978853|FG002|Randomized Phase|Lost to Follow-up|0|||
161433115|NCT01709721|582978851|FG000|Randomized Phase|Inadequate Pain Control|1|||
161433116|NCT01709721|582978852|FG001|Randomized Phase|Inadequate Pain Control|2|||
161433117|NCT01709721|582978853|FG002|Randomized Phase|Inadequate Pain Control|0|||
161433118|NCT01709721|582978851|FG000|Randomized Phase|Other, Specify text field in database|1|||
161433119|NCT01709721|582978852|FG001|Randomized Phase|Other, Specify text field in database|3|||
161433120|NCT01709721|582978853|FG002|Randomized Phase|Other, Specify text field in database|0|||
161433121|NCT02230410|582978856|FG000|Overall Study|Screen Failure|3|||
161433122|NCT02558894|582978862|FG000|Overall Study|Death; any cause, entire study duration|28|||
161433123|NCT02558894|582978863|FG001|Overall Study|Death; any cause, entire study duration|31|||
161433124|NCT02558894|582978862|FG000|Overall Study|Withdrawal by Subject|2|||
161433125|NCT02558894|582978863|FG001|Overall Study|Withdrawal by Subject|1|||
161433126|NCT02558894|582978862|FG000|Overall Study|Closure of Part A|2|||
161433127|NCT02558894|582978863|FG001|Overall Study|Closure of Part A|1|||
161433128|NCT02992288|582978864|FG000|Overall Study|Adverse Event|8|||
161433129|NCT02992288|582978865|FG001|Overall Study|Adverse Event|2|||
161433130|NCT02992288|582978866|FG002|Overall Study|Adverse Event|2|||
161433131|NCT02992288|582978867|FG003|Overall Study|Adverse Event|2|||
161433132|NCT02992288|582978868|FG004|Overall Study|Adverse Event|2|||
161433133|NCT02992288|582978869|FG005|Overall Study|Adverse Event|7|||
161433134|NCT02992288|582978864|FG000|Overall Study|Non-compliance with study drug|0|||
161433135|NCT02992288|582978865|FG001|Overall Study|Non-compliance with study drug|1|||
161433136|NCT02992288|582978866|FG002|Overall Study|Non-compliance with study drug|1|||
161433137|NCT02992288|582978867|FG003|Overall Study|Non-compliance with study drug|0|||
161433138|NCT02992288|582978868|FG004|Overall Study|Non-compliance with study drug|1|||
161433139|NCT02992288|582978869|FG005|Overall Study|Non-compliance with study drug|0|||
161433140|NCT02992288|582978864|FG000|Overall Study|Physician Decision|3|||
161433141|NCT02992288|582978865|FG001|Overall Study|Physician Decision|0|||
161433142|NCT02992288|582978866|FG002|Overall Study|Physician Decision|1|||
161433143|NCT02992288|582978867|FG003|Overall Study|Physician Decision|0|||
161433144|NCT02992288|582978868|FG004|Overall Study|Physician Decision|0|||
161433145|NCT02992288|582978869|FG005|Overall Study|Physician Decision|1|||
161433146|NCT02992288|582978864|FG000|Overall Study|Death|2|||
161433147|NCT02992288|582978865|FG001|Overall Study|Death|0|||
161433148|NCT02992288|582978866|FG002|Overall Study|Death|2|||
161433149|NCT02992288|582978867|FG003|Overall Study|Death|1|||
161433150|NCT02992288|582978868|FG004|Overall Study|Death|2|||
161433151|NCT02992288|582978869|FG005|Overall Study|Death|0|||
161433152|NCT02992288|582978864|FG000|Overall Study|Lost to Follow-up|0|||
161433153|NCT02992288|582978865|FG001|Overall Study|Lost to Follow-up|0|||
161433154|NCT02992288|582978866|FG002|Overall Study|Lost to Follow-up|0|||
161433155|NCT02992288|582978867|FG003|Overall Study|Lost to Follow-up|1|||
161433156|NCT02992288|582978868|FG004|Overall Study|Lost to Follow-up|0|||
161433157|NCT02992288|582978869|FG005|Overall Study|Lost to Follow-up|0|||
161433158|NCT02992288|582978864|FG000|Overall Study|Protocol Violation|0|||
161433159|NCT02992288|582978865|FG001|Overall Study|Protocol Violation|0|||
161433160|NCT02992288|582978866|FG002|Overall Study|Protocol Violation|0|||
161433161|NCT02992288|582978867|FG003|Overall Study|Protocol Violation|0|||
161433162|NCT02992288|582978868|FG004|Overall Study|Protocol Violation|0|||
161433163|NCT02992288|582978869|FG005|Overall Study|Protocol Violation|1|||
161433164|NCT02992288|582978864|FG000|Overall Study|Withdrawal by Subject|4|||
161433165|NCT02992288|582978865|FG001|Overall Study|Withdrawal by Subject|2|||
161433166|NCT02992288|582978866|FG002|Overall Study|Withdrawal by Subject|1|||
161433167|NCT02992288|582978867|FG003|Overall Study|Withdrawal by Subject|5|||
161433168|NCT02992288|582978868|FG004|Overall Study|Withdrawal by Subject|3|||
161433169|NCT02992288|582978869|FG005|Overall Study|Withdrawal by Subject|4|||
161433170|NCT00656513|582978870|FG000|Overall Study|Protocol Violation|1|||
161433171|NCT00656513|582978871|FG001|Overall Study|Protocol Violation|0|||
161433172|NCT00656513|582978872|FG002|Overall Study|Protocol Violation|2|||
161433173|NCT00656513|582978870|FG000|Overall Study|Withdrawal by Subject|0|||
161433174|NCT00656513|582978871|FG001|Overall Study|Withdrawal by Subject|11|||
161433175|NCT00656513|582978872|FG002|Overall Study|Withdrawal by Subject|4|||
161433176|NCT00656513|582978870|FG000|Overall Study|Death|0|||
161433177|NCT00656513|582978871|FG001|Overall Study|Death|0|||
161433178|NCT00656513|582978872|FG002|Overall Study|Death|1|||
161433179|NCT00656513|582978870|FG000|Overall Study|Missing data|0|||
161433180|NCT00656513|582978871|FG001|Overall Study|Missing data|11|||
161433181|NCT00656513|582978872|FG002|Overall Study|Missing data|9|||
161433182|NCT00656513|582978870|FG000|Overall Study|Incomplete treatment|3|||
161433183|NCT00656513|582978871|FG001|Overall Study|Incomplete treatment|0|||
161433184|NCT00656513|582978872|FG002|Overall Study|Incomplete treatment|0|||
161433185|NCT00656513|582978870|FG000|Overall Study|Treatment completed outside of timeframe|0|||
161433186|NCT00656513|582978871|FG001|Overall Study|Treatment completed outside of timeframe|3|||
161433187|NCT00656513|582978872|FG002|Overall Study|Treatment completed outside of timeframe|1|||
161433188|NCT00656513|582978870|FG000|Overall Study|Missing baseline form|0|||
161433189|NCT00656513|582978871|FG001|Overall Study|Missing baseline form|5|||
161433190|NCT00656513|582978872|FG002|Overall Study|Missing baseline form|5|||
161433191|NCT00412984|582978881|FG000|Overall Study|Death|331|||
161433192|NCT00412984|582978882|FG001|Overall Study|Death|349|||
161433193|NCT00412984|582978881|FG000|Overall Study|Adverse Event|679|||
161433194|NCT00412984|582978882|FG001|Overall Study|Adverse Event|738|||
161433195|NCT00412984|582978881|FG000|Overall Study|Withdrawal by Subject|921|||
161433196|NCT00412984|582978882|FG001|Overall Study|Withdrawal by Subject|989|||
161433197|NCT00412984|582978881|FG000|Overall Study|Lost to Follow-up|51|||
161433198|NCT00412984|582978882|FG001|Overall Study|Lost to Follow-up|39|||
161433199|NCT00412984|582978881|FG000|Overall Study|Poor/Noncompliance|57|||
161433200|NCT00412984|582978882|FG001|Overall Study|Poor/Noncompliance|77|||
161433201|NCT00412984|582978881|FG000|Overall Study|Pregnancy|1|||
161433202|NCT00412984|582978882|FG001|Overall Study|Pregnancy|0|||
161433203|NCT00412984|582978881|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
161433204|NCT00412984|582978882|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
161433205|NCT00412984|582978881|FG000|Overall Study|Administrative Reason by Sponsor|11|||
161433206|NCT00412984|582978882|FG001|Overall Study|Administrative Reason by Sponsor|8|||
161433207|NCT00412984|582978881|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
161433208|NCT00412984|582978882|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
161433209|NCT00412984|582978881|FG000|Overall Study|Other Reason|80|||
161433210|NCT00412984|582978882|FG001|Overall Study|Other Reason|92|||
161433211|NCT00412984|582978881|FG000|Overall Study|Not Reported|11|||
161433212|NCT00412984|582978882|FG001|Overall Study|Not Reported|12|||
161433213|NCT04218240|582978883|FG000|Overall Study|Withdrawal by Subject|6|||
161433214|NCT04218240|582978884|FG001|Overall Study|Withdrawal by Subject|0|||
161433215|NCT04218240|582978883|FG000|Overall Study|Lack of Efficacy|24|||
161433216|NCT04218240|582978884|FG001|Overall Study|Lack of Efficacy|19|||
161433217|NCT04218240|582978883|FG000|Overall Study|Physician Decision|0|||
161433218|NCT04218240|582978884|FG001|Overall Study|Physician Decision|1|||
161433219|NCT04218240|582978883|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
161433220|NCT04218240|582978884|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
161433221|NCT04097678|582978885|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
161433222|NCT04097678|582978886|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
161433223|NCT03694678|582978887|FG000|Overall Study|Withdrawal by Subject|2|||
161433224|NCT03694678|582978888|FG001|Overall Study|Withdrawal by Subject|0|||
161433225|NCT03694678|582978887|FG000|Overall Study|Lost to Follow-up|2|||
161433226|NCT03694678|582978888|FG001|Overall Study|Lost to Follow-up|3|||
161433227|NCT02435212|582978889|FG000|Core Phase|Adverse Event|8|||
161433228|NCT02435212|582978890|FG001|Core Phase|Adverse Event|5|||
161433229|NCT02435212|582978889|FG000|Core Phase|Withdrawal by Subject|3|||
161433230|NCT02435212|582978890|FG001|Core Phase|Withdrawal by Subject|0|||
161433231|NCT02435212|582978889|FG000|Core Phase|Withdrawal by parent/guardian|9|||
161433232|NCT02435212|582978890|FG001|Core Phase|Withdrawal by parent/guardian|4|||
161433233|NCT02435212|582978889|FG000|Core Phase|Protocol Violation|1|||
161433234|NCT02435212|582978890|FG001|Core Phase|Protocol Violation|2|||
161433235|NCT02435212|582978889|FG000|Core Phase|Physician Decision|3|||
161433236|NCT02435212|582978890|FG001|Core Phase|Physician Decision|0|||
161433237|NCT02435212|582978889|FG000|Core Phase|Lost to Follow-up|0|||
161433238|NCT02435212|582978890|FG001|Core Phase|Lost to Follow-up|1|||
161433239|NCT02435212|582978889|FG000|Core Phase|Lack of Efficacy|0|||
161433240|NCT02435212|582978890|FG001|Core Phase|Lack of Efficacy|1|||
161433241|NCT02435212|582978889|FG000|Core Phase|Recovery|1|||
161433242|NCT02435212|582978890|FG001|Core Phase|Recovery|0|||
161433243|NCT02435212|582978889|FG000|Optional Extension Phase|Adverse Event|3|||
161433244|NCT02435212|582978890|FG001|Optional Extension Phase|Adverse Event|9|||
161433245|NCT02435212|582978889|FG000|Optional Extension Phase|Physician Decision|6|||
161433246|NCT02435212|582978890|FG001|Optional Extension Phase|Physician Decision|8|||
161433247|NCT02435212|582978889|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
161433248|NCT02435212|582978890|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
161433249|NCT02435212|582978889|FG000|Optional Extension Phase|Lack of Efficacy|2|||
161433250|NCT02435212|582978890|FG001|Optional Extension Phase|Lack of Efficacy|3|||
161433251|NCT02435212|582978889|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
161433252|NCT02435212|582978890|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
161433253|NCT02435212|582978889|FG000|Optional Extension Phase|Protocol Violation|0|||
161433254|NCT02435212|582978890|FG001|Optional Extension Phase|Protocol Violation|1|||
161433255|NCT02435212|582978889|FG000|Optional Extension Phase|Recovery|1|||
161433256|NCT02435212|582978890|FG001|Optional Extension Phase|Recovery|1|||
161433257|NCT02435212|582978889|FG000|Optional Extension Phase|Death|1|||
161433258|NCT02435212|582978890|FG001|Optional Extension Phase|Death|0|||
161433259|NCT02435212|582978889|FG000|Optional Extension Phase|Technical problems|2|||
161433260|NCT02435212|582978890|FG001|Optional Extension Phase|Technical problems|0|||
161433261|NCT04819945|582978891|FG000|Overall Study|Lost to Follow-up|1|||
161433262|NCT04531176|582978894|FG000|Overall Study|Study was stopped early|24|||
161433263|NCT04531176|582978895|FG001|Overall Study|Study was stopped early|26|||
161433264|NCT04531176|582978896|FG002|Overall Study|Study was stopped early|24|||
161433265|NCT00561652|582978901|FG000|Overall Study|Withdrawal by Subject|0|||
161433266|NCT00561652|582978902|FG001|Overall Study|Withdrawal by Subject|1|||
161433267|NCT00771914|582978905|FG000|Overall Study|Physician Decision|0|||
161433268|NCT00771914|582978906|FG001|Overall Study|Physician Decision|0|||
161433269|NCT00771914|582978907|FG002|Overall Study|Physician Decision|0|||
161433270|NCT00771914|582978908|FG003|Overall Study|Physician Decision|1|||
161433271|NCT00771914|582978905|FG000|Overall Study|Lost to Follow-up|0|||
161433272|NCT00771914|582978906|FG001|Overall Study|Lost to Follow-up|0|||
161433273|NCT00771914|582978907|FG002|Overall Study|Lost to Follow-up|0|||
161433274|NCT00771914|582978908|FG003|Overall Study|Lost to Follow-up|1|||
161433275|NCT01743469|582978911|FG000|Active Treatment Phase|Adverse Event|10|||
161433276|NCT01743469|582978912|FG001|Active Treatment Phase|Adverse Event|5|||
161433277|NCT01743469|582978913|FG002|Active Treatment Phase|Adverse Event|8|||
161433278|NCT01743469|582978914|FG003|Active Treatment Phase|Adverse Event|1|||
161433279|NCT01743469|582978911|FG000|Active Treatment Phase|Disease Progression|40|||
161433280|NCT01743469|582978912|FG001|Active Treatment Phase|Disease Progression|47|||
161433281|NCT01743469|582978913|FG002|Active Treatment Phase|Disease Progression|30|||
161433282|NCT01743469|582978914|FG003|Active Treatment Phase|Disease Progression|20|||
161433283|NCT01743469|582978911|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
161433284|NCT01743469|582978912|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
161433285|NCT01743469|582978913|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
161433286|NCT01743469|582978914|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
161433287|NCT01743469|582978911|FG000|Active Treatment Phase|Missing|1|||
161433288|NCT01743469|582978912|FG001|Active Treatment Phase|Missing|0|||
161433289|NCT01743469|582978913|FG002|Active Treatment Phase|Missing|0|||
161433290|NCT01743469|582978914|FG003|Active Treatment Phase|Missing|0|||
161433291|NCT01743469|582978911|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
161433292|NCT01743469|582978912|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
161433293|NCT01743469|582978913|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
161433294|NCT01743469|582978914|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
161433295|NCT01743469|582978911|FG000|Follow-up Period - Post-Treatment|Death|43|||
161433296|NCT01743469|582978912|FG001|Follow-up Period - Post-Treatment|Death|47|||
161433297|NCT01743469|582978913|FG002|Follow-up Period - Post-Treatment|Death|22|||
161433298|NCT01743469|582978914|FG003|Follow-up Period - Post-Treatment|Death|16|||
161433299|NCT01743469|582978911|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
161433300|NCT01743469|582978912|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
161433301|NCT01743469|582978913|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
161433302|NCT01743469|582978914|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
161433303|NCT01451606|582978917|FG000|Overall Study|Withdrawal by Subject|4|||
161433304|NCT01451606|582978918|FG001|Overall Study|Withdrawal by Subject|3|||
161433305|NCT01667900|582978922|FG000|Part B|Death|0|||
161433306|NCT01667900|582978923|FG001|Part B|Death|0|||
161433307|NCT01667900|582978924|FG002|Part B|Death|0|||
161433308|NCT01667900|582978925|FG003|Part B|Death|0|||
161433309|NCT01667900|582978926|FG004|Part B|Death|0|||
161433310|NCT01667900|582978927|FG005|Part B|Death|0|||
161433311|NCT01667900|582978928|FG006|Part B|Death|0|||
161433312|NCT01667900|582978929|FG007|Part B|Death|0|||
161433313|NCT01667900|582978930|FG008|Part B|Death|0|||
161433314|NCT01667900|582978931|FG009|Part B|Death|0|||
161433315|NCT01667900|582978932|FG010|Part B|Death|0|||
161433316|NCT01667900|582978933|FG011|Part B|Death|0|||
161433317|NCT01667900|582978934|FG012|Part B|Death|0|||
161433318|NCT01667900|582978935|FG013|Part B|Death|0|||
161433319|NCT01667900|582978936|FG014|Part B|Death|0|||
161433320|NCT01667900|582978937|FG015|Part B|Death|0|||
161433321|NCT01667900|582978938|FG016|Part B|Death|1|||
161433322|NCT01667900|582978939|FG017|Part B|Death|0|||
161433323|NCT01667900|582978940|FG018|Part B|Death|0|||
161433324|NCT01667900|582978941|FG019|Part B|Death|0|||
161433325|NCT01345240|582978942|FG000|Overall Study|Adverse Event|3|||
161433326|NCT01345240|582978943|FG001|Overall Study|Adverse Event|5|||
161433327|NCT01345240|582978944|FG002|Overall Study|Adverse Event|4|||
161433328|NCT01345240|582978945|FG003|Overall Study|Adverse Event|2|||
161433329|NCT01345240|582978946|FG004|Overall Study|Adverse Event|1|||
161433330|NCT01345240|582978942|FG000|Overall Study|Lost to Follow-up|8|||
161433331|NCT01345240|582978943|FG001|Overall Study|Lost to Follow-up|9|||
161433332|NCT01345240|582978944|FG002|Overall Study|Lost to Follow-up|14|||
161433333|NCT01345240|582978945|FG003|Overall Study|Lost to Follow-up|7|||
161433334|NCT01345240|582978946|FG004|Overall Study|Lost to Follow-up|9|||
161433335|NCT00774046|582978949|FG000|Screening|Not eligible|56|||
161433336|NCT00774046|582978949|FG000|Enrollment|Desired other therapy/refused|28|||
161433337|NCT00774046|582978949|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
161433338|NCT01614249|582978950|FG000|Overall Study|Lost to Follow-up|11|||
161433339|NCT01614249|582978951|FG001|Overall Study|Lost to Follow-up|23|||
161433340|NCT05498649|582978952|FG000|Overall Study|Lost to Follow-up|1|||
161433341|NCT03094416|582978953|FG000|Run-in|Screening failure|8|||
161433342|NCT03094416|582978953|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
161433343|NCT03094416|582978953|FG000|Run-in|Withdrawal by Subject|3|||
161433344|NCT03094416|582978953|FG000|Treatment Period|Withdrawal by Subject|2|||
161433345|NCT00005780|582978955|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
161433346|NCT02651675|582978956|FG000|Overall Study|Death|0|||
161433347|NCT02651675|582978957|FG001|Overall Study|Death|0|||
161433348|NCT02651675|582978958|FG002|Overall Study|Death|1|||
161433349|NCT00374140|582978959|FG000|Overall Study|Lost to Follow-up|1|||
161433350|NCT00374140|582978959|FG000|Overall Study|Protocol Violation|1|||
161433351|NCT02246530|582978960|FG000|Overall Study|Lost to Follow-up|4|||
161433352|NCT02246530|582978961|FG001|Overall Study|Lost to Follow-up|0|||
161433353|NCT01586364|582981290|FG000|Overall Study|Withdrawal by Subject|40|||
161433354|NCT01586364|582981290|FG000|Overall Study|Adverse Event|37|||
161433355|NCT01586364|582981290|FG000|Overall Study|Lost to Follow-up|17|||
161433356|NCT01586364|582981290|FG000|Overall Study|Protocol Violation|16|||
161433357|NCT01586364|582981290|FG000|Overall Study|Lack of Efficacy|1|||
161433358|NCT01586364|582981290|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
161433359|NCT01586364|582981290|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
161433360|NCT01586364|582981290|FG000|Overall Study|Other-Site closure due to PI illness|1|||
161433361|NCT01586364|582981290|FG000|Overall Study|Other-PI discretion, site closing|2|||
161433362|NCT01586364|582981290|FG000|Overall Study|Other-Not specified|1|||
161433363|NCT02121535|582981291|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
161433364|NCT02121535|582981292|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
161433365|NCT02121535|582981291|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
161433366|NCT02121535|582981292|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
161433367|NCT04944992|582981293|FG000|Overall Study|Lost to Follow-up|1|||
161433368|NCT04944992|582981294|FG001|Overall Study|Lost to Follow-up|1|||
161433369|NCT04944992|582981293|FG000|Overall Study|Physician Decision|1|||
161433370|NCT04944992|582981294|FG001|Overall Study|Physician Decision|0|||
161433371|NCT04944992|582981293|FG000|Overall Study|Withdrawal by Subject|6|||
161433372|NCT04944992|582981294|FG001|Overall Study|Withdrawal by Subject|1|||
161433373|NCT02345070|582981301|FG000|Overall Study|Adverse Event|12|||
161433374|NCT02345070|582981302|FG001|Overall Study|Adverse Event|8|||
161433375|NCT02345070|582981303|FG002|Overall Study|Adverse Event|16|||
161433376|NCT02345070|582981301|FG000|Overall Study|Poor compliance to protocol|2|||
161433377|NCT02345070|582981302|FG001|Overall Study|Poor compliance to protocol|0|||
161433378|NCT02345070|582981303|FG002|Overall Study|Poor compliance to protocol|0|||
161433379|NCT02345070|582981301|FG000|Overall Study|Other than specified above|6|||
161433380|NCT02345070|582981302|FG001|Overall Study|Other than specified above|3|||
161433381|NCT02345070|582981303|FG002|Overall Study|Other than specified above|7|||
161433382|NCT00473564|582981304|FG000|Overall Study|robot surgery aborted in OR|23|||
161433383|NCT02379728|582981305|FG000|Overall Study|Lost to Follow-up|1|||
161433384|NCT02379728|582981306|FG001|Overall Study|Lost to Follow-up|0|||
161433385|NCT02379728|582981307|FG002|Overall Study|Lost to Follow-up|3|||
161433386|NCT02379728|582981308|FG003|Overall Study|Lost to Follow-up|0|||
161433387|NCT02379728|582981305|FG000|Overall Study|Withdrawal by Subject|5|||
161433388|NCT02379728|582981306|FG001|Overall Study|Withdrawal by Subject|0|||
161433389|NCT02379728|582981307|FG002|Overall Study|Withdrawal by Subject|5|||
161433390|NCT02379728|582981308|FG003|Overall Study|Withdrawal by Subject|3|||
161433391|NCT02379728|582981305|FG000|Overall Study|Protocol Violation|0|||
161433392|NCT02379728|582981306|FG001|Overall Study|Protocol Violation|0|||
161433393|NCT02379728|582981307|FG002|Overall Study|Protocol Violation|2|||
161433394|NCT02379728|582981308|FG003|Overall Study|Protocol Violation|0|||
161433395|NCT03044106|582981311|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
161433396|NCT03044106|582981312|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
161433397|NCT01207414|582981313|FG000|Overall Study|Adverse Event|25|||
161433398|NCT01207414|582981314|FG001|Overall Study|Adverse Event|39|||
161433399|NCT01207414|582981313|FG000|Overall Study|Abnormal test procedure results|0|||
161433400|NCT01207414|582981314|FG001|Overall Study|Abnormal test procedure results|1|||
161433401|NCT01207414|582981313|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161433402|NCT01207414|582981314|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161433403|NCT01207414|582981313|FG000|Overall Study|Patient withdrew consent|14|||
161433404|NCT01207414|582981314|FG001|Overall Study|Patient withdrew consent|11|||
161433405|NCT01207414|582981313|FG000|Overall Study|Lost to Follow-up|15|||
161433406|NCT01207414|582981314|FG001|Overall Study|Lost to Follow-up|17|||
161433407|NCT01207414|582981313|FG000|Overall Study|Administrative problems|1|||
161433408|NCT01207414|582981314|FG001|Overall Study|Administrative problems|1|||
161433409|NCT01207414|582981313|FG000|Overall Study|Protocol deviation|12|||
161433410|NCT01207414|582981314|FG001|Overall Study|Protocol deviation|9|||
161433411|NCT01207414|582981313|FG000|Overall Study|Randomized in error|1|||
161433412|NCT01207414|582981314|FG001|Overall Study|Randomized in error|0|||
161433413|NCT01748292|582981315|FG000|Overall Study|Adverse Event|2|||
161433414|NCT01748292|582981316|FG001|Overall Study|Adverse Event|4|||
161433415|NCT01748292|582981315|FG000|Overall Study|Lost to Follow-up|0|||
161433416|NCT01748292|582981316|FG001|Overall Study|Lost to Follow-up|3|||
161433417|NCT01748292|582981315|FG000|Overall Study|Death|0|||
161433418|NCT01748292|582981316|FG001|Overall Study|Death|3|||
161433419|NCT01748292|582981315|FG000|Overall Study|Withdrawal by Subject|0|||
161433420|NCT01748292|582981316|FG001|Overall Study|Withdrawal by Subject|2|||
161433421|NCT02057250|582981317|FG000|AID Assessment Phase|Adverse Event|3|||
161433422|NCT02057250|582981318|FG001|AID Assessment Phase|Adverse Event|2|||
161433423|NCT02057250|582981319|FG002|AID Assessment Phase|Adverse Event|6|||
161433424|NCT02057250|582981320|FG003|AID Assessment Phase|Adverse Event|1|||
161433425|NCT02057250|582981321|FG004|AID Assessment Phase|Adverse Event|0|||
161433426|NCT02057250|582981317|FG000|AID Assessment Phase|Other than specified above|1|||
161433427|NCT02057250|582981318|FG001|AID Assessment Phase|Other than specified above|1|||
161433428|NCT02057250|582981319|FG002|AID Assessment Phase|Other than specified above|1|||
161433429|NCT02057250|582981320|FG003|AID Assessment Phase|Other than specified above|1|||
161433430|NCT02057250|582981321|FG004|AID Assessment Phase|Other than specified above|0|||
161433431|NCT02057250|582981317|FG000|Extension Phase|Adverse Event|0|||
161433432|NCT02057250|582981318|FG001|Extension Phase|Adverse Event|0|||
161433433|NCT02057250|582981319|FG002|Extension Phase|Adverse Event|0|||
161433434|NCT02057250|582981320|FG003|Extension Phase|Adverse Event|0|||
161433435|NCT02057250|582981321|FG004|Extension Phase|Adverse Event|15|||
161433436|NCT02057250|582981317|FG000|Extension Phase|Lack of Efficacy|0|||
161433437|NCT02057250|582981318|FG001|Extension Phase|Lack of Efficacy|0|||
161433438|NCT02057250|582981319|FG002|Extension Phase|Lack of Efficacy|0|||
161433439|NCT02057250|582981320|FG003|Extension Phase|Lack of Efficacy|0|||
161433440|NCT02057250|582981321|FG004|Extension Phase|Lack of Efficacy|10|||
161433441|NCT02057250|582981317|FG000|Extension Phase|Entered in this period but not treated|0|||
161433442|NCT02057250|582981318|FG001|Extension Phase|Entered in this period but not treated|0|||
161433443|NCT02057250|582981319|FG002|Extension Phase|Entered in this period but not treated|0|||
161433444|NCT02057250|582981320|FG003|Extension Phase|Entered in this period but not treated|0|||
161433445|NCT02057250|582981321|FG004|Extension Phase|Entered in this period but not treated|4|||
161433446|NCT02057250|582981317|FG000|Extension Phase|Other than specified above|0|||
161433447|NCT02057250|582981318|FG001|Extension Phase|Other than specified above|0|||
161433448|NCT02057250|582981319|FG002|Extension Phase|Other than specified above|0|||
161433449|NCT02057250|582981320|FG003|Extension Phase|Other than specified above|0|||
161433450|NCT02057250|582981321|FG004|Extension Phase|Other than specified above|7|||
161433451|NCT03199976|582981325|FG000|Overall Study|Lack of Efficacy|3|||
161433452|NCT03199976|582981326|FG001|Overall Study|Lack of Efficacy|6|||
161433453|NCT03199976|582981327|FG002|Overall Study|Lack of Efficacy|13|||
161433454|NCT03199976|582981325|FG000|Overall Study|Withdrawal by Subject|1|||
161433455|NCT03199976|582981326|FG001|Overall Study|Withdrawal by Subject|0|||
161433456|NCT03199976|582981327|FG002|Overall Study|Withdrawal by Subject|0|||
161433457|NCT03199976|582981325|FG000|Overall Study|Lost to Follow-up|0|||
161433458|NCT03199976|582981326|FG001|Overall Study|Lost to Follow-up|1|||
161433459|NCT03199976|582981327|FG002|Overall Study|Lost to Follow-up|1|||
161433460|NCT03367793|582981328|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
161433461|NCT03367793|582981329|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
161433462|NCT03367793|582981330|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
161433463|NCT03367793|582981331|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
161433464|NCT03367793|582981332|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
161433465|NCT03367793|582981333|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
161433466|NCT00260533|582981336|FG000|Overall Study|Other|3|||
161433467|NCT00260533|582981337|FG001|Overall Study|Other|3|||
161433468|NCT01761877|582981338|FG000|Overall Study|Adverse Event|7|||
161433469|NCT01761877|582981339|FG001|Overall Study|Adverse Event|0|||
161433470|NCT01761877|582981338|FG000|Overall Study|Withdrawal by Subject|6|||
161433471|NCT01761877|582981339|FG001|Overall Study|Withdrawal by Subject|4|||
161433472|NCT01761877|582981338|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
161433473|NCT01761877|582981339|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
161433474|NCT01761877|582981338|FG000|Overall Study|Death|0|||
161433475|NCT01761877|582981339|FG001|Overall Study|Death|1|||
161433476|NCT01761877|582981338|FG000|Overall Study|MRI intolerant|1|||
161433477|NCT01761877|582981339|FG001|Overall Study|MRI intolerant|6|||
161433478|NCT00003475|582981340|FG000|Overall Study|Not evaluable|13|||
161433479|NCT03962491|582981341|FG000|Overall Study|Lost to Follow-up|4|||
161433480|NCT03962491|582981342|FG001|Overall Study|Lost to Follow-up|5|||
161433481|NCT00106704|582981349|FG000|Overall Study|Adverse Event|10|||
161433482|NCT00106704|582981350|FG001|Overall Study|Adverse Event|7|||
161433483|NCT00106704|582981349|FG000|Overall Study|Death|2|||
161433484|NCT00106704|582981350|FG001|Overall Study|Death|1|||
161433485|NCT00106704|582981349|FG000|Overall Study|Lack of Efficacy|67|||
161433486|NCT00106704|582981350|FG001|Overall Study|Lack of Efficacy|69|||
161433487|NCT00106704|582981349|FG000|Overall Study|Lost to Follow-up|7|||
161433488|NCT00106704|582981350|FG001|Overall Study|Lost to Follow-up|3|||
161433489|NCT00106704|582981349|FG000|Overall Study|Pregnancy|1|||
161433490|NCT00106704|582981350|FG001|Overall Study|Pregnancy|0|||
161433491|NCT00106704|582981349|FG000|Overall Study|Protocol Violation|4|||
161433492|NCT00106704|582981350|FG001|Overall Study|Protocol Violation|7|||
161433493|NCT00106704|582981349|FG000|Overall Study|Withdrawal by Subject|14|||
161433494|NCT00106704|582981350|FG001|Overall Study|Withdrawal by Subject|21|||
161433495|NCT00106704|582981349|FG000|Overall Study|Patient moved|1|||
161433496|NCT00106704|582981350|FG001|Overall Study|Patient moved|0|||
161433497|NCT00106704|582981349|FG000|Overall Study|Site terminated|0|||
161433498|NCT00106704|582981350|FG001|Overall Study|Site terminated|1|||
161433499|NCT00106704|582981349|FG000|Overall Study|Planned major surgery|1|||
161433500|NCT00106704|582981350|FG001|Overall Study|Planned major surgery|0|||
161433501|NCT00106704|582981349|FG000|Overall Study|Patient Received Glycemic Medication|22|||
161433502|NCT00106704|582981350|FG001|Overall Study|Patient Received Glycemic Medication|41|||
161433503|NCT00106704|582981349|FG000|Overall Study|Unable to re-enter US|1|||
161433504|NCT00106704|582981350|FG001|Overall Study|Unable to re-enter US|0|||
161433505|NCT00106704|582981349|FG000|Overall Study|Laboratory test|1|||
161433506|NCT00106704|582981350|FG001|Overall Study|Laboratory test|1|||
161433507|NCT01780506|582981351|FG000|Double-Blind Phase|Randomized but not Treated|3|||
161433508|NCT01780506|582981352|FG001|Double-Blind Phase|Randomized but not Treated|2|||
161433509|NCT01780506|582981351|FG000|Double-Blind Phase|Adverse Event|4|||
161433510|NCT01780506|582981352|FG001|Double-Blind Phase|Adverse Event|14|||
161433511|NCT01780506|582981351|FG000|Double-Blind Phase|Death|1|||
161433512|NCT01780506|582981352|FG001|Double-Blind Phase|Death|2|||
161433513|NCT01780506|582981351|FG000|Double-Blind Phase|Pregnancy|2|||
161433514|NCT01780506|582981352|FG001|Double-Blind Phase|Pregnancy|1|||
161433515|NCT01780506|582981351|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161433516|NCT01780506|582981352|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161433517|NCT01780506|582981351|FG000|Double-Blind Phase|Investigator's Discretion|5|||
161433518|NCT01780506|582981352|FG001|Double-Blind Phase|Investigator's Discretion|2|||
161433519|NCT01780506|582981351|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
161433520|NCT01780506|582981352|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161433521|NCT01780506|582981351|FG000|Double-Blind Phase|Protocol Violation|4|||
161433522|NCT01780506|582981352|FG001|Double-Blind Phase|Protocol Violation|3|||
161433523|NCT01780506|582981351|FG000|Double-Blind Phase|Withdrew Consent|23|||
161433524|NCT01780506|582981352|FG001|Double-Blind Phase|Withdrew Consent|24|||
161433525|NCT01780506|582981351|FG000|Double-Blind Phase|Lost to Follow-up|23|||
161433526|NCT01780506|582981352|FG001|Double-Blind Phase|Lost to Follow-up|26|||
161433527|NCT01780506|582981351|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
161433528|NCT01780506|582981352|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
161433529|NCT01867671|582981356|FG000|Overall Study|Adverse Event|5|||
161433530|NCT01867671|582981357|FG001|Overall Study|Adverse Event|3|||
161433531|NCT01867671|582981356|FG000|Overall Study|Anaphylaxis|0|||
161433532|NCT01867671|582981357|FG001|Overall Study|Anaphylaxis|1|||
161433533|NCT01867671|582981356|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
161433534|NCT01867671|582981357|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
161433535|NCT01867671|582981356|FG000|Overall Study|Lost to Follow-up|0|||
161433536|NCT01867671|582981357|FG001|Overall Study|Lost to Follow-up|1|||
161433537|NCT01867671|582981356|FG000|Overall Study|Non-compliance with Study Drug|1|||
161433538|NCT01867671|582981357|FG001|Overall Study|Non-compliance with Study Drug|2|||
161433539|NCT01867671|582981356|FG000|Overall Study|Withdrawal by Subject|21|||
161433540|NCT01867671|582981357|FG001|Overall Study|Withdrawal by Subject|21|||
161433541|NCT04852302|582981363|FG000|Overall Study|Withdrawal by Subject|2|||
161433542|NCT04852302|582981363|FG000|Overall Study|Did not complete CALM therapy.|2|||
161433543|NCT04711850|582981364|FG000|Overall Study|Graft loss|2|||
161433544|NCT04711850|582981365|FG001|Overall Study|Graft loss|1|||
161433545|NCT04711850|582981364|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
161433546|NCT04711850|582981365|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
161433547|NCT04711850|582981364|FG000|Overall Study|Study terminated by sponsor|5|||
161433548|NCT04711850|582981365|FG001|Overall Study|Study terminated by sponsor|3|||
161433549|NCT04711850|582981364|FG000|Overall Study|Sponsor decision|0|||
161433550|NCT04711850|582981365|FG001|Overall Study|Sponsor decision|2|||
161433551|NCT05249582|582981366|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
161433552|NCT05249582|582981367|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
161433553|NCT05249582|582981366|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
161433554|NCT05249582|582981367|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
161433555|NCT05249582|582981366|FG000|Overall Study|Declined to use virtual reality headset|1|||
161433556|NCT05249582|582981367|FG001|Overall Study|Declined to use virtual reality headset|0|||
161433557|NCT02738801|582981390|FG000|Overall Study|Adverse Event|1|||
161433558|NCT02738801|582981391|FG001|Overall Study|Adverse Event|1|||
161433559|NCT02738801|582981390|FG000|Overall Study|Withdrawal by Subject|0|||
161433560|NCT02738801|582981391|FG001|Overall Study|Withdrawal by Subject|1|||
161433561|NCT03279081|582981392|FG000|Overall Study|Withdrawal by Subject|12|||
161433562|NCT03279081|582981393|FG001|Overall Study|Withdrawal by Subject|20|||
161433563|NCT03279081|582981392|FG000|Overall Study|Physician Decision|4|||
161433564|NCT03279081|582981393|FG001|Overall Study|Physician Decision|1|||
161433565|NCT03279081|582981392|FG000|Overall Study|Lost to Follow-up|8|||
161433566|NCT03279081|582981393|FG001|Overall Study|Lost to Follow-up|8|||
161433567|NCT03279081|582981392|FG000|Overall Study|Death|0|||
161433568|NCT03279081|582981393|FG001|Overall Study|Death|1|||
161433569|NCT03279081|582981392|FG000|Overall Study|Adverse Event|1|||
161433570|NCT03279081|582981393|FG001|Overall Study|Adverse Event|0|||
161433571|NCT03279081|582981392|FG000|Overall Study|Reason not Specified|14|||
161433572|NCT03279081|582981393|FG001|Overall Study|Reason not Specified|4|||
161433573|NCT02163538|582981396|FG000|Overall Study|Protocol Violation|1|||
161433574|NCT02163538|582981397|FG001|Overall Study|Protocol Violation|0|||
161433575|NCT02163538|582981396|FG000|Overall Study|Physician Decision|0|||
161433576|NCT02163538|582981397|FG001|Overall Study|Physician Decision|1|||
161433577|NCT04484961|582981400|FG000|Overall Study|Lost to Follow-up|9|||
161433578|NCT04484961|582981401|FG001|Overall Study|Lost to Follow-up|9|||
161433579|NCT00388349|582981402|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
161433580|NCT00388349|582981403|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
161433581|NCT00976274|582981405|FG000|Overall Study|Lost to Follow-up|5|||
161433582|NCT00976274|582981406|FG001|Overall Study|Lost to Follow-up|5|||
161433583|NCT00976274|582981405|FG000|Overall Study|Withdrawal by Subject|1|||
161433584|NCT00976274|582981406|FG001|Overall Study|Withdrawal by Subject|1|||
161433585|NCT00976274|582981405|FG000|Overall Study|Physician Decision|1|||
161433586|NCT00976274|582981406|FG001|Overall Study|Physician Decision|2|||
161433587|NCT02954536|582981408|FG000|Overall Study|Adverse Event|2|||
161433588|NCT02954536|582981408|FG000|Overall Study|Death|12|||
161433589|NCT02946580|582981409|FG000|Overall Study|Withdrawal by Subject|1|||
161433590|NCT02946580|582981410|FG001|Overall Study|Withdrawal by Subject|2|||
161433591|NCT02946580|582981409|FG000|Overall Study|Adverse Event|0|||
161433592|NCT02946580|582981410|FG001|Overall Study|Adverse Event|2|||
161433593|NCT02946580|582981409|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
161433594|NCT02946580|582981410|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
161433595|NCT02158442|582981411|FG000|Overall Study|Withdrawal by Subject|1|||
161433596|NCT02158442|582981412|FG001|Overall Study|Withdrawal by Subject|0|||
161433597|NCT02158442|582981411|FG000|Overall Study|Perfusion staff not available|1|||
161433598|NCT02158442|582981412|FG001|Overall Study|Perfusion staff not available|0|||
161433599|NCT02761330|582981413|FG000|Treatment Week 1|Withdrawal by Subject|0|||
161433600|NCT02761330|582981414|FG001|Treatment Week 1|Withdrawal by Subject|0|||
161433601|NCT02761330|582981415|FG002|Treatment Week 1|Withdrawal by Subject|0|||
161433602|NCT02761330|582981416|FG003|Treatment Week 1|Withdrawal by Subject|1|||
161433603|NCT02761330|582981417|FG004|Treatment Week 1|Withdrawal by Subject|0|||
161433604|NCT02761330|582981418|FG005|Treatment Week 1|Withdrawal by Subject|1|||
161433605|NCT03043313|582981423|FG000|Overall Study|Withdrawal by Subject|5|||
161433606|NCT03043313|582981424|FG001|Overall Study|Withdrawal by Subject|1|||
161433607|NCT03043313|582981425|FG002|Overall Study|Withdrawal by Subject|1|||
161433608|NCT03043313|582981423|FG000|Overall Study|Lost to Follow-up|1|||
161433609|NCT03043313|582981424|FG001|Overall Study|Lost to Follow-up|1|||
161433610|NCT03043313|582981425|FG002|Overall Study|Lost to Follow-up|0|||
161433611|NCT03043313|582981423|FG000|Overall Study|Death|28|||
161433612|NCT03043313|582981424|FG001|Overall Study|Death|26|||
161433613|NCT03043313|582981425|FG002|Overall Study|Death|17|||
161433614|NCT03043313|582981423|FG000|Overall Study|Participation terminated by sponsor|11|||
161433615|NCT03043313|582981424|FG001|Overall Study|Participation terminated by sponsor|13|||
161433616|NCT03043313|582981425|FG002|Overall Study|Participation terminated by sponsor|13|||
161433617|NCT01506596|582981427|FG000|Overall Study|ineligible pathology|1|||
161433618|NCT05712460|582981428|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433619|NCT05712460|582981429|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433620|NCT05712460|582981430|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433621|NCT05712460|582981431|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433622|NCT05712460|582981432|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433623|NCT05712460|582981433|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433624|NCT05712460|582981434|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433625|NCT05712460|582981435|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
161433626|NCT05712460|582981436|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433627|NCT05712460|582981437|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433628|NCT05712460|582981438|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433629|NCT05712460|582981439|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
161433630|NCT05135767|582981443|FG000|Baseline|Lost to Follow-up|1|||
161433631|NCT05135767|582981444|FG001|Baseline|Lost to Follow-up|1|||
161433632|NCT05135767|582981443|FG000|Baseline|Withdrawal by Subject|0|||
161433633|NCT05135767|582981444|FG001|Baseline|Withdrawal by Subject|2|||
161433634|NCT05135767|582981443|FG000|Active Study Phase|Lost to Follow-up|2|||
161433635|NCT05135767|582981444|FG001|Active Study Phase|Lost to Follow-up|0|||
161433636|NCT02694185|582981445|FG000|Overall Study|Withdrawal by Subject|45|||
161433637|NCT02694185|582981446|FG001|Overall Study|Withdrawal by Subject|0|||
161433638|NCT05082857|582981447|FG000|Overall Study|participants relocated and could not continue|2|||
161433639|NCT05082857|582981448|FG001|Overall Study|participants relocated and could not continue|1|||
161433640|NCT05082857|582981447|FG000|Overall Study|Lost to Follow-up|1|||
161433641|NCT05082857|582981448|FG001|Overall Study|Lost to Follow-up|3|||
161433642|NCT04366349|582981449|FG000|Overall Study|Withdrawal by Subject|1|||
161435946|NCT04050553|582989735|FG000|Wash-out|Adverse Event|0|||
161433643|NCT04366349|582981450|FG001|Overall Study|Withdrawal by Subject|0|||
161433644|NCT04366349|582981451|FG002|Overall Study|Withdrawal by Subject|0|||
161433645|NCT04366349|582981452|FG003|Overall Study|Withdrawal by Subject|0|||
161433646|NCT04366349|582981453|FG004|Overall Study|Withdrawal by Subject|0|||
161433647|NCT04366349|582981454|FG005|Overall Study|Withdrawal by Subject|0|||
161433648|NCT03341299|582981455|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
161433649|NCT03341299|582981456|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
161433650|NCT03341299|582981457|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
161433651|NCT03341299|582981458|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
161433652|NCT01486966|582981471|FG000|Overall Study|Adverse Event|0|||
161433653|NCT01486966|582981472|FG001|Overall Study|Adverse Event|1|||
161433654|NCT01486966|582981471|FG000|Overall Study|Withdrawal by Subject|0|||
161433655|NCT01486966|582981472|FG001|Overall Study|Withdrawal by Subject|1|||
161433656|NCT03518086|582981475|FG000|Overall Study|Adverse Event|23|||
161433657|NCT03518086|582981476|FG001|Overall Study|Adverse Event|15|||
161433658|NCT03518086|582981477|FG002|Overall Study|Adverse Event|3|||
161433659|NCT03518086|582981478|FG003|Overall Study|Adverse Event|2|||
161433660|NCT03518086|582981475|FG000|Overall Study|Withdrawal by Subject|8|||
161433661|NCT03518086|582981476|FG001|Overall Study|Withdrawal by Subject|5|||
161433662|NCT03518086|582981477|FG002|Overall Study|Withdrawal by Subject|1|||
161433663|NCT03518086|582981478|FG003|Overall Study|Withdrawal by Subject|0|||
161433664|NCT03518086|582981475|FG000|Overall Study|Lack of Efficacy|5|||
161433665|NCT03518086|582981476|FG001|Overall Study|Lack of Efficacy|5|||
161433666|NCT03518086|582981477|FG002|Overall Study|Lack of Efficacy|0|||
161433667|NCT03518086|582981478|FG003|Overall Study|Lack of Efficacy|2|||
161433668|NCT03518086|582981475|FG000|Overall Study|Protocol Violation|1|||
161433669|NCT03518086|582981476|FG001|Overall Study|Protocol Violation|5|||
161433670|NCT03518086|582981477|FG002|Overall Study|Protocol Violation|1|||
161433671|NCT03518086|582981478|FG003|Overall Study|Protocol Violation|3|||
161433672|NCT03518086|582981475|FG000|Overall Study|Lost to Follow-up|0|||
161433673|NCT03518086|582981476|FG001|Overall Study|Lost to Follow-up|3|||
161433674|NCT03518086|582981477|FG002|Overall Study|Lost to Follow-up|0|||
161433675|NCT03518086|582981478|FG003|Overall Study|Lost to Follow-up|0|||
161433676|NCT03518086|582981475|FG000|Overall Study|Insufficient Diary Data|0|||
161433677|NCT03518086|582981476|FG001|Overall Study|Insufficient Diary Data|2|||
161433678|NCT03518086|582981477|FG002|Overall Study|Insufficient Diary Data|0|||
161433679|NCT03518086|582981478|FG003|Overall Study|Insufficient Diary Data|0|||
161433680|NCT03518086|582981475|FG000|Overall Study|Non- compliance to Protocol|0|||
161433681|NCT03518086|582981476|FG001|Overall Study|Non- compliance to Protocol|1|||
161433682|NCT03518086|582981477|FG002|Overall Study|Non- compliance to Protocol|0|||
161433683|NCT03518086|582981478|FG003|Overall Study|Non- compliance to Protocol|0|||
161433684|NCT03518086|582981475|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
161433685|NCT03518086|582981476|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
161433686|NCT03518086|582981477|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
161433687|NCT03518086|582981478|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
161433688|NCT03518086|582981475|FG000|Overall Study|Site Terminated by Sponsor|0|||
161433689|NCT03518086|582981476|FG001|Overall Study|Site Terminated by Sponsor|1|||
161433690|NCT03518086|582981477|FG002|Overall Study|Site Terminated by Sponsor|0|||
161433691|NCT03518086|582981478|FG003|Overall Study|Site Terminated by Sponsor|0|||
161433692|NCT03518086|582981475|FG000|Overall Study|Pregnancy|0|||
161433693|NCT03518086|582981476|FG001|Overall Study|Pregnancy|0|||
161433694|NCT03518086|582981477|FG002|Overall Study|Pregnancy|0|||
161433695|NCT03518086|582981478|FG003|Overall Study|Pregnancy|2|||
161433696|NCT02336282|582981479|FG000|Overall Study|Unrelated illness|1|||
161433697|NCT02336282|582981479|FG000|Overall Study|Uncomfortable with technology|1|||
161433698|NCT02336282|582981479|FG000|Overall Study|Lost to Follow-up|1|||
161433699|NCT02336282|582981479|FG000|Overall Study|Not enough time to complete sessions|2|||
161433700|NCT05565742|582981481|FG000|Overall Study|Withdrawal by Subject|0|||
161433701|NCT05565742|582981482|FG001|Overall Study|Withdrawal by Subject|0|||
161433702|NCT05565742|582981483|FG002|Overall Study|Withdrawal by Subject|2|||
161433703|NCT05565742|582981484|FG003|Overall Study|Withdrawal by Subject|2|||
161433704|NCT05565742|582981485|FG004|Overall Study|Withdrawal by Subject|2|||
161433705|NCT05565742|582981481|FG000|Overall Study|Death|1|||
161433706|NCT05565742|582981482|FG001|Overall Study|Death|0|||
161433707|NCT05565742|582981483|FG002|Overall Study|Death|0|||
161433708|NCT05565742|582981484|FG003|Overall Study|Death|0|||
161433709|NCT05565742|582981485|FG004|Overall Study|Death|0|||
161433710|NCT05565742|582981481|FG000|Overall Study|Participant Travelled Abroad|0|||
161433711|NCT05565742|582981482|FG001|Overall Study|Participant Travelled Abroad|0|||
161433712|NCT05565742|582981483|FG002|Overall Study|Participant Travelled Abroad|0|||
161433713|NCT05565742|582981484|FG003|Overall Study|Participant Travelled Abroad|0|||
161433714|NCT05565742|582981485|FG004|Overall Study|Participant Travelled Abroad|1|||
161433715|NCT04163341|582981486|FG000|Overall Study|Withdrawal by Subject|2|||
161433716|NCT04163341|582981487|FG001|Overall Study|Withdrawal by Subject|0|||
161433717|NCT04163341|582981486|FG000|Overall Study|Lost to Follow-up|3|||
161433718|NCT04163341|582981487|FG001|Overall Study|Lost to Follow-up|4|||
161433719|NCT00668148|582981502|FG000|Overall Study|Adverse Event|5|||
161433720|NCT00668148|582981502|FG000|Overall Study|Subject Non-compliance|1|||
161433721|NCT00668148|582981502|FG000|Overall Study|Progressive Disease Before Treatment|2|||
161433722|NCT00668148|582981502|FG000|Overall Study|Withdrawal of Consent|2|||
161433723|NCT05472090|582981504|FG000|Overall Study|Adverse Event|2|||
161433724|NCT05472090|582981505|FG001|Overall Study|Adverse Event|3|||
161433725|NCT05472090|582981504|FG000|Overall Study|Lack of Efficacy|1|||
161433726|NCT05472090|582981505|FG001|Overall Study|Lack of Efficacy|0|||
161433727|NCT05472090|582981504|FG000|Overall Study|Physician Decision|1|||
161433728|NCT05472090|582981505|FG001|Overall Study|Physician Decision|0|||
161433729|NCT05472090|582981504|FG000|Overall Study|Withdrawal by Subject|2|||
161433730|NCT05472090|582981505|FG001|Overall Study|Withdrawal by Subject|0|||
161433731|NCT05472090|582981504|FG000|Overall Study|Lost to Follow-up|0|||
161433732|NCT05472090|582981505|FG001|Overall Study|Lost to Follow-up|3|||
161433733|NCT00303069|582983347|FG000|Overall Study|Lost to Follow-up|1|||
161433734|NCT00303069|582983348|FG001|Overall Study|Lost to Follow-up|0|||
161433735|NCT00303069|582983349|FG002|Overall Study|Lost to Follow-up|0|||
161433736|NCT00303069|582983350|FG003|Overall Study|Lost to Follow-up|2|||
161433737|NCT00303069|582983347|FG000|Overall Study|subject moved|1|||
161433738|NCT00303069|582983348|FG001|Overall Study|subject moved|0|||
161433739|NCT00303069|582983349|FG002|Overall Study|subject moved|0|||
161433740|NCT00303069|582983350|FG003|Overall Study|subject moved|0|||
161433741|NCT00303069|582983347|FG000|Overall Study|Recruitment into Army Reserves|0|||
161433742|NCT00303069|582983348|FG001|Overall Study|Recruitment into Army Reserves|0|||
161433743|NCT00303069|582983349|FG002|Overall Study|Recruitment into Army Reserves|1|||
161433744|NCT00303069|582983350|FG003|Overall Study|Recruitment into Army Reserves|0|||
161433745|NCT00092417|582983351|FG000|Overall Study|Lost to Follow-up|2|||
161433746|NCT00092417|582983352|FG001|Overall Study|Lost to Follow-up|0|||
161433747|NCT00092417|582983351|FG000|Overall Study|Withdrawal by Subject|2|||
161433748|NCT00092417|582983352|FG001|Overall Study|Withdrawal by Subject|1|||
161433749|NCT00092417|582983351|FG000|Overall Study|Other|1|||
161433750|NCT00092417|582983352|FG001|Overall Study|Other|0|||
161433751|NCT00425269|582983353|FG000|Overall Study|Pregnancy|5|||
161433752|NCT00425269|582983354|FG001|Overall Study|Pregnancy|7|||
161433753|NCT00425269|582983353|FG000|Overall Study|Lost to Follow-up|9|||
161433754|NCT00425269|582983354|FG001|Overall Study|Lost to Follow-up|9|||
161433755|NCT00425269|582983353|FG000|Overall Study|moved or medical reason|5|||
161433756|NCT00425269|582983354|FG001|Overall Study|moved or medical reason|4|||
161433757|NCT01084655|582983357|FG000|Overall Study|Radiographic disease progression|3|||
161433758|NCT01084655|582983358|FG001|Overall Study|Radiographic disease progression|2|||
161433759|NCT01084655|582983359|FG002|Overall Study|Radiographic disease progression|8|||
161433760|NCT01084655|582983357|FG000|Overall Study|Withdrawal by Subject|1|||
161433761|NCT01084655|582983358|FG001|Overall Study|Withdrawal by Subject|0|||
161433762|NCT01084655|582983359|FG002|Overall Study|Withdrawal by Subject|4|||
161433763|NCT01084655|582983357|FG000|Overall Study|Adverse Event|2|||
161433764|NCT01084655|582983358|FG001|Overall Study|Adverse Event|1|||
161433765|NCT01084655|582983359|FG002|Overall Study|Adverse Event|2|||
161433766|NCT01084655|582983357|FG000|Overall Study|Other|0|||
161433767|NCT01084655|582983358|FG001|Overall Study|Other|3|||
161433768|NCT01084655|582983359|FG002|Overall Study|Other|2|||
161433769|NCT01084655|582983357|FG000|Overall Study|Symptomatic deterioration|0|||
161433770|NCT01084655|582983358|FG001|Overall Study|Symptomatic deterioration|0|||
161433771|NCT01084655|582983359|FG002|Overall Study|Symptomatic deterioration|2|||
161433772|NCT01084655|582983357|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
161433773|NCT01084655|582983358|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
161433774|NCT01084655|582983359|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
161433775|NCT00335777|582983360|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
161433776|NCT00335777|582983360|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
161433777|NCT00335777|582983360|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
161433778|NCT00335777|582983360|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
161433779|NCT00335777|582983360|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
161433780|NCT00535496|582983361|FG000|Overall Study|Lost to Follow-up|0|||
161433781|NCT00535496|582983362|FG001|Overall Study|Lost to Follow-up|1|||
161433782|NCT00535496|582983363|FG002|Overall Study|Lost to Follow-up|0|||
161433783|NCT00535496|582983364|FG003|Overall Study|Lost to Follow-up|0|||
161433784|NCT00535496|582983361|FG000|Overall Study|Not treated with sugammadex|0|||
161433785|NCT00535496|582983362|FG001|Overall Study|Not treated with sugammadex|1|||
161433786|NCT00535496|582983363|FG002|Overall Study|Not treated with sugammadex|0|||
161433787|NCT00535496|582983364|FG003|Overall Study|Not treated with sugammadex|0|||
161433788|NCT01209689|582983368|FG000|Overall Study|Insufficient Therapeutic Response|7|||
161433789|NCT01209689|582983369|FG001|Overall Study|Insufficient Therapeutic Response|2|||
161433790|NCT01209689|582983368|FG000|Overall Study|Refused Treatment|8|||
161433791|NCT01209689|582983369|FG001|Overall Study|Refused Treatment|3|||
161433792|NCT01209689|582983368|FG000|Overall Study|Adverse Event|4|||
161433793|NCT01209689|582983369|FG001|Overall Study|Adverse Event|0|||
161433794|NCT01209689|582983368|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161433795|NCT01209689|582983369|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161433796|NCT01209689|582983368|FG000|Overall Study|Failure to Return|3|||
161433797|NCT01209689|582983369|FG001|Overall Study|Failure to Return|0|||
161433798|NCT01209689|582983368|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
161433799|NCT01209689|582983369|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
161433800|NCT03780244|582983372|FG000|Overall Study|Lost to Follow-up|1|||
161433801|NCT03780244|582983373|FG001|Overall Study|Lost to Follow-up|0|||
161433802|NCT01083771|582983374|FG000|Overall Study|non-compliant|2|||
161433803|NCT01083771|582983374|FG000|Overall Study|Withdrawal by Subject|3|||
161433804|NCT03175367|582983377|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
161433805|NCT03175367|582983378|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
161433806|NCT03175367|582983379|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
161433807|NCT03175367|582983380|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
161433808|NCT03175367|582983381|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
161433809|NCT03175367|582983382|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
161433810|NCT03175367|582983383|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
161433811|NCT03175367|582983377|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
161433812|NCT03175367|582983378|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
161433813|NCT03175367|582983379|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
161433814|NCT03175367|582983380|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
161433815|NCT03175367|582983381|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
161433816|NCT03175367|582983382|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
161433817|NCT03175367|582983383|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
161433818|NCT03175367|582983377|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161433819|NCT03175367|582983378|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161433820|NCT03175367|582983379|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
161433821|NCT03175367|582983380|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
161433822|NCT03175367|582983381|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161433823|NCT03175367|582983382|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161433824|NCT03175367|582983383|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161433825|NCT03175367|582983377|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
161433826|NCT03175367|582983378|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
161433827|NCT03175367|582983379|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
161433828|NCT03175367|582983380|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
161433829|NCT03175367|582983381|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
161433830|NCT03175367|582983382|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
161433831|NCT03175367|582983383|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
161433832|NCT03175367|582983377|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161433833|NCT03175367|582983378|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161433834|NCT03175367|582983379|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
161433835|NCT03175367|582983380|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161433836|NCT03175367|582983381|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
161433837|NCT03175367|582983382|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161433838|NCT03175367|582983383|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161433839|NCT03175367|582983377|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
161433840|NCT03175367|582983378|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
161433841|NCT03175367|582983379|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
161433842|NCT03175367|582983380|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
161433843|NCT03175367|582983381|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
161433844|NCT03175367|582983382|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
161433845|NCT03175367|582983383|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
161433846|NCT03175367|582983377|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161433847|NCT03175367|582983378|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161433848|NCT03175367|582983379|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161433849|NCT03175367|582983380|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161433850|NCT03175367|582983381|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161433851|NCT03175367|582983382|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
161433852|NCT03175367|582983383|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
161433853|NCT03337477|582983386|FG000|Overall Study|not categorized into the listed ones|11|||
161433854|NCT03337477|582983387|FG001|Overall Study|not categorized into the listed ones|9|||
161433855|NCT03337477|582983386|FG000|Overall Study|Withdrawal by Subject|0|||
161433856|NCT03337477|582983387|FG001|Overall Study|Withdrawal by Subject|1|||
161433857|NCT03337477|582983386|FG000|Overall Study|Death|0|||
161433858|NCT03337477|582983387|FG001|Overall Study|Death|1|||
161433859|NCT03337477|582983386|FG000|Overall Study|Lost to Follow-up|0|||
161433860|NCT03337477|582983387|FG001|Overall Study|Lost to Follow-up|2|||
161433861|NCT03182374|582983390|FG000|Overall Study|Lost to Follow-up|3|||
161433862|NCT03182374|582983391|FG001|Overall Study|Lost to Follow-up|2|||
161433863|NCT03182374|582983390|FG000|Overall Study|Lack of Efficacy|8|||
161433864|NCT03182374|582983391|FG001|Overall Study|Lack of Efficacy|14|||
161433865|NCT03182374|582983390|FG000|Overall Study|Withdrawal by Subject|1|||
161433866|NCT03182374|582983391|FG001|Overall Study|Withdrawal by Subject|1|||
161433867|NCT03182374|582983390|FG000|Overall Study|exit for non-compliance|1|||
161433868|NCT03182374|582983391|FG001|Overall Study|exit for non-compliance|1|||
161433869|NCT03182374|582983390|FG000|Overall Study|one subject was randomized but not treated|1|||
161433870|NCT03182374|582983391|FG001|Overall Study|one subject was randomized but not treated|0|||
161433871|NCT03182374|582983390|FG000|Overall Study|Other reasons|0|||
161433872|NCT03182374|582983391|FG001|Overall Study|Other reasons|3|||
161433873|NCT01462370|582983392|FG000|Overall Study|Lack of Qualifying Event|1|||
161433874|NCT01462370|582983393|FG001|Overall Study|Lack of Qualifying Event|1|||
161433875|NCT01462370|582983392|FG000|Overall Study|Physician Decision|0|||
161433876|NCT01462370|582983393|FG001|Overall Study|Physician Decision|1|||
161433877|NCT01462370|582983392|FG000|Overall Study|Withdrawal by Subject|0|||
161433878|NCT01462370|582983393|FG001|Overall Study|Withdrawal by Subject|3|||
161433879|NCT00853307|582983396|FG000|Overall Study|Adverse Event|1|||
161433880|NCT00853307|582983397|FG001|Overall Study|Adverse Event|2|||
161433881|NCT00853307|582983396|FG000|Overall Study|Withdrawal by Subject|1|||
161433882|NCT00853307|582983397|FG001|Overall Study|Withdrawal by Subject|2|||
161433883|NCT00853307|582983396|FG000|Overall Study|Reason Not Specified|0|||
161433884|NCT00853307|582983397|FG001|Overall Study|Reason Not Specified|1|||
161433885|NCT00914316|582983400|FG000|Phase 1|Physician Decision|4|||
161433886|NCT00914316|582983401|FG001|Phase 1|Physician Decision|0|||
161433887|NCT00914316|582983402|FG002|Phase 1|Physician Decision|1|||
161433888|NCT00914316|582983403|FG003|Phase 1|Physician Decision|2|||
161433889|NCT00914316|582983400|FG000|Phase 1|Withdrawal by Subject|0|||
161433890|NCT00914316|582983401|FG001|Phase 1|Withdrawal by Subject|2|||
161433891|NCT00914316|582983402|FG002|Phase 1|Withdrawal by Subject|4|||
161433892|NCT00914316|582983403|FG003|Phase 1|Withdrawal by Subject|0|||
161433893|NCT00914316|582983400|FG000|Phase 1|Adverse Event|1|||
161433894|NCT00914316|582983401|FG001|Phase 1|Adverse Event|0|||
161433895|NCT00914316|582983402|FG002|Phase 1|Adverse Event|0|||
161433896|NCT00914316|582983403|FG003|Phase 1|Adverse Event|0|||
161433897|NCT00914316|582983400|FG000|Phase 2|Withdrawal by Subject|1|||
161433898|NCT00914316|582983401|FG001|Phase 2|Withdrawal by Subject|0|||
161433899|NCT00914316|582983402|FG002|Phase 2|Withdrawal by Subject|1|||
161433900|NCT00914316|582983403|FG003|Phase 2|Withdrawal by Subject|0|||
161433901|NCT01112917|582983404|FG000|Overall Study|Death|2|||
161433902|NCT01112917|582983405|FG001|Overall Study|Death|11|||
161433903|NCT01112917|582983404|FG000|Overall Study|Lost to Follow-up|1|||
161433904|NCT01112917|582983405|FG001|Overall Study|Lost to Follow-up|1|||
161433905|NCT01112917|582983404|FG000|Overall Study|Withdrawal by Subject|1|||
161433906|NCT01112917|582983405|FG001|Overall Study|Withdrawal by Subject|3|||
161433907|NCT01112917|582983404|FG000|Overall Study|Unable to Convert Filter|3|||
161433908|NCT01112917|582983405|FG001|Overall Study|Unable to Convert Filter|0|||
161433909|NCT05101122|582983406|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
161433910|NCT05101122|582983406|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
161433911|NCT05101122|582983406|FG000|AD313 80/5|Withdrawal by Subject|1|||
161433912|NCT05101122|582983406|FG000|AD313 80/10|Physician Decision|1|||
161433913|NCT03131219|582983407|FG000|Initial Evaluation Period|Adverse Event|2|||
161433914|NCT03131219|582983408|FG001|Initial Evaluation Period|Adverse Event|0|||
161433915|NCT03131219|582983407|FG000|Initial Evaluation Period|Protocol Violation|1|||
161433916|NCT03131219|582983408|FG001|Initial Evaluation Period|Protocol Violation|0|||
161433917|NCT03131219|582983407|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
161433918|NCT03131219|582983408|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
161433919|NCT03131219|582983407|FG000|Initial Evaluation Period|Physician Decision|1|||
161433920|NCT03131219|582983408|FG001|Initial Evaluation Period|Physician Decision|0|||
161433921|NCT03131219|582983407|FG000|Extension Period|Physician Decision|1|||
161433922|NCT03131219|582983408|FG001|Extension Period|Physician Decision|0|||
161433923|NCT00616759|582983410|FG000|Overall Study|Physician Decision|2|||
161433924|NCT00616759|582983411|FG001|Overall Study|Physician Decision|0|||
161433925|NCT00616759|582983410|FG000|Overall Study|Withdrawal by Subject|1|||
161433926|NCT00616759|582983411|FG001|Overall Study|Withdrawal by Subject|2|||
161433927|NCT02399163|582983414|FG000|Overall Study|Adverse Event|2|||
161433928|NCT02399163|582983414|FG000|Overall Study|Protocol Deviation|2|||
161433929|NCT02399163|582983414|FG000|Overall Study|Withdrawal by Participant|5|||
161433930|NCT02177123|582983420|FG000|Overall Study|Lost to Follow-up|6|||
161433931|NCT02177123|582983420|FG000|Overall Study|Withdrawal by Subject|4|||
161433932|NCT02177123|582983420|FG000|Overall Study|Adverse Event|4|||
161433933|NCT02177123|582983420|FG000|Overall Study|Physician Decision|3|||
161433934|NCT02177123|582983420|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
161433935|NCT02177123|582983420|FG000|Overall Study|Excluded for medical reasons|2|||
161433936|NCT02177123|582983420|FG000|Overall Study|Death|1|||
161433937|NCT02177123|582983420|FG000|Overall Study|Other|1|||
161433938|NCT02177123|582983420|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
161433939|NCT01391546|582983421|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
161433940|NCT01391546|582983422|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
161433941|NCT06271993|582983424|FG000|Overall Study|Not reactive to histamine|5|||
161433942|NCT06271993|582983425|FG001|Overall Study|Not reactive to histamine|5|||
161433943|NCT06271993|582983426|FG002|Overall Study|Not reactive to histamine|5|||
161433944|NCT01980017|582983435|FG000|Overall Study|Lost to Follow-up|30|||
161433945|NCT01980017|582983436|FG001|Overall Study|Lost to Follow-up|21|||
161433946|NCT01980017|582983435|FG000|Overall Study|Death|0|||
161433947|NCT01980017|582983436|FG001|Overall Study|Death|1|||
161433948|NCT01435382|582983438|FG000|Overall Study|Lost to Follow-up|1|||
161433949|NCT01435382|582983439|FG001|Overall Study|Lost to Follow-up|0|||
161433950|NCT01435382|582983440|FG002|Overall Study|Lost to Follow-up|1|||
161433951|NCT01435382|582983441|FG003|Overall Study|Lost to Follow-up|0|||
161433952|NCT01435382|582983438|FG000|Overall Study|Withdrawal by Subject|0|||
161433953|NCT01435382|582983439|FG001|Overall Study|Withdrawal by Subject|2|||
161433954|NCT01435382|582983440|FG002|Overall Study|Withdrawal by Subject|0|||
161433955|NCT01435382|582983441|FG003|Overall Study|Withdrawal by Subject|1|||
161433956|NCT03379818|582983442|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
161433957|NCT03379818|582983443|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
161433958|NCT03379818|582983442|FG000|Overall Study|Withdrawal by Subject|2|||
161433959|NCT03379818|582983443|FG001|Overall Study|Withdrawal by Subject|3|||
161433960|NCT03379818|582983442|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
161433961|NCT03379818|582983443|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
161433962|NCT00910650|582983444|FG000|Overall Study|Death|2|||
161433963|NCT00423579|582983445|FG000|Overall Study|Lost to Follow-up|3|||
161433964|NCT00423579|582983446|FG001|Overall Study|Lost to Follow-up|0|||
161433965|NCT00423579|582983445|FG000|Overall Study|Protocol Violation|1|||
161433966|NCT00423579|582983446|FG001|Overall Study|Protocol Violation|3|||
161433967|NCT00423579|582983445|FG000|Overall Study|Diagnosis of diabetes|0|||
161433968|NCT00423579|582983446|FG001|Overall Study|Diagnosis of diabetes|1|||
161433969|NCT01310777|582983447|FG000|Overall Study|Adverse Event|23|||
161433970|NCT01310777|582983448|FG001|Overall Study|Adverse Event|1|||
161433971|NCT01310777|582983449|FG002|Overall Study|Adverse Event|15|||
161433972|NCT01310777|582983447|FG000|Overall Study|Lost to Follow-up|0|||
161433973|NCT01310777|582983448|FG001|Overall Study|Lost to Follow-up|4|||
161433974|NCT01310777|582983449|FG002|Overall Study|Lost to Follow-up|1|||
161433975|NCT01310777|582983447|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
161433976|NCT01310777|582983448|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
161433977|NCT01310777|582983449|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
161433978|NCT01310777|582983447|FG000|Overall Study|Inadequate Control of IOP|5|||
161433979|NCT01310777|582983448|FG001|Overall Study|Inadequate Control of IOP|7|||
161433980|NCT01310777|582983449|FG002|Overall Study|Inadequate Control of IOP|10|||
161433981|NCT01310777|582983447|FG000|Overall Study|Other|4|||
161433982|NCT01310777|582983448|FG001|Overall Study|Other|1|||
161433983|NCT01310777|582983449|FG002|Overall Study|Other|2|||
161433984|NCT03697252|582983451|FG000|Overall Study|Adverse Event|3|||
161433985|NCT03697252|582983452|FG001|Overall Study|Adverse Event|2|||
161433986|NCT03697252|582983451|FG000|Overall Study|Withdrawal by Subject|14|||
161433987|NCT03697252|582983452|FG001|Overall Study|Withdrawal by Subject|14|||
161433988|NCT03697252|582983451|FG000|Overall Study|Lost to Follow-up|0|||
161433989|NCT03697252|582983452|FG001|Overall Study|Lost to Follow-up|1|||
161433990|NCT03697252|582983451|FG000|Overall Study|Physician Decision|1|||
161433991|NCT03697252|582983452|FG001|Overall Study|Physician Decision|1|||
161433992|NCT03697252|582983451|FG000|Overall Study|Other|0|||
161433993|NCT03697252|582983452|FG001|Overall Study|Other|1|||
161433994|NCT00317473|582983453|FG000|Overall Study|Withdrawal by Subject|2|||
161433995|NCT00317473|582983454|FG001|Overall Study|Withdrawal by Subject|1|||
161433996|NCT00317473|582983455|FG002|Overall Study|Withdrawal by Subject|2|||
161433997|NCT00317473|582983456|FG003|Overall Study|Withdrawal by Subject|1|||
161433998|NCT00317473|582983457|FG004|Overall Study|Withdrawal by Subject|3|||
161433999|NCT00317473|582983458|FG005|Overall Study|Withdrawal by Subject|1|||
161434000|NCT00317473|582983453|FG000|Overall Study|Relocation|1|||
161434001|NCT00317473|582983454|FG001|Overall Study|Relocation|0|||
161434002|NCT00317473|582983455|FG002|Overall Study|Relocation|1|||
161434003|NCT00317473|582983456|FG003|Overall Study|Relocation|1|||
161434004|NCT00317473|582983457|FG004|Overall Study|Relocation|5|||
161434005|NCT00317473|582983458|FG005|Overall Study|Relocation|2|||
161434006|NCT00317473|582983453|FG000|Overall Study|Death|1|||
161434007|NCT00317473|582983454|FG001|Overall Study|Death|0|||
161434008|NCT00317473|582983455|FG002|Overall Study|Death|0|||
161434009|NCT00317473|582983456|FG003|Overall Study|Death|0|||
161434010|NCT00317473|582983457|FG004|Overall Study|Death|0|||
161434011|NCT00317473|582983458|FG005|Overall Study|Death|0|||
161434012|NCT00317473|582983453|FG000|Overall Study|Other|0|||
161434013|NCT00317473|582983454|FG001|Overall Study|Other|2|||
161434014|NCT00317473|582983455|FG002|Overall Study|Other|0|||
161434015|NCT00317473|582983456|FG003|Overall Study|Other|0|||
161434016|NCT00317473|582983457|FG004|Overall Study|Other|0|||
161434017|NCT00317473|582983458|FG005|Overall Study|Other|0|||
161434018|NCT02285855|582983459|FG000|Overall Study|Withdrawal by Subject|2|||
161434019|NCT02285855|582983460|FG001|Overall Study|Withdrawal by Subject|1|||
161434020|NCT03253796|582983461|FG000|Period 1: Run-In|Adverse Event|4|||
161434021|NCT03253796|582983462|FG001|Period 1: Run-In|Adverse Event|0|||
161434022|NCT03253796|582983463|FG002|Period 1: Run-In|Adverse Event|0|||
161434023|NCT03253796|582983464|FG003|Period 1: Run-In|Adverse Event|0|||
161434024|NCT03253796|582983465|FG004|Period 1: Run-In|Adverse Event|0|||
161434025|NCT03253796|582983461|FG000|Period 1: Run-In|Lack of Efficacy|1|||
161434026|NCT03253796|582983462|FG001|Period 1: Run-In|Lack of Efficacy|0|||
161434027|NCT03253796|582983463|FG002|Period 1: Run-In|Lack of Efficacy|0|||
161434028|NCT03253796|582983464|FG003|Period 1: Run-In|Lack of Efficacy|0|||
161434029|NCT03253796|582983465|FG004|Period 1: Run-In|Lack of Efficacy|0|||
161434030|NCT03253796|582983461|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
161434031|NCT03253796|582983462|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
161434032|NCT03253796|582983463|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
161434033|NCT03253796|582983464|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
161434034|NCT03253796|582983465|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
161434035|NCT03253796|582983461|FG000|Period 1: Run-In|Protocol Violation|5|||
161434036|NCT03253796|582983462|FG001|Period 1: Run-In|Protocol Violation|0|||
161434037|NCT03253796|582983463|FG002|Period 1: Run-In|Protocol Violation|0|||
161434038|NCT03253796|582983464|FG003|Period 1: Run-In|Protocol Violation|0|||
161434039|NCT03253796|582983465|FG004|Period 1: Run-In|Protocol Violation|0|||
161434040|NCT03253796|582983461|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
161434041|NCT03253796|582983462|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
161434042|NCT03253796|582983463|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
161434043|NCT03253796|582983464|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
161434044|NCT03253796|582983465|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
161434045|NCT03253796|582983461|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
161434046|NCT03253796|582983462|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
161434047|NCT03253796|582983463|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
161434048|NCT03253796|582983464|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
161434049|NCT03253796|582983465|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
161434050|NCT03253796|582983461|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
161434051|NCT03253796|582983462|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
161434052|NCT03253796|582983463|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
161434053|NCT03253796|582983464|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
161434054|NCT03253796|582983465|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
161434055|NCT03253796|582983461|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
161434056|NCT03253796|582983462|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
161434057|NCT03253796|582983463|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
161434058|NCT03253796|582983464|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
161434059|NCT03253796|582983465|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
161434060|NCT03253796|582983461|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
161434061|NCT03253796|582983462|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
161434062|NCT03253796|582983463|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
161434063|NCT03253796|582983464|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
161434064|NCT03253796|582983465|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
161434065|NCT03253796|582983461|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
161434066|NCT03253796|582983462|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
161434067|NCT03253796|582983463|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
161434068|NCT03253796|582983464|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
161434069|NCT03253796|582983465|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
161434070|NCT03253796|582983461|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
161434071|NCT03253796|582983462|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
161434072|NCT03253796|582983463|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
161434073|NCT03253796|582983464|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
161434074|NCT03253796|582983465|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
161434075|NCT00528112|582983466|FG000|Treatment up to 3 Years|Adverse Event|313|||
161434076|NCT00528112|582983467|FG001|Treatment up to 3 Years|Adverse Event|278|||
161434077|NCT00528112|582983466|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
161434078|NCT00528112|582983467|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
161434079|NCT00528112|582983466|FG000|Treatment up to 3 Years|Protocol Violation|16|||
161434080|NCT00528112|582983467|FG001|Treatment up to 3 Years|Protocol Violation|16|||
161434081|NCT00528112|582983466|FG000|Treatment up to 3 Years|Death|0|||
161434082|NCT00528112|582983467|FG001|Treatment up to 3 Years|Death|1|||
161434083|NCT00528112|582983466|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
161434084|NCT00528112|582983467|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
161434085|NCT00528112|582983466|FG000|Treatment up to 3 Years|Pregnancy|9|||
161434086|NCT00528112|582983467|FG001|Treatment up to 3 Years|Pregnancy|10|||
161434087|NCT00528112|582983466|FG000|Treatment up to 3 Years|Other reasons|186|||
161434088|NCT00528112|582983467|FG001|Treatment up to 3 Years|Other reasons|186|||
161434089|NCT00528112|582983466|FG000|Extension Phase|Withdrawal by Subject|0|||
161434090|NCT00528112|582983467|FG001|Extension Phase|Withdrawal by Subject|3|||
161434091|NCT00528112|582983466|FG000|Extension Phase|Other reasons|0|||
161434092|NCT00528112|582983467|FG001|Extension Phase|Other reasons|100|||
161434093|NCT00528112|582983466|FG000|Extension Phase|Pregnancy|0|||
161434094|NCT00528112|582983467|FG001|Extension Phase|Pregnancy|3|||
161434095|NCT00528112|582983466|FG000|Extension Phase|Lost to Follow-up|0|||
161434096|NCT00528112|582983467|FG001|Extension Phase|Lost to Follow-up|12|||
161434097|NCT00528112|582983466|FG000|Extension Phase|Death|0|||
161434098|NCT00528112|582983467|FG001|Extension Phase|Death|1|||
161434099|NCT00528112|582983466|FG000|Extension Phase|Adverse Event|0|||
161434100|NCT00528112|582983467|FG001|Extension Phase|Adverse Event|36|||
161434101|NCT00528112|582983466|FG000|Extension Phase|Protocol Violation|0|||
161434102|NCT00528112|582983467|FG001|Extension Phase|Protocol Violation|2|||
161434103|NCT02718898|582983470|FG000|Blinded Treatment Period|Adverse Event|5|||
161434104|NCT02718898|582983471|FG001|Blinded Treatment Period|Adverse Event|1|||
161434105|NCT02718898|582983472|FG002|Blinded Treatment Period|Adverse Event|0|||
161434106|NCT02718898|582983473|FG003|Blinded Treatment Period|Adverse Event|0|||
161434107|NCT02718898|582983474|FG004|Blinded Treatment Period|Adverse Event|0|||
161434108|NCT02718898|582983475|FG005|Blinded Treatment Period|Adverse Event|0|||
161434109|NCT02718898|582983476|FG006|Blinded Treatment Period|Adverse Event|0|||
161434110|NCT02718898|582983470|FG000|Blinded Treatment Period|Physician Decision|1|||
161434111|NCT02718898|582983471|FG001|Blinded Treatment Period|Physician Decision|0|||
161434112|NCT02718898|582983472|FG002|Blinded Treatment Period|Physician Decision|0|||
161434113|NCT02718898|582983473|FG003|Blinded Treatment Period|Physician Decision|0|||
161434114|NCT02718898|582983474|FG004|Blinded Treatment Period|Physician Decision|0|||
161434115|NCT02718898|582983475|FG005|Blinded Treatment Period|Physician Decision|0|||
161434116|NCT02718898|582983476|FG006|Blinded Treatment Period|Physician Decision|0|||
161434117|NCT02718898|582983470|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
161434118|NCT02718898|582983471|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
161434119|NCT02718898|582983472|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
161434120|NCT02718898|582983473|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
161434121|NCT02718898|582983474|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
161434122|NCT02718898|582983475|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
161434123|NCT02718898|582983476|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
161434124|NCT02718898|582983470|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
161434125|NCT02718898|582983471|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
161434126|NCT02718898|582983472|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
161434127|NCT02718898|582983473|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
161434128|NCT02718898|582983474|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
161434129|NCT02718898|582983475|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
161434130|NCT02718898|582983476|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
161434131|NCT02718898|582983470|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
161434132|NCT02718898|582983471|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
161434133|NCT02718898|582983472|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
161434134|NCT02718898|582983473|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
161434135|NCT02718898|582983474|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
161434136|NCT02718898|582983475|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
161434137|NCT02718898|582983476|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
161434138|NCT02718898|582983470|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
161434139|NCT02718898|582983471|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
161434140|NCT02718898|582983472|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
161434141|NCT02718898|582983473|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
161434142|NCT02718898|582983474|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
161434143|NCT02718898|582983475|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
161434144|NCT02718898|582983476|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
161434145|NCT02718898|582983470|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161434146|NCT02718898|582983471|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161434147|NCT02718898|582983472|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
161434148|NCT02718898|582983473|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
161434149|NCT02718898|582983474|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161434150|NCT02718898|582983475|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161434151|NCT02718898|582983476|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161434152|NCT02718898|582983470|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
161434153|NCT02718898|582983471|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
161434154|NCT02718898|582983472|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
161434155|NCT02718898|582983473|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
161434156|NCT02718898|582983474|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
161434157|NCT02718898|582983475|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
161434158|NCT02718898|582983476|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
161434159|NCT02718898|582983470|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
161434160|NCT02718898|582983471|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
161434161|NCT02718898|582983472|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
161434162|NCT02718898|582983473|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
161434163|NCT02718898|582983474|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
161434164|NCT02718898|582983475|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
161434165|NCT02718898|582983476|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
161434166|NCT02718898|582983470|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
161434167|NCT02718898|582983471|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
161434168|NCT02718898|582983472|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
161434169|NCT02718898|582983473|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
161434170|NCT02718898|582983474|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
161434171|NCT02718898|582983475|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
161434172|NCT02718898|582983476|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
161434173|NCT02718898|582983470|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
161434174|NCT02718898|582983471|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
161434175|NCT02718898|582983472|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
161434176|NCT02718898|582983473|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
161434177|NCT02718898|582983474|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
161434178|NCT02718898|582983475|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
161434179|NCT02718898|582983476|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
161434180|NCT02718898|582983470|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
161434181|NCT02718898|582983471|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
161434182|NCT02718898|582983472|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
161434183|NCT02718898|582983473|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
161434184|NCT02718898|582983474|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
161434185|NCT02718898|582983475|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
161434186|NCT02718898|582983476|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
161434187|NCT02718898|582983470|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161434188|NCT02718898|582983471|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161434189|NCT02718898|582983472|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161434190|NCT02718898|582983473|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161434191|NCT02718898|582983474|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
161434192|NCT02718898|582983475|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
161434193|NCT02718898|582983476|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
161434194|NCT00231816|582983479|FG000|Overall Study|Adverse Event|1|||
161434195|NCT00231816|582983480|FG001|Overall Study|Adverse Event|0|||
161434196|NCT00231816|582983479|FG000|Overall Study|Lost to Follow-up|8|||
161434197|NCT00231816|582983480|FG001|Overall Study|Lost to Follow-up|5|||
161434198|NCT00231816|582983479|FG000|Overall Study|Protocol Violation|2|||
161434199|NCT00231816|582983480|FG001|Overall Study|Protocol Violation|3|||
161434200|NCT00231816|582983479|FG000|Overall Study|Withdrawal by Subject|3|||
161434201|NCT00231816|582983480|FG001|Overall Study|Withdrawal by Subject|3|||
161434202|NCT00231816|582983479|FG000|Overall Study|Other|2|||
161434203|NCT00231816|582983480|FG001|Overall Study|Other|1|||
161434204|NCT01668784|582983495|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
161434205|NCT01668784|582983496|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
161434206|NCT01668784|582983495|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
161434207|NCT01668784|582983496|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
161434208|NCT01668784|582983495|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
161434209|NCT01668784|582983496|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
161434210|NCT01668784|582983495|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
161434211|NCT01668784|582983496|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
161434212|NCT01668784|582983495|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
161434213|NCT01668784|582983496|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
161434214|NCT01668784|582983495|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
161434215|NCT01668784|582983496|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
161434216|NCT01668784|582983495|FG000|Treatment Period|Disease Progression|316|||
161434217|NCT01668784|582983496|FG001|Treatment Period|Disease Progression|293|||
161434218|NCT01668784|582983495|FG000|Treatment Period|Study Drug Toxicity|46|||
161434219|NCT01668784|582983496|FG001|Treatment Period|Study Drug Toxicity|53|||
161434220|NCT01668784|582983495|FG000|Treatment Period|Death|1|||
161434221|NCT01668784|582983496|FG001|Treatment Period|Death|1|||
161434222|NCT01668784|582983495|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
161434223|NCT01668784|582983496|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
161434224|NCT01668784|582983495|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
161434225|NCT01668784|582983496|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
161435947|NCT04050553|582989736|FG001|Wash-out|Adverse Event|1|||
161434226|NCT01668784|582983495|FG000|Treatment Period|Withdrawal by Subject|5|||
161434227|NCT01668784|582983496|FG001|Treatment Period|Withdrawal by Subject|3|||
161434228|NCT01668784|582983495|FG000|Treatment Period|Maximal Clinical Benefit|3|||
161434229|NCT01668784|582983496|FG001|Treatment Period|Maximal Clinical Benefit|3|||
161434230|NCT01668784|582983495|FG000|Treatment Period|Other|2|||
161434231|NCT01668784|582983496|FG001|Treatment Period|Other|8|||
161434232|NCT01668784|582983495|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
161434233|NCT01668784|582983496|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
161434234|NCT03137992|582983497|FG000|Washout Period 1|Adverse Event|1|||
161434235|NCT03137992|582983498|FG001|Washout Period 1|Adverse Event|1|||
161434236|NCT03137992|582983499|FG002|Washout Period 1|Adverse Event|0|||
161434237|NCT03137992|582983500|FG003|Washout Period 1|Adverse Event|0|||
161434238|NCT03137992|582983501|FG004|Washout Period 1|Adverse Event|0|||
161434239|NCT03137992|582983502|FG005|Washout Period 1|Adverse Event|1|||
161434240|NCT03137992|582983497|FG000|Washout Period 1|Withdrawal by Subject|0|||
161434241|NCT03137992|582983498|FG001|Washout Period 1|Withdrawal by Subject|1|||
161434242|NCT03137992|582983499|FG002|Washout Period 1|Withdrawal by Subject|1|||
161434243|NCT03137992|582983500|FG003|Washout Period 1|Withdrawal by Subject|0|||
161434244|NCT03137992|582983501|FG004|Washout Period 1|Withdrawal by Subject|0|||
161434245|NCT03137992|582983502|FG005|Washout Period 1|Withdrawal by Subject|0|||
161434246|NCT03137992|582983497|FG000|Washout Period 1|Principal Investigator Discretion|0|||
161434247|NCT03137992|582983498|FG001|Washout Period 1|Principal Investigator Discretion|1|||
161434248|NCT03137992|582983499|FG002|Washout Period 1|Principal Investigator Discretion|0|||
161434249|NCT03137992|582983500|FG003|Washout Period 1|Principal Investigator Discretion|0|||
161434250|NCT03137992|582983501|FG004|Washout Period 1|Principal Investigator Discretion|0|||
161434251|NCT03137992|582983502|FG005|Washout Period 1|Principal Investigator Discretion|0|||
161434252|NCT03137992|582983497|FG000|Washout Period 1|COPD Exacerbation|1|||
161434253|NCT03137992|582983498|FG001|Washout Period 1|COPD Exacerbation|1|||
161434254|NCT03137992|582983499|FG002|Washout Period 1|COPD Exacerbation|1|||
161434255|NCT03137992|582983500|FG003|Washout Period 1|COPD Exacerbation|0|||
161434256|NCT03137992|582983501|FG004|Washout Period 1|COPD Exacerbation|1|||
161434257|NCT03137992|582983502|FG005|Washout Period 1|COPD Exacerbation|1|||
161434258|NCT03137992|582983497|FG000|Washout Period 1|Subject Noncompliance|1|||
161434259|NCT03137992|582983498|FG001|Washout Period 1|Subject Noncompliance|0|||
161434260|NCT03137992|582983499|FG002|Washout Period 1|Subject Noncompliance|0|||
161434261|NCT03137992|582983500|FG003|Washout Period 1|Subject Noncompliance|0|||
161434262|NCT03137992|582983501|FG004|Washout Period 1|Subject Noncompliance|1|||
161434263|NCT03137992|582983502|FG005|Washout Period 1|Subject Noncompliance|0|||
161434264|NCT03137992|582983497|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
161434265|NCT03137992|582983498|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
161434266|NCT03137992|582983499|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
161434267|NCT03137992|582983500|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
161434268|NCT03137992|582983501|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
161434269|NCT03137992|582983502|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
161434270|NCT03137992|582983497|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
161434271|NCT03137992|582983498|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
161434272|NCT03137992|582983499|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
161434273|NCT03137992|582983500|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
161434274|NCT03137992|582983501|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
161434275|NCT03137992|582983502|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
161434276|NCT03137992|582983497|FG000|Period 2 (Visit 3)|Adverse Event|0|||
161434277|NCT03137992|582983498|FG001|Period 2 (Visit 3)|Adverse Event|1|||
161434278|NCT03137992|582983499|FG002|Period 2 (Visit 3)|Adverse Event|0|||
161434279|NCT03137992|582983500|FG003|Period 2 (Visit 3)|Adverse Event|0|||
161434280|NCT03137992|582983501|FG004|Period 2 (Visit 3)|Adverse Event|0|||
161434281|NCT03137992|582983502|FG005|Period 2 (Visit 3)|Adverse Event|0|||
161434282|NCT03137992|582983497|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
161434283|NCT03137992|582983498|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
161434284|NCT03137992|582983499|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
161434285|NCT03137992|582983500|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
161434286|NCT03137992|582983501|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
161434287|NCT03137992|582983502|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
161434288|NCT03137992|582983497|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
161434289|NCT03137992|582983498|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
161434290|NCT03137992|582983499|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
161434291|NCT03137992|582983500|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
161434292|NCT03137992|582983501|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
161434293|NCT03137992|582983502|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
161434294|NCT03137992|582983497|FG000|Washout Period 2|COPD Exacerbation|1|||
161434295|NCT03137992|582983498|FG001|Washout Period 2|COPD Exacerbation|1|||
161434296|NCT03137992|582983499|FG002|Washout Period 2|COPD Exacerbation|0|||
161434297|NCT03137992|582983500|FG003|Washout Period 2|COPD Exacerbation|0|||
161434298|NCT03137992|582983501|FG004|Washout Period 2|COPD Exacerbation|1|||
161434299|NCT03137992|582983502|FG005|Washout Period 2|COPD Exacerbation|0|||
161434300|NCT03137992|582983497|FG000|Washout Period 2|Subject Non-compliance|0|||
161434301|NCT03137992|582983498|FG001|Washout Period 2|Subject Non-compliance|1|||
161434302|NCT03137992|582983499|FG002|Washout Period 2|Subject Non-compliance|0|||
161434303|NCT03137992|582983500|FG003|Washout Period 2|Subject Non-compliance|0|||
161434304|NCT03137992|582983501|FG004|Washout Period 2|Subject Non-compliance|0|||
161434305|NCT03137992|582983502|FG005|Washout Period 2|Subject Non-compliance|0|||
161434306|NCT03137992|582983497|FG000|Washout Period 2|Adverse Event|0|||
161434307|NCT03137992|582983498|FG001|Washout Period 2|Adverse Event|0|||
161434308|NCT03137992|582983499|FG002|Washout Period 2|Adverse Event|0|||
161434309|NCT03137992|582983500|FG003|Washout Period 2|Adverse Event|1|||
161434310|NCT03137992|582983501|FG004|Washout Period 2|Adverse Event|1|||
161434311|NCT03137992|582983502|FG005|Washout Period 2|Adverse Event|0|||
161434312|NCT03137992|582983497|FG000|Washout Period 2|Withdrawal by Subject|1|||
161434313|NCT03137992|582983498|FG001|Washout Period 2|Withdrawal by Subject|0|||
161434314|NCT03137992|582983499|FG002|Washout Period 2|Withdrawal by Subject|0|||
161434315|NCT03137992|582983500|FG003|Washout Period 2|Withdrawal by Subject|0|||
161434316|NCT03137992|582983501|FG004|Washout Period 2|Withdrawal by Subject|1|||
161434317|NCT03137992|582983502|FG005|Washout Period 2|Withdrawal by Subject|0|||
161434318|NCT03137992|582983497|FG000|Washout Period 2|Sponsor Decision|0|||
161434319|NCT03137992|582983498|FG001|Washout Period 2|Sponsor Decision|0|||
161434320|NCT03137992|582983499|FG002|Washout Period 2|Sponsor Decision|0|||
161434321|NCT03137992|582983500|FG003|Washout Period 2|Sponsor Decision|0|||
161434322|NCT03137992|582983501|FG004|Washout Period 2|Sponsor Decision|0|||
161434323|NCT03137992|582983502|FG005|Washout Period 2|Sponsor Decision|1|||
161434324|NCT03137992|582983497|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
161434325|NCT03137992|582983498|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
161434326|NCT03137992|582983499|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
161434327|NCT03137992|582983500|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
161434328|NCT03137992|582983501|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
161434329|NCT03137992|582983502|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
161434330|NCT03137992|582983497|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
161434331|NCT03137992|582983498|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
161434332|NCT03137992|582983499|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
161434333|NCT03137992|582983500|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
161434334|NCT03137992|582983501|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
161434335|NCT03137992|582983502|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
161434336|NCT03137992|582983497|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
161434337|NCT03137992|582983498|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
161434338|NCT03137992|582983499|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
161434339|NCT03137992|582983500|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
161434340|NCT03137992|582983501|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
161434341|NCT03137992|582983502|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
161434342|NCT03137992|582983497|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
161434343|NCT03137992|582983498|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
161434344|NCT03137992|582983499|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
161434345|NCT03137992|582983500|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
161434346|NCT03137992|582983501|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
161434347|NCT03137992|582983502|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
161434348|NCT03137992|582983497|FG000|Part 2 (Open-label Extension)|Per study team|1|||
161434349|NCT03137992|582983498|FG001|Part 2 (Open-label Extension)|Per study team|0|||
161434350|NCT03137992|582983499|FG002|Part 2 (Open-label Extension)|Per study team|0|||
161434351|NCT03137992|582983500|FG003|Part 2 (Open-label Extension)|Per study team|0|||
161434352|NCT03137992|582983501|FG004|Part 2 (Open-label Extension)|Per study team|0|||
161434353|NCT03137992|582983502|FG005|Part 2 (Open-label Extension)|Per study team|0|||
161434354|NCT03137992|582983497|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
161434355|NCT03137992|582983498|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
161434356|NCT03137992|582983499|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
161434357|NCT03137992|582983500|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
161434358|NCT03137992|582983501|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
161434359|NCT03137992|582983502|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
161434360|NCT04609319|582983503|FG000|Overall Study|Death|64|||
161434361|NCT04609319|582983504|FG001|Overall Study|Death|49|||
161434362|NCT04609319|582983505|FG002|Overall Study|Death|1|||
161434363|NCT04609319|582983503|FG000|Overall Study|Withdrawal of consent|15|||
161434364|NCT04609319|582983504|FG001|Overall Study|Withdrawal of consent|3|||
161434365|NCT04609319|582983505|FG002|Overall Study|Withdrawal of consent|0|||
161434366|NCT04609319|582983503|FG000|Overall Study|Lost to Follow-up|20|||
161434367|NCT04609319|582983504|FG001|Overall Study|Lost to Follow-up|33|||
161434368|NCT04609319|582983505|FG002|Overall Study|Lost to Follow-up|0|||
161434369|NCT04609319|582983503|FG000|Overall Study|Alive until end of follow-up|60|||
161434370|NCT04609319|582983504|FG001|Overall Study|Alive until end of follow-up|53|||
161434371|NCT04609319|582983505|FG002|Overall Study|Alive until end of follow-up|1|||
161434372|NCT03221556|582983506|FG000|Allocation|post-randomization exclusion|0|||
161434373|NCT03221556|582983507|FG001|Allocation|post-randomization exclusion|1|||
161434374|NCT03221556|582983506|FG000|Follow-Up|Withdrawal by Subject|0|||
161434375|NCT03221556|582983507|FG001|Follow-Up|Withdrawal by Subject|1|||
161434376|NCT02234843|582983508|FG000|Overall Study|Death|1|||
161434377|NCT02234843|582983509|FG001|Overall Study|Death|0|||
161434378|NCT02234843|582983510|FG002|Overall Study|Death|0|||
161434379|NCT02234843|582983511|FG003|Overall Study|Death|0|||
161434380|NCT02234843|582983512|FG004|Overall Study|Death|0|||
161434381|NCT02234843|582983513|FG005|Overall Study|Death|0|||
161434382|NCT02234843|582983514|FG006|Overall Study|Death|0|||
161434383|NCT02234843|582983515|FG007|Overall Study|Death|0|||
161434384|NCT02234843|582983516|FG008|Overall Study|Death|0|||
161434385|NCT02234843|582983517|FG009|Overall Study|Death|0|||
161434386|NCT02234843|582983508|FG000|Overall Study|Protocol Violation|1|||
161434387|NCT02234843|582983509|FG001|Overall Study|Protocol Violation|0|||
161434388|NCT02234843|582983510|FG002|Overall Study|Protocol Violation|1|||
161434389|NCT02234843|582983511|FG003|Overall Study|Protocol Violation|0|||
161434390|NCT02234843|582983512|FG004|Overall Study|Protocol Violation|0|||
161434391|NCT02234843|582983513|FG005|Overall Study|Protocol Violation|0|||
161434392|NCT02234843|582983514|FG006|Overall Study|Protocol Violation|0|||
161434393|NCT02234843|582983515|FG007|Overall Study|Protocol Violation|0|||
161434394|NCT02234843|582983516|FG008|Overall Study|Protocol Violation|0|||
161434395|NCT02234843|582983517|FG009|Overall Study|Protocol Violation|0|||
161434396|NCT02234843|582983508|FG000|Overall Study|Efficacy outcome reached|2|||
161434397|NCT02234843|582983509|FG001|Overall Study|Efficacy outcome reached|0|||
161434398|NCT02234843|582983510|FG002|Overall Study|Efficacy outcome reached|0|||
161434399|NCT02234843|582983511|FG003|Overall Study|Efficacy outcome reached|0|||
161434400|NCT02234843|582983512|FG004|Overall Study|Efficacy outcome reached|0|||
161434401|NCT02234843|582983513|FG005|Overall Study|Efficacy outcome reached|2|||
161434402|NCT02234843|582983514|FG006|Overall Study|Efficacy outcome reached|0|||
161434403|NCT02234843|582983515|FG007|Overall Study|Efficacy outcome reached|0|||
161434404|NCT02234843|582983516|FG008|Overall Study|Efficacy outcome reached|0|||
161434405|NCT02234843|582983517|FG009|Overall Study|Efficacy outcome reached|0|||
161434406|NCT02234843|582983508|FG000|Overall Study|Patient convenience|2|||
161434407|NCT02234843|582983509|FG001|Overall Study|Patient convenience|0|||
161434408|NCT02234843|582983510|FG002|Overall Study|Patient convenience|0|||
161434409|NCT02234843|582983511|FG003|Overall Study|Patient convenience|0|||
161434410|NCT02234843|582983512|FG004|Overall Study|Patient convenience|0|||
161434411|NCT02234843|582983513|FG005|Overall Study|Patient convenience|1|||
161434412|NCT02234843|582983514|FG006|Overall Study|Patient convenience|0|||
161434413|NCT02234843|582983515|FG007|Overall Study|Patient convenience|0|||
161434414|NCT02234843|582983516|FG008|Overall Study|Patient convenience|0|||
161434415|NCT02234843|582983517|FG009|Overall Study|Patient convenience|0|||
161434416|NCT02234843|582983508|FG000|Overall Study|Withdrawal by Subject|5|||
161434417|NCT02234843|582983509|FG001|Overall Study|Withdrawal by Subject|1|||
161434418|NCT02234843|582983510|FG002|Overall Study|Withdrawal by Subject|1|||
161434419|NCT02234843|582983511|FG003|Overall Study|Withdrawal by Subject|0|||
161434420|NCT02234843|582983512|FG004|Overall Study|Withdrawal by Subject|0|||
161434421|NCT02234843|582983513|FG005|Overall Study|Withdrawal by Subject|7|||
161434422|NCT02234843|582983514|FG006|Overall Study|Withdrawal by Subject|0|||
161434423|NCT02234843|582983515|FG007|Overall Study|Withdrawal by Subject|0|||
161434424|NCT02234843|582983516|FG008|Overall Study|Withdrawal by Subject|0|||
161434425|NCT02234843|582983517|FG009|Overall Study|Withdrawal by Subject|0|||
161434426|NCT02234843|582983508|FG000|Overall Study|Recovery|1|||
161434427|NCT02234843|582983509|FG001|Overall Study|Recovery|0|||
161434428|NCT02234843|582983510|FG002|Overall Study|Recovery|0|||
161434429|NCT02234843|582983511|FG003|Overall Study|Recovery|0|||
161434430|NCT02234843|582983512|FG004|Overall Study|Recovery|0|||
161434431|NCT02234843|582983513|FG005|Overall Study|Recovery|0|||
161434432|NCT02234843|582983514|FG006|Overall Study|Recovery|0|||
161434433|NCT02234843|582983515|FG007|Overall Study|Recovery|0|||
161434434|NCT02234843|582983516|FG008|Overall Study|Recovery|0|||
161434435|NCT02234843|582983517|FG009|Overall Study|Recovery|0|||
161434436|NCT02234843|582983508|FG000|Overall Study|Other|0|||
161434437|NCT02234843|582983509|FG001|Overall Study|Other|2|||
161434438|NCT02234843|582983510|FG002|Overall Study|Other|0|||
161434439|NCT02234843|582983511|FG003|Overall Study|Other|1|||
161434440|NCT02234843|582983512|FG004|Overall Study|Other|0|||
161434441|NCT02234843|582983513|FG005|Overall Study|Other|1|||
161434442|NCT02234843|582983514|FG006|Overall Study|Other|0|||
161434443|NCT02234843|582983515|FG007|Overall Study|Other|1|||
161434444|NCT02234843|582983516|FG008|Overall Study|Other|0|||
161434445|NCT02234843|582983517|FG009|Overall Study|Other|0|||
161434446|NCT02234843|582983508|FG000|Overall Study|Physician Decision|4|||
161434447|NCT02234843|582983509|FG001|Overall Study|Physician Decision|1|||
161434448|NCT02234843|582983510|FG002|Overall Study|Physician Decision|0|||
161434449|NCT02234843|582983511|FG003|Overall Study|Physician Decision|1|||
161434450|NCT02234843|582983512|FG004|Overall Study|Physician Decision|0|||
161434451|NCT02234843|582983513|FG005|Overall Study|Physician Decision|0|||
161434452|NCT02234843|582983514|FG006|Overall Study|Physician Decision|0|||
161434453|NCT02234843|582983515|FG007|Overall Study|Physician Decision|1|||
161434454|NCT02234843|582983516|FG008|Overall Study|Physician Decision|0|||
161434455|NCT02234843|582983517|FG009|Overall Study|Physician Decision|0|||
161434456|NCT02234843|582983508|FG000|Overall Study|Adverse Event|5|||
161434457|NCT02234843|582983509|FG001|Overall Study|Adverse Event|1|||
161434458|NCT02234843|582983510|FG002|Overall Study|Adverse Event|1|||
161434459|NCT02234843|582983511|FG003|Overall Study|Adverse Event|3|||
161434460|NCT02234843|582983512|FG004|Overall Study|Adverse Event|2|||
161434461|NCT02234843|582983513|FG005|Overall Study|Adverse Event|1|||
161434462|NCT02234843|582983514|FG006|Overall Study|Adverse Event|0|||
161434463|NCT02234843|582983515|FG007|Overall Study|Adverse Event|0|||
161434464|NCT02234843|582983516|FG008|Overall Study|Adverse Event|1|||
161434465|NCT02234843|582983517|FG009|Overall Study|Adverse Event|0|||
161434466|NCT02234843|582983508|FG000|Overall Study|Non-compliance with study drug|1|||
161434467|NCT02234843|582983509|FG001|Overall Study|Non-compliance with study drug|0|||
161434468|NCT02234843|582983510|FG002|Overall Study|Non-compliance with study drug|0|||
161434469|NCT02234843|582983511|FG003|Overall Study|Non-compliance with study drug|0|||
161434470|NCT02234843|582983512|FG004|Overall Study|Non-compliance with study drug|0|||
161434471|NCT02234843|582983513|FG005|Overall Study|Non-compliance with study drug|1|||
161434472|NCT02234843|582983514|FG006|Overall Study|Non-compliance with study drug|1|||
161434473|NCT02234843|582983515|FG007|Overall Study|Non-compliance with study drug|0|||
161434474|NCT02234843|582983516|FG008|Overall Study|Non-compliance with study drug|0|||
161434475|NCT02234843|582983517|FG009|Overall Study|Non-compliance with study drug|0|||
161434476|NCT02234843|582983508|FG000|Overall Study|Lost to Follow-up|0|||
161434477|NCT02234843|582983509|FG001|Overall Study|Lost to Follow-up|1|||
161434478|NCT02234843|582983510|FG002|Overall Study|Lost to Follow-up|0|||
161434479|NCT02234843|582983511|FG003|Overall Study|Lost to Follow-up|0|||
161434480|NCT02234843|582983512|FG004|Overall Study|Lost to Follow-up|0|||
161434481|NCT02234843|582983513|FG005|Overall Study|Lost to Follow-up|0|||
161434482|NCT02234843|582983514|FG006|Overall Study|Lost to Follow-up|1|||
161434483|NCT02234843|582983515|FG007|Overall Study|Lost to Follow-up|0|||
161434484|NCT02234843|582983516|FG008|Overall Study|Lost to Follow-up|0|||
161434485|NCT02234843|582983517|FG009|Overall Study|Lost to Follow-up|0|||
161434486|NCT02331134|582983524|FG000|Overall Study|Withdrawal by Subject|1|||
161434487|NCT04825574|582983528|FG000|Overall Study|Commercial treatment became available|1|||
161434488|NCT04825574|582983528|FG000|Overall Study|Disease progression|1|||
161434489|NCT05967260|582983529|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
161434490|NCT05967260|582983530|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
161434491|NCT04272242|582983531|FG000|Overall Study|Withdrawal by Subject|3|||
161434492|NCT04272242|582983531|FG000|Overall Study|Lost to Follow-up|1|||
161434493|NCT04272242|582983531|FG000|Overall Study|Adverse Event|1|||
161434494|NCT00992108|582985958|FG000|Overall Study|Lost to Follow-up|0|||
161434495|NCT00992108|582985959|FG001|Overall Study|Lost to Follow-up|1|||
161434496|NCT04639245|582985960|FG000|Overall Study|Death|1|||
161434497|NCT02419001|582985963|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
161434498|NCT02419001|582985964|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
161434499|NCT02851615|582985965|FG000|Overall Study|Cognitive Issue|1|||
161434500|NCT02851615|582985966|FG001|Overall Study|Cognitive Issue|0|||
161434501|NCT02851615|582985965|FG000|Overall Study|Lost to Follow-up|0|||
161434502|NCT02851615|582985966|FG001|Overall Study|Lost to Follow-up|4|||
161434503|NCT00371150|582985968|FG000|Overall Study|Lost to Follow-up|3|||
161434504|NCT00371150|582985969|FG001|Overall Study|Lost to Follow-up|2|||
161434505|NCT02151058|582985971|FG000|Overall Study|Withdrawal by Subject|1|||
161434506|NCT02151058|582985972|FG001|Overall Study|Withdrawal by Subject|1|||
161434507|NCT02151058|582985973|FG002|Overall Study|Withdrawal by Subject|3|||
161434508|NCT02151058|582985971|FG000|Overall Study|Lost to Follow-up|1|||
161434509|NCT02151058|582985972|FG001|Overall Study|Lost to Follow-up|0|||
161434510|NCT02151058|582985973|FG002|Overall Study|Lost to Follow-up|2|||
161434511|NCT00321620|582985975|FG000|Overall Study|Death|269|||
161434512|NCT00321620|582985976|FG001|Overall Study|Death|294|||
161434513|NCT00321620|582985975|FG000|Overall Study|Withdrawal by Subject|164|||
161434514|NCT00321620|582985976|FG001|Overall Study|Withdrawal by Subject|147|||
161434515|NCT00321620|582985975|FG000|Overall Study|Disease progression|113|||
161434516|NCT00321620|582985976|FG001|Overall Study|Disease progression|117|||
161434517|NCT00321620|582985975|FG000|Overall Study|Adverse Event|43|||
161434518|NCT00321620|582985976|FG001|Overall Study|Adverse Event|56|||
161434519|NCT00321620|582985975|FG000|Overall Study|Lost to Follow-up|13|||
161434520|NCT00321620|582985976|FG001|Overall Study|Lost to Follow-up|9|||
161434521|NCT00321620|582985975|FG000|Overall Study|Physician Decision|4|||
161434522|NCT00321620|582985976|FG001|Overall Study|Physician Decision|1|||
161434523|NCT00321620|582985975|FG000|Overall Study|Noncompliance|14|||
161434524|NCT00321620|582985976|FG001|Overall Study|Noncompliance|7|||
161434525|NCT00321620|582985975|FG000|Overall Study|Protocol deviation|4|||
161434526|NCT00321620|582985976|FG001|Overall Study|Protocol deviation|3|||
161434527|NCT00321620|582985975|FG000|Overall Study|Ineligibility determined|2|||
161434528|NCT00321620|582985976|FG001|Overall Study|Ineligibility determined|3|||
161434529|NCT00321620|582985975|FG000|Overall Study|Participant request|75|||
161434530|NCT00321620|582985976|FG001|Overall Study|Participant request|52|||
161434531|NCT00321620|582985975|FG000|Overall Study|Other|42|||
161434532|NCT00321620|582985976|FG001|Overall Study|Other|33|||
161434533|NCT03304626|582985977|FG000|Overall Study|Adverse Event|1|||
161434534|NCT03304626|582985978|FG001|Overall Study|Adverse Event|0|||
161434535|NCT03304626|582985977|FG000|Overall Study|Lack of Efficacy|1|||
161434536|NCT03304626|582985978|FG001|Overall Study|Lack of Efficacy|1|||
161434537|NCT01747876|582985980|FG000|Overall Study|Adverse Event|1|||
161434538|NCT01747876|582985981|FG001|Overall Study|Adverse Event|0|||
161434539|NCT01747876|582985982|FG002|Overall Study|Adverse Event|2|||
161434540|NCT01747876|582985980|FG000|Overall Study|Withdrawal by Subject|0|||
161434541|NCT01747876|582985981|FG001|Overall Study|Withdrawal by Subject|1|||
161434542|NCT01747876|582985982|FG002|Overall Study|Withdrawal by Subject|1|||
161434543|NCT01747876|582985980|FG000|Overall Study|Disease progression|4|||
161434544|NCT01747876|582985981|FG001|Overall Study|Disease progression|13|||
161434545|NCT01747876|582985982|FG002|Overall Study|Disease progression|8|||
161434546|NCT01747876|582985980|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
161434547|NCT01747876|582985981|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
161434548|NCT01747876|582985982|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
161434549|NCT03198715|582985985|FG000|Overall Study|Death|0|||
161434550|NCT03198715|582985986|FG001|Overall Study|Death|0|||
161434551|NCT03198715|582985987|FG002|Overall Study|Death|1|||
161434552|NCT03198715|582985988|FG003|Overall Study|Death|0|||
161434553|NCT03198715|582985989|FG004|Overall Study|Death|2|||
161434554|NCT03198715|582985985|FG000|Overall Study|Other|0|||
161434555|NCT03198715|582985986|FG001|Overall Study|Other|1|||
161434556|NCT03198715|582985987|FG002|Overall Study|Other|1|||
161434557|NCT03198715|582985988|FG003|Overall Study|Other|0|||
161434558|NCT03198715|582985989|FG004|Overall Study|Other|0|||
161434559|NCT04613362|582985990|FG000|3 Month Follow-up|Lost to Follow-up|1|||
161434560|NCT04613362|582985991|FG001|3 Month Follow-up|Lost to Follow-up|2|||
161434561|NCT04613362|582985990|FG000|6 Month Follow-up|Lost to Follow-up|0|||
161434562|NCT04613362|582985991|FG001|6 Month Follow-up|Lost to Follow-up|1|||
161434563|NCT04225897|582985992|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434564|NCT04225897|582985993|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
161434565|NCT04225897|582985994|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434566|NCT04225897|582985995|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434567|NCT04225897|582985996|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434568|NCT04225897|582985997|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434569|NCT04225897|582985998|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434570|NCT04225897|582985999|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434571|NCT04225897|582986000|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434572|NCT04225897|582986001|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434573|NCT04225897|582986002|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434574|NCT04225897|582986003|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
161434575|NCT04225897|582985992|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434576|NCT04225897|582985993|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434577|NCT04225897|582985994|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
161434578|NCT04225897|582985995|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434579|NCT04225897|582985996|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434580|NCT04225897|582985997|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434581|NCT04225897|582985998|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434582|NCT04225897|582985999|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434583|NCT04225897|582986000|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434584|NCT04225897|582986001|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434585|NCT04225897|582986002|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434586|NCT04225897|582986003|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
161434587|NCT04225897|582985992|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434588|NCT04225897|582985993|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434589|NCT04225897|582985994|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
161434590|NCT04225897|582985995|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434591|NCT04225897|582985996|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434592|NCT04225897|582985997|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434593|NCT04225897|582985998|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434594|NCT04225897|582985999|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434595|NCT04225897|582986000|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434596|NCT04225897|582986001|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434597|NCT04225897|582986002|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434598|NCT04225897|582986003|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
161434599|NCT04225897|582985992|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434600|NCT04225897|582985993|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434601|NCT04225897|582985994|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434602|NCT04225897|582985995|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434603|NCT04225897|582985996|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434604|NCT04225897|582985997|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434605|NCT04225897|582985998|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434606|NCT04225897|582985999|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
161434607|NCT04225897|582986000|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434608|NCT04225897|582986001|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434609|NCT04225897|582986002|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434610|NCT04225897|582986003|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
161434611|NCT00074711|582986005|FG000|Overall Study|Withdrawal by Subject|1|||
161434612|NCT00074711|582986006|FG001|Overall Study|Withdrawal by Subject|1|||
161434613|NCT00074711|582986005|FG000|Overall Study|Lost to Follow-up|10|||
161434614|NCT00074711|582986006|FG001|Overall Study|Lost to Follow-up|8|||
161434615|NCT00074711|582986005|FG000|Overall Study|Participant stopped study drug|4|||
161434616|NCT00074711|582986006|FG001|Overall Study|Participant stopped study drug|6|||
161434617|NCT03466658|582986007|FG000|Overall Study|Withdrawal by Subject|3|||
161434618|NCT01921205|582986008|FG000|Overall Study|Adverse Event|12|||
161434619|NCT01921205|582986009|FG001|Overall Study|Adverse Event|7|||
161434620|NCT01921205|582986008|FG000|Overall Study|Lack of Efficacy|1|||
161434621|NCT01921205|582986009|FG001|Overall Study|Lack of Efficacy|0|||
161434622|NCT01921205|582986008|FG000|Overall Study|Protocol Violation|1|||
161434623|NCT01921205|582986009|FG001|Overall Study|Protocol Violation|3|||
161434624|NCT01921205|582986008|FG000|Overall Study|Lost to Follow-up|1|||
161434625|NCT01921205|582986009|FG001|Overall Study|Lost to Follow-up|1|||
161434626|NCT01921205|582986008|FG000|Overall Study|Withdrawal by Subject|6|||
161434627|NCT01921205|582986009|FG001|Overall Study|Withdrawal by Subject|5|||
161434628|NCT01921205|582986008|FG000|Overall Study|Use Of Prohibited Medication|0|||
161434629|NCT01921205|582986009|FG001|Overall Study|Use Of Prohibited Medication|1|||
161434630|NCT01921205|582986008|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
161434631|NCT01921205|582986009|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
161434632|NCT01921205|582986008|FG000|Overall Study|Non Compliance Of The Parent|0|||
161434633|NCT01921205|582986009|FG001|Overall Study|Non Compliance Of The Parent|1|||
161434634|NCT01921205|582986008|FG000|Overall Study|Non Compliance Of Child|0|||
161434635|NCT01921205|582986009|FG001|Overall Study|Non Compliance Of Child|1|||
161434636|NCT03331315|582986010|FG000|Overall Study|Physician Decision|18|||
161434637|NCT03331315|582986011|FG001|Overall Study|Physician Decision|14|||
161434638|NCT00481832|582986012|FG000|Enrollment|Physician Decision|8|||
161434639|NCT00481832|582986012|FG000|Enrollment|Unable to collect enough stem cells|2|||
161434640|NCT00481832|582986012|FG000|Inter-transplant Period|Adverse Event|4|||
161434641|NCT00481832|582986012|FG000|Inter-transplant Period|Death|3|||
161434642|NCT00481832|582986012|FG000|Inter-transplant Period|Physician Decision|4|||
161434643|NCT00481832|582986012|FG000|Inter-transplant Period|Disease relapse|11|||
161434644|NCT00481832|582986012|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
161434645|NCT00456846|582986016|FG000|Overall Study|Adverse Event|2|||
161434646|NCT00456846|582986017|FG001|Overall Study|Adverse Event|15|||
161434647|NCT00456846|582986016|FG000|Overall Study|Physician Decision|11|||
161434648|NCT00456846|582986017|FG001|Overall Study|Physician Decision|6|||
161434649|NCT00456846|582986016|FG000|Overall Study|Protocol Deviation|2|||
161434650|NCT00456846|582986017|FG001|Overall Study|Protocol Deviation|0|||
161434651|NCT00456846|582986016|FG000|Overall Study|Participant Discretion|1|||
161434652|NCT00456846|582986017|FG001|Overall Study|Participant Discretion|5|||
161434653|NCT00456846|582986016|FG000|Overall Study|Other|0|||
161434654|NCT00456846|582986017|FG001|Overall Study|Other|2|||
161434655|NCT00886379|582986018|FG000|Overall Study|Transferred Schools|0|||
161434656|NCT00886379|582986019|FG001|Overall Study|Transferred Schools|0|||
161434657|NCT00886379|582986020|FG002|Overall Study|Transferred Schools|2|||
161434658|NCT00886379|582986021|FG003|Overall Study|Transferred Schools|1|||
161434659|NCT00886379|582986022|FG004|Overall Study|Transferred Schools|1|||
161434660|NCT00886379|582986018|FG000|Overall Study|Final blood draw not obtained|3|||
161434661|NCT00886379|582986019|FG001|Overall Study|Final blood draw not obtained|3|||
161434662|NCT00886379|582986020|FG002|Overall Study|Final blood draw not obtained|4|||
161434663|NCT00886379|582986021|FG003|Overall Study|Final blood draw not obtained|2|||
161434664|NCT00886379|582986022|FG004|Overall Study|Final blood draw not obtained|2|||
161434665|NCT03219723|582986023|FG000|Overall Study|Case Report Forms Uncollected|6|||
161434666|NCT03219723|582986023|FG000|Overall Study|Protocol Deviation|4|||
161434667|NCT04558125|582986024|FG000|Overall Study|Death|1|||
161434668|NCT03137381|582986025|FG000|Overall Study|Adverse Event|3|||
161434669|NCT03137381|582986026|FG001|Overall Study|Adverse Event|0|||
161434670|NCT03137381|582986027|FG002|Overall Study|Adverse Event|2|||
161434671|NCT03137381|582986028|FG003|Overall Study|Adverse Event|0|||
161434672|NCT03137381|582986025|FG000|Overall Study|Lost to Follow-up|2|||
161434673|NCT03137381|582986026|FG001|Overall Study|Lost to Follow-up|1|||
161434674|NCT03137381|582986027|FG002|Overall Study|Lost to Follow-up|1|||
161434675|NCT03137381|582986028|FG003|Overall Study|Lost to Follow-up|0|||
161434676|NCT03137381|582986025|FG000|Overall Study|Protocol deviation|1|||
161434677|NCT03137381|582986026|FG001|Overall Study|Protocol deviation|1|||
161434678|NCT03137381|582986027|FG002|Overall Study|Protocol deviation|0|||
161434679|NCT03137381|582986028|FG003|Overall Study|Protocol deviation|1|||
161434680|NCT03137381|582986025|FG000|Overall Study|Withdrawal by Investigator|0|||
161434681|NCT03137381|582986026|FG001|Overall Study|Withdrawal by Investigator|1|||
161434682|NCT03137381|582986027|FG002|Overall Study|Withdrawal by Investigator|1|||
161434683|NCT03137381|582986028|FG003|Overall Study|Withdrawal by Investigator|0|||
161434684|NCT03137381|582986025|FG000|Overall Study|Withdrawal by Subject|3|||
161434685|NCT03137381|582986026|FG001|Overall Study|Withdrawal by Subject|4|||
161434686|NCT03137381|582986027|FG002|Overall Study|Withdrawal by Subject|3|||
161434687|NCT03137381|582986028|FG003|Overall Study|Withdrawal by Subject|0|||
161434688|NCT03137381|582986025|FG000|Overall Study|Pregnancy|0|||
161434689|NCT03137381|582986026|FG001|Overall Study|Pregnancy|0|||
161434690|NCT03137381|582986027|FG002|Overall Study|Pregnancy|1|||
161434691|NCT03137381|582986028|FG003|Overall Study|Pregnancy|0|||
161434692|NCT00459316|582986033|FG000|Steps 1 & 2|Other eligibility failure|1|||
161434693|NCT00459316|582986034|FG001|Steps 1 & 2|Other eligibility failure|1|||
161434694|NCT00459316|582986035|FG002|Steps 1 & 2|Other eligibility failure|0|||
161434695|NCT00459316|582986033|FG000|Steps 1 & 2|Death|1|||
161434696|NCT00459316|582986034|FG001|Steps 1 & 2|Death|1|||
161434697|NCT00459316|582986035|FG002|Steps 1 & 2|Death|0|||
161434698|NCT00459316|582986033|FG000|Steps 1 & 2|Not able to get to clinic|7|||
161434699|NCT00459316|582986034|FG001|Steps 1 & 2|Not able to get to clinic|4|||
161434700|NCT00459316|582986035|FG002|Steps 1 & 2|Not able to get to clinic|0|||
161434701|NCT00459316|582986033|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
161434702|NCT00459316|582986034|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
161434703|NCT00459316|582986035|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
161434704|NCT00459316|582986033|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
161434705|NCT00459316|582986034|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
161434706|NCT00459316|582986035|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
161434707|NCT00459316|582986033|FG000|Steps 1 & 2|Lost to Follow-up|5|||
161434708|NCT00459316|582986034|FG001|Steps 1 & 2|Lost to Follow-up|0|||
161434709|NCT00459316|582986035|FG002|Steps 1 & 2|Lost to Follow-up|2|||
161434710|NCT00459316|582986033|FG000|Step 3|Withdrawal by Subject|3|||
161434711|NCT00459316|582986034|FG001|Step 3|Withdrawal by Subject|0|||
161434712|NCT00459316|582986035|FG002|Step 3|Withdrawal by Subject|1|||
161434713|NCT01614886|582986036|FG000|Overall Study|Adverse Event|15|||
161434714|NCT01614886|582986037|FG001|Overall Study|Adverse Event|20|||
161434715|NCT01614886|582986036|FG000|Overall Study|Withdrawal by Subject|4|||
161434716|NCT01614886|582986037|FG001|Overall Study|Withdrawal by Subject|4|||
161434717|NCT01614886|582986036|FG000|Overall Study|Death|1|||
161434718|NCT01614886|582986037|FG001|Overall Study|Death|0|||
161434719|NCT01614886|582986036|FG000|Overall Study|Protocol deviation|0|||
161434720|NCT01614886|582986037|FG001|Overall Study|Protocol deviation|2|||
161434721|NCT04004988|582986040|FG000|Period 1|Physician Decision|2|||
161434722|NCT04004988|582986041|FG001|Period 1|Physician Decision|0|||
161434723|NCT04004988|582986040|FG000|Period 1|Withdrawal by Subject|0|||
161434724|NCT04004988|582986041|FG001|Period 1|Withdrawal by Subject|1|||
161434725|NCT04004988|582986040|FG000|Period 1|Adverse Event|1|||
161434726|NCT04004988|582986041|FG001|Period 1|Adverse Event|2|||
161434727|NCT03873116|582986042|FG000|Part 1|Study drug discontinuation due to rash|0|||
161434728|NCT03873116|582986043|FG001|Part 1|Study drug discontinuation due to rash|0|||
161434729|NCT03873116|582986044|FG002|Part 1|Study drug discontinuation due to rash|0|||
161434730|NCT03873116|582986045|FG003|Part 1|Study drug discontinuation due to rash|0|||
161434731|NCT03873116|582986046|FG004|Part 1|Study drug discontinuation due to rash|0|||
161434732|NCT03873116|582986047|FG005|Part 1|Study drug discontinuation due to rash|1|||
161434733|NCT03873116|582986042|FG000|Part 2|Withdrawal by Subject|0|||
161434734|NCT03873116|582986043|FG001|Part 2|Withdrawal by Subject|0|||
161434735|NCT03873116|582986044|FG002|Part 2|Withdrawal by Subject|1|||
161434736|NCT03873116|582986045|FG003|Part 2|Withdrawal by Subject|0|||
161434737|NCT03873116|582986046|FG004|Part 2|Withdrawal by Subject|0|||
161434738|NCT03873116|582986047|FG005|Part 2|Withdrawal by Subject|0|||
161434739|NCT03873116|582986042|FG000|Part 2|Lab abnormality or AE|0|||
161434740|NCT03873116|582986043|FG001|Part 2|Lab abnormality or AE|0|||
161434741|NCT03873116|582986044|FG002|Part 2|Lab abnormality or AE|0|||
161434742|NCT03873116|582986045|FG003|Part 2|Lab abnormality or AE|0|||
161434743|NCT03873116|582986046|FG004|Part 2|Lab abnormality or AE|1|||
161434744|NCT03873116|582986047|FG005|Part 2|Lab abnormality or AE|0|||
161434745|NCT03873116|582986042|FG000|Part 3|Withdrawal by Subject|0|||
161434746|NCT03873116|582986043|FG001|Part 3|Withdrawal by Subject|0|||
161434747|NCT03873116|582986044|FG002|Part 3|Withdrawal by Subject|0|||
161434748|NCT03873116|582986045|FG003|Part 3|Withdrawal by Subject|0|||
161434749|NCT03873116|582986046|FG004|Part 3|Withdrawal by Subject|1|||
161434750|NCT03873116|582986047|FG005|Part 3|Withdrawal by Subject|0|||
161434751|NCT04682366|582986048|FG000|Overall Study|Lost to Follow-up|1|||
161434752|NCT04682366|582986049|FG001|Overall Study|Lost to Follow-up|1|||
161434753|NCT03125395|582986050|FG000|Overall Study|Adverse Event|2|||
161434754|NCT03125395|582986050|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161434755|NCT03125395|582986050|FG000|Overall Study|Physician Decision|2|||
161434756|NCT03125395|582986050|FG000|Overall Study|Commercial drug is available|5|||
161434757|NCT02531802|582986051|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
161434758|NCT02531802|582986052|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
161434759|NCT02531802|582986053|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
161434760|NCT02531802|582986054|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
161434761|NCT02531802|582986055|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
161434762|NCT02531802|582986056|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
161434763|NCT02531802|582986057|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
161434764|NCT02531802|582986058|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
161434765|NCT02531802|582986059|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
161434766|NCT02531802|582986060|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
161434767|NCT02531802|582986061|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
161434768|NCT02531802|582986062|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
161434769|NCT02531802|582986063|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
161434770|NCT02531802|582986064|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
161434771|NCT02531802|582986065|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
161434772|NCT02531802|582986066|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
161434773|NCT02531802|582986067|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
161434774|NCT02531802|582986068|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
161434775|NCT02531802|582986069|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
161434776|NCT02531802|582986070|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
161434777|NCT02531802|582986071|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
161434778|NCT02531802|582986051|FG000|Received Vaccination 2|Physician Decision|0|||
161434779|NCT02531802|582986052|FG001|Received Vaccination 2|Physician Decision|0|||
161434780|NCT02531802|582986053|FG002|Received Vaccination 2|Physician Decision|0|||
161434781|NCT02531802|582986054|FG003|Received Vaccination 2|Physician Decision|0|||
161434782|NCT02531802|582986055|FG004|Received Vaccination 2|Physician Decision|0|||
161434783|NCT02531802|582986056|FG005|Received Vaccination 2|Physician Decision|1|||
161434784|NCT02531802|582986057|FG006|Received Vaccination 2|Physician Decision|0|||
161434785|NCT02531802|582986058|FG007|Received Vaccination 2|Physician Decision|0|||
161434786|NCT02531802|582986059|FG008|Received Vaccination 2|Physician Decision|0|||
161434787|NCT02531802|582986060|FG009|Received Vaccination 2|Physician Decision|2|||
161434788|NCT02531802|582986061|FG010|Received Vaccination 2|Physician Decision|0|||
161434789|NCT02531802|582986062|FG011|Received Vaccination 2|Physician Decision|0|||
161434790|NCT02531802|582986063|FG012|Received Vaccination 2|Physician Decision|0|||
161434791|NCT02531802|582986064|FG013|Received Vaccination 2|Physician Decision|1|||
161434792|NCT02531802|582986065|FG014|Received Vaccination 2|Physician Decision|0|||
161434793|NCT02531802|582986066|FG015|Received Vaccination 2|Physician Decision|0|||
161434794|NCT02531802|582986067|FG016|Received Vaccination 2|Physician Decision|0|||
161434795|NCT02531802|582986068|FG017|Received Vaccination 2|Physician Decision|1|||
161434796|NCT02531802|582986069|FG018|Received Vaccination 2|Physician Decision|0|||
161434797|NCT02531802|582986070|FG019|Received Vaccination 2|Physician Decision|0|||
161434798|NCT02531802|582986071|FG020|Received Vaccination 2|Physician Decision|0|||
161434799|NCT02531802|582986051|FG000|Received Vaccination 2|Adverse Event|0|||
161434800|NCT02531802|582986052|FG001|Received Vaccination 2|Adverse Event|0|||
161434801|NCT02531802|582986053|FG002|Received Vaccination 2|Adverse Event|0|||
161434802|NCT02531802|582986054|FG003|Received Vaccination 2|Adverse Event|0|||
161434803|NCT02531802|582986055|FG004|Received Vaccination 2|Adverse Event|0|||
161434804|NCT02531802|582986056|FG005|Received Vaccination 2|Adverse Event|2|||
161434805|NCT02531802|582986057|FG006|Received Vaccination 2|Adverse Event|0|||
161434806|NCT02531802|582986058|FG007|Received Vaccination 2|Adverse Event|0|||
161434807|NCT02531802|582986059|FG008|Received Vaccination 2|Adverse Event|0|||
161434808|NCT02531802|582986060|FG009|Received Vaccination 2|Adverse Event|0|||
161434809|NCT02531802|582986061|FG010|Received Vaccination 2|Adverse Event|0|||
161434810|NCT02531802|582986062|FG011|Received Vaccination 2|Adverse Event|0|||
161434811|NCT02531802|582986063|FG012|Received Vaccination 2|Adverse Event|0|||
161434812|NCT02531802|582986064|FG013|Received Vaccination 2|Adverse Event|0|||
161434813|NCT02531802|582986065|FG014|Received Vaccination 2|Adverse Event|0|||
161434814|NCT02531802|582986066|FG015|Received Vaccination 2|Adverse Event|0|||
161434815|NCT02531802|582986067|FG016|Received Vaccination 2|Adverse Event|0|||
161434816|NCT02531802|582986068|FG017|Received Vaccination 2|Adverse Event|2|||
161434817|NCT02531802|582986069|FG018|Received Vaccination 2|Adverse Event|1|||
161434818|NCT02531802|582986070|FG019|Received Vaccination 2|Adverse Event|0|||
161434819|NCT02531802|582986071|FG020|Received Vaccination 2|Adverse Event|1|||
161434820|NCT02531802|582986051|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
161434821|NCT02531802|582986052|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
161434822|NCT02531802|582986053|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
161434823|NCT02531802|582986054|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
161434824|NCT02531802|582986055|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
161434825|NCT02531802|582986056|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
161434826|NCT02531802|582986057|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
161434827|NCT02531802|582986058|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
161434828|NCT02531802|582986059|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
161434829|NCT02531802|582986060|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
161434830|NCT02531802|582986061|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
161434831|NCT02531802|582986062|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
161434832|NCT02531802|582986063|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
161434833|NCT02531802|582986064|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
161434834|NCT02531802|582986065|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
161434835|NCT02531802|582986066|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
161434836|NCT02531802|582986067|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
161434837|NCT02531802|582986068|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
161434838|NCT02531802|582986069|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
161434839|NCT02531802|582986070|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
161434840|NCT02531802|582986071|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
161434841|NCT00482053|582986072|FG000|Inter-treatment Period|Disease progression|1|||
161434842|NCT04842747|582986076|FG000|Overall Study|Withdrawal by Subject|6|||
161434843|NCT04842747|582986077|FG001|Overall Study|Withdrawal by Subject|2|||
161434844|NCT04842747|582986076|FG000|Overall Study|Lost to Follow-up|1|||
161434845|NCT04842747|582986077|FG001|Overall Study|Lost to Follow-up|2|||
161434846|NCT04842747|582986076|FG000|Overall Study|Physician Decision|1|||
161434847|NCT04842747|582986077|FG001|Overall Study|Physician Decision|0|||
161434848|NCT04842747|582986076|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
161434849|NCT04842747|582986077|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
161434850|NCT02559622|582986079|FG000|Overall Study|Progressive disease|0|||
161434851|NCT02559622|582986080|FG001|Overall Study|Progressive disease|1|||
161434852|NCT02559622|582986081|FG002|Overall Study|Progressive disease|0|||
161434853|NCT02559622|582986082|FG003|Overall Study|Progressive disease|0|||
161434854|NCT02559622|582986079|FG000|Overall Study|Adverse Event|0|||
161434855|NCT02559622|582986080|FG001|Overall Study|Adverse Event|2|||
161434856|NCT02559622|582986081|FG002|Overall Study|Adverse Event|2|||
161434857|NCT02559622|582986082|FG003|Overall Study|Adverse Event|2|||
161434858|NCT02559622|582986079|FG000|Overall Study|Patient/guardian decision|1|||
161434859|NCT02559622|582986080|FG001|Overall Study|Patient/guardian decision|2|||
161434860|NCT02559622|582986081|FG002|Overall Study|Patient/guardian decision|0|||
161434861|NCT02559622|582986082|FG003|Overall Study|Patient/guardian decision|1|||
161434862|NCT04011540|582986083|FG000|Overall Study|Lost to Follow-up|9|||
161434863|NCT04011540|582986084|FG001|Overall Study|Lost to Follow-up|6|||
161434864|NCT00449696|582986085|FG000|Overall Study|Other Treatment Required|6|||
161434865|NCT00449696|582986086|FG001|Overall Study|Other Treatment Required|1|||
161434866|NCT00449696|582986085|FG000|Overall Study|Withdrawal by Subject|5|||
161434867|NCT00449696|582986086|FG001|Overall Study|Withdrawal by Subject|5|||
161434868|NCT00449696|582986085|FG000|Overall Study|Lost to Follow-up|2|||
161434869|NCT00449696|582986086|FG001|Overall Study|Lost to Follow-up|3|||
161434870|NCT00449696|582986085|FG000|Overall Study|Others|7|||
161434871|NCT00449696|582986086|FG001|Overall Study|Others|0|||
161434872|NCT01033019|582986089|FG000|Overall Study|Withdrawal by Subject|1|||
161434873|NCT01033019|582986090|FG001|Overall Study|Withdrawal by Subject|0|||
161434874|NCT01339832|582986091|FG000|Overall Study|Lost to Follow-up|3|||
161434875|NCT01339832|582986091|FG000|Overall Study|Death|11|||
161434876|NCT01052493|582986092|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
161434877|NCT01052493|582986093|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
161434878|NCT01052493|582986094|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
161434879|NCT01075243|582986100|FG000|Overall Study|Lost to Follow-up|5|||
161434880|NCT01075243|582986101|FG001|Overall Study|Lost to Follow-up|2|||
161434881|NCT01075243|582986102|FG002|Overall Study|Lost to Follow-up|0|||
161434882|NCT01075243|582986100|FG000|Overall Study|Withdrawal by Subject|1|||
161434883|NCT01075243|582986101|FG001|Overall Study|Withdrawal by Subject|1|||
161434884|NCT01075243|582986102|FG002|Overall Study|Withdrawal by Subject|0|||
161434885|NCT00551642|582986103|FG000|Treatment Period|Protocol Deviation|6|||
161434886|NCT00551642|582986104|FG001|Treatment Period|Protocol Deviation|11|||
161434887|NCT00551642|582986103|FG000|Treatment Period|Delivery device failure|1|||
161434888|NCT00551642|582986104|FG001|Treatment Period|Delivery device failure|3|||
161434889|NCT00551642|582986103|FG000|Treatment Period|Physician Decision|0|||
161434890|NCT00551642|582986104|FG001|Treatment Period|Physician Decision|1|||
161434891|NCT00551642|582986103|FG000|Treatment Period|Death|33|||
161434892|NCT00551642|582986104|FG001|Treatment Period|Death|31|||
161434893|NCT00551642|582986103|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
161434894|NCT00551642|582986104|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
161434895|NCT00551642|582986103|FG000|Treatment Period|Adverse Event|15|||
161434896|NCT00551642|582986104|FG001|Treatment Period|Adverse Event|12|||
161434897|NCT00551642|582986103|FG000|Treatment Period|Withdrawal by Subject|2|||
161434898|NCT00551642|582986104|FG001|Treatment Period|Withdrawal by Subject|1|||
161434899|NCT05386329|582986105|FG000|Overall Study|Lost to Follow-up|3|||
161434900|NCT00888134|582986106|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
161434901|NCT00888134|582986106|FG000|Follow-up|being followed for long-term survival|1|||
161434902|NCT04973449|582986111|FG000|Overall Study|Withdrawal by Subject|3|||
161434903|NCT04973449|582986112|FG001|Overall Study|Withdrawal by Subject|3|||
161434904|NCT04973449|582986113|FG002|Overall Study|Withdrawal by Subject|2|||
161434905|NCT04973449|582986114|FG003|Overall Study|Withdrawal by Subject|5|||
161434906|NCT04973449|582986115|FG004|Overall Study|Withdrawal by Subject|5|||
161434907|NCT04973449|582986116|FG005|Overall Study|Withdrawal by Subject|4|||
161434908|NCT04973449|582986117|FG006|Overall Study|Withdrawal by Subject|7|||
161434909|NCT04973449|582986118|FG007|Overall Study|Withdrawal by Subject|5|||
161434910|NCT04973449|582986111|FG000|Overall Study|Lost to Follow-up|15|||
161434911|NCT04973449|582986112|FG001|Overall Study|Lost to Follow-up|16|||
161434912|NCT04973449|582986113|FG002|Overall Study|Lost to Follow-up|16|||
161434913|NCT04973449|582986114|FG003|Overall Study|Lost to Follow-up|13|||
161434914|NCT04973449|582986115|FG004|Overall Study|Lost to Follow-up|5|||
161434915|NCT04973449|582986116|FG005|Overall Study|Lost to Follow-up|6|||
161434916|NCT04973449|582986117|FG006|Overall Study|Lost to Follow-up|10|||
161434917|NCT04973449|582986118|FG007|Overall Study|Lost to Follow-up|6|||
161434918|NCT04973449|582986111|FG000|Overall Study|Death|1|||
161434919|NCT04973449|582986112|FG001|Overall Study|Death|0|||
161434920|NCT04973449|582986113|FG002|Overall Study|Death|0|||
161434921|NCT04973449|582986114|FG003|Overall Study|Death|0|||
161434922|NCT04973449|582986115|FG004|Overall Study|Death|0|||
161434923|NCT04973449|582986116|FG005|Overall Study|Death|1|||
161434924|NCT04973449|582986117|FG006|Overall Study|Death|0|||
161434925|NCT04973449|582986118|FG007|Overall Study|Death|0|||
161434926|NCT04973449|582986111|FG000|Overall Study|Other|1|||
161434927|NCT04973449|582986112|FG001|Overall Study|Other|1|||
161434928|NCT04973449|582986113|FG002|Overall Study|Other|2|||
161434929|NCT04973449|582986114|FG003|Overall Study|Other|1|||
161434930|NCT04973449|582986115|FG004|Overall Study|Other|4|||
161434931|NCT04973449|582986116|FG005|Overall Study|Other|0|||
161434932|NCT04973449|582986117|FG006|Overall Study|Other|2|||
161434933|NCT04973449|582986118|FG007|Overall Study|Other|2|||
161434934|NCT01488890|582986119|FG000|Overall Study|Serious adverse event|2|||
161434935|NCT01488890|582986120|FG001|Overall Study|Serious adverse event|0|||
161434936|NCT01488890|582986121|FG002|Overall Study|Serious adverse event|0|||
161434937|NCT01488890|582986122|FG003|Overall Study|Serious adverse event|0|||
161434938|NCT01488890|582986119|FG000|Overall Study|Protocol Violation|3|||
161434939|NCT01488890|582986120|FG001|Overall Study|Protocol Violation|0|||
161434940|NCT01488890|582986121|FG002|Overall Study|Protocol Violation|4|||
161434941|NCT01488890|582986122|FG003|Overall Study|Protocol Violation|0|||
161434942|NCT01488890|582986119|FG000|Overall Study|Lost to Follow-up|13|||
161434943|NCT01488890|582986120|FG001|Overall Study|Lost to Follow-up|10|||
161434944|NCT01488890|582986121|FG002|Overall Study|Lost to Follow-up|20|||
161434945|NCT01488890|582986122|FG003|Overall Study|Lost to Follow-up|3|||
161434946|NCT01488890|582986119|FG000|Overall Study|Withdrawal by Subject|14|||
161434947|NCT01488890|582986120|FG001|Overall Study|Withdrawal by Subject|10|||
161434948|NCT01488890|582986121|FG002|Overall Study|Withdrawal by Subject|11|||
161434949|NCT01488890|582986122|FG003|Overall Study|Withdrawal by Subject|2|||
161434950|NCT02532517|582986123|FG000|Overall Study|Did not complete 24-Month visit|4|||
161434951|NCT02532517|582986123|FG000|Overall Study|Failed Angiographic eligibility|1|||
161434952|NCT02532517|582986123|FG000|Overall Study|Lost to Follow-up|4|||
161434953|NCT02532517|582986123|FG000|Overall Study|Withdrawal by Subject|4|||
161434954|NCT02532517|582986123|FG000|Overall Study|Death|4|||
161434955|NCT03694353|582986124|FG000|Overall Study|Withdrawal by Subject|1|||
161434956|NCT03694353|582986124|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
161434957|NCT03804528|582986125|FG000|Overall Study|Time Commitment|18|||
161434958|NCT03804528|582986125|FG000|Overall Study|Health Reasons|5|||
161434959|NCT05138653|582986126|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
161434960|NCT05138653|582986127|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434961|NCT05138653|582986128|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434962|NCT05138653|582986129|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434963|NCT05138653|582986130|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434964|NCT05138653|582986131|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434965|NCT05138653|582986132|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434966|NCT05138653|582986133|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434967|NCT05138653|582986134|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434968|NCT05138653|582986135|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434969|NCT05138653|582986136|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434970|NCT05138653|582986137|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434971|NCT05138653|582986138|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434972|NCT05138653|582986139|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434973|NCT05138653|582986140|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434974|NCT05138653|582986141|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161434975|NCT05138653|582986126|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434976|NCT05138653|582986127|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
161434977|NCT05138653|582986128|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434978|NCT05138653|582986129|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434979|NCT05138653|582986130|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434980|NCT05138653|582986131|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434981|NCT05138653|582986132|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434982|NCT05138653|582986133|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434983|NCT05138653|582986134|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
161434984|NCT05138653|582986135|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434985|NCT05138653|582986136|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434986|NCT05138653|582986137|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434987|NCT05138653|582986138|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434988|NCT05138653|582986139|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434989|NCT05138653|582986140|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434990|NCT05138653|582986141|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161434991|NCT05138653|582986126|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161434992|NCT05138653|582986127|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
161434993|NCT05138653|582986128|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161434994|NCT05138653|582986129|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161434995|NCT05138653|582986130|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
161434996|NCT05138653|582986131|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161434997|NCT05138653|582986132|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161434998|NCT05138653|582986133|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161434999|NCT05138653|582986134|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435000|NCT05138653|582986135|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435001|NCT05138653|582986136|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435002|NCT05138653|582986137|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435003|NCT05138653|582986138|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435004|NCT05138653|582986139|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435005|NCT05138653|582986140|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435006|NCT05138653|582986141|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161435007|NCT05138653|582986126|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435008|NCT05138653|582986127|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435009|NCT05138653|582986128|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435010|NCT05138653|582986129|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435011|NCT05138653|582986130|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435012|NCT05138653|582986131|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435013|NCT05138653|582986132|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
161435014|NCT05138653|582986133|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435015|NCT05138653|582986134|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435016|NCT05138653|582986135|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435017|NCT05138653|582986136|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435018|NCT05138653|582986137|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435019|NCT05138653|582986138|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435020|NCT05138653|582986139|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435021|NCT05138653|582986140|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435022|NCT05138653|582986141|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
161435023|NCT05138653|582986126|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435024|NCT05138653|582986127|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435025|NCT05138653|582986128|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435026|NCT05138653|582986129|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435027|NCT05138653|582986130|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435028|NCT05138653|582986131|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435029|NCT05138653|582986132|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435030|NCT05138653|582986133|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435031|NCT05138653|582986134|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435032|NCT05138653|582986135|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435033|NCT05138653|582986136|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
161435034|NCT05138653|582986137|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435035|NCT05138653|582986138|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
161435036|NCT05138653|582986139|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435037|NCT05138653|582986140|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
161435038|NCT05138653|582986141|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
161435039|NCT05138653|582986126|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435948|NCT04050553|582989735|FG000|Wash-out|Withdrawal by Subject|0|||
161435040|NCT05138653|582986127|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435041|NCT05138653|582986128|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435042|NCT05138653|582986129|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435043|NCT05138653|582986130|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435044|NCT05138653|582986131|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435045|NCT05138653|582986132|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435046|NCT05138653|582986133|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435047|NCT05138653|582986134|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435048|NCT05138653|582986135|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435049|NCT05138653|582986136|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435050|NCT05138653|582986137|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435051|NCT05138653|582986138|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435052|NCT05138653|582986139|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435053|NCT05138653|582986140|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
161435054|NCT05138653|582986141|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
161435055|NCT05138653|582986126|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435056|NCT05138653|582986127|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435057|NCT05138653|582986128|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435058|NCT05138653|582986129|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435059|NCT05138653|582986130|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435060|NCT05138653|582986131|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435061|NCT05138653|582986132|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435062|NCT05138653|582986133|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435063|NCT05138653|582986134|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435064|NCT05138653|582986135|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435065|NCT05138653|582986136|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435066|NCT05138653|582986137|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435067|NCT05138653|582986138|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435068|NCT05138653|582986139|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
161435069|NCT05138653|582986140|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435070|NCT05138653|582986141|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
161435071|NCT03204188|582986147|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
161435072|NCT03204188|582986147|FG000|Immunotherapy Phase (1 Year)|Death|1|||
161435073|NCT03204188|582986147|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
161435074|NCT03204188|582986147|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
161435075|NCT01520506|582987924|FG000|Overall Study|Missed Visit|4|||
161435076|NCT01520506|582987924|FG000|Overall Study|Lost to Follow-up|1|||
161435077|NCT01520506|582987924|FG000|Overall Study|Withdrawal by Subject|1|||
161435078|NCT00906204|582987925|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
161435079|NCT00906204|582987926|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
161435080|NCT00906204|582987925|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
161435081|NCT00906204|582987926|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
161435082|NCT00906204|582987925|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
161435083|NCT00906204|582987926|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
161435084|NCT00906204|582987925|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
161435085|NCT00906204|582987926|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
161435086|NCT00906204|582987925|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
161435087|NCT00906204|582987926|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
161435088|NCT00696072|582987927|FG000|Overall Study|continuing active treatment|10|||
161435089|NCT00696072|582987928|FG001|Overall Study|continuing active treatment|13|||
161435090|NCT00696072|582987927|FG000|Overall Study|Adverse Event|10|||
161435091|NCT00696072|582987928|FG001|Overall Study|Adverse Event|6|||
161435092|NCT00696072|582987927|FG000|Overall Study|Patient Request|3|||
161435093|NCT00696072|582987928|FG001|Overall Study|Patient Request|7|||
161435094|NCT00696072|582987927|FG000|Overall Study|Investigator Request|1|||
161435095|NCT00696072|582987928|FG001|Overall Study|Investigator Request|4|||
161435096|NCT00696072|582987927|FG000|Overall Study|Sponsor Request|0|||
161435097|NCT00696072|582987928|FG001|Overall Study|Sponsor Request|1|||
161435098|NCT00696072|582987927|FG000|Overall Study|Disease Progression|32|||
161435099|NCT00696072|582987928|FG001|Overall Study|Disease Progression|30|||
161435100|NCT00696072|582987927|FG000|Overall Study|Non-specified|1|||
161435101|NCT00696072|582987928|FG001|Overall Study|Non-specified|2|||
161435102|NCT01597596|582987929|FG000|Overall Study|Study terminated by sponsor|1|||
161435103|NCT01597596|582987930|FG001|Overall Study|Study terminated by sponsor|0|||
161435104|NCT01597596|582987929|FG000|Overall Study|Physician Decision|0|||
161435105|NCT01597596|582987930|FG001|Overall Study|Physician Decision|1|||
161435106|NCT00124943|582987931|FG000|Phase II|Adverse Event|0|||
161435107|NCT00124943|582987932|FG001|Phase II|Adverse Event|2|||
161435108|NCT00124943|582987933|FG002|Phase II|Adverse Event|0|||
161435109|NCT00124943|582987934|FG003|Phase II|Adverse Event|1|||
161435110|NCT00124943|582987931|FG000|Phase II|Protocol Violation|0|||
161435111|NCT00124943|582987932|FG001|Phase II|Protocol Violation|0|||
161435112|NCT00124943|582987933|FG002|Phase II|Protocol Violation|0|||
161435113|NCT00124943|582987934|FG003|Phase II|Protocol Violation|1|||
161435114|NCT00124943|582987931|FG000|Phase II|Lost to Follow-up|0|||
161435115|NCT00124943|582987932|FG001|Phase II|Lost to Follow-up|0|||
161435116|NCT00124943|582987933|FG002|Phase II|Lost to Follow-up|0|||
161435117|NCT00124943|582987934|FG003|Phase II|Lost to Follow-up|1|||
161435118|NCT00124943|582987931|FG000|Phase II|Withdrawal by Subject|0|||
161435119|NCT00124943|582987932|FG001|Phase II|Withdrawal by Subject|0|||
161435120|NCT00124943|582987933|FG002|Phase II|Withdrawal by Subject|0|||
161435121|NCT00124943|582987934|FG003|Phase II|Withdrawal by Subject|2|||
161435122|NCT03181932|582987935|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
161435123|NCT03181932|582987936|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
161435124|NCT03181932|582987935|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
161435125|NCT03181932|582987936|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
161435126|NCT03181932|582987935|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
161435127|NCT03181932|582987936|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
161435128|NCT03181932|582987935|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
161435129|NCT03181932|582987936|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
161435130|NCT03181932|582987935|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
161435131|NCT03181932|582987936|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
161435132|NCT03181932|582987935|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
161435133|NCT03181932|582987936|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
161435134|NCT03181932|582987935|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
161435135|NCT03181932|582987936|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
161435136|NCT03181932|582987935|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
161435137|NCT03181932|582987936|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
161435138|NCT03181932|582987935|FG000|Period 2 (Open-label Period)|Reason missing|2|||
161435139|NCT03181932|582987936|FG001|Period 2 (Open-label Period)|Reason missing|0|||
161435140|NCT00408317|582987943|FG000|First Intervention Period|Adverse Event|0|||
161435141|NCT00408317|582987944|FG001|First Intervention Period|Adverse Event|1|||
161435142|NCT00408317|582987943|FG000|Second Intervention Period|Adverse Event|2|||
161435143|NCT00408317|582987944|FG001|Second Intervention Period|Adverse Event|0|||
161435144|NCT00408317|582987943|FG000|Second Intervention Period|Protocol Violation|0|||
161435145|NCT00408317|582987944|FG001|Second Intervention Period|Protocol Violation|1|||
161435146|NCT00408317|582987943|FG000|Second Intervention Period|Withdrawal of consent|0|||
161435147|NCT00408317|582987944|FG001|Second Intervention Period|Withdrawal of consent|1|||
161435148|NCT00360230|582987951|FG000|Overall Study|Withdrawal by Subject|1|||
161435149|NCT00360230|582987952|FG001|Overall Study|Withdrawal by Subject|1|||
161435150|NCT00360230|582987953|FG002|Overall Study|Withdrawal by Subject|0|||
161435151|NCT00360230|582987954|FG003|Overall Study|Withdrawal by Subject|1|||
161435152|NCT00360230|582987955|FG004|Overall Study|Withdrawal by Subject|1|||
161435153|NCT00360230|582987956|FG005|Overall Study|Withdrawal by Subject|1|||
161435154|NCT00360230|582987957|FG006|Overall Study|Withdrawal by Subject|0|||
161435155|NCT00360230|582987951|FG000|Overall Study|Migrated|4|||
161435156|NCT00360230|582987952|FG001|Overall Study|Migrated|1|||
161435157|NCT00360230|582987953|FG002|Overall Study|Migrated|3|||
161435158|NCT00360230|582987954|FG003|Overall Study|Migrated|1|||
161435159|NCT00360230|582987955|FG004|Overall Study|Migrated|4|||
161435160|NCT00360230|582987956|FG005|Overall Study|Migrated|1|||
161435161|NCT00360230|582987957|FG006|Overall Study|Migrated|1|||
161435162|NCT00360230|582987951|FG000|Overall Study|Other|1|||
161435163|NCT00360230|582987952|FG001|Overall Study|Other|0|||
161435164|NCT00360230|582987953|FG002|Overall Study|Other|0|||
161435165|NCT00360230|582987954|FG003|Overall Study|Other|0|||
161435166|NCT00360230|582987955|FG004|Overall Study|Other|0|||
161435167|NCT00360230|582987956|FG005|Overall Study|Other|0|||
161435168|NCT00360230|582987957|FG006|Overall Study|Other|0|||
161435169|NCT00360230|582987951|FG000|Overall Study|Protocol Violation|0|||
161435170|NCT00360230|582987952|FG001|Overall Study|Protocol Violation|0|||
161435171|NCT00360230|582987953|FG002|Overall Study|Protocol Violation|0|||
161435172|NCT00360230|582987954|FG003|Overall Study|Protocol Violation|0|||
161435173|NCT00360230|582987955|FG004|Overall Study|Protocol Violation|0|||
161435174|NCT00360230|582987956|FG005|Overall Study|Protocol Violation|1|||
161435175|NCT00360230|582987957|FG006|Overall Study|Protocol Violation|0|||
161435176|NCT00360230|582987951|FG000|Overall Study|Death|0|||
161435177|NCT00360230|582987952|FG001|Overall Study|Death|1|||
161435178|NCT00360230|582987953|FG002|Overall Study|Death|0|||
161435179|NCT00360230|582987954|FG003|Overall Study|Death|0|||
161435180|NCT00360230|582987955|FG004|Overall Study|Death|0|||
161435181|NCT00360230|582987956|FG005|Overall Study|Death|1|||
161435182|NCT00360230|582987957|FG006|Overall Study|Death|1|||
161435183|NCT02703597|582987958|FG000|Assignment to Baseline|Lost to Follow-up|17|||
161435184|NCT02703597|582987959|FG001|Assignment to Baseline|Lost to Follow-up|16|||
161435185|NCT02703597|582987958|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
161435186|NCT02703597|582987959|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
161435187|NCT02703597|582987958|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
161435188|NCT02703597|582987959|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
161435189|NCT02703597|582987958|FG000|First Post-test to First Follow-up|Site drop out|0|||
161435190|NCT02703597|582987959|FG001|First Post-test to First Follow-up|Site drop out|58|||
161435191|NCT02703597|582987958|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
161435192|NCT02703597|582987959|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
161435193|NCT02703597|582987958|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
161435194|NCT02703597|582987959|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
161435195|NCT02703597|582987958|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
161435196|NCT02703597|582987959|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
161435197|NCT00581308|582987960|FG000|Pre Discharge|Lost to Follow-up|1|||
161435198|NCT00581308|582987960|FG000|Pre Discharge|Device Removed|1|||
161435199|NCT00581308|582987960|FG000|Month 1|Lost to Follow-up|3|||
161435200|NCT00581308|582987960|FG000|Month 1|Withdrawal by Subject|2|||
161435201|NCT00581308|582987960|FG000|Month 1|Device Removed|2|||
161435202|NCT00581308|582987960|FG000|Month 1|Uknown|1|||
161435203|NCT00581308|582987960|FG000|Month 6|Lost to Follow-up|1|||
161435204|NCT00581308|582987960|FG000|Month 6|Withdrawal by Subject|2|||
161435205|NCT00581308|582987960|FG000|Month 12|Death|1|||
161435206|NCT00581308|582987960|FG000|Month 12|Lost to Follow-up|14|||
161435207|NCT00581308|582987960|FG000|Month 12|Withdrawal by Subject|3|||
161435208|NCT00581308|582987960|FG000|Month 12|Device Removed|1|||
161435209|NCT00581308|582987960|FG000|Month 12|Other|1|||
161435210|NCT02006472|582987961|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
161435211|NCT02006472|582987962|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
161435212|NCT02006472|582987963|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
161435213|NCT02006472|582987964|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
161435214|NCT02006472|582987965|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
161435215|NCT02006472|582987961|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
161435216|NCT02006472|582987962|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
161435217|NCT02006472|582987963|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
161435218|NCT02006472|582987964|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
161435219|NCT02006472|582987965|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
161435220|NCT02006472|582987961|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
161435221|NCT02006472|582987962|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
161435222|NCT02006472|582987963|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
161435223|NCT02006472|582987964|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
161435224|NCT02006472|582987965|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
161435225|NCT02006472|582987961|FG000|Period 1 (Through Week 26)|Other|1|||
161435226|NCT02006472|582987962|FG001|Period 1 (Through Week 26)|Other|5|||
161435227|NCT02006472|582987963|FG002|Period 1 (Through Week 26)|Other|0|||
161435228|NCT02006472|582987964|FG003|Period 1 (Through Week 26)|Other|2|||
161435229|NCT02006472|582987965|FG004|Period 1 (Through Week 26)|Other|3|||
161435230|NCT02006472|582987961|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
161435231|NCT02006472|582987962|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
161435232|NCT02006472|582987963|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
161435233|NCT02006472|582987964|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
161435234|NCT02006472|582987965|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
161435235|NCT02006472|582987961|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
161435236|NCT02006472|582987962|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
161435237|NCT02006472|582987963|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
161435238|NCT02006472|582987964|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
161435239|NCT02006472|582987965|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
161435240|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
161435241|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
161435242|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
161435243|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
161435244|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
161435245|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
161435246|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
161435247|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
161435248|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
161435249|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
161435250|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
161435251|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
161435252|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
161435253|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
161435254|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
161435255|NCT02006472|582987961|FG000|Period 2 (Through Week 52)|Other|0|||
161435256|NCT02006472|582987962|FG001|Period 2 (Through Week 52)|Other|1|||
161435257|NCT02006472|582987963|FG002|Period 2 (Through Week 52)|Other|0|||
161435258|NCT02006472|582987964|FG003|Period 2 (Through Week 52)|Other|1|||
161435259|NCT02006472|582987965|FG004|Period 2 (Through Week 52)|Other|0|||
161435341|NCT03104868|582988001|FG001|6 Week Follow up|Withdrawal by Subject|6|||
161435342|NCT03104868|582988000|FG000|6 Week Follow up|Completed Later Timepoint|24|||
161435343|NCT03104868|582988001|FG001|6 Week Follow up|Completed Later Timepoint|22|||
161435344|NCT03104868|582988000|FG000|6 Month Follow up|Lost to Follow-up|2|||
161435345|NCT03104868|582988001|FG001|6 Month Follow up|Lost to Follow-up|2|||
161435346|NCT03104868|582988000|FG000|6 Month Follow up|Death|0|||
161435347|NCT03104868|582988001|FG001|6 Month Follow up|Death|1|||
161435348|NCT03104868|582988000|FG000|6 Month Follow up|Completed Later Timepoint|22|||
161435349|NCT03104868|582988001|FG001|6 Month Follow up|Completed Later Timepoint|32|||
161435350|NCT03104868|582988000|FG000|12 Month Follow up|Lost to Follow-up|1|||
161435351|NCT03104868|582988001|FG001|12 Month Follow up|Lost to Follow-up|2|||
161435352|NCT03104868|582988000|FG000|12 Month Follow up|Death|0|||
161435353|NCT03104868|582988001|FG001|12 Month Follow up|Death|1|||
161435354|NCT03104868|582988000|FG000|12 Month Follow up|Withdrawal by Subject|0|||
161435355|NCT03104868|582988001|FG001|12 Month Follow up|Withdrawal by Subject|3|||
161435356|NCT03104868|582988000|FG000|12 Month Follow up|Completed Later Timepoint|32|||
161435357|NCT03104868|582988001|FG001|12 Month Follow up|Completed Later Timepoint|29|||
161435358|NCT03104868|582988000|FG000|18 Month Follow up|Lost to Follow-up|7|||
161435359|NCT03104868|582988001|FG001|18 Month Follow up|Lost to Follow-up|11|||
161435360|NCT03104868|582988000|FG000|18 Month Follow up|Death|2|||
161435361|NCT03104868|582988001|FG001|18 Month Follow up|Death|1|||
161435362|NCT03104868|582988000|FG000|18 Month Follow up|Withdrawal by Subject|1|||
161435363|NCT03104868|582988001|FG001|18 Month Follow up|Withdrawal by Subject|2|||
161435364|NCT03104868|582988000|FG000|18 Month Follow up|Graft Loss|1|||
161435365|NCT03104868|582988001|FG001|18 Month Follow up|Graft Loss|1|||
161435366|NCT03104868|582988000|FG000|18 Month Follow up|Completed Later Timepoint|19|||
161435367|NCT03104868|582988001|FG001|18 Month Follow up|Completed Later Timepoint|20|||
161435368|NCT03104868|582988000|FG000|24 Month Follow up|Lost to Follow-up|15|||
161435369|NCT03104868|582988001|FG001|24 Month Follow up|Lost to Follow-up|16|||
161435370|NCT03104868|582988000|FG000|24 Month Follow up|Death|3|||
161435371|NCT03104868|582988001|FG001|24 Month Follow up|Death|2|||
161435372|NCT03104868|582988000|FG000|24 Month Follow up|Withdrawal by Subject|1|||
161435373|NCT03104868|582988001|FG001|24 Month Follow up|Withdrawal by Subject|0|||
161435374|NCT03104868|582988000|FG000|24 Month Follow up|Graft Loss|2|||
161435375|NCT03104868|582988001|FG001|24 Month Follow up|Graft Loss|0|||
161435376|NCT00888173|582988005|FG000|Overall Study|Wrong Primary|1|||
161435377|NCT00888173|582988005|FG000|Overall Study|Ineligible: required test not done|1|||
161435378|NCT02059278|582988006|FG000|Overall Study|Adverse Event|1|||
161435379|NCT02059278|582988007|FG001|Overall Study|Adverse Event|1|||
161435380|NCT02059278|582988006|FG000|Overall Study|Lost to Follow-up|1|||
161435381|NCT02059278|582988007|FG001|Overall Study|Lost to Follow-up|0|||
161435382|NCT02059278|582988006|FG000|Overall Study|Withdrawal by Subject|0|||
161435383|NCT02059278|582988007|FG001|Overall Study|Withdrawal by Subject|3|||
161435384|NCT02059278|582988006|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
161435385|NCT02059278|582988007|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
161435386|NCT00829426|582988008|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161435387|NCT00829426|582988009|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161435388|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
161435389|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
161435390|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
161435391|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
161435392|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Adverse Event|2|||
161435393|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Adverse Event|5|||
161435394|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Adverse Event|1|||
161435395|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Adverse Event|2|||
161435396|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Death|13|||
161435397|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Death|17|||
161435398|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Death|1|||
161435399|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Death|0|||
161435400|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
161435401|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
161435402|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
161435403|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
161435404|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Disease Progression|2|||
161435405|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Disease Progression|0|||
161435406|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Disease Progression|0|||
161435407|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Disease Progression|0|||
161435408|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
161435409|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
161435410|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
161435411|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
161435412|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
161435413|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
161435414|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
161435415|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
161435416|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
161435417|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
161435418|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
161435419|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
161435420|NCT03955146|582988010|FG000|DB Period (48 Weeks)|Participant Decision|9|||
161435421|NCT03955146|582988011|FG001|DB Period (48 Weeks)|Participant Decision|12|||
161435422|NCT03955146|582988012|FG002|DB Period (48 Weeks)|Participant Decision|1|||
161435423|NCT03955146|582988013|FG003|DB Period (48 Weeks)|Participant Decision|1|||
161435424|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
161435425|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
161435426|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
161435427|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
161435428|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
161435429|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
161435430|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
161435431|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
161435432|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
161435433|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
161435434|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
161435435|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
161435436|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
161435437|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
161435438|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
161435439|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
161435440|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
161435441|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
161435442|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
161435443|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
161435444|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
161435445|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
161435446|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
161435447|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
161435448|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
161435449|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
161435450|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
161435451|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
161435452|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
161435453|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
161435454|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
161435455|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
161435456|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
161435457|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
161435458|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
161435459|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
161435460|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
161435461|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
161435462|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
161435463|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
161435464|NCT03955146|582988010|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
161435465|NCT03955146|582988011|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
161435466|NCT03955146|582988012|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
161435467|NCT03955146|582988013|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
161435468|NCT04408989|582988014|FG000|Overall Study|Lost to Follow-up|0|||
161435469|NCT04408989|582988015|FG001|Overall Study|Lost to Follow-up|0|||
161435470|NCT04408989|582988016|FG002|Overall Study|Lost to Follow-up|1|||
161435471|NCT04408989|582988014|FG000|Overall Study|Withdrawal by Subject|0|||
161435472|NCT04408989|582988015|FG001|Overall Study|Withdrawal by Subject|0|||
161435473|NCT04408989|582988016|FG002|Overall Study|Withdrawal by Subject|2|||
161435474|NCT04363320|582988019|FG000|Overall Study|Lost to Follow-up|43|||
161435475|NCT04363320|582988020|FG001|Overall Study|Lost to Follow-up|42|||
161435476|NCT04363320|582988021|FG002|Overall Study|Lost to Follow-up|24|||
161435477|NCT04363320|582988022|FG003|Overall Study|Lost to Follow-up|29|||
161435478|NCT04363320|582988019|FG000|Overall Study|Death|0|||
161435479|NCT04363320|582988020|FG001|Overall Study|Death|0|||
161435480|NCT04363320|582988021|FG002|Overall Study|Death|1|||
161435481|NCT04363320|582988022|FG003|Overall Study|Death|0|||
161435482|NCT00604565|582988026|FG000|Overall Study|Study terminated|0|||
161435483|NCT00604565|582988027|FG001|Overall Study|Study terminated|3|||
161435484|NCT02260934|582988037|FG000|Overall Study|Lost to Follow-up|2|||
161435485|NCT02260934|582988038|FG001|Overall Study|Lost to Follow-up|1|||
161435486|NCT02260934|582988037|FG000|Overall Study|Withdrawal by Subject|0|||
161435487|NCT02260934|582988038|FG001|Overall Study|Withdrawal by Subject|2|||
161435488|NCT02260934|582988037|FG000|Overall Study|Participant Relocated|1|||
161435489|NCT02260934|582988038|FG001|Overall Study|Participant Relocated|0|||
161435490|NCT02260934|582988037|FG000|Overall Study|Site error|0|||
161435491|NCT02260934|582988038|FG001|Overall Study|Site error|1|||
161435492|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
161435493|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
161435494|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
161435495|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
161435496|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
161435497|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
161435498|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
161435499|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
161435500|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
161435501|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
161435502|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
161435503|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
161435504|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
161435505|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
161435506|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
161435507|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
161435508|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
161435509|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
161435510|NCT03605667|582988041|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
161435511|NCT03605667|582988042|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
161435512|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
161435513|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
161435514|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Other|6|||
161435515|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Other|8|||
161435516|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
161435517|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
161435518|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
161435519|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
161435520|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
161435521|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
161435522|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
161435523|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
161435524|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
161435525|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
161435526|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
161435527|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
161435528|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Death|0|||
161435529|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Death|2|||
161435530|NCT03605667|582988041|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
161435531|NCT03605667|582988042|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
161435532|NCT05632211|582988043|FG000|Overall Study|Withdrawal by Subject|2|||
161435533|NCT05632211|582988044|FG001|Overall Study|Withdrawal by Subject|0|||
161435534|NCT05632211|582988045|FG002|Overall Study|Withdrawal by Subject|2|||
161435535|NCT05632211|582988043|FG000|Overall Study|Other reasons|1|||
161435536|NCT05632211|582988044|FG001|Overall Study|Other reasons|1|||
161435537|NCT05632211|582988045|FG002|Overall Study|Other reasons|1|||
161435538|NCT02628873|582988046|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
161435539|NCT02628873|582988047|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
161435540|NCT02628873|582988046|FG000|Second Test (1 Hour)|Physician Decision|1|||
161435541|NCT02628873|582988047|FG001|Second Test (1 Hour)|Physician Decision|0|||
161435542|NCT03597347|582988050|FG000|Overall Study|Withdrawal by Subject|1|||
161435543|NCT03597347|582988051|FG001|Overall Study|Withdrawal by Subject|1|||
161435544|NCT03597347|582988052|FG002|Overall Study|Withdrawal by Subject|0|||
161435545|NCT03597347|582988050|FG000|Overall Study|Withdrawal due to Covid-19|3|||
161435546|NCT03597347|582988051|FG001|Overall Study|Withdrawal due to Covid-19|0|||
161435547|NCT03597347|582988052|FG002|Overall Study|Withdrawal due to Covid-19|0|||
161435548|NCT03597347|582988050|FG000|Overall Study|Sponsor decision to terminate study|3|||
161435549|NCT03597347|582988051|FG001|Overall Study|Sponsor decision to terminate study|2|||
161435550|NCT03597347|582988052|FG002|Overall Study|Sponsor decision to terminate study|4|||
161435551|NCT04606134|582988053|FG000|Overall Study|Adverse Event|0|||
161435552|NCT04606134|582988054|FG001|Overall Study|Adverse Event|1|||
161435553|NCT00107653|582988055|FG000|Overall Study|Adverse Event|24|||
161435554|NCT00107653|582988056|FG001|Overall Study|Adverse Event|43|||
161435555|NCT00107653|582988055|FG000|Overall Study|Insufficient Therapeutic Response|25|||
161435556|NCT00107653|582988056|FG001|Overall Study|Insufficient Therapeutic Response|11|||
161435557|NCT00107653|582988055|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161435558|NCT00107653|582988056|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161435561|NCT00107653|582988055|FG000|Overall Study|Withdrawal by Subject|12|||
161435562|NCT00107653|582988056|FG001|Overall Study|Withdrawal by Subject|13|||
161435563|NCT00107653|582988055|FG000|Overall Study|Lost to Follow-up|13|||
161435564|NCT00107653|582988056|FG001|Overall Study|Lost to Follow-up|5|||
161435565|NCT00107653|582988055|FG000|Overall Study|Administrative Reasons|3|||
161435566|NCT00107653|582988056|FG001|Overall Study|Administrative Reasons|3|||
161435567|NCT00541658|582988058|FG000|Overall Study|Adverse Event|28|||
161435568|NCT00541658|582988059|FG001|Overall Study|Adverse Event|37|||
161435569|NCT00541658|582988060|FG002|Overall Study|Adverse Event|25|||
161435570|NCT00541658|582988058|FG000|Overall Study|Physician Decision|0|||
161435571|NCT00541658|582988059|FG001|Overall Study|Physician Decision|0|||
161435572|NCT00541658|582988060|FG002|Overall Study|Physician Decision|4|||
161435573|NCT00541658|582988058|FG000|Overall Study|Lost to Follow-up|3|||
161435574|NCT00541658|582988059|FG001|Overall Study|Lost to Follow-up|3|||
161435575|NCT00541658|582988060|FG002|Overall Study|Lost to Follow-up|6|||
161435576|NCT00541658|582988058|FG000|Overall Study|Protocol Violation|0|||
161435577|NCT00541658|582988059|FG001|Overall Study|Protocol Violation|1|||
161435578|NCT00541658|582988060|FG002|Overall Study|Protocol Violation|1|||
161435579|NCT00541658|582988058|FG000|Overall Study|Withdrawal by Subject|28|||
161435580|NCT00541658|582988059|FG001|Overall Study|Withdrawal by Subject|32|||
161435581|NCT00541658|582988060|FG002|Overall Study|Withdrawal by Subject|32|||
161435582|NCT00541658|582988058|FG000|Overall Study|Took No Study Drug|1|||
161435583|NCT00541658|582988059|FG001|Overall Study|Took No Study Drug|0|||
161435584|NCT00541658|582988060|FG002|Overall Study|Took No Study Drug|0|||
161435585|NCT01099267|582988061|FG000|MDS-003 Study|Adverse Event|37|||
161435586|NCT01099267|582988061|FG000|MDS-003 Study|Lack of Efficacy|52|||
161435587|NCT01099267|582988061|FG000|MDS-003 Study|Withdrawal by Subject|8|||
161435588|NCT01099267|582988061|FG000|MDS-003 Study|Lost to Follow-up|1|||
161435589|NCT01099267|582988061|FG000|MDS-003 Study|Death|11|||
161435590|NCT01099267|582988061|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
161435591|NCT01099267|582988061|FG000|MDS-003 Study|Disease Progression|7|||
161435592|NCT01099267|582988061|FG000|MDS-003 Study|Investigator Decision|2|||
161435593|NCT01099267|582988061|FG000|MDS-003 Study|Non-Compliance|2|||
161435594|NCT01099267|582988061|FG000|MDS-003 Study|Loss of Response|1|||
161435595|NCT01099267|582988061|FG000|MDS-003 Study|Secondary Malign Disease|1|||
161435596|NCT04986904|582988062|FG000|Overall Study|Lost to Follow-up|11|||
161435597|NCT04986904|582988062|FG000|Overall Study|Withdrawal by Subject|1|||
161435598|NCT05194124|582988074|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435599|NCT05194124|582988075|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435600|NCT05194124|582988076|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435601|NCT05194124|582988077|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
161435602|NCT05194124|582988078|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435603|NCT05194124|582988079|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
161435604|NCT05194124|582988080|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435605|NCT05194124|582988081|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435606|NCT05194124|582988082|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435607|NCT05194124|582988083|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
161435608|NCT05194124|582988074|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435609|NCT05194124|582988075|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435610|NCT05194124|582988076|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435611|NCT05194124|582988077|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435612|NCT05194124|582988078|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435613|NCT05194124|582988079|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435614|NCT05194124|582988080|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435615|NCT05194124|582988081|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435616|NCT05194124|582988082|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
161435617|NCT05194124|582988083|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
161435618|NCT05408429|582988088|FG000|Overall Study|Lost to Follow-up|1|||
161435619|NCT05408429|582988089|FG001|Overall Study|Lost to Follow-up|1|||
161435620|NCT05408429|582988090|FG002|Overall Study|Lost to Follow-up|0|||
161435621|NCT05408429|582988088|FG000|Overall Study|Withdrawal by Subject|5|||
161435622|NCT05408429|582988089|FG001|Overall Study|Withdrawal by Subject|0|||
161435623|NCT05408429|582988090|FG002|Overall Study|Withdrawal by Subject|1|||
161435624|NCT03642873|582988091|FG000|Third Intervention (1 Day)|Screen failure|0|||
161435625|NCT03642873|582988092|FG001|Third Intervention (1 Day)|Screen failure|0|||
161435626|NCT03642873|582988093|FG002|Third Intervention (1 Day)|Screen failure|0|||
161435627|NCT03642873|582988094|FG003|Third Intervention (1 Day)|Screen failure|0|||
161435628|NCT03642873|582988095|FG004|Third Intervention (1 Day)|Screen failure|1|||
161435629|NCT03642873|582988096|FG005|Third Intervention (1 Day)|Screen failure|0|||
161435630|NCT03312231|582988097|FG000|Overall Study|Lost to Follow-up|2|||
161435631|NCT03312231|582988098|FG001|Overall Study|Lost to Follow-up|6|||
161435632|NCT03312231|582988099|FG002|Overall Study|Lost to Follow-up|1|||
161435633|NCT03312231|582988100|FG003|Overall Study|Lost to Follow-up|3|||
161435634|NCT03312231|582988101|FG004|Overall Study|Lost to Follow-up|1|||
161435635|NCT03312231|582988097|FG000|Overall Study|Withdrawal by Subject|0|||
161435636|NCT03312231|582988098|FG001|Overall Study|Withdrawal by Subject|3|||
161435637|NCT03312231|582988099|FG002|Overall Study|Withdrawal by Subject|1|||
161435638|NCT03312231|582988100|FG003|Overall Study|Withdrawal by Subject|0|||
161435639|NCT03312231|582988101|FG004|Overall Study|Withdrawal by Subject|0|||
161435640|NCT03312231|582988097|FG000|Overall Study|Death|0|||
161435641|NCT03312231|582988098|FG001|Overall Study|Death|1|||
161435642|NCT03312231|582988099|FG002|Overall Study|Death|1|||
161435643|NCT03312231|582988100|FG003|Overall Study|Death|0|||
161435644|NCT03312231|582988101|FG004|Overall Study|Death|0|||
161435645|NCT03312231|582988097|FG000|Overall Study|Study Vaccination not Received|1|||
161435646|NCT03312231|582988098|FG001|Overall Study|Study Vaccination not Received|1|||
161435647|NCT03312231|582988099|FG002|Overall Study|Study Vaccination not Received|1|||
161435648|NCT03312231|582988100|FG003|Overall Study|Study Vaccination not Received|0|||
161435649|NCT03312231|582988101|FG004|Overall Study|Study Vaccination not Received|0|||
161435650|NCT03157830|582988105|FG000|Overall Study|Lost to Follow-up|1|||
161435651|NCT03157830|582988105|FG000|Overall Study|Withdrawal by Subject|1|||
161435652|NCT04607005|582988110|FG000|Overall Study|Adverse Event|0|||
161435653|NCT04607005|582988111|FG001|Overall Study|Adverse Event|1|||
161435654|NCT04607005|582988110|FG000|Overall Study|Lack of Efficacy|1|||
161435655|NCT04607005|582988111|FG001|Overall Study|Lack of Efficacy|6|||
161435656|NCT04607005|582988110|FG000|Overall Study|Withdrawal by Subject|4|||
161435657|NCT04607005|582988111|FG001|Overall Study|Withdrawal by Subject|9|||
161435658|NCT04607005|582988110|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
161435659|NCT04607005|582988111|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
161435660|NCT03472885|582988112|FG000|24-Week Treatment Period|Adverse Event|1|||
161435661|NCT00091949|582989599|FG000|Overall Study|Withdrawal by Subject|117|||
161435662|NCT00091949|582989600|FG001|Overall Study|Withdrawal by Subject|110|||
161435663|NCT00091949|582989599|FG000|Overall Study|Lost to Follow-up|58|||
161435664|NCT00091949|582989600|FG001|Overall Study|Lost to Follow-up|41|||
161435665|NCT01256788|582989603|FG000|Overall Study|Lost to Follow-up|5|||
161435666|NCT01256788|582989604|FG001|Overall Study|Lost to Follow-up|8|||
161435667|NCT01256788|582989605|FG002|Overall Study|Lost to Follow-up|3|||
161435668|NCT01352715|582989607|FG000|Overall Study|Death|3|||
161435669|NCT01352715|582989608|FG001|Overall Study|Death|3|||
161435670|NCT01352715|582989607|FG000|Overall Study|Lost to Follow-up|5|||
161435671|NCT01352715|582989608|FG001|Overall Study|Lost to Follow-up|7|||
161435672|NCT01352715|582989607|FG000|Overall Study|Withdrawal by Subject|4|||
161435673|NCT01352715|582989608|FG001|Overall Study|Withdrawal by Subject|8|||
161435674|NCT01352715|582989607|FG000|Overall Study|site closure|16|||
161435675|NCT01352715|582989608|FG001|Overall Study|site closure|15|||
161435676|NCT01352715|582989607|FG000|Overall Study|no final visit in closeout period|15|||
161435677|NCT01352715|582989608|FG001|Overall Study|no final visit in closeout period|12|||
161435678|NCT01352715|582989607|FG000|Overall Study|major ineligibility|2|||
161435679|NCT01352715|582989608|FG001|Overall Study|major ineligibility|1|||
161435680|NCT02000440|582989610|FG000|Overall Study|Adverse Event|3|||
161435681|NCT02000440|582989610|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
161435682|NCT02383576|582989611|FG000|Overall Study|Death|53|||
161435683|NCT02383576|582989612|FG001|Overall Study|Death|33|||
161435684|NCT02383576|582989611|FG000|Overall Study|Lost to Follow-up|7|||
161435685|NCT02383576|582989612|FG001|Overall Study|Lost to Follow-up|1|||
161435686|NCT02383576|582989611|FG000|Overall Study|Withdrew Consent|1|||
161435687|NCT02383576|582989612|FG001|Overall Study|Withdrew Consent|6|||
161435688|NCT02383576|582989611|FG000|Overall Study|Investigator's Decision|0|||
161435689|NCT02383576|582989612|FG001|Overall Study|Investigator's Decision|1|||
161435690|NCT02383576|582989611|FG000|Overall Study|Administrative/Other|2|||
161435691|NCT02383576|582989612|FG001|Overall Study|Administrative/Other|4|||
161435692|NCT00871975|582989613|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
161435693|NCT00871975|582989613|FG000|Overall Study|Catheters could not be inserted|1|||
161435694|NCT00871975|582989613|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
161435695|NCT00871975|582989613|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
161435696|NCT01436149|582989617|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
161435697|NCT01436149|582989618|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
161435698|NCT01436149|582989619|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
161435699|NCT01436149|582989617|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
161435700|NCT01436149|582989618|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
161435701|NCT01436149|582989619|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
161435702|NCT01436149|582989617|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
161435703|NCT01436149|582989618|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161435704|NCT01436149|582989619|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161435705|NCT01436149|582989617|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
161435706|NCT01436149|582989618|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161435707|NCT01436149|582989619|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161435708|NCT01436149|582989617|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
161435709|NCT01436149|582989618|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
161435710|NCT01436149|582989619|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
161435711|NCT01436149|582989617|FG000|Antidepressant Lead-in Phase|Other|119|||
161435712|NCT01436149|582989618|FG001|Antidepressant Lead-in Phase|Other|0|||
161435713|NCT01436149|582989619|FG002|Antidepressant Lead-in Phase|Other|0|||
161435714|NCT01436149|582989617|FG000|Randomized Phase|Adverse Event|9|||
161435715|NCT01436149|582989618|FG001|Randomized Phase|Adverse Event|10|||
161435716|NCT01436149|582989619|FG002|Randomized Phase|Adverse Event|11|||
161435717|NCT01436149|582989617|FG000|Randomized Phase|Protocol Violation|4|||
161435718|NCT01436149|582989618|FG001|Randomized Phase|Protocol Violation|5|||
161435719|NCT01436149|582989619|FG002|Randomized Phase|Protocol Violation|0|||
161435720|NCT01436149|582989617|FG000|Randomized Phase|Withdrawal by Subject|16|||
161435721|NCT01436149|582989618|FG001|Randomized Phase|Withdrawal by Subject|10|||
161435722|NCT01436149|582989619|FG002|Randomized Phase|Withdrawal by Subject|10|||
161435723|NCT01436149|582989617|FG000|Randomized Phase|Lost to Follow-up|34|||
161435724|NCT01436149|582989618|FG001|Randomized Phase|Lost to Follow-up|5|||
161435725|NCT01436149|582989619|FG002|Randomized Phase|Lost to Follow-up|6|||
161435726|NCT01436149|582989617|FG000|Randomized Phase|Lack of Efficacy|0|||
161435727|NCT01436149|582989618|FG001|Randomized Phase|Lack of Efficacy|0|||
161435728|NCT01436149|582989619|FG002|Randomized Phase|Lack of Efficacy|1|||
161435729|NCT01436149|582989617|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
161435730|NCT01436149|582989618|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
161435731|NCT01436149|582989619|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
161435732|NCT01436149|582989617|FG000|Randomized Phase|Other|12|||
161435733|NCT01436149|582989618|FG001|Randomized Phase|Other|5|||
161435734|NCT01436149|582989619|FG002|Randomized Phase|Other|11|||
161435735|NCT01690143|582989620|FG000|Overall Study|Withdrawal by Subject|1|||
161435736|NCT04849364|582989621|FG000|Overall Study|Eligibility criteria not meet|0|||
161435737|NCT04849364|582989622|FG001|Overall Study|Eligibility criteria not meet|1|||
161435738|NCT04849364|582989623|FG002|Overall Study|Eligibility criteria not meet|0|||
161435739|NCT01643668|582989624|FG000|Overall Study|Death|1|||
161435740|NCT00307801|582989633|FG000|Overall Study|Adverse Event|12|||
161435741|NCT00307801|582989634|FG001|Overall Study|Adverse Event|4|||
161435742|NCT00307801|582989633|FG000|Overall Study|Withdrawal by Subject|9|||
161435743|NCT00307801|582989634|FG001|Overall Study|Withdrawal by Subject|4|||
161435744|NCT00307801|582989633|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
161435745|NCT00307801|582989634|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
161435746|NCT00307801|582989633|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
161435747|NCT00307801|582989634|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
161435748|NCT00307801|582989633|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
161435749|NCT00307801|582989634|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
161435750|NCT00307801|582989633|FG000|Overall Study|Wrong Randomization|1|||
161435751|NCT00307801|582989634|FG001|Overall Study|Wrong Randomization|0|||
161435752|NCT00307801|582989633|FG000|Overall Study|Lack of Efficacy|0|||
161435753|NCT00307801|582989634|FG001|Overall Study|Lack of Efficacy|2|||
161435754|NCT00307801|582989633|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
161435755|NCT00307801|582989634|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
161435756|NCT00307801|582989633|FG000|Overall Study|Frustration with e-diary|1|||
161435757|NCT00307801|582989634|FG001|Overall Study|Frustration with e-diary|0|||
161435758|NCT00307801|582989633|FG000|Overall Study|Protocol Violation|3|||
161435759|NCT00307801|582989634|FG001|Overall Study|Protocol Violation|2|||
161435760|NCT00307801|582989633|FG000|Overall Study|No reason specified|2|||
161435761|NCT00307801|582989634|FG001|Overall Study|No reason specified|0|||
161435762|NCT00307801|582989633|FG000|Overall Study|Pregnancy|0|||
161435763|NCT00307801|582989634|FG001|Overall Study|Pregnancy|1|||
161435764|NCT03944577|582989640|FG000|Overall Study|Adverse Event|3|||
161435765|NCT03011099|582989643|FG000|Overall Study|Withdrawal by Subject|0|||
161435766|NCT03011099|582989644|FG001|Overall Study|Withdrawal by Subject|2|||
161435767|NCT01217229|582989647|FG000|Overall Study|Adverse Event|1|||
161435768|NCT01217229|582989647|FG000|Overall Study|Disease progression, deterioration|2|||
161435769|NCT01217229|582989647|FG000|Overall Study|Disease progression, Cheson criteria|14|||
161435770|NCT01217229|582989647|FG000|Overall Study|Protocol Violation|1|||
161435771|NCT01217229|582989647|FG000|Overall Study|Disease progression not confirmed|2|||
161435772|NCT00577889|582989650|FG000|Overall Study|Withdrawal by Subject|1|||
161435773|NCT00577889|582989651|FG001|Overall Study|Withdrawal by Subject|0|||
161435774|NCT00577889|582989652|FG002|Overall Study|Withdrawal by Subject|0|||
161435775|NCT01523756|582989654|FG000|Baseline Period|Adverse Event|0|||
161435776|NCT01523756|582989655|FG001|Baseline Period|Adverse Event|1|||
161435777|NCT01523756|582989654|FG000|Test Period 1|Adverse Event|1|||
161435778|NCT01523756|582989655|FG001|Test Period 1|Adverse Event|0|||
161435779|NCT01523756|582989654|FG000|Test Period 2|Withdrawal by Subject|0|||
161435780|NCT01523756|582989655|FG001|Test Period 2|Withdrawal by Subject|1|||
161435781|NCT03224819|582989658|FG000|Overall Study|Withdrawal by Subject|0|||
161435782|NCT03224819|582989659|FG001|Overall Study|Withdrawal by Subject|0|||
161435783|NCT03224819|582989660|FG002|Overall Study|Withdrawal by Subject|0|||
161435784|NCT03224819|582989661|FG003|Overall Study|Withdrawal by Subject|0|||
161435785|NCT03224819|582989662|FG004|Overall Study|Withdrawal by Subject|0|||
161435786|NCT03224819|582989663|FG005|Overall Study|Withdrawal by Subject|0|||
161435787|NCT03224819|582989664|FG006|Overall Study|Withdrawal by Subject|0|||
161435788|NCT03224819|582989665|FG007|Overall Study|Withdrawal by Subject|0|||
161435789|NCT03224819|582989666|FG008|Overall Study|Withdrawal by Subject|0|||
161435790|NCT03224819|582989667|FG009|Overall Study|Withdrawal by Subject|0|||
161435791|NCT03224819|582989668|FG010|Overall Study|Withdrawal by Subject|0|||
161435792|NCT03224819|582989669|FG011|Overall Study|Withdrawal by Subject|0|||
161435793|NCT03224819|582989670|FG012|Overall Study|Withdrawal by Subject|1|||
161435794|NCT03224819|582989671|FG013|Overall Study|Withdrawal by Subject|0|||
161435795|NCT03224819|582989658|FG000|Overall Study|Sponsor Decision|0|||
161435796|NCT03224819|582989659|FG001|Overall Study|Sponsor Decision|0|||
161435797|NCT03224819|582989660|FG002|Overall Study|Sponsor Decision|0|||
161435798|NCT03224819|582989661|FG003|Overall Study|Sponsor Decision|1|||
161435799|NCT03224819|582989662|FG004|Overall Study|Sponsor Decision|1|||
161435800|NCT03224819|582989663|FG005|Overall Study|Sponsor Decision|2|||
161435801|NCT03224819|582989664|FG006|Overall Study|Sponsor Decision|1|||
161435802|NCT03224819|582989665|FG007|Overall Study|Sponsor Decision|1|||
161435803|NCT03224819|582989666|FG008|Overall Study|Sponsor Decision|1|||
161435804|NCT03224819|582989667|FG009|Overall Study|Sponsor Decision|2|||
161435805|NCT03224819|582989668|FG010|Overall Study|Sponsor Decision|1|||
161435806|NCT03224819|582989669|FG011|Overall Study|Sponsor Decision|1|||
161435807|NCT03224819|582989670|FG012|Overall Study|Sponsor Decision|1|||
161435808|NCT03224819|582989671|FG013|Overall Study|Sponsor Decision|0|||
161435809|NCT03224819|582989658|FG000|Overall Study|Lost to Follow-up|0|||
161435810|NCT03224819|582989659|FG001|Overall Study|Lost to Follow-up|0|||
161435811|NCT03224819|582989660|FG002|Overall Study|Lost to Follow-up|0|||
161435812|NCT03224819|582989661|FG003|Overall Study|Lost to Follow-up|0|||
161435813|NCT03224819|582989662|FG004|Overall Study|Lost to Follow-up|0|||
161435814|NCT03224819|582989663|FG005|Overall Study|Lost to Follow-up|0|||
161435815|NCT03224819|582989664|FG006|Overall Study|Lost to Follow-up|0|||
161435816|NCT03224819|582989665|FG007|Overall Study|Lost to Follow-up|0|||
161435817|NCT03224819|582989666|FG008|Overall Study|Lost to Follow-up|1|||
161435818|NCT03224819|582989667|FG009|Overall Study|Lost to Follow-up|0|||
161435819|NCT03224819|582989668|FG010|Overall Study|Lost to Follow-up|0|||
161435820|NCT03224819|582989669|FG011|Overall Study|Lost to Follow-up|0|||
161435821|NCT03224819|582989670|FG012|Overall Study|Lost to Follow-up|0|||
161435822|NCT03224819|582989671|FG013|Overall Study|Lost to Follow-up|0|||
161435823|NCT03224819|582989658|FG000|Overall Study|Death|0|||
161435824|NCT03224819|582989659|FG001|Overall Study|Death|1|||
161435825|NCT03224819|582989660|FG002|Overall Study|Death|0|||
161435826|NCT03224819|582989661|FG003|Overall Study|Death|0|||
161435827|NCT03224819|582989662|FG004|Overall Study|Death|0|||
161435828|NCT03224819|582989663|FG005|Overall Study|Death|0|||
161435829|NCT03224819|582989664|FG006|Overall Study|Death|0|||
161435830|NCT03224819|582989665|FG007|Overall Study|Death|1|||
161435831|NCT03224819|582989666|FG008|Overall Study|Death|0|||
161435832|NCT03224819|582989667|FG009|Overall Study|Death|0|||
161435833|NCT03224819|582989668|FG010|Overall Study|Death|0|||
161435834|NCT03224819|582989669|FG011|Overall Study|Death|1|||
161435835|NCT03224819|582989670|FG012|Overall Study|Death|0|||
161435836|NCT03224819|582989671|FG013|Overall Study|Death|0|||
161435837|NCT03783078|582989672|FG000|Overall Study|Death|31|||
161435838|NCT03783078|582989672|FG000|Overall Study|Sponsor Decision|23|||
161435839|NCT03783078|582989672|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161435840|NCT01467960|582989673|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
161435841|NCT01467960|582989674|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
161435842|NCT01467960|582989675|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
161435843|NCT01467960|582989676|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
161435844|NCT01467960|582989677|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
161435845|NCT01467960|582989678|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
161435846|NCT00474812|582989679|FG000|Overall Study|Withdrawal by Subject|5|||
161435847|NCT00474812|582989679|FG000|Overall Study|No Initiation of treatment|2|||
161435848|NCT00737672|582989688|FG000|Overall Study|Graft Abandonment|48|||
161435849|NCT00737672|582989689|FG001|Overall Study|Graft Abandonment|56|||
161435850|NCT00737672|582989688|FG000|Overall Study|Death|23|||
161435851|NCT00737672|582989689|FG001|Overall Study|Death|22|||
161435852|NCT00737672|582989688|FG000|Overall Study|Withdrawal by Subject|1|||
161435853|NCT00737672|582989689|FG001|Overall Study|Withdrawal by Subject|2|||
161435854|NCT00737672|582989688|FG000|Overall Study|Lost to Follow-up|1|||
161435855|NCT00737672|582989689|FG001|Overall Study|Lost to Follow-up|0|||
161435856|NCT00737672|582989688|FG000|Overall Study|Miscellaneous|7|||
161435857|NCT00737672|582989689|FG001|Overall Study|Miscellaneous|1|||
161435858|NCT00737672|582989688|FG000|Overall Study|Physician Decision|0|||
161435859|NCT00737672|582989689|FG001|Overall Study|Physician Decision|2|||
161435860|NCT02002598|582989696|FG000|Dose Level 1|Withdrawal by Subject|1|||
161435861|NCT02002598|582989697|FG001|Dose Level 1|Withdrawal by Subject|0|||
161435862|NCT02002598|582989698|FG002|Dose Level 1|Withdrawal by Subject|0|||
161435863|NCT02002598|582989699|FG003|Dose Level 1|Withdrawal by Subject|0|||
161435864|NCT02002598|582989700|FG004|Dose Level 1|Withdrawal by Subject|0|||
161435949|NCT04050553|582989736|FG001|Wash-out|Withdrawal by Subject|1|||
161435865|NCT02018562|582989704|FG000|Overall Study|Withdrawal by Subject|2|||
161435866|NCT02018562|582989705|FG001|Overall Study|Withdrawal by Subject|0|||
161435867|NCT02018562|582989704|FG000|Overall Study|Discharged prior to study completion|1|||
161435868|NCT02018562|582989705|FG001|Overall Study|Discharged prior to study completion|0|||
161435869|NCT03435211|582989706|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
161435870|NCT01253291|582989708|FG000|Overall Study|Withdrawal by Subject|1|||
161435871|NCT01253291|582989709|FG001|Overall Study|Withdrawal by Subject|1|||
161435872|NCT01253291|582989710|FG002|Overall Study|Withdrawal by Subject|0|||
161435873|NCT01253291|582989711|FG003|Overall Study|Withdrawal by Subject|0|||
161435874|NCT01253291|582989712|FG004|Overall Study|Withdrawal by Subject|0|||
161435875|NCT01253291|582989708|FG000|Overall Study|Adverse Event|0|||
161435876|NCT01253291|582989709|FG001|Overall Study|Adverse Event|1|||
161435877|NCT01253291|582989710|FG002|Overall Study|Adverse Event|0|||
161435878|NCT01253291|582989711|FG003|Overall Study|Adverse Event|0|||
161435879|NCT01253291|582989712|FG004|Overall Study|Adverse Event|0|||
161435880|NCT01253291|582989708|FG000|Overall Study|Lack of Efficacy|1|||
161435881|NCT01253291|582989709|FG001|Overall Study|Lack of Efficacy|0|||
161435882|NCT01253291|582989710|FG002|Overall Study|Lack of Efficacy|0|||
161435883|NCT01253291|582989711|FG003|Overall Study|Lack of Efficacy|0|||
161435884|NCT01253291|582989712|FG004|Overall Study|Lack of Efficacy|0|||
161435885|NCT01253291|582989708|FG000|Overall Study|Physician Decision|2|||
161435886|NCT01253291|582989709|FG001|Overall Study|Physician Decision|0|||
161435887|NCT01253291|582989710|FG002|Overall Study|Physician Decision|0|||
161435888|NCT01253291|582989711|FG003|Overall Study|Physician Decision|0|||
161435889|NCT01253291|582989712|FG004|Overall Study|Physician Decision|2|||
161435890|NCT01838395|582989716|FG000|Overall Study|Withdrawal by Subject|0|||
161435891|NCT01838395|582989717|FG001|Overall Study|Withdrawal by Subject|0|||
161435892|NCT01838395|582989718|FG002|Overall Study|Withdrawal by Subject|0|||
161435893|NCT01838395|582989719|FG003|Overall Study|Withdrawal by Subject|0|||
161435894|NCT01838395|582989720|FG004|Overall Study|Withdrawal by Subject|1|||
161435895|NCT01838395|582989721|FG005|Overall Study|Withdrawal by Subject|0|||
161435896|NCT01838395|582989716|FG000|Overall Study|Death|0|||
161435897|NCT01838395|582989717|FG001|Overall Study|Death|0|||
161435898|NCT01838395|582989718|FG002|Overall Study|Death|1|||
161435899|NCT01838395|582989719|FG003|Overall Study|Death|0|||
161435900|NCT01838395|582989720|FG004|Overall Study|Death|0|||
161435901|NCT01838395|582989721|FG005|Overall Study|Death|0|||
161435902|NCT01838395|582989716|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
161435903|NCT01838395|582989717|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
161435904|NCT01838395|582989718|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
161435905|NCT01838395|582989719|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
161435906|NCT01838395|582989720|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
161435907|NCT01838395|582989721|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
161435908|NCT02195518|582989722|FG000|Overall Study|Adverse Event|1|||
161435909|NCT02195518|582989722|FG000|Overall Study|Protocol Violation|4|||
161435910|NCT02195518|582989722|FG000|Overall Study|Pregnancy|2|||
161435911|NCT02195518|582989722|FG000|Overall Study|Withdrawal by Subject|1|||
161435912|NCT02195518|582989722|FG000|Overall Study|Lost to Follow-up|1|||
161435913|NCT00651742|582989726|FG000|Overall Study|Objective Disease Progression|22|||
161435914|NCT00651742|582989726|FG000|Overall Study|Toxicity|3|||
161435915|NCT00651742|582989726|FG000|Overall Study|Investigator Judgment|1|||
161435916|NCT00651742|582989726|FG000|Overall Study|Withdrawal of Consent|1|||
161435917|NCT00651742|582989726|FG000|Overall Study|Enrolled but not treated|1|||
161435918|NCT05720897|582989729|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
161435919|NCT05720897|582989730|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
161435920|NCT00400179|582989731|FG000|Overall Study|Adverse Event|2|||
161435921|NCT00400179|582989732|FG001|Overall Study|Adverse Event|2|||
161435922|NCT00400179|582989731|FG000|Overall Study|Death|1|||
161435923|NCT00400179|582989732|FG001|Overall Study|Death|2|||
161435924|NCT00400179|582989731|FG000|Overall Study|Withdrew Consent|1|||
161435925|NCT00400179|582989732|FG001|Overall Study|Withdrew Consent|5|||
161435926|NCT00400179|582989731|FG000|Overall Study|Disease progression|1|||
161435927|NCT00400179|582989732|FG001|Overall Study|Disease progression|1|||
161435928|NCT00400179|582989731|FG000|Overall Study|Intercurrent illness|0|||
161435929|NCT00400179|582989732|FG001|Overall Study|Intercurrent illness|1|||
161435930|NCT00400179|582989731|FG000|Overall Study|Investigator judgment|0|||
161435931|NCT00400179|582989732|FG001|Overall Study|Investigator judgment|1|||
161435932|NCT00400179|582989731|FG000|Overall Study|Randomization error/patient ineligible|1|||
161435933|NCT00400179|582989732|FG001|Overall Study|Randomization error/patient ineligible|6|||
161435934|NCT04780061|582989733|FG000|Overall Study|Withdrawal by Subject|5|||
161435935|NCT04780061|582989734|FG001|Overall Study|Withdrawal by Subject|8|||
161435936|NCT04780061|582989733|FG000|Overall Study|Adverse Event|2|||
161435937|NCT04780061|582989734|FG001|Overall Study|Adverse Event|2|||
161435938|NCT04780061|582989733|FG000|Overall Study|Lost to Follow-up|1|||
161435952|NCT01535040|582989737|FG000|Overall Study|Withdrawal by Subject|13|||
161435953|NCT01535040|582989738|FG001|Overall Study|Withdrawal by Subject|10|||
161435954|NCT01535040|582989737|FG000|Overall Study|Never Started|9|||
161435955|NCT01535040|582989738|FG001|Overall Study|Never Started|4|||
161435956|NCT01535040|582989737|FG000|Overall Study|Toxicity|7|||
161435957|NCT01535040|582989738|FG001|Overall Study|Toxicity|5|||
161435958|NCT01535040|582989737|FG000|Overall Study|Multiple Reasons|1|||
161435959|NCT01535040|582989738|FG001|Overall Study|Multiple Reasons|1|||
161435960|NCT01074970|582989742|FG000|Overall Study|Never Treated|0|||
161435961|NCT01074970|582989743|FG001|Overall Study|Never Treated|0|||
161435962|NCT01074970|582989744|FG002|Overall Study|Never Treated|8|||
161435963|NCT01074970|582989745|FG003|Overall Study|Never Treated|1|||
161435964|NCT01074970|582989742|FG000|Overall Study|Adverse Event|1|||
161435965|NCT01074970|582989743|FG001|Overall Study|Adverse Event|0|||
161435966|NCT01074970|582989744|FG002|Overall Study|Adverse Event|4|||
161435967|NCT01074970|582989745|FG003|Overall Study|Adverse Event|3|||
161435968|NCT01074970|582989742|FG000|Overall Study|Disease progression during treatment|3|||
161435969|NCT01074970|582989743|FG001|Overall Study|Disease progression during treatment|1|||
161435970|NCT01074970|582989744|FG002|Overall Study|Disease progression during treatment|2|||
161435971|NCT01074970|582989745|FG003|Overall Study|Disease progression during treatment|9|||
161435972|NCT01074970|582989742|FG000|Overall Study|Lost to Follow-up|0|||
161435973|NCT01074970|582989743|FG001|Overall Study|Lost to Follow-up|0|||
161435974|NCT01074970|582989744|FG002|Overall Study|Lost to Follow-up|1|||
161435975|NCT01074970|582989745|FG003|Overall Study|Lost to Follow-up|0|||
161435976|NCT01074970|582989742|FG000|Overall Study|Withdrawal by Subject|0|||
161435977|NCT01074970|582989743|FG001|Overall Study|Withdrawal by Subject|0|||
161435978|NCT01074970|582989744|FG002|Overall Study|Withdrawal by Subject|6|||
161435979|NCT01074970|582989745|FG003|Overall Study|Withdrawal by Subject|4|||
161435980|NCT00734149|582989746|FG000|Overall Study|Withdrawal by Subject|1|||
161435981|NCT04314284|582989747|FG000|Overall Study|Withdrawal by Subject|4|||
161435982|NCT04314284|582989748|FG001|Overall Study|Withdrawal by Subject|7|||
161435983|NCT04314284|582989747|FG000|Overall Study|Consented but did not complete survey|0|||
161435984|NCT04314284|582989748|FG001|Overall Study|Consented but did not complete survey|6|||
161435985|NCT01652235|582989751|FG000|Overall Study|Death|9|||
161435986|NCT01652235|582989751|FG000|Overall Study|Lost to Follow-up|5|||
161435987|NCT01652235|582989751|FG000|Overall Study|Withdrawal by Subject|2|||
161435988|NCT02023086|582989754|FG000|Overall Study|Withdrawal by Subject|2|||
161435989|NCT02023086|582989755|FG001|Overall Study|Withdrawal by Subject|0|||
161435990|NCT03589859|582989756|FG000|Overall Study|Withdrawal by Subject|0|||
161435991|NCT03589859|582989757|FG001|Overall Study|Withdrawal by Subject|6|||
161435992|NCT03043794|582989760|FG000|Overall Study|Lost to Follow-up|1|||
161435993|NCT00626106|582989762|FG000|Overall Study|Withdrawal by Subject|2|||
161435994|NCT00626106|582989763|FG001|Overall Study|Withdrawal by Subject|1|||
161435995|NCT00626106|582989762|FG000|Overall Study|Lost to Follow-up|1|||
161435996|NCT00626106|582989763|FG001|Overall Study|Lost to Follow-up|4|||
161435997|NCT00626106|582989762|FG000|Overall Study|Death|64|||
161435998|NCT00626106|582989763|FG001|Overall Study|Death|19|||
161435999|NCT05417438|582989764|FG000|Overall Study|Withdrawal by Subject|3|||
161436000|NCT02201953|582989769|FG000|Overall Study|Randomized but Never Treated|1|||
161436001|NCT02201953|582989770|FG001|Overall Study|Randomized but Never Treated|5|||
161436002|NCT02201953|582989769|FG000|Overall Study|Lack of Efficacy|9|||
161436003|NCT02201953|582989770|FG001|Overall Study|Lack of Efficacy|30|||
161436004|NCT02201953|582989769|FG000|Overall Study|Lost to Follow-up|8|||
161436005|NCT02201953|582989770|FG001|Overall Study|Lost to Follow-up|8|||
161436006|NCT02201953|582989769|FG000|Overall Study|Withdrew Consent|2|||
161436007|NCT02201953|582989770|FG001|Overall Study|Withdrew Consent|5|||
161436008|NCT02201953|582989769|FG000|Overall Study|Adverse Event|0|||
161436009|NCT02201953|582989770|FG001|Overall Study|Adverse Event|5|||
161436010|NCT02201953|582989769|FG000|Overall Study|Death|0|||
161436011|NCT02201953|582989770|FG001|Overall Study|Death|3|||
